id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
105331332|NCT01623310|363214547|FG000|Overall Study|Adverse Event|21|||
105331333|NCT01623310|363214547|FG000|Overall Study|Lost to Follow-up|18|||
105331334|NCT01623310|363214547|FG000|Overall Study|Lack of Efficacy|6|||
105331335|NCT01623310|363214547|FG000|Overall Study|Protocol Violation|6|||
105331336|NCT01623310|363214547|FG000|Overall Study|Withdrawal by Subject|25|||
105331337|NCT01623310|363214547|FG000|Overall Study|Became potentially child-bearing|1|||
105331338|NCT01623310|363214547|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
105440432|NCT03210961|363619129|FG000|Overall Study|Adverse Event|0|||
105440433|NCT03210961|363619130|FG001|Overall Study|Adverse Event|0|||
105331339|NCT01623310|363214547|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
105331340|NCT00684411|363214548|FG000|Overall Study|New Primary Cancer|1|||
105331341|NCT00684411|363214548|FG000|Overall Study|Disease Progression|10|||
105331342|NCT00684411|363214548|FG000|Overall Study|Adverse Event|1|||
105331343|NCT04134767|363214551|FG000|Overall Study|Death|0|||
105331344|NCT04134767|363214552|FG001|Overall Study|Death|1|||
105331345|NCT04134767|363214551|FG000|Overall Study|Removed for harassing staff|0|||
105331346|NCT04134767|363214552|FG001|Overall Study|Removed for harassing staff|1|||
105331347|NCT04134767|363214551|FG000|Overall Study|Lost to Follow-up|44|||
105331348|NCT04134767|363214552|FG001|Overall Study|Lost to Follow-up|40|||
105331349|NCT02582242|363214553|FG000|Overall Study|Adverse Event|4|||
105331350|NCT02582242|363214554|FG001|Overall Study|Adverse Event|3|||
105331351|NCT02582242|363214553|FG000|Overall Study|Protocol Violation|3|||
105331352|NCT02582242|363214554|FG001|Overall Study|Protocol Violation|1|||
105331353|NCT02582242|363214553|FG000|Overall Study|Lost to Follow-up|0|||
105331354|NCT02582242|363214554|FG001|Overall Study|Lost to Follow-up|1|||
105331355|NCT02582242|363214553|FG000|Overall Study|Withdrawal by Subject|11|||
105331356|NCT02582242|363214554|FG001|Overall Study|Withdrawal by Subject|11|||
105331357|NCT02582242|363214553|FG000|Overall Study|Unclassified|2|||
105331358|NCT02582242|363214554|FG001|Overall Study|Unclassified|1|||
105331359|NCT01780038|363214555|FG000|Overall Study|Lost to Follow-up|4|||
105331360|NCT01780038|363214556|FG001|Overall Study|Lost to Follow-up|1|||
105331361|NCT00687271|363214562|FG000|Overall Study|Adverse Event|1|||
105331362|NCT00687271|363214563|FG001|Overall Study|Adverse Event|3|||
105331363|NCT00687271|363214564|FG002|Overall Study|Adverse Event|1|||
105331364|NCT00687271|363214565|FG003|Overall Study|Adverse Event|0|||
105331365|NCT00687271|363214562|FG000|Overall Study|Lost to Follow-up|0|||
105331366|NCT00687271|363214563|FG001|Overall Study|Lost to Follow-up|1|||
105331367|NCT00687271|363214564|FG002|Overall Study|Lost to Follow-up|0|||
105331368|NCT00687271|363214565|FG003|Overall Study|Lost to Follow-up|0|||
105331369|NCT00687271|363214562|FG000|Overall Study|Protocol Violation|2|||
105331370|NCT00687271|363214563|FG001|Overall Study|Protocol Violation|1|||
105769226|NCT03267511|364807345|FG000|Overall Study|Lost to Follow-up|0|||
105331371|NCT00687271|363214564|FG002|Overall Study|Protocol Violation|1|||
105331372|NCT00687271|363214565|FG003|Overall Study|Protocol Violation|0|||
105331373|NCT00687271|363214562|FG000|Overall Study|Withdrawal by Subject|0|||
105331374|NCT00687271|363214563|FG001|Overall Study|Withdrawal by Subject|1|||
105331375|NCT00687271|363214564|FG002|Overall Study|Withdrawal by Subject|3|||
105331376|NCT00687271|363214565|FG003|Overall Study|Withdrawal by Subject|0|||
105331377|NCT02727478|363214575|FG000|Overall Study|Withdrawal by Subject|8|||
105331378|NCT02727478|363214576|FG001|Overall Study|Withdrawal by Subject|10|||
105331379|NCT02633293|363214577|FG000|Overall Study|Death|56|||
105331380|NCT02633293|363214577|FG000|Overall Study|Progressive Disease|12|||
105331381|NCT02633293|363214577|FG000|Overall Study|Adverse Event|29|||
105769227|NCT03267511|364807346|FG001|Overall Study|Lost to Follow-up|0|||
105769228|NCT03267511|364807347|FG002|Overall Study|Lost to Follow-up|0|||
105769229|NCT03267511|364807348|FG003|Overall Study|Lost to Follow-up|1|||
105331382|NCT02633293|363214577|FG000|Overall Study|Withdrawal by Subject|41|||
105331383|NCT02633293|363214577|FG000|Overall Study|Protocol Violation|1|||
105331384|NCT02633293|363214577|FG000|Overall Study|Lost to Follow-up|1|||
105331385|NCT02633293|363214577|FG000|Overall Study|Study Terminated by Sponsor|24|||
105331386|NCT02633293|363214577|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
105331387|NCT02633293|363214577|FG000|Overall Study|Lung Transplant|5|||
105331388|NCT02633293|363214577|FG000|Overall Study|Lack of Efficacy|2|||
105331389|NCT02633293|363214577|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
105331390|NCT02356588|363214578|FG000|Overall Study|Lack of Efficacy|4|||
105440434|NCT03210961|363619131|FG002|Overall Study|Adverse Event|0|||
105440435|NCT03210961|363619132|FG003|Overall Study|Adverse Event|0|||
105440436|NCT03210961|363619133|FG004|Overall Study|Adverse Event|0|||
105769230|NCT00439309|364807349|FG000|Follow-Up|Death|1|||
105331391|NCT02356588|363214579|FG001|Overall Study|Lack of Efficacy|10|||
105440437|NCT03210961|363619134|FG005|Overall Study|Adverse Event|0|||
105440438|NCT03210961|363619135|FG006|Overall Study|Adverse Event|0|||
105440439|NCT03210961|363619136|FG007|Overall Study|Adverse Event|0|||
105769231|NCT00439309|364807350|FG001|Follow-Up|Death|0|||
105331392|NCT02356588|363214578|FG000|Overall Study|Adverse Event|0|||
105331393|NCT02356588|363214579|FG001|Overall Study|Adverse Event|2|||
105331394|NCT02356588|363214578|FG000|Overall Study|Withdrawal by Subject|1|||
105331395|NCT02356588|363214579|FG001|Overall Study|Withdrawal by Subject|0|||
105440440|NCT03210961|363619137|FG008|Overall Study|Adverse Event|0|||
105440441|NCT03210961|363619138|FG009|Overall Study|Adverse Event|0|||
105440442|NCT03210961|363619139|FG010|Overall Study|Adverse Event|0|||
105331396|NCT02356588|363214578|FG000|Overall Study|Protocol Violation|0|||
105331397|NCT02356588|363214579|FG001|Overall Study|Protocol Violation|1|||
105331398|NCT01418378|363214580|FG000|Overall Study|Death|1|||
105331399|NCT01418378|363214581|FG001|Overall Study|Death|2|||
105331400|NCT01418378|363214580|FG000|Overall Study|Physician Decision|0|||
105331401|NCT01418378|363214581|FG001|Overall Study|Physician Decision|1|||
105331402|NCT01418378|363214580|FG000|Overall Study|ligament imbalance|0|||
105331403|NCT01418378|363214581|FG001|Overall Study|ligament imbalance|1|||
105331404|NCT01418378|363214580|FG000|Overall Study|developed chronic myopathy|0|||
105331405|NCT01418378|363214581|FG001|Overall Study|developed chronic myopathy|1|||
105331406|NCT00839800|363214582|FG000|Overall Study|Adverse Event|8|||
105769232|NCT00439309|364807349|FG000|Follow-Up|Lost to Follow-up|2|||
105331407|NCT00839800|363214583|FG001|Overall Study|Adverse Event|12|||
105331408|NCT00839800|363214582|FG000|Overall Study|Lost to Follow-up|31|||
105331409|NCT00839800|363214583|FG001|Overall Study|Lost to Follow-up|26|||
105331410|NCT00839800|363214582|FG000|Overall Study|Withdrawal by Subject|28|||
105331411|NCT00839800|363214583|FG001|Overall Study|Withdrawal by Subject|34|||
105331412|NCT00839800|363214582|FG000|Overall Study|Incorrect Enrolment|3|||
105331413|NCT00839800|363214583|FG001|Overall Study|Incorrect Enrolment|3|||
105331414|NCT00839800|363214582|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
105331415|NCT00839800|363214583|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
105331416|NCT00839800|363214582|FG000|Overall Study|Safety Reasons|2|||
105331417|NCT00839800|363214583|FG001|Overall Study|Safety Reasons|1|||
105331418|NCT00839800|363214582|FG000|Overall Study|Other|8|||
105331419|NCT00839800|363214583|FG001|Overall Study|Other|14|||
105769233|NCT00439309|364807350|FG001|Follow-Up|Lost to Follow-up|0|||
105769234|NCT00439309|364807349|FG000|Follow-Up|Withdrawal by Subject|0|||
105769235|NCT00439309|364807350|FG001|Follow-Up|Withdrawal by Subject|1|||
105769236|NCT00439309|364807349|FG000|Follow-Up|Late response by subject|0|||
105769237|NCT00439309|364807350|FG001|Follow-Up|Late response by subject|1|||
105331420|NCT00839800|363214582|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
105769238|NCT01977040|364807353|FG000|Overall Study|Vasa previa not confirmed|2|||
105769239|NCT02667236|364807354|FG000|Overall Study|Adverse Event|1|||
105769240|NCT02667236|364807355|FG001|Overall Study|Adverse Event|1|||
105769241|NCT02667236|364807354|FG000|Overall Study|Withdrawal by Subject|2|||
105769242|NCT02667236|364807355|FG001|Overall Study|Withdrawal by Subject|0|||
105769243|NCT00444951|364807356|FG000|Overall Study|Lost to Follow-up|1|||
105769244|NCT00444951|364807357|FG001|Overall Study|Lost to Follow-up|1|||
105769245|NCT00444951|364807358|FG002|Overall Study|Lost to Follow-up|0|||
105769246|NCT00444951|364807356|FG000|Overall Study|Withdrawal by Subject|4|||
105769247|NCT00444951|364807357|FG001|Overall Study|Withdrawal by Subject|5|||
105769248|NCT00444951|364807358|FG002|Overall Study|Withdrawal by Subject|3|||
105769249|NCT01998906|364807359|FG000|Overall Study|Participants ongoing in follow-up|77|||
105769250|NCT01998906|364807360|FG001|Overall Study|Participants ongoing in follow-up|60|||
105769251|NCT01998906|364807361|FG002|Overall Study|Participants ongoing in follow-up|58|||
105769252|NCT01998906|364807359|FG000|Overall Study|Death|21|||
105769253|NCT01998906|364807360|FG001|Overall Study|Death|30|||
105769254|NCT01998906|364807361|FG002|Overall Study|Death|17|||
105769255|NCT01998906|364807359|FG000|Overall Study|Lack of Efficacy|10|||
105769256|NCT01998906|364807360|FG001|Overall Study|Lack of Efficacy|9|||
105769257|NCT01998906|364807361|FG002|Overall Study|Lack of Efficacy|8|||
105769258|NCT01998906|364807359|FG000|Overall Study|Failure to return|0|||
105769259|NCT01998906|364807360|FG001|Overall Study|Failure to return|2|||
105769260|NCT01998906|364807361|FG002|Overall Study|Failure to return|4|||
105769261|NCT01998906|364807359|FG000|Overall Study|Violation of Selection Criteria|0|||
105769262|NCT01998906|364807360|FG001|Overall Study|Violation of Selection Criteria|0|||
105769263|NCT01998906|364807361|FG002|Overall Study|Violation of Selection Criteria|1|||
105769264|NCT01998906|364807359|FG000|Overall Study|Withdrawal by Subject|1|||
105769265|NCT01998906|364807360|FG001|Overall Study|Withdrawal by Subject|4|||
105769266|NCT01998906|364807361|FG002|Overall Study|Withdrawal by Subject|3|||
105769267|NCT01998906|364807359|FG000|Overall Study|Administrative/Other|2|||
105769268|NCT01998906|364807360|FG001|Overall Study|Administrative/Other|1|||
105331421|NCT00839800|363214583|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
105331422|NCT01051791|363214584|FG000|Overall Study|Failed screening|3|||
105769269|NCT01998906|364807361|FG002|Overall Study|Administrative/Other|3|||
105769270|NCT01998906|364807359|FG000|Overall Study|Other|3|||
105769271|NCT01998906|364807360|FG001|Overall Study|Other|8|||
105769272|NCT01998906|364807361|FG002|Overall Study|Other|4|||
105769273|NCT02996110|364807365|FG000|Pre-Treatment|Other Reasons|0|||
105331423|NCT01051791|363214584|FG000|Overall Study|Withdrawal by Subject|1|||
105331424|NCT00288626|363214585|FG000|Overall Study|Death|3|||
105331425|NCT00288626|363214585|FG000|Overall Study|Withdrawal by Subject|4|||
105331426|NCT01346059|363214586|FG000|Overall Study|Withdrawal by Subject|1|||
105440443|NCT03210961|363619140|FG011|Overall Study|Adverse Event|0|||
105331427|NCT01346059|363214587|FG001|Overall Study|Withdrawal by Subject|0|||
105769274|NCT02996110|364807366|FG001|Pre-Treatment|Other Reasons|1|||
105769275|NCT02996110|364807367|FG002|Pre-Treatment|Other Reasons|0|||
105331428|NCT00105079|363214590|FG000|Overall Study|Adverse Event|5|||
105331429|NCT00105079|363214591|FG001|Overall Study|Adverse Event|12|||
105331430|NCT00105079|363214590|FG000|Overall Study|Death|3|||
105331431|NCT00105079|363214591|FG001|Overall Study|Death|1|||
105331432|NCT00105079|363214590|FG000|Overall Study|Lost to Follow-up|12|||
105331433|NCT00105079|363214591|FG001|Overall Study|Lost to Follow-up|12|||
105331434|NCT00105079|363214590|FG000|Overall Study|Lack of Efficacy|9|||
105331435|NCT00105079|363214591|FG001|Overall Study|Lack of Efficacy|3|||
105769276|NCT02996110|364807368|FG003|Pre-Treatment|Other Reasons|0|||
105769277|NCT02996110|364807369|FG004|Pre-Treatment|Other Reasons|1|||
105769278|NCT02996110|364807365|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
105769279|NCT02996110|364807366|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
105769280|NCT02996110|364807367|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
105769281|NCT02996110|364807368|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
105769282|NCT02996110|364807369|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
105769283|NCT02996110|364807365|FG000|Track 1|Disease Progression|15|||
105769284|NCT02996110|364807366|FG001|Track 1|Disease Progression|17|||
105769285|NCT02996110|364807367|FG002|Track 1|Disease Progression|0|||
105769286|NCT02996110|364807368|FG003|Track 1|Disease Progression|0|||
105769287|NCT02996110|364807369|FG004|Track 1|Disease Progression|0|||
105769288|NCT02996110|364807365|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
105769289|NCT02996110|364807366|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
105769290|NCT02996110|364807367|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
105769291|NCT02996110|364807368|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
105769292|NCT02996110|364807369|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
105769293|NCT02996110|364807365|FG000|Track 1|Study Drug Toxicity|5|||
105769294|NCT02996110|364807366|FG001|Track 1|Study Drug Toxicity|3|||
105331436|NCT00105079|363214590|FG000|Overall Study|Refused treatment|6|||
105331437|NCT00105079|363214591|FG001|Overall Study|Refused treatment|4|||
105769295|NCT02996110|364807367|FG002|Track 1|Study Drug Toxicity|0|||
105769296|NCT02996110|364807368|FG003|Track 1|Study Drug Toxicity|0|||
105331438|NCT00105079|363214590|FG000|Overall Study|Violation of selection criteria at entry|0|||
105331439|NCT00105079|363214591|FG001|Overall Study|Violation of selection criteria at entry|2|||
105331440|NCT00105079|363214590|FG000|Overall Study|Protocol Violation|1|||
105331441|NCT00105079|363214591|FG001|Overall Study|Protocol Violation|0|||
105331442|NCT00105079|363214590|FG000|Overall Study|Other|3|||
105331443|NCT00105079|363214591|FG001|Overall Study|Other|1|||
105331444|NCT01464424|363214594|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
105331445|NCT01464424|363214595|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
105331446|NCT01464333|363214596|FG000|Overall Study|Adverse Event|34|||
105331447|NCT01464333|363214596|FG000|Overall Study|Lack of Efficacy|72|||
105331448|NCT01464333|363214596|FG000|Overall Study|Withdrawal by Subject|11|||
105331449|NCT01464333|363214596|FG000|Overall Study|Other|4|||
105331450|NCT01464333|363214596|FG000|Overall Study|No Hospital Visit|42|||
105331451|NCT00789373|363214597|FG000|Induction|Adverse Event|64|||
105331452|NCT00789373|363214598|FG001|Induction|Adverse Event|0|||
105331453|NCT00789373|363214599|FG002|Induction|Adverse Event|0|||
105331454|NCT00789373|363214597|FG000|Induction|Death Due to study disease|24|||
105331455|NCT00789373|363214598|FG001|Induction|Death Due to study disease|0|||
105331456|NCT00789373|363214599|FG002|Induction|Death Due to study disease|0|||
105331457|NCT00789373|363214597|FG000|Induction|Death due to adverse event|19|||
105331458|NCT00789373|363214598|FG001|Induction|Death due to adverse event|0|||
105331459|NCT00789373|363214599|FG002|Induction|Death due to adverse event|0|||
105769297|NCT02996110|364807369|FG004|Track 1|Study Drug Toxicity|0|||
105769298|NCT02996110|364807365|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
105769299|NCT02996110|364807366|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
105331460|NCT00789373|363214597|FG000|Induction|Death due to toxicity|11|||
105331461|NCT00789373|363214598|FG001|Induction|Death due to toxicity|0|||
105769300|NCT02996110|364807367|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
105769301|NCT02996110|364807368|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
105769302|NCT02996110|364807369|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
105769303|NCT02996110|364807365|FG000|Track 1|Administrative Reason by Sponsor|0|||
105769304|NCT02996110|364807366|FG001|Track 1|Administrative Reason by Sponsor|1|||
105769305|NCT02996110|364807367|FG002|Track 1|Administrative Reason by Sponsor|0|||
105331462|NCT00789373|363214599|FG002|Induction|Death due to toxicity|0|||
105331463|NCT00789373|363214597|FG000|Induction|Death due to procedure|1|||
105769306|NCT02996110|364807368|FG003|Track 1|Administrative Reason by Sponsor|0|||
105769307|NCT02996110|364807369|FG004|Track 1|Administrative Reason by Sponsor|0|||
105769308|NCT02996110|364807365|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
105769309|NCT02996110|364807366|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
105769310|NCT02996110|364807367|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
105769311|NCT02996110|364807368|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
105331464|NCT00789373|363214598|FG001|Induction|Death due to procedure|0|||
105331465|NCT00789373|363214599|FG002|Induction|Death due to procedure|0|||
105331466|NCT00789373|363214597|FG000|Induction|Investigator decision|7|||
105331467|NCT00789373|363214598|FG001|Induction|Investigator decision|0|||
105331468|NCT00789373|363214599|FG002|Induction|Investigator decision|0|||
105331469|NCT00789373|363214597|FG000|Induction|Protocol entry criteria not met|9|||
105331470|NCT00789373|363214598|FG001|Induction|Protocol entry criteria not met|0|||
105769312|NCT02996110|364807369|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
105769313|NCT02996110|364807365|FG000|Track 2|Disease Progression|33|||
105769314|NCT02996110|364807366|FG001|Track 2|Disease Progression|26|||
105769315|NCT02996110|364807367|FG002|Track 2|Disease Progression|19|||
105769316|NCT02996110|364807368|FG003|Track 2|Disease Progression|16|||
105769317|NCT02996110|364807369|FG004|Track 2|Disease Progression|15|||
105331471|NCT00789373|363214599|FG002|Induction|Protocol entry criteria not met|0|||
105331472|NCT00789373|363214597|FG000|Induction|Lost to Follow-up|6|||
105331473|NCT00789373|363214598|FG001|Induction|Lost to Follow-up|0|||
105331474|NCT00789373|363214599|FG002|Induction|Lost to Follow-up|0|||
105331475|NCT00789373|363214597|FG000|Induction|Protocol Violation|1|||
105331476|NCT00789373|363214598|FG001|Induction|Protocol Violation|0|||
105331477|NCT00789373|363214599|FG002|Induction|Protocol Violation|0|||
105331478|NCT00789373|363214597|FG000|Induction|Progressive Disease|220|||
105331479|NCT00789373|363214598|FG001|Induction|Progressive Disease|0|||
105331480|NCT00789373|363214599|FG002|Induction|Progressive Disease|0|||
105769318|NCT02996110|364807365|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
105769319|NCT02996110|364807366|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
105769320|NCT02996110|364807367|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
105769321|NCT02996110|364807368|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
105769322|NCT02996110|364807369|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
105769323|NCT02996110|364807365|FG000|Track 2|Death|0|||
105769324|NCT02996110|364807366|FG001|Track 2|Death|0|||
105769325|NCT02996110|364807367|FG002|Track 2|Death|1|||
105769326|NCT02996110|364807368|FG003|Track 2|Death|0|||
105769327|NCT02996110|364807369|FG004|Track 2|Death|1|||
105769328|NCT02996110|364807365|FG000|Track 2|Study Drug Toxicity|4|||
105769329|NCT02996110|364807366|FG001|Track 2|Study Drug Toxicity|1|||
105769330|NCT02996110|364807367|FG002|Track 2|Study Drug Toxicity|4|||
105769331|NCT02996110|364807368|FG003|Track 2|Study Drug Toxicity|1|||
105769332|NCT02996110|364807369|FG004|Track 2|Study Drug Toxicity|0|||
105769333|NCT02996110|364807365|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
105769334|NCT02996110|364807366|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
105769335|NCT02996110|364807367|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
105769336|NCT02996110|364807368|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
105769337|NCT02996110|364807369|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
105769338|NCT02996110|364807365|FG000|Track 2|Participant Withdrew Consent|1|||
105769339|NCT02996110|364807366|FG001|Track 2|Participant Withdrew Consent|2|||
105769340|NCT02996110|364807367|FG002|Track 2|Participant Withdrew Consent|3|||
105769341|NCT02996110|364807368|FG003|Track 2|Participant Withdrew Consent|1|||
105769342|NCT02996110|364807369|FG004|Track 2|Participant Withdrew Consent|1|||
105769343|NCT02996110|364807365|FG000|Track 2|Other Reasons|0|||
105769344|NCT02996110|364807366|FG001|Track 2|Other Reasons|0|||
105769345|NCT02996110|364807367|FG002|Track 2|Other Reasons|1|||
105769346|NCT02996110|364807368|FG003|Track 2|Other Reasons|0|||
105769347|NCT02996110|364807369|FG004|Track 2|Other Reasons|1|||
105769348|NCT01518309|364807370|FG000|Overall Study|Adverse Event|6|||
105769349|NCT01518309|364807370|FG000|Overall Study|Death|6|||
105331481|NCT00789373|363214597|FG000|Induction|Withdrawal by Subject|37|||
105331482|NCT00789373|363214598|FG001|Induction|Withdrawal by Subject|0|||
105331483|NCT00789373|363214599|FG002|Induction|Withdrawal by Subject|0|||
105331484|NCT00789373|363214597|FG000|Maintenance|Adverse Event|0|||
105331485|NCT00789373|363214598|FG001|Maintenance|Adverse Event|65|||
105331486|NCT00789373|363214599|FG002|Maintenance|Adverse Event|12|||
105331487|NCT00789373|363214597|FG000|Maintenance|Death due to study disease|0|||
105331488|NCT00789373|363214598|FG001|Maintenance|Death due to study disease|3|||
105769350|NCT01518309|364807370|FG000|Overall Study|Lack of Efficacy|7|||
105769351|NCT01518309|364807370|FG000|Overall Study|Withdrawal by Subject|6|||
105769352|NCT01518309|364807370|FG000|Overall Study|Physician Decision|3|||
105769353|NCT01518309|364807370|FG000|Overall Study|Sponsor Decision|2|||
105769354|NCT01518309|364807370|FG000|Overall Study|Not in Predefined Categories|9|||
105331489|NCT00789373|363214599|FG002|Maintenance|Death due to study disease|1|||
105659642|NCT00816556|364418794|FG000|Overall Study|Adverse Event|1|||
105659643|NCT00816556|364418795|FG001|Overall Study|Adverse Event|1|||
105769355|NCT00863317|364807371|FG000|Overall Study|Lost to Follow-up|8|||
105659644|NCT00816556|364418796|FG002|Overall Study|Adverse Event|1|||
105769356|NCT00863317|364807372|FG001|Overall Study|Lost to Follow-up|9|||
105769357|NCT02579863|364807373|FG000|Overall Study|Final Disposition Unknown|2|||
105769358|NCT02579863|364807374|FG001|Overall Study|Final Disposition Unknown|1|||
105769359|NCT02579863|364807373|FG000|Overall Study|Adverse Event|18|||
105769360|NCT02579863|364807374|FG001|Overall Study|Adverse Event|11|||
105769361|NCT02579863|364807373|FG000|Overall Study|Death|31|||
105769362|NCT02579863|364807374|FG001|Overall Study|Death|29|||
105331490|NCT00789373|363214597|FG000|Maintenance|Death due to adverse event|0|||
105331491|NCT00789373|363214598|FG001|Maintenance|Death due to adverse event|4|||
105769363|NCT02579863|364807373|FG000|Overall Study|Lost to Follow-up|2|||
105769364|NCT02579863|364807374|FG001|Overall Study|Lost to Follow-up|1|||
105331492|NCT00789373|363214599|FG002|Maintenance|Death due to adverse event|1|||
105331493|NCT00789373|363214597|FG000|Maintenance|Death due to toxicity|0|||
105769365|NCT02579863|364807373|FG000|Overall Study|Physician Decision|1|||
105769366|NCT02579863|364807374|FG001|Overall Study|Physician Decision|2|||
105769367|NCT02579863|364807373|FG000|Overall Study|Screen Failure|0|||
105769368|NCT02579863|364807374|FG001|Overall Study|Screen Failure|2|||
105769369|NCT02579863|364807373|FG000|Overall Study|Study Terminated at Selected Sites|82|||
105769370|NCT02579863|364807374|FG001|Overall Study|Study Terminated at Selected Sites|88|||
105769371|NCT02579863|364807373|FG000|Overall Study|Withdrawal by Subject|20|||
105769372|NCT02579863|364807374|FG001|Overall Study|Withdrawal by Subject|20|||
105769373|NCT03878160|364807380|FG000|Overall Study|Lost to Follow-up|1|||
105769374|NCT03878160|364807381|FG001|Overall Study|Lost to Follow-up|1|||
105331494|NCT00789373|363214598|FG001|Maintenance|Death due to toxicity|1|||
105769375|NCT03878160|364807382|FG002|Overall Study|Lost to Follow-up|1|||
105769376|NCT03878160|364807380|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
105769377|NCT03878160|364807381|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
105769378|NCT03878160|364807382|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
105769379|NCT01100658|364807383|FG000|Overall Study|Withdrawal by Subject|1|||
105769380|NCT00038142|364807384|FG000|Overall Study|Ineligible|1|||
105769381|NCT00038142|364807385|FG001|Overall Study|Ineligible|0|||
105769382|NCT00038142|364807384|FG000|Overall Study|Progressive Disease|11|||
105769383|NCT00038142|364807385|FG001|Overall Study|Progressive Disease|7|||
105769384|NCT00038142|364807384|FG000|Overall Study|Death|1|||
105769385|NCT00038142|364807385|FG001|Overall Study|Death|0|||
105769386|NCT00038142|364807384|FG000|Overall Study|Adverse Event|1|||
105769387|NCT00038142|364807385|FG001|Overall Study|Adverse Event|0|||
105769388|NCT00038142|364807384|FG000|Overall Study|Unknown Reason|8|||
105769389|NCT00038142|364807385|FG001|Overall Study|Unknown Reason|0|||
105769390|NCT00673816|364807400|FG000|Overall Study|Adverse Event|1|||
105769391|NCT00673816|364807400|FG000|Overall Study|Withdrawal by Subject|1|||
105769392|NCT00809614|364807401|FG000|Overall Study|Lack of Efficacy|2|||
105769393|NCT00809614|364807402|FG001|Overall Study|Lack of Efficacy|3|||
105769394|NCT00809614|364807401|FG000|Overall Study|Withdrawal by Subject|1|||
105769395|NCT00809614|364807402|FG001|Overall Study|Withdrawal by Subject|1|||
105769396|NCT02658149|364807406|FG000|Overall Study|Physician Decision|1|||
105769397|NCT02658149|364807407|FG001|Overall Study|Physician Decision|0|||
105769398|NCT01804842|364807411|FG000|Overall Study|Adverse Event|1|||
105769399|NCT01804842|364807412|FG001|Overall Study|Adverse Event|1|||
105769400|NCT01804842|364807413|FG002|Overall Study|Adverse Event|0|||
105769401|NCT01804842|364807411|FG000|Overall Study|Lost to Follow-up|1|||
105769402|NCT01804842|364807412|FG001|Overall Study|Lost to Follow-up|0|||
105769403|NCT01804842|364807413|FG002|Overall Study|Lost to Follow-up|0|||
105769404|NCT01804842|364807411|FG000|Overall Study|Non-Compliance|1|||
105769405|NCT01804842|364807412|FG001|Overall Study|Non-Compliance|1|||
105769406|NCT01804842|364807413|FG002|Overall Study|Non-Compliance|0|||
105769407|NCT01804842|364807411|FG000|Overall Study|Personal Reason|0|||
105769408|NCT01804842|364807412|FG001|Overall Study|Personal Reason|0|||
105769409|NCT01804842|364807413|FG002|Overall Study|Personal Reason|1|||
105769410|NCT01017549|364807414|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
105769411|NCT01017549|364807414|FG000|One-year Follow-up|Lost to Follow-up|2|||
105769412|NCT01017549|364807414|FG000|One-year Follow-up|Withdrawal by Subject|5|||
105769413|NCT01017549|364807414|FG000|5 Year Follow-up|Lost to Follow-up|9|||
105769414|NCT01017549|364807414|FG000|5 Year Follow-up|Mastectomy|3|||
105769415|NCT01440972|364807419|FG000|Overall Study|Withdrawal by Subject|3|||
105769416|NCT01440972|364807420|FG001|Overall Study|Withdrawal by Subject|2|||
105769417|NCT05049122|364807421|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
105769418|NCT05049122|364807421|FG000|Overall Study|Participant moved|1|||
105769419|NCT05049122|364807421|FG000|Overall Study|At the direction of the doctor|1|||
105769420|NCT02352090|364807422|FG000|Overall Study|general malaise|1|||
105331495|NCT00789373|363214599|FG002|Maintenance|Death due to toxicity|2|||
105331496|NCT00789373|363214597|FG000|Maintenance|Investigator Decision|0|||
105331497|NCT00789373|363214598|FG001|Maintenance|Investigator Decision|4|||
105331498|NCT00789373|363214599|FG002|Maintenance|Investigator Decision|2|||
105331499|NCT00789373|363214597|FG000|Maintenance|Protocol entry criteria not met|0|||
105769421|NCT02352090|364807423|FG001|Overall Study|general malaise|0|||
105769422|NCT02352090|364807424|FG002|Overall Study|general malaise|0|||
105769423|NCT02352090|364807422|FG000|Overall Study|non-specified mild side-effects|0|||
105769424|NCT02352090|364807423|FG001|Overall Study|non-specified mild side-effects|0|||
105769425|NCT02352090|364807424|FG002|Overall Study|non-specified mild side-effects|2|||
105769426|NCT00735072|364807427|FG000|Overall Study|interrupted study med during ARV change|1|||
105769427|NCT00735072|364807428|FG001|Overall Study|interrupted study med during ARV change|0|||
105769428|NCT00735072|364807427|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
105769429|NCT00735072|364807428|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
105331500|NCT00789373|363214598|FG001|Maintenance|Protocol entry criteria not met|2|||
105331501|NCT00789373|363214599|FG002|Maintenance|Protocol entry criteria not met|0|||
105440444|NCT03210961|363619141|FG012|Overall Study|Adverse Event|0|||
105440445|NCT03210961|363619142|FG013|Overall Study|Adverse Event|1|||
105440446|NCT03210961|363619143|FG014|Overall Study|Adverse Event|0|||
105440447|NCT03210961|363619129|FG000|Overall Study|Lost to Follow-up|0|||
105440448|NCT03210961|363619130|FG001|Overall Study|Lost to Follow-up|0|||
105440449|NCT03210961|363619131|FG002|Overall Study|Lost to Follow-up|0|||
105440450|NCT03210961|363619132|FG003|Overall Study|Lost to Follow-up|0|||
105440451|NCT03210961|363619133|FG004|Overall Study|Lost to Follow-up|0|||
105440452|NCT03210961|363619134|FG005|Overall Study|Lost to Follow-up|0|||
105440453|NCT03210961|363619135|FG006|Overall Study|Lost to Follow-up|0|||
105440454|NCT03210961|363619136|FG007|Overall Study|Lost to Follow-up|0|||
105440455|NCT03210961|363619137|FG008|Overall Study|Lost to Follow-up|0|||
105440456|NCT03210961|363619138|FG009|Overall Study|Lost to Follow-up|0|||
105440457|NCT03210961|363619139|FG010|Overall Study|Lost to Follow-up|0|||
105440458|NCT03210961|363619140|FG011|Overall Study|Lost to Follow-up|0|||
105440459|NCT03210961|363619141|FG012|Overall Study|Lost to Follow-up|0|||
105440460|NCT03210961|363619142|FG013|Overall Study|Lost to Follow-up|0|||
105440461|NCT03210961|363619143|FG014|Overall Study|Lost to Follow-up|1|||
105440462|NCT03210961|363619129|FG000|Overall Study|Withdrawal by Subject|0|||
105440463|NCT03210961|363619130|FG001|Overall Study|Withdrawal by Subject|0|||
105440464|NCT03210961|363619131|FG002|Overall Study|Withdrawal by Subject|0|||
105769430|NCT00911144|364807430|FG000|Overall Study|Withdrawal by Subject|16|||
105769431|NCT00911144|364807431|FG001|Overall Study|Withdrawal by Subject|5|||
105769432|NCT00537771|364807434|FG000|Overall Study|Withdrawal by Subject|6|||
105769433|NCT00537771|364807435|FG001|Overall Study|Withdrawal by Subject|23|||
105769434|NCT00537771|364807434|FG000|Overall Study|Adverse Event|8|||
105769435|NCT00537771|364807435|FG001|Overall Study|Adverse Event|15|||
105769436|NCT00537771|364807434|FG000|Overall Study|Lost to Follow-up|9|||
105769437|NCT00537771|364807435|FG001|Overall Study|Lost to Follow-up|15|||
105769438|NCT00537771|364807434|FG000|Overall Study|Protocol Violation|2|||
105769439|NCT00537771|364807435|FG001|Overall Study|Protocol Violation|6|||
105769440|NCT00537771|364807434|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
105769441|NCT00537771|364807435|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
105769442|NCT02348840|364807438|FG000|Overall Study|Withdrawal by Subject|2|||
105769443|NCT02348840|364807439|FG001|Overall Study|Withdrawal by Subject|1|||
105769444|NCT02348840|364807440|FG002|Overall Study|Withdrawal by Subject|0|||
105769445|NCT02348840|364807441|FG003|Overall Study|Withdrawal by Subject|0|||
105769446|NCT03748420|364807442|FG000|Overall Study|No 12 month medication adherence data available|0|||
105769447|NCT03748420|364807443|FG001|Overall Study|No 12 month medication adherence data available|1|||
105769448|NCT03748420|364807442|FG000|Overall Study|Death|24|||
105769449|NCT03748420|364807443|FG001|Overall Study|Death|28|||
105769450|NCT03748420|364807442|FG000|Overall Study|Lost to Follow-up|231|||
105769451|NCT03748420|364807443|FG001|Overall Study|Lost to Follow-up|230|||
105769452|NCT01263444|364807444|FG000|Overall Study|Adverse Event|8|||
105769453|NCT01263444|364807444|FG000|Overall Study|Withdrawal by Subject|1|||
105769454|NCT01263444|364807444|FG000|Overall Study|Protocol Violation|1|||
105769455|NCT00621244|364807452|FG000|Overall Study|Withdrawal by Subject|7|||
105769456|NCT00621244|364807453|FG001|Overall Study|Withdrawal by Subject|3|||
105769457|NCT00621244|364807454|FG002|Overall Study|Withdrawal by Subject|3|||
105769458|NCT00621244|364807455|FG003|Overall Study|Withdrawal by Subject|3|||
105769459|NCT00621244|364807452|FG000|Overall Study|Disease progression|44|||
105769460|NCT00621244|364807453|FG001|Overall Study|Disease progression|20|||
105769461|NCT00621244|364807454|FG002|Overall Study|Disease progression|20|||
105769462|NCT00621244|364807455|FG003|Overall Study|Disease progression|15|||
105769463|NCT00621244|364807452|FG000|Overall Study|Death|3|||
105769464|NCT00621244|364807453|FG001|Overall Study|Death|3|||
105769465|NCT00621244|364807454|FG002|Overall Study|Death|1|||
105769466|NCT00621244|364807455|FG003|Overall Study|Death|1|||
105769467|NCT00621244|364807452|FG000|Overall Study|Adverse Event|27|||
105769468|NCT00621244|364807453|FG001|Overall Study|Adverse Event|7|||
105769469|NCT00621244|364807454|FG002|Overall Study|Adverse Event|9|||
105769470|NCT00621244|364807455|FG003|Overall Study|Adverse Event|2|||
105769471|NCT00621244|364807452|FG000|Overall Study|Administrative problems|5|||
105769472|NCT00621244|364807453|FG001|Overall Study|Administrative problems|1|||
105769473|NCT00621244|364807454|FG002|Overall Study|Administrative problems|0|||
105769474|NCT00621244|364807455|FG003|Overall Study|Administrative problems|2|||
105769475|NCT00338806|364807470|FG000|Acute Phase|Withdrawal by Subject|0|||
105769476|NCT00338806|364807471|FG001|Acute Phase|Withdrawal by Subject|1|||
105440465|NCT03210961|363619132|FG003|Overall Study|Withdrawal by Subject|0|||
105440466|NCT03210961|363619133|FG004|Overall Study|Withdrawal by Subject|0|||
105769477|NCT00338806|364807470|FG000|Follow-up|Lost to Follow-up|1|||
105769478|NCT00338806|364807471|FG001|Follow-up|Lost to Follow-up|3|||
105769479|NCT00744991|364807474|FG000|Overall Study|Progressive Disease|11|||
105769480|NCT00744991|364807474|FG000|Overall Study|Withdrawal by Subject|8|||
105769481|NCT00744991|364807474|FG000|Overall Study|Physician Decision|3|||
105769482|NCT00744991|364807474|FG000|Overall Study|Adverse Event|2|||
105769483|NCT00744991|364807474|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
105769484|NCT01487863|364807483|FG000|Overall Study|Death|19|||
105769485|NCT01487863|364807484|FG001|Overall Study|Death|19|||
105331502|NCT00789373|363214597|FG000|Maintenance|Lost to Follow-up|0|||
105331503|NCT00789373|363214598|FG001|Maintenance|Lost to Follow-up|2|||
105331504|NCT00789373|363214599|FG002|Maintenance|Lost to Follow-up|0|||
105331505|NCT00789373|363214597|FG000|Maintenance|Progressive Disease|0|||
105440467|NCT03210961|363619134|FG005|Overall Study|Withdrawal by Subject|0|||
105440468|NCT03210961|363619135|FG006|Overall Study|Withdrawal by Subject|0|||
105331506|NCT00789373|363214598|FG001|Maintenance|Progressive Disease|253|||
105440469|NCT03210961|363619136|FG007|Overall Study|Withdrawal by Subject|0|||
105440470|NCT03210961|363619137|FG008|Overall Study|Withdrawal by Subject|0|||
105440471|NCT03210961|363619138|FG009|Overall Study|Withdrawal by Subject|0|||
105331507|NCT00789373|363214599|FG002|Maintenance|Progressive Disease|152|||
105331508|NCT00789373|363214597|FG000|Maintenance|Withdrawal by Subject|0|||
105331509|NCT00789373|363214598|FG001|Maintenance|Withdrawal by Subject|21|||
105331510|NCT00789373|363214599|FG002|Maintenance|Withdrawal by Subject|8|||
105440472|NCT03210961|363619139|FG010|Overall Study|Withdrawal by Subject|0|||
105440473|NCT03210961|363619140|FG011|Overall Study|Withdrawal by Subject|0|||
105440474|NCT03210961|363619141|FG012|Overall Study|Withdrawal by Subject|0|||
105440475|NCT03210961|363619142|FG013|Overall Study|Withdrawal by Subject|0|||
105440476|NCT03210961|363619143|FG014|Overall Study|Withdrawal by Subject|1|||
105440477|NCT03210961|363619129|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
105331511|NCT00789373|363214597|FG000|Maintenance|Sponsor Decision|0|||
105331512|NCT00789373|363214598|FG001|Maintenance|Sponsor Decision|0|||
105331513|NCT00789373|363214599|FG002|Maintenance|Sponsor Decision|2|||
105331514|NCT00789373|363214597|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
105331515|NCT00789373|363214598|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
105331516|NCT00789373|363214599|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
105331517|NCT02476578|363214603|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
105331518|NCT02476578|363214604|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
105331519|NCT02476578|363214603|FG000|Overall Study|Lost to Follow-up|6|||
105331520|NCT02476578|363214604|FG001|Overall Study|Lost to Follow-up|13|||
105331521|NCT02187198|363214605|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
105331522|NCT02187198|363214606|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
105331523|NCT02187198|363214605|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
105331524|NCT02187198|363214606|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
105769486|NCT03198728|364807488|FG000|Overall Study|Adverse Event|10|||
105769487|NCT03198728|364807489|FG001|Overall Study|Adverse Event|5|||
105769488|NCT03198728|364807488|FG000|Overall Study|Lost to Follow-up|21|||
105769489|NCT03198728|364807489|FG001|Overall Study|Lost to Follow-up|7|||
105769490|NCT03198728|364807488|FG000|Overall Study|Physician Decision|7|||
105769491|NCT03198728|364807489|FG001|Overall Study|Physician Decision|2|||
105769492|NCT03198728|364807488|FG000|Overall Study|Withdrawal by Subject|14|||
105769493|NCT03198728|364807489|FG001|Overall Study|Withdrawal by Subject|10|||
105769494|NCT04157751|364807498|FG000|Overall Study|Withdrawal by Subject|12|||
105769495|NCT04157751|364807499|FG001|Overall Study|Withdrawal by Subject|17|||
105769496|NCT04157751|364807498|FG000|Overall Study|Lost to Follow-up|6|||
105769497|NCT04157751|364807499|FG001|Overall Study|Lost to Follow-up|2|||
105769498|NCT04157751|364807498|FG000|Overall Study|Adverse Event|34|||
105769499|NCT04157751|364807499|FG001|Overall Study|Adverse Event|23|||
105769500|NCT04157751|364807498|FG000|Overall Study|Not treated|1|||
105769501|NCT04157751|364807499|FG001|Overall Study|Not treated|5|||
105331525|NCT00546377|363214607|FG000|Overall Study|Deemed ineligible|1|||
105440478|NCT03210961|363619130|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
105440479|NCT03210961|363619131|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
105769502|NCT04157751|364807498|FG000|Overall Study|Other reason not stated above|10|||
105769503|NCT04157751|364807499|FG001|Overall Study|Other reason not stated above|10|||
105769504|NCT01332851|364807500|FG000|Overall Study|Withdrawal by Subject|4|||
105769505|NCT01332851|364807501|FG001|Overall Study|Withdrawal by Subject|2|||
105769506|NCT01332851|364807500|FG000|Overall Study|Lost to Follow-up|7|||
105769507|NCT01332851|364807501|FG001|Overall Study|Lost to Follow-up|11|||
105769508|NCT01437267|364807503|FG000|Overall Study|Withdrawal by Subject|0|||
105769509|NCT01437267|364807504|FG001|Overall Study|Withdrawal by Subject|0|||
105769510|NCT01437267|364807505|FG002|Overall Study|Withdrawal by Subject|0|||
105769511|NCT01437267|364807506|FG003|Overall Study|Withdrawal by Subject|1|||
105769512|NCT01437267|364807507|FG004|Overall Study|Withdrawal by Subject|0|||
105331526|NCT00546377|363214607|FG000|Overall Study|Adverse Event|6|||
105331527|NCT02282813|363214613|FG000|Overall Study|Withdrawal by Subject|4|||
105440480|NCT03210961|363619132|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
105440481|NCT03210961|363619133|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
105769513|NCT01437267|364807508|FG005|Overall Study|Withdrawal by Subject|0|||
105769514|NCT01437267|364807503|FG000|Overall Study|Protocol Violation|0|||
105769515|NCT01437267|364807504|FG001|Overall Study|Protocol Violation|1|||
105769516|NCT01437267|364807505|FG002|Overall Study|Protocol Violation|0|||
105769517|NCT01437267|364807506|FG003|Overall Study|Protocol Violation|0|||
105769518|NCT01437267|364807507|FG004|Overall Study|Protocol Violation|0|||
105331528|NCT02282813|363214614|FG001|Overall Study|Withdrawal by Subject|5|||
105440482|NCT03210961|363619134|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
105440483|NCT03210961|363619135|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
105440484|NCT03210961|363619136|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
105440485|NCT03210961|363619137|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
105440486|NCT03210961|363619138|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
105550163|NCT00902304|364014369|FG000|Overall Study|Adverse Event|4|||
105659645|NCT00816556|364418794|FG000|Overall Study|Withdrawal by Subject|1|||
105769519|NCT01437267|364807508|FG005|Overall Study|Protocol Violation|0|||
105331529|NCT02282813|363214615|FG002|Overall Study|Withdrawal by Subject|0|||
105331530|NCT02282813|363214613|FG000|Overall Study|Adverse Event|3|||
105331531|NCT02282813|363214614|FG001|Overall Study|Adverse Event|10|||
105331532|NCT02282813|363214615|FG002|Overall Study|Adverse Event|1|||
105331533|NCT02282813|363214613|FG000|Overall Study|Subject non-compliance|1|||
105331534|NCT02282813|363214614|FG001|Overall Study|Subject non-compliance|4|||
105331535|NCT02282813|363214615|FG002|Overall Study|Subject non-compliance|0|||
105331536|NCT02282813|363214613|FG000|Overall Study|Physician Decision|0|||
105331537|NCT02282813|363214614|FG001|Overall Study|Physician Decision|3|||
105331538|NCT02282813|363214615|FG002|Overall Study|Physician Decision|1|||
105331539|NCT02282813|363214613|FG000|Overall Study|Lost to Follow-up|2|||
105331540|NCT02282813|363214614|FG001|Overall Study|Lost to Follow-up|0|||
105331541|NCT02282813|363214615|FG002|Overall Study|Lost to Follow-up|1|||
105331542|NCT02282813|363214613|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
105331543|NCT02282813|363214614|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
105331544|NCT02282813|363214615|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
105331545|NCT02282813|363214613|FG000|Overall Study|Lack of Efficacy|1|||
105331546|NCT02282813|363214614|FG001|Overall Study|Lack of Efficacy|0|||
105331547|NCT02282813|363214615|FG002|Overall Study|Lack of Efficacy|0|||
105331548|NCT02282813|363214613|FG000|Overall Study|Administrative reasons|0|||
105331549|NCT02282813|363214614|FG001|Overall Study|Administrative reasons|1|||
105331550|NCT02282813|363214615|FG002|Overall Study|Administrative reasons|0|||
105331551|NCT03777436|363214616|FG000|Placebo-controlled Phase|Adverse Event|8|||
105331552|NCT03777436|363214617|FG001|Placebo-controlled Phase|Adverse Event|10|||
105331553|NCT03777436|363214618|FG002|Placebo-controlled Phase|Adverse Event|0|||
105331554|NCT03777436|363214616|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
105331555|NCT03777436|363214617|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
105331556|NCT03777436|363214618|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
105331557|NCT03777436|363214616|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
105331558|NCT03777436|363214617|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
105331559|NCT03777436|363214618|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
105331560|NCT03777436|363214616|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
105331561|NCT03777436|363214617|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
105331562|NCT03777436|363214618|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
105331563|NCT03777436|363214616|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
105331564|NCT03777436|363214617|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
105331565|NCT03777436|363214618|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
105331566|NCT03777436|363214616|FG000|Placebo-controlled Phase|Physician Decision|0|||
105331567|NCT03777436|363214617|FG001|Placebo-controlled Phase|Physician Decision|1|||
105331568|NCT03777436|363214618|FG002|Placebo-controlled Phase|Physician Decision|0|||
105331569|NCT03777436|363214616|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
105331570|NCT03777436|363214617|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
105769520|NCT00333970|364807509|FG000|Overall Study|Withdrawal by Subject|13|||
105659646|NCT00816556|364418795|FG001|Overall Study|Withdrawal by Subject|1|||
105659647|NCT00816556|364418796|FG002|Overall Study|Withdrawal by Subject|1|||
105659648|NCT00816556|364418794|FG000|Overall Study|Lost to Follow-up|0|||
105659649|NCT00816556|364418795|FG001|Overall Study|Lost to Follow-up|0|||
105659650|NCT00816556|364418796|FG002|Overall Study|Lost to Follow-up|1|||
105769521|NCT00333970|364807510|FG001|Overall Study|Withdrawal by Subject|7|||
105769522|NCT01810380|364807511|FG000|Overall Study|Randomised not treated|2|||
105769523|NCT01810380|364807512|FG001|Overall Study|Randomised not treated|1|||
105769524|NCT01810380|364807513|FG002|Overall Study|Randomised not treated|1|||
105769525|NCT01810380|364807511|FG000|Overall Study|Adverse Event|11|||
105769526|NCT01810380|364807512|FG001|Overall Study|Adverse Event|14|||
105769527|NCT01810380|364807513|FG002|Overall Study|Adverse Event|4|||
105769528|NCT01810380|364807511|FG000|Overall Study|Lack of Efficacy|24|||
105769529|NCT01810380|364807512|FG001|Overall Study|Lack of Efficacy|10|||
105769530|NCT01810380|364807513|FG002|Overall Study|Lack of Efficacy|11|||
105331571|NCT03777436|363214618|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
105331572|NCT03777436|363214616|FG000|Apremilast Extension Phase|Adverse Event|0|||
105331573|NCT03777436|363214617|FG001|Apremilast Extension Phase|Adverse Event|0|||
105331574|NCT03777436|363214618|FG002|Apremilast Extension Phase|Adverse Event|6|||
105331575|NCT03777436|363214616|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
105659651|NCT01010204|364418797|FG000|Overall Study|Lost to Follow-up|2|||
105769531|NCT01810380|364807511|FG000|Overall Study|Protocol Violation|1|||
105769532|NCT01810380|364807512|FG001|Overall Study|Protocol Violation|0|||
105769533|NCT01810380|364807513|FG002|Overall Study|Protocol Violation|1|||
105769534|NCT01810380|364807511|FG000|Overall Study|Withdrawal by Subject|6|||
105769535|NCT01810380|364807512|FG001|Overall Study|Withdrawal by Subject|0|||
105769536|NCT01810380|364807513|FG002|Overall Study|Withdrawal by Subject|6|||
105769537|NCT01810380|364807511|FG000|Overall Study|Administrative or other reasons|11|||
105769538|NCT01810380|364807512|FG001|Overall Study|Administrative or other reasons|13|||
105331576|NCT03777436|363214617|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
105331577|NCT03777436|363214618|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
105331578|NCT03777436|363214616|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
105331579|NCT03777436|363214617|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
105331580|NCT03777436|363214618|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
105331581|NCT03777436|363214616|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
105331582|NCT03777436|363214617|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
105331583|NCT03777436|363214618|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
105769539|NCT01810380|364807513|FG002|Overall Study|Administrative or other reasons|9|||
105769540|NCT00441480|364807514|FG000|Overall Study|Protocol Violation|1|||
105769541|NCT00441480|364807515|FG001|Overall Study|Protocol Violation|1|||
105769542|NCT00441480|364807514|FG000|Overall Study|Withdrawal by Subject|2|||
105769543|NCT00441480|364807515|FG001|Overall Study|Withdrawal by Subject|3|||
105769544|NCT02829775|364807516|FG000|Overall Study|Death|1|||
105769545|NCT02829775|364807516|FG000|Overall Study|Withdrawal by Subject|3|||
105769546|NCT02829775|364807516|FG000|Overall Study|Disease remission|1|||
105769547|NCT00033371|364807517|FG000|Overall Study|Adverse Event|1|||
105769548|NCT00033371|364807518|FG001|Overall Study|Adverse Event|5|||
105769549|NCT00033371|364807517|FG000|Overall Study|Lost to Follow-up|2|||
105769550|NCT00033371|364807518|FG001|Overall Study|Lost to Follow-up|1|||
105769551|NCT00033371|364807517|FG000|Overall Study|Withdrawal by Subject|3|||
105769552|NCT00033371|364807518|FG001|Overall Study|Withdrawal by Subject|3|||
105769553|NCT00033371|364807517|FG000|Overall Study|Disease Progression|0|||
105769554|NCT00033371|364807518|FG001|Overall Study|Disease Progression|1|||
105769555|NCT00062647|364807521|FG000|Overall Study|Death|2|||
105769556|NCT00062647|364807522|FG001|Overall Study|Death|2|||
105769557|NCT00062647|364807521|FG000|Overall Study|Adverse Event|1|||
105769558|NCT00062647|364807522|FG001|Overall Study|Adverse Event|1|||
105769559|NCT00062647|364807521|FG000|Overall Study|Withdrawal by Subject|2|||
105769560|NCT00062647|364807522|FG001|Overall Study|Withdrawal by Subject|1|||
105769561|NCT00062647|364807521|FG000|Overall Study|Protocol Violation|1|||
105769562|NCT00062647|364807522|FG001|Overall Study|Protocol Violation|0|||
105769563|NCT00062647|364807521|FG000|Overall Study|Lost to Follow-up|1|||
105769564|NCT00062647|364807522|FG001|Overall Study|Lost to Follow-up|2|||
105769565|NCT00062647|364807521|FG000|Overall Study|Failed continuation criteria|4|||
105769566|NCT00062647|364807522|FG001|Overall Study|Failed continuation criteria|2|||
105769567|NCT00062647|364807521|FG000|Overall Study|Other|4|||
105769568|NCT00062647|364807522|FG001|Overall Study|Other|4|||
105769569|NCT00062647|364807521|FG000|Overall Study|Never received study treatment|1|||
105769570|NCT00062647|364807522|FG001|Overall Study|Never received study treatment|1|||
105769571|NCT00002981|364807528|FG000|Overall Study|Inevaluable|6|||
105769572|NCT02201472|364807532|FG000|Overall Study|Lack of Efficacy|2|||
105769573|NCT00262314|364807533|FG000|Overall Study|Changing physicians|38|||
105769574|NCT00262314|364807533|FG000|Overall Study|Death|12|||
105769575|NCT00262314|364807533|FG000|Overall Study|Patient's decision|92|||
105769576|NCT00262314|364807533|FG000|Overall Study|Other|95|||
105769577|NCT00262314|364807533|FG000|Overall Study|Lost to Follow-up|70|||
105769578|NCT00262314|364807533|FG000|Overall Study|Administrative withdrawal|30|||
105769579|NCT01201967|364807535|FG000|Overall Study|Lost to Follow-up|6|||
105769580|NCT01201967|364807536|FG001|Overall Study|Lost to Follow-up|5|||
105769581|NCT03128307|364807537|FG000|Overall Study|Lost to Follow-up|29|||
105769582|NCT03128307|364807537|FG000|Overall Study|Withdrawal by Subject|5|||
105769583|NCT00736385|364809324|FG000|Overall Study|Withdrawal by Subject|2|||
105769584|NCT00736385|364809325|FG001|Overall Study|Withdrawal by Subject|2|||
105769585|NCT00736385|364809324|FG000|Overall Study|Adverse Event|0|||
105769586|NCT00736385|364809325|FG001|Overall Study|Adverse Event|1|||
105769587|NCT01594749|364809326|FG000|Overall Study|Adverse Event|2|||
105331584|NCT03777436|363214616|FG000|Apremilast Extension Phase|Miscellaneous|0|||
105331585|NCT03777436|363214617|FG001|Apremilast Extension Phase|Miscellaneous|0|||
105769588|NCT01594749|364809327|FG001|Overall Study|Adverse Event|1|||
105769589|NCT01594749|364809326|FG000|Overall Study|Withdrawal by Subject|2|||
105769590|NCT01594749|364809327|FG001|Overall Study|Withdrawal by Subject|2|||
105769591|NCT01594749|364809326|FG000|Overall Study|Protocol Violation|2|||
105769592|NCT01594749|364809327|FG001|Overall Study|Protocol Violation|0|||
105769593|NCT01594749|364809326|FG000|Overall Study|Physician Decision|1|||
105769594|NCT01594749|364809327|FG001|Overall Study|Physician Decision|1|||
105769595|NCT01594749|364809326|FG000|Overall Study|Non-compliance with Protocol|0|||
105769596|NCT01594749|364809327|FG001|Overall Study|Non-compliance with Protocol|1|||
105769597|NCT01594749|364809326|FG000|Overall Study|Lost to Follow-up|1|||
105769598|NCT01594749|364809327|FG001|Overall Study|Lost to Follow-up|0|||
105769599|NCT01594749|364809326|FG000|Overall Study|Death|9|||
105769600|NCT01594749|364809327|FG001|Overall Study|Death|3|||
105769601|NCT01594749|364809326|FG000|Overall Study|Not Treated|4|||
105769602|NCT01594749|364809327|FG001|Overall Study|Not Treated|10|||
105769603|NCT01594749|364809326|FG000|Overall Study|Lost Source Documentation|1|||
105769604|NCT01594749|364809327|FG001|Overall Study|Lost Source Documentation|0|||
105769605|NCT00364351|364809328|FG000|Overall Study|Adverse Event|90|||
105769606|NCT00364351|364809329|FG001|Overall Study|Adverse Event|44|||
105769607|NCT00364351|364809328|FG000|Overall Study|Condition under investigation worsened|469|||
105769608|NCT00364351|364809329|FG001|Overall Study|Condition under investigation worsened|497|||
105769609|NCT00364351|364809328|FG000|Overall Study|Prohibited concomitant medication|0|||
105769610|NCT00364351|364809329|FG001|Overall Study|Prohibited concomitant medication|2|||
105769611|NCT00364351|364809328|FG000|Overall Study|Lost to Follow-up|1|||
105769612|NCT00364351|364809329|FG001|Overall Study|Lost to Follow-up|1|||
105769613|NCT00364351|364809328|FG000|Overall Study|Withdrawal by Subject|30|||
105769614|NCT00364351|364809329|FG001|Overall Study|Withdrawal by Subject|29|||
105769615|NCT00364351|364809328|FG000|Overall Study|Incorrect enrollment|1|||
105769616|NCT00364351|364809329|FG001|Overall Study|Incorrect enrollment|1|||
105769617|NCT00364351|364809328|FG000|Overall Study|Sponsor decision|1|||
105769618|NCT00364351|364809329|FG001|Overall Study|Sponsor decision|0|||
105769619|NCT00364351|364809328|FG000|Overall Study|Poor treatment compliance|0|||
105769620|NCT00364351|364809329|FG001|Overall Study|Poor treatment compliance|3|||
105769621|NCT00364351|364809328|FG000|Overall Study|Investigator error|0|||
105769622|NCT00364351|364809329|FG001|Overall Study|Investigator error|2|||
105769623|NCT00364351|364809328|FG000|Overall Study|Patient could not travel to site|0|||
105769624|NCT00364351|364809329|FG001|Overall Study|Patient could not travel to site|1|||
105769625|NCT00364351|364809328|FG000|Overall Study|Randomised treatment not started|0|||
105769626|NCT00364351|364809329|FG001|Overall Study|Randomised treatment not started|3|||
105769627|NCT00976963|364809351|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
105769628|NCT00976963|364809352|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
105769629|NCT00976963|364809351|FG000|Overall Study|administrative error|1|||
105769630|NCT00976963|364809352|FG001|Overall Study|administrative error|0|||
105769631|NCT00976963|364809351|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
105769632|NCT00976963|364809352|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
105769633|NCT01426009|364809353|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
105769634|NCT01426009|364809353|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
105769635|NCT01426009|364809353|FG000|Washout 1|Withdrawal by Subject|1|||
105769636|NCT01426009|364809353|FG000|Washout 1|Personal Reasons|1|||
105769637|NCT01426009|364809353|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
105769638|NCT01426009|364809353|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
105769639|NCT01426009|364809353|FG000|Washout 2|electrive surgery|1|||
105769640|NCT01426009|364809353|FG000|Washout 3|personal reasons|1|||
105769641|NCT01426009|364809353|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
105769642|NCT01426009|364809353|FG000|Washout 4|Lost to Follow-up|1|||
105769643|NCT01688999|364809360|FG000|Overall Study|Withdrawal by Subject|5|||
105769644|NCT01688999|364809361|FG001|Overall Study|Withdrawal by Subject|1|||
105769645|NCT01688999|364809362|FG002|Overall Study|Withdrawal by Subject|1|||
105769646|NCT01688999|364809360|FG000|Overall Study|Adverse Event|2|||
105769647|NCT01688999|364809361|FG001|Overall Study|Adverse Event|0|||
105769648|NCT01688999|364809362|FG002|Overall Study|Adverse Event|2|||
105769649|NCT01688999|364809360|FG000|Overall Study|Ineligible/Not treated|1|||
105769650|NCT01688999|364809361|FG001|Overall Study|Ineligible/Not treated|0|||
105769651|NCT01688999|364809362|FG002|Overall Study|Ineligible/Not treated|0|||
105331586|NCT03777436|363214618|FG002|Apremilast Extension Phase|Miscellaneous|1|||
105331587|NCT00921557|363214619|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
105331588|NCT00921557|363214620|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
105331589|NCT00921557|363214621|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
105331590|NCT00921557|363214619|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
105331591|NCT00921557|363214620|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
105331592|NCT00921557|363214621|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
105331593|NCT00921557|363214619|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
105331594|NCT00921557|363214620|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
105331595|NCT00921557|363214621|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
105331596|NCT00921557|363214619|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
105331597|NCT00921557|363214620|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
105331598|NCT00921557|363214621|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
105769652|NCT02768103|364809363|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
105769653|NCT02182999|364809380|FG000|Overall Study|Adverse Event|4|||
105769654|NCT02182999|364809381|FG001|Overall Study|Adverse Event|3|||
105769655|NCT02182999|364809380|FG000|Overall Study|Physician Decision|1|||
105769656|NCT02182999|364809381|FG001|Overall Study|Physician Decision|0|||
105769657|NCT00373880|364809388|FG000|Overall Study|Physician Decision|3|||
105769658|NCT00373880|364809388|FG000|Overall Study|Arrested|1|||
105769659|NCT00373880|364809388|FG000|Overall Study|Protocol Violation|14|||
105769660|NCT01899768|364809389|FG000|Part A|Adverse Event|2|||
105331599|NCT00921557|363214619|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
105331600|NCT00921557|363214620|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
105331601|NCT00921557|363214621|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
105331602|NCT04157296|363214622|FG000|Overall Study|Withdrawal by Subject|0|||
105331603|NCT04157296|363214623|FG001|Overall Study|Withdrawal by Subject|1|||
105331604|NCT04157296|363214622|FG000|Overall Study|Did not obtain second fMRI.|0|||
105331605|NCT04157296|363214623|FG001|Overall Study|Did not obtain second fMRI.|1|||
105331606|NCT04157296|363214622|FG000|Overall Study|MRI failed/no second fMRI|0|||
105331607|NCT04157296|363214623|FG001|Overall Study|MRI failed/no second fMRI|1|||
105331608|NCT00267969|363214626|FG000|Controlled Period|Adverse Event|6|||
105331609|NCT00267969|363214627|FG001|Controlled Period|Adverse Event|0|||
105331610|NCT00267969|363214628|FG002|Controlled Period|Adverse Event|2|||
105331611|NCT00267969|363214629|FG003|Controlled Period|Adverse Event|0|||
105331612|NCT00267969|363214630|FG004|Controlled Period|Adverse Event|0|||
105331613|NCT00267969|363214631|FG005|Controlled Period|Adverse Event|0|||
105331614|NCT00267969|363214632|FG006|Controlled Period|Adverse Event|0|||
105331615|NCT00267969|363214626|FG000|Controlled Period|Lack of Efficacy|3|||
105331616|NCT00267969|363214627|FG001|Controlled Period|Lack of Efficacy|0|||
105331617|NCT00267969|363214628|FG002|Controlled Period|Lack of Efficacy|1|||
105769661|NCT01899768|364809389|FG000|Part A|Withdrawal by Subject|1|||
105769662|NCT01899768|364809389|FG000|Part B|Adverse Event|1|||
105769663|NCT01899768|364809389|FG000|Part B|Withdrawal by Subject|1|||
105769664|NCT01347073|364809390|FG000|Overall Study|Adverse Event|1|||
105769665|NCT01347073|364809390|FG000|Overall Study|Liver Transplant|1|||
105769666|NCT02203916|364809391|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
105769667|NCT02203916|364809392|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
105769668|NCT02203916|364809393|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
105769669|NCT02203916|364809391|FG000|Overall Study|Major Protocol Deviation|1|||
105769670|NCT02203916|364809392|FG001|Overall Study|Major Protocol Deviation|1|||
105769671|NCT02203916|364809393|FG002|Overall Study|Major Protocol Deviation|0|||
105769672|NCT02203916|364809391|FG000|Overall Study|Lost to Follow-up|0|||
105769673|NCT02203916|364809392|FG001|Overall Study|Lost to Follow-up|1|||
105769674|NCT02203916|364809393|FG002|Overall Study|Lost to Follow-up|0|||
105769675|NCT02203916|364809391|FG000|Overall Study|Voluntary Withdrawal|3|||
105769676|NCT02203916|364809392|FG001|Overall Study|Voluntary Withdrawal|3|||
105769677|NCT02203916|364809393|FG002|Overall Study|Voluntary Withdrawal|8|||
105769678|NCT02203916|364809391|FG000|Overall Study|Lack of Efficacy|3|||
105769679|NCT02203916|364809392|FG001|Overall Study|Lack of Efficacy|0|||
105769680|NCT02203916|364809393|FG002|Overall Study|Lack of Efficacy|0|||
105769681|NCT02203916|364809391|FG000|Overall Study|Reason Not Specified|0|||
105769682|NCT02203916|364809392|FG001|Overall Study|Reason Not Specified|2|||
105769683|NCT02203916|364809393|FG002|Overall Study|Reason Not Specified|1|||
105769684|NCT03152110|364809394|FG000|Overall Study|Withdrawal by Subject|3|||
105769685|NCT01925014|364809395|FG000|Overall Study|Inappropriate enrollment|4|||
105769686|NCT01925014|364809396|FG001|Overall Study|Inappropriate enrollment|6|||
105769687|NCT01925014|364809395|FG000|Overall Study|Withdrawal by Subject|5|||
105769688|NCT01925014|364809396|FG001|Overall Study|Withdrawal by Subject|13|||
105769689|NCT01634100|364809406|FG000|Overall Study|Withdrawal by Subject|1|||
105769690|NCT01634100|364809407|FG001|Overall Study|Withdrawal by Subject|0|||
105769691|NCT01634100|364809408|FG002|Overall Study|Withdrawal by Subject|1|||
105769692|NCT01634100|364809409|FG003|Overall Study|Withdrawal by Subject|0|||
105769693|NCT01634100|364809410|FG004|Overall Study|Withdrawal by Subject|0|||
105769694|NCT01634100|364809411|FG005|Overall Study|Withdrawal by Subject|0|||
105769695|NCT01662986|364809412|FG000|Overall Study|Adverse Event|5|||
105769696|NCT01662986|364809413|FG001|Overall Study|Adverse Event|4|||
105769697|NCT01662986|364809412|FG000|Overall Study|Protocol Violation|2|||
105769698|NCT01662986|364809413|FG001|Overall Study|Protocol Violation|3|||
105769699|NCT01662986|364809412|FG000|Overall Study|Lost to Follow-up|5|||
105769700|NCT01662986|364809413|FG001|Overall Study|Lost to Follow-up|4|||
105769701|NCT01662986|364809412|FG000|Overall Study|Withdrawal by Subject|2|||
105769702|NCT01662986|364809413|FG001|Overall Study|Withdrawal by Subject|2|||
105769703|NCT01662986|364809412|FG000|Overall Study|Not Treated|1|||
105769704|NCT01662986|364809413|FG001|Overall Study|Not Treated|0|||
105331618|NCT00267969|363214629|FG003|Controlled Period|Lack of Efficacy|0|||
105440487|NCT03210961|363619139|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
105769705|NCT01662986|364809412|FG000|Overall Study|Other than stated above|3|||
105769706|NCT01662986|364809413|FG001|Overall Study|Other than stated above|0|||
105769707|NCT00623766|364809414|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
105769708|NCT00623766|364809415|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
105769709|NCT00623766|364809414|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
105769710|NCT00623766|364809415|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
105769711|NCT00623766|364809414|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
105769712|NCT00623766|364809415|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
105769713|NCT00623766|364809414|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
105769714|NCT00623766|364809415|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
105769715|NCT00623766|364809414|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
105769716|NCT00623766|364809415|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
105769717|NCT00486889|364809417|FG000|Overall Study|Death|3|||
105769718|NCT00486889|364809417|FG000|Overall Study|Non-compliant|2|||
105769719|NCT00486889|364809417|FG000|Overall Study|Withdrawal by Subject|6|||
105769720|NCT02324049|364809418|FG000|Part C|Study terminated|11|||
105769721|NCT03797144|364809422|FG000|Enrollment|Protocol Violation|4|||
105769722|NCT03797144|364809423|FG001|Enrollment|Protocol Violation|1|||
105769723|NCT03797144|364809422|FG000|Surgery|Protocol Violation|1|||
105769724|NCT03797144|364809423|FG001|Surgery|Protocol Violation|0|||
105769725|NCT03797144|364809422|FG000|3 Month|Early termination cut-off date|2|||
105769726|NCT03797144|364809423|FG001|3 Month|Early termination cut-off date|0|||
105769727|NCT03797144|364809422|FG000|12 Month|Early termination cut-off date|8|||
105769728|NCT03797144|364809423|FG001|12 Month|Early termination cut-off date|9|||
105769729|NCT03797144|364809422|FG000|24 Month|Early termination cut-off date|1|||
105769730|NCT03797144|364809423|FG001|24 Month|Early termination cut-off date|1|||
105769731|NCT01878175|364809425|FG000|Overall Study|Developed contraindicated health problem|2|||
105769732|NCT04051944|364809426|FG000|Overall Study|Study ending|1|||
105769733|NCT04051944|364809427|FG001|Overall Study|Study ending|1|||
105769734|NCT04051944|364809426|FG000|Overall Study|Early study termination by participant|1|||
105769735|NCT04051944|364809427|FG001|Overall Study|Early study termination by participant|0|||
105769736|NCT04051944|364809426|FG000|Overall Study|Withdrawal by Subject|2|||
105769737|NCT04051944|364809427|FG001|Overall Study|Withdrawal by Subject|2|||
105769738|NCT04051944|364809426|FG000|Overall Study|Lack of Efficacy|3|||
105769739|NCT04051944|364809427|FG001|Overall Study|Lack of Efficacy|0|||
105769740|NCT04051944|364809426|FG000|Overall Study|Adverse event, non- fatal|1|||
105769741|NCT04051944|364809427|FG001|Overall Study|Adverse event, non- fatal|1|||
105769742|NCT00614991|364809432|FG000|Overall Study|Adverse Event|3|||
105769743|NCT00614991|364809433|FG001|Overall Study|Adverse Event|3|||
105769744|NCT00614991|364809434|FG002|Overall Study|Adverse Event|0|||
105769745|NCT00614991|364809435|FG003|Overall Study|Adverse Event|0|||
105769746|NCT00614991|364809436|FG004|Overall Study|Adverse Event|1|||
105769747|NCT00614991|364809437|FG005|Overall Study|Adverse Event|0|||
105769748|NCT03799627|364809438|FG000|Overall Study|Adverse Event|1|||
105769749|NCT03799627|364809439|FG001|Overall Study|Adverse Event|2|||
105769750|NCT03799627|364809440|FG002|Overall Study|Adverse Event|0|||
105769751|NCT03799627|364809441|FG003|Overall Study|Adverse Event|0|||
105769752|NCT03799627|364809442|FG004|Overall Study|Adverse Event|2|||
105769753|NCT03799627|364809443|FG005|Overall Study|Adverse Event|5|||
105769754|NCT03799627|364809444|FG006|Overall Study|Adverse Event|0|||
105769755|NCT03799627|364809445|FG007|Overall Study|Adverse Event|2|||
105769756|NCT03799627|364809446|FG008|Overall Study|Adverse Event|0|||
105769757|NCT03799627|364809438|FG000|Overall Study|Physician Decision|2|||
105769758|NCT03799627|364809439|FG001|Overall Study|Physician Decision|2|||
105769759|NCT03799627|364809440|FG002|Overall Study|Physician Decision|0|||
105769760|NCT03799627|364809441|FG003|Overall Study|Physician Decision|0|||
105769761|NCT03799627|364809442|FG004|Overall Study|Physician Decision|2|||
105769762|NCT03799627|364809443|FG005|Overall Study|Physician Decision|2|||
105769763|NCT03799627|364809444|FG006|Overall Study|Physician Decision|0|||
105769764|NCT03799627|364809445|FG007|Overall Study|Physician Decision|0|||
105769765|NCT03799627|364809446|FG008|Overall Study|Physician Decision|0|||
105769766|NCT03799627|364809438|FG000|Overall Study|Withdrawal by Subject|1|||
105769767|NCT03799627|364809439|FG001|Overall Study|Withdrawal by Subject|1|||
105769768|NCT03799627|364809440|FG002|Overall Study|Withdrawal by Subject|0|||
105769769|NCT03799627|364809441|FG003|Overall Study|Withdrawal by Subject|2|||
105769770|NCT03799627|364809442|FG004|Overall Study|Withdrawal by Subject|0|||
105769771|NCT03799627|364809443|FG005|Overall Study|Withdrawal by Subject|3|||
105769772|NCT03799627|364809444|FG006|Overall Study|Withdrawal by Subject|0|||
105769773|NCT03799627|364809445|FG007|Overall Study|Withdrawal by Subject|0|||
105769774|NCT03799627|364809446|FG008|Overall Study|Withdrawal by Subject|0|||
105769775|NCT03799627|364809438|FG000|Overall Study|Lack of Efficacy|0|||
105769776|NCT03799627|364809439|FG001|Overall Study|Lack of Efficacy|0|||
105769777|NCT03799627|364809440|FG002|Overall Study|Lack of Efficacy|0|||
105769778|NCT03799627|364809441|FG003|Overall Study|Lack of Efficacy|1|||
105769779|NCT03799627|364809442|FG004|Overall Study|Lack of Efficacy|0|||
105769780|NCT03799627|364809443|FG005|Overall Study|Lack of Efficacy|0|||
105769781|NCT03799627|364809444|FG006|Overall Study|Lack of Efficacy|0|||
105769782|NCT03799627|364809445|FG007|Overall Study|Lack of Efficacy|0|||
105769783|NCT03799627|364809446|FG008|Overall Study|Lack of Efficacy|0|||
105769784|NCT03799627|364809438|FG000|Overall Study|Lost to Follow-up|0|||
105769785|NCT03799627|364809439|FG001|Overall Study|Lost to Follow-up|0|||
105769786|NCT03799627|364809440|FG002|Overall Study|Lost to Follow-up|0|||
105769787|NCT03799627|364809441|FG003|Overall Study|Lost to Follow-up|0|||
105769788|NCT03799627|364809442|FG004|Overall Study|Lost to Follow-up|0|||
105769789|NCT03799627|364809443|FG005|Overall Study|Lost to Follow-up|0|||
105769790|NCT03799627|364809444|FG006|Overall Study|Lost to Follow-up|1|||
105769791|NCT03799627|364809445|FG007|Overall Study|Lost to Follow-up|0|||
105769792|NCT03799627|364809446|FG008|Overall Study|Lost to Follow-up|1|||
105769793|NCT03799627|364809438|FG000|Overall Study|Death|0|||
105769794|NCT03799627|364809439|FG001|Overall Study|Death|0|||
105769795|NCT03799627|364809440|FG002|Overall Study|Death|0|||
105769796|NCT03799627|364809441|FG003|Overall Study|Death|1|||
105769797|NCT03799627|364809442|FG004|Overall Study|Death|0|||
105769798|NCT03799627|364809443|FG005|Overall Study|Death|0|||
105769799|NCT03799627|364809444|FG006|Overall Study|Death|0|||
105769800|NCT03799627|364809445|FG007|Overall Study|Death|0|||
105769801|NCT03799627|364809446|FG008|Overall Study|Death|0|||
105769802|NCT03799627|364809438|FG000|Overall Study|Study Drug Put on Hold|1|||
105769803|NCT03799627|364809439|FG001|Overall Study|Study Drug Put on Hold|0|||
105769804|NCT03799627|364809440|FG002|Overall Study|Study Drug Put on Hold|0|||
105769805|NCT03799627|364809441|FG003|Overall Study|Study Drug Put on Hold|0|||
105769806|NCT03799627|364809442|FG004|Overall Study|Study Drug Put on Hold|0|||
105769807|NCT03799627|364809443|FG005|Overall Study|Study Drug Put on Hold|0|||
105769808|NCT03799627|364809444|FG006|Overall Study|Study Drug Put on Hold|0|||
105769809|NCT03799627|364809445|FG007|Overall Study|Study Drug Put on Hold|0|||
105769810|NCT03799627|364809446|FG008|Overall Study|Study Drug Put on Hold|0|||
105769811|NCT03799627|364809438|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
105769812|NCT03799627|364809439|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
105769813|NCT03799627|364809440|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
105769814|NCT03799627|364809441|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
105769815|NCT03799627|364809442|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
105769816|NCT03799627|364809443|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
105769817|NCT03799627|364809444|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
105769818|NCT03799627|364809445|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
105769819|NCT03799627|364809446|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
105769820|NCT03799627|364809438|FG000|Overall Study|Kidney Transplantation|1|||
105769821|NCT03799627|364809439|FG001|Overall Study|Kidney Transplantation|0|||
105769822|NCT03799627|364809440|FG002|Overall Study|Kidney Transplantation|0|||
105769823|NCT03799627|364809441|FG003|Overall Study|Kidney Transplantation|1|||
105769824|NCT03799627|364809442|FG004|Overall Study|Kidney Transplantation|1|||
105769825|NCT03799627|364809443|FG005|Overall Study|Kidney Transplantation|0|||
105769826|NCT03799627|364809444|FG006|Overall Study|Kidney Transplantation|0|||
105769827|NCT03799627|364809445|FG007|Overall Study|Kidney Transplantation|0|||
105769828|NCT03799627|364809446|FG008|Overall Study|Kidney Transplantation|0|||
105769829|NCT03799627|364809438|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
105769830|NCT03799627|364809439|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
105769831|NCT03799627|364809440|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
105769832|NCT03799627|364809441|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
105769833|NCT03799627|364809442|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
105769834|NCT03799627|364809443|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
105769835|NCT03799627|364809444|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
105769836|NCT03799627|364809445|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
105769837|NCT03799627|364809446|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
105769838|NCT03799627|364809438|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769839|NCT03799627|364809439|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
105769840|NCT03799627|364809440|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769841|NCT03799627|364809441|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769842|NCT03799627|364809442|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769843|NCT03799627|364809443|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769844|NCT03799627|364809444|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769845|NCT03799627|364809445|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769846|NCT03799627|364809446|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769847|NCT03799627|364809438|FG000|Overall Study|Met Exclusion Criteria|0|||
105769848|NCT03799627|364809439|FG001|Overall Study|Met Exclusion Criteria|0|||
105331619|NCT00267969|363214630|FG004|Controlled Period|Lack of Efficacy|0|||
105331620|NCT00267969|363214631|FG005|Controlled Period|Lack of Efficacy|0|||
105769849|NCT03799627|364809440|FG002|Overall Study|Met Exclusion Criteria|0|||
105769850|NCT03799627|364809441|FG003|Overall Study|Met Exclusion Criteria|1|||
105769851|NCT03799627|364809442|FG004|Overall Study|Met Exclusion Criteria|0|||
105769852|NCT03799627|364809443|FG005|Overall Study|Met Exclusion Criteria|0|||
105769853|NCT03799627|364809444|FG006|Overall Study|Met Exclusion Criteria|0|||
105769854|NCT03799627|364809445|FG007|Overall Study|Met Exclusion Criteria|0|||
105769855|NCT03799627|364809446|FG008|Overall Study|Met Exclusion Criteria|0|||
105769856|NCT03799627|364809438|FG000|Overall Study|Investigational Product Noncompliance|0|||
105769857|NCT03799627|364809439|FG001|Overall Study|Investigational Product Noncompliance|0|||
105769858|NCT03799627|364809440|FG002|Overall Study|Investigational Product Noncompliance|0|||
105769859|NCT03799627|364809441|FG003|Overall Study|Investigational Product Noncompliance|1|||
105769860|NCT03799627|364809442|FG004|Overall Study|Investigational Product Noncompliance|0|||
105331621|NCT00267969|363214632|FG006|Controlled Period|Lack of Efficacy|0|||
105769861|NCT03799627|364809443|FG005|Overall Study|Investigational Product Noncompliance|0|||
105769862|NCT03799627|364809444|FG006|Overall Study|Investigational Product Noncompliance|0|||
105769863|NCT03799627|364809445|FG007|Overall Study|Investigational Product Noncompliance|0|||
105769864|NCT03799627|364809446|FG008|Overall Study|Investigational Product Noncompliance|0|||
105769865|NCT03799627|364809438|FG000|Overall Study|Participant Relocation|0|||
105769866|NCT03799627|364809439|FG001|Overall Study|Participant Relocation|0|||
105769867|NCT03799627|364809440|FG002|Overall Study|Participant Relocation|0|||
105769868|NCT03799627|364809441|FG003|Overall Study|Participant Relocation|1|||
105769869|NCT03799627|364809442|FG004|Overall Study|Participant Relocation|0|||
105769870|NCT03799627|364809443|FG005|Overall Study|Participant Relocation|1|||
105769871|NCT03799627|364809444|FG006|Overall Study|Participant Relocation|0|||
105769872|NCT03799627|364809445|FG007|Overall Study|Participant Relocation|0|||
105769873|NCT03799627|364809446|FG008|Overall Study|Participant Relocation|0|||
105769874|NCT03799627|364809438|FG000|Overall Study|Eurofin Issue|0|||
105769875|NCT03799627|364809439|FG001|Overall Study|Eurofin Issue|0|||
105769876|NCT03799627|364809440|FG002|Overall Study|Eurofin Issue|0|||
105769877|NCT03799627|364809441|FG003|Overall Study|Eurofin Issue|0|||
105769878|NCT03799627|364809442|FG004|Overall Study|Eurofin Issue|1|||
105769879|NCT03799627|364809443|FG005|Overall Study|Eurofin Issue|0|||
105769880|NCT03799627|364809444|FG006|Overall Study|Eurofin Issue|0|||
105769881|NCT03799627|364809445|FG007|Overall Study|Eurofin Issue|0|||
105769882|NCT03799627|364809446|FG008|Overall Study|Eurofin Issue|0|||
105769883|NCT03799627|364809438|FG000|Overall Study|Noncompliance with Site Instructions|0|||
105769884|NCT03799627|364809439|FG001|Overall Study|Noncompliance with Site Instructions|0|||
105769885|NCT03799627|364809440|FG002|Overall Study|Noncompliance with Site Instructions|0|||
105769886|NCT03799627|364809441|FG003|Overall Study|Noncompliance with Site Instructions|0|||
105769887|NCT03799627|364809442|FG004|Overall Study|Noncompliance with Site Instructions|1|||
105769888|NCT03799627|364809443|FG005|Overall Study|Noncompliance with Site Instructions|0|||
105769889|NCT03799627|364809444|FG006|Overall Study|Noncompliance with Site Instructions|0|||
105769890|NCT03799627|364809445|FG007|Overall Study|Noncompliance with Site Instructions|0|||
105769891|NCT03799627|364809446|FG008|Overall Study|Noncompliance with Site Instructions|0|||
105769892|NCT03799627|364809438|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769893|NCT03799627|364809439|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769894|NCT03799627|364809440|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769895|NCT03799627|364809441|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769896|NCT03799627|364809442|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
105769897|NCT03799627|364809443|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769898|NCT03799627|364809444|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769899|NCT03799627|364809445|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769900|NCT03799627|364809446|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769901|NCT03799627|364809438|FG000|Overall Study|Changes In Hemoglobin Values|1|||
105769902|NCT03799627|364809439|FG001|Overall Study|Changes In Hemoglobin Values|2|||
105769903|NCT03799627|364809440|FG002|Overall Study|Changes In Hemoglobin Values|1|||
105769904|NCT03799627|364809441|FG003|Overall Study|Changes In Hemoglobin Values|0|||
105769905|NCT03799627|364809442|FG004|Overall Study|Changes In Hemoglobin Values|0|||
105769906|NCT03799627|364809443|FG005|Overall Study|Changes In Hemoglobin Values|2|||
105769907|NCT03799627|364809444|FG006|Overall Study|Changes In Hemoglobin Values|1|||
105769908|NCT03799627|364809445|FG007|Overall Study|Changes In Hemoglobin Values|0|||
105769909|NCT03799627|364809446|FG008|Overall Study|Changes In Hemoglobin Values|1|||
105769910|NCT01833806|364809455|FG000|Overall Study|Alternative treatment|2|||
105769911|NCT01833806|364809455|FG000|Overall Study|Death|5|||
105769912|NCT01833806|364809455|FG000|Overall Study|Physician Decision|1|||
105769913|NCT01833806|364809455|FG000|Overall Study|Lost to Follow-up|1|||
105769914|NCT05083949|364809456|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
105769915|NCT05083949|364809457|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
105769916|NCT05083949|364809456|FG000|Period 1|Adverse Event|1|||
105769917|NCT05083949|364809457|FG001|Period 1|Adverse Event|1|||
105769918|NCT05083949|364809456|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
105769919|NCT05083949|364809457|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
105769920|NCT05083949|364809456|FG000|Period 2|Adverse Event|0|||
105769921|NCT05083949|364809457|FG001|Period 2|Adverse Event|2|||
105769922|NCT05104749|364809460|FG000|Overall Study|Lost to Follow-up|2|||
105769923|NCT05104749|364809461|FG001|Overall Study|Lost to Follow-up|3|||
105769924|NCT02470429|364809464|FG000|Overall Study|Adverse Event|1|||
105769925|NCT02470429|364809465|FG001|Overall Study|Adverse Event|0|||
105440488|NCT03210961|363619140|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
105769926|NCT02470429|364809464|FG000|Overall Study|Withdrawal by Subject|1|||
105769927|NCT02470429|364809465|FG001|Overall Study|Withdrawal by Subject|0|||
105769928|NCT01300767|364809466|FG000|Overall Study|Discomfort|2|||
105769929|NCT01300767|364809466|FG000|Overall Study|Biomicroscopy|1|||
105769930|NCT01300767|364809466|FG000|Overall Study|Unacceptable fit|1|||
105769931|NCT00117572|364809471|FG000|Overall Study|Site withdrew before starting treatment|2|||
105806431|NCT01464827|364948984|FG003|Overall Study|Lost to Follow-up|2|||
105769932|NCT00117572|364809472|FG001|Overall Study|Site withdrew before starting treatment|3|||
105769933|NCT00117572|364809471|FG000|Overall Study|Withdrawal by Subject|3|||
105769934|NCT00117572|364809472|FG001|Overall Study|Withdrawal by Subject|3|||
105769935|NCT00117572|364809471|FG000|Overall Study|Protocol Violation|1|||
105769936|NCT00117572|364809472|FG001|Overall Study|Protocol Violation|0|||
105769937|NCT00322387|364809473|FG000|Treatment Period|Adverse Event|0|||
105769938|NCT00322387|364809474|FG001|Treatment Period|Adverse Event|1|||
105769939|NCT00322387|364809473|FG000|Follow-up Period|Final assessment not done|1|||
105769940|NCT00322387|364809474|FG001|Follow-up Period|Final assessment not done|3|||
105769941|NCT00322387|364809473|FG000|Follow-up Period|Death|1|||
105769942|NCT00322387|364809474|FG001|Follow-up Period|Death|0|||
105769943|NCT01188811|364809475|FG000|Overall Study|Withdrawal by Subject|0|||
105769944|NCT01188811|364809476|FG001|Overall Study|Withdrawal by Subject|2|||
105769945|NCT01188811|364809475|FG000|Overall Study|Adverse Event|6|||
105769946|NCT01188811|364809476|FG001|Overall Study|Adverse Event|0|||
105769947|NCT02485860|364809477|FG000|Overall Study|Lost to Follow-up|4|||
105769948|NCT02485860|364809478|FG001|Overall Study|Lost to Follow-up|1|||
105769949|NCT02485860|364809477|FG000|Overall Study|Physician Decision|1|||
105769950|NCT02485860|364809478|FG001|Overall Study|Physician Decision|2|||
105769951|NCT02485860|364809477|FG000|Overall Study|Health context (COVID-19)|1|||
105769952|NCT02485860|364809478|FG001|Overall Study|Health context (COVID-19)|0|||
105769953|NCT04412668|364809489|FG000|Overall Study|Death - multiple comorbidities|2|||
105769954|NCT04412668|364809490|FG001|Overall Study|Death - multiple comorbidities|0|||
105769955|NCT04412668|364809491|FG002|Overall Study|Death - multiple comorbidities|0|||
105769956|NCT04412668|364809489|FG000|Overall Study|Withdrawal by Subject|3|||
105769957|NCT04412668|364809490|FG001|Overall Study|Withdrawal by Subject|0|||
105769958|NCT04412668|364809491|FG002|Overall Study|Withdrawal by Subject|0|||
105769959|NCT04412668|364809489|FG000|Overall Study|Other than Specified|2|||
105769960|NCT04412668|364809490|FG001|Overall Study|Other than Specified|0|||
105769961|NCT04412668|364809491|FG002|Overall Study|Other than Specified|0|||
105769962|NCT00374127|364809494|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
105769963|NCT00374127|364809494|FG000|Overall Study|Blood could not be drawn.|2|||
105769964|NCT00374127|364809494|FG000|Overall Study|Protocol Violation|5|||
105769965|NCT00374127|364809494|FG000|Overall Study|Pregnancy|1|||
105769966|NCT02875366|364809495|FG000|Overall Study|Adverse Event|0|||
105769967|NCT02875366|364809496|FG001|Overall Study|Adverse Event|2|||
105769968|NCT02875366|364809495|FG000|Overall Study|Noncompliance|0|||
105769969|NCT02875366|364809496|FG001|Overall Study|Noncompliance|1|||
105769970|NCT00636155|364811000|FG000|Overall Study|Adverse Event|8|||
105360791|NCT00572455|363328086|FG006|Stage II (28 Days)|Adverse Event|0|||
105360792|NCT00572455|363328087|FG007|Stage II (28 Days)|Adverse Event|0|||
105360793|NCT00572455|363328088|FG008|Stage II (28 Days)|Adverse Event|1|||
105360794|NCT00572455|363328089|FG009|Stage II (28 Days)|Adverse Event|3|||
105360795|NCT00572455|363328090|FG010|Stage II (28 Days)|Adverse Event|3|||
105360796|NCT00572455|363328091|FG011|Stage II (28 Days)|Adverse Event|4|||
105360797|NCT00572455|363328092|FG012|Stage II (28 Days)|Adverse Event|5|||
105360798|NCT00572455|363328093|FG013|Stage II (28 Days)|Adverse Event|1|||
105360799|NCT00572455|363328080|FG000|Stage II (28 Days)|Death|0|||
105360800|NCT00572455|363328081|FG001|Stage II (28 Days)|Death|0|||
105360801|NCT00572455|363328082|FG002|Stage II (28 Days)|Death|0|||
105360802|NCT00572455|363328083|FG003|Stage II (28 Days)|Death|0|||
105360803|NCT00572455|363328084|FG004|Stage II (28 Days)|Death|0|||
105360804|NCT00572455|363328085|FG005|Stage II (28 Days)|Death|0|||
105360805|NCT00572455|363328086|FG006|Stage II (28 Days)|Death|0|||
105360806|NCT00572455|363328087|FG007|Stage II (28 Days)|Death|0|||
105360807|NCT00572455|363328088|FG008|Stage II (28 Days)|Death|1|||
105360808|NCT00572455|363328089|FG009|Stage II (28 Days)|Death|0|||
105360809|NCT00572455|363328090|FG010|Stage II (28 Days)|Death|0|||
105360810|NCT00572455|363328091|FG011|Stage II (28 Days)|Death|0|||
105360811|NCT00572455|363328092|FG012|Stage II (28 Days)|Death|0|||
105360812|NCT00572455|363328093|FG013|Stage II (28 Days)|Death|0|||
105360813|NCT00572455|363328080|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
105360814|NCT00572455|363328081|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
105360815|NCT00572455|363328082|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
105360816|NCT00572455|363328083|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
105360817|NCT00572455|363328084|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
105360818|NCT00572455|363328085|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
105360819|NCT00572455|363328086|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
105360820|NCT00572455|363328087|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
105360821|NCT00572455|363328088|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
105360822|NCT00572455|363328089|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
105360823|NCT00572455|363328090|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
105360824|NCT00572455|363328091|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
105360825|NCT00572455|363328092|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
105360826|NCT00572455|363328093|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
105360827|NCT00572455|363328080|FG000|Stage II (28 Days)|Other|0|||
105360828|NCT00572455|363328081|FG001|Stage II (28 Days)|Other|0|||
105360829|NCT00572455|363328082|FG002|Stage II (28 Days)|Other|0|||
105769971|NCT00636155|364811000|FG000|Overall Study|Lack of Efficacy|1|||
105769972|NCT00636155|364811000|FG000|Overall Study|Withdrawal by Subject|3|||
105769973|NCT00636155|364811000|FG000|Overall Study|Stem cell transplant|1|||
105769974|NCT00636155|364811000|FG000|Overall Study|Physician Decision|5|||
105769975|NCT01432756|364811001|FG000|Overall Study|Lost to Follow-up|1|||
105769976|NCT01432756|364811002|FG001|Overall Study|Lost to Follow-up|0|||
105769977|NCT01432756|364811003|FG002|Overall Study|Lost to Follow-up|2|||
105769978|NCT01432756|364811004|FG003|Overall Study|Lost to Follow-up|1|||
105769979|NCT00098865|364811009|FG000|Overall Study|Progressive Disease|6|||
105769980|NCT00098865|364811009|FG000|Overall Study|Adverse Event|2|||
105769981|NCT00098865|364811009|FG000|Overall Study|Alternative Therapy|1|||
105769982|NCT00413777|364811014|FG000|Fixed-dose Period|Lost to Follow-up|1|||
105769983|NCT00413777|364811015|FG001|Fixed-dose Period|Lost to Follow-up|1|||
105440489|NCT03210961|363619141|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
105440490|NCT03210961|363619142|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
105440491|NCT03210961|363619143|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
105440492|NCT03210961|363619129|FG000|Overall Study|Other|0|||
105440493|NCT03210961|363619130|FG001|Overall Study|Other|0|||
105440494|NCT03210961|363619131|FG002|Overall Study|Other|0|||
105440495|NCT03210961|363619132|FG003|Overall Study|Other|1|||
105769984|NCT00413777|364811014|FG000|Fixed-dose Period|Adverse Event|2|||
105769985|NCT00413777|364811015|FG001|Fixed-dose Period|Adverse Event|1|||
105769986|NCT00413777|364811014|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
105769987|NCT00413777|364811015|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
105440496|NCT03210961|363619133|FG004|Overall Study|Other|0|||
105440497|NCT03210961|363619134|FG005|Overall Study|Other|0|||
105440498|NCT03210961|363619135|FG006|Overall Study|Other|1|||
105440499|NCT03210961|363619136|FG007|Overall Study|Other|0|||
105440500|NCT03210961|363619137|FG008|Overall Study|Other|0|||
105440501|NCT03210961|363619138|FG009|Overall Study|Other|0|||
105440502|NCT03210961|363619139|FG010|Overall Study|Other|1|||
105440503|NCT03210961|363619140|FG011|Overall Study|Other|0|||
105440504|NCT03210961|363619141|FG012|Overall Study|Other|2|||
105440505|NCT03210961|363619142|FG013|Overall Study|Other|2|||
105440506|NCT03210961|363619143|FG014|Overall Study|Other|0|||
105769988|NCT00413777|364811014|FG000|Fixed-dose Period|Withdrew Consent|0|||
105769989|NCT00413777|364811015|FG001|Fixed-dose Period|Withdrew Consent|1|||
105769990|NCT02148952|364811016|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
105769991|NCT02148952|364811017|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
105769992|NCT02148952|364811016|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
105769993|NCT02148952|364811017|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
105769994|NCT02148952|364811016|FG000|Follow-Up|Lost to Follow-up|219|||
105769995|NCT02148952|364811017|FG001|Follow-Up|Lost to Follow-up|231|||
105769996|NCT02148952|364811016|FG000|Follow-Up|Withdrawal by Subject|46|||
105769997|NCT02148952|364811017|FG001|Follow-Up|Withdrawal by Subject|48|||
105769998|NCT01764022|364811020|FG000|Overall Study|Death|3|||
105769999|NCT01764022|364811021|FG001|Overall Study|Death|5|||
105770000|NCT01764022|364811020|FG000|Overall Study|Withdrawal by Subject|2|||
105770001|NCT01764022|364811021|FG001|Overall Study|Withdrawal by Subject|6|||
105770002|NCT01764022|364811020|FG000|Overall Study|Lack of Efficacy|0|||
105770003|NCT01764022|364811021|FG001|Overall Study|Lack of Efficacy|1|||
105770004|NCT01764022|364811020|FG000|Overall Study|Physician Decision|0|||
105770005|NCT01764022|364811021|FG001|Overall Study|Physician Decision|2|||
105770006|NCT01764022|364811020|FG000|Overall Study|Lost to Follow-up|2|||
105770007|NCT01764022|364811021|FG001|Overall Study|Lost to Follow-up|0|||
105770008|NCT01764022|364811020|FG000|Overall Study|Protocol Violation|1|||
105770009|NCT01764022|364811021|FG001|Overall Study|Protocol Violation|0|||
105770010|NCT03236506|364811022|FG000|Overall Study|Death|1|||
105770011|NCT03236506|364811023|FG001|Overall Study|Death|1|||
105770012|NCT03236506|364811024|FG002|Overall Study|Death|1|||
105770013|NCT03236506|364811022|FG000|Overall Study|Withdrawal by Subject|3|||
105770014|NCT03236506|364811023|FG001|Overall Study|Withdrawal by Subject|3|||
105770015|NCT03236506|364811024|FG002|Overall Study|Withdrawal by Subject|4|||
105770016|NCT03236506|364811022|FG000|Overall Study|Did not initiate treatment|2|||
105770017|NCT03236506|364811023|FG001|Overall Study|Did not initiate treatment|1|||
105440507|NCT02467582|363619144|FG000|Allocation|Withdrawal by Subject|1|||
105440508|NCT02467582|363619145|FG001|Allocation|Withdrawal by Subject|0|||
105770018|NCT03236506|364811024|FG002|Overall Study|Did not initiate treatment|2|||
105770019|NCT00376675|364811025|FG000|Overall Study|Withdrawal by Subject|9|||
105770020|NCT00376675|364811026|FG001|Overall Study|Withdrawal by Subject|2|||
105440509|NCT02467582|363619144|FG000|Follow-up|Death|5|||
105770021|NCT00376675|364811025|FG000|Overall Study|Adverse Event|10|||
105770022|NCT00376675|364811026|FG001|Overall Study|Adverse Event|5|||
105770023|NCT00376675|364811025|FG000|Overall Study|Other Reason|1|||
105770024|NCT00376675|364811026|FG001|Overall Study|Other Reason|7|||
105770025|NCT00736450|364811029|FG000|Overall Study|Not ABC gene eligible|19|||
105770026|NCT00736450|364811029|FG000|Overall Study|Withdrawal by Subject|5|||
105440510|NCT02467582|363619145|FG001|Follow-up|Death|4|||
105770027|NCT00736450|364811029|FG000|Overall Study|Physician Decision|1|||
105770028|NCT02943668|364811033|FG000|Overall Study|Disease Progression|1|||
105770029|NCT01313039|364811038|FG000|Overall Study|Physician Decision|1|||
105770030|NCT01313039|364811038|FG000|Overall Study|Adverse Event|1|||
105770031|NCT03630016|364811039|FG000|Overall Study|Poor Sensor Placement|1|||
105770032|NCT01678560|364811040|FG000|Overall Study|Physician Decision|4|||
105770033|NCT01678560|364811041|FG001|Overall Study|Physician Decision|4|||
105770034|NCT01678560|364811040|FG000|Overall Study|Death|0|||
105770035|NCT01678560|364811041|FG001|Overall Study|Death|1|||
105770036|NCT01678560|364811040|FG000|Overall Study|Withdrawal by Subject|0|||
105770037|NCT01678560|364811041|FG001|Overall Study|Withdrawal by Subject|1|||
105770038|NCT04489940|364811042|FG000|Overall Study|Other|2|||
105770039|NCT04489940|364811042|FG000|Overall Study|Withdrawal by Subject|2|||
105770040|NCT04489940|364811042|FG000|Overall Study|Death|5|||
105770041|NCT04489940|364811042|FG000|Overall Study|Lost to Follow-up|1|||
105770042|NCT03964493|364811045|FG000|Overall Study|Withdrawal by Subject|4|||
105770043|NCT03964493|364811046|FG001|Overall Study|Withdrawal by Subject|1|||
105770044|NCT03964493|364811045|FG000|Overall Study|Lost to Follow-up|13|||
105770045|NCT03964493|364811046|FG001|Overall Study|Lost to Follow-up|4|||
105770046|NCT04973085|364811047|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
105770047|NCT04973085|364811048|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
105770048|NCT01828567|364811049|FG000|Overall Study|Lost to Follow-up|27|||
105770049|NCT01828567|364811050|FG001|Overall Study|Lost to Follow-up|9|||
105770050|NCT01828567|364811049|FG000|Overall Study|Excluded - did not meet criteria|4|||
105770051|NCT01828567|364811050|FG001|Overall Study|Excluded - did not meet criteria|1|||
105770052|NCT00090766|364811060|FG000|Overall Study|Nephrectomy Planned|0|||
105770053|NCT00090766|364811061|FG001|Overall Study|Nephrectomy Planned|0|||
105770054|NCT00090766|364811062|FG002|Overall Study|Nephrectomy Planned|1|||
105770055|NCT00090766|364811060|FG000|Overall Study|Death|1|||
105331622|NCT00267969|363214626|FG000|Controlled Period|Lost to Follow-up|1|||
105331623|NCT00267969|363214627|FG001|Controlled Period|Lost to Follow-up|0|||
105331624|NCT00267969|363214628|FG002|Controlled Period|Lost to Follow-up|1|||
105331625|NCT00267969|363214629|FG003|Controlled Period|Lost to Follow-up|0|||
105331626|NCT00267969|363214630|FG004|Controlled Period|Lost to Follow-up|0|||
105331627|NCT00267969|363214631|FG005|Controlled Period|Lost to Follow-up|0|||
105331628|NCT00267969|363214632|FG006|Controlled Period|Lost to Follow-up|0|||
105331629|NCT00267969|363214626|FG000|Controlled Period|Randomized but not treated|0|||
105331630|NCT00267969|363214627|FG001|Controlled Period|Randomized but not treated|0|||
105331631|NCT00267969|363214628|FG002|Controlled Period|Randomized but not treated|1|||
105331632|NCT00267969|363214629|FG003|Controlled Period|Randomized but not treated|0|||
105331633|NCT00267969|363214630|FG004|Controlled Period|Randomized but not treated|0|||
105331634|NCT00267969|363214631|FG005|Controlled Period|Randomized but not treated|0|||
105331635|NCT00267969|363214632|FG006|Controlled Period|Randomized but not treated|0|||
105331636|NCT00267969|363214626|FG000|Controlled Period|Other|2|||
105331637|NCT00267969|363214627|FG001|Controlled Period|Other|1|||
105331638|NCT00267969|363214628|FG002|Controlled Period|Other|6|||
105331639|NCT00267969|363214629|FG003|Controlled Period|Other|0|||
105331640|NCT00267969|363214630|FG004|Controlled Period|Other|0|||
105331641|NCT00267969|363214631|FG005|Controlled Period|Other|0|||
105331642|NCT00267969|363214632|FG006|Controlled Period|Other|0|||
105331643|NCT00267969|363214626|FG000|After Controlled Period|Adverse Event|0|||
105331644|NCT00267969|363214627|FG001|After Controlled Period|Adverse Event|0|||
105331645|NCT00267969|363214628|FG002|After Controlled Period|Adverse Event|0|||
105331646|NCT00267969|363214629|FG003|After Controlled Period|Adverse Event|7|||
105331647|NCT00267969|363214630|FG004|After Controlled Period|Adverse Event|8|||
105331648|NCT00267969|363214631|FG005|After Controlled Period|Adverse Event|23|||
105331649|NCT00267969|363214632|FG006|After Controlled Period|Adverse Event|21|||
105331650|NCT00267969|363214626|FG000|After Controlled Period|Death|0|||
105331651|NCT00267969|363214627|FG001|After Controlled Period|Death|0|||
105331652|NCT00267969|363214628|FG002|After Controlled Period|Death|0|||
105331653|NCT00267969|363214629|FG003|After Controlled Period|Death|1|||
105331654|NCT00267969|363214630|FG004|After Controlled Period|Death|2|||
105331655|NCT00267969|363214631|FG005|After Controlled Period|Death|0|||
105331656|NCT00267969|363214632|FG006|After Controlled Period|Death|1|||
105331657|NCT00267969|363214626|FG000|After Controlled Period|Lack of Efficacy|0|||
105331658|NCT00267969|363214627|FG001|After Controlled Period|Lack of Efficacy|0|||
105331659|NCT00267969|363214628|FG002|After Controlled Period|Lack of Efficacy|0|||
105331660|NCT00267969|363214629|FG003|After Controlled Period|Lack of Efficacy|10|||
105331661|NCT00267969|363214630|FG004|After Controlled Period|Lack of Efficacy|6|||
105331662|NCT00267969|363214631|FG005|After Controlled Period|Lack of Efficacy|28|||
105331663|NCT00267969|363214632|FG006|After Controlled Period|Lack of Efficacy|15|||
105331664|NCT00267969|363214626|FG000|After Controlled Period|Lost to Follow-up|0|||
105360830|NCT00572455|363328083|FG003|Stage II (28 Days)|Other|0|||
105360831|NCT00572455|363328084|FG004|Stage II (28 Days)|Other|0|||
105770056|NCT00090766|364811061|FG001|Overall Study|Death|0|||
105770057|NCT00090766|364811062|FG002|Overall Study|Death|0|||
105770058|NCT00090766|364811060|FG000|Overall Study|Admin|0|||
105770059|NCT00090766|364811061|FG001|Overall Study|Admin|2|||
105770060|NCT00090766|364811062|FG002|Overall Study|Admin|0|||
105360832|NCT00572455|363328085|FG005|Stage II (28 Days)|Other|0|||
105331665|NCT00267969|363214627|FG001|After Controlled Period|Lost to Follow-up|0|||
105770061|NCT00090766|364811060|FG000|Overall Study|Lost to Follow-up|2|||
105331666|NCT00267969|363214628|FG002|After Controlled Period|Lost to Follow-up|0|||
105331667|NCT00267969|363214629|FG003|After Controlled Period|Lost to Follow-up|5|||
105331668|NCT00267969|363214630|FG004|After Controlled Period|Lost to Follow-up|8|||
105331669|NCT00267969|363214631|FG005|After Controlled Period|Lost to Follow-up|9|||
105331670|NCT00267969|363214632|FG006|After Controlled Period|Lost to Follow-up|10|||
105440511|NCT02467582|363619144|FG000|Follow-up|Lost to Follow-up|6|||
105331671|NCT00267969|363214626|FG000|After Controlled Period|Other|0|||
105331672|NCT00267969|363214627|FG001|After Controlled Period|Other|0|||
105331673|NCT00267969|363214628|FG002|After Controlled Period|Other|0|||
105331674|NCT00267969|363214629|FG003|After Controlled Period|Other|13|||
105331675|NCT00267969|363214630|FG004|After Controlled Period|Other|11|||
105331676|NCT00267969|363214631|FG005|After Controlled Period|Other|22|||
105331677|NCT00267969|363214632|FG006|After Controlled Period|Other|25|||
105331678|NCT03674112|363214638|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
105331679|NCT03674112|363214639|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
105331680|NCT03674112|363214638|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
105331681|NCT03674112|363214639|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
105331682|NCT03674112|363214638|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
105331683|NCT03674112|363214639|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
105331684|NCT03674112|363214638|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
105331685|NCT03674112|363214639|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
105331686|NCT03674112|363214638|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
105331687|NCT03674112|363214639|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
105331688|NCT03674112|363214638|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
105331689|NCT03674112|363214639|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
105331690|NCT03674112|363214638|FG000|Follow-Up Period (≥3 Years)|Death|2|||
105331691|NCT03674112|363214639|FG001|Follow-Up Period (≥3 Years)|Death|0|||
105331692|NCT03674112|363214638|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
105331693|NCT03674112|363214639|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
105331694|NCT00862823|363214640|FG000|First Intervention|Withdrawal by Subject|1|||
105331695|NCT00862823|363214641|FG001|First Intervention|Withdrawal by Subject|1|||
105331696|NCT00887315|363214642|FG000|Overall Study|Study termination|7|||
105331697|NCT00887315|363214643|FG001|Overall Study|Study termination|4|||
105331698|NCT01106911|363214650|FG000|Overall Study|Physician Decision|2|||
105331699|NCT01106911|363214650|FG000|Overall Study|deemed ineligible after screening|3|||
105331700|NCT03020992|363214651|FG000|Overall Study|Adverse Event|5|||
105440512|NCT02467582|363619145|FG001|Follow-up|Lost to Follow-up|5|||
105440513|NCT03343626|363619146|FG000|Overall Study|Lost to Follow-up|4|||
105440514|NCT03343626|363619147|FG001|Overall Study|Lost to Follow-up|3|||
105440515|NCT03343626|363619148|FG002|Overall Study|Lost to Follow-up|2|||
105440516|NCT03343626|363619149|FG003|Overall Study|Lost to Follow-up|5|||
105440517|NCT03343626|363619150|FG004|Overall Study|Lost to Follow-up|4|||
105440518|NCT03343626|363619151|FG005|Overall Study|Lost to Follow-up|4|||
105440519|NCT03343626|363619152|FG006|Overall Study|Lost to Follow-up|4|||
105440520|NCT03343626|363619153|FG007|Overall Study|Lost to Follow-up|7|||
105440521|NCT03343626|363619146|FG000|Overall Study|Withdrawal of Consent|2|||
105440522|NCT03343626|363619147|FG001|Overall Study|Withdrawal of Consent|1|||
105331701|NCT03020992|363214651|FG000|Overall Study|Withdrawal by Subject|1|||
105331702|NCT01006122|363214654|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
105331703|NCT01006122|363214655|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
105331704|NCT01006122|363214654|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
105331705|NCT01006122|363214655|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
105331706|NCT01006122|363214654|FG000|First Double-blind Intervention Period|Pregnancy|0|||
105331707|NCT01006122|363214655|FG001|First Double-blind Intervention Period|Pregnancy|1|||
105331708|NCT01006122|363214654|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
105440523|NCT03343626|363619148|FG002|Overall Study|Withdrawal of Consent|0|||
105440524|NCT03343626|363619149|FG003|Overall Study|Withdrawal of Consent|3|||
105770062|NCT00090766|364811061|FG001|Overall Study|Lost to Follow-up|0|||
105770063|NCT00090766|364811062|FG002|Overall Study|Lost to Follow-up|2|||
105770064|NCT00707486|364811063|FG000|Overall Study|Withdrawal by Subject|1|||
105770065|NCT00654368|364811064|FG000|Overall Study|Ineligibility determined|6|||
105770066|NCT00654368|364811065|FG001|Overall Study|Ineligibility determined|0|||
105770067|NCT00654368|364811066|FG002|Overall Study|Ineligibility determined|0|||
105770068|NCT00654368|364811064|FG000|Overall Study|Protocol deviation|3|||
105770069|NCT00654368|364811065|FG001|Overall Study|Protocol deviation|2|||
105440525|NCT03343626|363619150|FG004|Overall Study|Withdrawal of Consent|3|||
105440526|NCT03343626|363619151|FG005|Overall Study|Withdrawal of Consent|1|||
105770070|NCT00654368|364811066|FG002|Overall Study|Protocol deviation|1|||
105440527|NCT03343626|363619152|FG006|Overall Study|Withdrawal of Consent|1|||
105770071|NCT00654368|364811064|FG000|Overall Study|Non-compliance|2|||
105440528|NCT03343626|363619153|FG007|Overall Study|Withdrawal of Consent|2|||
105770072|NCT00654368|364811065|FG001|Overall Study|Non-compliance|1|||
105331709|NCT01006122|363214655|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
105331710|NCT01006122|363214654|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
105331711|NCT01006122|363214655|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
105331712|NCT01006122|363214654|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
105331713|NCT01006122|363214655|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
105331714|NCT01006122|363214654|FG000|First Double-blind Intervention Period|Other|3|||
105331715|NCT01006122|363214655|FG001|First Double-blind Intervention Period|Other|0|||
105331716|NCT01006122|363214654|FG000|First Double-blind Intervention Period|Adverse Event|0|||
105331717|NCT01006122|363214655|FG001|First Double-blind Intervention Period|Adverse Event|4|||
105331718|NCT01006122|363214654|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
105331719|NCT01006122|363214655|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
105331720|NCT01006122|363214654|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
105331721|NCT01006122|363214655|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
105331722|NCT01006122|363214654|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
105331723|NCT01006122|363214655|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
105331724|NCT01006122|363214654|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
105331725|NCT01006122|363214655|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
105331726|NCT01006122|363214654|FG000|Second Double-blind Intervention Period|Death|0|||
105331727|NCT01006122|363214655|FG001|Second Double-blind Intervention Period|Death|1|||
105331728|NCT01431716|363214656|FG000|Overall Study|Withdrawal of consent|1|||
105331729|NCT00634803|363214657|FG000|Overall Study|Lost to Follow-up|6|||
105331730|NCT00634803|363214658|FG001|Overall Study|Lost to Follow-up|7|||
105331731|NCT00634803|363214659|FG002|Overall Study|Lost to Follow-up|7|||
105331732|NCT01580670|363214660|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
105331733|NCT01580670|363214660|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
105331734|NCT02748356|363214661|FG000|Overall Study|Withdrawal by Subject|1|||
105331735|NCT02821754|363214662|FG000|Overall Study|Procedure not required prior to amendment change|13|||
105331736|NCT02821754|363214663|FG001|Overall Study|Procedure not required prior to amendment change|11|||
105331737|NCT02821754|363214664|FG002|Overall Study|Procedure not required prior to amendment change|0|||
105331738|NCT02821754|363214662|FG000|Overall Study|Participant's Clinical status|2|||
105331739|NCT02821754|363214663|FG001|Overall Study|Participant's Clinical status|0|||
105331740|NCT02821754|363214664|FG002|Overall Study|Participant's Clinical status|0|||
105331741|NCT02821754|363214662|FG000|Overall Study|Participant removed for noncompliance|1|||
105331742|NCT02821754|363214663|FG001|Overall Study|Participant removed for noncompliance|0|||
105331743|NCT02821754|363214664|FG002|Overall Study|Participant removed for noncompliance|0|||
105331744|NCT02821754|363214662|FG000|Overall Study|Drug not available.|0|||
105331745|NCT02821754|363214663|FG001|Overall Study|Drug not available.|0|||
105331746|NCT02821754|363214664|FG002|Overall Study|Drug not available.|1|||
105331747|NCT02821754|363214662|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
105331748|NCT02821754|363214663|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
105331749|NCT02821754|363214664|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
105331750|NCT01757184|363214667|FG000|Double-blind Period|Adverse Event|1|||
105331751|NCT01757184|363214668|FG001|Double-blind Period|Adverse Event|0|||
105331752|NCT01757184|363214669|FG002|Double-blind Period|Adverse Event|0|||
105331753|NCT01757184|363214670|FG003|Double-blind Period|Adverse Event|0|||
105331754|NCT01757184|363214667|FG000|Open-label Period|Lost to Follow-up|0|||
105331755|NCT01757184|363214668|FG001|Open-label Period|Lost to Follow-up|0|||
105331756|NCT01757184|363214669|FG002|Open-label Period|Lost to Follow-up|2|||
105331757|NCT01757184|363214670|FG003|Open-label Period|Lost to Follow-up|0|||
105331758|NCT01757184|363214667|FG000|Open-label Period|Withdrawal by Subject|0|||
105331759|NCT01757184|363214668|FG001|Open-label Period|Withdrawal by Subject|0|||
105331760|NCT01757184|363214669|FG002|Open-label Period|Withdrawal by Subject|1|||
105331761|NCT01757184|363214670|FG003|Open-label Period|Withdrawal by Subject|1|||
105331762|NCT01757184|363214667|FG000|Open-label Period|Discontinued by Sponsor|0|||
105331763|NCT01757184|363214668|FG001|Open-label Period|Discontinued by Sponsor|0|||
105331764|NCT01757184|363214669|FG002|Open-label Period|Discontinued by Sponsor|1|||
105331765|NCT01757184|363214670|FG003|Open-label Period|Discontinued by Sponsor|2|||
105331766|NCT00564850|363214679|FG000|Overall Study|Protocol Violation|2|||
105331767|NCT02640664|363214682|FG000|Epoch 1|Withdrawal of informed consent|1|||
105331768|NCT02640664|363214683|FG001|Epoch 1|Withdrawal of informed consent|0|||
105331769|NCT02640664|363214684|FG002|Epoch 1|Withdrawal of informed consent|0|||
105331770|NCT02640664|363214682|FG000|Epoch 1|Death|0|||
105331771|NCT02640664|363214683|FG001|Epoch 1|Death|0|||
105331772|NCT02640664|363214684|FG002|Epoch 1|Death|1|||
105331773|NCT02640664|363214682|FG000|Epoch 2|Withdrawal of informed consent|3|||
105331774|NCT02640664|363214683|FG001|Epoch 2|Withdrawal of informed consent|4|||
105440529|NCT03343626|363619146|FG000|Overall Study|Reason not Specified|0|||
105331775|NCT02640664|363214684|FG002|Epoch 2|Withdrawal of informed consent|2|||
105331776|NCT02640664|363214682|FG000|Epoch 2|Subject/guardian decision|0|||
105331777|NCT02640664|363214683|FG001|Epoch 2|Subject/guardian decision|2|||
105331778|NCT02640664|363214684|FG002|Epoch 2|Subject/guardian decision|2|||
105331779|NCT02640664|363214682|FG000|Epoch 2|Lost to Follow-up|3|||
105331780|NCT02640664|363214683|FG001|Epoch 2|Lost to Follow-up|4|||
105331781|NCT02640664|363214684|FG002|Epoch 2|Lost to Follow-up|1|||
105331782|NCT02640664|363214682|FG000|Epoch 2|Death|0|||
105331783|NCT02640664|363214683|FG001|Epoch 2|Death|0|||
105331784|NCT02640664|363214684|FG002|Epoch 2|Death|1|||
105331785|NCT00987337|363214685|FG000|Overall Study|Adverse Event|10|||
105331786|NCT00987337|363214686|FG001|Overall Study|Adverse Event|9|||
105331787|NCT00987337|363214687|FG002|Overall Study|Adverse Event|8|||
105331788|NCT00987337|363214685|FG000|Overall Study|Insufficient Virologic Response|10|||
105331789|NCT00987337|363214686|FG001|Overall Study|Insufficient Virologic Response|7|||
105331790|NCT00987337|363214687|FG002|Overall Study|Insufficient Virologic Response|12|||
105331791|NCT00987337|363214685|FG000|Overall Study|Virologic Breakthrough|2|||
105331792|NCT00987337|363214686|FG001|Overall Study|Virologic Breakthrough|2|||
105331793|NCT00987337|363214687|FG002|Overall Study|Virologic Breakthrough|8|||
105331794|NCT00987337|363214685|FG000|Overall Study|Lost to Follow-up|10|||
105331795|NCT00987337|363214686|FG001|Overall Study|Lost to Follow-up|6|||
105331796|NCT00987337|363214687|FG002|Overall Study|Lost to Follow-up|2|||
105331797|NCT00987337|363214685|FG000|Overall Study|Withdrawal by Subject|6|||
105331798|NCT00987337|363214686|FG001|Overall Study|Withdrawal by Subject|9|||
105331799|NCT00987337|363214687|FG002|Overall Study|Withdrawal by Subject|9|||
105331800|NCT00987337|363214685|FG000|Overall Study|Other|0|||
105331801|NCT00987337|363214686|FG001|Overall Study|Other|2|||
105331802|NCT00987337|363214687|FG002|Overall Study|Other|5|||
105331803|NCT00987337|363214685|FG000|Overall Study|Protocol Violation|1|||
105331804|NCT00987337|363214686|FG001|Overall Study|Protocol Violation|0|||
105331805|NCT00987337|363214687|FG002|Overall Study|Protocol Violation|2|||
105331806|NCT00987337|363214685|FG000|Overall Study|Participant Relapsed|18|||
105331807|NCT00987337|363214686|FG001|Overall Study|Participant Relapsed|20|||
105331808|NCT00987337|363214687|FG002|Overall Study|Participant Relapsed|5|||
105331809|NCT00603473|363214689|FG000|Overall Study|Adverse Event|4|||
105331810|NCT00603473|363214689|FG000|Overall Study|Lack of Efficacy|4|||
105331811|NCT00603473|363214689|FG000|Overall Study|Protocol Violation|1|||
105331812|NCT00489918|363214690|FG000|Overall Study|Withdrawal by Subject|2|||
105331813|NCT00489918|363214691|FG001|Overall Study|Withdrawal by Subject|1|||
105331814|NCT00489918|363214692|FG002|Overall Study|Withdrawal by Subject|1|||
105331815|NCT00489918|363214693|FG003|Overall Study|Withdrawal by Subject|0|||
105331816|NCT00489918|363214694|FG004|Overall Study|Withdrawal by Subject|1|||
105331817|NCT00489918|363214690|FG000|Overall Study|Adverse Event|0|||
105331818|NCT00489918|363214691|FG001|Overall Study|Adverse Event|1|||
105331819|NCT00489918|363214692|FG002|Overall Study|Adverse Event|1|||
105331820|NCT00489918|363214693|FG003|Overall Study|Adverse Event|0|||
105331821|NCT00489918|363214694|FG004|Overall Study|Adverse Event|0|||
105331822|NCT00489918|363214690|FG000|Overall Study|Lost to Follow-up|0|||
105331823|NCT00489918|363214691|FG001|Overall Study|Lost to Follow-up|0|||
105331824|NCT00489918|363214692|FG002|Overall Study|Lost to Follow-up|1|||
105331825|NCT00489918|363214693|FG003|Overall Study|Lost to Follow-up|1|||
105331826|NCT00489918|363214694|FG004|Overall Study|Lost to Follow-up|0|||
105331827|NCT00489918|363214690|FG000|Overall Study|Physician Decision|0|||
105331828|NCT00489918|363214691|FG001|Overall Study|Physician Decision|0|||
105331829|NCT00489918|363214692|FG002|Overall Study|Physician Decision|1|||
105331830|NCT00489918|363214693|FG003|Overall Study|Physician Decision|0|||
105331831|NCT00489918|363214694|FG004|Overall Study|Physician Decision|0|||
105331832|NCT01209520|363214695|FG000|Overall Study|Withdrawal by Subject|3|||
105331833|NCT00617890|363216167|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
105331834|NCT00617890|363216168|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
105331835|NCT00617890|363216169|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
105331836|NCT00617890|363216170|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
105331837|NCT00617890|363216167|FG000|Overall Study|Lack of Efficacy|23|||
105331838|NCT00617890|363216168|FG001|Overall Study|Lack of Efficacy|26|||
105331839|NCT00617890|363216169|FG002|Overall Study|Lack of Efficacy|30|||
105331840|NCT00617890|363216170|FG003|Overall Study|Lack of Efficacy|97|||
105331841|NCT00617890|363216167|FG000|Overall Study|Lost to Follow-up|0|||
105331842|NCT00617890|363216168|FG001|Overall Study|Lost to Follow-up|0|||
105331843|NCT00617890|363216169|FG002|Overall Study|Lost to Follow-up|1|||
105331844|NCT00617890|363216170|FG003|Overall Study|Lost to Follow-up|2|||
105331845|NCT00617890|363216167|FG000|Overall Study|Withdrawal by Subject|4|||
105331846|NCT00617890|363216168|FG001|Overall Study|Withdrawal by Subject|1|||
105331847|NCT00617890|363216169|FG002|Overall Study|Withdrawal by Subject|0|||
105331848|NCT00617890|363216170|FG003|Overall Study|Withdrawal by Subject|2|||
105331849|NCT00617890|363216167|FG000|Overall Study|Protocol Violation|2|||
105331850|NCT00617890|363216168|FG001|Overall Study|Protocol Violation|1|||
105331851|NCT00617890|363216169|FG002|Overall Study|Protocol Violation|0|||
105331852|NCT00617890|363216170|FG003|Overall Study|Protocol Violation|0|||
105331853|NCT00617890|363216167|FG000|Overall Study|Adverse Event|1|||
105331854|NCT00617890|363216168|FG001|Overall Study|Adverse Event|0|||
105331855|NCT00617890|363216169|FG002|Overall Study|Adverse Event|3|||
105331856|NCT00617890|363216170|FG003|Overall Study|Adverse Event|8|||
105331857|NCT00617890|363216167|FG000|Overall Study|Not treated|1|||
105331858|NCT00617890|363216168|FG001|Overall Study|Not treated|0|||
105331859|NCT00617890|363216169|FG002|Overall Study|Not treated|1|||
105331860|NCT00617890|363216170|FG003|Overall Study|Not treated|1|||
105331861|NCT02027545|363216172|FG000|Overall Study|Failed to sign HIPAA|0|||
105331862|NCT02027545|363216173|FG001|Overall Study|Failed to sign HIPAA|2|||
105331863|NCT02027545|363216172|FG000|Overall Study|Failed to attend study visit|2|||
105331864|NCT02027545|363216173|FG001|Overall Study|Failed to attend study visit|0|||
105331865|NCT02027545|363216172|FG000|Overall Study|Protocol Violation|1|||
105331866|NCT02027545|363216173|FG001|Overall Study|Protocol Violation|0|||
105331867|NCT02453334|363216174|FG000|Overall Study|Death|15|||
105331868|NCT02453334|363216175|FG001|Overall Study|Death|13|||
105331869|NCT02453334|363216174|FG000|Overall Study|Adverse Event|2|||
105331870|NCT02453334|363216175|FG001|Overall Study|Adverse Event|1|||
105331871|NCT02453334|363216174|FG000|Overall Study|Lost to Follow-up|5|||
105331872|NCT02453334|363216175|FG001|Overall Study|Lost to Follow-up|9|||
105331873|NCT02453334|363216174|FG000|Overall Study|Physician Decision|1|||
105331874|NCT02453334|363216175|FG001|Overall Study|Physician Decision|0|||
105331875|NCT02453334|363216174|FG000|Overall Study|Withdrawal by Subject|17|||
105331876|NCT02453334|363216175|FG001|Overall Study|Withdrawal by Subject|13|||
105331877|NCT02453334|363216174|FG000|Overall Study|Other reason|1|||
105331878|NCT02453334|363216175|FG001|Overall Study|Other reason|4|||
105331879|NCT01372618|363216180|FG000|Overall Study|PI Died. Study Terminated|9|||
105331880|NCT02801617|363216181|FG000|Overall Study|Protocol Violation|2|||
105331881|NCT02801617|363216182|FG001|Overall Study|Protocol Violation|6|||
105331882|NCT01954056|363216183|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
105331883|NCT01954056|363216184|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
105331884|NCT06110494|363216190|FG000|Overall Study|Protocol Violation|2|||
105331885|NCT06110494|363216191|FG001|Overall Study|Protocol Violation|0|||
105331886|NCT06110494|363216192|FG002|Overall Study|Protocol Violation|1|||
105331887|NCT06110494|363216190|FG000|Overall Study|Dixon's test for outlier analysis|1|||
105331888|NCT06110494|363216191|FG001|Overall Study|Dixon's test for outlier analysis|1|||
105331889|NCT06110494|363216192|FG002|Overall Study|Dixon's test for outlier analysis|0|||
105440530|NCT03343626|363619147|FG001|Overall Study|Reason not Specified|1|||
105440531|NCT03343626|363619148|FG002|Overall Study|Reason not Specified|0|||
105440532|NCT03343626|363619149|FG003|Overall Study|Reason not Specified|0|||
105440533|NCT03343626|363619150|FG004|Overall Study|Reason not Specified|0|||
105440534|NCT03343626|363619151|FG005|Overall Study|Reason not Specified|0|||
105440535|NCT03343626|363619152|FG006|Overall Study|Reason not Specified|0|||
105440536|NCT03343626|363619153|FG007|Overall Study|Reason not Specified|1|||
105770073|NCT00654368|364811066|FG002|Overall Study|Non-compliance|2|||
105770074|NCT00654368|364811064|FG000|Overall Study|Withdrawal by Subject|5|||
105770075|NCT00654368|364811065|FG001|Overall Study|Withdrawal by Subject|2|||
105770076|NCT00654368|364811066|FG002|Overall Study|Withdrawal by Subject|2|||
105770077|NCT00654368|364811064|FG000|Overall Study|Disease progression|21|||
105770078|NCT00654368|364811065|FG001|Overall Study|Disease progression|31|||
105770079|NCT00654368|364811066|FG002|Overall Study|Disease progression|13|||
105770080|NCT00654368|364811064|FG000|Overall Study|Requirement for alternative therapy|1|||
105770081|NCT00654368|364811065|FG001|Overall Study|Requirement for alternative therapy|1|||
105770082|NCT00654368|364811066|FG002|Overall Study|Requirement for alternative therapy|1|||
105770083|NCT00654368|364811064|FG000|Overall Study|Physician Decision|0|||
105770084|NCT00654368|364811065|FG001|Overall Study|Physician Decision|0|||
105770085|NCT00654368|364811066|FG002|Overall Study|Physician Decision|2|||
105770086|NCT00654368|364811064|FG000|Overall Study|Death|1|||
105770087|NCT00654368|364811065|FG001|Overall Study|Death|0|||
105770088|NCT00654368|364811066|FG002|Overall Study|Death|0|||
105770089|NCT00654368|364811064|FG000|Overall Study|Pregnancy|0|||
105770090|NCT00654368|364811065|FG001|Overall Study|Pregnancy|0|||
105770091|NCT00654368|364811066|FG002|Overall Study|Pregnancy|2|||
105770092|NCT00654368|364811064|FG000|Overall Study|Other|0|||
105770093|NCT00654368|364811065|FG001|Overall Study|Other|2|||
105770094|NCT00654368|364811066|FG002|Overall Study|Other|3|||
105770095|NCT00654368|364811064|FG000|Overall Study|Adverse Event|14|||
105770096|NCT00654368|364811065|FG001|Overall Study|Adverse Event|9|||
105770097|NCT00654368|364811066|FG002|Overall Study|Adverse Event|6|||
105770098|NCT00804986|364811073|FG000|Overall Study|Adverse Event|0|||
105770099|NCT00804986|364811074|FG001|Overall Study|Adverse Event|1|||
105770100|NCT00804986|364811075|FG002|Overall Study|Adverse Event|2|||
105331890|NCT01464593|363216193|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
105331891|NCT01288937|363216198|FG000|Overall Study|Adverse Event|1|||
105331892|NCT01288937|363216199|FG001|Overall Study|Adverse Event|0|||
105331893|NCT02230904|363216200|FG000|Overall Study|Safety follow up could not take place|0|||
105770101|NCT00804986|364811076|FG003|Overall Study|Adverse Event|1|||
105770102|NCT00804986|364811077|FG004|Overall Study|Adverse Event|3|||
105770103|NCT00804986|364811078|FG005|Overall Study|Adverse Event|0|||
105770104|NCT00804986|364811073|FG000|Overall Study|Lack of Efficacy|0|||
105770105|NCT00804986|364811074|FG001|Overall Study|Lack of Efficacy|0|||
105770106|NCT00804986|364811075|FG002|Overall Study|Lack of Efficacy|0|||
105770107|NCT00804986|364811076|FG003|Overall Study|Lack of Efficacy|1|||
105770108|NCT00804986|364811077|FG004|Overall Study|Lack of Efficacy|0|||
105770109|NCT00804986|364811078|FG005|Overall Study|Lack of Efficacy|3|||
105331894|NCT02230904|363216201|FG001|Overall Study|Safety follow up could not take place|1|||
105331895|NCT01681212|363216204|FG000|Overall Study|No longer met study criteria|5|||
105331896|NCT01681212|363216204|FG000|Overall Study|Administrative reason by sponsor|1|||
105331897|NCT01560234|363216205|FG000|Overall Study|Lost to Follow-up|3|||
105331898|NCT01560234|363216206|FG001|Overall Study|Lost to Follow-up|0|||
105331899|NCT01560234|363216207|FG002|Overall Study|Lost to Follow-up|1|||
105331900|NCT01560234|363216208|FG003|Overall Study|Lost to Follow-up|0|||
105331901|NCT01560234|363216209|FG004|Overall Study|Lost to Follow-up|0|||
105331902|NCT01560234|363216210|FG005|Overall Study|Lost to Follow-up|2|||
105331903|NCT01560234|363216211|FG006|Overall Study|Lost to Follow-up|0|||
105331904|NCT01560234|363216212|FG007|Overall Study|Lost to Follow-up|2|||
105331905|NCT02914613|363216213|FG000|Overall Study|Withdrawal by Subject|1|||
105331906|NCT02914613|363216214|FG001|Overall Study|Withdrawal by Subject|2|||
105331907|NCT02914613|363216213|FG000|Overall Study|Adverse Event|1|||
105331908|NCT02914613|363216214|FG001|Overall Study|Adverse Event|0|||
105331909|NCT01964222|363216219|FG000|Overall Study|Lost to Follow-up|7|||
105331910|NCT01964222|363216220|FG001|Overall Study|Lost to Follow-up|5|||
105331911|NCT01964222|363216219|FG000|Overall Study|Withdrawal by Subject|6|||
105331912|NCT01964222|363216220|FG001|Overall Study|Withdrawal by Subject|6|||
105331913|NCT01964222|363216219|FG000|Overall Study|Screening Failure|2|||
105331914|NCT01964222|363216220|FG001|Overall Study|Screening Failure|0|||
105331915|NCT01455597|363216223|FG000|Overall Study|Adverse Event|7|||
105331916|NCT01455597|363216224|FG001|Overall Study|Adverse Event|0|||
105331917|NCT01455597|363216225|FG002|Overall Study|Adverse Event|5|||
105331918|NCT01455597|363216226|FG003|Overall Study|Adverse Event|1|||
105331919|NCT01455597|363216223|FG000|Overall Study|Lack of Efficacy|0|||
105331920|NCT01455597|363216224|FG001|Overall Study|Lack of Efficacy|1|||
105331921|NCT01455597|363216225|FG002|Overall Study|Lack of Efficacy|2|||
105331922|NCT01455597|363216226|FG003|Overall Study|Lack of Efficacy|0|||
105331923|NCT01455597|363216223|FG000|Overall Study|Lost to Follow-up|3|||
105331924|NCT01455597|363216224|FG001|Overall Study|Lost to Follow-up|0|||
105331925|NCT01455597|363216225|FG002|Overall Study|Lost to Follow-up|2|||
105331926|NCT01455597|363216226|FG003|Overall Study|Lost to Follow-up|1|||
105331927|NCT01455597|363216223|FG000|Overall Study|Withdrew Consent|6|||
105331928|NCT01455597|363216224|FG001|Overall Study|Withdrew Consent|5|||
105331929|NCT01455597|363216225|FG002|Overall Study|Withdrew Consent|8|||
105331930|NCT01455597|363216226|FG003|Overall Study|Withdrew Consent|5|||
105331931|NCT01455597|363216223|FG000|Overall Study|Reason not Specified|1|||
105331932|NCT01455597|363216224|FG001|Overall Study|Reason not Specified|2|||
105331933|NCT01455597|363216225|FG002|Overall Study|Reason not Specified|3|||
105331934|NCT01455597|363216226|FG003|Overall Study|Reason not Specified|3|||
105331935|NCT03412734|363216227|FG000|Overall Study|Incorrect labeling of samples|2|||
105331936|NCT03412734|363216228|FG001|Overall Study|Incorrect labeling of samples|0|||
105331937|NCT03412734|363216227|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
105331938|NCT03412734|363216228|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
105440537|NCT03343626|363619146|FG000|Overall Study|Data Entry Error|0|||
105440538|NCT03343626|363619147|FG001|Overall Study|Data Entry Error|0|||
105440539|NCT03343626|363619148|FG002|Overall Study|Data Entry Error|0|||
105331939|NCT00758485|363216230|FG000|Overall Study|Lost to Follow-up|0|||
105440540|NCT03343626|363619149|FG003|Overall Study|Data Entry Error|0|||
105440541|NCT03343626|363619150|FG004|Overall Study|Data Entry Error|0|||
105440542|NCT03343626|363619151|FG005|Overall Study|Data Entry Error|0|||
105440543|NCT03343626|363619152|FG006|Overall Study|Data Entry Error|0|||
105440544|NCT03343626|363619153|FG007|Overall Study|Data Entry Error|1|||
105440545|NCT00602420|363619154|FG000|Overall Study|Death|1|||
105440546|NCT00602420|363619155|FG001|Overall Study|Death|4|||
105440547|NCT00602420|363619154|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
105440548|NCT00602420|363619155|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
105440549|NCT00602420|363619154|FG000|Overall Study|Withdrawal by Subject|18|||
105440550|NCT00602420|363619155|FG001|Overall Study|Withdrawal by Subject|17|||
105440551|NCT00602420|363619154|FG000|Overall Study|Adverse Event|1|||
105440552|NCT00602420|363619155|FG001|Overall Study|Adverse Event|0|||
105440553|NCT00703924|363619162|FG000|Overall Study|Withdrawal by Subject|1|||
105440554|NCT00703924|363619163|FG001|Overall Study|Withdrawal by Subject|1|||
105659652|NCT01010204|364418798|FG001|Overall Study|Lost to Follow-up|2|||
105331940|NCT00758485|363216231|FG001|Overall Study|Lost to Follow-up|1|||
105331941|NCT00758485|363216230|FG000|Overall Study|Not Treated|1|||
105331942|NCT00758485|363216231|FG001|Overall Study|Not Treated|2|||
105440555|NCT03077919|363619164|FG000|Overall Study|Lost to Follow-up|4|||
105440556|NCT03077919|363619165|FG001|Overall Study|Lost to Follow-up|1|||
105331943|NCT02347774|363216232|FG000|Study Participation|Lost to Follow-up|3|||
105331944|NCT02347774|363216233|FG001|Study Participation|Lost to Follow-up|6|||
105331945|NCT02347774|363216234|FG002|Study Participation|Lost to Follow-up|2|||
105331946|NCT02347774|363216232|FG000|Study Participation|Withdrawal by Subject|8|||
105331947|NCT02347774|363216233|FG001|Study Participation|Withdrawal by Subject|9|||
105440557|NCT03738618|363619166|FG000|Overall Study|Protocol deviation|23|||
105440558|NCT03738618|363619167|FG001|Overall Study|Protocol deviation|0|||
105440559|NCT03738618|363619166|FG000|Overall Study|Adverse Event|4|||
105659653|NCT01010204|364418797|FG000|Overall Study|Adverse Event|1|||
105770110|NCT00804986|364811073|FG000|Overall Study|Lost to Follow-up|0|||
105770111|NCT00804986|364811074|FG001|Overall Study|Lost to Follow-up|0|||
105770112|NCT00804986|364811075|FG002|Overall Study|Lost to Follow-up|0|||
105770113|NCT00804986|364811076|FG003|Overall Study|Lost to Follow-up|1|||
105770114|NCT00804986|364811077|FG004|Overall Study|Lost to Follow-up|1|||
105770115|NCT00804986|364811078|FG005|Overall Study|Lost to Follow-up|3|||
105770116|NCT00804986|364811073|FG000|Overall Study|Protocol Violation|0|||
105770117|NCT00804986|364811074|FG001|Overall Study|Protocol Violation|1|||
105770118|NCT00804986|364811075|FG002|Overall Study|Protocol Violation|0|||
105770119|NCT00804986|364811076|FG003|Overall Study|Protocol Violation|1|||
105770120|NCT00804986|364811077|FG004|Overall Study|Protocol Violation|0|||
105770121|NCT00804986|364811078|FG005|Overall Study|Protocol Violation|0|||
105770122|NCT00804986|364811073|FG000|Overall Study|Withdrawal by Subject|0|||
105770123|NCT00804986|364811074|FG001|Overall Study|Withdrawal by Subject|3|||
105770124|NCT00804986|364811075|FG002|Overall Study|Withdrawal by Subject|0|||
105770125|NCT00804986|364811076|FG003|Overall Study|Withdrawal by Subject|3|||
105770126|NCT00804986|364811077|FG004|Overall Study|Withdrawal by Subject|5|||
105770127|NCT00804986|364811078|FG005|Overall Study|Withdrawal by Subject|3|||
105770128|NCT00804986|364811073|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
105770129|NCT00804986|364811074|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
105770130|NCT00804986|364811075|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
105770131|NCT00804986|364811076|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
105770132|NCT00804986|364811077|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
105770133|NCT00804986|364811078|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
105770134|NCT00804986|364811073|FG000|Overall Study|Sponsor Decision|0|||
105770135|NCT00804986|364811074|FG001|Overall Study|Sponsor Decision|1|||
105770136|NCT00804986|364811075|FG002|Overall Study|Sponsor Decision|0|||
105770137|NCT00804986|364811076|FG003|Overall Study|Sponsor Decision|0|||
105770138|NCT00804986|364811077|FG004|Overall Study|Sponsor Decision|0|||
105770139|NCT00804986|364811078|FG005|Overall Study|Sponsor Decision|0|||
105770140|NCT00804986|364811073|FG000|Overall Study|Physician Decision|1|||
105770141|NCT00804986|364811074|FG001|Overall Study|Physician Decision|0|||
105770142|NCT00804986|364811075|FG002|Overall Study|Physician Decision|0|||
105770143|NCT00804986|364811076|FG003|Overall Study|Physician Decision|0|||
105770144|NCT00804986|364811077|FG004|Overall Study|Physician Decision|0|||
105770145|NCT00804986|364811078|FG005|Overall Study|Physician Decision|0|||
105770146|NCT01602744|364811079|FG000|Overall Study|Death|17|||
105770147|NCT01602744|364811080|FG001|Overall Study|Death|15|||
105770148|NCT01602744|364811079|FG000|Overall Study|Lost to Follow-up|13|||
105770149|NCT01602744|364811080|FG001|Overall Study|Lost to Follow-up|8|||
105770150|NCT00959699|364811085|FG000|Treatment Period|Adverse Event|3|||
105770151|NCT00959699|364811086|FG001|Treatment Period|Adverse Event|13|||
105770152|NCT00959699|364811085|FG000|Treatment Period|Lack of Efficacy|15|||
105770153|NCT00959699|364811086|FG001|Treatment Period|Lack of Efficacy|6|||
105770154|NCT00959699|364811085|FG000|Treatment Period|Lost to Follow-up|0|||
105770155|NCT00959699|364811086|FG001|Treatment Period|Lost to Follow-up|1|||
105770156|NCT00959699|364811085|FG000|Treatment Period|Withdrawal by Subject|1|||
105770157|NCT00959699|364811086|FG001|Treatment Period|Withdrawal by Subject|3|||
105770158|NCT00959699|364811085|FG000|Treatment Period|Non-Compliance with Protocol|0|||
105770159|NCT00959699|364811086|FG001|Treatment Period|Non-Compliance with Protocol|1|||
105770160|NCT00959699|364811085|FG000|Treatment Period|Did not receive treatment|0|||
105770161|NCT00959699|364811086|FG001|Treatment Period|Did not receive treatment|1|||
105770162|NCT00959699|364811085|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
105770163|NCT00959699|364811086|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
105770164|NCT00959699|364811085|FG000|Follow-up Period|Lost to Follow-up|3|||
105770165|NCT00959699|364811086|FG001|Follow-up Period|Lost to Follow-up|2|||
105770166|NCT00959699|364811085|FG000|Follow-up Period|Withdrawal by Subject|3|||
105770167|NCT00959699|364811086|FG001|Follow-up Period|Withdrawal by Subject|4|||
105770168|NCT00606294|364811091|FG000|Overall Study|Withdrawal by Subject|36|||
105770169|NCT00606294|364811092|FG001|Overall Study|Withdrawal by Subject|0|||
105770170|NCT01387594|364811094|FG000|Overall Study|Withdrawal by Subject|0|||
105770171|NCT01387594|364811095|FG001|Overall Study|Withdrawal by Subject|2|||
105770172|NCT01387594|364811094|FG000|Overall Study|Lost to Follow-up|0|||
105770173|NCT01387594|364811095|FG001|Overall Study|Lost to Follow-up|1|||
105770174|NCT02332876|364811096|FG000|Overall Study|Lost to Follow-up|1|||
105770175|NCT02332876|364811097|FG001|Overall Study|Lost to Follow-up|1|||
105770176|NCT00471315|364811100|FG000|Overall Study|Adverse Event|7|||
105770177|NCT00471315|364811100|FG000|Overall Study|Withdrawal by Subject|1|||
105770178|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
105770179|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
105770180|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
105770181|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
105770182|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
105770183|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
105770184|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
105440560|NCT03738618|363619167|FG001|Overall Study|Adverse Event|0|||
105440561|NCT03738618|363619166|FG000|Overall Study|Lost to Follow-up|2|||
105440562|NCT03738618|363619167|FG001|Overall Study|Lost to Follow-up|0|||
105440563|NCT03738618|363619166|FG000|Overall Study|Randomization failure|1|||
105770185|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
105770186|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
105770187|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
105770188|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
105770189|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105770190|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
105770191|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
105770192|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
105770193|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
105770194|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
105770195|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
105770196|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
105770197|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
105770198|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
105770199|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
105770200|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
105770201|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
105770202|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Screen failure|0|||
105770203|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Screen failure|1|||
105770204|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Screen failure|2|||
105770205|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Screen failure|0|||
105770206|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
105770207|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
105770208|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
105770209|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
105770210|NCT02614261|364811101|FG000|Open-Label Extension Phase|Adverse Event|23|||
105440564|NCT03738618|363619167|FG001|Overall Study|Randomization failure|0|||
105440565|NCT03738618|363619166|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
105440566|NCT03738618|363619167|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
105440567|NCT03738618|363619166|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
105770211|NCT02614261|364811102|FG001|Open-Label Extension Phase|Adverse Event|12|||
105770212|NCT02614261|364811103|FG002|Open-Label Extension Phase|Adverse Event|11|||
105770213|NCT02614261|364811104|FG003|Open-Label Extension Phase|Adverse Event|0|||
105440568|NCT03738618|363619167|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
105440569|NCT03831100|363619169|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
105440570|NCT03831100|363619170|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
105440571|NCT02008227|363619174|FG000|Overall Study|Lost to Follow-up|7|||
105440572|NCT02008227|363619175|FG001|Overall Study|Lost to Follow-up|9|||
105440573|NCT02008227|363619174|FG000|Overall Study|Death|494|||
105440574|NCT02008227|363619175|FG001|Overall Study|Death|485|||
105440575|NCT02008227|363619174|FG000|Overall Study|Withdrawal by Subject|67|||
105440576|NCT02008227|363619175|FG001|Overall Study|Withdrawal by Subject|36|||
105440577|NCT02008227|363619174|FG000|Overall Study|Study Terminated By Sponsor|44|||
105440578|NCT02008227|363619175|FG001|Overall Study|Study Terminated By Sponsor|83|||
105440579|NCT03354273|363619178|FG000|Overall Study|Adverse Event|5|||
105440580|NCT03354273|363619178|FG000|Overall Study|Screen Failure|21|||
105440581|NCT03354273|363619178|FG000|Overall Study|Withdrawal by Subject|34|||
105440582|NCT03354273|363619178|FG000|Overall Study|Technical Problems|30|||
105440583|NCT03354273|363619178|FG000|Overall Study|Lost to Follow-up|4|||
105440584|NCT03354273|363619178|FG000|Overall Study|Investigator Decision|3|||
105440585|NCT03354273|363619178|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
105440586|NCT03354273|363619178|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
105440587|NCT03354273|363619178|FG000|Overall Study|COVID-19 Restrictions|9|||
105440588|NCT03354273|363619178|FG000|Overall Study|Other|5|||
105440589|NCT03229109|363619179|FG000|Overall Study|Withdrawal by Subject|0|||
105440590|NCT03229109|363619180|FG001|Overall Study|Withdrawal by Subject|0|||
105440591|NCT03229109|363619181|FG002|Overall Study|Withdrawal by Subject|0|||
105440592|NCT03229109|363619182|FG003|Overall Study|Withdrawal by Subject|1|||
105440593|NCT00655629|363619183|FG000|Overall Study|Adverse Event|4|||
105440594|NCT00655629|363619184|FG001|Overall Study|Adverse Event|1|||
105440595|NCT00655629|363619183|FG000|Overall Study|Lack of Efficacy|2|||
105659654|NCT01010204|364418798|FG001|Overall Study|Adverse Event|3|||
105770214|NCT02614261|364811101|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
105440596|NCT00655629|363619184|FG001|Overall Study|Lack of Efficacy|12|||
105440597|NCT00655629|363619183|FG000|Overall Study|Lost to Follow-up|4|||
105440598|NCT00655629|363619184|FG001|Overall Study|Lost to Follow-up|3|||
105770215|NCT02614261|364811102|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
105659655|NCT01010204|364418797|FG000|Overall Study|Withdrawal by Subject|2|||
105659656|NCT01010204|364418798|FG001|Overall Study|Withdrawal by Subject|3|||
105659657|NCT01010204|364418797|FG000|Overall Study|psychiatric hospitalization|2|||
105770216|NCT02614261|364811103|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
105770217|NCT02614261|364811104|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
105770218|NCT02614261|364811101|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
105770219|NCT02614261|364811102|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
105770220|NCT02614261|364811103|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
105770221|NCT02614261|364811104|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
105770222|NCT02614261|364811101|FG000|Open-Label Extension Phase|Physician Decision|2|||
105770223|NCT02614261|364811102|FG001|Open-Label Extension Phase|Physician Decision|0|||
105770224|NCT02614261|364811103|FG002|Open-Label Extension Phase|Physician Decision|0|||
105770225|NCT02614261|364811104|FG003|Open-Label Extension Phase|Physician Decision|0|||
105770226|NCT02614261|364811101|FG000|Open-Label Extension Phase|Pregnancy|1|||
105770227|NCT02614261|364811102|FG001|Open-Label Extension Phase|Pregnancy|2|||
105770228|NCT02614261|364811103|FG002|Open-Label Extension Phase|Pregnancy|1|||
105770229|NCT02614261|364811104|FG003|Open-Label Extension Phase|Pregnancy|0|||
105770230|NCT02614261|364811101|FG000|Open-Label Extension Phase|Protocol Violation|3|||
105770231|NCT02614261|364811102|FG001|Open-Label Extension Phase|Protocol Violation|4|||
105770232|NCT02614261|364811103|FG002|Open-Label Extension Phase|Protocol Violation|1|||
105770233|NCT02614261|364811104|FG003|Open-Label Extension Phase|Protocol Violation|0|||
105770234|NCT02614261|364811101|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
105770235|NCT02614261|364811102|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
105770236|NCT02614261|364811103|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
105770237|NCT02614261|364811104|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
105770238|NCT02614261|364811101|FG000|Follow-up Phase|Adverse Event|2|||
105770239|NCT02614261|364811102|FG001|Follow-up Phase|Adverse Event|0|||
105770240|NCT02614261|364811103|FG002|Follow-up Phase|Adverse Event|1|||
105770241|NCT02614261|364811104|FG003|Follow-up Phase|Adverse Event|0|||
105770242|NCT02614261|364811101|FG000|Follow-up Phase|Lost to Follow-up|12|||
105770243|NCT02614261|364811102|FG001|Follow-up Phase|Lost to Follow-up|5|||
105770244|NCT02614261|364811103|FG002|Follow-up Phase|Lost to Follow-up|2|||
105770245|NCT02614261|364811104|FG003|Follow-up Phase|Lost to Follow-up|0|||
105770246|NCT02614261|364811101|FG000|Follow-up Phase|Physician Decision|5|||
105770247|NCT02614261|364811102|FG001|Follow-up Phase|Physician Decision|1|||
105770248|NCT02614261|364811103|FG002|Follow-up Phase|Physician Decision|0|||
105770249|NCT02614261|364811104|FG003|Follow-up Phase|Physician Decision|0|||
105770250|NCT02614261|364811101|FG000|Follow-up Phase|Pregnancy|0|||
105770251|NCT02614261|364811102|FG001|Follow-up Phase|Pregnancy|1|||
105770252|NCT02614261|364811103|FG002|Follow-up Phase|Pregnancy|0|||
105770253|NCT02614261|364811104|FG003|Follow-up Phase|Pregnancy|0|||
105770254|NCT02614261|364811101|FG000|Follow-up Phase|Protocol Violation|1|||
105770255|NCT02614261|364811102|FG001|Follow-up Phase|Protocol Violation|0|||
105770256|NCT02614261|364811103|FG002|Follow-up Phase|Protocol Violation|0|||
105770257|NCT02614261|364811104|FG003|Follow-up Phase|Protocol Violation|0|||
105770258|NCT02614261|364811101|FG000|Follow-up Phase|Withdrawal by Subject|12|||
105770259|NCT02614261|364811102|FG001|Follow-up Phase|Withdrawal by Subject|4|||
105770260|NCT02614261|364811103|FG002|Follow-up Phase|Withdrawal by Subject|11|||
105770261|NCT02614261|364811104|FG003|Follow-up Phase|Withdrawal by Subject|0|||
105770262|NCT02614261|364811101|FG000|Israel Addendum|Withdrawal by Subject|0|||
105770263|NCT02614261|364811102|FG001|Israel Addendum|Withdrawal by Subject|0|||
105770264|NCT02614261|364811103|FG002|Israel Addendum|Withdrawal by Subject|0|||
105770265|NCT02614261|364811104|FG003|Israel Addendum|Withdrawal by Subject|4|||
105770266|NCT03860844|364811106|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
105770267|NCT03860844|364811107|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
105770268|NCT03860844|364811108|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
105770269|NCT03860844|364811106|FG000|Overall Study|Progressive disease|5|||
105770270|NCT03860844|364811107|FG001|Overall Study|Progressive disease|3|||
105770271|NCT03860844|364811108|FG002|Overall Study|Progressive disease|4|||
105770272|NCT03860844|364811106|FG000|Overall Study|Other, Not related to COVID-19|0|||
105331948|NCT02347774|363216234|FG002|Study Participation|Withdrawal by Subject|15|||
105331949|NCT02347774|363216232|FG000|Study Participation|Adverse Event|1|||
105331950|NCT02347774|363216233|FG001|Study Participation|Adverse Event|4|||
105331951|NCT02347774|363216234|FG002|Study Participation|Adverse Event|6|||
105331952|NCT02347774|363216232|FG000|Study Participation|withdrew consent|1|||
105331953|NCT02347774|363216233|FG001|Study Participation|withdrew consent|1|||
105331954|NCT02347774|363216234|FG002|Study Participation|withdrew consent|1|||
105331955|NCT02347774|363216232|FG000|Study Participation|Met Prolonged QT criteria|1|||
105331956|NCT02347774|363216233|FG001|Study Participation|Met Prolonged QT criteria|0|||
105331957|NCT02347774|363216234|FG002|Study Participation|Met Prolonged QT criteria|0|||
105331958|NCT02347774|363216232|FG000|Study Participation|non-compliance with study drug|0|||
105331959|NCT02347774|363216233|FG001|Study Participation|non-compliance with study drug|1|||
105770273|NCT03860844|364811107|FG001|Overall Study|Other, Not related to COVID-19|1|||
105770274|NCT03860844|364811108|FG002|Overall Study|Other, Not related to COVID-19|0|||
105440599|NCT00655629|363619183|FG000|Overall Study|Protocol Violation|5|||
105440600|NCT00655629|363619184|FG001|Overall Study|Protocol Violation|3|||
105440601|NCT00655629|363619183|FG000|Overall Study|consent withdrawn|6|||
105440602|NCT00655629|363619184|FG001|Overall Study|consent withdrawn|4|||
105440603|NCT04440813|363619187|FG000|Overall Study|Lost to Follow-up|5|||
105440604|NCT04440813|363619188|FG001|Overall Study|Lost to Follow-up|5|||
105440605|NCT01610336|363619189|FG000|Overall Study|Progressive Disease|4|||
105440606|NCT01610336|363619190|FG001|Overall Study|Progressive Disease|6|||
105440607|NCT01610336|363619191|FG002|Overall Study|Progressive Disease|6|||
105440608|NCT01610336|363619192|FG003|Overall Study|Progressive Disease|5|||
105440609|NCT01610336|363619193|FG004|Overall Study|Progressive Disease|3|||
105331960|NCT02347774|363216234|FG002|Study Participation|non-compliance with study drug|0|||
105331961|NCT02347774|363216232|FG000|Study Participation|incarceration|1|||
105331962|NCT02347774|363216233|FG001|Study Participation|incarceration|0|||
105331963|NCT02347774|363216234|FG002|Study Participation|incarceration|0|||
105331964|NCT02347774|363216232|FG000|Study Participation|randomized in error|0|||
105331965|NCT02347774|363216233|FG001|Study Participation|randomized in error|0|||
105440610|NCT01610336|363619194|FG005|Overall Study|Progressive Disease|10|||
105770275|NCT03512275|364811109|FG000|Overall Study|Withdrawal by Subject|1|||
105770276|NCT03512275|364811110|FG001|Overall Study|Withdrawal by Subject|3|||
105770277|NCT03512275|364811109|FG000|Overall Study|Physician Decision|0|||
105770278|NCT03512275|364811110|FG001|Overall Study|Physician Decision|1|||
105770279|NCT03512275|364811109|FG000|Overall Study|Lost to Follow-up|0|||
105770280|NCT03512275|364811110|FG001|Overall Study|Lost to Follow-up|3|||
105770281|NCT03512275|364811109|FG000|Overall Study|Other|1|||
105770282|NCT03512275|364811110|FG001|Overall Study|Other|0|||
105770283|NCT03073200|364811111|FG000|Double Blind Treatment Period|Protocol Violation|1|||
105770284|NCT03073200|364811112|FG001|Double Blind Treatment Period|Protocol Violation|0|||
105770285|NCT03073200|364811113|FG002|Double Blind Treatment Period|Protocol Violation|0|||
105770286|NCT03073200|364811114|FG003|Double Blind Treatment Period|Protocol Violation|0|||
105770287|NCT03073200|364811115|FG004|Double Blind Treatment Period|Protocol Violation|0|||
105770288|NCT03073200|364811116|FG005|Double Blind Treatment Period|Protocol Violation|0|||
105770289|NCT03073200|364811117|FG006|Double Blind Treatment Period|Protocol Violation|0|||
105770290|NCT03073200|364811118|FG007|Double Blind Treatment Period|Protocol Violation|0|||
105770291|NCT03073200|364811119|FG008|Double Blind Treatment Period|Protocol Violation|0|||
105770292|NCT03073200|364811120|FG009|Double Blind Treatment Period|Protocol Violation|0|||
105770293|NCT03073200|364811121|FG010|Double Blind Treatment Period|Protocol Violation|0|||
105770294|NCT03073200|364811122|FG011|Double Blind Treatment Period|Protocol Violation|0|||
105770295|NCT03073200|364811123|FG012|Double Blind Treatment Period|Protocol Violation|0|||
105770296|NCT03073200|364811124|FG013|Double Blind Treatment Period|Protocol Violation|0|||
105770297|NCT03073200|364811125|FG014|Double Blind Treatment Period|Protocol Violation|0|||
105770298|NCT03073200|364811111|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770299|NCT03073200|364811112|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
105770300|NCT03073200|364811113|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770301|NCT03073200|364811114|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770302|NCT03073200|364811115|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770303|NCT03073200|364811116|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770304|NCT03073200|364811117|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770305|NCT03073200|364811118|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770306|NCT03073200|364811119|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770307|NCT03073200|364811120|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770308|NCT03073200|364811121|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770309|NCT03073200|364811122|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770310|NCT03073200|364811123|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770311|NCT03073200|364811124|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770312|NCT03073200|364811125|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770313|NCT03073200|364811111|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
105770314|NCT03073200|364811112|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
105331966|NCT02347774|363216234|FG002|Study Participation|randomized in error|1|||
105331967|NCT02347774|363216232|FG000|On Study Treatment|Adverse Event|9|||
105331968|NCT02347774|363216233|FG001|On Study Treatment|Adverse Event|15|||
105331969|NCT02347774|363216234|FG002|On Study Treatment|Adverse Event|19|||
105331970|NCT02347774|363216232|FG000|On Study Treatment|Lack of Efficacy|3|||
105770315|NCT03073200|364811113|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770316|NCT03073200|364811114|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770317|NCT03073200|364811115|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770318|NCT03073200|364811116|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
105440611|NCT01610336|363619195|FG006|Overall Study|Progressive Disease|1|||
105440612|NCT01610336|363619196|FG007|Overall Study|Progressive Disease|6|||
105440613|NCT01610336|363619197|FG008|Overall Study|Progressive Disease|6|||
105331971|NCT02347774|363216233|FG001|On Study Treatment|Lack of Efficacy|0|||
105440614|NCT01610336|363619198|FG009|Overall Study|Progressive Disease|40|||
105770319|NCT03073200|364811117|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770320|NCT03073200|364811118|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770321|NCT03073200|364811119|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770322|NCT03073200|364811120|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770323|NCT03073200|364811121|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770324|NCT03073200|364811122|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770325|NCT03073200|364811123|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770326|NCT03073200|364811124|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770327|NCT03073200|364811125|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770328|NCT03073200|364811111|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770329|NCT03073200|364811112|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770330|NCT03073200|364811113|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770331|NCT03073200|364811114|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
105770332|NCT03073200|364811115|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
105770333|NCT03073200|364811116|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770334|NCT03073200|364811117|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770335|NCT03073200|364811118|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770336|NCT03073200|364811119|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770337|NCT03073200|364811120|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770338|NCT03073200|364811121|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770339|NCT03073200|364811122|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770340|NCT03073200|364811123|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770341|NCT03073200|364811124|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770342|NCT03073200|364811125|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770343|NCT03073200|364811111|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
105770344|NCT03073200|364811112|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
105770345|NCT03073200|364811113|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
105770346|NCT03073200|364811114|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
105770347|NCT03073200|364811115|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
105770348|NCT03073200|364811116|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
105770349|NCT03073200|364811117|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
105770350|NCT03073200|364811118|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
105331972|NCT02347774|363216234|FG002|On Study Treatment|Lack of Efficacy|2|||
105331973|NCT02347774|363216232|FG000|On Study Treatment|non-complicance with study medication|0|||
105770351|NCT03073200|364811119|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
105770352|NCT03073200|364811120|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
105770353|NCT03073200|364811121|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
105770354|NCT03073200|364811122|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
105770355|NCT03073200|364811123|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
105770356|NCT03073200|364811124|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
105770357|NCT03073200|364811125|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
105770358|NCT03073200|364811111|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770359|NCT03073200|364811112|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770360|NCT03073200|364811113|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770361|NCT03073200|364811114|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770362|NCT03073200|364811115|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
105770363|NCT03073200|364811116|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770364|NCT03073200|364811117|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770365|NCT03073200|364811118|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770366|NCT03073200|364811119|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770367|NCT03073200|364811120|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770368|NCT03073200|364811121|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770369|NCT03073200|364811122|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770370|NCT03073200|364811123|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770371|NCT03073200|364811124|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770372|NCT03073200|364811125|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770373|NCT03073200|364811111|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770374|NCT03073200|364811112|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770375|NCT03073200|364811113|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770376|NCT03073200|364811114|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
105770377|NCT03073200|364811115|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
105770378|NCT03073200|364811116|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770379|NCT03073200|364811117|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105331974|NCT02347774|363216233|FG001|On Study Treatment|non-complicance with study medication|2|||
105440615|NCT01610336|363619199|FG010|Overall Study|Progressive Disease|36|||
105770380|NCT03073200|364811118|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770381|NCT03073200|364811119|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770382|NCT03073200|364811120|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770383|NCT03073200|364811121|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770384|NCT03073200|364811122|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770385|NCT03073200|364811123|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770386|NCT03073200|364811124|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770387|NCT03073200|364811125|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770388|NCT03073200|364811111|FG000|Extension Period|Lost to Follow-up|0|||
105770389|NCT03073200|364811112|FG001|Extension Period|Lost to Follow-up|0|||
105770390|NCT03073200|364811113|FG002|Extension Period|Lost to Follow-up|0|||
105770391|NCT03073200|364811114|FG003|Extension Period|Lost to Follow-up|0|||
105770392|NCT03073200|364811115|FG004|Extension Period|Lost to Follow-up|0|||
105770393|NCT03073200|364811116|FG005|Extension Period|Lost to Follow-up|0|||
105770394|NCT03073200|364811117|FG006|Extension Period|Lost to Follow-up|1|||
105770395|NCT03073200|364811118|FG007|Extension Period|Lost to Follow-up|1|||
105770396|NCT03073200|364811119|FG008|Extension Period|Lost to Follow-up|0|||
105770397|NCT03073200|364811120|FG009|Extension Period|Lost to Follow-up|0|||
105770398|NCT03073200|364811121|FG010|Extension Period|Lost to Follow-up|0|||
105770399|NCT03073200|364811122|FG011|Extension Period|Lost to Follow-up|0|||
105770400|NCT03073200|364811123|FG012|Extension Period|Lost to Follow-up|0|||
105770401|NCT03073200|364811124|FG013|Extension Period|Lost to Follow-up|0|||
105770402|NCT03073200|364811125|FG014|Extension Period|Lost to Follow-up|0|||
105770403|NCT03073200|364811111|FG000|Extension Period|Sponsor Decision|0|||
105770404|NCT03073200|364811112|FG001|Extension Period|Sponsor Decision|0|||
105770405|NCT03073200|364811113|FG002|Extension Period|Sponsor Decision|0|||
105770406|NCT03073200|364811114|FG003|Extension Period|Sponsor Decision|0|||
105770407|NCT03073200|364811115|FG004|Extension Period|Sponsor Decision|0|||
105770408|NCT03073200|364811116|FG005|Extension Period|Sponsor Decision|0|||
105770409|NCT03073200|364811117|FG006|Extension Period|Sponsor Decision|0|||
105770410|NCT03073200|364811118|FG007|Extension Period|Sponsor Decision|0|||
105770411|NCT03073200|364811119|FG008|Extension Period|Sponsor Decision|1|||
105770412|NCT03073200|364811120|FG009|Extension Period|Sponsor Decision|0|||
105770413|NCT03073200|364811121|FG010|Extension Period|Sponsor Decision|0|||
105770414|NCT03073200|364811122|FG011|Extension Period|Sponsor Decision|0|||
105770415|NCT03073200|364811123|FG012|Extension Period|Sponsor Decision|0|||
105770416|NCT03073200|364811124|FG013|Extension Period|Sponsor Decision|0|||
105770417|NCT03073200|364811125|FG014|Extension Period|Sponsor Decision|0|||
105770418|NCT03073200|364811111|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
105770419|NCT03073200|364811112|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
105770420|NCT03073200|364811113|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
105770421|NCT03073200|364811114|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
105770422|NCT03073200|364811115|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
105770423|NCT03073200|364811116|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
105770424|NCT03073200|364811117|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
105770425|NCT03073200|364811118|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
105770426|NCT03073200|364811119|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
105770427|NCT03073200|364811120|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
105770428|NCT03073200|364811121|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
105770429|NCT03073200|364811122|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
105770430|NCT03073200|364811123|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
105770431|NCT03073200|364811124|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
105770432|NCT03073200|364811125|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
105770433|NCT03073200|364811111|FG000|Extension Period|Withdrawal by Subject|0|||
105331975|NCT02347774|363216234|FG002|On Study Treatment|non-complicance with study medication|0|||
105331976|NCT02347774|363216232|FG000|On Study Treatment|Protocol Violation|0|||
105770434|NCT03073200|364811112|FG001|Extension Period|Withdrawal by Subject|0|||
105770435|NCT03073200|364811113|FG002|Extension Period|Withdrawal by Subject|0|||
105770436|NCT03073200|364811114|FG003|Extension Period|Withdrawal by Subject|0|||
105770437|NCT03073200|364811115|FG004|Extension Period|Withdrawal by Subject|0|||
105770438|NCT03073200|364811116|FG005|Extension Period|Withdrawal by Subject|0|||
105770439|NCT03073200|364811117|FG006|Extension Period|Withdrawal by Subject|1|||
105770440|NCT03073200|364811118|FG007|Extension Period|Withdrawal by Subject|2|||
105331977|NCT02347774|363216233|FG001|On Study Treatment|Protocol Violation|0|||
105331978|NCT02347774|363216234|FG002|On Study Treatment|Protocol Violation|1|||
105770441|NCT03073200|364811119|FG008|Extension Period|Withdrawal by Subject|0|||
105770442|NCT03073200|364811120|FG009|Extension Period|Withdrawal by Subject|0|||
105770443|NCT03073200|364811121|FG010|Extension Period|Withdrawal by Subject|0|||
105770444|NCT03073200|364811122|FG011|Extension Period|Withdrawal by Subject|0|||
105770445|NCT03073200|364811123|FG012|Extension Period|Withdrawal by Subject|0|||
105770446|NCT03073200|364811124|FG013|Extension Period|Withdrawal by Subject|0|||
105770447|NCT03073200|364811125|FG014|Extension Period|Withdrawal by Subject|0|||
105770448|NCT03073200|364811111|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770449|NCT03073200|364811112|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770450|NCT03073200|364811113|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770451|NCT03073200|364811114|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770452|NCT03073200|364811115|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770453|NCT03073200|364811116|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770454|NCT03073200|364811117|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770455|NCT03073200|364811118|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770456|NCT03073200|364811119|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770457|NCT03073200|364811120|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770458|NCT03073200|364811121|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770459|NCT03073200|364811122|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
105770460|NCT03073200|364811123|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770461|NCT03073200|364811124|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770462|NCT03073200|364811125|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770463|NCT03073200|364811111|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770464|NCT03073200|364811112|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770465|NCT03073200|364811113|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770466|NCT03073200|364811114|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770467|NCT03073200|364811115|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770468|NCT03073200|364811116|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770469|NCT03073200|364811117|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770470|NCT03073200|364811118|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770471|NCT03073200|364811119|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770472|NCT03073200|364811120|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770473|NCT03073200|364811121|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770474|NCT03073200|364811122|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
105770475|NCT03073200|364811123|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770476|NCT03073200|364811124|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770477|NCT03073200|364811125|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770478|NCT03073200|364811111|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770479|NCT03073200|364811112|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770480|NCT03073200|364811113|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770481|NCT03073200|364811114|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770482|NCT03073200|364811115|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770483|NCT03073200|364811116|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770484|NCT03073200|364811117|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770485|NCT03073200|364811118|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770486|NCT03073200|364811119|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770487|NCT03073200|364811120|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770488|NCT03073200|364811121|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
105770489|NCT03073200|364811122|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
105770490|NCT03073200|364811123|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770491|NCT03073200|364811124|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770492|NCT03073200|364811125|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770493|NCT03073200|364811111|FG000|Randomized Withdrawal Period|Adverse Event|0|||
105770494|NCT03073200|364811112|FG001|Randomized Withdrawal Period|Adverse Event|0|||
105770495|NCT03073200|364811113|FG002|Randomized Withdrawal Period|Adverse Event|0|||
105770496|NCT03073200|364811114|FG003|Randomized Withdrawal Period|Adverse Event|0|||
105770497|NCT03073200|364811115|FG004|Randomized Withdrawal Period|Adverse Event|0|||
105770498|NCT03073200|364811116|FG005|Randomized Withdrawal Period|Adverse Event|0|||
105770499|NCT03073200|364811117|FG006|Randomized Withdrawal Period|Adverse Event|0|||
105770500|NCT03073200|364811118|FG007|Randomized Withdrawal Period|Adverse Event|0|||
105770501|NCT03073200|364811119|FG008|Randomized Withdrawal Period|Adverse Event|0|||
105770502|NCT03073200|364811120|FG009|Randomized Withdrawal Period|Adverse Event|0|||
105770503|NCT03073200|364811121|FG010|Randomized Withdrawal Period|Adverse Event|1|||
105770504|NCT03073200|364811122|FG011|Randomized Withdrawal Period|Adverse Event|0|||
105770505|NCT03073200|364811123|FG012|Randomized Withdrawal Period|Adverse Event|0|||
105770506|NCT03073200|364811124|FG013|Randomized Withdrawal Period|Adverse Event|0|||
105770507|NCT03073200|364811125|FG014|Randomized Withdrawal Period|Adverse Event|0|||
105770508|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770509|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770510|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770511|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770512|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770513|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770514|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770515|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
105331979|NCT02347774|363216232|FG000|On Study Treatment|withdrew consent|9|||
105770516|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770517|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770518|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770519|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770520|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770521|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
105770522|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770523|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770524|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770525|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770526|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770527|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770528|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770529|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770530|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770531|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770532|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770533|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770534|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105331980|NCT02347774|363216233|FG001|On Study Treatment|withdrew consent|8|||
105331981|NCT02347774|363216234|FG002|On Study Treatment|withdrew consent|12|||
105331982|NCT02347774|363216232|FG000|On Study Treatment|Lost to Follow-up|2|||
105331983|NCT02347774|363216233|FG001|On Study Treatment|Lost to Follow-up|6|||
105331984|NCT02347774|363216234|FG002|On Study Treatment|Lost to Follow-up|1|||
105331985|NCT02347774|363216232|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
105331986|NCT02347774|363216233|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
105331987|NCT02347774|363216234|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
105331988|NCT02347774|363216232|FG000|On Study Treatment|ranomized in error|0|||
105331989|NCT02347774|363216233|FG001|On Study Treatment|ranomized in error|0|||
105331990|NCT02347774|363216234|FG002|On Study Treatment|ranomized in error|1|||
105331991|NCT00812981|363216237|FG000|Overall Study|Other|0|||
105331992|NCT00812981|363216238|FG001|Overall Study|Other|1|||
105331993|NCT04468347|363216255|FG000|Overall Study|Withdrawal by Subject|0|||
105331994|NCT04468347|363216256|FG001|Overall Study|Withdrawal by Subject|1|||
105331995|NCT04468347|363216257|FG002|Overall Study|Withdrawal by Subject|3|||
105331996|NCT04468347|363216258|FG003|Overall Study|Withdrawal by Subject|3|||
105331997|NCT04468347|363216255|FG000|Overall Study|Lost to Follow-up|0|||
105331998|NCT04468347|363216256|FG001|Overall Study|Lost to Follow-up|0|||
105331999|NCT04468347|363216257|FG002|Overall Study|Lost to Follow-up|1|||
105770535|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770536|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
105332000|NCT04468347|363216258|FG003|Overall Study|Lost to Follow-up|1|||
105332001|NCT04468347|363216255|FG000|Overall Study|Physician Decision|1|||
105332002|NCT04468347|363216256|FG001|Overall Study|Physician Decision|0|||
105332003|NCT04468347|363216257|FG002|Overall Study|Physician Decision|2|||
105332004|NCT04468347|363216258|FG003|Overall Study|Physician Decision|0|||
105332005|NCT04468347|363216255|FG000|Overall Study|Protocol Violation|1|||
105332006|NCT04468347|363216256|FG001|Overall Study|Protocol Violation|0|||
105332007|NCT04468347|363216257|FG002|Overall Study|Protocol Violation|0|||
105332008|NCT04468347|363216258|FG003|Overall Study|Protocol Violation|0|||
105332009|NCT01732458|363216259|FG000|Overall Study|Lost to Follow-up|0|||
105332010|NCT01732458|363216260|FG001|Overall Study|Lost to Follow-up|2|||
105332011|NCT01732458|363216261|FG002|Overall Study|Lost to Follow-up|0|||
105332012|NCT01732458|363216262|FG003|Overall Study|Lost to Follow-up|0|||
105332013|NCT01732458|363216259|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105332014|NCT01732458|363216260|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105770537|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770538|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105770539|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105332015|NCT01732458|363216261|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105332016|NCT01732458|363216262|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105332017|NCT01732458|363216259|FG000|Overall Study|Physician Decision|1|||
105770540|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105770541|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105770542|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105770543|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105659658|NCT01010204|364418798|FG001|Overall Study|psychiatric hospitalization|1|||
105770544|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105806432|NCT01464827|364948985|FG004|Overall Study|Lost to Follow-up|3|||
105332018|NCT01732458|363216260|FG001|Overall Study|Physician Decision|2|||
105332019|NCT01732458|363216261|FG002|Overall Study|Physician Decision|2|||
105332020|NCT01732458|363216262|FG003|Overall Study|Physician Decision|0|||
105332021|NCT01732458|363216259|FG000|Overall Study|Protocol Violation|2|||
105332022|NCT01732458|363216260|FG001|Overall Study|Protocol Violation|0|||
105332023|NCT01732458|363216261|FG002|Overall Study|Protocol Violation|0|||
105332024|NCT01732458|363216262|FG003|Overall Study|Protocol Violation|2|||
105332025|NCT01732458|363216259|FG000|Overall Study|Screen Failure|0|||
105332026|NCT01732458|363216260|FG001|Overall Study|Screen Failure|1|||
105332027|NCT01732458|363216261|FG002|Overall Study|Screen Failure|0|||
105332028|NCT01732458|363216262|FG003|Overall Study|Screen Failure|0|||
105332029|NCT00554515|363216265|FG000|Overall Study|Withdrawal by Subject|3|||
105332030|NCT00554515|363216265|FG000|Overall Study|Disease progression|52|||
105332031|NCT00554515|363216265|FG000|Overall Study|Physician Decision|18|||
105332032|NCT00554515|363216265|FG000|Overall Study|Withdrawal by Subject|11|||
105332033|NCT00554515|363216265|FG000|Overall Study|Adverse Event|9|||
105332034|NCT00554515|363216265|FG000|Overall Study|Death|2|||
105332035|NCT00554515|363216265|FG000|Overall Study|Achieved Stable Disease|7|||
105332036|NCT00554515|363216265|FG000|Overall Study|Other|1|||
105332037|NCT00554515|363216265|FG000|Overall Study|Misc|15|||
105332038|NCT00952068|363216266|FG000|Overall Study|Adverse Event|3|||
105332039|NCT00952068|363216266|FG000|Overall Study|Withdrawal by Subject|4|||
105332040|NCT00488644|363216267|FG000|Overall Study|Not Eligible|1|||
105332041|NCT00488644|363216267|FG000|Overall Study|Not Evaluable|1|||
105332042|NCT02203721|363216278|FG000|Overall Study|Lost to Follow-up|1|||
105332043|NCT02203721|363216279|FG001|Overall Study|Lost to Follow-up|0|||
105332044|NCT02203721|363216278|FG000|Overall Study|Death|0|||
105332045|NCT02203721|363216279|FG001|Overall Study|Death|2|||
105332046|NCT02203721|363216278|FG000|Overall Study|Illness|0|||
105332047|NCT02203721|363216279|FG001|Overall Study|Illness|1|||
105332048|NCT02589639|363216280|FG000|Overall Study|Lost to Follow-up|1|||
105332049|NCT02589639|363216281|FG001|Overall Study|Lost to Follow-up|0|||
105332050|NCT02589639|363216282|FG002|Overall Study|Lost to Follow-up|0|||
105332051|NCT02589639|363216280|FG000|Overall Study|Protocol Violation|1|||
105332052|NCT02589639|363216281|FG001|Overall Study|Protocol Violation|0|||
105332053|NCT02589639|363216282|FG002|Overall Study|Protocol Violation|0|||
105332054|NCT02589639|363216280|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
105332055|NCT02589639|363216281|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
105332056|NCT02589639|363216282|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
105332057|NCT02589639|363216280|FG000|Overall Study|Adverse Event|4|||
105332058|NCT02589639|363216281|FG001|Overall Study|Adverse Event|5|||
105332059|NCT02589639|363216282|FG002|Overall Study|Adverse Event|3|||
105659659|NCT00243022|364418800|FG000|Overall Study|Withdrawal by Subject|1|||
105659660|NCT00243022|364418801|FG001|Overall Study|Withdrawal by Subject|0|||
105659661|NCT00243022|364418800|FG000|Overall Study|Death|1|||
105659662|NCT00243022|364418801|FG001|Overall Study|Death|0|||
105659663|NCT00243022|364418800|FG000|Overall Study|Difficult Travel Distance|0|||
105659664|NCT00243022|364418801|FG001|Overall Study|Difficult Travel Distance|1|||
105659665|NCT00723125|364418802|FG000|Overall Study|Met Dx|1|||
105659666|NCT00723125|364418803|FG001|Overall Study|Met Dx|0|||
105659667|NCT00723125|364418802|FG000|Overall Study|Withdrawal by Subject|15|||
105659668|NCT00723125|364418803|FG001|Overall Study|Withdrawal by Subject|6|||
105659669|NCT00723125|364418802|FG000|Overall Study|Adverse Event|2|||
105659670|NCT00723125|364418803|FG001|Overall Study|Adverse Event|0|||
105659671|NCT04706793|364418804|FG000|Treatment|Disease worsening|10|||
105659672|NCT04706793|364418805|FG001|Treatment|Disease worsening|10|||
105659673|NCT04706793|364418804|FG000|Follow-up|Lack of Efficacy|1|||
105659674|NCT04706793|364418805|FG001|Follow-up|Lack of Efficacy|0|||
105659675|NCT04706793|364418804|FG000|Follow-up|Disease worsening|8|||
105659676|NCT04706793|364418805|FG001|Follow-up|Disease worsening|10|||
105659677|NCT04706793|364418804|FG000|Follow-up|Adverse Event|1|||
105659678|NCT04706793|364418805|FG001|Follow-up|Adverse Event|0|||
105659679|NCT00823836|364418809|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
105659680|NCT00823836|364418810|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
105659681|NCT00823836|364418809|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
105659682|NCT00823836|364418810|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
105659683|NCT00823836|364418809|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
105659684|NCT00823836|364418810|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
105659685|NCT00823836|364418809|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
105659686|NCT00823836|364418810|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
105659687|NCT00823836|364418809|FG000|Long-term Phase|Adverse Event|3|||
105659688|NCT00823836|364418810|FG001|Long-term Phase|Adverse Event|2|||
105659689|NCT00823836|364418809|FG000|Long-term Phase|Physician Decision|1|||
105659690|NCT00823836|364418810|FG001|Long-term Phase|Physician Decision|2|||
105659691|NCT00823836|364418809|FG000|Long-term Phase|Withdrawal by Subject|1|||
105659692|NCT00823836|364418810|FG001|Long-term Phase|Withdrawal by Subject|1|||
105659693|NCT01099579|364418811|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
105659694|NCT01099579|364418812|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
105332060|NCT02589639|363216280|FG000|Overall Study|Other reason than specified above|1|||
105332061|NCT02589639|363216281|FG001|Overall Study|Other reason than specified above|2|||
105332062|NCT02589639|363216282|FG002|Overall Study|Other reason than specified above|1|||
105332063|NCT02589639|363216280|FG000|Overall Study|Not Treated|0|||
105332064|NCT02589639|363216281|FG001|Overall Study|Not Treated|3|||
105332065|NCT02589639|363216282|FG002|Overall Study|Not Treated|0|||
105332066|NCT01276756|363216283|FG000|Overall Study|Lost to Follow-up|2|||
105806433|NCT01464827|364948986|FG005|Overall Study|Lost to Follow-up|1|||
105332067|NCT01276756|363216284|FG001|Overall Study|Lost to Follow-up|0|||
105332068|NCT01276756|363216283|FG000|Overall Study|Adverse Event|3|||
105332069|NCT01276756|363216284|FG001|Overall Study|Adverse Event|2|||
105332070|NCT03759587|363216292|FG000|Overall Study|Adverse Event|5|||
105332071|NCT03759587|363216292|FG000|Overall Study|Progressive Disease|10|||
105332072|NCT03759587|363216292|FG000|Overall Study|Site Terminated by Sponsor|3|||
105332073|NCT03759587|363216292|FG000|Overall Study|Withdrawal by Subject|1|||
105332074|NCT02522884|363216293|FG000|Overall Study|Withdrawal by Subject|6|||
105332075|NCT02522884|363216293|FG000|Overall Study|Death|3|||
105332076|NCT02522884|363216293|FG000|Overall Study|Missed 12-month Follow-up|9|||
105332077|NCT04615403|363216294|FG000|Overall Study|Death|1|||
105332078|NCT03340454|363216297|FG000|Overall Study|Lost to Follow-up|0|||
105332079|NCT03340454|363216298|FG001|Overall Study|Lost to Follow-up|4|||
105332080|NCT03482453|363216299|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105332081|NCT03482453|363216300|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105332082|NCT03482453|363216301|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105332083|NCT03482453|363216302|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105332084|NCT03482453|363216303|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105332085|NCT03482453|363216304|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105332086|NCT03482453|363216305|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105332087|NCT03482453|363216306|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105332088|NCT03482453|363216307|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105332089|NCT03482453|363216308|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105332090|NCT03482453|363216309|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
105332091|NCT03482453|363216310|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105332092|NCT01074268|363216311|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
105332093|NCT01074268|363216312|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
105332094|NCT01074268|363216311|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
105332095|NCT01074268|363216312|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
105332096|NCT01074268|363216311|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
105332097|NCT01074268|363216312|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
105332098|NCT01074268|363216311|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
105332099|NCT01074268|363216312|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
105332100|NCT01074268|363216311|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
105332101|NCT01074268|363216312|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
105332102|NCT01074268|363216311|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
105332103|NCT01074268|363216312|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
105332104|NCT01074268|363216311|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
105332105|NCT01074268|363216312|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
105332106|NCT01074268|363216311|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
105332107|NCT01074268|363216312|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
105332108|NCT01074268|363216311|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
105332109|NCT01074268|363216312|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
105332110|NCT00314327|363216317|FG000|Overall Study|Withdrawal by Subject|1|||
105332111|NCT02837731|363216318|FG000|Allocation|Admitted to General Floor|3|||
105332112|NCT02837731|363216319|FG001|Allocation|Admitted to General Floor|4|||
105332113|NCT02837731|363216318|FG000|Allocation|Immediate surgery/withdrew|2|||
105332114|NCT02837731|363216319|FG001|Allocation|Immediate surgery/withdrew|0|||
105332115|NCT02837731|363216318|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
105332116|NCT02837731|363216319|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
105332117|NCT02837731|363216318|FG000|Allocation|Withdrawal by Subject|2|||
105332118|NCT02837731|363216319|FG001|Allocation|Withdrawal by Subject|0|||
105332119|NCT02837731|363216318|FG000|Allocation|Device not available|1|||
105332120|NCT02837731|363216319|FG001|Allocation|Device not available|0|||
105332121|NCT02837731|363216318|FG000|Allocation|Protocol not implemented|7|||
105332122|NCT02837731|363216319|FG001|Allocation|Protocol not implemented|0|||
105332123|NCT02837731|363216318|FG000|Allocation|Moribund/Do not resuscitate|2|||
105332124|NCT02837731|363216319|FG001|Allocation|Moribund/Do not resuscitate|0|||
105332125|NCT02837731|363216318|FG000|Allocation|Did not meet sepsis criteria|1|||
105332126|NCT02837731|363216319|FG001|Allocation|Did not meet sepsis criteria|2|||
105332127|NCT02837731|363216318|FG000|Allocation|Known aortic abnormalities|0|||
105332128|NCT02837731|363216319|FG001|Allocation|Known aortic abnormalities|1|||
105332129|NCT02965573|363216320|FG000|Overall Study|Lack of Efficacy|1|||
105332130|NCT02965573|363216321|FG001|Overall Study|Lack of Efficacy|0|||
105332131|NCT01119859|363216325|FG000|Overall Study|Adverse Event|9|||
105332132|NCT01119859|363216326|FG001|Overall Study|Adverse Event|10|||
105332133|NCT01119859|363216325|FG000|Overall Study|Death|2|||
105332134|NCT01119859|363216326|FG001|Overall Study|Death|0|||
105332135|NCT01119859|363216325|FG000|Overall Study|Insufficient therapeutic response|7|||
105332136|NCT01119859|363216326|FG001|Overall Study|Insufficient therapeutic response|14|||
105332137|NCT01119859|363216325|FG000|Overall Study|Refused treatment|3|||
105332138|NCT01119859|363216326|FG001|Overall Study|Refused treatment|6|||
105332139|NCT01119859|363216325|FG000|Overall Study|Failure to return|3|||
105332140|NCT01119859|363216326|FG001|Overall Study|Failure to return|0|||
105332141|NCT00086619|363216327|FG000|Overall Study|Withdrawal by Subject|6|||
105332142|NCT00086619|363216328|FG001|Overall Study|Withdrawal by Subject|6|||
105332143|NCT00086619|363216327|FG000|Overall Study|Adverse Event|8|||
105332144|NCT00086619|363216328|FG001|Overall Study|Adverse Event|10|||
105332145|NCT00086619|363216327|FG000|Overall Study|Protocol Violation|1|||
105332146|NCT00086619|363216328|FG001|Overall Study|Protocol Violation|1|||
105332147|NCT00733421|363216330|FG000|Overall Study|Withdrawal by Subject|1|||
105332148|NCT00733421|363216331|FG001|Overall Study|Withdrawal by Subject|1|||
105332149|NCT01029782|363216332|FG000|Overall Study|Lost to Follow-up|2|||
105332150|NCT01029782|363216333|FG001|Overall Study|Lost to Follow-up|2|||
105332151|NCT01029782|363216332|FG000|Overall Study|Diagnosis changed|1|||
105332152|NCT01029782|363216333|FG001|Overall Study|Diagnosis changed|1|||
105332153|NCT01029782|363216332|FG000|Overall Study|Adverse Event|0|||
105332154|NCT01029782|363216333|FG001|Overall Study|Adverse Event|1|||
105332155|NCT01029782|363216332|FG000|Overall Study|Physician Decision|0|||
105332156|NCT01029782|363216333|FG001|Overall Study|Physician Decision|1|||
105332157|NCT01029782|363216332|FG000|Overall Study|Protocol Violation|0|||
105332158|NCT01029782|363216333|FG001|Overall Study|Protocol Violation|2|||
105332159|NCT01029782|363216332|FG000|Overall Study|Withdrawal by Subject|0|||
105332160|NCT01029782|363216333|FG001|Overall Study|Withdrawal by Subject|1|||
105332161|NCT01870973|363216337|FG000|Overall Study|Lost to Follow-up|10|||
105332162|NCT01870973|363216338|FG001|Overall Study|Lost to Follow-up|3|||
105332163|NCT00915018|363217815|FG000|Overall Study|Death|75|||
105332164|NCT00915018|363217816|FG001|Overall Study|Death|70|||
105332165|NCT00915018|363217815|FG000|Overall Study|Lost to Follow-up|10|||
105332166|NCT00915018|363217816|FG001|Overall Study|Lost to Follow-up|5|||
105332167|NCT00915018|363217815|FG000|Overall Study|Withdrawal by Subject|38|||
105332168|NCT00915018|363217816|FG001|Overall Study|Withdrawal by Subject|27|||
105332169|NCT00915018|363217815|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
105332170|NCT00915018|363217816|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
105332171|NCT02101736|363217820|FG000|Overall Study|Protocol Violation|3|||
105332172|NCT02101736|363217821|FG001|Overall Study|Protocol Violation|0|||
105332173|NCT02101736|363217820|FG000|Overall Study|Withdrawal by Subject|1|||
105332174|NCT02101736|363217821|FG001|Overall Study|Withdrawal by Subject|1|||
105332175|NCT02609607|363217827|FG000|Overall Study|Lost to Follow-up|0|||
105332176|NCT02609607|363217828|FG001|Overall Study|Lost to Follow-up|1|||
105332177|NCT00778817|363217829|FG000|Overall Study|Adverse Event|2|||
105332178|NCT00778817|363217829|FG000|Overall Study|Withdrawal by Subject|2|||
105332179|NCT04090060|363217831|FG000|Overall Study|Lost to Follow-up|76|||
105332180|NCT04090060|363217832|FG001|Overall Study|Lost to Follow-up|77|||
105332181|NCT01164579|363217839|FG000|Overall Study|Lack of Efficacy|0|||
105332182|NCT01164579|363217840|FG001|Overall Study|Lack of Efficacy|0|||
105332183|NCT01164579|363217841|FG002|Overall Study|Lack of Efficacy|6|||
105332184|NCT01164579|363217839|FG000|Overall Study|Lost to Follow-up|1|||
105332185|NCT01164579|363217840|FG001|Overall Study|Lost to Follow-up|1|||
105332186|NCT01164579|363217841|FG002|Overall Study|Lost to Follow-up|0|||
105332187|NCT01164579|363217839|FG000|Overall Study|Withdrawal by Subject|2|||
105332188|NCT01164579|363217840|FG001|Overall Study|Withdrawal by Subject|5|||
105332189|NCT01164579|363217841|FG002|Overall Study|Withdrawal by Subject|3|||
105332190|NCT01164579|363217839|FG000|Overall Study|Protocol Violation|0|||
105332191|NCT01164579|363217840|FG001|Overall Study|Protocol Violation|1|||
105332192|NCT01164579|363217841|FG002|Overall Study|Protocol Violation|2|||
105332193|NCT01164579|363217839|FG000|Overall Study|Adverse Event|4|||
105332194|NCT01164579|363217840|FG001|Overall Study|Adverse Event|2|||
105332195|NCT01164579|363217841|FG002|Overall Study|Adverse Event|5|||
105332196|NCT01164579|363217839|FG000|Overall Study|Reason not specified|1|||
105332197|NCT01164579|363217840|FG001|Overall Study|Reason not specified|0|||
105332198|NCT01164579|363217841|FG002|Overall Study|Reason not specified|0|||
105332199|NCT02490371|363217846|FG000|Overall Study|Lost to Follow-up|1|||
105332200|NCT02490371|363217847|FG001|Overall Study|Lost to Follow-up|1|||
105332201|NCT03018080|363217848|FG000|Overall Study|Death|12|||
105332202|NCT03018080|363217849|FG001|Overall Study|Death|19|||
105332203|NCT00740792|363217850|FG000|Overall Study|Adverse Event|3|||
105332204|NCT00740792|363217851|FG001|Overall Study|Adverse Event|1|||
105332205|NCT00740792|363217852|FG002|Overall Study|Adverse Event|1|||
105332206|NCT00740792|363217853|FG003|Overall Study|Adverse Event|3|||
105332207|NCT00740792|363217850|FG000|Overall Study|Lack of Efficacy|1|||
105332208|NCT00740792|363217851|FG001|Overall Study|Lack of Efficacy|1|||
105332209|NCT00740792|363217852|FG002|Overall Study|Lack of Efficacy|0|||
105332210|NCT00740792|363217853|FG003|Overall Study|Lack of Efficacy|3|||
105332211|NCT00740792|363217850|FG000|Overall Study|Lost to Follow-up|2|||
105332212|NCT00740792|363217851|FG001|Overall Study|Lost to Follow-up|1|||
105332213|NCT00740792|363217852|FG002|Overall Study|Lost to Follow-up|0|||
105332214|NCT00740792|363217853|FG003|Overall Study|Lost to Follow-up|0|||
105332215|NCT00740792|363217850|FG000|Overall Study|Protocol Violation|0|||
105332216|NCT00740792|363217851|FG001|Overall Study|Protocol Violation|1|||
105440616|NCT01610336|363619189|FG000|Overall Study|Adverse Event|0|||
105332217|NCT00740792|363217852|FG002|Overall Study|Protocol Violation|0|||
105332218|NCT00740792|363217853|FG003|Overall Study|Protocol Violation|2|||
105332219|NCT00740792|363217850|FG000|Overall Study|Withdrawal by Subject|1|||
105332220|NCT00740792|363217851|FG001|Overall Study|Withdrawal by Subject|1|||
105332221|NCT00740792|363217852|FG002|Overall Study|Withdrawal by Subject|0|||
105332222|NCT00740792|363217853|FG003|Overall Study|Withdrawal by Subject|0|||
105332223|NCT00740792|363217850|FG000|Overall Study|administrative|3|||
105332224|NCT00740792|363217851|FG001|Overall Study|administrative|3|||
105332225|NCT00740792|363217852|FG002|Overall Study|administrative|8|||
105332226|NCT00740792|363217853|FG003|Overall Study|administrative|2|||
105332227|NCT01532518|363217858|FG000|Overall Study|Withdrawal by Subject|0|||
105332228|NCT01532518|363217859|FG001|Overall Study|Withdrawal by Subject|0|||
105332229|NCT01532518|363217860|FG002|Overall Study|Withdrawal by Subject|1|||
105332230|NCT01019694|363217866|FG000|Overall Study|Adverse Event|12|||
105332231|NCT01019694|363217867|FG001|Overall Study|Adverse Event|16|||
105332232|NCT01019694|363217868|FG002|Overall Study|Adverse Event|19|||
105332233|NCT01019694|363217866|FG000|Overall Study|Protocol Violation|2|||
105332234|NCT01019694|363217867|FG001|Overall Study|Protocol Violation|6|||
105332235|NCT01019694|363217868|FG002|Overall Study|Protocol Violation|4|||
105332236|NCT01019694|363217866|FG000|Overall Study|Lost to Follow-up|5|||
105332237|NCT01019694|363217867|FG001|Overall Study|Lost to Follow-up|3|||
105332238|NCT01019694|363217868|FG002|Overall Study|Lost to Follow-up|3|||
105332239|NCT01019694|363217866|FG000|Overall Study|Withdrawal by Subject|4|||
105332240|NCT01019694|363217867|FG001|Overall Study|Withdrawal by Subject|6|||
105332241|NCT01019694|363217868|FG002|Overall Study|Withdrawal by Subject|12|||
105332242|NCT01019694|363217866|FG000|Overall Study|Not treated|0|||
105332243|NCT01019694|363217867|FG001|Overall Study|Not treated|2|||
105332244|NCT01019694|363217868|FG002|Overall Study|Not treated|3|||
105332245|NCT01019694|363217866|FG000|Overall Study|Other reason (not specified)|1|||
105332246|NCT01019694|363217867|FG001|Overall Study|Other reason (not specified)|5|||
105332247|NCT01019694|363217868|FG002|Overall Study|Other reason (not specified)|6|||
105332248|NCT00423332|363217871|FG000|Overall Study|Adverse Event|6|||
105332249|NCT00423332|363217872|FG001|Overall Study|Adverse Event|2|||
105332250|NCT00423332|363217871|FG000|Overall Study|Withdrawal by Subject|1|||
105332251|NCT00423332|363217872|FG001|Overall Study|Withdrawal by Subject|0|||
105332252|NCT00423332|363217871|FG000|Overall Study|Condition under investigation worsened|1|||
105332253|NCT00423332|363217872|FG001|Overall Study|Condition under investigation worsened|1|||
105332254|NCT00423332|363217871|FG000|Overall Study|Progressive at Week 6|0|||
105332255|NCT00423332|363217872|FG001|Overall Study|Progressive at Week 6|1|||
105332256|NCT00423332|363217871|FG000|Overall Study|Unblinded before 12 weeks|1|||
105332257|NCT00423332|363217872|FG001|Overall Study|Unblinded before 12 weeks|3|||
105332258|NCT04747886|363217873|FG000|Overall Study|Withdrawal by Subject|1|||
105332259|NCT04747886|363217874|FG001|Overall Study|Withdrawal by Subject|4|||
105332260|NCT03850496|363217877|FG000|Overall Study|Withdrawal by Subject|1|||
105332261|NCT03850496|363217878|FG001|Overall Study|Withdrawal by Subject|0|||
105332262|NCT03850496|363217879|FG002|Overall Study|Withdrawal by Subject|0|||
105332263|NCT03850496|363217877|FG000|Overall Study|Lost to Follow-up|0|||
105332264|NCT03850496|363217878|FG001|Overall Study|Lost to Follow-up|1|||
105332265|NCT03850496|363217879|FG002|Overall Study|Lost to Follow-up|4|||
105332266|NCT04478695|363217881|FG000|Overall Study|Death|1|||
105332267|NCT04478695|363217882|FG001|Overall Study|Death|0|||
105332268|NCT00927862|363217883|FG000|Overall Study|Missing data needed for endpt analyses|27|||
105332269|NCT00927862|363217884|FG001|Overall Study|Missing data needed for endpt analyses|45|||
105332270|NCT00820248|363217886|FG000|Overall Study|No treated|4|||
105332271|NCT00820248|363217887|FG001|Overall Study|No treated|1|||
105332272|NCT03259425|363217888|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
105332273|NCT02237196|363217889|FG000|Overall Study|Adverse Event|0|||
105332274|NCT02237196|363217890|FG001|Overall Study|Adverse Event|1|||
105332275|NCT02237196|363217891|FG002|Overall Study|Adverse Event|1|||
105332276|NCT02237196|363217892|FG003|Overall Study|Adverse Event|0|||
105332277|NCT02237196|363217889|FG000|Overall Study|Lost to Follow-up|4|||
105332278|NCT02237196|363217890|FG001|Overall Study|Lost to Follow-up|2|||
105332279|NCT02237196|363217891|FG002|Overall Study|Lost to Follow-up|4|||
105332280|NCT02237196|363217892|FG003|Overall Study|Lost to Follow-up|6|||
105332281|NCT02237196|363217889|FG000|Overall Study|Physician Decision|2|||
105332282|NCT02237196|363217890|FG001|Overall Study|Physician Decision|0|||
105332283|NCT02237196|363217891|FG002|Overall Study|Physician Decision|0|||
105332284|NCT02237196|363217892|FG003|Overall Study|Physician Decision|1|||
105332285|NCT02237196|363217889|FG000|Overall Study|Pregnancy|0|||
105332286|NCT02237196|363217890|FG001|Overall Study|Pregnancy|0|||
105332287|NCT02237196|363217891|FG002|Overall Study|Pregnancy|1|||
105806434|NCT01464827|364948987|FG006|Overall Study|Lost to Follow-up|2|||
105332288|NCT02237196|363217892|FG003|Overall Study|Pregnancy|1|||
105332289|NCT02237196|363217889|FG000|Overall Study|Withdrawal by Subject|1|||
105332290|NCT02237196|363217890|FG001|Overall Study|Withdrawal by Subject|1|||
105332291|NCT02237196|363217891|FG002|Overall Study|Withdrawal by Subject|4|||
105332292|NCT02237196|363217892|FG003|Overall Study|Withdrawal by Subject|1|||
105332293|NCT02237196|363217889|FG000|Overall Study|Site Error|1|||
105332294|NCT02237196|363217890|FG001|Overall Study|Site Error|2|||
105332295|NCT02237196|363217891|FG002|Overall Study|Site Error|0|||
105332296|NCT02237196|363217892|FG003|Overall Study|Site Error|2|||
105332297|NCT01750697|363217893|FG000|Overall Study|Transferred Back to Local Hospital|1|||
105332298|NCT01750697|363217893|FG000|Overall Study|Physician and Family Decision|1|||
105332299|NCT01750697|363217893|FG000|Overall Study|Transferred to Adult Services|5|||
105332300|NCT01750697|363217893|FG000|Overall Study|Physician Decision|1|||
105332301|NCT01750697|363217893|FG000|Overall Study|Withdrawal by Subject|1|||
105332302|NCT02088905|363217896|FG000|Overall Study|Withdrawal by Subject|5|||
105332303|NCT02088905|363217897|FG001|Overall Study|Withdrawal by Subject|1|||
105332304|NCT00619892|363217900|FG000|Overall Study|Adverse Event|3|||
105332305|NCT00619892|363217901|FG001|Overall Study|Adverse Event|0|||
105332306|NCT00619892|363217900|FG000|Overall Study|Lost to Follow-up|0|||
105332307|NCT00619892|363217901|FG001|Overall Study|Lost to Follow-up|1|||
105332308|NCT00619892|363217900|FG000|Overall Study|Intercurrent illness|0|||
105332309|NCT00619892|363217901|FG001|Overall Study|Intercurrent illness|1|||
105332310|NCT01562782|363217903|FG000|Overall Study|Withdrawal by Subject|3|||
105332311|NCT01562782|363217904|FG001|Overall Study|Withdrawal by Subject|3|||
105332312|NCT01562782|363217903|FG000|Overall Study|screen failure|1|||
105332313|NCT01562782|363217904|FG001|Overall Study|screen failure|2|||
105332314|NCT02285166|363217907|FG000|Overall Study|Case Report Forms Uncollected|564|||
105332315|NCT02285166|363217907|FG000|Overall Study|Protocol Deviation|402|||
105332316|NCT01421225|363217912|FG000|Overall Study|Withdrawal by Subject|0|||
105332317|NCT01421225|363217913|FG001|Overall Study|Withdrawal by Subject|1|||
105332318|NCT01814696|363217921|FG000|Overall Study|Withdrawal by Subject|1|||
105332319|NCT01814696|363217922|FG001|Overall Study|Withdrawal by Subject|0|||
105332320|NCT01814696|363217921|FG000|Overall Study|Randomized to wrong group|1|||
105332321|NCT01814696|363217922|FG001|Overall Study|Randomized to wrong group|0|||
105332322|NCT00713258|363217923|FG000|Overall Study|Adverse Event|2|||
105332323|NCT00713258|363217924|FG001|Overall Study|Adverse Event|4|||
105332324|NCT00713258|363217923|FG000|Overall Study|Non-Compliance|2|||
105332325|NCT00713258|363217924|FG001|Overall Study|Non-Compliance|1|||
105332326|NCT00713258|363217923|FG000|Overall Study|Other|1|||
105332327|NCT00713258|363217924|FG001|Overall Study|Other|1|||
105332328|NCT00568061|363217925|FG000|Overall Study|Inclusion / exclusion criteria|5|||
105332329|NCT00568061|363217926|FG001|Overall Study|Inclusion / exclusion criteria|1|||
105332330|NCT00568061|363217925|FG000|Overall Study|Adverse Event|0|||
105332331|NCT00568061|363217926|FG001|Overall Study|Adverse Event|1|||
105332332|NCT01896128|363217927|FG000|Overall Study|Withdrawal by Subject|3|||
105332333|NCT01896128|363217928|FG001|Overall Study|Withdrawal by Subject|3|||
105332334|NCT00356148|363217929|FG000|Overall Study|Reoperation within 30 days|2|||
105332335|NCT00356148|363217930|FG001|Overall Study|Reoperation within 30 days|1|||
105332336|NCT00460811|363217933|FG000|Overall Study|Adverse Event|4|||
105332337|NCT00460811|363217934|FG001|Overall Study|Adverse Event|6|||
105332338|NCT00460811|363217935|FG002|Overall Study|Adverse Event|3|||
105332339|NCT00460811|363217936|FG003|Overall Study|Adverse Event|10|||
105332340|NCT00460811|363217937|FG004|Overall Study|Adverse Event|2|||
105332341|NCT00460811|363217933|FG000|Overall Study|Noncompliance|1|||
105332342|NCT00460811|363217934|FG001|Overall Study|Noncompliance|0|||
105332343|NCT00460811|363217935|FG002|Overall Study|Noncompliance|0|||
105332344|NCT00460811|363217936|FG003|Overall Study|Noncompliance|2|||
105332345|NCT00460811|363217937|FG004|Overall Study|Noncompliance|1|||
105332346|NCT00460811|363217933|FG000|Overall Study|Withdrawal by Subject|7|||
105332347|NCT00460811|363217934|FG001|Overall Study|Withdrawal by Subject|7|||
105332348|NCT00460811|363217935|FG002|Overall Study|Withdrawal by Subject|6|||
105332349|NCT00460811|363217936|FG003|Overall Study|Withdrawal by Subject|3|||
105332350|NCT00460811|363217937|FG004|Overall Study|Withdrawal by Subject|11|||
105332351|NCT00460811|363217933|FG000|Overall Study|Physician Decision|1|||
105332352|NCT00460811|363217934|FG001|Overall Study|Physician Decision|0|||
105332353|NCT00460811|363217935|FG002|Overall Study|Physician Decision|0|||
105332354|NCT00460811|363217936|FG003|Overall Study|Physician Decision|0|||
105332355|NCT00460811|363217937|FG004|Overall Study|Physician Decision|0|||
105332356|NCT00460811|363217933|FG000|Overall Study|Lost to Follow-up|3|||
105332357|NCT00460811|363217934|FG001|Overall Study|Lost to Follow-up|2|||
105332358|NCT00460811|363217935|FG002|Overall Study|Lost to Follow-up|5|||
105332359|NCT00460811|363217936|FG003|Overall Study|Lost to Follow-up|3|||
105332360|NCT00460811|363217937|FG004|Overall Study|Lost to Follow-up|6|||
105332361|NCT02099110|363217939|FG000|Overall Study|Protocol Violation|2|||
105332362|NCT02099110|363217940|FG001|Overall Study|Protocol Violation|1|||
105332363|NCT02099110|363217941|FG002|Overall Study|Protocol Violation|0|||
105332364|NCT02099110|363217942|FG003|Overall Study|Protocol Violation|3|||
105332365|NCT02099110|363217943|FG004|Overall Study|Protocol Violation|1|||
105332366|NCT02099110|363217939|FG000|Overall Study|Participant moved|1|||
105332367|NCT02099110|363217940|FG001|Overall Study|Participant moved|1|||
105332368|NCT02099110|363217941|FG002|Overall Study|Participant moved|1|||
105332369|NCT02099110|363217942|FG003|Overall Study|Participant moved|0|||
105332370|NCT02099110|363217943|FG004|Overall Study|Participant moved|2|||
105332371|NCT02099110|363217939|FG000|Overall Study|Withdrawal by Subject|7|||
105332372|NCT02099110|363217940|FG001|Overall Study|Withdrawal by Subject|11|||
105332373|NCT02099110|363217941|FG002|Overall Study|Withdrawal by Subject|13|||
105332374|NCT02099110|363217942|FG003|Overall Study|Withdrawal by Subject|9|||
105332375|NCT02099110|363217943|FG004|Overall Study|Withdrawal by Subject|13|||
105332376|NCT02099110|363217939|FG000|Overall Study|Adverse Event|3|||
105332377|NCT02099110|363217940|FG001|Overall Study|Adverse Event|5|||
105332378|NCT02099110|363217941|FG002|Overall Study|Adverse Event|2|||
105332379|NCT02099110|363217942|FG003|Overall Study|Adverse Event|3|||
105332380|NCT02099110|363217943|FG004|Overall Study|Adverse Event|2|||
105332381|NCT02099110|363217939|FG000|Overall Study|Lost to Follow-up|6|||
105332382|NCT02099110|363217940|FG001|Overall Study|Lost to Follow-up|12|||
105332383|NCT02099110|363217941|FG002|Overall Study|Lost to Follow-up|11|||
105332384|NCT02099110|363217942|FG003|Overall Study|Lost to Follow-up|5|||
105332385|NCT02099110|363217943|FG004|Overall Study|Lost to Follow-up|6|||
105332386|NCT02099110|363217939|FG000|Overall Study|Death|0|||
105332387|NCT02099110|363217940|FG001|Overall Study|Death|1|||
105332388|NCT02099110|363217941|FG002|Overall Study|Death|0|||
105332389|NCT02099110|363217942|FG003|Overall Study|Death|0|||
105332390|NCT02099110|363217943|FG004|Overall Study|Death|0|||
105332391|NCT02099110|363217939|FG000|Overall Study|Screen failure|0|||
105332392|NCT02099110|363217940|FG001|Overall Study|Screen failure|0|||
105332393|NCT02099110|363217941|FG002|Overall Study|Screen failure|0|||
105332394|NCT02099110|363217942|FG003|Overall Study|Screen failure|0|||
105332395|NCT02099110|363217943|FG004|Overall Study|Screen failure|1|||
105332396|NCT02099110|363217939|FG000|Overall Study|Non-compliance with study drug|2|||
105332397|NCT02099110|363217940|FG001|Overall Study|Non-compliance with study drug|0|||
105332398|NCT02099110|363217941|FG002|Overall Study|Non-compliance with study drug|0|||
105332399|NCT02099110|363217942|FG003|Overall Study|Non-compliance with study drug|0|||
105332400|NCT02099110|363217943|FG004|Overall Study|Non-compliance with study drug|1|||
105332401|NCT02099110|363217939|FG000|Overall Study|Physician Decision|3|||
105332402|NCT02099110|363217940|FG001|Overall Study|Physician Decision|0|||
105332403|NCT02099110|363217941|FG002|Overall Study|Physician Decision|1|||
105332404|NCT02099110|363217942|FG003|Overall Study|Physician Decision|2|||
105332405|NCT02099110|363217943|FG004|Overall Study|Physician Decision|1|||
105332406|NCT02064816|363217944|FG000|Overall Study|Adverse Event|3|||
105332407|NCT02064816|363217945|FG001|Overall Study|Adverse Event|2|||
105332408|NCT02064816|363217944|FG000|Overall Study|Withdrawal by Subject|2|||
105332409|NCT02064816|363217945|FG001|Overall Study|Withdrawal by Subject|1|||
105332410|NCT02064816|363217944|FG000|Overall Study|Lost to Follow-up|2|||
105332411|NCT02064816|363217945|FG001|Overall Study|Lost to Follow-up|1|||
105332412|NCT02064816|363217944|FG000|Overall Study|Therapeutic failure|0|||
105332413|NCT02064816|363217945|FG001|Overall Study|Therapeutic failure|1|||
105332414|NCT02064816|363217944|FG000|Overall Study|Other|1|||
105332415|NCT02064816|363217945|FG001|Overall Study|Other|3|||
105332416|NCT00996125|363217946|FG000|Overall Study|Adverse Event|0|||
105332417|NCT00996125|363217947|FG001|Overall Study|Adverse Event|2|||
105332418|NCT00996125|363217946|FG000|Overall Study|Lost to Follow-up|1|||
105332419|NCT00996125|363217947|FG001|Overall Study|Lost to Follow-up|6|||
105332420|NCT00996125|363217946|FG000|Overall Study|Withdrawal by Subject|4|||
105332421|NCT00996125|363217947|FG001|Overall Study|Withdrawal by Subject|3|||
105332422|NCT00703157|363217952|FG000|Overall Study|Lost to Follow-up|0|||
105332423|NCT00703157|363217953|FG001|Overall Study|Lost to Follow-up|1|||
105332424|NCT00703157|363217952|FG000|Overall Study|source data permanently lost/ other|4|||
105332425|NCT00703157|363217953|FG001|Overall Study|source data permanently lost/ other|1|||
105332426|NCT03170362|363217954|FG000|Overall Study|Death|2|||
105332427|NCT03170362|363217955|FG001|Overall Study|Death|2|||
105332428|NCT03170362|363217954|FG000|Overall Study|Withdrawal by Subject|23|||
105332429|NCT03170362|363217955|FG001|Overall Study|Withdrawal by Subject|22|||
105332430|NCT03170362|363217954|FG000|Overall Study|Lost to Follow-up|187|||
105332431|NCT03170362|363217955|FG001|Overall Study|Lost to Follow-up|167|||
105332432|NCT00665431|363217956|FG000|Overall Study|Adverse Event|16|||
105332433|NCT00665431|363217957|FG001|Overall Study|Adverse Event|22|||
105332434|NCT00665431|363217958|FG002|Overall Study|Adverse Event|6|||
105332435|NCT00665431|363217956|FG000|Overall Study|Withdrawal by Subject|17|||
105332436|NCT00665431|363217957|FG001|Overall Study|Withdrawal by Subject|25|||
105332437|NCT00665431|363217958|FG002|Overall Study|Withdrawal by Subject|15|||
105332438|NCT00665431|363217956|FG000|Overall Study|Lost to Follow-up|3|||
105332439|NCT00665431|363217957|FG001|Overall Study|Lost to Follow-up|3|||
105332440|NCT00665431|363217958|FG002|Overall Study|Lost to Follow-up|1|||
105332441|NCT00665431|363217956|FG000|Overall Study|Other|4|||
105332442|NCT00665431|363217957|FG001|Overall Study|Other|7|||
105332443|NCT00665431|363217958|FG002|Overall Study|Other|2|||
105332444|NCT02347813|363217959|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
105332445|NCT02347813|363217960|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
105332446|NCT02347813|363217959|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
105332447|NCT02347813|363217960|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
105332448|NCT04185220|363217961|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
105332449|NCT04185220|363217962|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
105332450|NCT04185220|363217961|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
105360833|NCT00572455|363328086|FG006|Stage II (28 Days)|Other|0|||
105332451|NCT04185220|363217962|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
105332452|NCT00651261|363219359|FG000|Overall Study|Adverse Event|32|||
105332453|NCT00651261|363219360|FG001|Overall Study|Adverse Event|22|||
105332454|NCT00651261|363219359|FG000|Overall Study|Death|18|||
105332455|NCT00651261|363219360|FG001|Overall Study|Death|18|||
105332456|NCT00651261|363219359|FG000|Overall Study|Withdrawal by Subject|22|||
105332457|NCT00651261|363219360|FG001|Overall Study|Withdrawal by Subject|40|||
105332458|NCT00651261|363219359|FG000|Overall Study|Induction failure|24|||
105332459|NCT00651261|363219360|FG001|Overall Study|Induction failure|35|||
105332460|NCT00651261|363219359|FG000|Overall Study|Disease progression|58|||
105332461|NCT00651261|363219360|FG001|Overall Study|Disease progression|58|||
105332462|NCT00651261|363219359|FG000|Overall Study|Alternative therapy|109|||
105332463|NCT00651261|363219360|FG001|Overall Study|Alternative therapy|107|||
105332464|NCT00651261|363219359|FG000|Overall Study|Other disease or participant decisions|23|||
105332465|NCT00651261|363219360|FG001|Overall Study|Other disease or participant decisions|23|||
105332466|NCT00651261|363219359|FG000|Overall Study|Never treated|5|||
105332467|NCT00651261|363219360|FG001|Overall Study|Never treated|3|||
105332468|NCT04938180|363219363|FG000|Overall Study|Adverse Event|1|||
105332469|NCT03491462|363219364|FG000|Overall Study|Lost to Follow-up|2|||
105332470|NCT03491462|363219365|FG001|Overall Study|Lost to Follow-up|0|||
105332471|NCT03491462|363219364|FG000|Overall Study|Adverse Event|11|||
105332472|NCT03491462|363219365|FG001|Overall Study|Adverse Event|1|||
105332473|NCT03491462|363219364|FG000|Overall Study|Physician Decision|3|||
105332474|NCT03491462|363219365|FG001|Overall Study|Physician Decision|0|||
105332475|NCT03491462|363219364|FG000|Overall Study|Withdrawal by Subject|22|||
105332476|NCT03491462|363219365|FG001|Overall Study|Withdrawal by Subject|15|||
105332477|NCT00912743|363219368|FG000|Overall Study|Adverse Event|3|||
105332478|NCT00912743|363219369|FG001|Overall Study|Adverse Event|1|||
105332479|NCT00912743|363219368|FG000|Overall Study|Lack of Efficacy|9|||
105332480|NCT00912743|363219369|FG001|Overall Study|Lack of Efficacy|18|||
105332481|NCT00912743|363219368|FG000|Overall Study|Toxicity|0|||
105332482|NCT00912743|363219369|FG001|Overall Study|Toxicity|1|||
105332483|NCT00912743|363219368|FG000|Overall Study|End of treatment form was not collected|1|||
105332484|NCT00912743|363219369|FG001|Overall Study|End of treatment form was not collected|0|||
105332485|NCT00179660|363219370|FG000|Overall Study|Adverse Event|7|||
105332486|NCT00179660|363219370|FG000|Overall Study|Lack of therapeutic effect|28|||
105332487|NCT00179660|363219370|FG000|Overall Study|Withdrawal by Subject|2|||
105332488|NCT00179660|363219370|FG000|Overall Study|Lost to Follow-up|1|||
105332489|NCT00179660|363219370|FG000|Overall Study|Death|3|||
105332490|NCT00179660|363219370|FG000|Overall Study|Other - Unspecified|9|||
105332491|NCT00869999|363219374|FG000|Overall Study|Withdrawal by Subject|1|||
105332492|NCT00869999|363219374|FG000|Overall Study|removed prior to starting therapy|1|||
105332493|NCT04112043|363219375|FG000|Overall Study|Withdrawal by Subject|1|||
105332494|NCT04112043|363219376|FG001|Overall Study|Withdrawal by Subject|1|||
105332495|NCT04112043|363219377|FG002|Overall Study|Withdrawal by Subject|1|||
105332496|NCT04112043|363219375|FG000|Overall Study|Taking NR supplement|1|||
105332497|NCT04112043|363219376|FG001|Overall Study|Taking NR supplement|0|||
105332498|NCT04112043|363219377|FG002|Overall Study|Taking NR supplement|0|||
105332499|NCT04112043|363219375|FG000|Overall Study|Adverse Event|0|||
105332500|NCT04112043|363219376|FG001|Overall Study|Adverse Event|1|||
105332501|NCT04112043|363219377|FG002|Overall Study|Adverse Event|0|||
105332502|NCT00857896|363219385|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
105332503|NCT02308540|363219386|FG000|Overall Study|Lost to Follow-up|0|||
105332504|NCT02308540|363219387|FG001|Overall Study|Lost to Follow-up|0|||
105332505|NCT02308540|363219388|FG002|Overall Study|Lost to Follow-up|0|||
105332506|NCT02308540|363219389|FG003|Overall Study|Lost to Follow-up|0|||
105332507|NCT02308540|363219390|FG004|Overall Study|Lost to Follow-up|0|||
105332508|NCT02308540|363219391|FG005|Overall Study|Lost to Follow-up|1|||
105332509|NCT00443079|363219392|FG000|Overall Study|Lost to Follow-up|0|||
105332510|NCT00443079|363219393|FG001|Overall Study|Lost to Follow-up|1|||
105332511|NCT02049814|363219396|FG000|Overall Study|Reason not Specified|4|||
105332512|NCT02049814|363219397|FG001|Overall Study|Reason not Specified|3|||
105332513|NCT02049814|363219396|FG000|Overall Study|Pregnancy|1|||
105332514|NCT02049814|363219397|FG001|Overall Study|Pregnancy|0|||
105332515|NCT02049814|363219396|FG000|Overall Study|Lost to Follow-up|2|||
105332516|NCT02049814|363219397|FG001|Overall Study|Lost to Follow-up|3|||
105332517|NCT02049814|363219396|FG000|Overall Study|Serious Protocol Violation|5|||
105332518|NCT02049814|363219397|FG001|Overall Study|Serious Protocol Violation|7|||
105332519|NCT02049814|363219396|FG000|Overall Study|Study Termination|0|||
105332520|NCT02049814|363219397|FG001|Overall Study|Study Termination|1|||
105659695|NCT01099579|364418813|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
105806435|NCT01464827|364948988|FG007|Overall Study|Lost to Follow-up|2|||
105332521|NCT02049814|363219396|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
105332522|NCT02049814|363219397|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
105332523|NCT02049814|363219396|FG000|Overall Study|Voluntary withdrawal|9|||
105332524|NCT02049814|363219397|FG001|Overall Study|Voluntary withdrawal|8|||
105332525|NCT02097238|363219398|FG000|Overall Study|Death|1|||
105332526|NCT02097238|363219398|FG000|Overall Study|Physician Decision|1|||
105332527|NCT02097238|363219398|FG000|Overall Study|Progressive Disease|17|||
105332528|NCT02993250|363219400|FG000|Overall Study|Lost to Follow-up|0|||
105332529|NCT02993250|363219401|FG001|Overall Study|Lost to Follow-up|1|||
105332530|NCT01996254|363219404|FG000|Overall Study|Change in Eligibility|0|||
105332531|NCT01996254|363219405|FG001|Overall Study|Change in Eligibility|2|||
105332532|NCT01996254|363219406|FG002|Overall Study|Change in Eligibility|0|||
105332533|NCT01996254|363219404|FG000|Overall Study|Withdrawal by Subject|0|||
105332534|NCT01996254|363219405|FG001|Overall Study|Withdrawal by Subject|3|||
105332535|NCT01996254|363219406|FG002|Overall Study|Withdrawal by Subject|4|||
105332536|NCT01996254|363219404|FG000|Overall Study|Lost to Follow-up|1|||
105332537|NCT01996254|363219405|FG001|Overall Study|Lost to Follow-up|0|||
105332538|NCT01996254|363219406|FG002|Overall Study|Lost to Follow-up|4|||
105332539|NCT02693002|363219407|FG000|Overall Study|Withdrawal by Subject|1|||
105332540|NCT02693002|363219408|FG001|Overall Study|Withdrawal by Subject|0|||
105332541|NCT02865499|363219411|FG000|Baseline|Adverse Event|1|||
105332542|NCT02865499|363219411|FG000|Baseline|Withdrawal by Subject|1|||
105332543|NCT00014495|363219414|FG000|Overall Study|Death|0|||
105332544|NCT00014495|363219415|FG001|Overall Study|Death|0|||
105332545|NCT00014495|363219416|FG002|Overall Study|Death|1|||
105332546|NCT00014495|363219417|FG003|Overall Study|Death|0|||
105332547|NCT00014495|363219414|FG000|Overall Study|Clinical deterioration|0|||
105332548|NCT00014495|363219415|FG001|Overall Study|Clinical deterioration|0|||
105332549|NCT00014495|363219416|FG002|Overall Study|Clinical deterioration|0|||
105332550|NCT00014495|363219417|FG003|Overall Study|Clinical deterioration|1|||
105332551|NCT00828568|363219419|FG000|Randomized|Withdrawal by Subject|1|||
105332552|NCT00828568|363219420|FG001|Randomized|Withdrawal by Subject|0|||
105332553|NCT00828568|363219421|FG002|Randomized|Withdrawal by Subject|2|||
105332554|NCT00828568|363219419|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
105332555|NCT00828568|363219420|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
105332556|NCT00828568|363219421|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
105332557|NCT00828568|363219419|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
105332558|NCT00828568|363219420|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
105332559|NCT00828568|363219421|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
105332560|NCT00828568|363219419|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
105332561|NCT00828568|363219420|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
105332562|NCT00828568|363219421|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
105332563|NCT00828568|363219419|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
105332564|NCT00828568|363219420|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
105332565|NCT00828568|363219421|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
105332566|NCT00403481|363219422|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
105332567|NCT00403481|363219422|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
105332568|NCT00403481|363219422|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
105332569|NCT00403481|363219422|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
105332570|NCT00403481|363219422|FG000|Olm 40 mg|Adverse Event|2|||
105332571|NCT00403481|363219422|FG000|Olm 40 mg|Protocol Violation|1|||
105332572|NCT00403481|363219422|FG000|Olm 40 mg|Withdrawal by Subject|1|||
105332573|NCT00403481|363219422|FG000|Olm 40 mg|Other|1|||
105332574|NCT00403481|363219422|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
105332575|NCT00403481|363219422|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
105332576|NCT00403481|363219422|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
105332577|NCT00403481|363219422|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
105332578|NCT00403481|363219422|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
105332579|NCT00403481|363219422|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
105332580|NCT00396656|363219423|FG000|First Treatment Period|Withdrawal by Subject|0|||
105332581|NCT00396656|363219424|FG001|First Treatment Period|Withdrawal by Subject|2|||
105332582|NCT00396656|363219423|FG000|Second Treatment Period|Adverse Event|0|||
105332583|NCT00396656|363219424|FG001|Second Treatment Period|Adverse Event|1|||
105332584|NCT00994461|363219428|FG000|Overall Study|Adverse Event|2|||
105332585|NCT00994461|363219429|FG001|Overall Study|Adverse Event|1|||
105332586|NCT00994461|363219430|FG002|Overall Study|Adverse Event|0|||
105332587|NCT02477332|363219431|FG000|Overall Study|Adverse Event|0|||
105332588|NCT02477332|363219432|FG001|Overall Study|Adverse Event|1|||
105332589|NCT02477332|363219433|FG002|Overall Study|Adverse Event|1|||
105332590|NCT02477332|363219434|FG003|Overall Study|Adverse Event|2|||
105332591|NCT02477332|363219435|FG004|Overall Study|Adverse Event|1|||
105332592|NCT02477332|363219436|FG005|Overall Study|Adverse Event|2|||
105332593|NCT02477332|363219431|FG000|Overall Study|Lack of Efficacy|1|||
105332594|NCT02477332|363219432|FG001|Overall Study|Lack of Efficacy|2|||
105332595|NCT02477332|363219433|FG002|Overall Study|Lack of Efficacy|1|||
105332596|NCT02477332|363219434|FG003|Overall Study|Lack of Efficacy|2|||
105332597|NCT02477332|363219435|FG004|Overall Study|Lack of Efficacy|1|||
105659696|NCT01099579|364418811|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
105332598|NCT02477332|363219436|FG005|Overall Study|Lack of Efficacy|1|||
105332599|NCT02477332|363219431|FG000|Overall Study|Non-compliance with study treatment|0|||
105332600|NCT02477332|363219432|FG001|Overall Study|Non-compliance with study treatment|1|||
105332601|NCT02477332|363219433|FG002|Overall Study|Non-compliance with study treatment|2|||
105332602|NCT02477332|363219434|FG003|Overall Study|Non-compliance with study treatment|0|||
105332603|NCT02477332|363219435|FG004|Overall Study|Non-compliance with study treatment|0|||
105332604|NCT02477332|363219436|FG005|Overall Study|Non-compliance with study treatment|0|||
105332605|NCT02477332|363219431|FG000|Overall Study|Pregnancy|0|||
105332606|NCT02477332|363219432|FG001|Overall Study|Pregnancy|0|||
105332607|NCT02477332|363219433|FG002|Overall Study|Pregnancy|0|||
105332608|NCT02477332|363219434|FG003|Overall Study|Pregnancy|1|||
105332609|NCT02477332|363219435|FG004|Overall Study|Pregnancy|0|||
105332610|NCT02477332|363219436|FG005|Overall Study|Pregnancy|0|||
105332611|NCT02477332|363219431|FG000|Overall Study|Protocol Violation|2|||
105332612|NCT02477332|363219432|FG001|Overall Study|Protocol Violation|0|||
105332613|NCT02477332|363219433|FG002|Overall Study|Protocol Violation|3|||
105332614|NCT02477332|363219434|FG003|Overall Study|Protocol Violation|3|||
105332615|NCT02477332|363219435|FG004|Overall Study|Protocol Violation|1|||
105332616|NCT02477332|363219436|FG005|Overall Study|Protocol Violation|1|||
105332617|NCT02477332|363219431|FG000|Overall Study|Technical problems|0|||
105332618|NCT02477332|363219432|FG001|Overall Study|Technical problems|0|||
105332619|NCT02477332|363219433|FG002|Overall Study|Technical problems|1|||
105332620|NCT02477332|363219434|FG003|Overall Study|Technical problems|0|||
105332621|NCT02477332|363219435|FG004|Overall Study|Technical problems|0|||
105332622|NCT02477332|363219436|FG005|Overall Study|Technical problems|0|||
105332623|NCT02477332|363219431|FG000|Overall Study|Lost to Follow-up|0|||
105332624|NCT02477332|363219432|FG001|Overall Study|Lost to Follow-up|0|||
105332625|NCT02477332|363219433|FG002|Overall Study|Lost to Follow-up|2|||
105332626|NCT02477332|363219434|FG003|Overall Study|Lost to Follow-up|0|||
105332627|NCT02477332|363219435|FG004|Overall Study|Lost to Follow-up|0|||
105332628|NCT02477332|363219436|FG005|Overall Study|Lost to Follow-up|0|||
105332629|NCT02477332|363219431|FG000|Overall Study|Physician Decision|0|||
105332630|NCT02477332|363219432|FG001|Overall Study|Physician Decision|0|||
105332631|NCT02477332|363219433|FG002|Overall Study|Physician Decision|1|||
105332632|NCT02477332|363219434|FG003|Overall Study|Physician Decision|3|||
105332633|NCT02477332|363219435|FG004|Overall Study|Physician Decision|0|||
105332634|NCT02477332|363219436|FG005|Overall Study|Physician Decision|1|||
105332635|NCT02477332|363219431|FG000|Overall Study|Withdrawal by Subject|0|||
105332636|NCT02477332|363219432|FG001|Overall Study|Withdrawal by Subject|3|||
105332637|NCT02477332|363219433|FG002|Overall Study|Withdrawal by Subject|1|||
105332638|NCT02477332|363219434|FG003|Overall Study|Withdrawal by Subject|2|||
105332639|NCT02477332|363219435|FG004|Overall Study|Withdrawal by Subject|1|||
105332640|NCT02477332|363219436|FG005|Overall Study|Withdrawal by Subject|0|||
105332641|NCT02549287|363219437|FG000|Overall Study|Lost to Follow-up|65|||
105332642|NCT02549287|363219438|FG001|Overall Study|Lost to Follow-up|26|||
105332643|NCT02549287|363219437|FG000|Overall Study|Withdrawal by Subject|15|||
105332644|NCT02549287|363219438|FG001|Overall Study|Withdrawal by Subject|6|||
105332645|NCT04657198|363219439|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
105332646|NCT04657198|363219440|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
105332647|NCT04657198|363219441|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
105332648|NCT02977572|363219442|FG000|Overall Study|Exclusion criterion|2|||
105332649|NCT02977572|363219443|FG001|Overall Study|Exclusion criterion|2|||
105332650|NCT00591565|363219446|FG000|Overall Study|lost follow up, withdrawn|5|||
105332651|NCT01464164|363219447|FG000|Overall Study|Screen failure|0|||
105332652|NCT01464164|363219448|FG001|Overall Study|Screen failure|1|||
105332653|NCT01464164|363219449|FG002|Overall Study|Screen failure|2|||
105332654|NCT01464164|363219450|FG003|Overall Study|Screen failure|0|||
105332655|NCT01464164|363219451|FG004|Overall Study|Screen failure|0|||
105332656|NCT01464164|363219452|FG005|Overall Study|Screen failure|0|||
105332657|NCT01464164|363219453|FG006|Overall Study|Screen failure|0|||
105332658|NCT01464164|363219447|FG000|Overall Study|Physician Decision|0|||
105332659|NCT01464164|363219448|FG001|Overall Study|Physician Decision|1|||
105332660|NCT01464164|363219449|FG002|Overall Study|Physician Decision|0|||
105332661|NCT01464164|363219450|FG003|Overall Study|Physician Decision|0|||
105332662|NCT01464164|363219451|FG004|Overall Study|Physician Decision|0|||
105332663|NCT01464164|363219452|FG005|Overall Study|Physician Decision|0|||
105332664|NCT01464164|363219453|FG006|Overall Study|Physician Decision|2|||
105332665|NCT02644668|363219456|FG000|Overall Study|Adverse Event|2|||
105332666|NCT02644668|363219457|FG001|Overall Study|Adverse Event|0|||
105332667|NCT02644668|363219458|FG002|Overall Study|Adverse Event|1|||
105332668|NCT02644668|363219456|FG000|Overall Study|Protocol Violation|0|||
105332669|NCT02644668|363219457|FG001|Overall Study|Protocol Violation|0|||
105332670|NCT02644668|363219458|FG002|Overall Study|Protocol Violation|1|||
105332671|NCT02644668|363219456|FG000|Overall Study|Withdrawal by Subject|0|||
105332672|NCT02644668|363219457|FG001|Overall Study|Withdrawal by Subject|0|||
105332673|NCT02644668|363219458|FG002|Overall Study|Withdrawal by Subject|1|||
105332674|NCT00757042|363219461|FG000|Overall Study|Lost to Follow-up|0|||
105332675|NCT00757042|363219462|FG001|Overall Study|Lost to Follow-up|0|||
105332676|NCT00757042|363219463|FG002|Overall Study|Lost to Follow-up|0|||
105332677|NCT00757042|363219464|FG003|Overall Study|Lost to Follow-up|0|||
105332678|NCT00757042|363219465|FG004|Overall Study|Lost to Follow-up|0|||
105332679|NCT00757042|363219466|FG005|Overall Study|Lost to Follow-up|0|||
105332680|NCT00757042|363219467|FG006|Overall Study|Lost to Follow-up|0|||
105332681|NCT00757042|363219468|FG007|Overall Study|Lost to Follow-up|0|||
105332682|NCT00757042|363219469|FG008|Overall Study|Lost to Follow-up|1|||
105332683|NCT00757042|363219470|FG009|Overall Study|Lost to Follow-up|0|||
105332684|NCT00757042|363219471|FG010|Overall Study|Lost to Follow-up|0|||
105332685|NCT00757042|363219461|FG000|Overall Study|Ineligibility Determined|0|||
105332686|NCT00757042|363219462|FG001|Overall Study|Ineligibility Determined|0|||
105332687|NCT00757042|363219463|FG002|Overall Study|Ineligibility Determined|0|||
105332688|NCT00757042|363219464|FG003|Overall Study|Ineligibility Determined|0|||
105332689|NCT00757042|363219465|FG004|Overall Study|Ineligibility Determined|0|||
105332690|NCT00757042|363219466|FG005|Overall Study|Ineligibility Determined|0|||
105332691|NCT00757042|363219467|FG006|Overall Study|Ineligibility Determined|0|||
105332692|NCT00757042|363219468|FG007|Overall Study|Ineligibility Determined|0|||
105332693|NCT00757042|363219469|FG008|Overall Study|Ineligibility Determined|0|||
105332694|NCT00757042|363219470|FG009|Overall Study|Ineligibility Determined|0|||
105332695|NCT00757042|363219471|FG010|Overall Study|Ineligibility Determined|1|||
105332696|NCT00757042|363219461|FG000|Overall Study|Withdrawal by Subject|0|||
105332697|NCT00757042|363219462|FG001|Overall Study|Withdrawal by Subject|0|||
105332698|NCT00757042|363219463|FG002|Overall Study|Withdrawal by Subject|0|||
105332699|NCT00757042|363219464|FG003|Overall Study|Withdrawal by Subject|0|||
105332700|NCT00757042|363219465|FG004|Overall Study|Withdrawal by Subject|0|||
105332701|NCT00757042|363219466|FG005|Overall Study|Withdrawal by Subject|0|||
105332702|NCT00757042|363219467|FG006|Overall Study|Withdrawal by Subject|0|||
105332703|NCT00757042|363219468|FG007|Overall Study|Withdrawal by Subject|0|||
105332704|NCT00757042|363219469|FG008|Overall Study|Withdrawal by Subject|0|||
105332705|NCT00757042|363219470|FG009|Overall Study|Withdrawal by Subject|1|||
105332706|NCT00757042|363219471|FG010|Overall Study|Withdrawal by Subject|0|||
105332707|NCT00789698|363219472|FG000|Overall Study|Lack of Efficacy|10|||
105332708|NCT00789698|363219473|FG001|Overall Study|Lack of Efficacy|4|||
105332709|NCT00789698|363219474|FG002|Overall Study|Lack of Efficacy|5|||
105332710|NCT00789698|363219475|FG003|Overall Study|Lack of Efficacy|18|||
105332711|NCT00789698|363219472|FG000|Overall Study|Adverse Event|5|||
105332712|NCT00789698|363219473|FG001|Overall Study|Adverse Event|5|||
105332713|NCT00789698|363219474|FG002|Overall Study|Adverse Event|3|||
105332714|NCT00789698|363219475|FG003|Overall Study|Adverse Event|4|||
105332715|NCT00789698|363219472|FG000|Overall Study|Lost to Follow-up|5|||
105332716|NCT00789698|363219473|FG001|Overall Study|Lost to Follow-up|5|||
105332717|NCT00789698|363219474|FG002|Overall Study|Lost to Follow-up|2|||
105332718|NCT00789698|363219475|FG003|Overall Study|Lost to Follow-up|9|||
105332719|NCT00789698|363219472|FG000|Overall Study|Protocol Violation|6|||
105332720|NCT00789698|363219473|FG001|Overall Study|Protocol Violation|1|||
105332721|NCT00789698|363219474|FG002|Overall Study|Protocol Violation|2|||
105332722|NCT00789698|363219475|FG003|Overall Study|Protocol Violation|1|||
105332723|NCT00789698|363219472|FG000|Overall Study|Withdrawal by Subject|14|||
105332724|NCT00789698|363219473|FG001|Overall Study|Withdrawal by Subject|15|||
105332725|NCT00789698|363219474|FG002|Overall Study|Withdrawal by Subject|12|||
105332726|NCT00789698|363219475|FG003|Overall Study|Withdrawal by Subject|19|||
105332727|NCT00789698|363219472|FG000|Overall Study|Administrative|0|||
105332728|NCT00789698|363219473|FG001|Overall Study|Administrative|3|||
105332729|NCT00789698|363219474|FG002|Overall Study|Administrative|3|||
105332730|NCT00789698|363219475|FG003|Overall Study|Administrative|1|||
105332731|NCT01500382|363219477|FG000|Washout Period|Study site went out of business|0|||
105332732|NCT01500382|363219478|FG001|Washout Period|Study site went out of business|0|||
105332733|NCT01500382|363219479|FG002|Washout Period|Study site went out of business|1|||
105332734|NCT01500382|363219480|FG003|Washout Period|Study site went out of business|0|||
105332735|NCT01483027|363219481|FG000|Overall Study|Administrative Reasons|2|||
105332736|NCT01483027|363219482|FG001|Overall Study|Administrative Reasons|1|||
105332737|NCT01483027|363219481|FG000|Overall Study|Withdrawal by Subject|21|||
105332738|NCT01483027|363219482|FG001|Overall Study|Withdrawal by Subject|32|||
105332739|NCT01483027|363219481|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
105332740|NCT01483027|363219482|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
105332741|NCT01483027|363219481|FG000|Overall Study|Lost to Follow-up|1|||
105332742|NCT01483027|363219482|FG001|Overall Study|Lost to Follow-up|1|||
105332743|NCT01483027|363219481|FG000|Overall Study|Adverse Event|0|||
105332744|NCT01483027|363219482|FG001|Overall Study|Adverse Event|1|||
105332745|NCT01483027|363219481|FG000|Overall Study|Withdrawal by Subject|0|||
105332746|NCT01483027|363219482|FG001|Overall Study|Withdrawal by Subject|1|||
105332747|NCT04463251|363219484|FG000|Overall Study|Death|1|||
105332748|NCT04463251|363219485|FG001|Overall Study|Death|0|||
105332749|NCT04463251|363219486|FG002|Overall Study|Death|1|||
105332750|NCT04463251|363219484|FG000|Overall Study|Adverse Event|0|||
105332751|NCT04463251|363219485|FG001|Overall Study|Adverse Event|1|||
105332752|NCT04463251|363219486|FG002|Overall Study|Adverse Event|0|||
105332753|NCT04463251|363219484|FG000|Overall Study|Lost to Follow-up|0|||
105332754|NCT04463251|363219485|FG001|Overall Study|Lost to Follow-up|1|||
105332755|NCT04463251|363219486|FG002|Overall Study|Lost to Follow-up|0|||
105332756|NCT04463251|363219484|FG000|Overall Study|Withdrawal by Subject|0|||
105332757|NCT04463251|363219485|FG001|Overall Study|Withdrawal by Subject|2|||
105332758|NCT04463251|363219486|FG002|Overall Study|Withdrawal by Subject|2|||
105332759|NCT01266291|363219487|FG000|Overall Study|Adverse Event|1|||
105332760|NCT03291431|363219488|FG000|Overall Study|Protocol Violation|2|||
105332761|NCT03291431|363219489|FG001|Overall Study|Protocol Violation|1|||
105332762|NCT03291431|363219488|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
105332763|NCT03291431|363219489|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
105332764|NCT03291431|363219488|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
105332765|NCT03291431|363219489|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
105332766|NCT00550745|363219492|FG000|Overall Study|Death|20|||
105332767|NCT00550745|363219493|FG001|Overall Study|Death|16|||
105332768|NCT00550745|363219492|FG000|Overall Study|Lost to Follow-up|45|||
105332769|NCT00550745|363219493|FG001|Overall Study|Lost to Follow-up|30|||
105332770|NCT00550745|363219492|FG000|Overall Study|Physician Decision|0|||
105332771|NCT00550745|363219493|FG001|Overall Study|Physician Decision|2|||
105332772|NCT00550745|363219492|FG000|Overall Study|Protocol Violation|4|||
105332773|NCT00550745|363219493|FG001|Overall Study|Protocol Violation|2|||
105332774|NCT00550745|363219492|FG000|Overall Study|Withdrawal by Subject|17|||
105332775|NCT00550745|363219493|FG001|Overall Study|Withdrawal by Subject|10|||
105332776|NCT00550745|363219492|FG000|Overall Study|Screen failure|1|||
105332777|NCT00550745|363219493|FG001|Overall Study|Screen failure|0|||
105332778|NCT03850483|363219494|FG000|Treatment for Stage 1|Adverse Event|1|||
105332779|NCT03850483|363219495|FG001|Treatment for Stage 1|Adverse Event|1|||
105332780|NCT03850483|363219496|FG002|Treatment for Stage 1|Adverse Event|3|||
105332781|NCT03850483|363219497|FG003|Treatment for Stage 1|Adverse Event|0|||
105332782|NCT03850483|363219498|FG004|Treatment for Stage 1|Adverse Event|2|||
105332783|NCT03850483|363219499|FG005|Treatment for Stage 1|Adverse Event|0|||
105332784|NCT03850483|363219500|FG006|Treatment for Stage 1|Adverse Event|2|||
105332785|NCT03850483|363219501|FG007|Treatment for Stage 1|Adverse Event|2|||
105332786|NCT03850483|363219502|FG008|Treatment for Stage 1|Adverse Event|0|||
105332787|NCT03850483|363219503|FG009|Treatment for Stage 1|Adverse Event|0|||
105332788|NCT03850483|363219494|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
105332789|NCT03850483|363219495|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
105332790|NCT03850483|363219496|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
105332791|NCT03850483|363219497|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
105332792|NCT03850483|363219498|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
105332793|NCT03850483|363219499|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
105332794|NCT03850483|363219500|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
105332795|NCT03850483|363219501|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
105332796|NCT03850483|363219502|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
105332797|NCT03850483|363219503|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
105332798|NCT03850483|363219494|FG000|Treatment for Stage 1|Protocol Violation|1|||
105332799|NCT03850483|363219495|FG001|Treatment for Stage 1|Protocol Violation|0|||
105332800|NCT03850483|363219496|FG002|Treatment for Stage 1|Protocol Violation|0|||
105332801|NCT03850483|363219497|FG003|Treatment for Stage 1|Protocol Violation|0|||
105332802|NCT03850483|363219498|FG004|Treatment for Stage 1|Protocol Violation|0|||
105332803|NCT03850483|363219499|FG005|Treatment for Stage 1|Protocol Violation|0|||
105332804|NCT03850483|363219500|FG006|Treatment for Stage 1|Protocol Violation|1|||
105332805|NCT03850483|363219501|FG007|Treatment for Stage 1|Protocol Violation|0|||
105332806|NCT03850483|363219502|FG008|Treatment for Stage 1|Protocol Violation|0|||
105332807|NCT03850483|363219503|FG009|Treatment for Stage 1|Protocol Violation|0|||
105332808|NCT03850483|363219494|FG000|Treatment for Stage 1|Physician Decision|0|||
105332809|NCT03850483|363219495|FG001|Treatment for Stage 1|Physician Decision|0|||
105332810|NCT03850483|363219496|FG002|Treatment for Stage 1|Physician Decision|0|||
105332811|NCT03850483|363219497|FG003|Treatment for Stage 1|Physician Decision|0|||
105332812|NCT03850483|363219498|FG004|Treatment for Stage 1|Physician Decision|0|||
105332813|NCT03850483|363219499|FG005|Treatment for Stage 1|Physician Decision|1|||
105332814|NCT03850483|363219500|FG006|Treatment for Stage 1|Physician Decision|0|||
105332815|NCT03850483|363219501|FG007|Treatment for Stage 1|Physician Decision|0|||
105332816|NCT03850483|363219502|FG008|Treatment for Stage 1|Physician Decision|0|||
105332817|NCT03850483|363219503|FG009|Treatment for Stage 1|Physician Decision|0|||
105332818|NCT03850483|363219494|FG000|Treatment for Stage 1|Other|0|||
105332819|NCT03850483|363219495|FG001|Treatment for Stage 1|Other|0|||
105332820|NCT03850483|363219496|FG002|Treatment for Stage 1|Other|0|||
105332821|NCT03850483|363219497|FG003|Treatment for Stage 1|Other|0|||
105332822|NCT03850483|363219498|FG004|Treatment for Stage 1|Other|2|||
105332823|NCT03850483|363219499|FG005|Treatment for Stage 1|Other|1|||
105332824|NCT03850483|363219500|FG006|Treatment for Stage 1|Other|0|||
105332825|NCT03850483|363219501|FG007|Treatment for Stage 1|Other|0|||
105332826|NCT03850483|363219502|FG008|Treatment for Stage 1|Other|0|||
105332827|NCT03850483|363219503|FG009|Treatment for Stage 1|Other|0|||
105360834|NCT00572455|363328087|FG007|Stage II (28 Days)|Other|0|||
105360835|NCT00572455|363328088|FG008|Stage II (28 Days)|Other|1|||
105332828|NCT03850483|363219494|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105332829|NCT03850483|363219495|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105332830|NCT03850483|363219496|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
105332831|NCT03850483|363219497|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105332832|NCT03850483|363219498|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105332833|NCT03850483|363219499|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105332834|NCT03850483|363219500|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105332835|NCT03850483|363219501|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105332836|NCT03850483|363219502|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105332837|NCT03850483|363219503|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105332838|NCT03850483|363219494|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105332839|NCT03850483|363219495|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105332840|NCT03850483|363219496|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105332841|NCT03850483|363219497|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105332842|NCT03850483|363219498|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105332843|NCT03850483|363219499|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
105332844|NCT03850483|363219500|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105332845|NCT03850483|363219501|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105332846|NCT03850483|363219502|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105332847|NCT03850483|363219503|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105332848|NCT03850483|363219494|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
105332849|NCT03850483|363219495|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
105332850|NCT03850483|363219496|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
105332851|NCT03850483|363219497|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
105332852|NCT03850483|363219498|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
105332853|NCT03850483|363219499|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
105332854|NCT03850483|363219500|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
105332855|NCT03850483|363219501|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
105332856|NCT03850483|363219502|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
105332857|NCT03850483|363219503|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
105332858|NCT03850483|363219494|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
105332859|NCT03850483|363219495|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
105332860|NCT03850483|363219496|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
105332861|NCT03850483|363219497|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
105332862|NCT03850483|363219498|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
105332863|NCT03850483|363219499|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
105332864|NCT03850483|363219500|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
105332865|NCT03850483|363219501|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
105332866|NCT03850483|363219502|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
105332867|NCT03850483|363219503|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
105332868|NCT03850483|363219494|FG000|Treatment for Stage 1|Death|0|||
105332869|NCT03850483|363219495|FG001|Treatment for Stage 1|Death|0|||
105332870|NCT03850483|363219496|FG002|Treatment for Stage 1|Death|0|||
105332871|NCT03850483|363219497|FG003|Treatment for Stage 1|Death|0|||
105332872|NCT03850483|363219498|FG004|Treatment for Stage 1|Death|0|||
105332873|NCT03850483|363219499|FG005|Treatment for Stage 1|Death|1|||
105332874|NCT03850483|363219500|FG006|Treatment for Stage 1|Death|0|||
105332875|NCT03850483|363219501|FG007|Treatment for Stage 1|Death|0|||
105332876|NCT03850483|363219502|FG008|Treatment for Stage 1|Death|0|||
105332877|NCT03850483|363219503|FG009|Treatment for Stage 1|Death|0|||
105332878|NCT03850483|363219494|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
105332879|NCT03850483|363219495|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
105332880|NCT03850483|363219496|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
105332881|NCT03850483|363219497|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
105332882|NCT03850483|363219498|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
105332883|NCT03850483|363219499|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
105332884|NCT03850483|363219500|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
105332885|NCT03850483|363219501|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
105332886|NCT03850483|363219502|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
105332887|NCT03850483|363219503|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
105332888|NCT03850483|363219494|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
105332889|NCT03850483|363219495|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
105332890|NCT03850483|363219496|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
105332891|NCT03850483|363219497|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
105332892|NCT03850483|363219498|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
105332893|NCT03850483|363219499|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
105332894|NCT03850483|363219500|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
105332895|NCT03850483|363219501|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
105332896|NCT03850483|363219502|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
105332897|NCT03850483|363219503|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
105332898|NCT03850483|363219494|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
105332899|NCT03850483|363219495|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
105332900|NCT03850483|363219496|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
105332901|NCT03850483|363219497|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
105332902|NCT03850483|363219498|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
105332903|NCT03850483|363219499|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
105332904|NCT03850483|363219500|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
105332905|NCT03850483|363219501|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
105332906|NCT03850483|363219502|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
105332907|NCT03850483|363219503|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
105332908|NCT03850483|363219494|FG000|Follow-up for Stage 1|Physician Decision|0|||
105332909|NCT03850483|363219495|FG001|Follow-up for Stage 1|Physician Decision|0|||
105332910|NCT03850483|363219496|FG002|Follow-up for Stage 1|Physician Decision|0|||
105332911|NCT03850483|363219497|FG003|Follow-up for Stage 1|Physician Decision|0|||
105332912|NCT03850483|363219498|FG004|Follow-up for Stage 1|Physician Decision|1|||
105332913|NCT03850483|363219499|FG005|Follow-up for Stage 1|Physician Decision|0|||
105332914|NCT03850483|363219500|FG006|Follow-up for Stage 1|Physician Decision|1|||
105332915|NCT03850483|363219501|FG007|Follow-up for Stage 1|Physician Decision|0|||
105332916|NCT03850483|363219502|FG008|Follow-up for Stage 1|Physician Decision|0|||
105332917|NCT03850483|363219503|FG009|Follow-up for Stage 1|Physician Decision|0|||
105332918|NCT03850483|363219494|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
105332919|NCT03850483|363219495|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
105332920|NCT03850483|363219496|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
105332921|NCT03850483|363219497|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
105332922|NCT03850483|363219498|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
105332923|NCT03850483|363219499|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
105332924|NCT03850483|363219500|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
105332925|NCT03850483|363219501|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
105332926|NCT03850483|363219502|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
105332927|NCT03850483|363219503|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
105332928|NCT03850483|363219494|FG000|Follow-up for Stage 1|Adverse Event|0|||
105332929|NCT03850483|363219495|FG001|Follow-up for Stage 1|Adverse Event|0|||
105332930|NCT03850483|363219496|FG002|Follow-up for Stage 1|Adverse Event|1|||
105332931|NCT03850483|363219497|FG003|Follow-up for Stage 1|Adverse Event|0|||
105332932|NCT03850483|363219498|FG004|Follow-up for Stage 1|Adverse Event|0|||
105332933|NCT03850483|363219499|FG005|Follow-up for Stage 1|Adverse Event|1|||
105332934|NCT03850483|363219500|FG006|Follow-up for Stage 1|Adverse Event|0|||
105332935|NCT03850483|363219501|FG007|Follow-up for Stage 1|Adverse Event|0|||
105332936|NCT03850483|363219502|FG008|Follow-up for Stage 1|Adverse Event|0|||
105332937|NCT03850483|363219503|FG009|Follow-up for Stage 1|Adverse Event|0|||
105332938|NCT03850483|363219494|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
105332939|NCT03850483|363219495|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
105332940|NCT03850483|363219496|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
105332941|NCT03850483|363219497|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
105332942|NCT03850483|363219498|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
105332943|NCT03850483|363219499|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
105332944|NCT03850483|363219500|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
105332945|NCT03850483|363219501|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
105332946|NCT03850483|363219502|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
105332947|NCT03850483|363219503|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
105332948|NCT03850483|363219494|FG000|Follow-up for Stage 1|Other|0|||
105332949|NCT03850483|363219495|FG001|Follow-up for Stage 1|Other|2|||
105332950|NCT03850483|363219496|FG002|Follow-up for Stage 1|Other|0|||
105332951|NCT03850483|363219497|FG003|Follow-up for Stage 1|Other|2|||
105332952|NCT03850483|363219498|FG004|Follow-up for Stage 1|Other|0|||
105332953|NCT03850483|363219499|FG005|Follow-up for Stage 1|Other|1|||
105332954|NCT03850483|363219500|FG006|Follow-up for Stage 1|Other|0|||
105332955|NCT03850483|363219501|FG007|Follow-up for Stage 1|Other|0|||
105332956|NCT03850483|363219502|FG008|Follow-up for Stage 1|Other|0|||
105332957|NCT03850483|363219503|FG009|Follow-up for Stage 1|Other|0|||
105332958|NCT03850483|363219494|FG000|Treatment for Stage 2|Adverse Event|0|||
105332959|NCT03850483|363219495|FG001|Treatment for Stage 2|Adverse Event|0|||
105332960|NCT03850483|363219496|FG002|Treatment for Stage 2|Adverse Event|0|||
105332961|NCT03850483|363219497|FG003|Treatment for Stage 2|Adverse Event|0|||
105332962|NCT03850483|363219498|FG004|Treatment for Stage 2|Adverse Event|0|||
105332963|NCT03850483|363219499|FG005|Treatment for Stage 2|Adverse Event|0|||
105332964|NCT03850483|363219500|FG006|Treatment for Stage 2|Adverse Event|0|||
105332965|NCT03850483|363219501|FG007|Treatment for Stage 2|Adverse Event|0|||
105332966|NCT03850483|363219502|FG008|Treatment for Stage 2|Adverse Event|0|||
105332967|NCT03850483|363219503|FG009|Treatment for Stage 2|Adverse Event|1|||
105332968|NCT03850483|363219494|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
105332969|NCT03850483|363219495|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
105332970|NCT03850483|363219496|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
105332971|NCT03850483|363219497|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
105332972|NCT03850483|363219498|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
105332973|NCT03850483|363219499|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
105332974|NCT03850483|363219500|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
105332975|NCT03850483|363219501|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
105332976|NCT03850483|363219502|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
105332977|NCT03850483|363219503|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
105332978|NCT03850483|363219494|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
105332979|NCT03850483|363219495|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
105332980|NCT03850483|363219496|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
105332981|NCT03850483|363219497|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
105332982|NCT03850483|363219498|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
105332983|NCT03850483|363219499|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
105332984|NCT03850483|363219500|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
105332985|NCT03850483|363219501|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
105332986|NCT03850483|363219502|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
105332987|NCT03850483|363219503|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
105332988|NCT03850483|363219494|FG000|Treatment for Stage 2|Physician Decision|0|||
105332989|NCT03850483|363219495|FG001|Treatment for Stage 2|Physician Decision|0|||
105332990|NCT03850483|363219496|FG002|Treatment for Stage 2|Physician Decision|0|||
105332991|NCT03850483|363219497|FG003|Treatment for Stage 2|Physician Decision|0|||
105332992|NCT03850483|363219498|FG004|Treatment for Stage 2|Physician Decision|0|||
105332993|NCT03850483|363219499|FG005|Treatment for Stage 2|Physician Decision|0|||
105332994|NCT03850483|363219500|FG006|Treatment for Stage 2|Physician Decision|0|||
105332995|NCT03850483|363219501|FG007|Treatment for Stage 2|Physician Decision|0|||
105332996|NCT03850483|363219502|FG008|Treatment for Stage 2|Physician Decision|0|||
105332997|NCT03850483|363219503|FG009|Treatment for Stage 2|Physician Decision|1|||
105332998|NCT03850483|363219494|FG000|Treatment for Stage 2|Protocol Violation|0|||
105332999|NCT03850483|363219495|FG001|Treatment for Stage 2|Protocol Violation|0|||
105333000|NCT03850483|363219496|FG002|Treatment for Stage 2|Protocol Violation|0|||
105333001|NCT03850483|363219497|FG003|Treatment for Stage 2|Protocol Violation|0|||
105333002|NCT03850483|363219498|FG004|Treatment for Stage 2|Protocol Violation|0|||
105333003|NCT03850483|363219499|FG005|Treatment for Stage 2|Protocol Violation|0|||
105333004|NCT03850483|363219500|FG006|Treatment for Stage 2|Protocol Violation|0|||
105333005|NCT03850483|363219501|FG007|Treatment for Stage 2|Protocol Violation|0|||
105333006|NCT03850483|363219502|FG008|Treatment for Stage 2|Protocol Violation|1|||
105333007|NCT03850483|363219503|FG009|Treatment for Stage 2|Protocol Violation|0|||
105333008|NCT03850483|363219494|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
105333009|NCT03850483|363219495|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
105333010|NCT03850483|363219496|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
105333011|NCT03850483|363219497|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
105333012|NCT03850483|363219498|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
105333013|NCT03850483|363219499|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
105333014|NCT03850483|363219500|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
105333015|NCT03850483|363219501|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
105333016|NCT03850483|363219502|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
105333017|NCT03850483|363219503|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
105333018|NCT03850483|363219494|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105333019|NCT03850483|363219495|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105333020|NCT03850483|363219496|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105333021|NCT03850483|363219497|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105333022|NCT03850483|363219498|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105333023|NCT03850483|363219499|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105333024|NCT03850483|363219500|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105333025|NCT03850483|363219501|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105333026|NCT03850483|363219502|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105333027|NCT03850483|363219503|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
105333028|NCT03850483|363219494|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
105333029|NCT03850483|363219495|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
105333030|NCT03850483|363219496|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
105333031|NCT03850483|363219497|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
105333032|NCT03850483|363219498|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
105333033|NCT03850483|363219499|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
105333034|NCT03850483|363219500|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
105333035|NCT03850483|363219501|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
105333036|NCT03850483|363219502|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
105333037|NCT03850483|363219503|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
105333038|NCT03850483|363219494|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
105333039|NCT03850483|363219495|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
105333040|NCT03850483|363219496|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
105333041|NCT03850483|363219497|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
105333042|NCT03850483|363219498|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
105333043|NCT03850483|363219499|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
105360836|NCT00572455|363328089|FG009|Stage II (28 Days)|Other|0|||
105333044|NCT03850483|363219500|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
105333045|NCT03850483|363219501|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
105333046|NCT03850483|363219502|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
105333047|NCT03850483|363219503|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
105333048|NCT03850483|363219494|FG000|Follow-up For Stage 2|Other|0|||
105333049|NCT03850483|363219495|FG001|Follow-up For Stage 2|Other|0|||
105333050|NCT03850483|363219496|FG002|Follow-up For Stage 2|Other|0|||
105333051|NCT03850483|363219497|FG003|Follow-up For Stage 2|Other|0|||
105333052|NCT03850483|363219498|FG004|Follow-up For Stage 2|Other|0|||
105333053|NCT03850483|363219499|FG005|Follow-up For Stage 2|Other|0|||
105333054|NCT03850483|363219500|FG006|Follow-up For Stage 2|Other|0|||
105333055|NCT03850483|363219501|FG007|Follow-up For Stage 2|Other|0|||
105333056|NCT03850483|363219502|FG008|Follow-up For Stage 2|Other|0|||
105333057|NCT03850483|363219503|FG009|Follow-up For Stage 2|Other|1|||
105333058|NCT05119595|363221152|FG000|Overall Study|Death|1|||
105333059|NCT05119595|363221152|FG000|Overall Study|Lost to Follow-up|7|||
105333060|NCT03503370|363221153|FG000|Overall Study|Death|3|||
105333061|NCT03503370|363221154|FG001|Overall Study|Death|1|||
105333062|NCT00679029|363221155|FG000|Overall Study|Adverse Event|3|||
105333063|NCT00679029|363221155|FG000|Overall Study|Withdrawal by Subject|1|||
105333064|NCT00679029|363221155|FG000|Overall Study|Lost to Follow-up|1|||
105333065|NCT03056638|363221163|FG000|Overall Study|Death|1|||
105333066|NCT03056638|363221164|FG001|Overall Study|Death|0|||
105333067|NCT00596687|363221165|FG000|Overall Study|< 24 hours of insulin treatment|8|||
105333068|NCT00596687|363221166|FG001|Overall Study|< 24 hours of insulin treatment|6|||
105333069|NCT00596687|363221165|FG000|Overall Study|continuous insulin infusion during TPN|2|||
105333070|NCT00596687|363221166|FG001|Overall Study|continuous insulin infusion during TPN|1|||
105333071|NCT00596687|363221165|FG000|Overall Study|Withdrawal by Subject|3|||
105333072|NCT00596687|363221166|FG001|Overall Study|Withdrawal by Subject|1|||
105333073|NCT00596687|363221165|FG000|Overall Study|cancelled surgery|1|||
105333074|NCT00596687|363221166|FG001|Overall Study|cancelled surgery|1|||
105333075|NCT00932373|363221167|FG000|Overall Study|Progressive disease|3|||
105333076|NCT00932373|363221168|FG001|Overall Study|Progressive disease|1|||
105333077|NCT00932373|363221169|FG002|Overall Study|Progressive disease|0|||
105333078|NCT00932373|363221170|FG003|Overall Study|Progressive disease|0|||
105333079|NCT00932373|363221171|FG004|Overall Study|Progressive disease|10|||
105333080|NCT00932373|363221172|FG005|Overall Study|Progressive disease|1|||
105333081|NCT00932373|363221173|FG006|Overall Study|Progressive disease|0|||
105333082|NCT00932373|363221174|FG007|Overall Study|Progressive disease|2|||
105333083|NCT00932373|363221175|FG008|Overall Study|Progressive disease|1|||
105333084|NCT00932373|363221176|FG009|Overall Study|Progressive disease|9|||
105333085|NCT00932373|363221177|FG010|Overall Study|Progressive disease|2|||
105333086|NCT00932373|363221167|FG000|Overall Study|Adverse Event|0|||
105333087|NCT00932373|363221168|FG001|Overall Study|Adverse Event|0|||
105333088|NCT00932373|363221169|FG002|Overall Study|Adverse Event|0|||
105333089|NCT00932373|363221170|FG003|Overall Study|Adverse Event|0|||
105333090|NCT00932373|363221171|FG004|Overall Study|Adverse Event|2|||
105333091|NCT00932373|363221172|FG005|Overall Study|Adverse Event|1|||
105333092|NCT00932373|363221173|FG006|Overall Study|Adverse Event|0|||
105333093|NCT00932373|363221174|FG007|Overall Study|Adverse Event|1|||
105333094|NCT00932373|363221175|FG008|Overall Study|Adverse Event|0|||
105333095|NCT00932373|363221176|FG009|Overall Study|Adverse Event|2|||
105333096|NCT00932373|363221177|FG010|Overall Study|Adverse Event|1|||
105333097|NCT00932373|363221167|FG000|Overall Study|Physician Decision|0|||
105333098|NCT00932373|363221168|FG001|Overall Study|Physician Decision|0|||
105333099|NCT00932373|363221169|FG002|Overall Study|Physician Decision|1|||
105333100|NCT00932373|363221170|FG003|Overall Study|Physician Decision|0|||
105333101|NCT00932373|363221171|FG004|Overall Study|Physician Decision|2|||
105333102|NCT00932373|363221172|FG005|Overall Study|Physician Decision|0|||
105333103|NCT00932373|363221173|FG006|Overall Study|Physician Decision|0|||
105333104|NCT00932373|363221174|FG007|Overall Study|Physician Decision|0|||
105333105|NCT00932373|363221175|FG008|Overall Study|Physician Decision|0|||
105333106|NCT00932373|363221176|FG009|Overall Study|Physician Decision|1|||
105333107|NCT00932373|363221177|FG010|Overall Study|Physician Decision|0|||
105333108|NCT00932373|363221167|FG000|Overall Study|Dose limiting toxicity|0|||
105333109|NCT00932373|363221168|FG001|Overall Study|Dose limiting toxicity|0|||
105333110|NCT00932373|363221169|FG002|Overall Study|Dose limiting toxicity|0|||
105333111|NCT00932373|363221170|FG003|Overall Study|Dose limiting toxicity|0|||
105333112|NCT00932373|363221171|FG004|Overall Study|Dose limiting toxicity|0|||
105333113|NCT00932373|363221172|FG005|Overall Study|Dose limiting toxicity|1|||
105333114|NCT00932373|363221173|FG006|Overall Study|Dose limiting toxicity|0|||
105333115|NCT00932373|363221174|FG007|Overall Study|Dose limiting toxicity|0|||
105333116|NCT00932373|363221175|FG008|Overall Study|Dose limiting toxicity|0|||
105333117|NCT00932373|363221176|FG009|Overall Study|Dose limiting toxicity|0|||
105333118|NCT00932373|363221177|FG010|Overall Study|Dose limiting toxicity|0|||
105333119|NCT00932373|363221167|FG000|Overall Study|Withdrawal by Subject|0|||
105333120|NCT00932373|363221168|FG001|Overall Study|Withdrawal by Subject|0|||
105333121|NCT00932373|363221169|FG002|Overall Study|Withdrawal by Subject|0|||
105333122|NCT00932373|363221170|FG003|Overall Study|Withdrawal by Subject|0|||
105333123|NCT00932373|363221171|FG004|Overall Study|Withdrawal by Subject|0|||
105333124|NCT00932373|363221172|FG005|Overall Study|Withdrawal by Subject|0|||
105333125|NCT00932373|363221173|FG006|Overall Study|Withdrawal by Subject|0|||
105333126|NCT00932373|363221174|FG007|Overall Study|Withdrawal by Subject|0|||
105333127|NCT00932373|363221175|FG008|Overall Study|Withdrawal by Subject|1|||
105333128|NCT00932373|363221176|FG009|Overall Study|Withdrawal by Subject|0|||
105333129|NCT00932373|363221177|FG010|Overall Study|Withdrawal by Subject|0|||
105333130|NCT00932373|363221167|FG000|Overall Study|Clinical progression|0|||
105333131|NCT00932373|363221168|FG001|Overall Study|Clinical progression|0|||
105333132|NCT00932373|363221169|FG002|Overall Study|Clinical progression|0|||
105333133|NCT00932373|363221170|FG003|Overall Study|Clinical progression|0|||
105333134|NCT00932373|363221171|FG004|Overall Study|Clinical progression|0|||
105333135|NCT00932373|363221172|FG005|Overall Study|Clinical progression|0|||
105333136|NCT00932373|363221173|FG006|Overall Study|Clinical progression|1|||
105333137|NCT00932373|363221174|FG007|Overall Study|Clinical progression|0|||
105333138|NCT00932373|363221175|FG008|Overall Study|Clinical progression|0|||
105333139|NCT00932373|363221176|FG009|Overall Study|Clinical progression|0|||
105333140|NCT00932373|363221177|FG010|Overall Study|Clinical progression|0|||
105333141|NCT00932373|363221167|FG000|Overall Study|Lack of Efficacy|0|||
105333142|NCT00932373|363221168|FG001|Overall Study|Lack of Efficacy|0|||
105333143|NCT00932373|363221169|FG002|Overall Study|Lack of Efficacy|0|||
105333144|NCT00932373|363221170|FG003|Overall Study|Lack of Efficacy|0|||
105333145|NCT00932373|363221171|FG004|Overall Study|Lack of Efficacy|0|||
105333146|NCT00932373|363221172|FG005|Overall Study|Lack of Efficacy|0|||
105333147|NCT00932373|363221173|FG006|Overall Study|Lack of Efficacy|0|||
105333148|NCT00932373|363221174|FG007|Overall Study|Lack of Efficacy|0|||
105333149|NCT00932373|363221175|FG008|Overall Study|Lack of Efficacy|0|||
105333150|NCT00932373|363221176|FG009|Overall Study|Lack of Efficacy|1|||
105333151|NCT00932373|363221177|FG010|Overall Study|Lack of Efficacy|0|||
105333152|NCT01637922|363221178|FG000|Overall Study|Adverse Event|0|||
105333153|NCT01637922|363221179|FG001|Overall Study|Adverse Event|1|||
105333154|NCT01637922|363221178|FG000|Overall Study|Protocol Violation|0|||
105333155|NCT01637922|363221179|FG001|Overall Study|Protocol Violation|1|||
105333156|NCT01637922|363221178|FG000|Overall Study|Withdrawal by Subject|0|||
105333157|NCT01637922|363221179|FG001|Overall Study|Withdrawal by Subject|3|||
105333158|NCT01637922|363221178|FG000|Overall Study|Lost to Follow-up|2|||
105333159|NCT01637922|363221179|FG001|Overall Study|Lost to Follow-up|0|||
105333160|NCT01068730|363221180|FG000|Period 3|Personal reason|1|||
105333161|NCT01068730|363221181|FG001|Period 3|Personal reason|0|||
105333162|NCT01068730|363221182|FG002|Period 3|Personal reason|0|||
105333163|NCT01068730|363221183|FG003|Period 3|Personal reason|0|||
105333164|NCT01068730|363221180|FG000|Period 4|Family emergency|0|||
105333165|NCT01068730|363221181|FG001|Period 4|Family emergency|1|||
105333166|NCT01068730|363221182|FG002|Period 4|Family emergency|0|||
105333167|NCT01068730|363221183|FG003|Period 4|Family emergency|0|||
105333168|NCT02366637|363221184|FG000|First Intervention Period|Adverse Event|0|||
105333169|NCT02366637|363221185|FG001|First Intervention Period|Adverse Event|1|||
105333170|NCT02366637|363221184|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
105333171|NCT02366637|363221185|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
105333172|NCT02366637|363221184|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
105333173|NCT02366637|363221185|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
105333174|NCT03691207|363221186|FG000|Overall Study|Death|41|||
105333175|NCT03691207|363221187|FG001|Overall Study|Death|26|||
105333176|NCT03691207|363221186|FG000|Overall Study|Lost to Follow-up|1|||
105333177|NCT03691207|363221187|FG001|Overall Study|Lost to Follow-up|1|||
105333178|NCT03691207|363221186|FG000|Overall Study|Withdrawal by Subject|2|||
105333179|NCT03691207|363221187|FG001|Overall Study|Withdrawal by Subject|8|||
105333180|NCT03691207|363221186|FG000|Overall Study|Sponsor decision|1|||
105333181|NCT03691207|363221187|FG001|Overall Study|Sponsor decision|7|||
105333182|NCT02309411|363221188|FG000|Overall Study|Physician Decision|1|||
105333183|NCT02309411|363221189|FG001|Overall Study|Physician Decision|0|||
105333184|NCT02309411|363221190|FG002|Overall Study|Physician Decision|0|||
105333185|NCT02309411|363221188|FG000|Overall Study|Withdrawal by Subject|1|||
105333186|NCT02309411|363221189|FG001|Overall Study|Withdrawal by Subject|1|||
105333187|NCT02309411|363221190|FG002|Overall Study|Withdrawal by Subject|0|||
105333188|NCT02498444|363221191|FG000|Overall Study|Withdrawal by Subject|3|||
105333189|NCT02498444|363221192|FG001|Overall Study|Withdrawal by Subject|0|||
105333190|NCT02498444|363221191|FG000|Overall Study|Physician Decision|1|||
105333191|NCT02498444|363221192|FG001|Overall Study|Physician Decision|0|||
105333192|NCT00302328|363221193|FG000|Overall Study|Physician Decision|0|||
105333193|NCT00302328|363221194|FG001|Overall Study|Physician Decision|1|||
105333194|NCT00302328|363221195|FG002|Overall Study|Physician Decision|0|||
105333195|NCT04411810|363221198|FG000|Overall Study|Screen failure|1|||
105333196|NCT04411810|363221198|FG000|Overall Study|Withdrawal by Subject|1|||
105333197|NCT01920958|363221199|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
105333198|NCT01718535|363221200|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
105333199|NCT01718535|363221201|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
105333200|NCT01718535|363221202|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
105333201|NCT01718535|363221203|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
105333202|NCT01718535|363221204|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
105333203|NCT01718535|363221205|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
105333204|NCT01718535|363221206|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
105333205|NCT01718535|363221207|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
105333206|NCT01718535|363221208|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
105333207|NCT01718535|363221209|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
105333208|NCT00026494|363221212|FG000|Overall Study|Withdrawal by Subject|1|||
105333209|NCT00026494|363221213|FG001|Overall Study|Withdrawal by Subject|0|||
105333210|NCT00026494|363221214|FG002|Overall Study|Withdrawal by Subject|1|||
105333211|NCT00026494|363221215|FG003|Overall Study|Withdrawal by Subject|0|||
105333212|NCT00026494|363221212|FG000|Overall Study|Patient non-compliance|1|||
105333213|NCT00026494|363221213|FG001|Overall Study|Patient non-compliance|0|||
105333214|NCT00026494|363221214|FG002|Overall Study|Patient non-compliance|0|||
105333215|NCT00026494|363221215|FG003|Overall Study|Patient non-compliance|0|||
105333216|NCT00026494|363221212|FG000|Overall Study|Patient not treated|0|||
105333217|NCT00026494|363221213|FG001|Overall Study|Patient not treated|0|||
105333218|NCT00026494|363221214|FG002|Overall Study|Patient not treated|2|||
105333219|NCT00026494|363221215|FG003|Overall Study|Patient not treated|0|||
105333220|NCT00026494|363221212|FG000|Overall Study|Clinical progression|0|||
105333221|NCT00026494|363221213|FG001|Overall Study|Clinical progression|0|||
105333222|NCT00026494|363221214|FG002|Overall Study|Clinical progression|3|||
105333223|NCT00026494|363221215|FG003|Overall Study|Clinical progression|0|||
105333224|NCT00644917|363221223|FG000|Overall Study|Withdrawal by Subject|2|||
105333225|NCT01136356|363221224|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
105333226|NCT01136356|363221225|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
105333227|NCT01136356|363221224|FG000|First 18-day Withdrawal|Physician Decision|1|||
105333228|NCT01136356|363221225|FG001|First 18-day Withdrawal|Physician Decision|0|||
105333229|NCT01136356|363221224|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
105333230|NCT01136356|363221225|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
105333231|NCT00402688|363221226|FG000|Overall Study|Adverse Event|12|||
105333232|NCT00402688|363221227|FG001|Overall Study|Adverse Event|9|||
105333233|NCT00402688|363221228|FG002|Overall Study|Adverse Event|3|||
105333234|NCT00402688|363221226|FG000|Overall Study|Withdrawal by Subject|3|||
105333235|NCT00402688|363221227|FG001|Overall Study|Withdrawal by Subject|1|||
105333236|NCT00402688|363221228|FG002|Overall Study|Withdrawal by Subject|1|||
105333237|NCT00402688|363221226|FG000|Overall Study|Physician Decision|0|||
105333238|NCT00402688|363221227|FG001|Overall Study|Physician Decision|0|||
105333239|NCT00402688|363221228|FG002|Overall Study|Physician Decision|1|||
105333240|NCT00402688|363221226|FG000|Overall Study|Lack of Efficacy|4|||
105333241|NCT00402688|363221227|FG001|Overall Study|Lack of Efficacy|4|||
105333242|NCT00402688|363221228|FG002|Overall Study|Lack of Efficacy|5|||
105333243|NCT00402688|363221226|FG000|Overall Study|Protocol Violation|1|||
105333244|NCT00402688|363221227|FG001|Overall Study|Protocol Violation|1|||
105333245|NCT00402688|363221228|FG002|Overall Study|Protocol Violation|1|||
105333246|NCT00402688|363221226|FG000|Overall Study|Lost to Follow-up|1|||
105333247|NCT00402688|363221227|FG001|Overall Study|Lost to Follow-up|0|||
105333248|NCT00402688|363221228|FG002|Overall Study|Lost to Follow-up|2|||
105333249|NCT00402688|363221226|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
105333250|NCT00402688|363221227|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
105333251|NCT00402688|363221228|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
105333252|NCT00402688|363221226|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
105333253|NCT00402688|363221227|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
105333254|NCT00402688|363221228|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
105333255|NCT00402688|363221226|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
105333256|NCT00402688|363221227|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
105333257|NCT00402688|363221228|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
105333258|NCT02875613|363221229|FG000|Overall Study|Withdrawal by Subject|1|||
105333259|NCT02875613|363221229|FG000|Overall Study|Screen Failure|1|||
105333260|NCT00178685|363221230|FG000|Overall Study|Death|3|||
105333261|NCT00178685|363221231|FG001|Overall Study|Death|3|||
105333262|NCT00178685|363221232|FG002|Overall Study|Death|6|||
105333263|NCT00178685|363221230|FG000|Overall Study|Lost to Follow-up|100|||
105333264|NCT00178685|363221231|FG001|Overall Study|Lost to Follow-up|187|||
105333265|NCT00178685|363221232|FG002|Overall Study|Lost to Follow-up|183|||
105333266|NCT00178685|363221230|FG000|Overall Study|Withdrawal by Subject|8|||
105333267|NCT00178685|363221231|FG001|Overall Study|Withdrawal by Subject|14|||
105333268|NCT00178685|363221232|FG002|Overall Study|Withdrawal by Subject|7|||
105333269|NCT00656292|363221233|FG000|Overall Study|Withdrawal by Subject|2|||
105333270|NCT00656292|363221234|FG001|Overall Study|Withdrawal by Subject|3|||
105333271|NCT00656292|363221233|FG000|Overall Study|Screen failure|1|||
105333272|NCT00656292|363221234|FG001|Overall Study|Screen failure|2|||
105333273|NCT03645395|363221248|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
105333274|NCT03645395|363221249|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
105333275|NCT03645395|363221250|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
105333276|NCT03645395|363221251|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
105333277|NCT03645395|363221248|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
105333278|NCT03645395|363221249|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
105333279|NCT03645395|363221250|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
105333280|NCT03645395|363221251|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
105333281|NCT03645395|363221248|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
105333282|NCT03645395|363221249|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
105333283|NCT03645395|363221250|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
105333284|NCT03645395|363221251|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
105333285|NCT03645395|363221248|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
105333286|NCT03645395|363221249|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
105333287|NCT03645395|363221250|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
105333288|NCT03645395|363221251|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
105333289|NCT00892151|363221252|FG000|Overall Study|Protocol Violation|1|||
105333290|NCT02714595|363221256|FG000|Overall Study|Lost to Follow-up|1|||
105333291|NCT02714595|363221257|FG001|Overall Study|Lost to Follow-up|0|||
105333292|NCT02714595|363221256|FG000|Overall Study|Withdrawal by Subject|1|||
105333293|NCT02714595|363221257|FG001|Overall Study|Withdrawal by Subject|2|||
105333294|NCT02714595|363221256|FG000|Overall Study|Lack of Efficacy|0|||
105333295|NCT02714595|363221257|FG001|Overall Study|Lack of Efficacy|1|||
105333296|NCT02714595|363221256|FG000|Overall Study|Death|30|||
105333297|NCT02714595|363221257|FG001|Overall Study|Death|9|||
105333298|NCT02714595|363221256|FG000|Overall Study|Other-Miscellaneous|0|||
105333299|NCT02714595|363221257|FG001|Overall Study|Other-Miscellaneous|1|||
105333300|NCT02527434|363221258|FG000|Overall Study|Lost to Follow-up|2|||
105333301|NCT02527434|363221259|FG001|Overall Study|Lost to Follow-up|2|||
105333302|NCT02527434|363221260|FG002|Overall Study|Lost to Follow-up|0|||
105333303|NCT02527434|363221258|FG000|Overall Study|Death|19|||
105333304|NCT02527434|363221259|FG001|Overall Study|Death|6|||
105333305|NCT02527434|363221260|FG002|Overall Study|Death|17|||
105333306|NCT02527434|363221258|FG000|Overall Study|Withdrawal by Subject|5|||
105333307|NCT02527434|363221259|FG001|Overall Study|Withdrawal by Subject|3|||
105333308|NCT02527434|363221260|FG002|Overall Study|Withdrawal by Subject|3|||
105333309|NCT02527434|363221258|FG000|Overall Study|Reason Not Specified|1|||
105333310|NCT02527434|363221259|FG001|Overall Study|Reason Not Specified|0|||
105333311|NCT02527434|363221260|FG002|Overall Study|Reason Not Specified|0|||
105333312|NCT02527434|363221258|FG000|Overall Study|Site closure|1|||
105333313|NCT02527434|363221259|FG001|Overall Study|Site closure|0|||
105333314|NCT02527434|363221260|FG002|Overall Study|Site closure|0|||
105333315|NCT03348930|363221263|FG000|Washout (1 Week)|Lost to Follow-up|1|||
105333316|NCT03348930|363221264|FG001|Washout (1 Week)|Lost to Follow-up|1|||
105333317|NCT02199795|363221266|FG000|Overall Study|no longer met inclusion criteria|1|||
105333318|NCT02199795|363221267|FG001|Overall Study|no longer met inclusion criteria|0|||
105333319|NCT02199795|363221266|FG000|Overall Study|withdrew due to shoulder pain|1|||
105333320|NCT02199795|363221267|FG001|Overall Study|withdrew due to shoulder pain|0|||
105333321|NCT05107492|363221281|FG000|Overall Study|Lost to Follow-up|1|||
105333322|NCT05107492|363221282|FG001|Overall Study|Lost to Follow-up|0|||
105333323|NCT02438826|363221283|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
105333324|NCT02438826|363221284|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
105333325|NCT02438826|363221285|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
105333326|NCT02438826|363221286|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
105333327|NCT02438826|363221283|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
105333328|NCT02438826|363221284|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
105333329|NCT02438826|363221285|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
105333330|NCT02438826|363221286|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
105333331|NCT02438826|363221283|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
105333332|NCT02438826|363221284|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
105333333|NCT02438826|363221285|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
105333334|NCT02438826|363221286|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
105333335|NCT02438826|363221283|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
105333336|NCT02438826|363221284|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
105333337|NCT02438826|363221285|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
105333338|NCT02438826|363221286|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
105333339|NCT02438826|363221283|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
105333340|NCT02438826|363221284|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
105333341|NCT02438826|363221285|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
105333342|NCT02438826|363221286|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
105333343|NCT02438826|363221283|FG000|Open-Label Treatment Phase|Adverse Event|11|||
105333344|NCT02438826|363221284|FG001|Open-Label Treatment Phase|Adverse Event|6|||
105333345|NCT02438826|363221285|FG002|Open-Label Treatment Phase|Adverse Event|0|||
105333346|NCT02438826|363221286|FG003|Open-Label Treatment Phase|Adverse Event|0|||
105333347|NCT02438826|363221283|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
105333348|NCT02438826|363221284|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
105440617|NCT01610336|363619190|FG001|Overall Study|Adverse Event|0|||
105440618|NCT01610336|363619191|FG002|Overall Study|Adverse Event|0|||
105440619|NCT01610336|363619192|FG003|Overall Study|Adverse Event|1|||
105440620|NCT01610336|363619193|FG004|Overall Study|Adverse Event|1|||
105440621|NCT01610336|363619194|FG005|Overall Study|Adverse Event|1|||
105440622|NCT01610336|363619195|FG006|Overall Study|Adverse Event|0|||
105440623|NCT01610336|363619196|FG007|Overall Study|Adverse Event|0|||
105440624|NCT01610336|363619197|FG008|Overall Study|Adverse Event|2|||
105440625|NCT01610336|363619198|FG009|Overall Study|Adverse Event|8|||
105440626|NCT01610336|363619199|FG010|Overall Study|Adverse Event|6|||
105440627|NCT01610336|363619189|FG000|Overall Study|Subject/Guardian decision|1|||
105440628|NCT01610336|363619190|FG001|Overall Study|Subject/Guardian decision|1|||
105440629|NCT01610336|363619191|FG002|Overall Study|Subject/Guardian decision|0|||
105440630|NCT01610336|363619192|FG003|Overall Study|Subject/Guardian decision|1|||
105440631|NCT01610336|363619193|FG004|Overall Study|Subject/Guardian decision|0|||
105440632|NCT01610336|363619194|FG005|Overall Study|Subject/Guardian decision|0|||
105440633|NCT01610336|363619195|FG006|Overall Study|Subject/Guardian decision|0|||
105440634|NCT01610336|363619196|FG007|Overall Study|Subject/Guardian decision|1|||
105440635|NCT01610336|363619197|FG008|Overall Study|Subject/Guardian decision|0|||
105440636|NCT01610336|363619198|FG009|Overall Study|Subject/Guardian decision|2|||
105440637|NCT01610336|363619199|FG010|Overall Study|Subject/Guardian decision|2|||
105440638|NCT01610336|363619189|FG000|Overall Study|Death|0|||
105440639|NCT01610336|363619190|FG001|Overall Study|Death|0|||
105440640|NCT01610336|363619191|FG002|Overall Study|Death|0|||
105440641|NCT01610336|363619192|FG003|Overall Study|Death|0|||
105440642|NCT01610336|363619193|FG004|Overall Study|Death|0|||
105440643|NCT01610336|363619194|FG005|Overall Study|Death|1|||
105440644|NCT01610336|363619195|FG006|Overall Study|Death|3|||
105440645|NCT01610336|363619196|FG007|Overall Study|Death|0|||
105440646|NCT01610336|363619197|FG008|Overall Study|Death|0|||
105440647|NCT01610336|363619198|FG009|Overall Study|Death|1|||
105440648|NCT01610336|363619199|FG010|Overall Study|Death|2|||
105440649|NCT01610336|363619189|FG000|Overall Study|Non-Compliance with study treatment|0|||
105440650|NCT01610336|363619190|FG001|Overall Study|Non-Compliance with study treatment|0|||
105440651|NCT01610336|363619191|FG002|Overall Study|Non-Compliance with study treatment|0|||
105440652|NCT01610336|363619192|FG003|Overall Study|Non-Compliance with study treatment|0|||
105440653|NCT01610336|363619193|FG004|Overall Study|Non-Compliance with study treatment|0|||
105440654|NCT01610336|363619194|FG005|Overall Study|Non-Compliance with study treatment|0|||
105440655|NCT01610336|363619195|FG006|Overall Study|Non-Compliance with study treatment|0|||
105440656|NCT01610336|363619196|FG007|Overall Study|Non-Compliance with study treatment|0|||
105440657|NCT01610336|363619197|FG008|Overall Study|Non-Compliance with study treatment|0|||
105440658|NCT01610336|363619198|FG009|Overall Study|Non-Compliance with study treatment|1|||
105440659|NCT01610336|363619199|FG010|Overall Study|Non-Compliance with study treatment|0|||
105440660|NCT01610336|363619189|FG000|Overall Study|Physician Decision|0|||
105440661|NCT01610336|363619190|FG001|Overall Study|Physician Decision|0|||
105440662|NCT01610336|363619191|FG002|Overall Study|Physician Decision|0|||
105440663|NCT01610336|363619192|FG003|Overall Study|Physician Decision|0|||
105440664|NCT01610336|363619193|FG004|Overall Study|Physician Decision|0|||
105440665|NCT01610336|363619194|FG005|Overall Study|Physician Decision|0|||
105440666|NCT01610336|363619195|FG006|Overall Study|Physician Decision|1|||
105440667|NCT01610336|363619196|FG007|Overall Study|Physician Decision|0|||
105440668|NCT01610336|363619197|FG008|Overall Study|Physician Decision|0|||
105440669|NCT01610336|363619198|FG009|Overall Study|Physician Decision|0|||
105440670|NCT01610336|363619199|FG010|Overall Study|Physician Decision|0|||
105440671|NCT01610336|363619189|FG000|Overall Study|Protocol Deviation|0|||
105440672|NCT01610336|363619190|FG001|Overall Study|Protocol Deviation|0|||
105440673|NCT01610336|363619191|FG002|Overall Study|Protocol Deviation|0|||
105440674|NCT01610336|363619192|FG003|Overall Study|Protocol Deviation|0|||
105440675|NCT01610336|363619193|FG004|Overall Study|Protocol Deviation|0|||
105440676|NCT01610336|363619194|FG005|Overall Study|Protocol Deviation|0|||
105440677|NCT01610336|363619195|FG006|Overall Study|Protocol Deviation|0|||
105440678|NCT01610336|363619196|FG007|Overall Study|Protocol Deviation|0|||
105440679|NCT01610336|363619197|FG008|Overall Study|Protocol Deviation|0|||
105440680|NCT01610336|363619198|FG009|Overall Study|Protocol Deviation|1|||
105440681|NCT01610336|363619199|FG010|Overall Study|Protocol Deviation|0|||
105440682|NCT01610336|363619189|FG000|Overall Study|Transfer to another trial|0|||
105440683|NCT01610336|363619190|FG001|Overall Study|Transfer to another trial|0|||
105440684|NCT01610336|363619191|FG002|Overall Study|Transfer to another trial|0|||
105440685|NCT01610336|363619192|FG003|Overall Study|Transfer to another trial|0|||
105440686|NCT01610336|363619193|FG004|Overall Study|Transfer to another trial|0|||
105440687|NCT01610336|363619194|FG005|Overall Study|Transfer to another trial|0|||
105440688|NCT01610336|363619195|FG006|Overall Study|Transfer to another trial|0|||
105440689|NCT01610336|363619196|FG007|Overall Study|Transfer to another trial|0|||
105440690|NCT01610336|363619197|FG008|Overall Study|Transfer to another trial|0|||
105440691|NCT01610336|363619198|FG009|Overall Study|Transfer to another trial|0|||
105440692|NCT01610336|363619199|FG010|Overall Study|Transfer to another trial|1|||
105440693|NCT02629822|363619200|FG000|Base Study|Lost to Follow-up|2|||
105440694|NCT02629822|363619200|FG000|Base Study|Non-Compliance With Study Drug|1|||
105440695|NCT02629822|363619200|FG000|Extension Study|Adverse Event|1|||
105440696|NCT02629822|363619200|FG000|Extension Study|Lost to Follow-up|1|||
105440697|NCT00741013|363619201|FG000|Overall Study|Adverse Event|1|||
105440698|NCT00741013|363619202|FG001|Overall Study|Adverse Event|0|||
105440699|NCT00741013|363619203|FG002|Overall Study|Adverse Event|0|||
105440700|NCT00741013|363619201|FG000|Overall Study|Withdrawal by Subject|0|||
105440701|NCT00741013|363619202|FG001|Overall Study|Withdrawal by Subject|0|||
105440702|NCT00741013|363619203|FG002|Overall Study|Withdrawal by Subject|1|||
105440703|NCT00741013|363619201|FG000|Overall Study|Discovered failed screen after enrolled|0|||
105440704|NCT00741013|363619202|FG001|Overall Study|Discovered failed screen after enrolled|2|||
105440705|NCT00741013|363619203|FG002|Overall Study|Discovered failed screen after enrolled|0|||
105440706|NCT03437577|363619204|FG000|Pre-Randomization|Withdrawal by Subject|0|||
105440707|NCT03437577|363619205|FG001|Pre-Randomization|Withdrawal by Subject|0|||
105440708|NCT03437577|363619206|FG002|Pre-Randomization|Withdrawal by Subject|10|||
105440709|NCT03437577|363619204|FG000|Post-Randomization|Physician Decision|0|||
105440710|NCT03437577|363619205|FG001|Post-Randomization|Physician Decision|2|||
105440711|NCT03437577|363619206|FG002|Post-Randomization|Physician Decision|0|||
105440712|NCT03704688|363619207|FG000|Overall Study|Adverse Event|0|||
105440713|NCT03704688|363619208|FG001|Overall Study|Adverse Event|0|||
105440714|NCT03704688|363619209|FG002|Overall Study|Adverse Event|0|||
105440715|NCT03704688|363619210|FG003|Overall Study|Adverse Event|4|||
105440716|NCT03704688|363619211|FG004|Overall Study|Adverse Event|1|||
105440717|NCT03704688|363619212|FG005|Overall Study|Adverse Event|0|||
105440718|NCT03704688|363619207|FG000|Overall Study|Disease Progression|0|||
105440719|NCT03704688|363619208|FG001|Overall Study|Disease Progression|0|||
105440720|NCT03704688|363619209|FG002|Overall Study|Disease Progression|0|||
105440721|NCT03704688|363619210|FG003|Overall Study|Disease Progression|3|||
105440722|NCT03704688|363619211|FG004|Overall Study|Disease Progression|1|||
105440723|NCT03704688|363619212|FG005|Overall Study|Disease Progression|0|||
105440724|NCT03704688|363619207|FG000|Overall Study|Death|0|||
105440725|NCT03704688|363619208|FG001|Overall Study|Death|0|||
105440726|NCT03704688|363619209|FG002|Overall Study|Death|0|||
105440727|NCT03704688|363619210|FG003|Overall Study|Death|0|||
105440728|NCT03704688|363619211|FG004|Overall Study|Death|3|||
105440729|NCT03704688|363619212|FG005|Overall Study|Death|0|||
105440730|NCT01440816|363619221|FG000|Overall Study|Disease Progression|0|||
105440731|NCT01440816|363619222|FG001|Overall Study|Disease Progression|9|||
105440732|NCT01440816|363619221|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
105440733|NCT01440816|363619222|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
105440734|NCT00787189|363619223|FG000|Overall Study|Lost to Follow-up|2|||
105440735|NCT00787189|363619224|FG001|Overall Study|Lost to Follow-up|2|||
105440736|NCT03920254|363619225|FG000|Overall Study|Adverse Event|1|||
105440737|NCT03920254|363619226|FG001|Overall Study|Adverse Event|0|||
105440738|NCT03920254|363619227|FG002|Overall Study|Adverse Event|0|||
105440739|NCT03920254|363619225|FG000|Overall Study|Physician Decision|0|||
105440740|NCT03920254|363619226|FG001|Overall Study|Physician Decision|1|||
105440741|NCT03920254|363619227|FG002|Overall Study|Physician Decision|2|||
105440742|NCT03920254|363619225|FG000|Overall Study|Study Terminated By Sponsor|12|||
105440743|NCT03920254|363619226|FG001|Overall Study|Study Terminated By Sponsor|17|||
105440744|NCT03920254|363619227|FG002|Overall Study|Study Terminated By Sponsor|12|||
105440745|NCT03920254|363619225|FG000|Overall Study|Withdrawal by Subject|0|||
105440746|NCT03920254|363619226|FG001|Overall Study|Withdrawal by Subject|0|||
105440747|NCT03920254|363619227|FG002|Overall Study|Withdrawal by Subject|1|||
105440748|NCT01393821|363619228|FG000|Overall Study|Cancel|1|||
105440749|NCT01393821|363619229|FG001|Overall Study|Cancel|1|||
105440750|NCT01393821|363619228|FG000|Overall Study|not evaluable for primary endpoint|4|||
105440751|NCT01393821|363619229|FG001|Overall Study|not evaluable for primary endpoint|2|||
105440752|NCT01858740|363619230|FG000|Overall Study|Death|4|||
105440753|NCT03549104|363619231|FG000|Overall Study|Withdrawal by Subject|5|||
105440754|NCT03549104|363619232|FG001|Overall Study|Withdrawal by Subject|2|||
105440755|NCT03549104|363619231|FG000|Overall Study|Covid shelter in place|1|||
105440756|NCT03549104|363619232|FG001|Overall Study|Covid shelter in place|2|||
105440757|NCT02104947|363619245|FG000|Overall Study|Withdrawal by Subject|10|||
105440758|NCT02104947|363619246|FG001|Overall Study|Withdrawal by Subject|3|||
105440759|NCT02104947|363619245|FG000|Overall Study|Lost to Follow-up|4|||
105440760|NCT02104947|363619246|FG001|Overall Study|Lost to Follow-up|4|||
105440761|NCT02104947|363619245|FG000|Overall Study|Protocol Violation|6|||
105440762|NCT02104947|363619246|FG001|Overall Study|Protocol Violation|8|||
105440763|NCT02104947|363619245|FG000|Overall Study|Adverse Event|57|||
105440764|NCT02104947|363619246|FG001|Overall Study|Adverse Event|38|||
105440765|NCT02104947|363619245|FG000|Overall Study|Other than stated above|2|||
105440766|NCT02104947|363619246|FG001|Overall Study|Other than stated above|3|||
105440767|NCT02690714|363619248|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
105440768|NCT02690714|363619248|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
105440769|NCT00095173|363619251|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
105440770|NCT00095173|363619252|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
105440771|NCT00095173|363619253|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
105550164|NCT00902304|364014370|FG001|Overall Study|Adverse Event|10|||
105333349|NCT02438826|363221285|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
105333350|NCT02438826|363221286|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
105333351|NCT02438826|363221283|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
105333352|NCT02438826|363221284|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
105333353|NCT02438826|363221285|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
105333354|NCT02438826|363221286|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
105333355|NCT02438826|363221283|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
105333356|NCT02438826|363221284|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
105333357|NCT02438826|363221285|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
105333358|NCT02438826|363221286|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
105333359|NCT02438826|363221283|FG000|Post-Treatment Phase|Adverse Event|3|||
105333360|NCT02438826|363221284|FG001|Post-Treatment Phase|Adverse Event|0|||
105333361|NCT02438826|363221285|FG002|Post-Treatment Phase|Adverse Event|0|||
105333362|NCT02438826|363221286|FG003|Post-Treatment Phase|Adverse Event|0|||
105333363|NCT02438826|363221283|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
105333364|NCT02438826|363221284|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
105333365|NCT02438826|363221285|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
105333366|NCT02438826|363221286|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
105333367|NCT02438826|363221283|FG000|Post-Treatment Phase|Physician Decision|1|||
105333368|NCT02438826|363221284|FG001|Post-Treatment Phase|Physician Decision|0|||
105333369|NCT02438826|363221285|FG002|Post-Treatment Phase|Physician Decision|0|||
105333370|NCT02438826|363221286|FG003|Post-Treatment Phase|Physician Decision|0|||
105333371|NCT02438826|363221283|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
105333372|NCT02438826|363221284|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
105333373|NCT02438826|363221285|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
105333374|NCT02438826|363221286|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
105333375|NCT02858583|363221288|FG000|Overall Study|Declined consent|1|||
105333376|NCT02858583|363221289|FG001|Overall Study|Declined consent|1|||
105333377|NCT01218087|363221291|FG000|Overall Study|Death|2|||
105333378|NCT01218087|363221292|FG001|Overall Study|Death|1|||
105333379|NCT01218087|363221291|FG000|Overall Study|Withdrawal by Subject|5|||
105333380|NCT01218087|363221292|FG001|Overall Study|Withdrawal by Subject|0|||
105333381|NCT01218087|363221291|FG000|Overall Study|Transferred|8|||
105333382|NCT01218087|363221292|FG001|Overall Study|Transferred|5|||
105333383|NCT03682848|363221296|FG000|Overall Study|Withdrawal by Subject|2|||
105333384|NCT03682848|363221296|FG000|Overall Study|Site closed|5|||
105333385|NCT03682848|363221296|FG000|Overall Study|Protocol Deviation|1|||
105333386|NCT03682848|363221296|FG000|Overall Study|Adverse Event|1|||
105333387|NCT00454363|363221297|FG000|Overall Study|Adverse Event|1|||
105333388|NCT00454363|363221298|FG001|Overall Study|Adverse Event|2|||
105333389|NCT00454363|363221297|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
105333390|NCT00454363|363221298|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
105333391|NCT03274687|363222893|FG000|Overall Study|Protocol Violation|1|||
105333392|NCT03274687|363222894|FG001|Overall Study|Protocol Violation|1|||
105333393|NCT00638404|363222895|FG000|Overall Study|Physician Decision|8|||
105333394|NCT00638404|363222896|FG001|Overall Study|Physician Decision|0|||
105333395|NCT03508726|363222897|FG000|Overall Study|Withdrawal by Subject|0|||
105333396|NCT03508726|363222898|FG001|Overall Study|Withdrawal by Subject|1|||
105333397|NCT02492984|363222899|FG000|Overall Study|Adverse Event|1|||
105333398|NCT02492984|363222900|FG001|Overall Study|Adverse Event|0|||
105333399|NCT02492984|363222899|FG000|Overall Study|Protocol Violation|1|||
105333400|NCT02492984|363222900|FG001|Overall Study|Protocol Violation|0|||
105333401|NCT02492984|363222899|FG000|Overall Study|Withdrawal by Subject|1|||
105333402|NCT02492984|363222900|FG001|Overall Study|Withdrawal by Subject|0|||
105333403|NCT00459290|363222901|FG000|Overall Study|Adverse Event|3|||
105333404|NCT00459290|363222901|FG000|Overall Study|Ineligible|2|||
105333405|NCT02693106|363222903|FG000|Overall Study|No time|3|||
105333406|NCT03981926|363222912|FG000|Overall Study|Lost to Follow-up|5|||
105333407|NCT03981926|363222913|FG001|Overall Study|Lost to Follow-up|9|||
105333408|NCT00610155|363222914|FG000|Period 1|Withdrawal by Subject|0|||
105333409|NCT00610155|363222915|FG001|Period 1|Withdrawal by Subject|0|||
105333410|NCT00610155|363222916|FG002|Period 1|Withdrawal by Subject|1|||
105333411|NCT00610155|363222917|FG003|Period 1|Withdrawal by Subject|0|||
105333412|NCT00610155|363222918|FG004|Period 1|Withdrawal by Subject|0|||
105333413|NCT00610155|363222919|FG005|Period 1|Withdrawal by Subject|0|||
105333414|NCT00610155|363222914|FG000|Period 3|Adverse Event|1|||
105333415|NCT00610155|363222915|FG001|Period 3|Adverse Event|0|||
105333416|NCT00610155|363222916|FG002|Period 3|Adverse Event|0|||
105333417|NCT00610155|363222917|FG003|Period 3|Adverse Event|0|||
105333418|NCT00610155|363222918|FG004|Period 3|Adverse Event|0|||
105333419|NCT00610155|363222919|FG005|Period 3|Adverse Event|0|||
105333420|NCT01163851|363222920|FG000|Overall Study|Site Closure|0|||
105333421|NCT01163851|363222921|FG001|Overall Study|Site Closure|1|||
105333422|NCT01163851|363222920|FG000|Overall Study|Enrolled but not treated|1|||
105333423|NCT01163851|363222921|FG001|Overall Study|Enrolled but not treated|0|||
105333424|NCT01073605|363222925|FG000|Overall Study|Ongoing at Cutoff Date|1|||
105333425|NCT01073605|363222926|FG001|Overall Study|Ongoing at Cutoff Date|1|||
105333426|NCT01073605|363222927|FG002|Overall Study|Ongoing at Cutoff Date|0|||
105440772|NCT00095173|363619254|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
105333427|NCT01073605|363222925|FG000|Overall Study|Adverse Event|2|||
105333428|NCT01073605|363222926|FG001|Overall Study|Adverse Event|1|||
105333429|NCT01073605|363222927|FG002|Overall Study|Adverse Event|0|||
105333430|NCT01073605|363222925|FG000|Overall Study|Lost to Follow-up|3|||
105333431|NCT01073605|363222926|FG001|Overall Study|Lost to Follow-up|4|||
105333432|NCT01073605|363222927|FG002|Overall Study|Lost to Follow-up|9|||
105333433|NCT01073605|363222925|FG000|Overall Study|Other|25|||
105333434|NCT01073605|363222926|FG001|Overall Study|Other|21|||
105333435|NCT01073605|363222927|FG002|Overall Study|Other|29|||
105333436|NCT01073605|363222925|FG000|Overall Study|Withdrawal by Subject|31|||
105333437|NCT01073605|363222926|FG001|Overall Study|Withdrawal by Subject|39|||
105333438|NCT01073605|363222927|FG002|Overall Study|Withdrawal by Subject|22|||
105333439|NCT01073605|363222925|FG000|Overall Study|Randomized But Not Treated|0|||
105333440|NCT01073605|363222926|FG001|Overall Study|Randomized But Not Treated|1|||
105333441|NCT01073605|363222927|FG002|Overall Study|Randomized But Not Treated|1|||
105333442|NCT01284348|363222928|FG000|Overall Study|Death|1|||
105333443|NCT01284348|363222929|FG001|Overall Study|Death|1|||
105333444|NCT01284348|363222928|FG000|Overall Study|Withdrew consent|0|||
105333445|NCT01284348|363222929|FG001|Overall Study|Withdrew consent|1|||
105333446|NCT01284348|363222928|FG000|Overall Study|Status not recorded|9|||
105333447|NCT01284348|363222929|FG001|Overall Study|Status not recorded|10|||
105333448|NCT01684423|363222934|FG000|Overall Study|Withdrawal by Subject|0|||
105333449|NCT01684423|363222935|FG001|Overall Study|Withdrawal by Subject|0|||
105333450|NCT01684423|363222936|FG002|Overall Study|Withdrawal by Subject|1|||
105333451|NCT01684423|363222937|FG003|Overall Study|Withdrawal by Subject|0|||
105333452|NCT01684423|363222938|FG004|Overall Study|Withdrawal by Subject|0|||
105333453|NCT03192306|363222941|FG000|Overall Study|Did not treat cold sore during study|149|||
105333454|NCT03192306|363222942|FG001|Overall Study|Did not treat cold sore during study|143|||
105333455|NCT03192306|363222941|FG000|Overall Study|Withdrawal by Subject|1|||
105333456|NCT03192306|363222942|FG001|Overall Study|Withdrawal by Subject|1|||
105333457|NCT03192306|363222941|FG000|Overall Study|Lost to Follow-up|1|||
105333458|NCT03192306|363222942|FG001|Overall Study|Lost to Follow-up|0|||
105333459|NCT03192306|363222941|FG000|Overall Study|Protocol Violation|1|||
105333460|NCT03192306|363222942|FG001|Overall Study|Protocol Violation|1|||
105333461|NCT00441129|363222946|FG000|Overall Study|Withdrawal by Subject|6|||
105333462|NCT00441129|363222947|FG001|Overall Study|Withdrawal by Subject|14|||
105333463|NCT02035202|363222952|FG000|Overall Study|Lost to Follow-up|8|||
105333464|NCT02035202|363222953|FG001|Overall Study|Lost to Follow-up|16|||
105333465|NCT02035202|363222954|FG002|Overall Study|Lost to Follow-up|2|||
105333466|NCT00083759|363222956|FG000|Overall Study|Adverse Event|5|||
105333467|NCT00083759|363222957|FG001|Overall Study|Adverse Event|3|||
105333468|NCT00083759|363222956|FG000|Overall Study|Lost to Follow-up|1|||
105333469|NCT00083759|363222957|FG001|Overall Study|Lost to Follow-up|0|||
105333470|NCT00083759|363222956|FG000|Overall Study|Death|1|||
105333471|NCT00083759|363222957|FG001|Overall Study|Death|1|||
105333472|NCT00083759|363222956|FG000|Overall Study|Inadequate Therapeutic Response|32|||
105333473|NCT00083759|363222957|FG001|Overall Study|Inadequate Therapeutic Response|35|||
105333474|NCT00083759|363222956|FG000|Overall Study|Subject Withdrew Consent|2|||
105333475|NCT00083759|363222957|FG001|Overall Study|Subject Withdrew Consent|2|||
105333476|NCT00083759|363222956|FG000|Overall Study|Non-Compliance|1|||
105333477|NCT00083759|363222957|FG001|Overall Study|Non-Compliance|0|||
105333478|NCT00083759|363222956|FG000|Overall Study|Sponsor's Discretion|28|||
105333479|NCT00083759|363222957|FG001|Overall Study|Sponsor's Discretion|29|||
105333480|NCT00083759|363222956|FG000|Overall Study|Other|14|||
105333481|NCT00083759|363222957|FG001|Overall Study|Other|13|||
105333482|NCT00685399|363222958|FG000|Treatment Period 1|Withdrawal by Subject|2|||
105333483|NCT00685399|363222959|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105333484|NCT00685399|363222960|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105333485|NCT00685399|363222961|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105333486|NCT00685399|363222962|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105333487|NCT00685399|363222963|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105333488|NCT00685399|363222964|FG006|Treatment Period 1|Withdrawal by Subject|0|||
105333489|NCT00685399|363222965|FG007|Treatment Period 1|Withdrawal by Subject|0|||
105333490|NCT00685399|363222958|FG000|Treatment Period 1|Protocol Violation|1|||
105333491|NCT00685399|363222959|FG001|Treatment Period 1|Protocol Violation|0|||
105333492|NCT00685399|363222960|FG002|Treatment Period 1|Protocol Violation|0|||
105333493|NCT00685399|363222961|FG003|Treatment Period 1|Protocol Violation|0|||
105333494|NCT00685399|363222962|FG004|Treatment Period 1|Protocol Violation|0|||
105333495|NCT00685399|363222963|FG005|Treatment Period 1|Protocol Violation|0|||
105333496|NCT00685399|363222964|FG006|Treatment Period 1|Protocol Violation|0|||
105333497|NCT00685399|363222965|FG007|Treatment Period 1|Protocol Violation|0|||
105333498|NCT00685399|363222958|FG000|Treatment Period 1|Administrative|2|||
105333499|NCT00685399|363222959|FG001|Treatment Period 1|Administrative|0|||
105333500|NCT00685399|363222960|FG002|Treatment Period 1|Administrative|0|||
105333501|NCT00685399|363222961|FG003|Treatment Period 1|Administrative|0|||
105333502|NCT00685399|363222962|FG004|Treatment Period 1|Administrative|0|||
105333503|NCT00685399|363222963|FG005|Treatment Period 1|Administrative|0|||
105333504|NCT00685399|363222964|FG006|Treatment Period 1|Administrative|0|||
105333505|NCT00685399|363222965|FG007|Treatment Period 1|Administrative|0|||
105333506|NCT00685399|363222958|FG000|Treatment Period 1|Lack of Efficacy|1|||
105333507|NCT00685399|363222959|FG001|Treatment Period 1|Lack of Efficacy|0|||
105333508|NCT00685399|363222960|FG002|Treatment Period 1|Lack of Efficacy|0|||
105333509|NCT00685399|363222961|FG003|Treatment Period 1|Lack of Efficacy|0|||
105333510|NCT00685399|363222962|FG004|Treatment Period 1|Lack of Efficacy|0|||
105333511|NCT00685399|363222963|FG005|Treatment Period 1|Lack of Efficacy|0|||
105333512|NCT00685399|363222964|FG006|Treatment Period 1|Lack of Efficacy|0|||
105333513|NCT00685399|363222965|FG007|Treatment Period 1|Lack of Efficacy|0|||
105333514|NCT00685399|363222958|FG000|Treatment Period 2|Administrative Problems|0|||
105333515|NCT00685399|363222959|FG001|Treatment Period 2|Administrative Problems|2|||
105333516|NCT00685399|363222960|FG002|Treatment Period 2|Administrative Problems|1|||
105333517|NCT00685399|363222961|FG003|Treatment Period 2|Administrative Problems|0|||
105333518|NCT00685399|363222962|FG004|Treatment Period 2|Administrative Problems|0|||
105333519|NCT00685399|363222963|FG005|Treatment Period 2|Administrative Problems|0|||
105333520|NCT00685399|363222964|FG006|Treatment Period 2|Administrative Problems|0|||
105333521|NCT00685399|363222965|FG007|Treatment Period 2|Administrative Problems|0|||
105333522|NCT00685399|363222958|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105333523|NCT00685399|363222959|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105333524|NCT00685399|363222960|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105333525|NCT00685399|363222961|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105333526|NCT00685399|363222962|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105333527|NCT00685399|363222963|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105333528|NCT00685399|363222964|FG006|Treatment Period 2|Withdrawal by Subject|0|||
105333529|NCT00685399|363222965|FG007|Treatment Period 2|Withdrawal by Subject|2|||
105333530|NCT00685399|363222958|FG000|Treatment Period 2|Adverse Event|0|||
105333531|NCT00685399|363222959|FG001|Treatment Period 2|Adverse Event|0|||
105333532|NCT00685399|363222960|FG002|Treatment Period 2|Adverse Event|0|||
105333533|NCT00685399|363222961|FG003|Treatment Period 2|Adverse Event|0|||
105333534|NCT00685399|363222962|FG004|Treatment Period 2|Adverse Event|0|||
105333535|NCT00685399|363222963|FG005|Treatment Period 2|Adverse Event|1|||
105333536|NCT00685399|363222964|FG006|Treatment Period 2|Adverse Event|0|||
105333537|NCT00685399|363222965|FG007|Treatment Period 2|Adverse Event|0|||
105333538|NCT00685399|363222958|FG000|Treatment Period 2|Lack of Efficacy|0|||
105333539|NCT00685399|363222959|FG001|Treatment Period 2|Lack of Efficacy|10|||
105333540|NCT00685399|363222960|FG002|Treatment Period 2|Lack of Efficacy|2|||
105333541|NCT00685399|363222961|FG003|Treatment Period 2|Lack of Efficacy|0|||
105333542|NCT00685399|363222962|FG004|Treatment Period 2|Lack of Efficacy|0|||
105333543|NCT00685399|363222963|FG005|Treatment Period 2|Lack of Efficacy|1|||
105333544|NCT00685399|363222964|FG006|Treatment Period 2|Lack of Efficacy|0|||
105333545|NCT00685399|363222965|FG007|Treatment Period 2|Lack of Efficacy|0|||
105333546|NCT00685399|363222958|FG000|Extension|Administrative Issues|0|||
105333547|NCT00685399|363222959|FG001|Extension|Administrative Issues|0|||
105333548|NCT00685399|363222960|FG002|Extension|Administrative Issues|0|||
105333549|NCT00685399|363222961|FG003|Extension|Administrative Issues|1|||
105333550|NCT00685399|363222962|FG004|Extension|Administrative Issues|0|||
105333551|NCT00685399|363222963|FG005|Extension|Administrative Issues|0|||
105333552|NCT00685399|363222964|FG006|Extension|Administrative Issues|0|||
105333553|NCT00685399|363222965|FG007|Extension|Administrative Issues|0|||
105333554|NCT00685399|363222958|FG000|Extension|Withdrawal by Subject|0|||
105333555|NCT00685399|363222959|FG001|Extension|Withdrawal by Subject|0|||
105333556|NCT00685399|363222960|FG002|Extension|Withdrawal by Subject|0|||
105333557|NCT00685399|363222961|FG003|Extension|Withdrawal by Subject|1|||
105333558|NCT00685399|363222962|FG004|Extension|Withdrawal by Subject|0|||
105333559|NCT00685399|363222963|FG005|Extension|Withdrawal by Subject|0|||
105333560|NCT00685399|363222964|FG006|Extension|Withdrawal by Subject|0|||
105333561|NCT00685399|363222965|FG007|Extension|Withdrawal by Subject|0|||
105333562|NCT00685399|363222958|FG000|Extension|Protocol Violation|0|||
105333563|NCT00685399|363222959|FG001|Extension|Protocol Violation|0|||
105333564|NCT00685399|363222960|FG002|Extension|Protocol Violation|0|||
105333565|NCT00685399|363222961|FG003|Extension|Protocol Violation|1|||
105333566|NCT00685399|363222962|FG004|Extension|Protocol Violation|0|||
105333567|NCT00685399|363222963|FG005|Extension|Protocol Violation|0|||
105333568|NCT00685399|363222964|FG006|Extension|Protocol Violation|0|||
105333569|NCT00685399|363222965|FG007|Extension|Protocol Violation|0|||
105333570|NCT00685399|363222958|FG000|Extension|Lack of Efficacy|0|||
105333571|NCT00685399|363222959|FG001|Extension|Lack of Efficacy|0|||
105440773|NCT00095173|363619255|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
105333572|NCT00685399|363222960|FG002|Extension|Lack of Efficacy|0|||
105333573|NCT00685399|363222961|FG003|Extension|Lack of Efficacy|2|||
105333574|NCT00685399|363222962|FG004|Extension|Lack of Efficacy|0|||
105333575|NCT00685399|363222963|FG005|Extension|Lack of Efficacy|0|||
105333576|NCT00685399|363222964|FG006|Extension|Lack of Efficacy|0|||
105333577|NCT00685399|363222965|FG007|Extension|Lack of Efficacy|0|||
105333578|NCT00685399|363222958|FG000|Extension|Adverse Event|0|||
105333579|NCT00685399|363222959|FG001|Extension|Adverse Event|0|||
105333580|NCT00685399|363222960|FG002|Extension|Adverse Event|0|||
105333581|NCT00685399|363222961|FG003|Extension|Adverse Event|2|||
105333582|NCT00685399|363222962|FG004|Extension|Adverse Event|0|||
105333583|NCT00685399|363222963|FG005|Extension|Adverse Event|0|||
105333584|NCT00685399|363222964|FG006|Extension|Adverse Event|0|||
105333585|NCT00685399|363222965|FG007|Extension|Adverse Event|0|||
105333586|NCT01091662|363222967|FG000|Overall Study|Adverse Event|1|||
105333587|NCT01091662|363222968|FG001|Overall Study|Adverse Event|9|||
105333588|NCT01091662|363222967|FG000|Overall Study|Physician Decision|1|||
105333589|NCT01091662|363222968|FG001|Overall Study|Physician Decision|1|||
105333590|NCT01091662|363222967|FG000|Overall Study|Withdrawal by Subject|7|||
105333591|NCT01091662|363222968|FG001|Overall Study|Withdrawal by Subject|6|||
105333592|NCT01091662|363222967|FG000|Overall Study|met exit criteria|7|||
105333593|NCT01091662|363222968|FG001|Overall Study|met exit criteria|13|||
105333594|NCT01091662|363222967|FG000|Overall Study|met exclusion criteria|1|||
105333595|NCT01091662|363222968|FG001|Overall Study|met exclusion criteria|0|||
105333596|NCT01091662|363222967|FG000|Overall Study|Lost to Follow-up|0|||
105333597|NCT01091662|363222968|FG001|Overall Study|Lost to Follow-up|1|||
105333598|NCT01091662|363222967|FG000|Overall Study|Pregnancy|0|||
105333599|NCT01091662|363222968|FG001|Overall Study|Pregnancy|1|||
105333600|NCT01091662|363222967|FG000|Overall Study|Protocol Violation|0|||
105333601|NCT01091662|363222968|FG001|Overall Study|Protocol Violation|2|||
105333602|NCT01091662|363222967|FG000|Overall Study|unable to swallow capsule|0|||
105333603|NCT01091662|363222968|FG001|Overall Study|unable to swallow capsule|1|||
105333604|NCT04109391|363222969|FG000|Overall Study|Adverse Event|2|||
105333605|NCT04109391|363222970|FG001|Overall Study|Adverse Event|2|||
105333606|NCT04109391|363222971|FG002|Overall Study|Adverse Event|0|||
105333607|NCT04109391|363222969|FG000|Overall Study|Withdrawal by Subject|2|||
105333608|NCT04109391|363222970|FG001|Overall Study|Withdrawal by Subject|0|||
105333609|NCT04109391|363222971|FG002|Overall Study|Withdrawal by Subject|0|||
105333610|NCT04109391|363222969|FG000|Overall Study|Pregnancy|1|||
105333611|NCT04109391|363222970|FG001|Overall Study|Pregnancy|0|||
105333612|NCT04109391|363222971|FG002|Overall Study|Pregnancy|0|||
105333613|NCT04109391|363222969|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
105333614|NCT04109391|363222970|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
105333615|NCT04109391|363222971|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
105333616|NCT04109391|363222969|FG000|Overall Study|Lost to Follow-up|0|||
105333617|NCT04109391|363222970|FG001|Overall Study|Lost to Follow-up|0|||
105333618|NCT04109391|363222971|FG002|Overall Study|Lost to Follow-up|1|||
105333619|NCT04109391|363222969|FG000|Overall Study|Lack of Efficacy|2|||
105333620|NCT04109391|363222970|FG001|Overall Study|Lack of Efficacy|2|||
105333621|NCT04109391|363222971|FG002|Overall Study|Lack of Efficacy|3|||
105333622|NCT01222520|363222972|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
105333623|NCT01222520|363222973|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
105333624|NCT01222520|363222972|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
105333625|NCT01222520|363222973|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
105333626|NCT01222520|363222972|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
105333627|NCT01222520|363222973|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
105333628|NCT01222520|363222972|FG000|Double-blind Period|Adverse Event|0|||
105333629|NCT01222520|363222973|FG001|Double-blind Period|Adverse Event|1|||
105333630|NCT01222520|363222972|FG000|Double-blind Period|Lack of Efficacy|0|||
105333631|NCT01222520|363222973|FG001|Double-blind Period|Lack of Efficacy|1|||
105333632|NCT01222520|363222972|FG000|Double-blind Period|Study medication stolen|1|||
105333633|NCT01222520|363222973|FG001|Double-blind Period|Study medication stolen|0|||
105333634|NCT00596817|363222974|FG000|Open-label Period|Adverse Event|0|||
105333635|NCT00596817|363222975|FG001|Open-label Period|Adverse Event|49|||
105333636|NCT00596817|363222974|FG000|Open-label Period|Lack of Efficacy|0|||
105333637|NCT00596817|363222975|FG001|Open-label Period|Lack of Efficacy|33|||
105333638|NCT00596817|363222974|FG000|Open-label Period|Other Reasons|0|||
105333639|NCT00596817|363222975|FG001|Open-label Period|Other Reasons|65|||
105333640|NCT00596817|363222974|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
105333641|NCT00596817|363222975|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
105333642|NCT00596817|363222974|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
105333643|NCT00596817|363222975|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
105333644|NCT00596817|363222974|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
105333645|NCT00596817|363222975|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
105333646|NCT00596817|363222974|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
105333647|NCT00596817|363222975|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
105333648|NCT00596817|363222974|FG000|Double-blind Period|Adverse Event|5|||
105333649|NCT00596817|363222975|FG001|Double-blind Period|Adverse Event|16|||
105333650|NCT00596817|363222974|FG000|Double-blind Period|Lack of Efficacy|52|||
105333651|NCT00596817|363222975|FG001|Double-blind Period|Lack of Efficacy|28|||
105333652|NCT00596817|363222974|FG000|Double-blind Period|Non-compliance With Study Product|3|||
105333653|NCT00596817|363222975|FG001|Double-blind Period|Non-compliance With Study Product|4|||
105333654|NCT00596817|363222974|FG000|Double-blind Period|Protocol Violation|11|||
105333655|NCT00596817|363222975|FG001|Double-blind Period|Protocol Violation|8|||
105333656|NCT00596817|363222974|FG000|Double-blind Period|Withdrawal of Consent|7|||
105333657|NCT00596817|363222975|FG001|Double-blind Period|Withdrawal of Consent|3|||
105333658|NCT00596817|363222974|FG000|Double-blind Period|Lost to Follow-up|0|||
105333659|NCT00596817|363222975|FG001|Double-blind Period|Lost to Follow-up|2|||
105333660|NCT00596817|363222974|FG000|Double-blind Period|Other Reasons|10|||
105333661|NCT00596817|363222975|FG001|Double-blind Period|Other Reasons|18|||
105333662|NCT00384839|363222978|FG000|Overall Study|Adverse Event|4|||
105333663|NCT00384839|363222978|FG000|Overall Study|Investigator Request|1|||
105333664|NCT00384839|363222978|FG000|Overall Study|Patient Request|1|||
105333665|NCT00384839|363222978|FG000|Overall Study|Ineligible|2|||
105333666|NCT02649439|363222979|FG000|Overall Study|Switched to alternative treatment|6|||
105333667|NCT02649439|363222980|FG001|Overall Study|Switched to alternative treatment|4|||
105333668|NCT02649439|363222979|FG000|Overall Study|Patient decision|1|||
105333669|NCT02649439|363222980|FG001|Overall Study|Patient decision|0|||
105333670|NCT02649439|363222979|FG000|Overall Study|Patient going out of country|1|||
105333671|NCT02649439|363222980|FG001|Overall Study|Patient going out of country|0|||
105333672|NCT02649439|363222979|FG000|Overall Study|To start finasteride|1|||
105333673|NCT02649439|363222980|FG001|Overall Study|To start finasteride|0|||
105333674|NCT02649439|363222979|FG000|Overall Study|Physician Decision|1|||
105333675|NCT02649439|363222980|FG001|Overall Study|Physician Decision|0|||
105333676|NCT02649439|363222979|FG000|Overall Study|Disease progression on study|12|||
105333677|NCT02649439|363222980|FG001|Overall Study|Disease progression on study|13|||
105333678|NCT02649439|363222979|FG000|Overall Study|Refused further treatment|1|||
105333679|NCT02649439|363222980|FG001|Overall Study|Refused further treatment|0|||
105333680|NCT02649439|363222979|FG000|Overall Study|Refused further follow up|2|||
105333681|NCT02649439|363222980|FG001|Overall Study|Refused further follow up|7|||
105333682|NCT02649439|363222979|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
105333683|NCT02649439|363222980|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
105333684|NCT02649439|363222979|FG000|Overall Study|No treatment, per protocol|1|||
105333685|NCT02649439|363222980|FG001|Overall Study|No treatment, per protocol|0|||
105333686|NCT02649439|363222979|FG000|Overall Study|PSA DT makes ineligible|0|||
105333687|NCT02649439|363222980|FG001|Overall Study|PSA DT makes ineligible|1|||
105333688|NCT02649439|363222979|FG000|Overall Study|Rising PSA No Mets|0|||
105333689|NCT02649439|363222980|FG001|Overall Study|Rising PSA No Mets|1|||
105333690|NCT02649439|363222979|FG000|Overall Study|Rising PSA|0|||
105333691|NCT02649439|363222980|FG001|Overall Study|Rising PSA|1|||
105333692|NCT02649439|363222979|FG000|Overall Study|Signed follow up protocol|0|||
105333693|NCT02649439|363222980|FG001|Overall Study|Signed follow up protocol|1|||
105333694|NCT01322490|363222984|FG000|Treatment Period|Adverse Event|12|||
105333695|NCT01322490|363222985|FG001|Treatment Period|Adverse Event|18|||
105333696|NCT01322490|363222986|FG002|Treatment Period|Adverse Event|15|||
105333697|NCT01322490|363222984|FG000|Treatment Period|Death|5|||
105333698|NCT01322490|363222985|FG001|Treatment Period|Death|7|||
105333699|NCT01322490|363222986|FG002|Treatment Period|Death|3|||
105333700|NCT01322490|363222984|FG000|Treatment Period|Lack of Efficacy|89|||
105333701|NCT01322490|363222985|FG001|Treatment Period|Lack of Efficacy|100|||
105333702|NCT01322490|363222986|FG002|Treatment Period|Lack of Efficacy|112|||
105333703|NCT01322490|363222984|FG000|Treatment Period|Physician Decision|0|||
105333704|NCT01322490|363222985|FG001|Treatment Period|Physician Decision|2|||
105333705|NCT01322490|363222986|FG002|Treatment Period|Physician Decision|1|||
105333706|NCT01322490|363222984|FG000|Treatment Period|Protocol Violation|7|||
105333707|NCT01322490|363222985|FG001|Treatment Period|Protocol Violation|5|||
105333708|NCT01322490|363222986|FG002|Treatment Period|Protocol Violation|4|||
105333709|NCT01322490|363222984|FG000|Treatment Period|Withdrawal by Subject|14|||
105333710|NCT01322490|363222985|FG001|Treatment Period|Withdrawal by Subject|16|||
105333711|NCT01322490|363222986|FG002|Treatment Period|Withdrawal by Subject|11|||
105333712|NCT01322490|363222984|FG000|Treatment Period|Non-compliance with study drug|0|||
105333713|NCT01322490|363222985|FG001|Treatment Period|Non-compliance with study drug|0|||
105333714|NCT01322490|363222986|FG002|Treatment Period|Non-compliance with study drug|1|||
105333715|NCT01322490|363222984|FG000|Treatment Period|Other per report|2|||
105333716|NCT01322490|363222985|FG001|Treatment Period|Other per report|2|||
105333717|NCT01322490|363222986|FG002|Treatment Period|Other per report|1|||
105333718|NCT01322490|363222984|FG000|Treatment Period|Randomized but Not Treated|3|||
105333719|NCT01322490|363222985|FG001|Treatment Period|Randomized but Not Treated|3|||
105333720|NCT01322490|363222986|FG002|Treatment Period|Randomized but Not Treated|5|||
105333721|NCT01322490|363222984|FG000|Long Term Follow-up Period|Death|235|||
105333722|NCT01322490|363222985|FG001|Long Term Follow-up Period|Death|239|||
105333723|NCT01322490|363222986|FG002|Long Term Follow-up Period|Death|236|||
105333724|NCT01322490|363222984|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
105333725|NCT01322490|363222985|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
105333726|NCT01322490|363222986|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
105333727|NCT01322490|363222984|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
105333728|NCT01322490|363222985|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
105333729|NCT01322490|363222986|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
105440774|NCT00095173|363619256|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
105333730|NCT01322490|363222984|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
105333731|NCT01322490|363222985|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
105333732|NCT01322490|363222986|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
105333733|NCT01322490|363222984|FG000|Long Term Follow-up Period|Other per report|3|||
105333734|NCT01322490|363222985|FG001|Long Term Follow-up Period|Other per report|2|||
105333735|NCT01322490|363222986|FG002|Long Term Follow-up Period|Other per report|2|||
105333736|NCT01322490|363222984|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
105333737|NCT01322490|363222985|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
105333738|NCT01322490|363222986|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
105333739|NCT02257489|363222989|FG000|Overall Study|Withdrawal by Subject|0|||
105333740|NCT02257489|363222990|FG001|Overall Study|Withdrawal by Subject|0|||
105333741|NCT02257489|363222991|FG002|Overall Study|Withdrawal by Subject|0|||
105333742|NCT02257489|363222992|FG003|Overall Study|Withdrawal by Subject|1|||
105333743|NCT02257489|363222993|FG004|Overall Study|Withdrawal by Subject|0|||
105333744|NCT02257489|363222994|FG005|Overall Study|Withdrawal by Subject|0|||
105333745|NCT02257489|363222995|FG006|Overall Study|Withdrawal by Subject|0|||
105333746|NCT02257489|363222996|FG007|Overall Study|Withdrawal by Subject|0|||
105333747|NCT02257489|363222997|FG008|Overall Study|Withdrawal by Subject|0|||
105333748|NCT04606394|363222998|FG000|Overall Study|Withdrawal by Subject|3|||
105333749|NCT04606394|363222998|FG000|Overall Study|Exclusion criteria screen failure|12|||
105333750|NCT02484456|363223000|FG000|Washout Period|Withdrawal by Subject|0|||
105333751|NCT02484456|363223001|FG001|Washout Period|Withdrawal by Subject|1|||
105333752|NCT02484456|363223000|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
105333753|NCT02484456|363223001|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
105333754|NCT02484456|363223000|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
105333755|NCT02484456|363223001|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
105333756|NCT02484456|363223000|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
105333757|NCT02484456|363223001|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
105333758|NCT02920008|363223002|FG000|Overall Study|Death|117|||
105333759|NCT02920008|363223003|FG001|Overall Study|Death|127|||
105333760|NCT02920008|363223002|FG000|Overall Study|Withdrawal by Subject|3|||
105333761|NCT02920008|363223003|FG001|Overall Study|Withdrawal by Subject|6|||
105333762|NCT02920008|363223002|FG000|Overall Study|Lost to Follow-up|0|||
105333763|NCT02920008|363223003|FG001|Overall Study|Lost to Follow-up|1|||
105333764|NCT01053663|363223004|FG000|Overall Study|Death|2|||
105333765|NCT01053663|363223004|FG000|Overall Study|Lost to Follow-up|1|||
105333766|NCT01053663|363223004|FG000|Overall Study|Poor IV Access|1|||
105333767|NCT01053663|363223004|FG000|Overall Study|Transferred to Another Hospital|1|||
105333768|NCT01053663|363223004|FG000|Overall Study|Negative Influenza Diagnosis|1|||
105333769|NCT02737930|363223005|FG000|Overall Study|Withdrawal by Subject|0|||
105333770|NCT02737930|363223006|FG001|Overall Study|Withdrawal by Subject|1|||
105333771|NCT02016105|363223007|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
105333772|NCT02016105|363223008|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
105333773|NCT02016105|363223009|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
105333774|NCT02016105|363223010|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
105333775|NCT02016105|363223011|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
105333776|NCT02016105|363223012|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
105333777|NCT02016105|363223007|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
105333778|NCT02016105|363223008|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
105333779|NCT02016105|363223009|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
105440775|NCT00095173|363619251|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
105440776|NCT00095173|363619252|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
105440777|NCT00095173|363619253|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
105440778|NCT00095173|363619254|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
105440779|NCT00095173|363619255|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
105440780|NCT00095173|363619256|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
105440781|NCT00095173|363619251|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
105440782|NCT00095173|363619252|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
105440783|NCT00095173|363619253|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
105440784|NCT00095173|363619254|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
105440785|NCT00095173|363619255|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
105440786|NCT00095173|363619256|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
105440787|NCT00095173|363619251|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
105440788|NCT00095173|363619252|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
105440789|NCT00095173|363619253|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
105333780|NCT02016105|363223010|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
105333781|NCT02016105|363223011|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
105333782|NCT02016105|363223012|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
105333783|NCT02016105|363223007|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
105333784|NCT02016105|363223008|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
105333785|NCT02016105|363223009|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
105333786|NCT02016105|363223010|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
105440790|NCT00095173|363619254|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
105440791|NCT00095173|363619255|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
105440792|NCT00095173|363619256|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
105440793|NCT00095173|363619251|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
105440794|NCT00095173|363619252|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
105440795|NCT00095173|363619253|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
105440796|NCT00095173|363619254|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
105440797|NCT00095173|363619255|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
105440798|NCT00095173|363619256|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
105440799|NCT00095173|363619251|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
105440800|NCT00095173|363619252|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
105440801|NCT00095173|363619253|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
105440802|NCT00095173|363619254|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
105440803|NCT00095173|363619255|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
105440804|NCT00095173|363619256|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
105440805|NCT00095173|363619251|FG000|Open-Label Extension Phase (Period C)|Death|0|||
105440806|NCT00095173|363619252|FG001|Open-Label Extension Phase (Period C)|Death|0|||
105440807|NCT00095173|363619253|FG002|Open-Label Extension Phase (Period C)|Death|0|||
105440808|NCT00095173|363619254|FG003|Open-Label Extension Phase (Period C)|Death|0|||
105440809|NCT00095173|363619255|FG004|Open-Label Extension Phase (Period C)|Death|0|||
105440810|NCT00095173|363619256|FG005|Open-Label Extension Phase (Period C)|Death|1|||
105440811|NCT00095173|363619251|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
105440812|NCT00095173|363619252|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
105440813|NCT00095173|363619253|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
105440814|NCT00095173|363619254|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
105440815|NCT00095173|363619255|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
105440816|NCT00095173|363619256|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
105440817|NCT00095173|363619251|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
105440818|NCT00095173|363619252|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
105440819|NCT00095173|363619253|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
105440820|NCT00095173|363619254|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
105440821|NCT00095173|363619255|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
105440822|NCT00095173|363619256|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
105440823|NCT00095173|363619251|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
105440824|NCT00095173|363619252|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
105440825|NCT00095173|363619253|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
105440826|NCT00095173|363619254|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
105440827|NCT00095173|363619255|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
105440828|NCT00095173|363619256|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
105440829|NCT00095173|363619251|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
105440830|NCT00095173|363619252|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
105440831|NCT00095173|363619253|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
105440832|NCT00095173|363619254|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
105440833|NCT00095173|363619255|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
105440834|NCT00095173|363619256|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
105440835|NCT00095173|363619251|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
105440836|NCT00095173|363619252|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
105440837|NCT00095173|363619253|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
105440838|NCT00095173|363619254|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
105440839|NCT00095173|363619255|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
105440840|NCT00095173|363619256|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
105440841|NCT00095173|363619251|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
105440842|NCT00095173|363619252|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
105440843|NCT00095173|363619253|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
105440844|NCT00095173|363619254|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
105440845|NCT00095173|363619255|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
105440846|NCT00095173|363619256|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
105440847|NCT00095173|363619251|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
105440848|NCT00095173|363619252|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
105440849|NCT00095173|363619253|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
105440850|NCT00095173|363619254|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
105440851|NCT00095173|363619255|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
105440852|NCT00095173|363619256|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
105440853|NCT00095173|363619251|FG000|Open-Label Extension Phase (Period C)|Other|0|||
105440854|NCT00095173|363619252|FG001|Open-Label Extension Phase (Period C)|Other|0|||
105659697|NCT01099579|364418812|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
105440855|NCT00095173|363619253|FG002|Open-Label Extension Phase (Period C)|Other|0|||
105440856|NCT00095173|363619254|FG003|Open-Label Extension Phase (Period C)|Other|4|||
105440857|NCT00095173|363619255|FG004|Open-Label Extension Phase (Period C)|Other|6|||
105440858|NCT00095173|363619256|FG005|Open-Label Extension Phase (Period C)|Other|8|||
105440859|NCT01620528|363619259|FG000|Treatment Period|Did Not Receive Study Drug|0|||
105440860|NCT01620528|363619260|FG001|Treatment Period|Did Not Receive Study Drug|0|||
105440861|NCT01620528|363619261|FG002|Treatment Period|Did Not Receive Study Drug|1|||
105440862|NCT01620528|363619259|FG000|Treatment Period|Withdrawal by Subject|35|||
105440863|NCT01620528|363619260|FG001|Treatment Period|Withdrawal by Subject|21|||
105440864|NCT01620528|363619261|FG002|Treatment Period|Withdrawal by Subject|16|||
105440865|NCT01620528|363619259|FG000|Treatment Period|Adverse Event|17|||
105440866|NCT01620528|363619260|FG001|Treatment Period|Adverse Event|13|||
105440867|NCT01620528|363619261|FG002|Treatment Period|Adverse Event|21|||
105440868|NCT01620528|363619259|FG000|Treatment Period|Lost to Follow-up|16|||
105440869|NCT01620528|363619260|FG001|Treatment Period|Lost to Follow-up|8|||
105440870|NCT01620528|363619261|FG002|Treatment Period|Lost to Follow-up|14|||
105440871|NCT01620528|363619259|FG000|Treatment Period|Other|9|||
105440872|NCT01620528|363619260|FG001|Treatment Period|Other|5|||
105440873|NCT01620528|363619261|FG002|Treatment Period|Other|7|||
105440874|NCT01620528|363619259|FG000|Treatment Period|Subject Noncompliant|11|||
105440875|NCT01620528|363619260|FG001|Treatment Period|Subject Noncompliant|2|||
105440876|NCT01620528|363619261|FG002|Treatment Period|Subject Noncompliant|2|||
105440877|NCT01620528|363619259|FG000|Treatment Period|Pregnancy|7|||
105440878|NCT01620528|363619260|FG001|Treatment Period|Pregnancy|2|||
105440879|NCT01620528|363619261|FG002|Treatment Period|Pregnancy|2|||
105440880|NCT01620528|363619259|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
105440881|NCT01620528|363619260|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
105440882|NCT01620528|363619261|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
105440883|NCT01620528|363619259|FG000|Treatment Period|Exclusionary Medication Received|0|||
105440884|NCT01620528|363619260|FG001|Treatment Period|Exclusionary Medication Received|1|||
105440885|NCT01620528|363619261|FG002|Treatment Period|Exclusionary Medication Received|0|||
105440886|NCT01620528|363619259|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
105440887|NCT01620528|363619260|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
105440888|NCT01620528|363619261|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
105440889|NCT01620528|363619259|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
105440890|NCT01620528|363619260|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
105440891|NCT01620528|363619261|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
105440892|NCT01620528|363619259|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
105440893|NCT01620528|363619260|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
105440894|NCT01620528|363619261|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
105440895|NCT01620528|363619259|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
105440896|NCT01620528|363619260|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
105440897|NCT01620528|363619261|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
105440898|NCT01620528|363619259|FG000|Post-Treatment Follow-Up Period|Other|6|||
105440899|NCT01620528|363619260|FG001|Post-Treatment Follow-Up Period|Other|4|||
105440900|NCT01620528|363619261|FG002|Post-Treatment Follow-Up Period|Other|2|||
105440901|NCT01090063|363619264|FG000|Screen|Screen Failed|4|||
105440902|NCT01090063|363619264|FG000|Treatment|Withdrawal by Subject|4|||
105440903|NCT01496846|363619265|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
105440904|NCT01496846|363619266|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
105440905|NCT01496846|363619267|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
105440906|NCT01496846|363619268|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
105440907|NCT01496846|363619269|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
105440908|NCT01496846|363619270|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
105440909|NCT04038567|363619271|FG000|Overall Study|Lost to Follow-up|6|||
105440910|NCT04038567|363619272|FG001|Overall Study|Lost to Follow-up|4|||
105440911|NCT04038567|363619273|FG002|Overall Study|Lost to Follow-up|5|||
105440912|NCT04038567|363619274|FG003|Overall Study|Lost to Follow-up|4|||
105440913|NCT04038567|363619275|FG004|Overall Study|Lost to Follow-up|6|||
105440914|NCT04038567|363619276|FG005|Overall Study|Lost to Follow-up|4|||
105440915|NCT04038567|363619277|FG006|Overall Study|Lost to Follow-up|4|||
105440916|NCT04038567|363619278|FG007|Overall Study|Lost to Follow-up|1|||
105440917|NCT04038567|363619271|FG000|Overall Study|Withdrawal by Subject|2|||
105440918|NCT04038567|363619272|FG001|Overall Study|Withdrawal by Subject|1|||
105440919|NCT04038567|363619273|FG002|Overall Study|Withdrawal by Subject|1|||
105440920|NCT04038567|363619274|FG003|Overall Study|Withdrawal by Subject|1|||
105440921|NCT04038567|363619275|FG004|Overall Study|Withdrawal by Subject|4|||
105440922|NCT04038567|363619276|FG005|Overall Study|Withdrawal by Subject|1|||
105440923|NCT04038567|363619277|FG006|Overall Study|Withdrawal by Subject|1|||
105440924|NCT04038567|363619278|FG007|Overall Study|Withdrawal by Subject|1|||
105440925|NCT04038567|363619271|FG000|Overall Study|missed survey window|1|||
105440926|NCT04038567|363619272|FG001|Overall Study|missed survey window|2|||
105440927|NCT04038567|363619273|FG002|Overall Study|missed survey window|0|||
105333787|NCT02016105|363223011|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
105333788|NCT02016105|363223012|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
105333789|NCT02016105|363223007|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
105333790|NCT02016105|363223008|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
105333791|NCT02016105|363223009|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
105333792|NCT02016105|363223010|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
105333793|NCT02016105|363223011|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
105440928|NCT04038567|363619274|FG003|Overall Study|missed survey window|0|||
105440929|NCT04038567|363619275|FG004|Overall Study|missed survey window|1|||
105440930|NCT04038567|363619276|FG005|Overall Study|missed survey window|1|||
105440931|NCT04038567|363619277|FG006|Overall Study|missed survey window|2|||
105440932|NCT04038567|363619278|FG007|Overall Study|missed survey window|2|||
105440933|NCT04038567|363619271|FG000|Overall Study|technical issues|0|||
105440934|NCT04038567|363619272|FG001|Overall Study|technical issues|0|||
105440935|NCT04038567|363619273|FG002|Overall Study|technical issues|0|||
105440936|NCT04038567|363619274|FG003|Overall Study|technical issues|0|||
105440937|NCT04038567|363619275|FG004|Overall Study|technical issues|0|||
105440938|NCT04038567|363619276|FG005|Overall Study|technical issues|0|||
105440939|NCT04038567|363619277|FG006|Overall Study|technical issues|1|||
105440940|NCT04038567|363619278|FG007|Overall Study|technical issues|0|||
105440941|NCT04038567|363619271|FG000|Overall Study|Medical issues (i.e., illness)|0|||
105440942|NCT04038567|363619272|FG001|Overall Study|Medical issues (i.e., illness)|1|||
105440943|NCT04038567|363619273|FG002|Overall Study|Medical issues (i.e., illness)|2|||
105440944|NCT04038567|363619274|FG003|Overall Study|Medical issues (i.e., illness)|1|||
105440945|NCT04038567|363619275|FG004|Overall Study|Medical issues (i.e., illness)|1|||
105440946|NCT04038567|363619276|FG005|Overall Study|Medical issues (i.e., illness)|1|||
105440947|NCT04038567|363619277|FG006|Overall Study|Medical issues (i.e., illness)|0|||
105440948|NCT04038567|363619278|FG007|Overall Study|Medical issues (i.e., illness)|0|||
105440949|NCT04038567|363619271|FG000|Overall Study|Death|0|||
105440950|NCT04038567|363619272|FG001|Overall Study|Death|0|||
105440951|NCT04038567|363619273|FG002|Overall Study|Death|0|||
105440952|NCT04038567|363619274|FG003|Overall Study|Death|1|||
105440953|NCT04038567|363619275|FG004|Overall Study|Death|1|||
105440954|NCT04038567|363619276|FG005|Overall Study|Death|0|||
105440955|NCT04038567|363619277|FG006|Overall Study|Death|0|||
105440956|NCT04038567|363619278|FG007|Overall Study|Death|1|||
105440957|NCT01772576|363619282|FG000|Overall Study|Death|15|||
105440958|NCT01772576|363619282|FG000|Overall Study|Protocol Violation|1|||
105440959|NCT01772576|363619282|FG000|Overall Study|Lost to Follow-up|3|||
105440960|NCT01772576|363619282|FG000|Overall Study|Study device not used|3|||
105440961|NCT01772576|363619282|FG000|Overall Study|Adverse Event|6|||
105440962|NCT01772576|363619282|FG000|Overall Study|Withdrawal by Subject|6|||
105440963|NCT01817959|363619285|FG000|Overall Study|Graft loss|1|||
105440964|NCT01817959|363619286|FG001|Overall Study|Graft loss|1|||
105440965|NCT01817959|363619285|FG000|Overall Study|forbidden medication|1|||
105440966|NCT01817959|363619286|FG001|Overall Study|forbidden medication|1|||
105440967|NCT01817959|363619285|FG000|Overall Study|Adverse Event|1|||
105440968|NCT01817959|363619286|FG001|Overall Study|Adverse Event|0|||
105440969|NCT01817959|363619285|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
105333794|NCT02016105|363223012|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
105333795|NCT02016105|363223007|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
105333796|NCT02016105|363223008|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
105333797|NCT02016105|363223009|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
105333798|NCT02016105|363223010|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
105333799|NCT02016105|363223011|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
105333800|NCT02016105|363223012|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
105333801|NCT02016105|363223007|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
105333802|NCT02016105|363223008|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
105333803|NCT02016105|363223009|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
105333804|NCT02016105|363223010|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
105333805|NCT02016105|363223011|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
105333806|NCT02016105|363223012|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
105333807|NCT02016105|363223007|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
105333808|NCT02016105|363223008|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
105333809|NCT02016105|363223009|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
105333810|NCT02016105|363223010|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
105333811|NCT02016105|363223011|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
105333812|NCT02016105|363223012|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
105440970|NCT01817959|363619286|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
105440971|NCT04356352|363619290|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
105440972|NCT04356352|363619291|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
105333813|NCT02016105|363223007|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
105440973|NCT04356352|363619292|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
105440974|NCT04356352|363619290|FG000|Overall Study|Protocol Violation|0|||
105440975|NCT04356352|363619291|FG001|Overall Study|Protocol Violation|3|||
105440976|NCT04356352|363619292|FG002|Overall Study|Protocol Violation|1|||
105440977|NCT00330681|363619295|FG000|Overall Study|Adverse Event|3|||
105440978|NCT00330681|363619296|FG001|Overall Study|Adverse Event|6|||
105440979|NCT00330681|363619295|FG000|Overall Study|Protocol Violation|0|||
105440980|NCT00330681|363619296|FG001|Overall Study|Protocol Violation|1|||
105440981|NCT00330681|363619295|FG000|Overall Study|Withdrawal by Subject|5|||
105440982|NCT00330681|363619296|FG001|Overall Study|Withdrawal by Subject|5|||
105440983|NCT00330681|363619295|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
105440984|NCT00330681|363619296|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
105440985|NCT02578186|363619297|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
105440986|NCT02578186|363619298|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
105440987|NCT02578186|363619297|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
105440988|NCT02578186|363619298|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
105440989|NCT04405076|363619302|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
105440990|NCT04405076|363619303|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
105440991|NCT04405076|363619304|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
105440992|NCT04405076|363619305|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
105440993|NCT04405076|363619306|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
105440994|NCT04405076|363619307|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
105440995|NCT04405076|363619308|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
105440996|NCT04405076|363619309|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
105440997|NCT04405076|363619310|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
105440998|NCT04405076|363619302|FG000|Part A (Blinded Phase)|Physician Decision|1|||
105440999|NCT04405076|363619303|FG001|Part A (Blinded Phase)|Physician Decision|2|||
105441000|NCT04405076|363619304|FG002|Part A (Blinded Phase)|Physician Decision|0|||
105441001|NCT04405076|363619305|FG003|Part A (Blinded Phase)|Physician Decision|0|||
105441002|NCT04405076|363619306|FG004|Part A (Blinded Phase)|Physician Decision|0|||
105441003|NCT04405076|363619307|FG005|Part A (Blinded Phase)|Physician Decision|0|||
105441004|NCT04405076|363619308|FG006|Part A (Blinded Phase)|Physician Decision|0|||
105441005|NCT04405076|363619309|FG007|Part A (Blinded Phase)|Physician Decision|0|||
105441006|NCT04405076|363619310|FG008|Part A (Blinded Phase)|Physician Decision|0|||
105441007|NCT04405076|363619302|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
105441008|NCT04405076|363619303|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
105441009|NCT04405076|363619304|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
105441010|NCT04405076|363619305|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
105441011|NCT04405076|363619306|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
105441012|NCT04405076|363619307|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
105441013|NCT04405076|363619308|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
105441014|NCT04405076|363619309|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
105441015|NCT04405076|363619310|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
105441016|NCT04405076|363619302|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
105441017|NCT04405076|363619303|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105441018|NCT04405076|363619304|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105441019|NCT04405076|363619305|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105441020|NCT04405076|363619306|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105441021|NCT04405076|363619307|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105441022|NCT04405076|363619308|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105441023|NCT04405076|363619309|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105441024|NCT04405076|363619310|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105333814|NCT02016105|363223008|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
105333815|NCT02016105|363223009|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
105333816|NCT02016105|363223010|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
105333817|NCT02016105|363223011|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
105333818|NCT02016105|363223012|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
105333819|NCT02016105|363223007|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
105333820|NCT02016105|363223008|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
105333821|NCT02016105|363223009|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
105333822|NCT02016105|363223010|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
105333823|NCT02016105|363223011|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
105333824|NCT02016105|363223012|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
105333825|NCT02016105|363223007|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
105333826|NCT02016105|363223008|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
105333827|NCT02016105|363223009|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
105441025|NCT04405076|363619302|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
105659698|NCT01099579|364418813|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
105441026|NCT04405076|363619303|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
105333828|NCT02016105|363223010|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
105333829|NCT02016105|363223011|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
105333830|NCT02016105|363223012|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
105441027|NCT04405076|363619304|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
105441028|NCT04405076|363619305|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
105333831|NCT02016105|363223007|FG000|TREATMENT PERIOD 2|Death|0|||
105441029|NCT04405076|363619306|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
105441030|NCT04405076|363619307|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
105441031|NCT04405076|363619308|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
105441032|NCT04405076|363619309|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
105441033|NCT04405076|363619310|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
105441034|NCT04405076|363619302|FG000|Part A (Blinded Phase)|Other than Specified|0|||
105441035|NCT04405076|363619303|FG001|Part A (Blinded Phase)|Other than Specified|0|||
105441036|NCT04405076|363619304|FG002|Part A (Blinded Phase)|Other than Specified|3|||
105441037|NCT04405076|363619305|FG003|Part A (Blinded Phase)|Other than Specified|0|||
105441038|NCT04405076|363619306|FG004|Part A (Blinded Phase)|Other than Specified|0|||
105441039|NCT04405076|363619307|FG005|Part A (Blinded Phase)|Other than Specified|0|||
105441040|NCT04405076|363619308|FG006|Part A (Blinded Phase)|Other than Specified|0|||
105441041|NCT04405076|363619309|FG007|Part A (Blinded Phase)|Other than Specified|0|||
105441042|NCT04405076|363619310|FG008|Part A (Blinded Phase)|Other than Specified|0|||
105441043|NCT04405076|363619302|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
105441044|NCT04405076|363619303|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
105441045|NCT04405076|363619304|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
105441046|NCT04405076|363619305|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
105441047|NCT04405076|363619306|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
105441048|NCT04405076|363619307|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
105441049|NCT04405076|363619308|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
105441050|NCT04405076|363619309|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
105441051|NCT04405076|363619310|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
105441052|NCT04405076|363619302|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
105441053|NCT04405076|363619303|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
105441054|NCT04405076|363619304|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
105441055|NCT04405076|363619305|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
105441056|NCT04405076|363619306|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
105441057|NCT04405076|363619307|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
105441058|NCT04405076|363619308|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
105441059|NCT04405076|363619309|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
105441060|NCT04405076|363619310|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
105441061|NCT04405076|363619302|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
105441062|NCT04405076|363619303|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
105441063|NCT04405076|363619304|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
105441064|NCT04405076|363619305|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
105441065|NCT04405076|363619306|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
105441066|NCT04405076|363619307|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
105333832|NCT02016105|363223008|FG001|TREATMENT PERIOD 2|Death|0|||
105333833|NCT02016105|363223009|FG002|TREATMENT PERIOD 2|Death|0|||
105333834|NCT02016105|363223010|FG003|TREATMENT PERIOD 2|Death|0|||
105333835|NCT02016105|363223011|FG004|TREATMENT PERIOD 2|Death|0|||
105333836|NCT02016105|363223012|FG005|TREATMENT PERIOD 2|Death|1|||
105333837|NCT02016105|363223007|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
105333838|NCT02016105|363223008|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
105333839|NCT02016105|363223009|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
105333840|NCT02016105|363223010|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
105333841|NCT02016105|363223011|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
105333842|NCT02016105|363223012|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
105333843|NCT02016105|363223007|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
105333844|NCT02016105|363223008|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
105333845|NCT02016105|363223009|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
105333846|NCT02016105|363223010|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
105333847|NCT02016105|363223011|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
105333848|NCT02016105|363223012|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
105333849|NCT02016105|363223007|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
105333850|NCT02016105|363223008|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
105333851|NCT02016105|363223009|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
105333852|NCT02016105|363223010|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
105333853|NCT02016105|363223011|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
105333854|NCT02016105|363223012|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
105333855|NCT02016105|363223007|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
105441067|NCT04405076|363619308|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
105441068|NCT04405076|363619309|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
105333856|NCT02016105|363223008|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
105333857|NCT02016105|363223009|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
105333858|NCT02016105|363223010|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
105333859|NCT02016105|363223011|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
105333860|NCT02016105|363223012|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
105333861|NCT02016105|363223007|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
105441069|NCT04405076|363619310|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
105441070|NCT04405076|363619302|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
105441071|NCT04405076|363619303|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
105441072|NCT04405076|363619304|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
105441073|NCT04405076|363619305|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
105441074|NCT04405076|363619306|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
105441075|NCT04405076|363619307|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
105659699|NCT01099579|364418811|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
105659700|NCT01099579|364418812|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
105659701|NCT01099579|364418813|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
105659702|NCT01099579|364418811|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
105659703|NCT01099579|364418812|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
105659704|NCT01099579|364418813|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
105659705|NCT01099579|364418811|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
105659706|NCT01099579|364418812|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
105659707|NCT01099579|364418813|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
105659708|NCT01099579|364418811|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
105659709|NCT01099579|364418812|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
105659710|NCT01099579|364418813|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
105659711|NCT01099579|364418811|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
105659712|NCT01099579|364418812|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
105659713|NCT01099579|364418813|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
105659714|NCT01099579|364418811|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
105659715|NCT01099579|364418812|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
105659716|NCT01099579|364418813|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
105659717|NCT01099579|364418811|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
105659718|NCT01099579|364418812|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
105659719|NCT01099579|364418813|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
105659720|NCT01099579|364418811|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
105659721|NCT01099579|364418812|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
105333862|NCT02016105|363223008|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
105333863|NCT02016105|363223009|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
105333864|NCT02016105|363223010|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
105333865|NCT02016105|363223011|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
105333866|NCT02016105|363223012|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
105333867|NCT02016105|363223007|FG000|EXTENSION PERIOD|Adverse Event|0|||
105333868|NCT02016105|363223008|FG001|EXTENSION PERIOD|Adverse Event|0|||
105333869|NCT02016105|363223009|FG002|EXTENSION PERIOD|Adverse Event|2|||
105333870|NCT02016105|363223010|FG003|EXTENSION PERIOD|Adverse Event|0|||
105333871|NCT02016105|363223011|FG004|EXTENSION PERIOD|Adverse Event|1|||
105333872|NCT02016105|363223012|FG005|EXTENSION PERIOD|Adverse Event|0|||
105333873|NCT02016105|363223007|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
105333874|NCT02016105|363223008|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
105333875|NCT02016105|363223009|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
105333876|NCT02016105|363223010|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
105333877|NCT02016105|363223011|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
105333878|NCT02016105|363223012|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
105333879|NCT02016105|363223007|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
105333880|NCT02016105|363223008|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
105333881|NCT02016105|363223009|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
105333882|NCT02016105|363223010|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
105333883|NCT02016105|363223011|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
105333884|NCT02016105|363223012|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
105333885|NCT02016105|363223007|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
105333886|NCT02016105|363223008|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
105333887|NCT02016105|363223009|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
105333888|NCT02016105|363223010|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
105333889|NCT02016105|363223011|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
105659722|NCT01099579|364418813|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
105659723|NCT01774305|364418814|FG000|Overall Study|Physician Decision|1|||
105659724|NCT01774305|364418815|FG001|Overall Study|Physician Decision|0|||
105659725|NCT04211389|364418816|FG000|Overall Study|Adverse Event|1|||
105659726|NCT04211389|364418817|FG001|Overall Study|Adverse Event|2|||
105659727|NCT04211389|364418816|FG000|Overall Study|Lost to Follow-up|15|||
105333890|NCT02016105|363223012|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
105659728|NCT04211389|364418817|FG001|Overall Study|Lost to Follow-up|7|||
105659729|NCT04211389|364418816|FG000|Overall Study|Protocol Violation|0|||
105333891|NCT02792192|363223013|FG000|Overall Study|Death|1|||
105333892|NCT02792192|363223014|FG001|Overall Study|Death|0|||
105333893|NCT02792192|363223015|FG002|Overall Study|Death|0|||
105333894|NCT02792192|363223016|FG003|Overall Study|Death|0|||
105659730|NCT04211389|364418817|FG001|Overall Study|Protocol Violation|1|||
105659731|NCT04211389|364418816|FG000|Overall Study|Withdrawal by Subject|10|||
105659732|NCT04211389|364418817|FG001|Overall Study|Withdrawal by Subject|11|||
105659733|NCT02689453|364418822|FG000|Overall Study|Progressive disease|0|||
105659734|NCT02689453|364418823|FG001|Overall Study|Progressive disease|1|||
105659735|NCT02689453|364418824|FG002|Overall Study|Progressive disease|1|||
105659736|NCT01427738|364418827|FG000|Overall Study|Death|12|||
105659737|NCT01427738|364418828|FG001|Overall Study|Death|9|||
105659738|NCT01427738|364418827|FG000|Overall Study|Severe debilitation, unable to continue|0|||
105659739|NCT01427738|364418828|FG001|Overall Study|Severe debilitation, unable to continue|1|||
105659740|NCT01427738|364418827|FG000|Overall Study|Subject unable to get to clinic|5|||
105659741|NCT01427738|364418828|FG001|Overall Study|Subject unable to get to clinic|2|||
105659742|NCT01427738|364418827|FG000|Overall Study|Withdrawal by Subject|0|||
105441076|NCT04405076|363619308|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
105333895|NCT02792192|363223013|FG000|Overall Study|Informed Consent Withdrawn|4|||
105333896|NCT02792192|363223014|FG001|Overall Study|Informed Consent Withdrawn|0|||
105333897|NCT02792192|363223015|FG002|Overall Study|Informed Consent Withdrawn|0|||
105333898|NCT02792192|363223016|FG003|Overall Study|Informed Consent Withdrawn|0|||
105333899|NCT02792192|363223013|FG000|Overall Study|Physician Decision|1|||
105333900|NCT02792192|363223014|FG001|Overall Study|Physician Decision|0|||
105333901|NCT02792192|363223015|FG002|Overall Study|Physician Decision|0|||
105333902|NCT02792192|363223016|FG003|Overall Study|Physician Decision|0|||
105333903|NCT02792192|363223013|FG000|Overall Study|Progressive Disease|0|||
105333904|NCT02792192|363223014|FG001|Overall Study|Progressive Disease|1|||
105333905|NCT02792192|363223015|FG002|Overall Study|Progressive Disease|0|||
105333906|NCT02792192|363223016|FG003|Overall Study|Progressive Disease|0|||
105333907|NCT02792192|363223013|FG000|Overall Study|Study Terminated By Sponsor|6|||
105333908|NCT02792192|363223014|FG001|Overall Study|Study Terminated By Sponsor|10|||
105333909|NCT02792192|363223015|FG002|Overall Study|Study Terminated By Sponsor|0|||
105333910|NCT02792192|363223016|FG003|Overall Study|Study Terminated By Sponsor|0|||
105333911|NCT01339923|363223017|FG000|Overall Study|Adverse Event|1|||
105333912|NCT01339923|363223018|FG001|Overall Study|Adverse Event|1|||
105333913|NCT01339923|363223019|FG002|Overall Study|Adverse Event|1|||
105333914|NCT01339923|363223020|FG003|Overall Study|Adverse Event|0|||
105333915|NCT01339923|363223021|FG004|Overall Study|Adverse Event|0|||
105333916|NCT01339923|363223022|FG005|Overall Study|Adverse Event|0|||
105333917|NCT01339923|363223023|FG006|Overall Study|Adverse Event|1|||
105333918|NCT01339923|363223017|FG000|Overall Study|Inappropriate Enrollment|1|||
105333919|NCT01339923|363223018|FG001|Overall Study|Inappropriate Enrollment|0|||
105333920|NCT01339923|363223019|FG002|Overall Study|Inappropriate Enrollment|0|||
105333921|NCT01339923|363223020|FG003|Overall Study|Inappropriate Enrollment|0|||
105333922|NCT01339923|363223021|FG004|Overall Study|Inappropriate Enrollment|0|||
105333923|NCT01339923|363223022|FG005|Overall Study|Inappropriate Enrollment|1|||
105333924|NCT01339923|363223023|FG006|Overall Study|Inappropriate Enrollment|0|||
105333925|NCT01339923|363223017|FG000|Overall Study|Lost to Follow-up|4|||
105333926|NCT01339923|363223018|FG001|Overall Study|Lost to Follow-up|4|||
105333927|NCT01339923|363223019|FG002|Overall Study|Lost to Follow-up|0|||
105333928|NCT01339923|363223020|FG003|Overall Study|Lost to Follow-up|3|||
105333929|NCT01339923|363223021|FG004|Overall Study|Lost to Follow-up|1|||
105333930|NCT01339923|363223022|FG005|Overall Study|Lost to Follow-up|1|||
105333931|NCT01339923|363223023|FG006|Overall Study|Lost to Follow-up|5|||
105333932|NCT01339923|363223017|FG000|Overall Study|Protocol Violation|0|||
105333933|NCT01339923|363223018|FG001|Overall Study|Protocol Violation|0|||
105333934|NCT01339923|363223019|FG002|Overall Study|Protocol Violation|0|||
105333935|NCT01339923|363223020|FG003|Overall Study|Protocol Violation|0|||
105333936|NCT01339923|363223021|FG004|Overall Study|Protocol Violation|0|||
105333937|NCT01339923|363223022|FG005|Overall Study|Protocol Violation|3|||
105333938|NCT01339923|363223023|FG006|Overall Study|Protocol Violation|1|||
105333939|NCT01339923|363223017|FG000|Overall Study|Unable to Classify|1|||
105333940|NCT01339923|363223018|FG001|Overall Study|Unable to Classify|0|||
105333941|NCT01339923|363223019|FG002|Overall Study|Unable to Classify|1|||
105333942|NCT01339923|363223020|FG003|Overall Study|Unable to Classify|0|||
105333943|NCT01339923|363223021|FG004|Overall Study|Unable to Classify|0|||
105333944|NCT01339923|363223022|FG005|Overall Study|Unable to Classify|1|||
105659743|NCT01427738|364418828|FG001|Overall Study|Withdrawal by Subject|2|||
105333945|NCT01339923|363223023|FG006|Overall Study|Unable to Classify|5|||
105333946|NCT01339923|363223017|FG000|Overall Study|Withdrawal by Subject|7|||
105770545|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105806436|NCT01464827|364948989|FG008|Overall Study|Lost to Follow-up|0|||
105333947|NCT01339923|363223018|FG001|Overall Study|Withdrawal by Subject|11|||
105333948|NCT01339923|363223019|FG002|Overall Study|Withdrawal by Subject|6|||
105333949|NCT01339923|363223020|FG003|Overall Study|Withdrawal by Subject|1|||
105333950|NCT01339923|363223021|FG004|Overall Study|Withdrawal by Subject|4|||
105333951|NCT01339923|363223022|FG005|Overall Study|Withdrawal by Subject|3|||
105333952|NCT01339923|363223023|FG006|Overall Study|Withdrawal by Subject|2|||
105550165|NCT00902304|364014371|FG002|Overall Study|Adverse Event|25|||
105333953|NCT03124407|363223024|FG000|Overall Study|Lost to Follow-up|1|||
105333954|NCT03124407|363223025|FG001|Overall Study|Lost to Follow-up|0|||
105333955|NCT03124407|363223026|FG002|Overall Study|Lost to Follow-up|0|||
105333956|NCT03124407|363223027|FG003|Overall Study|Lost to Follow-up|0|||
105333957|NCT03124407|363223024|FG000|Overall Study|Adverse Event|0|||
105333958|NCT03124407|363223025|FG001|Overall Study|Adverse Event|0|||
105333959|NCT03124407|363223026|FG002|Overall Study|Adverse Event|1|||
105333960|NCT03124407|363223027|FG003|Overall Study|Adverse Event|0|||
105333961|NCT00364923|363223028|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
105333962|NCT00364923|363223028|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
105333963|NCT00766636|363223033|FG000|Overall Study|Withdrawal by Subject|1|||
105333964|NCT00766636|363223034|FG001|Overall Study|Withdrawal by Subject|1|||
105333965|NCT00766636|363223033|FG000|Overall Study|Incomplete Treatment|0|||
105333966|NCT00766636|363223034|FG001|Overall Study|Incomplete Treatment|1|||
105333967|NCT00766636|363223033|FG000|Overall Study|Adverse Event|1|||
105333968|NCT00766636|363223034|FG001|Overall Study|Adverse Event|0|||
105333969|NCT00766636|363223033|FG000|Overall Study|Disease Progression|1|||
105333970|NCT00766636|363223034|FG001|Overall Study|Disease Progression|0|||
105333971|NCT02887248|363223035|FG000|Overall Study|Withdrawal by Subject|1|||
105333972|NCT02887248|363223035|FG000|Overall Study|Adverse Event|1|||
105333973|NCT02887248|363223035|FG000|Overall Study|Progressive Disease|1|||
105333974|NCT00900159|363223036|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
105333975|NCT00900159|363223037|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
105333976|NCT01166438|363223038|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
105333977|NCT01166438|363223039|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
105441077|NCT04405076|363619309|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
105333978|NCT01166438|363223038|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
105333979|NCT01166438|363223039|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
105333980|NCT01166438|363223038|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
105333981|NCT01166438|363223039|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
105333982|NCT01166438|363223038|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
105333983|NCT01166438|363223039|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
105333984|NCT01166438|363223038|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
105333985|NCT01166438|363223039|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
105441078|NCT04405076|363619310|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
105441079|NCT04405076|363619302|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105441080|NCT04405076|363619303|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105441081|NCT04405076|363619304|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105441082|NCT04405076|363619305|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105441083|NCT04405076|363619306|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105441084|NCT04405076|363619307|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105441085|NCT04405076|363619308|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
105441086|NCT04405076|363619309|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105441087|NCT04405076|363619310|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105441088|NCT01019369|363619311|FG000|Overall Study|Lost to Follow-up|10|||
105441089|NCT01019369|363619312|FG001|Overall Study|Lost to Follow-up|6|||
105441090|NCT01019369|363619311|FG000|Overall Study|Withdrawal by Subject|0|||
105441091|NCT01019369|363619312|FG001|Overall Study|Withdrawal by Subject|1|||
105441092|NCT01031979|363621235|FG000|Overall Study|Lost to Follow-up|5|||
105441093|NCT01031979|363621236|FG001|Overall Study|Lost to Follow-up|4|||
105441094|NCT03592368|363621237|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
105441095|NCT03592368|363621238|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
105441096|NCT03592368|363621239|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
105441097|NCT03592368|363621240|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
105441098|NCT03592368|363621237|FG000|Overall Study|Adverse Event|0|||
105441099|NCT03592368|363621238|FG001|Overall Study|Adverse Event|0|||
105441100|NCT03592368|363621239|FG002|Overall Study|Adverse Event|0|||
105441101|NCT03592368|363621240|FG003|Overall Study|Adverse Event|1|||
105441102|NCT03592368|363621237|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
105659744|NCT01427738|364418827|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
105659745|NCT01427738|364418828|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
105659746|NCT01427738|364418827|FG000|Overall Study|Lost to Follow-up|1|||
105659747|NCT01427738|364418828|FG001|Overall Study|Lost to Follow-up|5|||
105659748|NCT00661713|364418829|FG000|Overall Study|Death|1|||
105659749|NCT00661713|364418830|FG001|Overall Study|Death|0|||
105333986|NCT01166438|363223038|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
105333987|NCT01166438|363223039|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
105333988|NCT00765336|363223043|FG000|Overall Study|Protocol Violation|4|||
105333989|NCT00765336|363223044|FG001|Overall Study|Protocol Violation|2|||
105441103|NCT03592368|363621238|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
105484830|NCT01992159|363786984|FG002|Overall Study|Withdrawal by Subject|0|||
105659750|NCT00661713|364418831|FG002|Overall Study|Death|0|||
105333990|NCT00765336|363223043|FG000|Overall Study|Withdrawal by Subject|6|||
105333991|NCT00765336|363223044|FG001|Overall Study|Withdrawal by Subject|4|||
105333992|NCT00765336|363223043|FG000|Overall Study|Lost to Follow-up|7|||
105333993|NCT00765336|363223044|FG001|Overall Study|Lost to Follow-up|9|||
105333994|NCT00765336|363223043|FG000|Overall Study|Adverse Event|2|||
105333995|NCT00765336|363223044|FG001|Overall Study|Adverse Event|1|||
105659751|NCT00661713|364418832|FG003|Overall Study|Death|0|||
105659752|NCT00661713|364418833|FG004|Overall Study|Death|1|||
105659753|NCT00661713|364418834|FG005|Overall Study|Death|0|||
105659754|NCT00661713|364418835|FG006|Overall Study|Death|0|||
105333996|NCT00347009|363223047|FG000|Overall Study|Death|1|||
105333997|NCT00347009|363223047|FG000|Overall Study|Adverse Event|6|||
105333998|NCT00347009|363223047|FG000|Overall Study|Withdrawal by Subject|3|||
105333999|NCT00347009|363223047|FG000|Overall Study|Physician Decision|5|||
105334000|NCT00347009|363223047|FG000|Overall Study|Lost to Follow-up|4|||
105334001|NCT00347009|363223047|FG000|Overall Study|Protocol Violation|2|||
105334002|NCT00347009|363223047|FG000|Overall Study|Adverse Laboratory Experience|1|||
105334003|NCT00347009|363223047|FG000|Overall Study|Insufficient Viral Suppression|3|||
105334004|NCT00347009|363223047|FG000|Overall Study|Increased ALT/HBV DNA|1|||
105334005|NCT00347009|363223047|FG000|Overall Study|Serious Adverse Event|1|||
105334006|NCT00552396|363223049|FG000|Overall Study|protocol withdrawal criteria|3|||
105334007|NCT00552396|363223050|FG001|Overall Study|protocol withdrawal criteria|3|||
105334008|NCT00552396|363223051|FG002|Overall Study|protocol withdrawal criteria|3|||
105334009|NCT00552396|363223052|FG003|Overall Study|protocol withdrawal criteria|6|||
105334010|NCT00552396|363223053|FG004|Overall Study|protocol withdrawal criteria|3|||
105334011|NCT00552396|363223054|FG005|Overall Study|protocol withdrawal criteria|3|||
105334012|NCT00552396|363223055|FG006|Overall Study|protocol withdrawal criteria|9|||
105334013|NCT03478644|363223056|FG000|Phase 2|Withdrawal by Subject|2|||
105334014|NCT03478644|363223057|FG001|Phase 2|Withdrawal by Subject|1|||
105334015|NCT03478644|363223056|FG000|Phase 2|Lost to Follow-up|1|||
105334016|NCT03478644|363223057|FG001|Phase 2|Lost to Follow-up|0|||
105334017|NCT02073929|363223062|FG000|Overall Study|Lost to Follow-up|2|||
105334018|NCT02073929|363223063|FG001|Overall Study|Lost to Follow-up|1|||
105334019|NCT02073929|363223062|FG000|Overall Study|Adverse Event|2|||
105334020|NCT02073929|363223063|FG001|Overall Study|Adverse Event|1|||
105334021|NCT02073929|363223062|FG000|Overall Study|Withdrawal by Subject|0|||
105334022|NCT02073929|363223063|FG001|Overall Study|Withdrawal by Subject|1|||
105334023|NCT00072280|363223064|FG000|Treatment|Found ineligible|1|||
105334024|NCT00072280|363223065|FG001|Treatment|Found ineligible|2|||
105334025|NCT00072280|363223064|FG000|Follow-up|Early termination of study|2|||
105334026|NCT00072280|363223065|FG001|Follow-up|Early termination of study|2|||
105334027|NCT00712543|363223066|FG000|Day 8-14|Lost to Follow-up|0|||
105334028|NCT00712543|363223067|FG001|Day 8-14|Lost to Follow-up|2|||
105334029|NCT02122887|363223068|FG000|Overall Study|Withdrawal by Subject|20|||
105334030|NCT02122887|363223069|FG001|Overall Study|Withdrawal by Subject|2|||
105334031|NCT01314872|363223070|FG000|Treatment Period 1|Protocol Violation|2|||
105334032|NCT01314872|363223071|FG001|Treatment Period 1|Protocol Violation|1|||
105334033|NCT01314872|363223072|FG002|Treatment Period 1|Protocol Violation|1|||
105334034|NCT01314872|363223073|FG003|Treatment Period 1|Protocol Violation|0|||
105441104|NCT03592368|363621239|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
105441105|NCT03592368|363621240|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
105659755|NCT00661713|364418836|FG007|Overall Study|Death|0|||
105659756|NCT00661713|364418829|FG000|Overall Study|Unable to Classify|1|||
105659757|NCT00661713|364418830|FG001|Overall Study|Unable to Classify|0|||
105659758|NCT00661713|364418831|FG002|Overall Study|Unable to Classify|0|||
105659759|NCT00661713|364418832|FG003|Overall Study|Unable to Classify|0|||
105659760|NCT00661713|364418833|FG004|Overall Study|Unable to Classify|0|||
105659761|NCT00661713|364418834|FG005|Overall Study|Unable to Classify|0|||
105659762|NCT00661713|364418835|FG006|Overall Study|Unable to Classify|0|||
105659763|NCT00661713|364418836|FG007|Overall Study|Unable to Classify|0|||
105659764|NCT00661713|364418829|FG000|Overall Study|Protocol Violation|1|||
105659765|NCT00661713|364418830|FG001|Overall Study|Protocol Violation|6|||
105659766|NCT00661713|364418831|FG002|Overall Study|Protocol Violation|3|||
105659767|NCT00661713|364418832|FG003|Overall Study|Protocol Violation|3|||
105659768|NCT00661713|364418833|FG004|Overall Study|Protocol Violation|0|||
105334035|NCT01314872|363223074|FG004|Treatment Period 1|Protocol Violation|1|||
105334036|NCT01314872|363223075|FG005|Treatment Period 1|Protocol Violation|0|||
105334037|NCT01314872|363223076|FG006|Treatment Period 1|Protocol Violation|0|||
105334038|NCT01314872|363223077|FG007|Treatment Period 1|Protocol Violation|0|||
105334039|NCT01314872|363223078|FG008|Treatment Period 1|Protocol Violation|0|||
105334040|NCT01314872|363223079|FG009|Treatment Period 1|Protocol Violation|1|||
105334041|NCT01314872|363223080|FG010|Treatment Period 1|Protocol Violation|1|||
105659769|NCT00661713|364418834|FG005|Overall Study|Protocol Violation|2|||
105659770|NCT00661713|364418835|FG006|Overall Study|Protocol Violation|2|||
105659771|NCT00661713|364418836|FG007|Overall Study|Protocol Violation|1|||
105659772|NCT00661713|364418829|FG000|Overall Study|Withdrawal by Subject|11|||
105659773|NCT00661713|364418830|FG001|Overall Study|Withdrawal by Subject|25|||
105659774|NCT00661713|364418831|FG002|Overall Study|Withdrawal by Subject|12|||
105659775|NCT00661713|364418832|FG003|Overall Study|Withdrawal by Subject|21|||
105659776|NCT00661713|364418833|FG004|Overall Study|Withdrawal by Subject|12|||
105659777|NCT00661713|364418834|FG005|Overall Study|Withdrawal by Subject|26|||
105659778|NCT00661713|364418835|FG006|Overall Study|Withdrawal by Subject|45|||
105659779|NCT00661713|364418836|FG007|Overall Study|Withdrawal by Subject|9|||
105659780|NCT00661713|364418829|FG000|Overall Study|Lost to Follow-up|2|||
105659781|NCT00661713|364418830|FG001|Overall Study|Lost to Follow-up|7|||
105659782|NCT00661713|364418831|FG002|Overall Study|Lost to Follow-up|2|||
105659783|NCT00661713|364418832|FG003|Overall Study|Lost to Follow-up|2|||
105659784|NCT00661713|364418833|FG004|Overall Study|Lost to Follow-up|5|||
105659785|NCT00661713|364418834|FG005|Overall Study|Lost to Follow-up|7|||
105659786|NCT00661713|364418835|FG006|Overall Study|Lost to Follow-up|14|||
105659787|NCT00661713|364418836|FG007|Overall Study|Lost to Follow-up|1|||
105659788|NCT00661713|364418829|FG000|Overall Study|Administrative Reason|0|||
105659789|NCT00661713|364418830|FG001|Overall Study|Administrative Reason|1|||
105659790|NCT00661713|364418831|FG002|Overall Study|Administrative Reason|0|||
105659791|NCT00661713|364418832|FG003|Overall Study|Administrative Reason|2|||
105659792|NCT00661713|364418833|FG004|Overall Study|Administrative Reason|2|||
105659793|NCT00661713|364418834|FG005|Overall Study|Administrative Reason|2|||
105659794|NCT00661713|364418835|FG006|Overall Study|Administrative Reason|1|||
105659795|NCT00661713|364418836|FG007|Overall Study|Administrative Reason|0|||
105659796|NCT00661713|364418829|FG000|Overall Study|Adverse Event|0|||
105659797|NCT00661713|364418830|FG001|Overall Study|Adverse Event|0|||
105659798|NCT00661713|364418831|FG002|Overall Study|Adverse Event|0|||
105659799|NCT00661713|364418832|FG003|Overall Study|Adverse Event|0|||
105659800|NCT00661713|364418833|FG004|Overall Study|Adverse Event|0|||
105659801|NCT00661713|364418834|FG005|Overall Study|Adverse Event|0|||
105659802|NCT00661713|364418835|FG006|Overall Study|Adverse Event|1|||
105659803|NCT00661713|364418836|FG007|Overall Study|Adverse Event|0|||
105659804|NCT00661713|364418829|FG000|Overall Study|Inappropriate Enrollment|0|||
105659805|NCT00661713|364418830|FG001|Overall Study|Inappropriate Enrollment|0|||
105659806|NCT00661713|364418831|FG002|Overall Study|Inappropriate Enrollment|0|||
105659807|NCT00661713|364418832|FG003|Overall Study|Inappropriate Enrollment|0|||
105770546|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105441106|NCT01732770|363621245|FG000|Overall Study|Lost to Follow-up|2|||
105441107|NCT01732770|363621246|FG001|Overall Study|Lost to Follow-up|3|||
105441108|NCT01732770|363621245|FG000|Overall Study|Withdrawal by Subject|5|||
105441109|NCT01732770|363621246|FG001|Overall Study|Withdrawal by Subject|3|||
105441110|NCT01732770|363621245|FG000|Overall Study|Decision by Sponsor|2|||
105441111|NCT01732770|363621246|FG001|Overall Study|Decision by Sponsor|2|||
105441112|NCT01732770|363621245|FG000|Overall Study|Death|1|||
105441113|NCT01732770|363621246|FG001|Overall Study|Death|0|||
105441114|NCT00931606|363621247|FG000|Overall Study|Death|1|||
105441115|NCT00931606|363621248|FG001|Overall Study|Death|3|||
105441116|NCT00931606|363621249|FG002|Overall Study|Death|2|||
105441117|NCT00931606|363621250|FG003|Overall Study|Death|0|||
105441118|NCT00931606|363621247|FG000|Overall Study|Lost to Follow-up|0|||
105441119|NCT00931606|363621248|FG001|Overall Study|Lost to Follow-up|1|||
105441120|NCT00931606|363621249|FG002|Overall Study|Lost to Follow-up|0|||
105441121|NCT00931606|363621250|FG003|Overall Study|Lost to Follow-up|0|||
105441122|NCT00931606|363621247|FG000|Overall Study|Physician Decision|0|||
105441123|NCT00931606|363621248|FG001|Overall Study|Physician Decision|0|||
105441124|NCT00931606|363621249|FG002|Overall Study|Physician Decision|3|||
105441125|NCT00931606|363621250|FG003|Overall Study|Physician Decision|0|||
105441126|NCT00931606|363621247|FG000|Overall Study|Sponsor Decision|1|||
105441127|NCT00931606|363621248|FG001|Overall Study|Sponsor Decision|4|||
105441128|NCT00931606|363621249|FG002|Overall Study|Sponsor Decision|0|||
105441129|NCT00931606|363621250|FG003|Overall Study|Sponsor Decision|2|||
105441130|NCT00931606|363621247|FG000|Overall Study|Withdrawal by Subject|3|||
105441131|NCT00931606|363621248|FG001|Overall Study|Withdrawal by Subject|1|||
105441132|NCT00931606|363621249|FG002|Overall Study|Withdrawal by Subject|1|||
105441133|NCT00931606|363621250|FG003|Overall Study|Withdrawal by Subject|1|||
105441134|NCT03047031|363621254|FG000|Overall Study|Other than listed|1|||
105441135|NCT03047031|363621255|FG001|Overall Study|Other than listed|0|||
105441136|NCT03047031|363621256|FG002|Overall Study|Other than listed|0|||
105441137|NCT03047031|363621254|FG000|Overall Study|Lost to Follow-up|4|||
105659808|NCT00661713|364418833|FG004|Overall Study|Inappropriate Enrollment|0|||
105659809|NCT00661713|364418834|FG005|Overall Study|Inappropriate Enrollment|0|||
105659810|NCT00661713|364418835|FG006|Overall Study|Inappropriate Enrollment|1|||
105659811|NCT00661713|364418836|FG007|Overall Study|Inappropriate Enrollment|0|||
105659812|NCT02353871|364418837|FG000|Overall Study|Protocol deviation|0|||
105659813|NCT02353871|364418838|FG001|Overall Study|Protocol deviation|1|||
105659814|NCT02353871|364418837|FG000|Overall Study|Consent withdrawn|1|||
105659815|NCT02353871|364418838|FG001|Overall Study|Consent withdrawn|8|||
105659816|NCT02353871|364418837|FG000|Overall Study|Lost to Follow-up|2|||
105659817|NCT02353871|364418838|FG001|Overall Study|Lost to Follow-up|0|||
105659818|NCT05314374|364418839|FG000|Overall Study|Adverse Event|2|||
105659819|NCT05314374|364418840|FG001|Overall Study|Adverse Event|2|||
105441138|NCT03047031|363621255|FG001|Overall Study|Lost to Follow-up|0|||
105441139|NCT03047031|363621256|FG002|Overall Study|Lost to Follow-up|0|||
105441140|NCT03047031|363621254|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
105441141|NCT03047031|363621255|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
105441142|NCT03047031|363621256|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
105441143|NCT03047031|363621254|FG000|Overall Study|Adverse Event|1|||
105441144|NCT03047031|363621255|FG001|Overall Study|Adverse Event|0|||
105441145|NCT03047031|363621256|FG002|Overall Study|Adverse Event|0|||
105441146|NCT03047031|363621254|FG000|Overall Study|Withdrawal by Subject|2|||
105441147|NCT03047031|363621255|FG001|Overall Study|Withdrawal by Subject|0|||
105441148|NCT03047031|363621256|FG002|Overall Study|Withdrawal by Subject|0|||
105441149|NCT03047031|363621254|FG000|Overall Study|Change to other medication|2|||
105441150|NCT03047031|363621255|FG001|Overall Study|Change to other medication|0|||
105441151|NCT03047031|363621256|FG002|Overall Study|Change to other medication|0|||
105441152|NCT03047031|363621254|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
105441153|NCT03047031|363621255|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
105441154|NCT03047031|363621256|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
105441155|NCT00780416|363621258|FG000|Overall Study|Physician Decision|3|||
105441156|NCT00780416|363621259|FG001|Overall Study|Physician Decision|3|||
105441157|NCT00780416|363621258|FG000|Overall Study|Protocol Violation|1|||
105441158|NCT00780416|363621259|FG001|Overall Study|Protocol Violation|0|||
105441159|NCT00780416|363621258|FG000|Overall Study|Withdrawal by Subject|8|||
105441160|NCT00780416|363621259|FG001|Overall Study|Withdrawal by Subject|6|||
105441161|NCT01702025|363621266|FG000|Overall Study|Equipment failure|1|||
105441162|NCT01702025|363621267|FG001|Overall Study|Equipment failure|0|||
105441163|NCT01702025|363621268|FG002|Overall Study|Equipment failure|0|||
105441164|NCT01702025|363621269|FG003|Overall Study|Equipment failure|0|||
105441165|NCT01702025|363621266|FG000|Overall Study|Adverse Event|1|||
105441166|NCT01702025|363621267|FG001|Overall Study|Adverse Event|1|||
105441167|NCT01702025|363621268|FG002|Overall Study|Adverse Event|1|||
105441168|NCT01702025|363621269|FG003|Overall Study|Adverse Event|0|||
105441169|NCT00303485|363621275|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
105441170|NCT00303485|363621276|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
105441171|NCT00303485|363621275|FG000|Overall Study|Failure to return|0|||
105441172|NCT00303485|363621276|FG001|Overall Study|Failure to return|1|||
105441173|NCT00303485|363621275|FG000|Overall Study|Withdrawal by Subject|1|||
105441174|NCT00303485|363621276|FG001|Overall Study|Withdrawal by Subject|0|||
105441175|NCT01128244|363621282|FG000|Overall Study|Adverse Event|1|||
105441176|NCT01128244|363621282|FG000|Overall Study|Scheduling conflict|2|||
105441177|NCT04171219|363621283|FG000|Overall Study|Adverse Event|1|||
105441178|NCT04171219|363621284|FG001|Overall Study|Adverse Event|0|||
105441179|NCT04171219|363621283|FG000|Overall Study|Death|0|||
105441180|NCT04171219|363621284|FG001|Overall Study|Death|1|||
105441181|NCT04171219|363621283|FG000|Overall Study|Lack of Efficacy|9|||
105441182|NCT04171219|363621284|FG001|Overall Study|Lack of Efficacy|13|||
105441183|NCT04171219|363621283|FG000|Overall Study|Withdrawal by Subject|1|||
105441184|NCT04171219|363621284|FG001|Overall Study|Withdrawal by Subject|2|||
105441185|NCT04171219|363621283|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
105441186|NCT04171219|363621284|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
105441187|NCT04171219|363621283|FG000|Overall Study|Clinical PD/Patient choice|1|||
105659820|NCT00115336|364418843|FG000|Overall Study|Hospital discharge before study drug|0|||
105659821|NCT00115336|364418844|FG001|Overall Study|Hospital discharge before study drug|1|||
105659822|NCT02658175|364418845|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
105659823|NCT02658175|364418846|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
105659824|NCT02658175|364418847|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
105659825|NCT02658175|364418845|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
105659826|NCT02658175|364418846|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
105659827|NCT02658175|364418847|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
105659828|NCT02658175|364418845|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
105659829|NCT02658175|364418846|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
105659830|NCT02658175|364418847|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
105659831|NCT02658175|364418845|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
105659832|NCT02658175|364418846|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
105806437|NCT01464827|364948990|FG009|Overall Study|Lost to Follow-up|0|||
105441188|NCT04171219|363621284|FG001|Overall Study|Clinical PD/Patient choice|0|||
105441189|NCT04171219|363621283|FG000|Overall Study|Toxicity/ Patient choice|1|||
105441190|NCT04171219|363621284|FG001|Overall Study|Toxicity/ Patient choice|0|||
105441191|NCT03350815|363621287|FG000|Period 1|Adverse Event|10|||
105441192|NCT03350815|363621288|FG001|Period 1|Adverse Event|0|||
105441193|NCT03350815|363621289|FG002|Period 1|Adverse Event|0|||
105441194|NCT03350815|363621290|FG003|Period 1|Adverse Event|0|||
105441195|NCT03350815|363621287|FG000|Period 1|Technical problems|1|||
105441196|NCT03350815|363621288|FG001|Period 1|Technical problems|0|||
105659833|NCT02658175|364418847|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
105659834|NCT02658175|364418845|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
105659835|NCT02658175|364418846|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
105659836|NCT02658175|364418847|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
105659837|NCT02658175|364418845|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
105659838|NCT02658175|364418846|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
105659839|NCT02658175|364418847|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
105659840|NCT02658175|364418845|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
105659841|NCT02658175|364418846|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
105659842|NCT02658175|364418847|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
105659843|NCT02658175|364418845|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
105659844|NCT02658175|364418846|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
105659845|NCT02658175|364418847|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
105659846|NCT02658175|364418845|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
105659847|NCT02658175|364418846|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
105659848|NCT02658175|364418847|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
105659849|NCT02658175|364418845|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
105659850|NCT02658175|364418846|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
105659851|NCT02658175|364418847|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
105659852|NCT01801982|364418849|FG000|Overall Study|Lost to Follow-up|1|||
105659853|NCT03561597|364418850|FG000|Overall Study|Lost to Follow-up|20|||
105659854|NCT00699842|364418854|FG000|Overall Study|Death|0|||
105659855|NCT00699842|364418855|FG001|Overall Study|Death|1|||
105659856|NCT00699842|364418856|FG002|Overall Study|Death|0|||
105659857|NCT04594733|364418857|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
105659858|NCT04594733|364418858|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
105659859|NCT04594733|364418857|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
105659860|NCT04594733|364418858|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
105659861|NCT04594733|364418857|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
105659862|NCT04594733|364418858|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
105659863|NCT00815919|364418859|FG000|Overall Study|Unrelated Fungal Infection|1|||
105659864|NCT00815919|364418859|FG000|Overall Study|AML Relapse|1|||
105659865|NCT00815919|364418859|FG000|Overall Study|Lack of Efficacy|2|||
105659866|NCT04750577|364418860|FG000|Overall Study|Adverse Event|2|||
105659867|NCT04750577|364418861|FG001|Overall Study|Adverse Event|10|||
105659868|NCT04750577|364418862|FG002|Overall Study|Adverse Event|8|||
105659869|NCT04750577|364418863|FG003|Overall Study|Adverse Event|1|||
105659870|NCT04750577|364418860|FG000|Overall Study|Change of residence|0|||
105659871|NCT04750577|364418861|FG001|Overall Study|Change of residence|0|||
105659872|NCT04750577|364418862|FG002|Overall Study|Change of residence|1|||
105659873|NCT04750577|364418863|FG003|Overall Study|Change of residence|0|||
105659874|NCT04750577|364418860|FG000|Overall Study|Burden of study procedures|0|||
105659875|NCT04750577|364418861|FG001|Overall Study|Burden of study procedures|2|||
105659876|NCT04750577|364418862|FG002|Overall Study|Burden of study procedures|2|||
105659877|NCT04750577|364418863|FG003|Overall Study|Burden of study procedures|0|||
105659878|NCT04750577|364418860|FG000|Overall Study|Prematurely discontinued|0|||
105659879|NCT04750577|364418861|FG001|Overall Study|Prematurely discontinued|0|||
105659880|NCT04750577|364418862|FG002|Overall Study|Prematurely discontinued|0|||
105659881|NCT04750577|364418863|FG003|Overall Study|Prematurely discontinued|2|||
105659882|NCT04750577|364418860|FG000|Overall Study|Protocol deviation|1|||
105659883|NCT04750577|364418861|FG001|Overall Study|Protocol deviation|1|||
105659884|NCT04750577|364418862|FG002|Overall Study|Protocol deviation|1|||
105659885|NCT04750577|364418863|FG003|Overall Study|Protocol deviation|1|||
105659886|NCT04750577|364418860|FG000|Overall Study|Other than listed|3|||
105659887|NCT04750577|364418861|FG001|Overall Study|Other than listed|2|||
105659888|NCT04750577|364418862|FG002|Overall Study|Other than listed|2|||
105659889|NCT04750577|364418863|FG003|Overall Study|Other than listed|1|||
105659890|NCT04750577|364418860|FG000|Overall Study|Not treated|0|||
105659891|NCT04750577|364418861|FG001|Overall Study|Not treated|0|||
105659892|NCT04750577|364418862|FG002|Overall Study|Not treated|0|||
105659893|NCT04750577|364418863|FG003|Overall Study|Not treated|2|||
105659894|NCT03170518|364418864|FG000|Overall Study|Lost to Follow-up|4|||
105659895|NCT03170518|364418865|FG001|Overall Study|Lost to Follow-up|1|||
105659896|NCT03170518|364418866|FG002|Overall Study|Lost to Follow-up|0|||
105659897|NCT03170518|364418864|FG000|Overall Study|Physician Decision|1|||
105659898|NCT03170518|364418865|FG001|Overall Study|Physician Decision|0|||
105659899|NCT03170518|364418866|FG002|Overall Study|Physician Decision|0|||
105659900|NCT03170518|364418864|FG000|Overall Study|Withdrawal by Subject|4|||
105659901|NCT03170518|364418865|FG001|Overall Study|Withdrawal by Subject|5|||
105659902|NCT03170518|364418866|FG002|Overall Study|Withdrawal by Subject|2|||
105659903|NCT03170518|364418864|FG000|Overall Study|Site terminated by sponsor|0|||
105659904|NCT03170518|364418865|FG001|Overall Study|Site terminated by sponsor|1|||
105770547|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105659905|NCT03170518|364418866|FG002|Overall Study|Site terminated by sponsor|0|||
105659906|NCT03170518|364418864|FG000|Overall Study|Non-compliance with study drug|1|||
105659907|NCT03170518|364418865|FG001|Overall Study|Non-compliance with study drug|0|||
105441197|NCT03350815|363621289|FG002|Period 1|Technical problems|0|||
105441198|NCT03350815|363621290|FG003|Period 1|Technical problems|0|||
105441199|NCT03350815|363621287|FG000|Period 1|Lost to Follow-up|3|||
105441200|NCT03350815|363621288|FG001|Period 1|Lost to Follow-up|0|||
105659908|NCT03170518|364418866|FG002|Overall Study|Non-compliance with study drug|1|||
105659909|NCT03170518|364418864|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105659910|NCT03170518|364418865|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105659911|NCT03170518|364418866|FG002|Overall Study|Withdrawal by parent/guardian|0|||
105441201|NCT03350815|363621289|FG002|Period 1|Lost to Follow-up|0|||
105441202|NCT03350815|363621290|FG003|Period 1|Lost to Follow-up|0|||
105441203|NCT03350815|363621287|FG000|Period 1|Physician Decision|1|||
105441204|NCT03350815|363621288|FG001|Period 1|Physician Decision|0|||
105441205|NCT03350815|363621289|FG002|Period 1|Physician Decision|0|||
105441206|NCT03350815|363621290|FG003|Period 1|Physician Decision|0|||
105441207|NCT03350815|363621287|FG000|Period 1|Withdrawal by Subject|8|||
105441208|NCT03350815|363621288|FG001|Period 1|Withdrawal by Subject|0|||
105441209|NCT03350815|363621289|FG002|Period 1|Withdrawal by Subject|0|||
105441210|NCT03350815|363621290|FG003|Period 1|Withdrawal by Subject|0|||
105441211|NCT03350815|363621287|FG000|Period 1|Lack of Efficacy|15|||
105441212|NCT03350815|363621288|FG001|Period 1|Lack of Efficacy|0|||
105441213|NCT03350815|363621289|FG002|Period 1|Lack of Efficacy|0|||
105441214|NCT03350815|363621290|FG003|Period 1|Lack of Efficacy|0|||
105441215|NCT03350815|363621287|FG000|Period 1|Non-compliance with study treatment|2|||
105441216|NCT03350815|363621288|FG001|Period 1|Non-compliance with study treatment|0|||
105441217|NCT03350815|363621289|FG002|Period 1|Non-compliance with study treatment|0|||
105441218|NCT03350815|363621290|FG003|Period 1|Non-compliance with study treatment|0|||
105441219|NCT03350815|363621287|FG000|Period 1|Protocol Violation|3|||
105441220|NCT03350815|363621288|FG001|Period 1|Protocol Violation|0|||
105441221|NCT03350815|363621289|FG002|Period 1|Protocol Violation|0|||
105441222|NCT03350815|363621290|FG003|Period 1|Protocol Violation|0|||
105441223|NCT03350815|363621287|FG000|Period 2|Adverse Event|0|||
105441224|NCT03350815|363621288|FG001|Period 2|Adverse Event|3|||
105659912|NCT02257918|364418867|FG000|Overall Study|Lost to Follow-up|4|||
105659913|NCT02257918|364418868|FG001|Overall Study|Lost to Follow-up|1|||
105659914|NCT02257918|364418869|FG002|Overall Study|Lost to Follow-up|0|||
105659915|NCT02257918|364418867|FG000|Overall Study|Withdrawal by Subject|0|||
105659916|NCT02257918|364418868|FG001|Overall Study|Withdrawal by Subject|0|||
105659917|NCT02257918|364418869|FG002|Overall Study|Withdrawal by Subject|1|||
105659918|NCT02257918|364418867|FG000|Overall Study|Pregnancy|0|||
105659919|NCT02257918|364418868|FG001|Overall Study|Pregnancy|0|||
105334042|NCT01314872|363223081|FG011|Treatment Period 1|Protocol Violation|0|||
105334043|NCT01314872|363223082|FG012|Treatment Period 1|Protocol Violation|0|||
105334044|NCT01314872|363223083|FG013|Treatment Period 1|Protocol Violation|0|||
105334045|NCT01314872|363223084|FG014|Treatment Period 1|Protocol Violation|0|||
105334046|NCT01314872|363223070|FG000|Treatment Period 1|Physician Decision|0|||
105334047|NCT01314872|363223071|FG001|Treatment Period 1|Physician Decision|1|||
105334048|NCT01314872|363223072|FG002|Treatment Period 1|Physician Decision|0|||
105334049|NCT01314872|363223073|FG003|Treatment Period 1|Physician Decision|1|||
105334050|NCT01314872|363223074|FG004|Treatment Period 1|Physician Decision|0|||
105334051|NCT01314872|363223075|FG005|Treatment Period 1|Physician Decision|0|||
105334052|NCT01314872|363223076|FG006|Treatment Period 1|Physician Decision|0|||
105334053|NCT01314872|363223077|FG007|Treatment Period 1|Physician Decision|0|||
105334054|NCT01314872|363223078|FG008|Treatment Period 1|Physician Decision|0|||
105334055|NCT01314872|363223079|FG009|Treatment Period 1|Physician Decision|1|||
105334056|NCT01314872|363223080|FG010|Treatment Period 1|Physician Decision|0|||
105334057|NCT01314872|363223081|FG011|Treatment Period 1|Physician Decision|0|||
105334058|NCT01314872|363223082|FG012|Treatment Period 1|Physician Decision|0|||
105334059|NCT01314872|363223083|FG013|Treatment Period 1|Physician Decision|0|||
105334060|NCT01314872|363223084|FG014|Treatment Period 1|Physician Decision|0|||
105334061|NCT01314872|363223070|FG000|Treatment Period 1|Lack of Efficacy|1|||
105334062|NCT01314872|363223071|FG001|Treatment Period 1|Lack of Efficacy|0|||
105334063|NCT01314872|363223072|FG002|Treatment Period 1|Lack of Efficacy|0|||
105334064|NCT01314872|363223073|FG003|Treatment Period 1|Lack of Efficacy|0|||
105334065|NCT01314872|363223074|FG004|Treatment Period 1|Lack of Efficacy|0|||
105334066|NCT01314872|363223075|FG005|Treatment Period 1|Lack of Efficacy|1|||
105441225|NCT03350815|363621289|FG002|Period 2|Adverse Event|5|||
105441226|NCT03350815|363621290|FG003|Period 2|Adverse Event|0|||
105441227|NCT03350815|363621287|FG000|Period 2|Technical problem|0|||
105441228|NCT03350815|363621288|FG001|Period 2|Technical problem|1|||
105441229|NCT03350815|363621289|FG002|Period 2|Technical problem|0|||
105441230|NCT03350815|363621290|FG003|Period 2|Technical problem|0|||
105441231|NCT03350815|363621287|FG000|Period 2|Lost to Follow-up|0|||
105441232|NCT03350815|363621288|FG001|Period 2|Lost to Follow-up|3|||
105441233|NCT03350815|363621289|FG002|Period 2|Lost to Follow-up|3|||
105441234|NCT03350815|363621290|FG003|Period 2|Lost to Follow-up|0|||
105659920|NCT02257918|364418869|FG002|Overall Study|Pregnancy|1|||
105659921|NCT04969276|364418876|FG000|Overall Study|Protocol Deviation|0|||
105659922|NCT04969276|364418877|FG001|Overall Study|Protocol Deviation|1|||
105659923|NCT04969276|364418878|FG002|Overall Study|Protocol Deviation|0|||
105659924|NCT04969276|364418876|FG000|Overall Study|Withdrawal by Subject|1|||
105659925|NCT04969276|364418877|FG001|Overall Study|Withdrawal by Subject|10|||
105659926|NCT04969276|364418878|FG002|Overall Study|Withdrawal by Subject|0|||
105659927|NCT04969276|364418876|FG000|Overall Study|Lost to Follow-up|0|||
105441235|NCT03350815|363621287|FG000|Period 2|Physician Decision|0|||
105441236|NCT03350815|363621288|FG001|Period 2|Physician Decision|0|||
105441237|NCT03350815|363621289|FG002|Period 2|Physician Decision|1|||
105441238|NCT03350815|363621290|FG003|Period 2|Physician Decision|0|||
105441239|NCT03350815|363621287|FG000|Period 2|Withdrawal by Subject|0|||
105441240|NCT03350815|363621288|FG001|Period 2|Withdrawal by Subject|3|||
105441241|NCT03350815|363621289|FG002|Period 2|Withdrawal by Subject|4|||
105441242|NCT03350815|363621290|FG003|Period 2|Withdrawal by Subject|0|||
105441243|NCT03350815|363621287|FG000|Period 2|Lack of Efficacy|0|||
105441244|NCT03350815|363621288|FG001|Period 2|Lack of Efficacy|6|||
105441245|NCT03350815|363621289|FG002|Period 2|Lack of Efficacy|2|||
105441246|NCT03350815|363621290|FG003|Period 2|Lack of Efficacy|0|||
105441247|NCT03350815|363621287|FG000|Period 2|Protocol Violation|0|||
105441248|NCT03350815|363621288|FG001|Period 2|Protocol Violation|0|||
105441249|NCT03350815|363621289|FG002|Period 2|Protocol Violation|1|||
105441250|NCT03350815|363621290|FG003|Period 2|Protocol Violation|0|||
105441251|NCT03350815|363621287|FG000|Period 2|New therapy for study indication|0|||
105441252|NCT03350815|363621288|FG001|Period 2|New therapy for study indication|0|||
105441253|NCT03350815|363621289|FG002|Period 2|New therapy for study indication|1|||
105441254|NCT03350815|363621290|FG003|Period 2|New therapy for study indication|0|||
105441255|NCT01964963|363621291|FG000|Overall Study|Case Report Forms Uncollected|888|||
105441256|NCT01964963|363621291|FG000|Overall Study|Protocol Deviation|50|||
105441257|NCT01964963|363621291|FG000|Overall Study|Data Reliability was not Assured|5|||
105441258|NCT00711971|363621296|FG000|Overall Study|Lost to Follow-up|3|||
105441259|NCT00711971|363621297|FG001|Overall Study|Lost to Follow-up|4|||
105441260|NCT00711971|363621298|FG002|Overall Study|Lost to Follow-up|1|||
105441261|NCT04774926|363621303|FG000|Overall Study|Adverse Event|15|||
105441262|NCT04774926|363621303|FG000|Overall Study|Lost to Follow-up|3|||
105441263|NCT04774926|363621303|FG000|Overall Study|Physician Decision|6|||
105441264|NCT04774926|363621303|FG000|Overall Study|Withdrawal by Subject|3|||
105441265|NCT04774926|363621303|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
105441266|NCT00856544|363621306|FG000|Overall Study|Randomized but not treated|3|||
105441267|NCT00856544|363621307|FG001|Overall Study|Randomized but not treated|0|||
105441268|NCT00856544|363621308|FG002|Overall Study|Randomized but not treated|0|||
105441269|NCT00856544|363621309|FG003|Overall Study|Randomized but not treated|0|||
105441270|NCT00856544|363621306|FG000|Overall Study|Death|0|||
105441271|NCT00856544|363621307|FG001|Overall Study|Death|2|||
105441272|NCT00856544|363621308|FG002|Overall Study|Death|0|||
105441273|NCT00856544|363621309|FG003|Overall Study|Death|0|||
105441274|NCT00856544|363621306|FG000|Overall Study|Adverse Event|20|||
105441275|NCT00856544|363621307|FG001|Overall Study|Adverse Event|29|||
105441276|NCT00856544|363621308|FG002|Overall Study|Adverse Event|2|||
105441277|NCT00856544|363621309|FG003|Overall Study|Adverse Event|3|||
105441278|NCT00856544|363621306|FG000|Overall Study|Lack of Efficacy|16|||
105441279|NCT00856544|363621307|FG001|Overall Study|Lack of Efficacy|12|||
105441280|NCT00856544|363621308|FG002|Overall Study|Lack of Efficacy|3|||
105441281|NCT00856544|363621309|FG003|Overall Study|Lack of Efficacy|3|||
105441282|NCT00856544|363621306|FG000|Overall Study|Other|9|||
105441283|NCT00856544|363621307|FG001|Overall Study|Other|16|||
105441284|NCT00856544|363621308|FG002|Overall Study|Other|1|||
105441285|NCT00856544|363621309|FG003|Overall Study|Other|6|||
105441286|NCT00856544|363621306|FG000|Overall Study|Lost to Follow-up|1|||
105441287|NCT00856544|363621307|FG001|Overall Study|Lost to Follow-up|2|||
105441288|NCT00856544|363621308|FG002|Overall Study|Lost to Follow-up|2|||
105441289|NCT00856544|363621309|FG003|Overall Study|Lost to Follow-up|0|||
105441290|NCT00856544|363621306|FG000|Overall Study|Withdrawal by Subject|8|||
105441291|NCT00856544|363621307|FG001|Overall Study|Withdrawal by Subject|5|||
105441292|NCT00856544|363621308|FG002|Overall Study|Withdrawal by Subject|0|||
105441293|NCT00856544|363621309|FG003|Overall Study|Withdrawal by Subject|1|||
105441294|NCT05274269|363621310|FG000|Overall Study|Adverse Event|0|||
105441295|NCT05274269|363621311|FG001|Overall Study|Adverse Event|3|||
105441296|NCT05274269|363621310|FG000|Overall Study|Death|0|||
105659928|NCT04969276|364418877|FG001|Overall Study|Lost to Follow-up|1|||
105659929|NCT04969276|364418878|FG002|Overall Study|Lost to Follow-up|0|||
105441297|NCT05274269|363621311|FG001|Overall Study|Death|1|||
105770548|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105441298|NCT05274269|363621310|FG000|Overall Study|Other|0|||
105659930|NCT00356811|364418880|FG000|Overall Study|Death|35|||
105659931|NCT00356811|364418880|FG000|Overall Study|Lost to Follow-up|2|||
105441299|NCT05274269|363621311|FG001|Overall Study|Other|2|||
105441300|NCT05274269|363621310|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
105441301|NCT05274269|363621311|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
105441302|NCT04303572|363621314|FG000|Overall Study|Study closed due to poor enrollment|1|||
105441303|NCT06312592|363621315|FG000|Overall Study|Lost to Follow-up|29|||
105441304|NCT06312592|363621316|FG001|Overall Study|Lost to Follow-up|13|||
105441305|NCT01369641|363621319|FG000|Overall Study|Withdrawal by Subject|1|||
105441306|NCT00842543|363621320|FG000|Overall Study|Withdrawal by Subject|2|||
105441307|NCT00842543|363621321|FG001|Overall Study|Withdrawal by Subject|0|||
105441308|NCT00842543|363621322|FG002|Overall Study|Withdrawal by Subject|3|||
105441309|NCT00842543|363621323|FG003|Overall Study|Withdrawal by Subject|4|||
105441310|NCT01858766|363621324|FG000|Overall Study|Randomized but Never Treated|0|||
105441311|NCT01858766|363621325|FG001|Overall Study|Randomized but Never Treated|0|||
105441312|NCT01858766|363621326|FG002|Overall Study|Randomized but Never Treated|0|||
105441313|NCT01858766|363621327|FG003|Overall Study|Randomized but Never Treated|0|||
105441314|NCT01858766|363621328|FG004|Overall Study|Randomized but Never Treated|0|||
105441315|NCT01858766|363621329|FG005|Overall Study|Randomized but Never Treated|1|||
105441316|NCT01858766|363621330|FG006|Overall Study|Randomized but Never Treated|0|||
105441317|NCT01858766|363621331|FG007|Overall Study|Randomized but Never Treated|0|||
105441318|NCT01858766|363621332|FG008|Overall Study|Randomized but Never Treated|0|||
105441319|NCT01858766|363621333|FG009|Overall Study|Randomized but Never Treated|0|||
105441320|NCT01858766|363621334|FG010|Overall Study|Randomized but Never Treated|0|||
105441321|NCT01858766|363621335|FG011|Overall Study|Randomized but Never Treated|0|||
105441322|NCT01858766|363621336|FG012|Overall Study|Randomized but Never Treated|0|||
105441323|NCT01858766|363621337|FG013|Overall Study|Randomized but Never Treated|0|||
105441324|NCT01858766|363621338|FG014|Overall Study|Randomized but Never Treated|0|||
105441325|NCT01858766|363621339|FG015|Overall Study|Randomized but Never Treated|0|||
105441326|NCT01858766|363621340|FG016|Overall Study|Randomized but Never Treated|0|||
105441327|NCT01858766|363621341|FG017|Overall Study|Randomized but Never Treated|1|||
105441328|NCT01858766|363621342|FG018|Overall Study|Randomized but Never Treated|0|||
105441329|NCT01858766|363621324|FG000|Overall Study|Death|0|||
105441330|NCT01858766|363621325|FG001|Overall Study|Death|0|||
105441331|NCT01858766|363621326|FG002|Overall Study|Death|1|||
105441332|NCT01858766|363621327|FG003|Overall Study|Death|0|||
105441333|NCT01858766|363621328|FG004|Overall Study|Death|0|||
105441334|NCT01858766|363621329|FG005|Overall Study|Death|0|||
105441335|NCT01858766|363621330|FG006|Overall Study|Death|0|||
105441336|NCT01858766|363621331|FG007|Overall Study|Death|0|||
105441337|NCT01858766|363621332|FG008|Overall Study|Death|0|||
105441338|NCT01858766|363621333|FG009|Overall Study|Death|0|||
105441339|NCT01858766|363621334|FG010|Overall Study|Death|0|||
105441340|NCT01858766|363621335|FG011|Overall Study|Death|0|||
105441341|NCT01858766|363621336|FG012|Overall Study|Death|0|||
105441342|NCT01858766|363621337|FG013|Overall Study|Death|0|||
105441343|NCT01858766|363621338|FG014|Overall Study|Death|0|||
105441344|NCT01858766|363621339|FG015|Overall Study|Death|0|||
105441345|NCT01858766|363621340|FG016|Overall Study|Death|0|||
105441346|NCT01858766|363621341|FG017|Overall Study|Death|0|||
105441347|NCT01858766|363621342|FG018|Overall Study|Death|0|||
105441348|NCT01858766|363621324|FG000|Overall Study|Lack of Efficacy|1|||
105441349|NCT01858766|363621325|FG001|Overall Study|Lack of Efficacy|0|||
105441350|NCT01858766|363621326|FG002|Overall Study|Lack of Efficacy|0|||
105441351|NCT01858766|363621327|FG003|Overall Study|Lack of Efficacy|0|||
105441352|NCT01858766|363621328|FG004|Overall Study|Lack of Efficacy|1|||
105441353|NCT01858766|363621329|FG005|Overall Study|Lack of Efficacy|2|||
105441354|NCT01858766|363621330|FG006|Overall Study|Lack of Efficacy|0|||
105441355|NCT01858766|363621331|FG007|Overall Study|Lack of Efficacy|0|||
105441356|NCT01858766|363621332|FG008|Overall Study|Lack of Efficacy|0|||
105441357|NCT01858766|363621333|FG009|Overall Study|Lack of Efficacy|0|||
105441358|NCT01858766|363621334|FG010|Overall Study|Lack of Efficacy|0|||
105441359|NCT01858766|363621335|FG011|Overall Study|Lack of Efficacy|3|||
105441360|NCT01858766|363621336|FG012|Overall Study|Lack of Efficacy|5|||
105441361|NCT01858766|363621337|FG013|Overall Study|Lack of Efficacy|3|||
105441362|NCT01858766|363621338|FG014|Overall Study|Lack of Efficacy|5|||
105441363|NCT01858766|363621339|FG015|Overall Study|Lack of Efficacy|5|||
105441364|NCT01858766|363621340|FG016|Overall Study|Lack of Efficacy|2|||
105441365|NCT01858766|363621341|FG017|Overall Study|Lack of Efficacy|3|||
105441366|NCT01858766|363621342|FG018|Overall Study|Lack of Efficacy|3|||
105441367|NCT01858766|363621324|FG000|Overall Study|Lost to Follow-up|0|||
105441368|NCT01858766|363621325|FG001|Overall Study|Lost to Follow-up|0|||
105441369|NCT01858766|363621326|FG002|Overall Study|Lost to Follow-up|0|||
105441370|NCT01858766|363621327|FG003|Overall Study|Lost to Follow-up|0|||
105441371|NCT01858766|363621328|FG004|Overall Study|Lost to Follow-up|0|||
105441372|NCT01858766|363621329|FG005|Overall Study|Lost to Follow-up|1|||
105441373|NCT01858766|363621330|FG006|Overall Study|Lost to Follow-up|0|||
105441374|NCT01858766|363621331|FG007|Overall Study|Lost to Follow-up|2|||
105441375|NCT01858766|363621332|FG008|Overall Study|Lost to Follow-up|0|||
105441376|NCT01858766|363621333|FG009|Overall Study|Lost to Follow-up|0|||
105441377|NCT01858766|363621334|FG010|Overall Study|Lost to Follow-up|0|||
105441378|NCT01858766|363621335|FG011|Overall Study|Lost to Follow-up|1|||
105441379|NCT01858766|363621336|FG012|Overall Study|Lost to Follow-up|0|||
105441380|NCT01858766|363621337|FG013|Overall Study|Lost to Follow-up|0|||
105441381|NCT01858766|363621338|FG014|Overall Study|Lost to Follow-up|3|||
105441382|NCT01858766|363621339|FG015|Overall Study|Lost to Follow-up|1|||
105441383|NCT01858766|363621340|FG016|Overall Study|Lost to Follow-up|1|||
105441384|NCT01858766|363621341|FG017|Overall Study|Lost to Follow-up|0|||
105441385|NCT01858766|363621342|FG018|Overall Study|Lost to Follow-up|1|||
105441386|NCT01858766|363621324|FG000|Overall Study|Withdrew Consent|0|||
105441387|NCT01858766|363621325|FG001|Overall Study|Withdrew Consent|0|||
105441388|NCT01858766|363621326|FG002|Overall Study|Withdrew Consent|0|||
105441389|NCT01858766|363621327|FG003|Overall Study|Withdrew Consent|0|||
105441390|NCT01858766|363621328|FG004|Overall Study|Withdrew Consent|0|||
105441391|NCT01858766|363621329|FG005|Overall Study|Withdrew Consent|0|||
105441392|NCT01858766|363621330|FG006|Overall Study|Withdrew Consent|0|||
105441393|NCT01858766|363621331|FG007|Overall Study|Withdrew Consent|0|||
105441394|NCT01858766|363621332|FG008|Overall Study|Withdrew Consent|0|||
105441395|NCT01858766|363621333|FG009|Overall Study|Withdrew Consent|0|||
105441396|NCT01858766|363621334|FG010|Overall Study|Withdrew Consent|0|||
105441397|NCT01858766|363621335|FG011|Overall Study|Withdrew Consent|1|||
105441398|NCT01858766|363621336|FG012|Overall Study|Withdrew Consent|0|||
105441399|NCT01858766|363621337|FG013|Overall Study|Withdrew Consent|0|||
105441400|NCT01858766|363621338|FG014|Overall Study|Withdrew Consent|0|||
105441401|NCT01858766|363621339|FG015|Overall Study|Withdrew Consent|0|||
105441402|NCT01858766|363621340|FG016|Overall Study|Withdrew Consent|0|||
105441403|NCT01858766|363621341|FG017|Overall Study|Withdrew Consent|0|||
105441404|NCT01858766|363621342|FG018|Overall Study|Withdrew Consent|0|||
105441405|NCT01483183|363621351|FG000|Overall Study|Physician Decision|0|||
105441406|NCT01483183|363621352|FG001|Overall Study|Physician Decision|0|||
105441407|NCT01483183|363621353|FG002|Overall Study|Physician Decision|0|||
105441408|NCT01483183|363621354|FG003|Overall Study|Physician Decision|0|||
105441409|NCT01483183|363621355|FG004|Overall Study|Physician Decision|0|||
105441410|NCT01483183|363621356|FG005|Overall Study|Physician Decision|0|||
105441411|NCT01483183|363621357|FG006|Overall Study|Physician Decision|2|||
105441412|NCT01483183|363621358|FG007|Overall Study|Physician Decision|0|||
105441413|NCT01483183|363621359|FG008|Overall Study|Physician Decision|0|||
105441414|NCT01483183|363621360|FG009|Overall Study|Physician Decision|0|||
105441415|NCT01483183|363621351|FG000|Overall Study|Withdrawal by Subject|0|||
105441416|NCT01483183|363621352|FG001|Overall Study|Withdrawal by Subject|0|||
105441417|NCT01483183|363621353|FG002|Overall Study|Withdrawal by Subject|0|||
105441418|NCT01483183|363621354|FG003|Overall Study|Withdrawal by Subject|0|||
105441419|NCT01483183|363621355|FG004|Overall Study|Withdrawal by Subject|0|||
105441420|NCT01483183|363621356|FG005|Overall Study|Withdrawal by Subject|0|||
105441421|NCT01483183|363621357|FG006|Overall Study|Withdrawal by Subject|0|||
105441422|NCT01483183|363621358|FG007|Overall Study|Withdrawal by Subject|0|||
105441423|NCT01483183|363621359|FG008|Overall Study|Withdrawal by Subject|0|||
105441424|NCT01483183|363621360|FG009|Overall Study|Withdrawal by Subject|1|||
105441425|NCT03781414|363621361|FG000|Overall Study|Study terminated by sponsor|39|||
105441426|NCT03781414|363621362|FG001|Overall Study|Study terminated by sponsor|34|||
105441427|NCT03781414|363621363|FG002|Overall Study|Study terminated by sponsor|25|||
105441428|NCT03781414|363621361|FG000|Overall Study|Adverse Event|3|||
105441429|NCT03781414|363621362|FG001|Overall Study|Adverse Event|6|||
105441430|NCT03781414|363621363|FG002|Overall Study|Adverse Event|3|||
105441431|NCT03781414|363621361|FG000|Overall Study|Physician Decision|2|||
105441432|NCT03781414|363621362|FG001|Overall Study|Physician Decision|0|||
105441433|NCT03781414|363621363|FG002|Overall Study|Physician Decision|1|||
105441434|NCT03781414|363621361|FG000|Overall Study|Withdrawal by Subject|2|||
105441435|NCT03781414|363621362|FG001|Overall Study|Withdrawal by Subject|3|||
105441436|NCT03781414|363621363|FG002|Overall Study|Withdrawal by Subject|3|||
105441437|NCT03781414|363621361|FG000|Overall Study|Death|1|||
105441438|NCT03781414|363621362|FG001|Overall Study|Death|4|||
105441439|NCT03781414|363621363|FG002|Overall Study|Death|0|||
105441440|NCT03781414|363621361|FG000|Overall Study|Lost to Follow-up|1|||
105441441|NCT03781414|363621362|FG001|Overall Study|Lost to Follow-up|1|||
105441442|NCT03781414|363621363|FG002|Overall Study|Lost to Follow-up|0|||
105441443|NCT02881762|363621364|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
105441444|NCT02881762|363621365|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
105441445|NCT02524158|363621366|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
105441446|NCT02524158|363621367|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
105441447|NCT02524158|363621366|FG000|12-weeks Assessment|Lost to Follow-up|18|||
105441448|NCT02524158|363621367|FG001|12-weeks Assessment|Lost to Follow-up|12|||
105441449|NCT02524158|363621366|FG000|6-month Assessment|Withdrawal by Subject|1|||
105441450|NCT02524158|363621367|FG001|6-month Assessment|Withdrawal by Subject|1|||
105441451|NCT02524158|363621366|FG000|6-month Assessment|Lost to Follow-up|21|||
105441452|NCT02524158|363621367|FG001|6-month Assessment|Lost to Follow-up|20|||
105441453|NCT00719355|363621372|FG000|Overall Study|Death|0|||
105441454|NCT00719355|363621373|FG001|Overall Study|Death|1|||
105441455|NCT00719355|363621372|FG000|Overall Study|Medical|14|||
105441456|NCT00719355|363621373|FG001|Overall Study|Medical|5|||
105441457|NCT00719355|363621372|FG000|Overall Study|Compliance|4|||
105441458|NCT00719355|363621373|FG001|Overall Study|Compliance|6|||
105441459|NCT00719355|363621372|FG000|Overall Study|Moved|0|||
105441460|NCT00719355|363621373|FG001|Overall Study|Moved|1|||
105441461|NCT03364738|363621374|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
105441462|NCT03364738|363621374|FG000|Overall Study|Withdrawal by Subject|1|||
105441463|NCT03364738|363621374|FG000|Overall Study|Adverse Event|1|||
105441464|NCT00774800|363621381|FG000|Intervention 4|Withdrawal by Subject|1|||
105441465|NCT01677858|363621386|FG000|Overall Study|Adverse Event|0|||
105441466|NCT01677858|363621387|FG001|Overall Study|Adverse Event|0|||
105441467|NCT01677858|363621388|FG002|Overall Study|Adverse Event|2|||
105441468|NCT01677858|363621389|FG003|Overall Study|Adverse Event|3|||
105441469|NCT01677858|363621390|FG004|Overall Study|Adverse Event|13|||
105441470|NCT01677858|363621386|FG000|Overall Study|Death|0|||
105441471|NCT01677858|363621387|FG001|Overall Study|Death|0|||
105441472|NCT01677858|363621388|FG002|Overall Study|Death|0|||
105441473|NCT01677858|363621389|FG003|Overall Study|Death|0|||
105441474|NCT01677858|363621390|FG004|Overall Study|Death|1|||
105441475|NCT01677858|363621386|FG000|Overall Study|Physician Decision|1|||
105441476|NCT01677858|363621387|FG001|Overall Study|Physician Decision|0|||
105441477|NCT01677858|363621388|FG002|Overall Study|Physician Decision|2|||
105441478|NCT01677858|363621389|FG003|Overall Study|Physician Decision|0|||
105441479|NCT01677858|363621390|FG004|Overall Study|Physician Decision|12|||
105441480|NCT01677858|363621386|FG000|Overall Study|Progressive Disease|2|||
105441481|NCT01677858|363621387|FG001|Overall Study|Progressive Disease|1|||
105441482|NCT01677858|363621388|FG002|Overall Study|Progressive Disease|9|||
105441483|NCT01677858|363621389|FG003|Overall Study|Progressive Disease|3|||
105441484|NCT01677858|363621390|FG004|Overall Study|Progressive Disease|43|||
105441485|NCT01677858|363621386|FG000|Overall Study|Withdrawal by Subject|0|||
105441486|NCT01677858|363621387|FG001|Overall Study|Withdrawal by Subject|1|||
105441487|NCT01677858|363621388|FG002|Overall Study|Withdrawal by Subject|1|||
105441488|NCT01677858|363621389|FG003|Overall Study|Withdrawal by Subject|0|||
105441489|NCT01677858|363621390|FG004|Overall Study|Withdrawal by Subject|15|||
105441490|NCT01677858|363621386|FG000|Overall Study|Lost to Follow-up|0|||
105441491|NCT01677858|363621387|FG001|Overall Study|Lost to Follow-up|0|||
105441492|NCT01677858|363621388|FG002|Overall Study|Lost to Follow-up|0|||
105441493|NCT01677858|363621389|FG003|Overall Study|Lost to Follow-up|0|||
105441494|NCT01677858|363621390|FG004|Overall Study|Lost to Follow-up|1|||
105441495|NCT01529034|363621393|FG000|Overall Study|Discontinued prior to study treatment|14|||
105441496|NCT01529034|363621393|FG000|Overall Study|Site closure|62|||
105441497|NCT01529034|363621393|FG000|Overall Study|Study termination|29|||
105441498|NCT01529034|363621393|FG000|Overall Study|Withdrawal by Subject|25|||
105441499|NCT01529034|363621393|FG000|Overall Study|No treated SCs within protocol window|13|||
105441500|NCT01529034|363621393|FG000|Overall Study|Noncompliance|8|||
105441501|NCT01529034|363621393|FG000|Overall Study|Caregiver no longer available|7|||
105441502|NCT01529034|363621393|FG000|Overall Study|Adverse Event|4|||
105441503|NCT01529034|363621393|FG000|Overall Study|Protocol Violation|4|||
105441504|NCT01529034|363621393|FG000|Overall Study|Lack of Efficacy|4|||
105441505|NCT01529034|363621393|FG000|Overall Study|Investigator no longer available|2|||
105441506|NCT01529034|363621393|FG000|Overall Study|Study drug not available|2|||
105441507|NCT03422536|363621396|FG000|Randomized|Physician Decision|1|||
105441508|NCT03422536|363621397|FG001|Randomized|Physician Decision|1|||
105441509|NCT03422536|363621396|FG000|Allocation - Received Intervention|Disease progression|19|||
105441510|NCT03422536|363621397|FG001|Allocation - Received Intervention|Disease progression|25|||
105441511|NCT03422536|363621396|FG000|Allocation - Received Intervention|Death|1|||
105441512|NCT03422536|363621397|FG001|Allocation - Received Intervention|Death|3|||
105441513|NCT03422536|363621396|FG000|Allocation - Received Intervention|Adverse Event|1|||
105441514|NCT03422536|363621397|FG001|Allocation - Received Intervention|Adverse Event|0|||
105441515|NCT03422536|363621396|FG000|Allocation - Received Intervention|Physician Decision|1|||
105441516|NCT03422536|363621397|FG001|Allocation - Received Intervention|Physician Decision|1|||
105441517|NCT03422536|363621396|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
105441518|NCT03422536|363621397|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
105441519|NCT03422536|363621396|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
105441520|NCT03422536|363621397|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
105441521|NCT00532298|363621398|FG000|Overall Study|Adverse Event|1|||
105441522|NCT00532298|363621399|FG001|Overall Study|Adverse Event|0|||
105441523|NCT00532298|363621400|FG002|Overall Study|Adverse Event|0|||
105441524|NCT00532298|363621401|FG003|Overall Study|Adverse Event|0|||
105441525|NCT00532298|363621402|FG004|Overall Study|Adverse Event|1|||
105441526|NCT00532298|363621403|FG005|Overall Study|Adverse Event|1|||
105441527|NCT00532298|363621398|FG000|Overall Study|Lost to Follow-up|1|||
105441528|NCT00532298|363621399|FG001|Overall Study|Lost to Follow-up|1|||
105441529|NCT00532298|363621400|FG002|Overall Study|Lost to Follow-up|1|||
105441530|NCT00532298|363621401|FG003|Overall Study|Lost to Follow-up|0|||
105441531|NCT00532298|363621402|FG004|Overall Study|Lost to Follow-up|0|||
105441532|NCT00532298|363621403|FG005|Overall Study|Lost to Follow-up|1|||
105441533|NCT00479856|363621404|FG000|Overall Study|Adverse Event|1|||
105441534|NCT00479856|363621404|FG000|Overall Study|Withdrawal by Subject|1|||
105441535|NCT00479856|363621404|FG000|Overall Study|Physician Decision|1|||
105441536|NCT04869358|363621407|FG000|Overall Study|Wish to have children.|1|||
105441537|NCT04869358|363621408|FG001|Overall Study|Wish to have children.|0|||
105441538|NCT04869358|363621409|FG002|Overall Study|Wish to have children.|0|||
105441539|NCT04869358|363621410|FG003|Overall Study|Wish to have children.|0|||
105441540|NCT00661622|363621411|FG000|Overall Study|Protocol Violation|1|||
105441541|NCT00661622|363621412|FG001|Overall Study|Protocol Violation|0|||
105441542|NCT01620762|363621417|FG000|Overall Study|Protocol Violation|1|||
105441543|NCT01620762|363621418|FG001|Overall Study|Protocol Violation|1|||
105441544|NCT01620762|363621419|FG002|Overall Study|Protocol Violation|1|||
105441545|NCT01620762|363621417|FG000|Overall Study|Adverse Event|9|||
105441546|NCT01620762|363621418|FG001|Overall Study|Adverse Event|5|||
105441547|NCT01620762|363621419|FG002|Overall Study|Adverse Event|2|||
105441548|NCT01620762|363621417|FG000|Overall Study|Withdrawal by Subject|23|||
105441549|NCT01620762|363621418|FG001|Overall Study|Withdrawal by Subject|26|||
105441550|NCT01620762|363621419|FG002|Overall Study|Withdrawal by Subject|27|||
105441551|NCT01620762|363621417|FG000|Overall Study|Lost to Follow-up|11|||
105441552|NCT01620762|363621418|FG001|Overall Study|Lost to Follow-up|17|||
105441553|NCT01620762|363621419|FG002|Overall Study|Lost to Follow-up|10|||
105441554|NCT01620762|363621417|FG000|Overall Study|Protocol deviation|1|||
105441555|NCT01620762|363621418|FG001|Overall Study|Protocol deviation|1|||
105441556|NCT01620762|363621419|FG002|Overall Study|Protocol deviation|6|||
105441557|NCT01620762|363621417|FG000|Overall Study|Subject deterioration|0|||
105441558|NCT01620762|363621418|FG001|Overall Study|Subject deterioration|1|||
105441559|NCT01620762|363621419|FG002|Overall Study|Subject deterioration|1|||
105441560|NCT01620762|363621417|FG000|Overall Study|Non-specified|3|||
105441561|NCT01620762|363621418|FG001|Overall Study|Non-specified|6|||
105441562|NCT01620762|363621419|FG002|Overall Study|Non-specified|5|||
105441563|NCT01620762|363621417|FG000|Overall Study|Use of prohibted therapies|0|||
105441564|NCT01620762|363621418|FG001|Overall Study|Use of prohibted therapies|1|||
105441565|NCT01620762|363621419|FG002|Overall Study|Use of prohibted therapies|1|||
105441566|NCT00705146|363621424|FG000|Overall Study|Lost to Follow-up|1|||
105441567|NCT00705146|363621425|FG001|Overall Study|Lost to Follow-up|1|||
105441568|NCT00835341|363621427|FG000|Overall Study|Lost to Follow-up|3|||
105441569|NCT00835341|363621428|FG001|Overall Study|Lost to Follow-up|12|||
105441570|NCT00106353|363621429|FG000|Part 1|Disease progression|3|||
105441571|NCT00106353|363621430|FG001|Part 1|Disease progression|4|||
105441572|NCT00106353|363621431|FG002|Part 1|Disease progression|1|||
105441573|NCT00106353|363621432|FG003|Part 1|Disease progression|3|||
105441574|NCT00106353|363621433|FG004|Part 1|Disease progression|0|||
105441575|NCT00106353|363621434|FG005|Part 1|Disease progression|0|||
105441576|NCT00106353|363621435|FG006|Part 1|Disease progression|0|||
105441577|NCT00106353|363621429|FG000|Part 1|Withdrawal by Subject|0|||
105441578|NCT00106353|363621430|FG001|Part 1|Withdrawal by Subject|0|||
105441579|NCT00106353|363621431|FG002|Part 1|Withdrawal by Subject|1|||
105441580|NCT00106353|363621432|FG003|Part 1|Withdrawal by Subject|2|||
105441581|NCT00106353|363621433|FG004|Part 1|Withdrawal by Subject|0|||
105441582|NCT00106353|363621434|FG005|Part 1|Withdrawal by Subject|0|||
105441583|NCT00106353|363621435|FG006|Part 1|Withdrawal by Subject|0|||
105441584|NCT00106353|363621429|FG000|Part 1|Symptomatic deterioration|0|||
105441585|NCT00106353|363621430|FG001|Part 1|Symptomatic deterioration|0|||
105441586|NCT00106353|363621431|FG002|Part 1|Symptomatic deterioration|1|||
105441587|NCT00106353|363621432|FG003|Part 1|Symptomatic deterioration|0|||
105441588|NCT00106353|363621433|FG004|Part 1|Symptomatic deterioration|0|||
105441589|NCT00106353|363621434|FG005|Part 1|Symptomatic deterioration|0|||
105441590|NCT00106353|363621435|FG006|Part 1|Symptomatic deterioration|0|||
105441591|NCT00106353|363621429|FG000|Part 1|Entered follow-up phase|1|||
105441592|NCT00106353|363621430|FG001|Part 1|Entered follow-up phase|1|||
105441593|NCT00106353|363621431|FG002|Part 1|Entered follow-up phase|0|||
105441594|NCT00106353|363621432|FG003|Part 1|Entered follow-up phase|1|||
105441595|NCT00106353|363621433|FG004|Part 1|Entered follow-up phase|0|||
105441596|NCT00106353|363621434|FG005|Part 1|Entered follow-up phase|0|||
105441597|NCT00106353|363621435|FG006|Part 1|Entered follow-up phase|0|||
105441598|NCT00106353|363621429|FG000|Part 1|Adverse Event|0|||
105441599|NCT00106353|363621430|FG001|Part 1|Adverse Event|0|||
105441600|NCT00106353|363621431|FG002|Part 1|Adverse Event|0|||
105441601|NCT00106353|363621432|FG003|Part 1|Adverse Event|1|||
105441602|NCT00106353|363621433|FG004|Part 1|Adverse Event|0|||
105441603|NCT00106353|363621434|FG005|Part 1|Adverse Event|0|||
105441604|NCT00106353|363621435|FG006|Part 1|Adverse Event|0|||
105441605|NCT00106353|363621429|FG000|Part 2|Disease progression|0|||
105441606|NCT00106353|363621430|FG001|Part 2|Disease progression|0|||
105441607|NCT00106353|363621431|FG002|Part 2|Disease progression|0|||
105441608|NCT00106353|363621432|FG003|Part 2|Disease progression|0|||
105441609|NCT00106353|363621433|FG004|Part 2|Disease progression|8|||
105441610|NCT00106353|363621434|FG005|Part 2|Disease progression|14|||
105441611|NCT00106353|363621435|FG006|Part 2|Disease progression|13|||
105441612|NCT00106353|363621429|FG000|Part 2|Death|0|||
105441613|NCT00106353|363621430|FG001|Part 2|Death|0|||
105441614|NCT00106353|363621431|FG002|Part 2|Death|0|||
105441615|NCT00106353|363621432|FG003|Part 2|Death|0|||
105441616|NCT00106353|363621433|FG004|Part 2|Death|3|||
105441617|NCT00106353|363621434|FG005|Part 2|Death|0|||
105441618|NCT00106353|363621435|FG006|Part 2|Death|1|||
105441619|NCT00106353|363621429|FG000|Part 2|Symptomatic deterioration|0|||
105441620|NCT00106353|363621430|FG001|Part 2|Symptomatic deterioration|0|||
105441621|NCT00106353|363621431|FG002|Part 2|Symptomatic deterioration|0|||
105441622|NCT00106353|363621432|FG003|Part 2|Symptomatic deterioration|0|||
105441623|NCT00106353|363621433|FG004|Part 2|Symptomatic deterioration|3|||
105441624|NCT00106353|363621434|FG005|Part 2|Symptomatic deterioration|0|||
105441625|NCT00106353|363621435|FG006|Part 2|Symptomatic deterioration|0|||
105441626|NCT00106353|363621429|FG000|Part 2|Adverse Event|0|||
105441627|NCT00106353|363621430|FG001|Part 2|Adverse Event|0|||
105441628|NCT00106353|363621431|FG002|Part 2|Adverse Event|0|||
105441629|NCT00106353|363621432|FG003|Part 2|Adverse Event|0|||
105441630|NCT00106353|363621433|FG004|Part 2|Adverse Event|0|||
105441631|NCT00106353|363621434|FG005|Part 2|Adverse Event|2|||
105441632|NCT00106353|363621435|FG006|Part 2|Adverse Event|1|||
105441633|NCT00106353|363621429|FG000|Part 2|Other|0|||
105441634|NCT00106353|363621430|FG001|Part 2|Other|0|||
105441635|NCT00106353|363621431|FG002|Part 2|Other|0|||
105441636|NCT00106353|363621432|FG003|Part 2|Other|0|||
105441637|NCT00106353|363621433|FG004|Part 2|Other|1|||
105441638|NCT00106353|363621434|FG005|Part 2|Other|1|||
105441639|NCT00106353|363621435|FG006|Part 2|Other|1|||
105441640|NCT00106353|363621429|FG000|Part 2|Withdrawal by Subject|0|||
105441641|NCT00106353|363621430|FG001|Part 2|Withdrawal by Subject|0|||
105441642|NCT00106353|363621431|FG002|Part 2|Withdrawal by Subject|0|||
105441643|NCT00106353|363621432|FG003|Part 2|Withdrawal by Subject|0|||
105441644|NCT00106353|363621433|FG004|Part 2|Withdrawal by Subject|1|||
105441645|NCT00106353|363621434|FG005|Part 2|Withdrawal by Subject|0|||
105441646|NCT00106353|363621435|FG006|Part 2|Withdrawal by Subject|0|||
105441647|NCT00106353|363621429|FG000|Part 2|Physician Decision|0|||
105441648|NCT00106353|363621430|FG001|Part 2|Physician Decision|0|||
105441649|NCT00106353|363621431|FG002|Part 2|Physician Decision|0|||
105441650|NCT00106353|363621432|FG003|Part 2|Physician Decision|0|||
105441651|NCT00106353|363621433|FG004|Part 2|Physician Decision|0|||
105441652|NCT00106353|363621434|FG005|Part 2|Physician Decision|1|||
105441653|NCT00106353|363621435|FG006|Part 2|Physician Decision|0|||
105441654|NCT01278797|363621436|FG000|Period 1|Adverse Event|0|||
105441655|NCT01278797|363621437|FG001|Period 1|Adverse Event|1|||
105441656|NCT01278797|363621436|FG000|Period 1|Protocol Violation|1|||
105441657|NCT01278797|363621437|FG001|Period 1|Protocol Violation|0|||
105441658|NCT01370265|363623927|FG000|First Intervention|Adverse Event|1|||
105441659|NCT01370265|363623928|FG001|First Intervention|Adverse Event|1|||
105441660|NCT02611817|363623933|FG000|Open-label Induction Phase|Reason not Specified|9|||
105441661|NCT02611817|363623934|FG001|Open-label Induction Phase|Reason not Specified|0|||
105441662|NCT02611817|363623935|FG002|Open-label Induction Phase|Reason not Specified|0|||
105441663|NCT02611817|363623933|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
105441664|NCT02611817|363623934|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
105441665|NCT02611817|363623935|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
105441666|NCT02611817|363623933|FG000|Open-label Induction Phase|Pregnancy|1|||
105441667|NCT02611817|363623934|FG001|Open-label Induction Phase|Pregnancy|0|||
105441668|NCT02611817|363623935|FG002|Open-label Induction Phase|Pregnancy|0|||
105441669|NCT02611817|363623933|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
105441670|NCT02611817|363623934|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
105441671|NCT02611817|363623935|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
105441672|NCT02611817|363623933|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
105441673|NCT02611817|363623934|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
105441674|NCT02611817|363623935|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
105441675|NCT02611817|363623933|FG000|Open-label Induction Phase|Protocol Violation|5|||
105441676|NCT02611817|363623934|FG001|Open-label Induction Phase|Protocol Violation|0|||
105441677|NCT02611817|363623935|FG002|Open-label Induction Phase|Protocol Violation|0|||
105441678|NCT02611817|363623933|FG000|Open-label Induction Phase|Adverse Event|16|||
105441679|NCT02611817|363623934|FG001|Open-label Induction Phase|Adverse Event|0|||
105441680|NCT02611817|363623935|FG002|Open-label Induction Phase|Adverse Event|0|||
105441681|NCT02611817|363623933|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
105441682|NCT02611817|363623934|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
105441683|NCT02611817|363623935|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
105441684|NCT02611817|363623933|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
105441685|NCT02611817|363623934|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
105441686|NCT02611817|363623935|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
105441687|NCT02611817|363623933|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
105441688|NCT02611817|363623934|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
105441689|NCT02611817|363623935|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
105441690|NCT02611817|363623933|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
105441691|NCT02611817|363623934|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
105441692|NCT02611817|363623935|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
105441693|NCT02611817|363623933|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
105441694|NCT02611817|363623934|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
105441695|NCT02611817|363623935|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
105441696|NCT02611817|363623933|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
105441697|NCT02611817|363623934|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
105441698|NCT02611817|363623935|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
105441699|NCT02611817|363623933|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
105441700|NCT02611817|363623934|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
105441701|NCT02611817|363623935|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
105441702|NCT05128578|363623936|FG000|Overall Study|Withdrawal by Subject|9|||
105441703|NCT05128578|363623936|FG000|Overall Study|Lost to Follow-up|5|||
105441704|NCT01959841|363623937|FG000|Overall Study|Adverse Event|1|||
105441705|NCT01959841|363623938|FG001|Overall Study|Adverse Event|3|||
105441706|NCT01959841|363623939|FG002|Overall Study|Adverse Event|2|||
105441707|NCT01959841|363623937|FG000|Overall Study|Lack of Efficacy|5|||
105441708|NCT01959841|363623938|FG001|Overall Study|Lack of Efficacy|0|||
105441709|NCT01959841|363623939|FG002|Overall Study|Lack of Efficacy|0|||
105441710|NCT01959841|363623937|FG000|Overall Study|Lost to Follow-up|1|||
105441711|NCT01959841|363623938|FG001|Overall Study|Lost to Follow-up|1|||
105441712|NCT01959841|363623939|FG002|Overall Study|Lost to Follow-up|0|||
105441713|NCT01959841|363623937|FG000|Overall Study|Physician Decision|0|||
105441714|NCT01959841|363623938|FG001|Overall Study|Physician Decision|2|||
105441715|NCT01959841|363623939|FG002|Overall Study|Physician Decision|3|||
105441716|NCT01959841|363623937|FG000|Overall Study|Protocol Violation|16|||
105441717|NCT01959841|363623938|FG001|Overall Study|Protocol Violation|23|||
105441718|NCT01959841|363623939|FG002|Overall Study|Protocol Violation|16|||
105441719|NCT01959841|363623937|FG000|Overall Study|Withdrawal by Subject|7|||
105441720|NCT01959841|363623938|FG001|Overall Study|Withdrawal by Subject|7|||
105441721|NCT01959841|363623939|FG002|Overall Study|Withdrawal by Subject|5|||
105441722|NCT01959841|363623937|FG000|Overall Study|Clinical laboratory value|2|||
105441723|NCT01959841|363623938|FG001|Overall Study|Clinical laboratory value|6|||
105441724|NCT01959841|363623939|FG002|Overall Study|Clinical laboratory value|6|||
105441725|NCT01959841|363623937|FG000|Overall Study|Platelet count below on day1 or 4|11|||
105441726|NCT01959841|363623938|FG001|Overall Study|Platelet count below on day1 or 4|15|||
105441727|NCT01959841|363623939|FG002|Overall Study|Platelet count below on day1 or 4|11|||
105441728|NCT00871338|363623945|FG000|Prior to Booster|Withdrawal by Subject|1|||
105441729|NCT00871338|363623946|FG001|Prior to Booster|Withdrawal by Subject|3|||
105441730|NCT00871338|363623945|FG000|Prior to Booster|Lost to Follow-up|1|||
105441731|NCT00871338|363623946|FG001|Prior to Booster|Lost to Follow-up|0|||
105441732|NCT02391363|363623947|FG000|Overall Study|Lost to Follow-up|5|||
105441733|NCT02391363|363623948|FG001|Overall Study|Lost to Follow-up|5|||
105441734|NCT02391363|363623947|FG000|Overall Study|Withdrawal by Subject|6|||
105441735|NCT02391363|363623948|FG001|Overall Study|Withdrawal by Subject|3|||
105441736|NCT03828617|363623949|FG000|Overall Study|Lost to Follow-up|22|||
105441737|NCT03828617|363623950|FG001|Overall Study|Lost to Follow-up|12|||
105441738|NCT03828617|363623951|FG002|Overall Study|Lost to Follow-up|23|||
105441739|NCT03828617|363623952|FG003|Overall Study|Lost to Follow-up|7|||
105441740|NCT03828617|363623949|FG000|Overall Study|No longer met eligibility criteria|0|||
105441741|NCT03828617|363623950|FG001|Overall Study|No longer met eligibility criteria|1|||
105441742|NCT03828617|363623951|FG002|Overall Study|No longer met eligibility criteria|1|||
105441743|NCT03828617|363623952|FG003|Overall Study|No longer met eligibility criteria|3|||
105441744|NCT03828617|363623949|FG000|Overall Study|Protocol Violation|0|||
105441745|NCT03828617|363623950|FG001|Overall Study|Protocol Violation|2|||
105441746|NCT03828617|363623951|FG002|Overall Study|Protocol Violation|0|||
105441747|NCT03828617|363623952|FG003|Overall Study|Protocol Violation|0|||
105441748|NCT03828617|363623949|FG000|Overall Study|Withdrawal by Subject|2|||
105441749|NCT03828617|363623950|FG001|Overall Study|Withdrawal by Subject|0|||
105441750|NCT03828617|363623951|FG002|Overall Study|Withdrawal by Subject|2|||
105441751|NCT03828617|363623952|FG003|Overall Study|Withdrawal by Subject|0|||
105441752|NCT01271725|363623955|FG000|Part A|Progressive disease according to RECIST|8|||
105441753|NCT01271725|363623956|FG001|Part A|Progressive disease according to RECIST|0|||
105441754|NCT01271725|363623955|FG000|Part A|Clinical signs/symptoms of progression|2|||
105441755|NCT01271725|363623956|FG001|Part A|Clinical signs/symptoms of progression|0|||
105441756|NCT01271725|363623955|FG000|Part A|Other Adverse Event|8|||
105441757|NCT01271725|363623956|FG001|Part A|Other Adverse Event|0|||
105441758|NCT01271725|363623955|FG000|Part A|Lost to Follow-up|1|||
105441759|NCT01271725|363623956|FG001|Part A|Lost to Follow-up|0|||
105441760|NCT01271725|363623955|FG000|Part A|Withdrawal by Subject|12|||
105441761|NCT01271725|363623956|FG001|Part A|Withdrawal by Subject|0|||
105441762|NCT01271725|363623955|FG000|Part A|Other than specified|3|||
105441763|NCT01271725|363623956|FG001|Part A|Other than specified|0|||
105441764|NCT01271725|363623955|FG000|Part A|Protocol Violation|1|||
105441765|NCT01271725|363623956|FG001|Part A|Protocol Violation|0|||
105441766|NCT01271725|363623955|FG000|Part B|Other than specified|0|||
105441767|NCT01271725|363623956|FG001|Part B|Other than specified|2|||
105441768|NCT01271725|363623955|FG000|Part B|Clinical signs/symptoms of progression|0|||
105441769|NCT01271725|363623956|FG001|Part B|Clinical signs/symptoms of progression|2|||
105441770|NCT01271725|363623955|FG000|Part B|Other Adverse Event|0|||
105441771|NCT01271725|363623956|FG001|Part B|Other Adverse Event|1|||
105441772|NCT01271725|363623955|FG000|Part B|Protocol Violation|0|||
105441773|NCT01271725|363623956|FG001|Part B|Protocol Violation|1|||
105441774|NCT01271725|363623955|FG000|Part B|Withdrawal by Subject|0|||
105441775|NCT01271725|363623956|FG001|Part B|Withdrawal by Subject|6|||
105441776|NCT00801229|363623957|FG000|Signed Consent|Withdrawal by Subject|2|||
105441777|NCT00801229|363623958|FG001|Signed Consent|Withdrawal by Subject|2|||
105441778|NCT00801229|363623957|FG000|Signed Consent|Found Ineligible|1|||
105441779|NCT00801229|363623958|FG001|Signed Consent|Found Ineligible|1|||
105441780|NCT00801229|363623957|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
105441781|NCT00801229|363623958|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
105441782|NCT00801229|363623957|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
105441783|NCT00801229|363623958|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
105441784|NCT00801229|363623957|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
105441785|NCT00801229|363623958|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
105441786|NCT00801229|363623957|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
105441787|NCT00801229|363623958|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
105441788|NCT00801229|363623957|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
105441789|NCT00801229|363623958|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
105441790|NCT00801229|363623957|FG000|Received Study Drug/Placebo|Adverse Event|1|||
105441791|NCT00801229|363623958|FG001|Received Study Drug/Placebo|Adverse Event|1|||
105441792|NCT01980095|363623963|FG000|Overall Study|Lost to Follow-up|6|||
105441793|NCT01980095|363623964|FG001|Overall Study|Lost to Follow-up|7|||
105441794|NCT01980095|363623963|FG000|Overall Study|Withdrawal by Subject|2|||
105441795|NCT01980095|363623964|FG001|Overall Study|Withdrawal by Subject|3|||
105441796|NCT01980095|363623963|FG000|Overall Study|Poor compliance|5|||
105441797|NCT01980095|363623964|FG001|Overall Study|Poor compliance|0|||
105441798|NCT01980095|363623963|FG000|Overall Study|Safety issue|0|||
105441799|NCT01980095|363623964|FG001|Overall Study|Safety issue|1|||
105441800|NCT01980095|363623963|FG000|Overall Study|Study drug discontinued|1|||
105441801|NCT01980095|363623964|FG001|Overall Study|Study drug discontinued|0|||
105441802|NCT01980095|363623963|FG000|Overall Study|Randomized by mistake|1|||
105441803|NCT01980095|363623964|FG001|Overall Study|Randomized by mistake|0|||
105441804|NCT02737475|363623965|FG000|Overall Study|Other reasons|0|||
105441805|NCT02737475|363623966|FG001|Overall Study|Other reasons|0|||
105441806|NCT02737475|363623967|FG002|Overall Study|Other reasons|0|||
105441807|NCT02737475|363623968|FG003|Overall Study|Other reasons|0|||
105441808|NCT02737475|363623969|FG004|Overall Study|Other reasons|1|||
105441809|NCT02737475|363623970|FG005|Overall Study|Other reasons|1|||
105441810|NCT02737475|363623971|FG006|Overall Study|Other reasons|0|||
105441811|NCT02737475|363623972|FG007|Overall Study|Other reasons|0|||
105441812|NCT02737475|363623973|FG008|Overall Study|Other reasons|1|||
105441813|NCT02737475|363623974|FG009|Overall Study|Other reasons|0|||
105441814|NCT02737475|363623975|FG010|Overall Study|Other reasons|1|||
105441815|NCT02737475|363623976|FG011|Overall Study|Other reasons|0|||
105441816|NCT02737475|363623977|FG012|Overall Study|Other reasons|0|||
105441817|NCT02737475|363623978|FG013|Overall Study|Other reasons|0|||
105441818|NCT02737475|363623979|FG014|Overall Study|Other reasons|0|||
105441819|NCT02737475|363623980|FG015|Overall Study|Other reasons|0|||
105441820|NCT02737475|363623981|FG016|Overall Study|Other reasons|0|||
105441821|NCT02737475|363623982|FG017|Overall Study|Other reasons|0|||
105441822|NCT02737475|363623983|FG018|Overall Study|Other reasons|0|||
105441823|NCT02737475|363623984|FG019|Overall Study|Other reasons|0|||
105441824|NCT02737475|363623985|FG020|Overall Study|Other reasons|0|||
105441825|NCT02737475|363623986|FG021|Overall Study|Other reasons|1|||
105441826|NCT02737475|363623987|FG022|Overall Study|Other reasons|0|||
105441827|NCT02737475|363623988|FG023|Overall Study|Other reasons|1|||
105441828|NCT02737475|363623989|FG024|Overall Study|Other reasons|1|||
105441829|NCT02737475|363623990|FG025|Overall Study|Other reasons|1|||
105441830|NCT02737475|363623991|FG026|Overall Study|Other reasons|0|||
105441831|NCT02737475|363623965|FG000|Overall Study|Death|1|||
105441832|NCT02737475|363623966|FG001|Overall Study|Death|0|||
105441833|NCT02737475|363623967|FG002|Overall Study|Death|0|||
105441834|NCT02737475|363623968|FG003|Overall Study|Death|1|||
105441835|NCT02737475|363623969|FG004|Overall Study|Death|0|||
105441836|NCT02737475|363623970|FG005|Overall Study|Death|0|||
105441837|NCT02737475|363623971|FG006|Overall Study|Death|0|||
105441838|NCT02737475|363623972|FG007|Overall Study|Death|2|||
105441839|NCT02737475|363623973|FG008|Overall Study|Death|0|||
105441840|NCT02737475|363623974|FG009|Overall Study|Death|0|||
105441841|NCT02737475|363623975|FG010|Overall Study|Death|0|||
105441842|NCT02737475|363623976|FG011|Overall Study|Death|4|||
105441843|NCT02737475|363623977|FG012|Overall Study|Death|2|||
105441844|NCT02737475|363623978|FG013|Overall Study|Death|2|||
105441845|NCT02737475|363623979|FG014|Overall Study|Death|0|||
105441846|NCT02737475|363623980|FG015|Overall Study|Death|2|||
105441847|NCT02737475|363623981|FG016|Overall Study|Death|2|||
105441848|NCT02737475|363623982|FG017|Overall Study|Death|2|||
105441849|NCT02737475|363623983|FG018|Overall Study|Death|1|||
105441850|NCT02737475|363623984|FG019|Overall Study|Death|0|||
105441851|NCT02737475|363623985|FG020|Overall Study|Death|0|||
105441852|NCT02737475|363623986|FG021|Overall Study|Death|0|||
105441853|NCT02737475|363623987|FG022|Overall Study|Death|0|||
105441854|NCT02737475|363623988|FG023|Overall Study|Death|0|||
105441855|NCT02737475|363623989|FG024|Overall Study|Death|0|||
105441856|NCT02737475|363623990|FG025|Overall Study|Death|0|||
105441857|NCT02737475|363623991|FG026|Overall Study|Death|0|||
105441858|NCT02737475|363623965|FG000|Overall Study|Participant withdrew consent|0|||
105441859|NCT02737475|363623966|FG001|Overall Study|Participant withdrew consent|0|||
105441860|NCT02737475|363623967|FG002|Overall Study|Participant withdrew consent|0|||
105441861|NCT02737475|363623968|FG003|Overall Study|Participant withdrew consent|0|||
105441862|NCT02737475|363623969|FG004|Overall Study|Participant withdrew consent|0|||
105441863|NCT02737475|363623970|FG005|Overall Study|Participant withdrew consent|2|||
105441864|NCT02737475|363623971|FG006|Overall Study|Participant withdrew consent|0|||
105441865|NCT02737475|363623972|FG007|Overall Study|Participant withdrew consent|0|||
105441866|NCT02737475|363623973|FG008|Overall Study|Participant withdrew consent|0|||
105441867|NCT02737475|363623974|FG009|Overall Study|Participant withdrew consent|0|||
105441868|NCT02737475|363623975|FG010|Overall Study|Participant withdrew consent|0|||
105441869|NCT02737475|363623976|FG011|Overall Study|Participant withdrew consent|0|||
105441870|NCT02737475|363623977|FG012|Overall Study|Participant withdrew consent|0|||
105441871|NCT02737475|363623978|FG013|Overall Study|Participant withdrew consent|0|||
105441872|NCT02737475|363623979|FG014|Overall Study|Participant withdrew consent|1|||
105441873|NCT02737475|363623980|FG015|Overall Study|Participant withdrew consent|0|||
105441874|NCT02737475|363623981|FG016|Overall Study|Participant withdrew consent|0|||
105441875|NCT02737475|363623982|FG017|Overall Study|Participant withdrew consent|2|||
105441876|NCT02737475|363623983|FG018|Overall Study|Participant withdrew consent|1|||
105441877|NCT02737475|363623984|FG019|Overall Study|Participant withdrew consent|0|||
105441878|NCT02737475|363623985|FG020|Overall Study|Participant withdrew consent|2|||
105441879|NCT02737475|363623986|FG021|Overall Study|Participant withdrew consent|0|||
105441880|NCT02737475|363623987|FG022|Overall Study|Participant withdrew consent|0|||
105441881|NCT02737475|363623988|FG023|Overall Study|Participant withdrew consent|0|||
105441882|NCT02737475|363623989|FG024|Overall Study|Participant withdrew consent|0|||
105441883|NCT02737475|363623990|FG025|Overall Study|Participant withdrew consent|0|||
105441884|NCT02737475|363623991|FG026|Overall Study|Participant withdrew consent|0|||
105441885|NCT02737475|363623965|FG000|Overall Study|Lost to Follow-up|0|||
105441886|NCT02737475|363623966|FG001|Overall Study|Lost to Follow-up|0|||
105441887|NCT02737475|363623967|FG002|Overall Study|Lost to Follow-up|0|||
105441888|NCT02737475|363623968|FG003|Overall Study|Lost to Follow-up|0|||
105441889|NCT02737475|363623969|FG004|Overall Study|Lost to Follow-up|0|||
105441890|NCT02737475|363623970|FG005|Overall Study|Lost to Follow-up|0|||
105441891|NCT02737475|363623971|FG006|Overall Study|Lost to Follow-up|0|||
105441892|NCT02737475|363623972|FG007|Overall Study|Lost to Follow-up|0|||
105441893|NCT02737475|363623973|FG008|Overall Study|Lost to Follow-up|0|||
105441894|NCT02737475|363623974|FG009|Overall Study|Lost to Follow-up|0|||
105441895|NCT02737475|363623975|FG010|Overall Study|Lost to Follow-up|0|||
105441896|NCT02737475|363623976|FG011|Overall Study|Lost to Follow-up|0|||
105441897|NCT02737475|363623977|FG012|Overall Study|Lost to Follow-up|0|||
105441898|NCT02737475|363623978|FG013|Overall Study|Lost to Follow-up|0|||
105441899|NCT02737475|363623979|FG014|Overall Study|Lost to Follow-up|0|||
105441900|NCT02737475|363623980|FG015|Overall Study|Lost to Follow-up|1|||
105441901|NCT02737475|363623981|FG016|Overall Study|Lost to Follow-up|0|||
105441902|NCT02737475|363623982|FG017|Overall Study|Lost to Follow-up|0|||
105441903|NCT02737475|363623983|FG018|Overall Study|Lost to Follow-up|0|||
105441904|NCT02737475|363623984|FG019|Overall Study|Lost to Follow-up|0|||
105441905|NCT02737475|363623985|FG020|Overall Study|Lost to Follow-up|0|||
105441906|NCT02737475|363623986|FG021|Overall Study|Lost to Follow-up|0|||
105441907|NCT02737475|363623987|FG022|Overall Study|Lost to Follow-up|0|||
105441908|NCT02737475|363623988|FG023|Overall Study|Lost to Follow-up|0|||
105441909|NCT02737475|363623989|FG024|Overall Study|Lost to Follow-up|0|||
105441910|NCT02737475|363623990|FG025|Overall Study|Lost to Follow-up|0|||
105441911|NCT02737475|363623991|FG026|Overall Study|Lost to Follow-up|0|||
105441912|NCT02737475|363623965|FG000|Overall Study|Disease Progression|0|||
105441913|NCT02737475|363623966|FG001|Overall Study|Disease Progression|0|||
105441914|NCT02737475|363623967|FG002|Overall Study|Disease Progression|0|||
105441915|NCT02737475|363623968|FG003|Overall Study|Disease Progression|0|||
105659932|NCT00356811|364418880|FG000|Overall Study|Withdrawal by Subject|6|||
105659933|NCT00356811|364418880|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
105659934|NCT00356811|364418880|FG000|Overall Study|Study Is Terminating|3|||
105441916|NCT02737475|363623969|FG004|Overall Study|Disease Progression|0|||
105441917|NCT02737475|363623970|FG005|Overall Study|Disease Progression|0|||
105441918|NCT02737475|363623971|FG006|Overall Study|Disease Progression|0|||
105441919|NCT02737475|363623972|FG007|Overall Study|Disease Progression|0|||
105441920|NCT02737475|363623973|FG008|Overall Study|Disease Progression|0|||
105441921|NCT02737475|363623974|FG009|Overall Study|Disease Progression|0|||
105441922|NCT02737475|363623975|FG010|Overall Study|Disease Progression|0|||
105441923|NCT02737475|363623976|FG011|Overall Study|Disease Progression|0|||
105441924|NCT02737475|363623977|FG012|Overall Study|Disease Progression|0|||
105441925|NCT02737475|363623978|FG013|Overall Study|Disease Progression|0|||
105441926|NCT02737475|363623979|FG014|Overall Study|Disease Progression|0|||
105441927|NCT02737475|363623980|FG015|Overall Study|Disease Progression|0|||
105806438|NCT01464827|364948991|FG010|Overall Study|Lost to Follow-up|0|||
105441928|NCT02737475|363623981|FG016|Overall Study|Disease Progression|0|||
105441929|NCT02737475|363623982|FG017|Overall Study|Disease Progression|0|||
105441930|NCT02737475|363623983|FG018|Overall Study|Disease Progression|0|||
105441931|NCT02737475|363623984|FG019|Overall Study|Disease Progression|0|||
105441932|NCT02737475|363623985|FG020|Overall Study|Disease Progression|0|||
105441933|NCT02737475|363623986|FG021|Overall Study|Disease Progression|0|||
105441934|NCT02737475|363623987|FG022|Overall Study|Disease Progression|0|||
105441935|NCT02737475|363623988|FG023|Overall Study|Disease Progression|0|||
105441936|NCT02737475|363623989|FG024|Overall Study|Disease Progression|0|||
105441937|NCT02737475|363623990|FG025|Overall Study|Disease Progression|0|||
105441938|NCT02737475|363623991|FG026|Overall Study|Disease Progression|1|||
105441939|NCT02510001|363623992|FG000|Overall Study|Early disease progression|0|||
105441940|NCT02510001|363623993|FG001|Overall Study|Early disease progression|0|||
105441941|NCT02510001|363623994|FG002|Overall Study|Early disease progression|0|||
105441942|NCT02510001|363623995|FG003|Overall Study|Early disease progression|1|||
105441943|NCT02510001|363623996|FG004|Overall Study|Early disease progression|1|||
105441944|NCT02510001|363623997|FG005|Overall Study|Early disease progression|1|||
105441945|NCT02510001|363623998|FG006|Overall Study|Early disease progression|0|||
105441946|NCT02510001|363623999|FG007|Overall Study|Early disease progression|0|||
105441947|NCT02510001|363623992|FG000|Overall Study|Adverse Event|0|||
105441948|NCT02510001|363623993|FG001|Overall Study|Adverse Event|0|||
105441949|NCT02510001|363623994|FG002|Overall Study|Adverse Event|0|||
105441950|NCT02510001|363623995|FG003|Overall Study|Adverse Event|1|||
105441951|NCT02510001|363623996|FG004|Overall Study|Adverse Event|2|||
105441952|NCT02510001|363623997|FG005|Overall Study|Adverse Event|1|||
105441953|NCT02510001|363623998|FG006|Overall Study|Adverse Event|2|||
105441954|NCT02510001|363623999|FG007|Overall Study|Adverse Event|5|||
105441955|NCT02510001|363623992|FG000|Overall Study|Physician Decision|0|||
105441956|NCT02510001|363623993|FG001|Overall Study|Physician Decision|0|||
105441957|NCT02510001|363623994|FG002|Overall Study|Physician Decision|0|||
105441958|NCT02510001|363623995|FG003|Overall Study|Physician Decision|0|||
105441959|NCT02510001|363623996|FG004|Overall Study|Physician Decision|1|||
105441960|NCT02510001|363623997|FG005|Overall Study|Physician Decision|0|||
105441961|NCT02510001|363623998|FG006|Overall Study|Physician Decision|0|||
105441962|NCT02510001|363623999|FG007|Overall Study|Physician Decision|0|||
105441963|NCT02510001|363623992|FG000|Overall Study|Withdrawal by Subject|0|||
105441964|NCT02510001|363623993|FG001|Overall Study|Withdrawal by Subject|0|||
105441965|NCT02510001|363623994|FG002|Overall Study|Withdrawal by Subject|0|||
105441966|NCT02510001|363623995|FG003|Overall Study|Withdrawal by Subject|0|||
105441967|NCT02510001|363623996|FG004|Overall Study|Withdrawal by Subject|0|||
105441968|NCT02510001|363623997|FG005|Overall Study|Withdrawal by Subject|0|||
105441969|NCT02510001|363623998|FG006|Overall Study|Withdrawal by Subject|0|||
105441970|NCT02510001|363623999|FG007|Overall Study|Withdrawal by Subject|2|||
105441971|NCT02950480|363624000|FG000|Overall Study|Withdrawal by Subject|1|||
105441972|NCT02950480|363624001|FG001|Overall Study|Withdrawal by Subject|0|||
105441973|NCT00536471|363624018|FG000|Overall Study|Lost to Follow-up|48|||
105441974|NCT00536471|363624019|FG001|Overall Study|Lost to Follow-up|23|||
105441975|NCT00536471|363624020|FG002|Overall Study|Lost to Follow-up|48|||
105441976|NCT00536471|363624021|FG003|Overall Study|Lost to Follow-up|22|||
105441977|NCT00536471|363624018|FG000|Overall Study|Adverse Event|32|||
105441978|NCT00536471|363624019|FG001|Overall Study|Adverse Event|16|||
105441979|NCT00536471|363624020|FG002|Overall Study|Adverse Event|28|||
105441980|NCT00536471|363624021|FG003|Overall Study|Adverse Event|13|||
105441981|NCT00536471|363624018|FG000|Overall Study|Withdrawal by Subject|40|||
105441982|NCT00536471|363624019|FG001|Overall Study|Withdrawal by Subject|24|||
105441983|NCT00536471|363624020|FG002|Overall Study|Withdrawal by Subject|43|||
105441984|NCT00536471|363624021|FG003|Overall Study|Withdrawal by Subject|21|||
105441985|NCT00536471|363624018|FG000|Overall Study|Lack of Efficacy|17|||
105441986|NCT00536471|363624019|FG001|Overall Study|Lack of Efficacy|18|||
105441987|NCT00536471|363624020|FG002|Overall Study|Lack of Efficacy|11|||
105441988|NCT00536471|363624021|FG003|Overall Study|Lack of Efficacy|9|||
105441989|NCT00536471|363624018|FG000|Overall Study|Protocol Violation|8|||
105441990|NCT00536471|363624019|FG001|Overall Study|Protocol Violation|1|||
105441991|NCT00536471|363624020|FG002|Overall Study|Protocol Violation|2|||
105441992|NCT00536471|363624021|FG003|Overall Study|Protocol Violation|3|||
105441993|NCT00536471|363624018|FG000|Overall Study|Physician Decision|11|||
105441994|NCT00536471|363624019|FG001|Overall Study|Physician Decision|1|||
105441995|NCT00536471|363624020|FG002|Overall Study|Physician Decision|3|||
105441996|NCT00536471|363624021|FG003|Overall Study|Physician Decision|2|||
105441997|NCT00536471|363624018|FG000|Overall Study|Death|0|||
105441998|NCT00536471|363624019|FG001|Overall Study|Death|0|||
105441999|NCT00536471|363624020|FG002|Overall Study|Death|1|||
105442000|NCT00536471|363624021|FG003|Overall Study|Death|2|||
105442001|NCT00536471|363624018|FG000|Overall Study|Sponsor Decision|0|||
105442002|NCT00536471|363624019|FG001|Overall Study|Sponsor Decision|1|||
105442003|NCT00536471|363624020|FG002|Overall Study|Sponsor Decision|3|||
105442004|NCT00536471|363624021|FG003|Overall Study|Sponsor Decision|2|||
105442005|NCT03668613|363624022|FG000|Overall Study|Adverse Event|1|||
105442006|NCT03668613|363624023|FG001|Overall Study|Adverse Event|2|||
105442007|NCT03668613|363624022|FG000|Overall Study|Lack of Efficacy|5|||
105442008|NCT03668613|363624023|FG001|Overall Study|Lack of Efficacy|1|||
105442009|NCT03668613|363624022|FG000|Overall Study|Pregnancy|0|||
105442010|NCT03668613|363624023|FG001|Overall Study|Pregnancy|2|||
105442011|NCT03668613|363624022|FG000|Overall Study|Protocol Violation|1|||
105442012|NCT03668613|363624023|FG001|Overall Study|Protocol Violation|0|||
105442013|NCT03668613|363624022|FG000|Overall Study|Physician Decision|1|||
105442014|NCT03668613|363624023|FG001|Overall Study|Physician Decision|0|||
105442015|NCT03668613|363624022|FG000|Overall Study|Withdrawal by Subject|2|||
105442016|NCT03668613|363624023|FG001|Overall Study|Withdrawal by Subject|1|||
105442017|NCT03668613|363624022|FG000|Overall Study|Guardian decision|1|||
105442018|NCT03668613|363624023|FG001|Overall Study|Guardian decision|0|||
105442019|NCT00709618|363624024|FG000|Overall Study|Withdrawal by Subject|4|||
105442020|NCT00709618|363624024|FG000|Overall Study|Lost to Follow-up|1|||
105442021|NCT00709618|363624024|FG000|Overall Study|Study Closed/Terminated|25|||
105442022|NCT02703324|363624025|FG000|Period Two|Withdrawal by Subject|0|||
105442023|NCT02703324|363624026|FG001|Period Two|Withdrawal by Subject|0|||
105442024|NCT02703324|363624027|FG002|Period Two|Withdrawal by Subject|1|||
105442025|NCT02703324|363624028|FG003|Period Two|Withdrawal by Subject|0|||
105442026|NCT02703324|363624029|FG004|Period Two|Withdrawal by Subject|0|||
105442027|NCT02703324|363624030|FG005|Period Two|Withdrawal by Subject|0|||
105442028|NCT02221674|363624031|FG000|Overall Study|Lost to Follow-up|1|||
105442029|NCT02221674|363624032|FG001|Overall Study|Lost to Follow-up|0|||
105442030|NCT02221674|363624033|FG002|Overall Study|Lost to Follow-up|0|||
105442031|NCT04042909|363624034|FG000|Overall Study|Withdrawal by Subject|1|||
105442032|NCT04042909|363624035|FG001|Overall Study|Withdrawal by Subject|0|||
105442033|NCT04042909|363624036|FG002|Overall Study|Withdrawal by Subject|0|||
105442034|NCT04042909|363624034|FG000|Overall Study|duplicate cases|2|||
105442035|NCT04042909|363624035|FG001|Overall Study|duplicate cases|0|||
105442036|NCT04042909|363624036|FG002|Overall Study|duplicate cases|0|||
105442037|NCT04042909|363624034|FG000|Overall Study|technical problem|0|||
105442038|NCT04042909|363624035|FG001|Overall Study|technical problem|1|||
105442039|NCT04042909|363624036|FG002|Overall Study|technical problem|0|||
105442040|NCT01948063|363624037|FG000|Overall Study|Boston MCI halted research protocol|0|||
105442041|NCT01948063|363624038|FG001|Overall Study|Boston MCI halted research protocol|1|||
105442042|NCT01948063|363624037|FG000|Overall Study|Discovered an enrollment in other study|0|||
105442043|NCT01948063|363624038|FG001|Overall Study|Discovered an enrollment in other study|1|||
105442044|NCT01948063|363624037|FG000|Overall Study|Blood samples were accidentally thawed|1|||
105442045|NCT01948063|363624038|FG001|Overall Study|Blood samples were accidentally thawed|0|||
105442046|NCT00894361|363624039|FG000|Overall Study|deaths and less than 2 years followup|24|||
105442047|NCT00894361|363624040|FG001|Overall Study|deaths and less than 2 years followup|64|||
105442048|NCT05438576|363624041|FG000|Overall Study|Death|1|||
105442049|NCT05438576|363624042|FG001|Overall Study|Death|1|||
105442050|NCT05438576|363624041|FG000|Overall Study|Withdrawal by Subject|4|||
105442051|NCT05438576|363624042|FG001|Overall Study|Withdrawal by Subject|2|||
105442052|NCT05438576|363624041|FG000|Overall Study|Not Eligible|2|||
105442053|NCT05438576|363624042|FG001|Overall Study|Not Eligible|1|||
105442054|NCT05438576|363624041|FG000|Overall Study|Did not complete baseline testing|22|||
105442055|NCT05438576|363624042|FG001|Overall Study|Did not complete baseline testing|4|||
105442056|NCT02669212|363624051|FG000|Overall Study|Lost to Follow-up|1|||
105442057|NCT02669212|363624052|FG001|Overall Study|Lost to Follow-up|0|||
105442058|NCT02669212|363624051|FG000|Overall Study|Medical Condition|3|||
105442059|NCT02669212|363624052|FG001|Overall Study|Medical Condition|4|||
105442060|NCT02669212|363624051|FG000|Overall Study|Withdrawal by Subject|0|||
105442061|NCT02669212|363624052|FG001|Overall Study|Withdrawal by Subject|2|||
105442062|NCT02669212|363624051|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
105442063|NCT02669212|363624052|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
105442064|NCT00391027|363624053|FG000|Overall Study|Adverse Event|8|||
105442065|NCT00391027|363624054|FG001|Overall Study|Adverse Event|8|||
105442066|NCT00391027|363624053|FG000|Overall Study|Lack of Efficacy|3|||
105442067|NCT00391027|363624054|FG001|Overall Study|Lack of Efficacy|0|||
105442068|NCT00391027|363624053|FG000|Overall Study|Withdrawal by Subject|10|||
105442069|NCT00391027|363624054|FG001|Overall Study|Withdrawal by Subject|1|||
105442070|NCT00391027|363624053|FG000|Overall Study|Other|4|||
105442071|NCT00391027|363624054|FG001|Overall Study|Other|3|||
105442072|NCT04124705|363624055|FG000|Titration Period|Adverse Event|9|||
105442073|NCT04124705|363624056|FG001|Titration Period|Adverse Event|5|||
105442074|NCT04124705|363624055|FG000|Titration Period|Withdrawal by Subject|6|||
105442075|NCT04124705|363624056|FG001|Titration Period|Withdrawal by Subject|3|||
105442076|NCT04124705|363624055|FG000|Titration Period|Lost to Follow-up|0|||
105442077|NCT04124705|363624056|FG001|Titration Period|Lost to Follow-up|1|||
105442078|NCT04124705|363624055|FG000|Titration Period|Death|1|||
105442079|NCT04124705|363624056|FG001|Titration Period|Death|1|||
105442080|NCT04124705|363624055|FG000|Titration Period|Lack of Efficacy|2|||
105442081|NCT04124705|363624056|FG001|Titration Period|Lack of Efficacy|0|||
105442082|NCT04124705|363624055|FG000|Titration Period|Physician Decision|2|||
105442083|NCT04124705|363624056|FG001|Titration Period|Physician Decision|0|||
105442084|NCT04124705|363624055|FG000|Titration Period|Non-compliance with Study Drug|2|||
105442085|NCT04124705|363624056|FG001|Titration Period|Non-compliance with Study Drug|0|||
105442086|NCT04124705|363624055|FG000|Titration Period|Other|4|||
105442087|NCT04124705|363624056|FG001|Titration Period|Other|9|||
105442088|NCT04124705|363624055|FG000|Stabilization Period|Adverse Event|4|||
105442089|NCT04124705|363624056|FG001|Stabilization Period|Adverse Event|2|||
105442090|NCT04124705|363624055|FG000|Stabilization Period|Withdrawal by Subject|1|||
105442091|NCT04124705|363624056|FG001|Stabilization Period|Withdrawal by Subject|1|||
105442092|NCT04124705|363624055|FG000|Stabilization Period|Lost to Follow-up|0|||
105442093|NCT04124705|363624056|FG001|Stabilization Period|Lost to Follow-up|1|||
105442094|NCT04124705|363624055|FG000|Stabilization Period|Lack of Efficacy|4|||
105442095|NCT04124705|363624056|FG001|Stabilization Period|Lack of Efficacy|2|||
105442096|NCT04124705|363624055|FG000|Stabilization Period|Protocol Deviation|0|||
105442097|NCT04124705|363624056|FG001|Stabilization Period|Protocol Deviation|2|||
105442098|NCT04124705|363624055|FG000|Stabilization Period|Other|2|||
105442099|NCT04124705|363624056|FG001|Stabilization Period|Other|2|||
105442100|NCT04164732|363624057|FG000|Treatment run-in Period|Adverse Event|4|||
105442101|NCT04164732|363624058|FG001|Treatment run-in Period|Adverse Event|0|||
105442102|NCT04164732|363624059|FG002|Treatment run-in Period|Adverse Event|0|||
105442103|NCT04164732|363624057|FG000|Treatment run-in Period|Physician Decision|1|||
105442104|NCT04164732|363624058|FG001|Treatment run-in Period|Physician Decision|0|||
105442105|NCT04164732|363624059|FG002|Treatment run-in Period|Physician Decision|0|||
105770549|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105442106|NCT04164732|363624057|FG000|Treatment run-in Period|Screen Failure|1|||
105442107|NCT04164732|363624058|FG001|Treatment run-in Period|Screen Failure|0|||
105442108|NCT04164732|363624059|FG002|Treatment run-in Period|Screen Failure|0|||
105442109|NCT04164732|363624057|FG000|Randomized Treatment Period|Adverse Event|0|||
105442110|NCT04164732|363624058|FG001|Randomized Treatment Period|Adverse Event|1|||
105442111|NCT04164732|363624059|FG002|Randomized Treatment Period|Adverse Event|0|||
105442112|NCT04164732|363624057|FG000|Randomized Treatment Period|Protocol Deviation|0|||
105442113|NCT04164732|363624058|FG001|Randomized Treatment Period|Protocol Deviation|1|||
105442114|NCT04164732|363624059|FG002|Randomized Treatment Period|Protocol Deviation|1|||
105442115|NCT04164732|363624057|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
105442116|NCT04164732|363624058|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
105442117|NCT04164732|363624059|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
105442118|NCT01846741|363624060|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
105442119|NCT03664765|363624061|FG000|Overall Study|Withdrawal by Subject|4|||
105442120|NCT03664765|363624062|FG001|Overall Study|Withdrawal by Subject|1|||
105442121|NCT03664765|363624061|FG000|Overall Study|Lost to Follow-up|0|||
105442122|NCT03664765|363624062|FG001|Overall Study|Lost to Follow-up|1|||
105442123|NCT01153698|363624063|FG000|Overall Study|Adverse Event|12|||
105442124|NCT01153698|363624063|FG000|Overall Study|Lost to Follow-up|4|||
105442125|NCT01153698|363624063|FG000|Overall Study|Withdrawal by Subject|2|||
105442126|NCT01153698|363624063|FG000|Overall Study|Switch to other anticoagulants|4|||
105442127|NCT01153698|363624063|FG000|Overall Study|Other|2|||
105442128|NCT01153698|363624063|FG000|Overall Study|Not treated with Pradaxa|5|||
105442129|NCT04698993|363624064|FG000|Overall Study|PCR results not accessible|2|||
105442130|NCT04698993|363624065|FG001|Overall Study|PCR results not accessible|7|||
105442131|NCT04698993|363624064|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
105442132|NCT04698993|363624065|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
105442133|NCT00527904|363624066|FG000|Overall Study|Adverse Event|45|||
105442134|NCT00527904|363624066|FG000|Overall Study|Withdrawal by Subject|21|||
105442135|NCT00527904|363624066|FG000|Overall Study|Lost to Follow-up|8|||
105442136|NCT00527904|363624066|FG000|Overall Study|misc|22|||
105442137|NCT04006392|363624070|FG000|Overall Study|Lost to Follow-up|0|||
105442138|NCT04006392|363624071|FG001|Overall Study|Lost to Follow-up|1|||
105442139|NCT01832532|363624074|FG000|Overall Study|Withdrawal by Subject|5|||
105442140|NCT01832532|363624075|FG001|Overall Study|Withdrawal by Subject|2|||
105442141|NCT01534195|363624076|FG000|Overall Study|Withdrawal by Subject|1|||
105442142|NCT01534195|363624077|FG001|Overall Study|Withdrawal by Subject|1|||
105442143|NCT03302247|363624078|FG000|Overall Study|the study has closed prematurely|2|||
105442144|NCT03302247|363624078|FG000|Overall Study|Death|1|||
105442145|NCT03216746|363624079|FG000|Overall Study|Lost to Follow-up|6|||
105442146|NCT03216746|363624080|FG001|Overall Study|Lost to Follow-up|8|||
105442147|NCT03216746|363624081|FG002|Overall Study|Lost to Follow-up|5|||
105442148|NCT03216746|363624082|FG003|Overall Study|Lost to Follow-up|6|||
105442149|NCT04384523|363624083|FG000|Overall Study|Lost to Follow-up|0|||
105442150|NCT04384523|363624084|FG001|Overall Study|Lost to Follow-up|0|||
105442151|NCT04384523|363624085|FG002|Overall Study|Lost to Follow-up|0|||
105442152|NCT04384523|363624086|FG003|Overall Study|Lost to Follow-up|0|||
105442153|NCT04384523|363624087|FG004|Overall Study|Lost to Follow-up|0|||
105442154|NCT04384523|363624088|FG005|Overall Study|Lost to Follow-up|1|||
105442155|NCT04384523|363624083|FG000|Overall Study|Protocol Violation|0|||
105442156|NCT04384523|363624084|FG001|Overall Study|Protocol Violation|1|||
105442157|NCT04384523|363624085|FG002|Overall Study|Protocol Violation|0|||
105442158|NCT04384523|363624086|FG003|Overall Study|Protocol Violation|0|||
105442159|NCT04384523|363624087|FG004|Overall Study|Protocol Violation|0|||
105442160|NCT04384523|363624088|FG005|Overall Study|Protocol Violation|0|||
105442161|NCT04384523|363624083|FG000|Overall Study|Withdrawal by Subject|1|||
105442162|NCT04384523|363624084|FG001|Overall Study|Withdrawal by Subject|0|||
105442163|NCT04384523|363624085|FG002|Overall Study|Withdrawal by Subject|0|||
105442164|NCT04384523|363624086|FG003|Overall Study|Withdrawal by Subject|0|||
105442165|NCT04384523|363624087|FG004|Overall Study|Withdrawal by Subject|0|||
105442166|NCT04384523|363624088|FG005|Overall Study|Withdrawal by Subject|0|||
105442167|NCT02305238|363624089|FG000|Overall Study|Death|2|||
105442168|NCT02305238|363624090|FG001|Overall Study|Death|1|||
105442169|NCT02305238|363624091|FG002|Overall Study|Death|0|||
105442170|NCT02305238|363624089|FG000|Overall Study|Progressive disease|4|||
105442171|NCT02305238|363624090|FG001|Overall Study|Progressive disease|4|||
105442172|NCT02305238|363624091|FG002|Overall Study|Progressive disease|0|||
105442173|NCT02305238|363624089|FG000|Overall Study|Logistical difficulties|1|||
105442174|NCT02305238|363624090|FG001|Overall Study|Logistical difficulties|3|||
105442175|NCT02305238|363624091|FG002|Overall Study|Logistical difficulties|0|||
105442176|NCT02305238|363624089|FG000|Overall Study|Protocol Violation|0|||
105442177|NCT02305238|363624090|FG001|Overall Study|Protocol Violation|3|||
105442178|NCT02305238|363624091|FG002|Overall Study|Protocol Violation|0|||
105442179|NCT02305238|363624089|FG000|Overall Study|Physician Decision|2|||
105442180|NCT02305238|363624090|FG001|Overall Study|Physician Decision|1|||
105442181|NCT02305238|363624091|FG002|Overall Study|Physician Decision|0|||
105442182|NCT02305238|363624089|FG000|Overall Study|Adverse Event|4|||
105442183|NCT02305238|363624090|FG001|Overall Study|Adverse Event|2|||
105442184|NCT02305238|363624091|FG002|Overall Study|Adverse Event|0|||
105442185|NCT02305238|363624089|FG000|Overall Study|Withdrawal by Subject|3|||
105442186|NCT02305238|363624090|FG001|Overall Study|Withdrawal by Subject|4|||
105442187|NCT02305238|363624091|FG002|Overall Study|Withdrawal by Subject|0|||
105442188|NCT02305238|363624089|FG000|Overall Study|Randomized failure|0|||
105442189|NCT02305238|363624090|FG001|Overall Study|Randomized failure|0|||
105442190|NCT02305238|363624091|FG002|Overall Study|Randomized failure|8|||
105442191|NCT02305238|363624089|FG000|Overall Study|Required procedure failed|0|||
105442192|NCT02305238|363624090|FG001|Overall Study|Required procedure failed|1|||
105442193|NCT02305238|363624091|FG002|Overall Study|Required procedure failed|0|||
105442194|NCT01380834|363624092|FG000|Overall Study|Physician Decision|1|||
105442195|NCT01380834|363624093|FG001|Overall Study|Physician Decision|0|||
105442196|NCT04565951|363624098|FG000|Overall Study|Lost to Follow-up|66|||
105442197|NCT04565951|363624099|FG001|Overall Study|Lost to Follow-up|38|||
105442198|NCT04565951|363624098|FG000|Overall Study|Withdrawal by Subject|14|||
105442199|NCT04565951|363624099|FG001|Overall Study|Withdrawal by Subject|7|||
105442200|NCT04565951|363624098|FG000|Overall Study|Death|0|||
105442201|NCT04565951|363624099|FG001|Overall Study|Death|1|||
105442202|NCT03182907|363624100|FG000|Overall Study|Death|3|||
105442203|NCT03182907|363624101|FG001|Overall Study|Death|0|||
105442204|NCT03182907|363624100|FG000|Overall Study|Protocol Violation|4|||
105442205|NCT03182907|363624101|FG001|Overall Study|Protocol Violation|0|||
105442206|NCT03182907|363624100|FG000|Overall Study|Lost to Follow-up|1|||
105442207|NCT03182907|363624101|FG001|Overall Study|Lost to Follow-up|0|||
105442208|NCT03182907|363624100|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105442209|NCT03182907|363624101|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
105442210|NCT00172042|363624106|FG000|Overall Study|Adverse Event|27|||
105442211|NCT00172042|363624107|FG001|Overall Study|Adverse Event|13|||
105442212|NCT00172042|363624106|FG000|Overall Study|Abnormal laboratory value(s)|5|||
105442213|NCT00172042|363624107|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105442214|NCT00172042|363624106|FG000|Overall Study|Abnormal test procedure(s)|0|||
105442215|NCT00172042|363624107|FG001|Overall Study|Abnormal test procedure(s)|3|||
105442216|NCT00172042|363624106|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
105442217|NCT00172042|363624107|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
105442218|NCT00172042|363624106|FG000|Overall Study|Patient no longer requires study drug|10|||
105442219|NCT00172042|363624107|FG001|Overall Study|Patient no longer requires study drug|8|||
105442220|NCT00172042|363624106|FG000|Overall Study|Protocol Violation|8|||
105442221|NCT00172042|363624107|FG001|Overall Study|Protocol Violation|7|||
105442222|NCT00172042|363624106|FG000|Overall Study|Withdrawal by Subject|37|||
105442223|NCT00172042|363624107|FG001|Overall Study|Withdrawal by Subject|25|||
105442224|NCT00172042|363624106|FG000|Overall Study|Lost to Follow-up|3|||
105442225|NCT00172042|363624107|FG001|Overall Study|Lost to Follow-up|5|||
105442226|NCT00172042|363624106|FG000|Overall Study|Administrative problems|13|||
105806439|NCT01464827|364948992|FG011|Overall Study|Lost to Follow-up|1|||
105442227|NCT00172042|363624107|FG001|Overall Study|Administrative problems|10|||
105442228|NCT00172042|363624106|FG000|Overall Study|Death|42|||
105442229|NCT00172042|363624107|FG001|Overall Study|Death|42|||
105442230|NCT01368081|363624108|FG000|Overall Study|Adverse Event|4|||
105442231|NCT01368081|363624109|FG001|Overall Study|Adverse Event|4|||
105442232|NCT01368081|363624110|FG002|Overall Study|Adverse Event|3|||
105442233|NCT01368081|363624111|FG003|Overall Study|Adverse Event|2|||
105442234|NCT01368081|363624112|FG004|Overall Study|Adverse Event|2|||
105442235|NCT01368081|363624113|FG005|Overall Study|Adverse Event|5|||
105442236|NCT01368081|363624114|FG006|Overall Study|Adverse Event|6|||
105442237|NCT01368081|363624115|FG007|Overall Study|Adverse Event|2|||
105442238|NCT01368081|363624116|FG008|Overall Study|Adverse Event|3|||
105442239|NCT01368081|363624117|FG009|Overall Study|Adverse Event|5|||
105442240|NCT01368081|363624118|FG010|Overall Study|Adverse Event|6|||
105442241|NCT01368081|363624119|FG011|Overall Study|Adverse Event|1|||
105442242|NCT01368081|363624120|FG012|Overall Study|Adverse Event|3|||
105442243|NCT01368081|363624108|FG000|Overall Study|Lack of Efficacy|0|||
105442244|NCT01368081|363624109|FG001|Overall Study|Lack of Efficacy|1|||
105442245|NCT01368081|363624110|FG002|Overall Study|Lack of Efficacy|0|||
105442246|NCT01368081|363624111|FG003|Overall Study|Lack of Efficacy|1|||
105442247|NCT01368081|363624112|FG004|Overall Study|Lack of Efficacy|0|||
105442248|NCT01368081|363624113|FG005|Overall Study|Lack of Efficacy|0|||
105442249|NCT01368081|363624114|FG006|Overall Study|Lack of Efficacy|0|||
105442250|NCT01368081|363624115|FG007|Overall Study|Lack of Efficacy|2|||
105442251|NCT01368081|363624116|FG008|Overall Study|Lack of Efficacy|0|||
105442252|NCT01368081|363624117|FG009|Overall Study|Lack of Efficacy|0|||
105442253|NCT01368081|363624118|FG010|Overall Study|Lack of Efficacy|0|||
105442254|NCT01368081|363624119|FG011|Overall Study|Lack of Efficacy|0|||
105442255|NCT01368081|363624120|FG012|Overall Study|Lack of Efficacy|0|||
105442256|NCT01368081|363624108|FG000|Overall Study|Protocol Violation|0|||
105442257|NCT01368081|363624109|FG001|Overall Study|Protocol Violation|0|||
105442258|NCT01368081|363624110|FG002|Overall Study|Protocol Violation|0|||
105442259|NCT01368081|363624111|FG003|Overall Study|Protocol Violation|0|||
105442260|NCT01368081|363624112|FG004|Overall Study|Protocol Violation|0|||
105442261|NCT01368081|363624113|FG005|Overall Study|Protocol Violation|1|||
105442262|NCT01368081|363624114|FG006|Overall Study|Protocol Violation|0|||
105442263|NCT01368081|363624115|FG007|Overall Study|Protocol Violation|1|||
105442264|NCT01368081|363624116|FG008|Overall Study|Protocol Violation|0|||
105442265|NCT01368081|363624117|FG009|Overall Study|Protocol Violation|0|||
105442266|NCT01368081|363624118|FG010|Overall Study|Protocol Violation|0|||
105442267|NCT01368081|363624119|FG011|Overall Study|Protocol Violation|0|||
105442268|NCT01368081|363624120|FG012|Overall Study|Protocol Violation|0|||
105442269|NCT01368081|363624108|FG000|Overall Study|Lost to Follow-up|0|||
105659935|NCT00356811|364418880|FG000|Overall Study|Site Closed during Follow-up|2|||
105659936|NCT02101983|364418881|FG000|Overall Study|Physician Decision|1|||
105659937|NCT02101983|364418882|FG001|Overall Study|Physician Decision|0|||
105659938|NCT01251887|364418883|FG000|Overall Study|Scheduling conflict|1|||
105659939|NCT01251887|364418884|FG001|Overall Study|Scheduling conflict|2|||
105659940|NCT01251887|364418885|FG002|Overall Study|Scheduling conflict|2|||
105659941|NCT01251887|364418883|FG000|Overall Study|Physician Decision|0|||
105659942|NCT01251887|364418884|FG001|Overall Study|Physician Decision|1|||
105659943|NCT01251887|364418885|FG002|Overall Study|Physician Decision|0|||
105659944|NCT03494985|364418886|FG000|Overall Study|Adverse Event|3|||
105659945|NCT03494985|364418887|FG001|Overall Study|Adverse Event|2|||
105659946|NCT03494985|364418888|FG002|Overall Study|Adverse Event|3|||
105659947|NCT03494985|364418889|FG003|Overall Study|Adverse Event|0|||
105659948|NCT03494985|364418886|FG000|Overall Study|Other (Withdrawal of consent)|2|||
105659949|NCT03494985|364418887|FG001|Overall Study|Other (Withdrawal of consent)|3|||
105659950|NCT03494985|364418888|FG002|Overall Study|Other (Withdrawal of consent)|2|||
105659951|NCT03494985|364418889|FG003|Overall Study|Other (Withdrawal of consent)|5|||
105659952|NCT03494985|364418886|FG000|Overall Study|Other (Not specified)|0|||
105659953|NCT03494985|364418887|FG001|Overall Study|Other (Not specified)|1|||
105659954|NCT03494985|364418888|FG002|Overall Study|Other (Not specified)|1|||
105659955|NCT03494985|364418889|FG003|Overall Study|Other (Not specified)|0|||
105659956|NCT03668223|364418890|FG000|Overall Study|Death|10|||
105659957|NCT03668223|364418891|FG001|Overall Study|Death|5|||
105659958|NCT03668223|364418890|FG000|Overall Study|Lost to Follow-up|12|||
105659959|NCT03668223|364418891|FG001|Overall Study|Lost to Follow-up|12|||
105659960|NCT03668223|364418890|FG000|Overall Study|Withdrawal by Subject|8|||
105659961|NCT03668223|364418891|FG001|Overall Study|Withdrawal by Subject|3|||
105659962|NCT01103232|364418892|FG000|Overall Study|Withdrawal by Subject|1|||
105659963|NCT01103232|364418893|FG001|Overall Study|Withdrawal by Subject|1|||
105659964|NCT01103232|364418892|FG000|Overall Study|Protocol Violation|0|||
105659965|NCT01103232|364418893|FG001|Overall Study|Protocol Violation|1|||
105659966|NCT02394925|364418894|FG000|Overall Study|Adverse Event|1|||
105659967|NCT02394925|364418894|FG000|Overall Study|Lens Discomfort|3|||
105442270|NCT01368081|363624109|FG001|Overall Study|Lost to Follow-up|0|||
105442271|NCT01368081|363624110|FG002|Overall Study|Lost to Follow-up|0|||
105659968|NCT02394925|364418894|FG000|Overall Study|Lens handling difficulities|5|||
105659969|NCT02394925|364418894|FG000|Overall Study|Lost to Follow-up|9|||
105659970|NCT02394925|364418894|FG000|Overall Study|Protocol Violation|5|||
105659971|NCT02394925|364418894|FG000|Overall Study|No longer meet eligibility criteria|1|||
105659972|NCT02394925|364418894|FG000|Overall Study|Unsatisfactory Visual Response|5|||
105659973|NCT04577573|364418902|FG000|Overall Study|Technical - invalid protocol|0|||
105659974|NCT04577573|364418903|FG001|Overall Study|Technical - invalid protocol|2|||
105442272|NCT01368081|363624111|FG003|Overall Study|Lost to Follow-up|0|||
105442273|NCT01368081|363624112|FG004|Overall Study|Lost to Follow-up|0|||
105442274|NCT01368081|363624113|FG005|Overall Study|Lost to Follow-up|0|||
105442275|NCT01368081|363624114|FG006|Overall Study|Lost to Follow-up|0|||
105442276|NCT01368081|363624115|FG007|Overall Study|Lost to Follow-up|0|||
105442277|NCT01368081|363624116|FG008|Overall Study|Lost to Follow-up|0|||
105659975|NCT04577573|364418904|FG002|Overall Study|Technical - invalid protocol|0|||
105659976|NCT05347485|364418905|FG000|Overall Study|Death|14|||
105659977|NCT05347485|364418905|FG000|Overall Study|Lost to Follow-up|2|||
105659978|NCT05347485|364418905|FG000|Overall Study|Withdrawal by Subject|13|||
105659979|NCT05347485|364418905|FG000|Overall Study|Progressive Disease|1|||
105659980|NCT05347485|364418905|FG000|Overall Study|Study Terminated by Sponsor|49|||
105659981|NCT05347485|364418905|FG000|Overall Study|Other|1|||
105659982|NCT05347485|364418905|FG000|Overall Study|Enrolled (consented) but not treated|4|||
105659983|NCT05347485|364418905|FG000|Overall Study|Disease Relapse|2|||
105659984|NCT03326193|364418906|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
105659985|NCT03326193|364418906|FG000|Overall Study|Death|19|||
105659986|NCT03326193|364418906|FG000|Overall Study|Withdrawal by Subject|8|||
105659987|NCT02600897|364418907|FG000|Overall Study|Death|1|||
105659988|NCT02600897|364418908|FG001|Overall Study|Death|2|||
105659989|NCT02600897|364418909|FG002|Overall Study|Death|1|||
105659990|NCT02600897|364418910|FG003|Overall Study|Death|2|||
105659991|NCT02600897|364418911|FG004|Overall Study|Death|3|||
105659992|NCT02600897|364418912|FG005|Overall Study|Death|2|||
105659993|NCT02600897|364418913|FG006|Overall Study|Death|10|||
105659994|NCT02600897|364418914|FG007|Overall Study|Death|7|||
105659995|NCT02600897|364418915|FG008|Overall Study|Death|20|||
105659996|NCT02600897|364418907|FG000|Overall Study|Lost to Follow-up|1|||
105659997|NCT02600897|364418908|FG001|Overall Study|Lost to Follow-up|0|||
105659998|NCT02600897|364418909|FG002|Overall Study|Lost to Follow-up|0|||
105659999|NCT02600897|364418910|FG003|Overall Study|Lost to Follow-up|0|||
105660000|NCT02600897|364418911|FG004|Overall Study|Lost to Follow-up|0|||
105660001|NCT02600897|364418912|FG005|Overall Study|Lost to Follow-up|0|||
105660002|NCT02600897|364418913|FG006|Overall Study|Lost to Follow-up|0|||
105660003|NCT02600897|364418914|FG007|Overall Study|Lost to Follow-up|1|||
105660004|NCT02600897|364418915|FG008|Overall Study|Lost to Follow-up|0|||
105660005|NCT02600897|364418907|FG000|Overall Study|Withdrawal by Subject|0|||
105660006|NCT02600897|364418908|FG001|Overall Study|Withdrawal by Subject|0|||
105660007|NCT02600897|364418909|FG002|Overall Study|Withdrawal by Subject|0|||
105660008|NCT02600897|364418910|FG003|Overall Study|Withdrawal by Subject|0|||
105660009|NCT02600897|364418911|FG004|Overall Study|Withdrawal by Subject|0|||
105660010|NCT02600897|364418912|FG005|Overall Study|Withdrawal by Subject|0|||
105660011|NCT02600897|364418913|FG006|Overall Study|Withdrawal by Subject|0|||
105660012|NCT02600897|364418914|FG007|Overall Study|Withdrawal by Subject|4|||
105660013|NCT02600897|364418915|FG008|Overall Study|Withdrawal by Subject|2|||
105660014|NCT02600897|364418907|FG000|Overall Study|Reason Not Specified|0|||
105660015|NCT02600897|364418908|FG001|Overall Study|Reason Not Specified|0|||
105660016|NCT02600897|364418909|FG002|Overall Study|Reason Not Specified|0|||
105660017|NCT02600897|364418910|FG003|Overall Study|Reason Not Specified|0|||
105660018|NCT02600897|364418911|FG004|Overall Study|Reason Not Specified|0|||
105660019|NCT02600897|364418912|FG005|Overall Study|Reason Not Specified|0|||
105660020|NCT02600897|364418913|FG006|Overall Study|Reason Not Specified|0|||
105660021|NCT02600897|364418914|FG007|Overall Study|Reason Not Specified|0|||
105660022|NCT02600897|364418915|FG008|Overall Study|Reason Not Specified|1|||
105660023|NCT03733899|364418916|FG000|Period 1|Protocol Violation|0|||
105660024|NCT03733899|364418917|FG001|Period 1|Protocol Violation|0|||
105660025|NCT03733899|364418918|FG002|Period 1|Protocol Violation|0|||
105660026|NCT03733899|364418919|FG003|Period 1|Protocol Violation|0|||
105660027|NCT03733899|364418920|FG004|Period 1|Protocol Violation|0|||
105660028|NCT03733899|364418921|FG005|Period 1|Protocol Violation|1|||
105660029|NCT03733899|364418916|FG000|Period 2|Unscuccessful Treatment|0|||
105660030|NCT03733899|364418917|FG001|Period 2|Unscuccessful Treatment|1|||
105660031|NCT03733899|364418918|FG002|Period 2|Unscuccessful Treatment|0|||
105660032|NCT03733899|364418919|FG003|Period 2|Unscuccessful Treatment|0|||
105660033|NCT03733899|364418920|FG004|Period 2|Unscuccessful Treatment|0|||
105660034|NCT03733899|364418921|FG005|Period 2|Unscuccessful Treatment|0|||
105660035|NCT03733899|364418916|FG000|Period 3|Withdrawal by Subject|1|||
105660036|NCT03733899|364418917|FG001|Period 3|Withdrawal by Subject|0|||
105660037|NCT03733899|364418918|FG002|Period 3|Withdrawal by Subject|0|||
105660038|NCT03733899|364418919|FG003|Period 3|Withdrawal by Subject|0|||
105660039|NCT03733899|364418920|FG004|Period 3|Withdrawal by Subject|0|||
105660040|NCT03733899|364418921|FG005|Period 3|Withdrawal by Subject|0|||
105660041|NCT03614676|364421004|FG000|Overall Study|Delivery before planned visit|2|||
105660042|NCT03614676|364421005|FG001|Overall Study|Delivery before planned visit|0|||
105660043|NCT03614676|364421004|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
105660044|NCT03614676|364421005|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
105660045|NCT03614676|364421004|FG000|Overall Study|Migrated / moved from the study area|30|||
105660046|NCT03614676|364421005|FG001|Overall Study|Migrated / moved from the study area|22|||
105660047|NCT03614676|364421004|FG000|Overall Study|Lost to Follow-up|17|||
105660048|NCT03614676|364421005|FG001|Overall Study|Lost to Follow-up|42|||
105660049|NCT03614676|364421004|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
105660050|NCT03614676|364421005|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
105660051|NCT03614676|364421004|FG000|Overall Study|Other|16|||
105660052|NCT03614676|364421005|FG001|Overall Study|Other|47|||
105660053|NCT03614676|364421004|FG000|Overall Study|Protocol Violation|0|||
105660054|NCT03614676|364421005|FG001|Overall Study|Protocol Violation|2|||
105660055|NCT03614676|364421004|FG000|Overall Study|Neonatal event of interest|0|||
105660056|NCT03614676|364421005|FG001|Overall Study|Neonatal event of interest|6|||
105660057|NCT03614676|364421004|FG000|Overall Study|Death in infant greater than 28 days old|0|||
105660058|NCT03614676|364421005|FG001|Overall Study|Death in infant greater than 28 days old|12|||
105660059|NCT03614676|364421004|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
105660060|NCT03614676|364421005|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
105660061|NCT01256671|364421013|FG000|Overall Study|Adverse Event|29|||
105660062|NCT01256671|364421013|FG000|Overall Study|Lost to Follow-up|16|||
105660063|NCT01256671|364421013|FG000|Overall Study|Withdrawal by Subject|31|||
105660064|NCT01256671|364421013|FG000|Overall Study|Physician Decision|3|||
105660065|NCT01256671|364421013|FG000|Overall Study|Lack of Efficacy|4|||
105660066|NCT01256671|364421013|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
105660067|NCT02161406|364421014|FG000|Overall Study|Death|2|||
105660068|NCT02161406|364421015|FG001|Overall Study|Death|1|||
105660069|NCT02161406|364421014|FG000|Overall Study|Lost to Follow-up|2|||
105660070|NCT02161406|364421015|FG001|Overall Study|Lost to Follow-up|1|||
105660071|NCT02161406|364421014|FG000|Overall Study|Withdrawal by Subject|2|||
105660072|NCT02161406|364421015|FG001|Overall Study|Withdrawal by Subject|4|||
105660073|NCT02161406|364421014|FG000|Overall Study|investigator withdrew subject|3|||
105660074|NCT02161406|364421015|FG001|Overall Study|investigator withdrew subject|1|||
105660075|NCT02161406|364421014|FG000|Overall Study|Lack of Efficacy|1|||
105660076|NCT02161406|364421015|FG001|Overall Study|Lack of Efficacy|1|||
105660077|NCT02161406|364421014|FG000|Overall Study|relocation|0|||
105660078|NCT02161406|364421015|FG001|Overall Study|relocation|1|||
105660079|NCT01986114|364421016|FG000|Overall Study|Adverse Event|59|||
105660080|NCT01986114|364421016|FG000|Overall Study|Lack of Efficacy|23|||
105660081|NCT01986114|364421016|FG000|Overall Study|Withdrawal by Subject|58|||
105660082|NCT01986114|364421016|FG000|Overall Study|Noncompliance|3|||
105660083|NCT01986114|364421016|FG000|Overall Study|Protocol Violation|1|||
105660084|NCT01986114|364421016|FG000|Overall Study|Lost to Follow-up|5|||
105660085|NCT01986114|364421016|FG000|Overall Study|Other reason|7|||
105660086|NCT01190644|364421017|FG000|Overall Study|Death|2|||
105660087|NCT01190644|364421017|FG000|Overall Study|Disease progression|1|||
105660088|NCT02808975|364421018|FG000|Overall Study|Adverse Event|3|||
105660089|NCT02808975|364421019|FG001|Overall Study|Adverse Event|4|||
105660090|NCT02808975|364421018|FG000|Overall Study|Withdrew consent|9|||
105660091|NCT02808975|364421019|FG001|Overall Study|Withdrew consent|8|||
105660092|NCT02808975|364421018|FG000|Overall Study|Lost to Follow-up|4|||
105660093|NCT02808975|364421019|FG001|Overall Study|Lost to Follow-up|6|||
105660094|NCT02808975|364421018|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
105660095|NCT02808975|364421019|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
105660096|NCT02808975|364421018|FG000|Overall Study|Other, not specified|5|||
105660097|NCT02808975|364421019|FG001|Overall Study|Other, not specified|1|||
105660098|NCT02418845|364421020|FG000|Overall Study|Lost to Follow-up|7|||
105660099|NCT02418845|364421021|FG001|Overall Study|Lost to Follow-up|2|||
105660100|NCT02418845|364421020|FG000|Overall Study|Lack of Efficacy|0|||
105660101|NCT02418845|364421021|FG001|Overall Study|Lack of Efficacy|3|||
105660102|NCT02418845|364421020|FG000|Overall Study|Physician Decision|5|||
105660103|NCT02418845|364421021|FG001|Overall Study|Physician Decision|5|||
105660104|NCT02418845|364421020|FG000|Overall Study|Protocol Violation|1|||
105660105|NCT02418845|364421021|FG001|Overall Study|Protocol Violation|0|||
105660106|NCT02418845|364421020|FG000|Overall Study|Withdrawal by Subject|3|||
105660107|NCT02418845|364421021|FG001|Overall Study|Withdrawal by Subject|2|||
105660108|NCT00730015|364421026|FG000|Overall Study|Adverse Event|11|||
105660109|NCT00730015|364421027|FG001|Overall Study|Adverse Event|10|||
105660110|NCT00730015|364421028|FG002|Overall Study|Adverse Event|8|||
105660111|NCT00730015|364421026|FG000|Overall Study|Protocol Violation|2|||
105660112|NCT00730015|364421027|FG001|Overall Study|Protocol Violation|6|||
105660113|NCT00730015|364421028|FG002|Overall Study|Protocol Violation|4|||
105660114|NCT00730015|364421026|FG000|Overall Study|Withdrawal by Subject|12|||
105660115|NCT00730015|364421027|FG001|Overall Study|Withdrawal by Subject|12|||
105660116|NCT00730015|364421028|FG002|Overall Study|Withdrawal by Subject|8|||
105660117|NCT00730015|364421026|FG000|Overall Study|Lost to Follow-up|4|||
105660118|NCT00730015|364421027|FG001|Overall Study|Lost to Follow-up|10|||
105660119|NCT00730015|364421028|FG002|Overall Study|Lost to Follow-up|3|||
105660120|NCT00730015|364421026|FG000|Overall Study|Lack of Efficacy|1|||
105660121|NCT00730015|364421027|FG001|Overall Study|Lack of Efficacy|2|||
105660122|NCT00730015|364421028|FG002|Overall Study|Lack of Efficacy|8|||
105660123|NCT00730015|364421026|FG000|Overall Study|Other Reason|1|||
105660124|NCT00730015|364421027|FG001|Overall Study|Other Reason|0|||
105660125|NCT00730015|364421028|FG002|Overall Study|Other Reason|1|||
105660126|NCT03113383|364421029|FG000|Overall Study|Death|4|||
105660127|NCT03113383|364421030|FG001|Overall Study|Death|0|||
105660128|NCT04120376|364421031|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
105660129|NCT04120376|364421032|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
105660130|NCT02053610|364421033|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
105660131|NCT02053610|364421034|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
105660132|NCT02053610|364421033|FG000|Overall Study|Withdrew Consent|2|||
105660133|NCT02053610|364421034|FG001|Overall Study|Withdrew Consent|9|||
105660134|NCT02053610|364421033|FG000|Overall Study|Death|5|||
105660135|NCT02053610|364421034|FG001|Overall Study|Death|5|||
105660136|NCT02053610|364421033|FG000|Overall Study|Administrative/Other|1|||
105660137|NCT02053610|364421034|FG001|Overall Study|Administrative/Other|1|||
105660138|NCT02053610|364421033|FG000|Overall Study|Disease Progression|2|||
105442278|NCT01368081|363624117|FG009|Overall Study|Lost to Follow-up|0|||
105442279|NCT01368081|363624118|FG010|Overall Study|Lost to Follow-up|0|||
105442280|NCT01368081|363624119|FG011|Overall Study|Lost to Follow-up|0|||
105442281|NCT01368081|363624120|FG012|Overall Study|Lost to Follow-up|1|||
105442282|NCT01368081|363624108|FG000|Overall Study|Withdrawal by Subject|4|||
105442283|NCT01368081|363624109|FG001|Overall Study|Withdrawal by Subject|4|||
105442284|NCT01368081|363624110|FG002|Overall Study|Withdrawal by Subject|1|||
105442285|NCT01368081|363624111|FG003|Overall Study|Withdrawal by Subject|1|||
105442286|NCT01368081|363624112|FG004|Overall Study|Withdrawal by Subject|0|||
105442287|NCT01368081|363624113|FG005|Overall Study|Withdrawal by Subject|3|||
105442288|NCT01368081|363624114|FG006|Overall Study|Withdrawal by Subject|4|||
105442289|NCT01368081|363624115|FG007|Overall Study|Withdrawal by Subject|2|||
105442290|NCT01368081|363624116|FG008|Overall Study|Withdrawal by Subject|5|||
105442291|NCT01368081|363624117|FG009|Overall Study|Withdrawal by Subject|4|||
105442292|NCT01368081|363624118|FG010|Overall Study|Withdrawal by Subject|3|||
105442293|NCT01368081|363624119|FG011|Overall Study|Withdrawal by Subject|2|||
105442294|NCT01368081|363624120|FG012|Overall Study|Withdrawal by Subject|0|||
105442295|NCT01368081|363624108|FG000|Overall Study|Other reason not defined above|2|||
105442296|NCT01368081|363624109|FG001|Overall Study|Other reason not defined above|0|||
105442297|NCT01368081|363624110|FG002|Overall Study|Other reason not defined above|0|||
105442298|NCT01368081|363624111|FG003|Overall Study|Other reason not defined above|1|||
105442299|NCT01368081|363624112|FG004|Overall Study|Other reason not defined above|0|||
105442300|NCT01368081|363624113|FG005|Overall Study|Other reason not defined above|1|||
105442301|NCT01368081|363624114|FG006|Overall Study|Other reason not defined above|2|||
105442302|NCT01368081|363624115|FG007|Overall Study|Other reason not defined above|0|||
105442303|NCT01368081|363624116|FG008|Overall Study|Other reason not defined above|0|||
105442304|NCT01368081|363624117|FG009|Overall Study|Other reason not defined above|1|||
105442305|NCT01368081|363624118|FG010|Overall Study|Other reason not defined above|0|||
105442306|NCT01368081|363624119|FG011|Overall Study|Other reason not defined above|0|||
105442307|NCT01368081|363624120|FG012|Overall Study|Other reason not defined above|3|||
105442308|NCT00782483|363624122|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
105442309|NCT02123576|363624125|FG000|Overall Study|Adverse Event|1|||
105442310|NCT02123576|363624126|FG001|Overall Study|Adverse Event|0|||
105442311|NCT02475278|363626684|FG000|Overall Study|Lost to Follow-up|1|||
105442312|NCT02475278|363626684|FG000|Overall Study|Reason Not Specified|1|||
105442313|NCT00826618|363626687|FG000|Overall Study|Withdrawal by Subject|1|||
105442314|NCT01487265|363626688|FG000|Overall Study|Adverse Event|8|||
105442315|NCT01487265|363626688|FG000|Overall Study|Withdrawal by Subject|5|||
105442316|NCT01487265|363626688|FG000|Overall Study|Disease Progression|21|||
105442317|NCT01487265|363626688|FG000|Overall Study|Death|2|||
105442318|NCT01487265|363626688|FG000|Overall Study|Still on Treatment|1|||
105442319|NCT05111249|363626689|FG000|Overall Study|Lost to Follow-up|0|||
105442320|NCT05111249|363626690|FG001|Overall Study|Lost to Follow-up|2|||
105442321|NCT05111249|363626689|FG000|Overall Study|Physician Decision|0|||
105442322|NCT05111249|363626690|FG001|Overall Study|Physician Decision|1|||
105442323|NCT05111249|363626689|FG000|Overall Study|Participant decision|1|||
105442324|NCT05111249|363626690|FG001|Overall Study|Participant decision|5|||
105442325|NCT03412812|363626691|FG000|Level 1|Death|3|||
105442326|NCT03412812|363626692|FG001|Level 1|Death|0|||
105442327|NCT03412812|363626691|FG000|Level 1|Adverse Event|0|||
105442328|NCT03412812|363626692|FG001|Level 1|Adverse Event|1|||
105442329|NCT01016600|363626694|FG000|Overall Study|Did not start treatment|1|||
105442330|NCT01016600|363626695|FG001|Overall Study|Did not start treatment|0|||
105442331|NCT01016600|363626696|FG002|Overall Study|Did not start treatment|0|||
105442332|NCT01016600|363626697|FG003|Overall Study|Did not start treatment|0|||
105442333|NCT00265317|363626700|FG000|Lead-In|Objective progression or relapse|6|||
105442334|NCT00265317|363626701|FG001|Lead-In|Objective progression or relapse|11|||
105442335|NCT00265317|363626702|FG002|Lead-In|Objective progression or relapse|0|||
105442336|NCT00265317|363626703|FG003|Lead-In|Objective progression or relapse|0|||
105442337|NCT00265317|363626700|FG000|Lead-In|Adverse Event|2|||
105442338|NCT00265317|363626701|FG001|Lead-In|Adverse Event|1|||
105442339|NCT00265317|363626702|FG002|Lead-In|Adverse Event|0|||
105442340|NCT00265317|363626703|FG003|Lead-In|Adverse Event|0|||
105442341|NCT00265317|363626700|FG000|Lead-In|Death|3|||
105442342|NCT00265317|363626701|FG001|Lead-In|Death|5|||
105660139|NCT02053610|364421034|FG001|Overall Study|Disease Progression|3|||
105660140|NCT02053610|364421033|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
105442343|NCT00265317|363626702|FG002|Lead-In|Death|0|||
105442344|NCT00265317|363626703|FG003|Lead-In|Death|0|||
105442345|NCT00265317|363626700|FG000|Lead-In|Withdrawal/other than adverse event|1|||
105442346|NCT00265317|363626701|FG001|Lead-In|Withdrawal/other than adverse event|0|||
105442347|NCT00265317|363626702|FG002|Lead-In|Withdrawal/other than adverse event|0|||
105442348|NCT00265317|363626703|FG003|Lead-In|Withdrawal/other than adverse event|0|||
105442349|NCT00265317|363626700|FG000|Phase 2|Objective progression or relapse|0|||
105442350|NCT00265317|363626701|FG001|Phase 2|Objective progression or relapse|0|||
105442351|NCT00265317|363626702|FG002|Phase 2|Objective progression or relapse|37|||
105442352|NCT00265317|363626703|FG003|Phase 2|Objective progression or relapse|38|||
105442353|NCT00265317|363626700|FG000|Phase 2|Global deterioration of health status|0|||
105442354|NCT00265317|363626701|FG001|Phase 2|Global deterioration of health status|0|||
105442355|NCT00265317|363626702|FG002|Phase 2|Global deterioration of health status|3|||
105442356|NCT00265317|363626703|FG003|Phase 2|Global deterioration of health status|0|||
105442357|NCT00265317|363626700|FG000|Phase 2|Adverse Event|0|||
105442358|NCT00265317|363626701|FG001|Phase 2|Adverse Event|0|||
105442359|NCT00265317|363626702|FG002|Phase 2|Adverse Event|7|||
105442360|NCT00265317|363626703|FG003|Phase 2|Adverse Event|5|||
105442361|NCT00265317|363626700|FG000|Phase 2|Death|0|||
105442362|NCT00265317|363626701|FG001|Phase 2|Death|0|||
105442363|NCT00265317|363626702|FG002|Phase 2|Death|12|||
105442364|NCT00265317|363626703|FG003|Phase 2|Death|15|||
105442365|NCT00265317|363626700|FG000|Phase 2|Protocol Violation|0|||
105442366|NCT00265317|363626701|FG001|Phase 2|Protocol Violation|0|||
105442367|NCT00265317|363626702|FG002|Phase 2|Protocol Violation|1|||
105442368|NCT00265317|363626703|FG003|Phase 2|Protocol Violation|4|||
105442369|NCT00265317|363626700|FG000|Phase 2|Lost to Follow-up|0|||
105442370|NCT00265317|363626701|FG001|Phase 2|Lost to Follow-up|0|||
105442371|NCT00265317|363626702|FG002|Phase 2|Lost to Follow-up|0|||
105442372|NCT00265317|363626703|FG003|Phase 2|Lost to Follow-up|1|||
105442373|NCT00265317|363626700|FG000|Phase 2|Withdrawal/other than adverse event|0|||
105442374|NCT00265317|363626701|FG001|Phase 2|Withdrawal/other than adverse event|0|||
105442375|NCT00265317|363626702|FG002|Phase 2|Withdrawal/other than adverse event|2|||
105442376|NCT00265317|363626703|FG003|Phase 2|Withdrawal/other than adverse event|1|||
105442377|NCT00265317|363626700|FG000|Phase 2|Study terminated by sponsor|0|||
105442378|NCT00265317|363626701|FG001|Phase 2|Study terminated by sponsor|0|||
105442379|NCT00265317|363626702|FG002|Phase 2|Study terminated by sponsor|1|||
105442380|NCT00265317|363626703|FG003|Phase 2|Study terminated by sponsor|0|||
105442381|NCT00265317|363626700|FG000|Phase 2|Other|0|||
105442382|NCT00265317|363626701|FG001|Phase 2|Other|0|||
105442383|NCT00265317|363626702|FG002|Phase 2|Other|1|||
105442384|NCT00265317|363626703|FG003|Phase 2|Other|1|||
105442385|NCT03826186|363626706|FG000|Overall Study|Protocol Violation|2|||
105442386|NCT03826186|363626707|FG001|Overall Study|Protocol Violation|0|||
105442387|NCT03826186|363626706|FG000|Overall Study|Withdrawal by Subject|1|||
105442388|NCT03826186|363626707|FG001|Overall Study|Withdrawal by Subject|0|||
105442389|NCT01424501|363626708|FG000|Overall Study|Withdrawal by Subject|1|||
105442390|NCT01424501|363626709|FG001|Overall Study|Withdrawal by Subject|0|||
105442391|NCT01424501|363626710|FG002|Overall Study|Withdrawal by Subject|1|||
105442392|NCT01424501|363626711|FG003|Overall Study|Withdrawal by Subject|0|||
105442393|NCT01424501|363626712|FG004|Overall Study|Withdrawal by Subject|0|||
105442394|NCT01424501|363626713|FG005|Overall Study|Withdrawal by Subject|0|||
105442395|NCT01424501|363626708|FG000|Overall Study|Lost to Follow-up|0|||
105442396|NCT01424501|363626709|FG001|Overall Study|Lost to Follow-up|1|||
105442397|NCT01424501|363626710|FG002|Overall Study|Lost to Follow-up|1|||
105442398|NCT01424501|363626711|FG003|Overall Study|Lost to Follow-up|0|||
105442399|NCT01424501|363626712|FG004|Overall Study|Lost to Follow-up|0|||
105442400|NCT01424501|363626713|FG005|Overall Study|Lost to Follow-up|0|||
105442401|NCT03688074|363626715|FG000|Overall Study|Adverse Event|0|||
105442402|NCT03688074|363626716|FG001|Overall Study|Adverse Event|1|||
105442403|NCT03688074|363626715|FG000|Overall Study|Other|1|||
105442404|NCT03688074|363626716|FG001|Overall Study|Other|0|||
105442405|NCT00660179|363626721|FG000|Overall Study|Death|44|||
105442406|NCT00660179|363626722|FG001|Overall Study|Death|47|||
105442407|NCT00660179|363626723|FG002|Overall Study|Death|34|||
105442408|NCT00660179|363626721|FG000|Overall Study|Withdrawal of consent|4|||
105442409|NCT00660179|363626722|FG001|Overall Study|Withdrawal of consent|6|||
105442410|NCT00660179|363626723|FG002|Overall Study|Withdrawal of consent|4|||
105442411|NCT00660179|363626721|FG000|Overall Study|Lost to Follow-up|7|||
105442412|NCT00660179|363626722|FG001|Overall Study|Lost to Follow-up|5|||
105442413|NCT00660179|363626723|FG002|Overall Study|Lost to Follow-up|2|||
105442414|NCT00660179|363626721|FG000|Overall Study|Administrative reason|0|||
105442415|NCT00660179|363626722|FG001|Overall Study|Administrative reason|0|||
105442416|NCT00660179|363626723|FG002|Overall Study|Administrative reason|1|||
105442417|NCT00660179|363626721|FG000|Overall Study|Incorrect randomization|1|||
105442418|NCT00660179|363626722|FG001|Overall Study|Incorrect randomization|0|||
105442419|NCT00660179|363626723|FG002|Overall Study|Incorrect randomization|0|||
105442420|NCT02255461|363626724|FG000|Overall Study|Adverse Event|0|||
105442421|NCT02255461|363626725|FG001|Overall Study|Adverse Event|1|||
105442422|NCT02255461|363626726|FG002|Overall Study|Adverse Event|0|||
105442423|NCT02255461|363626727|FG003|Overall Study|Adverse Event|0|||
105442424|NCT02255461|363626728|FG004|Overall Study|Adverse Event|1|||
105660141|NCT02053610|364421034|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
105660142|NCT02053610|364421033|FG000|Overall Study|Did not Receive Treatment|4|||
105660143|NCT02053610|364421034|FG001|Overall Study|Did not Receive Treatment|2|||
105660144|NCT02053610|364421033|FG000|Overall Study|Insufficient Therapeutic Response|1|||
105660145|NCT02053610|364421034|FG001|Overall Study|Insufficient Therapeutic Response|1|||
105660146|NCT02053610|364421033|FG000|Overall Study|Violation of Selection Criteria|1|||
105660147|NCT02053610|364421034|FG001|Overall Study|Violation of Selection Criteria|0|||
105660148|NCT03568812|364421035|FG000|Overall Study|Physician Decision|0|||
105660149|NCT03568812|364421036|FG001|Overall Study|Physician Decision|1|||
105660150|NCT00464945|364421037|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
105660151|NCT00464945|364421038|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
105660152|NCT00464945|364421037|FG000|Infant Series|Protocol Violation|1|||
105660153|NCT00464945|364421038|FG001|Infant Series|Protocol Violation|0|||
105660154|NCT00464945|364421037|FG000|Infant Series|Lost to Follow-up|1|||
105660155|NCT00464945|364421038|FG001|Infant Series|Lost to Follow-up|0|||
105660156|NCT00464945|364421037|FG000|After Infant Series|Withdrawal by Subject|0|||
105660157|NCT00464945|364421038|FG001|After Infant Series|Withdrawal by Subject|2|||
105660158|NCT00464945|364421037|FG000|Toddler Dose|Lost to Follow-up|0|||
105660159|NCT00464945|364421038|FG001|Toddler Dose|Lost to Follow-up|1|||
105660160|NCT01496365|364421043|FG000|Overall Study|Adverse Event|2|||
105660161|NCT01496365|364421044|FG001|Overall Study|Adverse Event|3|||
105660162|NCT01496365|364421045|FG002|Overall Study|Adverse Event|3|||
105660163|NCT01496365|364421046|FG003|Overall Study|Adverse Event|2|||
105770550|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105442425|NCT02255461|363626724|FG000|Overall Study|Withdrawal by Subject|0|||
105442426|NCT02255461|363626725|FG001|Overall Study|Withdrawal by Subject|0|||
105442427|NCT02255461|363626726|FG002|Overall Study|Withdrawal by Subject|1|||
105442428|NCT02255461|363626727|FG003|Overall Study|Withdrawal by Subject|0|||
105442429|NCT02255461|363626728|FG004|Overall Study|Withdrawal by Subject|1|||
105442430|NCT02255461|363626724|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
105442431|NCT02255461|363626725|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
105442432|NCT02255461|363626726|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
105442433|NCT02255461|363626727|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
105442434|NCT02255461|363626728|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
105442435|NCT04838626|363626731|FG000|Overall Study|Adverse Event|2|||
105442436|NCT04838626|363626731|FG000|Overall Study|Physician Decision|6|||
105442437|NCT04838626|363626731|FG000|Overall Study|Protocol Violation|3|||
105442438|NCT04838626|363626731|FG000|Overall Study|Withdrawal by Subject|9|||
105442439|NCT04838626|363626731|FG000|Overall Study|Technical Problems|2|||
105442440|NCT01726582|363626732|FG000|Overall Study|Physician Decision|99|||
105442441|NCT01726582|363626732|FG000|Overall Study|Death|85|||
105442442|NCT02034877|363626733|FG000|Overall Study|Lost to Follow-up|0|||
105442443|NCT02034877|363626734|FG001|Overall Study|Lost to Follow-up|3|||
105442444|NCT02034877|363626733|FG000|Overall Study|No Longer Willing to Participate|0|||
105442445|NCT02034877|363626734|FG001|Overall Study|No Longer Willing to Participate|3|||
105442446|NCT04878211|363626736|FG000|Overall Study|Lost to Follow-up|0|||
105442447|NCT04878211|363626737|FG001|Overall Study|Lost to Follow-up|0|||
105442448|NCT04878211|363626738|FG002|Overall Study|Lost to Follow-up|0|||
105442449|NCT04878211|363626739|FG003|Overall Study|Lost to Follow-up|1|||
105442450|NCT04878211|363626740|FG004|Overall Study|Lost to Follow-up|0|||
105442451|NCT04878211|363626741|FG005|Overall Study|Lost to Follow-up|1|||
105442452|NCT04878211|363626736|FG000|Overall Study|Protocol deviation|1|||
105442453|NCT04878211|363626737|FG001|Overall Study|Protocol deviation|0|||
105442454|NCT04878211|363626738|FG002|Overall Study|Protocol deviation|0|||
105442455|NCT04878211|363626739|FG003|Overall Study|Protocol deviation|0|||
105442456|NCT04878211|363626740|FG004|Overall Study|Protocol deviation|0|||
105442457|NCT04878211|363626741|FG005|Overall Study|Protocol deviation|0|||
105442458|NCT04878211|363626736|FG000|Overall Study|Study terminated by sponsor|0|||
105442459|NCT04878211|363626737|FG001|Overall Study|Study terminated by sponsor|0|||
105442460|NCT04878211|363626738|FG002|Overall Study|Study terminated by sponsor|0|||
105442461|NCT04878211|363626739|FG003|Overall Study|Study terminated by sponsor|0|||
105442462|NCT04878211|363626740|FG004|Overall Study|Study terminated by sponsor|9|||
105442463|NCT04878211|363626741|FG005|Overall Study|Study terminated by sponsor|4|||
105442464|NCT04878211|363626736|FG000|Overall Study|Subject decision|0|||
105660164|NCT01496365|364421047|FG004|Overall Study|Adverse Event|5|||
105660165|NCT01496365|364421048|FG005|Overall Study|Adverse Event|6|||
105660166|NCT01496365|364421049|FG006|Overall Study|Adverse Event|4|||
105660167|NCT01496365|364421043|FG000|Overall Study|Withdrawal by Subject|6|||
105770551|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
105442465|NCT04878211|363626737|FG001|Overall Study|Subject decision|0|||
105442466|NCT04878211|363626738|FG002|Overall Study|Subject decision|0|||
105442467|NCT04878211|363626739|FG003|Overall Study|Subject decision|0|||
105442468|NCT04878211|363626740|FG004|Overall Study|Subject decision|1|||
105442469|NCT04878211|363626741|FG005|Overall Study|Subject decision|0|||
105442470|NCT01564732|363626748|FG000|Overall Study|Early termination by the study sponsor|6|||
105660168|NCT01496365|364421044|FG001|Overall Study|Withdrawal by Subject|6|||
105660169|NCT01496365|364421045|FG002|Overall Study|Withdrawal by Subject|0|||
105660170|NCT01496365|364421046|FG003|Overall Study|Withdrawal by Subject|1|||
105660171|NCT01496365|364421047|FG004|Overall Study|Withdrawal by Subject|3|||
105660172|NCT01496365|364421048|FG005|Overall Study|Withdrawal by Subject|2|||
105660173|NCT01496365|364421049|FG006|Overall Study|Withdrawal by Subject|1|||
105660174|NCT01496365|364421043|FG000|Overall Study|Protocol Violation|2|||
105660175|NCT01496365|364421044|FG001|Overall Study|Protocol Violation|1|||
105660176|NCT01496365|364421045|FG002|Overall Study|Protocol Violation|1|||
105660177|NCT01496365|364421046|FG003|Overall Study|Protocol Violation|0|||
105660178|NCT01496365|364421047|FG004|Overall Study|Protocol Violation|0|||
105660179|NCT01496365|364421048|FG005|Overall Study|Protocol Violation|1|||
105660180|NCT01496365|364421049|FG006|Overall Study|Protocol Violation|0|||
105660181|NCT01496365|364421043|FG000|Overall Study|Lack of Efficacy|1|||
105660182|NCT01496365|364421044|FG001|Overall Study|Lack of Efficacy|0|||
105660183|NCT01496365|364421045|FG002|Overall Study|Lack of Efficacy|0|||
105660184|NCT01496365|364421046|FG003|Overall Study|Lack of Efficacy|0|||
105660185|NCT01496365|364421047|FG004|Overall Study|Lack of Efficacy|0|||
105660186|NCT01496365|364421048|FG005|Overall Study|Lack of Efficacy|1|||
105660187|NCT01496365|364421049|FG006|Overall Study|Lack of Efficacy|0|||
105660188|NCT01496365|364421043|FG000|Overall Study|Lost to Follow-up|0|||
105660189|NCT01496365|364421044|FG001|Overall Study|Lost to Follow-up|1|||
105660190|NCT01496365|364421045|FG002|Overall Study|Lost to Follow-up|0|||
105660191|NCT01496365|364421046|FG003|Overall Study|Lost to Follow-up|0|||
105660192|NCT01496365|364421047|FG004|Overall Study|Lost to Follow-up|2|||
105660193|NCT01496365|364421048|FG005|Overall Study|Lost to Follow-up|0|||
105660194|NCT01496365|364421049|FG006|Overall Study|Lost to Follow-up|0|||
105660195|NCT01496365|364421043|FG000|Overall Study|Other|4|||
105660196|NCT01496365|364421044|FG001|Overall Study|Other|4|||
105660197|NCT01496365|364421045|FG002|Overall Study|Other|2|||
105660198|NCT01496365|364421046|FG003|Overall Study|Other|1|||
105660199|NCT01496365|364421047|FG004|Overall Study|Other|3|||
105660200|NCT01496365|364421048|FG005|Overall Study|Other|0|||
105660201|NCT01496365|364421049|FG006|Overall Study|Other|1|||
105660202|NCT01843777|364421051|FG000|Overall Study|Withdrawal by Subject|1|||
105660203|NCT01843777|364421052|FG001|Overall Study|Withdrawal by Subject|0|||
105660204|NCT01475461|364421053|FG000|Run-in Period|Not meet eligibility criteria|16|||
105660205|NCT01475461|364421054|FG001|Run-in Period|Not meet eligibility criteria|0|||
105660206|NCT01475461|364421055|FG002|Run-in Period|Not meet eligibility criteria|0|||
105660207|NCT01475461|364421056|FG003|Run-in Period|Not meet eligibility criteria|0|||
105660208|NCT01475461|364421057|FG004|Run-in Period|Not meet eligibility criteria|0|||
105660209|NCT01475461|364421058|FG005|Run-in Period|Not meet eligibility criteria|0|||
105660210|NCT01475461|364421059|FG006|Run-in Period|Not meet eligibility criteria|0|||
105660211|NCT01475461|364421053|FG000|Run-in Period|Lost to Follow-up|7|||
105660212|NCT01475461|364421054|FG001|Run-in Period|Lost to Follow-up|0|||
105660213|NCT01475461|364421055|FG002|Run-in Period|Lost to Follow-up|0|||
105660214|NCT01475461|364421056|FG003|Run-in Period|Lost to Follow-up|0|||
105660215|NCT01475461|364421057|FG004|Run-in Period|Lost to Follow-up|0|||
105660216|NCT01475461|364421058|FG005|Run-in Period|Lost to Follow-up|0|||
105660217|NCT01475461|364421059|FG006|Run-in Period|Lost to Follow-up|0|||
105660218|NCT01475461|364421053|FG000|Run-in Period|Withdrawal by Subject|11|||
105660219|NCT01475461|364421054|FG001|Run-in Period|Withdrawal by Subject|0|||
105660220|NCT01475461|364421055|FG002|Run-in Period|Withdrawal by Subject|0|||
105660221|NCT01475461|364421056|FG003|Run-in Period|Withdrawal by Subject|0|||
105660222|NCT01475461|364421057|FG004|Run-in Period|Withdrawal by Subject|0|||
105660223|NCT01475461|364421058|FG005|Run-in Period|Withdrawal by Subject|0|||
105660224|NCT01475461|364421059|FG006|Run-in Period|Withdrawal by Subject|0|||
105660225|NCT01475461|364421053|FG000|Run-in Period|Other|3|||
105660226|NCT01475461|364421054|FG001|Run-in Period|Other|0|||
105660227|NCT01475461|364421055|FG002|Run-in Period|Other|0|||
105660228|NCT01475461|364421056|FG003|Run-in Period|Other|0|||
105660229|NCT01475461|364421057|FG004|Run-in Period|Other|0|||
105660230|NCT01475461|364421058|FG005|Run-in Period|Other|0|||
105660231|NCT01475461|364421059|FG006|Run-in Period|Other|0|||
105660232|NCT01475461|364421053|FG000|Run-in Period|Protocol Violation|4|||
105660233|NCT01475461|364421054|FG001|Run-in Period|Protocol Violation|0|||
105660234|NCT01475461|364421055|FG002|Run-in Period|Protocol Violation|0|||
105660235|NCT01475461|364421056|FG003|Run-in Period|Protocol Violation|0|||
105660236|NCT01475461|364421057|FG004|Run-in Period|Protocol Violation|0|||
105660237|NCT01475461|364421058|FG005|Run-in Period|Protocol Violation|0|||
105660238|NCT01475461|364421059|FG006|Run-in Period|Protocol Violation|0|||
105660239|NCT01475461|364421053|FG000|Treatment Period|Death|0|||
105660240|NCT01475461|364421054|FG001|Treatment Period|Death|0|||
105660241|NCT01475461|364421055|FG002|Treatment Period|Death|0|||
105660242|NCT01475461|364421056|FG003|Treatment Period|Death|1|||
105660243|NCT01475461|364421057|FG004|Treatment Period|Death|0|||
105660244|NCT01475461|364421058|FG005|Treatment Period|Death|0|||
105660245|NCT01475461|364421059|FG006|Treatment Period|Death|0|||
105660246|NCT01475461|364421053|FG000|Treatment Period|Lost to Follow-up|0|||
105660247|NCT01475461|364421054|FG001|Treatment Period|Lost to Follow-up|3|||
105660248|NCT01475461|364421055|FG002|Treatment Period|Lost to Follow-up|2|||
105660249|NCT01475461|364421056|FG003|Treatment Period|Lost to Follow-up|3|||
105660250|NCT01475461|364421057|FG004|Treatment Period|Lost to Follow-up|1|||
105660251|NCT01475461|364421058|FG005|Treatment Period|Lost to Follow-up|2|||
105660252|NCT01475461|364421059|FG006|Treatment Period|Lost to Follow-up|1|||
105660253|NCT01475461|364421053|FG000|Treatment Period|Withdrawal by Subject|0|||
105660254|NCT01475461|364421054|FG001|Treatment Period|Withdrawal by Subject|2|||
105660255|NCT01475461|364421055|FG002|Treatment Period|Withdrawal by Subject|2|||
105660256|NCT01475461|364421056|FG003|Treatment Period|Withdrawal by Subject|0|||
105660257|NCT01475461|364421057|FG004|Treatment Period|Withdrawal by Subject|2|||
105660258|NCT01475461|364421058|FG005|Treatment Period|Withdrawal by Subject|2|||
105660259|NCT01475461|364421059|FG006|Treatment Period|Withdrawal by Subject|0|||
105660260|NCT01475461|364421053|FG000|Treatment Period|Other|0|||
105660261|NCT01475461|364421054|FG001|Treatment Period|Other|1|||
105660262|NCT01475461|364421055|FG002|Treatment Period|Other|0|||
105660263|NCT01475461|364421056|FG003|Treatment Period|Other|0|||
105660264|NCT01475461|364421057|FG004|Treatment Period|Other|0|||
105660265|NCT01475461|364421058|FG005|Treatment Period|Other|0|||
105660266|NCT01475461|364421059|FG006|Treatment Period|Other|0|||
105660267|NCT01475461|364421053|FG000|Treatment Period|Protocol Violation|0|||
105660268|NCT01475461|364421054|FG001|Treatment Period|Protocol Violation|1|||
105660269|NCT01475461|364421055|FG002|Treatment Period|Protocol Violation|0|||
105660270|NCT01475461|364421056|FG003|Treatment Period|Protocol Violation|0|||
105660271|NCT01475461|364421057|FG004|Treatment Period|Protocol Violation|0|||
105660272|NCT01475461|364421058|FG005|Treatment Period|Protocol Violation|0|||
105660273|NCT01475461|364421059|FG006|Treatment Period|Protocol Violation|1|||
105660274|NCT01475461|364421053|FG000|Treatment Period|Lack of Efficacy|0|||
105660275|NCT01475461|364421054|FG001|Treatment Period|Lack of Efficacy|2|||
105660276|NCT01475461|364421055|FG002|Treatment Period|Lack of Efficacy|0|||
105660277|NCT01475461|364421056|FG003|Treatment Period|Lack of Efficacy|2|||
105660278|NCT01475461|364421057|FG004|Treatment Period|Lack of Efficacy|1|||
105660279|NCT01475461|364421058|FG005|Treatment Period|Lack of Efficacy|1|||
105660280|NCT01475461|364421059|FG006|Treatment Period|Lack of Efficacy|0|||
105660281|NCT01475461|364421053|FG000|Treatment Period|Medication Error|0|||
105660282|NCT01475461|364421054|FG001|Treatment Period|Medication Error|0|||
105660283|NCT01475461|364421055|FG002|Treatment Period|Medication Error|0|||
105660284|NCT01475461|364421056|FG003|Treatment Period|Medication Error|1|||
105660285|NCT01475461|364421057|FG004|Treatment Period|Medication Error|0|||
105660286|NCT01475461|364421058|FG005|Treatment Period|Medication Error|0|||
105660287|NCT01475461|364421059|FG006|Treatment Period|Medication Error|0|||
105660288|NCT01475461|364421053|FG000|Treatment Period|Adverse Event|0|||
105660289|NCT01475461|364421054|FG001|Treatment Period|Adverse Event|0|||
105660290|NCT01475461|364421055|FG002|Treatment Period|Adverse Event|0|||
105660291|NCT01475461|364421056|FG003|Treatment Period|Adverse Event|1|||
105660292|NCT01475461|364421057|FG004|Treatment Period|Adverse Event|0|||
105660293|NCT01475461|364421058|FG005|Treatment Period|Adverse Event|0|||
105660294|NCT01475461|364421059|FG006|Treatment Period|Adverse Event|0|||
105660295|NCT02088554|364421060|FG000|Overall Study|Exited before procedure|130|||
105660296|NCT02088554|364421060|FG000|Overall Study|Attempted but not implanted|31|||
105660297|NCT02088554|364421060|FG000|Overall Study|Implant not attempted|19|||
105660298|NCT02088554|364421060|FG000|Overall Study|Pending next visit|532|||
105660299|NCT02088554|364421060|FG000|Overall Study|Death|170|||
105660300|NCT02088554|364421060|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
105660301|NCT02088554|364421060|FG000|Overall Study|Lost to Follow-up|23|||
105660302|NCT02088554|364421060|FG000|Overall Study|Explanted|32|||
105660303|NCT02088554|364421060|FG000|Overall Study|Any other reason not covered by previous categories|11|||
105660304|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
105660305|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
105660306|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
105660307|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
105660308|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
105660309|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
105660310|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
105660311|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
105660312|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
105806440|NCT01464827|364948993|FG012|Overall Study|Lost to Follow-up|0|||
105660313|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
105660314|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
105660315|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
105660316|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
105660317|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
105660318|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
105660319|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
105660320|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
105660321|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
105660322|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
105660323|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
105660324|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
105660325|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
105660326|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
105660327|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
105660328|NCT04599855|364421061|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
105660329|NCT04599855|364421062|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
105660330|NCT04599855|364421063|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
105660331|NCT04599855|364421061|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
105660332|NCT04599855|364421062|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
105660333|NCT04599855|364421063|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
105660334|NCT04599855|364421061|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
105660335|NCT04599855|364421062|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
105660336|NCT04599855|364421063|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
105660337|NCT04599855|364421061|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
105660338|NCT04599855|364421062|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
105660339|NCT04599855|364421063|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
105660340|NCT04599855|364421061|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
105660341|NCT04599855|364421062|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
105660342|NCT04599855|364421063|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
105660343|NCT04599855|364421061|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
105660344|NCT04599855|364421062|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
105660345|NCT04599855|364421063|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
105660346|NCT02312206|364421071|FG000|Overall Study|Adverse Event|3|||
105660347|NCT02312206|364421072|FG001|Overall Study|Adverse Event|6|||
105660348|NCT02312206|364421071|FG000|Overall Study|Withdrawal by Subject|6|||
105660349|NCT02312206|364421072|FG001|Overall Study|Withdrawal by Subject|6|||
105660350|NCT02312206|364421071|FG000|Overall Study|Physician Decision|7|||
105660351|NCT02312206|364421072|FG001|Overall Study|Physician Decision|6|||
105660352|NCT02312206|364421071|FG000|Overall Study|Death|31|||
105660353|NCT02312206|364421072|FG001|Overall Study|Death|36|||
105660354|NCT02312206|364421071|FG000|Overall Study|Study Terminated by Sponsor|81|||
105660355|NCT02312206|364421072|FG001|Overall Study|Study Terminated by Sponsor|74|||
105660356|NCT02312206|364421071|FG000|Overall Study|Patient transferred to hospice|0|||
105660357|NCT02312206|364421072|FG001|Overall Study|Patient transferred to hospice|1|||
105660358|NCT02312206|364421071|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
105660359|NCT02312206|364421072|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
105660360|NCT02312206|364421071|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
105660361|NCT02312206|364421072|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
105660362|NCT02312206|364421071|FG000|Overall Study|Disease Progression|1|||
105660363|NCT02312206|364421072|FG001|Overall Study|Disease Progression|0|||
105660364|NCT00585975|364421073|FG000|Overall Study|Withdrawal by Subject|3|||
105660365|NCT00585975|364421074|FG001|Overall Study|Withdrawal by Subject|3|||
105660366|NCT00585975|364421073|FG000|Overall Study|Lost to Follow-up|2|||
105660367|NCT00585975|364421074|FG001|Overall Study|Lost to Follow-up|1|||
105660368|NCT00585975|364421073|FG000|Overall Study|Enrollment met/over-enrolled|10|||
105660369|NCT00585975|364421074|FG001|Overall Study|Enrollment met/over-enrolled|9|||
105660370|NCT02818998|364421075|FG000|Overall Study|Adverse Event|3|||
105660371|NCT02818998|364421076|FG001|Overall Study|Adverse Event|2|||
105660372|NCT02818998|364421077|FG002|Overall Study|Adverse Event|1|||
105660373|NCT02818998|364421075|FG000|Overall Study|Lost to Follow-up|4|||
105660374|NCT02818998|364421076|FG001|Overall Study|Lost to Follow-up|1|||
105660375|NCT02818998|364421077|FG002|Overall Study|Lost to Follow-up|2|||
105660376|NCT02818998|364421075|FG000|Overall Study|Withdrawal by sponsor|0|||
105660377|NCT02818998|364421076|FG001|Overall Study|Withdrawal by sponsor|1|||
105660378|NCT02818998|364421077|FG002|Overall Study|Withdrawal by sponsor|1|||
105660379|NCT02818998|364421075|FG000|Overall Study|Death|3|||
105660380|NCT02818998|364421076|FG001|Overall Study|Death|6|||
105660381|NCT02818998|364421077|FG002|Overall Study|Death|8|||
105660382|NCT02818998|364421075|FG000|Overall Study|Withdrawal by Subject|7|||
105660383|NCT02818998|364421076|FG001|Overall Study|Withdrawal by Subject|6|||
105660384|NCT02818998|364421077|FG002|Overall Study|Withdrawal by Subject|6|||
105660385|NCT02818998|364421075|FG000|Overall Study|Physician Decision|1|||
105660386|NCT02818998|364421076|FG001|Overall Study|Physician Decision|0|||
105770552|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105770553|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105660387|NCT02818998|364421077|FG002|Overall Study|Physician Decision|0|||
105660388|NCT00832000|364421078|FG000|Overall Study|Adverse Event|2|||
105660389|NCT00832000|364421079|FG001|Overall Study|Adverse Event|0|||
105660390|NCT00832000|364421078|FG000|Overall Study|Withdrawal by Subject|1|||
105660391|NCT00832000|364421079|FG001|Overall Study|Withdrawal by Subject|0|||
105660392|NCT00832000|364421078|FG000|Overall Study|No calls to IVR in either period|1|||
105660393|NCT00832000|364421079|FG001|Overall Study|No calls to IVR in either period|1|||
105660394|NCT00832000|364421078|FG000|Overall Study|No calls to IVR in period 2|2|||
105660395|NCT00832000|364421079|FG001|Overall Study|No calls to IVR in period 2|0|||
105660396|NCT01253447|364421081|FG000|Overall Study|Adverse Event|2|||
105660397|NCT02564718|364421084|FG000|Overall Study|Withdrew from treatment|0|||
105660398|NCT02564718|364421085|FG001|Overall Study|Withdrew from treatment|1|||
105660399|NCT03856047|364421086|FG000|Overall Study|Withdrawal by Subject|0|||
105660400|NCT03856047|364421087|FG001|Overall Study|Withdrawal by Subject|1|||
105660401|NCT03856047|364421088|FG002|Overall Study|Withdrawal by Subject|1|||
105660402|NCT03856047|364421089|FG003|Overall Study|Withdrawal by Subject|0|||
105660403|NCT03856047|364421090|FG004|Overall Study|Withdrawal by Subject|3|||
105660404|NCT03856047|364421091|FG005|Overall Study|Withdrawal by Subject|0|||
105660405|NCT03856047|364421092|FG006|Overall Study|Withdrawal by Subject|2|||
105660406|NCT03856047|364421086|FG000|Overall Study|Lost to Follow-up|4|||
105660407|NCT03856047|364421087|FG001|Overall Study|Lost to Follow-up|2|||
105660408|NCT03856047|364421088|FG002|Overall Study|Lost to Follow-up|3|||
105660409|NCT03856047|364421089|FG003|Overall Study|Lost to Follow-up|1|||
105660410|NCT03856047|364421090|FG004|Overall Study|Lost to Follow-up|4|||
105660411|NCT03856047|364421091|FG005|Overall Study|Lost to Follow-up|4|||
105660412|NCT03856047|364421092|FG006|Overall Study|Lost to Follow-up|4|||
105660413|NCT01017263|364421096|FG000|Overall Study|not eligible|12|||
105660414|NCT02049515|364421097|FG000|Overall Study|Adverse Event|46|||
105660415|NCT02049515|364421098|FG001|Overall Study|Adverse Event|2|||
105660416|NCT02049515|364421097|FG000|Overall Study|Protocol-specified Disease Progression|23|||
105660417|NCT02049515|364421098|FG001|Overall Study|Protocol-specified Disease Progression|2|||
105660418|NCT02049515|364421097|FG000|Overall Study|Death|6|||
105660419|NCT02049515|364421098|FG001|Overall Study|Death|0|||
105660420|NCT02049515|364421097|FG000|Overall Study|Physician Decision|5|||
105660421|NCT02049515|364421098|FG001|Overall Study|Physician Decision|1|||
105660422|NCT02049515|364421097|FG000|Overall Study|Withdrawal by Subject|3|||
105660423|NCT02049515|364421098|FG001|Overall Study|Withdrawal by Subject|0|||
105660424|NCT02049515|364421097|FG000|Overall Study|Termination of the Study by Sponsor|2|||
105660425|NCT02049515|364421098|FG001|Overall Study|Termination of the Study by Sponsor|0|||
105660426|NCT02049515|364421097|FG000|Overall Study|Protocol Violation|1|||
105660427|NCT02049515|364421098|FG001|Overall Study|Protocol Violation|1|||
105660428|NCT02049515|364421097|FG000|Overall Study|Clinical Deterioration|1|||
105660429|NCT02049515|364421098|FG001|Overall Study|Clinical Deterioration|0|||
105660430|NCT02049515|364421097|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
105660431|NCT02049515|364421098|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
105660432|NCT02049515|364421097|FG000|Overall Study|Treatment Interruption >42 Days|1|||
105660433|NCT02049515|364421098|FG001|Overall Study|Treatment Interruption >42 Days|0|||
105660434|NCT02049515|364421097|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
105660435|NCT02049515|364421098|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
105660436|NCT00770588|364421102|FG000|Overall Study|Adverse Event|9|||
105660437|NCT00770588|364421103|FG001|Overall Study|Adverse Event|2|||
105660438|NCT00770588|364421102|FG000|Overall Study|Death caused by progression of disease|70|||
105806441|NCT01464827|364948994|FG013|Overall Study|Lost to Follow-up|1|||
105442471|NCT01564732|363626749|FG001|Overall Study|Early termination by the study sponsor|5|||
105442472|NCT01957202|363626750|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442473|NCT01957202|363626751|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
105442474|NCT01957202|363626752|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442475|NCT01957202|363626753|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442476|NCT01957202|363626754|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442477|NCT01957202|363626755|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442478|NCT01957202|363626756|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442479|NCT01957202|363626757|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442480|NCT01957202|363626758|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442481|NCT01957202|363626759|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442482|NCT01957202|363626760|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442483|NCT01957202|363626761|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442484|NCT01957202|363626762|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442485|NCT01957202|363626763|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442486|NCT01957202|363626764|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442487|NCT01957202|363626765|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442488|NCT01957202|363626766|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
105442489|NCT01957202|363626767|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105442490|NCT01957202|363626750|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
105660439|NCT00770588|364421103|FG001|Overall Study|Death caused by progression of disease|91|||
105660440|NCT00770588|364421102|FG000|Overall Study|Lost to Follow-up|1|||
105660441|NCT00770588|364421103|FG001|Overall Study|Lost to Follow-up|1|||
105660442|NCT00770588|364421102|FG000|Overall Study|Withdrawal by Subject|1|||
105660443|NCT00770588|364421103|FG001|Overall Study|Withdrawal by Subject|1|||
105660444|NCT03635086|364421107|FG000|Overall Study|Withdrawal of consent|0|||
105660445|NCT03635086|364421108|FG001|Overall Study|Withdrawal of consent|0|||
105660446|NCT03635086|364421109|FG002|Overall Study|Withdrawal of consent|1|||
105660447|NCT03635086|364421110|FG003|Overall Study|Withdrawal of consent|0|||
105660448|NCT03635086|364421111|FG004|Overall Study|Withdrawal of consent|0|||
105660449|NCT03635086|364421107|FG000|Overall Study|Adverse Event|0|||
105660450|NCT03635086|364421108|FG001|Overall Study|Adverse Event|1|||
105660451|NCT03635086|364421109|FG002|Overall Study|Adverse Event|0|||
105660452|NCT03635086|364421110|FG003|Overall Study|Adverse Event|0|||
105660453|NCT03635086|364421111|FG004|Overall Study|Adverse Event|0|||
105660454|NCT03635086|364421107|FG000|Overall Study|Lost to Follow-up|1|||
105660455|NCT03635086|364421108|FG001|Overall Study|Lost to Follow-up|0|||
105660456|NCT03635086|364421109|FG002|Overall Study|Lost to Follow-up|0|||
105660457|NCT03635086|364421110|FG003|Overall Study|Lost to Follow-up|0|||
105660458|NCT03635086|364421111|FG004|Overall Study|Lost to Follow-up|0|||
105660459|NCT02872012|364421112|FG000|Overall Study|Withdrawal by Subject|1|||
105660460|NCT02872012|364421113|FG001|Overall Study|Withdrawal by Subject|0|||
105660461|NCT02872012|364421114|FG002|Overall Study|Withdrawal by Subject|0|||
105660462|NCT02872012|364421115|FG003|Overall Study|Withdrawal by Subject|0|||
105660463|NCT02872012|364421116|FG004|Overall Study|Withdrawal by Subject|0|||
105660464|NCT01728623|364421117|FG000|Overall Study|Disease progression|26|||
105660465|NCT01728623|364421117|FG000|Overall Study|Adverse Event|1|||
105660466|NCT01728623|364421117|FG000|Overall Study|Withdrawal by Subject|1|||
105660467|NCT01390441|364421122|FG000|Treatment Period|Protocol Violation|0|||
105660468|NCT01390441|364421123|FG001|Treatment Period|Protocol Violation|1|||
105660469|NCT01390441|364421124|FG002|Treatment Period|Protocol Violation|0|||
105660470|NCT01390441|364421125|FG003|Treatment Period|Protocol Violation|0|||
105660471|NCT01390441|364421126|FG004|Treatment Period|Protocol Violation|0|||
105660472|NCT01390441|364421122|FG000|Treatment Period|Physician Decision|0|||
105660473|NCT01390441|364421123|FG001|Treatment Period|Physician Decision|0|||
105660474|NCT01390441|364421124|FG002|Treatment Period|Physician Decision|0|||
105660475|NCT01390441|364421125|FG003|Treatment Period|Physician Decision|1|||
105660476|NCT01390441|364421126|FG004|Treatment Period|Physician Decision|0|||
105660477|NCT01390441|364421122|FG000|Treatment Period|Lack of Efficacy|0|||
105660478|NCT01390441|364421123|FG001|Treatment Period|Lack of Efficacy|0|||
105660479|NCT01390441|364421124|FG002|Treatment Period|Lack of Efficacy|0|||
105660480|NCT01390441|364421125|FG003|Treatment Period|Lack of Efficacy|0|||
105660481|NCT01390441|364421126|FG004|Treatment Period|Lack of Efficacy|1|||
105660482|NCT01390441|364421122|FG000|Treatment Period|Unknown due to early stopping of study|0|||
105660483|NCT01390441|364421123|FG001|Treatment Period|Unknown due to early stopping of study|0|||
105660484|NCT01390441|364421124|FG002|Treatment Period|Unknown due to early stopping of study|8|||
105660485|NCT01390441|364421125|FG003|Treatment Period|Unknown due to early stopping of study|11|||
105660486|NCT01390441|364421126|FG004|Treatment Period|Unknown due to early stopping of study|7|||
105660487|NCT01390441|364421122|FG000|Treatment Period|Adverse Event|0|||
105660488|NCT01390441|364421123|FG001|Treatment Period|Adverse Event|0|||
105660489|NCT01390441|364421124|FG002|Treatment Period|Adverse Event|1|||
105660490|NCT01390441|364421125|FG003|Treatment Period|Adverse Event|1|||
105660491|NCT01390441|364421126|FG004|Treatment Period|Adverse Event|2|||
105660492|NCT01390441|364421122|FG000|Treatment Period|Withdrawal by Subject|0|||
105660493|NCT01390441|364421123|FG001|Treatment Period|Withdrawal by Subject|0|||
105660494|NCT01390441|364421124|FG002|Treatment Period|Withdrawal by Subject|1|||
105660495|NCT01390441|364421125|FG003|Treatment Period|Withdrawal by Subject|0|||
105660496|NCT01390441|364421126|FG004|Treatment Period|Withdrawal by Subject|1|||
105660497|NCT01390441|364421122|FG000|Treatment Period|Lost to Follow-up|1|||
105660498|NCT01390441|364421123|FG001|Treatment Period|Lost to Follow-up|0|||
105660499|NCT01390441|364421124|FG002|Treatment Period|Lost to Follow-up|0|||
105660500|NCT01390441|364421125|FG003|Treatment Period|Lost to Follow-up|0|||
105660501|NCT01390441|364421126|FG004|Treatment Period|Lost to Follow-up|0|||
105660502|NCT01390441|364421122|FG000|Extension Period|Protocol Violation|3|||
105660503|NCT01390441|364421123|FG001|Extension Period|Protocol Violation|1|||
105660504|NCT01390441|364421124|FG002|Extension Period|Protocol Violation|0|||
105660505|NCT01390441|364421125|FG003|Extension Period|Protocol Violation|1|||
105660506|NCT01390441|364421126|FG004|Extension Period|Protocol Violation|0|||
105660507|NCT03517111|364421127|FG000|Enrolled|Withdrawal by Subject|0|||
105660508|NCT03517111|364421128|FG001|Enrolled|Withdrawal by Subject|1|||
105660509|NCT03517111|364421129|FG002|Enrolled|Withdrawal by Subject|0|||
105660510|NCT03517111|364421127|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
105660511|NCT03517111|364421128|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
105660512|NCT03517111|364421129|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
105660513|NCT03517111|364421127|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
105660514|NCT03517111|364421128|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
105660515|NCT03517111|364421129|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
105660516|NCT03517111|364421127|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
105660517|NCT03517111|364421128|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
105660518|NCT03517111|364421129|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
105660519|NCT03517111|364421127|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
105806442|NCT01464827|364948981|FG000|Overall Study|Other|2|||
105660520|NCT03517111|364421128|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
105660521|NCT03517111|364421129|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
105660522|NCT03713320|364421130|FG000|Randomized Period|Adverse Event|1|||
105660523|NCT03713320|364421131|FG001|Randomized Period|Adverse Event|5|||
105660524|NCT03713320|364421132|FG002|Randomized Period|Adverse Event|0|||
105660525|NCT03713320|364421130|FG000|Randomized Period|Physician Decision|1|||
105660526|NCT03713320|364421131|FG001|Randomized Period|Physician Decision|1|||
105660527|NCT03713320|364421132|FG002|Randomized Period|Physician Decision|0|||
105660528|NCT03713320|364421130|FG000|Randomized Period|Withdrawal by Subject|4|||
105660529|NCT03713320|364421131|FG001|Randomized Period|Withdrawal by Subject|0|||
105660530|NCT03713320|364421132|FG002|Randomized Period|Withdrawal by Subject|0|||
105660531|NCT03713320|364421130|FG000|Randomized Period|Participant decision|3|||
105660532|NCT03713320|364421131|FG001|Randomized Period|Participant decision|1|||
105660533|NCT03713320|364421132|FG002|Randomized Period|Participant decision|0|||
105660534|NCT03713320|364421130|FG000|Randomized Period|Study terminated by sponsor|6|||
105660535|NCT03713320|364421131|FG001|Randomized Period|Study terminated by sponsor|3|||
105660536|NCT03713320|364421132|FG002|Randomized Period|Study terminated by sponsor|0|||
105660537|NCT03713320|364421130|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
105660538|NCT03713320|364421131|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
105660539|NCT03713320|364421132|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
105660540|NCT03713320|364421130|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
105660541|NCT03713320|364421131|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
105660542|NCT03713320|364421132|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
105660543|NCT00909532|364421134|FG000|Overall Study|Adverse Event|4|||
105660544|NCT00909532|364421135|FG001|Overall Study|Adverse Event|1|||
105660545|NCT00909532|364421134|FG000|Overall Study|Pregnancy|0|||
105660546|NCT00909532|364421135|FG001|Overall Study|Pregnancy|1|||
105660547|NCT00909532|364421134|FG000|Overall Study|Prohibited Medication|2|||
105660548|NCT00909532|364421135|FG001|Overall Study|Prohibited Medication|1|||
105660549|NCT00909532|364421134|FG000|Overall Study|Withdrawal of Consent|1|||
105660550|NCT00909532|364421135|FG001|Overall Study|Withdrawal of Consent|1|||
105660551|NCT00909532|364421134|FG000|Overall Study|Noncompliance with Study Requirements|0|||
105660552|NCT00909532|364421135|FG001|Overall Study|Noncompliance with Study Requirements|2|||
105660553|NCT00909532|364421134|FG000|Overall Study|Physician Decision|1|||
105660554|NCT00909532|364421135|FG001|Overall Study|Physician Decision|0|||
105660555|NCT00909532|364421134|FG000|Overall Study|Wrong Genotype|1|||
105660556|NCT00909532|364421135|FG001|Overall Study|Wrong Genotype|0|||
105660557|NCT00909532|364421134|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
105660558|NCT00909532|364421135|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
105660559|NCT02601209|364421137|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
105660560|NCT02601209|364421138|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
105660561|NCT02601209|364421139|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
105660562|NCT02601209|364421140|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
105660563|NCT02601209|364421141|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
105660564|NCT02601209|364421142|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
105660565|NCT02601209|364421143|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
105660566|NCT02601209|364421144|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
105660567|NCT02601209|364421145|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
105660568|NCT02601209|364421137|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
105660569|NCT02601209|364421138|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
105660570|NCT02601209|364421139|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
105660571|NCT02601209|364421140|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
105770554|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105660572|NCT02601209|364421141|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
105660573|NCT02601209|364421142|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
105660574|NCT02601209|364421143|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
105660575|NCT02601209|364421144|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
105660576|NCT02601209|364421145|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
105660577|NCT00745498|364421146|FG000|Overall Study|Lost to Follow-up|1|||
105660578|NCT00745498|364421147|FG001|Overall Study|Lost to Follow-up|1|||
105660579|NCT00745498|364421148|FG002|Overall Study|Lost to Follow-up|3|||
105660580|NCT00745498|364421146|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
105660581|NCT00745498|364421147|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
105660582|NCT00745498|364421148|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
105660583|NCT00745498|364421146|FG000|Overall Study|Non-PDR related VH|0|||
105660584|NCT00745498|364421147|FG001|Overall Study|Non-PDR related VH|1|||
105660585|NCT00745498|364421148|FG002|Overall Study|Non-PDR related VH|1|||
105660586|NCT00745498|364421146|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
105660587|NCT00745498|364421147|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
105660588|NCT00745498|364421148|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
105660589|NCT00778921|364421149|FG000|Overall Study|Adverse Event|9|||
105660590|NCT00778921|364421150|FG001|Overall Study|Adverse Event|10|||
105660591|NCT00778921|364421151|FG002|Overall Study|Adverse Event|14|||
105660592|NCT00778921|364421149|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
105660593|NCT00778921|364421150|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
105660594|NCT00778921|364421151|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
105660595|NCT00778921|364421149|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
105660596|NCT00778921|364421150|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
105660597|NCT00778921|364421151|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
105660598|NCT00778921|364421149|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
105660599|NCT00778921|364421150|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
105660600|NCT00778921|364421151|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
105660601|NCT00778921|364421149|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
105660602|NCT00778921|364421150|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
105660603|NCT00778921|364421151|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
105660604|NCT00778921|364421149|FG000|Overall Study|Patient withdrew request|3|||
105660605|NCT00778921|364421150|FG001|Overall Study|Patient withdrew request|1|||
105660606|NCT00778921|364421151|FG002|Overall Study|Patient withdrew request|6|||
105660607|NCT00778921|364421149|FG000|Overall Study|Lost to Follow-up|0|||
105660608|NCT00778921|364421150|FG001|Overall Study|Lost to Follow-up|2|||
105660609|NCT00778921|364421151|FG002|Overall Study|Lost to Follow-up|1|||
105660610|NCT00778921|364421149|FG000|Overall Study|Administrative Problems|1|||
105660611|NCT00778921|364421150|FG001|Overall Study|Administrative Problems|2|||
105660612|NCT00778921|364421151|FG002|Overall Study|Administrative Problems|0|||
105660613|NCT00778921|364421149|FG000|Overall Study|Protocol Violation|3|||
105660614|NCT00778921|364421150|FG001|Overall Study|Protocol Violation|0|||
105660615|NCT00778921|364421151|FG002|Overall Study|Protocol Violation|2|||
105660616|NCT00778921|364421149|FG000|Overall Study|Not treated|0|||
105660617|NCT00778921|364421150|FG001|Overall Study|Not treated|2|||
105660618|NCT00778921|364421151|FG002|Overall Study|Not treated|2|||
105660619|NCT03432390|364421164|FG000|Apnea Period|Protocol Violation|2|||
105660620|NCT03432390|364421165|FG001|Apnea Period|Protocol Violation|2|||
105660621|NCT02058836|364421168|FG000|Overall Study|Withdrawal by Subject|1|||
105660622|NCT02058836|364421169|FG001|Overall Study|Withdrawal by Subject|1|||
105660623|NCT01236352|364421170|FG000|Overall Study|Death|0|||
105660624|NCT01236352|364421171|FG001|Overall Study|Death|0|||
105660625|NCT01236352|364421172|FG002|Overall Study|Death|0|||
105660626|NCT01236352|364421173|FG003|Overall Study|Death|0|||
105660627|NCT01236352|364421174|FG004|Overall Study|Death|0|||
105660628|NCT01236352|364421175|FG005|Overall Study|Death|0|||
105660629|NCT01236352|364421176|FG006|Overall Study|Death|0|||
105660630|NCT01236352|364421177|FG007|Overall Study|Death|1|||
105660631|NCT01236352|364421178|FG008|Overall Study|Death|0|||
105660632|NCT01236352|364421179|FG009|Overall Study|Death|0|||
105660633|NCT01236352|364421180|FG010|Overall Study|Death|0|||
105660634|NCT01236352|364421170|FG000|Overall Study|Withdrawal by Subject|0|||
105660635|NCT01236352|364421171|FG001|Overall Study|Withdrawal by Subject|0|||
105660636|NCT01236352|364421172|FG002|Overall Study|Withdrawal by Subject|0|||
105660637|NCT01236352|364421173|FG003|Overall Study|Withdrawal by Subject|0|||
105660638|NCT01236352|364421174|FG004|Overall Study|Withdrawal by Subject|0|||
105660639|NCT01236352|364421175|FG005|Overall Study|Withdrawal by Subject|0|||
105660640|NCT01236352|364421176|FG006|Overall Study|Withdrawal by Subject|0|||
105660641|NCT01236352|364421177|FG007|Overall Study|Withdrawal by Subject|0|||
105660642|NCT01236352|364421178|FG008|Overall Study|Withdrawal by Subject|0|||
105660643|NCT01236352|364421179|FG009|Overall Study|Withdrawal by Subject|2|||
105660644|NCT01236352|364421180|FG010|Overall Study|Withdrawal by Subject|1|||
105660645|NCT01236352|364421170|FG000|Overall Study|Adverse Event|0|||
105660646|NCT01236352|364421171|FG001|Overall Study|Adverse Event|0|||
105660647|NCT01236352|364421172|FG002|Overall Study|Adverse Event|0|||
105660648|NCT01236352|364421173|FG003|Overall Study|Adverse Event|0|||
105660649|NCT01236352|364421174|FG004|Overall Study|Adverse Event|0|||
105660650|NCT01236352|364421175|FG005|Overall Study|Adverse Event|0|||
105660651|NCT01236352|364421176|FG006|Overall Study|Adverse Event|2|||
105660652|NCT01236352|364421177|FG007|Overall Study|Adverse Event|0|||
105660653|NCT01236352|364421178|FG008|Overall Study|Adverse Event|0|||
105660654|NCT01236352|364421179|FG009|Overall Study|Adverse Event|4|||
105660655|NCT01236352|364421180|FG010|Overall Study|Adverse Event|1|||
105660656|NCT01236352|364421170|FG000|Overall Study|Study drug toxicity|0|||
105660657|NCT01236352|364421171|FG001|Overall Study|Study drug toxicity|0|||
105660658|NCT01236352|364421172|FG002|Overall Study|Study drug toxicity|0|||
105660659|NCT01236352|364421173|FG003|Overall Study|Study drug toxicity|0|||
105660660|NCT01236352|364421174|FG004|Overall Study|Study drug toxicity|0|||
105660661|NCT01236352|364421175|FG005|Overall Study|Study drug toxicity|1|||
105660662|NCT01236352|364421176|FG006|Overall Study|Study drug toxicity|1|||
105660663|NCT01236352|364421177|FG007|Overall Study|Study drug toxicity|0|||
105660664|NCT01236352|364421178|FG008|Overall Study|Study drug toxicity|0|||
105660665|NCT01236352|364421179|FG009|Overall Study|Study drug toxicity|2|||
105660666|NCT01236352|364421180|FG010|Overall Study|Study drug toxicity|2|||
105660667|NCT01236352|364421170|FG000|Overall Study|Disease progression|1|||
105660668|NCT01236352|364421171|FG001|Overall Study|Disease progression|2|||
105660669|NCT01236352|364421172|FG002|Overall Study|Disease progression|1|||
105660670|NCT01236352|364421173|FG003|Overall Study|Disease progression|2|||
105660671|NCT01236352|364421174|FG004|Overall Study|Disease progression|2|||
105660672|NCT01236352|364421175|FG005|Overall Study|Disease progression|2|||
105660673|NCT01236352|364421176|FG006|Overall Study|Disease progression|1|||
105660674|NCT01236352|364421177|FG007|Overall Study|Disease progression|3|||
105660675|NCT01236352|364421178|FG008|Overall Study|Disease progression|2|||
105660676|NCT01236352|364421179|FG009|Overall Study|Disease progression|2|||
105660677|NCT01236352|364421180|FG010|Overall Study|Disease progression|2|||
105660678|NCT01236352|364421170|FG000|Overall Study|Poor/Non-compliance|1|||
105660679|NCT01236352|364421171|FG001|Overall Study|Poor/Non-compliance|0|||
105660680|NCT01236352|364421172|FG002|Overall Study|Poor/Non-compliance|0|||
105660681|NCT01236352|364421173|FG003|Overall Study|Poor/Non-compliance|0|||
105660682|NCT01236352|364421174|FG004|Overall Study|Poor/Non-compliance|0|||
105660683|NCT01236352|364421175|FG005|Overall Study|Poor/Non-compliance|0|||
105660684|NCT01236352|364421176|FG006|Overall Study|Poor/Non-compliance|0|||
105660685|NCT01236352|364421177|FG007|Overall Study|Poor/Non-compliance|0|||
105660686|NCT01236352|364421178|FG008|Overall Study|Poor/Non-compliance|0|||
105660687|NCT01236352|364421179|FG009|Overall Study|Poor/Non-compliance|0|||
105660688|NCT01236352|364421180|FG010|Overall Study|Poor/Non-compliance|0|||
105660689|NCT01236352|364421170|FG000|Overall Study|Maximum clinical benefit|1|||
105660690|NCT01236352|364421171|FG001|Overall Study|Maximum clinical benefit|1|||
105660691|NCT01236352|364421172|FG002|Overall Study|Maximum clinical benefit|1|||
105660692|NCT01236352|364421173|FG003|Overall Study|Maximum clinical benefit|0|||
105660693|NCT01236352|364421174|FG004|Overall Study|Maximum clinical benefit|2|||
105660694|NCT01236352|364421175|FG005|Overall Study|Maximum clinical benefit|0|||
105660695|NCT01236352|364421176|FG006|Overall Study|Maximum clinical benefit|3|||
105660696|NCT01236352|364421177|FG007|Overall Study|Maximum clinical benefit|1|||
105660697|NCT01236352|364421178|FG008|Overall Study|Maximum clinical benefit|1|||
105660698|NCT01236352|364421179|FG009|Overall Study|Maximum clinical benefit|4|||
105660699|NCT01236352|364421180|FG010|Overall Study|Maximum clinical benefit|2|||
105660700|NCT01236352|364421170|FG000|Overall Study|Subject request to discontinue treatment|0|||
105660701|NCT01236352|364421171|FG001|Overall Study|Subject request to discontinue treatment|0|||
105660702|NCT01236352|364421172|FG002|Overall Study|Subject request to discontinue treatment|1|||
105660703|NCT01236352|364421173|FG003|Overall Study|Subject request to discontinue treatment|1|||
105660704|NCT01236352|364421174|FG004|Overall Study|Subject request to discontinue treatment|0|||
105660705|NCT01236352|364421175|FG005|Overall Study|Subject request to discontinue treatment|1|||
105660706|NCT01236352|364421176|FG006|Overall Study|Subject request to discontinue treatment|0|||
105660707|NCT01236352|364421177|FG007|Overall Study|Subject request to discontinue treatment|0|||
105660708|NCT01236352|364421178|FG008|Overall Study|Subject request to discontinue treatment|0|||
105660709|NCT01236352|364421179|FG009|Overall Study|Subject request to discontinue treatment|1|||
105660710|NCT01236352|364421180|FG010|Overall Study|Subject request to discontinue treatment|4|||
105660711|NCT01236352|364421170|FG000|Overall Study|Subject to receive drug via EAP|1|||
105660712|NCT01236352|364421171|FG001|Overall Study|Subject to receive drug via EAP|1|||
105660713|NCT01236352|364421172|FG002|Overall Study|Subject to receive drug via EAP|1|||
105660714|NCT01236352|364421173|FG003|Overall Study|Subject to receive drug via EAP|0|||
105660715|NCT01236352|364421174|FG004|Overall Study|Subject to receive drug via EAP|0|||
105660716|NCT01236352|364421175|FG005|Overall Study|Subject to receive drug via EAP|0|||
105660717|NCT01236352|364421176|FG006|Overall Study|Subject to receive drug via EAP|0|||
105660718|NCT01236352|364421177|FG007|Overall Study|Subject to receive drug via EAP|2|||
105660719|NCT01236352|364421178|FG008|Overall Study|Subject to receive drug via EAP|0|||
105660720|NCT01236352|364421179|FG009|Overall Study|Subject to receive drug via EAP|4|||
105660721|NCT01236352|364421180|FG010|Overall Study|Subject to receive drug via EAP|0|||
105660722|NCT01236352|364421170|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
105660723|NCT01236352|364421171|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
105660724|NCT01236352|364421172|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
105660725|NCT01236352|364421173|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
105660726|NCT01236352|364421174|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
105660727|NCT01236352|364421175|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
105660728|NCT01236352|364421176|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
105660729|NCT01236352|364421177|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
105660730|NCT01236352|364421178|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
105660731|NCT01236352|364421179|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
105660732|NCT01236352|364421180|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
105660733|NCT01236352|364421170|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660734|NCT01236352|364421171|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660735|NCT01236352|364421172|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660736|NCT01236352|364421173|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660737|NCT01236352|364421174|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660738|NCT01236352|364421175|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660739|NCT01236352|364421176|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660740|NCT01236352|364421177|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660741|NCT01236352|364421178|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660742|NCT01236352|364421179|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660743|NCT01236352|364421180|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
105660744|NCT01236352|364421170|FG000|Overall Study|Lack of response to drug|0|||
105660745|NCT01236352|364421171|FG001|Overall Study|Lack of response to drug|0|||
105660746|NCT01236352|364421172|FG002|Overall Study|Lack of response to drug|0|||
105660747|NCT01236352|364421173|FG003|Overall Study|Lack of response to drug|0|||
105660748|NCT01236352|364421174|FG004|Overall Study|Lack of response to drug|0|||
105660749|NCT01236352|364421175|FG005|Overall Study|Lack of response to drug|0|||
105660750|NCT01236352|364421176|FG006|Overall Study|Lack of response to drug|0|||
105660751|NCT01236352|364421177|FG007|Overall Study|Lack of response to drug|0|||
105660752|NCT01236352|364421178|FG008|Overall Study|Lack of response to drug|0|||
105660753|NCT01236352|364421179|FG009|Overall Study|Lack of response to drug|1|||
105660754|NCT01236352|364421180|FG010|Overall Study|Lack of response to drug|1|||
105660755|NCT01236352|364421170|FG000|Overall Study|Patient transferred to IST|0|||
105660756|NCT01236352|364421171|FG001|Overall Study|Patient transferred to IST|0|||
105660757|NCT01236352|364421172|FG002|Overall Study|Patient transferred to IST|0|||
105660758|NCT01236352|364421173|FG003|Overall Study|Patient transferred to IST|0|||
105660759|NCT01236352|364421174|FG004|Overall Study|Patient transferred to IST|0|||
105660760|NCT01236352|364421175|FG005|Overall Study|Patient transferred to IST|0|||
105660761|NCT01236352|364421176|FG006|Overall Study|Patient transferred to IST|0|||
105660762|NCT01236352|364421177|FG007|Overall Study|Patient transferred to IST|0|||
105660763|NCT01236352|364421178|FG008|Overall Study|Patient transferred to IST|0|||
105660764|NCT01236352|364421179|FG009|Overall Study|Patient transferred to IST|2|||
105660765|NCT01236352|364421180|FG010|Overall Study|Patient transferred to IST|6|||
105660766|NCT02688530|364421181|FG000|Overall Study|Withdrawal by Subject|0|||
105660767|NCT02688530|364421182|FG001|Overall Study|Withdrawal by Subject|1|||
105660768|NCT02688530|364421183|FG002|Overall Study|Withdrawal by Subject|0|||
105660769|NCT02688530|364421184|FG003|Overall Study|Withdrawal by Subject|0|||
105660770|NCT02688530|364421181|FG000|Overall Study|Lost to Follow-up|0|||
105660771|NCT02688530|364421182|FG001|Overall Study|Lost to Follow-up|0|||
105660772|NCT02688530|364421183|FG002|Overall Study|Lost to Follow-up|2|||
105660773|NCT02688530|364421184|FG003|Overall Study|Lost to Follow-up|0|||
105660774|NCT01658020|364421185|FG000|Overall Study|Adverse Event|3|||
105660775|NCT01658020|364421186|FG001|Overall Study|Adverse Event|3|||
105660776|NCT01658020|364421185|FG000|Overall Study|Lost to Follow-up|1|||
105660777|NCT01658020|364421186|FG001|Overall Study|Lost to Follow-up|0|||
105660778|NCT01658020|364421185|FG000|Overall Study|Withdrawal by Subject|4|||
105660779|NCT01658020|364421186|FG001|Overall Study|Withdrawal by Subject|5|||
105660780|NCT01658020|364421185|FG000|Overall Study|Protocol Violation|0|||
105660781|NCT01658020|364421186|FG001|Overall Study|Protocol Violation|1|||
105660782|NCT00725543|364421187|FG000|Overall Study|Adverse Event|10|||
105660783|NCT00725543|364421187|FG000|Overall Study|Lack of Efficacy|3|||
105660784|NCT00725543|364421187|FG000|Overall Study|Withdrawal by Subject|10|||
105660785|NCT00725543|364421187|FG000|Overall Study|Physician Decision|5|||
105660786|NCT00725543|364421187|FG000|Overall Study|Lost to Follow-up|4|||
105660787|NCT00725543|364421187|FG000|Overall Study|Non-compliance|2|||
105660788|NCT00725543|364421187|FG000|Overall Study|Other|119|||
105660789|NCT01530087|364421188|FG000|Overall Study|Physician Decision|2|||
105660790|NCT05992922|364421189|FG000|Overall Study|Adverse Event|6|||
105660791|NCT05992922|364421190|FG001|Overall Study|Adverse Event|0|||
105660792|NCT05992922|364421189|FG000|Overall Study|Sponsor Termination of Study|14|||
105660793|NCT05992922|364421190|FG001|Overall Study|Sponsor Termination of Study|20|||
105660794|NCT02034162|364423150|FG000|Double-blind|Lost to Follow-up|3|||
105660795|NCT02034162|364423151|FG001|Double-blind|Lost to Follow-up|0|||
105660796|NCT02034162|364423152|FG002|Double-blind|Lost to Follow-up|0|||
105660797|NCT02034162|364423150|FG000|Double-blind|Physician Decision|1|||
105660798|NCT02034162|364423151|FG001|Double-blind|Physician Decision|0|||
105660799|NCT02034162|364423152|FG002|Double-blind|Physician Decision|0|||
105660800|NCT02034162|364423150|FG000|Double-blind|Protocol Violation|0|||
105660801|NCT02034162|364423151|FG001|Double-blind|Protocol Violation|1|||
105660802|NCT02034162|364423152|FG002|Double-blind|Protocol Violation|0|||
105660803|NCT02034162|364423150|FG000|Double-blind|Withdrawal by Subject|5|||
105660804|NCT02034162|364423151|FG001|Double-blind|Withdrawal by Subject|7|||
105660805|NCT02034162|364423152|FG002|Double-blind|Withdrawal by Subject|0|||
105660806|NCT03305809|364423155|FG000|Overall Study|Adverse Event|2|||
105660807|NCT03305809|364423156|FG001|Overall Study|Adverse Event|2|||
105660808|NCT03305809|364423157|FG002|Overall Study|Adverse Event|6|||
105660809|NCT03305809|364423158|FG003|Overall Study|Adverse Event|6|||
105660810|NCT03305809|364423155|FG000|Overall Study|Death|0|||
105660811|NCT03305809|364423156|FG001|Overall Study|Death|0|||
105660812|NCT03305809|364423157|FG002|Overall Study|Death|1|||
105660813|NCT03305809|364423158|FG003|Overall Study|Death|1|||
105660814|NCT03305809|364423155|FG000|Overall Study|Lost to Follow-up|1|||
105660815|NCT03305809|364423156|FG001|Overall Study|Lost to Follow-up|2|||
105660816|NCT03305809|364423157|FG002|Overall Study|Lost to Follow-up|0|||
105660817|NCT03305809|364423158|FG003|Overall Study|Lost to Follow-up|0|||
105660818|NCT03305809|364423155|FG000|Overall Study|Sponsor Decision|1|||
105660819|NCT03305809|364423156|FG001|Overall Study|Sponsor Decision|0|||
105660820|NCT03305809|364423157|FG002|Overall Study|Sponsor Decision|1|||
105660821|NCT03305809|364423158|FG003|Overall Study|Sponsor Decision|8|||
105660822|NCT03305809|364423155|FG000|Overall Study|Physician Decision|0|||
105660823|NCT03305809|364423156|FG001|Overall Study|Physician Decision|0|||
105660824|NCT03305809|364423157|FG002|Overall Study|Physician Decision|2|||
105660825|NCT03305809|364423158|FG003|Overall Study|Physician Decision|4|||
105660826|NCT03305809|364423155|FG000|Overall Study|Progressive Disease|0|||
105660827|NCT03305809|364423156|FG001|Overall Study|Progressive Disease|0|||
105660828|NCT03305809|364423157|FG002|Overall Study|Progressive Disease|1|||
105660829|NCT03305809|364423158|FG003|Overall Study|Progressive Disease|0|||
105660830|NCT03305809|364423155|FG000|Overall Study|Protocol Violation|1|||
105660831|NCT03305809|364423156|FG001|Overall Study|Protocol Violation|0|||
105660832|NCT03305809|364423157|FG002|Overall Study|Protocol Violation|2|||
105660833|NCT03305809|364423158|FG003|Overall Study|Protocol Violation|3|||
105660834|NCT03305809|364423155|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
105660835|NCT03305809|364423156|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
105660836|NCT03305809|364423157|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
105660837|NCT03305809|364423158|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
105660838|NCT03305809|364423155|FG000|Overall Study|Withdrawal by Subject|2|||
105660839|NCT03305809|364423156|FG001|Overall Study|Withdrawal by Subject|4|||
105660840|NCT03305809|364423157|FG002|Overall Study|Withdrawal by Subject|5|||
105660841|NCT03305809|364423158|FG003|Overall Study|Withdrawal by Subject|2|||
105660842|NCT03305809|364423155|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
105660843|NCT03305809|364423156|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
105660844|NCT03305809|364423157|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
105660845|NCT03305809|364423158|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
105660846|NCT01161446|364423159|FG000|Overall Study|Lost to Follow-up|18|||
105660847|NCT01161446|364423160|FG001|Overall Study|Lost to Follow-up|14|||
105660848|NCT01161446|364423159|FG000|Overall Study|Withdrawal by Subject|0|||
105660849|NCT01161446|364423160|FG001|Overall Study|Withdrawal by Subject|1|||
105660850|NCT00810342|364423163|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
105660851|NCT00810342|364423164|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
105660852|NCT00810342|364423163|FG000|Month 1 Follow-up|Pregnancy|1|||
105660853|NCT00810342|364423164|FG001|Month 1 Follow-up|Pregnancy|0|||
105660854|NCT00810342|364423163|FG000|6-month Follow-up|Lost to Follow-up|18|||
105660855|NCT00810342|364423164|FG001|6-month Follow-up|Lost to Follow-up|6|||
105660856|NCT00810342|364423163|FG000|6-month Follow-up|Pregnancy|6|||
105660857|NCT00810342|364423164|FG001|6-month Follow-up|Pregnancy|2|||
105660858|NCT00810342|364423163|FG000|12-month Followup|Pregnancy|9|||
105660859|NCT00810342|364423164|FG001|12-month Followup|Pregnancy|10|||
105660860|NCT00810342|364423163|FG000|12-month Followup|Lost to Follow-up|3|||
105660861|NCT00810342|364423164|FG001|12-month Followup|Lost to Follow-up|1|||
105660862|NCT04486313|364423165|FG000|Overall Study|Lost to Follow-up|7|||
105660863|NCT04486313|364423166|FG001|Overall Study|Lost to Follow-up|9|||
105660864|NCT04486313|364423165|FG000|Overall Study|Withdrawal by Subject|8|||
105660865|NCT04486313|364423166|FG001|Overall Study|Withdrawal by Subject|6|||
105660866|NCT04486313|364423165|FG000|Overall Study|Physician Decision|1|||
105660867|NCT04486313|364423166|FG001|Overall Study|Physician Decision|1|||
105660868|NCT04486313|364423165|FG000|Overall Study|Death|2|||
105660869|NCT04486313|364423166|FG001|Overall Study|Death|0|||
105660870|NCT04486313|364423165|FG000|Overall Study|Protocol Violation|1|||
105660871|NCT04486313|364423166|FG001|Overall Study|Protocol Violation|1|||
105660872|NCT04629443|364423167|FG000|Overall Study|Adverse Event|2|||
105660873|NCT04629443|364423168|FG001|Overall Study|Adverse Event|1|||
105660874|NCT04629443|364423169|FG002|Overall Study|Adverse Event|2|||
105660875|NCT04629443|364423167|FG000|Overall Study|Progressive Disease|2|||
105660876|NCT04629443|364423168|FG001|Overall Study|Progressive Disease|3|||
105660877|NCT04629443|364423169|FG002|Overall Study|Progressive Disease|3|||
105660878|NCT04629443|364423167|FG000|Overall Study|Physician Decision|1|||
105660879|NCT04629443|364423168|FG001|Overall Study|Physician Decision|3|||
105660880|NCT04629443|364423169|FG002|Overall Study|Physician Decision|0|||
105660881|NCT01657799|364423170|FG000|Overall Study|Adverse Event Related to progression|6|||
105660882|NCT01657799|364423171|FG001|Overall Study|Adverse Event Related to progression|8|||
105660883|NCT01657799|364423172|FG002|Overall Study|Adverse Event Related to progression|12|||
105660884|NCT01657799|364423170|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
105660885|NCT01657799|364423171|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
105660886|NCT01657799|364423172|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
105660887|NCT01657799|364423170|FG000|Overall Study|Withdrawal by Subject|13|||
105660888|NCT01657799|364423171|FG001|Overall Study|Withdrawal by Subject|10|||
105660889|NCT01657799|364423172|FG002|Overall Study|Withdrawal by Subject|10|||
105660890|NCT01657799|364423170|FG000|Overall Study|Lost to Follow-up|1|||
105660891|NCT01657799|364423171|FG001|Overall Study|Lost to Follow-up|0|||
105660892|NCT01657799|364423172|FG002|Overall Study|Lost to Follow-up|1|||
105660893|NCT01657799|364423170|FG000|Overall Study|Disease Progression|2|||
105660894|NCT01657799|364423171|FG001|Overall Study|Disease Progression|4|||
105660895|NCT01657799|364423172|FG002|Overall Study|Disease Progression|4|||
105660896|NCT01657799|364423170|FG000|Overall Study|Progressive Disease Clinical|7|||
105660897|NCT01657799|364423171|FG001|Overall Study|Progressive Disease Clinical|4|||
105660898|NCT01657799|364423172|FG002|Overall Study|Progressive Disease Clinical|7|||
105660899|NCT01657799|364423170|FG000|Overall Study|Radiographic & Clinical Progression|16|||
105660900|NCT01657799|364423171|FG001|Overall Study|Radiographic & Clinical Progression|11|||
105660901|NCT01657799|364423172|FG002|Overall Study|Radiographic & Clinical Progression|15|||
105660902|NCT01657799|364423170|FG000|Overall Study|Other|52|||
105660903|NCT01657799|364423171|FG001|Overall Study|Other|62|||
105660904|NCT01657799|364423172|FG002|Overall Study|Other|49|||
105660905|NCT01015677|364423181|FG000|Overall Study|Adverse Event|0|||
105660906|NCT01015677|364423182|FG001|Overall Study|Adverse Event|1|||
105660907|NCT01015677|364423183|FG002|Overall Study|Adverse Event|0|||
105660908|NCT01015677|364423181|FG000|Overall Study|Lack of Efficacy|0|||
105660909|NCT01015677|364423182|FG001|Overall Study|Lack of Efficacy|1|||
105660910|NCT01015677|364423183|FG002|Overall Study|Lack of Efficacy|0|||
105660911|NCT01015677|364423181|FG000|Overall Study|Protocol Violation|0|||
105660912|NCT01015677|364423182|FG001|Overall Study|Protocol Violation|1|||
105660913|NCT01015677|364423183|FG002|Overall Study|Protocol Violation|0|||
105660914|NCT01015677|364423181|FG000|Overall Study|Withdrawal by Subject|1|||
105660915|NCT01015677|364423182|FG001|Overall Study|Withdrawal by Subject|1|||
105660916|NCT01015677|364423183|FG002|Overall Study|Withdrawal by Subject|0|||
105660917|NCT02232399|364423184|FG000|Overall Study|Adverse Event|1|||
105660918|NCT02232399|364423185|FG001|Overall Study|Adverse Event|0|||
105660919|NCT02232399|364423184|FG000|Overall Study|Withdrawal by Subject|0|||
105660920|NCT02232399|364423185|FG001|Overall Study|Withdrawal by Subject|1|||
105660921|NCT00236184|364423186|FG000|Overall Study|Adverse Event|5|||
105660922|NCT00236184|364423187|FG001|Overall Study|Adverse Event|2|||
105660923|NCT00236184|364423186|FG000|Overall Study|Lack of Efficacy|0|||
105660924|NCT00236184|364423187|FG001|Overall Study|Lack of Efficacy|1|||
105660925|NCT00236184|364423186|FG000|Overall Study|Lost to Follow-up|3|||
105660926|NCT00236184|364423187|FG001|Overall Study|Lost to Follow-up|4|||
105660927|NCT00236184|364423186|FG000|Overall Study|Physician Decision|1|||
105660928|NCT00236184|364423187|FG001|Overall Study|Physician Decision|1|||
105660929|NCT00236184|364423186|FG000|Overall Study|Withdrawal by Subject|3|||
105660930|NCT00236184|364423187|FG001|Overall Study|Withdrawal by Subject|0|||
105660931|NCT00236184|364423186|FG000|Overall Study|Protocol Violation|3|||
105660932|NCT00236184|364423187|FG001|Overall Study|Protocol Violation|0|||
105660933|NCT00236184|364423186|FG000|Overall Study|non-compliance with study drug|2|||
105660934|NCT00236184|364423187|FG001|Overall Study|non-compliance with study drug|1|||
105660935|NCT00236184|364423186|FG000|Overall Study|other|1|||
105660936|NCT00236184|364423187|FG001|Overall Study|other|2|||
105660937|NCT02599688|364423188|FG000|Overall Study|Lack of Efficacy|1|||
105660938|NCT02599688|364423188|FG000|Overall Study|Withdrawal by Subject|1|||
105660939|NCT02599688|364423188|FG000|Overall Study|Termination by Sponsor|2|||
105660940|NCT03470545|364423189|FG000|Overall Study|Death|0|||
105660941|NCT03470545|364423190|FG001|Overall Study|Death|1|||
105660942|NCT03470545|364423189|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
105660943|NCT03470545|364423190|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
105660944|NCT03470545|364423189|FG000|Overall Study|Adverse Event|2|||
105660945|NCT03470545|364423190|FG001|Overall Study|Adverse Event|0|||
105660946|NCT03470545|364423189|FG000|Overall Study|Withdrawal by Subject|1|||
105660947|NCT03470545|364423190|FG001|Overall Study|Withdrawal by Subject|1|||
105660948|NCT03470545|364423189|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
105660949|NCT03470545|364423190|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
105660950|NCT01086384|364423195|FG000|2-week Run-in Period|Adverse Event|1|||
105660951|NCT01086384|364423196|FG001|2-week Run-in Period|Adverse Event|0|||
105660952|NCT01086384|364423197|FG002|2-week Run-in Period|Adverse Event|0|||
105660953|NCT01086384|364423195|FG000|2-week Run-in Period|Protocol Violation|1|||
105660954|NCT01086384|364423196|FG001|2-week Run-in Period|Protocol Violation|0|||
105660955|NCT01086384|364423197|FG002|2-week Run-in Period|Protocol Violation|0|||
105660956|NCT01086384|364423195|FG000|2-week Run-in Period|Lost to Follow-up|1|||
105660957|NCT01086384|364423196|FG001|2-week Run-in Period|Lost to Follow-up|0|||
105660958|NCT01086384|364423197|FG002|2-week Run-in Period|Lost to Follow-up|0|||
105660959|NCT01086384|364423195|FG000|2-week Run-in Period|Physician Decision|6|||
105660960|NCT01086384|364423196|FG001|2-week Run-in Period|Physician Decision|0|||
105660961|NCT01086384|364423197|FG002|2-week Run-in Period|Physician Decision|0|||
105660962|NCT01086384|364423195|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
105660963|NCT01086384|364423196|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
105660964|NCT01086384|364423197|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
105660965|NCT01086384|364423195|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
105660966|NCT01086384|364423196|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
105660967|NCT01086384|364423197|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
105660968|NCT01086384|364423195|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
105660969|NCT01086384|364423196|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
105660970|NCT01086384|364423197|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
105660971|NCT01086384|364423195|FG000|2-week Run-in Period|Randomized in Error|1|||
105660972|NCT01086384|364423196|FG001|2-week Run-in Period|Randomized in Error|0|||
105660973|NCT01086384|364423197|FG002|2-week Run-in Period|Randomized in Error|0|||
105660974|NCT01086384|364423195|FG000|Treatment Period|Withdrawal by Subject|0|||
105660975|NCT01086384|364423196|FG001|Treatment Period|Withdrawal by Subject|53|||
105660976|NCT01086384|364423197|FG002|Treatment Period|Withdrawal by Subject|55|||
105660977|NCT01086384|364423195|FG000|Treatment Period|Protocol Violation|0|||
105660978|NCT01086384|364423196|FG001|Treatment Period|Protocol Violation|26|||
105660979|NCT01086384|364423197|FG002|Treatment Period|Protocol Violation|17|||
105660980|NCT01086384|364423195|FG000|Treatment Period|Lack of Efficacy|0|||
105660981|NCT01086384|364423196|FG001|Treatment Period|Lack of Efficacy|22|||
105660982|NCT01086384|364423197|FG002|Treatment Period|Lack of Efficacy|13|||
105660983|NCT01086384|364423195|FG000|Treatment Period|Adverse Event|0|||
105660984|NCT01086384|364423196|FG001|Treatment Period|Adverse Event|19|||
105660985|NCT01086384|364423197|FG002|Treatment Period|Adverse Event|15|||
105660986|NCT01086384|364423195|FG000|Treatment Period|Lost to Follow-up|0|||
105660987|NCT01086384|364423196|FG001|Treatment Period|Lost to Follow-up|11|||
105660988|NCT01086384|364423197|FG002|Treatment Period|Lost to Follow-up|9|||
105660989|NCT01086384|364423195|FG000|Treatment Period|Physician Decision|0|||
105660990|NCT01086384|364423196|FG001|Treatment Period|Physician Decision|9|||
105660991|NCT01086384|364423197|FG002|Treatment Period|Physician Decision|6|||
105660992|NCT01086384|364423195|FG000|Treatment Period|Study Closed/Terminated|0|||
105660993|NCT01086384|364423196|FG001|Treatment Period|Study Closed/Terminated|7|||
105660994|NCT01086384|364423197|FG002|Treatment Period|Study Closed/Terminated|8|||
105660995|NCT01086384|364423195|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
105660996|NCT01086384|364423196|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
105660997|NCT01086384|364423197|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
105660998|NCT01086384|364423195|FG000|Treatment Period|Received Treatment in Error|0|||
105660999|NCT01086384|364423196|FG001|Treatment Period|Received Treatment in Error|1|||
105661000|NCT01086384|364423197|FG002|Treatment Period|Received Treatment in Error|0|||
105661001|NCT00952848|364423204|FG000|Overall Study|Withdrawal by Subject|4|||
105661002|NCT02250534|364423205|FG000|Overall Study|Lost to Follow-up|18|||
105661003|NCT02250534|364423206|FG001|Overall Study|Lost to Follow-up|28|||
105661004|NCT02250534|364423207|FG002|Overall Study|Lost to Follow-up|33|||
105661005|NCT02250534|364423205|FG000|Overall Study|Personal reasons|7|||
105661006|NCT02250534|364423206|FG001|Overall Study|Personal reasons|8|||
105661007|NCT02250534|364423207|FG002|Overall Study|Personal reasons|14|||
105661008|NCT02250534|364423205|FG000|Overall Study|Adverse Event|6|||
105661009|NCT02250534|364423206|FG001|Overall Study|Adverse Event|3|||
105661010|NCT02250534|364423207|FG002|Overall Study|Adverse Event|8|||
105661011|NCT02250534|364423205|FG000|Overall Study|incarcerated|2|||
105661012|NCT02250534|364423206|FG001|Overall Study|incarcerated|1|||
105661013|NCT02250534|364423207|FG002|Overall Study|incarcerated|2|||
105661014|NCT02250534|364423205|FG000|Overall Study|Withdrawal by Subject|0|||
105661015|NCT02250534|364423206|FG001|Overall Study|Withdrawal by Subject|1|||
105661016|NCT02250534|364423207|FG002|Overall Study|Withdrawal by Subject|2|||
105661017|NCT02250534|364423205|FG000|Overall Study|Death|0|||
105661018|NCT02250534|364423206|FG001|Overall Study|Death|1|||
105661019|NCT02250534|364423207|FG002|Overall Study|Death|1|||
105661020|NCT02250534|364423205|FG000|Overall Study|Physician Decision|1|||
105661021|NCT02250534|364423206|FG001|Overall Study|Physician Decision|3|||
105661022|NCT02250534|364423207|FG002|Overall Study|Physician Decision|1|||
105661023|NCT02250534|364423205|FG000|Overall Study|Protocol Violation|1|||
105661024|NCT02250534|364423206|FG001|Overall Study|Protocol Violation|0|||
105661025|NCT02250534|364423207|FG002|Overall Study|Protocol Violation|1|||
105661026|NCT02250534|364423205|FG000|Overall Study|Reason unknown|1|||
105661027|NCT02250534|364423206|FG001|Overall Study|Reason unknown|0|||
105661028|NCT02250534|364423207|FG002|Overall Study|Reason unknown|0|||
105661029|NCT00458393|364423208|FG000|Overall Study|Withdrawal by Subject|67|||
105661030|NCT00458393|364423209|FG001|Overall Study|Withdrawal by Subject|80|||
105661031|NCT00458393|364423208|FG000|Overall Study|Physician Decision|31|||
105661032|NCT00458393|364423209|FG001|Overall Study|Physician Decision|22|||
105661033|NCT00458393|364423208|FG000|Overall Study|Relocated|77|||
105661034|NCT00458393|364423209|FG001|Overall Study|Relocated|81|||
105661035|NCT00458393|364423208|FG000|Overall Study|Lost to Follow-up|115|||
105661036|NCT00458393|364423209|FG001|Overall Study|Lost to Follow-up|92|||
105661037|NCT00458393|364423208|FG000|Overall Study|Sites marked other on the form.|19|||
105661038|NCT00458393|364423209|FG001|Overall Study|Sites marked other on the form.|20|||
105661039|NCT01628692|364423210|FG000|Overall Study|Lack of Efficacy|4|||
105661040|NCT01628692|364423211|FG001|Overall Study|Lack of Efficacy|4|||
105661041|NCT01628692|364423212|FG002|Overall Study|Lack of Efficacy|5|||
105661042|NCT01628692|364423213|FG003|Overall Study|Lack of Efficacy|1|||
105661043|NCT01628692|364423214|FG004|Overall Study|Lack of Efficacy|4|||
105661044|NCT01628692|364423215|FG005|Overall Study|Lack of Efficacy|7|||
105661045|NCT01628692|364423210|FG000|Overall Study|Adverse Event|2|||
105661046|NCT01628692|364423211|FG001|Overall Study|Adverse Event|0|||
105661047|NCT01628692|364423212|FG002|Overall Study|Adverse Event|2|||
105661048|NCT01628692|364423213|FG003|Overall Study|Adverse Event|0|||
105661049|NCT01628692|364423214|FG004|Overall Study|Adverse Event|0|||
105661050|NCT01628692|364423215|FG005|Overall Study|Adverse Event|0|||
105661051|NCT01628692|364423210|FG000|Overall Study|Withdrawal by Subject|0|||
105661052|NCT01628692|364423211|FG001|Overall Study|Withdrawal by Subject|1|||
105661053|NCT01628692|364423212|FG002|Overall Study|Withdrawal by Subject|1|||
105661054|NCT01628692|364423213|FG003|Overall Study|Withdrawal by Subject|0|||
105661055|NCT01628692|364423214|FG004|Overall Study|Withdrawal by Subject|0|||
105661056|NCT01628692|364423215|FG005|Overall Study|Withdrawal by Subject|0|||
105661057|NCT01628692|364423210|FG000|Overall Study|Death|0|||
105661058|NCT01628692|364423211|FG001|Overall Study|Death|1|||
105661059|NCT01628692|364423212|FG002|Overall Study|Death|0|||
105661060|NCT01628692|364423213|FG003|Overall Study|Death|0|||
105661061|NCT01628692|364423214|FG004|Overall Study|Death|0|||
105661062|NCT01628692|364423215|FG005|Overall Study|Death|0|||
105661063|NCT01628692|364423210|FG000|Overall Study|Poor compliance/noncompliance|1|||
105661064|NCT01628692|364423211|FG001|Overall Study|Poor compliance/noncompliance|0|||
105661065|NCT01628692|364423212|FG002|Overall Study|Poor compliance/noncompliance|0|||
105661066|NCT01628692|364423213|FG003|Overall Study|Poor compliance/noncompliance|0|||
105661067|NCT01628692|364423214|FG004|Overall Study|Poor compliance/noncompliance|0|||
105661068|NCT01628692|364423215|FG005|Overall Study|Poor compliance/noncompliance|0|||
105661069|NCT01628692|364423210|FG000|Overall Study|Administrative reason by sponsor|0|||
105661070|NCT01628692|364423211|FG001|Overall Study|Administrative reason by sponsor|0|||
105661071|NCT01628692|364423212|FG002|Overall Study|Administrative reason by sponsor|0|||
105661072|NCT01628692|364423213|FG003|Overall Study|Administrative reason by sponsor|0|||
105661073|NCT01628692|364423214|FG004|Overall Study|Administrative reason by sponsor|0|||
105661074|NCT01628692|364423215|FG005|Overall Study|Administrative reason by sponsor|1|||
105661075|NCT01628692|364423210|FG000|Overall Study|Completed 12 Week only|0|||
105661076|NCT01628692|364423211|FG001|Overall Study|Completed 12 Week only|0|||
105661077|NCT01628692|364423212|FG002|Overall Study|Completed 12 Week only|0|||
105661078|NCT01628692|364423213|FG003|Overall Study|Completed 12 Week only|0|||
105661079|NCT01628692|364423214|FG004|Overall Study|Completed 12 Week only|0|||
105661080|NCT01628692|364423215|FG005|Overall Study|Completed 12 Week only|1|||
105661081|NCT02413593|364423216|FG000|Overall Study|Lost to Follow-up|3|||
105661082|NCT02413593|364423216|FG000|Overall Study|Adverse Event|1|||
105661083|NCT01101061|364423217|FG000|Overall Study|Adverse Event|0|||
105661084|NCT01101061|364423218|FG001|Overall Study|Adverse Event|0|||
105661085|NCT01101061|364423219|FG002|Overall Study|Adverse Event|1|||
105661086|NCT01101061|364423220|FG003|Overall Study|Adverse Event|0|||
105661087|NCT01101061|364423221|FG004|Overall Study|Adverse Event|0|||
105661088|NCT01101061|364423222|FG005|Overall Study|Adverse Event|0|||
105661089|NCT00857233|364423223|FG000|Overall Study|Adverse Event|24|||
105661090|NCT00857233|364423223|FG000|Overall Study|Lack of Efficacy|1|||
105661091|NCT00857233|364423223|FG000|Overall Study|Non-compliance|1|||
105661092|NCT00857233|364423223|FG000|Overall Study|Withdrawal of Consent|9|||
105661093|NCT00857233|364423223|FG000|Overall Study|Lost to Follow-up|4|||
105661094|NCT00857233|364423223|FG000|Overall Study|Nursing Home Placement|14|||
105661095|NCT00857233|364423223|FG000|Overall Study|Other Reasons|2|||
105661096|NCT05043883|364423224|FG000|Overall Study|Minimum required measurements could not be taken|4|||
105661097|NCT01587118|364423225|FG000|Overall Study|Adverse Event|3|||
105661098|NCT01587118|364423225|FG000|Overall Study|Lost to Follow-up|2|||
105661099|NCT01587118|364423225|FG000|Overall Study|Relocation|1|||
105661100|NCT01587118|364423225|FG000|Overall Study|nonresponse|1|||
105661101|NCT00263575|364423226|FG000|Titration Period|Adverse Event|14|||
105661102|NCT00263575|364423226|FG000|Titration Period|Withdrawal by Subject|10|||
105661103|NCT00263575|364423226|FG000|Titration Period|Protocol Violation|9|||
105661104|NCT00263575|364423226|FG000|Titration Period|Sponsor Decision|2|||
105661105|NCT00263575|364423226|FG000|Titration Period|Other|2|||
105661106|NCT00263575|364423226|FG000|Titration Period|Lack of Efficacy|6|||
105661107|NCT00263575|364423226|FG000|Maintence Period|Adverse Event|23|||
105661108|NCT00263575|364423226|FG000|Maintence Period|Withdrawal by Subject|8|||
105661109|NCT00263575|364423226|FG000|Maintence Period|Protocol Violation|4|||
105661110|NCT00263575|364423226|FG000|Maintence Period|Lack of Efficacy|4|||
105661111|NCT00263575|364423226|FG000|Maintence Period|Physician Decision|6|||
105661112|NCT00263575|364423226|FG000|Maintence Period|Lost to Follow-up|1|||
105661113|NCT00263575|364423226|FG000|Maintence Period|Sponsor Decision|24|||
105661114|NCT00263575|364423226|FG000|Maintence Period|Other|7|||
105661115|NCT00224029|364423228|FG000|Overall Study|Lost to Follow-up|1|||
105661116|NCT00224029|364423228|FG000|Overall Study|Withdrawal by Subject|4|||
105661117|NCT00224029|364423228|FG000|Overall Study|Other|1|||
105661118|NCT03000348|364423229|FG000|Overall Study|Adverse Event|1|||
105661119|NCT03000348|364423230|FG001|Overall Study|Adverse Event|1|||
105661120|NCT03000348|364423231|FG002|Overall Study|Adverse Event|1|||
105661121|NCT03000348|364423232|FG003|Overall Study|Adverse Event|1|||
105661122|NCT03000348|364423233|FG004|Overall Study|Adverse Event|1|||
105661123|NCT03000348|364423234|FG005|Overall Study|Adverse Event|1|||
105661124|NCT03000348|364423229|FG000|Overall Study|Lost to Follow-up|0|||
105661125|NCT03000348|364423230|FG001|Overall Study|Lost to Follow-up|0|||
105661126|NCT03000348|364423231|FG002|Overall Study|Lost to Follow-up|1|||
105661127|NCT03000348|364423232|FG003|Overall Study|Lost to Follow-up|0|||
105661128|NCT03000348|364423233|FG004|Overall Study|Lost to Follow-up|0|||
105661129|NCT03000348|364423234|FG005|Overall Study|Lost to Follow-up|0|||
105661130|NCT03000348|364423229|FG000|Overall Study|Withdrawal by Subject|0|||
105661131|NCT03000348|364423230|FG001|Overall Study|Withdrawal by Subject|1|||
105661132|NCT03000348|364423231|FG002|Overall Study|Withdrawal by Subject|0|||
105661133|NCT03000348|364423232|FG003|Overall Study|Withdrawal by Subject|0|||
105661134|NCT03000348|364423233|FG004|Overall Study|Withdrawal by Subject|0|||
105661135|NCT03000348|364423234|FG005|Overall Study|Withdrawal by Subject|0|||
105661136|NCT03000348|364423229|FG000|Overall Study|Consent|0|||
105661137|NCT03000348|364423230|FG001|Overall Study|Consent|0|||
105661138|NCT03000348|364423231|FG002|Overall Study|Consent|0|||
105661139|NCT03000348|364423232|FG003|Overall Study|Consent|0|||
105661140|NCT03000348|364423233|FG004|Overall Study|Consent|1|||
105661141|NCT03000348|364423234|FG005|Overall Study|Consent|0|||
105661142|NCT03000348|364423229|FG000|Overall Study|Failure to expectorate sputum|1|||
105661143|NCT03000348|364423230|FG001|Overall Study|Failure to expectorate sputum|0|||
105661144|NCT03000348|364423231|FG002|Overall Study|Failure to expectorate sputum|1|||
105661145|NCT03000348|364423232|FG003|Overall Study|Failure to expectorate sputum|0|||
105661146|NCT03000348|364423233|FG004|Overall Study|Failure to expectorate sputum|1|||
105661147|NCT03000348|364423234|FG005|Overall Study|Failure to expectorate sputum|0|||
105661148|NCT03000348|364423229|FG000|Overall Study|No gram negative|1|||
105661149|NCT03000348|364423230|FG001|Overall Study|No gram negative|2|||
105661150|NCT03000348|364423231|FG002|Overall Study|No gram negative|1|||
105661151|NCT03000348|364423232|FG003|Overall Study|No gram negative|1|||
105661152|NCT03000348|364423233|FG004|Overall Study|No gram negative|1|||
105661153|NCT03000348|364423234|FG005|Overall Study|No gram negative|1|||
105661154|NCT03000348|364423229|FG000|Overall Study|Patient had no transport|0|||
105661155|NCT03000348|364423230|FG001|Overall Study|Patient had no transport|0|||
105661156|NCT03000348|364423231|FG002|Overall Study|Patient had no transport|0|||
105661157|NCT03000348|364423232|FG003|Overall Study|Patient had no transport|1|||
105661158|NCT03000348|364423233|FG004|Overall Study|Patient had no transport|0|||
105661159|NCT03000348|364423234|FG005|Overall Study|Patient had no transport|0|||
105661160|NCT03000348|364423229|FG000|Overall Study|Dosing|0|||
105661161|NCT03000348|364423230|FG001|Overall Study|Dosing|0|||
105661162|NCT03000348|364423231|FG002|Overall Study|Dosing|0|||
105661163|NCT03000348|364423232|FG003|Overall Study|Dosing|0|||
105661164|NCT03000348|364423233|FG004|Overall Study|Dosing|1|||
105661165|NCT03000348|364423234|FG005|Overall Study|Dosing|0|||
105661166|NCT03636373|364423236|FG000|Overall Study|Study closure due to Covid-19|1|||
105661167|NCT03636373|364423237|FG001|Overall Study|Study closure due to Covid-19|0|||
105661168|NCT01174264|364423238|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
105661169|NCT01174264|364423239|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
105661170|NCT01174264|364423240|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
105661171|NCT01174264|364423238|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
105661172|NCT01174264|364423239|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
105661173|NCT01174264|364423240|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
105661174|NCT01174264|364423238|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
105661175|NCT01174264|364423239|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
105661176|NCT01174264|364423240|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
105661177|NCT01185171|364423247|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
105661178|NCT01185171|364423247|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
105661179|NCT01185171|364423247|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
105661180|NCT01185171|364423247|FG000|Maintenance|Elevated liver transaminases|3|||
105661181|NCT01185171|364423247|FG000|Maintenance|Rush|2|||
105661182|NCT01185171|364423247|FG000|Maintenance|Diarrhea|1|||
105661183|NCT01185171|364423247|FG000|Maintenance|Xerostomia|1|||
105661184|NCT01185171|364423247|FG000|Maintenance|Nausea|1|||
105661185|NCT01185171|364423247|FG000|Maintenance|Comorbid Illness|2|||
105661186|NCT01185171|364423247|FG000|Maintenance|Withdrawal by Subject|1|||
105661187|NCT01185171|364423247|FG000|Maintenance|Disease Recurrence|1|||
105661188|NCT01214421|364423253|FG000|Overall Study|Lost to Follow-up|7|||
105661189|NCT01214421|364423254|FG001|Overall Study|Lost to Follow-up|3|||
105661190|NCT01214421|364423255|FG002|Overall Study|Lost to Follow-up|7|||
105661191|NCT01214421|364423256|FG003|Overall Study|Lost to Follow-up|3|||
105661192|NCT01214421|364423253|FG000|Overall Study|Adverse Event|16|||
105661193|NCT01214421|364423254|FG001|Overall Study|Adverse Event|35|||
105661194|NCT01214421|364423255|FG002|Overall Study|Adverse Event|14|||
105661195|NCT01214421|364423256|FG003|Overall Study|Adverse Event|3|||
105661196|NCT01214421|364423253|FG000|Overall Study|Sponsor Discontinued Site|1|||
105360837|NCT00572455|363328090|FG010|Stage II (28 Days)|Other|0|||
105661197|NCT01214421|364423254|FG001|Overall Study|Sponsor Discontinued Site|2|||
105661198|NCT01214421|364423255|FG002|Overall Study|Sponsor Discontinued Site|0|||
105661199|NCT01214421|364423256|FG003|Overall Study|Sponsor Discontinued Site|0|||
105661200|NCT01214421|364423253|FG000|Overall Study|Withdrawal Criteria Met|3|||
105661201|NCT01214421|364423254|FG001|Overall Study|Withdrawal Criteria Met|0|||
105661202|NCT01214421|364423255|FG002|Overall Study|Withdrawal Criteria Met|2|||
105661203|NCT01214421|364423256|FG003|Overall Study|Withdrawal Criteria Met|1|||
105661204|NCT01214421|364423253|FG000|Overall Study|Physician Decision|2|||
105661205|NCT01214421|364423254|FG001|Overall Study|Physician Decision|0|||
105661206|NCT01214421|364423255|FG002|Overall Study|Physician Decision|4|||
105661207|NCT01214421|364423256|FG003|Overall Study|Physician Decision|0|||
105661208|NCT01214421|364423253|FG000|Overall Study|Withdrawal by Subject|21|||
105661209|NCT01214421|364423254|FG001|Overall Study|Withdrawal by Subject|18|||
105661210|NCT01214421|364423255|FG002|Overall Study|Withdrawal by Subject|11|||
105661211|NCT01214421|364423256|FG003|Overall Study|Withdrawal by Subject|2|||
105661212|NCT01018732|364423257|FG000|Overall Study|Lost to Follow-up|0|||
105661213|NCT01018732|364423258|FG001|Overall Study|Lost to Follow-up|0|||
105661214|NCT01018732|364423259|FG002|Overall Study|Lost to Follow-up|3|||
105661215|NCT01018732|364423257|FG000|Overall Study|Protocol Violation|1|||
105661216|NCT01018732|364423258|FG001|Overall Study|Protocol Violation|1|||
105661217|NCT01018732|364423259|FG002|Overall Study|Protocol Violation|0|||
105661218|NCT01018732|364423257|FG000|Overall Study|Inappropriate Enrollment|0|||
105661219|NCT01018732|364423258|FG001|Overall Study|Inappropriate Enrollment|1|||
105661220|NCT01018732|364423259|FG002|Overall Study|Inappropriate Enrollment|0|||
105661221|NCT01018732|364423257|FG000|Overall Study|Unable to Classify|0|||
105661222|NCT01018732|364423258|FG001|Overall Study|Unable to Classify|0|||
105661223|NCT01018732|364423259|FG002|Overall Study|Unable to Classify|1|||
105661224|NCT01536171|364423260|FG000|Overall Study|Withdrawal by Subject|1|||
105661225|NCT03783689|364423265|FG000|Overall Study|Adverse Event|2|||
105661226|NCT03783689|364423266|FG001|Overall Study|Adverse Event|0|||
105661227|NCT03783689|364423265|FG000|Overall Study|Lost to Follow-up|2|||
105661228|NCT03783689|364423266|FG001|Overall Study|Lost to Follow-up|1|||
105661229|NCT03783689|364423265|FG000|Overall Study|Physician Decision|2|||
105661230|NCT03783689|364423266|FG001|Overall Study|Physician Decision|1|||
105661231|NCT03783689|364423265|FG000|Overall Study|Withdrawal by Subject|3|||
105661232|NCT03783689|364423266|FG001|Overall Study|Withdrawal by Subject|3|||
105661233|NCT03448536|364423269|FG000|Overall Study|Protocol Violation|2|||
105661234|NCT03448536|364423270|FG001|Overall Study|Protocol Violation|0|||
105661235|NCT03448536|364423269|FG000|Overall Study|Pregnancy|1|||
105661236|NCT03448536|364423270|FG001|Overall Study|Pregnancy|0|||
105661237|NCT03448536|364423269|FG000|Overall Study|Withdrawal by Subject|1|||
105661238|NCT03448536|364423270|FG001|Overall Study|Withdrawal by Subject|2|||
105661239|NCT03448536|364423269|FG000|Overall Study|Lost to Follow-up|3|||
105661240|NCT03448536|364423270|FG001|Overall Study|Lost to Follow-up|2|||
105661241|NCT03448536|364423269|FG000|Overall Study|Inadequate pain reporter|1|||
105661242|NCT03448536|364423270|FG001|Overall Study|Inadequate pain reporter|0|||
105661243|NCT03448536|364423269|FG000|Overall Study|Other|3|||
105661244|NCT03448536|364423270|FG001|Overall Study|Other|0|||
105661245|NCT03448536|364423269|FG000|Overall Study|Physician Decision|1|||
105661246|NCT03448536|364423270|FG001|Overall Study|Physician Decision|0|||
105661247|NCT02636608|364423271|FG000|Overall Study|Failure to Return|4|||
105661248|NCT02636608|364423271|FG000|Overall Study|Insufficient Virological Response|1|||
105661249|NCT02636608|364423271|FG000|Overall Study|Death|3|||
105661250|NCT02636608|364423271|FG000|Overall Study|Other|2|||
105661251|NCT02636608|364423271|FG000|Overall Study|Did Not Receive Treatment|1|||
105661252|NCT01255761|364423272|FG000|Overall Study|Adverse Event|29|||
105661253|NCT01255761|364423273|FG001|Overall Study|Adverse Event|43|||
105661254|NCT01255761|364423272|FG000|Overall Study|Lack of Efficacy|86|||
105661255|NCT01255761|364423273|FG001|Overall Study|Lack of Efficacy|74|||
105661256|NCT01255761|364423272|FG000|Overall Study|Protocol Violation|9|||
105661257|NCT01255761|364423273|FG001|Overall Study|Protocol Violation|5|||
105661258|NCT01255761|364423272|FG000|Overall Study|Lost to Follow-up|10|||
105661259|NCT01255761|364423273|FG001|Overall Study|Lost to Follow-up|8|||
105661260|NCT01255761|364423272|FG000|Overall Study|Withdrawal by Subject|11|||
105661261|NCT01255761|364423273|FG001|Overall Study|Withdrawal by Subject|27|||
105770555|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105442491|NCT01957202|363626751|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
105442492|NCT01957202|363626752|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
105661262|NCT01255761|364423272|FG000|Overall Study|Other Reasons|37|||
105661263|NCT01255761|364423273|FG001|Overall Study|Other Reasons|18|||
105661264|NCT00838929|364423276|FG000|Overall Study|Protocol Violation|0|||
105661265|NCT00838929|364423277|FG001|Overall Study|Protocol Violation|1|||
105661266|NCT00838929|364423278|FG002|Overall Study|Protocol Violation|0|||
105661267|NCT00838929|364423276|FG000|Overall Study|Disease progression|0|||
105661268|NCT00838929|364423277|FG001|Overall Study|Disease progression|2|||
105661269|NCT00838929|364423278|FG002|Overall Study|Disease progression|1|||
105661270|NCT00365547|364423279|FG000|Overall Study|Insurance did not cover Avastin|1|||
105661271|NCT00365547|364423279|FG000|Overall Study|Screen failure|1|||
105661272|NCT00365547|364423279|FG000|Overall Study|Withdrawal by Subject|1|||
105661273|NCT00546078|364423280|FG000|Overall Study|Lost to Follow-up|1|||
105661274|NCT00546078|364423281|FG001|Overall Study|Lost to Follow-up|3|||
105661275|NCT00546078|364423280|FG000|Overall Study|Withdrawal by Subject|2|||
105661276|NCT00546078|364423281|FG001|Overall Study|Withdrawal by Subject|3|||
105661277|NCT00546078|364423280|FG000|Overall Study|Other reason|1|||
105661278|NCT00546078|364423281|FG001|Overall Study|Other reason|1|||
105661279|NCT03512197|364423282|FG000|Overall Study|Guardian decision|1|||
105661280|NCT03512197|364423283|FG001|Overall Study|Guardian decision|1|||
105661281|NCT03512197|364423282|FG000|Overall Study|Lack of Efficacy|19|||
105661282|NCT03512197|364423283|FG001|Overall Study|Lack of Efficacy|11|||
105661283|NCT03512197|364423282|FG000|Overall Study|New Therapy for Study Indication|16|||
105661284|NCT03512197|364423283|FG001|Overall Study|New Therapy for Study Indication|16|||
105661285|NCT03512197|364423282|FG000|Overall Study|Physician Decision|60|||
105661286|NCT03512197|364423283|FG001|Overall Study|Physician Decision|60|||
105661287|NCT03512197|364423282|FG000|Overall Study|Protocol Violation|0|||
105661288|NCT03512197|364423283|FG001|Overall Study|Protocol Violation|2|||
105661289|NCT03512197|364423282|FG000|Overall Study|Terminated by Sponsored|46|||
105661290|NCT03512197|364423283|FG001|Overall Study|Terminated by Sponsored|50|||
105661291|NCT03512197|364423282|FG000|Overall Study|Subject Decision|15|||
105661292|NCT03512197|364423283|FG001|Overall Study|Subject Decision|12|||
105661293|NCT03512197|364423282|FG000|Overall Study|Withdrawal of informed consent|20|||
105661294|NCT03512197|364423283|FG001|Overall Study|Withdrawal of informed consent|14|||
105661295|NCT03512197|364423282|FG000|Overall Study|Adverse Event|30|||
105661296|NCT03512197|364423283|FG001|Overall Study|Adverse Event|34|||
105661297|NCT03512197|364423282|FG000|Overall Study|Death|14|||
105661298|NCT03512197|364423283|FG001|Overall Study|Death|9|||
105661299|NCT03512197|364423282|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
105661300|NCT03512197|364423283|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
105661301|NCT03512197|364423282|FG000|Overall Study|Missing|3|||
105661302|NCT03512197|364423283|FG001|Overall Study|Missing|13|||
105661303|NCT02386839|364423286|FG000|Overall Study|Death|1|||
105661304|NCT02386839|364423287|FG001|Overall Study|Death|0|||
105661305|NCT02386839|364423286|FG000|Overall Study|Withdrawal by Subject|9|||
105661306|NCT02386839|364423287|FG001|Overall Study|Withdrawal by Subject|10|||
105661307|NCT02386839|364423286|FG000|Overall Study|Lost to Follow-up|4|||
105661308|NCT02386839|364423287|FG001|Overall Study|Lost to Follow-up|4|||
105661309|NCT02386839|364423286|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
105661310|NCT02386839|364423287|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
105661311|NCT02386839|364423286|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
105661312|NCT02386839|364423287|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
105661313|NCT02386839|364423286|FG000|Overall Study|Other (unspecified)|1|||
105661314|NCT02386839|364423287|FG001|Overall Study|Other (unspecified)|0|||
105661315|NCT04886518|364423289|FG000|Overall Study|Noncompliance with study drug|1|||
105661316|NCT04886518|364423290|FG001|Overall Study|Noncompliance with study drug|0|||
105661317|NCT04886518|364423291|FG002|Overall Study|Noncompliance with study drug|0|||
105661318|NCT04886518|364423289|FG000|Overall Study|Adverse Event|0|||
105661319|NCT04886518|364423290|FG001|Overall Study|Adverse Event|1|||
105661320|NCT04886518|364423291|FG002|Overall Study|Adverse Event|0|||
105661321|NCT04886518|364423289|FG000|Overall Study|Withdrawal by Subject|1|||
105661322|NCT04886518|364423290|FG001|Overall Study|Withdrawal by Subject|0|||
105661323|NCT04886518|364423291|FG002|Overall Study|Withdrawal by Subject|0|||
105661324|NCT06840769|364423292|FG000|Overall Study|Withdrawal by Subject|1|||
105661325|NCT06840769|364423293|FG001|Overall Study|Withdrawal by Subject|0|||
105661326|NCT06840769|364423294|FG002|Overall Study|Withdrawal by Subject|0|||
105661327|NCT06840769|364423295|FG003|Overall Study|Withdrawal by Subject|0|||
105661328|NCT06840769|364423296|FG004|Overall Study|Withdrawal by Subject|0|||
105661329|NCT02726945|364423297|FG000|Overall Study|Withdrawal by Subject|0|||
105661330|NCT02726945|364423298|FG001|Overall Study|Withdrawal by Subject|0|||
105661331|NCT02726945|364423299|FG002|Overall Study|Withdrawal by Subject|1|||
105661332|NCT02726945|364423297|FG000|Overall Study|Elected to have total knee replacement|0|||
105661333|NCT02726945|364423298|FG001|Overall Study|Elected to have total knee replacement|1|||
105661334|NCT02726945|364423299|FG002|Overall Study|Elected to have total knee replacement|0|||
105661335|NCT02035696|364425004|FG000|Overall Study|Lost to Follow-up|0|||
105661336|NCT02035696|364425005|FG001|Overall Study|Lost to Follow-up|3|||
105661337|NCT02035696|364425006|FG002|Overall Study|Lost to Follow-up|1|||
105661338|NCT02035696|364425007|FG003|Overall Study|Lost to Follow-up|2|||
105661339|NCT02035696|364425004|FG000|Overall Study|Withdrawal by Subject|3|||
105661340|NCT02035696|364425005|FG001|Overall Study|Withdrawal by Subject|0|||
105661341|NCT02035696|364425006|FG002|Overall Study|Withdrawal by Subject|2|||
105661342|NCT02035696|364425007|FG003|Overall Study|Withdrawal by Subject|1|||
105661343|NCT00497874|364425008|FG000|Overall Study|Withdrawal by Subject|48|||
105661344|NCT00497874|364425009|FG001|Overall Study|Withdrawal by Subject|17|||
105661345|NCT00497874|364425008|FG000|Overall Study|Illness|8|||
105661346|NCT00497874|364425009|FG001|Overall Study|Illness|4|||
105661347|NCT00497874|364425008|FG000|Overall Study|Death|2|||
105661348|NCT00497874|364425009|FG001|Overall Study|Death|4|||
105661349|NCT00497874|364425008|FG000|Overall Study|Unable to contact|52|||
105661350|NCT00497874|364425009|FG001|Overall Study|Unable to contact|67|||
105661351|NCT00497874|364425008|FG000|Overall Study|Unable to schedule|37|||
105661352|NCT00497874|364425009|FG001|Overall Study|Unable to schedule|24|||
105661353|NCT01639742|364425011|FG000|Overall Study|Study Ongoing|17|||
105661354|NCT01639742|364425011|FG000|Overall Study|Lost to Follow-up|1|||
105661355|NCT01468077|364425014|FG000|Overall Study|Adverse Event|2|||
105661356|NCT01468077|364425015|FG001|Overall Study|Adverse Event|2|||
105661357|NCT01468077|364425014|FG000|Overall Study|Lack of Efficacy|1|||
105661358|NCT01468077|364425015|FG001|Overall Study|Lack of Efficacy|1|||
105661359|NCT01468077|364425014|FG000|Overall Study|Physician Decision|1|||
105661360|NCT01468077|364425015|FG001|Overall Study|Physician Decision|0|||
105661361|NCT03024996|364425016|FG000|Overall Study|Death|57|||
105661362|NCT03024996|364425017|FG001|Overall Study|Death|55|||
105661363|NCT03024996|364425016|FG000|Overall Study|Disease relapse|1|||
105661364|NCT03024996|364425017|FG001|Overall Study|Disease relapse|0|||
105661365|NCT03024996|364425016|FG000|Overall Study|Lost to Follow-up|5|||
105661366|NCT03024996|364425017|FG001|Overall Study|Lost to Follow-up|10|||
105661367|NCT03024996|364425016|FG000|Overall Study|Other|3|||
105661368|NCT03024996|364425017|FG001|Overall Study|Other|3|||
105661369|NCT03024996|364425016|FG000|Overall Study|Physician Decision|0|||
105661370|NCT03024996|364425017|FG001|Overall Study|Physician Decision|1|||
105661371|NCT03024996|364425016|FG000|Overall Study|Study terminated by sponsor|303|||
105661372|NCT03024996|364425017|FG001|Overall Study|Study terminated by sponsor|283|||
105661373|NCT03024996|364425016|FG000|Overall Study|Withdrawal by Subject|21|||
105661374|NCT03024996|364425017|FG001|Overall Study|Withdrawal by Subject|36|||
105661375|NCT00632021|364425028|FG000|Overall Study|Withdrawal/death|4|||
105661376|NCT00632021|364425029|FG001|Overall Study|Withdrawal/death|7|||
105661377|NCT03732820|364425030|FG000|Overall Study|Death|168|||
105661378|NCT03732820|364425031|FG001|Overall Study|Death|203|||
105661379|NCT03732820|364425030|FG000|Overall Study|Other|2|||
105661380|NCT03732820|364425031|FG001|Overall Study|Other|2|||
105661381|NCT03732820|364425030|FG000|Overall Study|Failure to meet randomisation criteria|1|||
105661382|NCT03732820|364425031|FG001|Overall Study|Failure to meet randomisation criteria|1|||
105661383|NCT03732820|364425030|FG000|Overall Study|Patient decision|14|||
105661384|NCT03732820|364425031|FG001|Overall Study|Patient decision|10|||
105661385|NCT03732820|364425030|FG000|Overall Study|Screen failure|0|||
105661386|NCT03732820|364425031|FG001|Overall Study|Screen failure|1|||
105661387|NCT03732820|364425030|FG000|Overall Study|Patients ongoing study at data cut off|210|||
105661388|NCT03732820|364425031|FG001|Overall Study|Patients ongoing study at data cut off|178|||
105661389|NCT03732820|364425030|FG000|Overall Study|Lost to Follow-up|4|||
105661390|NCT03732820|364425031|FG001|Overall Study|Lost to Follow-up|2|||
105661391|NCT00537329|364425032|FG000|Overall Study|Death|10|||
105661392|NCT00537329|364425032|FG000|Overall Study|Adverse Event|3|||
105661393|NCT00537329|364425032|FG000|Overall Study|Lack of Efficacy|2|||
105661394|NCT00537329|364425032|FG000|Overall Study|Lost to Follow-up|6|||
105661395|NCT00537329|364425032|FG000|Overall Study|Withdrawal by Subject|4|||
105661396|NCT00537329|364425032|FG000|Overall Study|Other|1|||
105661397|NCT00085566|364425033|FG000|Overall Study|Adverse Event|0|||
105661398|NCT00085566|364425034|FG001|Overall Study|Adverse Event|0|||
105661399|NCT00085566|364425035|FG002|Overall Study|Adverse Event|10|||
105661400|NCT00085566|364425033|FG000|Overall Study|Patient Not treated|0|||
105661401|NCT00085566|364425034|FG001|Overall Study|Patient Not treated|0|||
105661402|NCT00085566|364425035|FG002|Overall Study|Patient Not treated|3|||
105661403|NCT00085566|364425033|FG000|Overall Study|Clinical progression|0|||
105661404|NCT00085566|364425034|FG001|Overall Study|Clinical progression|0|||
105661405|NCT00085566|364425035|FG002|Overall Study|Clinical progression|1|||
105661406|NCT03174782|364425044|FG000|Overall Study|Protocol Violation|1|||
105661407|NCT03174782|364425045|FG001|Overall Study|Protocol Violation|0|||
105661408|NCT03174782|364425044|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
105661409|NCT03174782|364425045|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
105661410|NCT04805073|364425046|FG000|Overall Study|study personnel not available|2|||
105661411|NCT04805073|364425047|FG001|Overall Study|study personnel not available|0|||
105661412|NCT04805073|364425046|FG000|Overall Study|spinal anesthesia failure|0|||
105661413|NCT04805073|364425047|FG001|Overall Study|spinal anesthesia failure|1|||
105661414|NCT04805073|364425046|FG000|Overall Study|Lost to Follow-up|0|||
105661415|NCT04805073|364425047|FG001|Overall Study|Lost to Follow-up|2|||
105661416|NCT03178045|364425048|FG000|Overall Study|Withdrawal by Subject|5|||
105661417|NCT03178045|364425049|FG001|Overall Study|Withdrawal by Subject|7|||
105661418|NCT03178045|364425048|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
105661419|NCT03178045|364425049|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
105661420|NCT03178045|364425048|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
105661421|NCT03178045|364425049|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
105661422|NCT01078922|364425053|FG000|Overall Study|Adverse Event|1|||
105661423|NCT02706847|364425054|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
105661424|NCT02706847|364425055|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
105661425|NCT02706847|364425056|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
105661426|NCT02706847|364425057|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
105661427|NCT02706847|364425054|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
105661428|NCT02706847|364425055|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
105661429|NCT02706847|364425056|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
105661430|NCT02706847|364425057|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
105661431|NCT02706847|364425054|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
105661432|NCT02706847|364425055|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
105661433|NCT02706847|364425056|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
105661434|NCT02706847|364425057|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
105661435|NCT02706847|364425054|FG000|Period 1: Day 1 to Week 12|Other|4|||
105661436|NCT02706847|364425055|FG001|Period 1: Day 1 to Week 12|Other|4|||
105661437|NCT02706847|364425056|FG002|Period 1: Day 1 to Week 12|Other|2|||
105661438|NCT02706847|364425057|FG003|Period 1: Day 1 to Week 12|Other|2|||
105661439|NCT02706847|364425054|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
105661440|NCT02706847|364425055|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
105661441|NCT02706847|364425056|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
105661442|NCT02706847|364425057|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
105661443|NCT02706847|364425054|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
105661444|NCT02706847|364425055|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
105661445|NCT02706847|364425056|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
105661446|NCT02706847|364425057|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
105661447|NCT02706847|364425054|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
105661448|NCT02706847|364425055|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
105661449|NCT02706847|364425056|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
105661450|NCT02706847|364425057|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
105661451|NCT02706847|364425054|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
105661452|NCT02706847|364425055|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
105661453|NCT02706847|364425056|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
105661454|NCT02706847|364425057|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
105661455|NCT02706847|364425054|FG000|Period 1: Week 12 to Week 24|Other|1|||
105661456|NCT02706847|364425055|FG001|Period 1: Week 12 to Week 24|Other|0|||
105661457|NCT02706847|364425056|FG002|Period 1: Week 12 to Week 24|Other|1|||
105661458|NCT02706847|364425057|FG003|Period 1: Week 12 to Week 24|Other|4|||
105661459|NCT02706847|364425054|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
105661460|NCT02706847|364425055|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
105661461|NCT02706847|364425056|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
105661462|NCT02706847|364425057|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
105661463|NCT02706847|364425054|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
105661464|NCT02706847|364425055|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
105661465|NCT02706847|364425056|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
105661466|NCT02706847|364425057|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
105661467|NCT02706847|364425054|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
105661468|NCT02706847|364425055|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
105661469|NCT02706847|364425056|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
105661470|NCT02706847|364425057|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
105661471|NCT02706847|364425054|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
105661472|NCT02706847|364425055|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
105661473|NCT02706847|364425056|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
105661474|NCT02706847|364425057|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
105661475|NCT02706847|364425054|FG000|Period 2: Week 24 to Week 260|Other|8|||
105661476|NCT02706847|364425055|FG001|Period 2: Week 24 to Week 260|Other|5|||
105661477|NCT02706847|364425056|FG002|Period 2: Week 24 to Week 260|Other|15|||
105661478|NCT02706847|364425057|FG003|Period 2: Week 24 to Week 260|Other|15|||
105661479|NCT00003477|364425060|FG000|Overall Study|Not evalauable|4|||
105661480|NCT00267098|364425061|FG000|Overall Study|Death|0|||
105661481|NCT00267098|364425062|FG001|Overall Study|Death|0|||
105661482|NCT00267098|364425063|FG002|Overall Study|Death|57|||
105661483|NCT00267098|364425064|FG003|Overall Study|Death|66|||
105661484|NCT00267098|364425065|FG004|Overall Study|Death|14|||
105661485|NCT00267098|364425066|FG005|Overall Study|Death|23|||
105661486|NCT00267098|364425067|FG006|Overall Study|Death|28|||
105661487|NCT00267098|364425068|FG007|Overall Study|Death|9|||
105661488|NCT00267098|364425061|FG000|Overall Study|Lost to Follow-up|0|||
105661489|NCT00267098|364425062|FG001|Overall Study|Lost to Follow-up|0|||
105661490|NCT00267098|364425063|FG002|Overall Study|Lost to Follow-up|6|||
105661491|NCT00267098|364425064|FG003|Overall Study|Lost to Follow-up|5|||
105661492|NCT00267098|364425065|FG004|Overall Study|Lost to Follow-up|2|||
105661493|NCT00267098|364425066|FG005|Overall Study|Lost to Follow-up|3|||
105661494|NCT00267098|364425067|FG006|Overall Study|Lost to Follow-up|1|||
105661495|NCT00267098|364425068|FG007|Overall Study|Lost to Follow-up|1|||
105661496|NCT00267098|364425061|FG000|Overall Study|Withdrawal by Subject|8|||
105661497|NCT00267098|364425062|FG001|Overall Study|Withdrawal by Subject|0|||
105661498|NCT00267098|364425063|FG002|Overall Study|Withdrawal by Subject|24|||
105661499|NCT00267098|364425064|FG003|Overall Study|Withdrawal by Subject|21|||
105661500|NCT00267098|364425065|FG004|Overall Study|Withdrawal by Subject|12|||
105661501|NCT00267098|364425066|FG005|Overall Study|Withdrawal by Subject|9|||
105661502|NCT00267098|364425067|FG006|Overall Study|Withdrawal by Subject|12|||
105661503|NCT00267098|364425068|FG007|Overall Study|Withdrawal by Subject|5|||
105661504|NCT00267098|364425061|FG000|Overall Study|Physician Decision|5|||
105661505|NCT00267098|364425062|FG001|Overall Study|Physician Decision|0|||
105661506|NCT00267098|364425063|FG002|Overall Study|Physician Decision|7|||
105661507|NCT00267098|364425064|FG003|Overall Study|Physician Decision|11|||
105661508|NCT00267098|364425065|FG004|Overall Study|Physician Decision|5|||
105661509|NCT00267098|364425066|FG005|Overall Study|Physician Decision|4|||
105661510|NCT00267098|364425067|FG006|Overall Study|Physician Decision|3|||
105661511|NCT00267098|364425068|FG007|Overall Study|Physician Decision|0|||
105661512|NCT00267098|364425061|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
105661513|NCT00267098|364425062|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105661514|NCT00267098|364425063|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105661515|NCT00267098|364425064|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105661516|NCT00267098|364425065|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
105661517|NCT00267098|364425066|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105661518|NCT00267098|364425067|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105661519|NCT00267098|364425068|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105661520|NCT00267098|364425061|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
105661521|NCT00267098|364425062|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
105661522|NCT00267098|364425063|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
105661523|NCT00267098|364425064|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
105661524|NCT00267098|364425065|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
105661525|NCT00267098|364425066|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
105661526|NCT00267098|364425067|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
105661527|NCT00267098|364425068|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
105661528|NCT00267098|364425061|FG000|Overall Study|Site closure|0|||
105661529|NCT00267098|364425062|FG001|Overall Study|Site closure|0|||
105661530|NCT00267098|364425063|FG002|Overall Study|Site closure|0|||
105661531|NCT00267098|364425064|FG003|Overall Study|Site closure|1|||
105661532|NCT00267098|364425065|FG004|Overall Study|Site closure|0|||
105661533|NCT00267098|364425066|FG005|Overall Study|Site closure|1|||
105661534|NCT00267098|364425067|FG006|Overall Study|Site closure|1|||
105661535|NCT00267098|364425068|FG007|Overall Study|Site closure|0|||
105661536|NCT00267098|364425061|FG000|Overall Study|Explanted Medtronic device|0|||
105661537|NCT00267098|364425062|FG001|Overall Study|Explanted Medtronic device|0|||
105661538|NCT00267098|364425063|FG002|Overall Study|Explanted Medtronic device|0|||
105661539|NCT00267098|364425064|FG003|Overall Study|Explanted Medtronic device|1|||
105661540|NCT00267098|364425065|FG004|Overall Study|Explanted Medtronic device|0|||
105661541|NCT00267098|364425066|FG005|Overall Study|Explanted Medtronic device|0|||
105661542|NCT00267098|364425067|FG006|Overall Study|Explanted Medtronic device|0|||
105661543|NCT00267098|364425068|FG007|Overall Study|Explanted Medtronic device|0|||
105770556|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770557|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770558|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770559|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770560|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770561|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770562|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770563|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770564|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770565|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770566|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
105770567|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770568|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770569|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770570|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770571|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770572|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770573|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105442493|NCT01957202|363626753|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
105442494|NCT01957202|363626754|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
105661544|NCT00267098|364425061|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
105661545|NCT00267098|364425062|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
105661546|NCT00267098|364425063|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
105661547|NCT00267098|364425064|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
105661548|NCT00267098|364425065|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
105661549|NCT00267098|364425066|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
105661550|NCT00267098|364425067|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
105661551|NCT00267098|364425068|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
105661552|NCT00267098|364425061|FG000|Overall Study|Subject listed for heart transplant|0|||
105442495|NCT01957202|363626755|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
105661553|NCT00267098|364425062|FG001|Overall Study|Subject listed for heart transplant|0|||
105661554|NCT00267098|364425063|FG002|Overall Study|Subject listed for heart transplant|0|||
105661555|NCT00267098|364425064|FG003|Overall Study|Subject listed for heart transplant|0|||
105661556|NCT00267098|364425065|FG004|Overall Study|Subject listed for heart transplant|0|||
105661557|NCT00267098|364425066|FG005|Overall Study|Subject listed for heart transplant|0|||
105661558|NCT00267098|364425067|FG006|Overall Study|Subject listed for heart transplant|1|||
105661559|NCT00267098|364425068|FG007|Overall Study|Subject listed for heart transplant|0|||
105661560|NCT00267098|364425061|FG000|Overall Study|Sponsor withdrew subject|0|||
105661561|NCT00267098|364425062|FG001|Overall Study|Sponsor withdrew subject|0|||
105661562|NCT00267098|364425063|FG002|Overall Study|Sponsor withdrew subject|0|||
105661563|NCT00267098|364425064|FG003|Overall Study|Sponsor withdrew subject|1|||
105661564|NCT00267098|364425065|FG004|Overall Study|Sponsor withdrew subject|0|||
105661565|NCT00267098|364425066|FG005|Overall Study|Sponsor withdrew subject|0|||
105661566|NCT00267098|364425067|FG006|Overall Study|Sponsor withdrew subject|0|||
105661567|NCT00267098|364425068|FG007|Overall Study|Sponsor withdrew subject|0|||
105661568|NCT00547534|364425070|FG000|Overall Study|Adverse Event|7|||
105661569|NCT00547534|364425070|FG000|Overall Study|Disease Progression|4|||
105661570|NCT04206085|364425077|FG000|Overall Study|Lost to Follow-up|0|||
105661571|NCT04206085|364425078|FG001|Overall Study|Lost to Follow-up|1|||
105661572|NCT04206085|364425079|FG002|Overall Study|Lost to Follow-up|0|||
105661573|NCT04206085|364425077|FG000|Overall Study|Lost to Follow-up|0|||
105661574|NCT04206085|364425078|FG001|Overall Study|Lost to Follow-up|0|||
105661575|NCT04206085|364425079|FG002|Overall Study|Lost to Follow-up|1|||
105661576|NCT00763451|364425080|FG000|Overall Study|Adverse Event|4|||
105661577|NCT00763451|364425081|FG001|Overall Study|Adverse Event|6|||
105661578|NCT00763451|364425082|FG002|Overall Study|Adverse Event|19|||
105661579|NCT00763451|364425083|FG003|Overall Study|Adverse Event|14|||
105661580|NCT00763451|364425080|FG000|Overall Study|Lack of Efficacy|1|||
105661581|NCT00763451|364425081|FG001|Overall Study|Lack of Efficacy|4|||
105661582|NCT00763451|364425082|FG002|Overall Study|Lack of Efficacy|3|||
105661583|NCT00763451|364425083|FG003|Overall Study|Lack of Efficacy|2|||
105661584|NCT00763451|364425080|FG000|Overall Study|Withdrawal by Subject|1|||
105661585|NCT00763451|364425081|FG001|Overall Study|Withdrawal by Subject|6|||
105661586|NCT00763451|364425082|FG002|Overall Study|Withdrawal by Subject|9|||
105661587|NCT00763451|364425083|FG003|Overall Study|Withdrawal by Subject|7|||
105661588|NCT00763451|364425080|FG000|Overall Study|Protocol Violation|0|||
105661589|NCT00763451|364425081|FG001|Overall Study|Protocol Violation|0|||
105661590|NCT00763451|364425082|FG002|Overall Study|Protocol Violation|1|||
105661591|NCT00763451|364425083|FG003|Overall Study|Protocol Violation|0|||
105661592|NCT00763451|364425080|FG000|Overall Study|Poor Compliance to Protocol|1|||
105661593|NCT00763451|364425081|FG001|Overall Study|Poor Compliance to Protocol|1|||
105661594|NCT00763451|364425082|FG002|Overall Study|Poor Compliance to Protocol|2|||
105661595|NCT00763451|364425083|FG003|Overall Study|Poor Compliance to Protocol|2|||
105661596|NCT00763451|364425080|FG000|Overall Study|Familial and Personal Reasons|5|||
105661597|NCT00763451|364425081|FG001|Overall Study|Familial and Personal Reasons|3|||
105661598|NCT00763451|364425082|FG002|Overall Study|Familial and Personal Reasons|5|||
105661599|NCT00763451|364425083|FG003|Overall Study|Familial and Personal Reasons|4|||
105661600|NCT00763451|364425080|FG000|Overall Study|Randomized but not Treated|1|||
105661601|NCT00763451|364425081|FG001|Overall Study|Randomized but not Treated|1|||
105661602|NCT00763451|364425082|FG002|Overall Study|Randomized but not Treated|0|||
105661603|NCT00763451|364425083|FG003|Overall Study|Randomized but not Treated|0|||
105661604|NCT00763451|364425080|FG000|Overall Study|Study Site Reason|0|||
105661605|NCT00763451|364425081|FG001|Overall Study|Study Site Reason|1|||
105661606|NCT00763451|364425082|FG002|Overall Study|Study Site Reason|1|||
105661607|NCT00763451|364425083|FG003|Overall Study|Study Site Reason|1|||
105661608|NCT02554383|364425090|FG000|Overall Study|Ineligible|3|||
105661609|NCT02554383|364425091|FG001|Overall Study|Ineligible|2|||
105661610|NCT02554383|364425090|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
105661611|NCT02554383|364425091|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
105661612|NCT02554383|364425090|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
105661613|NCT02554383|364425091|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
105661614|NCT02554383|364425090|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
105661615|NCT02554383|364425091|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
105661616|NCT00727506|364425092|FG000|Overall Study|Adverse Event|0|||
105661617|NCT00727506|364425093|FG001|Overall Study|Adverse Event|0|||
105661618|NCT00727506|364425094|FG002|Overall Study|Adverse Event|4|||
105661619|NCT00727506|364425095|FG003|Overall Study|Adverse Event|4|||
105661620|NCT00727506|364425096|FG004|Overall Study|Adverse Event|1|||
105661621|NCT00727506|364425097|FG005|Overall Study|Adverse Event|8|||
105661622|NCT00727506|364425092|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
105661623|NCT00727506|364425093|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105661624|NCT00727506|364425094|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
105661625|NCT00727506|364425095|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105661626|NCT00727506|364425096|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105661627|NCT00727506|364425097|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105661628|NCT00727506|364425092|FG000|Overall Study|Progressive disease|4|||
105661629|NCT00727506|364425093|FG001|Overall Study|Progressive disease|7|||
105661630|NCT00727506|364425094|FG002|Overall Study|Progressive disease|9|||
105661631|NCT00727506|364425095|FG003|Overall Study|Progressive disease|28|||
105661632|NCT00727506|364425096|FG004|Overall Study|Progressive disease|38|||
105661633|NCT00727506|364425097|FG005|Overall Study|Progressive disease|28|||
105661634|NCT00727506|364425092|FG000|Overall Study|Refused to continue medication|0|||
105661635|NCT00727506|364425093|FG001|Overall Study|Refused to continue medication|1|||
105661636|NCT00727506|364425094|FG002|Overall Study|Refused to continue medication|2|||
105770574|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770575|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105661637|NCT00727506|364425095|FG003|Overall Study|Refused to continue medication|3|||
105661638|NCT00727506|364425096|FG004|Overall Study|Refused to continue medication|1|||
105661639|NCT00727506|364425097|FG005|Overall Study|Refused to continue medication|2|||
105661640|NCT00727506|364425092|FG000|Overall Study|Other reason not described above|0|||
105661641|NCT00727506|364425093|FG001|Overall Study|Other reason not described above|0|||
105661642|NCT00727506|364425094|FG002|Overall Study|Other reason not described above|1|||
105770576|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770577|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770578|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770579|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770580|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770581|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105661643|NCT00727506|364425095|FG003|Overall Study|Other reason not described above|4|||
105661644|NCT00727506|364425096|FG004|Overall Study|Other reason not described above|1|||
105661645|NCT00727506|364425097|FG005|Overall Study|Other reason not described above|1|||
105770582|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
105770583|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770584|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770585|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770586|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770587|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770588|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770589|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770590|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770591|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770592|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770593|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770594|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770595|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770596|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
105770597|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770598|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770599|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770600|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770601|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770602|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770603|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770604|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770605|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770606|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770607|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770608|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770609|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770610|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770611|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
105770612|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770613|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770614|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770615|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770616|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770617|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770618|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105334067|NCT01314872|363223076|FG006|Treatment Period 1|Lack of Efficacy|0|||
105770619|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770620|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770621|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770622|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770623|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770624|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770625|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770626|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
105770627|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770628|NCT00113555|364811126|FG000|Overall Study|Baseline Failure|59|||
105770629|NCT00113555|364811126|FG000|Overall Study|Permanently Explanted|7|||
105770630|NCT00113555|364811126|FG000|Overall Study|Death|1|||
105770631|NCT00113555|364811126|FG000|Overall Study|Missed Followup|4|||
105770632|NCT00113555|364811126|FG000|Overall Study|Lost to Follow-up|8|||
105770633|NCT04757376|364811127|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
105770634|NCT04757376|364811128|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
105770635|NCT04757376|364811129|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
105770636|NCT04757376|364811130|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
105770637|NCT04757376|364811131|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
105770638|NCT04757376|364811127|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
105770639|NCT04757376|364811128|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
105770640|NCT04757376|364811129|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
105770641|NCT04757376|364811130|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
105770642|NCT04757376|364811131|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
105770643|NCT04757376|364811127|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
105770644|NCT04757376|364811128|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
105770645|NCT04757376|364811129|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
105770646|NCT04757376|364811130|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
105770647|NCT04757376|364811131|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
105770648|NCT04757376|364811127|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
105770649|NCT04757376|364811128|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
105770650|NCT04757376|364811129|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
105770651|NCT04757376|364811130|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
105770652|NCT04757376|364811131|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
105770653|NCT04757376|364811127|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
105770654|NCT04757376|364811128|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
105770655|NCT04757376|364811129|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
105770656|NCT04757376|364811130|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
105770657|NCT04757376|364811131|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
105770658|NCT04757376|364811127|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
105770659|NCT04757376|364811128|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
105770660|NCT04757376|364811129|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
105770661|NCT04757376|364811130|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
105770662|NCT04757376|364811131|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
105770663|NCT04757376|364811127|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
105770664|NCT04757376|364811128|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
105770665|NCT04757376|364811129|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
105770666|NCT04757376|364811130|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
105770667|NCT04757376|364811131|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
105661646|NCT00383123|364425098|FG000|Overall Study|Adverse Event|1|||
105661647|NCT00383123|364425099|FG001|Overall Study|Adverse Event|0|||
105661648|NCT00383123|364425098|FG000|Overall Study|Lost to Follow-up|68|||
105661649|NCT00383123|364425099|FG001|Overall Study|Lost to Follow-up|61|||
105661650|NCT00383123|364425098|FG000|Overall Study|Protocol Violation|5|||
105661651|NCT00383123|364425099|FG001|Overall Study|Protocol Violation|1|||
105661652|NCT00383123|364425098|FG000|Overall Study|Withdrawal by Subject|27|||
105661653|NCT00383123|364425099|FG001|Overall Study|Withdrawal by Subject|18|||
105661654|NCT00383123|364425098|FG000|Overall Study|Other reason|10|||
105661655|NCT00383123|364425099|FG001|Overall Study|Other reason|6|||
105661656|NCT02781311|364425100|FG000|Overall Study|Adverse Event|2|||
105661657|NCT02781311|364425101|FG001|Overall Study|Adverse Event|6|||
105661658|NCT02781311|364425102|FG002|Overall Study|Adverse Event|1|||
105661659|NCT02781311|364425100|FG000|Overall Study|Withdrawal of Consent|11|||
105661660|NCT02781311|364425101|FG001|Overall Study|Withdrawal of Consent|12|||
105661661|NCT02781311|364425102|FG002|Overall Study|Withdrawal of Consent|2|||
105661662|NCT02781311|364425100|FG000|Overall Study|Lost to Follow-up|11|||
105661663|NCT02781311|364425101|FG001|Overall Study|Lost to Follow-up|8|||
105661664|NCT02781311|364425102|FG002|Overall Study|Lost to Follow-up|1|||
105661665|NCT02781311|364425100|FG000|Overall Study|Non-Compliance with Study Drug|2|||
105661666|NCT02781311|364425101|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105661667|NCT02781311|364425102|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105661668|NCT02165826|364425103|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
105661669|NCT02165826|364425104|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
105661670|NCT02165826|364425105|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
105661671|NCT02165826|364425103|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
105661672|NCT02165826|364425104|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
105661673|NCT02165826|364425105|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
105661674|NCT02165826|364425103|FG000|Main Treatment Period|Lost to Follow-up|4|||
105661675|NCT02165826|364425104|FG001|Main Treatment Period|Lost to Follow-up|2|||
105661676|NCT02165826|364425105|FG002|Main Treatment Period|Lost to Follow-up|1|||
105661677|NCT02165826|364425103|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
105661678|NCT02165826|364425104|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
105661679|NCT02165826|364425105|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
105661680|NCT02165826|364425103|FG000|Main Treatment Period|Lack of Efficacy|2|||
105661681|NCT02165826|364425104|FG001|Main Treatment Period|Lack of Efficacy|0|||
105661682|NCT02165826|364425105|FG002|Main Treatment Period|Lack of Efficacy|0|||
105661683|NCT02165826|364425103|FG000|Main Treatment Period|Reason Not Specified|8|||
105661684|NCT02165826|364425104|FG001|Main Treatment Period|Reason Not Specified|5|||
105661685|NCT02165826|364425105|FG002|Main Treatment Period|Reason Not Specified|16|||
105661686|NCT02165826|364425103|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
105770668|NCT04757376|364811127|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
105770669|NCT04757376|364811128|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
105770670|NCT04757376|364811129|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
105770671|NCT04757376|364811130|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
105770672|NCT04757376|364811131|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
105770673|NCT04474366|364811132|FG000|Overall Study|Lost to Follow-up|2|||
105770674|NCT04474366|364811133|FG001|Overall Study|Lost to Follow-up|5|||
105770675|NCT04063865|364811134|FG000|Overall Study|Physician Decision|1|||
105770676|NCT04063865|364811135|FG001|Overall Study|Physician Decision|3|||
105770677|NCT04063865|364811134|FG000|Overall Study|Study Closed Prior to Completion|4|||
105770678|NCT04063865|364811135|FG001|Overall Study|Study Closed Prior to Completion|4|||
105770679|NCT04063865|364811134|FG000|Overall Study|Withdrawal by Subject|1|||
105770680|NCT04063865|364811135|FG001|Overall Study|Withdrawal by Subject|1|||
105770681|NCT00609167|364811136|FG000|Overall Study|Withdrawal by Subject|1|||
105770682|NCT00609167|364811137|FG001|Overall Study|Withdrawal by Subject|0|||
105770683|NCT00609167|364811136|FG000|Overall Study|Lack of Efficacy|1|||
105770684|NCT00609167|364811137|FG001|Overall Study|Lack of Efficacy|0|||
105770685|NCT00609167|364811136|FG000|Overall Study|Adverse Event|5|||
105770686|NCT00609167|364811137|FG001|Overall Study|Adverse Event|1|||
105770687|NCT00609167|364811136|FG000|Overall Study|Disease Progression|1|||
105770688|NCT00609167|364811137|FG001|Overall Study|Disease Progression|0|||
105770689|NCT00609167|364811136|FG000|Overall Study|Stem Cell Transplant|0|||
105770690|NCT00609167|364811137|FG001|Overall Study|Stem Cell Transplant|6|||
105770691|NCT03898323|364811138|FG000|Overall Study|Physician Decision|1|||
105770692|NCT00320190|364811140|FG000|First 12 Months|Completed but did not enter extension|5|||
105770693|NCT00320190|364811141|FG001|First 12 Months|Completed but did not enter extension|3|||
105770694|NCT00320190|364811140|FG000|First 12 Months|Sponsor terminated study|2|||
105770695|NCT00320190|364811141|FG001|First 12 Months|Sponsor terminated study|2|||
105770696|NCT00320190|364811140|FG000|First 12 Months|Lost to Follow-up|0|||
105770697|NCT00320190|364811141|FG001|First 12 Months|Lost to Follow-up|1|||
105770698|NCT00320190|364811140|FG000|First 12 Months|Enrollment failure|0|||
105770699|NCT00320190|364811141|FG001|First 12 Months|Enrollment failure|1|||
105770700|NCT00320190|364811140|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
105770701|NCT00320190|364811141|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
105770702|NCT00320190|364811140|FG000|First 12 Months|Investigator request|0|||
105770703|NCT00320190|364811141|FG001|First 12 Months|Investigator request|1|||
105770704|NCT00320190|364811140|FG000|First 12 Months|Study drug toxicity|0|||
105770705|NCT00320190|364811141|FG001|First 12 Months|Study drug toxicity|1|||
105770706|NCT00320190|364811140|FG000|First 12 Months|Withdrawal by Subject|0|||
105770707|NCT00320190|364811141|FG001|First 12 Months|Withdrawal by Subject|1|||
105770708|NCT00320190|364811140|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
105770709|NCT00320190|364811141|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
105770710|NCT00320190|364811140|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
105334068|NCT01314872|363223077|FG007|Treatment Period 1|Lack of Efficacy|2|||
105770711|NCT00320190|364811141|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
105770712|NCT00320190|364811140|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
105770713|NCT00320190|364811141|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
105770714|NCT02574520|364811142|FG000|Overall Study|Not dosed|2|||
105770715|NCT02574520|364811143|FG001|Overall Study|Not dosed|0|||
105770716|NCT02574520|364811144|FG002|Overall Study|Not dosed|5|||
105770717|NCT02574520|364811145|FG003|Overall Study|Not dosed|4|||
105770718|NCT02574520|364811142|FG000|Overall Study|Adverse Event|0|||
105770719|NCT02574520|364811143|FG001|Overall Study|Adverse Event|0|||
105770720|NCT02574520|364811144|FG002|Overall Study|Adverse Event|0|||
105770721|NCT02574520|364811145|FG003|Overall Study|Adverse Event|1|||
105770722|NCT02574520|364811142|FG000|Overall Study|Withdrawal by Subject|0|||
105770723|NCT02574520|364811143|FG001|Overall Study|Withdrawal by Subject|0|||
105770724|NCT02574520|364811144|FG002|Overall Study|Withdrawal by Subject|0|||
105770725|NCT02574520|364811145|FG003|Overall Study|Withdrawal by Subject|1|||
105770726|NCT02574520|364811142|FG000|Overall Study|Other|0|||
105770727|NCT02574520|364811143|FG001|Overall Study|Other|0|||
105770728|NCT02574520|364811144|FG002|Overall Study|Other|0|||
105770729|NCT02574520|364811145|FG003|Overall Study|Other|2|||
105770730|NCT01365091|364811148|FG000|Period 1|Adverse Event|1|||
105770731|NCT01365091|364811149|FG001|Period 1|Adverse Event|0|||
105770732|NCT01365091|364811150|FG002|Period 1|Adverse Event|2|||
105770733|NCT01365091|364811151|FG003|Period 1|Adverse Event|3|||
105770734|NCT01365091|364811148|FG000|Period 1|Positive test result for drugs of abuse|1|||
105770735|NCT01365091|364811149|FG001|Period 1|Positive test result for drugs of abuse|0|||
105770736|NCT01365091|364811150|FG002|Period 1|Positive test result for drugs of abuse|0|||
105770737|NCT01365091|364811151|FG003|Period 1|Positive test result for drugs of abuse|0|||
105770738|NCT01365091|364811148|FG000|Period 1|No longer met study criteria|0|||
105770739|NCT01365091|364811149|FG001|Period 1|No longer met study criteria|1|||
105770740|NCT01365091|364811150|FG002|Period 1|No longer met study criteria|0|||
105770741|NCT01365091|364811151|FG003|Period 1|No longer met study criteria|0|||
105770742|NCT01365091|364811148|FG000|Period 1|Withdrawal by Subject|0|||
105770743|NCT01365091|364811149|FG001|Period 1|Withdrawal by Subject|1|||
105770744|NCT01365091|364811150|FG002|Period 1|Withdrawal by Subject|0|||
105770745|NCT01365091|364811151|FG003|Period 1|Withdrawal by Subject|0|||
105770746|NCT01365091|364811148|FG000|Period 1|Personal reasons|0|||
105770747|NCT01365091|364811149|FG001|Period 1|Personal reasons|0|||
105770748|NCT01365091|364811150|FG002|Period 1|Personal reasons|1|||
105770749|NCT01365091|364811151|FG003|Period 1|Personal reasons|0|||
105770750|NCT01365091|364811148|FG000|Period 2|Withdrawal by Subject|1|||
105770751|NCT01365091|364811149|FG001|Period 2|Withdrawal by Subject|0|||
105770752|NCT01365091|364811150|FG002|Period 2|Withdrawal by Subject|0|||
105770753|NCT01365091|364811151|FG003|Period 2|Withdrawal by Subject|0|||
105770754|NCT01365091|364811148|FG000|Period 2|Adverse Event|0|||
105770755|NCT01365091|364811149|FG001|Period 2|Adverse Event|0|||
105770756|NCT01365091|364811150|FG002|Period 2|Adverse Event|1|||
105770757|NCT01365091|364811151|FG003|Period 2|Adverse Event|0|||
105770758|NCT01474889|364811152|FG000|Overall Study|Physician Decision|1|||
105770759|NCT01474889|364811153|FG001|Overall Study|Physician Decision|0|||
105770760|NCT01474889|364811154|FG002|Overall Study|Physician Decision|0|||
105770761|NCT01474889|364811152|FG000|Overall Study|Did not meet inclusion|1|||
105770762|NCT01474889|364811153|FG001|Overall Study|Did not meet inclusion|0|||
105770763|NCT01474889|364811154|FG002|Overall Study|Did not meet inclusion|0|||
105770764|NCT01474889|364811152|FG000|Overall Study|Withdrawal by Subject|0|||
105770765|NCT01474889|364811153|FG001|Overall Study|Withdrawal by Subject|1|||
105770766|NCT01474889|364811154|FG002|Overall Study|Withdrawal by Subject|0|||
105770767|NCT03935594|364811161|FG000|Overall Study|Physician Decision|3|||
105770768|NCT03864627|364811163|FG000|Overall Study|Adverse Event|0|||
105770769|NCT03864627|364811164|FG001|Overall Study|Adverse Event|1|||
105770770|NCT03864627|364811163|FG000|Overall Study|Lack of Efficacy|0|||
105770771|NCT03864627|364811164|FG001|Overall Study|Lack of Efficacy|1|||
105770772|NCT03864627|364811163|FG000|Overall Study|Lost to Follow-up|0|||
105770773|NCT03864627|364811164|FG001|Overall Study|Lost to Follow-up|1|||
105770774|NCT03864627|364811163|FG000|Overall Study|Withdrawal by Subject|4|||
105770775|NCT03864627|364811164|FG001|Overall Study|Withdrawal by Subject|8|||
105770776|NCT03864627|364811163|FG000|Overall Study|Study terminated by sponsor|0|||
105770777|NCT03864627|364811164|FG001|Overall Study|Study terminated by sponsor|1|||
105770778|NCT04035473|364811169|FG000|Screening/Baseline|Death|0|||
105770779|NCT04035473|364811170|FG001|Screening/Baseline|Death|1|||
105770780|NCT04035473|364811169|FG000|Screening/Baseline|Adverse Event|0|||
105770781|NCT04035473|364811170|FG001|Screening/Baseline|Adverse Event|1|||
105770782|NCT04035473|364811169|FG000|Follow-up Period|Adverse Event|2|||
105770783|NCT04035473|364811170|FG001|Follow-up Period|Adverse Event|0|||
105770784|NCT03595176|364811171|FG000|Overall Study|Death|0|||
105770785|NCT03595176|364811172|FG001|Overall Study|Death|2|||
105770786|NCT03595176|364811171|FG000|Overall Study|Lost to Follow-up|0|||
105770787|NCT03595176|364811172|FG001|Overall Study|Lost to Follow-up|1|||
105770788|NCT03039569|364811175|FG000|Overall Study|Lost to Follow-up|5|||
105770789|NCT03039569|364811176|FG001|Overall Study|Lost to Follow-up|4|||
105770790|NCT00952419|364811179|FG000|Overall Study|Adverse Event|2|||
105770791|NCT00952419|364811180|FG001|Overall Study|Adverse Event|0|||
105770792|NCT00952419|364811181|FG002|Overall Study|Adverse Event|0|||
105770793|NCT00952419|364811179|FG000|Overall Study|Protocol Violation|3|||
105770794|NCT00952419|364811180|FG001|Overall Study|Protocol Violation|7|||
105770795|NCT00952419|364811181|FG002|Overall Study|Protocol Violation|0|||
105770796|NCT00952419|364811179|FG000|Overall Study|Withdrawal by Subject|1|||
105770797|NCT00952419|364811180|FG001|Overall Study|Withdrawal by Subject|3|||
105770798|NCT00952419|364811181|FG002|Overall Study|Withdrawal by Subject|0|||
105770799|NCT01004159|364813536|FG000|Overall Study|Adverse Event|2|||
105770800|NCT01004159|364813536|FG000|Overall Study|Disease Progression|18|||
105770801|NCT02531633|364813542|FG000|Part A (52 Weeks)|Sponsor request|24|||
105770802|NCT02531633|364813543|FG001|Part A (52 Weeks)|Sponsor request|24|||
105770803|NCT02531633|364813544|FG002|Part A (52 Weeks)|Sponsor request|18|||
105770804|NCT02531633|364813545|FG003|Part A (52 Weeks)|Sponsor request|18|||
105770805|NCT02531633|364813546|FG004|Part A (52 Weeks)|Sponsor request|19|||
105770806|NCT02531633|364813547|FG005|Part A (52 Weeks)|Sponsor request|0|||
105770807|NCT02531633|364813548|FG006|Part A (52 Weeks)|Sponsor request|0|||
105770808|NCT02531633|364813549|FG007|Part A (52 Weeks)|Sponsor request|0|||
105770809|NCT02531633|364813550|FG008|Part A (52 Weeks)|Sponsor request|0|||
105770810|NCT02531633|364813551|FG009|Part A (52 Weeks)|Sponsor request|0|||
105770811|NCT02531633|364813542|FG000|Part A (52 Weeks)|Protocol Violation|1|||
105770812|NCT02531633|364813543|FG001|Part A (52 Weeks)|Protocol Violation|0|||
105770813|NCT02531633|364813544|FG002|Part A (52 Weeks)|Protocol Violation|0|||
105770814|NCT02531633|364813545|FG003|Part A (52 Weeks)|Protocol Violation|0|||
105770815|NCT02531633|364813546|FG004|Part A (52 Weeks)|Protocol Violation|0|||
105770816|NCT02531633|364813547|FG005|Part A (52 Weeks)|Protocol Violation|0|||
105770817|NCT02531633|364813548|FG006|Part A (52 Weeks)|Protocol Violation|0|||
105770818|NCT02531633|364813549|FG007|Part A (52 Weeks)|Protocol Violation|0|||
105770819|NCT02531633|364813550|FG008|Part A (52 Weeks)|Protocol Violation|0|||
105770820|NCT02531633|364813551|FG009|Part A (52 Weeks)|Protocol Violation|0|||
105770821|NCT02531633|364813542|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
105770822|NCT02531633|364813543|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
105770823|NCT02531633|364813544|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
105770824|NCT02531633|364813545|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
105770825|NCT02531633|364813546|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
105770826|NCT02531633|364813547|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
105770827|NCT02531633|364813548|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
105770828|NCT02531633|364813549|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
105770829|NCT02531633|364813550|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
105770830|NCT02531633|364813551|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
105770831|NCT02531633|364813542|FG000|Part A (52 Weeks)|Physician Decision|1|||
105770832|NCT02531633|364813543|FG001|Part A (52 Weeks)|Physician Decision|4|||
105770833|NCT02531633|364813544|FG002|Part A (52 Weeks)|Physician Decision|3|||
105770834|NCT02531633|364813545|FG003|Part A (52 Weeks)|Physician Decision|1|||
105770835|NCT02531633|364813546|FG004|Part A (52 Weeks)|Physician Decision|0|||
105770836|NCT02531633|364813547|FG005|Part A (52 Weeks)|Physician Decision|0|||
105770837|NCT02531633|364813548|FG006|Part A (52 Weeks)|Physician Decision|0|||
105770838|NCT02531633|364813549|FG007|Part A (52 Weeks)|Physician Decision|0|||
105770839|NCT02531633|364813550|FG008|Part A (52 Weeks)|Physician Decision|0|||
105770840|NCT02531633|364813551|FG009|Part A (52 Weeks)|Physician Decision|0|||
105770841|NCT02531633|364813542|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
105770842|NCT02531633|364813543|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
105770843|NCT02531633|364813544|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
105770844|NCT02531633|364813545|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
105770845|NCT02531633|364813546|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
105770846|NCT02531633|364813547|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
105770847|NCT02531633|364813548|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
105770848|NCT02531633|364813549|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
105770849|NCT02531633|364813550|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
105770850|NCT02531633|364813551|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
105770851|NCT02531633|364813542|FG000|Part A (52 Weeks)|Other|2|||
105770852|NCT02531633|364813543|FG001|Part A (52 Weeks)|Other|0|||
105770853|NCT02531633|364813544|FG002|Part A (52 Weeks)|Other|0|||
105770854|NCT02531633|364813545|FG003|Part A (52 Weeks)|Other|0|||
105770855|NCT02531633|364813546|FG004|Part A (52 Weeks)|Other|0|||
105770856|NCT02531633|364813547|FG005|Part A (52 Weeks)|Other|0|||
105770857|NCT02531633|364813548|FG006|Part A (52 Weeks)|Other|0|||
105770858|NCT02531633|364813549|FG007|Part A (52 Weeks)|Other|0|||
105770859|NCT02531633|364813550|FG008|Part A (52 Weeks)|Other|0|||
105770860|NCT02531633|364813551|FG009|Part A (52 Weeks)|Other|0|||
105770861|NCT02531633|364813542|FG000|Part B (104 Weeks)|Sponsor request|0|||
105770862|NCT02531633|364813543|FG001|Part B (104 Weeks)|Sponsor request|0|||
105770863|NCT02531633|364813544|FG002|Part B (104 Weeks)|Sponsor request|0|||
105770864|NCT02531633|364813545|FG003|Part B (104 Weeks)|Sponsor request|0|||
105770865|NCT02531633|364813546|FG004|Part B (104 Weeks)|Sponsor request|0|||
105770866|NCT02531633|364813547|FG005|Part B (104 Weeks)|Sponsor request|8|||
105770867|NCT02531633|364813548|FG006|Part B (104 Weeks)|Sponsor request|5|||
105770868|NCT02531633|364813549|FG007|Part B (104 Weeks)|Sponsor request|3|||
105770869|NCT02531633|364813550|FG008|Part B (104 Weeks)|Sponsor request|5|||
105770870|NCT02531633|364813551|FG009|Part B (104 Weeks)|Sponsor request|4|||
105770871|NCT02531633|364813542|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
105770872|NCT02531633|364813543|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
105770873|NCT02531633|364813544|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
105770874|NCT02531633|364813545|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
105770875|NCT02531633|364813546|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
105770876|NCT02531633|364813547|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
105770877|NCT02531633|364813548|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
105770878|NCT02531633|364813549|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
105770879|NCT02531633|364813550|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
105770880|NCT02531633|364813551|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
105770881|NCT00425945|364813554|FG000|Overall Study|Concern about Supplement|2|||
105770882|NCT00425945|364813555|FG001|Overall Study|Concern about Supplement|0|||
105770883|NCT00425945|364813554|FG000|Overall Study|Inconvenience|0|||
105770884|NCT00425945|364813555|FG001|Overall Study|Inconvenience|2|||
105770885|NCT00425945|364813554|FG000|Overall Study|Lost to Follow-up|0|||
105770886|NCT00425945|364813555|FG001|Overall Study|Lost to Follow-up|2|||
105770887|NCT00425945|364813554|FG000|Overall Study|Began hypertension medication|1|||
105770888|NCT00425945|364813555|FG001|Overall Study|Began hypertension medication|0|||
105770889|NCT00425945|364813554|FG000|Overall Study|Began cancer treatments|1|||
105770890|NCT00425945|364813555|FG001|Overall Study|Began cancer treatments|0|||
105770891|NCT00425945|364813554|FG000|Overall Study|Moved from area|0|||
105770892|NCT00425945|364813555|FG001|Overall Study|Moved from area|1|||
105770893|NCT01536418|364813557|FG000|Overall Study|Protocol Violation|2|||
105770894|NCT01536418|364813558|FG001|Overall Study|Protocol Violation|3|||
105770895|NCT01536418|364813557|FG000|Overall Study|Physician Decision|1|||
105770896|NCT01536418|364813558|FG001|Overall Study|Physician Decision|3|||
105770897|NCT01536418|364813557|FG000|Overall Study|Study closed/terminated|41|||
105770898|NCT01536418|364813558|FG001|Overall Study|Study closed/terminated|37|||
105770899|NCT01536418|364813557|FG000|Overall Study|Lack of Efficacy|10|||
105770900|NCT01536418|364813558|FG001|Overall Study|Lack of Efficacy|16|||
105770901|NCT01536418|364813557|FG000|Overall Study|Adverse Event|9|||
105770902|NCT01536418|364813558|FG001|Overall Study|Adverse Event|4|||
105770903|NCT01536418|364813557|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
105770904|NCT01536418|364813558|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
105770905|NCT01536418|364813557|FG000|Overall Study|Withdrawal by Subject|5|||
105770906|NCT01536418|364813558|FG001|Overall Study|Withdrawal by Subject|3|||
105770907|NCT02365506|364813559|FG000|Overall Study|Investigator's Discretion|0|||
105770908|NCT02365506|364813560|FG001|Overall Study|Investigator's Discretion|0|||
105770909|NCT02365506|364813561|FG002|Overall Study|Investigator's Discretion|1|||
105770910|NCT01680991|364813562|FG000|Overall Study|Adverse Event|1|||
105770911|NCT01680991|364813563|FG001|Overall Study|Adverse Event|0|||
105770912|NCT01680991|364813564|FG002|Overall Study|Adverse Event|0|||
105770913|NCT01680991|364813562|FG000|Overall Study|Death|1|||
105770914|NCT01680991|364813563|FG001|Overall Study|Death|0|||
105770915|NCT01680991|364813564|FG002|Overall Study|Death|1|||
105770916|NCT01680991|364813562|FG000|Overall Study|Protocol Violation|0|||
105770917|NCT01680991|364813563|FG001|Overall Study|Protocol Violation|1|||
105770918|NCT01680991|364813564|FG002|Overall Study|Protocol Violation|0|||
105770919|NCT01680991|364813562|FG000|Overall Study|Withdrawal by Subject|5|||
105770920|NCT01680991|364813563|FG001|Overall Study|Withdrawal by Subject|1|||
105770921|NCT01680991|364813564|FG002|Overall Study|Withdrawal by Subject|0|||
105770922|NCT01680991|364813562|FG000|Overall Study|Progressive disease (PD)|0|||
105770923|NCT01680991|364813563|FG001|Overall Study|Progressive disease (PD)|10|||
105770924|NCT01680991|364813564|FG002|Overall Study|Progressive disease (PD)|0|||
105770925|NCT01680991|364813562|FG000|Overall Study|Physician Decision|0|||
105770926|NCT01680991|364813563|FG001|Overall Study|Physician Decision|7|||
105770927|NCT01680991|364813564|FG002|Overall Study|Physician Decision|2|||
105770928|NCT01680991|364813562|FG000|Overall Study|Bad physical condition|0|||
105770929|NCT01680991|364813563|FG001|Overall Study|Bad physical condition|0|||
105770930|NCT01680991|364813564|FG002|Overall Study|Bad physical condition|1|||
105770931|NCT01680991|364813562|FG000|Overall Study|PD confirmed in other hospital|1|||
105770932|NCT01680991|364813563|FG001|Overall Study|PD confirmed in other hospital|0|||
105770933|NCT01680991|364813564|FG002|Overall Study|PD confirmed in other hospital|0|||
105770934|NCT00610714|364813565|FG000|Overall Study|Adverse Event|3|||
105770935|NCT00610714|364813566|FG001|Overall Study|Adverse Event|1|||
105770936|NCT00610714|364813565|FG000|Overall Study|Death|12|||
105770937|NCT00610714|364813566|FG001|Overall Study|Death|18|||
105770938|NCT00610714|364813565|FG000|Overall Study|Withdrawal by Subject|9|||
105770939|NCT00610714|364813566|FG001|Overall Study|Withdrawal by Subject|3|||
105770940|NCT00610714|364813565|FG000|Overall Study|Study completion at 120 PFS events|2|||
105770941|NCT00610714|364813566|FG001|Overall Study|Study completion at 120 PFS events|2|||
105770942|NCT02756845|364813572|FG000|Overall Study|Death|12|||
105770943|NCT02756845|364813573|FG001|Overall Study|Death|2|||
105770944|NCT02756845|364813572|FG000|Overall Study|Withdrawal by Subject|1|||
105770945|NCT02756845|364813573|FG001|Overall Study|Withdrawal by Subject|0|||
105770946|NCT00285649|364813577|FG000|Overall Study|Lost to Follow-up|6|||
105770947|NCT00285649|364813578|FG001|Overall Study|Lost to Follow-up|4|||
105770948|NCT00285649|364813579|FG002|Overall Study|Lost to Follow-up|4|||
105770949|NCT00285649|364813577|FG000|Overall Study|Withdrawal by Subject|3|||
105770950|NCT00285649|364813578|FG001|Overall Study|Withdrawal by Subject|2|||
105770951|NCT00285649|364813579|FG002|Overall Study|Withdrawal by Subject|2|||
105770952|NCT02972593|364813580|FG000|Overall Study|Lost to Follow-up|19|||
105770953|NCT02972593|364813581|FG001|Overall Study|Lost to Follow-up|15|||
105770954|NCT02972593|364813580|FG000|Overall Study|Protocol Violation|1|||
105770955|NCT02972593|364813581|FG001|Overall Study|Protocol Violation|0|||
105770956|NCT01025232|364813585|FG000|Overall Study|Study drug no longer available|3|||
105770957|NCT01025232|364813586|FG001|Overall Study|Study drug no longer available|6|||
105770958|NCT00414973|364813587|FG000|Overall Study|Withdrawal by Subject|14|||
105770959|NCT00414973|364813588|FG001|Overall Study|Withdrawal by Subject|4|||
105770960|NCT00414973|364813589|FG002|Overall Study|Withdrawal by Subject|1|||
105770961|NCT00414973|364813590|FG003|Overall Study|Withdrawal by Subject|0|||
105770962|NCT00414973|364813587|FG000|Overall Study|Adverse Event|10|||
105770963|NCT00414973|364813588|FG001|Overall Study|Adverse Event|0|||
105770964|NCT00414973|364813589|FG002|Overall Study|Adverse Event|1|||
105770965|NCT00414973|364813590|FG003|Overall Study|Adverse Event|0|||
105770966|NCT00414973|364813587|FG000|Overall Study|Protocol Violation|3|||
105770967|NCT00414973|364813588|FG001|Overall Study|Protocol Violation|4|||
105770968|NCT00414973|364813589|FG002|Overall Study|Protocol Violation|0|||
105770969|NCT00414973|364813590|FG003|Overall Study|Protocol Violation|0|||
105770970|NCT00414973|364813587|FG000|Overall Study|Lost to Follow-up|0|||
105770971|NCT00414973|364813588|FG001|Overall Study|Lost to Follow-up|2|||
105770972|NCT00414973|364813589|FG002|Overall Study|Lost to Follow-up|0|||
105770973|NCT00414973|364813590|FG003|Overall Study|Lost to Follow-up|0|||
105770974|NCT00414973|364813587|FG000|Overall Study|Sponsor Decision|1|||
105770975|NCT00414973|364813588|FG001|Overall Study|Sponsor Decision|0|||
105770976|NCT00414973|364813589|FG002|Overall Study|Sponsor Decision|0|||
105770977|NCT00414973|364813590|FG003|Overall Study|Sponsor Decision|0|||
105770978|NCT00414973|364813587|FG000|Overall Study|Death|0|||
105770979|NCT00414973|364813588|FG001|Overall Study|Death|0|||
105770980|NCT00414973|364813589|FG002|Overall Study|Death|1|||
105770981|NCT00414973|364813590|FG003|Overall Study|Death|0|||
105770982|NCT01466062|364813591|FG000|Overall Study|Adverse Event|1|||
105770983|NCT01466062|364813591|FG000|Overall Study|Withdrawal by Subject|1|||
105770984|NCT03696576|364813594|FG000|Overall Study|Soreness of throat after therapy|1|||
105770985|NCT03696576|364813595|FG001|Overall Study|Soreness of throat after therapy|1|||
105770986|NCT03696576|364813594|FG000|Overall Study|Lost to Follow-up|2|||
105770987|NCT03696576|364813595|FG001|Overall Study|Lost to Follow-up|4|||
105770988|NCT00312728|364813596|FG000|Overall Study|Progressive disease|53|||
105770989|NCT00312728|364813596|FG000|Overall Study|Adverse Event|32|||
105770990|NCT00312728|364813596|FG000|Overall Study|Withdrawal by Subject|10|||
105770991|NCT00312728|364813596|FG000|Overall Study|Required non-protocol cancer treatment|2|||
105770992|NCT00312728|364813596|FG000|Overall Study|Protocol Violation|2|||
105770993|NCT00312728|364813596|FG000|Overall Study|Other|10|||
105770994|NCT00312728|364813596|FG000|Overall Study|Other|1|||
105770995|NCT00850135|364813597|FG000|Overall Study|Physician Decision|1|||
105770996|NCT02253992|364813598|FG000|Overall Study|Study drug toxicity|1|||
105770997|NCT02253992|364813599|FG001|Overall Study|Study drug toxicity|0|||
105770998|NCT02253992|364813600|FG002|Overall Study|Study drug toxicity|10|||
105770999|NCT02253992|364813598|FG000|Overall Study|Disease progression|4|||
105771000|NCT02253992|364813599|FG001|Overall Study|Disease progression|3|||
105771001|NCT02253992|364813600|FG002|Overall Study|Disease progression|98|||
105771002|NCT02253992|364813598|FG000|Overall Study|Withdrawal by Subject|0|||
105771003|NCT02253992|364813599|FG001|Overall Study|Withdrawal by Subject|0|||
105771004|NCT02253992|364813600|FG002|Overall Study|Withdrawal by Subject|3|||
105771005|NCT02253992|364813598|FG000|Overall Study|Adverse Event|0|||
105771006|NCT02253992|364813599|FG001|Overall Study|Adverse Event|0|||
105771007|NCT02253992|364813600|FG002|Overall Study|Adverse Event|8|||
105771008|NCT02253992|364813598|FG000|Overall Study|Death|0|||
105771009|NCT02253992|364813599|FG001|Overall Study|Death|0|||
105771010|NCT02253992|364813600|FG002|Overall Study|Death|1|||
105771011|NCT02253992|364813598|FG000|Overall Study|Subject discontinued study drug|1|||
105771012|NCT02253992|364813599|FG001|Overall Study|Subject discontinued study drug|0|||
105771013|NCT02253992|364813600|FG002|Overall Study|Subject discontinued study drug|1|||
105771014|NCT02253992|364813598|FG000|Overall Study|Completed treatment as per protocol|0|||
105771015|NCT02253992|364813599|FG001|Overall Study|Completed treatment as per protocol|1|||
105771016|NCT02253992|364813600|FG002|Overall Study|Completed treatment as per protocol|22|||
105771017|NCT02253992|364813598|FG000|Overall Study|Other|0|||
105771018|NCT02253992|364813599|FG001|Overall Study|Other|0|||
105771019|NCT02253992|364813600|FG002|Overall Study|Other|1|||
105771020|NCT00772889|364813601|FG000|Overall Study|Adverse Event|7|||
105771021|NCT00772889|364813602|FG001|Overall Study|Adverse Event|4|||
105771022|NCT00772889|364813603|FG002|Overall Study|Adverse Event|0|||
105771023|NCT00772889|364813601|FG000|Overall Study|Withdrawal by Subject|9|||
105771024|NCT00772889|364813602|FG001|Overall Study|Withdrawal by Subject|8|||
105771025|NCT00772889|364813603|FG002|Overall Study|Withdrawal by Subject|9|||
105771026|NCT00772889|364813601|FG000|Overall Study|Lost to Follow-up|6|||
105771027|NCT00772889|364813602|FG001|Overall Study|Lost to Follow-up|6|||
105771028|NCT00772889|364813603|FG002|Overall Study|Lost to Follow-up|7|||
105771029|NCT00085644|364813604|FG000|Double-Blind Period|Adverse Event|5|||
105771030|NCT00085644|364813605|FG001|Double-Blind Period|Adverse Event|2|||
105771031|NCT00085644|364813606|FG002|Double-Blind Period|Adverse Event|0|||
105771032|NCT00085644|364813604|FG000|Double-Blind Period|Withdrawal by Subject|3|||
105771033|NCT00085644|364813605|FG001|Double-Blind Period|Withdrawal by Subject|0|||
105771034|NCT00085644|364813606|FG002|Double-Blind Period|Withdrawal by Subject|0|||
105771035|NCT00085644|364813604|FG000|Double-Blind Period|Lost to Follow-up|2|||
105771036|NCT00085644|364813605|FG001|Double-Blind Period|Lost to Follow-up|1|||
105771037|NCT00085644|364813606|FG002|Double-Blind Period|Lost to Follow-up|0|||
105771038|NCT00085644|364813604|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
105771039|NCT00085644|364813605|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
105771040|NCT00085644|364813606|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
105771041|NCT00085644|364813604|FG000|Double-Blind Period|Contemplating pregnancy|1|||
105771042|NCT00085644|364813605|FG001|Double-Blind Period|Contemplating pregnancy|0|||
105771043|NCT00085644|364813606|FG002|Double-Blind Period|Contemplating pregnancy|0|||
105771044|NCT00085644|364813604|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
105771045|NCT00085644|364813605|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
105771046|NCT00085644|364813606|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
105771047|NCT00085644|364813604|FG000|Open-Label Period|Adverse Event|0|||
105771048|NCT00085644|364813605|FG001|Open-Label Period|Adverse Event|0|||
105771049|NCT00085644|364813606|FG002|Open-Label Period|Adverse Event|38|||
105771050|NCT00085644|364813604|FG000|Open-Label Period|Withdrawal by Subject|0|||
105771051|NCT00085644|364813605|FG001|Open-Label Period|Withdrawal by Subject|0|||
105771052|NCT00085644|364813606|FG002|Open-Label Period|Withdrawal by Subject|29|||
105771053|NCT00085644|364813604|FG000|Open-Label Period|Lost to Follow-up|0|||
105771054|NCT00085644|364813605|FG001|Open-Label Period|Lost to Follow-up|0|||
105771055|NCT00085644|364813606|FG002|Open-Label Period|Lost to Follow-up|13|||
105771056|NCT00085644|364813604|FG000|Open-Label Period|Lack of Efficacy|0|||
105771057|NCT00085644|364813605|FG001|Open-Label Period|Lack of Efficacy|0|||
105771058|NCT00085644|364813606|FG002|Open-Label Period|Lack of Efficacy|15|||
105771059|NCT00085644|364813604|FG000|Open-Label Period|Pregnancy|0|||
105771060|NCT00085644|364813605|FG001|Open-Label Period|Pregnancy|0|||
105771061|NCT00085644|364813606|FG002|Open-Label Period|Pregnancy|3|||
105771062|NCT00085644|364813604|FG000|Open-Label Period|Contemplating pregnancy|0|||
105771063|NCT00085644|364813605|FG001|Open-Label Period|Contemplating pregnancy|0|||
105771064|NCT00085644|364813606|FG002|Open-Label Period|Contemplating pregnancy|3|||
105771065|NCT00085644|364813604|FG000|Open-Label Period|Protocol Violation|0|||
105771066|NCT00085644|364813605|FG001|Open-Label Period|Protocol Violation|0|||
105771067|NCT00085644|364813606|FG002|Open-Label Period|Protocol Violation|4|||
105771068|NCT00085644|364813604|FG000|Open-Label Period|Personal reason|0|||
105771069|NCT00085644|364813605|FG001|Open-Label Period|Personal reason|0|||
105771070|NCT00085644|364813606|FG002|Open-Label Period|Personal reason|4|||
105771071|NCT04259346|364813607|FG000|Overall Study|Lost to Follow-up|1|||
105771072|NCT04259346|364813608|FG001|Overall Study|Lost to Follow-up|3|||
105771073|NCT04259346|364813607|FG000|Overall Study|Protocol Violation|1|||
105771074|NCT04259346|364813608|FG001|Overall Study|Protocol Violation|0|||
105771075|NCT04259346|364813607|FG000|Overall Study|Withdrawal by Subject|1|||
105771076|NCT04259346|364813608|FG001|Overall Study|Withdrawal by Subject|0|||
105771077|NCT04259346|364813607|FG000|Overall Study|Adverse Event|1|||
105771078|NCT04259346|364813608|FG001|Overall Study|Adverse Event|1|||
105771079|NCT03330106|364813609|FG000|Part A|Withdrawal by Subject|1|||
105771080|NCT03330106|364813610|FG001|Part A|Withdrawal by Subject|1|||
105771081|NCT03330106|364813611|FG002|Part A|Withdrawal by Subject|0|||
105771082|NCT03330106|364813612|FG003|Part A|Withdrawal by Subject|0|||
105771083|NCT03330106|364813609|FG000|Part A|Death|2|||
105771084|NCT03330106|364813610|FG001|Part A|Death|1|||
105771085|NCT03330106|364813611|FG002|Part A|Death|0|||
105771086|NCT03330106|364813612|FG003|Part A|Death|0|||
105771087|NCT03330106|364813609|FG000|Part A|Adverse Event|0|||
105771088|NCT03330106|364813610|FG001|Part A|Adverse Event|1|||
105771089|NCT03330106|364813611|FG002|Part A|Adverse Event|0|||
105771090|NCT03330106|364813612|FG003|Part A|Adverse Event|0|||
105771091|NCT03330106|364813609|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
105771092|NCT03330106|364813610|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
105771093|NCT03330106|364813611|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
105771094|NCT03330106|364813612|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
105771095|NCT03330106|364813609|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
105771096|NCT03330106|364813610|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
105771097|NCT03330106|364813611|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
105771098|NCT03330106|364813612|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
105771099|NCT03330106|364813609|FG000|Part A|Progressive Disease|0|||
105771100|NCT03330106|364813610|FG001|Part A|Progressive Disease|1|||
105771101|NCT03330106|364813611|FG002|Part A|Progressive Disease|0|||
105771102|NCT03330106|364813612|FG003|Part A|Progressive Disease|0|||
105771103|NCT03330106|364813609|FG000|Part B|Lost to Follow-up|0|||
105771104|NCT03330106|364813610|FG001|Part B|Lost to Follow-up|0|||
105771105|NCT03330106|364813611|FG002|Part B|Lost to Follow-up|0|||
105771106|NCT03330106|364813612|FG003|Part B|Lost to Follow-up|1|||
105771107|NCT03330106|364813609|FG000|Part B|Withdrawal by Subject|0|||
105771108|NCT03330106|364813610|FG001|Part B|Withdrawal by Subject|0|||
105771109|NCT03330106|364813611|FG002|Part B|Withdrawal by Subject|4|||
105771110|NCT03330106|364813612|FG003|Part B|Withdrawal by Subject|0|||
105771111|NCT03330106|364813609|FG000|Part B|Death|0|||
105771112|NCT03330106|364813610|FG001|Part B|Death|0|||
105771113|NCT03330106|364813611|FG002|Part B|Death|2|||
105771114|NCT03330106|364813612|FG003|Part B|Death|0|||
105771115|NCT03330106|364813609|FG000|Part B|Clinical Progression|0|||
105771116|NCT03330106|364813610|FG001|Part B|Clinical Progression|0|||
105771117|NCT03330106|364813611|FG002|Part B|Clinical Progression|1|||
105771118|NCT03330106|364813612|FG003|Part B|Clinical Progression|1|||
105771119|NCT03330106|364813609|FG000|Part B|Symptomatic Deterioration|0|||
105771120|NCT03330106|364813610|FG001|Part B|Symptomatic Deterioration|0|||
105771121|NCT03330106|364813611|FG002|Part B|Symptomatic Deterioration|0|||
105771122|NCT03330106|364813612|FG003|Part B|Symptomatic Deterioration|1|||
105771123|NCT03330106|364813609|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
105771124|NCT03330106|364813610|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
105771125|NCT03330106|364813611|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
105771126|NCT03330106|364813612|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
105771127|NCT03330106|364813609|FG000|Part B|Progressive Disease|0|||
105771128|NCT03330106|364813610|FG001|Part B|Progressive Disease|0|||
105771129|NCT03330106|364813611|FG002|Part B|Progressive Disease|11|||
105771130|NCT03330106|364813612|FG003|Part B|Progressive Disease|4|||
105771131|NCT00893763|364813614|FG000|Overall Study|extubated|110|||
105771132|NCT00893763|364813615|FG001|Overall Study|extubated|110|||
105771133|NCT00796549|364813616|FG000|Overall Study|Adverse Event|11|||
105771134|NCT00796549|364813616|FG000|Overall Study|not entered|149|||
105771135|NCT00796549|364813616|FG000|Overall Study|Other|2|||
105771136|NCT00796549|364813616|FG000|Overall Study|Progressive disease|56|||
105771137|NCT00606229|364813618|FG000|Overall Study|Adverse Event|11|||
105771138|NCT00606229|364813618|FG000|Overall Study|Lack of Efficacy|1|||
105771139|NCT00606229|364813618|FG000|Overall Study|Withdrawal by Subject|4|||
105771140|NCT00606229|364813618|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
105771141|NCT00606229|364813618|FG000|Overall Study|change of residence or other commitments|2|||
105771142|NCT01526928|364813619|FG000|Overall Study|Progressive Disease|35|||
105771143|NCT01526928|364813620|FG001|Overall Study|Progressive Disease|17|||
105771144|NCT01526928|364813621|FG002|Overall Study|Progressive Disease|150|||
105771145|NCT01526928|364813622|FG003|Overall Study|Progressive Disease|182|||
105771146|NCT01526928|364813623|FG004|Overall Study|Progressive Disease|76|||
105771147|NCT01526928|364813624|FG005|Overall Study|Progressive Disease|4|||
105771148|NCT01526928|364813619|FG000|Overall Study|Adverse Event|2|||
105771149|NCT01526928|364813620|FG001|Overall Study|Adverse Event|1|||
105771150|NCT01526928|364813621|FG002|Overall Study|Adverse Event|29|||
105771151|NCT01526928|364813622|FG003|Overall Study|Adverse Event|40|||
105771152|NCT01526928|364813623|FG004|Overall Study|Adverse Event|13|||
105771153|NCT01526928|364813624|FG005|Overall Study|Adverse Event|2|||
105771154|NCT01526928|364813619|FG000|Overall Study|Death|0|||
105771155|NCT01526928|364813620|FG001|Overall Study|Death|0|||
105771156|NCT01526928|364813621|FG002|Overall Study|Death|3|||
105442496|NCT01957202|363626756|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
105442497|NCT01957202|363626757|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
105442498|NCT01957202|363626758|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
105442499|NCT01957202|363626759|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
105442500|NCT01957202|363626760|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
105442501|NCT01957202|363626761|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
105442502|NCT01957202|363626762|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
105771157|NCT01526928|364813622|FG003|Overall Study|Death|0|||
105771158|NCT01526928|364813623|FG004|Overall Study|Death|0|||
105771159|NCT01526928|364813624|FG005|Overall Study|Death|0|||
105771160|NCT01526928|364813619|FG000|Overall Study|Withdrawal by Subject|1|||
105771161|NCT01526928|364813620|FG001|Overall Study|Withdrawal by Subject|0|||
105771162|NCT01526928|364813621|FG002|Overall Study|Withdrawal by Subject|13|||
105771163|NCT01526928|364813622|FG003|Overall Study|Withdrawal by Subject|11|||
105771164|NCT01526928|364813623|FG004|Overall Study|Withdrawal by Subject|3|||
105442503|NCT01957202|363626763|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
105771165|NCT01526928|364813624|FG005|Overall Study|Withdrawal by Subject|0|||
105771166|NCT01526928|364813619|FG000|Overall Study|Physician Decision|0|||
105771167|NCT01526928|364813620|FG001|Overall Study|Physician Decision|0|||
105771168|NCT01526928|364813621|FG002|Overall Study|Physician Decision|2|||
105771169|NCT01526928|364813622|FG003|Overall Study|Physician Decision|5|||
105771170|NCT01526928|364813623|FG004|Overall Study|Physician Decision|0|||
105771171|NCT01526928|364813624|FG005|Overall Study|Physician Decision|0|||
105771172|NCT01526928|364813619|FG000|Overall Study|Other Reason|0|||
105771173|NCT01526928|364813620|FG001|Overall Study|Other Reason|1|||
105771174|NCT01526928|364813621|FG002|Overall Study|Other Reason|11|||
105771175|NCT01526928|364813622|FG003|Overall Study|Other Reason|4|||
105771176|NCT01526928|364813623|FG004|Overall Study|Other Reason|1|||
105771177|NCT01526928|364813624|FG005|Overall Study|Other Reason|0|||
105771178|NCT01526928|364813619|FG000|Overall Study|Lost to Follow-up|0|||
105771179|NCT01526928|364813620|FG001|Overall Study|Lost to Follow-up|0|||
105771180|NCT01526928|364813621|FG002|Overall Study|Lost to Follow-up|0|||
105771181|NCT01526928|364813622|FG003|Overall Study|Lost to Follow-up|1|||
105771182|NCT01526928|364813623|FG004|Overall Study|Lost to Follow-up|0|||
105771183|NCT01526928|364813624|FG005|Overall Study|Lost to Follow-up|0|||
105771184|NCT01526928|364813619|FG000|Overall Study|Protocol Deviation|0|||
105771185|NCT01526928|364813620|FG001|Overall Study|Protocol Deviation|0|||
105771186|NCT01526928|364813621|FG002|Overall Study|Protocol Deviation|0|||
105771187|NCT01526928|364813622|FG003|Overall Study|Protocol Deviation|2|||
105771188|NCT01526928|364813623|FG004|Overall Study|Protocol Deviation|0|||
105771189|NCT01526928|364813624|FG005|Overall Study|Protocol Deviation|0|||
105771190|NCT01526928|364813619|FG000|Overall Study|Missing|0|||
105771191|NCT01526928|364813620|FG001|Overall Study|Missing|0|||
105771192|NCT01526928|364813621|FG002|Overall Study|Missing|1|||
105771193|NCT01526928|364813622|FG003|Overall Study|Missing|0|||
105771194|NCT01526928|364813623|FG004|Overall Study|Missing|2|||
105771195|NCT01526928|364813624|FG005|Overall Study|Missing|0|||
105771196|NCT02139280|364813625|FG000|Overall Study|No longer eligible|2|||
105771197|NCT02139280|364813626|FG001|Overall Study|No longer eligible|0|||
105771198|NCT01108068|364813627|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
105771199|NCT01108068|364813628|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
105771200|NCT00836953|364813629|FG000|Overall Study|Withdrawal by Subject|1|||
105771201|NCT00836953|364813629|FG000|Overall Study|Lost to Follow-up|1|||
105771202|NCT02877134|364813630|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771203|NCT02877134|364813631|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
105771204|NCT02877134|364813632|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771205|NCT02877134|364813633|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771206|NCT02877134|364813634|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771207|NCT02877134|364813635|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
105771208|NCT02877134|364813636|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771209|NCT02877134|364813637|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771210|NCT02877134|364813638|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771211|NCT02877134|364813639|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771212|NCT02877134|364813640|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771213|NCT02877134|364813641|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771214|NCT02877134|364813630|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771215|NCT02877134|364813631|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
105771216|NCT02877134|364813632|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771217|NCT02877134|364813633|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
105771218|NCT02877134|364813634|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771219|NCT02877134|364813635|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771220|NCT02877134|364813636|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
105771221|NCT02877134|364813637|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771222|NCT02877134|364813638|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771223|NCT02877134|364813639|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771224|NCT02877134|364813640|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771225|NCT02877134|364813641|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771226|NCT02877134|364813630|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
105771227|NCT02877134|364813631|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
105771228|NCT02877134|364813632|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
105771229|NCT02877134|364813633|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
105771230|NCT02877134|364813634|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
105771231|NCT02877134|364813635|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
105771232|NCT02877134|364813636|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
105771233|NCT02877134|364813637|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
105771234|NCT02877134|364813638|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
105771235|NCT02877134|364813639|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
105771236|NCT02877134|364813640|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
105771237|NCT02877134|364813641|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
105771238|NCT02877134|364813630|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
105771239|NCT02877134|364813631|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
105771240|NCT02877134|364813632|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
105771241|NCT02877134|364813633|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
105771242|NCT02877134|364813634|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
105771243|NCT02877134|364813635|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
105771244|NCT02877134|364813636|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
105771245|NCT02877134|364813637|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
105771246|NCT02877134|364813638|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
105771247|NCT02877134|364813639|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
105771248|NCT02877134|364813640|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
105771249|NCT02877134|364813641|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
105771250|NCT02877134|364813630|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771251|NCT02877134|364813631|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771252|NCT02877134|364813632|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771253|NCT02877134|364813633|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771254|NCT02877134|364813634|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771255|NCT02877134|364813635|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771256|NCT02877134|364813636|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771257|NCT02877134|364813637|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771258|NCT02877134|364813638|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
105771259|NCT02877134|364813639|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771260|NCT02877134|364813640|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771261|NCT02877134|364813641|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771262|NCT02877134|364813630|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
105771263|NCT02877134|364813631|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
105771264|NCT02877134|364813632|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
105771265|NCT02877134|364813633|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
105771266|NCT02877134|364813634|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
105771267|NCT02877134|364813635|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
105771268|NCT02877134|364813636|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
105771269|NCT02877134|364813637|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
105771270|NCT02877134|364813638|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
105771271|NCT02877134|364813639|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
105771272|NCT02877134|364813640|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
105771273|NCT02877134|364813641|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
105771274|NCT02877134|364813630|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771275|NCT02877134|364813631|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771276|NCT02877134|364813632|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771277|NCT02877134|364813633|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771278|NCT02877134|364813634|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771279|NCT02877134|364813635|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771280|NCT02877134|364813636|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771281|NCT02877134|364813637|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
105771282|NCT02877134|364813638|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
105771283|NCT02877134|364813639|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
105771284|NCT02877134|364813640|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771285|NCT02877134|364813641|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771286|NCT02877134|364813630|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
105771287|NCT02877134|364813631|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
105771288|NCT02877134|364813632|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
105771289|NCT02877134|364813633|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
105771290|NCT02877134|364813634|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
105771291|NCT02877134|364813635|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
105771292|NCT02877134|364813636|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
105771293|NCT02877134|364813637|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
105771294|NCT02877134|364813638|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
105771295|NCT02877134|364813639|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
105771296|NCT02877134|364813640|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
105771297|NCT02877134|364813641|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
105771298|NCT01249157|364813644|FG000|Overall Study|Withdrawal by Subject|1|||
105771299|NCT04445051|364813645|FG000|Overall Study|Adverse Event|0|||
105771300|NCT04445051|364813646|FG001|Overall Study|Adverse Event|0|||
105771301|NCT04445051|364813647|FG002|Overall Study|Adverse Event|1|||
105771302|NCT04445051|364813648|FG003|Overall Study|Adverse Event|0|||
105771303|NCT04445051|364813649|FG004|Overall Study|Adverse Event|0|||
105771304|NCT04445051|364813650|FG005|Overall Study|Adverse Event|0|||
105771305|NCT01197794|364813655|FG000|Overall Study|Adverse Event|3|||
105570233|NCT00405639|364086711|FG001|Overall Study|Adverse Event|0|||
105771306|NCT01197794|364813656|FG001|Overall Study|Adverse Event|2|||
105771307|NCT01197794|364813657|FG002|Overall Study|Adverse Event|4|||
105771308|NCT01197794|364813658|FG003|Overall Study|Adverse Event|4|||
105771309|NCT01197794|364813659|FG004|Overall Study|Adverse Event|4|||
105771310|NCT01197794|364813660|FG005|Overall Study|Adverse Event|2|||
105771311|NCT01197794|364813661|FG006|Overall Study|Adverse Event|3|||
105771312|NCT01197794|364813655|FG000|Overall Study|Protocol Violation|0|||
105771313|NCT01197794|364813656|FG001|Overall Study|Protocol Violation|0|||
105771314|NCT01197794|364813657|FG002|Overall Study|Protocol Violation|0|||
105771315|NCT01197794|364813658|FG003|Overall Study|Protocol Violation|0|||
105771316|NCT01197794|364813659|FG004|Overall Study|Protocol Violation|2|||
105771317|NCT01197794|364813660|FG005|Overall Study|Protocol Violation|0|||
105771318|NCT01197794|364813661|FG006|Overall Study|Protocol Violation|1|||
105771319|NCT01197794|364813655|FG000|Overall Study|Development of study withdrawal criteria|3|||
105771320|NCT01197794|364813656|FG001|Overall Study|Development of study withdrawal criteria|0|||
105771321|NCT01197794|364813657|FG002|Overall Study|Development of study withdrawal criteria|0|||
105771322|NCT01197794|364813658|FG003|Overall Study|Development of study withdrawal criteria|1|||
105771323|NCT01197794|364813659|FG004|Overall Study|Development of study withdrawal criteria|0|||
105771324|NCT01197794|364813660|FG005|Overall Study|Development of study withdrawal criteria|0|||
105771325|NCT01197794|364813661|FG006|Overall Study|Development of study withdrawal criteria|1|||
105771326|NCT01197794|364813655|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
105771327|NCT01197794|364813656|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
105771328|NCT01197794|364813657|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
105771329|NCT01197794|364813658|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
105771330|NCT01197794|364813659|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
105771331|NCT01197794|364813660|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
105771332|NCT01197794|364813661|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
105771333|NCT01197794|364813655|FG000|Overall Study|Withdrawal by Subject|3|||
105771334|NCT01197794|364813656|FG001|Overall Study|Withdrawal by Subject|3|||
105771335|NCT01197794|364813657|FG002|Overall Study|Withdrawal by Subject|4|||
105771336|NCT01197794|364813658|FG003|Overall Study|Withdrawal by Subject|1|||
105771337|NCT01197794|364813659|FG004|Overall Study|Withdrawal by Subject|1|||
105771338|NCT01197794|364813660|FG005|Overall Study|Withdrawal by Subject|5|||
105771339|NCT01197794|364813661|FG006|Overall Study|Withdrawal by Subject|6|||
105771340|NCT01197794|364813655|FG000|Overall Study|Lost to Follow-up|1|||
105771341|NCT01197794|364813656|FG001|Overall Study|Lost to Follow-up|1|||
105771342|NCT01197794|364813657|FG002|Overall Study|Lost to Follow-up|0|||
105771343|NCT01197794|364813658|FG003|Overall Study|Lost to Follow-up|1|||
105771344|NCT01197794|364813659|FG004|Overall Study|Lost to Follow-up|0|||
105771345|NCT01197794|364813660|FG005|Overall Study|Lost to Follow-up|1|||
105771346|NCT01197794|364813661|FG006|Overall Study|Lost to Follow-up|0|||
105771347|NCT01197794|364813655|FG000|Overall Study|Other|1|||
105771348|NCT01197794|364813656|FG001|Overall Study|Other|1|||
105771349|NCT01197794|364813657|FG002|Overall Study|Other|3|||
105771350|NCT01197794|364813658|FG003|Overall Study|Other|0|||
105771351|NCT01197794|364813659|FG004|Overall Study|Other|2|||
105771352|NCT01197794|364813660|FG005|Overall Study|Other|2|||
105771353|NCT01197794|364813661|FG006|Overall Study|Other|4|||
105771354|NCT04055844|364813663|FG000|Overall Study|Adverse Event|12|||
105771355|NCT04055844|364813663|FG000|Overall Study|Poor Performance|1|||
105771356|NCT04055844|364813663|FG000|Overall Study|Death|1|||
105771357|NCT00572728|364813664|FG000|Overall Study|Withdrawal by Subject|10|||
105771358|NCT00572728|364813664|FG000|Overall Study|Ineligible|3|||
105442504|NCT01957202|363626764|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
105442505|NCT01957202|363626765|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
105442506|NCT01957202|363626766|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
105442507|NCT01957202|363626767|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
105442508|NCT00413036|363626770|FG000|Overall Study|Adverse Event|44|||
105442509|NCT00413036|363626770|FG000|Overall Study|Lack of Efficacy|129|||
105442510|NCT00413036|363626770|FG000|Overall Study|Withdrawal by Subject|7|||
105442511|NCT00413036|363626770|FG000|Overall Study|Death|9|||
105442512|NCT00413036|363626770|FG000|Overall Study|Other|26|||
105442513|NCT00413036|363626770|FG000|Overall Study|Missing|2|||
105442514|NCT02652156|363626773|FG000|Overall Study|Physician Decision|1|||
105442515|NCT02652156|363626774|FG001|Overall Study|Physician Decision|0|||
105442516|NCT02652156|363626775|FG002|Overall Study|Physician Decision|0|||
105442517|NCT03040674|363626776|FG000|Overall Study|Lost to Follow-up|225|||
105442518|NCT03040674|363626776|FG000|Overall Study|Death|23|||
105442519|NCT05173012|363626777|FG000|Overall Study|Adverse Event|2|||
105442520|NCT05173012|363626778|FG001|Overall Study|Adverse Event|3|||
105442521|NCT05173012|363626779|FG002|Overall Study|Adverse Event|4|||
105442522|NCT05173012|363626780|FG003|Overall Study|Adverse Event|13|||
105442523|NCT05173012|363626781|FG004|Overall Study|Adverse Event|0|||
105442524|NCT05173012|363626782|FG005|Overall Study|Adverse Event|0|||
105442525|NCT05173012|363626783|FG006|Overall Study|Adverse Event|2|||
105442526|NCT05173012|363626784|FG007|Overall Study|Adverse Event|4|||
105442527|NCT05173012|363626777|FG000|Overall Study|Lost to Follow-up|0|||
105442528|NCT05173012|363626778|FG001|Overall Study|Lost to Follow-up|0|||
105442529|NCT05173012|363626779|FG002|Overall Study|Lost to Follow-up|0|||
105771359|NCT00572728|364813664|FG000|Overall Study|Enrolled under Amendment 4|5|||
105771360|NCT00572728|364813664|FG000|Overall Study|Offstudy due to complicating disease|1|||
105771361|NCT00572728|364813664|FG000|Overall Study|FLT1 not completed|4|||
105771362|NCT00572728|364813664|FG000|Overall Study|First Chemotherapy not initiated|2|||
105771363|NCT00572728|364813664|FG000|Overall Study|FLT2 not completed|5|||
105771364|NCT00572728|364813664|FG000|Overall Study|Second chemotherapy not initiated|1|||
105771365|NCT00572728|364813664|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
105771366|NCT00572728|364813664|FG000|Overall Study|Pathology missing|1|||
105771367|NCT00255008|364813667|FG000|Overall Study|Adverse Event|1|||
105771368|NCT00255008|364813668|FG001|Overall Study|Adverse Event|1|||
105771369|NCT00255008|364813669|FG002|Overall Study|Adverse Event|2|||
105771370|NCT00255008|364813670|FG003|Overall Study|Adverse Event|0|||
105771371|NCT00255008|364813667|FG000|Overall Study|Lost to Follow-up|1|||
105771372|NCT00255008|364813668|FG001|Overall Study|Lost to Follow-up|0|||
105771373|NCT00255008|364813669|FG002|Overall Study|Lost to Follow-up|1|||
105771374|NCT00255008|364813670|FG003|Overall Study|Lost to Follow-up|2|||
105771375|NCT00255008|364813667|FG000|Overall Study|Did not meet viral reduction criteria|4|||
105771376|NCT00255008|364813668|FG001|Overall Study|Did not meet viral reduction criteria|5|||
105771377|NCT00255008|364813669|FG002|Overall Study|Did not meet viral reduction criteria|0|||
105771378|NCT00255008|364813670|FG003|Overall Study|Did not meet viral reduction criteria|1|||
105771379|NCT00255008|364813667|FG000|Overall Study|Withdrew consent|0|||
105771380|NCT00255008|364813668|FG001|Overall Study|Withdrew consent|0|||
105771381|NCT00255008|364813669|FG002|Overall Study|Withdrew consent|2|||
105771382|NCT00255008|364813670|FG003|Overall Study|Withdrew consent|0|||
105771383|NCT00255008|364813667|FG000|Overall Study|Sponsor request|18|||
105771384|NCT00255008|364813668|FG001|Overall Study|Sponsor request|3|||
105771385|NCT00255008|364813669|FG002|Overall Study|Sponsor request|8|||
105771386|NCT00255008|364813670|FG003|Overall Study|Sponsor request|17|||
105771387|NCT00255008|364813667|FG000|Overall Study|Adverse lab experience|1|||
105771388|NCT00255008|364813668|FG001|Overall Study|Adverse lab experience|0|||
105771389|NCT00255008|364813669|FG002|Overall Study|Adverse lab experience|0|||
105771390|NCT00255008|364813670|FG003|Overall Study|Adverse lab experience|0|||
105771391|NCT00255008|364813667|FG000|Overall Study|Other|7|||
105771392|NCT00255008|364813668|FG001|Overall Study|Other|0|||
105771393|NCT00255008|364813669|FG002|Overall Study|Other|3|||
105771394|NCT00255008|364813670|FG003|Overall Study|Other|2|||
105771395|NCT03457636|364813673|FG000|Overall Study|Lost to Follow-up|2|||
105771396|NCT02724111|364813674|FG000|Overall Study|Protocol Violation|2|||
105771397|NCT02724111|364813675|FG001|Overall Study|Protocol Violation|5|||
105771398|NCT02996500|364813676|FG000|Overall Study|Adverse Event|1|||
105771399|NCT02996500|364813677|FG001|Overall Study|Adverse Event|1|||
105771400|NCT02996500|364813678|FG002|Overall Study|Adverse Event|4|||
105771401|NCT02996500|364813679|FG003|Overall Study|Adverse Event|3|||
105771402|NCT02996500|364813680|FG004|Overall Study|Adverse Event|1|||
105771403|NCT02996500|364813681|FG005|Overall Study|Adverse Event|2|||
105771404|NCT02996500|364813676|FG000|Overall Study|Lack of Efficacy|0|||
105771405|NCT02996500|364813677|FG001|Overall Study|Lack of Efficacy|0|||
105771406|NCT02996500|364813678|FG002|Overall Study|Lack of Efficacy|0|||
105771407|NCT02996500|364813679|FG003|Overall Study|Lack of Efficacy|0|||
105771408|NCT02996500|364813680|FG004|Overall Study|Lack of Efficacy|2|||
105771409|NCT02996500|364813681|FG005|Overall Study|Lack of Efficacy|0|||
105771410|NCT02996500|364813676|FG000|Overall Study|Lost to Follow-up|1|||
105771411|NCT02996500|364813677|FG001|Overall Study|Lost to Follow-up|0|||
105771412|NCT02996500|364813678|FG002|Overall Study|Lost to Follow-up|0|||
105771413|NCT02996500|364813679|FG003|Overall Study|Lost to Follow-up|0|||
105771414|NCT02996500|364813680|FG004|Overall Study|Lost to Follow-up|0|||
105771415|NCT02996500|364813681|FG005|Overall Study|Lost to Follow-up|1|||
105771416|NCT02996500|364813676|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
105771417|NCT02996500|364813677|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
105771418|NCT02996500|364813678|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
105771419|NCT02996500|364813679|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
105771420|NCT02996500|364813680|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
105771421|NCT02996500|364813681|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
105771422|NCT02996500|364813676|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105771423|NCT02996500|364813677|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105771424|NCT02996500|364813678|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105771425|NCT02996500|364813679|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105771426|NCT02996500|364813680|FG004|Overall Study|Non-Compliance With Study Drug|0|||
105771427|NCT02996500|364813681|FG005|Overall Study|Non-Compliance With Study Drug|1|||
105771428|NCT02996500|364813676|FG000|Overall Study|Progressive Disease|1|||
105771429|NCT02996500|364813677|FG001|Overall Study|Progressive Disease|0|||
105771430|NCT02996500|364813678|FG002|Overall Study|Progressive Disease|0|||
105771431|NCT02996500|364813679|FG003|Overall Study|Progressive Disease|0|||
105771432|NCT02996500|364813680|FG004|Overall Study|Progressive Disease|0|||
105771433|NCT02996500|364813681|FG005|Overall Study|Progressive Disease|0|||
105771434|NCT02996500|364813676|FG000|Overall Study|Other|2|||
105771435|NCT02996500|364813677|FG001|Overall Study|Other|0|||
105771436|NCT02996500|364813678|FG002|Overall Study|Other|2|||
105771437|NCT02996500|364813679|FG003|Overall Study|Other|0|||
105771438|NCT02996500|364813680|FG004|Overall Study|Other|0|||
105771439|NCT02996500|364813681|FG005|Overall Study|Other|0|||
105771440|NCT02996500|364813676|FG000|Overall Study|Protocol Violation|0|||
105771441|NCT02996500|364813677|FG001|Overall Study|Protocol Violation|0|||
105771442|NCT02996500|364813678|FG002|Overall Study|Protocol Violation|0|||
105771443|NCT02996500|364813679|FG003|Overall Study|Protocol Violation|1|||
105771444|NCT02996500|364813680|FG004|Overall Study|Protocol Violation|0|||
105771445|NCT02996500|364813681|FG005|Overall Study|Protocol Violation|0|||
105771446|NCT02996500|364813676|FG000|Overall Study|Withdrawal by Subject|3|||
105771447|NCT02996500|364813677|FG001|Overall Study|Withdrawal by Subject|0|||
105771448|NCT02996500|364813678|FG002|Overall Study|Withdrawal by Subject|3|||
105771449|NCT02996500|364813679|FG003|Overall Study|Withdrawal by Subject|0|||
105771450|NCT02996500|364813680|FG004|Overall Study|Withdrawal by Subject|2|||
105771451|NCT02996500|364813681|FG005|Overall Study|Withdrawal by Subject|0|||
105771452|NCT03924427|364813684|FG000|Overall Study|Adverse Event|4|||
105771453|NCT03924427|364813684|FG000|Overall Study|Lack of Efficacy|1|||
105771454|NCT03924427|364813684|FG000|Overall Study|Withdrawal by Subject|1|||
105771455|NCT01307046|364813691|FG000|Overall Study|Adverse Event|3|||
105771456|NCT01307046|364813692|FG001|Overall Study|Adverse Event|3|||
105771457|NCT01307046|364813691|FG000|Overall Study|Lack of Efficacy|0|||
105771458|NCT01307046|364813692|FG001|Overall Study|Lack of Efficacy|2|||
105771459|NCT01307046|364813691|FG000|Overall Study|Physician Decision|2|||
105771460|NCT01307046|364813692|FG001|Overall Study|Physician Decision|0|||
105771461|NCT01307046|364813691|FG000|Overall Study|Withdrawal by Subject|1|||
105771462|NCT01307046|364813692|FG001|Overall Study|Withdrawal by Subject|1|||
105771463|NCT01307046|364813691|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
105771464|NCT01307046|364813692|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
105771465|NCT01307046|364813691|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
105771466|NCT01307046|364813692|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
105771467|NCT01435122|364813693|FG000|Overall Study|Early withdrawal due to toxicity|8|||
105771468|NCT00112840|364813694|FG000|Overall Study|Physician Decision|1|||
105771469|NCT00112840|364813695|FG001|Overall Study|Physician Decision|0|||
105771470|NCT00112840|364813696|FG002|Overall Study|Physician Decision|0|||
105771471|NCT00112840|364813694|FG000|Overall Study|Withdrawal by Subject|1|||
105771472|NCT00112840|364813695|FG001|Overall Study|Withdrawal by Subject|0|||
105771473|NCT00112840|364813696|FG002|Overall Study|Withdrawal by Subject|1|||
105771474|NCT00112840|364813694|FG000|Overall Study|Protocol Violation|0|||
105771475|NCT00112840|364813695|FG001|Overall Study|Protocol Violation|0|||
105771476|NCT00112840|364813696|FG002|Overall Study|Protocol Violation|5|||
105771477|NCT02299206|364813697|FG000|Overall Study|Lost to Follow-up|1|||
105771478|NCT02299206|364813697|FG000|Overall Study|Withdrawal by Subject|1|||
105771479|NCT00683774|364813704|FG000|Overall Study|Withdrawal by Subject|0|||
105771480|NCT00683774|364813705|FG001|Overall Study|Withdrawal by Subject|1|||
105771481|NCT00683774|364813704|FG000|Overall Study|Physician Decision|3|||
105771482|NCT00683774|364813705|FG001|Overall Study|Physician Decision|0|||
105771483|NCT01222416|364813706|FG000|Overall Study|ineligible;metastasis|3|||
105771484|NCT01222416|364813707|FG001|Overall Study|ineligible;metastasis|0|||
105771485|NCT01222416|364813706|FG000|Overall Study|Adverse Event|4|||
105771486|NCT01222416|364813707|FG001|Overall Study|Adverse Event|0|||
105771487|NCT01222416|364813706|FG000|Overall Study|Withdrawal by Subject|5|||
105771488|NCT01222416|364813707|FG001|Overall Study|Withdrawal by Subject|0|||
105771489|NCT01222416|364813706|FG000|Overall Study|scheduling|6|||
105771490|NCT01222416|364813707|FG001|Overall Study|scheduling|0|||
105771491|NCT01222416|364813706|FG000|Overall Study|missed view/scan|1|||
105771492|NCT01222416|364813707|FG001|Overall Study|missed view/scan|0|||
105771493|NCT01222416|364813706|FG000|Overall Study|Death|1|||
105771494|NCT01222416|364813707|FG001|Overall Study|Death|0|||
105771495|NCT00691054|364813708|FG000|Overall Study|Withdrawal by Subject|1|||
105771496|NCT02178592|364813709|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
105771497|NCT02178592|364813710|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
105771498|NCT02178592|364813709|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
105771499|NCT02178592|364813710|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
105771500|NCT02178592|364813709|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
105771501|NCT02178592|364813710|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
105771502|NCT02178592|364813709|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
105771503|NCT02178592|364813710|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
105771504|NCT02178592|364813709|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
105771505|NCT02178592|364813710|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
105771506|NCT02178592|364813709|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
105771507|NCT02178592|364813710|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
105771508|NCT02178592|364813709|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
105771509|NCT02178592|364813710|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
105771510|NCT02178592|364813709|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
105771511|NCT02178592|364813710|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
105771512|NCT02178592|364813709|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
105771513|NCT02178592|364813710|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
105771514|NCT02178592|364813709|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
105771515|NCT02178592|364813710|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
105771516|NCT02178592|364813709|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
105771517|NCT02178592|364813710|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
105771518|NCT02178592|364813709|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
105771519|NCT02178592|364813710|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
105771520|NCT02520141|364813711|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
105771521|NCT02735044|364813713|FG000|Overall Study|Adverse Event|3|||
105771522|NCT02735044|364813714|FG001|Overall Study|Adverse Event|3|||
105771523|NCT02735044|364813713|FG000|Overall Study|Lack of Efficacy|1|||
105771524|NCT02735044|364813714|FG001|Overall Study|Lack of Efficacy|0|||
105771525|NCT02735044|364813713|FG000|Overall Study|Poor compliance to protocol|7|||
105771526|NCT02735044|364813714|FG001|Overall Study|Poor compliance to protocol|7|||
105771527|NCT02735044|364813713|FG000|Overall Study|Randomized and not treated|0|||
105771528|NCT02735044|364813714|FG001|Overall Study|Randomized and not treated|2|||
105771529|NCT02735044|364813713|FG000|Overall Study|Other, not specified above|5|||
105771530|NCT02735044|364813714|FG001|Overall Study|Other, not specified above|11|||
105771531|NCT00397891|364813715|FG000|Overall Study|Withdrawal by Subject|1|||
105771532|NCT00397891|364813716|FG001|Overall Study|Withdrawal by Subject|0|||
105771533|NCT00397891|364813717|FG002|Overall Study|Withdrawal by Subject|0|||
105771534|NCT00397891|364813718|FG003|Overall Study|Withdrawal by Subject|0|||
105771535|NCT00397891|364813719|FG004|Overall Study|Withdrawal by Subject|1|||
105771536|NCT02141854|364813720|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
105771537|NCT02141854|364813721|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105771538|NCT02141854|364813722|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105771539|NCT02141854|364813723|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105771540|NCT02141854|364813724|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105771541|NCT02141854|364813725|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105771542|NCT02141854|364813720|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
105771543|NCT02141854|364813721|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105771544|NCT02141854|364813722|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105771545|NCT02141854|364813723|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105771546|NCT02141854|364813724|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105771547|NCT02141854|364813725|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105771548|NCT02141854|364813720|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
105771549|NCT02141854|364813721|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105771550|NCT02141854|364813722|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105771551|NCT02141854|364813723|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105771552|NCT02141854|364813724|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105771553|NCT02141854|364813725|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105771554|NCT02141854|364813720|FG000|Run-In Period (Pre-assignment)|Other|14|||
105771555|NCT02141854|364813721|FG001|Run-In Period (Pre-assignment)|Other|0|||
105771556|NCT02141854|364813722|FG002|Run-In Period (Pre-assignment)|Other|0|||
105771557|NCT02141854|364813723|FG003|Run-In Period (Pre-assignment)|Other|0|||
105771558|NCT02141854|364813724|FG004|Run-In Period (Pre-assignment)|Other|0|||
105771559|NCT02141854|364813725|FG005|Run-In Period (Pre-assignment)|Other|0|||
105771560|NCT02141854|364813720|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
105771561|NCT02141854|364813721|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
105771562|NCT02141854|364813722|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
105771563|NCT02141854|364813723|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
105771564|NCT02141854|364813724|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
105771565|NCT02141854|364813725|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
105771566|NCT02141854|364813720|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
105771567|NCT02141854|364813721|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105771568|NCT02141854|364813722|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105771569|NCT02141854|364813723|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105771570|NCT02141854|364813724|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105771571|NCT02141854|364813725|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105771572|NCT02141854|364813720|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
105771573|NCT02141854|364813721|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105771574|NCT02141854|364813722|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105771575|NCT02141854|364813723|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105771576|NCT02141854|364813724|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105771577|NCT02141854|364813725|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105771578|NCT02141854|364813720|FG000|Treatment Period|Protocol Violation|0|||
105771579|NCT02141854|364813721|FG001|Treatment Period|Protocol Violation|1|||
105771580|NCT02141854|364813722|FG002|Treatment Period|Protocol Violation|0|||
105771581|NCT02141854|364813723|FG003|Treatment Period|Protocol Violation|2|||
105771582|NCT02141854|364813724|FG004|Treatment Period|Protocol Violation|2|||
105771583|NCT02141854|364813725|FG005|Treatment Period|Protocol Violation|1|||
105771584|NCT02141854|364813720|FG000|Treatment Period|Noncompliance|0|||
105771585|NCT02141854|364813721|FG001|Treatment Period|Noncompliance|0|||
105771586|NCT02141854|364813722|FG002|Treatment Period|Noncompliance|0|||
105771587|NCT02141854|364813723|FG003|Treatment Period|Noncompliance|1|||
105771588|NCT02141854|364813724|FG004|Treatment Period|Noncompliance|0|||
105771589|NCT02141854|364813725|FG005|Treatment Period|Noncompliance|0|||
105771590|NCT02141854|364813720|FG000|Treatment Period|Lack of Efficacy|0|||
105771591|NCT02141854|364813721|FG001|Treatment Period|Lack of Efficacy|0|||
105771592|NCT02141854|364813722|FG002|Treatment Period|Lack of Efficacy|0|||
105771593|NCT02141854|364813723|FG003|Treatment Period|Lack of Efficacy|1|||
105771594|NCT02141854|364813724|FG004|Treatment Period|Lack of Efficacy|1|||
105771595|NCT02141854|364813725|FG005|Treatment Period|Lack of Efficacy|7|||
105771596|NCT02141854|364813720|FG000|Treatment Period|Pregnancy|0|||
105771597|NCT02141854|364813721|FG001|Treatment Period|Pregnancy|1|||
105771598|NCT02141854|364813722|FG002|Treatment Period|Pregnancy|0|||
105771599|NCT02141854|364813723|FG003|Treatment Period|Pregnancy|0|||
105771600|NCT02141854|364813724|FG004|Treatment Period|Pregnancy|0|||
105771601|NCT02141854|364813725|FG005|Treatment Period|Pregnancy|0|||
105771602|NCT02141854|364813720|FG000|Treatment Period|Other|0|||
105771603|NCT02141854|364813721|FG001|Treatment Period|Other|1|||
105771604|NCT02141854|364813722|FG002|Treatment Period|Other|2|||
105771605|NCT02141854|364813723|FG003|Treatment Period|Other|0|||
105771606|NCT02141854|364813724|FG004|Treatment Period|Other|1|||
105771607|NCT02141854|364813725|FG005|Treatment Period|Other|2|||
105771608|NCT02141854|364813720|FG000|Treatment Period|Adverse Event|0|||
105771609|NCT02141854|364813721|FG001|Treatment Period|Adverse Event|2|||
105771610|NCT02141854|364813722|FG002|Treatment Period|Adverse Event|2|||
105771611|NCT02141854|364813723|FG003|Treatment Period|Adverse Event|0|||
105771612|NCT02141854|364813724|FG004|Treatment Period|Adverse Event|2|||
105771613|NCT02141854|364813725|FG005|Treatment Period|Adverse Event|2|||
105771614|NCT02141854|364813720|FG000|Treatment Period|Withdrawal by Subject|0|||
105771615|NCT02141854|364813721|FG001|Treatment Period|Withdrawal by Subject|2|||
105771616|NCT02141854|364813722|FG002|Treatment Period|Withdrawal by Subject|3|||
105771617|NCT02141854|364813723|FG003|Treatment Period|Withdrawal by Subject|3|||
105771618|NCT02141854|364813724|FG004|Treatment Period|Withdrawal by Subject|4|||
105771619|NCT02141854|364813725|FG005|Treatment Period|Withdrawal by Subject|7|||
105771620|NCT02141854|364813720|FG000|Treatment Period|Disease progression|0|||
105771621|NCT02141854|364813721|FG001|Treatment Period|Disease progression|2|||
105771622|NCT02141854|364813722|FG002|Treatment Period|Disease progression|1|||
105771623|NCT02141854|364813723|FG003|Treatment Period|Disease progression|3|||
105771624|NCT02141854|364813724|FG004|Treatment Period|Disease progression|0|||
105771625|NCT02141854|364813725|FG005|Treatment Period|Disease progression|18|||
105771626|NCT02141854|364813720|FG000|Treatment Period|Lost to Follow-up|0|||
105771627|NCT02141854|364813721|FG001|Treatment Period|Lost to Follow-up|1|||
105771628|NCT02141854|364813722|FG002|Treatment Period|Lost to Follow-up|1|||
105771629|NCT02141854|364813723|FG003|Treatment Period|Lost to Follow-up|1|||
105771630|NCT02141854|364813724|FG004|Treatment Period|Lost to Follow-up|0|||
105771631|NCT02141854|364813725|FG005|Treatment Period|Lost to Follow-up|1|||
105771632|NCT02659098|364813726|FG000|Overall Study|Withdrawal by Subject|7|||
105771633|NCT03277794|364813727|FG000|Overall Study|Lost to Follow-up|2|||
105771634|NCT03277794|364813728|FG001|Overall Study|Lost to Follow-up|4|||
105771635|NCT03277794|364813727|FG000|Overall Study|Withdrew due to high acuity|1|||
105771636|NCT03277794|364813728|FG001|Overall Study|Withdrew due to high acuity|0|||
105771637|NCT00400946|364815475|FG000|Overall Study|Ineligible|0|||
105771638|NCT00400946|364815476|FG001|Overall Study|Ineligible|0|||
105771639|NCT00400946|364815477|FG002|Overall Study|Ineligible|0|||
105771640|NCT00400946|364815478|FG003|Overall Study|Ineligible|5|||
105771641|NCT00400946|364815479|FG004|Overall Study|Ineligible|1|||
105771642|NCT00400946|364815475|FG000|Overall Study|Induction Failure|0|||
105771643|NCT00400946|364815476|FG001|Overall Study|Induction Failure|0|||
105771644|NCT00400946|364815477|FG002|Overall Study|Induction Failure|0|||
105771645|NCT00400946|364815478|FG003|Overall Study|Induction Failure|11|||
105771646|NCT00400946|364815479|FG004|Overall Study|Induction Failure|8|||
105771647|NCT00400946|364815475|FG000|Overall Study|Induction Death|0|||
105771648|NCT00400946|364815476|FG001|Overall Study|Induction Death|0|||
105771649|NCT00400946|364815477|FG002|Overall Study|Induction Death|0|||
105771650|NCT00400946|364815478|FG003|Overall Study|Induction Death|13|||
105771651|NCT00400946|364815479|FG004|Overall Study|Induction Death|3|||
105771652|NCT00400946|364815475|FG000|Overall Study|Lost to Follow-up|1|||
105771653|NCT00400946|364815476|FG001|Overall Study|Lost to Follow-up|1|||
105360838|NCT00572455|363328091|FG011|Stage II (28 Days)|Other|0|||
105771654|NCT00400946|364815477|FG002|Overall Study|Lost to Follow-up|0|||
105771655|NCT00400946|364815478|FG003|Overall Study|Lost to Follow-up|0|||
105771656|NCT00400946|364815479|FG004|Overall Study|Lost to Follow-up|1|||
105771657|NCT00400946|364815475|FG000|Overall Study|Remission Death|1|||
105771658|NCT00400946|364815476|FG001|Overall Study|Remission Death|1|||
105771659|NCT00400946|364815477|FG002|Overall Study|Remission Death|0|||
105771660|NCT00400946|364815478|FG003|Overall Study|Remission Death|0|||
105771661|NCT00400946|364815479|FG004|Overall Study|Remission Death|1|||
105771662|NCT00400946|364815475|FG000|Overall Study|Relapse|9|||
105771663|NCT00400946|364815476|FG001|Overall Study|Relapse|2|||
105771664|NCT00400946|364815477|FG002|Overall Study|Relapse|1|||
105771665|NCT00400946|364815478|FG003|Overall Study|Relapse|1|||
105771666|NCT00400946|364815479|FG004|Overall Study|Relapse|5|||
105771667|NCT00400946|364815475|FG000|Overall Study|Transplant in CR1|0|||
105771668|NCT00400946|364815476|FG001|Overall Study|Transplant in CR1|0|||
105771669|NCT00400946|364815477|FG002|Overall Study|Transplant in CR1|0|||
105771670|NCT00400946|364815478|FG003|Overall Study|Transplant in CR1|10|||
105771671|NCT00400946|364815479|FG004|Overall Study|Transplant in CR1|1|||
105771672|NCT00400946|364815475|FG000|Overall Study|Withdrawal by Subject|2|||
105771673|NCT00400946|364815476|FG001|Overall Study|Withdrawal by Subject|5|||
105771674|NCT00400946|364815477|FG002|Overall Study|Withdrawal by Subject|1|||
105771675|NCT00400946|364815478|FG003|Overall Study|Withdrawal by Subject|5|||
105771676|NCT00400946|364815479|FG004|Overall Study|Withdrawal by Subject|8|||
105771677|NCT00400946|364815475|FG000|Overall Study|Clinical|1|||
105771678|NCT00400946|364815476|FG001|Overall Study|Clinical|2|||
105771679|NCT00400946|364815477|FG002|Overall Study|Clinical|0|||
105771680|NCT00400946|364815478|FG003|Overall Study|Clinical|2|||
105771681|NCT00400946|364815479|FG004|Overall Study|Clinical|9|||
105771682|NCT00400946|364815475|FG000|Overall Study|Other|0|||
105771683|NCT00400946|364815476|FG001|Overall Study|Other|0|||
105771684|NCT00400946|364815477|FG002|Overall Study|Other|0|||
105771685|NCT00400946|364815478|FG003|Overall Study|Other|0|||
105771686|NCT00400946|364815479|FG004|Overall Study|Other|1|||
105771687|NCT01673373|364815480|FG000|Overall Study|Death|2|||
105771688|NCT00366444|364815481|FG000|Overall Study|Withdrawal by Subject|1|||
105771689|NCT00366444|364815482|FG001|Overall Study|Withdrawal by Subject|1|||
105771690|NCT00366444|364815481|FG000|Overall Study|Lack of Efficacy|0|||
105771691|NCT00366444|364815482|FG001|Overall Study|Lack of Efficacy|1|||
105771692|NCT01405027|364815483|FG000|Overall Study|Withdrawn consent|3|||
105771693|NCT01405027|364815484|FG001|Overall Study|Withdrawn consent|0|||
105771694|NCT01405027|364815483|FG000|Overall Study|Lost to Follow-up|16|||
105771695|NCT01405027|364815484|FG001|Overall Study|Lost to Follow-up|24|||
105771696|NCT01405027|364815483|FG000|Overall Study|Investigator judgement|0|||
105771697|NCT01405027|364815484|FG001|Overall Study|Investigator judgement|2|||
105771698|NCT01405027|364815483|FG000|Overall Study|Death|1|||
105771699|NCT01405027|364815484|FG001|Overall Study|Death|0|||
105771700|NCT01405027|364815483|FG000|Overall Study|Other or Unknown|12|||
105771701|NCT01405027|364815484|FG001|Overall Study|Other or Unknown|25|||
105771702|NCT00963469|364815488|FG000|Overall Study|Adverse Event|15|||
105771703|NCT00963469|364815489|FG001|Overall Study|Adverse Event|11|||
105771704|NCT00963469|364815490|FG002|Overall Study|Adverse Event|1|||
105771705|NCT00963469|364815488|FG000|Overall Study|Lack of Efficacy|10|||
105771706|NCT00963469|364815489|FG001|Overall Study|Lack of Efficacy|7|||
105771707|NCT00963469|364815490|FG002|Overall Study|Lack of Efficacy|2|||
105771708|NCT00963469|364815488|FG000|Overall Study|Lost to Follow-up|1|||
105771709|NCT00963469|364815489|FG001|Overall Study|Lost to Follow-up|1|||
105771710|NCT00963469|364815490|FG002|Overall Study|Lost to Follow-up|0|||
105771711|NCT00963469|364815488|FG000|Overall Study|Protocol Violation|5|||
105771712|NCT00963469|364815489|FG001|Overall Study|Protocol Violation|5|||
105771713|NCT00963469|364815490|FG002|Overall Study|Protocol Violation|3|||
105771714|NCT00963469|364815488|FG000|Overall Study|Withdrawal by Subject|4|||
105771715|NCT00963469|364815489|FG001|Overall Study|Withdrawal by Subject|1|||
105771716|NCT00963469|364815490|FG002|Overall Study|Withdrawal by Subject|1|||
105771717|NCT00963469|364815488|FG000|Overall Study|Pre-randomization Adverse Event|1|||
105771718|NCT00963469|364815489|FG001|Overall Study|Pre-randomization Adverse Event|2|||
105771719|NCT00963469|364815490|FG002|Overall Study|Pre-randomization Adverse Event|0|||
105771720|NCT00963469|364815488|FG000|Overall Study|Moved|1|||
105771721|NCT00963469|364815489|FG001|Overall Study|Moved|0|||
105771722|NCT00963469|364815490|FG002|Overall Study|Moved|0|||
105771723|NCT00963469|364815488|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
105771724|NCT00963469|364815489|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
105771725|NCT00963469|364815490|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
105771726|NCT01938391|364815499|FG000|6 Month Follow up|Withdrawal by Subject|1|||
105771727|NCT01938391|364815499|FG000|12 Month Follow up|Physician Decision|1|||
105771728|NCT01938391|364815499|FG000|12 Month Follow up|Withdrawal by Subject|1|||
105771729|NCT02094612|364815504|FG000|Overall Study|Lost to Follow-up|47|||
105771730|NCT02094612|364815505|FG001|Overall Study|Lost to Follow-up|47|||
105771731|NCT02094612|364815504|FG000|Overall Study|Never started ADHD medication|32|||
105771732|NCT02094612|364815505|FG001|Overall Study|Never started ADHD medication|23|||
105771733|NCT00584987|364815510|FG000|Overall Study|Protocol Violation|1|||
105771734|NCT00584987|364815511|FG001|Overall Study|Protocol Violation|1|||
105771735|NCT00584987|364815512|FG002|Overall Study|Protocol Violation|1|||
105771736|NCT00584987|364815513|FG003|Overall Study|Protocol Violation|0|||
105771737|NCT00584987|364815510|FG000|Overall Study|Adverse Event|0|||
105771738|NCT00584987|364815511|FG001|Overall Study|Adverse Event|0|||
105771739|NCT00584987|364815512|FG002|Overall Study|Adverse Event|0|||
105771740|NCT00584987|364815513|FG003|Overall Study|Adverse Event|1|||
105771741|NCT02234050|364815515|FG000|Overall Study|Lack of Efficacy|38|||
105771742|NCT02234050|364815516|FG001|Overall Study|Lack of Efficacy|22|||
105771743|NCT02234050|364815515|FG000|Overall Study|Adverse Event|13|||
105771744|NCT02234050|364815516|FG001|Overall Study|Adverse Event|1|||
105771745|NCT02234050|364815515|FG000|Overall Study|Withdrawal by Subject|4|||
105771746|NCT02234050|364815516|FG001|Overall Study|Withdrawal by Subject|2|||
105771747|NCT02234050|364815515|FG000|Overall Study|Sponsor's decision|6|||
105771748|NCT02234050|364815516|FG001|Overall Study|Sponsor's decision|0|||
105771749|NCT04992507|364815519|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
105771750|NCT04992507|364815520|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
105771751|NCT04992507|364815519|FG000|Overall Study|Death|0|||
105771752|NCT04992507|364815520|FG001|Overall Study|Death|1|||
105771753|NCT01852591|364815522|FG000|Overall Study|Withdrawal by Subject|2|||
105771754|NCT01852591|364815522|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
105771755|NCT03774875|364815523|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
105771756|NCT03774875|364815524|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
105771757|NCT03774875|364815523|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
105771758|NCT03774875|364815524|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
105771759|NCT03774875|364815523|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
105771760|NCT03774875|364815524|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
105771761|NCT03774875|364815523|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
105771762|NCT03774875|364815524|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
105771763|NCT03774875|364815523|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
105771764|NCT03774875|364815524|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
105771765|NCT03774875|364815523|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
105771766|NCT03774875|364815524|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
105771767|NCT03774875|364815523|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
105771768|NCT03774875|364815524|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
105771769|NCT03774875|364815523|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
105771770|NCT03774875|364815524|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
105771771|NCT03774875|364815523|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
105771772|NCT03774875|364815524|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
105771773|NCT03774875|364815523|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
105771774|NCT03774875|364815524|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
105771775|NCT03774875|364815523|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
105771776|NCT03774875|364815524|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
105771777|NCT03774875|364815523|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
105771778|NCT03774875|364815524|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
105771779|NCT03774875|364815523|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
105771780|NCT03774875|364815524|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
105771781|NCT00729560|364815527|FG000|Overall Study|Withdrawal by Subject|3|||
105771782|NCT03233308|364815528|FG000|Overall Study|Adverse Event|1|||
105771783|NCT03233308|364815528|FG000|Overall Study|Protocol Violation|1|||
105771784|NCT03287830|364815529|FG000|Overall Study|Withdrawal by Subject|1|||
105771785|NCT03287830|364815530|FG001|Overall Study|Withdrawal by Subject|1|||
105771786|NCT03287830|364815529|FG000|Overall Study|not meeting inclusion criteria|5|||
105771787|NCT03287830|364815530|FG001|Overall Study|not meeting inclusion criteria|12|||
105771788|NCT00764322|364815531|FG000|Overall Study|Withdrawal by Subject|11|||
105771789|NCT00764322|364815531|FG000|Overall Study|No CYP2D6 genotyping|9|||
105771790|NCT00732472|364815534|FG000|Overall Study|Adverse Event|0|||
105771791|NCT00732472|364815535|FG001|Overall Study|Adverse Event|1|||
105771792|NCT00732472|364815536|FG002|Overall Study|Adverse Event|1|||
105771793|NCT00732472|364815537|FG003|Overall Study|Adverse Event|1|||
105771794|NCT00732472|364815534|FG000|Overall Study|Protocol Violation|0|||
105771795|NCT00732472|364815535|FG001|Overall Study|Protocol Violation|0|||
105771796|NCT00732472|364815536|FG002|Overall Study|Protocol Violation|0|||
105771797|NCT00732472|364815537|FG003|Overall Study|Protocol Violation|1|||
105771798|NCT00732472|364815534|FG000|Overall Study|Withdrawal by Subject|0|||
105771799|NCT00732472|364815535|FG001|Overall Study|Withdrawal by Subject|2|||
105771800|NCT00732472|364815536|FG002|Overall Study|Withdrawal by Subject|0|||
105771801|NCT00732472|364815537|FG003|Overall Study|Withdrawal by Subject|1|||
105771802|NCT02354690|364815546|FG000|Overall Study|Physician Decision|1|||
105771803|NCT02871791|364815552|FG000|Phase 1b|Death|0|||
105771804|NCT02871791|364815553|FG001|Phase 1b|Death|1|||
105771805|NCT02871791|364815552|FG000|Phase 1b|progressive disease|6|||
105771806|NCT02871791|364815553|FG001|Phase 1b|progressive disease|2|||
105771807|NCT02871791|364815552|FG000|Phase 2|Death|1|||
105771808|NCT02871791|364815553|FG001|Phase 2|Death|0|||
105771809|NCT02871791|364815552|FG000|Phase 2|Lost to Follow-up|2|||
105771810|NCT02871791|364815553|FG001|Phase 2|Lost to Follow-up|0|||
105771811|NCT00129376|364815554|FG000|Overall Study|Adverse Event|1|||
105771812|NCT00129376|364815554|FG000|Overall Study|Lack of Efficacy|1|||
105771813|NCT01849562|364815555|FG000|Overall Study|Lost to Follow-up|1|||
105771814|NCT01849562|364815556|FG001|Overall Study|Lost to Follow-up|0|||
105771815|NCT01849562|364815557|FG002|Overall Study|Lost to Follow-up|0|||
105771816|NCT01849562|364815555|FG000|Overall Study|Non-compliance with Study Drug|1|||
105771817|NCT01849562|364815556|FG001|Overall Study|Non-compliance with Study Drug|0|||
105771818|NCT01849562|364815557|FG002|Overall Study|Non-compliance with Study Drug|0|||
105771819|NCT00611767|364815558|FG000|Overall Study|Withdrawal by Subject|4|||
105771820|NCT00611767|364815559|FG001|Overall Study|Withdrawal by Subject|1|||
105771821|NCT00611767|364815558|FG000|Overall Study|Thiopental not available|3|||
105771822|NCT00611767|364815559|FG001|Overall Study|Thiopental not available|0|||
105771823|NCT00611767|364815558|FG000|Overall Study|didn't like the medication|1|||
105771824|NCT00611767|364815559|FG001|Overall Study|didn't like the medication|1|||
105771825|NCT00611767|364815558|FG000|Overall Study|Physician Decision|1|||
105771826|NCT00611767|364815559|FG001|Overall Study|Physician Decision|0|||
105771827|NCT02447952|364815568|FG000|Overall Study|Adverse Event|2|||
105771828|NCT02447952|364815568|FG000|Overall Study|Physician Decision|1|||
105771829|NCT02447952|364815568|FG000|Overall Study|Withdrawal by Subject|4|||
105771830|NCT04476108|364815569|FG000|Overall Study|Adverse Event|4|||
105771831|NCT04476108|364815570|FG001|Overall Study|Adverse Event|1|||
105771832|NCT04476108|364815569|FG000|Overall Study|Lost to Follow-up|1|||
105771833|NCT04476108|364815570|FG001|Overall Study|Lost to Follow-up|0|||
105771834|NCT04476108|364815569|FG000|Overall Study|Inadvertent Enrollment|1|||
105771835|NCT04476108|364815570|FG001|Overall Study|Inadvertent Enrollment|0|||
105771836|NCT04476108|364815569|FG000|Overall Study|Protocol Violation|1|||
105771837|NCT04476108|364815570|FG001|Overall Study|Protocol Violation|1|||
105771838|NCT04476108|364815569|FG000|Overall Study|Withdrawal by Subject|1|||
105771839|NCT04476108|364815570|FG001|Overall Study|Withdrawal by Subject|1|||
105771840|NCT04247828|364815573|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
105771841|NCT02159365|364815574|FG000|Overall Study|Disease Progression|23|||
105771842|NCT02159365|364815574|FG000|Overall Study|Other reasons|11|||
105771843|NCT02159365|364815574|FG000|Overall Study|Administrative reason by Sponsor|9|||
105771844|NCT02159365|364815574|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
105771845|NCT02159365|364815574|FG000|Overall Study|Study drug toxicity|7|||
105771846|NCT02159365|364815574|FG000|Overall Study|Maximum clinical benefit|3|||
105771847|NCT02159365|364815574|FG000|Overall Study|Subject request to discontinue treatment|3|||
105771848|NCT02159365|364815574|FG000|Overall Study|Subject withdrew consent|3|||
105771849|NCT02159365|364815574|FG000|Overall Study|Death|1|||
105771850|NCT02159365|364815574|FG000|Overall Study|Lost to Follow-up|1|||
105771851|NCT03083470|364815577|FG000|Overall Study|Lost to Follow-up|0|||
105771852|NCT03083470|364815578|FG001|Overall Study|Lost to Follow-up|0|||
105771853|NCT03083470|364815579|FG002|Overall Study|Lost to Follow-up|0|||
105771854|NCT03083470|364815580|FG003|Overall Study|Lost to Follow-up|0|||
105771855|NCT03083470|364815581|FG004|Overall Study|Lost to Follow-up|1|||
105771856|NCT03083470|364815577|FG000|Overall Study|Withdrawal by Subject|0|||
105771857|NCT03083470|364815578|FG001|Overall Study|Withdrawal by Subject|0|||
105771858|NCT03083470|364815579|FG002|Overall Study|Withdrawal by Subject|0|||
105771859|NCT03083470|364815580|FG003|Overall Study|Withdrawal by Subject|0|||
105771860|NCT03083470|364815581|FG004|Overall Study|Withdrawal by Subject|1|||
105771861|NCT03077711|364815582|FG000|Overall Study|Lost to Follow-up|2|||
105771862|NCT03077711|364815583|FG001|Overall Study|Lost to Follow-up|2|||
105771863|NCT03077711|364815582|FG000|Overall Study|noncompliant taking medication|2|||
105771864|NCT03077711|364815583|FG001|Overall Study|noncompliant taking medication|0|||
105771865|NCT01055457|364815587|FG000|Overall Study|Lost to Follow-up|0|||
105771866|NCT01055457|364815588|FG001|Overall Study|Lost to Follow-up|1|||
105771867|NCT01055457|364815589|FG002|Overall Study|Lost to Follow-up|0|||
105771868|NCT01055457|364815590|FG003|Overall Study|Lost to Follow-up|0|||
105771869|NCT01055457|364815591|FG004|Overall Study|Lost to Follow-up|0|||
105771870|NCT01055457|364815592|FG005|Overall Study|Lost to Follow-up|1|||
105771871|NCT01055457|364815593|FG006|Overall Study|Lost to Follow-up|0|||
105771872|NCT01055457|364815594|FG007|Overall Study|Lost to Follow-up|0|||
105771873|NCT01055457|364815595|FG008|Overall Study|Lost to Follow-up|0|||
105771874|NCT01055457|364815596|FG009|Overall Study|Lost to Follow-up|0|||
105771875|NCT01055457|364815587|FG000|Overall Study|Protocol Violation|0|||
105771876|NCT01055457|364815588|FG001|Overall Study|Protocol Violation|0|||
105771877|NCT01055457|364815589|FG002|Overall Study|Protocol Violation|1|||
105771878|NCT01055457|364815590|FG003|Overall Study|Protocol Violation|1|||
105771879|NCT01055457|364815591|FG004|Overall Study|Protocol Violation|1|||
105771880|NCT01055457|364815592|FG005|Overall Study|Protocol Violation|2|||
105771881|NCT01055457|364815593|FG006|Overall Study|Protocol Violation|1|||
105771882|NCT01055457|364815594|FG007|Overall Study|Protocol Violation|0|||
105771883|NCT01055457|364815595|FG008|Overall Study|Protocol Violation|0|||
105771884|NCT01055457|364815596|FG009|Overall Study|Protocol Violation|1|||
105771885|NCT01055457|364815587|FG000|Overall Study|Subject Disinterest|0|||
105771886|NCT01055457|364815588|FG001|Overall Study|Subject Disinterest|0|||
105771887|NCT01055457|364815589|FG002|Overall Study|Subject Disinterest|0|||
105771888|NCT01055457|364815590|FG003|Overall Study|Subject Disinterest|0|||
105771889|NCT01055457|364815591|FG004|Overall Study|Subject Disinterest|0|||
105771890|NCT01055457|364815592|FG005|Overall Study|Subject Disinterest|0|||
105771891|NCT01055457|364815593|FG006|Overall Study|Subject Disinterest|0|||
105771892|NCT01055457|364815594|FG007|Overall Study|Subject Disinterest|1|||
105771893|NCT01055457|364815595|FG008|Overall Study|Subject Disinterest|0|||
105771894|NCT01055457|364815596|FG009|Overall Study|Subject Disinterest|0|||
105771895|NCT01055457|364815587|FG000|Overall Study|Subject Ineligible|1|||
105771896|NCT01055457|364815588|FG001|Overall Study|Subject Ineligible|0|||
105771897|NCT01055457|364815589|FG002|Overall Study|Subject Ineligible|1|||
105771898|NCT01055457|364815590|FG003|Overall Study|Subject Ineligible|0|||
105771899|NCT01055457|364815591|FG004|Overall Study|Subject Ineligible|1|||
105771900|NCT01055457|364815592|FG005|Overall Study|Subject Ineligible|0|||
105771901|NCT01055457|364815593|FG006|Overall Study|Subject Ineligible|0|||
105771902|NCT01055457|364815594|FG007|Overall Study|Subject Ineligible|0|||
105771903|NCT01055457|364815595|FG008|Overall Study|Subject Ineligible|0|||
105771904|NCT01055457|364815596|FG009|Overall Study|Subject Ineligible|0|||
105771905|NCT01055457|364815587|FG000|Overall Study|Discomfort|0|||
105771906|NCT01055457|364815588|FG001|Overall Study|Discomfort|0|||
105771907|NCT01055457|364815589|FG002|Overall Study|Discomfort|0|||
105771908|NCT01055457|364815590|FG003|Overall Study|Discomfort|0|||
105771909|NCT01055457|364815591|FG004|Overall Study|Discomfort|1|||
105771910|NCT01055457|364815592|FG005|Overall Study|Discomfort|0|||
105771911|NCT01055457|364815593|FG006|Overall Study|Discomfort|0|||
105771912|NCT01055457|364815594|FG007|Overall Study|Discomfort|0|||
105771913|NCT01055457|364815595|FG008|Overall Study|Discomfort|0|||
105771914|NCT01055457|364815596|FG009|Overall Study|Discomfort|0|||
105771915|NCT01055457|364815587|FG000|Overall Study|Pregnancy|0|||
105771916|NCT01055457|364815588|FG001|Overall Study|Pregnancy|0|||
105771917|NCT01055457|364815589|FG002|Overall Study|Pregnancy|0|||
105771918|NCT01055457|364815590|FG003|Overall Study|Pregnancy|1|||
105771919|NCT01055457|364815591|FG004|Overall Study|Pregnancy|0|||
105771920|NCT01055457|364815592|FG005|Overall Study|Pregnancy|0|||
105771921|NCT01055457|364815593|FG006|Overall Study|Pregnancy|0|||
105771922|NCT01055457|364815594|FG007|Overall Study|Pregnancy|0|||
105771923|NCT01055457|364815595|FG008|Overall Study|Pregnancy|0|||
105771924|NCT01055457|364815596|FG009|Overall Study|Pregnancy|0|||
105771925|NCT01055457|364815587|FG000|Overall Study|Adverse Event|0|||
105771926|NCT01055457|364815588|FG001|Overall Study|Adverse Event|0|||
105771927|NCT01055457|364815589|FG002|Overall Study|Adverse Event|0|||
105771928|NCT01055457|364815590|FG003|Overall Study|Adverse Event|1|||
105771929|NCT01055457|364815591|FG004|Overall Study|Adverse Event|0|||
105771930|NCT01055457|364815592|FG005|Overall Study|Adverse Event|0|||
105771931|NCT01055457|364815593|FG006|Overall Study|Adverse Event|0|||
105771932|NCT01055457|364815594|FG007|Overall Study|Adverse Event|0|||
105771933|NCT01055457|364815595|FG008|Overall Study|Adverse Event|0|||
105771934|NCT01055457|364815596|FG009|Overall Study|Adverse Event|0|||
105771935|NCT01885104|364815597|FG000|Overall Study|Withdrawal of Consent|1|||
105771936|NCT01885104|364815598|FG001|Overall Study|Withdrawal of Consent|0|||
105771937|NCT01885104|364815597|FG000|Overall Study|Lost to Follow-up|0|||
105771938|NCT01885104|364815598|FG001|Overall Study|Lost to Follow-up|1|||
105771939|NCT01885104|364815597|FG000|Overall Study|Physician Decision|1|||
105771940|NCT01885104|364815598|FG001|Overall Study|Physician Decision|0|||
105771941|NCT01316380|364815601|FG000|Overall Study|Adverse Event|0|||
105771942|NCT01316380|364815602|FG001|Overall Study|Adverse Event|2|||
105771943|NCT01316380|364815603|FG002|Overall Study|Adverse Event|1|||
105771944|NCT01316380|364815601|FG000|Overall Study|Protocol Violation|0|||
105771945|NCT01316380|364815602|FG001|Overall Study|Protocol Violation|0|||
105771946|NCT01316380|364815603|FG002|Overall Study|Protocol Violation|1|||
105771947|NCT01316380|364815601|FG000|Overall Study|Withdrawal by Subject|1|||
105771948|NCT01316380|364815602|FG001|Overall Study|Withdrawal by Subject|2|||
105771949|NCT01316380|364815603|FG002|Overall Study|Withdrawal by Subject|0|||
105771950|NCT01316380|364815601|FG000|Overall Study|Other|0|||
105771951|NCT01316380|364815602|FG001|Overall Study|Other|1|||
105771952|NCT01316380|364815603|FG002|Overall Study|Other|1|||
105771953|NCT01316380|364815601|FG000|Overall Study|Not treated|1|||
105771954|NCT01316380|364815602|FG001|Overall Study|Not treated|0|||
105771955|NCT01316380|364815603|FG002|Overall Study|Not treated|0|||
105771956|NCT01894776|364815604|FG000|Overall Study|Withdrawal by Subject|1|||
105771957|NCT02415595|364815606|FG000|Overall Study|Administrative reason by sponsor|39|||
105771958|NCT02415595|364815607|FG001|Overall Study|Administrative reason by sponsor|40|||
105771959|NCT02415595|364815608|FG002|Overall Study|Administrative reason by sponsor|41|||
105771960|NCT02415595|364815609|FG003|Overall Study|Administrative reason by sponsor|39|||
105771961|NCT02415595|364815606|FG000|Overall Study|Adverse Event|1|||
105771962|NCT02415595|364815607|FG001|Overall Study|Adverse Event|3|||
105771963|NCT02415595|364815608|FG002|Overall Study|Adverse Event|5|||
105771964|NCT02415595|364815609|FG003|Overall Study|Adverse Event|10|||
105771965|NCT02415595|364815606|FG000|Overall Study|Lack of Efficacy|4|||
105771966|NCT02415595|364815607|FG001|Overall Study|Lack of Efficacy|4|||
105771967|NCT02415595|364815608|FG002|Overall Study|Lack of Efficacy|0|||
105771968|NCT02415595|364815609|FG003|Overall Study|Lack of Efficacy|0|||
105771969|NCT02415595|364815606|FG000|Overall Study|Lost to Follow-up|1|||
105771970|NCT02415595|364815607|FG001|Overall Study|Lost to Follow-up|3|||
105771971|NCT02415595|364815608|FG002|Overall Study|Lost to Follow-up|1|||
105771972|NCT02415595|364815609|FG003|Overall Study|Lost to Follow-up|1|||
105771973|NCT02415595|364815606|FG000|Overall Study|Poor/Non-compliance|1|||
105771974|NCT02415595|364815607|FG001|Overall Study|Poor/Non-compliance|0|||
105771975|NCT02415595|364815608|FG002|Overall Study|Poor/Non-compliance|1|||
105771976|NCT02415595|364815609|FG003|Overall Study|Poor/Non-compliance|0|||
105771977|NCT02415595|364815606|FG000|Overall Study|Reached stopping criteria|0|||
105771978|NCT02415595|364815607|FG001|Overall Study|Reached stopping criteria|1|||
105771979|NCT02415595|364815608|FG002|Overall Study|Reached stopping criteria|1|||
105771980|NCT02415595|364815609|FG003|Overall Study|Reached stopping criteria|0|||
105771981|NCT02415595|364815606|FG000|Overall Study|Withdrawal by Subject|4|||
105771982|NCT02415595|364815607|FG001|Overall Study|Withdrawal by Subject|0|||
105771983|NCT02415595|364815608|FG002|Overall Study|Withdrawal by Subject|1|||
105771984|NCT02415595|364815609|FG003|Overall Study|Withdrawal by Subject|3|||
105771985|NCT02415595|364815606|FG000|Overall Study|Other|0|||
105771986|NCT02415595|364815607|FG001|Overall Study|Other|1|||
105771987|NCT02415595|364815608|FG002|Overall Study|Other|1|||
105771988|NCT02415595|364815609|FG003|Overall Study|Other|0|||
105771989|NCT03325010|364815610|FG000|Overall Study|Adverse Event|3|||
105771990|NCT03325010|364815611|FG001|Overall Study|Adverse Event|8|||
105771991|NCT03325010|364815610|FG000|Overall Study|Protocol Violation|1|||
105771992|NCT03325010|364815611|FG001|Overall Study|Protocol Violation|8|||
105771993|NCT03325010|364815610|FG000|Overall Study|Withdrawal by Subject|1|||
105771994|NCT03325010|364815611|FG001|Overall Study|Withdrawal by Subject|3|||
105771995|NCT03325010|364815610|FG000|Overall Study|Lost to Follow-up|1|||
105771996|NCT03325010|364815611|FG001|Overall Study|Lost to Follow-up|0|||
105771997|NCT03325010|364815610|FG000|Overall Study|Physician Decision|1|||
105771998|NCT03325010|364815611|FG001|Overall Study|Physician Decision|1|||
105771999|NCT03325010|364815610|FG000|Overall Study|Lack of Efficacy|2|||
105772000|NCT03325010|364815611|FG001|Overall Study|Lack of Efficacy|0|||
105772001|NCT00712270|364815618|FG000|Overall Study|Withdrawal by Subject|11|||
105772002|NCT00712270|364815618|FG000|Overall Study|Screen Failure|3|||
105772003|NCT01060124|364815620|FG000|Overall Study|Other|16|||
105772004|NCT01060124|364815620|FG000|Overall Study|Adverse Event|14|||
105772005|NCT01060124|364815620|FG000|Overall Study|Withdrawal by Subject|7|||
105772006|NCT00901394|364815622|FG000|Overall Study|Physician Decision|1|||
105772007|NCT00901394|364815623|FG001|Overall Study|Physician Decision|1|||
105772008|NCT00901394|364815624|FG002|Overall Study|Physician Decision|2|||
105772009|NCT00102804|364815628|FG000|Overall Study|Progressive Disease (PD)|307|||
105772010|NCT00102804|364815629|FG001|Overall Study|Progressive Disease (PD)|196|||
105772011|NCT00102804|364815628|FG000|Overall Study|Withdrawal by Subject|46|||
105772012|NCT00102804|364815629|FG001|Overall Study|Withdrawal by Subject|7|||
105772013|NCT00102804|364815628|FG000|Overall Study|Adverse Event|37|||
105772014|NCT00102804|364815629|FG001|Overall Study|Adverse Event|3|||
105772015|NCT00102804|364815628|FG000|Overall Study|Physician Decision|24|||
105772016|NCT00102804|364815629|FG001|Overall Study|Physician Decision|6|||
105772017|NCT00102804|364815628|FG000|Overall Study|Death|5|||
105772018|NCT00102804|364815629|FG001|Overall Study|Death|6|||
105772019|NCT00102804|364815628|FG000|Overall Study|Enrollment Criteria Not Met|6|||
105772020|NCT00102804|364815629|FG001|Overall Study|Enrollment Criteria Not Met|0|||
105772021|NCT00102804|364815628|FG000|Overall Study|Lost to Follow-up|4|||
105772022|NCT00102804|364815629|FG001|Overall Study|Lost to Follow-up|1|||
105772023|NCT00102804|364815628|FG000|Overall Study|Protocol Violation|2|||
105772024|NCT00102804|364815629|FG001|Overall Study|Protocol Violation|1|||
105772025|NCT00102804|364815628|FG000|Overall Study|Satisfactory Response|2|||
105772026|NCT00102804|364815629|FG001|Overall Study|Satisfactory Response|0|||
105772027|NCT00102804|364815628|FG000|Overall Study|Sponsor Decision|1|||
105772028|NCT00102804|364815629|FG001|Overall Study|Sponsor Decision|0|||
105772029|NCT00102804|364815628|FG000|Overall Study|Alive, Receiving Treatment|7|||
105772030|NCT00102804|364815629|FG001|Overall Study|Alive, Receiving Treatment|2|||
105772031|NCT03858686|364815630|FG000|Period 1|Adverse Event|1|||
105772032|NCT03858686|364815631|FG001|Period 1|Adverse Event|1|||
105772033|NCT03858686|364815630|FG000|Period 1|Lack of compliance|0|||
105772034|NCT03858686|364815631|FG001|Period 1|Lack of compliance|1|||
105772035|NCT03858686|364815630|FG000|Period 1|Adverse Event|0|||
105772036|NCT03858686|364815631|FG001|Period 1|Adverse Event|1|||
105772037|NCT03858686|364815630|FG000|Period 2|Adverse Event|0|||
105772038|NCT03858686|364815631|FG001|Period 2|Adverse Event|1|||
105772039|NCT00542425|364815633|FG000|Initial 24 Weeks|Administrative reasons|0|||
105772040|NCT00542425|364815634|FG001|Initial 24 Weeks|Administrative reasons|0|||
105772041|NCT00542425|364815635|FG002|Initial 24 Weeks|Administrative reasons|1|||
105772042|NCT00542425|364815636|FG003|Initial 24 Weeks|Administrative reasons|1|||
105772043|NCT00542425|364815637|FG004|Initial 24 Weeks|Administrative reasons|0|||
105772044|NCT00542425|364815633|FG000|Initial 24 Weeks|Adverse Event|0|||
105772045|NCT00542425|364815634|FG001|Initial 24 Weeks|Adverse Event|1|||
105772046|NCT00542425|364815635|FG002|Initial 24 Weeks|Adverse Event|1|||
105772047|NCT00542425|364815636|FG003|Initial 24 Weeks|Adverse Event|3|||
105772048|NCT00542425|364815637|FG004|Initial 24 Weeks|Adverse Event|2|||
105772049|NCT00542425|364815633|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
105772050|NCT00542425|364815634|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
105772051|NCT00542425|364815635|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
105772052|NCT00542425|364815636|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
105772053|NCT00542425|364815637|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
105772054|NCT00542425|364815633|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
105772055|NCT00542425|364815634|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
105772056|NCT00542425|364815635|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
105772057|NCT00542425|364815636|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
105772058|NCT00542425|364815637|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
105772059|NCT00542425|364815633|FG000|Initial 24 Weeks|Non-compliance|0|||
105772060|NCT00542425|364815634|FG001|Initial 24 Weeks|Non-compliance|0|||
105772061|NCT00542425|364815635|FG002|Initial 24 Weeks|Non-compliance|0|||
105772062|NCT00542425|364815636|FG003|Initial 24 Weeks|Non-compliance|1|||
105772063|NCT00542425|364815637|FG004|Initial 24 Weeks|Non-compliance|1|||
105772064|NCT00542425|364815633|FG000|Initial 24 Weeks|Protocol Violation|0|||
105772065|NCT00542425|364815634|FG001|Initial 24 Weeks|Protocol Violation|0|||
105772066|NCT00542425|364815635|FG002|Initial 24 Weeks|Protocol Violation|0|||
105772067|NCT00542425|364815636|FG003|Initial 24 Weeks|Protocol Violation|1|||
105772068|NCT00542425|364815637|FG004|Initial 24 Weeks|Protocol Violation|0|||
105772069|NCT00542425|364815633|FG000|Initial 24 Weeks|Refusal of treatment|2|||
105772070|NCT00542425|364815634|FG001|Initial 24 Weeks|Refusal of treatment|2|||
105772071|NCT00542425|364815635|FG002|Initial 24 Weeks|Refusal of treatment|1|||
105772072|NCT00542425|364815636|FG003|Initial 24 Weeks|Refusal of treatment|4|||
105772073|NCT00542425|364815637|FG004|Initial 24 Weeks|Refusal of treatment|1|||
105772074|NCT00542425|364815633|FG000|Initial 24 Weeks|Other|0|||
105772075|NCT00542425|364815634|FG001|Initial 24 Weeks|Other|2|||
105772076|NCT00542425|364815635|FG002|Initial 24 Weeks|Other|1|||
105772077|NCT00542425|364815636|FG003|Initial 24 Weeks|Other|0|||
105772078|NCT00542425|364815637|FG004|Initial 24 Weeks|Other|0|||
105772079|NCT00542425|364815633|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
105772080|NCT00542425|364815634|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
105772081|NCT00542425|364815635|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
105772082|NCT00542425|364815636|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
105772083|NCT00542425|364815637|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
105772084|NCT00542425|364815633|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
105772085|NCT00542425|364815634|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
105772086|NCT00542425|364815635|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
105772087|NCT00542425|364815636|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
105772088|NCT00542425|364815637|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
105772089|NCT00542425|364815633|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
105772090|NCT00542425|364815634|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
105772091|NCT00542425|364815635|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
105772092|NCT00542425|364815636|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
105772093|NCT00542425|364815637|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
105772094|NCT00542425|364815633|FG000|Extended 24 Weeks of Treatment|Other|1|||
105772095|NCT00542425|364815634|FG001|Extended 24 Weeks of Treatment|Other|1|||
105772096|NCT00542425|364815635|FG002|Extended 24 Weeks of Treatment|Other|0|||
105772097|NCT00542425|364815636|FG003|Extended 24 Weeks of Treatment|Other|0|||
105772098|NCT00542425|364815637|FG004|Extended 24 Weeks of Treatment|Other|1|||
105772099|NCT01432938|364815638|FG000|First Intervention|Protocol Violation|1|||
105772100|NCT01432938|364815639|FG001|First Intervention|Protocol Violation|0|||
105772101|NCT01432938|364815638|FG000|First Intervention|Physician Decision|1|||
105772102|NCT01432938|364815639|FG001|First Intervention|Physician Decision|0|||
105772103|NCT01432938|364815638|FG000|Second Intervention|Adverse Event|1|||
105772104|NCT01432938|364815639|FG001|Second Intervention|Adverse Event|0|||
105772105|NCT01868594|364815640|FG000|Overall Study|Do not meet inclusion criteria|4|||
105772106|NCT01868594|364815641|FG001|Overall Study|Do not meet inclusion criteria|3|||
105772107|NCT04964557|364815642|FG000|Overall Study|Withdrawal by Subject|3|||
105772108|NCT04964557|364815643|FG001|Overall Study|Withdrawal by Subject|2|||
105772109|NCT04964557|364815642|FG000|Overall Study|Lost to Follow-up|1|||
105772110|NCT04964557|364815643|FG001|Overall Study|Lost to Follow-up|2|||
105772111|NCT04964557|364815642|FG000|Overall Study|Physician Decision|2|||
105772112|NCT04964557|364815643|FG001|Overall Study|Physician Decision|0|||
105772113|NCT04964557|364815642|FG000|Overall Study|Death|3|||
105772114|NCT04964557|364815643|FG001|Overall Study|Death|0|||
105772115|NCT04964557|364815642|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
105772116|NCT04964557|364815643|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
105772117|NCT04363944|364815644|FG000|Overall Study|Withdrawal by Subject|2|||
105772118|NCT04363944|364815645|FG001|Overall Study|Withdrawal by Subject|0|||
105772119|NCT05643170|364817539|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
105772120|NCT05643170|364817539|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
105772121|NCT02358863|364817540|FG000|Overall Study|Physician Decision|3|||
105772122|NCT05426460|364817546|FG000|Overall Study|Protocol Violation|1|||
105772123|NCT05426460|364817547|FG001|Overall Study|Protocol Violation|1|||
105772124|NCT05426460|364817548|FG002|Overall Study|Protocol Violation|1|||
105772125|NCT05426460|364817549|FG003|Overall Study|Protocol Violation|0|||
105772126|NCT03793010|364817550|FG000|Overall Study|Withdrawal by Subject|5|||
105772127|NCT03793010|364817551|FG001|Overall Study|Withdrawal by Subject|7|||
105772128|NCT03793010|364817550|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
105772129|NCT03793010|364817551|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
105772130|NCT03793010|364817550|FG000|Overall Study|Lost to Follow-up|1|||
105772131|NCT03793010|364817551|FG001|Overall Study|Lost to Follow-up|2|||
105772132|NCT03793010|364817550|FG000|Overall Study|Patient couldn't sit still for injection|1|||
105772133|NCT03793010|364817551|FG001|Overall Study|Patient couldn't sit still for injection|0|||
105772134|NCT03793010|364817550|FG000|Overall Study|Withdrew to pursue other treatment|1|||
105772135|NCT03793010|364817551|FG001|Overall Study|Withdrew to pursue other treatment|0|||
105772136|NCT03793010|364817550|FG000|Overall Study|Did not meet eligibility criteria|1|||
105772137|NCT03793010|364817551|FG001|Overall Study|Did not meet eligibility criteria|0|||
105772138|NCT01572844|364817552|FG000|Overall Study|Physician Decision|1|||
105772139|NCT01572844|364817553|FG001|Overall Study|Physician Decision|1|||
105772140|NCT01320033|364817554|FG000|Overall Study|Lack of Efficacy|0|||
105772141|NCT01320033|364817555|FG001|Overall Study|Lack of Efficacy|0|||
105772142|NCT01320033|364817556|FG002|Overall Study|Lack of Efficacy|1|||
105772143|NCT01320033|364817554|FG000|Overall Study|Adverse Event|9|||
105772144|NCT01320033|364817555|FG001|Overall Study|Adverse Event|7|||
105772145|NCT01320033|364817556|FG002|Overall Study|Adverse Event|8|||
105772146|NCT01320033|364817554|FG000|Overall Study|Withdrawal by Subject|22|||
105772147|NCT01320033|364817555|FG001|Overall Study|Withdrawal by Subject|23|||
105772148|NCT01320033|364817556|FG002|Overall Study|Withdrawal by Subject|23|||
105772149|NCT01320033|364817554|FG000|Overall Study|Protocol Violation|3|||
105772150|NCT01320033|364817555|FG001|Overall Study|Protocol Violation|5|||
105772151|NCT01320033|364817556|FG002|Overall Study|Protocol Violation|3|||
105772152|NCT01320033|364817554|FG000|Overall Study|Lost to Follow-up|22|||
105772153|NCT01320033|364817555|FG001|Overall Study|Lost to Follow-up|26|||
105772154|NCT01320033|364817556|FG002|Overall Study|Lost to Follow-up|17|||
105772155|NCT01320033|364817554|FG000|Overall Study|Other|2|||
105772156|NCT01320033|364817555|FG001|Overall Study|Other|3|||
105772157|NCT01320033|364817556|FG002|Overall Study|Other|1|||
105772158|NCT04960202|364817560|FG000|Overall Study|Other|5|||
105772159|NCT04960202|364817561|FG001|Overall Study|Other|0|||
105772160|NCT04960202|364817560|FG000|Overall Study|Withdrawal by Subject|37|||
105772161|NCT04960202|364817561|FG001|Overall Study|Withdrawal by Subject|43|||
105772162|NCT04960202|364817560|FG000|Overall Study|Lost to Follow-up|20|||
105772163|NCT04960202|364817561|FG001|Overall Study|Lost to Follow-up|16|||
105772164|NCT04960202|364817560|FG000|Overall Study|Death|0|||
105772165|NCT04960202|364817561|FG001|Overall Study|Death|15|||
105772166|NCT00378534|364817563|FG000|Overall Study|Participants did not receive transplant|3|||
105772167|NCT00378534|364817564|FG001|Overall Study|Participants did not receive transplant|0|||
105772168|NCT03176134|364817571|FG000|Overall Study|Lost to Follow-up|0|||
105772169|NCT03176134|364817572|FG001|Overall Study|Lost to Follow-up|2|||
105772170|NCT03176134|364817573|FG002|Overall Study|Lost to Follow-up|0|||
105772171|NCT03176134|364817574|FG003|Overall Study|Lost to Follow-up|0|||
105772172|NCT03176134|364817575|FG004|Overall Study|Lost to Follow-up|0|||
105772173|NCT03176134|364817576|FG005|Overall Study|Lost to Follow-up|0|||
105772174|NCT03176134|364817577|FG006|Overall Study|Lost to Follow-up|0|||
105772175|NCT03176134|364817578|FG007|Overall Study|Lost to Follow-up|0|||
105772176|NCT03176134|364817571|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
105772177|NCT03176134|364817572|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105772178|NCT03176134|364817573|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
105772179|NCT03176134|364817574|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
105772180|NCT03176134|364817575|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
105772181|NCT03176134|364817576|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
105772182|NCT03176134|364817577|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
105772183|NCT03176134|364817578|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
105772184|NCT04566445|364817579|FG000|Overall Study|Death|4|||
105772185|NCT04566445|364817580|FG001|Overall Study|Death|1|||
105772186|NCT04566445|364817581|FG002|Overall Study|Death|1|||
105772187|NCT04566445|364817579|FG000|Overall Study|Lost to Follow-up|3|||
105772188|NCT04566445|364817580|FG001|Overall Study|Lost to Follow-up|1|||
105772189|NCT04566445|364817581|FG002|Overall Study|Lost to Follow-up|1|||
105772190|NCT04566445|364817579|FG000|Overall Study|Study terminated by sponsor|11|||
105772191|NCT04566445|364817580|FG001|Overall Study|Study terminated by sponsor|17|||
105772192|NCT04566445|364817581|FG002|Overall Study|Study terminated by sponsor|32|||
105772193|NCT04566445|364817579|FG000|Overall Study|Withdrawal by Subject|12|||
105772194|NCT04566445|364817580|FG001|Overall Study|Withdrawal by Subject|14|||
105772195|NCT04566445|364817581|FG002|Overall Study|Withdrawal by Subject|13|||
105772196|NCT04566445|364817579|FG000|Overall Study|Randomized but not treated due to AE|2|||
105772197|NCT04566445|364817580|FG001|Overall Study|Randomized but not treated due to AE|1|||
105772198|NCT04566445|364817581|FG002|Overall Study|Randomized but not treated due to AE|0|||
105772199|NCT04566445|364817579|FG000|Overall Study|Adverse Event|1|||
105772200|NCT04566445|364817580|FG001|Overall Study|Adverse Event|1|||
105772201|NCT04566445|364817581|FG002|Overall Study|Adverse Event|0|||
105772202|NCT04785144|364817582|FG000|Overall Study|Withdrawal by Subject|4|||
105772203|NCT04785144|364817583|FG001|Overall Study|Withdrawal by Subject|1|||
105772204|NCT04785144|364817584|FG002|Overall Study|Withdrawal by Subject|0|||
105772205|NCT04785144|364817585|FG003|Overall Study|Withdrawal by Subject|0|||
105772206|NCT04785144|364817586|FG004|Overall Study|Withdrawal by Subject|0|||
105772207|NCT04785144|364817587|FG005|Overall Study|Withdrawal by Subject|2|||
105772208|NCT04785144|364817588|FG006|Overall Study|Withdrawal by Subject|2|||
105772209|NCT04785144|364817589|FG007|Overall Study|Withdrawal by Subject|0|||
105772210|NCT04785144|364817590|FG008|Overall Study|Withdrawal by Subject|1|||
105772211|NCT04785144|364817591|FG009|Overall Study|Withdrawal by Subject|0|||
105772212|NCT04785144|364817582|FG000|Overall Study|Lost to Follow-up|1|||
105772213|NCT04785144|364817583|FG001|Overall Study|Lost to Follow-up|0|||
105772214|NCT04785144|364817584|FG002|Overall Study|Lost to Follow-up|0|||
105772215|NCT04785144|364817585|FG003|Overall Study|Lost to Follow-up|0|||
105772216|NCT04785144|364817586|FG004|Overall Study|Lost to Follow-up|1|||
105772217|NCT04785144|364817587|FG005|Overall Study|Lost to Follow-up|2|||
105772218|NCT04785144|364817588|FG006|Overall Study|Lost to Follow-up|1|||
105772219|NCT04785144|364817589|FG007|Overall Study|Lost to Follow-up|2|||
105772220|NCT04785144|364817590|FG008|Overall Study|Lost to Follow-up|4|||
105772221|NCT04785144|364817591|FG009|Overall Study|Lost to Follow-up|1|||
105772222|NCT04785144|364817582|FG000|Overall Study|Protocol Violation|0|||
105772223|NCT04785144|364817583|FG001|Overall Study|Protocol Violation|0|||
105772224|NCT04785144|364817584|FG002|Overall Study|Protocol Violation|0|||
105772225|NCT04785144|364817585|FG003|Overall Study|Protocol Violation|0|||
105772226|NCT04785144|364817586|FG004|Overall Study|Protocol Violation|0|||
105772227|NCT04785144|364817587|FG005|Overall Study|Protocol Violation|0|||
105772228|NCT04785144|364817588|FG006|Overall Study|Protocol Violation|1|||
105772229|NCT04785144|364817589|FG007|Overall Study|Protocol Violation|0|||
105772230|NCT04785144|364817590|FG008|Overall Study|Protocol Violation|0|||
105772231|NCT04785144|364817591|FG009|Overall Study|Protocol Violation|0|||
105772232|NCT04785144|364817582|FG000|Overall Study|Physician Decision|0|||
105772233|NCT04785144|364817583|FG001|Overall Study|Physician Decision|0|||
105772234|NCT04785144|364817584|FG002|Overall Study|Physician Decision|0|||
105772235|NCT04785144|364817585|FG003|Overall Study|Physician Decision|0|||
105772236|NCT04785144|364817586|FG004|Overall Study|Physician Decision|0|||
105772237|NCT04785144|364817587|FG005|Overall Study|Physician Decision|0|||
105772238|NCT04785144|364817588|FG006|Overall Study|Physician Decision|0|||
105772239|NCT04785144|364817589|FG007|Overall Study|Physician Decision|0|||
105772240|NCT04785144|364817590|FG008|Overall Study|Physician Decision|0|||
105772241|NCT04785144|364817591|FG009|Overall Study|Physician Decision|1|||
105772242|NCT04785144|364817582|FG000|Overall Study|Unable to continue due to work schedule|0|||
105772243|NCT04785144|364817583|FG001|Overall Study|Unable to continue due to work schedule|0|||
105772244|NCT04785144|364817584|FG002|Overall Study|Unable to continue due to work schedule|0|||
105772245|NCT04785144|364817585|FG003|Overall Study|Unable to continue due to work schedule|0|||
105772246|NCT04785144|364817586|FG004|Overall Study|Unable to continue due to work schedule|0|||
105772247|NCT04785144|364817587|FG005|Overall Study|Unable to continue due to work schedule|0|||
105772248|NCT04785144|364817588|FG006|Overall Study|Unable to continue due to work schedule|0|||
105772249|NCT04785144|364817589|FG007|Overall Study|Unable to continue due to work schedule|0|||
105772250|NCT04785144|364817590|FG008|Overall Study|Unable to continue due to work schedule|0|||
105772251|NCT04785144|364817591|FG009|Overall Study|Unable to continue due to work schedule|1|||
105772252|NCT01263470|364817592|FG000|Overall Study|Adverse Event|2|||
105772253|NCT01263470|364817593|FG001|Overall Study|Adverse Event|2|||
105772254|NCT01263470|364817594|FG002|Overall Study|Adverse Event|1|||
105772255|NCT01263470|364817595|FG003|Overall Study|Adverse Event|1|||
105772256|NCT01263470|364817596|FG004|Overall Study|Adverse Event|2|||
105772257|NCT01263470|364817597|FG005|Overall Study|Adverse Event|2|||
105772258|NCT01263470|364817592|FG000|Overall Study|Protocol Violation|0|||
105772259|NCT01263470|364817593|FG001|Overall Study|Protocol Violation|1|||
105772260|NCT01263470|364817594|FG002|Overall Study|Protocol Violation|0|||
105772261|NCT01263470|364817595|FG003|Overall Study|Protocol Violation|0|||
105772262|NCT01263470|364817596|FG004|Overall Study|Protocol Violation|0|||
105772263|NCT01263470|364817597|FG005|Overall Study|Protocol Violation|1|||
105772264|NCT01263470|364817592|FG000|Overall Study|Withdrawal by Subject|0|||
105772265|NCT01263470|364817593|FG001|Overall Study|Withdrawal by Subject|1|||
105772266|NCT01263470|364817594|FG002|Overall Study|Withdrawal by Subject|1|||
105772267|NCT01263470|364817595|FG003|Overall Study|Withdrawal by Subject|2|||
105772268|NCT01263470|364817596|FG004|Overall Study|Withdrawal by Subject|0|||
105772269|NCT01263470|364817597|FG005|Overall Study|Withdrawal by Subject|2|||
105772270|NCT01263470|364817592|FG000|Overall Study|Lack of Efficacy|0|||
105772271|NCT01263470|364817593|FG001|Overall Study|Lack of Efficacy|0|||
105772272|NCT01263470|364817594|FG002|Overall Study|Lack of Efficacy|2|||
105772273|NCT01263470|364817595|FG003|Overall Study|Lack of Efficacy|0|||
105772274|NCT01263470|364817596|FG004|Overall Study|Lack of Efficacy|0|||
105772275|NCT01263470|364817597|FG005|Overall Study|Lack of Efficacy|0|||
105772276|NCT01263470|364817592|FG000|Overall Study|Participant Unavailability|0|||
105772277|NCT01263470|364817593|FG001|Overall Study|Participant Unavailability|1|||
105772278|NCT01263470|364817594|FG002|Overall Study|Participant Unavailability|0|||
105772279|NCT01263470|364817595|FG003|Overall Study|Participant Unavailability|0|||
105772280|NCT01263470|364817596|FG004|Overall Study|Participant Unavailability|0|||
105772281|NCT01263470|364817597|FG005|Overall Study|Participant Unavailability|0|||
105772282|NCT01263470|364817592|FG000|Overall Study|Study Drug Non-compliance|0|||
105772283|NCT01263470|364817593|FG001|Overall Study|Study Drug Non-compliance|0|||
105772284|NCT01263470|364817594|FG002|Overall Study|Study Drug Non-compliance|0|||
105772285|NCT01263470|364817595|FG003|Overall Study|Study Drug Non-compliance|0|||
105772286|NCT01263470|364817596|FG004|Overall Study|Study Drug Non-compliance|1|||
105772287|NCT01263470|364817597|FG005|Overall Study|Study Drug Non-compliance|0|||
105772288|NCT01327573|364817598|FG000|Overall Study|Physician Decision|3|||
105772289|NCT01327573|364817599|FG001|Overall Study|Physician Decision|1|||
105772290|NCT01685372|364817600|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
105772291|NCT01685372|364817601|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
105772292|NCT00853112|364817605|FG000|Overall Study|Randomized but not treated|0|||
105772293|NCT00853112|364817606|FG001|Overall Study|Randomized but not treated|1|||
105772294|NCT00853112|364817607|FG002|Overall Study|Randomized but not treated|0|||
105772295|NCT00853112|364817608|FG003|Overall Study|Randomized but not treated|2|||
105772296|NCT00853112|364817609|FG004|Overall Study|Randomized but not treated|0|||
105772297|NCT00853112|364817610|FG005|Overall Study|Randomized but not treated|0|||
105772298|NCT00853112|364817611|FG006|Overall Study|Randomized but not treated|1|||
105772299|NCT01553591|364817612|FG000|Overall Study|Voluntarily withdrew|94|||
105772300|NCT01553591|364817613|FG001|Overall Study|Voluntarily withdrew|79|||
105772301|NCT01553591|364817614|FG002|Overall Study|Voluntarily withdrew|96|||
105772302|NCT01553591|364817612|FG000|Overall Study|Adverse Event|36|||
105772303|NCT01553591|364817613|FG001|Overall Study|Adverse Event|45|||
105772304|NCT01553591|364817614|FG002|Overall Study|Adverse Event|16|||
105772305|NCT01553591|364817612|FG000|Overall Study|Lost to Follow-up|25|||
105772306|NCT01553591|364817613|FG001|Overall Study|Lost to Follow-up|23|||
105772307|NCT01553591|364817614|FG002|Overall Study|Lost to Follow-up|16|||
105772308|NCT01553591|364817612|FG000|Overall Study|Physician decision: other|11|||
105772309|NCT01553591|364817613|FG001|Overall Study|Physician decision: other|14|||
105772310|NCT01553591|364817614|FG002|Overall Study|Physician decision: other|16|||
105772311|NCT01553591|364817612|FG000|Overall Study|Physician decision: lack of efficacy|2|||
105772312|NCT01553591|364817613|FG001|Overall Study|Physician decision: lack of efficacy|3|||
105772313|NCT01553591|364817614|FG002|Overall Study|Physician decision: lack of efficacy|7|||
105772314|NCT01553591|364817612|FG000|Overall Study|Protocol Violation|3|||
105772315|NCT01553591|364817613|FG001|Overall Study|Protocol Violation|4|||
105772316|NCT01553591|364817614|FG002|Overall Study|Protocol Violation|4|||
105772317|NCT01553591|364817612|FG000|Overall Study|Sponsor decision|1|||
105772318|NCT01553591|364817613|FG001|Overall Study|Sponsor decision|0|||
105772319|NCT01553591|364817614|FG002|Overall Study|Sponsor decision|3|||
105772320|NCT01553591|364817612|FG000|Overall Study|Randomized and never dispensed drug|0|||
105772321|NCT01553591|364817613|FG001|Overall Study|Randomized and never dispensed drug|1|||
105772322|NCT01553591|364817614|FG002|Overall Study|Randomized and never dispensed drug|0|||
105772323|NCT04005755|364817615|FG000|Overall Study|Adverse Event|6|||
105772324|NCT04005755|364817615|FG000|Overall Study|Physician Decision|3|||
105772325|NCT04005755|364817615|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
105772326|NCT04005755|364817615|FG000|Overall Study|Withdrawal by Subject|3|||
105772327|NCT04005755|364817615|FG000|Overall Study|Lost to Follow-up|1|||
105772328|NCT02723019|364817616|FG000|Overall Study|Death|17|||
105772329|NCT02723019|364817617|FG001|Overall Study|Death|13|||
105772330|NCT02723019|364817616|FG000|Overall Study|Withdrawal by Subject|11|||
105772331|NCT02723019|364817617|FG001|Overall Study|Withdrawal by Subject|7|||
105772332|NCT02723019|364817616|FG000|Overall Study|Lost to Follow-up|57|||
105772333|NCT02723019|364817617|FG001|Overall Study|Lost to Follow-up|70|||
105772334|NCT00958191|364817619|FG000|Overall Study|Death|4|||
105772335|NCT00958191|364817619|FG000|Overall Study|Lost to Follow-up|5|||
105772336|NCT00958191|364817619|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
105772337|NCT00958191|364817619|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
105772338|NCT00958191|364817619|FG000|Overall Study|Revision of study device|4|||
105772339|NCT00958191|364817619|FG000|Overall Study|Site termination|11|||
105772340|NCT00958191|364817619|FG000|Overall Study|No 5 yr x-rays|56|||
105772341|NCT00592072|364817620|FG000|Wash Out Period|Lost to Follow-up|1|||
105772342|NCT00592072|364817621|FG001|Wash Out Period|Lost to Follow-up|1|||
105772343|NCT01818765|364817622|FG000|Overall Study|Death|2|||
105772344|NCT01196091|364817629|FG000|Overall Study|Adverse Event|22|||
105772345|NCT01196091|364817630|FG001|Overall Study|Adverse Event|27|||
105772346|NCT01196091|364817631|FG002|Overall Study|Adverse Event|26|||
105772347|NCT01196091|364817629|FG000|Overall Study|Death|3|||
105772348|NCT01196091|364817630|FG001|Overall Study|Death|2|||
105772349|NCT01196091|364817631|FG002|Overall Study|Death|2|||
105772350|NCT01196091|364817629|FG000|Overall Study|Entry Criteria Not Met|11|||
105772351|NCT01196091|364817630|FG001|Overall Study|Entry Criteria Not Met|11|||
105772352|NCT01196091|364817631|FG002|Overall Study|Entry Criteria Not Met|10|||
105772353|NCT01196091|364817629|FG000|Overall Study|Lack of Efficacy|15|||
105772354|NCT01196091|364817630|FG001|Overall Study|Lack of Efficacy|12|||
105772355|NCT01196091|364817631|FG002|Overall Study|Lack of Efficacy|17|||
105772356|NCT01196091|364817629|FG000|Overall Study|Lost to Follow-up|5|||
105772357|NCT01196091|364817630|FG001|Overall Study|Lost to Follow-up|5|||
105772358|NCT01196091|364817631|FG002|Overall Study|Lost to Follow-up|6|||
105772359|NCT01196091|364817629|FG000|Overall Study|Parent/Caregiver Decision|0|||
105772360|NCT01196091|364817630|FG001|Overall Study|Parent/Caregiver Decision|0|||
105772361|NCT01196091|364817631|FG002|Overall Study|Parent/Caregiver Decision|1|||
105772362|NCT01196091|364817629|FG000|Overall Study|Withdrawal by Subject|16|||
105772363|NCT01196091|364817630|FG001|Overall Study|Withdrawal by Subject|19|||
105772364|NCT01196091|364817631|FG002|Overall Study|Withdrawal by Subject|22|||
105772365|NCT01196091|364817629|FG000|Overall Study|Physician Decision|3|||
105772366|NCT01196091|364817630|FG001|Overall Study|Physician Decision|3|||
105772367|NCT01196091|364817631|FG002|Overall Study|Physician Decision|4|||
105772368|NCT01196091|364817629|FG000|Overall Study|Protocol Violation|1|||
105772369|NCT01196091|364817630|FG001|Overall Study|Protocol Violation|3|||
105772370|NCT01196091|364817631|FG002|Overall Study|Protocol Violation|3|||
105772371|NCT01196091|364817629|FG000|Overall Study|Sponsor Decision|6|||
105772372|NCT01196091|364817630|FG001|Overall Study|Sponsor Decision|5|||
105772373|NCT01196091|364817631|FG002|Overall Study|Sponsor Decision|4|||
105772374|NCT01196091|364817629|FG000|Overall Study|Excluded Site|5|||
105772375|NCT01196091|364817630|FG001|Overall Study|Excluded Site|11|||
105772376|NCT01196091|364817631|FG002|Overall Study|Excluded Site|8|||
105772377|NCT01196091|364817629|FG000|Overall Study|Randomized, No Study Drug Received|1|||
105772378|NCT01196091|364817630|FG001|Overall Study|Randomized, No Study Drug Received|0|||
105772379|NCT01196091|364817631|FG002|Overall Study|Randomized, No Study Drug Received|1|||
105772380|NCT02202161|364817632|FG000|Overall Study|Adverse Event|1|||
105772381|NCT02202161|364817633|FG001|Overall Study|Adverse Event|1|||
105772382|NCT02202161|364817634|FG002|Overall Study|Adverse Event|0|||
105772383|NCT02202161|364817635|FG003|Overall Study|Adverse Event|0|||
105772384|NCT02202161|364817636|FG004|Overall Study|Adverse Event|0|||
105772385|NCT02202161|364817637|FG005|Overall Study|Adverse Event|1|||
105772386|NCT02202161|364817638|FG006|Overall Study|Adverse Event|0|||
105772387|NCT02202161|364817639|FG007|Overall Study|Adverse Event|0|||
105772388|NCT02202161|364817632|FG000|Overall Study|Did not meet continuation criteria|0|||
105772389|NCT02202161|364817633|FG001|Overall Study|Did not meet continuation criteria|0|||
105772390|NCT02202161|364817634|FG002|Overall Study|Did not meet continuation criteria|0|||
105772391|NCT02202161|364817635|FG003|Overall Study|Did not meet continuation criteria|0|||
105772392|NCT02202161|364817636|FG004|Overall Study|Did not meet continuation criteria|0|||
105772393|NCT02202161|364817637|FG005|Overall Study|Did not meet continuation criteria|0|||
105772394|NCT02202161|364817638|FG006|Overall Study|Did not meet continuation criteria|0|||
105772395|NCT02202161|364817639|FG007|Overall Study|Did not meet continuation criteria|3|||
105772396|NCT02202161|364817632|FG000|Overall Study|Physician Decision|0|||
105772397|NCT02202161|364817633|FG001|Overall Study|Physician Decision|0|||
105772398|NCT02202161|364817634|FG002|Overall Study|Physician Decision|0|||
105772399|NCT02202161|364817635|FG003|Overall Study|Physician Decision|0|||
105772400|NCT02202161|364817636|FG004|Overall Study|Physician Decision|0|||
105772401|NCT02202161|364817637|FG005|Overall Study|Physician Decision|0|||
105772402|NCT02202161|364817638|FG006|Overall Study|Physician Decision|0|||
105772403|NCT02202161|364817639|FG007|Overall Study|Physician Decision|3|||
105772404|NCT02202161|364817632|FG000|Overall Study|Withdrawal by Subject|0|||
105772405|NCT02202161|364817633|FG001|Overall Study|Withdrawal by Subject|0|||
105772406|NCT02202161|364817634|FG002|Overall Study|Withdrawal by Subject|0|||
105772407|NCT02202161|364817635|FG003|Overall Study|Withdrawal by Subject|0|||
105772408|NCT02202161|364817636|FG004|Overall Study|Withdrawal by Subject|1|||
105772409|NCT02202161|364817637|FG005|Overall Study|Withdrawal by Subject|0|||
105772410|NCT02202161|364817638|FG006|Overall Study|Withdrawal by Subject|0|||
105772411|NCT02202161|364817639|FG007|Overall Study|Withdrawal by Subject|0|||
105772412|NCT03323086|364817640|FG000|Overall Study|Lost to Follow-up|3|||
105772413|NCT03323086|364817641|FG001|Overall Study|Lost to Follow-up|2|||
105772414|NCT00832091|364817649|FG000|Overall Study|Adverse Event|1|||
105772415|NCT00832091|364817650|FG001|Overall Study|Adverse Event|1|||
105772416|NCT00832091|364817649|FG000|Overall Study|Protocol Violation|1|||
105772417|NCT00832091|364817650|FG001|Overall Study|Protocol Violation|0|||
105772418|NCT00832091|364817649|FG000|Overall Study|Withdrawal by Subject|2|||
105772419|NCT00832091|364817650|FG001|Overall Study|Withdrawal by Subject|1|||
105772420|NCT00832091|364817649|FG000|Overall Study|Prohibited Medication|1|||
105772421|NCT00832091|364817650|FG001|Overall Study|Prohibited Medication|0|||
105772422|NCT01756833|364817651|FG000|Overall Study|Withdrawal by Subject|4|||
105772423|NCT01756833|364817652|FG001|Overall Study|Withdrawal by Subject|3|||
105772424|NCT02181504|364817653|FG000|Overall Study|Adverse Event|1|||
105772425|NCT02181504|364817654|FG001|Overall Study|Adverse Event|1|||
105772426|NCT02181504|364817655|FG002|Overall Study|Adverse Event|1|||
105772427|NCT01010776|364817664|FG000|Main Phase|Withdrawal by Subject|14|||
105772428|NCT01010776|364817664|FG000|Main Phase|Lack of Efficacy|8|||
105772429|NCT01010776|364817664|FG000|Main Phase|Adverse Event|7|||
105772430|NCT01010776|364817664|FG000|Main Phase|Lost to Follow-up|6|||
105772431|NCT01010776|364817664|FG000|Main Phase|Non-compliance to study medication|5|||
105772432|NCT01010776|364817664|FG000|Main Phase|Selection failure|2|||
105772433|NCT01010776|364817664|FG000|Main Phase|Inform consent withdrawal|1|||
105772434|NCT01010776|364817664|FG000|Main Phase|Other|1|||
105772435|NCT01010776|364817664|FG000|Main Phase|Did not received study medication|5|||
105772436|NCT01010776|364817664|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
105772437|NCT01010776|364817664|FG000|Extension Phase|Other|3|||
105772438|NCT03954704|364817671|FG000|Overall Study|Death|1|||
105772439|NCT03954704|364817672|FG001|Overall Study|Death|1|||
105772440|NCT03954704|364817673|FG002|Overall Study|Death|1|||
105772441|NCT03954704|364817674|FG003|Overall Study|Death|3|||
105772442|NCT03954704|364817675|FG004|Overall Study|Death|2|||
105772443|NCT03954704|364817676|FG005|Overall Study|Death|2|||
105772444|NCT03954704|364817677|FG006|Overall Study|Death|0|||
105772445|NCT03954704|364817671|FG000|Overall Study|Withdrew Consent|0|||
105772446|NCT03954704|364817672|FG001|Overall Study|Withdrew Consent|0|||
105772447|NCT03954704|364817673|FG002|Overall Study|Withdrew Consent|1|||
105772448|NCT03954704|364817674|FG003|Overall Study|Withdrew Consent|0|||
105772449|NCT03954704|364817675|FG004|Overall Study|Withdrew Consent|0|||
105772450|NCT03954704|364817676|FG005|Overall Study|Withdrew Consent|1|||
105772451|NCT03954704|364817677|FG006|Overall Study|Withdrew Consent|0|||
105772452|NCT03954704|364817671|FG000|Overall Study|Lost to Follow-up|0|||
105772453|NCT03954704|364817672|FG001|Overall Study|Lost to Follow-up|0|||
105772454|NCT03954704|364817673|FG002|Overall Study|Lost to Follow-up|0|||
105772455|NCT03954704|364817674|FG003|Overall Study|Lost to Follow-up|0|||
105772456|NCT03954704|364817675|FG004|Overall Study|Lost to Follow-up|0|||
105772457|NCT03954704|364817676|FG005|Overall Study|Lost to Follow-up|0|||
105772458|NCT03954704|364817677|FG006|Overall Study|Lost to Follow-up|1|||
105772459|NCT03954704|364817671|FG000|Overall Study|Study Terminated by Sponsor|0|||
105772460|NCT03954704|364817672|FG001|Overall Study|Study Terminated by Sponsor|0|||
105772461|NCT03954704|364817673|FG002|Overall Study|Study Terminated by Sponsor|1|||
105772462|NCT03954704|364817674|FG003|Overall Study|Study Terminated by Sponsor|0|||
105772463|NCT03954704|364817675|FG004|Overall Study|Study Terminated by Sponsor|1|||
105772464|NCT03954704|364817676|FG005|Overall Study|Study Terminated by Sponsor|4|||
105772465|NCT03954704|364817677|FG006|Overall Study|Study Terminated by Sponsor|2|||
105772466|NCT03954704|364817671|FG000|Overall Study|Enrolled but not Treated|0|||
105772467|NCT03954704|364817672|FG001|Overall Study|Enrolled but not Treated|0|||
105772468|NCT03954704|364817673|FG002|Overall Study|Enrolled but not Treated|0|||
105772469|NCT03954704|364817674|FG003|Overall Study|Enrolled but not Treated|0|||
105772470|NCT03954704|364817675|FG004|Overall Study|Enrolled but not Treated|0|||
105772471|NCT03954704|364817676|FG005|Overall Study|Enrolled but not Treated|1|||
105772472|NCT03954704|364817677|FG006|Overall Study|Enrolled but not Treated|0|||
105772473|NCT02573012|364817680|FG000|Overall Study|Adverse Event|5|||
105772474|NCT02573012|364817681|FG001|Overall Study|Adverse Event|5|||
105772475|NCT02573012|364817680|FG000|Overall Study|Lack of Efficacy|5|||
105772476|NCT02573012|364817681|FG001|Overall Study|Lack of Efficacy|4|||
105772477|NCT02573012|364817680|FG000|Overall Study|Non-compliance|1|||
105772478|NCT02573012|364817681|FG001|Overall Study|Non-compliance|2|||
105772479|NCT02573012|364817680|FG000|Overall Study|Withdrawal by Subject|2|||
105772480|NCT02573012|364817681|FG001|Overall Study|Withdrawal by Subject|2|||
105772481|NCT02573012|364817680|FG000|Overall Study|Study Ended per Protocol|1|||
105772482|NCT02573012|364817681|FG001|Overall Study|Study Ended per Protocol|0|||
105772483|NCT02573012|364817680|FG000|Overall Study|Physician Decision|1|||
105772484|NCT02573012|364817681|FG001|Overall Study|Physician Decision|2|||
105772485|NCT01846208|364817682|FG000|Overall Study|Withdrew prior to treatment|1|||
105772486|NCT01846208|364817683|FG001|Overall Study|Withdrew prior to treatment|1|||
105772487|NCT01846208|364817684|FG002|Overall Study|Withdrew prior to treatment|1|||
105772488|NCT01846208|364817682|FG000|Overall Study|Dosing Symptoms|1|||
105772489|NCT01846208|364817683|FG001|Overall Study|Dosing Symptoms|2|||
105772490|NCT01846208|364817684|FG002|Overall Study|Dosing Symptoms|6|||
105772491|NCT01846208|364817682|FG000|Overall Study|Withdrawal by Subject|5|||
105772492|NCT01846208|364817683|FG001|Overall Study|Withdrawal by Subject|0|||
105772493|NCT01846208|364817684|FG002|Overall Study|Withdrawal by Subject|0|||
105772494|NCT01846208|364817682|FG000|Overall Study|Non-compliance|1|||
105772495|NCT01846208|364817683|FG001|Overall Study|Non-compliance|1|||
105772496|NCT01846208|364817684|FG002|Overall Study|Non-compliance|0|||
105772497|NCT01846208|364817682|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
105772498|NCT01846208|364817683|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
105772499|NCT01846208|364817684|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
105772500|NCT01846208|364817682|FG000|Overall Study|Refused SU OFC|0|||
105772501|NCT01846208|364817683|FG001|Overall Study|Refused SU OFC|0|||
105772502|NCT01846208|364817684|FG002|Overall Study|Refused SU OFC|1|||
105772503|NCT02736474|364817685|FG000|Overall Study|Lost to Follow-up|0|||
105772504|NCT02736474|364817686|FG001|Overall Study|Lost to Follow-up|1|||
105772505|NCT00703781|364817687|FG000|Overall Study|Withdrawal by Subject|1|||
105772506|NCT00703781|364817688|FG001|Overall Study|Withdrawal by Subject|2|||
105772507|NCT00703781|364817687|FG000|Overall Study|Cancelled surgery|1|||
105772508|NCT00703781|364817688|FG001|Overall Study|Cancelled surgery|0|||
105772509|NCT01682759|364817689|FG000|Overall Study|Death|2|||
105772510|NCT01682759|364817690|FG001|Overall Study|Death|1|||
105772511|NCT01682759|364817689|FG000|Overall Study|Lost to Follow-up|10|||
105772512|NCT01682759|364817690|FG001|Overall Study|Lost to Follow-up|13|||
105772513|NCT01682759|364817689|FG000|Overall Study|Physician Decision|1|||
105772514|NCT01682759|364817690|FG001|Overall Study|Physician Decision|1|||
105772515|NCT01682759|364817689|FG000|Overall Study|Withdrawal by Subject|56|||
105772516|NCT01682759|364817690|FG001|Overall Study|Withdrawal by Subject|55|||
105772517|NCT02691468|364817692|FG000|Overall Study|Bronchial blocker use|2|||
105772518|NCT02691468|364817693|FG001|Overall Study|Bronchial blocker use|1|||
105772519|NCT02691468|364817692|FG000|Overall Study|Lost to Follow-up|2|||
105772520|NCT02691468|364817693|FG001|Overall Study|Lost to Follow-up|1|||
105772521|NCT02691468|364817692|FG000|Overall Study|Failure to advance FOB|2|||
105772522|NCT02691468|364817693|FG001|Overall Study|Failure to advance FOB|0|||
105772523|NCT05815758|364819003|FG000|Overall Study|Adverse Event|6|||
105772524|NCT05815758|364819004|FG001|Overall Study|Adverse Event|2|||
105772525|NCT05815758|364819003|FG000|Overall Study|Lost to Follow-up|14|||
105772526|NCT05815758|364819004|FG001|Overall Study|Lost to Follow-up|1|||
105772527|NCT05815758|364819003|FG000|Overall Study|Withdrawal by Subject|6|||
105772528|NCT05815758|364819004|FG001|Overall Study|Withdrawal by Subject|6|||
105772529|NCT05815758|364819003|FG000|Overall Study|Protocol Violation|1|||
105772530|NCT05815758|364819004|FG001|Overall Study|Protocol Violation|1|||
105772531|NCT05815758|364819003|FG000|Overall Study|Discontinued|4|||
105772532|NCT05815758|364819004|FG001|Overall Study|Discontinued|4|||
105772533|NCT03661983|364819005|FG000|Open Label Stabilization Phase|Adverse Event|5|||
105772534|NCT03661983|364819006|FG001|Open Label Stabilization Phase|Adverse Event|0|||
105772535|NCT03661983|364819007|FG002|Open Label Stabilization Phase|Adverse Event|0|||
105772536|NCT03661983|364819008|FG003|Open Label Stabilization Phase|Adverse Event|0|||
105772537|NCT03661983|364819005|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
105772538|NCT03661983|364819006|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
105772539|NCT03661983|364819007|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
105772540|NCT03661983|364819008|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
105772541|NCT03661983|364819005|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
105772542|NCT03661983|364819006|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
105772543|NCT03661983|364819007|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
105772544|NCT03661983|364819008|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
105772545|NCT03661983|364819005|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
105772546|NCT03661983|364819006|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
105772547|NCT03661983|364819007|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
105772548|NCT03661983|364819008|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
105772549|NCT03661983|364819005|FG000|Double-blind Randomized Phase|Adverse Event|0|||
105772550|NCT03661983|364819006|FG001|Double-blind Randomized Phase|Adverse Event|1|||
105772551|NCT03661983|364819007|FG002|Double-blind Randomized Phase|Adverse Event|0|||
105772552|NCT03661983|364819008|FG003|Double-blind Randomized Phase|Adverse Event|0|||
105772553|NCT03661983|364819005|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
105772554|NCT03661983|364819006|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
105772555|NCT03661983|364819007|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
105772556|NCT03661983|364819008|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
105772557|NCT03661983|364819005|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
105772558|NCT03661983|364819006|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
105772559|NCT03661983|364819007|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
105772560|NCT03661983|364819008|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
105772561|NCT03661983|364819005|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
105772562|NCT03661983|364819006|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
105772563|NCT03661983|364819007|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
105772564|NCT03661983|364819008|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
105772565|NCT02903966|364819009|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
105772566|NCT02903966|364819010|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
105772567|NCT02903966|364819009|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
105772568|NCT02903966|364819010|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
105772569|NCT02903966|364819009|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
105772570|NCT02903966|364819010|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
105772571|NCT01077193|364819011|FG000|Overall Study|Lost to Follow-up|1|||
105772572|NCT01077193|364819011|FG000|Overall Study|Withdrawal by Subject|2|||
105772573|NCT01077193|364819011|FG000|Overall Study|Lack of Efficacy|1|||
105772574|NCT01077193|364819011|FG000|Overall Study|Study Terminated by Sponsor|40|||
105772575|NCT02987205|364819012|FG000|Overall Study|Adverse Event|1|||
105772576|NCT02987205|364819012|FG000|Overall Study|Withdrawal by Subject|3|||
105772577|NCT06048809|364819013|FG000|Overall Study|Adverse Event|2|||
105772578|NCT06048809|364819014|FG001|Overall Study|Adverse Event|0|||
105772579|NCT06048809|364819013|FG000|Overall Study|Withdrawal by Subject|1|||
105772580|NCT06048809|364819014|FG001|Overall Study|Withdrawal by Subject|1|||
105772581|NCT02943577|364819015|FG000|Overall Study|Protocol Violation|0|||
105772582|NCT02943577|364819016|FG001|Overall Study|Protocol Violation|1|||
105772583|NCT02943577|364819015|FG000|Overall Study|Adverse Event|3|||
105772584|NCT02943577|364819016|FG001|Overall Study|Adverse Event|2|||
105772585|NCT02943577|364819015|FG000|Overall Study|Lost to Follow-up|0|||
105772586|NCT02943577|364819016|FG001|Overall Study|Lost to Follow-up|1|||
105772587|NCT02943577|364819015|FG000|Overall Study|Withdrawal by Subject|1|||
105772588|NCT02943577|364819016|FG001|Overall Study|Withdrawal by Subject|1|||
105772589|NCT02943577|364819015|FG000|Overall Study|Pregnancy|1|||
105772590|NCT02943577|364819016|FG001|Overall Study|Pregnancy|0|||
105772591|NCT03991936|364819021|FG000|Overall Study|Lost to Follow-up|1|||
105772592|NCT03991936|364819022|FG001|Overall Study|Lost to Follow-up|1|||
105772593|NCT03991936|364819023|FG002|Overall Study|Lost to Follow-up|1|||
105772594|NCT03991936|364819024|FG003|Overall Study|Lost to Follow-up|1|||
105772595|NCT03991936|364819025|FG004|Overall Study|Lost to Follow-up|1|||
105772596|NCT00939055|364819026|FG000|Overall Study|Discontinuation prior to procedure|4|||
105772597|NCT00939055|364819027|FG001|Overall Study|Discontinuation prior to procedure|0|||
105772598|NCT02155712|364819032|FG000|Overall Study|Death|12|||
105772599|NCT02155712|364819033|FG001|Overall Study|Death|0|||
105772600|NCT02155712|364819032|FG000|Overall Study|Lost to Follow-up|37|||
105772601|NCT02155712|364819033|FG001|Overall Study|Lost to Follow-up|22|||
105772602|NCT02155712|364819032|FG000|Overall Study|Revision of device|4|||
105772603|NCT02155712|364819033|FG001|Overall Study|Revision of device|3|||
105772604|NCT02155712|364819032|FG000|Overall Study|Withdrawal by Subject|39|||
105772605|NCT02155712|364819033|FG001|Overall Study|Withdrawal by Subject|21|||
105772606|NCT02155712|364819032|FG000|Overall Study|Site termination|77|||
105772607|NCT02155712|364819033|FG001|Overall Study|Site termination|19|||
105772608|NCT02155712|364819032|FG000|Overall Study|Sponsor terminated study early|150|||
105772609|NCT02155712|364819033|FG001|Overall Study|Sponsor terminated study early|0|||
105772610|NCT02155712|364819032|FG000|Overall Study|Missed final 5-year protocol visit|0|||
105772611|NCT02155712|364819033|FG001|Overall Study|Missed final 5-year protocol visit|32|||
105772612|NCT02155712|364819032|FG000|Overall Study|Censored because surgery cancelled|6|||
105772613|NCT02155712|364819033|FG001|Overall Study|Censored because surgery cancelled|10|||
105772614|NCT02155712|364819032|FG000|Overall Study|Censored because study device was not implanted|61|||
105772615|NCT02155712|364819033|FG001|Overall Study|Censored because study device was not implanted|66|||
105772616|NCT02155712|364819032|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
105772617|NCT02155712|364819033|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
105772618|NCT02559115|364819035|FG000|Overall Study|Withdrawal by Subject|3|||
105772619|NCT02060903|364819038|FG000|Overall Study|Lost to Follow-up|4|||
105772620|NCT02060903|364819039|FG001|Overall Study|Lost to Follow-up|0|||
105772621|NCT02060903|364819038|FG000|Overall Study|Withdrawal by Subject|0|||
105772622|NCT02060903|364819039|FG001|Overall Study|Withdrawal by Subject|7|||
105772623|NCT00137267|364819040|FG000|Overall Study|Lost to Follow-up|15|||
105772624|NCT00137267|364819041|FG001|Overall Study|Lost to Follow-up|21|||
105772625|NCT01602822|364819048|FG000|Overall Study|Adverse Event|11|||
105772626|NCT05333289|364819056|FG000|Overall Study|Other|1|||
105772627|NCT05333289|364819057|FG001|Overall Study|Other|0|||
105772628|NCT05333289|364819058|FG002|Overall Study|Other|0|||
105772629|NCT05333289|364819059|FG003|Overall Study|Other|1|||
105772630|NCT05333289|364819060|FG004|Overall Study|Other|1|||
105772631|NCT05333289|364819061|FG005|Overall Study|Other|2|||
105772632|NCT05333289|364819062|FG006|Overall Study|Other|2|||
105772633|NCT05333289|364819063|FG007|Overall Study|Other|0|||
105772634|NCT05333289|364819056|FG000|Overall Study|Withdrawal by Subject|1|||
105772635|NCT05333289|364819057|FG001|Overall Study|Withdrawal by Subject|2|||
105772636|NCT05333289|364819058|FG002|Overall Study|Withdrawal by Subject|2|||
105772637|NCT05333289|364819059|FG003|Overall Study|Withdrawal by Subject|1|||
105772638|NCT05333289|364819060|FG004|Overall Study|Withdrawal by Subject|1|||
105772639|NCT05333289|364819061|FG005|Overall Study|Withdrawal by Subject|2|||
105772640|NCT05333289|364819062|FG006|Overall Study|Withdrawal by Subject|1|||
105772641|NCT05333289|364819063|FG007|Overall Study|Withdrawal by Subject|3|||
105772642|NCT05333289|364819056|FG000|Overall Study|Protocol Violation|1|||
105772643|NCT05333289|364819057|FG001|Overall Study|Protocol Violation|0|||
105772644|NCT05333289|364819058|FG002|Overall Study|Protocol Violation|0|||
105772645|NCT05333289|364819059|FG003|Overall Study|Protocol Violation|0|||
105772646|NCT05333289|364819060|FG004|Overall Study|Protocol Violation|0|||
105772647|NCT05333289|364819061|FG005|Overall Study|Protocol Violation|0|||
105772648|NCT05333289|364819062|FG006|Overall Study|Protocol Violation|0|||
105772649|NCT05333289|364819063|FG007|Overall Study|Protocol Violation|0|||
105772650|NCT05333289|364819056|FG000|Overall Study|Physician Decision|0|||
105772651|NCT05333289|364819057|FG001|Overall Study|Physician Decision|0|||
105772652|NCT05333289|364819058|FG002|Overall Study|Physician Decision|1|||
105772653|NCT05333289|364819059|FG003|Overall Study|Physician Decision|0|||
105772654|NCT05333289|364819060|FG004|Overall Study|Physician Decision|0|||
105772655|NCT05333289|364819061|FG005|Overall Study|Physician Decision|2|||
105772656|NCT05333289|364819062|FG006|Overall Study|Physician Decision|0|||
105772657|NCT05333289|364819063|FG007|Overall Study|Physician Decision|0|||
105772658|NCT05333289|364819056|FG000|Overall Study|Lost to Follow-up|6|||
105772659|NCT05333289|364819057|FG001|Overall Study|Lost to Follow-up|0|||
105772660|NCT05333289|364819058|FG002|Overall Study|Lost to Follow-up|1|||
105772661|NCT05333289|364819059|FG003|Overall Study|Lost to Follow-up|6|||
105772662|NCT05333289|364819060|FG004|Overall Study|Lost to Follow-up|3|||
105772663|NCT05333289|364819061|FG005|Overall Study|Lost to Follow-up|3|||
105772664|NCT05333289|364819062|FG006|Overall Study|Lost to Follow-up|2|||
105772665|NCT05333289|364819063|FG007|Overall Study|Lost to Follow-up|1|||
105772666|NCT05333289|364819056|FG000|Overall Study|Death|1|||
105772667|NCT05333289|364819057|FG001|Overall Study|Death|0|||
105772668|NCT05333289|364819058|FG002|Overall Study|Death|0|||
105772669|NCT05333289|364819059|FG003|Overall Study|Death|0|||
105772670|NCT05333289|364819060|FG004|Overall Study|Death|0|||
105772671|NCT05333289|364819061|FG005|Overall Study|Death|0|||
105772672|NCT05333289|364819062|FG006|Overall Study|Death|0|||
105772673|NCT05333289|364819063|FG007|Overall Study|Death|0|||
105772674|NCT02010567|364819068|FG000|Overall Study|Adverse Event|0|||
105772675|NCT02010567|364819069|FG001|Overall Study|Adverse Event|0|||
105772676|NCT02010567|364819070|FG002|Overall Study|Adverse Event|1|||
105772677|NCT02010567|364819071|FG003|Overall Study|Adverse Event|0|||
105772678|NCT02010567|364819072|FG004|Overall Study|Adverse Event|1|||
105772679|NCT00118040|364819073|FG000|Overall Study|Adverse Event|0|||
105772680|NCT00118040|364819074|FG001|Overall Study|Adverse Event|1|||
105772681|NCT00118040|364819075|FG002|Overall Study|Adverse Event|0|||
105772682|NCT00118040|364819073|FG000|Overall Study|Withdrawal by Subject|0|||
105772683|NCT00118040|364819074|FG001|Overall Study|Withdrawal by Subject|0|||
105772684|NCT00118040|364819075|FG002|Overall Study|Withdrawal by Subject|2|||
105772685|NCT00118040|364819073|FG000|Overall Study|Medical Contraindication|0|||
105772686|NCT00118040|364819074|FG001|Overall Study|Medical Contraindication|0|||
105772687|NCT00118040|364819075|FG002|Overall Study|Medical Contraindication|1|||
105772688|NCT00118040|364819073|FG000|Overall Study|Non-Compliant Participant|1|||
105772689|NCT00118040|364819074|FG001|Overall Study|Non-Compliant Participant|1|||
105772690|NCT00118040|364819075|FG002|Overall Study|Non-Compliant Participant|2|||
105772691|NCT00118040|364819073|FG000|Overall Study|Other|0|||
105772692|NCT00118040|364819074|FG001|Overall Study|Other|0|||
105772693|NCT00118040|364819075|FG002|Overall Study|Other|1|||
105772694|NCT02005211|364819078|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
105772695|NCT02005211|364819079|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
105772696|NCT02005211|364819080|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
105772697|NCT02005211|364819081|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
105772698|NCT02005211|364819082|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
105772699|NCT02005211|364819083|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
105772700|NCT02005211|364819084|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
105772701|NCT02192190|364819085|FG000|Overall Study|Adverse Event|1|||
105772702|NCT02192190|364819086|FG001|Overall Study|Adverse Event|1|||
105772703|NCT02192190|364819087|FG002|Overall Study|Adverse Event|0|||
105772704|NCT02192190|364819088|FG003|Overall Study|Adverse Event|0|||
105772705|NCT02192190|364819089|FG004|Overall Study|Adverse Event|0|||
105772706|NCT02192190|364819090|FG005|Overall Study|Adverse Event|0|||
105772707|NCT02192190|364819085|FG000|Overall Study|Lost to Follow-up|3|||
105772708|NCT02192190|364819086|FG001|Overall Study|Lost to Follow-up|3|||
105772709|NCT02192190|364819087|FG002|Overall Study|Lost to Follow-up|2|||
105772710|NCT02192190|364819088|FG003|Overall Study|Lost to Follow-up|1|||
105772711|NCT02192190|364819089|FG004|Overall Study|Lost to Follow-up|4|||
105772712|NCT02192190|364819090|FG005|Overall Study|Lost to Follow-up|3|||
105772713|NCT02192190|364819085|FG000|Overall Study|Physician Decision|2|||
105772714|NCT02192190|364819086|FG001|Overall Study|Physician Decision|0|||
105772715|NCT02192190|364819087|FG002|Overall Study|Physician Decision|0|||
105772716|NCT02192190|364819088|FG003|Overall Study|Physician Decision|0|||
105772717|NCT02192190|364819089|FG004|Overall Study|Physician Decision|0|||
105772718|NCT02192190|364819090|FG005|Overall Study|Physician Decision|0|||
105772719|NCT02192190|364819085|FG000|Overall Study|Terminated by Sponsor|43|||
105772720|NCT02192190|364819086|FG001|Overall Study|Terminated by Sponsor|23|||
105772721|NCT02192190|364819087|FG002|Overall Study|Terminated by Sponsor|20|||
105772722|NCT02192190|364819088|FG003|Overall Study|Terminated by Sponsor|23|||
105772723|NCT02192190|364819089|FG004|Overall Study|Terminated by Sponsor|21|||
105772724|NCT02192190|364819090|FG005|Overall Study|Terminated by Sponsor|23|||
105772725|NCT02192190|364819085|FG000|Overall Study|Withdrawal by Subject|4|||
105772726|NCT02192190|364819086|FG001|Overall Study|Withdrawal by Subject|1|||
105772727|NCT02192190|364819087|FG002|Overall Study|Withdrawal by Subject|2|||
105772728|NCT02192190|364819088|FG003|Overall Study|Withdrawal by Subject|1|||
105772729|NCT02192190|364819089|FG004|Overall Study|Withdrawal by Subject|5|||
105772730|NCT02192190|364819090|FG005|Overall Study|Withdrawal by Subject|3|||
105772731|NCT02192190|364819085|FG000|Overall Study|Could not Keep Visit Schedule|1|||
105772732|NCT02192190|364819086|FG001|Overall Study|Could not Keep Visit Schedule|0|||
105772733|NCT02192190|364819087|FG002|Overall Study|Could not Keep Visit Schedule|0|||
105772734|NCT02192190|364819088|FG003|Overall Study|Could not Keep Visit Schedule|0|||
105772735|NCT02192190|364819089|FG004|Overall Study|Could not Keep Visit Schedule|0|||
105772736|NCT02192190|364819090|FG005|Overall Study|Could not Keep Visit Schedule|0|||
105772737|NCT02192190|364819085|FG000|Overall Study|Positive Drug Screen|0|||
105772738|NCT02192190|364819086|FG001|Overall Study|Positive Drug Screen|0|||
105772739|NCT02192190|364819087|FG002|Overall Study|Positive Drug Screen|0|||
105772740|NCT02192190|364819088|FG003|Overall Study|Positive Drug Screen|1|||
105772741|NCT02192190|364819089|FG004|Overall Study|Positive Drug Screen|0|||
105772742|NCT02192190|364819090|FG005|Overall Study|Positive Drug Screen|0|||
105772743|NCT02192190|364819085|FG000|Overall Study|Inadequate Pain Relief|0|||
105772744|NCT02192190|364819086|FG001|Overall Study|Inadequate Pain Relief|1|||
105772745|NCT02192190|364819087|FG002|Overall Study|Inadequate Pain Relief|1|||
105772746|NCT02192190|364819088|FG003|Overall Study|Inadequate Pain Relief|0|||
105772747|NCT02192190|364819089|FG004|Overall Study|Inadequate Pain Relief|0|||
105772748|NCT02192190|364819090|FG005|Overall Study|Inadequate Pain Relief|0|||
105772749|NCT03733249|364819091|FG000|Overall Study|Death|7|||
105772750|NCT03733249|364819091|FG000|Overall Study|Disease relapse|16|||
105772751|NCT03733249|364819091|FG000|Overall Study|Lost to Follow-up|4|||
105772752|NCT03733249|364819091|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
105772753|NCT03733249|364819091|FG000|Overall Study|Withdrawal by Subject|1|||
105772754|NCT03523715|364819092|FG000|Overall Study|Lost to Follow-up|11|||
105772755|NCT03523715|364819093|FG001|Overall Study|Lost to Follow-up|14|||
105772756|NCT03523715|364819092|FG000|Overall Study|Did not meet inclusion criteria|1|||
105772757|NCT03523715|364819093|FG001|Overall Study|Did not meet inclusion criteria|0|||
105772758|NCT03523715|364819092|FG000|Overall Study|Internally inconsistent reporting|0|||
105772759|NCT03523715|364819093|FG001|Overall Study|Internally inconsistent reporting|2|||
105772760|NCT01950364|364819095|FG000|Overall Study|Adverse Event|3|||
105772761|NCT01950364|364819096|FG001|Overall Study|Adverse Event|0|||
105772762|NCT01950364|364819095|FG000|Overall Study|Stem Cell Transplant|2|||
105772763|NCT01950364|364819096|FG001|Overall Study|Stem Cell Transplant|6|||
105772764|NCT01950364|364819095|FG000|Overall Study|Disease Progression|5|||
105772765|NCT01950364|364819096|FG001|Overall Study|Disease Progression|2|||
105772766|NCT01950364|364819095|FG000|Overall Study|Withdrawal by Subject|0|||
105772767|NCT01950364|364819096|FG001|Overall Study|Withdrawal by Subject|1|||
105772768|NCT01950364|364819095|FG000|Overall Study|Protocol Violation|0|||
105772769|NCT01950364|364819096|FG001|Overall Study|Protocol Violation|1|||
105772770|NCT03299166|364819099|FG000|Overall Study|Adverse Event|9|||
105772771|NCT03299166|364819100|FG001|Overall Study|Adverse Event|4|||
105772772|NCT03299166|364819099|FG000|Overall Study|Withdrawal by Subject|6|||
105772773|NCT03299166|364819100|FG001|Overall Study|Withdrawal by Subject|5|||
105772774|NCT03299166|364819099|FG000|Overall Study|Physician Decision|1|||
105772775|NCT03299166|364819100|FG001|Overall Study|Physician Decision|1|||
105772776|NCT03299166|364819099|FG000|Overall Study|Sponsor Decision|3|||
105772777|NCT03299166|364819100|FG001|Overall Study|Sponsor Decision|0|||
105772778|NCT03299166|364819099|FG000|Overall Study|Lost to Follow-up|2|||
105772779|NCT03299166|364819100|FG001|Overall Study|Lost to Follow-up|4|||
105772780|NCT03299166|364819099|FG000|Overall Study|Randomization Error|0|||
105772781|NCT03299166|364819100|FG001|Overall Study|Randomization Error|1|||
105772782|NCT03299166|364819099|FG000|Overall Study|Subject unable to return due to COVID|1|||
105772783|NCT03299166|364819100|FG001|Overall Study|Subject unable to return due to COVID|0|||
105772784|NCT03299166|364819099|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
105772785|NCT03299166|364819100|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
105772786|NCT04048876|364819101|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
105772787|NCT04048876|364819102|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
105772788|NCT04048876|364819103|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
105772789|NCT04048876|364819104|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
105772790|NCT04048876|364819101|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
105772791|NCT04048876|364819102|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
105772792|NCT04048876|364819103|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
105772793|NCT04048876|364819104|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
105772794|NCT04048876|364819101|FG000|Placebo Controlled Phase|Adverse Event|0|||
105772795|NCT04048876|364819102|FG001|Placebo Controlled Phase|Adverse Event|1|||
105772796|NCT04048876|364819103|FG002|Placebo Controlled Phase|Adverse Event|0|||
105772797|NCT04048876|364819104|FG003|Placebo Controlled Phase|Adverse Event|0|||
105772798|NCT04048876|364819101|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
105772799|NCT04048876|364819102|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
105772800|NCT04048876|364819103|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
105772801|NCT04048876|364819104|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
105772802|NCT02187224|364819105|FG000|Overall Study|Did not show up for test day|1|||
105772803|NCT02187224|364819106|FG001|Overall Study|Did not show up for test day|0|||
105772804|NCT01436357|364819108|FG000|Overall Study|Death|5|||
105772805|NCT01436357|364819109|FG001|Overall Study|Death|1|||
105772806|NCT01436357|364819108|FG000|Overall Study|Enrolled but not vaccinated|1|||
105772807|NCT01436357|364819109|FG001|Overall Study|Enrolled but not vaccinated|1|||
105442530|NCT05173012|363626780|FG003|Overall Study|Lost to Follow-up|1|||
105772808|NCT01436357|364819108|FG000|Overall Study|Incarceration|18|||
105772809|NCT01436357|364819109|FG001|Overall Study|Incarceration|20|||
105772810|NCT01436357|364819108|FG000|Overall Study|Lost to Follow-up|67|||
105772811|NCT01436357|364819109|FG001|Overall Study|Lost to Follow-up|61|||
105772812|NCT01436357|364819108|FG000|Overall Study|Protocol Violation|1|||
105772813|NCT01436357|364819109|FG001|Overall Study|Protocol Violation|0|||
105772814|NCT01436357|364819108|FG000|Overall Study|Withdrawal by Subject|26|||
105772815|NCT01436357|364819109|FG001|Overall Study|Withdrawal by Subject|38|||
105442531|NCT05173012|363626781|FG004|Overall Study|Lost to Follow-up|0|||
105772816|NCT01436357|364819108|FG000|Overall Study|Physician Decision|3|||
105772817|NCT01436357|364819109|FG001|Overall Study|Physician Decision|4|||
105772818|NCT01436357|364819108|FG000|Overall Study|Moved out of area|1|||
105772819|NCT01436357|364819109|FG001|Overall Study|Moved out of area|2|||
105772820|NCT01436357|364819108|FG000|Overall Study|Subject in rehab|0|||
105772821|NCT01436357|364819109|FG001|Overall Study|Subject in rehab|1|||
105772822|NCT01693562|364819988|FG000|Escalation Phase|Withdrawal by Subject|0|||
105772823|NCT01693562|364819989|FG001|Escalation Phase|Withdrawal by Subject|1|||
105772824|NCT01693562|364819990|FG002|Escalation Phase|Withdrawal by Subject|0|||
105772825|NCT01693562|364819991|FG003|Escalation Phase|Withdrawal by Subject|0|||
105772826|NCT01693562|364819992|FG004|Escalation Phase|Withdrawal by Subject|0|||
105772827|NCT01693562|364819993|FG005|Escalation Phase|Withdrawal by Subject|2|||
105772828|NCT01693562|364819994|FG006|Escalation Phase|Withdrawal by Subject|0|||
105772829|NCT01693562|364819995|FG007|Escalation Phase|Withdrawal by Subject|0|||
105772830|NCT01693562|364819996|FG008|Escalation Phase|Withdrawal by Subject|0|||
105772831|NCT01693562|364819997|FG009|Escalation Phase|Withdrawal by Subject|0|||
105772832|NCT01693562|364819998|FG010|Escalation Phase|Withdrawal by Subject|0|||
105772833|NCT01693562|364819999|FG011|Escalation Phase|Withdrawal by Subject|0|||
105772834|NCT01693562|364820000|FG012|Escalation Phase|Withdrawal by Subject|0|||
105772835|NCT01693562|364820001|FG013|Escalation Phase|Withdrawal by Subject|0|||
105772836|NCT01693562|364820002|FG014|Escalation Phase|Withdrawal by Subject|0|||
105772837|NCT01693562|364820003|FG015|Escalation Phase|Withdrawal by Subject|0|||
105772838|NCT01693562|364820004|FG016|Escalation Phase|Withdrawal by Subject|0|||
105772839|NCT01693562|364820005|FG017|Escalation Phase|Withdrawal by Subject|0|||
105772840|NCT01693562|364820006|FG018|Escalation Phase|Withdrawal by Subject|0|||
105772841|NCT01693562|364820007|FG019|Escalation Phase|Withdrawal by Subject|0|||
105772842|NCT01693562|364820008|FG020|Escalation Phase|Withdrawal by Subject|0|||
105772843|NCT01693562|364820009|FG021|Escalation Phase|Withdrawal by Subject|0|||
105772844|NCT01693562|364820010|FG022|Escalation Phase|Withdrawal by Subject|0|||
105772845|NCT01693562|364819988|FG000|Escalation Phase|Death|4|||
105772846|NCT01693562|364819989|FG001|Escalation Phase|Death|2|||
105772847|NCT01693562|364819990|FG002|Escalation Phase|Death|0|||
105772848|NCT01693562|364819991|FG003|Escalation Phase|Death|3|||
105772849|NCT01693562|364819992|FG004|Escalation Phase|Death|6|||
105772850|NCT01693562|364819993|FG005|Escalation Phase|Death|4|||
105772851|NCT01693562|364819994|FG006|Escalation Phase|Death|0|||
105772852|NCT01693562|364819995|FG007|Escalation Phase|Death|0|||
105772853|NCT01693562|364819996|FG008|Escalation Phase|Death|0|||
105772854|NCT01693562|364819997|FG009|Escalation Phase|Death|0|||
105772855|NCT01693562|364819998|FG010|Escalation Phase|Death|0|||
105772856|NCT01693562|364819999|FG011|Escalation Phase|Death|0|||
105772857|NCT01693562|364820000|FG012|Escalation Phase|Death|0|||
105772858|NCT01693562|364820001|FG013|Escalation Phase|Death|0|||
105772859|NCT01693562|364820002|FG014|Escalation Phase|Death|0|||
105772860|NCT01693562|364820003|FG015|Escalation Phase|Death|0|||
105772861|NCT01693562|364820004|FG016|Escalation Phase|Death|0|||
105772862|NCT01693562|364820005|FG017|Escalation Phase|Death|0|||
105772863|NCT01693562|364820006|FG018|Escalation Phase|Death|0|||
105772864|NCT01693562|364820007|FG019|Escalation Phase|Death|0|||
105772865|NCT01693562|364820008|FG020|Escalation Phase|Death|0|||
105772866|NCT01693562|364820009|FG021|Escalation Phase|Death|0|||
105772867|NCT01693562|364820010|FG022|Escalation Phase|Death|0|||
105772868|NCT01693562|364819988|FG000|Escalation Phase|Lost to Follow-up|0|||
105772869|NCT01693562|364819989|FG001|Escalation Phase|Lost to Follow-up|1|||
105772870|NCT01693562|364819990|FG002|Escalation Phase|Lost to Follow-up|1|||
105772871|NCT01693562|364819991|FG003|Escalation Phase|Lost to Follow-up|0|||
105772872|NCT01693562|364819992|FG004|Escalation Phase|Lost to Follow-up|0|||
105772873|NCT01693562|364819993|FG005|Escalation Phase|Lost to Follow-up|0|||
105772874|NCT01693562|364819994|FG006|Escalation Phase|Lost to Follow-up|0|||
105772875|NCT01693562|364819995|FG007|Escalation Phase|Lost to Follow-up|0|||
105772876|NCT01693562|364819996|FG008|Escalation Phase|Lost to Follow-up|0|||
105772877|NCT01693562|364819997|FG009|Escalation Phase|Lost to Follow-up|0|||
105772878|NCT01693562|364819998|FG010|Escalation Phase|Lost to Follow-up|0|||
105772879|NCT01693562|364819999|FG011|Escalation Phase|Lost to Follow-up|0|||
105772880|NCT01693562|364820000|FG012|Escalation Phase|Lost to Follow-up|0|||
105772881|NCT01693562|364820001|FG013|Escalation Phase|Lost to Follow-up|0|||
105772882|NCT01693562|364820002|FG014|Escalation Phase|Lost to Follow-up|0|||
105772883|NCT01693562|364820003|FG015|Escalation Phase|Lost to Follow-up|0|||
105772884|NCT01693562|364820004|FG016|Escalation Phase|Lost to Follow-up|0|||
105442532|NCT05173012|363626782|FG005|Overall Study|Lost to Follow-up|0|||
105772885|NCT01693562|364820005|FG017|Escalation Phase|Lost to Follow-up|0|||
105442533|NCT05173012|363626783|FG006|Overall Study|Lost to Follow-up|0|||
105772886|NCT01693562|364820006|FG018|Escalation Phase|Lost to Follow-up|0|||
105772887|NCT01693562|364820007|FG019|Escalation Phase|Lost to Follow-up|0|||
105772888|NCT01693562|364820008|FG020|Escalation Phase|Lost to Follow-up|0|||
105772889|NCT01693562|364820009|FG021|Escalation Phase|Lost to Follow-up|0|||
105772890|NCT01693562|364820010|FG022|Escalation Phase|Lost to Follow-up|0|||
105772891|NCT01693562|364819988|FG000|Escalation Phase|Other|0|||
105772892|NCT01693562|364819989|FG001|Escalation Phase|Other|0|||
105772893|NCT01693562|364819990|FG002|Escalation Phase|Other|2|||
105772894|NCT01693562|364819991|FG003|Escalation Phase|Other|0|||
105772895|NCT01693562|364819992|FG004|Escalation Phase|Other|0|||
105772896|NCT01693562|364819993|FG005|Escalation Phase|Other|1|||
105772897|NCT01693562|364819994|FG006|Escalation Phase|Other|0|||
105772898|NCT01693562|364819995|FG007|Escalation Phase|Other|0|||
105772899|NCT01693562|364819996|FG008|Escalation Phase|Other|0|||
105772900|NCT01693562|364819997|FG009|Escalation Phase|Other|0|||
105772901|NCT01693562|364819998|FG010|Escalation Phase|Other|0|||
105772902|NCT01693562|364819999|FG011|Escalation Phase|Other|0|||
105772903|NCT01693562|364820000|FG012|Escalation Phase|Other|0|||
105772904|NCT01693562|364820001|FG013|Escalation Phase|Other|0|||
105772905|NCT01693562|364820002|FG014|Escalation Phase|Other|0|||
105772906|NCT01693562|364820003|FG015|Escalation Phase|Other|0|||
105772907|NCT01693562|364820004|FG016|Escalation Phase|Other|0|||
105772908|NCT01693562|364820005|FG017|Escalation Phase|Other|0|||
105772909|NCT01693562|364820006|FG018|Escalation Phase|Other|0|||
105772910|NCT01693562|364820007|FG019|Escalation Phase|Other|0|||
105772911|NCT01693562|364820008|FG020|Escalation Phase|Other|0|||
105772912|NCT01693562|364820009|FG021|Escalation Phase|Other|0|||
105772913|NCT01693562|364820010|FG022|Escalation Phase|Other|0|||
105772914|NCT01693562|364819988|FG000|Exploration Phase|Withdrawal by Subject|0|||
105772915|NCT01693562|364819989|FG001|Exploration Phase|Withdrawal by Subject|0|||
105772916|NCT01693562|364819990|FG002|Exploration Phase|Withdrawal by Subject|0|||
105772917|NCT01693562|364819991|FG003|Exploration Phase|Withdrawal by Subject|0|||
105772918|NCT01693562|364819992|FG004|Exploration Phase|Withdrawal by Subject|0|||
105772919|NCT01693562|364819993|FG005|Exploration Phase|Withdrawal by Subject|0|||
105772920|NCT01693562|364819994|FG006|Exploration Phase|Withdrawal by Subject|2|||
105772921|NCT01693562|364819995|FG007|Exploration Phase|Withdrawal by Subject|0|||
105772922|NCT01693562|364819996|FG008|Exploration Phase|Withdrawal by Subject|0|||
105772923|NCT01693562|364819997|FG009|Exploration Phase|Withdrawal by Subject|0|||
105772924|NCT01693562|364819998|FG010|Exploration Phase|Withdrawal by Subject|0|||
105772925|NCT01693562|364819999|FG011|Exploration Phase|Withdrawal by Subject|0|||
105772926|NCT01693562|364820000|FG012|Exploration Phase|Withdrawal by Subject|0|||
105772927|NCT01693562|364820001|FG013|Exploration Phase|Withdrawal by Subject|0|||
105772928|NCT01693562|364820002|FG014|Exploration Phase|Withdrawal by Subject|0|||
105772929|NCT01693562|364820003|FG015|Exploration Phase|Withdrawal by Subject|0|||
105772930|NCT01693562|364820004|FG016|Exploration Phase|Withdrawal by Subject|0|||
105772931|NCT01693562|364820005|FG017|Exploration Phase|Withdrawal by Subject|0|||
105772932|NCT01693562|364820006|FG018|Exploration Phase|Withdrawal by Subject|0|||
105772933|NCT01693562|364820007|FG019|Exploration Phase|Withdrawal by Subject|0|||
105772934|NCT01693562|364820008|FG020|Exploration Phase|Withdrawal by Subject|0|||
105772935|NCT01693562|364820009|FG021|Exploration Phase|Withdrawal by Subject|0|||
105772936|NCT01693562|364820010|FG022|Exploration Phase|Withdrawal by Subject|0|||
105772937|NCT01693562|364819988|FG000|Exploration Phase|Death|0|||
105772938|NCT01693562|364819989|FG001|Exploration Phase|Death|0|||
105772939|NCT01693562|364819990|FG002|Exploration Phase|Death|0|||
105772940|NCT01693562|364819991|FG003|Exploration Phase|Death|0|||
105772941|NCT01693562|364819992|FG004|Exploration Phase|Death|0|||
105772942|NCT01693562|364819993|FG005|Exploration Phase|Death|0|||
105772943|NCT01693562|364819994|FG006|Exploration Phase|Death|17|||
105772944|NCT01693562|364819995|FG007|Exploration Phase|Death|0|||
105772945|NCT01693562|364819996|FG008|Exploration Phase|Death|0|||
105772946|NCT01693562|364819997|FG009|Exploration Phase|Death|0|||
105772947|NCT01693562|364819998|FG010|Exploration Phase|Death|0|||
105772948|NCT01693562|364819999|FG011|Exploration Phase|Death|0|||
105772949|NCT01693562|364820000|FG012|Exploration Phase|Death|0|||
105772950|NCT01693562|364820001|FG013|Exploration Phase|Death|0|||
105772951|NCT01693562|364820002|FG014|Exploration Phase|Death|0|||
105772952|NCT01693562|364820003|FG015|Exploration Phase|Death|0|||
105772953|NCT01693562|364820004|FG016|Exploration Phase|Death|0|||
105772954|NCT01693562|364820005|FG017|Exploration Phase|Death|0|||
105772955|NCT01693562|364820006|FG018|Exploration Phase|Death|0|||
105772956|NCT01693562|364820007|FG019|Exploration Phase|Death|0|||
105772957|NCT01693562|364820008|FG020|Exploration Phase|Death|0|||
105772958|NCT01693562|364820009|FG021|Exploration Phase|Death|0|||
105772959|NCT01693562|364820010|FG022|Exploration Phase|Death|0|||
105772960|NCT01693562|364819988|FG000|Exploration Phase|Other|0|||
105772961|NCT01693562|364819989|FG001|Exploration Phase|Other|0|||
105772962|NCT01693562|364819990|FG002|Exploration Phase|Other|0|||
105772963|NCT01693562|364819991|FG003|Exploration Phase|Other|0|||
105772964|NCT01693562|364819992|FG004|Exploration Phase|Other|0|||
105772965|NCT01693562|364819993|FG005|Exploration Phase|Other|0|||
105772966|NCT01693562|364819994|FG006|Exploration Phase|Other|2|||
105772967|NCT01693562|364819995|FG007|Exploration Phase|Other|0|||
105772968|NCT01693562|364819996|FG008|Exploration Phase|Other|0|||
105772969|NCT01693562|364819997|FG009|Exploration Phase|Other|0|||
105772970|NCT01693562|364819998|FG010|Exploration Phase|Other|0|||
105772971|NCT01693562|364819999|FG011|Exploration Phase|Other|0|||
105772972|NCT01693562|364820000|FG012|Exploration Phase|Other|0|||
105772973|NCT01693562|364820001|FG013|Exploration Phase|Other|0|||
105772974|NCT01693562|364820002|FG014|Exploration Phase|Other|0|||
105772975|NCT01693562|364820003|FG015|Exploration Phase|Other|0|||
105772976|NCT01693562|364820004|FG016|Exploration Phase|Other|0|||
105772977|NCT01693562|364820005|FG017|Exploration Phase|Other|0|||
105772978|NCT01693562|364820006|FG018|Exploration Phase|Other|0|||
105772979|NCT01693562|364820007|FG019|Exploration Phase|Other|0|||
105772980|NCT01693562|364820008|FG020|Exploration Phase|Other|0|||
105772981|NCT01693562|364820009|FG021|Exploration Phase|Other|0|||
105772982|NCT01693562|364820010|FG022|Exploration Phase|Other|0|||
105772983|NCT01693562|364819988|FG000|Expansion Phase|Withdrawal by Subject|0|||
105772984|NCT01693562|364819989|FG001|Expansion Phase|Withdrawal by Subject|0|||
105772985|NCT01693562|364819990|FG002|Expansion Phase|Withdrawal by Subject|0|||
105772986|NCT01693562|364819991|FG003|Expansion Phase|Withdrawal by Subject|0|||
105772987|NCT01693562|364819992|FG004|Expansion Phase|Withdrawal by Subject|0|||
105772988|NCT01693562|364819993|FG005|Expansion Phase|Withdrawal by Subject|0|||
105772989|NCT01693562|364819994|FG006|Expansion Phase|Withdrawal by Subject|0|||
105772990|NCT01693562|364819995|FG007|Expansion Phase|Withdrawal by Subject|16|||
105772991|NCT01693562|364819996|FG008|Expansion Phase|Withdrawal by Subject|2|||
105772992|NCT01693562|364819997|FG009|Expansion Phase|Withdrawal by Subject|54|||
105772993|NCT01693562|364819998|FG010|Expansion Phase|Withdrawal by Subject|2|||
105772994|NCT01693562|364819999|FG011|Expansion Phase|Withdrawal by Subject|2|||
105772995|NCT01693562|364820000|FG012|Expansion Phase|Withdrawal by Subject|3|||
105772996|NCT01693562|364820001|FG013|Expansion Phase|Withdrawal by Subject|5|||
105772997|NCT01693562|364820002|FG014|Expansion Phase|Withdrawal by Subject|16|||
105772998|NCT01693562|364820003|FG015|Expansion Phase|Withdrawal by Subject|7|||
105772999|NCT01693562|364820004|FG016|Expansion Phase|Withdrawal by Subject|40|||
105773000|NCT01693562|364820005|FG017|Expansion Phase|Withdrawal by Subject|4|||
105773001|NCT01693562|364820006|FG018|Expansion Phase|Withdrawal by Subject|8|||
105773002|NCT01693562|364820007|FG019|Expansion Phase|Withdrawal by Subject|3|||
105773003|NCT01693562|364820008|FG020|Expansion Phase|Withdrawal by Subject|1|||
105773004|NCT01693562|364820009|FG021|Expansion Phase|Withdrawal by Subject|8|||
105773005|NCT01693562|364820010|FG022|Expansion Phase|Withdrawal by Subject|1|||
105773006|NCT01693562|364819988|FG000|Expansion Phase|Death|0|||
105773007|NCT01693562|364819989|FG001|Expansion Phase|Death|0|||
105773008|NCT01693562|364819990|FG002|Expansion Phase|Death|0|||
105773009|NCT01693562|364819991|FG003|Expansion Phase|Death|0|||
105773010|NCT01693562|364819992|FG004|Expansion Phase|Death|0|||
105773011|NCT01693562|364819993|FG005|Expansion Phase|Death|0|||
105773012|NCT01693562|364819994|FG006|Expansion Phase|Death|0|||
105773013|NCT01693562|364819995|FG007|Expansion Phase|Death|42|||
105773014|NCT01693562|364819996|FG008|Expansion Phase|Death|17|||
105773015|NCT01693562|364819997|FG009|Expansion Phase|Death|208|||
105773016|NCT01693562|364819998|FG010|Expansion Phase|Death|30|||
105773017|NCT01693562|364819999|FG011|Expansion Phase|Death|8|||
105773018|NCT01693562|364820000|FG012|Expansion Phase|Death|19|||
105773019|NCT01693562|364820001|FG013|Expansion Phase|Death|42|||
105773020|NCT01693562|364820002|FG014|Expansion Phase|Death|23|||
105773021|NCT01693562|364820003|FG015|Expansion Phase|Death|23|||
105773022|NCT01693562|364820004|FG016|Expansion Phase|Death|128|||
105773023|NCT01693562|364820005|FG017|Expansion Phase|Death|16|||
105773024|NCT01693562|364820006|FG018|Expansion Phase|Death|36|||
105773025|NCT01693562|364820007|FG019|Expansion Phase|Death|16|||
105773026|NCT01693562|364820008|FG020|Expansion Phase|Death|17|||
105773027|NCT01693562|364820009|FG021|Expansion Phase|Death|35|||
105773028|NCT01693562|364820010|FG022|Expansion Phase|Death|7|||
105773029|NCT01693562|364819988|FG000|Expansion Phase|Lost to Follow-up|0|||
105773030|NCT01693562|364819989|FG001|Expansion Phase|Lost to Follow-up|0|||
105773031|NCT01693562|364819990|FG002|Expansion Phase|Lost to Follow-up|0|||
105773032|NCT01693562|364819991|FG003|Expansion Phase|Lost to Follow-up|0|||
105773033|NCT01693562|364819992|FG004|Expansion Phase|Lost to Follow-up|0|||
105773034|NCT01693562|364819993|FG005|Expansion Phase|Lost to Follow-up|0|||
105773035|NCT01693562|364819994|FG006|Expansion Phase|Lost to Follow-up|0|||
105773036|NCT01693562|364819995|FG007|Expansion Phase|Lost to Follow-up|1|||
105773037|NCT01693562|364819996|FG008|Expansion Phase|Lost to Follow-up|2|||
105773038|NCT01693562|364819997|FG009|Expansion Phase|Lost to Follow-up|10|||
105773039|NCT01693562|364819998|FG010|Expansion Phase|Lost to Follow-up|4|||
105773040|NCT01693562|364819999|FG011|Expansion Phase|Lost to Follow-up|4|||
105773041|NCT01693562|364820000|FG012|Expansion Phase|Lost to Follow-up|1|||
105773042|NCT01693562|364820001|FG013|Expansion Phase|Lost to Follow-up|3|||
105773043|NCT01693562|364820002|FG014|Expansion Phase|Lost to Follow-up|0|||
105773044|NCT01693562|364820003|FG015|Expansion Phase|Lost to Follow-up|1|||
105773045|NCT01693562|364820004|FG016|Expansion Phase|Lost to Follow-up|1|||
105773046|NCT01693562|364820005|FG017|Expansion Phase|Lost to Follow-up|0|||
105773047|NCT01693562|364820006|FG018|Expansion Phase|Lost to Follow-up|2|||
105773048|NCT01693562|364820007|FG019|Expansion Phase|Lost to Follow-up|1|||
105773049|NCT01693562|364820008|FG020|Expansion Phase|Lost to Follow-up|2|||
105773050|NCT01693562|364820009|FG021|Expansion Phase|Lost to Follow-up|2|||
105773051|NCT01693562|364820010|FG022|Expansion Phase|Lost to Follow-up|1|||
105773052|NCT01693562|364819988|FG000|Expansion Phase|Other|0|||
105773053|NCT01693562|364819989|FG001|Expansion Phase|Other|0|||
105773054|NCT01693562|364819990|FG002|Expansion Phase|Other|0|||
105773055|NCT01693562|364819991|FG003|Expansion Phase|Other|0|||
105773056|NCT01693562|364819992|FG004|Expansion Phase|Other|0|||
105773057|NCT01693562|364819993|FG005|Expansion Phase|Other|0|||
105773058|NCT01693562|364819994|FG006|Expansion Phase|Other|0|||
105773059|NCT01693562|364819995|FG007|Expansion Phase|Other|3|||
105773060|NCT01693562|364819996|FG008|Expansion Phase|Other|1|||
105773061|NCT01693562|364819997|FG009|Expansion Phase|Other|28|||
105773062|NCT01693562|364819998|FG010|Expansion Phase|Other|4|||
105773063|NCT01693562|364819999|FG011|Expansion Phase|Other|7|||
105773064|NCT01693562|364820000|FG012|Expansion Phase|Other|0|||
105773065|NCT01693562|364820001|FG013|Expansion Phase|Other|1|||
105773066|NCT01693562|364820002|FG014|Expansion Phase|Other|1|||
105773067|NCT01693562|364820003|FG015|Expansion Phase|Other|0|||
105773068|NCT01693562|364820004|FG016|Expansion Phase|Other|28|||
105773069|NCT01693562|364820005|FG017|Expansion Phase|Other|0|||
105773070|NCT01693562|364820006|FG018|Expansion Phase|Other|1|||
105773071|NCT01693562|364820007|FG019|Expansion Phase|Other|0|||
105773072|NCT01693562|364820008|FG020|Expansion Phase|Other|1|||
105773073|NCT01693562|364820009|FG021|Expansion Phase|Other|17|||
105773074|NCT01693562|364820010|FG022|Expansion Phase|Other|1|||
105773075|NCT01599585|364820013|FG000|Overall Study|Withdrawal by Subject|16|||
105773076|NCT01599585|364820014|FG001|Overall Study|Withdrawal by Subject|9|||
105773077|NCT01599585|364820013|FG000|Overall Study|Lost to Follow-up|3|||
105773078|NCT01599585|364820014|FG001|Overall Study|Lost to Follow-up|5|||
105773079|NCT01599585|364820013|FG000|Overall Study|randomized did not start treatment|3|||
105773080|NCT01599585|364820014|FG001|Overall Study|randomized did not start treatment|3|||
105773081|NCT03829319|364820017|FG000|Overall Study|Ongoing|4|||
105773082|NCT03829319|364820018|FG001|Overall Study|Ongoing|125|||
105773083|NCT03829319|364820019|FG002|Overall Study|Ongoing|130|||
105773084|NCT03829319|364820017|FG000|Overall Study|Withdrawal by Subject|1|||
105773085|NCT03829319|364820018|FG001|Overall Study|Withdrawal by Subject|6|||
105773086|NCT03829319|364820019|FG002|Overall Study|Withdrawal by Subject|8|||
105773087|NCT03829319|364820017|FG000|Overall Study|Physician Decision|0|||
105773088|NCT03829319|364820018|FG001|Overall Study|Physician Decision|1|||
105773089|NCT03829319|364820019|FG002|Overall Study|Physician Decision|0|||
105773090|NCT03829319|364820017|FG000|Overall Study|Lost to Follow-up|0|||
105773091|NCT03829319|364820018|FG001|Overall Study|Lost to Follow-up|0|||
105773092|NCT03829319|364820019|FG002|Overall Study|Lost to Follow-up|1|||
105773093|NCT03829319|364820017|FG000|Overall Study|Death|8|||
105773094|NCT03829319|364820018|FG001|Overall Study|Death|243|||
105773095|NCT03829319|364820019|FG002|Overall Study|Death|234|||
105773096|NCT04517253|364820020|FG000|Primary Treatment Period|Adverse Event|1|||
105773097|NCT04517253|364820021|FG001|Primary Treatment Period|Adverse Event|0|||
105773098|NCT04517253|364820022|FG002|Primary Treatment Period|Adverse Event|0|||
105773099|NCT04517253|364820020|FG000|Primary Treatment Period|Death|0|||
105773100|NCT04517253|364820021|FG001|Primary Treatment Period|Death|1|||
105773101|NCT04517253|364820022|FG002|Primary Treatment Period|Death|0|||
105773102|NCT04517253|364820020|FG000|Maintenance Period|Withdrawal by Subject|1|||
105773103|NCT04517253|364820021|FG001|Maintenance Period|Withdrawal by Subject|0|||
105773104|NCT04517253|364820022|FG002|Maintenance Period|Withdrawal by Subject|0|||
105773105|NCT04517253|364820020|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
105773106|NCT04517253|364820021|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
105773107|NCT04517253|364820022|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
105773108|NCT03598140|364820023|FG000|Overall Study|enrolled but didn't start|1|||
105773109|NCT03598140|364820024|FG001|Overall Study|enrolled but didn't start|0|||
105773110|NCT01842334|364820025|FG000|Overall Study|Withdrawal by Subject|3|||
105773111|NCT01842334|364820026|FG001|Overall Study|Withdrawal by Subject|3|||
105773112|NCT01842334|364820025|FG000|Overall Study|Moved away mid-study|0|||
105773113|NCT01842334|364820026|FG001|Overall Study|Moved away mid-study|1|||
105773114|NCT01021553|364820028|FG000|Overall Study|Adverse Event|1|||
105773115|NCT01021553|364820029|FG001|Overall Study|Adverse Event|0|||
105773116|NCT01021553|364820030|FG002|Overall Study|Adverse Event|0|||
105773117|NCT01021553|364820028|FG000|Overall Study|Lack of Efficacy|2|||
105773118|NCT01021553|364820029|FG001|Overall Study|Lack of Efficacy|2|||
105773119|NCT01021553|364820030|FG002|Overall Study|Lack of Efficacy|0|||
105773120|NCT01021553|364820028|FG000|Overall Study|Protocol Violation|0|||
105773121|NCT01021553|364820029|FG001|Overall Study|Protocol Violation|2|||
105773122|NCT01021553|364820030|FG002|Overall Study|Protocol Violation|2|||
105773123|NCT01021553|364820028|FG000|Overall Study|Lost to Follow-up|0|||
105773124|NCT01021553|364820029|FG001|Overall Study|Lost to Follow-up|0|||
105773125|NCT01021553|364820030|FG002|Overall Study|Lost to Follow-up|1|||
105773126|NCT01021553|364820028|FG000|Overall Study|Withdrawal by Subject|1|||
105442534|NCT05173012|363626784|FG007|Overall Study|Lost to Follow-up|0|||
105773127|NCT01021553|364820029|FG001|Overall Study|Withdrawal by Subject|1|||
105442535|NCT05173012|363626777|FG000|Overall Study|Withdrawal by Subject|1|||
105442536|NCT05173012|363626778|FG001|Overall Study|Withdrawal by Subject|0|||
105442537|NCT05173012|363626779|FG002|Overall Study|Withdrawal by Subject|1|||
105773128|NCT01021553|364820030|FG002|Overall Study|Withdrawal by Subject|0|||
105773129|NCT00126425|364820035|FG000|Overall Study|Withdrawal by Subject|17|||
105773130|NCT00126425|364820036|FG001|Overall Study|Withdrawal by Subject|1|||
105773131|NCT00126425|364820035|FG000|Overall Study|Lost to Follow-up|8|||
105773132|NCT00126425|364820036|FG001|Overall Study|Lost to Follow-up|4|||
105773133|NCT00126425|364820035|FG000|Overall Study|Protocol Violation|9|||
105773134|NCT00126425|364820036|FG001|Overall Study|Protocol Violation|6|||
105773135|NCT00126425|364820035|FG000|Overall Study|Adverse Event|1|||
105773136|NCT00126425|364820036|FG001|Overall Study|Adverse Event|0|||
105773137|NCT00126425|364820035|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
105773138|NCT00126425|364820036|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
105773139|NCT00126425|364820035|FG000|Overall Study|Other|5|||
105773140|NCT00126425|364820036|FG001|Overall Study|Other|0|||
105773141|NCT00149890|364820039|FG000|Overall Study|Adverse Event|1|||
105773142|NCT00149890|364820040|FG001|Overall Study|Adverse Event|8|||
105773143|NCT00149890|364820039|FG000|Overall Study|Lack of Efficacy|8|||
105773144|NCT00149890|364820040|FG001|Overall Study|Lack of Efficacy|9|||
105773145|NCT00149890|364820039|FG000|Overall Study|Protocol Violation|1|||
105773146|NCT00149890|364820040|FG001|Overall Study|Protocol Violation|0|||
105773147|NCT00149890|364820039|FG000|Overall Study|Lost to Follow-up|1|||
105773148|NCT00149890|364820040|FG001|Overall Study|Lost to Follow-up|0|||
105773149|NCT00149890|364820039|FG000|Overall Study|Graft Loss|2|||
105773150|NCT00149890|364820040|FG001|Overall Study|Graft Loss|1|||
105773151|NCT00998985|364820044|FG000|Overall Study|Withdrawal by Subject|0|||
105773152|NCT00998985|364820045|FG001|Overall Study|Withdrawal by Subject|0|||
105773153|NCT00998985|364820046|FG002|Overall Study|Withdrawal by Subject|0|||
105773154|NCT00998985|364820047|FG003|Overall Study|Withdrawal by Subject|0|||
105773155|NCT00998985|364820048|FG004|Overall Study|Withdrawal by Subject|0|||
105773156|NCT00998985|364820049|FG005|Overall Study|Withdrawal by Subject|0|||
105773157|NCT00998985|364820050|FG006|Overall Study|Withdrawal by Subject|0|||
105773158|NCT00998985|364820051|FG007|Overall Study|Withdrawal by Subject|0|||
105773159|NCT00998985|364820052|FG008|Overall Study|Withdrawal by Subject|1|||
105773160|NCT00998985|364820053|FG009|Overall Study|Withdrawal by Subject|0|||
105773161|NCT00998985|364820054|FG010|Overall Study|Withdrawal by Subject|0|||
105773162|NCT00998985|364820055|FG011|Overall Study|Withdrawal by Subject|0|||
105773163|NCT00998985|364820056|FG012|Overall Study|Withdrawal by Subject|0|||
105773164|NCT00998985|364820057|FG013|Overall Study|Withdrawal by Subject|0|||
105773165|NCT00998985|364820044|FG000|Overall Study|Protocol Violation|0|||
105773166|NCT00998985|364820045|FG001|Overall Study|Protocol Violation|0|||
105773167|NCT00998985|364820046|FG002|Overall Study|Protocol Violation|0|||
105773168|NCT00998985|364820047|FG003|Overall Study|Protocol Violation|0|||
105773169|NCT00998985|364820048|FG004|Overall Study|Protocol Violation|0|||
105773170|NCT00998985|364820049|FG005|Overall Study|Protocol Violation|1|||
105773171|NCT00998985|364820050|FG006|Overall Study|Protocol Violation|0|||
105773172|NCT00998985|364820051|FG007|Overall Study|Protocol Violation|0|||
105773173|NCT00998985|364820052|FG008|Overall Study|Protocol Violation|0|||
105773174|NCT00998985|364820053|FG009|Overall Study|Protocol Violation|0|||
105773175|NCT00998985|364820054|FG010|Overall Study|Protocol Violation|0|||
105773176|NCT00998985|364820055|FG011|Overall Study|Protocol Violation|0|||
105773177|NCT00998985|364820056|FG012|Overall Study|Protocol Violation|0|||
105773178|NCT00998985|364820057|FG013|Overall Study|Protocol Violation|0|||
105773179|NCT01040728|364820058|FG000|Overall Study|Adverse Event|4|||
105773180|NCT01040728|364820059|FG001|Overall Study|Adverse Event|8|||
105773181|NCT01040728|364820060|FG002|Overall Study|Adverse Event|0|||
105773182|NCT01040728|364820061|FG003|Overall Study|Adverse Event|4|||
105773183|NCT01040728|364820058|FG000|Overall Study|Withdrawal by Subject|0|||
105773184|NCT01040728|364820059|FG001|Overall Study|Withdrawal by Subject|1|||
105773185|NCT01040728|364820060|FG002|Overall Study|Withdrawal by Subject|1|||
105773186|NCT01040728|364820061|FG003|Overall Study|Withdrawal by Subject|0|||
105773187|NCT01040728|364820058|FG000|Overall Study|Protocol Violation|0|||
105773188|NCT01040728|364820059|FG001|Overall Study|Protocol Violation|0|||
105773189|NCT01040728|364820060|FG002|Overall Study|Protocol Violation|0|||
105773190|NCT01040728|364820061|FG003|Overall Study|Protocol Violation|1|||
105773191|NCT01040728|364820058|FG000|Overall Study|Lack of Efficacy|0|||
105773192|NCT01040728|364820059|FG001|Overall Study|Lack of Efficacy|1|||
105773193|NCT01040728|364820060|FG002|Overall Study|Lack of Efficacy|0|||
105773194|NCT01040728|364820061|FG003|Overall Study|Lack of Efficacy|1|||
105773195|NCT01040728|364820058|FG000|Overall Study|Other reasons not listed above|0|||
105773196|NCT01040728|364820059|FG001|Overall Study|Other reasons not listed above|1|||
105773197|NCT01040728|364820060|FG002|Overall Study|Other reasons not listed above|0|||
105773198|NCT01040728|364820061|FG003|Overall Study|Other reasons not listed above|0|||
105773199|NCT02583711|364820064|FG000|Overall Study|Withdrawal by Subject|0|||
105773200|NCT02583711|364820065|FG001|Overall Study|Withdrawal by Subject|10|||
105773201|NCT02583711|364820066|FG002|Overall Study|Withdrawal by Subject|0|||
105773202|NCT01875874|364820067|FG000|Overall Study|Death|3|||
105773203|NCT02382276|364820068|FG000|Overall Study|Withdrawal by Subject|4|||
105773204|NCT02382276|364820069|FG001|Overall Study|Withdrawal by Subject|8|||
105773205|NCT02382276|364820070|FG002|Overall Study|Withdrawal by Subject|5|||
105773206|NCT02382276|364820068|FG000|Overall Study|Adverse Event|7|||
105773207|NCT02382276|364820069|FG001|Overall Study|Adverse Event|2|||
105773208|NCT02382276|364820070|FG002|Overall Study|Adverse Event|32|||
105773209|NCT02382276|364820068|FG000|Overall Study|Physician Decision|0|||
105773210|NCT02382276|364820069|FG001|Overall Study|Physician Decision|0|||
105773211|NCT02382276|364820070|FG002|Overall Study|Physician Decision|2|||
105773212|NCT03452397|364820072|FG000|Overall Study|Adverse Event|1|||
105773213|NCT03452397|364820073|FG001|Overall Study|Adverse Event|0|||
105773214|NCT03452397|364820074|FG002|Overall Study|Adverse Event|0|||
105773215|NCT03452397|364820075|FG003|Overall Study|Adverse Event|0|||
105773216|NCT03452397|364820072|FG000|Overall Study|Administrative reason|0|||
105773217|NCT03452397|364820073|FG001|Overall Study|Administrative reason|0|||
105773218|NCT03452397|364820074|FG002|Overall Study|Administrative reason|1|||
105773219|NCT03452397|364820075|FG003|Overall Study|Administrative reason|1|||
105773220|NCT03452397|364820072|FG000|Overall Study|Withdrawal by Subject|0|||
105773221|NCT03452397|364820073|FG001|Overall Study|Withdrawal by Subject|0|||
105773222|NCT03452397|364820074|FG002|Overall Study|Withdrawal by Subject|1|||
105773223|NCT03452397|364820075|FG003|Overall Study|Withdrawal by Subject|0|||
105773224|NCT00286156|364820078|FG000|Overall Study|Missed 12 month visit|0|||
105773225|NCT00286156|364820079|FG001|Overall Study|Missed 12 month visit|0|||
105773226|NCT00286156|364820080|FG002|Overall Study|Missed 12 month visit|1|||
105773227|NCT00286156|364820078|FG000|Overall Study|AE: pulmonary embolus|0|||
105773228|NCT00286156|364820079|FG001|Overall Study|AE: pulmonary embolus|1|||
105773229|NCT00286156|364820080|FG002|Overall Study|AE: pulmonary embolus|0|||
105773230|NCT00286156|364820078|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
105773231|NCT00286156|364820079|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
105773232|NCT00286156|364820080|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
105773233|NCT00286156|364820078|FG000|Overall Study|AE: pneumonia|1|||
105773234|NCT00286156|364820079|FG001|Overall Study|AE: pneumonia|0|||
105773235|NCT00286156|364820080|FG002|Overall Study|AE: pneumonia|0|||
105773236|NCT05281094|364820082|FG000|Overall Study|Adverse Event|1|||
105773237|NCT05281094|364820083|FG001|Overall Study|Adverse Event|0|||
105773238|NCT05281094|364820082|FG000|Overall Study|Lost to Follow-up|29|||
105773239|NCT05281094|364820083|FG001|Overall Study|Lost to Follow-up|22|||
105773240|NCT05281094|364820082|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
105773241|NCT05281094|364820083|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
105773242|NCT05281094|364820082|FG000|Overall Study|Death|1|||
105773243|NCT05281094|364820083|FG001|Overall Study|Death|2|||
105773244|NCT05281094|364820082|FG000|Overall Study|Not pre-specified reason|8|||
105773245|NCT05281094|364820083|FG001|Overall Study|Not pre-specified reason|5|||
105773246|NCT04459416|364821565|FG000|Overall Study|Lost to Follow-up|2|||
105773247|NCT04459416|364821566|FG001|Overall Study|Lost to Follow-up|0|||
105773248|NCT04459416|364821565|FG000|Overall Study|Withdrawal by Subject|8|||
105773249|NCT04459416|364821566|FG001|Overall Study|Withdrawal by Subject|10|||
105773250|NCT04459416|364821565|FG000|Overall Study|Disease progression|0|||
105773251|NCT04459416|364821566|FG001|Overall Study|Disease progression|3|||
105773252|NCT04418427|364821571|FG000|Overall Study|Death|0|||
105773253|NCT04418427|364821572|FG001|Overall Study|Death|1|||
105773254|NCT04418427|364821573|FG002|Overall Study|Death|0|||
105773255|NCT04418427|364821571|FG000|Overall Study|Lost to Follow-up|0|||
105773256|NCT04418427|364821572|FG001|Overall Study|Lost to Follow-up|2|||
105773257|NCT04418427|364821573|FG002|Overall Study|Lost to Follow-up|2|||
105773258|NCT04418427|364821571|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
105773259|NCT04418427|364821572|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
105773260|NCT04418427|364821573|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
105773261|NCT04418427|364821571|FG000|Overall Study|Pre-existing medical condition|0|||
105773262|NCT04418427|364821572|FG001|Overall Study|Pre-existing medical condition|1|||
105773263|NCT04418427|364821573|FG002|Overall Study|Pre-existing medical condition|0|||
105773264|NCT02554721|364821578|FG000|Overall Study|Adverse Event|1|||
105773265|NCT02554721|364821579|FG001|Overall Study|Adverse Event|0|||
105773266|NCT02554721|364821580|FG002|Overall Study|Adverse Event|0|||
105773267|NCT02554721|364821581|FG003|Overall Study|Adverse Event|0|||
105773268|NCT02554721|364821582|FG004|Overall Study|Adverse Event|1|||
105773269|NCT02554721|364821578|FG000|Overall Study|Noncompliance|0|||
105773270|NCT02554721|364821579|FG001|Overall Study|Noncompliance|0|||
105773271|NCT02554721|364821580|FG002|Overall Study|Noncompliance|0|||
105773272|NCT02554721|364821581|FG003|Overall Study|Noncompliance|0|||
105773273|NCT02554721|364821582|FG004|Overall Study|Noncompliance|1|||
105773274|NCT01888965|364821584|FG000|Overall Study|Adverse Event|5|||
105773275|NCT01888965|364821584|FG000|Overall Study|Lack of Efficacy|4|||
105773276|NCT04610827|364821585|FG000|Overall Study|Withdrawal by Subject|1|||
105773277|NCT04610827|364821586|FG001|Overall Study|Withdrawal by Subject|1|||
105773278|NCT04610827|364821587|FG002|Overall Study|Withdrawal by Subject|0|||
105773279|NCT00908895|364821589|FG000|Overall Study|Lost to Follow-up|1|||
105773280|NCT00908895|364821590|FG001|Overall Study|Lost to Follow-up|3|||
105773281|NCT00908895|364821589|FG000|Overall Study|algodystrophy|2|||
105773282|NCT00908895|364821590|FG001|Overall Study|algodystrophy|2|||
105773283|NCT00908895|364821589|FG000|Overall Study|Adverse Event|1|||
105773284|NCT00908895|364821590|FG001|Overall Study|Adverse Event|1|||
105773285|NCT00443534|364821592|FG000|Overall Study|Lack of Efficacy|67|||
105773286|NCT00443534|364821592|FG000|Overall Study|Adverse Event|16|||
105773287|NCT00443534|364821592|FG000|Overall Study|Death|9|||
105773288|NCT00443534|364821592|FG000|Overall Study|Withdrawal by Subject|8|||
105773289|NCT00443534|364821592|FG000|Overall Study|Study Terminated by Sponsor|12|||
105773290|NCT00443534|364821592|FG000|Overall Study|Other|10|||
105773291|NCT00443534|364821592|FG000|Overall Study|Enrolled, Not Treated|1|||
105773292|NCT00364611|364821594|FG000|Overall Study|Did not receive study medication|0|||
105773293|NCT00364611|364821595|FG001|Overall Study|Did not receive study medication|1|||
105773294|NCT00364611|364821594|FG000|Overall Study|Adverse Event|7|||
105773295|NCT00364611|364821595|FG001|Overall Study|Adverse Event|4|||
105773296|NCT00364611|364821594|FG000|Overall Study|Participant's Request|3|||
105773297|NCT00364611|364821595|FG001|Overall Study|Participant's Request|4|||
105773298|NCT00364611|364821594|FG000|Overall Study|Disease Progression|38|||
105773299|NCT00364611|364821595|FG001|Overall Study|Disease Progression|8|||
105773300|NCT00364611|364821594|FG000|Overall Study|Investigator decision|2|||
105773301|NCT00364611|364821595|FG001|Overall Study|Investigator decision|2|||
105773302|NCT00364611|364821594|FG000|Overall Study|Found Ineligible|1|||
105773303|NCT00364611|364821595|FG001|Overall Study|Found Ineligible|0|||
105773304|NCT00364611|364821594|FG000|Overall Study|Presumed CR on Study|0|||
105773305|NCT00364611|364821595|FG001|Overall Study|Presumed CR on Study|1|||
105773306|NCT00364611|364821594|FG000|Overall Study|Receiving Liver Ablation|0|||
105773307|NCT00364611|364821595|FG001|Overall Study|Receiving Liver Ablation|1|||
105773308|NCT02881151|364821602|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
105773309|NCT03225833|364821603|FG000|Overall Study|Adverse Event|0|||
105773310|NCT03225833|364821604|FG001|Overall Study|Adverse Event|1|||
105773311|NCT03225833|364821605|FG002|Overall Study|Adverse Event|2|||
105773312|NCT03225833|364821606|FG003|Overall Study|Adverse Event|0|||
105773313|NCT03225833|364821607|FG004|Overall Study|Adverse Event|0|||
105773314|NCT03225833|364821608|FG005|Overall Study|Adverse Event|2|||
105773315|NCT03225833|364821603|FG000|Overall Study|Withdrawal by Subject|1|||
105773316|NCT03225833|364821604|FG001|Overall Study|Withdrawal by Subject|0|||
105773317|NCT03225833|364821605|FG002|Overall Study|Withdrawal by Subject|0|||
105773318|NCT03225833|364821606|FG003|Overall Study|Withdrawal by Subject|0|||
105773319|NCT03225833|364821607|FG004|Overall Study|Withdrawal by Subject|1|||
105773320|NCT03225833|364821608|FG005|Overall Study|Withdrawal by Subject|0|||
105773321|NCT03225833|364821603|FG000|Overall Study|Termination of Study by Sponsor|4|||
105773322|NCT03225833|364821604|FG001|Overall Study|Termination of Study by Sponsor|0|||
105773323|NCT03225833|364821605|FG002|Overall Study|Termination of Study by Sponsor|0|||
105773324|NCT03225833|364821606|FG003|Overall Study|Termination of Study by Sponsor|0|||
105773325|NCT03225833|364821607|FG004|Overall Study|Termination of Study by Sponsor|0|||
105773326|NCT03225833|364821608|FG005|Overall Study|Termination of Study by Sponsor|7|||
105773327|NCT03225833|364821603|FG000|Overall Study|Sponsor Decision|0|||
105773328|NCT03225833|364821604|FG001|Overall Study|Sponsor Decision|0|||
105773329|NCT03225833|364821605|FG002|Overall Study|Sponsor Decision|0|||
105773330|NCT03225833|364821606|FG003|Overall Study|Sponsor Decision|0|||
105773331|NCT03225833|364821607|FG004|Overall Study|Sponsor Decision|0|||
105773332|NCT03225833|364821608|FG005|Overall Study|Sponsor Decision|1|||
105773333|NCT00723489|364821609|FG000|Overall Study|Physician Decision|0|||
105773334|NCT00723489|364821610|FG001|Overall Study|Physician Decision|1|||
105773335|NCT00723489|364821611|FG002|Overall Study|Physician Decision|0|||
105773336|NCT00723489|364821612|FG003|Overall Study|Physician Decision|0|||
105773337|NCT00723489|364821609|FG000|Overall Study|Pregnancy|0|||
105773338|NCT00723489|364821610|FG001|Overall Study|Pregnancy|0|||
105773339|NCT00723489|364821611|FG002|Overall Study|Pregnancy|0|||
105773340|NCT00723489|364821612|FG003|Overall Study|Pregnancy|1|||
105773341|NCT00723489|364821609|FG000|Overall Study|Withdrawal by Subject|0|||
105773342|NCT00723489|364821610|FG001|Overall Study|Withdrawal by Subject|0|||
105773343|NCT00723489|364821611|FG002|Overall Study|Withdrawal by Subject|0|||
105773344|NCT00723489|364821612|FG003|Overall Study|Withdrawal by Subject|1|||
105773345|NCT00723489|364821609|FG000|Overall Study|Seropositive at baseline|1|||
105773346|NCT00723489|364821610|FG001|Overall Study|Seropositive at baseline|0|||
105773347|NCT00723489|364821611|FG002|Overall Study|Seropositive at baseline|0|||
105773348|NCT00723489|364821612|FG003|Overall Study|Seropositive at baseline|0|||
105773349|NCT00723489|364821609|FG000|Overall Study|Prohibited Medication|0|||
105773350|NCT00723489|364821610|FG001|Overall Study|Prohibited Medication|0|||
105773351|NCT00723489|364821611|FG002|Overall Study|Prohibited Medication|0|||
105773352|NCT00723489|364821612|FG003|Overall Study|Prohibited Medication|1|||
105773353|NCT00723489|364821609|FG000|Overall Study|Samples Collected Out of Window|0|||
105773354|NCT00723489|364821610|FG001|Overall Study|Samples Collected Out of Window|3|||
105773355|NCT00723489|364821611|FG002|Overall Study|Samples Collected Out of Window|0|||
105773356|NCT00723489|364821612|FG003|Overall Study|Samples Collected Out of Window|0|||
105334069|NCT01314872|363223078|FG008|Treatment Period 1|Lack of Efficacy|0|||
105773357|NCT02721732|364821613|FG000|Overall Study|Adverse Event|2|||
105773358|NCT02721732|364821614|FG001|Overall Study|Adverse Event|0|||
105773359|NCT02721732|364821615|FG002|Overall Study|Adverse Event|2|||
105773360|NCT02721732|364821616|FG003|Overall Study|Adverse Event|0|||
105773361|NCT02721732|364821617|FG004|Overall Study|Adverse Event|1|||
105773362|NCT02721732|364821618|FG005|Overall Study|Adverse Event|0|||
105773363|NCT02721732|364821619|FG006|Overall Study|Adverse Event|1|||
105773364|NCT02721732|364821620|FG007|Overall Study|Adverse Event|0|||
105773365|NCT02721732|364821621|FG008|Overall Study|Adverse Event|1|||
105773366|NCT02721732|364821622|FG009|Overall Study|Adverse Event|1|||
105773367|NCT02721732|364821613|FG000|Overall Study|Death|0|||
105773368|NCT02721732|364821614|FG001|Overall Study|Death|0|||
105773369|NCT02721732|364821615|FG002|Overall Study|Death|0|||
105773370|NCT02721732|364821616|FG003|Overall Study|Death|0|||
105773371|NCT02721732|364821617|FG004|Overall Study|Death|1|||
105334070|NCT01314872|363223079|FG009|Treatment Period 1|Lack of Efficacy|0|||
105773372|NCT02721732|364821618|FG005|Overall Study|Death|0|||
105773373|NCT02721732|364821619|FG006|Overall Study|Death|1|||
105773374|NCT02721732|364821620|FG007|Overall Study|Death|0|||
105773375|NCT02721732|364821621|FG008|Overall Study|Death|0|||
105773376|NCT02721732|364821622|FG009|Overall Study|Death|1|||
105773377|NCT02721732|364821613|FG000|Overall Study|Lack of Efficacy|12|||
105773378|NCT02721732|364821614|FG001|Overall Study|Lack of Efficacy|11|||
105773379|NCT02721732|364821615|FG002|Overall Study|Lack of Efficacy|18|||
105773380|NCT02721732|364821616|FG003|Overall Study|Lack of Efficacy|5|||
105773381|NCT02721732|364821617|FG004|Overall Study|Lack of Efficacy|21|||
105773382|NCT02721732|364821618|FG005|Overall Study|Lack of Efficacy|2|||
105773383|NCT02721732|364821619|FG006|Overall Study|Lack of Efficacy|8|||
105773384|NCT02721732|364821620|FG007|Overall Study|Lack of Efficacy|11|||
105773385|NCT02721732|364821621|FG008|Overall Study|Lack of Efficacy|10|||
105773386|NCT02721732|364821622|FG009|Overall Study|Lack of Efficacy|20|||
105773387|NCT02721732|364821613|FG000|Overall Study|Physician Decision|0|||
105773388|NCT02721732|364821614|FG001|Overall Study|Physician Decision|0|||
105773389|NCT02721732|364821615|FG002|Overall Study|Physician Decision|1|||
105773390|NCT02721732|364821616|FG003|Overall Study|Physician Decision|0|||
105773391|NCT02721732|364821617|FG004|Overall Study|Physician Decision|0|||
105773392|NCT02721732|364821618|FG005|Overall Study|Physician Decision|0|||
105773393|NCT02721732|364821619|FG006|Overall Study|Physician Decision|0|||
105773394|NCT02721732|364821620|FG007|Overall Study|Physician Decision|0|||
105773395|NCT02721732|364821621|FG008|Overall Study|Physician Decision|0|||
105773396|NCT02721732|364821622|FG009|Overall Study|Physician Decision|0|||
105773397|NCT02721732|364821613|FG000|Overall Study|Withdrawal by Subject|1|||
105773398|NCT02721732|364821614|FG001|Overall Study|Withdrawal by Subject|0|||
105773399|NCT02721732|364821615|FG002|Overall Study|Withdrawal by Subject|0|||
105773400|NCT02721732|364821616|FG003|Overall Study|Withdrawal by Subject|0|||
105773401|NCT02721732|364821617|FG004|Overall Study|Withdrawal by Subject|3|||
105773402|NCT02721732|364821618|FG005|Overall Study|Withdrawal by Subject|0|||
105773403|NCT02721732|364821619|FG006|Overall Study|Withdrawal by Subject|1|||
105773404|NCT02721732|364821620|FG007|Overall Study|Withdrawal by Subject|1|||
105773405|NCT02721732|364821621|FG008|Overall Study|Withdrawal by Subject|0|||
105773406|NCT02721732|364821622|FG009|Overall Study|Withdrawal by Subject|1|||
105773407|NCT02721732|364821613|FG000|Overall Study|Participant Choice|1|||
105773408|NCT02721732|364821614|FG001|Overall Study|Participant Choice|0|||
105773409|NCT02721732|364821615|FG002|Overall Study|Participant Choice|0|||
105773410|NCT02721732|364821616|FG003|Overall Study|Participant Choice|0|||
105773411|NCT02721732|364821617|FG004|Overall Study|Participant Choice|0|||
105773412|NCT02721732|364821618|FG005|Overall Study|Participant Choice|0|||
105773413|NCT02721732|364821619|FG006|Overall Study|Participant Choice|0|||
105773414|NCT02721732|364821620|FG007|Overall Study|Participant Choice|0|||
105773415|NCT02721732|364821621|FG008|Overall Study|Participant Choice|0|||
105773416|NCT02721732|364821622|FG009|Overall Study|Participant Choice|1|||
105773417|NCT02721732|364821613|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
105773418|NCT02721732|364821614|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
105773419|NCT02721732|364821615|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
105773420|NCT02721732|364821616|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
105773421|NCT02721732|364821617|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
105773422|NCT02721732|364821618|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
105773423|NCT02721732|364821619|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
105773424|NCT02721732|364821620|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
105773425|NCT02721732|364821621|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
105773426|NCT02721732|364821622|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
105773427|NCT02721732|364821613|FG000|Overall Study|Progression and withdrew consent|1|||
105773428|NCT02721732|364821614|FG001|Overall Study|Progression and withdrew consent|1|||
105773429|NCT02721732|364821615|FG002|Overall Study|Progression and withdrew consent|0|||
105773430|NCT02721732|364821616|FG003|Overall Study|Progression and withdrew consent|0|||
105773431|NCT02721732|364821617|FG004|Overall Study|Progression and withdrew consent|0|||
105773432|NCT02721732|364821618|FG005|Overall Study|Progression and withdrew consent|0|||
105773433|NCT02721732|364821619|FG006|Overall Study|Progression and withdrew consent|0|||
105773434|NCT02721732|364821620|FG007|Overall Study|Progression and withdrew consent|0|||
105773435|NCT02721732|364821621|FG008|Overall Study|Progression and withdrew consent|0|||
105773436|NCT02721732|364821622|FG009|Overall Study|Progression and withdrew consent|1|||
105773437|NCT02721732|364821613|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
105773438|NCT02721732|364821614|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
105773439|NCT02721732|364821615|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
105773440|NCT02721732|364821616|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
105773441|NCT02721732|364821617|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
105773442|NCT02721732|364821618|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
105773443|NCT02721732|364821619|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
105773444|NCT02721732|364821620|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
105773445|NCT02721732|364821621|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
105773446|NCT02721732|364821622|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
105773447|NCT05827978|364821623|FG000|Overall Study|Adverse Event|1|||
105773448|NCT05827978|364821624|FG001|Overall Study|Adverse Event|0|||
105773449|NCT05827978|364821625|FG002|Overall Study|Adverse Event|0|||
105773450|NCT05827978|364821626|FG003|Overall Study|Adverse Event|1|||
105773451|NCT05827978|364821627|FG004|Overall Study|Adverse Event|0|||
105773452|NCT05827978|364821628|FG005|Overall Study|Adverse Event|0|||
105773453|NCT05827978|364821623|FG000|Overall Study|Death|1|||
105773454|NCT05827978|364821624|FG001|Overall Study|Death|5|||
105773455|NCT05827978|364821625|FG002|Overall Study|Death|2|||
105773456|NCT05827978|364821626|FG003|Overall Study|Death|3|||
105773457|NCT05827978|364821627|FG004|Overall Study|Death|1|||
105773458|NCT05827978|364821628|FG005|Overall Study|Death|3|||
105773459|NCT05827978|364821623|FG000|Overall Study|Lost to Follow-up|57|||
105773460|NCT05827978|364821624|FG001|Overall Study|Lost to Follow-up|88|||
105773461|NCT05827978|364821625|FG002|Overall Study|Lost to Follow-up|54|||
105773462|NCT05827978|364821626|FG003|Overall Study|Lost to Follow-up|47|||
105773463|NCT05827978|364821627|FG004|Overall Study|Lost to Follow-up|25|||
105773464|NCT05827978|364821628|FG005|Overall Study|Lost to Follow-up|10|||
105773465|NCT05827978|364821623|FG000|Overall Study|Noncompliance with Study Procedures|0|||
105773466|NCT05827978|364821624|FG001|Overall Study|Noncompliance with Study Procedures|1|||
105773467|NCT05827978|364821625|FG002|Overall Study|Noncompliance with Study Procedures|1|||
105773468|NCT05827978|364821626|FG003|Overall Study|Noncompliance with Study Procedures|1|||
105773469|NCT05827978|364821627|FG004|Overall Study|Noncompliance with Study Procedures|1|||
105773470|NCT05827978|364821628|FG005|Overall Study|Noncompliance with Study Procedures|0|||
105773471|NCT05827978|364821623|FG000|Overall Study|Physician Decision|2|||
105773472|NCT05827978|364821624|FG001|Overall Study|Physician Decision|0|||
105773473|NCT05827978|364821625|FG002|Overall Study|Physician Decision|1|||
105773474|NCT05827978|364821626|FG003|Overall Study|Physician Decision|2|||
105773475|NCT05827978|364821627|FG004|Overall Study|Physician Decision|1|||
105773476|NCT05827978|364821628|FG005|Overall Study|Physician Decision|1|||
105773477|NCT05827978|364821623|FG000|Overall Study|Protocol Violation|5|||
105773478|NCT05827978|364821624|FG001|Overall Study|Protocol Violation|2|||
105773479|NCT05827978|364821625|FG002|Overall Study|Protocol Violation|0|||
105773480|NCT05827978|364821626|FG003|Overall Study|Protocol Violation|0|||
105773481|NCT05827978|364821627|FG004|Overall Study|Protocol Violation|0|||
105773482|NCT05827978|364821628|FG005|Overall Study|Protocol Violation|0|||
105773483|NCT05827978|364821623|FG000|Overall Study|Withdrawal by Subject|17|||
105773484|NCT05827978|364821624|FG001|Overall Study|Withdrawal by Subject|16|||
105773485|NCT05827978|364821625|FG002|Overall Study|Withdrawal by Subject|10|||
105773486|NCT05827978|364821626|FG003|Overall Study|Withdrawal by Subject|12|||
105773487|NCT05827978|364821627|FG004|Overall Study|Withdrawal by Subject|10|||
105773488|NCT05827978|364821628|FG005|Overall Study|Withdrawal by Subject|9|||
105773489|NCT05827978|364821623|FG000|Overall Study|Other Than Specified|0|||
105773490|NCT05827978|364821624|FG001|Overall Study|Other Than Specified|0|||
105773491|NCT05827978|364821625|FG002|Overall Study|Other Than Specified|1|||
105773492|NCT05827978|364821626|FG003|Overall Study|Other Than Specified|0|||
105773493|NCT05827978|364821627|FG004|Overall Study|Other Than Specified|2|||
105773494|NCT05827978|364821628|FG005|Overall Study|Other Than Specified|0|||
105773495|NCT01108263|364821629|FG000|Overall Study|Adverse Event|0|||
105773496|NCT01108263|364821630|FG001|Overall Study|Adverse Event|1|||
105773497|NCT01023516|364821631|FG000|Overall Study|Voluntary discontinuation|7|||
105773498|NCT01023516|364821632|FG001|Overall Study|Voluntary discontinuation|5|||
105773499|NCT01023516|364821631|FG000|Overall Study|Adverse Event|9|||
105773500|NCT01023516|364821632|FG001|Overall Study|Adverse Event|6|||
105773501|NCT01023516|364821631|FG000|Overall Study|Safety reason|0|||
105773502|NCT01023516|364821632|FG001|Overall Study|Safety reason|3|||
105773503|NCT01023516|364821631|FG000|Overall Study|Study-specific criteria|4|||
105773504|NCT01023516|364821632|FG001|Overall Study|Study-specific criteria|2|||
105773505|NCT01023516|364821631|FG000|Overall Study|Incorrect enrolment|4|||
105773506|NCT01023516|364821632|FG001|Overall Study|Incorrect enrolment|2|||
105773507|NCT01266876|364821633|FG000|Overall Study|Adverse Event|0|||
105773508|NCT01266876|364821634|FG001|Overall Study|Adverse Event|0|||
105773509|NCT01266876|364821635|FG002|Overall Study|Adverse Event|0|||
105442538|NCT05173012|363626780|FG003|Overall Study|Withdrawal by Subject|3|||
105773510|NCT01266876|364821636|FG003|Overall Study|Adverse Event|1|||
105773511|NCT01266876|364821637|FG004|Overall Study|Adverse Event|0|||
105773512|NCT05180721|364821638|FG000|Overall Study|Lost to Follow-up|4|||
105773513|NCT01996865|364821639|FG000|Induction Period|Protocol Violation|1|||
105773514|NCT01996865|364821640|FG001|Induction Period|Protocol Violation|0|||
105773515|NCT01996865|364821641|FG002|Induction Period|Protocol Violation|0|||
105773516|NCT01996865|364821639|FG000|Induction Period|Progressive Disease|4|||
105773517|NCT01996865|364821640|FG001|Induction Period|Progressive Disease|0|||
105773518|NCT01996865|364821641|FG002|Induction Period|Progressive Disease|0|||
105773519|NCT01996865|364821639|FG000|Induction Period|Lost to Follow-up|10|||
105773520|NCT01996865|364821640|FG001|Induction Period|Lost to Follow-up|0|||
105773521|NCT01996865|364821641|FG002|Induction Period|Lost to Follow-up|0|||
105773522|NCT01996865|364821639|FG000|Induction Period|Other Reasons|13|||
105773523|NCT01996865|364821640|FG001|Induction Period|Other Reasons|0|||
105773524|NCT01996865|364821641|FG002|Induction Period|Other Reasons|0|||
105773525|NCT01996865|364821639|FG000|Induction Period|Adverse Event|20|||
105773526|NCT01996865|364821640|FG001|Induction Period|Adverse Event|0|||
105773527|NCT01996865|364821641|FG002|Induction Period|Adverse Event|0|||
105773528|NCT01996865|364821639|FG000|Induction Period|Withdrawal by Subject|60|||
105773529|NCT01996865|364821640|FG001|Induction Period|Withdrawal by Subject|0|||
105773530|NCT01996865|364821641|FG002|Induction Period|Withdrawal by Subject|0|||
105773531|NCT01996865|364821639|FG000|Induction Period|Death|111|||
105773532|NCT01996865|364821640|FG001|Induction Period|Death|0|||
105773533|NCT01996865|364821641|FG002|Induction Period|Death|0|||
105773534|NCT01996865|364821639|FG000|Maintenance Period|Protocol Violation|0|||
105773535|NCT01996865|364821640|FG001|Maintenance Period|Protocol Violation|1|||
105773536|NCT01996865|364821641|FG002|Maintenance Period|Protocol Violation|1|||
105773537|NCT01996865|364821639|FG000|Maintenance Period|Other reasons|0|||
105773538|NCT01996865|364821640|FG001|Maintenance Period|Other reasons|8|||
105773539|NCT01996865|364821641|FG002|Maintenance Period|Other reasons|5|||
105773540|NCT01996865|364821639|FG000|Maintenance Period|Progressive Disease|0|||
105773541|NCT01996865|364821640|FG001|Maintenance Period|Progressive Disease|6|||
105773542|NCT01996865|364821641|FG002|Maintenance Period|Progressive Disease|23|||
105773543|NCT01996865|364821639|FG000|Maintenance Period|Withdrawal by Subject|0|||
105773544|NCT01996865|364821640|FG001|Maintenance Period|Withdrawal by Subject|18|||
105773545|NCT01996865|364821641|FG002|Maintenance Period|Withdrawal by Subject|4|||
105773546|NCT01996865|364821639|FG000|Maintenance Period|Adverse Event|0|||
105773547|NCT01996865|364821640|FG001|Maintenance Period|Adverse Event|7|||
105773548|NCT01996865|364821641|FG002|Maintenance Period|Adverse Event|7|||
105773549|NCT01996865|364821639|FG000|Maintenance Period|Death|0|||
105773550|NCT01996865|364821640|FG001|Maintenance Period|Death|15|||
105773551|NCT01996865|364821641|FG002|Maintenance Period|Death|3|||
105773552|NCT01996865|364821639|FG000|Maintenance Period|Lost to Follow-up|0|||
105773553|NCT01996865|364821640|FG001|Maintenance Period|Lost to Follow-up|2|||
105773554|NCT01996865|364821641|FG002|Maintenance Period|Lost to Follow-up|0|||
105773555|NCT05304611|364821644|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773556|NCT05304611|364821645|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773557|NCT05304611|364821646|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773558|NCT05304611|364821647|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773559|NCT05304611|364821648|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773560|NCT05304611|364821649|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773561|NCT05304611|364821650|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
105773562|NCT05304611|364821651|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773563|NCT05304611|364821652|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
105773564|NCT05304611|364821653|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773565|NCT05304611|364821654|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773566|NCT05304611|364821655|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773567|NCT05304611|364821644|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
105773568|NCT05304611|364821645|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
105773569|NCT05304611|364821646|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
105773570|NCT05304611|364821647|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
105773571|NCT05304611|364821648|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
105773572|NCT05304611|364821649|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
105773573|NCT05304611|364821650|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
105773574|NCT05304611|364821651|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
105773575|NCT05304611|364821652|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
105773576|NCT05304611|364821653|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
105773577|NCT05304611|364821654|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
105773578|NCT05304611|364821655|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
105773579|NCT05304611|364821644|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
105773580|NCT05304611|364821645|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
105773581|NCT05304611|364821646|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
105773582|NCT05304611|364821647|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
105773583|NCT05304611|364821648|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
105773584|NCT05304611|364821649|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
105773585|NCT05304611|364821650|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
105773586|NCT05304611|364821651|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
105773587|NCT05304611|364821652|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
105442539|NCT05173012|363626781|FG004|Overall Study|Withdrawal by Subject|1|||
105773588|NCT05304611|364821653|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
105773589|NCT05304611|364821654|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
105773590|NCT05304611|364821655|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
105773591|NCT03442595|364821656|FG000|Overall Study|Lost to Follow-up|94|||
105773592|NCT03442595|364821657|FG001|Overall Study|Lost to Follow-up|0|||
105773593|NCT00515099|364821658|FG000|Overall Study|Lost to Follow-up|0|||
105773594|NCT00515099|364821659|FG001|Overall Study|Lost to Follow-up|4|||
105806443|NCT01464827|364948982|FG001|Overall Study|Other|3|||
105773595|NCT00515099|364821658|FG000|Overall Study|Withdrawal by Subject|2|||
105773596|NCT00515099|364821659|FG001|Overall Study|Withdrawal by Subject|0|||
105773597|NCT00515099|364821658|FG000|Overall Study|IRB Recommendation|1|||
105773598|NCT00515099|364821659|FG001|Overall Study|IRB Recommendation|0|||
105773599|NCT02607865|364821662|FG000|Overall Study|Lost to Follow-up|9|||
105773600|NCT02607865|364821663|FG001|Overall Study|Lost to Follow-up|7|||
105773601|NCT02607865|364821664|FG002|Overall Study|Lost to Follow-up|7|||
105773602|NCT02607865|364821665|FG003|Overall Study|Lost to Follow-up|5|||
105773603|NCT02607865|364821662|FG000|Overall Study|Withdrawal by Subject|18|||
105773604|NCT02607865|364821663|FG001|Overall Study|Withdrawal by Subject|18|||
105773605|NCT02607865|364821664|FG002|Overall Study|Withdrawal by Subject|17|||
105773606|NCT02607865|364821665|FG003|Overall Study|Withdrawal by Subject|8|||
105773607|NCT02607865|364821662|FG000|Overall Study|Death|5|||
105773608|NCT02607865|364821663|FG001|Overall Study|Death|4|||
105773609|NCT02607865|364821664|FG002|Overall Study|Death|1|||
105773610|NCT02607865|364821665|FG003|Overall Study|Death|3|||
105773611|NCT02607865|364821662|FG000|Overall Study|Unclassified|1|||
105773612|NCT02607865|364821663|FG001|Overall Study|Unclassified|1|||
105773613|NCT02607865|364821664|FG002|Overall Study|Unclassified|2|||
105773614|NCT02607865|364821665|FG003|Overall Study|Unclassified|0|||
105773615|NCT03227692|364821666|FG000|Overall Study|Protocol Violation|1|||
105773616|NCT03227692|364821667|FG001|Overall Study|Protocol Violation|1|||
105773617|NCT03227692|364821666|FG000|Overall Study|Lost to Follow-up|4|||
105773618|NCT03227692|364821667|FG001|Overall Study|Lost to Follow-up|2|||
105773619|NCT03227692|364821666|FG000|Overall Study|Adverse Event|0|||
105773620|NCT03227692|364821667|FG001|Overall Study|Adverse Event|2|||
105773621|NCT00528840|364821668|FG000|Overall Study|Lost to Follow-up|10|||
105773622|NCT00528840|364821668|FG000|Overall Study|Adverse Event|1|||
105773623|NCT00528840|364821668|FG000|Overall Study|Withdrawal by Subject|17|||
105773624|NCT00528840|364821668|FG000|Overall Study|Death|2|||
105773625|NCT00528840|364821668|FG000|Overall Study|Administrative Reasons|1|||
105773626|NCT00528840|364821668|FG000|Overall Study|Other|2|||
105773627|NCT01657253|364821669|FG000|Overall Study|Lost to Follow-up|6|||
105773628|NCT01657253|364821670|FG001|Overall Study|Lost to Follow-up|5|||
105773629|NCT01657253|364821669|FG000|Overall Study|Withdrawal by Subject|11|||
105773630|NCT01657253|364821670|FG001|Overall Study|Withdrawal by Subject|12|||
105773631|NCT01657253|364821669|FG000|Overall Study|Adverse Event|0|||
105773632|NCT01657253|364821670|FG001|Overall Study|Adverse Event|1|||
105773633|NCT00397631|364821672|FG000|Overall Study|Adverse Event|5|||
105773634|NCT00397631|364821673|FG001|Overall Study|Adverse Event|6|||
105773635|NCT00397631|364821672|FG000|Overall Study|Lack of Efficacy|7|||
105773636|NCT00397631|364821673|FG001|Overall Study|Lack of Efficacy|10|||
105773637|NCT00397631|364821672|FG000|Overall Study|Lost to Follow-up|8|||
105773638|NCT00397631|364821673|FG001|Overall Study|Lost to Follow-up|9|||
105773639|NCT00397631|364821672|FG000|Overall Study|Physician Decision|2|||
105773640|NCT00397631|364821673|FG001|Overall Study|Physician Decision|0|||
105773641|NCT00397631|364821672|FG000|Overall Study|Protocol Violation|0|||
105773642|NCT00397631|364821673|FG001|Overall Study|Protocol Violation|1|||
105773643|NCT00397631|364821672|FG000|Overall Study|Withdrawal by Subject|7|||
105773644|NCT00397631|364821673|FG001|Overall Study|Withdrawal by Subject|14|||
105773645|NCT00397631|364821672|FG000|Overall Study|protocol discontinuation criteria|1|||
105773646|NCT00397631|364821673|FG001|Overall Study|protocol discontinuation criteria|4|||
105773647|NCT00355615|364821676|FG000|Randomized Double Blind Period|Adverse Event|1|||
105773648|NCT00355615|364821677|FG001|Randomized Double Blind Period|Adverse Event|0|||
105773649|NCT00355615|364821678|FG002|Randomized Double Blind Period|Adverse Event|0|||
105773650|NCT00355615|364821679|FG003|Randomized Double Blind Period|Adverse Event|0|||
105773651|NCT00355615|364821680|FG004|Randomized Double Blind Period|Adverse Event|0|||
105773652|NCT00355615|364821676|FG000|Randomized Double Blind Period|Protocol Violation|0|||
105773653|NCT00355615|364821677|FG001|Randomized Double Blind Period|Protocol Violation|0|||
105773654|NCT00355615|364821678|FG002|Randomized Double Blind Period|Protocol Violation|1|||
105773655|NCT00355615|364821679|FG003|Randomized Double Blind Period|Protocol Violation|1|||
105773656|NCT00355615|364821680|FG004|Randomized Double Blind Period|Protocol Violation|0|||
105773657|NCT00355615|364821676|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
105773658|NCT00355615|364821677|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
105773659|NCT00355615|364821678|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
105773660|NCT00355615|364821679|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
105773661|NCT00355615|364821680|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
105773662|NCT00355615|364821676|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
105773663|NCT00355615|364821677|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
105773664|NCT00355615|364821678|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
105773665|NCT00355615|364821679|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
105773666|NCT00355615|364821680|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
105773667|NCT00355615|364821676|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
105773668|NCT00355615|364821677|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
105773669|NCT00355615|364821678|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
105773670|NCT00355615|364821679|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
105773671|NCT00355615|364821680|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
105773672|NCT00355615|364821676|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
105773673|NCT00355615|364821677|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
105773674|NCT00355615|364821678|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
105773675|NCT00355615|364821679|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
105773676|NCT00355615|364821680|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
105773677|NCT03685643|364821681|FG000|Overall Study|Lost to Follow-up|14|||
105773678|NCT03685643|364821682|FG001|Overall Study|Lost to Follow-up|22|||
105773679|NCT02750501|364821683|FG000|Overall Study|Adverse Event|4|||
105773680|NCT02750501|364821683|FG000|Overall Study|Physician Decision|1|||
105773681|NCT02750501|364821683|FG000|Overall Study|Protocol Violation|1|||
105773682|NCT02750501|364821683|FG000|Overall Study|G-tube came out|1|||
105773683|NCT02750501|364821683|FG000|Overall Study|Non-compliant use of PERT|1|||
105773684|NCT01347840|364821685|FG000|Overall Study|Withdrawal by Subject|1|||
105773685|NCT00415623|364821687|FG000|Overall Study|Adverse Event|3|||
105773686|NCT00415623|364821688|FG001|Overall Study|Adverse Event|4|||
105773687|NCT00415623|364821687|FG000|Overall Study|Death|1|||
105773688|NCT00415623|364821688|FG001|Overall Study|Death|0|||
105773689|NCT00415623|364821687|FG000|Overall Study|Withdrawal by Subject|1|||
105773690|NCT00415623|364821688|FG001|Overall Study|Withdrawal by Subject|1|||
105773691|NCT01708915|364821689|FG000|Overall Study|Adverse Event|1|||
105773692|NCT01708915|364821690|FG001|Overall Study|Adverse Event|0|||
105773693|NCT01708915|364821691|FG002|Overall Study|Adverse Event|9|||
105773694|NCT01708915|364821692|FG003|Overall Study|Adverse Event|13|||
105773695|NCT01708915|364821689|FG000|Overall Study|Lack of Efficacy|84|||
105773696|NCT01708915|364821690|FG001|Overall Study|Lack of Efficacy|60|||
105773697|NCT01708915|364821691|FG002|Overall Study|Lack of Efficacy|35|||
105773698|NCT01708915|364821692|FG003|Overall Study|Lack of Efficacy|15|||
105773699|NCT01708915|364821689|FG000|Overall Study|Protocol Violation|0|||
105773700|NCT01708915|364821690|FG001|Overall Study|Protocol Violation|0|||
105773701|NCT01708915|364821691|FG002|Overall Study|Protocol Violation|0|||
105773702|NCT01708915|364821692|FG003|Overall Study|Protocol Violation|1|||
105773703|NCT01708915|364821689|FG000|Overall Study|Withdrawal by Subject|0|||
105773704|NCT01708915|364821690|FG001|Overall Study|Withdrawal by Subject|1|||
105773705|NCT01708915|364821691|FG002|Overall Study|Withdrawal by Subject|2|||
105773706|NCT01708915|364821692|FG003|Overall Study|Withdrawal by Subject|2|||
105773707|NCT01708915|364821689|FG000|Overall Study|Other reasons than stated above|1|||
105773708|NCT01708915|364821690|FG001|Overall Study|Other reasons than stated above|1|||
105773709|NCT01708915|364821691|FG002|Overall Study|Other reasons than stated above|0|||
105773710|NCT01708915|364821692|FG003|Overall Study|Other reasons than stated above|2|||
105773711|NCT00882362|364821693|FG000|Overall Study|Adverse Event|13|||
105773712|NCT00882362|364821694|FG001|Overall Study|Adverse Event|10|||
105773713|NCT00882362|364821693|FG000|Overall Study|Withdrawal by Subject|13|||
105773714|NCT00882362|364821694|FG001|Overall Study|Withdrawal by Subject|10|||
105773715|NCT00882362|364821693|FG000|Overall Study|Lack of Efficacy|3|||
105773716|NCT00882362|364821694|FG001|Overall Study|Lack of Efficacy|0|||
105773717|NCT00882362|364821693|FG000|Overall Study|Protocol Violation|7|||
105773718|NCT00882362|364821694|FG001|Overall Study|Protocol Violation|2|||
105773719|NCT00882362|364821693|FG000|Overall Study|Pregnancy|1|||
105773720|NCT00882362|364821694|FG001|Overall Study|Pregnancy|0|||
105773721|NCT00882362|364821693|FG000|Overall Study|Physician Decision|5|||
105773722|NCT00882362|364821694|FG001|Overall Study|Physician Decision|1|||
105773723|NCT00882362|364821693|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
105773724|NCT00882362|364821694|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
105773725|NCT00882362|364821693|FG000|Overall Study|change of residence or other commitments|5|||
105773726|NCT00882362|364821694|FG001|Overall Study|change of residence or other commitments|0|||
105773727|NCT01268514|364821695|FG000|Overall Study|Adverse Event|20|||
105773728|NCT01268514|364821695|FG000|Overall Study|Death|8|||
105773729|NCT01268514|364821695|FG000|Overall Study|Lost to Follow-up|5|||
105773730|NCT01268514|364821695|FG000|Overall Study|Withdrawal by Subject|3|||
105773731|NCT01268514|364821695|FG000|Overall Study|Withdrawal by Surgeon|5|||
105773732|NCT01424306|364821696|FG000|Overall Study|Protocol Violation|0|||
105773733|NCT01424306|364821697|FG001|Overall Study|Protocol Violation|0|||
105773734|NCT01424306|364821698|FG002|Overall Study|Protocol Violation|0|||
105773735|NCT01424306|364821699|FG003|Overall Study|Protocol Violation|0|||
105773736|NCT01424306|364821700|FG004|Overall Study|Protocol Violation|1|||
105773737|NCT01424306|364821701|FG005|Overall Study|Protocol Violation|0|||
105773738|NCT01601873|364821704|FG000|Overall Study|Lost to Follow-up|2|||
105773739|NCT01601873|364821705|FG001|Overall Study|Lost to Follow-up|3|||
105773740|NCT00590031|364821706|FG000|Overall Study|Adverse Event|3|||
105773741|NCT00590031|364821706|FG000|Overall Study|Withdrawal by Subject|1|||
105773742|NCT00590031|364821706|FG000|Overall Study|Metastatic Disease|1|||
105773743|NCT00590031|364821706|FG000|Overall Study|Admin Hold|1|||
105773744|NCT00826540|364821707|FG000|Overall Study|ineligible|3|||
105773745|NCT00826540|364821707|FG000|Overall Study|Withdrawal by Subject|1|||
105773746|NCT02483611|364821708|FG000|Overall Study|Protocol Violation|0|||
105773747|NCT02483611|364821709|FG001|Overall Study|Protocol Violation|0|||
105773748|NCT02483611|364821710|FG002|Overall Study|Protocol Violation|1|||
105773749|NCT06334055|364821713|FG000|Overall Study|Adverse Event|4|||
105773750|NCT06334055|364821713|FG000|Overall Study|Disqualified|72|||
105773751|NCT04097925|364823247|FG000|Overall Study|Withdrawal by Subject|1|||
105773752|NCT03763942|364823265|FG000|Overall Study|Lost to Follow-up|114|||
105773753|NCT03763942|364823266|FG001|Overall Study|Lost to Follow-up|54|||
105773754|NCT03763942|364823265|FG000|Overall Study|Protocol Violation|1|||
105773755|NCT03763942|364823266|FG001|Overall Study|Protocol Violation|0|||
105773756|NCT03763942|364823265|FG000|Overall Study|Withdrawal by Subject|2|||
105773757|NCT03763942|364823266|FG001|Overall Study|Withdrawal by Subject|0|||
105773758|NCT03763942|364823265|FG000|Overall Study|Other|2|||
105773759|NCT03763942|364823266|FG001|Overall Study|Other|3|||
105773760|NCT03345849|364823267|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
105773761|NCT03345849|364823268|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
105773762|NCT03345849|364823269|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
105773763|NCT03345849|364823270|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
105773764|NCT03345849|364823267|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
105773765|NCT03345849|364823268|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
105773766|NCT03345849|364823269|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
105773767|NCT03345849|364823270|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
105773768|NCT03345849|364823267|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
105773769|NCT03345849|364823268|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
105773770|NCT03345849|364823269|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
105773771|NCT03345849|364823270|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
105773772|NCT03345849|364823267|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
105773773|NCT03345849|364823268|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
105773774|NCT03345849|364823269|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
105773775|NCT03345849|364823270|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
105773776|NCT03345849|364823267|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
105773777|NCT03345849|364823268|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
105773778|NCT03345849|364823269|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
105773779|NCT03345849|364823270|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
105773780|NCT03345849|364823267|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
105773781|NCT03345849|364823268|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
105773782|NCT03345849|364823269|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
105773783|NCT03345849|364823270|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
105773784|NCT03345849|364823267|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
105773785|NCT03345849|364823268|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
105773786|NCT03345849|364823269|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
105773787|NCT03345849|364823270|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
105773788|NCT03345849|364823267|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
105773789|NCT03345849|364823268|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
105773790|NCT03345849|364823269|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
105773791|NCT03345849|364823270|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
105773792|NCT03345849|364823267|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
105773793|NCT03345849|364823268|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
105773794|NCT03345849|364823269|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
105773795|NCT03345849|364823270|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
105773796|NCT03345849|364823267|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
105773797|NCT03345849|364823268|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
105773798|NCT03345849|364823269|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
105773799|NCT03345849|364823270|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
105773800|NCT03345849|364823267|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
105773801|NCT03345849|364823268|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
105773802|NCT03345849|364823269|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
105773803|NCT03345849|364823270|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
105773804|NCT03261037|364823271|FG000|Overall Study|Withdrawal by Subject|2|||
105773805|NCT03261037|364823272|FG001|Overall Study|Withdrawal by Subject|13|||
105773806|NCT03261037|364823273|FG002|Overall Study|Withdrawal by Subject|0|||
105773807|NCT03261037|364823274|FG003|Overall Study|Withdrawal by Subject|18|||
105773808|NCT03261037|364823271|FG000|Overall Study|Non-compliance with study procedures|0|||
105773809|NCT03261037|364823272|FG001|Overall Study|Non-compliance with study procedures|2|||
105773810|NCT03261037|364823273|FG002|Overall Study|Non-compliance with study procedures|0|||
105773811|NCT03261037|364823274|FG003|Overall Study|Non-compliance with study procedures|6|||
105773812|NCT03261037|364823271|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
105442540|NCT05173012|363626782|FG005|Overall Study|Withdrawal by Subject|0|||
105773813|NCT03261037|364823272|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
105773814|NCT03261037|364823273|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
105773815|NCT03261037|364823274|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
105773816|NCT03261037|364823271|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
105773817|NCT03261037|364823272|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
105773818|NCT03261037|364823273|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
105773819|NCT03261037|364823274|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
105773820|NCT03261037|364823271|FG000|Overall Study|Diagnosed but protocol deviation|1|||
105773821|NCT03261037|364823272|FG001|Overall Study|Diagnosed but protocol deviation|0|||
105773822|NCT03261037|364823273|FG002|Overall Study|Diagnosed but protocol deviation|0|||
105773823|NCT03261037|364823274|FG003|Overall Study|Diagnosed but protocol deviation|0|||
105773824|NCT03261037|364823271|FG000|Overall Study|Participant did not want to continue the study|0|||
105773825|NCT03261037|364823272|FG001|Overall Study|Participant did not want to continue the study|1|||
105773826|NCT03261037|364823273|FG002|Overall Study|Participant did not want to continue the study|0|||
105773827|NCT03261037|364823274|FG003|Overall Study|Participant did not want to continue the study|0|||
105773828|NCT03261037|364823271|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
105773829|NCT03261037|364823272|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
105773830|NCT03261037|364823273|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
105773831|NCT03261037|364823274|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
105773832|NCT03261037|364823271|FG000|Overall Study|Participant presented clinical improvement|0|||
105773833|NCT03261037|364823272|FG001|Overall Study|Participant presented clinical improvement|2|||
105773834|NCT03261037|364823273|FG002|Overall Study|Participant presented clinical improvement|0|||
105773835|NCT03261037|364823274|FG003|Overall Study|Participant presented clinical improvement|0|||
105773836|NCT03261037|364823271|FG000|Overall Study|Technical difficulties|0|||
105773837|NCT03261037|364823272|FG001|Overall Study|Technical difficulties|0|||
105773838|NCT03261037|364823273|FG002|Overall Study|Technical difficulties|0|||
105773839|NCT03261037|364823274|FG003|Overall Study|Technical difficulties|1|||
105773840|NCT03261037|364823271|FG000|Overall Study|Equipment failed to work|0|||
105773841|NCT03261037|364823272|FG001|Overall Study|Equipment failed to work|0|||
105773842|NCT03261037|364823273|FG002|Overall Study|Equipment failed to work|0|||
105773843|NCT03261037|364823274|FG003|Overall Study|Equipment failed to work|1|||
105773844|NCT03261037|364823271|FG000|Overall Study|End of study for participant and no follow up|0|||
105773845|NCT03261037|364823272|FG001|Overall Study|End of study for participant and no follow up|0|||
105773846|NCT03261037|364823273|FG002|Overall Study|End of study for participant and no follow up|0|||
105773847|NCT03261037|364823274|FG003|Overall Study|End of study for participant and no follow up|1|||
105773848|NCT03261037|364823271|FG000|Overall Study|Participant was too weak to continue in study|1|||
105773849|NCT03261037|364823272|FG001|Overall Study|Participant was too weak to continue in study|0|||
105773850|NCT03261037|364823273|FG002|Overall Study|Participant was too weak to continue in study|0|||
105773851|NCT03261037|364823274|FG003|Overall Study|Participant was too weak to continue in study|0|||
105773852|NCT00103207|364823277|FG000|Overall Study|Adverse Event|3|||
105773853|NCT00103207|364823277|FG000|Overall Study|Death|1|||
105773854|NCT00103207|364823277|FG000|Overall Study|Withdrawal by Subject|2|||
105773855|NCT00103207|364823277|FG000|Overall Study|Other complicating disease|1|||
105773856|NCT00103207|364823277|FG000|Overall Study|Ineligible|4|||
105773857|NCT00103207|364823277|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
105773858|NCT03662789|364823278|FG000|Overall Study|Lost to Follow-up|1|||
105773859|NCT03662789|364823279|FG001|Overall Study|Lost to Follow-up|2|||
105773860|NCT03662789|364823278|FG000|Overall Study|Could not perform treadmill test|4|||
105773861|NCT03662789|364823279|FG001|Overall Study|Could not perform treadmill test|4|||
105773862|NCT03662789|364823278|FG000|Overall Study|Death|0|||
105773863|NCT03662789|364823279|FG001|Overall Study|Death|1|||
105773864|NCT01029691|364823280|FG000|Continued APAP to Delivery|Death|0|||
105773865|NCT01029691|364823281|FG001|Continued APAP to Delivery|Death|0|||
105773866|NCT01029691|364823282|FG002|Continued APAP to Delivery|Death|1|||
105773867|NCT03659916|364823283|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
105773868|NCT03659916|364823284|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
105773869|NCT03659916|364823285|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
105773870|NCT03659916|364823283|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
105773871|NCT03659916|364823284|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
105773872|NCT03659916|364823285|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
105773873|NCT03659916|364823283|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
105773874|NCT03659916|364823284|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
105773875|NCT03659916|364823285|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
105773876|NCT03659916|364823283|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
105773877|NCT03659916|364823284|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
105773878|NCT03659916|364823285|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
105773879|NCT03659916|364823283|FG000|Treatment Period (72 Weeks)|Other|1|||
105773880|NCT03659916|364823284|FG001|Treatment Period (72 Weeks)|Other|3|||
105773881|NCT03659916|364823285|FG002|Treatment Period (72 Weeks)|Other|9|||
105773882|NCT03659916|364823283|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
105773883|NCT03659916|364823284|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
105773884|NCT03659916|364823285|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
105773885|NCT03659916|364823283|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
105773886|NCT03659916|364823284|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
105773887|NCT03659916|364823285|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
105773888|NCT03659916|364823283|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
105773889|NCT03659916|364823284|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
105773890|NCT03659916|364823285|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
105773891|NCT03659916|364823283|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
105773892|NCT03659916|364823284|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
105773893|NCT03659916|364823285|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
105773894|NCT03659916|364823283|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
105773895|NCT03659916|364823284|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
105773896|NCT03659916|364823285|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
105773897|NCT03659916|364823283|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
105773898|NCT03659916|364823284|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
105773899|NCT03659916|364823285|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
105773900|NCT00170846|364823292|FG000|Overall Study|Subject withdrew Informed Consent|5|||
105773901|NCT00170846|364823293|FG001|Overall Study|Subject withdrew Informed Consent|12|||
105773902|NCT00170846|364823294|FG002|Overall Study|Subject withdrew Informed Consent|8|||
105773903|NCT00170846|364823292|FG000|Overall Study|Lost to Follow-up|6|||
105773904|NCT00170846|364823293|FG001|Overall Study|Lost to Follow-up|3|||
105773905|NCT00170846|364823294|FG002|Overall Study|Lost to Follow-up|2|||
105773906|NCT00170846|364823292|FG000|Overall Study|Death|0|||
105773907|NCT00170846|364823293|FG001|Overall Study|Death|3|||
105773908|NCT00170846|364823294|FG002|Overall Study|Death|3|||
105773909|NCT00170846|364823292|FG000|Overall Study|Reason Missing|0|||
105773910|NCT00170846|364823293|FG001|Overall Study|Reason Missing|1|||
105773911|NCT00170846|364823294|FG002|Overall Study|Reason Missing|0|||
105773912|NCT01738594|364823295|FG000|Registration and Treatment Start|Adverse Event|0|||
105773913|NCT01738594|364823296|FG001|Registration and Treatment Start|Adverse Event|1|||
105773914|NCT01738594|364823297|FG002|Registration and Treatment Start|Adverse Event|0|||
105773915|NCT01738594|364823298|FG003|Registration and Treatment Start|Adverse Event|0|||
105773916|NCT01738594|364823299|FG004|Registration and Treatment Start|Adverse Event|0|||
105773917|NCT01738594|364823300|FG005|Registration and Treatment Start|Adverse Event|0|||
105773918|NCT01738594|364823301|FG006|Registration and Treatment Start|Adverse Event|0|||
105773919|NCT01738594|364823302|FG007|Registration and Treatment Start|Adverse Event|0|||
105773920|NCT01738594|364823295|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
105773921|NCT01738594|364823296|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
105773922|NCT01738594|364823297|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
105773923|NCT01738594|364823298|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
105773924|NCT01738594|364823299|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
105773925|NCT01738594|364823300|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
105773926|NCT01738594|364823301|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
105773927|NCT01738594|364823302|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
105773928|NCT01738594|364823295|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
105773929|NCT01738594|364823296|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
105773930|NCT01738594|364823297|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
105773931|NCT01738594|364823298|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
105773932|NCT01738594|364823299|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
105773933|NCT01738594|364823300|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
105773934|NCT01738594|364823301|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
105773935|NCT01738594|364823302|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
105773936|NCT01738594|364823295|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
105773937|NCT01738594|364823296|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
105773938|NCT01738594|364823297|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
105773939|NCT01738594|364823298|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
105773940|NCT01738594|364823299|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
105773941|NCT01738594|364823300|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
105773942|NCT01738594|364823301|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
105773943|NCT01738594|364823302|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
105773944|NCT01738594|364823295|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
105773945|NCT01738594|364823296|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
105773946|NCT01738594|364823297|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
105773947|NCT01738594|364823298|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
105773948|NCT01738594|364823299|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
105773949|NCT01738594|364823300|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
105773950|NCT01738594|364823301|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
105773951|NCT01738594|364823302|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
105773952|NCT01738594|364823295|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
105773953|NCT01738594|364823296|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
105773954|NCT01738594|364823297|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
105773955|NCT01738594|364823298|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
105773956|NCT01738594|364823299|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
105773957|NCT01738594|364823300|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
105773958|NCT01738594|364823301|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
105773959|NCT01738594|364823302|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
105773960|NCT01738594|364823295|FG000|Follow up for 1 Year|Death|0|||
105773961|NCT01738594|364823296|FG001|Follow up for 1 Year|Death|0|||
105773962|NCT01738594|364823297|FG002|Follow up for 1 Year|Death|0|||
105773963|NCT01738594|364823298|FG003|Follow up for 1 Year|Death|0|||
105773964|NCT01738594|364823299|FG004|Follow up for 1 Year|Death|0|||
105773965|NCT01738594|364823300|FG005|Follow up for 1 Year|Death|1|||
105773966|NCT01738594|364823301|FG006|Follow up for 1 Year|Death|0|||
105773967|NCT01738594|364823302|FG007|Follow up for 1 Year|Death|0|||
105773968|NCT01738594|364823295|FG000|Follow up for 1 Year|Other|0|||
105773969|NCT01738594|364823296|FG001|Follow up for 1 Year|Other|0|||
105773970|NCT01738594|364823297|FG002|Follow up for 1 Year|Other|0|||
105773971|NCT01738594|364823298|FG003|Follow up for 1 Year|Other|0|||
105773972|NCT01738594|364823299|FG004|Follow up for 1 Year|Other|0|||
105773973|NCT01738594|364823300|FG005|Follow up for 1 Year|Other|2|||
105773974|NCT01738594|364823301|FG006|Follow up for 1 Year|Other|0|||
105773975|NCT01738594|364823302|FG007|Follow up for 1 Year|Other|0|||
105773976|NCT04430036|364823303|FG000|Safety Run in Phase|Progression of disease|2|||
105773977|NCT00942422|364823304|FG000|Overall Study|Withdrawal by Subject|1|||
105773978|NCT00942422|364823304|FG000|Overall Study|Death|1|||
105773979|NCT00942422|364823304|FG000|Overall Study|Progressive diease|1|||
105773980|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
105773981|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
105773982|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
105773983|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
105773984|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
105773985|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
105773986|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
105773987|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
105773988|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Death|0|||
105773989|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Death|0|||
105773990|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Death|0|||
105773991|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Death|1|||
105773992|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Death|1|||
105773993|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Death|0|||
105773994|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Death|2|||
105773995|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Death|0|||
105773996|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
105773997|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
105773998|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
105773999|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
105774000|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
105774001|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
105774002|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
105774003|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
105774004|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
105774005|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
105774006|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
105774007|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
105774008|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
105774009|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
105774010|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
105774011|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
105774012|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
105774013|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
105774014|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
105774015|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
105774016|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
105774017|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
105774018|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
105774019|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
105774020|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
105774021|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
105774022|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
105774023|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
105774024|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
105774025|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
105774026|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
105774027|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
105774028|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
105774029|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
105774030|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
105774031|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
105774032|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
105774033|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
105774034|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
105774035|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
105774036|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
105774037|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
105774038|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
105774039|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
105774040|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
105774041|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
105774042|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
105774043|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
105774044|NCT03117309|364823315|FG000|Overall Study|Not meeting inclusion criteria|0|||
105774045|NCT03117309|364823316|FG001|Overall Study|Not meeting inclusion criteria|1|||
105774046|NCT02120469|364823317|FG000|Overall Study|HER-2/neu-amplified|1|||
105774047|NCT02120469|364823318|FG001|Overall Study|HER-2/neu-amplified|0|||
105774048|NCT02120469|364823319|FG002|Overall Study|HER-2/neu-amplified|1|||
105774049|NCT02774291|364823323|FG000|Overall Study|Lost to Follow-up|1|||
105774050|NCT01012037|364823324|FG000|Overall Study|Adverse Event|0|||
105774051|NCT01012037|364823325|FG001|Overall Study|Adverse Event|8|||
105774052|NCT01012037|364823326|FG002|Overall Study|Adverse Event|3|||
105774053|NCT01012037|364823324|FG000|Overall Study|Protocol Violation|0|||
105774054|NCT01012037|364823325|FG001|Overall Study|Protocol Violation|3|||
105774055|NCT01012037|364823326|FG002|Overall Study|Protocol Violation|5|||
105774056|NCT01012037|364823324|FG000|Overall Study|Withdrawal by Subject|0|||
105774057|NCT01012037|364823325|FG001|Overall Study|Withdrawal by Subject|4|||
105774058|NCT01012037|364823326|FG002|Overall Study|Withdrawal by Subject|1|||
105774059|NCT01012037|364823324|FG000|Overall Study|Other reason (not specified)|1|||
105774060|NCT01012037|364823325|FG001|Overall Study|Other reason (not specified)|1|||
105774061|NCT01012037|364823326|FG002|Overall Study|Other reason (not specified)|1|||
105774062|NCT01700140|364823328|FG000|Overall Study|Use of rescue drugs|3|||
105774063|NCT01700140|364823329|FG001|Overall Study|Use of rescue drugs|3|||
105774064|NCT01700140|364823330|FG002|Overall Study|Use of rescue drugs|1|||
105774065|NCT01700140|364823328|FG000|Overall Study|Discontinuation of radiotherapy|1|||
105774066|NCT01700140|364823329|FG001|Overall Study|Discontinuation of radiotherapy|0|||
105774067|NCT01700140|364823330|FG002|Overall Study|Discontinuation of radiotherapy|0|||
105774068|NCT01700140|364823328|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
105774069|NCT01700140|364823329|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
105774070|NCT01700140|364823330|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
105774071|NCT01700140|364823328|FG000|Overall Study|Aggravation of symptoms|1|||
105774072|NCT01700140|364823329|FG001|Overall Study|Aggravation of symptoms|0|||
105774073|NCT01700140|364823330|FG002|Overall Study|Aggravation of symptoms|0|||
105774074|NCT01700140|364823328|FG000|Overall Study|Adverse Event|0|||
105774075|NCT01700140|364823329|FG001|Overall Study|Adverse Event|1|||
105774076|NCT01700140|364823330|FG002|Overall Study|Adverse Event|0|||
105774077|NCT01700140|364823328|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
105774078|NCT01700140|364823329|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
105774079|NCT01700140|364823330|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
105774080|NCT05307523|364823332|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
105774081|NCT05307523|364823333|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
105774082|NCT05307523|364823332|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
105774083|NCT05307523|364823333|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
105774084|NCT03231228|364823339|FG000|Overall Study|Lost to Follow-up|2|||
105774085|NCT03231228|364823340|FG001|Overall Study|Lost to Follow-up|0|||
105774086|NCT03231228|364823339|FG000|Overall Study|Physician Decision|1|||
105774087|NCT03231228|364823340|FG001|Overall Study|Physician Decision|0|||
105774088|NCT02096471|364823343|FG000|Overall Study|Adverse Event|1|||
105774089|NCT02096471|364823343|FG000|Overall Study|Lack of Efficacy|7|||
105806444|NCT01464827|364948983|FG002|Overall Study|Other|0|||
105774090|NCT02096471|364823343|FG000|Overall Study|Withdrawal by Subject|3|||
105774091|NCT02096471|364823343|FG000|Overall Study|Non-Compliant|2|||
105774092|NCT03196973|364823344|FG000|Overall Study|Adverse Event|1|||
105774093|NCT03196973|364823345|FG001|Overall Study|Adverse Event|1|||
105774094|NCT03196973|364823346|FG002|Overall Study|Adverse Event|2|||
105774095|NCT03196973|364823344|FG000|Overall Study|Lack of Efficacy|2|||
105774096|NCT03196973|364823345|FG001|Overall Study|Lack of Efficacy|6|||
105774097|NCT03196973|364823346|FG002|Overall Study|Lack of Efficacy|1|||
105774098|NCT03196973|364823344|FG000|Overall Study|Lost to Follow-up|4|||
105774099|NCT03196973|364823345|FG001|Overall Study|Lost to Follow-up|3|||
105774100|NCT03196973|364823346|FG002|Overall Study|Lost to Follow-up|2|||
105774101|NCT03196973|364823344|FG000|Overall Study|Consent withdrawn|2|||
105774102|NCT03196973|364823345|FG001|Overall Study|Consent withdrawn|1|||
105774103|NCT03196973|364823346|FG002|Overall Study|Consent withdrawn|0|||
105774104|NCT03196973|364823344|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
105774105|NCT03196973|364823345|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
105774106|NCT03196973|364823346|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
105774107|NCT01809327|364823347|FG000|Overall Study|Lost to Follow-up|5|||
105774108|NCT01809327|364823348|FG001|Overall Study|Lost to Follow-up|2|||
105774109|NCT01809327|364823349|FG002|Overall Study|Lost to Follow-up|4|||
105774110|NCT01809327|364823350|FG003|Overall Study|Lost to Follow-up|2|||
105774111|NCT01809327|364823351|FG004|Overall Study|Lost to Follow-up|3|||
105774112|NCT01809327|364823347|FG000|Overall Study|Withdrawal by Subject|6|||
105774113|NCT01809327|364823348|FG001|Overall Study|Withdrawal by Subject|4|||
105774114|NCT01809327|364823349|FG002|Overall Study|Withdrawal by Subject|4|||
105774115|NCT01809327|364823350|FG003|Overall Study|Withdrawal by Subject|2|||
105774116|NCT01809327|364823351|FG004|Overall Study|Withdrawal by Subject|5|||
105774117|NCT01809327|364823347|FG000|Overall Study|Adverse Event|4|||
105774118|NCT01809327|364823348|FG001|Overall Study|Adverse Event|3|||
105774119|NCT01809327|364823349|FG002|Overall Study|Adverse Event|7|||
105774120|NCT01809327|364823350|FG003|Overall Study|Adverse Event|4|||
105774121|NCT01809327|364823351|FG004|Overall Study|Adverse Event|8|||
105774122|NCT01809327|364823347|FG000|Overall Study|Death|1|||
105774123|NCT01809327|364823348|FG001|Overall Study|Death|0|||
105774124|NCT01809327|364823349|FG002|Overall Study|Death|0|||
105774125|NCT01809327|364823350|FG003|Overall Study|Death|0|||
105774126|NCT01809327|364823351|FG004|Overall Study|Death|0|||
105774127|NCT01809327|364823347|FG000|Overall Study|Protocol Violation|0|||
105774128|NCT01809327|364823348|FG001|Overall Study|Protocol Violation|1|||
105774129|NCT01809327|364823349|FG002|Overall Study|Protocol Violation|0|||
105774130|NCT01809327|364823350|FG003|Overall Study|Protocol Violation|0|||
105774131|NCT01809327|364823351|FG004|Overall Study|Protocol Violation|0|||
105774132|NCT01809327|364823347|FG000|Overall Study|Physician Decision|1|||
105774133|NCT01809327|364823348|FG001|Overall Study|Physician Decision|1|||
105774134|NCT01809327|364823349|FG002|Overall Study|Physician Decision|0|||
105774135|NCT01809327|364823350|FG003|Overall Study|Physician Decision|0|||
105774136|NCT01809327|364823351|FG004|Overall Study|Physician Decision|0|||
105774137|NCT01809327|364823347|FG000|Overall Study|Pregnancy|1|||
105774138|NCT01809327|364823348|FG001|Overall Study|Pregnancy|0|||
105774139|NCT01809327|364823349|FG002|Overall Study|Pregnancy|0|||
105774140|NCT01809327|364823350|FG003|Overall Study|Pregnancy|0|||
105774141|NCT01809327|364823351|FG004|Overall Study|Pregnancy|0|||
105774142|NCT01809327|364823347|FG000|Overall Study|Other|14|||
105774143|NCT01809327|364823348|FG001|Overall Study|Other|15|||
105774144|NCT01809327|364823349|FG002|Overall Study|Other|7|||
105774145|NCT01809327|364823350|FG003|Overall Study|Other|4|||
105774146|NCT01809327|364823351|FG004|Overall Study|Other|9|||
105774147|NCT01610414|364823356|FG000|Study Start - Month 13|Serious Adverse Event|65|||
105774148|NCT01610414|364823357|FG001|Study Start - Month 13|Serious Adverse Event|67|||
105774149|NCT01610414|364823356|FG000|Study Start - Month 13|Adverse Event|14|||
105774150|NCT01610414|364823357|FG001|Study Start - Month 13|Adverse Event|14|||
105774151|NCT01610414|364823356|FG000|Study Start - Month 13|Protocol Violation|3|||
105774152|NCT01610414|364823357|FG001|Study Start - Month 13|Protocol Violation|1|||
105774153|NCT01610414|364823356|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
105774154|NCT01610414|364823357|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
105774155|NCT01610414|364823356|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
105774156|NCT01610414|364823357|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
105774157|NCT01610414|364823356|FG000|Study Start - Month 13|Lost to Follow-up|4|||
105774158|NCT01610414|364823357|FG001|Study Start - Month 13|Lost to Follow-up|6|||
105774159|NCT01610414|364823356|FG000|Study Start - Month 13|Suspected HZ episode|1|||
105774160|NCT01610414|364823357|FG001|Study Start - Month 13|Suspected HZ episode|3|||
105774161|NCT01610414|364823356|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
105774162|NCT01610414|364823357|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
105774163|NCT01610414|364823356|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
105774164|NCT01610414|364823357|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
105774165|NCT01610414|364823356|FG000|Month 13 - Month 25|Adverse Event|8|||
105774166|NCT01610414|364823357|FG001|Month 13 - Month 25|Adverse Event|4|||
105774167|NCT01610414|364823356|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
105774168|NCT01610414|364823357|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
105774169|NCT01610414|364823356|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
105774170|NCT01610414|364823357|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
105774171|NCT01610414|364823356|FG000|Month 13 - Month 25|Protocol Violation|0|||
105774172|NCT01610414|364823357|FG001|Month 13 - Month 25|Protocol Violation|2|||
105774173|NCT01610414|364823356|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
105774174|NCT01610414|364823357|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
105774175|NCT01610414|364823356|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
105774176|NCT01610414|364823357|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
105774177|NCT01610414|364823356|FG000|After Month 25|Study end not reached|48|||
105774178|NCT01610414|364823357|FG001|After Month 25|Study end not reached|53|||
105774179|NCT00518336|364823360|FG000|Year 7|Lost to Follow-up|2|||
105774180|NCT00518336|364823361|FG001|Year 7|Lost to Follow-up|0|||
105774181|NCT00518336|364823360|FG000|Year 7|Could not attend in time|0|||
105774182|NCT00518336|364823361|FG001|Year 7|Could not attend in time|3|||
105774183|NCT00518336|364823360|FG000|Year 8|Lost to Follow-up|1|||
105774184|NCT00518336|364823361|FG001|Year 8|Lost to Follow-up|1|||
105774185|NCT00518336|364823360|FG000|Year 8|Could not attend in time|0|||
105774186|NCT00518336|364823361|FG001|Year 8|Could not attend in time|1|||
105774187|NCT00518336|364823360|FG000|Year 9|Migrated/moved from study area|1|||
105774188|NCT00518336|364823361|FG001|Year 9|Migrated/moved from study area|1|||
105774189|NCT00518336|364823360|FG000|Year 9|Lost to Follow-up|3|||
105774190|NCT00518336|364823361|FG001|Year 9|Lost to Follow-up|0|||
105774191|NCT00518336|364823360|FG000|Year 9|Personal reasons|1|||
105774192|NCT00518336|364823361|FG001|Year 9|Personal reasons|0|||
105774193|NCT00125268|364823362|FG000|Overall Study|Withdrawal by Subject|1|||
105774194|NCT00125268|364823363|FG001|Overall Study|Withdrawal by Subject|1|||
105774195|NCT02985684|364823368|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
105774196|NCT02985684|364823368|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
105774197|NCT02985684|364823368|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
105774198|NCT04303780|364823371|FG000|Overall Study|Death|104|||
105774199|NCT04303780|364823372|FG001|Overall Study|Death|85|||
105774200|NCT04303780|364823371|FG000|Overall Study|Lost to Follow-up|5|||
105774201|NCT04303780|364823372|FG001|Overall Study|Lost to Follow-up|2|||
105774202|NCT04303780|364823371|FG000|Overall Study|Withdrawal by Subject|12|||
105774203|NCT04303780|364823372|FG001|Overall Study|Withdrawal by Subject|39|||
105774204|NCT04303780|364823371|FG000|Overall Study|Ongoing in study|50|||
105774205|NCT04303780|364823372|FG001|Overall Study|Ongoing in study|45|||
105774206|NCT03455530|364824907|FG000|Overall Study|Withdrawal by Subject|9|||
105774207|NCT03455530|364824908|FG001|Overall Study|Withdrawal by Subject|1|||
105774208|NCT03455530|364824909|FG002|Overall Study|Withdrawal by Subject|3|||
105774209|NCT03455530|364824910|FG003|Overall Study|Withdrawal by Subject|3|||
105774210|NCT00740116|364824914|FG000|Overall Study|Withdrawal by Subject|1|||
105774211|NCT00740116|364824915|FG001|Overall Study|Withdrawal by Subject|1|||
105774212|NCT00740116|364824914|FG000|Overall Study|Protocol Violation|1|||
105774213|NCT00740116|364824915|FG001|Overall Study|Protocol Violation|4|||
105774214|NCT03958149|364824916|FG000|Overall Study|Withdrawal by Subject|0|||
105774215|NCT03958149|364824917|FG001|Overall Study|Withdrawal by Subject|1|||
105774216|NCT00621764|364824918|FG000|Overall Study|Protocol Violation|0|||
105774217|NCT00621764|364824919|FG001|Overall Study|Protocol Violation|0|||
105774218|NCT00621764|364824920|FG002|Overall Study|Protocol Violation|0|||
105774219|NCT00621764|364824921|FG003|Overall Study|Protocol Violation|1|||
105774220|NCT00121485|364824922|FG000|Overall Study|Not implanted|1|||
105774221|NCT00121485|364824923|FG001|Overall Study|Not implanted|5|||
105774222|NCT00121485|364824922|FG000|Overall Study|Crossover|0|||
105774223|NCT00121485|364824923|FG001|Overall Study|Crossover|2|||
105774224|NCT00669240|364824924|FG000|Overall Study|Lack of Efficacy|33|||
105774225|NCT00669240|364824924|FG000|Overall Study|Withdrawal by Subject|42|||
105774226|NCT00669240|364824924|FG000|Overall Study|Lost to Follow-up|34|||
105774227|NCT00669240|364824924|FG000|Overall Study|Adverse Event|21|||
105774228|NCT00669240|364824924|FG000|Overall Study|Other|19|||
105774229|NCT00669240|364824924|FG000|Overall Study|Enrolled but not treated|15|||
105774230|NCT00669240|364824924|FG000|Overall Study|Enrolled but no dosing record|1|||
105774231|NCT02583399|364824925|FG000|Overall Study|Able to be discharged|3|||
105774232|NCT02583399|364824925|FG000|Overall Study|Wanted to use a restricted medication|3|||
105774233|NCT01004861|364824926|FG000|Overall Study|Disease progression|3|||
105774234|NCT01004861|364824927|FG001|Overall Study|Disease progression|4|||
105774235|NCT01004861|364824928|FG002|Overall Study|Disease progression|5|||
105774236|NCT01004861|364824929|FG003|Overall Study|Disease progression|4|||
105774237|NCT01004861|364824930|FG004|Overall Study|Disease progression|4|||
105774238|NCT01004861|364824931|FG005|Overall Study|Disease progression|4|||
105774239|NCT01004861|364824932|FG006|Overall Study|Disease progression|5|||
105774240|NCT01004861|364824933|FG007|Overall Study|Disease progression|1|||
105774241|NCT01004861|364824934|FG008|Overall Study|Disease progression|4|||
105774242|NCT01004861|364824935|FG009|Overall Study|Disease progression|7|||
105774243|NCT01004861|364824936|FG010|Overall Study|Disease progression|6|||
105774244|NCT01004861|364824937|FG011|Overall Study|Disease progression|3|||
105774245|NCT01004861|364824938|FG012|Overall Study|Disease progression|8|||
105774246|NCT01004861|364824926|FG000|Overall Study|Physician Decision|0|||
105774247|NCT01004861|364824927|FG001|Overall Study|Physician Decision|2|||
105774248|NCT01004861|364824928|FG002|Overall Study|Physician Decision|1|||
105774249|NCT01004861|364824929|FG003|Overall Study|Physician Decision|1|||
105774250|NCT01004861|364824930|FG004|Overall Study|Physician Decision|1|||
105774251|NCT01004861|364824931|FG005|Overall Study|Physician Decision|0|||
105774252|NCT01004861|364824932|FG006|Overall Study|Physician Decision|0|||
105774253|NCT01004861|364824933|FG007|Overall Study|Physician Decision|1|||
105774254|NCT01004861|364824934|FG008|Overall Study|Physician Decision|0|||
105774255|NCT01004861|364824935|FG009|Overall Study|Physician Decision|0|||
105774256|NCT01004861|364824936|FG010|Overall Study|Physician Decision|0|||
105774257|NCT01004861|364824937|FG011|Overall Study|Physician Decision|0|||
105774258|NCT01004861|364824938|FG012|Overall Study|Physician Decision|3|||
105774259|NCT01004861|364824926|FG000|Overall Study|Adverse Event|0|||
105774260|NCT01004861|364824927|FG001|Overall Study|Adverse Event|0|||
105774261|NCT01004861|364824928|FG002|Overall Study|Adverse Event|0|||
105774262|NCT01004861|364824929|FG003|Overall Study|Adverse Event|1|||
105774263|NCT01004861|364824930|FG004|Overall Study|Adverse Event|0|||
105774264|NCT01004861|364824931|FG005|Overall Study|Adverse Event|2|||
105774265|NCT01004861|364824932|FG006|Overall Study|Adverse Event|1|||
105774266|NCT01004861|364824933|FG007|Overall Study|Adverse Event|1|||
105774267|NCT01004861|364824934|FG008|Overall Study|Adverse Event|13|||
105774268|NCT01004861|364824935|FG009|Overall Study|Adverse Event|1|||
105774269|NCT01004861|364824936|FG010|Overall Study|Adverse Event|1|||
105774270|NCT01004861|364824937|FG011|Overall Study|Adverse Event|0|||
105774271|NCT01004861|364824938|FG012|Overall Study|Adverse Event|2|||
105774272|NCT01004861|364824926|FG000|Overall Study|Protocol Violation|0|||
105774273|NCT01004861|364824927|FG001|Overall Study|Protocol Violation|0|||
105774274|NCT01004861|364824928|FG002|Overall Study|Protocol Violation|0|||
105774275|NCT01004861|364824929|FG003|Overall Study|Protocol Violation|0|||
105774276|NCT01004861|364824930|FG004|Overall Study|Protocol Violation|1|||
105774277|NCT01004861|364824931|FG005|Overall Study|Protocol Violation|0|||
105774278|NCT01004861|364824932|FG006|Overall Study|Protocol Violation|0|||
105774279|NCT01004861|364824933|FG007|Overall Study|Protocol Violation|0|||
105774280|NCT01004861|364824934|FG008|Overall Study|Protocol Violation|0|||
105774281|NCT01004861|364824935|FG009|Overall Study|Protocol Violation|0|||
105774282|NCT01004861|364824936|FG010|Overall Study|Protocol Violation|0|||
105774283|NCT01004861|364824937|FG011|Overall Study|Protocol Violation|0|||
105774284|NCT01004861|364824938|FG012|Overall Study|Protocol Violation|0|||
105774285|NCT01004861|364824926|FG000|Overall Study|Lost to Follow-up|0|||
105774286|NCT01004861|364824927|FG001|Overall Study|Lost to Follow-up|0|||
105774287|NCT01004861|364824928|FG002|Overall Study|Lost to Follow-up|0|||
105774288|NCT01004861|364824929|FG003|Overall Study|Lost to Follow-up|0|||
105774289|NCT01004861|364824930|FG004|Overall Study|Lost to Follow-up|0|||
105774290|NCT01004861|364824931|FG005|Overall Study|Lost to Follow-up|0|||
105774291|NCT01004861|364824932|FG006|Overall Study|Lost to Follow-up|0|||
105774292|NCT01004861|364824933|FG007|Overall Study|Lost to Follow-up|1|||
105774293|NCT01004861|364824934|FG008|Overall Study|Lost to Follow-up|3|||
105774294|NCT01004861|364824935|FG009|Overall Study|Lost to Follow-up|0|||
105774295|NCT01004861|364824936|FG010|Overall Study|Lost to Follow-up|0|||
105774296|NCT01004861|364824937|FG011|Overall Study|Lost to Follow-up|1|||
105774297|NCT01004861|364824938|FG012|Overall Study|Lost to Follow-up|0|||
105774298|NCT01004861|364824926|FG000|Overall Study|Non-compliance|0|||
105774299|NCT01004861|364824927|FG001|Overall Study|Non-compliance|0|||
105774300|NCT01004861|364824928|FG002|Overall Study|Non-compliance|0|||
105774301|NCT01004861|364824929|FG003|Overall Study|Non-compliance|0|||
105774302|NCT01004861|364824930|FG004|Overall Study|Non-compliance|0|||
105774303|NCT01004861|364824931|FG005|Overall Study|Non-compliance|0|||
105774304|NCT01004861|364824932|FG006|Overall Study|Non-compliance|0|||
105774305|NCT01004861|364824933|FG007|Overall Study|Non-compliance|0|||
105774306|NCT01004861|364824934|FG008|Overall Study|Non-compliance|5|||
105774307|NCT01004861|364824935|FG009|Overall Study|Non-compliance|0|||
105774308|NCT01004861|364824936|FG010|Overall Study|Non-compliance|0|||
105774309|NCT01004861|364824937|FG011|Overall Study|Non-compliance|0|||
105774310|NCT01004861|364824938|FG012|Overall Study|Non-compliance|1|||
105774311|NCT01004861|364824926|FG000|Overall Study|Other|0|||
105774312|NCT01004861|364824927|FG001|Overall Study|Other|0|||
105774313|NCT01004861|364824928|FG002|Overall Study|Other|0|||
105774314|NCT01004861|364824929|FG003|Overall Study|Other|0|||
105774315|NCT01004861|364824930|FG004|Overall Study|Other|0|||
105774316|NCT01004861|364824931|FG005|Overall Study|Other|0|||
105774317|NCT01004861|364824932|FG006|Overall Study|Other|0|||
105774318|NCT01004861|364824933|FG007|Overall Study|Other|0|||
105774319|NCT01004861|364824934|FG008|Overall Study|Other|0|||
105774320|NCT01004861|364824935|FG009|Overall Study|Other|2|||
105774321|NCT01004861|364824936|FG010|Overall Study|Other|1|||
105774322|NCT01004861|364824937|FG011|Overall Study|Other|2|||
105774323|NCT01004861|364824938|FG012|Overall Study|Other|3|||
105774324|NCT01004861|364824926|FG000|Overall Study|Patient decision|0|||
105774325|NCT01004861|364824927|FG001|Overall Study|Patient decision|0|||
105774326|NCT01004861|364824928|FG002|Overall Study|Patient decision|0|||
105774327|NCT01004861|364824929|FG003|Overall Study|Patient decision|0|||
105774328|NCT01004861|364824930|FG004|Overall Study|Patient decision|1|||
105774329|NCT01004861|364824931|FG005|Overall Study|Patient decision|0|||
105774330|NCT01004861|364824932|FG006|Overall Study|Patient decision|1|||
105774331|NCT01004861|364824933|FG007|Overall Study|Patient decision|0|||
105774332|NCT01004861|364824934|FG008|Overall Study|Patient decision|7|||
105774333|NCT01004861|364824935|FG009|Overall Study|Patient decision|1|||
105774334|NCT01004861|364824936|FG010|Overall Study|Patient decision|1|||
105774335|NCT01004861|364824937|FG011|Overall Study|Patient decision|2|||
105774336|NCT01004861|364824938|FG012|Overall Study|Patient decision|3|||
105774337|NCT01004861|364824926|FG000|Overall Study|Transitioned to Phase 4 study|0|||
105774338|NCT01004861|364824927|FG001|Overall Study|Transitioned to Phase 4 study|0|||
105774339|NCT01004861|364824928|FG002|Overall Study|Transitioned to Phase 4 study|0|||
105774340|NCT01004861|364824929|FG003|Overall Study|Transitioned to Phase 4 study|0|||
105774341|NCT01004861|364824930|FG004|Overall Study|Transitioned to Phase 4 study|0|||
105774342|NCT01004861|364824931|FG005|Overall Study|Transitioned to Phase 4 study|0|||
105774343|NCT01004861|364824932|FG006|Overall Study|Transitioned to Phase 4 study|0|||
105774344|NCT01004861|364824933|FG007|Overall Study|Transitioned to Phase 4 study|0|||
105774345|NCT01004861|364824934|FG008|Overall Study|Transitioned to Phase 4 study|2|||
105774346|NCT01004861|364824935|FG009|Overall Study|Transitioned to Phase 4 study|0|||
105774347|NCT01004861|364824936|FG010|Overall Study|Transitioned to Phase 4 study|0|||
105774348|NCT01004861|364824937|FG011|Overall Study|Transitioned to Phase 4 study|0|||
105774349|NCT01004861|364824938|FG012|Overall Study|Transitioned to Phase 4 study|0|||
105774350|NCT01004861|364824926|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774351|NCT01004861|364824927|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774352|NCT01004861|364824928|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774353|NCT01004861|364824929|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774354|NCT01004861|364824930|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774355|NCT01004861|364824931|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774356|NCT01004861|364824932|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774357|NCT01004861|364824933|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774358|NCT01004861|364824934|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
105774359|NCT01004861|364824935|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774360|NCT01004861|364824936|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774361|NCT01004861|364824937|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774362|NCT01004861|364824938|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774363|NCT01004861|364824926|FG000|Overall Study|Patient withdrew|0|||
105774364|NCT01004861|364824927|FG001|Overall Study|Patient withdrew|0|||
105774365|NCT01004861|364824928|FG002|Overall Study|Patient withdrew|0|||
105774366|NCT01004861|364824929|FG003|Overall Study|Patient withdrew|0|||
105774367|NCT01004861|364824930|FG004|Overall Study|Patient withdrew|0|||
105774368|NCT01004861|364824931|FG005|Overall Study|Patient withdrew|0|||
105774369|NCT01004861|364824932|FG006|Overall Study|Patient withdrew|0|||
105774370|NCT01004861|364824933|FG007|Overall Study|Patient withdrew|0|||
105774371|NCT01004861|364824934|FG008|Overall Study|Patient withdrew|1|||
105774372|NCT01004861|364824935|FG009|Overall Study|Patient withdrew|0|||
105774373|NCT01004861|364824936|FG010|Overall Study|Patient withdrew|0|||
105774374|NCT01004861|364824937|FG011|Overall Study|Patient withdrew|0|||
105774375|NCT01004861|364824938|FG012|Overall Study|Patient withdrew|0|||
105774376|NCT01004861|364824926|FG000|Overall Study|Surgical resection|0|||
105774377|NCT01004861|364824927|FG001|Overall Study|Surgical resection|0|||
105774378|NCT01004861|364824928|FG002|Overall Study|Surgical resection|0|||
105774379|NCT01004861|364824929|FG003|Overall Study|Surgical resection|0|||
105774380|NCT01004861|364824930|FG004|Overall Study|Surgical resection|0|||
105774381|NCT01004861|364824931|FG005|Overall Study|Surgical resection|0|||
105774382|NCT01004861|364824932|FG006|Overall Study|Surgical resection|0|||
105774383|NCT01004861|364824933|FG007|Overall Study|Surgical resection|0|||
105774384|NCT01004861|364824934|FG008|Overall Study|Surgical resection|1|||
105774385|NCT01004861|364824935|FG009|Overall Study|Surgical resection|0|||
105774386|NCT01004861|364824936|FG010|Overall Study|Surgical resection|0|||
105774387|NCT01004861|364824937|FG011|Overall Study|Surgical resection|0|||
105774388|NCT01004861|364824938|FG012|Overall Study|Surgical resection|0|||
105774389|NCT01004861|364824926|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774390|NCT01004861|364824927|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774391|NCT01004861|364824928|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774392|NCT01004861|364824929|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105360839|NCT00572455|363328092|FG012|Stage II (28 Days)|Other|0|||
105774393|NCT01004861|364824930|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774394|NCT01004861|364824931|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774395|NCT01004861|364824932|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774396|NCT01004861|364824933|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774397|NCT01004861|364824934|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
105774398|NCT01004861|364824935|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774399|NCT01004861|364824936|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774400|NCT01004861|364824937|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774401|NCT01004861|364824938|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774402|NCT01004861|364824926|FG000|Overall Study|Study termination by Sponsor|0|||
105774403|NCT01004861|364824927|FG001|Overall Study|Study termination by Sponsor|0|||
105774404|NCT01004861|364824928|FG002|Overall Study|Study termination by Sponsor|0|||
105774405|NCT01004861|364824929|FG003|Overall Study|Study termination by Sponsor|0|||
105774406|NCT01004861|364824930|FG004|Overall Study|Study termination by Sponsor|0|||
105774407|NCT01004861|364824931|FG005|Overall Study|Study termination by Sponsor|0|||
105774408|NCT01004861|364824932|FG006|Overall Study|Study termination by Sponsor|0|||
105774409|NCT01004861|364824933|FG007|Overall Study|Study termination by Sponsor|0|||
105774410|NCT01004861|364824934|FG008|Overall Study|Study termination by Sponsor|1|||
105774411|NCT01004861|364824935|FG009|Overall Study|Study termination by Sponsor|0|||
105774412|NCT01004861|364824936|FG010|Overall Study|Study termination by Sponsor|0|||
105774413|NCT01004861|364824937|FG011|Overall Study|Study termination by Sponsor|0|||
105774414|NCT01004861|364824938|FG012|Overall Study|Study termination by Sponsor|0|||
105774415|NCT00003389|364824939|FG000|Overall Study|Disease progression|6|||
105774416|NCT00003389|364824940|FG001|Overall Study|Disease progression|1|||
105774417|NCT00003389|364824939|FG000|Overall Study|Adverse Event|13|||
105774418|NCT00003389|364824940|FG001|Overall Study|Adverse Event|2|||
105774419|NCT00003389|364824939|FG000|Overall Study|Death|0|||
105774420|NCT00003389|364824940|FG001|Overall Study|Death|3|||
105774421|NCT00003389|364824939|FG000|Overall Study|Withdrawal by Subject|12|||
105774422|NCT00003389|364824940|FG001|Overall Study|Withdrawal by Subject|5|||
105774423|NCT00003389|364824939|FG000|Overall Study|Alternative therapy|2|||
105774424|NCT00003389|364824940|FG001|Overall Study|Alternative therapy|1|||
105774425|NCT00003389|364824939|FG000|Overall Study|Complicating disease|1|||
105774426|NCT00003389|364824940|FG001|Overall Study|Complicating disease|0|||
105774427|NCT00003389|364824939|FG000|Overall Study|Off-treatment reason missing|31|||
105774428|NCT00003389|364824940|FG001|Overall Study|Off-treatment reason missing|21|||
105774429|NCT00003389|364824939|FG000|Overall Study|Ineligible|33|||
105774430|NCT00003389|364824940|FG001|Overall Study|Ineligible|27|||
105774431|NCT00686699|364824942|FG000|Treatment Period 1|Adverse Event|0|||
105774432|NCT00686699|364824943|FG001|Treatment Period 1|Adverse Event|2|||
105774433|NCT01997892|364824946|FG000|Overall Study|Physician Decision|2|||
105774434|NCT01997892|364824946|FG000|Overall Study|Lost to Follow-up|6|||
105774435|NCT01997892|364824946|FG000|Overall Study|Death|14|||
105774436|NCT01997892|364824946|FG000|Overall Study|Renal transplant|8|||
105774437|NCT01997892|364824946|FG000|Overall Study|Other|3|||
105774438|NCT01997892|364824946|FG000|Overall Study|Study completion data not recorded|35|||
105774439|NCT02710422|364824947|FG000|Overall Study|Termination of study|9|||
105774440|NCT02710422|364824948|FG001|Overall Study|Termination of study|9|||
105774441|NCT02306148|364824958|FG000|Overall Study|Adverse Event|12|||
105774442|NCT02306148|364824959|FG001|Overall Study|Adverse Event|6|||
105774443|NCT02306148|364824958|FG000|Overall Study|Lost to Follow-up|1|||
105774444|NCT02306148|364824959|FG001|Overall Study|Lost to Follow-up|4|||
105774445|NCT04657003|364824960|FG000|Overall Study|Adverse Event|5|||
105774446|NCT04657003|364824961|FG001|Overall Study|Adverse Event|1|||
105774447|NCT04657003|364824962|FG002|Overall Study|Adverse Event|5|||
105774448|NCT04657003|364824960|FG000|Overall Study|Death|0|||
105774449|NCT04657003|364824961|FG001|Overall Study|Death|2|||
105774450|NCT04657003|364824962|FG002|Overall Study|Death|0|||
105774451|NCT04657003|364824960|FG000|Overall Study|Lost to Follow-up|8|||
105774452|NCT04657003|364824961|FG001|Overall Study|Lost to Follow-up|4|||
105774453|NCT04657003|364824962|FG002|Overall Study|Lost to Follow-up|10|||
105774454|NCT04657003|364824960|FG000|Overall Study|Other - As Reported by Investigator|3|||
105774455|NCT04657003|364824961|FG001|Overall Study|Other - As Reported by Investigator|2|||
105774456|NCT04657003|364824962|FG002|Overall Study|Other - As Reported by Investigator|2|||
105774457|NCT04657003|364824960|FG000|Overall Study|Pregnancy|2|||
105774458|NCT04657003|364824961|FG001|Overall Study|Pregnancy|0|||
105774459|NCT04657003|364824962|FG002|Overall Study|Pregnancy|2|||
105774460|NCT04657003|364824960|FG000|Overall Study|Withdrawal by Subject|16|||
105774461|NCT04657003|364824961|FG001|Overall Study|Withdrawal by Subject|7|||
105774462|NCT04657003|364824962|FG002|Overall Study|Withdrawal by Subject|10|||
105774463|NCT01736176|364824965|FG000|Overall Study|Adverse Event|3|||
105774464|NCT01736176|364824965|FG000|Overall Study|Withdrawal by Subject|4|||
105774465|NCT01736176|364824965|FG000|Overall Study|Lack of Efficacy|3|||
105774466|NCT01736176|364824965|FG000|Overall Study|Unable to Complete PEG Placement|1|||
105774467|NCT00186121|364824968|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
105774468|NCT00186121|364824968|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
105774469|NCT00186121|364824968|FG000|Overall Study|Not eligible (no treatment)|1|||
105774470|NCT03650387|364824969|FG000|Overall Study|Withdrawal by Subject|13|||
105774471|NCT03650387|364824969|FG000|Overall Study|Lost to Follow-up|12|||
105774472|NCT03650387|364824969|FG000|Overall Study|Adverse Event (Not related)|1|||
105774473|NCT03650387|364824969|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
105774474|NCT01569568|364824970|FG000|Overall Study|Physician Decision|0|||
105774475|NCT01569568|364824971|FG001|Overall Study|Physician Decision|2|||
105774476|NCT03347279|364824972|FG000|Overall Study|Withdrawal by Subject|8|||
105774477|NCT03347279|364824973|FG001|Overall Study|Withdrawal by Subject|15|||
105774478|NCT03347279|364824972|FG000|Overall Study|Death|0|||
105774479|NCT03347279|364824973|FG001|Overall Study|Death|2|||
105774480|NCT03347279|364824972|FG000|Overall Study|Lost to Follow-up|5|||
105774481|NCT03347279|364824973|FG001|Overall Study|Lost to Follow-up|2|||
105774482|NCT03347279|364824972|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
105774483|NCT03347279|364824973|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
105774484|NCT03818399|364824974|FG000|Overall Study|Lost to Follow-up|11|||
105774485|NCT03818399|364824974|FG000|Overall Study|Withdrawal by Subject|1|||
105774486|NCT03818399|364824974|FG000|Overall Study|Protocol Violation|2|||
105774487|NCT00934791|364824975|FG000|Overall Study|Withdrawal by Subject|1|||
105774488|NCT00934791|364824976|FG001|Overall Study|Withdrawal by Subject|0|||
105774489|NCT02045979|364824980|FG000|Overall Study|Informed Consent Withdrawn|2|||
105774490|NCT02045979|364824981|FG001|Overall Study|Informed Consent Withdrawn|0|||
105774491|NCT02045979|364824982|FG002|Overall Study|Informed Consent Withdrawn|1|||
105774492|NCT02045979|364824980|FG000|Overall Study|not specified above|0|||
105774493|NCT02045979|364824981|FG001|Overall Study|not specified above|1|||
105774494|NCT02045979|364824982|FG002|Overall Study|not specified above|0|||
105774495|NCT02425891|364824983|FG000|Overall Study|Death|333|||
105774496|NCT02425891|364824984|FG001|Overall Study|Death|314|||
105774497|NCT02425891|364824983|FG000|Overall Study|Lost to Follow-up|4|||
105774498|NCT02425891|364824984|FG001|Overall Study|Lost to Follow-up|6|||
105774499|NCT02425891|364824983|FG000|Overall Study|Non-Compliance|1|||
105774500|NCT02425891|364824984|FG001|Overall Study|Non-Compliance|1|||
105774501|NCT02425891|364824983|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
105774502|NCT02425891|364824984|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
105774503|NCT02425891|364824983|FG000|Overall Study|Physician Decision|0|||
105774504|NCT02425891|364824984|FG001|Overall Study|Physician Decision|1|||
105774505|NCT02425891|364824983|FG000|Overall Study|Protocol Violation|1|||
105774506|NCT02425891|364824984|FG001|Overall Study|Protocol Violation|1|||
105774507|NCT02425891|364824983|FG000|Overall Study|Study Terminated By Sponsor|85|||
105774508|NCT02425891|364824984|FG001|Overall Study|Study Terminated By Sponsor|95|||
105774509|NCT02425891|364824983|FG000|Overall Study|Withdrawal by Subject|27|||
105774510|NCT02425891|364824984|FG001|Overall Study|Withdrawal by Subject|32|||
105774511|NCT00535236|364824985|FG000|Overall Study|Adverse Event|1|||
105774512|NCT00535236|364824986|FG001|Overall Study|Adverse Event|0|||
105774513|NCT00535236|364824987|FG002|Overall Study|Adverse Event|9|||
105774514|NCT00535236|364824988|FG003|Overall Study|Adverse Event|3|||
105774515|NCT00535236|364824989|FG004|Overall Study|Adverse Event|3|||
105774516|NCT00535236|364824990|FG005|Overall Study|Adverse Event|0|||
105774517|NCT00535236|364824991|FG006|Overall Study|Adverse Event|5|||
105774518|NCT00535236|364824992|FG007|Overall Study|Adverse Event|1|||
105774519|NCT00535236|364824993|FG008|Overall Study|Adverse Event|2|||
105774520|NCT00535236|364824994|FG009|Overall Study|Adverse Event|1|||
105774521|NCT00535236|364824985|FG000|Overall Study|Lost to Follow-up|1|||
105774522|NCT00535236|364824986|FG001|Overall Study|Lost to Follow-up|2|||
105774523|NCT00535236|364824987|FG002|Overall Study|Lost to Follow-up|0|||
105774524|NCT00535236|364824988|FG003|Overall Study|Lost to Follow-up|0|||
105774525|NCT00535236|364824989|FG004|Overall Study|Lost to Follow-up|2|||
105774526|NCT00535236|364824990|FG005|Overall Study|Lost to Follow-up|0|||
105774527|NCT00535236|364824991|FG006|Overall Study|Lost to Follow-up|0|||
105774528|NCT00535236|364824992|FG007|Overall Study|Lost to Follow-up|0|||
105774529|NCT00535236|364824993|FG008|Overall Study|Lost to Follow-up|6|||
105774530|NCT00535236|364824994|FG009|Overall Study|Lost to Follow-up|1|||
105774531|NCT00535236|364824985|FG000|Overall Study|Physician Decision|0|||
105774532|NCT00535236|364824986|FG001|Overall Study|Physician Decision|0|||
105774533|NCT00535236|364824987|FG002|Overall Study|Physician Decision|0|||
105774534|NCT00535236|364824988|FG003|Overall Study|Physician Decision|0|||
105774535|NCT00535236|364824989|FG004|Overall Study|Physician Decision|1|||
105774536|NCT00535236|364824990|FG005|Overall Study|Physician Decision|0|||
105774537|NCT00535236|364824991|FG006|Overall Study|Physician Decision|1|||
105774538|NCT00535236|364824992|FG007|Overall Study|Physician Decision|0|||
105774539|NCT00535236|364824993|FG008|Overall Study|Physician Decision|0|||
105774540|NCT00535236|364824994|FG009|Overall Study|Physician Decision|0|||
105774541|NCT00535236|364824985|FG000|Overall Study|Protocol Violation|2|||
105774542|NCT00535236|364824986|FG001|Overall Study|Protocol Violation|0|||
105774543|NCT00535236|364824987|FG002|Overall Study|Protocol Violation|1|||
105774544|NCT00535236|364824988|FG003|Overall Study|Protocol Violation|0|||
105774545|NCT00535236|364824989|FG004|Overall Study|Protocol Violation|0|||
105774546|NCT00535236|364824990|FG005|Overall Study|Protocol Violation|0|||
105774547|NCT00535236|364824991|FG006|Overall Study|Protocol Violation|0|||
105774548|NCT00535236|364824992|FG007|Overall Study|Protocol Violation|0|||
105774549|NCT00535236|364824993|FG008|Overall Study|Protocol Violation|1|||
105774550|NCT00535236|364824994|FG009|Overall Study|Protocol Violation|0|||
105774551|NCT00535236|364824985|FG000|Overall Study|Withdrawal by Subject|3|||
105774552|NCT00535236|364824986|FG001|Overall Study|Withdrawal by Subject|0|||
105774553|NCT00535236|364824987|FG002|Overall Study|Withdrawal by Subject|2|||
105774554|NCT00535236|364824988|FG003|Overall Study|Withdrawal by Subject|1|||
105774555|NCT00535236|364824989|FG004|Overall Study|Withdrawal by Subject|6|||
105774556|NCT00535236|364824990|FG005|Overall Study|Withdrawal by Subject|1|||
105774557|NCT00535236|364824991|FG006|Overall Study|Withdrawal by Subject|5|||
105774558|NCT00535236|364824992|FG007|Overall Study|Withdrawal by Subject|0|||
105774559|NCT00535236|364824993|FG008|Overall Study|Withdrawal by Subject|4|||
105774560|NCT00535236|364824994|FG009|Overall Study|Withdrawal by Subject|2|||
105774561|NCT04124952|364824995|FG000|Overall Study|Lost to Follow-up|1|||
105774562|NCT01654224|364824999|FG000|Overall Study|Lost to Follow-up|2|||
105774563|NCT01654224|364825000|FG001|Overall Study|Lost to Follow-up|2|||
105774564|NCT01654224|364824999|FG000|Overall Study|Did not receive allocation|1|||
105774565|NCT01654224|364825000|FG001|Overall Study|Did not receive allocation|8|||
105774566|NCT01654224|364824999|FG000|Overall Study|Insufficient blood sample|3|||
105774567|NCT01654224|364825000|FG001|Overall Study|Insufficient blood sample|2|||
105774568|NCT00846027|364825003|FG000|Overall Study|Death|3|||
105774569|NCT00846027|364825003|FG000|Overall Study|Disease Progression|30|||
105774570|NCT00846027|364825003|FG000|Overall Study|Toxicity|12|||
105774571|NCT00846027|364825003|FG000|Overall Study|Patient Decision|7|||
105774572|NCT00846027|364825003|FG000|Overall Study|Investigator Discretion|29|||
105774573|NCT00846027|364825003|FG000|Overall Study|Protocol Violation|2|||
105774574|NCT00846027|364825003|FG000|Overall Study|Subject Not Treated|7|||
105774575|NCT02646891|364825004|FG000|Overall Study|Adverse Event|0|||
105774576|NCT02646891|364825005|FG001|Overall Study|Adverse Event|1|||
105774577|NCT02646891|364825006|FG002|Overall Study|Adverse Event|0|||
105774578|NCT02646891|364825007|FG003|Overall Study|Adverse Event|0|||
105774579|NCT02646891|364825008|FG004|Overall Study|Adverse Event|0|||
105774580|NCT02646891|364825009|FG005|Overall Study|Adverse Event|0|||
105774581|NCT02646891|364825010|FG006|Overall Study|Adverse Event|0|||
105774582|NCT02646891|364825011|FG007|Overall Study|Adverse Event|0|||
105774583|NCT02646891|364825012|FG008|Overall Study|Adverse Event|0|||
105774584|NCT02646891|364825013|FG009|Overall Study|Adverse Event|0|||
105774585|NCT02646891|364825004|FG000|Overall Study|Lost to Follow-up|0|||
105774586|NCT02646891|364825005|FG001|Overall Study|Lost to Follow-up|0|||
105774587|NCT02646891|364825006|FG002|Overall Study|Lost to Follow-up|0|||
105774588|NCT02646891|364825007|FG003|Overall Study|Lost to Follow-up|0|||
105774589|NCT02646891|364825008|FG004|Overall Study|Lost to Follow-up|0|||
105774590|NCT02646891|364825009|FG005|Overall Study|Lost to Follow-up|0|||
105774591|NCT02646891|364825010|FG006|Overall Study|Lost to Follow-up|2|||
105774592|NCT02646891|364825011|FG007|Overall Study|Lost to Follow-up|2|||
105774593|NCT02646891|364825012|FG008|Overall Study|Lost to Follow-up|2|||
105774594|NCT02646891|364825013|FG009|Overall Study|Lost to Follow-up|2|||
105774595|NCT02646891|364825004|FG000|Overall Study|Protocol Violation|0|||
105774596|NCT02646891|364825005|FG001|Overall Study|Protocol Violation|0|||
105774597|NCT02646891|364825006|FG002|Overall Study|Protocol Violation|0|||
105774598|NCT02646891|364825007|FG003|Overall Study|Protocol Violation|0|||
105774599|NCT02646891|364825008|FG004|Overall Study|Protocol Violation|0|||
105774600|NCT02646891|364825009|FG005|Overall Study|Protocol Violation|0|||
105774601|NCT02646891|364825010|FG006|Overall Study|Protocol Violation|1|||
105774602|NCT02646891|364825011|FG007|Overall Study|Protocol Violation|1|||
105774603|NCT02646891|364825012|FG008|Overall Study|Protocol Violation|0|||
105774604|NCT02646891|364825013|FG009|Overall Study|Protocol Violation|0|||
105774605|NCT02646891|364825004|FG000|Overall Study|Withdrawal by Subject|2|||
105774606|NCT02646891|364825005|FG001|Overall Study|Withdrawal by Subject|0|||
105774607|NCT02646891|364825006|FG002|Overall Study|Withdrawal by Subject|1|||
105774608|NCT02646891|364825007|FG003|Overall Study|Withdrawal by Subject|0|||
105774609|NCT02646891|364825008|FG004|Overall Study|Withdrawal by Subject|0|||
105774610|NCT02646891|364825009|FG005|Overall Study|Withdrawal by Subject|0|||
105774611|NCT02646891|364825010|FG006|Overall Study|Withdrawal by Subject|5|||
105774612|NCT02646891|364825011|FG007|Overall Study|Withdrawal by Subject|9|||
105774613|NCT02646891|364825012|FG008|Overall Study|Withdrawal by Subject|7|||
105774614|NCT02646891|364825013|FG009|Overall Study|Withdrawal by Subject|3|||
105774615|NCT02646891|364825004|FG000|Overall Study|Death|0|||
105774616|NCT02646891|364825005|FG001|Overall Study|Death|0|||
105442541|NCT05173012|363626783|FG006|Overall Study|Withdrawal by Subject|1|||
105774617|NCT02646891|364825006|FG002|Overall Study|Death|0|||
105774618|NCT02646891|364825007|FG003|Overall Study|Death|0|||
105774619|NCT02646891|364825008|FG004|Overall Study|Death|0|||
105774620|NCT02646891|364825009|FG005|Overall Study|Death|0|||
105774621|NCT02646891|364825010|FG006|Overall Study|Death|1|||
105774622|NCT02646891|364825011|FG007|Overall Study|Death|1|||
105774623|NCT02646891|364825012|FG008|Overall Study|Death|1|||
105774624|NCT02646891|364825013|FG009|Overall Study|Death|0|||
105774625|NCT00638989|364825014|FG000|Overall Study|Lost to Follow-up|0|||
105774626|NCT00638989|364825015|FG001|Overall Study|Lost to Follow-up|0|||
105774627|NCT00638989|364825016|FG002|Overall Study|Lost to Follow-up|1|||
105774628|NCT01058395|364825018|FG000|Overall Study|Death|2|||
105774629|NCT01058395|364825019|FG001|Overall Study|Death|1|||
105442542|NCT05173012|363626784|FG007|Overall Study|Withdrawal by Subject|0|||
105442543|NCT05173012|363626777|FG000|Overall Study|Protocol Deviation|0|||
105442544|NCT05173012|363626778|FG001|Overall Study|Protocol Deviation|0|||
105442545|NCT05173012|363626779|FG002|Overall Study|Protocol Deviation|0|||
105442546|NCT05173012|363626780|FG003|Overall Study|Protocol Deviation|1|||
105442547|NCT05173012|363626781|FG004|Overall Study|Protocol Deviation|0|||
105442548|NCT05173012|363626782|FG005|Overall Study|Protocol Deviation|0|||
105442549|NCT05173012|363626783|FG006|Overall Study|Protocol Deviation|0|||
105442550|NCT05173012|363626784|FG007|Overall Study|Protocol Deviation|0|||
105442551|NCT05173012|363626777|FG000|Overall Study|Other|0|||
105442552|NCT05173012|363626778|FG001|Overall Study|Other|0|||
105774630|NCT01058395|364825018|FG000|Overall Study|Lost to Follow-up|1|||
105774631|NCT01058395|364825019|FG001|Overall Study|Lost to Follow-up|0|||
105774632|NCT00963820|364825020|FG000|Dose Escalation Phase|Progressive Disease|3|||
105774633|NCT00963820|364825021|FG001|Dose Escalation Phase|Progressive Disease|3|||
105774634|NCT00963820|364825022|FG002|Dose Escalation Phase|Progressive Disease|3|||
105774635|NCT00963820|364825023|FG003|Dose Escalation Phase|Progressive Disease|3|||
105774636|NCT00963820|364825024|FG004|Dose Escalation Phase|Progressive Disease|4|||
105774637|NCT00963820|364825025|FG005|Dose Escalation Phase|Progressive Disease|3|||
105774638|NCT00963820|364825026|FG006|Dose Escalation Phase|Progressive Disease|3|||
105774639|NCT00963820|364825027|FG007|Dose Escalation Phase|Progressive Disease|2|||
105774640|NCT00963820|364825028|FG008|Dose Escalation Phase|Progressive Disease|0|||
105774641|NCT00963820|364825029|FG009|Dose Escalation Phase|Progressive Disease|0|||
105774642|NCT00963820|364825030|FG010|Dose Escalation Phase|Progressive Disease|0|||
105774643|NCT00963820|364825031|FG011|Dose Escalation Phase|Progressive Disease|0|||
105774644|NCT00963820|364825020|FG000|Dose Escalation Phase|Adverse Event|0|||
105774645|NCT00963820|364825021|FG001|Dose Escalation Phase|Adverse Event|0|||
105774646|NCT00963820|364825022|FG002|Dose Escalation Phase|Adverse Event|0|||
105774647|NCT00963820|364825023|FG003|Dose Escalation Phase|Adverse Event|0|||
105774648|NCT00963820|364825024|FG004|Dose Escalation Phase|Adverse Event|0|||
105774649|NCT00963820|364825025|FG005|Dose Escalation Phase|Adverse Event|0|||
105774650|NCT00963820|364825026|FG006|Dose Escalation Phase|Adverse Event|3|||
105774651|NCT00963820|364825027|FG007|Dose Escalation Phase|Adverse Event|1|||
105774652|NCT00963820|364825028|FG008|Dose Escalation Phase|Adverse Event|0|||
105774653|NCT00963820|364825029|FG009|Dose Escalation Phase|Adverse Event|0|||
105774654|NCT00963820|364825030|FG010|Dose Escalation Phase|Adverse Event|0|||
105774655|NCT00963820|364825031|FG011|Dose Escalation Phase|Adverse Event|0|||
105774656|NCT00963820|364825020|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
105774657|NCT00963820|364825021|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
105774658|NCT00963820|364825022|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
105774659|NCT00963820|364825023|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
105774660|NCT00963820|364825024|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
105774661|NCT00963820|364825025|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
105774662|NCT00963820|364825026|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
105774663|NCT00963820|364825027|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
105774664|NCT00963820|364825028|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
105774665|NCT00963820|364825029|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
105774666|NCT00963820|364825030|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
105774667|NCT00963820|364825031|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
105774668|NCT00963820|364825020|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774669|NCT00963820|364825021|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774670|NCT00963820|364825022|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774671|NCT00963820|364825023|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774672|NCT00963820|364825024|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774673|NCT00963820|364825025|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774674|NCT00963820|364825026|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
105774675|NCT00963820|364825027|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774676|NCT00963820|364825028|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774677|NCT00963820|364825029|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774678|NCT00963820|364825030|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774679|NCT00963820|364825031|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774680|NCT00963820|364825020|FG000|Expansion Phase|Progressive Disease|0|||
105774681|NCT00963820|364825021|FG001|Expansion Phase|Progressive Disease|0|||
105774682|NCT00963820|364825022|FG002|Expansion Phase|Progressive Disease|0|||
105774683|NCT00963820|364825023|FG003|Expansion Phase|Progressive Disease|0|||
105774684|NCT00963820|364825024|FG004|Expansion Phase|Progressive Disease|0|||
105774685|NCT00963820|364825025|FG005|Expansion Phase|Progressive Disease|0|||
105442553|NCT05173012|363626779|FG002|Overall Study|Other|0|||
105442554|NCT05173012|363626780|FG003|Overall Study|Other|2|||
105442555|NCT05173012|363626781|FG004|Overall Study|Other|0|||
105774686|NCT00963820|364825026|FG006|Expansion Phase|Progressive Disease|0|||
105774687|NCT00963820|364825027|FG007|Expansion Phase|Progressive Disease|0|||
105774688|NCT00963820|364825028|FG008|Expansion Phase|Progressive Disease|8|||
105774689|NCT00963820|364825029|FG009|Expansion Phase|Progressive Disease|6|||
105774690|NCT00963820|364825030|FG010|Expansion Phase|Progressive Disease|4|||
105774691|NCT00963820|364825031|FG011|Expansion Phase|Progressive Disease|2|||
105774692|NCT00963820|364825020|FG000|Expansion Phase|Adverse Event|0|||
105774693|NCT00963820|364825021|FG001|Expansion Phase|Adverse Event|0|||
105774694|NCT00963820|364825022|FG002|Expansion Phase|Adverse Event|0|||
105774695|NCT00963820|364825023|FG003|Expansion Phase|Adverse Event|0|||
105774696|NCT00963820|364825024|FG004|Expansion Phase|Adverse Event|0|||
105774697|NCT00963820|364825025|FG005|Expansion Phase|Adverse Event|0|||
105774698|NCT00963820|364825026|FG006|Expansion Phase|Adverse Event|0|||
105774699|NCT00963820|364825027|FG007|Expansion Phase|Adverse Event|0|||
105774700|NCT00963820|364825028|FG008|Expansion Phase|Adverse Event|1|||
105774701|NCT00963820|364825029|FG009|Expansion Phase|Adverse Event|3|||
105774702|NCT00963820|364825030|FG010|Expansion Phase|Adverse Event|0|||
105774703|NCT00963820|364825031|FG011|Expansion Phase|Adverse Event|0|||
105774704|NCT00963820|364825020|FG000|Expansion Phase|Withdrawal by Subject|0|||
105774705|NCT00963820|364825021|FG001|Expansion Phase|Withdrawal by Subject|0|||
105774706|NCT00963820|364825022|FG002|Expansion Phase|Withdrawal by Subject|0|||
105774707|NCT00963820|364825023|FG003|Expansion Phase|Withdrawal by Subject|0|||
105774708|NCT00963820|364825024|FG004|Expansion Phase|Withdrawal by Subject|0|||
105774709|NCT00963820|364825025|FG005|Expansion Phase|Withdrawal by Subject|0|||
105774710|NCT00963820|364825026|FG006|Expansion Phase|Withdrawal by Subject|0|||
105774711|NCT00963820|364825027|FG007|Expansion Phase|Withdrawal by Subject|0|||
105774712|NCT00963820|364825028|FG008|Expansion Phase|Withdrawal by Subject|1|||
105774713|NCT00963820|364825029|FG009|Expansion Phase|Withdrawal by Subject|0|||
105774714|NCT00963820|364825030|FG010|Expansion Phase|Withdrawal by Subject|1|||
105774715|NCT00963820|364825031|FG011|Expansion Phase|Withdrawal by Subject|1|||
105774716|NCT00963820|364825020|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774717|NCT00963820|364825021|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774718|NCT00963820|364825022|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774719|NCT00963820|364825023|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774720|NCT00963820|364825024|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774721|NCT00963820|364825025|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774722|NCT00963820|364825026|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774723|NCT00963820|364825027|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774724|NCT00963820|364825028|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774725|NCT00963820|364825029|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774726|NCT00963820|364825030|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774727|NCT00963820|364825031|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
105774728|NCT02477800|364825032|FG000|Placebo-Controlled Period|Adverse Event|16|||
105774729|NCT02477800|364825033|FG001|Placebo-Controlled Period|Adverse Event|25|||
105774730|NCT02477800|364825034|FG002|Placebo-Controlled Period|Adverse Event|28|||
105774731|NCT02477800|364825035|FG003|Placebo-Controlled Period|Adverse Event|0|||
105774732|NCT02477800|364825036|FG004|Placebo-Controlled Period|Adverse Event|0|||
105774733|NCT02477800|364825037|FG005|Placebo-Controlled Period|Adverse Event|0|||
105774734|NCT02477800|364825038|FG006|Placebo-Controlled Period|Adverse Event|0|||
105774735|NCT02477800|364825032|FG000|Placebo-Controlled Period|Change of Treatment|1|||
105774736|NCT02477800|364825033|FG001|Placebo-Controlled Period|Change of Treatment|2|||
105774737|NCT02477800|364825034|FG002|Placebo-Controlled Period|Change of Treatment|1|||
105774738|NCT02477800|364825035|FG003|Placebo-Controlled Period|Change of Treatment|0|||
105774739|NCT02477800|364825036|FG004|Placebo-Controlled Period|Change of Treatment|0|||
105774740|NCT02477800|364825037|FG005|Placebo-Controlled Period|Change of Treatment|0|||
105774741|NCT02477800|364825038|FG006|Placebo-Controlled Period|Change of Treatment|0|||
105774742|NCT02477800|364825032|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
105774743|NCT02477800|364825033|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
105774744|NCT02477800|364825034|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
105774745|NCT02477800|364825035|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
105774746|NCT02477800|364825036|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
105774747|NCT02477800|364825037|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
105774748|NCT02477800|364825038|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
105774749|NCT02477800|364825032|FG000|Placebo-Controlled Period|Death|0|||
105774750|NCT02477800|364825033|FG001|Placebo-Controlled Period|Death|3|||
105774751|NCT02477800|364825034|FG002|Placebo-Controlled Period|Death|2|||
105774752|NCT02477800|364825035|FG003|Placebo-Controlled Period|Death|0|||
105774753|NCT02477800|364825036|FG004|Placebo-Controlled Period|Death|0|||
105774754|NCT02477800|364825037|FG005|Placebo-Controlled Period|Death|0|||
105774755|NCT02477800|364825038|FG006|Placebo-Controlled Period|Death|0|||
105774756|NCT02477800|364825032|FG000|Placebo-Controlled Period|Disease Progression|1|||
105774757|NCT02477800|364825033|FG001|Placebo-Controlled Period|Disease Progression|0|||
105774758|NCT02477800|364825034|FG002|Placebo-Controlled Period|Disease Progression|1|||
105806445|NCT01464827|364948984|FG003|Overall Study|Other|2|||
105774759|NCT02477800|364825035|FG003|Placebo-Controlled Period|Disease Progression|0|||
105774760|NCT02477800|364825036|FG004|Placebo-Controlled Period|Disease Progression|0|||
105774761|NCT02477800|364825037|FG005|Placebo-Controlled Period|Disease Progression|0|||
105774762|NCT02477800|364825038|FG006|Placebo-Controlled Period|Disease Progression|0|||
105774763|NCT02477800|364825032|FG000|Placebo-Controlled Period|Investigator Decision|3|||
105774764|NCT02477800|364825033|FG001|Placebo-Controlled Period|Investigator Decision|2|||
105774765|NCT02477800|364825034|FG002|Placebo-Controlled Period|Investigator Decision|1|||
105774766|NCT02477800|364825035|FG003|Placebo-Controlled Period|Investigator Decision|0|||
105774767|NCT02477800|364825036|FG004|Placebo-Controlled Period|Investigator Decision|0|||
105774768|NCT02477800|364825037|FG005|Placebo-Controlled Period|Investigator Decision|0|||
105774769|NCT02477800|364825038|FG006|Placebo-Controlled Period|Investigator Decision|0|||
105774770|NCT02477800|364825032|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
105774771|NCT02477800|364825033|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
105774772|NCT02477800|364825034|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
105774773|NCT02477800|364825035|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
105774774|NCT02477800|364825036|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
105774775|NCT02477800|364825037|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
105774776|NCT02477800|364825038|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
105774777|NCT02477800|364825032|FG000|Placebo-Controlled Period|Relocation|2|||
105774778|NCT02477800|364825033|FG001|Placebo-Controlled Period|Relocation|0|||
105774779|NCT02477800|364825034|FG002|Placebo-Controlled Period|Relocation|0|||
105774780|NCT02477800|364825035|FG003|Placebo-Controlled Period|Relocation|0|||
105774781|NCT02477800|364825036|FG004|Placebo-Controlled Period|Relocation|0|||
105774782|NCT02477800|364825037|FG005|Placebo-Controlled Period|Relocation|0|||
105774783|NCT02477800|364825038|FG006|Placebo-Controlled Period|Relocation|0|||
105774784|NCT02477800|364825032|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
105774785|NCT02477800|364825033|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
105774786|NCT02477800|364825034|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
105774787|NCT02477800|364825035|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
105774788|NCT02477800|364825036|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
105774789|NCT02477800|364825037|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
105774790|NCT02477800|364825038|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
105774791|NCT02477800|364825032|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
105774792|NCT02477800|364825033|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
105774793|NCT02477800|364825034|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
105774794|NCT02477800|364825035|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
105774795|NCT02477800|364825036|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
105774796|NCT02477800|364825037|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
105774797|NCT02477800|364825038|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
105774798|NCT02477800|364825032|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
105774799|NCT02477800|364825033|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
105774800|NCT02477800|364825034|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
105774801|NCT02477800|364825035|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
105774802|NCT02477800|364825036|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
105774803|NCT02477800|364825037|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
105774804|NCT02477800|364825038|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
105774805|NCT02477800|364825032|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
105774806|NCT02477800|364825033|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
105774807|NCT02477800|364825034|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
105774808|NCT02477800|364825035|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105774809|NCT02477800|364825036|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105774810|NCT02477800|364825037|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105774811|NCT02477800|364825038|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105774812|NCT02477800|364825032|FG000|Placebo-Controlled Period|Reason not Specified|161|||
105774813|NCT02477800|364825033|FG001|Placebo-Controlled Period|Reason not Specified|161|||
105774814|NCT02477800|364825034|FG002|Placebo-Controlled Period|Reason not Specified|189|||
105774815|NCT02477800|364825035|FG003|Placebo-Controlled Period|Reason not Specified|0|||
105774816|NCT02477800|364825036|FG004|Placebo-Controlled Period|Reason not Specified|0|||
105774817|NCT02477800|364825037|FG005|Placebo-Controlled Period|Reason not Specified|0|||
105774818|NCT02477800|364825038|FG006|Placebo-Controlled Period|Reason not Specified|0|||
105774819|NCT02477800|364825032|FG000|Long Term Extension Period|Adverse Event|0|||
105774820|NCT02477800|364825033|FG001|Long Term Extension Period|Adverse Event|0|||
105774821|NCT02477800|364825034|FG002|Long Term Extension Period|Adverse Event|0|||
105774822|NCT02477800|364825035|FG003|Long Term Extension Period|Adverse Event|6|||
105774823|NCT02477800|364825036|FG004|Long Term Extension Period|Adverse Event|2|||
105774824|NCT02477800|364825037|FG005|Long Term Extension Period|Adverse Event|4|||
105774825|NCT02477800|364825038|FG006|Long Term Extension Period|Adverse Event|3|||
105774826|NCT02477800|364825032|FG000|Long Term Extension Period|Death|0|||
105550166|NCT00902304|364014369|FG000|Overall Study|Investigator discretion|3|||
105774827|NCT02477800|364825033|FG001|Long Term Extension Period|Death|0|||
105774828|NCT02477800|364825034|FG002|Long Term Extension Period|Death|0|||
105774829|NCT02477800|364825035|FG003|Long Term Extension Period|Death|1|||
105774830|NCT02477800|364825036|FG004|Long Term Extension Period|Death|1|||
105774831|NCT02477800|364825037|FG005|Long Term Extension Period|Death|1|||
105774832|NCT02477800|364825038|FG006|Long Term Extension Period|Death|2|||
105774833|NCT02477800|364825032|FG000|Long Term Extension Period|Consent Withdrawn|0|||
105774834|NCT02477800|364825033|FG001|Long Term Extension Period|Consent Withdrawn|0|||
105774835|NCT02477800|364825034|FG002|Long Term Extension Period|Consent Withdrawn|0|||
105774836|NCT02477800|364825035|FG003|Long Term Extension Period|Consent Withdrawn|10|||
105774837|NCT02477800|364825036|FG004|Long Term Extension Period|Consent Withdrawn|4|||
105774838|NCT02477800|364825037|FG005|Long Term Extension Period|Consent Withdrawn|13|||
105774839|NCT02477800|364825038|FG006|Long Term Extension Period|Consent Withdrawn|16|||
105774840|NCT02477800|364825032|FG000|Long Term Extension Period|Disease Progression|0|||
105774841|NCT02477800|364825033|FG001|Long Term Extension Period|Disease Progression|0|||
105774842|NCT02477800|364825034|FG002|Long Term Extension Period|Disease Progression|0|||
105774843|NCT02477800|364825035|FG003|Long Term Extension Period|Disease Progression|3|||
105774844|NCT02477800|364825036|FG004|Long Term Extension Period|Disease Progression|1|||
105774845|NCT02477800|364825037|FG005|Long Term Extension Period|Disease Progression|1|||
105774846|NCT02477800|364825038|FG006|Long Term Extension Period|Disease Progression|0|||
105774847|NCT02477800|364825032|FG000|Long Term Extension Period|Investigator Decision|0|||
105774848|NCT02477800|364825033|FG001|Long Term Extension Period|Investigator Decision|0|||
105774849|NCT02477800|364825034|FG002|Long Term Extension Period|Investigator Decision|0|||
105774850|NCT02477800|364825035|FG003|Long Term Extension Period|Investigator Decision|0|||
105774851|NCT02477800|364825036|FG004|Long Term Extension Period|Investigator Decision|0|||
105774852|NCT02477800|364825037|FG005|Long Term Extension Period|Investigator Decision|0|||
105774853|NCT02477800|364825038|FG006|Long Term Extension Period|Investigator Decision|2|||
105774854|NCT02477800|364825032|FG000|Long Term Extension Period|Lost to Follow-up|0|||
105774855|NCT02477800|364825033|FG001|Long Term Extension Period|Lost to Follow-up|0|||
105774856|NCT02477800|364825034|FG002|Long Term Extension Period|Lost to Follow-up|0|||
105774857|NCT02477800|364825035|FG003|Long Term Extension Period|Lost to Follow-up|0|||
105774858|NCT02477800|364825036|FG004|Long Term Extension Period|Lost to Follow-up|1|||
105774859|NCT02477800|364825037|FG005|Long Term Extension Period|Lost to Follow-up|3|||
105774860|NCT02477800|364825038|FG006|Long Term Extension Period|Lost to Follow-up|0|||
105774861|NCT02477800|364825032|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
105774862|NCT02477800|364825033|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
105774863|NCT02477800|364825034|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
105774864|NCT02477800|364825035|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
105774865|NCT02477800|364825036|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
105774866|NCT02477800|364825037|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
105774867|NCT02477800|364825038|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
105774868|NCT02477800|364825032|FG000|Long Term Extension Period|Study Visit Burden|0|||
105774869|NCT02477800|364825033|FG001|Long Term Extension Period|Study Visit Burden|0|||
105774870|NCT02477800|364825034|FG002|Long Term Extension Period|Study Visit Burden|0|||
105774871|NCT02477800|364825035|FG003|Long Term Extension Period|Study Visit Burden|3|||
105774872|NCT02477800|364825036|FG004|Long Term Extension Period|Study Visit Burden|0|||
105774873|NCT02477800|364825037|FG005|Long Term Extension Period|Study Visit Burden|2|||
105774874|NCT02477800|364825038|FG006|Long Term Extension Period|Study Visit Burden|2|||
105774875|NCT02477800|364825032|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
105774876|NCT02477800|364825033|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
105774877|NCT02477800|364825034|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
105774878|NCT02477800|364825035|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
105774879|NCT02477800|364825036|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
105774880|NCT02477800|364825037|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
105774881|NCT02477800|364825038|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
105774882|NCT02477800|364825032|FG000|Long Term Extension Period|Reason not Specified|0|||
105774883|NCT02477800|364825033|FG001|Long Term Extension Period|Reason not Specified|0|||
105774884|NCT02477800|364825034|FG002|Long Term Extension Period|Reason not Specified|0|||
105774885|NCT02477800|364825035|FG003|Long Term Extension Period|Reason not Specified|126|||
105774886|NCT02477800|364825036|FG004|Long Term Extension Period|Reason not Specified|140|||
105774887|NCT02477800|364825037|FG005|Long Term Extension Period|Reason not Specified|270|||
105774888|NCT02477800|364825038|FG006|Long Term Extension Period|Reason not Specified|224|||
105774889|NCT00474539|364825041|FG000|Infant Series|Withdrawal by Subject|3|||
105774890|NCT00474539|364825042|FG001|Infant Series|Withdrawal by Subject|4|||
105774891|NCT00474539|364825041|FG000|Infant Series|Randomization error|5|||
105774892|NCT00474539|364825042|FG001|Infant Series|Randomization error|0|||
105774893|NCT00474539|364825041|FG000|Infant Series|Lost to Follow-up|2|||
105774894|NCT00474539|364825042|FG001|Infant Series|Lost to Follow-up|1|||
105774895|NCT00474539|364825041|FG000|Infant Series|Protocol Violation|0|||
105774896|NCT00474539|364825042|FG001|Infant Series|Protocol Violation|1|||
105774897|NCT00474539|364825041|FG000|After Infant Series|Lost to Follow-up|3|||
105774898|NCT00474539|364825042|FG001|After Infant Series|Lost to Follow-up|0|||
105774899|NCT00474539|364825041|FG000|After Infant Series|Withdrawal by Subject|1|||
105774900|NCT00474539|364825042|FG001|After Infant Series|Withdrawal by Subject|0|||
105774901|NCT00474539|364825041|FG000|Toddler Dose|Protocol Violation|1|||
105774902|NCT00474539|364825042|FG001|Toddler Dose|Protocol Violation|0|||
105774903|NCT01117428|364825043|FG000|Overall Study|Lack of Efficacy|1|||
105774904|NCT01117428|364825044|FG001|Overall Study|Lack of Efficacy|0|||
105774905|NCT01117428|364825045|FG002|Overall Study|Lack of Efficacy|0|||
105774906|NCT01117428|364825046|FG003|Overall Study|Lack of Efficacy|0|||
105774907|NCT01117428|364825047|FG004|Overall Study|Lack of Efficacy|0|||
105774908|NCT01117428|364825048|FG005|Overall Study|Lack of Efficacy|0|||
105774909|NCT01117428|364825043|FG000|Overall Study|Adverse Event|4|||
105774910|NCT01117428|364825044|FG001|Overall Study|Adverse Event|0|||
105774911|NCT01117428|364825045|FG002|Overall Study|Adverse Event|0|||
105774912|NCT01117428|364825046|FG003|Overall Study|Adverse Event|0|||
105774913|NCT01117428|364825047|FG004|Overall Study|Adverse Event|1|||
105774914|NCT01117428|364825048|FG005|Overall Study|Adverse Event|2|||
105774915|NCT01117428|364825043|FG000|Overall Study|Death|0|||
105774916|NCT01117428|364825044|FG001|Overall Study|Death|1|||
105774917|NCT01117428|364825045|FG002|Overall Study|Death|2|||
105774918|NCT01117428|364825046|FG003|Overall Study|Death|0|||
105774919|NCT01117428|364825047|FG004|Overall Study|Death|0|||
105774920|NCT01117428|364825048|FG005|Overall Study|Death|1|||
105774921|NCT01117428|364825043|FG000|Overall Study|Physician Decision|0|||
105774922|NCT01117428|364825044|FG001|Overall Study|Physician Decision|1|||
105774923|NCT01117428|364825045|FG002|Overall Study|Physician Decision|0|||
105774924|NCT01117428|364825046|FG003|Overall Study|Physician Decision|0|||
105774925|NCT01117428|364825047|FG004|Overall Study|Physician Decision|0|||
105774926|NCT01117428|364825048|FG005|Overall Study|Physician Decision|0|||
105774927|NCT01117428|364825043|FG000|Overall Study|Withdrawal by Subject|0|||
105774928|NCT01117428|364825044|FG001|Overall Study|Withdrawal by Subject|0|||
105774929|NCT01117428|364825045|FG002|Overall Study|Withdrawal by Subject|1|||
105774930|NCT01117428|364825046|FG003|Overall Study|Withdrawal by Subject|0|||
105774931|NCT01117428|364825047|FG004|Overall Study|Withdrawal by Subject|0|||
105774932|NCT01117428|364825048|FG005|Overall Study|Withdrawal by Subject|0|||
105774933|NCT01117428|364825043|FG000|Overall Study|Progressive disease|15|||
105774934|NCT01117428|364825044|FG001|Overall Study|Progressive disease|27|||
105774935|NCT01117428|364825045|FG002|Overall Study|Progressive disease|10|||
105774936|NCT01117428|364825046|FG003|Overall Study|Progressive disease|12|||
105774937|NCT01117428|364825047|FG004|Overall Study|Progressive disease|16|||
105774938|NCT01117428|364825048|FG005|Overall Study|Progressive disease|17|||
105774939|NCT02289833|364825051|FG000|Overall Study|Study discontinuation|0|||
105774940|NCT02289833|364825052|FG001|Overall Study|Study discontinuation|1|||
105774941|NCT02289833|364825051|FG000|Overall Study|Lost to Follow-up|4|||
105774942|NCT02289833|364825052|FG001|Overall Study|Lost to Follow-up|0|||
105774943|NCT02289833|364825051|FG000|Overall Study|Death|23|||
105774944|NCT02289833|364825052|FG001|Overall Study|Death|16|||
105774945|NCT02449915|364825053|FG000|Overall Study|Exclusion criteria - drug use|1|||
105774946|NCT02449915|364825054|FG001|Overall Study|Exclusion criteria - drug use|0|||
105774947|NCT02449915|364825053|FG000|Overall Study|Withdrawal by Subject|0|||
105774948|NCT02449915|364825054|FG001|Overall Study|Withdrawal by Subject|2|||
105774949|NCT02449915|364825053|FG000|Overall Study|Intraoperative surgical findings|1|||
105774950|NCT02449915|364825054|FG001|Overall Study|Intraoperative surgical findings|1|||
105774951|NCT02449915|364825053|FG000|Overall Study|Abnormal preop lab|0|||
105774952|NCT02449915|364825054|FG001|Overall Study|Abnormal preop lab|1|||
105774953|NCT02561273|364825055|FG000|Overall Study|Protocol Violation|1|||
105774954|NCT02561273|364825056|FG001|Overall Study|Protocol Violation|0|||
105774955|NCT01603628|364825059|FG000|Overall Study|Personal Reasons|1|||
105774956|NCT01603628|364825060|FG001|Overall Study|Personal Reasons|1|||
105774957|NCT01603628|364825061|FG002|Overall Study|Personal Reasons|2|||
105774958|NCT01603628|364825059|FG000|Overall Study|Protocol Violation|1|||
105774959|NCT01603628|364825060|FG001|Overall Study|Protocol Violation|1|||
105774960|NCT01603628|364825061|FG002|Overall Study|Protocol Violation|0|||
105774961|NCT01603628|364825059|FG000|Overall Study|Lost to Follow-up|0|||
105774962|NCT01603628|364825060|FG001|Overall Study|Lost to Follow-up|1|||
105774963|NCT01603628|364825061|FG002|Overall Study|Lost to Follow-up|0|||
105774964|NCT01603628|364825059|FG000|Overall Study|Other Miscellaneous Reason|1|||
105774965|NCT01603628|364825060|FG001|Overall Study|Other Miscellaneous Reason|0|||
105774966|NCT01603628|364825061|FG002|Overall Study|Other Miscellaneous Reason|0|||
105774967|NCT00403390|364825066|FG000|Overall Study|Withdrawal by Subject|1|||
105774968|NCT00403390|364825067|FG001|Overall Study|Withdrawal by Subject|0|||
105774969|NCT00403390|364825066|FG000|Overall Study|samples lost|1|||
105774970|NCT00403390|364825067|FG001|Overall Study|samples lost|0|||
105774971|NCT00403390|364825066|FG000|Overall Study|non-compliant|1|||
105774972|NCT00403390|364825067|FG001|Overall Study|non-compliant|0|||
105774973|NCT00935701|364825068|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
105774974|NCT02087241|364825069|FG000|Overall Study|Death|2|||
105774975|NCT02087241|364825070|FG001|Overall Study|Death|1|||
105774976|NCT02087241|364825071|FG002|Overall Study|Death|1|||
105774977|NCT02087241|364825072|FG003|Overall Study|Death|1|||
105774978|NCT02087241|364825069|FG000|Overall Study|Withdrawal by Subject|1|||
105774979|NCT02087241|364825070|FG001|Overall Study|Withdrawal by Subject|0|||
105774980|NCT02087241|364825071|FG002|Overall Study|Withdrawal by Subject|0|||
105774981|NCT02087241|364825072|FG003|Overall Study|Withdrawal by Subject|1|||
105774982|NCT02087241|364825069|FG000|Overall Study|Progressive Disease|0|||
105774983|NCT02087241|364825070|FG001|Overall Study|Progressive Disease|0|||
105774984|NCT02087241|364825071|FG002|Overall Study|Progressive Disease|0|||
105774985|NCT02087241|364825072|FG003|Overall Study|Progressive Disease|1|||
105774986|NCT02087241|364825069|FG000|Overall Study|Study Terminated by Sponsor|0|||
105774987|NCT02087241|364825070|FG001|Overall Study|Study Terminated by Sponsor|2|||
105774988|NCT02087241|364825071|FG002|Overall Study|Study Terminated by Sponsor|0|||
105774989|NCT02087241|364825072|FG003|Overall Study|Study Terminated by Sponsor|4|||
105806446|NCT01464827|364948985|FG004|Overall Study|Other|3|||
105806447|NCT01464827|364948986|FG005|Overall Study|Other|0|||
105806448|NCT01464827|364948987|FG006|Overall Study|Other|1|||
105806449|NCT01464827|364948988|FG007|Overall Study|Other|0|||
105806450|NCT01464827|364948989|FG008|Overall Study|Other|3|||
105806451|NCT01464827|364948990|FG009|Overall Study|Other|1|||
105806452|NCT01464827|364948991|FG010|Overall Study|Other|2|||
105806453|NCT01464827|364948992|FG011|Overall Study|Other|0|||
105806454|NCT01464827|364948993|FG012|Overall Study|Other|1|||
105806455|NCT01464827|364948994|FG013|Overall Study|Other|0|||
105806456|NCT01464827|364948981|FG000|Overall Study|Not Treated|0|||
105806457|NCT01464827|364948982|FG001|Overall Study|Not Treated|2|||
105806458|NCT01464827|364948983|FG002|Overall Study|Not Treated|0|||
105806459|NCT01464827|364948984|FG003|Overall Study|Not Treated|0|||
105806460|NCT01464827|364948985|FG004|Overall Study|Not Treated|1|||
105806461|NCT01464827|364948986|FG005|Overall Study|Not Treated|0|||
105806462|NCT01464827|364948987|FG006|Overall Study|Not Treated|1|||
105806463|NCT01464827|364948988|FG007|Overall Study|Not Treated|0|||
105806464|NCT01464827|364948989|FG008|Overall Study|Not Treated|0|||
105806465|NCT01464827|364948990|FG009|Overall Study|Not Treated|2|||
105806466|NCT01464827|364948991|FG010|Overall Study|Not Treated|0|||
105806467|NCT01464827|364948992|FG011|Overall Study|Not Treated|1|||
105806468|NCT01464827|364948993|FG012|Overall Study|Not Treated|0|||
105806469|NCT01464827|364948994|FG013|Overall Study|Not Treated|2|||
105806470|NCT00294723|364948997|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
105806471|NCT00294723|364948998|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
105806472|NCT00294723|364948999|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
105806473|NCT00294723|364948997|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
105806474|NCT00294723|364948998|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
105806475|NCT00294723|364948999|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
105806476|NCT00294723|364948997|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
105806477|NCT00294723|364948998|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
105806478|NCT00294723|364948999|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
105806479|NCT00294723|364948997|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
105806480|NCT00294723|364948998|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
105806481|NCT00294723|364948999|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
105806482|NCT00294723|364948997|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
105806483|NCT00294723|364948998|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
105806484|NCT00294723|364948999|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
105806485|NCT00294723|364948997|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
105806486|NCT00294723|364948998|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
105806487|NCT00294723|364948999|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
105806488|NCT00294723|364948997|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
105806489|NCT00294723|364948998|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
105806490|NCT00294723|364948999|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
105806491|NCT00294723|364948997|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
105806492|NCT00294723|364948998|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
105806493|NCT00294723|364948999|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
105806494|NCT00294723|364948997|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
105806495|NCT00294723|364948998|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
105806496|NCT00294723|364948999|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
105806497|NCT00294723|364948997|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
105806498|NCT00294723|364948998|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
105806499|NCT00294723|364948999|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
105806500|NCT00294723|364948997|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
105806501|NCT00294723|364948998|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
105806502|NCT00294723|364948999|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
105806503|NCT00294723|364948997|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
105806504|NCT00294723|364948998|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
105806505|NCT00294723|364948999|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
105806506|NCT03038113|364949000|FG000|Overall Study|Withdrawal by Subject|0|||
105806507|NCT03038113|364949001|FG001|Overall Study|Withdrawal by Subject|0|||
105806508|NCT03038113|364949002|FG002|Overall Study|Withdrawal by Subject|1|||
105774990|NCT00211536|364826730|FG000|Overall Study|Withdrawal by Subject|2|||
105774991|NCT00211536|364826731|FG001|Overall Study|Withdrawal by Subject|2|||
105774992|NCT00211536|364826730|FG000|Overall Study|Physician Decision|0|||
105774993|NCT00211536|364826731|FG001|Overall Study|Physician Decision|5|||
105774994|NCT00211536|364826730|FG000|Overall Study|Adverse Event|2|||
105774995|NCT00211536|364826731|FG001|Overall Study|Adverse Event|0|||
105774996|NCT00305773|364826734|FG000|Overall Study|Death|3|||
105774997|NCT00305773|364826735|FG001|Overall Study|Death|2|||
105774998|NCT00305773|364826734|FG000|Overall Study|Adverse Event|1|||
105774999|NCT00305773|364826735|FG001|Overall Study|Adverse Event|2|||
105775000|NCT00305773|364826734|FG000|Overall Study|Alternative Treatment|4|||
105775001|NCT00305773|364826735|FG001|Overall Study|Alternative Treatment|4|||
105775002|NCT00305773|364826734|FG000|Overall Study|Physician Decision|1|||
105775003|NCT00305773|364826735|FG001|Overall Study|Physician Decision|1|||
105775004|NCT00305773|364826734|FG000|Overall Study|Withdrawal by Subject|1|||
105775005|NCT00305773|364826735|FG001|Overall Study|Withdrawal by Subject|4|||
105775006|NCT00305773|364826734|FG000|Overall Study|Disease Progression|1|||
105775007|NCT00305773|364826735|FG001|Overall Study|Disease Progression|3|||
105775008|NCT00305773|364826734|FG000|Overall Study|All other reasons|3|||
105775009|NCT00305773|364826735|FG001|Overall Study|All other reasons|2|||
105775010|NCT02059174|364826737|FG000|Period 1|Withdrawal by Subject|0|||
105775011|NCT02059174|364826738|FG001|Period 1|Withdrawal by Subject|2|||
105775012|NCT02059174|364826737|FG000|Period 2|Withdrawal by Subject|0|||
105775013|NCT02059174|364826738|FG001|Period 2|Withdrawal by Subject|2|||
105775014|NCT02059174|364826737|FG000|Period 2|Protocol Violation|1|||
105775015|NCT02059174|364826738|FG001|Period 2|Protocol Violation|0|||
105775016|NCT02059174|364826737|FG000|Period 3|Physician Decision|1|||
105775017|NCT02059174|364826738|FG001|Period 3|Physician Decision|0|||
105775018|NCT02608099|364826739|FG000|Overall Study|Ablation procedure not initiated|3|||
105775019|NCT02608099|364826740|FG001|Overall Study|Ablation procedure not initiated|2|||
105775020|NCT00087594|364826741|FG000|Overall Study|Adverse Event|2|||
105775021|NCT00087594|364826742|FG001|Overall Study|Adverse Event|3|||
105775022|NCT00087594|364826741|FG000|Overall Study|Lost to Follow-up|0|||
105775023|NCT00087594|364826742|FG001|Overall Study|Lost to Follow-up|2|||
105775024|NCT00087594|364826741|FG000|Overall Study|Withdrawal by Subject|4|||
105775025|NCT00087594|364826742|FG001|Overall Study|Withdrawal by Subject|2|||
105775026|NCT00087594|364826741|FG000|Overall Study|Lack of Efficacy|2|||
105775027|NCT00087594|364826742|FG001|Overall Study|Lack of Efficacy|5|||
105775028|NCT00768040|364826748|FG000|Overall Study|Adverse Event|3|||
105775029|NCT00768040|364826749|FG001|Overall Study|Adverse Event|2|||
105775030|NCT00768040|364826748|FG000|Overall Study|Abnormal laboratory value|1|||
105775031|NCT00768040|364826749|FG001|Overall Study|Abnormal laboratory value|1|||
105775032|NCT01823991|364826750|FG000|Overall Study|Withdrawal by Subject|8|||
105775033|NCT01823991|364826751|FG001|Overall Study|Withdrawal by Subject|5|||
105775034|NCT00417248|364826754|FG000|Overall Study|Study Terminated|6|||
105775035|NCT00417248|364826754|FG000|Overall Study|Death|1|||
105775036|NCT00417248|364826754|FG000|Overall Study|Lack of Efficacy|1|||
105775037|NCT01370499|364826755|FG000|Overall Study|Adverse Event|38|||
105775038|NCT01370499|364826756|FG001|Overall Study|Adverse Event|12|||
105775039|NCT01370499|364826755|FG000|Overall Study|Lack of Efficacy|4|||
105775040|NCT01370499|364826756|FG001|Overall Study|Lack of Efficacy|2|||
105775041|NCT01370499|364826755|FG000|Overall Study|Lost to Follow-up|2|||
105775042|NCT01370499|364826756|FG001|Overall Study|Lost to Follow-up|1|||
105775043|NCT01370499|364826755|FG000|Overall Study|Physician Decision|3|||
105775044|NCT01370499|364826756|FG001|Overall Study|Physician Decision|3|||
105775045|NCT01370499|364826755|FG000|Overall Study|Protocol Violation|5|||
105775046|NCT01370499|364826756|FG001|Overall Study|Protocol Violation|4|||
105775047|NCT01370499|364826755|FG000|Overall Study|Withdrawal by Subject|18|||
105775048|NCT01370499|364826756|FG001|Overall Study|Withdrawal by Subject|7|||
105775049|NCT01370499|364826755|FG000|Overall Study|Sponsor Decision|41|||
105775050|NCT01370499|364826756|FG001|Overall Study|Sponsor Decision|15|||
105775051|NCT02185040|364826757|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
105775052|NCT02185040|364826758|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
105775053|NCT02185040|364826759|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
105775054|NCT02185040|364826760|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
105775055|NCT02185040|364826761|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
105775056|NCT02185040|364826762|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
105775057|NCT02185040|364826763|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
105775058|NCT02185040|364826757|FG000|Part 1 Treatment Phase|Adverse Event|1|||
105775059|NCT02185040|364826758|FG001|Part 1 Treatment Phase|Adverse Event|0|||
105775060|NCT02185040|364826759|FG002|Part 1 Treatment Phase|Adverse Event|0|||
105775061|NCT02185040|364826760|FG003|Part 1 Treatment Phase|Adverse Event|2|||
105775062|NCT02185040|364826761|FG004|Part 1 Treatment Phase|Adverse Event|3|||
105661687|NCT02165826|364425104|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
105775063|NCT02185040|364826762|FG005|Part 1 Treatment Phase|Adverse Event|0|||
105775064|NCT02185040|364826763|FG006|Part 1 Treatment Phase|Adverse Event|0|||
105775065|NCT02185040|364826757|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
105775066|NCT02185040|364826758|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
105775067|NCT02185040|364826759|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
105775068|NCT02185040|364826760|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
105775069|NCT02185040|364826761|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
105775070|NCT02185040|364826762|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
105775071|NCT02185040|364826763|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
105775072|NCT02185040|364826757|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
105775073|NCT02185040|364826758|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
105775074|NCT02185040|364826759|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
105775075|NCT02185040|364826760|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
105775076|NCT02185040|364826761|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
105775077|NCT02185040|364826762|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
105775078|NCT02185040|364826763|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
105775079|NCT02185040|364826757|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
105775080|NCT02185040|364826758|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
105775081|NCT02185040|364826759|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
105775082|NCT02185040|364826760|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
105775083|NCT02185040|364826761|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
105775084|NCT02185040|364826762|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
105775085|NCT02185040|364826763|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
105775086|NCT02185040|364826757|FG000|Active Treatment Extension Phase|Adverse Event|0|||
105775087|NCT02185040|364826758|FG001|Active Treatment Extension Phase|Adverse Event|0|||
105661688|NCT02165826|364425105|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
105661689|NCT02165826|364425103|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
105661690|NCT02165826|364425104|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
105661691|NCT02165826|364425105|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
105661692|NCT02165826|364425103|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
105661693|NCT02165826|364425104|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
105661694|NCT02165826|364425105|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
105661695|NCT02165826|364425103|FG000|Down-Titration Period|Reason Not Specified|1|||
105661696|NCT02165826|364425104|FG001|Down-Titration Period|Reason Not Specified|0|||
105661697|NCT02165826|364425105|FG002|Down-Titration Period|Reason Not Specified|2|||
105661698|NCT02392104|364425106|FG000|Overall Study|discontinuation of warfarin|3|||
105661699|NCT02392104|364425106|FG000|Overall Study|bleeding event|1|||
105661700|NCT02392104|364425106|FG000|Overall Study|transferred care to another doctor|2|||
105661701|NCT02392104|364425106|FG000|Overall Study|INR goal range changed|1|||
105661702|NCT02392104|364425106|FG000|Overall Study|admitted to skilled nursing facility|3|||
105661703|NCT02392104|364425106|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
105661704|NCT02581059|364425107|FG000|Study Treatment|Disease Progression|1|||
105661705|NCT02581059|364425108|FG001|Study Treatment|Disease Progression|1|||
105661706|NCT02581059|364425107|FG000|Study Treatment|Adverse Event|2|||
105661707|NCT02581059|364425108|FG001|Study Treatment|Adverse Event|1|||
105661708|NCT02581059|364425107|FG000|Study Treatment|Death|1|||
105661709|NCT02581059|364425108|FG001|Study Treatment|Death|1|||
105661710|NCT02581059|364425107|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
105661711|NCT02581059|364425108|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
105661712|NCT02581059|364425107|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
105661713|NCT02581059|364425108|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
105661714|NCT02581059|364425107|FG000|Follow up|Death|1|||
105661715|NCT02581059|364425108|FG001|Follow up|Death|3|||
105661716|NCT02581059|364425107|FG000|Follow up|study terminated|1|||
105661717|NCT02581059|364425108|FG001|Follow up|study terminated|1|||
105661718|NCT02581059|364425107|FG000|Follow up|screen failure|0|||
105661719|NCT02581059|364425108|FG001|Follow up|screen failure|1|||
105661720|NCT02581059|364425107|FG000|Follow up|Patient started new clinical trial|1|||
105661721|NCT02581059|364425108|FG001|Follow up|Patient started new clinical trial|0|||
105661722|NCT04547023|364425109|FG000|Overall Study|Did Not Receive Intervention|3|||
105661723|NCT04547023|364425110|FG001|Overall Study|Did Not Receive Intervention|2|||
105661724|NCT04547023|364425109|FG000|Overall Study|Lost to Follow-up|1|||
105661725|NCT04547023|364425110|FG001|Overall Study|Lost to Follow-up|1|||
105661726|NCT02394665|364425111|FG000|Overall Study|Physician Decision|1|||
105661727|NCT02394665|364425112|FG001|Overall Study|Physician Decision|0|||
105661728|NCT02394665|364425113|FG002|Overall Study|Physician Decision|0|||
105661729|NCT04147858|364425116|FG000|Overall Study|Adverse Event|6|||
105661730|NCT04147858|364425117|FG001|Overall Study|Adverse Event|6|||
105661731|NCT04147858|364425118|FG002|Overall Study|Adverse Event|6|||
105661732|NCT04147858|364425116|FG000|Overall Study|Lack of Efficacy|3|||
105661733|NCT04147858|364425117|FG001|Overall Study|Lack of Efficacy|3|||
105661734|NCT04147858|364425118|FG002|Overall Study|Lack of Efficacy|1|||
105661735|NCT04147858|364425116|FG000|Overall Study|Lost to Follow-up|1|||
105661736|NCT04147858|364425117|FG001|Overall Study|Lost to Follow-up|6|||
105661737|NCT04147858|364425118|FG002|Overall Study|Lost to Follow-up|2|||
105661738|NCT04147858|364425116|FG000|Overall Study|Withdrawal by Subject|3|||
105661739|NCT04147858|364425117|FG001|Overall Study|Withdrawal by Subject|4|||
105775088|NCT02185040|364826759|FG002|Active Treatment Extension Phase|Adverse Event|0|||
105775089|NCT02185040|364826760|FG003|Active Treatment Extension Phase|Adverse Event|0|||
105775090|NCT02185040|364826761|FG004|Active Treatment Extension Phase|Adverse Event|0|||
105775091|NCT02185040|364826762|FG005|Active Treatment Extension Phase|Adverse Event|1|||
105775092|NCT02185040|364826763|FG006|Active Treatment Extension Phase|Adverse Event|4|||
105775093|NCT02185040|364826757|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
105775094|NCT02185040|364826758|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
105775095|NCT02185040|364826759|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
105775096|NCT02185040|364826760|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
105775097|NCT02185040|364826761|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
105775098|NCT02185040|364826762|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
105775099|NCT02185040|364826763|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
105775100|NCT02185040|364826757|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
105775101|NCT02185040|364826758|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
105775102|NCT02185040|364826759|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
105775103|NCT02185040|364826760|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
105775104|NCT02185040|364826761|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
105775105|NCT02185040|364826762|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
105775106|NCT02185040|364826763|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
105775107|NCT00887822|364826764|FG000|Overall Study|Insufficient therapeutic response|53|||
105775108|NCT00887822|364826765|FG001|Overall Study|Insufficient therapeutic response|55|||
105775109|NCT00887822|364826764|FG000|Overall Study|Adverse Event|14|||
105775110|NCT00887822|364826765|FG001|Overall Study|Adverse Event|17|||
105775111|NCT00887822|364826764|FG000|Overall Study|Failure to return|11|||
105775112|NCT00887822|364826765|FG001|Overall Study|Failure to return|11|||
105775113|NCT00887822|364826764|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
105775114|NCT00887822|364826765|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
105775115|NCT00887822|364826764|FG000|Overall Study|Administrative/Other than specified|5|||
105775116|NCT00887822|364826765|FG001|Overall Study|Administrative/Other than specified|4|||
105775117|NCT00887822|364826764|FG000|Overall Study|Death|2|||
105775118|NCT00887822|364826765|FG001|Overall Study|Death|3|||
105775119|NCT00887822|364826764|FG000|Overall Study|Protocol Violation|0|||
105775120|NCT00887822|364826765|FG001|Overall Study|Protocol Violation|1|||
105775121|NCT00887822|364826764|FG000|Overall Study|Randomized but not treated|0|||
105775122|NCT00887822|364826765|FG001|Overall Study|Randomized but not treated|1|||
105775123|NCT00141297|364826767|FG000|Overall Study|Adverse Event|0|||
105775124|NCT00141297|364826768|FG001|Overall Study|Adverse Event|0|||
105775125|NCT00141297|364826769|FG002|Overall Study|Adverse Event|1|||
105775126|NCT00141297|364826770|FG003|Overall Study|Adverse Event|0|||
105775127|NCT00141297|364826771|FG004|Overall Study|Adverse Event|1|||
105775128|NCT00141297|364826772|FG005|Overall Study|Adverse Event|1|||
105775129|NCT00141297|364826773|FG006|Overall Study|Adverse Event|0|||
105775130|NCT00141297|364826774|FG007|Overall Study|Adverse Event|1|||
105775131|NCT00141297|364826775|FG008|Overall Study|Adverse Event|1|||
105775132|NCT00141297|364826776|FG009|Overall Study|Adverse Event|0|||
105775133|NCT00141297|364826767|FG000|Overall Study|Death|1|||
105775134|NCT00141297|364826768|FG001|Overall Study|Death|0|||
105775135|NCT00141297|364826769|FG002|Overall Study|Death|0|||
105775136|NCT00141297|364826770|FG003|Overall Study|Death|0|||
105775137|NCT00141297|364826771|FG004|Overall Study|Death|0|||
105775138|NCT00141297|364826772|FG005|Overall Study|Death|0|||
105775139|NCT00141297|364826773|FG006|Overall Study|Death|0|||
105775140|NCT00141297|364826774|FG007|Overall Study|Death|0|||
105775141|NCT00141297|364826775|FG008|Overall Study|Death|1|||
105775142|NCT00141297|364826776|FG009|Overall Study|Death|0|||
105775143|NCT00141297|364826767|FG000|Overall Study|Withdrawal by Subject|0|||
105775144|NCT00141297|364826768|FG001|Overall Study|Withdrawal by Subject|0|||
105775145|NCT00141297|364826769|FG002|Overall Study|Withdrawal by Subject|0|||
105775146|NCT00141297|364826770|FG003|Overall Study|Withdrawal by Subject|0|||
105775147|NCT00141297|364826771|FG004|Overall Study|Withdrawal by Subject|0|||
105775148|NCT00141297|364826772|FG005|Overall Study|Withdrawal by Subject|0|||
105775149|NCT00141297|364826773|FG006|Overall Study|Withdrawal by Subject|0|||
105775150|NCT00141297|364826774|FG007|Overall Study|Withdrawal by Subject|0|||
105775151|NCT00141297|364826775|FG008|Overall Study|Withdrawal by Subject|1|||
105775152|NCT00141297|364826776|FG009|Overall Study|Withdrawal by Subject|0|||
105775153|NCT00141297|364826767|FG000|Overall Study|Other|0|||
105775154|NCT00141297|364826768|FG001|Overall Study|Other|0|||
105775155|NCT00141297|364826769|FG002|Overall Study|Other|0|||
105775156|NCT00141297|364826770|FG003|Overall Study|Other|1|||
105775157|NCT00141297|364826771|FG004|Overall Study|Other|5|||
105775158|NCT00141297|364826772|FG005|Overall Study|Other|0|||
105775159|NCT00141297|364826773|FG006|Overall Study|Other|0|||
105775160|NCT00141297|364826774|FG007|Overall Study|Other|0|||
105775161|NCT00141297|364826775|FG008|Overall Study|Other|2|||
105775162|NCT00141297|364826776|FG009|Overall Study|Other|0|||
105775163|NCT00141297|364826767|FG000|Overall Study|Progressive Disease|2|||
105775164|NCT00141297|364826768|FG001|Overall Study|Progressive Disease|3|||
105775165|NCT00141297|364826769|FG002|Overall Study|Progressive Disease|6|||
105775166|NCT00141297|364826770|FG003|Overall Study|Progressive Disease|2|||
105775167|NCT00141297|364826771|FG004|Overall Study|Progressive Disease|15|||
105775168|NCT00141297|364826772|FG005|Overall Study|Progressive Disease|2|||
105775169|NCT00141297|364826773|FG006|Overall Study|Progressive Disease|3|||
105775170|NCT00141297|364826774|FG007|Overall Study|Progressive Disease|3|||
105775171|NCT00141297|364826775|FG008|Overall Study|Progressive Disease|15|||
105775172|NCT00141297|364826776|FG009|Overall Study|Progressive Disease|6|||
105775173|NCT00141297|364826767|FG000|Overall Study|Transitioned|0|||
105775174|NCT00141297|364826768|FG001|Overall Study|Transitioned|0|||
105775175|NCT00141297|364826769|FG002|Overall Study|Transitioned|0|||
105775176|NCT00141297|364826770|FG003|Overall Study|Transitioned|0|||
105775177|NCT00141297|364826771|FG004|Overall Study|Transitioned|1|||
105775178|NCT00141297|364826772|FG005|Overall Study|Transitioned|0|||
105775179|NCT00141297|364826773|FG006|Overall Study|Transitioned|0|||
105775180|NCT00141297|364826774|FG007|Overall Study|Transitioned|0|||
105775181|NCT00141297|364826775|FG008|Overall Study|Transitioned|0|||
105775182|NCT00141297|364826776|FG009|Overall Study|Transitioned|0|||
105775183|NCT00166504|364826777|FG000|Overall Study|Adverse Event|3|||
105775184|NCT00166504|364826778|FG001|Overall Study|Adverse Event|3|||
105775185|NCT00166504|364826777|FG000|Overall Study|Lost to Follow-up|1|||
105775186|NCT00166504|364826778|FG001|Overall Study|Lost to Follow-up|1|||
105775187|NCT00166504|364826777|FG000|Overall Study|Withdrawal by Subject|1|||
105775188|NCT00166504|364826778|FG001|Overall Study|Withdrawal by Subject|0|||
105775189|NCT03558503|364826779|FG000|Overall Study|Adverse Event|1|||
105775190|NCT03558503|364826779|FG000|Overall Study|Death|1|||
105775191|NCT03558503|364826779|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
105775192|NCT02200510|364826780|FG000|Overall Study|Death|1|||
105775193|NCT02200510|364826781|FG001|Overall Study|Death|1|||
105775194|NCT02200510|364826780|FG000|Overall Study|Protocol Violation|0|||
105775195|NCT02200510|364826781|FG001|Overall Study|Protocol Violation|1|||
105775196|NCT02200510|364826780|FG000|Overall Study|Lost to Follow-up|7|||
105775197|NCT02200510|364826781|FG001|Overall Study|Lost to Follow-up|1|||
105775198|NCT02200510|364826780|FG000|Overall Study|potential COI - joined study team|1|||
105775199|NCT02200510|364826781|FG001|Overall Study|potential COI - joined study team|0|||
105775200|NCT03288987|364826782|FG000|Overall Study|Protocol Violation|10|||
105775201|NCT03288987|364826783|FG001|Overall Study|Protocol Violation|4|||
105775202|NCT02807376|364826784|FG000|Overall Study|Intra-operative exclusion criteria|3|||
105775203|NCT02807376|364826785|FG001|Overall Study|Intra-operative exclusion criteria|0|||
105775204|NCT02807376|364826784|FG000|Overall Study|Lost to Follow-up|0|||
105775205|NCT02807376|364826785|FG001|Overall Study|Lost to Follow-up|1|||
105775206|NCT01542632|364826786|FG000|Overall Study|Withdrawal of Consent|0|||
105775207|NCT01542632|364826787|FG001|Overall Study|Withdrawal of Consent|0|||
105775208|NCT01542632|364826788|FG002|Overall Study|Withdrawal of Consent|0|||
105775209|NCT01542632|364826789|FG003|Overall Study|Withdrawal of Consent|2|||
105775210|NCT01542632|364826790|FG004|Overall Study|Withdrawal of Consent|3|||
105775211|NCT01542632|364826791|FG005|Overall Study|Withdrawal of Consent|0|||
105775212|NCT01542632|364826786|FG000|Overall Study|Adverse Event|0|||
105775213|NCT01542632|364826787|FG001|Overall Study|Adverse Event|0|||
105775214|NCT01542632|364826788|FG002|Overall Study|Adverse Event|1|||
105775215|NCT01542632|364826789|FG003|Overall Study|Adverse Event|0|||
105775216|NCT01542632|364826790|FG004|Overall Study|Adverse Event|0|||
105775217|NCT01542632|364826791|FG005|Overall Study|Adverse Event|0|||
105775218|NCT01542632|364826786|FG000|Overall Study|Lost to Follow-up|0|||
105775219|NCT01542632|364826787|FG001|Overall Study|Lost to Follow-up|1|||
105775220|NCT01542632|364826788|FG002|Overall Study|Lost to Follow-up|0|||
105775221|NCT01542632|364826789|FG003|Overall Study|Lost to Follow-up|0|||
105775222|NCT01542632|364826790|FG004|Overall Study|Lost to Follow-up|0|||
105775223|NCT01542632|364826791|FG005|Overall Study|Lost to Follow-up|0|||
105775224|NCT01542632|364826786|FG000|Overall Study|Sponsor/Investigator Decision|0|||
105775225|NCT01542632|364826787|FG001|Overall Study|Sponsor/Investigator Decision|0|||
105775226|NCT01542632|364826788|FG002|Overall Study|Sponsor/Investigator Decision|0|||
105775227|NCT01542632|364826789|FG003|Overall Study|Sponsor/Investigator Decision|0|||
105775228|NCT01542632|364826790|FG004|Overall Study|Sponsor/Investigator Decision|1|||
105775229|NCT01542632|364826791|FG005|Overall Study|Sponsor/Investigator Decision|0|||
105775230|NCT01944462|364826799|FG000|PPPP Educational Program|Lost to Follow-up|60|||
105775231|NCT00808028|364826800|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
105775232|NCT00808028|364826801|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
105775233|NCT00808028|364826802|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
105775234|NCT00808028|364826803|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
105775235|NCT00808028|364826800|FG000|Stage 1 (6 Months)|Other|1|||
105775236|NCT00808028|364826801|FG001|Stage 1 (6 Months)|Other|0|||
105775237|NCT00808028|364826802|FG002|Stage 1 (6 Months)|Other|2|||
105775238|NCT00808028|364826803|FG003|Stage 1 (6 Months)|Other|4|||
105775239|NCT00808028|364826800|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
105775240|NCT00808028|364826801|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
105775241|NCT00808028|364826802|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
105775242|NCT00808028|364826803|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
105775243|NCT00808028|364826800|FG000|Stage 1 (6 Months)|Adverse Event|0|||
105775244|NCT00808028|364826801|FG001|Stage 1 (6 Months)|Adverse Event|0|||
105775245|NCT00808028|364826802|FG002|Stage 1 (6 Months)|Adverse Event|1|||
105775246|NCT00808028|364826803|FG003|Stage 1 (6 Months)|Adverse Event|2|||
105775247|NCT00808028|364826800|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
105775248|NCT00808028|364826801|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
105775249|NCT00808028|364826802|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
105775250|NCT00808028|364826803|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
105775251|NCT00808028|364826800|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
105775252|NCT00808028|364826801|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
105775253|NCT00808028|364826802|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
105775254|NCT00808028|364826803|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
105775255|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
105775256|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
105775257|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
105775258|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
105775259|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
105775260|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
105775261|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
105775262|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
105775263|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
105775264|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
105775265|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
105775266|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
105775267|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
105775268|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
105775269|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
105775270|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
105775271|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
105775272|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
105775273|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
105775274|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
105775275|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
105775276|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
105775277|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
105775278|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
105775279|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
105775280|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
105775281|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
105775282|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
105775283|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
105775284|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
105775285|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
105775286|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
105775287|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
105775288|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
105775289|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
105775290|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
105775291|NCT01222767|364826808|FG000|Overall Study|Progressive disease|13|||
105775292|NCT01222767|364826808|FG000|Overall Study|Adverse Event|2|||
105775293|NCT01222767|364826808|FG000|Overall Study|Surgical resection|1|||
105775294|NCT01222767|364826808|FG000|Overall Study|Never treated|1|||
105775295|NCT02274311|364826809|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
105775296|NCT00081263|364826810|FG000|Overall Study|clerical error|1|||
105775297|NCT00081263|364826811|FG001|Overall Study|clerical error|0|||
105775298|NCT00081263|364826810|FG000|Overall Study|wrong cell type|7|||
105775299|NCT00081263|364826811|FG001|Overall Study|wrong cell type|5|||
105775300|NCT00081263|364826810|FG000|Overall Study|improper pre-protocol therapy|0|||
105775301|NCT00081263|364826811|FG001|Overall Study|improper pre-protocol therapy|1|||
105775302|NCT00081263|364826810|FG000|Overall Study|Inadequate pathology|0|||
105775303|NCT00081263|364826811|FG001|Overall Study|Inadequate pathology|1|||
105775304|NCT00081263|364826810|FG000|Overall Study|Never treated|4|||
105775305|NCT00081263|364826811|FG001|Overall Study|Never treated|5|||
105775306|NCT00081263|364826810|FG000|Overall Study|Inadequate data|5|||
105775307|NCT00081263|364826811|FG001|Overall Study|Inadequate data|10|||
105775308|NCT00106626|364826812|FG000|Overall Study|Adverse Event|5|||
105775309|NCT00106626|364826813|FG001|Overall Study|Adverse Event|4|||
105775310|NCT00106626|364826814|FG002|Overall Study|Adverse Event|3|||
105775311|NCT00106626|364826815|FG003|Overall Study|Adverse Event|3|||
105775312|NCT00106626|364826812|FG000|Overall Study|Progressive Disease|4|||
105360840|NCT00572455|363328093|FG013|Stage II (28 Days)|Other|0|||
105775313|NCT00106626|364826813|FG001|Overall Study|Progressive Disease|1|||
105775314|NCT00106626|364826814|FG002|Overall Study|Progressive Disease|9|||
105775315|NCT00106626|364826815|FG003|Overall Study|Progressive Disease|10|||
105775316|NCT00106626|364826812|FG000|Overall Study|Received radiation on new therapy|1|||
105775317|NCT00106626|364826813|FG001|Overall Study|Received radiation on new therapy|0|||
105775318|NCT00106626|364826814|FG002|Overall Study|Received radiation on new therapy|0|||
105775319|NCT00106626|364826815|FG003|Overall Study|Received radiation on new therapy|0|||
105775320|NCT00106626|364826812|FG000|Overall Study|> 14 day delay in therapy start|0|||
105775321|NCT00106626|364826813|FG001|Overall Study|> 14 day delay in therapy start|1|||
105775322|NCT00106626|364826814|FG002|Overall Study|> 14 day delay in therapy start|0|||
105775323|NCT00106626|364826815|FG003|Overall Study|> 14 day delay in therapy start|0|||
105775324|NCT00672139|364826816|FG000|Overall Study|Death|14|||
105775325|NCT00672139|364826817|FG001|Overall Study|Death|23|||
105775326|NCT00672139|364826816|FG000|Overall Study|Withdrawal by Subject|2|||
105775327|NCT00672139|364826817|FG001|Overall Study|Withdrawal by Subject|11|||
105775328|NCT00672139|364826816|FG000|Overall Study|Adverse Event|4|||
105775329|NCT00672139|364826817|FG001|Overall Study|Adverse Event|7|||
105775330|NCT00672139|364826816|FG000|Overall Study|Physician Decision|2|||
105775331|NCT00672139|364826817|FG001|Overall Study|Physician Decision|0|||
105775332|NCT00672139|364826816|FG000|Overall Study|Lack of Efficacy|4|||
105775333|NCT00672139|364826817|FG001|Overall Study|Lack of Efficacy|1|||
105775334|NCT00672139|364826816|FG000|Overall Study|Protocol Violation|1|||
105775335|NCT00672139|364826817|FG001|Overall Study|Protocol Violation|1|||
105775336|NCT00672139|364826816|FG000|Overall Study|hospice discharge, caregiver requests|3|||
105775337|NCT00672139|364826817|FG001|Overall Study|hospice discharge, caregiver requests|2|||
105775338|NCT02176226|364826821|FG000|Overall Study|Lost to Follow-up|3|||
105775339|NCT02176226|364826821|FG000|Overall Study|Withdrew prior to treatment|6|||
105775340|NCT03798366|364826824|FG000|Overall Study|Lost to Follow-up|0|||
105775341|NCT03798366|364826825|FG001|Overall Study|Lost to Follow-up|1|||
105775342|NCT02061540|364826827|FG000|Overall Study|Adverse Event|2|||
105775343|NCT02061540|364826827|FG000|Overall Study|Withdrawal by Subject|2|||
105775344|NCT01642004|364826836|FG000|Randomization|Adverse Event unrelated to study drug|1|||
105775345|NCT01642004|364826837|FG001|Randomization|Adverse Event unrelated to study drug|0|||
105775346|NCT01642004|364826836|FG000|Randomization|Participant withdrew consent|1|||
105775347|NCT01642004|364826837|FG001|Randomization|Participant withdrew consent|6|||
105775348|NCT01642004|364826836|FG000|Randomization|No longer meets study criteria|2|||
105775349|NCT01642004|364826837|FG001|Randomization|No longer meets study criteria|2|||
105775350|NCT01642004|364826836|FG000|Treatment|Disease progression|95|||
105775351|NCT01642004|364826837|FG001|Treatment|Disease progression|79|||
105775352|NCT01642004|364826836|FG000|Treatment|Study drug toxicity|10|||
105775353|NCT01642004|364826837|FG001|Treatment|Study drug toxicity|13|||
105775354|NCT01642004|364826836|FG000|Treatment|Death|1|||
105775355|NCT01642004|364826837|FG001|Treatment|Death|1|||
105775356|NCT01642004|364826836|FG000|Treatment|Adverse event unrelated to study drug|9|||
105775357|NCT01642004|364826837|FG001|Treatment|Adverse event unrelated to study drug|13|||
105775358|NCT01642004|364826836|FG000|Treatment|Maximum clinical benefit|1|||
105775359|NCT01642004|364826837|FG001|Treatment|Maximum clinical benefit|9|||
105775360|NCT01642004|364826836|FG000|Treatment|Poor/non-compliance|1|||
105775361|NCT01642004|364826837|FG001|Treatment|Poor/non-compliance|0|||
105775362|NCT01642004|364826836|FG000|Treatment|No longer meets study criteria|1|||
105775363|NCT01642004|364826837|FG001|Treatment|No longer meets study criteria|2|||
105775364|NCT01642004|364826836|FG000|Treatment|Other reasons|2|||
105775365|NCT01642004|364826837|FG001|Treatment|Other reasons|0|||
105775366|NCT01642004|364826836|FG000|Treatment|Not reported|0|||
105775367|NCT01642004|364826837|FG001|Treatment|Not reported|3|||
105775368|NCT01642004|364826836|FG000|Treatment|Participant request to discontinue study treatment|6|||
105775369|NCT01642004|364826837|FG001|Treatment|Participant request to discontinue study treatment|4|||
105775370|NCT01642004|364826836|FG000|Treatment|Participant withdrew consent|5|||
105775371|NCT01642004|364826837|FG001|Treatment|Participant withdrew consent|5|||
105775372|NCT00811395|364826838|FG000|Extension Treatment|Adverse Event|1|||
105775373|NCT00811395|364826839|FG001|Extension Treatment|Adverse Event|2|||
105775374|NCT00811395|364826840|FG002|Extension Treatment|Adverse Event|2|||
105775375|NCT00811395|364826841|FG003|Extension Treatment|Adverse Event|2|||
105775376|NCT00811395|364826842|FG004|Extension Treatment|Adverse Event|0|||
105775377|NCT00811395|364826843|FG005|Extension Treatment|Adverse Event|1|||
105775378|NCT00811395|364826838|FG000|Extension Treatment|Progressive disease|1|||
105775379|NCT00811395|364826839|FG001|Extension Treatment|Progressive disease|1|||
105775380|NCT00811395|364826840|FG002|Extension Treatment|Progressive disease|0|||
105775381|NCT00811395|364826841|FG003|Extension Treatment|Progressive disease|0|||
105775382|NCT00811395|364826842|FG004|Extension Treatment|Progressive disease|0|||
105775383|NCT00811395|364826843|FG005|Extension Treatment|Progressive disease|0|||
105775384|NCT00811395|364826838|FG000|Extension Treatment|Participant did not wish to continue|0|||
105775385|NCT00811395|364826839|FG001|Extension Treatment|Participant did not wish to continue|3|||
105775386|NCT00811395|364826840|FG002|Extension Treatment|Participant did not wish to continue|0|||
105775387|NCT00811395|364826841|FG003|Extension Treatment|Participant did not wish to continue|1|||
105775388|NCT00811395|364826842|FG004|Extension Treatment|Participant did not wish to continue|0|||
105775389|NCT00811395|364826843|FG005|Extension Treatment|Participant did not wish to continue|1|||
105775390|NCT00811395|364826838|FG000|Extension Treatment|Other than above|0|||
105775391|NCT00811395|364826839|FG001|Extension Treatment|Other than above|0|||
105775392|NCT00811395|364826840|FG002|Extension Treatment|Other than above|1|||
105775393|NCT00811395|364826841|FG003|Extension Treatment|Other than above|0|||
105775394|NCT00811395|364826842|FG004|Extension Treatment|Other than above|0|||
105775395|NCT00811395|364826843|FG005|Extension Treatment|Other than above|0|||
105775396|NCT02795182|364826846|FG000|Overall Study|Death|5|||
105775397|NCT02795182|364826847|FG001|Overall Study|Death|4|||
105775398|NCT02795182|364826848|FG002|Overall Study|Death|4|||
105775399|NCT02795182|364826849|FG003|Overall Study|Death|18|||
105775400|NCT02795182|364826846|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
105775401|NCT02795182|364826847|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
105775402|NCT02795182|364826848|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
105775403|NCT02795182|364826849|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
105775404|NCT02795182|364826846|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
105775405|NCT02795182|364826847|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
105775406|NCT02795182|364826848|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
105775407|NCT02795182|364826849|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
105775408|NCT02795182|364826846|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
105775409|NCT02795182|364826847|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
105775410|NCT02795182|364826848|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
105775411|NCT02795182|364826849|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
105775412|NCT02795182|364826846|FG000|Overall Study|Withdrawal by Subject|4|||
105775413|NCT02795182|364826847|FG001|Overall Study|Withdrawal by Subject|0|||
105775414|NCT02795182|364826848|FG002|Overall Study|Withdrawal by Subject|0|||
105775415|NCT02795182|364826849|FG003|Overall Study|Withdrawal by Subject|3|||
105775416|NCT02795182|364826846|FG000|Overall Study|Lost to Follow-up|0|||
105775417|NCT02795182|364826847|FG001|Overall Study|Lost to Follow-up|0|||
105775418|NCT02795182|364826848|FG002|Overall Study|Lost to Follow-up|1|||
105775419|NCT02795182|364826849|FG003|Overall Study|Lost to Follow-up|1|||
105775420|NCT02795182|364826846|FG000|Overall Study|Roll Over to Long Term Extension|3|||
105775421|NCT02795182|364826847|FG001|Overall Study|Roll Over to Long Term Extension|3|||
105775422|NCT02795182|364826848|FG002|Overall Study|Roll Over to Long Term Extension|2|||
105775423|NCT02795182|364826849|FG003|Overall Study|Roll Over to Long Term Extension|5|||
105775424|NCT02795182|364826846|FG000|Overall Study|Progressive Disease|0|||
105775425|NCT02795182|364826847|FG001|Overall Study|Progressive Disease|1|||
105775426|NCT02795182|364826848|FG002|Overall Study|Progressive Disease|0|||
105775427|NCT02795182|364826849|FG003|Overall Study|Progressive Disease|4|||
105775428|NCT02795182|364826846|FG000|Overall Study|Physician Decision|0|||
105775429|NCT02795182|364826847|FG001|Overall Study|Physician Decision|0|||
105775430|NCT02795182|364826848|FG002|Overall Study|Physician Decision|0|||
105775431|NCT02795182|364826849|FG003|Overall Study|Physician Decision|1|||
105775432|NCT03267576|364826857|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
105775433|NCT03267576|364826858|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
105775434|NCT03267576|364826857|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
105775435|NCT03267576|364826858|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
105775436|NCT01369069|364826859|FG000|Overall Study|Lost to Follow-up|8|||
105775437|NCT01369069|364826860|FG001|Overall Study|Lost to Follow-up|9|||
105775438|NCT01369069|364826859|FG000|Overall Study|Withdrawal by Subject|9|||
105775439|NCT01369069|364826860|FG001|Overall Study|Withdrawal by Subject|7|||
105775440|NCT02692560|364826861|FG000|Overall Study|Withdrawal by Subject|0|||
105775441|NCT02692560|364826862|FG001|Overall Study|Withdrawal by Subject|6|||
105775442|NCT03344562|364826863|FG000|Overall Study|Withdrawal by Subject|2|||
105775443|NCT03344562|364826864|FG001|Overall Study|Withdrawal by Subject|0|||
105775444|NCT03032523|364826865|FG000|Overall Study|Withdrawal by Subject|2|||
105775445|NCT03032523|364826866|FG001|Overall Study|Withdrawal by Subject|2|||
105775446|NCT03032523|364826865|FG000|Overall Study|Physician Decision|1|||
105775447|NCT03032523|364826866|FG001|Overall Study|Physician Decision|0|||
105775448|NCT01646255|364826867|FG000|Overall Study|Adverse Event|7|||
105775449|NCT01646255|364826868|FG001|Overall Study|Adverse Event|8|||
105775450|NCT01646255|364826867|FG000|Overall Study|Lack of Efficacy|2|||
105775451|NCT01646255|364826868|FG001|Overall Study|Lack of Efficacy|0|||
105775452|NCT01646255|364826867|FG000|Overall Study|Withdrawal by Subject|10|||
105775453|NCT01646255|364826868|FG001|Overall Study|Withdrawal by Subject|6|||
105775454|NCT01646255|364826867|FG000|Overall Study|Compliance is not well|1|||
105775455|NCT01646255|364826868|FG001|Overall Study|Compliance is not well|0|||
105775456|NCT01646255|364826867|FG000|Overall Study|Inclusion Criteria Deviation|1|||
105775457|NCT01646255|364826868|FG001|Overall Study|Inclusion Criteria Deviation|0|||
105775458|NCT02168816|364826869|FG000|Overall Study|Lost to Follow-up|2|||
105775459|NCT02168816|364826870|FG001|Overall Study|Lost to Follow-up|2|||
105775460|NCT01987609|364826873|FG000|Overall Study|Adverse Event|1|||
105775461|NCT02417935|364826874|FG000|Treatment Period|Adverse Event|12|||
105775462|NCT02417935|364826875|FG001|Treatment Period|Adverse Event|10|||
105775463|NCT02417935|364826874|FG000|Treatment Period|Lost to Follow-up|1|||
105775464|NCT02417935|364826875|FG001|Treatment Period|Lost to Follow-up|0|||
105775465|NCT02417935|364826874|FG000|Treatment Period|Entry Criteria not met|0|||
105775466|NCT02417935|364826875|FG001|Treatment Period|Entry Criteria not met|1|||
105775467|NCT02417935|364826874|FG000|Treatment Period|Protocol Violation|2|||
105775468|NCT02417935|364826875|FG001|Treatment Period|Protocol Violation|1|||
105775469|NCT02417935|364826874|FG000|Treatment Period|Withdrawal by Subject|3|||
105775470|NCT02417935|364826875|FG001|Treatment Period|Withdrawal by Subject|3|||
105775471|NCT02417935|364826874|FG000|Treatment Period|Physician Decision|3|||
105775472|NCT02417935|364826875|FG001|Treatment Period|Physician Decision|1|||
105775473|NCT03258762|364826876|FG000|Overall Study|Lost to Follow-up|0|||
105775474|NCT03258762|364826877|FG001|Overall Study|Lost to Follow-up|1|||
105775475|NCT02698176|364826878|FG000|Overall Study|Progressive disease|4|||
105775476|NCT02698176|364826879|FG001|Overall Study|Progressive disease|3|||
105775477|NCT02698176|364826880|FG002|Overall Study|Progressive disease|1|||
105775478|NCT02698176|364826881|FG003|Overall Study|Progressive disease|0|||
105775479|NCT02698176|364826878|FG000|Overall Study|Adverse Event|2|||
105775480|NCT02698176|364826879|FG001|Overall Study|Adverse Event|0|||
105775481|NCT02698176|364826880|FG002|Overall Study|Adverse Event|0|||
105775482|NCT02698176|364826881|FG003|Overall Study|Adverse Event|0|||
105775483|NCT02698176|364826878|FG000|Overall Study|Clinical progression|3|||
105775484|NCT02698176|364826879|FG001|Overall Study|Clinical progression|0|||
105775485|NCT02698176|364826880|FG002|Overall Study|Clinical progression|0|||
105775486|NCT02698176|364826881|FG003|Overall Study|Clinical progression|0|||
105775487|NCT00410514|364826882|FG000|Overall Study|Adverse Event|2|||
105775488|NCT00410514|364826883|FG001|Overall Study|Adverse Event|2|||
105775489|NCT00410514|364826884|FG002|Overall Study|Adverse Event|2|||
105775490|NCT00410514|364826882|FG000|Overall Study|Protocol Violation|0|||
105775491|NCT00410514|364826883|FG001|Overall Study|Protocol Violation|1|||
105775492|NCT00410514|364826884|FG002|Overall Study|Protocol Violation|1|||
105775493|NCT00410514|364826882|FG000|Overall Study|Lost to Follow-up|0|||
105775494|NCT00410514|364826883|FG001|Overall Study|Lost to Follow-up|0|||
105775495|NCT00410514|364826884|FG002|Overall Study|Lost to Follow-up|2|||
105775496|NCT00410514|364826882|FG000|Overall Study|Non-compliant with study procedures|0|||
105775497|NCT00410514|364826883|FG001|Overall Study|Non-compliant with study procedures|0|||
105775498|NCT00410514|364826884|FG002|Overall Study|Non-compliant with study procedures|2|||
105775499|NCT03756285|364826887|FG000|Overall Study|Lost to Follow-up|0|||
105775500|NCT03756285|364826888|FG001|Overall Study|Lost to Follow-up|1|||
105775501|NCT03756285|364826887|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
105775502|NCT03756285|364826888|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
105775503|NCT03756285|364826887|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
105775504|NCT03756285|364826888|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
105775505|NCT02098733|364826889|FG000|Overall Study|Data Not Available|5|||
105775506|NCT02098733|364826889|FG000|Overall Study|Lost to Follow-up|5|||
105775507|NCT02545049|364826890|FG000|Overall Study|Withdrawal by Subject|1|||
105775508|NCT02545049|364826891|FG001|Overall Study|Withdrawal by Subject|7|||
105775509|NCT02545049|364826890|FG000|Overall Study|Lost to Follow-up|4|||
105775510|NCT02545049|364826891|FG001|Overall Study|Lost to Follow-up|6|||
105775511|NCT02545049|364826890|FG000|Overall Study|GCP violations|37|||
105775512|NCT02545049|364826891|FG001|Overall Study|GCP violations|48|||
105775513|NCT03458234|364826892|FG000|Overall Study|Withdrawal by Subject|1|||
105775514|NCT01855919|364828879|FG000|Overall Study|Adverse Event|16|||
105775515|NCT01855919|364828880|FG001|Overall Study|Adverse Event|8|||
105775516|NCT01855919|364828879|FG000|Overall Study|Lack of Efficacy|1|||
105775517|NCT01855919|364828880|FG001|Overall Study|Lack of Efficacy|3|||
105775518|NCT01855919|364828879|FG000|Overall Study|Withdrawal by Subject|4|||
105775519|NCT01855919|364828880|FG001|Overall Study|Withdrawal by Subject|10|||
105775520|NCT01855919|364828879|FG000|Overall Study|Entry Criteria Not Met|1|||
105775521|NCT01855919|364828880|FG001|Overall Study|Entry Criteria Not Met|1|||
105775522|NCT01855919|364828879|FG000|Overall Study|Protocol Violation|1|||
105775523|NCT01855919|364828880|FG001|Overall Study|Protocol Violation|4|||
105775524|NCT01592773|364828881|FG000|Overall Study|Study Terminated by Sponsor|582|||
105775525|NCT01592773|364828881|FG000|Overall Study|Withdrawal by Subject|35|||
105775526|NCT01592773|364828881|FG000|Overall Study|Lost to Follow-up|19|||
105775527|NCT01592773|364828881|FG000|Overall Study|Adverse Event|17|||
105775528|NCT01592773|364828881|FG000|Overall Study|Lack of Efficacy|9|||
105775529|NCT01592773|364828881|FG000|Overall Study|Protocol Violation|2|||
105775530|NCT01592773|364828881|FG000|Overall Study|Inclusion/exclusion not meet|1|||
105775531|NCT01592773|364828881|FG000|Overall Study|Other Reason|1|||
105775532|NCT02972658|364828882|FG000|Overall Study|Adverse Event|0|||
105775533|NCT02972658|364828883|FG001|Overall Study|Adverse Event|3|||
105775534|NCT02972658|364828884|FG002|Overall Study|Adverse Event|0|||
105775535|NCT02972658|364828885|FG003|Overall Study|Adverse Event|2|||
105775536|NCT02972658|364828882|FG000|Overall Study|Other-determined by Investigator|1|||
105775537|NCT02972658|364828883|FG001|Overall Study|Other-determined by Investigator|1|||
105775538|NCT02972658|364828884|FG002|Overall Study|Other-determined by Investigator|0|||
105775539|NCT02972658|364828885|FG003|Overall Study|Other-determined by Investigator|0|||
105775540|NCT02972658|364828882|FG000|Overall Study|Death|0|||
105775541|NCT02972658|364828883|FG001|Overall Study|Death|0|||
105775542|NCT02972658|364828884|FG002|Overall Study|Death|0|||
105775543|NCT02972658|364828885|FG003|Overall Study|Death|1|||
105775544|NCT02972658|364828882|FG000|Overall Study|Lost to Follow-up|0|||
105775545|NCT02972658|364828883|FG001|Overall Study|Lost to Follow-up|1|||
105775546|NCT02972658|364828884|FG002|Overall Study|Lost to Follow-up|1|||
105775547|NCT02972658|364828885|FG003|Overall Study|Lost to Follow-up|2|||
105775548|NCT02972658|364828882|FG000|Overall Study|Progressive Disease|0|||
105775549|NCT02972658|364828883|FG001|Overall Study|Progressive Disease|1|||
105775550|NCT02972658|364828884|FG002|Overall Study|Progressive Disease|0|||
105775551|NCT02972658|364828885|FG003|Overall Study|Progressive Disease|1|||
105775552|NCT02972658|364828882|FG000|Overall Study|Withdrawal by Subject|4|||
105775553|NCT02972658|364828883|FG001|Overall Study|Withdrawal by Subject|4|||
105775554|NCT02972658|364828884|FG002|Overall Study|Withdrawal by Subject|1|||
105775555|NCT02972658|364828885|FG003|Overall Study|Withdrawal by Subject|6|||
105775556|NCT02972658|364828882|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
105775557|NCT02972658|364828883|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
105775558|NCT02972658|364828884|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
105775559|NCT02972658|364828885|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
105775560|NCT02972658|364828882|FG000|Overall Study|Sponsor Decision|70|||
105775561|NCT02972658|364828883|FG001|Overall Study|Sponsor Decision|127|||
105775562|NCT02972658|364828884|FG002|Overall Study|Sponsor Decision|72|||
105775563|NCT02972658|364828885|FG003|Overall Study|Sponsor Decision|119|||
105775564|NCT02785588|364828887|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
105775565|NCT02785588|364828887|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
105775566|NCT03037489|364828888|FG000|Overall Study|Adverse Event|4|||
105775567|NCT03037489|364828889|FG001|Overall Study|Adverse Event|0|||
105775568|NCT03037489|364828888|FG000|Overall Study|Withdrawal by Subject|3|||
105775569|NCT03037489|364828889|FG001|Overall Study|Withdrawal by Subject|0|||
105775570|NCT02499172|364828891|FG000|Overall Study|Financial reason|0|||
105775571|NCT02499172|364828892|FG001|Overall Study|Financial reason|0|||
105775572|NCT02499172|364828893|FG002|Overall Study|Financial reason|523|||
105775573|NCT02499172|364828894|FG003|Overall Study|Financial reason|436|||
105775574|NCT02499172|364828891|FG000|Overall Study|Lost to Follow-up|65|||
105775575|NCT02499172|364828892|FG001|Overall Study|Lost to Follow-up|64|||
105775576|NCT02499172|364828893|FG002|Overall Study|Lost to Follow-up|0|||
105775577|NCT02499172|364828894|FG003|Overall Study|Lost to Follow-up|0|||
105775578|NCT01293123|364828895|FG000|Overall Study|Lost to Follow-up|0|||
105775579|NCT01293123|364828896|FG001|Overall Study|Lost to Follow-up|1|||
105775580|NCT00724243|364828899|FG000|Overall Study|Lack of Efficacy|10|||
105775581|NCT00724243|364828899|FG000|Overall Study|Adverse Event|5|||
105775582|NCT03031327|364828902|FG000|Overall Study|Withdrawal by Subject|0|||
105775583|NCT03031327|364828903|FG001|Overall Study|Withdrawal by Subject|1|||
105775584|NCT03031327|364828904|FG002|Overall Study|Withdrawal by Subject|1|||
105775585|NCT03557801|364828906|FG000|Overall Study|Protocol Violation|1|||
105775586|NCT03557801|364828907|FG001|Overall Study|Protocol Violation|0|||
105775587|NCT03557801|364828908|FG002|Overall Study|Protocol Violation|0|||
105775588|NCT03557801|364828906|FG000|Overall Study|Withdrawal by Subject|1|||
105775589|NCT03557801|364828907|FG001|Overall Study|Withdrawal by Subject|0|||
105775590|NCT03557801|364828908|FG002|Overall Study|Withdrawal by Subject|3|||
105775591|NCT03557801|364828906|FG000|Overall Study|Lost to Follow-up|0|||
105775592|NCT03557801|364828907|FG001|Overall Study|Lost to Follow-up|1|||
105775593|NCT03557801|364828908|FG002|Overall Study|Lost to Follow-up|0|||
105775594|NCT02145429|364828909|FG000|Overall Study|Death|4|||
105775595|NCT02145429|364828910|FG001|Overall Study|Death|5|||
105775596|NCT02145429|364828909|FG000|Overall Study|Lost to Follow-up|4|||
105775597|NCT02145429|364828910|FG001|Overall Study|Lost to Follow-up|3|||
105775598|NCT02145429|364828909|FG000|Overall Study|Withdrawal by Subject|8|||
105775599|NCT02145429|364828910|FG001|Overall Study|Withdrawal by Subject|3|||
105775600|NCT02516306|364828911|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
105775601|NCT02516306|364828912|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
105775602|NCT04652102|364828913|FG000|Overall Study|Adverse Event|14|||
105775603|NCT04652102|364828914|FG001|Overall Study|Adverse Event|13|||
105775604|NCT04652102|364828913|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
105775605|NCT04652102|364828914|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
105775606|NCT04652102|364828913|FG000|Overall Study|Physician Decision|78|||
105775607|NCT04652102|364828914|FG001|Overall Study|Physician Decision|40|||
105775608|NCT04652102|364828913|FG000|Overall Study|Study Ended by Sponsor|64|||
105775609|NCT04652102|364828914|FG001|Overall Study|Study Ended by Sponsor|17|||
105775610|NCT04652102|364828913|FG000|Overall Study|Withdrawal by Subject|4625|||
105775611|NCT04652102|364828914|FG001|Overall Study|Withdrawal by Subject|5594|||
105775612|NCT04652102|364828913|FG000|Overall Study|Lost to Follow-up|2019|||
105775613|NCT04652102|364828914|FG001|Overall Study|Lost to Follow-up|1082|||
105775614|NCT04652102|364828913|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
105775615|NCT04652102|364828914|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
105775616|NCT04652102|364828913|FG000|Overall Study|Miscellaneous|80|||
105775617|NCT04652102|364828914|FG001|Overall Study|Miscellaneous|64|||
105775618|NCT01970540|364828915|FG000|Overall Study|Non-treatment-related AE|0|||
105775619|NCT01970540|364828916|FG001|Overall Study|Non-treatment-related AE|0|||
105775620|NCT01970540|364828917|FG002|Overall Study|Non-treatment-related AE|1|||
105775621|NCT01970540|364828915|FG000|Overall Study|Progressive disease|55|||
105775622|NCT01970540|364828916|FG001|Overall Study|Progressive disease|23|||
105775623|NCT01970540|364828917|FG002|Overall Study|Progressive disease|10|||
105775624|NCT01970540|364828915|FG000|Overall Study|Treatment delay over protocol|0|||
105775625|NCT01970540|364828916|FG001|Overall Study|Treatment delay over protocol|0|||
105775626|NCT01970540|364828917|FG002|Overall Study|Treatment delay over protocol|1|||
105775627|NCT01970540|364828915|FG000|Overall Study|Physician Decision|7|||
105775628|NCT01970540|364828916|FG001|Overall Study|Physician Decision|2|||
105775629|NCT01970540|364828917|FG002|Overall Study|Physician Decision|0|||
105775630|NCT01970540|364828915|FG000|Overall Study|Clinical progression|0|||
105775631|NCT01970540|364828916|FG001|Overall Study|Clinical progression|1|||
105775632|NCT01970540|364828917|FG002|Overall Study|Clinical progression|1|||
105775633|NCT01970540|364828915|FG000|Overall Study|End of study|2|||
105775634|NCT01970540|364828916|FG001|Overall Study|End of study|0|||
105775635|NCT01970540|364828917|FG002|Overall Study|End of study|2|||
105775636|NCT01970540|364828915|FG000|Overall Study|Adverse Event|0|||
105775637|NCT01970540|364828916|FG001|Overall Study|Adverse Event|2|||
105775638|NCT01970540|364828917|FG002|Overall Study|Adverse Event|1|||
105775639|NCT01970540|364828915|FG000|Overall Study|Treatment-related AE|4|||
105775640|NCT01970540|364828916|FG001|Overall Study|Treatment-related AE|0|||
105775641|NCT01970540|364828917|FG002|Overall Study|Treatment-related AE|2|||
105775642|NCT01970540|364828915|FG000|Overall Study|Withdrawal by Subject|4|||
105775643|NCT01970540|364828916|FG001|Overall Study|Withdrawal by Subject|0|||
105775644|NCT01970540|364828917|FG002|Overall Study|Withdrawal by Subject|1|||
105775645|NCT01970540|364828915|FG000|Overall Study|Clinical deterioration|1|||
105775646|NCT01970540|364828916|FG001|Overall Study|Clinical deterioration|0|||
105775647|NCT01970540|364828917|FG002|Overall Study|Clinical deterioration|0|||
105775648|NCT01057394|364828921|FG000|Overall Study|Not eligible|0|||
105775649|NCT01057394|364828922|FG001|Overall Study|Not eligible|2|||
105775650|NCT03961529|364828923|FG000|Overall Study|Adverse Event|13|||
105775651|NCT03961529|364828924|FG001|Overall Study|Adverse Event|5|||
105775652|NCT03961529|364828925|FG002|Overall Study|Adverse Event|2|||
105775653|NCT03961529|364828923|FG000|Overall Study|Withdrawal by Subject|17|||
105775654|NCT03961529|364828924|FG001|Overall Study|Withdrawal by Subject|2|||
105775655|NCT03961529|364828925|FG002|Overall Study|Withdrawal by Subject|1|||
105775656|NCT03961529|364828923|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105775657|NCT03961529|364828924|FG001|Overall Study|Withdrawal by parent/guardian|7|||
105775658|NCT03961529|364828925|FG002|Overall Study|Withdrawal by parent/guardian|0|||
105775659|NCT03961529|364828923|FG000|Overall Study|Physician Decision|2|||
105775660|NCT03961529|364828924|FG001|Overall Study|Physician Decision|1|||
105775661|NCT03961529|364828925|FG002|Overall Study|Physician Decision|1|||
105775662|NCT03961529|364828923|FG000|Overall Study|Lost to Follow-up|2|||
105775663|NCT03961529|364828924|FG001|Overall Study|Lost to Follow-up|1|||
105775664|NCT03961529|364828925|FG002|Overall Study|Lost to Follow-up|0|||
105775665|NCT03961529|364828923|FG000|Overall Study|Lack of Efficacy|2|||
105775666|NCT03961529|364828924|FG001|Overall Study|Lack of Efficacy|0|||
105775667|NCT03961529|364828925|FG002|Overall Study|Lack of Efficacy|1|||
105775668|NCT03961529|364828923|FG000|Overall Study|Other|6|||
105775669|NCT03961529|364828924|FG001|Overall Study|Other|1|||
105775670|NCT03961529|364828925|FG002|Overall Study|Other|0|||
105442556|NCT05173012|363626782|FG005|Overall Study|Other|0|||
105775671|NCT03500419|364828926|FG000|Overall Study|Withdrawal by Subject|2|||
105775672|NCT03500419|364828927|FG001|Overall Study|Withdrawal by Subject|25|||
105775673|NCT01566981|364828928|FG000|Overall Study|Lost to Follow-up|5|||
105775674|NCT01566981|364828929|FG001|Overall Study|Lost to Follow-up|8|||
105775675|NCT01766401|364828930|FG000|Overall Study|Adverse Event|7|||
105775676|NCT01766401|364828931|FG001|Overall Study|Adverse Event|22|||
105775677|NCT01766401|364828930|FG000|Overall Study|Lack of Efficacy|1|||
105775678|NCT01766401|364828931|FG001|Overall Study|Lack of Efficacy|2|||
105775679|NCT01766401|364828930|FG000|Overall Study|Protocol Violation|3|||
105775680|NCT01766401|364828931|FG001|Overall Study|Protocol Violation|8|||
105442557|NCT05173012|363626783|FG006|Overall Study|Other|0|||
105775681|NCT01766401|364828930|FG000|Overall Study|Withdrawal by Subject|15|||
105775682|NCT01766401|364828931|FG001|Overall Study|Withdrawal by Subject|12|||
105775683|NCT01766401|364828930|FG000|Overall Study|Lost to Follow-up|10|||
105775684|NCT01766401|364828931|FG001|Overall Study|Lost to Follow-up|11|||
105775685|NCT01766401|364828930|FG000|Overall Study|Pregnancy|1|||
105775686|NCT01766401|364828931|FG001|Overall Study|Pregnancy|1|||
105442558|NCT05173012|363626784|FG007|Overall Study|Other|0|||
105775687|NCT02177942|364828932|FG000|Overall Study|Adverse Event|1|||
105775688|NCT02177942|364828933|FG001|Overall Study|Adverse Event|0|||
105775689|NCT02177942|364828932|FG000|Overall Study|Lost to Follow-up|1|||
105775690|NCT02177942|364828933|FG001|Overall Study|Lost to Follow-up|1|||
105775691|NCT02177942|364828932|FG000|Overall Study|Protocol Violation|4|||
105775692|NCT02177942|364828933|FG001|Overall Study|Protocol Violation|6|||
105775693|NCT02177942|364828932|FG000|Overall Study|Withdrawal by Subject|71|||
105775694|NCT02177942|364828933|FG001|Overall Study|Withdrawal by Subject|81|||
105775695|NCT00886587|364828934|FG000|Overall Study|Adverse Event|2|||
105775696|NCT00886587|364828935|FG001|Overall Study|Adverse Event|1|||
105775697|NCT00886587|364828934|FG000|Overall Study|Protocol Violation|2|||
105775698|NCT00886587|364828935|FG001|Overall Study|Protocol Violation|0|||
105775699|NCT00886587|364828934|FG000|Overall Study|Withdrawal by Subject|0|||
105775700|NCT00886587|364828935|FG001|Overall Study|Withdrawal by Subject|1|||
105775701|NCT04107935|364828940|FG000|Overall Study|Death|1|||
105775702|NCT04107935|364828941|FG001|Overall Study|Death|0|||
105775703|NCT00398086|364828944|FG000|Overall Study|Unacceptable Toxicity|2|||
105775704|NCT00398086|364828945|FG001|Overall Study|Unacceptable Toxicity|8|||
105775705|NCT00398086|364828946|FG002|Overall Study|Unacceptable Toxicity|2|||
105775706|NCT00398086|364828944|FG000|Overall Study|Adverse Event|1|||
105775707|NCT00398086|364828945|FG001|Overall Study|Adverse Event|4|||
105775708|NCT00398086|364828946|FG002|Overall Study|Adverse Event|0|||
105775709|NCT00398086|364828944|FG000|Overall Study|Physician Decision|1|||
105775710|NCT00398086|364828945|FG001|Overall Study|Physician Decision|4|||
105775711|NCT00398086|364828946|FG002|Overall Study|Physician Decision|0|||
105775712|NCT00398086|364828944|FG000|Overall Study|Withdrawal by Subject|5|||
105775713|NCT00398086|364828945|FG001|Overall Study|Withdrawal by Subject|7|||
105775714|NCT00398086|364828946|FG002|Overall Study|Withdrawal by Subject|0|||
105775715|NCT01948791|364828953|FG000|Overall Study|Adverse Event|12|||
105775716|NCT01948791|364828953|FG000|Overall Study|Lack of Efficacy|3|||
105775717|NCT01948791|364828953|FG000|Overall Study|Protocol Violation|2|||
105775718|NCT01948791|364828953|FG000|Overall Study|Withdrawal by Subject|5|||
105775719|NCT01948791|364828953|FG000|Overall Study|Lost to Follow-up|6|||
105775720|NCT01948791|364828953|FG000|Overall Study|Management issues|1|||
105775721|NCT01948791|364828953|FG000|Overall Study|Others|7|||
105775722|NCT01948791|364828953|FG000|Overall Study|Screening failure|35|||
105775723|NCT00887913|364828954|FG000|Overall Study|Withdrawal by Subject|6|||
105775724|NCT01371721|364828955|FG000|Overall Study|Adverse Event|5|||
105775725|NCT01371721|364828956|FG001|Overall Study|Adverse Event|4|||
105775726|NCT01371721|364828957|FG002|Overall Study|Adverse Event|5|||
105775727|NCT01371721|364828955|FG000|Overall Study|Protocol Violation|6|||
105775728|NCT01371721|364828956|FG001|Overall Study|Protocol Violation|4|||
105775729|NCT01371721|364828957|FG002|Overall Study|Protocol Violation|5|||
105775730|NCT01371721|364828955|FG000|Overall Study|Lost to Follow-up|8|||
105775731|NCT01371721|364828956|FG001|Overall Study|Lost to Follow-up|2|||
105775732|NCT01371721|364828957|FG002|Overall Study|Lost to Follow-up|6|||
105775733|NCT01371721|364828955|FG000|Overall Study|Withdrawal by Subject|5|||
105775734|NCT01371721|364828956|FG001|Overall Study|Withdrawal by Subject|7|||
105775735|NCT01371721|364828957|FG002|Overall Study|Withdrawal by Subject|11|||
105775736|NCT01371721|364828955|FG000|Overall Study|Other|2|||
105775737|NCT01371721|364828956|FG001|Overall Study|Other|3|||
105775738|NCT01371721|364828957|FG002|Overall Study|Other|0|||
105775739|NCT01371721|364828955|FG000|Overall Study|Lack of Efficacy|2|||
105775740|NCT01371721|364828956|FG001|Overall Study|Lack of Efficacy|4|||
105775741|NCT01371721|364828957|FG002|Overall Study|Lack of Efficacy|3|||
105775742|NCT01371721|364828955|FG000|Overall Study|Randomized but not treated|1|||
105775743|NCT01371721|364828956|FG001|Overall Study|Randomized but not treated|0|||
105775744|NCT01371721|364828957|FG002|Overall Study|Randomized but not treated|0|||
105775745|NCT01200758|364828958|FG000|Stage I|Death|0|||
105775746|NCT01200758|364828959|FG001|Stage I|Death|1|||
105775747|NCT01200758|364828960|FG002|Stage I|Death|0|||
105775748|NCT01200758|364828961|FG003|Stage I|Death|0|||
105775749|NCT01200758|364828958|FG000|Stage I|Physician Decision|1|||
105775750|NCT01200758|364828959|FG001|Stage I|Physician Decision|1|||
105775751|NCT01200758|364828960|FG002|Stage I|Physician Decision|0|||
105775752|NCT01200758|364828961|FG003|Stage I|Physician Decision|0|||
105775753|NCT01200758|364828958|FG000|Stage I|Lack of Efficacy|2|||
105775754|NCT01200758|364828959|FG001|Stage I|Lack of Efficacy|1|||
105775755|NCT01200758|364828960|FG002|Stage I|Lack of Efficacy|0|||
105775756|NCT01200758|364828961|FG003|Stage I|Lack of Efficacy|0|||
105775757|NCT01200758|364828958|FG000|Stage I|Adverse Event|5|||
105775758|NCT01200758|364828959|FG001|Stage I|Adverse Event|5|||
105775759|NCT01200758|364828960|FG002|Stage I|Adverse Event|0|||
105775760|NCT01200758|364828961|FG003|Stage I|Adverse Event|0|||
105775761|NCT01200758|364828958|FG000|Stage I|Withdrawal by Subject|1|||
105775762|NCT01200758|364828959|FG001|Stage I|Withdrawal by Subject|2|||
105775763|NCT01200758|364828960|FG002|Stage I|Withdrawal by Subject|0|||
105775764|NCT01200758|364828961|FG003|Stage I|Withdrawal by Subject|0|||
105775765|NCT01200758|364828958|FG000|Stage I|Disease Progression|9|||
105775766|NCT01200758|364828959|FG001|Stage I|Disease Progression|7|||
105775767|NCT01200758|364828960|FG002|Stage I|Disease Progression|0|||
105775768|NCT01200758|364828961|FG003|Stage I|Disease Progression|0|||
105775769|NCT01200758|364828958|FG000|Stage 2|Disease Progression|0|||
105775770|NCT01200758|364828959|FG001|Stage 2|Disease Progression|0|||
105775771|NCT01200758|364828960|FG002|Stage 2|Disease Progression|16|||
105775772|NCT01200758|364828961|FG003|Stage 2|Disease Progression|21|||
105775773|NCT01200758|364828958|FG000|Stage 2|Lack of Efficacy|0|||
105775774|NCT01200758|364828959|FG001|Stage 2|Lack of Efficacy|0|||
105775775|NCT01200758|364828960|FG002|Stage 2|Lack of Efficacy|4|||
105775776|NCT01200758|364828961|FG003|Stage 2|Lack of Efficacy|2|||
105775777|NCT01200758|364828958|FG000|Stage 2|Physician Decision|0|||
105775778|NCT01200758|364828959|FG001|Stage 2|Physician Decision|0|||
105775779|NCT01200758|364828960|FG002|Stage 2|Physician Decision|5|||
105775780|NCT01200758|364828961|FG003|Stage 2|Physician Decision|7|||
105775781|NCT01200758|364828958|FG000|Stage 2|Adverse Event|0|||
105775782|NCT01200758|364828959|FG001|Stage 2|Adverse Event|0|||
105775783|NCT01200758|364828960|FG002|Stage 2|Adverse Event|5|||
105775784|NCT01200758|364828961|FG003|Stage 2|Adverse Event|9|||
105775785|NCT01200758|364828958|FG000|Stage 2|Withdrawal by Subject|0|||
105775786|NCT01200758|364828959|FG001|Stage 2|Withdrawal by Subject|0|||
105775787|NCT01200758|364828960|FG002|Stage 2|Withdrawal by Subject|4|||
105775788|NCT01200758|364828961|FG003|Stage 2|Withdrawal by Subject|1|||
105775789|NCT01200758|364828958|FG000|Stage 2|Lost to Follow-up|0|||
105775790|NCT01200758|364828959|FG001|Stage 2|Lost to Follow-up|0|||
105775791|NCT01200758|364828960|FG002|Stage 2|Lost to Follow-up|3|||
105775792|NCT01200758|364828961|FG003|Stage 2|Lost to Follow-up|1|||
105775793|NCT01200758|364828958|FG000|Stage 2|Protocol Violation|0|||
105775794|NCT01200758|364828959|FG001|Stage 2|Protocol Violation|0|||
105775795|NCT01200758|364828960|FG002|Stage 2|Protocol Violation|1|||
105775796|NCT01200758|364828961|FG003|Stage 2|Protocol Violation|4|||
105775797|NCT01200758|364828958|FG000|Stage 2|Death|0|||
105775798|NCT01200758|364828959|FG001|Stage 2|Death|0|||
105775799|NCT01200758|364828960|FG002|Stage 2|Death|3|||
105775800|NCT01200758|364828961|FG003|Stage 2|Death|5|||
105775801|NCT00545584|364828962|FG000|Overall Study|Only one reason for discontinuation|62|||
105775802|NCT00545584|364828963|FG001|Overall Study|Only one reason for discontinuation|61|||
105775803|NCT00545584|364828964|FG002|Overall Study|Only one reason for discontinuation|48|||
105775804|NCT00545584|364828962|FG000|Overall Study|Two or more reasons for discontinuation|17|||
105775805|NCT00545584|364828963|FG001|Overall Study|Two or more reasons for discontinuation|19|||
105775806|NCT00545584|364828964|FG002|Overall Study|Two or more reasons for discontinuation|8|||
105775807|NCT03525613|364828967|FG000|Overall Study|Adverse Event|11|||
105775808|NCT03525613|364828968|FG001|Overall Study|Adverse Event|8|||
105775809|NCT03525613|364828969|FG002|Overall Study|Adverse Event|3|||
105775810|NCT03525613|364828970|FG003|Overall Study|Adverse Event|3|||
105775811|NCT03525613|364828967|FG000|Overall Study|Lost to Follow-up|4|||
105775812|NCT03525613|364828968|FG001|Overall Study|Lost to Follow-up|5|||
105775813|NCT03525613|364828969|FG002|Overall Study|Lost to Follow-up|3|||
105775814|NCT03525613|364828970|FG003|Overall Study|Lost to Follow-up|2|||
105775815|NCT03525613|364828967|FG000|Overall Study|Physician Decision|0|||
105775816|NCT03525613|364828968|FG001|Overall Study|Physician Decision|1|||
105775817|NCT03525613|364828969|FG002|Overall Study|Physician Decision|0|||
105775818|NCT03525613|364828970|FG003|Overall Study|Physician Decision|1|||
105775819|NCT03525613|364828967|FG000|Overall Study|Consent Withdrawal|25|||
105775820|NCT03525613|364828968|FG001|Overall Study|Consent Withdrawal|16|||
105775821|NCT03525613|364828969|FG002|Overall Study|Consent Withdrawal|12|||
105775822|NCT03525613|364828970|FG003|Overall Study|Consent Withdrawal|9|||
105775823|NCT03525613|364828967|FG000|Overall Study|Death|20|||
105775824|NCT03525613|364828968|FG001|Overall Study|Death|9|||
105775825|NCT03525613|364828969|FG002|Overall Study|Death|7|||
105775826|NCT03525613|364828970|FG003|Overall Study|Death|1|||
105775827|NCT03525613|364828967|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
105775828|NCT03525613|364828968|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
105775829|NCT03525613|364828969|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
105775830|NCT03525613|364828970|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
105775831|NCT02584660|364828974|FG000|Overall Study|Adverse Event|4|||
105775832|NCT02584660|364828975|FG001|Overall Study|Adverse Event|0|||
105775833|NCT02584660|364828974|FG000|Overall Study|Lost to Follow-up|3|||
105775834|NCT02584660|364828975|FG001|Overall Study|Lost to Follow-up|4|||
105775835|NCT02584660|364828974|FG000|Overall Study|Protocol Violation|0|||
105775836|NCT02584660|364828975|FG001|Overall Study|Protocol Violation|1|||
105775837|NCT02584660|364828974|FG000|Overall Study|Withdrawal by Subject|0|||
105442559|NCT02936843|363626785|FG000|Overall Study|Lost to Follow-up|3|||
105442560|NCT02936843|363626786|FG001|Overall Study|Lost to Follow-up|1|||
105442561|NCT02936843|363626785|FG000|Overall Study|Withdrawal by Subject|1|||
105775838|NCT02584660|364828975|FG001|Overall Study|Withdrawal by Subject|2|||
105775839|NCT02584660|364828974|FG000|Overall Study|Other|0|||
105775840|NCT02584660|364828975|FG001|Overall Study|Other|1|||
105775841|NCT00461552|364828978|FG000|Overall Study|Drug Dispensing error|0|||
105775842|NCT00461552|364828979|FG001|Overall Study|Drug Dispensing error|2|||
105775843|NCT02463331|364828989|FG000|Overall Study|Adverse Event|4|||
105775844|NCT02463331|364828990|FG001|Overall Study|Adverse Event|2|||
105775845|NCT02463331|364828989|FG000|Overall Study|Lost to Follow-up|1|||
105775846|NCT02463331|364828990|FG001|Overall Study|Lost to Follow-up|1|||
105775847|NCT02463331|364828989|FG000|Overall Study|Pregnancy|2|||
105775848|NCT02463331|364828990|FG001|Overall Study|Pregnancy|3|||
105775849|NCT02463331|364828989|FG000|Overall Study|Lack of Efficacy|6|||
105775850|NCT02463331|364828990|FG001|Overall Study|Lack of Efficacy|0|||
105775851|NCT02463331|364828989|FG000|Overall Study|Physician Decision|3|||
105775852|NCT02463331|364828990|FG001|Overall Study|Physician Decision|0|||
105775853|NCT01166386|364828991|FG000|Overall Study|Withdrawal by Subject|3|||
105775854|NCT01166386|364828992|FG001|Overall Study|Withdrawal by Subject|5|||
105775855|NCT03922711|364828995|FG000|Overall Study|Adverse Event|3|||
105775856|NCT03922711|364828996|FG001|Overall Study|Adverse Event|2|||
105775857|NCT03922711|364828997|FG002|Overall Study|Adverse Event|2|||
105775858|NCT03922711|364828995|FG000|Overall Study|Protocol Violation|1|||
105775859|NCT03922711|364828996|FG001|Overall Study|Protocol Violation|0|||
105775860|NCT03922711|364828997|FG002|Overall Study|Protocol Violation|0|||
105775861|NCT03922711|364828995|FG000|Overall Study|Withdrawal by Subject|0|||
105775862|NCT03922711|364828996|FG001|Overall Study|Withdrawal by Subject|3|||
105775863|NCT03922711|364828997|FG002|Overall Study|Withdrawal by Subject|1|||
105775864|NCT03922711|364828995|FG000|Overall Study|Not further specified|0|||
105775865|NCT03922711|364828996|FG001|Overall Study|Not further specified|0|||
105775866|NCT03922711|364828997|FG002|Overall Study|Not further specified|1|||
105775867|NCT04009824|364828998|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
105775868|NCT04009824|364828999|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
105775869|NCT04009824|364829000|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
105775870|NCT04009824|364829001|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
105775871|NCT04009824|364829002|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
105775872|NCT03147495|364829003|FG000|Overall Study|Physician Decision|0|||
105775873|NCT03147495|364829004|FG001|Overall Study|Physician Decision|6|||
105775874|NCT01024946|364829005|FG000|Overall Study|Screen Failure|3|||
105775875|NCT01024946|364829005|FG000|Overall Study|Withdrawal by Subject|1|||
105775876|NCT01024946|364829005|FG000|Overall Study|Adverse Event|1|||
105775877|NCT02274766|364829008|FG000|Overall Study|Withdrawal by Subject|3|||
105775878|NCT02274766|364829009|FG001|Overall Study|Withdrawal by Subject|6|||
105775879|NCT02274766|364829008|FG000|Overall Study|Did Not Receive Study Drug|1|||
105775880|NCT02274766|364829009|FG001|Overall Study|Did Not Receive Study Drug|1|||
105775881|NCT02274766|364829008|FG000|Overall Study|Subject Unwilling to Proceed|0|||
105775882|NCT02274766|364829009|FG001|Overall Study|Subject Unwilling to Proceed|1|||
105775883|NCT02274766|364829008|FG000|Overall Study|Adverse Event|0|||
105775884|NCT02274766|364829009|FG001|Overall Study|Adverse Event|1|||
105775885|NCT01142791|364829019|FG000|Overall Study|Alternative Treatment|1|||
105775886|NCT01142791|364829020|FG001|Overall Study|Alternative Treatment|0|||
105775887|NCT01142791|364829019|FG000|Overall Study|Lost to Follow-up|1|||
105775888|NCT01142791|364829020|FG001|Overall Study|Lost to Follow-up|0|||
105775889|NCT01142791|364829019|FG000|Overall Study|Withdrawal by Subject|5|||
105775890|NCT01142791|364829020|FG001|Overall Study|Withdrawal by Subject|0|||
105775891|NCT01142791|364829019|FG000|Overall Study|Received only 1 sonication|0|||
105775892|NCT01142791|364829020|FG001|Overall Study|Received only 1 sonication|6|||
105775893|NCT02608892|364829021|FG000|Overall Study|Lost to Follow-up|1|||
105775894|NCT02608892|364829022|FG001|Overall Study|Lost to Follow-up|0|||
105775895|NCT01681836|364829023|FG000|Second Intervention|Withdrawal by Subject|0|||
105775896|NCT01681836|364829024|FG001|Second Intervention|Withdrawal by Subject|1|||
105775897|NCT00742391|364829025|FG000|Overall Study|Adverse Event|2|||
105775898|NCT00742391|364829026|FG001|Overall Study|Adverse Event|1|||
105775899|NCT00742391|364829025|FG000|Overall Study|Lost to Follow-up|1|||
105775900|NCT00742391|364829026|FG001|Overall Study|Lost to Follow-up|0|||
105775901|NCT00742391|364829025|FG000|Overall Study|Protocol Violation|1|||
105775902|NCT00742391|364829026|FG001|Overall Study|Protocol Violation|0|||
105775903|NCT02975206|364829031|FG000|Overall Study|Withdrawal by Subject|14|||
105775904|NCT02975206|364829032|FG001|Overall Study|Withdrawal by Subject|11|||
105775905|NCT02975206|364829033|FG002|Overall Study|Withdrawal by Subject|11|||
105775906|NCT02975206|364829031|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
105775907|NCT02975206|364829032|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
105775908|NCT02975206|364829033|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
105775909|NCT01984294|364829044|FG000|Overall Study|Randomized but Never Treated|0|||
105775910|NCT01984294|364829045|FG001|Overall Study|Randomized but Never Treated|0|||
105775911|NCT01984294|364829046|FG002|Overall Study|Randomized but Never Treated|1|||
105775912|NCT01984294|364829044|FG000|Overall Study|Lack of Efficacy|4|||
105775913|NCT01984294|364829045|FG001|Overall Study|Lack of Efficacy|2|||
105775914|NCT01984294|364829046|FG002|Overall Study|Lack of Efficacy|6|||
105775915|NCT01984294|364829044|FG000|Overall Study|Adverse Event|0|||
105775916|NCT01984294|364829045|FG001|Overall Study|Adverse Event|1|||
105775917|NCT01984294|364829046|FG002|Overall Study|Adverse Event|0|||
105775918|NCT02355665|364829047|FG000|Overall Study|Adverse Event|16|||
105775919|NCT02355665|364829048|FG001|Overall Study|Adverse Event|24|||
105775920|NCT02355665|364829047|FG000|Overall Study|Protocol Violation|2|||
105775921|NCT02355665|364829048|FG001|Overall Study|Protocol Violation|0|||
105775922|NCT02355665|364829047|FG000|Overall Study|Withdrawal by Subject|90|||
105775923|NCT02355665|364829048|FG001|Overall Study|Withdrawal by Subject|100|||
105775924|NCT02355665|364829047|FG000|Overall Study|Lost to Follow-up|131|||
105775925|NCT02355665|364829048|FG001|Overall Study|Lost to Follow-up|103|||
105775926|NCT02355665|364829047|FG000|Overall Study|Death|4|||
105775927|NCT02355665|364829048|FG001|Overall Study|Death|2|||
105775928|NCT02355665|364829047|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
105775929|NCT02355665|364829048|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
105775930|NCT01058356|364829051|FG000|Overall Study|Adverse Event|5|||
105775931|NCT01058356|364829051|FG000|Overall Study|Administration of contraindicated drugs|12|||
105775932|NCT01058356|364829051|FG000|Overall Study|Withdrawal by Subject|21|||
105775933|NCT01058356|364829051|FG000|Overall Study|Lost to Follow-up|4|||
105775934|NCT02993783|364829054|FG000|Overall Study|Reason not Specified|6|||
105775935|NCT02993783|364829055|FG001|Overall Study|Reason not Specified|9|||
105775936|NCT01066546|364829056|FG000|Overall Study|Study terminated by sponsor|5|||
105775937|NCT02679222|364831406|FG000|Overall Study|No time for project|1|||
105775938|NCT00303329|364831407|FG000|Overall Study|Adverse Event|7|||
105775939|NCT00303329|364831408|FG001|Overall Study|Adverse Event|14|||
105775940|NCT00303329|364831407|FG000|Overall Study|Abnormal Laboratory Values|0|||
105775941|NCT00303329|364831408|FG001|Overall Study|Abnormal Laboratory Values|1|||
105775942|NCT00303329|364831407|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
105775943|NCT00303329|364831408|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105775944|NCT00303329|364831407|FG000|Overall Study|Condition no longer requires study drug|0|||
105775945|NCT00303329|364831408|FG001|Overall Study|Condition no longer requires study drug|8|||
105775946|NCT00303329|364831407|FG000|Overall Study|Protocol Violation|3|||
105775947|NCT00303329|364831408|FG001|Overall Study|Protocol Violation|0|||
105775948|NCT00303329|364831407|FG000|Overall Study|Withdrawal by Subject|9|||
105775949|NCT00303329|364831408|FG001|Overall Study|Withdrawal by Subject|15|||
105775950|NCT00303329|364831407|FG000|Overall Study|Lost to Follow-up|0|||
105775951|NCT00303329|364831408|FG001|Overall Study|Lost to Follow-up|1|||
105775952|NCT00303329|364831407|FG000|Overall Study|Administrative problems|1|||
105775953|NCT00303329|364831408|FG001|Overall Study|Administrative problems|0|||
105775954|NCT00303329|364831407|FG000|Overall Study|Death|2|||
105775955|NCT00303329|364831408|FG001|Overall Study|Death|12|||
105775956|NCT00303329|364831407|FG000|Overall Study|Stopped at end of core|3|||
105775957|NCT00303329|364831408|FG001|Overall Study|Stopped at end of core|9|||
105775958|NCT00303329|364831407|FG000|Overall Study|Stopped at end of extension 1|1|||
105775959|NCT00303329|364831408|FG001|Overall Study|Stopped at end of extension 1|0|||
105775960|NCT04397757|364831409|FG000|Overall Study|Death|3|||
105775961|NCT04397757|364831410|FG001|Overall Study|Death|11|||
105775962|NCT04397757|364831409|FG000|Overall Study|Withdrawal by Subject|2|||
105775963|NCT04397757|364831410|FG001|Overall Study|Withdrawal by Subject|0|||
105775964|NCT04397757|364831409|FG000|Overall Study|Lost to Follow-up|4|||
105775965|NCT04397757|364831410|FG001|Overall Study|Lost to Follow-up|3|||
105775966|NCT03384316|364831411|FG000|Overall Study|Screen failure|0|||
105775967|NCT03384316|364831412|FG001|Overall Study|Screen failure|1|||
105775968|NCT01952041|364831417|FG000|Overall Study|Lost to Follow-up|9|||
105775969|NCT01952041|364831418|FG001|Overall Study|Lost to Follow-up|16|||
105775970|NCT01952041|364831417|FG000|Overall Study|Withdrawal by Subject|7|||
105775971|NCT01952041|364831418|FG001|Overall Study|Withdrawal by Subject|5|||
105775972|NCT01952041|364831417|FG000|Overall Study|Death|1|||
105775973|NCT01952041|364831418|FG001|Overall Study|Death|0|||
105775974|NCT00626327|364831419|FG000|Overall Study|Withdrawal by Subject|21|||
105775975|NCT00626327|364831420|FG001|Overall Study|Withdrawal by Subject|29|||
105775976|NCT00626327|364831421|FG002|Overall Study|Withdrawal by Subject|30|||
105775977|NCT00626327|364831419|FG000|Overall Study|Adverse Event|1|||
105775978|NCT00626327|364831420|FG001|Overall Study|Adverse Event|0|||
105775979|NCT00626327|364831421|FG002|Overall Study|Adverse Event|0|||
105775980|NCT00626327|364831419|FG000|Overall Study|Lost to Follow-up|24|||
105775981|NCT00626327|364831420|FG001|Overall Study|Lost to Follow-up|21|||
105775982|NCT00626327|364831421|FG002|Overall Study|Lost to Follow-up|23|||
105775983|NCT00626327|364831419|FG000|Overall Study|Inappropriate enrollment|4|||
105775984|NCT00626327|364831420|FG001|Overall Study|Inappropriate enrollment|5|||
105775985|NCT00626327|364831421|FG002|Overall Study|Inappropriate enrollment|3|||
105775986|NCT00626327|364831419|FG000|Overall Study|Administrative Reason|2|||
105775987|NCT00626327|364831420|FG001|Overall Study|Administrative Reason|0|||
105775988|NCT00626327|364831421|FG002|Overall Study|Administrative Reason|6|||
105775989|NCT00626327|364831419|FG000|Overall Study|Protocol Violation|26|||
105775990|NCT00626327|364831420|FG001|Overall Study|Protocol Violation|4|||
105775991|NCT00626327|364831421|FG002|Overall Study|Protocol Violation|26|||
105775992|NCT00945945|364831422|FG000|Overall Study|Adverse Event|15|||
105775993|NCT00945945|364831423|FG001|Overall Study|Adverse Event|35|||
105775994|NCT00945945|364831422|FG000|Overall Study|Withdrawal by Subject|7|||
105775995|NCT00945945|364831423|FG001|Overall Study|Withdrawal by Subject|10|||
105775996|NCT00945945|364831422|FG000|Overall Study|Lost to Follow-up|4|||
105775997|NCT00945945|364831423|FG001|Overall Study|Lost to Follow-up|5|||
105775998|NCT00945945|364831422|FG000|Overall Study|Lack of Efficacy|6|||
105775999|NCT00945945|364831423|FG001|Overall Study|Lack of Efficacy|2|||
105776000|NCT00945945|364831422|FG000|Overall Study|Protocol Violation|4|||
105776001|NCT00945945|364831423|FG001|Overall Study|Protocol Violation|2|||
105776002|NCT00945945|364831422|FG000|Overall Study|Entry Criteria Not Met|0|||
105776003|NCT00945945|364831423|FG001|Overall Study|Entry Criteria Not Met|1|||
105776004|NCT02275052|364831425|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105776005|NCT02275052|364831426|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
105776006|NCT02275052|364831427|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105776007|NCT02275052|364831428|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105776008|NCT02275052|364831425|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
105776009|NCT02275052|364831426|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
105776010|NCT02275052|364831427|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
105776011|NCT02275052|364831428|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
105776012|NCT02275052|364831425|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
105776013|NCT02275052|364831426|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
105776014|NCT02275052|364831427|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
105776015|NCT02275052|364831428|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
105776016|NCT02275052|364831425|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
105776017|NCT02275052|364831426|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
105776018|NCT02275052|364831427|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
105776019|NCT02275052|364831428|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
105776020|NCT02275052|364831425|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
105776021|NCT02275052|364831426|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
105776022|NCT02275052|364831427|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
105776023|NCT02275052|364831428|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
105776024|NCT02275052|364831425|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
105776025|NCT02275052|364831426|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
105776026|NCT02275052|364831427|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
105776027|NCT02275052|364831428|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
105776028|NCT02275052|364831425|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
105776029|NCT02275052|364831426|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
105776030|NCT02275052|364831427|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
105776031|NCT02275052|364831428|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
105776032|NCT02275052|364831425|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
105776033|NCT02275052|364831426|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
105776034|NCT02275052|364831427|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
105776035|NCT02275052|364831428|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
105776036|NCT02275052|364831425|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105776037|NCT02275052|364831426|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105776038|NCT02275052|364831427|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
105776039|NCT02275052|364831428|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
105776040|NCT02275052|364831425|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
105776041|NCT02275052|364831426|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
105776042|NCT02275052|364831427|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
105776043|NCT02275052|364831428|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
105776044|NCT02275052|364831425|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
105776045|NCT02275052|364831426|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
105776046|NCT02275052|364831427|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
105776047|NCT02275052|364831428|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
105776048|NCT00290355|364831431|FG000|Overall Study|Serious adverse event|7|||
105776049|NCT00290355|364831432|FG001|Overall Study|Serious adverse event|4|||
105776050|NCT00290355|364831431|FG000|Overall Study|Study product reactogenicity|1|||
105776051|NCT00290355|364831432|FG001|Overall Study|Study product reactogenicity|0|||
105776052|NCT00290355|364831431|FG000|Overall Study|Protocol Violation|1|||
105776053|NCT00290355|364831432|FG001|Overall Study|Protocol Violation|0|||
105776054|NCT00290355|364831431|FG000|Overall Study|Withdrawal by Subject|2|||
105776055|NCT00290355|364831432|FG001|Overall Study|Withdrawal by Subject|0|||
105776056|NCT00290355|364831431|FG000|Overall Study|Migrated / moved from the study area|1|||
105776057|NCT00290355|364831432|FG001|Overall Study|Migrated / moved from the study area|0|||
105776058|NCT00290355|364831431|FG000|Overall Study|Lost to Follow-up|3|||
105776059|NCT00290355|364831432|FG001|Overall Study|Lost to Follow-up|1|||
105776060|NCT00290355|364831431|FG000|Overall Study|Other|2|||
105776061|NCT00290355|364831432|FG001|Overall Study|Other|0|||
105776062|NCT01797302|364831435|FG000|Overall Study|Lost to Follow-up|16|||
105776063|NCT01797302|364831436|FG001|Overall Study|Lost to Follow-up|23|||
105776064|NCT01797302|364831437|FG002|Overall Study|Lost to Follow-up|22|||
105776065|NCT01797302|364831435|FG000|Overall Study|Withdrawal by Subject|1|||
105776066|NCT01797302|364831436|FG001|Overall Study|Withdrawal by Subject|3|||
105776067|NCT01797302|364831437|FG002|Overall Study|Withdrawal by Subject|4|||
105776068|NCT02773849|364831438|FG000|Overall Study|Lost to Follow-up|11|||
105776069|NCT02773849|364831438|FG000|Overall Study|Death|26|||
105776070|NCT02773849|364831438|FG000|Overall Study|Withdrawal by Subject|5|||
105776071|NCT02773849|364831438|FG000|Overall Study|Withdrawal of Consent|9|||
105776072|NCT02773849|364831438|FG000|Overall Study|Other: not due to lack of tolerability|11|||
105776073|NCT00948389|364831439|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
105776074|NCT00948389|364831440|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
105776075|NCT00948389|364831441|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
105776076|NCT00948389|364831442|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
105776077|NCT00948389|364831443|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
105776078|NCT00948389|364831439|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
105776079|NCT00948389|364831440|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
105776080|NCT00948389|364831441|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
105776081|NCT00948389|364831442|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
105776082|NCT00948389|364831443|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
105776083|NCT00948389|364831439|FG000|Overall Study|Both Progression and Toxicity|1|||
105776084|NCT00948389|364831440|FG001|Overall Study|Both Progression and Toxicity|0|||
105776085|NCT00948389|364831441|FG002|Overall Study|Both Progression and Toxicity|0|||
105776086|NCT00948389|364831442|FG003|Overall Study|Both Progression and Toxicity|0|||
105776087|NCT00948389|364831443|FG004|Overall Study|Both Progression and Toxicity|0|||
105776088|NCT04249076|364831450|FG000|Overall Study|Adverse Event|1|||
105776089|NCT04249076|364831451|FG001|Overall Study|Adverse Event|1|||
105776090|NCT04249076|364831450|FG000|Overall Study|Protocol Violation|1|||
105776091|NCT04249076|364831451|FG001|Overall Study|Protocol Violation|2|||
105776092|NCT04249076|364831450|FG000|Overall Study|Lack of Efficacy|0|||
105776093|NCT04249076|364831451|FG001|Overall Study|Lack of Efficacy|1|||
105776094|NCT04249076|364831450|FG000|Overall Study|Withdrawal by Subject|0|||
105776095|NCT04249076|364831451|FG001|Overall Study|Withdrawal by Subject|1|||
105776096|NCT00783263|364831452|FG000|Overall Study|Adverse Event|3|||
105776097|NCT00783263|364831453|FG001|Overall Study|Adverse Event|0|||
105776098|NCT00783263|364831454|FG002|Overall Study|Adverse Event|2|||
105776099|NCT00783263|364831455|FG003|Overall Study|Adverse Event|1|||
105776100|NCT00783263|364831452|FG000|Overall Study|Lost to Follow-up|1|||
105776101|NCT00783263|364831453|FG001|Overall Study|Lost to Follow-up|1|||
105776102|NCT00783263|364831454|FG002|Overall Study|Lost to Follow-up|0|||
105776103|NCT00783263|364831455|FG003|Overall Study|Lost to Follow-up|0|||
105776104|NCT00783263|364831452|FG000|Overall Study|Withdrawal by Subject|0|||
105776105|NCT00783263|364831453|FG001|Overall Study|Withdrawal by Subject|1|||
105776106|NCT00783263|364831454|FG002|Overall Study|Withdrawal by Subject|1|||
105776107|NCT00783263|364831455|FG003|Overall Study|Withdrawal by Subject|2|||
105776108|NCT02381795|364831459|FG000|Overall Study|Withdrawal by Subject|1|||
105776109|NCT02381795|364831459|FG000|Overall Study|Study Terminated|2|||
105776110|NCT01072500|364831462|FG000|Overall Study|Death|2|||
105776111|NCT01072500|364831463|FG001|Overall Study|Death|2|||
105776112|NCT01072500|364831462|FG000|Overall Study|Lost to Follow-up|5|||
105776113|NCT01072500|364831463|FG001|Overall Study|Lost to Follow-up|2|||
105776114|NCT01072500|364831462|FG000|Overall Study|Withdrawal by Subject|17|||
105776115|NCT01072500|364831463|FG001|Overall Study|Withdrawal by Subject|10|||
105776116|NCT02908841|364831464|FG000|Overall Study|Physician Decision|4|||
105776117|NCT02908841|364831465|FG001|Overall Study|Physician Decision|0|||
105776118|NCT01227252|364831466|FG000|Overall Study|Sponsor Decision|0|||
105776119|NCT01227252|364831467|FG001|Overall Study|Sponsor Decision|1|||
105776120|NCT01227252|364831468|FG002|Overall Study|Sponsor Decision|0|||
105776121|NCT01227252|364831469|FG003|Overall Study|Sponsor Decision|0|||
105776122|NCT01227252|364831466|FG000|Overall Study|Lost to Follow-up|0|||
105776123|NCT01227252|364831467|FG001|Overall Study|Lost to Follow-up|1|||
105776124|NCT01227252|364831468|FG002|Overall Study|Lost to Follow-up|0|||
105776125|NCT01227252|364831469|FG003|Overall Study|Lost to Follow-up|0|||
105776126|NCT01227252|364831466|FG000|Overall Study|Withdrawal by Subject|0|||
105776127|NCT01227252|364831467|FG001|Overall Study|Withdrawal by Subject|1|||
105776128|NCT01227252|364831468|FG002|Overall Study|Withdrawal by Subject|0|||
105776129|NCT01227252|364831469|FG003|Overall Study|Withdrawal by Subject|0|||
105776130|NCT04062240|364831472|FG000|Overall Study|equipment malfunction|1|||
105776131|NCT00579527|364831473|FG000|Overall Study|Death|4|||
105776132|NCT00952588|364831474|FG000|Overall Study|Death|28|||
105776133|NCT00952588|364831475|FG001|Overall Study|Death|13|||
105776134|NCT00952588|364831474|FG000|Overall Study|Withdrawal by Subject|2|||
105776135|NCT00952588|364831475|FG001|Overall Study|Withdrawal by Subject|5|||
105776136|NCT00952588|364831474|FG000|Overall Study|Adverse Event|2|||
105776137|NCT00952588|364831475|FG001|Overall Study|Adverse Event|3|||
105776138|NCT00952588|364831474|FG000|Overall Study|Lost to Follow-up|2|||
105776139|NCT00952588|364831475|FG001|Overall Study|Lost to Follow-up|0|||
105776140|NCT00952588|364831474|FG000|Overall Study|Physician Decision|0|||
105776141|NCT00952588|364831475|FG001|Overall Study|Physician Decision|1|||
105776142|NCT00952588|364831474|FG000|Overall Study|Lack of Efficacy|2|||
105776143|NCT00952588|364831475|FG001|Overall Study|Lack of Efficacy|2|||
105776144|NCT04554394|364831476|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
105776145|NCT04554394|364831477|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
105776146|NCT04554394|364831476|FG000|Overall Study|Withdrawal by Subject|2|||
105776147|NCT04554394|364831477|FG001|Overall Study|Withdrawal by Subject|2|||
105776148|NCT04554394|364831476|FG000|Overall Study|Lost to Follow-up|2|||
105776149|NCT04554394|364831477|FG001|Overall Study|Lost to Follow-up|2|||
105776150|NCT04554394|364831476|FG000|Overall Study|Physician Decision|1|||
105776151|NCT04554394|364831477|FG001|Overall Study|Physician Decision|1|||
105776152|NCT00256204|364831481|FG000|Overall Study|Adverse Event|10|||
105776153|NCT00256204|364831482|FG001|Overall Study|Adverse Event|14|||
105776154|NCT00256204|364831483|FG002|Overall Study|Adverse Event|16|||
105776155|NCT00256204|364831484|FG003|Overall Study|Adverse Event|14|||
105776156|NCT00256204|364831481|FG000|Overall Study|Death|0|||
105776157|NCT00256204|364831482|FG001|Overall Study|Death|1|||
105776158|NCT00256204|364831483|FG002|Overall Study|Death|0|||
105776159|NCT00256204|364831484|FG003|Overall Study|Death|0|||
105776160|NCT00256204|364831481|FG000|Overall Study|Lost to Follow-up|1|||
105776161|NCT00256204|364831482|FG001|Overall Study|Lost to Follow-up|1|||
105776162|NCT00256204|364831483|FG002|Overall Study|Lost to Follow-up|1|||
105776163|NCT00256204|364831484|FG003|Overall Study|Lost to Follow-up|2|||
105776164|NCT00256204|364831481|FG000|Overall Study|Protocol Violation|1|||
105776165|NCT00256204|364831482|FG001|Overall Study|Protocol Violation|0|||
105776166|NCT00256204|364831483|FG002|Overall Study|Protocol Violation|2|||
105776167|NCT00256204|364831484|FG003|Overall Study|Protocol Violation|1|||
105776168|NCT00256204|364831481|FG000|Overall Study|Physician Decision|0|||
105776169|NCT00256204|364831482|FG001|Overall Study|Physician Decision|0|||
105776170|NCT00256204|364831483|FG002|Overall Study|Physician Decision|1|||
105776171|NCT00256204|364831484|FG003|Overall Study|Physician Decision|2|||
105776172|NCT00256204|364831481|FG000|Overall Study|Withdrawal by Subject|17|||
105776173|NCT00256204|364831482|FG001|Overall Study|Withdrawal by Subject|6|||
105776174|NCT00256204|364831483|FG002|Overall Study|Withdrawal by Subject|7|||
105776175|NCT00256204|364831484|FG003|Overall Study|Withdrawal by Subject|5|||
105776176|NCT00256204|364831481|FG000|Overall Study|Need for additional prohibited treatment|38|||
105776177|NCT00256204|364831482|FG001|Overall Study|Need for additional prohibited treatment|28|||
105776178|NCT00256204|364831483|FG002|Overall Study|Need for additional prohibited treatment|27|||
105776179|NCT00256204|364831484|FG003|Overall Study|Need for additional prohibited treatment|25|||
105776180|NCT02364999|364831485|FG000|Overall Study|Death|136|||
105776181|NCT02364999|364831486|FG001|Overall Study|Death|138|||
105776182|NCT02364999|364831485|FG000|Overall Study|Lost to Follow-up|10|||
105776183|NCT02364999|364831486|FG001|Overall Study|Lost to Follow-up|15|||
105776184|NCT02364999|364831485|FG000|Overall Study|Protocol Violation|3|||
105776185|NCT02364999|364831486|FG001|Overall Study|Protocol Violation|2|||
105776186|NCT02364999|364831485|FG000|Overall Study|Withdrawal by Subject|14|||
105776187|NCT02364999|364831486|FG001|Overall Study|Withdrawal by Subject|14|||
105776188|NCT02364999|364831485|FG000|Overall Study|Other|0|||
105776189|NCT02364999|364831486|FG001|Overall Study|Other|1|||
105776190|NCT02364999|364831485|FG000|Overall Study|Randomized but did not receive treatment|2|||
105776191|NCT02364999|364831486|FG001|Overall Study|Randomized but did not receive treatment|3|||
105776192|NCT00696774|364831490|FG000|Period II|Adverse Event|0|||
105776193|NCT00696774|364831491|FG001|Period II|Adverse Event|0|||
105776194|NCT00696774|364831492|FG002|Period II|Adverse Event|15|||
105776195|NCT00696774|364831490|FG000|Period II|Lost to Follow-up|0|||
105776196|NCT00696774|364831491|FG001|Period II|Lost to Follow-up|0|||
105776197|NCT00696774|364831492|FG002|Period II|Lost to Follow-up|4|||
105776198|NCT00696774|364831490|FG000|Period II|Protocol Violation|0|||
105776199|NCT00696774|364831491|FG001|Period II|Protocol Violation|0|||
105776200|NCT00696774|364831492|FG002|Period II|Protocol Violation|11|||
105776201|NCT00696774|364831490|FG000|Period II|Withdrawal by Subject|0|||
105776202|NCT00696774|364831491|FG001|Period II|Withdrawal by Subject|0|||
105776203|NCT00696774|364831492|FG002|Period II|Withdrawal by Subject|4|||
105776204|NCT00696774|364831490|FG000|Period II|Sponsor Decision|0|||
105776205|NCT00696774|364831491|FG001|Period II|Sponsor Decision|0|||
105776206|NCT00696774|364831492|FG002|Period II|Sponsor Decision|0|||
105776207|NCT00696774|364831490|FG000|Period II|Lack of Efficacy|0|||
105776208|NCT00696774|364831491|FG001|Period II|Lack of Efficacy|0|||
105776209|NCT00696774|364831492|FG002|Period II|Lack of Efficacy|2|||
105776210|NCT00696774|364831490|FG000|Period III|Adverse Event|1|||
105776211|NCT00696774|364831491|FG001|Period III|Adverse Event|1|||
105776212|NCT00696774|364831492|FG002|Period III|Adverse Event|0|||
105776213|NCT00696774|364831490|FG000|Period III|Lost to Follow-up|2|||
105776214|NCT00696774|364831491|FG001|Period III|Lost to Follow-up|1|||
105776215|NCT00696774|364831492|FG002|Period III|Lost to Follow-up|0|||
105776216|NCT00696774|364831490|FG000|Period III|Protocol Violation|1|||
105776217|NCT00696774|364831491|FG001|Period III|Protocol Violation|1|||
105776218|NCT00696774|364831492|FG002|Period III|Protocol Violation|0|||
105776219|NCT00696774|364831490|FG000|Period III|Withdrawal by Subject|1|||
105776220|NCT00696774|364831491|FG001|Period III|Withdrawal by Subject|2|||
105776221|NCT00696774|364831492|FG002|Period III|Withdrawal by Subject|0|||
105776222|NCT00696774|364831490|FG000|Period III|Sponsor Decision|2|||
105776223|NCT00696774|364831491|FG001|Period III|Sponsor Decision|0|||
105776224|NCT00696774|364831492|FG002|Period III|Sponsor Decision|0|||
105776225|NCT00696774|364831490|FG000|Period III|Lack of Efficacy|0|||
105776226|NCT00696774|364831491|FG001|Period III|Lack of Efficacy|2|||
105776227|NCT00696774|364831492|FG002|Period III|Lack of Efficacy|0|||
105776228|NCT03490734|364831502|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
105776229|NCT03490734|364831503|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
105776230|NCT03490734|364831504|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
105776231|NCT03490734|364831505|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
105776232|NCT03490734|364831502|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
105776233|NCT03490734|364831503|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
105776234|NCT03490734|364831504|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
105776235|NCT03490734|364831505|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
105776236|NCT03490734|364831502|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
105776237|NCT03490734|364831503|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
105776238|NCT03490734|364831504|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
105776239|NCT03490734|364831505|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
105776240|NCT03490734|364831502|FG000|Post-intervention Scan Visit|Adverse Event|2|||
105776241|NCT03490734|364831503|FG001|Post-intervention Scan Visit|Adverse Event|0|||
105776242|NCT03490734|364831504|FG002|Post-intervention Scan Visit|Adverse Event|0|||
105776243|NCT03490734|364831505|FG003|Post-intervention Scan Visit|Adverse Event|0|||
105776244|NCT03490734|364831502|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
105776245|NCT03490734|364831503|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
105776246|NCT03490734|364831504|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
105776247|NCT03490734|364831505|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
105776248|NCT03490734|364831502|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
105776249|NCT03490734|364831503|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
105776250|NCT03490734|364831504|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
105776251|NCT03490734|364831505|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
105776252|NCT00890201|364831508|FG000|Overall Study|Protocol Violation|5|||
105776253|NCT00890201|364831509|FG001|Overall Study|Protocol Violation|56|||
105776254|NCT01289028|364831510|FG000|Overall Study|Progressive Disease|49|||
105776255|NCT01289028|364831510|FG000|Overall Study|Adverse Event|14|||
105776256|NCT01289028|364831510|FG000|Overall Study|Withdrawal by Subject|6|||
105776257|NCT01289028|364831510|FG000|Overall Study|Death|4|||
105776258|NCT01289028|364831510|FG000|Overall Study|Lack of Efficacy|2|||
105776259|NCT01289028|364831510|FG000|Overall Study|No longer required|2|||
105776260|NCT01289028|364831510|FG000|Overall Study|Lost to Follow-up|2|||
105776261|NCT01289028|364831510|FG000|Overall Study|New Cancer Therapy|2|||
105776262|NCT01289028|364831510|FG000|Overall Study|Abnormal Lab Value|1|||
105776263|NCT01289028|364831510|FG000|Overall Study|Missing reason for discon|1|||
105776264|NCT03099304|364831512|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
105442562|NCT02936843|363626786|FG001|Overall Study|Withdrawal by Subject|1|||
105442563|NCT04034004|363626791|FG000|Overall Study|Withdrawal by Subject|1|||
105776265|NCT03099304|364831513|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
105776266|NCT03099304|364831514|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
105776267|NCT03099304|364831515|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
105776268|NCT03099304|364831516|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
105776269|NCT03099304|364831517|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
105776270|NCT03099304|364831512|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
105776271|NCT03099304|364831513|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
105776272|NCT03099304|364831514|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
105776273|NCT03099304|364831515|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
105776274|NCT03099304|364831516|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
105776275|NCT03099304|364831517|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
105776276|NCT03099304|364831512|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
105776277|NCT03099304|364831513|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
105776278|NCT03099304|364831514|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
105776279|NCT03099304|364831515|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
105776280|NCT03099304|364831516|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
105776281|NCT03099304|364831517|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
105776282|NCT03099304|364831512|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
105776283|NCT03099304|364831513|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
105776284|NCT03099304|364831514|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
105776285|NCT03099304|364831515|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
105776286|NCT03099304|364831516|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
105776287|NCT03099304|364831517|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
105776288|NCT03099304|364831512|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
105776289|NCT03099304|364831513|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
105776290|NCT03099304|364831514|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
105776291|NCT03099304|364831515|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
105776292|NCT03099304|364831516|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
105776293|NCT03099304|364831517|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
105776294|NCT03099304|364831512|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
105776295|NCT03099304|364831513|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
105776296|NCT03099304|364831514|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
105776297|NCT03099304|364831515|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
105776298|NCT03099304|364831516|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
105776299|NCT03099304|364831517|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
105776300|NCT03099304|364831512|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
105776301|NCT03099304|364831513|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
105776302|NCT03099304|364831514|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
105776303|NCT03099304|364831515|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
105776304|NCT03099304|364831516|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
105776305|NCT03099304|364831517|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
105776306|NCT03099304|364831512|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
105776307|NCT03099304|364831513|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
105776308|NCT03099304|364831514|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
105776309|NCT03099304|364831515|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
105776310|NCT03099304|364831516|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
105776311|NCT03099304|364831517|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
105776312|NCT03099304|364831512|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
105776313|NCT03099304|364831513|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
105776314|NCT03099304|364831514|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
105776315|NCT03099304|364831515|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
105776316|NCT03099304|364831516|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
105776317|NCT03099304|364831517|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
105776318|NCT03099304|364831512|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
105776319|NCT03099304|364831513|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
105776320|NCT03099304|364831514|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
105776321|NCT03099304|364831515|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
105776322|NCT03099304|364831516|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
105776323|NCT03099304|364831517|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
105776324|NCT03099304|364831512|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
105776325|NCT03099304|364831513|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
105776326|NCT03099304|364831514|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
105776327|NCT03099304|364831515|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
105776328|NCT03099304|364831516|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
105776329|NCT03099304|364831517|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
105776330|NCT03099304|364831512|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
105776331|NCT03099304|364831513|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
105776332|NCT03099304|364831514|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
105776333|NCT03099304|364831515|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
105776334|NCT03099304|364831516|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
105776335|NCT03099304|364831517|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
105776336|NCT03099304|364831512|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
105776337|NCT03099304|364831513|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
105776338|NCT03099304|364831514|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
105776339|NCT03099304|364831515|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
105776340|NCT03099304|364831516|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
105776341|NCT03099304|364831517|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
105776342|NCT03099304|364831512|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
105776343|NCT03099304|364831513|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
105776344|NCT03099304|364831514|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
105776345|NCT03099304|364831515|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
105776346|NCT03099304|364831516|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
105776347|NCT03099304|364831517|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
105776348|NCT03099304|364831512|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
105776349|NCT03099304|364831513|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
105776350|NCT03099304|364831514|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
105776351|NCT03099304|364831515|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
105776352|NCT03099304|364831516|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
105776353|NCT03099304|364831517|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
105776354|NCT03099304|364831512|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
105776355|NCT03099304|364831513|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
105776356|NCT03099304|364831514|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
105776357|NCT03099304|364831515|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
105776358|NCT03099304|364831516|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
105776359|NCT03099304|364831517|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
105776360|NCT03099304|364831512|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
105776361|NCT03099304|364831513|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
105776362|NCT03099304|364831514|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
105776363|NCT03099304|364831515|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
105776364|NCT03099304|364831516|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
105776365|NCT03099304|364831517|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
105776366|NCT00472043|364831518|FG000|Overall Study|Withdrawal by Subject|1|||
105776367|NCT00472043|364831519|FG001|Overall Study|Withdrawal by Subject|0|||
105776368|NCT00472043|364831518|FG000|Overall Study|Death|1|||
105776369|NCT00472043|364831519|FG001|Overall Study|Death|0|||
105776370|NCT00715949|364831522|FG000|Overall Study|could not finish first test|4|||
105776371|NCT02590406|364831525|FG000|Overall Study|Adverse Event|1|||
105776372|NCT02590406|364831526|FG001|Overall Study|Adverse Event|0|||
105776373|NCT02590406|364831525|FG000|Overall Study|Saturometer malfunction|0|||
105776374|NCT02590406|364831526|FG001|Overall Study|Saturometer malfunction|1|||
105776375|NCT02363322|364831542|FG000|Overall Study|Lost to Follow-up|1|||
105776376|NCT02363322|364831543|FG001|Overall Study|Lost to Follow-up|0|||
105776377|NCT01843933|364831544|FG000|Overall Study|Data lost|6|||
105776378|NCT01843933|364831545|FG001|Overall Study|Data lost|4|||
105776379|NCT02055976|364831546|FG000|Overall Study|Other|0|||
105776380|NCT02055976|364831547|FG001|Overall Study|Other|0|||
105776381|NCT02055976|364831548|FG002|Overall Study|Other|1|||
105776382|NCT02055976|364831549|FG003|Overall Study|Other|0|||
105776383|NCT02055976|364831550|FG004|Overall Study|Other|0|||
105776384|NCT02055976|364831551|FG005|Overall Study|Other|0|||
105776385|NCT02055976|364831552|FG006|Overall Study|Other|0|||
105776386|NCT02055976|364831553|FG007|Overall Study|Other|0|||
105776387|NCT02055976|364831554|FG008|Overall Study|Other|0|||
105776388|NCT02055976|364831546|FG000|Overall Study|Adverse Event|0|||
105776389|NCT02055976|364831547|FG001|Overall Study|Adverse Event|0|||
105776390|NCT02055976|364831548|FG002|Overall Study|Adverse Event|0|||
105776391|NCT02055976|364831549|FG003|Overall Study|Adverse Event|0|||
105776392|NCT02055976|364831550|FG004|Overall Study|Adverse Event|0|||
105776393|NCT02055976|364831551|FG005|Overall Study|Adverse Event|1|||
105776394|NCT02055976|364831552|FG006|Overall Study|Adverse Event|1|||
105776395|NCT02055976|364831553|FG007|Overall Study|Adverse Event|0|||
105776396|NCT02055976|364831554|FG008|Overall Study|Adverse Event|0|||
105776397|NCT02055976|364831546|FG000|Overall Study|Does not meet entrance criteria|0|||
105776398|NCT02055976|364831547|FG001|Overall Study|Does not meet entrance criteria|0|||
105776399|NCT02055976|364831548|FG002|Overall Study|Does not meet entrance criteria|0|||
105776400|NCT02055976|364831549|FG003|Overall Study|Does not meet entrance criteria|0|||
105776401|NCT02055976|364831550|FG004|Overall Study|Does not meet entrance criteria|0|||
105776402|NCT02055976|364831551|FG005|Overall Study|Does not meet entrance criteria|0|||
105776403|NCT02055976|364831552|FG006|Overall Study|Does not meet entrance criteria|1|||
105776404|NCT02055976|364831553|FG007|Overall Study|Does not meet entrance criteria|0|||
105776405|NCT02055976|364831554|FG008|Overall Study|Does not meet entrance criteria|0|||
105776406|NCT02055976|364831546|FG000|Overall Study|Lost to Follow-up|0|||
105776407|NCT02055976|364831547|FG001|Overall Study|Lost to Follow-up|0|||
105776408|NCT02055976|364831548|FG002|Overall Study|Lost to Follow-up|0|||
105776409|NCT02055976|364831549|FG003|Overall Study|Lost to Follow-up|1|||
105776410|NCT02055976|364831550|FG004|Overall Study|Lost to Follow-up|0|||
105776411|NCT02055976|364831551|FG005|Overall Study|Lost to Follow-up|0|||
105776412|NCT02055976|364831552|FG006|Overall Study|Lost to Follow-up|0|||
105776413|NCT02055976|364831553|FG007|Overall Study|Lost to Follow-up|0|||
105776414|NCT02055976|364831554|FG008|Overall Study|Lost to Follow-up|0|||
105776415|NCT02504424|364831555|FG000|Overall Study|Withdrawal by Subject|2|||
105776416|NCT02146352|364831557|FG000|Overall Study|Death|1|||
105776417|NCT02146352|364831557|FG000|Overall Study|Patient entered hospice care|1|||
105776418|NCT02561572|364831562|FG000|Overall Study|Inadequate time before surgery|2|||
105776419|NCT02561572|364831563|FG001|Overall Study|Inadequate time before surgery|1|||
105776420|NCT02561572|364831562|FG000|Overall Study|Protocol Violation|0|||
105776421|NCT02561572|364831563|FG001|Overall Study|Protocol Violation|1|||
105776422|NCT01021423|364831565|FG000|Overall Study|Study terminated|4|||
105776423|NCT01021423|364831566|FG001|Overall Study|Study terminated|5|||
105776424|NCT02475564|364831568|FG000|Overall Study|Withdrawal by Subject|1|||
105776425|NCT02475564|364831569|FG001|Overall Study|Withdrawal by Subject|0|||
105776426|NCT02475564|364831568|FG000|Overall Study|Lost to Follow-up|2|||
105776427|NCT02475564|364831569|FG001|Overall Study|Lost to Follow-up|1|||
105776428|NCT02475564|364831568|FG000|Overall Study|Intense Menstrual bleeding|1|||
105776429|NCT02475564|364831569|FG001|Overall Study|Intense Menstrual bleeding|0|||
105776430|NCT01156012|364831570|FG000|Overall Study|Adverse Event|3|||
105776431|NCT01156012|364831571|FG001|Overall Study|Adverse Event|1|||
105776432|NCT01156012|364831570|FG000|Overall Study|Lost to Follow-up|1|||
105776433|NCT01156012|364831571|FG001|Overall Study|Lost to Follow-up|0|||
105776434|NCT01156012|364831570|FG000|Overall Study|Withdrawal by Subject|1|||
105776435|NCT01156012|364831571|FG001|Overall Study|Withdrawal by Subject|0|||
105776436|NCT01156012|364831570|FG000|Overall Study|use of commercial drug instead of study|0|||
105776437|NCT01156012|364831571|FG001|Overall Study|use of commercial drug instead of study|1|||
105776438|NCT01156012|364831570|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
105776439|NCT01156012|364831571|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
105776440|NCT03619902|364831572|FG000|Overall Study|Termination of Study by Investigator|1|||
105776441|NCT03619902|364831572|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
105776442|NCT00939094|364831573|FG000|Overall Study|Adverse Event|9|||
105776443|NCT00939094|364831574|FG001|Overall Study|Adverse Event|0|||
105776444|NCT00939094|364831573|FG000|Overall Study|Withdrawal by Subject|1|||
105776445|NCT00939094|364831574|FG001|Overall Study|Withdrawal by Subject|6|||
105776446|NCT00939094|364831573|FG000|Overall Study|Lost to Follow-up|1|||
105776447|NCT00939094|364831574|FG001|Overall Study|Lost to Follow-up|1|||
105776448|NCT00939094|364831573|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
105776449|NCT00939094|364831574|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105776450|NCT00939094|364831573|FG000|Overall Study|Severe non-compliance to protocol|0|||
105776451|NCT00939094|364831574|FG001|Overall Study|Severe non-compliance to protocol|1|||
105776452|NCT00939094|364831573|FG000|Overall Study|Study stopped by sponsor|0|||
105776453|NCT00939094|364831574|FG001|Overall Study|Study stopped by sponsor|2|||
105776454|NCT00939094|364831573|FG000|Overall Study|Abnormal ECG findings|1|||
105776455|NCT00939094|364831574|FG001|Overall Study|Abnormal ECG findings|0|||
105776456|NCT02705755|364831575|FG000|Part A (6 Days)|Adverse Event|1|||
105776457|NCT02705755|364831576|FG001|Part A (6 Days)|Adverse Event|0|||
105776458|NCT02705755|364831577|FG002|Part A (6 Days)|Adverse Event|0|||
105776459|NCT02705755|364831578|FG003|Part A (6 Days)|Adverse Event|0|||
105776460|NCT02705755|364831575|FG000|Part A (6 Days)|Physician Decision|3|||
105776461|NCT02705755|364831576|FG001|Part A (6 Days)|Physician Decision|0|||
105776462|NCT02705755|364831577|FG002|Part A (6 Days)|Physician Decision|0|||
105776463|NCT02705755|364831578|FG003|Part A (6 Days)|Physician Decision|0|||
105776464|NCT02705755|364831575|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
105776465|NCT02705755|364831576|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
105776466|NCT02705755|364831577|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
105776467|NCT02705755|364831578|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
105776468|NCT02705755|364831575|FG000|Part C (20 Weeks)|Physician Decision|0|||
105776469|NCT02705755|364831576|FG001|Part C (20 Weeks)|Physician Decision|0|||
105776470|NCT02705755|364831577|FG002|Part C (20 Weeks)|Physician Decision|0|||
105776471|NCT02705755|364831578|FG003|Part C (20 Weeks)|Physician Decision|2|||
105776472|NCT02705755|364831575|FG000|Part C (20 Weeks)|Adverse Event|0|||
105776473|NCT02705755|364831576|FG001|Part C (20 Weeks)|Adverse Event|0|||
105776474|NCT02705755|364831577|FG002|Part C (20 Weeks)|Adverse Event|0|||
105776475|NCT02705755|364831578|FG003|Part C (20 Weeks)|Adverse Event|6|||
105776476|NCT02705755|364831575|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
105776477|NCT02705755|364831576|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
105776478|NCT02705755|364831577|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
105776479|NCT02705755|364831578|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
105776480|NCT00424463|364831579|FG000|Overall Study|Adverse Event|2|||
105776481|NCT00424463|364831580|FG001|Overall Study|Adverse Event|3|||
105776482|NCT00424463|364831581|FG002|Overall Study|Adverse Event|2|||
105776483|NCT00424463|364831579|FG000|Overall Study|Physician Decision|0|||
105776484|NCT00424463|364831580|FG001|Overall Study|Physician Decision|2|||
105776485|NCT00424463|364831581|FG002|Overall Study|Physician Decision|2|||
105776486|NCT00424463|364831579|FG000|Overall Study|Withdrawal by Subject|4|||
105776487|NCT00424463|364831580|FG001|Overall Study|Withdrawal by Subject|2|||
105776488|NCT00424463|364831581|FG002|Overall Study|Withdrawal by Subject|5|||
105776489|NCT00424463|364831579|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
105776490|NCT00424463|364831580|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
105776491|NCT00424463|364831581|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
105776492|NCT00424463|364831579|FG000|Overall Study|Patient's convenience|0|||
105776493|NCT00424463|364831580|FG001|Overall Study|Patient's convenience|0|||
105776494|NCT00424463|364831581|FG002|Overall Study|Patient's convenience|1|||
105776495|NCT01906489|364831582|FG000|Overall Study|Adverse Event|10|||
105776496|NCT01906489|364831583|FG001|Overall Study|Adverse Event|3|||
105776497|NCT01906489|364831582|FG000|Overall Study|Worsening of CKD|6|||
105776498|NCT01906489|364831583|FG001|Overall Study|Worsening of CKD|4|||
105776499|NCT01906489|364831582|FG000|Overall Study|Withdrawal by Subject|5|||
105776500|NCT01906489|364831583|FG001|Overall Study|Withdrawal by Subject|0|||
105776501|NCT01906489|364831582|FG000|Overall Study|Worsening of Anemia|1|||
105776502|NCT01906489|364831583|FG001|Overall Study|Worsening of Anemia|0|||
105776503|NCT01906489|364831582|FG000|Overall Study|Protocol Violation|0|||
105776504|NCT01906489|364831583|FG001|Overall Study|Protocol Violation|1|||
105776505|NCT01906489|364831582|FG000|Overall Study|Non- Compliance|1|||
105776506|NCT01906489|364831583|FG001|Overall Study|Non- Compliance|0|||
105776507|NCT01906489|364831582|FG000|Overall Study|Sponsor Decision|1|||
105776508|NCT01906489|364831583|FG001|Overall Study|Sponsor Decision|0|||
105776509|NCT01906489|364831582|FG000|Overall Study|Lost to Follow-up|1|||
105776510|NCT01906489|364831583|FG001|Overall Study|Lost to Follow-up|1|||
105776511|NCT01906489|364831582|FG000|Overall Study|Other|1|||
105776512|NCT01906489|364831583|FG001|Overall Study|Other|0|||
105776513|NCT01021293|364831584|FG000|Overall Study|Serious Adverse Event|2|||
105776514|NCT01021293|364831585|FG001|Overall Study|Serious Adverse Event|1|||
105776515|NCT01021293|364831584|FG000|Overall Study|Adverse Event|2|||
105776516|NCT01021293|364831585|FG001|Overall Study|Adverse Event|1|||
105776517|NCT01021293|364831584|FG000|Overall Study|Withdrawal by Subject|1|||
105776518|NCT01021293|364831585|FG001|Overall Study|Withdrawal by Subject|3|||
105776519|NCT01021293|364831584|FG000|Overall Study|Migrated/moved from study area|6|||
105776520|NCT01021293|364831585|FG001|Overall Study|Migrated/moved from study area|18|||
105776521|NCT01021293|364831584|FG000|Overall Study|Lost to Follow-up|1|||
105776522|NCT01021293|364831585|FG001|Overall Study|Lost to Follow-up|1|||
105776523|NCT04728815|364831586|FG000|Overall Study|Lost to Follow-up|3|||
105776524|NCT04728815|364831587|FG001|Overall Study|Lost to Follow-up|0|||
105776525|NCT04728815|364831588|FG002|Overall Study|Lost to Follow-up|0|||
105776526|NCT04728815|364831589|FG003|Overall Study|Lost to Follow-up|1|||
105776527|NCT04728815|364831590|FG004|Overall Study|Lost to Follow-up|1|||
105776528|NCT04728815|364831591|FG005|Overall Study|Lost to Follow-up|0|||
105776529|NCT04728815|364831592|FG006|Overall Study|Lost to Follow-up|2|||
105776530|NCT04728815|364831593|FG007|Overall Study|Lost to Follow-up|0|||
105776531|NCT04728815|364831586|FG000|Overall Study|Physician Decision|0|||
105776532|NCT04728815|364831587|FG001|Overall Study|Physician Decision|0|||
105776533|NCT04728815|364831588|FG002|Overall Study|Physician Decision|1|||
105776534|NCT04728815|364831589|FG003|Overall Study|Physician Decision|0|||
105776535|NCT04728815|364831590|FG004|Overall Study|Physician Decision|0|||
105776536|NCT04728815|364831591|FG005|Overall Study|Physician Decision|0|||
105776537|NCT04728815|364831592|FG006|Overall Study|Physician Decision|0|||
105776538|NCT04728815|364831593|FG007|Overall Study|Physician Decision|0|||
105776539|NCT04728815|364831586|FG000|Overall Study|Treatment drop|0|||
105776540|NCT04728815|364831587|FG001|Overall Study|Treatment drop|2|||
105776541|NCT04728815|364831588|FG002|Overall Study|Treatment drop|1|||
105776542|NCT04728815|364831589|FG003|Overall Study|Treatment drop|0|||
105776543|NCT04728815|364831590|FG004|Overall Study|Treatment drop|3|||
105776544|NCT04728815|364831591|FG005|Overall Study|Treatment drop|1|||
105776545|NCT04728815|364831592|FG006|Overall Study|Treatment drop|3|||
105776546|NCT04728815|364831593|FG007|Overall Study|Treatment drop|0|||
105776547|NCT04728815|364831586|FG000|Overall Study|Study drop|0|||
105776548|NCT04728815|364831587|FG001|Overall Study|Study drop|3|||
105776549|NCT04728815|364831588|FG002|Overall Study|Study drop|3|||
105776550|NCT04728815|364831589|FG003|Overall Study|Study drop|0|||
105776551|NCT04728815|364831590|FG004|Overall Study|Study drop|0|||
105776552|NCT04728815|364831591|FG005|Overall Study|Study drop|0|||
105776553|NCT04728815|364831592|FG006|Overall Study|Study drop|7|||
105776554|NCT04728815|364831593|FG007|Overall Study|Study drop|0|||
105776555|NCT00631969|364831594|FG000|Overall Study|Adverse Event|3|||
105776556|NCT00631969|364831595|FG001|Overall Study|Adverse Event|1|||
105776557|NCT00631969|364831594|FG000|Overall Study|Lack of Efficacy|2|||
105776558|NCT00631969|364831595|FG001|Overall Study|Lack of Efficacy|8|||
105776559|NCT00631969|364831594|FG000|Overall Study|Lost to Follow-up|2|||
105776560|NCT00631969|364831595|FG001|Overall Study|Lost to Follow-up|1|||
105776561|NCT00631969|364831594|FG000|Overall Study|Protocol Violation|1|||
105776562|NCT00631969|364831595|FG001|Overall Study|Protocol Violation|1|||
105776563|NCT00631969|364831594|FG000|Overall Study|Consent Withdrawn|5|||
105776564|NCT00631969|364831595|FG001|Overall Study|Consent Withdrawn|7|||
105776565|NCT00631969|364831594|FG000|Overall Study|Noncompliant With Study Medication|0|||
105776566|NCT00631969|364831595|FG001|Overall Study|Noncompliant With Study Medication|1|||
105776567|NCT00631969|364831594|FG000|Overall Study|No Drug Exposure|2|||
105776568|NCT00631969|364831595|FG001|Overall Study|No Drug Exposure|2|||
105776569|NCT03053180|364833260|FG000|Overall Study|Failure to Return|1|||
105776570|NCT00959192|364833265|FG000|Overall Study|Adverse Event|1|||
105776571|NCT00959192|364833266|FG001|Overall Study|Adverse Event|1|||
105776572|NCT00959192|364833267|FG002|Overall Study|Adverse Event|1|||
105776573|NCT00959192|364833268|FG003|Overall Study|Adverse Event|0|||
105776574|NCT00959192|364833265|FG000|Overall Study|Investigator Request|1|||
105776575|NCT00959192|364833266|FG001|Overall Study|Investigator Request|0|||
105776576|NCT00959192|364833267|FG002|Overall Study|Investigator Request|0|||
105776577|NCT00959192|364833268|FG003|Overall Study|Investigator Request|0|||
105776578|NCT00959192|364833265|FG000|Overall Study|Caregiver Request|0|||
105776579|NCT00959192|364833266|FG001|Overall Study|Caregiver Request|0|||
105776580|NCT00959192|364833267|FG002|Overall Study|Caregiver Request|2|||
105776581|NCT00959192|364833268|FG003|Overall Study|Caregiver Request|1|||
105776582|NCT00532441|364833269|FG000|Overall Study|Death|1|||
105776583|NCT00532441|364833270|FG001|Overall Study|Death|0|||
105776584|NCT05466240|364833271|FG000|Overall Study|Adverse Event|1|||
105776585|NCT05466240|364833272|FG001|Overall Study|Adverse Event|0|||
105776586|NCT05466240|364833271|FG000|Overall Study|Withdrawal by Subject|1|||
105776587|NCT05466240|364833272|FG001|Overall Study|Withdrawal by Subject|0|||
105776588|NCT01603615|364833274|FG000|Overall Study|Did not Receive Treatment|7|||
105776589|NCT01603615|364833274|FG000|Overall Study|Lost to Follow-up|9|||
105776590|NCT01603615|364833274|FG000|Overall Study|Personal Reasons|17|||
105776591|NCT01603615|364833274|FG000|Overall Study|Other Miscellaneous|1|||
105776592|NCT02759939|364833275|FG000|Overall Study|Missing data on first outcome assessed|11|||
105776593|NCT02759939|364833276|FG001|Overall Study|Missing data on first outcome assessed|2|||
105776594|NCT02759939|364833277|FG002|Overall Study|Missing data on first outcome assessed|5|||
105776595|NCT02759939|364833278|FG003|Overall Study|Missing data on first outcome assessed|2|||
105776596|NCT02759939|364833275|FG000|Overall Study|Ineligible for T2 and T3|310|||
105776597|NCT02759939|364833276|FG001|Overall Study|Ineligible for T2 and T3|179|||
105776598|NCT02759939|364833277|FG002|Overall Study|Ineligible for T2 and T3|366|||
105776599|NCT02759939|364833278|FG003|Overall Study|Ineligible for T2 and T3|391|||
105776600|NCT02759939|364833275|FG000|Overall Study|Lost to Follow-up|735|||
105776601|NCT02759939|364833276|FG001|Overall Study|Lost to Follow-up|791|||
105776602|NCT02759939|364833277|FG002|Overall Study|Lost to Follow-up|783|||
105776603|NCT02759939|364833278|FG003|Overall Study|Lost to Follow-up|650|||
105776604|NCT04735432|364833279|FG000|Overall Study|Other - due to personal reason|1|||
105776605|NCT04735432|364833280|FG001|Overall Study|Other - due to personal reason|0|||
105776606|NCT04735432|364833279|FG000|Overall Study|Adverse Event|2|||
105776607|NCT04735432|364833280|FG001|Overall Study|Adverse Event|0|||
105776608|NCT00413231|364833281|FG000|0 to 30-day Post Treatment|Death|5|||
105776609|NCT00413231|364833281|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
105776610|NCT00413231|364833281|FG000|30-day to 365-day Post Treatment|Death|13|||
105776611|NCT00413231|364833281|FG000|365-day to 60-month Post Treatment|Death|36|||
105776612|NCT00413231|364833281|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
105776613|NCT00413231|364833281|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
105776614|NCT00413231|364833281|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
105776615|NCT03228836|364833286|FG000|Overall Study|Adverse Event|3|||
105776616|NCT03228836|364833286|FG000|Overall Study|Withdrawal by Subject|1|||
105776617|NCT03228836|364833286|FG000|Overall Study|Death|1|||
105776618|NCT03228836|364833286|FG000|Overall Study|Physician Decision|1|||
105776619|NCT03228836|364833286|FG000|Overall Study|Disease Progression|7|||
105776620|NCT03228836|364833286|FG000|Overall Study|Other|4|||
105776621|NCT02870348|364833292|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
105776622|NCT00829010|364833295|FG000|Overall Study|Adverse Event|1|||
105776623|NCT00829010|364833296|FG001|Overall Study|Adverse Event|0|||
105776624|NCT00829010|364833297|FG002|Overall Study|Adverse Event|0|||
105776625|NCT00829010|364833298|FG003|Overall Study|Adverse Event|0|||
105776626|NCT00829010|364833299|FG004|Overall Study|Adverse Event|0|||
105776627|NCT00829010|364833295|FG000|Overall Study|Withdrawal by Subject|0|||
105776628|NCT00829010|364833296|FG001|Overall Study|Withdrawal by Subject|1|||
105776629|NCT00829010|364833297|FG002|Overall Study|Withdrawal by Subject|1|||
105776630|NCT00829010|364833298|FG003|Overall Study|Withdrawal by Subject|0|||
105776631|NCT00829010|364833299|FG004|Overall Study|Withdrawal by Subject|2|||
105776632|NCT00829010|364833295|FG000|Overall Study|Lost to Follow-up|1|||
105776633|NCT00829010|364833296|FG001|Overall Study|Lost to Follow-up|0|||
105776634|NCT00829010|364833297|FG002|Overall Study|Lost to Follow-up|2|||
105776635|NCT00829010|364833298|FG003|Overall Study|Lost to Follow-up|0|||
105776636|NCT00829010|364833299|FG004|Overall Study|Lost to Follow-up|0|||
105776637|NCT00829010|364833295|FG000|Overall Study|Fatality|5|||
105776638|NCT00829010|364833296|FG001|Overall Study|Fatality|4|||
105776639|NCT00829010|364833297|FG002|Overall Study|Fatality|0|||
105776640|NCT00829010|364833298|FG003|Overall Study|Fatality|3|||
105776641|NCT00829010|364833299|FG004|Overall Study|Fatality|0|||
105776642|NCT00829010|364833295|FG000|Overall Study|Migrated/Moved from study area|3|||
105776643|NCT00829010|364833296|FG001|Overall Study|Migrated/Moved from study area|4|||
105776644|NCT00829010|364833297|FG002|Overall Study|Migrated/Moved from study area|0|||
105776645|NCT00829010|364833298|FG003|Overall Study|Migrated/Moved from study area|5|||
105776646|NCT00829010|364833299|FG004|Overall Study|Migrated/Moved from study area|0|||
105776647|NCT04005885|364833313|FG000|First Intervention|Withdrawal by Subject|1|||
105776648|NCT04005885|364833314|FG001|First Intervention|Withdrawal by Subject|1|||
105776649|NCT04005885|364833313|FG000|Second Intervention|Withdrawal by Subject|0|||
105776650|NCT04005885|364833314|FG001|Second Intervention|Withdrawal by Subject|2|||
105776651|NCT02718625|364833319|FG000|Overall Study|Adverse Event|0|||
105776652|NCT02718625|364833320|FG001|Overall Study|Adverse Event|1|||
105776653|NCT02718625|364833319|FG000|Overall Study|Termination of Study by Sponsor|0|||
105776654|NCT02718625|364833320|FG001|Overall Study|Termination of Study by Sponsor|1|||
105776655|NCT00381706|364833321|FG000|Overall Study|Never treated|7|||
105776656|NCT00381706|364833322|FG001|Overall Study|Never treated|2|||
105776657|NCT00381706|364833323|FG002|Overall Study|Never treated|1|||
105776658|NCT01796106|364833325|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
105776659|NCT01796106|364833326|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
105776660|NCT01234337|364833333|FG000|Overall Study|Adverse Event|58|||
105776661|NCT01234337|364833334|FG001|Overall Study|Adverse Event|21|||
105776662|NCT01234337|364833333|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
105776663|NCT01234337|364833334|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
105776664|NCT01234337|364833333|FG000|Overall Study|Investi. decision not protocol driven|5|||
105776665|NCT01234337|364833334|FG001|Overall Study|Investi. decision not protocol driven|6|||
105776666|NCT01234337|364833333|FG000|Overall Study|Non-compliant with study medication|3|||
105776667|NCT01234337|364833334|FG001|Overall Study|Non-compliant with study medication|2|||
105776668|NCT01234337|364833333|FG000|Overall Study|Randomized but not treated|6|||
105776669|NCT01234337|364833334|FG001|Overall Study|Randomized but not treated|4|||
105776670|NCT01234337|364833333|FG000|Overall Study|Lost to Follow-up|0|||
105776671|NCT01234337|364833334|FG001|Overall Study|Lost to Follow-up|1|||
105776672|NCT01234337|364833333|FG000|Overall Study|Protocol Violation|2|||
105776673|NCT01234337|364833334|FG001|Overall Study|Protocol Violation|3|||
105776674|NCT01234337|364833333|FG000|Overall Study|Withdrawal by Subject|11|||
105776675|NCT01234337|364833334|FG001|Overall Study|Withdrawal by Subject|9|||
105776676|NCT01234337|364833333|FG000|Overall Study|Death|0|||
105776677|NCT01234337|364833334|FG001|Overall Study|Death|1|||
105776678|NCT01234337|364833333|FG000|Overall Study|Switch to commercial drug|0|||
105776679|NCT01234337|364833334|FG001|Overall Study|Switch to commercial drug|1|||
105776680|NCT03481634|364833335|FG000|Overall Study|Withdrawal by Subject|16|||
105776681|NCT03481634|364833336|FG001|Overall Study|Withdrawal by Subject|19|||
105776682|NCT03481634|364833337|FG002|Overall Study|Withdrawal by Subject|14|||
105776683|NCT03481634|364833335|FG000|Overall Study|Protocol Violation|1|||
105776684|NCT03481634|364833336|FG001|Overall Study|Protocol Violation|0|||
105776685|NCT03481634|364833337|FG002|Overall Study|Protocol Violation|1|||
105776686|NCT03481634|364833335|FG000|Overall Study|Progressive disease|0|||
105776687|NCT03481634|364833336|FG001|Overall Study|Progressive disease|1|||
105776688|NCT03481634|364833337|FG002|Overall Study|Progressive disease|0|||
105776689|NCT03481634|364833335|FG000|Overall Study|Physician Decision|3|||
105776690|NCT03481634|364833336|FG001|Overall Study|Physician Decision|0|||
105776691|NCT03481634|364833337|FG002|Overall Study|Physician Decision|1|||
105776692|NCT03481634|364833335|FG000|Overall Study|Lost to Follow-up|3|||
105776693|NCT03481634|364833336|FG001|Overall Study|Lost to Follow-up|4|||
105776694|NCT03481634|364833337|FG002|Overall Study|Lost to Follow-up|4|||
105776695|NCT03481634|364833335|FG000|Overall Study|Death|4|||
105776696|NCT03481634|364833336|FG001|Overall Study|Death|8|||
105776697|NCT03481634|364833337|FG002|Overall Study|Death|7|||
105776698|NCT03481634|364833335|FG000|Overall Study|Adverse Event|6|||
105776699|NCT03481634|364833336|FG001|Overall Study|Adverse Event|3|||
105776700|NCT03481634|364833337|FG002|Overall Study|Adverse Event|7|||
105776701|NCT03323385|364833345|FG000|Overall Study|Withdrawal by Subject|1|||
105776702|NCT03323385|364833346|FG001|Overall Study|Withdrawal by Subject|2|||
105776703|NCT03323385|364833345|FG000|Overall Study|Noncompliance|0|||
105776704|NCT03323385|364833346|FG001|Overall Study|Noncompliance|1|||
105776705|NCT00033293|364833347|FG000|Overall Study|Death|0|||
105776706|NCT00033293|364833348|FG001|Overall Study|Death|1|||
105776707|NCT00033293|364833347|FG000|Overall Study|Lack of Efficacy|5|||
105776708|NCT00033293|364833348|FG001|Overall Study|Lack of Efficacy|8|||
105776709|NCT00033293|364833347|FG000|Overall Study|Lost to Follow-up|0|||
105776710|NCT00033293|364833348|FG001|Overall Study|Lost to Follow-up|1|||
105776711|NCT00033293|364833347|FG000|Overall Study|Physician Decision|3|||
105776712|NCT00033293|364833348|FG001|Overall Study|Physician Decision|1|||
105776713|NCT00033293|364833347|FG000|Overall Study|Withdrawal by Subject|1|||
105776714|NCT00033293|364833348|FG001|Overall Study|Withdrawal by Subject|0|||
105776715|NCT00033293|364833347|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
105776716|NCT00033293|364833348|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
105776717|NCT00033293|364833347|FG000|Overall Study|Treatment refused|0|||
105776718|NCT00033293|364833348|FG001|Overall Study|Treatment refused|6|||
105776719|NCT02555722|364833349|FG000|Week 2|Adverse Event|0|||
105776720|NCT02555722|364833350|FG001|Week 2|Adverse Event|1|||
105776721|NCT02555722|364833349|FG000|Week 2|Withdrawal by Subject|1|||
105776722|NCT02555722|364833350|FG001|Week 2|Withdrawal by Subject|0|||
105776723|NCT02555722|364833349|FG000|Month 1|Lens Discomfort|1|||
105776724|NCT02555722|364833350|FG001|Month 1|Lens Discomfort|0|||
105776725|NCT02555722|364833349|FG000|Month 2|Withdrawal by Subject|3|||
105776726|NCT02555722|364833350|FG001|Month 2|Withdrawal by Subject|0|||
105776727|NCT02555722|364833349|FG000|Month 2|Lost to Follow-up|1|||
105776728|NCT02555722|364833350|FG001|Month 2|Lost to Follow-up|0|||
105776729|NCT00374452|364833351|FG000|Overall Study|Left clinic before intervention started|4|||
105776730|NCT00374452|364833352|FG001|Overall Study|Left clinic before intervention started|1|||
105776731|NCT00374452|364833351|FG000|Overall Study|Change in job role before intervention|0|||
105776732|NCT00374452|364833352|FG001|Overall Study|Change in job role before intervention|1|||
105776733|NCT00374452|364833351|FG000|Overall Study|Left clinic after intervention started|1|||
105776734|NCT00374452|364833352|FG001|Overall Study|Left clinic after intervention started|1|||
105776735|NCT00374452|364833351|FG000|Overall Study|Withdrawal by Subject|0|||
105776736|NCT00374452|364833352|FG001|Overall Study|Withdrawal by Subject|2|||
105776737|NCT02802735|364833355|FG000|Overall Study|Withdrawal by Subject|0|||
105776738|NCT02802735|364833356|FG001|Overall Study|Withdrawal by Subject|1|||
105776739|NCT02802735|364833357|FG002|Overall Study|Withdrawal by Subject|0|||
105776740|NCT02802735|364833358|FG003|Overall Study|Withdrawal by Subject|0|||
105776741|NCT02802735|364833359|FG004|Overall Study|Withdrawal by Subject|0|||
105776742|NCT01326910|364833360|FG000|Overall Study|Withdrawal by Subject|3|||
105776743|NCT01326910|364833361|FG001|Overall Study|Withdrawal by Subject|2|||
105776744|NCT01326910|364833360|FG000|Overall Study|Protocol Violation|1|||
105776745|NCT01326910|364833361|FG001|Overall Study|Protocol Violation|1|||
105776746|NCT02036476|364833370|FG000|Overall Study|Withdrawal by Subject|2|||
105776747|NCT02036476|364833370|FG000|Overall Study|Progressive Disease|4|||
105442564|NCT04034004|363626792|FG001|Overall Study|Withdrawal by Subject|2|||
105776748|NCT02036476|364833370|FG000|Overall Study|Unacceptable Toxicity|2|||
105776749|NCT01241318|364833374|FG000|Overall Study|Woman: false pregnancies|27|||
105776750|NCT01241318|364833375|FG001|Overall Study|Woman: false pregnancies|15|||
105776751|NCT01241318|364833374|FG000|Overall Study|Woman: miscarriage/abortion|46|||
105776752|NCT01241318|364833375|FG001|Overall Study|Woman: miscarriage/abortion|38|||
105776753|NCT01241318|364833374|FG000|Overall Study|Withdrawal by Subject|175|||
105776754|NCT01241318|364833375|FG001|Overall Study|Withdrawal by Subject|46|||
105776755|NCT01241318|364833374|FG000|Overall Study|Lost to Follow-up|740|||
105776756|NCT01241318|364833375|FG001|Overall Study|Lost to Follow-up|455|||
105776757|NCT01241318|364833374|FG000|Overall Study|Death|2|||
105776758|NCT01241318|364833375|FG001|Overall Study|Death|4|||
105776759|NCT01241318|364833374|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
105776760|NCT01241318|364833375|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
105776761|NCT01241318|364833374|FG000|Overall Study|Woman: Stillborn infant|129|||
105776762|NCT01241318|364833375|FG001|Overall Study|Woman: Stillborn infant|146|||
105776763|NCT00606021|364833378|FG000|Induction Phase|Death|73|||
105776764|NCT00606021|364833379|FG001|Induction Phase|Death|0|||
105776765|NCT00606021|364833380|FG002|Induction Phase|Death|0|||
105776766|NCT00606021|364833378|FG000|Induction Phase|Physician Decision|2|||
105776767|NCT00606021|364833379|FG001|Induction Phase|Physician Decision|0|||
105776768|NCT00606021|364833380|FG002|Induction Phase|Physician Decision|0|||
105776769|NCT00606021|364833378|FG000|Induction Phase|Withdrawal by Subject|2|||
105776770|NCT00606021|364833379|FG001|Induction Phase|Withdrawal by Subject|0|||
105776771|NCT00606021|364833380|FG002|Induction Phase|Withdrawal by Subject|0|||
105776772|NCT00606021|364833378|FG000|Induction Phase|Lost to Follow-up|10|||
105776773|NCT00606021|364833379|FG001|Induction Phase|Lost to Follow-up|0|||
105776774|NCT00606021|364833380|FG002|Induction Phase|Lost to Follow-up|0|||
105776775|NCT00606021|364833378|FG000|Maintenance Phase|Death|0|||
105776776|NCT00606021|364833379|FG001|Maintenance Phase|Death|17|||
105776777|NCT00606021|364833380|FG002|Maintenance Phase|Death|15|||
105776778|NCT00606021|364833378|FG000|Maintenance Phase|Physician Decision|0|||
105776779|NCT00606021|364833379|FG001|Maintenance Phase|Physician Decision|1|||
105776780|NCT00606021|364833380|FG002|Maintenance Phase|Physician Decision|0|||
105776781|NCT00606021|364833378|FG000|Maintenance Phase|Lost to Follow-up|0|||
105776782|NCT00606021|364833379|FG001|Maintenance Phase|Lost to Follow-up|5|||
105776783|NCT00606021|364833380|FG002|Maintenance Phase|Lost to Follow-up|2|||
105776784|NCT01362049|364833381|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
105776785|NCT01362049|364833382|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
105776786|NCT01362049|364833383|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
105776787|NCT01362049|364833384|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
105776788|NCT01362049|364833381|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
105776789|NCT01362049|364833382|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
105776790|NCT01362049|364833383|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
105776791|NCT01362049|364833384|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
105776792|NCT02853318|364833389|FG000|Overall Study|Withdrawal by Subject|1|||
105776793|NCT00252499|364833390|FG000|Overall Study|Lost to Follow-up|1|||
105776794|NCT00252499|364833391|FG001|Overall Study|Lost to Follow-up|0|||
105776795|NCT00252499|364833392|FG002|Overall Study|Lost to Follow-up|0|||
105776796|NCT00554840|364833397|FG000|Overall Study|Physician Decision|0|||
105776797|NCT00554840|364833398|FG001|Overall Study|Physician Decision|1|||
105776798|NCT01385098|364833399|FG000|Overall Study|Adverse Event|10|||
105776799|NCT01385098|364833399|FG000|Overall Study|Lost to Follow-up|4|||
105776800|NCT01230827|364833400|FG000|Overall Study|Lost to Follow-up|0|||
105776801|NCT01230827|364833401|FG001|Overall Study|Lost to Follow-up|0|||
105776802|NCT01230827|364833402|FG002|Overall Study|Lost to Follow-up|1|||
105776803|NCT01230827|364833403|FG003|Overall Study|Lost to Follow-up|3|||
105776804|NCT01230827|364833400|FG000|Overall Study|Withdrawal by Subject|1|||
105776805|NCT01230827|364833401|FG001|Overall Study|Withdrawal by Subject|0|||
105776806|NCT01230827|364833402|FG002|Overall Study|Withdrawal by Subject|3|||
105776807|NCT01230827|364833403|FG003|Overall Study|Withdrawal by Subject|2|||
105776808|NCT01230827|364833400|FG000|Overall Study|Lack of Efficacy|14|||
105776809|NCT01230827|364833401|FG001|Overall Study|Lack of Efficacy|1|||
105776810|NCT01230827|364833402|FG002|Overall Study|Lack of Efficacy|2|||
105776811|NCT01230827|364833403|FG003|Overall Study|Lack of Efficacy|3|||
105776812|NCT01230827|364833400|FG000|Overall Study|Adverse Event|4|||
105776813|NCT01230827|364833401|FG001|Overall Study|Adverse Event|2|||
105776814|NCT01230827|364833402|FG002|Overall Study|Adverse Event|3|||
105776815|NCT01230827|364833403|FG003|Overall Study|Adverse Event|7|||
105776816|NCT01230827|364833400|FG000|Overall Study|Recovery|0|||
105776817|NCT01230827|364833401|FG001|Overall Study|Recovery|6|||
105776818|NCT01230827|364833402|FG002|Overall Study|Recovery|0|||
105776819|NCT01230827|364833403|FG003|Overall Study|Recovery|0|||
105776820|NCT01230827|364833400|FG000|Overall Study|Study terminated by Sponsor|0|||
105776821|NCT01230827|364833401|FG001|Overall Study|Study terminated by Sponsor|2|||
105776822|NCT01230827|364833402|FG002|Overall Study|Study terminated by Sponsor|56|||
105776823|NCT01230827|364833403|FG003|Overall Study|Study terminated by Sponsor|63|||
105776824|NCT00925522|364833411|FG000|Overall Study|study closed -- business decision|20|||
105776825|NCT01854918|364833414|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
105776826|NCT01854918|364833415|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
105776827|NCT01854918|364833414|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
105776828|NCT01854918|364833415|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
105442565|NCT04034004|363626793|FG002|Overall Study|Withdrawal by Subject|2|||
105776829|NCT01854918|364833414|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
105776830|NCT01854918|364833415|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
105776831|NCT01854918|364833414|FG000|SOC-controlled Period (Year 1)|Death|5|||
105776832|NCT01854918|364833415|FG001|SOC-controlled Period (Year 1)|Death|5|||
105776833|NCT01854918|364833414|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
105776834|NCT01854918|364833415|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
105776835|NCT01854918|364833414|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
105776836|NCT01854918|364833415|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
105776837|NCT01854918|364833414|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
105776838|NCT01854918|364833415|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
105776839|NCT01854918|364833414|FG000|All-IP Period (Years 2 and 3)|Death|5|||
105776840|NCT01854918|364833415|FG001|All-IP Period (Years 2 and 3)|Death|16|||
105776841|NCT02918006|364833417|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
105776842|NCT02918006|364833418|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
105776843|NCT02918006|364833419|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
105776844|NCT02918006|364833417|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
105776845|NCT02918006|364833418|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
105776846|NCT02918006|364833419|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
105776847|NCT02918006|364833417|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
105776848|NCT02918006|364833418|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
105776849|NCT02918006|364833419|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
105776850|NCT02918006|364833417|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
105776851|NCT02918006|364833418|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
105776852|NCT02918006|364833419|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
105776853|NCT02918006|364833417|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
105776854|NCT02918006|364833418|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
105776855|NCT02918006|364833419|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
105776856|NCT02918006|364833417|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
105776857|NCT02918006|364833418|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
105776858|NCT02918006|364833419|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
105776859|NCT02918006|364833417|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
105776860|NCT02918006|364833418|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
105776861|NCT02918006|364833419|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
105776862|NCT02918006|364833417|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
105776863|NCT02918006|364833418|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
105776864|NCT02918006|364833419|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
105776865|NCT02918006|364833417|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
105776866|NCT02918006|364833418|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
105776867|NCT02918006|364833419|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
105776868|NCT00122317|364833420|FG000|Overall Study|Death|3|||
105776869|NCT00122317|364833420|FG000|Overall Study|Adverse Event|4|||
105776870|NCT00122317|364833420|FG000|Overall Study|Physician Decision|2|||
105776871|NCT00122317|364833420|FG000|Overall Study|patient non-compliance|1|||
105776872|NCT00122317|364833420|FG000|Overall Study|Withdrawal by Subject|1|||
105776873|NCT02886338|364833421|FG000|Overall Study|Withdrawal by Subject|1|||
105776874|NCT00394654|364833422|FG000|Overall Study|Lost to Follow-up|1|||
105776875|NCT00394654|364833423|FG001|Overall Study|Lost to Follow-up|0|||
105776876|NCT00394654|364833422|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
105776877|NCT00394654|364833423|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
105776878|NCT00656799|364833424|FG000|Overall Study|Death|2|||
105776879|NCT00027027|364835692|FG000|Overall Study|Adverse Event|0|||
105776880|NCT00027027|364835693|FG001|Overall Study|Adverse Event|0|||
105776881|NCT00027027|364835694|FG002|Overall Study|Adverse Event|1|||
105776882|NCT00027027|364835695|FG003|Overall Study|Adverse Event|0|||
105776883|NCT00027027|364835696|FG004|Overall Study|Adverse Event|1|||
105776884|NCT00027027|364835692|FG000|Overall Study|Admitted for Signs of PD|0|||
105776885|NCT00027027|364835693|FG001|Overall Study|Admitted for Signs of PD|0|||
105776886|NCT00027027|364835694|FG002|Overall Study|Admitted for Signs of PD|0|||
105776887|NCT00027027|364835695|FG003|Overall Study|Admitted for Signs of PD|0|||
105776888|NCT00027027|364835696|FG004|Overall Study|Admitted for Signs of PD|1|||
105776889|NCT00027027|364835692|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
105776890|NCT00027027|364835693|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
105776891|NCT00027027|364835694|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
105776892|NCT00027027|364835695|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
105776893|NCT00027027|364835696|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
105776894|NCT00027027|364835692|FG000|Overall Study|PD Requiring Surgery|0|||
105776895|NCT00027027|364835693|FG001|Overall Study|PD Requiring Surgery|0|||
105776896|NCT00027027|364835694|FG002|Overall Study|PD Requiring Surgery|1|||
105776897|NCT00027027|364835695|FG003|Overall Study|PD Requiring Surgery|0|||
105776898|NCT00027027|364835696|FG004|Overall Study|PD Requiring Surgery|0|||
105776899|NCT00027027|364835692|FG000|Overall Study|Physician Decision Due To PD|2|||
105776900|NCT00027027|364835693|FG001|Overall Study|Physician Decision Due To PD|3|||
105776901|NCT00027027|364835694|FG002|Overall Study|Physician Decision Due To PD|2|||
105776902|NCT00027027|364835695|FG003|Overall Study|Physician Decision Due To PD|3|||
105776903|NCT00027027|364835696|FG004|Overall Study|Physician Decision Due To PD|5|||
105776904|NCT00027027|364835692|FG000|Overall Study|Withdrawal by Subject|0|||
105776905|NCT00027027|364835693|FG001|Overall Study|Withdrawal by Subject|0|||
105776906|NCT00027027|364835694|FG002|Overall Study|Withdrawal by Subject|0|||
105776907|NCT00027027|364835695|FG003|Overall Study|Withdrawal by Subject|0|||
105776908|NCT00027027|364835696|FG004|Overall Study|Withdrawal by Subject|1|||
105776909|NCT03758612|364835699|FG000|Washout Period|Withdrawal by Subject|0|||
105776910|NCT03758612|364835700|FG001|Washout Period|Withdrawal by Subject|0|||
105776911|NCT03758612|364835701|FG002|Washout Period|Withdrawal by Subject|2|||
105776912|NCT03758612|364835702|FG003|Washout Period|Withdrawal by Subject|0|||
105776913|NCT03758612|364835703|FG004|Washout Period|Withdrawal by Subject|0|||
105776914|NCT03758612|364835704|FG005|Washout Period|Withdrawal by Subject|0|||
105776915|NCT03758612|364835705|FG006|Washout Period|Withdrawal by Subject|0|||
105776916|NCT03758612|364835706|FG007|Washout Period|Withdrawal by Subject|0|||
105776917|NCT03758612|364835707|FG008|Washout Period|Withdrawal by Subject|0|||
105776918|NCT03758612|364835708|FG009|Washout Period|Withdrawal by Subject|0|||
105776919|NCT03758612|364835709|FG010|Washout Period|Withdrawal by Subject|0|||
105776920|NCT03758612|364835710|FG011|Washout Period|Withdrawal by Subject|0|||
105776921|NCT03758612|364835699|FG000|Period 2|Protocol Violation|0|||
105776922|NCT03758612|364835700|FG001|Period 2|Protocol Violation|0|||
105776923|NCT03758612|364835701|FG002|Period 2|Protocol Violation|0|||
105776924|NCT03758612|364835702|FG003|Period 2|Protocol Violation|0|||
105776925|NCT03758612|364835703|FG004|Period 2|Protocol Violation|1|||
105776926|NCT03758612|364835704|FG005|Period 2|Protocol Violation|0|||
105776927|NCT03758612|364835705|FG006|Period 2|Protocol Violation|0|||
105776928|NCT03758612|364835706|FG007|Period 2|Protocol Violation|0|||
105776929|NCT03758612|364835707|FG008|Period 2|Protocol Violation|0|||
105776930|NCT03758612|364835708|FG009|Period 2|Protocol Violation|0|||
105776931|NCT03758612|364835709|FG010|Period 2|Protocol Violation|0|||
105776932|NCT03758612|364835710|FG011|Period 2|Protocol Violation|0|||
105776933|NCT01967134|364835711|FG000|Overall Study|Lost to Follow-up|0|||
105776934|NCT01967134|364835712|FG001|Overall Study|Lost to Follow-up|1|||
105776935|NCT01967134|364835713|FG002|Overall Study|Lost to Follow-up|0|||
105776936|NCT05158244|364835718|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
105776937|NCT05158244|364835719|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
105776938|NCT05158244|364835720|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
105776939|NCT05158244|364835721|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
105776940|NCT05158244|364835722|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
105776941|NCT05158244|364835718|FG000|Overall Study|Withdrawal by Subject|0|||
105776942|NCT05158244|364835719|FG001|Overall Study|Withdrawal by Subject|0|||
105776943|NCT05158244|364835720|FG002|Overall Study|Withdrawal by Subject|1|||
105776944|NCT05158244|364835721|FG003|Overall Study|Withdrawal by Subject|0|||
105776945|NCT05158244|364835722|FG004|Overall Study|Withdrawal by Subject|0|||
105776946|NCT00125138|364835723|FG000|Overall Study|Adverse Event|1|||
105776947|NCT00125138|364835724|FG001|Overall Study|Adverse Event|0|||
105776948|NCT00125138|364835725|FG002|Overall Study|Adverse Event|3|||
105776949|NCT00125138|364835726|FG003|Overall Study|Adverse Event|2|||
105776950|NCT00125138|364835723|FG000|Overall Study|Withdrawal by Subject|2|||
105776951|NCT00125138|364835724|FG001|Overall Study|Withdrawal by Subject|3|||
105776952|NCT00125138|364835725|FG002|Overall Study|Withdrawal by Subject|1|||
105776953|NCT00125138|364835726|FG003|Overall Study|Withdrawal by Subject|1|||
105776954|NCT00125138|364835723|FG000|Overall Study|Lack of Efficacy|0|||
105776955|NCT00125138|364835724|FG001|Overall Study|Lack of Efficacy|0|||
105776956|NCT00125138|364835725|FG002|Overall Study|Lack of Efficacy|0|||
105776957|NCT00125138|364835726|FG003|Overall Study|Lack of Efficacy|1|||
105776958|NCT00125138|364835723|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
105776959|NCT00125138|364835724|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
105776960|NCT00125138|364835725|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
105776961|NCT00125138|364835726|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
105776962|NCT02630459|364835727|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
105776963|NCT02630459|364835728|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
105776964|NCT02630459|364835729|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
105776965|NCT02630459|364835730|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
105776966|NCT02630459|364835731|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
105776967|NCT02630459|364835732|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
105776968|NCT02630459|364835733|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
105776969|NCT02630459|364835734|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
105776970|NCT02630459|364835727|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
105776971|NCT02630459|364835728|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
105776972|NCT02630459|364835729|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
105776973|NCT02630459|364835730|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
105776974|NCT02630459|364835731|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
105776975|NCT02630459|364835732|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
105776976|NCT02630459|364835733|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
105776977|NCT02630459|364835734|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
105776978|NCT02630459|364835727|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
105776979|NCT02630459|364835728|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
105776980|NCT02630459|364835729|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
105776981|NCT02630459|364835730|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
105776982|NCT02630459|364835731|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
105776983|NCT02630459|364835732|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
105776984|NCT02630459|364835733|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
105776985|NCT02630459|364835734|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
105776986|NCT02630459|364835727|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
105776987|NCT02630459|364835728|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
105776988|NCT02630459|364835729|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
105776989|NCT02630459|364835730|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
105776990|NCT02630459|364835731|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
105776991|NCT02630459|364835732|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
105776992|NCT02630459|364835733|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
105776993|NCT02630459|364835734|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
105776994|NCT02630459|364835727|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
105776995|NCT02630459|364835728|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
105776996|NCT02630459|364835729|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
105776997|NCT02630459|364835730|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
105776998|NCT02630459|364835731|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
105776999|NCT02630459|364835732|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
105777000|NCT02630459|364835733|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
105777001|NCT02630459|364835734|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
105777002|NCT02630459|364835727|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
105777003|NCT02630459|364835728|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
105777004|NCT02630459|364835729|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
105777005|NCT02630459|364835730|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
105777006|NCT02630459|364835731|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
105777007|NCT02630459|364835732|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
105777008|NCT02630459|364835733|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
105777009|NCT02630459|364835734|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
105777010|NCT02630459|364835727|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
105777011|NCT02630459|364835728|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
105777012|NCT02630459|364835729|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
105777013|NCT02630459|364835730|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
105777014|NCT02630459|364835731|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
105777015|NCT02630459|364835732|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
105777016|NCT02630459|364835733|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
105777017|NCT02630459|364835734|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
105777018|NCT01453439|364835735|FG000|Treatment Phase|Withdrawal by Subject|13|||
105777019|NCT01453439|364835736|FG001|Treatment Phase|Withdrawal by Subject|10|||
105777020|NCT01453439|364835735|FG000|Treatment Phase|Suicidal Ideation|2|||
105777021|NCT01453439|364835736|FG001|Treatment Phase|Suicidal Ideation|0|||
105777022|NCT01453439|364835735|FG000|Treatment Phase|Need for higher level of care|1|||
105777023|NCT01453439|364835736|FG001|Treatment Phase|Need for higher level of care|1|||
105777024|NCT01453439|364835735|FG000|Treatment Phase|Therapist conflict of interest|1|||
105777025|NCT01453439|364835736|FG001|Treatment Phase|Therapist conflict of interest|0|||
105777026|NCT01453439|364835735|FG000|Follow-up|Withdrawal by Subject|0|||
105777027|NCT01453439|364835736|FG001|Follow-up|Withdrawal by Subject|1|||
105777028|NCT01453439|364835735|FG000|Follow-up|Lost to Follow-up|5|||
105777029|NCT01453439|364835736|FG001|Follow-up|Lost to Follow-up|10|||
105777030|NCT00568399|364835743|FG000|Overall Study|Death|2|||
105777031|NCT00568399|364835743|FG000|Overall Study|Adverse Event|5|||
105777032|NCT00568399|364835743|FG000|Overall Study|Withdrawal by Subject|8|||
105777033|NCT02967562|364835750|FG000|Overall Study|Consent not obtained|1|||
105777034|NCT02967562|364835751|FG001|Overall Study|Consent not obtained|0|||
105777035|NCT02967562|364835750|FG000|Overall Study|High leak precluding analysis|1|||
105777036|NCT02967562|364835751|FG001|Overall Study|High leak precluding analysis|1|||
105777037|NCT00089505|364835752|FG000|Overall Study|Death|4|||
105777038|NCT00089505|364835753|FG001|Overall Study|Death|1|||
105777039|NCT00089505|364835754|FG002|Overall Study|Death|5|||
105777040|NCT00089505|364835755|FG003|Overall Study|Death|8|||
105777041|NCT00089505|364835752|FG000|Overall Study|Withdrawal by Subject|3|||
105777042|NCT00089505|364835753|FG001|Overall Study|Withdrawal by Subject|0|||
105777043|NCT00089505|364835754|FG002|Overall Study|Withdrawal by Subject|6|||
105777044|NCT00089505|364835755|FG003|Overall Study|Withdrawal by Subject|6|||
105777045|NCT00089505|364835752|FG000|Overall Study|Lost to Follow-up|1|||
105777046|NCT00089505|364835753|FG001|Overall Study|Lost to Follow-up|1|||
105777047|NCT00089505|364835754|FG002|Overall Study|Lost to Follow-up|9|||
105777048|NCT00089505|364835755|FG003|Overall Study|Lost to Follow-up|7|||
105777049|NCT00089505|364835752|FG000|Overall Study|Physician Decision|1|||
105777050|NCT00089505|364835753|FG001|Overall Study|Physician Decision|0|||
105777051|NCT00089505|364835754|FG002|Overall Study|Physician Decision|0|||
105777052|NCT00089505|364835755|FG003|Overall Study|Physician Decision|0|||
105777053|NCT00089505|364835752|FG000|Overall Study|Protocol Violation|0|||
105777054|NCT00089505|364835753|FG001|Overall Study|Protocol Violation|0|||
105777055|NCT00089505|364835754|FG002|Overall Study|Protocol Violation|1|||
105777056|NCT00089505|364835755|FG003|Overall Study|Protocol Violation|0|||
105777057|NCT02519777|364835756|FG000|Overall Study|Death|1|||
105777058|NCT02519777|364835757|FG001|Overall Study|Death|0|||
105777059|NCT02519777|364835758|FG002|Overall Study|Death|0|||
105777060|NCT02519777|364835756|FG000|Overall Study|Lost to Follow-up|0|||
105777061|NCT02519777|364835757|FG001|Overall Study|Lost to Follow-up|4|||
105777062|NCT02519777|364835758|FG002|Overall Study|Lost to Follow-up|2|||
105777063|NCT02519777|364835756|FG000|Overall Study|Withdrawal by Subject|3|||
105777064|NCT02519777|364835757|FG001|Overall Study|Withdrawal by Subject|1|||
105777065|NCT02519777|364835758|FG002|Overall Study|Withdrawal by Subject|0|||
105777066|NCT02519777|364835756|FG000|Overall Study|Severe Debilitation|1|||
105777067|NCT02519777|364835757|FG001|Overall Study|Severe Debilitation|1|||
105777068|NCT02519777|364835758|FG002|Overall Study|Severe Debilitation|1|||
105777069|NCT02519777|364835756|FG000|Overall Study|Not able to get to clinic|1|||
105777070|NCT02519777|364835757|FG001|Overall Study|Not able to get to clinic|2|||
105777071|NCT02519777|364835758|FG002|Overall Study|Not able to get to clinic|1|||
105777072|NCT02195531|364835759|FG000|Overall Study|Withdrawal by Subject|1|||
105777073|NCT02195531|364835760|FG001|Overall Study|Withdrawal by Subject|1|||
105777074|NCT02195531|364835761|FG002|Overall Study|Withdrawal by Subject|1|||
105777075|NCT01038635|364835762|FG000|Overall Study|Disease Progression|2|||
105777076|NCT01038635|364835763|FG001|Overall Study|Disease Progression|0|||
105777077|NCT01038635|364835764|FG002|Overall Study|Disease Progression|0|||
105777078|NCT01038635|364835765|FG003|Overall Study|Disease Progression|0|||
105777079|NCT01038635|364835766|FG004|Overall Study|Disease Progression|0|||
105777080|NCT01038635|364835767|FG005|Overall Study|Disease Progression|0|||
105777081|NCT01038635|364835768|FG006|Overall Study|Disease Progression|1|||
105777082|NCT01038635|364835769|FG007|Overall Study|Disease Progression|4|||
105777083|NCT01038635|364835770|FG008|Overall Study|Disease Progression|0|||
105777084|NCT01038635|364835762|FG000|Overall Study|Death|0|||
105777085|NCT01038635|364835763|FG001|Overall Study|Death|0|||
105777086|NCT01038635|364835764|FG002|Overall Study|Death|0|||
105777087|NCT01038635|364835765|FG003|Overall Study|Death|0|||
105777088|NCT01038635|364835766|FG004|Overall Study|Death|1|||
105777089|NCT01038635|364835767|FG005|Overall Study|Death|0|||
105777090|NCT01038635|364835768|FG006|Overall Study|Death|1|||
105777091|NCT01038635|364835769|FG007|Overall Study|Death|1|||
105777092|NCT01038635|364835770|FG008|Overall Study|Death|2|||
105777093|NCT01562327|364835771|FG000|Overall Study|Adverse Event|2|||
105777094|NCT01562327|364835771|FG000|Overall Study|Lack of Efficacy|1|||
105777095|NCT01562327|364835771|FG000|Overall Study|Participant drop-out|1|||
105777096|NCT01562327|364835771|FG000|Overall Study|Infusion not received at 6 month window|4|||
105777097|NCT01836549|364835772|FG000|Overall Study|Did not receive study drug|0|||
105777098|NCT01836549|364835773|FG001|Overall Study|Did not receive study drug|0|||
105777099|NCT01836549|364835774|FG002|Overall Study|Did not receive study drug|1|||
105777100|NCT01836549|364835775|FG003|Overall Study|Did not receive study drug|0|||
105777101|NCT01836549|364835776|FG004|Overall Study|Did not receive study drug|0|||
105777102|NCT01836549|364835777|FG005|Overall Study|Did not receive study drug|0|||
105777103|NCT01836549|364835778|FG006|Overall Study|Did not receive study drug|0|||
105777104|NCT01836549|364835772|FG000|Overall Study|Patient declared ineligible|0|||
105777105|NCT01836549|364835773|FG001|Overall Study|Patient declared ineligible|0|||
105777106|NCT01836549|364835774|FG002|Overall Study|Patient declared ineligible|0|||
105777107|NCT01836549|364835775|FG003|Overall Study|Patient declared ineligible|1|||
105777108|NCT01836549|364835776|FG004|Overall Study|Patient declared ineligible|0|||
105777109|NCT01836549|364835777|FG005|Overall Study|Patient declared ineligible|0|||
105777110|NCT01836549|364835778|FG006|Overall Study|Patient declared ineligible|0|||
105777111|NCT01836549|364835772|FG000|Overall Study|Patient inevaluable to start therapy|0|||
105777112|NCT01836549|364835773|FG001|Overall Study|Patient inevaluable to start therapy|0|||
105777113|NCT01836549|364835774|FG002|Overall Study|Patient inevaluable to start therapy|0|||
105777114|NCT01836549|364835775|FG003|Overall Study|Patient inevaluable to start therapy|0|||
105777115|NCT01836549|364835776|FG004|Overall Study|Patient inevaluable to start therapy|0|||
105777116|NCT01836549|364835777|FG005|Overall Study|Patient inevaluable to start therapy|0|||
105777117|NCT01836549|364835778|FG006|Overall Study|Patient inevaluable to start therapy|1|||
105777118|NCT01969565|364835781|FG000|Overall Study|Withdrawal by Subject|1|||
105777119|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Adverse Event|30|||
105777120|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Adverse Event|25|||
105777121|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Adverse Event|23|||
105777122|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Adverse Event|14|||
105777123|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Death|0|||
105777124|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Death|0|||
105777125|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Death|1|||
105777126|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Death|0|||
105777127|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Physician Decision|0|||
105777128|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Physician Decision|1|||
105777129|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Physician Decision|0|||
105777130|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Physician Decision|1|||
105777131|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
105777132|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
105777133|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
105777134|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
105777135|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Other|6|||
105777136|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Other|1|||
105777137|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Other|0|||
105777138|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Other|2|||
105777139|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
105777140|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
105777141|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
105777142|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
105777143|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
105777144|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
105777145|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
105777146|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
105777147|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
105777148|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
105777149|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
105777150|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
105777151|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
105777152|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
105777153|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
105777154|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
105777155|NCT00242710|364835782|FG000|Period Between Core Study and Extension|Adverse Event|2|||
105777156|NCT00242710|364835783|FG001|Period Between Core Study and Extension|Adverse Event|3|||
105777157|NCT00242710|364835784|FG002|Period Between Core Study and Extension|Adverse Event|5|||
105777158|NCT00242710|364835785|FG003|Period Between Core Study and Extension|Adverse Event|2|||
105777159|NCT00242710|364835782|FG000|Period Between Core Study and Extension|Physician Decision|1|||
105777160|NCT00242710|364835783|FG001|Period Between Core Study and Extension|Physician Decision|1|||
105777161|NCT00242710|364835784|FG002|Period Between Core Study and Extension|Physician Decision|0|||
105777162|NCT00242710|364835785|FG003|Period Between Core Study and Extension|Physician Decision|0|||
105777163|NCT00242710|364835782|FG000|Period Between Core Study and Extension|Other|24|||
105777164|NCT00242710|364835783|FG001|Period Between Core Study and Extension|Other|24|||
105777165|NCT00242710|364835784|FG002|Period Between Core Study and Extension|Other|9|||
105777166|NCT00242710|364835785|FG003|Period Between Core Study and Extension|Other|11|||
105777167|NCT00242710|364835782|FG000|Period Between Core Study and Extension|Extension not Available|17|||
105777168|NCT00242710|364835783|FG001|Period Between Core Study and Extension|Extension not Available|21|||
105777169|NCT00242710|364835784|FG002|Period Between Core Study and Extension|Extension not Available|8|||
105777170|NCT00242710|364835785|FG003|Period Between Core Study and Extension|Extension not Available|7|||
105777171|NCT00242710|364835782|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
105777172|NCT00242710|364835783|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
105777173|NCT00242710|364835784|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
105777174|NCT00242710|364835785|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
105777175|NCT00242710|364835782|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
105777176|NCT00242710|364835783|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
105777177|NCT00242710|364835784|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
105777178|NCT00242710|364835785|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
105777179|NCT00242710|364835782|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
105777180|NCT00242710|364835783|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
105777181|NCT00242710|364835784|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
105777182|NCT00242710|364835785|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
105777183|NCT00242710|364835782|FG000|Study Extension (up to Year 2)|Death|0|||
105777184|NCT00242710|364835783|FG001|Study Extension (up to Year 2)|Death|0|||
105777185|NCT00242710|364835784|FG002|Study Extension (up to Year 2)|Death|0|||
105777186|NCT00242710|364835785|FG003|Study Extension (up to Year 2)|Death|1|||
105777187|NCT00242710|364835782|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
105777188|NCT00242710|364835783|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
105777189|NCT00242710|364835784|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
105777190|NCT00242710|364835785|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
105777191|NCT00242710|364835782|FG000|Study Extension (up to Year 2)|Other|3|||
105777192|NCT00242710|364835783|FG001|Study Extension (up to Year 2)|Other|5|||
105777193|NCT00242710|364835784|FG002|Study Extension (up to Year 2)|Other|4|||
105777194|NCT00242710|364835785|FG003|Study Extension (up to Year 2)|Other|3|||
105777195|NCT00242710|364835782|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
105777196|NCT00242710|364835783|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
105777197|NCT00242710|364835784|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
105777198|NCT00242710|364835785|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
105777199|NCT00242710|364835782|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
105777200|NCT00242710|364835783|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
105777201|NCT00242710|364835784|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
105777202|NCT00242710|364835785|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
105777203|NCT01683058|364835789|FG000|Overall Study|Lost to Follow-up|9|||
105777204|NCT01683058|364835789|FG000|Overall Study|Adverse Event|6|||
105777205|NCT01683058|364835789|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
105777206|NCT01683058|364835789|FG000|Overall Study|Withdrawal by Subject|7|||
105777207|NCT01683058|364835789|FG000|Overall Study|Lack of Efficacy|2|||
105777208|NCT01957111|364835790|FG000|Overall Study|Withdrawal by Subject|1|||
105777209|NCT01957111|364835791|FG001|Overall Study|Withdrawal by Subject|1|||
105777210|NCT00203294|364835794|FG000|Overall Study|Withdrawal by Subject|8|||
105777211|NCT00203294|364835795|FG001|Overall Study|Withdrawal by Subject|13|||
105777212|NCT00082628|364835796|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
105777213|NCT00082628|364835797|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
105777214|NCT00082628|364835798|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
105777215|NCT00082628|364835799|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
105777216|NCT00082628|364835800|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
105777217|NCT00082628|364835796|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
105777218|NCT00082628|364835797|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
105777219|NCT00082628|364835798|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
105777220|NCT00082628|364835799|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
105777221|NCT00082628|364835800|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
105777222|NCT00082628|364835796|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
105777223|NCT00082628|364835797|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
105777224|NCT00082628|364835798|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
105777225|NCT00082628|364835799|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
105777226|NCT00082628|364835800|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
105777227|NCT00082628|364835796|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
105777228|NCT00082628|364835797|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
105777229|NCT00082628|364835798|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
105777230|NCT00082628|364835799|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
105777231|NCT00082628|364835800|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
105777232|NCT00082628|364835796|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
105777233|NCT00082628|364835797|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
105777234|NCT00082628|364835798|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
105777235|NCT00082628|364835799|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
105777236|NCT00082628|364835800|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
105777237|NCT00082628|364835796|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
105777238|NCT00082628|364835797|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
105777239|NCT00082628|364835798|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
105777240|NCT00082628|364835799|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
105777241|NCT00082628|364835800|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
105777242|NCT00082628|364835796|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
105777243|NCT00082628|364835797|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
105777244|NCT00082628|364835798|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
105777245|NCT00082628|364835799|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
105777246|NCT00082628|364835800|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
105777247|NCT00550615|364835801|FG000|Overall Study|Withdrawal by Subject|0|||
105777248|NCT00550615|364835802|FG001|Overall Study|Withdrawal by Subject|0|||
105442566|NCT04034004|363626794|FG003|Overall Study|Withdrawal by Subject|3|||
105442567|NCT04034004|363626791|FG000|Overall Study|could not find vein to administer IV|2|||
105777249|NCT00550615|364835803|FG002|Overall Study|Withdrawal by Subject|2|||
105777250|NCT00550615|364835804|FG003|Overall Study|Withdrawal by Subject|3|||
105777251|NCT00550615|364835801|FG000|Overall Study|Not evaluable|0|||
105777252|NCT00550615|364835802|FG001|Overall Study|Not evaluable|0|||
105777253|NCT00550615|364835803|FG002|Overall Study|Not evaluable|2|||
105777254|NCT00550615|364835804|FG003|Overall Study|Not evaluable|7|||
105777255|NCT02405091|364835805|FG000|Overall Study|Adverse Event|16|||
105777256|NCT02405091|364835806|FG001|Overall Study|Adverse Event|10|||
105777257|NCT02405091|364835807|FG002|Overall Study|Adverse Event|0|||
105777258|NCT02405091|364835805|FG000|Overall Study|Protocol Violation|1|||
105777259|NCT02405091|364835806|FG001|Overall Study|Protocol Violation|0|||
105777260|NCT02405091|364835807|FG002|Overall Study|Protocol Violation|0|||
105777261|NCT02405091|364835805|FG000|Overall Study|Noncompliance|1|||
105777262|NCT02405091|364835806|FG001|Overall Study|Noncompliance|6|||
105777263|NCT02405091|364835807|FG002|Overall Study|Noncompliance|2|||
105777264|NCT02405091|364835805|FG000|Overall Study|Withdrawal by Subject|4|||
105777265|NCT02405091|364835806|FG001|Overall Study|Withdrawal by Subject|8|||
105777266|NCT02405091|364835807|FG002|Overall Study|Withdrawal by Subject|0|||
105777267|NCT02405091|364835805|FG000|Overall Study|Death|0|||
105777268|NCT02405091|364835806|FG001|Overall Study|Death|1|||
105777269|NCT02405091|364835807|FG002|Overall Study|Death|0|||
105777270|NCT02405091|364835805|FG000|Overall Study|Lost to Follow-up|5|||
105777271|NCT02405091|364835806|FG001|Overall Study|Lost to Follow-up|6|||
105777272|NCT02405091|364835807|FG002|Overall Study|Lost to Follow-up|0|||
105777273|NCT02405091|364835805|FG000|Overall Study|Physician Decision|2|||
105777274|NCT02405091|364835806|FG001|Overall Study|Physician Decision|2|||
105777275|NCT02405091|364835807|FG002|Overall Study|Physician Decision|0|||
105777276|NCT04491591|364835808|FG000|Overall Study|Accidently randomized|3|||
105777277|NCT04491591|364835809|FG001|Overall Study|Accidently randomized|1|||
105777278|NCT04491591|364835810|FG002|Overall Study|Accidently randomized|0|||
105777279|NCT04491591|364835808|FG000|Overall Study|Did not complete survey|28|||
105777280|NCT04491591|364835809|FG001|Overall Study|Did not complete survey|20|||
105777281|NCT04491591|364835810|FG002|Overall Study|Did not complete survey|3|||
105777282|NCT03480360|364835811|FG000|Overall Study|Death|2|||
105777283|NCT00523744|364835815|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
105777284|NCT00523744|364835815|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
105777285|NCT00523744|364835815|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
105777286|NCT00523744|364835815|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
105777287|NCT00523744|364835815|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
105777288|NCT00523744|364835815|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
105777289|NCT00636506|364835816|FG000|Overall Study|Lost to Follow-up|8|||
105777290|NCT00636506|364835816|FG000|Overall Study|Explanted|1|||
105777291|NCT00636506|364835816|FG000|Overall Study|Withdrawal by Subject|6|||
105777292|NCT00636506|364835816|FG000|Overall Study|Procedure aborted|1|||
105777293|NCT03742271|364835817|FG000|Overall Study|Unsatisfactory Visual Response|1|||
105777294|NCT03742271|364835817|FG000|Overall Study|Withdrawal by Subject|3|||
105777295|NCT03742271|364835817|FG000|Overall Study|Lost to Follow-up|4|||
105777296|NCT03742271|364835817|FG000|Overall Study|Failed Insertion & removal|3|||
105777297|NCT03742271|364835817|FG000|Overall Study|Protocol Violation|1|||
105777298|NCT01624974|364835818|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
105777299|NCT01624974|364835819|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
105777300|NCT01624974|364835818|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
105777301|NCT01624974|364835819|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
105777302|NCT01624974|364835818|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
105777303|NCT01624974|364835819|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
105777304|NCT01624974|364835818|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
105777305|NCT01624974|364835819|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
105777306|NCT01624974|364835818|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
105777307|NCT01624974|364835819|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
105777308|NCT01624974|364835818|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
105777309|NCT01624974|364835819|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
105777310|NCT01624974|364835818|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
105777311|NCT01624974|364835819|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
105777312|NCT01624974|364835818|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
105777313|NCT01624974|364835819|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
105777314|NCT01624974|364835818|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
105777315|NCT01624974|364835819|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
105777316|NCT01624974|364835818|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
105334071|NCT01314872|363223080|FG010|Treatment Period 1|Lack of Efficacy|0|||
105334072|NCT01314872|363223081|FG011|Treatment Period 1|Lack of Efficacy|0|||
105777317|NCT01624974|364835819|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
105777318|NCT01624974|364835818|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
105777319|NCT01624974|364835819|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
105777320|NCT01624974|364835818|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
105777321|NCT01624974|364835819|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
105777322|NCT00957034|364835820|FG000|Overall Study|Adverse Event|0|||
105777323|NCT00957034|364835821|FG001|Overall Study|Adverse Event|1|||
105777324|NCT00957034|364835822|FG002|Overall Study|Adverse Event|1|||
105777325|NCT00957034|364835820|FG000|Overall Study|Sponsor Terminated Study|6|||
105777326|NCT00957034|364835821|FG001|Overall Study|Sponsor Terminated Study|1|||
105777327|NCT00957034|364835822|FG002|Overall Study|Sponsor Terminated Study|5|||
105777328|NCT00957034|364835820|FG000|Overall Study|Withdrawal by Subject|0|||
105777329|NCT00957034|364835821|FG001|Overall Study|Withdrawal by Subject|2|||
105777330|NCT00957034|364835822|FG002|Overall Study|Withdrawal by Subject|0|||
105777331|NCT02607735|364835823|FG000|Primary Study|Randomized but Never Treated|1|||
105777332|NCT02607735|364835824|FG001|Primary Study|Randomized but Never Treated|0|||
105777333|NCT02607735|364835825|FG002|Primary Study|Randomized but Never Treated|0|||
105777334|NCT02607735|364835823|FG000|Primary Study|Lost to Follow-up|4|||
105777335|NCT02607735|364835824|FG001|Primary Study|Lost to Follow-up|0|||
105777336|NCT02607735|364835825|FG002|Primary Study|Lost to Follow-up|0|||
105777337|NCT02607735|364835823|FG000|Primary Study|Withdrew Consent|2|||
105777338|NCT02607735|364835824|FG001|Primary Study|Withdrew Consent|0|||
105777339|NCT02607735|364835825|FG002|Primary Study|Withdrew Consent|0|||
105777340|NCT02607735|364835823|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
105777341|NCT02607735|364835824|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
105777342|NCT02607735|364835825|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
105777343|NCT02607735|364835823|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
105777344|NCT02607735|364835824|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
105777345|NCT02607735|364835825|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
105777346|NCT00957723|364835828|FG000|Overall Study|Death|3|||
105777347|NCT00957723|364835828|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
105777348|NCT00957723|364835828|FG000|Overall Study|Lost to Follow-up|8|||
105777349|NCT00957723|364835828|FG000|Overall Study|Withdrawal by Subject|24|||
105777350|NCT00957723|364835828|FG000|Overall Study|Investigative Site Terminated|61|||
105777351|NCT00957723|364835828|FG000|Overall Study|Intercurrent Illness|2|||
105777352|NCT00957723|364835828|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
105777353|NCT05375838|364835829|FG000|Overall Study|Other|0|||
105777354|NCT05375838|364835830|FG001|Overall Study|Other|0|||
105777355|NCT05375838|364835831|FG002|Overall Study|Other|0|||
105777356|NCT05375838|364835832|FG003|Overall Study|Other|1|||
105777357|NCT05375838|364835833|FG004|Overall Study|Other|1|||
105777358|NCT05375838|364835834|FG005|Overall Study|Other|0|||
105777359|NCT05375838|364835829|FG000|Overall Study|Withdrawal by Subject|2|||
105777360|NCT05375838|364835830|FG001|Overall Study|Withdrawal by Subject|1|||
105777361|NCT05375838|364835831|FG002|Overall Study|Withdrawal by Subject|3|||
105777362|NCT05375838|364835832|FG003|Overall Study|Withdrawal by Subject|2|||
105777363|NCT05375838|364835833|FG004|Overall Study|Withdrawal by Subject|2|||
105777364|NCT05375838|364835834|FG005|Overall Study|Withdrawal by Subject|0|||
105777365|NCT05375838|364835829|FG000|Overall Study|Protocol Violation|0|||
105777366|NCT05375838|364835830|FG001|Overall Study|Protocol Violation|0|||
105777367|NCT05375838|364835831|FG002|Overall Study|Protocol Violation|0|||
105777368|NCT05375838|364835832|FG003|Overall Study|Protocol Violation|0|||
105777369|NCT05375838|364835833|FG004|Overall Study|Protocol Violation|1|||
105777370|NCT05375838|364835834|FG005|Overall Study|Protocol Violation|0|||
105777371|NCT05375838|364835829|FG000|Overall Study|Physician Decision|0|||
105777372|NCT05375838|364835830|FG001|Overall Study|Physician Decision|1|||
105777373|NCT05375838|364835831|FG002|Overall Study|Physician Decision|0|||
105777374|NCT05375838|364835832|FG003|Overall Study|Physician Decision|0|||
105777375|NCT05375838|364835833|FG004|Overall Study|Physician Decision|0|||
105777376|NCT05375838|364835834|FG005|Overall Study|Physician Decision|1|||
105777377|NCT05375838|364835829|FG000|Overall Study|Lost to Follow-up|2|||
105777378|NCT05375838|364835830|FG001|Overall Study|Lost to Follow-up|7|||
105777379|NCT05375838|364835831|FG002|Overall Study|Lost to Follow-up|0|||
105777380|NCT05375838|364835832|FG003|Overall Study|Lost to Follow-up|4|||
105777381|NCT05375838|364835833|FG004|Overall Study|Lost to Follow-up|2|||
105777382|NCT05375838|364835834|FG005|Overall Study|Lost to Follow-up|3|||
105777383|NCT00877890|364835835|FG000|Overall Study|Adverse Event|6|||
105777384|NCT00877890|364835836|FG001|Overall Study|Adverse Event|6|||
105777385|NCT00877890|364835835|FG000|Overall Study|Lost to Follow-up|5|||
105777386|NCT00877890|364835836|FG001|Overall Study|Lost to Follow-up|5|||
105777387|NCT00877890|364835835|FG000|Overall Study|Protocol Violation|0|||
105777388|NCT00877890|364835836|FG001|Overall Study|Protocol Violation|1|||
105777389|NCT00877890|364835835|FG000|Overall Study|Withdrawal of Consent|6|||
105777390|NCT00877890|364835836|FG001|Overall Study|Withdrawal of Consent|12|||
105777391|NCT00877890|364835835|FG000|Overall Study|Investigator Decision|0|||
105777392|NCT00877890|364835836|FG001|Overall Study|Investigator Decision|2|||
105777393|NCT00877890|364835835|FG000|Overall Study|Loss of Glucose Control|3|||
105777394|NCT00877890|364835836|FG001|Overall Study|Loss of Glucose Control|4|||
105777395|NCT00984009|364835837|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
105777396|NCT00281528|364835838|FG000|Overall Study|Progressive Disease|28|||
105777397|NCT00281528|364835839|FG001|Overall Study|Progressive Disease|18|||
105777398|NCT00281528|364835840|FG002|Overall Study|Progressive Disease|27|||
105777399|NCT00281528|364835838|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
105777400|NCT00281528|364835839|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
105777401|NCT00281528|364835840|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
105777402|NCT00281528|364835838|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
105777403|NCT00281528|364835839|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
105777404|NCT00281528|364835840|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
105777405|NCT00281528|364835838|FG000|Overall Study|Physician Decision|11|||
105777406|NCT00281528|364835839|FG001|Overall Study|Physician Decision|4|||
105777407|NCT00281528|364835840|FG002|Overall Study|Physician Decision|5|||
105777408|NCT00281528|364835838|FG000|Overall Study|Protocol Violation|1|||
105777409|NCT00281528|364835839|FG001|Overall Study|Protocol Violation|0|||
105777410|NCT00281528|364835840|FG002|Overall Study|Protocol Violation|1|||
105777411|NCT00281528|364835838|FG000|Overall Study|Withdrawal by Subject|5|||
105777412|NCT00281528|364835839|FG001|Overall Study|Withdrawal by Subject|5|||
105777413|NCT00281528|364835840|FG002|Overall Study|Withdrawal by Subject|7|||
105777414|NCT00281528|364835838|FG000|Overall Study|Other|6|||
105777415|NCT00281528|364835839|FG001|Overall Study|Other|3|||
105777416|NCT00281528|364835840|FG002|Overall Study|Other|5|||
105777417|NCT02394028|364835841|FG000|Induction Phase|Adverse Event|2|||
105777418|NCT02394028|364835842|FG001|Induction Phase|Adverse Event|4|||
105777419|NCT02394028|364835843|FG002|Induction Phase|Adverse Event|1|||
105777420|NCT02394028|364835844|FG003|Induction Phase|Adverse Event|2|||
105777421|NCT02394028|364835845|FG004|Induction Phase|Adverse Event|5|||
105777422|NCT02394028|364835846|FG005|Induction Phase|Adverse Event|2|||
105777423|NCT02394028|364835847|FG006|Induction Phase|Adverse Event|0|||
105777424|NCT02394028|364835848|FG007|Induction Phase|Adverse Event|0|||
105777425|NCT02394028|364835849|FG008|Induction Phase|Adverse Event|0|||
105777426|NCT02394028|364835850|FG009|Induction Phase|Adverse Event|0|||
105777427|NCT02394028|364835851|FG010|Induction Phase|Adverse Event|0|||
105777428|NCT02394028|364835841|FG000|Induction Phase|Lack of Efficacy|3|||
105777429|NCT02394028|364835842|FG001|Induction Phase|Lack of Efficacy|6|||
105777430|NCT02394028|364835843|FG002|Induction Phase|Lack of Efficacy|2|||
105777431|NCT02394028|364835844|FG003|Induction Phase|Lack of Efficacy|17|||
105777432|NCT02394028|364835845|FG004|Induction Phase|Lack of Efficacy|14|||
105777433|NCT02394028|364835846|FG005|Induction Phase|Lack of Efficacy|8|||
105777434|NCT02394028|364835847|FG006|Induction Phase|Lack of Efficacy|17|||
105777435|NCT02394028|364835848|FG007|Induction Phase|Lack of Efficacy|23|||
105777436|NCT02394028|364835849|FG008|Induction Phase|Lack of Efficacy|0|||
105777437|NCT02394028|364835850|FG009|Induction Phase|Lack of Efficacy|0|||
105777438|NCT02394028|364835851|FG010|Induction Phase|Lack of Efficacy|0|||
105777439|NCT02394028|364835841|FG000|Induction Phase|Lost to Follow-up|1|||
105777440|NCT02394028|364835842|FG001|Induction Phase|Lost to Follow-up|0|||
105777441|NCT02394028|364835843|FG002|Induction Phase|Lost to Follow-up|0|||
105777442|NCT02394028|364835844|FG003|Induction Phase|Lost to Follow-up|1|||
105777443|NCT02394028|364835845|FG004|Induction Phase|Lost to Follow-up|0|||
105777444|NCT02394028|364835846|FG005|Induction Phase|Lost to Follow-up|0|||
105777445|NCT02394028|364835847|FG006|Induction Phase|Lost to Follow-up|1|||
105777446|NCT02394028|364835848|FG007|Induction Phase|Lost to Follow-up|0|||
105777447|NCT02394028|364835849|FG008|Induction Phase|Lost to Follow-up|0|||
105777448|NCT02394028|364835850|FG009|Induction Phase|Lost to Follow-up|0|||
105777449|NCT02394028|364835851|FG010|Induction Phase|Lost to Follow-up|0|||
105777450|NCT02394028|364835841|FG000|Induction Phase|Non-compliance|0|||
105777451|NCT02394028|364835842|FG001|Induction Phase|Non-compliance|1|||
105777452|NCT02394028|364835843|FG002|Induction Phase|Non-compliance|3|||
105777453|NCT02394028|364835844|FG003|Induction Phase|Non-compliance|1|||
105777454|NCT02394028|364835845|FG004|Induction Phase|Non-compliance|3|||
105777455|NCT02394028|364835846|FG005|Induction Phase|Non-compliance|0|||
105777456|NCT02394028|364835847|FG006|Induction Phase|Non-compliance|1|||
105777457|NCT02394028|364835848|FG007|Induction Phase|Non-compliance|1|||
105777458|NCT02394028|364835849|FG008|Induction Phase|Non-compliance|0|||
105777459|NCT02394028|364835850|FG009|Induction Phase|Non-compliance|0|||
105777460|NCT02394028|364835851|FG010|Induction Phase|Non-compliance|0|||
105777461|NCT02394028|364835841|FG000|Induction Phase|Physician Decision|0|||
105777462|NCT02394028|364835842|FG001|Induction Phase|Physician Decision|0|||
105777463|NCT02394028|364835843|FG002|Induction Phase|Physician Decision|1|||
105777464|NCT02394028|364835844|FG003|Induction Phase|Physician Decision|4|||
105777465|NCT02394028|364835845|FG004|Induction Phase|Physician Decision|0|||
105777466|NCT02394028|364835846|FG005|Induction Phase|Physician Decision|2|||
105777467|NCT02394028|364835847|FG006|Induction Phase|Physician Decision|1|||
105777468|NCT02394028|364835848|FG007|Induction Phase|Physician Decision|0|||
105777469|NCT02394028|364835849|FG008|Induction Phase|Physician Decision|0|||
105777470|NCT02394028|364835850|FG009|Induction Phase|Physician Decision|0|||
105777471|NCT02394028|364835851|FG010|Induction Phase|Physician Decision|0|||
105777472|NCT02394028|364835841|FG000|Induction Phase|Protocol Violation|0|||
105777473|NCT02394028|364835842|FG001|Induction Phase|Protocol Violation|2|||
105777474|NCT02394028|364835843|FG002|Induction Phase|Protocol Violation|0|||
105777475|NCT02394028|364835844|FG003|Induction Phase|Protocol Violation|3|||
105777476|NCT02394028|364835845|FG004|Induction Phase|Protocol Violation|0|||
105777477|NCT02394028|364835846|FG005|Induction Phase|Protocol Violation|1|||
105777478|NCT02394028|364835847|FG006|Induction Phase|Protocol Violation|1|||
105777479|NCT02394028|364835848|FG007|Induction Phase|Protocol Violation|0|||
105777480|NCT02394028|364835849|FG008|Induction Phase|Protocol Violation|0|||
105777481|NCT02394028|364835850|FG009|Induction Phase|Protocol Violation|0|||
105777482|NCT02394028|364835851|FG010|Induction Phase|Protocol Violation|0|||
105777483|NCT02394028|364835841|FG000|Induction Phase|Withdrawal by Subject|1|||
105777484|NCT02394028|364835842|FG001|Induction Phase|Withdrawal by Subject|2|||
105777485|NCT02394028|364835843|FG002|Induction Phase|Withdrawal by Subject|4|||
105777486|NCT02394028|364835844|FG003|Induction Phase|Withdrawal by Subject|6|||
105777487|NCT02394028|364835845|FG004|Induction Phase|Withdrawal by Subject|7|||
105777488|NCT02394028|364835846|FG005|Induction Phase|Withdrawal by Subject|4|||
105777489|NCT02394028|364835847|FG006|Induction Phase|Withdrawal by Subject|3|||
105777490|NCT02394028|364835848|FG007|Induction Phase|Withdrawal by Subject|6|||
105777491|NCT02394028|364835849|FG008|Induction Phase|Withdrawal by Subject|0|||
105777492|NCT02394028|364835850|FG009|Induction Phase|Withdrawal by Subject|0|||
105777493|NCT02394028|364835851|FG010|Induction Phase|Withdrawal by Subject|0|||
105777494|NCT02394028|364835841|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777495|NCT02394028|364835842|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777496|NCT02394028|364835843|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777497|NCT02394028|364835844|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777498|NCT02394028|364835845|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777499|NCT02394028|364835846|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777500|NCT02394028|364835847|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
105777501|NCT02394028|364835848|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777502|NCT02394028|364835849|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777503|NCT02394028|364835850|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777504|NCT02394028|364835851|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777505|NCT02394028|364835841|FG000|Induction Phase|Sponsor decision|0|||
105777506|NCT02394028|364835842|FG001|Induction Phase|Sponsor decision|1|||
105777507|NCT02394028|364835843|FG002|Induction Phase|Sponsor decision|2|||
105777508|NCT02394028|364835844|FG003|Induction Phase|Sponsor decision|0|||
105777509|NCT02394028|364835845|FG004|Induction Phase|Sponsor decision|0|||
105777510|NCT02394028|364835846|FG005|Induction Phase|Sponsor decision|0|||
105777511|NCT02394028|364835847|FG006|Induction Phase|Sponsor decision|0|||
105777512|NCT02394028|364835848|FG007|Induction Phase|Sponsor decision|0|||
105777513|NCT02394028|364835849|FG008|Induction Phase|Sponsor decision|0|||
105777514|NCT02394028|364835850|FG009|Induction Phase|Sponsor decision|0|||
105777515|NCT02394028|364835851|FG010|Induction Phase|Sponsor decision|0|||
105777516|NCT02394028|364835841|FG000|Induction Phase|Technical reason|0|||
105777517|NCT02394028|364835842|FG001|Induction Phase|Technical reason|0|||
105777518|NCT02394028|364835843|FG002|Induction Phase|Technical reason|0|||
105777519|NCT02394028|364835844|FG003|Induction Phase|Technical reason|1|||
105777520|NCT02394028|364835845|FG004|Induction Phase|Technical reason|0|||
105777521|NCT02394028|364835846|FG005|Induction Phase|Technical reason|0|||
105777522|NCT02394028|364835847|FG006|Induction Phase|Technical reason|0|||
105777523|NCT02394028|364835848|FG007|Induction Phase|Technical reason|0|||
105777524|NCT02394028|364835849|FG008|Induction Phase|Technical reason|0|||
105777525|NCT02394028|364835850|FG009|Induction Phase|Technical reason|0|||
105777526|NCT02394028|364835851|FG010|Induction Phase|Technical reason|0|||
105777527|NCT02394028|364835841|FG000|Induction Phase|:ack of calculation|0|||
105777528|NCT02394028|364835842|FG001|Induction Phase|:ack of calculation|0|||
105777529|NCT02394028|364835843|FG002|Induction Phase|:ack of calculation|0|||
105777530|NCT02394028|364835844|FG003|Induction Phase|:ack of calculation|0|||
105777531|NCT02394028|364835845|FG004|Induction Phase|:ack of calculation|0|||
105777532|NCT02394028|364835846|FG005|Induction Phase|:ack of calculation|0|||
105777533|NCT02394028|364835847|FG006|Induction Phase|:ack of calculation|0|||
105777534|NCT02394028|364835848|FG007|Induction Phase|:ack of calculation|1|||
105777535|NCT02394028|364835849|FG008|Induction Phase|:ack of calculation|0|||
105777536|NCT02394028|364835850|FG009|Induction Phase|:ack of calculation|0|||
105777537|NCT02394028|364835851|FG010|Induction Phase|:ack of calculation|0|||
105777538|NCT02394028|364835841|FG000|Maintenance Phase|Protocol Violation|0|||
105777539|NCT02394028|364835842|FG001|Maintenance Phase|Protocol Violation|0|||
105777540|NCT02394028|364835843|FG002|Maintenance Phase|Protocol Violation|0|||
105777541|NCT02394028|364835844|FG003|Maintenance Phase|Protocol Violation|0|||
105777542|NCT02394028|364835845|FG004|Maintenance Phase|Protocol Violation|0|||
105777543|NCT02394028|364835846|FG005|Maintenance Phase|Protocol Violation|0|||
105777544|NCT02394028|364835847|FG006|Maintenance Phase|Protocol Violation|0|||
105777545|NCT02394028|364835848|FG007|Maintenance Phase|Protocol Violation|0|||
105777546|NCT02394028|364835849|FG008|Maintenance Phase|Protocol Violation|0|||
105777547|NCT02394028|364835850|FG009|Maintenance Phase|Protocol Violation|0|||
105777548|NCT02394028|364835851|FG010|Maintenance Phase|Protocol Violation|1|||
105777549|NCT02394028|364835841|FG000|Maintenance Phase|Physician Decision|0|||
105777550|NCT02394028|364835842|FG001|Maintenance Phase|Physician Decision|0|||
105777551|NCT02394028|364835843|FG002|Maintenance Phase|Physician Decision|0|||
105777552|NCT02394028|364835844|FG003|Maintenance Phase|Physician Decision|0|||
105777553|NCT02394028|364835845|FG004|Maintenance Phase|Physician Decision|0|||
105777554|NCT02394028|364835846|FG005|Maintenance Phase|Physician Decision|0|||
105777555|NCT02394028|364835847|FG006|Maintenance Phase|Physician Decision|0|||
105777556|NCT02394028|364835848|FG007|Maintenance Phase|Physician Decision|0|||
105777557|NCT02394028|364835849|FG008|Maintenance Phase|Physician Decision|1|||
105777558|NCT02394028|364835850|FG009|Maintenance Phase|Physician Decision|3|||
105777559|NCT02394028|364835851|FG010|Maintenance Phase|Physician Decision|2|||
105777560|NCT02394028|364835841|FG000|Maintenance Phase|Lack of Efficacy|0|||
105777561|NCT02394028|364835842|FG001|Maintenance Phase|Lack of Efficacy|0|||
105777562|NCT02394028|364835843|FG002|Maintenance Phase|Lack of Efficacy|0|||
105777563|NCT02394028|364835844|FG003|Maintenance Phase|Lack of Efficacy|0|||
105777564|NCT02394028|364835845|FG004|Maintenance Phase|Lack of Efficacy|0|||
105777565|NCT02394028|364835846|FG005|Maintenance Phase|Lack of Efficacy|0|||
105777566|NCT02394028|364835847|FG006|Maintenance Phase|Lack of Efficacy|0|||
105777567|NCT02394028|364835848|FG007|Maintenance Phase|Lack of Efficacy|0|||
105777568|NCT02394028|364835849|FG008|Maintenance Phase|Lack of Efficacy|7|||
105777569|NCT02394028|364835850|FG009|Maintenance Phase|Lack of Efficacy|25|||
105777570|NCT02394028|364835851|FG010|Maintenance Phase|Lack of Efficacy|33|||
105777571|NCT02394028|364835841|FG000|Maintenance Phase|Death|0|||
105777572|NCT02394028|364835842|FG001|Maintenance Phase|Death|0|||
105777573|NCT02394028|364835843|FG002|Maintenance Phase|Death|0|||
105777574|NCT02394028|364835844|FG003|Maintenance Phase|Death|0|||
105777575|NCT02394028|364835845|FG004|Maintenance Phase|Death|0|||
105777576|NCT02394028|364835846|FG005|Maintenance Phase|Death|0|||
105777577|NCT02394028|364835847|FG006|Maintenance Phase|Death|0|||
105777578|NCT02394028|364835848|FG007|Maintenance Phase|Death|0|||
105777579|NCT02394028|364835849|FG008|Maintenance Phase|Death|0|||
105777580|NCT02394028|364835850|FG009|Maintenance Phase|Death|0|||
105777581|NCT02394028|364835851|FG010|Maintenance Phase|Death|1|||
105777582|NCT02394028|364835841|FG000|Maintenance Phase|Adverse Event|0|||
105777583|NCT02394028|364835842|FG001|Maintenance Phase|Adverse Event|0|||
105777584|NCT02394028|364835843|FG002|Maintenance Phase|Adverse Event|0|||
105777585|NCT02394028|364835844|FG003|Maintenance Phase|Adverse Event|0|||
105777586|NCT02394028|364835845|FG004|Maintenance Phase|Adverse Event|0|||
105777587|NCT02394028|364835846|FG005|Maintenance Phase|Adverse Event|0|||
105777588|NCT02394028|364835847|FG006|Maintenance Phase|Adverse Event|0|||
105777589|NCT02394028|364835848|FG007|Maintenance Phase|Adverse Event|0|||
105777590|NCT02394028|364835849|FG008|Maintenance Phase|Adverse Event|1|||
105777591|NCT02394028|364835850|FG009|Maintenance Phase|Adverse Event|1|||
105777592|NCT02394028|364835851|FG010|Maintenance Phase|Adverse Event|3|||
105777593|NCT02394028|364835841|FG000|Maintenance Phase|Site closure|0|||
105777594|NCT02394028|364835842|FG001|Maintenance Phase|Site closure|0|||
105777595|NCT02394028|364835843|FG002|Maintenance Phase|Site closure|0|||
105777596|NCT02394028|364835844|FG003|Maintenance Phase|Site closure|0|||
105777597|NCT02394028|364835845|FG004|Maintenance Phase|Site closure|0|||
105777598|NCT02394028|364835846|FG005|Maintenance Phase|Site closure|0|||
105777599|NCT02394028|364835847|FG006|Maintenance Phase|Site closure|0|||
105777600|NCT02394028|364835848|FG007|Maintenance Phase|Site closure|0|||
105777601|NCT02394028|364835849|FG008|Maintenance Phase|Site closure|0|||
105777602|NCT02394028|364835850|FG009|Maintenance Phase|Site closure|1|||
105777603|NCT02394028|364835851|FG010|Maintenance Phase|Site closure|0|||
105777604|NCT02394028|364835841|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105777605|NCT02394028|364835842|FG001|Maintenance Phase|Withdrawal by Subject|0|||
105777606|NCT02394028|364835843|FG002|Maintenance Phase|Withdrawal by Subject|0|||
105777607|NCT02394028|364835844|FG003|Maintenance Phase|Withdrawal by Subject|0|||
105777608|NCT02394028|364835845|FG004|Maintenance Phase|Withdrawal by Subject|0|||
105777609|NCT02394028|364835846|FG005|Maintenance Phase|Withdrawal by Subject|0|||
105777610|NCT02394028|364835847|FG006|Maintenance Phase|Withdrawal by Subject|0|||
105777611|NCT02394028|364835848|FG007|Maintenance Phase|Withdrawal by Subject|0|||
105777612|NCT02394028|364835849|FG008|Maintenance Phase|Withdrawal by Subject|3|||
105777613|NCT02394028|364835850|FG009|Maintenance Phase|Withdrawal by Subject|12|||
105777614|NCT02394028|364835851|FG010|Maintenance Phase|Withdrawal by Subject|12|||
105777615|NCT01468844|364835854|FG000|Overall Study|Adverse Event|1|||
105777616|NCT01468844|364835855|FG001|Overall Study|Adverse Event|0|||
105777617|NCT01468844|364835854|FG000|Overall Study|Withdrawal by Subject|1|||
105777618|NCT01468844|364835855|FG001|Overall Study|Withdrawal by Subject|0|||
105777619|NCT02142712|364835856|FG000|Overall Study|Lost to Follow-up|1|||
105777620|NCT02142712|364835857|FG001|Overall Study|Lost to Follow-up|1|||
105777621|NCT02142712|364835858|FG002|Overall Study|Lost to Follow-up|1|||
105777622|NCT02142712|364835859|FG003|Overall Study|Lost to Follow-up|0|||
105777623|NCT00866606|364835860|FG000|Overall Study|Lost to Follow-up|3|||
105777624|NCT00866606|364835860|FG000|Overall Study|Adverse Event|1|||
105777625|NCT02067104|364835861|FG000|Overall Study|Study termination due to low accrual|4|||
105777626|NCT02067104|364835862|FG001|Overall Study|Study termination due to low accrual|5|||
105777627|NCT00806494|364835863|FG000|Overall Study|Adverse Event|29|||
105777628|NCT00806494|364835863|FG000|Overall Study|Lack of Efficacy|6|||
105777629|NCT00806494|364835863|FG000|Overall Study|Lost to Follow-up|10|||
105777630|NCT00806494|364835863|FG000|Overall Study|Other|30|||
105777631|NCT00806494|364835863|FG000|Overall Study|Withdrawal by Subject|5|||
105777632|NCT03607994|364835864|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
105777633|NCT03607994|364835865|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
105777634|NCT02610231|364835866|FG000|Overall Study|Withdrawal by Subject|27|||
105777635|NCT02610231|364835866|FG000|Overall Study|Adverse Event|20|||
105777636|NCT02610231|364835866|FG000|Overall Study|Death|5|||
105777637|NCT02610231|364835866|FG000|Overall Study|Surgery|2|||
105777638|NCT02610231|364835866|FG000|Overall Study|Physician Decision|1|||
105777639|NCT02610231|364835866|FG000|Overall Study|Non Compliance|2|||
105777640|NCT02610231|364835866|FG000|Overall Study|Other|3|||
105777641|NCT01279954|364835871|FG000|Overall Study|Lack of Efficacy|3|||
105777642|NCT01279954|364835872|FG001|Overall Study|Lack of Efficacy|4|||
105777643|NCT02140762|364835873|FG000|Overall Study|Adverse Event|1|||
105777644|NCT02140762|364835874|FG001|Overall Study|Adverse Event|1|||
105777645|NCT02140762|364835873|FG000|Overall Study|Lost to Follow-up|9|||
105777646|NCT02140762|364835874|FG001|Overall Study|Lost to Follow-up|5|||
105777647|NCT02140762|364835873|FG000|Overall Study|Protocol Violation|1|||
105777648|NCT02140762|364835874|FG001|Overall Study|Protocol Violation|1|||
105777649|NCT02140762|364835873|FG000|Overall Study|Withdrawal by Subject|6|||
105777650|NCT02140762|364835874|FG001|Overall Study|Withdrawal by Subject|4|||
105777651|NCT02140762|364835873|FG000|Overall Study|Other|0|||
105777652|NCT02140762|364835874|FG001|Overall Study|Other|1|||
105777653|NCT01454531|364835875|FG000|Overall Study|Adverse Event|14|||
105777654|NCT01454531|364835875|FG000|Overall Study|Withdrawal by Subject|5|||
105777655|NCT01454531|364835875|FG000|Overall Study|Lost to Follow-up|1|||
105777656|NCT01454531|364835875|FG000|Overall Study|Physician Decision|1|||
105777657|NCT01454531|364835875|FG000|Overall Study|Delay in IMP administration|1|||
105777658|NCT01454531|364835875|FG000|Overall Study|Other|1|||
105777659|NCT00989664|364835877|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
105777660|NCT00989664|364835877|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
105777661|NCT00989664|364835877|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
105777662|NCT00989664|364835877|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
105777663|NCT00989664|364835877|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
105777664|NCT00989664|364835877|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
105777665|NCT00989664|364835877|FG000|Long-Term Follow-Up|Death|3|||
105777666|NCT03125902|364835885|FG000|Overall Study|Adverse Event|0|||
105777667|NCT03125902|364835886|FG001|Overall Study|Adverse Event|1|||
105777668|NCT03125902|364835885|FG000|Overall Study|Death|119|||
105777669|NCT03125902|364835886|FG001|Overall Study|Death|229|||
105777670|NCT03125902|364835885|FG000|Overall Study|Lost to Follow-up|4|||
105777671|NCT03125902|364835886|FG001|Overall Study|Lost to Follow-up|13|||
105777672|NCT03125902|364835885|FG000|Overall Study|Other|0|||
105777673|NCT03125902|364835886|FG001|Overall Study|Other|4|||
105777674|NCT03125902|364835885|FG000|Overall Study|Physician Decision|2|||
105777675|NCT03125902|364835886|FG001|Overall Study|Physician Decision|1|||
105777676|NCT03125902|364835885|FG000|Overall Study|Progressive Disease|0|||
105777677|NCT03125902|364835886|FG001|Overall Study|Progressive Disease|3|||
105777678|NCT03125902|364835885|FG000|Overall Study|Study Terminated By Sponsor|74|||
105777679|NCT03125902|364835886|FG001|Overall Study|Study Terminated By Sponsor|143|||
105777680|NCT03125902|364835885|FG000|Overall Study|Withdrawal by Subject|21|||
105777681|NCT03125902|364835886|FG001|Overall Study|Withdrawal by Subject|37|||
105777682|NCT01711359|364835887|FG000|Treatment Period|Withdrawal by Subject|18|||
105777683|NCT01711359|364835888|FG001|Treatment Period|Withdrawal by Subject|7|||
105777684|NCT01711359|364835889|FG002|Treatment Period|Withdrawal by Subject|13|||
105777685|NCT01711359|364835887|FG000|Treatment Period|Lack of Efficacy|13|||
105777686|NCT01711359|364835888|FG001|Treatment Period|Lack of Efficacy|2|||
105777687|NCT01711359|364835889|FG002|Treatment Period|Lack of Efficacy|2|||
105777688|NCT01711359|364835887|FG000|Treatment Period|Adverse Event|8|||
105777689|NCT01711359|364835888|FG001|Treatment Period|Adverse Event|10|||
105777690|NCT01711359|364835889|FG002|Treatment Period|Adverse Event|24|||
105777691|NCT01711359|364835887|FG000|Treatment Period|Physician Decision|4|||
105777692|NCT01711359|364835888|FG001|Treatment Period|Physician Decision|3|||
105777693|NCT01711359|364835889|FG002|Treatment Period|Physician Decision|2|||
105777694|NCT01711359|364835887|FG000|Treatment Period|Death|3|||
105777695|NCT01711359|364835888|FG001|Treatment Period|Death|0|||
105777696|NCT01711359|364835889|FG002|Treatment Period|Death|0|||
105777697|NCT01711359|364835887|FG000|Treatment Period|Entry Criteria Not Met|1|||
105777698|NCT01711359|364835888|FG001|Treatment Period|Entry Criteria Not Met|0|||
105777699|NCT01711359|364835889|FG002|Treatment Period|Entry Criteria Not Met|0|||
105777700|NCT01711359|364835887|FG000|Treatment Period|Sponsor Decision|1|||
105777701|NCT01711359|364835888|FG001|Treatment Period|Sponsor Decision|0|||
105777702|NCT01711359|364835889|FG002|Treatment Period|Sponsor Decision|0|||
105777703|NCT01711359|364835887|FG000|Treatment Period|Lost to Follow-up|1|||
105777704|NCT01711359|364835888|FG001|Treatment Period|Lost to Follow-up|1|||
105777705|NCT01711359|364835889|FG002|Treatment Period|Lost to Follow-up|1|||
105777706|NCT01711359|364835887|FG000|Treatment Period|Randomized, Not Treated|3|||
105777707|NCT01711359|364835888|FG001|Treatment Period|Randomized, Not Treated|1|||
105777708|NCT01711359|364835889|FG002|Treatment Period|Randomized, Not Treated|0|||
105777709|NCT00805142|364835890|FG000|Titration Period|Adverse Event|3|||
105777710|NCT00805142|364835891|FG001|Titration Period|Adverse Event|3|||
105777711|NCT00805142|364835890|FG000|Titration Period|Lack of Efficacy|1|||
105777712|NCT00805142|364835891|FG001|Titration Period|Lack of Efficacy|1|||
105777713|NCT00805142|364835890|FG000|Titration Period|Lost to Follow-up|0|||
105777714|NCT00805142|364835891|FG001|Titration Period|Lost to Follow-up|1|||
105777715|NCT00805142|364835890|FG000|Titration Period|Disease Progression|2|||
105777716|NCT00805142|364835891|FG001|Titration Period|Disease Progression|1|||
105777717|NCT00805142|364835890|FG000|Titration Period|Withdrawal of consent|0|||
105777718|NCT00805142|364835891|FG001|Titration Period|Withdrawal of consent|1|||
105777719|NCT00805142|364835890|FG000|Titration Period|Other|0|||
105777720|NCT00805142|364835891|FG001|Titration Period|Other|3|||
105777721|NCT00805142|364835890|FG000|Maintenance Period|Adverse Event|0|||
105777722|NCT00805142|364835891|FG001|Maintenance Period|Adverse Event|1|||
105777723|NCT00805142|364835890|FG000|Maintenance Period|Other|0|||
105777724|NCT00805142|364835891|FG001|Maintenance Period|Other|1|||
105777725|NCT02889861|364838126|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
105777726|NCT01640353|364838129|FG000|Overall Study|Withdrew prior to treatment|10|||
105777727|NCT01640353|364838129|FG000|Overall Study|Withdrawn from analysis at term site|12|||
105777728|NCT01640353|364838129|FG000|Overall Study|Withdrawal by Subject|5|||
105777729|NCT01640353|364838129|FG000|Overall Study|Death|2|||
105777730|NCT01640353|364838129|FG000|Overall Study|Early site termination|3|||
105777731|NCT01640353|364838129|FG000|Overall Study|Lost to Follow-up|12|||
105777732|NCT01640353|364838129|FG000|Overall Study|Physician Decision|1|||
105777733|NCT01524900|364838130|FG000|Overall Study|Lost to Follow-up|3|||
105777734|NCT01524900|364838131|FG001|Overall Study|Lost to Follow-up|12|||
105777735|NCT01524900|364838132|FG002|Overall Study|Lost to Follow-up|1|||
105777736|NCT01524900|364838133|FG003|Overall Study|Lost to Follow-up|0|||
105777737|NCT01524900|364838134|FG004|Overall Study|Lost to Follow-up|0|||
105777738|NCT01524900|364838130|FG000|Overall Study|Other reason than stated above|1|||
105777739|NCT01524900|364838131|FG001|Overall Study|Other reason than stated above|1|||
105777740|NCT01524900|364838132|FG002|Overall Study|Other reason than stated above|0|||
105777741|NCT01524900|364838133|FG003|Overall Study|Other reason than stated above|0|||
105777742|NCT01524900|364838134|FG004|Overall Study|Other reason than stated above|0|||
105777743|NCT01524900|364838130|FG000|Overall Study|No reason documented|2|||
105777744|NCT01524900|364838131|FG001|Overall Study|No reason documented|1|||
105777745|NCT01524900|364838132|FG002|Overall Study|No reason documented|0|||
105777746|NCT01524900|364838133|FG003|Overall Study|No reason documented|1|||
105777747|NCT01524900|364838134|FG004|Overall Study|No reason documented|0|||
105777748|NCT04354870|364838135|FG000|Overall Study|Lost to Follow-up|32|||
105777749|NCT04354870|364838136|FG001|Overall Study|Lost to Follow-up|12|||
105777750|NCT04354870|364838135|FG000|Overall Study|Withdrawal by Subject|10|||
105777751|NCT04354870|364838136|FG001|Overall Study|Withdrawal by Subject|16|||
105777752|NCT04354870|364838135|FG000|Overall Study|Did not complete all study visits|6|||
105777753|NCT04354870|364838136|FG001|Overall Study|Did not complete all study visits|5|||
105777754|NCT00298766|364838137|FG000|Overall Study|Adverse Event|18|||
105777755|NCT00298766|364838137|FG000|Overall Study|Death|2|||
105777756|NCT00298766|364838137|FG000|Overall Study|Withdrawal by Subject|9|||
105777757|NCT00298766|364838137|FG000|Overall Study|Treatment ongoing|4|||
105777758|NCT00298766|364838137|FG000|Overall Study|Progression of amyloid markers|4|||
105777759|NCT00298766|364838137|FG000|Overall Study|Deterioration in KPS and organ function|1|||
105777760|NCT00298766|364838137|FG000|Overall Study|Subjects overall condition deterioration|4|||
105777761|NCT00298766|364838137|FG000|Overall Study|Other|4|||
105777762|NCT02500901|364838138|FG000|Overall Study|Disease ProgressionDD|2|||
105777763|NCT03055806|364838141|FG000|Overall Study|Adverse Event|0|||
105777764|NCT03055806|364838142|FG001|Overall Study|Adverse Event|0|||
105777765|NCT03055806|364838143|FG002|Overall Study|Adverse Event|1|||
105777766|NCT03055806|364838144|FG003|Overall Study|Adverse Event|1|||
105777767|NCT03055806|364838141|FG000|Overall Study|Lost to Follow-up|0|||
105777768|NCT03055806|364838142|FG001|Overall Study|Lost to Follow-up|3|||
105777769|NCT03055806|364838143|FG002|Overall Study|Lost to Follow-up|6|||
105777770|NCT03055806|364838144|FG003|Overall Study|Lost to Follow-up|7|||
105777771|NCT03055806|364838141|FG000|Overall Study|Physician Decision|1|||
105777772|NCT03055806|364838142|FG001|Overall Study|Physician Decision|0|||
105777773|NCT03055806|364838143|FG002|Overall Study|Physician Decision|0|||
105777774|NCT03055806|364838144|FG003|Overall Study|Physician Decision|1|||
105777775|NCT03055806|364838141|FG000|Overall Study|Protocol Violation|1|||
105777776|NCT03055806|364838142|FG001|Overall Study|Protocol Violation|0|||
105777777|NCT03055806|364838143|FG002|Overall Study|Protocol Violation|0|||
105777778|NCT03055806|364838144|FG003|Overall Study|Protocol Violation|0|||
105777779|NCT03055806|364838141|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
105777780|NCT03055806|364838142|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
105777781|NCT03055806|364838143|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
105777782|NCT03055806|364838144|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
105777783|NCT03055806|364838141|FG000|Overall Study|Withdrawal of consent to continue study|2|||
105777784|NCT03055806|364838142|FG001|Overall Study|Withdrawal of consent to continue study|3|||
105777785|NCT03055806|364838143|FG002|Overall Study|Withdrawal of consent to continue study|4|||
105777786|NCT03055806|364838144|FG003|Overall Study|Withdrawal of consent to continue study|6|||
105777787|NCT03055806|364838141|FG000|Overall Study|Partner not willing to try intercourse|1|||
105777788|NCT03055806|364838142|FG001|Overall Study|Partner not willing to try intercourse|0|||
105777789|NCT03055806|364838143|FG002|Overall Study|Partner not willing to try intercourse|0|||
105777790|NCT03055806|364838144|FG003|Overall Study|Partner not willing to try intercourse|0|||
105777791|NCT00033514|364838145|FG000|Overall Study|Lost to Follow-up|1|||
105777792|NCT00033514|364838146|FG001|Overall Study|Lost to Follow-up|1|||
105777793|NCT00033514|364838145|FG000|Overall Study|Withdrawal by Subject|0|||
105777794|NCT00033514|364838146|FG001|Overall Study|Withdrawal by Subject|3|||
105777795|NCT00348686|364838147|FG000|Overall Study|Withdrawal by Subject|45|||
105777796|NCT00348686|364838147|FG000|Overall Study|Adverse Event|5|||
105777797|NCT00348686|364838147|FG000|Overall Study|Protocol Violation|6|||
105777798|NCT00348686|364838147|FG000|Overall Study|Lost to Follow-up|2|||
105777799|NCT00348686|364838147|FG000|Overall Study|Multiple Reasons|8|||
105777800|NCT01258738|364838148|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
105777801|NCT01258738|364838149|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
105777802|NCT01258738|364838148|FG000|Double-blind Period|Withdrawal by Subject|2|||
105777803|NCT01258738|364838149|FG001|Double-blind Period|Withdrawal by Subject|2|||
105777804|NCT01258738|364838148|FG000|Double-blind Period|Protocol Violation|1|||
105777805|NCT01258738|364838149|FG001|Double-blind Period|Protocol Violation|1|||
105777806|NCT01258738|364838148|FG000|Double-blind Period|Adverse Event|3|||
105777807|NCT01258738|364838149|FG001|Double-blind Period|Adverse Event|1|||
105777808|NCT01258738|364838148|FG000|Open-label Period|Did not meet inclusion criteria|0|||
105777809|NCT01258738|364838149|FG001|Open-label Period|Did not meet inclusion criteria|1|||
105777810|NCT01258738|364838148|FG000|Open-label Period|Insufficient clinical response|5|||
105777811|NCT01258738|364838149|FG001|Open-label Period|Insufficient clinical response|3|||
105777812|NCT01258738|364838148|FG000|Open-label Period|Lost to Follow-up|0|||
105777813|NCT01258738|364838149|FG001|Open-label Period|Lost to Follow-up|2|||
105777814|NCT01258738|364838148|FG000|Open-label Period|Withdrawal by Subject|5|||
105777815|NCT01258738|364838149|FG001|Open-label Period|Withdrawal by Subject|6|||
105777816|NCT01258738|364838148|FG000|Open-label Period|Protocol Violation|2|||
105777817|NCT01258738|364838149|FG001|Open-label Period|Protocol Violation|2|||
105777818|NCT01258738|364838148|FG000|Open-label Period|Adverse Event|4|||
105777819|NCT01258738|364838149|FG001|Open-label Period|Adverse Event|5|||
105777820|NCT01258738|364838148|FG000|Open-label Period|Other Reasons|0|||
105777821|NCT01258738|364838149|FG001|Open-label Period|Other Reasons|1|||
105777822|NCT01258738|364838148|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
105777823|NCT01258738|364838149|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
105777824|NCT00689611|364838150|FG000|Overall Study|Death|6|||
105777825|NCT00689611|364838151|FG001|Overall Study|Death|9|||
105777826|NCT00689611|364838150|FG000|Overall Study|Withdrawal by Subject|8|||
105777827|NCT00689611|364838151|FG001|Overall Study|Withdrawal by Subject|9|||
105777828|NCT00689611|364838150|FG000|Overall Study|Lost to Follow-up|27|||
105777829|NCT00689611|364838151|FG001|Overall Study|Lost to Follow-up|28|||
105777830|NCT01220024|364838154|FG000|Overall Study|Lost to Follow-up|1|||
105777831|NCT01220024|364838155|FG001|Overall Study|Lost to Follow-up|1|||
105777832|NCT00490815|364838156|FG000|Overall Study|Adverse Event|2|||
105777833|NCT00490815|364838157|FG001|Overall Study|Adverse Event|3|||
105777834|NCT00490815|364838156|FG000|Overall Study|Withdrawal by Subject|4|||
105777835|NCT00490815|364838157|FG001|Overall Study|Withdrawal by Subject|0|||
105777836|NCT00490815|364838156|FG000|Overall Study|Lost to Follow-up|1|||
105777837|NCT00490815|364838157|FG001|Overall Study|Lost to Follow-up|3|||
105777838|NCT00490815|364838156|FG000|Overall Study|Death|1|||
105777839|NCT00490815|364838157|FG001|Overall Study|Death|3|||
105777840|NCT00732199|364838165|FG000|Overall Study|Withdrawal by Subject|25|||
105777841|NCT00732199|364838166|FG001|Overall Study|Withdrawal by Subject|18|||
105777842|NCT00732199|364838165|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
105777843|NCT00732199|364838166|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
105777844|NCT01488994|364838180|FG000|Overall Study|Withdrawal by Subject|0|||
105777845|NCT01488994|364838181|FG001|Overall Study|Withdrawal by Subject|1|||
105777846|NCT03018028|364838184|FG000|Overall Study|Withdrawal by Subject|3|||
105777847|NCT03018028|364838185|FG001|Overall Study|Withdrawal by Subject|0|||
105777848|NCT03018028|364838186|FG002|Overall Study|Withdrawal by Subject|1|||
105777849|NCT03018028|364838187|FG003|Overall Study|Withdrawal by Subject|2|||
105777850|NCT03018028|364838188|FG004|Overall Study|Withdrawal by Subject|0|||
105777851|NCT00545740|364838192|FG000|Overall Study|Lack of Efficacy|34|||
105777852|NCT00545740|364838193|FG001|Overall Study|Lack of Efficacy|35|||
105777853|NCT00545740|364838194|FG002|Overall Study|Lack of Efficacy|47|||
105777854|NCT00545740|364838195|FG003|Overall Study|Lack of Efficacy|36|||
105777855|NCT00545740|364838192|FG000|Overall Study|Withdrawal by Subject|17|||
105777856|NCT00545740|364838193|FG001|Overall Study|Withdrawal by Subject|15|||
105777857|NCT00545740|364838194|FG002|Overall Study|Withdrawal by Subject|16|||
105442568|NCT04034004|363626792|FG001|Overall Study|could not find vein to administer IV|1|||
105777858|NCT00545740|364838195|FG003|Overall Study|Withdrawal by Subject|18|||
105777859|NCT00545740|364838192|FG000|Overall Study|Adverse Event|10|||
105777860|NCT00545740|364838193|FG001|Overall Study|Adverse Event|18|||
105777861|NCT00545740|364838194|FG002|Overall Study|Adverse Event|19|||
105777862|NCT00545740|364838195|FG003|Overall Study|Adverse Event|9|||
105777863|NCT00545740|364838192|FG000|Overall Study|Lost to Follow-up|7|||
105777864|NCT00545740|364838193|FG001|Overall Study|Lost to Follow-up|5|||
105777865|NCT00545740|364838194|FG002|Overall Study|Lost to Follow-up|5|||
105777866|NCT00545740|364838195|FG003|Overall Study|Lost to Follow-up|6|||
105777867|NCT00545740|364838192|FG000|Overall Study|Protocol Violation|1|||
105777868|NCT00545740|364838193|FG001|Overall Study|Protocol Violation|3|||
105777869|NCT00545740|364838194|FG002|Overall Study|Protocol Violation|1|||
105777870|NCT00545740|364838195|FG003|Overall Study|Protocol Violation|0|||
105777871|NCT00545740|364838192|FG000|Overall Study|Non-compliance|0|||
105777872|NCT00545740|364838193|FG001|Overall Study|Non-compliance|2|||
105777873|NCT00545740|364838194|FG002|Overall Study|Non-compliance|1|||
105777874|NCT00545740|364838195|FG003|Overall Study|Non-compliance|0|||
105777875|NCT00545740|364838192|FG000|Overall Study|Moved|2|||
105777876|NCT00545740|364838193|FG001|Overall Study|Moved|0|||
105777877|NCT00545740|364838194|FG002|Overall Study|Moved|1|||
105777878|NCT00545740|364838195|FG003|Overall Study|Moved|0|||
105777879|NCT00545740|364838192|FG000|Overall Study|Diverticulitis attack|0|||
105777880|NCT00545740|364838193|FG001|Overall Study|Diverticulitis attack|0|||
105777881|NCT00545740|364838194|FG002|Overall Study|Diverticulitis attack|1|||
105777882|NCT00545740|364838195|FG003|Overall Study|Diverticulitis attack|1|||
105777883|NCT00545740|364838192|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
105777884|NCT00545740|364838193|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
105777885|NCT00545740|364838194|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
105777886|NCT00545740|364838195|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
105777887|NCT00545740|364838192|FG000|Overall Study|Site closure|1|||
105777888|NCT00545740|364838193|FG001|Overall Study|Site closure|0|||
105777889|NCT00545740|364838194|FG002|Overall Study|Site closure|0|||
105777890|NCT00545740|364838195|FG003|Overall Study|Site closure|0|||
105777891|NCT00545740|364838192|FG000|Overall Study|Missed visit|1|||
105777892|NCT00545740|364838193|FG001|Overall Study|Missed visit|0|||
105777893|NCT00545740|364838194|FG002|Overall Study|Missed visit|0|||
105777894|NCT00545740|364838195|FG003|Overall Study|Missed visit|0|||
105777895|NCT00545740|364838192|FG000|Overall Study|Physician Decision|0|||
105777896|NCT00545740|364838193|FG001|Overall Study|Physician Decision|0|||
105777897|NCT00545740|364838194|FG002|Overall Study|Physician Decision|3|||
105777898|NCT00545740|364838195|FG003|Overall Study|Physician Decision|0|||
105777899|NCT00545740|364838192|FG000|Overall Study|Accepted only monthly telephone calls|1|||
105777900|NCT00545740|364838193|FG001|Overall Study|Accepted only monthly telephone calls|0|||
105777901|NCT00545740|364838194|FG002|Overall Study|Accepted only monthly telephone calls|0|||
105777902|NCT00545740|364838195|FG003|Overall Study|Accepted only monthly telephone calls|0|||
105777903|NCT00545740|364838192|FG000|Overall Study|Sponsor decision|0|||
105777904|NCT00545740|364838193|FG001|Overall Study|Sponsor decision|1|||
105777905|NCT00545740|364838194|FG002|Overall Study|Sponsor decision|0|||
105777906|NCT00545740|364838195|FG003|Overall Study|Sponsor decision|0|||
105777907|NCT00545740|364838192|FG000|Overall Study|Lack of time|0|||
105777908|NCT00545740|364838193|FG001|Overall Study|Lack of time|1|||
105777909|NCT00545740|364838194|FG002|Overall Study|Lack of time|0|||
105777910|NCT00545740|364838195|FG003|Overall Study|Lack of time|0|||
105777911|NCT00545740|364838192|FG000|Overall Study|Non-adherence to visits|0|||
105777912|NCT00545740|364838193|FG001|Overall Study|Non-adherence to visits|1|||
105777913|NCT00545740|364838194|FG002|Overall Study|Non-adherence to visits|0|||
105777914|NCT00545740|364838195|FG003|Overall Study|Non-adherence to visits|0|||
105777915|NCT00545740|364838192|FG000|Overall Study|Patient difficulties|0|||
105777916|NCT00545740|364838193|FG001|Overall Study|Patient difficulties|1|||
105777917|NCT00545740|364838194|FG002|Overall Study|Patient difficulties|0|||
105777918|NCT00545740|364838195|FG003|Overall Study|Patient difficulties|0|||
105777919|NCT00545740|364838192|FG000|Overall Study|Husband against study|0|||
105777920|NCT00545740|364838193|FG001|Overall Study|Husband against study|0|||
105777921|NCT00545740|364838194|FG002|Overall Study|Husband against study|1|||
105777922|NCT00545740|364838195|FG003|Overall Study|Husband against study|0|||
105777923|NCT01947127|364838196|FG000|Overall Study|Protocol Violation|18|||
105777924|NCT01947127|364838197|FG001|Overall Study|Protocol Violation|38|||
105777925|NCT01947127|364838196|FG000|Overall Study|Withdrawal by Subject|1|||
105777926|NCT01947127|364838197|FG001|Overall Study|Withdrawal by Subject|1|||
105777927|NCT01947127|364838196|FG000|Overall Study|Data loss|4|||
105777928|NCT01947127|364838197|FG001|Overall Study|Data loss|4|||
105777929|NCT03018340|364838198|FG000|Overall Study|Adverse Event|1|||
105777930|NCT03018340|364838199|FG001|Overall Study|Adverse Event|2|||
105777931|NCT03018340|364838198|FG000|Overall Study|Withdrawal by Subject|0|||
105777932|NCT03018340|364838199|FG001|Overall Study|Withdrawal by Subject|8|||
105777933|NCT03018340|364838198|FG000|Overall Study|Lack of Efficacy|0|||
105777934|NCT03018340|364838199|FG001|Overall Study|Lack of Efficacy|1|||
105777935|NCT03018340|364838198|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
105777936|NCT03018340|364838199|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
105777937|NCT03018340|364838198|FG000|Overall Study|Lost to Follow-up|1|||
105777938|NCT03018340|364838199|FG001|Overall Study|Lost to Follow-up|7|||
105777939|NCT03018340|364838198|FG000|Overall Study|Protocol Violation|3|||
105777940|NCT03018340|364838199|FG001|Overall Study|Protocol Violation|7|||
105777941|NCT03018340|364838198|FG000|Overall Study|Not further specified|0|||
105777942|NCT03018340|364838199|FG001|Overall Study|Not further specified|1|||
105777943|NCT00994890|364838213|FG000|Overall Study|Adverse Event|13|||
105777944|NCT00994890|364838214|FG001|Overall Study|Adverse Event|9|||
105777945|NCT00994890|364838215|FG002|Overall Study|Adverse Event|11|||
105777946|NCT00994890|364838213|FG000|Overall Study|Lack of Efficacy|0|||
105777947|NCT00994890|364838214|FG001|Overall Study|Lack of Efficacy|0|||
105777948|NCT00994890|364838215|FG002|Overall Study|Lack of Efficacy|1|||
105777949|NCT00994890|364838213|FG000|Overall Study|Lost to Follow-up|6|||
105777950|NCT00994890|364838214|FG001|Overall Study|Lost to Follow-up|1|||
105777951|NCT00994890|364838215|FG002|Overall Study|Lost to Follow-up|3|||
105777952|NCT00994890|364838213|FG000|Overall Study|No longer willing to participate|8|||
105777953|NCT00994890|364838214|FG001|Overall Study|No longer willing to participate|5|||
105777954|NCT00994890|364838215|FG002|Overall Study|No longer willing to participate|13|||
105777955|NCT00994890|364838213|FG000|Overall Study|Protocol Violation|2|||
105777956|NCT00994890|364838214|FG001|Overall Study|Protocol Violation|4|||
105777957|NCT00994890|364838215|FG002|Overall Study|Protocol Violation|0|||
105777958|NCT00994890|364838213|FG000|Overall Study|Study terminated by sponsor|199|||
105777959|NCT00994890|364838214|FG001|Overall Study|Study terminated by sponsor|201|||
105777960|NCT00994890|364838215|FG002|Overall Study|Study terminated by sponsor|197|||
105777961|NCT00994890|364838213|FG000|Overall Study|Randomized, but not treated|1|||
105777962|NCT00994890|364838214|FG001|Overall Study|Randomized, but not treated|0|||
105777963|NCT00994890|364838215|FG002|Overall Study|Randomized, but not treated|0|||
105777964|NCT00994890|364838213|FG000|Overall Study|Other|2|||
105777965|NCT00994890|364838214|FG001|Overall Study|Other|2|||
105777966|NCT00994890|364838215|FG002|Overall Study|Other|1|||
105777967|NCT01849289|364838218|FG000|Overall Study|Adverse Event|3|||
105777968|NCT01849289|364838219|FG001|Overall Study|Adverse Event|3|||
105777969|NCT01849289|364838218|FG000|Overall Study|Protocol Violation|3|||
105777970|NCT01849289|364838219|FG001|Overall Study|Protocol Violation|3|||
105777971|NCT01849289|364838218|FG000|Overall Study|Withdrawal criteria|1|||
105777972|NCT01849289|364838219|FG001|Overall Study|Withdrawal criteria|0|||
105777973|NCT01849289|364838218|FG000|Overall Study|Unclassified|25|||
105777974|NCT01849289|364838219|FG001|Overall Study|Unclassified|18|||
105777975|NCT00352027|364838224|FG000|Overall Study|Progressive disease|3|||
105777976|NCT00702949|364838225|FG000|Overall Study|Refusal|3|||
105777977|NCT00702949|364838226|FG001|Overall Study|Refusal|2|||
105777978|NCT00702949|364838227|FG002|Overall Study|Refusal|2|||
105777979|NCT00702949|364838225|FG000|Overall Study|Adverse Event|1|||
105777980|NCT00702949|364838226|FG001|Overall Study|Adverse Event|6|||
105777981|NCT00702949|364838227|FG002|Overall Study|Adverse Event|3|||
105777982|NCT00702949|364838225|FG000|Overall Study|Other Medical Reason/unknown|1|||
105777983|NCT00702949|364838226|FG001|Overall Study|Other Medical Reason/unknown|1|||
105777984|NCT00702949|364838227|FG002|Overall Study|Other Medical Reason/unknown|3|||
105777985|NCT01469637|364838228|FG000|First Intervention|Unacceptable behavior|0|||
105777986|NCT01469637|364838229|FG001|First Intervention|Unacceptable behavior|1|||
105777987|NCT01469637|364838228|FG000|Second Intervention|Incarcerated|1|||
105777988|NCT01469637|364838229|FG001|Second Intervention|Incarcerated|0|||
105777989|NCT00420212|364838237|FG000|Overall Study|Adverse Event|22|||
105777990|NCT00420212|364838238|FG001|Overall Study|Adverse Event|40|||
105777991|NCT00420212|364838239|FG002|Overall Study|Adverse Event|36|||
105777992|NCT00420212|364838237|FG000|Overall Study|Lost to Follow-up|9|||
105777993|NCT00420212|364838238|FG001|Overall Study|Lost to Follow-up|11|||
105777994|NCT00420212|364838239|FG002|Overall Study|Lost to Follow-up|11|||
105777995|NCT00420212|364838237|FG000|Overall Study|Withdrawal by Subject|31|||
105777996|NCT00420212|364838238|FG001|Overall Study|Withdrawal by Subject|22|||
105777997|NCT00420212|364838239|FG002|Overall Study|Withdrawal by Subject|19|||
105777998|NCT00420212|364838237|FG000|Overall Study|Physician Decision|4|||
105777999|NCT00420212|364838238|FG001|Overall Study|Physician Decision|4|||
105778000|NCT00420212|364838239|FG002|Overall Study|Physician Decision|3|||
105778001|NCT00420212|364838237|FG000|Overall Study|Protocol Violation|4|||
105778002|NCT00420212|364838238|FG001|Overall Study|Protocol Violation|4|||
105778003|NCT00420212|364838239|FG002|Overall Study|Protocol Violation|8|||
105778004|NCT00420212|364838237|FG000|Overall Study|Death|0|||
105778005|NCT00420212|364838238|FG001|Overall Study|Death|0|||
105778006|NCT00420212|364838239|FG002|Overall Study|Death|1|||
105778007|NCT00420212|364838237|FG000|Overall Study|Other-Unspecified|21|||
105778008|NCT00420212|364838238|FG001|Overall Study|Other-Unspecified|14|||
105778009|NCT00420212|364838239|FG002|Overall Study|Other-Unspecified|18|||
105778010|NCT02390362|364838240|FG000|Overall Study|Withdrawal by Subject|0|||
105778011|NCT02390362|364838241|FG001|Overall Study|Withdrawal by Subject|1|||
105778012|NCT01376908|364838242|FG000|Overall Study|Protocol Violation|1|||
105778013|NCT01376908|364838243|FG001|Overall Study|Protocol Violation|1|||
105778014|NCT01376908|364838242|FG000|Overall Study|Withdrawal by Subject|1|||
105778015|NCT01376908|364838243|FG001|Overall Study|Withdrawal by Subject|2|||
105778016|NCT00392210|364838244|FG000|First Voiding Trial|Physician Decision|2|||
105778017|NCT00392210|364838245|FG001|First Voiding Trial|Physician Decision|2|||
105778018|NCT03049852|364838249|FG000|Overall Study|Lost to Follow-up|0|||
105778019|NCT03049852|364838250|FG001|Overall Study|Lost to Follow-up|1|||
105778020|NCT03049852|364838251|FG002|Overall Study|Lost to Follow-up|0|||
105778021|NCT00434876|364838252|FG000|Overall Study|Lost to Follow-up|1|||
105778022|NCT00434876|364838253|FG001|Overall Study|Lost to Follow-up|1|||
105778023|NCT04815291|364838254|FG000|Overall Study|Lost to Follow-up|1|||
105778024|NCT04815291|364838254|FG000|Overall Study|Physician Decision|4|||
105778025|NCT04815291|364838254|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
105778026|NCT01899729|364838257|FG000|Overall Study|Adverse Event|1|||
105778027|NCT01899729|364838258|FG001|Overall Study|Adverse Event|0|||
105778028|NCT01899729|364838259|FG002|Overall Study|Adverse Event|0|||
105778029|NCT01899729|364838260|FG003|Overall Study|Adverse Event|0|||
105778030|NCT01899729|364838261|FG004|Overall Study|Adverse Event|1|||
105778031|NCT01899729|364838257|FG000|Overall Study|Withdrawal by Subject|1|||
105778032|NCT01899729|364838258|FG001|Overall Study|Withdrawal by Subject|2|||
105778033|NCT01899729|364838259|FG002|Overall Study|Withdrawal by Subject|0|||
105778034|NCT01899729|364838260|FG003|Overall Study|Withdrawal by Subject|0|||
105778035|NCT01899729|364838261|FG004|Overall Study|Withdrawal by Subject|0|||
105778036|NCT01899729|364838257|FG000|Overall Study|Lack of Efficacy|0|||
105778037|NCT01899729|364838258|FG001|Overall Study|Lack of Efficacy|0|||
105778038|NCT01899729|364838259|FG002|Overall Study|Lack of Efficacy|2|||
105778039|NCT01899729|364838260|FG003|Overall Study|Lack of Efficacy|0|||
105778040|NCT01899729|364838261|FG004|Overall Study|Lack of Efficacy|1|||
105778041|NCT00095836|364838262|FG000|Overall Study|Lost to Follow-up|1|||
105778042|NCT00095836|364838262|FG000|Overall Study|Adverse Event|1|||
105778043|NCT00095836|364838262|FG000|Overall Study|Death|2|||
105778044|NCT00982111|364838265|FG000|Overall Study|Adverse Event|1|||
105778045|NCT00982111|364838266|FG001|Overall Study|Adverse Event|1|||
105778046|NCT00982111|364838265|FG000|Overall Study|Progressive Disease|46|||
105778047|NCT00982111|364838266|FG001|Overall Study|Progressive Disease|39|||
105778048|NCT00982111|364838265|FG000|Overall Study|Lost to Follow-up|9|||
105778049|NCT00982111|364838266|FG001|Overall Study|Lost to Follow-up|6|||
105778050|NCT00982111|364838265|FG000|Overall Study|New Anti-Cancer Therapy|5|||
105778051|NCT00982111|364838266|FG001|Overall Study|New Anti-Cancer Therapy|5|||
105778052|NCT00982111|364838265|FG000|Overall Study|Medical Decision|1|||
105778053|NCT00982111|364838266|FG001|Overall Study|Medical Decision|0|||
105778054|NCT00982111|364838265|FG000|Overall Study|Withdrawal by Subject|17|||
105778055|NCT00982111|364838266|FG001|Overall Study|Withdrawal by Subject|19|||
105778056|NCT00982111|364838265|FG000|Overall Study|Global Study End|0|||
105778057|NCT00982111|364838266|FG001|Overall Study|Global Study End|1|||
105778058|NCT00982111|364838265|FG000|Overall Study|Sponsor's Decision|0|||
105778059|NCT00982111|364838266|FG001|Overall Study|Sponsor's Decision|1|||
105778060|NCT01070381|364838267|FG000|Period 2, 1 Week of Wear|Handling|0|||
105778061|NCT01070381|364838268|FG001|Period 2, 1 Week of Wear|Handling|1|||
105778062|NCT01070381|364838267|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
105778063|NCT01070381|364838268|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
105778064|NCT00620815|364838269|FG000|Overall Study|Adverse Event|1|||
105778065|NCT00620815|364838270|FG001|Overall Study|Adverse Event|1|||
105778066|NCT00620815|364838271|FG002|Overall Study|Adverse Event|2|||
105778067|NCT00620815|364838269|FG000|Overall Study|Withdrawal by Subject|1|||
105778068|NCT00620815|364838270|FG001|Overall Study|Withdrawal by Subject|2|||
105778069|NCT00620815|364838271|FG002|Overall Study|Withdrawal by Subject|0|||
105778070|NCT00620815|364838269|FG000|Overall Study|Lost to Follow-up|1|||
105778071|NCT00620815|364838270|FG001|Overall Study|Lost to Follow-up|6|||
105778072|NCT00620815|364838271|FG002|Overall Study|Lost to Follow-up|3|||
105778073|NCT00620815|364838269|FG000|Overall Study|Inappropriate enrolment|0|||
105778074|NCT00620815|364838270|FG001|Overall Study|Inappropriate enrolment|0|||
105778075|NCT00620815|364838271|FG002|Overall Study|Inappropriate enrolment|1|||
105778076|NCT00620815|364838269|FG000|Overall Study|Protocol Violation|1|||
105778077|NCT00620815|364838270|FG001|Overall Study|Protocol Violation|2|||
105778078|NCT00620815|364838271|FG002|Overall Study|Protocol Violation|1|||
105778079|NCT00983827|364838272|FG000|Overall Study|Withdrawal by Subject|1|||
105778080|NCT00795717|364838273|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
105778081|NCT00795717|364838274|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
105778082|NCT00795717|364838273|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
105778083|NCT00795717|364838274|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
105778084|NCT00795717|364838273|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
105778085|NCT00795717|364838274|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
105778086|NCT00795717|364838273|FG000|Phase II|too busy|0|||
105778087|NCT00795717|364838274|FG001|Phase II|too busy|1|||
105778088|NCT00695318|364838275|FG000|Overall Study|Lost to Follow-up|1|||
105778089|NCT00695318|364838276|FG001|Overall Study|Lost to Follow-up|0|||
105778090|NCT00695318|364838275|FG000|Overall Study|Withdrawal by Subject|2|||
105778091|NCT00695318|364838276|FG001|Overall Study|Withdrawal by Subject|0|||
105778092|NCT00695318|364838275|FG000|Overall Study|Death|1|||
105778093|NCT00695318|364838276|FG001|Overall Study|Death|1|||
105778094|NCT00695318|364838275|FG000|Overall Study|Study Terminated|1|||
105778095|NCT00695318|364838276|FG001|Overall Study|Study Terminated|0|||
105778096|NCT02390167|364840243|FG000|Overall Study|Lost to Follow-up|1|||
105778097|NCT04335929|364840247|FG000|Overall Study|Lost to Follow-up|10|||
105778098|NCT01005966|364840248|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
105778099|NCT01005966|364840249|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
105778100|NCT01005966|364840250|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
105778101|NCT01005966|364840251|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
105778102|NCT01005966|364840252|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
105778103|NCT01005966|364840248|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
105778104|NCT01005966|364840249|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
105778105|NCT01005966|364840250|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
105778106|NCT01005966|364840251|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
105778107|NCT01005966|364840252|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
105778108|NCT01005966|364840248|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
105778109|NCT01005966|364840249|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
105778110|NCT01005966|364840250|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
105778111|NCT01005966|364840251|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
105778112|NCT01005966|364840252|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
105778113|NCT01005966|364840248|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
105778114|NCT01005966|364840249|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
105778115|NCT01005966|364840250|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
105778116|NCT01005966|364840251|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
105778117|NCT01005966|364840252|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
105778118|NCT01005966|364840248|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105778119|NCT01005966|364840249|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105778120|NCT01005966|364840250|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105778121|NCT01005966|364840251|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
105778122|NCT01005966|364840252|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105778123|NCT01005966|364840248|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
105778124|NCT01005966|364840249|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
105778125|NCT01005966|364840250|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
105778126|NCT01005966|364840251|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
105778127|NCT01005966|364840252|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
105778128|NCT01005966|364840248|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
105778129|NCT01005966|364840249|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
105778130|NCT01005966|364840250|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
105778131|NCT01005966|364840251|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
105778132|NCT01005966|364840252|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
105778133|NCT01005966|364840248|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
105778134|NCT01005966|364840249|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
105778135|NCT01005966|364840250|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
105778136|NCT01005966|364840251|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
105778137|NCT01005966|364840252|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
105778138|NCT01005966|364840248|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
105778139|NCT01005966|364840249|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
105778140|NCT01005966|364840250|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
105778141|NCT01005966|364840251|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
105778142|NCT01005966|364840252|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
105778143|NCT03419741|364840257|FG000|Overall Study|Adverse Event|1|||
105778144|NCT03419741|364840258|FG001|Overall Study|Adverse Event|0|||
105778145|NCT03419741|364840257|FG000|Overall Study|Withdrawal by Subject|1|||
105778146|NCT03419741|364840258|FG001|Overall Study|Withdrawal by Subject|2|||
105778147|NCT00577382|364840267|FG000|Overall Study|Adverse Event|0|||
105778148|NCT00577382|364840268|FG001|Overall Study|Adverse Event|6|||
105778149|NCT00577382|364840267|FG000|Overall Study|Withdrawal by Subject|0|||
105778150|NCT00577382|364840268|FG001|Overall Study|Withdrawal by Subject|1|||
105778151|NCT00577382|364840267|FG000|Overall Study|Progressive Disease|17|||
105778152|NCT00577382|364840268|FG001|Overall Study|Progressive Disease|19|||
105778153|NCT00577382|364840267|FG000|Overall Study|Intercurrent Illness|1|||
105442569|NCT04034004|363626793|FG002|Overall Study|could not find vein to administer IV|0|||
105442570|NCT04034004|363626794|FG003|Overall Study|could not find vein to administer IV|0|||
105778154|NCT00577382|364840268|FG001|Overall Study|Intercurrent Illness|2|||
105778155|NCT00577382|364840267|FG000|Overall Study|Death|1|||
105778156|NCT00577382|364840268|FG001|Overall Study|Death|1|||
105778157|NCT00577382|364840267|FG000|Overall Study|Lost to Follow-up|2|||
105778158|NCT00577382|364840268|FG001|Overall Study|Lost to Follow-up|2|||
105778159|NCT00253747|364840269|FG000|Overall Study|Lost to Follow-up|13|||
105778160|NCT00253747|364840270|FG001|Overall Study|Lost to Follow-up|14|||
105778161|NCT00253747|364840269|FG000|Overall Study|Withdrawal by Subject|10|||
105778162|NCT00253747|364840270|FG001|Overall Study|Withdrawal by Subject|11|||
105778163|NCT00253747|364840269|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
105778164|NCT00253747|364840270|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
105778165|NCT00661362|364840271|FG000|Overall Study|Adverse Event|5|||
105778166|NCT00661362|364840272|FG001|Overall Study|Adverse Event|4|||
105778167|NCT00661362|364840271|FG000|Overall Study|Incorrect enrollment|2|||
105778168|NCT00661362|364840272|FG001|Overall Study|Incorrect enrollment|0|||
105778169|NCT00661362|364840271|FG000|Overall Study|Study specific discontinuation criteria|4|||
105778170|NCT00661362|364840272|FG001|Overall Study|Study specific discontinuation criteria|11|||
105778171|NCT00661362|364840271|FG000|Overall Study|Withdrawal by Subject|13|||
105778172|NCT00661362|364840272|FG001|Overall Study|Withdrawal by Subject|23|||
105778173|NCT00661362|364840271|FG000|Overall Study|Lost to Follow-up|3|||
105778174|NCT00661362|364840272|FG001|Overall Study|Lost to Follow-up|1|||
105778175|NCT00661362|364840271|FG000|Overall Study|Severe non-compliance to protocol|0|||
105778176|NCT00661362|364840272|FG001|Overall Study|Severe non-compliance to protocol|1|||
105778177|NCT00661362|364840271|FG000|Overall Study|Safety reasons|1|||
105778178|NCT00661362|364840272|FG001|Overall Study|Safety reasons|0|||
105778179|NCT00661362|364840271|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
105778180|NCT00661362|364840272|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
105778181|NCT00718887|364840273|FG000|Overall Study|Withdrawal by Subject|3|||
105778182|NCT00718887|364840274|FG001|Overall Study|Withdrawal by Subject|2|||
105778183|NCT00718887|364840273|FG000|Overall Study|Not identified|2|||
105778184|NCT00718887|364840274|FG001|Overall Study|Not identified|7|||
105778185|NCT00775138|364840275|FG000|Overall Study|Withdrawal by Subject|0|||
105778186|NCT00775138|364840276|FG001|Overall Study|Withdrawal by Subject|0|||
105778187|NCT00775138|364840277|FG002|Overall Study|Withdrawal by Subject|2|||
105778188|NCT00775138|364840278|FG003|Overall Study|Withdrawal by Subject|2|||
105778189|NCT00775138|364840275|FG000|Overall Study|Adverse Event|0|||
105778190|NCT00775138|364840276|FG001|Overall Study|Adverse Event|0|||
105778191|NCT00775138|364840277|FG002|Overall Study|Adverse Event|1|||
105778192|NCT00775138|364840278|FG003|Overall Study|Adverse Event|0|||
105778193|NCT04880642|364840279|FG000|Randomization|Withdrawal by Subject|2|||
105778194|NCT04880642|364840280|FG001|Randomization|Withdrawal by Subject|3|||
105778195|NCT04880642|364840279|FG000|Treatment Period|Adverse Event|0|||
105778196|NCT04880642|364840280|FG001|Treatment Period|Adverse Event|1|||
105778197|NCT04880642|364840279|FG000|Treatment Period|Death|6|||
105778198|NCT04880642|364840280|FG001|Treatment Period|Death|6|||
105778199|NCT04880642|364840279|FG000|Treatment Period|Lost to Follow-up|1|||
105778200|NCT04880642|364840280|FG001|Treatment Period|Lost to Follow-up|0|||
105778201|NCT04880642|364840279|FG000|Treatment Period|Protocol Violation|0|||
105778202|NCT04880642|364840280|FG001|Treatment Period|Protocol Violation|1|||
105778203|NCT04880642|364840279|FG000|Treatment Period|Withdrawal by Subject|5|||
105778204|NCT04880642|364840280|FG001|Treatment Period|Withdrawal by Subject|3|||
105778205|NCT04880642|364840279|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
105778206|NCT04880642|364840280|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
105778207|NCT04880642|364840279|FG000|Follow-up|Death|4|||
105778208|NCT04880642|364840280|FG001|Follow-up|Death|3|||
105778209|NCT04880642|364840279|FG000|Follow-up|Withdrawal by Subject|1|||
105778210|NCT04880642|364840280|FG001|Follow-up|Withdrawal by Subject|0|||
105778211|NCT00104299|364840281|FG000|Overall Study|Adverse Event|3|||
105778212|NCT00104299|364840282|FG001|Overall Study|Adverse Event|1|||
105778213|NCT00104299|364840281|FG000|Overall Study|Death|2|||
105778214|NCT00104299|364840282|FG001|Overall Study|Death|2|||
105778215|NCT00104299|364840281|FG000|Overall Study|Withdrawal by Subject|2|||
105778216|NCT00104299|364840282|FG001|Overall Study|Withdrawal by Subject|6|||
105778217|NCT00104299|364840281|FG000|Overall Study|Physician Decision|1|||
105778218|NCT00104299|364840282|FG001|Overall Study|Physician Decision|1|||
105778219|NCT00104299|364840281|FG000|Overall Study|To have renal transplant|1|||
105778220|NCT00104299|364840282|FG001|Overall Study|To have renal transplant|0|||
105778221|NCT04601194|364840283|FG000|Overall Study|Lost to Follow-up|7|||
105778222|NCT04905563|364840284|FG000|Overall Study|Withdrawal by Subject|1|||
105778223|NCT04905563|364840285|FG001|Overall Study|Withdrawal by Subject|0|||
105778224|NCT04905563|364840284|FG000|Overall Study|Standard of care orders entered by resident|1|||
105778225|NCT04905563|364840285|FG001|Overall Study|Standard of care orders entered by resident|0|||
105778226|NCT04905563|364840284|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
105778227|NCT04905563|364840285|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
105778228|NCT04905563|364840284|FG000|Overall Study|Withdrawal by Subject|0|||
105778229|NCT04905563|364840285|FG001|Overall Study|Withdrawal by Subject|1|||
105778230|NCT00508001|364840288|FG000|Overall Study|Adverse Event|2|||
105778231|NCT00508001|364840289|FG001|Overall Study|Adverse Event|0|||
105778232|NCT00508001|364840290|FG002|Overall Study|Adverse Event|4|||
105778233|NCT00508001|364840288|FG000|Overall Study|condition under investigation worsened|13|||
105778234|NCT00508001|364840289|FG001|Overall Study|condition under investigation worsened|7|||
105778235|NCT00508001|364840290|FG002|Overall Study|condition under investigation worsened|1|||
105778236|NCT00508001|364840288|FG000|Overall Study|Death|0|||
105778237|NCT00508001|364840289|FG001|Overall Study|Death|1|||
105778238|NCT00508001|364840290|FG002|Overall Study|Death|1|||
105778239|NCT00508001|364840288|FG000|Overall Study|Withdrawal by Subject|4|||
105778240|NCT00508001|364840289|FG001|Overall Study|Withdrawal by Subject|4|||
105778241|NCT00508001|364840290|FG002|Overall Study|Withdrawal by Subject|1|||
105778242|NCT01051856|364840291|FG000|Overall Study|Withdrawal by Subject|1|||
105778243|NCT01051856|364840292|FG001|Overall Study|Withdrawal by Subject|0|||
105778244|NCT01611558|364840293|FG000|Induction Phase|Study drug toxicity|15|||
105778245|NCT01611558|364840293|FG000|Induction Phase|Disease progression|18|||
105778246|NCT01611558|364840293|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
105778247|NCT01611558|364840293|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
105778248|NCT01611558|364840293|FG000|Induction Phase|Death|1|||
105778249|NCT01611558|364840293|FG000|Maintenance Phase|Withdrawal by Subject|1|||
105778250|NCT01611558|364840293|FG000|Maintenance Phase|Elevated Uric acid|1|||
105778251|NCT01412333|364840294|FG000|Overall Study|Adverse Event|40|||
105778252|NCT01412333|364840295|FG001|Overall Study|Adverse Event|42|||
105778253|NCT01412333|364840294|FG000|Overall Study|Death|5|||
105778254|NCT01412333|364840295|FG001|Overall Study|Death|6|||
105778255|NCT01412333|364840294|FG000|Overall Study|Lack of Efficacy|22|||
105778256|NCT01412333|364840295|FG001|Overall Study|Lack of Efficacy|10|||
105778257|NCT01412333|364840294|FG000|Overall Study|Lost to Follow-up|15|||
105778258|NCT01412333|364840295|FG001|Overall Study|Lost to Follow-up|12|||
105778259|NCT01412333|364840294|FG000|Overall Study|Non-Compliance|3|||
105778260|NCT01412333|364840295|FG001|Overall Study|Non-Compliance|7|||
105778261|NCT01412333|364840294|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105778262|NCT01412333|364840295|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105778263|NCT01412333|364840294|FG000|Overall Study|Other|30|||
105778264|NCT01412333|364840295|FG001|Overall Study|Other|33|||
105778265|NCT01412333|364840294|FG000|Overall Study|Physician Decision|11|||
105778266|NCT01412333|364840295|FG001|Overall Study|Physician Decision|16|||
105778267|NCT01412333|364840294|FG000|Overall Study|Pregnancy|6|||
105778268|NCT01412333|364840295|FG001|Overall Study|Pregnancy|4|||
105778269|NCT01412333|364840294|FG000|Overall Study|Protocol Violation|1|||
105778270|NCT01412333|364840295|FG001|Overall Study|Protocol Violation|2|||
105778271|NCT01412333|364840294|FG000|Overall Study|Study Terminated By Sponsor|3|||
105778272|NCT01412333|364840295|FG001|Overall Study|Study Terminated By Sponsor|2|||
105778273|NCT01412333|364840294|FG000|Overall Study|Withdrawal by Subject|51|||
105778274|NCT01412333|364840295|FG001|Overall Study|Withdrawal by Subject|54|||
105778275|NCT01412333|364840294|FG000|Overall Study|Missing|1|||
105778276|NCT01412333|364840295|FG001|Overall Study|Missing|3|||
105778277|NCT00750867|364840296|FG000|Overall Study|Adverse Event|2|||
105778278|NCT02543801|364840297|FG000|Overall Study|Protocol Violation|1|||
105778279|NCT02543801|364840298|FG001|Overall Study|Protocol Violation|2|||
105778280|NCT02543801|364840299|FG002|Overall Study|Protocol Violation|0|||
105778281|NCT02543801|364840300|FG003|Overall Study|Protocol Violation|0|||
105778282|NCT01981096|364840304|FG000|Overall Study|Parent illness|1|||
105778283|NCT01981096|364840305|FG001|Overall Study|Parent illness|0|||
105778284|NCT01981096|364840304|FG000|Overall Study|Withdrawal by Subject|0|||
105778285|NCT01981096|364840305|FG001|Overall Study|Withdrawal by Subject|1|||
105778286|NCT01981096|364840304|FG000|Overall Study|Lost to Follow-up|2|||
105778287|NCT01981096|364840305|FG001|Overall Study|Lost to Follow-up|0|||
105778288|NCT01225211|364840306|FG000|Overall Study|Adverse Event|0|||
105778289|NCT01225211|364840307|FG001|Overall Study|Adverse Event|0|||
105778290|NCT01225211|364840308|FG002|Overall Study|Adverse Event|1|||
105778291|NCT01225211|364840309|FG003|Overall Study|Adverse Event|0|||
105778292|NCT01225211|364840310|FG004|Overall Study|Adverse Event|0|||
105778293|NCT01225211|364840311|FG005|Overall Study|Adverse Event|0|||
105778294|NCT01225211|364840312|FG006|Overall Study|Adverse Event|0|||
105778295|NCT01225211|364840313|FG007|Overall Study|Adverse Event|0|||
105778296|NCT01225211|364840314|FG008|Overall Study|Adverse Event|0|||
105778297|NCT01225211|364840315|FG009|Overall Study|Adverse Event|1|||
105778298|NCT01225211|364840306|FG000|Overall Study|Withdrawal by Subject|0|||
105778299|NCT01225211|364840307|FG001|Overall Study|Withdrawal by Subject|0|||
105778300|NCT01225211|364840308|FG002|Overall Study|Withdrawal by Subject|0|||
105778301|NCT01225211|364840309|FG003|Overall Study|Withdrawal by Subject|0|||
105778302|NCT01225211|364840310|FG004|Overall Study|Withdrawal by Subject|0|||
105778303|NCT01225211|364840311|FG005|Overall Study|Withdrawal by Subject|0|||
105778304|NCT01225211|364840312|FG006|Overall Study|Withdrawal by Subject|1|||
105778305|NCT01225211|364840313|FG007|Overall Study|Withdrawal by Subject|0|||
105778306|NCT01225211|364840314|FG008|Overall Study|Withdrawal by Subject|1|||
105778307|NCT01225211|364840315|FG009|Overall Study|Withdrawal by Subject|3|||
105778308|NCT01225211|364840306|FG000|Overall Study|Other|0|||
105778309|NCT01225211|364840307|FG001|Overall Study|Other|0|||
105778310|NCT01225211|364840308|FG002|Overall Study|Other|0|||
105778311|NCT01225211|364840309|FG003|Overall Study|Other|0|||
105778312|NCT01225211|364840310|FG004|Overall Study|Other|0|||
105778313|NCT01225211|364840311|FG005|Overall Study|Other|0|||
105778314|NCT01225211|364840312|FG006|Overall Study|Other|0|||
105778315|NCT01225211|364840313|FG007|Overall Study|Other|0|||
105778316|NCT01225211|364840314|FG008|Overall Study|Other|0|||
105778317|NCT01225211|364840315|FG009|Overall Study|Other|1|||
105778318|NCT04129242|364840320|FG000|Overall Study|Physician Decision|1|||
105778319|NCT04129242|364840321|FG001|Overall Study|Physician Decision|1|||
105778320|NCT04129242|364840320|FG000|Overall Study|Protocol Violation|0|||
105778321|NCT04129242|364840321|FG001|Overall Study|Protocol Violation|1|||
105778322|NCT02380703|364840324|FG000|Overall Study|Withdrawal by Subject|12|||
105778323|NCT02380703|364840325|FG001|Overall Study|Withdrawal by Subject|9|||
105778324|NCT02380703|364840324|FG000|Overall Study|Lost to Follow-up|12|||
105778325|NCT02380703|364840325|FG001|Overall Study|Lost to Follow-up|12|||
105778326|NCT02380703|364840324|FG000|Overall Study|Caregiver death|1|||
105778327|NCT02380703|364840325|FG001|Overall Study|Caregiver death|0|||
105778328|NCT02380703|364840324|FG000|Overall Study|Person with dementia (PWD) death|7|||
105778329|NCT02380703|364840325|FG001|Overall Study|Person with dementia (PWD) death|8|||
105778330|NCT02380703|364840324|FG000|Overall Study|Entered Long-term Care|4|||
105778331|NCT02380703|364840325|FG001|Overall Study|Entered Long-term Care|7|||
105778332|NCT02709889|364840333|FG000|Overall Study|Withdrawal by Subject|11|||
105778333|NCT02709889|364840334|FG001|Overall Study|Withdrawal by Subject|10|||
105778334|NCT02709889|364840335|FG002|Overall Study|Withdrawal by Subject|2|||
105778335|NCT02709889|364840336|FG003|Overall Study|Withdrawal by Subject|12|||
105778336|NCT02709889|364840333|FG000|Overall Study|Death|25|||
105778337|NCT02709889|364840334|FG001|Overall Study|Death|38|||
105778338|NCT02709889|364840335|FG002|Overall Study|Death|4|||
105778339|NCT02709889|364840336|FG003|Overall Study|Death|44|||
105778340|NCT02709889|364840333|FG000|Overall Study|Physician Decision|1|||
105778341|NCT02709889|364840334|FG001|Overall Study|Physician Decision|2|||
105778342|NCT02709889|364840335|FG002|Overall Study|Physician Decision|3|||
105778343|NCT02709889|364840336|FG003|Overall Study|Physician Decision|5|||
105778344|NCT02709889|364840333|FG000|Overall Study|Lost to Follow-up|2|||
105778345|NCT02709889|364840334|FG001|Overall Study|Lost to Follow-up|0|||
105778346|NCT02709889|364840335|FG002|Overall Study|Lost to Follow-up|0|||
105778347|NCT02709889|364840336|FG003|Overall Study|Lost to Follow-up|4|||
105778348|NCT02709889|364840333|FG000|Overall Study|Study Terminated by Sponsor|4|||
105778349|NCT02709889|364840334|FG001|Overall Study|Study Terminated by Sponsor|6|||
105778350|NCT02709889|364840335|FG002|Overall Study|Study Terminated by Sponsor|2|||
105778351|NCT02709889|364840336|FG003|Overall Study|Study Terminated by Sponsor|17|||
105778352|NCT02709889|364840333|FG000|Overall Study|Other, Not Specified|0|||
105778353|NCT02709889|364840334|FG001|Overall Study|Other, Not Specified|1|||
105778354|NCT02709889|364840335|FG002|Overall Study|Other, Not Specified|1|||
105778355|NCT02709889|364840336|FG003|Overall Study|Other, Not Specified|6|||
105778356|NCT00537810|364840338|FG000|Overall Study|Withdrawal by Subject|4|||
105778357|NCT00537810|364840339|FG001|Overall Study|Withdrawal by Subject|11|||
105778358|NCT00537810|364840340|FG002|Overall Study|Withdrawal by Subject|4|||
105778359|NCT00537810|364840341|FG003|Overall Study|Withdrawal by Subject|3|||
105778360|NCT00537810|364840338|FG000|Overall Study|Medically withdrawn|2|||
105778361|NCT00537810|364840339|FG001|Overall Study|Medically withdrawn|2|||
105778362|NCT00537810|364840340|FG002|Overall Study|Medically withdrawn|0|||
105778363|NCT00537810|364840341|FG003|Overall Study|Medically withdrawn|1|||
105778364|NCT00962780|364840343|FG000|Overall Study|Death|0|||
105778365|NCT00962780|364840344|FG001|Overall Study|Death|1|||
105778366|NCT00962780|364840343|FG000|Overall Study|Protocol Violation|9|||
105778367|NCT00962780|364840344|FG001|Overall Study|Protocol Violation|4|||
105778368|NCT00962780|364840343|FG000|Overall Study|Withdrawal by Subject|1|||
105778369|NCT00962780|364840344|FG001|Overall Study|Withdrawal by Subject|8|||
105778370|NCT00962780|364840343|FG000|Overall Study|Other|0|||
105778371|NCT00962780|364840344|FG001|Overall Study|Other|1|||
105778372|NCT01775995|364840348|FG000|Overall Study|Lost to Follow-up|1|||
105778373|NCT01775995|364840349|FG001|Overall Study|Lost to Follow-up|1|||
105778374|NCT02269709|364840350|FG000|Time of Enrollment|Withdrawal by Subject|3|||
105778375|NCT02269709|364840350|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
105778376|NCT02269709|364840350|FG000|Six Month Follow-up|Lost to Follow-up|12|||
105778377|NCT01657903|364840353|FG000|Overall Study|Lost to Follow-up|1|||
105778378|NCT01657903|364840353|FG000|Overall Study|Withdrawal by Subject|1|||
105778379|NCT01259388|364840356|FG000|Overall Study|Adverse Event|3|||
105778380|NCT01259388|364840357|FG001|Overall Study|Adverse Event|0|||
105778381|NCT01259388|364840356|FG000|Overall Study|Withdrawal by Subject|1|||
105778382|NCT01259388|364840357|FG001|Overall Study|Withdrawal by Subject|1|||
105778383|NCT01259388|364840356|FG000|Overall Study|Physician Decision|1|||
105778384|NCT01259388|364840357|FG001|Overall Study|Physician Decision|0|||
105778385|NCT03512028|364840358|FG000|Overall Study|Withdrawal by Subject|2|||
105778386|NCT03512028|364840359|FG001|Overall Study|Withdrawal by Subject|0|||
105778387|NCT03512028|364840358|FG000|Overall Study|Protocol Violation|2|||
105778388|NCT03512028|364840359|FG001|Overall Study|Protocol Violation|0|||
105778389|NCT01475214|364840360|FG000|Overall Study|Lost to Follow-up|1|||
105778390|NCT01475214|364840361|FG001|Overall Study|Lost to Follow-up|0|||
105778391|NCT01475214|364840362|FG002|Overall Study|Lost to Follow-up|1|||
105778392|NCT01475214|364840360|FG000|Overall Study|Physician Decision|2|||
105778393|NCT01475214|364840361|FG001|Overall Study|Physician Decision|0|||
105778394|NCT01475214|364840362|FG002|Overall Study|Physician Decision|0|||
105778395|NCT01475214|364840360|FG000|Overall Study|Withdrawal by Subject|2|||
105778396|NCT01475214|364840361|FG001|Overall Study|Withdrawal by Subject|4|||
105778397|NCT01475214|364840362|FG002|Overall Study|Withdrawal by Subject|1|||
105778398|NCT02743494|364840363|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
105778399|NCT02743494|364840364|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
105778400|NCT02743494|364840363|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
105778401|NCT02743494|364840364|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
105778402|NCT02743494|364840363|FG000|Treatment Period|Completed treatment|229|||
105778403|NCT02743494|364840364|FG001|Treatment Period|Completed treatment|99|||
105778404|NCT02743494|364840363|FG000|Treatment Period|Disease recurrence|149|||
105778405|NCT02743494|364840364|FG001|Treatment Period|Disease recurrence|113|||
105778406|NCT02743494|364840363|FG000|Treatment Period|Study drug toxicity|57|||
105778407|NCT02743494|364840364|FG001|Treatment Period|Study drug toxicity|8|||
105778408|NCT02743494|364840363|FG000|Treatment Period|Death|1|||
105778409|NCT02743494|364840364|FG001|Treatment Period|Death|0|||
105778410|NCT02743494|364840363|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
105778411|NCT02743494|364840364|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
105778412|NCT02743494|364840363|FG000|Treatment Period|Participant request to discontinue treatment|30|||
105778413|NCT02743494|364840364|FG001|Treatment Period|Participant request to discontinue treatment|5|||
105778414|NCT02743494|364840363|FG000|Treatment Period|Participant withdrew consent|12|||
105778415|NCT02743494|364840364|FG001|Treatment Period|Participant withdrew consent|4|||
105778416|NCT02743494|364840363|FG000|Treatment Period|Lost to Follow-up|0|||
105778417|NCT02743494|364840364|FG001|Treatment Period|Lost to Follow-up|1|||
105778418|NCT02743494|364840363|FG000|Treatment Period|Poor/Non-compliance|1|||
105778419|NCT02743494|364840364|FG001|Treatment Period|Poor/Non-compliance|0|||
105778420|NCT02743494|364840363|FG000|Treatment Period|Other reasons|7|||
105778421|NCT02743494|364840364|FG001|Treatment Period|Other reasons|2|||
105778422|NCT00643851|364840367|FG000|Overall Study|Death|0|||
105778423|NCT00643851|364840368|FG001|Overall Study|Death|1|||
105778424|NCT00643851|364840369|FG002|Overall Study|Death|0|||
105778425|NCT00643851|364840367|FG000|Overall Study|Lack of Efficacy|0|||
105778426|NCT00643851|364840368|FG001|Overall Study|Lack of Efficacy|1|||
105778427|NCT00643851|364840369|FG002|Overall Study|Lack of Efficacy|0|||
105778428|NCT00643851|364840367|FG000|Overall Study|Adverse Event|2|||
105778429|NCT00643851|364840368|FG001|Overall Study|Adverse Event|6|||
105778430|NCT00643851|364840369|FG002|Overall Study|Adverse Event|6|||
105778431|NCT00643851|364840367|FG000|Overall Study|Lost to Follow-up|4|||
105778432|NCT00643851|364840368|FG001|Overall Study|Lost to Follow-up|6|||
105778433|NCT00643851|364840369|FG002|Overall Study|Lost to Follow-up|9|||
105778434|NCT00643851|364840367|FG000|Overall Study|Withdrawal by Subject|8|||
105778435|NCT00643851|364840368|FG001|Overall Study|Withdrawal by Subject|15|||
105778436|NCT00643851|364840369|FG002|Overall Study|Withdrawal by Subject|9|||
105778437|NCT00643851|364840367|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
105778438|NCT00643851|364840368|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
105778439|NCT00643851|364840369|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
105778440|NCT03529162|364840370|FG000|Overall Study|Lost to Follow-up|2|||
105778441|NCT03529162|364840371|FG001|Overall Study|Lost to Follow-up|2|||
105778442|NCT01521494|364840372|FG000|Overall Study|Adverse Event|1|||
105778443|NCT01521494|364840373|FG001|Overall Study|Adverse Event|2|||
105778444|NCT01521494|364840374|FG002|Overall Study|Adverse Event|9|||
105778445|NCT01521494|364840375|FG003|Overall Study|Adverse Event|6|||
105778446|NCT01521494|364840376|FG004|Overall Study|Adverse Event|2|||
105778447|NCT01521494|364840372|FG000|Overall Study|Lack of Efficacy|0|||
105778448|NCT01521494|364840373|FG001|Overall Study|Lack of Efficacy|0|||
105778449|NCT01521494|364840374|FG002|Overall Study|Lack of Efficacy|0|||
105778450|NCT01521494|364840375|FG003|Overall Study|Lack of Efficacy|0|||
105778451|NCT01521494|364840376|FG004|Overall Study|Lack of Efficacy|2|||
105778452|NCT01521494|364840372|FG000|Overall Study|Withdrawal by Subject|1|||
105778453|NCT01521494|364840373|FG001|Overall Study|Withdrawal by Subject|1|||
105778454|NCT01521494|364840374|FG002|Overall Study|Withdrawal by Subject|0|||
105778455|NCT01521494|364840375|FG003|Overall Study|Withdrawal by Subject|2|||
105778456|NCT01521494|364840376|FG004|Overall Study|Withdrawal by Subject|0|||
105778457|NCT01521494|364840372|FG000|Overall Study|Decrease in serum phosphate|0|||
105778458|NCT01521494|364840373|FG001|Overall Study|Decrease in serum phosphate|2|||
105778459|NCT01521494|364840374|FG002|Overall Study|Decrease in serum phosphate|3|||
105778460|NCT01521494|364840375|FG003|Overall Study|Decrease in serum phosphate|12|||
105778461|NCT01521494|364840376|FG004|Overall Study|Decrease in serum phosphate|0|||
105778462|NCT01521494|364840372|FG000|Overall Study|Decrease in serum calcium|0|||
105778463|NCT01521494|364840373|FG001|Overall Study|Decrease in serum calcium|0|||
105778464|NCT01521494|364840374|FG002|Overall Study|Decrease in serum calcium|0|||
105778465|NCT01521494|364840375|FG003|Overall Study|Decrease in serum calcium|1|||
105778466|NCT01521494|364840376|FG004|Overall Study|Decrease in serum calcium|1|||
105778467|NCT01521494|364840372|FG000|Overall Study|Physician Decision|0|||
105778468|NCT01521494|364840373|FG001|Overall Study|Physician Decision|0|||
105778469|NCT01521494|364840374|FG002|Overall Study|Physician Decision|0|||
105778470|NCT01521494|364840375|FG003|Overall Study|Physician Decision|0|||
105778471|NCT01521494|364840376|FG004|Overall Study|Physician Decision|2|||
105778472|NCT02728804|364840379|FG000|Overall Study|Ineligible|3|||
105778473|NCT02728804|364840379|FG000|Overall Study|Did not complete baseline questionnaire|9|||
105778474|NCT02728804|364840379|FG000|Overall Study|Death|99|||
105778475|NCT00591786|364840380|FG000|Overall Study|Withdrawal of Informed Consent|0|||
105778476|NCT00591786|364840381|FG001|Overall Study|Withdrawal of Informed Consent|0|||
105778477|NCT00591786|364840382|FG002|Overall Study|Withdrawal of Informed Consent|1|||
105778478|NCT00591786|364840383|FG003|Overall Study|Withdrawal of Informed Consent|0|||
105778479|NCT00591786|364840384|FG004|Overall Study|Withdrawal of Informed Consent|0|||
105778480|NCT00591786|364840385|FG005|Overall Study|Withdrawal of Informed Consent|0|||
105778481|NCT00591786|364840386|FG006|Overall Study|Withdrawal of Informed Consent|0|||
105778482|NCT00591786|364840387|FG007|Overall Study|Withdrawal of Informed Consent|0|||
105778483|NCT00591786|364840388|FG008|Overall Study|Withdrawal of Informed Consent|0|||
105778484|NCT00591786|364840389|FG009|Overall Study|Withdrawal of Informed Consent|0|||
105778485|NCT01920061|364840393|FG000|Overall Study|Death|1|||
105778486|NCT01920061|364840394|FG001|Overall Study|Death|1|||
105778487|NCT01920061|364840395|FG002|Overall Study|Death|0|||
105778488|NCT01920061|364840396|FG003|Overall Study|Death|1|||
105778489|NCT01920061|364840397|FG004|Overall Study|Death|1|||
105778490|NCT01920061|364840398|FG005|Overall Study|Death|0|||
105778491|NCT01920061|364840399|FG006|Overall Study|Death|0|||
105778492|NCT01920061|364840400|FG007|Overall Study|Death|1|||
105778493|NCT01920061|364840401|FG008|Overall Study|Death|0|||
105778494|NCT01920061|364840402|FG009|Overall Study|Death|1|||
105778495|NCT01920061|364840403|FG010|Overall Study|Death|0|||
105778496|NCT01920061|364840404|FG011|Overall Study|Death|1|||
105778497|NCT01920061|364840405|FG012|Overall Study|Death|0|||
105778498|NCT01920061|364840406|FG013|Overall Study|Death|2|||
105778499|NCT01920061|364840407|FG014|Overall Study|Death|0|||
105778500|NCT01920061|364840408|FG015|Overall Study|Death|0|||
105778501|NCT01920061|364840409|FG016|Overall Study|Death|0|||
105778502|NCT01920061|364840410|FG017|Overall Study|Death|0|||
105778503|NCT01920061|364840411|FG018|Overall Study|Death|1|||
105778504|NCT01920061|364840412|FG019|Overall Study|Death|0|||
105778505|NCT01920061|364840393|FG000|Overall Study|Lost to Follow-up|0|||
105778506|NCT01920061|364840394|FG001|Overall Study|Lost to Follow-up|2|||
105778507|NCT01920061|364840395|FG002|Overall Study|Lost to Follow-up|0|||
105778508|NCT01920061|364840396|FG003|Overall Study|Lost to Follow-up|0|||
105778509|NCT01920061|364840397|FG004|Overall Study|Lost to Follow-up|0|||
105778510|NCT01920061|364840398|FG005|Overall Study|Lost to Follow-up|0|||
105778511|NCT01920061|364840399|FG006|Overall Study|Lost to Follow-up|1|||
105778512|NCT01920061|364840400|FG007|Overall Study|Lost to Follow-up|0|||
105778513|NCT01920061|364840401|FG008|Overall Study|Lost to Follow-up|0|||
105778514|NCT01920061|364840402|FG009|Overall Study|Lost to Follow-up|0|||
105778515|NCT01920061|364840403|FG010|Overall Study|Lost to Follow-up|3|||
105778516|NCT01920061|364840404|FG011|Overall Study|Lost to Follow-up|0|||
105778517|NCT01920061|364840405|FG012|Overall Study|Lost to Follow-up|0|||
105778518|NCT01920061|364840406|FG013|Overall Study|Lost to Follow-up|0|||
105778519|NCT01920061|364840407|FG014|Overall Study|Lost to Follow-up|0|||
105778520|NCT01920061|364840408|FG015|Overall Study|Lost to Follow-up|0|||
105778521|NCT01920061|364840409|FG016|Overall Study|Lost to Follow-up|0|||
105778522|NCT01920061|364840410|FG017|Overall Study|Lost to Follow-up|1|||
105778523|NCT01920061|364840411|FG018|Overall Study|Lost to Follow-up|4|||
105778524|NCT01920061|364840412|FG019|Overall Study|Lost to Follow-up|3|||
105778525|NCT01920061|364840393|FG000|Overall Study|Other|1|||
105778526|NCT01920061|364840394|FG001|Overall Study|Other|1|||
105778527|NCT01920061|364840395|FG002|Overall Study|Other|2|||
105778528|NCT01920061|364840396|FG003|Overall Study|Other|1|||
105778529|NCT01920061|364840397|FG004|Overall Study|Other|0|||
105778530|NCT01920061|364840398|FG005|Overall Study|Other|1|||
105778531|NCT01920061|364840399|FG006|Overall Study|Other|0|||
105778532|NCT01920061|364840400|FG007|Overall Study|Other|0|||
105778533|NCT01920061|364840401|FG008|Overall Study|Other|0|||
105778534|NCT01920061|364840402|FG009|Overall Study|Other|1|||
105778535|NCT01920061|364840403|FG010|Overall Study|Other|1|||
105778536|NCT01920061|364840404|FG011|Overall Study|Other|2|||
105778537|NCT01920061|364840405|FG012|Overall Study|Other|1|||
105778538|NCT01920061|364840406|FG013|Overall Study|Other|4|||
105778539|NCT01920061|364840407|FG014|Overall Study|Other|0|||
105778540|NCT01920061|364840408|FG015|Overall Study|Other|1|||
105778541|NCT01920061|364840409|FG016|Overall Study|Other|1|||
105778542|NCT01920061|364840410|FG017|Overall Study|Other|0|||
105778543|NCT01920061|364840411|FG018|Overall Study|Other|1|||
105778544|NCT01920061|364840412|FG019|Overall Study|Other|1|||
105778545|NCT01920061|364840393|FG000|Overall Study|Participant refused further follow-up|0|||
105778546|NCT01920061|364840394|FG001|Overall Study|Participant refused further follow-up|0|||
105778547|NCT01920061|364840395|FG002|Overall Study|Participant refused further follow-up|0|||
105778548|NCT01920061|364840396|FG003|Overall Study|Participant refused further follow-up|0|||
105778549|NCT01920061|364840397|FG004|Overall Study|Participant refused further follow-up|1|||
105778550|NCT01920061|364840398|FG005|Overall Study|Participant refused further follow-up|1|||
105778551|NCT01920061|364840399|FG006|Overall Study|Participant refused further follow-up|0|||
105778552|NCT01920061|364840400|FG007|Overall Study|Participant refused further follow-up|0|||
105778553|NCT01920061|364840401|FG008|Overall Study|Participant refused further follow-up|1|||
105778554|NCT01920061|364840402|FG009|Overall Study|Participant refused further follow-up|0|||
105778555|NCT01920061|364840403|FG010|Overall Study|Participant refused further follow-up|1|||
105778556|NCT01920061|364840404|FG011|Overall Study|Participant refused further follow-up|0|||
105334073|NCT01314872|363223082|FG012|Treatment Period 1|Lack of Efficacy|0|||
105334074|NCT01314872|363223083|FG013|Treatment Period 1|Lack of Efficacy|0|||
105334075|NCT01314872|363223084|FG014|Treatment Period 1|Lack of Efficacy|0|||
105334076|NCT01314872|363223070|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
105334077|NCT01314872|363223071|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
105334078|NCT01314872|363223072|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
105334079|NCT01314872|363223073|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
105334080|NCT01314872|363223074|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
105334081|NCT01314872|363223075|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
105334082|NCT01314872|363223076|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
105334083|NCT01314872|363223077|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
105334084|NCT01314872|363223078|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
105334085|NCT01314872|363223079|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
105334086|NCT01314872|363223080|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
105334087|NCT01314872|363223081|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
105334088|NCT01314872|363223082|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
105778557|NCT01920061|364840405|FG012|Overall Study|Participant refused further follow-up|1|||
105778558|NCT01920061|364840406|FG013|Overall Study|Participant refused further follow-up|0|||
105778559|NCT01920061|364840407|FG014|Overall Study|Participant refused further follow-up|1|||
105778560|NCT01920061|364840408|FG015|Overall Study|Participant refused further follow-up|2|||
105778561|NCT01920061|364840409|FG016|Overall Study|Participant refused further follow-up|1|||
105778562|NCT01920061|364840410|FG017|Overall Study|Participant refused further follow-up|1|||
105778563|NCT01920061|364840411|FG018|Overall Study|Participant refused further follow-up|0|||
105778564|NCT01920061|364840412|FG019|Overall Study|Participant refused further follow-up|0|||
105778565|NCT00554229|364840413|FG000|Overall Study|Lost to Follow-up|3|||
105778566|NCT00554229|364840414|FG001|Overall Study|Lost to Follow-up|6|||
105778567|NCT00554229|364840413|FG000|Overall Study|Withdrawal by Subject|29|||
105778568|NCT00554229|364840414|FG001|Overall Study|Withdrawal by Subject|37|||
105778569|NCT00554229|364840413|FG000|Overall Study|Adverse Event|71|||
105778570|NCT00554229|364840414|FG001|Overall Study|Adverse Event|39|||
105778571|NCT00554229|364840413|FG000|Overall Study|Protocol Violation|3|||
105778572|NCT00554229|364840414|FG001|Overall Study|Protocol Violation|3|||
105778573|NCT00554229|364840413|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
105778574|NCT00554229|364840414|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
105778575|NCT00554229|364840413|FG000|Overall Study|Randomised but no treatment received|1|||
105778576|NCT00554229|364840414|FG001|Overall Study|Randomised but no treatment received|0|||
105778577|NCT01140646|364840415|FG000|Overall Study|Adverse Event|4|||
105778578|NCT01140646|364840415|FG000|Overall Study|Refused Further Treatment|5|||
105778579|NCT04557189|364840419|FG000|Overall Study|Adverse Event|0|||
105778580|NCT04557189|364840420|FG001|Overall Study|Adverse Event|1|||
105778581|NCT04557189|364840419|FG000|Overall Study|Lost to Follow-up|1|||
105778582|NCT04557189|364840420|FG001|Overall Study|Lost to Follow-up|1|||
105778583|NCT04557189|364840419|FG000|Overall Study|Withdrawal by Subject|2|||
105778584|NCT04557189|364840420|FG001|Overall Study|Withdrawal by Subject|1|||
105778585|NCT04557189|364840419|FG000|Overall Study|Reason not Specified|3|||
105778586|NCT04557189|364840420|FG001|Overall Study|Reason not Specified|6|||
105778587|NCT01636076|364840424|FG000|Overall Study|Terminated by sponsor|1|||
105778588|NCT01636076|364840425|FG001|Overall Study|Terminated by sponsor|1|||
105778589|NCT01636076|364840424|FG000|Overall Study|Lack of Efficacy|0|||
105778590|NCT01636076|364840425|FG001|Overall Study|Lack of Efficacy|1|||
105778591|NCT01636076|364840424|FG000|Overall Study|Lost to Follow-up|1|||
105778592|NCT01636076|364840425|FG001|Overall Study|Lost to Follow-up|0|||
105778593|NCT01636076|364840424|FG000|Overall Study|Physician Decision|1|||
105778594|NCT01636076|364840425|FG001|Overall Study|Physician Decision|1|||
105778595|NCT01636076|364840424|FG000|Overall Study|Non-compliance with study treatment|1|||
105778596|NCT01636076|364840425|FG001|Overall Study|Non-compliance with study treatment|1|||
105778597|NCT01636076|364840424|FG000|Overall Study|Adverse Event|6|||
105778598|NCT01636076|364840425|FG001|Overall Study|Adverse Event|11|||
105778599|NCT01636076|364840424|FG000|Overall Study|Withdrawal by Subject|7|||
105778600|NCT01636076|364840425|FG001|Overall Study|Withdrawal by Subject|10|||
105778601|NCT01681004|364840428|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
105778602|NCT01681004|364840429|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
105778603|NCT01681004|364840428|FG000|Study Completion|Lost to Follow-up|8|||
105778604|NCT01681004|364840429|FG001|Study Completion|Lost to Follow-up|3|||
105778605|NCT01681004|364840428|FG000|Study Completion|Physician Decision|1|||
105778606|NCT01681004|364840429|FG001|Study Completion|Physician Decision|3|||
105778607|NCT01681004|364840428|FG000|Study Completion|Site Termination|2|||
105778608|NCT01681004|364840429|FG001|Study Completion|Site Termination|1|||
105334089|NCT01314872|363223083|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
105334090|NCT01314872|363223084|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
105334091|NCT01314872|363223070|FG000|Treatment Period 1|Withdrawal by Subject|3|||
105334092|NCT01314872|363223071|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105334093|NCT01314872|363223072|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105334094|NCT01314872|363223073|FG003|Treatment Period 1|Withdrawal by Subject|2|||
105334095|NCT01314872|363223074|FG004|Treatment Period 1|Withdrawal by Subject|3|||
105334096|NCT01314872|363223075|FG005|Treatment Period 1|Withdrawal by Subject|1|||
105334097|NCT01314872|363223076|FG006|Treatment Period 1|Withdrawal by Subject|3|||
105334098|NCT01314872|363223077|FG007|Treatment Period 1|Withdrawal by Subject|2|||
105334099|NCT01314872|363223078|FG008|Treatment Period 1|Withdrawal by Subject|2|||
105334100|NCT01314872|363223079|FG009|Treatment Period 1|Withdrawal by Subject|2|||
105334101|NCT01314872|363223080|FG010|Treatment Period 1|Withdrawal by Subject|1|||
105334102|NCT01314872|363223081|FG011|Treatment Period 1|Withdrawal by Subject|0|||
105334103|NCT01314872|363223082|FG012|Treatment Period 1|Withdrawal by Subject|0|||
105334104|NCT01314872|363223083|FG013|Treatment Period 1|Withdrawal by Subject|0|||
105334105|NCT01314872|363223084|FG014|Treatment Period 1|Withdrawal by Subject|0|||
105334106|NCT01314872|363223070|FG000|Treatment Period 1|Lost to Follow-up|0|||
105334107|NCT01314872|363223071|FG001|Treatment Period 1|Lost to Follow-up|1|||
105334108|NCT01314872|363223072|FG002|Treatment Period 1|Lost to Follow-up|2|||
105334109|NCT01314872|363223073|FG003|Treatment Period 1|Lost to Follow-up|2|||
105334110|NCT01314872|363223074|FG004|Treatment Period 1|Lost to Follow-up|1|||
105334111|NCT01314872|363223075|FG005|Treatment Period 1|Lost to Follow-up|1|||
105334112|NCT01314872|363223076|FG006|Treatment Period 1|Lost to Follow-up|1|||
105334113|NCT01314872|363223077|FG007|Treatment Period 1|Lost to Follow-up|1|||
105334114|NCT01314872|363223078|FG008|Treatment Period 1|Lost to Follow-up|1|||
105334115|NCT01314872|363223079|FG009|Treatment Period 1|Lost to Follow-up|0|||
105334116|NCT01314872|363223080|FG010|Treatment Period 1|Lost to Follow-up|0|||
105334117|NCT01314872|363223081|FG011|Treatment Period 1|Lost to Follow-up|0|||
105334118|NCT01314872|363223082|FG012|Treatment Period 1|Lost to Follow-up|0|||
105334119|NCT01314872|363223083|FG013|Treatment Period 1|Lost to Follow-up|0|||
105334120|NCT01314872|363223084|FG014|Treatment Period 1|Lost to Follow-up|0|||
105334121|NCT01314872|363223070|FG000|Period 2|Protocol Violation|0|||
105334122|NCT01314872|363223071|FG001|Period 2|Protocol Violation|0|||
105334123|NCT01314872|363223072|FG002|Period 2|Protocol Violation|0|||
105334124|NCT01314872|363223073|FG003|Period 2|Protocol Violation|0|||
105334125|NCT01314872|363223074|FG004|Period 2|Protocol Violation|0|||
105334126|NCT01314872|363223075|FG005|Period 2|Protocol Violation|0|||
105334127|NCT01314872|363223076|FG006|Period 2|Protocol Violation|0|||
105334128|NCT01314872|363223077|FG007|Period 2|Protocol Violation|0|||
105334129|NCT01314872|363223078|FG008|Period 2|Protocol Violation|0|||
105334130|NCT01314872|363223079|FG009|Period 2|Protocol Violation|0|||
105334131|NCT01314872|363223080|FG010|Period 2|Protocol Violation|0|||
105334132|NCT01314872|363223081|FG011|Period 2|Protocol Violation|3|||
105334133|NCT01314872|363223082|FG012|Period 2|Protocol Violation|3|||
105334134|NCT01314872|363223083|FG013|Period 2|Protocol Violation|2|||
105334135|NCT01314872|363223084|FG014|Period 2|Protocol Violation|0|||
105334136|NCT01314872|363223070|FG000|Period 2|Non-compliance with study drug|0|||
105334137|NCT01314872|363223071|FG001|Period 2|Non-compliance with study drug|0|||
105334138|NCT01314872|363223072|FG002|Period 2|Non-compliance with study drug|0|||
105334139|NCT01314872|363223073|FG003|Period 2|Non-compliance with study drug|0|||
105334140|NCT01314872|363223074|FG004|Period 2|Non-compliance with study drug|0|||
105334141|NCT01314872|363223075|FG005|Period 2|Non-compliance with study drug|0|||
105334142|NCT01314872|363223076|FG006|Period 2|Non-compliance with study drug|0|||
105334143|NCT01314872|363223077|FG007|Period 2|Non-compliance with study drug|0|||
105334144|NCT01314872|363223078|FG008|Period 2|Non-compliance with study drug|0|||
105334145|NCT01314872|363223079|FG009|Period 2|Non-compliance with study drug|0|||
105334146|NCT01314872|363223080|FG010|Period 2|Non-compliance with study drug|0|||
105334147|NCT01314872|363223081|FG011|Period 2|Non-compliance with study drug|3|||
105334148|NCT01314872|363223082|FG012|Period 2|Non-compliance with study drug|3|||
105334149|NCT01314872|363223083|FG013|Period 2|Non-compliance with study drug|1|||
105334150|NCT01314872|363223084|FG014|Period 2|Non-compliance with study drug|2|||
105334151|NCT01314872|363223070|FG000|Period 2|Lack of Efficacy|0|||
105334152|NCT01314872|363223071|FG001|Period 2|Lack of Efficacy|0|||
105334153|NCT01314872|363223072|FG002|Period 2|Lack of Efficacy|0|||
105334154|NCT01314872|363223073|FG003|Period 2|Lack of Efficacy|0|||
105334155|NCT01314872|363223074|FG004|Period 2|Lack of Efficacy|0|||
105334156|NCT01314872|363223075|FG005|Period 2|Lack of Efficacy|0|||
105334157|NCT01314872|363223076|FG006|Period 2|Lack of Efficacy|0|||
105334158|NCT01314872|363223077|FG007|Period 2|Lack of Efficacy|0|||
105334159|NCT01314872|363223078|FG008|Period 2|Lack of Efficacy|0|||
105442571|NCT04034004|363626791|FG000|Overall Study|nurse accidentally unblinded subject|0|||
105778609|NCT01681004|364840428|FG000|Study Completion|Death|1|||
105334160|NCT01314872|363223079|FG009|Period 2|Lack of Efficacy|0|||
105334161|NCT01314872|363223080|FG010|Period 2|Lack of Efficacy|0|||
105334162|NCT01314872|363223081|FG011|Period 2|Lack of Efficacy|7|||
105334163|NCT01314872|363223082|FG012|Period 2|Lack of Efficacy|12|||
105334164|NCT01314872|363223083|FG013|Period 2|Lack of Efficacy|9|||
105334165|NCT01314872|363223084|FG014|Period 2|Lack of Efficacy|2|||
105334166|NCT01314872|363223070|FG000|Period 2|Pregnancy|0|||
105334167|NCT01314872|363223071|FG001|Period 2|Pregnancy|0|||
105334168|NCT01314872|363223072|FG002|Period 2|Pregnancy|0|||
105334169|NCT01314872|363223073|FG003|Period 2|Pregnancy|0|||
105334170|NCT01314872|363223074|FG004|Period 2|Pregnancy|0|||
105334171|NCT01314872|363223075|FG005|Period 2|Pregnancy|0|||
105334172|NCT01314872|363223076|FG006|Period 2|Pregnancy|0|||
105334173|NCT01314872|363223077|FG007|Period 2|Pregnancy|0|||
105334174|NCT01314872|363223078|FG008|Period 2|Pregnancy|0|||
105334175|NCT01314872|363223079|FG009|Period 2|Pregnancy|0|||
105334176|NCT01314872|363223080|FG010|Period 2|Pregnancy|0|||
105334177|NCT01314872|363223081|FG011|Period 2|Pregnancy|0|||
105334178|NCT01314872|363223082|FG012|Period 2|Pregnancy|0|||
105334179|NCT01314872|363223083|FG013|Period 2|Pregnancy|0|||
105334180|NCT01314872|363223084|FG014|Period 2|Pregnancy|1|||
105334181|NCT01314872|363223070|FG000|Period 2|Study terminated by Sponsor|0|||
105334182|NCT01314872|363223071|FG001|Period 2|Study terminated by Sponsor|0|||
105334183|NCT01314872|363223072|FG002|Period 2|Study terminated by Sponsor|0|||
105334184|NCT01314872|363223073|FG003|Period 2|Study terminated by Sponsor|0|||
105334185|NCT01314872|363223074|FG004|Period 2|Study terminated by Sponsor|0|||
105334186|NCT01314872|363223075|FG005|Period 2|Study terminated by Sponsor|0|||
105334187|NCT01314872|363223076|FG006|Period 2|Study terminated by Sponsor|0|||
105334188|NCT01314872|363223077|FG007|Period 2|Study terminated by Sponsor|0|||
105334189|NCT01314872|363223078|FG008|Period 2|Study terminated by Sponsor|0|||
105334190|NCT01314872|363223079|FG009|Period 2|Study terminated by Sponsor|0|||
105334191|NCT01314872|363223080|FG010|Period 2|Study terminated by Sponsor|0|||
105334192|NCT01314872|363223081|FG011|Period 2|Study terminated by Sponsor|2|||
105334193|NCT01314872|363223082|FG012|Period 2|Study terminated by Sponsor|2|||
105334194|NCT01314872|363223083|FG013|Period 2|Study terminated by Sponsor|3|||
105334195|NCT01314872|363223084|FG014|Period 2|Study terminated by Sponsor|0|||
105334196|NCT01314872|363223070|FG000|Period 2|Adverse event, non-fatal|0|||
105334197|NCT01314872|363223071|FG001|Period 2|Adverse event, non-fatal|0|||
105334198|NCT01314872|363223072|FG002|Period 2|Adverse event, non-fatal|0|||
105334199|NCT01314872|363223073|FG003|Period 2|Adverse event, non-fatal|0|||
105334200|NCT01314872|363223074|FG004|Period 2|Adverse event, non-fatal|0|||
105334201|NCT01314872|363223075|FG005|Period 2|Adverse event, non-fatal|0|||
105334202|NCT01314872|363223076|FG006|Period 2|Adverse event, non-fatal|0|||
105334203|NCT01314872|363223077|FG007|Period 2|Adverse event, non-fatal|0|||
105334204|NCT01314872|363223078|FG008|Period 2|Adverse event, non-fatal|0|||
105334205|NCT01314872|363223079|FG009|Period 2|Adverse event, non-fatal|0|||
105334206|NCT01314872|363223080|FG010|Period 2|Adverse event, non-fatal|0|||
105334207|NCT01314872|363223081|FG011|Period 2|Adverse event, non-fatal|13|||
105334208|NCT01314872|363223082|FG012|Period 2|Adverse event, non-fatal|16|||
105334209|NCT01314872|363223083|FG013|Period 2|Adverse event, non-fatal|24|||
105334210|NCT01314872|363223084|FG014|Period 2|Adverse event, non-fatal|9|||
105334211|NCT01314872|363223070|FG000|Period 2|Withdrawal by Subject|0|||
105334212|NCT01314872|363223071|FG001|Period 2|Withdrawal by Subject|0|||
105334213|NCT01314872|363223072|FG002|Period 2|Withdrawal by Subject|0|||
105334214|NCT01314872|363223073|FG003|Period 2|Withdrawal by Subject|0|||
105334215|NCT01314872|363223074|FG004|Period 2|Withdrawal by Subject|0|||
105334216|NCT01314872|363223075|FG005|Period 2|Withdrawal by Subject|0|||
105334217|NCT01314872|363223076|FG006|Period 2|Withdrawal by Subject|0|||
105334218|NCT01314872|363223077|FG007|Period 2|Withdrawal by Subject|0|||
105334219|NCT01314872|363223078|FG008|Period 2|Withdrawal by Subject|0|||
105334220|NCT01314872|363223079|FG009|Period 2|Withdrawal by Subject|0|||
105334221|NCT01314872|363223080|FG010|Period 2|Withdrawal by Subject|0|||
105334222|NCT01314872|363223081|FG011|Period 2|Withdrawal by Subject|14|||
105334223|NCT01314872|363223082|FG012|Period 2|Withdrawal by Subject|17|||
105334224|NCT01314872|363223083|FG013|Period 2|Withdrawal by Subject|12|||
105334225|NCT01314872|363223084|FG014|Period 2|Withdrawal by Subject|4|||
105334226|NCT01314872|363223070|FG000|Period 2|Lost to Follow-up|0|||
105334227|NCT01314872|363223071|FG001|Period 2|Lost to Follow-up|0|||
105334228|NCT01314872|363223072|FG002|Period 2|Lost to Follow-up|0|||
105334229|NCT01314872|363223073|FG003|Period 2|Lost to Follow-up|0|||
105334230|NCT01314872|363223074|FG004|Period 2|Lost to Follow-up|0|||
105334231|NCT01314872|363223075|FG005|Period 2|Lost to Follow-up|0|||
105334232|NCT01314872|363223076|FG006|Period 2|Lost to Follow-up|0|||
105334233|NCT01314872|363223077|FG007|Period 2|Lost to Follow-up|0|||
105334234|NCT01314872|363223078|FG008|Period 2|Lost to Follow-up|0|||
105334235|NCT01314872|363223079|FG009|Period 2|Lost to Follow-up|0|||
105334236|NCT01314872|363223080|FG010|Period 2|Lost to Follow-up|0|||
105334237|NCT01314872|363223081|FG011|Period 2|Lost to Follow-up|6|||
105334238|NCT01314872|363223082|FG012|Period 2|Lost to Follow-up|7|||
105334239|NCT01314872|363223083|FG013|Period 2|Lost to Follow-up|2|||
105334240|NCT01314872|363223084|FG014|Period 2|Lost to Follow-up|6|||
105334241|NCT05488470|363225221|FG000|Overall Study|Physician Decision|2|||
105334242|NCT05488470|363225221|FG000|Overall Study|Withdrawal by Subject|1|||
105334243|NCT05488470|363225221|FG000|Overall Study|Death|1|||
105334244|NCT00068393|363225223|FG000|Overall Study|Adverse Event|2|||
105334245|NCT00068393|363225223|FG000|Overall Study|Death|3|||
105334246|NCT00068393|363225223|FG000|Overall Study|Withdrawal by Subject|3|||
105334247|NCT00068393|363225223|FG000|Overall Study|Alternative treatment|1|||
105334248|NCT00068393|363225223|FG000|Overall Study|Quality of life worsening|1|||
105778610|NCT01681004|364840429|FG001|Study Completion|Death|1|||
105778611|NCT03395704|364840430|FG000|Overall Study|Adverse Event|2|||
105778612|NCT03395704|364840431|FG001|Overall Study|Adverse Event|1|||
105778613|NCT03395704|364840430|FG000|Overall Study|Withdrawal by Subject|2|||
105778614|NCT03395704|364840431|FG001|Overall Study|Withdrawal by Subject|1|||
105778615|NCT03395704|364840430|FG000|Overall Study|Physician Decision|0|||
105778616|NCT03395704|364840431|FG001|Overall Study|Physician Decision|1|||
105778617|NCT01084096|364842374|FG000|Overall Study|Lost to Follow-up|1501|||
105778618|NCT01084096|364842375|FG001|Overall Study|Lost to Follow-up|1833|||
105778619|NCT01084096|364842374|FG000|Overall Study|Withdrawal by Subject|3|||
105778620|NCT01084096|364842375|FG001|Overall Study|Withdrawal by Subject|0|||
105778621|NCT01084096|364842374|FG000|Overall Study|Woman had a miscarriage|21|||
105778622|NCT01084096|364842375|FG001|Overall Study|Woman had a miscarriage|17|||
105778623|NCT00027846|364842376|FG000|Overall Study|Lost to Follow-up|0|||
105778624|NCT00027846|364842377|FG001|Overall Study|Lost to Follow-up|41|||
105778625|NCT00027846|364842378|FG002|Overall Study|Lost to Follow-up|9|||
105778626|NCT00027846|364842376|FG000|Overall Study|Withdrawal by Subject|0|||
105778627|NCT00027846|364842377|FG001|Overall Study|Withdrawal by Subject|14|||
105778628|NCT00027846|364842378|FG002|Overall Study|Withdrawal by Subject|7|||
105778629|NCT00027846|364842376|FG000|Overall Study|Ineligible for study|2|||
105778630|NCT00027846|364842377|FG001|Overall Study|Ineligible for study|6|||
105778631|NCT00027846|364842378|FG002|Overall Study|Ineligible for study|14|||
105778632|NCT00027846|364842376|FG000|Overall Study|Entry into another COG therapeutic study|0|||
105778633|NCT00027846|364842377|FG001|Overall Study|Entry into another COG therapeutic study|5|||
105778634|NCT00027846|364842378|FG002|Overall Study|Entry into another COG therapeutic study|2|||
105778635|NCT00027846|364842376|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
105778636|NCT00027846|364842377|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
105778637|NCT00027846|364842378|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
105778638|NCT02033369|364842379|FG000|Overall Study|Physician Decision|1|||
105778639|NCT02033369|364842380|FG001|Overall Study|Physician Decision|2|||
105778640|NCT02033369|364842379|FG000|Overall Study|Not a good demographic match|0|||
105778641|NCT02033369|364842380|FG001|Overall Study|Not a good demographic match|2|||
105778642|NCT02033369|364842379|FG000|Overall Study|Withdrawal by Subject|1|||
105778643|NCT02033369|364842380|FG001|Overall Study|Withdrawal by Subject|1|||
105778644|NCT02033369|364842379|FG000|Overall Study|Lost to Follow-up|1|||
105778645|NCT02033369|364842380|FG001|Overall Study|Lost to Follow-up|0|||
105778646|NCT02033369|364842379|FG000|Overall Study|Protocol Violation|2|||
105778647|NCT02033369|364842380|FG001|Overall Study|Protocol Violation|0|||
105778648|NCT01354964|364842381|FG000|Overall Study|Lost to Follow-up|2|||
105778649|NCT01354964|364842382|FG001|Overall Study|Lost to Follow-up|0|||
105778650|NCT01354964|364842381|FG000|Overall Study|IV access issues|1|||
105778651|NCT01354964|364842382|FG001|Overall Study|IV access issues|1|||
105778652|NCT01354964|364842381|FG000|Overall Study|Physician Decision|1|||
105778653|NCT01354964|364842382|FG001|Overall Study|Physician Decision|0|||
105778654|NCT01265719|364842384|FG000|Overall Study|Does not meet entrance criteria|0|||
105778655|NCT01265719|364842385|FG001|Overall Study|Does not meet entrance criteria|3|||
105778656|NCT01265719|364842384|FG000|Overall Study|Other reasons|2|||
105778657|NCT01265719|364842385|FG001|Overall Study|Other reasons|0|||
105778658|NCT01265719|364842384|FG000|Overall Study|Withdrawal by Subject|8|||
105778659|NCT01265719|364842385|FG001|Overall Study|Withdrawal by Subject|3|||
105778660|NCT01265719|364842384|FG000|Overall Study|Lost to Follow-up|2|||
105778661|NCT01265719|364842385|FG001|Overall Study|Lost to Follow-up|7|||
105778662|NCT01265719|364842384|FG000|Overall Study|Adverse Event|2|||
105778663|NCT01265719|364842385|FG001|Overall Study|Adverse Event|0|||
105778664|NCT05604781|364842388|FG000|Overall Study|Lost to Follow-up|3|||
105778665|NCT05604781|364842388|FG000|Overall Study|Adverse Event|1|||
105778666|NCT01451203|364842389|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
105778667|NCT01451203|364842390|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
105778668|NCT01451203|364842389|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
105778669|NCT01451203|364842390|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
105778670|NCT01451203|364842389|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
105778671|NCT01451203|364842390|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
105778672|NCT01451203|364842389|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
105778673|NCT01451203|364842390|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
105778674|NCT01451203|364842389|FG000|Double-blind Treatment Period|Adverse Event|6|||
105778675|NCT01451203|364842390|FG001|Double-blind Treatment Period|Adverse Event|9|||
105778676|NCT01451203|364842389|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
105778677|NCT01451203|364842390|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
105778678|NCT01451203|364842389|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
105778679|NCT01451203|364842390|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
105778680|NCT01451203|364842389|FG000|Double-blind Treatment Period|Investigator decision|2|||
105778681|NCT01451203|364842390|FG001|Double-blind Treatment Period|Investigator decision|0|||
105778682|NCT01451203|364842389|FG000|Post-treatment Period|Consent withdrawn|2|||
105778683|NCT01451203|364842390|FG001|Post-treatment Period|Consent withdrawn|4|||
105778684|NCT01451203|364842389|FG000|Post-treatment Period|Lack of Efficacy|12|||
105778685|NCT01451203|364842390|FG001|Post-treatment Period|Lack of Efficacy|28|||
105778686|NCT01451203|364842389|FG000|Post-treatment Period|Adverse Event|0|||
105778687|NCT01451203|364842390|FG001|Post-treatment Period|Adverse Event|1|||
105778688|NCT01451203|364842389|FG000|Post-treatment Period|Investigator decision|0|||
105778689|NCT01451203|364842390|FG001|Post-treatment Period|Investigator decision|1|||
105778690|NCT03890731|364842391|FG000|Overall Study|Progressive disease|1|||
105778691|NCT03890731|364842391|FG000|Overall Study|Patient's decision|1|||
105778692|NCT03890731|364842391|FG000|Overall Study|Adverse Event|4|||
105778693|NCT00960323|364842395|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
105778694|NCT04450394|364842398|FG000|Overall Study|Adverse Event|2|||
105778695|NCT04450394|364842399|FG001|Overall Study|Adverse Event|0|||
105778696|NCT04450394|364842400|FG002|Overall Study|Adverse Event|0|||
105778697|NCT04450394|364842398|FG000|Overall Study|Death|0|||
105778698|NCT04450394|364842399|FG001|Overall Study|Death|1|||
105778699|NCT04450394|364842400|FG002|Overall Study|Death|0|||
105778700|NCT04450394|364842398|FG000|Overall Study|Lost to Follow-up|0|||
105778701|NCT04450394|364842399|FG001|Overall Study|Lost to Follow-up|3|||
105778702|NCT04450394|364842400|FG002|Overall Study|Lost to Follow-up|0|||
105778703|NCT04450394|364842398|FG000|Overall Study|Physician Decision|0|||
105778704|NCT04450394|364842399|FG001|Overall Study|Physician Decision|1|||
105778705|NCT04450394|364842400|FG002|Overall Study|Physician Decision|0|||
105778706|NCT04450394|364842398|FG000|Overall Study|Protocol Violation|2|||
105778707|NCT04450394|364842399|FG001|Overall Study|Protocol Violation|0|||
105778708|NCT04450394|364842400|FG002|Overall Study|Protocol Violation|0|||
105778709|NCT04450394|364842398|FG000|Overall Study|Withdrawal by Subject|6|||
105778710|NCT04450394|364842399|FG001|Overall Study|Withdrawal by Subject|9|||
105778711|NCT04450394|364842400|FG002|Overall Study|Withdrawal by Subject|0|||
105778712|NCT01066819|364842405|FG000|Overall Study|Adverse Event|18|||
105778713|NCT01066819|364842406|FG001|Overall Study|Adverse Event|1|||
105778714|NCT01066819|364842407|FG002|Overall Study|Adverse Event|6|||
105778715|NCT01066819|364842408|FG003|Overall Study|Adverse Event|0|||
105778716|NCT01066819|364842409|FG004|Overall Study|Adverse Event|0|||
105778717|NCT01066819|364842410|FG005|Overall Study|Adverse Event|0|||
105778718|NCT01066819|364842405|FG000|Overall Study|Death|5|||
105778719|NCT01066819|364842406|FG001|Overall Study|Death|0|||
105778720|NCT01066819|364842407|FG002|Overall Study|Death|1|||
105778721|NCT01066819|364842408|FG003|Overall Study|Death|0|||
105778722|NCT01066819|364842409|FG004|Overall Study|Death|0|||
105778723|NCT01066819|364842410|FG005|Overall Study|Death|0|||
105778724|NCT01066819|364842405|FG000|Overall Study|Lack of Efficacy|22|||
105778725|NCT01066819|364842406|FG001|Overall Study|Lack of Efficacy|1|||
105778726|NCT01066819|364842407|FG002|Overall Study|Lack of Efficacy|2|||
105778727|NCT01066819|364842408|FG003|Overall Study|Lack of Efficacy|1|||
105778728|NCT01066819|364842409|FG004|Overall Study|Lack of Efficacy|0|||
105778729|NCT01066819|364842410|FG005|Overall Study|Lack of Efficacy|0|||
105778730|NCT01066819|364842405|FG000|Overall Study|Physician Decision|6|||
105778731|NCT01066819|364842406|FG001|Overall Study|Physician Decision|2|||
105778732|NCT01066819|364842407|FG002|Overall Study|Physician Decision|3|||
105778733|NCT01066819|364842408|FG003|Overall Study|Physician Decision|0|||
105778734|NCT01066819|364842409|FG004|Overall Study|Physician Decision|0|||
105778735|NCT01066819|364842410|FG005|Overall Study|Physician Decision|0|||
105778736|NCT01066819|364842405|FG000|Overall Study|Protocol Violation|12|||
105778737|NCT01066819|364842406|FG001|Overall Study|Protocol Violation|6|||
105778738|NCT01066819|364842407|FG002|Overall Study|Protocol Violation|0|||
105778739|NCT01066819|364842408|FG003|Overall Study|Protocol Violation|0|||
105778740|NCT01066819|364842409|FG004|Overall Study|Protocol Violation|0|||
105778741|NCT01066819|364842410|FG005|Overall Study|Protocol Violation|0|||
105778742|NCT01066819|364842405|FG000|Overall Study|Withdrawal by Subject|29|||
105778743|NCT01066819|364842406|FG001|Overall Study|Withdrawal by Subject|11|||
105778744|NCT01066819|364842407|FG002|Overall Study|Withdrawal by Subject|6|||
105778745|NCT01066819|364842408|FG003|Overall Study|Withdrawal by Subject|0|||
105778746|NCT01066819|364842409|FG004|Overall Study|Withdrawal by Subject|0|||
105778747|NCT01066819|364842410|FG005|Overall Study|Withdrawal by Subject|0|||
105778748|NCT01066819|364842405|FG000|Overall Study|Administrative|6|||
105778749|NCT01066819|364842406|FG001|Overall Study|Administrative|4|||
105778750|NCT01066819|364842407|FG002|Overall Study|Administrative|2|||
105778751|NCT01066819|364842408|FG003|Overall Study|Administrative|0|||
105778752|NCT01066819|364842409|FG004|Overall Study|Administrative|0|||
105778753|NCT01066819|364842410|FG005|Overall Study|Administrative|0|||
105778754|NCT01066819|364842405|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
105778755|NCT01066819|364842406|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
105778756|NCT01066819|364842407|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
105778757|NCT01066819|364842408|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
105778758|NCT01066819|364842409|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
105778759|NCT01066819|364842410|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
105778760|NCT01066819|364842405|FG000|Overall Study|Early termination|2|||
105778761|NCT01066819|364842406|FG001|Overall Study|Early termination|0|||
105778762|NCT01066819|364842407|FG002|Overall Study|Early termination|0|||
105778763|NCT01066819|364842408|FG003|Overall Study|Early termination|0|||
105778764|NCT01066819|364842409|FG004|Overall Study|Early termination|0|||
105778765|NCT01066819|364842410|FG005|Overall Study|Early termination|0|||
105778766|NCT01066819|364842405|FG000|Overall Study|Failed to return|298|||
105778767|NCT01066819|364842406|FG001|Overall Study|Failed to return|107|||
105778768|NCT01066819|364842407|FG002|Overall Study|Failed to return|68|||
105778769|NCT01066819|364842408|FG003|Overall Study|Failed to return|7|||
105778770|NCT01066819|364842409|FG004|Overall Study|Failed to return|2|||
105778771|NCT01066819|364842410|FG005|Overall Study|Failed to return|3|||
105334249|NCT00078767|363225224|FG000|Overall Study|Withdrawal by Subject|1|||
105334250|NCT00078767|363225225|FG001|Overall Study|Withdrawal by Subject|1|||
105334251|NCT02564900|363225238|FG000|Dose Escalation|Progressive disease per RECIST|2|||
105334252|NCT02564900|363225239|FG001|Dose Escalation|Progressive disease per RECIST|3|||
105334253|NCT02564900|363225240|FG002|Dose Escalation|Progressive disease per RECIST|3|||
105334254|NCT02564900|363225241|FG003|Dose Escalation|Progressive disease per RECIST|3|||
105334255|NCT02564900|363225242|FG004|Dose Escalation|Progressive disease per RECIST|3|||
105334256|NCT02564900|363225243|FG005|Dose Escalation|Progressive disease per RECIST|1|||
105334257|NCT02564900|363225244|FG006|Dose Escalation|Progressive disease per RECIST|0|||
105334258|NCT02564900|363225245|FG007|Dose Escalation|Progressive disease per RECIST|0|||
105334259|NCT02564900|363225246|FG008|Dose Escalation|Progressive disease per RECIST|0|||
105334260|NCT02564900|363225247|FG009|Dose Escalation|Progressive disease per RECIST|0|||
105334261|NCT02564900|363225248|FG010|Dose Escalation|Progressive disease per RECIST|0|||
105334262|NCT02564900|363225249|FG011|Dose Escalation|Progressive disease per RECIST|0|||
105334263|NCT02564900|363225250|FG012|Dose Escalation|Progressive disease per RECIST|0|||
105334264|NCT02564900|363225251|FG013|Dose Escalation|Progressive disease per RECIST|0|||
105334265|NCT02564900|363225252|FG014|Dose Escalation|Progressive disease per RECIST|0|||
105334266|NCT02564900|363225238|FG000|Dose Escalation|Ongoing|1|||
105334267|NCT02564900|363225239|FG001|Dose Escalation|Ongoing|0|||
105334268|NCT02564900|363225240|FG002|Dose Escalation|Ongoing|0|||
105334269|NCT02564900|363225241|FG003|Dose Escalation|Ongoing|2|||
105334270|NCT02564900|363225242|FG004|Dose Escalation|Ongoing|2|||
105334271|NCT02564900|363225243|FG005|Dose Escalation|Ongoing|2|||
105334272|NCT02564900|363225244|FG006|Dose Escalation|Ongoing|0|||
105334273|NCT02564900|363225245|FG007|Dose Escalation|Ongoing|0|||
105334274|NCT02564900|363225246|FG008|Dose Escalation|Ongoing|0|||
105334275|NCT02564900|363225247|FG009|Dose Escalation|Ongoing|0|||
105334276|NCT02564900|363225248|FG010|Dose Escalation|Ongoing|0|||
105334277|NCT02564900|363225249|FG011|Dose Escalation|Ongoing|0|||
105334278|NCT02564900|363225250|FG012|Dose Escalation|Ongoing|0|||
105334279|NCT02564900|363225251|FG013|Dose Escalation|Ongoing|0|||
105778772|NCT01066819|364842405|FG000|Overall Study|Lab test not done|9|||
105778773|NCT01066819|364842406|FG001|Overall Study|Lab test not done|0|||
105778774|NCT01066819|364842407|FG002|Overall Study|Lab test not done|2|||
105778775|NCT01066819|364842408|FG003|Overall Study|Lab test not done|1|||
105778776|NCT01066819|364842409|FG004|Overall Study|Lab test not done|0|||
105778777|NCT01066819|364842410|FG005|Overall Study|Lab test not done|0|||
105778778|NCT01066819|364842405|FG000|Overall Study|Miscellaneous|28|||
105778779|NCT01066819|364842406|FG001|Overall Study|Miscellaneous|10|||
105778780|NCT01066819|364842407|FG002|Overall Study|Miscellaneous|18|||
105778781|NCT01066819|364842408|FG003|Overall Study|Miscellaneous|1|||
105334280|NCT02564900|363225252|FG014|Dose Escalation|Ongoing|0|||
105334281|NCT02564900|363225238|FG000|Dose Escalation|Adverse Event|0|||
105334282|NCT02564900|363225239|FG001|Dose Escalation|Adverse Event|0|||
105334283|NCT02564900|363225240|FG002|Dose Escalation|Adverse Event|0|||
105334284|NCT02564900|363225241|FG003|Dose Escalation|Adverse Event|1|||
105334285|NCT02564900|363225242|FG004|Dose Escalation|Adverse Event|1|||
105334286|NCT02564900|363225243|FG005|Dose Escalation|Adverse Event|3|||
105334287|NCT02564900|363225244|FG006|Dose Escalation|Adverse Event|0|||
105778782|NCT01066819|364842409|FG004|Overall Study|Miscellaneous|0|||
105778783|NCT01066819|364842410|FG005|Overall Study|Miscellaneous|0|||
105778784|NCT01066819|364842405|FG000|Overall Study|Non responders|123|||
105778785|NCT01066819|364842406|FG001|Overall Study|Non responders|2|||
105778786|NCT01066819|364842407|FG002|Overall Study|Non responders|7|||
105778787|NCT01066819|364842408|FG003|Overall Study|Non responders|2|||
105778788|NCT01066819|364842409|FG004|Overall Study|Non responders|0|||
105778789|NCT01066819|364842410|FG005|Overall Study|Non responders|1|||
105334288|NCT02564900|363225245|FG007|Dose Escalation|Adverse Event|0|||
105778790|NCT01066819|364842405|FG000|Overall Study|Not categorised|9|||
105778791|NCT01066819|364842406|FG001|Overall Study|Not categorised|2|||
105778792|NCT01066819|364842407|FG002|Overall Study|Not categorised|6|||
105778793|NCT01066819|364842408|FG003|Overall Study|Not categorised|1|||
105778794|NCT01066819|364842409|FG004|Overall Study|Not categorised|0|||
105778795|NCT01066819|364842410|FG005|Overall Study|Not categorised|0|||
105778796|NCT01066819|364842405|FG000|Overall Study|Relapse|16|||
105778797|NCT01066819|364842406|FG001|Overall Study|Relapse|4|||
105778798|NCT01066819|364842407|FG002|Overall Study|Relapse|3|||
105778799|NCT01066819|364842408|FG003|Overall Study|Relapse|0|||
105334289|NCT02564900|363225246|FG008|Dose Escalation|Adverse Event|0|||
105334290|NCT02564900|363225247|FG009|Dose Escalation|Adverse Event|0|||
105334291|NCT02564900|363225248|FG010|Dose Escalation|Adverse Event|0|||
105778800|NCT01066819|364842409|FG004|Overall Study|Relapse|0|||
105778801|NCT01066819|364842410|FG005|Overall Study|Relapse|0|||
105778802|NCT01066819|364842405|FG000|Overall Study|Results not available|1|||
105778803|NCT01066819|364842406|FG001|Overall Study|Results not available|0|||
105778804|NCT01066819|364842407|FG002|Overall Study|Results not available|0|||
105778805|NCT01066819|364842408|FG003|Overall Study|Results not available|0|||
105778806|NCT01066819|364842409|FG004|Overall Study|Results not available|0|||
105778807|NCT01066819|364842410|FG005|Overall Study|Results not available|0|||
105778808|NCT01066819|364842405|FG000|Overall Study|Screen failure|1|||
105778809|NCT01066819|364842406|FG001|Overall Study|Screen failure|0|||
105778810|NCT01066819|364842407|FG002|Overall Study|Screen failure|0|||
105778811|NCT01066819|364842408|FG003|Overall Study|Screen failure|0|||
105778812|NCT01066819|364842409|FG004|Overall Study|Screen failure|0|||
105778813|NCT01066819|364842410|FG005|Overall Study|Screen failure|0|||
105778814|NCT01066819|364842405|FG000|Overall Study|Spontaneous cure|1|||
105778815|NCT01066819|364842406|FG001|Overall Study|Spontaneous cure|0|||
105778816|NCT01066819|364842407|FG002|Overall Study|Spontaneous cure|0|||
105778817|NCT01066819|364842408|FG003|Overall Study|Spontaneous cure|0|||
105778818|NCT01066819|364842409|FG004|Overall Study|Spontaneous cure|0|||
105778819|NCT01066819|364842410|FG005|Overall Study|Spontaneous cure|0|||
105778820|NCT01066819|364842405|FG000|Overall Study|Treatment never started|85|||
105778821|NCT01066819|364842406|FG001|Overall Study|Treatment never started|19|||
105778822|NCT01066819|364842407|FG002|Overall Study|Treatment never started|19|||
105778823|NCT01066819|364842408|FG003|Overall Study|Treatment never started|3|||
105778824|NCT01066819|364842409|FG004|Overall Study|Treatment never started|2|||
105778825|NCT01066819|364842410|FG005|Overall Study|Treatment never started|2|||
105778826|NCT01066819|364842405|FG000|Overall Study|Treatment stopped|12|||
105778827|NCT01066819|364842406|FG001|Overall Study|Treatment stopped|1|||
105778828|NCT01066819|364842407|FG002|Overall Study|Treatment stopped|2|||
105778829|NCT01066819|364842408|FG003|Overall Study|Treatment stopped|1|||
105778830|NCT01066819|364842409|FG004|Overall Study|Treatment stopped|0|||
105778831|NCT01066819|364842410|FG005|Overall Study|Treatment stopped|0|||
105778832|NCT01066819|364842405|FG000|Overall Study|Other|5|||
105778833|NCT01066819|364842406|FG001|Overall Study|Other|1|||
105778834|NCT01066819|364842407|FG002|Overall Study|Other|1|||
105778835|NCT01066819|364842408|FG003|Overall Study|Other|0|||
105778836|NCT01066819|364842409|FG004|Overall Study|Other|0|||
105778837|NCT01066819|364842410|FG005|Overall Study|Other|0|||
105778838|NCT03322540|364842411|FG000|Overall Study|Death|21|||
105778839|NCT03322540|364842412|FG001|Overall Study|Death|28|||
105778840|NCT03322540|364842411|FG000|Overall Study|Lost to Follow-up|0|||
105778841|NCT03322540|364842412|FG001|Overall Study|Lost to Follow-up|1|||
105778842|NCT03322540|364842411|FG000|Overall Study|Physician Decision|7|||
105778843|NCT03322540|364842412|FG001|Overall Study|Physician Decision|6|||
105778844|NCT03322540|364842411|FG000|Overall Study|Withdrawal by Subject|3|||
105778845|NCT03322540|364842412|FG001|Overall Study|Withdrawal by Subject|1|||
105778846|NCT03322540|364842411|FG000|Overall Study|Study terminated by sponsor|0|||
105778847|NCT03322540|364842412|FG001|Overall Study|Study terminated by sponsor|1|||
105778848|NCT03287960|364842416|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
105778849|NCT03287960|364842416|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
105778850|NCT01014442|364842420|FG000|Overall Study|Adverse Event|0|||
105778851|NCT01014442|364842421|FG001|Overall Study|Adverse Event|8|||
105778852|NCT01014442|364842420|FG000|Overall Study|Withdrawal by Subject|4|||
105778853|NCT01014442|364842421|FG001|Overall Study|Withdrawal by Subject|4|||
105778854|NCT01014442|364842420|FG000|Overall Study|Protocol Violation|2|||
105778855|NCT01014442|364842421|FG001|Overall Study|Protocol Violation|5|||
105778856|NCT01014442|364842420|FG000|Overall Study|Lack of Compliance|0|||
105778857|NCT01014442|364842421|FG001|Overall Study|Lack of Compliance|1|||
105778858|NCT01014442|364842420|FG000|Overall Study|Unspecified Reason|1|||
105778859|NCT01014442|364842421|FG001|Overall Study|Unspecified Reason|1|||
105778860|NCT01904760|364842427|FG000|Overall Study|Protocol Violation|1|||
105778861|NCT01904760|364842428|FG001|Overall Study|Protocol Violation|0|||
105778862|NCT04047472|364842429|FG000|Overall Study|Adverse Event|3|||
105778863|NCT04047472|364842430|FG001|Overall Study|Adverse Event|3|||
105778864|NCT04047472|364842429|FG000|Overall Study|Death|0|||
105778865|NCT04047472|364842430|FG001|Overall Study|Death|1|||
105778866|NCT04047472|364842429|FG000|Overall Study|Lost to Follow-up|1|||
105778867|NCT04047472|364842430|FG001|Overall Study|Lost to Follow-up|0|||
105778868|NCT04047472|364842429|FG000|Overall Study|Physician Decision|1|||
105778869|NCT04047472|364842430|FG001|Overall Study|Physician Decision|2|||
105778870|NCT04047472|364842429|FG000|Overall Study|Protocol Violation|1|||
105778871|NCT04047472|364842430|FG001|Overall Study|Protocol Violation|0|||
105778872|NCT04047472|364842429|FG000|Overall Study|Withdrawal by Subject|10|||
105778873|NCT04047472|364842430|FG001|Overall Study|Withdrawal by Subject|10|||
105778874|NCT02243306|364842431|FG000|Overall Study|Adverse Event|0|||
105778875|NCT02243306|364842432|FG001|Overall Study|Adverse Event|1|||
105778876|NCT02243306|364842431|FG000|Overall Study|Other: Reached stopping criteria|0|||
105778877|NCT02243306|364842432|FG001|Overall Study|Other: Reached stopping criteria|1|||
105778878|NCT02243306|364842431|FG000|Overall Study|Physician Decision|0|||
105778879|NCT02243306|364842432|FG001|Overall Study|Physician Decision|1|||
105778880|NCT01034709|364842437|FG000|Overall Study|Protocol Violation|9|||
105778881|NCT01034709|364842438|FG001|Overall Study|Protocol Violation|16|||
105778882|NCT01060150|364842439|FG000|Overall Study|Adverse Event|6|||
105778883|NCT01060150|364842439|FG000|Overall Study|Lost to Follow-up|1|||
105778884|NCT01060150|364842439|FG000|Overall Study|Protocol Violation|6|||
105778885|NCT01060150|364842439|FG000|Overall Study|Withdrawal by Subject|8|||
105778886|NCT01060150|364842439|FG000|Overall Study|Enrolled, but not treated|2|||
105778887|NCT01195636|364842440|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
105778888|NCT01195636|364842441|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
105778889|NCT01195636|364842440|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
105778890|NCT01195636|364842441|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
105778891|NCT01195636|364842440|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
105778892|NCT01195636|364842441|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
105778893|NCT01195636|364842440|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
105778894|NCT01195636|364842441|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
105778895|NCT01195636|364842440|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
105778896|NCT01195636|364842441|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
105778897|NCT01195636|364842440|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
105778898|NCT01195636|364842441|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
105778899|NCT01195636|364842440|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
105778900|NCT01195636|364842441|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
105778901|NCT01195636|364842440|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
105778902|NCT01195636|364842441|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
105778903|NCT03644173|364842442|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
105778904|NCT03644173|364842442|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
105778905|NCT03644173|364842442|FG000|Participants at the 1-month Follow up|Death|2|||
105778906|NCT03644173|364842442|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
105778907|NCT00808132|364842445|FG000|Overall Study|Adverse Event|34|||
105778908|NCT00808132|364842446|FG001|Overall Study|Adverse Event|33|||
105778909|NCT00808132|364842447|FG002|Overall Study|Adverse Event|16|||
105778910|NCT00808132|364842448|FG003|Overall Study|Adverse Event|31|||
105778911|NCT00808132|364842449|FG004|Overall Study|Adverse Event|33|||
105778912|NCT00808132|364842445|FG000|Overall Study|Death|0|||
105778913|NCT00808132|364842446|FG001|Overall Study|Death|0|||
105778914|NCT00808132|364842447|FG002|Overall Study|Death|0|||
105778915|NCT00808132|364842448|FG003|Overall Study|Death|0|||
105778916|NCT00808132|364842449|FG004|Overall Study|Death|1|||
105778917|NCT00808132|364842445|FG000|Overall Study|Physician Decision|0|||
105778918|NCT00808132|364842446|FG001|Overall Study|Physician Decision|1|||
105778919|NCT00808132|364842447|FG002|Overall Study|Physician Decision|0|||
105778920|NCT00808132|364842448|FG003|Overall Study|Physician Decision|0|||
105778921|NCT00808132|364842449|FG004|Overall Study|Physician Decision|0|||
105778922|NCT00808132|364842445|FG000|Overall Study|Lost to Follow-up|8|||
105778923|NCT00808132|364842446|FG001|Overall Study|Lost to Follow-up|10|||
105778924|NCT00808132|364842447|FG002|Overall Study|Lost to Follow-up|11|||
105778925|NCT00808132|364842448|FG003|Overall Study|Lost to Follow-up|8|||
105778926|NCT00808132|364842449|FG004|Overall Study|Lost to Follow-up|9|||
105778927|NCT00808132|364842445|FG000|Overall Study|Protocol Violation|8|||
105778928|NCT00808132|364842446|FG001|Overall Study|Protocol Violation|9|||
105778929|NCT00808132|364842447|FG002|Overall Study|Protocol Violation|4|||
105778930|NCT00808132|364842448|FG003|Overall Study|Protocol Violation|9|||
105778931|NCT00808132|364842449|FG004|Overall Study|Protocol Violation|5|||
105778932|NCT00808132|364842445|FG000|Overall Study|Withdrawal by Subject|27|||
105778933|NCT00808132|364842446|FG001|Overall Study|Withdrawal by Subject|18|||
105778934|NCT00808132|364842447|FG002|Overall Study|Withdrawal by Subject|2|||
105778935|NCT00808132|364842448|FG003|Overall Study|Withdrawal by Subject|7|||
105778936|NCT00808132|364842449|FG004|Overall Study|Withdrawal by Subject|16|||
105778937|NCT00808132|364842445|FG000|Overall Study|Other|6|||
105778938|NCT00808132|364842446|FG001|Overall Study|Other|4|||
105778939|NCT00808132|364842447|FG002|Overall Study|Other|6|||
105778940|NCT00808132|364842448|FG003|Overall Study|Other|2|||
105778941|NCT00808132|364842449|FG004|Overall Study|Other|15|||
105778942|NCT00808132|364842445|FG000|Overall Study|Randomized, but not treated|10|||
105778943|NCT00808132|364842446|FG001|Overall Study|Randomized, but not treated|7|||
105778944|NCT00808132|364842447|FG002|Overall Study|Randomized, but not treated|9|||
105778945|NCT00808132|364842448|FG003|Overall Study|Randomized, but not treated|8|||
105778946|NCT00808132|364842449|FG004|Overall Study|Randomized, but not treated|9|||
105778947|NCT00808132|364842445|FG000|Overall Study|Unsatisfactory response|5|||
105778948|NCT00808132|364842446|FG001|Overall Study|Unsatisfactory response|6|||
105778949|NCT00808132|364842447|FG002|Overall Study|Unsatisfactory response|6|||
105778950|NCT00808132|364842448|FG003|Overall Study|Unsatisfactory response|4|||
105778951|NCT00808132|364842449|FG004|Overall Study|Unsatisfactory response|12|||
105778952|NCT01351415|364842450|FG000|Overall Study|Withdrawal by Subject|15|||
105778953|NCT01351415|364842451|FG001|Overall Study|Withdrawal by Subject|17|||
105778954|NCT01351415|364842450|FG000|Overall Study|Trial termination by the Sponsor|28|||
105778955|NCT01351415|364842451|FG001|Overall Study|Trial termination by the Sponsor|19|||
105442572|NCT04034004|363626792|FG001|Overall Study|nurse accidentally unblinded subject|0|||
105778956|NCT01351415|364842450|FG000|Overall Study|Lost to Follow-up|5|||
105778957|NCT01351415|364842451|FG001|Overall Study|Lost to Follow-up|7|||
105778958|NCT01351415|364842450|FG000|Overall Study|Death|190|||
105778959|NCT01351415|364842451|FG001|Overall Study|Death|187|||
105778960|NCT01351415|364842450|FG000|Overall Study|Physician Decision|2|||
105778961|NCT01351415|364842451|FG001|Overall Study|Physician Decision|3|||
105778962|NCT01351415|364842450|FG000|Overall Study|Reason unknown|0|||
105778963|NCT01351415|364842451|FG001|Overall Study|Reason unknown|2|||
105778964|NCT01351415|364842450|FG000|Overall Study|Never Started|5|||
105778965|NCT01351415|364842451|FG001|Overall Study|Never Started|5|||
105778966|NCT00247962|364842460|FG000|Overall Study|Adverse Event|15|||
105778967|NCT00247962|364842461|FG001|Overall Study|Adverse Event|12|||
105778968|NCT00247962|364842460|FG000|Overall Study|Lost to Follow-up|3|||
105778969|NCT00247962|364842461|FG001|Overall Study|Lost to Follow-up|1|||
105778970|NCT00247962|364842460|FG000|Overall Study|Physician Decision|0|||
105778971|NCT00247962|364842461|FG001|Overall Study|Physician Decision|1|||
105778972|NCT00247962|364842460|FG000|Overall Study|Protocol Violation|1|||
105778973|NCT00247962|364842461|FG001|Overall Study|Protocol Violation|1|||
105778974|NCT00247962|364842460|FG000|Overall Study|Withdrawal by Subject|3|||
105778975|NCT00247962|364842461|FG001|Overall Study|Withdrawal by Subject|2|||
105778976|NCT00247962|364842460|FG000|Overall Study|Lack of Efficacy|4|||
105778977|NCT00247962|364842461|FG001|Overall Study|Lack of Efficacy|2|||
105778978|NCT01955005|364842462|FG000|Overall Study|Withdrawal by Subject|3|||
105778979|NCT01955005|364842463|FG001|Overall Study|Withdrawal by Subject|5|||
105778980|NCT00598585|364842465|FG000|Overall Study|Lost to Follow-up|1|||
105778981|NCT00598585|364842466|FG001|Overall Study|Lost to Follow-up|0|||
105778982|NCT03480841|364842469|FG000|Overall Study|Lost to Follow-up|2|||
105778983|NCT04490499|364842477|FG000|Overall Study|Withdrawal by Subject|2|||
105778984|NCT02646332|364842478|FG000|Overall Study|Lost to Follow-up|0|||
105778985|NCT02646332|364842479|FG001|Overall Study|Lost to Follow-up|3|||
105778986|NCT01882439|364842480|FG000|Overall Study|Adverse event related to study drug|3|||
105778987|NCT01882439|364842481|FG001|Overall Study|Adverse event related to study drug|8|||
105778988|NCT01882439|364842482|FG002|Overall Study|Adverse event related to study drug|1|||
105778989|NCT01882439|364842483|FG003|Overall Study|Adverse event related to study drug|2|||
105778990|NCT01882439|364842480|FG000|Overall Study|Pregnancy|0|||
105778991|NCT01882439|364842481|FG001|Overall Study|Pregnancy|1|||
105778992|NCT01882439|364842482|FG002|Overall Study|Pregnancy|0|||
105778993|NCT01882439|364842483|FG003|Overall Study|Pregnancy|0|||
105778994|NCT01882439|364842480|FG000|Overall Study|Protocol Violation|2|||
105778995|NCT01882439|364842481|FG001|Overall Study|Protocol Violation|2|||
105778996|NCT01882439|364842482|FG002|Overall Study|Protocol Violation|0|||
105778997|NCT01882439|364842483|FG003|Overall Study|Protocol Violation|1|||
105778998|NCT01882439|364842480|FG000|Overall Study|No longer willing to participate|1|||
105778999|NCT01882439|364842481|FG001|Overall Study|No longer willing to participate|4|||
105779000|NCT01882439|364842482|FG002|Overall Study|No longer willing to participate|2|||
105779001|NCT01882439|364842483|FG003|Overall Study|No longer willing to participate|3|||
105779002|NCT01882439|364842480|FG000|Overall Study|Medication error with no associated AE|0|||
105779003|NCT01882439|364842481|FG001|Overall Study|Medication error with no associated AE|0|||
105779004|NCT01882439|364842482|FG002|Overall Study|Medication error with no associated AE|2|||
105779005|NCT01882439|364842483|FG003|Overall Study|Medication error with no associated AE|0|||
105779006|NCT01882439|364842480|FG000|Overall Study|Insufficient clinical response|1|||
105779007|NCT01882439|364842481|FG001|Overall Study|Insufficient clinical response|4|||
105779008|NCT01882439|364842482|FG002|Overall Study|Insufficient clinical response|4|||
105779009|NCT01882439|364842483|FG003|Overall Study|Insufficient clinical response|2|||
105779010|NCT01882439|364842480|FG000|Overall Study|Adverse event unrelated to study drug|2|||
105779011|NCT01882439|364842481|FG001|Overall Study|Adverse event unrelated to study drug|2|||
105779012|NCT01882439|364842482|FG002|Overall Study|Adverse event unrelated to study drug|1|||
105779013|NCT01882439|364842483|FG003|Overall Study|Adverse event unrelated to study drug|1|||
105779014|NCT01997333|364842486|FG000|Randomization and Treatment|Disease Progression|70|||
105779015|NCT01997333|364842487|FG001|Randomization and Treatment|Disease Progression|159|||
105779016|NCT01997333|364842486|FG000|Randomization and Treatment|Adverse Event|10|||
105779017|NCT01997333|364842487|FG001|Randomization and Treatment|Adverse Event|32|||
105779018|NCT01997333|364842486|FG000|Randomization and Treatment|Physician Decision|0|||
105779019|NCT01997333|364842487|FG001|Randomization and Treatment|Physician Decision|4|||
105779020|NCT01997333|364842486|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
105779021|NCT01997333|364842487|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
105779022|NCT01997333|364842486|FG000|Randomization and Treatment|Did not receive treatment|17|||
105779023|NCT01997333|364842487|FG001|Randomization and Treatment|Did not receive treatment|5|||
105779024|NCT01997333|364842486|FG000|Survival Follow up|Withdrawal by Subject|15|||
105779025|NCT01997333|364842487|FG001|Survival Follow up|Withdrawal by Subject|6|||
105779026|NCT01997333|364842486|FG000|Survival Follow up|Lost to Follow-up|0|||
105779027|NCT01997333|364842487|FG001|Survival Follow up|Lost to Follow-up|6|||
105779028|NCT01997333|364842486|FG000|Survival Follow up|Various|1|||
105779029|NCT01997333|364842487|FG001|Survival Follow up|Various|2|||
105779030|NCT02909504|364842488|FG000|Overall Study|Adverse Event|2|||
105779031|NCT02909504|364842488|FG000|Overall Study|Lack of Efficacy|3|||
105779032|NCT02909504|364842488|FG000|Overall Study|Withdrawal by Subject|4|||
105779033|NCT02909504|364842488|FG000|Overall Study|Pregnancy|1|||
105779034|NCT02909504|364842488|FG000|Overall Study|Subject moved|1|||
105779035|NCT02909504|364842488|FG000|Overall Study|Lost to Follow-up|1|||
105779036|NCT04411472|364842489|FG000|Overall Study|Adverse Event|5|||
105779037|NCT04411472|364842490|FG001|Overall Study|Adverse Event|10|||
105779038|NCT04411472|364842491|FG002|Overall Study|Adverse Event|1|||
105779039|NCT04411472|364842492|FG003|Overall Study|Adverse Event|0|||
105779040|NCT04411472|364842493|FG004|Overall Study|Adverse Event|0|||
105779041|NCT04411472|364842494|FG005|Overall Study|Adverse Event|0|||
105779042|NCT04411472|364842489|FG000|Overall Study|Protocol Violation|1|||
105779043|NCT04411472|364842490|FG001|Overall Study|Protocol Violation|0|||
105779044|NCT04411472|364842491|FG002|Overall Study|Protocol Violation|0|||
105779045|NCT04411472|364842492|FG003|Overall Study|Protocol Violation|0|||
105779046|NCT04411472|364842493|FG004|Overall Study|Protocol Violation|0|||
105779047|NCT04411472|364842494|FG005|Overall Study|Protocol Violation|0|||
105779048|NCT04411472|364842489|FG000|Overall Study|Withdrawal by Subject|0|||
105779049|NCT04411472|364842490|FG001|Overall Study|Withdrawal by Subject|1|||
105779050|NCT04411472|364842491|FG002|Overall Study|Withdrawal by Subject|0|||
105779051|NCT04411472|364842492|FG003|Overall Study|Withdrawal by Subject|1|||
105779052|NCT04411472|364842493|FG004|Overall Study|Withdrawal by Subject|0|||
105779053|NCT04411472|364842494|FG005|Overall Study|Withdrawal by Subject|0|||
105779054|NCT04411472|364842489|FG000|Overall Study|Physician Decision|1|||
105779055|NCT04411472|364842490|FG001|Overall Study|Physician Decision|0|||
105779056|NCT04411472|364842491|FG002|Overall Study|Physician Decision|0|||
105779057|NCT04411472|364842492|FG003|Overall Study|Physician Decision|0|||
105779058|NCT04411472|364842493|FG004|Overall Study|Physician Decision|0|||
105779059|NCT04411472|364842494|FG005|Overall Study|Physician Decision|0|||
105779060|NCT04411472|364842489|FG000|Overall Study|Study terminated by sponsor|17|||
105779061|NCT04411472|364842490|FG001|Overall Study|Study terminated by sponsor|20|||
105779062|NCT04411472|364842491|FG002|Overall Study|Study terminated by sponsor|3|||
105779063|NCT04411472|364842492|FG003|Overall Study|Study terminated by sponsor|0|||
105779064|NCT04411472|364842493|FG004|Overall Study|Study terminated by sponsor|0|||
105779065|NCT04411472|364842494|FG005|Overall Study|Study terminated by sponsor|0|||
105779066|NCT00440232|364842495|FG000|Overall Study|Lost to Follow-up|1|||
105779067|NCT00440232|364842496|FG001|Overall Study|Lost to Follow-up|1|||
105779068|NCT00440232|364842495|FG000|Overall Study|Unable to treat within allowed time|0|||
105779069|NCT00440232|364842496|FG001|Overall Study|Unable to treat within allowed time|1|||
105779070|NCT00440232|364842495|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
105779071|NCT00440232|364842496|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
105779072|NCT05060003|364842497|FG000|Overall Study|ctDNA negative|7|||
105779073|NCT01535638|364842498|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
105779074|NCT01535638|364842499|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
105779075|NCT01535638|364842500|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
105779076|NCT01535638|364842501|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
105779077|NCT01535638|364842502|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
105779078|NCT01535638|364842503|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
105779079|NCT01535638|364842498|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
105779080|NCT01535638|364842499|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
105779081|NCT01535638|364842500|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
105779082|NCT01535638|364842501|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
105779083|NCT01535638|364842502|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
105779084|NCT01535638|364842503|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
105779085|NCT00426842|364842504|FG000|Overall Study|Lost to Follow-up|1|||
105779086|NCT01277666|364842505|FG000|Overall Study|Adverse Event|26|||
105779087|NCT01277666|364842506|FG001|Overall Study|Adverse Event|25|||
105779088|NCT01277666|364842507|FG002|Overall Study|Adverse Event|20|||
105779089|NCT01277666|364842505|FG000|Overall Study|Lack of Efficacy|8|||
105779090|NCT01277666|364842506|FG001|Overall Study|Lack of Efficacy|20|||
105779091|NCT01277666|364842507|FG002|Overall Study|Lack of Efficacy|12|||
105779092|NCT01277666|364842505|FG000|Overall Study|Protocol Violation|2|||
105779093|NCT01277666|364842506|FG001|Overall Study|Protocol Violation|3|||
105779094|NCT01277666|364842507|FG002|Overall Study|Protocol Violation|2|||
105779095|NCT01277666|364842505|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
105779096|NCT01277666|364842506|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
105779097|NCT01277666|364842507|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
105779098|NCT01277666|364842505|FG000|Overall Study|Lost to Follow-up|1|||
105779099|NCT01277666|364842506|FG001|Overall Study|Lost to Follow-up|1|||
105779100|NCT01277666|364842507|FG002|Overall Study|Lost to Follow-up|2|||
105779101|NCT01277666|364842505|FG000|Overall Study|Withdrawal by Subject|7|||
105779102|NCT01277666|364842506|FG001|Overall Study|Withdrawal by Subject|8|||
105334292|NCT02564900|363225249|FG011|Dose Escalation|Adverse Event|0|||
105779103|NCT01277666|364842507|FG002|Overall Study|Withdrawal by Subject|6|||
105779104|NCT01277666|364842505|FG000|Overall Study|Death|0|||
105779105|NCT01277666|364842506|FG001|Overall Study|Death|0|||
105779106|NCT01277666|364842507|FG002|Overall Study|Death|1|||
105779107|NCT01747655|364842508|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
105779108|NCT01747655|364842509|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
105779109|NCT01747655|364842508|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
105779110|NCT01747655|364842509|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
105779111|NCT01747655|364842508|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
105779112|NCT01747655|364842509|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
105779113|NCT01373294|364842510|FG000|Overall Study|Adverse Event|1|||
105779114|NCT01373294|364842511|FG001|Overall Study|Adverse Event|0|||
105779115|NCT00423267|364842512|FG000|Period A|Withdrawal by Subject|0|||
105779116|NCT00423267|364842513|FG001|Period A|Withdrawal by Subject|1|||
105779117|NCT00423267|364842512|FG000|Period A|Non-compliance with protocol|1|||
105779118|NCT00423267|364842513|FG001|Period A|Non-compliance with protocol|0|||
105779119|NCT00423267|364842512|FG000|Period A|Administrative|1|||
105779120|NCT00423267|364842513|FG001|Period A|Administrative|0|||
105779121|NCT00827112|364842514|FG000|Overall Study|Adverse Event|2|||
105779122|NCT00827112|364842515|FG001|Overall Study|Adverse Event|0|||
105779123|NCT00827112|364842514|FG000|Overall Study|Lack of Efficacy|2|||
105779124|NCT00827112|364842515|FG001|Overall Study|Lack of Efficacy|0|||
105779125|NCT00827112|364842514|FG000|Overall Study|Lost to Follow-up|3|||
105779126|NCT00827112|364842515|FG001|Overall Study|Lost to Follow-up|2|||
105779127|NCT00827112|364842514|FG000|Overall Study|Pregnancy|0|||
105779128|NCT00827112|364842515|FG001|Overall Study|Pregnancy|1|||
105779129|NCT00827112|364842514|FG000|Overall Study|Protocol Violation|0|||
105779130|NCT00827112|364842515|FG001|Overall Study|Protocol Violation|2|||
105779131|NCT00827112|364842514|FG000|Overall Study|Withdrawal by Subject|2|||
105779132|NCT00827112|364842515|FG001|Overall Study|Withdrawal by Subject|1|||
105779133|NCT00827112|364842514|FG000|Overall Study|Randomized but not treated|5|||
105779134|NCT00827112|364842515|FG001|Overall Study|Randomized but not treated|3|||
105779135|NCT00827112|364842514|FG000|Overall Study|Other|1|||
105779136|NCT00827112|364842515|FG001|Overall Study|Other|3|||
105779137|NCT03702166|364842516|FG000|Overall Study|Lost to Follow-up|1|||
105779138|NCT03702166|364842516|FG000|Overall Study|Withdrawal by Subject|1|||
105779139|NCT01333865|364842517|FG000|Overall Study|Adverse Event|2|||
105779140|NCT00684073|364842518|FG000|Selection|Selection/non-selection criteria|3|||
105779141|NCT00684073|364842518|FG000|Selection|Death|1|||
105779142|NCT00684073|364842518|FG000|Selection|noncompliance|1|||
105779143|NCT00684073|364842518|FG000|Selection|Lost to Follow-up|1|||
105779144|NCT00684073|364842518|FG000|Selection|request of the sponsor|1|||
105779145|NCT00684073|364842518|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
105779146|NCT00842829|364842519|FG000|Dose Titration Period|Adverse Event|11|||
105779147|NCT00842829|364842520|FG001|Dose Titration Period|Adverse Event|10|||
105779148|NCT00842829|364842521|FG002|Dose Titration Period|Adverse Event|0|||
105779149|NCT00842829|364842519|FG000|Dose Titration Period|Lack of Efficacy|4|||
105779150|NCT00842829|364842520|FG001|Dose Titration Period|Lack of Efficacy|1|||
105779151|NCT00842829|364842521|FG002|Dose Titration Period|Lack of Efficacy|0|||
105779152|NCT00842829|364842519|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
105779153|NCT00842829|364842520|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
105779154|NCT00842829|364842521|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
105779155|NCT00842829|364842519|FG000|Dose Titration Period|Withdrawal by Subject|2|||
105779156|NCT00842829|364842520|FG001|Dose Titration Period|Withdrawal by Subject|6|||
105779157|NCT00842829|364842521|FG002|Dose Titration Period|Withdrawal by Subject|0|||
105779158|NCT00842829|364842519|FG000|Dose Titration Period|Other|5|||
105779159|NCT00842829|364842520|FG001|Dose Titration Period|Other|4|||
105779160|NCT00842829|364842521|FG002|Dose Titration Period|Other|0|||
105779161|NCT00842829|364842519|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
105779162|NCT00842829|364842520|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
105779163|NCT00842829|364842521|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
105779164|NCT00842829|364842519|FG000|Dose Titration Period|Non-compliance to study drug|2|||
105779165|NCT00842829|364842520|FG001|Dose Titration Period|Non-compliance to study drug|1|||
105779166|NCT00842829|364842521|FG002|Dose Titration Period|Non-compliance to study drug|0|||
105779167|NCT00842829|364842519|FG000|Treatment Period|Adverse Event|0|||
105779168|NCT00842829|364842520|FG001|Treatment Period|Adverse Event|0|||
105779169|NCT00842829|364842521|FG002|Treatment Period|Adverse Event|15|||
105779170|NCT00842829|364842519|FG000|Treatment Period|Lack of Efficacy|0|||
105779171|NCT00842829|364842520|FG001|Treatment Period|Lack of Efficacy|0|||
105779172|NCT00842829|364842521|FG002|Treatment Period|Lack of Efficacy|6|||
105779173|NCT00842829|364842519|FG000|Treatment Period|Unstable persistent cancer pain|0|||
105779174|NCT00842829|364842520|FG001|Treatment Period|Unstable persistent cancer pain|0|||
105779175|NCT00842829|364842521|FG002|Treatment Period|Unstable persistent cancer pain|5|||
105779176|NCT00842829|364842519|FG000|Treatment Period|Withdrawal by Subject|0|||
105779177|NCT00842829|364842520|FG001|Treatment Period|Withdrawal by Subject|0|||
105779178|NCT00842829|364842521|FG002|Treatment Period|Withdrawal by Subject|11|||
105779179|NCT00842829|364842519|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
105442573|NCT04034004|363626793|FG002|Overall Study|nurse accidentally unblinded subject|0|||
105779180|NCT00842829|364842520|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
105779181|NCT00842829|364842521|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
105779182|NCT00842829|364842519|FG000|Treatment Period|Protocol Violation|0|||
105779183|NCT00842829|364842520|FG001|Treatment Period|Protocol Violation|0|||
105779184|NCT00842829|364842521|FG002|Treatment Period|Protocol Violation|2|||
105779185|NCT00842829|364842519|FG000|Treatment Period|Other|0|||
105779186|NCT00842829|364842520|FG001|Treatment Period|Other|0|||
105779187|NCT00842829|364842521|FG002|Treatment Period|Other|18|||
105779188|NCT00842829|364842519|FG000|Treatment Period|Non-compliance to study procedures|0|||
105779189|NCT00842829|364842520|FG001|Treatment Period|Non-compliance to study procedures|0|||
105779190|NCT00842829|364842521|FG002|Treatment Period|Non-compliance to study procedures|4|||
105779191|NCT00842829|364842519|FG000|Treatment Period|Unclear completion status|0|||
105779192|NCT00842829|364842520|FG001|Treatment Period|Unclear completion status|0|||
105779193|NCT00842829|364842521|FG002|Treatment Period|Unclear completion status|1|||
105779194|NCT00842829|364842519|FG000|Continuation Period|Adverse Event|0|||
105779195|NCT00842829|364842520|FG001|Continuation Period|Adverse Event|0|||
105779196|NCT00842829|364842521|FG002|Continuation Period|Adverse Event|32|||
105779197|NCT00842829|364842519|FG000|Continuation Period|Lack of Efficacy|0|||
105779198|NCT00842829|364842520|FG001|Continuation Period|Lack of Efficacy|0|||
105779199|NCT00842829|364842521|FG002|Continuation Period|Lack of Efficacy|6|||
105779200|NCT00842829|364842519|FG000|Continuation Period|Unstable persistent cancer pain|0|||
105779201|NCT00842829|364842520|FG001|Continuation Period|Unstable persistent cancer pain|0|||
105779202|NCT00842829|364842521|FG002|Continuation Period|Unstable persistent cancer pain|3|||
105779203|NCT00842829|364842519|FG000|Continuation Period|Withdrawal by Subject|0|||
105779204|NCT00842829|364842520|FG001|Continuation Period|Withdrawal by Subject|0|||
105779205|NCT00842829|364842521|FG002|Continuation Period|Withdrawal by Subject|10|||
105779206|NCT00842829|364842519|FG000|Continuation Period|Other|0|||
105779207|NCT00842829|364842520|FG001|Continuation Period|Other|0|||
105779208|NCT00842829|364842521|FG002|Continuation Period|Other|7|||
105779209|NCT00842829|364842519|FG000|Continuation Period|Non-compliance to study procedures|0|||
105779210|NCT00842829|364842520|FG001|Continuation Period|Non-compliance to study procedures|0|||
105779211|NCT00842829|364842521|FG002|Continuation Period|Non-compliance to study procedures|2|||
105779212|NCT00842829|364842519|FG000|Continuation Period|Non-compliance to study drug|0|||
105779213|NCT00842829|364842520|FG001|Continuation Period|Non-compliance to study drug|0|||
105779214|NCT00842829|364842521|FG002|Continuation Period|Non-compliance to study drug|1|||
105779215|NCT03091920|364842524|FG000|Overall Study|Adverse Event|0|||
105779216|NCT03091920|364842525|FG001|Overall Study|Adverse Event|1|||
105779217|NCT03091920|364842526|FG002|Overall Study|Adverse Event|0|||
105779218|NCT03143855|364842527|FG000|Overall Study|Withdrawal by Subject|4|||
105779219|NCT03143855|364842528|FG001|Overall Study|Withdrawal by Subject|3|||
105779220|NCT03143855|364842527|FG000|Overall Study|Protocol Violation|1|||
105779221|NCT03143855|364842528|FG001|Overall Study|Protocol Violation|0|||
105779222|NCT03143855|364842527|FG000|Overall Study|Participant experienced withdrawal|0|||
105779223|NCT03143855|364842528|FG001|Overall Study|Participant experienced withdrawal|1|||
105779224|NCT00453349|364842529|FG000|Randomized|Adverse Event|12|||
105779225|NCT00453349|364842530|FG001|Randomized|Adverse Event|11|||
105779226|NCT00453349|364842529|FG000|Randomized|Lack of Efficacy|2|||
105779227|NCT00453349|364842530|FG001|Randomized|Lack of Efficacy|1|||
105779228|NCT00453349|364842529|FG000|Randomized|Lost to Follow-up|7|||
105779229|NCT00453349|364842530|FG001|Randomized|Lost to Follow-up|5|||
105779230|NCT00453349|364842529|FG000|Randomized|Protocol Violation|1|||
105779231|NCT00453349|364842530|FG001|Randomized|Protocol Violation|1|||
105779232|NCT00453349|364842529|FG000|Randomized|Withdrawal by Subject|3|||
105779233|NCT00453349|364842530|FG001|Randomized|Withdrawal by Subject|5|||
105779234|NCT00453349|364842529|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
105779235|NCT00453349|364842530|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
105779236|NCT00453349|364842529|FG000|Completed Study|Adverse Event|12|||
105779237|NCT00453349|364842530|FG001|Completed Study|Adverse Event|11|||
105779238|NCT00453349|364842529|FG000|Completed Study|Lack of Efficacy|2|||
105779239|NCT00453349|364842530|FG001|Completed Study|Lack of Efficacy|1|||
105779240|NCT00453349|364842529|FG000|Completed Study|Lost to Follow-up|7|||
105779241|NCT00453349|364842530|FG001|Completed Study|Lost to Follow-up|5|||
105779242|NCT00453349|364842529|FG000|Completed Study|Protocol Violation|1|||
105779243|NCT00453349|364842530|FG001|Completed Study|Protocol Violation|1|||
105779244|NCT00453349|364842529|FG000|Completed Study|Withdrawal by Subject|3|||
105779245|NCT00453349|364842530|FG001|Completed Study|Withdrawal by Subject|5|||
105779246|NCT00453349|364842529|FG000|Completed Study|Lost to follow up after study treatment|2|||
105779247|NCT00453349|364842530|FG001|Completed Study|Lost to follow up after study treatment|11|||
105779248|NCT00280059|364842531|FG000|Efficacy Assessment Phase|Death|2|||
105779249|NCT00280059|364842532|FG001|Efficacy Assessment Phase|Death|0|||
105779250|NCT00280059|364842531|FG000|Efficacy Assessment Phase|Adverse Event|33|||
105779251|NCT00280059|364842532|FG001|Efficacy Assessment Phase|Adverse Event|31|||
105779252|NCT00280059|364842531|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
105779253|NCT00280059|364842532|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
105779254|NCT00280059|364842531|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
105779255|NCT00280059|364842532|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
105779256|NCT00280059|364842531|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
105779257|NCT00280059|364842532|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
105779258|NCT00280059|364842531|FG000|Efficacy Assessment Phase|Other|7|||
105334293|NCT02564900|363225250|FG012|Dose Escalation|Adverse Event|0|||
105334294|NCT02564900|363225251|FG013|Dose Escalation|Adverse Event|0|||
105334295|NCT02564900|363225252|FG014|Dose Escalation|Adverse Event|0|||
105334296|NCT02564900|363225238|FG000|Dose Expansion|Progressive disease per RECIST|0|||
105334297|NCT02564900|363225239|FG001|Dose Expansion|Progressive disease per RECIST|0|||
105334298|NCT02564900|363225240|FG002|Dose Expansion|Progressive disease per RECIST|0|||
105334299|NCT02564900|363225241|FG003|Dose Expansion|Progressive disease per RECIST|0|||
105334300|NCT02564900|363225242|FG004|Dose Expansion|Progressive disease per RECIST|0|||
105334301|NCT02564900|363225243|FG005|Dose Expansion|Progressive disease per RECIST|0|||
105334302|NCT02564900|363225244|FG006|Dose Expansion|Progressive disease per RECIST|19|||
105334303|NCT02564900|363225245|FG007|Dose Expansion|Progressive disease per RECIST|17|||
105334304|NCT02564900|363225246|FG008|Dose Expansion|Progressive disease per RECIST|8|||
105334305|NCT02564900|363225247|FG009|Dose Expansion|Progressive disease per RECIST|16|||
105334306|NCT02564900|363225248|FG010|Dose Expansion|Progressive disease per RECIST|13|||
105334307|NCT02564900|363225249|FG011|Dose Expansion|Progressive disease per RECIST|19|||
105334308|NCT02564900|363225250|FG012|Dose Expansion|Progressive disease per RECIST|10|||
105334309|NCT02564900|363225251|FG013|Dose Expansion|Progressive disease per RECIST|13|||
105334310|NCT02564900|363225252|FG014|Dose Expansion|Progressive disease per RECIST|11|||
105334311|NCT02564900|363225238|FG000|Dose Expansion|Clinical progression|0|||
105334312|NCT02564900|363225239|FG001|Dose Expansion|Clinical progression|0|||
105334313|NCT02564900|363225240|FG002|Dose Expansion|Clinical progression|0|||
105334314|NCT02564900|363225241|FG003|Dose Expansion|Clinical progression|0|||
105334315|NCT02564900|363225242|FG004|Dose Expansion|Clinical progression|0|||
105334316|NCT02564900|363225243|FG005|Dose Expansion|Clinical progression|0|||
105334317|NCT02564900|363225244|FG006|Dose Expansion|Clinical progression|5|||
105779259|NCT00280059|364842532|FG001|Efficacy Assessment Phase|Other|8|||
105779260|NCT00280059|364842531|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
105779261|NCT00280059|364842532|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
105779262|NCT04369742|364842533|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
105779263|NCT04369742|364842534|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
105779264|NCT04369742|364842533|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
105779265|NCT04369742|364842534|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
105779266|NCT01864746|364844685|FG000|Overall Study|Disease recurrence|25|||
105779267|NCT01864746|364844686|FG001|Overall Study|Disease recurrence|40|||
105779268|NCT01864746|364844685|FG000|Overall Study|Second primary invasive nonbreast|2|||
105779269|NCT01864746|364844686|FG001|Overall Study|Second primary invasive nonbreast|3|||
105779270|NCT01864746|364844685|FG000|Overall Study|Death|2|||
105779271|NCT01864746|364844686|FG001|Overall Study|Death|1|||
105779272|NCT01864746|364844685|FG000|Overall Study|Adverse Event|33|||
105779273|NCT01864746|364844686|FG001|Overall Study|Adverse Event|5|||
105779274|NCT01864746|364844685|FG000|Overall Study|Withdrawal by Subject|56|||
105779275|NCT01864746|364844686|FG001|Overall Study|Withdrawal by Subject|41|||
105779276|NCT01864746|364844685|FG000|Overall Study|Physician Decision|5|||
105779277|NCT01864746|364844686|FG001|Overall Study|Physician Decision|6|||
105779278|NCT04144140|364844687|FG000|Overall Study|Other|0|||
105779279|NCT04144140|364844688|FG001|Overall Study|Other|0|||
105779280|NCT04144140|364844689|FG002|Overall Study|Other|0|||
105779281|NCT04144140|364844690|FG003|Overall Study|Other|0|||
105779282|NCT04144140|364844691|FG004|Overall Study|Other|0|||
105779283|NCT04144140|364844692|FG005|Overall Study|Other|1|||
105779284|NCT04144140|364844693|FG006|Overall Study|Other|0|||
105779285|NCT01465958|364844694|FG000|Run-in Phase|Protocol Violation|1|||
105779286|NCT01465958|364844695|FG001|Run-in Phase|Protocol Violation|0|||
105779287|NCT01465958|364844694|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
105779288|NCT01465958|364844695|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
105779289|NCT02039687|364844699|FG000|Overall Study|Adverse Event|0|||
105779290|NCT02039687|364844700|FG001|Overall Study|Adverse Event|0|||
105779291|NCT02039687|364844701|FG002|Overall Study|Adverse Event|1|||
105779292|NCT02039687|364844702|FG003|Overall Study|Adverse Event|0|||
105779293|NCT02039687|364844699|FG000|Overall Study|Withdrawal by Subject|0|||
105779294|NCT02039687|364844700|FG001|Overall Study|Withdrawal by Subject|1|||
105779295|NCT02039687|364844701|FG002|Overall Study|Withdrawal by Subject|0|||
105779296|NCT02039687|364844702|FG003|Overall Study|Withdrawal by Subject|0|||
105779297|NCT02039687|364844699|FG000|Overall Study|treatment assignment could not be confir|0|||
105779298|NCT02039687|364844700|FG001|Overall Study|treatment assignment could not be confir|0|||
105779299|NCT02039687|364844701|FG002|Overall Study|treatment assignment could not be confir|2|||
105779300|NCT02039687|364844702|FG003|Overall Study|treatment assignment could not be confir|0|||
105779301|NCT03824704|364844718|FG000|Overall Study|Study Terminated by Sponsor|1|||
105779302|NCT02194699|364844720|FG000|Randomised|Did not receive treatment|1|||
105334318|NCT02564900|363225245|FG007|Dose Expansion|Clinical progression|12|||
105334319|NCT02564900|363225246|FG008|Dose Expansion|Clinical progression|0|||
105334320|NCT02564900|363225247|FG009|Dose Expansion|Clinical progression|3|||
105334321|NCT02564900|363225248|FG010|Dose Expansion|Clinical progression|2|||
105334322|NCT02564900|363225249|FG011|Dose Expansion|Clinical progression|0|||
105334323|NCT02564900|363225250|FG012|Dose Expansion|Clinical progression|1|||
105334324|NCT02564900|363225251|FG013|Dose Expansion|Clinical progression|3|||
105334325|NCT02564900|363225252|FG014|Dose Expansion|Clinical progression|1|||
105334326|NCT02564900|363225238|FG000|Dose Expansion|Adverse Event|0|||
105334327|NCT02564900|363225239|FG001|Dose Expansion|Adverse Event|0|||
105334328|NCT02564900|363225240|FG002|Dose Expansion|Adverse Event|0|||
105334329|NCT02564900|363225241|FG003|Dose Expansion|Adverse Event|0|||
105334330|NCT02564900|363225242|FG004|Dose Expansion|Adverse Event|0|||
105334331|NCT02564900|363225243|FG005|Dose Expansion|Adverse Event|0|||
105334332|NCT02564900|363225244|FG006|Dose Expansion|Adverse Event|9|||
105334333|NCT02564900|363225245|FG007|Dose Expansion|Adverse Event|22|||
105334334|NCT02564900|363225246|FG008|Dose Expansion|Adverse Event|0|||
105334335|NCT02564900|363225247|FG009|Dose Expansion|Adverse Event|11|||
105334336|NCT02564900|363225248|FG010|Dose Expansion|Adverse Event|0|||
105334337|NCT02564900|363225249|FG011|Dose Expansion|Adverse Event|5|||
105334338|NCT02564900|363225250|FG012|Dose Expansion|Adverse Event|2|||
105334339|NCT02564900|363225251|FG013|Dose Expansion|Adverse Event|2|||
105334340|NCT02564900|363225252|FG014|Dose Expansion|Adverse Event|1|||
105334341|NCT02564900|363225238|FG000|Dose Expansion|Ongoing|0|||
105334342|NCT02564900|363225239|FG001|Dose Expansion|Ongoing|0|||
105334343|NCT02564900|363225240|FG002|Dose Expansion|Ongoing|0|||
105334344|NCT02564900|363225241|FG003|Dose Expansion|Ongoing|0|||
105334345|NCT02564900|363225242|FG004|Dose Expansion|Ongoing|0|||
105334346|NCT02564900|363225243|FG005|Dose Expansion|Ongoing|0|||
105334347|NCT02564900|363225244|FG006|Dose Expansion|Ongoing|9|||
105334348|NCT02564900|363225245|FG007|Dose Expansion|Ongoing|10|||
105334349|NCT02564900|363225246|FG008|Dose Expansion|Ongoing|11|||
105334350|NCT02564900|363225247|FG009|Dose Expansion|Ongoing|3|||
105334351|NCT02564900|363225248|FG010|Dose Expansion|Ongoing|0|||
105334352|NCT02564900|363225249|FG011|Dose Expansion|Ongoing|0|||
105334353|NCT02564900|363225250|FG012|Dose Expansion|Ongoing|4|||
105334354|NCT02564900|363225251|FG013|Dose Expansion|Ongoing|0|||
105334355|NCT02564900|363225252|FG014|Dose Expansion|Ongoing|6|||
105334356|NCT02564900|363225238|FG000|Dose Expansion|Death|0|||
105334357|NCT02564900|363225239|FG001|Dose Expansion|Death|0|||
105334358|NCT02564900|363225240|FG002|Dose Expansion|Death|0|||
105334359|NCT02564900|363225241|FG003|Dose Expansion|Death|0|||
105334360|NCT02564900|363225242|FG004|Dose Expansion|Death|0|||
105334361|NCT02564900|363225243|FG005|Dose Expansion|Death|0|||
105334362|NCT02564900|363225244|FG006|Dose Expansion|Death|1|||
105334363|NCT02564900|363225245|FG007|Dose Expansion|Death|0|||
105334364|NCT02564900|363225246|FG008|Dose Expansion|Death|0|||
105334365|NCT02564900|363225247|FG009|Dose Expansion|Death|0|||
105334366|NCT02564900|363225248|FG010|Dose Expansion|Death|1|||
105334367|NCT02564900|363225249|FG011|Dose Expansion|Death|0|||
105334368|NCT02564900|363225250|FG012|Dose Expansion|Death|1|||
105334369|NCT02564900|363225251|FG013|Dose Expansion|Death|1|||
105334370|NCT02564900|363225252|FG014|Dose Expansion|Death|0|||
105334371|NCT02564900|363225238|FG000|Dose Expansion|Withdrawal by Subject|0|||
105334372|NCT02564900|363225239|FG001|Dose Expansion|Withdrawal by Subject|0|||
105334373|NCT02564900|363225240|FG002|Dose Expansion|Withdrawal by Subject|0|||
105334374|NCT02564900|363225241|FG003|Dose Expansion|Withdrawal by Subject|0|||
105334375|NCT02564900|363225242|FG004|Dose Expansion|Withdrawal by Subject|0|||
105334376|NCT02564900|363225243|FG005|Dose Expansion|Withdrawal by Subject|0|||
105334377|NCT02564900|363225244|FG006|Dose Expansion|Withdrawal by Subject|4|||
105334378|NCT02564900|363225245|FG007|Dose Expansion|Withdrawal by Subject|0|||
105334379|NCT02564900|363225246|FG008|Dose Expansion|Withdrawal by Subject|0|||
105334380|NCT02564900|363225247|FG009|Dose Expansion|Withdrawal by Subject|0|||
105334381|NCT02564900|363225248|FG010|Dose Expansion|Withdrawal by Subject|1|||
105334382|NCT02564900|363225249|FG011|Dose Expansion|Withdrawal by Subject|0|||
105334383|NCT02564900|363225250|FG012|Dose Expansion|Withdrawal by Subject|0|||
105334384|NCT02564900|363225251|FG013|Dose Expansion|Withdrawal by Subject|1|||
105334385|NCT02564900|363225252|FG014|Dose Expansion|Withdrawal by Subject|1|||
105334386|NCT02564900|363225238|FG000|Dose Expansion|Other|0|||
105334387|NCT02564900|363225239|FG001|Dose Expansion|Other|0|||
105334388|NCT02564900|363225240|FG002|Dose Expansion|Other|0|||
105779303|NCT02194699|364844721|FG001|Randomised|Did not receive treatment|5|||
105334389|NCT02564900|363225241|FG003|Dose Expansion|Other|0|||
105334390|NCT02564900|363225242|FG004|Dose Expansion|Other|0|||
105334391|NCT02564900|363225243|FG005|Dose Expansion|Other|0|||
105334392|NCT02564900|363225244|FG006|Dose Expansion|Other|1|||
105334393|NCT02564900|363225245|FG007|Dose Expansion|Other|0|||
105442574|NCT04034004|363626794|FG003|Overall Study|nurse accidentally unblinded subject|1|||
105779304|NCT02194699|364844720|FG000|Randomised|Without potential for 52 weeks of IP|5|||
105334394|NCT02564900|363225246|FG008|Dose Expansion|Other|1|||
105334395|NCT02564900|363225247|FG009|Dose Expansion|Other|0|||
105334396|NCT02564900|363225248|FG010|Dose Expansion|Other|0|||
105334397|NCT02564900|363225249|FG011|Dose Expansion|Other|0|||
105334398|NCT02564900|363225250|FG012|Dose Expansion|Other|0|||
105334399|NCT02564900|363225251|FG013|Dose Expansion|Other|0|||
105334400|NCT02564900|363225252|FG014|Dose Expansion|Other|1|||
105334401|NCT02564900|363225238|FG000|Dose Expansion|Did not receive treatment|0|||
105334402|NCT02564900|363225239|FG001|Dose Expansion|Did not receive treatment|0|||
105334403|NCT02564900|363225240|FG002|Dose Expansion|Did not receive treatment|0|||
105334404|NCT02564900|363225241|FG003|Dose Expansion|Did not receive treatment|0|||
105334405|NCT02564900|363225242|FG004|Dose Expansion|Did not receive treatment|0|||
105334406|NCT02564900|363225243|FG005|Dose Expansion|Did not receive treatment|0|||
105334407|NCT02564900|363225244|FG006|Dose Expansion|Did not receive treatment|1|||
105334408|NCT02564900|363225245|FG007|Dose Expansion|Did not receive treatment|1|||
105334409|NCT02564900|363225246|FG008|Dose Expansion|Did not receive treatment|0|||
105334410|NCT02564900|363225247|FG009|Dose Expansion|Did not receive treatment|0|||
105334411|NCT02564900|363225248|FG010|Dose Expansion|Did not receive treatment|0|||
105334412|NCT02564900|363225249|FG011|Dose Expansion|Did not receive treatment|0|||
105334413|NCT02564900|363225250|FG012|Dose Expansion|Did not receive treatment|0|||
105334414|NCT02564900|363225251|FG013|Dose Expansion|Did not receive treatment|0|||
105334415|NCT02564900|363225252|FG014|Dose Expansion|Did not receive treatment|1|||
105334416|NCT04075682|363225254|FG000|Overall Study|Lost to Follow-up|5|||
105334417|NCT04075682|363225255|FG001|Overall Study|Lost to Follow-up|5|||
105334418|NCT04075682|363225256|FG002|Overall Study|Lost to Follow-up|2|||
105334419|NCT04075682|363225257|FG003|Overall Study|Lost to Follow-up|2|||
105334420|NCT04075682|363225254|FG000|Overall Study|Withdrawal by Subject|1|||
105334421|NCT04075682|363225255|FG001|Overall Study|Withdrawal by Subject|0|||
105334422|NCT04075682|363225256|FG002|Overall Study|Withdrawal by Subject|1|||
105334423|NCT04075682|363225257|FG003|Overall Study|Withdrawal by Subject|0|||
105334424|NCT04075682|363225254|FG000|Overall Study|Protocol Violation|0|||
105334425|NCT04075682|363225255|FG001|Overall Study|Protocol Violation|1|||
105334426|NCT04075682|363225256|FG002|Overall Study|Protocol Violation|1|||
105334427|NCT04075682|363225257|FG003|Overall Study|Protocol Violation|0|||
105334428|NCT04075682|363225254|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
105334429|NCT04075682|363225255|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
105334430|NCT04075682|363225256|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
105334431|NCT04075682|363225257|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
105334432|NCT04075682|363225254|FG000|Overall Study|Lost study phone the first day of study participation|0|||
105334433|NCT04075682|363225255|FG001|Overall Study|Lost study phone the first day of study participation|1|||
105334434|NCT04075682|363225256|FG002|Overall Study|Lost study phone the first day of study participation|0|||
105334435|NCT04075682|363225257|FG003|Overall Study|Lost study phone the first day of study participation|0|||
105334436|NCT01289639|363225259|FG000|Overall Study|Lost to Follow-up|1|||
105334437|NCT01289639|363225260|FG001|Overall Study|Lost to Follow-up|0|||
105334438|NCT01289639|363225261|FG002|Overall Study|Lost to Follow-up|0|||
105334439|NCT02780713|363225262|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
105334440|NCT02780713|363225263|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
105334441|NCT02780713|363225264|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
105334442|NCT02780713|363225265|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
105334443|NCT02780713|363225266|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
105334444|NCT01089608|363225267|FG000|Overall Study|Adverse Event|0|||
105334445|NCT01089608|363225268|FG001|Overall Study|Adverse Event|4|||
105334446|NCT01089608|363225267|FG000|Overall Study|Lost to Follow-up|0|||
105334447|NCT01089608|363225268|FG001|Overall Study|Lost to Follow-up|2|||
105334448|NCT01282372|363225270|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
105334449|NCT01282372|363225270|FG000|Overall Study|Lost to Follow-up|23|||
105334450|NCT01282372|363225270|FG000|Overall Study|Withdrawal by Subject|11|||
105334451|NCT01282372|363225270|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
105334452|NCT01282372|363225270|FG000|Overall Study|Death|1|||
105334453|NCT01282372|363225270|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
105334454|NCT01282372|363225270|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
105334455|NCT01282372|363225270|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
105334456|NCT01282372|363225270|FG000|Overall Study|Adverse Event|12|||
105334457|NCT02411396|363225272|FG000|Overall Study|Lost to Follow-up|31|||
105334458|NCT02411396|363225272|FG000|Overall Study|Death|10|||
105334459|NCT01680861|363225273|FG000|Early Post-transplant Period|Protocol Violation|1|||
105334460|NCT01680861|363225274|FG001|Early Post-transplant Period|Protocol Violation|1|||
105334461|NCT01014988|363225278|FG000|Overall Study|Adverse Event|20|||
105334462|NCT01014988|363225279|FG001|Overall Study|Adverse Event|0|||
105334463|NCT01014988|363225280|FG002|Overall Study|Adverse Event|1|||
105334464|NCT01014988|363225281|FG003|Overall Study|Adverse Event|0|||
105334465|NCT01014988|363225282|FG004|Overall Study|Adverse Event|1|||
105334466|NCT01014988|363225283|FG005|Overall Study|Adverse Event|3|||
105334467|NCT01014988|363225278|FG000|Overall Study|Lost to Follow-up|1|||
105334468|NCT01014988|363225279|FG001|Overall Study|Lost to Follow-up|0|||
105334469|NCT01014988|363225280|FG002|Overall Study|Lost to Follow-up|1|||
105334470|NCT01014988|363225281|FG003|Overall Study|Lost to Follow-up|0|||
105334471|NCT01014988|363225282|FG004|Overall Study|Lost to Follow-up|0|||
105334472|NCT01014988|363225283|FG005|Overall Study|Lost to Follow-up|0|||
105334473|NCT01014988|363225278|FG000|Overall Study|Physician Decision|1|||
105779305|NCT02194699|364844721|FG001|Randomised|Without potential for 52 weeks of IP|5|||
105779306|NCT02194699|364844720|FG000|Randomised|Duplicate patient|2|||
105779307|NCT02194699|364844721|FG001|Randomised|Duplicate patient|1|||
105779308|NCT02194699|364844720|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
105779309|NCT02194699|364844721|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
105779310|NCT02194699|364844720|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
105779311|NCT02194699|364844721|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
105779312|NCT02194699|364844720|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
105779313|NCT02194699|364844721|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
105779314|NCT02194699|364844720|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
105779315|NCT02194699|364844721|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
105779316|NCT02194699|364844720|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
105779317|NCT02194699|364844721|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
105779318|NCT02194699|364844720|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
105779319|NCT02194699|364844721|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
105779320|NCT02408016|364844722|FG000|Overall Study|Death|6|||
105779321|NCT02408016|364844723|FG001|Overall Study|Death|1|||
105779322|NCT02408016|364844724|FG002|Overall Study|Death|0|||
105779323|NCT02408016|364844722|FG000|Overall Study|Physician Decision|0|||
105779324|NCT02408016|364844723|FG001|Overall Study|Physician Decision|2|||
105779325|NCT02408016|364844724|FG002|Overall Study|Physician Decision|0|||
105779326|NCT00805194|364844725|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
105779327|NCT00805194|364844726|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
105779328|NCT00805194|364844725|FG000|Overall Study|Worsening or AE of underlying disease|64|||
105779329|NCT00805194|364844726|FG001|Overall Study|Worsening or AE of underlying disease|70|||
105779330|NCT00805194|364844725|FG000|Overall Study|Other AE|84|||
105779331|NCT00805194|364844726|FG001|Overall Study|Other AE|73|||
105779332|NCT00805194|364844725|FG000|Overall Study|Protocol Violation|9|||
105779333|NCT00805194|364844726|FG001|Overall Study|Protocol Violation|9|||
105779334|NCT00805194|364844725|FG000|Overall Study|Lost to Follow-up|5|||
105779335|NCT00805194|364844726|FG001|Overall Study|Lost to Follow-up|5|||
105779336|NCT00805194|364844725|FG000|Overall Study|Withdrawal by Subject|60|||
105779337|NCT00805194|364844726|FG001|Overall Study|Withdrawal by Subject|42|||
105779338|NCT00805194|364844725|FG000|Overall Study|Not treated|3|||
105779339|NCT00805194|364844726|FG001|Overall Study|Not treated|4|||
105779340|NCT00805194|364844725|FG000|Overall Study|Reasons other than stated above|20|||
105779341|NCT00805194|364844726|FG001|Overall Study|Reasons other than stated above|16|||
105779342|NCT02155660|364844727|FG000|Overall Study|Other Reason|8|||
105779343|NCT02155660|364844728|FG001|Overall Study|Other Reason|6|||
105779344|NCT02155660|364844729|FG002|Overall Study|Other Reason|10|||
105779345|NCT02155660|364844730|FG003|Overall Study|Other Reason|10|||
105779346|NCT02155660|364844727|FG000|Overall Study|Study-specific withdrawal criteria|0|||
105779347|NCT02155660|364844728|FG001|Overall Study|Study-specific withdrawal criteria|1|||
105779348|NCT02155660|364844729|FG002|Overall Study|Study-specific withdrawal criteria|1|||
105779349|NCT02155660|364844730|FG003|Overall Study|Study-specific withdrawal criteria|1|||
105779350|NCT02155660|364844727|FG000|Overall Study|Severe non-compliance|0|||
105779351|NCT02155660|364844728|FG001|Overall Study|Severe non-compliance|4|||
105779352|NCT02155660|364844729|FG002|Overall Study|Severe non-compliance|0|||
105779353|NCT02155660|364844730|FG003|Overall Study|Severe non-compliance|1|||
105779354|NCT02155660|364844727|FG000|Overall Study|Adverse Event|2|||
105779355|NCT02155660|364844728|FG001|Overall Study|Adverse Event|6|||
105779356|NCT02155660|364844729|FG002|Overall Study|Adverse Event|3|||
105779357|NCT02155660|364844730|FG003|Overall Study|Adverse Event|1|||
105779358|NCT02155660|364844727|FG000|Overall Study|Lost to Follow-up|3|||
105779359|NCT02155660|364844728|FG001|Overall Study|Lost to Follow-up|6|||
105779360|NCT02155660|364844729|FG002|Overall Study|Lost to Follow-up|5|||
105779361|NCT02155660|364844730|FG003|Overall Study|Lost to Follow-up|8|||
105779362|NCT02155660|364844727|FG000|Overall Study|Death|17|||
105779363|NCT02155660|364844728|FG001|Overall Study|Death|19|||
105779364|NCT02155660|364844729|FG002|Overall Study|Death|17|||
105779365|NCT02155660|364844730|FG003|Overall Study|Death|19|||
105779366|NCT02155660|364844727|FG000|Overall Study|Withdrawal by Subject|28|||
105779367|NCT02155660|364844728|FG001|Overall Study|Withdrawal by Subject|31|||
105779368|NCT02155660|364844729|FG002|Overall Study|Withdrawal by Subject|24|||
105779369|NCT02155660|364844730|FG003|Overall Study|Withdrawal by Subject|21|||
105779370|NCT03812224|364844737|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
105779371|NCT03812224|364844738|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
105779372|NCT03812224|364844737|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
105779373|NCT03812224|364844738|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
105779374|NCT03812224|364844737|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
105779375|NCT03812224|364844738|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
105779376|NCT03812224|364844737|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
105779377|NCT03812224|364844738|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
105779378|NCT01641952|364844739|FG000|Overall Study|Lost to Follow-up|28|||
105779379|NCT01641952|364844739|FG000|Overall Study|Adverse Event|6|||
105334474|NCT01014988|363225279|FG001|Overall Study|Physician Decision|0|||
105334475|NCT01014988|363225280|FG002|Overall Study|Physician Decision|0|||
105334476|NCT01014988|363225281|FG003|Overall Study|Physician Decision|0|||
105334477|NCT01014988|363225282|FG004|Overall Study|Physician Decision|0|||
105334478|NCT01014988|363225283|FG005|Overall Study|Physician Decision|0|||
105334479|NCT01014988|363225278|FG000|Overall Study|Withdrawal by Subject|1|||
105334480|NCT01014988|363225279|FG001|Overall Study|Withdrawal by Subject|0|||
105334481|NCT01014988|363225280|FG002|Overall Study|Withdrawal by Subject|0|||
105334482|NCT01014988|363225281|FG003|Overall Study|Withdrawal by Subject|0|||
105334483|NCT01014988|363225282|FG004|Overall Study|Withdrawal by Subject|0|||
105334484|NCT01014988|363225283|FG005|Overall Study|Withdrawal by Subject|0|||
105334485|NCT02217410|363225284|FG000|Overall Study|Graft Loss|0|||
105334486|NCT02217410|363225285|FG001|Overall Study|Graft Loss|0|||
105334487|NCT02217410|363225286|FG002|Overall Study|Graft Loss|2|||
105334488|NCT02217410|363225284|FG000|Overall Study|Withdrawal by Subject|0|||
105334489|NCT02217410|363225285|FG001|Overall Study|Withdrawal by Subject|0|||
105334490|NCT02217410|363225286|FG002|Overall Study|Withdrawal by Subject|2|||
105334491|NCT02217410|363225284|FG000|Overall Study|Lost to Follow-up|0|||
105334492|NCT02217410|363225285|FG001|Overall Study|Lost to Follow-up|0|||
105334493|NCT02217410|363225286|FG002|Overall Study|Lost to Follow-up|1|||
105334494|NCT02217410|363225284|FG000|Overall Study|Lack of Efficacy|0|||
105334495|NCT02217410|363225285|FG001|Overall Study|Lack of Efficacy|1|||
105334496|NCT02217410|363225286|FG002|Overall Study|Lack of Efficacy|0|||
105334497|NCT02217410|363225284|FG000|Overall Study|Physician Decision|1|||
105334498|NCT02217410|363225285|FG001|Overall Study|Physician Decision|3|||
105334499|NCT02217410|363225286|FG002|Overall Study|Physician Decision|0|||
105334500|NCT00492648|363225295|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
105334501|NCT00492648|363225296|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
105334502|NCT03474731|363225300|FG000|Overall Study|Withdrawal by Subject|36|||
105334503|NCT03474731|363225301|FG001|Overall Study|Withdrawal by Subject|29|||
105334504|NCT03474731|363225302|FG002|Overall Study|Withdrawal by Subject|11|||
105334505|NCT03474731|363225303|FG003|Overall Study|Withdrawal by Subject|27|||
105334506|NCT03474731|363225300|FG000|Overall Study|COVID|0|||
105334507|NCT03474731|363225301|FG001|Overall Study|COVID|23|||
105334508|NCT03474731|363225302|FG002|Overall Study|COVID|0|||
105334509|NCT03474731|363225303|FG003|Overall Study|COVID|0|||
105334510|NCT03474731|363225300|FG000|Overall Study|Participant moved from area|1|||
105334511|NCT03474731|363225301|FG001|Overall Study|Participant moved from area|0|||
105334512|NCT03474731|363225302|FG002|Overall Study|Participant moved from area|0|||
105334513|NCT03474731|363225303|FG003|Overall Study|Participant moved from area|0|||
105334514|NCT03474731|363225300|FG000|Overall Study|Lost to Follow-up|11|||
105334515|NCT03474731|363225301|FG001|Overall Study|Lost to Follow-up|3|||
105334516|NCT03474731|363225302|FG002|Overall Study|Lost to Follow-up|18|||
105334517|NCT03474731|363225303|FG003|Overall Study|Lost to Follow-up|17|||
105334518|NCT03474731|363225300|FG000|Overall Study|Death|0|||
105334519|NCT03474731|363225301|FG001|Overall Study|Death|1|||
105334520|NCT03474731|363225302|FG002|Overall Study|Death|0|||
105334521|NCT03474731|363225303|FG003|Overall Study|Death|0|||
105334522|NCT03474731|363225300|FG000|Overall Study|Participant Removed|0|||
105334523|NCT03474731|363225301|FG001|Overall Study|Participant Removed|0|||
105334524|NCT03474731|363225302|FG002|Overall Study|Participant Removed|0|||
105334525|NCT03474731|363225303|FG003|Overall Study|Participant Removed|1|||
105334526|NCT00427921|363225307|FG000|Overall Study|Adverse Event|26|||
105334527|NCT00427921|363225307|FG000|Overall Study|Withdrawal by Subject|4|||
105334528|NCT00427921|363225307|FG000|Overall Study|Lost to Follow-up|2|||
105334529|NCT00427921|363225307|FG000|Overall Study|Other reason not specified|10|||
105334530|NCT00427921|363225307|FG000|Overall Study|Adverse Event + Hospitalization|1|||
105334531|NCT00427921|363225307|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
105334532|NCT00427921|363225307|FG000|Overall Study|Adverse Event + No Response|1|||
105334533|NCT00427921|363225307|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
105334534|NCT00427921|363225307|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
105334535|NCT00427921|363225307|FG000|Overall Study|Adverse Event + Lost Response|1|||
105334536|NCT00427921|363225307|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
105334537|NCT00427921|363225307|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
105334538|NCT00478777|363225308|FG000|Overall Study|Adverse Event|29|||
105334539|NCT00478777|363225308|FG000|Overall Study|Lack of Efficacy|23|||
105334540|NCT00478777|363225308|FG000|Overall Study|Withdrawal by Subject|4|||
105442575|NCT04776317|363626795|FG000|Overall Study|Physician Decision|0|||
105334541|NCT00478777|363225308|FG000|Overall Study|Death|3|||
105334542|NCT00478777|363225308|FG000|Overall Study|Protocol Violation|3|||
105334543|NCT00478777|363225308|FG000|Overall Study|Lost to Follow-up|3|||
105334544|NCT00478777|363225308|FG000|Overall Study|Physician Decision|1|||
105334545|NCT00478777|363225308|FG000|Overall Study|Intolerance of therapy|1|||
105334546|NCT00478777|363225308|FG000|Overall Study|Lack of compliance|1|||
105334547|NCT00478777|363225308|FG000|Overall Study|Lymphocytes infusion|1|||
105334548|NCT00478777|363225308|FG000|Overall Study|End of therapy|2|||
105334549|NCT00478777|363225308|FG000|Overall Study|Not treated with lenalidomide|6|||
105334550|NCT01377922|363225309|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
105334551|NCT01377922|363225310|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
105334552|NCT01435460|363225313|FG000|Overall Study|Adverse Event|2|||
105334553|NCT01435460|363225314|FG001|Overall Study|Adverse Event|1|||
105334554|NCT01435460|363225313|FG000|Overall Study|Lost to Follow-up|6|||
105334555|NCT01435460|363225314|FG001|Overall Study|Lost to Follow-up|1|||
105334556|NCT01435460|363225313|FG000|Overall Study|Withdrawal by Subject|1|||
105334557|NCT01435460|363225314|FG001|Overall Study|Withdrawal by Subject|3|||
105334558|NCT01435460|363225313|FG000|Overall Study|Protocol Violation|0|||
105334559|NCT01435460|363225314|FG001|Overall Study|Protocol Violation|1|||
105334560|NCT01435460|363225313|FG000|Overall Study|Did not meet eligibility criteria|2|||
105334561|NCT01435460|363225314|FG001|Overall Study|Did not meet eligibility criteria|0|||
105334562|NCT01706939|363225315|FG000|Pre Randomization|Screen Failure|1|||
105334563|NCT01706939|363225316|FG001|Pre Randomization|Screen Failure|0|||
105334564|NCT01706939|363225317|FG002|Pre Randomization|Screen Failure|0|||
105334565|NCT01706939|363225315|FG000|Pre Randomization|Ineligible for Randomization|1|||
105334566|NCT01706939|363225316|FG001|Pre Randomization|Ineligible for Randomization|0|||
105334567|NCT01706939|363225317|FG002|Pre Randomization|Ineligible for Randomization|0|||
105334568|NCT01706939|363225315|FG000|Pre Randomization|Withdrawal by Subject|1|||
105334569|NCT01706939|363225316|FG001|Pre Randomization|Withdrawal by Subject|0|||
105334570|NCT01706939|363225317|FG002|Pre Randomization|Withdrawal by Subject|0|||
105334571|NCT01706939|363225315|FG000|Randomization|Insufficient QoL survey compliance|0|||
105334572|NCT01706939|363225316|FG001|Randomization|Insufficient QoL survey compliance|1|||
105334573|NCT01706939|363225317|FG002|Randomization|Insufficient QoL survey compliance|1|||
105334574|NCT01706939|363225315|FG000|Randomization|Progression of disease|0|||
105334575|NCT01706939|363225316|FG001|Randomization|Progression of disease|2|||
105334576|NCT01706939|363225317|FG002|Randomization|Progression of disease|1|||
105334577|NCT04537234|363225318|FG000|Overall Study|Withdrawal by Subject|2|||
105334578|NCT04537234|363225319|FG001|Overall Study|Withdrawal by Subject|0|||
105334579|NCT01323387|363225320|FG000|Overall Study|Withdrawal by Subject|41|||
105334580|NCT01323387|363225320|FG000|Overall Study|Radiographic Data Unavailable|1|||
105334581|NCT01323387|363225320|FG000|Overall Study|Revision|14|||
105334582|NCT01323387|363225320|FG000|Overall Study|Protocol Violation|12|||
105334583|NCT01323387|363225320|FG000|Overall Study|Randomized but Never Treated|16|||
105334584|NCT01972438|363225321|FG000|Baseline-Month 3 Crossover Period|Death|1|||
105334585|NCT01972438|363225322|FG001|Baseline-Month 3 Crossover Period|Death|0|||
105334586|NCT01972438|363225321|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
105334587|NCT01972438|363225322|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
105334588|NCT01972438|363225321|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
105334589|NCT01972438|363225322|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
105334590|NCT01972438|363225321|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
105334591|NCT01972438|363225322|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
105334592|NCT01972438|363225321|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
105334593|NCT01972438|363225322|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
105334594|NCT01972438|363225321|FG000|Months 6-12 Study Period|Death|1|||
105334595|NCT01972438|363225322|FG001|Months 6-12 Study Period|Death|0|||
105334596|NCT01972438|363225321|FG000|Months 6-12 Study Period|Early Study Closure|2|||
105334597|NCT01972438|363225322|FG001|Months 6-12 Study Period|Early Study Closure|2|||
105334598|NCT01972438|363225321|FG000|Post Month 12 Study Period|Early Study Closure|3|||
105334599|NCT01972438|363225322|FG001|Post Month 12 Study Period|Early Study Closure|4|||
105334600|NCT03887442|363225328|FG000|Overall Study|Adverse Event|1|||
105334601|NCT03887442|363225329|FG001|Overall Study|Adverse Event|0|||
105334602|NCT03319732|363225330|FG000|Overall Study|Adverse Event|40|||
105334603|NCT03319732|363225330|FG000|Overall Study|Withdrawal by Subject|50|||
105334604|NCT03319732|363225330|FG000|Overall Study|MS relapse|10|||
105334605|NCT03319732|363225330|FG000|Overall Study|reason not specified|5|||
105334606|NCT00767455|363225331|FG000|Overall Study|Investigator error|19|||
105334607|NCT01295827|363225332|FG000|Overall Study|Adverse Event|1|||
105334608|NCT01295827|363225333|FG001|Overall Study|Adverse Event|2|||
105334609|NCT01295827|363225334|FG002|Overall Study|Adverse Event|2|||
105334610|NCT01295827|363225335|FG003|Overall Study|Adverse Event|1|||
105334611|NCT01295827|363225336|FG004|Overall Study|Adverse Event|1|||
105334612|NCT01295827|363225337|FG005|Overall Study|Adverse Event|4|||
105334613|NCT01295827|363225338|FG006|Overall Study|Adverse Event|15|||
105334614|NCT01295827|363225339|FG007|Overall Study|Adverse Event|49|||
105334615|NCT01295827|363225340|FG008|Overall Study|Adverse Event|22|||
105334616|NCT01295827|363225341|FG009|Overall Study|Adverse Event|7|||
105334617|NCT01295827|363225342|FG010|Overall Study|Adverse Event|50|||
105334618|NCT01295827|363225343|FG011|Overall Study|Adverse Event|21|||
105334619|NCT01295827|363225344|FG012|Overall Study|Adverse Event|0|||
105334620|NCT01295827|363225345|FG013|Overall Study|Adverse Event|0|||
105334621|NCT01295827|363225346|FG014|Overall Study|Adverse Event|0|||
105334622|NCT01295827|363225332|FG000|Overall Study|Lost to Follow-up|0|||
105334623|NCT01295827|363225333|FG001|Overall Study|Lost to Follow-up|0|||
105334624|NCT01295827|363225334|FG002|Overall Study|Lost to Follow-up|3|||
105334625|NCT01295827|363225335|FG003|Overall Study|Lost to Follow-up|0|||
105334626|NCT01295827|363225336|FG004|Overall Study|Lost to Follow-up|1|||
105334627|NCT01295827|363225337|FG005|Overall Study|Lost to Follow-up|0|||
105334628|NCT01295827|363225338|FG006|Overall Study|Lost to Follow-up|4|||
105334629|NCT01295827|363225339|FG007|Overall Study|Lost to Follow-up|8|||
105334630|NCT01295827|363225340|FG008|Overall Study|Lost to Follow-up|7|||
105334631|NCT01295827|363225341|FG009|Overall Study|Lost to Follow-up|4|||
105334632|NCT01295827|363225342|FG010|Overall Study|Lost to Follow-up|7|||
105334633|NCT01295827|363225343|FG011|Overall Study|Lost to Follow-up|3|||
105334634|NCT01295827|363225344|FG012|Overall Study|Lost to Follow-up|0|||
105334635|NCT01295827|363225345|FG013|Overall Study|Lost to Follow-up|0|||
105334636|NCT01295827|363225346|FG014|Overall Study|Lost to Follow-up|0|||
105334637|NCT01295827|363225332|FG000|Overall Study|Not Reported|0|||
105334638|NCT01295827|363225333|FG001|Overall Study|Not Reported|0|||
105334639|NCT01295827|363225334|FG002|Overall Study|Not Reported|0|||
105334640|NCT01295827|363225335|FG003|Overall Study|Not Reported|1|||
105334641|NCT01295827|363225336|FG004|Overall Study|Not Reported|0|||
105334642|NCT01295827|363225337|FG005|Overall Study|Not Reported|0|||
105334643|NCT01295827|363225338|FG006|Overall Study|Not Reported|24|||
105334644|NCT01295827|363225339|FG007|Overall Study|Not Reported|58|||
105334645|NCT01295827|363225340|FG008|Overall Study|Not Reported|41|||
105334646|NCT01295827|363225341|FG009|Overall Study|Not Reported|2|||
105334647|NCT01295827|363225342|FG010|Overall Study|Not Reported|23|||
105334648|NCT01295827|363225343|FG011|Overall Study|Not Reported|13|||
105334649|NCT01295827|363225344|FG012|Overall Study|Not Reported|0|||
105334650|NCT01295827|363225345|FG013|Overall Study|Not Reported|0|||
105334651|NCT01295827|363225346|FG014|Overall Study|Not Reported|0|||
105334652|NCT01295827|363225332|FG000|Overall Study|Progressive Disease|2|||
105334653|NCT01295827|363225333|FG001|Overall Study|Progressive Disease|1|||
105334654|NCT01295827|363225334|FG002|Overall Study|Progressive Disease|5|||
105334655|NCT01295827|363225335|FG003|Overall Study|Progressive Disease|2|||
105334656|NCT01295827|363225336|FG004|Overall Study|Progressive Disease|0|||
105334657|NCT01295827|363225337|FG005|Overall Study|Progressive Disease|1|||
105334658|NCT01295827|363225338|FG006|Overall Study|Progressive Disease|87|||
105334659|NCT01295827|363225339|FG007|Overall Study|Progressive Disease|144|||
105334660|NCT01295827|363225340|FG008|Overall Study|Progressive Disease|85|||
105334661|NCT01295827|363225341|FG009|Overall Study|Progressive Disease|40|||
105334662|NCT01295827|363225342|FG010|Overall Study|Progressive Disease|175|||
105334663|NCT01295827|363225343|FG011|Overall Study|Progressive Disease|136|||
105334664|NCT01295827|363225344|FG012|Overall Study|Progressive Disease|0|||
105334665|NCT01295827|363225345|FG013|Overall Study|Progressive Disease|0|||
105334666|NCT01295827|363225346|FG014|Overall Study|Progressive Disease|0|||
105334667|NCT01295827|363225332|FG000|Overall Study|Screen Failure|0|||
105334668|NCT01295827|363225333|FG001|Overall Study|Screen Failure|0|||
105334669|NCT01295827|363225334|FG002|Overall Study|Screen Failure|0|||
105334670|NCT01295827|363225335|FG003|Overall Study|Screen Failure|0|||
105334671|NCT01295827|363225336|FG004|Overall Study|Screen Failure|0|||
105334672|NCT01295827|363225337|FG005|Overall Study|Screen Failure|0|||
105334673|NCT01295827|363225338|FG006|Overall Study|Screen Failure|2|||
105334674|NCT01295827|363225339|FG007|Overall Study|Screen Failure|2|||
105334675|NCT01295827|363225340|FG008|Overall Study|Screen Failure|2|||
105334676|NCT01295827|363225341|FG009|Overall Study|Screen Failure|0|||
105334677|NCT01295827|363225342|FG010|Overall Study|Screen Failure|1|||
105334678|NCT01295827|363225343|FG011|Overall Study|Screen Failure|0|||
105334679|NCT01295827|363225344|FG012|Overall Study|Screen Failure|0|||
105334680|NCT01295827|363225345|FG013|Overall Study|Screen Failure|0|||
105334681|NCT01295827|363225346|FG014|Overall Study|Screen Failure|0|||
105334682|NCT01295827|363225332|FG000|Overall Study|Withdrawal by Subject|1|||
105334683|NCT01295827|363225333|FG001|Overall Study|Withdrawal by Subject|0|||
105334684|NCT01295827|363225334|FG002|Overall Study|Withdrawal by Subject|2|||
105334685|NCT01295827|363225335|FG003|Overall Study|Withdrawal by Subject|0|||
105334686|NCT01295827|363225336|FG004|Overall Study|Withdrawal by Subject|0|||
105334687|NCT01295827|363225337|FG005|Overall Study|Withdrawal by Subject|1|||
105334688|NCT01295827|363225338|FG006|Overall Study|Withdrawal by Subject|13|||
105334689|NCT01295827|363225339|FG007|Overall Study|Withdrawal by Subject|35|||
105334690|NCT01295827|363225340|FG008|Overall Study|Withdrawal by Subject|11|||
105334691|NCT01295827|363225341|FG009|Overall Study|Withdrawal by Subject|2|||
105334692|NCT01295827|363225342|FG010|Overall Study|Withdrawal by Subject|18|||
105334693|NCT01295827|363225343|FG011|Overall Study|Withdrawal by Subject|13|||
105334694|NCT01295827|363225344|FG012|Overall Study|Withdrawal by Subject|0|||
105661740|NCT04147858|364425118|FG002|Overall Study|Withdrawal by Subject|10|||
105661741|NCT04147858|364425116|FG000|Overall Study|Subject Noncompliance, Other|4|||
105334695|NCT01295827|363225345|FG013|Overall Study|Withdrawal by Subject|0|||
105442576|NCT04776317|363626796|FG001|Overall Study|Physician Decision|1|||
105334696|NCT01295827|363225346|FG014|Overall Study|Withdrawal by Subject|0|||
105334697|NCT01295827|363225332|FG000|Overall Study|Other|0|||
105334698|NCT01295827|363225333|FG001|Overall Study|Other|0|||
105334699|NCT01295827|363225334|FG002|Overall Study|Other|0|||
105334700|NCT01295827|363225335|FG003|Overall Study|Other|0|||
105334701|NCT01295827|363225336|FG004|Overall Study|Other|0|||
105334702|NCT01295827|363225337|FG005|Overall Study|Other|0|||
105334703|NCT01295827|363225338|FG006|Overall Study|Other|1|||
105334704|NCT01295827|363225339|FG007|Overall Study|Other|1|||
105334705|NCT01295827|363225340|FG008|Overall Study|Other|1|||
105334706|NCT01295827|363225341|FG009|Overall Study|Other|0|||
105334707|NCT01295827|363225342|FG010|Overall Study|Other|2|||
105334708|NCT01295827|363225343|FG011|Overall Study|Other|0|||
105334709|NCT01295827|363225344|FG012|Overall Study|Other|0|||
105334710|NCT01295827|363225345|FG013|Overall Study|Other|0|||
105334711|NCT01295827|363225346|FG014|Overall Study|Other|0|||
105334712|NCT00022698|363225347|FG000|Overall Study|Adverse Event|5|||
105334713|NCT00022698|363225348|FG001|Overall Study|Adverse Event|9|||
105334714|NCT00022698|363225347|FG000|Overall Study|Death|0|||
105334715|NCT00022698|363225348|FG001|Overall Study|Death|2|||
105334716|NCT00022698|363225347|FG000|Overall Study|Failure to return|0|||
105334717|NCT00022698|363225348|FG001|Overall Study|Failure to return|1|||
105334718|NCT00022698|363225347|FG000|Overall Study|Refused treatment|0|||
105334719|NCT00022698|363225348|FG001|Overall Study|Refused treatment|2|||
105334720|NCT00022698|363225347|FG000|Overall Study|Insufficient therapeutic response|2|||
105334721|NCT00022698|363225348|FG001|Overall Study|Insufficient therapeutic response|14|||
105334722|NCT00022698|363225347|FG000|Overall Study|Administrative /other|1|||
105334723|NCT00022698|363225348|FG001|Overall Study|Administrative /other|7|||
105334724|NCT01628198|363225349|FG000|Overall Study|Lost to Follow-up|7|||
105334725|NCT01628198|363225349|FG000|Overall Study|Withdrawal by Subject|10|||
105334726|NCT01628198|363225349|FG000|Overall Study|Screen failure|1|||
105334727|NCT02504827|363225353|FG000|Overall Study|Could not produce sputum|1|||
105334728|NCT02729051|363225369|FG000|Overall Study|Adverse Event|21|||
105334729|NCT02729051|363225370|FG001|Overall Study|Adverse Event|11|||
105334730|NCT02729051|363225369|FG000|Overall Study|Lack of Efficacy|1|||
105334731|NCT02729051|363225370|FG001|Overall Study|Lack of Efficacy|1|||
105334732|NCT02729051|363225369|FG000|Overall Study|Lost to Follow-up|1|||
105334733|NCT02729051|363225370|FG001|Overall Study|Lost to Follow-up|2|||
105334734|NCT02729051|363225369|FG000|Overall Study|Physician Decision|1|||
105334735|NCT02729051|363225370|FG001|Overall Study|Physician Decision|1|||
105334736|NCT02729051|363225369|FG000|Overall Study|Withdrawal by Subject|6|||
105334737|NCT02729051|363225370|FG001|Overall Study|Withdrawal by Subject|17|||
105334738|NCT04390503|363226927|FG000|Overall Study|Physician Decision|2|||
105334739|NCT04390503|363226928|FG001|Overall Study|Physician Decision|1|||
105334740|NCT04390503|363226927|FG000|Overall Study|Adverse Event|1|||
105334741|NCT04390503|363226928|FG001|Overall Study|Adverse Event|0|||
105334742|NCT00593684|363226929|FG000|Overall Study|Death|2|||
105334743|NCT00593684|363226930|FG001|Overall Study|Death|1|||
105334744|NCT03625466|363226931|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
105334745|NCT03625466|363226932|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
105334746|NCT03625466|363226933|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
105334747|NCT03625466|363226931|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
105334748|NCT03625466|363226932|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
105334749|NCT03625466|363226933|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
105334750|NCT03625466|363226931|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
105334751|NCT03625466|363226932|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
105334752|NCT03625466|363226933|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
105334753|NCT01270464|363226937|FG000|Overall Study|Protocol Violation|4|||
105334754|NCT01270464|363226938|FG001|Overall Study|Protocol Violation|3|||
105334755|NCT01270464|363226939|FG002|Overall Study|Protocol Violation|2|||
105334756|NCT01270464|363226937|FG000|Overall Study|Lack of Efficacy|2|||
105334757|NCT01270464|363226938|FG001|Overall Study|Lack of Efficacy|3|||
105334758|NCT01270464|363226939|FG002|Overall Study|Lack of Efficacy|1|||
105334759|NCT01270464|363226937|FG000|Overall Study|Adverse Event|9|||
105334760|NCT01270464|363226938|FG001|Overall Study|Adverse Event|1|||
105334761|NCT01270464|363226939|FG002|Overall Study|Adverse Event|7|||
105334762|NCT01270464|363226937|FG000|Overall Study|Withdrawal by Subject|2|||
105334763|NCT01270464|363226938|FG001|Overall Study|Withdrawal by Subject|1|||
105334764|NCT01270464|363226939|FG002|Overall Study|Withdrawal by Subject|4|||
105334765|NCT01270464|363226937|FG000|Overall Study|Lost to Follow-up|2|||
105334766|NCT01270464|363226938|FG001|Overall Study|Lost to Follow-up|3|||
105334767|NCT01270464|363226939|FG002|Overall Study|Lost to Follow-up|1|||
105334768|NCT01270464|363226937|FG000|Overall Study|Other|1|||
105334769|NCT01270464|363226938|FG001|Overall Study|Other|1|||
105334770|NCT01270464|363226939|FG002|Overall Study|Other|3|||
105334771|NCT05483686|363226940|FG000|Overall Study|Lost to Follow-up|5|||
105334772|NCT05483686|363226941|FG001|Overall Study|Lost to Follow-up|7|||
105334773|NCT00379080|363226951|FG000|Overall Study|Withdrawal by Subject|0|||
105334774|NCT00379080|363226952|FG001|Overall Study|Withdrawal by Subject|4|||
105334775|NCT00379080|363226953|FG002|Overall Study|Withdrawal by Subject|0|||
105334776|NCT01931475|363226954|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
105334777|NCT01931475|363226955|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
105334778|NCT01931475|363226954|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
105334779|NCT01931475|363226955|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
105334780|NCT01931475|363226954|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
105334781|NCT01931475|363226955|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
105334782|NCT01931475|363226954|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
105334783|NCT01931475|363226955|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
105334784|NCT01931475|363226954|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
105334785|NCT01931475|363226955|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
105334786|NCT01931475|363226954|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
105334787|NCT01931475|363226955|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
105334788|NCT01931475|363226954|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
105334789|NCT01931475|363226955|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
105334790|NCT01931475|363226954|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
105334791|NCT01931475|363226955|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
105334792|NCT01931475|363226954|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
105334793|NCT01931475|363226955|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
105334794|NCT01931475|363226954|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
105334795|NCT01931475|363226955|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
105334796|NCT01931475|363226954|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
105334797|NCT01931475|363226955|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
105334798|NCT00280397|363226957|FG000|Overall Study|Adverse Event|1|||
105334799|NCT00955955|363226964|FG000|Overall Study|Lost to Follow-up|2|||
105334800|NCT00955955|363226965|FG001|Overall Study|Lost to Follow-up|0|||
105334801|NCT00955955|363226966|FG002|Overall Study|Lost to Follow-up|0|||
105334802|NCT03423173|363226967|FG000|Overall Study|Randomized but not vaccinated|1|||
105334803|NCT03423173|363226968|FG001|Overall Study|Randomized but not vaccinated|0|||
105334804|NCT03423173|363226969|FG002|Overall Study|Randomized but not vaccinated|2|||
105334805|NCT03423173|363226970|FG003|Overall Study|Randomized but not vaccinated|1|||
105334806|NCT03423173|363226967|FG000|Overall Study|Adverse Event|1|||
105334807|NCT03423173|363226968|FG001|Overall Study|Adverse Event|1|||
105334808|NCT03423173|363226969|FG002|Overall Study|Adverse Event|1|||
105334809|NCT03423173|363226970|FG003|Overall Study|Adverse Event|1|||
105334810|NCT03423173|363226967|FG000|Overall Study|Lost to Follow-up|10|||
105334811|NCT03423173|363226968|FG001|Overall Study|Lost to Follow-up|19|||
105334812|NCT03423173|363226969|FG002|Overall Study|Lost to Follow-up|17|||
105334813|NCT03423173|363226970|FG003|Overall Study|Lost to Follow-up|22|||
105334814|NCT03423173|363226967|FG000|Overall Study|Withdrawal of consent|4|||
105334815|NCT03423173|363226968|FG001|Overall Study|Withdrawal of consent|10|||
105334816|NCT03423173|363226969|FG002|Overall Study|Withdrawal of consent|4|||
105334817|NCT03423173|363226970|FG003|Overall Study|Withdrawal of consent|5|||
105334818|NCT03423173|363226967|FG000|Overall Study|Death|1|||
105334819|NCT03423173|363226968|FG001|Overall Study|Death|0|||
105334820|NCT03423173|363226969|FG002|Overall Study|Death|0|||
105334821|NCT03423173|363226970|FG003|Overall Study|Death|0|||
105334822|NCT03423173|363226967|FG000|Overall Study|Reason not Specified|2|||
105334823|NCT03423173|363226968|FG001|Overall Study|Reason not Specified|5|||
105334824|NCT03423173|363226969|FG002|Overall Study|Reason not Specified|3|||
105334825|NCT03423173|363226970|FG003|Overall Study|Reason not Specified|1|||
105334826|NCT00708214|363226973|FG000|Overall Study|Other Adverse Event|3|||
105334827|NCT00708214|363226974|FG001|Overall Study|Other Adverse Event|6|||
105334828|NCT00708214|363226975|FG002|Overall Study|Other Adverse Event|2|||
105334829|NCT00708214|363226973|FG000|Overall Study|Other|0|||
105334830|NCT00708214|363226974|FG001|Overall Study|Other|1|||
105334831|NCT00708214|363226975|FG002|Overall Study|Other|1|||
105334832|NCT00708214|363226973|FG000|Overall Study|Progressive Disease|4|||
105334833|NCT00708214|363226974|FG001|Overall Study|Progressive Disease|6|||
105334834|NCT00708214|363226975|FG002|Overall Study|Progressive Disease|5|||
105334835|NCT03533114|363226976|FG000|Overall|Adverse Event|16|||
105334836|NCT03533114|363226977|FG001|Overall|Adverse Event|11|||
105334837|NCT03533114|363226976|FG000|Overall|Consent Withdrawal by Participant|7|||
105334838|NCT03533114|363226977|FG001|Overall|Consent Withdrawal by Participant|6|||
105334839|NCT03533114|363226976|FG000|Overall|Lack of Efficacy|5|||
105334840|NCT03533114|363226977|FG001|Overall|Lack of Efficacy|3|||
105334841|NCT03533114|363226976|FG000|Overall|Lost to Follow-up|1|||
105334842|NCT03533114|363226977|FG001|Overall|Lost to Follow-up|1|||
105334843|NCT03533114|363226976|FG000|Overall|Physician Decision|0|||
105334844|NCT03533114|363226977|FG001|Overall|Physician Decision|2|||
105334845|NCT03533114|363226976|FG000|Overall|Protocol deviation|1|||
105334846|NCT03533114|363226977|FG001|Overall|Protocol deviation|1|||
105334847|NCT03533114|363226976|FG000|Overall|Failure to meet randomization criteria|1|||
105334848|NCT03533114|363226977|FG001|Overall|Failure to meet randomization criteria|2|||
105334849|NCT03533114|363226976|FG000|Overall|Non-Compliance with study drug|0|||
105334850|NCT03533114|363226977|FG001|Overall|Non-Compliance with study drug|1|||
105334851|NCT03533114|363226976|FG000|Overall|Other|0|||
105334852|NCT03533114|363226977|FG001|Overall|Other|1|||
105334853|NCT03533114|363226976|FG000|Open Label Titration and Optimization|Adverse Event|11|||
105334854|NCT03533114|363226977|FG001|Open Label Titration and Optimization|Adverse Event|8|||
105442577|NCT04776317|363626797|FG002|Overall Study|Physician Decision|0|||
105334855|NCT03533114|363226976|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
105334856|NCT03533114|363226977|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
105334857|NCT03533114|363226976|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
105334858|NCT03533114|363226977|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
105334859|NCT03533114|363226976|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
105334860|NCT03533114|363226977|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
105334861|NCT03533114|363226976|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
105334862|NCT03533114|363226977|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
105334863|NCT03533114|363226976|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
105334864|NCT03533114|363226977|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
105334865|NCT03533114|363226976|FG000|Stable Dose|Adverse Event|0|||
105334866|NCT03533114|363226977|FG001|Stable Dose|Adverse Event|2|||
105334867|NCT03533114|363226976|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
105334868|NCT03533114|363226977|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
105334869|NCT03533114|363226976|FG000|Stable Dose|Lack of Efficacy|1|||
105334870|NCT03533114|363226977|FG001|Stable Dose|Lack of Efficacy|0|||
105334871|NCT03533114|363226976|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
105334872|NCT03533114|363226977|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
105334873|NCT03533114|363226976|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
105334874|NCT03533114|363226977|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
105334875|NCT03533114|363226976|FG000|Open-Label Safety Extension|Adverse Event|3|||
105334876|NCT03533114|363226977|FG001|Open-Label Safety Extension|Adverse Event|0|||
105334877|NCT03533114|363226976|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
105334878|NCT03533114|363226977|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
105334879|NCT03533114|363226976|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
105334880|NCT03533114|363226977|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
105334881|NCT03533114|363226976|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
105334882|NCT03533114|363226977|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
105334883|NCT03533114|363226976|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
105334884|NCT03533114|363226977|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
105334885|NCT03169881|363226978|FG000|Overall Study|Incomplete Follow-up|10|||
105334886|NCT03169881|363226979|FG001|Overall Study|Incomplete Follow-up|15|||
105334887|NCT03169881|363226978|FG000|Overall Study|Lost to Follow-up|18|||
105334888|NCT03169881|363226979|FG001|Overall Study|Lost to Follow-up|20|||
105334889|NCT03169881|363226978|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
105334890|NCT03169881|363226979|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
105334891|NCT01862250|363226980|FG000|Overall Study|Adverse Event|4|||
105334892|NCT03852264|363226981|FG000|Third Research Visit|Lost to Follow-up|1|||
105334893|NCT03852264|363226982|FG001|Third Research Visit|Lost to Follow-up|0|||
105334894|NCT01028014|363226986|FG000|Overall Study|Lost to Follow-up|1|||
105334895|NCT01028014|363226987|FG001|Overall Study|Lost to Follow-up|2|||
105334896|NCT01028014|363226988|FG002|Overall Study|Lost to Follow-up|0|||
105334897|NCT01028014|363226989|FG003|Overall Study|Lost to Follow-up|1|||
105334898|NCT01028014|363226990|FG004|Overall Study|Lost to Follow-up|1|||
105334899|NCT01028014|363226991|FG005|Overall Study|Lost to Follow-up|2|||
105334900|NCT05338502|363226992|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
105334901|NCT05338502|363226993|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
105334902|NCT05338502|363226994|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
105334903|NCT05338502|363226992|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
105334904|NCT05338502|363226993|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
105334905|NCT05338502|363226994|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
105334906|NCT01250873|363226999|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
105334907|NCT01250873|363226999|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
105334908|NCT02423343|363227000|FG000|Overall Study|Withdrawal by Subject|0|||
105334909|NCT02423343|363227001|FG001|Overall Study|Withdrawal by Subject|1|||
105334910|NCT02423343|363227002|FG002|Overall Study|Withdrawal by Subject|0|||
105334911|NCT02423343|363227003|FG003|Overall Study|Withdrawal by Subject|0|||
105334912|NCT02423343|363227004|FG004|Overall Study|Withdrawal by Subject|0|||
105334913|NCT02423343|363227005|FG005|Overall Study|Withdrawal by Subject|0|||
105334914|NCT02423343|363227000|FG000|Overall Study|Progressive Disease|0|||
105334915|NCT02423343|363227001|FG001|Overall Study|Progressive Disease|0|||
105334916|NCT02423343|363227002|FG002|Overall Study|Progressive Disease|0|||
105334917|NCT02423343|363227003|FG003|Overall Study|Progressive Disease|0|||
105334918|NCT02423343|363227004|FG004|Overall Study|Progressive Disease|2|||
105334919|NCT02423343|363227005|FG005|Overall Study|Progressive Disease|0|||
105334920|NCT02423343|363227000|FG000|Overall Study|Adverse Event|0|||
105334921|NCT02423343|363227001|FG001|Overall Study|Adverse Event|0|||
105334922|NCT02423343|363227002|FG002|Overall Study|Adverse Event|0|||
105334923|NCT02423343|363227003|FG003|Overall Study|Adverse Event|0|||
105334924|NCT02423343|363227004|FG004|Overall Study|Adverse Event|2|||
105334925|NCT02423343|363227005|FG005|Overall Study|Adverse Event|0|||
105442578|NCT04776317|363626798|FG003|Overall Study|Physician Decision|0|||
105442579|NCT04776317|363626799|FG004|Overall Study|Physician Decision|0|||
105334926|NCT02423343|363227000|FG000|Overall Study|Death|0|||
105334927|NCT02423343|363227001|FG001|Overall Study|Death|0|||
105334928|NCT02423343|363227002|FG002|Overall Study|Death|0|||
105334929|NCT02423343|363227003|FG003|Overall Study|Death|0|||
105334930|NCT02423343|363227004|FG004|Overall Study|Death|1|||
105334931|NCT02423343|363227005|FG005|Overall Study|Death|0|||
105334932|NCT00090493|363227006|FG000|Overall Study|Physician Decision|2|||
105334933|NCT02111577|363227007|FG000|Overall Study|Protocol Violation|2|||
105334934|NCT02111577|363227008|FG001|Overall Study|Protocol Violation|0|||
105334935|NCT02111577|363227007|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
105334936|NCT02111577|363227008|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
105334937|NCT02111577|363227007|FG000|Overall Study|Failure to produce study treatment|6|||
105334938|NCT02111577|363227008|FG001|Overall Study|Failure to produce study treatment|0|||
105334939|NCT02111577|363227007|FG000|Overall Study|Death|518|||
105442580|NCT04776317|363626800|FG005|Overall Study|Physician Decision|0|||
105442581|NCT04776317|363626801|FG006|Overall Study|Physician Decision|0|||
105442582|NCT04776317|363626802|FG007|Overall Study|Physician Decision|0|||
105442583|NCT04776317|363626803|FG008|Overall Study|Physician Decision|0|||
105442584|NCT04776317|363626804|FG009|Overall Study|Physician Decision|0|||
105442585|NCT04776317|363626805|FG010|Overall Study|Physician Decision|0|||
105442586|NCT04776317|363626806|FG011|Overall Study|Physician Decision|0|||
105442587|NCT04776317|363626807|FG012|Overall Study|Physician Decision|0|||
105442588|NCT04776317|363626808|FG013|Overall Study|Physician Decision|0|||
105442589|NCT04776317|363626809|FG014|Overall Study|Physician Decision|0|||
105442590|NCT04776317|363626795|FG000|Overall Study|Protocol Violation|0|||
105442591|NCT04776317|363626796|FG001|Overall Study|Protocol Violation|0|||
105442592|NCT04776317|363626797|FG002|Overall Study|Protocol Violation|1|||
105442593|NCT04776317|363626798|FG003|Overall Study|Protocol Violation|0|||
105442594|NCT04776317|363626799|FG004|Overall Study|Protocol Violation|0|||
105442595|NCT04776317|363626800|FG005|Overall Study|Protocol Violation|0|||
105442596|NCT04776317|363626801|FG006|Overall Study|Protocol Violation|0|||
105442597|NCT04776317|363626802|FG007|Overall Study|Protocol Violation|0|||
105442598|NCT04776317|363626803|FG008|Overall Study|Protocol Violation|0|||
105442599|NCT04776317|363626804|FG009|Overall Study|Protocol Violation|0|||
105442600|NCT04776317|363626805|FG010|Overall Study|Protocol Violation|0|||
105442601|NCT04776317|363626806|FG011|Overall Study|Protocol Violation|0|||
105442602|NCT04776317|363626807|FG012|Overall Study|Protocol Violation|0|||
105442603|NCT04776317|363626808|FG013|Overall Study|Protocol Violation|0|||
105442604|NCT04776317|363626809|FG014|Overall Study|Protocol Violation|0|||
105442605|NCT04776317|363626795|FG000|Overall Study|Withdrawal by Subject|0|||
105442606|NCT04776317|363626796|FG001|Overall Study|Withdrawal by Subject|0|||
105442607|NCT04776317|363626797|FG002|Overall Study|Withdrawal by Subject|0|||
105442608|NCT04776317|363626798|FG003|Overall Study|Withdrawal by Subject|0|||
105442609|NCT04776317|363626799|FG004|Overall Study|Withdrawal by Subject|1|||
105442610|NCT04776317|363626800|FG005|Overall Study|Withdrawal by Subject|0|||
105442611|NCT04776317|363626801|FG006|Overall Study|Withdrawal by Subject|0|||
105442612|NCT04776317|363626802|FG007|Overall Study|Withdrawal by Subject|0|||
105442613|NCT04776317|363626803|FG008|Overall Study|Withdrawal by Subject|0|||
105442614|NCT04776317|363626804|FG009|Overall Study|Withdrawal by Subject|0|||
105442615|NCT04776317|363626805|FG010|Overall Study|Withdrawal by Subject|0|||
105442616|NCT04776317|363626806|FG011|Overall Study|Withdrawal by Subject|0|||
105442617|NCT04776317|363626807|FG012|Overall Study|Withdrawal by Subject|0|||
105442618|NCT04776317|363626808|FG013|Overall Study|Withdrawal by Subject|0|||
105442619|NCT04776317|363626809|FG014|Overall Study|Withdrawal by Subject|0|||
105442620|NCT04207060|363626810|FG000|Overall Study|Lost to Follow-up|2|||
105442621|NCT04207060|363626811|FG001|Overall Study|Lost to Follow-up|0|||
105334940|NCT02111577|363227008|FG001|Overall Study|Death|254|||
105334941|NCT02111577|363227007|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
105334942|NCT02111577|363227008|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
105334943|NCT02111577|363227007|FG000|Overall Study|Adverse Event|1|||
105334944|NCT02111577|363227008|FG001|Overall Study|Adverse Event|1|||
105334945|NCT02111577|363227007|FG000|Overall Study|Withdrawal by Subject|51|||
105334946|NCT02111577|363227008|FG001|Overall Study|Withdrawal by Subject|23|||
105334947|NCT02111577|363227007|FG000|Overall Study|Disease progression|0|||
105334948|NCT02111577|363227008|FG001|Overall Study|Disease progression|1|||
105334949|NCT02111577|363227007|FG000|Overall Study|Lost to Follow-up|19|||
105442622|NCT01835158|363626817|FG000|Overall Study|Withdrawal by Subject|1|||
105442623|NCT01835158|363626818|FG001|Overall Study|Withdrawal by Subject|6|||
105442624|NCT01856582|363626819|FG000|Overall Study|Died prior to Boost infusion|1|||
105442625|NCT00773747|363626820|FG000|Overall Study|Lack of Efficacy|112|||
105442626|NCT00773747|363626821|FG001|Overall Study|Lack of Efficacy|144|||
105442627|NCT00773747|363626820|FG000|Overall Study|Physician Decision|26|||
105442628|NCT00773747|363626821|FG001|Overall Study|Physician Decision|18|||
105442629|NCT00773747|363626820|FG000|Overall Study|Lost to Follow-up|0|||
105334950|NCT02111577|363227008|FG001|Overall Study|Lost to Follow-up|10|||
105442630|NCT00773747|363626821|FG001|Overall Study|Lost to Follow-up|1|||
105442631|NCT00773747|363626820|FG000|Overall Study|Protocol Violation|2|||
105334951|NCT01908829|363227011|FG000|Overall Study|Adverse Event|13|||
105334952|NCT01908829|363227012|FG001|Overall Study|Adverse Event|11|||
105334953|NCT01908829|363227013|FG002|Overall Study|Adverse Event|13|||
105334954|NCT01908829|363227011|FG000|Overall Study|Lost to Follow-up|4|||
105334955|NCT01908829|363227012|FG001|Overall Study|Lost to Follow-up|2|||
105334956|NCT01908829|363227013|FG002|Overall Study|Lost to Follow-up|1|||
105334957|NCT01908829|363227011|FG000|Overall Study|Randomized no double-blind drug received|1|||
105334958|NCT01908829|363227012|FG001|Overall Study|Randomized no double-blind drug received|0|||
105334959|NCT01908829|363227013|FG002|Overall Study|Randomized no double-blind drug received|1|||
105334960|NCT01908829|363227011|FG000|Overall Study|Discontinued (no EoT page)|2|||
105334961|NCT01908829|363227012|FG001|Overall Study|Discontinued (no EoT page)|0|||
105334962|NCT01908829|363227013|FG002|Overall Study|Discontinued (no EoT page)|0|||
105334963|NCT01908829|363227011|FG000|Overall Study|Miscellaneous|0|||
105334964|NCT01908829|363227012|FG001|Overall Study|Miscellaneous|2|||
105334965|NCT01908829|363227013|FG002|Overall Study|Miscellaneous|0|||
105334966|NCT01908829|363227011|FG000|Overall Study|Protocol Violation|2|||
105334967|NCT01908829|363227012|FG001|Overall Study|Protocol Violation|2|||
105334968|NCT01908829|363227013|FG002|Overall Study|Protocol Violation|0|||
105334969|NCT01908829|363227011|FG000|Overall Study|Lack of Efficacy|1|||
105334970|NCT01908829|363227012|FG001|Overall Study|Lack of Efficacy|3|||
105334971|NCT01908829|363227013|FG002|Overall Study|Lack of Efficacy|2|||
105334972|NCT01908829|363227011|FG000|Overall Study|Withdrawal by Subject|26|||
105334973|NCT01908829|363227012|FG001|Overall Study|Withdrawal by Subject|29|||
105334974|NCT01908829|363227013|FG002|Overall Study|Withdrawal by Subject|22|||
105334975|NCT04967885|363227014|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
105334976|NCT04967885|363227015|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
105334977|NCT04967885|363227014|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
105334978|NCT04967885|363227015|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
105334979|NCT04967885|363227014|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
105334980|NCT04967885|363227015|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
105334981|NCT04967885|363227014|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
105334982|NCT04967885|363227015|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
105334983|NCT04967885|363227014|FG000|EMI-II Intervention|Lost to Follow-up|14|||
105334984|NCT04967885|363227015|FG001|EMI-II Intervention|Lost to Follow-up|10|||
105334985|NCT02320058|363227016|FG000|Overall Study|Death|25|||
105334986|NCT02320058|363227017|FG001|Overall Study|Death|10|||
105334987|NCT02320058|363227016|FG000|Overall Study|Lost to Follow-up|4|||
105334988|NCT02320058|363227017|FG001|Overall Study|Lost to Follow-up|0|||
105334989|NCT02320058|363227016|FG000|Overall Study|Other reasons|4|||
105334990|NCT02320058|363227017|FG001|Overall Study|Other reasons|1|||
105334991|NCT02320058|363227016|FG000|Overall Study|Withdrawal by Subject|8|||
105334992|NCT02320058|363227017|FG001|Overall Study|Withdrawal by Subject|2|||
105334993|NCT02320058|363227016|FG000|Overall Study|Not reported|1|||
105334994|NCT02320058|363227017|FG001|Overall Study|Not reported|0|||
105334995|NCT00729157|363227018|FG000|Overall Study|Withdrawal by Subject|1|||
105334996|NCT01940887|363227019|FG000|Year 1|Protocol Violation|0|||
105334997|NCT01940887|363227020|FG001|Year 1|Protocol Violation|1|||
105334998|NCT01940887|363227019|FG000|Year 1|Physician Decision|7|||
105334999|NCT01940887|363227020|FG001|Year 1|Physician Decision|3|||
105335000|NCT01940887|363227019|FG000|Year 1|Death|5|||
105335001|NCT01940887|363227020|FG001|Year 1|Death|3|||
105335002|NCT01940887|363227019|FG000|Year 1|Adverse Event|7|||
105335003|NCT01940887|363227020|FG001|Year 1|Adverse Event|6|||
105335004|NCT01940887|363227019|FG000|Year 1|Withdrawal by Subject|18|||
105335005|NCT01940887|363227020|FG001|Year 1|Withdrawal by Subject|9|||
105335006|NCT01940887|363227019|FG000|Year 1|Lost to Follow-up|2|||
105335007|NCT01940887|363227020|FG001|Year 1|Lost to Follow-up|1|||
105335008|NCT01940887|363227019|FG000|Year 2|Physician Decision|8|||
105335009|NCT01940887|363227020|FG001|Year 2|Physician Decision|1|||
105335010|NCT01940887|363227019|FG000|Year 2|Death|0|||
105335011|NCT01940887|363227020|FG001|Year 2|Death|2|||
105335012|NCT01940887|363227019|FG000|Year 2|Sponsor Decision, early termination|192|||
105335013|NCT01940887|363227020|FG001|Year 2|Sponsor Decision, early termination|203|||
105335014|NCT01940887|363227019|FG000|Year 2|Adverse Event|8|||
105335015|NCT01940887|363227020|FG001|Year 2|Adverse Event|2|||
105335016|NCT01940887|363227019|FG000|Year 2|Withdrawal by Subject|8|||
105335017|NCT01940887|363227020|FG001|Year 2|Withdrawal by Subject|8|||
105335018|NCT01940887|363227019|FG000|Year 2|Lost to Follow-up|1|||
105335019|NCT01940887|363227020|FG001|Year 2|Lost to Follow-up|6|||
105335020|NCT01430403|363227024|FG000|Overall Study|Lost to Follow-up|5|||
105335021|NCT01430403|363227025|FG001|Overall Study|Lost to Follow-up|5|||
105335022|NCT01430403|363227026|FG002|Overall Study|Lost to Follow-up|3|||
105335023|NCT01430403|363227024|FG000|Overall Study|Physician Decision|1|||
105335024|NCT01430403|363227025|FG001|Overall Study|Physician Decision|0|||
105335025|NCT01430403|363227026|FG002|Overall Study|Physician Decision|0|||
105335026|NCT01430403|363227024|FG000|Overall Study|Protocol Violation|2|||
105335027|NCT01430403|363227025|FG001|Overall Study|Protocol Violation|3|||
105335028|NCT01430403|363227026|FG002|Overall Study|Protocol Violation|2|||
105335029|NCT01430403|363227024|FG000|Overall Study|Withdrawal by Subject|9|||
105335030|NCT01430403|363227025|FG001|Overall Study|Withdrawal by Subject|1|||
105335031|NCT01430403|363227026|FG002|Overall Study|Withdrawal by Subject|3|||
105335032|NCT01290679|363227029|FG000|Overall Study|Adverse Event|2|||
105335033|NCT01290679|363227030|FG001|Overall Study|Adverse Event|0|||
105335034|NCT01290679|363227029|FG000|Overall Study|Lost to Follow-up|8|||
105335035|NCT01290679|363227030|FG001|Overall Study|Lost to Follow-up|10|||
105335036|NCT01290679|363227029|FG000|Overall Study|Protocol Violation|0|||
105335037|NCT01290679|363227030|FG001|Overall Study|Protocol Violation|1|||
105335038|NCT01290679|363227029|FG000|Overall Study|Withdrawal by Subject|6|||
105335039|NCT01290679|363227030|FG001|Overall Study|Withdrawal by Subject|5|||
105335040|NCT01290679|363227029|FG000|Overall Study|Subject Entered Another Trial|0|||
105335041|NCT01290679|363227030|FG001|Overall Study|Subject Entered Another Trial|5|||
105335042|NCT01855243|363227031|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
105335043|NCT01855243|363227032|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
105335044|NCT01855243|363227033|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
105335045|NCT01860040|363227036|FG000|Overall Study|Withdrawal by Subject|1|||
105335046|NCT01860040|363227037|FG001|Overall Study|Withdrawal by Subject|0|||
105335047|NCT04087720|363227040|FG000|Overall Study|Withdrawal by Subject|2|||
105335048|NCT04087720|363227040|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
105335049|NCT03706430|363227045|FG000|Overall Study|No A-Line placed|5|||
105335050|NCT03706430|363227045|FG000|Overall Study|Subject had gel nail polish|1|||
105335051|NCT03706430|363227045|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
105335052|NCT03706430|363227045|FG000|Overall Study|Cancelled Case|6|||
105335053|NCT03706430|363227045|FG000|Overall Study|Physician Decision|2|||
105335054|NCT02294396|363227046|FG000|Overall Study|Adverse Event|26|||
105335055|NCT02294396|363227047|FG001|Overall Study|Adverse Event|25|||
105335056|NCT02294396|363227048|FG002|Overall Study|Adverse Event|21|||
105335057|NCT02294396|363227049|FG003|Overall Study|Adverse Event|24|||
105335058|NCT02294396|363227046|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
105335059|NCT02294396|363227047|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
105335060|NCT02294396|363227048|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
105335061|NCT02294396|363227049|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
105335062|NCT02294396|363227046|FG000|Overall Study|Withdrawal by Subject|8|||
105335063|NCT02294396|363227047|FG001|Overall Study|Withdrawal by Subject|6|||
105335064|NCT02294396|363227048|FG002|Overall Study|Withdrawal by Subject|6|||
105335065|NCT02294396|363227049|FG003|Overall Study|Withdrawal by Subject|8|||
105335066|NCT02294396|363227046|FG000|Overall Study|Lost to Follow-up|0|||
105335067|NCT02294396|363227047|FG001|Overall Study|Lost to Follow-up|0|||
105335068|NCT02294396|363227048|FG002|Overall Study|Lost to Follow-up|1|||
105335069|NCT02294396|363227049|FG003|Overall Study|Lost to Follow-up|1|||
105335070|NCT02294396|363227046|FG000|Overall Study|Protocol Deviation|3|||
105335071|NCT02294396|363227047|FG001|Overall Study|Protocol Deviation|2|||
105335072|NCT02294396|363227048|FG002|Overall Study|Protocol Deviation|2|||
105335073|NCT02294396|363227049|FG003|Overall Study|Protocol Deviation|1|||
105335074|NCT02294396|363227046|FG000|Overall Study|Miscellaneous|2|||
105335075|NCT02294396|363227047|FG001|Overall Study|Miscellaneous|0|||
105335076|NCT02294396|363227048|FG002|Overall Study|Miscellaneous|5|||
105335077|NCT02294396|363227049|FG003|Overall Study|Miscellaneous|2|||
105335078|NCT01075256|363227050|FG000|Overall Study|Withdrawal by Subject|1|||
105335079|NCT01075256|363227051|FG001|Overall Study|Withdrawal by Subject|0|||
105335080|NCT01075256|363227052|FG002|Overall Study|Withdrawal by Subject|0|||
105335081|NCT05020665|363227063|FG000|Overall Study|Study terminated by Sponsor|5|||
105335082|NCT05020665|363227064|FG001|Overall Study|Study terminated by Sponsor|4|||
105335083|NCT05020665|363227063|FG000|Overall Study|Death|2|||
105335084|NCT05020665|363227064|FG001|Overall Study|Death|1|||
105335085|NCT05020665|363227063|FG000|Overall Study|Physician Decision|0|||
105335086|NCT05020665|363227064|FG001|Overall Study|Physician Decision|1|||
105335087|NCT05020665|363227063|FG000|Overall Study|Withdrawal by Subject|0|||
105335088|NCT05020665|363227064|FG001|Overall Study|Withdrawal by Subject|1|||
105335089|NCT05020665|363227063|FG000|Overall Study|Reason not specified|1|||
105335090|NCT05020665|363227064|FG001|Overall Study|Reason not specified|0|||
105335091|NCT00101166|363227065|FG000|Overall Study|progressive disease|10|||
105335092|NCT01732640|363227069|FG000|Overall Study|Adverse Event|0|||
105335093|NCT01732640|363227070|FG001|Overall Study|Adverse Event|1|||
105335094|NCT01732640|363227069|FG000|Overall Study|Death|0|||
105335095|NCT01732640|363227070|FG001|Overall Study|Death|1|||
105335096|NCT01441765|363227073|FG000|Overall Study|Death|1|||
105335097|NCT01441765|363227074|FG001|Overall Study|Death|0|||
105335098|NCT04520997|363227075|FG000|Overall Study|Lost to Follow-up|1|||
105335099|NCT04520997|363227076|FG001|Overall Study|Lost to Follow-up|1|||
105335100|NCT04520997|363227075|FG000|Overall Study|Withdrawal by Subject|1|||
105335101|NCT04520997|363227076|FG001|Overall Study|Withdrawal by Subject|0|||
105335102|NCT04520997|363227075|FG000|Overall Study|Not Treated|0|||
105335103|NCT04520997|363227076|FG001|Overall Study|Not Treated|1|||
105335104|NCT04925557|363228203|FG000|Overall Study|Study closed|5|||
105335105|NCT04925557|363228204|FG001|Overall Study|Study closed|3|||
105335106|NCT04432831|363228205|FG000|Overall Study|Withdrawal by Subject|24|||
105335107|NCT04432831|363228206|FG001|Overall Study|Withdrawal by Subject|28|||
105335108|NCT04432831|363228207|FG002|Overall Study|Withdrawal by Subject|21|||
105335109|NCT04432831|363228205|FG000|Overall Study|Death|23|||
105335110|NCT04432831|363228206|FG001|Overall Study|Death|23|||
105335111|NCT04432831|363228207|FG002|Overall Study|Death|17|||
105335112|NCT04432831|363228205|FG000|Overall Study|Lost to Follow-up|15|||
105335113|NCT04432831|363228206|FG001|Overall Study|Lost to Follow-up|15|||
105335114|NCT04432831|363228207|FG002|Overall Study|Lost to Follow-up|12|||
105335115|NCT04432831|363228205|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
105335116|NCT04432831|363228206|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
105335117|NCT04432831|363228207|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
105335118|NCT04432831|363228205|FG000|Overall Study|Reason Not Specified|7|||
105335119|NCT04432831|363228206|FG001|Overall Study|Reason Not Specified|11|||
105335120|NCT04432831|363228207|FG002|Overall Study|Reason Not Specified|9|||
105335121|NCT04432831|363228205|FG000|Overall Study|Adverse Event|7|||
105335122|NCT04432831|363228206|FG001|Overall Study|Adverse Event|7|||
105335123|NCT04432831|363228207|FG002|Overall Study|Adverse Event|7|||
105335124|NCT04432831|363228205|FG000|Overall Study|Physician Decision|1|||
105335125|NCT04432831|363228206|FG001|Overall Study|Physician Decision|3|||
105335126|NCT04432831|363228207|FG002|Overall Study|Physician Decision|6|||
105335127|NCT04432831|363228205|FG000|Overall Study|Protocol Violation|1|||
105335128|NCT04432831|363228206|FG001|Overall Study|Protocol Violation|0|||
105335129|NCT04432831|363228207|FG002|Overall Study|Protocol Violation|2|||
105335130|NCT04432831|363228205|FG000|Overall Study|Pregnancy|0|||
105335131|NCT04432831|363228206|FG001|Overall Study|Pregnancy|1|||
105335132|NCT04432831|363228207|FG002|Overall Study|Pregnancy|0|||
105335133|NCT04432831|363228205|FG000|Overall Study|Lack of Efficacy|0|||
105335134|NCT04432831|363228206|FG001|Overall Study|Lack of Efficacy|0|||
105335135|NCT04432831|363228207|FG002|Overall Study|Lack of Efficacy|2|||
105335136|NCT03300505|363228209|FG000|Overall Study|Death|0|||
105335137|NCT03300505|363228210|FG001|Overall Study|Death|1|||
105335138|NCT03300505|363228211|FG002|Overall Study|Death|0|||
105335139|NCT03300505|363228209|FG000|Overall Study|Withdrawal by Subject|0|||
105335140|NCT03300505|363228210|FG001|Overall Study|Withdrawal by Subject|1|||
105335141|NCT03300505|363228211|FG002|Overall Study|Withdrawal by Subject|1|||
105335142|NCT03300505|363228209|FG000|Overall Study|Sponsor Termination|0|||
105335143|NCT03300505|363228210|FG001|Overall Study|Sponsor Termination|1|||
105335144|NCT03300505|363228211|FG002|Overall Study|Sponsor Termination|0|||
105335145|NCT03300505|363228209|FG000|Overall Study|Adverse Event|0|||
105335146|NCT03300505|363228210|FG001|Overall Study|Adverse Event|0|||
105335147|NCT03300505|363228211|FG002|Overall Study|Adverse Event|2|||
105335148|NCT01108341|363228212|FG000|Overall Study|Death|2|||
105335149|NCT01108341|363228212|FG000|Overall Study|Withdrawal by Subject|1|||
105335150|NCT01108341|363228212|FG000|Overall Study|Lost to Follow-up|1|||
105335151|NCT01108341|363228212|FG000|Overall Study|Other|1|||
105335152|NCT03831113|363228214|FG000|Overall Study|Withdrawal by Subject|0|||
105335153|NCT03831113|363228215|FG001|Overall Study|Withdrawal by Subject|2|||
105335154|NCT03831113|363228214|FG000|Overall Study|Protocol Violation|0|||
105335155|NCT03831113|363228215|FG001|Overall Study|Protocol Violation|9|||
105335156|NCT02162719|363228217|FG000|Overall Study|Death|41|||
105335157|NCT02162719|363228218|FG001|Overall Study|Death|46|||
105335158|NCT02162719|363228217|FG000|Overall Study|Lost to Follow-up|1|||
105335159|NCT02162719|363228218|FG001|Overall Study|Lost to Follow-up|3|||
105335160|NCT02162719|363228217|FG000|Overall Study|Disease Progression|2|||
105335161|NCT02162719|363228218|FG001|Overall Study|Disease Progression|1|||
105335162|NCT02162719|363228217|FG000|Overall Study|Withdrawal by Subject|8|||
105335163|NCT02162719|363228218|FG001|Overall Study|Withdrawal by Subject|2|||
105335164|NCT02162719|363228217|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
105335165|NCT02162719|363228218|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
105335166|NCT04696055|363228222|FG000|Overall Study|Adverse Event|10|||
105335167|NCT04696055|363228223|FG001|Overall Study|Adverse Event|2|||
105335168|NCT04696055|363228222|FG000|Overall Study|Death|4|||
105335169|NCT04696055|363228223|FG001|Overall Study|Death|0|||
105335170|NCT04696055|363228222|FG000|Overall Study|Other|7|||
105335171|NCT04696055|363228223|FG001|Overall Study|Other|2|||
105335172|NCT04696055|363228222|FG000|Overall Study|Physician Decision|3|||
105335173|NCT04696055|363228223|FG001|Overall Study|Physician Decision|0|||
105335174|NCT04696055|363228222|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
105335175|NCT04696055|363228223|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
105335176|NCT04696055|363228222|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
105335177|NCT04696055|363228223|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
105335178|NCT04696055|363228222|FG000|Overall Study|Subject Decision|1|||
105335179|NCT04696055|363228223|FG001|Overall Study|Subject Decision|2|||
105335180|NCT02589626|363228226|FG000|Overall Study|Other than the reason specified|1|||
105335181|NCT02589626|363228227|FG001|Overall Study|Other than the reason specified|0|||
105335182|NCT02589626|363228226|FG000|Overall Study|Withdrawal by Subject|1|||
105335183|NCT02589626|363228227|FG001|Overall Study|Withdrawal by Subject|1|||
105335184|NCT02589626|363228226|FG000|Overall Study|Adverse Event|1|||
105335185|NCT02589626|363228227|FG001|Overall Study|Adverse Event|1|||
105335186|NCT01057810|363228228|FG000|Overall Study|Disease progression|156|||
105335187|NCT01057810|363228229|FG001|Overall Study|Disease progression|197|||
105335188|NCT01057810|363228228|FG000|Overall Study|Study drug toxicity|5|||
105335189|NCT01057810|363228229|FG001|Overall Study|Study drug toxicity|114|||
105335190|NCT01057810|363228228|FG000|Overall Study|Adverse event unrelated to study drug|13|||
105335191|NCT01057810|363228229|FG001|Overall Study|Adverse event unrelated to study drug|29|||
105335192|NCT01057810|363228228|FG000|Overall Study|Withdrawal by Subject|10|||
105335193|NCT01057810|363228229|FG001|Overall Study|Withdrawal by Subject|25|||
105335194|NCT01057810|363228228|FG000|Overall Study|Death|2|||
105335195|NCT01057810|363228229|FG001|Overall Study|Death|12|||
105335196|NCT01057810|363228228|FG000|Overall Study|Maximum clinical benefit|5|||
105335197|NCT01057810|363228229|FG001|Overall Study|Maximum clinical benefit|5|||
105335198|NCT01057810|363228228|FG000|Overall Study|Poor/non-compliance|0|||
105335199|NCT01057810|363228229|FG001|Overall Study|Poor/non-compliance|1|||
105335200|NCT01057810|363228228|FG000|Overall Study|No longer met study criteria|0|||
105335201|NCT01057810|363228229|FG001|Overall Study|No longer met study criteria|1|||
105335202|NCT01057810|363228228|FG000|Overall Study|Other|7|||
105335203|NCT01057810|363228229|FG001|Overall Study|Other|14|||
105335204|NCT02278939|363228234|FG000|Overall Study|lack of time|1|||
105335205|NCT02278939|363228235|FG001|Overall Study|lack of time|0|||
105335206|NCT02278939|363228234|FG000|Overall Study|Lost to Follow-up|1|||
105335207|NCT02278939|363228235|FG001|Overall Study|Lost to Follow-up|1|||
105335208|NCT02278939|363228234|FG000|Overall Study|death in family|1|||
105335209|NCT02278939|363228235|FG001|Overall Study|death in family|0|||
105335210|NCT02278939|363228234|FG000|Overall Study|family emergency unable to commit|2|||
105335211|NCT02278939|363228235|FG001|Overall Study|family emergency unable to commit|0|||
105335212|NCT03728426|363228236|FG000|Overall Study|Death|3|||
105335213|NCT01127451|363228240|FG000|Overall Study|Other|2|||
105335214|NCT01127451|363228241|FG001|Overall Study|Other|1|||
105335215|NCT01127451|363228240|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
105335216|NCT01127451|363228241|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
105335217|NCT01127451|363228240|FG000|Overall Study|Death|22|||
105335218|NCT01127451|363228241|FG001|Overall Study|Death|17|||
105335219|NCT01127451|363228240|FG000|Overall Study|Lost to Follow-up|3|||
105335220|NCT01127451|363228241|FG001|Overall Study|Lost to Follow-up|0|||
105335221|NCT01127451|363228240|FG000|Overall Study|Administrative Reason by Sponsor|2|||
105335222|NCT01127451|363228241|FG001|Overall Study|Administrative Reason by Sponsor|2|||
105335223|NCT03075891|363228245|FG000|Overall Study|Withdrawal by Subject|3|||
105335224|NCT03075891|363228246|FG001|Overall Study|Withdrawal by Subject|6|||
105335225|NCT03075891|363228245|FG000|Overall Study|Lost to Follow-up|1|||
105335226|NCT03075891|363228246|FG001|Overall Study|Lost to Follow-up|0|||
105335227|NCT03075891|363228245|FG000|Overall Study|Pregnancy|3|||
105335228|NCT03075891|363228246|FG001|Overall Study|Pregnancy|1|||
105335229|NCT03075891|363228245|FG000|Overall Study|visits not performed (no time)|1|||
105335230|NCT03075891|363228246|FG001|Overall Study|visits not performed (no time)|0|||
105335231|NCT03075891|363228245|FG000|Overall Study|Drug abuse relapse issue|0|||
105335232|NCT03075891|363228246|FG001|Overall Study|Drug abuse relapse issue|1|||
105335233|NCT03075891|363228245|FG000|Overall Study|Participant requiring study withdrawal|0|||
105335234|NCT03075891|363228246|FG001|Overall Study|Participant requiring study withdrawal|1|||
105335235|NCT03075891|363228245|FG000|Overall Study|Adverse event, non-fatal|1|||
105335236|NCT03075891|363228246|FG001|Overall Study|Adverse event, non-fatal|4|||
105335237|NCT03793842|363228248|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
105335238|NCT03793842|363228249|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
105335239|NCT03793842|363228248|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
105335240|NCT03793842|363228249|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
105335241|NCT00520533|363228250|FG000|Overall Study|Death|1|||
105335242|NCT00520533|363228250|FG000|Overall Study|Suspension of the study for safety reasons|1|||
105335243|NCT00520533|363228250|FG000|Overall Study|Withdrawal by Subject|1|||
105335244|NCT00520533|363228250|FG000|Overall Study|Physician Decision|1|||
105335245|NCT02120833|363228251|FG000|Overall Study|Adverse Event|1|||
105335246|NCT02120833|363228252|FG001|Overall Study|Adverse Event|0|||
105335247|NCT02120833|363228251|FG000|Overall Study|Withdrawal by Subject|2|||
105335248|NCT02120833|363228252|FG001|Overall Study|Withdrawal by Subject|0|||
105335249|NCT02120833|363228251|FG000|Overall Study|Lost to Follow-up|1|||
105335250|NCT02120833|363228252|FG001|Overall Study|Lost to Follow-up|1|||
105335251|NCT03502070|363228253|FG000|Overall Study|Withdrawal by Subject|1|||
105335252|NCT03502070|363228253|FG000|Overall Study|Screen Failure|1|||
105335253|NCT04105218|363228255|FG000|Overall Study|Withdrawal by Subject|3|||
105335254|NCT04105218|363228256|FG001|Overall Study|Withdrawal by Subject|2|||
105335255|NCT04105218|363228255|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
105335256|NCT04105218|363228256|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
105335257|NCT04105218|363228255|FG000|Overall Study|Failed screening tests|2|||
105335258|NCT04105218|363228256|FG001|Overall Study|Failed screening tests|1|||
105335259|NCT01167881|363228257|FG000|Overall Study|Adverse Event|47|||
105335260|NCT01167881|363228258|FG001|Overall Study|Adverse Event|51|||
105335261|NCT01167881|363228257|FG000|Overall Study|Lack of Efficacy|4|||
105335262|NCT01167881|363228258|FG001|Overall Study|Lack of Efficacy|7|||
105335263|NCT01167881|363228257|FG000|Overall Study|Non compliant with protocol|9|||
105335264|NCT01167881|363228258|FG001|Overall Study|Non compliant with protocol|18|||
105335265|NCT01167881|363228257|FG000|Overall Study|Lost to Follow-up|19|||
105335266|NCT01167881|363228258|FG001|Overall Study|Lost to Follow-up|20|||
105335267|NCT01167881|363228257|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
105335268|NCT01167881|363228258|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
105335269|NCT01167881|363228257|FG000|Overall Study|Not treated|4|||
105335270|NCT01167881|363228258|FG001|Overall Study|Not treated|0|||
105335271|NCT01167881|363228257|FG000|Overall Study|Other not defined above|31|||
105335272|NCT01167881|363228258|FG001|Overall Study|Other not defined above|55|||
105335273|NCT01726270|363228265|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
105335274|NCT01726270|363228265|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
105335275|NCT01726270|363228265|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
105335276|NCT01726270|363228265|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
105335277|NCT01726270|363228265|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
105335278|NCT01726270|363228265|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
105335279|NCT04013672|363228266|FG000|Overall Study|Withdrawal by Subject|3|||
105335280|NCT04013672|363228267|FG001|Overall Study|Withdrawal by Subject|0|||
105335281|NCT04013672|363228266|FG000|Overall Study|Death|1|||
105335282|NCT04013672|363228267|FG001|Overall Study|Death|0|||
105335283|NCT04013672|363228266|FG000|Overall Study|Physician Decision|5|||
105335284|NCT04013672|363228267|FG001|Overall Study|Physician Decision|0|||
105335285|NCT00430573|363228281|FG000|Overall Study|Withdrawal by Subject|5|||
105335286|NCT01516008|363228286|FG000|Overall Study|Adverse Event|0|||
105335287|NCT01516008|363228287|FG001|Overall Study|Adverse Event|2|||
105335288|NCT01516008|363228288|FG002|Overall Study|Adverse Event|7|||
105335289|NCT01516008|363228286|FG000|Overall Study|Lack of Efficacy|44|||
105335290|NCT01516008|363228287|FG001|Overall Study|Lack of Efficacy|14|||
105335291|NCT01516008|363228288|FG002|Overall Study|Lack of Efficacy|10|||
105335292|NCT01516008|363228286|FG000|Overall Study|Protocol Violation|1|||
105335293|NCT01516008|363228287|FG001|Overall Study|Protocol Violation|0|||
105335294|NCT01516008|363228288|FG002|Overall Study|Protocol Violation|0|||
105335295|NCT01516008|363228286|FG000|Overall Study|Reason not specified|0|||
105335296|NCT01516008|363228287|FG001|Overall Study|Reason not specified|0|||
105335297|NCT01516008|363228288|FG002|Overall Study|Reason not specified|1|||
105335298|NCT01684943|363228289|FG000|Overall Study|Inadequate Venous Access|3|||
105335299|NCT01684943|363228290|FG001|Overall Study|Inadequate Venous Access|0|||
105335300|NCT01684943|363228291|FG002|Overall Study|Inadequate Venous Access|0|||
105335301|NCT01684943|363228289|FG000|Overall Study|Principal Investigator Determination|1|||
105335302|NCT01684943|363228290|FG001|Overall Study|Principal Investigator Determination|0|||
105335303|NCT01684943|363228291|FG002|Overall Study|Principal Investigator Determination|0|||
105335304|NCT01684943|363228289|FG000|Overall Study|Excluded from Analysis|1|||
105335305|NCT01684943|363228290|FG001|Overall Study|Excluded from Analysis|1|||
105335306|NCT01684943|363228291|FG002|Overall Study|Excluded from Analysis|1|||
105335307|NCT01684943|363228289|FG000|Overall Study|Lost to Follow-up|3|||
105335308|NCT01684943|363228290|FG001|Overall Study|Lost to Follow-up|0|||
105335309|NCT01684943|363228291|FG002|Overall Study|Lost to Follow-up|0|||
105335310|NCT01684943|363228289|FG000|Overall Study|Planning Pregnancy|1|||
105335311|NCT01684943|363228290|FG001|Overall Study|Planning Pregnancy|0|||
105335312|NCT01684943|363228291|FG002|Overall Study|Planning Pregnancy|0|||
105335313|NCT04445714|363228293|FG000|Overall Study|Discontinuation of the study|14|||
105335314|NCT04445714|363228293|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
105335315|NCT04445714|363228293|FG000|Overall Study|Withdrawal of Informed Consent|8|||
105335316|NCT00833482|363228294|FG000|Days 11-20|Adverse Event|0|||
105335317|NCT00833482|363228295|FG001|Days 11-20|Adverse Event|2|||
105335318|NCT00833482|363228296|FG002|Days 11-20|Adverse Event|0|||
105335319|NCT00833482|363228297|FG003|Days 11-20|Adverse Event|0|||
105335320|NCT00833482|363228298|FG004|Days 11-20|Adverse Event|0|||
105335321|NCT00833482|363228299|FG005|Days 11-20|Adverse Event|0|||
105335322|NCT00833482|363228294|FG000|Days 11-20|Withdrawal by Subject|0|||
105335323|NCT00833482|363228295|FG001|Days 11-20|Withdrawal by Subject|1|||
105335324|NCT00833482|363228296|FG002|Days 11-20|Withdrawal by Subject|0|||
105335325|NCT00833482|363228297|FG003|Days 11-20|Withdrawal by Subject|0|||
105335326|NCT00833482|363228298|FG004|Days 11-20|Withdrawal by Subject|0|||
105335327|NCT00833482|363228299|FG005|Days 11-20|Withdrawal by Subject|0|||
105335328|NCT00833482|363228294|FG000|Days 21-30|Adverse Event|0|||
105335329|NCT00833482|363228295|FG001|Days 21-30|Adverse Event|0|||
105335330|NCT00833482|363228296|FG002|Days 21-30|Adverse Event|1|||
105335331|NCT00833482|363228297|FG003|Days 21-30|Adverse Event|0|||
105335332|NCT00833482|363228298|FG004|Days 21-30|Adverse Event|0|||
105335333|NCT00833482|363228299|FG005|Days 21-30|Adverse Event|0|||
105335334|NCT00833482|363228294|FG000|Days 21-30|Withdrawal by Subject|0|||
105335335|NCT00833482|363228295|FG001|Days 21-30|Withdrawal by Subject|0|||
105335336|NCT00833482|363228296|FG002|Days 21-30|Withdrawal by Subject|0|||
105335337|NCT00833482|363228297|FG003|Days 21-30|Withdrawal by Subject|0|||
105335338|NCT00833482|363228298|FG004|Days 21-30|Withdrawal by Subject|1|||
105335339|NCT00833482|363228299|FG005|Days 21-30|Withdrawal by Subject|0|||
105335340|NCT02805660|363228300|FG000|Overall Study|Death|5|||
105335341|NCT02805660|363228301|FG001|Overall Study|Death|2|||
105335342|NCT02805660|363228302|FG002|Overall Study|Death|9|||
105335343|NCT02805660|363228303|FG003|Overall Study|Death|5|||
105335344|NCT02805660|363228304|FG004|Overall Study|Death|0|||
105335345|NCT02805660|363228305|FG005|Overall Study|Death|14|||
105335346|NCT02805660|363228306|FG006|Overall Study|Death|12|||
105335347|NCT02805660|363228300|FG000|Overall Study|Lost to Follow-up|0|||
105335348|NCT02805660|363228301|FG001|Overall Study|Lost to Follow-up|1|||
105335349|NCT02805660|363228302|FG002|Overall Study|Lost to Follow-up|1|||
105335350|NCT02805660|363228303|FG003|Overall Study|Lost to Follow-up|2|||
105335351|NCT02805660|363228304|FG004|Overall Study|Lost to Follow-up|0|||
105335352|NCT02805660|363228305|FG005|Overall Study|Lost to Follow-up|0|||
105335353|NCT02805660|363228306|FG006|Overall Study|Lost to Follow-up|0|||
105335354|NCT02805660|363228300|FG000|Overall Study|Withdrawal by Subject|0|||
105335355|NCT02805660|363228301|FG001|Overall Study|Withdrawal by Subject|0|||
105335356|NCT02805660|363228302|FG002|Overall Study|Withdrawal by Subject|0|||
105335357|NCT02805660|363228303|FG003|Overall Study|Withdrawal by Subject|3|||
105335358|NCT02805660|363228304|FG004|Overall Study|Withdrawal by Subject|1|||
105335359|NCT02805660|363228305|FG005|Overall Study|Withdrawal by Subject|0|||
105335360|NCT02805660|363228306|FG006|Overall Study|Withdrawal by Subject|2|||
105335361|NCT02805660|363228300|FG000|Overall Study|Study terminated by Sponsor|0|||
105335362|NCT02805660|363228301|FG001|Overall Study|Study terminated by Sponsor|0|||
105335363|NCT02805660|363228302|FG002|Overall Study|Study terminated by Sponsor|1|||
105335364|NCT02805660|363228303|FG003|Overall Study|Study terminated by Sponsor|4|||
105335365|NCT02805660|363228304|FG004|Overall Study|Study terminated by Sponsor|2|||
105335366|NCT02805660|363228305|FG005|Overall Study|Study terminated by Sponsor|3|||
105335367|NCT02805660|363228306|FG006|Overall Study|Study terminated by Sponsor|1|||
105335368|NCT02805660|363228300|FG000|Overall Study|Miscellaneous|0|||
105335369|NCT02805660|363228301|FG001|Overall Study|Miscellaneous|1|||
105335370|NCT02805660|363228302|FG002|Overall Study|Miscellaneous|0|||
105335371|NCT02805660|363228303|FG003|Overall Study|Miscellaneous|4|||
105335372|NCT02805660|363228304|FG004|Overall Study|Miscellaneous|0|||
105335373|NCT02805660|363228305|FG005|Overall Study|Miscellaneous|6|||
105335374|NCT02805660|363228306|FG006|Overall Study|Miscellaneous|4|||
105335375|NCT01672710|363228307|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
105335376|NCT01672710|363228308|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
105335377|NCT01672710|363228307|FG000|3 Month Follow up|Lost to Follow-up|2|||
105335378|NCT01672710|363228308|FG001|3 Month Follow up|Lost to Follow-up|3|||
105335379|NCT01672710|363228307|FG000|3 Month Follow up|follow up due after termination date|4|||
105335380|NCT01672710|363228308|FG001|3 Month Follow up|follow up due after termination date|1|||
105335381|NCT03725761|363228309|FG000|Overall Study|still on study|1|||
105335382|NCT03483961|363229991|FG000|Overall Study|Lost to Follow-up|7|||
105335383|NCT03483961|363229992|FG001|Overall Study|Lost to Follow-up|6|||
105335384|NCT03483961|363229993|FG002|Overall Study|Lost to Follow-up|6|||
105335385|NCT03483961|363229994|FG003|Overall Study|Lost to Follow-up|6|||
105335386|NCT03483961|363229995|FG004|Overall Study|Lost to Follow-up|6|||
105335387|NCT03483961|363229996|FG005|Overall Study|Lost to Follow-up|4|||
105335388|NCT03483961|363229997|FG006|Overall Study|Lost to Follow-up|4|||
105335389|NCT03483961|363229998|FG007|Overall Study|Lost to Follow-up|11|||
105335390|NCT03483961|363229999|FG008|Overall Study|Lost to Follow-up|1|||
105335391|NCT03483961|363230000|FG009|Overall Study|Lost to Follow-up|0|||
105335392|NCT03483961|363229991|FG000|Overall Study|Withdrawal by Subject|3|||
105335393|NCT03483961|363229992|FG001|Overall Study|Withdrawal by Subject|4|||
105335394|NCT03483961|363229993|FG002|Overall Study|Withdrawal by Subject|5|||
105335395|NCT03483961|363229994|FG003|Overall Study|Withdrawal by Subject|3|||
105335396|NCT03483961|363229995|FG004|Overall Study|Withdrawal by Subject|4|||
105335397|NCT03483961|363229996|FG005|Overall Study|Withdrawal by Subject|2|||
105335398|NCT03483961|363229997|FG006|Overall Study|Withdrawal by Subject|1|||
105335399|NCT03483961|363229998|FG007|Overall Study|Withdrawal by Subject|2|||
105335400|NCT03483961|363229999|FG008|Overall Study|Withdrawal by Subject|1|||
105335401|NCT03483961|363230000|FG009|Overall Study|Withdrawal by Subject|0|||
105335402|NCT03483961|363229991|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
105335403|NCT03483961|363229992|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105335404|NCT03483961|363229993|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105335405|NCT03483961|363229994|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105335406|NCT03483961|363229995|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105335407|NCT03483961|363229996|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105335408|NCT03483961|363229997|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105335409|NCT03483961|363229998|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105335410|NCT03483961|363229999|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105335411|NCT03483961|363230000|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105335412|NCT03483961|363229991|FG000|Overall Study|Adverse Event|0|||
105335413|NCT03483961|363229992|FG001|Overall Study|Adverse Event|0|||
105335414|NCT03483961|363229993|FG002|Overall Study|Adverse Event|1|||
105335415|NCT03483961|363229994|FG003|Overall Study|Adverse Event|0|||
105335416|NCT03483961|363229995|FG004|Overall Study|Adverse Event|0|||
105335417|NCT03483961|363229996|FG005|Overall Study|Adverse Event|0|||
105335418|NCT03483961|363229997|FG006|Overall Study|Adverse Event|0|||
105335419|NCT03483961|363229998|FG007|Overall Study|Adverse Event|0|||
105335420|NCT03483961|363229999|FG008|Overall Study|Adverse Event|0|||
105335421|NCT03483961|363230000|FG009|Overall Study|Adverse Event|0|||
105335422|NCT00652626|363230003|FG000|Initial Treatment Phase|Adverse Event|0|||
105335423|NCT00652626|363230004|FG001|Initial Treatment Phase|Adverse Event|0|||
105335424|NCT00652626|363230005|FG002|Initial Treatment Phase|Adverse Event|0|||
105335425|NCT00652626|363230006|FG003|Initial Treatment Phase|Adverse Event|0|||
105335426|NCT00652626|363230007|FG004|Initial Treatment Phase|Adverse Event|1|||
105335427|NCT00652626|363230008|FG005|Initial Treatment Phase|Adverse Event|0|||
105335428|NCT00652626|363230009|FG006|Initial Treatment Phase|Adverse Event|0|||
105335429|NCT00652626|363230003|FG000|Initial Treatment Phase|Protocol Violation|0|||
105335430|NCT00652626|363230004|FG001|Initial Treatment Phase|Protocol Violation|0|||
105335431|NCT00652626|363230005|FG002|Initial Treatment Phase|Protocol Violation|0|||
105335432|NCT00652626|363230006|FG003|Initial Treatment Phase|Protocol Violation|1|||
105335433|NCT00652626|363230007|FG004|Initial Treatment Phase|Protocol Violation|0|||
105335434|NCT00652626|363230008|FG005|Initial Treatment Phase|Protocol Violation|0|||
105335435|NCT00652626|363230009|FG006|Initial Treatment Phase|Protocol Violation|0|||
105335436|NCT00652626|363230003|FG000|Initial Treatment Phase|Physician Decision|0|||
105335437|NCT00652626|363230004|FG001|Initial Treatment Phase|Physician Decision|0|||
105335438|NCT00652626|363230005|FG002|Initial Treatment Phase|Physician Decision|0|||
105335439|NCT00652626|363230006|FG003|Initial Treatment Phase|Physician Decision|0|||
105335440|NCT00652626|363230007|FG004|Initial Treatment Phase|Physician Decision|1|||
105335441|NCT00652626|363230008|FG005|Initial Treatment Phase|Physician Decision|0|||
105335442|NCT00652626|363230009|FG006|Initial Treatment Phase|Physician Decision|0|||
105335443|NCT00652626|363230003|FG000|Initial Treatment Phase|Sponsor Request|0|||
105335444|NCT00652626|363230004|FG001|Initial Treatment Phase|Sponsor Request|0|||
105335445|NCT00652626|363230005|FG002|Initial Treatment Phase|Sponsor Request|1|||
105335446|NCT00652626|363230006|FG003|Initial Treatment Phase|Sponsor Request|0|||
105335447|NCT00652626|363230007|FG004|Initial Treatment Phase|Sponsor Request|0|||
105335448|NCT00652626|363230008|FG005|Initial Treatment Phase|Sponsor Request|0|||
105335449|NCT00652626|363230009|FG006|Initial Treatment Phase|Sponsor Request|0|||
105335450|NCT00652626|363230003|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
105335451|NCT00652626|363230004|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
105335452|NCT00652626|363230005|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
105335453|NCT00652626|363230006|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
105335454|NCT00652626|363230007|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
105335455|NCT00652626|363230008|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
105335456|NCT00652626|363230009|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
105335457|NCT00652626|363230003|FG000|Extension Phase|Withdrawal by Subject|0|||
105335458|NCT00652626|363230004|FG001|Extension Phase|Withdrawal by Subject|0|||
105335459|NCT00652626|363230005|FG002|Extension Phase|Withdrawal by Subject|0|||
105335460|NCT00652626|363230006|FG003|Extension Phase|Withdrawal by Subject|0|||
105335461|NCT00652626|363230007|FG004|Extension Phase|Withdrawal by Subject|0|||
105335462|NCT00652626|363230008|FG005|Extension Phase|Withdrawal by Subject|2|||
105335463|NCT00652626|363230009|FG006|Extension Phase|Withdrawal by Subject|0|||
105335464|NCT00652626|363230003|FG000|Extension Phase|Adverse Event|0|||
105335465|NCT00652626|363230004|FG001|Extension Phase|Adverse Event|0|||
105335466|NCT00652626|363230005|FG002|Extension Phase|Adverse Event|0|||
105335467|NCT00652626|363230006|FG003|Extension Phase|Adverse Event|0|||
105335468|NCT00652626|363230007|FG004|Extension Phase|Adverse Event|0|||
105335469|NCT00652626|363230008|FG005|Extension Phase|Adverse Event|2|||
105335470|NCT00652626|363230009|FG006|Extension Phase|Adverse Event|1|||
105335471|NCT00652626|363230003|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
105335472|NCT00652626|363230004|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
105335473|NCT00652626|363230005|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
105335474|NCT00652626|363230006|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
105335475|NCT00652626|363230007|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
105335476|NCT00652626|363230008|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
105335477|NCT00652626|363230009|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
105335478|NCT00652626|363230003|FG000|Extension Phase|Physician Decision|0|||
105335479|NCT00652626|363230004|FG001|Extension Phase|Physician Decision|0|||
105335480|NCT00652626|363230005|FG002|Extension Phase|Physician Decision|0|||
105335481|NCT00652626|363230006|FG003|Extension Phase|Physician Decision|0|||
105335482|NCT00652626|363230007|FG004|Extension Phase|Physician Decision|0|||
105335483|NCT00652626|363230008|FG005|Extension Phase|Physician Decision|1|||
105335484|NCT00652626|363230009|FG006|Extension Phase|Physician Decision|1|||
105442632|NCT00773747|363626821|FG001|Overall Study|Protocol Violation|2|||
105335485|NCT00652626|363230003|FG000|Extension Phase|Death|0|||
105335486|NCT00652626|363230004|FG001|Extension Phase|Death|0|||
105335487|NCT00652626|363230005|FG002|Extension Phase|Death|0|||
105335488|NCT00652626|363230006|FG003|Extension Phase|Death|0|||
105335489|NCT00652626|363230007|FG004|Extension Phase|Death|0|||
105335490|NCT00652626|363230008|FG005|Extension Phase|Death|1|||
105335491|NCT00652626|363230009|FG006|Extension Phase|Death|1|||
105335492|NCT04402138|363230010|FG000|Overall Study|Progressive Disease|2|||
105335493|NCT04402138|363230010|FG000|Overall Study|Adverse Event|1|||
105335494|NCT00468481|363230011|FG000|Overall Study|Adverse Event|13|||
105335495|NCT00468481|363230012|FG001|Overall Study|Adverse Event|3|||
105335496|NCT00468481|363230011|FG000|Overall Study|Lost to Follow-up|25|||
105335497|NCT00468481|363230012|FG001|Overall Study|Lost to Follow-up|8|||
105335498|NCT00468481|363230011|FG000|Overall Study|Pregnancy|2|||
105335499|NCT00468481|363230012|FG001|Overall Study|Pregnancy|0|||
105335500|NCT00468481|363230011|FG000|Overall Study|Protocol Violation|18|||
105335501|NCT00468481|363230012|FG001|Overall Study|Protocol Violation|8|||
105335502|NCT00468481|363230011|FG000|Overall Study|Withdrawal by Subject|12|||
105335503|NCT00468481|363230012|FG001|Overall Study|Withdrawal by Subject|3|||
105335504|NCT00468481|363230011|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
105335505|NCT00468481|363230012|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
105335506|NCT00468481|363230011|FG000|Overall Study|Prohibited Medication|1|||
105335507|NCT00468481|363230012|FG001|Overall Study|Prohibited Medication|1|||
105335508|NCT00468481|363230011|FG000|Overall Study|Egg Donor|1|||
105335509|NCT00468481|363230012|FG001|Overall Study|Egg Donor|0|||
105335510|NCT00468481|363230011|FG000|Overall Study|Moved out of area|4|||
105335511|NCT00468481|363230012|FG001|Overall Study|Moved out of area|1|||
105335512|NCT00468481|363230011|FG000|Overall Study|Non-Compliance|5|||
105335513|NCT00468481|363230012|FG001|Overall Study|Non-Compliance|0|||
105335514|NCT00468481|363230011|FG000|Overall Study|Other|6|||
105335515|NCT00468481|363230012|FG001|Overall Study|Other|0|||
105335516|NCT03806933|363230013|FG000|Main Period|Physician Decision|0|||
105335517|NCT03806933|363230014|FG001|Main Period|Physician Decision|0|||
105335518|NCT03806933|363230015|FG002|Main Period|Physician Decision|0|||
105335519|NCT03806933|363230016|FG003|Main Period|Physician Decision|1|||
105335520|NCT03806933|363230013|FG000|Main Period|Pregnancy|0|||
105335521|NCT03806933|363230014|FG001|Main Period|Pregnancy|0|||
105335522|NCT03806933|363230015|FG002|Main Period|Pregnancy|1|||
105335523|NCT03806933|363230016|FG003|Main Period|Pregnancy|0|||
105335524|NCT03806933|363230013|FG000|Main Period|Withdrawal by Subject|2|||
105335525|NCT03806933|363230014|FG001|Main Period|Withdrawal by Subject|1|||
105335526|NCT03806933|363230015|FG002|Main Period|Withdrawal by Subject|1|||
105335527|NCT03806933|363230016|FG003|Main Period|Withdrawal by Subject|2|||
105335528|NCT03806933|363230013|FG000|Main Period|Lost to Follow-up|2|||
105335529|NCT03806933|363230014|FG001|Main Period|Lost to Follow-up|2|||
105335530|NCT03806933|363230015|FG002|Main Period|Lost to Follow-up|0|||
105335531|NCT03806933|363230016|FG003|Main Period|Lost to Follow-up|0|||
105335532|NCT03806933|363230013|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
105335533|NCT03806933|363230014|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
105335534|NCT03806933|363230015|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
105335535|NCT03806933|363230016|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
105335536|NCT00734162|363230017|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
105335537|NCT00734162|363230018|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
105335538|NCT00734162|363230019|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
105335539|NCT00734162|363230020|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
105335540|NCT00734162|363230017|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
105335541|NCT00734162|363230018|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
105335542|NCT00734162|363230019|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
105335543|NCT00734162|363230020|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
105442633|NCT00773747|363626820|FG000|Overall Study|Withdrawal by Subject|89|||
105442634|NCT00773747|363626821|FG001|Overall Study|Withdrawal by Subject|61|||
105442635|NCT00773747|363626820|FG000|Overall Study|Adverse Event|61|||
105442636|NCT00773747|363626821|FG001|Overall Study|Adverse Event|62|||
105442637|NCT00773747|363626820|FG000|Overall Study|Death|5|||
105442638|NCT00773747|363626821|FG001|Overall Study|Death|8|||
105442639|NCT00773747|363626820|FG000|Overall Study|Not Treated|2|||
105442640|NCT00773747|363626821|FG001|Overall Study|Not Treated|0|||
105442641|NCT01973998|363626830|FG000|Overall Study|Death|2|||
105442642|NCT01973998|363626831|FG001|Overall Study|Death|2|||
105442643|NCT01636986|363626834|FG000|Overall Study|Withdrawal by Subject|0|||
105442644|NCT01636986|363626835|FG001|Overall Study|Withdrawal by Subject|1|||
105335544|NCT00734162|363230017|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
105442645|NCT01636986|363626834|FG000|Overall Study|Corneal Staining|0|||
105442646|NCT01636986|363626835|FG001|Overall Study|Corneal Staining|1|||
105335545|NCT00734162|363230018|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
105335546|NCT00734162|363230019|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
105335547|NCT00734162|363230020|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
105442647|NCT00206440|363626838|FG000|Overall Study|Protocol Violation|1|||
105442648|NCT00206440|363626839|FG001|Overall Study|Protocol Violation|2|||
105442649|NCT00206440|363626838|FG000|Overall Study|Adverse Event|4|||
105442650|NCT00206440|363626839|FG001|Overall Study|Adverse Event|2|||
105442651|NCT00766051|363626840|FG000|Overall Study|Withdrawal by Subject|2|||
105442652|NCT00766051|363626841|FG001|Overall Study|Withdrawal by Subject|0|||
105442653|NCT02669121|363626842|FG000|Overall Study|Adverse Event|4|||
105442654|NCT02669121|363626843|FG001|Overall Study|Adverse Event|5|||
105442655|NCT02669121|363626842|FG000|Overall Study|Lost to Follow-up|15|||
105442656|NCT02669121|363626843|FG001|Overall Study|Lost to Follow-up|27|||
105442657|NCT02669121|363626842|FG000|Overall Study|Withdrawal by Subject|132|||
105442658|NCT02669121|363626843|FG001|Overall Study|Withdrawal by Subject|140|||
105442659|NCT02669121|363626842|FG000|Overall Study|Pregnancy|0|||
105442660|NCT02669121|363626843|FG001|Overall Study|Pregnancy|1|||
105442661|NCT02669121|363626842|FG000|Overall Study|Discharged from US Military Active Service|117|||
105442662|NCT02669121|363626843|FG001|Overall Study|Discharged from US Military Active Service|91|||
105442663|NCT02669121|363626842|FG000|Overall Study|Reason not Specified|22|||
105442664|NCT02669121|363626843|FG001|Overall Study|Reason not Specified|18|||
105442665|NCT02708355|363626844|FG000|Overall Study|Adverse Event|1|||
105442666|NCT02708355|363626845|FG001|Overall Study|Adverse Event|0|||
105442667|NCT02708355|363626846|FG002|Overall Study|Adverse Event|0|||
105442668|NCT00635882|363626847|FG000|Overall Study|Protocol Violation|1|||
105442669|NCT00635882|363626848|FG001|Overall Study|Protocol Violation|0|||
105442670|NCT00635882|363626849|FG002|Overall Study|Protocol Violation|0|||
105442671|NCT00635882|363626850|FG003|Overall Study|Protocol Violation|0|||
105442672|NCT00635882|363626851|FG004|Overall Study|Protocol Violation|0|||
105442673|NCT00635882|363626852|FG005|Overall Study|Protocol Violation|0|||
105442674|NCT01320202|363626853|FG000|Overall Study|Adverse Event|5|||
105442675|NCT01320202|363626854|FG001|Overall Study|Adverse Event|5|||
105442676|NCT01320202|363626853|FG000|Overall Study|Death|5|||
105442677|NCT01320202|363626854|FG001|Overall Study|Death|3|||
105442678|NCT01320202|363626853|FG000|Overall Study|Lost to Follow-up|1|||
105442679|NCT01320202|363626854|FG001|Overall Study|Lost to Follow-up|0|||
105442680|NCT01320202|363626853|FG000|Overall Study|Physician Decision|3|||
105442681|NCT01320202|363626854|FG001|Overall Study|Physician Decision|1|||
105442682|NCT01320202|363626853|FG000|Overall Study|Protocol Violation|2|||
105442683|NCT01320202|363626854|FG001|Overall Study|Protocol Violation|1|||
105442684|NCT01320202|363626853|FG000|Overall Study|Withdrawal by Subject|10|||
105442685|NCT01320202|363626854|FG001|Overall Study|Withdrawal by Subject|3|||
105442686|NCT01320202|363626853|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
105442687|NCT01320202|363626854|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
105442688|NCT01320202|363626853|FG000|Overall Study|kidney transplant|1|||
105442689|NCT01320202|363626854|FG001|Overall Study|kidney transplant|2|||
105442690|NCT01320202|363626853|FG000|Overall Study|blood transfusion|1|||
105442691|NCT01320202|363626854|FG001|Overall Study|blood transfusion|7|||
105442692|NCT01320202|363626853|FG000|Overall Study|moved/changed dialysis|5|||
105442693|NCT01320202|363626854|FG001|Overall Study|moved/changed dialysis|2|||
105442694|NCT01320202|363626853|FG000|Overall Study|sponsor request|2|||
105442695|NCT01320202|363626854|FG001|Overall Study|sponsor request|0|||
105442696|NCT01320202|363626853|FG000|Overall Study|ineligible|3|||
105442697|NCT01320202|363626854|FG001|Overall Study|ineligible|0|||
105442698|NCT01320202|363626853|FG000|Overall Study|regained renal function|1|||
105442699|NCT01320202|363626854|FG001|Overall Study|regained renal function|0|||
105442700|NCT02513472|363626856|FG000|Overall Study|Radiological Disease Progression|45|||
105442701|NCT02513472|363626857|FG001|Overall Study|Radiological Disease Progression|57|||
105442702|NCT02513472|363626856|FG000|Overall Study|Clinical Disease Progression|5|||
105442703|NCT02513472|363626857|FG001|Overall Study|Clinical Disease Progression|13|||
105442704|NCT02513472|363626856|FG000|Overall Study|Adverse Event|8|||
105442705|NCT02513472|363626857|FG001|Overall Study|Adverse Event|11|||
105442706|NCT02513472|363626856|FG000|Overall Study|Withdrawal by Subject|0|||
105442707|NCT02513472|363626857|FG001|Overall Study|Withdrawal by Subject|4|||
105442708|NCT02513472|363626856|FG000|Overall Study|Subject Choice|2|||
105442709|NCT02513472|363626857|FG001|Overall Study|Subject Choice|7|||
105442710|NCT02513472|363626856|FG000|Overall Study|Treatment Completed as per Protocol|3|||
105442711|NCT02513472|363626857|FG001|Overall Study|Treatment Completed as per Protocol|3|||
105442712|NCT02513472|363626856|FG000|Overall Study|Other|3|||
105442713|NCT02513472|363626857|FG001|Overall Study|Other|6|||
105442714|NCT03214406|363626858|FG000|Overall Study|did not meet enrollment criteria|9|||
105442715|NCT03214406|363626859|FG001|Overall Study|did not meet enrollment criteria|13|||
105442716|NCT03214406|363626858|FG000|Overall Study|Withdrawal by Subject|1|||
105442717|NCT03214406|363626859|FG001|Overall Study|Withdrawal by Subject|0|||
105442718|NCT03214406|363626858|FG000|Overall Study|Lost to Follow-up|0|||
105442719|NCT03214406|363626859|FG001|Overall Study|Lost to Follow-up|2|||
105442720|NCT01098305|363626862|FG000|Overall Study|Lost to Follow-up|31|||
105442721|NCT01098305|363626863|FG001|Overall Study|Lost to Follow-up|33|||
105442722|NCT00392990|363626864|FG000|Treatment on Study|Adverse Event|3|||
105442723|NCT00392990|363626865|FG001|Treatment on Study|Adverse Event|1|||
105442724|NCT00392990|363626864|FG000|Follow up for 2 Years|Death|4|||
105442725|NCT00392990|363626865|FG001|Follow up for 2 Years|Death|0|||
105442726|NCT00429169|363626870|FG000|Overall Study|Lost to Follow-up|0|||
105442727|NCT00429169|363626871|FG001|Overall Study|Lost to Follow-up|1|||
105442728|NCT00429169|363626870|FG000|Overall Study|Ineligibility discovered after entry|2|||
105442729|NCT00429169|363626871|FG001|Overall Study|Ineligibility discovered after entry|1|||
105442730|NCT03052049|363626874|FG000|Overall Study|Withdrawal by Subject|2|||
105442731|NCT02328027|363626875|FG000|Overall Study|Withdrawal by Subject|0|||
105442732|NCT02328027|363626876|FG001|Overall Study|Withdrawal by Subject|1|||
105442733|NCT00250276|363626880|FG000|Overall Study|Serious Adverse Event|0|||
105442734|NCT00250276|363626881|FG001|Overall Study|Serious Adverse Event|0|||
105442735|NCT00250276|363626882|FG002|Overall Study|Serious Adverse Event|1|||
105442736|NCT00250276|363626883|FG003|Overall Study|Serious Adverse Event|0|||
105442737|NCT00250276|363626880|FG000|Overall Study|Non-serious Adverse Event|2|||
105442738|NCT00250276|363626881|FG001|Overall Study|Non-serious Adverse Event|0|||
105442739|NCT00250276|363626882|FG002|Overall Study|Non-serious Adverse Event|0|||
105442740|NCT00250276|363626883|FG003|Overall Study|Non-serious Adverse Event|2|||
105442741|NCT00250276|363626880|FG000|Overall Study|Protocol Violation|0|||
105442742|NCT00250276|363626881|FG001|Overall Study|Protocol Violation|1|||
105442743|NCT00250276|363626882|FG002|Overall Study|Protocol Violation|0|||
105442744|NCT00250276|363626883|FG003|Overall Study|Protocol Violation|0|||
105442745|NCT00250276|363626880|FG000|Overall Study|Withdrawal by Subject|1|||
105442746|NCT00250276|363626881|FG001|Overall Study|Withdrawal by Subject|2|||
105442747|NCT00250276|363626882|FG002|Overall Study|Withdrawal by Subject|3|||
105442748|NCT00250276|363626883|FG003|Overall Study|Withdrawal by Subject|2|||
105442749|NCT00250276|363626880|FG000|Overall Study|Migrated/moved from study area|3|||
105442750|NCT00250276|363626881|FG001|Overall Study|Migrated/moved from study area|0|||
105442751|NCT00250276|363626882|FG002|Overall Study|Migrated/moved from study area|2|||
105442752|NCT00250276|363626883|FG003|Overall Study|Migrated/moved from study area|7|||
105442753|NCT00250276|363626880|FG000|Overall Study|Lost to Follow-up|11|||
105442754|NCT00250276|363626881|FG001|Overall Study|Lost to Follow-up|18|||
105442755|NCT00250276|363626882|FG002|Overall Study|Lost to Follow-up|13|||
105442756|NCT00250276|363626883|FG003|Overall Study|Lost to Follow-up|8|||
105442757|NCT01036321|363628699|FG000|Overall Study|Ineligible after randomization|0|||
105442758|NCT01036321|363628700|FG001|Overall Study|Ineligible after randomization|1|||
105442759|NCT01036321|363628699|FG000|Overall Study|Withdrawal by Subject|3|||
105442760|NCT01036321|363628700|FG001|Overall Study|Withdrawal by Subject|2|||
105442761|NCT01036321|363628699|FG000|Overall Study|Adverse Event|2|||
105442762|NCT01036321|363628700|FG001|Overall Study|Adverse Event|1|||
105442763|NCT00847886|363628701|FG000|Overall Study|Adverse Event|0|||
105442764|NCT00847886|363628702|FG001|Overall Study|Adverse Event|1|||
105442765|NCT01687101|363628703|FG000|Overall Study|Lost to Follow-up|7|||
105442766|NCT01979952|363628713|FG000|Overall Study|Adverse Event|4|||
105442767|NCT01979952|363628714|FG001|Overall Study|Adverse Event|5|||
105442768|NCT01979952|363628713|FG000|Overall Study|Protocol Violation|1|||
105442769|NCT01979952|363628714|FG001|Overall Study|Protocol Violation|0|||
105442770|NCT01979952|363628713|FG000|Overall Study|Withdrawal by Subject|2|||
105442771|NCT01979952|363628714|FG001|Overall Study|Withdrawal by Subject|1|||
105442772|NCT01979952|363628713|FG000|Overall Study|Other than specified above|1|||
105442773|NCT01979952|363628714|FG001|Overall Study|Other than specified above|0|||
105442774|NCT00286494|363628715|FG000|Overall Study|Hyperglycemic rescue|12|||
105442775|NCT00286494|363628716|FG001|Overall Study|Hyperglycemic rescue|19|||
105442776|NCT00286494|363628717|FG002|Overall Study|Hyperglycemic rescue|18|||
105442777|NCT00286494|363628715|FG000|Overall Study|Withdrawal by Subject|2|||
105442778|NCT00286494|363628716|FG001|Overall Study|Withdrawal by Subject|10|||
105442779|NCT00286494|363628717|FG002|Overall Study|Withdrawal by Subject|9|||
105442780|NCT00286494|363628715|FG000|Overall Study|Adverse Event|3|||
105442781|NCT00286494|363628716|FG001|Overall Study|Adverse Event|8|||
105442782|NCT00286494|363628717|FG002|Overall Study|Adverse Event|6|||
105442783|NCT00286494|363628715|FG000|Overall Study|Physician Decision|5|||
105442784|NCT00286494|363628716|FG001|Overall Study|Physician Decision|5|||
105442785|NCT00286494|363628717|FG002|Overall Study|Physician Decision|1|||
105442786|NCT00286494|363628715|FG000|Overall Study|Lost to Follow-up|3|||
105442787|NCT00286494|363628716|FG001|Overall Study|Lost to Follow-up|1|||
105442788|NCT00286494|363628717|FG002|Overall Study|Lost to Follow-up|3|||
105779380|NCT00386152|364844740|FG000|Overall Study|Adverse Event|6|||
105442789|NCT00286494|363628715|FG000|Overall Study|Protocol Violation|1|||
105442790|NCT00286494|363628716|FG001|Overall Study|Protocol Violation|1|||
105442791|NCT00286494|363628717|FG002|Overall Study|Protocol Violation|2|||
105442792|NCT00245037|363628718|FG000|Overall Study|Death|17|||
105442793|NCT00475709|363628721|FG000|Overall Study|Did not meet eligibility criteria|8|||
105442794|NCT00475709|363628721|FG000|Overall Study|Death|41|||
105442795|NCT00475709|363628721|FG000|Overall Study|Device Explant|6|||
105779381|NCT00386152|364844741|FG001|Overall Study|Adverse Event|5|||
105442796|NCT00475709|363628721|FG000|Overall Study|Lost to Follow-up|21|||
105442797|NCT02735343|363628722|FG000|Overall Study|screen fail|0|||
105442798|NCT02735343|363628723|FG001|Overall Study|screen fail|2|||
105442799|NCT03078855|363628724|FG000|Overall Study|Lack of Efficacy|62|||
105442800|NCT03078855|363628725|FG001|Overall Study|Lack of Efficacy|31|||
105442801|NCT03078855|363628724|FG000|Overall Study|Death|1|||
105442802|NCT03078855|363628725|FG001|Overall Study|Death|0|||
105442803|NCT03078855|363628724|FG000|Overall Study|Withdrawal by Subject|12|||
105442804|NCT03078855|363628725|FG001|Overall Study|Withdrawal by Subject|6|||
105442805|NCT03078855|363628724|FG000|Overall Study|Physician Decision|3|||
105442806|NCT03078855|363628725|FG001|Overall Study|Physician Decision|2|||
105442807|NCT03078855|363628724|FG000|Overall Study|Second Malignancy|4|||
105442808|NCT03078855|363628725|FG001|Overall Study|Second Malignancy|0|||
105442809|NCT03078855|363628724|FG000|Overall Study|Ineligible|2|||
105442810|NCT03078855|363628725|FG001|Overall Study|Ineligible|0|||
105442811|NCT03078855|363628724|FG000|Overall Study|Withdrew before day 1 treatment|2|||
105442812|NCT03078855|363628725|FG001|Overall Study|Withdrew before day 1 treatment|1|||
105442813|NCT02023996|363628726|FG000|Overall Study|Protocol Violation|6|||
105442814|NCT03400176|363628728|FG000|Dose Escalation|Progressive disease|1|||
105442815|NCT03400176|363628729|FG001|Dose Escalation|Progressive disease|1|||
105442816|NCT03400176|363628730|FG002|Dose Escalation|Progressive disease|0|||
105442817|NCT03400176|363628731|FG003|Dose Escalation|Progressive disease|0|||
105442818|NCT03400176|363628732|FG004|Dose Escalation|Progressive disease|1|||
105442819|NCT03400176|363628728|FG000|Dose Escalation|Patient decision|0|||
105442820|NCT03400176|363628729|FG001|Dose Escalation|Patient decision|0|||
105442821|NCT03400176|363628730|FG002|Dose Escalation|Patient decision|0|||
105442822|NCT03400176|363628731|FG003|Dose Escalation|Patient decision|0|||
105442823|NCT03400176|363628732|FG004|Dose Escalation|Patient decision|1|||
105442824|NCT03400176|363628728|FG000|Dose Expansion|Patient decision|0|||
105442825|NCT03400176|363628729|FG001|Dose Expansion|Patient decision|0|||
105442826|NCT03400176|363628730|FG002|Dose Expansion|Patient decision|0|||
105442827|NCT03400176|363628731|FG003|Dose Expansion|Patient decision|1|||
105442828|NCT03400176|363628732|FG004|Dose Expansion|Patient decision|0|||
105442829|NCT03400176|363628728|FG000|Dose Expansion|Adverse Event|0|||
105442830|NCT03400176|363628729|FG001|Dose Expansion|Adverse Event|0|||
105442831|NCT03400176|363628730|FG002|Dose Expansion|Adverse Event|0|||
105442832|NCT03400176|363628731|FG003|Dose Expansion|Adverse Event|1|||
105442833|NCT03400176|363628732|FG004|Dose Expansion|Adverse Event|0|||
105442834|NCT03400176|363628728|FG000|Dose Expansion|Physician Decision|0|||
105442835|NCT03400176|363628729|FG001|Dose Expansion|Physician Decision|0|||
105442836|NCT03400176|363628730|FG002|Dose Expansion|Physician Decision|0|||
105442837|NCT03400176|363628731|FG003|Dose Expansion|Physician Decision|1|||
105442838|NCT03400176|363628732|FG004|Dose Expansion|Physician Decision|0|||
105442839|NCT03400176|363628728|FG000|Dose Expansion|Progressive disease|0|||
105442840|NCT03400176|363628729|FG001|Dose Expansion|Progressive disease|0|||
105442841|NCT03400176|363628730|FG002|Dose Expansion|Progressive disease|1|||
105442842|NCT03400176|363628731|FG003|Dose Expansion|Progressive disease|1|||
105442843|NCT03400176|363628732|FG004|Dose Expansion|Progressive disease|0|||
105442844|NCT01298765|363628733|FG000|Titration Period|Adverse Event|26|||
105442845|NCT01298765|363628733|FG000|Titration Period|Death|1|||
105442846|NCT01298765|363628733|FG000|Titration Period|Lack of Efficacy|21|||
105442847|NCT01298765|363628733|FG000|Titration Period|Lost to Follow-up|9|||
105442848|NCT01298765|363628733|FG000|Titration Period|Physician Decision|1|||
105442849|NCT01298765|363628733|FG000|Titration Period|Withdrawal by Subject|10|||
105442850|NCT01298765|363628733|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
105442851|NCT01298765|363628733|FG000|Long-Term Treatment Period|Adverse Event|19|||
105442852|NCT01298765|363628733|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
105442853|NCT01298765|363628733|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
105442854|NCT01298765|363628733|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
105442855|NCT01298765|363628733|FG000|Long-Term Treatment Period|Physician Decision|1|||
105442856|NCT01298765|363628733|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
105442857|NCT00828750|363628734|FG000|Overall Study|Lack of Efficacy|3|||
105442858|NCT00828750|363628734|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
105442859|NCT00858637|363628736|FG000|Active Comparison Phase|Adverse Event|14|||
105442860|NCT00858637|363628737|FG001|Active Comparison Phase|Adverse Event|0|||
105442861|NCT00858637|363628738|FG002|Active Comparison Phase|Adverse Event|0|||
105442862|NCT00858637|363628739|FG003|Active Comparison Phase|Adverse Event|9|||
105442863|NCT00858637|363628740|FG004|Active Comparison Phase|Adverse Event|0|||
105442864|NCT00858637|363628741|FG005|Active Comparison Phase|Adverse Event|0|||
105442865|NCT00858637|363628736|FG000|Active Comparison Phase|Death|1|||
105442866|NCT00858637|363628737|FG001|Active Comparison Phase|Death|0|||
105442867|NCT00858637|363628738|FG002|Active Comparison Phase|Death|0|||
105442868|NCT00858637|363628739|FG003|Active Comparison Phase|Death|1|||
105442869|NCT00858637|363628740|FG004|Active Comparison Phase|Death|0|||
105442870|NCT00858637|363628741|FG005|Active Comparison Phase|Death|0|||
105442871|NCT00858637|363628736|FG000|Active Comparison Phase|Physician Decision|1|||
105442872|NCT00858637|363628737|FG001|Active Comparison Phase|Physician Decision|0|||
105442873|NCT00858637|363628738|FG002|Active Comparison Phase|Physician Decision|0|||
105442874|NCT00858637|363628739|FG003|Active Comparison Phase|Physician Decision|1|||
105442875|NCT00858637|363628740|FG004|Active Comparison Phase|Physician Decision|0|||
105442876|NCT00858637|363628741|FG005|Active Comparison Phase|Physician Decision|0|||
105442877|NCT00858637|363628736|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
105442878|NCT00858637|363628737|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
105779382|NCT00386152|364844742|FG002|Overall Study|Adverse Event|4|||
105442879|NCT00858637|363628738|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
105442880|NCT00858637|363628739|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
105442881|NCT00858637|363628740|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
105442882|NCT00858637|363628741|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
105442883|NCT00858637|363628736|FG000|Active Comparison Phase|Other Reasons|1|||
105442884|NCT00858637|363628737|FG001|Active Comparison Phase|Other Reasons|0|||
105442885|NCT00858637|363628738|FG002|Active Comparison Phase|Other Reasons|0|||
105442886|NCT00858637|363628739|FG003|Active Comparison Phase|Other Reasons|1|||
105442887|NCT00858637|363628740|FG004|Active Comparison Phase|Other Reasons|0|||
105442888|NCT00858637|363628741|FG005|Active Comparison Phase|Other Reasons|0|||
105442889|NCT00858637|363628736|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
105442890|NCT00858637|363628737|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
105442891|NCT00858637|363628738|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
105442892|NCT00858637|363628739|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
105442893|NCT00858637|363628740|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
105442894|NCT00858637|363628741|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
105442895|NCT00858637|363628736|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
105442896|NCT00858637|363628737|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
105442897|NCT00858637|363628738|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
105442898|NCT00858637|363628739|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
105442899|NCT00858637|363628740|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
105442900|NCT00858637|363628741|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
105442901|NCT04310566|363628746|FG000|Period 1|Study Termination due to COVID-19|15|||
105442902|NCT04310566|363628747|FG001|Period 1|Study Termination due to COVID-19|17|||
105442903|NCT04310566|363628746|FG000|Period 1|Protocol Violation|0|||
105442904|NCT04310566|363628747|FG001|Period 1|Protocol Violation|1|||
105442905|NCT04310566|363628746|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
105442906|NCT04310566|363628747|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
105442907|NCT04310566|363628746|FG000|Period 1|Lost to Follow-up|1|||
105442908|NCT04310566|363628747|FG001|Period 1|Lost to Follow-up|0|||
105442909|NCT04310566|363628746|FG000|Period 1|Withdrawal by Subject|0|||
105442910|NCT04310566|363628747|FG001|Period 1|Withdrawal by Subject|1|||
105442911|NCT04310566|363628746|FG000|Period 2|Study Termination|7|||
105442912|NCT04310566|363628747|FG001|Period 2|Study Termination|5|||
105442913|NCT02396589|363628748|FG000|Intervention|Lost to Follow-up|1|||
105442914|NCT02396589|363628749|FG001|Intervention|Lost to Follow-up|0|||
105442915|NCT02396589|363628748|FG000|6 Month Follow-up|change in health status|0|||
105442916|NCT02396589|363628749|FG001|6 Month Follow-up|change in health status|1|||
105442917|NCT02396589|363628748|FG000|9 Month Follow-up|Death|0|||
105442918|NCT02396589|363628749|FG001|9 Month Follow-up|Death|1|||
105442919|NCT02396589|363628748|FG000|12 Month Follow up|Lost to Follow-up|0|||
105442920|NCT02396589|363628749|FG001|12 Month Follow up|Lost to Follow-up|2|||
105442921|NCT00825812|363628750|FG000|Overall Study|Never entered follow up|0|||
105442922|NCT00825812|363628751|FG001|Overall Study|Never entered follow up|0|||
105442923|NCT00825812|363628752|FG002|Overall Study|Never entered follow up|0|||
105442924|NCT00825812|363628753|FG003|Overall Study|Never entered follow up|1|||
105442925|NCT00825812|363628750|FG000|Overall Study|Adverse Event|0|||
105442926|NCT00825812|363628751|FG001|Overall Study|Adverse Event|0|||
105442927|NCT00825812|363628752|FG002|Overall Study|Adverse Event|0|||
105442928|NCT00825812|363628753|FG003|Overall Study|Adverse Event|1|||
105442929|NCT00825812|363628750|FG000|Overall Study|Subject withdrew consent|0|||
105442930|NCT00825812|363628751|FG001|Overall Study|Subject withdrew consent|0|||
105442931|NCT00825812|363628752|FG002|Overall Study|Subject withdrew consent|3|||
105442932|NCT00825812|363628753|FG003|Overall Study|Subject withdrew consent|2|||
105442933|NCT00825812|363628750|FG000|Overall Study|Non-compliance with protocol|0|||
105442934|NCT00825812|363628751|FG001|Overall Study|Non-compliance with protocol|0|||
105442935|NCT00825812|363628752|FG002|Overall Study|Non-compliance with protocol|0|||
105442936|NCT00825812|363628753|FG003|Overall Study|Non-compliance with protocol|1|||
105442937|NCT00825812|363628750|FG000|Overall Study|Administrative|0|||
105442938|NCT00825812|363628751|FG001|Overall Study|Administrative|1|||
105442939|NCT00825812|363628752|FG002|Overall Study|Administrative|3|||
105442940|NCT00825812|363628753|FG003|Overall Study|Administrative|5|||
105442941|NCT01746173|363628756|FG000|Overall Study|Disease Progression|2|||
105442942|NCT01771250|363628759|FG000|Period 1|Met exclusion criteria|1|||
105442943|NCT01771250|363628760|FG001|Period 1|Met exclusion criteria|0|||
105442944|NCT00483938|363628761|FG000|Overall Study|Protocol Violation|0|||
105442945|NCT00483938|363628762|FG001|Overall Study|Protocol Violation|0|||
105442946|NCT00483938|363628763|FG002|Overall Study|Protocol Violation|0|||
105442947|NCT00483938|363628764|FG003|Overall Study|Protocol Violation|0|||
105442948|NCT00483938|363628765|FG004|Overall Study|Protocol Violation|0|||
105442949|NCT00483938|363628766|FG005|Overall Study|Protocol Violation|0|||
105442950|NCT00483938|363628767|FG006|Overall Study|Protocol Violation|3|||
105442951|NCT00483938|363628761|FG000|Overall Study|Withdrawal by Subject|1|||
105442952|NCT00483938|363628762|FG001|Overall Study|Withdrawal by Subject|6|||
105442953|NCT00483938|363628763|FG002|Overall Study|Withdrawal by Subject|0|||
105442954|NCT00483938|363628764|FG003|Overall Study|Withdrawal by Subject|0|||
105442955|NCT00483938|363628765|FG004|Overall Study|Withdrawal by Subject|1|||
105442956|NCT00483938|363628766|FG005|Overall Study|Withdrawal by Subject|3|||
105442957|NCT00483938|363628767|FG006|Overall Study|Withdrawal by Subject|2|||
105442958|NCT00483938|363628761|FG000|Overall Study|Lost to Follow-up|1|||
105442959|NCT00483938|363628762|FG001|Overall Study|Lost to Follow-up|2|||
105442960|NCT00483938|363628763|FG002|Overall Study|Lost to Follow-up|0|||
105442961|NCT00483938|363628764|FG003|Overall Study|Lost to Follow-up|2|||
105442962|NCT00483938|363628765|FG004|Overall Study|Lost to Follow-up|1|||
105442963|NCT00483938|363628766|FG005|Overall Study|Lost to Follow-up|1|||
105442964|NCT00483938|363628767|FG006|Overall Study|Lost to Follow-up|3|||
105442965|NCT00483938|363628761|FG000|Overall Study|Death|0|||
105442966|NCT00483938|363628762|FG001|Overall Study|Death|2|||
105335548|NCT00734162|363230017|FG000|Open-Label Phase|Withdrew Consent|1|||
105335549|NCT00734162|363230018|FG001|Open-Label Phase|Withdrew Consent|0|||
105335550|NCT00734162|363230019|FG002|Open-Label Phase|Withdrew Consent|1|||
105335551|NCT00734162|363230020|FG003|Open-Label Phase|Withdrew Consent|1|||
105335552|NCT00734162|363230017|FG000|Open-Label Phase|Lost to Follow-up|1|||
105335553|NCT00734162|363230018|FG001|Open-Label Phase|Lost to Follow-up|2|||
105335554|NCT00734162|363230019|FG002|Open-Label Phase|Lost to Follow-up|0|||
105335555|NCT00734162|363230020|FG003|Open-Label Phase|Lost to Follow-up|1|||
105335556|NCT00734162|363230017|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
105335557|NCT00734162|363230018|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
105335558|NCT00734162|363230019|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
105335559|NCT00734162|363230020|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
105335560|NCT01515865|363230022|FG000|Part A (Open-label)|Other|3|||
105335561|NCT01515865|363230023|FG001|Part A (Open-label)|Other|0|||
105335562|NCT01515865|363230024|FG002|Part A (Open-label)|Other|0|||
105335563|NCT01515865|363230022|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
105335564|NCT01515865|363230023|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
105335565|NCT01515865|363230024|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
105335566|NCT01515865|363230022|FG000|Part B (Open-label)|Other|1|||
105335567|NCT01515865|363230023|FG001|Part B (Open-label)|Other|0|||
105335568|NCT01515865|363230024|FG002|Part B (Open-label)|Other|0|||
105335569|NCT01868438|363230025|FG000|First Intervention|Withdrawal by Subject|5|||
105335570|NCT01868438|363230026|FG001|First Intervention|Withdrawal by Subject|1|||
105335571|NCT01868438|363230025|FG000|First Intervention|Lost to Follow-up|2|||
105335572|NCT01868438|363230026|FG001|First Intervention|Lost to Follow-up|3|||
105335573|NCT01868438|363230025|FG000|First Intervention|Meeting the non-redosing criteria|0|||
105335574|NCT01868438|363230026|FG001|First Intervention|Meeting the non-redosing criteria|1|||
105335575|NCT01868438|363230025|FG000|Second Intervention|Adverse Event|3|||
105335576|NCT01868438|363230026|FG001|Second Intervention|Adverse Event|3|||
105335577|NCT00956592|363230029|FG000|Overall Study|Protocol Violation|1|||
105335578|NCT00956592|363230030|FG001|Overall Study|Protocol Violation|3|||
105335579|NCT03981900|363230031|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
105335580|NCT03981900|363230031|FG000|Overall Study|Adverse Event|5|||
105335581|NCT03981900|363230031|FG000|Overall Study|Protocol Violation|1|||
105335582|NCT03981900|363230031|FG000|Overall Study|Withdrawal by Subject|7|||
105335583|NCT03981900|363230031|FG000|Overall Study|Lost to Follow-up|46|||
105335584|NCT03981900|363230031|FG000|Overall Study|Decision of the researcher|3|||
105335585|NCT03981900|363230031|FG000|Overall Study|Death|3|||
105335586|NCT03981900|363230031|FG000|Overall Study|Other|5|||
105335587|NCT00160706|363230032|FG000|Overall Study|Adverse Event|53|||
105335588|NCT00160706|363230032|FG000|Overall Study|Adverse Event and Other Reason|105|||
105335589|NCT00160706|363230032|FG000|Overall Study|Protocol Violation|3|||
105335590|NCT00160706|363230032|FG000|Overall Study|Withdrawal by Subject|41|||
105335591|NCT00160706|363230032|FG000|Overall Study|Withdrawal by Subject and Other|12|||
105335592|NCT00160706|363230032|FG000|Overall Study|Physician Decision|10|||
105335593|NCT00160706|363230032|FG000|Overall Study|Physician Decision and Other|3|||
105335594|NCT00160706|363230032|FG000|Overall Study|Lost to Follow-up|4|||
105335595|NCT00160706|363230032|FG000|Overall Study|Lost to Follow-up and Other|1|||
105335596|NCT00160706|363230032|FG000|Overall Study|Lack of Efficacy|42|||
105335597|NCT00160706|363230032|FG000|Overall Study|Lack of Efficacy and Other|1|||
105335598|NCT00160706|363230032|FG000|Overall Study|Other Reason|11|||
105335599|NCT00562302|363230036|FG000|Overall Study|Lost to Follow-up|3|||
105335600|NCT00562302|363230037|FG001|Overall Study|Lost to Follow-up|3|||
105335601|NCT00562302|363230036|FG000|Overall Study|Adverse Event|0|||
105335602|NCT00562302|363230037|FG001|Overall Study|Adverse Event|6|||
105335603|NCT00562302|363230036|FG000|Overall Study|Non-compliance|1|||
105335604|NCT00562302|363230037|FG001|Overall Study|Non-compliance|2|||
105335605|NCT00562302|363230036|FG000|Overall Study|Withdrawal by Subject|7|||
105335606|NCT00562302|363230037|FG001|Overall Study|Withdrawal by Subject|8|||
105335607|NCT00562302|363230036|FG000|Overall Study|Death|1|||
105335608|NCT00562302|363230037|FG001|Overall Study|Death|2|||
105335609|NCT00562302|363230036|FG000|Overall Study|Lung resection prior to study completion|7|||
105442967|NCT00483938|363628763|FG002|Overall Study|Death|0|||
105335610|NCT00562302|363230037|FG001|Overall Study|Lung resection prior to study completion|7|||
105335611|NCT00562302|363230036|FG000|Overall Study|Not stated|1|||
105442968|NCT00483938|363628764|FG003|Overall Study|Death|0|||
105442969|NCT00483938|363628765|FG004|Overall Study|Death|0|||
105442970|NCT00483938|363628766|FG005|Overall Study|Death|0|||
105442971|NCT00483938|363628767|FG006|Overall Study|Death|0|||
105442972|NCT00483938|363628761|FG000|Overall Study|Other|3|||
105442973|NCT00483938|363628762|FG001|Overall Study|Other|9|||
105442974|NCT00483938|363628763|FG002|Overall Study|Other|0|||
105442975|NCT00483938|363628764|FG003|Overall Study|Other|4|||
105442976|NCT00483938|363628765|FG004|Overall Study|Other|0|||
105442977|NCT00483938|363628766|FG005|Overall Study|Other|4|||
105442978|NCT00483938|363628767|FG006|Overall Study|Other|32|||
105442979|NCT02038075|363628772|FG000|Overall Study|Withdrawal by Subject|3|||
105442980|NCT02038075|363628773|FG001|Overall Study|Withdrawal by Subject|0|||
105442981|NCT04039217|363628774|FG000|Overall Study|Lost to Follow-up|1|||
105442982|NCT04000581|363628775|FG000|Overall Study|Withdrawal by Subject|0|||
105442983|NCT04000581|363628776|FG001|Overall Study|Withdrawal by Subject|1|||
105442984|NCT01371552|363628777|FG000|Part 1, First 3 Days|Inconvenience|0|||
105442985|NCT01371552|363628778|FG001|Part 1, First 3 Days|Inconvenience|0|||
105442986|NCT01371552|363628779|FG002|Part 1, First 3 Days|Inconvenience|1|||
105442987|NCT01371552|363628780|FG003|Part 1, First 3 Days|Inconvenience|0|||
105442988|NCT01371552|363628781|FG004|Part 1, First 3 Days|Inconvenience|0|||
105442989|NCT01371552|363628782|FG005|Part 1, First 3 Days|Inconvenience|0|||
105442990|NCT03364309|363628783|FG000|Induction Period|Adverse Event|4|||
105442991|NCT03364309|363628784|FG001|Induction Period|Adverse Event|0|||
105442992|NCT03364309|363628785|FG002|Induction Period|Adverse Event|1|||
105442993|NCT03364309|363628786|FG003|Induction Period|Adverse Event|0|||
105442994|NCT03364309|363628787|FG004|Induction Period|Adverse Event|0|||
105442995|NCT03364309|363628788|FG005|Induction Period|Adverse Event|0|||
105442996|NCT03364309|363628789|FG006|Induction Period|Adverse Event|0|||
105442997|NCT03364309|363628790|FG007|Induction Period|Adverse Event|0|||
105442998|NCT03364309|363628791|FG008|Induction Period|Adverse Event|0|||
105442999|NCT03364309|363628792|FG009|Induction Period|Adverse Event|0|||
105443000|NCT03364309|363628793|FG010|Induction Period|Adverse Event|0|||
105443001|NCT03364309|363628794|FG011|Induction Period|Adverse Event|0|||
105443002|NCT03364309|363628795|FG012|Induction Period|Adverse Event|0|||
105443003|NCT03364309|363628796|FG013|Induction Period|Adverse Event|0|||
105443004|NCT03364309|363628797|FG014|Induction Period|Adverse Event|0|||
105443005|NCT03364309|363628798|FG015|Induction Period|Adverse Event|0|||
105443006|NCT03364309|363628799|FG016|Induction Period|Adverse Event|0|||
105443007|NCT03364309|363628800|FG017|Induction Period|Adverse Event|0|||
105443008|NCT03364309|363628801|FG018|Induction Period|Adverse Event|0|||
105443009|NCT03364309|363628783|FG000|Induction Period|Withdrawal by Subject|1|||
105443010|NCT03364309|363628784|FG001|Induction Period|Withdrawal by Subject|3|||
105443011|NCT03364309|363628785|FG002|Induction Period|Withdrawal by Subject|0|||
105335612|NCT00562302|363230037|FG001|Overall Study|Not stated|4|||
105335613|NCT01355575|363230038|FG000|Overall Study|Withdrawal by Subject|2|||
105335614|NCT01894100|363230051|FG000|Overall Study|Lost to Follow-up|0|||
105335615|NCT01894100|363230052|FG001|Overall Study|Lost to Follow-up|1|||
105335616|NCT01894100|363230051|FG000|Overall Study|Withdrawal by Subject|3|||
105335617|NCT01894100|363230052|FG001|Overall Study|Withdrawal by Subject|0|||
105335618|NCT00135512|363230053|FG000|Overall Study|Adverse Event|56|||
105335619|NCT00135512|363230053|FG000|Overall Study|Lack of Efficacy|25|||
105335620|NCT00135512|363230053|FG000|Overall Study|Other|42|||
105335621|NCT01094301|363230054|FG000|Trial Stage|Withdrawal by Subject|1|||
105335622|NCT01094301|363230054|FG000|Implant Stage|Adverse Event|1|||
105335623|NCT01094301|363230054|FG000|Implant Stage|Protocol Violation|1|||
105335624|NCT01094301|363230054|FG000|Implant Stage|Withdrawal by Subject|2|||
105335625|NCT01094301|363230054|FG000|Implant Stage|No return of pain|4|||
105335626|NCT02553499|363230055|FG000|Overall Study|Adverse Event|0|||
105335627|NCT02553499|363230056|FG001|Overall Study|Adverse Event|0|||
105335628|NCT02553499|363230057|FG002|Overall Study|Adverse Event|0|||
105335629|NCT02553499|363230058|FG003|Overall Study|Adverse Event|0|||
105335630|NCT02553499|363230059|FG004|Overall Study|Adverse Event|0|||
105335631|NCT02553499|363230060|FG005|Overall Study|Adverse Event|0|||
105335632|NCT02553499|363230061|FG006|Overall Study|Adverse Event|1|||
105335633|NCT02553499|363230062|FG007|Overall Study|Adverse Event|1|||
105335634|NCT02553499|363230063|FG008|Overall Study|Adverse Event|0|||
105335635|NCT02553499|363230064|FG009|Overall Study|Adverse Event|0|||
105335636|NCT02553499|363230065|FG010|Overall Study|Adverse Event|0|||
105335637|NCT02553499|363230066|FG011|Overall Study|Adverse Event|0|||
105335638|NCT02553499|363230067|FG012|Overall Study|Adverse Event|0|||
105335639|NCT02553499|363230068|FG013|Overall Study|Adverse Event|1|||
105335640|NCT02553499|363230055|FG000|Overall Study|Death|0|||
105443012|NCT03364309|363628786|FG003|Induction Period|Withdrawal by Subject|0|||
105335641|NCT02553499|363230056|FG001|Overall Study|Death|1|||
105443013|NCT03364309|363628787|FG004|Induction Period|Withdrawal by Subject|0|||
105443014|NCT03364309|363628788|FG005|Induction Period|Withdrawal by Subject|0|||
105443015|NCT03364309|363628789|FG006|Induction Period|Withdrawal by Subject|0|||
105443016|NCT03364309|363628790|FG007|Induction Period|Withdrawal by Subject|0|||
105443017|NCT03364309|363628791|FG008|Induction Period|Withdrawal by Subject|0|||
105443018|NCT03364309|363628792|FG009|Induction Period|Withdrawal by Subject|0|||
105443019|NCT03364309|363628793|FG010|Induction Period|Withdrawal by Subject|0|||
105443020|NCT03364309|363628794|FG011|Induction Period|Withdrawal by Subject|0|||
105443021|NCT03364309|363628795|FG012|Induction Period|Withdrawal by Subject|0|||
105443022|NCT03364309|363628796|FG013|Induction Period|Withdrawal by Subject|0|||
105443023|NCT03364309|363628797|FG014|Induction Period|Withdrawal by Subject|0|||
105443024|NCT03364309|363628798|FG015|Induction Period|Withdrawal by Subject|0|||
105443025|NCT03364309|363628799|FG016|Induction Period|Withdrawal by Subject|0|||
105443026|NCT03364309|363628800|FG017|Induction Period|Withdrawal by Subject|0|||
105443027|NCT03364309|363628801|FG018|Induction Period|Withdrawal by Subject|0|||
105443028|NCT03364309|363628783|FG000|Induction Period|Lost to Follow-up|1|||
105443029|NCT03364309|363628784|FG001|Induction Period|Lost to Follow-up|0|||
105443030|NCT03364309|363628785|FG002|Induction Period|Lost to Follow-up|0|||
105443031|NCT03364309|363628786|FG003|Induction Period|Lost to Follow-up|0|||
105443032|NCT03364309|363628787|FG004|Induction Period|Lost to Follow-up|0|||
105443033|NCT03364309|363628788|FG005|Induction Period|Lost to Follow-up|0|||
105443034|NCT03364309|363628789|FG006|Induction Period|Lost to Follow-up|0|||
105443035|NCT03364309|363628790|FG007|Induction Period|Lost to Follow-up|0|||
105443036|NCT03364309|363628791|FG008|Induction Period|Lost to Follow-up|0|||
105443037|NCT03364309|363628792|FG009|Induction Period|Lost to Follow-up|0|||
105443038|NCT03364309|363628793|FG010|Induction Period|Lost to Follow-up|0|||
105443039|NCT03364309|363628794|FG011|Induction Period|Lost to Follow-up|0|||
105443040|NCT03364309|363628795|FG012|Induction Period|Lost to Follow-up|0|||
105443041|NCT03364309|363628796|FG013|Induction Period|Lost to Follow-up|0|||
105443042|NCT03364309|363628797|FG014|Induction Period|Lost to Follow-up|0|||
105443043|NCT03364309|363628798|FG015|Induction Period|Lost to Follow-up|0|||
105443044|NCT03364309|363628799|FG016|Induction Period|Lost to Follow-up|0|||
105443045|NCT03364309|363628800|FG017|Induction Period|Lost to Follow-up|0|||
105443046|NCT03364309|363628801|FG018|Induction Period|Lost to Follow-up|0|||
105443047|NCT03364309|363628783|FG000|Induction Period|Physician Decision|0|||
105443048|NCT03364309|363628784|FG001|Induction Period|Physician Decision|1|||
105443049|NCT03364309|363628785|FG002|Induction Period|Physician Decision|0|||
105443050|NCT03364309|363628786|FG003|Induction Period|Physician Decision|0|||
105443051|NCT03364309|363628787|FG004|Induction Period|Physician Decision|0|||
105443052|NCT03364309|363628788|FG005|Induction Period|Physician Decision|0|||
105443053|NCT03364309|363628789|FG006|Induction Period|Physician Decision|0|||
105443054|NCT03364309|363628790|FG007|Induction Period|Physician Decision|0|||
105443055|NCT03364309|363628791|FG008|Induction Period|Physician Decision|0|||
105443056|NCT03364309|363628792|FG009|Induction Period|Physician Decision|0|||
105443057|NCT03364309|363628793|FG010|Induction Period|Physician Decision|0|||
105443058|NCT03364309|363628794|FG011|Induction Period|Physician Decision|0|||
105443059|NCT03364309|363628795|FG012|Induction Period|Physician Decision|0|||
105443060|NCT03364309|363628796|FG013|Induction Period|Physician Decision|0|||
105443061|NCT03364309|363628797|FG014|Induction Period|Physician Decision|0|||
105443062|NCT03364309|363628798|FG015|Induction Period|Physician Decision|0|||
105443063|NCT03364309|363628799|FG016|Induction Period|Physician Decision|0|||
105443064|NCT03364309|363628800|FG017|Induction Period|Physician Decision|0|||
105443065|NCT03364309|363628801|FG018|Induction Period|Physician Decision|0|||
105443066|NCT03364309|363628783|FG000|Maintenance Period|Withdrawal by Subject|0|||
105443067|NCT03364309|363628784|FG001|Maintenance Period|Withdrawal by Subject|0|||
105443068|NCT03364309|363628785|FG002|Maintenance Period|Withdrawal by Subject|0|||
105443069|NCT03364309|363628786|FG003|Maintenance Period|Withdrawal by Subject|1|||
105443070|NCT03364309|363628787|FG004|Maintenance Period|Withdrawal by Subject|3|||
105443071|NCT03364309|363628788|FG005|Maintenance Period|Withdrawal by Subject|1|||
105443072|NCT03364309|363628789|FG006|Maintenance Period|Withdrawal by Subject|3|||
105443073|NCT03364309|363628790|FG007|Maintenance Period|Withdrawal by Subject|0|||
105443074|NCT03364309|363628791|FG008|Maintenance Period|Withdrawal by Subject|1|||
105443075|NCT03364309|363628792|FG009|Maintenance Period|Withdrawal by Subject|1|||
105443076|NCT03364309|363628793|FG010|Maintenance Period|Withdrawal by Subject|2|||
105443077|NCT03364309|363628794|FG011|Maintenance Period|Withdrawal by Subject|0|||
105443078|NCT03364309|363628795|FG012|Maintenance Period|Withdrawal by Subject|0|||
105443079|NCT03364309|363628796|FG013|Maintenance Period|Withdrawal by Subject|0|||
105443080|NCT03364309|363628797|FG014|Maintenance Period|Withdrawal by Subject|0|||
105443081|NCT03364309|363628798|FG015|Maintenance Period|Withdrawal by Subject|0|||
105443082|NCT03364309|363628799|FG016|Maintenance Period|Withdrawal by Subject|0|||
105443083|NCT03364309|363628800|FG017|Maintenance Period|Withdrawal by Subject|0|||
105443084|NCT03364309|363628801|FG018|Maintenance Period|Withdrawal by Subject|0|||
105443085|NCT03364309|363628783|FG000|Maintenance Period|Adverse Event|0|||
105443086|NCT03364309|363628784|FG001|Maintenance Period|Adverse Event|0|||
105443087|NCT03364309|363628785|FG002|Maintenance Period|Adverse Event|0|||
105443088|NCT03364309|363628786|FG003|Maintenance Period|Adverse Event|0|||
105443089|NCT03364309|363628787|FG004|Maintenance Period|Adverse Event|2|||
105443090|NCT03364309|363628788|FG005|Maintenance Period|Adverse Event|0|||
105443091|NCT03364309|363628789|FG006|Maintenance Period|Adverse Event|3|||
105443092|NCT03364309|363628790|FG007|Maintenance Period|Adverse Event|0|||
105443093|NCT03364309|363628791|FG008|Maintenance Period|Adverse Event|1|||
105443094|NCT03364309|363628792|FG009|Maintenance Period|Adverse Event|0|||
105443095|NCT03364309|363628793|FG010|Maintenance Period|Adverse Event|2|||
105443096|NCT03364309|363628794|FG011|Maintenance Period|Adverse Event|0|||
105443097|NCT03364309|363628795|FG012|Maintenance Period|Adverse Event|0|||
105443098|NCT03364309|363628796|FG013|Maintenance Period|Adverse Event|0|||
105443099|NCT03364309|363628797|FG014|Maintenance Period|Adverse Event|0|||
105443100|NCT03364309|363628798|FG015|Maintenance Period|Adverse Event|0|||
105443101|NCT03364309|363628799|FG016|Maintenance Period|Adverse Event|0|||
105443102|NCT03364309|363628800|FG017|Maintenance Period|Adverse Event|0|||
105443103|NCT03364309|363628801|FG018|Maintenance Period|Adverse Event|0|||
105443104|NCT03364309|363628783|FG000|Maintenance Period|Relapsed|0|||
105443105|NCT03364309|363628784|FG001|Maintenance Period|Relapsed|0|||
105443106|NCT03364309|363628785|FG002|Maintenance Period|Relapsed|0|||
105443107|NCT03364309|363628786|FG003|Maintenance Period|Relapsed|43|||
105443108|NCT03364309|363628787|FG004|Maintenance Period|Relapsed|7|||
105443109|NCT03364309|363628788|FG005|Maintenance Period|Relapsed|45|||
105443110|NCT03364309|363628789|FG006|Maintenance Period|Relapsed|10|||
105443111|NCT03364309|363628790|FG007|Maintenance Period|Relapsed|2|||
105443112|NCT03364309|363628791|FG008|Maintenance Period|Relapsed|0|||
105443113|NCT03364309|363628792|FG009|Maintenance Period|Relapsed|0|||
105443114|NCT03364309|363628793|FG010|Maintenance Period|Relapsed|0|||
105443115|NCT03364309|363628794|FG011|Maintenance Period|Relapsed|0|||
105443116|NCT03364309|363628795|FG012|Maintenance Period|Relapsed|0|||
105443117|NCT03364309|363628796|FG013|Maintenance Period|Relapsed|0|||
105443118|NCT03364309|363628797|FG014|Maintenance Period|Relapsed|0|||
105443119|NCT03364309|363628798|FG015|Maintenance Period|Relapsed|0|||
105443120|NCT03364309|363628799|FG016|Maintenance Period|Relapsed|0|||
105443121|NCT03364309|363628800|FG017|Maintenance Period|Relapsed|0|||
105443122|NCT03364309|363628801|FG018|Maintenance Period|Relapsed|0|||
105443123|NCT03364309|363628783|FG000|Maintenance Period|Lack of Efficacy|0|||
105443124|NCT03364309|363628784|FG001|Maintenance Period|Lack of Efficacy|0|||
105443125|NCT03364309|363628785|FG002|Maintenance Period|Lack of Efficacy|0|||
105443126|NCT03364309|363628786|FG003|Maintenance Period|Lack of Efficacy|0|||
105443127|NCT03364309|363628787|FG004|Maintenance Period|Lack of Efficacy|0|||
105443128|NCT03364309|363628788|FG005|Maintenance Period|Lack of Efficacy|0|||
105443129|NCT03364309|363628789|FG006|Maintenance Period|Lack of Efficacy|0|||
105443130|NCT03364309|363628790|FG007|Maintenance Period|Lack of Efficacy|0|||
105443131|NCT03364309|363628791|FG008|Maintenance Period|Lack of Efficacy|1|||
105443132|NCT03364309|363628792|FG009|Maintenance Period|Lack of Efficacy|3|||
105443133|NCT03364309|363628793|FG010|Maintenance Period|Lack of Efficacy|2|||
105443134|NCT03364309|363628794|FG011|Maintenance Period|Lack of Efficacy|0|||
105443135|NCT03364309|363628795|FG012|Maintenance Period|Lack of Efficacy|0|||
105443136|NCT03364309|363628796|FG013|Maintenance Period|Lack of Efficacy|0|||
105443137|NCT03364309|363628797|FG014|Maintenance Period|Lack of Efficacy|0|||
105443138|NCT03364309|363628798|FG015|Maintenance Period|Lack of Efficacy|0|||
105443139|NCT03364309|363628799|FG016|Maintenance Period|Lack of Efficacy|0|||
105443140|NCT03364309|363628800|FG017|Maintenance Period|Lack of Efficacy|0|||
105443141|NCT03364309|363628801|FG018|Maintenance Period|Lack of Efficacy|0|||
105443142|NCT03364309|363628783|FG000|Maintenance Period|Death|0|||
105443143|NCT03364309|363628784|FG001|Maintenance Period|Death|0|||
105443144|NCT03364309|363628785|FG002|Maintenance Period|Death|0|||
105443145|NCT03364309|363628786|FG003|Maintenance Period|Death|0|||
105443146|NCT03364309|363628787|FG004|Maintenance Period|Death|0|||
105443147|NCT03364309|363628788|FG005|Maintenance Period|Death|0|||
105443148|NCT03364309|363628789|FG006|Maintenance Period|Death|0|||
105443149|NCT03364309|363628790|FG007|Maintenance Period|Death|0|||
105443150|NCT03364309|363628791|FG008|Maintenance Period|Death|1|||
105443151|NCT03364309|363628792|FG009|Maintenance Period|Death|0|||
105443152|NCT03364309|363628793|FG010|Maintenance Period|Death|0|||
105443153|NCT03364309|363628794|FG011|Maintenance Period|Death|0|||
105443154|NCT03364309|363628795|FG012|Maintenance Period|Death|0|||
105443155|NCT03364309|363628796|FG013|Maintenance Period|Death|0|||
105443156|NCT03364309|363628797|FG014|Maintenance Period|Death|0|||
105443157|NCT03364309|363628798|FG015|Maintenance Period|Death|0|||
105443158|NCT03364309|363628799|FG016|Maintenance Period|Death|0|||
105443159|NCT03364309|363628800|FG017|Maintenance Period|Death|0|||
105443160|NCT03364309|363628801|FG018|Maintenance Period|Death|0|||
105443161|NCT03364309|363628783|FG000|Maintenance Period|Lost to Follow-up|0|||
105443162|NCT03364309|363628784|FG001|Maintenance Period|Lost to Follow-up|0|||
105443163|NCT03364309|363628785|FG002|Maintenance Period|Lost to Follow-up|0|||
105443164|NCT03364309|363628786|FG003|Maintenance Period|Lost to Follow-up|0|||
105443165|NCT03364309|363628787|FG004|Maintenance Period|Lost to Follow-up|0|||
105443166|NCT03364309|363628788|FG005|Maintenance Period|Lost to Follow-up|0|||
105443167|NCT03364309|363628789|FG006|Maintenance Period|Lost to Follow-up|0|||
105443168|NCT03364309|363628790|FG007|Maintenance Period|Lost to Follow-up|0|||
105443169|NCT03364309|363628791|FG008|Maintenance Period|Lost to Follow-up|1|||
105443170|NCT03364309|363628792|FG009|Maintenance Period|Lost to Follow-up|0|||
105443171|NCT03364309|363628793|FG010|Maintenance Period|Lost to Follow-up|0|||
105443172|NCT03364309|363628794|FG011|Maintenance Period|Lost to Follow-up|0|||
105443173|NCT03364309|363628795|FG012|Maintenance Period|Lost to Follow-up|0|||
105443174|NCT03364309|363628796|FG013|Maintenance Period|Lost to Follow-up|0|||
105779383|NCT00386152|364844740|FG000|Overall Study|Chang from original chemo stratification|4|||
105335642|NCT02553499|363230057|FG002|Overall Study|Death|1|||
105335643|NCT02553499|363230058|FG003|Overall Study|Death|0|||
105335644|NCT02553499|363230059|FG004|Overall Study|Death|1|||
105335645|NCT02553499|363230060|FG005|Overall Study|Death|2|||
105335646|NCT02553499|363230061|FG006|Overall Study|Death|0|||
105335647|NCT02553499|363230062|FG007|Overall Study|Death|0|||
105335648|NCT02553499|363230063|FG008|Overall Study|Death|0|||
105335649|NCT02553499|363230064|FG009|Overall Study|Death|0|||
105335650|NCT02553499|363230065|FG010|Overall Study|Death|1|||
105335651|NCT02553499|363230066|FG011|Overall Study|Death|0|||
105335652|NCT02553499|363230067|FG012|Overall Study|Death|0|||
105335653|NCT02553499|363230068|FG013|Overall Study|Death|0|||
105335654|NCT02553499|363230055|FG000|Overall Study|Lost to Follow-up|0|||
105335655|NCT02553499|363230056|FG001|Overall Study|Lost to Follow-up|0|||
105335656|NCT02553499|363230057|FG002|Overall Study|Lost to Follow-up|0|||
105335657|NCT02553499|363230058|FG003|Overall Study|Lost to Follow-up|0|||
105335658|NCT02553499|363230059|FG004|Overall Study|Lost to Follow-up|0|||
105335659|NCT02553499|363230060|FG005|Overall Study|Lost to Follow-up|0|||
105335660|NCT02553499|363230061|FG006|Overall Study|Lost to Follow-up|1|||
105335661|NCT02553499|363230062|FG007|Overall Study|Lost to Follow-up|0|||
105335662|NCT02553499|363230063|FG008|Overall Study|Lost to Follow-up|0|||
105335663|NCT02553499|363230064|FG009|Overall Study|Lost to Follow-up|0|||
105335664|NCT02553499|363230065|FG010|Overall Study|Lost to Follow-up|0|||
105335665|NCT02553499|363230066|FG011|Overall Study|Lost to Follow-up|0|||
105335666|NCT02553499|363230067|FG012|Overall Study|Lost to Follow-up|0|||
105335667|NCT02553499|363230068|FG013|Overall Study|Lost to Follow-up|0|||
105335668|NCT02553499|363230055|FG000|Overall Study|Physician Decision|0|||
105335669|NCT02553499|363230056|FG001|Overall Study|Physician Decision|1|||
105335670|NCT02553499|363230057|FG002|Overall Study|Physician Decision|1|||
105335671|NCT02553499|363230058|FG003|Overall Study|Physician Decision|0|||
105335672|NCT02553499|363230059|FG004|Overall Study|Physician Decision|1|||
105335673|NCT02553499|363230060|FG005|Overall Study|Physician Decision|0|||
105335674|NCT02553499|363230061|FG006|Overall Study|Physician Decision|0|||
105335675|NCT02553499|363230062|FG007|Overall Study|Physician Decision|1|||
105335676|NCT02553499|363230063|FG008|Overall Study|Physician Decision|1|||
105335677|NCT02553499|363230064|FG009|Overall Study|Physician Decision|2|||
105335678|NCT02553499|363230065|FG010|Overall Study|Physician Decision|1|||
105335679|NCT02553499|363230066|FG011|Overall Study|Physician Decision|3|||
105335680|NCT02553499|363230067|FG012|Overall Study|Physician Decision|1|||
105335681|NCT02553499|363230068|FG013|Overall Study|Physician Decision|0|||
105335682|NCT02553499|363230055|FG000|Overall Study|Progressive Disease|0|||
105335683|NCT02553499|363230056|FG001|Overall Study|Progressive Disease|0|||
105335684|NCT02553499|363230057|FG002|Overall Study|Progressive Disease|0|||
105335685|NCT02553499|363230058|FG003|Overall Study|Progressive Disease|2|||
105335686|NCT02553499|363230059|FG004|Overall Study|Progressive Disease|1|||
105335687|NCT02553499|363230060|FG005|Overall Study|Progressive Disease|1|||
105335688|NCT02553499|363230061|FG006|Overall Study|Progressive Disease|1|||
105335689|NCT02553499|363230062|FG007|Overall Study|Progressive Disease|0|||
105335690|NCT02553499|363230063|FG008|Overall Study|Progressive Disease|0|||
105335691|NCT02553499|363230064|FG009|Overall Study|Progressive Disease|1|||
105335692|NCT02553499|363230065|FG010|Overall Study|Progressive Disease|0|||
105335693|NCT02553499|363230066|FG011|Overall Study|Progressive Disease|0|||
105335694|NCT02553499|363230067|FG012|Overall Study|Progressive Disease|2|||
105335695|NCT02553499|363230068|FG013|Overall Study|Progressive Disease|1|||
105335696|NCT02553499|363230055|FG000|Overall Study|Study Terminated by Sponsor|0|||
105335697|NCT02553499|363230056|FG001|Overall Study|Study Terminated by Sponsor|0|||
105335698|NCT02553499|363230057|FG002|Overall Study|Study Terminated by Sponsor|0|||
105335699|NCT02553499|363230058|FG003|Overall Study|Study Terminated by Sponsor|0|||
105335700|NCT02553499|363230059|FG004|Overall Study|Study Terminated by Sponsor|0|||
105335701|NCT02553499|363230060|FG005|Overall Study|Study Terminated by Sponsor|0|||
105335702|NCT02553499|363230061|FG006|Overall Study|Study Terminated by Sponsor|0|||
105335703|NCT02553499|363230062|FG007|Overall Study|Study Terminated by Sponsor|0|||
105335704|NCT02553499|363230063|FG008|Overall Study|Study Terminated by Sponsor|1|||
105335705|NCT02553499|363230064|FG009|Overall Study|Study Terminated by Sponsor|0|||
105335706|NCT02553499|363230065|FG010|Overall Study|Study Terminated by Sponsor|0|||
105335707|NCT02553499|363230066|FG011|Overall Study|Study Terminated by Sponsor|0|||
105335708|NCT02553499|363230067|FG012|Overall Study|Study Terminated by Sponsor|0|||
105335709|NCT02553499|363230068|FG013|Overall Study|Study Terminated by Sponsor|0|||
105335710|NCT02553499|363230055|FG000|Overall Study|Withdrawal by Subject|2|||
105335711|NCT02553499|363230056|FG001|Overall Study|Withdrawal by Subject|0|||
105335712|NCT02553499|363230057|FG002|Overall Study|Withdrawal by Subject|0|||
105335713|NCT02553499|363230058|FG003|Overall Study|Withdrawal by Subject|0|||
105335714|NCT02553499|363230059|FG004|Overall Study|Withdrawal by Subject|0|||
105335715|NCT02553499|363230060|FG005|Overall Study|Withdrawal by Subject|0|||
105335716|NCT02553499|363230061|FG006|Overall Study|Withdrawal by Subject|0|||
105335717|NCT02553499|363230062|FG007|Overall Study|Withdrawal by Subject|1|||
105335718|NCT02553499|363230063|FG008|Overall Study|Withdrawal by Subject|1|||
105335719|NCT02553499|363230064|FG009|Overall Study|Withdrawal by Subject|0|||
105335720|NCT02553499|363230065|FG010|Overall Study|Withdrawal by Subject|1|||
105443175|NCT03364309|363628797|FG014|Maintenance Period|Lost to Follow-up|0|||
105443176|NCT03364309|363628798|FG015|Maintenance Period|Lost to Follow-up|0|||
105443177|NCT03364309|363628799|FG016|Maintenance Period|Lost to Follow-up|0|||
105443178|NCT03364309|363628800|FG017|Maintenance Period|Lost to Follow-up|0|||
105443179|NCT03364309|363628801|FG018|Maintenance Period|Lost to Follow-up|0|||
105443180|NCT03364309|363628783|FG000|Maintenance Period|Miscellaneous|0|||
105443181|NCT03364309|363628784|FG001|Maintenance Period|Miscellaneous|0|||
105443182|NCT03364309|363628785|FG002|Maintenance Period|Miscellaneous|0|||
105443183|NCT03364309|363628786|FG003|Maintenance Period|Miscellaneous|0|||
105443184|NCT03364309|363628787|FG004|Maintenance Period|Miscellaneous|0|||
105443185|NCT03364309|363628788|FG005|Maintenance Period|Miscellaneous|0|||
105443186|NCT03364309|363628789|FG006|Maintenance Period|Miscellaneous|0|||
105443187|NCT03364309|363628790|FG007|Maintenance Period|Miscellaneous|0|||
105443188|NCT03364309|363628791|FG008|Maintenance Period|Miscellaneous|1|||
105443189|NCT03364309|363628792|FG009|Maintenance Period|Miscellaneous|0|||
105443190|NCT03364309|363628793|FG010|Maintenance Period|Miscellaneous|0|||
105443191|NCT03364309|363628794|FG011|Maintenance Period|Miscellaneous|0|||
105443192|NCT03364309|363628795|FG012|Maintenance Period|Miscellaneous|0|||
105443193|NCT03364309|363628796|FG013|Maintenance Period|Miscellaneous|0|||
105443194|NCT03364309|363628797|FG014|Maintenance Period|Miscellaneous|0|||
105443195|NCT03364309|363628798|FG015|Maintenance Period|Miscellaneous|0|||
105443196|NCT03364309|363628799|FG016|Maintenance Period|Miscellaneous|0|||
105443197|NCT03364309|363628800|FG017|Maintenance Period|Miscellaneous|0|||
105443198|NCT03364309|363628801|FG018|Maintenance Period|Miscellaneous|0|||
105443199|NCT03364309|363628783|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443200|NCT03364309|363628784|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443201|NCT03364309|363628785|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443202|NCT03364309|363628786|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443203|NCT03364309|363628787|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443204|NCT03364309|363628788|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443205|NCT03364309|363628789|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443206|NCT03364309|363628790|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443207|NCT03364309|363628791|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443208|NCT03364309|363628792|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443209|NCT03364309|363628793|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443210|NCT03364309|363628794|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443211|NCT03364309|363628795|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443212|NCT03364309|363628796|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
105443213|NCT03364309|363628797|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
105443214|NCT03364309|363628798|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
105443215|NCT03364309|363628799|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443216|NCT03364309|363628800|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443217|NCT03364309|363628801|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105443218|NCT03364309|363628783|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443219|NCT03364309|363628784|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443220|NCT03364309|363628785|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443221|NCT03364309|363628786|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443222|NCT03364309|363628787|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443223|NCT03364309|363628788|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443224|NCT03364309|363628789|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443225|NCT03364309|363628790|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443226|NCT03364309|363628791|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443227|NCT03364309|363628792|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443228|NCT03364309|363628793|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443229|NCT03364309|363628794|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443230|NCT03364309|363628795|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443231|NCT03364309|363628796|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443232|NCT03364309|363628797|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
105443233|NCT03364309|363628798|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443234|NCT03364309|363628799|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443235|NCT03364309|363628800|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443236|NCT03364309|363628801|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
105443237|NCT03364309|363628783|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
105443238|NCT03364309|363628784|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
105443239|NCT03364309|363628785|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
105443240|NCT03364309|363628786|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
105443241|NCT03364309|363628787|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
105443242|NCT03364309|363628788|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
105443243|NCT03364309|363628789|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
105443244|NCT03364309|363628790|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
105443245|NCT03364309|363628791|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
105443246|NCT03364309|363628792|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
105443247|NCT03364309|363628793|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
105443248|NCT03364309|363628794|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
105443249|NCT03364309|363628795|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
105443250|NCT03364309|363628796|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
105443251|NCT03364309|363628797|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
105443252|NCT03364309|363628798|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
105443253|NCT03364309|363628799|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
105443254|NCT03364309|363628800|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
105443255|NCT03364309|363628801|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
105443256|NCT03364309|363628783|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443257|NCT03364309|363628784|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443258|NCT03364309|363628785|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443259|NCT03364309|363628786|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443260|NCT03364309|363628787|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443261|NCT03364309|363628788|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443262|NCT03364309|363628789|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443263|NCT03364309|363628790|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443264|NCT03364309|363628791|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443265|NCT03364309|363628792|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443266|NCT03364309|363628793|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443267|NCT03364309|363628794|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443268|NCT03364309|363628795|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443269|NCT03364309|363628796|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443270|NCT03364309|363628797|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443271|NCT03364309|363628798|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105443272|NCT03364309|363628799|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
105443273|NCT03364309|363628800|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
105443274|NCT03364309|363628801|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
105443275|NCT03364309|363628783|FG000|Post-Treatment Followup Period|Adverse Event|0|||
105443276|NCT03364309|363628784|FG001|Post-Treatment Followup Period|Adverse Event|0|||
105443277|NCT03364309|363628785|FG002|Post-Treatment Followup Period|Adverse Event|0|||
105443278|NCT03364309|363628786|FG003|Post-Treatment Followup Period|Adverse Event|0|||
105443279|NCT03364309|363628787|FG004|Post-Treatment Followup Period|Adverse Event|0|||
105443280|NCT03364309|363628788|FG005|Post-Treatment Followup Period|Adverse Event|0|||
105443281|NCT03364309|363628789|FG006|Post-Treatment Followup Period|Adverse Event|0|||
105443282|NCT03364309|363628790|FG007|Post-Treatment Followup Period|Adverse Event|0|||
105443283|NCT03364309|363628791|FG008|Post-Treatment Followup Period|Adverse Event|0|||
105443284|NCT03364309|363628792|FG009|Post-Treatment Followup Period|Adverse Event|0|||
105443285|NCT03364309|363628793|FG010|Post-Treatment Followup Period|Adverse Event|0|||
105443286|NCT03364309|363628794|FG011|Post-Treatment Followup Period|Adverse Event|0|||
105443287|NCT03364309|363628795|FG012|Post-Treatment Followup Period|Adverse Event|0|||
105443288|NCT03364309|363628796|FG013|Post-Treatment Followup Period|Adverse Event|0|||
105443289|NCT03364309|363628797|FG014|Post-Treatment Followup Period|Adverse Event|0|||
105443290|NCT03364309|363628798|FG015|Post-Treatment Followup Period|Adverse Event|0|||
105443291|NCT03364309|363628799|FG016|Post-Treatment Followup Period|Adverse Event|2|||
105443292|NCT03364309|363628800|FG017|Post-Treatment Followup Period|Adverse Event|6|||
105443293|NCT03364309|363628801|FG018|Post-Treatment Followup Period|Adverse Event|1|||
105443294|NCT03364309|363628783|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443295|NCT03364309|363628784|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443296|NCT03364309|363628785|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443297|NCT03364309|363628786|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443298|NCT03364309|363628787|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443299|NCT03364309|363628788|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443300|NCT03364309|363628789|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443301|NCT03364309|363628790|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443302|NCT03364309|363628791|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443303|NCT03364309|363628792|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443304|NCT03364309|363628793|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443305|NCT03364309|363628794|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443306|NCT03364309|363628795|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443307|NCT03364309|363628796|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443308|NCT03364309|363628797|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443309|NCT03364309|363628798|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443310|NCT03364309|363628799|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443311|NCT03364309|363628800|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
105443312|NCT03364309|363628801|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
105443313|NCT03364309|363628783|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
105443314|NCT03364309|363628784|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
105779384|NCT00386152|364844741|FG001|Overall Study|Chang from original chemo stratification|5|||
105335721|NCT02553499|363230066|FG011|Overall Study|Withdrawal by Subject|0|||
105335722|NCT02553499|363230067|FG012|Overall Study|Withdrawal by Subject|0|||
105335723|NCT02553499|363230068|FG013|Overall Study|Withdrawal by Subject|0|||
105335724|NCT00582608|363230069|FG000|Overall Study|Not Treated|7|||
105335725|NCT00582608|363230069|FG000|Overall Study|Patient Ineligible|1|||
105335726|NCT00582608|363230069|FG000|Overall Study|Lack of accrual|4|||
105335727|NCT04152837|363230070|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
105335728|NCT04152837|363230070|FG000|Maintenance Period|Adverse Event|1|||
105335729|NCT04152837|363230070|FG000|Maintenance Period|Withdrawal by Subject|1|||
105335730|NCT04152837|363230070|FG000|Maintenance Period|Sponsor Termination of Study|2|||
105335731|NCT01186692|363230071|FG000|Overall Study|Not Catheterized|11|||
105335732|NCT01186692|363230071|FG000|Overall Study|Futher testing contraindicated implant|19|||
105335733|NCT01186692|363230071|FG000|Overall Study|Adverse Event|2|||
105335734|NCT01668173|363230075|FG000|Overall Study|Adverse Event|3|||
105335735|NCT01668173|363230075|FG000|Overall Study|Trial suspension|4|||
105335736|NCT03386994|363230080|FG000|Overall Study|Lung transplant|1|||
105335737|NCT03386994|363230080|FG000|Overall Study|Adverse Event|14|||
105335738|NCT03386994|363230080|FG000|Overall Study|Lost to Follow-up|4|||
105335739|NCT03386994|363230080|FG000|Overall Study|Withdrawal by Subject|3|||
105335740|NCT03386994|363230080|FG000|Overall Study|Death|16|||
105335741|NCT00686829|363230081|FG000|Overall Study|Adverse Event|5|||
105335742|NCT00686829|363230081|FG000|Overall Study|Lack of Efficacy|6|||
105335743|NCT00686829|363230081|FG000|Overall Study|Lost to Follow-up|4|||
105335744|NCT00686829|363230081|FG000|Overall Study|Withdrawal by Subject|14|||
105335745|NCT00686829|363230081|FG000|Overall Study|Protocol Violation|3|||
105335746|NCT00686829|363230081|FG000|Overall Study|Sponsor discontinued VCV|47|||
105335747|NCT01827267|363230082|FG000|Overall Study|Did not receive study drug|1|||
105335748|NCT01827267|363230083|FG001|Overall Study|Did not receive study drug|1|||
105335749|NCT01827267|363230082|FG000|Overall Study|Physician Decision|1|||
105335750|NCT01827267|363230083|FG001|Overall Study|Physician Decision|0|||
105335751|NCT01827267|363230082|FG000|Overall Study|Disease Progression|1|||
105335752|NCT01827267|363230083|FG001|Overall Study|Disease Progression|1|||
105335753|NCT01827267|363230082|FG000|Overall Study|Sponsor Discontinued Study|2|||
105335754|NCT01827267|363230083|FG001|Overall Study|Sponsor Discontinued Study|8|||
105335755|NCT01827267|363230082|FG000|Overall Study|Still on study|0|||
105335756|NCT01827267|363230083|FG001|Overall Study|Still on study|2|||
105335757|NCT03226769|363230084|FG000|Overall Study|Withdrawal by Subject|0|||
105335758|NCT03226769|363230085|FG001|Overall Study|Withdrawal by Subject|1|||
105335759|NCT02640677|363230088|FG000|Overall Study|Lost to Follow-up|1|||
105335760|NCT02640677|363230088|FG000|Overall Study|Withdrawal by Subject|1|||
105335761|NCT00877487|363230089|FG000|Open-label Treatment Phase|Adverse Event|1|||
105335762|NCT00877487|363230090|FG001|Open-label Treatment Phase|Adverse Event|0|||
105335763|NCT00877487|363230089|FG000|Open-label Treatment Phase|Protocol Violation|3|||
105335764|NCT00877487|363230090|FG001|Open-label Treatment Phase|Protocol Violation|0|||
105335765|NCT00877487|363230089|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
105335766|NCT00877487|363230090|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
105335767|NCT00877487|363230089|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
105335768|NCT00877487|363230090|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
105335769|NCT00877487|363230089|FG000|Open-label Treatment Phase|Out of country for business|1|||
105335770|NCT00877487|363230090|FG001|Open-label Treatment Phase|Out of country for business|0|||
105335771|NCT00877487|363230089|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
105335772|NCT00877487|363230090|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
105335773|NCT00877487|363230089|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
105335774|NCT00877487|363230090|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
105335775|NCT00877487|363230089|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
105335776|NCT00877487|363230090|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
105335777|NCT00877487|363230089|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
105335778|NCT00877487|363230090|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
105335779|NCT03070002|363230091|FG000|Follow up for 2 Years|Death|1|||
105335780|NCT04553471|363230094|FG000|Overall Study|Did not start treatment on protocol|3|||
105335781|NCT04553471|363230094|FG000|Overall Study|Death|1|||
105335782|NCT02702388|363230095|FG000|Overall Study|Disease Progression|18|||
105335783|NCT02702388|363230096|FG001|Overall Study|Disease Progression|25|||
105335784|NCT02702388|363230095|FG000|Overall Study|Withdrawal by Subject|9|||
105335785|NCT02702388|363230096|FG001|Overall Study|Withdrawal by Subject|7|||
105335786|NCT02702388|363230095|FG000|Overall Study|Adverse Event|11|||
105335787|NCT02702388|363230096|FG001|Overall Study|Adverse Event|15|||
105335788|NCT02702388|363230095|FG000|Overall Study|Other|2|||
105335789|NCT02702388|363230096|FG001|Overall Study|Other|4|||
105335790|NCT01217476|363230106|FG000|Overall Study|Adverse Event|6|||
105335791|NCT01217476|363230107|FG001|Overall Study|Adverse Event|1|||
105335792|NCT01217476|363230106|FG000|Overall Study|Physician Decision|0|||
105335793|NCT01217476|363230107|FG001|Overall Study|Physician Decision|1|||
105335794|NCT01217476|363230106|FG000|Overall Study|Withdrawal by Subject|3|||
105335795|NCT01217476|363230107|FG001|Overall Study|Withdrawal by Subject|3|||
105443315|NCT03364309|363628785|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
105443316|NCT03364309|363628786|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
105443317|NCT03364309|363628787|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
105443318|NCT03364309|363628788|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
105443319|NCT03364309|363628789|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
105443320|NCT03364309|363628790|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
105443321|NCT03364309|363628791|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
105443322|NCT03364309|363628792|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
105443323|NCT03364309|363628793|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
105443324|NCT03364309|363628794|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
105443325|NCT03364309|363628795|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
105443326|NCT03364309|363628796|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
105443327|NCT03364309|363628797|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
105443328|NCT03364309|363628798|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
105443329|NCT03364309|363628799|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
105443330|NCT03364309|363628800|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
105443331|NCT03364309|363628801|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
105443332|NCT03477838|363628802|FG000|Overall Study|Lost to Follow-up|14|||
105443333|NCT02519595|363628804|FG000|Overall Study|Protocol Violation|8|||
105443334|NCT02519595|363628805|FG001|Overall Study|Protocol Violation|22|||
105443335|NCT02519595|363628806|FG002|Overall Study|Protocol Violation|16|||
105443336|NCT00850538|363628807|FG000|Overall Study|unable/unwilling to complete MRI|13|||
105443337|NCT00850538|363628807|FG000|Overall Study|specimen missed due to scheduling error|14|||
105443338|NCT00850538|363628807|FG000|Overall Study|specimen unusable|7|||
105443339|NCT00850538|363628807|FG000|Overall Study|Withdrawal by Subject|3|||
105443340|NCT00850538|363628807|FG000|Overall Study|radiology error|2|||
105443341|NCT00850538|363628807|FG000|Overall Study|Protocol Violation|2|||
105443342|NCT00615992|363628810|FG000|Overall Study|Protocol Violation|67|||
105443343|NCT00167310|363628816|FG000|Overall Study|Protocol Violation|5|||
105443344|NCT00167310|363628817|FG001|Overall Study|Protocol Violation|3|||
105443345|NCT00167310|363628816|FG000|Overall Study|Withdrawal by Subject|3|||
105443346|NCT00167310|363628817|FG001|Overall Study|Withdrawal by Subject|7|||
105443347|NCT03188510|363628818|FG000|Overall Study|Inappropriate behavior with site staff|0|||
105443348|NCT03188510|363628819|FG001|Overall Study|Inappropriate behavior with site staff|1|||
105443349|NCT03188510|363628820|FG002|Overall Study|Inappropriate behavior with site staff|0|||
105443350|NCT03319212|363628822|FG000|Overall Study|Discontinued as moving out of local area|0|||
105443351|NCT03319212|363628823|FG001|Overall Study|Discontinued as moving out of local area|1|||
105443352|NCT03319212|363628822|FG000|Overall Study|Adverse Event|2|||
105443353|NCT03319212|363628823|FG001|Overall Study|Adverse Event|2|||
105443354|NCT03319212|363628822|FG000|Overall Study|Withdrawal by Subject|0|||
105443355|NCT03319212|363628823|FG001|Overall Study|Withdrawal by Subject|1|||
105443356|NCT03319212|363628822|FG000|Overall Study|Lost to Follow-up|0|||
105443357|NCT03319212|363628823|FG001|Overall Study|Lost to Follow-up|1|||
105443358|NCT03319212|363628822|FG000|Overall Study|Physician Decision|1|||
105443359|NCT03319212|363628823|FG001|Overall Study|Physician Decision|0|||
105443360|NCT01088399|363628824|FG000|Overall Study|Adverse Event|211|||
105443361|NCT01088399|363628825|FG001|Overall Study|Adverse Event|16|||
105443362|NCT01088399|363628826|FG002|Overall Study|Adverse Event|0|||
105443363|NCT01088399|363628824|FG000|Overall Study|Death|204|||
105443364|NCT01088399|363628825|FG001|Overall Study|Death|45|||
105443365|NCT01088399|363628826|FG002|Overall Study|Death|0|||
105443366|NCT01088399|363628824|FG000|Overall Study|Lack of Efficacy|298|||
105443367|NCT01088399|363628825|FG001|Overall Study|Lack of Efficacy|7|||
105443368|NCT01088399|363628826|FG002|Overall Study|Lack of Efficacy|5|||
105443369|NCT01088399|363628824|FG000|Overall Study|Lost to Follow-up|1070|||
105443370|NCT01088399|363628825|FG001|Overall Study|Lost to Follow-up|278|||
105443371|NCT01088399|363628826|FG002|Overall Study|Lost to Follow-up|58|||
105443372|NCT01088399|363628824|FG000|Overall Study|Physician Decision|531|||
105443373|NCT01088399|363628825|FG001|Overall Study|Physician Decision|88|||
105443374|NCT01088399|363628826|FG002|Overall Study|Physician Decision|16|||
105443375|NCT01088399|363628824|FG000|Overall Study|Withdrawal by Subject|544|||
105443376|NCT01088399|363628825|FG001|Overall Study|Withdrawal by Subject|195|||
105443377|NCT01088399|363628826|FG002|Overall Study|Withdrawal by Subject|33|||
105443378|NCT01088399|363628824|FG000|Overall Study|Change to or start of somatropin therapy|234|||
105443379|NCT01088399|363628825|FG001|Overall Study|Change to or start of somatropin therapy|17|||
105443380|NCT01088399|363628826|FG002|Overall Study|Change to or start of somatropin therapy|12|||
105779385|NCT00386152|364844742|FG002|Overall Study|Chang from original chemo stratification|6|||
105443381|NCT01088399|363628824|FG000|Overall Study|Sponsor decision|1573|||
105443382|NCT01088399|363628825|FG001|Overall Study|Sponsor decision|298|||
105443383|NCT01088399|363628826|FG002|Overall Study|Sponsor decision|7|||
105443384|NCT01088399|363628824|FG000|Overall Study|Protocol Violation|10|||
105443385|NCT01088399|363628825|FG001|Overall Study|Protocol Violation|1|||
105443386|NCT01088399|363628826|FG002|Overall Study|Protocol Violation|0|||
105443387|NCT01088399|363628824|FG000|Overall Study|Enrollment criteria not met|48|||
105443388|NCT01088399|363628825|FG001|Overall Study|Enrollment criteria not met|119|||
105443389|NCT01088399|363628826|FG002|Overall Study|Enrollment criteria not met|70|||
105443390|NCT01088399|363628824|FG000|Overall Study|Study summary visit not completed|2398|||
105443391|NCT01088399|363628825|FG001|Overall Study|Study summary visit not completed|283|||
105443392|NCT01088399|363628826|FG002|Overall Study|Study summary visit not completed|80|||
105443393|NCT00042991|363628829|FG000|Overall Study|Adverse Event|1|||
105443394|NCT00042991|363628830|FG001|Overall Study|Adverse Event|4|||
105443395|NCT00042991|363628831|FG002|Overall Study|Adverse Event|2|||
105443396|NCT00042991|363628832|FG003|Overall Study|Adverse Event|0|||
105443397|NCT00042991|363628833|FG004|Overall Study|Adverse Event|0|||
105443398|NCT00042991|363628834|FG005|Overall Study|Adverse Event|1|||
105443399|NCT00042991|363628835|FG006|Overall Study|Adverse Event|0|||
105443400|NCT00042991|363628829|FG000|Overall Study|Withdrawal by Subject|0|||
105443401|NCT00042991|363628830|FG001|Overall Study|Withdrawal by Subject|7|||
105443402|NCT00042991|363628831|FG002|Overall Study|Withdrawal by Subject|2|||
105443403|NCT00042991|363628832|FG003|Overall Study|Withdrawal by Subject|0|||
105443404|NCT00042991|363628833|FG004|Overall Study|Withdrawal by Subject|1|||
105443405|NCT00042991|363628834|FG005|Overall Study|Withdrawal by Subject|0|||
105443406|NCT00042991|363628835|FG006|Overall Study|Withdrawal by Subject|0|||
105443407|NCT00042991|363628829|FG000|Overall Study|Disease Progression|5|||
105443408|NCT00042991|363628830|FG001|Overall Study|Disease Progression|29|||
105443409|NCT00042991|363628831|FG002|Overall Study|Disease Progression|2|||
105443410|NCT00042991|363628832|FG003|Overall Study|Disease Progression|2|||
105443411|NCT00042991|363628833|FG004|Overall Study|Disease Progression|1|||
105443412|NCT00042991|363628834|FG005|Overall Study|Disease Progression|4|||
105443413|NCT00042991|363628835|FG006|Overall Study|Disease Progression|2|||
105443414|NCT00042991|363628829|FG000|Overall Study|Alternative Therapy|0|||
105443415|NCT00042991|363628830|FG001|Overall Study|Alternative Therapy|0|||
105443416|NCT00042991|363628831|FG002|Overall Study|Alternative Therapy|0|||
105443417|NCT00042991|363628832|FG003|Overall Study|Alternative Therapy|0|||
105443418|NCT00042991|363628833|FG004|Overall Study|Alternative Therapy|1|||
105443419|NCT00042991|363628834|FG005|Overall Study|Alternative Therapy|0|||
105443420|NCT00042991|363628835|FG006|Overall Study|Alternative Therapy|0|||
105443421|NCT01153724|363628840|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105443422|NCT01153724|363628840|FG000|Treatment Period 2|Adverse Event|1|||
105443423|NCT01153724|363628840|FG000|Treatment Period 2|Other reason not defined above|1|||
105443424|NCT02697435|363628845|FG000|Overall Study|Withdrawal by Subject|1|||
105443425|NCT02697435|363628846|FG001|Overall Study|Withdrawal by Subject|0|||
105443426|NCT02697435|363628845|FG000|Overall Study|Physician Decision|0|||
105443427|NCT02697435|363628846|FG001|Overall Study|Physician Decision|4|||
105443428|NCT00367835|363628847|FG000|Overall Study|Adverse Event|14|||
105443429|NCT00367835|363628848|FG001|Overall Study|Adverse Event|1|||
105443430|NCT00367835|363628847|FG000|Overall Study|Protocol Violation|1|||
105443431|NCT00367835|363628848|FG001|Overall Study|Protocol Violation|7|||
105443432|NCT00367835|363628847|FG000|Overall Study|Withdrawal by Subject|7|||
105443433|NCT00367835|363628848|FG001|Overall Study|Withdrawal by Subject|6|||
105443434|NCT00367835|363628847|FG000|Overall Study|Lost to Follow-up|1|||
105443435|NCT00367835|363628848|FG001|Overall Study|Lost to Follow-up|4|||
105443436|NCT00367835|363628847|FG000|Overall Study|Lack of Efficacy|3|||
105443437|NCT00367835|363628848|FG001|Overall Study|Lack of Efficacy|12|||
105443438|NCT00367835|363628847|FG000|Overall Study|Subject in juvenile detention center|1|||
105443439|NCT00367835|363628848|FG001|Overall Study|Subject in juvenile detention center|0|||
105443440|NCT00367835|363628847|FG000|Overall Study|refused blood collection|1|||
105443441|NCT00367835|363628848|FG001|Overall Study|refused blood collection|0|||
105443442|NCT00367835|363628847|FG000|Overall Study|Did not respond to calls|1|||
105443443|NCT00367835|363628848|FG001|Overall Study|Did not respond to calls|0|||
105443444|NCT00367835|363628847|FG000|Overall Study|History of lead poisoning|0|||
105443445|NCT00367835|363628848|FG001|Overall Study|History of lead poisoning|1|||
105443446|NCT04371666|363628855|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
105443447|NCT04371666|363628856|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
105443448|NCT04371666|363628855|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
105443449|NCT04371666|363628856|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
105443450|NCT04371666|363628855|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
105443451|NCT04371666|363628856|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
105443452|NCT04371666|363628855|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
105443453|NCT04371666|363628856|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
105443454|NCT04371666|363628855|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
105443455|NCT04371666|363628856|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
105443456|NCT04371666|363628855|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
105443457|NCT04371666|363628856|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
105443458|NCT01445080|363628869|FG000|Overall Study|Adverse Event|5|||
105443459|NCT01445080|363628870|FG001|Overall Study|Adverse Event|3|||
105443460|NCT01445080|363628871|FG002|Overall Study|Adverse Event|11|||
105443461|NCT01445080|363628872|FG003|Overall Study|Adverse Event|6|||
105443462|NCT01445080|363628873|FG004|Overall Study|Adverse Event|2|||
105443463|NCT01445080|363628874|FG005|Overall Study|Adverse Event|3|||
105443464|NCT01445080|363628875|FG006|Overall Study|Adverse Event|0|||
105443465|NCT01445080|363628876|FG007|Overall Study|Adverse Event|3|||
105443466|NCT01445080|363628877|FG008|Overall Study|Adverse Event|10|||
105443467|NCT01445080|363628869|FG000|Overall Study|Physician Decision|0|||
105443468|NCT01445080|363628870|FG001|Overall Study|Physician Decision|0|||
105443469|NCT01445080|363628871|FG002|Overall Study|Physician Decision|1|||
105443470|NCT01445080|363628872|FG003|Overall Study|Physician Decision|0|||
105443471|NCT01445080|363628873|FG004|Overall Study|Physician Decision|0|||
105443472|NCT01445080|363628874|FG005|Overall Study|Physician Decision|3|||
105443473|NCT01445080|363628875|FG006|Overall Study|Physician Decision|2|||
105443474|NCT01445080|363628876|FG007|Overall Study|Physician Decision|2|||
105443475|NCT01445080|363628877|FG008|Overall Study|Physician Decision|0|||
105443476|NCT01445080|363628869|FG000|Overall Study|Withdrawal by Subject|1|||
105443477|NCT01445080|363628870|FG001|Overall Study|Withdrawal by Subject|0|||
105443478|NCT01445080|363628871|FG002|Overall Study|Withdrawal by Subject|0|||
105443479|NCT01445080|363628872|FG003|Overall Study|Withdrawal by Subject|1|||
105443480|NCT01445080|363628873|FG004|Overall Study|Withdrawal by Subject|0|||
105443481|NCT01445080|363628874|FG005|Overall Study|Withdrawal by Subject|0|||
105443482|NCT01445080|363628875|FG006|Overall Study|Withdrawal by Subject|0|||
105443483|NCT01445080|363628876|FG007|Overall Study|Withdrawal by Subject|0|||
105443484|NCT01445080|363628877|FG008|Overall Study|Withdrawal by Subject|2|||
105443485|NCT01445080|363628869|FG000|Overall Study|Ineligible/Inevaluable|1|||
105443486|NCT01445080|363628870|FG001|Overall Study|Ineligible/Inevaluable|2|||
105443487|NCT01445080|363628871|FG002|Overall Study|Ineligible/Inevaluable|0|||
105443488|NCT01445080|363628872|FG003|Overall Study|Ineligible/Inevaluable|1|||
105443489|NCT01445080|363628873|FG004|Overall Study|Ineligible/Inevaluable|2|||
105443490|NCT01445080|363628874|FG005|Overall Study|Ineligible/Inevaluable|3|||
105443491|NCT01445080|363628875|FG006|Overall Study|Ineligible/Inevaluable|0|||
105443492|NCT01445080|363628876|FG007|Overall Study|Ineligible/Inevaluable|0|||
105443493|NCT01445080|363628877|FG008|Overall Study|Ineligible/Inevaluable|6|||
105443494|NCT03887221|363628878|FG000|Overall Study|Protocol Violation|1|||
105443495|NCT03887221|363628879|FG001|Overall Study|Protocol Violation|0|||
105443496|NCT03228212|363628881|FG000|Period 1|Adverse Event|1|||
105443497|NCT03228212|363628882|FG001|Period 1|Adverse Event|0|||
105443498|NCT03228212|363628881|FG000|Period 1|no longer meets eligibility criteria|0|||
105443499|NCT03228212|363628882|FG001|Period 1|no longer meets eligibility criteria|1|||
105443500|NCT03228212|363628881|FG000|Period 2|Lost to Follow-up|1|||
105443501|NCT03228212|363628882|FG001|Period 2|Lost to Follow-up|0|||
105443502|NCT00934128|363628883|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
105443503|NCT00934128|363628884|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
105443504|NCT00934128|363628883|FG000|First Intervention (2 Hours)|Adverse Event|4|||
105443505|NCT00934128|363628884|FG001|First Intervention (2 Hours)|Adverse Event|1|||
105443506|NCT00934128|363628883|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
105443507|NCT00934128|363628884|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
105443508|NCT00934128|363628883|FG000|Washout Period (1 Hour)|Patient preference|1|||
105443509|NCT00934128|363628884|FG001|Washout Period (1 Hour)|Patient preference|3|||
105443510|NCT00934128|363628883|FG000|Washout Period (1 Hour)|Pain|1|||
105443511|NCT00934128|363628884|FG001|Washout Period (1 Hour)|Pain|0|||
105443512|NCT00934128|363628883|FG000|Washout Period (1 Hour)|Too tired|1|||
105443513|NCT00934128|363628884|FG001|Washout Period (1 Hour)|Too tired|0|||
105443514|NCT00934128|363628883|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
105443515|NCT00934128|363628884|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
105443516|NCT00934128|363628883|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
105443517|NCT00934128|363628884|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
105443518|NCT00872599|363629958|FG000|Second Washout Period|Adverse Event|1|||
105443519|NCT00872599|363629959|FG001|Second Washout Period|Adverse Event|1|||
105443520|NCT00732875|363629962|FG000|Overall Study|Adverse Event|16|||
105443521|NCT00732875|363629962|FG000|Overall Study|Withdrawal by Subject|6|||
105443522|NCT00732875|363629962|FG000|Overall Study|Lack of Efficacy|13|||
105443523|NCT00546000|363629964|FG000|Overall Study|Adverse Event|1|||
105443524|NCT00546000|363629964|FG000|Overall Study|Lost to Follow-up|1|||
105443525|NCT00546000|363629964|FG000|Overall Study|Baseline HPA Axis Supression|2|||
105443526|NCT02630472|363629965|FG000|Overall Study|Physician Decision|10|||
105443527|NCT02630472|363629966|FG001|Overall Study|Physician Decision|0|||
105443528|NCT02828436|363629967|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
105443529|NCT02828436|363629968|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
105443530|NCT02828436|363629967|FG000|Period 1|Lost to Follow-up|0|||
105443531|NCT02828436|363629968|FG001|Period 1|Lost to Follow-up|1|||
105443532|NCT02828436|363629967|FG000|Period 2|Withdrawal by Subject|4|||
105443533|NCT02828436|363629968|FG001|Period 2|Withdrawal by Subject|0|||
105443534|NCT02828436|363629967|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
105443535|NCT02828436|363629968|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
105443536|NCT02828436|363629967|FG000|Period 2|Lost to Follow-up|1|||
105443537|NCT02828436|363629968|FG001|Period 2|Lost to Follow-up|0|||
105443538|NCT04426318|363629977|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
105779386|NCT00386152|364844740|FG000|Overall Study|Death|3|||
105443539|NCT04426318|363629978|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
105443540|NCT03781778|363629983|FG000|Overall Study|Withdrawal by Subject|2|||
105443541|NCT03781778|363629984|FG001|Overall Study|Withdrawal by Subject|2|||
105443542|NCT02287467|363629985|FG000|Overall Study|Protocol Violation|12|||
105443543|NCT02287467|363629986|FG001|Overall Study|Protocol Violation|9|||
105443544|NCT03755882|363629989|FG000|Period 1|Protocol Violation|1|||
105443545|NCT03755882|363629990|FG001|Period 1|Protocol Violation|0|||
105443546|NCT03755882|363629989|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
105443547|NCT03755882|363629990|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
105443548|NCT02292446|363629991|FG000|Overall Study|Adverse Event|12|||
105443549|NCT02292446|363629991|FG000|Overall Study|Death|1|||
105443550|NCT02292446|363629991|FG000|Overall Study|Disease progression|2|||
105443551|NCT02292446|363629991|FG000|Overall Study|Subject/guardian decision|2|||
105443552|NCT02292446|363629991|FG000|Overall Study|Withdrawal by Subject|3|||
105443553|NCT03386487|363629993|FG000|Overall Study|Lost to Follow-up|5|||
105443554|NCT03386487|363629994|FG001|Overall Study|Lost to Follow-up|6|||
105443555|NCT03386487|363629993|FG000|Overall Study|Withdrawal by Subject|11|||
105443556|NCT03386487|363629994|FG001|Overall Study|Withdrawal by Subject|7|||
105443557|NCT03386487|363629993|FG000|Overall Study|Physician Decision|11|||
105443558|NCT03386487|363629994|FG001|Overall Study|Physician Decision|8|||
105443559|NCT03534141|363629995|FG000|Overall Study|Enrolled in other clinical trial|1|||
105443560|NCT03534141|363629996|FG001|Overall Study|Enrolled in other clinical trial|0|||
105443561|NCT03534141|363629995|FG000|Overall Study|Liver transplant aborted after randomization|0|||
105443562|NCT03534141|363629996|FG001|Overall Study|Liver transplant aborted after randomization|2|||
105443563|NCT03534141|363629995|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
105443564|NCT03534141|363629996|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
105443565|NCT06136897|363629997|FG000|Overall Study|Ineligible|3|||
105443566|NCT06136897|363629997|FG000|Overall Study|Mutation status not confirmed|7|||
105443567|NCT06136897|363629997|FG000|Overall Study|Adverse Event|2|||
105443568|NCT06136897|363629997|FG000|Overall Study|Death|1|||
105443569|NCT06136897|363629997|FG000|Overall Study|Disease progression|18|||
105443570|NCT06136897|363629997|FG000|Overall Study|Other complicating disease|1|||
105443571|NCT06136897|363629997|FG000|Overall Study|Withdrawal by Subject|1|||
105443572|NCT06136897|363629997|FG000|Overall Study|Still on treatment|1|||
105443573|NCT06136897|363629997|FG000|Overall Study|Lost to Follow-up|1|||
105443574|NCT00195091|363629998|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
105443575|NCT00239928|363629999|FG000|Overall Study|Lack of Efficacy|1|||
105443576|NCT00239928|363629999|FG000|Overall Study|Adverse Event|4|||
105443577|NCT00239928|363629999|FG000|Overall Study|Not need to continue study|3|||
105443578|NCT00239928|363629999|FG000|Overall Study|Withdrawal by Subject|2|||
105443579|NCT01067144|363630002|FG000|Treatment|Did not receive allocated intervention|4|||
105443580|NCT01067144|363630003|FG001|Treatment|Did not receive allocated intervention|7|||
105443581|NCT01067144|363630002|FG000|Follow-up|Lost to Follow-up|22|||
105443582|NCT01067144|363630003|FG001|Follow-up|Lost to Follow-up|12|||
105443583|NCT01067144|363630002|FG000|Follow-up|Censored owing to second surgery|19|||
105443584|NCT01067144|363630003|FG001|Follow-up|Censored owing to second surgery|28|||
105443585|NCT01067144|363630002|FG000|Follow-up|Withdrawal by Subject|18|||
105443586|NCT01067144|363630003|FG001|Follow-up|Withdrawal by Subject|14|||
105443587|NCT01067144|363630002|FG000|Follow-up|Surgery cancelled|0|||
105443588|NCT01067144|363630003|FG001|Follow-up|Surgery cancelled|1|||
105443589|NCT01067144|363630002|FG000|Follow-up|Death|0|||
105443590|NCT01067144|363630003|FG001|Follow-up|Death|1|||
105443591|NCT00203424|363630005|FG000|Treatment Period|Withdrawal by Subject|4|||
105443592|NCT00203424|363630005|FG000|Treatment Period|Adverse Event|5|||
105443593|NCT00203424|363630005|FG000|Treatment Period|progressive disease|2|||
105443594|NCT00203424|363630005|FG000|Follow-up Period|Withdrawal by Subject|1|||
105443595|NCT00203424|363630005|FG000|Follow-up Period|progressive disease|4|||
105443596|NCT00203424|363630005|FG000|Follow-up Period|Lost to Follow-up|1|||
105443597|NCT00555672|363630006|FG000|Overall Study|Death|0|||
105443598|NCT00555672|363630007|FG001|Overall Study|Death|2|||
105443599|NCT00555672|363630006|FG000|Overall Study|Adverse Event|8|||
105443600|NCT00555672|363630007|FG001|Overall Study|Adverse Event|2|||
105443601|NCT00555672|363630006|FG000|Overall Study|Objective progression or relapse|11|||
105443602|NCT00555672|363630007|FG001|Overall Study|Objective progression or relapse|5|||
105443603|NCT00555672|363630006|FG000|Overall Study|Other|3|||
105443604|NCT00555672|363630007|FG001|Overall Study|Other|1|||
105443605|NCT00555672|363630006|FG000|Overall Study|Participant refused|2|||
105443606|NCT00555672|363630007|FG001|Overall Study|Participant refused|0|||
105443607|NCT01053988|363630008|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
105443608|NCT01053988|363630009|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105443609|NCT01053988|363630010|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105443610|NCT01053988|363630011|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105443611|NCT01053988|363630012|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105443612|NCT01053988|363630013|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105443613|NCT01053988|363630008|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
105443614|NCT01053988|363630009|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
105443615|NCT01053988|363630010|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
105443616|NCT01053988|363630011|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
105443617|NCT01053988|363630012|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
105443618|NCT01053988|363630013|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
105443619|NCT01053988|363630008|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
105443620|NCT01053988|363630009|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105443621|NCT01053988|363630010|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105443622|NCT01053988|363630011|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105443623|NCT01053988|363630012|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105443624|NCT01053988|363630013|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105443625|NCT01053988|363630008|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
105443626|NCT01053988|363630009|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
105443627|NCT01053988|363630010|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
105443628|NCT01053988|363630011|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
105443629|NCT01053988|363630012|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
105443630|NCT01053988|363630013|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
105443631|NCT01053988|363630008|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
105443632|NCT01053988|363630009|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
105443633|NCT01053988|363630010|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
105443634|NCT01053988|363630011|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
105443635|NCT01053988|363630012|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
105443636|NCT01053988|363630013|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
105443637|NCT01053988|363630008|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
105443638|NCT01053988|363630009|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105443639|NCT01053988|363630010|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105443640|NCT01053988|363630011|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105443641|NCT01053988|363630012|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105443642|NCT01053988|363630013|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105443643|NCT01053988|363630008|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
105443644|NCT01053988|363630009|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
105443645|NCT01053988|363630010|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
105443646|NCT01053988|363630011|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
105443647|NCT01053988|363630012|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
105443648|NCT01053988|363630013|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
105443649|NCT01053988|363630008|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
105443650|NCT01053988|363630009|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
105443651|NCT01053988|363630010|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
105443652|NCT01053988|363630011|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
105443653|NCT01053988|363630012|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
105443654|NCT01053988|363630013|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
105443655|NCT01053988|363630008|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
105443656|NCT01053988|363630009|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
105443657|NCT01053988|363630010|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
105443658|NCT01053988|363630011|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
105443659|NCT01053988|363630012|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
105443660|NCT01053988|363630013|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
105443661|NCT01053988|363630008|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
105443662|NCT01053988|363630009|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
105443663|NCT01053988|363630010|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
105443664|NCT01053988|363630011|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
105443665|NCT01053988|363630012|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
105443666|NCT01053988|363630013|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
105443667|NCT01053988|363630008|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
105443668|NCT01053988|363630009|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
105443669|NCT01053988|363630010|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
105443670|NCT01053988|363630011|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
105443671|NCT01053988|363630012|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
105443672|NCT01053988|363630013|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
105443673|NCT01053988|363630008|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105779387|NCT00386152|364844741|FG001|Overall Study|Death|0|||
105779388|NCT00386152|364844742|FG002|Overall Study|Death|1|||
105779389|NCT00386152|364844740|FG000|Overall Study|Disease progression|7|||
105443674|NCT01053988|363630009|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
105443675|NCT01053988|363630010|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105443676|NCT01053988|363630011|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
105443677|NCT01053988|363630012|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
105443678|NCT01053988|363630013|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
105443679|NCT01053988|363630008|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
105443680|NCT01053988|363630009|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
105443681|NCT01053988|363630010|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
105443682|NCT01053988|363630011|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
105443683|NCT01053988|363630012|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
105443684|NCT01053988|363630013|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
105443685|NCT01053988|363630008|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
105443686|NCT01053988|363630009|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
105443687|NCT01053988|363630010|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
105443688|NCT01053988|363630011|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
105443689|NCT01053988|363630012|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
105443690|NCT01053988|363630013|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
105443691|NCT01415401|363630020|FG000|Overall Study|Adverse Event|5|||
105443692|NCT01415401|363630020|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
105443693|NCT01415401|363630020|FG000|Overall Study|Terminated by Sponsor|1|||
105443694|NCT01824355|363630021|FG000|Overall Study|Adverse Event|2|||
105443695|NCT01824355|363630021|FG000|Overall Study|unevaluable reference method results per|1|||
105443696|NCT02097030|363630023|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
105443697|NCT02097030|363630024|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
105443698|NCT02097030|363630023|FG000|First Intervention (3 Days)|Visual Acuity|0|||
105443699|NCT02097030|363630024|FG001|First Intervention (3 Days)|Visual Acuity|1|||
105443700|NCT01919801|363630025|FG000|Overall Study|Withdrawal by Subject|1|||
105443701|NCT01919801|363630026|FG001|Overall Study|Withdrawal by Subject|0|||
105443702|NCT01919801|363630025|FG000|Overall Study|Physician Decision|0|||
105443703|NCT01919801|363630026|FG001|Overall Study|Physician Decision|1|||
105443704|NCT01919801|363630025|FG000|Overall Study|Lost to Follow-up|0|||
105443705|NCT01919801|363630026|FG001|Overall Study|Lost to Follow-up|1|||
105443706|NCT01919801|363630025|FG000|Overall Study|Other|0|||
105443707|NCT01919801|363630026|FG001|Overall Study|Other|1|||
105443708|NCT01843062|363630027|FG000|Overall Study|Protocol Violation|1|||
105443709|NCT01843062|363630028|FG001|Overall Study|Protocol Violation|0|||
105443710|NCT01843062|363630027|FG000|Overall Study|New treatment following progression|2|||
105443711|NCT01843062|363630028|FG001|Overall Study|New treatment following progression|0|||
105443712|NCT01843062|363630027|FG000|Overall Study|Pregnancy|1|||
105443713|NCT01843062|363630028|FG001|Overall Study|Pregnancy|0|||
105443714|NCT01843062|363630027|FG000|Overall Study|Adverse Event|2|||
105443715|NCT01843062|363630028|FG001|Overall Study|Adverse Event|0|||
105443716|NCT01843062|363630027|FG000|Overall Study|Incorrect randomisation|1|||
105443717|NCT01843062|363630028|FG001|Overall Study|Incorrect randomisation|0|||
105443718|NCT01843062|363630027|FG000|Overall Study|Withdrawal by Subject|12|||
105443719|NCT01843062|363630028|FG001|Overall Study|Withdrawal by Subject|3|||
105443720|NCT01843062|363630027|FG000|Overall Study|Death|1|||
105443721|NCT01843062|363630028|FG001|Overall Study|Death|2|||
105443722|NCT01843062|363630027|FG000|Overall Study|Lost to Follow-up|2|||
105443723|NCT01843062|363630028|FG001|Overall Study|Lost to Follow-up|4|||
105443724|NCT00994422|363630029|FG000|Overall Study|Lost to Follow-up|7|||
105443725|NCT00994422|363630030|FG001|Overall Study|Lost to Follow-up|1|||
105443726|NCT01625000|363630031|FG000|Overall Study|Physician Decision|15|||
105443727|NCT01625000|363630032|FG001|Overall Study|Physician Decision|7|||
105443728|NCT01625000|363630033|FG002|Overall Study|Physician Decision|7|||
105443729|NCT01625000|363630034|FG003|Overall Study|Physician Decision|2|||
105443730|NCT01625000|363630035|FG004|Overall Study|Physician Decision|15|||
105443731|NCT01625000|363630031|FG000|Overall Study|Protocol Violation|3|||
105443732|NCT01625000|363630032|FG001|Overall Study|Protocol Violation|10|||
105443733|NCT01625000|363630033|FG002|Overall Study|Protocol Violation|4|||
105443734|NCT01625000|363630034|FG003|Overall Study|Protocol Violation|1|||
105443735|NCT01625000|363630035|FG004|Overall Study|Protocol Violation|2|||
105443736|NCT01625000|363630031|FG000|Overall Study|Withdrawal by Subject|19|||
105443737|NCT01625000|363630032|FG001|Overall Study|Withdrawal by Subject|16|||
105443738|NCT01625000|363630033|FG002|Overall Study|Withdrawal by Subject|11|||
105443739|NCT01625000|363630034|FG003|Overall Study|Withdrawal by Subject|9|||
105443740|NCT01625000|363630035|FG004|Overall Study|Withdrawal by Subject|17|||
105443741|NCT01625000|363630031|FG000|Overall Study|Adverse Event (including Death)|15|||
105443742|NCT01625000|363630032|FG001|Overall Study|Adverse Event (including Death)|19|||
105443743|NCT01625000|363630033|FG002|Overall Study|Adverse Event (including Death)|11|||
105443744|NCT01625000|363630034|FG003|Overall Study|Adverse Event (including Death)|7|||
105443745|NCT01625000|363630035|FG004|Overall Study|Adverse Event (including Death)|21|||
105779390|NCT00386152|364844741|FG001|Overall Study|Disease progression|4|||
105443746|NCT04346654|363630037|FG000|Overall Study|Adverse Event|2|||
105443747|NCT04346654|363630038|FG001|Overall Study|Adverse Event|0|||
105443748|NCT04346654|363630037|FG000|Overall Study|Non-response|1|||
105443749|NCT04346654|363630038|FG001|Overall Study|Non-response|1|||
105443750|NCT04346654|363630037|FG000|Overall Study|Withdrawal by Subject|2|||
105443751|NCT04346654|363630038|FG001|Overall Study|Withdrawal by Subject|0|||
105443752|NCT04346654|363630037|FG000|Overall Study|Lost to Follow-up|0|||
105443753|NCT04346654|363630038|FG001|Overall Study|Lost to Follow-up|1|||
105443754|NCT04346654|363630037|FG000|Overall Study|Pregnancy|0|||
105443755|NCT04346654|363630038|FG001|Overall Study|Pregnancy|1|||
105443756|NCT04929249|363630039|FG000|Overall Study|Adverse Event|2|||
105443757|NCT04929249|363630040|FG001|Overall Study|Adverse Event|1|||
105443758|NCT04929249|363630039|FG000|Overall Study|Death|2|||
105443759|NCT04929249|363630040|FG001|Overall Study|Death|1|||
105443760|NCT04929249|363630039|FG000|Overall Study|Lost to Follow-up|3|||
105443761|NCT04929249|363630040|FG001|Overall Study|Lost to Follow-up|11|||
105443762|NCT04929249|363630039|FG000|Overall Study|Technical problems|0|||
105443763|NCT04929249|363630040|FG001|Overall Study|Technical problems|1|||
105443764|NCT04929249|363630039|FG000|Overall Study|Subject decision|6|||
105443765|NCT04929249|363630040|FG001|Overall Study|Subject decision|8|||
105443766|NCT04929249|363630039|FG000|Overall Study|Withdrew consent|0|||
105443767|NCT04929249|363630040|FG001|Overall Study|Withdrew consent|8|||
105443768|NCT04677504|363630044|FG000|Overall Study|Death|51|||
105443769|NCT04677504|363630045|FG001|Overall Study|Death|49|||
105443770|NCT04677504|363630044|FG000|Overall Study|Progressive Disease|1|||
105443771|NCT04677504|363630045|FG001|Overall Study|Progressive Disease|0|||
105443772|NCT04677504|363630044|FG000|Overall Study|Symptomatic Deterioration|1|||
105443773|NCT04677504|363630045|FG001|Overall Study|Symptomatic Deterioration|0|||
105443774|NCT04677504|363630044|FG000|Overall Study|Withdrawal by Subject|2|||
105443775|NCT04677504|363630045|FG001|Overall Study|Withdrawal by Subject|5|||
105443776|NCT04677504|363630044|FG000|Overall Study|Study Terminated By Sponsor|28|||
105443777|NCT04677504|363630045|FG001|Overall Study|Study Terminated By Sponsor|24|||
105443778|NCT04677504|363630044|FG000|Overall Study|Adverse Event|0|||
105443779|NCT04677504|363630045|FG001|Overall Study|Adverse Event|1|||
105443780|NCT05513053|363630047|FG000|Overall Study|Lost to Follow-up|9|||
105443781|NCT05513053|363630048|FG001|Overall Study|Lost to Follow-up|11|||
105443782|NCT05513053|363630047|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105443783|NCT05513053|363630048|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105443784|NCT05513053|363630047|FG000|Overall Study|Withdrawal by Subject|2|||
105443785|NCT05513053|363630048|FG001|Overall Study|Withdrawal by Subject|9|||
105443786|NCT05513053|363630047|FG000|Overall Study|Protocol Violation|6|||
105443787|NCT05513053|363630048|FG001|Overall Study|Protocol Violation|3|||
105443788|NCT05513053|363630047|FG000|Overall Study|Adverse Event|0|||
105443789|NCT05513053|363630048|FG001|Overall Study|Adverse Event|2|||
105443790|NCT00166439|363630049|FG000|Overall Study|Ineligible|5|||
105443791|NCT01180296|363630050|FG000|Overall Study|Protocol Violation|1|||
105443792|NCT01180296|363630051|FG001|Overall Study|Protocol Violation|2|||
105443793|NCT03304873|363630052|FG000|Overall Study|Lost to Follow-up|1|||
105443794|NCT03304873|363630053|FG001|Overall Study|Lost to Follow-up|8|||
105443795|NCT01546688|363630054|FG000|Overall Study|Adverse Event|0|||
105443796|NCT01546688|363630055|FG001|Overall Study|Adverse Event|4|||
105443797|NCT01546688|363630054|FG000|Overall Study|Withdrawal by Subject|2|||
105443798|NCT01546688|363630055|FG001|Overall Study|Withdrawal by Subject|1|||
105443799|NCT01546688|363630054|FG000|Overall Study|Lack of Efficacy|1|||
105443800|NCT01546688|363630055|FG001|Overall Study|Lack of Efficacy|0|||
105443801|NCT03543137|363630058|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
105443802|NCT03543137|363630059|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
105443803|NCT03543137|363630058|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
105443804|NCT03543137|363630059|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
105443805|NCT03543137|363630058|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
105443806|NCT03543137|363630059|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
105443807|NCT01868477|363630060|FG000|Overall Study|Adverse Event|2|||
105443808|NCT01868477|363630061|FG001|Overall Study|Adverse Event|4|||
105443809|NCT01868477|363630060|FG000|Overall Study|Disease progression|1|||
105443810|NCT01868477|363630061|FG001|Overall Study|Disease progression|1|||
105443811|NCT01868477|363630060|FG000|Overall Study|Withdrawal by Subject|1|||
105443812|NCT01868477|363630061|FG001|Overall Study|Withdrawal by Subject|0|||
105443813|NCT01052077|363630062|FG000|Phase A|Lost to Follow-up|22|||
105443814|NCT01052077|363630063|FG001|Phase A|Lost to Follow-up|0|||
105443815|NCT01052077|363630064|FG002|Phase A|Lost to Follow-up|0|||
105443816|NCT01052077|363630065|FG003|Phase A|Lost to Follow-up|0|||
105443817|NCT01052077|363630062|FG000|Phase A|Adverse Event|32|||
105443818|NCT01052077|363630063|FG001|Phase A|Adverse Event|0|||
105443819|NCT01052077|363630064|FG002|Phase A|Adverse Event|0|||
105443820|NCT01052077|363630065|FG003|Phase A|Adverse Event|0|||
105443821|NCT01052077|363630062|FG000|Phase A|Met Withdrawal Criteria|26|||
105443822|NCT01052077|363630063|FG001|Phase A|Met Withdrawal Criteria|0|||
105443823|NCT01052077|363630064|FG002|Phase A|Met Withdrawal Criteria|0|||
105443824|NCT01052077|363630065|FG003|Phase A|Met Withdrawal Criteria|0|||
105443825|NCT01052077|363630062|FG000|Phase A|Physician Decision|10|||
105443826|NCT01052077|363630063|FG001|Phase A|Physician Decision|0|||
105779391|NCT00386152|364844742|FG002|Overall Study|Disease progression|5|||
105779392|NCT00386152|364844740|FG000|Overall Study|Physician Decision|13|||
105779393|NCT00386152|364844741|FG001|Overall Study|Physician Decision|10|||
105779394|NCT00386152|364844742|FG002|Overall Study|Physician Decision|4|||
105779395|NCT00386152|364844740|FG000|Overall Study|Lost to Follow-up|1|||
105779396|NCT00386152|364844741|FG001|Overall Study|Lost to Follow-up|0|||
105779397|NCT00386152|364844742|FG002|Overall Study|Lost to Follow-up|0|||
105779398|NCT00386152|364844740|FG000|Overall Study|Completed chemotherapy|4|||
105779399|NCT00386152|364844741|FG001|Overall Study|Completed chemotherapy|5|||
105779400|NCT00386152|364844742|FG002|Overall Study|Completed chemotherapy|1|||
105779401|NCT00386152|364844740|FG000|Overall Study|Protocol Violation|3|||
105779402|NCT00386152|364844741|FG001|Overall Study|Protocol Violation|5|||
105779403|NCT00386152|364844742|FG002|Overall Study|Protocol Violation|2|||
105779404|NCT00386152|364844740|FG000|Overall Study|Withdrawal by Subject|3|||
105779405|NCT00386152|364844741|FG001|Overall Study|Withdrawal by Subject|6|||
105779406|NCT00386152|364844742|FG002|Overall Study|Withdrawal by Subject|10|||
105779407|NCT00561912|364844755|FG000|Overall Study|ineligible|1|||
105779408|NCT02643420|364844756|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
105779409|NCT02643420|364844757|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
105779410|NCT02643420|364844756|FG000|Overall Study|Withdrawal by Subject|25|||
105779411|NCT02643420|364844757|FG001|Overall Study|Withdrawal by Subject|19|||
105779412|NCT02643420|364844756|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
105779413|NCT02643420|364844757|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
105779414|NCT02643420|364844756|FG000|Overall Study|Lost to Follow-up|6|||
105779415|NCT02643420|364844757|FG001|Overall Study|Lost to Follow-up|10|||
105779416|NCT02643420|364844756|FG000|Overall Study|Investigator Decision|2|||
105779417|NCT02643420|364844757|FG001|Overall Study|Investigator Decision|4|||
105779418|NCT02643420|364844756|FG000|Overall Study|Sponsor decision|1|||
105779419|NCT02643420|364844757|FG001|Overall Study|Sponsor decision|1|||
105779420|NCT02643420|364844756|FG000|Overall Study|Death|0|||
105779421|NCT02643420|364844757|FG001|Overall Study|Death|2|||
105779422|NCT02643420|364844756|FG000|Overall Study|Reason not Specified|8|||
105779423|NCT02643420|364844757|FG001|Overall Study|Reason not Specified|7|||
105779424|NCT02127970|364844758|FG000|Overall Study|Adverse Event|2|||
105779425|NCT02127970|364844759|FG001|Overall Study|Adverse Event|1|||
105779426|NCT02127970|364844758|FG000|Overall Study|Death|1|||
105779427|NCT02127970|364844759|FG001|Overall Study|Death|1|||
105779428|NCT02127970|364844758|FG000|Overall Study|Lost to Follow-up|14|||
105779429|NCT02127970|364844759|FG001|Overall Study|Lost to Follow-up|14|||
105779430|NCT02127970|364844758|FG000|Overall Study|Reason not Specified|4|||
105779431|NCT02127970|364844759|FG001|Overall Study|Reason not Specified|7|||
105779432|NCT02127970|364844758|FG000|Overall Study|Pregnancy|0|||
105779433|NCT02127970|364844759|FG001|Overall Study|Pregnancy|1|||
105779434|NCT02127970|364844758|FG000|Overall Study|Subject Withdrew Consent|5|||
105779435|NCT02127970|364844759|FG001|Overall Study|Subject Withdrew Consent|3|||
105779436|NCT04052425|364844760|FG000|24-Week Double-blind Period|Adverse Event|0|||
105779437|NCT04052425|364844761|FG001|24-Week Double-blind Period|Adverse Event|1|||
105779438|NCT04052425|364844762|FG002|24-Week Double-blind Period|Adverse Event|0|||
105779439|NCT04052425|364844763|FG003|24-Week Double-blind Period|Adverse Event|0|||
105779440|NCT04052425|364844760|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
105779441|NCT04052425|364844761|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
105779442|NCT04052425|364844762|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
105779443|NCT04052425|364844763|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
105779444|NCT04052425|364844760|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
105779445|NCT04052425|364844761|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
105779446|NCT04052425|364844762|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
105779447|NCT04052425|364844763|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
105779448|NCT04052425|364844760|FG000|24-Week Double-blind Period|Physician Decision|1|||
105779449|NCT04052425|364844761|FG001|24-Week Double-blind Period|Physician Decision|0|||
105779450|NCT04052425|364844762|FG002|24-Week Double-blind Period|Physician Decision|0|||
105779451|NCT04052425|364844763|FG003|24-Week Double-blind Period|Physician Decision|0|||
105779452|NCT04052425|364844760|FG000|24-Week Double-blind Period|Protocol Violation|1|||
105779453|NCT04052425|364844761|FG001|24-Week Double-blind Period|Protocol Violation|0|||
105779454|NCT04052425|364844762|FG002|24-Week Double-blind Period|Protocol Violation|0|||
105779455|NCT04052425|364844763|FG003|24-Week Double-blind Period|Protocol Violation|0|||
105779456|NCT04052425|364844760|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
105779457|NCT04052425|364844761|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
105779458|NCT04052425|364844762|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
105779459|NCT04052425|364844763|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
105779460|NCT04052425|364844760|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
105779461|NCT04052425|364844761|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
105779462|NCT04052425|364844762|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
105779463|NCT04052425|364844763|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
105443827|NCT01052077|363630064|FG002|Phase A|Physician Decision|0|||
105443828|NCT01052077|363630065|FG003|Phase A|Physician Decision|0|||
105443829|NCT01052077|363630062|FG000|Phase A|Withdrawal by Subject|29|||
105443830|NCT01052077|363630063|FG001|Phase A|Withdrawal by Subject|0|||
105443831|NCT01052077|363630064|FG002|Phase A|Withdrawal by Subject|0|||
105443832|NCT01052077|363630065|FG003|Phase A|Withdrawal by Subject|0|||
105443833|NCT01052077|363630062|FG000|Phase A|Protocol Deviation|27|||
105443834|NCT01052077|363630063|FG001|Phase A|Protocol Deviation|0|||
105443835|NCT01052077|363630064|FG002|Phase A|Protocol Deviation|0|||
105443836|NCT01052077|363630065|FG003|Phase A|Protocol Deviation|0|||
105443837|NCT01052077|363630062|FG000|Phase B|Lost to Follow-up|0|||
105443838|NCT01052077|363630063|FG001|Phase B|Lost to Follow-up|2|||
105443839|NCT01052077|363630064|FG002|Phase B|Lost to Follow-up|3|||
105443840|NCT01052077|363630065|FG003|Phase B|Lost to Follow-up|0|||
105443841|NCT01052077|363630062|FG000|Phase B|Adverse Event|0|||
105443842|NCT01052077|363630063|FG001|Phase B|Adverse Event|9|||
105443843|NCT01052077|363630064|FG002|Phase B|Adverse Event|2|||
105443844|NCT01052077|363630065|FG003|Phase B|Adverse Event|0|||
105443845|NCT01052077|363630062|FG000|Phase B|Met Withdrawal Criteria|0|||
105443846|NCT01052077|363630063|FG001|Phase B|Met Withdrawal Criteria|2|||
105443847|NCT01052077|363630064|FG002|Phase B|Met Withdrawal Criteria|1|||
105443848|NCT01052077|363630065|FG003|Phase B|Met Withdrawal Criteria|0|||
105443849|NCT01052077|363630062|FG000|Phase B|Physician Decision|0|||
105443850|NCT01052077|363630063|FG001|Phase B|Physician Decision|1|||
105443851|NCT01052077|363630064|FG002|Phase B|Physician Decision|1|||
105443852|NCT01052077|363630065|FG003|Phase B|Physician Decision|0|||
105443853|NCT01052077|363630062|FG000|Phase B|Withdrawal by Subject|0|||
105443854|NCT01052077|363630063|FG001|Phase B|Withdrawal by Subject|0|||
105443855|NCT01052077|363630064|FG002|Phase B|Withdrawal by Subject|5|||
105443856|NCT01052077|363630065|FG003|Phase B|Withdrawal by Subject|0|||
105443857|NCT01052077|363630062|FG000|Phase B|Protocol Deviation|0|||
105443858|NCT01052077|363630063|FG001|Phase B|Protocol Deviation|3|||
105443859|NCT01052077|363630064|FG002|Phase B|Protocol Deviation|4|||
105443860|NCT01052077|363630065|FG003|Phase B|Protocol Deviation|0|||
105443861|NCT01052077|363630062|FG000|Phase B|Lack of Efficacy|0|||
105443862|NCT01052077|363630063|FG001|Phase B|Lack of Efficacy|1|||
105443863|NCT01052077|363630064|FG002|Phase B|Lack of Efficacy|0|||
105443864|NCT01052077|363630065|FG003|Phase B|Lack of Efficacy|0|||
105443865|NCT01052077|363630062|FG000|Phase A+|Lost to Follow-up|0|||
105443866|NCT01052077|363630063|FG001|Phase A+|Lost to Follow-up|0|||
105443867|NCT01052077|363630064|FG002|Phase A+|Lost to Follow-up|0|||
105443868|NCT01052077|363630065|FG003|Phase A+|Lost to Follow-up|8|||
105443869|NCT01052077|363630062|FG000|Phase A+|Adverse Event|0|||
105443870|NCT01052077|363630063|FG001|Phase A+|Adverse Event|0|||
105443871|NCT01052077|363630064|FG002|Phase A+|Adverse Event|0|||
105443872|NCT01052077|363630065|FG003|Phase A+|Adverse Event|4|||
105443873|NCT01052077|363630062|FG000|Phase A+|Met Withdrawal Criteria|0|||
105443874|NCT01052077|363630063|FG001|Phase A+|Met Withdrawal Criteria|0|||
105443875|NCT01052077|363630064|FG002|Phase A+|Met Withdrawal Criteria|0|||
105443876|NCT01052077|363630065|FG003|Phase A+|Met Withdrawal Criteria|2|||
105443877|NCT01052077|363630062|FG000|Phase A+|Withdrawal by Subject|0|||
105443878|NCT01052077|363630063|FG001|Phase A+|Withdrawal by Subject|0|||
105443879|NCT01052077|363630064|FG002|Phase A+|Withdrawal by Subject|0|||
105443880|NCT01052077|363630065|FG003|Phase A+|Withdrawal by Subject|7|||
105443881|NCT02465203|363630066|FG000|Overall Study|Protocol Violation|1|||
105443882|NCT02465203|363630067|FG001|Overall Study|Protocol Violation|1|||
105443883|NCT02465203|363630068|FG002|Overall Study|Protocol Violation|1|||
105443884|NCT02465203|363630066|FG000|Overall Study|Study terminated by sponsor|50|||
105443885|NCT02465203|363630067|FG001|Overall Study|Study terminated by sponsor|34|||
105443886|NCT02465203|363630068|FG002|Overall Study|Study terminated by sponsor|11|||
105443887|NCT02465203|363630066|FG000|Overall Study|New therapy for study indication|4|||
105443888|NCT02465203|363630067|FG001|Overall Study|New therapy for study indication|0|||
105443889|NCT02465203|363630068|FG002|Overall Study|New therapy for study indication|0|||
105443890|NCT02465203|363630066|FG000|Overall Study|Patient/guardian decision|1|||
105443891|NCT02465203|363630067|FG001|Overall Study|Patient/guardian decision|1|||
105443892|NCT02465203|363630068|FG002|Overall Study|Patient/guardian decision|1|||
105443893|NCT04072887|363630073|FG000|Overall Study|Withdrawal by Subject|3|||
105443894|NCT04072887|363630074|FG001|Overall Study|Withdrawal by Subject|8|||
105443895|NCT04072887|363630075|FG002|Overall Study|Withdrawal by Subject|1|||
105443896|NCT04072887|363630076|FG003|Overall Study|Withdrawal by Subject|3|||
105443897|NCT04072887|363630077|FG004|Overall Study|Withdrawal by Subject|3|||
105443898|NCT04072887|363630078|FG005|Overall Study|Withdrawal by Subject|13|||
105443899|NCT04072887|363630073|FG000|Overall Study|Adverse Event|2|||
105443900|NCT04072887|363630074|FG001|Overall Study|Adverse Event|4|||
105443901|NCT04072887|363630075|FG002|Overall Study|Adverse Event|1|||
105443902|NCT04072887|363630076|FG003|Overall Study|Adverse Event|4|||
105443903|NCT04072887|363630077|FG004|Overall Study|Adverse Event|0|||
105443904|NCT04072887|363630078|FG005|Overall Study|Adverse Event|1|||
105443905|NCT04072887|363630073|FG000|Overall Study|Physician Decision|2|||
105443906|NCT04072887|363630074|FG001|Overall Study|Physician Decision|0|||
105443907|NCT04072887|363630075|FG002|Overall Study|Physician Decision|0|||
105443908|NCT04072887|363630076|FG003|Overall Study|Physician Decision|0|||
105443909|NCT04072887|363630077|FG004|Overall Study|Physician Decision|0|||
105443910|NCT04072887|363630078|FG005|Overall Study|Physician Decision|1|||
105443911|NCT04072887|363630073|FG000|Overall Study|Lost to Follow-up|1|||
105443912|NCT04072887|363630074|FG001|Overall Study|Lost to Follow-up|3|||
105443913|NCT04072887|363630075|FG002|Overall Study|Lost to Follow-up|0|||
105443914|NCT04072887|363630076|FG003|Overall Study|Lost to Follow-up|0|||
105443915|NCT04072887|363630077|FG004|Overall Study|Lost to Follow-up|0|||
105443916|NCT04072887|363630078|FG005|Overall Study|Lost to Follow-up|0|||
105443917|NCT04072887|363630073|FG000|Overall Study|Death|0|||
105443918|NCT04072887|363630074|FG001|Overall Study|Death|2|||
105443919|NCT04072887|363630075|FG002|Overall Study|Death|0|||
105443920|NCT04072887|363630076|FG003|Overall Study|Death|2|||
105443921|NCT04072887|363630077|FG004|Overall Study|Death|3|||
105443922|NCT04072887|363630078|FG005|Overall Study|Death|0|||
105443923|NCT00856297|363630079|FG000|Overall Study|Unable to classify|2|||
105443924|NCT00856297|363630080|FG001|Overall Study|Unable to classify|0|||
105443925|NCT00856297|363630081|FG002|Overall Study|Unable to classify|0|||
105443926|NCT00856297|363630082|FG003|Overall Study|Unable to classify|0|||
105443927|NCT00856297|363630083|FG004|Overall Study|Unable to classify|0|||
105443928|NCT02508428|363630085|FG000|Overall Study|Death|32|||
105443929|NCT02508428|363630086|FG001|Overall Study|Death|33|||
105443930|NCT02508428|363630085|FG000|Overall Study|Liner revised|3|||
105443931|NCT02508428|363630086|FG001|Overall Study|Liner revised|19|||
105443932|NCT02508428|363630085|FG000|Overall Study|Incomplete follow-up|17|||
105443933|NCT02508428|363630086|FG001|Overall Study|Incomplete follow-up|15|||
105443934|NCT03761810|363630087|FG000|Overall Study|Adverse Event|12|||
105443935|NCT03761810|363630088|FG001|Overall Study|Adverse Event|0|||
105443936|NCT03761810|363630087|FG000|Overall Study|Lost to Follow-up|15|||
105443937|NCT03761810|363630088|FG001|Overall Study|Lost to Follow-up|7|||
105443938|NCT03761810|363630087|FG000|Overall Study|Pregnancy|1|||
105443939|NCT03761810|363630088|FG001|Overall Study|Pregnancy|0|||
105443940|NCT03761810|363630087|FG000|Overall Study|Withdrawal by Subject|14|||
105443941|NCT03761810|363630088|FG001|Overall Study|Withdrawal by Subject|5|||
105443942|NCT03761810|363630087|FG000|Overall Study|Physician Decision|1|||
105443943|NCT03761810|363630088|FG001|Overall Study|Physician Decision|0|||
105443944|NCT03761810|363630087|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
105443945|NCT03761810|363630088|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105443946|NCT03761810|363630087|FG000|Overall Study|Other Than Specified|1|||
105443947|NCT03761810|363630088|FG001|Overall Study|Other Than Specified|0|||
105443948|NCT00264537|363630089|FG000|Overall Study|Death|0|||
105443949|NCT00264537|363630090|FG001|Overall Study|Death|3|||
105443950|NCT00264537|363630091|FG002|Overall Study|Death|3|||
105443951|NCT00264537|363630092|FG003|Overall Study|Death|2|||
105443952|NCT00264537|363630089|FG000|Overall Study|Lost to Follow-up|3|||
105443953|NCT00264537|363630090|FG001|Overall Study|Lost to Follow-up|4|||
105443954|NCT00264537|363630091|FG002|Overall Study|Lost to Follow-up|7|||
105443955|NCT00264537|363630092|FG003|Overall Study|Lost to Follow-up|6|||
105443956|NCT00264537|363630089|FG000|Overall Study|Adverse Event|21|||
105443957|NCT00264537|363630090|FG001|Overall Study|Adverse Event|32|||
105443958|NCT00264537|363630091|FG002|Overall Study|Adverse Event|24|||
105443959|NCT00264537|363630092|FG003|Overall Study|Adverse Event|34|||
105443960|NCT00264537|363630089|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
105443961|NCT00264537|363630090|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
105443962|NCT00264537|363630091|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
105443963|NCT00264537|363630092|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
105443964|NCT00264537|363630089|FG000|Overall Study|Other|21|||
105443965|NCT00264537|363630090|FG001|Overall Study|Other|11|||
105443966|NCT00264537|363630091|FG002|Overall Study|Other|10|||
105443967|NCT00264537|363630092|FG003|Overall Study|Other|11|||
105443968|NCT00264537|363630089|FG000|Overall Study|Not treated|0|||
105443969|NCT00264537|363630090|FG001|Overall Study|Not treated|2|||
105443970|NCT00264537|363630091|FG002|Overall Study|Not treated|1|||
105443971|NCT00264537|363630092|FG003|Overall Study|Not treated|0|||
105443972|NCT00811174|363630093|FG000|Overall Study|Protocol Violation|2|||
105443973|NCT00811174|363630093|FG000|Overall Study|Sponsors Decision|1|||
105443974|NCT01959139|363631457|FG000|Phase II|Disease progression|0|||
105443975|NCT01959139|363631458|FG001|Phase II|Disease progression|0|||
105443976|NCT01959139|363631459|FG002|Phase II|Disease progression|26|||
105443977|NCT01959139|363631460|FG003|Phase II|Disease progression|34|||
105443978|NCT01959139|363631457|FG000|Phase II|Adverse Event|0|||
105443979|NCT01959139|363631458|FG001|Phase II|Adverse Event|0|||
105443980|NCT01959139|363631459|FG002|Phase II|Adverse Event|10|||
105443981|NCT01959139|363631460|FG003|Phase II|Adverse Event|11|||
105443982|NCT01959139|363631457|FG000|Phase II|Patient Refusal|0|||
105443983|NCT01959139|363631458|FG001|Phase II|Patient Refusal|0|||
105443984|NCT01959139|363631459|FG002|Phase II|Patient Refusal|5|||
105443985|NCT01959139|363631460|FG003|Phase II|Patient Refusal|4|||
105443986|NCT01959139|363631457|FG000|Phase II|Death|0|||
105443987|NCT01959139|363631458|FG001|Phase II|Death|0|||
105443988|NCT01959139|363631459|FG002|Phase II|Death|3|||
105443989|NCT01959139|363631460|FG003|Phase II|Death|1|||
105443990|NCT01959139|363631457|FG000|Phase II|Other/Unknown|0|||
105443991|NCT01959139|363631458|FG001|Phase II|Other/Unknown|0|||
105443992|NCT01959139|363631459|FG002|Phase II|Other/Unknown|8|||
105443993|NCT01959139|363631460|FG003|Phase II|Other/Unknown|5|||
105443994|NCT01959139|363631457|FG000|Phase II|On treatment|0|||
105443995|NCT01959139|363631458|FG001|Phase II|On treatment|0|||
105443996|NCT01959139|363631459|FG002|Phase II|On treatment|4|||
105443997|NCT01959139|363631460|FG003|Phase II|On treatment|0|||
105443998|NCT01559675|363631461|FG000|Overall Study|Protocol Violation|1|||
105443999|NCT01559675|363631462|FG001|Overall Study|Protocol Violation|2|||
105444000|NCT01559675|363631461|FG000|Overall Study|2nd operation on same patient excluded|14|||
105444001|NCT01559675|363631462|FG001|Overall Study|2nd operation on same patient excluded|12|||
105444002|NCT01504412|363631463|FG000|Overall Study|Adverse Event|1|||
105444003|NCT01504412|363631464|FG001|Overall Study|Adverse Event|8|||
105444004|NCT01504412|363631465|FG002|Overall Study|Adverse Event|1|||
105444005|NCT01504412|363631466|FG003|Overall Study|Adverse Event|7|||
105444006|NCT01504412|363631467|FG004|Overall Study|Adverse Event|10|||
105444007|NCT01504412|363631463|FG000|Overall Study|Withdrawal by Subject|2|||
105444008|NCT01504412|363631464|FG001|Overall Study|Withdrawal by Subject|1|||
105444009|NCT01504412|363631465|FG002|Overall Study|Withdrawal by Subject|1|||
105444010|NCT01504412|363631466|FG003|Overall Study|Withdrawal by Subject|5|||
105444011|NCT01504412|363631467|FG004|Overall Study|Withdrawal by Subject|1|||
105444012|NCT01504412|363631463|FG000|Overall Study|Other|2|||
105444013|NCT01504412|363631464|FG001|Overall Study|Other|1|||
105444014|NCT01504412|363631465|FG002|Overall Study|Other|1|||
105444015|NCT01504412|363631466|FG003|Overall Study|Other|6|||
105444016|NCT01504412|363631467|FG004|Overall Study|Other|1|||
105444017|NCT01504412|363631463|FG000|Overall Study|Lost to Follow-up|0|||
105444018|NCT01504412|363631464|FG001|Overall Study|Lost to Follow-up|2|||
105444019|NCT01504412|363631465|FG002|Overall Study|Lost to Follow-up|0|||
105444020|NCT01504412|363631466|FG003|Overall Study|Lost to Follow-up|0|||
105444021|NCT01504412|363631467|FG004|Overall Study|Lost to Follow-up|0|||
105444022|NCT01504412|363631463|FG000|Overall Study|Lack of Efficacy|0|||
105444023|NCT01504412|363631464|FG001|Overall Study|Lack of Efficacy|0|||
105444024|NCT01504412|363631465|FG002|Overall Study|Lack of Efficacy|1|||
105444025|NCT01504412|363631466|FG003|Overall Study|Lack of Efficacy|0|||
105444026|NCT01504412|363631467|FG004|Overall Study|Lack of Efficacy|1|||
105444027|NCT01504412|363631463|FG000|Overall Study|Death|0|||
105444028|NCT01504412|363631464|FG001|Overall Study|Death|0|||
105444029|NCT01504412|363631465|FG002|Overall Study|Death|0|||
105444030|NCT01504412|363631466|FG003|Overall Study|Death|1|||
105444031|NCT01504412|363631467|FG004|Overall Study|Death|0|||
105444032|NCT02219334|363631468|FG000|Overall Study|Withdrawal by Subject|1|||
105444033|NCT02219334|363631469|FG001|Overall Study|Withdrawal by Subject|0|||
105444034|NCT02219334|363631468|FG000|Overall Study|Protocol Violation|7|||
105444035|NCT02219334|363631469|FG001|Overall Study|Protocol Violation|3|||
105444036|NCT03329092|363631473|FG000|Overall Study|Other|2|||
105444037|NCT03329092|363631474|FG001|Overall Study|Other|2|||
105444038|NCT03329092|363631473|FG000|Overall Study|Withdrawal by Subject|16|||
105444039|NCT03329092|363631474|FG001|Overall Study|Withdrawal by Subject|3|||
105444040|NCT03329092|363631473|FG000|Overall Study|Physician Decision|1|||
105444041|NCT03329092|363631474|FG001|Overall Study|Physician Decision|0|||
105444042|NCT03329092|363631473|FG000|Overall Study|Death|17|||
105444043|NCT03329092|363631474|FG001|Overall Study|Death|11|||
105444044|NCT03329092|363631473|FG000|Overall Study|Adverse Event|3|||
105444045|NCT03329092|363631474|FG001|Overall Study|Adverse Event|1|||
105444046|NCT03329092|363631473|FG000|Overall Study|Lost to Follow-up|1|||
105444047|NCT03329092|363631474|FG001|Overall Study|Lost to Follow-up|1|||
105444048|NCT02588261|363631477|FG000|Overall Study|Study Terminated by Sponsor|157|||
105444049|NCT02588261|363631478|FG001|Overall Study|Study Terminated by Sponsor|142|||
105444050|NCT02588261|363631477|FG000|Overall Study|Protocol Deviation|1|||
105444051|NCT02588261|363631478|FG001|Overall Study|Protocol Deviation|0|||
105444052|NCT02588261|363631477|FG000|Overall Study|Death|1|||
105444053|NCT02588261|363631478|FG001|Overall Study|Death|2|||
105444054|NCT02588261|363631477|FG000|Overall Study|Withdrawal by Subject|12|||
105444055|NCT02588261|363631478|FG001|Overall Study|Withdrawal by Subject|8|||
105444056|NCT02588261|363631477|FG000|Overall Study|Noncompliance with Study Drug|0|||
105444057|NCT02588261|363631478|FG001|Overall Study|Noncompliance with Study Drug|1|||
105444058|NCT02588261|363631477|FG000|Overall Study|Miscellaneous|5|||
105444059|NCT02588261|363631478|FG001|Overall Study|Miscellaneous|4|||
105444060|NCT02588261|363631477|FG000|Overall Study|Progressive Disease|61|||
105444061|NCT02588261|363631478|FG001|Overall Study|Progressive Disease|82|||
105444062|NCT02588261|363631477|FG000|Overall Study|Adverse Event|29|||
105444063|NCT02588261|363631478|FG001|Overall Study|Adverse Event|24|||
105444064|NCT02588261|363631477|FG000|Overall Study|Lost to Follow-up|1|||
105444065|NCT02588261|363631478|FG001|Overall Study|Lost to Follow-up|0|||
105444066|NCT02152761|363631486|FG000|Epoch: Treatment Epoch|Technical problems|0|||
105444067|NCT02152761|363631487|FG001|Epoch: Treatment Epoch|Technical problems|0|||
105444068|NCT02152761|363631488|FG002|Epoch: Treatment Epoch|Technical problems|0|||
105444069|NCT02152761|363631489|FG003|Epoch: Treatment Epoch|Technical problems|1|||
105444070|NCT02152761|363631486|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
105444071|NCT02152761|363631487|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
105444072|NCT02152761|363631488|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
105444073|NCT02152761|363631489|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
105444074|NCT02152761|363631486|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
105444075|NCT02152761|363631487|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
105444076|NCT02152761|363631488|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
105444077|NCT02152761|363631489|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
105444078|NCT02152761|363631486|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
105444079|NCT02152761|363631487|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
105444080|NCT02152761|363631488|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
105444081|NCT02152761|363631489|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
105444082|NCT02152761|363631486|FG000|Epoch: Treatment Epoch|Death|0|||
105444083|NCT02152761|363631487|FG001|Epoch: Treatment Epoch|Death|3|||
105444084|NCT02152761|363631488|FG002|Epoch: Treatment Epoch|Death|1|||
105444085|NCT02152761|363631489|FG003|Epoch: Treatment Epoch|Death|0|||
105444086|NCT02152761|363631486|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
105444087|NCT02152761|363631487|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
105444088|NCT02152761|363631488|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
105444089|NCT02152761|363631489|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
105444090|NCT02152761|363631486|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
105444091|NCT02152761|363631487|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
105444092|NCT02152761|363631488|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
105444093|NCT02152761|363631489|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
105444094|NCT02152761|363631486|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
105444095|NCT02152761|363631487|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
105444096|NCT02152761|363631488|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
105444097|NCT02152761|363631489|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
105444098|NCT02152761|363631486|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
105444099|NCT02152761|363631487|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
105444100|NCT02152761|363631488|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
105444101|NCT02152761|363631489|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
105444102|NCT02152761|363631486|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
105444103|NCT02152761|363631487|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
105444104|NCT02152761|363631488|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
105444105|NCT02152761|363631489|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
105444106|NCT02506192|363631490|FG000|Overall Study|Withdrawal by Subject|1|||
105444107|NCT02506192|363631491|FG001|Overall Study|Withdrawal by Subject|1|||
105444108|NCT01685697|363631492|FG000|Overall Study|Protocol Violation|3|||
105444109|NCT01685697|363631493|FG001|Overall Study|Protocol Violation|3|||
105444110|NCT05292131|363631498|FG000|Overall Study|Lost to Follow-up|1|||
105444111|NCT05292131|363631499|FG001|Overall Study|Lost to Follow-up|1|||
105444112|NCT05292131|363631498|FG000|Overall Study|Withdrawal by Subject|0|||
105444113|NCT05292131|363631499|FG001|Overall Study|Withdrawal by Subject|1|||
105444114|NCT04390880|363631501|FG000|Overall Study|Withdrawal by Subject|1|||
105444115|NCT02557542|363631502|FG000|Overall Study|Poor recruitment|3|||
105444116|NCT02557542|363631503|FG001|Overall Study|Poor recruitment|0|||
105444117|NCT03785405|363631504|FG000|Overall Study|Adverse Event|16|||
105444118|NCT03785405|363631505|FG001|Overall Study|Adverse Event|1|||
105444119|NCT03785405|363631504|FG000|Overall Study|Death|6|||
105444120|NCT03785405|363631505|FG001|Overall Study|Death|4|||
105444121|NCT03785405|363631504|FG000|Overall Study|Guardian decision|4|||
105444122|NCT03785405|363631505|FG001|Overall Study|Guardian decision|1|||
105444123|NCT03785405|363631504|FG000|Overall Study|Lost to Follow-up|1|||
105444124|NCT03785405|363631505|FG001|Overall Study|Lost to Follow-up|0|||
105444125|NCT03785405|363631504|FG000|Overall Study|Physician Decision|8|||
105444126|NCT03785405|363631505|FG001|Overall Study|Physician Decision|5|||
105444127|NCT03785405|363631504|FG000|Overall Study|Participant decision|2|||
105444128|NCT03785405|363631505|FG001|Overall Study|Participant decision|0|||
105444129|NCT03785405|363631504|FG000|Overall Study|Other|1|||
105444130|NCT03785405|363631505|FG001|Overall Study|Other|0|||
105444131|NCT03785405|363631504|FG000|Overall Study|No treatment was received|0|||
105444132|NCT03785405|363631505|FG001|Overall Study|No treatment was received|1|||
105444133|NCT03705559|363631506|FG000|Overall Study|COVID Shut down|1|||
105444134|NCT03517228|363631507|FG000|Overall Study|Withdrawal by Subject|2|||
105444135|NCT03517228|363631507|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
105444136|NCT03517228|363631507|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
105444137|NCT03517228|363631507|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
105779464|NCT04052425|364844760|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
105444138|NCT03517228|363631507|FG000|Overall Study|Canceled due to device being updated|1|||
105444139|NCT03517228|363631507|FG000|Overall Study|No V Cares in stock|1|||
105444140|NCT03517228|363631507|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
105444141|NCT01345188|363631508|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
105444142|NCT01345188|363631508|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
105444143|NCT01397461|363631509|FG000|Overall Study|Withdrawal by Subject|2|||
105444144|NCT01397461|363631510|FG001|Overall Study|Withdrawal by Subject|1|||
105444145|NCT01397461|363631511|FG002|Overall Study|Withdrawal by Subject|0|||
105444146|NCT01397461|363631509|FG000|Overall Study|Lost to Follow-up|0|||
105444147|NCT01397461|363631510|FG001|Overall Study|Lost to Follow-up|2|||
105444148|NCT01397461|363631511|FG002|Overall Study|Lost to Follow-up|1|||
105444149|NCT01397461|363631509|FG000|Overall Study|Lack of Efficacy|0|||
105444150|NCT01397461|363631510|FG001|Overall Study|Lack of Efficacy|3|||
105444151|NCT01397461|363631511|FG002|Overall Study|Lack of Efficacy|0|||
105444152|NCT01397461|363631509|FG000|Overall Study|Not treated|0|||
105444153|NCT01397461|363631510|FG001|Overall Study|Not treated|0|||
105444154|NCT01397461|363631511|FG002|Overall Study|Not treated|1|||
105444155|NCT01922271|363631512|FG000|WASHOUT Period|Withdrawal by Subject|1|||
105444156|NCT01922271|363631513|FG001|WASHOUT Period|Withdrawal by Subject|0|||
105444157|NCT02534909|363631534|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
105444158|NCT04079816|363631535|FG000|Overall Study|Request of Subject|2|||
105444159|NCT04079816|363631535|FG000|Overall Study|Unable to draw samples|1|||
105444160|NCT01702246|363631536|FG000|Overall Study|Lost to Follow-up|2|||
105444161|NCT01702246|363631536|FG000|Overall Study|Withdrawal by Subject|2|||
105444162|NCT01702246|363631536|FG000|Overall Study|Physician Decision|1|||
105444163|NCT04300309|363631539|FG000|Overall Study|Lost to Follow-up|1|||
105444164|NCT04300309|363631540|FG001|Overall Study|Lost to Follow-up|0|||
105444165|NCT04427072|363631543|FG000|Randomized Treatment Phase|Progressive disease|9|||
105444166|NCT04427072|363631544|FG001|Randomized Treatment Phase|Progressive disease|4|||
105444167|NCT04427072|363631543|FG000|Randomized Treatment Phase|Adverse Event|3|||
105444168|NCT04427072|363631544|FG001|Randomized Treatment Phase|Adverse Event|1|||
105444169|NCT04427072|363631543|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
105444170|NCT04427072|363631544|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
105444171|NCT04427072|363631543|FG000|Randomized Treatment Phase|Death|0|||
105444172|NCT04427072|363631544|FG001|Randomized Treatment Phase|Death|1|||
105444173|NCT04427072|363631543|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
105444174|NCT04427072|363631544|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
105444175|NCT04427072|363631543|FG000|Extension Treatment Phase|Progressive disease|0|||
105444176|NCT04427072|363631544|FG001|Extension Treatment Phase|Progressive disease|5|||
105444177|NCT05232864|363631545|FG000|Overall Study|Adverse Event|0|||
105444178|NCT05232864|363631546|FG001|Overall Study|Adverse Event|1|||
105444179|NCT05232864|363631545|FG000|Overall Study|Study terminated by sponsor|16|||
105444180|NCT05232864|363631546|FG001|Overall Study|Study terminated by sponsor|14|||
105444181|NCT00465452|363631562|FG000|Overall Study|Adverse Event|1|||
105444182|NCT04209205|363631567|FG000|Overall Study|Adverse Event|2|||
105444183|NCT04209205|363631568|FG001|Overall Study|Adverse Event|3|||
105444184|NCT04209205|363631567|FG000|Overall Study|Lost to Follow-up|3|||
105444185|NCT04209205|363631568|FG001|Overall Study|Lost to Follow-up|1|||
105444186|NCT04209205|363631567|FG000|Overall Study|Physician Decision|1|||
105444187|NCT04209205|363631568|FG001|Overall Study|Physician Decision|1|||
105444188|NCT04209205|363631567|FG000|Overall Study|Subject decision|10|||
105444189|NCT04209205|363631568|FG001|Overall Study|Subject decision|10|||
105444190|NCT04209205|363631567|FG000|Overall Study|Progressive disease|1|||
105444191|NCT04209205|363631568|FG001|Overall Study|Progressive disease|0|||
105444192|NCT04209205|363631567|FG000|Overall Study|Protocol deviation|0|||
105444193|NCT04209205|363631568|FG001|Overall Study|Protocol deviation|1|||
105444194|NCT04209205|363631567|FG000|Overall Study|New therapy for study indication|1|||
105444195|NCT04209205|363631568|FG001|Overall Study|New therapy for study indication|0|||
105444196|NCT04209205|363631567|FG000|Overall Study|Adverse event - placebo not switched|0|||
105444197|NCT04209205|363631568|FG001|Overall Study|Adverse event - placebo not switched|1|||
105444198|NCT04209205|363631567|FG000|Overall Study|Subject decision - placebo not switched|0|||
105444199|NCT04209205|363631568|FG001|Overall Study|Subject decision - placebo not switched|5|||
105444200|NCT04209205|363631567|FG000|Overall Study|Death - placebo not switched|0|||
105444201|NCT04209205|363631568|FG001|Overall Study|Death - placebo not switched|1|||
105444202|NCT05870865|363631569|FG000|Randomized|Did not receive study treatment|2|||
105444203|NCT05870865|363631570|FG001|Randomized|Did not receive study treatment|4|||
105444204|NCT05870865|363631571|FG002|Randomized|Did not receive study treatment|4|||
105444205|NCT05870865|363631572|FG003|Randomized|Did not receive study treatment|3|||
105444206|NCT05870865|363631569|FG000|Treatment Period|Adverse Event|1|||
105444207|NCT05870865|363631570|FG001|Treatment Period|Adverse Event|1|||
105444208|NCT05870865|363631571|FG002|Treatment Period|Adverse Event|1|||
105444209|NCT05870865|363631572|FG003|Treatment Period|Adverse Event|1|||
105444210|NCT05870865|363631569|FG000|Treatment Period|Lost to Follow-up|0|||
105444211|NCT05870865|363631570|FG001|Treatment Period|Lost to Follow-up|1|||
105444212|NCT05870865|363631571|FG002|Treatment Period|Lost to Follow-up|2|||
105444213|NCT05870865|363631572|FG003|Treatment Period|Lost to Follow-up|0|||
105444214|NCT05870865|363631569|FG000|Treatment Period|Protocol Violation|0|||
105444215|NCT05870865|363631570|FG001|Treatment Period|Protocol Violation|0|||
105444216|NCT05870865|363631571|FG002|Treatment Period|Protocol Violation|0|||
105444217|NCT05870865|363631572|FG003|Treatment Period|Protocol Violation|1|||
105444218|NCT05870865|363631569|FG000|Treatment Period|Withdrawal by Subject|0|||
105444219|NCT05870865|363631570|FG001|Treatment Period|Withdrawal by Subject|1|||
105444220|NCT05870865|363631571|FG002|Treatment Period|Withdrawal by Subject|1|||
105444221|NCT05870865|363631572|FG003|Treatment Period|Withdrawal by Subject|1|||
105444222|NCT04739761|363631573|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
105444223|NCT04739761|363631574|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
105444224|NCT04739761|363631573|FG000|Overall Study|By complete response from the participant|1|||
105444225|NCT04739761|363631574|FG001|Overall Study|By complete response from the participant|0|||
105444226|NCT04739761|363631573|FG000|Overall Study|Lost to Follow-up|3|||
105444227|NCT04739761|363631574|FG001|Overall Study|Lost to Follow-up|3|||
105444228|NCT04739761|363631573|FG000|Overall Study|Death|13|||
105444229|NCT04739761|363631574|FG001|Overall Study|Death|13|||
105444230|NCT04739761|363631573|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
105444231|NCT04739761|363631574|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
105444232|NCT04739761|363631573|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
105444233|NCT04739761|363631574|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
105444234|NCT04739761|363631573|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
105444235|NCT04739761|363631574|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
105444236|NCT04739761|363631573|FG000|Overall Study|Adverse Event|0|||
105444237|NCT04739761|363631574|FG001|Overall Study|Adverse Event|3|||
105444238|NCT04739761|363631573|FG000|Overall Study|Participant decision|1|||
105444239|NCT04739761|363631574|FG001|Overall Study|Participant decision|0|||
105444240|NCT04739761|363631573|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
105444241|NCT04739761|363631574|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
105444242|NCT04739761|363631573|FG000|Overall Study|Participant immediately started next line of treatment|1|||
105444243|NCT04739761|363631574|FG001|Overall Study|Participant immediately started next line of treatment|0|||
105444244|NCT04739761|363631573|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
105444245|NCT04739761|363631574|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
105444246|NCT04739761|363631573|FG000|Overall Study|Lack of clinical benefit|1|||
105444247|NCT04739761|363631574|FG001|Overall Study|Lack of clinical benefit|0|||
105444248|NCT04739761|363631573|FG000|Overall Study|Disease progression|5|||
105444249|NCT04739761|363631574|FG001|Overall Study|Disease progression|5|||
105444250|NCT04739761|363631573|FG000|Overall Study|Withdrawal by Subject|14|||
105444251|NCT04739761|363631574|FG001|Overall Study|Withdrawal by Subject|13|||
105444252|NCT04739761|363631573|FG000|Overall Study|Protocol Violation|1|||
105444253|NCT04739761|363631574|FG001|Overall Study|Protocol Violation|0|||
105444254|NCT04739761|363631573|FG000|Overall Study|Physician Decision|2|||
105444255|NCT04739761|363631574|FG001|Overall Study|Physician Decision|0|||
105444256|NCT01711645|363631582|FG000|Overall Study|Withdrawal by Subject|8|||
105444257|NCT01711645|363631582|FG000|Overall Study|Lost to Follow-up|6|||
105444258|NCT01711645|363631582|FG000|Overall Study|Physician Decision|5|||
105444259|NCT02058563|363631585|FG000|Overall Study|Lost to Follow-up|26|||
105444260|NCT02058563|363631586|FG001|Overall Study|Lost to Follow-up|22|||
105444261|NCT02058563|363631585|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
105444262|NCT02058563|363631586|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
105444263|NCT02058563|363631585|FG000|Overall Study|Consent Withdrawal|1|||
105444264|NCT02058563|363631586|FG001|Overall Study|Consent Withdrawal|1|||
105444265|NCT02058563|363631585|FG000|Overall Study|Other (patient incarcerated)|0|||
105444266|NCT02058563|363631586|FG001|Overall Study|Other (patient incarcerated)|1|||
105444267|NCT04522141|363631587|FG000|Overall Study|Withdrawal by Subject|1|||
105444268|NCT04522141|363631588|FG001|Overall Study|Withdrawal by Subject|0|||
105444269|NCT00186901|363631589|FG000|Overall Study|Pregnancy|6|||
105444270|NCT00186901|363631590|FG001|Overall Study|Pregnancy|3|||
105444271|NCT00186901|363631591|FG002|Overall Study|Pregnancy|0|||
105444272|NCT00186901|363631589|FG000|Overall Study|Lost to Follow-up|6|||
105444273|NCT00186901|363631590|FG001|Overall Study|Lost to Follow-up|3|||
105444274|NCT00186901|363631591|FG002|Overall Study|Lost to Follow-up|0|||
105444275|NCT00186901|363631589|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
105444276|NCT00186901|363631590|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
105444277|NCT00186901|363631591|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
105444278|NCT00186901|363631589|FG000|Overall Study|ALL relapse or second malignancy|1|||
105444279|NCT00186901|363631590|FG001|Overall Study|ALL relapse or second malignancy|2|||
105444280|NCT00186901|363631591|FG002|Overall Study|ALL relapse or second malignancy|0|||
105444281|NCT00186901|363631589|FG000|Overall Study|Withdrawal by Subject|4|||
105444282|NCT00186901|363631590|FG001|Overall Study|Withdrawal by Subject|5|||
105444283|NCT00186901|363631591|FG002|Overall Study|Withdrawal by Subject|0|||
105444284|NCT00186901|363631589|FG000|Overall Study|Open label|3|||
105444285|NCT00186901|363631590|FG001|Overall Study|Open label|2|||
105444286|NCT00186901|363631591|FG002|Overall Study|Open label|0|||
105444287|NCT00186901|363631589|FG000|Overall Study|Limited adherence to study requirements|20|||
105444288|NCT00186901|363631590|FG001|Overall Study|Limited adherence to study requirements|23|||
105444289|NCT00186901|363631591|FG002|Overall Study|Limited adherence to study requirements|0|||
105444290|NCT00186901|363631589|FG000|Overall Study|Bone Mineral Density > 0|0|||
105444291|NCT00186901|363631590|FG001|Overall Study|Bone Mineral Density > 0|0|||
105444292|NCT00186901|363631591|FG002|Overall Study|Bone Mineral Density > 0|149|||
105444293|NCT03193736|363631593|FG000|Overall Study|Death|2|||
105444294|NCT03193736|363631593|FG000|Overall Study|Withdrawal by Subject|1|||
105444295|NCT03193736|363631593|FG000|Overall Study|Lost to Follow-up|1|||
105444296|NCT03193736|363631593|FG000|Overall Study|implant not received|1|||
105444297|NCT00003199|363631597|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
105444298|NCT00003199|363631597|FG000|Overall Study|Lack of insurance clearance|2|||
105444299|NCT00003199|363631597|FG000|Overall Study|Screen fail|15|||
105444300|NCT03058692|363633238|FG000|Overall Study|Lost to Follow-up|2|||
105444301|NCT03058692|363633239|FG001|Overall Study|Lost to Follow-up|1|||
105444302|NCT03058692|363633238|FG000|Overall Study|Withdrawal by Subject|1|||
105444303|NCT03058692|363633239|FG001|Overall Study|Withdrawal by Subject|1|||
105444304|NCT00615017|363633240|FG000|Overall Study|Adverse Event|0|||
105444305|NCT00615017|363633241|FG001|Overall Study|Adverse Event|1|||
105444306|NCT00615017|363633242|FG002|Overall Study|Adverse Event|2|||
105444307|NCT00615017|363633243|FG003|Overall Study|Adverse Event|0|||
105444308|NCT00615017|363633244|FG004|Overall Study|Adverse Event|0|||
105444309|NCT00615017|363633245|FG005|Overall Study|Adverse Event|1|||
105444310|NCT00615017|363633240|FG000|Overall Study|Death|0|||
105444311|NCT00615017|363633241|FG001|Overall Study|Death|0|||
105444312|NCT00615017|363633242|FG002|Overall Study|Death|2|||
105444313|NCT00615017|363633243|FG003|Overall Study|Death|0|||
105444314|NCT00615017|363633244|FG004|Overall Study|Death|1|||
105444315|NCT00615017|363633245|FG005|Overall Study|Death|1|||
105444316|NCT00615017|363633240|FG000|Overall Study|Sepsis resolved|0|||
105444317|NCT00615017|363633241|FG001|Overall Study|Sepsis resolved|0|||
105444318|NCT00615017|363633242|FG002|Overall Study|Sepsis resolved|1|||
105444319|NCT00615017|363633243|FG003|Overall Study|Sepsis resolved|0|||
105444320|NCT00615017|363633244|FG004|Overall Study|Sepsis resolved|0|||
105444321|NCT00615017|363633245|FG005|Overall Study|Sepsis resolved|0|||
105444322|NCT00615017|363633240|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
105444323|NCT00615017|363633241|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
105444324|NCT00615017|363633242|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
105444325|NCT00615017|363633243|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
105444326|NCT00615017|363633244|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
105444327|NCT00615017|363633245|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
105444328|NCT00615017|363633240|FG000|Overall Study|Physician discontinued drug|0|||
105444329|NCT00615017|363633241|FG001|Overall Study|Physician discontinued drug|0|||
105444330|NCT00615017|363633242|FG002|Overall Study|Physician discontinued drug|0|||
105444331|NCT00615017|363633243|FG003|Overall Study|Physician discontinued drug|0|||
105444332|NCT00615017|363633244|FG004|Overall Study|Physician discontinued drug|0|||
105444333|NCT00615017|363633245|FG005|Overall Study|Physician discontinued drug|1|||
105444334|NCT01525615|363633246|FG000|Overall Study|Adverse Event|11|||
105444335|NCT01525615|363633247|FG001|Overall Study|Adverse Event|7|||
105444336|NCT01525615|363633248|FG002|Overall Study|Adverse Event|5|||
105444337|NCT01525615|363633246|FG000|Overall Study|Lost to Follow-up|1|||
105444338|NCT01525615|363633247|FG001|Overall Study|Lost to Follow-up|0|||
105444339|NCT01525615|363633248|FG002|Overall Study|Lost to Follow-up|0|||
105444340|NCT01525615|363633246|FG000|Overall Study|Withdrawal by Subject|1|||
105444341|NCT01525615|363633247|FG001|Overall Study|Withdrawal by Subject|0|||
105444342|NCT01525615|363633248|FG002|Overall Study|Withdrawal by Subject|0|||
105444343|NCT01525615|363633246|FG000|Overall Study|Other reason not described above|1|||
105444344|NCT01525615|363633247|FG001|Overall Study|Other reason not described above|0|||
105444345|NCT01525615|363633248|FG002|Overall Study|Other reason not described above|1|||
105444346|NCT01946152|363633249|FG000|Overall Study|Adverse Event|1|||
105444347|NCT01946152|363633250|FG001|Overall Study|Adverse Event|0|||
105444348|NCT01946152|363633251|FG002|Overall Study|Adverse Event|0|||
105779465|NCT04052425|364844761|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
105444349|NCT01946152|363633252|FG003|Overall Study|Adverse Event|0|||
105444350|NCT01946152|363633249|FG000|Overall Study|Withdrawal by Subject|0|||
105444351|NCT01946152|363633250|FG001|Overall Study|Withdrawal by Subject|2|||
105444352|NCT01946152|363633251|FG002|Overall Study|Withdrawal by Subject|0|||
105444353|NCT01946152|363633252|FG003|Overall Study|Withdrawal by Subject|0|||
105444354|NCT01946152|363633249|FG000|Overall Study|Progression|0|||
105444355|NCT01946152|363633250|FG001|Overall Study|Progression|1|||
105444356|NCT01946152|363633251|FG002|Overall Study|Progression|4|||
105444357|NCT01946152|363633252|FG003|Overall Study|Progression|7|||
105444358|NCT01946152|363633249|FG000|Overall Study|Physician Decision|0|||
105444359|NCT01946152|363633250|FG001|Overall Study|Physician Decision|0|||
105444360|NCT01946152|363633251|FG002|Overall Study|Physician Decision|1|||
105444361|NCT01946152|363633252|FG003|Overall Study|Physician Decision|0|||
105444362|NCT01946152|363633249|FG000|Overall Study|Second malignancy|0|||
105444363|NCT01946152|363633250|FG001|Overall Study|Second malignancy|0|||
105779466|NCT04052425|364844762|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
105444364|NCT01946152|363633251|FG002|Overall Study|Second malignancy|1|||
105444365|NCT01946152|363633252|FG003|Overall Study|Second malignancy|0|||
105444366|NCT01946152|363633249|FG000|Overall Study|Adverse Event|0|||
105444367|NCT01946152|363633250|FG001|Overall Study|Adverse Event|0|||
105444368|NCT01946152|363633251|FG002|Overall Study|Adverse Event|0|||
105444369|NCT01946152|363633252|FG003|Overall Study|Adverse Event|1|||
105444370|NCT03712787|363633253|FG000|Overall Study|Adverse Event|2|||
105444371|NCT03712787|363633254|FG001|Overall Study|Adverse Event|3|||
105444372|NCT03712787|363633255|FG002|Overall Study|Adverse Event|0|||
105444373|NCT03712787|363633256|FG003|Overall Study|Adverse Event|4|||
105444374|NCT03712787|363633253|FG000|Overall Study|Withdrawal by Subject|4|||
105444375|NCT03712787|363633254|FG001|Overall Study|Withdrawal by Subject|14|||
105444376|NCT03712787|363633255|FG002|Overall Study|Withdrawal by Subject|12|||
105444377|NCT03712787|363633256|FG003|Overall Study|Withdrawal by Subject|8|||
105444378|NCT03712787|363633253|FG000|Overall Study|Lost to Follow-up|1|||
105444379|NCT03712787|363633254|FG001|Overall Study|Lost to Follow-up|1|||
105444380|NCT03712787|363633255|FG002|Overall Study|Lost to Follow-up|2|||
105444381|NCT03712787|363633256|FG003|Overall Study|Lost to Follow-up|1|||
105444382|NCT03712787|363633253|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
105444383|NCT03712787|363633254|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
105444384|NCT03712787|363633255|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
105444385|NCT03712787|363633256|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
105444386|NCT03712787|363633253|FG000|Overall Study|COVID-19 Infection|0|||
105444387|NCT03712787|363633254|FG001|Overall Study|COVID-19 Infection|1|||
105444388|NCT03712787|363633255|FG002|Overall Study|COVID-19 Infection|0|||
105444389|NCT03712787|363633256|FG003|Overall Study|COVID-19 Infection|0|||
105444390|NCT03712787|363633253|FG000|Overall Study|Other, Not Specified|79|||
105444391|NCT03712787|363633254|FG001|Overall Study|Other, Not Specified|77|||
105444392|NCT03712787|363633255|FG002|Overall Study|Other, Not Specified|74|||
105444393|NCT03712787|363633256|FG003|Overall Study|Other, Not Specified|78|||
105444394|NCT04794270|363633264|FG000|Period 1|Non Compliance|1|||
105444395|NCT04794270|363633265|FG001|Period 1|Non Compliance|0|||
105444396|NCT04794270|363633264|FG000|Period 1|Adverse Event|1|||
105444397|NCT04794270|363633265|FG001|Period 1|Adverse Event|0|||
105444398|NCT04794270|363633264|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
105444399|NCT04794270|363633265|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
105444400|NCT02679755|363633266|FG000|Overall Study|Death|0|||
105444401|NCT02679755|363633267|FG001|Overall Study|Death|3|||
105444402|NCT02679755|363633266|FG000|Overall Study|Global deterioration of health status|1|||
105444403|NCT02679755|363633267|FG001|Overall Study|Global deterioration of health status|8|||
105444404|NCT02679755|363633266|FG000|Overall Study|Lost to Follow-up|1|||
105444405|NCT02679755|363633267|FG001|Overall Study|Lost to Follow-up|0|||
105444406|NCT02679755|363633266|FG000|Overall Study|Objective progression or relapse|24|||
105444407|NCT02679755|363633267|FG001|Overall Study|Objective progression or relapse|83|||
105444408|NCT02679755|363633266|FG000|Overall Study|Not defined|0|||
105444409|NCT02679755|363633267|FG001|Overall Study|Not defined|2|||
105444410|NCT02679755|363633266|FG000|Overall Study|Withdrawal by participant|6|||
105444411|NCT02679755|363633267|FG001|Overall Study|Withdrawal by participant|3|||
105444412|NCT02679755|363633266|FG000|Overall Study|Adverse Event|1|||
105444413|NCT02679755|363633267|FG001|Overall Study|Adverse Event|4|||
105444414|NCT02679755|363633266|FG000|Overall Study|Adverse events not related to study drug|1|||
105444415|NCT02679755|363633267|FG001|Overall Study|Adverse events not related to study drug|2|||
105444416|NCT01061359|363633268|FG000|Overall Study|Death|32|||
105444417|NCT01061359|363633268|FG000|Overall Study|Lost to Follow-up|1072|||
105444418|NCT01061359|363633268|FG000|Overall Study|Relapse|187|||
105779467|NCT04052425|364844763|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
105335796|NCT01217476|363230106|FG000|Overall Study|Surgery on the Target Limb|0|||
105779468|NCT04052425|364844760|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
105779469|NCT04052425|364844761|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
105779470|NCT04052425|364844762|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
105779471|NCT04052425|364844763|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
105444419|NCT01061359|363633268|FG000|Overall Study|Secondary neoplasm|11|||
105779472|NCT04052425|364844760|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
105779473|NCT04052425|364844761|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
105444420|NCT04014062|363633269|FG000|Period I: Dosing|Medical Grounds|4|||
105444421|NCT04014062|363633270|FG001|Period I: Dosing|Medical Grounds|5|||
105444422|NCT04014062|363633269|FG000|Period I: Dosing|Withdrawal by Subject|3|||
105444423|NCT04014062|363633270|FG001|Period I: Dosing|Withdrawal by Subject|1|||
105444424|NCT03038126|363633271|FG000|Overall Study|Death|1|||
105444425|NCT03038126|363633272|FG001|Overall Study|Death|1|||
105444426|NCT03038126|363633271|FG000|Overall Study|Withdrawal by Subject|5|||
105444427|NCT03038126|363633272|FG001|Overall Study|Withdrawal by Subject|0|||
105444428|NCT03038126|363633271|FG000|Overall Study|Lost to Follow-up|0|||
105444429|NCT03038126|363633272|FG001|Overall Study|Lost to Follow-up|1|||
105444430|NCT03038126|363633271|FG000|Overall Study|Long Term Hospitalization|2|||
105444431|NCT03038126|363633272|FG001|Overall Study|Long Term Hospitalization|0|||
105779474|NCT04052425|364844762|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
105444432|NCT03038126|363633271|FG000|Overall Study|Too Ill to Participate|1|||
105444433|NCT03038126|363633272|FG001|Overall Study|Too Ill to Participate|2|||
105444434|NCT02610777|363633273|FG000|Overall Study|Lost to Follow-up|1|||
105779475|NCT04052425|364844763|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
105779476|NCT04052425|364844760|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
105779477|NCT04052425|364844761|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
105779478|NCT04052425|364844762|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
105779479|NCT04052425|364844763|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
105779480|NCT04052425|364844760|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
105779481|NCT04052425|364844761|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
105779482|NCT04052425|364844762|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
105779483|NCT04052425|364844763|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
105779484|NCT04052425|364844760|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
105779485|NCT04052425|364844761|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
105779486|NCT04052425|364844762|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
105779487|NCT04052425|364844763|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
105779488|NCT04052425|364844760|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
105779489|NCT04052425|364844761|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
105779490|NCT04052425|364844762|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
105779491|NCT04052425|364844763|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
105779492|NCT02452034|364844764|FG000|Overall Study|Adverse Event|0|||
105779493|NCT02452034|364844765|FG001|Overall Study|Adverse Event|0|||
105779494|NCT02452034|364844766|FG002|Overall Study|Adverse Event|0|||
105779495|NCT02452034|364844767|FG003|Overall Study|Adverse Event|0|||
105779496|NCT02452034|364844768|FG004|Overall Study|Adverse Event|0|||
105779497|NCT02452034|364844769|FG005|Overall Study|Adverse Event|1|||
105779498|NCT02452034|364844764|FG000|Overall Study|Death|0|||
105779499|NCT02452034|364844765|FG001|Overall Study|Death|0|||
105779500|NCT02452034|364844766|FG002|Overall Study|Death|0|||
105779501|NCT02452034|364844767|FG003|Overall Study|Death|0|||
105779502|NCT02452034|364844768|FG004|Overall Study|Death|1|||
105779503|NCT02452034|364844769|FG005|Overall Study|Death|1|||
105779504|NCT02452034|364844764|FG000|Overall Study|Physician Decision|0|||
105779505|NCT02452034|364844765|FG001|Overall Study|Physician Decision|1|||
105444435|NCT02610777|363633274|FG001|Overall Study|Lost to Follow-up|0|||
105444436|NCT02610777|363633273|FG000|Overall Study|Site Terminated by Sponsor|9|||
105444437|NCT02610777|363633274|FG001|Overall Study|Site Terminated by Sponsor|8|||
105444438|NCT02610777|363633273|FG000|Overall Study|Withdrawal by Subject|2|||
105444439|NCT02610777|363633274|FG001|Overall Study|Withdrawal by Subject|2|||
105444440|NCT02610777|363633273|FG000|Overall Study|Reason not Specified|0|||
105444441|NCT02610777|363633274|FG001|Overall Study|Reason not Specified|1|||
105444442|NCT02610777|363633273|FG000|Overall Study|Death|50|||
105444443|NCT02610777|363633274|FG001|Overall Study|Death|47|||
105444444|NCT01724866|363633275|FG000|Overall Study|Adverse Event|0|||
105444445|NCT01724866|363633276|FG001|Overall Study|Adverse Event|0|||
105444446|NCT01724866|363633277|FG002|Overall Study|Adverse Event|1|||
105779506|NCT02452034|364844766|FG002|Overall Study|Physician Decision|1|||
105779507|NCT02452034|364844767|FG003|Overall Study|Physician Decision|0|||
105779508|NCT02452034|364844768|FG004|Overall Study|Physician Decision|0|||
105779509|NCT02452034|364844769|FG005|Overall Study|Physician Decision|0|||
105779510|NCT02452034|364844764|FG000|Overall Study|Protocol Violation|0|||
105779511|NCT02452034|364844765|FG001|Overall Study|Protocol Violation|0|||
105779512|NCT02452034|364844766|FG002|Overall Study|Protocol Violation|0|||
105779513|NCT02452034|364844767|FG003|Overall Study|Protocol Violation|0|||
105779514|NCT02452034|364844768|FG004|Overall Study|Protocol Violation|0|||
105779515|NCT02452034|364844769|FG005|Overall Study|Protocol Violation|1|||
105779516|NCT02452034|364844764|FG000|Overall Study|Screen Failure|1|||
105779517|NCT02452034|364844765|FG001|Overall Study|Screen Failure|0|||
105779518|NCT02452034|364844766|FG002|Overall Study|Screen Failure|0|||
105779519|NCT02452034|364844767|FG003|Overall Study|Screen Failure|1|||
105779520|NCT02452034|364844768|FG004|Overall Study|Screen Failure|0|||
105779521|NCT02452034|364844769|FG005|Overall Study|Screen Failure|0|||
105779522|NCT02452034|364844764|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
105779523|NCT02452034|364844765|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
105779524|NCT02452034|364844766|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
105779525|NCT02452034|364844767|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
105779526|NCT02452034|364844768|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
105779527|NCT02452034|364844769|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
105779528|NCT05102734|364844773|FG000|Overall Study|Did not require vasopressors|1|||
105779529|NCT05102734|364844774|FG001|Overall Study|Did not require vasopressors|0|||
105779530|NCT05102734|364844773|FG000|Overall Study|Did not have functioning PA catheter|1|||
105779531|NCT05102734|364844774|FG001|Overall Study|Did not have functioning PA catheter|0|||
105779532|NCT05102734|364844773|FG000|Overall Study|Inadequate video quality|2|||
105779533|NCT05102734|364844774|FG001|Overall Study|Inadequate video quality|0|||
105444447|NCT01724866|363633278|FG003|Overall Study|Adverse Event|1|||
105779534|NCT02074059|364844776|FG000|Overall Study|Death|0|||
105779535|NCT02074059|364844777|FG001|Overall Study|Death|0|||
105779536|NCT02074059|364844778|FG002|Overall Study|Death|0|||
105779537|NCT02074059|364844779|FG003|Overall Study|Death|0|||
105779538|NCT02074059|364844780|FG004|Overall Study|Death|1|||
105779539|NCT02074059|364844781|FG005|Overall Study|Death|1|||
105779540|NCT00917553|364844783|FG000|Overall Study|Lost to Follow-up|2|||
105779541|NCT00917553|364844784|FG001|Overall Study|Lost to Follow-up|1|||
105779542|NCT03432819|364844786|FG000|Overall Study|Lost to Follow-up|2|||
105779543|NCT03432819|364844787|FG001|Overall Study|Lost to Follow-up|2|||
105779544|NCT03432819|364844786|FG000|Overall Study|Withdrawal by Subject|5|||
105779545|NCT03432819|364844787|FG001|Overall Study|Withdrawal by Subject|3|||
105779546|NCT02418000|364844788|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
105779547|NCT02418000|364844789|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779548|NCT02418000|364844790|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779549|NCT02418000|364844791|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779550|NCT02418000|364844792|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779551|NCT02418000|364844788|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
105779552|NCT02418000|364844789|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
105779553|NCT02418000|364844790|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
105779554|NCT02418000|364844791|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
105779555|NCT02418000|364844792|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
105779556|NCT02418000|364844788|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
105779557|NCT02418000|364844789|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
105779558|NCT02418000|364844790|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
105779559|NCT02418000|364844791|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
105779560|NCT02418000|364844792|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
105779561|NCT02418000|364844788|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779562|NCT02418000|364844789|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
105779563|NCT02418000|364844790|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779564|NCT02418000|364844791|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779565|NCT02418000|364844792|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779566|NCT02418000|364844788|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
105779567|NCT02418000|364844789|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
105779568|NCT02418000|364844790|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
105779569|NCT02418000|364844791|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
105779570|NCT02418000|364844792|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
105779571|NCT02418000|364844788|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779572|NCT02418000|364844789|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779573|NCT02418000|364844790|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
105779574|NCT02418000|364844791|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779575|NCT02418000|364844792|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779576|NCT02418000|364844788|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779577|NCT02418000|364844789|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779578|NCT02418000|364844790|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779579|NCT02418000|364844791|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
105779580|NCT02418000|364844792|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779581|NCT02418000|364844788|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
105779582|NCT02418000|364844789|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
105779583|NCT02418000|364844790|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
105779584|NCT02418000|364844791|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
105779585|NCT02418000|364844792|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
105779586|NCT02418000|364844788|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779587|NCT02418000|364844789|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779588|NCT02418000|364844790|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779589|NCT02418000|364844791|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779590|NCT02418000|364844792|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
105779591|NCT02030067|364844793|FG000|Overall Study|Disease Progression|1|||
105779592|NCT02030067|364844794|FG001|Overall Study|Disease Progression|1|||
105779593|NCT02030067|364844795|FG002|Overall Study|Disease Progression|2|||
105779594|NCT02030067|364844796|FG003|Overall Study|Disease Progression|2|||
105779595|NCT02030067|364844797|FG004|Overall Study|Disease Progression|3|||
105444448|NCT01724866|363633275|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
105779596|NCT02030067|364844798|FG005|Overall Study|Disease Progression|2|||
105779597|NCT02030067|364844799|FG006|Overall Study|Disease Progression|3|||
105779598|NCT02030067|364844800|FG007|Overall Study|Disease Progression|3|||
105779599|NCT02030067|364844801|FG008|Overall Study|Disease Progression|4|||
105779600|NCT02030067|364844802|FG009|Overall Study|Disease Progression|3|||
105779601|NCT02030067|364844803|FG010|Overall Study|Disease Progression|7|||
105484831|NCT01992159|363786985|FG003|Overall Study|Withdrawal by Subject|3|||
105779602|NCT02030067|364844804|FG011|Overall Study|Disease Progression|2|||
105779603|NCT02030067|364844805|FG012|Overall Study|Disease Progression|59|||
105779604|NCT02030067|364844793|FG000|Overall Study|Withdrawal by Subject|0|||
105779605|NCT02030067|364844794|FG001|Overall Study|Withdrawal by Subject|0|||
105779606|NCT02030067|364844795|FG002|Overall Study|Withdrawal by Subject|0|||
105779607|NCT02030067|364844796|FG003|Overall Study|Withdrawal by Subject|1|||
105779608|NCT02030067|364844797|FG004|Overall Study|Withdrawal by Subject|0|||
105779609|NCT02030067|364844798|FG005|Overall Study|Withdrawal by Subject|0|||
105779610|NCT02030067|364844799|FG006|Overall Study|Withdrawal by Subject|0|||
105779611|NCT02030067|364844800|FG007|Overall Study|Withdrawal by Subject|1|||
105779612|NCT02030067|364844801|FG008|Overall Study|Withdrawal by Subject|0|||
105779613|NCT02030067|364844802|FG009|Overall Study|Withdrawal by Subject|0|||
105779614|NCT02030067|364844803|FG010|Overall Study|Withdrawal by Subject|3|||
105779615|NCT02030067|364844804|FG011|Overall Study|Withdrawal by Subject|0|||
105779616|NCT02030067|364844805|FG012|Overall Study|Withdrawal by Subject|6|||
105779617|NCT02030067|364844793|FG000|Overall Study|Physician Decision|0|||
105779618|NCT02030067|364844794|FG001|Overall Study|Physician Decision|0|||
105779619|NCT02030067|364844795|FG002|Overall Study|Physician Decision|0|||
105779620|NCT02030067|364844796|FG003|Overall Study|Physician Decision|0|||
105779621|NCT02030067|364844797|FG004|Overall Study|Physician Decision|0|||
105779622|NCT02030067|364844798|FG005|Overall Study|Physician Decision|0|||
105779623|NCT02030067|364844799|FG006|Overall Study|Physician Decision|0|||
105779624|NCT02030067|364844800|FG007|Overall Study|Physician Decision|0|||
105779625|NCT02030067|364844801|FG008|Overall Study|Physician Decision|0|||
105779626|NCT02030067|364844802|FG009|Overall Study|Physician Decision|0|||
105779627|NCT02030067|364844803|FG010|Overall Study|Physician Decision|1|||
105779628|NCT02030067|364844804|FG011|Overall Study|Physician Decision|0|||
105779629|NCT02030067|364844805|FG012|Overall Study|Physician Decision|3|||
105779630|NCT02030067|364844793|FG000|Overall Study|other reasons|0|||
105779631|NCT02030067|364844794|FG001|Overall Study|other reasons|0|||
105779632|NCT02030067|364844795|FG002|Overall Study|other reasons|0|||
105779633|NCT02030067|364844796|FG003|Overall Study|other reasons|0|||
105779634|NCT02030067|364844797|FG004|Overall Study|other reasons|0|||
105779635|NCT02030067|364844798|FG005|Overall Study|other reasons|1|||
105779636|NCT02030067|364844799|FG006|Overall Study|other reasons|0|||
105779637|NCT02030067|364844800|FG007|Overall Study|other reasons|0|||
105779638|NCT02030067|364844801|FG008|Overall Study|other reasons|2|||
105779639|NCT02030067|364844802|FG009|Overall Study|other reasons|0|||
105779640|NCT02030067|364844803|FG010|Overall Study|other reasons|0|||
105779641|NCT02030067|364844804|FG011|Overall Study|other reasons|0|||
105779642|NCT02030067|364844805|FG012|Overall Study|other reasons|4|||
105779643|NCT02030067|364844793|FG000|Overall Study|Adverse Event|0|||
105779644|NCT02030067|364844794|FG001|Overall Study|Adverse Event|0|||
105779645|NCT02030067|364844795|FG002|Overall Study|Adverse Event|0|||
105779646|NCT02030067|364844796|FG003|Overall Study|Adverse Event|0|||
105779647|NCT02030067|364844797|FG004|Overall Study|Adverse Event|0|||
105779648|NCT02030067|364844798|FG005|Overall Study|Adverse Event|0|||
105779649|NCT02030067|364844799|FG006|Overall Study|Adverse Event|0|||
105779650|NCT02030067|364844800|FG007|Overall Study|Adverse Event|0|||
105779651|NCT02030067|364844801|FG008|Overall Study|Adverse Event|0|||
105779652|NCT02030067|364844802|FG009|Overall Study|Adverse Event|0|||
105779653|NCT02030067|364844803|FG010|Overall Study|Adverse Event|0|||
105779654|NCT02030067|364844804|FG011|Overall Study|Adverse Event|1|||
105779655|NCT02030067|364844805|FG012|Overall Study|Adverse Event|8|||
105779656|NCT00496782|364844806|FG000|Overall Study|Protocol Violation|1|||
105779657|NCT00496782|364844807|FG001|Overall Study|Protocol Violation|2|||
105779658|NCT00760994|364844808|FG000|Overall Study|Lost to Follow-up|4|||
105779659|NCT00760994|364844809|FG001|Overall Study|Lost to Follow-up|4|||
105779660|NCT00760994|364844810|FG002|Overall Study|Lost to Follow-up|3|||
105779661|NCT00660816|364844811|FG000|Overall Study|Adverse Event|1|||
105779662|NCT00660816|364844812|FG001|Overall Study|Adverse Event|2|||
105779663|NCT00660816|364844811|FG000|Overall Study|Withdrawal by Subject|1|||
105779664|NCT00660816|364844812|FG001|Overall Study|Withdrawal by Subject|0|||
105335797|NCT01217476|363230107|FG001|Overall Study|Surgery on the Target Limb|2|||
105779665|NCT00660816|364844811|FG000|Overall Study|Death|0|||
105779666|NCT00660816|364844812|FG001|Overall Study|Death|2|||
105779667|NCT00660816|364844811|FG000|Overall Study|Lack of Efficacy|1|||
105779668|NCT00660816|364844812|FG001|Overall Study|Lack of Efficacy|0|||
105779669|NCT00660816|364844811|FG000|Overall Study|Physician Decision|0|||
105779670|NCT00660816|364844812|FG001|Overall Study|Physician Decision|2|||
105779671|NCT00660816|364844811|FG000|Overall Study|Protocol Violation|1|||
105779672|NCT00660816|364844812|FG001|Overall Study|Protocol Violation|0|||
105779673|NCT00660816|364844811|FG000|Overall Study|Disease Progression|16|||
105779674|NCT00660816|364844812|FG001|Overall Study|Disease Progression|12|||
105779675|NCT00660816|364844811|FG000|Overall Study|Complicating Disease|0|||
105779676|NCT00660816|364844812|FG001|Overall Study|Complicating Disease|1|||
105779677|NCT04212221|364844813|FG000|Overall Study|Remained on Treatment|0|||
105779678|NCT04212221|364844814|FG001|Overall Study|Remained on Treatment|0|||
105779679|NCT04212221|364844815|FG002|Overall Study|Remained on Treatment|0|||
105779680|NCT04212221|364844816|FG003|Overall Study|Remained on Treatment|1|||
105779681|NCT04212221|364844817|FG004|Overall Study|Remained on Treatment|0|||
105779682|NCT04212221|364844818|FG005|Overall Study|Remained on Treatment|0|||
105779683|NCT04212221|364844819|FG006|Overall Study|Remained on Treatment|3|||
105779684|NCT04212221|364844820|FG007|Overall Study|Remained on Treatment|9|||
105779685|NCT04212221|364844813|FG000|Overall Study|Adverse Event|0|||
105779686|NCT04212221|364844814|FG001|Overall Study|Adverse Event|0|||
105779687|NCT04212221|364844815|FG002|Overall Study|Adverse Event|0|||
105779688|NCT04212221|364844816|FG003|Overall Study|Adverse Event|0|||
105779689|NCT04212221|364844817|FG004|Overall Study|Adverse Event|0|||
105779690|NCT04212221|364844818|FG005|Overall Study|Adverse Event|0|||
105779691|NCT04212221|364844819|FG006|Overall Study|Adverse Event|2|||
105779692|NCT04212221|364844820|FG007|Overall Study|Adverse Event|3|||
105779693|NCT04212221|364844813|FG000|Overall Study|Death|0|||
105779694|NCT04212221|364844814|FG001|Overall Study|Death|0|||
105779695|NCT04212221|364844815|FG002|Overall Study|Death|0|||
105779696|NCT04212221|364844816|FG003|Overall Study|Death|0|||
105779697|NCT04212221|364844817|FG004|Overall Study|Death|0|||
105779698|NCT04212221|364844818|FG005|Overall Study|Death|0|||
105779699|NCT04212221|364844819|FG006|Overall Study|Death|0|||
105779700|NCT04212221|364844820|FG007|Overall Study|Death|2|||
105779701|NCT04212221|364844813|FG000|Overall Study|Disease progression according to irRECIST|1|||
105779702|NCT04212221|364844814|FG001|Overall Study|Disease progression according to irRECIST|2|||
105779703|NCT04212221|364844815|FG002|Overall Study|Disease progression according to irRECIST|3|||
105779704|NCT04212221|364844816|FG003|Overall Study|Disease progression according to irRECIST|3|||
105779705|NCT04212221|364844817|FG004|Overall Study|Disease progression according to irRECIST|2|||
105779706|NCT04212221|364844818|FG005|Overall Study|Disease progression according to irRECIST|2|||
105779707|NCT04212221|364844819|FG006|Overall Study|Disease progression according to irRECIST|21|||
105779708|NCT04212221|364844820|FG007|Overall Study|Disease progression according to irRECIST|17|||
105779709|NCT04212221|364844813|FG000|Overall Study|Global Deterioration of Health Status|0|||
105779710|NCT04212221|364844814|FG001|Overall Study|Global Deterioration of Health Status|0|||
105779711|NCT04212221|364844815|FG002|Overall Study|Global Deterioration of Health Status|0|||
105779712|NCT04212221|364844816|FG003|Overall Study|Global Deterioration of Health Status|0|||
105779713|NCT04212221|364844817|FG004|Overall Study|Global Deterioration of Health Status|0|||
105779714|NCT04212221|364844818|FG005|Overall Study|Global Deterioration of Health Status|0|||
105779715|NCT04212221|364844819|FG006|Overall Study|Global Deterioration of Health Status|0|||
105779716|NCT04212221|364844820|FG007|Overall Study|Global Deterioration of Health Status|2|||
105779717|NCT04212221|364844813|FG000|Overall Study|Investigator's Decision|0|||
105779718|NCT04212221|364844814|FG001|Overall Study|Investigator's Decision|0|||
105779719|NCT04212221|364844815|FG002|Overall Study|Investigator's Decision|0|||
105779720|NCT04212221|364844816|FG003|Overall Study|Investigator's Decision|1|||
105779721|NCT04212221|364844817|FG004|Overall Study|Investigator's Decision|0|||
105779722|NCT04212221|364844818|FG005|Overall Study|Investigator's Decision|0|||
105779723|NCT04212221|364844819|FG006|Overall Study|Investigator's Decision|3|||
105779724|NCT04212221|364844820|FG007|Overall Study|Investigator's Decision|0|||
105779725|NCT04212221|364844813|FG000|Overall Study|Participant refused to continue treatment|0|||
105779726|NCT04212221|364844814|FG001|Overall Study|Participant refused to continue treatment|1|||
105779727|NCT04212221|364844815|FG002|Overall Study|Participant refused to continue treatment|0|||
105779728|NCT04212221|364844816|FG003|Overall Study|Participant refused to continue treatment|1|||
105779729|NCT04212221|364844817|FG004|Overall Study|Participant refused to continue treatment|1|||
105779730|NCT04212221|364844818|FG005|Overall Study|Participant refused to continue treatment|2|||
105779731|NCT04212221|364844819|FG006|Overall Study|Participant refused to continue treatment|4|||
105779732|NCT04212221|364844820|FG007|Overall Study|Participant refused to continue treatment|2|||
105779733|NCT04212221|364844813|FG000|Overall Study|Protocol Violation|0|||
105779734|NCT04212221|364844814|FG001|Overall Study|Protocol Violation|0|||
105779735|NCT04212221|364844815|FG002|Overall Study|Protocol Violation|0|||
105484832|NCT01992159|363786982|FG000|Overall Study|Adverse Event|0|||
105779736|NCT04212221|364844816|FG003|Overall Study|Protocol Violation|0|||
105779737|NCT04212221|364844817|FG004|Overall Study|Protocol Violation|0|||
105779738|NCT04212221|364844818|FG005|Overall Study|Protocol Violation|0|||
105779739|NCT04212221|364844819|FG006|Overall Study|Protocol Violation|0|||
105779740|NCT04212221|364844820|FG007|Overall Study|Protocol Violation|1|||
105779741|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
105779742|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
105779743|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
105779744|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
105779745|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
105779746|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
105779747|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Death|1|||
105779748|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Death|1|||
105779749|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Death|1|||
105779750|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Death|0|||
105779751|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Death|0|||
105779752|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Death|0|||
105779753|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
105779754|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
105779755|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
105779756|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
105779757|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
105779758|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
105779759|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
105779760|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
105779761|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
105779762|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
105779763|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
105779764|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
105779765|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
105779766|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
105779767|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
105779768|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
105779769|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
105779770|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
105779771|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
105779772|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
105779773|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
105779774|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
105779775|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
105779776|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
105779777|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
105779778|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
105779779|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
105779780|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
105779781|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
105779782|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
105779783|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
105779784|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
105779785|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
105779786|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
105779787|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
105779788|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
105779789|NCT03370133|364844825|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
105779790|NCT03370133|364844826|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
105779791|NCT03370133|364844827|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
105779792|NCT03370133|364844828|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
105779793|NCT03370133|364844829|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
105779794|NCT03370133|364844830|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
105779795|NCT03370133|364844825|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
105779796|NCT03370133|364844826|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
105779797|NCT03370133|364844827|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
105779798|NCT03370133|364844828|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
105779799|NCT03370133|364844829|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
105779800|NCT03370133|364844830|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
105779801|NCT03370133|364844825|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
105779802|NCT03370133|364844826|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
105779803|NCT03370133|364844827|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
105779804|NCT03370133|364844828|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
105779805|NCT03370133|364844829|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
105779806|NCT03370133|364844830|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
105779807|NCT03370133|364844825|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
105779808|NCT03370133|364844826|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
105779809|NCT03370133|364844827|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
105779810|NCT03370133|364844828|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
105779811|NCT03370133|364844829|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
105779812|NCT03370133|364844830|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
105779813|NCT03370133|364844825|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
105779814|NCT03370133|364844826|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
105779815|NCT03370133|364844827|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
105779816|NCT03370133|364844828|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
105779817|NCT03370133|364844829|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
105779818|NCT03370133|364844830|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
105779819|NCT03370133|364844825|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
105779820|NCT03370133|364844826|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
105779821|NCT03370133|364844827|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
105779822|NCT03370133|364844828|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
105779823|NCT03370133|364844829|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
105779824|NCT03370133|364844830|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
105779825|NCT03370133|364844825|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
105779826|NCT03370133|364844826|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
105779827|NCT03370133|364844827|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
105779828|NCT03370133|364844828|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
105779829|NCT03370133|364844829|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
105779830|NCT03370133|364844830|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
105779831|NCT00266695|364844837|FG000|Overall Study|Adverse Event|1|||
105779832|NCT00266695|364844837|FG000|Overall Study|Death|9|||
105779833|NCT00266695|364844837|FG000|Overall Study|Physician Decision|1|||
105779834|NCT00266695|364844837|FG000|Overall Study|Lost to Follow-up|3|||
105779835|NCT00266695|364844837|FG000|Overall Study|Withdrawal by Subject|15|||
105779836|NCT00819052|364844839|FG000|Overall Study|Adverse Event|0|||
105779837|NCT00819052|364844840|FG001|Overall Study|Adverse Event|5|||
105779838|NCT00819052|364844839|FG000|Overall Study|Protocol Violation|1|||
105779839|NCT00819052|364844840|FG001|Overall Study|Protocol Violation|2|||
105779840|NCT00819052|364844839|FG000|Overall Study|Lost to Follow-up|1|||
105779841|NCT00819052|364844840|FG001|Overall Study|Lost to Follow-up|2|||
105779842|NCT00819052|364844839|FG000|Overall Study|Withdrawal by Subject|1|||
105779843|NCT00819052|364844840|FG001|Overall Study|Withdrawal by Subject|2|||
105779844|NCT00819052|364844839|FG000|Overall Study|Lack of Efficacy|1|||
105779845|NCT00819052|364844840|FG001|Overall Study|Lack of Efficacy|1|||
105779846|NCT00819052|364844839|FG000|Overall Study|Pregnancy|1|||
105779847|NCT00819052|364844840|FG001|Overall Study|Pregnancy|2|||
105779848|NCT00819052|364844839|FG000|Overall Study|Death or events leading to death|1|||
105779849|NCT00819052|364844840|FG001|Overall Study|Death or events leading to death|0|||
105779850|NCT00362297|364844841|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
105779851|NCT00362297|364844842|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
105779852|NCT01365468|364844847|FG000|Overall Study|Physician Decision|1|||
105779853|NCT01365468|364844848|FG001|Overall Study|Physician Decision|0|||
105779854|NCT01365468|364844847|FG000|Overall Study|Disease progression|1|||
105779855|NCT01365468|364844848|FG001|Overall Study|Disease progression|0|||
105779856|NCT01365468|364844847|FG000|Overall Study|Lost to Follow-up|2|||
105779857|NCT01365468|364844848|FG001|Overall Study|Lost to Follow-up|0|||
105779858|NCT03524664|364844849|FG000|Overall Study|Withdrawal by Subject|1|||
105779859|NCT03524664|364844850|FG001|Overall Study|Withdrawal by Subject|2|||
105779860|NCT03524664|364844849|FG000|Overall Study|Lost to Follow-up|4|||
105779861|NCT03524664|364844850|FG001|Overall Study|Lost to Follow-up|13|||
105779862|NCT01815099|364844851|FG000|Overall Study|Lack of Efficacy|1|||
105779863|NCT01815099|364844851|FG000|Overall Study|unable to attend study visits|1|||
105779864|NCT03769753|364844854|FG000|Overall Study|Not Treated|6|||
105779865|NCT03769753|364844854|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
105779866|NCT02694562|364844855|FG000|Overall Study|Death|8|||
105779867|NCT02694562|364844855|FG000|Overall Study|Protocol Violation|4|||
105779868|NCT02694562|364844855|FG000|Overall Study|Lost to Follow-up|3|||
105779869|NCT02694562|364844855|FG000|Overall Study|Screen Failure|2|||
105779870|NCT02694562|364844855|FG000|Overall Study|Physician Decision|1|||
105779871|NCT01888367|364844858|FG000|Overall Study|Physician Decision|3|||
105779872|NCT01888367|364844859|FG001|Overall Study|Physician Decision|4|||
105779873|NCT01888367|364844860|FG002|Overall Study|Physician Decision|2|||
105779874|NCT01888367|364844858|FG000|Overall Study|Death|2|||
105779875|NCT01888367|364844859|FG001|Overall Study|Death|0|||
105779876|NCT01888367|364844860|FG002|Overall Study|Death|1|||
105779877|NCT01888367|364844858|FG000|Overall Study|Withdrawal by Subject|1|||
105779878|NCT01888367|364844859|FG001|Overall Study|Withdrawal by Subject|0|||
105779879|NCT01888367|364844860|FG002|Overall Study|Withdrawal by Subject|1|||
105779880|NCT01888367|364844858|FG000|Overall Study|Lost to Follow-up|1|||
105779881|NCT01888367|364844859|FG001|Overall Study|Lost to Follow-up|1|||
105779882|NCT01888367|364844860|FG002|Overall Study|Lost to Follow-up|0|||
105779883|NCT01888367|364844858|FG000|Overall Study|Protocol Violation|0|||
105779884|NCT01888367|364844859|FG001|Overall Study|Protocol Violation|0|||
105779885|NCT01888367|364844860|FG002|Overall Study|Protocol Violation|1|||
105779886|NCT01888367|364844858|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
105779887|NCT01888367|364844859|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
105779888|NCT01888367|364844860|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
105779889|NCT00877929|364844861|FG000|Overall Study|Adverse Event|11|||
105779890|NCT00877929|364844862|FG001|Overall Study|Adverse Event|20|||
105335798|NCT01217476|363230106|FG000|Overall Study|Protocol Deviation|1|||
105779891|NCT00877929|364844861|FG000|Overall Study|Protocol Violation|3|||
105779892|NCT00877929|364844862|FG001|Overall Study|Protocol Violation|3|||
105779893|NCT00877929|364844861|FG000|Overall Study|Lost to Follow-up|0|||
105779894|NCT00877929|364844862|FG001|Overall Study|Lost to Follow-up|1|||
105779895|NCT00877929|364844861|FG000|Overall Study|Withdrawal by Subject|4|||
105779896|NCT00877929|364844862|FG001|Overall Study|Withdrawal by Subject|4|||
105779897|NCT00877929|364844861|FG000|Overall Study|Lack of Efficacy|0|||
105779898|NCT00877929|364844862|FG001|Overall Study|Lack of Efficacy|1|||
105779899|NCT00877929|364844861|FG000|Overall Study|Other reason (not specified)|2|||
105779900|NCT00877929|364844862|FG001|Overall Study|Other reason (not specified)|6|||
105779901|NCT00784836|364844865|FG000|Overall Study|Early Study Termination|3|||
105779902|NCT00660829|364844866|FG000|Overall Study|Adverse Event|3|||
105779903|NCT00660829|364844867|FG001|Overall Study|Adverse Event|4|||
105779904|NCT00660829|364844866|FG000|Overall Study|Lack of Efficacy|2|||
105779905|NCT00660829|364844867|FG001|Overall Study|Lack of Efficacy|3|||
105779906|NCT00660829|364844866|FG000|Overall Study|Non-Compliance|0|||
105779907|NCT00660829|364844867|FG001|Overall Study|Non-Compliance|4|||
105779908|NCT00660829|364844866|FG000|Overall Study|Withdrawal by Subject|1|||
105779909|NCT00660829|364844867|FG001|Overall Study|Withdrawal by Subject|2|||
105779910|NCT00660829|364844866|FG000|Overall Study|Lost to Follow-up|3|||
105779911|NCT00660829|364844867|FG001|Overall Study|Lost to Follow-up|2|||
105779912|NCT00660829|364844866|FG000|Overall Study|Other|9|||
105779913|NCT00660829|364844867|FG001|Overall Study|Other|4|||
105779914|NCT00967343|364844874|FG000|Overall Study|Study termination by sponsor|12|||
105779915|NCT00967343|364844874|FG000|Overall Study|Death|24|||
105779916|NCT00967343|364844874|FG000|Overall Study|Relapse|1|||
105779917|NCT00967343|364844874|FG000|Overall Study|Lost to Follow-up|1|||
105779918|NCT00758394|364844875|FG000|2nd Intervention Order|Lost to Follow-up|0|||
105779919|NCT00758394|364844876|FG001|2nd Intervention Order|Lost to Follow-up|1|||
105779920|NCT00758394|364844877|FG002|2nd Intervention Order|Lost to Follow-up|0|||
105779921|NCT00758394|364844878|FG003|2nd Intervention Order|Lost to Follow-up|0|||
105779922|NCT00758394|364844875|FG000|3rd Intervention|Lost to Follow-up|1|||
105779923|NCT00758394|364844876|FG001|3rd Intervention|Lost to Follow-up|0|||
105779924|NCT00758394|364844877|FG002|3rd Intervention|Lost to Follow-up|0|||
105779925|NCT00758394|364844878|FG003|3rd Intervention|Lost to Follow-up|1|||
105779926|NCT03044730|364844886|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
105779927|NCT03044730|364844886|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
105779928|NCT03044730|364844886|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
105779929|NCT03044730|364844886|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
105779930|NCT03044730|364844886|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
105779931|NCT03044730|364844886|FG000|Cycles 4 and Beyond|Adverse Event|1|||
105779932|NCT03044730|364844886|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
105779933|NCT03044730|364844886|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
105779934|NCT03044730|364844886|FG000|On Follow-up for 2 Years|Death|17|||
105779935|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
105779936|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
105779937|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
105779938|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
105779939|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
105779940|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
105484833|NCT01992159|363786983|FG001|Overall Study|Adverse Event|1|||
105779941|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
105779942|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
105779943|NCT00950755|364844887|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
105779944|NCT00950755|364844887|FG000|Long-Term Follow-Up|Death|8|||
105779945|NCT00508820|364844888|FG000|Overall Study|Adverse Event|6|||
105779946|NCT00508820|364844889|FG001|Overall Study|Adverse Event|10|||
105779947|NCT00508820|364844888|FG000|Overall Study|Death|6|||
105779948|NCT00508820|364844889|FG001|Overall Study|Death|8|||
105779949|NCT00508820|364844888|FG000|Overall Study|Lost to Follow-up|1|||
105779950|NCT00508820|364844889|FG001|Overall Study|Lost to Follow-up|1|||
105779951|NCT00508820|364844888|FG000|Overall Study|Physician Decision|8|||
105779952|NCT00508820|364844889|FG001|Overall Study|Physician Decision|2|||
105779953|NCT00508820|364844888|FG000|Overall Study|Pregnancy|0|||
105779954|NCT00508820|364844889|FG001|Overall Study|Pregnancy|2|||
105779955|NCT00508820|364844888|FG000|Overall Study|Protocol Violation|2|||
105779956|NCT00508820|364844889|FG001|Overall Study|Protocol Violation|0|||
105779957|NCT00508820|364844888|FG000|Overall Study|Withdrawal by Subject|10|||
105779958|NCT00508820|364844889|FG001|Overall Study|Withdrawal by Subject|12|||
105779959|NCT00508820|364844888|FG000|Overall Study|Other|11|||
105779960|NCT00508820|364844889|FG001|Overall Study|Other|2|||
105335799|NCT01217476|363230107|FG001|Overall Study|Protocol Deviation|0|||
105779961|NCT00508820|364844888|FG000|Overall Study|Noncompliance|1|||
105779962|NCT00508820|364844889|FG001|Overall Study|Noncompliance|0|||
105779963|NCT00508820|364844888|FG000|Overall Study|Requirement for alternative therapy|7|||
105779964|NCT00508820|364844889|FG001|Overall Study|Requirement for alternative therapy|15|||
105779965|NCT00508820|364844888|FG000|Overall Study|Protocol-specified Criteria|3|||
105779966|NCT00508820|364844889|FG001|Overall Study|Protocol-specified Criteria|12|||
105779967|NCT04563845|364846493|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779968|NCT04563845|364846494|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779969|NCT04563845|364846495|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779970|NCT04563845|364846496|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779971|NCT04563845|364846497|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779972|NCT04563845|364846498|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779973|NCT04563845|364846499|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779974|NCT04563845|364846500|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
105779975|NCT04563845|364846501|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779976|NCT04563845|364846502|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779977|NCT04563845|364846503|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779978|NCT04563845|364846504|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779979|NCT04563845|364846505|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779980|NCT04563845|364846506|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779981|NCT04563845|364846493|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779982|NCT04563845|364846494|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779983|NCT04563845|364846495|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779984|NCT04563845|364846496|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105444449|NCT01724866|363633276|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
105444450|NCT01724866|363633277|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
105444451|NCT01724866|363633278|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
105444452|NCT01724866|363633275|FG000|Overall Study|Investigator's Discretion|0|||
105444453|NCT01724866|363633276|FG001|Overall Study|Investigator's Discretion|1|||
105444454|NCT01724866|363633277|FG002|Overall Study|Investigator's Discretion|1|||
105444455|NCT01724866|363633278|FG003|Overall Study|Investigator's Discretion|0|||
105484834|NCT01992159|363786984|FG002|Overall Study|Adverse Event|0|||
105779985|NCT04563845|364846497|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
105779986|NCT04563845|364846498|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779987|NCT04563845|364846499|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779988|NCT04563845|364846500|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779989|NCT04563845|364846501|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779990|NCT04563845|364846502|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779991|NCT04563845|364846503|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779992|NCT04563845|364846504|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779993|NCT04563845|364846505|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779994|NCT04563845|364846506|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779995|NCT01020812|364846507|FG000|Overall Study|Physician Decision|1|||
105779996|NCT01020812|364846507|FG000|Overall Study|Withdrawal by Subject|1|||
105779997|NCT01020812|364846507|FG000|Overall Study|Protocol Violation|1|||
105779998|NCT02146274|364846508|FG000|Overall Study|Protocol Violation|73|||
105779999|NCT00303719|364846514|FG000|Overall Study|Not evaluable, prior therapies|0|||
105780000|NCT00303719|364846515|FG001|Overall Study|Not evaluable, prior therapies|30|||
105780001|NCT00303719|364846514|FG000|Overall Study|Lost to Follow-up|0|||
105780002|NCT00303719|364846515|FG001|Overall Study|Lost to Follow-up|7|||
105780003|NCT01097057|364846519|FG000|Overall Study|Physician Decision|3|||
105780004|NCT00134563|364846523|FG000|Overall Study|Not treated due to protocol violation|0|||
105780005|NCT00134563|364846524|FG001|Overall Study|Not treated due to protocol violation|1|||
105780006|NCT00134563|364846525|FG002|Overall Study|Not treated due to protocol violation|1|||
105780007|NCT00134563|364846523|FG000|Overall Study|Adverse Event|29|||
105780008|NCT00134563|364846524|FG001|Overall Study|Adverse Event|37|||
105780009|NCT00134563|364846525|FG002|Overall Study|Adverse Event|38|||
105780010|NCT00134563|364846523|FG000|Overall Study|Lack of Efficacy|24|||
105780011|NCT00134563|364846524|FG001|Overall Study|Lack of Efficacy|14|||
105780012|NCT00134563|364846525|FG002|Overall Study|Lack of Efficacy|17|||
105780013|NCT00134563|364846523|FG000|Overall Study|Protocol Violation|3|||
105780014|NCT00134563|364846524|FG001|Overall Study|Protocol Violation|2|||
105780015|NCT00134563|364846525|FG002|Overall Study|Protocol Violation|5|||
105780016|NCT00134563|364846523|FG000|Overall Study|Lost to Follow-up|4|||
105780017|NCT00134563|364846524|FG001|Overall Study|Lost to Follow-up|0|||
105780018|NCT00134563|364846525|FG002|Overall Study|Lost to Follow-up|2|||
105780019|NCT00134563|364846523|FG000|Overall Study|progressive disease|11|||
105780020|NCT00134563|364846524|FG001|Overall Study|progressive disease|4|||
105780021|NCT00134563|364846525|FG002|Overall Study|progressive disease|2|||
105780022|NCT00134563|364846523|FG000|Overall Study|did not wish to continue|33|||
105780023|NCT00134563|364846524|FG001|Overall Study|did not wish to continue|32|||
105780024|NCT00134563|364846525|FG002|Overall Study|did not wish to continue|26|||
105780025|NCT00134563|364846523|FG000|Overall Study|Reason other than above|0|||
105780026|NCT00134563|364846524|FG001|Overall Study|Reason other than above|2|||
105780027|NCT00134563|364846525|FG002|Overall Study|Reason other than above|5|||
105780028|NCT03802331|364846526|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
105780029|NCT03802331|364846527|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
105780030|NCT04738123|364846542|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
105780031|NCT04738123|364846543|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
105780032|NCT04738123|364846542|FG000|Overall Study|Progressive Disease|0|||
105780033|NCT04738123|364846543|FG001|Overall Study|Progressive Disease|4|||
105780034|NCT04738123|364846542|FG000|Overall Study|Adverse Event|8|||
105780035|NCT04738123|364846543|FG001|Overall Study|Adverse Event|7|||
105780036|NCT04738123|364846542|FG000|Overall Study|Other Reasons|0|||
105780037|NCT04738123|364846543|FG001|Overall Study|Other Reasons|1|||
105780038|NCT04738123|364846542|FG000|Overall Study|Suicidal or assaultive behavior|0|||
105780039|NCT04738123|364846543|FG001|Overall Study|Suicidal or assaultive behavior|2|||
105780040|NCT04738123|364846542|FG000|Overall Study|Protocol Violation|2|||
105780041|NCT04738123|364846543|FG001|Overall Study|Protocol Violation|2|||
105780042|NCT04738123|364846542|FG000|Overall Study|Consent Withdrawn|35|||
105780043|NCT04738123|364846543|FG001|Overall Study|Consent Withdrawn|22|||
105780044|NCT00405756|364846544|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
105780045|NCT00405756|364846545|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
105780046|NCT00405756|364846546|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
105780047|NCT00405756|364846544|FG000|Double-blind Treatment|Adverse Event|31|||
105780048|NCT00405756|364846545|FG001|Double-blind Treatment|Adverse Event|27|||
105780049|NCT00405756|364846546|FG002|Double-blind Treatment|Adverse Event|12|||
105780050|NCT00405756|364846544|FG000|Double-blind Treatment|Disease Progression|47|||
105780051|NCT00405756|364846545|FG001|Double-blind Treatment|Disease Progression|81|||
105780052|NCT00405756|364846546|FG002|Double-blind Treatment|Disease Progression|102|||
105780053|NCT00405756|364846544|FG000|Double-blind Treatment|Lack of Efficacy|1|||
105780054|NCT00405756|364846545|FG001|Double-blind Treatment|Lack of Efficacy|4|||
105780055|NCT00405756|364846546|FG002|Double-blind Treatment|Lack of Efficacy|2|||
105780056|NCT00405756|364846544|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
105780057|NCT00405756|364846545|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
105780058|NCT00405756|364846546|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
105780059|NCT00405756|364846544|FG000|Double-blind Treatment|Lost to Follow-up|1|||
105780060|NCT00405756|364846545|FG001|Double-blind Treatment|Lost to Follow-up|0|||
105780061|NCT00405756|364846546|FG002|Double-blind Treatment|Lost to Follow-up|0|||
105780062|NCT00405756|364846544|FG000|Double-blind Treatment|Death|4|||
105780063|NCT00405756|364846545|FG001|Double-blind Treatment|Death|4|||
105780064|NCT00405756|364846546|FG002|Double-blind Treatment|Death|4|||
105780065|NCT00405756|364846544|FG000|Double-blind Treatment|Protocol Violation|1|||
105780066|NCT00405756|364846545|FG001|Double-blind Treatment|Protocol Violation|0|||
105780067|NCT00405756|364846546|FG002|Double-blind Treatment|Protocol Violation|2|||
105780068|NCT00405756|364846544|FG000|Double-blind Treatment|Other|7|||
105780069|NCT00405756|364846545|FG001|Double-blind Treatment|Other|4|||
105780070|NCT00405756|364846546|FG002|Double-blind Treatment|Other|4|||
105780071|NCT00405756|364846544|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
105780072|NCT00405756|364846545|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
105780073|NCT00405756|364846546|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
105780074|NCT00405756|364846544|FG000|Open-label Extension|Adverse Event|1|||
105780075|NCT00405756|364846545|FG001|Open-label Extension|Adverse Event|3|||
105780076|NCT00405756|364846546|FG002|Open-label Extension|Adverse Event|7|||
105780077|NCT00405756|364846544|FG000|Open-label Extension|Disease Progression|8|||
105780078|NCT00405756|364846545|FG001|Open-label Extension|Disease Progression|23|||
105780079|NCT00405756|364846546|FG002|Open-label Extension|Disease Progression|26|||
105780080|NCT00405756|364846544|FG000|Open-label Extension|Withdrawal by Subject|2|||
105780081|NCT00405756|364846545|FG001|Open-label Extension|Withdrawal by Subject|3|||
105780082|NCT00405756|364846546|FG002|Open-label Extension|Withdrawal by Subject|3|||
105780083|NCT00405756|364846544|FG000|Open-label Extension|Death|1|||
105780084|NCT00405756|364846545|FG001|Open-label Extension|Death|2|||
105780085|NCT00405756|364846546|FG002|Open-label Extension|Death|4|||
105780086|NCT00405756|364846544|FG000|Open-label Extension|Other|0|||
105780087|NCT00405756|364846545|FG001|Open-label Extension|Other|1|||
105780088|NCT00405756|364846546|FG002|Open-label Extension|Other|7|||
105780089|NCT00405756|364846544|FG000|Follow-up|Ongoing in Follow-up Period|52|||
105780090|NCT00405756|364846545|FG001|Follow-up|Ongoing in Follow-up Period|51|||
105780091|NCT00405756|364846546|FG002|Follow-up|Ongoing in Follow-up Period|60|||
105780092|NCT00405756|364846544|FG000|Follow-up|Death|21|||
105780093|NCT00405756|364846545|FG001|Follow-up|Death|31|||
105780094|NCT00405756|364846546|FG002|Follow-up|Death|24|||
105780095|NCT00405756|364846544|FG000|Follow-up|Lost to Follow-up|2|||
105780096|NCT00405756|364846545|FG001|Follow-up|Lost to Follow-up|8|||
105780097|NCT00405756|364846546|FG002|Follow-up|Lost to Follow-up|4|||
105780098|NCT00851721|364846547|FG000|Overall Study|planned surgery|1|||
105780099|NCT00851721|364846548|FG001|Overall Study|planned surgery|0|||
105780100|NCT00851721|364846547|FG000|Overall Study|Death|1|||
105780101|NCT00851721|364846548|FG001|Overall Study|Death|0|||
105780102|NCT00851721|364846547|FG000|Overall Study|Adverse Event|0|||
105780103|NCT00851721|364846548|FG001|Overall Study|Adverse Event|1|||
105780104|NCT03982069|364846549|FG000|Overall Study|Lost to Follow-up|5|||
105780105|NCT03982069|364846550|FG001|Overall Study|Lost to Follow-up|5|||
105780106|NCT03982069|364846551|FG002|Overall Study|Lost to Follow-up|3|||
105780107|NCT03982069|364846552|FG003|Overall Study|Lost to Follow-up|5|||
105780108|NCT03982069|364846549|FG000|Overall Study|Physician Decision|0|||
105780109|NCT03982069|364846550|FG001|Overall Study|Physician Decision|1|||
105780110|NCT03982069|364846551|FG002|Overall Study|Physician Decision|0|||
105780111|NCT03982069|364846552|FG003|Overall Study|Physician Decision|0|||
105780112|NCT03982069|364846549|FG000|Overall Study|Withdrawal by Subject|2|||
105780113|NCT03982069|364846550|FG001|Overall Study|Withdrawal by Subject|1|||
105780114|NCT03982069|364846551|FG002|Overall Study|Withdrawal by Subject|5|||
105780115|NCT03982069|364846552|FG003|Overall Study|Withdrawal by Subject|2|||
105780116|NCT03982069|364846549|FG000|Overall Study|Specimen loss|3|||
105780117|NCT03982069|364846550|FG001|Overall Study|Specimen loss|3|||
105780118|NCT03982069|364846551|FG002|Overall Study|Specimen loss|1|||
105780119|NCT03982069|364846552|FG003|Overall Study|Specimen loss|1|||
105780120|NCT01218477|364846553|FG000|Overall Study|Disease progression|2|||
105780121|NCT01218477|364846554|FG001|Overall Study|Disease progression|3|||
105780122|NCT01218477|364846555|FG002|Overall Study|Disease progression|6|||
105780123|NCT01218477|364846556|FG003|Overall Study|Disease progression|2|||
105780124|NCT01218477|364846553|FG000|Overall Study|Study drug toxicity|0|||
105780125|NCT01218477|364846554|FG001|Overall Study|Study drug toxicity|2|||
105780126|NCT01218477|364846555|FG002|Overall Study|Study drug toxicity|5|||
105780127|NCT01218477|364846556|FG003|Overall Study|Study drug toxicity|0|||
105780128|NCT01218477|364846553|FG000|Overall Study|No longer meets study criteria|1|||
105780129|NCT01218477|364846554|FG001|Overall Study|No longer meets study criteria|0|||
105780130|NCT01218477|364846555|FG002|Overall Study|No longer meets study criteria|0|||
105780131|NCT01218477|364846556|FG003|Overall Study|No longer meets study criteria|0|||
105780132|NCT01218477|364846553|FG000|Overall Study|Withdrawal by Subject|0|||
105780133|NCT01218477|364846554|FG001|Overall Study|Withdrawal by Subject|0|||
105780134|NCT01218477|364846555|FG002|Overall Study|Withdrawal by Subject|1|||
105780135|NCT01218477|364846556|FG003|Overall Study|Withdrawal by Subject|0|||
105780136|NCT01218477|364846553|FG000|Overall Study|Prepared for cell transplantation|0|||
105780137|NCT01218477|364846554|FG001|Overall Study|Prepared for cell transplantation|1|||
105780138|NCT01218477|364846555|FG002|Overall Study|Prepared for cell transplantation|1|||
105780139|NCT01218477|364846556|FG003|Overall Study|Prepared for cell transplantation|0|||
105780140|NCT01218477|364846553|FG000|Overall Study|Administrative reason by sponsor|0|||
105780141|NCT01218477|364846554|FG001|Overall Study|Administrative reason by sponsor|0|||
105780142|NCT01218477|364846555|FG002|Overall Study|Administrative reason by sponsor|1|||
105780143|NCT01218477|364846556|FG003|Overall Study|Administrative reason by sponsor|0|||
105780144|NCT01218477|364846553|FG000|Overall Study|Maximum clinical benefit|0|||
105780145|NCT01218477|364846554|FG001|Overall Study|Maximum clinical benefit|2|||
105780146|NCT01218477|364846555|FG002|Overall Study|Maximum clinical benefit|0|||
105780147|NCT01218477|364846556|FG003|Overall Study|Maximum clinical benefit|0|||
105780148|NCT02135848|364846557|FG000|Overall Study|Adverse Event|2|||
105780149|NCT02135848|364846558|FG001|Overall Study|Adverse Event|0|||
105780150|NCT02135848|364846557|FG000|Overall Study|Withdrawal by Subject|1|||
105780151|NCT02135848|364846558|FG001|Overall Study|Withdrawal by Subject|1|||
105780152|NCT03137433|364846561|FG000|Overall Study|Withdrawal by Subject|11|||
105780153|NCT03137433|364846562|FG001|Overall Study|Withdrawal by Subject|11|||
105780154|NCT03137433|364846561|FG000|Overall Study|Lost to Follow-up|5|||
105780155|NCT03137433|364846562|FG001|Overall Study|Lost to Follow-up|6|||
105780156|NCT03137433|364846561|FG000|Overall Study|Physician Decision|2|||
105780157|NCT03137433|364846562|FG001|Overall Study|Physician Decision|0|||
105780158|NCT03137433|364846561|FG000|Overall Study|Moved out of study area|1|||
105780159|NCT03137433|364846562|FG001|Overall Study|Moved out of study area|0|||
105780160|NCT03137433|364846561|FG000|Overall Study|Too far out of window due to COVID|0|||
105780161|NCT03137433|364846562|FG001|Overall Study|Too far out of window due to COVID|1|||
105780162|NCT00083616|364846563|FG000|Overall Study|Disease Progression|16|||
105780163|NCT00083616|364846563|FG000|Overall Study|Lost to Follow-up|1|||
105780164|NCT00083616|364846563|FG000|Overall Study|Physician Decision|2|||
105780165|NCT00083616|364846563|FG000|Overall Study|Withdrawal by Subject|3|||
105780166|NCT00083616|364846563|FG000|Overall Study|Ineligibility determined|2|||
105780167|NCT00083616|364846563|FG000|Overall Study|Non-compliance|1|||
105780168|NCT00083616|364846563|FG000|Overall Study|Other|6|||
105444456|NCT01724866|363633275|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
105444457|NCT01724866|363633276|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
105780169|NCT00265382|364846567|FG000|Overall Study|Adverse Event|21|||
105780170|NCT00265382|364846567|FG000|Overall Study|Laboratory Abnormality|1|||
105780171|NCT00265382|364846567|FG000|Overall Study|Lost to Follow-up|3|||
105780172|NCT00265382|364846567|FG000|Overall Study|Lack of Efficacy|6|||
105780173|NCT00265382|364846567|FG000|Overall Study|Miscellaneous|6|||
105780174|NCT00265382|364846567|FG000|Overall Study|Withdrawal by Subject|13|||
105780175|NCT00265382|364846567|FG000|Overall Study|Study terminated by sponsor|94|||
105780176|NCT00265382|364846567|FG000|Overall Study|Death|1|||
105780177|NCT01474993|364846571|FG000|Overall Study|Lost to Follow-up|1|||
105780178|NCT01474993|364846572|FG001|Overall Study|Lost to Follow-up|2|||
105780179|NCT01474993|364846571|FG000|Overall Study|Adverse Event|0|||
105780180|NCT01474993|364846572|FG001|Overall Study|Adverse Event|1|||
105780181|NCT01632345|364846573|FG000|Treatment: Part I|Adverse Event|1|||
105780182|NCT01632345|364846574|FG001|Treatment: Part I|Adverse Event|4|||
105780183|NCT01632345|364846575|FG002|Treatment: Part I|Adverse Event|2|||
105780184|NCT01632345|364846576|FG003|Treatment: Part I|Adverse Event|1|||
105780185|NCT01632345|364846577|FG004|Treatment: Part I|Adverse Event|3|||
105780186|NCT01632345|364846578|FG005|Treatment: Part I|Adverse Event|0|||
105780187|NCT01632345|364846579|FG006|Treatment: Part I|Adverse Event|0|||
105780188|NCT01632345|364846573|FG000|Treatment: Part I|Lack of Efficacy|0|||
105780189|NCT01632345|364846574|FG001|Treatment: Part I|Lack of Efficacy|1|||
105780190|NCT01632345|364846575|FG002|Treatment: Part I|Lack of Efficacy|0|||
105780191|NCT01632345|364846576|FG003|Treatment: Part I|Lack of Efficacy|1|||
105780192|NCT01632345|364846577|FG004|Treatment: Part I|Lack of Efficacy|1|||
105780193|NCT01632345|364846578|FG005|Treatment: Part I|Lack of Efficacy|0|||
105780194|NCT01632345|364846579|FG006|Treatment: Part I|Lack of Efficacy|0|||
105780195|NCT01632345|364846573|FG000|Treatment: Part I|Lost to Follow-up|3|||
105780196|NCT01632345|364846574|FG001|Treatment: Part I|Lost to Follow-up|2|||
105780197|NCT01632345|364846575|FG002|Treatment: Part I|Lost to Follow-up|1|||
105780198|NCT01632345|364846576|FG003|Treatment: Part I|Lost to Follow-up|3|||
105780199|NCT01632345|364846577|FG004|Treatment: Part I|Lost to Follow-up|4|||
105780200|NCT01632345|364846578|FG005|Treatment: Part I|Lost to Follow-up|0|||
105780201|NCT01632345|364846579|FG006|Treatment: Part I|Lost to Follow-up|0|||
105780202|NCT01632345|364846573|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
105780203|NCT01632345|364846574|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
105780204|NCT01632345|364846575|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
105780205|NCT01632345|364846576|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
105780206|NCT01632345|364846577|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
105780207|NCT01632345|364846578|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
105780208|NCT01632345|364846579|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
105780209|NCT01632345|364846573|FG000|Treatment: Part I|Physician Decision|2|||
105780210|NCT01632345|364846574|FG001|Treatment: Part I|Physician Decision|1|||
105780211|NCT01632345|364846575|FG002|Treatment: Part I|Physician Decision|0|||
105780212|NCT01632345|364846576|FG003|Treatment: Part I|Physician Decision|0|||
105780213|NCT01632345|364846577|FG004|Treatment: Part I|Physician Decision|1|||
105780214|NCT01632345|364846578|FG005|Treatment: Part I|Physician Decision|0|||
105780215|NCT01632345|364846579|FG006|Treatment: Part I|Physician Decision|0|||
105780216|NCT01632345|364846573|FG000|Treatment: Part I|Pregnancy|0|||
105780217|NCT01632345|364846574|FG001|Treatment: Part I|Pregnancy|1|||
105780218|NCT01632345|364846575|FG002|Treatment: Part I|Pregnancy|0|||
105780219|NCT01632345|364846576|FG003|Treatment: Part I|Pregnancy|0|||
105780220|NCT01632345|364846577|FG004|Treatment: Part I|Pregnancy|0|||
105780221|NCT01632345|364846578|FG005|Treatment: Part I|Pregnancy|0|||
105780222|NCT01632345|364846579|FG006|Treatment: Part I|Pregnancy|0|||
105780223|NCT01632345|364846573|FG000|Treatment: Part I|Protocol Deviation|0|||
105780224|NCT01632345|364846574|FG001|Treatment: Part I|Protocol Deviation|0|||
105780225|NCT01632345|364846575|FG002|Treatment: Part I|Protocol Deviation|1|||
105780226|NCT01632345|364846576|FG003|Treatment: Part I|Protocol Deviation|1|||
105780227|NCT01632345|364846577|FG004|Treatment: Part I|Protocol Deviation|0|||
105780228|NCT01632345|364846578|FG005|Treatment: Part I|Protocol Deviation|0|||
105780229|NCT01632345|364846579|FG006|Treatment: Part I|Protocol Deviation|0|||
105780230|NCT01632345|364846573|FG000|Treatment: Part I|Withdrawal by Subject|3|||
105780231|NCT01632345|364846574|FG001|Treatment: Part I|Withdrawal by Subject|4|||
105780232|NCT01632345|364846575|FG002|Treatment: Part I|Withdrawal by Subject|4|||
105780233|NCT01632345|364846576|FG003|Treatment: Part I|Withdrawal by Subject|1|||
105780234|NCT01632345|364846577|FG004|Treatment: Part I|Withdrawal by Subject|4|||
105780235|NCT01632345|364846578|FG005|Treatment: Part I|Withdrawal by Subject|0|||
105780236|NCT01632345|364846579|FG006|Treatment: Part I|Withdrawal by Subject|0|||
105780237|NCT01632345|364846573|FG000|Treatment: Part II|Adverse Event|0|||
105780238|NCT01632345|364846574|FG001|Treatment: Part II|Adverse Event|0|||
105780239|NCT01632345|364846575|FG002|Treatment: Part II|Adverse Event|0|||
105780240|NCT01632345|364846576|FG003|Treatment: Part II|Adverse Event|0|||
105780241|NCT01632345|364846577|FG004|Treatment: Part II|Adverse Event|0|||
105780242|NCT01632345|364846578|FG005|Treatment: Part II|Adverse Event|3|||
105780243|NCT01632345|364846579|FG006|Treatment: Part II|Adverse Event|8|||
105780244|NCT01632345|364846573|FG000|Treatment: Part II|Lost to Follow-up|0|||
105780245|NCT01632345|364846574|FG001|Treatment: Part II|Lost to Follow-up|0|||
105780246|NCT01632345|364846575|FG002|Treatment: Part II|Lost to Follow-up|0|||
105780247|NCT01632345|364846576|FG003|Treatment: Part II|Lost to Follow-up|0|||
105780248|NCT01632345|364846577|FG004|Treatment: Part II|Lost to Follow-up|0|||
105780249|NCT01632345|364846578|FG005|Treatment: Part II|Lost to Follow-up|3|||
105780250|NCT01632345|364846579|FG006|Treatment: Part II|Lost to Follow-up|1|||
105780251|NCT01632345|364846573|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
105780252|NCT01632345|364846574|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
105780253|NCT01632345|364846575|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
105780254|NCT01632345|364846576|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
105780255|NCT01632345|364846577|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
105780256|NCT01632345|364846578|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
105780257|NCT01632345|364846579|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
105780258|NCT01632345|364846573|FG000|Treatment: Part II|Withdrawal by Subject|0|||
105780259|NCT01632345|364846574|FG001|Treatment: Part II|Withdrawal by Subject|0|||
105780260|NCT01632345|364846575|FG002|Treatment: Part II|Withdrawal by Subject|0|||
105780261|NCT01632345|364846576|FG003|Treatment: Part II|Withdrawal by Subject|0|||
105780262|NCT01632345|364846577|FG004|Treatment: Part II|Withdrawal by Subject|0|||
105780263|NCT01632345|364846578|FG005|Treatment: Part II|Withdrawal by Subject|2|||
105780264|NCT01632345|364846579|FG006|Treatment: Part II|Withdrawal by Subject|2|||
105780265|NCT01284127|364846582|FG000|Overall Study|Adverse Event|2|||
105780266|NCT01284127|364846582|FG000|Overall Study|Withdrawal by Subject|4|||
105780267|NCT01284127|364846582|FG000|Overall Study|Physician Decision|1|||
105780268|NCT04118127|364846592|FG000|Overall Study|Trial terminated by sponsor|0|||
105780269|NCT04118127|364846593|FG001|Overall Study|Trial terminated by sponsor|12|||
105780270|NCT04118127|364846592|FG000|Overall Study|Adverse Event|1|||
105780271|NCT04118127|364846593|FG001|Overall Study|Adverse Event|2|||
105780272|NCT04118127|364846592|FG000|Overall Study|Physician Decision|0|||
105780273|NCT04118127|364846593|FG001|Overall Study|Physician Decision|1|||
105780274|NCT04118127|364846592|FG000|Overall Study|Withdrawal by Subject|2|||
105780275|NCT04118127|364846593|FG001|Overall Study|Withdrawal by Subject|1|||
105780276|NCT00135694|364846595|FG000|Overall Study|Adverse Event|17|||
105780277|NCT00135694|364846596|FG001|Overall Study|Adverse Event|4|||
105780278|NCT00135694|364846597|FG002|Overall Study|Adverse Event|0|||
105780279|NCT00135694|364846595|FG000|Overall Study|Death|14|||
105780280|NCT00135694|364846596|FG001|Overall Study|Death|1|||
105780281|NCT00135694|364846597|FG002|Overall Study|Death|2|||
105780282|NCT00135694|364846595|FG000|Overall Study|Lost to Follow-up|8|||
105780283|NCT00135694|364846596|FG001|Overall Study|Lost to Follow-up|7|||
105780284|NCT00135694|364846597|FG002|Overall Study|Lost to Follow-up|1|||
105780285|NCT00135694|364846595|FG000|Overall Study|Withdrawal by Subject|41|||
105780286|NCT00135694|364846596|FG001|Overall Study|Withdrawal by Subject|7|||
105780287|NCT00135694|364846597|FG002|Overall Study|Withdrawal by Subject|4|||
105780288|NCT00135694|364846595|FG000|Overall Study|Protocol Violation|19|||
105780289|NCT00135694|364846596|FG001|Overall Study|Protocol Violation|1|||
105780290|NCT00135694|364846597|FG002|Overall Study|Protocol Violation|0|||
105780291|NCT00135694|364846595|FG000|Overall Study|Hepatitis C related reasons|39|||
105780292|NCT00135694|364846596|FG001|Overall Study|Hepatitis C related reasons|1|||
105780293|NCT00135694|364846597|FG002|Overall Study|Hepatitis C related reasons|0|||
105780294|NCT00135694|364846595|FG000|Overall Study|Ineligible for Random assignment|42|||
105780295|NCT00135694|364846596|FG001|Overall Study|Ineligible for Random assignment|0|||
105780296|NCT00135694|364846597|FG002|Overall Study|Ineligible for Random assignment|0|||
105780297|NCT02850276|364846602|FG000|Overall Study|screen failure|43|||
105780298|NCT02850276|364846602|FG000|Overall Study|Withdrawal by Subject|14|||
105780299|NCT02850276|364846602|FG000|Overall Study|Physician Decision|2|||
105780300|NCT02850276|364846602|FG000|Overall Study|Lost to Follow-up|2|||
105780301|NCT03137173|364846603|FG000|Overall Study|Withdrawal by Subject|8|||
105780302|NCT03137173|364846604|FG001|Overall Study|Withdrawal by Subject|13|||
105780303|NCT03137173|364846603|FG000|Overall Study|Death|1|||
105780304|NCT03137173|364846604|FG001|Overall Study|Death|3|||
105780305|NCT03137173|364846603|FG000|Overall Study|Physician Decision|1|||
105780306|NCT03137173|364846604|FG001|Overall Study|Physician Decision|0|||
105780307|NCT03137173|364846603|FG000|Overall Study|Lost to Follow-up|13|||
105780308|NCT03137173|364846604|FG001|Overall Study|Lost to Follow-up|18|||
105780309|NCT03137173|364846603|FG000|Overall Study|Other reasons|3|||
105780310|NCT03137173|364846604|FG001|Overall Study|Other reasons|2|||
105780311|NCT01482598|364846605|FG000|Overall Study|Death|7|||
105780312|NCT01482598|364846606|FG001|Overall Study|Death|10|||
105780313|NCT01482598|364846605|FG000|Overall Study|Physician Decision|0|||
105780314|NCT01482598|364846606|FG001|Overall Study|Physician Decision|3|||
105780315|NCT01482598|364846605|FG000|Overall Study|Withdrawal by Subject|4|||
105780316|NCT01482598|364846606|FG001|Overall Study|Withdrawal by Subject|5|||
105780317|NCT01482598|364846605|FG000|Overall Study|Lost to Follow-up|5|||
105780318|NCT01482598|364846606|FG001|Overall Study|Lost to Follow-up|4|||
105780319|NCT00951912|364846611|FG000|Overall Study|Lack of Efficacy|1|||
105780320|NCT00951912|364846612|FG001|Overall Study|Lack of Efficacy|0|||
105780321|NCT00951912|364846613|FG002|Overall Study|Lack of Efficacy|0|||
105780322|NCT00951912|364846611|FG000|Overall Study|Adverse Event|0|||
105780323|NCT00951912|364846612|FG001|Overall Study|Adverse Event|1|||
105780324|NCT00951912|364846613|FG002|Overall Study|Adverse Event|1|||
105780325|NCT00951912|364846611|FG000|Overall Study|Lost to Follow-up|2|||
105780326|NCT00951912|364846612|FG001|Overall Study|Lost to Follow-up|2|||
105780327|NCT00951912|364846613|FG002|Overall Study|Lost to Follow-up|0|||
105780328|NCT00951912|364846611|FG000|Overall Study|Physician Decision|1|||
105780329|NCT00951912|364846612|FG001|Overall Study|Physician Decision|0|||
105780330|NCT00951912|364846613|FG002|Overall Study|Physician Decision|1|||
105780331|NCT00951912|364846611|FG000|Overall Study|Withdrawal by Subject|1|||
105780332|NCT00951912|364846612|FG001|Overall Study|Withdrawal by Subject|1|||
105780333|NCT00951912|364846613|FG002|Overall Study|Withdrawal by Subject|0|||
105780334|NCT00951912|364846611|FG000|Overall Study|Other:Depression|1|||
105780335|NCT00951912|364846612|FG001|Overall Study|Other:Depression|0|||
105780336|NCT00951912|364846613|FG002|Overall Study|Other:Depression|0|||
105780337|NCT00951912|364846611|FG000|Overall Study|Other: Colon cancer|1|||
105780338|NCT00951912|364846612|FG001|Overall Study|Other: Colon cancer|0|||
105780339|NCT00951912|364846613|FG002|Overall Study|Other: Colon cancer|0|||
105780340|NCT00951912|364846611|FG000|Overall Study|Other: Stroke|0|||
105780341|NCT00951912|364846612|FG001|Overall Study|Other: Stroke|1|||
105780342|NCT00951912|364846613|FG002|Overall Study|Other: Stroke|0|||
105780343|NCT03417999|364846614|FG000|Overall Study|Withdrawal by Subject|1|||
105780344|NCT03417999|364846615|FG001|Overall Study|Withdrawal by Subject|0|||
105780345|NCT03417999|364846616|FG002|Overall Study|Withdrawal by Subject|0|||
105780346|NCT03417999|364846614|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
105780347|NCT03417999|364846615|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
105780348|NCT03417999|364846616|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
105780349|NCT03417999|364846614|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
105780350|NCT03417999|364846615|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
105780351|NCT03417999|364846616|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
105780352|NCT03417999|364846614|FG000|Overall Study|Inadequate study staff available to process samples|0|||
105780353|NCT03417999|364846615|FG001|Overall Study|Inadequate study staff available to process samples|0|||
105780354|NCT03417999|364846616|FG002|Overall Study|Inadequate study staff available to process samples|1|||
105780355|NCT03039699|364846621|FG000|Overall Study|Incorrect inclusion|5|||
105780356|NCT03039699|364846622|FG001|Overall Study|Incorrect inclusion|4|||
105780357|NCT03039699|364846621|FG000|Overall Study|Lack of data to assess study endpoint|5|||
105780358|NCT03039699|364846622|FG001|Overall Study|Lack of data to assess study endpoint|3|||
105780359|NCT03039699|364846621|FG000|Overall Study|Bacterial infection|12|||
105780360|NCT03039699|364846622|FG001|Overall Study|Bacterial infection|28|||
105780361|NCT02539160|364846623|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
105780362|NCT02539160|364846624|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
105780363|NCT02539160|364846625|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
105780364|NCT02539160|364846626|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
105780365|NCT02539160|364846623|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
105780366|NCT02539160|364846624|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
105780367|NCT02539160|364846625|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
105780368|NCT02539160|364846626|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
105780369|NCT02539160|364846623|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
105780370|NCT02539160|364846624|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
105780371|NCT02539160|364846625|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
105780372|NCT02539160|364846626|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
105780373|NCT02312934|364846630|FG000|Overall Study|Lost to Follow-up|1|||
105780374|NCT02312934|364846631|FG001|Overall Study|Lost to Follow-up|0|||
105780375|NCT02312934|364846630|FG000|Overall Study|Physician Decision|1|||
105780376|NCT02312934|364846631|FG001|Overall Study|Physician Decision|0|||
105780377|NCT00689299|364846632|FG000|Overall Study|Adverse Event|2|||
105780378|NCT00689299|364846633|FG001|Overall Study|Adverse Event|1|||
105780379|NCT00689299|364846634|FG002|Overall Study|Adverse Event|1|||
105780380|NCT00689299|364846632|FG000|Overall Study|Lost to Follow-up|0|||
105780381|NCT00689299|364846633|FG001|Overall Study|Lost to Follow-up|1|||
105780382|NCT00689299|364846634|FG002|Overall Study|Lost to Follow-up|1|||
105780383|NCT00689299|364846632|FG000|Overall Study|Withdrawal by Subject|4|||
105780384|NCT00689299|364846633|FG001|Overall Study|Withdrawal by Subject|1|||
105780385|NCT00689299|364846634|FG002|Overall Study|Withdrawal by Subject|3|||
105780386|NCT00689299|364846632|FG000|Overall Study|Protocol Violation|1|||
105780387|NCT00689299|364846633|FG001|Overall Study|Protocol Violation|0|||
105780388|NCT00689299|364846634|FG002|Overall Study|Protocol Violation|0|||
105780389|NCT01002573|364848564|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
105780390|NCT01002573|364848565|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
105780391|NCT04823494|364848566|FG000|Overall Study|Programming software malfunction.|1|||
105780392|NCT04823494|364848567|FG001|Overall Study|Programming software malfunction.|0|||
105780393|NCT04823494|364848566|FG000|Overall Study|Withdrawal by Subject|1|||
105780394|NCT04823494|364848567|FG001|Overall Study|Withdrawal by Subject|0|||
105780395|NCT04823494|364848566|FG000|Overall Study|Devices lost|0|||
105780396|NCT04823494|364848567|FG001|Overall Study|Devices lost|1|||
105780397|NCT04524663|364848570|FG000|Overall Study|Withdrawal by Subject|0|||
105780398|NCT04524663|364848571|FG001|Overall Study|Withdrawal by Subject|2|||
105780399|NCT00337935|364848572|FG000|Overall Study|Adverse Event|2|||
105780400|NCT00337935|364848573|FG001|Overall Study|Adverse Event|5|||
105780401|NCT00337935|364848572|FG000|Overall Study|Death|2|||
105780402|NCT00337935|364848573|FG001|Overall Study|Death|8|||
105780403|NCT00337935|364848572|FG000|Overall Study|Physician Decision|1|||
105484835|NCT01992159|363786985|FG003|Overall Study|Adverse Event|1|||
105780404|NCT00337935|364848573|FG001|Overall Study|Physician Decision|1|||
105780405|NCT00337935|364848572|FG000|Overall Study|Lost to Follow-up|0|||
105780406|NCT00337935|364848573|FG001|Overall Study|Lost to Follow-up|1|||
105780407|NCT00337935|364848572|FG000|Overall Study|Protocol Violation|4|||
105780408|NCT00337935|364848573|FG001|Overall Study|Protocol Violation|3|||
105780409|NCT00337935|364848572|FG000|Overall Study|Withdrawal by Subject|1|||
105780410|NCT00337935|364848573|FG001|Overall Study|Withdrawal by Subject|7|||
105780411|NCT00337935|364848572|FG000|Overall Study|Other|0|||
105780412|NCT00337935|364848573|FG001|Overall Study|Other|1|||
105780413|NCT00337935|364848572|FG000|Overall Study|Lack of Efficacy|0|||
105780414|NCT00337935|364848573|FG001|Overall Study|Lack of Efficacy|1|||
105780415|NCT01884675|364848574|FG000|Overall Study|Study closed/terminated|3|||
105780416|NCT01884675|364848575|FG001|Overall Study|Study closed/terminated|2|||
105780417|NCT03359811|364848576|FG000|Overall Study|Protocol Violation|2|||
105780418|NCT03359811|364848577|FG001|Overall Study|Protocol Violation|0|||
105780419|NCT02534324|364848578|FG000|Overall Study|Protocol Violation|4|||
105780420|NCT02534324|364848579|FG001|Overall Study|Protocol Violation|1|||
105780421|NCT02534324|364848578|FG000|Overall Study|Lost to Follow-up|20|||
105780422|NCT02534324|364848579|FG001|Overall Study|Lost to Follow-up|7|||
105780423|NCT02534324|364848578|FG000|Overall Study|Adverse Event|1|||
105780424|NCT02534324|364848579|FG001|Overall Study|Adverse Event|0|||
105780425|NCT00303602|364848583|FG000|Overall Study|Adverse Event|2|||
105780426|NCT00303602|364848584|FG001|Overall Study|Adverse Event|2|||
105780427|NCT00303602|364848583|FG000|Overall Study|Withdrawal by Subject|5|||
105780428|NCT00303602|364848584|FG001|Overall Study|Withdrawal by Subject|6|||
105780429|NCT00303602|364848583|FG000|Overall Study|Lost to Follow-up|5|||
105780430|NCT00303602|364848584|FG001|Overall Study|Lost to Follow-up|2|||
105780431|NCT00303602|364848583|FG000|Overall Study|Protocol entry criteria not met|2|||
105780432|NCT00303602|364848584|FG001|Overall Study|Protocol entry criteria not met|2|||
105780433|NCT00303602|364848583|FG000|Overall Study|Physician Decision|2|||
105780434|NCT00303602|364848584|FG001|Overall Study|Physician Decision|1|||
105780435|NCT00303602|364848583|FG000|Overall Study|Noncompliance|2|||
105780436|NCT00303602|364848584|FG001|Overall Study|Noncompliance|2|||
105780437|NCT00303602|364848583|FG000|Overall Study|Protocol Violation|1|||
105780438|NCT00303602|364848584|FG001|Overall Study|Protocol Violation|0|||
105780439|NCT01491802|364848595|FG000|Overall Study|Adverse Event|1|||
105780440|NCT01491802|364848596|FG001|Overall Study|Adverse Event|1|||
105780441|NCT01491802|364848595|FG000|Overall Study|Withdrawal by Subject|0|||
105780442|NCT01491802|364848596|FG001|Overall Study|Withdrawal by Subject|1|||
105780443|NCT00663208|364848597|FG000|Treatment Period|Lost to Follow-up|0|||
105780444|NCT00663208|364848598|FG001|Treatment Period|Lost to Follow-up|1|||
105780445|NCT00663208|364848599|FG002|Treatment Period|Lost to Follow-up|0|||
105780446|NCT00663208|364848600|FG003|Treatment Period|Lost to Follow-up|0|||
105780447|NCT00663208|364848601|FG004|Treatment Period|Lost to Follow-up|0|||
105780448|NCT00663208|364848602|FG005|Treatment Period|Lost to Follow-up|0|||
105780449|NCT00663208|364848603|FG006|Treatment Period|Lost to Follow-up|0|||
105780450|NCT00663208|364848597|FG000|Follow-up Period|Lost to Follow-up|2|||
105780451|NCT00663208|364848598|FG001|Follow-up Period|Lost to Follow-up|0|||
105780452|NCT00663208|364848599|FG002|Follow-up Period|Lost to Follow-up|3|||
105780453|NCT00663208|364848600|FG003|Follow-up Period|Lost to Follow-up|2|||
105780454|NCT00663208|364848601|FG004|Follow-up Period|Lost to Follow-up|0|||
105780455|NCT00663208|364848602|FG005|Follow-up Period|Lost to Follow-up|0|||
105780456|NCT00663208|364848603|FG006|Follow-up Period|Lost to Follow-up|0|||
105780457|NCT00663208|364848597|FG000|Follow-up Period|Other reason|1|||
105780458|NCT00663208|364848598|FG001|Follow-up Period|Other reason|0|||
105780459|NCT00663208|364848599|FG002|Follow-up Period|Other reason|0|||
105780460|NCT00663208|364848600|FG003|Follow-up Period|Other reason|0|||
105780461|NCT00663208|364848601|FG004|Follow-up Period|Other reason|0|||
105780462|NCT00663208|364848602|FG005|Follow-up Period|Other reason|0|||
105780463|NCT00663208|364848603|FG006|Follow-up Period|Other reason|1|||
105780464|NCT02927990|364848608|FG000|Overall Study|Protocol Violation|4|||
105780465|NCT02927990|364848608|FG000|Overall Study|Physician Decision|9|||
105780466|NCT02927990|364848608|FG000|Overall Study|Room switched and therefore no study device available|15|||
105780467|NCT02927990|364848608|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
105780468|NCT02839330|364848609|FG000|Overall Study|Adverse Event|0|||
105780469|NCT02839330|364848610|FG001|Overall Study|Adverse Event|1|||
105780470|NCT02839330|364848611|FG002|Overall Study|Adverse Event|2|||
105780471|NCT02839330|364848612|FG003|Overall Study|Adverse Event|2|||
105780472|NCT02839330|364848609|FG000|Overall Study|Death|4|||
105780473|NCT02839330|364848610|FG001|Overall Study|Death|6|||
105780474|NCT02839330|364848611|FG002|Overall Study|Death|1|||
105780475|NCT02839330|364848612|FG003|Overall Study|Death|1|||
105780476|NCT02839330|364848609|FG000|Overall Study|Withdrawal by Subject|27|||
105780477|NCT02839330|364848610|FG001|Overall Study|Withdrawal by Subject|19|||
105780478|NCT02839330|364848611|FG002|Overall Study|Withdrawal by Subject|11|||
105780479|NCT02839330|364848612|FG003|Overall Study|Withdrawal by Subject|13|||
105780480|NCT02839330|364848609|FG000|Overall Study|Lost to Follow-up|22|||
105780481|NCT02839330|364848610|FG001|Overall Study|Lost to Follow-up|27|||
105780482|NCT02839330|364848611|FG002|Overall Study|Lost to Follow-up|29|||
105780483|NCT02839330|364848612|FG003|Overall Study|Lost to Follow-up|25|||
105780484|NCT02839330|364848609|FG000|Overall Study|Administrative Reason|0|||
105780485|NCT02839330|364848610|FG001|Overall Study|Administrative Reason|0|||
105780486|NCT02839330|364848611|FG002|Overall Study|Administrative Reason|0|||
105780487|NCT02839330|364848612|FG003|Overall Study|Administrative Reason|1|||
105780488|NCT02839330|364848609|FG000|Overall Study|Protocol Violation|1|||
105780489|NCT02839330|364848610|FG001|Overall Study|Protocol Violation|2|||
105780490|NCT02839330|364848611|FG002|Overall Study|Protocol Violation|2|||
105780491|NCT02839330|364848612|FG003|Overall Study|Protocol Violation|3|||
105780492|NCT02839330|364848609|FG000|Overall Study|Other reason, not specified|4|||
105780493|NCT02839330|364848610|FG001|Overall Study|Other reason, not specified|3|||
105780494|NCT02839330|364848611|FG002|Overall Study|Other reason, not specified|3|||
105780495|NCT02839330|364848612|FG003|Overall Study|Other reason, not specified|6|||
105780496|NCT01710709|364848613|FG000|Overall Study|Lost to Follow-up|29|||
105780497|NCT01710709|364848613|FG000|Overall Study|Adverse Event|48|||
105780498|NCT01710709|364848613|FG000|Overall Study|Participant met withdrawal criteria|33|||
105780499|NCT01710709|364848613|FG000|Overall Study|Participant withdrawn by investigator|2|||
105780500|NCT01710709|364848613|FG000|Overall Study|Withdrawal by Subject|53|||
105780501|NCT01710709|364848613|FG000|Overall Study|Protocol Violation|5|||
105780502|NCT01710709|364848613|FG000|Overall Study|Lack of Efficacy|3|||
105780503|NCT01345162|364848618|FG000|Overall Study|Protocol Violation|2|||
105780504|NCT01345162|364848619|FG001|Overall Study|Protocol Violation|4|||
105780505|NCT01398176|364848620|FG000|Overall Study|Lost to Follow-up|1|||
105780506|NCT01398176|364848621|FG001|Overall Study|Lost to Follow-up|3|||
105780507|NCT01398176|364848620|FG000|Overall Study|Physician Decision|2|||
105780508|NCT01398176|364848621|FG001|Overall Study|Physician Decision|3|||
105780509|NCT00508872|364848622|FG000|Overall Study|Lost to Follow-up|1|||
105780510|NCT00508872|364848622|FG000|Overall Study|Physician Decision|1|||
105780511|NCT00542321|364848623|FG000|Overall Study|Death|0|||
105780512|NCT00542321|364848624|FG001|Overall Study|Death|1|||
105780513|NCT01871870|364848628|FG000|Overall Study|Hardware issues|7|||
105780514|NCT01871870|364848628|FG000|Overall Study|hyperglycemia|2|||
105780515|NCT03007472|364848629|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
105780516|NCT03007472|364848629|FG000|Overall Study|Death|2|||
105780517|NCT03007472|364848629|FG000|Overall Study|Loss to Follow Up|1|||
105780518|NCT00883896|364848630|FG000|Overall Study|Lost to Follow-up|0|||
105780519|NCT00883896|364848631|FG001|Overall Study|Lost to Follow-up|0|||
105780520|NCT00883896|364848632|FG002|Overall Study|Lost to Follow-up|0|||
105780521|NCT00883896|364848633|FG003|Overall Study|Lost to Follow-up|2|||
105780522|NCT00883896|364848630|FG000|Overall Study|Withdrawal by Subject|5|||
105780523|NCT00883896|364848631|FG001|Overall Study|Withdrawal by Subject|0|||
105780524|NCT00883896|364848632|FG002|Overall Study|Withdrawal by Subject|1|||
105780525|NCT00883896|364848633|FG003|Overall Study|Withdrawal by Subject|3|||
105780526|NCT00883896|364848630|FG000|Overall Study|Lack of Efficacy|0|||
105780527|NCT00883896|364848631|FG001|Overall Study|Lack of Efficacy|0|||
105780528|NCT00883896|364848632|FG002|Overall Study|Lack of Efficacy|0|||
105780529|NCT00883896|364848633|FG003|Overall Study|Lack of Efficacy|2|||
105780530|NCT00883896|364848630|FG000|Overall Study|Other|1|||
105780531|NCT00883896|364848631|FG001|Overall Study|Other|0|||
105780532|NCT00883896|364848632|FG002|Overall Study|Other|0|||
105780533|NCT00883896|364848633|FG003|Overall Study|Other|0|||
105780534|NCT00148109|364848639|FG000|Overall Study|Lack of Efficacy|10|||
105780535|NCT00148109|364848640|FG001|Overall Study|Lack of Efficacy|18|||
105780536|NCT00148109|364848639|FG000|Overall Study|Adverse Event|0|||
105780537|NCT00148109|364848640|FG001|Overall Study|Adverse Event|2|||
105780538|NCT00148109|364848639|FG000|Overall Study|Withdrawal by Subject|2|||
105780539|NCT00148109|364848640|FG001|Overall Study|Withdrawal by Subject|0|||
105780540|NCT02988115|364848641|FG000|Overall Study|Adverse Event|6|||
105780541|NCT02988115|364848642|FG001|Overall Study|Adverse Event|1|||
105780542|NCT02988115|364848641|FG000|Overall Study|Sponsor Decision|5|||
105780543|NCT02988115|364848642|FG001|Overall Study|Sponsor Decision|2|||
105780544|NCT02988115|364848641|FG000|Overall Study|Withdrawal by Subject|1|||
105780545|NCT02988115|364848642|FG001|Overall Study|Withdrawal by Subject|1|||
105780546|NCT02988115|364848641|FG000|Overall Study|Withdrawn by Mistake|1|||
105780547|NCT02988115|364848642|FG001|Overall Study|Withdrawn by Mistake|0|||
105780548|NCT02988115|364848641|FG000|Overall Study|Lost to Follow-up|1|||
105780549|NCT02988115|364848642|FG001|Overall Study|Lost to Follow-up|0|||
105780550|NCT01731951|364848643|FG000|Overall Study|Documented Disease Progression|1|||
105780551|NCT01731951|364848644|FG001|Overall Study|Documented Disease Progression|0|||
105780552|NCT01731951|364848645|FG002|Overall Study|Documented Disease Progression|0|||
105780553|NCT01731951|364848646|FG003|Overall Study|Documented Disease Progression|0|||
105780554|NCT01731951|364848647|FG004|Overall Study|Documented Disease Progression|0|||
105780555|NCT01731951|364848648|FG005|Overall Study|Documented Disease Progression|0|||
105335800|NCT01217476|363230106|FG000|Overall Study|Other|2|||
105780556|NCT01731951|364848643|FG000|Overall Study|Lost to Follow-up|2|||
105780557|NCT01731951|364848644|FG001|Overall Study|Lost to Follow-up|0|||
105780558|NCT01731951|364848645|FG002|Overall Study|Lost to Follow-up|0|||
105780559|NCT01731951|364848646|FG003|Overall Study|Lost to Follow-up|1|||
105780560|NCT01731951|364848647|FG004|Overall Study|Lost to Follow-up|3|||
105780561|NCT01731951|364848648|FG005|Overall Study|Lost to Follow-up|1|||
105780562|NCT01731951|364848643|FG000|Overall Study|Withdrawal of Consent|1|||
105780563|NCT01731951|364848644|FG001|Overall Study|Withdrawal of Consent|0|||
105335801|NCT01217476|363230107|FG001|Overall Study|Other|0|||
105335802|NCT04740827|363230108|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
105335803|NCT04740827|363230109|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
105335804|NCT04740827|363230108|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
105335805|NCT04740827|363230109|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
105335806|NCT04740827|363230108|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
105335807|NCT04740827|363230109|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
105335808|NCT04740827|363230108|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
105335809|NCT04740827|363230109|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
105335810|NCT04740827|363230108|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
105335811|NCT04740827|363230109|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
105335812|NCT04740827|363230108|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
105335813|NCT04740827|363230109|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
105335814|NCT03033602|363230110|FG000|Overall Study|Withdrawal by Subject|11|||
105335815|NCT03033602|363230111|FG001|Overall Study|Withdrawal by Subject|21|||
105335816|NCT03033602|363230110|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
105335817|NCT03033602|363230111|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
105335818|NCT03425396|363230112|FG000|Overall Study|Lost to Follow-up|2|||
105335819|NCT03425396|363230113|FG001|Overall Study|Lost to Follow-up|5|||
105335820|NCT03425396|363230114|FG002|Overall Study|Lost to Follow-up|2|||
105335821|NCT03425396|363230115|FG003|Overall Study|Lost to Follow-up|0|||
105335822|NCT03425396|363230116|FG004|Overall Study|Lost to Follow-up|0|||
105335823|NCT03425396|363230112|FG000|Overall Study|Withdrawal by Subject|0|||
105335824|NCT03425396|363230113|FG001|Overall Study|Withdrawal by Subject|1|||
105335825|NCT03425396|363230114|FG002|Overall Study|Withdrawal by Subject|0|||
105335826|NCT03425396|363230115|FG003|Overall Study|Withdrawal by Subject|1|||
105335827|NCT03425396|363230116|FG004|Overall Study|Withdrawal by Subject|0|||
105335828|NCT03425396|363230112|FG000|Overall Study|Other|0|||
105335829|NCT03425396|363230113|FG001|Overall Study|Other|1|||
105335830|NCT03425396|363230114|FG002|Overall Study|Other|1|||
105335831|NCT03425396|363230115|FG003|Overall Study|Other|0|||
105335832|NCT03425396|363230116|FG004|Overall Study|Other|1|||
105335833|NCT00940823|363230117|FG000|Overall Study|Death|8|||
105335834|NCT00940823|363230118|FG001|Overall Study|Death|12|||
105335835|NCT00940823|363230117|FG000|Overall Study|Lost to Follow-up|27|||
105335836|NCT00940823|363230118|FG001|Overall Study|Lost to Follow-up|20|||
105550167|NCT00902304|364014370|FG001|Overall Study|Investigator discretion|5|||
105550168|NCT00902304|364014371|FG002|Overall Study|Investigator discretion|13|||
105550169|NCT00902304|364014369|FG000|Overall Study|Lost to Follow-up|7|||
105550170|NCT00902304|364014370|FG001|Overall Study|Lost to Follow-up|7|||
105550171|NCT00902304|364014371|FG002|Overall Study|Lost to Follow-up|7|||
105550172|NCT00902304|364014369|FG000|Overall Study|Protocol Violation|9|||
105550173|NCT00902304|364014370|FG001|Overall Study|Protocol Violation|18|||
105550174|NCT00902304|364014371|FG002|Overall Study|Protocol Violation|20|||
105550175|NCT00902304|364014369|FG000|Overall Study|Withdrawal by Subject|32|||
105550176|NCT00902304|364014370|FG001|Overall Study|Withdrawal by Subject|22|||
105550177|NCT00902304|364014371|FG002|Overall Study|Withdrawal by Subject|43|||
105550178|NCT00902304|364014369|FG000|Overall Study|includes pregnancy|3|||
105550179|NCT00902304|364014370|FG001|Overall Study|includes pregnancy|9|||
105550180|NCT00902304|364014371|FG002|Overall Study|includes pregnancy|2|||
105550181|NCT04743908|364014372|FG000|Overall Study|Death|1|||
105335852|NCT02981082|363230124|FG000|Overall Study|Withdrawal by Subject|2|||
105335853|NCT02981082|363230125|FG001|Overall Study|Withdrawal by Subject|0|||
105335854|NCT02981082|363230124|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
105335855|NCT02981082|363230125|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
105335856|NCT02981082|363230124|FG000|Overall Study|Adverse Event|0|||
105335857|NCT02981082|363230125|FG001|Overall Study|Adverse Event|1|||
105335858|NCT03689374|363230126|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
105335859|NCT03689374|363230127|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
105335860|NCT03689374|363230128|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
105335861|NCT03689374|363230126|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
105335862|NCT03689374|363230127|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
105335863|NCT03689374|363230128|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
105335864|NCT03689374|363230126|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
105335865|NCT03689374|363230127|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
105335866|NCT03689374|363230128|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
105335867|NCT03689374|363230126|FG000|Treatment Period (Week 0 to 52)|Death|0|||
105335868|NCT03689374|363230127|FG001|Treatment Period (Week 0 to 52)|Death|11|||
105335869|NCT03689374|363230128|FG002|Treatment Period (Week 0 to 52)|Death|1|||
105335870|NCT05367973|363230129|FG000|Overall Study|Adverse Event|0|||
105335871|NCT05367973|363230130|FG001|Overall Study|Adverse Event|2|||
105335872|NCT00986921|363230133|FG000|Overall Study|Physician Decision|1|||
105335873|NCT00986921|363230134|FG001|Overall Study|Physician Decision|0|||
105335874|NCT00813813|363230135|FG000|Overall Study|Withdrawal by Subject|1|||
105780564|NCT01731951|364848645|FG002|Overall Study|Withdrawal of Consent|0|||
105780565|NCT01731951|364848646|FG003|Overall Study|Withdrawal of Consent|0|||
105780566|NCT01731951|364848647|FG004|Overall Study|Withdrawal of Consent|0|||
105780567|NCT01731951|364848648|FG005|Overall Study|Withdrawal of Consent|2|||
105780568|NCT01731951|364848643|FG000|Overall Study|Death|13|||
105780569|NCT01731951|364848644|FG001|Overall Study|Death|15|||
105780570|NCT01731951|364848645|FG002|Overall Study|Death|9|||
105780571|NCT01731951|364848646|FG003|Overall Study|Death|8|||
105780572|NCT01731951|364848647|FG004|Overall Study|Death|9|||
105780573|NCT01731951|364848648|FG005|Overall Study|Death|6|||
105780574|NCT01977651|364848658|FG000|4 Month Treatment Period|Adverse Event|34|||
105780575|NCT01977651|364848658|FG000|4 Month Treatment Period|Death|3|||
105780576|NCT01977651|364848658|FG000|4 Month Treatment Period|Progressive Disease|43|||
105780577|NCT01977651|364848658|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
105780578|NCT01977651|364848658|FG000|4 Month Treatment Period|Physician Decision|4|||
105780579|NCT01977651|364848658|FG000|1 Year Extension Period|Adverse Event|14|||
105780580|NCT01977651|364848658|FG000|1 Year Extension Period|Death|10|||
105780581|NCT01977651|364848658|FG000|1 Year Extension Period|Lost to Follow-up|2|||
105780582|NCT01977651|364848658|FG000|1 Year Extension Period|Progressive Disease|86|||
105780583|NCT01977651|364848658|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
105780584|NCT01977651|364848658|FG000|1 Year Extension Period|Physician Decision|6|||
105780585|NCT01977651|364848658|FG000|1 Year Extension Period|Miscellaneous|1|||
105780586|NCT01977651|364848658|FG000|Post 1 Year Extension Period|Adverse Event|5|||
105780587|NCT01977651|364848658|FG000|Post 1 Year Extension Period|Death|13|||
105780588|NCT01977651|364848658|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
105780589|NCT01977651|364848658|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
105780590|NCT01977651|364848658|FG000|Post 1 Year Extension Period|Physician Decision|4|||
105780591|NCT01977651|364848658|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
105780592|NCT01856920|364848659|FG000|Overall Study|Disease Progression On Study|3|||
105780593|NCT01856920|364848660|FG001|Overall Study|Disease Progression On Study|4|||
105780594|NCT01856920|364848659|FG000|Overall Study|Disease Progression before Treatment|1|||
105780595|NCT01856920|364848660|FG001|Overall Study|Disease Progression before Treatment|0|||
105780596|NCT01856920|364848659|FG000|Overall Study|Ineligible|0|||
105780597|NCT01856920|364848660|FG001|Overall Study|Ineligible|1|||
105780598|NCT01856920|364848659|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
105780599|NCT01856920|364848660|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
105780600|NCT01856920|364848659|FG000|Overall Study|Refused further Treatment|5|||
105780601|NCT01856920|364848660|FG001|Overall Study|Refused further Treatment|1|||
105780602|NCT01856920|364848659|FG000|Overall Study|Other Reasons|0|||
105780603|NCT01856920|364848660|FG001|Overall Study|Other Reasons|1|||
105780604|NCT01856920|364848659|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
105780605|NCT01856920|364848660|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
105780606|NCT03287089|364848662|FG000|Overall Study|Lost to Follow-up|0|||
105780607|NCT03287089|364848663|FG001|Overall Study|Lost to Follow-up|2|||
105780608|NCT03287089|364848662|FG000|Overall Study|Physician Decision|0|||
105780609|NCT03287089|364848663|FG001|Overall Study|Physician Decision|2|||
105780610|NCT03287089|364848662|FG000|Overall Study|Withdrawal by Subject|0|||
105780611|NCT03287089|364848663|FG001|Overall Study|Withdrawal by Subject|2|||
105780612|NCT02906644|364848664|FG000|First 2 Weeks|Withdrawal by Subject|0|||
105780613|NCT02906644|364848665|FG001|First 2 Weeks|Withdrawal by Subject|2|||
105780614|NCT02906644|364848664|FG000|First 2 Weeks|Physician Decision|1|||
105780615|NCT02906644|364848665|FG001|First 2 Weeks|Physician Decision|1|||
105780616|NCT02906644|364848664|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
105780617|NCT02906644|364848665|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
105780618|NCT02906644|364848664|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
105780619|NCT02906644|364848665|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
105780620|NCT00561795|364848666|FG000|Overall Study|Adverse Event|3|||
105780621|NCT00561795|364848667|FG001|Overall Study|Adverse Event|3|||
105780622|NCT00561795|364848668|FG002|Overall Study|Adverse Event|0|||
105780623|NCT00561795|364848669|FG003|Overall Study|Adverse Event|0|||
105780624|NCT00561795|364848666|FG000|Overall Study|Study Closed/Terminated|0|||
105780625|NCT00561795|364848667|FG001|Overall Study|Study Closed/Terminated|3|||
105780626|NCT00561795|364848668|FG002|Overall Study|Study Closed/Terminated|0|||
105780627|NCT00561795|364848669|FG003|Overall Study|Study Closed/Terminated|0|||
105780628|NCT00561795|364848666|FG000|Overall Study|Physician Decision|1|||
105780629|NCT00561795|364848667|FG001|Overall Study|Physician Decision|0|||
105780630|NCT00561795|364848668|FG002|Overall Study|Physician Decision|0|||
105780631|NCT00561795|364848669|FG003|Overall Study|Physician Decision|0|||
105780632|NCT03672006|364848670|FG000|Overall Study|exclusion criteria met|0|||
105780633|NCT03672006|364848671|FG001|Overall Study|exclusion criteria met|1|||
105444458|NCT01724866|363633277|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
105780634|NCT04235959|364848672|FG000|Overall Study|Protocol Violation|0|||
105780635|NCT04235959|364848673|FG001|Overall Study|Protocol Violation|1|||
105780636|NCT04235959|364848674|FG002|Overall Study|Protocol Violation|0|||
105780637|NCT04235959|364848672|FG000|Overall Study|Adverse Event|1|||
105780638|NCT04235959|364848673|FG001|Overall Study|Adverse Event|0|||
105780639|NCT04235959|364848674|FG002|Overall Study|Adverse Event|0|||
105780640|NCT00608426|364848675|FG000|Overall Study|Death|32|||
105780641|NCT00608426|364848676|FG001|Overall Study|Death|36|||
105780642|NCT00608426|364848675|FG000|Overall Study|Lost to Follow-up|485|||
105780643|NCT00608426|364848676|FG001|Overall Study|Lost to Follow-up|521|||
105780644|NCT00608426|364848675|FG000|Overall Study|refused, health issues, wrong address|319|||
105780645|NCT00608426|364848676|FG001|Overall Study|refused, health issues, wrong address|348|||
105780646|NCT00761891|364848680|FG000|Overall Study|Withdrawal by Subject|10|||
105780647|NCT01707667|364848681|FG000|Period 1|expulsion of colonic sensor catheter|1|||
105780648|NCT01707667|364848682|FG001|Period 1|expulsion of colonic sensor catheter|0|||
105780649|NCT00579059|364848686|FG000|Overall Study|Study Canceled at 1 Year|21|||
105780650|NCT00579059|364848687|FG001|Overall Study|Study Canceled at 1 Year|10|||
105780651|NCT02764229|364848688|FG000|Overall Study|Withdrawal by Subject|15|||
105780652|NCT02764229|364848688|FG000|Overall Study|Adverse Event|9|||
105780653|NCT02764229|364848688|FG000|Overall Study|Physician Decision|5|||
105780654|NCT02764229|364848688|FG000|Overall Study|Lost to Follow-up|3|||
105780655|NCT02764229|364848688|FG000|Overall Study|Lack of Efficacy|1|||
105780656|NCT02764229|364848688|FG000|Overall Study|Study Stopped by Sponsor|69|||
105780657|NCT00779142|364848689|FG000|Overall Study|Screen Failures|3|||
105780658|NCT00672490|364848691|FG000|Overall Study|Withdrawal by Subject|8|||
105780659|NCT00672490|364848692|FG001|Overall Study|Withdrawal by Subject|8|||
105780660|NCT00672490|364848691|FG000|Overall Study|Lack of Compliance|2|||
105780661|NCT00672490|364848692|FG001|Overall Study|Lack of Compliance|7|||
105780662|NCT00672490|364848691|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
105780663|NCT00672490|364848692|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
105780664|NCT00672490|364848691|FG000|Overall Study|Adverse Event|5|||
105780665|NCT00672490|364848692|FG001|Overall Study|Adverse Event|8|||
105780666|NCT00672490|364848691|FG000|Overall Study|Violation of Concomitant Medicine|1|||
105780667|NCT00672490|364848692|FG001|Overall Study|Violation of Concomitant Medicine|0|||
105780668|NCT00672490|364848691|FG000|Overall Study|Intolerance|0|||
105780669|NCT00672490|364848692|FG001|Overall Study|Intolerance|2|||
105780670|NCT00672490|364848691|FG000|Overall Study|Lost to Follow-up|1|||
105780671|NCT00672490|364848692|FG001|Overall Study|Lost to Follow-up|5|||
105780672|NCT00672490|364848691|FG000|Overall Study|No reason was provided|6|||
105780673|NCT00672490|364848692|FG001|Overall Study|No reason was provided|2|||
105780674|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Adverse Event|6|||
105780675|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Adverse Event|6|||
105780676|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Death|14|||
105780677|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Death|11|||
105780678|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
105780679|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
105780680|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
105780681|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
105444459|NCT01724866|363633278|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
105444460|NCT01724866|363633275|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
105444461|NCT01724866|363633276|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
105444462|NCT01724866|363633277|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
105444463|NCT01724866|363633278|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
105444464|NCT01362608|363633284|FG000|Overall Study|Protocol Violation|0|||
105444465|NCT01362608|363633285|FG001|Overall Study|Protocol Violation|1|||
105444466|NCT01362608|363633284|FG000|Overall Study|Lost to Follow-up|3|||
105444467|NCT01362608|363633285|FG001|Overall Study|Lost to Follow-up|1|||
105444468|NCT01362608|363633284|FG000|Overall Study|Withdrawal by Subject|1|||
105444469|NCT01362608|363633285|FG001|Overall Study|Withdrawal by Subject|2|||
105444470|NCT01362608|363633284|FG000|Overall Study|Lack of Efficacy|0|||
105444471|NCT01362608|363633285|FG001|Overall Study|Lack of Efficacy|2|||
105444472|NCT01362608|363633284|FG000|Overall Study|Adverse Event|0|||
105444473|NCT01362608|363633285|FG001|Overall Study|Adverse Event|2|||
105444474|NCT01510158|363633287|FG000|Overall Study|Adverse Event|7|||
105444475|NCT01510158|363633288|FG001|Overall Study|Adverse Event|8|||
105444476|NCT01510158|363633289|FG002|Overall Study|Adverse Event|5|||
105780682|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
105780683|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
105780684|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Disease Progression|1|||
105780685|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Disease Progression|0|||
105780686|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
105780687|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
105780688|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
105780689|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
105780690|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Participant Decision|4|||
105780691|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Participant Decision|3|||
105780692|NCT04419558|364848695|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
105780693|NCT04419558|364848696|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
105444477|NCT01510158|363633287|FG000|Overall Study|Gout flare|1|||
105780694|NCT04419558|364848695|FG000|OLE Period (48 Weeks)|Death|4|||
105780695|NCT04419558|364848696|FG001|OLE Period (48 Weeks)|Death|6|||
105780696|NCT04419558|364848695|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
105780697|NCT04419558|364848696|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
105780698|NCT04419558|364848695|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
105780699|NCT04419558|364848696|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
105780700|NCT00697255|364848698|FG000|Stage 1a|Insufficient ovarian response|1|||
105780701|NCT00697255|364848699|FG001|Stage 1a|Insufficient ovarian response|0|||
105780702|NCT00697255|364848698|FG000|Stage 1a|Multifollicular growth|1|||
105780703|NCT00697255|364848699|FG001|Stage 1a|Multifollicular growth|0|||
105780704|NCT00697255|364848698|FG000|Stage 1a|Not growing of dominant follicle|1|||
105780705|NCT00697255|364848699|FG001|Stage 1a|Not growing of dominant follicle|0|||
105780706|NCT00697255|364848698|FG000|Stage 1b|Not growing of dominant follicle|0|||
105780707|NCT00697255|364848699|FG001|Stage 1b|Not growing of dominant follicle|1|||
105444478|NCT01510158|363633288|FG001|Overall Study|Gout flare|0|||
105444479|NCT01510158|363633289|FG002|Overall Study|Gout flare|0|||
105444480|NCT01510158|363633287|FG000|Overall Study|Protocol Violation|17|||
105444481|NCT01510158|363633288|FG001|Overall Study|Protocol Violation|16|||
105444482|NCT01510158|363633289|FG002|Overall Study|Protocol Violation|24|||
105444483|NCT01510158|363633287|FG000|Overall Study|Sponsor terminated study.|2|||
105444484|NCT01510158|363633288|FG001|Overall Study|Sponsor terminated study.|0|||
105444485|NCT01510158|363633289|FG002|Overall Study|Sponsor terminated study.|2|||
105444486|NCT01510158|363633287|FG000|Overall Study|Lost to Follow-up|13|||
105444487|NCT01510158|363633288|FG001|Overall Study|Lost to Follow-up|16|||
105444488|NCT01510158|363633289|FG002|Overall Study|Lost to Follow-up|9|||
105444489|NCT01510158|363633287|FG000|Overall Study|Withdrawal by Subject|10|||
105444490|NCT01510158|363633288|FG001|Overall Study|Withdrawal by Subject|13|||
105444491|NCT01510158|363633289|FG002|Overall Study|Withdrawal by Subject|10|||
105444492|NCT01510158|363633287|FG000|Overall Study|Death|1|||
105444493|NCT01510158|363633288|FG001|Overall Study|Death|0|||
105444494|NCT01510158|363633289|FG002|Overall Study|Death|0|||
105444495|NCT02837029|363633290|FG000|Screening|Failed to meet screening requirements.|7|||
105444496|NCT02837029|363633291|FG001|Screening|Failed to meet screening requirements.|3|||
105444497|NCT02837029|363633292|FG002|Screening|Failed to meet screening requirements.|0|||
105444498|NCT02837029|363633290|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
105444499|NCT02837029|363633291|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
105444500|NCT02837029|363633292|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
105444501|NCT02837029|363633290|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
105444502|NCT02837029|363633291|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
105444503|NCT02837029|363633292|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
105444504|NCT02837029|363633290|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
105444505|NCT02837029|363633291|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
105444506|NCT02837029|363633292|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
105444507|NCT02837029|363633290|FG000|Cycle 2 and Beyond|Adverse Event|1|||
105444508|NCT02837029|363633291|FG001|Cycle 2 and Beyond|Adverse Event|0|||
105444509|NCT02837029|363633292|FG002|Cycle 2 and Beyond|Adverse Event|0|||
105444510|NCT02837029|363633290|FG000|2 Year Follow-up|Death|6|||
105444511|NCT02837029|363633291|FG001|2 Year Follow-up|Death|7|||
105444512|NCT02837029|363633292|FG002|2 Year Follow-up|Death|0|||
105444513|NCT02644343|363633293|FG000|Overall Study|Withdrawal by Subject|1|||
105444514|NCT00570310|363633301|FG000|Overall Study|Adverse Event|1|||
105444515|NCT00570310|363633302|FG001|Overall Study|Adverse Event|2|||
105444516|NCT00570310|363633301|FG000|Overall Study|Lack of Efficacy|1|||
105444517|NCT00570310|363633302|FG001|Overall Study|Lack of Efficacy|4|||
105444518|NCT03329846|363633303|FG000|Overall Study|Disease progression|4|||
105444519|NCT03329846|363633304|FG001|Overall Study|Disease progression|6|||
105444520|NCT03329846|363633303|FG000|Overall Study|Study drug toxicity|1|||
105444521|NCT03329846|363633304|FG001|Overall Study|Study drug toxicity|0|||
105444522|NCT03329846|363633303|FG000|Overall Study|Participant request to discontinue treatment|0|||
105444523|NCT03329846|363633304|FG001|Overall Study|Participant request to discontinue treatment|1|||
105444524|NCT03329846|363633303|FG000|Overall Study|Participant withdrew consent|1|||
105444525|NCT03329846|363633304|FG001|Overall Study|Participant withdrew consent|0|||
105444526|NCT03329846|363633303|FG000|Overall Study|Other reasons|2|||
105444527|NCT03329846|363633304|FG001|Overall Study|Other reasons|2|||
105444528|NCT00108862|363633305|FG000|Overall Study|Death|31|||
105444529|NCT00108862|363633306|FG001|Overall Study|Death|37|||
105444530|NCT00108862|363633305|FG000|Overall Study|Withdrawal by Subject|10|||
105444531|NCT00108862|363633306|FG001|Overall Study|Withdrawal by Subject|6|||
105444532|NCT00108862|363633305|FG000|Overall Study|Lost to Follow-up|27|||
105444533|NCT00108862|363633306|FG001|Overall Study|Lost to Follow-up|19|||
105444534|NCT04854551|363633307|FG000|Overall Study|Withdrawal by Subject|1|||
105444535|NCT04854551|363633308|FG001|Overall Study|Withdrawal by Subject|1|||
105780708|NCT00697255|364848698|FG000|Stage 1b|Insufficient ovarian response|0|||
105444536|NCT03472950|363633309|FG000|Overall Study|Lost to Follow-up|0|||
105444537|NCT03472950|363633310|FG001|Overall Study|Lost to Follow-up|1|||
105444538|NCT03472950|363633309|FG000|Overall Study|Adverse Event|0|||
105444539|NCT03472950|363633310|FG001|Overall Study|Adverse Event|3|||
105444540|NCT00080301|363633311|FG000|Overall Study|Randomized but Never Treated|5|||
105444541|NCT00080301|363633312|FG001|Overall Study|Randomized but Never Treated|10|||
105444542|NCT00080301|363633311|FG000|Overall Study|Still on Treatment as of CSR date|0|||
105444543|NCT00080301|363633312|FG001|Overall Study|Still on Treatment as of CSR date|1|||
105444544|NCT00726232|363633315|FG000|Initial Phase (Dose-finding)|Death|0|||
105444545|NCT00726232|363633316|FG001|Initial Phase (Dose-finding)|Death|0|||
105444546|NCT00726232|363633317|FG002|Initial Phase (Dose-finding)|Death|0|||
105444547|NCT00726232|363633318|FG003|Initial Phase (Dose-finding)|Death|0|||
105444548|NCT00726232|363633319|FG004|Initial Phase (Dose-finding)|Death|1|||
105444549|NCT00726232|363633320|FG005|Initial Phase (Dose-finding)|Death|0|||
105780709|NCT00697255|364848699|FG001|Stage 1b|Insufficient ovarian response|1|||
105780710|NCT01853397|364848710|FG000|Overall Study|Withdrawal by Subject|0|||
105780711|NCT01853397|364848711|FG001|Overall Study|Withdrawal by Subject|0|||
105780712|NCT01853397|364848712|FG002|Overall Study|Withdrawal by Subject|0|||
105780713|NCT01853397|364848713|FG003|Overall Study|Withdrawal by Subject|1|||
105780714|NCT01853397|364848710|FG000|Overall Study|Subject Noncompliance|0|||
105780715|NCT01853397|364848711|FG001|Overall Study|Subject Noncompliance|0|||
105780716|NCT01853397|364848712|FG002|Overall Study|Subject Noncompliance|0|||
105780717|NCT01853397|364848713|FG003|Overall Study|Subject Noncompliance|1|||
105780718|NCT02452892|364848714|FG000|Week 1 Initial Randommization|Adverse Event|1|||
105780719|NCT02452892|364848715|FG001|Week 1 Initial Randommization|Adverse Event|0|||
105780720|NCT02452892|364848716|FG002|Week 1 Initial Randommization|Adverse Event|0|||
105780721|NCT02452892|364848717|FG003|Week 1 Initial Randommization|Adverse Event|0|||
105780722|NCT02452892|364848714|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
105780723|NCT02452892|364848715|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
105780724|NCT02452892|364848716|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
105780725|NCT02452892|364848717|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
105780726|NCT02452892|364848714|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
105780727|NCT02452892|364848715|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
105780728|NCT02452892|364848716|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
105780729|NCT02452892|364848717|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
105780730|NCT02452892|364848714|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
105780731|NCT02452892|364848715|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
105780732|NCT02452892|364848716|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
105780733|NCT02452892|364848717|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
105780734|NCT02452892|364848714|FG000|Follow-up|Withdrawal by Subject|0|||
105780735|NCT02452892|364848715|FG001|Follow-up|Withdrawal by Subject|0|||
105780736|NCT02452892|364848716|FG002|Follow-up|Withdrawal by Subject|0|||
105780737|NCT02452892|364848717|FG003|Follow-up|Withdrawal by Subject|1|||
105780738|NCT02452892|364848714|FG000|Follow-up|Subject left town on Day 42|1|||
105780739|NCT02452892|364848715|FG001|Follow-up|Subject left town on Day 42|0|||
105780740|NCT02452892|364848716|FG002|Follow-up|Subject left town on Day 42|0|||
105780741|NCT02452892|364848717|FG003|Follow-up|Subject left town on Day 42|0|||
105780742|NCT00565721|364848722|FG000|Overall Study|Screen Failure|2|||
105780743|NCT00565721|364848722|FG000|Overall Study|Lost to Follow-up|6|||
105780744|NCT00565721|364848722|FG000|Overall Study|Technical Problems|1|||
105780745|NCT00565721|364848722|FG000|Overall Study|Physician Decision|2|||
105780746|NCT00565721|364848722|FG000|Overall Study|Other reasons|6|||
105780747|NCT05047601|364848723|FG000|Overall Study|Lost to Follow-up|9|||
105780748|NCT05047601|364848724|FG001|Overall Study|Lost to Follow-up|11|||
105780749|NCT05047601|364848725|FG002|Overall Study|Lost to Follow-up|7|||
105780750|NCT05047601|364848723|FG000|Overall Study|Withdrawal by Subject|25|||
105780751|NCT05047601|364848724|FG001|Overall Study|Withdrawal by Subject|36|||
105780752|NCT05047601|364848725|FG002|Overall Study|Withdrawal by Subject|23|||
105780753|NCT05047601|364848723|FG000|Overall Study|Other|10|||
105780754|NCT05047601|364848724|FG001|Overall Study|Other|6|||
105780755|NCT05047601|364848725|FG002|Overall Study|Other|5|||
105780756|NCT00286234|364848726|FG000|Overall Study|Protocol Violation|1|||
105780757|NCT00286234|364848727|FG001|Overall Study|Protocol Violation|2|||
105780758|NCT00286234|364848728|FG002|Overall Study|Protocol Violation|0|||
105780759|NCT00286234|364848729|FG003|Overall Study|Protocol Violation|1|||
105780760|NCT00286234|364848726|FG000|Overall Study|Physician Decision|1|||
105780761|NCT00286234|364848727|FG001|Overall Study|Physician Decision|0|||
105780762|NCT00286234|364848728|FG002|Overall Study|Physician Decision|0|||
105780763|NCT00286234|364848729|FG003|Overall Study|Physician Decision|1|||
105780764|NCT00286234|364848726|FG000|Overall Study|Adverse Event|0|||
105780765|NCT00286234|364848727|FG001|Overall Study|Adverse Event|0|||
105780766|NCT00286234|364848728|FG002|Overall Study|Adverse Event|0|||
105780767|NCT00286234|364848729|FG003|Overall Study|Adverse Event|1|||
105780768|NCT00286234|364848726|FG000|Overall Study|Adverse Event|0|||
105780769|NCT00286234|364848727|FG001|Overall Study|Adverse Event|0|||
105780770|NCT00286234|364848728|FG002|Overall Study|Adverse Event|0|||
105780771|NCT00286234|364848729|FG003|Overall Study|Adverse Event|1|||
105780772|NCT00699582|364848732|FG000|Overall Study|Adverse Event|4|||
105484836|NCT01992159|363786982|FG000|Overall Study|Death|0|||
105780773|NCT00699582|364848733|FG001|Overall Study|Adverse Event|11|||
105780774|NCT00699582|364848734|FG002|Overall Study|Adverse Event|23|||
105780775|NCT00699582|364848732|FG000|Overall Study|Withdrawal by Subject|6|||
105780776|NCT00699582|364848733|FG001|Overall Study|Withdrawal by Subject|7|||
105780777|NCT00699582|364848734|FG002|Overall Study|Withdrawal by Subject|4|||
105780778|NCT00699582|364848732|FG000|Overall Study|Lack of Efficacy|1|||
105780779|NCT00699582|364848733|FG001|Overall Study|Lack of Efficacy|0|||
105780780|NCT00699582|364848734|FG002|Overall Study|Lack of Efficacy|1|||
105780781|NCT00699582|364848732|FG000|Overall Study|Progressive Disease|1|||
105780782|NCT00699582|364848733|FG001|Overall Study|Progressive Disease|0|||
105780783|NCT00699582|364848734|FG002|Overall Study|Progressive Disease|0|||
105780784|NCT00699582|364848732|FG000|Overall Study|Administrative/Other|4|||
105780785|NCT00699582|364848733|FG001|Overall Study|Administrative/Other|3|||
105780786|NCT00699582|364848734|FG002|Overall Study|Administrative/Other|0|||
105780787|NCT00699582|364848732|FG000|Overall Study|Randomized, Not Treated|2|||
105780788|NCT00699582|364848733|FG001|Overall Study|Randomized, Not Treated|1|||
105780789|NCT00699582|364848734|FG002|Overall Study|Randomized, Not Treated|0|||
105780790|NCT00283062|364848736|FG000|Overall Study|Did not receive any study medication|5|||
105780791|NCT00283062|364848737|FG001|Overall Study|Did not receive any study medication|4|||
105780792|NCT00283062|364848738|FG002|Overall Study|Did not receive any study medication|36|||
105780793|NCT00283062|364848739|FG003|Overall Study|Did not receive any study medication|45|||
105780794|NCT00283062|364848736|FG000|Overall Study|Adverse Event|2|||
105780795|NCT00283062|364848737|FG001|Overall Study|Adverse Event|0|||
105780796|NCT00283062|364848738|FG002|Overall Study|Adverse Event|1|||
105780797|NCT00283062|364848739|FG003|Overall Study|Adverse Event|0|||
105780798|NCT00283062|364848736|FG000|Overall Study|Lost to Follow-up|1|||
105780799|NCT00283062|364848737|FG001|Overall Study|Lost to Follow-up|0|||
105780800|NCT00283062|364848738|FG002|Overall Study|Lost to Follow-up|1|||
105780801|NCT00283062|364848739|FG003|Overall Study|Lost to Follow-up|0|||
105780802|NCT00283062|364848736|FG000|Overall Study|Progressive disease|0|||
105780803|NCT00283062|364848737|FG001|Overall Study|Progressive disease|0|||
105780804|NCT00283062|364848738|FG002|Overall Study|Progressive disease|1|||
105780805|NCT00283062|364848739|FG003|Overall Study|Progressive disease|0|||
105780806|NCT00283062|364848736|FG000|Overall Study|Participant did not wish to continue|3|||
105780807|NCT00283062|364848737|FG001|Overall Study|Participant did not wish to continue|2|||
105780808|NCT00283062|364848738|FG002|Overall Study|Participant did not wish to continue|1|||
105780809|NCT00283062|364848739|FG003|Overall Study|Participant did not wish to continue|0|||
105780810|NCT00283062|364848736|FG000|Overall Study|Undefined|0|||
105780811|NCT00283062|364848737|FG001|Overall Study|Undefined|1|||
105780812|NCT00283062|364848738|FG002|Overall Study|Undefined|1|||
105780813|NCT00283062|364848739|FG003|Overall Study|Undefined|4|||
105780814|NCT00283062|364848736|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
105780815|NCT00283062|364848737|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
105780816|NCT00283062|364848738|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
105444550|NCT00726232|363633321|FG006|Initial Phase (Dose-finding)|Death|0|||
105444551|NCT00726232|363633322|FG007|Initial Phase (Dose-finding)|Death|0|||
105444552|NCT00726232|363633315|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
105444553|NCT00726232|363633316|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
105444554|NCT00726232|363633317|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
105444555|NCT00726232|363633318|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
105444556|NCT00726232|363633319|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
105444557|NCT00726232|363633320|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
105444558|NCT00726232|363633321|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
105444559|NCT00726232|363633322|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
105444560|NCT00726232|363633315|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
105444561|NCT00726232|363633316|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
105444562|NCT00726232|363633317|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
105444563|NCT00726232|363633318|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
105780817|NCT00283062|364848739|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
105780818|NCT00242658|364848740|FG000|Overall Study|Lost to Follow-up|22|||
105780819|NCT00242658|364848741|FG001|Overall Study|Lost to Follow-up|19|||
105780820|NCT00689728|364848742|FG000|Double-Blind Treatment|Adverse Event|1|||
105780821|NCT00689728|364848743|FG001|Double-Blind Treatment|Adverse Event|0|||
105780822|NCT00689728|364848744|FG002|Double-Blind Treatment|Adverse Event|0|||
105780823|NCT00689728|364848742|FG000|Double-Blind Treatment|Protocol Violation|0|||
105780824|NCT00689728|364848743|FG001|Double-Blind Treatment|Protocol Violation|0|||
105780825|NCT00689728|364848744|FG002|Double-Blind Treatment|Protocol Violation|1|||
105780826|NCT00689728|364848742|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
105780827|NCT00689728|364848743|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
105780828|NCT00689728|364848744|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
105780829|NCT00689728|364848742|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
105444564|NCT00726232|363633319|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
105444565|NCT00726232|363633320|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
105444566|NCT00726232|363633321|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
105780830|NCT00689728|364848743|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
105780831|NCT00689728|364848744|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
105780832|NCT00689728|364848742|FG000|Rescue|Adverse Event|0|||
105780833|NCT00689728|364848743|FG001|Rescue|Adverse Event|1|||
105780834|NCT00689728|364848744|FG002|Rescue|Adverse Event|0|||
105780835|NCT00689728|364848742|FG000|Rescue|Withdrawal by Subject|1|||
105780836|NCT00689728|364848743|FG001|Rescue|Withdrawal by Subject|1|||
105780837|NCT00689728|364848744|FG002|Rescue|Withdrawal by Subject|1|||
105780838|NCT00689728|364848742|FG000|Optional Follow-Up|Adverse Event|1|||
105780839|NCT00689728|364848743|FG001|Optional Follow-Up|Adverse Event|0|||
105780840|NCT00689728|364848744|FG002|Optional Follow-Up|Adverse Event|0|||
105780841|NCT00689728|364848742|FG000|Optional Follow-Up|Lack of Efficacy|0|||
105780842|NCT00689728|364848743|FG001|Optional Follow-Up|Lack of Efficacy|1|||
105780843|NCT00689728|364848744|FG002|Optional Follow-Up|Lack of Efficacy|1|||
105780844|NCT00689728|364848742|FG000|Optional Follow-Up|Lost to Follow-up|0|||
105780845|NCT00689728|364848743|FG001|Optional Follow-Up|Lost to Follow-up|1|||
105780846|NCT00689728|364848744|FG002|Optional Follow-Up|Lost to Follow-up|1|||
105780847|NCT00689728|364848742|FG000|Optional Follow-Up|Protocol Violation|0|||
105780848|NCT00689728|364848743|FG001|Optional Follow-Up|Protocol Violation|0|||
105780849|NCT00689728|364848744|FG002|Optional Follow-Up|Protocol Violation|1|||
105780850|NCT00689728|364848742|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
105780851|NCT00689728|364848743|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
105780852|NCT00689728|364848744|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
105780853|NCT00517634|364848755|FG000|Second Treatment Period|Withdrawal by Subject|0|||
105780854|NCT00517634|364848756|FG001|Second Treatment Period|Withdrawal by Subject|0|||
105780855|NCT00517634|364848757|FG002|Second Treatment Period|Withdrawal by Subject|0|||
105444567|NCT00726232|363633322|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
105444568|NCT00726232|363633315|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
105444569|NCT00726232|363633316|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
105444570|NCT00726232|363633317|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
105444571|NCT00726232|363633318|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
105444572|NCT00726232|363633319|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
105444573|NCT00726232|363633320|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
105444574|NCT00726232|363633321|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
105444575|NCT00726232|363633322|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
105444576|NCT00726232|363633315|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
105444577|NCT00726232|363633316|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
105444578|NCT00726232|363633317|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
105444579|NCT00726232|363633318|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
105444580|NCT00726232|363633319|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
105444581|NCT00726232|363633320|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
105444582|NCT00726232|363633321|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
105444583|NCT00726232|363633322|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
105444584|NCT00726232|363633315|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
105444585|NCT00726232|363633316|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
105444586|NCT00726232|363633317|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
105444587|NCT00726232|363633318|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
105444588|NCT00726232|363633319|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
105444589|NCT00726232|363633320|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
105444590|NCT00726232|363633321|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
105444591|NCT00726232|363633322|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
105444592|NCT00726232|363633315|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
105444593|NCT00726232|363633316|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
105444594|NCT00726232|363633317|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
105444595|NCT00726232|363633318|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
105444596|NCT00726232|363633319|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
105444597|NCT00726232|363633320|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
105444598|NCT00726232|363633321|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
105444599|NCT00726232|363633322|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
105444600|NCT00726232|363633315|FG000|Expansion Phase|Death|0|||
105444601|NCT00726232|363633316|FG001|Expansion Phase|Death|0|||
105444602|NCT00726232|363633317|FG002|Expansion Phase|Death|0|||
105444603|NCT00726232|363633318|FG003|Expansion Phase|Death|0|||
105444604|NCT00726232|363633319|FG004|Expansion Phase|Death|0|||
105444605|NCT00726232|363633320|FG005|Expansion Phase|Death|0|||
105444606|NCT00726232|363633321|FG006|Expansion Phase|Death|0|||
105444607|NCT00726232|363633322|FG007|Expansion Phase|Death|1|||
105780856|NCT00517634|364848758|FG003|Second Treatment Period|Withdrawal by Subject|0|||
105780857|NCT00517634|364848759|FG004|Second Treatment Period|Withdrawal by Subject|1|||
105780858|NCT00517634|364848760|FG005|Second Treatment Period|Withdrawal by Subject|0|||
105780859|NCT03590613|364848761|FG000|Period 2, 4 Days|Physician Decision|0|||
105780860|NCT03590613|364848762|FG001|Period 2, 4 Days|Physician Decision|0|||
105444608|NCT00726232|363633315|FG000|Expansion Phase|Adverse Event|0|||
105444609|NCT00726232|363633316|FG001|Expansion Phase|Adverse Event|0|||
105444610|NCT00726232|363633317|FG002|Expansion Phase|Adverse Event|0|||
105444611|NCT00726232|363633318|FG003|Expansion Phase|Adverse Event|0|||
105444612|NCT00726232|363633319|FG004|Expansion Phase|Adverse Event|0|||
105444613|NCT00726232|363633320|FG005|Expansion Phase|Adverse Event|0|||
105444614|NCT00726232|363633321|FG006|Expansion Phase|Adverse Event|6|||
105444615|NCT00726232|363633322|FG007|Expansion Phase|Adverse Event|11|||
105444616|NCT00726232|363633315|FG000|Expansion Phase|Withdrawal by Subject|0|||
105444617|NCT00726232|363633316|FG001|Expansion Phase|Withdrawal by Subject|0|||
105444618|NCT00726232|363633317|FG002|Expansion Phase|Withdrawal by Subject|0|||
105444619|NCT00726232|363633318|FG003|Expansion Phase|Withdrawal by Subject|0|||
105780861|NCT03590613|364848763|FG002|Period 2, 4 Days|Physician Decision|0|||
105780862|NCT03590613|364848764|FG003|Period 2, 4 Days|Physician Decision|1|||
105780863|NCT02613910|364848766|FG000|Overall Study|Termination of study|1|||
105780864|NCT02993731|364848767|FG000|Overall Study|Study Termination|101|||
105780865|NCT02993731|364848768|FG001|Overall Study|Study Termination|105|||
105780866|NCT01503229|364850715|FG000|Overall Study|Withdrew consent|1|||
105780867|NCT01078389|364850716|FG000|Overall Study|Adverse Event|10|||
105780868|NCT01078389|364850717|FG001|Overall Study|Adverse Event|6|||
105780869|NCT01078389|364850716|FG000|Overall Study|Major Protocol Deviation|2|||
105780870|NCT01078389|364850717|FG001|Overall Study|Major Protocol Deviation|0|||
105780871|NCT01078389|364850716|FG000|Overall Study|Lost to Follow-up|23|||
105780872|NCT01078389|364850717|FG001|Overall Study|Lost to Follow-up|23|||
105444620|NCT00726232|363633319|FG004|Expansion Phase|Withdrawal by Subject|0|||
105444621|NCT00726232|363633320|FG005|Expansion Phase|Withdrawal by Subject|0|||
105780873|NCT01078389|364850716|FG000|Overall Study|Voluntary Withdrawal|20|||
105780874|NCT01078389|364850717|FG001|Overall Study|Voluntary Withdrawal|36|||
105780875|NCT01078389|364850716|FG000|Overall Study|Other|9|||
105780876|NCT01078389|364850717|FG001|Overall Study|Other|2|||
105780877|NCT02028182|364850720|FG000|Overall Study|Protocol Violation|2|||
105780878|NCT02198040|364850721|FG000|Overall Study|Work reasons|0|||
105780879|NCT02198040|364850722|FG001|Overall Study|Work reasons|1|||
105780880|NCT02198040|364850723|FG002|Overall Study|Work reasons|0|||
105780881|NCT02198040|364850721|FG000|Overall Study|Withdrawal by Subject|0|||
105780882|NCT02198040|364850722|FG001|Overall Study|Withdrawal by Subject|0|||
105780883|NCT02198040|364850723|FG002|Overall Study|Withdrawal by Subject|1|||
105780884|NCT00711009|364850724|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
105780885|NCT00711009|364850725|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
105780886|NCT00711009|364850724|FG000|Overall Study|Withdrawal by Subject|4|||
105780887|NCT00711009|364850725|FG001|Overall Study|Withdrawal by Subject|2|||
105780888|NCT00711009|364850724|FG000|Overall Study|Lost to Follow-up|3|||
105780889|NCT00711009|364850725|FG001|Overall Study|Lost to Follow-up|9|||
105780890|NCT00711009|364850724|FG000|Overall Study|Participant Noncompliant|0|||
105780891|NCT00711009|364850725|FG001|Overall Study|Participant Noncompliant|1|||
105780892|NCT00711009|364850724|FG000|Overall Study|Virologic Failure|2|||
105780893|NCT00711009|364850725|FG001|Overall Study|Virologic Failure|1|||
105780894|NCT00711009|364850724|FG000|Overall Study|Pregnancy|1|||
105780895|NCT00711009|364850725|FG001|Overall Study|Pregnancy|0|||
105780896|NCT00711009|364850724|FG000|Overall Study|Site closing|0|||
105780897|NCT00711009|364850725|FG001|Overall Study|Site closing|1|||
105780898|NCT00711009|364850724|FG000|Overall Study|Dose adjustment|1|||
105780899|NCT00711009|364850725|FG001|Overall Study|Dose adjustment|0|||
105780900|NCT00911508|364850726|FG000|Overall Study|Lost to Follow-up|27|||
105780901|NCT00911508|364850727|FG001|Overall Study|Lost to Follow-up|18|||
105444622|NCT00726232|363633321|FG006|Expansion Phase|Withdrawal by Subject|2|||
105444623|NCT00726232|363633322|FG007|Expansion Phase|Withdrawal by Subject|3|||
105444624|NCT00726232|363633315|FG000|Expansion Phase|Disease progression|0|||
105444625|NCT00726232|363633316|FG001|Expansion Phase|Disease progression|0|||
105444626|NCT00726232|363633317|FG002|Expansion Phase|Disease progression|0|||
105444627|NCT00726232|363633318|FG003|Expansion Phase|Disease progression|0|||
105444628|NCT00726232|363633319|FG004|Expansion Phase|Disease progression|0|||
105444629|NCT00726232|363633320|FG005|Expansion Phase|Disease progression|0|||
105444630|NCT00726232|363633321|FG006|Expansion Phase|Disease progression|4|||
105444631|NCT00726232|363633322|FG007|Expansion Phase|Disease progression|0|||
105444632|NCT00726232|363633315|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
105444633|NCT00726232|363633316|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
105444634|NCT00726232|363633317|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
105444635|NCT00726232|363633318|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
105444636|NCT00726232|363633319|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
105444637|NCT00726232|363633320|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
105444638|NCT00726232|363633321|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
105444639|NCT00726232|363633322|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
105780902|NCT00911508|364850726|FG000|Overall Study|Withdrawal by Subject|79|||
105780903|NCT00911508|364850727|FG001|Overall Study|Withdrawal by Subject|112|||
105780904|NCT00240331|364850728|FG000|Overall Study|Withdrawal by Subject|125|||
105780905|NCT00240331|364850729|FG001|Overall Study|Withdrawal by Subject|132|||
105444640|NCT00726232|363633315|FG000|Expansion Phase|Per Investigator: lack of response|0|||
105444641|NCT00726232|363633316|FG001|Expansion Phase|Per Investigator: lack of response|0|||
105444642|NCT00726232|363633317|FG002|Expansion Phase|Per Investigator: lack of response|0|||
105444643|NCT00726232|363633318|FG003|Expansion Phase|Per Investigator: lack of response|0|||
105444644|NCT00726232|363633319|FG004|Expansion Phase|Per Investigator: lack of response|0|||
105444645|NCT00726232|363633320|FG005|Expansion Phase|Per Investigator: lack of response|0|||
105780906|NCT00240331|364850728|FG000|Overall Study|Option selected by investigator|1|||
105780907|NCT00240331|364850729|FG001|Overall Study|Option selected by investigator|2|||
105444646|NCT00726232|363633321|FG006|Expansion Phase|Per Investigator: lack of response|1|||
105444647|NCT00726232|363633322|FG007|Expansion Phase|Per Investigator: lack of response|7|||
105444648|NCT00726232|363633315|FG000|Expansion Phase|Unspecified reason|0|||
105444649|NCT00726232|363633316|FG001|Expansion Phase|Unspecified reason|0|||
105780908|NCT01409382|364850730|FG000|Overall Study|Lost to Follow-up|1|||
105780909|NCT01409382|364850731|FG001|Overall Study|Lost to Follow-up|1|||
105780910|NCT01409382|364850730|FG000|Overall Study|Protocol Violation|0|||
105780911|NCT01409382|364850731|FG001|Overall Study|Protocol Violation|3|||
105780912|NCT01409382|364850730|FG000|Overall Study|Multiple pregnancy|2|||
105780913|NCT01409382|364850731|FG001|Overall Study|Multiple pregnancy|4|||
105780914|NCT01409382|364850730|FG000|Overall Study|Still pregnant when study ended|13|||
105780915|NCT01409382|364850731|FG001|Overall Study|Still pregnant when study ended|2|||
105780916|NCT01409382|364850730|FG000|Overall Study|Did not manage to get pregnant|64|||
105780917|NCT01409382|364850731|FG001|Overall Study|Did not manage to get pregnant|70|||
105780918|NCT01409382|364850730|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
105780919|NCT01409382|364850731|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
105780920|NCT02491463|364850732|FG000|Overall Study|Withdrawal by Subject|1|||
105780921|NCT02491463|364850733|FG001|Overall Study|Withdrawal by Subject|2|||
105780922|NCT02491463|364850734|FG002|Overall Study|Withdrawal by Subject|0|||
105780923|NCT02491463|364850735|FG003|Overall Study|Withdrawal by Subject|0|||
105780924|NCT02491463|364850732|FG000|Overall Study|Migrated/moved from study area|1|||
105780925|NCT02491463|364850733|FG001|Overall Study|Migrated/moved from study area|5|||
105780926|NCT02491463|364850734|FG002|Overall Study|Migrated/moved from study area|1|||
105780927|NCT02491463|364850735|FG003|Overall Study|Migrated/moved from study area|1|||
105780928|NCT02491463|364850732|FG000|Overall Study|Lost to Follow-up|0|||
105780929|NCT02491463|364850733|FG001|Overall Study|Lost to Follow-up|3|||
105780930|NCT02491463|364850734|FG002|Overall Study|Lost to Follow-up|3|||
105444650|NCT00726232|363633317|FG002|Expansion Phase|Unspecified reason|0|||
105444651|NCT00726232|363633318|FG003|Expansion Phase|Unspecified reason|0|||
105444652|NCT00726232|363633319|FG004|Expansion Phase|Unspecified reason|0|||
105444653|NCT00726232|363633320|FG005|Expansion Phase|Unspecified reason|0|||
105444654|NCT00726232|363633321|FG006|Expansion Phase|Unspecified reason|1|||
105444655|NCT00726232|363633322|FG007|Expansion Phase|Unspecified reason|0|||
105444656|NCT00466921|363633323|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
105444657|NCT00466921|363633323|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
105444658|NCT00466921|363633323|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
105444659|NCT00466921|363633323|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
105444660|NCT00466921|363633323|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
105444661|NCT00466921|363633323|FG000|Follow up for a Minimum of 1 Year|Death|6|||
105444662|NCT04526145|363633324|FG000|Overall Study|Withdrawal by Subject|5|||
105444663|NCT01502228|363633325|FG000|Overall Study|Death|1|||
105444664|NCT01221350|363633326|FG000|Overall Study|Discontinued intervention (GERD)|1|||
105444665|NCT01221350|363633327|FG001|Overall Study|Discontinued intervention (GERD)|0|||
105444666|NCT01221350|363633326|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
105444667|NCT01221350|363633327|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
105444668|NCT01221350|363633326|FG000|Overall Study|Withdrawal by Subject|4|||
105444669|NCT01221350|363633327|FG001|Overall Study|Withdrawal by Subject|2|||
105780931|NCT02491463|364850735|FG003|Overall Study|Lost to Follow-up|0|||
105780932|NCT00039377|364850737|FG000|Initial Registration|Adverse Event|2|||
105780933|NCT00039377|364850738|FG001|Initial Registration|Adverse Event|0|||
105780934|NCT00039377|364850739|FG002|Initial Registration|Adverse Event|0|||
105780935|NCT00039377|364850740|FG003|Initial Registration|Adverse Event|0|||
105780936|NCT00039377|364850737|FG000|Initial Registration|Relapsed|6|||
105780937|NCT00039377|364850738|FG001|Initial Registration|Relapsed|0|||
105780938|NCT00039377|364850739|FG002|Initial Registration|Relapsed|0|||
105780939|NCT00039377|364850740|FG003|Initial Registration|Relapsed|0|||
105780940|NCT00039377|364850737|FG000|Initial Registration|Received non-protocol therapy|11|||
105780941|NCT00039377|364850738|FG001|Initial Registration|Received non-protocol therapy|0|||
105444670|NCT02362464|363633334|FG000|Overall Study|Switched to alternative therapy|1|||
105444671|NCT02362464|363633334|FG000|Overall Study|Refused further treatment|1|||
105444672|NCT02362464|363633334|FG000|Overall Study|Physician Decision|4|||
105444673|NCT01635855|363633335|FG000|Overall Study|Withdrawal by Subject|4|||
105484837|NCT01992159|363786983|FG001|Overall Study|Death|0|||
105780942|NCT00039377|364850739|FG002|Initial Registration|Received non-protocol therapy|0|||
105780943|NCT00039377|364850740|FG003|Initial Registration|Received non-protocol therapy|0|||
105780944|NCT00039377|364850737|FG000|Initial Registration|Withdrawal by Subject|3|||
105780945|NCT00039377|364850738|FG001|Initial Registration|Withdrawal by Subject|0|||
105780946|NCT00039377|364850739|FG002|Initial Registration|Withdrawal by Subject|0|||
105780947|NCT00039377|364850740|FG003|Initial Registration|Withdrawal by Subject|0|||
105780948|NCT01249404|364850744|FG000|Overall Study|Study treatment not received|0|||
105780949|NCT01249404|364850745|FG001|Overall Study|Study treatment not received|1|||
105780950|NCT01249404|364850746|FG002|Overall Study|Study treatment not received|2|||
105780951|NCT01249404|364850744|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
105780952|NCT01249404|364850745|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
105780953|NCT01249404|364850746|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
105780954|NCT01249404|364850744|FG000|Overall Study|Adverse Event|2|||
105780955|NCT01249404|364850745|FG001|Overall Study|Adverse Event|2|||
105780956|NCT01249404|364850746|FG002|Overall Study|Adverse Event|2|||
105780957|NCT01249404|364850744|FG000|Overall Study|Withdrawal by Subject|2|||
105780958|NCT01249404|364850745|FG001|Overall Study|Withdrawal by Subject|2|||
105780959|NCT01249404|364850746|FG002|Overall Study|Withdrawal by Subject|0|||
105780960|NCT01249404|364850744|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
105780961|NCT01249404|364850745|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
105780962|NCT01249404|364850746|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
105780963|NCT01249404|364850744|FG000|Overall Study|Non compliance to visit schedule|0|||
105780964|NCT01249404|364850745|FG001|Overall Study|Non compliance to visit schedule|1|||
105780965|NCT01249404|364850746|FG002|Overall Study|Non compliance to visit schedule|0|||
105780966|NCT01096017|364850752|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
105780967|NCT01096017|364850753|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
105780968|NCT02719028|364850759|FG000|Overall Study|Adverse Event|2|||
105780969|NCT02719028|364850760|FG001|Overall Study|Adverse Event|1|||
105780970|NCT02719028|364850761|FG002|Overall Study|Adverse Event|4|||
105780971|NCT02719028|364850762|FG003|Overall Study|Adverse Event|8|||
105780972|NCT02719028|364850759|FG000|Overall Study|Physician Decision|0|||
105780973|NCT02719028|364850760|FG001|Overall Study|Physician Decision|1|||
105780974|NCT02719028|364850761|FG002|Overall Study|Physician Decision|1|||
105780975|NCT02719028|364850762|FG003|Overall Study|Physician Decision|1|||
105780976|NCT02719028|364850759|FG000|Overall Study|Use of prohibited medication|0|||
105780977|NCT02719028|364850760|FG001|Overall Study|Use of prohibited medication|0|||
105780978|NCT02719028|364850761|FG002|Overall Study|Use of prohibited medication|1|||
105780979|NCT02719028|364850762|FG003|Overall Study|Use of prohibited medication|0|||
105780980|NCT02719028|364850759|FG000|Overall Study|Protocol Violation|0|||
105780981|NCT02719028|364850760|FG001|Overall Study|Protocol Violation|0|||
105780982|NCT02719028|364850761|FG002|Overall Study|Protocol Violation|0|||
105780983|NCT02719028|364850762|FG003|Overall Study|Protocol Violation|1|||
105780984|NCT01539720|364850763|FG000|Overall Study|Screen Fail|15|||
105780985|NCT01539720|364850764|FG001|Overall Study|Screen Fail|3|||
105780986|NCT01539720|364850763|FG000|Overall Study|Lost to Follow-up|14|||
105780987|NCT01539720|364850764|FG001|Overall Study|Lost to Follow-up|7|||
105780988|NCT00656136|364850773|FG000|Overall Study|Progressive disease|177|||
105780989|NCT00656136|364850774|FG001|Overall Study|Progressive disease|322|||
105780990|NCT00656136|364850773|FG000|Overall Study|Other Adverse Event|5|||
105780991|NCT00656136|364850774|FG001|Overall Study|Other Adverse Event|51|||
105780992|NCT00656136|364850773|FG000|Overall Study|Protocol Violation|2|||
105780993|NCT00656136|364850774|FG001|Overall Study|Protocol Violation|3|||
105780994|NCT00656136|364850773|FG000|Overall Study|Patient refused to take study medication|7|||
105780995|NCT00656136|364850774|FG001|Overall Study|Patient refused to take study medication|10|||
105780996|NCT00656136|364850773|FG000|Overall Study|Unknown and others|4|||
105780997|NCT00656136|364850774|FG001|Overall Study|Unknown and others|4|||
105780998|NCT02505945|364850775|FG000|Overall Study|Withdrawal by Subject|13|||
105780999|NCT02505945|364850776|FG001|Overall Study|Withdrawal by Subject|2|||
105781000|NCT02505945|364850775|FG000|Overall Study|Adverse Event|1|||
105781001|NCT02505945|364850776|FG001|Overall Study|Adverse Event|0|||
105781002|NCT02505945|364850775|FG000|Overall Study|Physician Decision|2|||
105781003|NCT02505945|364850776|FG001|Overall Study|Physician Decision|1|||
105781004|NCT02505945|364850775|FG000|Overall Study|Lost to Follow-up|6|||
105781005|NCT02505945|364850776|FG001|Overall Study|Lost to Follow-up|1|||
105781006|NCT01928758|364850777|FG000|Overall Study|Lost to Follow-up|14|||
105781007|NCT01928758|364850778|FG001|Overall Study|Lost to Follow-up|9|||
105781008|NCT01928758|364850777|FG000|Overall Study|Withdrawal by Subject|5|||
105781009|NCT01928758|364850778|FG001|Overall Study|Withdrawal by Subject|2|||
105781010|NCT01928758|364850777|FG000|Overall Study|Adverse Event|3|||
105781011|NCT01928758|364850778|FG001|Overall Study|Adverse Event|5|||
105781012|NCT01928758|364850777|FG000|Overall Study|Protocol Violation|3|||
105781013|NCT01928758|364850778|FG001|Overall Study|Protocol Violation|4|||
105781014|NCT01667731|364850779|FG000|Overall Study|Enrolled but not treated|0|||
105781015|NCT01667731|364850780|FG001|Overall Study|Enrolled but not treated|0|||
105781016|NCT01667731|364850781|FG002|Overall Study|Enrolled but not treated|0|||
105781017|NCT01667731|364850782|FG003|Overall Study|Enrolled but not treated|0|||
105781018|NCT01667731|364850783|FG004|Overall Study|Enrolled but not treated|1|||
105781019|NCT01667731|364850779|FG000|Overall Study|Efficacy Failure|1|||
105781020|NCT01667731|364850780|FG001|Overall Study|Efficacy Failure|12|||
105781021|NCT01667731|364850781|FG002|Overall Study|Efficacy Failure|0|||
105781022|NCT01667731|364850782|FG003|Overall Study|Efficacy Failure|1|||
105781023|NCT01667731|364850783|FG004|Overall Study|Efficacy Failure|24|||
105781024|NCT01667731|364850779|FG000|Overall Study|Lost to Follow-up|2|||
105781025|NCT01667731|364850780|FG001|Overall Study|Lost to Follow-up|3|||
105781026|NCT01667731|364850781|FG002|Overall Study|Lost to Follow-up|1|||
105781027|NCT01667731|364850782|FG003|Overall Study|Lost to Follow-up|1|||
105781028|NCT01667731|364850783|FG004|Overall Study|Lost to Follow-up|2|||
105781029|NCT01667731|364850779|FG000|Overall Study|Subject Withdrew Consent|2|||
105781030|NCT01667731|364850780|FG001|Overall Study|Subject Withdrew Consent|0|||
105781031|NCT01667731|364850781|FG002|Overall Study|Subject Withdrew Consent|1|||
105781032|NCT01667731|364850782|FG003|Overall Study|Subject Withdrew Consent|0|||
105781033|NCT01667731|364850783|FG004|Overall Study|Subject Withdrew Consent|1|||
105781034|NCT01667731|364850779|FG000|Overall Study|Death|0|||
105781035|NCT01667731|364850780|FG001|Overall Study|Death|1|||
105781036|NCT01667731|364850781|FG002|Overall Study|Death|0|||
105781037|NCT01667731|364850782|FG003|Overall Study|Death|0|||
105781038|NCT01667731|364850783|FG004|Overall Study|Death|0|||
105781039|NCT01425268|364850788|FG000|Overall Study|Withdrawal by Subject|2|||
105781040|NCT01425268|364850789|FG001|Overall Study|Withdrawal by Subject|0|||
105781041|NCT01425268|364850788|FG000|Overall Study|Sponsor Decision|5|||
105781042|NCT01425268|364850789|FG001|Overall Study|Sponsor Decision|0|||
105781043|NCT01425268|364850788|FG000|Overall Study|Physician Decision|1|||
105781044|NCT01425268|364850789|FG001|Overall Study|Physician Decision|0|||
105781045|NCT01101321|364850790|FG000|Period 1|Withdrawal by Subject|1|||
105781046|NCT01101321|364850791|FG001|Period 1|Withdrawal by Subject|1|||
105781047|NCT01101321|364850790|FG000|Period 1|Adverse Event|3|||
105781048|NCT01101321|364850791|FG001|Period 1|Adverse Event|3|||
105781049|NCT00719706|364850792|FG000|Overall Study|Adverse Event|5|||
105781050|NCT00719706|364850793|FG001|Overall Study|Adverse Event|4|||
105781051|NCT00719706|364850792|FG000|Overall Study|Withdrawal by Subject|1|||
105781052|NCT00719706|364850793|FG001|Overall Study|Withdrawal by Subject|2|||
105781053|NCT00719706|364850792|FG000|Overall Study|Protocol Violation|3|||
105781054|NCT00719706|364850793|FG001|Overall Study|Protocol Violation|0|||
105781055|NCT03633461|364850794|FG000|Overall Study|Lost to Follow-up|0|||
105781056|NCT03633461|364850795|FG001|Overall Study|Lost to Follow-up|1|||
105781057|NCT03938857|364850800|FG000|Overall Study|Physician Decision|1|||
105781058|NCT03938857|364850801|FG001|Overall Study|Physician Decision|0|||
105781059|NCT03938857|364850802|FG002|Overall Study|Physician Decision|0|||
105781060|NCT03938857|364850803|FG003|Overall Study|Physician Decision|0|||
105781061|NCT02406586|364850804|FG000|Overall Study|Lost to Follow-up|0|||
105781062|NCT02406586|364850805|FG001|Overall Study|Lost to Follow-up|4|||
105781063|NCT02406586|364850806|FG002|Overall Study|Lost to Follow-up|2|||
105781064|NCT02406586|364850804|FG000|Overall Study|Withdrawal by Subject|1|||
105781065|NCT02406586|364850805|FG001|Overall Study|Withdrawal by Subject|0|||
105781066|NCT02406586|364850806|FG002|Overall Study|Withdrawal by Subject|0|||
105781067|NCT03198559|364850807|FG000|Overall Study|Adverse Event|2|||
105781068|NCT02577107|364850808|FG000|Overall Study|Protocol deviation|0|||
105781069|NCT02577107|364850809|FG001|Overall Study|Protocol deviation|1|||
105781070|NCT02516605|364850810|FG000|Overall Study|Protocol Violation|0|||
105781071|NCT02516605|364850811|FG001|Overall Study|Protocol Violation|0|||
105781072|NCT02516605|364850812|FG002|Overall Study|Protocol Violation|0|||
105781073|NCT02516605|364850813|FG003|Overall Study|Protocol Violation|0|||
105781074|NCT02516605|364850814|FG004|Overall Study|Protocol Violation|1|||
105781075|NCT02516605|364850810|FG000|Overall Study|Withdrawal by Subject|0|||
105781076|NCT02516605|364850811|FG001|Overall Study|Withdrawal by Subject|0|||
105781077|NCT02516605|364850812|FG002|Overall Study|Withdrawal by Subject|0|||
105781078|NCT02516605|364850813|FG003|Overall Study|Withdrawal by Subject|1|||
105781079|NCT02516605|364850814|FG004|Overall Study|Withdrawal by Subject|0|||
105781080|NCT00682539|364850815|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
105781081|NCT00682539|364850816|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
105781082|NCT00682539|364850817|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
105781083|NCT00682539|364850815|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
105781084|NCT00682539|364850816|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
105781085|NCT00682539|364850817|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
105781086|NCT00679354|364850818|FG000|Overall Study|Death|3|||
105781087|NCT00679354|364850818|FG000|Overall Study|Lack of Efficacy|22|||
105781088|NCT00679354|364850818|FG000|Overall Study|Physician Decision|4|||
105781089|NCT00679354|364850818|FG000|Overall Study|Ineligible|1|||
105781090|NCT03764813|364850823|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
105781091|NCT03764813|364850824|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
105781092|NCT03764813|364850825|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
105781093|NCT03764813|364850826|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
105781094|NCT02898662|364850829|FG000|Overall Study|Adverse Event|1|||
105781095|NCT02898662|364850830|FG001|Overall Study|Adverse Event|0|||
105781096|NCT02898662|364850829|FG000|Overall Study|Loss of asthma control|23|||
105781097|NCT02898662|364850830|FG001|Overall Study|Loss of asthma control|24|||
105484838|NCT01992159|363786984|FG002|Overall Study|Death|1|||
105781098|NCT02898662|364850829|FG000|Overall Study|Withdrawal by Subject|4|||
105781099|NCT02898662|364850830|FG001|Overall Study|Withdrawal by Subject|1|||
105781100|NCT02898662|364850829|FG000|Overall Study|Technical issue|0|||
105781101|NCT02898662|364850830|FG001|Overall Study|Technical issue|1|||
105781102|NCT02898662|364850829|FG000|Overall Study|Randomized in error|0|||
105781103|NCT02898662|364850830|FG001|Overall Study|Randomized in error|1|||
105781104|NCT02898662|364850829|FG000|Overall Study|Subject decision|1|||
105781105|NCT02898662|364850830|FG001|Overall Study|Subject decision|0|||
105781106|NCT02898662|364850829|FG000|Overall Study|Other|0|||
105781107|NCT02898662|364850830|FG001|Overall Study|Other|1|||
105781108|NCT00267202|364850831|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
105781109|NCT00267202|364850832|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
105781110|NCT00267202|364850831|FG000|Overall Study|Withdrawal by Subject|12|||
105781111|NCT00267202|364850832|FG001|Overall Study|Withdrawal by Subject|15|||
105781112|NCT00267202|364850831|FG000|Overall Study|Adverse Event|13|||
105781113|NCT00267202|364850832|FG001|Overall Study|Adverse Event|7|||
105781114|NCT00267202|364850831|FG000|Overall Study|Protocol Violation|2|||
105781115|NCT00267202|364850832|FG001|Overall Study|Protocol Violation|3|||
105781116|NCT00267202|364850831|FG000|Overall Study|Administrative problems|2|||
105781117|NCT00267202|364850832|FG001|Overall Study|Administrative problems|1|||
105781118|NCT00267202|364850831|FG000|Overall Study|Lost to Follow-up|3|||
105781119|NCT00267202|364850832|FG001|Overall Study|Lost to Follow-up|0|||
105781120|NCT04382066|364850834|FG000|Overall Study|Adverse Event|1|||
105781121|NCT04382066|364850835|FG001|Overall Study|Adverse Event|0|||
105781122|NCT04382066|364850836|FG002|Overall Study|Adverse Event|0|||
105781123|NCT04382066|364850834|FG000|Overall Study|Death|1|||
105781124|NCT04382066|364850835|FG001|Overall Study|Death|0|||
105781125|NCT04382066|364850836|FG002|Overall Study|Death|1|||
105781126|NCT00174460|364850842|FG000|Overall Study|Withdrawal by Subject|0|||
105781127|NCT00174460|364850843|FG001|Overall Study|Withdrawal by Subject|1|||
105781128|NCT04225026|364850844|FG000|Overall Study|Withdrawal by Subject|4|||
105781129|NCT04225026|364850844|FG000|Overall Study|Adverse Event|1|||
105781130|NCT04225026|364850844|FG000|Overall Study|Other|1|||
105781131|NCT04225026|364850844|FG000|Overall Study|Death|11|||
105781132|NCT04225026|364850844|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
105781133|NCT00334893|364850845|FG000|Overall Study|Not Treated|1|||
105781134|NCT00334893|364850846|FG001|Overall Study|Not Treated|0|||
105781135|NCT00779506|364850849|FG000|Overall Study|Screening Failed|2|||
105781136|NCT00779506|364850849|FG000|Overall Study|Adverse Event|4|||
105781137|NCT00779506|364850849|FG000|Overall Study|Lack of Efficacy|11|||
105781138|NCT00779506|364850849|FG000|Overall Study|Protocol Violation|5|||
105781139|NCT00779506|364850849|FG000|Overall Study|Withdrawal by Subject|6|||
105781140|NCT00779506|364850849|FG000|Overall Study|Lost to Follow-up|1|||
105781141|NCT01303159|364850852|FG000|Overall Study|Death|16|||
105781142|NCT01303159|364850852|FG000|Overall Study|Study Termination|7|||
105781143|NCT03258710|364850857|FG000|Overall Study|Adverse Event|1|||
105781144|NCT03258710|364850857|FG000|Overall Study|Protocol-defined stopping criteria|1|||
105781145|NCT03258710|364850857|FG000|Overall Study|Physician Decision|1|||
105781146|NCT03451630|364850858|FG000|Overall Study|Death|15|||
105781147|NCT03451630|364850859|FG001|Overall Study|Death|16|||
105781148|NCT03451630|364850860|FG002|Overall Study|Death|11|||
105781149|NCT03451630|364850858|FG000|Overall Study|Lost to Follow-up|9|||
105781150|NCT03451630|364850859|FG001|Overall Study|Lost to Follow-up|0|||
105781151|NCT03451630|364850860|FG002|Overall Study|Lost to Follow-up|4|||
105781152|NCT03451630|364850858|FG000|Overall Study|Withdrawal by Subject|0|||
105781153|NCT03451630|364850859|FG001|Overall Study|Withdrawal by Subject|3|||
105781154|NCT03451630|364850860|FG002|Overall Study|Withdrawal by Subject|0|||
105781155|NCT03451630|364850858|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
105781156|NCT03451630|364850859|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
105781157|NCT03451630|364850860|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
105781158|NCT01724021|364850863|FG000|Overall Study|Adverse Event|11|||
105781159|NCT01724021|364850864|FG001|Overall Study|Adverse Event|6|||
105781160|NCT01724021|364850863|FG000|Overall Study|Death|46|||
105781161|NCT01724021|364850864|FG001|Overall Study|Death|58|||
105781162|NCT01724021|364850863|FG000|Overall Study|Participant request/ Withdrew consent|18|||
105781163|NCT01724021|364850864|FG001|Overall Study|Participant request/ Withdrew consent|14|||
105781164|NCT01724021|364850863|FG000|Overall Study|Lost to Follow-up|15|||
105781165|NCT01724021|364850864|FG001|Overall Study|Lost to Follow-up|15|||
105781166|NCT01724021|364850863|FG000|Overall Study|Reason Not Specified|36|||
105781167|NCT01724021|364850864|FG001|Overall Study|Reason Not Specified|39|||
105781168|NCT01724021|364850863|FG000|Overall Study|Missing|1|||
105781169|NCT01724021|364850864|FG001|Overall Study|Missing|1|||
105781170|NCT00486720|364850867|FG000|Overall Study|Adverse Event|1|||
105781171|NCT00486720|364850868|FG001|Overall Study|Adverse Event|2|||
105781172|NCT00486720|364850867|FG000|Overall Study|Lack of Efficacy|4|||
105781173|NCT00486720|364850868|FG001|Overall Study|Lack of Efficacy|6|||
105781174|NCT00486720|364850867|FG000|Overall Study|Physician Decision|1|||
105781175|NCT00486720|364850868|FG001|Overall Study|Physician Decision|2|||
105781176|NCT00486720|364850867|FG000|Overall Study|Protocol Violation|1|||
105444674|NCT05236257|363633336|FG000|Overall Study|Ongoing with study treatment|29|||
105444675|NCT05236257|363633337|FG001|Overall Study|Ongoing with study treatment|1|||
105444676|NCT05236257|363633336|FG000|Overall Study|Discontinued study treatment|22|||
105444677|NCT05236257|363633337|FG001|Overall Study|Discontinued study treatment|41|||
105444678|NCT02915978|363633338|FG000|Overall Study|Adverse Event|2|||
105444679|NCT02915978|363633339|FG001|Overall Study|Adverse Event|1|||
105444680|NCT02915978|363633340|FG002|Overall Study|Adverse Event|0|||
105444681|NCT00145574|363633342|FG000|Double Blind|Adverse Event|0|||
105444682|NCT00145574|363633343|FG001|Double Blind|Adverse Event|3|||
105444683|NCT00145574|363633344|FG002|Double Blind|Adverse Event|1|||
105444684|NCT00145574|363633342|FG000|Double Blind|Withdrawal by Subject|1|||
105444685|NCT00145574|363633343|FG001|Double Blind|Withdrawal by Subject|1|||
105444686|NCT00145574|363633344|FG002|Double Blind|Withdrawal by Subject|1|||
105444687|NCT00145574|363633342|FG000|Double Blind|required restricted medicine|0|||
105781177|NCT00486720|364850868|FG001|Overall Study|Protocol Violation|0|||
105781178|NCT00486720|364850867|FG000|Overall Study|Withdrawal by Subject|3|||
105781179|NCT00486720|364850868|FG001|Overall Study|Withdrawal by Subject|1|||
105781180|NCT00486720|364850867|FG000|Overall Study|Progressive Disease|0|||
105781181|NCT00486720|364850868|FG001|Overall Study|Progressive Disease|1|||
105781182|NCT00955682|364850869|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
105781183|NCT00955682|364850870|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
105781184|NCT02041533|364850874|FG000|Pre-Treatment Period|Disease Progression|1|||
105781185|NCT02041533|364850875|FG001|Pre-Treatment Period|Disease Progression|1|||
105781186|NCT02041533|364850874|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
105781187|NCT02041533|364850875|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
105781188|NCT02041533|364850874|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
105781189|NCT02041533|364850875|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
105781190|NCT02041533|364850874|FG000|Treatment Period|Disease progression|189|||
105781191|NCT02041533|364850875|FG001|Treatment Period|Disease progression|146|||
105781192|NCT02041533|364850874|FG000|Treatment Period|Study drug toxicity|30|||
105781193|NCT02041533|364850875|FG001|Treatment Period|Study drug toxicity|34|||
105781194|NCT02041533|364850874|FG000|Treatment Period|Death|1|||
105781195|NCT02041533|364850875|FG001|Treatment Period|Death|0|||
105781196|NCT02041533|364850874|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
105781197|NCT02041533|364850875|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
105781198|NCT02041533|364850874|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
105781199|NCT02041533|364850875|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
105781200|NCT02041533|364850874|FG000|Treatment Period|Participant withdrew consent|2|||
105781201|NCT02041533|364850875|FG001|Treatment Period|Participant withdrew consent|2|||
105781202|NCT02041533|364850874|FG000|Treatment Period|Maximum clinical benefit|0|||
105781203|NCT02041533|364850875|FG001|Treatment Period|Maximum clinical benefit|18|||
105781204|NCT02041533|364850874|FG000|Treatment Period|Poor/Non-compliance|1|||
105781205|NCT02041533|364850875|FG001|Treatment Period|Poor/Non-compliance|0|||
105781206|NCT02041533|364850874|FG000|Treatment Period|Administrative reason by sponsor|1|||
105781207|NCT02041533|364850875|FG001|Treatment Period|Administrative reason by sponsor|0|||
105781208|NCT02041533|364850874|FG000|Treatment Period|Other reasons|9|||
105781209|NCT02041533|364850875|FG001|Treatment Period|Other reasons|2|||
105781210|NCT02041533|364850874|FG000|Treatment Period|Not Reported|0|||
105781211|NCT02041533|364850875|FG001|Treatment Period|Not Reported|1|||
105781212|NCT01756846|364850876|FG000|Overall Study|Lost to Follow-up|5|||
105781213|NCT01756846|364850877|FG001|Overall Study|Lost to Follow-up|10|||
105781214|NCT01756846|364850876|FG000|Overall Study|Withdrawal by Subject|1|||
105444688|NCT00145574|363633343|FG001|Double Blind|required restricted medicine|1|||
105444689|NCT00145574|363633344|FG002|Double Blind|required restricted medicine|0|||
105444690|NCT00145574|363633342|FG000|Open Label Long-term Extension|Adverse Event|0|||
105444691|NCT00145574|363633343|FG001|Open Label Long-term Extension|Adverse Event|0|||
105444692|NCT00145574|363633344|FG002|Open Label Long-term Extension|Adverse Event|5|||
105444693|NCT00145574|363633342|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
105444694|NCT00145574|363633343|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
105444695|NCT00145574|363633344|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
105444696|NCT00145574|363633342|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
105444697|NCT00145574|363633343|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
105444698|NCT00145574|363633344|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
105444699|NCT00145574|363633342|FG000|Open Label Long-term Extension|required restricted medicine|0|||
105444700|NCT00145574|363633343|FG001|Open Label Long-term Extension|required restricted medicine|0|||
105781215|NCT01756846|364850877|FG001|Overall Study|Withdrawal by Subject|2|||
105781216|NCT01497899|364850878|FG000|Double-Blind Phase|Randomized but not Treated|1|||
105781217|NCT01497899|364850879|FG001|Double-Blind Phase|Randomized but not Treated|0|||
105781218|NCT01497899|364850880|FG002|Double-Blind Phase|Randomized but not Treated|0|||
105781219|NCT01497899|364850881|FG003|Double-Blind Phase|Randomized but not Treated|0|||
105484839|NCT01992159|363786985|FG003|Overall Study|Death|0|||
105781220|NCT01497899|364850878|FG000|Double-Blind Phase|Adverse Event|1|||
105781221|NCT01497899|364850879|FG001|Double-Blind Phase|Adverse Event|0|||
105781222|NCT01497899|364850880|FG002|Double-Blind Phase|Adverse Event|0|||
105781223|NCT01497899|364850881|FG003|Double-Blind Phase|Adverse Event|0|||
105781224|NCT01497899|364850878|FG000|Double-Blind Phase|Lack of Efficacy|0|||
105781225|NCT01497899|364850879|FG001|Double-Blind Phase|Lack of Efficacy|1|||
105781226|NCT01497899|364850880|FG002|Double-Blind Phase|Lack of Efficacy|0|||
105781227|NCT01497899|364850881|FG003|Double-Blind Phase|Lack of Efficacy|0|||
105781228|NCT01497899|364850878|FG000|Double-Blind Phase|Investigator's Discretion|1|||
105781229|NCT01497899|364850879|FG001|Double-Blind Phase|Investigator's Discretion|0|||
105781230|NCT01497899|364850880|FG002|Double-Blind Phase|Investigator's Discretion|0|||
105781231|NCT01497899|364850881|FG003|Double-Blind Phase|Investigator's Discretion|0|||
105781232|NCT01497899|364850878|FG000|Double-Blind Phase|Withdrew Consent|0|||
105781233|NCT01497899|364850879|FG001|Double-Blind Phase|Withdrew Consent|1|||
105781234|NCT01497899|364850880|FG002|Double-Blind Phase|Withdrew Consent|0|||
105781235|NCT01497899|364850881|FG003|Double-Blind Phase|Withdrew Consent|0|||
105781236|NCT01497899|364850878|FG000|Double-Blind Phase|Lost to Follow-up|3|||
105781237|NCT01497899|364850879|FG001|Double-Blind Phase|Lost to Follow-up|2|||
105781238|NCT01497899|364850880|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105781239|NCT01497899|364850881|FG003|Double-Blind Phase|Lost to Follow-up|0|||
105781240|NCT01497899|364850878|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
105781241|NCT01497899|364850879|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
105781242|NCT01497899|364850880|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
105781243|NCT01497899|364850881|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
105781244|NCT01497899|364850878|FG000|Open-Label Extension Phase|Adverse Event|1|||
105781245|NCT01497899|364850879|FG001|Open-Label Extension Phase|Adverse Event|0|||
105781246|NCT01497899|364850880|FG002|Open-Label Extension Phase|Adverse Event|0|||
105781247|NCT01497899|364850881|FG003|Open-Label Extension Phase|Adverse Event|0|||
105781248|NCT01497899|364850878|FG000|Open-Label Extension Phase|Death|1|||
105781249|NCT01497899|364850879|FG001|Open-Label Extension Phase|Death|0|||
105781250|NCT01497899|364850880|FG002|Open-Label Extension Phase|Death|0|||
105781251|NCT01497899|364850881|FG003|Open-Label Extension Phase|Death|0|||
105781252|NCT01497899|364850878|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
105781253|NCT01497899|364850879|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
105781254|NCT01497899|364850880|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
105781255|NCT01497899|364850881|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
105781256|NCT01497899|364850878|FG000|Open-Label Extension Phase|Pregnancy|0|||
105781257|NCT01497899|364850879|FG001|Open-Label Extension Phase|Pregnancy|1|||
105781258|NCT01497899|364850880|FG002|Open-Label Extension Phase|Pregnancy|1|||
105781259|NCT01497899|364850881|FG003|Open-Label Extension Phase|Pregnancy|0|||
105781260|NCT01497899|364850878|FG000|Open-Label Extension Phase|Protocol Violation|0|||
105781261|NCT01497899|364850879|FG001|Open-Label Extension Phase|Protocol Violation|0|||
105781262|NCT01497899|364850880|FG002|Open-Label Extension Phase|Protocol Violation|1|||
105781263|NCT01497899|364850881|FG003|Open-Label Extension Phase|Protocol Violation|0|||
105781264|NCT01497899|364850878|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
105781265|NCT01497899|364850879|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
105781266|NCT01497899|364850880|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
105781267|NCT01497899|364850881|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
105781268|NCT00701064|364850884|FG000|Overall Study|Protocol Violation|1|||
105781269|NCT00701064|364850885|FG001|Overall Study|Protocol Violation|1|||
105781270|NCT00701064|364850884|FG000|Overall Study|Withdrawal by Subject|1|||
105781271|NCT00701064|364850885|FG001|Overall Study|Withdrawal by Subject|1|||
105781272|NCT00701064|364850884|FG000|Overall Study|initiated other PTSD treatment|2|||
105781273|NCT00701064|364850885|FG001|Overall Study|initiated other PTSD treatment|2|||
105781274|NCT01791543|364850886|FG000|Overall Study|Lost to Follow-up|1|||
105781275|NCT01791543|364850886|FG000|Overall Study|Adverse Event|1|||
105781276|NCT00323479|364850890|FG000|Overall Study|Adverse Event|2|||
105781277|NCT00323479|364850890|FG000|Overall Study|Withdrawal by Subject|2|||
105781278|NCT00323479|364850890|FG000|Overall Study|Protocol Violation|3|||
105781279|NCT00323479|364850890|FG000|Overall Study|house moving|1|||
105781280|NCT02361307|364852873|FG000|Overall Study|Unstable medical condition.|0|||
105781281|NCT02361307|364852874|FG001|Overall Study|Unstable medical condition.|1|||
105781282|NCT01682876|364852875|FG000|Overall Study|Administrative reason|4|||
105781283|NCT01682876|364852876|FG001|Overall Study|Administrative reason|4|||
105781284|NCT01682876|364852877|FG002|Overall Study|Administrative reason|0|||
105781285|NCT01682876|364852878|FG003|Overall Study|Administrative reason|3|||
105781286|NCT01682876|364852875|FG000|Overall Study|Adverse Event|0|||
105781287|NCT01682876|364852876|FG001|Overall Study|Adverse Event|0|||
105781288|NCT01682876|364852877|FG002|Overall Study|Adverse Event|0|||
105781289|NCT01682876|364852878|FG003|Overall Study|Adverse Event|1|||
105781290|NCT01682876|364852875|FG000|Overall Study|Lost to Follow-up|11|||
105781291|NCT01682876|364852876|FG001|Overall Study|Lost to Follow-up|15|||
105781292|NCT01682876|364852877|FG002|Overall Study|Lost to Follow-up|9|||
105781293|NCT01682876|364852878|FG003|Overall Study|Lost to Follow-up|11|||
105781294|NCT01682876|364852875|FG000|Overall Study|Protocol Violation|1|||
105781295|NCT01682876|364852876|FG001|Overall Study|Protocol Violation|1|||
105781296|NCT01682876|364852877|FG002|Overall Study|Protocol Violation|1|||
105781297|NCT01682876|364852878|FG003|Overall Study|Protocol Violation|1|||
105781298|NCT01682876|364852875|FG000|Overall Study|Withdrawal by Subject|4|||
105781299|NCT01682876|364852876|FG001|Overall Study|Withdrawal by Subject|0|||
105781300|NCT01682876|364852877|FG002|Overall Study|Withdrawal by Subject|0|||
105781301|NCT01682876|364852878|FG003|Overall Study|Withdrawal by Subject|2|||
105781302|NCT01682876|364852875|FG000|Overall Study|Other|1|||
105781303|NCT01682876|364852876|FG001|Overall Study|Other|0|||
105781304|NCT01682876|364852877|FG002|Overall Study|Other|1|||
105781305|NCT01682876|364852878|FG003|Overall Study|Other|1|||
105781306|NCT02551874|364852887|FG000|Overall Study|Lost to Follow-up|0|||
105781307|NCT02551874|364852888|FG001|Overall Study|Lost to Follow-up|2|||
105781308|NCT02551874|364852887|FG000|Overall Study|Pregnancy|0|||
105781309|NCT02551874|364852888|FG001|Overall Study|Pregnancy|1|||
105781310|NCT02551874|364852887|FG000|Overall Study|Reason not reported|10|||
105781311|NCT02551874|364852888|FG001|Overall Study|Reason not reported|4|||
105781312|NCT02551874|364852887|FG000|Overall Study|Did not receive randomized treatment|0|||
105781313|NCT02551874|364852888|FG001|Overall Study|Did not receive randomized treatment|7|||
105781314|NCT02551874|364852887|FG000|Overall Study|Did not enter long-term study|18|||
105781315|NCT02551874|364852888|FG001|Overall Study|Did not enter long-term study|25|||
105781316|NCT03730987|364852891|FG000|Overall Study|Lost to Follow-up|2|||
105781317|NCT03730987|364852892|FG001|Overall Study|Lost to Follow-up|0|||
105781318|NCT03730987|364852893|FG002|Overall Study|Lost to Follow-up|2|||
105781319|NCT03730987|364852894|FG003|Overall Study|Lost to Follow-up|0|||
105781320|NCT02718131|364852895|FG000|Overall Study|Withdrawal by Subject|1|||
105781321|NCT02718131|364852896|FG001|Overall Study|Withdrawal by Subject|0|||
105781322|NCT02718131|364852895|FG000|Overall Study|Adverse Event|1|||
105781323|NCT02718131|364852896|FG001|Overall Study|Adverse Event|0|||
105781324|NCT02718131|364852895|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
105781325|NCT02718131|364852896|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
105781326|NCT01474291|364852903|FG000|Overall Study|Not Evaluable for Efficacy|26|||
105781327|NCT01474291|364852903|FG000|Overall Study|Lack of Treatment Efficacy|88|||
105781328|NCT01474291|364852903|FG000|Overall Study|Adverse Event|53|||
105781329|NCT01474291|364852903|FG000|Overall Study|Lost to Follow-up|29|||
105781330|NCT01474291|364852903|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
105781331|NCT01474291|364852903|FG000|Overall Study|No Reason Reported|10|||
105781332|NCT01474291|364852903|FG000|Overall Study|Death|2|||
105781333|NCT00310440|364852904|FG000|Overall Study|Lost to Follow-up|17|||
105781334|NCT00310440|364852905|FG001|Overall Study|Lost to Follow-up|8|||
105781335|NCT00310440|364852904|FG000|Overall Study|Withdrawal by Subject|2|||
105781336|NCT00310440|364852905|FG001|Overall Study|Withdrawal by Subject|1|||
105781337|NCT00310440|364852904|FG000|Overall Study|Missed 12 Month Visit|7|||
105781338|NCT00310440|364852905|FG001|Overall Study|Missed 12 Month Visit|4|||
105781339|NCT01098266|364852906|FG000|Overall Study|Physician Decision|1|||
105781340|NCT01098266|364852907|FG001|Overall Study|Physician Decision|0|||
105781341|NCT01098266|364852906|FG000|Overall Study|Death|3|||
105781342|NCT01098266|364852907|FG001|Overall Study|Death|2|||
105781343|NCT01098266|364852906|FG000|Overall Study|Withdrawal by Subject|3|||
105781344|NCT01098266|364852907|FG001|Overall Study|Withdrawal by Subject|5|||
105781345|NCT00525499|364852908|FG000|Overall Study|Lost to Follow-up|2|||
105781346|NCT00525499|364852909|FG001|Overall Study|Lost to Follow-up|4|||
105781347|NCT00525499|364852910|FG002|Overall Study|Lost to Follow-up|1|||
105781348|NCT00525499|364852911|FG003|Overall Study|Lost to Follow-up|4|||
105781349|NCT00525499|364852908|FG000|Overall Study|Adverse Event|0|||
105781350|NCT00525499|364852909|FG001|Overall Study|Adverse Event|1|||
105781351|NCT00525499|364852910|FG002|Overall Study|Adverse Event|0|||
105781352|NCT00525499|364852911|FG003|Overall Study|Adverse Event|1|||
105781353|NCT00525499|364852908|FG000|Overall Study|Withdrawal by Subject|5|||
105781354|NCT00525499|364852909|FG001|Overall Study|Withdrawal by Subject|1|||
105781355|NCT00525499|364852910|FG002|Overall Study|Withdrawal by Subject|5|||
105781356|NCT00525499|364852911|FG003|Overall Study|Withdrawal by Subject|2|||
105781357|NCT00525499|364852908|FG000|Overall Study|Protocol Violation|0|||
105781358|NCT00525499|364852909|FG001|Overall Study|Protocol Violation|1|||
105781359|NCT00525499|364852910|FG002|Overall Study|Protocol Violation|1|||
105781360|NCT00525499|364852911|FG003|Overall Study|Protocol Violation|0|||
105781361|NCT03339999|364852912|FG000|Overall Study|Adverse Event|1|||
105781362|NCT03339999|364852913|FG001|Overall Study|Adverse Event|2|||
105781363|NCT03339999|364852914|FG002|Overall Study|Adverse Event|2|||
105781364|NCT03339999|364852915|FG003|Overall Study|Adverse Event|1|||
105781365|NCT03339999|364852912|FG000|Overall Study|Lack of Efficacy|0|||
105781366|NCT03339999|364852913|FG001|Overall Study|Lack of Efficacy|1|||
105781367|NCT03339999|364852914|FG002|Overall Study|Lack of Efficacy|0|||
105781368|NCT03339999|364852915|FG003|Overall Study|Lack of Efficacy|0|||
105781369|NCT03339999|364852912|FG000|Overall Study|Lost to Follow-up|0|||
105781370|NCT03339999|364852913|FG001|Overall Study|Lost to Follow-up|0|||
105781371|NCT03339999|364852914|FG002|Overall Study|Lost to Follow-up|0|||
105781372|NCT03339999|364852915|FG003|Overall Study|Lost to Follow-up|1|||
105781373|NCT03339999|364852912|FG000|Overall Study|Study Terminated by Sponsor|6|||
105781374|NCT03339999|364852913|FG001|Overall Study|Study Terminated by Sponsor|3|||
105781375|NCT03339999|364852914|FG002|Overall Study|Study Terminated by Sponsor|4|||
105781376|NCT03339999|364852915|FG003|Overall Study|Study Terminated by Sponsor|3|||
105781377|NCT05602818|364852920|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
105781378|NCT05602818|364852921|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
105444701|NCT00145574|363633344|FG002|Open Label Long-term Extension|required restricted medicine|1|||
105444702|NCT03508609|363633349|FG000|Overall Study|Withdrawal by Subject|1|||
105444703|NCT00423449|363633352|FG000|Overall Study|Clinical Adverse Event|1|||
105444704|NCT00423449|363633353|FG001|Overall Study|Clinical Adverse Event|0|||
105444705|NCT00423449|363633354|FG002|Overall Study|Clinical Adverse Event|1|||
105444706|NCT00423449|363633355|FG003|Overall Study|Clinical Adverse Event|8|||
105444707|NCT00423449|363633356|FG004|Overall Study|Clinical Adverse Event|2|||
105444708|NCT00423449|363633352|FG000|Overall Study|Death|1|||
105444709|NCT00423449|363633353|FG001|Overall Study|Death|0|||
105444710|NCT00423449|363633354|FG002|Overall Study|Death|2|||
105444711|NCT00423449|363633355|FG003|Overall Study|Death|1|||
105444712|NCT00423449|363633356|FG004|Overall Study|Death|1|||
105781379|NCT05602818|364852922|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
105781380|NCT05602818|364852923|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
105781381|NCT05602818|364852924|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
105781382|NCT05602818|364852925|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
105781383|NCT05602818|364852926|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
105781384|NCT05602818|364852927|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
105781385|NCT05602818|364852928|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
105781386|NCT05602818|364852929|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
105781387|NCT05602818|364852930|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
105781388|NCT05602818|364852931|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
105781389|NCT05602818|364852920|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
105781390|NCT05602818|364852921|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
105781391|NCT05602818|364852922|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781392|NCT05602818|364852923|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781393|NCT05602818|364852924|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781394|NCT05602818|364852925|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781395|NCT05602818|364852926|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781396|NCT05602818|364852927|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781397|NCT05602818|364852928|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781398|NCT05602818|364852929|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781399|NCT05602818|364852930|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781400|NCT05602818|364852931|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781401|NCT05602818|364852920|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
105781402|NCT05602818|364852921|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781403|NCT05602818|364852922|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781404|NCT05602818|364852923|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781405|NCT05602818|364852924|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781406|NCT05602818|364852925|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781407|NCT05602818|364852926|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781408|NCT05602818|364852927|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781409|NCT05602818|364852928|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781410|NCT05602818|364852929|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781411|NCT05602818|364852930|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781412|NCT05602818|364852931|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781413|NCT05602818|364852920|FG000|Qualification Phase (3 Days)|Other|1|||
105781414|NCT05602818|364852921|FG001|Qualification Phase (3 Days)|Other|0|||
105781415|NCT05602818|364852922|FG002|Qualification Phase (3 Days)|Other|0|||
105781416|NCT05602818|364852923|FG003|Qualification Phase (3 Days)|Other|0|||
105781417|NCT05602818|364852924|FG004|Qualification Phase (3 Days)|Other|0|||
105781418|NCT05602818|364852925|FG005|Qualification Phase (3 Days)|Other|0|||
105781419|NCT05602818|364852926|FG006|Qualification Phase (3 Days)|Other|0|||
105781420|NCT05602818|364852927|FG007|Qualification Phase (3 Days)|Other|0|||
105781421|NCT05602818|364852928|FG008|Qualification Phase (3 Days)|Other|0|||
105781422|NCT05602818|364852929|FG009|Qualification Phase (3 Days)|Other|0|||
105781423|NCT05602818|364852930|FG010|Qualification Phase (3 Days)|Other|0|||
105781424|NCT05602818|364852931|FG011|Qualification Phase (3 Days)|Other|0|||
105781425|NCT05602818|364852920|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781426|NCT05602818|364852921|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
105781427|NCT05602818|364852922|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781428|NCT05602818|364852923|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105444713|NCT00423449|363633352|FG000|Overall Study|Progressive Disease|1|||
105444714|NCT00423449|363633353|FG001|Overall Study|Progressive Disease|3|||
105444715|NCT00423449|363633354|FG002|Overall Study|Progressive Disease|8|||
105335875|NCT00813813|363230136|FG001|Overall Study|Withdrawal by Subject|1|||
105335876|NCT00813813|363230135|FG000|Overall Study|Lost to Follow-up|2|||
105335877|NCT00813813|363230136|FG001|Overall Study|Lost to Follow-up|7|||
105335878|NCT00813813|363230135|FG000|Overall Study|Other|0|||
105335879|NCT00813813|363230136|FG001|Overall Study|Other|1|||
105335880|NCT04999163|363230144|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
105335881|NCT04999163|363230145|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
105335882|NCT04999163|363230144|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
105335883|NCT04999163|363230145|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
105335884|NCT04999163|363230144|FG000|Overall Study|Withdrawal by Subject|1|||
105335885|NCT04999163|363230145|FG001|Overall Study|Withdrawal by Subject|0|||
105335886|NCT03232931|363231296|FG000|Overall Study|Physician Decision|1|||
105335887|NCT03232931|363231297|FG001|Overall Study|Physician Decision|1|||
105335888|NCT03232931|363231296|FG000|Overall Study|Withdrawal by Subject|6|||
105335889|NCT03232931|363231297|FG001|Overall Study|Withdrawal by Subject|0|||
105335890|NCT03232931|363231296|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
105335891|NCT03232931|363231297|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
105335892|NCT03232931|363231296|FG000|Overall Study|Parent did not record voice|1|||
105335893|NCT03232931|363231297|FG001|Overall Study|Parent did not record voice|2|||
105335894|NCT03232931|363231296|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
105335895|NCT03232931|363231297|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
105335896|NCT00504725|363231299|FG000|Overall Study|Protocol Violation|1|||
105335897|NCT00504725|363231300|FG001|Overall Study|Protocol Violation|0|||
105335898|NCT04981470|363231303|FG000|Overall Study|Device failure in all 4 patients|4|||
105335899|NCT00809471|363231304|FG000|Overall Study|Protocol non-compliance|15|||
105335900|NCT00809471|363231305|FG001|Overall Study|Protocol non-compliance|15|||
105335901|NCT00809471|363231306|FG002|Overall Study|Protocol non-compliance|6|||
105335902|NCT00809471|363231304|FG000|Overall Study|Lost to Follow-up|4|||
105335903|NCT00809471|363231305|FG001|Overall Study|Lost to Follow-up|2|||
105335904|NCT00809471|363231306|FG002|Overall Study|Lost to Follow-up|9|||
105335905|NCT00809471|363231304|FG000|Overall Study|Adverse Event|0|||
105335906|NCT00809471|363231305|FG001|Overall Study|Adverse Event|2|||
105335907|NCT00809471|363231306|FG002|Overall Study|Adverse Event|2|||
105335908|NCT00809471|363231304|FG000|Overall Study|Requirement for restricted medication|1|||
105335909|NCT00809471|363231305|FG001|Overall Study|Requirement for restricted medication|1|||
105335910|NCT00809471|363231306|FG002|Overall Study|Requirement for restricted medication|0|||
105335911|NCT01736397|363231307|FG000|Overall Study|Lack of Efficacy|1|||
105335912|NCT01736397|363231308|FG001|Overall Study|Lack of Efficacy|11|||
105335913|NCT01736397|363231307|FG000|Overall Study|Withdrawal by Subject|6|||
105335914|NCT01736397|363231308|FG001|Overall Study|Withdrawal by Subject|5|||
105335915|NCT01736397|363231307|FG000|Overall Study|Lost to Follow-up|0|||
105335916|NCT01736397|363231308|FG001|Overall Study|Lost to Follow-up|1|||
105335917|NCT01736397|363231307|FG000|Overall Study|Adverse Event|6|||
105335918|NCT01736397|363231308|FG001|Overall Study|Adverse Event|3|||
105335919|NCT01736397|363231307|FG000|Overall Study|Not stated|1|||
105335920|NCT01736397|363231308|FG001|Overall Study|Not stated|4|||
105335921|NCT00831311|363231309|FG000|Overall Study|Definitive Contraindication|3|||
105335922|NCT00831311|363231310|FG001|Overall Study|Definitive Contraindication|3|||
105335923|NCT00831311|363231309|FG000|Overall Study|Lost to Follow-up|3|||
105335924|NCT00831311|363231310|FG001|Overall Study|Lost to Follow-up|0|||
105335925|NCT00831311|363231309|FG000|Overall Study|Physician Decision|0|||
105335926|NCT00831311|363231310|FG001|Overall Study|Physician Decision|1|||
105335927|NCT00831311|363231309|FG000|Overall Study|Withdrawal by Subject|6|||
105335928|NCT00831311|363231310|FG001|Overall Study|Withdrawal by Subject|4|||
105335929|NCT05088603|363231313|FG000|Overall Study|Protocol Violation|6|||
105335930|NCT05088603|363231314|FG001|Overall Study|Protocol Violation|1|||
105335931|NCT00594100|363231318|FG000|Procedure|Technical Failure|9|||
105335932|NCT00594100|363231318|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
105335933|NCT00594100|363231318|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
105335934|NCT00594100|363231318|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
105335935|NCT02448537|363231319|FG000|Overall Study|Withdrawal by Subject|1|||
105335936|NCT02448537|363231320|FG001|Overall Study|Withdrawal by Subject|1|||
105335937|NCT02448537|363231321|FG002|Overall Study|Withdrawal by Subject|1|||
105335938|NCT03555565|363231326|FG000|Overall Study|Case Report Forms Uncollected|2|||
105335939|NCT03555565|363231326|FG000|Overall Study|Protocol Deviation|13|||
105335940|NCT04292912|363231327|FG000|Overall Study|Physician Decision|1|||
105335941|NCT04292912|363231327|FG000|Overall Study|Protocol Violation|6|||
105335942|NCT04720911|363231332|FG000|Overall Study|Withdrawal by Subject|0|||
105335943|NCT04720911|363231333|FG001|Overall Study|Withdrawal by Subject|1|||
105335944|NCT04720911|363231334|FG002|Overall Study|Withdrawal by Subject|0|||
105335945|NCT00661609|363231335|FG000|Overall Study|Adverse Event|4|||
105335946|NCT00661609|363231335|FG000|Overall Study|Death|20|||
105335947|NCT00661609|363231335|FG000|Overall Study|Withdrawal by Subject|2|||
105335948|NCT00661609|363231335|FG000|Overall Study|PI Decision|1|||
105781429|NCT05602818|364852924|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781430|NCT05602818|364852925|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781431|NCT05602818|364852926|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781432|NCT05602818|364852927|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781433|NCT05602818|364852928|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781434|NCT05602818|364852929|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781435|NCT05602818|364852930|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781436|NCT05602818|364852931|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781437|NCT05602818|364852920|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
105781438|NCT05602818|364852921|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
105781439|NCT05602818|364852922|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
105781440|NCT05602818|364852923|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
105781441|NCT05602818|364852924|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
105781442|NCT05602818|364852925|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
105781443|NCT05602818|364852926|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
105781444|NCT05602818|364852927|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
105781445|NCT05602818|364852928|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
105781446|NCT05602818|364852929|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
105781447|NCT05602818|364852930|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
105781448|NCT05602818|364852931|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
105781449|NCT05602818|364852920|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781450|NCT05602818|364852921|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781451|NCT05602818|364852922|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781452|NCT05602818|364852923|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781453|NCT05602818|364852924|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781454|NCT05602818|364852925|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781455|NCT05602818|364852926|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781456|NCT05602818|364852927|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781457|NCT05602818|364852928|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781458|NCT05602818|364852929|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781459|NCT05602818|364852930|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
105781460|NCT05602818|364852931|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
105781461|NCT05602818|364852920|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
105781462|NCT05602818|364852921|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
105781463|NCT05602818|364852922|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
105781464|NCT05602818|364852923|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
105781465|NCT05602818|364852924|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
105781466|NCT05602818|364852925|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
105781467|NCT05602818|364852926|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
105781468|NCT05602818|364852927|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
105781469|NCT05602818|364852928|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
105781470|NCT05602818|364852929|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
105781471|NCT05602818|364852930|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
105781472|NCT05602818|364852931|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
105781473|NCT04594213|364852932|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
105781474|NCT04594213|364852933|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
105781475|NCT04594213|364852934|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
105781476|NCT04594213|364852935|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
105781477|NCT04594213|364852936|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
105781478|NCT04594213|364852937|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
105781479|NCT04594213|364852932|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
105781480|NCT04594213|364852933|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
105781481|NCT04594213|364852934|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
105781482|NCT04594213|364852935|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
105781483|NCT04594213|364852936|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
105781484|NCT04594213|364852937|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
105781485|NCT04594213|364852932|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
105781486|NCT04594213|364852933|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
105781487|NCT04594213|364852934|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
105781488|NCT04594213|364852935|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
105781489|NCT04594213|364852936|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
105781490|NCT04594213|364852937|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
105781491|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
105781492|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
105781493|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
105781494|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
105781495|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
105781496|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
105444716|NCT00423449|363633355|FG003|Overall Study|Progressive Disease|11|||
105444717|NCT00423449|363633356|FG004|Overall Study|Progressive Disease|4|||
105444718|NCT00423449|363633352|FG000|Overall Study|Laboratory Adverse Event|0|||
105444719|NCT00423449|363633353|FG001|Overall Study|Laboratory Adverse Event|1|||
105444720|NCT00423449|363633354|FG002|Overall Study|Laboratory Adverse Event|2|||
105444721|NCT00423449|363633355|FG003|Overall Study|Laboratory Adverse Event|0|||
105444722|NCT00423449|363633356|FG004|Overall Study|Laboratory Adverse Event|0|||
105444723|NCT00423449|363633352|FG000|Overall Study|Other|0|||
105444724|NCT00423449|363633353|FG001|Overall Study|Other|0|||
105444725|NCT00423449|363633354|FG002|Overall Study|Other|0|||
105444726|NCT00423449|363633355|FG003|Overall Study|Other|1|||
105444727|NCT00423449|363633356|FG004|Overall Study|Other|0|||
105444728|NCT00423449|363633352|FG000|Overall Study|Protocol Violation|0|||
105444729|NCT00423449|363633353|FG001|Overall Study|Protocol Violation|0|||
105444730|NCT00423449|363633354|FG002|Overall Study|Protocol Violation|2|||
105444731|NCT00423449|363633355|FG003|Overall Study|Protocol Violation|1|||
105444732|NCT00423449|363633356|FG004|Overall Study|Protocol Violation|0|||
105444733|NCT00869518|363633360|FG000|Overall Study|Lost to Follow-up|1|||
105444734|NCT00869518|363633361|FG001|Overall Study|Lost to Follow-up|1|||
105781497|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
105781498|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
105781499|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
105781500|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
105781501|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
105781502|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
105781503|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
105781504|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
105781505|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
105781506|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
105781507|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
105781508|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
105781509|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
105781510|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
105781511|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
105781512|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
105781513|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
105781514|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
105781515|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
105781516|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
105781517|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
105781518|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
105781519|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
105781520|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
105781521|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
105781522|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
105781523|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
105781524|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
105781525|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
105781526|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
105781527|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
105781528|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
105781529|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
105781530|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
105781531|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
105781532|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
105781533|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
105781534|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
105781535|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
105781536|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
105781537|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
105781538|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
105781539|NCT01716585|364852938|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
105781540|NCT01716585|364852939|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
105781541|NCT01716585|364852938|FG000|Double-blind Treatment|Adverse Event|2|||
105781542|NCT01716585|364852939|FG001|Double-blind Treatment|Adverse Event|1|||
105781543|NCT01716585|364852938|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
105781544|NCT01716585|364852939|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
105781545|NCT01716585|364852938|FG000|Double-blind Treatment|Lost to Follow-up|2|||
105781546|NCT01716585|364852939|FG001|Double-blind Treatment|Lost to Follow-up|0|||
105781547|NCT01716585|364852938|FG000|Double-blind Treatment|Subject Noncompliant|1|||
105781548|NCT01716585|364852939|FG001|Double-blind Treatment|Subject Noncompliant|0|||
105335949|NCT00661609|363231335|FG000|Overall Study|Survival follow up stage discontinued|11|||
105781549|NCT01716585|364852938|FG000|Double-blind Treatment|Other|1|||
105781550|NCT01716585|364852939|FG001|Double-blind Treatment|Other|0|||
105781551|NCT01716585|364852938|FG000|Open-label Treatment|Adverse Event|0|||
105781552|NCT01716585|364852939|FG001|Open-label Treatment|Adverse Event|2|||
105781553|NCT01716585|364852938|FG000|Open-label Treatment|Virologic Failure|0|||
105781554|NCT01716585|364852939|FG001|Open-label Treatment|Virologic Failure|2|||
105781555|NCT01716585|364852938|FG000|Open-label Treatment|Withdrawal by Subject|0|||
105781556|NCT01716585|364852939|FG001|Open-label Treatment|Withdrawal by Subject|3|||
105781557|NCT00408408|364852940|FG000|Overall Study|No follow up data|2|||
105781558|NCT00408408|364852941|FG001|Overall Study|No follow up data|3|||
105781559|NCT00408408|364852942|FG002|Overall Study|No follow up data|0|||
105781560|NCT00408408|364852943|FG003|Overall Study|No follow up data|7|||
105781561|NCT00408408|364852944|FG004|Overall Study|No follow up data|5|||
105781562|NCT00408408|364852945|FG005|Overall Study|No follow up data|3|||
105781563|NCT01616173|364852948|FG000|Overall Study|Lost to Follow-up|0|||
105781564|NCT01616173|364852949|FG001|Overall Study|Lost to Follow-up|2|||
105781565|NCT01616173|364852950|FG002|Overall Study|Lost to Follow-up|0|||
105781566|NCT00504595|364852954|FG000|Overall Study|Lack of Efficacy|1|||
105781567|NCT00504595|364852955|FG001|Overall Study|Lack of Efficacy|0|||
105781568|NCT00504595|364852956|FG002|Overall Study|Lack of Efficacy|0|||
105781569|NCT00504595|364852957|FG003|Overall Study|Lack of Efficacy|0|||
105781570|NCT00504595|364852954|FG000|Overall Study|Other|0|||
105781571|NCT00504595|364852955|FG001|Overall Study|Other|0|||
105781572|NCT00504595|364852956|FG002|Overall Study|Other|2|||
105781573|NCT00504595|364852957|FG003|Overall Study|Other|0|||
105781574|NCT00808665|364852960|FG000|Overall Study|Withdrawal by Subject|1|||
105781575|NCT00808665|364852961|FG001|Overall Study|Withdrawal by Subject|0|||
105781576|NCT00808665|364852960|FG000|Overall Study|only required minimally invasive surgery|1|||
105781577|NCT00808665|364852961|FG001|Overall Study|only required minimally invasive surgery|0|||
105781578|NCT00808665|364852960|FG000|Overall Study|surgery cancelled|1|||
105781579|NCT00808665|364852961|FG001|Overall Study|surgery cancelled|0|||
105781580|NCT00808665|364852960|FG000|Overall Study|required an additional procedure|0|||
105781581|NCT00808665|364852961|FG001|Overall Study|required an additional procedure|1|||
105781582|NCT00808665|364852960|FG000|Overall Study|Physician Decision|3|||
105781583|NCT00808665|364852961|FG001|Overall Study|Physician Decision|1|||
105781584|NCT00808665|364852960|FG000|Overall Study|Medication stopped by resident|0|||
105781585|NCT00808665|364852961|FG001|Overall Study|Medication stopped by resident|1|||
105781586|NCT03326323|364852962|FG000|Overall Study|Unable to receive ANH protocol|3|||
105781587|NCT01552408|364852966|FG000|Overall Study|Lost to Follow-up|2|||
105781588|NCT01552408|364852967|FG001|Overall Study|Lost to Follow-up|0|||
105781589|NCT01552408|364852966|FG000|Overall Study|Relocation|0|||
105781590|NCT01552408|364852967|FG001|Overall Study|Relocation|1|||
105781591|NCT01552408|364852966|FG000|Overall Study|Withdrawal by Subject|2|||
105781592|NCT01552408|364852967|FG001|Overall Study|Withdrawal by Subject|1|||
105781593|NCT03319160|364852968|FG000|Overall Study|Data not available.|7|||
105781594|NCT00665002|364852969|FG000|Overall Study|Progression/relapse during treatment|11|||
105781595|NCT00665002|364852969|FG000|Overall Study|Cytogenetic resistance|1|||
105781596|NCT03604159|364852970|FG000|Overall Study|Lost to Follow-up|6|||
105781597|NCT03604159|364852971|FG001|Overall Study|Lost to Follow-up|7|||
105781598|NCT04533204|364852975|FG000|Overall Study|Unable to understand training instructions|1|||
105781599|NCT04533204|364852976|FG001|Overall Study|Unable to understand training instructions|1|||
105781600|NCT00787527|364852977|FG000|Overall Study|Toxicity|3|||
105781601|NCT02242305|364852978|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
105781602|NCT02242305|364852979|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
105781603|NCT02242305|364852978|FG000|Overall Study|Adverse Event|1|||
105781604|NCT02242305|364852979|FG001|Overall Study|Adverse Event|0|||
105781605|NCT02242305|364852978|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
105781606|NCT02242305|364852979|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
105781607|NCT02242305|364852978|FG000|Overall Study|Subject withdraws inform consent|0|||
105781608|NCT02242305|364852979|FG001|Overall Study|Subject withdraws inform consent|4|||
105781609|NCT02242305|364852978|FG000|Overall Study|Lost to Follow-up|2|||
105781610|NCT02242305|364852979|FG001|Overall Study|Lost to Follow-up|0|||
105781611|NCT02543918|364852982|FG000|Overall Study|Never treated|0|||
105781612|NCT02543918|364852983|FG001|Overall Study|Never treated|1|||
105781613|NCT02543918|364852982|FG000|Overall Study|Lost to Follow-up|1|||
105781614|NCT02543918|364852983|FG001|Overall Study|Lost to Follow-up|1|||
105781615|NCT02543918|364852982|FG000|Overall Study|Withdrawal by Subject|1|||
105781616|NCT02543918|364852983|FG001|Overall Study|Withdrawal by Subject|1|||
105781617|NCT02543918|364852982|FG000|Overall Study|Adverse Event|1|||
105781618|NCT02543918|364852983|FG001|Overall Study|Adverse Event|1|||
105781619|NCT02117024|364852984|FG000|Overall Study|Progressive Disease|26|||
105781620|NCT02117024|364852985|FG001|Overall Study|Progressive Disease|9|||
105781621|NCT02117024|364852984|FG000|Overall Study|Significant Clinical Progression|7|||
105781622|NCT02117024|364852985|FG001|Overall Study|Significant Clinical Progression|4|||
105781623|NCT02117024|364852984|FG000|Overall Study|Death|5|||
105781624|NCT02117024|364852985|FG001|Overall Study|Death|0|||
105781625|NCT02117024|364852984|FG000|Overall Study|Withdrawal by Subject|3|||
105781626|NCT02117024|364852985|FG001|Overall Study|Withdrawal by Subject|1|||
105781627|NCT02117024|364852984|FG000|Overall Study|Protocol Violation|1|||
105781628|NCT02117024|364852985|FG001|Overall Study|Protocol Violation|0|||
105781629|NCT02117024|364852984|FG000|Overall Study|Adverse Event|1|||
105781630|NCT02117024|364852985|FG001|Overall Study|Adverse Event|2|||
105781631|NCT02117024|364852984|FG000|Overall Study|Randomized in Error|1|||
105781632|NCT02117024|364852985|FG001|Overall Study|Randomized in Error|0|||
105781633|NCT02117024|364852984|FG000|Overall Study|Patient returned to primary oncologist|0|||
105781634|NCT02117024|364852985|FG001|Overall Study|Patient returned to primary oncologist|1|||
105781635|NCT02117024|364852984|FG000|Overall Study|Patient took treatment break|0|||
105781636|NCT02117024|364852985|FG001|Overall Study|Patient took treatment break|1|||
105781637|NCT02117024|364852984|FG000|Overall Study|Physician Decision|0|||
105781638|NCT02117024|364852985|FG001|Overall Study|Physician Decision|2|||
105781639|NCT02500706|364852986|FG000|Overall Study|Adverse Event|0|||
105781640|NCT02500706|364852987|FG001|Overall Study|Adverse Event|0|||
105781641|NCT02500706|364852988|FG002|Overall Study|Adverse Event|1|||
105781642|NCT02500706|364852986|FG000|Overall Study|Lost to Follow-up|0|||
105781643|NCT02500706|364852987|FG001|Overall Study|Lost to Follow-up|1|||
105781644|NCT02500706|364852988|FG002|Overall Study|Lost to Follow-up|1|||
105781645|NCT02500706|364852986|FG000|Overall Study|Withdrawal by Subject|4|||
105781646|NCT02500706|364852987|FG001|Overall Study|Withdrawal by Subject|6|||
105781647|NCT02500706|364852988|FG002|Overall Study|Withdrawal by Subject|4|||
105781648|NCT02500706|364852986|FG000|Overall Study|Unclassified|0|||
105781649|NCT02500706|364852987|FG001|Overall Study|Unclassified|0|||
105781650|NCT02500706|364852988|FG002|Overall Study|Unclassified|1|||
105781651|NCT00529152|364852989|FG000|Overall Study|Adverse Event|2|||
105781652|NCT00529152|364852989|FG000|Overall Study|Withdrawal by Subject|2|||
105781653|NCT00529152|364852989|FG000|Overall Study|Lost to Follow-up|1|||
105781654|NCT01005875|364852992|FG000|Overall Study|Death|3|||
105781655|NCT02924129|364853007|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
105781656|NCT02924129|364853008|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
105781657|NCT02924129|364853007|FG000|Overall Study|Withdrawal by Subject|2|||
105781658|NCT02924129|364853008|FG001|Overall Study|Withdrawal by Subject|2|||
105781659|NCT02924129|364853007|FG000|Overall Study|Physician Decision|1|||
105781660|NCT02924129|364853008|FG001|Overall Study|Physician Decision|0|||
105781661|NCT02924129|364853007|FG000|Overall Study|Missed Visit|0|||
105781662|NCT02924129|364853008|FG001|Overall Study|Missed Visit|1|||
105781663|NCT01348828|364853014|FG000|Overall Study|Death|20|||
105781664|NCT01348828|364853014|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
105781665|NCT01348828|364853014|FG000|Overall Study|Conversion|2|||
105781666|NCT01348828|364853014|FG000|Overall Study|missed visit|1|||
105781667|NCT01365182|364853015|FG000|Overall Study|Withdrawal by Subject|10|||
105781668|NCT01365182|364853016|FG001|Overall Study|Withdrawal by Subject|13|||
105781669|NCT01365182|364853017|FG002|Overall Study|Withdrawal by Subject|12|||
105781670|NCT01990339|364853018|FG000|Overall Study|Data Not Available|49|||
105781671|NCT01990339|364853018|FG000|Overall Study|Voluntary Withdrawal|1402|||
105781672|NCT01990339|364853018|FG000|Overall Study|Lost to Follow-up|861|||
105781673|NCT01590810|364853019|FG000|Overall Study|Physician Decision|0|||
105781674|NCT01590810|364853020|FG001|Overall Study|Physician Decision|1|||
105781675|NCT01590810|364853021|FG002|Overall Study|Physician Decision|1|||
105781676|NCT01590810|364853022|FG003|Overall Study|Physician Decision|0|||
105781677|NCT01590810|364853023|FG004|Overall Study|Physician Decision|0|||
105781678|NCT01078974|364853027|FG000|Overall Study|Adverse Event|3|||
105781679|NCT00553319|364853028|FG000|Overall Study|Lost to Follow-up|10|||
105781680|NCT00553319|364853029|FG001|Overall Study|Lost to Follow-up|9|||
105781681|NCT00553319|364853030|FG002|Overall Study|Lost to Follow-up|5|||
105781682|NCT00553319|364853028|FG000|Overall Study|wanted treatment elsewhere|2|||
105781683|NCT00553319|364853029|FG001|Overall Study|wanted treatment elsewhere|1|||
105781684|NCT00553319|364853030|FG002|Overall Study|wanted treatment elsewhere|1|||
105781685|NCT00553319|364853028|FG000|Overall Study|non-compliance|0|||
105781686|NCT00553319|364853029|FG001|Overall Study|non-compliance|0|||
105781687|NCT00553319|364853030|FG002|Overall Study|non-compliance|2|||
105781688|NCT00553319|364853028|FG000|Overall Study|incarceration|1|||
105781689|NCT00553319|364853029|FG001|Overall Study|incarceration|0|||
105781690|NCT00553319|364853030|FG002|Overall Study|incarceration|0|||
105781691|NCT00553319|364853028|FG000|Overall Study|moved|1|||
105781692|NCT00553319|364853029|FG001|Overall Study|moved|0|||
105781693|NCT00553319|364853030|FG002|Overall Study|moved|1|||
105781694|NCT01159665|364853035|FG000|Overall Study|Withdrawal by Subject|0|||
105781695|NCT01159665|364853036|FG001|Overall Study|Withdrawal by Subject|1|||
105781696|NCT01159665|364853037|FG002|Overall Study|Withdrawal by Subject|0|||
105781697|NCT01159665|364853038|FG003|Overall Study|Withdrawal by Subject|0|||
105781698|NCT01159665|364853039|FG004|Overall Study|Withdrawal by Subject|0|||
105781699|NCT01159665|364853040|FG005|Overall Study|Withdrawal by Subject|0|||
105781700|NCT01130831|364853041|FG000|Overall Study|Withdrawal by Subject|7|||
105781701|NCT01130831|364853041|FG000|Overall Study|Death|4|||
105781702|NCT01130831|364853041|FG000|Overall Study|Information was missing|3|||
105781703|NCT00422942|364853042|FG000|Overall Study|Study terminated by Sponsor|3|||
105781704|NCT02173158|364853043|FG000|Efficacy Phase|Adverse Event|1|||
105781705|NCT01230489|364853055|FG000|Overall Study|Death|2|||
105781706|NCT01230489|364853055|FG000|Overall Study|Adverse Event|2|||
105781707|NCT01230489|364853055|FG000|Overall Study|Treatment modality changed|1|||
105781708|NCT03077646|364853056|FG000|Overall Study|Lost to Follow-up|29|||
105781709|NCT03077646|364853057|FG001|Overall Study|Lost to Follow-up|30|||
105444735|NCT01574651|363633362|FG000|Overall Study|Lost to Follow-up|2|||
105444736|NCT01574651|363633363|FG001|Overall Study|Lost to Follow-up|4|||
105444737|NCT01574651|363633362|FG000|Overall Study|Administrative problems|0|||
105444738|NCT01574651|363633363|FG001|Overall Study|Administrative problems|1|||
105444739|NCT01574651|363633362|FG000|Overall Study|Death|3|||
105444740|NCT01574651|363633363|FG001|Overall Study|Death|3|||
105444741|NCT01574651|363633362|FG000|Overall Study|Patient's inability to use the device|0|||
105444742|NCT01574651|363633363|FG001|Overall Study|Patient's inability to use the device|1|||
105444743|NCT01574651|363633362|FG000|Overall Study|Adverse Event|36|||
105444744|NCT01574651|363633363|FG001|Overall Study|Adverse Event|27|||
105444745|NCT01574651|363633362|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105444746|NCT01574651|363633363|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105444747|NCT01574651|363633362|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105444748|NCT01574651|363633363|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105444749|NCT01574651|363633362|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
105444750|NCT01574651|363633363|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105444751|NCT01574651|363633362|FG000|Overall Study|Protocol Violation|3|||
105444752|NCT01574651|363633363|FG001|Overall Study|Protocol Violation|5|||
105444753|NCT01574651|363633362|FG000|Overall Study|Withdrawal by Subject|9|||
105444754|NCT01574651|363633363|FG001|Overall Study|Withdrawal by Subject|10|||
105444755|NCT02487030|363633364|FG000|Overall Study|Lack of Efficacy|2|||
105444756|NCT02487030|363633365|FG001|Overall Study|Lack of Efficacy|4|||
105444757|NCT02487030|363633366|FG002|Overall Study|Lack of Efficacy|1|||
105444758|NCT02487030|363633367|FG003|Overall Study|Lack of Efficacy|0|||
105444759|NCT02487030|363633368|FG004|Overall Study|Lack of Efficacy|1|||
105444760|NCT02487030|363633369|FG005|Overall Study|Lack of Efficacy|0|||
105444761|NCT02487030|363633370|FG006|Overall Study|Lack of Efficacy|0|||
105444762|NCT02487030|363633364|FG000|Overall Study|Lost to Follow-up|0|||
105444763|NCT02487030|363633365|FG001|Overall Study|Lost to Follow-up|0|||
105444764|NCT02487030|363633366|FG002|Overall Study|Lost to Follow-up|1|||
105444765|NCT02487030|363633367|FG003|Overall Study|Lost to Follow-up|1|||
105444766|NCT02487030|363633368|FG004|Overall Study|Lost to Follow-up|0|||
105444767|NCT02487030|363633369|FG005|Overall Study|Lost to Follow-up|1|||
105444768|NCT02487030|363633370|FG006|Overall Study|Lost to Follow-up|0|||
105444769|NCT02487030|363633364|FG000|Overall Study|Adverse Event|0|||
105444770|NCT02487030|363633365|FG001|Overall Study|Adverse Event|0|||
105444771|NCT02487030|363633366|FG002|Overall Study|Adverse Event|0|||
105444772|NCT02487030|363633367|FG003|Overall Study|Adverse Event|1|||
105444773|NCT02487030|363633368|FG004|Overall Study|Adverse Event|0|||
105444774|NCT02487030|363633369|FG005|Overall Study|Adverse Event|0|||
105444775|NCT02487030|363633370|FG006|Overall Study|Adverse Event|0|||
105444776|NCT02487030|363633364|FG000|Overall Study|Death|0|||
105444777|NCT02487030|363633365|FG001|Overall Study|Death|0|||
105444778|NCT02487030|363633366|FG002|Overall Study|Death|0|||
105444779|NCT02487030|363633367|FG003|Overall Study|Death|0|||
105444780|NCT02487030|363633368|FG004|Overall Study|Death|1|||
105444781|NCT02487030|363633369|FG005|Overall Study|Death|0|||
105444782|NCT02487030|363633370|FG006|Overall Study|Death|0|||
105444783|NCT00947115|363633371|FG000|Overall Study|Missed reporting interval|3|||
105444784|NCT00947115|363633372|FG001|Overall Study|Missed reporting interval|4|||
105444785|NCT00947115|363633373|FG002|Overall Study|Missed reporting interval|2|||
105444786|NCT00947115|363633371|FG000|Overall Study|Physician Decision|0|||
105444787|NCT00947115|363633372|FG001|Overall Study|Physician Decision|2|||
105444788|NCT00947115|363633373|FG002|Overall Study|Physician Decision|0|||
105444789|NCT00947115|363633371|FG000|Overall Study|Death|0|||
105444790|NCT00947115|363633372|FG001|Overall Study|Death|1|||
105444791|NCT00947115|363633373|FG002|Overall Study|Death|1|||
105444792|NCT00947115|363633371|FG000|Overall Study|Migrated from study area|2|||
105781710|NCT03077646|364853058|FG002|Overall Study|Lost to Follow-up|31|||
105781711|NCT00313716|364854823|FG000|Overall Study|Death|3|||
105781712|NCT00313716|364854824|FG001|Overall Study|Death|2|||
105781713|NCT00313716|364854825|FG002|Overall Study|Death|9|||
105781714|NCT00313716|364854826|FG003|Overall Study|Death|3|||
105781715|NCT00313716|364854827|FG004|Overall Study|Death|5|||
105781716|NCT00313716|364854828|FG005|Overall Study|Death|9|||
105781717|NCT00313716|364854823|FG000|Overall Study|Lost to Follow-up|2|||
105781718|NCT00313716|364854824|FG001|Overall Study|Lost to Follow-up|5|||
105781719|NCT00313716|364854825|FG002|Overall Study|Lost to Follow-up|2|||
105781720|NCT00313716|364854826|FG003|Overall Study|Lost to Follow-up|1|||
105781721|NCT00313716|364854827|FG004|Overall Study|Lost to Follow-up|0|||
105781722|NCT00313716|364854828|FG005|Overall Study|Lost to Follow-up|4|||
105781723|NCT00313716|364854823|FG000|Overall Study|Withdrawal by Subject|0|||
105781724|NCT00313716|364854824|FG001|Overall Study|Withdrawal by Subject|1|||
105444793|NCT00947115|363633372|FG001|Overall Study|Migrated from study area|0|||
105444794|NCT00947115|363633373|FG002|Overall Study|Migrated from study area|0|||
105444795|NCT00947115|363633371|FG000|Overall Study|Withdrawal by Subject|1|||
105444796|NCT00947115|363633372|FG001|Overall Study|Withdrawal by Subject|3|||
105444797|NCT00947115|363633373|FG002|Overall Study|Withdrawal by Subject|4|||
105444798|NCT00947115|363633371|FG000|Overall Study|Lost to Follow-up|11|||
105444799|NCT00947115|363633372|FG001|Overall Study|Lost to Follow-up|12|||
105444800|NCT00947115|363633373|FG002|Overall Study|Lost to Follow-up|8|||
105444801|NCT02092025|363633374|FG000|Overall Study|Case Report Forms Uncollected|44|||
105444802|NCT02092025|363633374|FG000|Overall Study|Protocol Deviation|24|||
105444803|NCT01223183|363633376|FG000|Imaging Day 1|Physician Decision|0|||
105444804|NCT01223183|363633377|FG001|Imaging Day 1|Physician Decision|1|||
105444805|NCT01223183|363633376|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
105444806|NCT01223183|363633377|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
105444807|NCT01223183|363633376|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
105444808|NCT01223183|363633377|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
105444809|NCT02709330|363633382|FG000|Overall Study|Death|5|||
105444810|NCT02709330|363633383|FG001|Overall Study|Death|0|||
105444811|NCT02709330|363633382|FG000|Overall Study|Lost to Follow-up|2|||
105444812|NCT02709330|363633383|FG001|Overall Study|Lost to Follow-up|0|||
105444813|NCT02709330|363633382|FG000|Overall Study|Physician Decision|2|||
105444814|NCT02709330|363633383|FG001|Overall Study|Physician Decision|0|||
105444815|NCT02709330|363633382|FG000|Overall Study|Withdrawal by Subject|4|||
105444816|NCT02709330|363633383|FG001|Overall Study|Withdrawal by Subject|0|||
105444817|NCT01807299|363633384|FG000|Overall Study|Protocol Violation|3|||
105444818|NCT01807299|363633385|FG001|Overall Study|Protocol Violation|1|||
105444819|NCT01807299|363633386|FG002|Overall Study|Protocol Violation|0|||
105444820|NCT01807299|363633387|FG003|Overall Study|Protocol Violation|2|||
105444821|NCT00511238|363633388|FG000|Overall Study|Adverse Event|13|||
105444822|NCT00511238|363633389|FG001|Overall Study|Adverse Event|33|||
105444823|NCT00511238|363633388|FG000|Overall Study|Withdrawal by Subject|2|||
105444824|NCT00511238|363633389|FG001|Overall Study|Withdrawal by Subject|22|||
105444825|NCT00511238|363633388|FG000|Overall Study|Progressive Disease|23|||
105444826|NCT00511238|363633389|FG001|Overall Study|Progressive Disease|157|||
105444827|NCT00511238|363633388|FG000|Overall Study|various reasons|4|||
105444828|NCT00511238|363633389|FG001|Overall Study|various reasons|14|||
105444829|NCT03772665|363633390|FG000|Overall Study|Protocol Violation|1|||
105444830|NCT03772665|363633391|FG001|Overall Study|Protocol Violation|0|||
105444831|NCT01478971|363635010|FG000|Standard of Care Period|Adverse Event|1|||
105444832|NCT01478971|363635010|FG000|Standard of Care Period|Withdrawal by Subject|3|||
105444833|NCT01478971|363635010|FG000|Standard of Care Period|Death|8|||
105444834|NCT01478971|363635010|FG000|Standard of Care Period|Lost to Follow-up|9|||
105444835|NCT01478971|363635010|FG000|Standard of Care Period|Other|4|||
105444836|NCT01478971|363635010|FG000|Peginesatide Treatment Period|Adverse Event|1|||
105444837|NCT01478971|363635010|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
105444838|NCT01478971|363635010|FG000|Peginesatide Treatment Period|Death|4|||
105444839|NCT01478971|363635010|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
105444840|NCT01478971|363635010|FG000|Peginesatide Treatment Period|Other|4|||
105444841|NCT01865448|363635011|FG000|Overall Study|Adverse Event|1|||
105444842|NCT01865448|363635012|FG001|Overall Study|Adverse Event|1|||
105444843|NCT01865448|363635011|FG000|Overall Study|Pregnancy|0|||
105444844|NCT01865448|363635012|FG001|Overall Study|Pregnancy|1|||
105444845|NCT01865448|363635011|FG000|Overall Study|dropout unrelated to study|1|||
105444846|NCT01865448|363635012|FG001|Overall Study|dropout unrelated to study|1|||
105444847|NCT01698814|363635013|FG000|Overall Study|Adverse Event|0|||
105444848|NCT01698814|363635014|FG001|Overall Study|Adverse Event|2|||
105444849|NCT01698814|363635013|FG000|Overall Study|Lost to Follow-up|0|||
105444850|NCT01698814|363635014|FG001|Overall Study|Lost to Follow-up|1|||
105444851|NCT01698814|363635013|FG000|Overall Study|Pregnancy|1|||
105444852|NCT01698814|363635014|FG001|Overall Study|Pregnancy|0|||
105444853|NCT01698814|363635013|FG000|Overall Study|Randomized in error|1|||
105444854|NCT01698814|363635014|FG001|Overall Study|Randomized in error|0|||
105444855|NCT02451917|363635017|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
105444856|NCT02451917|363635018|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
105444857|NCT02451917|363635017|FG000|First Intervention (24 Weeks)|Death|0|||
105444858|NCT02451917|363635018|FG001|First Intervention (24 Weeks)|Death|1|||
105444859|NCT02451917|363635017|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
105444860|NCT02451917|363635018|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
105444861|NCT02300259|363635021|FG000|Period 1|Adverse Event|0|||
105444862|NCT02300259|363635022|FG001|Period 1|Adverse Event|0|||
105444863|NCT02300259|363635023|FG002|Period 1|Adverse Event|1|||
105444864|NCT02300259|363635021|FG000|Period 1|Withdrawal by Subject|0|||
105444865|NCT02300259|363635022|FG001|Period 1|Withdrawal by Subject|0|||
105444866|NCT02300259|363635023|FG002|Period 1|Withdrawal by Subject|1|||
105444867|NCT02300259|363635021|FG000|Period 2|Adverse Event|1|||
105444868|NCT02300259|363635022|FG001|Period 2|Adverse Event|0|||
105444869|NCT02300259|363635023|FG002|Period 2|Adverse Event|0|||
105444870|NCT02300259|363635021|FG000|Period 2|Withdrawal by Subject|0|||
105444871|NCT02300259|363635022|FG001|Period 2|Withdrawal by Subject|0|||
105444872|NCT02300259|363635023|FG002|Period 2|Withdrawal by Subject|1|||
105444873|NCT04506502|363635026|FG000|Overall Study|Withdrawal by Subject|1|||
105444874|NCT04506502|363635026|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
105444875|NCT03526146|363635027|FG000|Overall Study|Lost to Follow-up|5|||
105444876|NCT03526146|363635027|FG000|Overall Study|Withdrawal by Subject|6|||
105444877|NCT03526146|363635027|FG000|Overall Study|class canceled due to COVID-19|4|||
105444878|NCT01136408|363635032|FG000|Overall Study|Adverse Event|4|||
105444879|NCT01136408|363635033|FG001|Overall Study|Adverse Event|8|||
105444880|NCT01136408|363635034|FG002|Overall Study|Adverse Event|4|||
105444881|NCT01136408|363635032|FG000|Overall Study|Protocol Violation|1|||
105444882|NCT01136408|363635033|FG001|Overall Study|Protocol Violation|1|||
105444883|NCT01136408|363635034|FG002|Overall Study|Protocol Violation|1|||
105444884|NCT00398567|363635035|FG000|Overall Study|Disease Progression|3|||
105444885|NCT00398567|363635036|FG001|Overall Study|Disease Progression|4|||
105444886|NCT00398567|363635037|FG002|Overall Study|Disease Progression|27|||
105444887|NCT00398567|363635035|FG000|Overall Study|Withdrawal by Subject|1|||
105444888|NCT00398567|363635036|FG001|Overall Study|Withdrawal by Subject|0|||
105444889|NCT00398567|363635037|FG002|Overall Study|Withdrawal by Subject|4|||
105444890|NCT00398567|363635035|FG000|Overall Study|Adverse Event|0|||
105444891|NCT00398567|363635036|FG001|Overall Study|Adverse Event|0|||
105444892|NCT00398567|363635037|FG002|Overall Study|Adverse Event|2|||
105444893|NCT00398567|363635035|FG000|Overall Study|Protocol Violation|0|||
105444894|NCT00398567|363635036|FG001|Overall Study|Protocol Violation|0|||
105444895|NCT00398567|363635037|FG002|Overall Study|Protocol Violation|1|||
105444896|NCT01200368|363635044|FG000|Infant Series|Adverse Event|2|||
105444897|NCT01200368|363635045|FG001|Infant Series|Adverse Event|2|||
105444898|NCT01200368|363635046|FG002|Infant Series|Adverse Event|3|||
105444899|NCT01200368|363635044|FG000|Infant Series|Withdrawal by Subject|0|||
105444900|NCT01200368|363635045|FG001|Infant Series|Withdrawal by Subject|2|||
105444901|NCT01200368|363635046|FG002|Infant Series|Withdrawal by Subject|2|||
105444902|NCT01200368|363635044|FG000|Infant Series|Did not meet entrance criteria|0|||
105444903|NCT01200368|363635045|FG001|Infant Series|Did not meet entrance criteria|1|||
105444904|NCT01200368|363635046|FG002|Infant Series|Did not meet entrance criteria|0|||
105444905|NCT01200368|363635044|FG000|Infant Series|Randomized, not vaccinated|0|||
105444906|NCT01200368|363635045|FG001|Infant Series|Randomized, not vaccinated|1|||
105444907|NCT01200368|363635046|FG002|Infant Series|Randomized, not vaccinated|1|||
105444908|NCT01200368|363635044|FG000|Infant Series|Other|1|||
105444909|NCT01200368|363635045|FG001|Infant Series|Other|0|||
105444910|NCT01200368|363635046|FG002|Infant Series|Other|0|||
105444911|NCT01200368|363635044|FG000|After Infant Series|Adverse Event|6|||
105444912|NCT01200368|363635045|FG001|After Infant Series|Adverse Event|6|||
105444913|NCT01200368|363635046|FG002|After Infant Series|Adverse Event|3|||
105444914|NCT01200368|363635044|FG000|After Infant Series|Withdrawal by Subject|10|||
105444915|NCT01200368|363635045|FG001|After Infant Series|Withdrawal by Subject|8|||
105444916|NCT01200368|363635046|FG002|After Infant Series|Withdrawal by Subject|4|||
105444917|NCT01200368|363635044|FG000|After Infant Series|Lost to Follow-up|1|||
105444918|NCT01200368|363635045|FG001|After Infant Series|Lost to Follow-up|0|||
105444919|NCT01200368|363635046|FG002|After Infant Series|Lost to Follow-up|0|||
105444920|NCT01200368|363635044|FG000|After Infant Series|Other|1|||
105444921|NCT01200368|363635045|FG001|After Infant Series|Other|2|||
105444922|NCT01200368|363635046|FG002|After Infant Series|Other|2|||
105444923|NCT01200368|363635044|FG000|Toddler Dose|Adverse Event|0|||
105444924|NCT01200368|363635045|FG001|Toddler Dose|Adverse Event|3|||
105444925|NCT01200368|363635046|FG002|Toddler Dose|Adverse Event|1|||
105444926|NCT03066193|363635047|FG000|Overall Study|Withdrawal by Subject|1|||
105444927|NCT00377858|363635058|FG000|Overall Study|Withdrawal by Subject|12|||
105444928|NCT00377858|363635059|FG001|Overall Study|Withdrawal by Subject|11|||
105444929|NCT00377858|363635058|FG000|Overall Study|Lost to Follow-up|6|||
105444930|NCT00377858|363635059|FG001|Overall Study|Lost to Follow-up|1|||
105444931|NCT00377858|363635058|FG000|Overall Study|Physician Decision|5|||
105444932|NCT00377858|363635059|FG001|Overall Study|Physician Decision|5|||
105444933|NCT00377858|363635058|FG000|Overall Study|Protocol Violation|3|||
105444934|NCT00377858|363635059|FG001|Overall Study|Protocol Violation|4|||
105444935|NCT00377858|363635058|FG000|Overall Study|Adverse Event|2|||
105444936|NCT00377858|363635059|FG001|Overall Study|Adverse Event|1|||
105444937|NCT00377858|363635058|FG000|Overall Study|Entry Criteria Not Met|2|||
105444938|NCT00377858|363635059|FG001|Overall Study|Entry Criteria Not Met|0|||
105444939|NCT00377858|363635058|FG000|Overall Study|Sponsor Decision|1|||
105444940|NCT00377858|363635059|FG001|Overall Study|Sponsor Decision|2|||
105444941|NCT00377858|363635058|FG000|Overall Study|Death|0|||
105444942|NCT00377858|363635059|FG001|Overall Study|Death|3|||
105444943|NCT00517361|363635060|FG000|Overall Study|Death|6|||
105444944|NCT00517361|363635060|FG000|Overall Study|The study was terminated|5|||
105444945|NCT02073682|363635064|FG000|Overall Study|Low Creatinine Clearance|1|||
105444946|NCT02073682|363635065|FG001|Overall Study|Low Creatinine Clearance|2|||
105444947|NCT02073682|363635064|FG000|Overall Study|Death|86|||
105444948|NCT02073682|363635065|FG001|Overall Study|Death|100|||
105444949|NCT02073682|363635064|FG000|Overall Study|Cancer Cured|10|||
105444950|NCT02073682|363635065|FG001|Overall Study|Cancer Cured|15|||
105444951|NCT02073682|363635064|FG000|Overall Study|ID: Patient Noncompliance|1|||
105444952|NCT02073682|363635065|FG001|Overall Study|ID: Patient Noncompliance|2|||
105444953|NCT02073682|363635064|FG000|Overall Study|ID: Palliative Treatment Only|10|||
105444954|NCT02073682|363635065|FG001|Overall Study|ID: Palliative Treatment Only|7|||
105444955|NCT02073682|363635064|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
105444956|NCT02073682|363635065|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
105444957|NCT02073682|363635064|FG000|Overall Study|Platelet Count <50,000/mL|1|||
105444958|NCT02073682|363635065|FG001|Overall Study|Platelet Count <50,000/mL|2|||
105444959|NCT02073682|363635064|FG000|Overall Study|Surgery/Medical Procedure|3|||
105444960|NCT02073682|363635065|FG001|Overall Study|Surgery/Medical Procedure|1|||
105444961|NCT02073682|363635064|FG000|Overall Study|Withdrawal by Subject|6|||
105444962|NCT02073682|363635065|FG001|Overall Study|Withdrawal by Subject|8|||
105444963|NCT02073682|363635064|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
105444964|NCT02073682|363635065|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
105444965|NCT02073682|363635064|FG000|Overall Study|Cancer Progression|53|||
105444966|NCT02073682|363635065|FG001|Overall Study|Cancer Progression|33|||
105444967|NCT02073682|363635064|FG000|Overall Study|Protocol Violation|1|||
105444968|NCT02073682|363635065|FG001|Overall Study|Protocol Violation|0|||
105444969|NCT02073682|363635064|FG000|Overall Study|Adverse Event|79|||
105444970|NCT02073682|363635065|FG001|Overall Study|Adverse Event|62|||
105444971|NCT02073682|363635064|FG000|Overall Study|No reason provided|11|||
105444972|NCT02073682|363635065|FG001|Overall Study|No reason provided|9|||
105444973|NCT02073682|363635064|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
105444974|NCT02073682|363635065|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
105444975|NCT02073682|363635064|FG000|Overall Study|Lost to Follow-up|1|||
105444976|NCT02073682|363635065|FG001|Overall Study|Lost to Follow-up|1|||
105444977|NCT02073682|363635064|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
105444978|NCT02073682|363635065|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
105444979|NCT03461146|363635066|FG000|Overall Study|Adverse Event|2|||
105444980|NCT03461146|363635066|FG000|Overall Study|Physician Decision|1|||
105444981|NCT00855816|363635067|FG000|Overall Study|Withdrawal by Subject|22|||
105444982|NCT00855816|363635068|FG001|Overall Study|Withdrawal by Subject|15|||
105444983|NCT00855816|363635067|FG000|Overall Study|Lost to Follow-up|3|||
105444984|NCT00855816|363635068|FG001|Overall Study|Lost to Follow-up|5|||
105444985|NCT00855816|363635067|FG000|Overall Study|Death|1|||
105444986|NCT00855816|363635068|FG001|Overall Study|Death|0|||
105444987|NCT00855816|363635067|FG000|Overall Study|Became ineligible|0|||
105444988|NCT00855816|363635068|FG001|Overall Study|Became ineligible|1|||
105444989|NCT01076036|363635069|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
105444990|NCT00837213|363635070|FG000|Overall Study|Lost to Follow-up|3|||
105444991|NCT00837213|363635071|FG001|Overall Study|Lost to Follow-up|2|||
105444992|NCT00837213|363635070|FG000|Overall Study|Withdrawal by Subject|2|||
105444993|NCT00837213|363635071|FG001|Overall Study|Withdrawal by Subject|2|||
105444994|NCT00837213|363635070|FG000|Overall Study|not stated|1|||
105444995|NCT00837213|363635071|FG001|Overall Study|not stated|1|||
105444996|NCT02855268|363635072|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
105444997|NCT02855268|363635073|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
105444998|NCT02855268|363635072|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
105444999|NCT02855268|363635073|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
105445000|NCT02855268|363635072|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
105445001|NCT02855268|363635073|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
105445002|NCT02855268|363635072|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
105445003|NCT02855268|363635073|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
105445004|NCT02855268|363635072|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
105445005|NCT02855268|363635073|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
105445006|NCT02855268|363635072|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
105445007|NCT02855268|363635073|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
105445008|NCT04181762|363635081|FG000|Overall Study|Adverse Event|1|||
105445009|NCT04181762|363635082|FG001|Overall Study|Adverse Event|3|||
105445010|NCT04181762|363635081|FG000|Overall Study|Lost to Follow-up|1|||
105445011|NCT04181762|363635082|FG001|Overall Study|Lost to Follow-up|1|||
105445012|NCT04181762|363635081|FG000|Overall Study|Physician Decision|1|||
105445013|NCT04181762|363635082|FG001|Overall Study|Physician Decision|3|||
105445014|NCT04181762|363635081|FG000|Overall Study|Pregnancy|0|||
105445015|NCT04181762|363635082|FG001|Overall Study|Pregnancy|1|||
105445016|NCT04181762|363635081|FG000|Overall Study|Lack of Efficacy|2|||
105445017|NCT04181762|363635082|FG001|Overall Study|Lack of Efficacy|2|||
105445018|NCT04181762|363635081|FG000|Overall Study|Study terminated by sponsor|95|||
105781725|NCT00313716|364854825|FG002|Overall Study|Withdrawal by Subject|1|||
105445019|NCT04181762|363635082|FG001|Overall Study|Study terminated by sponsor|97|||
105445020|NCT04181762|363635081|FG000|Overall Study|Subject decision|11|||
105445021|NCT04181762|363635082|FG001|Overall Study|Subject decision|4|||
105445022|NCT04181762|363635081|FG000|Overall Study|Death|1|||
105445023|NCT04181762|363635082|FG001|Overall Study|Death|1|||
105445024|NCT04181762|363635081|FG000|Overall Study|Protocol deviation|1|||
105445025|NCT04181762|363635082|FG001|Overall Study|Protocol deviation|0|||
105445026|NCT04181762|363635081|FG000|Overall Study|Withdrawal of informed consent|1|||
105445027|NCT04181762|363635082|FG001|Overall Study|Withdrawal of informed consent|3|||
105445028|NCT01219985|363635083|FG000|Overall Study|Physician Decision|20|||
105445029|NCT01514201|363635089|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
105445030|NCT01514201|363635090|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
105445031|NCT01514201|363635091|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
105445032|NCT01514201|363635092|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
105445033|NCT01514201|363635089|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
105445034|NCT01514201|363635090|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
105445035|NCT01514201|363635091|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
105445036|NCT01514201|363635092|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
105445037|NCT01514201|363635089|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
105445038|NCT01514201|363635090|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
105445039|NCT01514201|363635091|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
105445040|NCT01514201|363635092|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
105445041|NCT01514201|363635089|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
105445042|NCT01514201|363635090|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
105445043|NCT01514201|363635091|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
105445044|NCT01514201|363635092|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
105445045|NCT01514201|363635089|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
105445046|NCT01514201|363635090|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
105445047|NCT01514201|363635091|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
105445048|NCT01514201|363635092|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
105445049|NCT01514201|363635089|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
105445050|NCT01514201|363635090|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
105445051|NCT01514201|363635091|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
105445052|NCT01514201|363635092|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
105445053|NCT01514201|363635089|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
105445054|NCT01514201|363635090|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
105445055|NCT01514201|363635091|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
105445056|NCT01514201|363635092|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
105445057|NCT01514201|363635089|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
105445058|NCT01514201|363635090|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
105445059|NCT01514201|363635091|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
105445060|NCT01514201|363635092|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
105445061|NCT01514201|363635089|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
105445062|NCT01514201|363635090|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
105445063|NCT01514201|363635091|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
105445064|NCT01514201|363635092|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
105445065|NCT01514201|363635089|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
105445066|NCT01514201|363635090|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
105445067|NCT01514201|363635091|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
105445068|NCT01514201|363635092|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
105445069|NCT01514201|363635089|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
105445070|NCT01514201|363635090|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
105445071|NCT01514201|363635091|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
105445072|NCT01514201|363635092|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
105445073|NCT01514201|363635089|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
105445074|NCT01514201|363635090|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
105445075|NCT01514201|363635091|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
105445076|NCT01514201|363635092|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
105445077|NCT05888181|363635093|FG000|Overall Study|Lost to Follow-up|1|||
105445078|NCT05888181|363635094|FG001|Overall Study|Lost to Follow-up|1|||
105445079|NCT05888181|363635095|FG002|Overall Study|Lost to Follow-up|0|||
105445080|NCT00577824|363635107|FG000|Overall Study|Adverse Event|6|||
105445081|NCT00577824|363635108|FG001|Overall Study|Adverse Event|18|||
105445082|NCT00577824|363635109|FG002|Overall Study|Adverse Event|1|||
105445083|NCT00577824|363635107|FG000|Overall Study|Patient decision|0|||
105445084|NCT00577824|363635108|FG001|Overall Study|Patient decision|1|||
105445085|NCT00577824|363635109|FG002|Overall Study|Patient decision|1|||
105445086|NCT00577824|363635107|FG000|Overall Study|Protocol Violation|1|||
105445087|NCT00577824|363635108|FG001|Overall Study|Protocol Violation|1|||
105445088|NCT00577824|363635109|FG002|Overall Study|Protocol Violation|0|||
105445089|NCT00836186|363635110|FG000|Overall Study|Blood could not be drawn|1|||
105445090|NCT04137731|363635111|FG000|Overall Study|Surgery Cancellation|1|||
105445091|NCT04137731|363635112|FG001|Overall Study|Surgery Cancellation|2|||
105445092|NCT04137731|363635111|FG000|Overall Study|Withdrawal by Subject|2|||
105445093|NCT04137731|363635112|FG001|Overall Study|Withdrawal by Subject|0|||
105335950|NCT00661609|363231335|FG000|Overall Study|Disease progression|3|||
105335951|NCT01981954|363231342|FG000|Titration Period|Protocol Deviation|1|||
105445094|NCT04137731|363635111|FG000|Overall Study|Protocol Violation|0|||
105445095|NCT04137731|363635112|FG001|Overall Study|Protocol Violation|1|||
105445096|NCT02717611|363635125|FG000|Overall Study|Death|13|||
105445097|NCT02717611|363635125|FG000|Overall Study|Withdrawal by Subject|6|||
105445098|NCT02717611|363635125|FG000|Overall Study|Active, not recruiting|40|||
105445099|NCT02717611|363635125|FG000|Overall Study|Complicating disease|1|||
105445100|NCT01587040|363635126|FG000|Overall Study|Protocol Violation|0|||
105445101|NCT01587040|363635127|FG001|Overall Study|Protocol Violation|0|||
105445102|NCT01587040|363635128|FG002|Overall Study|Protocol Violation|1|||
105445103|NCT01587040|363635129|FG003|Overall Study|Protocol Violation|0|||
105445104|NCT01587040|363635126|FG000|Overall Study|Adverse Event|0|||
105445105|NCT01587040|363635127|FG001|Overall Study|Adverse Event|1|||
105445106|NCT01587040|363635128|FG002|Overall Study|Adverse Event|10|||
105445107|NCT01587040|363635129|FG003|Overall Study|Adverse Event|0|||
105445108|NCT01587040|363635126|FG000|Overall Study|Disease progression|12|||
105445109|NCT01587040|363635127|FG001|Overall Study|Disease progression|1|||
105445110|NCT01587040|363635128|FG002|Overall Study|Disease progression|15|||
105445111|NCT01587040|363635129|FG003|Overall Study|Disease progression|3|||
105445112|NCT01587040|363635126|FG000|Overall Study|Other than specified|5|||
105445113|NCT01587040|363635127|FG001|Overall Study|Other than specified|1|||
105445114|NCT01587040|363635128|FG002|Overall Study|Other than specified|11|||
105445115|NCT01587040|363635129|FG003|Overall Study|Other than specified|1|||
105445116|NCT03724890|363635130|FG000|Overall Study|Death|2|||
105445117|NCT03724890|363635131|FG001|Overall Study|Death|6|||
105445118|NCT03724890|363635132|FG002|Overall Study|Death|3|||
105445119|NCT03724890|363635133|FG003|Overall Study|Death|5|||
105445120|NCT03724890|363635134|FG004|Overall Study|Death|2|||
105445121|NCT03724890|363635135|FG005|Overall Study|Death|0|||
105445122|NCT03724890|363635136|FG006|Overall Study|Death|2|||
105445123|NCT03724890|363635137|FG007|Overall Study|Death|3|||
105445124|NCT03724890|363635138|FG008|Overall Study|Death|4|||
105445125|NCT03724890|363635139|FG009|Overall Study|Death|2|||
105445126|NCT03724890|363635140|FG010|Overall Study|Death|2|||
105445127|NCT03724890|363635130|FG000|Overall Study|Lost to Follow-up|0|||
105445128|NCT03724890|363635131|FG001|Overall Study|Lost to Follow-up|3|||
105445129|NCT03724890|363635132|FG002|Overall Study|Lost to Follow-up|0|||
105445130|NCT03724890|363635133|FG003|Overall Study|Lost to Follow-up|1|||
105445131|NCT03724890|363635134|FG004|Overall Study|Lost to Follow-up|2|||
105445132|NCT03724890|363635135|FG005|Overall Study|Lost to Follow-up|2|||
105445133|NCT03724890|363635136|FG006|Overall Study|Lost to Follow-up|1|||
105445134|NCT03724890|363635137|FG007|Overall Study|Lost to Follow-up|0|||
105445135|NCT03724890|363635138|FG008|Overall Study|Lost to Follow-up|2|||
105445136|NCT03724890|363635139|FG009|Overall Study|Lost to Follow-up|0|||
105445137|NCT03724890|363635140|FG010|Overall Study|Lost to Follow-up|0|||
105445138|NCT03724890|363635130|FG000|Overall Study|Withdrawal by Subject|1|||
105445139|NCT03724890|363635131|FG001|Overall Study|Withdrawal by Subject|2|||
105445140|NCT03724890|363635132|FG002|Overall Study|Withdrawal by Subject|1|||
105445141|NCT03724890|363635133|FG003|Overall Study|Withdrawal by Subject|0|||
105445142|NCT03724890|363635134|FG004|Overall Study|Withdrawal by Subject|0|||
105445143|NCT03724890|363635135|FG005|Overall Study|Withdrawal by Subject|1|||
105445144|NCT03724890|363635136|FG006|Overall Study|Withdrawal by Subject|0|||
105445145|NCT03724890|363635137|FG007|Overall Study|Withdrawal by Subject|0|||
105445146|NCT03724890|363635138|FG008|Overall Study|Withdrawal by Subject|2|||
105445147|NCT03724890|363635139|FG009|Overall Study|Withdrawal by Subject|2|||
105445148|NCT03724890|363635140|FG010|Overall Study|Withdrawal by Subject|1|||
105445149|NCT03724890|363635130|FG000|Overall Study|Other|1|||
105445150|NCT03724890|363635131|FG001|Overall Study|Other|0|||
105445151|NCT03724890|363635132|FG002|Overall Study|Other|0|||
105445152|NCT03724890|363635133|FG003|Overall Study|Other|0|||
105445153|NCT03724890|363635134|FG004|Overall Study|Other|0|||
105445154|NCT03724890|363635135|FG005|Overall Study|Other|0|||
105445155|NCT03724890|363635136|FG006|Overall Study|Other|0|||
105445156|NCT03724890|363635137|FG007|Overall Study|Other|1|||
105445157|NCT03724890|363635138|FG008|Overall Study|Other|1|||
105445158|NCT03724890|363635139|FG009|Overall Study|Other|0|||
105445159|NCT03724890|363635140|FG010|Overall Study|Other|2|||
105445160|NCT04765202|363635145|FG000|Overall Study|Lost to Follow-up|1|||
105445161|NCT04765202|363635146|FG001|Overall Study|Lost to Follow-up|1|||
105445162|NCT04765202|363635147|FG002|Overall Study|Lost to Follow-up|2|||
105445163|NCT04765202|363635148|FG003|Overall Study|Lost to Follow-up|2|||
105445164|NCT04765202|363635145|FG000|Overall Study|Physician Decision|0|||
105445165|NCT04765202|363635146|FG001|Overall Study|Physician Decision|0|||
105445166|NCT04765202|363635147|FG002|Overall Study|Physician Decision|1|||
105445167|NCT04765202|363635148|FG003|Overall Study|Physician Decision|1|||
105445168|NCT05715242|363635149|FG000|Overall Study|Lost to Follow-up|0|||
105445169|NCT05715242|363635150|FG001|Overall Study|Lost to Follow-up|0|||
105445170|NCT05715242|363635151|FG002|Overall Study|Lost to Follow-up|1|||
105445171|NCT05715242|363635152|FG003|Overall Study|Lost to Follow-up|0|||
105445172|NCT05715242|363635153|FG004|Overall Study|Lost to Follow-up|0|||
105445173|NCT05715242|363635154|FG005|Overall Study|Lost to Follow-up|1|||
105445174|NCT05715242|363635155|FG006|Overall Study|Lost to Follow-up|0|||
105445175|NCT05715242|363635156|FG007|Overall Study|Lost to Follow-up|0|||
105445176|NCT05715242|363635157|FG008|Overall Study|Lost to Follow-up|0|||
105445177|NCT05715242|363635158|FG009|Overall Study|Lost to Follow-up|0|||
105445178|NCT05715242|363635159|FG010|Overall Study|Lost to Follow-up|0|||
105445179|NCT05715242|363635160|FG011|Overall Study|Lost to Follow-up|0|||
105445180|NCT05715242|363635161|FG012|Overall Study|Lost to Follow-up|0|||
105445181|NCT05715242|363635162|FG013|Overall Study|Lost to Follow-up|0|||
105445182|NCT05715242|363635163|FG014|Overall Study|Lost to Follow-up|0|||
105445183|NCT05715242|363635164|FG015|Overall Study|Lost to Follow-up|0|||
105445184|NCT00048347|363635170|FG000|Overall Study|Screen failure|2|||
105445185|NCT02343406|363635171|FG000|Overall Study|Progressive disease|72|||
105445186|NCT02343406|363635172|FG001|Overall Study|Progressive disease|70|||
105445187|NCT02343406|363635173|FG002|Overall Study|Progressive disease|43|||
105445188|NCT02343406|363635174|FG003|Overall Study|Progressive disease|15|||
105445189|NCT02343406|363635175|FG004|Overall Study|Progressive disease|5|||
105445190|NCT02343406|363635171|FG000|Overall Study|Adverse Event|6|||
105445191|NCT02343406|363635172|FG001|Overall Study|Adverse Event|8|||
105445192|NCT02343406|363635173|FG002|Overall Study|Adverse Event|6|||
105445193|NCT02343406|363635174|FG003|Overall Study|Adverse Event|3|||
105445194|NCT02343406|363635175|FG004|Overall Study|Adverse Event|0|||
105445195|NCT02343406|363635171|FG000|Overall Study|Withdrawal by Subject|6|||
105445196|NCT02343406|363635172|FG001|Overall Study|Withdrawal by Subject|4|||
105445197|NCT02343406|363635173|FG002|Overall Study|Withdrawal by Subject|8|||
105445198|NCT02343406|363635174|FG003|Overall Study|Withdrawal by Subject|3|||
105445199|NCT02343406|363635175|FG004|Overall Study|Withdrawal by Subject|0|||
105445200|NCT02343406|363635171|FG000|Overall Study|Death|2|||
105445201|NCT02343406|363635172|FG001|Overall Study|Death|1|||
105445202|NCT02343406|363635173|FG002|Overall Study|Death|0|||
105445203|NCT02343406|363635174|FG003|Overall Study|Death|0|||
105445204|NCT02343406|363635175|FG004|Overall Study|Death|0|||
105445205|NCT02343406|363635171|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
105445206|NCT02343406|363635172|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
105445207|NCT02343406|363635173|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
105445208|NCT02343406|363635174|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
105445209|NCT02343406|363635175|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
105445210|NCT02343406|363635171|FG000|Overall Study|Other primary malignancy|0|||
105445211|NCT02343406|363635172|FG001|Overall Study|Other primary malignancy|1|||
105445212|NCT02343406|363635173|FG002|Overall Study|Other primary malignancy|0|||
105445213|NCT02343406|363635174|FG003|Overall Study|Other primary malignancy|0|||
105445214|NCT02343406|363635175|FG004|Overall Study|Other primary malignancy|0|||
105445215|NCT02343406|363635171|FG000|Overall Study|Other, not specified|2|||
105445216|NCT02343406|363635172|FG001|Overall Study|Other, not specified|1|||
105445217|NCT02343406|363635173|FG002|Overall Study|Other, not specified|1|||
105445218|NCT02343406|363635174|FG003|Overall Study|Other, not specified|4|||
105445219|NCT02343406|363635175|FG004|Overall Study|Other, not specified|0|||
105445220|NCT02119663|363635176|FG000|Overall Study|Disease progression|26|||
105445221|NCT02119663|363635177|FG001|Overall Study|Disease progression|27|||
105445222|NCT02119663|363635176|FG000|Overall Study|Adverse Event|5|||
105445223|NCT02119663|363635177|FG001|Overall Study|Adverse Event|5|||
105445224|NCT02119663|363635176|FG000|Overall Study|Death|3|||
105445225|NCT02119663|363635177|FG001|Overall Study|Death|2|||
105445226|NCT02119663|363635176|FG000|Overall Study|Physician Decision|1|||
105445227|NCT02119663|363635177|FG001|Overall Study|Physician Decision|2|||
105445228|NCT02119663|363635176|FG000|Overall Study|Other unspecified|2|||
105445229|NCT02119663|363635177|FG001|Overall Study|Other unspecified|0|||
105445230|NCT02119663|363635176|FG000|Overall Study|Subject decision|0|||
105445231|NCT02119663|363635177|FG001|Overall Study|Subject decision|1|||
105445232|NCT02119663|363635176|FG000|Overall Study|Study Terminated by the Sponsor|3|||
105445233|NCT02119663|363635177|FG001|Overall Study|Study Terminated by the Sponsor|4|||
105445234|NCT00604695|363635178|FG000|Overall Study|Did not receive first bolus.|0|||
105445235|NCT00604695|363635179|FG001|Overall Study|Did not receive first bolus.|4|||
105445236|NCT01123395|363635182|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
105445237|NCT01123395|363635183|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
105445238|NCT03691571|363635184|FG000|Overall Study|Withdrawal by Subject|9|||
105445239|NCT03691571|363635185|FG001|Overall Study|Withdrawal by Subject|2|||
105445240|NCT00584012|363637389|FG000|Overall Study|Withdrawal by Subject|1|||
105445241|NCT04404556|363637390|FG000|Intervention|Withdrawal by Subject|15|||
105445242|NCT04404556|363637391|FG001|Intervention|Withdrawal by Subject|3|||
105445243|NCT04404556|363637390|FG000|Intervention|Did not complete all intervention sessions|2|||
105445244|NCT04404556|363637391|FG001|Intervention|Did not complete all intervention sessions|1|||
105445245|NCT04404556|363637390|FG000|Post-Intervention|Missing Data|1|||
105445246|NCT04404556|363637391|FG001|Post-Intervention|Missing Data|2|||
105445247|NCT04404556|363637390|FG000|Follow-up 1|Withdrawal by Subject|5|||
105445248|NCT04404556|363637391|FG001|Follow-up 1|Withdrawal by Subject|1|||
105445249|NCT04404556|363637390|FG000|Follow-up 1|Missing Data|4|||
105445250|NCT04404556|363637391|FG001|Follow-up 1|Missing Data|7|||
105445251|NCT04404556|363637390|FG000|Follow-up 2|Withdrawal by Subject|1|||
105445252|NCT04404556|363637391|FG001|Follow-up 2|Withdrawal by Subject|1|||
105445253|NCT04404556|363637390|FG000|Follow-up 2|Missing Data|6|||
105445254|NCT04404556|363637391|FG001|Follow-up 2|Missing Data|5|||
105445255|NCT02333799|363637392|FG000|Treatment Period|Withdrawal by Subject|1|||
105445256|NCT02333799|363637392|FG000|Treatment Period|Death|6|||
105445257|NCT02333799|363637392|FG000|6 Month Follow Up Period|Physician Decision|1|||
105445258|NCT02333799|363637392|FG000|6 Month Follow Up Period|Death|1|||
105445259|NCT02333799|363637392|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
105445260|NCT02333799|363637392|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
105445261|NCT02451943|363637394|FG000|Overall Study|Withdrawal by Subject|13|||
105445262|NCT02451943|363637395|FG001|Overall Study|Withdrawal by Subject|16|||
105445263|NCT02451943|363637394|FG000|Overall Study|Lost to Follow-up|3|||
105445264|NCT02451943|363637395|FG001|Overall Study|Lost to Follow-up|4|||
105445265|NCT02451943|363637394|FG000|Overall Study|Sponsor Decision|0|||
105445266|NCT02451943|363637395|FG001|Overall Study|Sponsor Decision|4|||
105445267|NCT00368641|363637396|FG000|Overall Study|Adverse Event|2|||
105445268|NCT00368641|363637397|FG001|Overall Study|Adverse Event|1|||
105445269|NCT00368641|363637396|FG000|Overall Study|Death|1|||
105445270|NCT00368641|363637397|FG001|Overall Study|Death|0|||
105445271|NCT00368641|363637396|FG000|Overall Study|Withdrawal by Subject|1|||
105445272|NCT00368641|363637397|FG001|Overall Study|Withdrawal by Subject|0|||
105445273|NCT00368641|363637396|FG000|Overall Study|Sponsor decision to terminate study|2|||
105445274|NCT00368641|363637397|FG001|Overall Study|Sponsor decision to terminate study|5|||
105445275|NCT00799266|363637400|FG000|Overall Study|Adverse Event|0|||
105445276|NCT00799266|363637401|FG001|Overall Study|Adverse Event|1|||
105445277|NCT00799266|363637400|FG000|Overall Study|Subject withdrew consent|3|||
105445278|NCT00799266|363637401|FG001|Overall Study|Subject withdrew consent|0|||
105445279|NCT04809285|363637407|FG000|Phase 1|Lost to Follow-up|6|||
105445280|NCT04809285|363637407|FG000|Phase 1|Protocol Violation|2|||
105445281|NCT04809285|363637407|FG000|Phase 1|Physician Decision|3|||
105445282|NCT04809285|363637407|FG000|Phase 1|Withdrawal by Subject|29|||
105445283|NCT04809285|363637407|FG000|Phase 2|Protocol Violation|3|||
105445284|NCT04809285|363637407|FG000|Phase 2|Withdrawal by Subject|4|||
105445285|NCT02974257|363637410|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
105445286|NCT02974257|363637411|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
105445287|NCT02974257|363637410|FG000|Overall Study|Clinical indication for thiamine|1|||
105445288|NCT02974257|363637411|FG001|Overall Study|Clinical indication for thiamine|0|||
105445289|NCT02974257|363637410|FG000|Overall Study|Already on thiamine|1|||
105445290|NCT02974257|363637411|FG001|Overall Study|Already on thiamine|0|||
105445291|NCT02974257|363637410|FG000|Overall Study|Extubated prior to study drug|0|||
105445292|NCT02974257|363637411|FG001|Overall Study|Extubated prior to study drug|1|||
105445293|NCT02974257|363637410|FG000|Overall Study|Death|0|||
105445294|NCT02974257|363637411|FG001|Overall Study|Death|1|||
105445295|NCT01449006|363637412|FG000|Overall Study|Lost to Follow-up|1|||
105445296|NCT01449006|363637413|FG001|Overall Study|Lost to Follow-up|0|||
105445297|NCT01449006|363637412|FG000|Overall Study|Withdrawal by Subject|1|||
105445298|NCT01449006|363637413|FG001|Overall Study|Withdrawal by Subject|0|||
105445299|NCT01449006|363637412|FG000|Overall Study|Protocol Violation|1|||
105445300|NCT01449006|363637413|FG001|Overall Study|Protocol Violation|0|||
105445301|NCT02114606|363637414|FG000|Overall Study|Unable to swallow Cytosponge|6|||
105445302|NCT04421482|363637415|FG000|Overall Study|Physician Decision|1|||
105445303|NCT02128724|363637418|FG000|Overall Study|Death|1|||
105445304|NCT02128724|363637419|FG001|Overall Study|Death|0|||
105445305|NCT02128724|363637420|FG002|Overall Study|Death|0|||
105445306|NCT02128724|363637421|FG003|Overall Study|Death|0|||
105445307|NCT02128724|363637418|FG000|Overall Study|Adverse Event|0|||
105445308|NCT02128724|363637419|FG001|Overall Study|Adverse Event|1|||
105445309|NCT02128724|363637420|FG002|Overall Study|Adverse Event|0|||
105445310|NCT02128724|363637421|FG003|Overall Study|Adverse Event|0|||
105445311|NCT02128724|363637418|FG000|Overall Study|Physician Decision|0|||
105445312|NCT02128724|363637419|FG001|Overall Study|Physician Decision|0|||
105445313|NCT02128724|363637420|FG002|Overall Study|Physician Decision|0|||
105445314|NCT02128724|363637421|FG003|Overall Study|Physician Decision|2|||
105445315|NCT02128724|363637418|FG000|Overall Study|Withdrawal by Subject|0|||
105445316|NCT02128724|363637419|FG001|Overall Study|Withdrawal by Subject|0|||
105445317|NCT02128724|363637420|FG002|Overall Study|Withdrawal by Subject|0|||
105445318|NCT02128724|363637421|FG003|Overall Study|Withdrawal by Subject|1|||
105445319|NCT04720417|363637424|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
105445320|NCT04273893|363637425|FG000|Overall Study|Withdrawal by Subject|0|||
105445321|NCT04273893|363637426|FG001|Overall Study|Withdrawal by Subject|2|||
105445322|NCT04273893|363637425|FG000|Overall Study|Treatment of Disease Progression|0|||
105445323|NCT04273893|363637426|FG001|Overall Study|Treatment of Disease Progression|2|||
105445324|NCT04273893|363637425|FG000|Overall Study|Death|1|||
105445325|NCT04273893|363637426|FG001|Overall Study|Death|2|||
105445326|NCT04273893|363637425|FG000|Overall Study|Lost to Follow-up|0|||
105445327|NCT04273893|363637426|FG001|Overall Study|Lost to Follow-up|2|||
105445328|NCT04273893|363637425|FG000|Overall Study|Physician Decision|1|||
105445329|NCT04273893|363637426|FG001|Overall Study|Physician Decision|0|||
105445330|NCT03906071|363637427|FG000|Overall Study|Death|180|||
105445331|NCT03906071|363637428|FG001|Overall Study|Death|185|||
105445332|NCT03906071|363637427|FG000|Overall Study|Lost to Follow-up|3|||
105445333|NCT03906071|363637428|FG001|Overall Study|Lost to Follow-up|3|||
105445334|NCT03906071|363637427|FG000|Overall Study|Withdrawal by Subject|15|||
105445335|NCT03906071|363637428|FG001|Overall Study|Withdrawal by Subject|27|||
105445336|NCT03906071|363637427|FG000|Overall Study|Other|2|||
105445337|NCT03906071|363637428|FG001|Overall Study|Other|1|||
105445338|NCT03574779|363637429|FG000|Overall Study|Screening failure|13|||
105445339|NCT03574779|363637430|FG001|Overall Study|Screening failure|83|||
105445340|NCT00381693|363637432|FG000|Overall Study|Death|1|||
105445341|NCT00381693|363637432|FG000|Overall Study|Adverse Event|4|||
105445342|NCT00381693|363637432|FG000|Overall Study|Patient Choice|1|||
105445343|NCT00381693|363637432|FG000|Overall Study|Progression|2|||
105445344|NCT04669301|363637433|FG000|Overall Study|Lost to Follow-up|0|||
105445345|NCT04669301|363637434|FG001|Overall Study|Lost to Follow-up|1|||
105445346|NCT04669301|363637435|FG002|Overall Study|Lost to Follow-up|0|||
105445347|NCT04669301|363637433|FG000|Overall Study|Withdrawal by Subject|3|||
105445348|NCT04669301|363637434|FG001|Overall Study|Withdrawal by Subject|2|||
105445349|NCT04669301|363637435|FG002|Overall Study|Withdrawal by Subject|0|||
105445350|NCT00637416|363637436|FG000|Overall Study|Lost to Follow-up|1|||
105445351|NCT00637416|363637437|FG001|Overall Study|Lost to Follow-up|1|||
105445352|NCT00637416|363637436|FG000|Overall Study|Unable to take study drug|0|||
105445353|NCT00637416|363637437|FG001|Overall Study|Unable to take study drug|1|||
105445354|NCT04531241|363637442|FG000|Period 1|Withdrawal by Subject|2|||
105445355|NCT04531241|363637443|FG001|Period 1|Withdrawal by Subject|0|||
105445356|NCT04531241|363637442|FG000|Period 1|Dispesed incorrect lens power|1|||
105445357|NCT04531241|363637443|FG001|Period 1|Dispesed incorrect lens power|0|||
105445358|NCT04531241|363637442|FG000|Period 1|Protocol Violation|1|||
105445359|NCT04531241|363637443|FG001|Period 1|Protocol Violation|0|||
105445360|NCT04531241|363637442|FG000|Period 1|No longer eligible|0|||
105445361|NCT04531241|363637443|FG001|Period 1|No longer eligible|1|||
105445362|NCT04531241|363637442|FG000|Period 1|Lens Discomfort|0|||
105445363|NCT04531241|363637443|FG001|Period 1|Lens Discomfort|1|||
105445364|NCT04531241|363637442|FG000|Period 2|Covid-19 Related|1|||
105445365|NCT04531241|363637443|FG001|Period 2|Covid-19 Related|1|||
105445366|NCT00310817|363637444|FG000|Overall Study|AE or Death|3|||
105445367|NCT00310817|363637445|FG001|Overall Study|AE or Death|1|||
105445368|NCT00310817|363637446|FG002|Overall Study|AE or Death|0|||
105445369|NCT00310817|363637447|FG003|Overall Study|AE or Death|0|||
105445370|NCT00310817|363637444|FG000|Overall Study|Withdrawal by Subject|1|||
105445371|NCT00310817|363637445|FG001|Overall Study|Withdrawal by Subject|4|||
105445372|NCT00310817|363637446|FG002|Overall Study|Withdrawal by Subject|6|||
105445373|NCT00310817|363637447|FG003|Overall Study|Withdrawal by Subject|7|||
105445374|NCT00310817|363637444|FG000|Overall Study|Lost to Follow-up|2|||
105445375|NCT00310817|363637445|FG001|Overall Study|Lost to Follow-up|1|||
105445376|NCT00310817|363637446|FG002|Overall Study|Lost to Follow-up|0|||
105445377|NCT00310817|363637447|FG003|Overall Study|Lost to Follow-up|0|||
105445378|NCT00310817|363637444|FG000|Overall Study|Inappropriate Enrollment|1|||
105445379|NCT00310817|363637445|FG001|Overall Study|Inappropriate Enrollment|0|||
105445380|NCT00310817|363637446|FG002|Overall Study|Inappropriate Enrollment|1|||
105445381|NCT00310817|363637447|FG003|Overall Study|Inappropriate Enrollment|0|||
105445382|NCT00310817|363637444|FG000|Overall Study|Protocol Violation|1|||
105445383|NCT00310817|363637445|FG001|Overall Study|Protocol Violation|1|||
105445384|NCT00310817|363637446|FG002|Overall Study|Protocol Violation|1|||
105445385|NCT00310817|363637447|FG003|Overall Study|Protocol Violation|1|||
105445386|NCT00310817|363637444|FG000|Overall Study|Unable to classify|3|||
105445387|NCT00310817|363637445|FG001|Overall Study|Unable to classify|1|||
105445388|NCT00310817|363637446|FG002|Overall Study|Unable to classify|0|||
105445389|NCT00310817|363637447|FG003|Overall Study|Unable to classify|0|||
105445390|NCT01518374|363637448|FG000|Overall Study|Withdrawal by Subject|2|||
105445391|NCT01518374|363637448|FG000|Overall Study|Protocol Violation|3|||
105445392|NCT01518374|363637448|FG000|Overall Study|Lost to Follow-up|2|||
105445393|NCT04607837|363637450|FG000|Overall Study|Adverse Event|8|||
105445394|NCT04607837|363637451|FG001|Overall Study|Adverse Event|2|||
105445395|NCT04607837|363637450|FG000|Overall Study|Withdrawal by Subject|8|||
105445396|NCT04607837|363637451|FG001|Overall Study|Withdrawal by Subject|7|||
105445397|NCT04607837|363637450|FG000|Overall Study|Physician Decision|2|||
105445398|NCT04607837|363637451|FG001|Overall Study|Physician Decision|0|||
105445399|NCT04607837|363637450|FG000|Overall Study|Lack of Efficacy|2|||
105445400|NCT04607837|363637451|FG001|Overall Study|Lack of Efficacy|0|||
105445401|NCT04607837|363637450|FG000|Overall Study|Participant terminated by sponsor|1|||
105445402|NCT04607837|363637451|FG001|Overall Study|Participant terminated by sponsor|0|||
105445403|NCT04607837|363637450|FG000|Overall Study|Disease worsening|36|||
105445404|NCT04607837|363637451|FG001|Overall Study|Disease worsening|36|||
105445405|NCT04607837|363637450|FG000|Overall Study|Other|1|||
105445406|NCT04607837|363637451|FG001|Overall Study|Other|0|||
105445407|NCT02123823|363637453|FG000|Overall Study|Lack of Efficacy|0|||
105445408|NCT02123823|363637454|FG001|Overall Study|Lack of Efficacy|2|||
105445409|NCT02123823|363637455|FG002|Overall Study|Lack of Efficacy|8|||
105445410|NCT02123823|363637456|FG003|Overall Study|Lack of Efficacy|10|||
105445411|NCT02123823|363637453|FG000|Overall Study|Progressive disease|3|||
105445412|NCT02123823|363637454|FG001|Overall Study|Progressive disease|19|||
105445413|NCT02123823|363637455|FG002|Overall Study|Progressive disease|52|||
105445414|NCT02123823|363637456|FG003|Overall Study|Progressive disease|53|||
105445415|NCT02123823|363637453|FG000|Overall Study|Withdrawal by Subject|0|||
105445416|NCT02123823|363637454|FG001|Overall Study|Withdrawal by Subject|0|||
105445417|NCT02123823|363637455|FG002|Overall Study|Withdrawal by Subject|7|||
105445418|NCT02123823|363637456|FG003|Overall Study|Withdrawal by Subject|2|||
105445419|NCT02123823|363637453|FG000|Overall Study|Adverse Event|0|||
105445420|NCT02123823|363637454|FG001|Overall Study|Adverse Event|0|||
105445421|NCT02123823|363637455|FG002|Overall Study|Adverse Event|3|||
105445422|NCT02123823|363637456|FG003|Overall Study|Adverse Event|5|||
105445423|NCT03828019|363637459|FG000|Overall Study|Withdrawal by Subject|3|||
105445424|NCT03828019|363637460|FG001|Overall Study|Withdrawal by Subject|8|||
105445425|NCT03828019|363637459|FG000|Overall Study|Lost to Follow-up|1|||
105445426|NCT03828019|363637460|FG001|Overall Study|Lost to Follow-up|6|||
105445427|NCT03828019|363637459|FG000|Overall Study|Incarcerated|1|||
105445428|NCT03828019|363637460|FG001|Overall Study|Incarcerated|0|||
105445429|NCT03828019|363637459|FG000|Overall Study|Adverse Event|0|||
105445430|NCT03828019|363637460|FG001|Overall Study|Adverse Event|1|||
105445431|NCT00924443|363637461|FG000|Overall Study|Physician Decision|2|||
105445432|NCT00924443|363637461|FG000|Overall Study|Protocol Violation|1|||
105445433|NCT02863328|363637466|FG000|Overall Study|Lost to Follow-up|4|||
105445434|NCT02863328|363637467|FG001|Overall Study|Lost to Follow-up|10|||
105445435|NCT02863328|363637466|FG000|Overall Study|Withdrawal by Subject|7|||
105445436|NCT02863328|363637467|FG001|Overall Study|Withdrawal by Subject|12|||
105445437|NCT02863328|363637466|FG000|Overall Study|Died|0|||
105445438|NCT02863328|363637467|FG001|Overall Study|Died|1|||
105445439|NCT00699660|363637468|FG000|Overall Study|Lost to Follow-up|4|||
105445440|NCT00699660|363637469|FG001|Overall Study|Lost to Follow-up|2|||
105445441|NCT00699660|363637468|FG000|Overall Study|missing reports and recording failures|10|||
105445442|NCT00699660|363637469|FG001|Overall Study|missing reports and recording failures|6|||
105445443|NCT00398320|363637470|FG000|Overall Study|Death|1|||
105445444|NCT00398320|363637470|FG000|Overall Study|Adverse Event|4|||
105445445|NCT00398320|363637470|FG000|Overall Study|Physician Decision|1|||
105445446|NCT01870726|363637471|FG000|Overall Study|Withdrawal of informed consent|0|||
105445447|NCT01870726|363637472|FG001|Overall Study|Withdrawal of informed consent|0|||
105445448|NCT01870726|363637473|FG002|Overall Study|Withdrawal of informed consent|0|||
105445449|NCT01870726|363637474|FG003|Overall Study|Withdrawal of informed consent|1|||
105445450|NCT01870726|363637475|FG004|Overall Study|Withdrawal of informed consent|0|||
105445451|NCT01870726|363637476|FG005|Overall Study|Withdrawal of informed consent|0|||
105445452|NCT01870726|363637477|FG006|Overall Study|Withdrawal of informed consent|0|||
105445453|NCT01870726|363637471|FG000|Overall Study|Withdrawal by Subject|0|||
105445454|NCT01870726|363637472|FG001|Overall Study|Withdrawal by Subject|1|||
105445455|NCT01870726|363637473|FG002|Overall Study|Withdrawal by Subject|0|||
105445456|NCT01870726|363637474|FG003|Overall Study|Withdrawal by Subject|0|||
105445457|NCT01870726|363637475|FG004|Overall Study|Withdrawal by Subject|0|||
105445458|NCT01870726|363637476|FG005|Overall Study|Withdrawal by Subject|0|||
105445459|NCT01870726|363637477|FG006|Overall Study|Withdrawal by Subject|0|||
105445460|NCT01870726|363637471|FG000|Overall Study|Adverse Event|0|||
105445461|NCT01870726|363637472|FG001|Overall Study|Adverse Event|0|||
105445462|NCT01870726|363637473|FG002|Overall Study|Adverse Event|0|||
105445463|NCT01870726|363637474|FG003|Overall Study|Adverse Event|0|||
105445464|NCT01870726|363637475|FG004|Overall Study|Adverse Event|1|||
105781726|NCT00313716|364854826|FG003|Overall Study|Withdrawal by Subject|0|||
105445465|NCT01870726|363637476|FG005|Overall Study|Adverse Event|1|||
105445466|NCT01870726|363637477|FG006|Overall Study|Adverse Event|0|||
105445467|NCT01870726|363637471|FG000|Overall Study|Progressive disease|5|||
105445468|NCT01870726|363637472|FG001|Overall Study|Progressive disease|5|||
105445469|NCT01870726|363637473|FG002|Overall Study|Progressive disease|4|||
105445470|NCT01870726|363637474|FG003|Overall Study|Progressive disease|5|||
105445471|NCT01870726|363637475|FG004|Overall Study|Progressive disease|6|||
105445472|NCT01870726|363637476|FG005|Overall Study|Progressive disease|4|||
105445473|NCT01870726|363637477|FG006|Overall Study|Progressive disease|10|||
105445474|NCT01248949|363637478|FG000|Overall Study|Lost to Follow-up|2|||
105445475|NCT01248949|363637479|FG001|Overall Study|Lost to Follow-up|2|||
105445476|NCT01248949|363637480|FG002|Overall Study|Lost to Follow-up|2|||
105445477|NCT01248949|363637481|FG003|Overall Study|Lost to Follow-up|1|||
105445478|NCT01248949|363637482|FG004|Overall Study|Lost to Follow-up|0|||
105445479|NCT01248949|363637478|FG000|Overall Study|Withdrawal by Subject|5|||
105445480|NCT01248949|363637479|FG001|Overall Study|Withdrawal by Subject|3|||
105445481|NCT01248949|363637480|FG002|Overall Study|Withdrawal by Subject|11|||
105445482|NCT01248949|363637481|FG003|Overall Study|Withdrawal by Subject|3|||
105445483|NCT01248949|363637482|FG004|Overall Study|Withdrawal by Subject|1|||
105445484|NCT01248949|363637478|FG000|Overall Study|Death|22|||
105445485|NCT01248949|363637479|FG001|Overall Study|Death|7|||
105445486|NCT01248949|363637480|FG002|Overall Study|Death|21|||
105445487|NCT01248949|363637481|FG003|Overall Study|Death|6|||
105445488|NCT01248949|363637482|FG004|Overall Study|Death|2|||
105445489|NCT01248949|363637478|FG000|Overall Study|Alternative Therapy|1|||
105445490|NCT01248949|363637479|FG001|Overall Study|Alternative Therapy|0|||
105445491|NCT01248949|363637480|FG002|Overall Study|Alternative Therapy|0|||
105445492|NCT01248949|363637481|FG003|Overall Study|Alternative Therapy|0|||
105445493|NCT01248949|363637482|FG004|Overall Study|Alternative Therapy|0|||
105445494|NCT01248949|363637478|FG000|Overall Study|Alternative Therapy.|1|||
105445495|NCT01248949|363637479|FG001|Overall Study|Alternative Therapy.|0|||
105445496|NCT01248949|363637480|FG002|Overall Study|Alternative Therapy.|0|||
105445497|NCT01248949|363637481|FG003|Overall Study|Alternative Therapy.|0|||
105445498|NCT01248949|363637482|FG004|Overall Study|Alternative Therapy.|0|||
105445499|NCT01248949|363637478|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
105445500|NCT01248949|363637479|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
105445501|NCT01248949|363637480|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
105445502|NCT01248949|363637481|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
105445503|NCT01248949|363637482|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
105445504|NCT01248949|363637478|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
105445505|NCT01248949|363637479|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
105445506|NCT01248949|363637480|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
105445507|NCT01248949|363637481|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
105445508|NCT01248949|363637482|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
105445509|NCT01248949|363637478|FG000|Overall Study|Participant Went To Hospice|0|||
105445510|NCT01248949|363637479|FG001|Overall Study|Participant Went To Hospice|0|||
105445511|NCT01248949|363637480|FG002|Overall Study|Participant Went To Hospice|1|||
105445512|NCT01248949|363637481|FG003|Overall Study|Participant Went To Hospice|0|||
105445513|NCT01248949|363637482|FG004|Overall Study|Participant Went To Hospice|0|||
105445514|NCT01248949|363637478|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
105445515|NCT01248949|363637479|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
105445516|NCT01248949|363637480|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
105445517|NCT01248949|363637481|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
105445518|NCT01248949|363637482|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
105445519|NCT01248949|363637478|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
105445520|NCT01248949|363637479|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
105445521|NCT01248949|363637480|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
105445522|NCT01248949|363637481|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
105445523|NCT01248949|363637482|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
105445524|NCT01248949|363637478|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
105445525|NCT01248949|363637479|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
105445526|NCT01248949|363637480|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
105445527|NCT01248949|363637481|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
105445528|NCT01248949|363637482|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
105445529|NCT01248949|363637478|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
105445530|NCT01248949|363637479|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
105445531|NCT01248949|363637480|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
105445532|NCT01248949|363637481|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
105445533|NCT01248949|363637482|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
105445534|NCT00286429|363637483|FG000|Overall Study|Adverse Event|4|||
105445535|NCT00286429|363637484|FG001|Overall Study|Adverse Event|1|||
105445536|NCT00286429|363637485|FG002|Overall Study|Adverse Event|6|||
105445537|NCT00286429|363637483|FG000|Overall Study|Lack of Efficacy|52|||
105445538|NCT00286429|363637484|FG001|Overall Study|Lack of Efficacy|27|||
105445539|NCT00286429|363637485|FG002|Overall Study|Lack of Efficacy|25|||
105445540|NCT00286429|363637483|FG000|Overall Study|Lost to Follow-up|2|||
105445541|NCT00286429|363637484|FG001|Overall Study|Lost to Follow-up|4|||
105445542|NCT00286429|363637485|FG002|Overall Study|Lost to Follow-up|3|||
105445543|NCT00286429|363637483|FG000|Overall Study|Physician Decision|10|||
105445544|NCT00286429|363637484|FG001|Overall Study|Physician Decision|7|||
105445545|NCT00286429|363637485|FG002|Overall Study|Physician Decision|7|||
105445546|NCT00286429|363637483|FG000|Overall Study|Protocol Violation|3|||
105445547|NCT00286429|363637484|FG001|Overall Study|Protocol Violation|5|||
105445548|NCT00286429|363637485|FG002|Overall Study|Protocol Violation|4|||
105445549|NCT00286429|363637483|FG000|Overall Study|Withdrawal by Subject|3|||
105445550|NCT00286429|363637484|FG001|Overall Study|Withdrawal by Subject|2|||
105445551|NCT00286429|363637485|FG002|Overall Study|Withdrawal by Subject|6|||
105445552|NCT00286429|363637483|FG000|Overall Study|Administrative Error|1|||
105445553|NCT00286429|363637484|FG001|Overall Study|Administrative Error|1|||
105445554|NCT00286429|363637485|FG002|Overall Study|Administrative Error|1|||
105445555|NCT00286429|363637483|FG000|Overall Study|Administrative Decision|0|||
105445556|NCT00286429|363637484|FG001|Overall Study|Administrative Decision|1|||
105445557|NCT00286429|363637485|FG002|Overall Study|Administrative Decision|0|||
105445558|NCT00958165|363637486|FG000|Overall Study|Lost to Follow-up|5|||
105445559|NCT00958165|363637486|FG000|Overall Study|Not eligible|9|||
105445560|NCT01746225|363637489|FG000|Overall Study|Death|1|||
105445561|NCT01746225|363637490|FG001|Overall Study|Death|0|||
105445562|NCT01746225|363637491|FG002|Overall Study|Death|1|||
105445563|NCT01746225|363637489|FG000|Overall Study|Withdrawal by Subject|5|||
105445564|NCT01746225|363637490|FG001|Overall Study|Withdrawal by Subject|15|||
105445565|NCT01746225|363637491|FG002|Overall Study|Withdrawal by Subject|19|||
105445566|NCT01746225|363637489|FG000|Overall Study|Physician Decision|14|||
105445567|NCT01746225|363637490|FG001|Overall Study|Physician Decision|11|||
105445568|NCT01746225|363637491|FG002|Overall Study|Physician Decision|3|||
105445569|NCT01746225|363637489|FG000|Overall Study|Adverse Event|15|||
105445570|NCT01746225|363637490|FG001|Overall Study|Adverse Event|12|||
105445571|NCT01746225|363637491|FG002|Overall Study|Adverse Event|17|||
105445572|NCT01746225|363637489|FG000|Overall Study|Continuing Treatment|5|||
105445573|NCT01746225|363637490|FG001|Overall Study|Continuing Treatment|8|||
105445574|NCT01746225|363637491|FG002|Overall Study|Continuing Treatment|3|||
105445575|NCT03915470|363637494|FG000|Overall Study|Death|3|||
105445576|NCT03915470|363637495|FG001|Overall Study|Death|1|||
105445577|NCT03915470|363637494|FG000|Overall Study|Adverse Event|1|||
105445578|NCT03915470|363637495|FG001|Overall Study|Adverse Event|0|||
105445579|NCT03915470|363637494|FG000|Overall Study|Physician Decision|1|||
105445580|NCT03915470|363637495|FG001|Overall Study|Physician Decision|0|||
105445581|NCT03915470|363637494|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
105445582|NCT03915470|363637495|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
105445583|NCT00595478|363637496|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
105445584|NCT00595478|363637497|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
105445585|NCT00595478|363637496|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
105445586|NCT00595478|363637497|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
105445587|NCT03245775|363637500|FG000|Overall Study|Lost to Follow-up|25|||
105445588|NCT03245775|363637501|FG001|Overall Study|Lost to Follow-up|26|||
105445589|NCT03245775|363637502|FG002|Overall Study|Lost to Follow-up|16|||
105445590|NCT03245775|363637503|FG003|Overall Study|Lost to Follow-up|16|||
105445591|NCT02713828|363637504|FG000|Overall Study|Death|2|||
105445592|NCT02713828|363637505|FG001|Overall Study|Death|0|||
105445593|NCT02713828|363637504|FG000|Overall Study|Withdrawal by Subject|1|||
105445594|NCT02713828|363637505|FG001|Overall Study|Withdrawal by Subject|0|||
105445595|NCT02713828|363637504|FG000|Overall Study|study terminated but patient allowed to|2|||
105445596|NCT02713828|363637505|FG001|Overall Study|study terminated but patient allowed to|0|||
105445597|NCT03197376|363637509|FG000|Primary and Booster Phase|Adverse Event|0|||
105445598|NCT03197376|363637510|FG001|Primary and Booster Phase|Adverse Event|0|||
105445599|NCT03197376|363637511|FG002|Primary and Booster Phase|Adverse Event|0|||
105445600|NCT03197376|363637512|FG003|Primary and Booster Phase|Adverse Event|1|||
105445601|NCT03197376|363637509|FG000|Primary and Booster Phase|Death|1|||
105445602|NCT03197376|363637510|FG001|Primary and Booster Phase|Death|0|||
105445603|NCT03197376|363637511|FG002|Primary and Booster Phase|Death|0|||
105445604|NCT03197376|363637512|FG003|Primary and Booster Phase|Death|2|||
105445605|NCT03197376|363637509|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
105445606|NCT03197376|363637510|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
105445607|NCT03197376|363637511|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
105445608|NCT03197376|363637512|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
105445609|NCT03197376|363637509|FG000|Primary and Booster Phase|Physician Decision|1|||
105445610|NCT03197376|363637510|FG001|Primary and Booster Phase|Physician Decision|0|||
105445611|NCT03197376|363637511|FG002|Primary and Booster Phase|Physician Decision|1|||
105445612|NCT03197376|363637512|FG003|Primary and Booster Phase|Physician Decision|3|||
105445613|NCT03197376|363637509|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
105445614|NCT03197376|363637510|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
105445615|NCT03197376|363637511|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
105445616|NCT03197376|363637512|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
105445617|NCT03197376|363637509|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
105445618|NCT03197376|363637510|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
105445619|NCT03197376|363637511|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
105445620|NCT03197376|363637512|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
105445621|NCT03197376|363637509|FG000|Primary and Booster Phase|Not vaccine related|1|||
105445622|NCT03197376|363637510|FG001|Primary and Booster Phase|Not vaccine related|2|||
105445623|NCT03197376|363637511|FG002|Primary and Booster Phase|Not vaccine related|0|||
105445624|NCT03197376|363637512|FG003|Primary and Booster Phase|Not vaccine related|6|||
105445625|NCT03197376|363637509|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
105445626|NCT03197376|363637510|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
105445627|NCT03197376|363637511|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
105445628|NCT03197376|363637512|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
105445629|NCT03197376|363637509|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
105445630|NCT03197376|363637510|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
105445631|NCT03197376|363637511|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
105445632|NCT03197376|363637512|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
105445633|NCT03197376|363637509|FG000|Immune Persistence Phase|Not vaccine related|1|||
105445634|NCT03197376|363637510|FG001|Immune Persistence Phase|Not vaccine related|0|||
105445635|NCT03197376|363637511|FG002|Immune Persistence Phase|Not vaccine related|1|||
105445636|NCT03197376|363637512|FG003|Immune Persistence Phase|Not vaccine related|1|||
105445637|NCT04090242|363637513|FG000|Overall Study|Withdrawal by Subject|1|||
105445638|NCT04090242|363637514|FG001|Overall Study|Withdrawal by Subject|0|||
105445639|NCT00434109|363637516|FG000|Overall Study|Physician Decision|9|||
105445640|NCT00434109|363637516|FG000|Overall Study|Adverse Event|5|||
105445641|NCT00434109|363637516|FG000|Overall Study|Protocol Violation|1|||
105445642|NCT00434109|363637516|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
105445643|NCT01059318|363637517|FG000|Core Study (26 Week)|Adverse Event|3|||
105445644|NCT01059318|363637517|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
105445645|NCT01059318|363637517|FG000|Extension (36 Week)|Adverse Event|3|||
105445646|NCT03790917|363637518|FG000|Overall Study|Death|1|||
105445647|NCT04186871|363637519|FG000|Overall Study|Lack of Efficacy|0|||
105445648|NCT04186871|363637520|FG001|Overall Study|Lack of Efficacy|1|||
105445649|NCT04186871|363637521|FG002|Overall Study|Lack of Efficacy|0|||
105445650|NCT04186871|363637522|FG003|Overall Study|Lack of Efficacy|0|||
105445651|NCT04186871|363637523|FG004|Overall Study|Lack of Efficacy|1|||
105445652|NCT04186871|363637524|FG005|Overall Study|Lack of Efficacy|1|||
105445653|NCT04186871|363637519|FG000|Overall Study|Adverse Event|1|||
105445654|NCT04186871|363637520|FG001|Overall Study|Adverse Event|1|||
105445655|NCT04186871|363637521|FG002|Overall Study|Adverse Event|0|||
105445656|NCT04186871|363637522|FG003|Overall Study|Adverse Event|0|||
105445657|NCT04186871|363637523|FG004|Overall Study|Adverse Event|0|||
105445658|NCT04186871|363637524|FG005|Overall Study|Adverse Event|2|||
105445659|NCT04186871|363637519|FG000|Overall Study|Study terminated by sponsor|1|||
105445660|NCT04186871|363637520|FG001|Overall Study|Study terminated by sponsor|2|||
105445661|NCT04186871|363637521|FG002|Overall Study|Study terminated by sponsor|0|||
105445662|NCT04186871|363637522|FG003|Overall Study|Study terminated by sponsor|1|||
105445663|NCT04186871|363637523|FG004|Overall Study|Study terminated by sponsor|0|||
105445664|NCT04186871|363637524|FG005|Overall Study|Study terminated by sponsor|0|||
105445665|NCT04186871|363637519|FG000|Overall Study|Other reasons|0|||
105445666|NCT04186871|363637520|FG001|Overall Study|Other reasons|0|||
105445667|NCT04186871|363637521|FG002|Overall Study|Other reasons|0|||
105445668|NCT04186871|363637522|FG003|Overall Study|Other reasons|0|||
105445669|NCT04186871|363637523|FG004|Overall Study|Other reasons|0|||
105445670|NCT04186871|363637524|FG005|Overall Study|Other reasons|1|||
105445671|NCT04186871|363637519|FG000|Overall Study|Withdrawal by Subject|0|||
105445672|NCT04186871|363637520|FG001|Overall Study|Withdrawal by Subject|0|||
105445673|NCT04186871|363637521|FG002|Overall Study|Withdrawal by Subject|0|||
105445674|NCT04186871|363637522|FG003|Overall Study|Withdrawal by Subject|0|||
105445675|NCT04186871|363637523|FG004|Overall Study|Withdrawal by Subject|0|||
105445676|NCT04186871|363637524|FG005|Overall Study|Withdrawal by Subject|1|||
105445677|NCT04186871|363637519|FG000|Overall Study|Lost to Follow-up|0|||
105445678|NCT04186871|363637520|FG001|Overall Study|Lost to Follow-up|0|||
105445679|NCT04186871|363637521|FG002|Overall Study|Lost to Follow-up|0|||
105445680|NCT04186871|363637522|FG003|Overall Study|Lost to Follow-up|0|||
105445681|NCT04186871|363637523|FG004|Overall Study|Lost to Follow-up|0|||
105445682|NCT04186871|363637524|FG005|Overall Study|Lost to Follow-up|1|||
105445683|NCT00291486|363637526|FG000|Overall Study|Adverse Event|0|||
105445684|NCT00291486|363637527|FG001|Overall Study|Adverse Event|3|||
105445685|NCT00291486|363637528|FG002|Overall Study|Adverse Event|0|||
105445686|NCT00291486|363637529|FG003|Overall Study|Adverse Event|1|||
105445687|NCT00291486|363637530|FG004|Overall Study|Adverse Event|0|||
105445688|NCT00291486|363637526|FG000|Overall Study|Withdrawal by Subject|0|||
105445689|NCT00291486|363637527|FG001|Overall Study|Withdrawal by Subject|0|||
105445690|NCT00291486|363637528|FG002|Overall Study|Withdrawal by Subject|0|||
105445691|NCT00291486|363637529|FG003|Overall Study|Withdrawal by Subject|0|||
105445692|NCT00291486|363637530|FG004|Overall Study|Withdrawal by Subject|1|||
105445693|NCT00291486|363637526|FG000|Overall Study|Disease progression|1|||
105445694|NCT00291486|363637527|FG001|Overall Study|Disease progression|0|||
105445695|NCT00291486|363637528|FG002|Overall Study|Disease progression|1|||
105445696|NCT00291486|363637529|FG003|Overall Study|Disease progression|0|||
105445697|NCT00291486|363637530|FG004|Overall Study|Disease progression|0|||
105445698|NCT04178720|363637535|FG000|Overall Study|Withdrawal by Subject|2|||
105445699|NCT04178720|363637536|FG001|Overall Study|Withdrawal by Subject|0|||
105445700|NCT04178720|363637535|FG000|Overall Study|Relocation|0|||
105445701|NCT04178720|363637536|FG001|Overall Study|Relocation|1|||
105445702|NCT00930930|363637540|FG000|Overall Study|Death|1|||
105445703|NCT00930930|363637541|FG001|Overall Study|Death|0|||
105445704|NCT00930930|363637540|FG000|Overall Study|Physician Decision|1|||
105445705|NCT00930930|363637541|FG001|Overall Study|Physician Decision|0|||
105445706|NCT00930930|363637540|FG000|Overall Study|Adverse Event|13|||
105445707|NCT00930930|363637541|FG001|Overall Study|Adverse Event|3|||
105445708|NCT00930930|363637540|FG000|Overall Study|Withdrawal by Subject|3|||
105445709|NCT00930930|363637541|FG001|Overall Study|Withdrawal by Subject|1|||
105445710|NCT00930930|363637540|FG000|Overall Study|Disease progression|2|||
105445711|NCT00930930|363637541|FG001|Overall Study|Disease progression|3|||
105445712|NCT00930930|363637540|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
105445713|NCT00930930|363637541|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
105445714|NCT00930930|363637540|FG000|Overall Study|patients not compliant|1|||
105445715|NCT00930930|363637541|FG001|Overall Study|patients not compliant|1|||
105445716|NCT04618744|363637542|FG000|Overall Study|Adverse Event|0|||
105445717|NCT04618744|363637543|FG001|Overall Study|Adverse Event|1|||
105445718|NCT04618744|363637542|FG000|Overall Study|Withdrawal by Subject|0|||
105445719|NCT04618744|363637543|FG001|Overall Study|Withdrawal by Subject|1|||
105445720|NCT00900029|363637544|FG000|Overall Study|Lost to Follow-up|0|||
105445721|NCT00900029|363637545|FG001|Overall Study|Lost to Follow-up|2|||
105445722|NCT00900029|363637546|FG002|Overall Study|Lost to Follow-up|1|||
105445723|NCT00900029|363637547|FG003|Overall Study|Lost to Follow-up|4|||
105445724|NCT00900029|363637548|FG004|Overall Study|Lost to Follow-up|4|||
105445725|NCT00900029|363637544|FG000|Overall Study|Withdrawal by Subject|2|||
105445726|NCT00900029|363637545|FG001|Overall Study|Withdrawal by Subject|2|||
105445727|NCT00900029|363637546|FG002|Overall Study|Withdrawal by Subject|1|||
105445728|NCT00900029|363637547|FG003|Overall Study|Withdrawal by Subject|1|||
105445729|NCT00900029|363637548|FG004|Overall Study|Withdrawal by Subject|1|||
105445730|NCT00900029|363637544|FG000|Overall Study|Adverse Event|0|||
105445731|NCT00900029|363637545|FG001|Overall Study|Adverse Event|0|||
105445732|NCT00900029|363637546|FG002|Overall Study|Adverse Event|1|||
105445733|NCT00900029|363637547|FG003|Overall Study|Adverse Event|1|||
105445734|NCT00900029|363637548|FG004|Overall Study|Adverse Event|1|||
105445735|NCT00900029|363637544|FG000|Overall Study|Death|1|||
105445736|NCT00900029|363637545|FG001|Overall Study|Death|0|||
105445737|NCT00900029|363637546|FG002|Overall Study|Death|0|||
105445738|NCT00900029|363637547|FG003|Overall Study|Death|1|||
105445739|NCT00900029|363637548|FG004|Overall Study|Death|0|||
105445740|NCT02587819|363637551|FG000|Overall Study|Adverse Event|1|||
105445741|NCT02587819|363637551|FG000|Overall Study|Lost to Follow-up|1|||
105445742|NCT00163020|363637552|FG000|Overall Study|Lost to Follow-up|0|||
105445743|NCT00163020|363637553|FG001|Overall Study|Lost to Follow-up|2|||
105484840|NCT01437995|363786986|FG000|Overall Study|Lost to Follow-up|11|||
105484841|NCT01437995|363786987|FG001|Overall Study|Lost to Follow-up|18|||
105484842|NCT01437995|363786988|FG002|Overall Study|Lost to Follow-up|20|||
105484843|NCT02038829|363786991|FG000|Washout Period 1|Death|0|||
105484844|NCT02038829|363786992|FG001|Washout Period 1|Death|0|||
105484845|NCT02038829|363786993|FG002|Washout Period 1|Death|0|||
105484846|NCT02038829|363786994|FG003|Washout Period 1|Death|0|||
105484847|NCT02038829|363786995|FG004|Washout Period 1|Death|1|||
105484848|NCT02038829|363786996|FG005|Washout Period 1|Death|0|||
105484849|NCT02038829|363786997|FG006|Washout Period 1|Death|0|||
105484850|NCT02038829|363786998|FG007|Washout Period 1|Death|0|||
105484851|NCT02038829|363786999|FG008|Washout Period 1|Death|0|||
105484852|NCT02038829|363787000|FG009|Washout Period 1|Death|0|||
105484853|NCT02038829|363787001|FG010|Washout Period 1|Death|0|||
105484854|NCT02038829|363787002|FG011|Washout Period 1|Death|0|||
105484855|NCT02038829|363786991|FG000|Treatment Period 2|Adverse Event|0|||
105484856|NCT02038829|363786992|FG001|Treatment Period 2|Adverse Event|0|||
105484857|NCT02038829|363786993|FG002|Treatment Period 2|Adverse Event|0|||
105484858|NCT02038829|363786994|FG003|Treatment Period 2|Adverse Event|0|||
105484859|NCT02038829|363786995|FG004|Treatment Period 2|Adverse Event|0|||
105484860|NCT02038829|363786996|FG005|Treatment Period 2|Adverse Event|0|||
105484861|NCT02038829|363786997|FG006|Treatment Period 2|Adverse Event|0|||
105484862|NCT02038829|363786998|FG007|Treatment Period 2|Adverse Event|0|||
105484863|NCT02038829|363786999|FG008|Treatment Period 2|Adverse Event|0|||
105484864|NCT02038829|363787000|FG009|Treatment Period 2|Adverse Event|0|||
105484865|NCT02038829|363787001|FG010|Treatment Period 2|Adverse Event|1|||
105484866|NCT02038829|363787002|FG011|Treatment Period 2|Adverse Event|0|||
105484867|NCT02038829|363786991|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105484868|NCT02038829|363786992|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105484869|NCT02038829|363786993|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105484870|NCT02038829|363786994|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105484871|NCT02038829|363786995|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105484872|NCT02038829|363786996|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105484873|NCT02038829|363786997|FG006|Treatment Period 2|Withdrawal by Subject|0|||
105484874|NCT02038829|363786998|FG007|Treatment Period 2|Withdrawal by Subject|0|||
105484875|NCT02038829|363786999|FG008|Treatment Period 2|Withdrawal by Subject|0|||
105484876|NCT02038829|363787000|FG009|Treatment Period 2|Withdrawal by Subject|0|||
105484877|NCT02038829|363787001|FG010|Treatment Period 2|Withdrawal by Subject|0|||
105484878|NCT02038829|363787002|FG011|Treatment Period 2|Withdrawal by Subject|0|||
105484879|NCT02038829|363786991|FG000|Washout Period 2|Adverse Event|0|||
105484880|NCT02038829|363786992|FG001|Washout Period 2|Adverse Event|0|||
105484881|NCT02038829|363786993|FG002|Washout Period 2|Adverse Event|0|||
105484882|NCT02038829|363786994|FG003|Washout Period 2|Adverse Event|0|||
105484883|NCT02038829|363786995|FG004|Washout Period 2|Adverse Event|0|||
105484884|NCT02038829|363786996|FG005|Washout Period 2|Adverse Event|0|||
105484885|NCT02038829|363786997|FG006|Washout Period 2|Adverse Event|0|||
105484886|NCT02038829|363786998|FG007|Washout Period 2|Adverse Event|0|||
105484887|NCT02038829|363786999|FG008|Washout Period 2|Adverse Event|1|||
105484888|NCT02038829|363787000|FG009|Washout Period 2|Adverse Event|0|||
105484889|NCT02038829|363787001|FG010|Washout Period 2|Adverse Event|0|||
105445744|NCT00269919|363638668|FG000|Overall Study|Other|26|||
105445745|NCT00269919|363638668|FG000|Overall Study|Started but not treated|1|||
105445746|NCT05636852|363638669|FG000|Overall Study|Withdrawal by Subject|1|||
105445747|NCT05636852|363638669|FG000|Overall Study|Other than specified|1|||
105445748|NCT01784068|363638675|FG000|NTCS Phase|Adverse Event|5|||
105445749|NCT01784068|363638676|FG001|NTCS Phase|Adverse Event|0|||
105445750|NCT01784068|363638675|FG000|NTCS Phase|Physician Decision|2|||
105445751|NCT01784068|363638676|FG001|NTCS Phase|Physician Decision|0|||
105445752|NCT01784068|363638675|FG000|NTCS Phase|Patient/guardian decision|3|||
105445753|NCT01784068|363638676|FG001|NTCS Phase|Patient/guardian decision|0|||
105445754|NCT01784068|363638675|FG000|NTCS Phase|Death|2|||
105445755|NCT01784068|363638676|FG001|NTCS Phase|Death|0|||
105445756|NCT01784068|363638675|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
105445757|NCT01784068|363638676|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
105445758|NCT01784068|363638675|FG000|TFR Phase|Physician Decision|0|||
105445759|NCT01784068|363638676|FG001|TFR Phase|Physician Decision|1|||
105445760|NCT01784068|363638675|FG000|TFR Phase|Patient/guardian decision|0|||
105445761|NCT01784068|363638676|FG001|TFR Phase|Patient/guardian decision|3|||
105445762|NCT01784068|363638675|FG000|TFR Phase|Death|0|||
105445763|NCT01784068|363638676|FG001|TFR Phase|Death|1|||
105445764|NCT01784068|363638675|FG000|TFR Phase|Lack of Efficacy|0|||
105445765|NCT01784068|363638676|FG001|TFR Phase|Lack of Efficacy|88|||
105445766|NCT03672292|363638684|FG000|Overall Study|Adverse Event|3|||
105445767|NCT03672292|363638685|FG001|Overall Study|Adverse Event|1|||
105445768|NCT03672292|363638684|FG000|Overall Study|Physician Decision|0|||
105445769|NCT03672292|363638685|FG001|Overall Study|Physician Decision|1|||
105445770|NCT03672292|363638684|FG000|Overall Study|Withdrawal by Subject|1|||
105445771|NCT03672292|363638685|FG001|Overall Study|Withdrawal by Subject|2|||
105445772|NCT02518971|363638686|FG000|Overall Study|Lost to Follow-up|0|||
105445773|NCT02518971|363638687|FG001|Overall Study|Lost to Follow-up|1|||
105445774|NCT02518971|363638686|FG000|Overall Study|Physician Decision|6|||
105445775|NCT02518971|363638687|FG001|Overall Study|Physician Decision|6|||
105445776|NCT02518971|363638686|FG000|Overall Study|Protocol Violation|6|||
105445777|NCT02518971|363638687|FG001|Overall Study|Protocol Violation|4|||
105445778|NCT02518971|363638686|FG000|Overall Study|Withdrawal by Subject|4|||
105445779|NCT02518971|363638687|FG001|Overall Study|Withdrawal by Subject|5|||
105445780|NCT02518971|363638686|FG000|Overall Study|Side effects|1|||
105445781|NCT02518971|363638687|FG001|Overall Study|Side effects|0|||
105445782|NCT02518971|363638686|FG000|Overall Study|medication lost in mail|0|||
105445783|NCT02518971|363638687|FG001|Overall Study|medication lost in mail|1|||
105445784|NCT02518971|363638686|FG000|Overall Study|eligibility criteria no longer met|6|||
105445785|NCT02518971|363638687|FG001|Overall Study|eligibility criteria no longer met|3|||
105445786|NCT04451161|363638688|FG000|Overall Study|Lost to Follow-up|28|||
105445787|NCT04451161|363638689|FG001|Overall Study|Lost to Follow-up|37|||
105445788|NCT04451161|363638690|FG002|Overall Study|Lost to Follow-up|22|||
105445789|NCT04451161|363638691|FG003|Overall Study|Lost to Follow-up|13|||
105445790|NCT04451161|363638692|FG004|Overall Study|Lost to Follow-up|11|||
105445791|NCT04451161|363638693|FG005|Overall Study|Lost to Follow-up|14|||
105445792|NCT04451161|363638688|FG000|Overall Study|Withdrawal by Subject|3|||
105445793|NCT04451161|363638689|FG001|Overall Study|Withdrawal by Subject|0|||
105445794|NCT04451161|363638690|FG002|Overall Study|Withdrawal by Subject|0|||
105445795|NCT04451161|363638691|FG003|Overall Study|Withdrawal by Subject|0|||
105445796|NCT04451161|363638692|FG004|Overall Study|Withdrawal by Subject|2|||
105445797|NCT04451161|363638693|FG005|Overall Study|Withdrawal by Subject|4|||
105445798|NCT03088917|363638694|FG000|Overall Study|In care/cured elsewhere|15|||
105445799|NCT03088917|363638694|FG000|Overall Study|Refuse re-evaluation|13|||
105445800|NCT03088917|363638694|FG000|Overall Study|Contact not established|13|||
105445801|NCT03088917|363638694|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
105445802|NCT03088917|363638694|FG000|Overall Study|Moved outside study region|50|||
105445803|NCT02336230|363638695|FG000|Overall Study|Adverse Event|1|||
105445804|NCT02336230|363638695|FG000|Overall Study|Withdrawal of consent|1|||
105445805|NCT02336230|363638695|FG000|Overall Study|Death|9|||
105445806|NCT02336230|363638695|FG000|Overall Study|Dose not received due to shipping delay|1|||
105445807|NCT02336230|363638695|FG000|Overall Study|Discontinuation of MSC infusion|1|||
105445808|NCT05150990|363638696|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
105445809|NCT05150990|363638697|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
105445810|NCT05150990|363638696|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
105445811|NCT05150990|363638697|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
105445812|NCT05150990|363638696|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
105445813|NCT05150990|363638697|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
105445814|NCT05150990|363638696|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
105445815|NCT05150990|363638697|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
105445816|NCT05150990|363638696|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
105335952|NCT01981954|363231342|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
105335953|NCT03063086|363231343|FG000|Overall Study|technical problems|1|||
105335954|NCT03063086|363231344|FG001|Overall Study|technical problems|0|||
105335955|NCT03063086|363231345|FG002|Overall Study|technical problems|0|||
105335956|NCT03063086|363231346|FG003|Overall Study|technical problems|0|||
105335957|NCT03063086|363231347|FG004|Overall Study|technical problems|0|||
105335958|NCT03063086|363231348|FG005|Overall Study|technical problems|0|||
105335959|NCT03063086|363231343|FG000|Overall Study|Adverse Event|1|||
105335960|NCT03063086|363231344|FG001|Overall Study|Adverse Event|1|||
105335961|NCT03063086|363231345|FG002|Overall Study|Adverse Event|1|||
105335962|NCT03063086|363231346|FG003|Overall Study|Adverse Event|1|||
105335963|NCT03063086|363231347|FG004|Overall Study|Adverse Event|0|||
105335964|NCT03063086|363231348|FG005|Overall Study|Adverse Event|0|||
105335965|NCT03063086|363231343|FG000|Overall Study|subject/guardian decision|1|||
105335966|NCT03063086|363231344|FG001|Overall Study|subject/guardian decision|0|||
105335967|NCT03063086|363231345|FG002|Overall Study|subject/guardian decision|0|||
105335968|NCT03063086|363231346|FG003|Overall Study|subject/guardian decision|0|||
105335969|NCT03063086|363231347|FG004|Overall Study|subject/guardian decision|0|||
105335970|NCT03063086|363231348|FG005|Overall Study|subject/guardian decision|0|||
105335971|NCT03063086|363231343|FG000|Overall Study|Non-compliance with study treatment|0|||
105335972|NCT03063086|363231344|FG001|Overall Study|Non-compliance with study treatment|0|||
105335973|NCT03063086|363231345|FG002|Overall Study|Non-compliance with study treatment|0|||
105335974|NCT03063086|363231346|FG003|Overall Study|Non-compliance with study treatment|1|||
105335975|NCT03063086|363231347|FG004|Overall Study|Non-compliance with study treatment|0|||
105335976|NCT03063086|363231348|FG005|Overall Study|Non-compliance with study treatment|1|||
105335977|NCT03063086|363231343|FG000|Overall Study|Physician Decision|0|||
105335978|NCT03063086|363231344|FG001|Overall Study|Physician Decision|0|||
105335979|NCT03063086|363231345|FG002|Overall Study|Physician Decision|0|||
105335980|NCT03063086|363231346|FG003|Overall Study|Physician Decision|1|||
105335981|NCT03063086|363231347|FG004|Overall Study|Physician Decision|0|||
105335982|NCT03063086|363231348|FG005|Overall Study|Physician Decision|0|||
105335983|NCT01893281|363231349|FG000|Overall Study|Adverse Event|1|||
105335984|NCT01893281|363231349|FG000|Overall Study|Protocol Violation|1|||
105335985|NCT01893281|363231349|FG000|Overall Study|Withdrawal by Subject|1|||
105335986|NCT02218736|363231350|FG000|Overall Study|Withdrawal by Subject|10|||
105335987|NCT02218736|363231351|FG001|Overall Study|Withdrawal by Subject|9|||
105335988|NCT02218736|363231350|FG000|Overall Study|Protocol Violation|2|||
105335989|NCT02218736|363231351|FG001|Overall Study|Protocol Violation|0|||
105335990|NCT05481125|363231352|FG000|Overall Study|Adverse Event|1|||
105335991|NCT05481125|363231353|FG001|Overall Study|Adverse Event|0|||
105335992|NCT05481125|363231352|FG000|Overall Study|Lost to Follow-up|0|||
105335993|NCT05481125|363231353|FG001|Overall Study|Lost to Follow-up|1|||
105335994|NCT05481125|363231352|FG000|Overall Study|Withdrawal by Subject|0|||
105335995|NCT05481125|363231353|FG001|Overall Study|Withdrawal by Subject|1|||
105335996|NCT00839527|363231356|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
105335997|NCT00839527|363231357|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
105335998|NCT00839527|363231358|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
105335999|NCT00839527|363231356|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
105336000|NCT00839527|363231357|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
105336001|NCT00839527|363231358|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
105336002|NCT00839527|363231356|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
105336003|NCT00839527|363231357|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
105336004|NCT00839527|363231358|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
105336005|NCT00839527|363231356|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
105336006|NCT00839527|363231357|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
105336007|NCT00839527|363231358|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
105336008|NCT00839527|363231356|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
105336009|NCT00839527|363231357|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
105336010|NCT00839527|363231358|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
105336011|NCT00839527|363231356|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
105336012|NCT00839527|363231357|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
105336013|NCT00839527|363231358|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
105336014|NCT00839527|363231356|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
105336015|NCT00839527|363231357|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
105336016|NCT00839527|363231358|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
105336017|NCT00839527|363231356|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
105336018|NCT00839527|363231357|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
105336019|NCT00839527|363231358|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
105336020|NCT00839527|363231356|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
105336021|NCT00839527|363231357|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
105336022|NCT00839527|363231358|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
105336023|NCT00839527|363231356|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
105336024|NCT00839527|363231357|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
105445817|NCT05150990|363638697|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
105445818|NCT05150990|363638696|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
105445819|NCT05150990|363638697|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
105445820|NCT05150990|363638696|FG000|Overall Study|Death (unrelated to the intervention)|1|||
105445821|NCT05150990|363638697|FG001|Overall Study|Death (unrelated to the intervention)|2|||
105445822|NCT05729568|363638699|FG000|Overall Study|Still on Study|52|||
105445823|NCT05729568|363638700|FG001|Overall Study|Still on Study|26|||
105445824|NCT05729568|363638699|FG000|Overall Study|Randomized but Never Treated|3|||
105445825|NCT05729568|363638700|FG001|Overall Study|Randomized but Never Treated|0|||
105445826|NCT05729568|363638699|FG000|Overall Study|Adverse Event|0|||
105445827|NCT05729568|363638700|FG001|Overall Study|Adverse Event|1|||
105445828|NCT05729568|363638699|FG000|Overall Study|Investigator's Discretion|1|||
105445829|NCT05729568|363638700|FG001|Overall Study|Investigator's Discretion|0|||
105445830|NCT02864901|363638701|FG000|Overall Study|Withdrawal by Subject|1|||
105445831|NCT02864901|363638702|FG001|Overall Study|Withdrawal by Subject|0|||
105445832|NCT02940496|363638709|FG000|Overall Study|Adverse Event|1|||
105445833|NCT02940496|363638710|FG001|Overall Study|Adverse Event|0|||
105445834|NCT02940496|363638709|FG000|Overall Study|Death|2|||
105445835|NCT02940496|363638710|FG001|Overall Study|Death|0|||
105445836|NCT02940496|363638709|FG000|Overall Study|Hospice Care|1|||
105445837|NCT02940496|363638710|FG001|Overall Study|Hospice Care|0|||
105445838|NCT02940496|363638709|FG000|Overall Study|No MRE Done|1|||
105445839|NCT02940496|363638710|FG001|Overall Study|No MRE Done|0|||
105445840|NCT02940496|363638709|FG000|Overall Study|MRE Failure|1|||
105445841|NCT02940496|363638710|FG001|Overall Study|MRE Failure|0|||
105445842|NCT06964165|363638711|FG000|Overall Study|Withdrawal by Subject|0|||
105445843|NCT06964165|363638712|FG001|Overall Study|Withdrawal by Subject|1|||
105445844|NCT06964165|363638711|FG000|Overall Study|Ongoing at the time of analysis|15|||
105445845|NCT06964165|363638712|FG001|Overall Study|Ongoing at the time of analysis|14|||
105445846|NCT06964165|363638711|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
105445847|NCT06964165|363638712|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
105445848|NCT06964165|363638711|FG000|Overall Study|Participant removed due to non-compliance|0|||
105445849|NCT06964165|363638712|FG001|Overall Study|Participant removed due to non-compliance|1|||
105445850|NCT02657551|363638722|FG000|Overall Study|Adverse Event|2|||
105445851|NCT02657551|363638722|FG000|Overall Study|Withdrawal by Subject|1|||
105445852|NCT02657551|363638722|FG000|Overall Study|Non-Compliance|1|||
105445853|NCT02657551|363638722|FG000|Overall Study|Progression / Relapse|4|||
105445854|NCT00362648|363638723|FG000|Overall Study|Adverse Event|12|||
105445855|NCT00362648|363638724|FG001|Overall Study|Adverse Event|21|||
105445856|NCT00362648|363638725|FG002|Overall Study|Adverse Event|1|||
105445857|NCT00362648|363638726|FG003|Overall Study|Adverse Event|0|||
105445858|NCT00362648|363638723|FG000|Overall Study|Lost to Follow-up|62|||
105445859|NCT00362648|363638724|FG001|Overall Study|Lost to Follow-up|69|||
105445860|NCT00362648|363638725|FG002|Overall Study|Lost to Follow-up|4|||
105445861|NCT00362648|363638726|FG003|Overall Study|Lost to Follow-up|3|||
105445862|NCT00362648|363638723|FG000|Overall Study|Protocol Violation|4|||
105445863|NCT00362648|363638724|FG001|Overall Study|Protocol Violation|2|||
105445864|NCT00362648|363638725|FG002|Overall Study|Protocol Violation|2|||
105445865|NCT00362648|363638726|FG003|Overall Study|Protocol Violation|2|||
105445866|NCT00362648|363638723|FG000|Overall Study|Withdrawal by Subject|48|||
105445867|NCT00362648|363638724|FG001|Overall Study|Withdrawal by Subject|42|||
105445868|NCT00362648|363638725|FG002|Overall Study|Withdrawal by Subject|2|||
105445869|NCT00362648|363638726|FG003|Overall Study|Withdrawal by Subject|6|||
105445870|NCT02576795|363638727|FG000|Overall Study|Lost to Follow-up|0|||
105445871|NCT02576795|363638728|FG001|Overall Study|Lost to Follow-up|0|||
105445872|NCT02576795|363638729|FG002|Overall Study|Lost to Follow-up|1|||
105445873|NCT02576795|363638730|FG003|Overall Study|Lost to Follow-up|0|||
105445874|NCT03983304|363638731|FG000|Overall Study|Withdrawal by Subject|5|||
105445875|NCT03983304|363638731|FG000|Overall Study|Lost to Follow-up|2|||
105445876|NCT04752332|363638734|FG000|Overall Study|Adverse Event|3|||
105445877|NCT04752332|363638735|FG001|Overall Study|Adverse Event|1|||
105445878|NCT04752332|363638734|FG000|Overall Study|Disease Relapse|1|||
105445879|NCT04752332|363638735|FG001|Overall Study|Disease Relapse|0|||
105445880|NCT04752332|363638734|FG000|Overall Study|Non-compliance With Study Drug|2|||
105445881|NCT04752332|363638735|FG001|Overall Study|Non-compliance With Study Drug|0|||
105445882|NCT04752332|363638734|FG000|Overall Study|Physician Decision|2|||
105445883|NCT04752332|363638735|FG001|Overall Study|Physician Decision|1|||
105445884|NCT04752332|363638734|FG000|Overall Study|Protocol Violation|1|||
105445885|NCT04752332|363638735|FG001|Overall Study|Protocol Violation|1|||
105445886|NCT04752332|363638734|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
105445887|NCT04752332|363638735|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
105445888|NCT04752332|363638734|FG000|Overall Study|Study Terminated by Sponsor|10|||
105445889|NCT04752332|363638735|FG001|Overall Study|Study Terminated by Sponsor|48|||
105445890|NCT04752332|363638734|FG000|Overall Study|Withdrawal by Subject|11|||
105484890|NCT02038829|363787002|FG011|Washout Period 2|Adverse Event|0|||
105445891|NCT04752332|363638735|FG001|Overall Study|Withdrawal by Subject|3|||
105445892|NCT02777827|363638738|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
105445893|NCT02777827|363638739|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
105445894|NCT02777827|363638740|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
105445895|NCT02777827|363638741|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
105445896|NCT02777827|363638742|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
105445897|NCT02777827|363638743|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
105445898|NCT00548145|363638744|FG000|Overall Study|Death|0|||
105445899|NCT00548145|363638745|FG001|Overall Study|Death|1|||
105445900|NCT00548145|363638744|FG000|Overall Study|Withdrawal by Subject|0|||
105445901|NCT00548145|363638745|FG001|Overall Study|Withdrawal by Subject|2|||
105445902|NCT00548145|363638744|FG000|Overall Study|Physician Decision|1|||
105445903|NCT00548145|363638745|FG001|Overall Study|Physician Decision|1|||
105445904|NCT02451124|363638746|FG000|Overall Study|Withdrawal by Subject|1|||
105445905|NCT00195663|363638748|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
105445906|NCT00195663|363638749|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
105445907|NCT00195663|363638750|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
105445908|NCT00195663|363638748|FG000|2-year Double-blind Treatment Period|Death|0|||
105445909|NCT00195663|363638749|FG001|2-year Double-blind Treatment Period|Death|2|||
105445910|NCT00195663|363638750|FG002|2-year Double-blind Treatment Period|Death|0|||
105445911|NCT00195663|363638748|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
105445912|NCT00195663|363638749|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
105445913|NCT00195663|363638750|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
105445914|NCT00195663|363638748|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
105445915|NCT00195663|363638749|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
105445916|NCT00195663|363638750|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
105445917|NCT00195663|363638748|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
105445918|NCT00195663|363638749|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
105445919|NCT00195663|363638750|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
105445920|NCT00195663|363638748|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
105445921|NCT00195663|363638749|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
105445922|NCT00195663|363638750|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
105445923|NCT00195663|363638748|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
105445924|NCT00195663|363638749|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
105445925|NCT00195663|363638750|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
105445926|NCT00195663|363638748|FG000|2-year Double-blind Treatment Period|Recovery|1|||
105445927|NCT00195663|363638749|FG001|2-year Double-blind Treatment Period|Recovery|0|||
105445928|NCT00195663|363638750|FG002|2-year Double-blind Treatment Period|Recovery|1|||
105445929|NCT00195663|363638748|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
105445930|NCT00195663|363638749|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
105445931|NCT00195663|363638750|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
105445932|NCT00195663|363638748|FG000|Open-Label Extension Period|Adverse Event|21|||
105445933|NCT00195663|363638749|FG001|Open-Label Extension Period|Adverse Event|32|||
105445934|NCT00195663|363638750|FG002|Open-Label Extension Period|Adverse Event|36|||
105445935|NCT00195663|363638748|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
105445936|NCT00195663|363638749|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
105445937|NCT00195663|363638750|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
105445938|NCT00195663|363638748|FG000|Open-Label Extension Period|Recovery|0|||
105445939|NCT00195663|363638749|FG001|Open-Label Extension Period|Recovery|2|||
105445940|NCT00195663|363638750|FG002|Open-Label Extension Period|Recovery|2|||
105445941|NCT00195663|363638748|FG000|Open-Label Extension Period|Protocol Violation|3|||
105445942|NCT00195663|363638749|FG001|Open-Label Extension Period|Protocol Violation|4|||
105445943|NCT00195663|363638750|FG002|Open-Label Extension Period|Protocol Violation|4|||
105445944|NCT00195663|363638748|FG000|Open-Label Extension Period|Death|2|||
105445945|NCT00195663|363638749|FG001|Open-Label Extension Period|Death|2|||
105445946|NCT00195663|363638750|FG002|Open-Label Extension Period|Death|2|||
105445947|NCT00195663|363638748|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
105445948|NCT00195663|363638749|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
105445949|NCT00195663|363638750|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
105445950|NCT00195663|363638748|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
105445951|NCT00195663|363638749|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
105445952|NCT00195663|363638750|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
105445953|NCT00195663|363638748|FG000|Open-Label Extension Period|Administrative reasons|11|||
105445954|NCT00195663|363638749|FG001|Open-Label Extension Period|Administrative reasons|11|||
105445955|NCT00195663|363638750|FG002|Open-Label Extension Period|Administrative reasons|13|||
105445956|NCT02978833|363638751|FG000|Overall Study|Study terminated|1|||
105445957|NCT02978833|363638752|FG001|Overall Study|Study terminated|1|||
105445958|NCT00103740|363638753|FG000|Period 1 - Core|Adverse Event|1|||
105445959|NCT00103740|363638754|FG001|Period 1 - Core|Adverse Event|0|||
105445960|NCT00103740|363638753|FG000|Period 1 - Core|Protocol Violation|3|||
105445961|NCT00103740|363638754|FG001|Period 1 - Core|Protocol Violation|2|||
105445962|NCT00103740|363638753|FG000|Period 1 - Core|Patient withdrew consent|3|||
105445963|NCT00103740|363638754|FG001|Period 1 - Core|Patient withdrew consent|2|||
105445964|NCT00103740|363638753|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
105445965|NCT00103740|363638754|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
105445966|NCT00103740|363638753|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
105445967|NCT00103740|363638754|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
105445968|NCT00103740|363638753|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
105445969|NCT00103740|363638754|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
105445970|NCT00103740|363638753|FG000|Period 2 - Extended Observation Period|Death|6|||
105445971|NCT00103740|363638754|FG001|Period 2 - Extended Observation Period|Death|2|||
105445972|NCT00103740|363638753|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
105445973|NCT00103740|363638754|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
105445974|NCT00555217|363638755|FG000|Overall Study|Withdrawal by Subject|35|||
105445975|NCT00555217|363638756|FG001|Overall Study|Withdrawal by Subject|31|||
105445976|NCT00555217|363638755|FG000|Overall Study|Lost to Follow-up|19|||
105445977|NCT00555217|363638756|FG001|Overall Study|Lost to Follow-up|20|||
105445978|NCT00555217|363638755|FG000|Overall Study|close out sites|21|||
105445979|NCT00555217|363638756|FG001|Overall Study|close out sites|17|||
105445980|NCT01099397|363638763|FG000|Overall Study|Lost to Follow-up|4|||
105445981|NCT01099397|363638763|FG000|Overall Study|Protocol Violation|4|||
105445982|NCT01099397|363638763|FG000|Overall Study|Withdrawal by Subject|5|||
105445983|NCT02363959|363638764|FG000|Overall Study|Medical instability|1|||
105445984|NCT02363959|363638765|FG001|Overall Study|Medical instability|0|||
105445985|NCT01408459|363638766|FG000|Overall Study|Withdrawal by Subject|1|||
105445986|NCT01408459|363638767|FG001|Overall Study|Withdrawal by Subject|1|||
105445987|NCT00950248|363638775|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
105445988|NCT00950248|363638776|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
105445989|NCT00950248|363638777|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
105445990|NCT00950248|363638775|FG000|Year 1: Baseline|worsening of symptoms|2|||
105445991|NCT00950248|363638776|FG001|Year 1: Baseline|worsening of symptoms|0|||
105445992|NCT00950248|363638777|FG002|Year 1: Baseline|worsening of symptoms|0|||
105445993|NCT00950248|363638775|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
105445994|NCT00950248|363638776|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
105445995|NCT00950248|363638777|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
105445996|NCT00950248|363638775|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
105445997|NCT00950248|363638776|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
105445998|NCT00950248|363638777|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
105445999|NCT00950248|363638775|FG000|Year 2&3 Treatment Randomization|Death|0|||
105446000|NCT00950248|363638776|FG001|Year 2&3 Treatment Randomization|Death|0|||
105446001|NCT00950248|363638777|FG002|Year 2&3 Treatment Randomization|Death|1|||
105446002|NCT00950248|363638775|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
105446003|NCT00950248|363638776|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
105446004|NCT00950248|363638777|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
105446005|NCT04725500|363638780|FG000|Screening|Screen Failure|26|||
105446006|NCT04725500|363638780|FG000|Screening|Withdrawal by Subject|1|||
105446007|NCT04725500|363638780|FG000|2 Week Take Home|Screen Fail|5|||
105446008|NCT01792115|363638781|FG000|Overall Study|Lost to Follow-up|0|||
105446009|NCT01792115|363638782|FG001|Overall Study|Lost to Follow-up|1|||
105446010|NCT01792115|363638783|FG002|Overall Study|Lost to Follow-up|0|||
105446011|NCT01101035|363639563|FG000|Overall Study|Adverse Event|191|||
105446012|NCT01101035|363639564|FG001|Overall Study|Adverse Event|172|||
105446013|NCT01101035|363639563|FG000|Overall Study|Major Protocol Deviation|52|||
105446014|NCT01101035|363639564|FG001|Overall Study|Major Protocol Deviation|46|||
105446015|NCT01101035|363639563|FG000|Overall Study|Lost to Follow-up|226|||
105446016|NCT01101035|363639564|FG001|Overall Study|Lost to Follow-up|223|||
105446017|NCT01101035|363639563|FG000|Overall Study|Voluntary Withdrawal|595|||
105446018|NCT01101035|363639564|FG001|Overall Study|Voluntary Withdrawal|587|||
105446019|NCT01101035|363639563|FG000|Overall Study|Reason not Specified|333|||
105446020|NCT01101035|363639564|FG001|Overall Study|Reason not Specified|363|||
105446021|NCT02871635|363639565|FG000|Overall Study|Primary lack of efficacy|4|||
105446022|NCT02871635|363639566|FG001|Overall Study|Primary lack of efficacy|4|||
105446023|NCT02871635|363639565|FG000|Overall Study|Protocol Violation|3|||
105446024|NCT02871635|363639566|FG001|Overall Study|Protocol Violation|1|||
105446025|NCT02871635|363639565|FG000|Overall Study|Lost to Follow-up|1|||
105446026|NCT02871635|363639566|FG001|Overall Study|Lost to Follow-up|2|||
105446027|NCT02871635|363639565|FG000|Overall Study|Pregnancy|0|||
105446028|NCT02871635|363639566|FG001|Overall Study|Pregnancy|2|||
105446029|NCT02871635|363639565|FG000|Overall Study|Physician Decision|1|||
105446030|NCT02871635|363639566|FG001|Overall Study|Physician Decision|1|||
105446031|NCT02871635|363639565|FG000|Overall Study|Withdrawal by Subject|3|||
105446032|NCT02871635|363639566|FG001|Overall Study|Withdrawal by Subject|4|||
105781727|NCT00313716|364854827|FG004|Overall Study|Withdrawal by Subject|1|||
105781728|NCT00313716|364854828|FG005|Overall Study|Withdrawal by Subject|0|||
105446033|NCT02871635|363639565|FG000|Overall Study|Adverse Event|4|||
105446034|NCT02871635|363639566|FG001|Overall Study|Adverse Event|4|||
105446035|NCT02871635|363639565|FG000|Overall Study|Secondary lack of efficacy|2|||
105446036|NCT02871635|363639566|FG001|Overall Study|Secondary lack of efficacy|1|||
105446037|NCT02420379|363639567|FG000|Overall Study|Withdrawal by Subject|0|||
105446038|NCT02420379|363639568|FG001|Overall Study|Withdrawal by Subject|3|||
105446039|NCT02420379|363639567|FG000|Overall Study|Unable to complete due to schooling|0|||
105446040|NCT02420379|363639568|FG001|Overall Study|Unable to complete due to schooling|1|||
105446041|NCT02420379|363639567|FG000|Overall Study|Transitioned to commercial drug|1|||
105446042|NCT02420379|363639568|FG001|Overall Study|Transitioned to commercial drug|0|||
105446043|NCT04737278|363639569|FG000|Overall Study|Lost to Follow-up|1|||
105446044|NCT04737278|363639570|FG001|Overall Study|Lost to Follow-up|1|||
105446045|NCT04737278|363639569|FG000|Overall Study|Withdrawal by Subject|1|||
105446046|NCT04737278|363639570|FG001|Overall Study|Withdrawal by Subject|0|||
105446047|NCT04737278|363639569|FG000|Overall Study|Protocol Violation|1|||
105446048|NCT04737278|363639570|FG001|Overall Study|Protocol Violation|1|||
105446049|NCT04737278|363639569|FG000|Overall Study|failure to complete questionnaire|1|||
105446050|NCT04737278|363639570|FG001|Overall Study|failure to complete questionnaire|1|||
105446051|NCT02751580|363639573|FG000|Overall Study|Lost to Follow-up|4|||
105446052|NCT02751580|363639573|FG000|Overall Study|Death|2|||
105446053|NCT04829916|363639574|FG000|Overall Study|Withdrawal by Subject|1|||
105446054|NCT04829916|363639575|FG001|Overall Study|Withdrawal by Subject|0|||
105446055|NCT00394706|363639576|FG000|Overall Study|Withdrawal by Subject|2|||
105446056|NCT00394706|363639577|FG001|Overall Study|Withdrawal by Subject|0|||
105446057|NCT00394706|363639578|FG002|Overall Study|Withdrawal by Subject|1|||
105446058|NCT00394706|363639579|FG003|Overall Study|Withdrawal by Subject|0|||
105446059|NCT00394706|363639580|FG004|Overall Study|Withdrawal by Subject|0|||
105446060|NCT00394706|363639581|FG005|Overall Study|Withdrawal by Subject|2|||
105446061|NCT00394706|363639582|FG006|Overall Study|Withdrawal by Subject|1|||
105446062|NCT00394706|363639583|FG007|Overall Study|Withdrawal by Subject|0|||
105446063|NCT00394706|363639576|FG000|Overall Study|Lost to Follow-up|2|||
105446064|NCT00394706|363639577|FG001|Overall Study|Lost to Follow-up|2|||
105446065|NCT00394706|363639578|FG002|Overall Study|Lost to Follow-up|8|||
105446066|NCT00394706|363639579|FG003|Overall Study|Lost to Follow-up|1|||
105446067|NCT00394706|363639580|FG004|Overall Study|Lost to Follow-up|2|||
105446068|NCT00394706|363639581|FG005|Overall Study|Lost to Follow-up|5|||
105446069|NCT00394706|363639582|FG006|Overall Study|Lost to Follow-up|2|||
105446070|NCT00394706|363639583|FG007|Overall Study|Lost to Follow-up|0|||
105446071|NCT04098809|363639585|FG000|Overall Study|Withdrawal by Subject|1|||
105446072|NCT04098809|363639586|FG001|Overall Study|Withdrawal by Subject|3|||
105446073|NCT04098809|363639585|FG000|Overall Study|Physician Decision|2|||
105446074|NCT04098809|363639586|FG001|Overall Study|Physician Decision|1|||
105446075|NCT02741596|363639592|FG000|Overall Study|Adverse Event|1|||
105446076|NCT02741596|363639593|FG001|Overall Study|Adverse Event|5|||
105446077|NCT02741596|363639592|FG000|Overall Study|Lost to Follow-up|1|||
105446078|NCT02741596|363639593|FG001|Overall Study|Lost to Follow-up|1|||
105446079|NCT02741596|363639592|FG000|Overall Study|Physician Decision|2|||
105446080|NCT02741596|363639593|FG001|Overall Study|Physician Decision|1|||
105446081|NCT02741596|363639592|FG000|Overall Study|Pregnancy|3|||
105446082|NCT02741596|363639593|FG001|Overall Study|Pregnancy|1|||
105446083|NCT02741596|363639592|FG000|Overall Study|Other (Unspecified)|0|||
105446084|NCT02741596|363639593|FG001|Overall Study|Other (Unspecified)|3|||
105446085|NCT02741596|363639592|FG000|Overall Study|Subject withdrawn-Other|17|||
105446086|NCT02741596|363639593|FG001|Overall Study|Subject withdrawn-Other|4|||
105446087|NCT02741596|363639592|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
105446088|NCT02741596|363639593|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
105446089|NCT00479336|363639594|FG000|Overall Study|Adverse Event|1|||
105446090|NCT00479336|363639595|FG001|Overall Study|Adverse Event|1|||
105446091|NCT00479336|363639596|FG002|Overall Study|Adverse Event|1|||
105446092|NCT00479336|363639597|FG003|Overall Study|Adverse Event|3|||
105446093|NCT00479336|363639594|FG000|Overall Study|Lack of Efficacy|1|||
105446094|NCT00479336|363639595|FG001|Overall Study|Lack of Efficacy|0|||
105446095|NCT00479336|363639596|FG002|Overall Study|Lack of Efficacy|0|||
105446096|NCT00479336|363639597|FG003|Overall Study|Lack of Efficacy|0|||
105446097|NCT00479336|363639594|FG000|Overall Study|Protocol Violation|0|||
105446098|NCT00479336|363639595|FG001|Overall Study|Protocol Violation|1|||
105446099|NCT00479336|363639596|FG002|Overall Study|Protocol Violation|0|||
105446100|NCT00479336|363639597|FG003|Overall Study|Protocol Violation|0|||
105446101|NCT00479336|363639594|FG000|Overall Study|Withdrawal by Subject|1|||
105446102|NCT00479336|363639595|FG001|Overall Study|Withdrawal by Subject|2|||
105446103|NCT00479336|363639596|FG002|Overall Study|Withdrawal by Subject|0|||
105446104|NCT00479336|363639597|FG003|Overall Study|Withdrawal by Subject|0|||
105446105|NCT00479336|363639594|FG000|Overall Study|Physician Decision|0|||
105446106|NCT00479336|363639595|FG001|Overall Study|Physician Decision|1|||
105446107|NCT00479336|363639596|FG002|Overall Study|Physician Decision|0|||
105446108|NCT00479336|363639597|FG003|Overall Study|Physician Decision|2|||
105446109|NCT00479336|363639594|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
105446110|NCT00479336|363639595|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
105446111|NCT00479336|363639596|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
105446112|NCT00479336|363639597|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
105446113|NCT02021643|363639598|FG000|Overall Study|Enrolled but Never Treated|1|||
105446114|NCT02021643|363639599|FG001|Overall Study|Enrolled but Never Treated|0|||
105446115|NCT02021643|363639600|FG002|Overall Study|Enrolled but Never Treated|0|||
105446116|NCT02021643|363639601|FG003|Overall Study|Enrolled but Never Treated|0|||
105446117|NCT02021643|363639598|FG000|Overall Study|Adverse Event|0|||
105446118|NCT02021643|363639599|FG001|Overall Study|Adverse Event|1|||
105446119|NCT02021643|363639600|FG002|Overall Study|Adverse Event|0|||
105446120|NCT02021643|363639601|FG003|Overall Study|Adverse Event|0|||
105446121|NCT02021643|363639598|FG000|Overall Study|Death|0|||
105446122|NCT02021643|363639599|FG001|Overall Study|Death|1|||
105446123|NCT02021643|363639600|FG002|Overall Study|Death|0|||
105446124|NCT02021643|363639601|FG003|Overall Study|Death|0|||
105446125|NCT02021643|363639598|FG000|Overall Study|Investigator's Discretion|1|||
105446126|NCT02021643|363639599|FG001|Overall Study|Investigator's Discretion|0|||
105446127|NCT02021643|363639600|FG002|Overall Study|Investigator's Discretion|0|||
105446128|NCT02021643|363639601|FG003|Overall Study|Investigator's Discretion|0|||
105446129|NCT02021643|363639598|FG000|Overall Study|Lack of Efficacy|7|||
105446130|NCT02021643|363639599|FG001|Overall Study|Lack of Efficacy|6|||
105446131|NCT02021643|363639600|FG002|Overall Study|Lack of Efficacy|0|||
105446132|NCT02021643|363639601|FG003|Overall Study|Lack of Efficacy|12|||
105446133|NCT02021643|363639598|FG000|Overall Study|Lost to Follow-up|0|||
105446134|NCT02021643|363639599|FG001|Overall Study|Lost to Follow-up|1|||
105446135|NCT02021643|363639600|FG002|Overall Study|Lost to Follow-up|0|||
105446136|NCT02021643|363639601|FG003|Overall Study|Lost to Follow-up|0|||
105446137|NCT02021643|363639598|FG000|Overall Study|Withdrew Consent|0|||
105446138|NCT02021643|363639599|FG001|Overall Study|Withdrew Consent|1|||
105446139|NCT02021643|363639600|FG002|Overall Study|Withdrew Consent|0|||
105446140|NCT02021643|363639601|FG003|Overall Study|Withdrew Consent|0|||
105446141|NCT04112303|363639604|FG000|Overall Study|Death|1|||
105446142|NCT01461707|363639607|FG000|Overall Study|Withdrawal by Subject|1|||
105446143|NCT01461707|363639608|FG001|Overall Study|Withdrawal by Subject|0|||
105446144|NCT01450761|363639609|FG000|Randomization|Subject no longer meets study criteria|1|||
105446145|NCT01450761|363639610|FG001|Randomization|Subject no longer meets study criteria|2|||
105446146|NCT01450761|363639609|FG000|Randomization|Withdrawal by Subject|2|||
105446147|NCT01450761|363639610|FG001|Randomization|Withdrawal by Subject|0|||
105446148|NCT01450761|363639609|FG000|Randomization|Disease progression|0|||
105446149|NCT01450761|363639610|FG001|Randomization|Disease progression|2|||
105446150|NCT01450761|363639609|FG000|Randomization|Adverse Event unrelated to study drug|1|||
105446151|NCT01450761|363639610|FG001|Randomization|Adverse Event unrelated to study drug|0|||
105446152|NCT01450761|363639609|FG000|Randomization|Other|0|||
105446153|NCT01450761|363639610|FG001|Randomization|Other|1|||
105446154|NCT01450761|363639609|FG000|Lead-in Chemotherapy|Disease progression|33|||
105446155|NCT01450761|363639610|FG001|Lead-in Chemotherapy|Disease progression|32|||
105446156|NCT01450761|363639609|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
105446157|NCT01450761|363639610|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
105446158|NCT01450761|363639609|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
105446159|NCT01450761|363639610|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
105446160|NCT01450761|363639609|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
105446161|NCT01450761|363639610|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
105446162|NCT01450761|363639609|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
105446163|NCT01450761|363639610|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
105446164|NCT01450761|363639609|FG000|Lead-in Chemotherapy|Death|3|||
105446165|NCT01450761|363639610|FG001|Lead-in Chemotherapy|Death|3|||
105446166|NCT01450761|363639609|FG000|Lead-in Chemotherapy|Other|2|||
105446167|NCT01450761|363639610|FG001|Lead-in Chemotherapy|Other|2|||
105446168|NCT01450761|363639609|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
105446169|NCT01450761|363639610|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
105446170|NCT01450761|363639609|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
105446171|NCT01450761|363639610|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
105446172|NCT01450761|363639609|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
105446173|NCT01450761|363639610|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
105446174|NCT01450761|363639609|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
105446175|NCT01450761|363639610|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
105446176|NCT01450761|363639609|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
105446177|NCT01450761|363639610|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
105446178|NCT01450761|363639609|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
105446179|NCT01450761|363639610|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
105446180|NCT01450761|363639609|FG000|Treatment With Blinded Study Therapy|Death|5|||
105446181|NCT01450761|363639610|FG001|Treatment With Blinded Study Therapy|Death|6|||
105446182|NCT01450761|363639609|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
105446183|NCT01450761|363639610|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
105446184|NCT01450761|363639609|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
105446185|NCT01450761|363639610|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
105446186|NCT01450761|363639609|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
105446187|NCT01450761|363639610|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
105446188|NCT01450761|363639609|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
105446189|NCT01450761|363639610|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
105446190|NCT01450761|363639609|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
105446191|NCT01450761|363639610|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
105446192|NCT01450761|363639609|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
105446193|NCT01450761|363639610|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
105446194|NCT01450761|363639609|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
105446195|NCT01450761|363639610|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
105446196|NCT01818596|363639619|FG000|Overall Study|Enrolled but Not Treated|4|||
105446197|NCT01818596|363639620|FG001|Overall Study|Enrolled but Not Treated|0|||
105446198|NCT01818596|363639619|FG000|Overall Study|Adverse Event|7|||
105446199|NCT01818596|363639620|FG001|Overall Study|Adverse Event|0|||
105446200|NCT01818596|363639619|FG000|Overall Study|Death|3|||
105446201|NCT01818596|363639620|FG001|Overall Study|Death|0|||
105446202|NCT01818596|363639619|FG000|Overall Study|Investigator's Discretion|4|||
105446203|NCT01818596|363639620|FG001|Overall Study|Investigator's Discretion|0|||
105446204|NCT01818596|363639619|FG000|Overall Study|Protocol Violation|1|||
105446205|NCT01818596|363639620|FG001|Overall Study|Protocol Violation|0|||
105446206|NCT01818596|363639619|FG000|Overall Study|Withdrew Consent|5|||
105446207|NCT01818596|363639620|FG001|Overall Study|Withdrew Consent|0|||
105446208|NCT01818596|363639619|FG000|Overall Study|Lost to Follow-up|7|||
105446209|NCT01818596|363639620|FG001|Overall Study|Lost to Follow-up|0|||
105446210|NCT02754726|363639625|FG000|Overall Study|Progressive Disease by RECIST|13|||
105446211|NCT02754726|363639625|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
105446212|NCT02754726|363639625|FG000|Overall Study|Clinical Disease Progression|5|||
105446213|NCT02754726|363639625|FG000|Overall Study|Adverse Event|3|||
105446214|NCT02754726|363639625|FG000|Overall Study|Withdrawal by Subject|1|||
105446215|NCT02754726|363639625|FG000|Overall Study|Tolerability|1|||
105446216|NCT00799903|363639630|FG000|Overall Study|Investigator Site Closed|25|||
105446217|NCT00799903|363639631|FG001|Overall Study|Investigator Site Closed|23|||
105446218|NCT00799903|363639630|FG000|Overall Study|Withdrawal by Subject|179|||
105446219|NCT00799903|363639631|FG001|Overall Study|Withdrawal by Subject|175|||
105446220|NCT00799903|363639630|FG000|Overall Study|Lost to Follow-up|69|||
105446221|NCT00799903|363639631|FG001|Overall Study|Lost to Follow-up|80|||
105446222|NCT02524171|363639632|FG000|6-month Follow-up|Lost to Follow-up|53|||
105446223|NCT02524171|363639633|FG001|6-month Follow-up|Lost to Follow-up|45|||
105446224|NCT02524171|363639632|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
105446225|NCT02524171|363639633|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
105446226|NCT00757237|363639636|FG000|Overall Study|Lost to Follow-up|0|||
105446227|NCT00757237|363639637|FG001|Overall Study|Lost to Follow-up|1|||
105446228|NCT00757237|363639636|FG000|Overall Study|Protocol Violation|0|||
105446229|NCT00757237|363639637|FG001|Overall Study|Protocol Violation|2|||
105446230|NCT00757237|363639636|FG000|Overall Study|Physician Decision|2|||
105446231|NCT00757237|363639637|FG001|Overall Study|Physician Decision|3|||
105446232|NCT00757237|363639636|FG000|Overall Study|Withdrawal by Subject|8|||
105446233|NCT00757237|363639637|FG001|Overall Study|Withdrawal by Subject|12|||
105446234|NCT00757237|363639636|FG000|Overall Study|Safety or Tolerability|3|||
105446235|NCT00757237|363639637|FG001|Overall Study|Safety or Tolerability|5|||
105446236|NCT00757237|363639636|FG000|Overall Study|Other|0|||
105446237|NCT00757237|363639637|FG001|Overall Study|Other|2|||
105446238|NCT00779025|363639638|FG000|Overall Study|Withdrawal by Subject|1|||
105446239|NCT06041919|363639639|FG000|Overall Study|Lost to Follow-up|1|||
105446240|NCT06041919|363639640|FG001|Overall Study|Lost to Follow-up|0|||
105446241|NCT06041919|363639641|FG002|Overall Study|Lost to Follow-up|0|||
105446242|NCT06041919|363639642|FG003|Overall Study|Lost to Follow-up|0|||
105446243|NCT06041919|363639643|FG004|Overall Study|Lost to Follow-up|0|||
105446244|NCT06041919|363639639|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
105446245|NCT06041919|363639640|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
105446246|NCT06041919|363639641|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
105446247|NCT06041919|363639642|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
105446248|NCT06041919|363639643|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
105446249|NCT05973006|363639644|FG000|Overall Study|Early termination|3|||
105446250|NCT05973006|363639645|FG001|Overall Study|Early termination|9|||
105446251|NCT02204072|363639649|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
105446252|NCT02204072|363639650|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
105446253|NCT02204072|363639651|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
105446254|NCT02204072|363639652|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
105446255|NCT02204072|363639653|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
105446256|NCT02204072|363639649|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
105446257|NCT02204072|363639650|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
105446258|NCT02204072|363639651|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
105446259|NCT02204072|363639652|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
105446260|NCT02204072|363639653|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
105446261|NCT02204072|363639649|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
105446262|NCT02204072|363639650|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
105446263|NCT02204072|363639651|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
105446264|NCT02204072|363639652|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
105446265|NCT02204072|363639653|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
105446266|NCT02204072|363639649|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
105446267|NCT02204072|363639650|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
105446268|NCT02204072|363639651|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
105446269|NCT02204072|363639652|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
105446270|NCT02204072|363639653|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
105446271|NCT01900652|363639657|FG000|Overall Study|Progressive Disease|1|||
105446272|NCT01900652|363639658|FG001|Overall Study|Progressive Disease|0|||
105446273|NCT01900652|363639657|FG000|Overall Study|Consent withdrawn by subject|1|||
105446274|NCT01900652|363639658|FG001|Overall Study|Consent withdrawn by subject|1|||
105446275|NCT01900652|363639657|FG000|Overall Study|Death|3|||
105446276|NCT01900652|363639658|FG001|Overall Study|Death|0|||
105446277|NCT01900652|363639657|FG000|Overall Study|Adverse Event|2|||
105446278|NCT01900652|363639658|FG001|Overall Study|Adverse Event|1|||
105446279|NCT01900652|363639657|FG000|Overall Study|Physician Decision|1|||
105446280|NCT01900652|363639658|FG001|Overall Study|Physician Decision|1|||
105446281|NCT04775953|363641108|FG000|Overall Study|Lost to Follow-up|6|||
105446282|NCT04775953|363641109|FG001|Overall Study|Lost to Follow-up|11|||
105446283|NCT04775953|363641108|FG000|Overall Study|Death|5|||
105446284|NCT04775953|363641109|FG001|Overall Study|Death|4|||
105446285|NCT04775953|363641108|FG000|Overall Study|Withdrawal by Subject|3|||
105446286|NCT04775953|363641109|FG001|Overall Study|Withdrawal by Subject|3|||
105446287|NCT04775953|363641108|FG000|Overall Study|Protocol Violation|2|||
105446288|NCT04775953|363641109|FG001|Overall Study|Protocol Violation|0|||
105446289|NCT04775953|363641108|FG000|Overall Study|Participant non-compliance|0|||
105446290|NCT04775953|363641109|FG001|Overall Study|Participant non-compliance|1|||
105446291|NCT00411671|363641116|FG000|Overall Study|Adverse Event|15|||
105446292|NCT00411671|363641116|FG000|Overall Study|Death|2|||
105446293|NCT00411671|363641116|FG000|Overall Study|Lost to Follow-up|3|||
105446294|NCT01173601|363641120|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
105446295|NCT01173601|363641121|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105446296|NCT01173601|363641122|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105446297|NCT01173601|363641123|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105446298|NCT01173601|363641124|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105446299|NCT01173601|363641120|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
105446300|NCT01173601|363641121|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105446301|NCT01173601|363641122|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105446302|NCT01173601|363641123|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105446303|NCT01173601|363641124|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105446304|NCT01173601|363641120|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
105446305|NCT01173601|363641121|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105446306|NCT01173601|363641122|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105446307|NCT01173601|363641123|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105446308|NCT01173601|363641124|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105446309|NCT01173601|363641120|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
105446310|NCT01173601|363641121|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105446311|NCT01173601|363641122|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105446312|NCT01173601|363641123|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105446313|NCT01173601|363641124|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105446314|NCT01173601|363641120|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
105446315|NCT01173601|363641121|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105446316|NCT01173601|363641122|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105446317|NCT01173601|363641123|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105446318|NCT01173601|363641124|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105446319|NCT01173601|363641120|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
105446320|NCT01173601|363641121|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105446321|NCT01173601|363641122|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105446322|NCT01173601|363641123|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105446323|NCT01173601|363641124|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105446324|NCT01173601|363641120|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
105446325|NCT01173601|363641121|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105446326|NCT01173601|363641122|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105446327|NCT01173601|363641123|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105446328|NCT01173601|363641124|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105446329|NCT01173601|363641120|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
105446330|NCT01173601|363641121|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
105446331|NCT01173601|363641122|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
105446332|NCT01173601|363641123|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
105446333|NCT01173601|363641124|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
105446334|NCT01173601|363641120|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
105446335|NCT01173601|363641121|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
105446336|NCT01173601|363641122|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
105446337|NCT01173601|363641123|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
105446338|NCT01173601|363641124|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
105446339|NCT01173601|363641120|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
105446340|NCT01173601|363641121|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
105446341|NCT01173601|363641122|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
105446342|NCT01173601|363641123|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
105446343|NCT01173601|363641124|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
105446344|NCT01173601|363641120|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
105446345|NCT01173601|363641121|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
105446346|NCT01173601|363641122|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
105446347|NCT01173601|363641123|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
105446348|NCT01173601|363641124|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
105446349|NCT01173601|363641120|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
105446350|NCT01173601|363641121|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
105446351|NCT01173601|363641122|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
105446352|NCT01173601|363641123|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
105446353|NCT01173601|363641124|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
105446354|NCT01173601|363641120|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
105446355|NCT01173601|363641121|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
105446356|NCT01173601|363641122|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
105446357|NCT01173601|363641123|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
105446358|NCT01173601|363641124|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
105446359|NCT01173601|363641120|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
105446360|NCT01173601|363641121|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
105446361|NCT01173601|363641122|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
105446362|NCT01173601|363641123|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
105446363|NCT01173601|363641124|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
105446364|NCT03951077|363641125|FG000|Overall Study|Adverse Event|1|||
105446365|NCT03951077|363641126|FG001|Overall Study|Adverse Event|0|||
105446366|NCT03951077|363641127|FG002|Overall Study|Adverse Event|0|||
105446367|NCT03951077|363641128|FG003|Overall Study|Adverse Event|0|||
105446368|NCT03951077|363641129|FG004|Overall Study|Adverse Event|0|||
105446369|NCT03951077|363641130|FG005|Overall Study|Adverse Event|0|||
105446370|NCT03951077|363641125|FG000|Overall Study|Withdrawal by Subject|3|||
105446371|NCT03951077|363641126|FG001|Overall Study|Withdrawal by Subject|3|||
105446372|NCT03951077|363641127|FG002|Overall Study|Withdrawal by Subject|0|||
105446373|NCT03951077|363641128|FG003|Overall Study|Withdrawal by Subject|3|||
105446374|NCT03951077|363641129|FG004|Overall Study|Withdrawal by Subject|3|||
105446375|NCT03951077|363641130|FG005|Overall Study|Withdrawal by Subject|2|||
105446376|NCT03951077|363641125|FG000|Overall Study|Lost to Follow-up|1|||
105446377|NCT03951077|363641126|FG001|Overall Study|Lost to Follow-up|1|||
105446378|NCT03951077|363641127|FG002|Overall Study|Lost to Follow-up|2|||
105446379|NCT03951077|363641128|FG003|Overall Study|Lost to Follow-up|3|||
105446380|NCT03951077|363641129|FG004|Overall Study|Lost to Follow-up|2|||
105446381|NCT03951077|363641130|FG005|Overall Study|Lost to Follow-up|3|||
105446382|NCT03951077|363641125|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
105446383|NCT03951077|363641126|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
105446384|NCT03951077|363641127|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
105446385|NCT03951077|363641128|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
105446386|NCT03951077|363641129|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
105446387|NCT03951077|363641130|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
105446388|NCT03951077|363641125|FG000|Overall Study|Other, Not Specified|12|||
105446389|NCT03951077|363641126|FG001|Overall Study|Other, Not Specified|10|||
105446390|NCT03951077|363641127|FG002|Overall Study|Other, Not Specified|10|||
105446391|NCT03951077|363641128|FG003|Overall Study|Other, Not Specified|5|||
105781729|NCT01347931|364854829|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
105446392|NCT03951077|363641129|FG004|Overall Study|Other, Not Specified|9|||
105446393|NCT03951077|363641130|FG005|Overall Study|Other, Not Specified|6|||
105446394|NCT03951077|363641125|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
105446395|NCT03951077|363641126|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
105446396|NCT03951077|363641127|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
105446397|NCT03951077|363641128|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
105446398|NCT03951077|363641129|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
105446399|NCT03951077|363641130|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
105446400|NCT00853151|363641133|FG000|Overall Study|Adverse Event|1|||
105446401|NCT00853151|363641134|FG001|Overall Study|Adverse Event|4|||
105446402|NCT00853151|363641135|FG002|Overall Study|Adverse Event|2|||
105446403|NCT00853151|363641136|FG003|Overall Study|Adverse Event|0|||
105446404|NCT00853151|363641133|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
105446405|NCT00853151|363641134|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105446406|NCT00853151|363641135|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105446407|NCT00853151|363641136|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105446408|NCT00853151|363641133|FG000|Overall Study|Lost to Follow-up|2|||
105446409|NCT00853151|363641134|FG001|Overall Study|Lost to Follow-up|0|||
105446410|NCT00853151|363641135|FG002|Overall Study|Lost to Follow-up|3|||
105446411|NCT00853151|363641136|FG003|Overall Study|Lost to Follow-up|0|||
105446412|NCT00853151|363641133|FG000|Overall Study|Death|1|||
105446413|NCT00853151|363641134|FG001|Overall Study|Death|0|||
105446414|NCT00853151|363641135|FG002|Overall Study|Death|0|||
105446415|NCT00853151|363641136|FG003|Overall Study|Death|1|||
105446416|NCT00853151|363641133|FG000|Overall Study|Protocol Violation|0|||
105446417|NCT00853151|363641134|FG001|Overall Study|Protocol Violation|0|||
105446418|NCT00853151|363641135|FG002|Overall Study|Protocol Violation|0|||
105446419|NCT00853151|363641136|FG003|Overall Study|Protocol Violation|1|||
105446420|NCT00853151|363641133|FG000|Overall Study|Withdrawal by Subject|5|||
105446421|NCT00853151|363641134|FG001|Overall Study|Withdrawal by Subject|4|||
105446422|NCT00853151|363641135|FG002|Overall Study|Withdrawal by Subject|2|||
105446423|NCT00853151|363641136|FG003|Overall Study|Withdrawal by Subject|1|||
105446424|NCT00853151|363641133|FG000|Overall Study|Physician Decision|0|||
105446425|NCT00853151|363641134|FG001|Overall Study|Physician Decision|2|||
105446426|NCT00853151|363641135|FG002|Overall Study|Physician Decision|1|||
105446427|NCT00853151|363641136|FG003|Overall Study|Physician Decision|0|||
105446428|NCT00853151|363641133|FG000|Overall Study|Sponsor Decision|0|||
105446429|NCT00853151|363641134|FG001|Overall Study|Sponsor Decision|3|||
105446430|NCT00853151|363641135|FG002|Overall Study|Sponsor Decision|0|||
105446431|NCT00853151|363641136|FG003|Overall Study|Sponsor Decision|0|||
105446432|NCT00713544|363641137|FG000|Overall Study|Adverse Event|5|||
105446433|NCT00713544|363641138|FG001|Overall Study|Adverse Event|3|||
105446434|NCT00713544|363641139|FG002|Overall Study|Adverse Event|7|||
105446435|NCT00713544|363641140|FG003|Overall Study|Adverse Event|7|||
105446436|NCT00713544|363641141|FG004|Overall Study|Adverse Event|3|||
105446437|NCT00713544|363641142|FG005|Overall Study|Adverse Event|5|||
105446438|NCT00713544|363641137|FG000|Overall Study|Withdrawal by Subject|2|||
105446439|NCT00713544|363641138|FG001|Overall Study|Withdrawal by Subject|0|||
105446440|NCT00713544|363641139|FG002|Overall Study|Withdrawal by Subject|3|||
105446441|NCT00713544|363641140|FG003|Overall Study|Withdrawal by Subject|2|||
105446442|NCT00713544|363641141|FG004|Overall Study|Withdrawal by Subject|3|||
105446443|NCT00713544|363641142|FG005|Overall Study|Withdrawal by Subject|1|||
105446444|NCT00713544|363641137|FG000|Overall Study|Protocol Violation|0|||
105446445|NCT00713544|363641138|FG001|Overall Study|Protocol Violation|0|||
105446446|NCT00713544|363641139|FG002|Overall Study|Protocol Violation|0|||
105446447|NCT00713544|363641140|FG003|Overall Study|Protocol Violation|0|||
105446448|NCT00713544|363641141|FG004|Overall Study|Protocol Violation|0|||
105446449|NCT00713544|363641142|FG005|Overall Study|Protocol Violation|1|||
105446450|NCT00713544|363641137|FG000|Overall Study|Physician Decision|0|||
105446451|NCT00713544|363641138|FG001|Overall Study|Physician Decision|0|||
105446452|NCT00713544|363641139|FG002|Overall Study|Physician Decision|0|||
105446453|NCT00713544|363641140|FG003|Overall Study|Physician Decision|0|||
105446454|NCT00713544|363641141|FG004|Overall Study|Physician Decision|0|||
105446455|NCT00713544|363641142|FG005|Overall Study|Physician Decision|2|||
105446456|NCT00713544|363641137|FG000|Overall Study|Lack of Efficacy|0|||
105446457|NCT00713544|363641138|FG001|Overall Study|Lack of Efficacy|1|||
105446458|NCT00713544|363641139|FG002|Overall Study|Lack of Efficacy|0|||
105446459|NCT00713544|363641140|FG003|Overall Study|Lack of Efficacy|1|||
105446460|NCT00713544|363641141|FG004|Overall Study|Lack of Efficacy|1|||
105446461|NCT00713544|363641142|FG005|Overall Study|Lack of Efficacy|0|||
105446462|NCT00713544|363641137|FG000|Overall Study|Lost to Follow-up|0|||
105446463|NCT00713544|363641138|FG001|Overall Study|Lost to Follow-up|0|||
105446464|NCT00713544|363641139|FG002|Overall Study|Lost to Follow-up|1|||
105446465|NCT00713544|363641140|FG003|Overall Study|Lost to Follow-up|0|||
105446466|NCT00713544|363641141|FG004|Overall Study|Lost to Follow-up|0|||
105446467|NCT00713544|363641142|FG005|Overall Study|Lost to Follow-up|0|||
105446468|NCT00713544|363641137|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
105446469|NCT00713544|363641138|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
105446470|NCT00713544|363641139|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
105446471|NCT00713544|363641140|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
105446472|NCT00713544|363641141|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
105446473|NCT00713544|363641142|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
105446474|NCT00713544|363641137|FG000|Overall Study|Incorrect enrollment|0|||
105446475|NCT00713544|363641138|FG001|Overall Study|Incorrect enrollment|1|||
105446476|NCT00713544|363641139|FG002|Overall Study|Incorrect enrollment|0|||
105446477|NCT00713544|363641140|FG003|Overall Study|Incorrect enrollment|0|||
105446478|NCT00713544|363641141|FG004|Overall Study|Incorrect enrollment|0|||
105446479|NCT00713544|363641142|FG005|Overall Study|Incorrect enrollment|0|||
105446480|NCT00713544|363641137|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
105446481|NCT00713544|363641138|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
105446482|NCT00713544|363641139|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
105446483|NCT00713544|363641140|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
105446484|NCT00713544|363641141|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
105446485|NCT00713544|363641142|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
105446486|NCT00592904|363641143|FG000|Overall Study|Adverse Event|15|||
105446487|NCT00592904|363641144|FG001|Overall Study|Adverse Event|25|||
105446488|NCT00592904|363641145|FG002|Overall Study|Adverse Event|13|||
105446489|NCT00592904|363641146|FG003|Overall Study|Adverse Event|5|||
105446490|NCT00592904|363641143|FG000|Overall Study|Protocol Violation|1|||
105446491|NCT00592904|363641144|FG001|Overall Study|Protocol Violation|1|||
105446492|NCT00592904|363641145|FG002|Overall Study|Protocol Violation|0|||
105446493|NCT00592904|363641146|FG003|Overall Study|Protocol Violation|1|||
105446494|NCT00592904|363641143|FG000|Overall Study|Withdrawal by Subject|4|||
105446495|NCT00592904|363641144|FG001|Overall Study|Withdrawal by Subject|16|||
105446496|NCT00592904|363641145|FG002|Overall Study|Withdrawal by Subject|1|||
105446497|NCT00592904|363641146|FG003|Overall Study|Withdrawal by Subject|2|||
105446498|NCT00592904|363641143|FG000|Overall Study|Lack of Efficacy|2|||
105446499|NCT00592904|363641144|FG001|Overall Study|Lack of Efficacy|7|||
105446500|NCT00592904|363641145|FG002|Overall Study|Lack of Efficacy|2|||
105446501|NCT00592904|363641146|FG003|Overall Study|Lack of Efficacy|3|||
105446502|NCT00592904|363641143|FG000|Overall Study|Physician Decision|0|||
105446503|NCT00592904|363641144|FG001|Overall Study|Physician Decision|3|||
105446504|NCT00592904|363641145|FG002|Overall Study|Physician Decision|1|||
105446505|NCT00592904|363641146|FG003|Overall Study|Physician Decision|0|||
105446506|NCT00592904|363641143|FG000|Overall Study|Other|3|||
105446507|NCT00592904|363641144|FG001|Overall Study|Other|3|||
105446508|NCT00592904|363641145|FG002|Overall Study|Other|0|||
105446509|NCT00592904|363641146|FG003|Overall Study|Other|0|||
105446510|NCT03078556|363641147|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
105446511|NCT03078556|363641148|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
105446512|NCT03078556|363641149|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
105446513|NCT03078556|363641150|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
105446514|NCT03078556|363641147|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
105446515|NCT03078556|363641148|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
105446516|NCT03078556|363641149|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
105446517|NCT03078556|363641150|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
105446518|NCT03078556|363641147|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
105446519|NCT03078556|363641148|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
105446520|NCT03078556|363641149|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
105446521|NCT03078556|363641150|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
105446522|NCT03078556|363641147|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
105446523|NCT03078556|363641148|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
105446524|NCT03078556|363641149|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
105446525|NCT03078556|363641150|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
105446526|NCT00832416|363641151|FG000|Overall Study|Lack of Efficacy|17|||
105446527|NCT00832416|363641152|FG001|Overall Study|Lack of Efficacy|15|||
105446528|NCT00832416|363641153|FG002|Overall Study|Lack of Efficacy|13|||
105446529|NCT00832416|363641154|FG003|Overall Study|Lack of Efficacy|52|||
105446530|NCT00832416|363641151|FG000|Overall Study|Withdrawal by Subject|5|||
105446531|NCT00832416|363641152|FG001|Overall Study|Withdrawal by Subject|7|||
105446532|NCT00832416|363641153|FG002|Overall Study|Withdrawal by Subject|2|||
105446533|NCT00832416|363641154|FG003|Overall Study|Withdrawal by Subject|10|||
105446534|NCT00832416|363641151|FG000|Overall Study|Physician Decision|2|||
105446535|NCT00832416|363641152|FG001|Overall Study|Physician Decision|12|||
105446536|NCT00832416|363641153|FG002|Overall Study|Physician Decision|5|||
105446537|NCT00832416|363641154|FG003|Overall Study|Physician Decision|10|||
105446538|NCT00832416|363641151|FG000|Overall Study|Administrative|0|||
105446539|NCT00832416|363641152|FG001|Overall Study|Administrative|0|||
105446540|NCT00832416|363641153|FG002|Overall Study|Administrative|0|||
105446541|NCT00832416|363641154|FG003|Overall Study|Administrative|1|||
105446542|NCT00832416|363641151|FG000|Overall Study|Adverse Event|21|||
105446543|NCT00832416|363641152|FG001|Overall Study|Adverse Event|19|||
105446544|NCT00832416|363641153|FG002|Overall Study|Adverse Event|41|||
105446545|NCT00832416|363641154|FG003|Overall Study|Adverse Event|10|||
105446546|NCT00832416|363641151|FG000|Overall Study|Death|1|||
105446547|NCT00832416|363641152|FG001|Overall Study|Death|0|||
105446548|NCT00832416|363641153|FG002|Overall Study|Death|0|||
105446549|NCT00832416|363641154|FG003|Overall Study|Death|0|||
105446550|NCT00483405|363641155|FG000|Overall Study|Adverse Event|8|||
105446551|NCT00483405|363641155|FG000|Overall Study|Lack of Efficacy|14|||
105446552|NCT00483405|363641155|FG000|Overall Study|Death|3|||
105446553|NCT00483405|363641155|FG000|Overall Study|Withdrawal by Subject|2|||
105446554|NCT00483405|363641155|FG000|Overall Study|Other complicating disease|1|||
105446555|NCT03010319|363641156|FG000|Overall Study|Adverse Event|15|||
105446556|NCT03010319|363641157|FG001|Overall Study|Adverse Event|9|||
105446557|NCT03010319|363641156|FG000|Overall Study|Withdrawal by Subject|1|||
105446558|NCT03010319|363641157|FG001|Overall Study|Withdrawal by Subject|6|||
105446559|NCT03010319|363641156|FG000|Overall Study|Physician Decision|2|||
105446560|NCT03010319|363641157|FG001|Overall Study|Physician Decision|4|||
105446561|NCT03010319|363641156|FG000|Overall Study|Sponsor requested withdrawal|2|||
105446562|NCT03010319|363641157|FG001|Overall Study|Sponsor requested withdrawal|2|||
105446563|NCT03010319|363641156|FG000|Overall Study|Death|1|||
105446564|NCT03010319|363641157|FG001|Overall Study|Death|0|||
105446565|NCT03010319|363641156|FG000|Overall Study|Lost to Follow-up|0|||
105446566|NCT03010319|363641157|FG001|Overall Study|Lost to Follow-up|1|||
105446567|NCT03010319|363641156|FG000|Overall Study|Other Reason|5|||
105446568|NCT03010319|363641157|FG001|Overall Study|Other Reason|7|||
105446569|NCT05786508|363641158|FG000|Overall Study|Withdrawal by Subject|2|||
105446570|NCT05786508|363641159|FG001|Overall Study|Withdrawal by Subject|0|||
105446571|NCT03314987|363641160|FG000|Overall Study|Lost to Follow-up|13|||
105446572|NCT03314987|363641161|FG001|Overall Study|Lost to Follow-up|13|||
105446573|NCT04343755|363641164|FG000|Overall Study|Death|11|||
105446574|NCT04343755|363641164|FG000|Overall Study|Screen Failure|1|||
105446575|NCT01456169|363641165|FG000|Overall Study|Adverse Event|1|||
105446576|NCT01456169|363641166|FG001|Overall Study|Adverse Event|2|||
105446577|NCT01456169|363641167|FG002|Overall Study|Adverse Event|7|||
105446578|NCT01456169|363641165|FG000|Overall Study|Major Protocol Deviation|3|||
105446579|NCT01456169|363641166|FG001|Overall Study|Major Protocol Deviation|2|||
105446580|NCT01456169|363641167|FG002|Overall Study|Major Protocol Deviation|3|||
105446581|NCT01456169|363641165|FG000|Overall Study|Voluntary Withdrawal|3|||
105446582|NCT01456169|363641166|FG001|Overall Study|Voluntary Withdrawal|0|||
105446583|NCT01456169|363641167|FG002|Overall Study|Voluntary Withdrawal|2|||
105446584|NCT01456169|363641165|FG000|Overall Study|Lack of Efficacy|2|||
105446585|NCT01456169|363641166|FG001|Overall Study|Lack of Efficacy|0|||
105446586|NCT01456169|363641167|FG002|Overall Study|Lack of Efficacy|0|||
105446587|NCT01456169|363641165|FG000|Overall Study|Other|1|||
105446588|NCT01456169|363641166|FG001|Overall Study|Other|1|||
105446589|NCT01456169|363641167|FG002|Overall Study|Other|0|||
105446590|NCT02598297|363641168|FG000|Overall Study|Study terminated by Sponsor|21|||
105446591|NCT02598297|363641169|FG001|Overall Study|Study terminated by Sponsor|23|||
105446592|NCT02598297|363641168|FG000|Overall Study|Adverse Event|1|||
105446593|NCT02598297|363641169|FG001|Overall Study|Adverse Event|1|||
105446594|NCT02598297|363641168|FG000|Overall Study|Physician Decision|1|||
105446595|NCT02598297|363641169|FG001|Overall Study|Physician Decision|0|||
105446596|NCT02598297|363641168|FG000|Overall Study|Subject/guardian decision|1|||
105446597|NCT02598297|363641169|FG001|Overall Study|Subject/guardian decision|0|||
105446598|NCT02598297|363641168|FG000|Overall Study|Followed for survival|1|||
105446599|NCT02598297|363641169|FG001|Overall Study|Followed for survival|0|||
105446600|NCT00193206|363641170|FG000|Preoperative Therapy|Lack of Efficacy|2|||
105446601|NCT00193206|363641170|FG000|Preoperative Therapy|Adverse Event|2|||
105446602|NCT00193206|363641170|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
105446603|NCT00193206|363641170|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
105446604|NCT00193206|363641170|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
105446605|NCT00193206|363641170|FG000|Postoperative Therapy|Physician Decision|3|||
105446606|NCT00193206|363641170|FG000|Postoperative Therapy|Intercurrent Illness|2|||
105446607|NCT00193206|363641170|FG000|Postoperative Therapy|Lack of Efficacy|1|||
105446608|NCT00193206|363641170|FG000|Postoperative Therapy|Protocol Violation|1|||
105446609|NCT02631551|363641172|FG000|Overall Study|Adverse Event|1|||
105446610|NCT02631551|363641173|FG001|Overall Study|Adverse Event|2|||
105446611|NCT02631551|363641174|FG002|Overall Study|Adverse Event|4|||
105446612|NCT02631551|363641175|FG003|Overall Study|Adverse Event|0|||
105446613|NCT02631551|363641172|FG000|Overall Study|Lack of Efficacy|0|||
105446614|NCT02631551|363641173|FG001|Overall Study|Lack of Efficacy|0|||
105446615|NCT02631551|363641174|FG002|Overall Study|Lack of Efficacy|1|||
105446616|NCT02631551|363641175|FG003|Overall Study|Lack of Efficacy|0|||
105446617|NCT02631551|363641172|FG000|Overall Study|Lost to Follow-up|1|||
105446618|NCT02631551|363641173|FG001|Overall Study|Lost to Follow-up|2|||
105446619|NCT02631551|363641174|FG002|Overall Study|Lost to Follow-up|0|||
105446620|NCT02631551|363641175|FG003|Overall Study|Lost to Follow-up|3|||
105446621|NCT02631551|363641172|FG000|Overall Study|Withdrawal by Subject|2|||
105446622|NCT02631551|363641173|FG001|Overall Study|Withdrawal by Subject|2|||
105446623|NCT02631551|363641174|FG002|Overall Study|Withdrawal by Subject|0|||
105446624|NCT02631551|363641175|FG003|Overall Study|Withdrawal by Subject|5|||
105446625|NCT02631551|363641172|FG000|Overall Study|Protocol deviation|3|||
105446626|NCT02631551|363641173|FG001|Overall Study|Protocol deviation|6|||
105446627|NCT02631551|363641174|FG002|Overall Study|Protocol deviation|3|||
105446628|NCT02631551|363641175|FG003|Overall Study|Protocol deviation|0|||
105446629|NCT02631551|363641172|FG000|Overall Study|Non-compliance with study procedures|0|||
105446630|NCT02631551|363641173|FG001|Overall Study|Non-compliance with study procedures|0|||
105446631|NCT02631551|363641174|FG002|Overall Study|Non-compliance with study procedures|1|||
105446632|NCT02631551|363641175|FG003|Overall Study|Non-compliance with study procedures|1|||
105446633|NCT02631551|363641172|FG000|Overall Study|Non-compliance with study drug|1|||
105446634|NCT02631551|363641173|FG001|Overall Study|Non-compliance with study drug|0|||
105446635|NCT02631551|363641174|FG002|Overall Study|Non-compliance with study drug|0|||
105446636|NCT02631551|363641175|FG003|Overall Study|Non-compliance with study drug|0|||
105446637|NCT02631551|363641172|FG000|Overall Study|Other, specific reasons not collected|5|||
105446638|NCT02631551|363641173|FG001|Overall Study|Other, specific reasons not collected|7|||
105446639|NCT02631551|363641174|FG002|Overall Study|Other, specific reasons not collected|2|||
105446640|NCT02631551|363641175|FG003|Overall Study|Other, specific reasons not collected|2|||
105446641|NCT00216671|363641181|FG000|Overall Study|Adverse Event|4|||
105446642|NCT00216671|363641182|FG001|Overall Study|Adverse Event|9|||
105446643|NCT00216671|363641181|FG000|Overall Study|Pregnancy|0|||
105446644|NCT00216671|363641182|FG001|Overall Study|Pregnancy|1|||
105446645|NCT00216671|363641181|FG000|Overall Study|Withdrawal by Subject|4|||
105446646|NCT00216671|363641182|FG001|Overall Study|Withdrawal by Subject|2|||
105446647|NCT00216671|363641181|FG000|Overall Study|Refused Injections|3|||
105446648|NCT00216671|363641182|FG001|Overall Study|Refused Injections|13|||
105446649|NCT00216671|363641181|FG000|Overall Study|No Need to Continue Medication|1|||
105446650|NCT00216671|363641182|FG001|Overall Study|No Need to Continue Medication|1|||
105446651|NCT00216671|363641181|FG000|Overall Study|Insufficient Response|9|||
105446652|NCT00216671|363641182|FG001|Overall Study|Insufficient Response|4|||
105446653|NCT00216671|363641181|FG000|Overall Study|Lost to Follow-up|3|||
105446654|NCT00216671|363641182|FG001|Overall Study|Lost to Follow-up|5|||
105446655|NCT00216671|363641181|FG000|Overall Study|Non compliant|2|||
105446656|NCT00216671|363641182|FG001|Overall Study|Non compliant|2|||
105446657|NCT00216671|363641181|FG000|Overall Study|Ineligible|0|||
105446658|NCT00216671|363641182|FG001|Overall Study|Ineligible|2|||
105446659|NCT00216671|363641181|FG000|Overall Study|Physician Decision|1|||
105446660|NCT00216671|363641182|FG001|Overall Study|Physician Decision|1|||
105446661|NCT00216671|363641181|FG000|Overall Study|Protocol Violation|3|||
105446662|NCT00216671|363641182|FG001|Overall Study|Protocol Violation|5|||
105446663|NCT00216671|363641181|FG000|Overall Study|Relapse|1|||
105446664|NCT00216671|363641182|FG001|Overall Study|Relapse|0|||
105446665|NCT00216671|363641181|FG000|Overall Study|Investigator Illness|0|||
105446666|NCT00216671|363641182|FG001|Overall Study|Investigator Illness|1|||
105446667|NCT00216671|363641181|FG000|Overall Study|Patient Moved|0|||
105446668|NCT00216671|363641182|FG001|Overall Study|Patient Moved|1|||
105446669|NCT00216671|363641181|FG000|Overall Study|Ineligible, no efficacy data|2|||
105446670|NCT00216671|363641182|FG001|Overall Study|Ineligible, no efficacy data|2|||
105446671|NCT00216671|363641181|FG000|Overall Study|Insufficient Response Adverse Event|2|||
105446672|NCT00216671|363641182|FG001|Overall Study|Insufficient Response Adverse Event|1|||
105446673|NCT03710642|363641183|FG000|Overall Study|Adverse Event|5|||
105446674|NCT03710642|363641184|FG001|Overall Study|Adverse Event|1|||
105446675|NCT03710642|363641183|FG000|Overall Study|non-site physician recommendation|1|||
105446676|NCT03710642|363641184|FG001|Overall Study|non-site physician recommendation|0|||
105446677|NCT03710642|363641183|FG000|Overall Study|Participant unwilling or unable to participate|1|||
105446678|NCT03710642|363641184|FG001|Overall Study|Participant unwilling or unable to participate|1|||
105446679|NCT03710642|363641183|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
105446680|NCT03710642|363641184|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
105446681|NCT03710642|363641183|FG000|Overall Study|NA-no code provided|1|||
105446682|NCT03710642|363641184|FG001|Overall Study|NA-no code provided|0|||
105446683|NCT03710642|363641183|FG000|Overall Study|Withdrawal by Subject|1|||
105446684|NCT03710642|363641184|FG001|Overall Study|Withdrawal by Subject|0|||
105446685|NCT01427933|363641185|FG000|Overall Study|Withdrawal by Subject|5|||
105446686|NCT01427933|363641186|FG001|Overall Study|Withdrawal by Subject|8|||
105446687|NCT01427933|363641185|FG000|Overall Study|Lost to Follow-up|1|||
105446688|NCT01427933|363641186|FG001|Overall Study|Lost to Follow-up|5|||
105446689|NCT01427933|363641185|FG000|Overall Study|Other|1|||
105446690|NCT01427933|363641186|FG001|Overall Study|Other|0|||
105446691|NCT01427933|363641185|FG000|Overall Study|Investigator's Decision|1|||
105446692|NCT01427933|363641186|FG001|Overall Study|Investigator's Decision|0|||
105446693|NCT03472326|363641187|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
105446694|NCT03472326|363641188|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
105446695|NCT03472326|363641189|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
105446696|NCT03472326|363641190|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
105446697|NCT03472326|363641187|FG000|Part 2: Combination Therapy|Pregnancy|0|||
105446698|NCT03472326|363641188|FG001|Part 2: Combination Therapy|Pregnancy|0|||
105446699|NCT03472326|363641189|FG002|Part 2: Combination Therapy|Pregnancy|0|||
105446700|NCT03472326|363641190|FG003|Part 2: Combination Therapy|Pregnancy|1|||
105446701|NCT05447663|363641191|FG000|Overall Study|Study terminated by Sponsor|5|||
105446702|NCT05447663|363641191|FG000|Overall Study|Death|2|||
105446703|NCT05447663|363641191|FG000|Overall Study|Withdrawal by Subject|1|||
105446704|NCT03797586|363641192|FG000|Overall Study|Lost to Follow-up|3|||
105446705|NCT03797586|363641193|FG001|Overall Study|Lost to Follow-up|6|||
105446706|NCT03797586|363641192|FG000|Overall Study|Death|1|||
105446707|NCT03797586|363641193|FG001|Overall Study|Death|1|||
105446708|NCT03797586|363641192|FG000|Overall Study|Adverse Event|0|||
105446709|NCT03797586|363641193|FG001|Overall Study|Adverse Event|2|||
105446710|NCT01369784|363641194|FG000|Overall Study|Protocol Violation|12|||
105446711|NCT04797780|363641195|FG000|Overall Study|Lost to Follow-up|1|||
105446712|NCT04797780|363641196|FG001|Overall Study|Lost to Follow-up|1|||
105446713|NCT04797780|363641195|FG000|Overall Study|Withdrawal by Subject|14|||
105446714|NCT04797780|363641196|FG001|Overall Study|Withdrawal by Subject|9|||
105446715|NCT04797780|363641195|FG000|Overall Study|Death|49|||
105446716|NCT04797780|363641196|FG001|Overall Study|Death|20|||
105446717|NCT02586727|363641197|FG000|Overall Study|Lost to Follow-up|1|||
105446718|NCT02586727|363641198|FG001|Overall Study|Lost to Follow-up|0|||
105446719|NCT00566852|363641201|FG000|Overall Study|Protocol Violation|22|||
105446720|NCT00566852|363641202|FG001|Overall Study|Protocol Violation|24|||
105446721|NCT00566852|363641201|FG000|Overall Study|Death|95|||
105446722|NCT00566852|363641202|FG001|Overall Study|Death|78|||
105446723|NCT00566852|363641201|FG000|Overall Study|Withdrawal by Subject|30|||
105446724|NCT00566852|363641202|FG001|Overall Study|Withdrawal by Subject|25|||
105446725|NCT00566852|363641201|FG000|Overall Study|Patient refusal|37|||
105446726|NCT00566852|363641202|FG001|Overall Study|Patient refusal|37|||
105446727|NCT00566852|363641201|FG000|Overall Study|Not tested due to disability|6|||
105446728|NCT00566852|363641202|FG001|Overall Study|Not tested due to disability|12|||
105446729|NCT00566852|363641201|FG000|Overall Study|Missing reason not specified|1|||
105446730|NCT00566852|363641202|FG001|Overall Study|Missing reason not specified|2|||
105446731|NCT00566852|363641201|FG000|Overall Study|Missing reason not reported|16|||
105446732|NCT00566852|363641202|FG001|Overall Study|Missing reason not reported|20|||
105446733|NCT01147055|363641203|FG000|First Intervention Period|Lost to Follow-up|1|||
105446734|NCT01147055|363641204|FG001|First Intervention Period|Lost to Follow-up|0|||
105446735|NCT01327599|363641205|FG000|Overall Study|Adverse Event|1|||
105446736|NCT01327599|363641205|FG000|Overall Study|Could Not Attend Visit|1|||
105446737|NCT01327599|363641205|FG000|Overall Study|Withdrawal of Consent|1|||
105446738|NCT04544956|363641206|FG000|Overall Study|Withdrawal by Subject|1|||
105446739|NCT03952039|363641207|FG000|Overall Study|Adverse Event|22|||
105446740|NCT03952039|363641208|FG001|Overall Study|Adverse Event|8|||
105446741|NCT03952039|363641207|FG000|Overall Study|Withdrawal by Participant|17|||
105446742|NCT03952039|363641208|FG001|Overall Study|Withdrawal by Participant|12|||
105446743|NCT03952039|363641207|FG000|Overall Study|Death|13|||
105446744|NCT03952039|363641208|FG001|Overall Study|Death|6|||
105446745|NCT03952039|363641207|FG000|Overall Study|Lack of Efficacy|12|||
105446746|NCT03952039|363641208|FG001|Overall Study|Lack of Efficacy|2|||
105446747|NCT03952039|363641207|FG000|Overall Study|Physician Decision|9|||
105446748|NCT03952039|363641208|FG001|Overall Study|Physician Decision|3|||
105446749|NCT03952039|363641207|FG000|Overall Study|Progressive Disease|6|||
105446750|NCT03952039|363641208|FG001|Overall Study|Progressive Disease|4|||
105446751|NCT03952039|363641207|FG000|Overall Study|Other Reasons|12|||
105446752|NCT03952039|363641208|FG001|Overall Study|Other Reasons|4|||
105446753|NCT00874848|363641211|FG000|Overall Study|Adverse Event|13|||
105446754|NCT00874848|363641212|FG001|Overall Study|Adverse Event|2|||
105446755|NCT00874848|363641211|FG000|Overall Study|Progressive neoplastic disease|38|||
105446756|NCT00874848|363641212|FG001|Overall Study|Progressive neoplastic disease|18|||
105446757|NCT00874848|363641211|FG000|Overall Study|Withdrawal by Subject|7|||
105446758|NCT00874848|363641212|FG001|Overall Study|Withdrawal by Subject|4|||
105446759|NCT00874848|363641211|FG000|Overall Study|Noncompliance|1|||
105446760|NCT00874848|363641212|FG001|Overall Study|Noncompliance|1|||
105446761|NCT00874848|363641211|FG000|Overall Study|Failure to comply with protocol|0|||
105446762|NCT00874848|363641212|FG001|Overall Study|Failure to comply with protocol|1|||
105446763|NCT00874848|363641211|FG000|Overall Study|Physician Decision|0|||
105446764|NCT00874848|363641212|FG001|Overall Study|Physician Decision|2|||
105446765|NCT00892775|363641216|FG000|Overall Study|Protocol Violation|1|||
105446766|NCT00892775|363641217|FG001|Overall Study|Protocol Violation|0|||
105446767|NCT00892775|363641216|FG000|Overall Study|Subject difficulties with blood drawing|1|||
105446768|NCT00892775|363641217|FG001|Overall Study|Subject difficulties with blood drawing|0|||
105446769|NCT00892775|363641216|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
105446770|NCT00892775|363641217|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
105446771|NCT00892775|363641216|FG000|Overall Study|Migrated/ moved from study area|1|||
105446772|NCT00892775|363641217|FG001|Overall Study|Migrated/ moved from study area|0|||
105446773|NCT00892775|363641216|FG000|Overall Study|Withdrawal by Subject|0|||
105446774|NCT00892775|363641217|FG001|Overall Study|Withdrawal by Subject|1|||
105446775|NCT00892775|363641216|FG000|Overall Study|Lost to Follow-up|1|||
105446776|NCT00892775|363641217|FG001|Overall Study|Lost to Follow-up|0|||
105446777|NCT00064792|363641218|FG000|Overall Study|Withdrawal by Subject|2|||
105446778|NCT00064792|363641219|FG001|Overall Study|Withdrawal by Subject|0|||
105446779|NCT00064792|363641218|FG000|Overall Study|Adverse Event|3|||
105446780|NCT00064792|363641219|FG001|Overall Study|Adverse Event|0|||
105446781|NCT03301350|363641220|FG000|Overall Study|Withdrawal by Subject|4|||
105446782|NCT03301350|363641220|FG000|Overall Study|Adverse Event|1|||
105446783|NCT03301350|363641220|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
105446784|NCT03301350|363641220|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
105446785|NCT03301350|363641220|FG000|Overall Study|no detail provided|1|||
105446786|NCT03405818|363641223|FG000|Overall Study|Withdrawal by Subject|4|||
105446787|NCT03405818|363641223|FG000|Overall Study|Lost to Follow-up|4|||
105446788|NCT02464410|363641226|FG000|Overall Study|Death|3|||
105446789|NCT02464410|363641227|FG001|Overall Study|Death|4|||
105446790|NCT02464410|363641226|FG000|Overall Study|Lost to Follow-up|7|||
105446791|NCT02464410|363641227|FG001|Overall Study|Lost to Follow-up|9|||
105446792|NCT02464410|363641226|FG000|Overall Study|Withdrawal by Subject|12|||
105446793|NCT02464410|363641227|FG001|Overall Study|Withdrawal by Subject|3|||
105446794|NCT00176462|363641228|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
105446795|NCT00176462|363641229|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
105446796|NCT00176462|363641228|FG000|Induction (4 Weeks)|Death|1|||
105446797|NCT00176462|363641229|FG001|Induction (4 Weeks)|Death|2|||
105446798|NCT00176462|363641228|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
105446799|NCT00176462|363641229|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
105446800|NCT00176462|363641228|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
105446801|NCT00176462|363641229|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
105446802|NCT00176462|363641228|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
105446803|NCT00176462|363641229|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
105446804|NCT00176462|363641228|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
105446805|NCT00176462|363641229|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
105446806|NCT00176462|363641228|FG000|Consolidation (12 Weeks)|Not documented|0|||
105446807|NCT00176462|363641229|FG001|Consolidation (12 Weeks)|Not documented|1|||
105446808|NCT00176462|363641228|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
105446809|NCT00176462|363641229|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
105446810|NCT00176462|363641228|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
105446811|NCT00176462|363641229|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
105446812|NCT00543387|363641230|FG000|Panel 1 + Panel 2|Adverse Event|0|||
105446813|NCT00543387|363641231|FG001|Panel 1 + Panel 2|Adverse Event|1|||
105446814|NCT00543387|363641232|FG002|Panel 1 + Panel 2|Adverse Event|0|||
105446815|NCT00543387|363641233|FG003|Panel 1 + Panel 2|Adverse Event|0|||
105446816|NCT00543387|363641234|FG004|Panel 1 + Panel 2|Adverse Event|0|||
105446817|NCT00543387|363641235|FG005|Panel 1 + Panel 2|Adverse Event|0|||
105446818|NCT00543387|363641236|FG006|Panel 1 + Panel 2|Adverse Event|0|||
105446819|NCT00543387|363641237|FG007|Panel 1 + Panel 2|Adverse Event|1|||
105446820|NCT00543387|363641238|FG008|Panel 1 + Panel 2|Adverse Event|1|||
105446821|NCT00543387|363641239|FG009|Panel 1 + Panel 2|Adverse Event|0|||
105446822|NCT00543387|363641240|FG010|Panel 1 + Panel 2|Adverse Event|0|||
105446823|NCT00543387|363641230|FG000|Panel 1 + Panel 2|Physician Decision|0|||
105446824|NCT00543387|363641231|FG001|Panel 1 + Panel 2|Physician Decision|0|||
105446825|NCT00543387|363641232|FG002|Panel 1 + Panel 2|Physician Decision|1|||
105446826|NCT00543387|363641233|FG003|Panel 1 + Panel 2|Physician Decision|0|||
105446827|NCT00543387|363641234|FG004|Panel 1 + Panel 2|Physician Decision|0|||
105446828|NCT00543387|363641235|FG005|Panel 1 + Panel 2|Physician Decision|0|||
105446829|NCT00543387|363641236|FG006|Panel 1 + Panel 2|Physician Decision|0|||
105446830|NCT00543387|363641237|FG007|Panel 1 + Panel 2|Physician Decision|1|||
105446831|NCT00543387|363641238|FG008|Panel 1 + Panel 2|Physician Decision|0|||
105446832|NCT00543387|363641239|FG009|Panel 1 + Panel 2|Physician Decision|0|||
105446833|NCT00543387|363641240|FG010|Panel 1 + Panel 2|Physician Decision|0|||
105446834|NCT00543387|363641230|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
105446835|NCT00543387|363641231|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
105446836|NCT00543387|363641232|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
105446837|NCT00543387|363641233|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
105446838|NCT00543387|363641234|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
105446839|NCT00543387|363641235|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
105446840|NCT00543387|363641236|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
105446841|NCT00543387|363641237|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
105446842|NCT00543387|363641238|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
105446843|NCT00543387|363641239|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
105446844|NCT00543387|363641240|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
105446845|NCT00543387|363641230|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105781730|NCT02493712|364854830|FG000|Overall Study|Withdrawal by Subject|1|||
105446846|NCT00543387|363641231|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105446847|NCT00543387|363641232|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105781731|NCT02493712|364854831|FG001|Overall Study|Withdrawal by Subject|0|||
105781732|NCT02493712|364854832|FG002|Overall Study|Withdrawal by Subject|2|||
105446848|NCT00543387|363641233|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105446849|NCT00543387|363641234|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105446850|NCT00543387|363641235|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105446851|NCT00543387|363641236|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
105446852|NCT00543387|363641237|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105446853|NCT00543387|363641238|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105446854|NCT00543387|363641239|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105446855|NCT00543387|363641240|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105446856|NCT00543387|363641230|FG000|Crossover Participants|Progressive Disease|0|||
105446857|NCT00543387|363641231|FG001|Crossover Participants|Progressive Disease|0|||
105446858|NCT00543387|363641232|FG002|Crossover Participants|Progressive Disease|0|||
105446859|NCT00543387|363641233|FG003|Crossover Participants|Progressive Disease|0|||
105446860|NCT00543387|363641234|FG004|Crossover Participants|Progressive Disease|0|||
105446861|NCT00543387|363641235|FG005|Crossover Participants|Progressive Disease|0|||
105446862|NCT00543387|363641236|FG006|Crossover Participants|Progressive Disease|0|||
105446863|NCT00543387|363641237|FG007|Crossover Participants|Progressive Disease|0|||
105446864|NCT00543387|363641238|FG008|Crossover Participants|Progressive Disease|0|||
105446865|NCT00543387|363641239|FG009|Crossover Participants|Progressive Disease|1|||
105446866|NCT00543387|363641240|FG010|Crossover Participants|Progressive Disease|2|||
105446867|NCT00543387|363641230|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
105446868|NCT00543387|363641231|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
105446869|NCT00543387|363641232|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
105446870|NCT00543387|363641233|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
105446871|NCT00543387|363641234|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
105446872|NCT00543387|363641235|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
105446873|NCT00543387|363641236|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
105446874|NCT00543387|363641237|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
105446875|NCT00543387|363641238|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
105446876|NCT00543387|363641239|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
105446877|NCT00543387|363641240|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
105446878|NCT03922620|363641241|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
105446879|NCT03922620|363641242|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
105446880|NCT03566082|363641243|FG000|Overall Study|Death|7|||
105446881|NCT03566082|363641243|FG000|Overall Study|Failures (revision required)|2|||
105446882|NCT03566082|363641243|FG000|Overall Study|Lost to Follow-up|8|||
105446883|NCT02663622|363641244|FG000|Overall Study|Death|3|||
105446884|NCT02663622|363641245|FG001|Overall Study|Death|1|||
105446885|NCT02663622|363641246|FG002|Overall Study|Death|1|||
105446886|NCT02663622|363641247|FG003|Overall Study|Death|8|||
105446887|NCT02663622|363641244|FG000|Overall Study|Protocol Violation|0|||
105446888|NCT02663622|363641245|FG001|Overall Study|Protocol Violation|0|||
105446889|NCT02663622|363641246|FG002|Overall Study|Protocol Violation|0|||
105446890|NCT02663622|363641247|FG003|Overall Study|Protocol Violation|1|||
105446891|NCT01799226|363643889|FG000|Overall Study|Withdrawal by Subject|1|||
105446892|NCT01799226|363643890|FG001|Overall Study|Withdrawal by Subject|0|||
105446893|NCT01799226|363643889|FG000|Overall Study|Disqualified at Day 14|1|||
105446894|NCT01799226|363643890|FG001|Overall Study|Disqualified at Day 14|0|||
105446895|NCT02178995|363643891|FG000|Double Blind|Adverse Event|0|||
105446896|NCT02178995|363643892|FG001|Double Blind|Adverse Event|0|||
105446897|NCT02178995|363643893|FG002|Double Blind|Adverse Event|0|||
105446898|NCT02178995|363643894|FG003|Double Blind|Adverse Event|0|||
105446899|NCT02178995|363643895|FG004|Double Blind|Adverse Event|0|||
105446900|NCT02178995|363643896|FG005|Double Blind|Adverse Event|1|||
105446901|NCT02178995|363643897|FG006|Double Blind|Adverse Event|0|||
105446902|NCT02178995|363643898|FG007|Double Blind|Adverse Event|1|||
105446903|NCT02178995|363643899|FG008|Double Blind|Adverse Event|1|||
105446904|NCT02178995|363643891|FG000|Double Blind|Lost to Follow-up|0|||
105446905|NCT02178995|363643892|FG001|Double Blind|Lost to Follow-up|1|||
105446906|NCT02178995|363643893|FG002|Double Blind|Lost to Follow-up|0|||
105446907|NCT02178995|363643894|FG003|Double Blind|Lost to Follow-up|0|||
105446908|NCT02178995|363643895|FG004|Double Blind|Lost to Follow-up|0|||
105446909|NCT02178995|363643896|FG005|Double Blind|Lost to Follow-up|0|||
105446910|NCT02178995|363643897|FG006|Double Blind|Lost to Follow-up|0|||
105446911|NCT02178995|363643898|FG007|Double Blind|Lost to Follow-up|1|||
105446912|NCT02178995|363643899|FG008|Double Blind|Lost to Follow-up|0|||
105446913|NCT02178995|363643891|FG000|Open Label|Adverse Event|2|||
105446914|NCT02178995|363643892|FG001|Open Label|Adverse Event|0|||
105446915|NCT02178995|363643893|FG002|Open Label|Adverse Event|0|||
105446916|NCT02178995|363643894|FG003|Open Label|Adverse Event|0|||
105446917|NCT02178995|363643895|FG004|Open Label|Adverse Event|0|||
105446918|NCT02178995|363643896|FG005|Open Label|Adverse Event|0|||
105446919|NCT02178995|363643897|FG006|Open Label|Adverse Event|0|||
105446920|NCT02178995|363643898|FG007|Open Label|Adverse Event|0|||
105446921|NCT02178995|363643899|FG008|Open Label|Adverse Event|0|||
105446922|NCT00699608|363643900|FG000|First Intervention|Withdrawal by Subject|0|||
105446923|NCT00699608|363643901|FG001|First Intervention|Withdrawal by Subject|0|||
105446924|NCT00699608|363643902|FG002|First Intervention|Withdrawal by Subject|1|||
105446925|NCT00699608|363643903|FG003|First Intervention|Withdrawal by Subject|0|||
105446926|NCT00699608|363643904|FG004|First Intervention|Withdrawal by Subject|0|||
105446927|NCT00699608|363643905|FG005|First Intervention|Withdrawal by Subject|0|||
105446928|NCT00699608|363643900|FG000|First Intervention|Protocol Violation|0|||
105446929|NCT00699608|363643901|FG001|First Intervention|Protocol Violation|0|||
105446930|NCT00699608|363643902|FG002|First Intervention|Protocol Violation|0|||
105446931|NCT00699608|363643903|FG003|First Intervention|Protocol Violation|0|||
105446932|NCT00699608|363643904|FG004|First Intervention|Protocol Violation|1|||
105446933|NCT00699608|363643905|FG005|First Intervention|Protocol Violation|0|||
105446934|NCT00699608|363643900|FG000|Second Intervention|Adverse Event|0|||
105446935|NCT00699608|363643901|FG001|Second Intervention|Adverse Event|0|||
105446936|NCT00699608|363643902|FG002|Second Intervention|Adverse Event|1|||
105446937|NCT00699608|363643903|FG003|Second Intervention|Adverse Event|0|||
105446938|NCT00699608|363643904|FG004|Second Intervention|Adverse Event|0|||
105446939|NCT00699608|363643905|FG005|Second Intervention|Adverse Event|0|||
105446940|NCT00699608|363643900|FG000|Second Intervention|Withdrawal by Subject|0|||
105446941|NCT00699608|363643901|FG001|Second Intervention|Withdrawal by Subject|0|||
105446942|NCT00699608|363643902|FG002|Second Intervention|Withdrawal by Subject|0|||
105446943|NCT00699608|363643903|FG003|Second Intervention|Withdrawal by Subject|1|||
105446944|NCT00699608|363643904|FG004|Second Intervention|Withdrawal by Subject|0|||
105446945|NCT00699608|363643905|FG005|Second Intervention|Withdrawal by Subject|0|||
105446946|NCT02003534|363643906|FG000|Overall Study|Lost to Follow-up|47|||
105446947|NCT03187132|363643907|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
105446948|NCT03187132|363643908|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
105446949|NCT03187132|363643907|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
105446950|NCT03187132|363643908|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
105446951|NCT03187132|363643907|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
105446952|NCT03187132|363643908|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
105446953|NCT03187132|363643907|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
105446954|NCT03187132|363643908|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
105446955|NCT03187132|363643907|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
105446956|NCT03187132|363643908|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
105446957|NCT03187132|363643907|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
105446958|NCT03187132|363643908|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
105446959|NCT03187132|363643907|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
105446960|NCT03187132|363643908|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
105446961|NCT03187132|363643907|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
105446962|NCT03187132|363643908|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
105446963|NCT03187132|363643907|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
105446964|NCT03187132|363643908|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
105446965|NCT03187132|363643907|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
105446966|NCT03187132|363643908|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
105446967|NCT03187132|363643907|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
105446968|NCT03187132|363643908|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
105446969|NCT03594773|363643909|FG000|Overall Study|Withdrawal by Subject|3|||
105446970|NCT03594773|363643910|FG001|Overall Study|Withdrawal by Subject|2|||
105446971|NCT03594773|363643909|FG000|Overall Study|Lost to Follow-up|3|||
105446972|NCT03594773|363643910|FG001|Overall Study|Lost to Follow-up|4|||
105446973|NCT02342223|363643914|FG000|Overall Study|Lost to Follow-up|1|||
105446974|NCT00496080|363643917|FG000|Overall Study|Lost to Follow-up|9|||
105446975|NCT00496080|363643917|FG000|Overall Study|Surgical re-intervention|7|||
105446976|NCT00496080|363643917|FG000|Overall Study|Withdrawal by Subject|5|||
105446977|NCT00496080|363643917|FG000|Overall Study|Physician Decision|6|||
105446978|NCT01290757|363643918|FG000|Overall Study|Adverse Event|1|||
105446979|NCT01290757|363643919|FG001|Overall Study|Adverse Event|0|||
105446980|NCT01290757|363643918|FG000|Overall Study|Protocol Violation|1|||
105446981|NCT01290757|363643919|FG001|Overall Study|Protocol Violation|1|||
105446982|NCT01290757|363643918|FG000|Overall Study|Other|0|||
105446983|NCT01290757|363643919|FG001|Overall Study|Other|1|||
105446984|NCT00887549|363643920|FG000|Induction Therapy|Adverse Event|8|||
105446985|NCT00887549|363643920|FG000|Induction Therapy|Physician Decision|1|||
105446986|NCT00887549|363643920|FG000|Induction Therapy|Progressive Disease|13|||
105446987|NCT00887549|363643920|FG000|Induction Therapy|Death due to Study Disease|4|||
105446988|NCT00887549|363643920|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
105446989|NCT00887549|363643920|FG000|Maintenance Therapy|Adverse Event|16|||
105446990|NCT00887549|363643920|FG000|Maintenance Therapy|Physician Decision|1|||
105446991|NCT00887549|363643920|FG000|Maintenance Therapy|Progressive Disease|25|||
105446992|NCT00887549|363643920|FG000|Maintenance Therapy|Death due to adverse event|1|||
105446993|NCT00100789|363643921|FG000|Overall Study|Adverse Event|10|||
105446994|NCT00100789|363643921|FG000|Overall Study|Withdrawal by Subject|1|||
105446995|NCT00100789|363643921|FG000|Overall Study|Progression/relapse|42|||
105446996|NCT00100789|363643921|FG000|Overall Study|Death|2|||
105446997|NCT00100789|363643921|FG000|Overall Study|Not protocol specified|5|||
105446998|NCT00100789|363643921|FG000|Overall Study|Ineligible|3|||
105446999|NCT00100789|363643921|FG000|Overall Study|Never received treatment|1|||
105447000|NCT00991939|363643925|FG000|Overall Study|Lost to Follow-up|0|||
105447001|NCT00991939|363643926|FG001|Overall Study|Lost to Follow-up|1|||
105447002|NCT00991939|363643925|FG000|Overall Study|Withdrawal by Subject|1|||
105447003|NCT00991939|363643926|FG001|Overall Study|Withdrawal by Subject|0|||
105447004|NCT00991939|363643925|FG000|Overall Study|Entire study terminated|4|||
105447005|NCT00991939|363643926|FG001|Overall Study|Entire study terminated|1|||
105447006|NCT00714415|363643929|FG000|Overall Study|Lack of Efficacy|1|||
105447007|NCT00714415|363643930|FG001|Overall Study|Lack of Efficacy|0|||
105447008|NCT00714415|363643929|FG000|Overall Study|Death|1|||
105447009|NCT00714415|363643930|FG001|Overall Study|Death|0|||
105447010|NCT00740584|363643931|FG000|Overall Study|Withdrawal by Subject|1|||
105447011|NCT00687804|363643943|FG000|Core Study|Adverse Event|5|||
105447012|NCT00687804|363643944|FG001|Core Study|Adverse Event|3|||
105447013|NCT00687804|363643945|FG002|Core Study|Adverse Event|3|||
105447014|NCT00687804|363643943|FG000|Core Study|Abnormal laboratory value(s)|1|||
105447015|NCT00687804|363643944|FG001|Core Study|Abnormal laboratory value(s)|0|||
105447016|NCT00687804|363643945|FG002|Core Study|Abnormal laboratory value(s)|0|||
105447017|NCT00687804|363643943|FG000|Core Study|Lack of Efficacy|1|||
105447018|NCT00687804|363643944|FG001|Core Study|Lack of Efficacy|1|||
105447019|NCT00687804|363643945|FG002|Core Study|Lack of Efficacy|1|||
105447020|NCT00687804|363643943|FG000|Core Study|Withdrawal by Subject|4|||
105447021|NCT00687804|363643944|FG001|Core Study|Withdrawal by Subject|7|||
105447022|NCT00687804|363643945|FG002|Core Study|Withdrawal by Subject|7|||
105447023|NCT00687804|363643943|FG000|Core Study|Lost to Follow-up|0|||
105447024|NCT00687804|363643944|FG001|Core Study|Lost to Follow-up|1|||
105447025|NCT00687804|363643945|FG002|Core Study|Lost to Follow-up|0|||
105447026|NCT00687804|363643943|FG000|Core Study|Death|2|||
105447027|NCT00687804|363643944|FG001|Core Study|Death|2|||
105447028|NCT00687804|363643945|FG002|Core Study|Death|2|||
105447029|NCT00687804|363643943|FG000|Core Study|Protocol Violation|1|||
105447030|NCT00687804|363643944|FG001|Core Study|Protocol Violation|1|||
105447031|NCT00687804|363643945|FG002|Core Study|Protocol Violation|0|||
105447032|NCT00687804|363643943|FG000|Open-Label Extension Study|Adverse Event|2|||
105447033|NCT00687804|363643944|FG001|Open-Label Extension Study|Adverse Event|2|||
105447034|NCT00687804|363643945|FG002|Open-Label Extension Study|Adverse Event|2|||
105447035|NCT00687804|363643943|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
105447036|NCT00687804|363643944|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
105447037|NCT00687804|363643945|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
105447038|NCT00687804|363643943|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
105447039|NCT00687804|363643944|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
105447040|NCT00687804|363643945|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
105447041|NCT00687804|363643943|FG000|Open-Label Extension Study|Administrative problems|1|||
105447042|NCT00687804|363643944|FG001|Open-Label Extension Study|Administrative problems|1|||
105447043|NCT00687804|363643945|FG002|Open-Label Extension Study|Administrative problems|0|||
105447044|NCT00687804|363643943|FG000|Open-Label Extension Study|Death|2|||
105447045|NCT00687804|363643944|FG001|Open-Label Extension Study|Death|3|||
105447046|NCT00687804|363643945|FG002|Open-Label Extension Study|Death|3|||
105447047|NCT04390243|363643946|FG000|Overall Study|Death|1|||
105447048|NCT04390243|363643946|FG000|Overall Study|Disease Progression|4|||
105447049|NCT04390243|363643946|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
105447050|NCT00337207|363643947|FG000|Overall Study|Withdrawal by Subject|3|||
105447051|NCT01196026|363643949|FG000|Overall Study|Withdrawal by Subject|1|||
105447052|NCT01196026|363643950|FG001|Overall Study|Withdrawal by Subject|4|||
105447053|NCT01196026|363643951|FG002|Overall Study|Withdrawal by Subject|0|||
105447054|NCT01196026|363643952|FG003|Overall Study|Withdrawal by Subject|0|||
105447055|NCT01196026|363643953|FG004|Overall Study|Withdrawal by Subject|0|||
105447056|NCT01196026|363643954|FG005|Overall Study|Withdrawal by Subject|0|||
105447057|NCT01196026|363643949|FG000|Overall Study|Lost to Follow-up|0|||
105447058|NCT01196026|363643950|FG001|Overall Study|Lost to Follow-up|3|||
105447059|NCT01196026|363643951|FG002|Overall Study|Lost to Follow-up|0|||
105447060|NCT01196026|363643952|FG003|Overall Study|Lost to Follow-up|0|||
105447061|NCT01196026|363643953|FG004|Overall Study|Lost to Follow-up|1|||
105447062|NCT01196026|363643954|FG005|Overall Study|Lost to Follow-up|0|||
105447063|NCT01196026|363643949|FG000|Overall Study|Other|0|||
105447064|NCT01196026|363643950|FG001|Overall Study|Other|1|||
105447065|NCT01196026|363643951|FG002|Overall Study|Other|0|||
105447066|NCT01196026|363643952|FG003|Overall Study|Other|0|||
105447067|NCT01196026|363643953|FG004|Overall Study|Other|0|||
105447068|NCT01196026|363643954|FG005|Overall Study|Other|0|||
105447069|NCT02915263|363643957|FG000|Overall Study|Covid|3|||
105447070|NCT02915263|363643958|FG001|Overall Study|Covid|2|||
105447071|NCT04950465|363643961|FG000|Overall Study|Lost to Follow-up|1|||
105447072|NCT04950465|363643962|FG001|Overall Study|Lost to Follow-up|0|||
105447073|NCT04950465|363643963|FG002|Overall Study|Lost to Follow-up|0|||
105447074|NCT00684996|363643964|FG000|Overall Study|Adverse Event|1|||
105447075|NCT00684996|363643964|FG000|Overall Study|Refusal unrelated to adverse event|1|||
105447076|NCT00684996|363643964|FG000|Overall Study|Progression/relapse|2|||
105447077|NCT00684996|363643964|FG000|Overall Study|Other reasons not protocol specified|1|||
105447078|NCT03030417|363643965|FG000|Dose Expansion|Disease progression before treatment|0|||
105447079|NCT03030417|363643966|FG001|Dose Expansion|Disease progression before treatment|0|||
105447080|NCT03030417|363643967|FG002|Dose Expansion|Disease progression before treatment|0|||
105447081|NCT03030417|363643968|FG003|Dose Expansion|Disease progression before treatment|0|||
105447082|NCT03030417|363643969|FG004|Dose Expansion|Disease progression before treatment|0|||
105447083|NCT03030417|363643970|FG005|Dose Expansion|Disease progression before treatment|0|||
105447084|NCT03030417|363643971|FG006|Dose Expansion|Disease progression before treatment|0|||
105447085|NCT03030417|363643972|FG007|Dose Expansion|Disease progression before treatment|0|||
105447086|NCT03030417|363643973|FG008|Dose Expansion|Disease progression before treatment|0|||
105447087|NCT03030417|363643974|FG009|Dose Expansion|Disease progression before treatment|0|||
105447088|NCT03030417|363643975|FG010|Dose Expansion|Disease progression before treatment|0|||
105447089|NCT03030417|363643976|FG011|Dose Expansion|Disease progression before treatment|0|||
105447090|NCT03030417|363643977|FG012|Dose Expansion|Disease progression before treatment|1|||
105447091|NCT02491983|363643978|FG000|Overall Study|Physician Decision|1|||
105447092|NCT02491983|363643979|FG001|Overall Study|Physician Decision|0|||
105447093|NCT02491983|363643978|FG000|Overall Study|Not meet selection criteria|1|||
105447094|NCT02491983|363643979|FG001|Overall Study|Not meet selection criteria|0|||
105447095|NCT02491983|363643978|FG000|Overall Study|Withdrawal by Subject|0|||
105447096|NCT02491983|363643979|FG001|Overall Study|Withdrawal by Subject|1|||
105447097|NCT04961541|363643980|FG000|Overall Study|Adverse Event|0|||
105447098|NCT04961541|363643981|FG001|Overall Study|Adverse Event|0|||
105447099|NCT04961541|363643982|FG002|Overall Study|Adverse Event|0|||
105447100|NCT04961541|363643983|FG003|Overall Study|Adverse Event|0|||
105447101|NCT04961541|363643984|FG004|Overall Study|Adverse Event|0|||
105447102|NCT04961541|363643985|FG005|Overall Study|Adverse Event|1|||
105447103|NCT04961541|363643986|FG006|Overall Study|Adverse Event|0|||
105447104|NCT04961541|363643987|FG007|Overall Study|Adverse Event|0|||
105447105|NCT04961541|363643988|FG008|Overall Study|Adverse Event|0|||
105447106|NCT04961541|363643989|FG009|Overall Study|Adverse Event|0|||
105447107|NCT04961541|363643990|FG010|Overall Study|Adverse Event|0|||
105447108|NCT04961541|363643991|FG011|Overall Study|Adverse Event|0|||
105447109|NCT04961541|363643992|FG012|Overall Study|Adverse Event|0|||
105447110|NCT04961541|363643993|FG013|Overall Study|Adverse Event|0|||
105447111|NCT04961541|363643980|FG000|Overall Study|Lost to Follow-up|0|||
105447112|NCT04961541|363643981|FG001|Overall Study|Lost to Follow-up|0|||
105447113|NCT04961541|363643982|FG002|Overall Study|Lost to Follow-up|3|||
105447114|NCT04961541|363643983|FG003|Overall Study|Lost to Follow-up|0|||
105447115|NCT04961541|363643984|FG004|Overall Study|Lost to Follow-up|0|||
105447116|NCT04961541|363643985|FG005|Overall Study|Lost to Follow-up|0|||
105447117|NCT04961541|363643986|FG006|Overall Study|Lost to Follow-up|1|||
105447118|NCT04961541|363643987|FG007|Overall Study|Lost to Follow-up|1|||
105447119|NCT04961541|363643988|FG008|Overall Study|Lost to Follow-up|0|||
105447120|NCT04961541|363643989|FG009|Overall Study|Lost to Follow-up|1|||
105447121|NCT04961541|363643990|FG010|Overall Study|Lost to Follow-up|0|||
105447122|NCT04961541|363643991|FG011|Overall Study|Lost to Follow-up|0|||
105447123|NCT04961541|363643992|FG012|Overall Study|Lost to Follow-up|1|||
105447124|NCT04961541|363643993|FG013|Overall Study|Lost to Follow-up|0|||
105447125|NCT04961541|363643980|FG000|Overall Study|Withdrawal by Subject|0|||
105447126|NCT04961541|363643981|FG001|Overall Study|Withdrawal by Subject|0|||
105447127|NCT04961541|363643982|FG002|Overall Study|Withdrawal by Subject|1|||
105447128|NCT04961541|363643983|FG003|Overall Study|Withdrawal by Subject|1|||
105447129|NCT04961541|363643984|FG004|Overall Study|Withdrawal by Subject|0|||
105447130|NCT04961541|363643985|FG005|Overall Study|Withdrawal by Subject|0|||
105447131|NCT04961541|363643986|FG006|Overall Study|Withdrawal by Subject|0|||
105447132|NCT04961541|363643987|FG007|Overall Study|Withdrawal by Subject|0|||
105447133|NCT04961541|363643988|FG008|Overall Study|Withdrawal by Subject|0|||
105447134|NCT04961541|363643989|FG009|Overall Study|Withdrawal by Subject|1|||
105447135|NCT04961541|363643990|FG010|Overall Study|Withdrawal by Subject|0|||
105447136|NCT04961541|363643991|FG011|Overall Study|Withdrawal by Subject|0|||
105447137|NCT04961541|363643992|FG012|Overall Study|Withdrawal by Subject|0|||
105447138|NCT04961541|363643993|FG013|Overall Study|Withdrawal by Subject|0|||
105550182|NCT04743908|364014373|FG001|Overall Study|Death|0|||
105550183|NCT04743908|364014372|FG000|Overall Study|Lost to Follow-up|181|||
105550184|NCT04743908|364014373|FG001|Overall Study|Lost to Follow-up|180|||
105550185|NCT04743908|364014372|FG000|Overall Study|Withdrawal by Subject|1|||
105447143|NCT01684202|363643996|FG000|Dose-escalation Period|Adverse Event|0|||
105447144|NCT01684202|363643997|FG001|Dose-escalation Period|Adverse Event|1|||
105447145|NCT01684202|363643998|FG002|Dose-escalation Period|Adverse Event|0|||
105447146|NCT01684202|363643999|FG003|Dose-escalation Period|Adverse Event|0|||
105447147|NCT01684202|363643996|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
105447148|NCT01684202|363643997|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
105781733|NCT02493712|364854830|FG000|Overall Study|Protocol Violation|0|||
105781734|NCT02493712|364854831|FG001|Overall Study|Protocol Violation|0|||
105447149|NCT01684202|363643998|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
105447150|NCT01684202|363643999|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
105550186|NCT04743908|364014373|FG001|Overall Study|Withdrawal by Subject|2|||
105550187|NCT00467870|364014374|FG000|Overall Study|Adverse Event|13|||
105447151|NCT01684202|363643996|FG000|Maintenance Period|Adverse Event|1|||
105447152|NCT01684202|363643997|FG001|Maintenance Period|Adverse Event|1|||
105447153|NCT01684202|363643998|FG002|Maintenance Period|Adverse Event|1|||
105447154|NCT01684202|363643999|FG003|Maintenance Period|Adverse Event|1|||
105447155|NCT01684202|363643996|FG000|Maintenance Period|Physician Decision|0|||
105447156|NCT01684202|363643997|FG001|Maintenance Period|Physician Decision|1|||
105447157|NCT01684202|363643998|FG002|Maintenance Period|Physician Decision|0|||
105447158|NCT01684202|363643999|FG003|Maintenance Period|Physician Decision|0|||
105447159|NCT01684202|363643996|FG000|Maintenance Period|Withdrawal by Subject|0|||
105447160|NCT01684202|363643997|FG001|Maintenance Period|Withdrawal by Subject|1|||
105447161|NCT01684202|363643998|FG002|Maintenance Period|Withdrawal by Subject|0|||
105447162|NCT01684202|363643999|FG003|Maintenance Period|Withdrawal by Subject|0|||
105447163|NCT03539601|363644001|FG000|Overall Study|Withdraw by parent/guardian|1|||
105447164|NCT03539601|363644002|FG001|Overall Study|Withdraw by parent/guardian|0|||
105447165|NCT03539601|363644003|FG002|Overall Study|Withdraw by parent/guardian|1|||
105447166|NCT03539601|363644004|FG003|Overall Study|Withdraw by parent/guardian|0|||
105447167|NCT03539601|363644001|FG000|Overall Study|Adverse Event|0|||
105447168|NCT03539601|363644002|FG001|Overall Study|Adverse Event|2|||
105447169|NCT03539601|363644003|FG002|Overall Study|Adverse Event|0|||
105447170|NCT03539601|363644004|FG003|Overall Study|Adverse Event|0|||
105447171|NCT03539601|363644001|FG000|Overall Study|Lost to Follow-up|2|||
105447172|NCT03539601|363644002|FG001|Overall Study|Lost to Follow-up|4|||
105447173|NCT03539601|363644003|FG002|Overall Study|Lost to Follow-up|5|||
105447174|NCT03539601|363644004|FG003|Overall Study|Lost to Follow-up|0|||
105447175|NCT03539601|363644001|FG000|Overall Study|Withdrawal by Subject|2|||
105447176|NCT03539601|363644002|FG001|Overall Study|Withdrawal by Subject|0|||
105447177|NCT03539601|363644003|FG002|Overall Study|Withdrawal by Subject|0|||
105447178|NCT03539601|363644004|FG003|Overall Study|Withdrawal by Subject|1|||
105447179|NCT03539601|363644001|FG000|Overall Study|Randomized but not treated|1|||
105447180|NCT03539601|363644002|FG001|Overall Study|Randomized but not treated|1|||
105447181|NCT03539601|363644003|FG002|Overall Study|Randomized but not treated|0|||
105447182|NCT03539601|363644004|FG003|Overall Study|Randomized but not treated|0|||
105447183|NCT01633541|363644005|FG000|Overall Study|Death|1|||
105447184|NCT01633541|363644006|FG001|Overall Study|Death|0|||
105447185|NCT00700713|363644010|FG000|Overall Study|Protocol Violation|1|||
105447186|NCT00700713|363644011|FG001|Overall Study|Protocol Violation|0|||
105447187|NCT00700713|363644012|FG002|Overall Study|Protocol Violation|1|||
105447188|NCT00700713|363644010|FG000|Overall Study|Withdrawal by Subject|0|||
105447189|NCT00700713|363644011|FG001|Overall Study|Withdrawal by Subject|0|||
105447190|NCT00700713|363644012|FG002|Overall Study|Withdrawal by Subject|1|||
105447191|NCT04980612|363644013|FG000|Overall Study|Withdrawal by Subject|7|||
105447192|NCT04980612|363644014|FG001|Overall Study|Withdrawal by Subject|5|||
105447193|NCT00770601|363644015|FG000|Overall Study|Withdrawal by Subject|1|||
105447194|NCT00132808|363644016|FG000|Stratum I|Adverse Event|2|||
105447195|NCT00132808|363644017|FG001|Stratum I|Adverse Event|1|||
105447196|NCT00132808|363644018|FG002|Stratum I|Adverse Event|0|||
105447197|NCT00132808|363644016|FG000|Stratum I|Lost to Follow-up|3|||
105447198|NCT00132808|363644017|FG001|Stratum I|Lost to Follow-up|4|||
105447199|NCT00132808|363644018|FG002|Stratum I|Lost to Follow-up|1|||
105447200|NCT00132808|363644016|FG000|Stratum I|Withdrawal by Subject|4|||
105447201|NCT00132808|363644017|FG001|Stratum I|Withdrawal by Subject|7|||
105447202|NCT00132808|363644018|FG002|Stratum I|Withdrawal by Subject|3|||
105447203|NCT00132808|363644016|FG000|Stratum I|Abnormal test procedure result (s)|0|||
105447204|NCT00132808|363644017|FG001|Stratum I|Abnormal test procedure result (s)|0|||
105447205|NCT00132808|363644018|FG002|Stratum I|Abnormal test procedure result (s)|1|||
105447206|NCT00132808|363644016|FG000|Stratum II|Adverse Event|1|||
105447207|NCT00132808|363644017|FG001|Stratum II|Adverse Event|2|||
105447208|NCT00132808|363644018|FG002|Stratum II|Adverse Event|1|||
105447209|NCT00132808|363644016|FG000|Stratum II|Death|1|||
105447210|NCT00132808|363644017|FG001|Stratum II|Death|0|||
105447211|NCT00132808|363644018|FG002|Stratum II|Death|0|||
105447212|NCT00132808|363644016|FG000|Stratum II|Lost to Follow-up|2|||
105447213|NCT00132808|363644017|FG001|Stratum II|Lost to Follow-up|2|||
105447214|NCT00132808|363644018|FG002|Stratum II|Lost to Follow-up|1|||
105447215|NCT00132808|363644016|FG000|Stratum II|Protocol Violation|0|||
105447216|NCT00132808|363644017|FG001|Stratum II|Protocol Violation|2|||
105447217|NCT00132808|363644018|FG002|Stratum II|Protocol Violation|1|||
105447218|NCT00132808|363644016|FG000|Stratum II|Withdrawal by Subject|4|||
105447219|NCT00132808|363644017|FG001|Stratum II|Withdrawal by Subject|9|||
105447220|NCT00132808|363644018|FG002|Stratum II|Withdrawal by Subject|6|||
105447221|NCT04739436|363644019|FG000|Overall Study|Lost to Follow-up|21|||
105447222|NCT04739436|363644020|FG001|Overall Study|Lost to Follow-up|23|||
105447223|NCT04739436|363644019|FG000|Overall Study|Withdrawal by Subject|4|||
105447224|NCT04739436|363644020|FG001|Overall Study|Withdrawal by Subject|6|||
105447225|NCT04739436|363644019|FG000|Overall Study|not randomized properly|1|||
105447226|NCT04739436|363644020|FG001|Overall Study|not randomized properly|0|||
105447227|NCT04491136|363644021|FG000|Overall Study|Patient withdraw informed consent|9|||
105447228|NCT04491136|363644021|FG000|Overall Study|Adverse Event|2|||
105447229|NCT04491136|363644021|FG000|Overall Study|Death|3|||
105447230|NCT04491136|363644021|FG000|Overall Study|Lost to Follow-up|3|||
105447231|NCT04491136|363644021|FG000|Overall Study|Physician Decision|45|||
105447232|NCT04491136|363644021|FG000|Overall Study|sponsor terminated the study early|16|||
105447233|NCT04491136|363644021|FG000|Overall Study|Patient/guardian's decision|1|||
105447234|NCT02452424|363644025|FG000|Overall Study|Death|2|||
105447235|NCT02452424|363644026|FG001|Overall Study|Death|2|||
105447236|NCT02452424|363644027|FG002|Overall Study|Death|2|||
105447237|NCT02452424|363644028|FG003|Overall Study|Death|6|||
105447238|NCT02452424|363644029|FG004|Overall Study|Death|2|||
105447239|NCT02452424|363644030|FG005|Overall Study|Death|0|||
105447240|NCT02452424|363644031|FG006|Overall Study|Death|5|||
105447241|NCT02452424|363644032|FG007|Overall Study|Death|1|||
105447242|NCT02452424|363644033|FG008|Overall Study|Death|3|||
105447243|NCT02452424|363644034|FG009|Overall Study|Death|1|||
105447244|NCT02452424|363644035|FG010|Overall Study|Death|0|||
105447245|NCT02452424|363644025|FG000|Overall Study|Lost to Follow-up|0|||
105447246|NCT02452424|363644026|FG001|Overall Study|Lost to Follow-up|1|||
105447247|NCT02452424|363644027|FG002|Overall Study|Lost to Follow-up|1|||
105447248|NCT02452424|363644028|FG003|Overall Study|Lost to Follow-up|0|||
105447249|NCT02452424|363644029|FG004|Overall Study|Lost to Follow-up|0|||
105447250|NCT02452424|363644030|FG005|Overall Study|Lost to Follow-up|0|||
105447251|NCT02452424|363644031|FG006|Overall Study|Lost to Follow-up|0|||
105447252|NCT02452424|363644032|FG007|Overall Study|Lost to Follow-up|0|||
105447253|NCT02452424|363644033|FG008|Overall Study|Lost to Follow-up|0|||
105447254|NCT02452424|363644034|FG009|Overall Study|Lost to Follow-up|0|||
105447255|NCT02452424|363644035|FG010|Overall Study|Lost to Follow-up|0|||
105447256|NCT02452424|363644025|FG000|Overall Study|Withdrawal by Subject|0|||
105447257|NCT02452424|363644026|FG001|Overall Study|Withdrawal by Subject|0|||
105447258|NCT02452424|363644027|FG002|Overall Study|Withdrawal by Subject|3|||
105447259|NCT02452424|363644028|FG003|Overall Study|Withdrawal by Subject|2|||
105447260|NCT02452424|363644029|FG004|Overall Study|Withdrawal by Subject|0|||
105447261|NCT02452424|363644030|FG005|Overall Study|Withdrawal by Subject|0|||
105447262|NCT02452424|363644031|FG006|Overall Study|Withdrawal by Subject|1|||
105447263|NCT02452424|363644032|FG007|Overall Study|Withdrawal by Subject|0|||
105447264|NCT02452424|363644033|FG008|Overall Study|Withdrawal by Subject|1|||
105447265|NCT02452424|363644034|FG009|Overall Study|Withdrawal by Subject|1|||
105447266|NCT02452424|363644035|FG010|Overall Study|Withdrawal by Subject|0|||
105447267|NCT02452424|363644025|FG000|Overall Study|Other|0|||
105447268|NCT02452424|363644026|FG001|Overall Study|Other|0|||
105447269|NCT02452424|363644027|FG002|Overall Study|Other|1|||
105447270|NCT02452424|363644028|FG003|Overall Study|Other|0|||
105447271|NCT02452424|363644029|FG004|Overall Study|Other|0|||
105447272|NCT02452424|363644030|FG005|Overall Study|Other|1|||
105447273|NCT02452424|363644031|FG006|Overall Study|Other|4|||
105447274|NCT02452424|363644032|FG007|Overall Study|Other|3|||
105447275|NCT02452424|363644033|FG008|Overall Study|Other|0|||
105447276|NCT02452424|363644034|FG009|Overall Study|Other|0|||
105447277|NCT02452424|363644035|FG010|Overall Study|Other|1|||
105447278|NCT02452424|363644025|FG000|Overall Study|Progressive disease (per RECIST)|0|||
105447279|NCT02452424|363644026|FG001|Overall Study|Progressive disease (per RECIST)|0|||
105447280|NCT02452424|363644027|FG002|Overall Study|Progressive disease (per RECIST)|0|||
105447281|NCT02452424|363644028|FG003|Overall Study|Progressive disease (per RECIST)|0|||
105447282|NCT02452424|363644029|FG004|Overall Study|Progressive disease (per RECIST)|0|||
105447283|NCT02452424|363644030|FG005|Overall Study|Progressive disease (per RECIST)|0|||
105447284|NCT02452424|363644031|FG006|Overall Study|Progressive disease (per RECIST)|0|||
105447285|NCT02452424|363644032|FG007|Overall Study|Progressive disease (per RECIST)|0|||
105447286|NCT02452424|363644033|FG008|Overall Study|Progressive disease (per RECIST)|2|||
105447287|NCT02452424|363644034|FG009|Overall Study|Progressive disease (per RECIST)|0|||
105447288|NCT02452424|363644035|FG010|Overall Study|Progressive disease (per RECIST)|0|||
105447289|NCT02452424|363644025|FG000|Overall Study|Adverse Event|0|||
105447290|NCT02452424|363644026|FG001|Overall Study|Adverse Event|0|||
105447291|NCT02452424|363644027|FG002|Overall Study|Adverse Event|0|||
105447292|NCT02452424|363644028|FG003|Overall Study|Adverse Event|0|||
105447293|NCT02452424|363644029|FG004|Overall Study|Adverse Event|0|||
105781735|NCT02493712|364854832|FG002|Overall Study|Protocol Violation|1|||
105447294|NCT02452424|363644030|FG005|Overall Study|Adverse Event|0|||
105447295|NCT02452424|363644031|FG006|Overall Study|Adverse Event|0|||
105447296|NCT02452424|363644032|FG007|Overall Study|Adverse Event|0|||
105447297|NCT02452424|363644033|FG008|Overall Study|Adverse Event|0|||
105447298|NCT02452424|363644034|FG009|Overall Study|Adverse Event|0|||
105447299|NCT02452424|363644035|FG010|Overall Study|Adverse Event|1|||
105447300|NCT02679287|363644043|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
105447301|NCT02679287|363644044|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
105447302|NCT02679287|363644043|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
105447303|NCT02679287|363644044|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
105447304|NCT02679287|363644043|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
105447305|NCT02679287|363644044|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
105550188|NCT00467870|364014375|FG001|Overall Study|Adverse Event|9|||
105447306|NCT02679287|363644043|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
105447307|NCT02679287|363644044|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
105447308|NCT02679287|363644043|FG000|Period 2|Work/Scheduling Conflict|1|||
105447309|NCT02679287|363644044|FG001|Period 2|Work/Scheduling Conflict|0|||
105447310|NCT02679287|363644043|FG000|Period 2|Disliked Mobile System|2|||
105447311|NCT02679287|363644044|FG001|Period 2|Disliked Mobile System|0|||
105447312|NCT02679287|363644043|FG000|Period 3|Work/Scheduling Conflict|0|||
105447313|NCT02679287|363644044|FG001|Period 3|Work/Scheduling Conflict|1|||
105447314|NCT01045694|363644045|FG000|Overall Study|Withdrawal by Subject|2|||
105447315|NCT00983385|363644046|FG000|Observation Period|Not eligible to be dosed|20|||
105447316|NCT00983385|363644046|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
105447317|NCT04177212|363644050|FG000|Overall Study|Withdrawal by Subject|9|||
105447318|NCT04177212|363644051|FG001|Overall Study|Withdrawal by Subject|7|||
105447319|NCT04177212|363644050|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
105447320|NCT04177212|363644051|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
105447321|NCT04177212|363644050|FG000|Overall Study|Physician Decision|1|||
105447322|NCT04177212|363644051|FG001|Overall Study|Physician Decision|0|||
105447323|NCT04177212|363644050|FG000|Overall Study|Lost to Follow-up|0|||
105447324|NCT04177212|363644051|FG001|Overall Study|Lost to Follow-up|3|||
105447325|NCT04177212|363644050|FG000|Overall Study|Adverse Event|0|||
105447326|NCT04177212|363644051|FG001|Overall Study|Adverse Event|1|||
105447327|NCT04177212|363644050|FG000|Overall Study|Other|1|||
105447328|NCT04177212|363644051|FG001|Overall Study|Other|2|||
105447329|NCT01392547|363646347|FG000|Overall Study|Adverse Event|2|||
105447330|NCT01392547|363646347|FG000|Overall Study|Non-compliance|2|||
105447331|NCT01392547|363646347|FG000|Overall Study|Withdrawal criteria|3|||
105447332|NCT01392547|363646347|FG000|Overall Study|Unclassified|1|||
105447333|NCT02936635|363646348|FG000|Overall Study|Adverse Event|43|||
105447334|NCT02936635|363646349|FG001|Overall Study|Adverse Event|25|||
105447335|NCT02936635|363646348|FG000|Overall Study|Progressive Disease|10|||
105447336|NCT02936635|363646349|FG001|Overall Study|Progressive Disease|18|||
105447337|NCT02936635|363646348|FG000|Overall Study|Sponsor Discretion|10|||
105447338|NCT02936635|363646349|FG001|Overall Study|Sponsor Discretion|16|||
105447339|NCT02936635|363646348|FG000|Overall Study|Death|9|||
105447340|NCT02936635|363646349|FG001|Overall Study|Death|15|||
105447341|NCT02936635|363646348|FG000|Overall Study|Withdrawal by Subject|8|||
105447342|NCT02936635|363646349|FG001|Overall Study|Withdrawal by Subject|15|||
105447343|NCT02936635|363646348|FG000|Overall Study|Physician Decision|2|||
105447344|NCT02936635|363646349|FG001|Overall Study|Physician Decision|9|||
105447345|NCT02936635|363646348|FG000|Overall Study|Lost to Follow-up|1|||
105447346|NCT02936635|363646349|FG001|Overall Study|Lost to Follow-up|2|||
105447347|NCT02936635|363646348|FG000|Overall Study|Protocol Violation|1|||
105447348|NCT02936635|363646349|FG001|Overall Study|Protocol Violation|0|||
105447349|NCT02936635|363646348|FG000|Overall Study|Lack of effect/Entry into other study|31|||
105447350|NCT02936635|363646349|FG001|Overall Study|Lack of effect/Entry into other study|65|||
105447351|NCT04050618|363646355|FG000|First Intervention|Withdrawal by Subject|2|||
105447352|NCT04050618|363646356|FG001|First Intervention|Withdrawal by Subject|0|||
105447353|NCT04050618|363646355|FG000|Second Intervention|Withdrawal by Subject|1|||
105447354|NCT04050618|363646356|FG001|Second Intervention|Withdrawal by Subject|0|||
105447355|NCT03777059|363646357|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
105447356|NCT03777059|363646358|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
105447357|NCT03777059|363646359|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
105447358|NCT03777059|363646360|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
105447359|NCT03777059|363646357|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
105447360|NCT03777059|363646358|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
105447361|NCT03777059|363646359|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
105447362|NCT03777059|363646360|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
105447363|NCT03777059|363646357|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
105447364|NCT03777059|363646358|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
105447365|NCT03777059|363646359|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
105447366|NCT03777059|363646360|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
105447367|NCT03777059|363646357|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
105447368|NCT03777059|363646358|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
105447369|NCT03777059|363646359|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
105447370|NCT03777059|363646360|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
105447371|NCT03777059|363646357|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
105447372|NCT03777059|363646358|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
105447373|NCT03777059|363646359|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
105447374|NCT03777059|363646360|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
105447375|NCT03777059|363646357|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
105447376|NCT03777059|363646358|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
105447377|NCT03777059|363646359|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
105447378|NCT03777059|363646360|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
105550189|NCT00467870|364014376|FG002|Overall Study|Adverse Event|1|||
105447379|NCT03777059|363646357|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
105447380|NCT03777059|363646358|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
105447381|NCT03777059|363646359|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
105447382|NCT03777059|363646360|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
105447383|NCT03777059|363646357|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
105447384|NCT03777059|363646358|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
105447385|NCT03777059|363646359|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
105447386|NCT03777059|363646360|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
105447387|NCT03777059|363646357|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
105447388|NCT03777059|363646358|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
105447389|NCT03777059|363646359|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
105447390|NCT03777059|363646360|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
105447391|NCT03777059|363646357|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
105447392|NCT03777059|363646358|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
105447393|NCT03777059|363646359|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
105447394|NCT03777059|363646360|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
105447395|NCT03777059|363646357|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
105447396|NCT03777059|363646358|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
105447397|NCT03777059|363646359|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
105447398|NCT03777059|363646360|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
105447399|NCT00763386|363646368|FG000|Overall Study|Adverse Event|43|||
105447400|NCT00763386|363646369|FG001|Overall Study|Adverse Event|33|||
105447401|NCT00763386|363646368|FG000|Overall Study|Death|1|||
105447402|NCT00763386|363646369|FG001|Overall Study|Death|2|||
105447403|NCT00763386|363646368|FG000|Overall Study|Lost to Follow-up|3|||
105447404|NCT00763386|363646369|FG001|Overall Study|Lost to Follow-up|3|||
105447405|NCT00763386|363646368|FG000|Overall Study|Withdrawal by Subject|0|||
105447406|NCT00763386|363646369|FG001|Overall Study|Withdrawal by Subject|1|||
105447407|NCT00763386|363646368|FG000|Overall Study|CRF missing|0|||
105447408|NCT00763386|363646369|FG001|Overall Study|CRF missing|1|||
105447409|NCT00763386|363646368|FG000|Overall Study|Study Prosthesis Removed|1|||
105447410|NCT00763386|363646369|FG001|Overall Study|Study Prosthesis Removed|0|||
105447411|NCT01395901|363646373|FG000|Overall Study|Lost to Follow-up|4|||
105447412|NCT01395901|363646374|FG001|Overall Study|Lost to Follow-up|0|||
105447413|NCT01395901|363646373|FG000|Overall Study|Randomized but not received study drug|5|||
105447414|NCT01395901|363646374|FG001|Overall Study|Randomized but not received study drug|4|||
105447415|NCT01395901|363646373|FG000|Overall Study|Adverse Event|0|||
105447416|NCT01395901|363646374|FG001|Overall Study|Adverse Event|1|||
105447417|NCT01395901|363646373|FG000|Overall Study|Withdrawal of consent|1|||
105447418|NCT01395901|363646374|FG001|Overall Study|Withdrawal of consent|0|||
105447419|NCT02471014|363646375|FG000|Overall Study|Lost to Follow-up|2|||
105447420|NCT02471014|363646376|FG001|Overall Study|Lost to Follow-up|2|||
105447421|NCT02380287|363646377|FG000|Overall Study|Adverse Event|0|||
105447422|NCT02380287|363646378|FG001|Overall Study|Adverse Event|0|||
105447423|NCT02380287|363646379|FG002|Overall Study|Adverse Event|1|||
105447424|NCT02380287|363646380|FG003|Overall Study|Adverse Event|0|||
105447425|NCT02380287|363646381|FG004|Overall Study|Adverse Event|0|||
105447426|NCT02380287|363646382|FG005|Overall Study|Adverse Event|0|||
105447427|NCT02380287|363646383|FG006|Overall Study|Adverse Event|0|||
105447428|NCT02380287|363646384|FG007|Overall Study|Adverse Event|0|||
105447429|NCT01751984|363646385|FG000|Overall Study|Adverse Event|5|||
105447430|NCT01751984|363646386|FG001|Overall Study|Adverse Event|3|||
105447431|NCT01751984|363646385|FG000|Overall Study|Withdrawal by Subject|0|||
105447432|NCT01751984|363646386|FG001|Overall Study|Withdrawal by Subject|1|||
105447433|NCT01751984|363646385|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
105447434|NCT01751984|363646386|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
105447435|NCT04473963|363646387|FG000|Overall Study|Withdrawal by Subject|1|||
105447436|NCT04473963|363646388|FG001|Overall Study|Withdrawal by Subject|1|||
105447437|NCT04473963|363646389|FG002|Overall Study|Withdrawal by Subject|0|||
105447438|NCT04473963|363646387|FG000|Overall Study|Not inducible in AF|0|||
105447439|NCT04473963|363646388|FG001|Overall Study|Not inducible in AF|0|||
105447440|NCT04473963|363646389|FG002|Overall Study|Not inducible in AF|2|||
105447441|NCT04640311|363646390|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
105447442|NCT04640311|363646391|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447443|NCT04640311|363646392|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447444|NCT04640311|363646393|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447445|NCT04640311|363646394|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447446|NCT04640311|363646395|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447447|NCT04640311|363646396|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447448|NCT04640311|363646397|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447449|NCT04640311|363646398|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447450|NCT04640311|363646399|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447451|NCT04640311|363646400|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447452|NCT04640311|363646401|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447453|NCT04640311|363646402|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447454|NCT04640311|363646390|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105447455|NCT04640311|363646391|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
105447456|NCT04640311|363646392|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105447457|NCT04640311|363646393|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105447458|NCT04640311|363646394|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105447459|NCT04640311|363646395|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105447460|NCT04640311|363646396|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105447461|NCT04640311|363646397|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105447462|NCT04640311|363646398|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105447463|NCT04640311|363646399|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105447464|NCT04640311|363646400|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105447465|NCT04640311|363646401|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105447466|NCT04640311|363646402|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105447467|NCT04640311|363646390|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447468|NCT04640311|363646391|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
105447469|NCT04640311|363646392|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447470|NCT04640311|363646393|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447471|NCT04640311|363646394|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447472|NCT04640311|363646395|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447473|NCT04640311|363646396|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447474|NCT04640311|363646397|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447475|NCT04640311|363646398|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447476|NCT04640311|363646399|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447477|NCT04640311|363646400|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447478|NCT04640311|363646401|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447479|NCT04640311|363646402|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447480|NCT04640311|363646390|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
105447481|NCT04640311|363646391|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
105447482|NCT04640311|363646392|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
105447483|NCT04640311|363646393|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447484|NCT04640311|363646394|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447485|NCT04640311|363646395|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447486|NCT04640311|363646396|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447487|NCT04640311|363646397|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447488|NCT04640311|363646398|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447489|NCT04640311|363646399|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447490|NCT04640311|363646400|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447491|NCT04640311|363646401|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447492|NCT04640311|363646402|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105447493|NCT04640311|363646390|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105447494|NCT04640311|363646391|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105447495|NCT04640311|363646392|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
105447496|NCT04640311|363646393|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105447497|NCT04640311|363646394|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105447498|NCT04640311|363646395|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105447499|NCT04640311|363646396|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105447500|NCT04640311|363646397|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105447501|NCT04640311|363646398|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105447502|NCT04640311|363646399|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105447503|NCT04640311|363646400|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105781736|NCT02493712|364854830|FG000|Overall Study|Lost to Follow-up|1|||
105781737|NCT02493712|364854831|FG001|Overall Study|Lost to Follow-up|0|||
105447504|NCT04640311|363646401|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105447505|NCT04640311|363646402|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105447506|NCT04640311|363646390|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105447507|NCT04640311|363646391|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105447508|NCT04640311|363646392|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105447509|NCT04640311|363646393|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
105447510|NCT04640311|363646394|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105447511|NCT04640311|363646395|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105447512|NCT04640311|363646396|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
105447513|NCT04640311|363646397|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105447514|NCT04640311|363646398|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105447515|NCT04640311|363646399|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105447516|NCT04640311|363646400|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105447517|NCT04640311|363646401|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105447518|NCT04640311|363646402|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105447519|NCT04640311|363646390|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447520|NCT04640311|363646391|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447521|NCT04640311|363646392|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447522|NCT04640311|363646393|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447523|NCT04640311|363646394|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447524|NCT04640311|363646395|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
105447525|NCT04640311|363646396|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447526|NCT04640311|363646397|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447527|NCT04640311|363646398|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
105447528|NCT04640311|363646399|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447529|NCT04640311|363646400|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447530|NCT04640311|363646401|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447531|NCT04640311|363646402|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105447532|NCT04640311|363646390|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105447533|NCT04640311|363646391|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105447534|NCT04640311|363646392|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105447535|NCT04640311|363646393|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105447536|NCT04640311|363646394|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105447537|NCT04640311|363646395|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105447538|NCT04640311|363646396|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
105447539|NCT04640311|363646397|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105447540|NCT04640311|363646398|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105447541|NCT04640311|363646399|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105447542|NCT04640311|363646400|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
105447543|NCT04640311|363646401|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105447544|NCT04640311|363646402|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105447545|NCT04640311|363646390|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105447546|NCT04640311|363646391|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105447547|NCT04640311|363646392|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105447548|NCT04640311|363646393|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105447549|NCT04640311|363646394|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105447550|NCT04640311|363646395|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105447551|NCT04640311|363646396|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105447552|NCT04640311|363646397|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105447553|NCT04640311|363646398|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105447554|NCT04640311|363646399|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105447555|NCT04640311|363646400|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105447556|NCT04640311|363646401|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
105447557|NCT04640311|363646402|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105447558|NCT00950846|363646403|FG000|Overall Study|Death|6|||
105447559|NCT00950846|363646403|FG000|Overall Study|Lost to Follow-up|3|||
105447560|NCT00950846|363646403|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
105447561|NCT00587158|363646404|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
105447562|NCT00587158|363646405|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
105447563|NCT00587158|363646404|FG000|Overall Study|Physician Decision|0|||
105447564|NCT00587158|363646405|FG001|Overall Study|Physician Decision|1|||
105447565|NCT00587158|363646404|FG000|Overall Study|Lost to Follow-up|1|||
105447566|NCT00587158|363646405|FG001|Overall Study|Lost to Follow-up|2|||
105447567|NCT00587158|363646404|FG000|Overall Study|Death|0|||
105447568|NCT00587158|363646405|FG001|Overall Study|Death|1|||
105447569|NCT00587158|363646404|FG000|Overall Study|Subject did not want to take study med|0|||
105447570|NCT00587158|363646405|FG001|Overall Study|Subject did not want to take study med|1|||
105447571|NCT02517541|363646406|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
105447572|NCT02517541|363646406|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
105447573|NCT02517541|363646406|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
105447574|NCT02517541|363646406|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
105447575|NCT02517541|363646406|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
105447576|NCT02517541|363646406|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
105447577|NCT05258149|363646415|FG000|Period 1|Protocol Deviation|1|||
105447578|NCT05258149|363646416|FG001|Period 1|Protocol Deviation|0|||
105447579|NCT05258149|363646415|FG000|Period 1|Adverse Event|0|||
105447580|NCT05258149|363646416|FG001|Period 1|Adverse Event|1|||
105447581|NCT05258149|363646415|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
105447582|NCT05258149|363646416|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
105447583|NCT05258149|363646415|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
105447584|NCT05258149|363646416|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
105447585|NCT05258149|363646415|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
105447586|NCT05258149|363646416|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
105447587|NCT01388907|363646419|FG000|Overall Study|Adverse Event|2|||
105447588|NCT01388907|363646420|FG001|Overall Study|Adverse Event|0|||
105447589|NCT00981461|363646421|FG000|Overall Study|Lost to Follow-up|5|||
105447590|NCT00981461|363646422|FG001|Overall Study|Lost to Follow-up|2|||
105447591|NCT03361293|363646431|FG000|Overall Study|Lost to Follow-up|0|||
105447592|NCT03361293|363646432|FG001|Overall Study|Lost to Follow-up|2|||
105447593|NCT03361293|363646431|FG000|Overall Study|Withdrawal by Subject|1|||
105447594|NCT03361293|363646432|FG001|Overall Study|Withdrawal by Subject|3|||
105447595|NCT01910402|363646435|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
105447596|NCT01910402|363646436|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
105447597|NCT01910402|363646437|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
105447598|NCT01910402|363646435|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
105447599|NCT01910402|363646436|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
105447600|NCT01910402|363646437|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
105447601|NCT01910402|363646435|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
105447602|NCT01910402|363646436|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
105447603|NCT01910402|363646437|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
105447604|NCT01910402|363646435|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
105447605|NCT01910402|363646436|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
105447606|NCT01910402|363646437|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
105447607|NCT01910402|363646435|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
105447608|NCT01910402|363646436|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
105447609|NCT01910402|363646437|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
105447610|NCT01910402|363646435|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
105447611|NCT01910402|363646436|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
105447612|NCT01910402|363646437|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
105447613|NCT01910402|363646435|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
105447614|NCT01910402|363646436|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
105447615|NCT01910402|363646437|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
105447616|NCT01910402|363646435|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
105447617|NCT01910402|363646436|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
105447618|NCT01910402|363646437|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
105447619|NCT01910402|363646435|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
105447620|NCT01910402|363646436|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
105447621|NCT01910402|363646437|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
105447622|NCT01910402|363646435|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
105447623|NCT01910402|363646436|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
105447624|NCT01910402|363646437|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
105447625|NCT01910402|363646435|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
105447626|NCT01910402|363646436|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
105447627|NCT01910402|363646437|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
105447628|NCT01910402|363646435|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
105447629|NCT01910402|363646436|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
105447630|NCT01910402|363646437|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
105447631|NCT01910402|363646435|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
105447632|NCT01910402|363646436|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
105447633|NCT01910402|363646437|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
105447634|NCT00571038|363646438|FG000|Overall Study|Lost to Follow-up|1|||
105447635|NCT00571038|363646439|FG001|Overall Study|Lost to Follow-up|4|||
105447636|NCT00571038|363646438|FG000|Overall Study|Death|7|||
105447637|NCT00571038|363646439|FG001|Overall Study|Death|5|||
105447638|NCT00571038|363646438|FG000|Overall Study|Withdrawal by Subject|1|||
105447639|NCT00571038|363646439|FG001|Overall Study|Withdrawal by Subject|3|||
105447640|NCT00571038|363646438|FG000|Overall Study|Moved out of state|2|||
105447641|NCT00571038|363646439|FG001|Overall Study|Moved out of state|2|||
105447642|NCT01442714|363646440|FG000|Overall Study|Death|11|||
105447643|NCT01442714|363646440|FG000|Overall Study|Withdrawal by Subject|1|||
105447644|NCT04306510|363646441|FG000|Overall Study|Voluntarily withdrawal|1|||
105447645|NCT04306510|363646441|FG000|Overall Study|Enrolled but Not Treated|1|||
105447646|NCT00622505|363646446|FG000|Overall Study|Adverse Event|9|||
105447647|NCT00622505|363646447|FG001|Overall Study|Adverse Event|7|||
105447648|NCT00622505|363646446|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
105447649|NCT00622505|363646447|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
105447650|NCT00622505|363646446|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
105447651|NCT00622505|363646447|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
105447652|NCT00622505|363646446|FG000|Overall Study|Withdrawal by Subject|12|||
105447653|NCT00622505|363646447|FG001|Overall Study|Withdrawal by Subject|5|||
105447654|NCT00622505|363646446|FG000|Overall Study|Administrative Problems|2|||
105447655|NCT00622505|363646447|FG001|Overall Study|Administrative Problems|4|||
105447656|NCT00622505|363646446|FG000|Overall Study|Death|2|||
105447657|NCT00622505|363646447|FG001|Overall Study|Death|2|||
105447658|NCT01359904|363646448|FG000|Overall Study|Withdrawal by Subject|1|||
105447659|NCT01359904|363646449|FG001|Overall Study|Withdrawal by Subject|0|||
105447660|NCT01797263|363646451|FG000|Overall Study|Withdrawal by Subject|21|||
105447661|NCT01797263|363646452|FG001|Overall Study|Withdrawal by Subject|25|||
105447662|NCT01797263|363646451|FG000|Overall Study|Death|1|||
105447663|NCT01797263|363646452|FG001|Overall Study|Death|0|||
105447664|NCT01797263|363646451|FG000|Overall Study|Lost to Follow-up|15|||
105447665|NCT01797263|363646452|FG001|Overall Study|Lost to Follow-up|15|||
105447666|NCT02045095|363646453|FG000|Overall Study|Other|0|||
105447667|NCT02045095|363646454|FG001|Overall Study|Other|0|||
105447668|NCT02045095|363646455|FG002|Overall Study|Other|1|||
105447669|NCT02045095|363646456|FG003|Overall Study|Other|0|||
105447670|NCT02045095|363646457|FG004|Overall Study|Other|0|||
105447671|NCT02045095|363646458|FG005|Overall Study|Other|2|||
105447672|NCT02045095|363646459|FG006|Overall Study|Other|0|||
105447673|NCT02045095|363646453|FG000|Overall Study|Progressive Disease|3|||
105447674|NCT02045095|363646454|FG001|Overall Study|Progressive Disease|3|||
105447675|NCT02045095|363646455|FG002|Overall Study|Progressive Disease|2|||
105447676|NCT02045095|363646456|FG003|Overall Study|Progressive Disease|4|||
105447677|NCT02045095|363646457|FG004|Overall Study|Progressive Disease|2|||
105447678|NCT02045095|363646458|FG005|Overall Study|Progressive Disease|4|||
105447679|NCT02045095|363646459|FG006|Overall Study|Progressive Disease|1|||
105447680|NCT02045095|363646453|FG000|Overall Study|Withdrawal by Subject|0|||
105447681|NCT02045095|363646454|FG001|Overall Study|Withdrawal by Subject|0|||
105447682|NCT02045095|363646455|FG002|Overall Study|Withdrawal by Subject|0|||
105447683|NCT02045095|363646456|FG003|Overall Study|Withdrawal by Subject|0|||
105447684|NCT02045095|363646457|FG004|Overall Study|Withdrawal by Subject|3|||
105447685|NCT02045095|363646458|FG005|Overall Study|Withdrawal by Subject|0|||
105447686|NCT02045095|363646459|FG006|Overall Study|Withdrawal by Subject|0|||
105447687|NCT02045095|363646453|FG000|Overall Study|Adverse Event|0|||
105447688|NCT02045095|363646454|FG001|Overall Study|Adverse Event|1|||
105447689|NCT02045095|363646455|FG002|Overall Study|Adverse Event|1|||
105447690|NCT02045095|363646456|FG003|Overall Study|Adverse Event|0|||
105447691|NCT02045095|363646457|FG004|Overall Study|Adverse Event|0|||
105447692|NCT02045095|363646458|FG005|Overall Study|Adverse Event|2|||
105447693|NCT02045095|363646459|FG006|Overall Study|Adverse Event|0|||
105447694|NCT01550757|363646460|FG000|Overall Study|Lost to Follow-up|21|||
105447695|NCT01550757|363646461|FG001|Overall Study|Lost to Follow-up|14|||
105447696|NCT01550757|363646462|FG002|Overall Study|Lost to Follow-up|42|||
105447697|NCT01550757|363646463|FG003|Overall Study|Lost to Follow-up|53|||
105447698|NCT01550757|363646460|FG000|Overall Study|Withdrawal by Subject|2|||
105447699|NCT01550757|363646461|FG001|Overall Study|Withdrawal by Subject|0|||
105447700|NCT01550757|363646462|FG002|Overall Study|Withdrawal by Subject|3|||
105447701|NCT01550757|363646463|FG003|Overall Study|Withdrawal by Subject|1|||
105447702|NCT01879683|363646467|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
105447703|NCT01970306|363646468|FG000|Overall Study|Not eligible|3|||
105447704|NCT01970306|363646468|FG000|Overall Study|Not able to be treated|9|||
105447705|NCT03384940|363646469|FG000|Overall Study|Progressive disease|36|||
105447706|NCT03384940|363646470|FG001|Overall Study|Progressive disease|11|||
105447707|NCT03384940|363646471|FG002|Overall Study|Progressive disease|13|||
105447708|NCT03384940|363646469|FG000|Overall Study|Clinical progression|4|||
105447709|NCT03384940|363646470|FG001|Overall Study|Clinical progression|0|||
105447710|NCT03384940|363646471|FG002|Overall Study|Clinical progression|3|||
105447711|NCT03384940|363646469|FG000|Overall Study|Adverse Event|7|||
105447712|NCT03384940|363646470|FG001|Overall Study|Adverse Event|1|||
105447713|NCT03384940|363646471|FG002|Overall Study|Adverse Event|1|||
105447714|NCT03384940|363646469|FG000|Overall Study|Withdrawal by Subject|3|||
105447715|NCT03384940|363646470|FG001|Overall Study|Withdrawal by Subject|1|||
105447716|NCT03384940|363646471|FG002|Overall Study|Withdrawal by Subject|0|||
105447717|NCT03384940|363646469|FG000|Overall Study|Physician Decision|1|||
105447718|NCT03384940|363646470|FG001|Overall Study|Physician Decision|1|||
105447719|NCT03384940|363646471|FG002|Overall Study|Physician Decision|0|||
105447720|NCT03384940|363646469|FG000|Overall Study|Death|2|||
105447721|NCT03384940|363646470|FG001|Overall Study|Death|1|||
105447722|NCT03384940|363646471|FG002|Overall Study|Death|0|||
105447723|NCT03384940|363646469|FG000|Overall Study|Other|0|||
105447724|NCT03384940|363646470|FG001|Overall Study|Other|0|||
105447725|NCT03384940|363646471|FG002|Overall Study|Other|1|||
105447726|NCT01288989|363646475|FG000|Overall Study|Death|0|||
105447727|NCT01288989|363646476|FG001|Overall Study|Death|0|||
105447728|NCT01288989|363646477|FG002|Overall Study|Death|0|||
105447729|NCT01288989|363646478|FG003|Overall Study|Death|1|||
105447730|NCT01288989|363646479|FG004|Overall Study|Death|0|||
105447731|NCT01288989|363646475|FG000|Overall Study|Dose limiting toxicity|1|||
105447732|NCT01288989|363646476|FG001|Overall Study|Dose limiting toxicity|0|||
105447733|NCT01288989|363646477|FG002|Overall Study|Dose limiting toxicity|0|||
105447734|NCT01288989|363646478|FG003|Overall Study|Dose limiting toxicity|0|||
105447735|NCT01288989|363646479|FG004|Overall Study|Dose limiting toxicity|0|||
105447736|NCT01288989|363646475|FG000|Overall Study|Adverse Event|0|||
105447737|NCT01288989|363646476|FG001|Overall Study|Adverse Event|0|||
105447738|NCT01288989|363646477|FG002|Overall Study|Adverse Event|0|||
105447739|NCT01288989|363646478|FG003|Overall Study|Adverse Event|0|||
105447740|NCT01288989|363646479|FG004|Overall Study|Adverse Event|2|||
105781738|NCT02493712|364854832|FG002|Overall Study|Lost to Follow-up|0|||
105781739|NCT02493712|364854830|FG000|Overall Study|Physician Decision|0|||
105781740|NCT02493712|364854831|FG001|Overall Study|Physician Decision|1|||
105781741|NCT02493712|364854832|FG002|Overall Study|Physician Decision|0|||
105781742|NCT02493712|364854830|FG000|Overall Study|Lack of Efficacy|0|||
105781743|NCT02493712|364854831|FG001|Overall Study|Lack of Efficacy|5|||
105781744|NCT02493712|364854832|FG002|Overall Study|Lack of Efficacy|3|||
105781745|NCT03808298|364854833|FG000|Overall Study|Adverse Event|3|||
105781746|NCT03808298|364854833|FG000|Overall Study|Physician Decision|1|||
105781747|NCT03808298|364854833|FG000|Overall Study|Withdrawal by Subject|1|||
105447741|NCT01288989|363646475|FG000|Overall Study|Physician Decision|0|||
105447742|NCT01288989|363646476|FG001|Overall Study|Physician Decision|0|||
105447743|NCT01288989|363646477|FG002|Overall Study|Physician Decision|0|||
105781748|NCT03808298|364854833|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
105447744|NCT01288989|363646478|FG003|Overall Study|Physician Decision|0|||
105447745|NCT01288989|363646479|FG004|Overall Study|Physician Decision|1|||
105447746|NCT01288989|363646475|FG000|Overall Study|Withdrawal by Subject|0|||
105447747|NCT01288989|363646476|FG001|Overall Study|Withdrawal by Subject|0|||
105447748|NCT01288989|363646477|FG002|Overall Study|Withdrawal by Subject|0|||
105447749|NCT01288989|363646478|FG003|Overall Study|Withdrawal by Subject|0|||
105447750|NCT01288989|363646479|FG004|Overall Study|Withdrawal by Subject|3|||
105447751|NCT04378270|363646480|FG000|Overall Study|Lack of Efficacy|1|||
105447752|NCT04378270|363646480|FG000|Overall Study|Withdrawal by Subject|1|||
105447753|NCT04378270|363646480|FG000|Overall Study|Screen Failure|1|||
105447754|NCT04378270|363646480|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
105447755|NCT01156714|363646481|FG000|Overall Study|Withdrawal by Subject|9|||
105447756|NCT01156714|363646482|FG001|Overall Study|Withdrawal by Subject|4|||
105447757|NCT01156714|363646483|FG002|Overall Study|Withdrawal by Subject|3|||
105447758|NCT03201419|363646496|FG000|Overall Study|Adverse Event|3|||
105447759|NCT03201419|363646497|FG001|Overall Study|Adverse Event|1|||
105447760|NCT03201419|363646498|FG002|Overall Study|Adverse Event|0|||
105447761|NCT03201419|363646499|FG003|Overall Study|Adverse Event|0|||
105447762|NCT03201419|363646500|FG004|Overall Study|Adverse Event|1|||
105447763|NCT03201419|363646501|FG005|Overall Study|Adverse Event|1|||
105447764|NCT03201419|363646502|FG006|Overall Study|Adverse Event|5|||
105447765|NCT03201419|363646503|FG007|Overall Study|Adverse Event|0|||
105447766|NCT03201419|363646504|FG008|Overall Study|Adverse Event|0|||
105447767|NCT03201419|363646496|FG000|Overall Study|Lost to Follow-up|1|||
105447768|NCT03201419|363646497|FG001|Overall Study|Lost to Follow-up|0|||
105447769|NCT03201419|363646498|FG002|Overall Study|Lost to Follow-up|0|||
105781749|NCT01858701|364854834|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
105447770|NCT03201419|363646499|FG003|Overall Study|Lost to Follow-up|0|||
105447771|NCT03201419|363646500|FG004|Overall Study|Lost to Follow-up|0|||
105447772|NCT03201419|363646501|FG005|Overall Study|Lost to Follow-up|0|||
105447773|NCT03201419|363646502|FG006|Overall Study|Lost to Follow-up|0|||
105781750|NCT01858701|364854835|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
105447774|NCT03201419|363646503|FG007|Overall Study|Lost to Follow-up|0|||
105447775|NCT03201419|363646504|FG008|Overall Study|Lost to Follow-up|0|||
105447776|NCT03201419|363646496|FG000|Overall Study|Protocol Deviation|0|||
105447777|NCT03201419|363646497|FG001|Overall Study|Protocol Deviation|0|||
105447778|NCT03201419|363646498|FG002|Overall Study|Protocol Deviation|0|||
105447779|NCT03201419|363646499|FG003|Overall Study|Protocol Deviation|0|||
105447780|NCT03201419|363646500|FG004|Overall Study|Protocol Deviation|0|||
105447781|NCT03201419|363646501|FG005|Overall Study|Protocol Deviation|0|||
105447782|NCT03201419|363646502|FG006|Overall Study|Protocol Deviation|1|||
105447783|NCT03201419|363646503|FG007|Overall Study|Protocol Deviation|0|||
105447784|NCT03201419|363646504|FG008|Overall Study|Protocol Deviation|0|||
105447785|NCT03201419|363646496|FG000|Overall Study|Withdrawal by Subject|4|||
105447786|NCT03201419|363646497|FG001|Overall Study|Withdrawal by Subject|2|||
105447787|NCT03201419|363646498|FG002|Overall Study|Withdrawal by Subject|1|||
105447788|NCT03201419|363646499|FG003|Overall Study|Withdrawal by Subject|0|||
105447789|NCT03201419|363646500|FG004|Overall Study|Withdrawal by Subject|0|||
105447790|NCT03201419|363646501|FG005|Overall Study|Withdrawal by Subject|0|||
105447791|NCT03201419|363646502|FG006|Overall Study|Withdrawal by Subject|0|||
105447792|NCT03201419|363646503|FG007|Overall Study|Withdrawal by Subject|1|||
105447793|NCT03201419|363646504|FG008|Overall Study|Withdrawal by Subject|2|||
105447794|NCT03201419|363646496|FG000|Overall Study|Other|0|||
105447795|NCT03201419|363646497|FG001|Overall Study|Other|0|||
105447796|NCT03201419|363646498|FG002|Overall Study|Other|1|||
105447797|NCT03201419|363646499|FG003|Overall Study|Other|0|||
105447798|NCT03201419|363646500|FG004|Overall Study|Other|0|||
105447799|NCT03201419|363646501|FG005|Overall Study|Other|0|||
105447800|NCT03201419|363646502|FG006|Overall Study|Other|0|||
105447801|NCT03201419|363646503|FG007|Overall Study|Other|0|||
105447802|NCT03201419|363646504|FG008|Overall Study|Other|0|||
105447803|NCT05864586|363646507|FG000|Overall Study|Ineligible|4|||
105447804|NCT05864586|363646508|FG001|Overall Study|Ineligible|12|||
105447805|NCT05864586|363646507|FG000|Overall Study|Pregnancy|0|||
105447806|NCT05864586|363646508|FG001|Overall Study|Pregnancy|1|||
105447807|NCT05864586|363646507|FG000|Overall Study|Withdrawal by Subject|0|||
105447808|NCT05864586|363646508|FG001|Overall Study|Withdrawal by Subject|1|||
105447809|NCT00801216|363646541|FG000|Overall Study|Screening Failure|2|||
105447810|NCT05907395|363646542|FG000|Period 1|No longer met eligibility criteria|0|||
105447811|NCT05907395|363646543|FG001|Period 1|No longer met eligibility criteria|1|||
105447812|NCT05907395|363646544|FG002|Period 1|No longer met eligibility criteria|0|||
105447813|NCT05907395|363646545|FG003|Period 1|No longer met eligibility criteria|0|||
105447814|NCT05907395|363646546|FG004|Period 1|No longer met eligibility criteria|0|||
105447815|NCT05907395|363646547|FG005|Period 1|No longer met eligibility criteria|1|||
105447816|NCT05907395|363646548|FG006|Period 1|No longer met eligibility criteria|1|||
105447817|NCT05907395|363646549|FG007|Period 1|No longer met eligibility criteria|0|||
105447818|NCT05907395|363646550|FG008|Period 1|No longer met eligibility criteria|0|||
105447819|NCT05907395|363646551|FG009|Period 1|No longer met eligibility criteria|0|||
105447820|NCT05907395|363646552|FG010|Period 1|No longer met eligibility criteria|0|||
105447821|NCT05907395|363646553|FG011|Period 1|No longer met eligibility criteria|0|||
105447822|NCT05907395|363646542|FG000|Period 2|Adverse Event|0|||
105447823|NCT05907395|363646543|FG001|Period 2|Adverse Event|0|||
105447824|NCT05907395|363646544|FG002|Period 2|Adverse Event|0|||
105447825|NCT05907395|363646545|FG003|Period 2|Adverse Event|1|||
105447826|NCT05907395|363646546|FG004|Period 2|Adverse Event|0|||
105447827|NCT05907395|363646547|FG005|Period 2|Adverse Event|0|||
105447828|NCT05907395|363646548|FG006|Period 2|Adverse Event|0|||
105447829|NCT05907395|363646549|FG007|Period 2|Adverse Event|1|||
105447830|NCT05907395|363646550|FG008|Period 2|Adverse Event|0|||
105447831|NCT05907395|363646551|FG009|Period 2|Adverse Event|0|||
105447832|NCT05907395|363646552|FG010|Period 2|Adverse Event|0|||
105447833|NCT05907395|363646553|FG011|Period 2|Adverse Event|0|||
105447834|NCT05907395|363646542|FG000|Period 2|Personal reason|0|||
105447835|NCT05907395|363646543|FG001|Period 2|Personal reason|0|||
105447836|NCT05907395|363646544|FG002|Period 2|Personal reason|0|||
105447837|NCT05907395|363646545|FG003|Period 2|Personal reason|0|||
105447838|NCT05907395|363646546|FG004|Period 2|Personal reason|0|||
105447839|NCT05907395|363646547|FG005|Period 2|Personal reason|0|||
105447840|NCT05907395|363646548|FG006|Period 2|Personal reason|0|||
105447841|NCT05907395|363646549|FG007|Period 2|Personal reason|0|||
105447842|NCT05907395|363646550|FG008|Period 2|Personal reason|0|||
105447843|NCT05907395|363646551|FG009|Period 2|Personal reason|1|||
105447844|NCT05907395|363646552|FG010|Period 2|Personal reason|0|||
105447845|NCT05907395|363646553|FG011|Period 2|Personal reason|0|||
105447846|NCT05907395|363646542|FG000|Period 3|Adverse Event|0|||
105447847|NCT05907395|363646543|FG001|Period 3|Adverse Event|0|||
105447848|NCT05907395|363646544|FG002|Period 3|Adverse Event|0|||
105447849|NCT05907395|363646545|FG003|Period 3|Adverse Event|0|||
105447850|NCT05907395|363646546|FG004|Period 3|Adverse Event|1|||
105447851|NCT05907395|363646547|FG005|Period 3|Adverse Event|0|||
105447852|NCT05907395|363646548|FG006|Period 3|Adverse Event|0|||
105447853|NCT05907395|363646549|FG007|Period 3|Adverse Event|0|||
105447854|NCT05907395|363646550|FG008|Period 3|Adverse Event|0|||
105447855|NCT05907395|363646551|FG009|Period 3|Adverse Event|0|||
105447856|NCT05907395|363646552|FG010|Period 3|Adverse Event|0|||
105447857|NCT05907395|363646553|FG011|Period 3|Adverse Event|0|||
105447858|NCT01712204|363646557|FG000|Overall Study|Adverse Event|3|||
105447859|NCT01712204|363646558|FG001|Overall Study|Adverse Event|1|||
105447860|NCT01712204|363646557|FG000|Overall Study|Withdrawal by Subject|3|||
105447861|NCT01712204|363646558|FG001|Overall Study|Withdrawal by Subject|3|||
105447862|NCT01712204|363646557|FG000|Overall Study|Lost to Follow-up|1|||
105447863|NCT01712204|363646558|FG001|Overall Study|Lost to Follow-up|0|||
105447864|NCT01712204|363646557|FG000|Overall Study|Protocol Violation|1|||
105447865|NCT01712204|363646558|FG001|Overall Study|Protocol Violation|1|||
105447866|NCT02360228|363646559|FG000|Overall Study|Withdrawal by Subject|1|||
105447867|NCT02360228|363646560|FG001|Overall Study|Withdrawal by Subject|0|||
105447868|NCT02360228|363646561|FG002|Overall Study|Withdrawal by Subject|0|||
105447869|NCT02360228|363646559|FG000|Overall Study|Self-discontinued medication|0|||
105447870|NCT02360228|363646560|FG001|Overall Study|Self-discontinued medication|1|||
105447871|NCT02360228|363646561|FG002|Overall Study|Self-discontinued medication|0|||
105447872|NCT02360228|363646559|FG000|Overall Study|Unstable symptoms during screening|0|||
105447873|NCT02360228|363646560|FG001|Overall Study|Unstable symptoms during screening|0|||
105447874|NCT02360228|363646561|FG002|Overall Study|Unstable symptoms during screening|1|||
105447875|NCT00999544|363648229|FG000|Overall Study|Withdrawal by Subject|1|||
105447876|NCT01594931|363648230|FG000|Overall Study|Adverse Event|3|||
105447877|NCT01594931|363648231|FG001|Overall Study|Adverse Event|1|||
105447878|NCT01594931|363648232|FG002|Overall Study|Adverse Event|1|||
105447879|NCT01594931|363648230|FG000|Overall Study|Withdrawal by Subject|2|||
105447880|NCT01594931|363648231|FG001|Overall Study|Withdrawal by Subject|1|||
105447881|NCT01594931|363648232|FG002|Overall Study|Withdrawal by Subject|1|||
105447882|NCT01594931|363648230|FG000|Overall Study|Lack of Efficacy|7|||
105447883|NCT01594931|363648231|FG001|Overall Study|Lack of Efficacy|2|||
105447884|NCT01594931|363648232|FG002|Overall Study|Lack of Efficacy|2|||
105447885|NCT01594931|363648230|FG000|Overall Study|Lost to Follow-up|4|||
105447886|NCT01594931|363648231|FG001|Overall Study|Lost to Follow-up|3|||
105447887|NCT01594931|363648232|FG002|Overall Study|Lost to Follow-up|3|||
105447888|NCT01594931|363648230|FG000|Overall Study|Protocol Violation|2|||
105447889|NCT01594931|363648231|FG001|Overall Study|Protocol Violation|1|||
105447890|NCT01594931|363648232|FG002|Overall Study|Protocol Violation|0|||
105447891|NCT01594931|363648230|FG000|Overall Study|No defiined|11|||
105447892|NCT01594931|363648231|FG001|Overall Study|No defiined|4|||
105447893|NCT01594931|363648232|FG002|Overall Study|No defiined|7|||
105447894|NCT01633788|363648240|FG000|Overall Study|Adverse Event|1|||
105447895|NCT01633788|363648241|FG001|Overall Study|Adverse Event|3|||
105447896|NCT01633788|363648242|FG002|Overall Study|Adverse Event|3|||
105447897|NCT01633788|363648243|FG003|Overall Study|Adverse Event|3|||
105447898|NCT01633788|363648240|FG000|Overall Study|Lost to Follow-up|2|||
105447899|NCT01633788|363648241|FG001|Overall Study|Lost to Follow-up|2|||
105447900|NCT01633788|363648242|FG002|Overall Study|Lost to Follow-up|2|||
105447901|NCT01633788|363648243|FG003|Overall Study|Lost to Follow-up|0|||
105447902|NCT01633788|363648240|FG000|Overall Study|Personal Reasons|3|||
105447903|NCT01633788|363648241|FG001|Overall Study|Personal Reasons|1|||
105447904|NCT01633788|363648242|FG002|Overall Study|Personal Reasons|1|||
105447905|NCT01633788|363648243|FG003|Overall Study|Personal Reasons|3|||
105447906|NCT01633788|363648240|FG000|Overall Study|Protocol Violation|1|||
105447907|NCT01633788|363648241|FG001|Overall Study|Protocol Violation|0|||
105447908|NCT01633788|363648242|FG002|Overall Study|Protocol Violation|1|||
105447909|NCT01633788|363648243|FG003|Overall Study|Protocol Violation|0|||
105447910|NCT01633788|363648240|FG000|Overall Study|Other Reasons|0|||
105447911|NCT01633788|363648241|FG001|Overall Study|Other Reasons|2|||
105447912|NCT01633788|363648242|FG002|Overall Study|Other Reasons|3|||
105447913|NCT01633788|363648243|FG003|Overall Study|Other Reasons|7|||
105447914|NCT02407223|363648244|FG000|Overall Study|Adverse Event|1|||
105447915|NCT02407223|363648245|FG001|Overall Study|Adverse Event|0|||
105447916|NCT02407223|363648246|FG002|Overall Study|Adverse Event|1|||
105447917|NCT02407223|363648244|FG000|Overall Study|Lack of Efficacy|6|||
105447918|NCT02407223|363648245|FG001|Overall Study|Lack of Efficacy|6|||
105447919|NCT02407223|363648246|FG002|Overall Study|Lack of Efficacy|4|||
105447920|NCT02407223|363648244|FG000|Overall Study|Lost to Follow-up|1|||
105447921|NCT02407223|363648245|FG001|Overall Study|Lost to Follow-up|0|||
105447922|NCT02407223|363648246|FG002|Overall Study|Lost to Follow-up|2|||
105447923|NCT02407223|363648244|FG000|Overall Study|Withdrawal by Subject|2|||
105447924|NCT02407223|363648245|FG001|Overall Study|Withdrawal by Subject|4|||
105447925|NCT02407223|363648246|FG002|Overall Study|Withdrawal by Subject|4|||
105447926|NCT02407223|363648244|FG000|Overall Study|Study Terminated by Sponsor|77|||
105447927|NCT02407223|363648245|FG001|Overall Study|Study Terminated by Sponsor|80|||
105447928|NCT02407223|363648246|FG002|Overall Study|Study Terminated by Sponsor|86|||
105447929|NCT02407223|363648244|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
105447930|NCT02407223|363648245|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
105447931|NCT02407223|363648246|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
105447932|NCT02407223|363648244|FG000|Overall Study|Other|29|||
105447933|NCT02407223|363648245|FG001|Overall Study|Other|27|||
105447934|NCT02407223|363648246|FG002|Overall Study|Other|25|||
105447935|NCT00855959|363648253|FG000|Overall Study|Adverse Event|2|||
105447936|NCT00855959|363648253|FG000|Overall Study|Lost to Follow-up|2|||
105447937|NCT00855959|363648253|FG000|Overall Study|Withdrawal by Subject|3|||
105447938|NCT00855959|363648253|FG000|Overall Study|Pregnancy|1|||
105447939|NCT00855959|363648253|FG000|Overall Study|Incorrect enrolment|1|||
105447940|NCT02813889|363648254|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
105484891|NCT02038829|363786991|FG000|Washout Period 2|Withdrawal by Subject|0|||
105447941|NCT02813889|363648255|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
105447942|NCT00502671|363648258|FG000|Overall Study|Disease Progression|13|||
105447943|NCT00502671|363648258|FG000|Overall Study|Personal Reasons|22|||
105447944|NCT00502671|363648258|FG000|Overall Study|Lost to Follow-up|7|||
105447945|NCT00502671|363648258|FG000|Overall Study|Protocol Violation|16|||
105447946|NCT00502671|363648258|FG000|Overall Study|Adverse Event|19|||
105447947|NCT00681629|363648265|FG000|Overall Study|Study termination|4|||
105447948|NCT00681629|363648266|FG001|Overall Study|Study termination|2|||
105447949|NCT00681629|363648265|FG000|Overall Study|Adverse Event|1|||
105447950|NCT00681629|363648266|FG001|Overall Study|Adverse Event|0|||
105447951|NCT02859246|363648277|FG000|Overall Study|Screen fails|3|||
105447952|NCT02859246|363648277|FG000|Overall Study|Adverse Event|1|||
105447953|NCT02859246|363648277|FG000|Overall Study|Withdrawal by Subject|1|||
105447954|NCT01746368|363648278|FG000|Overall Study|Lost to Follow-up|2|||
105447955|NCT01746368|363648279|FG001|Overall Study|Lost to Follow-up|0|||
105447956|NCT01746368|363648278|FG000|Overall Study|Withdrawal by Subject|0|||
105447957|NCT01746368|363648279|FG001|Overall Study|Withdrawal by Subject|1|||
105447958|NCT02562716|363648280|FG000|Overall Study|Adverse Event|7|||
105447959|NCT02562716|363648281|FG001|Overall Study|Adverse Event|14|||
105447960|NCT02562716|363648280|FG000|Overall Study|Withdrawal unrelated to AE|7|||
105447961|NCT02562716|363648281|FG001|Overall Study|Withdrawal unrelated to AE|1|||
105447962|NCT02562716|363648280|FG000|Overall Study|Progression|8|||
105447963|NCT02562716|363648281|FG001|Overall Study|Progression|10|||
105447964|NCT02562716|363648280|FG000|Overall Study|Death|2|||
105447965|NCT02562716|363648281|FG001|Overall Study|Death|1|||
105447966|NCT02562716|363648280|FG000|Overall Study|Not protocol specified|4|||
105447967|NCT02562716|363648281|FG001|Overall Study|Not protocol specified|2|||
105447968|NCT00556998|363648282|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
105447969|NCT00556998|363648282|FG000|Voriconazole Intravenous (IV)|Other|4|||
105447970|NCT00556998|363648282|FG000|Voriconazole Oral|Adverse Event|1|||
105447971|NCT00556998|363648282|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
105447972|NCT01843023|363648283|FG000|Overall Study|Death|1|||
105447973|NCT01843023|363648284|FG001|Overall Study|Death|0|||
105447974|NCT01843023|363648283|FG000|Overall Study|Lost to Follow-up|24|||
105447975|NCT01843023|363648284|FG001|Overall Study|Lost to Follow-up|29|||
105447976|NCT01843023|363648283|FG000|Overall Study|Withdrawal by Subject|8|||
105447977|NCT01843023|363648284|FG001|Overall Study|Withdrawal by Subject|6|||
105447978|NCT00226811|363648287|FG000|Overall Study|Death|8|||
105447979|NCT00226811|363648287|FG000|Overall Study|Adverse Event|11|||
105447980|NCT00226811|363648287|FG000|Overall Study|Lack of Efficacy|55|||
105447981|NCT00226811|363648287|FG000|Overall Study|Withdrawal by Subject|2|||
105447982|NCT00369577|363648290|FG000|Overall Study|Withdrawal by Subject|0|||
105447983|NCT00369577|363648291|FG001|Overall Study|Withdrawal by Subject|0|||
105447984|NCT00369577|363648292|FG002|Overall Study|Withdrawal by Subject|1|||
105447985|NCT03386721|363648293|FG000|Overall Study|Death|12|||
105447986|NCT03386721|363648294|FG001|Overall Study|Death|21|||
105447987|NCT03386721|363648295|FG002|Overall Study|Death|2|||
105447988|NCT03386721|363648296|FG003|Overall Study|Death|5|||
105447989|NCT03386721|363648297|FG004|Overall Study|Death|1|||
105447990|NCT03386721|363648298|FG005|Overall Study|Death|12|||
105447991|NCT03386721|363648299|FG006|Overall Study|Death|1|||
105447992|NCT03386721|363648300|FG007|Overall Study|Death|1|||
105447993|NCT03386721|363648301|FG008|Overall Study|Death|12|||
105447994|NCT03386721|363648302|FG009|Overall Study|Death|20|||
105447995|NCT03386721|363648303|FG010|Overall Study|Death|21|||
105447996|NCT03386721|363648304|FG011|Overall Study|Death|21|||
105447997|NCT03386721|363648305|FG012|Overall Study|Death|14|||
105447998|NCT03386721|363648306|FG013|Overall Study|Death|2|||
105447999|NCT03386721|363648307|FG014|Overall Study|Death|1|||
105448000|NCT03386721|363648293|FG000|Overall Study|Lost to Follow-up|1|||
105448001|NCT03386721|363648294|FG001|Overall Study|Lost to Follow-up|3|||
105448002|NCT03386721|363648295|FG002|Overall Study|Lost to Follow-up|0|||
105448003|NCT03386721|363648296|FG003|Overall Study|Lost to Follow-up|0|||
105448004|NCT03386721|363648297|FG004|Overall Study|Lost to Follow-up|0|||
105448005|NCT03386721|363648298|FG005|Overall Study|Lost to Follow-up|2|||
105448006|NCT03386721|363648299|FG006|Overall Study|Lost to Follow-up|1|||
105448007|NCT03386721|363648300|FG007|Overall Study|Lost to Follow-up|0|||
105448008|NCT03386721|363648301|FG008|Overall Study|Lost to Follow-up|1|||
105448009|NCT03386721|363648302|FG009|Overall Study|Lost to Follow-up|2|||
105448010|NCT03386721|363648303|FG010|Overall Study|Lost to Follow-up|1|||
105448011|NCT03386721|363648304|FG011|Overall Study|Lost to Follow-up|0|||
105448012|NCT03386721|363648305|FG012|Overall Study|Lost to Follow-up|0|||
105448013|NCT03386721|363648306|FG013|Overall Study|Lost to Follow-up|0|||
105448014|NCT03386721|363648307|FG014|Overall Study|Lost to Follow-up|0|||
105448015|NCT03386721|363648293|FG000|Overall Study|Reason not specified|3|||
105448016|NCT03386721|363648294|FG001|Overall Study|Reason not specified|0|||
105448017|NCT03386721|363648295|FG002|Overall Study|Reason not specified|0|||
105448018|NCT03386721|363648296|FG003|Overall Study|Reason not specified|0|||
105448019|NCT03386721|363648297|FG004|Overall Study|Reason not specified|0|||
105448020|NCT03386721|363648298|FG005|Overall Study|Reason not specified|3|||
105448021|NCT03386721|363648299|FG006|Overall Study|Reason not specified|1|||
105448022|NCT03386721|363648300|FG007|Overall Study|Reason not specified|0|||
105448023|NCT03386721|363648301|FG008|Overall Study|Reason not specified|0|||
105448024|NCT03386721|363648302|FG009|Overall Study|Reason not specified|1|||
105448025|NCT03386721|363648303|FG010|Overall Study|Reason not specified|2|||
105448026|NCT03386721|363648304|FG011|Overall Study|Reason not specified|6|||
105448027|NCT03386721|363648305|FG012|Overall Study|Reason not specified|1|||
105448028|NCT03386721|363648306|FG013|Overall Study|Reason not specified|0|||
105448029|NCT03386721|363648307|FG014|Overall Study|Reason not specified|0|||
105448030|NCT03386721|363648293|FG000|Overall Study|Progressive Disease|0|||
105448031|NCT03386721|363648294|FG001|Overall Study|Progressive Disease|0|||
105448032|NCT03386721|363648295|FG002|Overall Study|Progressive Disease|1|||
105448033|NCT03386721|363648296|FG003|Overall Study|Progressive Disease|0|||
105448034|NCT03386721|363648297|FG004|Overall Study|Progressive Disease|0|||
105448035|NCT03386721|363648298|FG005|Overall Study|Progressive Disease|1|||
105448036|NCT03386721|363648299|FG006|Overall Study|Progressive Disease|0|||
105448037|NCT03386721|363648300|FG007|Overall Study|Progressive Disease|0|||
105448038|NCT03386721|363648301|FG008|Overall Study|Progressive Disease|2|||
105448039|NCT03386721|363648302|FG009|Overall Study|Progressive Disease|1|||
105448040|NCT03386721|363648303|FG010|Overall Study|Progressive Disease|1|||
105448041|NCT03386721|363648304|FG011|Overall Study|Progressive Disease|0|||
105448042|NCT03386721|363648305|FG012|Overall Study|Progressive Disease|1|||
105448043|NCT03386721|363648306|FG013|Overall Study|Progressive Disease|0|||
105448044|NCT03386721|363648307|FG014|Overall Study|Progressive Disease|0|||
105448045|NCT03386721|363648293|FG000|Overall Study|Site Terminated by Sponsor|5|||
105448046|NCT03386721|363648294|FG001|Overall Study|Site Terminated by Sponsor|5|||
105448047|NCT03386721|363648295|FG002|Overall Study|Site Terminated by Sponsor|0|||
105448048|NCT03386721|363648296|FG003|Overall Study|Site Terminated by Sponsor|0|||
105448049|NCT03386721|363648297|FG004|Overall Study|Site Terminated by Sponsor|1|||
105448050|NCT03386721|363648298|FG005|Overall Study|Site Terminated by Sponsor|3|||
105448051|NCT03386721|363648299|FG006|Overall Study|Site Terminated by Sponsor|0|||
105448052|NCT03386721|363648300|FG007|Overall Study|Site Terminated by Sponsor|1|||
105448053|NCT03386721|363648301|FG008|Overall Study|Site Terminated by Sponsor|4|||
105448054|NCT03386721|363648302|FG009|Overall Study|Site Terminated by Sponsor|5|||
105448055|NCT03386721|363648303|FG010|Overall Study|Site Terminated by Sponsor|3|||
105448056|NCT03386721|363648304|FG011|Overall Study|Site Terminated by Sponsor|11|||
105448057|NCT03386721|363648305|FG012|Overall Study|Site Terminated by Sponsor|6|||
105448058|NCT03386721|363648306|FG013|Overall Study|Site Terminated by Sponsor|0|||
105448059|NCT03386721|363648307|FG014|Overall Study|Site Terminated by Sponsor|0|||
105448060|NCT03386721|363648293|FG000|Overall Study|Symptomatic Deterioration|0|||
105448061|NCT03386721|363648294|FG001|Overall Study|Symptomatic Deterioration|0|||
105448062|NCT03386721|363648295|FG002|Overall Study|Symptomatic Deterioration|0|||
105448063|NCT03386721|363648296|FG003|Overall Study|Symptomatic Deterioration|0|||
105448064|NCT03386721|363648297|FG004|Overall Study|Symptomatic Deterioration|0|||
105448065|NCT03386721|363648298|FG005|Overall Study|Symptomatic Deterioration|0|||
105448066|NCT03386721|363648299|FG006|Overall Study|Symptomatic Deterioration|0|||
105448067|NCT03386721|363648300|FG007|Overall Study|Symptomatic Deterioration|0|||
105448068|NCT03386721|363648301|FG008|Overall Study|Symptomatic Deterioration|1|||
105448069|NCT03386721|363648302|FG009|Overall Study|Symptomatic Deterioration|0|||
105448070|NCT03386721|363648303|FG010|Overall Study|Symptomatic Deterioration|0|||
105448071|NCT03386721|363648304|FG011|Overall Study|Symptomatic Deterioration|1|||
105448072|NCT03386721|363648305|FG012|Overall Study|Symptomatic Deterioration|0|||
105448073|NCT03386721|363648306|FG013|Overall Study|Symptomatic Deterioration|0|||
105448074|NCT03386721|363648307|FG014|Overall Study|Symptomatic Deterioration|0|||
105448075|NCT03386721|363648293|FG000|Overall Study|Withdrawal by Subject|1|||
105448076|NCT03386721|363648294|FG001|Overall Study|Withdrawal by Subject|2|||
105448077|NCT03386721|363648295|FG002|Overall Study|Withdrawal by Subject|0|||
105448078|NCT03386721|363648296|FG003|Overall Study|Withdrawal by Subject|0|||
105448079|NCT03386721|363648297|FG004|Overall Study|Withdrawal by Subject|0|||
105448080|NCT03386721|363648298|FG005|Overall Study|Withdrawal by Subject|0|||
105448081|NCT03386721|363648299|FG006|Overall Study|Withdrawal by Subject|0|||
105448082|NCT03386721|363648300|FG007|Overall Study|Withdrawal by Subject|0|||
105448083|NCT03386721|363648301|FG008|Overall Study|Withdrawal by Subject|2|||
105448084|NCT03386721|363648302|FG009|Overall Study|Withdrawal by Subject|1|||
105448085|NCT03386721|363648303|FG010|Overall Study|Withdrawal by Subject|3|||
105448086|NCT03386721|363648304|FG011|Overall Study|Withdrawal by Subject|2|||
105448087|NCT03386721|363648305|FG012|Overall Study|Withdrawal by Subject|3|||
105448088|NCT03386721|363648306|FG013|Overall Study|Withdrawal by Subject|0|||
105448089|NCT03386721|363648307|FG014|Overall Study|Withdrawal by Subject|0|||
105448090|NCT03081884|363648308|FG000|Overall Study|deferred prostate cancer treatment|1|||
105448091|NCT03081884|363648308|FG000|Overall Study|metastasis managed with systemic therapy|3|||
105448092|NCT03948334|363648309|FG000|Overall Study|Adverse Event|1|||
105448093|NCT03948334|363648310|FG001|Overall Study|Adverse Event|4|||
105781751|NCT01858701|364854834|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
105448094|NCT03948334|363648309|FG000|Overall Study|Lack of Efficacy|2|||
105448095|NCT03948334|363648310|FG001|Overall Study|Lack of Efficacy|0|||
105448096|NCT03948334|363648309|FG000|Overall Study|Lost to Follow-up|1|||
105448097|NCT03948334|363648310|FG001|Overall Study|Lost to Follow-up|0|||
105448098|NCT03948334|363648309|FG000|Overall Study|Physician Decision|1|||
105448099|NCT03948334|363648310|FG001|Overall Study|Physician Decision|0|||
105448100|NCT03948334|363648309|FG000|Overall Study|Pregnancy|0|||
105448101|NCT03948334|363648310|FG001|Overall Study|Pregnancy|1|||
105448102|NCT03948334|363648309|FG000|Overall Study|Protocol Deviation|1|||
105448103|NCT03948334|363648310|FG001|Overall Study|Protocol Deviation|0|||
105448104|NCT03948334|363648309|FG000|Overall Study|Study terminated by Sponsor|50|||
105448105|NCT03948334|363648310|FG001|Overall Study|Study terminated by Sponsor|51|||
105448106|NCT03948334|363648309|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
105448107|NCT03948334|363648310|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
105448108|NCT02294058|363648311|FG000|Overall Study|Adverse Event|16|||
105448109|NCT02294058|363648312|FG001|Overall Study|Adverse Event|7|||
105448110|NCT02294058|363648313|FG002|Overall Study|Adverse Event|13|||
105448111|NCT02294058|363648311|FG000|Overall Study|Lack of Efficacy|3|||
105448112|NCT02294058|363648312|FG001|Overall Study|Lack of Efficacy|3|||
105448113|NCT02294058|363648313|FG002|Overall Study|Lack of Efficacy|0|||
105448114|NCT02294058|363648311|FG000|Overall Study|Lost to Follow-up|1|||
105448115|NCT02294058|363648312|FG001|Overall Study|Lost to Follow-up|0|||
105448116|NCT02294058|363648313|FG002|Overall Study|Lost to Follow-up|2|||
105448117|NCT02294058|363648311|FG000|Overall Study|Withdrawal by Subject|10|||
105448118|NCT02294058|363648312|FG001|Overall Study|Withdrawal by Subject|14|||
105448119|NCT02294058|363648313|FG002|Overall Study|Withdrawal by Subject|13|||
105448120|NCT02294058|363648311|FG000|Overall Study|Physician Decision|2|||
105448121|NCT02294058|363648312|FG001|Overall Study|Physician Decision|1|||
105448122|NCT02294058|363648313|FG002|Overall Study|Physician Decision|0|||
105448123|NCT02294058|363648311|FG000|Overall Study|Miscellaneous|4|||
105448124|NCT02294058|363648312|FG001|Overall Study|Miscellaneous|1|||
105448125|NCT02294058|363648313|FG002|Overall Study|Miscellaneous|1|||
105448126|NCT03575403|363648315|FG000|Overall Study|Adverse Event|1|||
105448127|NCT03575403|363648316|FG001|Overall Study|Adverse Event|0|||
105448128|NCT03575403|363648317|FG002|Overall Study|Adverse Event|0|||
105448129|NCT03575403|363648315|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
105448130|NCT03575403|363648316|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
105448131|NCT03575403|363648317|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
105448132|NCT05114473|363648318|FG000|Overall Study|Lost to Follow-up|2|||
105448133|NCT05114473|363648319|FG001|Overall Study|Lost to Follow-up|2|||
105448134|NCT05114473|363648320|FG002|Overall Study|Lost to Follow-up|0|||
105448135|NCT05730387|363648322|FG000|Overall Study|Stillbirth|0|||
105448136|NCT05730387|363648323|FG001|Overall Study|Stillbirth|262|||
105448137|NCT05730387|363648322|FG000|Overall Study|Died during or after delivery|2|||
105448138|NCT05730387|363648323|FG001|Overall Study|Died during or after delivery|85|||
105448139|NCT05730387|363648322|FG000|Overall Study|Died after being admitted|0|||
105448140|NCT05730387|363648323|FG001|Overall Study|Died after being admitted|44|||
105448141|NCT05730387|363648322|FG000|Overall Study|Lost to Follow-up|69|||
105448142|NCT05730387|363648323|FG001|Overall Study|Lost to Follow-up|77|||
105448143|NCT00782717|363648326|FG000|Overall Study|Adverse Event|2|||
105448144|NCT00782717|363648327|FG001|Overall Study|Adverse Event|5|||
105448145|NCT00782717|363648326|FG000|Overall Study|Patient decision unrelated to AE|6|||
105448146|NCT00782717|363648327|FG001|Overall Study|Patient decision unrelated to AE|3|||
105448147|NCT00782717|363648326|FG000|Overall Study|Noncompliance|2|||
105448148|NCT00782717|363648327|FG001|Overall Study|Noncompliance|1|||
105448149|NCT00782717|363648326|FG000|Overall Study|Treatment failure|3|||
105448150|NCT00782717|363648327|FG001|Overall Study|Treatment failure|14|||
105448151|NCT00782717|363648326|FG000|Overall Study|Enrollment close prior to surgery|1|||
105448152|NCT00782717|363648327|FG001|Overall Study|Enrollment close prior to surgery|0|||
105448153|NCT00782717|363648326|FG000|Overall Study|Did not meet entrance criteria|1|||
105448154|NCT00782717|363648327|FG001|Overall Study|Did not meet entrance criteria|3|||
105448155|NCT00782717|363648326|FG000|Overall Study|Exited in error|0|||
105448156|NCT00782717|363648327|FG001|Overall Study|Exited in error|2|||
105448157|NCT02446717|363648328|FG000|Overall Study|Adverse Event|0|||
105448158|NCT02446717|363648329|FG001|Overall Study|Adverse Event|0|||
105448159|NCT02446717|363648330|FG002|Overall Study|Adverse Event|1|||
105448160|NCT02446717|363648331|FG003|Overall Study|Adverse Event|0|||
105448161|NCT02446717|363648332|FG004|Overall Study|Adverse Event|0|||
105448162|NCT02446717|363648328|FG000|Overall Study|Lost to Follow-up|0|||
105448163|NCT02446717|363648329|FG001|Overall Study|Lost to Follow-up|1|||
105448164|NCT02446717|363648330|FG002|Overall Study|Lost to Follow-up|1|||
105448165|NCT02446717|363648331|FG003|Overall Study|Lost to Follow-up|0|||
105448166|NCT02446717|363648332|FG004|Overall Study|Lost to Follow-up|1|||
105448167|NCT02446717|363648328|FG000|Overall Study|Withdrew consent|0|||
105448168|NCT02446717|363648329|FG001|Overall Study|Withdrew consent|0|||
105448169|NCT02446717|363648330|FG002|Overall Study|Withdrew consent|0|||
105448170|NCT02446717|363648331|FG003|Overall Study|Withdrew consent|1|||
105448171|NCT02446717|363648332|FG004|Overall Study|Withdrew consent|0|||
105448172|NCT02680665|363648333|FG000|Overall Study|No visit after the first prescription|5|||
105781752|NCT01858701|364854835|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
105781753|NCT01858701|364854834|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
105781754|NCT01858701|364854835|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
105781755|NCT01858701|364854834|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
105781756|NCT01858701|364854835|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
105781757|NCT02079077|364854837|FG000|Overall Study|Lost to Follow-up|5|||
105781758|NCT02079077|364854838|FG001|Overall Study|Lost to Follow-up|7|||
105781759|NCT02079077|364854837|FG000|Overall Study|Became STIs Positive|1|||
105781760|NCT02079077|364854838|FG001|Overall Study|Became STIs Positive|2|||
105781761|NCT01270139|364854840|FG000|Overall Study|Adverse Event|8|||
105448173|NCT02292719|363648337|FG000|Overall Study|Withdrawal by Subject|0|||
105781762|NCT01270139|364854841|FG001|Overall Study|Adverse Event|17|||
105781763|NCT01270139|364854842|FG002|Overall Study|Adverse Event|18|||
105781764|NCT01270139|364854840|FG000|Overall Study|Lost to Follow-up|10|||
105781765|NCT01270139|364854841|FG001|Overall Study|Lost to Follow-up|9|||
105781766|NCT01270139|364854842|FG002|Overall Study|Lost to Follow-up|2|||
105781767|NCT03704194|364854845|FG000|Overall Study|Withdrawal by Subject|0|||
105781768|NCT03704194|364854846|FG001|Overall Study|Withdrawal by Subject|1|||
105781769|NCT01072175|364854847|FG000|Part A (Drug-Drug Interaction)|Death|1|||
105781770|NCT01072175|364854848|FG001|Part A (Drug-Drug Interaction)|Death|0|||
105781771|NCT01072175|364854849|FG002|Part A (Drug-Drug Interaction)|Death|0|||
105781772|NCT01072175|364854850|FG003|Part A (Drug-Drug Interaction)|Death|0|||
105781773|NCT01072175|364854851|FG004|Part A (Drug-Drug Interaction)|Death|0|||
105781774|NCT01072175|364854852|FG005|Part A (Drug-Drug Interaction)|Death|0|||
105781775|NCT01072175|364854853|FG006|Part A (Drug-Drug Interaction)|Death|0|||
105781776|NCT01072175|364854854|FG007|Part A (Drug-Drug Interaction)|Death|0|||
105781777|NCT01072175|364854855|FG008|Part A (Drug-Drug Interaction)|Death|0|||
105781778|NCT01072175|364854856|FG009|Part A (Drug-Drug Interaction)|Death|0|||
105781779|NCT01072175|364854857|FG010|Part A (Drug-Drug Interaction)|Death|0|||
105781780|NCT01072175|364854858|FG011|Part A (Drug-Drug Interaction)|Death|0|||
105781781|NCT01072175|364854859|FG012|Part A (Drug-Drug Interaction)|Death|0|||
105781782|NCT01072175|364854847|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
105781783|NCT01072175|364854848|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781784|NCT01072175|364854849|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781785|NCT01072175|364854850|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781786|NCT01072175|364854851|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781787|NCT01072175|364854852|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781788|NCT01072175|364854853|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781789|NCT01072175|364854854|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781790|NCT01072175|364854855|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781791|NCT01072175|364854856|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781792|NCT01072175|364854857|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781793|NCT01072175|364854858|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781794|NCT01072175|364854859|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781795|NCT01072175|364854847|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
105781796|NCT01072175|364854848|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781797|NCT01072175|364854849|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781798|NCT01072175|364854850|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781799|NCT01072175|364854851|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781800|NCT01072175|364854852|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781801|NCT01072175|364854853|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781802|NCT01072175|364854854|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781803|NCT01072175|364854855|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781804|NCT01072175|364854856|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781805|NCT01072175|364854857|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781806|NCT01072175|364854858|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781807|NCT01072175|364854859|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781808|NCT01072175|364854847|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
105781809|NCT01072175|364854848|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
105336025|NCT00839527|363231358|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
105448174|NCT02292719|363648338|FG001|Overall Study|Withdrawal by Subject|0|||
105448175|NCT02292719|363648339|FG002|Overall Study|Withdrawal by Subject|0|||
105448176|NCT02292719|363648340|FG003|Overall Study|Withdrawal by Subject|1|||
105448177|NCT02292719|363648341|FG004|Overall Study|Withdrawal by Subject|1|||
105448178|NCT02292719|363648342|FG005|Overall Study|Withdrawal by Subject|0|||
105448179|NCT02292719|363648337|FG000|Overall Study|Subject enrolled in new study.|0|||
105448180|NCT02292719|363648338|FG001|Overall Study|Subject enrolled in new study.|0|||
105448181|NCT02292719|363648339|FG002|Overall Study|Subject enrolled in new study.|1|||
105448182|NCT02292719|363648340|FG003|Overall Study|Subject enrolled in new study.|0|||
105448183|NCT02292719|363648341|FG004|Overall Study|Subject enrolled in new study.|0|||
105448184|NCT02292719|363648342|FG005|Overall Study|Subject enrolled in new study.|0|||
105336026|NCT00839527|363231356|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
105448185|NCT00596752|363648343|FG000|Overall Study|Other Reason|44|||
105448186|NCT00596752|363648344|FG001|Overall Study|Other Reason|49|||
105448187|NCT00596752|363648343|FG000|Overall Study|Adverse Event|34|||
105448188|NCT00596752|363648344|FG001|Overall Study|Adverse Event|34|||
105448189|NCT00596752|363648343|FG000|Overall Study|Lost to Follow-up|22|||
105448190|NCT00596752|363648344|FG001|Overall Study|Lost to Follow-up|38|||
105448191|NCT00596752|363648343|FG000|Overall Study|Withdrawal by Subject|12|||
105448192|NCT00596752|363648344|FG001|Overall Study|Withdrawal by Subject|9|||
105448193|NCT00596752|363648343|FG000|Overall Study|Unsatisfactory Compliance|9|||
105448194|NCT00596752|363648344|FG001|Overall Study|Unsatisfactory Compliance|6|||
105448195|NCT00596752|363648343|FG000|Overall Study|Lack of Efficacy|4|||
105448196|NCT00596752|363648344|FG001|Overall Study|Lack of Efficacy|7|||
105448197|NCT00596752|363648343|FG000|Overall Study|Protocol Violation|1|||
105448198|NCT00596752|363648344|FG001|Overall Study|Protocol Violation|0|||
105448199|NCT01807598|363648348|FG000|Overall Study|Withdrawal by Subject|4|||
105448200|NCT01807598|363648348|FG000|Overall Study|Adverse Event|1|||
105448201|NCT01807598|363648348|FG000|Overall Study|Other Physician Decision|1|||
105448202|NCT03622814|363648349|FG000|Overall Study|Lost to Follow-up|8|||
105448203|NCT03622814|363648350|FG001|Overall Study|Lost to Follow-up|14|||
105448204|NCT04037891|363648353|FG000|Open-label Period|Withdrawal by Subject|1|||
105448205|NCT04037891|363648354|FG001|Open-label Period|Withdrawal by Subject|0|||
105448206|NCT04037891|363648355|FG002|Open-label Period|Withdrawal by Subject|0|||
105448207|NCT04037891|363648353|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
105448208|NCT04037891|363648354|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
105448209|NCT04037891|363648355|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
105448210|NCT03828292|363648358|FG000|Part 1 (Up to 141 Weeks)|Death|0|||
105448211|NCT03828292|363648359|FG001|Part 1 (Up to 141 Weeks)|Death|1|||
105448212|NCT03828292|363648360|FG002|Part 1 (Up to 141 Weeks)|Death|0|||
105448213|NCT03828292|363648361|FG003|Part 1 (Up to 141 Weeks)|Death|0|||
105448214|NCT03828292|363648358|FG000|Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
105448215|NCT03828292|363648359|FG001|Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
105448216|NCT03828292|363648360|FG002|Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
105448217|NCT03828292|363648361|FG003|Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
105448218|NCT03828292|363648358|FG000|Part 2 (Up to 212 Weeks)|Progressive disease|0|||
105448219|NCT03828292|363648359|FG001|Part 2 (Up to 212 Weeks)|Progressive disease|0|||
105448220|NCT03828292|363648360|FG002|Part 2 (Up to 212 Weeks)|Progressive disease|0|||
105448221|NCT03828292|363648361|FG003|Part 2 (Up to 212 Weeks)|Progressive disease|1|||
105448222|NCT03828292|363648358|FG000|Part 2 (Up to 212 Weeks)|Adverse Event|0|||
105448223|NCT03828292|363648359|FG001|Part 2 (Up to 212 Weeks)|Adverse Event|0|||
105448224|NCT03828292|363648360|FG002|Part 2 (Up to 212 Weeks)|Adverse Event|0|||
105448225|NCT03828292|363648361|FG003|Part 2 (Up to 212 Weeks)|Adverse Event|1|||
105448226|NCT03828292|363648358|FG000|Part 2 (Up to 212 Weeks)|Ongoing at the time of analysis|0|||
105448227|NCT03828292|363648359|FG001|Part 2 (Up to 212 Weeks)|Ongoing at the time of analysis|0|||
105448228|NCT03828292|363648360|FG002|Part 2 (Up to 212 Weeks)|Ongoing at the time of analysis|2|||
105448229|NCT03828292|363648361|FG003|Part 2 (Up to 212 Weeks)|Ongoing at the time of analysis|2|||
105448230|NCT04896593|363648362|FG000|Overall Study|Withdrawal by Subject|2|||
105448231|NCT04896593|363648362|FG000|Overall Study|Lost to Follow-up|1|||
105448232|NCT04896593|363648362|FG000|Overall Study|Did not complete onboarding|2|||
105448233|NCT00319254|363648367|FG000|Overall Study|Withdrawal by Subject|4|||
105448234|NCT00319254|363648367|FG000|Overall Study|Death|46|||
105448235|NCT00319254|363648367|FG000|Overall Study|Lost to Follow-up|2|||
105448236|NCT00319254|363648367|FG000|Overall Study|Enrolled, Not Treated|2|||
105448237|NCT01657292|363648372|FG000|Overall Study|Adverse Event|6|||
105448238|NCT01657292|363648372|FG000|Overall Study|Withdrawal by Subject|2|||
105448239|NCT01657292|363648372|FG000|Overall Study|Violation of eligibility criteria|1|||
105448240|NCT01657292|363648372|FG000|Overall Study|Change of therapy|1|||
105448241|NCT01279681|363648374|FG000|Overall Study|Disease Progression|9|||
105448242|NCT01279681|363648375|FG001|Overall Study|Disease Progression|6|||
105448243|NCT01279681|363648374|FG000|Overall Study|Withdrawal by Subject|3|||
105448244|NCT01279681|363648375|FG001|Overall Study|Withdrawal by Subject|4|||
105448245|NCT01279681|363648374|FG000|Overall Study|Adverse Event|2|||
105448246|NCT01279681|363648375|FG001|Overall Study|Adverse Event|3|||
105448247|NCT01279681|363648374|FG000|Overall Study|Death|0|||
105448248|NCT01279681|363648375|FG001|Overall Study|Death|1|||
105448249|NCT01279681|363648374|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
105448250|NCT01279681|363648375|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
105448251|NCT01279681|363648374|FG000|Overall Study|Physician Decision|1|||
105448252|NCT01279681|363648375|FG001|Overall Study|Physician Decision|0|||
105448253|NCT01279681|363648374|FG000|Overall Study|Other Reason|0|||
105448254|NCT01279681|363648375|FG001|Overall Study|Other Reason|2|||
105448255|NCT01943591|363648376|FG000|Overall Study|Lost to Follow-up|3|||
105448256|NCT01943591|363648377|FG001|Overall Study|Lost to Follow-up|4|||
105448257|NCT01943591|363648376|FG000|Overall Study|Death|2|||
105448258|NCT01943591|363648377|FG001|Overall Study|Death|7|||
105448259|NCT01929226|363650087|FG000|Overall Study|Lost to Follow-up|4|||
105448260|NCT01929226|363650088|FG001|Overall Study|Lost to Follow-up|0|||
105448261|NCT01929226|363650087|FG000|Overall Study|Withdrawal by Subject|1|||
105448262|NCT01929226|363650088|FG001|Overall Study|Withdrawal by Subject|1|||
105448263|NCT03553758|363650089|FG000|Overall Study|Lost to Follow-up|1|||
105448264|NCT00412893|363650093|FG000|Overall Study|Adverse Event|31|||
105448265|NCT00412893|363650094|FG001|Overall Study|Adverse Event|53|||
105448266|NCT00412893|363650093|FG000|Overall Study|Death|17|||
105448267|NCT00412893|363650094|FG001|Overall Study|Death|21|||
105448268|NCT00412893|363650093|FG000|Overall Study|Insufficient Therapeutic Response|39|||
105781810|NCT01072175|364854849|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
105781811|NCT01072175|364854850|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
105781812|NCT01072175|364854851|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
105781813|NCT01072175|364854852|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
105781814|NCT01072175|364854853|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
105781815|NCT01072175|364854854|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
105781816|NCT01072175|364854855|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
105781817|NCT01072175|364854856|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
105781818|NCT01072175|364854857|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
105781819|NCT01072175|364854858|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
105781820|NCT01072175|364854859|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
105781821|NCT01072175|364854847|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781822|NCT01072175|364854848|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781823|NCT01072175|364854849|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
105781824|NCT01072175|364854850|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781825|NCT01072175|364854851|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
105781826|NCT01072175|364854852|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781827|NCT01072175|364854853|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781828|NCT01072175|364854854|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781829|NCT01072175|364854855|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781830|NCT01072175|364854856|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781831|NCT01072175|364854857|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781832|NCT01072175|364854858|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781833|NCT01072175|364854859|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781834|NCT01072175|364854847|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781835|NCT01072175|364854848|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
105781836|NCT01072175|364854849|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781837|NCT01072175|364854850|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
105781838|NCT01072175|364854851|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
105781839|NCT01072175|364854852|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781840|NCT01072175|364854853|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781841|NCT01072175|364854854|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781842|NCT01072175|364854855|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781843|NCT01072175|364854856|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781844|NCT01072175|364854857|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781845|NCT01072175|364854858|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781846|NCT01072175|364854859|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781847|NCT01072175|364854847|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781848|NCT01072175|364854848|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781849|NCT01072175|364854849|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
105781850|NCT01072175|364854850|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
105781851|NCT01072175|364854851|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
105781852|NCT01072175|364854852|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781853|NCT01072175|364854853|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781854|NCT01072175|364854854|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781855|NCT01072175|364854855|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105448269|NCT00412893|363650094|FG001|Overall Study|Insufficient Therapeutic Response|23|||
105448270|NCT00412893|363650093|FG000|Overall Study|Lost to Follow-up|2|||
105448271|NCT00412893|363650094|FG001|Overall Study|Lost to Follow-up|1|||
105448272|NCT00412893|363650093|FG000|Overall Study|Violation of Selection at Entry|17|||
105448273|NCT00412893|363650094|FG001|Overall Study|Violation of Selection at Entry|10|||
105448274|NCT00412893|363650093|FG000|Overall Study|Other Protocol Violation|10|||
105448275|NCT00412893|363650094|FG001|Overall Study|Other Protocol Violation|6|||
105448276|NCT00412893|363650093|FG000|Overall Study|Did Not Cooperate|12|||
105448277|NCT00412893|363650094|FG001|Overall Study|Did Not Cooperate|9|||
105448278|NCT00412893|363650093|FG000|Overall Study|Administrative Reason|12|||
105448279|NCT00412893|363650094|FG001|Overall Study|Administrative Reason|15|||
105448280|NCT00412893|363650093|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
105448281|NCT00412893|363650094|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
105448282|NCT01217944|363650100|FG000|Overall Study|Protocol Violation|1|||
105448283|NCT01217944|363650101|FG001|Overall Study|Protocol Violation|1|||
105448284|NCT01217944|363650102|FG002|Overall Study|Protocol Violation|0|||
105448285|NCT01217944|363650100|FG000|Overall Study|Lost to Follow-up|3|||
105448286|NCT01217944|363650101|FG001|Overall Study|Lost to Follow-up|1|||
105448287|NCT01217944|363650102|FG002|Overall Study|Lost to Follow-up|0|||
105448288|NCT01217944|363650100|FG000|Overall Study|Withdrawal by Subject|1|||
105448289|NCT01217944|363650101|FG001|Overall Study|Withdrawal by Subject|2|||
105448290|NCT01217944|363650102|FG002|Overall Study|Withdrawal by Subject|0|||
105448291|NCT01217944|363650100|FG000|Overall Study|Lack of Efficacy|1|||
105448292|NCT01217944|363650101|FG001|Overall Study|Lack of Efficacy|0|||
105448293|NCT01217944|363650102|FG002|Overall Study|Lack of Efficacy|0|||
105448294|NCT01380769|363650103|FG000|Overall Study|Withdrawal by Subject|7|||
105448295|NCT01380769|363650104|FG001|Overall Study|Withdrawal by Subject|11|||
105448296|NCT01380769|363650103|FG000|Overall Study|Physician Decision|1|||
105448297|NCT01380769|363650104|FG001|Overall Study|Physician Decision|1|||
105448298|NCT01380769|363650103|FG000|Overall Study|Adverse Event|1|||
105448299|NCT01380769|363650104|FG001|Overall Study|Adverse Event|1|||
105448300|NCT01380769|363650103|FG000|Overall Study|Protocol Violation|0|||
105448301|NCT01380769|363650104|FG001|Overall Study|Protocol Violation|1|||
105448302|NCT01080807|363650113|FG000|Overall Study|Adverse Event|9|||
105448303|NCT01080807|363650114|FG001|Overall Study|Adverse Event|1|||
105448304|NCT01080807|363650113|FG000|Overall Study|Lack of Efficacy|0|||
105448305|NCT01080807|363650114|FG001|Overall Study|Lack of Efficacy|1|||
105448306|NCT01080807|363650113|FG000|Overall Study|Withdrawal by Subject|7|||
105448307|NCT01080807|363650114|FG001|Overall Study|Withdrawal by Subject|2|||
105448308|NCT01080807|363650113|FG000|Overall Study|Protocol Violation|7|||
105448309|NCT01080807|363650114|FG001|Overall Study|Protocol Violation|6|||
105448310|NCT01080807|363650113|FG000|Overall Study|Lost to Follow-up|6|||
105448311|NCT01080807|363650114|FG001|Overall Study|Lost to Follow-up|4|||
105448312|NCT01080807|363650113|FG000|Overall Study|Noncompliance with drug administration|1|||
105448313|NCT01080807|363650114|FG001|Overall Study|Noncompliance with drug administration|1|||
105448314|NCT01080807|363650113|FG000|Overall Study|Noncompliance to study procedures|1|||
105448315|NCT01080807|363650114|FG001|Overall Study|Noncompliance to study procedures|1|||
105448316|NCT01080807|363650113|FG000|Overall Study|Began working day shift|0|||
105448317|NCT01080807|363650114|FG001|Overall Study|Began working day shift|2|||
105448318|NCT01080807|363650113|FG000|Overall Study|Laid off or terminated from job|1|||
105448319|NCT01080807|363650114|FG001|Overall Study|Laid off or terminated from job|2|||
105448320|NCT01080807|363650113|FG000|Overall Study|Stopped working consistent night shifts|0|||
105448321|NCT01080807|363650114|FG001|Overall Study|Stopped working consistent night shifts|1|||
105448322|NCT01080807|363650113|FG000|Overall Study|Work schedule changing|1|||
105448323|NCT01080807|363650114|FG001|Overall Study|Work schedule changing|1|||
105448324|NCT01080807|363650113|FG000|Overall Study|Work schedule and travel|0|||
105448325|NCT01080807|363650114|FG001|Overall Study|Work schedule and travel|1|||
105448326|NCT01080807|363650113|FG000|Overall Study|Switched to first shift|1|||
105448327|NCT01080807|363650114|FG001|Overall Study|Switched to first shift|0|||
105448328|NCT01080807|363650113|FG000|Overall Study|Moved away without notifying center|1|||
105448329|NCT01080807|363650114|FG001|Overall Study|Moved away without notifying center|0|||
105448330|NCT01641601|363650115|FG000|Overall Study|Study discontinued.|3|||
105448331|NCT01641601|363650116|FG001|Overall Study|Study discontinued.|5|||
105448332|NCT03400852|363650124|FG000|Blinded Treatment Period|Physician Decision|0|||
105448333|NCT03400852|363650125|FG001|Blinded Treatment Period|Physician Decision|1|||
105448334|NCT03400852|363650126|FG002|Blinded Treatment Period|Physician Decision|0|||
105448335|NCT03400852|363650124|FG000|Blinded Treatment Period|Adverse Event|1|||
105448336|NCT03400852|363650125|FG001|Blinded Treatment Period|Adverse Event|1|||
105448337|NCT03400852|363650126|FG002|Blinded Treatment Period|Adverse Event|0|||
105448338|NCT03400852|363650124|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
105448339|NCT03400852|363650125|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
105448340|NCT03400852|363650126|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
105448341|NCT03400852|363650124|FG000|Open Label Period|Physician Decision|0|||
105448342|NCT03400852|363650125|FG001|Open Label Period|Physician Decision|0|||
105448343|NCT03400852|363650126|FG002|Open Label Period|Physician Decision|1|||
105448344|NCT03400852|363650124|FG000|Open Label Period|Study terminated by sponsor|0|||
105448345|NCT03400852|363650125|FG001|Open Label Period|Study terminated by sponsor|0|||
105448346|NCT03400852|363650126|FG002|Open Label Period|Study terminated by sponsor|21|||
105448347|NCT02274792|363650127|FG000|Overall Study|Withdrawal by Subject|13|||
105448348|NCT02274792|363650127|FG000|Overall Study|Lost to Follow-up|8|||
105448349|NCT02274792|363650127|FG000|Overall Study|Protocol Specified Criteria|2|||
105448350|NCT02274792|363650127|FG000|Overall Study|Sponsor Decision|2|||
105448351|NCT01485094|363650128|FG000|Overall Study|Adverse Event|1|||
105448352|NCT01485094|363650129|FG001|Overall Study|Adverse Event|1|||
105448353|NCT01485094|363650130|FG002|Overall Study|Adverse Event|1|||
105448354|NCT01485094|363650128|FG000|Overall Study|Lost to Follow-up|1|||
105448355|NCT01485094|363650129|FG001|Overall Study|Lost to Follow-up|0|||
105448356|NCT01485094|363650130|FG002|Overall Study|Lost to Follow-up|0|||
105448357|NCT01485094|363650128|FG000|Overall Study|Withdrawal by Subject|1|||
105448358|NCT01485094|363650129|FG001|Overall Study|Withdrawal by Subject|1|||
105448359|NCT01485094|363650130|FG002|Overall Study|Withdrawal by Subject|0|||
105448360|NCT01426958|363650131|FG000|Overall Study|Adverse Event|2|||
105448361|NCT00965081|363650133|FG000|Overall Study|Adverse Event|14|||
105448362|NCT00965081|363650134|FG001|Overall Study|Adverse Event|9|||
105448363|NCT00965081|363650133|FG000|Overall Study|Lack of Efficacy|2|||
105448364|NCT00965081|363650134|FG001|Overall Study|Lack of Efficacy|5|||
105448365|NCT00965081|363650133|FG000|Overall Study|Lost to Follow-up|4|||
105448366|NCT00965081|363650134|FG001|Overall Study|Lost to Follow-up|5|||
105448367|NCT00965081|363650133|FG000|Overall Study|Physician Decision|2|||
105448368|NCT00965081|363650134|FG001|Overall Study|Physician Decision|0|||
105448369|NCT00965081|363650133|FG000|Overall Study|Protocol Violation|2|||
105448370|NCT00965081|363650134|FG001|Overall Study|Protocol Violation|5|||
105448371|NCT00965081|363650133|FG000|Overall Study|Sponsor Decision|1|||
105448372|NCT00965081|363650134|FG001|Overall Study|Sponsor Decision|0|||
105448373|NCT00965081|363650133|FG000|Overall Study|Withdrawal by Subject|4|||
105448374|NCT00965081|363650134|FG001|Overall Study|Withdrawal by Subject|7|||
105448375|NCT00965081|363650133|FG000|Overall Study|Switched to Rescue Arm|5|||
105448376|NCT00965081|363650134|FG001|Overall Study|Switched to Rescue Arm|12|||
105448377|NCT00796666|363650135|FG000|Overall Study|Death|2|||
105448378|NCT00796666|363650136|FG001|Overall Study|Death|4|||
105448379|NCT00796666|363650135|FG000|Overall Study|Withdrawal by Subject|2|||
105448380|NCT00796666|363650136|FG001|Overall Study|Withdrawal by Subject|0|||
105448381|NCT00796666|363650135|FG000|Overall Study|Adverse Event|7|||
105448382|NCT00796666|363650136|FG001|Overall Study|Adverse Event|5|||
105448383|NCT00796666|363650135|FG000|Overall Study|Protocol Violation|1|||
105448384|NCT00796666|363650136|FG001|Overall Study|Protocol Violation|0|||
105448385|NCT00796666|363650135|FG000|Overall Study|Other|1|||
105448386|NCT00796666|363650136|FG001|Overall Study|Other|0|||
105448387|NCT00796666|363650135|FG000|Overall Study|Terminated by sponsor|53|||
105448388|NCT00796666|363650136|FG001|Overall Study|Terminated by sponsor|55|||
105448389|NCT00796666|363650135|FG000|Overall Study|Randomized and not treated|1|||
105448390|NCT00796666|363650136|FG001|Overall Study|Randomized and not treated|0|||
105448391|NCT05280717|363650137|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
105448392|NCT05280717|363650138|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
105448393|NCT05280717|363650139|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
105448394|NCT05280717|363650140|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
105448395|NCT05280717|363650141|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
105448396|NCT05280717|363650142|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
105448397|NCT05280717|363650143|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
105448398|NCT05280717|363650137|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
105448399|NCT05280717|363650138|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
105448400|NCT05280717|363650139|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
105448401|NCT05280717|363650140|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
105448402|NCT05280717|363650141|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
105448403|NCT05280717|363650142|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
105448404|NCT05280717|363650143|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
105448405|NCT05280717|363650137|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
105448406|NCT05280717|363650138|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
105448407|NCT05280717|363650139|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
105448408|NCT05280717|363650140|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
105448409|NCT05280717|363650141|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
105448410|NCT05280717|363650142|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
105448411|NCT05280717|363650143|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
105448412|NCT05280717|363650137|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
105448413|NCT05280717|363650138|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
105448414|NCT05280717|363650139|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
105448415|NCT05280717|363650140|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
105448416|NCT05280717|363650141|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
105448417|NCT05280717|363650142|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
105448418|NCT05280717|363650143|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
105448419|NCT05280717|363650137|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
105448420|NCT05280717|363650138|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
105448421|NCT05280717|363650139|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
105448422|NCT05280717|363650140|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
105448423|NCT05280717|363650141|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
105448424|NCT05280717|363650142|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
105448425|NCT05280717|363650143|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
105448426|NCT05280717|363650137|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
105448427|NCT05280717|363650138|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
105448428|NCT05280717|363650139|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
105448429|NCT05280717|363650140|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
105448430|NCT05280717|363650141|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
105448431|NCT05280717|363650142|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
105448432|NCT05280717|363650143|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
105448433|NCT03801174|363650147|FG000|Overall Study|Withdrawal by Subject|14|||
105448434|NCT03801174|363650148|FG001|Overall Study|Withdrawal by Subject|15|||
105448435|NCT03801174|363650147|FG000|Overall Study|Death|1|||
105448436|NCT03801174|363650148|FG001|Overall Study|Death|0|||
105448437|NCT03801174|363650147|FG000|Overall Study|Pregnancy|2|||
105448438|NCT03801174|363650148|FG001|Overall Study|Pregnancy|2|||
105448439|NCT03801174|363650147|FG000|Overall Study|Lost to Follow-up|19|||
105448440|NCT03801174|363650148|FG001|Overall Study|Lost to Follow-up|10|||
105448441|NCT03801174|363650147|FG000|Overall Study|Other|4|||
105448442|NCT03801174|363650148|FG001|Overall Study|Other|3|||
105448443|NCT03801174|363650147|FG000|Overall Study|Lack of Efficacy|4|||
105448444|NCT03801174|363650148|FG001|Overall Study|Lack of Efficacy|0|||
105448445|NCT03801174|363650147|FG000|Overall Study|Unwilling to complete activities|5|||
105448446|NCT03801174|363650148|FG001|Overall Study|Unwilling to complete activities|6|||
105448447|NCT03801174|363650147|FG000|Overall Study|Moved out of area|3|||
105448448|NCT03801174|363650148|FG001|Overall Study|Moved out of area|0|||
105448449|NCT00181766|363650149|FG000|Overall Study|Lost to Follow-up|6|||
105448450|NCT00181766|363650149|FG000|Overall Study|Adverse Event|4|||
105448451|NCT00181766|363650149|FG000|Overall Study|non-compliance|2|||
105448452|NCT00413218|363650154|FG000|Overall Study|Randomized but didn't receive study drug|2|||
105448453|NCT00413218|363650155|FG001|Overall Study|Randomized but didn't receive study drug|8|||
105448454|NCT00413218|363650154|FG000|Overall Study|Death|57|||
105448455|NCT00413218|363650155|FG001|Overall Study|Death|56|||
105448456|NCT00413218|363650154|FG000|Overall Study|Lost to Follow-up|14|||
105448457|NCT00413218|363650155|FG001|Overall Study|Lost to Follow-up|17|||
105448458|NCT00413218|363650154|FG000|Overall Study|Admin|20|||
105448459|NCT00413218|363650155|FG001|Overall Study|Admin|14|||
105448460|NCT00413218|363650154|FG000|Overall Study|Missing|1|||
105448461|NCT00413218|363650155|FG001|Overall Study|Missing|0|||
105448462|NCT00413218|363650154|FG000|Overall Study|Withdrawal by Subject|9|||
105448463|NCT00413218|363650155|FG001|Overall Study|Withdrawal by Subject|1|||
105448464|NCT01687296|363650157|FG000|Overall Study|Lack of Efficacy|1|||
105448465|NCT01687296|363650158|FG001|Overall Study|Lack of Efficacy|1|||
105448466|NCT01687296|363650157|FG000|Overall Study|Protocol Violation|0|||
105448467|NCT01687296|363650158|FG001|Overall Study|Protocol Violation|1|||
105448468|NCT01687296|363650157|FG000|Overall Study|Withdrawal by Subject|6|||
105448469|NCT01687296|363650158|FG001|Overall Study|Withdrawal by Subject|3|||
105448470|NCT02698826|363650159|FG000|Overall Study|Death|13|||
105448471|NCT02698826|363650159|FG000|Overall Study|Adverse Event|1|||
105448472|NCT02478463|363650160|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
105448473|NCT02478463|363650160|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
105448474|NCT02478463|363650160|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
105448475|NCT01618669|363650165|FG000|Overall Study|Lost to Follow-up|1|||
105448476|NCT01618669|363650166|FG001|Overall Study|Lost to Follow-up|1|||
105448477|NCT01618669|363650165|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
105448478|NCT01618669|363650166|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
105448479|NCT01618669|363650165|FG000|Overall Study|Adverse Event|16|||
105448480|NCT01618669|363650166|FG001|Overall Study|Adverse Event|7|||
105448481|NCT01618669|363650165|FG000|Overall Study|Protocol Violation|5|||
105448482|NCT01618669|363650166|FG001|Overall Study|Protocol Violation|3|||
105448483|NCT01618669|363650165|FG000|Overall Study|Withdrawal by Subject|9|||
105448484|NCT01618669|363650166|FG001|Overall Study|Withdrawal by Subject|9|||
105448485|NCT01618669|363650165|FG000|Overall Study|Miscellaneous Reason|0|||
105448486|NCT01618669|363650166|FG001|Overall Study|Miscellaneous Reason|1|||
105448487|NCT04317040|363650167|FG000|Overall Study|Lost to Follow-up|2|||
105448488|NCT04317040|363650168|FG001|Overall Study|Lost to Follow-up|0|||
105448489|NCT04317040|363650167|FG000|Overall Study|Death|16|||
105448490|NCT04317040|363650168|FG001|Overall Study|Death|18|||
105448491|NCT04317040|363650167|FG000|Overall Study|Withdrawal by Subject|0|||
105448492|NCT04317040|363650168|FG001|Overall Study|Withdrawal by Subject|1|||
105448493|NCT04317040|363650167|FG000|Overall Study|Incomplete assessments|0|||
105448494|NCT04317040|363650168|FG001|Overall Study|Incomplete assessments|1|||
105448495|NCT01177007|363650169|FG000|Overall Study|Lost to Follow-up|2|||
105448496|NCT01177007|363650169|FG000|Overall Study|Death|4|||
105336027|NCT00839527|363231357|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
105448497|NCT01177007|363650169|FG000|Overall Study|Entered hospice care|5|||
105448498|NCT01177007|363650169|FG000|Overall Study|Required additional Y90 treatment|6|||
105448499|NCT01177007|363650169|FG000|Overall Study|Change in treatment modality|21|||
105448500|NCT01012258|363650170|FG000|Overall Study|Death|14|||
105448501|NCT01012258|363650170|FG000|Overall Study|Lost to Follow-up|1|||
105448502|NCT01012258|363650170|FG000|Overall Study|Adverse Event|1|||
105448503|NCT01012258|363650170|FG000|Overall Study|Progressive Disease (PD)|18|||
105448504|NCT01012258|363650170|FG000|Overall Study|Symptomatic Deterioration|1|||
105448505|NCT01012258|363650170|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
105781856|NCT01072175|364854856|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781857|NCT01072175|364854857|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781858|NCT01072175|364854858|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781859|NCT01072175|364854859|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781860|NCT01072175|364854847|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105448506|NCT01012258|363650170|FG000|Overall Study|Another Tumor Discovered|1|||
105448507|NCT01012258|363650170|FG000|Overall Study|Ongoing|29|||
105448508|NCT01292187|363650171|FG000|Overall Study|Adverse Event|10|||
105448509|NCT01292187|363650172|FG001|Overall Study|Adverse Event|5|||
105448510|NCT01292187|363650171|FG000|Overall Study|Withdrawal by Subject|6|||
105448511|NCT01292187|363650172|FG001|Overall Study|Withdrawal by Subject|5|||
105448512|NCT01292187|363650171|FG000|Overall Study|All other reasons|1|||
105448513|NCT01292187|363650172|FG001|Overall Study|All other reasons|3|||
105448514|NCT01702558|363650173|FG000|Overall Study|Withdrawal by Subject|0|||
105448515|NCT01702558|363650174|FG001|Overall Study|Withdrawal by Subject|0|||
105448516|NCT01702558|363650175|FG002|Overall Study|Withdrawal by Subject|0|||
105448517|NCT01702558|363650176|FG003|Overall Study|Withdrawal by Subject|12|||
105448518|NCT01702558|363650177|FG004|Overall Study|Withdrawal by Subject|4|||
105448519|NCT01702558|363650173|FG000|Overall Study|Lost to Follow-up|0|||
105448520|NCT01702558|363650174|FG001|Overall Study|Lost to Follow-up|0|||
105448521|NCT01702558|363650175|FG002|Overall Study|Lost to Follow-up|0|||
105448522|NCT01702558|363650176|FG003|Overall Study|Lost to Follow-up|3|||
105448523|NCT01702558|363650177|FG004|Overall Study|Lost to Follow-up|0|||
105448524|NCT01702558|363650173|FG000|Overall Study|Death|4|||
105448525|NCT01702558|363650174|FG001|Overall Study|Death|3|||
105448526|NCT01702558|363650175|FG002|Overall Study|Death|3|||
105448527|NCT01702558|363650176|FG003|Overall Study|Death|16|||
105448528|NCT01702558|363650177|FG004|Overall Study|Death|20|||
105448529|NCT01702558|363650173|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
105448530|NCT01702558|363650174|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
105448531|NCT01702558|363650175|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
105448532|NCT01702558|363650176|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
105448533|NCT01702558|363650177|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
105448534|NCT01702558|363650173|FG000|Overall Study|Study Terminated by Sponsor|0|||
105448535|NCT01702558|363650174|FG001|Overall Study|Study Terminated by Sponsor|1|||
105781861|NCT01072175|364854848|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
105781862|NCT01072175|364854849|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781863|NCT01072175|364854850|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
105781864|NCT01072175|364854851|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
105781865|NCT01072175|364854852|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781866|NCT01072175|364854853|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781867|NCT01072175|364854854|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781868|NCT01072175|364854855|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781869|NCT01072175|364854856|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781870|NCT01072175|364854857|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781871|NCT01072175|364854858|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781872|NCT01072175|364854859|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105448536|NCT01702558|363650175|FG002|Overall Study|Study Terminated by Sponsor|0|||
105448537|NCT01702558|363650176|FG003|Overall Study|Study Terminated by Sponsor|0|||
105448538|NCT01702558|363650177|FG004|Overall Study|Study Terminated by Sponsor|1|||
105448539|NCT01702558|363650173|FG000|Overall Study|Other|0|||
105448540|NCT01702558|363650174|FG001|Overall Study|Other|0|||
105448541|NCT01702558|363650175|FG002|Overall Study|Other|0|||
105448542|NCT01702558|363650176|FG003|Overall Study|Other|16|||
105781873|NCT01072175|364854847|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
105781874|NCT01072175|364854848|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
105781875|NCT01072175|364854849|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
105448543|NCT01702558|363650177|FG004|Overall Study|Other|17|||
105448544|NCT03259087|363650180|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
105448545|NCT03259087|363650181|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
105448546|NCT03259087|363650182|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
105448547|NCT03259087|363650183|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
105448548|NCT03259087|363650184|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
105448549|NCT03259087|363650180|FG000|Period 2 of Part 2|Adverse Event|0|||
105448550|NCT03259087|363650181|FG001|Period 2 of Part 2|Adverse Event|0|||
105448551|NCT03259087|363650182|FG002|Period 2 of Part 2|Adverse Event|0|||
105448552|NCT03259087|363650183|FG003|Period 2 of Part 2|Adverse Event|0|||
105448553|NCT03259087|363650184|FG004|Period 2 of Part 2|Adverse Event|1|||
105781876|NCT01072175|364854850|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
105781877|NCT01072175|364854851|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
105781878|NCT01072175|364854852|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
105781879|NCT01072175|364854853|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
105781880|NCT01072175|364854854|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
105781881|NCT01072175|364854855|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
105781882|NCT01072175|364854856|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
105781883|NCT01072175|364854857|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
105448554|NCT03571204|363650185|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
105448555|NCT03571204|363650186|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
105448556|NCT03571204|363650187|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
105448557|NCT03571204|363650185|FG000|Overall Study|Physician Decision|0|||
105448558|NCT03571204|363650186|FG001|Overall Study|Physician Decision|1|||
105448559|NCT03571204|363650187|FG002|Overall Study|Physician Decision|0|||
105448560|NCT02396212|363650188|FG000|Overall Study|Adverse Event|1|||
105448561|NCT02396212|363650188|FG000|Overall Study|Lack of Efficacy|2|||
105448562|NCT02366195|363650195|FG000|Overall Study|Protocol-specified criteria|3|||
105448563|NCT02366195|363650195|FG000|Overall Study|Withdrawal by Subject|9|||
105448564|NCT02366195|363650195|FG000|Overall Study|Lost to Follow-up|1|||
105448565|NCT02366195|363650195|FG000|Overall Study|Death|41|||
105781884|NCT01072175|364854858|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
105781885|NCT01072175|364854859|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
105781886|NCT01072175|364854847|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781887|NCT01072175|364854848|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781888|NCT01072175|364854849|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781889|NCT01072175|364854850|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781890|NCT01072175|364854851|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781891|NCT01072175|364854852|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
105781892|NCT01072175|364854853|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
105781893|NCT01072175|364854854|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
105781894|NCT01072175|364854855|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781895|NCT01072175|364854856|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781896|NCT01072175|364854857|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781897|NCT01072175|364854858|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781898|NCT01072175|364854859|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781899|NCT01072175|364854847|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781900|NCT01072175|364854848|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781901|NCT01072175|364854849|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781902|NCT01072175|364854850|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781903|NCT01072175|364854851|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781904|NCT01072175|364854852|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781905|NCT01072175|364854853|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
105781906|NCT01072175|364854854|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
105781907|NCT01072175|364854855|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781908|NCT01072175|364854856|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781909|NCT01072175|364854857|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781910|NCT01072175|364854858|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781911|NCT01072175|364854859|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781912|NCT01072175|364854847|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781913|NCT01072175|364854848|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781914|NCT01072175|364854849|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781915|NCT01072175|364854850|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781916|NCT01072175|364854851|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781917|NCT01072175|364854852|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
105781918|NCT01072175|364854853|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
105781919|NCT01072175|364854854|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
105781920|NCT01072175|364854855|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781921|NCT01072175|364854856|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781922|NCT01072175|364854857|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781923|NCT01072175|364854858|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781924|NCT01072175|364854859|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781925|NCT01072175|364854847|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781926|NCT01072175|364854848|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781927|NCT01072175|364854849|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781928|NCT01072175|364854850|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781929|NCT01072175|364854851|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781930|NCT01072175|364854852|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
105448566|NCT01338818|363650196|FG000|Overall Study|Adverse Event|8|||
105448567|NCT01338818|363650196|FG000|Overall Study|Lack of Efficacy|5|||
105448568|NCT01338818|363650196|FG000|Overall Study|no longer require study drug|1|||
105448569|NCT01338818|363650196|FG000|Overall Study|Withdrawal by Subject|11|||
105448570|NCT01338818|363650196|FG000|Overall Study|Lost to Follow-up|4|||
105448571|NCT01338818|363650196|FG000|Overall Study|Administrative problems|3|||
105448572|NCT01338818|363650196|FG000|Overall Study|Protocol Deviation|4|||
105448573|NCT01620086|363650197|FG000|Overall Study|Withdrawal by Subject|3|||
105448574|NCT01620086|363650198|FG001|Overall Study|Withdrawal by Subject|3|||
105448575|NCT01620086|363650199|FG002|Overall Study|Withdrawal by Subject|0|||
105781931|NCT01072175|364854853|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
105781932|NCT01072175|364854854|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781933|NCT01072175|364854855|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781934|NCT01072175|364854856|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781935|NCT01072175|364854857|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781936|NCT01072175|364854858|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781937|NCT01072175|364854859|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781938|NCT01072175|364854847|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781939|NCT01072175|364854848|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781940|NCT01072175|364854849|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781941|NCT01072175|364854850|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781942|NCT01072175|364854851|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781943|NCT01072175|364854852|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781944|NCT01072175|364854853|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781945|NCT01072175|364854854|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781946|NCT01072175|364854855|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
105448576|NCT01620086|363650197|FG000|Overall Study|failed study criteria|1|||
105448577|NCT01620086|363650198|FG001|Overall Study|failed study criteria|4|||
105448578|NCT01620086|363650199|FG002|Overall Study|failed study criteria|0|||
105448579|NCT01620086|363650197|FG000|Overall Study|Physician Decision|1|||
105448580|NCT01620086|363650198|FG001|Overall Study|Physician Decision|0|||
105448581|NCT01620086|363650199|FG002|Overall Study|Physician Decision|0|||
105448582|NCT02714569|363650207|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
105448583|NCT02714569|363650208|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
105448584|NCT02714569|363650209|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
105448585|NCT02714569|363650210|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
105448586|NCT02714569|363650211|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
105448587|NCT02714569|363650212|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
105448588|NCT02714569|363650213|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
105448589|NCT02714569|363650214|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
105781947|NCT01072175|364854856|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781948|NCT01072175|364854857|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781949|NCT01072175|364854858|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781950|NCT01072175|364854859|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781951|NCT01072175|364854847|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781952|NCT01072175|364854848|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781953|NCT01072175|364854849|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781954|NCT01072175|364854850|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781955|NCT01072175|364854851|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781956|NCT01072175|364854852|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781957|NCT01072175|364854853|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781958|NCT01072175|364854854|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781959|NCT01072175|364854855|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
105781960|NCT01072175|364854856|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781961|NCT01072175|364854857|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105448590|NCT02714569|363650215|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
105448591|NCT02714569|363650216|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
105448592|NCT02714569|363650217|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
105781962|NCT01072175|364854858|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781963|NCT01072175|364854859|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781964|NCT01072175|364854847|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105448593|NCT02714569|363650207|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105448594|NCT02714569|363650208|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105448595|NCT02714569|363650209|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105448596|NCT02714569|363650210|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
105781965|NCT01072175|364854848|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781966|NCT01072175|364854849|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105448597|NCT02714569|363650211|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105448598|NCT02714569|363650212|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105781967|NCT01072175|364854850|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781968|NCT01072175|364854851|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781969|NCT01072175|364854852|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781970|NCT01072175|364854853|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781971|NCT01072175|364854854|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781972|NCT01072175|364854855|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
105781973|NCT01072175|364854856|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781974|NCT01072175|364854857|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781975|NCT01072175|364854858|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781976|NCT01072175|364854859|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781977|NCT01072175|364854847|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781978|NCT01072175|364854848|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781979|NCT01072175|364854849|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781980|NCT01072175|364854850|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781981|NCT01072175|364854851|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781982|NCT01072175|364854852|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781983|NCT01072175|364854853|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781984|NCT01072175|364854854|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781985|NCT01072175|364854855|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
105781986|NCT01072175|364854856|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781987|NCT01072175|364854857|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781988|NCT01072175|364854858|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781989|NCT01072175|364854859|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781990|NCT01072175|364854847|FG000|Part D (HPMC Capsules)|Death|0|||
105781991|NCT01072175|364854848|FG001|Part D (HPMC Capsules)|Death|0|||
105781992|NCT01072175|364854849|FG002|Part D (HPMC Capsules)|Death|0|||
105781993|NCT01072175|364854850|FG003|Part D (HPMC Capsules)|Death|0|||
105781994|NCT01072175|364854851|FG004|Part D (HPMC Capsules)|Death|0|||
105781995|NCT01072175|364854852|FG005|Part D (HPMC Capsules)|Death|0|||
105781996|NCT01072175|364854853|FG006|Part D (HPMC Capsules)|Death|0|||
105781997|NCT01072175|364854854|FG007|Part D (HPMC Capsules)|Death|0|||
105781998|NCT01072175|364854855|FG008|Part D (HPMC Capsules)|Death|0|||
105781999|NCT01072175|364854856|FG009|Part D (HPMC Capsules)|Death|10|||
105782000|NCT01072175|364854857|FG010|Part D (HPMC Capsules)|Death|12|||
105782001|NCT01072175|364854858|FG011|Part D (HPMC Capsules)|Death|28|||
105782002|NCT01072175|364854859|FG012|Part D (HPMC Capsules)|Death|26|||
105782003|NCT01072175|364854847|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
105782004|NCT01072175|364854848|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
105448599|NCT02714569|363650213|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105448600|NCT02714569|363650214|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105782005|NCT01072175|364854849|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
105448601|NCT02714569|363650215|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105448602|NCT02714569|363650216|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105448603|NCT02714569|363650217|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105448604|NCT02714569|363650207|FG000|Part A Third Intervention|Adverse Event|0|||
105448605|NCT02714569|363650208|FG001|Part A Third Intervention|Adverse Event|0|||
105448606|NCT02714569|363650209|FG002|Part A Third Intervention|Adverse Event|1|||
105448607|NCT02714569|363650210|FG003|Part A Third Intervention|Adverse Event|0|||
105448608|NCT02714569|363650211|FG004|Part A Third Intervention|Adverse Event|0|||
105448609|NCT02714569|363650212|FG005|Part A Third Intervention|Adverse Event|0|||
105448610|NCT02714569|363650213|FG006|Part A Third Intervention|Adverse Event|0|||
105448611|NCT02714569|363650214|FG007|Part A Third Intervention|Adverse Event|0|||
105448612|NCT02714569|363650215|FG008|Part A Third Intervention|Adverse Event|0|||
105448613|NCT02714569|363650216|FG009|Part A Third Intervention|Adverse Event|0|||
105448614|NCT02714569|363650217|FG010|Part A Third Intervention|Adverse Event|0|||
105448615|NCT02714569|363650207|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
105448616|NCT02714569|363650208|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105448617|NCT02714569|363650209|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105782006|NCT01072175|364854850|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
105448618|NCT02714569|363650210|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105448619|NCT02714569|363650211|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105448620|NCT02714569|363650212|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
105448621|NCT02714569|363650213|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105782007|NCT01072175|364854851|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
105782008|NCT01072175|364854852|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
105782009|NCT01072175|364854853|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
105782010|NCT01072175|364854854|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
105782011|NCT01072175|364854855|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
105782012|NCT01072175|364854856|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
105782013|NCT01072175|364854857|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
105782014|NCT01072175|364854858|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
105782015|NCT01072175|364854859|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
105782016|NCT01072175|364854847|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782017|NCT01072175|364854848|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782018|NCT01072175|364854849|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782019|NCT01072175|364854850|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782020|NCT01072175|364854851|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782021|NCT01072175|364854852|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782022|NCT01072175|364854853|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782023|NCT01072175|364854854|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782024|NCT01072175|364854855|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782025|NCT01072175|364854856|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782026|NCT01072175|364854857|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
105782027|NCT01072175|364854858|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
105782028|NCT01072175|364854859|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
105782029|NCT01072175|364854847|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782030|NCT01072175|364854848|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782031|NCT01072175|364854849|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782032|NCT01072175|364854850|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782033|NCT01072175|364854851|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782034|NCT01072175|364854852|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782035|NCT01072175|364854853|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782036|NCT01072175|364854854|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782037|NCT01072175|364854855|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782038|NCT01072175|364854856|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
105782039|NCT01072175|364854857|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
105782040|NCT01072175|364854858|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
105782041|NCT01072175|364854859|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
105782042|NCT01072175|364854847|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782043|NCT01072175|364854848|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782044|NCT01072175|364854849|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782045|NCT01072175|364854850|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782046|NCT01072175|364854851|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782047|NCT01072175|364854852|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782048|NCT01072175|364854853|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782049|NCT01072175|364854854|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782050|NCT01072175|364854855|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782051|NCT01072175|364854856|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782052|NCT01072175|364854857|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
105782053|NCT01072175|364854858|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
105782054|NCT01072175|364854859|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782055|NCT02477215|364854864|FG000|Dose Escalation Phase|Physician Decision|1|||
105782056|NCT02477215|364854865|FG001|Dose Escalation Phase|Physician Decision|2|||
105782057|NCT02477215|364854866|FG002|Dose Escalation Phase|Physician Decision|0|||
105782058|NCT02477215|364854864|FG000|Fixed Dose Phase|Physician Decision|0|||
105782059|NCT02477215|364854865|FG001|Fixed Dose Phase|Physician Decision|7|||
105782060|NCT02477215|364854866|FG002|Fixed Dose Phase|Physician Decision|0|||
105782061|NCT01161173|364854870|FG000|Overall Study|Protocol Violation|13|||
105782062|NCT01161173|364854870|FG000|Overall Study|Lost to Follow-up|7|||
105782063|NCT01161173|364854870|FG000|Overall Study|Progressive Disease|82|||
105782064|NCT01161173|364854870|FG000|Overall Study|Withdrawal of Consent|5|||
105782065|NCT01161173|364854870|FG000|Overall Study|Unacceptable Toxicity|21|||
105782066|NCT01161173|364854870|FG000|Overall Study|Death|194|||
105782067|NCT01161173|364854870|FG000|Overall Study|End of Study|2|||
105782068|NCT01161173|364854870|FG000|Overall Study|Reasons Not Specified|23|||
105782069|NCT01911546|364854871|FG000|Overall Study|Lost to Follow-up|1|||
105782070|NCT01911546|364854871|FG000|Overall Study|Everolimus was discontinued|5|||
105782071|NCT02210559|364854872|FG000|Overall Study|Progressive Disease|3|||
105782072|NCT02210559|364854873|FG001|Overall Study|Progressive Disease|2|||
105782073|NCT02210559|364854872|FG000|Overall Study|Adverse Event|2|||
105782074|NCT02210559|364854873|FG001|Overall Study|Adverse Event|2|||
105782075|NCT02210559|364854872|FG000|Overall Study|Physician Decision|1|||
105782076|NCT02210559|364854873|FG001|Overall Study|Physician Decision|0|||
105782077|NCT02210559|364854872|FG000|Overall Study|Withdrawal by Subject|0|||
105782078|NCT02210559|364854873|FG001|Overall Study|Withdrawal by Subject|1|||
105782079|NCT02210559|364854872|FG000|Overall Study|Other than specified|0|||
105782080|NCT02210559|364854873|FG001|Overall Study|Other than specified|1|||
105782081|NCT03172026|364854881|FG000|Overall Study|Withdrawal by Subject|1|||
105782082|NCT03172026|364854882|FG001|Overall Study|Withdrawal by Subject|0|||
105782083|NCT03172026|364854881|FG000|Overall Study|COVID restrictions|1|||
105782084|NCT03172026|364854882|FG001|Overall Study|COVID restrictions|0|||
105782085|NCT01430559|364854886|FG000|Overall Study|Adverse Event|7|||
105782086|NCT01430559|364854887|FG001|Overall Study|Adverse Event|3|||
105782087|NCT01430559|364854886|FG000|Overall Study|Entry criteria not met|1|||
105782088|NCT01430559|364854887|FG001|Overall Study|Entry criteria not met|1|||
105782089|NCT01430559|364854886|FG000|Overall Study|Lost to Follow-up|1|||
105782090|NCT01430559|364854887|FG001|Overall Study|Lost to Follow-up|0|||
105782091|NCT01430559|364854886|FG000|Overall Study|Medication error|1|||
105782092|NCT01430559|364854887|FG001|Overall Study|Medication error|0|||
105782093|NCT01430559|364854886|FG000|Overall Study|Withdrawal by Subject|3|||
105782094|NCT01430559|364854887|FG001|Overall Study|Withdrawal by Subject|2|||
105782095|NCT01430559|364854886|FG000|Overall Study|Protocol Violation|1|||
105782096|NCT01430559|364854887|FG001|Overall Study|Protocol Violation|0|||
105782097|NCT01430559|364854886|FG000|Overall Study|Other|3|||
105782098|NCT01430559|364854887|FG001|Overall Study|Other|3|||
105782099|NCT01430559|364854886|FG000|Overall Study|Randomized, Not Treated|3|||
105782100|NCT01430559|364854887|FG001|Overall Study|Randomized, Not Treated|3|||
105782101|NCT02132312|364854891|FG000|Overall Study|Adverse Event|2|||
105782102|NCT02132312|364854892|FG001|Overall Study|Adverse Event|0|||
105782103|NCT02132312|364854891|FG000|Overall Study|Physician Decision|1|||
105782104|NCT02132312|364854892|FG001|Overall Study|Physician Decision|1|||
105782105|NCT02132312|364854891|FG000|Overall Study|Protocol Violation|0|||
105782106|NCT02132312|364854892|FG001|Overall Study|Protocol Violation|1|||
105782107|NCT02132312|364854891|FG000|Overall Study|Withdrawal by Subject|1|||
105782108|NCT02132312|364854892|FG001|Overall Study|Withdrawal by Subject|0|||
105782109|NCT02132312|364854891|FG000|Overall Study|Lost to Follow-up|2|||
105782110|NCT02132312|364854892|FG001|Overall Study|Lost to Follow-up|1|||
105782111|NCT02813681|364854893|FG000|Overall Study|Physician Decision|5|||
105782112|NCT02813681|364854894|FG001|Overall Study|Physician Decision|5|||
105782113|NCT02813681|364854895|FG002|Overall Study|Physician Decision|0|||
105782114|NCT02813681|364854893|FG000|Overall Study|Lost to Follow-up|0|||
105782115|NCT02813681|364854894|FG001|Overall Study|Lost to Follow-up|1|||
105782116|NCT02813681|364854895|FG002|Overall Study|Lost to Follow-up|0|||
105782117|NCT01326481|364854896|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
105782118|NCT00307736|364854897|FG000|Overall Study|Adverse Event|0|||
105782119|NCT00307736|364854898|FG001|Overall Study|Adverse Event|0|||
105782120|NCT00307736|364854899|FG002|Overall Study|Adverse Event|1|||
105782121|NCT00307736|364854900|FG003|Overall Study|Adverse Event|3|||
105782122|NCT00307736|364854897|FG000|Overall Study|Withdrawal by Subject|0|||
105782123|NCT00307736|364854898|FG001|Overall Study|Withdrawal by Subject|0|||
105782124|NCT00307736|364854899|FG002|Overall Study|Withdrawal by Subject|2|||
105782125|NCT00307736|364854900|FG003|Overall Study|Withdrawal by Subject|0|||
105782126|NCT01411917|364854905|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
105782127|NCT01411917|364854906|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
105782128|NCT01874288|364854910|FG000|Overall Study|Withdrawal by Subject|1|||
105782129|NCT01874288|364854911|FG001|Overall Study|Withdrawal by Subject|0|||
105782130|NCT01874288|364854912|FG002|Overall Study|Withdrawal by Subject|2|||
105782131|NCT01874288|364854913|FG003|Overall Study|Withdrawal by Subject|1|||
105782132|NCT01874288|364854914|FG004|Overall Study|Withdrawal by Subject|1|||
105782133|NCT01874288|364854910|FG000|Overall Study|Physician Decision|0|||
105782134|NCT01874288|364854911|FG001|Overall Study|Physician Decision|0|||
105782135|NCT01874288|364854912|FG002|Overall Study|Physician Decision|0|||
105782136|NCT01874288|364854913|FG003|Overall Study|Physician Decision|1|||
105782137|NCT01874288|364854914|FG004|Overall Study|Physician Decision|0|||
105782138|NCT01874288|364854910|FG000|Overall Study|Progressive disease|2|||
105782139|NCT01874288|364854911|FG001|Overall Study|Progressive disease|0|||
105782140|NCT01874288|364854912|FG002|Overall Study|Progressive disease|3|||
105782141|NCT01874288|364854913|FG003|Overall Study|Progressive disease|5|||
105782142|NCT01874288|364854914|FG004|Overall Study|Progressive disease|1|||
105782143|NCT02309372|364854915|FG000|Overall Study|Lost to Follow-up|3|||
105782144|NCT02309372|364854916|FG001|Overall Study|Lost to Follow-up|2|||
105782145|NCT02354599|364854925|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
105782146|NCT02354599|364854926|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
105782147|NCT02354599|364854927|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
105782148|NCT02354599|364854928|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
105782149|NCT02354599|364854929|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
105782150|NCT02354599|364854930|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
105782151|NCT02354599|364854925|FG000|Overall Study|Withdrawal by Subject|1|||
105782152|NCT02354599|364854926|FG001|Overall Study|Withdrawal by Subject|1|||
105782153|NCT02354599|364854927|FG002|Overall Study|Withdrawal by Subject|0|||
105782154|NCT02354599|364854928|FG003|Overall Study|Withdrawal by Subject|0|||
105782155|NCT02354599|364854929|FG004|Overall Study|Withdrawal by Subject|0|||
105782156|NCT02354599|364854930|FG005|Overall Study|Withdrawal by Subject|0|||
105782157|NCT04806334|364854935|FG000|Overall Study|Withdrawal by Subject|1|||
105782158|NCT02811640|364854936|FG000|Overall Study|Technology malfunction|2|||
105782159|NCT03969589|364854943|FG000|Overall Study|Lost to Follow-up|3|||
105782160|NCT03969589|364854944|FG001|Overall Study|Lost to Follow-up|2|||
105782161|NCT03969589|364854943|FG000|Overall Study|Declined Follow-Up|0|||
105782162|NCT03969589|364854944|FG001|Overall Study|Declined Follow-Up|1|||
105782163|NCT01731600|364854946|FG000|Overall Study|Adverse Event|2|||
105782164|NCT01731600|364854947|FG001|Overall Study|Adverse Event|0|||
105782165|NCT01731600|364854946|FG000|Overall Study|Withdrawal criteria|1|||
105782166|NCT01731600|364854947|FG001|Overall Study|Withdrawal criteria|0|||
105782167|NCT01731600|364854946|FG000|Overall Study|Other reasons|3|||
105782168|NCT01731600|364854947|FG001|Overall Study|Other reasons|0|||
105782169|NCT00465894|364854948|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
105782170|NCT00465894|364854949|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
105782171|NCT00465894|364854948|FG000|Treatment For 12 Weeks|Family Issues|1|||
105782172|NCT00465894|364854949|FG001|Treatment For 12 Weeks|Family Issues|1|||
105782173|NCT00465894|364854948|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
105782174|NCT00465894|364854949|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
105782175|NCT02127931|364854950|FG000|Overall Study|Glitch in Game|1|||
105782176|NCT02441517|364854951|FG000|Overall Study|Lost to Follow-up|1|||
105782177|NCT02441517|364854951|FG000|Overall Study|Withdrawal by Subject|2|||
105782178|NCT02441517|364854951|FG000|Overall Study|Study Terminated by Sponsor|1|||
105782179|NCT01513460|364854952|FG000|Overall Study|Death|0|||
105782180|NCT01513460|364854953|FG001|Overall Study|Death|0|||
105782181|NCT01513460|364854954|FG002|Overall Study|Death|1|||
105782182|NCT01513460|364854952|FG000|Overall Study|Lost to Follow-up|0|||
105782183|NCT01513460|364854953|FG001|Overall Study|Lost to Follow-up|0|||
105782184|NCT01513460|364854954|FG002|Overall Study|Lost to Follow-up|2|||
105782185|NCT01513460|364854952|FG000|Overall Study|Abnormal laboratory value|1|||
105782186|NCT01513460|364854953|FG001|Overall Study|Abnormal laboratory value|0|||
105782187|NCT01513460|364854954|FG002|Overall Study|Abnormal laboratory value|1|||
105782188|NCT01513460|364854952|FG000|Overall Study|Lack of Efficacy|1|||
105782189|NCT01513460|364854953|FG001|Overall Study|Lack of Efficacy|2|||
105782190|NCT01513460|364854954|FG002|Overall Study|Lack of Efficacy|5|||
105782191|NCT01513460|364854952|FG000|Overall Study|Protocol deviations|3|||
105782192|NCT01513460|364854953|FG001|Overall Study|Protocol deviations|4|||
105782193|NCT01513460|364854954|FG002|Overall Study|Protocol deviations|3|||
105782194|NCT01513460|364854952|FG000|Overall Study|Withdrawal by Subject|7|||
105782195|NCT01513460|364854953|FG001|Overall Study|Withdrawal by Subject|8|||
105782196|NCT01513460|364854954|FG002|Overall Study|Withdrawal by Subject|21|||
105782197|NCT01513460|364854952|FG000|Overall Study|Adverse Event|16|||
105782198|NCT01513460|364854953|FG001|Overall Study|Adverse Event|18|||
105782199|NCT01513460|364854954|FG002|Overall Study|Adverse Event|23|||
105782200|NCT01513460|364854952|FG000|Overall Study|Abnormal test procedure|1|||
105782201|NCT01513460|364854953|FG001|Overall Study|Abnormal test procedure|0|||
105782202|NCT01513460|364854954|FG002|Overall Study|Abnormal test procedure|0|||
105782203|NCT00489216|364854955|FG000|Overall Study|Adverse Event|1|||
105782204|NCT02612194|364854957|FG000|Overall Study|Death|5|||
105782205|NCT02612194|364854958|FG001|Overall Study|Death|0|||
105782206|NCT02612194|364854959|FG002|Overall Study|Death|2|||
105782207|NCT02612194|364854957|FG000|Overall Study|Early Study Termination|1|||
105782208|NCT02612194|364854958|FG001|Overall Study|Early Study Termination|0|||
105782209|NCT02612194|364854959|FG002|Overall Study|Early Study Termination|0|||
105782210|NCT00540228|364854960|FG000|Overall Study|Adverse Event|2|||
105782211|NCT00540228|364854961|FG001|Overall Study|Adverse Event|0|||
105782212|NCT00540228|364854962|FG002|Overall Study|Adverse Event|0|||
105782213|NCT00540228|364854963|FG003|Overall Study|Adverse Event|0|||
105782214|NCT00540228|364854964|FG004|Overall Study|Adverse Event|0|||
105782215|NCT00540228|364854960|FG000|Overall Study|Lost to Follow-up|1|||
105782216|NCT00540228|364854961|FG001|Overall Study|Lost to Follow-up|1|||
105782217|NCT00540228|364854962|FG002|Overall Study|Lost to Follow-up|0|||
105782218|NCT00540228|364854963|FG003|Overall Study|Lost to Follow-up|0|||
105782219|NCT00540228|364854964|FG004|Overall Study|Lost to Follow-up|0|||
105782220|NCT02828982|364854965|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
105448622|NCT02714569|363650214|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105448623|NCT02714569|363650215|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105782221|NCT02828982|364854966|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
105782222|NCT01349816|364854968|FG000|Overall Study|Withdrawal by Subject|4|||
105448624|NCT02714569|363650216|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105782223|NCT01349816|364854968|FG000|Overall Study|Physician Decision|1|||
105782224|NCT01349816|364854968|FG000|Overall Study|Adverse Event|14|||
105782225|NCT01349816|364854968|FG000|Overall Study|Lost to Follow-up|2|||
105448625|NCT02714569|363650217|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105782226|NCT01349816|364854968|FG000|Overall Study|Protocol Violation|1|||
105782227|NCT01349816|364854968|FG000|Overall Study|Protocol-specified criteria|8|||
105782228|NCT01190839|364854969|FG000|Overall Study|Adverse Event|32|||
105782229|NCT01190839|364854970|FG001|Overall Study|Adverse Event|41|||
105782230|NCT01190839|364854969|FG000|Overall Study|Protocol Violation|2|||
105782231|NCT01190839|364854970|FG001|Overall Study|Protocol Violation|2|||
105782232|NCT01190839|364854969|FG000|Overall Study|Lost to Follow-up|7|||
105782233|NCT01190839|364854970|FG001|Overall Study|Lost to Follow-up|1|||
105782234|NCT01190839|364854969|FG000|Overall Study|Death|1|||
105782235|NCT01190839|364854970|FG001|Overall Study|Death|0|||
105782236|NCT01190839|364854969|FG000|Overall Study|Trial stopped by Sponsor|71|||
105782237|NCT01190839|364854970|FG001|Overall Study|Trial stopped by Sponsor|68|||
105782238|NCT01190839|364854969|FG000|Overall Study|Undefined|35|||
105448626|NCT02714569|363650207|FG000|Part B (Overall)|Lost to Follow-up|0|||
105448627|NCT02714569|363650208|FG001|Part B (Overall)|Lost to Follow-up|0|||
105448628|NCT02714569|363650209|FG002|Part B (Overall)|Lost to Follow-up|0|||
105448629|NCT02714569|363650210|FG003|Part B (Overall)|Lost to Follow-up|0|||
105448630|NCT02714569|363650211|FG004|Part B (Overall)|Lost to Follow-up|0|||
105448631|NCT02714569|363650212|FG005|Part B (Overall)|Lost to Follow-up|0|||
105448632|NCT02714569|363650213|FG006|Part B (Overall)|Lost to Follow-up|1|||
105448633|NCT02714569|363650214|FG007|Part B (Overall)|Lost to Follow-up|0|||
105448634|NCT02714569|363650215|FG008|Part B (Overall)|Lost to Follow-up|0|||
105448635|NCT02714569|363650216|FG009|Part B (Overall)|Lost to Follow-up|0|||
105448636|NCT02714569|363650217|FG010|Part B (Overall)|Lost to Follow-up|0|||
105448637|NCT02714569|363650207|FG000|Part B (Overall)|Withdrawal by Subject|0|||
105448638|NCT02714569|363650208|FG001|Part B (Overall)|Withdrawal by Subject|0|||
105448639|NCT02714569|363650209|FG002|Part B (Overall)|Withdrawal by Subject|0|||
105448640|NCT02714569|363650210|FG003|Part B (Overall)|Withdrawal by Subject|0|||
105448641|NCT02714569|363650211|FG004|Part B (Overall)|Withdrawal by Subject|0|||
105448642|NCT02714569|363650212|FG005|Part B (Overall)|Withdrawal by Subject|0|||
105448643|NCT02714569|363650213|FG006|Part B (Overall)|Withdrawal by Subject|0|||
105448644|NCT02714569|363650214|FG007|Part B (Overall)|Withdrawal by Subject|1|||
105448645|NCT02714569|363650215|FG008|Part B (Overall)|Withdrawal by Subject|0|||
105448646|NCT02714569|363650216|FG009|Part B (Overall)|Withdrawal by Subject|1|||
105448647|NCT02714569|363650217|FG010|Part B (Overall)|Withdrawal by Subject|0|||
105448648|NCT02714569|363650207|FG000|Part B (Overall)|Adverse Event|0|||
105448649|NCT02714569|363650208|FG001|Part B (Overall)|Adverse Event|0|||
105448650|NCT02714569|363650209|FG002|Part B (Overall)|Adverse Event|0|||
105448651|NCT02714569|363650210|FG003|Part B (Overall)|Adverse Event|0|||
105448652|NCT02714569|363650211|FG004|Part B (Overall)|Adverse Event|0|||
105448653|NCT02714569|363650212|FG005|Part B (Overall)|Adverse Event|0|||
105448654|NCT02714569|363650213|FG006|Part B (Overall)|Adverse Event|0|||
105448655|NCT02714569|363650214|FG007|Part B (Overall)|Adverse Event|0|||
105448656|NCT02714569|363650215|FG008|Part B (Overall)|Adverse Event|0|||
105448657|NCT02714569|363650216|FG009|Part B (Overall)|Adverse Event|1|||
105448658|NCT02714569|363650217|FG010|Part B (Overall)|Adverse Event|0|||
105448659|NCT04915729|363650218|FG000|Overall Study|Lost to Follow-up|20|||
105448660|NCT04915729|363650219|FG001|Overall Study|Lost to Follow-up|10|||
105448661|NCT04915729|363650218|FG000|Overall Study|Withdrawal by Subject|12|||
105448662|NCT04915729|363650219|FG001|Overall Study|Withdrawal by Subject|5|||
105448663|NCT04915729|363650218|FG000|Overall Study|Death|34|||
105448664|NCT04915729|363650219|FG001|Overall Study|Death|44|||
105448665|NCT04915729|363650218|FG000|Overall Study|not treated|3|||
105448666|NCT04915729|363650219|FG001|Overall Study|not treated|6|||
105448667|NCT04915729|363650218|FG000|Overall Study|Investigator removed subject|1|||
105448668|NCT04915729|363650219|FG001|Overall Study|Investigator removed subject|2|||
105448669|NCT04915729|363650218|FG000|Overall Study|questionnaire result not evaluated|1|||
105448670|NCT04915729|363650219|FG001|Overall Study|questionnaire result not evaluated|0|||
105448671|NCT04915729|363650218|FG000|Overall Study|refuse of hospital visit|1|||
105448672|NCT04915729|363650219|FG001|Overall Study|refuse of hospital visit|3|||
105448673|NCT04915729|363650218|FG000|Overall Study|Subject withdrew|1|||
105448674|NCT04915729|363650219|FG001|Overall Study|Subject withdrew|0|||
105448675|NCT00191308|363650220|FG000|Overall Study|Adverse Event|1|||
105448676|NCT01433172|363650221|FG000|Overall Study|Withdrawal by Subject|0|||
105448677|NCT01433172|363650222|FG001|Overall Study|Withdrawal by Subject|1|||
105448678|NCT01433172|363650223|FG002|Overall Study|Withdrawal by Subject|0|||
105448679|NCT01433172|363650221|FG000|Overall Study|Disease Progression|0|||
105448680|NCT01433172|363650222|FG001|Overall Study|Disease Progression|0|||
105448681|NCT01433172|363650223|FG002|Overall Study|Disease Progression|1|||
105448682|NCT01433172|363650221|FG000|Overall Study|Death|0|||
105448683|NCT01433172|363650222|FG001|Overall Study|Death|2|||
105448684|NCT01433172|363650223|FG002|Overall Study|Death|0|||
105448685|NCT01010971|363650224|FG000|Overall Study|Adverse Event|2|||
105448686|NCT01010971|363650225|FG001|Overall Study|Adverse Event|4|||
105448687|NCT01010971|363650226|FG002|Overall Study|Adverse Event|3|||
105448688|NCT01010971|363650224|FG000|Overall Study|Withdrawal by Subject|0|||
105448689|NCT01010971|363650225|FG001|Overall Study|Withdrawal by Subject|2|||
105448690|NCT01010971|363650226|FG002|Overall Study|Withdrawal by Subject|5|||
105448691|NCT01010971|363650224|FG000|Overall Study|Lost to Follow-up|0|||
105448692|NCT01010971|363650225|FG001|Overall Study|Lost to Follow-up|2|||
105448693|NCT01010971|363650226|FG002|Overall Study|Lost to Follow-up|3|||
105782239|NCT01190839|364854970|FG001|Overall Study|Undefined|31|||
105782240|NCT01190839|364854969|FG000|Overall Study|Randomized but not treated|2|||
105448694|NCT01010971|363650224|FG000|Overall Study|Other|1|||
105448695|NCT01010971|363650225|FG001|Overall Study|Other|0|||
105448696|NCT01010971|363650226|FG002|Overall Study|Other|2|||
105448697|NCT02717494|363650228|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
105448698|NCT02717494|363650229|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
105448699|NCT02717494|363650230|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
105782241|NCT01190839|364854970|FG001|Overall Study|Randomized but not treated|4|||
105448700|NCT02717494|363650228|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
105448701|NCT02717494|363650229|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
105448702|NCT02717494|363650230|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
105448703|NCT02717494|363650228|FG000|First Intervention (Step 1)|Death|0|||
105448704|NCT02717494|363650229|FG001|First Intervention (Step 1)|Death|0|||
105448705|NCT02717494|363650230|FG002|First Intervention (Step 1)|Death|1|||
105448706|NCT02717494|363650228|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
105448707|NCT02717494|363650229|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
105448708|NCT02717494|363650230|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
105448709|NCT00731679|363650233|FG000|Overall Study|Adverse Event|7|||
105448710|NCT00731679|363650234|FG001|Overall Study|Adverse Event|8|||
105448711|NCT00731679|363650233|FG000|Overall Study|Withdrawal by Subject|8|||
105448712|NCT00731679|363650234|FG001|Overall Study|Withdrawal by Subject|8|||
105448713|NCT00731679|363650233|FG000|Overall Study|Lost to Follow-up|7|||
105448714|NCT00731679|363650234|FG001|Overall Study|Lost to Follow-up|8|||
105448715|NCT00731679|363650233|FG000|Overall Study|Noncompliance|0|||
105448716|NCT00731679|363650234|FG001|Overall Study|Noncompliance|1|||
105448717|NCT00731679|363650233|FG000|Overall Study|Pregnancy|0|||
105448718|NCT00731679|363650234|FG001|Overall Study|Pregnancy|1|||
105448719|NCT03089580|363650239|FG000|Overall Study|Lost to Follow-up|2|||
105448720|NCT04089761|363650240|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
105448721|NCT04089761|363650240|FG000|"Run In Phase"|Lost to Follow-up|1|||
105448722|NCT04089761|363650240|FG000|"Treatment Phase"|No evaluable data|5|||
105448723|NCT04089761|363650240|FG000|"Treatment Phase"|Lost to Follow-up|1|||
105448724|NCT04864639|363651683|FG000|Overall Study|Death|1|||
105448725|NCT04864639|363651683|FG000|Overall Study|Lost to Follow-up|1|||
105448726|NCT00447226|363651684|FG000|12-Week Open-label Phase|Adverse Event|0|||
105448727|NCT00447226|363651685|FG001|12-Week Open-label Phase|Adverse Event|3|||
105448728|NCT00447226|363651684|FG000|12-Week Open-label Phase|Protocol Violation|0|||
105448729|NCT00447226|363651685|FG001|12-Week Open-label Phase|Protocol Violation|1|||
105448730|NCT00447226|363651684|FG000|12-Week Open-label Phase|Disease Progression|0|||
105448731|NCT00447226|363651685|FG001|12-Week Open-label Phase|Disease Progression|20|||
105448732|NCT00447226|363651684|FG000|12-Week Open-label Phase|Physician Decision|0|||
105448733|NCT00447226|363651685|FG001|12-Week Open-label Phase|Physician Decision|1|||
105448734|NCT00447226|363651684|FG000|Double-blind Phase|Disease Progression|4|||
105448735|NCT00447226|363651685|FG001|Double-blind Phase|Disease Progression|3|||
105448736|NCT01467505|363651689|FG000|Overall Study|Adverse Event|1|||
105448737|NCT01467505|363651690|FG001|Overall Study|Adverse Event|0|||
105448738|NCT01467505|363651689|FG000|Overall Study|Withdrawal by Subject|4|||
105448739|NCT01467505|363651690|FG001|Overall Study|Withdrawal by Subject|0|||
105448740|NCT01467505|363651689|FG000|Overall Study|Study Terminated by Sponsor|28|||
105448741|NCT01467505|363651690|FG001|Overall Study|Study Terminated by Sponsor|3|||
105448742|NCT02807623|363651691|FG000|Overall Study|Lost to Follow-up|23|||
105448743|NCT02807623|363651692|FG001|Overall Study|Lost to Follow-up|18|||
105448744|NCT02807623|363651693|FG002|Overall Study|Lost to Follow-up|22|||
105448745|NCT02807623|363651691|FG000|Overall Study|Drug intolerance|0|||
105448746|NCT02807623|363651692|FG001|Overall Study|Drug intolerance|1|||
105448747|NCT02807623|363651693|FG002|Overall Study|Drug intolerance|0|||
105448748|NCT02807623|363651691|FG000|Overall Study|incomplete blood draw|0|||
105448749|NCT02807623|363651692|FG001|Overall Study|incomplete blood draw|2|||
105448750|NCT02807623|363651693|FG002|Overall Study|incomplete blood draw|1|||
105448751|NCT00227721|363651694|FG000|Overall Study|On study, but never treated.|1|||
105448752|NCT00806988|363651701|FG000|Overall Study|Death|15|||
105448753|NCT00806988|363651702|FG001|Overall Study|Death|16|||
105448754|NCT00806988|363651701|FG000|Overall Study|Withdrawal by Subject|8|||
105448755|NCT00806988|363651702|FG001|Overall Study|Withdrawal by Subject|8|||
105448756|NCT00806988|363651701|FG000|Overall Study|Lost to Follow-up|4|||
105448757|NCT00806988|363651702|FG001|Overall Study|Lost to Follow-up|19|||
105448758|NCT01389882|363651711|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
105448759|NCT01389882|363651712|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
105448760|NCT01389882|363651711|FG000|Overall Study|Withdrawal by Subject|0|||
105448761|NCT01389882|363651712|FG001|Overall Study|Withdrawal by Subject|1|||
105448762|NCT01402817|363651713|FG000|Overall Study|Withdrawal by Subject|3|||
105448763|NCT01402817|363651713|FG000|Overall Study|Study Suspended by FDA|8|||
105448764|NCT02223715|363651725|FG000|Overall Study|Death|31|||
105448765|NCT02223715|363651725|FG000|Overall Study|Lost to Follow-up|73|||
105448766|NCT03956550|363651726|FG000|Overall Study|Sponsor decision|65|||
105448767|NCT03956550|363651727|FG001|Overall Study|Sponsor decision|66|||
105448768|NCT03956550|363651728|FG002|Overall Study|Sponsor decision|64|||
105448769|NCT03956550|363651726|FG000|Overall Study|Adverse Event|0|||
105448770|NCT03956550|363651727|FG001|Overall Study|Adverse Event|1|||
105448771|NCT03956550|363651728|FG002|Overall Study|Adverse Event|0|||
105448772|NCT03956550|363651726|FG000|Overall Study|Withdrawal by Subject|5|||
105448773|NCT03956550|363651727|FG001|Overall Study|Withdrawal by Subject|5|||
105448774|NCT03956550|363651728|FG002|Overall Study|Withdrawal by Subject|6|||
105448775|NCT00824473|363651733|FG000|Overall Study|Adverse Event|4|||
105448776|NCT00824473|363651734|FG001|Overall Study|Adverse Event|5|||
105782242|NCT01362062|364854971|FG000|Overall Study|Adverse Event|1|||
105782243|NCT01362062|364854972|FG001|Overall Study|Adverse Event|0|||
105782244|NCT01362062|364854971|FG000|Overall Study|Lost to Follow-up|11|||
105782245|NCT01362062|364854972|FG001|Overall Study|Lost to Follow-up|0|||
105782246|NCT01362062|364854971|FG000|Overall Study|Withdrawal by Subject|2|||
105782247|NCT01362062|364854972|FG001|Overall Study|Withdrawal by Subject|0|||
105448777|NCT00824473|363651733|FG000|Overall Study|Lack of Efficacy|2|||
105448778|NCT00824473|363651734|FG001|Overall Study|Lack of Efficacy|2|||
105448779|NCT00824473|363651733|FG000|Overall Study|Protocol Violation|2|||
105448780|NCT00824473|363651734|FG001|Overall Study|Protocol Violation|0|||
105448781|NCT00824473|363651733|FG000|Overall Study|Non-Compliance|4|||
105448782|NCT00824473|363651734|FG001|Overall Study|Non-Compliance|2|||
105448783|NCT00824473|363651733|FG000|Overall Study|Withdrawal by Subject|2|||
105448784|NCT00824473|363651734|FG001|Overall Study|Withdrawal by Subject|3|||
105448785|NCT00824473|363651733|FG000|Overall Study|Other|1|||
105448786|NCT00824473|363651734|FG001|Overall Study|Other|1|||
105448787|NCT00466440|363651739|FG000|Overall Study|Adverse Event|0|||
105448788|NCT00466440|363651740|FG001|Overall Study|Adverse Event|3|||
105448789|NCT00466440|363651741|FG002|Overall Study|Adverse Event|1|||
105448790|NCT00466440|363651739|FG000|Overall Study|Death|1|||
105448791|NCT00466440|363651740|FG001|Overall Study|Death|1|||
105448792|NCT00466440|363651741|FG002|Overall Study|Death|0|||
105448793|NCT00466440|363651739|FG000|Overall Study|Progressive disease|13|||
105448794|NCT00466440|363651740|FG001|Overall Study|Progressive disease|5|||
105448795|NCT00466440|363651741|FG002|Overall Study|Progressive disease|4|||
105448796|NCT00466440|363651739|FG000|Overall Study|Lost to Follow-up|0|||
105448797|NCT00466440|363651740|FG001|Overall Study|Lost to Follow-up|1|||
105448798|NCT00466440|363651741|FG002|Overall Study|Lost to Follow-up|0|||
105448799|NCT00466440|363651739|FG000|Overall Study|Physician Decision|0|||
105448800|NCT00466440|363651740|FG001|Overall Study|Physician Decision|1|||
105448801|NCT00466440|363651741|FG002|Overall Study|Physician Decision|2|||
105448802|NCT00466440|363651739|FG000|Overall Study|Protocol entry criteria not met|0|||
105448803|NCT00466440|363651740|FG001|Overall Study|Protocol entry criteria not met|0|||
105448804|NCT00466440|363651741|FG002|Overall Study|Protocol entry criteria not met|4|||
105448805|NCT00466440|363651739|FG000|Overall Study|Withdrawal by Subject|0|||
105448806|NCT00466440|363651740|FG001|Overall Study|Withdrawal by Subject|1|||
105448807|NCT00466440|363651741|FG002|Overall Study|Withdrawal by Subject|0|||
105448808|NCT00466440|363651739|FG000|Overall Study|Sponsor decision|0|||
105448809|NCT00466440|363651740|FG001|Overall Study|Sponsor decision|0|||
105448810|NCT00466440|363651741|FG002|Overall Study|Sponsor decision|1|||
105448811|NCT03191630|363651744|FG000|Overall Study|Lost to Follow-up|7|||
105448812|NCT03191630|363651745|FG001|Overall Study|Lost to Follow-up|7|||
105448813|NCT03369418|363651747|FG000|Overall Study|Withdrawal by Subject|3|||
105448814|NCT03369418|363651748|FG001|Overall Study|Withdrawal by Subject|3|||
105448815|NCT01479868|363651758|FG000|Overall Study|Adverse Event|1|||
105448816|NCT01479868|363651758|FG000|Overall Study|Lost to Follow-up|4|||
105448817|NCT01479868|363651758|FG000|Overall Study|Protocol Violation|1|||
105448818|NCT01479868|363651758|FG000|Overall Study|Withdrawal by Subject|1|||
105448819|NCT01479868|363651758|FG000|Overall Study|Sponsor's Decision|1|||
105448820|NCT01479868|363651758|FG000|Overall Study|Initiation of new HCV Therapy|1|||
105448821|NCT01076959|363651762|FG000|Overall Study|Adverse Event|767|||
105448822|NCT01076959|363651762|FG000|Overall Study|Lack of Efficacy|849|||
105448823|NCT01076959|363651762|FG000|Overall Study|Non-compliance|274|||
105448824|NCT01076959|363651762|FG000|Overall Study|Lost to Follow-up|241|||
105448825|NCT01076959|363651762|FG000|Overall Study|Other|119|||
105448826|NCT01078441|363651763|FG000|Overall Study|Withdrawal by Subject|1|||
105448827|NCT01425801|363651764|FG000|Period 1|Withdrawal by Subject|0|||
105448828|NCT01425801|363651765|FG001|Period 1|Withdrawal by Subject|0|||
105448829|NCT01425801|363651766|FG002|Period 1|Withdrawal by Subject|0|||
105448830|NCT01425801|363651767|FG003|Period 1|Withdrawal by Subject|0|||
105448831|NCT01425801|363651768|FG004|Period 1|Withdrawal by Subject|1|||
105448832|NCT01425801|363651769|FG005|Period 1|Withdrawal by Subject|0|||
105448833|NCT01425801|363651764|FG000|Period 2|Withdrawal by Subject|0|||
105448834|NCT01425801|363651765|FG001|Period 2|Withdrawal by Subject|0|||
105448835|NCT01425801|363651766|FG002|Period 2|Withdrawal by Subject|0|||
105448836|NCT01425801|363651767|FG003|Period 2|Withdrawal by Subject|0|||
105448837|NCT01425801|363651768|FG004|Period 2|Withdrawal by Subject|1|||
105448838|NCT01425801|363651769|FG005|Period 2|Withdrawal by Subject|0|||
105448839|NCT01425801|363651764|FG000|Period 3|Stability criteria not fullfilled|0|||
105448840|NCT01425801|363651765|FG001|Period 3|Stability criteria not fullfilled|0|||
105448841|NCT01425801|363651766|FG002|Period 3|Stability criteria not fullfilled|1|||
105448842|NCT01425801|363651767|FG003|Period 3|Stability criteria not fullfilled|0|||
105448843|NCT01425801|363651768|FG004|Period 3|Stability criteria not fullfilled|0|||
105782248|NCT01362062|364854971|FG000|Overall Study|Non-compliant participant|2|||
105448844|NCT01425801|363651769|FG005|Period 3|Stability criteria not fullfilled|0|||
105782249|NCT01362062|364854972|FG001|Overall Study|Non-compliant participant|0|||
105448845|NCT01425801|363651764|FG000|Period 4|Not able to maintain visit schedule|0|||
105448846|NCT01425801|363651765|FG001|Period 4|Not able to maintain visit schedule|0|||
105550190|NCT00467870|364014377|FG003|Overall Study|Adverse Event|15|||
105448847|NCT01425801|363651766|FG002|Period 4|Not able to maintain visit schedule|1|||
105448848|NCT01425801|363651767|FG003|Period 4|Not able to maintain visit schedule|0|||
105448849|NCT01425801|363651768|FG004|Period 4|Not able to maintain visit schedule|0|||
105448850|NCT01425801|363651769|FG005|Period 4|Not able to maintain visit schedule|0|||
105448851|NCT02175017|363651770|FG000|Overall Study|Did not receive the investigational product|1|||
105448852|NCT02175017|363651771|FG001|Overall Study|Did not receive the investigational product|2|||
105448853|NCT02175017|363651770|FG000|Overall Study|Withdrawal by Subject|6|||
105448854|NCT02175017|363651771|FG001|Overall Study|Withdrawal by Subject|3|||
105448855|NCT02175017|363651770|FG000|Overall Study|Met an exclusion criteria|0|||
105448856|NCT02175017|363651771|FG001|Overall Study|Met an exclusion criteria|1|||
105448857|NCT02175017|363651770|FG000|Overall Study|Adverse Event|3|||
105448858|NCT02175017|363651771|FG001|Overall Study|Adverse Event|10|||
105448859|NCT02175017|363651770|FG000|Overall Study|Disease progression|20|||
105448860|NCT02175017|363651771|FG001|Overall Study|Disease progression|27|||
105448861|NCT02175017|363651770|FG000|Overall Study|Other than above reasons|3|||
105448862|NCT02175017|363651771|FG001|Overall Study|Other than above reasons|0|||
105448863|NCT02741635|363651776|FG000|Overall Study|Withdrawal by Subject|1|||
105448864|NCT00104650|363651780|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
105448865|NCT00104650|363651781|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
105448866|NCT00104650|363651782|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
105448867|NCT00104650|363651780|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
105448868|NCT00104650|363651781|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
105448869|NCT00104650|363651782|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
105448870|NCT00104650|363651780|FG000|Treatment Period (25 Weeks)|Death|7|||
105448871|NCT00104650|363651781|FG001|Treatment Period (25 Weeks)|Death|5|||
105448872|NCT00104650|363651782|FG002|Treatment Period (25 Weeks)|Death|6|||
105448873|NCT00104650|363651780|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
105448874|NCT00104650|363651781|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
105448875|NCT00104650|363651782|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
105448876|NCT00104650|363651780|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
105448877|NCT00104650|363651781|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
105448878|NCT00104650|363651782|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
105448879|NCT00104650|363651780|FG000|Treatment Period (25 Weeks)|Other|1|||
105448880|NCT00104650|363651781|FG001|Treatment Period (25 Weeks)|Other|0|||
105448881|NCT00104650|363651782|FG002|Treatment Period (25 Weeks)|Other|0|||
105448882|NCT00104650|363651780|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
105448883|NCT00104650|363651781|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
105448884|NCT00104650|363651782|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
105782250|NCT01362062|364854971|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
105782251|NCT01362062|364854972|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
105782252|NCT01362062|364854971|FG000|Overall Study|Had significant improvement|9|||
105448885|NCT00104650|363651780|FG000|Follow-up Period|Physician Decision|1|||
105448886|NCT00104650|363651781|FG001|Follow-up Period|Physician Decision|1|||
105782253|NCT01362062|364854972|FG001|Overall Study|Had significant improvement|0|||
105782254|NCT02545504|364854973|FG000|Overall Study|Death|174|||
105448887|NCT00104650|363651782|FG002|Follow-up Period|Physician Decision|0|||
105448888|NCT00104650|363651780|FG000|Follow-up Period|Adverse Event|1|||
105448889|NCT00104650|363651781|FG001|Follow-up Period|Adverse Event|0|||
105448890|NCT00104650|363651782|FG002|Follow-up Period|Adverse Event|1|||
105448891|NCT00104650|363651780|FG000|Follow-up Period|Withdrawal by Subject|0|||
105448892|NCT00104650|363651781|FG001|Follow-up Period|Withdrawal by Subject|3|||
105448893|NCT00104650|363651782|FG002|Follow-up Period|Withdrawal by Subject|3|||
105448894|NCT00104650|363651780|FG000|Follow-up Period|Death|6|||
105448895|NCT00104650|363651781|FG001|Follow-up Period|Death|6|||
105448896|NCT00104650|363651782|FG002|Follow-up Period|Death|4|||
105448897|NCT00104650|363651780|FG000|Follow-up Period|Disease progression|3|||
105448898|NCT00104650|363651781|FG001|Follow-up Period|Disease progression|1|||
105448899|NCT00104650|363651782|FG002|Follow-up Period|Disease progression|0|||
105448900|NCT00104650|363651780|FG000|Follow-up Period|Lost to Follow-up|0|||
105448901|NCT00104650|363651781|FG001|Follow-up Period|Lost to Follow-up|1|||
105448902|NCT00104650|363651782|FG002|Follow-up Period|Lost to Follow-up|2|||
105448903|NCT00104650|363651780|FG000|Follow-up Period|Other|0|||
105448904|NCT00104650|363651781|FG001|Follow-up Period|Other|1|||
105782255|NCT02545504|364854974|FG001|Overall Study|Death|168|||
105448905|NCT00104650|363651782|FG002|Follow-up Period|Other|0|||
105448906|NCT02330055|363651788|FG000|Overall Study|technical issues|2|||
105448907|NCT02330055|363651789|FG001|Overall Study|technical issues|0|||
105448908|NCT02330055|363651788|FG000|Overall Study|participant forgot to wear device|5|||
105782256|NCT02545504|364854973|FG000|Overall Study|Unknown reason|30|||
105448909|NCT02330055|363651789|FG001|Overall Study|participant forgot to wear device|5|||
105448910|NCT02330055|363651788|FG000|Overall Study|data for less than 60 minutes|3|||
105448911|NCT02330055|363651789|FG001|Overall Study|data for less than 60 minutes|3|||
105448912|NCT02330055|363651788|FG000|Overall Study|participant did not sleep|0|||
105782257|NCT02545504|364854974|FG001|Overall Study|Unknown reason|32|||
105782258|NCT02545504|364854973|FG000|Overall Study|Withdrew consent|9|||
105782259|NCT02545504|364854974|FG001|Overall Study|Withdrew consent|11|||
105782260|NCT02545504|364854973|FG000|Overall Study|Investigator's discretion|3|||
105782261|NCT02545504|364854974|FG001|Overall Study|Investigator's discretion|1|||
105782262|NCT02545504|364854973|FG000|Overall Study|Lost to Follow-up|2|||
105782263|NCT02545504|364854974|FG001|Overall Study|Lost to Follow-up|2|||
105782264|NCT01459016|364856135|FG000|Overall Study|Withdrawal by Subject|11|||
105782265|NCT01459016|364856135|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
105782266|NCT03922945|364856136|FG000|Overall Study|Adverse Event|1|||
105782267|NCT03922945|364856137|FG001|Overall Study|Adverse Event|1|||
105782268|NCT03922945|364856138|FG002|Overall Study|Adverse Event|2|||
105782269|NCT03922945|364856136|FG000|Overall Study|Lost to Follow-up|13|||
105782270|NCT03922945|364856137|FG001|Overall Study|Lost to Follow-up|9|||
105782271|NCT03922945|364856138|FG002|Overall Study|Lost to Follow-up|20|||
105782272|NCT03922945|364856136|FG000|Overall Study|Lack of Efficacy|2|||
105782273|NCT03922945|364856137|FG001|Overall Study|Lack of Efficacy|0|||
105782274|NCT03922945|364856138|FG002|Overall Study|Lack of Efficacy|1|||
105782275|NCT03922945|364856136|FG000|Overall Study|Protocol Non-Compliance|0|||
105782276|NCT03922945|364856137|FG001|Overall Study|Protocol Non-Compliance|0|||
105782277|NCT03922945|364856138|FG002|Overall Study|Protocol Non-Compliance|1|||
105782278|NCT03922945|364856136|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
105782279|NCT03922945|364856137|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
105782280|NCT03922945|364856138|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
105782281|NCT03922945|364856136|FG000|Overall Study|All Other Personal Reasons|1|||
105782282|NCT03922945|364856137|FG001|Overall Study|All Other Personal Reasons|1|||
105782283|NCT03922945|364856138|FG002|Overall Study|All Other Personal Reasons|2|||
105782284|NCT04067310|364856140|FG000|Overall Study|Physician Decision|2|||
105782285|NCT04067310|364856141|FG001|Overall Study|Physician Decision|6|||
105782286|NCT04067310|364856140|FG000|Overall Study|Lost to Follow-up|0|||
105782287|NCT04067310|364856141|FG001|Overall Study|Lost to Follow-up|1|||
105782288|NCT04067310|364856140|FG000|Overall Study|Withdrawal by Subject|3|||
105782289|NCT04067310|364856141|FG001|Overall Study|Withdrawal by Subject|0|||
105782290|NCT01041027|364856142|FG000|Overall Study|Withdrawal by Subject|2|||
105782291|NCT01041027|364856142|FG000|Overall Study|Protocol Violation|1|||
105782292|NCT01041027|364856142|FG000|Overall Study|Delayed Radiation Therapy|1|||
105782293|NCT01041027|364856142|FG000|Overall Study|Adverse Event|4|||
105782294|NCT04308668|364856143|FG000|Overall Study|Lost to Follow-up|32|||
105448913|NCT02330055|363651789|FG001|Overall Study|participant did not sleep|1|||
105448914|NCT01100320|363651790|FG000|Period 1|Withdrawal by Subject|2|||
105448915|NCT01100320|363651791|FG001|Period 1|Withdrawal by Subject|4|||
105448916|NCT01100320|363651790|FG000|Period 1|Positive Drug Screen|1|||
105448917|NCT01100320|363651791|FG001|Period 1|Positive Drug Screen|1|||
105448918|NCT01100320|363651790|FG000|Period 1|Adverse Event|2|||
105448919|NCT01100320|363651791|FG001|Period 1|Adverse Event|2|||
105448920|NCT01100320|363651790|FG000|Period 2|Withdrawal by Subject|1|||
105448921|NCT01100320|363651791|FG001|Period 2|Withdrawal by Subject|1|||
105448922|NCT00550953|363651792|FG000|Overall Study|Adverse Event|4|||
105448923|NCT00550953|363651793|FG001|Overall Study|Adverse Event|3|||
105448924|NCT00550953|363651792|FG000|Overall Study|Not able to visit the site|2|||
105448925|NCT00550953|363651793|FG001|Overall Study|Not able to visit the site|3|||
105782295|NCT04308668|364856144|FG001|Overall Study|Lost to Follow-up|38|||
105782296|NCT04308668|364856143|FG000|Overall Study|Withdrawal by Subject|4|||
105782297|NCT04308668|364856144|FG001|Overall Study|Withdrawal by Subject|4|||
105782298|NCT01801475|364856145|FG000|Overall Study|Withdrawal by Subject|0|||
105448926|NCT02488005|363651794|FG000|Overall Study|Lost to Follow-up|2|||
105448927|NCT02326597|363651799|FG000|Overall Study|Lost to Follow-up|42|||
105448928|NCT02326597|363651800|FG001|Overall Study|Lost to Follow-up|32|||
105448929|NCT04970654|363651801|FG000|Overall Study|Withdrawal by parents/guardian|1|||
105448930|NCT04970654|363651802|FG001|Overall Study|Withdrawal by parents/guardian|2|||
105448931|NCT04970654|363651801|FG000|Overall Study|Unclassified|2|||
105448932|NCT04970654|363651802|FG001|Overall Study|Unclassified|1|||
105448933|NCT04970654|363651801|FG000|Overall Study|Lost to Follow-up|1|||
105448934|NCT04970654|363651802|FG001|Overall Study|Lost to Follow-up|0|||
105448935|NCT00866814|363651803|FG000|Overall Study|Lost to Follow-up|12|||
105448936|NCT00866814|363651803|FG000|Overall Study|Adverse Event|2|||
105448937|NCT00866814|363651803|FG000|Overall Study|Physician Decision|1|||
105448938|NCT00866814|363651803|FG000|Overall Study|Death|1|||
105448939|NCT00866814|363651803|FG000|Overall Study|No longer wished to participate|1|||
105448940|NCT00866814|363651803|FG000|Overall Study|Unable to meet follow-up requirements|2|||
105448941|NCT00866814|363651803|FG000|Overall Study|Moved to area without study site|1|||
105448942|NCT03160898|363651805|FG000|Overall Study|Adverse Event|4|||
105448943|NCT03160898|363651806|FG001|Overall Study|Adverse Event|8|||
105448944|NCT03160898|363651807|FG002|Overall Study|Adverse Event|7|||
105448945|NCT03160898|363651808|FG003|Overall Study|Adverse Event|10|||
105448946|NCT03160898|363651805|FG000|Overall Study|Death|1|||
105448947|NCT03160898|363651806|FG001|Overall Study|Death|0|||
105782299|NCT01801475|364856146|FG001|Overall Study|Withdrawal by Subject|0|||
105782300|NCT01801475|364856147|FG002|Overall Study|Withdrawal by Subject|0|||
105782301|NCT01801475|364856148|FG003|Overall Study|Withdrawal by Subject|0|||
105448948|NCT03160898|363651807|FG002|Overall Study|Death|0|||
105448949|NCT03160898|363651808|FG003|Overall Study|Death|1|||
105448950|NCT03160898|363651805|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
105448951|NCT03160898|363651806|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
105448952|NCT03160898|363651807|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
105448953|NCT03160898|363651808|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
105448954|NCT03160898|363651805|FG000|Overall Study|Lost to Follow-up|1|||
105448955|NCT03160898|363651806|FG001|Overall Study|Lost to Follow-up|1|||
105448956|NCT03160898|363651807|FG002|Overall Study|Lost to Follow-up|1|||
105448957|NCT03160898|363651808|FG003|Overall Study|Lost to Follow-up|2|||
105448958|NCT03160898|363651805|FG000|Overall Study|Physician Decision|1|||
105448959|NCT03160898|363651806|FG001|Overall Study|Physician Decision|0|||
105448960|NCT03160898|363651807|FG002|Overall Study|Physician Decision|0|||
105448961|NCT03160898|363651808|FG003|Overall Study|Physician Decision|1|||
105448962|NCT03160898|363651805|FG000|Overall Study|Progressive Disease|4|||
105448963|NCT03160898|363651806|FG001|Overall Study|Progressive Disease|1|||
105448964|NCT03160898|363651807|FG002|Overall Study|Progressive Disease|2|||
105448965|NCT03160898|363651808|FG003|Overall Study|Progressive Disease|1|||
105448966|NCT03160898|363651805|FG000|Overall Study|Protocol Violation|1|||
105448967|NCT03160898|363651806|FG001|Overall Study|Protocol Violation|0|||
105448968|NCT03160898|363651807|FG002|Overall Study|Protocol Violation|2|||
105448969|NCT03160898|363651808|FG003|Overall Study|Protocol Violation|0|||
105448970|NCT03160898|363651805|FG000|Overall Study|Sponsor Discretion|2|||
105448971|NCT03160898|363651806|FG001|Overall Study|Sponsor Discretion|0|||
105448972|NCT03160898|363651807|FG002|Overall Study|Sponsor Discretion|0|||
105448973|NCT03160898|363651808|FG003|Overall Study|Sponsor Discretion|0|||
105448974|NCT03160898|363651805|FG000|Overall Study|Withdrawal by Subject|1|||
105448975|NCT03160898|363651806|FG001|Overall Study|Withdrawal by Subject|3|||
105448976|NCT03160898|363651807|FG002|Overall Study|Withdrawal by Subject|2|||
105448977|NCT03160898|363651808|FG003|Overall Study|Withdrawal by Subject|1|||
105448978|NCT03160898|363651805|FG000|Overall Study|Other|2|||
105448979|NCT03160898|363651806|FG001|Overall Study|Other|0|||
105448980|NCT03160898|363651807|FG002|Overall Study|Other|2|||
105448981|NCT03160898|363651808|FG003|Overall Study|Other|2|||
105448982|NCT01463306|363651809|FG000|Overall Study|Adverse Event|6|||
105448983|NCT01463306|363651810|FG001|Overall Study|Adverse Event|9|||
105448984|NCT01463306|363651811|FG002|Overall Study|Adverse Event|3|||
105448985|NCT01463306|363651809|FG000|Overall Study|Death|3|||
105448986|NCT01463306|363651810|FG001|Overall Study|Death|3|||
105448987|NCT01463306|363651811|FG002|Overall Study|Death|0|||
105448988|NCT01463306|363651809|FG000|Overall Study|Lack of Efficacy|22|||
105448989|NCT01463306|363651810|FG001|Overall Study|Lack of Efficacy|16|||
105448990|NCT01463306|363651811|FG002|Overall Study|Lack of Efficacy|1|||
105448991|NCT01463306|363651809|FG000|Overall Study|Lost to Follow-up|5|||
105448992|NCT01463306|363651810|FG001|Overall Study|Lost to Follow-up|2|||
105448993|NCT01463306|363651811|FG002|Overall Study|Lost to Follow-up|0|||
105448994|NCT01463306|363651809|FG000|Overall Study|Protocol Violation|4|||
105448995|NCT01463306|363651810|FG001|Overall Study|Protocol Violation|0|||
105448996|NCT01463306|363651811|FG002|Overall Study|Protocol Violation|0|||
105448997|NCT01463306|363651809|FG000|Overall Study|Withdrawal by Subject|19|||
105448998|NCT01463306|363651810|FG001|Overall Study|Withdrawal by Subject|9|||
105448999|NCT01463306|363651811|FG002|Overall Study|Withdrawal by Subject|1|||
105449000|NCT01463306|363651809|FG000|Overall Study|Other|26|||
105449001|NCT01463306|363651810|FG001|Overall Study|Other|13|||
105449002|NCT01463306|363651811|FG002|Overall Study|Other|0|||
105449003|NCT01463306|363651809|FG000|Overall Study|Approval expiry at site|1|||
105449004|NCT01463306|363651810|FG001|Overall Study|Approval expiry at site|0|||
105449005|NCT01463306|363651811|FG002|Overall Study|Approval expiry at site|0|||
105449006|NCT01150097|363651816|FG000|Months 24 to 36 Post-transplantation|Death|2|||
105449007|NCT01150097|363651817|FG001|Months 24 to 36 Post-transplantation|Death|0|||
105449008|NCT01150097|363651818|FG002|Months 24 to 36 Post-transplantation|Death|0|||
105449009|NCT01150097|363651816|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
105449010|NCT01150097|363651817|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
105449011|NCT01150097|363651818|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
105449012|NCT01150097|363651816|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
105449013|NCT01150097|363651817|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
105449014|NCT01150097|363651818|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
105449015|NCT01150097|363651816|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
105449016|NCT01150097|363651817|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
105449017|NCT01150097|363651818|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
105449018|NCT01150097|363651816|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
105449019|NCT01150097|363651817|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
105449020|NCT01150097|363651818|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
105449021|NCT01150097|363651816|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
105449022|NCT01150097|363651817|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
105550191|NCT00467870|364014378|FG004|Overall Study|Adverse Event|15|||
105782302|NCT01801475|364856149|FG004|Overall Study|Withdrawal by Subject|1|||
105782303|NCT05056311|364856150|FG000|Overall Study|Lost to Follow-up|14|||
105782304|NCT05056311|364856150|FG000|Overall Study|Withdrawal by Subject|1|||
105782305|NCT05056311|364856150|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
105782306|NCT02528643|364856151|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
105782307|NCT02528643|364856152|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
105782308|NCT02528643|364856151|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
105782309|NCT02528643|364856152|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
105449023|NCT01150097|363651818|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
105449024|NCT01150097|363651816|FG000|Months 24 to 48 Post-transplantation|Death|2|||
105449025|NCT01150097|363651817|FG001|Months 24 to 48 Post-transplantation|Death|0|||
105449026|NCT01150097|363651818|FG002|Months 24 to 48 Post-transplantation|Death|0|||
105449027|NCT00992459|363651819|FG000|Overall Study|Withdrawal by Subject|0|||
105449028|NCT00992459|363651820|FG001|Overall Study|Withdrawal by Subject|1|||
105449029|NCT00992459|363651819|FG000|Overall Study|Adverse Event|1|||
105449030|NCT00992459|363651820|FG001|Overall Study|Adverse Event|0|||
105449031|NCT00940498|363651821|FG000|Overall Study|Death|2|||
105449032|NCT00940498|363651822|FG001|Overall Study|Death|0|||
105449033|NCT00940498|363651823|FG002|Overall Study|Death|0|||
105449034|NCT00940498|363651824|FG003|Overall Study|Death|1|||
105449035|NCT00940498|363651825|FG004|Overall Study|Death|5|||
105449036|NCT00940498|363651826|FG005|Overall Study|Death|0|||
105449037|NCT00940498|363651827|FG006|Overall Study|Death|1|||
105449038|NCT00940498|363651828|FG007|Overall Study|Death|0|||
105449039|NCT00940498|363651821|FG000|Overall Study|Lost to Follow-up|1|||
105449040|NCT00940498|363651822|FG001|Overall Study|Lost to Follow-up|1|||
105449041|NCT00940498|363651823|FG002|Overall Study|Lost to Follow-up|2|||
105449042|NCT00940498|363651824|FG003|Overall Study|Lost to Follow-up|0|||
105449043|NCT00940498|363651825|FG004|Overall Study|Lost to Follow-up|1|||
105449044|NCT00940498|363651826|FG005|Overall Study|Lost to Follow-up|0|||
105449045|NCT00940498|363651827|FG006|Overall Study|Lost to Follow-up|0|||
105449046|NCT00940498|363651828|FG007|Overall Study|Lost to Follow-up|1|||
105449047|NCT00940498|363651821|FG000|Overall Study|Disease Progression|0|||
105449048|NCT00940498|363651822|FG001|Overall Study|Disease Progression|0|||
105449049|NCT00940498|363651823|FG002|Overall Study|Disease Progression|1|||
105449050|NCT00940498|363651824|FG003|Overall Study|Disease Progression|1|||
105449051|NCT00940498|363651825|FG004|Overall Study|Disease Progression|0|||
105449052|NCT00940498|363651826|FG005|Overall Study|Disease Progression|1|||
105449053|NCT00940498|363651827|FG006|Overall Study|Disease Progression|0|||
105449054|NCT00940498|363651828|FG007|Overall Study|Disease Progression|0|||
105449055|NCT00940498|363651821|FG000|Overall Study|Physician Decision|0|||
105449056|NCT00940498|363651822|FG001|Overall Study|Physician Decision|0|||
105449057|NCT00940498|363651823|FG002|Overall Study|Physician Decision|0|||
105449058|NCT00940498|363651824|FG003|Overall Study|Physician Decision|0|||
105449059|NCT00940498|363651825|FG004|Overall Study|Physician Decision|2|||
105449060|NCT00940498|363651826|FG005|Overall Study|Physician Decision|0|||
105449061|NCT00940498|363651827|FG006|Overall Study|Physician Decision|0|||
105449062|NCT00940498|363651828|FG007|Overall Study|Physician Decision|0|||
105449063|NCT00940498|363651821|FG000|Overall Study|Not treated due to disease related pain|0|||
105449064|NCT00940498|363651822|FG001|Overall Study|Not treated due to disease related pain|0|||
105449065|NCT00940498|363651823|FG002|Overall Study|Not treated due to disease related pain|0|||
105449066|NCT00940498|363651824|FG003|Overall Study|Not treated due to disease related pain|0|||
105449067|NCT00940498|363651825|FG004|Overall Study|Not treated due to disease related pain|1|||
105449068|NCT00940498|363651826|FG005|Overall Study|Not treated due to disease related pain|0|||
105449069|NCT00940498|363651827|FG006|Overall Study|Not treated due to disease related pain|0|||
105449070|NCT00940498|363651828|FG007|Overall Study|Not treated due to disease related pain|0|||
105449071|NCT00650845|363651831|FG000|Overall Study|Withdrawal by Subject|5|||
105449072|NCT00650845|363651832|FG001|Overall Study|Withdrawal by Subject|0|||
105449073|NCT00650845|363651831|FG000|Overall Study|Protocol Violation|0|||
105449074|NCT00650845|363651832|FG001|Overall Study|Protocol Violation|13|||
105449075|NCT00549445|363651833|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
105449076|NCT00549445|363651834|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
105449077|NCT03932760|363651835|FG000|Overall Study|Became Ineligible|2|||
105449078|NCT03932760|363651836|FG001|Overall Study|Became Ineligible|5|||
105449079|NCT03932760|363651835|FG000|Overall Study|Withdrawal by Subject|6|||
105449080|NCT03932760|363651836|FG001|Overall Study|Withdrawal by Subject|6|||
105449081|NCT02775916|363651837|FG000|Overall Study|Adverse Event|1|||
105449082|NCT02775916|363651838|FG001|Overall Study|Adverse Event|0|||
105449083|NCT02775916|363651837|FG000|Overall Study|Subject/Guardian Decision|2|||
105449084|NCT02775916|363651838|FG001|Overall Study|Subject/Guardian Decision|0|||
105449085|NCT03310723|363653135|FG000|Overall Study|Withdrawal by Subject|0|||
105449086|NCT03310723|363653136|FG001|Overall Study|Withdrawal by Subject|1|||
105449087|NCT03310723|363653135|FG000|Overall Study|Protocol Violation|0|||
105449088|NCT03310723|363653136|FG001|Overall Study|Protocol Violation|2|||
105449089|NCT02098746|363653137|FG000|Overall Study|Changes of Investigator|2|||
105449090|NCT02098746|363653137|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105782310|NCT02528643|364856151|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
105449091|NCT02098746|363653137|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
105449092|NCT02098746|363653137|FG000|Overall Study|Data Not Available After Treatment|1|||
105449093|NCT01410890|363653138|FG000|Overall Study|Withdrawal by Subject|0|||
105449094|NCT01410890|363653139|FG001|Overall Study|Withdrawal by Subject|1|||
105449095|NCT00330759|363653142|FG000|Overall Study|Death|316|||
105449096|NCT00330759|363653143|FG001|Overall Study|Death|310|||
105449097|NCT00330759|363653142|FG000|Overall Study|Disease progression|104|||
105449098|NCT00330759|363653143|FG001|Overall Study|Disease progression|126|||
105449099|NCT00330759|363653142|FG000|Overall Study|Withdrawal by Subject|143|||
105449100|NCT00330759|363653143|FG001|Overall Study|Withdrawal by Subject|124|||
105449101|NCT00330759|363653142|FG000|Overall Study|Adverse Event|48|||
105449102|NCT00330759|363653143|FG001|Overall Study|Adverse Event|36|||
105449103|NCT00330759|363653142|FG000|Overall Study|Participant request|31|||
105449104|NCT00330759|363653143|FG001|Overall Study|Participant request|22|||
105449105|NCT00330759|363653142|FG000|Overall Study|Lost to Follow-up|16|||
105449106|NCT00330759|363653143|FG001|Overall Study|Lost to Follow-up|22|||
105449107|NCT00330759|363653142|FG000|Overall Study|Noncompliance|15|||
105449108|NCT00330759|363653143|FG001|Overall Study|Noncompliance|17|||
105449109|NCT00330759|363653142|FG000|Overall Study|Physician Decision|1|||
105449110|NCT00330759|363653143|FG001|Overall Study|Physician Decision|2|||
105449111|NCT00330759|363653142|FG000|Overall Study|Protocol deviation|0|||
105449112|NCT00330759|363653143|FG001|Overall Study|Protocol deviation|2|||
105449113|NCT00330759|363653142|FG000|Overall Study|Ineligibility determined|2|||
105449114|NCT00330759|363653143|FG001|Overall Study|Ineligibility determined|1|||
105449115|NCT00330759|363653142|FG000|Overall Study|Other|36|||
105449116|NCT00330759|363653143|FG001|Overall Study|Other|44|||
105449117|NCT03654690|363653146|FG000|Overall Study|Withdrawal by Subject|1|||
105449118|NCT03654690|363653147|FG001|Overall Study|Withdrawal by Subject|0|||
105449119|NCT03654690|363653148|FG002|Overall Study|Withdrawal by Subject|0|||
105449120|NCT00742183|363653149|FG000|Overall Study|Adverse Event|2|||
105449121|NCT00742183|363653150|FG001|Overall Study|Adverse Event|2|||
105449122|NCT00742183|363653149|FG000|Overall Study|Death|1|||
105449123|NCT00742183|363653150|FG001|Overall Study|Death|0|||
105449124|NCT00742183|363653149|FG000|Overall Study|Physician Decision|0|||
105449125|NCT00742183|363653150|FG001|Overall Study|Physician Decision|2|||
105449126|NCT00742183|363653149|FG000|Overall Study|Lost to Follow-up|4|||
105449127|NCT00742183|363653150|FG001|Overall Study|Lost to Follow-up|4|||
105449128|NCT00742183|363653149|FG000|Overall Study|Required skin-graft|1|||
105449129|NCT00742183|363653150|FG001|Overall Study|Required skin-graft|1|||
105449130|NCT00742183|363653149|FG000|Overall Study|Withdrawal by Subject|1|||
105449131|NCT00742183|363653150|FG001|Overall Study|Withdrawal by Subject|0|||
105449132|NCT00742183|363653149|FG000|Overall Study|Lack of Efficacy|0|||
105449133|NCT00742183|363653150|FG001|Overall Study|Lack of Efficacy|3|||
105449134|NCT00786799|363653153|FG000|Overall Study|Lost to Follow-up|1|||
105449135|NCT00786799|363653154|FG001|Overall Study|Lost to Follow-up|1|||
105449136|NCT02544503|363653155|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
105449137|NCT02544503|363653156|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
105449138|NCT02544503|363653155|FG000|Overall Study|Lost to Follow-up|9|||
105449139|NCT02544503|363653156|FG001|Overall Study|Lost to Follow-up|0|||
105449140|NCT02544503|363653155|FG000|Overall Study|Withdrawal by Subject|1|||
105449141|NCT02544503|363653156|FG001|Overall Study|Withdrawal by Subject|0|||
105449142|NCT03922581|363653160|FG000|Overall Study|Lost to Follow-up|20|||
105449143|NCT03922581|363653161|FG001|Overall Study|Lost to Follow-up|9|||
105449144|NCT03922581|363653160|FG000|Overall Study|Physician Decision|1|||
105449145|NCT03922581|363653161|FG001|Overall Study|Physician Decision|1|||
105449146|NCT03922581|363653160|FG000|Overall Study|Withdrawal by Subject|1|||
105449147|NCT03922581|363653161|FG001|Overall Study|Withdrawal by Subject|0|||
105449148|NCT04685798|363653162|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
105782311|NCT02528643|364856152|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
105782312|NCT02528643|364856151|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
105782313|NCT02528643|364856152|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
105449149|NCT01745367|363653163|FG000|Overall Study|Death|1|||
105449150|NCT01745367|363653164|FG001|Overall Study|Death|0|||
105449151|NCT01745367|363653163|FG000|Overall Study|Withdrawal by Subject|1|||
105449152|NCT01745367|363653164|FG001|Overall Study|Withdrawal by Subject|2|||
105449153|NCT01745367|363653163|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
105449154|NCT01745367|363653164|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
105449155|NCT01745367|363653163|FG000|Overall Study|Other Reasons Unspecified|0|||
105449156|NCT01745367|363653164|FG001|Overall Study|Other Reasons Unspecified|2|||
105449157|NCT01544920|363653165|FG000|Overall Study|Adverse Event|0|||
105449158|NCT01544920|363653166|FG001|Overall Study|Adverse Event|3|||
105449159|NCT01544920|363653165|FG000|Overall Study|Death|0|||
105449160|NCT01544920|363653166|FG001|Overall Study|Death|1|||
105449161|NCT01544920|363653165|FG000|Overall Study|Lost to Follow-up|11|||
105449162|NCT01544920|363653166|FG001|Overall Study|Lost to Follow-up|12|||
105782314|NCT02528643|364856151|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
105449163|NCT01544920|363653165|FG000|Overall Study|Protocol Violation|0|||
105449164|NCT01544920|363653166|FG001|Overall Study|Protocol Violation|2|||
105449165|NCT01544920|363653165|FG000|Overall Study|Physician Decision|4|||
105449166|NCT01544920|363653166|FG001|Overall Study|Physician Decision|1|||
105449167|NCT01544920|363653165|FG000|Overall Study|Withdrawal by Subject|4|||
105449168|NCT01544920|363653166|FG001|Overall Study|Withdrawal by Subject|4|||
105449169|NCT03294590|363653167|FG000|Overall Study|Lost to Follow-up|105|||
105449170|NCT03294590|363653168|FG001|Overall Study|Lost to Follow-up|107|||
105449171|NCT02640547|363653169|FG000|Overall Study|Failure to Return|1|||
105449172|NCT02640547|363653169|FG000|Overall Study|Withdrawal by Subject|1|||
105449173|NCT02640547|363653169|FG000|Overall Study|Death|6|||
105449174|NCT02640547|363653169|FG000|Overall Study|Miscellaneous|3|||
105449175|NCT01367834|363653171|FG000|Overall Study|Withdrawal by Subject|2|||
105449176|NCT01367834|363653172|FG001|Overall Study|Withdrawal by Subject|2|||
105449177|NCT01367834|363653171|FG000|Overall Study|Study was ended.|0|||
105449178|NCT01367834|363653172|FG001|Overall Study|Study was ended.|1|||
105449179|NCT00474955|363653173|FG000|Overall Study|Adverse Event|2|||
105449180|NCT00474955|363653173|FG000|Overall Study|Drug unavailability|1|||
105449181|NCT00474955|363653173|FG000|Overall Study|Personal reasons|5|||
105449182|NCT01172535|363653180|FG000|Overall Study|Death|3|||
105449183|NCT01172535|363653180|FG000|Overall Study|Withdrawal by Subject|2|||
105449184|NCT01172535|363653180|FG000|Overall Study|Lost to Follow-up|1|||
105449185|NCT01172535|363653180|FG000|Overall Study|Ineligible at study entry|1|||
105449186|NCT01172535|363653180|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
105449187|NCT01020786|363653181|FG000|Induction Period|Entry Criteria Not Met|2|||
105449188|NCT01020786|363653181|FG000|Induction Period|Adverse Event|10|||
105449189|NCT01020786|363653181|FG000|Induction Period|Progressive Disease|31|||
105449190|NCT01020786|363653181|FG000|Induction Period|Investigator Decision|3|||
105449191|NCT01020786|363653181|FG000|Induction Period|Withdrawal by Subject|3|||
105449192|NCT01020786|363653181|FG000|Maintenance Period|Adverse Event|8|||
105449193|NCT01020786|363653181|FG000|Maintenance Period|Progressive Disease|43|||
105449194|NCT01020786|363653181|FG000|Maintenance Period|Withdrawal by Subject|8|||
105449195|NCT01020786|363653181|FG000|Maintenance Period|Sponsor Decision|1|||
105449196|NCT01217463|363653184|FG000|Overall Study|Adverse Event|8|||
105449197|NCT01217463|363653185|FG001|Overall Study|Adverse Event|5|||
105449198|NCT01217463|363653184|FG000|Overall Study|Physician Decision|0|||
105449199|NCT01217463|363653185|FG001|Overall Study|Physician Decision|1|||
105449200|NCT01217463|363653184|FG000|Overall Study|Withdrawal by Subject|3|||
105449201|NCT01217463|363653185|FG001|Overall Study|Withdrawal by Subject|0|||
105449202|NCT01217463|363653184|FG000|Overall Study|Surgery on the Target Limb|0|||
105449203|NCT01217463|363653185|FG001|Overall Study|Surgery on the Target Limb|1|||
105449204|NCT01217463|363653184|FG000|Overall Study|Patient Non-compliant|1|||
105449205|NCT01217463|363653185|FG001|Overall Study|Patient Non-compliant|0|||
105449206|NCT01217463|363653184|FG000|Overall Study|Other|1|||
105449207|NCT01217463|363653185|FG001|Overall Study|Other|1|||
105449208|NCT01965704|363653192|FG000|Overall Study|Withdrawal by Subject|2|||
105449209|NCT01965704|363653193|FG001|Overall Study|Withdrawal by Subject|2|||
105449210|NCT01965704|363653194|FG002|Overall Study|Withdrawal by Subject|1|||
105449211|NCT01965704|363653195|FG003|Overall Study|Withdrawal by Subject|1|||
105449212|NCT01965704|363653192|FG000|Overall Study|Delivered at home|1|||
105449213|NCT01965704|363653193|FG001|Overall Study|Delivered at home|1|||
105449214|NCT01965704|363653194|FG002|Overall Study|Delivered at home|0|||
105449215|NCT01965704|363653195|FG003|Overall Study|Delivered at home|0|||
105449216|NCT01965704|363653192|FG000|Overall Study|Experienced complications|0|||
105449217|NCT01965704|363653193|FG001|Overall Study|Experienced complications|0|||
105449218|NCT01965704|363653194|FG002|Overall Study|Experienced complications|2|||
105449219|NCT01965704|363653195|FG003|Overall Study|Experienced complications|2|||
105449220|NCT01965704|363653192|FG000|Overall Study|Adverse Event|0|||
105449221|NCT01965704|363653193|FG001|Overall Study|Adverse Event|0|||
105449222|NCT01965704|363653194|FG002|Overall Study|Adverse Event|1|||
105449223|NCT01965704|363653195|FG003|Overall Study|Adverse Event|1|||
105449224|NCT01965704|363653192|FG000|Overall Study|Did not meet inclusion criteria|0|||
105449225|NCT01965704|363653193|FG001|Overall Study|Did not meet inclusion criteria|0|||
105449226|NCT01965704|363653194|FG002|Overall Study|Did not meet inclusion criteria|1|||
105449227|NCT01965704|363653195|FG003|Overall Study|Did not meet inclusion criteria|1|||
105449228|NCT02519439|363653200|FG000|Overall Study|Study Termination|19|||
105449229|NCT02519439|363653200|FG000|Overall Study|Withdrawal by Subject|1|||
105449230|NCT02519439|363653200|FG000|Overall Study|Adverse Event|1|||
105449231|NCT01539759|363653203|FG000|Overall Study|Lost to Follow-up|6|||
105449232|NCT01539759|363653204|FG001|Overall Study|Lost to Follow-up|8|||
105449233|NCT02872116|363653205|FG000|Pre-Treatment|Disease Progression|0|||
105449234|NCT02872116|363653206|FG001|Pre-Treatment|Disease Progression|1|||
105449235|NCT02872116|363653207|FG002|Pre-Treatment|Disease Progression|0|||
105449236|NCT02872116|363653205|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
105449237|NCT02872116|363653206|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
105449238|NCT02872116|363653207|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
105449239|NCT02872116|363653205|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
105449240|NCT02872116|363653206|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
105449241|NCT02872116|363653207|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
105449242|NCT02872116|363653205|FG000|Pre-Treatment|Participant withdrew consent|2|||
105449243|NCT02872116|363653206|FG001|Pre-Treatment|Participant withdrew consent|20|||
105449244|NCT02872116|363653207|FG002|Pre-Treatment|Participant withdrew consent|3|||
105449245|NCT02872116|363653205|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
105449246|NCT02872116|363653206|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
105449247|NCT02872116|363653207|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
105449248|NCT02872116|363653205|FG000|Pre-Treatment|Other reasons|1|||
105449249|NCT02872116|363653206|FG001|Pre-Treatment|Other reasons|2|||
105449250|NCT02872116|363653207|FG002|Pre-Treatment|Other reasons|2|||
105449251|NCT02872116|363653205|FG000|Treatment|Death|122|||
105449252|NCT02872116|363653206|FG001|Treatment|Death|94|||
105449253|NCT02872116|363653207|FG002|Treatment|Death|68|||
105449254|NCT02872116|363653205|FG000|Treatment|Lost to Follow-up|5|||
105449255|NCT02872116|363653206|FG001|Treatment|Lost to Follow-up|7|||
105449256|NCT02872116|363653207|FG002|Treatment|Lost to Follow-up|3|||
105449257|NCT02872116|363653205|FG000|Treatment|Participant withdrew consent|20|||
105449258|NCT02872116|363653206|FG001|Treatment|Participant withdrew consent|40|||
105449259|NCT02872116|363653207|FG002|Treatment|Participant withdrew consent|8|||
105449260|NCT02872116|363653205|FG000|Treatment|Other reasons|12|||
105449261|NCT02872116|363653206|FG001|Treatment|Other reasons|12|||
105449262|NCT02872116|363653207|FG002|Treatment|Other reasons|5|||
105449263|NCT01329978|363653211|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
105449264|NCT01329978|363653212|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
105449265|NCT01329978|363653213|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
105449266|NCT01329978|363653214|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
105449267|NCT01329978|363653215|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
105449268|NCT01329978|363653211|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
105449269|NCT01329978|363653212|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
105449270|NCT01329978|363653213|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
105449271|NCT01329978|363653214|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
105449272|NCT01329978|363653215|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
105449273|NCT01329978|363653211|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
105449274|NCT01329978|363653212|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
105449275|NCT01329978|363653213|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
105449276|NCT01329978|363653214|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
105449277|NCT01329978|363653215|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
105449278|NCT01329978|363653211|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
105449279|NCT01329978|363653212|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
105449280|NCT01329978|363653213|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
105449281|NCT01329978|363653214|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
105449282|NCT01329978|363653215|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
105449283|NCT01329978|363653211|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
105449284|NCT01329978|363653212|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
105449285|NCT01329978|363653213|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
105449286|NCT01329978|363653214|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
105449287|NCT01329978|363653215|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
105449288|NCT01329978|363653211|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
105449289|NCT01329978|363653212|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
105449290|NCT01329978|363653213|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
105449291|NCT01329978|363653214|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
105449292|NCT01329978|363653215|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
105449293|NCT01329978|363653211|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
105449294|NCT01329978|363653212|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
105449295|NCT01329978|363653213|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
105449296|NCT01329978|363653214|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
105449297|NCT01329978|363653215|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
105449298|NCT02868554|363653216|FG000|Overall Study|Lost to Follow-up|3|||
105449299|NCT02868554|363653217|FG001|Overall Study|Lost to Follow-up|0|||
105449300|NCT02868554|363653218|FG002|Overall Study|Lost to Follow-up|1|||
105449301|NCT03305770|363653219|FG000|Overall Study|Physician Decision - prior to dispense|0|||
105449302|NCT03305770|363653220|FG001|Overall Study|Physician Decision - prior to dispense|1|||
105449303|NCT03305770|363653219|FG000|Overall Study|Subject moved|1|||
105449304|NCT03305770|363653220|FG001|Overall Study|Subject moved|0|||
105449305|NCT00773513|363653221|FG000|Overall Study|Renal Transplant|254|||
105449306|NCT00773513|363653222|FG001|Overall Study|Renal Transplant|263|||
105449307|NCT00773513|363653221|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
105449308|NCT00773513|363653222|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
105449309|NCT00773513|363653221|FG000|Overall Study|Withdrew Consent|68|||
105449310|NCT00773513|363653222|FG001|Overall Study|Withdrew Consent|69|||
105449311|NCT00773513|363653221|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
105449312|NCT00773513|363653222|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
105449313|NCT00773513|363653221|FG000|Overall Study|Failure to Return|22|||
105449314|NCT00773513|363653222|FG001|Overall Study|Failure to Return|8|||
105449315|NCT00773513|363653221|FG000|Overall Study|Insufficient Therapeutic Response|1|||
105449316|NCT00773513|363653222|FG001|Overall Study|Insufficient Therapeutic Response|18|||
105449317|NCT00773513|363653221|FG000|Overall Study|Reason Not Specified|159|||
105449318|NCT00773513|363653222|FG001|Overall Study|Reason Not Specified|126|||
105449319|NCT00773513|363653221|FG000|Overall Study|Death|531|||
105449320|NCT00773513|363653222|FG001|Overall Study|Death|545|||
105449321|NCT02905266|363653224|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
105449322|NCT02905266|363653225|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
105449323|NCT02905266|363653224|FG000|Treatment Phase Part 1|Disease Progression|6|||
105449324|NCT02905266|363653225|FG001|Treatment Phase Part 1|Disease Progression|7|||
105449325|NCT02905266|363653224|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
105449326|NCT02905266|363653225|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
105449327|NCT02905266|363653224|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
105449328|NCT02905266|363653225|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
105449329|NCT02905266|363653224|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
105449330|NCT02905266|363653225|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
105449331|NCT02905266|363653224|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
105449332|NCT02905266|363653225|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
105449333|NCT02905266|363653224|FG000|Transition From Part 1 to Part 2|Death|0|||
105449334|NCT02905266|363653225|FG001|Transition From Part 1 to Part 2|Death|1|||
105449335|NCT02905266|363653224|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
105449336|NCT02905266|363653225|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
105449337|NCT02905266|363653224|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
105449338|NCT02905266|363653225|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
105449339|NCT02905266|363653224|FG000|Maintenance Phase Part 2|Disease Progression|9|||
105449340|NCT02905266|363653225|FG001|Maintenance Phase Part 2|Disease Progression|2|||
105449341|NCT02905266|363653224|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
105449342|NCT02905266|363653225|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
105449343|NCT02905266|363653224|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
105449344|NCT02905266|363653225|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
105449345|NCT03259555|363653232|FG000|Overall Study|Adverse Event|6|||
105449346|NCT03259555|363653233|FG001|Overall Study|Adverse Event|4|||
105449347|NCT03259555|363653232|FG000|Overall Study|Lack of Efficacy|6|||
105449348|NCT03259555|363653233|FG001|Overall Study|Lack of Efficacy|4|||
105449349|NCT03259555|363653232|FG000|Overall Study|Lost to Follow-up|0|||
105449350|NCT03259555|363653233|FG001|Overall Study|Lost to Follow-up|2|||
105449351|NCT03259555|363653232|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105449352|NCT03259555|363653233|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105449353|NCT03259555|363653232|FG000|Overall Study|Progressive Disease|0|||
105449354|NCT03259555|363653233|FG001|Overall Study|Progressive Disease|2|||
105449355|NCT03259555|363653232|FG000|Overall Study|Withdrawal by Subject|19|||
105449356|NCT03259555|363653233|FG001|Overall Study|Withdrawal by Subject|16|||
105449357|NCT03259555|363653232|FG000|Overall Study|Physician Decision|1|||
105449358|NCT03259555|363653233|FG001|Overall Study|Physician Decision|2|||
105449359|NCT03259555|363653232|FG000|Overall Study|Other|1|||
105449360|NCT03259555|363653233|FG001|Overall Study|Other|0|||
105449361|NCT00279916|363653234|FG000|Overall Study|Withdrawal by Subject|4|||
105449362|NCT00279916|363653235|FG001|Overall Study|Withdrawal by Subject|3|||
105449363|NCT00279916|363653234|FG000|Overall Study|Lost to Follow-up|3|||
105449364|NCT00279916|363653235|FG001|Overall Study|Lost to Follow-up|2|||
105449365|NCT04303559|363653236|FG000|Overall Study|Study closed due to poor enrollment.|1|||
105449366|NCT02715609|363653244|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
105449367|NCT02715609|363653245|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
105449368|NCT02715609|363653246|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
105449369|NCT02715609|363653244|FG000|Overall Study|Withdrawal by Subject|0|||
105449370|NCT02715609|363653245|FG001|Overall Study|Withdrawal by Subject|0|||
105449371|NCT02715609|363653246|FG002|Overall Study|Withdrawal by Subject|1|||
105449372|NCT00348673|363653258|FG000|Stage 1|Randomized but not Treated|0|||
105449373|NCT00348673|363653259|FG001|Stage 1|Randomized but not Treated|0|||
105449374|NCT00348673|363653260|FG002|Stage 1|Randomized but not Treated|1|||
105449375|NCT00348673|363653261|FG003|Stage 1|Randomized but not Treated|0|||
105449376|NCT00348673|363653262|FG004|Stage 1|Randomized but not Treated|0|||
105449377|NCT00348673|363653263|FG005|Stage 1|Randomized but not Treated|0|||
105449378|NCT00348673|363653264|FG006|Stage 1|Randomized but not Treated|0|||
105449379|NCT00348673|363653265|FG007|Stage 1|Randomized but not Treated|0|||
105449380|NCT00348673|363653266|FG008|Stage 1|Randomized but not Treated|0|||
105449381|NCT01871519|363653269|FG000|Overall Study|Death|26|||
105449382|NCT01871519|363653269|FG000|Overall Study|Lost to Follow-up|15|||
105782315|NCT02528643|364856152|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
105782316|NCT02528643|364856151|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
105782317|NCT02528643|364856152|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
105782318|NCT02528643|364856151|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
105782319|NCT02528643|364856152|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
105782320|NCT00438815|364856153|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
105782321|NCT00438815|364856153|FG000|Overall Study|3-month follow-up no longer required|12|||
105782322|NCT00438815|364856153|FG000|Overall Study|Noncompliance with protocol requirements|9|||
105782323|NCT00438815|364856153|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
105782324|NCT00438815|364856153|FG000|Overall Study|Lost to Follow-up|6|||
105782325|NCT00438815|364856153|FG000|Overall Study|Withdrawal by Subject|6|||
105782326|NCT00438815|364856153|FG000|Overall Study|Death|1|||
105782327|NCT01399619|364856154|FG000|Overall Study|Adverse Event|10|||
105782328|NCT01399619|364856155|FG001|Overall Study|Adverse Event|0|||
105782329|NCT01399619|364856156|FG002|Overall Study|Adverse Event|4|||
105782330|NCT01399619|364856157|FG003|Overall Study|Adverse Event|10|||
105782331|NCT01399619|364856154|FG000|Overall Study|Lack of Efficacy|9|||
105782332|NCT01399619|364856155|FG001|Overall Study|Lack of Efficacy|0|||
105782333|NCT01399619|364856156|FG002|Overall Study|Lack of Efficacy|5|||
105782334|NCT01399619|364856157|FG003|Overall Study|Lack of Efficacy|0|||
105782335|NCT01399619|364856154|FG000|Overall Study|Withdrawal by Subject|6|||
105782336|NCT01399619|364856155|FG001|Overall Study|Withdrawal by Subject|0|||
105782337|NCT01399619|364856156|FG002|Overall Study|Withdrawal by Subject|3|||
105782338|NCT01399619|364856157|FG003|Overall Study|Withdrawal by Subject|4|||
105782339|NCT01399619|364856154|FG000|Overall Study|Protocol Violation|0|||
105782340|NCT01399619|364856155|FG001|Overall Study|Protocol Violation|0|||
105782341|NCT01399619|364856156|FG002|Overall Study|Protocol Violation|0|||
105782342|NCT01399619|364856157|FG003|Overall Study|Protocol Violation|1|||
105782343|NCT01399619|364856154|FG000|Overall Study|Not treated|0|||
105782344|NCT01399619|364856155|FG001|Overall Study|Not treated|0|||
105782345|NCT01399619|364856156|FG002|Overall Study|Not treated|0|||
105782346|NCT01399619|364856157|FG003|Overall Study|Not treated|2|||
105782347|NCT02545270|364856161|FG000|Overall Study|technical difficulties|0|||
105782348|NCT02545270|364856162|FG001|Overall Study|technical difficulties|1|||
105782349|NCT02545270|364856163|FG002|Overall Study|technical difficulties|0|||
105782350|NCT02545270|364856161|FG000|Overall Study|Videos being too similar to other|0|||
105782351|NCT02545270|364856162|FG001|Overall Study|Videos being too similar to other|0|||
105782352|NCT02545270|364856163|FG002|Overall Study|Videos being too similar to other|2|||
105782353|NCT03814499|364856173|FG000|Overall Study|Lost to Follow-up|3|||
105449383|NCT01871519|363653269|FG000|Overall Study|Withdrawal by Subject|49|||
105449384|NCT00320515|363653270|FG000|Overall Study|Death|33|||
105449385|NCT00320515|363653270|FG000|Overall Study|Lost to Follow-up|6|||
105449386|NCT00320515|363653270|FG000|Overall Study|Physician Decision|2|||
105449387|NCT00320515|363653270|FG000|Overall Study|Withdrawal by Subject|8|||
105449388|NCT02485704|363653271|FG000|Overall Study|Lost to Follow-up|4|||
105449389|NCT02485704|363653272|FG001|Overall Study|Lost to Follow-up|5|||
105449390|NCT02485704|363653271|FG000|Overall Study|Withdrawal by Subject|0|||
105449391|NCT02485704|363653272|FG001|Overall Study|Withdrawal by Subject|3|||
105449392|NCT02485704|363653271|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
105449393|NCT02485704|363653272|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
105449394|NCT01777776|363653273|FG000|Overall Study|Adverse Event|2|||
105449395|NCT01777776|363653274|FG001|Overall Study|Adverse Event|4|||
105449396|NCT01777776|363653275|FG002|Overall Study|Adverse Event|0|||
105449397|NCT01777776|363653276|FG003|Overall Study|Adverse Event|0|||
105449398|NCT01777776|363653273|FG000|Overall Study|Disease Progression|4|||
105449399|NCT01777776|363653274|FG001|Overall Study|Disease Progression|8|||
105449400|NCT01777776|363653275|FG002|Overall Study|Disease Progression|6|||
105449401|NCT01777776|363653276|FG003|Overall Study|Disease Progression|3|||
105449402|NCT01777776|363653273|FG000|Overall Study|Withdrawal by Subject|0|||
105449403|NCT01777776|363653274|FG001|Overall Study|Withdrawal by Subject|0|||
105449404|NCT01777776|363653275|FG002|Overall Study|Withdrawal by Subject|0|||
105449405|NCT01777776|363653276|FG003|Overall Study|Withdrawal by Subject|1|||
105449406|NCT00851786|363653277|FG000|Overall Study|Withdrawal by Subject|0|||
105449407|NCT00851786|363653278|FG001|Overall Study|Withdrawal by Subject|1|||
105449408|NCT00851786|363653277|FG000|Overall Study|Protocol Violation|0|||
105449409|NCT00851786|363653278|FG001|Overall Study|Protocol Violation|1|||
105449410|NCT00851786|363653277|FG000|Overall Study|Lost to Follow-up|1|||
105449411|NCT00851786|363653278|FG001|Overall Study|Lost to Follow-up|0|||
105449412|NCT00851786|363653277|FG000|Overall Study|Incarceration|1|||
105449413|NCT00851786|363653278|FG001|Overall Study|Incarceration|0|||
105782354|NCT01980056|364856174|FG000|Overall Study|Death|1|||
105782355|NCT01980056|364856175|FG001|Overall Study|Death|1|||
105782356|NCT01980056|364856176|FG002|Overall Study|Death|0|||
105782357|NCT00351611|364856177|FG000|Overall Study|Adverse Event|11|||
105782358|NCT00351611|364856178|FG001|Overall Study|Adverse Event|3|||
105782359|NCT00351611|364856177|FG000|Overall Study|Death|1|||
105782360|NCT00351611|364856178|FG001|Overall Study|Death|0|||
105782361|NCT00351611|364856177|FG000|Overall Study|Lost to Follow-up|1|||
105782362|NCT00351611|364856178|FG001|Overall Study|Lost to Follow-up|0|||
105782363|NCT00351611|364856177|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
105782364|NCT00351611|364856178|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
105782365|NCT00351611|364856177|FG000|Overall Study|Other|1|||
105782366|NCT00351611|364856178|FG001|Overall Study|Other|0|||
105782367|NCT00351611|364856177|FG000|Overall Study|Protocol Violation|0|||
105782368|NCT00351611|364856178|FG001|Overall Study|Protocol Violation|2|||
105782369|NCT02046993|364856179|FG000|Overall Study|Withdrawal by Subject|2|||
105782370|NCT02046993|364856180|FG001|Overall Study|Withdrawal by Subject|10|||
105782371|NCT02046993|364856179|FG000|Overall Study|Lost to Follow-up|1|||
105782372|NCT02046993|364856180|FG001|Overall Study|Lost to Follow-up|1|||
105782373|NCT01589185|364856181|FG000|Overall Study|Death|1|||
105782374|NCT01589185|364856182|FG001|Overall Study|Death|2|||
105782375|NCT01589185|364856183|FG002|Overall Study|Death|2|||
105782376|NCT01589185|364856184|FG003|Overall Study|Death|0|||
105782377|NCT01589185|364856185|FG004|Overall Study|Death|1|||
105782378|NCT01589185|364856181|FG000|Overall Study|Lost to Follow-up|1|||
105782379|NCT01589185|364856182|FG001|Overall Study|Lost to Follow-up|0|||
105782380|NCT01589185|364856183|FG002|Overall Study|Lost to Follow-up|2|||
105782381|NCT01589185|364856184|FG003|Overall Study|Lost to Follow-up|3|||
105782382|NCT01589185|364856185|FG004|Overall Study|Lost to Follow-up|0|||
105782383|NCT00598442|364856188|FG000|Overall Study|Adverse Event|3|||
105449414|NCT00851786|363653277|FG000|Overall Study|Site Closure|1|||
105449415|NCT00851786|363653278|FG001|Overall Study|Site Closure|0|||
105449416|NCT00851786|363653277|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
105449417|NCT00851786|363653278|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
105449418|NCT00350844|363653281|FG000|Overall Study|Lost to Follow-up|1|||
105449419|NCT01517750|363654782|FG000|Overall Study|Lost to Follow-up|1|||
105449420|NCT01517750|363654783|FG001|Overall Study|Lost to Follow-up|2|||
105449421|NCT01517750|363654784|FG002|Overall Study|Lost to Follow-up|4|||
105449422|NCT01517750|363654785|FG003|Overall Study|Lost to Follow-up|1|||
105449423|NCT00217425|363654792|FG000|Overall Study|Never started treatment|2|||
105449424|NCT00217425|363654792|FG000|Overall Study|Patient ineligible|5|||
105449425|NCT00217425|363654792|FG000|Overall Study|Lack of Efficacy|13|||
105449426|NCT00217425|363654792|FG000|Overall Study|Adverse Event|8|||
105449427|NCT00217425|363654792|FG000|Overall Study|Withdrawal by Subject|4|||
105449428|NCT00217425|363654792|FG000|Overall Study|Other complicating disease|1|||
105449429|NCT00217425|363654792|FG000|Overall Study|Other|4|||
105449430|NCT01121146|363654793|FG000|Overall Study|Death|17|||
105449431|NCT01121146|363654794|FG001|Overall Study|Death|15|||
105449432|NCT01121146|363654793|FG000|Overall Study|Adverse Event|2|||
105449433|NCT01121146|363654794|FG001|Overall Study|Adverse Event|11|||
105449434|NCT01121146|363654793|FG000|Overall Study|Lost to Follow-up|7|||
105449435|NCT01121146|363654794|FG001|Overall Study|Lost to Follow-up|16|||
105449436|NCT00086047|363654796|FG000|Overall Study|Lost to Follow-up|7|||
105449437|NCT00086047|363654797|FG001|Overall Study|Lost to Follow-up|6|||
105449438|NCT00086047|363654796|FG000|Overall Study|Physician Decision|0|||
105449439|NCT00086047|363654797|FG001|Overall Study|Physician Decision|1|||
105449440|NCT03579940|363654799|FG000|Period 2|Withdrawal by Subject|0|||
105449441|NCT03579940|363654800|FG001|Period 2|Withdrawal by Subject|0|||
105449442|NCT03579940|363654801|FG002|Period 2|Withdrawal by Subject|1|||
105449443|NCT03579940|363654802|FG003|Period 2|Withdrawal by Subject|0|||
105449444|NCT03579940|363654803|FG004|Period 2|Withdrawal by Subject|0|||
105449445|NCT03579940|363654804|FG005|Period 2|Withdrawal by Subject|0|||
105449446|NCT03579940|363654805|FG006|Period 2|Withdrawal by Subject|0|||
105449447|NCT03579940|363654806|FG007|Period 2|Withdrawal by Subject|0|||
105449448|NCT03579940|363654807|FG008|Period 2|Withdrawal by Subject|0|||
105449449|NCT03579940|363654808|FG009|Period 2|Withdrawal by Subject|0|||
105449450|NCT03579940|363654809|FG010|Period 2|Withdrawal by Subject|0|||
105449451|NCT01272232|363654812|FG000|Weeks 0-56|Adverse Event|39|||
105449452|NCT01272232|363654813|FG001|Weeks 0-56|Adverse Event|18|||
105449453|NCT01272232|363654814|FG002|Weeks 0-56|Adverse Event|7|||
105449454|NCT01272232|363654812|FG000|Weeks 0-56|Lack of Efficacy|0|||
105449455|NCT01272232|363654813|FG001|Weeks 0-56|Lack of Efficacy|0|||
105782384|NCT00598442|364856189|FG001|Overall Study|Adverse Event|0|||
105782385|NCT00598442|364856190|FG002|Overall Study|Adverse Event|0|||
105782386|NCT00598442|364856188|FG000|Overall Study|Death|19|||
105449456|NCT01272232|363654814|FG002|Weeks 0-56|Lack of Efficacy|3|||
105449457|NCT01272232|363654812|FG000|Weeks 0-56|Protocol Violation|12|||
105449458|NCT01272232|363654813|FG001|Weeks 0-56|Protocol Violation|8|||
105449459|NCT01272232|363654814|FG002|Weeks 0-56|Protocol Violation|13|||
105449460|NCT01272232|363654812|FG000|Weeks 0-56|Withdrawal criteria|32|||
105782387|NCT00598442|364856189|FG001|Overall Study|Death|11|||
105782388|NCT00598442|364856190|FG002|Overall Study|Death|11|||
105782389|NCT00598442|364856188|FG000|Overall Study|Lost to Follow-up|4|||
105782390|NCT00598442|364856189|FG001|Overall Study|Lost to Follow-up|3|||
105782391|NCT00598442|364856190|FG002|Overall Study|Lost to Follow-up|3|||
105782392|NCT00598442|364856188|FG000|Overall Study|Physician Decision|2|||
105782393|NCT00598442|364856189|FG001|Overall Study|Physician Decision|1|||
105782394|NCT00598442|364856190|FG002|Overall Study|Physician Decision|1|||
105782395|NCT00598442|364856188|FG000|Overall Study|Withdrawal by Subject|8|||
105449461|NCT01272232|363654813|FG001|Weeks 0-56|Withdrawal criteria|14|||
105449462|NCT01272232|363654814|FG002|Weeks 0-56|Withdrawal criteria|37|||
105449463|NCT01272232|363654812|FG000|Weeks 0-56|Unclassified|16|||
105449464|NCT01272232|363654813|FG001|Weeks 0-56|Unclassified|7|||
105449465|NCT01272232|363654814|FG002|Weeks 0-56|Unclassified|12|||
105449466|NCT01272232|363654812|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
105449467|NCT01272232|363654813|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
105449468|NCT01272232|363654814|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
105449469|NCT01272232|363654812|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
105449470|NCT01272232|363654813|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
105449471|NCT01272232|363654814|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
105449472|NCT01272232|363654812|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
105449473|NCT01272232|363654813|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
105449474|NCT01272232|363654814|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
105449475|NCT01272232|363654812|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
105449476|NCT01272232|363654813|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
105449477|NCT01272232|363654814|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
105449478|NCT01272232|363654812|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
105449479|NCT01272232|363654813|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
105449480|NCT01272232|363654814|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
105449481|NCT02576639|363654818|FG000|Overall Study|Withdrawal by Subject|1|||
105449482|NCT02576639|363654819|FG001|Overall Study|Withdrawal by Subject|2|||
105449483|NCT02576639|363654820|FG002|Overall Study|Withdrawal by Subject|1|||
105449484|NCT02576639|363654821|FG003|Overall Study|Withdrawal by Subject|0|||
105449485|NCT02576639|363654822|FG004|Overall Study|Withdrawal by Subject|1|||
105449486|NCT02576639|363654818|FG000|Overall Study|Adverse Event|1|||
105449487|NCT02576639|363654819|FG001|Overall Study|Adverse Event|0|||
105449488|NCT02576639|363654820|FG002|Overall Study|Adverse Event|1|||
105449489|NCT02576639|363654821|FG003|Overall Study|Adverse Event|1|||
105449490|NCT02576639|363654822|FG004|Overall Study|Adverse Event|2|||
105449491|NCT02576639|363654818|FG000|Overall Study|Physician Decision|0|||
105449492|NCT02576639|363654819|FG001|Overall Study|Physician Decision|0|||
105449493|NCT02576639|363654820|FG002|Overall Study|Physician Decision|0|||
105449494|NCT02576639|363654821|FG003|Overall Study|Physician Decision|0|||
105449495|NCT02576639|363654822|FG004|Overall Study|Physician Decision|1|||
105449496|NCT01859923|363654831|FG000|Overall Study|Adverse Event|0|||
105449497|NCT01859923|363654832|FG001|Overall Study|Adverse Event|0|||
105449498|NCT01859923|363654833|FG002|Overall Study|Adverse Event|1|||
105449499|NCT01859923|363654834|FG003|Overall Study|Adverse Event|1|||
105449500|NCT00764361|363654840|FG000|Overall Study|Withdrawal by Subject|2|||
105449501|NCT00764361|363654841|FG001|Overall Study|Withdrawal by Subject|3|||
105449502|NCT00764361|363654840|FG000|Overall Study|Adverse Event|0|||
105449503|NCT00764361|363654841|FG001|Overall Study|Adverse Event|1|||
105449504|NCT02090426|363654842|FG000|Overall Study|Lost to Follow-up|12|||
105449505|NCT02090426|363654843|FG001|Overall Study|Lost to Follow-up|6|||
105449506|NCT02079038|363654844|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
105449507|NCT02079038|363654845|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
105449508|NCT02079038|363654844|FG000|Modified Intent to Treat Population|Death|1|||
105449509|NCT02079038|363654845|FG001|Modified Intent to Treat Population|Death|0|||
105449510|NCT02079038|363654844|FG000|Completed 6 Months|Lost to Follow-up|2|||
105449511|NCT02079038|363654845|FG001|Completed 6 Months|Lost to Follow-up|1|||
105449512|NCT03573323|363654846|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
105449513|NCT03573323|363654847|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
105449514|NCT03573323|363654846|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
105449515|NCT03573323|363654847|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
105449516|NCT03573323|363654846|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
105449517|NCT03573323|363654847|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
105449518|NCT03573323|363654846|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
105449519|NCT03573323|363654847|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
105449520|NCT03573323|363654846|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
105449521|NCT03573323|363654847|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
105449522|NCT03573323|363654846|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
105449523|NCT03573323|363654847|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
105449524|NCT03573323|363654846|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
105449525|NCT03573323|363654847|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
105449526|NCT03573323|363654846|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
105449527|NCT03573323|363654847|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
105449528|NCT03573323|363654846|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
105449529|NCT03573323|363654847|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
105449530|NCT03573323|363654846|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
105449531|NCT03573323|363654847|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
105449532|NCT03573323|363654846|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
105449533|NCT03573323|363654847|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
105449534|NCT03573323|363654846|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
105449535|NCT03573323|363654847|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
105449536|NCT03573323|363654846|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
105449537|NCT03573323|363654847|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
105449538|NCT03573323|363654846|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
105449539|NCT03573323|363654847|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
105449540|NCT03573323|363654846|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
105449541|NCT03573323|363654847|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
105449542|NCT03573323|363654846|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
105449543|NCT03573323|363654847|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
105449544|NCT03573323|363654846|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
105449545|NCT03573323|363654847|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
105449546|NCT03573323|363654846|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
105449547|NCT03573323|363654847|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
105449548|NCT03573323|363654846|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
105782396|NCT00598442|364856189|FG001|Overall Study|Withdrawal by Subject|16|||
105449549|NCT03573323|363654847|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
105449550|NCT01946139|363654854|FG000|Overall Study|Withdrawal by Subject|8|||
105449551|NCT01946139|363654854|FG000|Overall Study|ineligible|8|||
105449552|NCT01946139|363654854|FG000|Overall Study|Specimens not available|4|||
105449553|NCT00890825|363654858|FG000|Overall Study|Withdrawal by Subject|1|||
105449554|NCT00890825|363654859|FG001|Overall Study|Withdrawal by Subject|0|||
105449555|NCT00890825|363654858|FG000|Overall Study|Alive at data cut off (DCO)|13|||
105449556|NCT00890825|363654859|FG001|Overall Study|Alive at data cut off (DCO)|14|||
105449557|NCT01508169|363654860|FG000|Overall Study|Adverse Event|1|||
105449558|NCT01508169|363654861|FG001|Overall Study|Adverse Event|0|||
105449559|NCT01508169|363654860|FG000|Overall Study|Withdrawal by Subject|1|||
105449560|NCT01508169|363654861|FG001|Overall Study|Withdrawal by Subject|0|||
105449561|NCT01508169|363654860|FG000|Overall Study|Lost to Follow-up|1|||
105449562|NCT01508169|363654861|FG001|Overall Study|Lost to Follow-up|2|||
105449563|NCT04701333|363654867|FG000|Overall Study|Lost to Follow-up|3|||
105449564|NCT04701333|363654868|FG001|Overall Study|Lost to Follow-up|7|||
105449565|NCT04701333|363654867|FG000|Overall Study|Withdrawal by Subject|0|||
105449566|NCT04701333|363654868|FG001|Overall Study|Withdrawal by Subject|1|||
105449567|NCT03600740|363654871|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
105449568|NCT01814527|363654875|FG000|Overall Study|RTP greater than 30 days|6|||
105449569|NCT01814527|363654876|FG001|Overall Study|RTP greater than 30 days|1|||
105449570|NCT04524858|363654879|FG000|Overall Study|Adverse Event|1|||
105449571|NCT03901144|363654882|FG000|Overall Study|Lost to Follow-up|1|||
105449572|NCT03901144|363654883|FG001|Overall Study|Lost to Follow-up|1|||
105449573|NCT03901144|363654884|FG002|Overall Study|Lost to Follow-up|1|||
105449574|NCT03901144|363654885|FG003|Overall Study|Lost to Follow-up|1|||
105449575|NCT02728089|363654889|FG000|Overall Study|Physician Decision|2|||
105449576|NCT02728089|363654889|FG000|Overall Study|Withdrawal by Subject|1|||
105449577|NCT03359174|363654895|FG000|Overall Study|Adverse Event|1|||
105449578|NCT02800863|363654904|FG000|Overall Study|Adverse Event|14|||
105449579|NCT02800863|363654904|FG000|Overall Study|Another Device Implanted|1|||
105449580|NCT02800863|363654904|FG000|Overall Study|Device Explanted|1|||
105449581|NCT02800863|363654904|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
105449582|NCT02800863|363654904|FG000|Overall Study|Health Issues|1|||
105449583|NCT02800863|363654904|FG000|Overall Study|Insurance Denial|8|||
105449584|NCT02800863|363654904|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
105449585|NCT02800863|363654904|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
105449586|NCT02800863|363654904|FG000|Overall Study|Screen Failure|1|||
105449587|NCT02800863|363654904|FG000|Overall Study|Sponsor Request|6|||
105782397|NCT00598442|364856190|FG002|Overall Study|Withdrawal by Subject|6|||
105782398|NCT00598442|364856188|FG000|Overall Study|Noncompliance|0|||
105782399|NCT00598442|364856189|FG001|Overall Study|Noncompliance|2|||
105782400|NCT00598442|364856190|FG002|Overall Study|Noncompliance|1|||
105782401|NCT00598442|364856188|FG000|Overall Study|Relocation|1|||
105782402|NCT00598442|364856189|FG001|Overall Study|Relocation|4|||
105782403|NCT00598442|364856190|FG002|Overall Study|Relocation|0|||
105782404|NCT00598442|364856188|FG000|Overall Study|Renal transplant|0|||
105782405|NCT00598442|364856189|FG001|Overall Study|Renal transplant|0|||
105782406|NCT00598442|364856190|FG002|Overall Study|Renal transplant|1|||
105782407|NCT00598442|364856188|FG000|Overall Study|Site closed by sponsor|5|||
105782408|NCT00598442|364856189|FG001|Overall Study|Site closed by sponsor|2|||
105782409|NCT00598442|364856190|FG002|Overall Study|Site closed by sponsor|1|||
105782410|NCT00598442|364856188|FG000|Overall Study|Started dialysis|1|||
105782411|NCT00598442|364856189|FG001|Overall Study|Started dialysis|0|||
105782412|NCT00598442|364856190|FG002|Overall Study|Started dialysis|0|||
105449588|NCT02800863|363654904|FG000|Overall Study|Death|3|||
105449589|NCT02800863|363654904|FG000|Overall Study|Subject Implant at Another Facility|1|||
105449590|NCT02800863|363654904|FG000|Overall Study|Lost to Follow-up|26|||
105449591|NCT02800863|363654904|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
105449592|NCT02800863|363654904|FG000|Overall Study|Subject and/or Family Request|64|||
105449593|NCT02800863|363654904|FG000|Overall Study|Trial Failure|81|||
105449594|NCT02800863|363654904|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
105449595|NCT00428948|363654908|FG000|Overall Study|Lost to Follow-up|15|||
105449596|NCT00428948|363654909|FG001|Overall Study|Lost to Follow-up|8|||
105449597|NCT00428948|363654908|FG000|Overall Study|Adverse Event|148|||
105449598|NCT00428948|363654909|FG001|Overall Study|Adverse Event|24|||
105449599|NCT00428948|363654908|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
105449600|NCT00428948|363654909|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
105449601|NCT00428948|363654908|FG000|Overall Study|Investigator Withdrew Subject|3|||
105449602|NCT00428948|363654909|FG001|Overall Study|Investigator Withdrew Subject|4|||
105449603|NCT00428948|363654908|FG000|Overall Study|Subject Withdrew Consent|50|||
105449604|NCT00428948|363654909|FG001|Overall Study|Subject Withdrew Consent|30|||
105449605|NCT00428948|363654908|FG000|Overall Study|Protocol Deviation|1|||
105449606|NCT00428948|363654909|FG001|Overall Study|Protocol Deviation|1|||
105449607|NCT04417361|363654910|FG000|Overall Study|Withdrawal by Subject|1|||
105449608|NCT04417361|363654911|FG001|Overall Study|Withdrawal by Subject|0|||
105449609|NCT04417361|363654910|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
105449610|NCT04417361|363654911|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
105449611|NCT01987102|363654912|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
105449612|NCT01987102|363654913|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
105449613|NCT01987102|363654912|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
105449614|NCT01987102|363654913|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
105782413|NCT01729559|364856196|FG000|Overall Study|Protocol Violation|31|||
105782414|NCT01729559|364856197|FG001|Overall Study|Protocol Violation|28|||
105782415|NCT01654666|364856201|FG000|Overall Study|Protocol Violation|7|||
105782416|NCT01654666|364856202|FG001|Overall Study|Protocol Violation|4|||
105782417|NCT01654666|364856203|FG002|Overall Study|Protocol Violation|8|||
105782418|NCT01654666|364856201|FG000|Overall Study|Lost to Follow-up|4|||
105782419|NCT01654666|364856202|FG001|Overall Study|Lost to Follow-up|5|||
105782420|NCT01654666|364856203|FG002|Overall Study|Lost to Follow-up|5|||
105782421|NCT01654666|364856201|FG000|Overall Study|Withdrawal by Subject|4|||
105782422|NCT01654666|364856202|FG001|Overall Study|Withdrawal by Subject|4|||
105782423|NCT01654666|364856203|FG002|Overall Study|Withdrawal by Subject|1|||
105782424|NCT00535262|364856204|FG000|Overall Study|No funding|3|||
105449615|NCT01987102|363654912|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
105449616|NCT01987102|363654913|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
105449617|NCT01987102|363654912|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
105449618|NCT01987102|363654913|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
105449619|NCT01987102|363654912|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
105449620|NCT01987102|363654913|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
105449621|NCT01987102|363654912|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
105449622|NCT01987102|363654913|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
105449623|NCT06172348|363654921|FG000|Treatment Period 2|Adverse Event|0|||
105449624|NCT06172348|363654922|FG001|Treatment Period 2|Adverse Event|0|||
105449625|NCT06172348|363654923|FG002|Treatment Period 2|Adverse Event|1|||
105449626|NCT06172348|363654924|FG003|Treatment Period 2|Adverse Event|0|||
105449627|NCT06172348|363654925|FG004|Treatment Period 2|Adverse Event|0|||
105449628|NCT06172348|363654926|FG005|Treatment Period 2|Adverse Event|0|||
105449629|NCT05481359|363654927|FG000|Overall Study|Lost to Follow-up|3|||
105449630|NCT05481359|363654927|FG000|Overall Study|Withdrawal by Subject|1|||
105449631|NCT00452790|363654928|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
105449632|NCT00452790|363654929|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
105449633|NCT00452790|363654928|FG000|Infant Series|Parent/legal guardian request|8|||
105449634|NCT00452790|363654929|FG001|Infant Series|Parent/legal guardian request|6|||
105449635|NCT00452790|363654928|FG000|Infant Series|Failed to return|4|||
105449636|NCT00452790|363654929|FG001|Infant Series|Failed to return|1|||
105449637|NCT00452790|363654928|FG000|Infant Series|Protocol Violation|1|||
105449638|NCT00452790|363654929|FG001|Infant Series|Protocol Violation|3|||
105449639|NCT00452790|363654928|FG000|Infant Series|Lost to Follow-up|2|||
105449640|NCT00452790|363654929|FG001|Infant Series|Lost to Follow-up|2|||
105449641|NCT00452790|363654928|FG000|Infant Series|Adverse Event|1|||
105449642|NCT00452790|363654929|FG001|Infant Series|Adverse Event|2|||
105449643|NCT00452790|363654928|FG000|Infant Series|Other reasons|1|||
105449644|NCT00452790|363654929|FG001|Infant Series|Other reasons|2|||
105449645|NCT00452790|363654928|FG000|Infant Series|Investigator request|0|||
105449646|NCT00452790|363654929|FG001|Infant Series|Investigator request|1|||
105782425|NCT00612456|364856210|FG000|Overall Study|Adverse Event|1|||
105782426|NCT00612456|364856211|FG001|Overall Study|Adverse Event|0|||
105782427|NCT00612456|364856212|FG002|Overall Study|Adverse Event|0|||
105449647|NCT00452790|363654928|FG000|Infant Series|Death|0|||
105449648|NCT00452790|363654929|FG001|Infant Series|Death|1|||
105449649|NCT00452790|363654928|FG000|After Infant Series|Investigator request|10|||
105449650|NCT00452790|363654929|FG001|After Infant Series|Investigator request|10|||
105449651|NCT00452790|363654928|FG000|After Infant Series|Adverse Event|4|||
105449652|NCT00452790|363654929|FG001|After Infant Series|Adverse Event|1|||
105449653|NCT00452790|363654928|FG000|After Infant Series|Parent/legal guardian request|1|||
105449654|NCT00452790|363654929|FG001|After Infant Series|Parent/legal guardian request|3|||
105449655|NCT00452790|363654928|FG000|After Infant Series|Lost to Follow-up|4|||
105449656|NCT00452790|363654929|FG001|After Infant Series|Lost to Follow-up|0|||
105449657|NCT00452790|363654928|FG000|After Infant Series|Failed to return|1|||
105449658|NCT00452790|363654929|FG001|After Infant Series|Failed to return|0|||
105449659|NCT00452790|363654928|FG000|After Infant Series|Other reasons|1|||
105449660|NCT00452790|363654929|FG001|After Infant Series|Other reasons|0|||
105449661|NCT00452790|363654928|FG000|Toddler Dose|Failed to return|0|||
105449662|NCT00452790|363654929|FG001|Toddler Dose|Failed to return|1|||
105449663|NCT00452790|363654928|FG000|Toddler Dose|Parent/legal guardian request|0|||
105449664|NCT00452790|363654929|FG001|Toddler Dose|Parent/legal guardian request|1|||
105449665|NCT01505374|363654930|FG000|Overall Study|Lost to Follow-up|1|||
105449666|NCT01505374|363654931|FG001|Overall Study|Lost to Follow-up|0|||
105449667|NCT04158583|363654934|FG000|Overall Study|Withdrawal by Subject|1|||
105449668|NCT04158583|363654935|FG001|Overall Study|Withdrawal by Subject|1|||
105449669|NCT04158583|363654936|FG002|Overall Study|Withdrawal by Subject|0|||
105449670|NCT04158583|363654937|FG003|Overall Study|Withdrawal by Subject|0|||
105449671|NCT04158583|363654938|FG004|Overall Study|Withdrawal by Subject|1|||
105449672|NCT04158583|363654939|FG005|Overall Study|Withdrawal by Subject|0|||
105449673|NCT04158583|363654940|FG006|Overall Study|Withdrawal by Subject|0|||
105449674|NCT04158583|363654941|FG007|Overall Study|Withdrawal by Subject|0|||
105449675|NCT04158583|363654942|FG008|Overall Study|Withdrawal by Subject|2|||
105449676|NCT04158583|363654943|FG009|Overall Study|Withdrawal by Subject|0|||
105449677|NCT04158583|363654934|FG000|Overall Study|Study Terminated by Sponsor|0|||
105449678|NCT04158583|363654935|FG001|Overall Study|Study Terminated by Sponsor|0|||
105449679|NCT04158583|363654936|FG002|Overall Study|Study Terminated by Sponsor|0|||
105449680|NCT04158583|363654937|FG003|Overall Study|Study Terminated by Sponsor|1|||
105449681|NCT04158583|363654938|FG004|Overall Study|Study Terminated by Sponsor|0|||
105449682|NCT04158583|363654939|FG005|Overall Study|Study Terminated by Sponsor|0|||
105449683|NCT04158583|363654940|FG006|Overall Study|Study Terminated by Sponsor|0|||
105449684|NCT04158583|363654941|FG007|Overall Study|Study Terminated by Sponsor|0|||
105449685|NCT04158583|363654942|FG008|Overall Study|Study Terminated by Sponsor|0|||
105449686|NCT04158583|363654943|FG009|Overall Study|Study Terminated by Sponsor|0|||
105449687|NCT04158583|363654934|FG000|Overall Study|Progressive Disease|1|||
105449688|NCT04158583|363654935|FG001|Overall Study|Progressive Disease|0|||
105449689|NCT04158583|363654936|FG002|Overall Study|Progressive Disease|3|||
105449690|NCT04158583|363654937|FG003|Overall Study|Progressive Disease|5|||
105449691|NCT04158583|363654938|FG004|Overall Study|Progressive Disease|0|||
105449692|NCT04158583|363654939|FG005|Overall Study|Progressive Disease|1|||
105449693|NCT04158583|363654940|FG006|Overall Study|Progressive Disease|6|||
105449694|NCT04158583|363654941|FG007|Overall Study|Progressive Disease|2|||
105336028|NCT00839527|363231358|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
105336029|NCT00839527|363231356|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
105336030|NCT00839527|363231357|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
105336031|NCT00839527|363231358|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
105336032|NCT00839527|363231356|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
105336033|NCT00839527|363231357|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
105336034|NCT00839527|363231358|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
105336035|NCT00839527|363231356|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
105336036|NCT00839527|363231357|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
105336037|NCT00839527|363231358|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
105336038|NCT00839527|363231356|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
105336039|NCT00839527|363231357|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
105336040|NCT00839527|363231358|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
105336041|NCT00839527|363231356|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
105336042|NCT00839527|363231357|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
105336043|NCT00839527|363231358|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
105336044|NCT00839527|363231356|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
105449695|NCT04158583|363654942|FG008|Overall Study|Progressive Disease|1|||
105449696|NCT04158583|363654943|FG009|Overall Study|Progressive Disease|2|||
105449697|NCT04158583|363654934|FG000|Overall Study|Lost to Follow-up|0|||
105449698|NCT04158583|363654935|FG001|Overall Study|Lost to Follow-up|0|||
105449699|NCT04158583|363654936|FG002|Overall Study|Lost to Follow-up|1|||
105449700|NCT04158583|363654937|FG003|Overall Study|Lost to Follow-up|1|||
105449701|NCT04158583|363654938|FG004|Overall Study|Lost to Follow-up|1|||
105449702|NCT04158583|363654939|FG005|Overall Study|Lost to Follow-up|0|||
105449703|NCT04158583|363654940|FG006|Overall Study|Lost to Follow-up|0|||
105449704|NCT04158583|363654941|FG007|Overall Study|Lost to Follow-up|0|||
105336045|NCT00839527|363231357|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
105336046|NCT00839527|363231358|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
105336047|NCT00839527|363231356|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
105336048|NCT00839527|363231357|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
105336049|NCT00839527|363231358|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
105336050|NCT00839527|363231356|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
105336051|NCT00839527|363231357|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
105336052|NCT00839527|363231358|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
105336053|NCT00839527|363231356|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
105336054|NCT00839527|363231357|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
105336055|NCT00839527|363231358|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
105336056|NCT00839527|363231356|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
105336057|NCT00839527|363231357|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
105336058|NCT00839527|363231358|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
105336059|NCT00839527|363231356|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
105336060|NCT00839527|363231357|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
105336061|NCT00839527|363231358|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
105336062|NCT00839527|363231356|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
105336063|NCT00839527|363231357|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
105336064|NCT00839527|363231358|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
105336065|NCT00839527|363231356|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
105336066|NCT00839527|363231357|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
105336067|NCT00839527|363231358|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
105336068|NCT02751450|363231359|FG000|Overall Study|Adverse Event|1|||
105336069|NCT02751450|363231360|FG001|Overall Study|Adverse Event|0|||
105336070|NCT01598090|363231361|FG000|Treatment Period|Poor/non-compliance|0|||
105336071|NCT01598090|363231362|FG001|Treatment Period|Poor/non-compliance|2|||
105336072|NCT01598090|363231363|FG002|Treatment Period|Poor/non-compliance|0|||
105336073|NCT01598090|363231361|FG000|Treatment Period|No longer meet study criteria|0|||
105336074|NCT01598090|363231362|FG001|Treatment Period|No longer meet study criteria|1|||
105336075|NCT01598090|363231363|FG002|Treatment Period|No longer meet study criteria|0|||
105336076|NCT01598090|363231361|FG000|Treatment Period|Lack of Efficacy|5|||
105336077|NCT01598090|363231362|FG001|Treatment Period|Lack of Efficacy|14|||
105336078|NCT01598090|363231363|FG002|Treatment Period|Lack of Efficacy|6|||
105336079|NCT01598090|363231361|FG000|Treatment Period|Adverse Event|2|||
105336080|NCT01598090|363231362|FG001|Treatment Period|Adverse Event|33|||
105336081|NCT01598090|363231363|FG002|Treatment Period|Adverse Event|17|||
105336082|NCT01598090|363231361|FG000|Treatment Period|Other reasons|0|||
105336083|NCT01598090|363231362|FG001|Treatment Period|Other reasons|4|||
105336084|NCT01598090|363231363|FG002|Treatment Period|Other reasons|1|||
105336085|NCT01598090|363231361|FG000|Treatment Period|Withdrawal by Subject|3|||
105336086|NCT01598090|363231362|FG001|Treatment Period|Withdrawal by Subject|13|||
105336087|NCT01598090|363231363|FG002|Treatment Period|Withdrawal by Subject|10|||
105336088|NCT01598090|363231361|FG000|Treatment Period|Lost to Follow-up|1|||
105336089|NCT01598090|363231362|FG001|Treatment Period|Lost to Follow-up|5|||
105336090|NCT01598090|363231363|FG002|Treatment Period|Lost to Follow-up|1|||
105336091|NCT01598090|363231361|FG000|Follow-up Period|Death|0|||
105336092|NCT01598090|363231362|FG001|Follow-up Period|Death|1|||
105336093|NCT01598090|363231363|FG002|Follow-up Period|Death|0|||
105336094|NCT01598090|363231361|FG000|Follow-up Period|No longer required per protocol|1|||
105336095|NCT01598090|363231362|FG001|Follow-up Period|No longer required per protocol|3|||
105336096|NCT01598090|363231363|FG002|Follow-up Period|No longer required per protocol|2|||
105336097|NCT01598090|363231361|FG000|Follow-up Period|Not reported|0|||
105336098|NCT01598090|363231362|FG001|Follow-up Period|Not reported|10|||
105336099|NCT01598090|363231363|FG002|Follow-up Period|Not reported|4|||
105336100|NCT01598090|363231361|FG000|Follow-up Period|Withdrawal by Subject|0|||
105336101|NCT01598090|363231362|FG001|Follow-up Period|Withdrawal by Subject|3|||
105336102|NCT01598090|363231363|FG002|Follow-up Period|Withdrawal by Subject|2|||
105336103|NCT01598090|363231361|FG000|Follow-up Period|Other reasons|2|||
105336104|NCT01598090|363231362|FG001|Follow-up Period|Other reasons|8|||
105336105|NCT01598090|363231363|FG002|Follow-up Period|Other reasons|8|||
105336106|NCT01598090|363231361|FG000|Follow-up Period|Lost to Follow-up|2|||
105336107|NCT01598090|363231362|FG001|Follow-up Period|Lost to Follow-up|10|||
105336108|NCT01598090|363231363|FG002|Follow-up Period|Lost to Follow-up|12|||
105336109|NCT03615144|363231364|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
105336110|NCT03615144|363231365|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
105336111|NCT02587598|363231366|FG000|Overall Study|Death|4|||
105336112|NCT02587598|363231367|FG001|Overall Study|Death|8|||
105336113|NCT02587598|363231368|FG002|Overall Study|Death|4|||
105336114|NCT02587598|363231369|FG003|Overall Study|Death|16|||
105336115|NCT02587598|363231370|FG004|Overall Study|Death|9|||
105336116|NCT02587598|363231371|FG005|Overall Study|Death|4|||
105336117|NCT02587598|363231372|FG006|Overall Study|Death|6|||
105336118|NCT02587598|363231373|FG007|Overall Study|Death|7|||
105336119|NCT02587598|363231374|FG008|Overall Study|Death|9|||
105336120|NCT02587598|363231375|FG009|Overall Study|Death|1|||
105336121|NCT02587598|363231376|FG010|Overall Study|Death|3|||
105336122|NCT02587598|363231366|FG000|Overall Study|Study Terminated by the Sponsor|0|||
105336123|NCT02587598|363231367|FG001|Overall Study|Study Terminated by the Sponsor|1|||
105336124|NCT02587598|363231368|FG002|Overall Study|Study Terminated by the Sponsor|0|||
105336125|NCT02587598|363231369|FG003|Overall Study|Study Terminated by the Sponsor|3|||
105336126|NCT02587598|363231370|FG004|Overall Study|Study Terminated by the Sponsor|0|||
105336127|NCT02587598|363231371|FG005|Overall Study|Study Terminated by the Sponsor|1|||
105336128|NCT02587598|363231372|FG006|Overall Study|Study Terminated by the Sponsor|0|||
105336129|NCT02587598|363231373|FG007|Overall Study|Study Terminated by the Sponsor|0|||
105336130|NCT02587598|363231374|FG008|Overall Study|Study Terminated by the Sponsor|0|||
105336131|NCT02587598|363231375|FG009|Overall Study|Study Terminated by the Sponsor|1|||
105336132|NCT02587598|363231376|FG010|Overall Study|Study Terminated by the Sponsor|6|||
105336133|NCT02587598|363231366|FG000|Overall Study|Reason for study withdrawal not specified|0|||
105336134|NCT02587598|363231367|FG001|Overall Study|Reason for study withdrawal not specified|1|||
105336135|NCT02587598|363231368|FG002|Overall Study|Reason for study withdrawal not specified|0|||
105449705|NCT04158583|363654942|FG008|Overall Study|Lost to Follow-up|0|||
105449706|NCT04158583|363654943|FG009|Overall Study|Lost to Follow-up|0|||
105449707|NCT04158583|363654934|FG000|Overall Study|Due To Patient Status|0|||
105449708|NCT04158583|363654935|FG001|Overall Study|Due To Patient Status|0|||
105449709|NCT04158583|363654936|FG002|Overall Study|Due To Patient Status|0|||
105449710|NCT04158583|363654937|FG003|Overall Study|Due To Patient Status|0|||
105449711|NCT04158583|363654938|FG004|Overall Study|Due To Patient Status|0|||
105449712|NCT04158583|363654939|FG005|Overall Study|Due To Patient Status|0|||
105449713|NCT04158583|363654940|FG006|Overall Study|Due To Patient Status|0|||
105449714|NCT04158583|363654941|FG007|Overall Study|Due To Patient Status|0|||
105449715|NCT04158583|363654942|FG008|Overall Study|Due To Patient Status|1|||
105449716|NCT04158583|363654943|FG009|Overall Study|Due To Patient Status|0|||
105449717|NCT04158583|363654934|FG000|Overall Study|Death|3|||
105449718|NCT04158583|363654935|FG001|Overall Study|Death|4|||
105449719|NCT04158583|363654936|FG002|Overall Study|Death|2|||
105449720|NCT04158583|363654937|FG003|Overall Study|Death|2|||
105449721|NCT04158583|363654938|FG004|Overall Study|Death|4|||
105449722|NCT04158583|363654939|FG005|Overall Study|Death|3|||
105449723|NCT04158583|363654940|FG006|Overall Study|Death|5|||
105449724|NCT04158583|363654941|FG007|Overall Study|Death|2|||
105449725|NCT04158583|363654942|FG008|Overall Study|Death|0|||
105449726|NCT04158583|363654943|FG009|Overall Study|Death|1|||
105449727|NCT04158583|363654934|FG000|Overall Study|Clinical Progression Disease|0|||
105449728|NCT04158583|363654935|FG001|Overall Study|Clinical Progression Disease|0|||
105449729|NCT04158583|363654936|FG002|Overall Study|Clinical Progression Disease|0|||
105449730|NCT04158583|363654937|FG003|Overall Study|Clinical Progression Disease|1|||
105449731|NCT04158583|363654938|FG004|Overall Study|Clinical Progression Disease|0|||
105449732|NCT04158583|363654939|FG005|Overall Study|Clinical Progression Disease|0|||
105449733|NCT04158583|363654940|FG006|Overall Study|Clinical Progression Disease|0|||
105449734|NCT04158583|363654941|FG007|Overall Study|Clinical Progression Disease|0|||
105449735|NCT04158583|363654942|FG008|Overall Study|Clinical Progression Disease|0|||
105449736|NCT04158583|363654943|FG009|Overall Study|Clinical Progression Disease|0|||
105449737|NCT04158583|363654934|FG000|Overall Study|Clinical Progression|0|||
105449738|NCT04158583|363654935|FG001|Overall Study|Clinical Progression|0|||
105449739|NCT04158583|363654936|FG002|Overall Study|Clinical Progression|0|||
105449740|NCT04158583|363654937|FG003|Overall Study|Clinical Progression|0|||
105449741|NCT04158583|363654938|FG004|Overall Study|Clinical Progression|1|||
105449742|NCT04158583|363654939|FG005|Overall Study|Clinical Progression|0|||
105449743|NCT04158583|363654940|FG006|Overall Study|Clinical Progression|2|||
105449744|NCT04158583|363654941|FG007|Overall Study|Clinical Progression|0|||
105449745|NCT04158583|363654942|FG008|Overall Study|Clinical Progression|0|||
105449746|NCT04158583|363654943|FG009|Overall Study|Clinical Progression|0|||
105449747|NCT04158583|363654934|FG000|Overall Study|Clinical Deterioration|0|||
105449748|NCT04158583|363654935|FG001|Overall Study|Clinical Deterioration|0|||
105449749|NCT04158583|363654936|FG002|Overall Study|Clinical Deterioration|0|||
105449750|NCT04158583|363654937|FG003|Overall Study|Clinical Deterioration|1|||
105449751|NCT04158583|363654938|FG004|Overall Study|Clinical Deterioration|0|||
105449752|NCT04158583|363654939|FG005|Overall Study|Clinical Deterioration|0|||
105449753|NCT04158583|363654940|FG006|Overall Study|Clinical Deterioration|0|||
105449754|NCT04158583|363654941|FG007|Overall Study|Clinical Deterioration|0|||
105449755|NCT04158583|363654942|FG008|Overall Study|Clinical Deterioration|0|||
105449756|NCT04158583|363654943|FG009|Overall Study|Clinical Deterioration|1|||
105449757|NCT01114828|363654944|FG000|Overall Study|Adverse Event|1|||
105336136|NCT02587598|363231369|FG003|Overall Study|Reason for study withdrawal not specified|0|||
105336137|NCT02587598|363231370|FG004|Overall Study|Reason for study withdrawal not specified|0|||
105336138|NCT02587598|363231371|FG005|Overall Study|Reason for study withdrawal not specified|0|||
105449758|NCT01114828|363654945|FG001|Overall Study|Adverse Event|1|||
105782428|NCT00612456|364856210|FG000|Overall Study|Lack of Efficacy|1|||
105782429|NCT00612456|364856211|FG001|Overall Study|Lack of Efficacy|1|||
105782430|NCT00612456|364856212|FG002|Overall Study|Lack of Efficacy|0|||
105782431|NCT00612456|364856210|FG000|Overall Study|Withdrawal by Subject|0|||
105449759|NCT01114828|363654944|FG000|Overall Study|Lack of Efficacy|0|||
105449760|NCT01114828|363654945|FG001|Overall Study|Lack of Efficacy|2|||
105449761|NCT01114828|363654944|FG000|Overall Study|Protocol Violation|2|||
105449762|NCT01114828|363654945|FG001|Overall Study|Protocol Violation|0|||
105449763|NCT01114828|363654944|FG000|Overall Study|Withdrawal by Subject|0|||
105449764|NCT01114828|363654945|FG001|Overall Study|Withdrawal by Subject|1|||
105449765|NCT01063153|363654946|FG000|Overall Study|Found Ineligible During Screening|2|||
105449766|NCT01063153|363654947|FG001|Overall Study|Found Ineligible During Screening|0|||
105449767|NCT01063153|363654946|FG000|Overall Study|Lost to Follow-up|0|||
105449768|NCT01063153|363654947|FG001|Overall Study|Lost to Follow-up|7|||
105449769|NCT01063153|363654946|FG000|Overall Study|Withdrawal by Subject|0|||
105449770|NCT01063153|363654947|FG001|Overall Study|Withdrawal by Subject|1|||
105449771|NCT01063153|363654946|FG000|Overall Study|Physician Decision|0|||
105449772|NCT01063153|363654947|FG001|Overall Study|Physician Decision|4|||
105449773|NCT01301833|363654948|FG000|Overall Study|Adverse Event|7|||
105449774|NCT01301833|363654949|FG001|Overall Study|Adverse Event|5|||
105449775|NCT01301833|363654950|FG002|Overall Study|Adverse Event|5|||
105449776|NCT01301833|363654951|FG003|Overall Study|Adverse Event|5|||
105449777|NCT01301833|363654948|FG000|Overall Study|Lack of Efficacy|1|||
105449778|NCT01301833|363654949|FG001|Overall Study|Lack of Efficacy|1|||
105449779|NCT01301833|363654950|FG002|Overall Study|Lack of Efficacy|0|||
105449780|NCT01301833|363654951|FG003|Overall Study|Lack of Efficacy|0|||
105449781|NCT01301833|363654948|FG000|Overall Study|Physician Decision|3|||
105449782|NCT01301833|363654949|FG001|Overall Study|Physician Decision|1|||
105449783|NCT01301833|363654950|FG002|Overall Study|Physician Decision|1|||
105449784|NCT01301833|363654951|FG003|Overall Study|Physician Decision|0|||
105449785|NCT01301833|363654948|FG000|Overall Study|Withdrawal by Subject|3|||
105449786|NCT01301833|363654949|FG001|Overall Study|Withdrawal by Subject|1|||
105449787|NCT01301833|363654950|FG002|Overall Study|Withdrawal by Subject|1|||
105449788|NCT01301833|363654951|FG003|Overall Study|Withdrawal by Subject|2|||
105449789|NCT01301833|363654948|FG000|Overall Study|Personal matter|1|||
105449790|NCT01301833|363654949|FG001|Overall Study|Personal matter|0|||
105449791|NCT01301833|363654950|FG002|Overall Study|Personal matter|0|||
105449792|NCT01301833|363654951|FG003|Overall Study|Personal matter|0|||
105449793|NCT03449758|363656325|FG000|Overall Study|Major protocol deviation|1|||
105449794|NCT03449758|363656325|FG000|Overall Study|Treatment inefficacy|5|||
105449795|NCT03449758|363656325|FG000|Overall Study|Adverse Event|9|||
105449796|NCT03449758|363656325|FG000|Overall Study|Consent withdrawal|1|||
105449797|NCT03449758|363656325|FG000|Overall Study|Other unspecified reason|3|||
105449798|NCT00859547|363656328|FG000|Overall Study|Lost to Follow-up|1|||
105449799|NCT00859547|363656328|FG000|Overall Study|Parent withdrew consent|1|||
105449800|NCT01276639|363656331|FG000|Week 0 to 16|Death|1|||
105449801|NCT01276639|363656332|FG001|Week 0 to 16|Death|0|||
105449802|NCT01276639|363656333|FG002|Week 0 to 16|Death|0|||
105449803|NCT01276639|363656334|FG003|Week 0 to 16|Death|0|||
105449804|NCT01276639|363656335|FG004|Week 0 to 16|Death|0|||
105449805|NCT01276639|363656331|FG000|Week 0 to 16|Adverse Event|11|||
105782432|NCT00612456|364856211|FG001|Overall Study|Withdrawal by Subject|1|||
105782433|NCT00612456|364856212|FG002|Overall Study|Withdrawal by Subject|0|||
105782434|NCT03907072|364856213|FG000|Overall Study|Study Terminated by Sponsor|2|||
105782435|NCT03907072|364856214|FG001|Overall Study|Study Terminated by Sponsor|2|||
105782436|NCT03907072|364856215|FG002|Overall Study|Study Terminated by Sponsor|2|||
105782437|NCT03205605|364856222|FG000|Overall Study|Withdrawal by Subject|1|||
105782438|NCT04246996|364856227|FG000|Overall Study|Physician Decision|1|||
105782439|NCT04246996|364856228|FG001|Overall Study|Physician Decision|1|||
105782440|NCT04246996|364856227|FG000|Overall Study|Did not meet eligibility criteria|1|||
105782441|NCT04246996|364856228|FG001|Overall Study|Did not meet eligibility criteria|4|||
105782442|NCT04604015|364856229|FG000|Overall Study|Incomplete Data Collection|33|||
105782443|NCT03289676|364856230|FG000|Overall Study|Withdrawal by Subject|2|||
105782444|NCT03289676|364856231|FG001|Overall Study|Withdrawal by Subject|0|||
105782445|NCT03289676|364856230|FG000|Overall Study|Protocol Violation|2|||
105449806|NCT01276639|363656332|FG001|Week 0 to 16|Adverse Event|8|||
105449807|NCT01276639|363656333|FG002|Week 0 to 16|Adverse Event|11|||
105449808|NCT01276639|363656334|FG003|Week 0 to 16|Adverse Event|0|||
105449809|NCT01276639|363656335|FG004|Week 0 to 16|Adverse Event|0|||
105449810|NCT01276639|363656331|FG000|Week 0 to 16|Lack of Efficacy|20|||
105449811|NCT01276639|363656332|FG001|Week 0 to 16|Lack of Efficacy|15|||
105449812|NCT01276639|363656333|FG002|Week 0 to 16|Lack of Efficacy|25|||
105449813|NCT01276639|363656334|FG003|Week 0 to 16|Lack of Efficacy|0|||
105449814|NCT01276639|363656335|FG004|Week 0 to 16|Lack of Efficacy|0|||
105449815|NCT01276639|363656331|FG000|Week 0 to 16|Lost to Follow-up|3|||
105449816|NCT01276639|363656332|FG001|Week 0 to 16|Lost to Follow-up|5|||
105782446|NCT03289676|364856231|FG001|Overall Study|Protocol Violation|0|||
105782447|NCT03289676|364856230|FG000|Overall Study|Lost to Follow-up|0|||
105782448|NCT03289676|364856231|FG001|Overall Study|Lost to Follow-up|1|||
105782449|NCT00372905|364856232|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
105782450|NCT00372905|364856233|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
105782451|NCT00372905|364856234|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
105782452|NCT00372905|364856235|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
105782453|NCT00372905|364856232|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
105782454|NCT00372905|364856233|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
105782455|NCT00372905|364856234|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
105782456|NCT00372905|364856235|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
105782457|NCT00372905|364856232|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
105782458|NCT00372905|364856233|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
105782459|NCT00372905|364856234|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
105782460|NCT00372905|364856235|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
105782461|NCT00372905|364856232|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
105782462|NCT00372905|364856233|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
105782463|NCT00372905|364856234|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
105782464|NCT00372905|364856235|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
105782465|NCT00372905|364856232|FG000|Follow up Until Relapse or Progression|Study closed|0|||
105782466|NCT00372905|364856233|FG001|Follow up Until Relapse or Progression|Study closed|0|||
105782467|NCT00372905|364856234|FG002|Follow up Until Relapse or Progression|Study closed|0|||
105782468|NCT00372905|364856235|FG003|Follow up Until Relapse or Progression|Study closed|3|||
105782469|NCT00372905|364856232|FG000|Follow up Until Relapse or Progression|Other|0|||
105782470|NCT00372905|364856233|FG001|Follow up Until Relapse or Progression|Other|1|||
105782471|NCT00372905|364856234|FG002|Follow up Until Relapse or Progression|Other|0|||
105782472|NCT00372905|364856235|FG003|Follow up Until Relapse or Progression|Other|0|||
105782473|NCT01728454|364856236|FG000|Stage 1 and 2|Pregnancy|1|||
105782474|NCT01728454|364856237|FG001|Stage 1 and 2|Pregnancy|0|||
105782475|NCT01728454|364856238|FG002|Stage 1 and 2|Pregnancy|0|||
105782476|NCT01728454|364856236|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
105782477|NCT01728454|364856237|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
105782478|NCT01728454|364856238|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
105782479|NCT01728454|364856236|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
105782480|NCT01728454|364856237|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
105782481|NCT01728454|364856238|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
105336139|NCT02587598|363231372|FG006|Overall Study|Reason for study withdrawal not specified|0|||
105336140|NCT02587598|363231373|FG007|Overall Study|Reason for study withdrawal not specified|0|||
105336141|NCT02587598|363231374|FG008|Overall Study|Reason for study withdrawal not specified|0|||
105449817|NCT01276639|363656333|FG002|Week 0 to 16|Lost to Follow-up|3|||
105449818|NCT01276639|363656334|FG003|Week 0 to 16|Lost to Follow-up|0|||
105449819|NCT01276639|363656335|FG004|Week 0 to 16|Lost to Follow-up|0|||
105449820|NCT01276639|363656331|FG000|Week 0 to 16|Withdrawal by Subject|8|||
105449821|NCT01276639|363656332|FG001|Week 0 to 16|Withdrawal by Subject|5|||
105449822|NCT01276639|363656333|FG002|Week 0 to 16|Withdrawal by Subject|4|||
105449823|NCT01276639|363656334|FG003|Week 0 to 16|Withdrawal by Subject|0|||
105449824|NCT01276639|363656335|FG004|Week 0 to 16|Withdrawal by Subject|0|||
105449825|NCT01276639|363656331|FG000|Week 0 to 16|Other|7|||
105449826|NCT01276639|363656332|FG001|Week 0 to 16|Other|7|||
105449827|NCT01276639|363656333|FG002|Week 0 to 16|Other|2|||
105449828|NCT01276639|363656334|FG003|Week 0 to 16|Other|0|||
105449829|NCT01276639|363656335|FG004|Week 0 to 16|Other|0|||
105449830|NCT01276639|363656331|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
105449831|NCT01276639|363656332|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
105449832|NCT01276639|363656333|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
105449833|NCT01276639|363656334|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
105449834|NCT01276639|363656335|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
105449835|NCT01276639|363656331|FG000|Week 16 to 52|Death|1|||
105449836|NCT01276639|363656332|FG001|Week 16 to 52|Death|0|||
105449837|NCT01276639|363656333|FG002|Week 16 to 52|Death|0|||
105449838|NCT01276639|363656334|FG003|Week 16 to 52|Death|0|||
105336142|NCT02587598|363231375|FG009|Overall Study|Reason for study withdrawal not specified|0|||
105336143|NCT02587598|363231376|FG010|Overall Study|Reason for study withdrawal not specified|0|||
105336144|NCT02587598|363231366|FG000|Overall Study|Withdrawal by Subject|0|||
105336145|NCT02587598|363231367|FG001|Overall Study|Withdrawal by Subject|1|||
105336146|NCT02587598|363231368|FG002|Overall Study|Withdrawal by Subject|0|||
105336147|NCT02587598|363231369|FG003|Overall Study|Withdrawal by Subject|2|||
105336148|NCT02587598|363231370|FG004|Overall Study|Withdrawal by Subject|3|||
105336149|NCT02587598|363231371|FG005|Overall Study|Withdrawal by Subject|1|||
105449839|NCT01276639|363656335|FG004|Week 16 to 52|Death|0|||
105449840|NCT01276639|363656331|FG000|Week 16 to 52|Adverse Event|10|||
105782482|NCT01728454|364856236|FG000|Stage 1 and 2|Lost to Follow-up|1|||
105782483|NCT01728454|364856237|FG001|Stage 1 and 2|Lost to Follow-up|1|||
105782484|NCT01728454|364856238|FG002|Stage 1 and 2|Lost to Follow-up|0|||
105449841|NCT01276639|363656332|FG001|Week 16 to 52|Adverse Event|13|||
105449842|NCT01276639|363656333|FG002|Week 16 to 52|Adverse Event|0|||
105449843|NCT01276639|363656334|FG003|Week 16 to 52|Adverse Event|1|||
105449844|NCT01276639|363656335|FG004|Week 16 to 52|Adverse Event|3|||
105449845|NCT01276639|363656331|FG000|Week 16 to 52|Lack of Efficacy|99|||
105449846|NCT01276639|363656332|FG001|Week 16 to 52|Lack of Efficacy|71|||
105449847|NCT01276639|363656333|FG002|Week 16 to 52|Lack of Efficacy|0|||
105449848|NCT01276639|363656334|FG003|Week 16 to 52|Lack of Efficacy|14|||
105449849|NCT01276639|363656335|FG004|Week 16 to 52|Lack of Efficacy|13|||
105449850|NCT01276639|363656331|FG000|Week 16 to 52|Lost to Follow-up|3|||
105449851|NCT01276639|363656332|FG001|Week 16 to 52|Lost to Follow-up|1|||
105449852|NCT01276639|363656333|FG002|Week 16 to 52|Lost to Follow-up|0|||
105449853|NCT01276639|363656334|FG003|Week 16 to 52|Lost to Follow-up|0|||
105449854|NCT01276639|363656335|FG004|Week 16 to 52|Lost to Follow-up|1|||
105449855|NCT01276639|363656331|FG000|Week 16 to 52|Withdrawal by Subject|4|||
105449856|NCT01276639|363656332|FG001|Week 16 to 52|Withdrawal by Subject|4|||
105449857|NCT01276639|363656333|FG002|Week 16 to 52|Withdrawal by Subject|0|||
105449858|NCT01276639|363656334|FG003|Week 16 to 52|Withdrawal by Subject|0|||
105449859|NCT01276639|363656335|FG004|Week 16 to 52|Withdrawal by Subject|1|||
105449860|NCT01276639|363656331|FG000|Week 16 to 52|Other|10|||
105449861|NCT01276639|363656332|FG001|Week 16 to 52|Other|12|||
105449862|NCT01276639|363656333|FG002|Week 16 to 52|Other|0|||
105449863|NCT01276639|363656334|FG003|Week 16 to 52|Other|1|||
105449864|NCT01276639|363656335|FG004|Week 16 to 52|Other|3|||
105449865|NCT00936702|363656338|FG000|Overall Study|Disease progression|34|||
105449866|NCT00936702|363656338|FG000|Overall Study|Adverse Event|8|||
105449867|NCT00936702|363656338|FG000|Overall Study|Withdrawal by Subject|2|||
105449868|NCT00936702|363656338|FG000|Overall Study|Alternative Treatment|1|||
105449869|NCT00936702|363656338|FG000|Overall Study|Other|1|||
105449870|NCT02532465|363656339|FG000|Overall Study|Protocol Violation|1|||
105449871|NCT02532465|363656340|FG001|Overall Study|Protocol Violation|0|||
105449872|NCT02532465|363656339|FG000|Overall Study|Lack of Efficacy|0|||
105449873|NCT02532465|363656340|FG001|Overall Study|Lack of Efficacy|1|||
105449874|NCT01135134|363656349|FG000|Overall Study|Adverse Event|1|||
105449875|NCT01135134|363656350|FG001|Overall Study|Adverse Event|1|||
105449876|NCT01135134|363656349|FG000|Overall Study|Did not meet protocol eligibility|1|||
105449877|NCT01135134|363656350|FG001|Overall Study|Did not meet protocol eligibility|0|||
105449878|NCT00628030|363656353|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
105449879|NCT00628030|363656354|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
105449880|NCT00628030|363656353|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
105449881|NCT00628030|363656354|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
105449882|NCT00628030|363656353|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
105449883|NCT00628030|363656354|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
105449884|NCT04537793|363656355|FG000|Part B (24 Weeks)|Adverse Event|0|||
105449885|NCT04537793|363656356|FG001|Part B (24 Weeks)|Adverse Event|1|||
105449886|NCT00988598|363656357|FG000|Overall Study|Withdrawal by Subject|2|||
105449887|NCT00988598|363656358|FG001|Overall Study|Withdrawal by Subject|0|||
105449888|NCT03367858|363656359|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
105449889|NCT03367858|363656360|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
105449890|NCT03367858|363656359|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
105449891|NCT03367858|363656360|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
105449892|NCT03367858|363656359|FG000|3 Month Follow Up|Lost to Follow-up|8|||
105449893|NCT03367858|363656360|FG001|3 Month Follow Up|Lost to Follow-up|3|||
105449894|NCT03367858|363656359|FG000|3 Month Follow Up|Moved out of study area|2|||
105449895|NCT03367858|363656360|FG001|3 Month Follow Up|Moved out of study area|6|||
105449896|NCT03367858|363656359|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
105449897|NCT03367858|363656360|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
105449898|NCT03367858|363656359|FG000|3 Month Follow Up|MRI contraindication|2|||
105449899|NCT03367858|363656360|FG001|3 Month Follow Up|MRI contraindication|1|||
105449900|NCT03367858|363656359|FG000|3 Month Follow Up|Incarcerated|0|||
105449901|NCT03367858|363656360|FG001|3 Month Follow Up|Incarcerated|1|||
105449902|NCT03367858|363656359|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
105449903|NCT03367858|363656360|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
105449904|NCT03367858|363656359|FG000|6 Month Follow Up|Lost to Follow-up|5|||
105449905|NCT03367858|363656360|FG001|6 Month Follow Up|Lost to Follow-up|2|||
105449906|NCT03367858|363656359|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
105449907|NCT03367858|363656360|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
105449908|NCT03367858|363656359|FG000|12 Month Follow Up|Lost to Follow-up|3|||
105449909|NCT03367858|363656360|FG001|12 Month Follow Up|Lost to Follow-up|3|||
105449910|NCT03367858|363656359|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
105449911|NCT03367858|363656360|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
105449912|NCT01176058|363656363|FG000|Overall Study|Adverse Event|1|||
105449913|NCT01176058|363656364|FG001|Overall Study|Adverse Event|0|||
105449914|NCT01176058|363656363|FG000|Overall Study|Insufficient clinical response|2|||
105449915|NCT01176058|363656364|FG001|Overall Study|Insufficient clinical response|2|||
105449916|NCT01176058|363656363|FG000|Overall Study|Insufficient mycological response|0|||
105449917|NCT01176058|363656364|FG001|Overall Study|Insufficient mycological response|1|||
105449918|NCT01176058|363656363|FG000|Overall Study|Withdrawal by Subject|1|||
105449919|NCT01176058|363656364|FG001|Overall Study|Withdrawal by Subject|0|||
105449920|NCT00256724|363656365|FG000|Overall Study|Physician Decision|2|||
105449921|NCT00256724|363656366|FG001|Overall Study|Physician Decision|5|||
105449922|NCT00256724|363656365|FG000|Overall Study|Protocol Violation|3|||
105449923|NCT00256724|363656366|FG001|Overall Study|Protocol Violation|3|||
105449924|NCT00057863|363656368|FG000|Overall Study|Death|1|||
105449925|NCT00057863|363656368|FG000|Overall Study|Withdrawal by Subject|2|||
105449926|NCT01521507|363656369|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
105336150|NCT02587598|363231372|FG006|Overall Study|Withdrawal by Subject|0|||
105336151|NCT02587598|363231373|FG007|Overall Study|Withdrawal by Subject|0|||
105336152|NCT02587598|363231374|FG008|Overall Study|Withdrawal by Subject|0|||
105336153|NCT02587598|363231375|FG009|Overall Study|Withdrawal by Subject|1|||
105336154|NCT02587598|363231376|FG010|Overall Study|Withdrawal by Subject|2|||
105336155|NCT02587598|363231366|FG000|Overall Study|Physician Decision|0|||
105336156|NCT02587598|363231367|FG001|Overall Study|Physician Decision|0|||
105336157|NCT02587598|363231368|FG002|Overall Study|Physician Decision|0|||
105336158|NCT02587598|363231369|FG003|Overall Study|Physician Decision|0|||
105336159|NCT02587598|363231370|FG004|Overall Study|Physician Decision|0|||
105336160|NCT02587598|363231371|FG005|Overall Study|Physician Decision|0|||
105336161|NCT02587598|363231372|FG006|Overall Study|Physician Decision|0|||
105336162|NCT02587598|363231373|FG007|Overall Study|Physician Decision|0|||
105336163|NCT02587598|363231374|FG008|Overall Study|Physician Decision|0|||
105336164|NCT02587598|363231375|FG009|Overall Study|Physician Decision|0|||
105336165|NCT02587598|363231376|FG010|Overall Study|Physician Decision|3|||
105336166|NCT03315286|363231383|FG000|Overall Study|Lost to Follow-up|0|||
105336167|NCT03315286|363231384|FG001|Overall Study|Lost to Follow-up|3|||
105336168|NCT03315286|363231383|FG000|Overall Study|Withdrawal by Subject|1|||
105336169|NCT03315286|363231384|FG001|Overall Study|Withdrawal by Subject|0|||
105336170|NCT03315286|363231383|FG000|Overall Study|Protocol Violation|0|||
105336171|NCT03315286|363231384|FG001|Overall Study|Protocol Violation|1|||
105336172|NCT01931995|363231385|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
105336173|NCT01931995|363231386|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
105336174|NCT01931995|363231385|FG000|First Intervention (1 Day)|Physician Decision|1|||
105336175|NCT01931995|363231386|FG001|First Intervention (1 Day)|Physician Decision|1|||
105336176|NCT01931995|363231385|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
105336177|NCT01931995|363231386|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
105336178|NCT00791661|363231388|FG000|7 Day Wash-out|Adverse Event|0|||
105336179|NCT00791661|363231389|FG001|7 Day Wash-out|Adverse Event|0|||
105336180|NCT00791661|363231390|FG002|7 Day Wash-out|Adverse Event|1|||
105336181|NCT00791661|363231388|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
105336182|NCT00791661|363231389|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
105336183|NCT00791661|363231390|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
105336184|NCT04603482|363231391|FG000|Overall Study|Lost to Follow-up|15|||
105336185|NCT04603482|363231392|FG001|Overall Study|Lost to Follow-up|15|||
105336186|NCT04603482|363231393|FG002|Overall Study|Lost to Follow-up|15|||
105336187|NCT04439214|363231394|FG000|Overall Study|Adverse Event|13|||
105336188|NCT04439214|363231394|FG000|Overall Study|Disease progression|16|||
105336189|NCT04439214|363231394|FG000|Overall Study|Death|1|||
105336190|NCT04439214|363231394|FG000|Overall Study|Withdrawal by Subject|2|||
105336191|NCT04439214|363231394|FG000|Overall Study|Declining health|1|||
105336192|NCT04439214|363231394|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
105336193|NCT04439214|363231394|FG000|Overall Study|Ineligible|5|||
105336194|NCT02235077|363231395|FG000|Overall Study|Death|5|||
105336195|NCT02235077|363231396|FG001|Overall Study|Death|7|||
105336196|NCT02235077|363231395|FG000|Overall Study|Lost to Follow-up|5|||
105336197|NCT02235077|363231396|FG001|Overall Study|Lost to Follow-up|6|||
105336198|NCT02235077|363231395|FG000|Overall Study|Withdrawal by Subject|8|||
105336199|NCT02235077|363231396|FG001|Overall Study|Withdrawal by Subject|5|||
105336200|NCT02235077|363231395|FG000|Overall Study|Physician Decision|0|||
105336201|NCT02235077|363231396|FG001|Overall Study|Physician Decision|1|||
105336202|NCT00556933|363231397|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
105336203|NCT00556933|363231398|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
105336204|NCT00556933|363231399|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
105336205|NCT00556933|363231400|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
105336206|NCT00556933|363231397|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
105336207|NCT00556933|363231398|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
105336208|NCT00556933|363231399|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
105449927|NCT01521507|363656370|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
105336209|NCT00556933|363231400|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
105336210|NCT00556933|363231397|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
105336211|NCT00556933|363231398|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
105336212|NCT00556933|363231399|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
105336213|NCT00556933|363231400|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
105336214|NCT00556933|363231397|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
105336215|NCT00556933|363231398|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
105336216|NCT00556933|363231399|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
105336217|NCT00556933|363231400|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
105449928|NCT01521507|363656369|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
105449929|NCT01521507|363656370|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
105449930|NCT01521507|363656369|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
105449931|NCT01521507|363656370|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
105336218|NCT00556933|363231397|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
105336219|NCT00556933|363231398|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
105336220|NCT00556933|363231399|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
105336221|NCT00556933|363231400|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
105336222|NCT00556933|363231397|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
105336223|NCT00556933|363231398|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
105336224|NCT00556933|363231399|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
105336225|NCT00556933|363231400|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
105336226|NCT00556933|363231397|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
105336227|NCT00556933|363231398|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
105336228|NCT00556933|363231399|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
105336229|NCT00556933|363231400|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
105336230|NCT00556933|363231397|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
105336231|NCT00556933|363231398|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
105336232|NCT00556933|363231399|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
105336233|NCT00556933|363231400|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
105449932|NCT01521507|363656369|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
105449933|NCT01521507|363656370|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
105449934|NCT01521507|363656369|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
105449935|NCT01521507|363656370|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
105449936|NCT01521507|363656369|FG000|Stage 2: Observational Design|Physician Decision|1|||
105449937|NCT01521507|363656370|FG001|Stage 2: Observational Design|Physician Decision|0|||
105449938|NCT04276233|363656374|FG000|Overall Study|Adverse Event|1|||
105449939|NCT04276233|363656374|FG000|Overall Study|Lost to Follow-up|3|||
105449940|NCT04276233|363656374|FG000|Overall Study|Physician Decision|4|||
105449941|NCT04276233|363656374|FG000|Overall Study|Withdrawal by Subject|2|||
105449942|NCT00296816|363656379|FG000|Overall Study|Disease Progression|37|||
105449943|NCT00296816|363656379|FG000|Overall Study|Adverse Event|18|||
105449944|NCT00296816|363656379|FG000|Overall Study|Investigator/Participant request|5|||
105449945|NCT00296816|363656379|FG000|Overall Study|Non-compliance|1|||
105449946|NCT00296816|363656379|FG000|Overall Study|Missing for end of treatment|4|||
105449947|NCT00296816|363656379|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
105449948|NCT00296816|363656379|FG000|Overall Study|Poor performance status|1|||
105449949|NCT00296816|363656379|FG000|Overall Study|Relocation to Florida|1|||
105449950|NCT00296816|363656379|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
105449951|NCT00296816|363656379|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
105449952|NCT00296816|363656379|FG000|Overall Study|Neuropathy/patient preference|1|||
105449953|NCT00296816|363656379|FG000|Overall Study|Proteinuria|1|||
105449954|NCT00296816|363656379|FG000|Overall Study|ineligibility due to radiation treatment|1|||
105449955|NCT00113841|363656380|FG000|Overall Study|Disease progression|0|||
105449956|NCT00113841|363656381|FG001|Overall Study|Disease progression|2|||
105449957|NCT00113841|363656380|FG000|Overall Study|Non-compliant|1|||
105449958|NCT00113841|363656381|FG001|Overall Study|Non-compliant|0|||
105449959|NCT01092728|363656382|FG000|Overall Study|Withdrawal by Subject|2|||
105449960|NCT01092728|363656383|FG001|Overall Study|Withdrawal by Subject|0|||
105449961|NCT01092728|363656382|FG000|Overall Study|Adverse Event|0|||
105449962|NCT01092728|363656383|FG001|Overall Study|Adverse Event|1|||
105449963|NCT01092728|363656382|FG000|Overall Study|Disease Progression|1|||
105449964|NCT01092728|363656383|FG001|Overall Study|Disease Progression|13|||
105449965|NCT01092728|363656382|FG000|Overall Study|Prohibited Concomitant Medications|1|||
105449966|NCT01092728|363656383|FG001|Overall Study|Prohibited Concomitant Medications|0|||
105449967|NCT01788566|363656390|FG000|Overall Study|Death|4|||
105449968|NCT01788566|363656390|FG000|Overall Study|Adverse Event|1|||
105449969|NCT01788566|363656390|FG000|Overall Study|Clinical Progressive Disease|3|||
105449970|NCT02721875|363656394|FG000|Overall Study|Progressive disease/relapse|1|||
105449971|NCT02721875|363656395|FG001|Overall Study|Progressive disease/relapse|0|||
105449972|NCT01332994|363656403|FG000|Overall Study|Adverse Event|34|||
105449973|NCT01332994|363656403|FG000|Overall Study|Death|1|||
105449974|NCT01332994|363656403|FG000|Overall Study|Lack of Efficacy|1|||
105449975|NCT01332994|363656403|FG000|Overall Study|Lost to Follow-up|4|||
105449976|NCT01332994|363656403|FG000|Overall Study|Protocol Violation|6|||
105449977|NCT01332994|363656403|FG000|Overall Study|Withdrawal by Subject|15|||
105449978|NCT01332994|363656403|FG000|Overall Study|Administrative Problem|2|||
105449979|NCT01332994|363656403|FG000|Overall Study|Other|8|||
105449980|NCT04170543|363656406|FG000|Overall Study|Death|1|||
105449981|NCT04170543|363656407|FG001|Overall Study|Death|1|||
105449982|NCT04170543|363656408|FG002|Overall Study|Death|1|||
105449983|NCT04170543|363656409|FG003|Overall Study|Death|1|||
105449984|NCT04170543|363656410|FG004|Overall Study|Death|1|||
105449985|NCT04170543|363656406|FG000|Overall Study|Lost to Follow-up|3|||
105449986|NCT04170543|363656407|FG001|Overall Study|Lost to Follow-up|3|||
105449987|NCT04170543|363656408|FG002|Overall Study|Lost to Follow-up|0|||
105449988|NCT04170543|363656409|FG003|Overall Study|Lost to Follow-up|3|||
105449989|NCT04170543|363656410|FG004|Overall Study|Lost to Follow-up|1|||
105449990|NCT04170543|363656406|FG000|Overall Study|Withdrawal by Subject|13|||
105449991|NCT04170543|363656407|FG001|Overall Study|Withdrawal by Subject|6|||
105449992|NCT04170543|363656408|FG002|Overall Study|Withdrawal by Subject|5|||
105449993|NCT04170543|363656409|FG003|Overall Study|Withdrawal by Subject|4|||
105449994|NCT04170543|363656410|FG004|Overall Study|Withdrawal by Subject|9|||
105449995|NCT04170543|363656406|FG000|Overall Study|Not able to transition to phase 2b|8|||
105449996|NCT04170543|363656407|FG001|Overall Study|Not able to transition to phase 2b|0|||
105449997|NCT04170543|363656408|FG002|Overall Study|Not able to transition to phase 2b|10|||
105449998|NCT04170543|363656409|FG003|Overall Study|Not able to transition to phase 2b|0|||
105449999|NCT04170543|363656410|FG004|Overall Study|Not able to transition to phase 2b|6|||
105450000|NCT04170543|363656406|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
105782485|NCT01728454|364856236|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
105782486|NCT01728454|364856237|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
105782487|NCT01728454|364856238|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
105782488|NCT01728454|364856236|FG000|Stage 3|Reason Missing|0|||
105782489|NCT01728454|364856237|FG001|Stage 3|Reason Missing|0|||
105782490|NCT01728454|364856238|FG002|Stage 3|Reason Missing|1|||
105782491|NCT01728454|364856236|FG000|Stage 3|Subject Required Other Treatment|0|||
105782492|NCT01728454|364856237|FG001|Stage 3|Subject Required Other Treatment|1|||
105782493|NCT01728454|364856238|FG002|Stage 3|Subject Required Other Treatment|0|||
105782494|NCT01728454|364856236|FG000|Stage 3|Pregnancy|1|||
105782495|NCT01728454|364856237|FG001|Stage 3|Pregnancy|0|||
105782496|NCT01728454|364856238|FG002|Stage 3|Pregnancy|0|||
105782497|NCT01728454|364856236|FG000|Stage 3|Withdrew Consent|1|||
105782498|NCT01728454|364856237|FG001|Stage 3|Withdrew Consent|0|||
105782499|NCT01728454|364856238|FG002|Stage 3|Withdrew Consent|1|||
105782500|NCT01728454|364856236|FG000|Stage 3|Non-compliance with Protocol|0|||
105782501|NCT01728454|364856237|FG001|Stage 3|Non-compliance with Protocol|0|||
105782502|NCT01728454|364856238|FG002|Stage 3|Non-compliance with Protocol|1|||
105782503|NCT01728454|364856236|FG000|Stage 3|Lost to Follow-up|0|||
105782504|NCT01728454|364856237|FG001|Stage 3|Lost to Follow-up|3|||
105782505|NCT01728454|364856238|FG002|Stage 3|Lost to Follow-up|1|||
105782506|NCT01728454|364856236|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
105782507|NCT01728454|364856237|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
105782508|NCT01728454|364856238|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
105782509|NCT02058966|364856239|FG000|Open-Label Methamphetamine|Adverse Event|1|||
105782510|NCT02058966|364856239|FG000|First Intervention|Withdrawal by Subject|1|||
105782511|NCT01396434|364856242|FG000|Overall Study|Lost to Follow-up|1|||
105782512|NCT01396434|364856243|FG001|Overall Study|Lost to Follow-up|0|||
105782513|NCT01396434|364856244|FG002|Overall Study|Lost to Follow-up|0|||
105782514|NCT01396434|364856242|FG000|Overall Study|Other|10|||
105782515|NCT01396434|364856243|FG001|Overall Study|Other|0|||
105782516|NCT01396434|364856244|FG002|Overall Study|Other|0|||
105782517|NCT00157157|364856246|FG000|Overall Study|Withdrawal by Subject|6|||
105782518|NCT00157157|364856246|FG000|Overall Study|Physician Decision|1|||
105782519|NCT00157157|364856246|FG000|Overall Study|Lost to Follow-up|1|||
105782520|NCT00157157|364856246|FG000|Overall Study|Enrolled in another study|1|||
105782521|NCT00157157|364856246|FG000|Overall Study|Met exclusion criteria|1|||
105782522|NCT00157157|364856246|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
105782523|NCT02260804|364856249|FG000|Induction Study Period|Protocol Violation|2|||
105782524|NCT02260804|364856250|FG001|Induction Study Period|Protocol Violation|0|||
105782525|NCT02260804|364856249|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
105782526|NCT02260804|364856250|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
105782527|NCT02260804|364856249|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
105782528|NCT02260804|364856250|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
105782529|NCT02260804|364856249|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
105782530|NCT02260804|364856250|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
105782531|NCT02260804|364856249|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
105782532|NCT02260804|364856250|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
105782533|NCT02260804|364856249|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
105782534|NCT02260804|364856250|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
105782535|NCT02260804|364856249|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
105782536|NCT02260804|364856250|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
105782537|NCT02260804|364856249|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
105450001|NCT04170543|363656407|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
105450002|NCT04170543|363656408|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
105450003|NCT04170543|363656409|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
105450004|NCT04170543|363656410|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
105450005|NCT04170543|363656406|FG000|Overall Study|Not Treated|0|||
105450006|NCT04170543|363656407|FG001|Overall Study|Not Treated|0|||
105450007|NCT04170543|363656408|FG002|Overall Study|Not Treated|0|||
105450008|NCT04170543|363656409|FG003|Overall Study|Not Treated|0|||
105450009|NCT04170543|363656410|FG004|Overall Study|Not Treated|2|||
105450010|NCT04170543|363656406|FG000|Overall Study|(CRF)|16|||
105450011|NCT04170543|363656407|FG001|Overall Study|(CRF)|15|||
105450012|NCT04170543|363656408|FG002|Overall Study|(CRF)|12|||
105450013|NCT04170543|363656409|FG003|Overall Study|(CRF)|17|||
105450014|NCT04170543|363656410|FG004|Overall Study|(CRF)|17|||
105450015|NCT04170543|363656406|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
105450016|NCT04170543|363656407|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
105450017|NCT04170543|363656408|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
105450018|NCT04170543|363656409|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
105450019|NCT04170543|363656410|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
105450020|NCT04628780|363656411|FG000|Overall Study|Death|0|||
105450021|NCT04628780|363656412|FG001|Overall Study|Death|1|||
105450022|NCT04628780|363656413|FG002|Overall Study|Death|0|||
105450023|NCT04628780|363656414|FG003|Overall Study|Death|0|||
105450024|NCT04628780|363656415|FG004|Overall Study|Death|1|||
105450025|NCT04628780|363656416|FG005|Overall Study|Death|0|||
105450026|NCT04628780|363656411|FG000|Overall Study|Physician Decision|2|||
105450027|NCT04628780|363656412|FG001|Overall Study|Physician Decision|0|||
105450028|NCT04628780|363656413|FG002|Overall Study|Physician Decision|0|||
105450029|NCT04628780|363656414|FG003|Overall Study|Physician Decision|0|||
105450030|NCT04628780|363656415|FG004|Overall Study|Physician Decision|2|||
105450031|NCT04628780|363656416|FG005|Overall Study|Physician Decision|0|||
105450032|NCT04628780|363656411|FG000|Overall Study|Progressive disease|2|||
105450033|NCT04628780|363656412|FG001|Overall Study|Progressive disease|2|||
105450034|NCT04628780|363656413|FG002|Overall Study|Progressive disease|2|||
105450035|NCT04628780|363656414|FG003|Overall Study|Progressive disease|3|||
105450036|NCT04628780|363656415|FG004|Overall Study|Progressive disease|9|||
105450037|NCT04628780|363656416|FG005|Overall Study|Progressive disease|4|||
105450038|NCT04628780|363656411|FG000|Overall Study|Withdrawal by Subject|0|||
105450039|NCT04628780|363656412|FG001|Overall Study|Withdrawal by Subject|1|||
105450040|NCT04628780|363656413|FG002|Overall Study|Withdrawal by Subject|2|||
105450041|NCT04628780|363656414|FG003|Overall Study|Withdrawal by Subject|0|||
105450042|NCT04628780|363656415|FG004|Overall Study|Withdrawal by Subject|3|||
105450043|NCT04628780|363656416|FG005|Overall Study|Withdrawal by Subject|1|||
105450044|NCT04628780|363656411|FG000|Overall Study|Global deterioration of health status|0|||
105450045|NCT04628780|363656412|FG001|Overall Study|Global deterioration of health status|0|||
105450046|NCT04628780|363656413|FG002|Overall Study|Global deterioration of health status|0|||
105450047|NCT04628780|363656414|FG003|Overall Study|Global deterioration of health status|0|||
105450048|NCT04628780|363656415|FG004|Overall Study|Global deterioration of health status|1|||
105450049|NCT04628780|363656416|FG005|Overall Study|Global deterioration of health status|1|||
105450050|NCT01132313|363656417|FG000|Overall Study|Lack of Efficacy|1|||
105450051|NCT01132313|363656418|FG001|Overall Study|Lack of Efficacy|0|||
105450052|NCT01132313|363656419|FG002|Overall Study|Lack of Efficacy|0|||
105450053|NCT01132313|363656420|FG003|Overall Study|Lack of Efficacy|0|||
105450054|NCT01132313|363656421|FG004|Overall Study|Lack of Efficacy|0|||
105450055|NCT01132313|363656422|FG005|Overall Study|Lack of Efficacy|0|||
105450056|NCT01132313|363656423|FG006|Overall Study|Lack of Efficacy|0|||
105450057|NCT01132313|363656424|FG007|Overall Study|Lack of Efficacy|3|||
105450058|NCT01132313|363656425|FG008|Overall Study|Lack of Efficacy|14|||
105450059|NCT01132313|363656426|FG009|Overall Study|Lack of Efficacy|16|||
105450060|NCT01132313|363656427|FG010|Overall Study|Lack of Efficacy|0|||
105450061|NCT01132313|363656428|FG011|Overall Study|Lack of Efficacy|0|||
105450062|NCT01132313|363656417|FG000|Overall Study|Not treated|2|||
105450063|NCT01132313|363656418|FG001|Overall Study|Not treated|0|||
105450064|NCT01132313|363656419|FG002|Overall Study|Not treated|0|||
105450065|NCT01132313|363656420|FG003|Overall Study|Not treated|0|||
105450066|NCT01132313|363656421|FG004|Overall Study|Not treated|2|||
105450067|NCT01132313|363656422|FG005|Overall Study|Not treated|1|||
105450068|NCT01132313|363656423|FG006|Overall Study|Not treated|3|||
105450069|NCT01132313|363656424|FG007|Overall Study|Not treated|0|||
105450070|NCT01132313|363656425|FG008|Overall Study|Not treated|0|||
105450071|NCT01132313|363656426|FG009|Overall Study|Not treated|0|||
105450072|NCT01132313|363656427|FG010|Overall Study|Not treated|0|||
105450073|NCT01132313|363656428|FG011|Overall Study|Not treated|0|||
105450074|NCT01132313|363656417|FG000|Overall Study|Adverse Event|0|||
105450075|NCT01132313|363656418|FG001|Overall Study|Adverse Event|0|||
105450076|NCT01132313|363656419|FG002|Overall Study|Adverse Event|4|||
105450077|NCT01132313|363656420|FG003|Overall Study|Adverse Event|10|||
105450078|NCT01132313|363656421|FG004|Overall Study|Adverse Event|19|||
105450079|NCT01132313|363656422|FG005|Overall Study|Adverse Event|6|||
105450080|NCT01132313|363656423|FG006|Overall Study|Adverse Event|5|||
105450081|NCT01132313|363656424|FG007|Overall Study|Adverse Event|3|||
105450082|NCT01132313|363656425|FG008|Overall Study|Adverse Event|7|||
105450083|NCT01132313|363656426|FG009|Overall Study|Adverse Event|2|||
105336234|NCT00556933|363231397|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
105336235|NCT00556933|363231398|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
105336236|NCT00556933|363231399|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
105336237|NCT00556933|363231400|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
105336238|NCT00556933|363231397|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
105336239|NCT00556933|363231398|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
105336240|NCT00556933|363231399|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
105336241|NCT00556933|363231400|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
105336242|NCT00556933|363231397|FG000|CNI Withdrawal vs. Minimization|Death|0|||
105336243|NCT00556933|363231398|FG001|CNI Withdrawal vs. Minimization|Death|0|||
105336244|NCT00556933|363231399|FG002|CNI Withdrawal vs. Minimization|Death|0|||
105336245|NCT00556933|363231400|FG003|CNI Withdrawal vs. Minimization|Death|1|||
105336246|NCT03617770|363231403|FG000|Overall Study|Lost to Follow-up|1|||
105336247|NCT03617770|363231404|FG001|Overall Study|Lost to Follow-up|0|||
105336248|NCT00356135|363231405|FG000|Overall Study|Protocol Violation|1|||
105336249|NCT00356135|363231406|FG001|Overall Study|Protocol Violation|0|||
105336250|NCT00356135|363231407|FG002|Overall Study|Protocol Violation|0|||
105336251|NCT00356135|363231405|FG000|Overall Study|Adverse Event|1|||
105336252|NCT00356135|363231406|FG001|Overall Study|Adverse Event|0|||
105336253|NCT00356135|363231407|FG002|Overall Study|Adverse Event|0|||
105336254|NCT00356135|363231405|FG000|Overall Study|Lost to Follow-up|0|||
105336255|NCT00356135|363231406|FG001|Overall Study|Lost to Follow-up|0|||
105336256|NCT00356135|363231407|FG002|Overall Study|Lost to Follow-up|1|||
105336257|NCT00356135|363231405|FG000|Overall Study|Physician Decision|1|||
105336258|NCT00356135|363231406|FG001|Overall Study|Physician Decision|1|||
105336259|NCT00356135|363231407|FG002|Overall Study|Physician Decision|1|||
105336260|NCT00356135|363231405|FG000|Overall Study|Subject non-compliance|1|||
105336261|NCT00356135|363231406|FG001|Overall Study|Subject non-compliance|1|||
105336262|NCT00356135|363231407|FG002|Overall Study|Subject non-compliance|3|||
105336263|NCT03963232|363231408|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
105336264|NCT03963232|363231409|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
105336265|NCT03963232|363231408|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
105336266|NCT03963232|363231409|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
105336267|NCT03963232|363231408|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
105336268|NCT03963232|363231409|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
105336269|NCT03963232|363231408|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
105336270|NCT03963232|363231409|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
105336271|NCT03963232|363231408|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
105336272|NCT03963232|363231409|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
105336273|NCT03963232|363231408|FG000|Open-Label Treatment Phase|Adverse Event|1|||
105336274|NCT03963232|363231409|FG001|Open-Label Treatment Phase|Adverse Event|2|||
105336275|NCT03963232|363231408|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
105336276|NCT03963232|363231409|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
105336277|NCT03963232|363231408|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
105336278|NCT03963232|363231409|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
105336279|NCT03963232|363231408|FG000|Open-Label Treatment Phase|Pregnancy|1|||
105336280|NCT03963232|363231409|FG001|Open-Label Treatment Phase|Pregnancy|0|||
105336281|NCT03963232|363231408|FG000|Follow-up Phase|Withdrawal by Subject|7|||
105336282|NCT03963232|363231409|FG001|Follow-up Phase|Withdrawal by Subject|5|||
105336283|NCT03963232|363231408|FG000|Follow-up Phase|Protocol Violation|0|||
105336284|NCT03963232|363231409|FG001|Follow-up Phase|Protocol Violation|2|||
105336285|NCT03963232|363231408|FG000|Follow-up Phase|Adverse Event|0|||
105336286|NCT03963232|363231409|FG001|Follow-up Phase|Adverse Event|1|||
105336287|NCT03963232|363231408|FG000|Follow-up Phase|Lost to Follow-up|0|||
105336288|NCT03963232|363231409|FG001|Follow-up Phase|Lost to Follow-up|1|||
105336289|NCT03512210|363231411|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
105336290|NCT03512210|363231411|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
105336291|NCT03512210|363231411|FG000|Step 2:Post-MINMON|Death|2|||
105336292|NCT03512210|363231411|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
105336293|NCT03512210|363231411|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
105336294|NCT05270395|363231413|FG000|Overall Study|Lost to Follow-up|2|||
105336295|NCT05270395|363231414|FG001|Overall Study|Lost to Follow-up|2|||
105782538|NCT02260804|364856250|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
105336296|NCT05270395|363231413|FG000|Overall Study|Death|1|||
105336297|NCT05270395|363231414|FG001|Overall Study|Death|2|||
105336298|NCT05270395|363231413|FG000|Overall Study|Study Team Withdrew|1|||
105336299|NCT05270395|363231414|FG001|Overall Study|Study Team Withdrew|0|||
105336300|NCT00930774|363232934|FG000|Overall Study|Withdrawal by Subject|1|||
105336301|NCT00930774|363232935|FG001|Overall Study|Withdrawal by Subject|9|||
105336302|NCT00930774|363232936|FG002|Overall Study|Withdrawal by Subject|2|||
105336303|NCT00930774|363232937|FG003|Overall Study|Withdrawal by Subject|0|||
105336304|NCT02042950|363232939|FG000|Overall Study|Progressive Disease|4|||
105336305|NCT00723008|363232940|FG000|Enrollment|Lost to Follow-up|1|||
105336306|NCT00723008|363232941|FG001|Enrollment|Lost to Follow-up|0|||
105336307|NCT00723008|363232940|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
105336308|NCT00723008|363232941|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
105336309|NCT00723008|363232940|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
105336310|NCT00723008|363232941|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
105336311|NCT00723008|363232940|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
105336312|NCT00723008|363232941|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
105336313|NCT00723008|363232940|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
105336314|NCT00723008|363232941|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
105336315|NCT00723008|363232940|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
105336316|NCT00723008|363232941|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
105336317|NCT05835011|363232946|FG000|Overall Study|Study Terminated by the Sponsor|1|||
105336318|NCT05835011|363232946|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
105336319|NCT01683266|363232949|FG000|Overall Study|Adverse Event|5|||
105336320|NCT01683266|363232950|FG001|Overall Study|Adverse Event|4|||
105336321|NCT01683266|363232949|FG000|Overall Study|Lack of Efficacy|5|||
105336322|NCT01683266|363232950|FG001|Overall Study|Lack of Efficacy|2|||
105336323|NCT01683266|363232949|FG000|Overall Study|Protocol Violation|13|||
105336324|NCT01683266|363232950|FG001|Overall Study|Protocol Violation|6|||
105336325|NCT01683266|363232949|FG000|Overall Study|Personal Reason|17|||
105336326|NCT01683266|363232950|FG001|Overall Study|Personal Reason|25|||
105336327|NCT01683266|363232949|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
105336328|NCT01683266|363232950|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
105336329|NCT01683266|363232949|FG000|Overall Study|Lost to Follow-up|5|||
105336330|NCT01683266|363232950|FG001|Overall Study|Lost to Follow-up|0|||
105336331|NCT01683266|363232949|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
105336332|NCT01683266|363232950|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
105336333|NCT01683266|363232949|FG000|Overall Study|Nonserious Hypoglycemia|0|||
105336334|NCT01683266|363232950|FG001|Overall Study|Nonserious Hypoglycemia|3|||
105336335|NCT01683266|363232949|FG000|Overall Study|Perceived Lack of Efficacy|1|||
105336336|NCT01683266|363232950|FG001|Overall Study|Perceived Lack of Efficacy|1|||
105336337|NCT01683266|363232949|FG000|Overall Study|Possibly Hypoglycemia|1|||
105336338|NCT01683266|363232950|FG001|Overall Study|Possibly Hypoglycemia|0|||
105336339|NCT01683266|363232949|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
105336340|NCT01683266|363232950|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
105336341|NCT05217641|363232951|FG000|Overall Study|Lost to Follow-up|1|||
105336342|NCT05217641|363232952|FG001|Overall Study|Lost to Follow-up|1|||
105336343|NCT05217641|363232953|FG002|Overall Study|Lost to Follow-up|0|||
105336344|NCT05217641|363232954|FG003|Overall Study|Lost to Follow-up|1|||
105336345|NCT05217641|363232955|FG004|Overall Study|Lost to Follow-up|1|||
105336346|NCT05217641|363232956|FG005|Overall Study|Lost to Follow-up|0|||
105336347|NCT05217641|363232951|FG000|Overall Study|Withdrawal by Subject|0|||
105336348|NCT05217641|363232952|FG001|Overall Study|Withdrawal by Subject|0|||
105336349|NCT05217641|363232953|FG002|Overall Study|Withdrawal by Subject|0|||
105336350|NCT05217641|363232954|FG003|Overall Study|Withdrawal by Subject|3|||
105336351|NCT05217641|363232955|FG004|Overall Study|Withdrawal by Subject|1|||
105336352|NCT05217641|363232956|FG005|Overall Study|Withdrawal by Subject|0|||
105336353|NCT05217641|363232951|FG000|Overall Study|Other: participant did not specify reason|0|||
105336354|NCT05217641|363232952|FG001|Overall Study|Other: participant did not specify reason|0|||
105336355|NCT05217641|363232953|FG002|Overall Study|Other: participant did not specify reason|0|||
105336356|NCT05217641|363232954|FG003|Overall Study|Other: participant did not specify reason|0|||
105336357|NCT05217641|363232955|FG004|Overall Study|Other: participant did not specify reason|1|||
105336358|NCT05217641|363232956|FG005|Overall Study|Other: participant did not specify reason|0|||
105336359|NCT05217641|363232951|FG000|Overall Study|Extended Follow up|1|||
105336360|NCT05217641|363232952|FG001|Overall Study|Extended Follow up|1|||
105336361|NCT05217641|363232953|FG002|Overall Study|Extended Follow up|0|||
105336362|NCT05217641|363232954|FG003|Overall Study|Extended Follow up|0|||
105336363|NCT05217641|363232955|FG004|Overall Study|Extended Follow up|1|||
105336364|NCT05217641|363232956|FG005|Overall Study|Extended Follow up|0|||
105336365|NCT01062113|363232960|FG000|Overall Study|Adverse Event|1|||
105336366|NCT01062113|363232961|FG001|Overall Study|Adverse Event|0|||
105336367|NCT01062113|363232962|FG002|Overall Study|Adverse Event|0|||
105336368|NCT01062113|363232960|FG000|Overall Study|Lack of Efficacy|38|||
105336369|NCT01062113|363232961|FG001|Overall Study|Lack of Efficacy|22|||
105336370|NCT01062113|363232962|FG002|Overall Study|Lack of Efficacy|31|||
105336371|NCT01062113|363232960|FG000|Overall Study|Withdrawal by Subject|1|||
105336372|NCT01062113|363232961|FG001|Overall Study|Withdrawal by Subject|0|||
105336373|NCT01062113|363232962|FG002|Overall Study|Withdrawal by Subject|0|||
105336374|NCT03521115|363232963|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
105336375|NCT03521115|363232964|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
105336376|NCT03521115|363232963|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
105336377|NCT03521115|363232964|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
105336378|NCT01471340|363232966|FG000|Overall Study|Death|5|||
105336379|NCT01471340|363232967|FG001|Overall Study|Death|4|||
105336380|NCT01471340|363232966|FG000|Overall Study|Lost to Follow-up|0|||
105336381|NCT01471340|363232967|FG001|Overall Study|Lost to Follow-up|1|||
105336382|NCT01471340|363232966|FG000|Overall Study|Investigational site closure|0|||
105450084|NCT01132313|363656427|FG010|Overall Study|Adverse Event|0|||
105450085|NCT01132313|363656428|FG011|Overall Study|Adverse Event|0|||
105450086|NCT01132313|363656417|FG000|Overall Study|Protocol Violation|0|||
105450087|NCT01132313|363656418|FG001|Overall Study|Protocol Violation|0|||
105450088|NCT01132313|363656419|FG002|Overall Study|Protocol Violation|0|||
105450089|NCT01132313|363656420|FG003|Overall Study|Protocol Violation|1|||
105450090|NCT01132313|363656421|FG004|Overall Study|Protocol Violation|0|||
105450091|NCT01132313|363656422|FG005|Overall Study|Protocol Violation|0|||
105450092|NCT01132313|363656423|FG006|Overall Study|Protocol Violation|0|||
105450093|NCT01132313|363656424|FG007|Overall Study|Protocol Violation|0|||
105450094|NCT01132313|363656425|FG008|Overall Study|Protocol Violation|0|||
105450095|NCT01132313|363656426|FG009|Overall Study|Protocol Violation|0|||
105450096|NCT01132313|363656427|FG010|Overall Study|Protocol Violation|0|||
105450097|NCT01132313|363656428|FG011|Overall Study|Protocol Violation|0|||
105450098|NCT01132313|363656417|FG000|Overall Study|Lost to Follow-up|0|||
105782539|NCT02260804|364856249|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
105782540|NCT02260804|364856250|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
105782541|NCT02260804|364856249|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
105450099|NCT01132313|363656418|FG001|Overall Study|Lost to Follow-up|0|||
105450100|NCT01132313|363656419|FG002|Overall Study|Lost to Follow-up|1|||
105450101|NCT01132313|363656420|FG003|Overall Study|Lost to Follow-up|0|||
105450102|NCT01132313|363656421|FG004|Overall Study|Lost to Follow-up|0|||
105450103|NCT01132313|363656422|FG005|Overall Study|Lost to Follow-up|0|||
105450104|NCT01132313|363656423|FG006|Overall Study|Lost to Follow-up|0|||
105450105|NCT01132313|363656424|FG007|Overall Study|Lost to Follow-up|1|||
105450106|NCT01132313|363656425|FG008|Overall Study|Lost to Follow-up|0|||
105450107|NCT01132313|363656426|FG009|Overall Study|Lost to Follow-up|0|||
105450108|NCT01132313|363656427|FG010|Overall Study|Lost to Follow-up|0|||
105450109|NCT01132313|363656428|FG011|Overall Study|Lost to Follow-up|0|||
105450110|NCT01132313|363656417|FG000|Overall Study|Withdrawal by Subject|0|||
105450111|NCT01132313|363656418|FG001|Overall Study|Withdrawal by Subject|0|||
105450112|NCT01132313|363656419|FG002|Overall Study|Withdrawal by Subject|3|||
105450113|NCT01132313|363656420|FG003|Overall Study|Withdrawal by Subject|3|||
105450114|NCT01132313|363656421|FG004|Overall Study|Withdrawal by Subject|6|||
105450115|NCT01132313|363656422|FG005|Overall Study|Withdrawal by Subject|0|||
105450116|NCT01132313|363656423|FG006|Overall Study|Withdrawal by Subject|1|||
105450117|NCT01132313|363656424|FG007|Overall Study|Withdrawal by Subject|0|||
105450118|NCT01132313|363656425|FG008|Overall Study|Withdrawal by Subject|0|||
105450119|NCT01132313|363656426|FG009|Overall Study|Withdrawal by Subject|2|||
105450120|NCT01132313|363656427|FG010|Overall Study|Withdrawal by Subject|0|||
105450121|NCT01132313|363656428|FG011|Overall Study|Withdrawal by Subject|0|||
105450122|NCT01132313|363656417|FG000|Overall Study|Lack of antiviral response|0|||
105450123|NCT01132313|363656418|FG001|Overall Study|Lack of antiviral response|0|||
105450124|NCT01132313|363656419|FG002|Overall Study|Lack of antiviral response|12|||
105450125|NCT01132313|363656420|FG003|Overall Study|Lack of antiviral response|18|||
105450126|NCT01132313|363656421|FG004|Overall Study|Lack of antiviral response|18|||
105450127|NCT01132313|363656422|FG005|Overall Study|Lack of antiviral response|18|||
105450128|NCT01132313|363656423|FG006|Overall Study|Lack of antiviral response|21|||
105450129|NCT01132313|363656424|FG007|Overall Study|Lack of antiviral response|0|||
105450130|NCT01132313|363656425|FG008|Overall Study|Lack of antiviral response|0|||
105450131|NCT01132313|363656426|FG009|Overall Study|Lack of antiviral response|0|||
105450132|NCT01132313|363656427|FG010|Overall Study|Lack of antiviral response|1|||
105450133|NCT01132313|363656428|FG011|Overall Study|Lack of antiviral response|0|||
105450134|NCT01132313|363656417|FG000|Overall Study|Other reason not defined above|0|||
105450135|NCT01132313|363656418|FG001|Overall Study|Other reason not defined above|0|||
105450136|NCT01132313|363656419|FG002|Overall Study|Other reason not defined above|0|||
105450137|NCT01132313|363656420|FG003|Overall Study|Other reason not defined above|0|||
105450138|NCT01132313|363656421|FG004|Overall Study|Other reason not defined above|0|||
105782542|NCT02260804|364856250|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
105782543|NCT02260804|364856249|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
105782544|NCT02260804|364856250|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
105782545|NCT02207413|364856253|FG000|Overall Study|Withdrawal by Subject|1|||
105782546|NCT02207413|364856254|FG001|Overall Study|Withdrawal by Subject|0|||
105782547|NCT02207413|364856255|FG002|Overall Study|Withdrawal by Subject|0|||
105782548|NCT02207413|364856256|FG003|Overall Study|Withdrawal by Subject|0|||
105782549|NCT02207413|364856257|FG004|Overall Study|Withdrawal by Subject|3|||
105782550|NCT02207413|364856258|FG005|Overall Study|Withdrawal by Subject|7|||
105782551|NCT02207413|364856253|FG000|Overall Study|Lost to Follow-up|0|||
105782552|NCT02207413|364856254|FG001|Overall Study|Lost to Follow-up|0|||
105782553|NCT02207413|364856255|FG002|Overall Study|Lost to Follow-up|0|||
105782554|NCT02207413|364856256|FG003|Overall Study|Lost to Follow-up|1|||
105782555|NCT02207413|364856257|FG004|Overall Study|Lost to Follow-up|1|||
105782556|NCT02207413|364856258|FG005|Overall Study|Lost to Follow-up|5|||
105782557|NCT02207413|364856253|FG000|Overall Study|Adverse Event|0|||
105450139|NCT01132313|363656422|FG005|Overall Study|Other reason not defined above|0|||
105450140|NCT01132313|363656423|FG006|Overall Study|Other reason not defined above|0|||
105450141|NCT01132313|363656424|FG007|Overall Study|Other reason not defined above|1|||
105450142|NCT01132313|363656425|FG008|Overall Study|Other reason not defined above|0|||
105450143|NCT01132313|363656426|FG009|Overall Study|Other reason not defined above|0|||
105782558|NCT02207413|364856254|FG001|Overall Study|Adverse Event|0|||
105782559|NCT02207413|364856255|FG002|Overall Study|Adverse Event|0|||
105782560|NCT02207413|364856256|FG003|Overall Study|Adverse Event|0|||
105782561|NCT02207413|364856257|FG004|Overall Study|Adverse Event|2|||
105782562|NCT02207413|364856258|FG005|Overall Study|Adverse Event|1|||
105450144|NCT01132313|363656427|FG010|Overall Study|Other reason not defined above|0|||
105450145|NCT01132313|363656428|FG011|Overall Study|Other reason not defined above|0|||
105450146|NCT01236521|363656429|FG000|Overall Study|Withdrawal by Subject|12|||
105450147|NCT01236521|363656430|FG001|Overall Study|Withdrawal by Subject|17|||
105450148|NCT01236521|363656429|FG000|Overall Study|Death|2|||
105450149|NCT01236521|363656430|FG001|Overall Study|Death|1|||
105450150|NCT01236521|363656429|FG000|Overall Study|Lost to Follow-up|9|||
105450151|NCT01236521|363656430|FG001|Overall Study|Lost to Follow-up|7|||
105450152|NCT00165672|363656431|FG000|Overall Study|Adverse Event|0|||
105450153|NCT00165672|363656432|FG001|Overall Study|Adverse Event|1|||
105450154|NCT01670721|363656436|FG000|Overall Study|Participant's decision|15|||
105450155|NCT01670721|363656436|FG000|Overall Study|Other than specified above|38|||
105450156|NCT04965688|363656442|FG000|Overall Study|Withdrawal by Subject|2|||
105450157|NCT03116685|363656443|FG000|Overall Study|Physician Decision|0|||
105450158|NCT03116685|363656444|FG001|Overall Study|Physician Decision|1|||
105450159|NCT05274958|363656445|FG000|Overall Study|Only completed 1 set of PROMs|22|||
105450160|NCT05274958|363656446|FG001|Overall Study|Only completed 1 set of PROMs|35|||
105450161|NCT02796677|363658329|FG000|Overall Study|Adverse Event|11|||
105450162|NCT02796677|363658330|FG001|Overall Study|Adverse Event|22|||
105450163|NCT02796677|363658331|FG002|Overall Study|Adverse Event|14|||
105450164|NCT02796677|363658332|FG003|Overall Study|Adverse Event|14|||
105450165|NCT02796677|363658329|FG000|Overall Study|Protocol Violation|7|||
105450166|NCT02796677|363658330|FG001|Overall Study|Protocol Violation|5|||
105450167|NCT02796677|363658331|FG002|Overall Study|Protocol Violation|4|||
105450168|NCT02796677|363658332|FG003|Overall Study|Protocol Violation|8|||
105450169|NCT02796677|363658329|FG000|Overall Study|Lost to Follow-up|1|||
105450170|NCT02796677|363658330|FG001|Overall Study|Lost to Follow-up|5|||
105450171|NCT02796677|363658331|FG002|Overall Study|Lost to Follow-up|2|||
105450172|NCT02796677|363658332|FG003|Overall Study|Lost to Follow-up|2|||
105450173|NCT02796677|363658329|FG000|Overall Study|Lack of Efficacy|7|||
105450174|NCT02796677|363658330|FG001|Overall Study|Lack of Efficacy|9|||
105450175|NCT02796677|363658331|FG002|Overall Study|Lack of Efficacy|14|||
105450176|NCT02796677|363658332|FG003|Overall Study|Lack of Efficacy|20|||
105450177|NCT02796677|363658329|FG000|Overall Study|Withdrawal by Subject|4|||
105450178|NCT02796677|363658330|FG001|Overall Study|Withdrawal by Subject|14|||
105450179|NCT02796677|363658331|FG002|Overall Study|Withdrawal by Subject|6|||
105450180|NCT02796677|363658332|FG003|Overall Study|Withdrawal by Subject|7|||
105450181|NCT02796677|363658329|FG000|Overall Study|Progressive disease|6|||
105450182|NCT02796677|363658330|FG001|Overall Study|Progressive disease|15|||
105450183|NCT02796677|363658331|FG002|Overall Study|Progressive disease|13|||
105450184|NCT02796677|363658332|FG003|Overall Study|Progressive disease|18|||
105450185|NCT02796677|363658329|FG000|Overall Study|Reason not mentioned|2|||
105450186|NCT02796677|363658330|FG001|Overall Study|Reason not mentioned|3|||
105450187|NCT02796677|363658331|FG002|Overall Study|Reason not mentioned|0|||
105450188|NCT02796677|363658332|FG003|Overall Study|Reason not mentioned|5|||
105450189|NCT02544321|363658337|FG000|Overall Study|Withdrawal by Subject|1|||
105450190|NCT02544321|363658338|FG001|Overall Study|Withdrawal by Subject|2|||
105450191|NCT02544321|363658337|FG000|Overall Study|Adverse Event|1|||
105450192|NCT02544321|363658338|FG001|Overall Study|Adverse Event|1|||
105450193|NCT02544321|363658337|FG000|Overall Study|Protocol Violation|0|||
105450194|NCT02544321|363658338|FG001|Overall Study|Protocol Violation|1|||
105450195|NCT01473732|363658347|FG000|Overall Study|Adverse Event|1|||
105450196|NCT01473732|363658348|FG001|Overall Study|Adverse Event|0|||
105450197|NCT01473732|363658347|FG000|Overall Study|Death|1|||
105450198|NCT01473732|363658348|FG001|Overall Study|Death|0|||
105450199|NCT00671034|363658350|FG000|Overall Study|Adverse Event|5|||
105450200|NCT00671034|363658351|FG001|Overall Study|Adverse Event|7|||
105450201|NCT00671034|363658352|FG002|Overall Study|Adverse Event|1|||
105450202|NCT00671034|363658350|FG000|Overall Study|Death|3|||
105450203|NCT00671034|363658351|FG001|Overall Study|Death|2|||
105450204|NCT00671034|363658352|FG002|Overall Study|Death|1|||
105450205|NCT00671034|363658350|FG000|Overall Study|Physician Decision|12|||
105450206|NCT00671034|363658351|FG001|Overall Study|Physician Decision|4|||
105450207|NCT00671034|363658352|FG002|Overall Study|Physician Decision|5|||
105782563|NCT02207413|364856253|FG000|Overall Study|Migrated/moved from study area|0|||
105782564|NCT02207413|364856254|FG001|Overall Study|Migrated/moved from study area|0|||
105450208|NCT00671034|363658350|FG000|Overall Study|VHR ALL feature|8|||
105782565|NCT02207413|364856255|FG002|Overall Study|Migrated/moved from study area|0|||
105450209|NCT00671034|363658351|FG001|Overall Study|VHR ALL feature|3|||
105450210|NCT00671034|363658352|FG002|Overall Study|VHR ALL feature|5|||
105450211|NCT00671034|363658350|FG000|Overall Study|Refusal|5|||
105336383|NCT01471340|363232967|FG001|Overall Study|Investigational site closure|1|||
105336384|NCT01471340|363232966|FG000|Overall Study|Invalid informed consent|1|||
105336385|NCT01471340|363232967|FG001|Overall Study|Invalid informed consent|0|||
105336386|NCT02475265|363232968|FG000|Overall Study|Physician Decision|1|||
105336387|NCT02475265|363232968|FG000|Overall Study|Withdrawal by Subject|2|||
105336388|NCT00526669|363232969|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
105336389|NCT00526669|363232970|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
105336390|NCT00526669|363232969|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
105336391|NCT00526669|363232970|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
105336392|NCT00526669|363232969|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
105336393|NCT00526669|363232970|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
105336394|NCT00526669|363232969|FG000|Combined Treatment Phase|Death|0|||
105336395|NCT00526669|363232970|FG001|Combined Treatment Phase|Death|2|||
105336396|NCT03499899|363232971|FG000|Overall Study|Adverse Event|2|||
105336397|NCT03499899|363232972|FG001|Overall Study|Adverse Event|3|||
105336398|NCT03499899|363232973|FG002|Overall Study|Adverse Event|3|||
105336399|NCT03499899|363232971|FG000|Overall Study|Death|0|||
105336400|NCT03499899|363232972|FG001|Overall Study|Death|0|||
105336401|NCT03499899|363232973|FG002|Overall Study|Death|1|||
105336402|NCT03499899|363232971|FG000|Overall Study|Physician Decision|3|||
105336403|NCT03499899|363232972|FG001|Overall Study|Physician Decision|6|||
105336404|NCT03499899|363232973|FG002|Overall Study|Physician Decision|6|||
105336405|NCT03499899|363232971|FG000|Overall Study|Progressive disease|15|||
105336406|NCT03499899|363232972|FG001|Overall Study|Progressive disease|23|||
105336407|NCT03499899|363232973|FG002|Overall Study|Progressive disease|23|||
105336408|NCT03499899|363232971|FG000|Overall Study|Patient decision|0|||
105336409|NCT03499899|363232972|FG001|Overall Study|Patient decision|1|||
105336410|NCT03499899|363232973|FG002|Overall Study|Patient decision|1|||
105336411|NCT03499899|363232971|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
105336412|NCT03499899|363232972|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
105450212|NCT00671034|363658351|FG001|Overall Study|Refusal|3|||
105450213|NCT00671034|363658352|FG002|Overall Study|Refusal|5|||
105450214|NCT00671034|363658350|FG000|Overall Study|includes Alternative therapy, etc.|6|||
105450215|NCT00671034|363658351|FG001|Overall Study|includes Alternative therapy, etc.|1|||
105450216|NCT00671034|363658352|FG002|Overall Study|includes Alternative therapy, etc.|7|||
105450217|NCT00997035|363658353|FG000|3-week Followup Visit|Lost to Follow-up|9|||
105450218|NCT00997035|363658354|FG001|3-week Followup Visit|Lost to Follow-up|6|||
105450219|NCT00997035|363658353|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
105336413|NCT03499899|363232973|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
105336414|NCT04590586|363232980|FG000|Overall Study|Death|7|||
105336415|NCT04590586|363232981|FG001|Overall Study|Death|1|||
105336416|NCT04590586|363232982|FG002|Overall Study|Death|37|||
105336417|NCT04590586|363232983|FG003|Overall Study|Death|34|||
105336418|NCT04590586|363232984|FG004|Overall Study|Death|19|||
105336419|NCT04590586|363232985|FG005|Overall Study|Death|3|||
105336420|NCT04590586|363232980|FG000|Overall Study|Lost to Follow-up|3|||
105336421|NCT04590586|363232981|FG001|Overall Study|Lost to Follow-up|0|||
105336422|NCT04590586|363232982|FG002|Overall Study|Lost to Follow-up|11|||
105336423|NCT04590586|363232983|FG003|Overall Study|Lost to Follow-up|11|||
105336424|NCT04590586|363232984|FG004|Overall Study|Lost to Follow-up|6|||
105336425|NCT04590586|363232985|FG005|Overall Study|Lost to Follow-up|0|||
105336426|NCT04590586|363232980|FG000|Overall Study|Withdrawal by Subject|0|||
105336427|NCT04590586|363232981|FG001|Overall Study|Withdrawal by Subject|0|||
105336428|NCT04590586|363232982|FG002|Overall Study|Withdrawal by Subject|6|||
105336429|NCT04590586|363232983|FG003|Overall Study|Withdrawal by Subject|0|||
105336430|NCT04590586|363232984|FG004|Overall Study|Withdrawal by Subject|3|||
105336431|NCT04590586|363232985|FG005|Overall Study|Withdrawal by Subject|0|||
105336432|NCT04590586|363232980|FG000|Overall Study|Other|3|||
105336433|NCT04590586|363232981|FG001|Overall Study|Other|0|||
105336434|NCT04590586|363232982|FG002|Overall Study|Other|1|||
105336435|NCT04590586|363232983|FG003|Overall Study|Other|1|||
105336436|NCT04590586|363232984|FG004|Overall Study|Other|2|||
105336437|NCT04590586|363232985|FG005|Overall Study|Other|1|||
105336438|NCT00637000|363232986|FG000|Overall Study|Withdrawal by Subject|4|||
105336439|NCT00637000|363232987|FG001|Overall Study|Withdrawal by Subject|3|||
105336440|NCT02295020|363232990|FG000|Overall Study|Adverse Event|0|||
105336441|NCT02295020|363232991|FG001|Overall Study|Adverse Event|1|||
105336442|NCT02295020|363232990|FG000|Overall Study|Withdrawal by Subject|3|||
105336443|NCT02295020|363232991|FG001|Overall Study|Withdrawal by Subject|2|||
105450220|NCT00997035|363658354|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
105336444|NCT04481789|363232992|FG000|Period 1|Withdrawal by Subject|1|||
105336445|NCT04481789|363232993|FG001|Period 1|Withdrawal by Subject|0|||
105336446|NCT04481789|363232994|FG002|Period 1|Withdrawal by Subject|0|||
105336447|NCT04481789|363232995|FG003|Period 1|Withdrawal by Subject|0|||
105336448|NCT04481789|363232996|FG004|Period 1|Withdrawal by Subject|0|||
105336449|NCT04481789|363232997|FG005|Period 1|Withdrawal by Subject|0|||
105336450|NCT04791319|363232998|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
105450221|NCT01169103|363658360|FG000|Overall Study|Lost to Follow-up|3|||
105336451|NCT04791319|363232999|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
105336452|NCT04791319|363233000|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
105336453|NCT04791319|363233001|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
105450222|NCT01169103|363658361|FG001|Overall Study|Lost to Follow-up|3|||
105450223|NCT01169103|363658360|FG000|Overall Study|Withdrawal by Subject|3|||
105450224|NCT01169103|363658361|FG001|Overall Study|Withdrawal by Subject|1|||
105450225|NCT03010527|363658362|FG000|Overall Study|Death|0|||
105450226|NCT03010527|363658363|FG001|Overall Study|Death|0|||
105450227|NCT03010527|363658364|FG002|Overall Study|Death|1|||
105450228|NCT03010527|363658362|FG000|Overall Study|Adverse Event|0|||
105450229|NCT03010527|363658363|FG001|Overall Study|Adverse Event|4|||
105450230|NCT03010527|363658364|FG002|Overall Study|Adverse Event|2|||
105450231|NCT03010527|363658362|FG000|Overall Study|Protocol Violation|0|||
105450232|NCT03010527|363658363|FG001|Overall Study|Protocol Violation|1|||
105782566|NCT02207413|364856256|FG003|Overall Study|Migrated/moved from study area|0|||
105782567|NCT02207413|364856257|FG004|Overall Study|Migrated/moved from study area|1|||
105450233|NCT03010527|363658364|FG002|Overall Study|Protocol Violation|0|||
105450234|NCT03010527|363658362|FG000|Overall Study|Lost to Follow-up|0|||
105450235|NCT03010527|363658363|FG001|Overall Study|Lost to Follow-up|2|||
105450236|NCT03010527|363658364|FG002|Overall Study|Lost to Follow-up|1|||
105450237|NCT03010527|363658362|FG000|Overall Study|Withdrawal by Subject|0|||
105450238|NCT03010527|363658363|FG001|Overall Study|Withdrawal by Subject|3|||
105450239|NCT03010527|363658364|FG002|Overall Study|Withdrawal by Subject|4|||
105450240|NCT03010527|363658362|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
105450241|NCT03010527|363658363|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
105450242|NCT03010527|363658364|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
105450243|NCT03010527|363658362|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
105450244|NCT03010527|363658363|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
105450245|NCT03010527|363658364|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
105450246|NCT03010527|363658362|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
105450247|NCT03010527|363658363|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
105450248|NCT03010527|363658364|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
105450249|NCT02222558|363658369|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
105450250|NCT02222558|363658370|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
105450251|NCT02222558|363658371|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
105450252|NCT02222558|363658372|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
105450253|NCT02222558|363658373|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
105450254|NCT02222558|363658374|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
105450255|NCT02222558|363658369|FG000|Period 3|Withdrawal by Subject|0|||
105450256|NCT02222558|363658370|FG001|Period 3|Withdrawal by Subject|0|||
105450257|NCT02222558|363658371|FG002|Period 3|Withdrawal by Subject|0|||
105450258|NCT02222558|363658372|FG003|Period 3|Withdrawal by Subject|0|||
105450259|NCT02222558|363658373|FG004|Period 3|Withdrawal by Subject|0|||
105450260|NCT02222558|363658374|FG005|Period 3|Withdrawal by Subject|1|||
105450261|NCT01755234|363658377|FG000|Overall Study|Lost to Follow-up|11|||
105450262|NCT01755234|363658378|FG001|Overall Study|Lost to Follow-up|6|||
105450263|NCT01755234|363658377|FG000|Overall Study|Change in surgical case|2|||
105450264|NCT01755234|363658378|FG001|Overall Study|Change in surgical case|1|||
105450265|NCT01755234|363658377|FG000|Overall Study|case cancelled|1|||
105450266|NCT01755234|363658378|FG001|Overall Study|case cancelled|0|||
105450267|NCT01755234|363658377|FG000|Overall Study|Withdrawal by Subject|0|||
105450268|NCT01755234|363658378|FG001|Overall Study|Withdrawal by Subject|1|||
105450269|NCT01755234|363658377|FG000|Overall Study|unblinded|1|||
105450270|NCT01755234|363658378|FG001|Overall Study|unblinded|0|||
105450271|NCT02836652|363658379|FG000|Overall Study|Death|3|||
105450272|NCT02836652|363658380|FG001|Overall Study|Death|3|||
105450273|NCT02836652|363658379|FG000|Overall Study|Transplant/Explant|3|||
105450274|NCT02836652|363658380|FG001|Overall Study|Transplant/Explant|4|||
105450275|NCT02836652|363658379|FG000|Overall Study|Withdrawn|9|||
105450276|NCT02836652|363658380|FG001|Overall Study|Withdrawn|9|||
105782568|NCT02207413|364856258|FG005|Overall Study|Migrated/moved from study area|0|||
105782569|NCT03726320|364857924|FG000|Overall Study|Lost to Follow-up|2|||
105782570|NCT03726320|364857925|FG001|Overall Study|Lost to Follow-up|4|||
105782571|NCT03726320|364857926|FG002|Overall Study|Lost to Follow-up|0|||
105782572|NCT03726320|364857924|FG000|Overall Study|Time Constraints|4|||
105782573|NCT03726320|364857925|FG001|Overall Study|Time Constraints|1|||
105782574|NCT03726320|364857926|FG002|Overall Study|Time Constraints|0|||
105782575|NCT03726320|364857924|FG000|Overall Study|Ineligible after enrollment|3|||
105782576|NCT03726320|364857925|FG001|Overall Study|Ineligible after enrollment|3|||
105782577|NCT03726320|364857926|FG002|Overall Study|Ineligible after enrollment|0|||
105450277|NCT02836652|363658379|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
105450278|NCT02836652|363658380|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
105450279|NCT01220167|363658384|FG000|Period 3|Urine positive for substance abuse|0|||
105450280|NCT01220167|363658385|FG001|Period 3|Urine positive for substance abuse|1|||
105450281|NCT01220167|363658386|FG002|Period 3|Urine positive for substance abuse|0|||
105782578|NCT03726320|364857924|FG000|Overall Study|Clinic / insurance issue|2|||
105336454|NCT04791319|363233002|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
105336455|NCT04791319|363233003|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
105336456|NCT04791319|363233004|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
105336457|NCT04791319|363233005|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
105336458|NCT04791319|363233006|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
105336459|NCT04791319|363233007|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
105336460|NCT04791319|363233008|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
105336461|NCT04791319|363232998|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
105336462|NCT04791319|363232999|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
105336463|NCT04791319|363233000|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
105336464|NCT04791319|363233001|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
105336465|NCT04791319|363233002|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
105336466|NCT04791319|363233003|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
105336467|NCT04791319|363233004|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
105336468|NCT04791319|363233005|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
105336469|NCT04791319|363233006|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
105336470|NCT04791319|363233007|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
105336471|NCT04791319|363233008|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
105336472|NCT04791319|363232998|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
105336473|NCT04791319|363232999|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
105336474|NCT04791319|363233000|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
105336475|NCT04791319|363233001|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
105336476|NCT04791319|363233002|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
105336477|NCT04791319|363233003|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
105336478|NCT04791319|363233004|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
105336479|NCT04791319|363233005|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
105336480|NCT04791319|363233006|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
105450282|NCT00354679|363658389|FG000|Overall Study|Patient Not Treated|1|||
105450283|NCT03719131|363658390|FG000|Overall Study|Death|1|||
105450284|NCT03719131|363658391|FG001|Overall Study|Death|2|||
105450285|NCT02525588|363658392|FG000|Overall Study|Death|3|||
105450286|NCT02525588|363658393|FG001|Overall Study|Death|1|||
105450287|NCT02525588|363658392|FG000|Overall Study|Lost to Follow-up|2|||
105450288|NCT02525588|363658393|FG001|Overall Study|Lost to Follow-up|0|||
105450289|NCT02525588|363658392|FG000|Overall Study|Withdrawal by Subject|1|||
105450290|NCT02525588|363658393|FG001|Overall Study|Withdrawal by Subject|1|||
105450291|NCT02525588|363658392|FG000|Overall Study|Adverse Event|0|||
105450292|NCT02525588|363658393|FG001|Overall Study|Adverse Event|1|||
105450293|NCT03018691|363658394|FG000|Overall Study|Adverse Event|1|||
105450294|NCT03018691|363658395|FG001|Overall Study|Adverse Event|1|||
105450295|NCT03018691|363658396|FG002|Overall Study|Adverse Event|4|||
105450296|NCT03018691|363658394|FG000|Overall Study|Lack of Efficacy|0|||
105450297|NCT03018691|363658395|FG001|Overall Study|Lack of Efficacy|0|||
105450298|NCT03018691|363658396|FG002|Overall Study|Lack of Efficacy|1|||
105450299|NCT03018691|363658394|FG000|Overall Study|Withdrawal by Subject|0|||
105450300|NCT03018691|363658395|FG001|Overall Study|Withdrawal by Subject|0|||
105450301|NCT03018691|363658396|FG002|Overall Study|Withdrawal by Subject|1|||
105450302|NCT03018691|363658394|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105450303|NCT03018691|363658395|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105450304|NCT03018691|363658396|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105450305|NCT00743249|363658399|FG000|Overall Study|Adverse Event|0|||
105450306|NCT00743249|363658400|FG001|Overall Study|Adverse Event|4|||
105450307|NCT00743249|363658399|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
105450308|NCT00743249|363658400|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
105450309|NCT00743249|363658399|FG000|Overall Study|Unsuccessful insertion of stent|2|||
105450310|NCT00743249|363658400|FG001|Overall Study|Unsuccessful insertion of stent|1|||
105450311|NCT01147666|363658401|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
105450312|NCT01147666|363658402|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
105450313|NCT01147666|363658403|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
105450314|NCT01147666|363658404|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105450315|NCT01147666|363658405|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105450316|NCT01147666|363658406|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105450317|NCT01147666|363658407|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105450318|NCT01147666|363658408|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105450319|NCT01147666|363658409|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105450320|NCT01147666|363658410|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105450321|NCT01147666|363658411|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105450322|NCT01147666|363658412|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105450323|NCT01147666|363658413|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
105450324|NCT01147666|363658414|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105550192|NCT00467870|364014379|FG005|Overall Study|Adverse Event|1|||
105450325|NCT01147666|363658415|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105450326|NCT01147666|363658401|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
105450327|NCT01147666|363658402|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
105450328|NCT01147666|363658403|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
105450329|NCT01147666|363658404|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
105450330|NCT01147666|363658405|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
105450331|NCT01147666|363658406|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
105450332|NCT01147666|363658407|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
105450333|NCT01147666|363658408|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
105450334|NCT01147666|363658409|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
105450335|NCT01147666|363658410|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
105450336|NCT01147666|363658411|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
105450337|NCT01147666|363658412|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
105450338|NCT01147666|363658413|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
105450339|NCT01147666|363658414|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
105450340|NCT01147666|363658415|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
105450341|NCT01147666|363658401|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
105450342|NCT01147666|363658402|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
105450343|NCT01147666|363658403|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
105450344|NCT01147666|363658404|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
105450345|NCT01147666|363658405|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
105450346|NCT01147666|363658406|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
105450347|NCT01147666|363658407|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
105450348|NCT01147666|363658408|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
105450349|NCT01147666|363658409|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
105450350|NCT01147666|363658410|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
105450351|NCT01147666|363658411|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
105450352|NCT01147666|363658412|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
105450353|NCT01147666|363658413|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
105450354|NCT01147666|363658414|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
105450355|NCT01147666|363658415|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
105450356|NCT01147666|363658401|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
105450357|NCT01147666|363658402|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105450358|NCT01147666|363658403|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105450359|NCT01147666|363658404|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
105450360|NCT01147666|363658405|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105450361|NCT01147666|363658406|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105450362|NCT01147666|363658407|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105450363|NCT01147666|363658408|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105450364|NCT01147666|363658409|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105450365|NCT01147666|363658410|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105450366|NCT01147666|363658411|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
105450367|NCT01147666|363658412|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105450368|NCT01147666|363658413|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105450369|NCT01147666|363658414|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105450370|NCT01147666|363658415|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105450371|NCT01147666|363658401|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105450372|NCT01147666|363658402|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105450373|NCT01147666|363658403|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105450374|NCT01147666|363658404|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105450375|NCT01147666|363658405|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
105450376|NCT01147666|363658406|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
105450377|NCT01147666|363658407|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105450378|NCT01147666|363658408|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
105450379|NCT01147666|363658409|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105450380|NCT01147666|363658410|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
105450381|NCT01147666|363658411|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105450382|NCT01147666|363658412|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
105450383|NCT01147666|363658413|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105450384|NCT01147666|363658414|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
105450385|NCT01147666|363658415|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105450386|NCT01147666|363658401|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105450387|NCT01147666|363658402|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105450388|NCT01147666|363658403|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105450389|NCT01147666|363658404|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
105450390|NCT01147666|363658405|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105450391|NCT01147666|363658406|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105550193|NCT00467870|364014374|FG000|Overall Study|Protocol Violation|2|||
105450392|NCT01147666|363658407|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105450393|NCT01147666|363658408|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105450394|NCT01147666|363658409|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105450395|NCT01147666|363658410|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105450396|NCT01147666|363658411|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
105450397|NCT01147666|363658412|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105450398|NCT01147666|363658413|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105450399|NCT01147666|363658414|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105450400|NCT01147666|363658415|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105450401|NCT01147666|363658401|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105450402|NCT01147666|363658402|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105450403|NCT01147666|363658403|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105450404|NCT01147666|363658404|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105450405|NCT01147666|363658405|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105450406|NCT01147666|363658406|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105450407|NCT01147666|363658407|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105450408|NCT01147666|363658408|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105450409|NCT01147666|363658409|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105450410|NCT01147666|363658410|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105450411|NCT01147666|363658411|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105450412|NCT01147666|363658412|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
105450413|NCT01147666|363658413|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
105450414|NCT01147666|363658414|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105450415|NCT01147666|363658415|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
105450416|NCT01147666|363658401|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
105450417|NCT01147666|363658402|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
105450418|NCT01147666|363658403|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
105450419|NCT01147666|363658404|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
105450420|NCT01147666|363658405|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
105450421|NCT01147666|363658406|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
105450422|NCT01147666|363658407|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
105450423|NCT01147666|363658408|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
105450424|NCT01147666|363658409|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
105450425|NCT01147666|363658410|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
105450426|NCT01147666|363658411|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
105450427|NCT01147666|363658412|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
105450428|NCT01147666|363658413|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
105450429|NCT01147666|363658414|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
105450430|NCT01147666|363658415|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
105450431|NCT01147666|363658401|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105450432|NCT01147666|363658402|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105450433|NCT01147666|363658403|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105450434|NCT01147666|363658404|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105450435|NCT01147666|363658405|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
105450436|NCT01147666|363658406|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
105450437|NCT01147666|363658407|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
105450438|NCT01147666|363658408|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
105450439|NCT01147666|363658409|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105450440|NCT01147666|363658410|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
105450441|NCT01147666|363658411|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105450442|NCT01147666|363658412|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105450443|NCT01147666|363658413|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
105450444|NCT01147666|363658414|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105450445|NCT01147666|363658415|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
105450446|NCT01147666|363658401|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105450447|NCT01147666|363658402|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105450448|NCT01147666|363658403|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105450449|NCT01147666|363658404|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
105450450|NCT01147666|363658405|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105450451|NCT01147666|363658406|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105450452|NCT01147666|363658407|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105450453|NCT01147666|363658408|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105450454|NCT01147666|363658409|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105450455|NCT01147666|363658410|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105450456|NCT01147666|363658411|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105450457|NCT01147666|363658412|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105550194|NCT00467870|364014375|FG001|Overall Study|Protocol Violation|1|||
105782579|NCT03726320|364857925|FG001|Overall Study|Clinic / insurance issue|0|||
105782580|NCT03726320|364857926|FG002|Overall Study|Clinic / insurance issue|0|||
105782581|NCT03726320|364857924|FG000|Overall Study|Language barrier|1|||
105782582|NCT03726320|364857925|FG001|Overall Study|Language barrier|0|||
105782583|NCT03726320|364857926|FG002|Overall Study|Language barrier|0|||
105782584|NCT03726320|364857924|FG000|Overall Study|Provider left the clinic|0|||
105782585|NCT03726320|364857925|FG001|Overall Study|Provider left the clinic|0|||
105782586|NCT03726320|364857926|FG002|Overall Study|Provider left the clinic|1|||
105782587|NCT03691831|364857932|FG000|Overall Study|Lost to Follow-up|16|||
105782588|NCT03691831|364857933|FG001|Overall Study|Lost to Follow-up|12|||
105782589|NCT03691831|364857932|FG000|Overall Study|Withdrawal by Subject|9|||
105782590|NCT03691831|364857933|FG001|Overall Study|Withdrawal by Subject|17|||
105782591|NCT03691831|364857932|FG000|Overall Study|Investigator Decision|2|||
105782592|NCT03691831|364857933|FG001|Overall Study|Investigator Decision|2|||
105782593|NCT01684930|364857934|FG000|Overall Study|Withdrawal by Subject|3|||
105782594|NCT01684930|364857935|FG001|Overall Study|Withdrawal by Subject|1|||
105782595|NCT00690612|364857936|FG000|Overall Study|Adverse Event|1|||
105782596|NCT00690612|364857936|FG000|Overall Study|Withdrawal by Subject|2|||
105782597|NCT02926833|364857937|FG000|Overall Study|Death|1|||
105782598|NCT02926833|364857938|FG001|Overall Study|Death|1|||
105782599|NCT02926833|364857939|FG002|Overall Study|Death|2|||
105782600|NCT02926833|364857940|FG003|Overall Study|Death|13|||
105782601|NCT02926833|364857937|FG000|Overall Study|Lost to Follow-up|1|||
105782602|NCT02926833|364857938|FG001|Overall Study|Lost to Follow-up|2|||
105782603|NCT02926833|364857939|FG002|Overall Study|Lost to Follow-up|0|||
105782604|NCT02926833|364857940|FG003|Overall Study|Lost to Follow-up|3|||
105782605|NCT02926833|364857937|FG000|Overall Study|Full Consent Withdrawal|0|||
105782606|NCT02926833|364857938|FG001|Overall Study|Full Consent Withdrawal|0|||
105782607|NCT02926833|364857939|FG002|Overall Study|Full Consent Withdrawal|0|||
105450458|NCT01147666|363658413|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105450459|NCT01147666|363658414|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105450460|NCT01147666|363658415|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105450461|NCT01147666|363658401|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105450462|NCT01147666|363658402|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105450463|NCT01147666|363658403|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105450464|NCT01147666|363658404|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105782608|NCT02926833|364857940|FG003|Overall Study|Full Consent Withdrawal|2|||
105450465|NCT01147666|363658405|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
105450466|NCT01147666|363658406|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
105450467|NCT01147666|363658407|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105450468|NCT01147666|363658408|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
105450469|NCT01147666|363658409|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105450470|NCT01147666|363658410|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
105450471|NCT01147666|363658411|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105450472|NCT01147666|363658412|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105450473|NCT01147666|363658413|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105450474|NCT01147666|363658414|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
105450475|NCT01147666|363658415|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105450476|NCT01147666|363658401|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105450477|NCT01147666|363658402|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105450478|NCT01147666|363658403|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105450479|NCT01147666|363658404|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
105450480|NCT01147666|363658405|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105450481|NCT01147666|363658406|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105450482|NCT01147666|363658407|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105450483|NCT01147666|363658408|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105450484|NCT01147666|363658409|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105450485|NCT01147666|363658410|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105782609|NCT02926833|364857937|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
105782610|NCT02926833|364857938|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
105782611|NCT02926833|364857939|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
105782612|NCT02926833|364857940|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
105782613|NCT02926833|364857937|FG000|Overall Study|Investigator Decision|0|||
105450486|NCT01147666|363658411|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
105450487|NCT01147666|363658412|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105450488|NCT01147666|363658413|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105550195|NCT00467870|364014376|FG002|Overall Study|Protocol Violation|1|||
105782614|NCT02926833|364857938|FG001|Overall Study|Investigator Decision|1|||
105782615|NCT02926833|364857939|FG002|Overall Study|Investigator Decision|0|||
105782616|NCT02926833|364857940|FG003|Overall Study|Investigator Decision|0|||
105782617|NCT02926833|364857937|FG000|Overall Study|Adverse Event|0|||
105782618|NCT02926833|364857938|FG001|Overall Study|Adverse Event|0|||
105450489|NCT01147666|363658414|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105450490|NCT01147666|363658415|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105450491|NCT01147666|363658401|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105450492|NCT01147666|363658402|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105450493|NCT01147666|363658403|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105450494|NCT01147666|363658404|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105450495|NCT01147666|363658405|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105450496|NCT01147666|363658406|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105450497|NCT01147666|363658407|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105450498|NCT01147666|363658408|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105450499|NCT01147666|363658409|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105450500|NCT01147666|363658410|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105450501|NCT01147666|363658411|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105450502|NCT01147666|363658412|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105450503|NCT01147666|363658413|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
105450504|NCT01147666|363658414|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105450505|NCT01147666|363658415|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105450506|NCT01147666|363658401|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105450507|NCT01147666|363658402|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105450508|NCT01147666|363658403|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105450509|NCT01147666|363658404|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105450510|NCT01147666|363658405|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105450511|NCT01147666|363658406|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105450512|NCT01147666|363658407|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105450513|NCT01147666|363658408|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105450514|NCT01147666|363658409|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105450515|NCT01147666|363658410|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105450516|NCT01147666|363658411|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105450517|NCT01147666|363658412|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105450518|NCT01147666|363658413|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
105450519|NCT01147666|363658414|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105450520|NCT01147666|363658415|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
105450521|NCT02748863|363658416|FG000|Treatment Period 1|Adverse Event|0|||
105450522|NCT02748863|363658417|FG001|Treatment Period 1|Adverse Event|1|||
105450523|NCT02748863|363658418|FG002|Treatment Period 1|Adverse Event|0|||
105450524|NCT02748863|363658419|FG003|Treatment Period 1|Adverse Event|0|||
105450525|NCT02748863|363658420|FG004|Treatment Period 1|Adverse Event|0|||
105450526|NCT02748863|363658416|FG000|Treatment Period 1|Lack of Efficacy|0|||
105450527|NCT02748863|363658417|FG001|Treatment Period 1|Lack of Efficacy|0|||
105450528|NCT02748863|363658418|FG002|Treatment Period 1|Lack of Efficacy|1|||
105450529|NCT02748863|363658419|FG003|Treatment Period 1|Lack of Efficacy|0|||
105450530|NCT02748863|363658420|FG004|Treatment Period 1|Lack of Efficacy|0|||
105450531|NCT02748863|363658416|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105450532|NCT02748863|363658417|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105450533|NCT02748863|363658418|FG002|Treatment Period 1|Withdrawal by Subject|1|||
105450534|NCT02748863|363658419|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105450535|NCT02748863|363658420|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105450536|NCT02748863|363658416|FG000|Treatment Period 2|Lost to Follow-up|2|||
105450537|NCT02748863|363658417|FG001|Treatment Period 2|Lost to Follow-up|0|||
105450538|NCT02748863|363658418|FG002|Treatment Period 2|Lost to Follow-up|0|||
105450539|NCT02748863|363658419|FG003|Treatment Period 2|Lost to Follow-up|0|||
105450540|NCT02748863|363658420|FG004|Treatment Period 2|Lost to Follow-up|0|||
105450541|NCT02748863|363658416|FG000|Treatment Period 2|Adverse Event|3|||
105450542|NCT02748863|363658417|FG001|Treatment Period 2|Adverse Event|2|||
105450543|NCT02748863|363658418|FG002|Treatment Period 2|Adverse Event|0|||
105450544|NCT02748863|363658419|FG003|Treatment Period 2|Adverse Event|2|||
105450545|NCT02748863|363658420|FG004|Treatment Period 2|Adverse Event|0|||
105450546|NCT02748863|363658416|FG000|Treatment Period 2|Lack of Efficacy|0|||
105450547|NCT02748863|363658417|FG001|Treatment Period 2|Lack of Efficacy|1|||
105450548|NCT02748863|363658418|FG002|Treatment Period 2|Lack of Efficacy|0|||
105450549|NCT02748863|363658419|FG003|Treatment Period 2|Lack of Efficacy|0|||
105450550|NCT02748863|363658420|FG004|Treatment Period 2|Lack of Efficacy|0|||
105450551|NCT02748863|363658416|FG000|Treatment Period 2|Pregnancy|0|||
105450552|NCT02748863|363658417|FG001|Treatment Period 2|Pregnancy|0|||
105450553|NCT02748863|363658418|FG002|Treatment Period 2|Pregnancy|0|||
105450554|NCT02748863|363658419|FG003|Treatment Period 2|Pregnancy|0|||
105450555|NCT02748863|363658420|FG004|Treatment Period 2|Pregnancy|1|||
105450556|NCT02653326|363658421|FG000|Overall Study|Lost to Follow-up|10|||
105450557|NCT02653326|363658422|FG001|Overall Study|Lost to Follow-up|7|||
105450558|NCT00300755|363658424|FG000|Overall Study|Adverse Event|1|||
105450559|NCT00300755|363658425|FG001|Overall Study|Adverse Event|2|||
105450560|NCT00300755|363658426|FG002|Overall Study|Adverse Event|1|||
105450561|NCT00300755|363658424|FG000|Overall Study|Withdrawal by Subject|0|||
105450562|NCT00300755|363658425|FG001|Overall Study|Withdrawal by Subject|2|||
105450563|NCT00300755|363658426|FG002|Overall Study|Withdrawal by Subject|0|||
105450564|NCT00300755|363658424|FG000|Overall Study|Protocol Violation|0|||
105450565|NCT00300755|363658425|FG001|Overall Study|Protocol Violation|0|||
105450566|NCT00300755|363658426|FG002|Overall Study|Protocol Violation|1|||
105450567|NCT03275740|363658429|FG000|Overall Study|Adverse Event|0|||
105450568|NCT03275740|363658430|FG001|Overall Study|Adverse Event|0|||
105450569|NCT03275740|363658431|FG002|Overall Study|Adverse Event|0|||
105450570|NCT03275740|363658432|FG003|Overall Study|Adverse Event|0|||
105450571|NCT03275740|363658433|FG004|Overall Study|Adverse Event|1|||
105450572|NCT03275740|363658434|FG005|Overall Study|Adverse Event|0|||
105450573|NCT03275740|363658435|FG006|Overall Study|Adverse Event|0|||
105450574|NCT03275740|363658436|FG007|Overall Study|Adverse Event|0|||
105450575|NCT03275740|363658437|FG008|Overall Study|Adverse Event|0|||
105450576|NCT03275740|363658438|FG009|Overall Study|Adverse Event|0|||
105450577|NCT03275740|363658439|FG010|Overall Study|Adverse Event|0|||
105450578|NCT03275740|363658440|FG011|Overall Study|Adverse Event|0|||
105450579|NCT03275740|363658429|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
105450580|NCT03275740|363658430|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
105450581|NCT03275740|363658431|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
105450582|NCT03275740|363658432|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
105450583|NCT03275740|363658433|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
105450584|NCT03275740|363658434|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
105450585|NCT03275740|363658435|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
105782619|NCT02926833|364857939|FG002|Overall Study|Adverse Event|1|||
105782620|NCT02926833|364857940|FG003|Overall Study|Adverse Event|0|||
105782621|NCT02926833|364857937|FG000|Overall Study|Partial Withdrawal of Consent|0|||
105782622|NCT02926833|364857938|FG001|Overall Study|Partial Withdrawal of Consent|0|||
105782623|NCT02926833|364857939|FG002|Overall Study|Partial Withdrawal of Consent|0|||
105450586|NCT03275740|363658436|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
105450587|NCT03275740|363658437|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
105450588|NCT03275740|363658438|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
105782624|NCT02926833|364857940|FG003|Overall Study|Partial Withdrawal of Consent|1|||
105782625|NCT01189201|364857948|FG000|Overall Study|Adverse Event|1|||
105782626|NCT01277757|364857949|FG000|Overall Study|Disease Progression|1|||
105782627|NCT01277757|364857949|FG000|Overall Study|Withdrawal by Subject|1|||
105782628|NCT01266967|364857952|FG000|Overall Study|Death|69|||
105782629|NCT01266967|364857953|FG001|Overall Study|Death|61|||
105782630|NCT01266967|364857952|FG000|Overall Study|Study Closed/Terminated|15|||
105782631|NCT01266967|364857953|FG001|Overall Study|Study Closed/Terminated|17|||
105782632|NCT01266967|364857952|FG000|Overall Study|Lost to Follow-up|2|||
105782633|NCT01266967|364857953|FG001|Overall Study|Lost to Follow-up|1|||
105782634|NCT01266967|364857952|FG000|Overall Study|Physician Decision|0|||
105782635|NCT01266967|364857953|FG001|Overall Study|Physician Decision|1|||
105782636|NCT01266967|364857952|FG000|Overall Study|Withdrawal by Subject|3|||
105782637|NCT01266967|364857953|FG001|Overall Study|Withdrawal by Subject|3|||
105782638|NCT01945866|364857954|FG000|Overall Study|Eyes did not complete or were dropped|2|||
105782639|NCT01945866|364857955|FG001|Overall Study|Eyes did not complete or were dropped|0|||
105782640|NCT03799198|364857957|FG000|Overall Study|Lost to Follow-up|4|||
105782641|NCT03799198|364857958|FG001|Overall Study|Lost to Follow-up|8|||
105782642|NCT03799198|364857957|FG000|Overall Study|Death|0|||
105782643|NCT03799198|364857958|FG001|Overall Study|Death|1|||
105782644|NCT00960869|364857959|FG000|Overall Study|Adverse Event|17|||
105782645|NCT00960869|364857960|FG001|Overall Study|Adverse Event|26|||
105782646|NCT00960869|364857959|FG000|Overall Study|Withdrawal by Subject|16|||
105782647|NCT00960869|364857960|FG001|Overall Study|Withdrawal by Subject|14|||
105782648|NCT00960869|364857959|FG000|Overall Study|Lost to Follow-up|1|||
105782649|NCT00960869|364857960|FG001|Overall Study|Lost to Follow-up|4|||
105782650|NCT00960869|364857959|FG000|Overall Study|Misc|19|||
105782651|NCT00960869|364857960|FG001|Overall Study|Misc|18|||
105782652|NCT02501642|364857961|FG000|Overall Study|Lost to Follow-up|7|||
105782653|NCT02501642|364857962|FG001|Overall Study|Lost to Follow-up|11|||
105782654|NCT00548340|364857965|FG000|Overall Study|Protocol Violation|2|||
105782655|NCT00548340|364857966|FG001|Overall Study|Protocol Violation|3|||
105782656|NCT00548340|364857967|FG002|Overall Study|Protocol Violation|3|||
105782657|NCT00548340|364857965|FG000|Overall Study|Adverse Event|2|||
105782658|NCT00548340|364857966|FG001|Overall Study|Adverse Event|2|||
105782659|NCT00548340|364857967|FG002|Overall Study|Adverse Event|2|||
105782660|NCT00548340|364857965|FG000|Overall Study|Lost to Follow-up|1|||
105782661|NCT00548340|364857966|FG001|Overall Study|Lost to Follow-up|1|||
105450589|NCT03275740|363658439|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
105782662|NCT00548340|364857967|FG002|Overall Study|Lost to Follow-up|0|||
105782663|NCT00548340|364857965|FG000|Overall Study|Withdrawal by Subject|2|||
105782664|NCT00548340|364857966|FG001|Overall Study|Withdrawal by Subject|4|||
105782665|NCT00548340|364857967|FG002|Overall Study|Withdrawal by Subject|3|||
105336481|NCT04791319|363233007|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
105336482|NCT04791319|363233008|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
105336483|NCT04791319|363232998|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
105336484|NCT04791319|363232999|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
105336485|NCT04791319|363233000|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
105336486|NCT04791319|363233001|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
105336487|NCT04791319|363233002|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
105336488|NCT04791319|363233003|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
105336489|NCT04791319|363233004|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
105336490|NCT04791319|363233005|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
105336491|NCT04791319|363233006|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
105336492|NCT04791319|363233007|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
105336493|NCT04791319|363233008|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
105336494|NCT04791319|363232998|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105336495|NCT04791319|363232999|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105336496|NCT04791319|363233000|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105336497|NCT04791319|363233001|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
105336498|NCT04791319|363233002|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105336499|NCT04791319|363233003|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105336500|NCT04791319|363233004|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105336501|NCT04791319|363233005|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105336502|NCT04791319|363233006|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105336503|NCT04791319|363233007|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105336504|NCT04791319|363233008|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105336505|NCT04791319|363232998|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
105336506|NCT04791319|363232999|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
105336507|NCT04791319|363233000|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
105336508|NCT04791319|363233001|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
105336509|NCT04791319|363233002|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
105336510|NCT04791319|363233003|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
105336511|NCT04791319|363233004|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
105336512|NCT04791319|363233005|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
105336513|NCT04791319|363233006|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
105336514|NCT04791319|363233007|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
105336515|NCT04791319|363233008|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
105336516|NCT04791319|363232998|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105336517|NCT04791319|363232999|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105336518|NCT04791319|363233000|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105336519|NCT04791319|363233001|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105336520|NCT04791319|363233002|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105336521|NCT04791319|363233003|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105336522|NCT04791319|363233004|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105336523|NCT04791319|363233005|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105336524|NCT04791319|363233006|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105336525|NCT04791319|363233007|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
105336526|NCT04791319|363233008|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105336527|NCT04791319|363232998|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
105782666|NCT00548340|364857965|FG000|Overall Study|Other|1|||
105336528|NCT04791319|363232999|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
105360841|NCT00572455|363328080|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
105360842|NCT00572455|363328081|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
105360843|NCT00572455|363328082|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
105360844|NCT00572455|363328083|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
105360845|NCT00572455|363328084|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
105360846|NCT00572455|363328085|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
105360847|NCT00572455|363328086|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
105360848|NCT00572455|363328087|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
105360849|NCT00572455|363328088|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
105360850|NCT00572455|363328089|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
105360851|NCT00572455|363328090|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
105360852|NCT00572455|363328091|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
105360853|NCT00572455|363328092|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
105360854|NCT00572455|363328093|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
105450590|NCT03275740|363658440|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
105450591|NCT03275740|363658429|FG000|Overall Study|Withdrawal by Subject|0|||
105450592|NCT03275740|363658430|FG001|Overall Study|Withdrawal by Subject|0|||
105450593|NCT03275740|363658431|FG002|Overall Study|Withdrawal by Subject|0|||
105450594|NCT03275740|363658432|FG003|Overall Study|Withdrawal by Subject|0|||
105450595|NCT03275740|363658433|FG004|Overall Study|Withdrawal by Subject|0|||
105450596|NCT03275740|363658434|FG005|Overall Study|Withdrawal by Subject|0|||
105450597|NCT03275740|363658435|FG006|Overall Study|Withdrawal by Subject|0|||
105450598|NCT03275740|363658436|FG007|Overall Study|Withdrawal by Subject|0|||
105450599|NCT03275740|363658437|FG008|Overall Study|Withdrawal by Subject|1|||
105336529|NCT04791319|363233000|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
105336530|NCT04791319|363233001|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
105336531|NCT04791319|363233002|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
105336532|NCT04791319|363233003|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
105336533|NCT04791319|363233004|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
105336534|NCT04791319|363233005|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
105336535|NCT04791319|363233006|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
105336536|NCT04791319|363233007|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
105336537|NCT04791319|363233008|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
105336538|NCT04791319|363232998|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
105336539|NCT04791319|363232999|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
105336540|NCT04791319|363233000|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
105336541|NCT04791319|363233001|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
105336542|NCT04791319|363233002|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
105336543|NCT04791319|363233003|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
105336544|NCT04791319|363233004|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
105336545|NCT04791319|363233005|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
105336546|NCT04791319|363233006|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
105336547|NCT04791319|363233007|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
105336548|NCT04791319|363233008|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
105336549|NCT01704651|363233011|FG000|Overall Study|Pre-op withdrawal by subject|1|||
105336550|NCT01704651|363233012|FG001|Overall Study|Pre-op withdrawal by subject|1|||
105336551|NCT01704651|363233011|FG000|Overall Study|Pre-op change in treatment plan|1|||
105336552|NCT01704651|363233012|FG001|Overall Study|Pre-op change in treatment plan|4|||
105336553|NCT01704651|363233011|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
105336554|NCT01704651|363233012|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
105336555|NCT01704651|363233011|FG000|Overall Study|Post-op did not have laparotomy|2|||
105336556|NCT01704651|363233012|FG001|Overall Study|Post-op did not have laparotomy|1|||
105336557|NCT03557931|363233019|FG000|Overall Study|Adverse Event|4|||
105336558|NCT03557931|363233020|FG001|Overall Study|Adverse Event|6|||
105336559|NCT03557931|363233021|FG002|Overall Study|Adverse Event|1|||
105336560|NCT03557931|363233019|FG000|Overall Study|Lost to Follow-up|4|||
105336561|NCT03557931|363233020|FG001|Overall Study|Lost to Follow-up|4|||
105336562|NCT03557931|363233021|FG002|Overall Study|Lost to Follow-up|1|||
105336563|NCT03557931|363233019|FG000|Overall Study|Protocol Violation|1|||
105336564|NCT03557931|363233020|FG001|Overall Study|Protocol Violation|4|||
105336565|NCT03557931|363233021|FG002|Overall Study|Protocol Violation|1|||
105336566|NCT03557931|363233019|FG000|Overall Study|Withdrawal by Subject|14|||
105336567|NCT03557931|363233020|FG001|Overall Study|Withdrawal by Subject|0|||
105336568|NCT03557931|363233021|FG002|Overall Study|Withdrawal by Subject|7|||
105450600|NCT03275740|363658438|FG009|Overall Study|Withdrawal by Subject|1|||
105450601|NCT03275740|363658439|FG010|Overall Study|Withdrawal by Subject|0|||
105450602|NCT03275740|363658440|FG011|Overall Study|Withdrawal by Subject|0|||
105450603|NCT00985465|363658441|FG000|Overall Study|Withdrawal by Subject|1|||
105450604|NCT00985465|363658442|FG001|Overall Study|Withdrawal by Subject|2|||
105450605|NCT00985465|363658441|FG000|Overall Study|Considered to be part of the other group|0|||
105450606|NCT00985465|363658442|FG001|Overall Study|Considered to be part of the other group|1|||
105450607|NCT02336607|363658443|FG000|Overall Study|Physician Decision|1|||
105450608|NCT02336607|363658444|FG001|Overall Study|Physician Decision|4|||
105450609|NCT02336607|363658445|FG002|Overall Study|Physician Decision|3|||
105336569|NCT03557931|363233019|FG000|Overall Study|Miscellaneous|8|||
105336570|NCT03557931|363233020|FG001|Overall Study|Miscellaneous|5|||
105336571|NCT03557931|363233021|FG002|Overall Study|Miscellaneous|3|||
105450610|NCT02336607|363658446|FG003|Overall Study|Physician Decision|15|||
105450611|NCT02336607|363658443|FG000|Overall Study|Lack of Efficacy|1|||
105450612|NCT02336607|363658444|FG001|Overall Study|Lack of Efficacy|0|||
105450613|NCT02336607|363658445|FG002|Overall Study|Lack of Efficacy|0|||
105450614|NCT02336607|363658446|FG003|Overall Study|Lack of Efficacy|2|||
105782667|NCT00548340|364857966|FG001|Overall Study|Other|1|||
105782668|NCT00548340|364857967|FG002|Overall Study|Other|1|||
105782669|NCT02600559|364857970|FG000|Overall Study|Withdrawal by Subject|3|||
105782670|NCT02600559|364857970|FG000|Overall Study|Lost to Follow-up|20|||
105782671|NCT01153971|364857971|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
105782672|NCT01153971|364857971|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
105782673|NCT01153971|364857971|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
105782674|NCT01153971|364857971|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
105782675|NCT01153971|364857971|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
105782676|NCT01153971|364857971|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
105782677|NCT01153971|364857971|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
105782678|NCT00953576|364857972|FG000|Overall Study|Adverse Event|0|||
105782679|NCT00953576|364857973|FG001|Overall Study|Adverse Event|1|||
105782680|NCT00953576|364857972|FG000|Overall Study|Ineligible after Consent|2|||
105782681|NCT00953576|364857973|FG001|Overall Study|Ineligible after Consent|0|||
105782682|NCT00594958|364857974|FG000|Overall Study|Withdrawal by Subject|1|||
105782683|NCT00594958|364857975|FG001|Overall Study|Withdrawal by Subject|0|||
105782684|NCT00594958|364857976|FG002|Overall Study|Withdrawal by Subject|1|||
105782685|NCT00594958|364857974|FG000|Overall Study|Adverse Event|4|||
105782686|NCT00594958|364857975|FG001|Overall Study|Adverse Event|1|||
105782687|NCT00594958|364857976|FG002|Overall Study|Adverse Event|2|||
105782688|NCT00594958|364857974|FG000|Overall Study|Pregnancy|0|||
105782689|NCT00594958|364857975|FG001|Overall Study|Pregnancy|2|||
105782690|NCT00594958|364857976|FG002|Overall Study|Pregnancy|0|||
105782691|NCT00594958|364857974|FG000|Overall Study|Protocol Violation|1|||
105782692|NCT00594958|364857975|FG001|Overall Study|Protocol Violation|0|||
105782693|NCT00594958|364857976|FG002|Overall Study|Protocol Violation|2|||
105782694|NCT00594958|364857974|FG000|Overall Study|Lost to Follow-up|5|||
105782695|NCT00594958|364857975|FG001|Overall Study|Lost to Follow-up|0|||
105782696|NCT00594958|364857976|FG002|Overall Study|Lost to Follow-up|3|||
105782697|NCT00594958|364857974|FG000|Overall Study|administrative|3|||
105782698|NCT00594958|364857975|FG001|Overall Study|administrative|0|||
105782699|NCT00594958|364857976|FG002|Overall Study|administrative|2|||
105782700|NCT02087085|364857978|FG000|Overall Study|Adverse Event|10|||
105782701|NCT02087085|364857979|FG001|Overall Study|Adverse Event|14|||
105782702|NCT02087085|364857978|FG000|Overall Study|Lack of Efficacy|4|||
105782703|NCT02087085|364857979|FG001|Overall Study|Lack of Efficacy|3|||
105782704|NCT02087085|364857978|FG000|Overall Study|Lost to Follow-up|6|||
105782705|NCT02087085|364857979|FG001|Overall Study|Lost to Follow-up|4|||
105782706|NCT02087085|364857978|FG000|Overall Study|Withdrawal by Subject|9|||
105782707|NCT02087085|364857979|FG001|Overall Study|Withdrawal by Subject|11|||
105782708|NCT02087085|364857978|FG000|Overall Study|Protocol Violation|1|||
105782709|NCT02087085|364857979|FG001|Overall Study|Protocol Violation|0|||
105782710|NCT02087085|364857978|FG000|Overall Study|Study Terminated by Sponsor|87|||
105782711|NCT02087085|364857979|FG001|Overall Study|Study Terminated by Sponsor|80|||
105782712|NCT02087085|364857978|FG000|Overall Study|Other Miscellaneous Reasons|3|||
105782713|NCT02087085|364857979|FG001|Overall Study|Other Miscellaneous Reasons|4|||
105782714|NCT01191190|364857980|FG000|Overall Study|Withdrawal by Subject|1|||
105782715|NCT01982942|364857981|FG000|Overall Study|Adverse Event|10|||
105782716|NCT01982942|364857982|FG001|Overall Study|Adverse Event|5|||
105782717|NCT01982942|364857981|FG000|Overall Study|Lost to Follow-up|4|||
105782718|NCT01982942|364857982|FG001|Overall Study|Lost to Follow-up|3|||
105782719|NCT01982942|364857981|FG000|Overall Study|Multiple sclerosis progression|3|||
105782720|NCT01982942|364857982|FG001|Overall Study|Multiple sclerosis progression|2|||
105782721|NCT01982942|364857981|FG000|Overall Study|Wanted to try therapy not permitted|1|||
105782722|NCT01982942|364857982|FG001|Overall Study|Wanted to try therapy not permitted|0|||
105450615|NCT02336607|363658443|FG000|Overall Study|Lost to Follow-up|2|||
105450616|NCT02336607|363658444|FG001|Overall Study|Lost to Follow-up|1|||
105450617|NCT02336607|363658445|FG002|Overall Study|Lost to Follow-up|0|||
105450618|NCT02336607|363658446|FG003|Overall Study|Lost to Follow-up|21|||
105450619|NCT02336607|363658443|FG000|Overall Study|Protocol Violation|0|||
105450620|NCT02336607|363658444|FG001|Overall Study|Protocol Violation|1|||
105450621|NCT02336607|363658445|FG002|Overall Study|Protocol Violation|1|||
105450622|NCT02336607|363658446|FG003|Overall Study|Protocol Violation|3|||
105450623|NCT02336607|363658443|FG000|Overall Study|Adverse Event|0|||
105782723|NCT01982942|364857981|FG000|Overall Study|Subject declined future visits|0|||
105782724|NCT01982942|364857982|FG001|Overall Study|Subject declined future visits|1|||
105782725|NCT01982942|364857981|FG000|Overall Study|Left geographical area|2|||
105782726|NCT01982942|364857982|FG001|Overall Study|Left geographical area|0|||
105782727|NCT01982942|364857981|FG000|Overall Study|Too many pills|1|||
105782728|NCT01982942|364857982|FG001|Overall Study|Too many pills|0|||
105782729|NCT01982942|364857981|FG000|Overall Study|MS Relapse|0|||
105782730|NCT01982942|364857982|FG001|Overall Study|MS Relapse|1|||
105450624|NCT02336607|363658444|FG001|Overall Study|Adverse Event|2|||
105782731|NCT01982942|364857981|FG000|Overall Study|Chose to join a stem cell trial|0|||
105782732|NCT01982942|364857982|FG001|Overall Study|Chose to join a stem cell trial|1|||
105782733|NCT01982942|364857981|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
105336572|NCT00256854|363233024|FG000|Overall Study|Withdrawal by Subject|2|||
105336573|NCT00256854|363233025|FG001|Overall Study|Withdrawal by Subject|3|||
105336574|NCT00256854|363233026|FG002|Overall Study|Withdrawal by Subject|0|||
105336575|NCT00256854|363233027|FG003|Overall Study|Withdrawal by Subject|0|||
105336576|NCT00256854|363233028|FG004|Overall Study|Withdrawal by Subject|0|||
105336577|NCT00256854|363233029|FG005|Overall Study|Withdrawal by Subject|0|||
105336578|NCT00256854|363233024|FG000|Overall Study|Lack of Efficacy|1|||
105336579|NCT00256854|363233025|FG001|Overall Study|Lack of Efficacy|0|||
105336580|NCT00256854|363233026|FG002|Overall Study|Lack of Efficacy|0|||
105336581|NCT00256854|363233027|FG003|Overall Study|Lack of Efficacy|0|||
105336582|NCT00256854|363233028|FG004|Overall Study|Lack of Efficacy|0|||
105336583|NCT00256854|363233029|FG005|Overall Study|Lack of Efficacy|0|||
105336584|NCT00256854|363233024|FG000|Overall Study|Protocol Violation|0|||
105336585|NCT00256854|363233025|FG001|Overall Study|Protocol Violation|1|||
105336586|NCT00256854|363233026|FG002|Overall Study|Protocol Violation|1|||
105336587|NCT00256854|363233027|FG003|Overall Study|Protocol Violation|1|||
105336588|NCT00256854|363233028|FG004|Overall Study|Protocol Violation|0|||
105336589|NCT00256854|363233029|FG005|Overall Study|Protocol Violation|0|||
105336590|NCT00256854|363233024|FG000|Overall Study|Adverse Event|0|||
105336591|NCT00256854|363233025|FG001|Overall Study|Adverse Event|0|||
105336592|NCT00256854|363233026|FG002|Overall Study|Adverse Event|2|||
105336593|NCT00256854|363233027|FG003|Overall Study|Adverse Event|2|||
105336594|NCT00256854|363233028|FG004|Overall Study|Adverse Event|0|||
105336595|NCT00256854|363233029|FG005|Overall Study|Adverse Event|1|||
105336596|NCT00256854|363233024|FG000|Overall Study|Not compliant with the study drug|0|||
105336597|NCT00256854|363233025|FG001|Overall Study|Not compliant with the study drug|0|||
105336598|NCT00256854|363233026|FG002|Overall Study|Not compliant with the study drug|0|||
105336599|NCT00256854|363233027|FG003|Overall Study|Not compliant with the study drug|0|||
105336600|NCT00256854|363233028|FG004|Overall Study|Not compliant with the study drug|1|||
105336601|NCT00256854|363233029|FG005|Overall Study|Not compliant with the study drug|0|||
105336602|NCT02353442|363233030|FG000|Overall Study|Withdrawal by Subject|3|||
105336603|NCT02353442|363233031|FG001|Overall Study|Withdrawal by Subject|4|||
105336604|NCT02691936|363233034|FG000|Overall Study|Withdrawal by Subject|2|||
105336605|NCT02691936|363233035|FG001|Overall Study|Withdrawal by Subject|5|||
105336606|NCT01876784|363233036|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
105336607|NCT01876784|363233037|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
105336608|NCT01876784|363233036|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
105336609|NCT01876784|363233037|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
105336610|NCT01876784|363233036|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
105336611|NCT01876784|363233037|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
105336612|NCT01876784|363233036|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
105336613|NCT01876784|363233037|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
105336614|NCT01876784|363233036|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
105336615|NCT01876784|363233037|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
105336616|NCT01876784|363233036|FG000|Randomized Treatment Period (40 Months)|Death|1|||
105336617|NCT01876784|363233037|FG001|Randomized Treatment Period (40 Months)|Death|0|||
105336618|NCT01876784|363233036|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
105336619|NCT01876784|363233037|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
105336620|NCT01876784|363233036|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
105450625|NCT02336607|363658445|FG002|Overall Study|Adverse Event|2|||
105450626|NCT02336607|363658446|FG003|Overall Study|Adverse Event|26|||
105450627|NCT02336607|363658443|FG000|Overall Study|Withdrawal by Subject|0|||
105450628|NCT02336607|363658444|FG001|Overall Study|Withdrawal by Subject|2|||
105450629|NCT02336607|363658445|FG002|Overall Study|Withdrawal by Subject|0|||
105450630|NCT02336607|363658446|FG003|Overall Study|Withdrawal by Subject|20|||
105450631|NCT00721396|363658447|FG000|Overall Study|Adverse Event|4|||
105450632|NCT00721396|363658448|FG001|Overall Study|Adverse Event|7|||
105450633|NCT00721396|363658449|FG002|Overall Study|Adverse Event|2|||
105450634|NCT00721396|363658450|FG003|Overall Study|Adverse Event|0|||
105450635|NCT00721396|363658447|FG000|Overall Study|Withdrawal by Subject|12|||
105450636|NCT00721396|363658448|FG001|Overall Study|Withdrawal by Subject|15|||
105450637|NCT00721396|363658449|FG002|Overall Study|Withdrawal by Subject|3|||
105450638|NCT00721396|363658450|FG003|Overall Study|Withdrawal by Subject|7|||
105450639|NCT00721396|363658447|FG000|Overall Study|Lost to Follow-up|7|||
105450640|NCT00721396|363658448|FG001|Overall Study|Lost to Follow-up|9|||
105450641|NCT00721396|363658449|FG002|Overall Study|Lost to Follow-up|3|||
105450642|NCT00721396|363658450|FG003|Overall Study|Lost to Follow-up|3|||
105450643|NCT00721396|363658447|FG000|Overall Study|Protocol Violation|4|||
105450644|NCT00721396|363658448|FG001|Overall Study|Protocol Violation|3|||
105336621|NCT01876784|363233037|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
105336622|NCT01876784|363233036|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
105336623|NCT01876784|363233037|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
105450645|NCT00721396|363658449|FG002|Overall Study|Protocol Violation|1|||
105450646|NCT00721396|363658450|FG003|Overall Study|Protocol Violation|0|||
105450647|NCT00721396|363658447|FG000|Overall Study|Inappropriate enrollment|0|||
105450648|NCT00721396|363658448|FG001|Overall Study|Inappropriate enrollment|2|||
105450649|NCT00721396|363658449|FG002|Overall Study|Inappropriate enrollment|0|||
105450650|NCT00721396|363658450|FG003|Overall Study|Inappropriate enrollment|0|||
105450651|NCT00721396|363658447|FG000|Overall Study|Administrative reason|3|||
105450652|NCT00721396|363658448|FG001|Overall Study|Administrative reason|0|||
105450653|NCT00721396|363658449|FG002|Overall Study|Administrative reason|1|||
105450654|NCT00721396|363658450|FG003|Overall Study|Administrative reason|0|||
105450655|NCT01695135|363658451|FG000|Double-blind Treatment Phase|Progressive disease|50|||
105450656|NCT01695135|363658452|FG001|Double-blind Treatment Phase|Progressive disease|110|||
105450657|NCT01695135|363658453|FG002|Double-blind Treatment Phase|Progressive disease|0|||
105450658|NCT01695135|363658454|FG003|Double-blind Treatment Phase|Progressive disease|0|||
105450659|NCT01695135|363658451|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
105450660|NCT01695135|363658452|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
105450661|NCT01695135|363658453|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105450662|NCT01695135|363658454|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105450663|NCT01695135|363658451|FG000|Double-blind Treatment Phase|Adverse Event|7|||
105450664|NCT01695135|363658452|FG001|Double-blind Treatment Phase|Adverse Event|7|||
105450665|NCT01695135|363658453|FG002|Double-blind Treatment Phase|Adverse Event|0|||
105450666|NCT01695135|363658454|FG003|Double-blind Treatment Phase|Adverse Event|0|||
105450667|NCT01695135|363658451|FG000|Double-blind Treatment Phase|Other|1|||
105450668|NCT01695135|363658452|FG001|Double-blind Treatment Phase|Other|3|||
105450669|NCT01695135|363658453|FG002|Double-blind Treatment Phase|Other|0|||
105450670|NCT01695135|363658454|FG003|Double-blind Treatment Phase|Other|0|||
105450671|NCT01695135|363658451|FG000|Double-blind Treatment Phase|Physician Decision|6|||
105450672|NCT01695135|363658452|FG001|Double-blind Treatment Phase|Physician Decision|3|||
105450673|NCT01695135|363658453|FG002|Double-blind Treatment Phase|Physician Decision|0|||
105450674|NCT01695135|363658454|FG003|Double-blind Treatment Phase|Physician Decision|0|||
105450675|NCT01695135|363658451|FG000|Double-blind Treatment Phase|Death|1|||
105450676|NCT01695135|363658452|FG001|Double-blind Treatment Phase|Death|1|||
105450677|NCT01695135|363658453|FG002|Double-blind Treatment Phase|Death|0|||
105450678|NCT01695135|363658454|FG003|Double-blind Treatment Phase|Death|0|||
105450679|NCT01695135|363658451|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
105450680|NCT01695135|363658452|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
105450681|NCT01695135|363658453|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
105450682|NCT01695135|363658454|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
105450683|NCT01695135|363658451|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
105450684|NCT01695135|363658452|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
105450685|NCT01695135|363658453|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
105450686|NCT01695135|363658454|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
105450687|NCT01695135|363658451|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
105450688|NCT01695135|363658452|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
105450689|NCT01695135|363658453|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
105450690|NCT01695135|363658454|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
105450691|NCT01695135|363658451|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
105450692|NCT01695135|363658452|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
105450693|NCT01695135|363658453|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
105450694|NCT01695135|363658454|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
105450695|NCT01695135|363658451|FG000|Open Label Extension Treatment Phase|Other|0|||
105450696|NCT01695135|363658452|FG001|Open Label Extension Treatment Phase|Other|0|||
105450697|NCT01695135|363658453|FG002|Open Label Extension Treatment Phase|Other|4|||
105450698|NCT01695135|363658454|FG003|Open Label Extension Treatment Phase|Other|7|||
105450699|NCT01695135|363658451|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
105450700|NCT01695135|363658452|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
105450701|NCT01695135|363658453|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
105450702|NCT01695135|363658454|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
105450703|NCT01695135|363658451|FG000|Open Label Extension Treatment Phase|Death|0|||
105450704|NCT01695135|363658452|FG001|Open Label Extension Treatment Phase|Death|0|||
105450705|NCT01695135|363658453|FG002|Open Label Extension Treatment Phase|Death|2|||
105450706|NCT01695135|363658454|FG003|Open Label Extension Treatment Phase|Death|7|||
105450707|NCT01695135|363658451|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
105450708|NCT01695135|363658452|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
105450709|NCT01695135|363658453|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
105450710|NCT01695135|363658454|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
105450711|NCT00148759|363658455|FG000|Overall Study|Withdrawal by Subject|1|||
105450712|NCT00148759|363658456|FG001|Overall Study|Withdrawal by Subject|1|||
105450713|NCT00148759|363658455|FG000|Overall Study|Lost to Follow-up|1|||
105450714|NCT00148759|363658456|FG001|Overall Study|Lost to Follow-up|0|||
105782734|NCT01982942|364857982|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
105782735|NCT00635804|364857983|FG000|Overall Study|Adverse Event|0|||
105782736|NCT00635804|364857984|FG001|Overall Study|Adverse Event|0|||
105782737|NCT00635804|364857985|FG002|Overall Study|Adverse Event|0|||
105450715|NCT02753946|363658457|FG000|Overall Study|Adverse Event|7|||
105450716|NCT02753946|363658458|FG001|Overall Study|Adverse Event|6|||
105450717|NCT02753946|363658457|FG000|Overall Study|Withdrawal by Subject|6|||
105450718|NCT02753946|363658458|FG001|Overall Study|Withdrawal by Subject|1|||
105782738|NCT00635804|364857986|FG003|Overall Study|Adverse Event|0|||
105782739|NCT00635804|364857987|FG004|Overall Study|Adverse Event|0|||
105782740|NCT00635804|364857988|FG005|Overall Study|Adverse Event|1|||
105782741|NCT00635804|364857989|FG006|Overall Study|Adverse Event|0|||
105782742|NCT00635804|364857990|FG007|Overall Study|Adverse Event|0|||
105782743|NCT00635804|364857983|FG000|Overall Study|Withdrawal by Subject|1|||
105782744|NCT00635804|364857984|FG001|Overall Study|Withdrawal by Subject|0|||
105782745|NCT00635804|364857985|FG002|Overall Study|Withdrawal by Subject|0|||
105782746|NCT00635804|364857986|FG003|Overall Study|Withdrawal by Subject|0|||
105782747|NCT00635804|364857987|FG004|Overall Study|Withdrawal by Subject|0|||
105782748|NCT00635804|364857988|FG005|Overall Study|Withdrawal by Subject|0|||
105782749|NCT00635804|364857989|FG006|Overall Study|Withdrawal by Subject|0|||
105782750|NCT00635804|364857990|FG007|Overall Study|Withdrawal by Subject|0|||
105782751|NCT02681094|364857997|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
105782752|NCT02681094|364857998|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
105782753|NCT02681094|364857999|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
105782754|NCT02681094|364857997|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
105782755|NCT02681094|364857998|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
105450719|NCT02753946|363658457|FG000|Overall Study|Lack of Efficacy|1|||
105450720|NCT02753946|363658458|FG001|Overall Study|Lack of Efficacy|0|||
105450721|NCT02753946|363658457|FG000|Overall Study|Physician Decision|0|||
105450722|NCT02753946|363658458|FG001|Overall Study|Physician Decision|2|||
105450723|NCT00430716|363658459|FG000|Double Blind Phase|Death|1|||
105450724|NCT00430716|363658460|FG001|Double Blind Phase|Death|0|||
105450725|NCT00430716|363658461|FG002|Double Blind Phase|Death|0|||
105450726|NCT00430716|363658459|FG000|Double Blind Phase|No longer willing to participate|2|||
105450727|NCT00430716|363658460|FG001|Double Blind Phase|No longer willing to participate|1|||
105450728|NCT00430716|363658461|FG002|Double Blind Phase|No longer willing to participate|1|||
105450729|NCT00430716|363658459|FG000|Double Blind Phase|Other|0|||
105450730|NCT00430716|363658460|FG001|Double Blind Phase|Other|2|||
105450731|NCT00430716|363658461|FG002|Double Blind Phase|Other|0|||
105450732|NCT00430716|363658459|FG000|Double Blind Phase|Study terminated by sponsor|1|||
105782756|NCT02681094|364857999|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
105782757|NCT02681094|364857997|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
105782758|NCT02681094|364857998|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
105782759|NCT02681094|364857999|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
105782760|NCT02681094|364857997|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
105782761|NCT02681094|364857998|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
105782762|NCT02681094|364857999|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
105782763|NCT02681094|364857997|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
105782764|NCT02681094|364857998|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
105782765|NCT02681094|364857999|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
105782766|NCT02681094|364857997|FG000|1 -Modified Enrolled Participants Set|Other|6|||
105782767|NCT02681094|364857998|FG001|1 -Modified Enrolled Participants Set|Other|6|||
105782768|NCT02681094|364857999|FG002|1 -Modified Enrolled Participants Set|Other|7|||
105782769|NCT02681094|364857997|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
105782770|NCT02681094|364857998|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
105782771|NCT02681094|364857999|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
105782772|NCT02681094|364857997|FG000|2 - Enrolled Participants Set|Participant decision|7|||
105782773|NCT02681094|364857998|FG001|2 - Enrolled Participants Set|Participant decision|10|||
105782774|NCT02681094|364857999|FG002|2 - Enrolled Participants Set|Participant decision|9|||
105782775|NCT02681094|364857997|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
105782776|NCT02681094|364857998|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
105782777|NCT02681094|364857999|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
105782778|NCT02681094|364857997|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
105782779|NCT02681094|364857998|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
105782780|NCT02681094|364857999|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
105782781|NCT02681094|364857997|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
105450733|NCT00430716|363658460|FG001|Double Blind Phase|Study terminated by sponsor|1|||
105450734|NCT00430716|363658461|FG002|Double Blind Phase|Study terminated by sponsor|2|||
105450735|NCT00430716|363658459|FG000|Double Blind Phase|Adverse Event|1|||
105450736|NCT00430716|363658460|FG001|Double Blind Phase|Adverse Event|1|||
105450737|NCT00430716|363658461|FG002|Double Blind Phase|Adverse Event|3|||
105450738|NCT00430716|363658459|FG000|Double Blind Phase|Not treated|1|||
105450739|NCT00430716|363658460|FG001|Double Blind Phase|Not treated|0|||
105450740|NCT00430716|363658461|FG002|Double Blind Phase|Not treated|0|||
105450741|NCT00430716|363658459|FG000|Open Label Phase|Lost to Follow-up|1|||
105450742|NCT00430716|363658460|FG001|Open Label Phase|Lost to Follow-up|0|||
105450743|NCT00430716|363658461|FG002|Open Label Phase|Lost to Follow-up|1|||
105450744|NCT00430716|363658459|FG000|Open Label Phase|No longer willing to participate|0|||
105450745|NCT00430716|363658460|FG001|Open Label Phase|No longer willing to participate|1|||
105450746|NCT00430716|363658461|FG002|Open Label Phase|No longer willing to participate|1|||
105450747|NCT00430716|363658459|FG000|Open Label Phase|Other|3|||
105450748|NCT00430716|363658460|FG001|Open Label Phase|Other|1|||
105450749|NCT00430716|363658461|FG002|Open Label Phase|Other|1|||
105450750|NCT00430716|363658459|FG000|Open Label Phase|Protocol Violation|1|||
105450751|NCT00430716|363658460|FG001|Open Label Phase|Protocol Violation|0|||
105450752|NCT00430716|363658461|FG002|Open Label Phase|Protocol Violation|0|||
105450753|NCT00430716|363658459|FG000|Open Label Phase|Study terminated by sponsor|4|||
105450754|NCT00430716|363658460|FG001|Open Label Phase|Study terminated by sponsor|5|||
105450755|NCT00430716|363658461|FG002|Open Label Phase|Study terminated by sponsor|4|||
105450756|NCT03087513|363658466|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
105450757|NCT03064490|363658476|FG000|Overall Study|Physician Decision|5|||
105450758|NCT05579977|363658478|FG000|Treatment Phase|Other|0|||
105450759|NCT05579977|363658479|FG001|Treatment Phase|Other|0|||
105450760|NCT05579977|363658480|FG002|Treatment Phase|Other|0|||
105450761|NCT05579977|363658481|FG003|Treatment Phase|Other|2|||
105450762|NCT05579977|363658482|FG004|Treatment Phase|Other|1|||
105450763|NCT05579977|363658483|FG005|Treatment Phase|Other|2|||
105450764|NCT05579977|363658484|FG006|Treatment Phase|Other|1|||
105450765|NCT05579977|363658485|FG007|Treatment Phase|Other|2|||
105450766|NCT05579977|363658486|FG008|Treatment Phase|Other|2|||
105450767|NCT05579977|363658487|FG009|Treatment Phase|Other|1|||
105450768|NCT05579977|363658488|FG010|Treatment Phase|Other|0|||
105450769|NCT05579977|363658489|FG011|Treatment Phase|Other|0|||
105450770|NCT05579977|363658490|FG012|Treatment Phase|Other|3|||
105450771|NCT05579977|363658478|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
105450772|NCT05579977|363658479|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
105450773|NCT05579977|363658480|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
105450774|NCT05579977|363658481|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
105450775|NCT05579977|363658482|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
105450776|NCT05579977|363658483|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
105450777|NCT05579977|363658484|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
105450778|NCT05579977|363658485|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
105450779|NCT05579977|363658486|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
105450780|NCT05579977|363658487|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
105450781|NCT05579977|363658488|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
105450782|NCT05579977|363658489|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
105450783|NCT05579977|363658490|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
105450784|NCT05579977|363658478|FG000|Treatment Phase|Withdrawal by Subject|2|||
105450785|NCT05579977|363658479|FG001|Treatment Phase|Withdrawal by Subject|0|||
105450786|NCT05579977|363658480|FG002|Treatment Phase|Withdrawal by Subject|0|||
105450787|NCT05579977|363658481|FG003|Treatment Phase|Withdrawal by Subject|1|||
105450788|NCT05579977|363658482|FG004|Treatment Phase|Withdrawal by Subject|2|||
105450789|NCT05579977|363658483|FG005|Treatment Phase|Withdrawal by Subject|0|||
105450790|NCT05579977|363658484|FG006|Treatment Phase|Withdrawal by Subject|1|||
105450791|NCT05579977|363658485|FG007|Treatment Phase|Withdrawal by Subject|8|||
105450792|NCT05579977|363658486|FG008|Treatment Phase|Withdrawal by Subject|3|||
105450793|NCT05579977|363658487|FG009|Treatment Phase|Withdrawal by Subject|3|||
105450794|NCT05579977|363658488|FG010|Treatment Phase|Withdrawal by Subject|5|||
105450795|NCT05579977|363658489|FG011|Treatment Phase|Withdrawal by Subject|1|||
105450796|NCT05579977|363658490|FG012|Treatment Phase|Withdrawal by Subject|3|||
105450797|NCT05579977|363658478|FG000|Treatment Phase|Study terminated by sponsor|70|||
105450798|NCT05579977|363658479|FG001|Treatment Phase|Study terminated by sponsor|70|||
105450799|NCT05579977|363658480|FG002|Treatment Phase|Study terminated by sponsor|61|||
105450800|NCT05579977|363658481|FG003|Treatment Phase|Study terminated by sponsor|59|||
105450801|NCT05579977|363658482|FG004|Treatment Phase|Study terminated by sponsor|63|||
105450802|NCT05579977|363658483|FG005|Treatment Phase|Study terminated by sponsor|53|||
105450803|NCT05579977|363658484|FG006|Treatment Phase|Study terminated by sponsor|66|||
105450804|NCT05579977|363658485|FG007|Treatment Phase|Study terminated by sponsor|48|||
105450805|NCT05579977|363658486|FG008|Treatment Phase|Study terminated by sponsor|47|||
105450806|NCT05579977|363658487|FG009|Treatment Phase|Study terminated by sponsor|37|||
105450807|NCT05579977|363658488|FG010|Treatment Phase|Study terminated by sponsor|44|||
105450808|NCT05579977|363658489|FG011|Treatment Phase|Study terminated by sponsor|36|||
105450809|NCT05579977|363658490|FG012|Treatment Phase|Study terminated by sponsor|32|||
105450810|NCT05579977|363658478|FG000|Treatment Phase|Pregnancy|0|||
105336624|NCT01876784|363233036|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
105336625|NCT01876784|363233037|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
105336626|NCT01876784|363233036|FG000|Open-label Period (31 Months)|Adverse Event|2|||
105336627|NCT01876784|363233037|FG001|Open-label Period (31 Months)|Adverse Event|6|||
105336628|NCT01876784|363233036|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
105336629|NCT01876784|363233037|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
105336630|NCT01876784|363233036|FG000|Open-label Period (31 Months)|Progressive disease|4|||
105336631|NCT01876784|363233037|FG001|Open-label Period (31 Months)|Progressive disease|35|||
105336632|NCT01876784|363233036|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
105336633|NCT01876784|363233037|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
105336634|NCT01876784|363233036|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
105336635|NCT01876784|363233037|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
105336636|NCT01876784|363233036|FG000|Open-label Period (31 Months)|Death|0|||
105336637|NCT01876784|363233037|FG001|Open-label Period (31 Months)|Death|1|||
105336638|NCT01876784|363233036|FG000|Open-label Period (31 Months)|Other than specified above|9|||
105336639|NCT01876784|363233037|FG001|Open-label Period (31 Months)|Other than specified above|18|||
105336640|NCT03605862|363233038|FG000|Overall Study|Withdrawal by Subject|12|||
105336641|NCT03605862|363233039|FG001|Overall Study|Withdrawal by Subject|9|||
105336642|NCT03605862|363233038|FG000|Overall Study|Adverse Event|2|||
105336643|NCT03605862|363233039|FG001|Overall Study|Adverse Event|1|||
105336644|NCT03605862|363233038|FG000|Overall Study|Physician Decision|3|||
105336645|NCT03605862|363233039|FG001|Overall Study|Physician Decision|1|||
105336646|NCT03605862|363233038|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
105336647|NCT03605862|363233039|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
105336648|NCT01194531|363233040|FG000|Overall Study|Withdrawal by Subject|1|||
105336649|NCT01194531|363233041|FG001|Overall Study|Withdrawal by Subject|0|||
105336650|NCT01194531|363233040|FG000|Overall Study|Protocol Violation|4|||
105336651|NCT01194531|363233041|FG001|Overall Study|Protocol Violation|1|||
105336652|NCT01194531|363233040|FG000|Overall Study|Physician Decision|0|||
105336653|NCT01194531|363233041|FG001|Overall Study|Physician Decision|2|||
105336654|NCT05239494|363233042|FG000|Overall Study|Lost to Follow-up|1|||
105336655|NCT04143594|363233045|FG000|Overall Study|Withdrew consent|3|||
105336656|NCT04143594|363233046|FG001|Overall Study|Withdrew consent|10|||
105336657|NCT04143594|363233047|FG002|Overall Study|Withdrew consent|3|||
105336658|NCT04143594|363233048|FG003|Overall Study|Withdrew consent|1|||
105336659|NCT04143594|363233045|FG000|Overall Study|Lost to Follow-up|3|||
105336660|NCT04143594|363233046|FG001|Overall Study|Lost to Follow-up|5|||
105336661|NCT04143594|363233047|FG002|Overall Study|Lost to Follow-up|11|||
105336662|NCT04143594|363233048|FG003|Overall Study|Lost to Follow-up|0|||
105336663|NCT04143594|363233045|FG000|Overall Study|Investigator's discretion|2|||
105336664|NCT04143594|363233046|FG001|Overall Study|Investigator's discretion|2|||
105336665|NCT04143594|363233047|FG002|Overall Study|Investigator's discretion|0|||
105336666|NCT04143594|363233048|FG003|Overall Study|Investigator's discretion|0|||
105336667|NCT04143594|363233045|FG000|Overall Study|Randomized but never treated|0|||
105336668|NCT04143594|363233046|FG001|Overall Study|Randomized but never treated|0|||
105336669|NCT04143594|363233047|FG002|Overall Study|Randomized but never treated|0|||
105336670|NCT04143594|363233048|FG003|Overall Study|Randomized but never treated|1|||
105336671|NCT04143594|363233045|FG000|Overall Study|Death|1|||
105336672|NCT04143594|363233046|FG001|Overall Study|Death|0|||
105336673|NCT04143594|363233047|FG002|Overall Study|Death|1|||
105336674|NCT04143594|363233048|FG003|Overall Study|Death|0|||
105336675|NCT04143594|363233045|FG000|Overall Study|Adverse Event|1|||
105336676|NCT04143594|363233046|FG001|Overall Study|Adverse Event|0|||
105336677|NCT04143594|363233047|FG002|Overall Study|Adverse Event|0|||
105336678|NCT04143594|363233048|FG003|Overall Study|Adverse Event|0|||
105336679|NCT04143594|363233045|FG000|Overall Study|Pregnancy|0|||
105336680|NCT04143594|363233046|FG001|Overall Study|Pregnancy|0|||
105336681|NCT04143594|363233047|FG002|Overall Study|Pregnancy|1|||
105336682|NCT04143594|363233048|FG003|Overall Study|Pregnancy|0|||
105336683|NCT04143594|363233045|FG000|Overall Study|Lack of Efficacy|1|||
105336684|NCT04143594|363233046|FG001|Overall Study|Lack of Efficacy|1|||
105336685|NCT04143594|363233047|FG002|Overall Study|Lack of Efficacy|0|||
105336686|NCT04143594|363233048|FG003|Overall Study|Lack of Efficacy|0|||
105336687|NCT00179673|363233051|FG000|Overall Study|Adverse Event|7|||
105336688|NCT00179673|363233051|FG000|Overall Study|Lack of Efficacy|15|||
105336689|NCT00179673|363233051|FG000|Overall Study|Withdrawal by Subject|3|||
105336690|NCT00179673|363233051|FG000|Overall Study|Death|4|||
105336691|NCT00179673|363233051|FG000|Overall Study|Other Observations and options|14|||
105336692|NCT00282113|363233052|FG000|Overall Study|Removed at parents request|1|||
105336693|NCT00282113|363233053|FG001|Overall Study|Removed at parents request|0|||
105336694|NCT00282113|363233054|FG002|Overall Study|Removed at parents request|0|||
105336695|NCT02949843|363233057|FG000|Overall Study|Withdrawal by Subject|0|||
105336696|NCT02949843|363233058|FG001|Overall Study|Withdrawal by Subject|1|||
105336697|NCT02949843|363233059|FG002|Overall Study|Withdrawal by Subject|1|||
105450811|NCT05579977|363658479|FG001|Treatment Phase|Pregnancy|0|||
105782782|NCT02681094|364857998|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
105782783|NCT02681094|364857999|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
105782784|NCT02681094|364857997|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
105782785|NCT02681094|364857998|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
105782786|NCT02681094|364857999|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
105782787|NCT02681094|364857997|FG000|2 - Enrolled Participants Set|Other|6|||
105782788|NCT02681094|364857998|FG001|2 - Enrolled Participants Set|Other|6|||
105782789|NCT02681094|364857999|FG002|2 - Enrolled Participants Set|Other|7|||
105782790|NCT02681094|364857997|FG000|2 - Enrolled Participants Set|No treatment given|0|||
105782791|NCT02681094|364857998|FG001|2 - Enrolled Participants Set|No treatment given|1|||
105782792|NCT02681094|364857999|FG002|2 - Enrolled Participants Set|No treatment given|1|||
105782793|NCT02452320|364858000|FG000|Overall Study|Adverse Event|0|||
105782794|NCT02452320|364858001|FG001|Overall Study|Adverse Event|1|||
105782795|NCT00285857|364858002|FG000|Overall Study|Withdrawal by Subject|2|||
105782796|NCT00285857|364858002|FG000|Overall Study|Inadequate initial breast cytology|1|||
105782797|NCT00285857|364858002|FG000|Overall Study|Adverse Event|1|||
105782798|NCT00649220|364858003|FG000|Overall Study|Adverse Event|2|||
105782799|NCT00649220|364858003|FG000|Overall Study|Withdrawal by Subject|1|||
105782800|NCT01733758|364858004|FG000|Overall Study|Adverse Event|5|||
105782801|NCT01733758|364858005|FG001|Overall Study|Adverse Event|7|||
105782802|NCT01733758|364858006|FG002|Overall Study|Adverse Event|8|||
105782803|NCT01733758|364858007|FG003|Overall Study|Adverse Event|1|||
105782804|NCT01733758|364858004|FG000|Overall Study|Withdrawal by Subject|1|||
105782805|NCT01733758|364858005|FG001|Overall Study|Withdrawal by Subject|1|||
105782806|NCT01733758|364858006|FG002|Overall Study|Withdrawal by Subject|5|||
105782807|NCT01733758|364858007|FG003|Overall Study|Withdrawal by Subject|3|||
105782808|NCT01733758|364858004|FG000|Overall Study|Persistent Hyperglycemia|3|||
105782809|NCT01733758|364858005|FG001|Overall Study|Persistent Hyperglycemia|2|||
105782810|NCT01733758|364858006|FG002|Overall Study|Persistent Hyperglycemia|0|||
105782811|NCT01733758|364858007|FG003|Overall Study|Persistent Hyperglycemia|0|||
105782812|NCT01733758|364858004|FG000|Overall Study|Protocol Violation|0|||
105782813|NCT01733758|364858005|FG001|Overall Study|Protocol Violation|1|||
105782814|NCT01733758|364858006|FG002|Overall Study|Protocol Violation|2|||
105782815|NCT01733758|364858007|FG003|Overall Study|Protocol Violation|2|||
105782816|NCT01733758|364858004|FG000|Overall Study|Non-compliance|1|||
105782817|NCT01733758|364858005|FG001|Overall Study|Non-compliance|0|||
105782818|NCT01733758|364858006|FG002|Overall Study|Non-compliance|0|||
105782819|NCT01733758|364858007|FG003|Overall Study|Non-compliance|0|||
105782820|NCT01733758|364858004|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
105782821|NCT01733758|364858005|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
105782822|NCT01733758|364858006|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
105782823|NCT01733758|364858007|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
105782824|NCT01733758|364858004|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
105782825|NCT01733758|364858005|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
105782826|NCT01733758|364858006|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
105782827|NCT01733758|364858007|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
105782828|NCT02557308|364858010|FG000|Overall Study|Withdrawal by Subject|11|||
105782829|NCT02557308|364858011|FG001|Overall Study|Withdrawal by Subject|3|||
105782830|NCT02557308|364858012|FG002|Overall Study|Withdrawal by Subject|2|||
105336698|NCT01680159|363233060|FG000|Screening Period|Not meet criteria for dose-up period|7|||
105336699|NCT01680159|363233060|FG000|Increased Dose Period|Adverse Event|6|||
105336700|NCT01680159|363233060|FG000|Increased Dose Period|Withdrawal by Subject|2|||
105336701|NCT02147158|363233067|FG000|Treatment Course 1|Adverse Event|1|||
105336702|NCT02147158|363233068|FG001|Treatment Course 1|Adverse Event|4|||
105336703|NCT02147158|363233069|FG002|Treatment Course 1|Adverse Event|3|||
105336704|NCT02147158|363233070|FG003|Treatment Course 1|Adverse Event|4|||
105336705|NCT02147158|363233071|FG004|Treatment Course 1|Adverse Event|1|||
105336706|NCT02147158|363233072|FG005|Treatment Course 1|Adverse Event|2|||
105336707|NCT02147158|363233067|FG000|Treatment Course 1|Lost to Follow-up|2|||
105336708|NCT02147158|363233068|FG001|Treatment Course 1|Lost to Follow-up|4|||
105336709|NCT02147158|363233069|FG002|Treatment Course 1|Lost to Follow-up|3|||
105336710|NCT02147158|363233070|FG003|Treatment Course 1|Lost to Follow-up|3|||
105336711|NCT02147158|363233071|FG004|Treatment Course 1|Lost to Follow-up|2|||
105336712|NCT02147158|363233072|FG005|Treatment Course 1|Lost to Follow-up|4|||
105336713|NCT02147158|363233067|FG000|Treatment Course 1|Protocol Violation|0|||
105336714|NCT02147158|363233068|FG001|Treatment Course 1|Protocol Violation|0|||
105336715|NCT02147158|363233069|FG002|Treatment Course 1|Protocol Violation|1|||
105450812|NCT05579977|363658480|FG002|Treatment Phase|Pregnancy|0|||
105450813|NCT05579977|363658481|FG003|Treatment Phase|Pregnancy|0|||
105782831|NCT02557308|364858013|FG003|Overall Study|Withdrawal by Subject|0|||
105782832|NCT02557308|364858014|FG004|Overall Study|Withdrawal by Subject|1|||
105782833|NCT02557308|364858015|FG005|Overall Study|Withdrawal by Subject|0|||
105450814|NCT05579977|363658482|FG004|Treatment Phase|Pregnancy|0|||
105336716|NCT02147158|363233070|FG003|Treatment Course 1|Protocol Violation|1|||
105336717|NCT02147158|363233071|FG004|Treatment Course 1|Protocol Violation|0|||
105336718|NCT02147158|363233072|FG005|Treatment Course 1|Protocol Violation|0|||
105336719|NCT02147158|363233067|FG000|Treatment Course 1|Withdrawal of Consent|1|||
105336720|NCT02147158|363233068|FG001|Treatment Course 1|Withdrawal of Consent|1|||
105336721|NCT02147158|363233069|FG002|Treatment Course 1|Withdrawal of Consent|1|||
105336722|NCT02147158|363233070|FG003|Treatment Course 1|Withdrawal of Consent|5|||
105336723|NCT02147158|363233071|FG004|Treatment Course 1|Withdrawal of Consent|3|||
105336724|NCT02147158|363233072|FG005|Treatment Course 1|Withdrawal of Consent|2|||
105336725|NCT02147158|363233067|FG000|Off-Treatment Interval 1|Adverse Event|1|||
105336726|NCT02147158|363233068|FG001|Off-Treatment Interval 1|Adverse Event|0|||
105336727|NCT02147158|363233069|FG002|Off-Treatment Interval 1|Adverse Event|0|||
105336728|NCT02147158|363233070|FG003|Off-Treatment Interval 1|Adverse Event|1|||
105336729|NCT02147158|363233071|FG004|Off-Treatment Interval 1|Adverse Event|0|||
105336730|NCT02147158|363233072|FG005|Off-Treatment Interval 1|Adverse Event|0|||
105336731|NCT02147158|363233067|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
105336732|NCT02147158|363233068|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
105336733|NCT02147158|363233069|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
105336734|NCT02147158|363233070|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
105336735|NCT02147158|363233071|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
105336736|NCT02147158|363233072|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
105336737|NCT02147158|363233067|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
105336738|NCT02147158|363233068|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
105336739|NCT02147158|363233069|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
105336740|NCT02147158|363233070|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
105336741|NCT02147158|363233071|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
105336742|NCT02147158|363233072|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
105336743|NCT02147158|363233067|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
105336744|NCT02147158|363233068|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
105336745|NCT02147158|363233069|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
105336746|NCT02147158|363233070|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
105336747|NCT02147158|363233071|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
105336748|NCT02147158|363233072|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
105336749|NCT02147158|363233067|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
105336750|NCT02147158|363233068|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
105336751|NCT02147158|363233069|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
105336752|NCT02147158|363233070|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
105336753|NCT02147158|363233071|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
105336754|NCT02147158|363233072|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
105336755|NCT02147158|363233067|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
105336756|NCT02147158|363233068|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
105336757|NCT02147158|363233069|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
105336758|NCT02147158|363233070|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
105336759|NCT02147158|363233071|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
105336760|NCT02147158|363233072|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
105336761|NCT02147158|363233067|FG000|Treatment Course 2|Adverse Event|0|||
105336762|NCT02147158|363233068|FG001|Treatment Course 2|Adverse Event|4|||
105336763|NCT02147158|363233069|FG002|Treatment Course 2|Adverse Event|2|||
105336764|NCT02147158|363233070|FG003|Treatment Course 2|Adverse Event|1|||
105336765|NCT02147158|363233071|FG004|Treatment Course 2|Adverse Event|0|||
105336766|NCT02147158|363233072|FG005|Treatment Course 2|Adverse Event|1|||
105336767|NCT02147158|363233067|FG000|Treatment Course 2|Withdrawal of Consent|0|||
105336768|NCT02147158|363233068|FG001|Treatment Course 2|Withdrawal of Consent|1|||
105336769|NCT02147158|363233069|FG002|Treatment Course 2|Withdrawal of Consent|2|||
105336770|NCT02147158|363233070|FG003|Treatment Course 2|Withdrawal of Consent|3|||
105336771|NCT02147158|363233071|FG004|Treatment Course 2|Withdrawal of Consent|0|||
105336772|NCT02147158|363233072|FG005|Treatment Course 2|Withdrawal of Consent|0|||
105336773|NCT02147158|363233067|FG000|Treatment Course 2|Lost to Follow-up|1|||
105336774|NCT02147158|363233068|FG001|Treatment Course 2|Lost to Follow-up|0|||
105336775|NCT02147158|363233069|FG002|Treatment Course 2|Lost to Follow-up|1|||
105336776|NCT02147158|363233070|FG003|Treatment Course 2|Lost to Follow-up|1|||
105336777|NCT02147158|363233071|FG004|Treatment Course 2|Lost to Follow-up|0|||
105336778|NCT02147158|363233072|FG005|Treatment Course 2|Lost to Follow-up|1|||
105336779|NCT02147158|363233067|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
105336780|NCT02147158|363233068|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
105336781|NCT02147158|363233069|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
105336782|NCT02147158|363233070|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
105336783|NCT02147158|363233071|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
105336784|NCT02147158|363233072|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
105336785|NCT02147158|363233067|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
105336786|NCT02147158|363233068|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
105336787|NCT02147158|363233069|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
105336788|NCT02147158|363233070|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
105336789|NCT02147158|363233071|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
105336790|NCT02147158|363233072|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
105336791|NCT02147158|363233067|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
105336792|NCT02147158|363233068|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
105336793|NCT02147158|363233069|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
105336794|NCT02147158|363233070|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
105336795|NCT02147158|363233071|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
105336796|NCT02147158|363233072|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
105336797|NCT02147158|363233067|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
105336798|NCT02147158|363233068|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
105336799|NCT02147158|363233069|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
105336800|NCT02147158|363233070|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
105336801|NCT02147158|363233071|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
105336802|NCT02147158|363233072|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
105336803|NCT02147158|363233067|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
105336804|NCT02147158|363233068|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
105336805|NCT02147158|363233069|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
105336806|NCT02147158|363233070|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
105336807|NCT02147158|363233071|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
105336808|NCT02147158|363233072|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
105336809|NCT00915876|363233077|FG000|Overall Study|Adverse Event|0|||
105336810|NCT00915876|363233078|FG001|Overall Study|Adverse Event|1|||
105336811|NCT02778074|363233079|FG000|Overall Study|Lost to Follow-up|7|||
105336812|NCT02778074|363233080|FG001|Overall Study|Lost to Follow-up|10|||
105360855|NCT04547140|363328094|FG000|Overall Study|Adverse Event|0|||
105360856|NCT04547140|363328095|FG001|Overall Study|Adverse Event|1|||
105360857|NCT04547140|363328094|FG000|Overall Study|Withdrawal by Subject|0|||
105360858|NCT04547140|363328095|FG001|Overall Study|Withdrawal by Subject|1|||
105360859|NCT04547140|363328094|FG000|Overall Study|Lost to Follow-up|3|||
105360860|NCT04547140|363328095|FG001|Overall Study|Lost to Follow-up|1|||
105360861|NCT04547140|363328094|FG000|Overall Study|Death|2|||
105360862|NCT04547140|363328095|FG001|Overall Study|Death|1|||
105360863|NCT04547140|363328094|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
105450815|NCT05579977|363658483|FG005|Treatment Phase|Pregnancy|0|||
105450816|NCT05579977|363658484|FG006|Treatment Phase|Pregnancy|0|||
105450817|NCT05579977|363658485|FG007|Treatment Phase|Pregnancy|0|||
105450818|NCT05579977|363658486|FG008|Treatment Phase|Pregnancy|0|||
105360864|NCT04547140|363328095|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
105360865|NCT04547140|363328094|FG000|Overall Study|Pregnancy|1|||
105360866|NCT04547140|363328095|FG001|Overall Study|Pregnancy|0|||
105450819|NCT05579977|363658487|FG009|Treatment Phase|Pregnancy|1|||
105450820|NCT05579977|363658488|FG010|Treatment Phase|Pregnancy|0|||
105450821|NCT05579977|363658489|FG011|Treatment Phase|Pregnancy|0|||
105450822|NCT05579977|363658490|FG012|Treatment Phase|Pregnancy|0|||
105450823|NCT05579977|363658478|FG000|Treatment Phase|Physician Decision|0|||
105450824|NCT05579977|363658479|FG001|Treatment Phase|Physician Decision|0|||
105450825|NCT05579977|363658480|FG002|Treatment Phase|Physician Decision|0|||
105450826|NCT05579977|363658481|FG003|Treatment Phase|Physician Decision|0|||
105450827|NCT05579977|363658482|FG004|Treatment Phase|Physician Decision|0|||
105450828|NCT05579977|363658483|FG005|Treatment Phase|Physician Decision|0|||
105450829|NCT05579977|363658484|FG006|Treatment Phase|Physician Decision|0|||
105450830|NCT05579977|363658485|FG007|Treatment Phase|Physician Decision|0|||
105450831|NCT05579977|363658486|FG008|Treatment Phase|Physician Decision|0|||
105450832|NCT05579977|363658487|FG009|Treatment Phase|Physician Decision|0|||
105450833|NCT05579977|363658488|FG010|Treatment Phase|Physician Decision|0|||
105450834|NCT05579977|363658489|FG011|Treatment Phase|Physician Decision|1|||
105450835|NCT05579977|363658490|FG012|Treatment Phase|Physician Decision|0|||
105450836|NCT05579977|363658478|FG000|Treatment Phase|Lost to Follow-up|0|||
105450837|NCT05579977|363658479|FG001|Treatment Phase|Lost to Follow-up|0|||
105450838|NCT05579977|363658480|FG002|Treatment Phase|Lost to Follow-up|0|||
105450839|NCT05579977|363658481|FG003|Treatment Phase|Lost to Follow-up|1|||
105450840|NCT05579977|363658482|FG004|Treatment Phase|Lost to Follow-up|1|||
105450841|NCT05579977|363658483|FG005|Treatment Phase|Lost to Follow-up|1|||
105450842|NCT05579977|363658484|FG006|Treatment Phase|Lost to Follow-up|0|||
105450843|NCT05579977|363658485|FG007|Treatment Phase|Lost to Follow-up|1|||
105450844|NCT05579977|363658486|FG008|Treatment Phase|Lost to Follow-up|2|||
105450845|NCT05579977|363658487|FG009|Treatment Phase|Lost to Follow-up|2|||
105450846|NCT05579977|363658488|FG010|Treatment Phase|Lost to Follow-up|1|||
105450847|NCT05579977|363658489|FG011|Treatment Phase|Lost to Follow-up|4|||
105450848|NCT05579977|363658490|FG012|Treatment Phase|Lost to Follow-up|3|||
105450849|NCT05579977|363658478|FG000|Treatment Phase|Death|1|||
105450850|NCT05579977|363658479|FG001|Treatment Phase|Death|0|||
105450851|NCT05579977|363658480|FG002|Treatment Phase|Death|0|||
105450852|NCT05579977|363658481|FG003|Treatment Phase|Death|0|||
105450853|NCT05579977|363658482|FG004|Treatment Phase|Death|0|||
105450854|NCT05579977|363658483|FG005|Treatment Phase|Death|0|||
105450855|NCT05579977|363658484|FG006|Treatment Phase|Death|0|||
105450856|NCT05579977|363658485|FG007|Treatment Phase|Death|0|||
105336813|NCT03260244|363234703|FG000|Overall Study|Death|19|||
105450857|NCT05579977|363658486|FG008|Treatment Phase|Death|0|||
105450858|NCT05579977|363658487|FG009|Treatment Phase|Death|0|||
105450859|NCT05579977|363658488|FG010|Treatment Phase|Death|0|||
105450860|NCT05579977|363658489|FG011|Treatment Phase|Death|0|||
105450861|NCT05579977|363658490|FG012|Treatment Phase|Death|0|||
105450862|NCT05579977|363658478|FG000|Treatment Phase|Adverse Event|0|||
105450863|NCT05579977|363658479|FG001|Treatment Phase|Adverse Event|3|||
105450864|NCT05579977|363658480|FG002|Treatment Phase|Adverse Event|11|||
105450865|NCT05579977|363658481|FG003|Treatment Phase|Adverse Event|10|||
105450866|NCT05579977|363658482|FG004|Treatment Phase|Adverse Event|5|||
105450867|NCT05579977|363658483|FG005|Treatment Phase|Adverse Event|17|||
105450868|NCT05579977|363658484|FG006|Treatment Phase|Adverse Event|5|||
105450869|NCT05579977|363658485|FG007|Treatment Phase|Adverse Event|5|||
105450870|NCT05579977|363658486|FG008|Treatment Phase|Adverse Event|12|||
105450871|NCT05579977|363658487|FG009|Treatment Phase|Adverse Event|20|||
105450872|NCT05579977|363658488|FG010|Treatment Phase|Adverse Event|15|||
105450873|NCT05579977|363658489|FG011|Treatment Phase|Adverse Event|24|||
105450874|NCT05579977|363658490|FG012|Treatment Phase|Adverse Event|23|||
105450875|NCT05579977|363658478|FG000|Treatment Phase|Randomized not treated|0|||
105450876|NCT05579977|363658479|FG001|Treatment Phase|Randomized not treated|0|||
105450877|NCT05579977|363658480|FG002|Treatment Phase|Randomized not treated|0|||
105450878|NCT05579977|363658481|FG003|Treatment Phase|Randomized not treated|0|||
105450879|NCT05579977|363658482|FG004|Treatment Phase|Randomized not treated|1|||
105450880|NCT05579977|363658483|FG005|Treatment Phase|Randomized not treated|0|||
105450881|NCT05579977|363658484|FG006|Treatment Phase|Randomized not treated|0|||
105450882|NCT05579977|363658485|FG007|Treatment Phase|Randomized not treated|0|||
105450883|NCT05579977|363658486|FG008|Treatment Phase|Randomized not treated|0|||
105450884|NCT05579977|363658487|FG009|Treatment Phase|Randomized not treated|0|||
105450885|NCT05579977|363658488|FG010|Treatment Phase|Randomized not treated|0|||
105450886|NCT05579977|363658489|FG011|Treatment Phase|Randomized not treated|0|||
105450887|NCT05579977|363658490|FG012|Treatment Phase|Randomized not treated|0|||
105450888|NCT05579977|363658478|FG000|Follow up|Death|1|||
105450889|NCT05579977|363658479|FG001|Follow up|Death|0|||
105450890|NCT05579977|363658480|FG002|Follow up|Death|0|||
105450891|NCT05579977|363658481|FG003|Follow up|Death|0|||
105782834|NCT02557308|364858016|FG006|Overall Study|Withdrawal by Subject|10|||
105782835|NCT02557308|364858017|FG007|Overall Study|Withdrawal by Subject|1|||
105782836|NCT02557308|364858010|FG000|Overall Study|Disease Progression|0|||
105782837|NCT02557308|364858011|FG001|Overall Study|Disease Progression|1|||
105782838|NCT02557308|364858012|FG002|Overall Study|Disease Progression|0|||
105782839|NCT02557308|364858013|FG003|Overall Study|Disease Progression|0|||
105782840|NCT02557308|364858014|FG004|Overall Study|Disease Progression|0|||
105336814|NCT03260244|363234703|FG000|Overall Study|Lost to Follow-up|60|||
105336815|NCT03260244|363234703|FG000|Overall Study|Withdrawal by Subject|48|||
105336816|NCT03260244|363234703|FG000|Overall Study|Procedure Not Performed|21|||
105336817|NCT03260244|363234703|FG000|Overall Study|Enrollment Criteria Not Met|31|||
105336818|NCT03260244|363234703|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
105336819|NCT03260244|363234703|FG000|Overall Study|Subject Noncompliance|6|||
105336820|NCT03260244|363234703|FG000|Overall Study|No inducible Arrhythmia|2|||
105336821|NCT03260244|363234703|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
105336822|NCT03260244|363234703|FG000|Overall Study|Screen Failure|2|||
105336823|NCT03260244|363234703|FG000|Overall Study|Treated Off Label|69|||
105336824|NCT03260244|363234703|FG000|Overall Study|No Radiofrequency Ablation|14|||
105336825|NCT02028767|363234710|FG000|Treatment Period 2|Non compliant with protocol|1|||
105336826|NCT02028767|363234711|FG001|Treatment Period 2|Non compliant with protocol|0|||
105336827|NCT02028767|363234710|FG000|Treatment Period 2|Reason other than those specified above|1|||
105336828|NCT02028767|363234711|FG001|Treatment Period 2|Reason other than those specified above|0|||
105336829|NCT03575793|363234716|FG000|Overall Study|Withdrawal by Subject|0|||
105336830|NCT03575793|363234717|FG001|Overall Study|Withdrawal by Subject|1|||
105336831|NCT03575793|363234716|FG000|Overall Study|Never Treated|0|||
105336832|NCT03575793|363234717|FG001|Overall Study|Never Treated|2|||
105336833|NCT03200704|363234720|FG000|Overall Study|Withdrawal by Subject|1|||
105336834|NCT03436693|363234721|FG000|Overall Study|Adverse Event|22|||
105336835|NCT03436693|363234722|FG001|Overall Study|Adverse Event|10|||
105336836|NCT03436693|363234721|FG000|Overall Study|Physician Decision|3|||
105336837|NCT03436693|363234722|FG001|Overall Study|Physician Decision|3|||
105336838|NCT03436693|363234721|FG000|Overall Study|Withdrawal by Subject|4|||
105450892|NCT05579977|363658482|FG004|Follow up|Death|0|||
105450893|NCT05579977|363658483|FG005|Follow up|Death|0|||
105450894|NCT05579977|363658484|FG006|Follow up|Death|0|||
105450895|NCT05579977|363658485|FG007|Follow up|Death|0|||
105450896|NCT05579977|363658486|FG008|Follow up|Death|0|||
105450897|NCT05579977|363658487|FG009|Follow up|Death|0|||
105450898|NCT05579977|363658488|FG010|Follow up|Death|0|||
105450899|NCT05579977|363658489|FG011|Follow up|Death|0|||
105450900|NCT05579977|363658490|FG012|Follow up|Death|0|||
105450901|NCT05579977|363658478|FG000|Follow up|Lost to Follow-up|0|||
105782841|NCT02557308|364858015|FG005|Overall Study|Disease Progression|0|||
105782842|NCT02557308|364858016|FG006|Overall Study|Disease Progression|0|||
105336839|NCT03436693|363234722|FG001|Overall Study|Withdrawal by Subject|13|||
105336840|NCT03436693|363234721|FG000|Overall Study|Progressive Disease|1|||
105336841|NCT03436693|363234722|FG001|Overall Study|Progressive Disease|1|||
105336842|NCT02071706|363234723|FG000|Overall Study|Adverse Event|1|||
105336843|NCT02071706|363234723|FG000|Overall Study|Withdrawal by Subject|2|||
105336844|NCT01895270|363234726|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
105336845|NCT01895270|363234727|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
105336846|NCT01895270|363234726|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
105336847|NCT01895270|363234727|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
105336848|NCT01895270|363234726|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
105336849|NCT01895270|363234727|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
105336850|NCT01895270|363234726|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
105336851|NCT01895270|363234727|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
105336852|NCT01895270|363234726|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
105336853|NCT01895270|363234727|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
105336854|NCT01895270|363234726|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
105336855|NCT01895270|363234727|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
105336856|NCT01895270|363234726|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
105336857|NCT01895270|363234727|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
105336858|NCT01194999|363234728|FG000|Overall Study|Lost to Follow-up|17|||
105336859|NCT00654875|363234729|FG000|Overall Study|Adverse Event|5|||
105336860|NCT00654875|363234730|FG001|Overall Study|Adverse Event|5|||
105336861|NCT00654875|363234729|FG000|Overall Study|Withdrawal by Subject|4|||
105336862|NCT00654875|363234730|FG001|Overall Study|Withdrawal by Subject|4|||
105336863|NCT00654875|363234729|FG000|Overall Study|Protocol Violation|3|||
105336864|NCT00654875|363234730|FG001|Overall Study|Protocol Violation|3|||
105336865|NCT00654875|363234729|FG000|Overall Study|Lack of Efficacy|2|||
105336866|NCT00654875|363234730|FG001|Overall Study|Lack of Efficacy|2|||
105336867|NCT00654875|363234729|FG000|Overall Study|Lost to Follow-up|1|||
105336868|NCT00654875|363234730|FG001|Overall Study|Lost to Follow-up|3|||
105336869|NCT00654875|363234729|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
105336870|NCT00654875|363234730|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
105336871|NCT00654875|363234729|FG000|Overall Study|Administrative Problems|1|||
105336872|NCT00654875|363234730|FG001|Overall Study|Administrative Problems|0|||
105336873|NCT01011465|363234732|FG000|Overall Study|Withdrawal by Subject|2|||
105336874|NCT01011465|363234733|FG001|Overall Study|Withdrawal by Subject|1|||
105336875|NCT01011465|363234734|FG002|Overall Study|Withdrawal by Subject|0|||
105336876|NCT01011465|363234735|FG003|Overall Study|Withdrawal by Subject|0|||
105336877|NCT01011465|363234736|FG004|Overall Study|Withdrawal by Subject|1|||
105336878|NCT01011465|363234737|FG005|Overall Study|Withdrawal by Subject|0|||
105336879|NCT01011465|363234738|FG006|Overall Study|Withdrawal by Subject|1|||
105336880|NCT01011465|363234739|FG007|Overall Study|Withdrawal by Subject|0|||
105336881|NCT02247440|363234740|FG000|Overall Study|Withdrawal by Subject|1|||
105336882|NCT02247440|363234740|FG000|Overall Study|Lack of Efficacy|3|||
105336883|NCT02682823|363234743|FG000|Overall Study|Withdrawal by Subject|0|||
105336884|NCT02682823|363234744|FG001|Overall Study|Withdrawal by Subject|0|||
105336885|NCT02682823|363234745|FG002|Overall Study|Withdrawal by Subject|1|||
105336886|NCT02682823|363234746|FG003|Overall Study|Withdrawal by Subject|0|||
105336887|NCT02682823|363234747|FG004|Overall Study|Withdrawal by Subject|1|||
105336888|NCT02682823|363234743|FG000|Overall Study|Protocol Deviation|0|||
105336889|NCT02682823|363234744|FG001|Overall Study|Protocol Deviation|1|||
105336890|NCT02682823|363234745|FG002|Overall Study|Protocol Deviation|0|||
105336891|NCT02682823|363234746|FG003|Overall Study|Protocol Deviation|0|||
105336892|NCT02682823|363234747|FG004|Overall Study|Protocol Deviation|0|||
105336893|NCT02682823|363234743|FG000|Overall Study|Adverse Event|0|||
105336894|NCT02682823|363234744|FG001|Overall Study|Adverse Event|0|||
105336895|NCT02682823|363234745|FG002|Overall Study|Adverse Event|0|||
105336896|NCT02682823|363234746|FG003|Overall Study|Adverse Event|1|||
105336897|NCT02682823|363234747|FG004|Overall Study|Adverse Event|0|||
105336898|NCT00886743|363234750|FG000|Overall Study|Adverse Event|3|||
105336899|NCT00886743|363234750|FG000|Overall Study|Other|1|||
105336900|NCT00626821|363234753|FG000|Overall Study|Adverse Event|44|||
105336901|NCT00626821|363234753|FG000|Overall Study|Protocol Violation|33|||
105336902|NCT00626821|363234753|FG000|Overall Study|Withdrawal by Subject|10|||
105336903|NCT00626821|363234753|FG000|Overall Study|Physician Decision|9|||
105336904|NCT00626821|363234753|FG000|Overall Study|Product dysfunction|21|||
105336905|NCT00626821|363234753|FG000|Overall Study|other/unknown reason|104|||
105336906|NCT02632409|363234758|FG000|Randomized|AE unrelated to study Drug|0|||
105336907|NCT02632409|363234759|FG001|Randomized|AE unrelated to study Drug|1|||
105336908|NCT02632409|363234758|FG000|Randomized|Participant withdrew consent|2|||
105336909|NCT02632409|363234759|FG001|Randomized|Participant withdrew consent|1|||
105336910|NCT02632409|363234758|FG000|Randomized|No Longer meets study criteria|5|||
105336911|NCT02632409|363234759|FG001|Randomized|No Longer meets study criteria|0|||
105336912|NCT02632409|363234758|FG000|Randomized|other reasons|1|||
105336913|NCT02632409|363234759|FG001|Randomized|other reasons|0|||
105450902|NCT05579977|363658479|FG001|Follow up|Lost to Follow-up|0|||
105450903|NCT05579977|363658480|FG002|Follow up|Lost to Follow-up|0|||
105782843|NCT02557308|364858017|FG007|Overall Study|Disease Progression|0|||
105782844|NCT02557308|364858010|FG000|Overall Study|Lack of Efficacy|3|||
105782845|NCT02557308|364858011|FG001|Overall Study|Lack of Efficacy|0|||
105782846|NCT02557308|364858012|FG002|Overall Study|Lack of Efficacy|0|||
105782847|NCT02557308|364858013|FG003|Overall Study|Lack of Efficacy|0|||
105782848|NCT02557308|364858014|FG004|Overall Study|Lack of Efficacy|0|||
105782849|NCT02557308|364858015|FG005|Overall Study|Lack of Efficacy|0|||
105782850|NCT02557308|364858016|FG006|Overall Study|Lack of Efficacy|1|||
105782851|NCT02557308|364858017|FG007|Overall Study|Lack of Efficacy|0|||
105782852|NCT02557308|364858010|FG000|Overall Study|Adverse Event|4|||
105782853|NCT02557308|364858011|FG001|Overall Study|Adverse Event|1|||
105782854|NCT02557308|364858012|FG002|Overall Study|Adverse Event|2|||
105782855|NCT02557308|364858013|FG003|Overall Study|Adverse Event|0|||
105782856|NCT02557308|364858014|FG004|Overall Study|Adverse Event|0|||
105782857|NCT02557308|364858015|FG005|Overall Study|Adverse Event|0|||
105782858|NCT02557308|364858016|FG006|Overall Study|Adverse Event|4|||
105782859|NCT02557308|364858017|FG007|Overall Study|Adverse Event|1|||
105782860|NCT02557308|364858010|FG000|Overall Study|Lost to Follow-up|2|||
105782861|NCT02557308|364858011|FG001|Overall Study|Lost to Follow-up|0|||
105782862|NCT02557308|364858012|FG002|Overall Study|Lost to Follow-up|1|||
105782863|NCT02557308|364858013|FG003|Overall Study|Lost to Follow-up|0|||
105782864|NCT02557308|364858014|FG004|Overall Study|Lost to Follow-up|0|||
105782865|NCT02557308|364858015|FG005|Overall Study|Lost to Follow-up|0|||
105782866|NCT02557308|364858016|FG006|Overall Study|Lost to Follow-up|2|||
105782867|NCT02557308|364858017|FG007|Overall Study|Lost to Follow-up|0|||
105782868|NCT02557308|364858010|FG000|Overall Study|Death|1|||
105782869|NCT02557308|364858011|FG001|Overall Study|Death|0|||
105782870|NCT02557308|364858012|FG002|Overall Study|Death|0|||
105782871|NCT02557308|364858013|FG003|Overall Study|Death|0|||
105782872|NCT02557308|364858014|FG004|Overall Study|Death|0|||
105782873|NCT02557308|364858015|FG005|Overall Study|Death|0|||
105782874|NCT02557308|364858016|FG006|Overall Study|Death|0|||
105782875|NCT02557308|364858017|FG007|Overall Study|Death|0|||
105782876|NCT02557308|364858010|FG000|Overall Study|Study Close|98|||
105782877|NCT02557308|364858011|FG001|Overall Study|Study Close|18|||
105782878|NCT02557308|364858012|FG002|Overall Study|Study Close|5|||
105782879|NCT02557308|364858013|FG003|Overall Study|Study Close|3|||
105782880|NCT02557308|364858014|FG004|Overall Study|Study Close|1|||
105782881|NCT02557308|364858015|FG005|Overall Study|Study Close|0|||
105782882|NCT02557308|364858016|FG006|Overall Study|Study Close|123|||
105782883|NCT02557308|364858017|FG007|Overall Study|Study Close|5|||
105782884|NCT02557308|364858010|FG000|Overall Study|Except for study close|5|||
105782885|NCT02557308|364858011|FG001|Overall Study|Except for study close|0|||
105782886|NCT02557308|364858012|FG002|Overall Study|Except for study close|0|||
105782887|NCT02557308|364858013|FG003|Overall Study|Except for study close|0|||
105782888|NCT02557308|364858014|FG004|Overall Study|Except for study close|3|||
105782889|NCT02557308|364858015|FG005|Overall Study|Except for study close|0|||
105782890|NCT02557308|364858016|FG006|Overall Study|Except for study close|6|||
105782891|NCT02557308|364858017|FG007|Overall Study|Except for study close|10|||
105782892|NCT03380091|364858018|FG000|Overall Study|Withdrawal by Subject|2|||
105782893|NCT03380091|364858019|FG001|Overall Study|Withdrawal by Subject|1|||
105782894|NCT02918968|364858020|FG000|1st Line AAT|Progressive disease|9|||
105782895|NCT02918968|364858021|FG001|1st Line AAT|Progressive disease|4|||
105782896|NCT02918968|364858020|FG000|1st Line AAT|Adverse Event|12|||
105782897|NCT02918968|364858021|FG001|1st Line AAT|Adverse Event|3|||
105782898|NCT02918968|364858020|FG000|1st Line AAT|Physician Decision|4|||
105782899|NCT02918968|364858021|FG001|1st Line AAT|Physician Decision|2|||
105782900|NCT02918968|364858020|FG000|1st Line AAT|Withdrawal by Subject|2|||
105782901|NCT02918968|364858021|FG001|1st Line AAT|Withdrawal by Subject|1|||
105782902|NCT02918968|364858020|FG000|1st Line AAT|Lost to Follow-up|0|||
105782903|NCT02918968|364858021|FG001|1st Line AAT|Lost to Follow-up|1|||
105782904|NCT02918968|364858020|FG000|1st Line AAT|Death|1|||
105782905|NCT02918968|364858021|FG001|1st Line AAT|Death|0|||
105782906|NCT02918968|364858020|FG000|1st Line AAT|Miscellaneous|1|||
105782907|NCT02918968|364858021|FG001|1st Line AAT|Miscellaneous|0|||
105782908|NCT02918968|364858020|FG000|2nd Line AAT|Progressive disease|21|||
105782909|NCT02918968|364858021|FG001|2nd Line AAT|Progressive disease|3|||
105782910|NCT02918968|364858020|FG000|2nd Line AAT|Adverse Event|2|||
105782911|NCT02918968|364858021|FG001|2nd Line AAT|Adverse Event|5|||
105782912|NCT02918968|364858020|FG000|2nd Line AAT|Physician Decision|0|||
105782913|NCT02918968|364858021|FG001|2nd Line AAT|Physician Decision|1|||
105782914|NCT02918968|364858020|FG000|2nd Line AAT|Withdrawal by Subject|2|||
105782915|NCT02918968|364858021|FG001|2nd Line AAT|Withdrawal by Subject|2|||
105782916|NCT02918968|364858020|FG000|2nd Line AAT|Death|0|||
105782917|NCT02918968|364858021|FG001|2nd Line AAT|Death|1|||
105782918|NCT00265109|364858033|FG000|Overall Study|Withdrawal by Subject|5|||
105782919|NCT00265109|364858033|FG000|Overall Study|Adverse Event|1|||
105782920|NCT02463097|364858034|FG000|Overall Study|Withdrawal by Subject|1|||
105782921|NCT01177943|364858035|FG000|First Intervention|Withdrawal by Subject|2|||
105782922|NCT01177943|364858036|FG001|First Intervention|Withdrawal by Subject|0|||
105782923|NCT01757821|364858037|FG000|Overall Study|Adverse Event|1|||
105782924|NCT04652245|364858038|FG000|Wash-Out Period|Adverse Event|0|||
105782925|NCT04652245|364858039|FG001|Wash-Out Period|Adverse Event|2|||
105782926|NCT04652245|364858038|FG000|Wash-Out Period|Withdrawal by Subject|0|||
105782927|NCT04652245|364858039|FG001|Wash-Out Period|Withdrawal by Subject|2|||
105782928|NCT00764465|364858042|FG000|Overall Study|Adverse Event|2|||
105782929|NCT00764465|364858043|FG001|Overall Study|Adverse Event|0|||
105782930|NCT00764465|364858044|FG002|Overall Study|Adverse Event|0|||
105782931|NCT00764465|364858045|FG003|Overall Study|Adverse Event|1|||
105782932|NCT00764465|364858046|FG004|Overall Study|Adverse Event|1|||
105782933|NCT00764465|364858047|FG005|Overall Study|Adverse Event|1|||
105782934|NCT00764465|364858042|FG000|Overall Study|Withdrawal by Subject|0|||
105450904|NCT05579977|363658481|FG003|Follow up|Lost to Follow-up|1|||
105450905|NCT05579977|363658482|FG004|Follow up|Lost to Follow-up|1|||
105450906|NCT05579977|363658483|FG005|Follow up|Lost to Follow-up|2|||
105450907|NCT05579977|363658484|FG006|Follow up|Lost to Follow-up|1|||
105450908|NCT05579977|363658485|FG007|Follow up|Lost to Follow-up|1|||
105450909|NCT05579977|363658486|FG008|Follow up|Lost to Follow-up|3|||
105450910|NCT05579977|363658487|FG009|Follow up|Lost to Follow-up|2|||
105450911|NCT05579977|363658488|FG010|Follow up|Lost to Follow-up|2|||
105450912|NCT05579977|363658489|FG011|Follow up|Lost to Follow-up|4|||
105450913|NCT05579977|363658490|FG012|Follow up|Lost to Follow-up|4|||
105450914|NCT05579977|363658478|FG000|Follow up|Withdrawal by Subject|2|||
105450915|NCT05579977|363658479|FG001|Follow up|Withdrawal by Subject|0|||
105450916|NCT05579977|363658480|FG002|Follow up|Withdrawal by Subject|0|||
105450917|NCT05579977|363658481|FG003|Follow up|Withdrawal by Subject|0|||
105450918|NCT05579977|363658482|FG004|Follow up|Withdrawal by Subject|1|||
105450919|NCT05579977|363658483|FG005|Follow up|Withdrawal by Subject|0|||
105450920|NCT05579977|363658484|FG006|Follow up|Withdrawal by Subject|1|||
105450921|NCT05579977|363658485|FG007|Follow up|Withdrawal by Subject|4|||
105450922|NCT05579977|363658486|FG008|Follow up|Withdrawal by Subject|2|||
105450923|NCT05579977|363658487|FG009|Follow up|Withdrawal by Subject|3|||
105450924|NCT05579977|363658488|FG010|Follow up|Withdrawal by Subject|3|||
105450925|NCT05579977|363658489|FG011|Follow up|Withdrawal by Subject|1|||
105450926|NCT05579977|363658490|FG012|Follow up|Withdrawal by Subject|3|||
105450927|NCT00794950|363658493|FG000|BCG Induction|Withdrawal by Subject|2|||
105450928|NCT00794950|363658493|FG000|BCG Induction|ineligible|3|||
105450929|NCT00794950|363658493|FG000|BCG Induction|noncompliant w. BCG|1|||
105450930|NCT00794950|363658493|FG000|BCG Induction|Adverse Event|1|||
105450931|NCT00794950|363658493|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
105450932|NCT00794950|363658493|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
105450933|NCT00794950|363658493|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
105450934|NCT00794950|363658493|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
105450935|NCT01420926|363658494|FG000|Overall Study|Adverse Event|6|||
105450936|NCT01420926|363658495|FG001|Overall Study|Adverse Event|4|||
105450937|NCT01420926|363658494|FG000|Overall Study|Death|18|||
105450938|NCT01420926|363658495|FG001|Overall Study|Death|17|||
105336914|NCT02632409|363234758|FG000|Treatment Period|Ongoing Treatment|20|||
105336915|NCT02632409|363234759|FG001|Treatment Period|Ongoing Treatment|21|||
105336916|NCT02632409|363234758|FG000|Treatment Period|Disease Recurrence|147|||
105336917|NCT02632409|363234759|FG001|Treatment Period|Disease Recurrence|90|||
105336918|NCT02632409|363234758|FG000|Treatment Period|Study Drug Toxicity|8|||
105336919|NCT02632409|363234759|FG001|Treatment Period|Study Drug Toxicity|49|||
105336920|NCT02632409|363234758|FG000|Treatment Period|Death|1|||
105336921|NCT02632409|363234759|FG001|Treatment Period|Death|0|||
105336922|NCT02632409|363234758|FG000|Treatment Period|AE unrelated to study drug|15|||
105336923|NCT02632409|363234759|FG001|Treatment Period|AE unrelated to study drug|16|||
105336924|NCT02632409|363234758|FG000|Treatment Period|Request to discontinue treatment|4|||
105782935|NCT00764465|364858043|FG001|Overall Study|Withdrawal by Subject|1|||
105336925|NCT02632409|363234759|FG001|Treatment Period|Request to discontinue treatment|19|||
105336926|NCT02632409|363234758|FG000|Treatment Period|Participant withdrew consent|7|||
105336927|NCT02632409|363234759|FG001|Treatment Period|Participant withdrew consent|5|||
105450939|NCT01420926|363658494|FG000|Overall Study|Withdrawal by Subject|11|||
105336928|NCT02632409|363234758|FG000|Treatment Period|Lost to Follow-up|0|||
105336929|NCT02632409|363234759|FG001|Treatment Period|Lost to Follow-up|1|||
105336930|NCT02632409|363234758|FG000|Treatment Period|Maximum clinical benefit|1|||
105450940|NCT01420926|363658495|FG001|Overall Study|Withdrawal by Subject|17|||
105782936|NCT00764465|364858044|FG002|Overall Study|Withdrawal by Subject|1|||
105782937|NCT00764465|364858045|FG003|Overall Study|Withdrawal by Subject|0|||
105782938|NCT00764465|364858046|FG004|Overall Study|Withdrawal by Subject|0|||
105782939|NCT00764465|364858047|FG005|Overall Study|Withdrawal by Subject|0|||
105806509|NCT03038113|364949003|FG003|Overall Study|Withdrawal by Subject|0|||
105336931|NCT02632409|363234759|FG001|Treatment Period|Maximum clinical benefit|0|||
105336932|NCT02632409|363234758|FG000|Treatment Period|No longer meets study criteria|3|||
105450941|NCT01420926|363658494|FG000|Overall Study|Non-protocol treatment|17|||
105450942|NCT01420926|363658495|FG001|Overall Study|Non-protocol treatment|20|||
105450943|NCT01420926|363658494|FG000|Overall Study|Physician Decision|8|||
105782940|NCT03457701|364858048|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
105782941|NCT03457701|364858049|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
105782942|NCT03457701|364858048|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
105782943|NCT03457701|364858049|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
105782944|NCT05664672|364858050|FG000|Overall Study|Adverse Event|0|||
105782945|NCT05664672|364858051|FG001|Overall Study|Adverse Event|0|||
105782946|NCT05664672|364858052|FG002|Overall Study|Adverse Event|0|||
105782947|NCT05664672|364858053|FG003|Overall Study|Adverse Event|0|||
105782948|NCT05664672|364858054|FG004|Overall Study|Adverse Event|0|||
105782949|NCT05664672|364858055|FG005|Overall Study|Adverse Event|1|||
105782950|NCT05664672|364858050|FG000|Overall Study|Withdrawal by Subject|0|||
105782951|NCT05664672|364858051|FG001|Overall Study|Withdrawal by Subject|1|||
105782952|NCT05664672|364858052|FG002|Overall Study|Withdrawal by Subject|3|||
105782953|NCT05664672|364858053|FG003|Overall Study|Withdrawal by Subject|0|||
105782954|NCT05664672|364858054|FG004|Overall Study|Withdrawal by Subject|5|||
105782955|NCT05664672|364858055|FG005|Overall Study|Withdrawal by Subject|6|||
105782956|NCT05664672|364858050|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
105782957|NCT05664672|364858051|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
105782958|NCT05664672|364858052|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
105782959|NCT05664672|364858053|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
105782960|NCT05664672|364858054|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
105782961|NCT05664672|364858055|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
105782962|NCT05664672|364858050|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
105782963|NCT05664672|364858051|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
105782964|NCT05664672|364858052|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
105782965|NCT05664672|364858053|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
105782966|NCT05664672|364858054|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
105782967|NCT05664672|364858055|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
105782968|NCT01000311|364858058|FG000|Overall Study|Adverse Event|2|||
105782969|NCT01000311|364858059|FG001|Overall Study|Adverse Event|5|||
105782970|NCT01000311|364858058|FG000|Overall Study|Withdrawal by Subject|16|||
105782971|NCT01000311|364858059|FG001|Overall Study|Withdrawal by Subject|24|||
105782972|NCT01000311|364858058|FG000|Overall Study|Lost to Follow-up|15|||
105782973|NCT01000311|364858059|FG001|Overall Study|Lost to Follow-up|24|||
105782974|NCT01000311|364858058|FG000|Overall Study|Protocol Violation|1|||
105782975|NCT01000311|364858059|FG001|Overall Study|Protocol Violation|2|||
105782976|NCT01000311|364858058|FG000|Overall Study|Inappropriate enrollment|2|||
105782977|NCT01000311|364858059|FG001|Overall Study|Inappropriate enrollment|0|||
105782978|NCT01000311|364858058|FG000|Overall Study|Administrative reason|9|||
105782979|NCT01000311|364858059|FG001|Overall Study|Administrative reason|15|||
105782980|NCT02815670|364858060|FG000|Overall Study|Prematurely discontinued of the trial|1|||
105782981|NCT01314261|364858065|FG000|Overall Study|Adverse Event|1|||
105782982|NCT01314261|364858066|FG001|Overall Study|Adverse Event|0|||
105782983|NCT01314261|364858067|FG002|Overall Study|Adverse Event|0|||
105782984|NCT01314261|364858068|FG003|Overall Study|Adverse Event|0|||
105782985|NCT01314261|364858065|FG000|Overall Study|Withdrawal by Subject|0|||
105782986|NCT01314261|364858066|FG001|Overall Study|Withdrawal by Subject|3|||
105782987|NCT01314261|364858067|FG002|Overall Study|Withdrawal by Subject|1|||
105782988|NCT01314261|364858068|FG003|Overall Study|Withdrawal by Subject|0|||
105782989|NCT01314261|364858065|FG000|Overall Study|Lost to Follow-up|1|||
105782990|NCT01314261|364858066|FG001|Overall Study|Lost to Follow-up|0|||
105782991|NCT01314261|364858067|FG002|Overall Study|Lost to Follow-up|2|||
105782992|NCT01314261|364858068|FG003|Overall Study|Lost to Follow-up|2|||
105782993|NCT01314261|364858065|FG000|Overall Study|Virologic Failure|0|||
105782994|NCT01314261|364858066|FG001|Overall Study|Virologic Failure|1|||
105782995|NCT01314261|364858067|FG002|Overall Study|Virologic Failure|0|||
105782996|NCT01314261|364858068|FG003|Overall Study|Virologic Failure|1|||
105782997|NCT04524507|364858069|FG000|Overall Study|Lost to Follow-up|2|||
105782998|NCT04524507|364858070|FG001|Overall Study|Lost to Follow-up|4|||
105782999|NCT04524507|364858069|FG000|Overall Study|Withdrawal by Subject|2|||
105783000|NCT04524507|364858070|FG001|Overall Study|Withdrawal by Subject|9|||
105783001|NCT04524507|364858069|FG000|Overall Study|Death|2|||
105783002|NCT04524507|364858070|FG001|Overall Study|Death|10|||
105783003|NCT00412360|364858071|FG000|Overall Study|Lost to Follow-up|0|||
105783004|NCT00412360|364858072|FG001|Overall Study|Lost to Follow-up|1|||
105783005|NCT00412360|364858071|FG000|Overall Study|Not Transplanted|1|||
105783006|NCT00412360|364858072|FG001|Overall Study|Not Transplanted|2|||
105783007|NCT02711306|364858074|FG000|Overall Study|Withdrawal by Subject|2|||
105783008|NCT02711306|364858075|FG001|Overall Study|Withdrawal by Subject|2|||
105783009|NCT03655951|364858077|FG000|Overall Study|Lost to Follow-up|39|||
105783010|NCT03655951|364858078|FG001|Overall Study|Lost to Follow-up|20|||
105783011|NCT03655951|364858077|FG000|Overall Study|Withdrawal by Subject|0|||
105336933|NCT02632409|363234759|FG001|Treatment Period|No longer meets study criteria|0|||
105783012|NCT03655951|364858078|FG001|Overall Study|Withdrawal by Subject|1|||
105450944|NCT01420926|363658495|FG001|Overall Study|Physician Decision|5|||
105450945|NCT00961181|363660295|FG000|Overall Study|Death|2|||
105450946|NCT00961181|363660295|FG000|Overall Study|Withdrawal by Subject|2|||
105450947|NCT00961181|363660295|FG000|Overall Study|Lost to Follow-up|1|||
105450948|NCT01045967|363660296|FG000|Second Intervention|Protocol Violation|0|||
105450949|NCT01045967|363660297|FG001|Second Intervention|Protocol Violation|1|||
105450950|NCT02252146|363660298|FG000|Overall Study|Lack of Efficacy|4|||
105450951|NCT02252146|363660298|FG000|Overall Study|Entered hospice care|1|||
105450952|NCT02252146|363660298|FG000|Overall Study|Inability to travel to study site|1|||
105783013|NCT01233076|364859440|FG000|Period 2, One Week|Lost to Follow-up|1|||
105450953|NCT00404651|363660299|FG000|Overall Study|Serious Adverse Event|0|||
105450954|NCT00404651|363660300|FG001|Overall Study|Serious Adverse Event|0|||
105450955|NCT00404651|363660301|FG002|Overall Study|Serious Adverse Event|2|||
105450956|NCT00404651|363660302|FG003|Overall Study|Serious Adverse Event|0|||
105450957|NCT00404651|363660299|FG000|Overall Study|Protocol Violation|10|||
105450958|NCT00404651|363660300|FG001|Overall Study|Protocol Violation|5|||
105450959|NCT00404651|363660301|FG002|Overall Study|Protocol Violation|14|||
105450960|NCT00404651|363660302|FG003|Overall Study|Protocol Violation|5|||
105450961|NCT00404651|363660299|FG000|Overall Study|Lost to Follow-up|15|||
105450962|NCT00404651|363660300|FG001|Overall Study|Lost to Follow-up|11|||
105450963|NCT00404651|363660301|FG002|Overall Study|Lost to Follow-up|13|||
105450964|NCT00404651|363660302|FG003|Overall Study|Lost to Follow-up|10|||
105450965|NCT00404651|363660299|FG000|Overall Study|Withdrawal by Subject|14|||
105450966|NCT00404651|363660300|FG001|Overall Study|Withdrawal by Subject|12|||
105450967|NCT00404651|363660301|FG002|Overall Study|Withdrawal by Subject|16|||
105450968|NCT00404651|363660302|FG003|Overall Study|Withdrawal by Subject|6|||
105450969|NCT01132807|363660303|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
105450970|NCT01132807|363660304|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
105783014|NCT01233076|364859441|FG001|Period 2, One Week|Lost to Follow-up|0|||
105783015|NCT01674010|364859442|FG000|Open Treatment Phase 1|Adverse Event|10|||
105783016|NCT01674010|364859443|FG001|Open Treatment Phase 1|Adverse Event|0|||
105783017|NCT01674010|364859444|FG002|Open Treatment Phase 1|Adverse Event|0|||
105783018|NCT01674010|364859442|FG000|Open Treatment Phase 1|Death|1|||
105783019|NCT01674010|364859443|FG001|Open Treatment Phase 1|Death|0|||
105783020|NCT01674010|364859444|FG002|Open Treatment Phase 1|Death|0|||
105783021|NCT01674010|364859442|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
105783022|NCT01674010|364859443|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
105783023|NCT01674010|364859444|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
105783024|NCT01674010|364859442|FG000|Open Treatment Phase 1|Physician Decision|9|||
105783025|NCT01674010|364859443|FG001|Open Treatment Phase 1|Physician Decision|0|||
105783026|NCT01674010|364859444|FG002|Open Treatment Phase 1|Physician Decision|0|||
105783027|NCT01674010|364859442|FG000|Open Treatment Phase 1|Protocol Violation|7|||
105783028|NCT01674010|364859443|FG001|Open Treatment Phase 1|Protocol Violation|0|||
105783029|NCT01674010|364859444|FG002|Open Treatment Phase 1|Protocol Violation|0|||
105783030|NCT01674010|364859442|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
105783031|NCT01674010|364859443|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
105783032|NCT01674010|364859444|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
105783033|NCT01674010|364859442|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
105783034|NCT01674010|364859443|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
105783035|NCT01674010|364859444|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
105783036|NCT01674010|364859442|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
105783037|NCT01674010|364859443|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
105783038|NCT01674010|364859444|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
105783039|NCT01674010|364859442|FG000|Randomization Phase 2|Adverse Event|0|||
105783040|NCT01674010|364859443|FG001|Randomization Phase 2|Adverse Event|1|||
105783041|NCT01674010|364859444|FG002|Randomization Phase 2|Adverse Event|1|||
105783042|NCT01674010|364859442|FG000|Randomization Phase 2|Lost to Follow-up|0|||
105783043|NCT01674010|364859443|FG001|Randomization Phase 2|Lost to Follow-up|1|||
105783044|NCT01674010|364859444|FG002|Randomization Phase 2|Lost to Follow-up|2|||
105783045|NCT01674010|364859442|FG000|Randomization Phase 2|Mood episode recurrence|0|||
105783046|NCT01674010|364859443|FG001|Randomization Phase 2|Mood episode recurrence|8|||
105783047|NCT01674010|364859444|FG002|Randomization Phase 2|Mood episode recurrence|2|||
105783048|NCT01674010|364859442|FG000|Randomization Phase 2|Physician Decision|0|||
105783049|NCT01674010|364859443|FG001|Randomization Phase 2|Physician Decision|0|||
105783050|NCT01674010|364859444|FG002|Randomization Phase 2|Physician Decision|2|||
105783051|NCT01674010|364859442|FG000|Randomization Phase 2|Pregnancy|0|||
105783052|NCT01674010|364859443|FG001|Randomization Phase 2|Pregnancy|1|||
105783053|NCT01674010|364859444|FG002|Randomization Phase 2|Pregnancy|1|||
105783054|NCT01674010|364859442|FG000|Randomization Phase 2|Protocol Violation|0|||
105783055|NCT01674010|364859443|FG001|Randomization Phase 2|Protocol Violation|1|||
105783056|NCT01674010|364859444|FG002|Randomization Phase 2|Protocol Violation|1|||
105450971|NCT01132807|363660305|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
105783057|NCT01674010|364859442|FG000|Randomization Phase 2|Sponsor Decision|0|||
105783058|NCT01674010|364859443|FG001|Randomization Phase 2|Sponsor Decision|42|||
105450972|NCT01132807|363660303|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
105336934|NCT02632409|363234758|FG000|Treatment Period|Administrative Reason by sponsor|0|||
105336935|NCT02632409|363234759|FG001|Treatment Period|Administrative Reason by sponsor|1|||
105336936|NCT02632409|363234758|FG000|Treatment Period|Other Reasons|10|||
105336937|NCT02632409|363234759|FG001|Treatment Period|Other Reasons|6|||
105336938|NCT00090220|363234761|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
105336939|NCT00090220|363234762|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
105336940|NCT00090220|363234763|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
105336941|NCT00090220|363234764|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
105336942|NCT00090220|363234765|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
105336943|NCT00090220|363234766|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
105336944|NCT00090220|363234761|FG000|Base Study Vaccination Period|Adverse Event|6|||
105336945|NCT00090220|363234762|FG001|Base Study Vaccination Period|Adverse Event|1|||
105336946|NCT00090220|363234763|FG002|Base Study Vaccination Period|Adverse Event|0|||
105450973|NCT01132807|363660304|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
105450974|NCT01132807|363660305|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
105450975|NCT04073186|363660306|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
105450976|NCT04073186|363660306|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
105450977|NCT04073186|363660306|FG000|First Wearing Cycle|Protocol Violation|1|||
105450978|NCT04073186|363660306|FG000|First Wearing Cycle|Lens Discomfort|2|||
105450979|NCT04073186|363660306|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
105450980|NCT04073186|363660306|FG000|Second Wearing Cycle|Adverse Event|1|||
105783059|NCT01674010|364859444|FG002|Randomization Phase 2|Sponsor Decision|45|||
105336947|NCT00090220|363234764|FG003|Base Study Vaccination Period|Adverse Event|0|||
105336948|NCT00090220|363234765|FG004|Base Study Vaccination Period|Adverse Event|0|||
105336949|NCT00090220|363234766|FG005|Base Study Vaccination Period|Adverse Event|0|||
105336950|NCT00090220|363234761|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
105336951|NCT00090220|363234762|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
105336952|NCT00090220|363234763|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
105336953|NCT00090220|363234764|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
105336954|NCT00090220|363234765|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
105336955|NCT00090220|363234766|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
105336956|NCT00090220|363234761|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
105336957|NCT00090220|363234762|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
105336958|NCT00090220|363234763|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
105336959|NCT00090220|363234764|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
105336960|NCT00090220|363234765|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
105336961|NCT00090220|363234766|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
105783060|NCT01674010|364859442|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
105783061|NCT01674010|364859443|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
105783062|NCT01674010|364859444|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
105783063|NCT03159455|364859446|FG000|Overall Study|Adverse Event|0|||
105783064|NCT03159455|364859447|FG001|Overall Study|Adverse Event|0|||
105783065|NCT03159455|364859448|FG002|Overall Study|Adverse Event|0|||
105783066|NCT03159455|364859449|FG003|Overall Study|Adverse Event|0|||
105783067|NCT03159455|364859450|FG004|Overall Study|Adverse Event|0|||
105783068|NCT03159455|364859451|FG005|Overall Study|Adverse Event|1|||
105783069|NCT02058940|364859454|FG000|Overall Study|Discharged from Critical Care Unit|1|||
105783070|NCT02713490|364859455|FG000|Overall Study|Withdrawal by Subject|2|||
105783071|NCT02713490|364859456|FG001|Overall Study|Withdrawal by Subject|1|||
105783072|NCT02713490|364859455|FG000|Overall Study|Did not receive study drug|1|||
105783073|NCT02713490|364859456|FG001|Overall Study|Did not receive study drug|0|||
105783074|NCT02713490|364859455|FG000|Overall Study|Met exclusion criteria|0|||
105783075|NCT02713490|364859456|FG001|Overall Study|Met exclusion criteria|1|||
105783076|NCT02985541|364859464|FG000|Overall Study|Withdrawal by Subject|33|||
105783077|NCT02985541|364859464|FG000|Overall Study|Lost to Follow-up|26|||
105783078|NCT02985541|364859464|FG000|Overall Study|Adverse Event|27|||
105783079|NCT02985541|364859464|FG000|Overall Study|Physician Decision|2|||
105783080|NCT02985541|364859464|FG000|Overall Study|Pregnancy|2|||
105783081|NCT02985541|364859464|FG000|Overall Study|Wish for pregnancy|44|||
105783082|NCT02985541|364859464|FG000|Overall Study|Other reason|5|||
105783083|NCT02985541|364859464|FG000|Overall Study|Not valid for analysis|2|||
105783084|NCT04120116|364859472|FG000|Overall Study|Lost to Follow-up|0|||
105783085|NCT04120116|364859473|FG001|Overall Study|Lost to Follow-up|1|||
105783086|NCT04120116|364859474|FG002|Overall Study|Lost to Follow-up|0|||
105783087|NCT04120116|364859475|FG003|Overall Study|Lost to Follow-up|2|||
105783088|NCT04120116|364859472|FG000|Overall Study|Withdrawal by Subject|1|||
105783089|NCT04120116|364859473|FG001|Overall Study|Withdrawal by Subject|0|||
105783090|NCT04120116|364859474|FG002|Overall Study|Withdrawal by Subject|1|||
105783091|NCT04120116|364859475|FG003|Overall Study|Withdrawal by Subject|1|||
105783092|NCT04120116|364859472|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
105783093|NCT04120116|364859473|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
105450981|NCT03001557|363660307|FG000|Core Phase|Randomized but not treated|0|||
105450982|NCT03001557|363660308|FG001|Core Phase|Randomized but not treated|0|||
105450983|NCT03001557|363660309|FG002|Core Phase|Randomized but not treated|1|||
105450984|NCT03001557|363660310|FG003|Core Phase|Randomized but not treated|0|||
105783094|NCT04120116|364859474|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
105450985|NCT03001557|363660311|FG004|Core Phase|Randomized but not treated|0|||
105450986|NCT03001557|363660312|FG005|Core Phase|Randomized but not treated|0|||
105450987|NCT03001557|363660313|FG006|Core Phase|Randomized but not treated|0|||
105450988|NCT03001557|363660314|FG007|Core Phase|Randomized but not treated|0|||
105450989|NCT03001557|363660307|FG000|Extension Phase|Adverse Event|0|||
105450990|NCT03001557|363660308|FG001|Extension Phase|Adverse Event|0|||
105450991|NCT03001557|363660309|FG002|Extension Phase|Adverse Event|0|||
105450992|NCT03001557|363660310|FG003|Extension Phase|Adverse Event|0|||
105450993|NCT03001557|363660311|FG004|Extension Phase|Adverse Event|0|||
105450994|NCT03001557|363660312|FG005|Extension Phase|Adverse Event|2|||
105450995|NCT03001557|363660313|FG006|Extension Phase|Adverse Event|0|||
105450996|NCT03001557|363660314|FG007|Extension Phase|Adverse Event|0|||
105450997|NCT03001557|363660307|FG000|Extension Phase|Withdrawal by Subject|0|||
105450998|NCT03001557|363660308|FG001|Extension Phase|Withdrawal by Subject|0|||
105450999|NCT03001557|363660309|FG002|Extension Phase|Withdrawal by Subject|0|||
105451000|NCT03001557|363660310|FG003|Extension Phase|Withdrawal by Subject|0|||
105451001|NCT03001557|363660311|FG004|Extension Phase|Withdrawal by Subject|0|||
105451002|NCT03001557|363660312|FG005|Extension Phase|Withdrawal by Subject|1|||
105451003|NCT03001557|363660313|FG006|Extension Phase|Withdrawal by Subject|5|||
105451004|NCT03001557|363660314|FG007|Extension Phase|Withdrawal by Subject|2|||
105451005|NCT03001557|363660307|FG000|Extension Phase|Lost to Follow-up|0|||
105451006|NCT03001557|363660308|FG001|Extension Phase|Lost to Follow-up|0|||
105451007|NCT03001557|363660309|FG002|Extension Phase|Lost to Follow-up|0|||
105451008|NCT03001557|363660310|FG003|Extension Phase|Lost to Follow-up|0|||
105451009|NCT03001557|363660311|FG004|Extension Phase|Lost to Follow-up|0|||
105451010|NCT03001557|363660312|FG005|Extension Phase|Lost to Follow-up|0|||
105451011|NCT03001557|363660313|FG006|Extension Phase|Lost to Follow-up|2|||
105451012|NCT03001557|363660314|FG007|Extension Phase|Lost to Follow-up|1|||
105451013|NCT03001557|363660307|FG000|Extension Phase|Administrative Reason|0|||
105451014|NCT03001557|363660308|FG001|Extension Phase|Administrative Reason|0|||
105451015|NCT03001557|363660309|FG002|Extension Phase|Administrative Reason|0|||
105451016|NCT03001557|363660310|FG003|Extension Phase|Administrative Reason|0|||
105451017|NCT03001557|363660311|FG004|Extension Phase|Administrative Reason|0|||
105451018|NCT03001557|363660312|FG005|Extension Phase|Administrative Reason|1|||
105451019|NCT03001557|363660313|FG006|Extension Phase|Administrative Reason|3|||
105451020|NCT03001557|363660314|FG007|Extension Phase|Administrative Reason|3|||
105451021|NCT03001557|363660307|FG000|Extension Phase|Loss of caregiver|0|||
105451022|NCT03001557|363660308|FG001|Extension Phase|Loss of caregiver|0|||
105661742|NCT04147858|364425117|FG001|Overall Study|Subject Noncompliance, Other|3|||
105783095|NCT04120116|364859475|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
105783096|NCT03410693|364859476|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
105783097|NCT03410693|364859477|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
105783098|NCT03410693|364859476|FG000|Overall Study|Disc trt: Lost to follow up|0|||
105783099|NCT03410693|364859477|FG001|Overall Study|Disc trt: Lost to follow up|1|||
105783100|NCT03410693|364859476|FG000|Overall Study|Disc trt: radiological progression|58|||
105783101|NCT03410693|364859477|FG001|Overall Study|Disc trt: radiological progression|50|||
105783102|NCT03410693|364859476|FG000|Overall Study|Disc trt: Other|1|||
105783103|NCT03410693|364859477|FG001|Overall Study|Disc trt: Other|0|||
105783104|NCT03410693|364859476|FG000|Overall Study|Study drug never administered|1|||
105783105|NCT03410693|364859477|FG001|Overall Study|Study drug never administered|6|||
105783106|NCT03410693|364859476|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
105783107|NCT03410693|364859477|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
105783108|NCT03410693|364859476|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
105783109|NCT03410693|364859477|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
105783110|NCT03410693|364859476|FG000|Overall Study|Disc trt: Physician decision|0|||
105783111|NCT03410693|364859477|FG001|Overall Study|Disc trt: Physician decision|5|||
105783112|NCT03410693|364859476|FG000|Overall Study|Disc trt: clinical progression|1|||
105783113|NCT03410693|364859477|FG001|Overall Study|Disc trt: clinical progression|5|||
105783114|NCT03410693|364859476|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
105783115|NCT03410693|364859477|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
105783116|NCT01789476|364859478|FG000|Overall Study|Lack of Efficacy|6|||
105783117|NCT01789476|364859479|FG001|Overall Study|Lack of Efficacy|2|||
105783118|NCT01789476|364859478|FG000|Overall Study|Adverse Event|1|||
105783119|NCT01789476|364859479|FG001|Overall Study|Adverse Event|0|||
105783120|NCT01789476|364859478|FG000|Overall Study|Unable to get IV access|1|||
105783121|NCT01789476|364859479|FG001|Overall Study|Unable to get IV access|0|||
105783122|NCT00501969|364859480|FG000|Overall Study|Major Protocol Violation|4|||
105783123|NCT00501969|364859480|FG000|Overall Study|Lack of Efficacy|29|||
105783124|NCT00501969|364859480|FG000|Overall Study|Adverse Event|76|||
105451023|NCT03001557|363660309|FG002|Extension Phase|Loss of caregiver|0|||
105451024|NCT03001557|363660310|FG003|Extension Phase|Loss of caregiver|0|||
105451025|NCT03001557|363660311|FG004|Extension Phase|Loss of caregiver|0|||
105451026|NCT03001557|363660312|FG005|Extension Phase|Loss of caregiver|0|||
105451027|NCT03001557|363660313|FG006|Extension Phase|Loss of caregiver|1|||
105451028|NCT03001557|363660314|FG007|Extension Phase|Loss of caregiver|0|||
105451029|NCT03001557|363660307|FG000|Extension Phase|Others|0|||
105451030|NCT03001557|363660308|FG001|Extension Phase|Others|0|||
105451031|NCT03001557|363660309|FG002|Extension Phase|Others|0|||
105451032|NCT03001557|363660310|FG003|Extension Phase|Others|0|||
105451033|NCT03001557|363660311|FG004|Extension Phase|Others|0|||
105451034|NCT03001557|363660312|FG005|Extension Phase|Others|1|||
105451035|NCT03001557|363660313|FG006|Extension Phase|Others|3|||
105451036|NCT03001557|363660314|FG007|Extension Phase|Others|0|||
105451037|NCT04033367|363660315|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
105451038|NCT04033367|363660316|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
105451039|NCT04033367|363660315|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
105451040|NCT04033367|363660316|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
105451041|NCT04033367|363660315|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
105451042|NCT04033367|363660316|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
105451043|NCT04033367|363660315|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
105451044|NCT04033367|363660316|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
105451045|NCT01156480|363660322|FG000|Overall Study|change in diagnosis|0|||
105451046|NCT01156480|363660323|FG001|Overall Study|change in diagnosis|1|||
105783125|NCT00501969|364859480|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
105783126|NCT00501969|364859480|FG000|Overall Study|Subject withdrew consent|51|||
105783127|NCT00501969|364859480|FG000|Overall Study|Lost to Follow-up|4|||
105783128|NCT00501969|364859480|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
105783129|NCT00501969|364859480|FG000|Overall Study|Other: Sponsors Request|10|||
105783130|NCT00501969|364859480|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
105783131|NCT00501969|364859480|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
105783132|NCT00501969|364859480|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
105783133|NCT00501969|364859480|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
105783134|NCT00501969|364859480|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
105783135|NCT00501969|364859480|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
105783136|NCT00501969|364859480|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
105783137|NCT00501969|364859480|FG000|Overall Study|Other: As Required by Local EC|2|||
105783138|NCT00501969|364859480|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
105783139|NCT00501969|364859480|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
105783140|NCT00965458|364859483|FG000|Overall Study|Adverse Event|1|||
105783141|NCT00965458|364859484|FG001|Overall Study|Adverse Event|0|||
105783142|NCT00965458|364859483|FG000|Overall Study|Lost to Follow-up|1|||
105783143|NCT00965458|364859484|FG001|Overall Study|Lost to Follow-up|3|||
105783144|NCT00965458|364859483|FG000|Overall Study|Withdrawal by Subject|0|||
105783145|NCT00965458|364859484|FG001|Overall Study|Withdrawal by Subject|1|||
105783146|NCT00656669|364859485|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
105783147|NCT00656669|364859485|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
105783148|NCT00656669|364859485|FG000|AC (Cycles 6-9)|Adverse Event|1|||
105783149|NCT00656669|364859485|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
105783150|NCT00679042|364859491|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
105783151|NCT00679042|364859491|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
105783152|NCT00679042|364859491|FG000|5-Year Follow Up|Death|1|||
105783153|NCT00679042|364859491|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
105783154|NCT00679042|364859491|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
105783155|NCT04511533|364859494|FG000|Treatment|Other|2|||
105783156|NCT04511533|364859494|FG000|Treatment|Withdrawal by Subject|11|||
105783157|NCT04511533|364859494|FG000|Treatment|Death|5|||
105783158|NCT04511533|364859494|FG000|Treatment|Physician Decision|1|||
105783159|NCT04511533|364859494|FG000|Treatment|Progressive Disease|61|||
105783160|NCT04511533|364859494|FG000|Follow-Up|Other|7|||
105783161|NCT04511533|364859494|FG000|Follow-Up|Withdrawal by Subject|5|||
105783162|NCT04511533|364859494|FG000|Follow-Up|Lost to Follow-up|2|||
105783163|NCT04511533|364859494|FG000|Follow-Up|Death|4|||
105336962|NCT00090220|363234761|FG000|Base Study Vaccination Period|Patient Moved|6|||
105451047|NCT01582061|363660324|FG000|Overall Study|Lack of Efficacy|3|||
105451048|NCT01582061|363660325|FG001|Overall Study|Lack of Efficacy|23|||
105451049|NCT01582061|363660324|FG000|Overall Study|Adverse Event|12|||
105451050|NCT01582061|363660325|FG001|Overall Study|Adverse Event|8|||
105451051|NCT01582061|363660324|FG000|Overall Study|Withdrawal by Subject|10|||
105783164|NCT03382639|364859495|FG000|Overall Study|Adverse Event|2|||
105783165|NCT03382639|364859496|FG001|Overall Study|Adverse Event|0|||
105783166|NCT03382639|364859497|FG002|Overall Study|Adverse Event|1|||
105783167|NCT03382639|364859498|FG003|Overall Study|Adverse Event|1|||
105783168|NCT03382639|364859495|FG000|Overall Study|Lost to Follow-up|1|||
105783169|NCT03382639|364859496|FG001|Overall Study|Lost to Follow-up|0|||
105783170|NCT03382639|364859497|FG002|Overall Study|Lost to Follow-up|0|||
105783171|NCT03382639|364859498|FG003|Overall Study|Lost to Follow-up|0|||
105451052|NCT01582061|363660325|FG001|Overall Study|Withdrawal by Subject|4|||
105451053|NCT01582061|363660324|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105451054|NCT01582061|363660325|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105451055|NCT01582061|363660324|FG000|Overall Study|Death|0|||
105451056|NCT01582061|363660325|FG001|Overall Study|Death|1|||
105451057|NCT01582061|363660324|FG000|Overall Study|condition no longer requires study drug|1|||
105451058|NCT01582061|363660325|FG001|Overall Study|condition no longer requires study drug|0|||
105451059|NCT01582061|363660324|FG000|Overall Study|Lost to Follow-up|1|||
105451060|NCT01582061|363660325|FG001|Overall Study|Lost to Follow-up|0|||
105451061|NCT01569841|363660326|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
105451062|NCT01569841|363660327|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
105451063|NCT01308736|363660335|FG000|Overall Study|Did not attend a single session|6|||
105451064|NCT01308736|363660336|FG001|Overall Study|Did not attend a single session|5|||
105451065|NCT03634085|363660337|FG000|Overall Study|Adverse Event|1|||
105451066|NCT03634085|363660338|FG001|Overall Study|Adverse Event|0|||
105451067|NCT03634085|363660337|FG000|Overall Study|Withdrawal by Subject|0|||
105451068|NCT03634085|363660338|FG001|Overall Study|Withdrawal by Subject|2|||
105451069|NCT00867165|363660345|FG000|Overall Study|Adverse Event|3|||
105451070|NCT00867165|363660346|FG001|Overall Study|Adverse Event|0|||
105451071|NCT00867165|363660345|FG000|Overall Study|Withdrawal by Subject|1|||
105451072|NCT00867165|363660346|FG001|Overall Study|Withdrawal by Subject|0|||
105451073|NCT02920892|363660347|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
105451074|NCT02920892|363660348|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
105451075|NCT02920892|363660349|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
105451076|NCT02920892|363660347|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
105451077|NCT02920892|363660348|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
105451078|NCT02920892|363660349|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
105451079|NCT02920892|363660347|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
105451080|NCT02920892|363660348|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
105451081|NCT02920892|363660349|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
105451082|NCT02920892|363660347|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
105451083|NCT02920892|363660348|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
105451084|NCT02920892|363660349|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
105451085|NCT02920892|363660347|FG000|Placebo-Controlled Period|Physician Decision|0|||
105451086|NCT02920892|363660348|FG001|Placebo-Controlled Period|Physician Decision|0|||
105451087|NCT02920892|363660349|FG002|Placebo-Controlled Period|Physician Decision|1|||
105451088|NCT02920892|363660347|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
105451089|NCT02920892|363660348|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
105451090|NCT02920892|363660349|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
105451091|NCT02920892|363660347|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105451092|NCT02920892|363660348|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
105451093|NCT02920892|363660349|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
105451094|NCT02920892|363660347|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
105451095|NCT02920892|363660348|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
105451096|NCT02920892|363660349|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
105451097|NCT00580723|363660351|FG000|Overall Study|Did not want to participate in extension|3|||
105451098|NCT00580723|363660351|FG000|Overall Study|Lost to Follow-up|5|||
105451099|NCT05202418|363660352|FG000|Overall Study|Withdrawal by Subject|2|||
105451100|NCT05202418|363660353|FG001|Overall Study|Withdrawal by Subject|1|||
105451101|NCT05202418|363660352|FG000|Overall Study|Lost to Follow-up|1|||
105451102|NCT05202418|363660353|FG001|Overall Study|Lost to Follow-up|1|||
105451103|NCT01454596|363660354|FG000|Overall Study|Death|0|||
105451104|NCT01454596|363660355|FG001|Overall Study|Death|0|||
105451105|NCT01454596|363660356|FG002|Overall Study|Death|0|||
105451106|NCT01454596|363660357|FG003|Overall Study|Death|0|||
105451107|NCT01454596|363660358|FG004|Overall Study|Death|0|||
105451108|NCT01454596|363660359|FG005|Overall Study|Death|0|||
105451109|NCT01454596|363660360|FG006|Overall Study|Death|0|||
105451110|NCT01454596|363660361|FG007|Overall Study|Death|0|||
105451111|NCT01454596|363660362|FG008|Overall Study|Death|0|||
105451112|NCT01454596|363660363|FG009|Overall Study|Death|1|||
105451113|NCT01454596|363660364|FG010|Overall Study|Death|1|||
105451114|NCT01454596|363660365|FG011|Overall Study|Death|0|||
105451115|NCT00857285|363660373|FG000|Overall Study|Adverse Event|4|||
105451116|NCT00857285|363660374|FG001|Overall Study|Adverse Event|2|||
105451117|NCT00857285|363660373|FG000|Overall Study|Lack of Efficacy|0|||
105451118|NCT00857285|363660374|FG001|Overall Study|Lack of Efficacy|2|||
105451119|NCT00857285|363660373|FG000|Overall Study|Protocol Violation|3|||
105451120|NCT00857285|363660374|FG001|Overall Study|Protocol Violation|1|||
105451121|NCT00857285|363660373|FG000|Overall Study|Withdrawal by Subject|4|||
105451122|NCT00857285|363660374|FG001|Overall Study|Withdrawal by Subject|0|||
105451123|NCT00857285|363660373|FG000|Overall Study|Randomization criteria not met|1|||
105451124|NCT00857285|363660374|FG001|Overall Study|Randomization criteria not met|1|||
105451125|NCT00880698|363660375|FG000|Overall Study|Death|0|||
105451126|NCT00880698|363660376|FG001|Overall Study|Death|0|||
105783172|NCT03382639|364859495|FG000|Overall Study|Withdrawal by Subject|4|||
105336963|NCT00090220|363234762|FG001|Base Study Vaccination Period|Patient Moved|2|||
105451127|NCT00880698|363660377|FG002|Overall Study|Death|1|||
105451128|NCT00880698|363660378|FG003|Overall Study|Death|2|||
105451129|NCT00880698|363660375|FG000|Overall Study|Lost to Follow-up|1|||
105451130|NCT00880698|363660376|FG001|Overall Study|Lost to Follow-up|3|||
105451131|NCT00880698|363660377|FG002|Overall Study|Lost to Follow-up|0|||
105451132|NCT00880698|363660378|FG003|Overall Study|Lost to Follow-up|1|||
105451133|NCT02021565|363660392|FG000|Baseline Through Intervention|Death|0|||
105451134|NCT02021565|363660393|FG001|Baseline Through Intervention|Death|1|||
105451135|NCT02021565|363660392|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
105451136|NCT02021565|363660393|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
105451137|NCT02021565|363660392|FG000|Baseline Through Intervention|Protocol Violation|0|||
105451138|NCT02021565|363660393|FG001|Baseline Through Intervention|Protocol Violation|7|||
105451139|NCT02021565|363660392|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
105451140|NCT02021565|363660393|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
105451141|NCT02021565|363660392|FG000|3-month Follow-up|Death|3|||
105451142|NCT02021565|363660393|FG001|3-month Follow-up|Death|0|||
105451143|NCT02021565|363660392|FG000|3-month Follow-up|Withdrawal by Subject|4|||
105451144|NCT02021565|363660393|FG001|3-month Follow-up|Withdrawal by Subject|0|||
105451145|NCT02021565|363660392|FG000|3-month Follow-up|Protocol Violation|3|||
105451146|NCT02021565|363660393|FG001|3-month Follow-up|Protocol Violation|2|||
105451147|NCT01188772|363660394|FG000|Overall Study|Randomized but Not Treated|0|||
105451148|NCT01188772|363660395|FG001|Overall Study|Randomized but Not Treated|1|||
105451149|NCT01188772|363660396|FG002|Overall Study|Randomized but Not Treated|0|||
105451150|NCT01188772|363660397|FG003|Overall Study|Randomized but Not Treated|0|||
105451151|NCT01188772|363660394|FG000|Overall Study|Adverse Event|0|||
105451152|NCT01188772|363660395|FG001|Overall Study|Adverse Event|1|||
105451153|NCT01188772|363660396|FG002|Overall Study|Adverse Event|2|||
105451154|NCT01188772|363660397|FG003|Overall Study|Adverse Event|0|||
105451155|NCT01188772|363660394|FG000|Overall Study|Lost to Follow-up|4|||
105451156|NCT01188772|363660395|FG001|Overall Study|Lost to Follow-up|1|||
105451157|NCT01188772|363660396|FG002|Overall Study|Lost to Follow-up|1|||
105451158|NCT01188772|363660397|FG003|Overall Study|Lost to Follow-up|1|||
105451159|NCT01188772|363660394|FG000|Overall Study|Non-responder|0|||
105451160|NCT01188772|363660395|FG001|Overall Study|Non-responder|0|||
105451161|NCT01188772|363660396|FG002|Overall Study|Non-responder|3|||
105451162|NCT01188772|363660397|FG003|Overall Study|Non-responder|0|||
105451163|NCT01188772|363660394|FG000|Overall Study|Physician Decision|0|||
105451164|NCT01188772|363660395|FG001|Overall Study|Physician Decision|0|||
105451165|NCT01188772|363660396|FG002|Overall Study|Physician Decision|1|||
105451166|NCT01188772|363660397|FG003|Overall Study|Physician Decision|0|||
105451167|NCT01188772|363660394|FG000|Overall Study|Terminated by Sponsor|0|||
105451168|NCT01188772|363660395|FG001|Overall Study|Terminated by Sponsor|0|||
105451169|NCT01188772|363660396|FG002|Overall Study|Terminated by Sponsor|1|||
105451170|NCT01188772|363660397|FG003|Overall Study|Terminated by Sponsor|0|||
105451171|NCT01188772|363660394|FG000|Overall Study|Treatment Failure|0|||
105451172|NCT01188772|363660395|FG001|Overall Study|Treatment Failure|0|||
105451173|NCT01188772|363660396|FG002|Overall Study|Treatment Failure|1|||
105451174|NCT01188772|363660397|FG003|Overall Study|Treatment Failure|0|||
105451175|NCT01188772|363660394|FG000|Overall Study|Virologic Failure|1|||
105451176|NCT01188772|363660395|FG001|Overall Study|Virologic Failure|0|||
105451177|NCT01188772|363660396|FG002|Overall Study|Virologic Failure|0|||
105451178|NCT01188772|363660397|FG003|Overall Study|Virologic Failure|0|||
105451179|NCT01188772|363660394|FG000|Overall Study|Withdrawal by Subject|0|||
105451180|NCT01188772|363660395|FG001|Overall Study|Withdrawal by Subject|0|||
105451181|NCT01188772|363660396|FG002|Overall Study|Withdrawal by Subject|2|||
105451182|NCT01188772|363660397|FG003|Overall Study|Withdrawal by Subject|0|||
105451183|NCT03318549|363660398|FG000|Overall Study|Withdrawal by Subject|5|||
105451184|NCT03318549|363660399|FG001|Overall Study|Withdrawal by Subject|19|||
105451185|NCT03318549|363660400|FG002|Overall Study|Withdrawal by Subject|2|||
105451186|NCT03318549|363660401|FG003|Overall Study|Withdrawal by Subject|0|||
105451187|NCT03318549|363660402|FG004|Overall Study|Withdrawal by Subject|0|||
105451188|NCT03318549|363660403|FG005|Overall Study|Withdrawal by Subject|0|||
105451189|NCT03318549|363660404|FG006|Overall Study|Withdrawal by Subject|0|||
105451190|NCT03318549|363660398|FG000|Overall Study|Physician Decision|0|||
105451191|NCT03318549|363660399|FG001|Overall Study|Physician Decision|4|||
105451192|NCT03318549|363660400|FG002|Overall Study|Physician Decision|1|||
105451193|NCT03318549|363660401|FG003|Overall Study|Physician Decision|0|||
105451194|NCT03318549|363660402|FG004|Overall Study|Physician Decision|0|||
105451195|NCT03318549|363660403|FG005|Overall Study|Physician Decision|0|||
105451196|NCT03318549|363660404|FG006|Overall Study|Physician Decision|0|||
105451197|NCT03318549|363660398|FG000|Overall Study|Lost to Follow-up|0|||
105451198|NCT03318549|363660399|FG001|Overall Study|Lost to Follow-up|3|||
105451199|NCT03318549|363660400|FG002|Overall Study|Lost to Follow-up|3|||
105451200|NCT03318549|363660401|FG003|Overall Study|Lost to Follow-up|0|||
105451201|NCT03318549|363660402|FG004|Overall Study|Lost to Follow-up|0|||
105451202|NCT03318549|363660403|FG005|Overall Study|Lost to Follow-up|0|||
105451203|NCT03318549|363660404|FG006|Overall Study|Lost to Follow-up|0|||
105451204|NCT00920855|363660405|FG000|Overall Study|Adverse Event|1|||
105451205|NCT00920855|363660406|FG001|Overall Study|Adverse Event|1|||
105451206|NCT00920855|363660407|FG002|Overall Study|Adverse Event|4|||
105451207|NCT00920855|363660405|FG000|Overall Study|Withdrawal by Subject|2|||
105451208|NCT00920855|363660406|FG001|Overall Study|Withdrawal by Subject|1|||
105451209|NCT00920855|363660407|FG002|Overall Study|Withdrawal by Subject|6|||
105451210|NCT00920855|363660405|FG000|Overall Study|Disease progression|2|||
105451211|NCT00920855|363660406|FG001|Overall Study|Disease progression|1|||
105451212|NCT00920855|363660407|FG002|Overall Study|Disease progression|10|||
105451213|NCT00920855|363660405|FG000|Overall Study|Noncompliance to study medication|0|||
105451214|NCT00920855|363660406|FG001|Overall Study|Noncompliance to study medication|0|||
105451215|NCT00920855|363660407|FG002|Overall Study|Noncompliance to study medication|1|||
105451216|NCT00920855|363660405|FG000|Overall Study|Response plateau; started maintenance|0|||
105451217|NCT00920855|363660406|FG001|Overall Study|Response plateau; started maintenance|0|||
105451218|NCT00920855|363660407|FG002|Overall Study|Response plateau; started maintenance|1|||
105451219|NCT01894607|363660408|FG000|Overall Study|Ineligible|1|||
105451220|NCT00539994|363660409|FG000|Overall Study|Lost to Follow-up|2|||
105451221|NCT00539994|363660410|FG001|Overall Study|Lost to Follow-up|1|||
105451222|NCT00539994|363660411|FG002|Overall Study|Lost to Follow-up|0|||
105451223|NCT00539994|363660409|FG000|Overall Study|Withdrawal by Subject|1|||
105451224|NCT00539994|363660410|FG001|Overall Study|Withdrawal by Subject|0|||
105451225|NCT00539994|363660411|FG002|Overall Study|Withdrawal by Subject|1|||
105451226|NCT00539994|363660409|FG000|Overall Study|Physician Decision|0|||
105451227|NCT00539994|363660410|FG001|Overall Study|Physician Decision|0|||
105451228|NCT00539994|363660411|FG002|Overall Study|Physician Decision|1|||
105451229|NCT05470985|363660414|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
105451230|NCT05470985|363660415|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
105451231|NCT05470985|363660414|FG000|Double Blind Treatment Period|Physician Decision|0|||
105451232|NCT05470985|363660415|FG001|Double Blind Treatment Period|Physician Decision|1|||
105451233|NCT05470985|363660414|FG000|Long Term Extension|Adverse Event|0|||
105451234|NCT05470985|363660415|FG001|Long Term Extension|Adverse Event|1|||
105451235|NCT05470985|363660414|FG000|Long Term Extension|Study terminated by sponsor|2|||
105451236|NCT05470985|363660415|FG001|Long Term Extension|Study terminated by sponsor|0|||
105451237|NCT01787461|363660420|FG000|Overall Study|Adverse Event|4|||
105451238|NCT01787461|363660421|FG001|Overall Study|Adverse Event|3|||
105451239|NCT01787461|363660420|FG000|Overall Study|Lost to Follow-up|3|||
105451240|NCT01787461|363660421|FG001|Overall Study|Lost to Follow-up|2|||
105451241|NCT01787461|363660420|FG000|Overall Study|No longer met eligibility criteria|1|||
105451242|NCT01787461|363660421|FG001|Overall Study|No longer met eligibility criteria|0|||
105451243|NCT01787461|363660420|FG000|Overall Study|Withdrawal by Subject|3|||
105451244|NCT01787461|363660421|FG001|Overall Study|Withdrawal by Subject|4|||
105451245|NCT01787461|363660420|FG000|Overall Study|Protocol Violation|3|||
105451246|NCT01787461|363660421|FG001|Overall Study|Protocol Violation|0|||
105451247|NCT00607087|363660422|FG000|Overall Study|Withdrawal by Subject|9|||
105451248|NCT00607087|363660423|FG001|Overall Study|Withdrawal by Subject|4|||
105451249|NCT00607087|363660424|FG002|Overall Study|Withdrawal by Subject|4|||
105451250|NCT00607087|363660422|FG000|Overall Study|Adverse Event|3|||
105451251|NCT00607087|363660423|FG001|Overall Study|Adverse Event|2|||
105451252|NCT00607087|363660424|FG002|Overall Study|Adverse Event|3|||
105451253|NCT00607087|363660422|FG000|Overall Study|Other reason|1|||
105451254|NCT00607087|363660423|FG001|Overall Study|Other reason|5|||
105451255|NCT00607087|363660424|FG002|Overall Study|Other reason|2|||
105451256|NCT00607087|363660422|FG000|Overall Study|Poor compliance to protocol|1|||
105451257|NCT00607087|363660423|FG001|Overall Study|Poor compliance to protocol|0|||
105451258|NCT00607087|363660424|FG002|Overall Study|Poor compliance to protocol|1|||
105451259|NCT00607087|363660422|FG000|Overall Study|Lost to Follow-up|1|||
105451260|NCT00607087|363660423|FG001|Overall Study|Lost to Follow-up|0|||
105451261|NCT00607087|363660424|FG002|Overall Study|Lost to Follow-up|0|||
105451262|NCT00607087|363660422|FG000|Period 1|Withdrawal by Subject|7|||
105451263|NCT00607087|363660423|FG001|Period 1|Withdrawal by Subject|2|||
105451264|NCT00607087|363660424|FG002|Period 1|Withdrawal by Subject|3|||
105451265|NCT00607087|363660422|FG000|Period 1|Adverse Event|3|||
105451266|NCT00607087|363660423|FG001|Period 1|Adverse Event|0|||
105451267|NCT00607087|363660424|FG002|Period 1|Adverse Event|0|||
105451268|NCT00607087|363660422|FG000|Period 1|Poor compliance to protocol|1|||
105451269|NCT00607087|363660423|FG001|Period 1|Poor compliance to protocol|0|||
105451270|NCT00607087|363660424|FG002|Period 1|Poor compliance to protocol|0|||
105451271|NCT00607087|363660422|FG000|Period 1|Lost to Follow-up|1|||
105451272|NCT00607087|363660423|FG001|Period 1|Lost to Follow-up|0|||
105451273|NCT00607087|363660424|FG002|Period 1|Lost to Follow-up|0|||
105451274|NCT00607087|363660422|FG000|Period 1|Other reason|0|||
105451275|NCT00607087|363660423|FG001|Period 1|Other reason|4|||
105451276|NCT00607087|363660424|FG002|Period 1|Other reason|2|||
105451277|NCT00607087|363660422|FG000|Period 2|Withdrawal by Subject|0|||
105451278|NCT00607087|363660423|FG001|Period 2|Withdrawal by Subject|1|||
105451279|NCT00607087|363660424|FG002|Period 2|Withdrawal by Subject|1|||
105451280|NCT00607087|363660422|FG000|Period 2|Other reason|1|||
105783173|NCT03382639|364859496|FG001|Overall Study|Withdrawal by Subject|3|||
105783174|NCT03382639|364859497|FG002|Overall Study|Withdrawal by Subject|2|||
105783175|NCT03382639|364859498|FG003|Overall Study|Withdrawal by Subject|3|||
105783176|NCT03382639|364859495|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
105783177|NCT03382639|364859496|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
105451281|NCT00607087|363660423|FG001|Period 2|Other reason|1|||
105451282|NCT00607087|363660424|FG002|Period 2|Other reason|0|||
105451283|NCT00607087|363660422|FG000|Period 2|Adverse Event|0|||
105451284|NCT00607087|363660423|FG001|Period 2|Adverse Event|1|||
105451285|NCT00607087|363660424|FG002|Period 2|Adverse Event|3|||
105451286|NCT00607087|363660422|FG000|Period 2|Poor compliance to protocol|0|||
105451287|NCT00607087|363660423|FG001|Period 2|Poor compliance to protocol|0|||
105451288|NCT00607087|363660424|FG002|Period 2|Poor compliance to protocol|1|||
105451289|NCT00607087|363660422|FG000|Period 3|Withdrawal by Subject|2|||
105451290|NCT00607087|363660423|FG001|Period 3|Withdrawal by Subject|1|||
105451291|NCT00607087|363660424|FG002|Period 3|Withdrawal by Subject|0|||
105451292|NCT00607087|363660422|FG000|Period 3|Adverse Event|0|||
105451293|NCT00607087|363660423|FG001|Period 3|Adverse Event|1|||
105451294|NCT00607087|363660424|FG002|Period 3|Adverse Event|0|||
105451295|NCT04816214|363660428|FG000|Overall Study|Progressive Disease|4|||
105451296|NCT04816214|363660429|FG001|Overall Study|Progressive Disease|0|||
105451297|NCT04816214|363660430|FG002|Overall Study|Progressive Disease|0|||
105451298|NCT04816214|363660428|FG000|Overall Study|Death|1|||
105451299|NCT04816214|363660429|FG001|Overall Study|Death|0|||
105451300|NCT04816214|363660430|FG002|Overall Study|Death|0|||
105451301|NCT04816214|363660428|FG000|Overall Study|Study Terminated by Sponsor|1|||
105451302|NCT04816214|363660429|FG001|Overall Study|Study Terminated by Sponsor|0|||
105451303|NCT04816214|363660430|FG002|Overall Study|Study Terminated by Sponsor|0|||
105451304|NCT00550407|363660431|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
105451305|NCT00550407|363660432|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
105451306|NCT00550407|363660433|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
105451307|NCT00550407|363660431|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
105451308|NCT00550407|363660432|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
105451309|NCT00550407|363660433|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
105451310|NCT00550407|363660431|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
105451311|NCT00550407|363660432|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
105451312|NCT00550407|363660433|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
105451313|NCT00550407|363660431|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
105451314|NCT00550407|363660432|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
105451315|NCT00550407|363660433|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
105451316|NCT00550407|363660431|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
105451317|NCT00550407|363660432|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
105451318|NCT00550407|363660433|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
105451319|NCT00550407|363660431|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
105451320|NCT00550407|363660432|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
105451321|NCT00550407|363660433|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
105451322|NCT00550407|363660431|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
105451323|NCT00550407|363660432|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
105451324|NCT00550407|363660433|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
105451325|NCT00550407|363660431|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
105451326|NCT00550407|363660432|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
105451327|NCT00550407|363660433|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
105451328|NCT00550407|363660431|FG000|26-Week Randomized Phase|Adverse Event|0|||
105451329|NCT00550407|363660432|FG001|26-Week Randomized Phase|Adverse Event|5|||
105451330|NCT00550407|363660433|FG002|26-Week Randomized Phase|Adverse Event|2|||
105451331|NCT00550407|363660431|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
105451332|NCT00550407|363660432|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
105451333|NCT00550407|363660433|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
105451334|NCT00550407|363660431|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
105451335|NCT00550407|363660432|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
105451336|NCT00550407|363660433|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
105451337|NCT00550407|363660431|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
105451338|NCT00550407|363660432|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
105451339|NCT00550407|363660433|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
105451340|NCT00556894|363660434|FG000|Overall Study|Adverse Event|2|||
105451341|NCT00556894|363660435|FG001|Overall Study|Adverse Event|3|||
105451342|NCT00556894|363660436|FG002|Overall Study|Adverse Event|3|||
105451343|NCT00556894|363660434|FG000|Overall Study|Death|1|||
105451344|NCT00556894|363660435|FG001|Overall Study|Death|0|||
105451345|NCT00556894|363660436|FG002|Overall Study|Death|0|||
105550196|NCT00467870|364014377|FG003|Overall Study|Protocol Violation|2|||
105783178|NCT03382639|364859497|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
105451346|NCT00556894|363660434|FG000|Overall Study|regulatory decision in Bulgaria|10|||
105451347|NCT00556894|363660435|FG001|Overall Study|regulatory decision in Bulgaria|14|||
105451348|NCT00556894|363660436|FG002|Overall Study|regulatory decision in Bulgaria|13|||
105451349|NCT00556894|363660434|FG000|Overall Study|Change in therapy|2|||
105451350|NCT00556894|363660435|FG001|Overall Study|Change in therapy|1|||
105451351|NCT00556894|363660436|FG002|Overall Study|Change in therapy|2|||
105451352|NCT00556894|363660434|FG000|Overall Study|Withdrawal by Subject|1|||
105451353|NCT00556894|363660435|FG001|Overall Study|Withdrawal by Subject|1|||
105451354|NCT00556894|363660436|FG002|Overall Study|Withdrawal by Subject|1|||
105451355|NCT04393493|363660437|FG000|First 4 Days of Intervention|Early improvement|5|||
105451356|NCT04393493|363660438|FG001|First 4 Days of Intervention|Early improvement|7|||
105451357|NCT02910466|363660439|FG000|Overall Study|Adverse Event|1|||
105451358|NCT02910466|363660439|FG000|Overall Study|Withdrawal by Subject|3|||
105451359|NCT02910466|363660439|FG000|Overall Study|Lost to Follow-up|5|||
105451360|NCT02910466|363660439|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
105451361|NCT02910466|363660439|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
105451362|NCT01125800|363660440|FG000|Phase I|Protocol Violation|0|||
105451363|NCT01125800|363660441|FG001|Phase I|Protocol Violation|3|||
105451364|NCT01125800|363660442|FG002|Phase I|Protocol Violation|1|||
105451365|NCT01125800|363660443|FG003|Phase I|Protocol Violation|1|||
105451366|NCT01125800|363660444|FG004|Phase I|Protocol Violation|0|||
105451367|NCT01125800|363660440|FG000|Phase I|Adverse Event|2|||
105451368|NCT01125800|363660441|FG001|Phase I|Adverse Event|2|||
105451369|NCT01125800|363660442|FG002|Phase I|Adverse Event|1|||
105451370|NCT01125800|363660443|FG003|Phase I|Adverse Event|7|||
105451371|NCT01125800|363660444|FG004|Phase I|Adverse Event|0|||
105451372|NCT01125800|363660440|FG000|Phase I|Administrative problems|1|||
105451373|NCT01125800|363660441|FG001|Phase I|Administrative problems|0|||
105451374|NCT01125800|363660442|FG002|Phase I|Administrative problems|0|||
105451375|NCT01125800|363660443|FG003|Phase I|Administrative problems|0|||
105451376|NCT01125800|363660444|FG004|Phase I|Administrative problems|0|||
105451377|NCT01125800|363660440|FG000|Phase I|Withdrawal by Subject|0|||
105451378|NCT01125800|363660441|FG001|Phase I|Withdrawal by Subject|0|||
105451379|NCT01125800|363660442|FG002|Phase I|Withdrawal by Subject|1|||
105451380|NCT01125800|363660443|FG003|Phase I|Withdrawal by Subject|0|||
105451381|NCT01125800|363660444|FG004|Phase I|Withdrawal by Subject|0|||
105451382|NCT01125800|363660440|FG000|Phase I|Disease progression|5|||
105451383|NCT01125800|363660441|FG001|Phase I|Disease progression|4|||
105451384|NCT01125800|363660442|FG002|Phase I|Disease progression|1|||
105451385|NCT01125800|363660443|FG003|Phase I|Disease progression|3|||
105451386|NCT01125800|363660444|FG004|Phase I|Disease progression|0|||
105451387|NCT01125800|363660440|FG000|Phase II|Protocol Violation|0|||
105451388|NCT01125800|363660441|FG001|Phase II|Protocol Violation|0|||
105451389|NCT01125800|363660442|FG002|Phase II|Protocol Violation|0|||
105451390|NCT01125800|363660443|FG003|Phase II|Protocol Violation|0|||
105451391|NCT01125800|363660444|FG004|Phase II|Protocol Violation|1|||
105451392|NCT01125800|363660440|FG000|Phase II|Adverse Event|0|||
105451393|NCT01125800|363660441|FG001|Phase II|Adverse Event|0|||
105451394|NCT01125800|363660442|FG002|Phase II|Adverse Event|0|||
105451395|NCT01125800|363660443|FG003|Phase II|Adverse Event|0|||
105451396|NCT01125800|363660444|FG004|Phase II|Adverse Event|2|||
105451397|NCT01125800|363660440|FG000|Phase II|Disease progression|0|||
105451398|NCT01125800|363660441|FG001|Phase II|Disease progression|0|||
105451399|NCT01125800|363660442|FG002|Phase II|Disease progression|0|||
105451400|NCT01125800|363660443|FG003|Phase II|Disease progression|1|||
105451401|NCT01125800|363660444|FG004|Phase II|Disease progression|8|||
105451402|NCT03446313|363660450|FG000|Overall Study|Lost to Follow-up|1|||
105451403|NCT03446313|363660451|FG001|Overall Study|Lost to Follow-up|2|||
105451404|NCT03446313|363660450|FG000|Overall Study|Failed primary screening|3|||
105451405|NCT03446313|363660451|FG001|Overall Study|Failed primary screening|0|||
105451406|NCT03446313|363660450|FG000|Overall Study|Diagnosed with terminal cancer|1|||
105451407|NCT03446313|363660451|FG001|Overall Study|Diagnosed with terminal cancer|0|||
105451408|NCT03446313|363660450|FG000|Overall Study|Excluded from analysis|1|||
105451409|NCT03446313|363660451|FG001|Overall Study|Excluded from analysis|1|||
105451410|NCT00410956|363660452|FG000|Overall Study|Adverse Event|1|||
105451411|NCT00410956|363660452|FG000|Overall Study|Death|2|||
105451412|NCT00410956|363660452|FG000|Overall Study|Lack of Efficacy|10|||
105451413|NCT00410956|363660452|FG000|Overall Study|Physician Decision|6|||
105451414|NCT01650194|363660453|FG000|Overall Study|Progressive Disease (PD)|35|||
105451415|NCT01650194|363660453|FG000|Overall Study|Withdrawal by Subject|2|||
105451416|NCT01650194|363660453|FG000|Overall Study|Miscellaneous|10|||
105451417|NCT01611194|363660454|FG000|Overall Study|Lost to Follow-up|0|||
105451418|NCT01611194|363660455|FG001|Overall Study|Lost to Follow-up|1|||
105451419|NCT01611194|363660454|FG000|Overall Study|Withdrawal by Subject|0|||
105451420|NCT01611194|363660455|FG001|Overall Study|Withdrawal by Subject|1|||
105451421|NCT01611194|363660454|FG000|Overall Study|drug use|0|||
105451422|NCT01611194|363660455|FG001|Overall Study|drug use|1|||
105451423|NCT03790111|363662009|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
105451424|NCT02831764|363662010|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
105451425|NCT02831764|363662011|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
105451426|NCT02831764|363662012|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
105451427|NCT02831764|363662013|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
105451428|NCT02831764|363662014|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
105451429|NCT02831764|363662010|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
105451430|NCT02831764|363662011|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
105451431|NCT02831764|363662012|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
105451432|NCT02831764|363662013|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
105451433|NCT02831764|363662014|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
105451434|NCT02831764|363662010|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
105451435|NCT02831764|363662011|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
105451436|NCT02831764|363662012|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
105451437|NCT02831764|363662013|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
105451438|NCT02831764|363662014|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
105451439|NCT02831764|363662010|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
105451440|NCT02831764|363662011|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
105451441|NCT02831764|363662012|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
105451442|NCT02831764|363662013|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
105451443|NCT02831764|363662014|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
105451444|NCT02831764|363662010|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
105451445|NCT02831764|363662011|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
105451446|NCT02831764|363662012|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
105451447|NCT02831764|363662013|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
105451448|NCT02831764|363662014|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
105451449|NCT02831764|363662010|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
105451450|NCT02831764|363662011|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
105451451|NCT02831764|363662012|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
105451452|NCT02831764|363662013|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
105451453|NCT02831764|363662014|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
105451454|NCT02831764|363662010|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
105451455|NCT02831764|363662011|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
105451456|NCT02831764|363662012|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
105451457|NCT02831764|363662013|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
105451458|NCT02831764|363662014|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
105451459|NCT02831764|363662010|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
105451460|NCT02831764|363662011|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
105451461|NCT02831764|363662012|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
105451462|NCT02831764|363662013|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
105451463|NCT02831764|363662014|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
105451464|NCT02831764|363662010|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
105451465|NCT02831764|363662011|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
105451466|NCT02831764|363662012|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
105451467|NCT02831764|363662013|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
105451468|NCT02831764|363662014|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
105451469|NCT02831764|363662010|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
105451470|NCT02831764|363662011|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
105451471|NCT02831764|363662012|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
105451472|NCT02831764|363662013|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
105451473|NCT02831764|363662014|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
105451474|NCT02831764|363662010|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
105451475|NCT02831764|363662011|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
105451476|NCT02831764|363662012|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
105451477|NCT02831764|363662013|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
105451478|NCT02831764|363662014|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
105451479|NCT02831764|363662010|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
105451480|NCT02831764|363662011|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
105451481|NCT02831764|363662012|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
105451482|NCT02831764|363662013|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
105451483|NCT02831764|363662014|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
105451484|NCT02831764|363662010|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
105451485|NCT02831764|363662011|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
105451486|NCT02831764|363662012|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
105550197|NCT00467870|364014378|FG004|Overall Study|Protocol Violation|0|||
105451487|NCT02831764|363662013|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
105451488|NCT02831764|363662014|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
105451489|NCT02831764|363662010|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
105783179|NCT03382639|364859498|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
105451490|NCT02831764|363662011|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
105451491|NCT02831764|363662012|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
105451492|NCT02831764|363662013|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
105451493|NCT02831764|363662014|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
105451494|NCT02831764|363662010|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
105451495|NCT02831764|363662011|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
105451496|NCT02831764|363662012|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
105451497|NCT02831764|363662013|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
105451498|NCT02831764|363662014|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
105451499|NCT02831764|363662010|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
105451500|NCT02831764|363662011|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
105451501|NCT02831764|363662012|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
105451502|NCT02831764|363662013|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
105451503|NCT02831764|363662014|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
105451504|NCT02831764|363662010|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
105451505|NCT02831764|363662011|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
105451506|NCT02831764|363662012|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
105451507|NCT02831764|363662013|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
105451508|NCT02831764|363662014|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
105451509|NCT02831764|363662010|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
105451510|NCT02831764|363662011|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
105451511|NCT02831764|363662012|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
105451512|NCT02831764|363662013|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
105451513|NCT02831764|363662014|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
105451514|NCT02831764|363662010|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
105451515|NCT02831764|363662011|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
105451516|NCT02831764|363662012|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
105451517|NCT02831764|363662013|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
105451518|NCT02831764|363662014|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
105451519|NCT03798717|363662016|FG000|Overall Study|Failed Screening|0|||
105451520|NCT03798717|363662017|FG001|Overall Study|Failed Screening|0|||
105451521|NCT03798717|363662018|FG002|Overall Study|Failed Screening|0|||
105451522|NCT03798717|363662019|FG003|Overall Study|Failed Screening|0|||
105451523|NCT03798717|363662020|FG004|Overall Study|Failed Screening|0|||
105451524|NCT03798717|363662021|FG005|Overall Study|Failed Screening|1|||
105451525|NCT03798717|363662016|FG000|Overall Study|Physician Decision|1|||
105451526|NCT03798717|363662017|FG001|Overall Study|Physician Decision|0|||
105451527|NCT03798717|363662018|FG002|Overall Study|Physician Decision|1|||
105451528|NCT03798717|363662019|FG003|Overall Study|Physician Decision|0|||
105451529|NCT03798717|363662020|FG004|Overall Study|Physician Decision|0|||
105451530|NCT03798717|363662021|FG005|Overall Study|Physician Decision|0|||
105451531|NCT03798717|363662016|FG000|Overall Study|Withdrawal by Subject|0|||
105451532|NCT03798717|363662017|FG001|Overall Study|Withdrawal by Subject|0|||
105451533|NCT03798717|363662018|FG002|Overall Study|Withdrawal by Subject|0|||
105451534|NCT03798717|363662019|FG003|Overall Study|Withdrawal by Subject|1|||
105451535|NCT03798717|363662020|FG004|Overall Study|Withdrawal by Subject|0|||
105451536|NCT03798717|363662021|FG005|Overall Study|Withdrawal by Subject|0|||
105451537|NCT03798717|363662016|FG000|Overall Study|Lost to Follow-up|1|||
105451538|NCT03798717|363662017|FG001|Overall Study|Lost to Follow-up|0|||
105451539|NCT03798717|363662018|FG002|Overall Study|Lost to Follow-up|0|||
105451540|NCT03798717|363662019|FG003|Overall Study|Lost to Follow-up|1|||
105451541|NCT03798717|363662020|FG004|Overall Study|Lost to Follow-up|0|||
105451542|NCT03798717|363662021|FG005|Overall Study|Lost to Follow-up|0|||
105451543|NCT03798717|363662016|FG000|Overall Study|Adverse Event|0|||
105451544|NCT03798717|363662017|FG001|Overall Study|Adverse Event|1|||
105451545|NCT03798717|363662018|FG002|Overall Study|Adverse Event|0|||
105451546|NCT03798717|363662019|FG003|Overall Study|Adverse Event|0|||
105451547|NCT03798717|363662020|FG004|Overall Study|Adverse Event|0|||
105451548|NCT03798717|363662021|FG005|Overall Study|Adverse Event|0|||
105451549|NCT03798717|363662016|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
105451550|NCT03798717|363662017|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
105451551|NCT03798717|363662018|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
105451552|NCT03798717|363662019|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
105451553|NCT03798717|363662020|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
105451554|NCT03798717|363662021|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
105451555|NCT04002960|363662023|FG000|Overall Study|Withdrawn prior to Completion|2|||
105451556|NCT03811340|363662026|FG000|Overall Study|subjects did not complete the survey.|90|||
105451557|NCT00865345|363662032|FG000|Overall Study|Withdrawal by Subject|2|||
105451558|NCT02219464|363662033|FG000|Overall Study|Withdrawal by Subject|1|||
105451559|NCT02219464|363662034|FG001|Overall Study|Withdrawal by Subject|0|||
105451560|NCT02219464|363662033|FG000|Overall Study|case cancelled|1|||
105451561|NCT02219464|363662034|FG001|Overall Study|case cancelled|0|||
105451562|NCT02219464|363662033|FG000|Overall Study|catheter malfunction|1|||
105451563|NCT02219464|363662034|FG001|Overall Study|catheter malfunction|0|||
105451564|NCT00984256|363662035|FG000|Overall Study|Withdrawal by Subject|0|||
105451565|NCT00984256|363662036|FG001|Overall Study|Withdrawal by Subject|1|||
105451566|NCT02038153|363662044|FG000|Overall Study|Withdrawal by Subject|1|||
105451567|NCT03683173|363662053|FG000|Completed Follow-up|Unavailable|235|||
105451568|NCT03683173|363662054|FG001|Completed Follow-up|Unavailable|217|||
105451569|NCT03683173|363662053|FG000|Completed Follow-up|Refused|69|||
105451570|NCT03683173|363662054|FG001|Completed Follow-up|Refused|59|||
105451571|NCT03683173|363662053|FG000|Completed Follow-up|Disconnected phone|65|||
105451572|NCT03683173|363662054|FG001|Completed Follow-up|Disconnected phone|95|||
105451573|NCT03683173|363662053|FG000|Completed Follow-up|Health issue/deceased|10|||
105451574|NCT03683173|363662054|FG001|Completed Follow-up|Health issue/deceased|4|||
105451575|NCT03683173|363662053|FG000|Completed Follow-up|Moved away|8|||
105451576|NCT03683173|363662054|FG001|Completed Follow-up|Moved away|1|||
105451577|NCT01329263|363662055|FG000|Overall Study|Lost to Follow-up|4|||
105451578|NCT01329263|363662056|FG001|Overall Study|Lost to Follow-up|21|||
105451579|NCT01329263|363662055|FG000|Overall Study|Withdrawal by Subject|1|||
105451580|NCT01329263|363662056|FG001|Overall Study|Withdrawal by Subject|2|||
105451581|NCT01421017|363662057|FG000|Overall Study|Withdrawal by Subject|2|||
105451582|NCT01421017|363662058|FG001|Overall Study|Withdrawal by Subject|0|||
105451583|NCT01421017|363662059|FG002|Overall Study|Withdrawal by Subject|0|||
105451584|NCT01421017|363662057|FG000|Overall Study|POD|0|||
105451585|NCT01421017|363662058|FG001|Overall Study|POD|6|||
105451586|NCT01421017|363662059|FG002|Overall Study|POD|3|||
105451587|NCT02313766|363662066|FG000|Overall Study|surgery cancelled|1|||
105451588|NCT02313766|363662067|FG001|Overall Study|surgery cancelled|0|||
105451589|NCT02313766|363662068|FG002|Overall Study|surgery cancelled|0|||
105451590|NCT02313766|363662066|FG000|Overall Study|Lost to Follow-up|0|||
105451591|NCT02313766|363662067|FG001|Overall Study|Lost to Follow-up|2|||
105451592|NCT02313766|363662068|FG002|Overall Study|Lost to Follow-up|0|||
105451593|NCT02313766|363662066|FG000|Overall Study|Adverse Event|0|||
105451594|NCT02313766|363662067|FG001|Overall Study|Adverse Event|1|||
105451595|NCT02313766|363662068|FG002|Overall Study|Adverse Event|0|||
105451596|NCT00248495|363662079|FG000|Overall Study|Withdrawal by Subject|1|||
105451597|NCT03812380|363662080|FG000|Overall Study|Protocol Violation|3|||
105451598|NCT03812380|363662081|FG001|Overall Study|Protocol Violation|3|||
105451599|NCT03812380|363662080|FG000|Overall Study|Withdrawal by Subject|5|||
105451600|NCT03812380|363662081|FG001|Overall Study|Withdrawal by Subject|4|||
105451601|NCT03812380|363662080|FG000|Overall Study|Early termination of study|14|||
105451602|NCT03812380|363662081|FG001|Overall Study|Early termination of study|14|||
105451603|NCT00473434|363662082|FG000|Overall Study|Physician Decision|3|||
105451604|NCT00473434|363662082|FG000|Overall Study|Withdrawal by Subject|9|||
105451605|NCT00473434|363662082|FG000|Overall Study|Compliance|3|||
105451606|NCT00473434|363662082|FG000|Overall Study|Lack of Efficacy|3|||
105451607|NCT00473434|363662082|FG000|Overall Study|Adverse Event|3|||
105451608|NCT00473434|363662082|FG000|Overall Study|Patient was selling medication to others|1|||
105451609|NCT00473434|363662082|FG000|Overall Study|Safety evaluation|1|||
105451610|NCT00473434|363662082|FG000|Overall Study|Reason not specified|6|||
105451611|NCT00473434|363662082|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
105451612|NCT00473434|363662082|FG000|Overall Study|Switching to trial medication|1|||
105451613|NCT00473434|363662082|FG000|Overall Study|No longer required|1|||
105783180|NCT03382639|364859495|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
105783181|NCT03382639|364859496|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
105783182|NCT03382639|364859497|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
105783183|NCT03382639|364859498|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
105783184|NCT03382639|364859495|FG000|Overall Study|Other|2|||
105783185|NCT03382639|364859496|FG001|Overall Study|Other|0|||
105451614|NCT02322281|363662083|FG000|Overall Study|Progressive Disease|42|||
105451615|NCT02322281|363662084|FG001|Overall Study|Progressive Disease|14|||
105451616|NCT02322281|363662085|FG002|Overall Study|Progressive Disease|49|||
105451617|NCT02322281|363662083|FG000|Overall Study|Adverse Event|3|||
105451618|NCT02322281|363662084|FG001|Overall Study|Adverse Event|4|||
105451619|NCT02322281|363662085|FG002|Overall Study|Adverse Event|6|||
105451620|NCT02322281|363662083|FG000|Overall Study|Death|3|||
105451621|NCT02322281|363662084|FG001|Overall Study|Death|3|||
105451622|NCT02322281|363662085|FG002|Overall Study|Death|3|||
105451623|NCT02322281|363662083|FG000|Overall Study|Withdrawal by Subject|1|||
105451624|NCT02322281|363662084|FG001|Overall Study|Withdrawal by Subject|1|||
105783186|NCT03382639|364859497|FG002|Overall Study|Other|0|||
105783187|NCT03382639|364859498|FG003|Overall Study|Other|3|||
105783188|NCT00399542|364859507|FG000|Overall Study|Adverse Event|18|||
105783189|NCT00399542|364859508|FG001|Overall Study|Adverse Event|15|||
105783190|NCT00399542|364859507|FG000|Overall Study|Protocol Violation|13|||
105783191|NCT00399542|364859508|FG001|Overall Study|Protocol Violation|3|||
105783192|NCT00399542|364859507|FG000|Overall Study|Withdrawal by Subject|28|||
105783193|NCT00399542|364859508|FG001|Overall Study|Withdrawal by Subject|10|||
105783194|NCT00399542|364859507|FG000|Overall Study|Lack of Efficacy|18|||
105783195|NCT00399542|364859508|FG001|Overall Study|Lack of Efficacy|8|||
105783196|NCT00399542|364859507|FG000|Overall Study|Lost to Follow-up|6|||
105783197|NCT00399542|364859508|FG001|Overall Study|Lost to Follow-up|6|||
105783198|NCT00399542|364859507|FG000|Overall Study|Other|1|||
105783199|NCT00399542|364859508|FG001|Overall Study|Other|0|||
105783200|NCT00399542|364859507|FG000|Overall Study|Physician Decision|0|||
105783201|NCT00399542|364859508|FG001|Overall Study|Physician Decision|1|||
105783202|NCT02260791|364859515|FG000|Overall Study|Lost to Follow-up|4|||
105783203|NCT02260791|364859516|FG001|Overall Study|Lost to Follow-up|4|||
105783204|NCT02260791|364859515|FG000|Overall Study|Lack of Efficacy|2|||
105783205|NCT02260791|364859516|FG001|Overall Study|Lack of Efficacy|1|||
105783206|NCT02260791|364859515|FG000|Overall Study|Adverse Event|13|||
105783207|NCT02260791|364859516|FG001|Overall Study|Adverse Event|9|||
105783208|NCT02260791|364859515|FG000|Overall Study|Death|1|||
105783209|NCT02260791|364859516|FG001|Overall Study|Death|0|||
105783210|NCT02260791|364859515|FG000|Overall Study|Withdrawal by Subject|11|||
105783211|NCT02260791|364859516|FG001|Overall Study|Withdrawal by Subject|16|||
105783212|NCT02260791|364859515|FG000|Overall Study|Screen failure|0|||
105783213|NCT02260791|364859516|FG001|Overall Study|Screen failure|1|||
105783214|NCT02260791|364859515|FG000|Overall Study|Protocol deviation|2|||
105783215|NCT02260791|364859516|FG001|Overall Study|Protocol deviation|3|||
105783216|NCT00606931|364859517|FG000|Overall Study|Withdrawal by Subject|3|||
105783217|NCT02442284|364859527|FG000|Overall Study|Adverse Event|1|||
105783218|NCT02442284|364859527|FG000|Overall Study|Withdrew Consent|2|||
105783219|NCT02442284|364859527|FG000|Overall Study|Lost to Follow-up|3|||
105783220|NCT02442284|364859527|FG000|Overall Study|Other|1|||
105783221|NCT00302731|364859528|FG000|Overall Study|Lost to Follow-up|1|||
105783222|NCT00302731|364859529|FG001|Overall Study|Lost to Follow-up|2|||
105783223|NCT00302731|364859530|FG002|Overall Study|Lost to Follow-up|0|||
105783224|NCT00302731|364859531|FG003|Overall Study|Lost to Follow-up|0|||
105783225|NCT00302731|364859528|FG000|Overall Study|Adverse Event|0|||
105783226|NCT00302731|364859529|FG001|Overall Study|Adverse Event|2|||
105783227|NCT00302731|364859530|FG002|Overall Study|Adverse Event|2|||
105783228|NCT00302731|364859531|FG003|Overall Study|Adverse Event|0|||
105783229|NCT00302731|364859528|FG000|Overall Study|Withdrawal by Subject|1|||
105783230|NCT00302731|364859529|FG001|Overall Study|Withdrawal by Subject|1|||
105783231|NCT00302731|364859530|FG002|Overall Study|Withdrawal by Subject|0|||
105336964|NCT00090220|363234763|FG002|Base Study Vaccination Period|Patient Moved|0|||
105451625|NCT02322281|363662085|FG002|Overall Study|Withdrawal by Subject|6|||
105451626|NCT02322281|363662083|FG000|Overall Study|Physician Decision|2|||
105451627|NCT02322281|363662084|FG001|Overall Study|Physician Decision|0|||
105451628|NCT02322281|363662085|FG002|Overall Study|Physician Decision|5|||
105451629|NCT02322281|363662083|FG000|Overall Study|Study Terminated by Sponsor|2|||
105451630|NCT02322281|363662084|FG001|Overall Study|Study Terminated by Sponsor|0|||
105451631|NCT02322281|363662085|FG002|Overall Study|Study Terminated by Sponsor|0|||
105451632|NCT02322281|363662083|FG000|Overall Study|Missing|0|||
105451633|NCT02322281|363662084|FG001|Overall Study|Missing|0|||
105451634|NCT02322281|363662085|FG002|Overall Study|Missing|1|||
105451635|NCT02322281|363662083|FG000|Overall Study|Miscellaneous|0|||
105451636|NCT02322281|363662084|FG001|Overall Study|Miscellaneous|0|||
105451637|NCT02322281|363662085|FG002|Overall Study|Miscellaneous|4|||
105451638|NCT01285401|363662086|FG000|Overall Study|Prematurely withdrawn from the study|17|||
105451639|NCT01285401|363662087|FG001|Overall Study|Prematurely withdrawn from the study|29|||
105451640|NCT02366312|363662091|FG000|Overall Study|Lost to Follow-up|0|||
105451641|NCT02366312|363662092|FG001|Overall Study|Lost to Follow-up|1|||
105451642|NCT04581824|363662093|FG000|Overall Study|Ongoing|75|||
105451643|NCT04581824|363662094|FG001|Overall Study|Ongoing|69|||
105451644|NCT04581824|363662093|FG000|Overall Study|Withdrawal by Subject|3|||
105451645|NCT04581824|363662094|FG001|Overall Study|Withdrawal by Subject|5|||
105451646|NCT04581824|363662093|FG000|Overall Study|Lost to Follow-up|1|||
105451647|NCT04581824|363662094|FG001|Overall Study|Lost to Follow-up|0|||
105451648|NCT00619515|363662095|FG000|Overall Study|Study Termination by IRB|73|||
105451649|NCT02420093|363662098|FG000|Overall Study|Withdrawal by Subject|1|||
105451650|NCT02420093|363662099|FG001|Overall Study|Withdrawal by Subject|1|||
105451651|NCT04862065|363662100|FG000|Screening|Protocol Violation|54|||
105451652|NCT04862065|363662101|FG001|Screening|Protocol Violation|0|||
105451653|NCT04862065|363662102|FG002|Screening|Protocol Violation|0|||
105451654|NCT04862065|363662100|FG000|Screening|Insufficient Sample|1|||
105783232|NCT00302731|364859531|FG003|Overall Study|Withdrawal by Subject|0|||
105783233|NCT00302731|364859528|FG000|Overall Study|Protocol Violation|1|||
105783234|NCT00302731|364859529|FG001|Overall Study|Protocol Violation|0|||
105783235|NCT00302731|364859530|FG002|Overall Study|Protocol Violation|0|||
105783236|NCT00302731|364859531|FG003|Overall Study|Protocol Violation|0|||
105451655|NCT04862065|363662101|FG001|Screening|Insufficient Sample|0|||
105451656|NCT04862065|363662102|FG002|Screening|Insufficient Sample|0|||
105451657|NCT04862065|363662100|FG000|Follow-Up|Lost to Follow-up|3|||
105451658|NCT04862065|363662101|FG001|Follow-Up|Lost to Follow-up|0|||
105451659|NCT04862065|363662102|FG002|Follow-Up|Lost to Follow-up|0|||
105451660|NCT03244917|363662103|FG000|Overall Study|Lost to Follow-up|2|||
105451661|NCT03244917|363662104|FG001|Overall Study|Lost to Follow-up|2|||
105451662|NCT00255190|363662105|FG000|Overall Study|Adverse Event|17|||
105451663|NCT00255190|363662106|FG001|Overall Study|Adverse Event|36|||
105451664|NCT00255190|363662105|FG000|Overall Study|Protocol Violation|2|||
105451665|NCT00255190|363662106|FG001|Overall Study|Protocol Violation|2|||
105451666|NCT00255190|363662105|FG000|Overall Study|Lost to Follow-up|10|||
105451667|NCT00255190|363662106|FG001|Overall Study|Lost to Follow-up|27|||
105451668|NCT00255190|363662105|FG000|Overall Study|Withdrew Consent|17|||
105451669|NCT00255190|363662106|FG001|Overall Study|Withdrew Consent|48|||
105451670|NCT00255190|363662105|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
105451671|NCT00255190|363662106|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
105451672|NCT00255190|363662105|FG000|Overall Study|Erosive esophagitis not healed|0|||
105451673|NCT00255190|363662106|FG001|Overall Study|Erosive esophagitis not healed|20|||
105451674|NCT00255190|363662105|FG000|Overall Study|Various|4|||
105451675|NCT00255190|363662106|FG001|Overall Study|Various|23|||
105451676|NCT02903914|363662107|FG000|Overall Study|Adverse Event|0|||
105451677|NCT02903914|363662108|FG001|Overall Study|Adverse Event|0|||
105451678|NCT02903914|363662109|FG002|Overall Study|Adverse Event|1|||
105451679|NCT02903914|363662110|FG003|Overall Study|Adverse Event|0|||
105451680|NCT02903914|363662111|FG004|Overall Study|Adverse Event|0|||
105451681|NCT02903914|363662112|FG005|Overall Study|Adverse Event|0|||
105451682|NCT02903914|363662113|FG006|Overall Study|Adverse Event|2|||
105451683|NCT02903914|363662114|FG007|Overall Study|Adverse Event|0|||
105451684|NCT02903914|363662107|FG000|Overall Study|Withdrawal by Subject|3|||
105451685|NCT02903914|363662108|FG001|Overall Study|Withdrawal by Subject|1|||
105451686|NCT02903914|363662109|FG002|Overall Study|Withdrawal by Subject|28|||
105451687|NCT02903914|363662110|FG003|Overall Study|Withdrawal by Subject|0|||
105451688|NCT02903914|363662111|FG004|Overall Study|Withdrawal by Subject|1|||
105451689|NCT02903914|363662112|FG005|Overall Study|Withdrawal by Subject|2|||
105451690|NCT02903914|363662113|FG006|Overall Study|Withdrawal by Subject|12|||
105451691|NCT02903914|363662114|FG007|Overall Study|Withdrawal by Subject|0|||
105451692|NCT02903914|363662107|FG000|Overall Study|Progressive Disease|1|||
105451693|NCT02903914|363662108|FG001|Overall Study|Progressive Disease|0|||
105451694|NCT02903914|363662109|FG002|Overall Study|Progressive Disease|4|||
105451695|NCT02903914|363662110|FG003|Overall Study|Progressive Disease|0|||
105451696|NCT02903914|363662111|FG004|Overall Study|Progressive Disease|0|||
105451697|NCT02903914|363662112|FG005|Overall Study|Progressive Disease|0|||
105451698|NCT02903914|363662113|FG006|Overall Study|Progressive Disease|2|||
105451699|NCT02903914|363662114|FG007|Overall Study|Progressive Disease|0|||
105451700|NCT02903914|363662107|FG000|Overall Study|Death|0|||
105451701|NCT02903914|363662108|FG001|Overall Study|Death|0|||
105451702|NCT02903914|363662109|FG002|Overall Study|Death|9|||
105451703|NCT02903914|363662110|FG003|Overall Study|Death|0|||
105451704|NCT02903914|363662111|FG004|Overall Study|Death|1|||
105451705|NCT02903914|363662112|FG005|Overall Study|Death|3|||
105451706|NCT02903914|363662113|FG006|Overall Study|Death|24|||
105451707|NCT02903914|363662114|FG007|Overall Study|Death|2|||
105451708|NCT02903914|363662107|FG000|Overall Study|Lost to Follow-up|0|||
105451709|NCT02903914|363662108|FG001|Overall Study|Lost to Follow-up|1|||
105451710|NCT02903914|363662109|FG002|Overall Study|Lost to Follow-up|0|||
105451711|NCT02903914|363662110|FG003|Overall Study|Lost to Follow-up|0|||
105451712|NCT02903914|363662111|FG004|Overall Study|Lost to Follow-up|2|||
105451713|NCT02903914|363662112|FG005|Overall Study|Lost to Follow-up|0|||
105451714|NCT02903914|363662113|FG006|Overall Study|Lost to Follow-up|1|||
105451715|NCT02903914|363662114|FG007|Overall Study|Lost to Follow-up|0|||
105451716|NCT02903914|363662107|FG000|Overall Study|Physician Decision|0|||
105451717|NCT02903914|363662108|FG001|Overall Study|Physician Decision|0|||
105451718|NCT02903914|363662109|FG002|Overall Study|Physician Decision|1|||
105451719|NCT02903914|363662110|FG003|Overall Study|Physician Decision|0|||
105451720|NCT02903914|363662111|FG004|Overall Study|Physician Decision|0|||
105451721|NCT02903914|363662112|FG005|Overall Study|Physician Decision|0|||
105451722|NCT02903914|363662113|FG006|Overall Study|Physician Decision|1|||
105451723|NCT02903914|363662114|FG007|Overall Study|Physician Decision|0|||
105451724|NCT02903914|363662107|FG000|Overall Study|Symptomatic Deterioration|0|||
105451725|NCT02903914|363662108|FG001|Overall Study|Symptomatic Deterioration|0|||
105451726|NCT02903914|363662109|FG002|Overall Study|Symptomatic Deterioration|1|||
105451727|NCT02903914|363662110|FG003|Overall Study|Symptomatic Deterioration|0|||
105451728|NCT02903914|363662111|FG004|Overall Study|Symptomatic Deterioration|0|||
105451729|NCT02903914|363662112|FG005|Overall Study|Symptomatic Deterioration|0|||
105451730|NCT02903914|363662113|FG006|Overall Study|Symptomatic Deterioration|0|||
105451731|NCT02903914|363662114|FG007|Overall Study|Symptomatic Deterioration|0|||
105451732|NCT02903914|363662107|FG000|Overall Study|New Cancer Therapy|2|||
105451733|NCT02903914|363662108|FG001|Overall Study|New Cancer Therapy|2|||
105451734|NCT02903914|363662109|FG002|Overall Study|New Cancer Therapy|21|||
105451735|NCT02903914|363662110|FG003|Overall Study|New Cancer Therapy|4|||
105451736|NCT02903914|363662111|FG004|Overall Study|New Cancer Therapy|3|||
105451737|NCT02903914|363662112|FG005|Overall Study|New Cancer Therapy|6|||
105451738|NCT02903914|363662113|FG006|Overall Study|New Cancer Therapy|56|||
105451739|NCT02903914|363662114|FG007|Overall Study|New Cancer Therapy|3|||
105451740|NCT02903914|363662107|FG000|Overall Study|Didn't Return to Site|1|||
105451741|NCT02903914|363662108|FG001|Overall Study|Didn't Return to Site|0|||
105451742|NCT02903914|363662109|FG002|Overall Study|Didn't Return to Site|1|||
105451743|NCT02903914|363662110|FG003|Overall Study|Didn't Return to Site|1|||
105451744|NCT02903914|363662111|FG004|Overall Study|Didn't Return to Site|0|||
105451745|NCT02903914|363662112|FG005|Overall Study|Didn't Return to Site|0|||
105451746|NCT02903914|363662113|FG006|Overall Study|Didn't Return to Site|2|||
105451747|NCT02903914|363662114|FG007|Overall Study|Didn't Return to Site|0|||
105451748|NCT02903914|363662107|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
105451749|NCT02903914|363662108|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
105451750|NCT02903914|363662109|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
105451751|NCT02903914|363662110|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
105451752|NCT02903914|363662111|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
105451753|NCT02903914|363662112|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
105451754|NCT02903914|363662113|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
105451755|NCT02903914|363662114|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
105451756|NCT02903914|363662107|FG000|Overall Study|Follow-up Did Not Occur|0|||
105451757|NCT02903914|363662108|FG001|Overall Study|Follow-up Did Not Occur|1|||
105451758|NCT02903914|363662109|FG002|Overall Study|Follow-up Did Not Occur|1|||
105451759|NCT02903914|363662110|FG003|Overall Study|Follow-up Did Not Occur|0|||
105451760|NCT02903914|363662111|FG004|Overall Study|Follow-up Did Not Occur|2|||
105451761|NCT02903914|363662112|FG005|Overall Study|Follow-up Did Not Occur|0|||
105451762|NCT02903914|363662113|FG006|Overall Study|Follow-up Did Not Occur|8|||
105451763|NCT02903914|363662114|FG007|Overall Study|Follow-up Did Not Occur|0|||
105451764|NCT02903914|363662107|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
105451765|NCT02903914|363662108|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
105451766|NCT02903914|363662109|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
105451767|NCT02903914|363662110|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
105451768|NCT02903914|363662111|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
105451769|NCT02903914|363662112|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
105451770|NCT02903914|363662113|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
105451771|NCT02903914|363662114|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
105451772|NCT02903914|363662107|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
105451773|NCT02903914|363662108|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
105451774|NCT02903914|363662109|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
105451775|NCT02903914|363662110|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
105451776|NCT02903914|363662111|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
105451777|NCT02903914|363662112|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
105451778|NCT02903914|363662113|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
105451779|NCT02903914|363662114|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
105451780|NCT02903914|363662107|FG000|Overall Study|Clinical Disease Progression|0|||
105451781|NCT02903914|363662108|FG001|Overall Study|Clinical Disease Progression|0|||
105451782|NCT02903914|363662109|FG002|Overall Study|Clinical Disease Progression|2|||
105451783|NCT02903914|363662110|FG003|Overall Study|Clinical Disease Progression|0|||
105451784|NCT02903914|363662111|FG004|Overall Study|Clinical Disease Progression|0|||
105451785|NCT02903914|363662112|FG005|Overall Study|Clinical Disease Progression|0|||
105451786|NCT02903914|363662113|FG006|Overall Study|Clinical Disease Progression|0|||
105451787|NCT02903914|363662114|FG007|Overall Study|Clinical Disease Progression|0|||
105451788|NCT02903914|363662107|FG000|Overall Study|Completed Follow-up Period|0|||
105451789|NCT02903914|363662108|FG001|Overall Study|Completed Follow-up Period|0|||
105451790|NCT02903914|363662109|FG002|Overall Study|Completed Follow-up Period|6|||
105451791|NCT02903914|363662110|FG003|Overall Study|Completed Follow-up Period|2|||
105451792|NCT02903914|363662111|FG004|Overall Study|Completed Follow-up Period|1|||
105451793|NCT02903914|363662112|FG005|Overall Study|Completed Follow-up Period|0|||
105451794|NCT02903914|363662113|FG006|Overall Study|Completed Follow-up Period|9|||
105451795|NCT02903914|363662114|FG007|Overall Study|Completed Follow-up Period|1|||
105451796|NCT02903914|363662107|FG000|Overall Study|Taken off Treatment per Protocol|0|||
105451797|NCT02903914|363662108|FG001|Overall Study|Taken off Treatment per Protocol|0|||
105451798|NCT02903914|363662109|FG002|Overall Study|Taken off Treatment per Protocol|0|||
105451799|NCT02903914|363662110|FG003|Overall Study|Taken off Treatment per Protocol|0|||
105451800|NCT02903914|363662111|FG004|Overall Study|Taken off Treatment per Protocol|0|||
105451801|NCT02903914|363662112|FG005|Overall Study|Taken off Treatment per Protocol|1|||
105451802|NCT02903914|363662113|FG006|Overall Study|Taken off Treatment per Protocol|0|||
105451803|NCT02903914|363662114|FG007|Overall Study|Taken off Treatment per Protocol|0|||
105451804|NCT02903914|363662107|FG000|Overall Study|Refused Further Treatment/Contact|0|||
105451805|NCT02903914|363662108|FG001|Overall Study|Refused Further Treatment/Contact|0|||
105451806|NCT02903914|363662109|FG002|Overall Study|Refused Further Treatment/Contact|0|||
105451807|NCT02903914|363662110|FG003|Overall Study|Refused Further Treatment/Contact|0|||
105451808|NCT02903914|363662111|FG004|Overall Study|Refused Further Treatment/Contact|0|||
105451809|NCT02903914|363662112|FG005|Overall Study|Refused Further Treatment/Contact|0|||
105451810|NCT02903914|363662113|FG006|Overall Study|Refused Further Treatment/Contact|1|||
105451811|NCT02903914|363662114|FG007|Overall Study|Refused Further Treatment/Contact|0|||
105451812|NCT02903914|363662107|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
105451813|NCT02903914|363662108|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
105451814|NCT02903914|363662109|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
105451815|NCT02903914|363662110|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
105451816|NCT02903914|363662111|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
105451817|NCT02903914|363662112|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
105451818|NCT02903914|363662113|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
105451819|NCT02903914|363662114|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
105451820|NCT01255423|363662115|FG000|Overall Study|Abnormal Laboratory value|3|||
105451821|NCT01255423|363662116|FG001|Overall Study|Abnormal Laboratory value|2|||
105451822|NCT01255423|363662115|FG000|Overall Study|Use of prohibited medications|0|||
105451823|NCT01255423|363662116|FG001|Overall Study|Use of prohibited medications|1|||
105451824|NCT05470387|363662117|FG000|Overall Study|Protocol Violation|0|||
105451825|NCT05470387|363662118|FG001|Overall Study|Protocol Violation|3|||
105451826|NCT00657046|363662119|FG000|Overall Study|Adverse Event|1|||
105451827|NCT00657046|363662120|FG001|Overall Study|Adverse Event|1|||
105451828|NCT00657046|363662121|FG002|Overall Study|Adverse Event|0|||
105451829|NCT00657046|363662119|FG000|Overall Study|Protocol Violation|2|||
105451830|NCT00657046|363662120|FG001|Overall Study|Protocol Violation|2|||
105451831|NCT00657046|363662121|FG002|Overall Study|Protocol Violation|0|||
105451832|NCT00657046|363662119|FG000|Overall Study|Withdrawal by Subject|1|||
105451833|NCT00657046|363662120|FG001|Overall Study|Withdrawal by Subject|0|||
105451834|NCT00657046|363662121|FG002|Overall Study|Withdrawal by Subject|0|||
105451835|NCT00657046|363662119|FG000|Overall Study|Death|0|||
105451836|NCT00657046|363662120|FG001|Overall Study|Death|0|||
105451837|NCT00657046|363662121|FG002|Overall Study|Death|1|||
105451838|NCT00657046|363662119|FG000|Overall Study|Surgery|0|||
105451839|NCT00657046|363662120|FG001|Overall Study|Surgery|0|||
105451840|NCT00657046|363662121|FG002|Overall Study|Surgery|1|||
105451841|NCT01858363|363662122|FG000|Overall Study|Death|35|||
105451842|NCT01858363|363662123|FG001|Overall Study|Death|9|||
105451843|NCT01858363|363662122|FG000|Overall Study|Withdrawal by Subject|28|||
105451844|NCT01858363|363662123|FG001|Overall Study|Withdrawal by Subject|14|||
105451845|NCT01858363|363662122|FG000|Overall Study|Lost to Follow-up|13|||
105451846|NCT01858363|363662123|FG001|Overall Study|Lost to Follow-up|3|||
105451847|NCT00088530|363662128|FG000|Overall Study|Progressive/Relapsed Disease|28|||
105451848|NCT00088530|363662129|FG001|Overall Study|Progressive/Relapsed Disease|39|||
105451849|NCT00088530|363662128|FG000|Overall Study|Adverse Event|15|||
105451850|NCT00088530|363662129|FG001|Overall Study|Adverse Event|9|||
105451851|NCT00088530|363662128|FG000|Overall Study|Withdrawal by Subject|2|||
105451852|NCT00088530|363662129|FG001|Overall Study|Withdrawal by Subject|5|||
105451853|NCT00088530|363662128|FG000|Overall Study|Lost to Follow-up|2|||
105451854|NCT00088530|363662129|FG001|Overall Study|Lost to Follow-up|0|||
105451855|NCT00088530|363662128|FG000|Overall Study|Physician Decision|2|||
105451856|NCT00088530|363662129|FG001|Overall Study|Physician Decision|0|||
105451857|NCT00088530|363662128|FG000|Overall Study|Sponsor decision|0|||
105451858|NCT00088530|363662129|FG001|Overall Study|Sponsor decision|1|||
105451859|NCT00088530|363662128|FG000|Overall Study|Patient never treated|1|||
105451860|NCT00088530|363662129|FG001|Overall Study|Patient never treated|0|||
105451861|NCT01141712|363662130|FG000|Overall Study|Disease progression|3|||
105451862|NCT00101686|363662131|FG000|Overall Study|Progressive Disease|37|||
105451863|NCT00101686|363662132|FG001|Overall Study|Progressive Disease|28|||
105451864|NCT00101686|363662133|FG002|Overall Study|Progressive Disease|37|||
105451865|NCT00101686|363662134|FG003|Overall Study|Progressive Disease|38|||
105451866|NCT00101686|363662135|FG004|Overall Study|Progressive Disease|28|||
105451867|NCT00101686|363662136|FG005|Overall Study|Progressive Disease|25|||
105451868|NCT00101686|363662137|FG006|Overall Study|Progressive Disease|5|||
105451869|NCT00101686|363662138|FG007|Overall Study|Progressive Disease|7|||
105451870|NCT00101686|363662139|FG008|Overall Study|Progressive Disease|10|||
105451871|NCT00101686|363662140|FG009|Overall Study|Progressive Disease|8|||
105451872|NCT00101686|363662131|FG000|Overall Study|initiation other anti-cancer treatment|4|||
105451873|NCT00101686|363662132|FG001|Overall Study|initiation other anti-cancer treatment|3|||
105451874|NCT00101686|363662133|FG002|Overall Study|initiation other anti-cancer treatment|4|||
105451875|NCT00101686|363662134|FG003|Overall Study|initiation other anti-cancer treatment|3|||
105451876|NCT00101686|363662135|FG004|Overall Study|initiation other anti-cancer treatment|1|||
105451877|NCT00101686|363662136|FG005|Overall Study|initiation other anti-cancer treatment|1|||
105451878|NCT00101686|363662137|FG006|Overall Study|initiation other anti-cancer treatment|2|||
105451879|NCT00101686|363662138|FG007|Overall Study|initiation other anti-cancer treatment|2|||
105451880|NCT00101686|363662139|FG008|Overall Study|initiation other anti-cancer treatment|3|||
105451881|NCT00101686|363662140|FG009|Overall Study|initiation other anti-cancer treatment|3|||
105451882|NCT00101686|363662131|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
105451883|NCT00101686|363662132|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
105451884|NCT00101686|363662133|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
105451885|NCT00101686|363662134|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
105451886|NCT00101686|363662135|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
105451887|NCT00101686|363662136|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
105451888|NCT00101686|363662137|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
105451889|NCT00101686|363662138|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
105451890|NCT00101686|363662139|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
105451891|NCT00101686|363662140|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
105451892|NCT00101686|363662131|FG000|Overall Study|unacceptable toxicity|3|||
105451893|NCT00101686|363662132|FG001|Overall Study|unacceptable toxicity|9|||
105451894|NCT00101686|363662133|FG002|Overall Study|unacceptable toxicity|10|||
105451895|NCT00101686|363662134|FG003|Overall Study|unacceptable toxicity|6|||
105451896|NCT00101686|363662135|FG004|Overall Study|unacceptable toxicity|16|||
105451897|NCT00101686|363662136|FG005|Overall Study|unacceptable toxicity|10|||
105451898|NCT00101686|363662137|FG006|Overall Study|unacceptable toxicity|4|||
105451899|NCT00101686|363662138|FG007|Overall Study|unacceptable toxicity|2|||
105451900|NCT00101686|363662139|FG008|Overall Study|unacceptable toxicity|1|||
105451901|NCT00101686|363662140|FG009|Overall Study|unacceptable toxicity|4|||
105451902|NCT00101686|363662131|FG000|Overall Study|Randomized but did not receive treament|1|||
105451903|NCT00101686|363662132|FG001|Overall Study|Randomized but did not receive treament|6|||
105451904|NCT00101686|363662133|FG002|Overall Study|Randomized but did not receive treament|2|||
105451905|NCT00101686|363662134|FG003|Overall Study|Randomized but did not receive treament|2|||
105451906|NCT00101686|363662135|FG004|Overall Study|Randomized but did not receive treament|2|||
105451907|NCT00101686|363662136|FG005|Overall Study|Randomized but did not receive treament|2|||
105451908|NCT00101686|363662137|FG006|Overall Study|Randomized but did not receive treament|0|||
105451909|NCT00101686|363662138|FG007|Overall Study|Randomized but did not receive treament|1|||
105451910|NCT00101686|363662139|FG008|Overall Study|Randomized but did not receive treament|0|||
105451911|NCT00101686|363662140|FG009|Overall Study|Randomized but did not receive treament|1|||
105451912|NCT00101686|363662131|FG000|Overall Study|intercurrent non-cancer related illness|0|||
105451913|NCT00101686|363662132|FG001|Overall Study|intercurrent non-cancer related illness|0|||
105451914|NCT00101686|363662133|FG002|Overall Study|intercurrent non-cancer related illness|2|||
105451915|NCT00101686|363662134|FG003|Overall Study|intercurrent non-cancer related illness|0|||
105451916|NCT00101686|363662135|FG004|Overall Study|intercurrent non-cancer related illness|1|||
105451917|NCT00101686|363662136|FG005|Overall Study|intercurrent non-cancer related illness|3|||
105451918|NCT00101686|363662137|FG006|Overall Study|intercurrent non-cancer related illness|1|||
105451919|NCT00101686|363662138|FG007|Overall Study|intercurrent non-cancer related illness|0|||
105451920|NCT00101686|363662139|FG008|Overall Study|intercurrent non-cancer related illness|1|||
105451921|NCT00101686|363662140|FG009|Overall Study|intercurrent non-cancer related illness|1|||
105451922|NCT00101686|363662131|FG000|Overall Study|Physician Decision|10|||
105451923|NCT00101686|363662132|FG001|Overall Study|Physician Decision|13|||
105451924|NCT00101686|363662133|FG002|Overall Study|Physician Decision|6|||
105451925|NCT00101686|363662134|FG003|Overall Study|Physician Decision|7|||
105451926|NCT00101686|363662135|FG004|Overall Study|Physician Decision|8|||
105451927|NCT00101686|363662136|FG005|Overall Study|Physician Decision|9|||
105451928|NCT00101686|363662137|FG006|Overall Study|Physician Decision|5|||
105451929|NCT00101686|363662138|FG007|Overall Study|Physician Decision|5|||
105451930|NCT00101686|363662139|FG008|Overall Study|Physician Decision|1|||
105451931|NCT00101686|363662140|FG009|Overall Study|Physician Decision|1|||
105451932|NCT00101686|363662131|FG000|Overall Study|Other|1|||
105451933|NCT00101686|363662132|FG001|Overall Study|Other|4|||
105451934|NCT00101686|363662133|FG002|Overall Study|Other|1|||
105451935|NCT00101686|363662134|FG003|Overall Study|Other|6|||
105451936|NCT00101686|363662135|FG004|Overall Study|Other|2|||
105451937|NCT00101686|363662136|FG005|Overall Study|Other|12|||
105451938|NCT00101686|363662137|FG006|Overall Study|Other|1|||
105451939|NCT00101686|363662138|FG007|Overall Study|Other|5|||
105451940|NCT00101686|363662139|FG008|Overall Study|Other|3|||
105451941|NCT00101686|363662140|FG009|Overall Study|Other|3|||
105451942|NCT00101686|363662131|FG000|Overall Study|Withdrawal by Subject|9|||
105451943|NCT00101686|363662132|FG001|Overall Study|Withdrawal by Subject|8|||
105451944|NCT00101686|363662133|FG002|Overall Study|Withdrawal by Subject|6|||
105451945|NCT00101686|363662134|FG003|Overall Study|Withdrawal by Subject|8|||
105451946|NCT00101686|363662135|FG004|Overall Study|Withdrawal by Subject|8|||
105451947|NCT00101686|363662136|FG005|Overall Study|Withdrawal by Subject|7|||
105451948|NCT00101686|363662137|FG006|Overall Study|Withdrawal by Subject|7|||
105451949|NCT00101686|363662138|FG007|Overall Study|Withdrawal by Subject|7|||
105451950|NCT00101686|363662139|FG008|Overall Study|Withdrawal by Subject|8|||
105451951|NCT00101686|363662140|FG009|Overall Study|Withdrawal by Subject|9|||
105451952|NCT01358825|363662141|FG000|Overall Study|Blood sample not drawn|0|||
105451953|NCT01358825|363662142|FG001|Overall Study|Blood sample not drawn|1|||
105451954|NCT01623115|363662143|FG000|Overall Study|Randomized but not treated|0|||
105451955|NCT01623115|363662144|FG001|Overall Study|Randomized but not treated|1|||
105451956|NCT01623115|363662143|FG000|Overall Study|Physician Decision|1|||
105451957|NCT01623115|363662144|FG001|Overall Study|Physician Decision|0|||
105451958|NCT01623115|363662143|FG000|Overall Study|Participants moved|1|||
105451959|NCT01623115|363662144|FG001|Overall Study|Participants moved|5|||
105451960|NCT01623115|363662143|FG000|Overall Study|Adverse Event|10|||
105451961|NCT01623115|363662144|FG001|Overall Study|Adverse Event|13|||
105451962|NCT01623115|363662143|FG000|Overall Study|Poor compliance to protocol|4|||
105451963|NCT01623115|363662144|FG001|Overall Study|Poor compliance to protocol|10|||
105451964|NCT01623115|363662143|FG000|Overall Study|Consent withdrawn by participant|2|||
105451965|NCT01623115|363662144|FG001|Overall Study|Consent withdrawn by participant|6|||
105451966|NCT01623115|363662143|FG000|Overall Study|Related to study drug administration|0|||
105451967|NCT01623115|363662144|FG001|Overall Study|Related to study drug administration|2|||
105451968|NCT01623115|363662143|FG000|Overall Study|Last visit outside protocol visit window|14|||
105451969|NCT01623115|363662144|FG001|Overall Study|Last visit outside protocol visit window|26|||
105451970|NCT01623115|363662143|FG000|Overall Study|Site closure|1|||
105451971|NCT01623115|363662144|FG001|Overall Study|Site closure|7|||
105451972|NCT01623115|363662143|FG000|Overall Study|Death|0|||
105451973|NCT01623115|363662144|FG001|Overall Study|Death|4|||
105451974|NCT01623115|363662143|FG000|Overall Study|Other than specified above|0|||
105451975|NCT01623115|363662144|FG001|Overall Study|Other than specified above|3|||
105451976|NCT00687401|363662147|FG000|Overall Study|Protocol Violation|7|||
105451977|NCT00687401|363662147|FG000|Overall Study|Adverse Event|6|||
105451978|NCT00687401|363662147|FG000|Overall Study|Lack of Efficacy|6|||
105451979|NCT00687401|363662147|FG000|Overall Study|Withdrawal by Subject|4|||
105451980|NCT00687401|363662147|FG000|Overall Study|Did not return for visit|3|||
105451981|NCT00687401|363662147|FG000|Overall Study|For reasons different from those above|4|||
105451982|NCT01363700|363662148|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
105451983|NCT01363700|363662149|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
105451984|NCT01363700|363662150|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
105451985|NCT01363700|363662151|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
105451986|NCT01363700|363662152|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
105451987|NCT03827655|363662159|FG000|Overall Study|Death|0|||
105451988|NCT03827655|363662160|FG001|Overall Study|Death|0|||
105451989|NCT03827655|363662161|FG002|Overall Study|Death|0|||
105451990|NCT03827655|363662162|FG003|Overall Study|Death|0|||
105451991|NCT03827655|363662163|FG004|Overall Study|Death|1|||
105451992|NCT03827655|363662159|FG000|Overall Study|Protocol Deviation|1|||
105451993|NCT03827655|363662160|FG001|Overall Study|Protocol Deviation|0|||
105451994|NCT03827655|363662161|FG002|Overall Study|Protocol Deviation|1|||
105451995|NCT03827655|363662162|FG003|Overall Study|Protocol Deviation|1|||
105451996|NCT03827655|363662163|FG004|Overall Study|Protocol Deviation|0|||
105451997|NCT03827655|363662159|FG000|Overall Study|Withdrawal by Subject|3|||
105451998|NCT03827655|363662160|FG001|Overall Study|Withdrawal by Subject|2|||
105451999|NCT03827655|363662161|FG002|Overall Study|Withdrawal by Subject|2|||
105452000|NCT03827655|363662162|FG003|Overall Study|Withdrawal by Subject|0|||
105452001|NCT03827655|363662163|FG004|Overall Study|Withdrawal by Subject|1|||
105452002|NCT03827655|363662159|FG000|Overall Study|Reason not Specified|3|||
105452003|NCT03827655|363662160|FG001|Overall Study|Reason not Specified|1|||
105452004|NCT03827655|363662161|FG002|Overall Study|Reason not Specified|1|||
105452005|NCT03827655|363662162|FG003|Overall Study|Reason not Specified|1|||
105452006|NCT03827655|363662163|FG004|Overall Study|Reason not Specified|1|||
105452007|NCT03550378|363662164|FG000|Overall Study|Death|0|||
105452008|NCT03550378|363662165|FG001|Overall Study|Death|1|||
105452009|NCT00468299|363662168|FG000|Overall Study|Withdrawal by Subject|0|||
105452010|NCT00468299|363662169|FG001|Overall Study|Withdrawal by Subject|1|||
105452011|NCT03649217|363662171|FG000|Overall Study|subject had severe ataxia not initially found|1|||
105452012|NCT03649217|363662171|FG000|Overall Study|subject had cognitive issues not initially found|1|||
105452013|NCT02520726|363662172|FG000|Overall Study|Lost to Follow-up|3|||
105452014|NCT02520726|363662173|FG001|Overall Study|Lost to Follow-up|2|||
105452015|NCT01362348|363662174|FG000|Overall Study|Protocol-defined stopping criteria|9|||
105452016|NCT01362348|363662174|FG000|Overall Study|Study closed/terminated|5|||
105452017|NCT04332107|363662177|FG000|Day 3|Lost to Follow-up|23|||
105452018|NCT04332107|363662178|FG001|Day 3|Lost to Follow-up|14|||
105452019|NCT04332107|363662177|FG000|Day 3|Missing outcome data|3|||
105452020|NCT04332107|363662178|FG001|Day 3|Missing outcome data|6|||
105452021|NCT04332107|363662177|FG000|Day 14|Lost to Follow-up|13|||
105452022|NCT04332107|363662178|FG001|Day 14|Lost to Follow-up|4|||
105452023|NCT04332107|363662177|FG000|Day 14|Missing outcome data|4|||
105452024|NCT04332107|363662178|FG001|Day 14|Missing outcome data|4|||
105452025|NCT04332107|363662177|FG000|Day 21|Lost to Follow-up|10|||
105452026|NCT04332107|363662178|FG001|Day 21|Lost to Follow-up|2|||
105452027|NCT00717249|363662183|FG000|Overall Study|Lens Discomfort|4|||
105452028|NCT00717249|363662184|FG001|Overall Study|Lens Discomfort|1|||
105452029|NCT00717249|363662183|FG000|Overall Study|Unsatisfactory visual Response|0|||
105452030|NCT00717249|363662184|FG001|Overall Study|Unsatisfactory visual Response|2|||
105452031|NCT00717249|363662183|FG000|Overall Study|Adverse Event|4|||
105452032|NCT00717249|363662184|FG001|Overall Study|Adverse Event|2|||
105452033|NCT00717249|363662183|FG000|Overall Study|Lost to Follow-up|2|||
105452034|NCT00717249|363662184|FG001|Overall Study|Lost to Follow-up|0|||
105452035|NCT00717249|363662183|FG000|Overall Study|Withdrawal by Subject|1|||
105452036|NCT00717249|363662184|FG001|Overall Study|Withdrawal by Subject|2|||
105452037|NCT00717249|363662183|FG000|Overall Study|Pregnancy|6|||
105452038|NCT00717249|363662184|FG001|Overall Study|Pregnancy|3|||
105452039|NCT00717249|363662183|FG000|Overall Study|Protocol Violation|0|||
105452040|NCT00717249|363662184|FG001|Overall Study|Protocol Violation|2|||
105452041|NCT00717249|363662183|FG000|Overall Study|Subject became Ineligible|1|||
105452042|NCT00717249|363662184|FG001|Overall Study|Subject became Ineligible|1|||
105452043|NCT00717249|363662183|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
105452044|NCT00717249|363662184|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
105452045|NCT00717249|363662183|FG000|Overall Study|Gastric Surgery|0|||
105452046|NCT00717249|363662184|FG001|Overall Study|Gastric Surgery|1|||
105452047|NCT00717249|363662183|FG000|Overall Study|Diagnosed with Diabetes|1|||
105452048|NCT00717249|363662184|FG001|Overall Study|Diagnosed with Diabetes|0|||
105452049|NCT00717249|363662183|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
105452050|NCT00717249|363662184|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
105452051|NCT00717249|363662183|FG000|Overall Study|Subject relocated|1|||
105452052|NCT00717249|363662184|FG001|Overall Study|Subject relocated|0|||
105452053|NCT00717249|363662183|FG000|Overall Study|Headaches|1|||
105452054|NCT00717249|363662184|FG001|Overall Study|Headaches|0|||
105452055|NCT03370718|363662185|FG000|Overall Study|Withdrawal by Subject|1|||
105452056|NCT00479713|363662186|FG000|Overall Study|Adverse Event|8|||
105452057|NCT00479713|363662187|FG001|Overall Study|Adverse Event|6|||
105452058|NCT00479713|363662186|FG000|Overall Study|Death|1|||
105452059|NCT00479713|363662187|FG001|Overall Study|Death|0|||
105452060|NCT00479713|363662186|FG000|Overall Study|Lost to Follow-up|0|||
105452061|NCT00479713|363662187|FG001|Overall Study|Lost to Follow-up|1|||
105452062|NCT00479713|363662186|FG000|Overall Study|Protocol Violation|0|||
105452063|NCT00479713|363662187|FG001|Overall Study|Protocol Violation|1|||
105452064|NCT00479713|363662186|FG000|Overall Study|Withdrawal by Subject|4|||
105452065|NCT00479713|363662187|FG001|Overall Study|Withdrawal by Subject|1|||
105452066|NCT02719171|363664672|FG000|Overall Study|Adverse Event|1|||
105452067|NCT02719171|363664673|FG001|Overall Study|Adverse Event|2|||
105452068|NCT02719171|363664674|FG002|Overall Study|Adverse Event|0|||
105452069|NCT02719171|363664675|FG003|Overall Study|Adverse Event|0|||
105452070|NCT02719171|363664676|FG004|Overall Study|Adverse Event|2|||
105452071|NCT02719171|363664672|FG000|Overall Study|Lost to Follow-up|0|||
105452072|NCT02719171|363664673|FG001|Overall Study|Lost to Follow-up|0|||
105452073|NCT02719171|363664674|FG002|Overall Study|Lost to Follow-up|1|||
105452074|NCT02719171|363664675|FG003|Overall Study|Lost to Follow-up|0|||
105452075|NCT02719171|363664676|FG004|Overall Study|Lost to Follow-up|0|||
105452076|NCT02719171|363664672|FG000|Overall Study|Subject Withdrawal|0|||
105452077|NCT02719171|363664673|FG001|Overall Study|Subject Withdrawal|2|||
105452078|NCT02719171|363664674|FG002|Overall Study|Subject Withdrawal|2|||
105452079|NCT02719171|363664675|FG003|Overall Study|Subject Withdrawal|1|||
105452080|NCT02719171|363664676|FG004|Overall Study|Subject Withdrawal|0|||
105452081|NCT02719171|363664672|FG000|Overall Study|Other|0|||
105452082|NCT02719171|363664673|FG001|Overall Study|Other|0|||
105452083|NCT02719171|363664674|FG002|Overall Study|Other|0|||
105452084|NCT02719171|363664675|FG003|Overall Study|Other|1|||
105452085|NCT02719171|363664676|FG004|Overall Study|Other|0|||
105452086|NCT02614729|363664677|FG000|Overall Study|Withdrawal by Subject|1|||
105452087|NCT02614729|363664678|FG001|Overall Study|Withdrawal by Subject|0|||
105452088|NCT01232868|363664679|FG000|Overall Study|Lost to Follow-up|2|||
105452089|NCT01232868|363664680|FG001|Overall Study|Lost to Follow-up|4|||
105452090|NCT04564846|363664681|FG000|Overall Study|Withdrawal by Subject|2|||
105452091|NCT04564846|363664682|FG001|Overall Study|Withdrawal by Subject|1|||
105452092|NCT04564846|363664681|FG000|Overall Study|Physician Decision|0|||
105452093|NCT04564846|363664682|FG001|Overall Study|Physician Decision|1|||
105452094|NCT04564846|363664681|FG000|Overall Study|Lost to Follow-up|0|||
105452095|NCT04564846|363664682|FG001|Overall Study|Lost to Follow-up|1|||
105452096|NCT04564846|363664681|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
105452097|NCT04564846|363664682|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
105452098|NCT04564846|363664681|FG000|Overall Study|Subject non-compliance|1|||
105452099|NCT04564846|363664682|FG001|Overall Study|Subject non-compliance|0|||
105452100|NCT00985673|363664685|FG000|Overall Study|Lost to Follow-up|6|||
105452101|NCT00985673|363664686|FG001|Overall Study|Lost to Follow-up|7|||
105452102|NCT00985673|363664687|FG002|Overall Study|Lost to Follow-up|6|||
105452103|NCT00985673|363664688|FG003|Overall Study|Lost to Follow-up|10|||
105452104|NCT00985673|363664689|FG004|Overall Study|Lost to Follow-up|5|||
105452105|NCT00985673|363664690|FG005|Overall Study|Lost to Follow-up|3|||
105452106|NCT00985673|363664685|FG000|Overall Study|Withdrawal by Subject|0|||
105452107|NCT00985673|363664686|FG001|Overall Study|Withdrawal by Subject|4|||
105452108|NCT00985673|363664687|FG002|Overall Study|Withdrawal by Subject|5|||
105452109|NCT00985673|363664688|FG003|Overall Study|Withdrawal by Subject|2|||
105783237|NCT00302731|364859528|FG000|Overall Study|cancer unrelated to study discovered|1|||
105783238|NCT00302731|364859529|FG001|Overall Study|cancer unrelated to study discovered|0|||
105783239|NCT00302731|364859530|FG002|Overall Study|cancer unrelated to study discovered|1|||
105783240|NCT00302731|364859531|FG003|Overall Study|cancer unrelated to study discovered|0|||
105783241|NCT01610752|364859534|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
105783242|NCT01610752|364859535|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
105783243|NCT01610752|364859536|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
105783244|NCT00736840|364859537|FG000|Overall Study|Lost to Follow-up|13|||
105783245|NCT00945815|364859538|FG000|Overall Study|Death|3|||
105452110|NCT00985673|363664689|FG004|Overall Study|Withdrawal by Subject|2|||
105452111|NCT00985673|363664690|FG005|Overall Study|Withdrawal by Subject|3|||
105783246|NCT00945815|364859538|FG000|Overall Study|Not protocol specified|1|||
105783247|NCT00945815|364859538|FG000|Overall Study|Ineligible|3|||
105452112|NCT00985673|363664685|FG000|Overall Study|Other|1|||
105452113|NCT00985673|363664686|FG001|Overall Study|Other|0|||
105452114|NCT00985673|363664687|FG002|Overall Study|Other|1|||
105452115|NCT00985673|363664688|FG003|Overall Study|Other|0|||
105452116|NCT00985673|363664689|FG004|Overall Study|Other|1|||
105452117|NCT00985673|363664690|FG005|Overall Study|Other|0|||
105452118|NCT00531284|363664691|FG000|Overall Study|Progressive Disease|1|||
105452119|NCT00531284|363664692|FG001|Overall Study|Progressive Disease|3|||
105452120|NCT00531284|363664693|FG002|Overall Study|Progressive Disease|5|||
105452121|NCT00531284|363664694|FG003|Overall Study|Progressive Disease|42|||
105452122|NCT00531284|363664695|FG004|Overall Study|Progressive Disease|4|||
105452123|NCT00531284|363664696|FG005|Overall Study|Progressive Disease|4|||
105452124|NCT00531284|363664697|FG006|Overall Study|Progressive Disease|3|||
105452125|NCT00531284|363664698|FG007|Overall Study|Progressive Disease|8|||
105452126|NCT00531284|363664699|FG008|Overall Study|Progressive Disease|6|||
105452127|NCT00531284|363664700|FG009|Overall Study|Progressive Disease|3|||
105452128|NCT00531284|363664701|FG010|Overall Study|Progressive Disease|3|||
105452129|NCT00531284|363664702|FG011|Overall Study|Progressive Disease|14|||
105452130|NCT00531284|363664703|FG012|Overall Study|Progressive Disease|2|||
105452131|NCT00531284|363664704|FG013|Overall Study|Progressive Disease|1|||
105452132|NCT00531284|363664705|FG014|Overall Study|Progressive Disease|2|||
105452133|NCT00531284|363664706|FG015|Overall Study|Progressive Disease|11|||
105452134|NCT00531284|363664707|FG016|Overall Study|Progressive Disease|5|||
105452135|NCT00531284|363664691|FG000|Overall Study|Adverse Event|0|||
105452136|NCT00531284|363664692|FG001|Overall Study|Adverse Event|1|||
105452137|NCT00531284|363664693|FG002|Overall Study|Adverse Event|1|||
105452138|NCT00531284|363664694|FG003|Overall Study|Adverse Event|7|||
105452139|NCT00531284|363664695|FG004|Overall Study|Adverse Event|0|||
105452140|NCT00531284|363664696|FG005|Overall Study|Adverse Event|2|||
105452141|NCT00531284|363664697|FG006|Overall Study|Adverse Event|3|||
105452142|NCT00531284|363664698|FG007|Overall Study|Adverse Event|2|||
105452143|NCT00531284|363664699|FG008|Overall Study|Adverse Event|3|||
105452144|NCT00531284|363664700|FG009|Overall Study|Adverse Event|0|||
105452145|NCT00531284|363664701|FG010|Overall Study|Adverse Event|0|||
105452146|NCT00531284|363664702|FG011|Overall Study|Adverse Event|5|||
105452147|NCT00531284|363664703|FG012|Overall Study|Adverse Event|0|||
105452148|NCT00531284|363664704|FG013|Overall Study|Adverse Event|1|||
105452149|NCT00531284|363664705|FG014|Overall Study|Adverse Event|1|||
105452150|NCT00531284|363664706|FG015|Overall Study|Adverse Event|0|||
105452151|NCT00531284|363664707|FG016|Overall Study|Adverse Event|2|||
105452152|NCT00531284|363664691|FG000|Overall Study|Withdrawal by Subject|1|||
105452153|NCT00531284|363664692|FG001|Overall Study|Withdrawal by Subject|0|||
105452154|NCT00531284|363664693|FG002|Overall Study|Withdrawal by Subject|0|||
105452155|NCT00531284|363664694|FG003|Overall Study|Withdrawal by Subject|4|||
105452156|NCT00531284|363664695|FG004|Overall Study|Withdrawal by Subject|0|||
105452157|NCT00531284|363664696|FG005|Overall Study|Withdrawal by Subject|0|||
105452158|NCT00531284|363664697|FG006|Overall Study|Withdrawal by Subject|0|||
105452159|NCT00531284|363664698|FG007|Overall Study|Withdrawal by Subject|0|||
105452160|NCT00531284|363664699|FG008|Overall Study|Withdrawal by Subject|0|||
105452161|NCT00531284|363664700|FG009|Overall Study|Withdrawal by Subject|0|||
105661743|NCT04147858|364425118|FG002|Overall Study|Subject Noncompliance, Other|1|||
105783248|NCT00945815|364859538|FG000|Overall Study|Did not begin protocol therapy|1|||
105452162|NCT00531284|363664701|FG010|Overall Study|Withdrawal by Subject|0|||
105452163|NCT00531284|363664702|FG011|Overall Study|Withdrawal by Subject|3|||
105452164|NCT00531284|363664703|FG012|Overall Study|Withdrawal by Subject|0|||
105452165|NCT00531284|363664704|FG013|Overall Study|Withdrawal by Subject|1|||
105452166|NCT00531284|363664705|FG014|Overall Study|Withdrawal by Subject|0|||
105452167|NCT00531284|363664706|FG015|Overall Study|Withdrawal by Subject|1|||
105452168|NCT00531284|363664707|FG016|Overall Study|Withdrawal by Subject|1|||
105452169|NCT00531284|363664691|FG000|Overall Study|Other|1|||
105452170|NCT00531284|363664692|FG001|Overall Study|Other|0|||
105452171|NCT00531284|363664693|FG002|Overall Study|Other|0|||
105452172|NCT00531284|363664694|FG003|Overall Study|Other|10|||
105452173|NCT00531284|363664695|FG004|Overall Study|Other|2|||
105452174|NCT00531284|363664696|FG005|Overall Study|Other|1|||
105452175|NCT00531284|363664697|FG006|Overall Study|Other|0|||
105452176|NCT00531284|363664698|FG007|Overall Study|Other|0|||
105452177|NCT00531284|363664699|FG008|Overall Study|Other|2|||
105452178|NCT00531284|363664700|FG009|Overall Study|Other|1|||
105452179|NCT00531284|363664701|FG010|Overall Study|Other|0|||
105452180|NCT00531284|363664702|FG011|Overall Study|Other|2|||
105783249|NCT01728194|364859539|FG000|Overall Study|Lost to Follow-up|4|||
105783250|NCT01728194|364859540|FG001|Overall Study|Lost to Follow-up|3|||
105452181|NCT00531284|363664703|FG012|Overall Study|Other|0|||
105452182|NCT00531284|363664704|FG013|Overall Study|Other|0|||
105452183|NCT00531284|363664705|FG014|Overall Study|Other|1|||
105783251|NCT01728194|364859539|FG000|Overall Study|Physician Decision|4|||
105783252|NCT01728194|364859540|FG001|Overall Study|Physician Decision|0|||
105783253|NCT01728194|364859539|FG000|Overall Study|Withdrawal by Subject|7|||
105783254|NCT01728194|364859540|FG001|Overall Study|Withdrawal by Subject|3|||
105783255|NCT01728194|364859539|FG000|Overall Study|Perceived Medication Side Effects|4|||
105783256|NCT01728194|364859540|FG001|Overall Study|Perceived Medication Side Effects|0|||
105783257|NCT01728194|364859539|FG000|Overall Study|Family Member Request|1|||
105783258|NCT01728194|364859540|FG001|Overall Study|Family Member Request|0|||
105783259|NCT02129192|364859543|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
105452184|NCT00531284|363664706|FG015|Overall Study|Other|0|||
105452185|NCT00531284|363664707|FG016|Overall Study|Other|0|||
105452186|NCT04388111|363664708|FG000|Overall Study|Lost to Follow-up|5|||
105452187|NCT04388111|363664709|FG001|Overall Study|Lost to Follow-up|3|||
105452188|NCT04388111|363664708|FG000|Overall Study|Adverse Event|1|||
105452189|NCT04388111|363664709|FG001|Overall Study|Adverse Event|1|||
105452190|NCT04388111|363664708|FG000|Overall Study|Protocol Violation|2|||
105452191|NCT04388111|363664709|FG001|Overall Study|Protocol Violation|4|||
105783260|NCT02129192|364859544|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
105783261|NCT01231620|364859545|FG000|Overall Study|Physician Decision|3|||
105783262|NCT01231620|364859546|FG001|Overall Study|Physician Decision|5|||
105783263|NCT01231620|364859547|FG002|Overall Study|Physician Decision|10|||
105783264|NCT01231620|364859545|FG000|Overall Study|Death|12|||
105783265|NCT01231620|364859546|FG001|Overall Study|Death|14|||
105783266|NCT01231620|364859547|FG002|Overall Study|Death|11|||
105783267|NCT01231620|364859545|FG000|Overall Study|Adverse Event|2|||
105783268|NCT01231620|364859546|FG001|Overall Study|Adverse Event|2|||
105783269|NCT01231620|364859547|FG002|Overall Study|Adverse Event|1|||
105783270|NCT01231620|364859545|FG000|Overall Study|Withdrawal by Subject|6|||
105783271|NCT01231620|364859546|FG001|Overall Study|Withdrawal by Subject|6|||
105783272|NCT01231620|364859547|FG002|Overall Study|Withdrawal by Subject|8|||
105783273|NCT01231620|364859545|FG000|Overall Study|Lost to Follow-up|3|||
105783274|NCT01231620|364859546|FG001|Overall Study|Lost to Follow-up|4|||
105783275|NCT01231620|364859547|FG002|Overall Study|Lost to Follow-up|9|||
105783276|NCT02400281|364859548|FG000|Overall Study|Adverse Event|0|||
105783277|NCT02400281|364859549|FG001|Overall Study|Adverse Event|0|||
105783278|NCT02400281|364859550|FG002|Overall Study|Adverse Event|1|||
105452192|NCT04388111|363664708|FG000|Overall Study|Withdrawal by Subject|1|||
105452193|NCT04388111|363664709|FG001|Overall Study|Withdrawal by Subject|0|||
105452194|NCT02735239|363664710|FG000|Overall Study|Adverse Event|0|||
105452195|NCT02735239|363664711|FG001|Overall Study|Adverse Event|0|||
105452196|NCT02735239|363664712|FG002|Overall Study|Adverse Event|4|||
105452197|NCT02735239|363664713|FG003|Overall Study|Adverse Event|0|||
105452198|NCT02735239|363664714|FG004|Overall Study|Adverse Event|0|||
105452199|NCT02735239|363664715|FG005|Overall Study|Adverse Event|0|||
105452200|NCT02735239|363664710|FG000|Overall Study|Death|1|||
105452201|NCT02735239|363664711|FG001|Overall Study|Death|1|||
105452202|NCT02735239|363664712|FG002|Overall Study|Death|0|||
105452203|NCT02735239|363664713|FG003|Overall Study|Death|0|||
105452204|NCT02735239|363664714|FG004|Overall Study|Death|0|||
105452205|NCT02735239|363664715|FG005|Overall Study|Death|0|||
105452206|NCT02735239|363664710|FG000|Overall Study|Physician Decision|0|||
105452207|NCT02735239|363664711|FG001|Overall Study|Physician Decision|0|||
105452208|NCT02735239|363664712|FG002|Overall Study|Physician Decision|1|||
105452209|NCT02735239|363664713|FG003|Overall Study|Physician Decision|0|||
105783279|NCT02400281|364859551|FG003|Overall Study|Adverse Event|0|||
105783280|NCT02400281|364859552|FG004|Overall Study|Adverse Event|1|||
105783281|NCT02400281|364859553|FG005|Overall Study|Adverse Event|0|||
105783282|NCT02400281|364859548|FG000|Overall Study|Physician Decision|0|||
105452210|NCT02735239|363664714|FG004|Overall Study|Physician Decision|0|||
105452211|NCT02735239|363664715|FG005|Overall Study|Physician Decision|0|||
105452212|NCT02735239|363664710|FG000|Overall Study|Progressive disease|3|||
105452213|NCT02735239|363664711|FG001|Overall Study|Progressive disease|1|||
105452214|NCT02735239|363664712|FG002|Overall Study|Progressive disease|3|||
105452215|NCT02735239|363664713|FG003|Overall Study|Progressive disease|0|||
105452216|NCT02735239|363664714|FG004|Overall Study|Progressive disease|0|||
105452217|NCT02735239|363664715|FG005|Overall Study|Progressive disease|2|||
105452218|NCT02735239|363664710|FG000|Overall Study|Withdrawal by Subject|0|||
105452219|NCT02735239|363664711|FG001|Overall Study|Withdrawal by Subject|1|||
105452220|NCT02735239|363664712|FG002|Overall Study|Withdrawal by Subject|0|||
105783283|NCT02400281|364859549|FG001|Overall Study|Physician Decision|0|||
105783284|NCT02400281|364859550|FG002|Overall Study|Physician Decision|1|||
105452221|NCT02735239|363664713|FG003|Overall Study|Withdrawal by Subject|0|||
105452222|NCT02735239|363664714|FG004|Overall Study|Withdrawal by Subject|0|||
105452223|NCT02735239|363664715|FG005|Overall Study|Withdrawal by Subject|0|||
105452224|NCT01342913|363664716|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
105452225|NCT01342913|363664717|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
105452226|NCT01342913|363664718|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
105452227|NCT01342913|363664716|FG000|2-week Run-in Period|Physician Decision|6|||
105452228|NCT01342913|363664717|FG001|2-week Run-in Period|Physician Decision|0|||
105452229|NCT01342913|363664718|FG002|2-week Run-in Period|Physician Decision|0|||
105452230|NCT01342913|363664716|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
105452231|NCT01342913|363664717|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
105452232|NCT01342913|363664718|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
105452233|NCT01342913|363664716|FG000|2-week Run-in Period|Adverse Event|2|||
105452234|NCT01342913|363664717|FG001|2-week Run-in Period|Adverse Event|0|||
105452235|NCT01342913|363664718|FG002|2-week Run-in Period|Adverse Event|0|||
105452236|NCT01342913|363664716|FG000|2-week Run-in Period|Protocol Violation|5|||
105452237|NCT01342913|363664717|FG001|2-week Run-in Period|Protocol Violation|0|||
105452238|NCT01342913|363664718|FG002|2-week Run-in Period|Protocol Violation|0|||
105452239|NCT01342913|363664716|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
105452240|NCT01342913|363664717|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
105452241|NCT01342913|363664718|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
105452242|NCT01342913|363664716|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105452243|NCT01342913|363664717|FG001|Double-Blind Treatment Period|Adverse Event|3|||
105452244|NCT01342913|363664718|FG002|Double-Blind Treatment Period|Adverse Event|6|||
105452245|NCT01342913|363664716|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
105452246|NCT01342913|363664717|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
105452247|NCT01342913|363664718|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
105452248|NCT01342913|363664716|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
105452249|NCT01342913|363664717|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
105452250|NCT01342913|363664718|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
105452251|NCT01342913|363664716|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105452252|NCT01342913|363664717|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
105452253|NCT01342913|363664718|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
105452254|NCT01342913|363664716|FG000|Double-Blind Treatment Period|Physician Decision|0|||
105452255|NCT01342913|363664717|FG001|Double-Blind Treatment Period|Physician Decision|2|||
105452256|NCT01342913|363664718|FG002|Double-Blind Treatment Period|Physician Decision|0|||
105452257|NCT01342913|363664716|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105452258|NCT01342913|363664717|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
105452259|NCT01342913|363664718|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
105452260|NCT00387881|363664722|FG000|Overall Study|Lost to Follow-up|23|||
105452261|NCT00387881|363664723|FG001|Overall Study|Lost to Follow-up|23|||
105452262|NCT00387881|363664722|FG000|Overall Study|Protocol Violation|2|||
105452263|NCT00387881|363664723|FG001|Overall Study|Protocol Violation|12|||
105452264|NCT00387881|363664722|FG000|Overall Study|Withdrawal by Subject|15|||
105452265|NCT00387881|363664723|FG001|Overall Study|Withdrawal by Subject|18|||
105452266|NCT00387881|363664722|FG000|Overall Study|Sponsor terminated Study|0|||
105452267|NCT00387881|363664723|FG001|Overall Study|Sponsor terminated Study|1|||
105452268|NCT00387881|363664722|FG000|Overall Study|Not eligible|6|||
105452269|NCT00387881|363664723|FG001|Overall Study|Not eligible|7|||
105452270|NCT00387881|363664722|FG000|Overall Study|No opportunity to treat headache|32|||
105452271|NCT00387881|363664723|FG001|Overall Study|No opportunity to treat headache|34|||
105452272|NCT00387881|363664722|FG000|Overall Study|Not otherwise specified|11|||
105452273|NCT00387881|363664723|FG001|Overall Study|Not otherwise specified|7|||
105452274|NCT03629886|363664724|FG000|Overall Study|Migrated / moved from the study area|0|||
105452275|NCT03629886|363664725|FG001|Overall Study|Migrated / moved from the study area|55|||
105452276|NCT03629886|363664724|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
105452277|NCT03629886|363664725|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
105452278|NCT03629886|363664724|FG000|Overall Study|Study vaccine not administrated|0|||
105452279|NCT03629886|363664725|FG001|Overall Study|Study vaccine not administrated|3|||
105452280|NCT03629886|363664724|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
105452281|NCT03629886|363664725|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
105452282|NCT03629886|363664724|FG000|Overall Study|Refused vaccination step of the study|0|||
105661744|NCT01191008|364425119|FG000|Overall Study|Protocol Violation|7|||
105452283|NCT03629886|363664725|FG001|Overall Study|Refused vaccination step of the study|44|||
105452284|NCT01790594|363664726|FG000|Overall Study|Death|1|||
105452285|NCT01790594|363664727|FG001|Overall Study|Death|0|||
105452286|NCT01790594|363664728|FG002|Overall Study|Death|0|||
105452287|NCT01790594|363664726|FG000|Overall Study|Physician Decision|2|||
105452288|NCT01790594|363664727|FG001|Overall Study|Physician Decision|1|||
105452289|NCT01790594|363664728|FG002|Overall Study|Physician Decision|0|||
105452290|NCT01790594|363664726|FG000|Overall Study|Withdrawal by Subject|2|||
105452291|NCT01790594|363664727|FG001|Overall Study|Withdrawal by Subject|0|||
105452292|NCT01790594|363664728|FG002|Overall Study|Withdrawal by Subject|0|||
105452293|NCT01790594|363664726|FG000|Overall Study|Transplant was not done|0|||
105452294|NCT01790594|363664727|FG001|Overall Study|Transplant was not done|0|||
105452295|NCT01790594|363664728|FG002|Overall Study|Transplant was not done|3|||
105452296|NCT01790594|363664726|FG000|Overall Study|Terminated prior to week 76|0|||
105452297|NCT01790594|363664727|FG001|Overall Study|Terminated prior to week 76|2|||
105452298|NCT01790594|363664728|FG002|Overall Study|Terminated prior to week 76|0|||
105452299|NCT02730728|363664730|FG000|Overall Study|Withdrawal by Subject|0|||
105452300|NCT02730728|363664731|FG001|Overall Study|Withdrawal by Subject|1|||
105452301|NCT02730728|363664732|FG002|Overall Study|Withdrawal by Subject|0|||
105452302|NCT02730728|363664730|FG000|Overall Study|Lack of Efficacy|0|||
105452303|NCT02730728|363664731|FG001|Overall Study|Lack of Efficacy|1|||
105452304|NCT02730728|363664732|FG002|Overall Study|Lack of Efficacy|1|||
105452305|NCT00922623|363664733|FG000|Overall Study|Other|4|||
105452306|NCT00922623|363664733|FG000|Overall Study|Lost to Follow-up|1|||
105452307|NCT02210000|363664735|FG000|Overall Study|Study Terminated|11|||
105452308|NCT02210000|363664736|FG001|Overall Study|Study Terminated|12|||
105452309|NCT02210000|363664735|FG000|Overall Study|Withdrawal by Subject|7|||
105452310|NCT02210000|363664736|FG001|Overall Study|Withdrawal by Subject|1|||
105452311|NCT02210000|363664735|FG000|Overall Study|Adverse Event|1|||
105452312|NCT02210000|363664736|FG001|Overall Study|Adverse Event|5|||
105452313|NCT02210000|363664735|FG000|Overall Study|Lost to Follow-up|0|||
105452314|NCT02210000|363664736|FG001|Overall Study|Lost to Follow-up|2|||
105452315|NCT02210000|363664735|FG000|Overall Study|Physician Decision|0|||
105452316|NCT02210000|363664736|FG001|Overall Study|Physician Decision|1|||
105452317|NCT03347123|363664740|FG000|Overall Study|Death|1|||
105452318|NCT03347123|363664741|FG001|Overall Study|Death|2|||
105452319|NCT03347123|363664742|FG002|Overall Study|Death|0|||
105452320|NCT03347123|363664743|FG003|Overall Study|Death|0|||
105452321|NCT03347123|363664744|FG004|Overall Study|Death|0|||
105452322|NCT03347123|363664745|FG005|Overall Study|Death|0|||
105452323|NCT03347123|363664746|FG006|Overall Study|Death|0|||
105452324|NCT03347123|363664740|FG000|Overall Study|Withdrawal by Subject|1|||
105452325|NCT03347123|363664741|FG001|Overall Study|Withdrawal by Subject|0|||
105452326|NCT03347123|363664742|FG002|Overall Study|Withdrawal by Subject|0|||
105452327|NCT03347123|363664743|FG003|Overall Study|Withdrawal by Subject|0|||
105452328|NCT03347123|363664744|FG004|Overall Study|Withdrawal by Subject|0|||
105452329|NCT03347123|363664745|FG005|Overall Study|Withdrawal by Subject|0|||
105452330|NCT03347123|363664746|FG006|Overall Study|Withdrawal by Subject|0|||
105452331|NCT03347123|363664740|FG000|Overall Study|Reason not Specified|3|||
105452332|NCT03347123|363664741|FG001|Overall Study|Reason not Specified|4|||
105452333|NCT03347123|363664742|FG002|Overall Study|Reason not Specified|0|||
105452334|NCT03347123|363664743|FG003|Overall Study|Reason not Specified|0|||
105452335|NCT03347123|363664744|FG004|Overall Study|Reason not Specified|0|||
105452336|NCT03347123|363664745|FG005|Overall Study|Reason not Specified|0|||
105452337|NCT03347123|363664746|FG006|Overall Study|Reason not Specified|0|||
105452338|NCT02123134|363664747|FG000|Overall Study|Withdrawal of consent|3|||
105452339|NCT02123134|363664748|FG001|Overall Study|Withdrawal of consent|2|||
105452340|NCT02123134|363664747|FG000|Overall Study|Administrative decision|0|||
105452341|NCT02123134|363664748|FG001|Overall Study|Administrative decision|1|||
105452342|NCT02632344|363664753|FG000|Overall Study|Adverse Event|3|||
105452343|NCT02632344|363664753|FG000|Overall Study|Lack of Efficacy|3|||
105452344|NCT02632344|363664753|FG000|Overall Study|Withdrawal by Subject|2|||
105452345|NCT02469623|363664756|FG000|Overall Study|Not consented for long-term follow-up|4|||
105452346|NCT02469623|363664756|FG000|Overall Study|Lost to Follow-up|4|||
105452347|NCT02469623|363664756|FG000|Overall Study|Withdrawal by Subject|2|||
105452348|NCT02469623|363664756|FG000|Overall Study|Death|3|||
105452349|NCT03309878|363664757|FG000|Overall Study|Adverse Event|1|||
105452350|NCT03309878|363664758|FG001|Overall Study|Adverse Event|0|||
105452351|NCT03309878|363664759|FG002|Overall Study|Adverse Event|0|||
105452352|NCT03309878|363664760|FG003|Overall Study|Adverse Event|0|||
105452353|NCT03309878|363664757|FG000|Overall Study|Did not maintain eligibility|2|||
105452354|NCT03309878|363664758|FG001|Overall Study|Did not maintain eligibility|1|||
105452355|NCT03309878|363664759|FG002|Overall Study|Did not maintain eligibility|0|||
105452356|NCT03309878|363664760|FG003|Overall Study|Did not maintain eligibility|0|||
105452357|NCT03309878|363664757|FG000|Overall Study|Withdrawal by Subject|0|||
105452358|NCT03309878|363664758|FG001|Overall Study|Withdrawal by Subject|1|||
105452359|NCT03309878|363664759|FG002|Overall Study|Withdrawal by Subject|0|||
105452360|NCT03309878|363664760|FG003|Overall Study|Withdrawal by Subject|0|||
105452361|NCT01096316|363664761|FG000|Overall Study|Lost to Follow-up|15|||
105452362|NCT01096316|363664762|FG001|Overall Study|Lost to Follow-up|9|||
105452363|NCT02763644|363664763|FG000|Overall Study|Patient/guardian decision|1|||
105452364|NCT02763644|363664764|FG001|Overall Study|Patient/guardian decision|0|||
105452365|NCT02763644|363664763|FG000|Overall Study|Death|1|||
105452366|NCT02763644|363664764|FG001|Overall Study|Death|1|||
105452367|NCT02763644|363664763|FG000|Overall Study|Adverse Event|1|||
105452368|NCT02763644|363664764|FG001|Overall Study|Adverse Event|1|||
105452369|NCT01884077|363664765|FG000|Overall Study|screen fail|0|||
105783285|NCT02400281|364859551|FG003|Overall Study|Physician Decision|0|||
105783286|NCT02400281|364859552|FG004|Overall Study|Physician Decision|0|||
105783287|NCT02400281|364859553|FG005|Overall Study|Physician Decision|0|||
105783288|NCT02576652|364859554|FG000|Overall Study|Withdrawal by Subject|2|||
105783289|NCT01087944|364859558|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
105783290|NCT01087944|364859559|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
105783291|NCT01087944|364859558|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
105783292|NCT01087944|364859559|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
105452370|NCT01884077|363664766|FG001|Overall Study|screen fail|2|||
105452371|NCT01884077|363664765|FG000|Overall Study|canceled surgery|2|||
105452372|NCT01884077|363664766|FG001|Overall Study|canceled surgery|0|||
105452373|NCT01884077|363664765|FG000|Overall Study|Lost to Follow-up|0|||
105452374|NCT01884077|363664766|FG001|Overall Study|Lost to Follow-up|4|||
105452375|NCT01884077|363664765|FG000|Overall Study|study closed|6|||
105452376|NCT01884077|363664766|FG001|Overall Study|study closed|4|||
105452377|NCT01008943|363664767|FG000|Overall Study|Withdrawal by Subject|1|||
105452378|NCT05789745|363664769|FG000|Overall Study|Withdrawal by Subject|0|||
105452379|NCT05789745|363664770|FG001|Overall Study|Withdrawal by Subject|0|||
105452380|NCT05789745|363664771|FG002|Overall Study|Withdrawal by Subject|0|||
105452381|NCT05789745|363664772|FG003|Overall Study|Withdrawal by Subject|0|||
105452382|NCT05789745|363664773|FG004|Overall Study|Withdrawal by Subject|1|||
105452383|NCT03480152|363664779|FG000|Phase I|Signed consent. Died before treatment.|1|||
105452384|NCT03480152|363664780|FG001|Phase I|Signed consent. Died before treatment.|0|||
105452385|NCT03480152|363664781|FG002|Phase I|Signed consent. Died before treatment.|0|||
105452386|NCT02903160|363664782|FG000|Overall Study|Adverse Event|2|||
105452387|NCT02903160|363664782|FG000|Overall Study|Death|1|||
105452388|NCT02903160|363664782|FG000|Overall Study|Lost to Follow-up|2|||
105452389|NCT02903160|363664782|FG000|Overall Study|Withdrawal by Subject|1|||
105452390|NCT02903160|363664782|FG000|Overall Study|Medical Insurance Barriers|1|||
105452391|NCT02525471|363664785|FG000|Overall Study|Screen Failure|6|||
105452392|NCT02525471|363664785|FG000|Overall Study|Withdrawal by Subject|4|||
105452393|NCT02525471|363664785|FG000|Overall Study|Death|1|||
105452394|NCT01168349|363664786|FG000|Overall Study|Death|157|||
105452395|NCT01168349|363664786|FG000|Overall Study|Lost to Follow-up|34|||
105452396|NCT01168349|363664786|FG000|Overall Study|Withdrawal by Subject|9|||
105452397|NCT01168349|363664786|FG000|Overall Study|Kidney transplantation|3|||
105452398|NCT01168349|363664786|FG000|Overall Study|Other|22|||
105452399|NCT01168349|363664786|FG000|Overall Study|Protocol Violation|76|||
105452400|NCT01091675|363664791|FG000|Overall Study|Adverse Event|7|||
105452401|NCT01091675|363664791|FG000|Overall Study|Lack of Efficacy|27|||
105452402|NCT02888106|363664795|FG000|Overall Study|Withdrawal by Subject|1|||
105452403|NCT02888106|363664796|FG001|Overall Study|Withdrawal by Subject|2|||
105452404|NCT02888106|363664797|FG002|Overall Study|Withdrawal by Subject|0|||
105452405|NCT02888106|363664798|FG003|Overall Study|Withdrawal by Subject|1|||
105452406|NCT02888106|363664799|FG004|Overall Study|Withdrawal by Subject|0|||
105452407|NCT02888106|363664800|FG005|Overall Study|Withdrawal by Subject|0|||
105452408|NCT02888106|363664795|FG000|Overall Study|Lost to Follow-up|1|||
105452409|NCT02888106|363664796|FG001|Overall Study|Lost to Follow-up|0|||
105452410|NCT02888106|363664797|FG002|Overall Study|Lost to Follow-up|0|||
105452411|NCT02888106|363664798|FG003|Overall Study|Lost to Follow-up|1|||
105452412|NCT02888106|363664799|FG004|Overall Study|Lost to Follow-up|0|||
105452413|NCT02888106|363664800|FG005|Overall Study|Lost to Follow-up|1|||
105452414|NCT02888106|363664795|FG000|Overall Study|Adverse Event|2|||
105452415|NCT02888106|363664796|FG001|Overall Study|Adverse Event|0|||
105452416|NCT02888106|363664797|FG002|Overall Study|Adverse Event|0|||
105452417|NCT02888106|363664798|FG003|Overall Study|Adverse Event|0|||
105452418|NCT02888106|363664799|FG004|Overall Study|Adverse Event|0|||
105452419|NCT02888106|363664800|FG005|Overall Study|Adverse Event|0|||
105452420|NCT02888106|363664795|FG000|Overall Study|Withdrawal of consent|0|||
105452421|NCT02888106|363664796|FG001|Overall Study|Withdrawal of consent|0|||
105452422|NCT02888106|363664797|FG002|Overall Study|Withdrawal of consent|0|||
105452423|NCT02888106|363664798|FG003|Overall Study|Withdrawal of consent|0|||
105452424|NCT02888106|363664799|FG004|Overall Study|Withdrawal of consent|1|||
105452425|NCT02888106|363664800|FG005|Overall Study|Withdrawal of consent|0|||
105452426|NCT02888106|363664795|FG000|Overall Study|Pregnancy|1|||
105783293|NCT02451137|364859566|FG000|Overall Study|Randomized but not treated|19|||
105452427|NCT02888106|363664796|FG001|Overall Study|Pregnancy|0|||
105452428|NCT02888106|363664797|FG002|Overall Study|Pregnancy|0|||
105452429|NCT02888106|363664798|FG003|Overall Study|Pregnancy|0|||
105783294|NCT02451137|364859567|FG001|Overall Study|Randomized but not treated|27|||
105452430|NCT02888106|363664799|FG004|Overall Study|Pregnancy|0|||
105452431|NCT02888106|363664800|FG005|Overall Study|Pregnancy|0|||
105452432|NCT01391663|363664801|FG000|Overall Study|Withdrawal by Subject|0|||
105452433|NCT01391663|363664802|FG001|Overall Study|Withdrawal by Subject|0|||
105452434|NCT01391663|363664803|FG002|Overall Study|Withdrawal by Subject|1|||
105452435|NCT01391663|363664804|FG003|Overall Study|Withdrawal by Subject|0|||
105452436|NCT03515824|363664805|FG000|Overall Study|Death|3|||
105452437|NCT03515824|363664806|FG001|Overall Study|Death|2|||
105783295|NCT02451137|364859566|FG000|Overall Study|Adverse Event|43|||
105452438|NCT03515824|363664807|FG002|Overall Study|Death|6|||
105452439|NCT03515824|363664808|FG003|Overall Study|Death|0|||
105452440|NCT03515824|363664805|FG000|Overall Study|Lost to Follow-up|0|||
105452441|NCT03515824|363664806|FG001|Overall Study|Lost to Follow-up|1|||
105452442|NCT03515824|363664807|FG002|Overall Study|Lost to Follow-up|1|||
105452443|NCT03515824|363664808|FG003|Overall Study|Lost to Follow-up|0|||
105452444|NCT03515824|363664805|FG000|Overall Study|Study terminated by sponsor|0|||
105452445|NCT03515824|363664806|FG001|Overall Study|Study terminated by sponsor|1|||
105452446|NCT03515824|363664807|FG002|Overall Study|Study terminated by sponsor|6|||
105452447|NCT03515824|363664808|FG003|Overall Study|Study terminated by sponsor|0|||
105452448|NCT03515824|363664805|FG000|Overall Study|Status not recorded|0|||
105452449|NCT03515824|363664806|FG001|Overall Study|Status not recorded|0|||
105452450|NCT03515824|363664807|FG002|Overall Study|Status not recorded|2|||
105452451|NCT03515824|363664808|FG003|Overall Study|Status not recorded|0|||
105452452|NCT01384734|363664809|FG000|Overall Study|Adverse Event|0|||
105452453|NCT01384734|363664810|FG001|Overall Study|Adverse Event|3|||
105452454|NCT01384734|363664811|FG002|Overall Study|Adverse Event|0|||
105452455|NCT01384734|363664812|FG003|Overall Study|Adverse Event|2|||
105452456|NCT01384734|363664813|FG004|Overall Study|Adverse Event|7|||
105452457|NCT01384734|363664809|FG000|Overall Study|Death|1|||
105452458|NCT01384734|363664810|FG001|Overall Study|Death|0|||
105452459|NCT01384734|363664811|FG002|Overall Study|Death|1|||
105452460|NCT01384734|363664812|FG003|Overall Study|Death|0|||
105452461|NCT01384734|363664813|FG004|Overall Study|Death|0|||
105452462|NCT01384734|363664809|FG000|Overall Study|Continuation criteria not met|0|||
105452463|NCT01384734|363664810|FG001|Overall Study|Continuation criteria not met|0|||
105452464|NCT01384734|363664811|FG002|Overall Study|Continuation criteria not met|1|||
105452465|NCT01384734|363664812|FG003|Overall Study|Continuation criteria not met|1|||
105452466|NCT01384734|363664813|FG004|Overall Study|Continuation criteria not met|0|||
105452467|NCT01384734|363664809|FG000|Overall Study|Lack of Efficacy|3|||
105452468|NCT01384734|363664810|FG001|Overall Study|Lack of Efficacy|7|||
105452469|NCT01384734|363664811|FG002|Overall Study|Lack of Efficacy|4|||
105452470|NCT01384734|363664812|FG003|Overall Study|Lack of Efficacy|4|||
105452471|NCT01384734|363664813|FG004|Overall Study|Lack of Efficacy|2|||
105452472|NCT01384734|363664809|FG000|Overall Study|Lost to Follow-up|5|||
105452473|NCT01384734|363664810|FG001|Overall Study|Lost to Follow-up|3|||
105452474|NCT01384734|363664811|FG002|Overall Study|Lost to Follow-up|3|||
105452475|NCT01384734|363664812|FG003|Overall Study|Lost to Follow-up|8|||
105452476|NCT01384734|363664813|FG004|Overall Study|Lost to Follow-up|5|||
105452477|NCT01384734|363664809|FG000|Overall Study|Non-compliance with study drug|1|||
105452478|NCT01384734|363664810|FG001|Overall Study|Non-compliance with study drug|2|||
105452479|NCT01384734|363664811|FG002|Overall Study|Non-compliance with study drug|6|||
105452480|NCT01384734|363664812|FG003|Overall Study|Non-compliance with study drug|0|||
105452481|NCT01384734|363664813|FG004|Overall Study|Non-compliance with study drug|2|||
105452482|NCT01384734|363664809|FG000|Overall Study|Pregnancy|0|||
105452483|NCT01384734|363664810|FG001|Overall Study|Pregnancy|1|||
105452484|NCT01384734|363664811|FG002|Overall Study|Pregnancy|0|||
105452485|NCT01384734|363664812|FG003|Overall Study|Pregnancy|0|||
105452486|NCT01384734|363664813|FG004|Overall Study|Pregnancy|1|||
105452487|NCT01384734|363664809|FG000|Overall Study|Sponsor terminated|0|||
105452488|NCT01384734|363664810|FG001|Overall Study|Sponsor terminated|0|||
105452489|NCT01384734|363664811|FG002|Overall Study|Sponsor terminated|0|||
105452490|NCT01384734|363664812|FG003|Overall Study|Sponsor terminated|0|||
105452491|NCT01384734|363664813|FG004|Overall Study|Sponsor terminated|1|||
105452492|NCT01384734|363664809|FG000|Overall Study|Withdrawal by Subject|5|||
105452493|NCT01384734|363664810|FG001|Overall Study|Withdrawal by Subject|5|||
105452494|NCT01384734|363664811|FG002|Overall Study|Withdrawal by Subject|6|||
105452495|NCT01384734|363664812|FG003|Overall Study|Withdrawal by Subject|7|||
105452496|NCT01384734|363664813|FG004|Overall Study|Withdrawal by Subject|9|||
105452497|NCT01384734|363664809|FG000|Overall Study|Investigator relocating|0|||
105452498|NCT01384734|363664810|FG001|Overall Study|Investigator relocating|2|||
105452499|NCT01384734|363664811|FG002|Overall Study|Investigator relocating|0|||
105452500|NCT01384734|363664812|FG003|Overall Study|Investigator relocating|3|||
105452501|NCT01384734|363664813|FG004|Overall Study|Investigator relocating|1|||
105452502|NCT01384734|363664809|FG000|Overall Study|Unable to come back for visit|1|||
105452503|NCT01384734|363664810|FG001|Overall Study|Unable to come back for visit|0|||
105452504|NCT01384734|363664811|FG002|Overall Study|Unable to come back for visit|1|||
105452505|NCT01384734|363664812|FG003|Overall Study|Unable to come back for visit|1|||
105452506|NCT01384734|363664813|FG004|Overall Study|Unable to come back for visit|0|||
105452507|NCT01384734|363664809|FG000|Overall Study|Prison|0|||
105452508|NCT01384734|363664810|FG001|Overall Study|Prison|0|||
105452509|NCT01384734|363664811|FG002|Overall Study|Prison|1|||
105452510|NCT01384734|363664812|FG003|Overall Study|Prison|0|||
105452511|NCT01384734|363664813|FG004|Overall Study|Prison|0|||
105452512|NCT01384734|363664809|FG000|Overall Study|As per Exclusion criteria|0|||
105452513|NCT01384734|363664810|FG001|Overall Study|As per Exclusion criteria|1|||
105452514|NCT01384734|363664811|FG002|Overall Study|As per Exclusion criteria|0|||
105452515|NCT01384734|363664812|FG003|Overall Study|As per Exclusion criteria|0|||
105452516|NCT01384734|363664813|FG004|Overall Study|As per Exclusion criteria|0|||
105783296|NCT02451137|364859567|FG001|Overall Study|Adverse Event|42|||
105783297|NCT02451137|364859566|FG000|Overall Study|Lack of Efficacy|4|||
105783298|NCT02451137|364859567|FG001|Overall Study|Lack of Efficacy|9|||
105783299|NCT02451137|364859566|FG000|Overall Study|Participant decision:discontinue insulin|41|||
105783300|NCT02451137|364859567|FG001|Overall Study|Participant decision:discontinue insulin|43|||
105452517|NCT01384734|363664809|FG000|Overall Study|Missed End of treatment visit|0|||
105452518|NCT01384734|363664810|FG001|Overall Study|Missed End of treatment visit|0|||
105452519|NCT01384734|363664811|FG002|Overall Study|Missed End of treatment visit|0|||
105452520|NCT01384734|363664812|FG003|Overall Study|Missed End of treatment visit|1|||
105783301|NCT02451137|364859566|FG000|Overall Study|Hypoglycemia|2|||
105783302|NCT02451137|364859567|FG001|Overall Study|Hypoglycemia|1|||
105452521|NCT01384734|363664813|FG004|Overall Study|Missed End of treatment visit|0|||
105452522|NCT01384734|363664809|FG000|Overall Study|Adhesion problem|0|||
105452523|NCT01384734|363664810|FG001|Overall Study|Adhesion problem|0|||
105452524|NCT01384734|363664811|FG002|Overall Study|Adhesion problem|0|||
105452525|NCT01384734|363664812|FG003|Overall Study|Adhesion problem|1|||
105452526|NCT01384734|363664813|FG004|Overall Study|Adhesion problem|0|||
105452527|NCT01384734|363664809|FG000|Overall Study|Early termination|0|||
105452528|NCT01384734|363664810|FG001|Overall Study|Early termination|0|||
105452529|NCT01384734|363664811|FG002|Overall Study|Early termination|0|||
105452530|NCT01384734|363664812|FG003|Overall Study|Early termination|0|||
105452531|NCT01384734|363664813|FG004|Overall Study|Early termination|1|||
105452532|NCT01384734|363664809|FG000|Overall Study|Physician Decision|1|||
105452533|NCT01384734|363664810|FG001|Overall Study|Physician Decision|0|||
105452534|NCT01384734|363664811|FG002|Overall Study|Physician Decision|0|||
105452535|NCT01384734|363664812|FG003|Overall Study|Physician Decision|0|||
105452536|NCT01384734|363664813|FG004|Overall Study|Physician Decision|0|||
105452537|NCT03084796|363664814|FG000|Overall Study|Adverse Event|4|||
105452538|NCT03084796|363664815|FG001|Overall Study|Adverse Event|5|||
105452539|NCT03084796|363664816|FG002|Overall Study|Adverse Event|6|||
105452540|NCT03084796|363664817|FG003|Overall Study|Adverse Event|2|||
105452541|NCT03084796|363664818|FG004|Overall Study|Adverse Event|3|||
105452542|NCT03084796|363664819|FG005|Overall Study|Adverse Event|5|||
105452543|NCT03084796|363664814|FG000|Overall Study|Withdrawal by Subject|3|||
105452544|NCT03084796|363664815|FG001|Overall Study|Withdrawal by Subject|5|||
105452545|NCT03084796|363664816|FG002|Overall Study|Withdrawal by Subject|2|||
105452546|NCT03084796|363664817|FG003|Overall Study|Withdrawal by Subject|1|||
105452547|NCT03084796|363664818|FG004|Overall Study|Withdrawal by Subject|3|||
105452548|NCT03084796|363664819|FG005|Overall Study|Withdrawal by Subject|0|||
105452549|NCT03084796|363664814|FG000|Overall Study|Protocol Violation|0|||
105452550|NCT03084796|363664815|FG001|Overall Study|Protocol Violation|0|||
105452551|NCT03084796|363664816|FG002|Overall Study|Protocol Violation|1|||
105452552|NCT03084796|363664817|FG003|Overall Study|Protocol Violation|0|||
105452553|NCT03084796|363664818|FG004|Overall Study|Protocol Violation|1|||
105452554|NCT03084796|363664819|FG005|Overall Study|Protocol Violation|1|||
105452555|NCT03084796|363664814|FG000|Overall Study|Lack of Efficacy|0|||
105452556|NCT03084796|363664815|FG001|Overall Study|Lack of Efficacy|0|||
105452557|NCT03084796|363664816|FG002|Overall Study|Lack of Efficacy|1|||
105452558|NCT03084796|363664817|FG003|Overall Study|Lack of Efficacy|0|||
105452559|NCT03084796|363664818|FG004|Overall Study|Lack of Efficacy|1|||
105452560|NCT03084796|363664819|FG005|Overall Study|Lack of Efficacy|0|||
105452561|NCT03084796|363664814|FG000|Overall Study|Lost to Follow-up|0|||
105452562|NCT03084796|363664815|FG001|Overall Study|Lost to Follow-up|0|||
105783303|NCT02451137|364859566|FG000|Overall Study|Investigator's decision|23|||
105783304|NCT02451137|364859567|FG001|Overall Study|Investigator's decision|19|||
105783305|NCT02451137|364859566|FG000|Overall Study|Lost to Follow-up|53|||
105783306|NCT02451137|364859567|FG001|Overall Study|Lost to Follow-up|61|||
105783307|NCT02451137|364859566|FG000|Overall Study|Physician Decision|6|||
105783308|NCT02451137|364859567|FG001|Overall Study|Physician Decision|5|||
105783309|NCT02451137|364859566|FG000|Overall Study|Sponsor decision|13|||
105783310|NCT02451137|364859567|FG001|Overall Study|Sponsor decision|25|||
105452563|NCT03084796|363664816|FG002|Overall Study|Lost to Follow-up|1|||
105783311|NCT02451137|364859566|FG000|Overall Study|Withdrawal by Subject|40|||
105783312|NCT02451137|364859567|FG001|Overall Study|Withdrawal by Subject|63|||
105783313|NCT02451137|364859566|FG000|Overall Study|Other than specified above|2|||
105452564|NCT03084796|363664817|FG003|Overall Study|Lost to Follow-up|1|||
105452565|NCT03084796|363664818|FG004|Overall Study|Lost to Follow-up|3|||
105452566|NCT03084796|363664819|FG005|Overall Study|Lost to Follow-up|1|||
105452567|NCT03084796|363664814|FG000|Overall Study|Randomization error|0|||
105452568|NCT03084796|363664815|FG001|Overall Study|Randomization error|0|||
105452569|NCT03084796|363664816|FG002|Overall Study|Randomization error|1|||
105783314|NCT02451137|364859567|FG001|Overall Study|Other than specified above|3|||
105452570|NCT03084796|363664817|FG003|Overall Study|Randomization error|0|||
105452571|NCT03084796|363664818|FG004|Overall Study|Randomization error|0|||
105452572|NCT03084796|363664819|FG005|Overall Study|Randomization error|0|||
105452573|NCT00650767|363664821|FG000|Overall Study|Adverse Event|0|||
105452574|NCT00650767|363664822|FG001|Overall Study|Adverse Event|3|||
105452575|NCT00650767|363664823|FG002|Overall Study|Adverse Event|10|||
105783315|NCT01977573|364859568|FG000|Overall Study|Adverse Event|7|||
105783316|NCT01977573|364859569|FG001|Overall Study|Adverse Event|0|||
105783317|NCT01977573|364859570|FG002|Overall Study|Adverse Event|2|||
105783318|NCT01977573|364859571|FG003|Overall Study|Adverse Event|1|||
105783319|NCT01977573|364859568|FG000|Overall Study|Lost to Follow-up|1|||
105783320|NCT01977573|364859569|FG001|Overall Study|Lost to Follow-up|0|||
105783321|NCT01977573|364859570|FG002|Overall Study|Lost to Follow-up|0|||
105783322|NCT01977573|364859571|FG003|Overall Study|Lost to Follow-up|1|||
105783323|NCT01977573|364859568|FG000|Overall Study|Physician Decision|1|||
105783324|NCT01977573|364859569|FG001|Overall Study|Physician Decision|0|||
105783325|NCT01977573|364859570|FG002|Overall Study|Physician Decision|0|||
105783326|NCT01977573|364859571|FG003|Overall Study|Physician Decision|0|||
105783327|NCT01977573|364859568|FG000|Overall Study|Protocol Violation|3|||
105783328|NCT01977573|364859569|FG001|Overall Study|Protocol Violation|1|||
105783329|NCT01977573|364859570|FG002|Overall Study|Protocol Violation|0|||
105783330|NCT01977573|364859571|FG003|Overall Study|Protocol Violation|0|||
105783331|NCT01977573|364859568|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
105783332|NCT01977573|364859569|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
105783333|NCT01977573|364859570|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
105783334|NCT01977573|364859571|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
105783335|NCT01977573|364859568|FG000|Overall Study|Withdrawal by Subject|6|||
105783336|NCT01977573|364859569|FG001|Overall Study|Withdrawal by Subject|1|||
105783337|NCT01977573|364859570|FG002|Overall Study|Withdrawal by Subject|1|||
105783338|NCT01977573|364859571|FG003|Overall Study|Withdrawal by Subject|1|||
105783339|NCT00765726|364859575|FG000|Overall Study|Withdrawal by Subject|1|||
105783340|NCT00765726|364859575|FG000|Overall Study|Discontinuation of study by sponsor|8|||
105783341|NCT01265511|364859576|FG000|Overall Study|Lack of Efficacy|2|||
105783342|NCT01265511|364859577|FG001|Overall Study|Lack of Efficacy|1|||
105783343|NCT01265511|364859576|FG000|Overall Study|Met stopping rules|0|||
105783344|NCT01265511|364859577|FG001|Overall Study|Met stopping rules|2|||
105783345|NCT01790633|364859578|FG000|Overall Study|Protocol Violation|1|||
105783346|NCT01790633|364859579|FG001|Overall Study|Protocol Violation|2|||
105783347|NCT01790633|364859578|FG000|Overall Study|Did not have serology performed|47|||
105783348|NCT01790633|364859579|FG001|Overall Study|Did not have serology performed|0|||
105783349|NCT01790633|364859578|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
105783350|NCT01790633|364859579|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
105783351|NCT00223990|364859580|FG000|Overall Study|Moved from area|2|||
105783352|NCT00223990|364859581|FG001|Overall Study|Moved from area|1|||
105783353|NCT00223990|364859580|FG000|Overall Study|Withdrawal by Subject|4|||
105783354|NCT00223990|364859581|FG001|Overall Study|Withdrawal by Subject|8|||
105783355|NCT00223990|364859580|FG000|Overall Study|Lost to Follow-up|1|||
105783356|NCT00223990|364859581|FG001|Overall Study|Lost to Follow-up|0|||
105783357|NCT01519700|364860717|FG000|Overall Study|Death|1|||
105783358|NCT01519700|364860718|FG001|Overall Study|Death|0|||
105783359|NCT01519700|364860719|FG002|Overall Study|Death|0|||
105783360|NCT01519700|364860720|FG003|Overall Study|Death|0|||
105783361|NCT01519700|364860717|FG000|Overall Study|Lost to Follow-up|0|||
105783362|NCT01519700|364860718|FG001|Overall Study|Lost to Follow-up|0|||
105783363|NCT01519700|364860719|FG002|Overall Study|Lost to Follow-up|1|||
105783364|NCT01519700|364860720|FG003|Overall Study|Lost to Follow-up|1|||
105783365|NCT01519700|364860717|FG000|Overall Study|Physician Decision|1|||
105783366|NCT01519700|364860718|FG001|Overall Study|Physician Decision|1|||
105783367|NCT01519700|364860719|FG002|Overall Study|Physician Decision|3|||
105783368|NCT01519700|364860720|FG003|Overall Study|Physician Decision|0|||
105452576|NCT00650767|363664824|FG003|Overall Study|Adverse Event|8|||
105452577|NCT00650767|363664821|FG000|Overall Study|Death|1|||
105452578|NCT00650767|363664822|FG001|Overall Study|Death|0|||
105452579|NCT00650767|363664823|FG002|Overall Study|Death|0|||
105452580|NCT00650767|363664824|FG003|Overall Study|Death|0|||
105452581|NCT00650767|363664821|FG000|Overall Study|Withdrawal by Subject|2|||
105452582|NCT00650767|363664822|FG001|Overall Study|Withdrawal by Subject|4|||
105452583|NCT00650767|363664823|FG002|Overall Study|Withdrawal by Subject|3|||
105452584|NCT00650767|363664824|FG003|Overall Study|Withdrawal by Subject|3|||
105452585|NCT00650767|363664821|FG000|Overall Study|Lost to Follow-up|1|||
105452586|NCT00650767|363664822|FG001|Overall Study|Lost to Follow-up|1|||
105452587|NCT00650767|363664823|FG002|Overall Study|Lost to Follow-up|1|||
105452588|NCT00650767|363664824|FG003|Overall Study|Lost to Follow-up|0|||
105452589|NCT00650767|363664821|FG000|Overall Study|Other|1|||
105783369|NCT01519700|364860717|FG000|Overall Study|Withdrawal by Subject|5|||
105452590|NCT00650767|363664822|FG001|Overall Study|Other|1|||
105452591|NCT00650767|363664823|FG002|Overall Study|Other|0|||
105783370|NCT01519700|364860718|FG001|Overall Study|Withdrawal by Subject|3|||
105783371|NCT01519700|364860719|FG002|Overall Study|Withdrawal by Subject|3|||
105783372|NCT01519700|364860720|FG003|Overall Study|Withdrawal by Subject|2|||
105783373|NCT01519700|364860717|FG000|Overall Study|Other Reason|2|||
105783374|NCT01519700|364860718|FG001|Overall Study|Other Reason|2|||
105783375|NCT01519700|364860719|FG002|Overall Study|Other Reason|0|||
105783376|NCT01519700|364860720|FG003|Overall Study|Other Reason|4|||
105783377|NCT00346775|364860721|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
105452592|NCT00650767|363664824|FG003|Overall Study|Other|0|||
105783378|NCT00346775|364860722|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
105783379|NCT00346775|364860721|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
105783380|NCT00346775|364860722|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
105783381|NCT00346775|364860721|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
105783382|NCT00346775|364860722|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
105783383|NCT02946515|364860723|FG000|Overall Study|Lost to Follow-up|2|||
105783384|NCT02946515|364860724|FG001|Overall Study|Lost to Follow-up|1|||
105783385|NCT01714726|364860725|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
105783386|NCT01714726|364860726|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
105783387|NCT01714726|364860727|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
105783388|NCT01714726|364860728|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
105783389|NCT01714726|364860725|FG000|Double-Blinded Induction Period|Adverse Event|0|||
105783390|NCT01714726|364860726|FG001|Double-Blinded Induction Period|Adverse Event|1|||
105783391|NCT01714726|364860727|FG002|Double-Blinded Induction Period|Adverse Event|0|||
105783392|NCT01714726|364860728|FG003|Double-Blinded Induction Period|Adverse Event|0|||
105783393|NCT01714726|364860725|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
105783394|NCT01714726|364860726|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
105783395|NCT01714726|364860727|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
105783396|NCT01714726|364860728|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
105783397|NCT01714726|364860725|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
105783398|NCT01714726|364860726|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
105452593|NCT02586623|363664825|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
105452594|NCT02586623|363664826|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
105452595|NCT02586623|363664827|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
105452596|NCT02586623|363664825|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
105452597|NCT02586623|363664826|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
105452598|NCT02586623|363664827|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
105452599|NCT02586623|363664825|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
105452600|NCT02586623|363664826|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
105452601|NCT02586623|363664827|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
105452602|NCT02586623|363664825|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
105452603|NCT02586623|363664826|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
105452604|NCT02586623|363664827|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
105452605|NCT02586623|363664825|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
105452606|NCT02586623|363664826|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
105783399|NCT01714726|364860727|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
105783400|NCT01714726|364860728|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
105783401|NCT01714726|364860725|FG000|Open-Label Period|Other|0|||
105783402|NCT01714726|364860726|FG001|Open-Label Period|Other|0|||
105783403|NCT01714726|364860727|FG002|Open-Label Period|Other|1|||
105783404|NCT01714726|364860728|FG003|Open-Label Period|Other|3|||
105452607|NCT02586623|363664827|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
105452608|NCT02586623|363664825|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
105452609|NCT02586623|363664826|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
105452610|NCT02586623|363664827|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
105452611|NCT02586623|363664825|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
105452612|NCT02586623|363664826|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
105452613|NCT02586623|363664827|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
105452614|NCT02586623|363664825|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
105452615|NCT02586623|363664826|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
105452616|NCT02586623|363664827|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
105452617|NCT02586623|363664825|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
105452618|NCT02586623|363664826|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
105452619|NCT02586623|363664827|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
105452620|NCT02586623|363664825|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
105452621|NCT02586623|363664826|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
105452622|NCT02586623|363664827|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
105452623|NCT02586623|363664825|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
105452624|NCT02586623|363664826|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
105452625|NCT02586623|363664827|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
105452626|NCT02586623|363664825|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
105783405|NCT01714726|364860725|FG000|Open-Label Period|Adverse Event|0|||
105783406|NCT01714726|364860726|FG001|Open-Label Period|Adverse Event|0|||
105783407|NCT01714726|364860727|FG002|Open-Label Period|Adverse Event|1|||
105452627|NCT02586623|363664826|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
105452628|NCT02586623|363664827|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
105452629|NCT02586623|363664825|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
105550198|NCT00467870|364014379|FG005|Overall Study|Protocol Violation|0|||
105783408|NCT01714726|364860728|FG003|Open-Label Period|Adverse Event|0|||
105452630|NCT02586623|363664826|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
105452631|NCT02586623|363664827|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
105452632|NCT02586623|363664825|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
105452633|NCT02586623|363664826|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
105452634|NCT02586623|363664827|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
105452635|NCT02586623|363664825|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
105452636|NCT02586623|363664826|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
105452637|NCT02586623|363664827|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
105452638|NCT02586623|363664825|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
105452639|NCT02586623|363664826|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
105452640|NCT02586623|363664827|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
105452641|NCT02586623|363664825|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
105452642|NCT02586623|363664826|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
105452643|NCT02586623|363664827|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
105452644|NCT02586623|363664825|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
105452645|NCT02586623|363664826|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
105452646|NCT02586623|363664827|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
105452647|NCT02586623|363664825|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
105452648|NCT02586623|363664826|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
105452649|NCT02586623|363664827|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
105452650|NCT02586623|363664825|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
105452651|NCT02586623|363664826|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
105452652|NCT02586623|363664827|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
105452653|NCT02586623|363664825|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
105452654|NCT02586623|363664826|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
105452655|NCT02586623|363664827|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
105452656|NCT00795704|363664828|FG000|Overall Study|Withdrawal by Subject|3|||
105452657|NCT00795704|363664829|FG001|Overall Study|Withdrawal by Subject|2|||
105452658|NCT00795704|363664828|FG000|Overall Study|Adverse Event|1|||
105452659|NCT00795704|363664829|FG001|Overall Study|Adverse Event|1|||
105452660|NCT00360412|363664832|FG000|Overall Study|Adverse Event|37|||
105452661|NCT00360412|363664833|FG001|Overall Study|Adverse Event|65|||
105452662|NCT00360412|363664832|FG000|Overall Study|Protocol Violation|2|||
105452663|NCT00360412|363664833|FG001|Overall Study|Protocol Violation|5|||
105452664|NCT00360412|363664832|FG000|Overall Study|Patient withdrew consent|27|||
105452665|NCT00360412|363664833|FG001|Overall Study|Patient withdrew consent|52|||
105452666|NCT00360412|363664832|FG000|Overall Study|Lack of therapeutic efficacy|46|||
105452667|NCT00360412|363664833|FG001|Overall Study|Lack of therapeutic efficacy|61|||
105452668|NCT00360412|363664832|FG000|Overall Study|Physician Decision|2|||
105452669|NCT00360412|363664833|FG001|Overall Study|Physician Decision|4|||
105452670|NCT00360412|363664832|FG000|Overall Study|Other|5|||
105452671|NCT00360412|363664833|FG001|Overall Study|Other|6|||
105452672|NCT00360412|363664832|FG000|Overall Study|Study termination by Sponsor|214|||
105452673|NCT00360412|363664833|FG001|Overall Study|Study termination by Sponsor|469|||
105452674|NCT01572480|363664836|FG000|Participants Enrolled|Withdrawal by Subject|1|||
105452675|NCT01572480|363664836|FG000|Drug Administration|Discontinued drug/Off Study|1|||
105452676|NCT01572480|363664836|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
105452677|NCT01572480|363664836|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
105452678|NCT00191334|363664837|FG000|Overall Study|Adverse Event|4|||
105452679|NCT00191334|363664837|FG000|Overall Study|Disease Progression or Relapse|8|||
105452680|NCT00191334|363664837|FG000|Overall Study|Physician Decision|1|||
105452681|NCT00191334|363664837|FG000|Overall Study|Withdrawal by Subject|4|||
105452682|NCT02429830|363664846|FG000|Overall Study|Lost to Follow-up|1|||
105452683|NCT02429830|363664846|FG000|Overall Study|Device Explant|2|||
105452684|NCT04481243|363667366|FG000|Overall Study|Withdrawal by Subject|4|||
105452685|NCT02539797|363667367|FG000|Overall Study|Lost to Follow-up|0|||
105452686|NCT02539797|363667368|FG001|Overall Study|Lost to Follow-up|1|||
105452687|NCT02539797|363667369|FG002|Overall Study|Lost to Follow-up|0|||
105452688|NCT01777308|363667370|FG000|Overall Study|Withdrawal by Subject|5|||
105452689|NCT01777308|363667371|FG001|Overall Study|Withdrawal by Subject|1|||
105452690|NCT01777308|363667370|FG000|Overall Study|Migrated/moved from study area|1|||
105452691|NCT01777308|363667371|FG001|Overall Study|Migrated/moved from study area|0|||
105452692|NCT01777308|363667370|FG000|Overall Study|Lost to Follow-up|7|||
105452693|NCT01777308|363667371|FG001|Overall Study|Lost to Follow-up|2|||
105452694|NCT01777308|363667370|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
105452695|NCT01777308|363667371|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
105452696|NCT03212326|363667372|FG000|Overall Study|Physician Decision|4|||
105452697|NCT00383786|363667382|FG000|Overall Study|Protocol Violation|2|||
105452698|NCT00383786|363667383|FG001|Overall Study|Protocol Violation|6|||
105452699|NCT00383786|363667382|FG000|Overall Study|Withdrawal by Subject|2|||
105452700|NCT00383786|363667383|FG001|Overall Study|Withdrawal by Subject|5|||
105452701|NCT00383786|363667382|FG000|Overall Study|Physician Decision|0|||
105783409|NCT01714726|364860725|FG000|Open-Label Period|Withdrawal by Subject|0|||
105783410|NCT01714726|364860726|FG001|Open-Label Period|Withdrawal by Subject|0|||
105783411|NCT01714726|364860727|FG002|Open-Label Period|Withdrawal by Subject|9|||
105783412|NCT01714726|364860728|FG003|Open-Label Period|Withdrawal by Subject|19|||
105783413|NCT01714726|364860725|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
105783414|NCT01714726|364860726|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
105783415|NCT01714726|364860727|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
105783416|NCT01714726|364860728|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
105783417|NCT01714726|364860725|FG000|Open-Label Period|Lost to Follow-up|0|||
105783418|NCT01714726|364860726|FG001|Open-Label Period|Lost to Follow-up|0|||
105783419|NCT01714726|364860727|FG002|Open-Label Period|Lost to Follow-up|3|||
105783420|NCT01714726|364860728|FG003|Open-Label Period|Lost to Follow-up|4|||
105783421|NCT03778021|364860735|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
105783422|NCT03778021|364860736|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
105783423|NCT01545375|364860737|FG000|Overall Study|Adverse Event|2|||
105783424|NCT01545375|364860738|FG001|Overall Study|Adverse Event|1|||
105783425|NCT01545375|364860737|FG000|Overall Study|Lost to Follow-up|34|||
105783426|NCT01545375|364860738|FG001|Overall Study|Lost to Follow-up|31|||
105783427|NCT01545375|364860737|FG000|Overall Study|Protocol Violation|3|||
105783428|NCT01545375|364860738|FG001|Overall Study|Protocol Violation|3|||
105783429|NCT01545375|364860737|FG000|Overall Study|Withdrawal by Subject|58|||
105783430|NCT01545375|364860738|FG001|Overall Study|Withdrawal by Subject|55|||
105783431|NCT05111548|364860740|FG000|Overall Study|Withdrawal by Subject|2|||
105783432|NCT05111548|364860741|FG001|Overall Study|Withdrawal by Subject|1|||
105783433|NCT05111548|364860740|FG000|Overall Study|Adverse Event|1|||
105783434|NCT05111548|364860741|FG001|Overall Study|Adverse Event|0|||
105783435|NCT00379639|364860742|FG000|Overall Study|Disease Progression|3|||
105783436|NCT00379639|364860743|FG001|Overall Study|Disease Progression|3|||
105783437|NCT00379639|364860744|FG002|Overall Study|Disease Progression|3|||
105783438|NCT00379639|364860745|FG003|Overall Study|Disease Progression|4|||
105783439|NCT00379639|364860746|FG004|Overall Study|Disease Progression|4|||
105783440|NCT00379639|364860742|FG000|Overall Study|Physician Decision|0|||
105783441|NCT00379639|364860743|FG001|Overall Study|Physician Decision|2|||
105783442|NCT00379639|364860744|FG002|Overall Study|Physician Decision|1|||
105783443|NCT00379639|364860745|FG003|Overall Study|Physician Decision|1|||
105783444|NCT00379639|364860746|FG004|Overall Study|Physician Decision|0|||
105783445|NCT00379639|364860742|FG000|Overall Study|Symptomatic Deterioration|0|||
105783446|NCT00379639|364860743|FG001|Overall Study|Symptomatic Deterioration|0|||
105783447|NCT00379639|364860744|FG002|Overall Study|Symptomatic Deterioration|1|||
105783448|NCT00379639|364860745|FG003|Overall Study|Symptomatic Deterioration|0|||
105783449|NCT00379639|364860746|FG004|Overall Study|Symptomatic Deterioration|1|||
105783450|NCT00379639|364860742|FG000|Overall Study|Adverse Event|0|||
105783451|NCT00379639|364860743|FG001|Overall Study|Adverse Event|0|||
105783452|NCT00379639|364860744|FG002|Overall Study|Adverse Event|1|||
105783453|NCT00379639|364860745|FG003|Overall Study|Adverse Event|0|||
105783454|NCT00379639|364860746|FG004|Overall Study|Adverse Event|1|||
105783455|NCT00379639|364860742|FG000|Overall Study|Lost to Follow-up|0|||
105783456|NCT00379639|364860743|FG001|Overall Study|Lost to Follow-up|0|||
105783457|NCT00379639|364860744|FG002|Overall Study|Lost to Follow-up|0|||
105783458|NCT00379639|364860745|FG003|Overall Study|Lost to Follow-up|1|||
105783459|NCT00379639|364860746|FG004|Overall Study|Lost to Follow-up|0|||
105783460|NCT00379639|364860742|FG000|Overall Study|Other|0|||
105783461|NCT00379639|364860743|FG001|Overall Study|Other|0|||
105783462|NCT00379639|364860744|FG002|Overall Study|Other|3|||
105783463|NCT00379639|364860745|FG003|Overall Study|Other|0|||
105783464|NCT00379639|364860746|FG004|Overall Study|Other|0|||
105783465|NCT00151775|364860759|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
105783466|NCT00151775|364860760|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
105783467|NCT00151775|364860761|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783468|NCT00151775|364860762|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783469|NCT00151775|364860763|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783470|NCT00151775|364860764|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783471|NCT00151775|364860765|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105661745|NCT01191008|364425119|FG000|Overall Study|Lost to Follow-up|8|||
105783472|NCT00151775|364860766|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783473|NCT00151775|364860767|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783474|NCT00151775|364860768|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783475|NCT00151775|364860769|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783476|NCT00151775|364860770|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783477|NCT00151775|364860759|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
105783478|NCT00151775|364860760|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783479|NCT00151775|364860761|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783480|NCT00151775|364860762|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783481|NCT00151775|364860763|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783482|NCT00151775|364860764|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783483|NCT00151775|364860765|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
105783484|NCT00151775|364860766|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783485|NCT00151775|364860767|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783486|NCT00151775|364860768|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783487|NCT00151775|364860769|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
105783488|NCT00151775|364860770|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783489|NCT00151775|364860759|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783490|NCT00151775|364860760|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
105783491|NCT00151775|364860761|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783492|NCT00151775|364860762|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783493|NCT00151775|364860763|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783494|NCT00151775|364860764|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783495|NCT00151775|364860765|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783496|NCT00151775|364860766|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783497|NCT00151775|364860767|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783498|NCT00151775|364860768|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783499|NCT00151775|364860769|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783500|NCT00151775|364860770|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783501|NCT00151775|364860759|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
105783502|NCT00151775|364860760|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
105783503|NCT00151775|364860761|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
105783504|NCT00151775|364860762|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
105452702|NCT00383786|363667383|FG001|Overall Study|Physician Decision|1|||
105452703|NCT03057496|363667388|FG000|Overall Study|Withdrawal by Subject|8|||
105452704|NCT03057496|363667388|FG000|Overall Study|Lost to Follow-up|5|||
105452705|NCT03057496|363667388|FG000|Overall Study|Did not use device during home trial|3|||
105452706|NCT03057496|363667388|FG000|Overall Study|Device failure|2|||
105452707|NCT03737123|363667389|FG000|Study Treatment|Adverse Event|2|||
105452708|NCT03737123|363667390|FG001|Study Treatment|Adverse Event|0|||
105452709|NCT03737123|363667389|FG000|Study Treatment|Disease Progression|2|||
105452710|NCT03737123|363667390|FG001|Study Treatment|Disease Progression|0|||
105452711|NCT03737123|363667389|FG000|Study Treatment|Withdrawal by Subject|2|||
105452712|NCT03737123|363667390|FG001|Study Treatment|Withdrawal by Subject|0|||
105452713|NCT03737123|363667389|FG000|Follow up|Death|1|||
105452714|NCT03737123|363667390|FG001|Follow up|Death|0|||
105452715|NCT03737123|363667389|FG000|Follow up|Withdrawal by Subject|1|||
105452716|NCT03737123|363667390|FG001|Follow up|Withdrawal by Subject|0|||
105452717|NCT03737123|363667389|FG000|Follow up|Termination of study|4|||
105452718|NCT03737123|363667390|FG001|Follow up|Termination of study|0|||
105452719|NCT04617782|363667393|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
105452720|NCT04617782|363667393|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
105452721|NCT04617782|363667393|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
105452722|NCT04617782|363667393|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
105452723|NCT04617782|363667393|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
105452724|NCT04617782|363667393|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
105452725|NCT01584232|363667398|FG000|Overall Study|Adverse Event|3|||
105452726|NCT01584232|363667399|FG001|Overall Study|Adverse Event|1|||
105452727|NCT01584232|363667398|FG000|Overall Study|Withdrawal by Subject|2|||
105452728|NCT01584232|363667399|FG001|Overall Study|Withdrawal by Subject|1|||
105452729|NCT01584232|363667398|FG000|Overall Study|Physician Decision|2|||
105452730|NCT01584232|363667399|FG001|Overall Study|Physician Decision|1|||
105452731|NCT01584232|363667398|FG000|Overall Study|Lost to Follow-up|1|||
105452732|NCT01584232|363667399|FG001|Overall Study|Lost to Follow-up|0|||
105452733|NCT01307319|363667400|FG000|Overall Study|Adverse Event|2|||
105452734|NCT01307319|363667401|FG001|Overall Study|Adverse Event|2|||
105783505|NCT00151775|364860763|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
105783506|NCT00151775|364860764|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
105783507|NCT00151775|364860765|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
105783508|NCT00151775|364860766|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
105783509|NCT00151775|364860767|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
105452735|NCT01307319|363667402|FG002|Overall Study|Adverse Event|1|||
105452736|NCT01307319|363667400|FG000|Overall Study|Lost to Follow-up|1|||
105452737|NCT01307319|363667401|FG001|Overall Study|Lost to Follow-up|0|||
105452738|NCT01307319|363667402|FG002|Overall Study|Lost to Follow-up|1|||
105452739|NCT01307319|363667400|FG000|Overall Study|Protocol Violation|1|||
105452740|NCT01307319|363667401|FG001|Overall Study|Protocol Violation|1|||
105452741|NCT01307319|363667402|FG002|Overall Study|Protocol Violation|0|||
105452742|NCT01307319|363667400|FG000|Overall Study|Withdrawal by Subject|0|||
105452743|NCT01307319|363667401|FG001|Overall Study|Withdrawal by Subject|1|||
105452744|NCT01307319|363667402|FG002|Overall Study|Withdrawal by Subject|2|||
105452745|NCT01307319|363667400|FG000|Overall Study|Other|0|||
105452746|NCT01307319|363667401|FG001|Overall Study|Other|4|||
105783510|NCT00151775|364860768|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
105783511|NCT00151775|364860769|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
105783512|NCT00151775|364860770|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
105783513|NCT00151775|364860759|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783514|NCT00151775|364860760|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783515|NCT00151775|364860761|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783516|NCT00151775|364860762|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783517|NCT00151775|364860763|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783518|NCT00151775|364860764|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
105783519|NCT00151775|364860765|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783520|NCT00151775|364860766|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783521|NCT00151775|364860767|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783522|NCT00151775|364860768|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783523|NCT00151775|364860769|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783524|NCT00151775|364860770|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783525|NCT00151775|364860759|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783526|NCT00151775|364860760|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783527|NCT00151775|364860761|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783528|NCT00151775|364860762|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783529|NCT00151775|364860763|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783530|NCT00151775|364860764|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
105783531|NCT00151775|364860765|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783532|NCT00151775|364860766|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783533|NCT00151775|364860767|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783534|NCT00151775|364860768|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783535|NCT00151775|364860769|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783536|NCT00151775|364860770|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783537|NCT00151775|364860759|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783538|NCT00151775|364860760|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783539|NCT00151775|364860761|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783540|NCT00151775|364860762|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783541|NCT00151775|364860763|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783542|NCT00151775|364860764|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783543|NCT00151775|364860765|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
105783544|NCT00151775|364860766|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783545|NCT00151775|364860767|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783546|NCT00151775|364860768|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783547|NCT00151775|364860769|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783548|NCT00151775|364860770|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783549|NCT00151775|364860759|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783550|NCT00151775|364860760|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783551|NCT00151775|364860761|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783552|NCT00151775|364860762|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783553|NCT00151775|364860763|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783554|NCT00151775|364860764|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
105783555|NCT00151775|364860765|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783556|NCT00151775|364860766|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783557|NCT00151775|364860767|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783558|NCT00151775|364860768|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783559|NCT00151775|364860769|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783560|NCT00151775|364860770|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783561|NCT00151775|364860759|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
105783562|NCT00151775|364860760|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
105783563|NCT00151775|364860761|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
105783564|NCT00151775|364860762|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
105783565|NCT00151775|364860763|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
105783566|NCT00151775|364860764|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
105783567|NCT00151775|364860765|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
105783568|NCT00151775|364860766|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
105783569|NCT00151775|364860767|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
105783570|NCT00151775|364860768|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
105783571|NCT00151775|364860769|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
105783572|NCT00151775|364860770|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
105783573|NCT00151775|364860759|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783574|NCT00151775|364860760|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783575|NCT00151775|364860761|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783576|NCT00151775|364860762|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783577|NCT00151775|364860763|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783578|NCT00151775|364860764|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783579|NCT00151775|364860765|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
105783580|NCT00151775|364860766|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783581|NCT00151775|364860767|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783582|NCT00151775|364860768|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783583|NCT00151775|364860769|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783584|NCT00151775|364860770|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783585|NCT00151775|364860759|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783586|NCT00151775|364860760|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783587|NCT00151775|364860761|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
105783588|NCT00151775|364860762|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783589|NCT00151775|364860763|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783590|NCT00151775|364860764|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783591|NCT00151775|364860765|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783592|NCT00151775|364860766|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783593|NCT00151775|364860767|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783594|NCT00151775|364860768|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783595|NCT00151775|364860769|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783596|NCT00151775|364860770|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783597|NCT00151775|364860759|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783598|NCT00151775|364860760|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783599|NCT00151775|364860761|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
105783600|NCT00151775|364860762|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783601|NCT00151775|364860763|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783602|NCT00151775|364860764|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783603|NCT00151775|364860765|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783604|NCT00151775|364860766|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783605|NCT00151775|364860767|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783606|NCT00151775|364860768|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783607|NCT00151775|364860769|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783608|NCT00151775|364860770|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783609|NCT00151775|364860759|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783610|NCT00151775|364860760|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783611|NCT00151775|364860761|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783612|NCT00151775|364860762|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783613|NCT00151775|364860763|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783614|NCT00151775|364860764|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783615|NCT00151775|364860765|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783616|NCT00151775|364860766|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783617|NCT00151775|364860767|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783618|NCT00151775|364860768|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783619|NCT00151775|364860769|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783620|NCT00151775|364860770|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
105783621|NCT00151775|364860759|FG000|Period 4: Open Label|Increased blood pressure|0|||
105783622|NCT00151775|364860760|FG001|Period 4: Open Label|Increased blood pressure|0|||
105783623|NCT00151775|364860761|FG002|Period 4: Open Label|Increased blood pressure|0|||
105783624|NCT00151775|364860762|FG003|Period 4: Open Label|Increased blood pressure|0|||
105783625|NCT00151775|364860763|FG004|Period 4: Open Label|Increased blood pressure|1|||
105783626|NCT00151775|364860764|FG005|Period 4: Open Label|Increased blood pressure|0|||
105783627|NCT00151775|364860765|FG006|Period 4: Open Label|Increased blood pressure|0|||
105452747|NCT01307319|363667402|FG002|Overall Study|Other|3|||
105452748|NCT04233801|363667405|FG000|Overall Study|Other than listed|0|||
105452749|NCT04233801|363667406|FG001|Overall Study|Other than listed|0|||
105452750|NCT04233801|363667407|FG002|Overall Study|Other than listed|1|||
105452751|NCT04233801|363667405|FG000|Overall Study|Withdrawal by Subject|0|||
105452752|NCT04233801|363667406|FG001|Overall Study|Withdrawal by Subject|2|||
105452753|NCT04233801|363667407|FG002|Overall Study|Withdrawal by Subject|3|||
105452754|NCT03633396|363667408|FG000|Overall Study|Withdrawal by Subject|4|||
105452755|NCT03633396|363667409|FG001|Overall Study|Withdrawal by Subject|4|||
105452756|NCT03633396|363667408|FG000|Overall Study|Adverse Event|1|||
105452757|NCT03633396|363667409|FG001|Overall Study|Adverse Event|1|||
105452758|NCT03633396|363667408|FG000|Overall Study|Lack of Efficacy|1|||
105783628|NCT00151775|364860766|FG007|Period 4: Open Label|Increased blood pressure|0|||
105783629|NCT00151775|364860767|FG008|Period 4: Open Label|Increased blood pressure|0|||
105783630|NCT00151775|364860768|FG009|Period 4: Open Label|Increased blood pressure|1|||
105452759|NCT03633396|363667409|FG001|Overall Study|Lack of Efficacy|0|||
105452760|NCT03633396|363667408|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
105452761|NCT03633396|363667409|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
105452762|NCT00928486|363667412|FG000|Overall Study|Adverse Event|2|||
105452763|NCT00928486|363667412|FG000|Overall Study|Disease Progression|7|||
105452764|NCT00928486|363667412|FG000|Overall Study|Withdrawal by Subject|1|||
105452765|NCT04024891|363667416|FG000|Overall Study|Pregnancy|0|||
105452766|NCT04024891|363667417|FG001|Overall Study|Pregnancy|1|||
105452767|NCT02723773|363667420|FG000|Overall Study|Adverse Event|934|||
105452768|NCT02723773|363667421|FG001|Overall Study|Adverse Event|3|||
105452769|NCT02723773|363667422|FG002|Overall Study|Adverse Event|1|||
105452770|NCT02723773|363667423|FG003|Overall Study|Adverse Event|9|||
105452771|NCT02723773|363667420|FG000|Overall Study|Protocol Violation|1|||
105452772|NCT02723773|363667421|FG001|Overall Study|Protocol Violation|0|||
105452773|NCT02723773|363667422|FG002|Overall Study|Protocol Violation|0|||
105452774|NCT02723773|363667423|FG003|Overall Study|Protocol Violation|0|||
105452775|NCT02723773|363667420|FG000|Overall Study|Withdrawal by Subject|360|||
105452776|NCT02723773|363667421|FG001|Overall Study|Withdrawal by Subject|5|||
105452777|NCT02723773|363667422|FG002|Overall Study|Withdrawal by Subject|6|||
105452778|NCT02723773|363667423|FG003|Overall Study|Withdrawal by Subject|10|||
105452779|NCT02723773|363667420|FG000|Overall Study|Migrated/moved from study area|37|||
105452780|NCT02723773|363667421|FG001|Overall Study|Migrated/moved from study area|0|||
105452781|NCT02723773|363667422|FG002|Overall Study|Migrated/moved from study area|0|||
105452782|NCT02723773|363667423|FG003|Overall Study|Migrated/moved from study area|1|||
105452783|NCT02723773|363667420|FG000|Overall Study|Lost to Follow-up|198|||
105452784|NCT02723773|363667421|FG001|Overall Study|Lost to Follow-up|0|||
105452785|NCT02723773|363667422|FG002|Overall Study|Lost to Follow-up|0|||
105452786|NCT02723773|363667423|FG003|Overall Study|Lost to Follow-up|0|||
105452787|NCT02723773|363667420|FG000|Overall Study|Other|189|||
105452788|NCT02723773|363667421|FG001|Overall Study|Other|1|||
105452789|NCT02723773|363667422|FG002|Overall Study|Other|2|||
105452790|NCT02723773|363667423|FG003|Overall Study|Other|2|||
105452791|NCT02152631|363667429|FG000|Overall Study|Adverse Event|32|||
105452792|NCT02152631|363667430|FG001|Overall Study|Adverse Event|4|||
105452793|NCT02152631|363667429|FG000|Overall Study|Withdrawal by Subject|13|||
105452794|NCT02152631|363667430|FG001|Overall Study|Withdrawal by Subject|16|||
105452795|NCT02152631|363667429|FG000|Overall Study|Noncompliance with study drug|1|||
105452796|NCT02152631|363667430|FG001|Overall Study|Noncompliance with study drug|0|||
105452797|NCT02152631|363667429|FG000|Overall Study|Physician Decision|1|||
105452798|NCT02152631|363667430|FG001|Overall Study|Physician Decision|2|||
105452799|NCT02152631|363667429|FG000|Overall Study|Lost to Follow-up|0|||
105452800|NCT02152631|363667430|FG001|Overall Study|Lost to Follow-up|1|||
105452801|NCT02152631|363667429|FG000|Overall Study|On Treatment|19|||
105452802|NCT02152631|363667430|FG001|Overall Study|On Treatment|3|||
105452803|NCT05473026|363667431|FG000|Overall Study|Lost to Follow-up|5|||
105452804|NCT05473026|363667432|FG001|Overall Study|Lost to Follow-up|2|||
105452805|NCT01050634|363667433|FG000|Overall Study|Enrolled, but Not Treated|56|||
105452806|NCT01050634|363667433|FG000|Overall Study|Death|2|||
105452807|NCT01050634|363667433|FG000|Overall Study|Adverse Event|42|||
105452808|NCT01050634|363667433|FG000|Overall Study|Lost to Follow-up|2|||
105452809|NCT01050634|363667433|FG000|Overall Study|Other|21|||
105452810|NCT01050634|363667433|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
105452811|NCT00496015|363667434|FG000|Overall Study|Other|1|||
105452812|NCT00496015|363667435|FG001|Overall Study|Other|0|||
105452813|NCT00496015|363667436|FG002|Overall Study|Other|0|||
105452814|NCT00496015|363667437|FG003|Overall Study|Other|1|||
105452815|NCT00496015|363667438|FG004|Overall Study|Other|0|||
105452816|NCT00527735|363667439|FG000|Overall Study|Disease progression|47|||
105452817|NCT00527735|363667440|FG001|Overall Study|Disease progression|61|||
105452818|NCT00527735|363667441|FG002|Overall Study|Disease progression|53|||
105452819|NCT00527735|363667439|FG000|Overall Study|Death|23|||
105452820|NCT00527735|363667440|FG001|Overall Study|Death|13|||
105452821|NCT00527735|363667441|FG002|Overall Study|Death|15|||
105452822|NCT00527735|363667439|FG000|Overall Study|Completed treatment in treatment phase|14|||
105452823|NCT00527735|363667440|FG001|Overall Study|Completed treatment in treatment phase|13|||
105452824|NCT00527735|363667441|FG002|Overall Study|Completed treatment in treatment phase|18|||
105452825|NCT00527735|363667439|FG000|Overall Study|Adverse Event|10|||
105452826|NCT00527735|363667440|FG001|Overall Study|Adverse Event|6|||
105452827|NCT00527735|363667441|FG002|Overall Study|Adverse Event|7|||
105452828|NCT00527735|363667439|FG000|Overall Study|Not identified|5|||
105452829|NCT00527735|363667440|FG001|Overall Study|Not identified|5|||
105452830|NCT00527735|363667441|FG002|Overall Study|Not identified|5|||
105452831|NCT00527735|363667439|FG000|Overall Study|Withdrawal by Subject|5|||
105452832|NCT00527735|363667440|FG001|Overall Study|Withdrawal by Subject|4|||
105452833|NCT00527735|363667441|FG002|Overall Study|Withdrawal by Subject|3|||
105452834|NCT00527735|363667439|FG000|Overall Study|No longer met study criteria|2|||
105452835|NCT00527735|363667440|FG001|Overall Study|No longer met study criteria|2|||
105452836|NCT00527735|363667441|FG002|Overall Study|No longer met study criteria|1|||
105783631|NCT00151775|364860769|FG010|Period 4: Open Label|Increased blood pressure|0|||
105783632|NCT00151775|364860770|FG011|Period 4: Open Label|Increased blood pressure|0|||
105783633|NCT00151775|364860759|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
105783634|NCT00151775|364860760|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
105783635|NCT00151775|364860761|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
105783636|NCT00151775|364860762|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
105783637|NCT00151775|364860763|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
105783638|NCT00151775|364860764|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
105783639|NCT00151775|364860765|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
105783640|NCT00151775|364860766|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
105783641|NCT00151775|364860767|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
105783642|NCT00151775|364860768|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
105783643|NCT00151775|364860769|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
105783644|NCT00151775|364860770|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
105783645|NCT00151775|364860759|FG000|Period 4: Open Label|Adverse Event|0|||
105783646|NCT00151775|364860760|FG001|Period 4: Open Label|Adverse Event|0|||
105783647|NCT00151775|364860761|FG002|Period 4: Open Label|Adverse Event|0|||
105783648|NCT00151775|364860762|FG003|Period 4: Open Label|Adverse Event|0|||
105783649|NCT00151775|364860763|FG004|Period 4: Open Label|Adverse Event|1|||
105783650|NCT00151775|364860764|FG005|Period 4: Open Label|Adverse Event|0|||
105783651|NCT00151775|364860765|FG006|Period 4: Open Label|Adverse Event|0|||
105783652|NCT00151775|364860766|FG007|Period 4: Open Label|Adverse Event|0|||
105783653|NCT00151775|364860767|FG008|Period 4: Open Label|Adverse Event|0|||
105783654|NCT00151775|364860768|FG009|Period 4: Open Label|Adverse Event|2|||
105783655|NCT00151775|364860769|FG010|Period 4: Open Label|Adverse Event|0|||
105783656|NCT00151775|364860770|FG011|Period 4: Open Label|Adverse Event|0|||
105783657|NCT00151775|364860759|FG000|Period 4: Open Label|Lost to Follow-up|0|||
105783658|NCT00151775|364860760|FG001|Period 4: Open Label|Lost to Follow-up|0|||
105783659|NCT00151775|364860761|FG002|Period 4: Open Label|Lost to Follow-up|0|||
105783660|NCT00151775|364860762|FG003|Period 4: Open Label|Lost to Follow-up|0|||
105783661|NCT00151775|364860763|FG004|Period 4: Open Label|Lost to Follow-up|17|||
105783662|NCT00151775|364860764|FG005|Period 4: Open Label|Lost to Follow-up|0|||
105783663|NCT00151775|364860765|FG006|Period 4: Open Label|Lost to Follow-up|0|||
105783664|NCT00151775|364860766|FG007|Period 4: Open Label|Lost to Follow-up|0|||
105783665|NCT00151775|364860767|FG008|Period 4: Open Label|Lost to Follow-up|0|||
105783666|NCT00151775|364860768|FG009|Period 4: Open Label|Lost to Follow-up|7|||
105783667|NCT00151775|364860769|FG010|Period 4: Open Label|Lost to Follow-up|0|||
105783668|NCT00151775|364860770|FG011|Period 4: Open Label|Lost to Follow-up|0|||
105783669|NCT00151775|364860759|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
105783670|NCT00151775|364860760|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
105783671|NCT00151775|364860761|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
105783672|NCT00151775|364860762|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
105783673|NCT00151775|364860763|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
105783674|NCT00151775|364860764|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
105783675|NCT00151775|364860765|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
105783676|NCT00151775|364860766|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
105783677|NCT00151775|364860767|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
105783678|NCT00151775|364860768|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
105783679|NCT00151775|364860769|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
105783680|NCT00151775|364860770|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
105783681|NCT00151775|364860759|FG000|Period 4: Open Label|Other|0|||
105783682|NCT00151775|364860760|FG001|Period 4: Open Label|Other|0|||
105783683|NCT00151775|364860761|FG002|Period 4: Open Label|Other|0|||
105783684|NCT00151775|364860762|FG003|Period 4: Open Label|Other|0|||
105783685|NCT00151775|364860763|FG004|Period 4: Open Label|Other|1|||
105452837|NCT00527735|363667439|FG000|Overall Study|Lost to Follow-up|0|||
105452838|NCT00527735|363667440|FG001|Overall Study|Lost to Follow-up|0|||
105452839|NCT00527735|363667441|FG002|Overall Study|Lost to Follow-up|3|||
105452840|NCT00527735|363667439|FG000|Overall Study|Poor compliance or noncompliance|0|||
105452841|NCT00527735|363667440|FG001|Overall Study|Poor compliance or noncompliance|1|||
105452842|NCT00527735|363667441|FG002|Overall Study|Poor compliance or noncompliance|1|||
105452843|NCT00527735|363667439|FG000|Overall Study|Completed treatment during maintenance|2|||
105452844|NCT00527735|363667440|FG001|Overall Study|Completed treatment during maintenance|2|||
105452845|NCT00527735|363667441|FG002|Overall Study|Completed treatment during maintenance|1|||
105783686|NCT00151775|364860764|FG005|Period 4: Open Label|Other|0|||
105336965|NCT00090220|363234764|FG003|Base Study Vaccination Period|Patient Moved|0|||
105452846|NCT01535807|363667442|FG000|Overall Study|Withdrawal by Subject|1|||
105783687|NCT00151775|364860765|FG006|Period 4: Open Label|Other|0|||
105783688|NCT00151775|364860766|FG007|Period 4: Open Label|Other|0|||
105783689|NCT00151775|364860767|FG008|Period 4: Open Label|Other|0|||
105783690|NCT00151775|364860768|FG009|Period 4: Open Label|Other|3|||
105783691|NCT00151775|364860769|FG010|Period 4: Open Label|Other|0|||
105783692|NCT00151775|364860770|FG011|Period 4: Open Label|Other|0|||
105783693|NCT00151775|364860759|FG000|Period 4: Open Label|Physician Decision|0|||
105783694|NCT00151775|364860760|FG001|Period 4: Open Label|Physician Decision|0|||
105783695|NCT00151775|364860761|FG002|Period 4: Open Label|Physician Decision|0|||
105783696|NCT00151775|364860762|FG003|Period 4: Open Label|Physician Decision|0|||
105783697|NCT00151775|364860763|FG004|Period 4: Open Label|Physician Decision|0|||
105783698|NCT00151775|364860764|FG005|Period 4: Open Label|Physician Decision|0|||
105783699|NCT00151775|364860765|FG006|Period 4: Open Label|Physician Decision|0|||
105783700|NCT00151775|364860766|FG007|Period 4: Open Label|Physician Decision|0|||
105783701|NCT00151775|364860767|FG008|Period 4: Open Label|Physician Decision|0|||
105783702|NCT00151775|364860768|FG009|Period 4: Open Label|Physician Decision|2|||
105783703|NCT00151775|364860769|FG010|Period 4: Open Label|Physician Decision|0|||
105783704|NCT00151775|364860770|FG011|Period 4: Open Label|Physician Decision|0|||
105783705|NCT00151775|364860759|FG000|Period 4: Open Label|Protocol Violation|0|||
105783706|NCT00151775|364860760|FG001|Period 4: Open Label|Protocol Violation|0|||
105783707|NCT00151775|364860761|FG002|Period 4: Open Label|Protocol Violation|0|||
105783708|NCT00151775|364860762|FG003|Period 4: Open Label|Protocol Violation|0|||
105783709|NCT00151775|364860763|FG004|Period 4: Open Label|Protocol Violation|1|||
105783710|NCT00151775|364860764|FG005|Period 4: Open Label|Protocol Violation|0|||
105783711|NCT00151775|364860765|FG006|Period 4: Open Label|Protocol Violation|0|||
105783712|NCT00151775|364860766|FG007|Period 4: Open Label|Protocol Violation|0|||
105783713|NCT00151775|364860767|FG008|Period 4: Open Label|Protocol Violation|0|||
105783714|NCT00151775|364860768|FG009|Period 4: Open Label|Protocol Violation|0|||
105783715|NCT00151775|364860769|FG010|Period 4: Open Label|Protocol Violation|0|||
105783716|NCT00151775|364860770|FG011|Period 4: Open Label|Protocol Violation|0|||
105783717|NCT03971422|364860785|FG000|Overall Study|Lost to Follow-up|0|||
105783718|NCT03971422|364860786|FG001|Overall Study|Lost to Follow-up|1|||
105783719|NCT03971422|364860787|FG002|Overall Study|Lost to Follow-up|0|||
105783720|NCT03971422|364860785|FG000|Overall Study|Lack of Efficacy|5|||
105783721|NCT03971422|364860786|FG001|Overall Study|Lack of Efficacy|1|||
105783722|NCT03971422|364860787|FG002|Overall Study|Lack of Efficacy|1|||
105783723|NCT03971422|364860785|FG000|Overall Study|Adverse event, not fatal|2|||
105783724|NCT03971422|364860786|FG001|Overall Study|Adverse event, not fatal|2|||
105783725|NCT03971422|364860787|FG002|Overall Study|Adverse event, not fatal|5|||
105783726|NCT03971422|364860785|FG000|Overall Study|Worsening of MG Symptoms|1|||
105783727|NCT03971422|364860786|FG001|Overall Study|Worsening of MG Symptoms|4|||
105783728|NCT03971422|364860787|FG002|Overall Study|Worsening of MG Symptoms|2|||
105783729|NCT03971422|364860785|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
105783730|NCT03971422|364860786|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
105783731|NCT03971422|364860787|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
105783732|NCT03971422|364860785|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
105783733|NCT03971422|364860786|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
105783734|NCT03971422|364860787|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
105783735|NCT03971422|364860785|FG000|Overall Study|Due to COVID-19 pandemic|0|||
105783736|NCT03971422|364860786|FG001|Overall Study|Due to COVID-19 pandemic|1|||
105783737|NCT03971422|364860787|FG002|Overall Study|Due to COVID-19 pandemic|1|||
105783738|NCT02706327|364860788|FG000|Overall Study|Lost to Follow-up|1|||
105783739|NCT02706327|364860789|FG001|Overall Study|Lost to Follow-up|1|||
105783740|NCT02706327|364860790|FG002|Overall Study|Lost to Follow-up|2|||
105783741|NCT00772031|364860793|FG000|Overall Study|Early termination of trial|12|||
105783742|NCT00772031|364860794|FG001|Overall Study|Early termination of trial|10|||
105783743|NCT00772031|364860793|FG000|Overall Study|Lost to Follow-up|20|||
105783744|NCT00772031|364860794|FG001|Overall Study|Lost to Follow-up|33|||
105783745|NCT06045026|364860795|FG000|Overall Study|Lost to Follow-up|60|||
105783746|NCT06045026|364860795|FG000|Overall Study|Adverse Event|12|||
105783747|NCT06045026|364860795|FG000|Overall Study|Withdrawal by Subject|3|||
105783748|NCT06045026|364860795|FG000|Overall Study|Enrollment closed|1|||
105452847|NCT01535807|363667443|FG001|Overall Study|Withdrawal by Subject|1|||
105452848|NCT01535807|363667442|FG000|Overall Study|Data collection error|1|||
105452849|NCT01535807|363667443|FG001|Overall Study|Data collection error|1|||
105452850|NCT01855412|363667446|FG000|Overall Study|Death|77|||
105452851|NCT01855412|363667447|FG001|Overall Study|Death|123|||
105452852|NCT01855412|363667448|FG002|Overall Study|Death|30|||
105452853|NCT01855412|363667446|FG000|Overall Study|Lost to Follow-up|28|||
105452854|NCT01855412|363667447|FG001|Overall Study|Lost to Follow-up|46|||
105783749|NCT01224171|364860796|FG000|Overall Study|Adverse Event|8|||
105783750|NCT01224171|364860797|FG001|Overall Study|Adverse Event|4|||
105783751|NCT01224171|364860796|FG000|Overall Study|Protocol Violation|0|||
105783752|NCT01224171|364860797|FG001|Overall Study|Protocol Violation|1|||
105783753|NCT01224171|364860796|FG000|Overall Study|Lack of Efficacy|5|||
105783754|NCT01224171|364860797|FG001|Overall Study|Lack of Efficacy|1|||
105783755|NCT01224171|364860796|FG000|Overall Study|Withdrawal of Consent|2|||
105452855|NCT01855412|363667448|FG002|Overall Study|Lost to Follow-up|15|||
105452856|NCT01855412|363667446|FG000|Overall Study|Withdrawal by Subject|77|||
105452857|NCT01855412|363667447|FG001|Overall Study|Withdrawal by Subject|123|||
105783756|NCT01224171|364860797|FG001|Overall Study|Withdrawal of Consent|4|||
105783757|NCT01224171|364860796|FG000|Overall Study|Lost to Follow-up|0|||
105783758|NCT01224171|364860797|FG001|Overall Study|Lost to Follow-up|3|||
105783759|NCT02624713|364860800|FG000|Overall Study|Lost to Follow-up|14|||
105452858|NCT01855412|363667448|FG002|Overall Study|Withdrawal by Subject|24|||
105452859|NCT01855412|363667446|FG000|Overall Study|Physician Decision|25|||
105452860|NCT01855412|363667447|FG001|Overall Study|Physician Decision|31|||
105452861|NCT01855412|363667448|FG002|Overall Study|Physician Decision|3|||
105452862|NCT01855412|363667446|FG000|Overall Study|Site Closure|4|||
105452863|NCT01855412|363667447|FG001|Overall Study|Site Closure|18|||
105452864|NCT01855412|363667448|FG002|Overall Study|Site Closure|1|||
105452865|NCT01855412|363667446|FG000|Overall Study|Reason not Specified|1|||
105452866|NCT01855412|363667447|FG001|Overall Study|Reason not Specified|2|||
105452867|NCT01855412|363667448|FG002|Overall Study|Reason not Specified|3|||
105452868|NCT01631435|363667450|FG000|Overall Study|Adverse Event|2|||
105452869|NCT01631435|363667450|FG000|Overall Study|Withdrawal by Subject|2|||
105452870|NCT01631435|363667450|FG000|Overall Study|incomplete study procedure|5|||
105452871|NCT00308139|363667451|FG000|Overall Study|Adverse Event|20|||
105452872|NCT00308139|363667452|FG001|Overall Study|Adverse Event|14|||
105452873|NCT00308139|363667451|FG000|Overall Study|Lost to Follow-up|13|||
105452874|NCT00308139|363667452|FG001|Overall Study|Lost to Follow-up|8|||
105452875|NCT00308139|363667451|FG000|Overall Study|Protocol Violation|3|||
105452876|NCT00308139|363667452|FG001|Overall Study|Protocol Violation|2|||
105452877|NCT00308139|363667451|FG000|Overall Study|Withdrawal of Consent|40|||
105452878|NCT00308139|363667452|FG001|Overall Study|Withdrawal of Consent|42|||
105452879|NCT00308139|363667451|FG000|Overall Study|Investigator Decision|11|||
105452880|NCT00308139|363667452|FG001|Overall Study|Investigator Decision|10|||
105452881|NCT00308139|363667451|FG000|Overall Study|Loss of Glucose Control|5|||
105452882|NCT00308139|363667452|FG001|Overall Study|Loss of Glucose Control|7|||
105452883|NCT00308139|363667451|FG000|Overall Study|Administrative|1|||
105452884|NCT00308139|363667452|FG001|Overall Study|Administrative|4|||
105452885|NCT00308139|363667451|FG000|Overall Study|Other|1|||
105452886|NCT00308139|363667452|FG001|Overall Study|Other|0|||
105452887|NCT02349633|363667455|FG000|Overall Study|Death|0|||
105452888|NCT02349633|363667456|FG001|Overall Study|Death|1|||
105452889|NCT02349633|363667457|FG002|Overall Study|Death|0|||
105452890|NCT02349633|363667458|FG003|Overall Study|Death|0|||
105452891|NCT02349633|363667459|FG004|Overall Study|Death|0|||
105452892|NCT02349633|363667460|FG005|Overall Study|Death|1|||
105452893|NCT02349633|363667461|FG006|Overall Study|Death|1|||
105452894|NCT02349633|363667462|FG007|Overall Study|Death|1|||
105783760|NCT02624713|364860801|FG001|Overall Study|Lost to Follow-up|0|||
105783761|NCT00792467|364860809|FG000|Overall Study|progression of disease|17|||
105783762|NCT00792467|364860809|FG000|Overall Study|Adverse Event|1|||
105783763|NCT00792467|364860809|FG000|Overall Study|patient request|1|||
105783764|NCT00792467|364860809|FG000|Overall Study|Lost to Follow-up|1|||
105783765|NCT00792467|364860809|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
105783766|NCT00792467|364860809|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
105783767|NCT01287403|364860810|FG000|1st Intervention (1 Day)|Adverse Event|1|||
105783768|NCT03911401|364860811|FG000|Overall Study|Adverse Event|1|||
105783769|NCT03911401|364860812|FG001|Overall Study|Adverse Event|2|||
105783770|NCT03911401|364860813|FG002|Overall Study|Adverse Event|5|||
105783771|NCT03911401|364860811|FG000|Overall Study|Lack of Efficacy|1|||
105783772|NCT03911401|364860812|FG001|Overall Study|Lack of Efficacy|1|||
105783773|NCT03911401|364860813|FG002|Overall Study|Lack of Efficacy|8|||
105783774|NCT03911401|364860811|FG000|Overall Study|Physician Decision|0|||
105783775|NCT03911401|364860812|FG001|Overall Study|Physician Decision|0|||
105783776|NCT03911401|364860813|FG002|Overall Study|Physician Decision|1|||
105783777|NCT03911401|364860811|FG000|Overall Study|Withdrawal by Subject|1|||
105783778|NCT03911401|364860812|FG001|Overall Study|Withdrawal by Subject|2|||
105783779|NCT03911401|364860813|FG002|Overall Study|Withdrawal by Subject|0|||
105783780|NCT03911401|364860811|FG000|Overall Study|Withdrawal by parent/guardian|4|||
105783781|NCT03911401|364860812|FG001|Overall Study|Withdrawal by parent/guardian|4|||
105783782|NCT03911401|364860813|FG002|Overall Study|Withdrawal by parent/guardian|11|||
105783783|NCT04165824|364860818|FG000|Overall Study|Adverse Event|23|||
105783784|NCT04165824|364860818|FG000|Overall Study|Physician Decision|1|||
105783785|NCT04165824|364860818|FG000|Overall Study|Withdrawal by Subject|17|||
105783786|NCT04165824|364860818|FG000|Overall Study|Other|5|||
105783787|NCT00368069|364860819|FG000|Overall Study|Adverse Event|5|||
105783788|NCT00368069|364860820|FG001|Overall Study|Adverse Event|2|||
105452895|NCT02349633|363667463|FG008|Overall Study|Death|0|||
105452896|NCT02349633|363667464|FG009|Overall Study|Death|1|||
105452897|NCT02349633|363667465|FG010|Overall Study|Death|0|||
105452898|NCT02349633|363667466|FG011|Overall Study|Death|0|||
105452899|NCT02349633|363667467|FG012|Overall Study|Death|0|||
105452900|NCT02349633|363667468|FG013|Overall Study|Death|0|||
105452901|NCT02349633|363667455|FG000|Overall Study|Withdrawal by Subject|0|||
105452902|NCT02349633|363667456|FG001|Overall Study|Withdrawal by Subject|0|||
105783789|NCT00368069|364860819|FG000|Overall Study|Lack of Efficacy|0|||
105783790|NCT00368069|364860820|FG001|Overall Study|Lack of Efficacy|1|||
105783791|NCT00368069|364860819|FG000|Overall Study|Lost to Follow-up|1|||
105783792|NCT00368069|364860820|FG001|Overall Study|Lost to Follow-up|0|||
105783793|NCT00368069|364860819|FG000|Overall Study|Protocol Violation|0|||
105783794|NCT00368069|364860820|FG001|Overall Study|Protocol Violation|2|||
105783795|NCT00368069|364860819|FG000|Overall Study|Withdrawal of Consent|2|||
105783796|NCT00368069|364860820|FG001|Overall Study|Withdrawal of Consent|1|||
105783797|NCT00368069|364860819|FG000|Overall Study|no blood sampling possible|0|||
105783798|NCT00368069|364860820|FG001|Overall Study|no blood sampling possible|1|||
105783799|NCT00914940|364860823|FG000|D0 to D100 Post-transplant|Death|2|||
105783800|NCT00914940|364860823|FG000|D101 to 2 Years Post-transplant|Death|8|||
105783801|NCT00914940|364860823|FG000|2 Years to 5 Years Post-transplant|Death|3|||
105783802|NCT02221882|364860824|FG000|Overall Study|Withdrawal by Subject|0|||
105783803|NCT02221882|364860825|FG001|Overall Study|Withdrawal by Subject|0|||
105783804|NCT02221882|364860826|FG002|Overall Study|Withdrawal by Subject|4|||
105783805|NCT02221882|364860827|FG003|Overall Study|Withdrawal by Subject|2|||
105783806|NCT02221882|364860828|FG004|Overall Study|Withdrawal by Subject|2|||
105783807|NCT02221882|364860829|FG005|Overall Study|Withdrawal by Subject|2|||
105783808|NCT02221882|364860824|FG000|Overall Study|Death|0|||
105783809|NCT02221882|364860825|FG001|Overall Study|Death|1|||
105783810|NCT02221882|364860826|FG002|Overall Study|Death|0|||
105783811|NCT02221882|364860827|FG003|Overall Study|Death|0|||
105783812|NCT02221882|364860828|FG004|Overall Study|Death|0|||
105783813|NCT02221882|364860829|FG005|Overall Study|Death|0|||
105783814|NCT02431559|364860830|FG000|Overall Study|Adverse Event|0|||
105783815|NCT02431559|364860831|FG001|Overall Study|Adverse Event|1|||
105783816|NCT02431559|364860832|FG002|Overall Study|Adverse Event|0|||
105783817|NCT02431559|364860833|FG003|Overall Study|Adverse Event|4|||
105783818|NCT02431559|364860830|FG000|Overall Study|Progressive disease|2|||
105783819|NCT02431559|364860831|FG001|Overall Study|Progressive disease|1|||
105783820|NCT02431559|364860832|FG002|Overall Study|Progressive disease|4|||
105783821|NCT02431559|364860833|FG003|Overall Study|Progressive disease|22|||
105783822|NCT02431559|364860830|FG000|Overall Study|Withdrawal by Subject|0|||
105783823|NCT02431559|364860831|FG001|Overall Study|Withdrawal by Subject|1|||
105783824|NCT02431559|364860832|FG002|Overall Study|Withdrawal by Subject|0|||
105783825|NCT02431559|364860833|FG003|Overall Study|Withdrawal by Subject|4|||
105783826|NCT02431559|364860830|FG000|Overall Study|Physician Decision|0|||
105783827|NCT02431559|364860831|FG001|Overall Study|Physician Decision|0|||
105783828|NCT02431559|364860832|FG002|Overall Study|Physician Decision|0|||
105783829|NCT02431559|364860833|FG003|Overall Study|Physician Decision|1|||
105783830|NCT04236986|364860834|FG000|Overall Study|Withdrawal by Subject|3|||
105783831|NCT04236986|364860835|FG001|Overall Study|Withdrawal by Subject|1|||
105783832|NCT03328325|364860836|FG000|Overall Study|Lost to Follow-up|4|||
105783833|NCT03328325|364860836|FG000|Overall Study|Physician Decision|1|||
105783834|NCT03328325|364860836|FG000|Overall Study|Withdrawal by Subject|3|||
105783835|NCT03328325|364860836|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
105783836|NCT03575975|364860842|FG000|Overall Study|Lost to Follow-up|1|||
105783837|NCT03575975|364860843|FG001|Overall Study|Lost to Follow-up|0|||
105783838|NCT03575975|364860844|FG002|Overall Study|Lost to Follow-up|0|||
105783839|NCT00129220|364860845|FG000|Study Period II|Adverse Event|9|||
105783840|NCT00129220|364860846|FG001|Study Period II|Adverse Event|5|||
105783841|NCT00129220|364860847|FG002|Study Period II|Adverse Event|7|||
105783842|NCT00129220|364860845|FG000|Study Period II|Lack of Efficacy|15|||
105783843|NCT00129220|364860846|FG001|Study Period II|Lack of Efficacy|1|||
105783844|NCT00129220|364860847|FG002|Study Period II|Lack of Efficacy|28|||
105783845|NCT00129220|364860845|FG000|Study Period II|Entry Criteria Not Met|2|||
105783846|NCT00129220|364860846|FG001|Study Period II|Entry Criteria Not Met|0|||
105783847|NCT00129220|364860847|FG002|Study Period II|Entry Criteria Not Met|2|||
105783848|NCT00129220|364860845|FG000|Study Period II|Protocol Violation|4|||
105783849|NCT00129220|364860846|FG001|Study Period II|Protocol Violation|2|||
105783850|NCT00129220|364860847|FG002|Study Period II|Protocol Violation|1|||
105783851|NCT00129220|364860845|FG000|Study Period II|Physician Decision|0|||
105783852|NCT00129220|364860846|FG001|Study Period II|Physician Decision|1|||
105783853|NCT00129220|364860847|FG002|Study Period II|Physician Decision|0|||
105783854|NCT00129220|364860845|FG000|Study Period II|Withdrawal by Subject|1|||
105783855|NCT00129220|364860846|FG001|Study Period II|Withdrawal by Subject|3|||
105783856|NCT00129220|364860847|FG002|Study Period II|Withdrawal by Subject|4|||
105452903|NCT02349633|363667457|FG002|Overall Study|Withdrawal by Subject|0|||
105783857|NCT00129220|364860845|FG000|Study Period II|Reason Not Specified|2|||
105783858|NCT00129220|364860846|FG001|Study Period II|Reason Not Specified|0|||
105783859|NCT00129220|364860847|FG002|Study Period II|Reason Not Specified|5|||
105783860|NCT00129220|364860845|FG000|Study Period III|Adverse Event|1|||
105783861|NCT00129220|364860846|FG001|Study Period III|Adverse Event|0|||
105783862|NCT00129220|364860847|FG002|Study Period III|Adverse Event|3|||
105783863|NCT00129220|364860845|FG000|Study Period III|Protocol Violation|1|||
105783864|NCT00129220|364860846|FG001|Study Period III|Protocol Violation|1|||
105783865|NCT00129220|364860847|FG002|Study Period III|Protocol Violation|2|||
105783866|NCT00129220|364860845|FG000|Study Period III|Withdrawal by Subject|1|||
105783867|NCT00129220|364860846|FG001|Study Period III|Withdrawal by Subject|0|||
105783868|NCT00129220|364860847|FG002|Study Period III|Withdrawal by Subject|3|||
105783869|NCT00129220|364860845|FG000|Study Period III|Sponsor Decision|1|||
105783870|NCT00129220|364860846|FG001|Study Period III|Sponsor Decision|0|||
105783871|NCT00129220|364860847|FG002|Study Period III|Sponsor Decision|0|||
105783872|NCT00129220|364860845|FG000|Study Period III|Reason Not Specified|9|||
105783873|NCT00129220|364860846|FG001|Study Period III|Reason Not Specified|0|||
105783874|NCT00129220|364860847|FG002|Study Period III|Reason Not Specified|2|||
105783875|NCT02569996|364860851|FG000|Overall Study|Adverse Event|6|||
105783876|NCT02569996|364860851|FG000|Overall Study|Physician Decision|3|||
105783877|NCT02569996|364860851|FG000|Overall Study|Progression of the disease|18|||
105783878|NCT02569996|364860851|FG000|Overall Study|New anti-lymphoma treatment|1|||
105783879|NCT02569996|364860851|FG000|Overall Study|Non-compliance|9|||
105783880|NCT02569996|364860851|FG000|Overall Study|Withdrawal by Subject|5|||
105783881|NCT02569996|364860851|FG000|Overall Study|Lost to Follow-up|5|||
105783882|NCT02569996|364860851|FG000|Overall Study|Complete remission|7|||
105783883|NCT02569996|364860851|FG000|Overall Study|Unknown reason|1|||
105783884|NCT01383317|364860852|FG000|Overall Study|Lost to Follow-up|2|||
105783885|NCT01383317|364860853|FG001|Overall Study|Lost to Follow-up|1|||
105783886|NCT01383317|364860852|FG000|Overall Study|Death|1|||
105783887|NCT01383317|364860853|FG001|Overall Study|Death|0|||
105783888|NCT01383317|364860852|FG000|Overall Study|Adverse Event|0|||
105783889|NCT01383317|364860853|FG001|Overall Study|Adverse Event|1|||
105783890|NCT01377194|364860856|FG000|Overall Study|Adverse Event|3|||
105783891|NCT01377194|364860857|FG001|Overall Study|Adverse Event|12|||
105783892|NCT01377194|364860858|FG002|Overall Study|Adverse Event|19|||
105783893|NCT01377194|364860856|FG000|Overall Study|Lack of Efficacy|3|||
105783894|NCT01377194|364860857|FG001|Overall Study|Lack of Efficacy|3|||
105783895|NCT01377194|364860858|FG002|Overall Study|Lack of Efficacy|3|||
105783896|NCT01377194|364860856|FG000|Overall Study|Protocol Violation|4|||
105783897|NCT01377194|364860857|FG001|Overall Study|Protocol Violation|10|||
105783898|NCT01377194|364860858|FG002|Overall Study|Protocol Violation|6|||
105783899|NCT01377194|364860856|FG000|Overall Study|Withdrawal by Subject|8|||
105783900|NCT01377194|364860857|FG001|Overall Study|Withdrawal by Subject|10|||
105783901|NCT01377194|364860858|FG002|Overall Study|Withdrawal by Subject|7|||
105783902|NCT01377194|364860856|FG000|Overall Study|Lost to Follow-up|14|||
105783903|NCT01377194|364860857|FG001|Overall Study|Lost to Follow-up|8|||
105783904|NCT01377194|364860858|FG002|Overall Study|Lost to Follow-up|11|||
105783905|NCT02911285|364860859|FG000|Overall Study|Lost to Follow-up|8|||
105783906|NCT02911285|364860860|FG001|Overall Study|Lost to Follow-up|5|||
105783907|NCT02911285|364860859|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
105783908|NCT02911285|364860860|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
105783909|NCT01397409|364860861|FG000|Stage 2|Adverse Event|0|||
105783910|NCT01397409|364860862|FG001|Stage 2|Adverse Event|0|||
105783911|NCT01397409|364860863|FG002|Stage 2|Adverse Event|0|||
105783912|NCT01397409|364860864|FG003|Stage 2|Adverse Event|0|||
105783913|NCT01397409|364860865|FG004|Stage 2|Adverse Event|6|||
105783914|NCT01397409|364860866|FG005|Stage 2|Adverse Event|3|||
105783915|NCT01397409|364860867|FG006|Stage 2|Adverse Event|0|||
105783916|NCT01397409|364860868|FG007|Stage 2|Adverse Event|0|||
105783917|NCT01397409|364860869|FG008|Stage 2|Adverse Event|0|||
105783918|NCT01397409|364860870|FG009|Stage 2|Adverse Event|0|||
105783919|NCT01397409|364860861|FG000|Stage 2|Personal Reasons|0|||
105783920|NCT01397409|364860862|FG001|Stage 2|Personal Reasons|0|||
105783921|NCT01397409|364860863|FG002|Stage 2|Personal Reasons|0|||
105783922|NCT01397409|364860864|FG003|Stage 2|Personal Reasons|0|||
105783923|NCT01397409|364860865|FG004|Stage 2|Personal Reasons|1|||
105783924|NCT01397409|364860866|FG005|Stage 2|Personal Reasons|0|||
105783925|NCT01397409|364860867|FG006|Stage 2|Personal Reasons|0|||
105783926|NCT01397409|364860868|FG007|Stage 2|Personal Reasons|0|||
105783927|NCT01397409|364860869|FG008|Stage 2|Personal Reasons|0|||
105783928|NCT01397409|364860870|FG009|Stage 2|Personal Reasons|0|||
105783929|NCT01397409|364860861|FG000|Stage 2|Other Miscellaneous Reasons|0|||
105783930|NCT01397409|364860862|FG001|Stage 2|Other Miscellaneous Reasons|0|||
105452904|NCT02349633|363667458|FG003|Overall Study|Withdrawal by Subject|1|||
105452905|NCT02349633|363667459|FG004|Overall Study|Withdrawal by Subject|0|||
105452906|NCT02349633|363667460|FG005|Overall Study|Withdrawal by Subject|0|||
105452907|NCT02349633|363667461|FG006|Overall Study|Withdrawal by Subject|0|||
105452908|NCT02349633|363667462|FG007|Overall Study|Withdrawal by Subject|2|||
105783931|NCT01397409|364860863|FG002|Stage 2|Other Miscellaneous Reasons|0|||
105783932|NCT01397409|364860864|FG003|Stage 2|Other Miscellaneous Reasons|0|||
105783933|NCT01397409|364860865|FG004|Stage 2|Other Miscellaneous Reasons|1|||
105783934|NCT01397409|364860866|FG005|Stage 2|Other Miscellaneous Reasons|1|||
105783935|NCT01397409|364860867|FG006|Stage 2|Other Miscellaneous Reasons|0|||
105783936|NCT01397409|364860868|FG007|Stage 2|Other Miscellaneous Reasons|0|||
105783937|NCT01397409|364860869|FG008|Stage 2|Other Miscellaneous Reasons|0|||
105783938|NCT01397409|364860870|FG009|Stage 2|Other Miscellaneous Reasons|0|||
105452909|NCT02349633|363667463|FG008|Overall Study|Withdrawal by Subject|2|||
105783939|NCT01397409|364860861|FG000|Stage 3|Adverse Event|0|||
105783940|NCT01397409|364860862|FG001|Stage 3|Adverse Event|0|||
105783941|NCT01397409|364860863|FG002|Stage 3|Adverse Event|0|||
105783942|NCT01397409|364860864|FG003|Stage 3|Adverse Event|0|||
105783943|NCT01397409|364860865|FG004|Stage 3|Adverse Event|0|||
105783944|NCT01397409|364860866|FG005|Stage 3|Adverse Event|0|||
105783945|NCT01397409|364860867|FG006|Stage 3|Adverse Event|0|||
105783946|NCT01397409|364860868|FG007|Stage 3|Adverse Event|1|||
105783947|NCT01397409|364860869|FG008|Stage 3|Adverse Event|0|||
105783948|NCT01397409|364860870|FG009|Stage 3|Adverse Event|0|||
105783949|NCT01397409|364860861|FG000|Stage 3|Other Miscellaneous Reasons|0|||
105783950|NCT01397409|364860862|FG001|Stage 3|Other Miscellaneous Reasons|0|||
105783951|NCT01397409|364860863|FG002|Stage 3|Other Miscellaneous Reasons|0|||
105783952|NCT01397409|364860864|FG003|Stage 3|Other Miscellaneous Reasons|0|||
105783953|NCT01397409|364860865|FG004|Stage 3|Other Miscellaneous Reasons|0|||
105783954|NCT01397409|364860866|FG005|Stage 3|Other Miscellaneous Reasons|0|||
105783955|NCT01397409|364860867|FG006|Stage 3|Other Miscellaneous Reasons|0|||
105783956|NCT01397409|364860868|FG007|Stage 3|Other Miscellaneous Reasons|1|||
105783957|NCT01397409|364860869|FG008|Stage 3|Other Miscellaneous Reasons|0|||
105783958|NCT01397409|364860870|FG009|Stage 3|Other Miscellaneous Reasons|0|||
105783959|NCT01207427|364860871|FG000|Double-blind Treatment Period|Adverse Event|0|||
105783960|NCT01207427|364860872|FG001|Double-blind Treatment Period|Adverse Event|1|||
105783961|NCT01207427|364860873|FG002|Double-blind Treatment Period|Adverse Event|0|||
105783962|NCT01207427|364860871|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
105783963|NCT01207427|364860872|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
105783964|NCT01207427|364860873|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
105452910|NCT02349633|363667464|FG009|Overall Study|Withdrawal by Subject|1|||
105452911|NCT02349633|363667465|FG010|Overall Study|Withdrawal by Subject|0|||
105452912|NCT02349633|363667466|FG011|Overall Study|Withdrawal by Subject|0|||
105452913|NCT02349633|363667467|FG012|Overall Study|Withdrawal by Subject|0|||
105452914|NCT02349633|363667468|FG013|Overall Study|Withdrawal by Subject|0|||
105452915|NCT02349633|363667455|FG000|Overall Study|Withdrawal of informed consent|0|||
105452916|NCT02349633|363667456|FG001|Overall Study|Withdrawal of informed consent|0|||
105452917|NCT02349633|363667457|FG002|Overall Study|Withdrawal of informed consent|0|||
105452918|NCT02349633|363667458|FG003|Overall Study|Withdrawal of informed consent|1|||
105452919|NCT02349633|363667459|FG004|Overall Study|Withdrawal of informed consent|1|||
105452920|NCT02349633|363667460|FG005|Overall Study|Withdrawal of informed consent|0|||
105452921|NCT02349633|363667461|FG006|Overall Study|Withdrawal of informed consent|0|||
105452922|NCT02349633|363667462|FG007|Overall Study|Withdrawal of informed consent|3|||
105452923|NCT02349633|363667463|FG008|Overall Study|Withdrawal of informed consent|0|||
105452924|NCT02349633|363667464|FG009|Overall Study|Withdrawal of informed consent|0|||
105452925|NCT02349633|363667465|FG010|Overall Study|Withdrawal of informed consent|0|||
105452926|NCT02349633|363667466|FG011|Overall Study|Withdrawal of informed consent|0|||
105452927|NCT02349633|363667467|FG012|Overall Study|Withdrawal of informed consent|0|||
105452928|NCT02349633|363667468|FG013|Overall Study|Withdrawal of informed consent|0|||
105452929|NCT02349633|363667455|FG000|Overall Study|Transition to compassionate use|0|||
105452930|NCT02349633|363667456|FG001|Overall Study|Transition to compassionate use|0|||
105452931|NCT02349633|363667457|FG002|Overall Study|Transition to compassionate use|0|||
105452932|NCT02349633|363667458|FG003|Overall Study|Transition to compassionate use|0|||
105452933|NCT02349633|363667459|FG004|Overall Study|Transition to compassionate use|1|||
105452934|NCT02349633|363667460|FG005|Overall Study|Transition to compassionate use|0|||
105452935|NCT02349633|363667461|FG006|Overall Study|Transition to compassionate use|0|||
105452936|NCT02349633|363667462|FG007|Overall Study|Transition to compassionate use|3|||
105452937|NCT02349633|363667463|FG008|Overall Study|Transition to compassionate use|0|||
105452938|NCT02349633|363667464|FG009|Overall Study|Transition to compassionate use|1|||
105452939|NCT02349633|363667465|FG010|Overall Study|Transition to compassionate use|0|||
105452940|NCT02349633|363667466|FG011|Overall Study|Transition to compassionate use|0|||
105452941|NCT02349633|363667467|FG012|Overall Study|Transition to compassionate use|0|||
105452942|NCT02349633|363667468|FG013|Overall Study|Transition to compassionate use|0|||
105452943|NCT02349633|363667455|FG000|Overall Study|Early termination of survival follow-up|0|||
105452944|NCT02349633|363667456|FG001|Overall Study|Early termination of survival follow-up|0|||
105452945|NCT02349633|363667457|FG002|Overall Study|Early termination of survival follow-up|0|||
105452946|NCT02349633|363667458|FG003|Overall Study|Early termination of survival follow-up|0|||
105452947|NCT02349633|363667459|FG004|Overall Study|Early termination of survival follow-up|0|||
105452948|NCT02349633|363667460|FG005|Overall Study|Early termination of survival follow-up|0|||
105452949|NCT02349633|363667461|FG006|Overall Study|Early termination of survival follow-up|0|||
105452950|NCT02349633|363667462|FG007|Overall Study|Early termination of survival follow-up|4|||
105452951|NCT02349633|363667463|FG008|Overall Study|Early termination of survival follow-up|0|||
105783965|NCT01207427|364860871|FG000|Double-blind Treatment Period|Protocol Violation|2|||
105452952|NCT02349633|363667464|FG009|Overall Study|Early termination of survival follow-up|0|||
105452953|NCT02349633|363667465|FG010|Overall Study|Early termination of survival follow-up|0|||
105452954|NCT02349633|363667466|FG011|Overall Study|Early termination of survival follow-up|0|||
105452955|NCT02349633|363667467|FG012|Overall Study|Early termination of survival follow-up|0|||
105452956|NCT02349633|363667468|FG013|Overall Study|Early termination of survival follow-up|0|||
105452957|NCT02349633|363667455|FG000|Overall Study|Termination by sponsor|0|||
105783966|NCT01207427|364860872|FG001|Double-blind Treatment Period|Protocol Violation|1|||
105783967|NCT01207427|364860873|FG002|Double-blind Treatment Period|Protocol Violation|1|||
105783968|NCT01207427|364860871|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
105783969|NCT01207427|364860872|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
105783970|NCT01207427|364860873|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105783971|NCT00422227|364860874|FG000|Overall Study|Adverse Event|3|||
105783972|NCT00422227|364860875|FG001|Overall Study|Adverse Event|8|||
105783973|NCT00422227|364860874|FG000|Overall Study|Lost to Follow-up|1|||
105783974|NCT00422227|364860875|FG001|Overall Study|Lost to Follow-up|3|||
105783975|NCT00422227|364860874|FG000|Overall Study|Withdrawal by Subject|0|||
105783976|NCT00422227|364860875|FG001|Overall Study|Withdrawal by Subject|4|||
105783977|NCT00686894|364860876|FG000|Overall Study|Relapse|2|||
105783978|NCT00686894|364860876|FG000|Overall Study|Protocol Violation|4|||
105783979|NCT01336647|364862712|FG000|Overall Study|Lost to Follow-up|4|||
105783980|NCT01336647|364862713|FG001|Overall Study|Lost to Follow-up|1|||
105783981|NCT01336647|364862714|FG002|Overall Study|Lost to Follow-up|3|||
105783982|NCT04398030|364862715|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
105783983|NCT04398030|364862716|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
105783984|NCT04398030|364862715|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
105783985|NCT04398030|364862716|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
105783986|NCT01004822|364862717|FG000|Overall Study|Objective progression or relapse|3|||
105783987|NCT01004822|364862718|FG001|Overall Study|Objective progression or relapse|3|||
105783988|NCT01004822|364862719|FG002|Overall Study|Objective progression or relapse|0|||
105783989|NCT01004822|364862720|FG003|Overall Study|Objective progression or relapse|1|||
105783990|NCT01004822|364862721|FG004|Overall Study|Objective progression or relapse|2|||
105783991|NCT01004822|364862722|FG005|Overall Study|Objective progression or relapse|2|||
105783992|NCT01004822|364862723|FG006|Overall Study|Objective progression or relapse|1|||
105783993|NCT01004822|364862724|FG007|Overall Study|Objective progression or relapse|4|||
105783994|NCT01004822|364862717|FG000|Overall Study|Global deterioration of health status|0|||
105783995|NCT01004822|364862718|FG001|Overall Study|Global deterioration of health status|0|||
105783996|NCT01004822|364862719|FG002|Overall Study|Global deterioration of health status|0|||
105783997|NCT01004822|364862720|FG003|Overall Study|Global deterioration of health status|1|||
105783998|NCT01004822|364862721|FG004|Overall Study|Global deterioration of health status|0|||
105783999|NCT01004822|364862722|FG005|Overall Study|Global deterioration of health status|0|||
105784000|NCT01004822|364862723|FG006|Overall Study|Global deterioration of health status|1|||
105784001|NCT01004822|364862724|FG007|Overall Study|Global deterioration of health status|0|||
105784002|NCT01004822|364862717|FG000|Overall Study|No longer willing to continue|0|||
105784003|NCT01004822|364862718|FG001|Overall Study|No longer willing to continue|0|||
105784004|NCT01004822|364862719|FG002|Overall Study|No longer willing to continue|0|||
105784005|NCT01004822|364862720|FG003|Overall Study|No longer willing to continue|1|||
105784006|NCT01004822|364862721|FG004|Overall Study|No longer willing to continue|2|||
105784007|NCT01004822|364862722|FG005|Overall Study|No longer willing to continue|1|||
105784008|NCT01004822|364862723|FG006|Overall Study|No longer willing to continue|1|||
105784009|NCT01004822|364862724|FG007|Overall Study|No longer willing to continue|0|||
105784010|NCT01004822|364862717|FG000|Overall Study|Adverse Event|0|||
105784011|NCT01004822|364862718|FG001|Overall Study|Adverse Event|0|||
105784012|NCT01004822|364862719|FG002|Overall Study|Adverse Event|0|||
105784013|NCT01004822|364862720|FG003|Overall Study|Adverse Event|0|||
105784014|NCT01004822|364862721|FG004|Overall Study|Adverse Event|0|||
105784015|NCT01004822|364862722|FG005|Overall Study|Adverse Event|0|||
105784016|NCT01004822|364862723|FG006|Overall Study|Adverse Event|1|||
105784017|NCT01004822|364862724|FG007|Overall Study|Adverse Event|1|||
105784018|NCT01004822|364862717|FG000|Overall Study|Other|0|||
105784019|NCT01004822|364862718|FG001|Overall Study|Other|0|||
105784020|NCT01004822|364862719|FG002|Overall Study|Other|4|||
105784021|NCT01004822|364862720|FG003|Overall Study|Other|1|||
105784022|NCT01004822|364862721|FG004|Overall Study|Other|0|||
105784023|NCT01004822|364862722|FG005|Overall Study|Other|1|||
105784024|NCT01004822|364862723|FG006|Overall Study|Other|0|||
105784025|NCT01004822|364862724|FG007|Overall Study|Other|0|||
105784026|NCT02181634|364862726|FG000|Overall Study|Lack of Efficacy|33|||
105784027|NCT02181634|364862726|FG000|Overall Study|Adverse Event|17|||
105336966|NCT00090220|363234765|FG004|Base Study Vaccination Period|Patient Moved|0|||
105336967|NCT00090220|363234766|FG005|Base Study Vaccination Period|Patient Moved|0|||
105336968|NCT00090220|363234761|FG000|Base Study Vaccination Period|Other|4|||
105336969|NCT00090220|363234762|FG001|Base Study Vaccination Period|Other|4|||
105336970|NCT00090220|363234763|FG002|Base Study Vaccination Period|Other|0|||
105336971|NCT00090220|363234764|FG003|Base Study Vaccination Period|Other|0|||
105336972|NCT00090220|363234765|FG004|Base Study Vaccination Period|Other|0|||
105336973|NCT00090220|363234766|FG005|Base Study Vaccination Period|Other|0|||
105336974|NCT00090220|363234761|FG000|Base Study Follow-up Period|Adverse Event|6|||
105336975|NCT00090220|363234762|FG001|Base Study Follow-up Period|Adverse Event|1|||
105336976|NCT00090220|363234763|FG002|Base Study Follow-up Period|Adverse Event|0|||
105336977|NCT00090220|363234764|FG003|Base Study Follow-up Period|Adverse Event|0|||
105336978|NCT00090220|363234765|FG004|Base Study Follow-up Period|Adverse Event|0|||
105336979|NCT00090220|363234766|FG005|Base Study Follow-up Period|Adverse Event|0|||
105336980|NCT00090220|363234761|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
105784028|NCT02181634|364862726|FG000|Overall Study|Physician Decision|8|||
105784029|NCT02181634|364862726|FG000|Overall Study|Withdrawal by Subject|5|||
105784030|NCT02181634|364862726|FG000|Overall Study|Death|2|||
105784031|NCT02181634|364862726|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
105784032|NCT02181634|364862726|FG000|Overall Study|Ineligible|1|||
105784033|NCT02181634|364862726|FG000|Overall Study|Max number of dose reduction|1|||
105784034|NCT02181634|364862726|FG000|Overall Study|Symptomatic progression|1|||
105784035|NCT02181634|364862726|FG000|Overall Study|Patient opted to proceed to surgery|1|||
105784036|NCT04001790|364862730|FG000|Overall Study|Withdrawal by Subject|1|||
105784037|NCT04001790|364862731|FG001|Overall Study|Withdrawal by Subject|2|||
105784038|NCT03737812|364862735|FG000|Overall Study|Withdrawal by Subject|1|||
105784039|NCT03737812|364862736|FG001|Overall Study|Withdrawal by Subject|2|||
105784040|NCT03737812|364862737|FG002|Overall Study|Withdrawal by Subject|1|||
105784041|NCT03737812|364862735|FG000|Overall Study|Sponsor Discontinued the Study|4|||
105784042|NCT03737812|364862736|FG001|Overall Study|Sponsor Discontinued the Study|3|||
105784043|NCT03737812|364862737|FG002|Overall Study|Sponsor Discontinued the Study|2|||
105784044|NCT03737812|364862735|FG000|Overall Study|Adverse Event|0|||
105784045|NCT03737812|364862736|FG001|Overall Study|Adverse Event|1|||
105784046|NCT03737812|364862737|FG002|Overall Study|Adverse Event|0|||
105784047|NCT03737812|364862735|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
105784048|NCT03737812|364862736|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
105784049|NCT03737812|364862737|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
105784050|NCT02546193|364862741|FG000|Overall Study|Withdrawal by Subject|2|||
105784051|NCT02546193|364862742|FG001|Overall Study|Withdrawal by Subject|0|||
105784052|NCT02546193|364862743|FG002|Overall Study|Withdrawal by Subject|1|||
105784053|NCT02546193|364862744|FG003|Overall Study|Withdrawal by Subject|0|||
105784054|NCT02546193|364862741|FG000|Overall Study|Not eligible at time of induction|4|||
105784055|NCT02546193|364862742|FG001|Overall Study|Not eligible at time of induction|6|||
105784056|NCT02546193|364862743|FG002|Overall Study|Not eligible at time of induction|1|||
105784057|NCT02546193|364862744|FG003|Overall Study|Not eligible at time of induction|0|||
105784058|NCT01151085|364862745|FG000|Overall Study|Lost to Follow-up|31|||
105784059|NCT01151085|364862745|FG000|Overall Study|Protocol Violation|25|||
105784060|NCT01319422|364862746|FG000|Overall Study|Withdrawal by Subject|1|||
105784061|NCT01319422|364862747|FG001|Overall Study|Withdrawal by Subject|0|||
105784062|NCT01308476|364862749|FG000|Overall Study|Lost to Follow-up|2|||
105784063|NCT01308476|364862750|FG001|Overall Study|Lost to Follow-up|2|||
105784064|NCT01308476|364862749|FG000|Overall Study|Other|1|||
105784065|NCT01308476|364862750|FG001|Overall Study|Other|0|||
105784066|NCT03781167|364862756|FG000|Overall Study|Adverse Event|23|||
105784067|NCT03781167|364862757|FG001|Overall Study|Adverse Event|25|||
105784068|NCT03781167|364862756|FG000|Overall Study|Withdrew consent|16|||
105784069|NCT03781167|364862757|FG001|Overall Study|Withdrew consent|12|||
105784070|NCT03781167|364862756|FG000|Overall Study|Lost to Follow-up|0|||
105784071|NCT03781167|364862757|FG001|Overall Study|Lost to Follow-up|1|||
105784072|NCT03781167|364862756|FG000|Overall Study|Lack of Efficacy|4|||
105784073|NCT03781167|364862757|FG001|Overall Study|Lack of Efficacy|5|||
105784074|NCT03781167|364862756|FG000|Overall Study|Difficulty with drug delivery system|2|||
105784075|NCT03781167|364862757|FG001|Overall Study|Difficulty with drug delivery system|3|||
105784076|NCT03781167|364862756|FG000|Overall Study|Other, not specified|2|||
105784077|NCT03781167|364862757|FG001|Overall Study|Other, not specified|2|||
105784078|NCT00462501|364862758|FG000|Overall Study|Not treated|3|||
105784079|NCT00462501|364862758|FG000|Overall Study|Adverse Event|2|||
105784080|NCT03246152|364862759|FG000|Overall Study|Lost to Follow-up|2|||
105784081|NCT03246152|364862759|FG000|Overall Study|Protocol Violation|1|||
105784082|NCT01590628|364862767|FG000|Overall Study|Death|2|||
105784083|NCT01590628|364862768|FG001|Overall Study|Death|0|||
105784084|NCT00475657|364862773|FG000|Overall Study|Death|1|||
105784085|NCT00475657|364862773|FG000|Overall Study|Sponsor's Decision|3|||
105784086|NCT02992743|364862774|FG000|Overall Study|Withdrawal by Subject|1|||
105784087|NCT02992743|364862775|FG001|Overall Study|Withdrawal by Subject|1|||
105784088|NCT02992743|364862774|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
105784089|NCT02992743|364862775|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
105784090|NCT02992743|364862774|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
105784091|NCT02992743|364862775|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
105784092|NCT02992743|364862774|FG000|Overall Study|No measurable disease|1|||
105784093|NCT02992743|364862775|FG001|Overall Study|No measurable disease|0|||
105784094|NCT02992743|364862774|FG000|Overall Study|Lost to Follow-up|0|||
105784095|NCT02992743|364862775|FG001|Overall Study|Lost to Follow-up|1|||
105784096|NCT00361504|364862776|FG000|Overall Study|Withdrawal by Subject|94|||
105784097|NCT00361504|364862777|FG001|Overall Study|Withdrawal by Subject|31|||
105784098|NCT00361504|364862776|FG000|Overall Study|Lost to Follow-up|40|||
105784099|NCT00361504|364862777|FG001|Overall Study|Lost to Follow-up|7|||
105784100|NCT00361504|364862776|FG000|Overall Study|Adverse Event|203|||
105784101|NCT00361504|364862777|FG001|Overall Study|Adverse Event|82|||
105784102|NCT00361504|364862776|FG000|Overall Study|Lack of Efficacy|72|||
105784103|NCT00361504|364862777|FG001|Overall Study|Lack of Efficacy|7|||
105784104|NCT00361504|364862776|FG000|Overall Study|Resolution of Pain|2|||
105784105|NCT00361504|364862777|FG001|Overall Study|Resolution of Pain|0|||
105784106|NCT00361504|364862776|FG000|Overall Study|Study medication non compliant|42|||
105784107|NCT00361504|364862777|FG001|Overall Study|Study medication non compliant|15|||
105784108|NCT00361504|364862776|FG000|Overall Study|All other|28|||
105784109|NCT00361504|364862777|FG001|Overall Study|All other|3|||
105784110|NCT00450814|364862778|FG000|Overall Study|Failed to complete the initial therapy|0|||
105784111|NCT00450814|364862779|FG001|Overall Study|Failed to complete the initial therapy|0|||
105784112|NCT00450814|364862780|FG002|Overall Study|Failed to complete the initial therapy|0|||
105784113|NCT00450814|364862781|FG003|Overall Study|Failed to complete the initial therapy|1|||
105784114|NCT00450814|364862782|FG004|Overall Study|Failed to complete the initial therapy|1|||
105784115|NCT00450814|364862783|FG005|Overall Study|Failed to complete the initial therapy|1|||
105784116|NCT00450814|364862784|FG006|Overall Study|Failed to complete the initial therapy|0|||
105784117|NCT00450814|364862785|FG007|Overall Study|Failed to complete the initial therapy|0|||
105784118|NCT00450814|364862786|FG008|Overall Study|Failed to complete the initial therapy|0|||
105784119|NCT00450814|364862787|FG009|Overall Study|Failed to complete the initial therapy|0|||
105784120|NCT00450814|364862788|FG010|Overall Study|Failed to complete the initial therapy|0|||
105784121|NCT00450814|364862778|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
105784122|NCT00450814|364862779|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
105784123|NCT00450814|364862780|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
105784124|NCT00450814|364862781|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
105784125|NCT00450814|364862782|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
105784126|NCT00450814|364862783|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
105784127|NCT00450814|364862784|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
105784128|NCT00450814|364862785|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
105784129|NCT00450814|364862786|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
105784130|NCT00450814|364862787|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
105784131|NCT00450814|364862788|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
105784132|NCT00401726|364862789|FG000|Overall Study|Adverse Event|34|||
105784133|NCT00401726|364862790|FG001|Overall Study|Adverse Event|45|||
105784134|NCT00401726|364862789|FG000|Overall Study|Death|0|||
105784135|NCT00401726|364862790|FG001|Overall Study|Death|3|||
105784136|NCT00401726|364862789|FG000|Overall Study|Sponsor Request|0|||
105784137|NCT00401726|364862790|FG001|Overall Study|Sponsor Request|1|||
105784138|NCT00401726|364862789|FG000|Overall Study|Physician Decision|3|||
105784139|NCT00401726|364862790|FG001|Overall Study|Physician Decision|6|||
105784140|NCT00401726|364862789|FG000|Overall Study|Lost to Follow-up|23|||
105784141|NCT00401726|364862790|FG001|Overall Study|Lost to Follow-up|20|||
105784142|NCT00401726|364862789|FG000|Overall Study|Protocol Violation|6|||
105784143|NCT00401726|364862790|FG001|Overall Study|Protocol Violation|3|||
105784144|NCT00401726|364862789|FG000|Overall Study|Withdrawal by Subject|18|||
105784145|NCT00401726|364862790|FG001|Overall Study|Withdrawal by Subject|24|||
105784146|NCT00401726|364862789|FG000|Overall Study|Lack of Efficacy|4|||
105784147|NCT00401726|364862790|FG001|Overall Study|Lack of Efficacy|6|||
105784148|NCT00401726|364862789|FG000|Overall Study|Protocol Deviation|9|||
105784149|NCT00401726|364862790|FG001|Overall Study|Protocol Deviation|4|||
105784150|NCT02067728|364862791|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
105784151|NCT02067728|364862792|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
105784152|NCT02067728|364862791|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
105784153|NCT02067728|364862792|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
105452958|NCT02349633|363667456|FG001|Overall Study|Termination by sponsor|0|||
105452959|NCT02349633|363667457|FG002|Overall Study|Termination by sponsor|0|||
105452960|NCT02349633|363667458|FG003|Overall Study|Termination by sponsor|0|||
105452961|NCT02349633|363667459|FG004|Overall Study|Termination by sponsor|0|||
105452962|NCT02349633|363667460|FG005|Overall Study|Termination by sponsor|0|||
105452963|NCT02349633|363667461|FG006|Overall Study|Termination by sponsor|0|||
105452964|NCT02349633|363667462|FG007|Overall Study|Termination by sponsor|1|||
105452965|NCT02349633|363667463|FG008|Overall Study|Termination by sponsor|0|||
105452966|NCT02349633|363667464|FG009|Overall Study|Termination by sponsor|2|||
105452967|NCT02349633|363667465|FG010|Overall Study|Termination by sponsor|0|||
105452968|NCT02349633|363667466|FG011|Overall Study|Termination by sponsor|0|||
105452969|NCT02349633|363667467|FG012|Overall Study|Termination by sponsor|0|||
105784154|NCT02067728|364862791|FG000|6 Month Measurements|Unable to attend|114|||
105784155|NCT02067728|364862792|FG001|6 Month Measurements|Unable to attend|97|||
105784156|NCT00933543|364862793|FG000|Overall Study|Adverse Event|2|||
105784157|NCT00933543|364862794|FG001|Overall Study|Adverse Event|1|||
105784158|NCT00933543|364862793|FG000|Overall Study|Lost to Follow-up|0|||
105784159|NCT00933543|364862794|FG001|Overall Study|Lost to Follow-up|1|||
105784160|NCT00933543|364862793|FG000|Overall Study|Withdrawal by Subject|0|||
105784161|NCT00933543|364862794|FG001|Overall Study|Withdrawal by Subject|1|||
105452970|NCT02349633|363667468|FG013|Overall Study|Termination by sponsor|0|||
105452971|NCT02349633|363667455|FG000|Overall Study|Other|0|||
105784162|NCT00933543|364862793|FG000|Overall Study|Lack of Efficacy|0|||
105452972|NCT02349633|363667456|FG001|Overall Study|Other|0|||
105452973|NCT02349633|363667457|FG002|Overall Study|Other|0|||
105452974|NCT02349633|363667458|FG003|Overall Study|Other|0|||
105784163|NCT00933543|364862794|FG001|Overall Study|Lack of Efficacy|3|||
105784164|NCT00933543|364862793|FG000|Overall Study|Other|1|||
105784165|NCT00933543|364862794|FG001|Overall Study|Other|1|||
105784166|NCT01050998|364862800|FG000|Overall Study|Adverse Event|1|||
105784167|NCT01050998|364862801|FG001|Overall Study|Adverse Event|0|||
105784168|NCT01050998|364862802|FG002|Overall Study|Adverse Event|1|||
105784169|NCT01050998|364862803|FG003|Overall Study|Adverse Event|0|||
105784170|NCT01050998|364862804|FG004|Overall Study|Adverse Event|2|||
105784171|NCT01050998|364862800|FG000|Overall Study|Withdrawal by Subject|0|||
105784172|NCT01050998|364862801|FG001|Overall Study|Withdrawal by Subject|0|||
105784173|NCT01050998|364862802|FG002|Overall Study|Withdrawal by Subject|0|||
105784174|NCT01050998|364862803|FG003|Overall Study|Withdrawal by Subject|1|||
105784175|NCT01050998|364862804|FG004|Overall Study|Withdrawal by Subject|3|||
105784176|NCT01050998|364862800|FG000|Overall Study|Other|3|||
105784177|NCT01050998|364862801|FG001|Overall Study|Other|2|||
105784178|NCT01050998|364862802|FG002|Overall Study|Other|1|||
105784179|NCT01050998|364862803|FG003|Overall Study|Other|1|||
105784180|NCT01050998|364862804|FG004|Overall Study|Other|5|||
105784181|NCT01050998|364862800|FG000|Overall Study|Data integrity issues|0|||
105784182|NCT01050998|364862801|FG001|Overall Study|Data integrity issues|0|||
105784183|NCT01050998|364862802|FG002|Overall Study|Data integrity issues|1|||
105784184|NCT01050998|364862803|FG003|Overall Study|Data integrity issues|1|||
105784185|NCT01050998|364862804|FG004|Overall Study|Data integrity issues|4|||
105784186|NCT01428882|364862807|FG000|Overall Study|Lack of Efficacy|2|||
105784187|NCT01428882|364862808|FG001|Overall Study|Lack of Efficacy|7|||
105784188|NCT01428882|364862807|FG000|Overall Study|Protocol Violation|4|||
105784189|NCT01428882|364862808|FG001|Overall Study|Protocol Violation|3|||
105784190|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
105784191|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
105784192|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
105784193|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
105784194|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
105784195|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Death|1|||
105784196|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Death|0|||
105784197|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Death|0|||
105784198|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Death|0|||
105784199|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Death|0|||
105784200|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
105784201|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
105784202|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
105784203|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
105784204|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
105784205|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
105784206|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
105784207|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
105784208|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
105784209|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
105784210|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
105784211|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
105784212|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
105784213|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
105784214|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
105784215|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
105784216|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
105784217|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
105784218|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
105784219|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
105784220|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
105452975|NCT02349633|363667459|FG004|Overall Study|Other|0|||
105452976|NCT02349633|363667460|FG005|Overall Study|Other|0|||
105784221|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
105784222|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
105784223|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
105784224|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
105452977|NCT02349633|363667461|FG006|Overall Study|Other|0|||
105452978|NCT02349633|363667462|FG007|Overall Study|Other|2|||
105452979|NCT02349633|363667463|FG008|Overall Study|Other|0|||
105784225|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Other|1|||
105784226|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Other|8|||
105784227|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Other|5|||
105784228|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Other|0|||
105784229|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Other|0|||
105452980|NCT02349633|363667464|FG009|Overall Study|Other|0|||
105784230|NCT00634933|364862810|FG000|Between Part A and Part B|Physician Decision|0|||
105784231|NCT00634933|364862811|FG001|Between Part A and Part B|Physician Decision|1|||
105452981|NCT02349633|363667465|FG010|Overall Study|Other|0|||
105452982|NCT02349633|363667466|FG011|Overall Study|Other|0|||
105784232|NCT00634933|364862812|FG002|Between Part A and Part B|Physician Decision|0|||
105784233|NCT00634933|364862813|FG003|Between Part A and Part B|Physician Decision|0|||
105784234|NCT00634933|364862814|FG004|Between Part A and Part B|Physician Decision|0|||
105784235|NCT00634933|364862810|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
105784236|NCT00634933|364862811|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
105784237|NCT00634933|364862812|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
105784238|NCT00634933|364862813|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
105784239|NCT00634933|364862814|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
105784240|NCT00634933|364862810|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
105784241|NCT00634933|364862811|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
105784242|NCT00634933|364862812|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
105784243|NCT00634933|364862813|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
105784244|NCT00634933|364862814|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
105784245|NCT00634933|364862810|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
105784246|NCT00634933|364862811|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
105784247|NCT00634933|364862812|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
105784248|NCT00634933|364862813|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
105784249|NCT00634933|364862814|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
105784250|NCT00634933|364862810|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
105784251|NCT00634933|364862811|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
105784252|NCT00634933|364862812|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
105784253|NCT00634933|364862813|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
105784254|NCT00634933|364862814|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
105784255|NCT00634933|364862810|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
105784256|NCT00634933|364862811|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
105784257|NCT00634933|364862812|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
105784258|NCT00634933|364862813|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
105784259|NCT00634933|364862814|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
105784260|NCT00634933|364862810|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
105784261|NCT00634933|364862811|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
105784262|NCT00634933|364862812|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
105784263|NCT00634933|364862813|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
105784264|NCT00634933|364862814|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
105784265|NCT00634933|364862810|FG000|Part B: Week 24 to Week 52|Other|0|||
105784266|NCT00634933|364862811|FG001|Part B: Week 24 to Week 52|Other|0|||
105784267|NCT00634933|364862812|FG002|Part B: Week 24 to Week 52|Other|5|||
105784268|NCT00634933|364862813|FG003|Part B: Week 24 to Week 52|Other|0|||
105784269|NCT00634933|364862814|FG004|Part B: Week 24 to Week 52|Other|1|||
105784270|NCT03831282|364862815|FG000|Overall Study|Could not place sensor|1|||
105784271|NCT01694849|364862816|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
105784272|NCT01694849|364862817|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
105784273|NCT01694849|364862818|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
105784274|NCT01694849|364862816|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
105784275|NCT01694849|364862817|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
105784276|NCT01694849|364862818|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
105784277|NCT01694849|364862816|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
105784278|NCT01694849|364862817|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
105784279|NCT01694849|364862818|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
105784280|NCT01694849|364862816|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
105784281|NCT01694849|364862817|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
105784282|NCT01694849|364862818|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
105784283|NCT01694849|364862816|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
105784284|NCT01694849|364862817|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
105784285|NCT01694849|364862818|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
105784286|NCT01694849|364862816|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
105784287|NCT01694849|364862817|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
105452983|NCT02349633|363667467|FG012|Overall Study|Other|0|||
105452984|NCT02349633|363667468|FG013|Overall Study|Other|0|||
105784288|NCT01694849|364862818|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
105784289|NCT01694849|364862816|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
105452985|NCT00981149|363667470|FG000|Overall Study|Lost to Follow-up|1|||
105452986|NCT00981149|363667471|FG001|Overall Study|Lost to Follow-up|2|||
105452987|NCT00981149|363667470|FG000|Overall Study|Withdrawal by Subject|1|||
105784290|NCT01694849|364862817|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
105784291|NCT01694849|364862818|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
105784292|NCT01694849|364862816|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
105784293|NCT01694849|364862817|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
105784294|NCT01694849|364862818|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
105452988|NCT00981149|363667471|FG001|Overall Study|Withdrawal by Subject|1|||
105784295|NCT01258803|364862819|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
105784296|NCT01258803|364862820|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
105784297|NCT01258803|364862821|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
105784298|NCT01258803|364862822|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
105784299|NCT01258803|364862823|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
105784300|NCT01258803|364862824|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
105784301|NCT01258803|364862819|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
105784302|NCT01258803|364862820|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
105784303|NCT01258803|364862821|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
105784304|NCT01258803|364862822|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
105784305|NCT01258803|364862823|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
105784306|NCT01258803|364862824|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
105784307|NCT01258803|364862819|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
105784308|NCT01258803|364862820|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
105784309|NCT01258803|364862821|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
105784310|NCT01258803|364862822|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
105784311|NCT01258803|364862823|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
105784312|NCT01258803|364862824|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
105784313|NCT01326312|364862825|FG000|Overall Study|Adverse Event|11|||
105784314|NCT01326312|364862826|FG001|Overall Study|Adverse Event|11|||
105784315|NCT01326312|364862827|FG002|Overall Study|Adverse Event|1|||
105784316|NCT01326312|364862825|FG000|Overall Study|Withdrawal by Subject|1|||
105784317|NCT01326312|364862826|FG001|Overall Study|Withdrawal by Subject|2|||
105784318|NCT01326312|364862827|FG002|Overall Study|Withdrawal by Subject|1|||
105784319|NCT01326312|364862825|FG000|Overall Study|Protocol Violation|0|||
105784320|NCT01326312|364862826|FG001|Overall Study|Protocol Violation|1|||
105784321|NCT01326312|364862827|FG002|Overall Study|Protocol Violation|0|||
105784322|NCT01326312|364862825|FG000|Overall Study|Lack of Efficacy|13|||
105784323|NCT01326312|364862826|FG001|Overall Study|Lack of Efficacy|7|||
105784324|NCT01326312|364862827|FG002|Overall Study|Lack of Efficacy|1|||
105784325|NCT01326312|364862825|FG000|Overall Study|Death|1|||
105784326|NCT01326312|364862826|FG001|Overall Study|Death|0|||
105784327|NCT01326312|364862827|FG002|Overall Study|Death|1|||
105784328|NCT01326312|364862825|FG000|Overall Study|progressive disease|0|||
105784329|NCT01326312|364862826|FG001|Overall Study|progressive disease|1|||
105784330|NCT01326312|364862827|FG002|Overall Study|progressive disease|1|||
105784331|NCT01326312|364862825|FG000|Overall Study|Study terminated by Sponsor|8|||
105784332|NCT01326312|364862826|FG001|Overall Study|Study terminated by Sponsor|32|||
105784333|NCT01326312|364862827|FG002|Overall Study|Study terminated by Sponsor|46|||
105784334|NCT01326312|364862825|FG000|Overall Study|Treatment arm terminated|19|||
105784335|NCT01326312|364862826|FG001|Overall Study|Treatment arm terminated|0|||
105784336|NCT01326312|364862827|FG002|Overall Study|Treatment arm terminated|0|||
105784337|NCT01326312|364862825|FG000|Overall Study|QTc > 500|0|||
105784338|NCT01326312|364862826|FG001|Overall Study|QTc > 500|1|||
105784339|NCT01326312|364862827|FG002|Overall Study|QTc > 500|0|||
105784340|NCT02370173|364862833|FG000|Overall Study|Protocol Violation|1|||
105784341|NCT02370173|364862834|FG001|Overall Study|Protocol Violation|1|||
105784342|NCT02370173|364862833|FG000|Overall Study|Withdrawal by Subject|2|||
105452989|NCT02648204|363667472|FG000|Overall Study|Withdrawal by Subject|12|||
105784343|NCT02370173|364862834|FG001|Overall Study|Withdrawal by Subject|2|||
105784344|NCT04034225|364862835|FG000|Overall Study|Death|3|||
105784345|NCT04034225|364862835|FG000|Overall Study|Withdrawal by Subject|2|||
105784346|NCT04034225|364862835|FG000|Overall Study|Study termination by Sponsor|18|||
105784347|NCT04034225|364862835|FG000|Overall Study|Physician Decision|1|||
105784348|NCT04034225|364862835|FG000|Overall Study|Lack of Efficacy|1|||
105784349|NCT03759340|364862837|FG000|Overall Study|Adverse Event|2|||
105784350|NCT03759340|364862837|FG000|Overall Study|Lost to Follow-up|1|||
105784351|NCT03759340|364862837|FG000|Overall Study|Withdrawal by Subject|15|||
105784352|NCT03759340|364862837|FG000|Overall Study|Study Terminated by Sponsor|38|||
105784353|NCT00167414|364862839|FG000|Overall Study|Death|10|||
105784354|NCT01593761|364862840|FG000|Overall Study|Lost to Follow-up|1|||
105784355|NCT01593761|364862840|FG000|Overall Study|culture negative for MRSA at baseline|5|||
105784356|NCT01593761|364862840|FG000|Overall Study|positive for hepatitis C virus|1|||
105784357|NCT01593761|364862840|FG000|Overall Study|secondary cellulitis|1|||
105784358|NCT01038609|364862841|FG000|Overall Study|Adverse Event|0|||
105784359|NCT01038609|364862842|FG001|Overall Study|Adverse Event|0|||
105784360|NCT01038609|364862843|FG002|Overall Study|Adverse Event|1|||
105784361|NCT01038609|364862844|FG003|Overall Study|Adverse Event|0|||
105784362|NCT01038609|364862845|FG004|Overall Study|Adverse Event|0|||
105784363|NCT01038609|364862841|FG000|Overall Study|Dosing Error|0|||
105784364|NCT01038609|364862842|FG001|Overall Study|Dosing Error|0|||
105784365|NCT01038609|364862843|FG002|Overall Study|Dosing Error|0|||
105784366|NCT01038609|364862844|FG003|Overall Study|Dosing Error|1|||
105784367|NCT01038609|364862845|FG004|Overall Study|Dosing Error|1|||
105784368|NCT01038609|364862841|FG000|Overall Study|Death in the Family|1|||
105784369|NCT01038609|364862842|FG001|Overall Study|Death in the Family|0|||
105784370|NCT01038609|364862843|FG002|Overall Study|Death in the Family|0|||
105784371|NCT01038609|364862844|FG003|Overall Study|Death in the Family|0|||
105784372|NCT01038609|364862845|FG004|Overall Study|Death in the Family|0|||
105784373|NCT01038609|364862841|FG000|Overall Study|Refusal of Blood Draws|0|||
105784374|NCT01038609|364862842|FG001|Overall Study|Refusal of Blood Draws|1|||
105784375|NCT01038609|364862843|FG002|Overall Study|Refusal of Blood Draws|0|||
105784376|NCT01038609|364862844|FG003|Overall Study|Refusal of Blood Draws|0|||
105784377|NCT01038609|364862845|FG004|Overall Study|Refusal of Blood Draws|0|||
105784378|NCT00495794|364862849|FG000|Overall Study|Pharmacist did not activate patient|522|||
105784379|NCT00495794|364862850|FG001|Overall Study|Pharmacist did not activate patient|0|||
105784380|NCT01393444|364862851|FG000|Overall Study|Withdrawal by Subject|1|||
105784381|NCT01393444|364862851|FG000|Overall Study|Determined ineligible during screening.|2|||
105784382|NCT01883362|364862852|FG000|Treatment|Adverse Event|1|||
105784383|NCT01883362|364862853|FG001|Treatment|Adverse Event|8|||
105784384|NCT01883362|364862852|FG000|Treatment|Withdrawal by Subject|6|||
105784385|NCT01883362|364862853|FG001|Treatment|Withdrawal by Subject|2|||
105784386|NCT01883362|364862852|FG000|Treatment|Administrative problems|4|||
105784387|NCT01883362|364862853|FG001|Treatment|Administrative problems|1|||
105784388|NCT01883362|364862852|FG000|Treatment|Relapse|4|||
105784389|NCT01883362|364862853|FG001|Treatment|Relapse|2|||
105784390|NCT01883362|364862852|FG000|Treatment|Randomized, not treated|1|||
105784391|NCT01883362|364862853|FG001|Treatment|Randomized, not treated|1|||
105784392|NCT01883362|364862852|FG000|Post Treatment Follow-up|Protocol Violation|0|||
105784393|NCT01883362|364862853|FG001|Post Treatment Follow-up|Protocol Violation|1|||
105784394|NCT01883362|364862852|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
105784395|NCT01883362|364862853|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
105784396|NCT01883362|364862852|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
105784397|NCT01883362|364862853|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
105784398|NCT01883362|364862852|FG000|Post Treatment Follow-up|Administrative problems|2|||
105784399|NCT01883362|364862853|FG001|Post Treatment Follow-up|Administrative problems|0|||
105784400|NCT01883362|364862852|FG000|Post Treatment Follow-up|Death|8|||
105784401|NCT01883362|364862853|FG001|Post Treatment Follow-up|Death|4|||
105784402|NCT01883362|364862852|FG000|Post Treatment Follow-up|Relapse|1|||
105784403|NCT01883362|364862853|FG001|Post Treatment Follow-up|Relapse|2|||
105784404|NCT04678557|364862860|FG000|Overall Study|Withdrawal by Subject|1|||
105784405|NCT04678557|364862861|FG001|Overall Study|Withdrawal by Subject|0|||
105784406|NCT04678557|364862860|FG000|Overall Study|Lack of Efficacy|0|||
105784407|NCT04678557|364862861|FG001|Overall Study|Lack of Efficacy|13|||
105784408|NCT04678557|364862860|FG000|Overall Study|Safety Evaluation|0|||
105784409|NCT04678557|364862861|FG001|Overall Study|Safety Evaluation|1|||
105784410|NCT00421928|364864313|FG000|Overall Study|Adverse Event|61|||
105784411|NCT00421928|364864314|FG001|Overall Study|Adverse Event|140|||
105784412|NCT00421928|364864315|FG002|Overall Study|Adverse Event|22|||
105784413|NCT00421928|364864313|FG000|Overall Study|Lost to Follow-up|5|||
105784414|NCT00421928|364864314|FG001|Overall Study|Lost to Follow-up|0|||
105784415|NCT00421928|364864315|FG002|Overall Study|Lost to Follow-up|3|||
105784416|NCT00421928|364864313|FG000|Overall Study|Withdrawal by Subject|50|||
105784417|NCT00421928|364864314|FG001|Overall Study|Withdrawal by Subject|48|||
105784418|NCT00421928|364864315|FG002|Overall Study|Withdrawal by Subject|43|||
105784419|NCT00421928|364864313|FG000|Overall Study|Lack of Efficacy|15|||
105784420|NCT00421928|364864314|FG001|Overall Study|Lack of Efficacy|7|||
105784421|NCT00421928|364864315|FG002|Overall Study|Lack of Efficacy|35|||
105784422|NCT00421928|364864313|FG000|Overall Study|Study drug non-compliant|6|||
105784423|NCT00421928|364864314|FG001|Overall Study|Study drug non-compliant|7|||
105784424|NCT00421928|364864315|FG002|Overall Study|Study drug non-compliant|4|||
105784425|NCT00421928|364864313|FG000|Overall Study|All other|26|||
105784426|NCT00421928|364864314|FG001|Overall Study|All other|21|||
105784427|NCT00421928|364864315|FG002|Overall Study|All other|27|||
105784428|NCT00421928|364864313|FG000|Overall Study|Death|0|||
105784429|NCT00421928|364864314|FG001|Overall Study|Death|1|||
105784430|NCT00421928|364864315|FG002|Overall Study|Death|0|||
105784431|NCT01846442|364864321|FG000|Overall Study|Adverse Event|2|||
105784432|NCT01846442|364864322|FG001|Overall Study|Adverse Event|4|||
105784433|NCT01846442|364864323|FG002|Overall Study|Adverse Event|2|||
105784434|NCT01846442|364864324|FG003|Overall Study|Adverse Event|1|||
105784435|NCT01846442|364864321|FG000|Overall Study|Lost to Follow-up|0|||
105452990|NCT02648204|363667473|FG001|Overall Study|Withdrawal by Subject|8|||
105784436|NCT01846442|364864322|FG001|Overall Study|Lost to Follow-up|0|||
105784437|NCT01846442|364864323|FG002|Overall Study|Lost to Follow-up|1|||
105784438|NCT01846442|364864324|FG003|Overall Study|Lost to Follow-up|0|||
105784439|NCT01846442|364864321|FG000|Overall Study|Withdrawal by Subject|3|||
105784440|NCT01846442|364864322|FG001|Overall Study|Withdrawal by Subject|2|||
105784441|NCT01846442|364864323|FG002|Overall Study|Withdrawal by Subject|0|||
105784442|NCT01846442|364864324|FG003|Overall Study|Withdrawal by Subject|1|||
105784443|NCT01846442|364864321|FG000|Overall Study|Left the city/Lost medication|1|||
105784444|NCT01846442|364864322|FG001|Overall Study|Left the city/Lost medication|0|||
105784445|NCT01846442|364864323|FG002|Overall Study|Left the city/Lost medication|1|||
105784446|NCT01846442|364864324|FG003|Overall Study|Left the city/Lost medication|1|||
105784447|NCT00451191|364864325|FG000|Overall Study|withdrawal or received alternate tx|15|||
105784448|NCT00451191|364864326|FG001|Overall Study|withdrawal or received alternate tx|11|||
105784449|NCT02687815|364864327|FG000|Overall Study|Lost to Follow-up|2|||
105784450|NCT02687815|364864328|FG001|Overall Study|Lost to Follow-up|4|||
105784451|NCT02687815|364864327|FG000|Overall Study|Withdrawal by Subject|2|||
105784452|NCT02687815|364864328|FG001|Overall Study|Withdrawal by Subject|4|||
105784453|NCT02777554|364864329|FG000|Overall Study|Adverse Event|4|||
105784454|NCT02777554|364864330|FG001|Overall Study|Adverse Event|4|||
105784455|NCT02777554|364864331|FG002|Overall Study|Adverse Event|0|||
105784456|NCT02777554|364864332|FG003|Overall Study|Adverse Event|1|||
105784457|NCT02777554|364864333|FG004|Overall Study|Adverse Event|0|||
105784458|NCT02777554|364864334|FG005|Overall Study|Adverse Event|0|||
105784459|NCT02777554|364864329|FG000|Overall Study|Withdrawal by Subject|3|||
105784460|NCT02777554|364864330|FG001|Overall Study|Withdrawal by Subject|1|||
105784461|NCT02777554|364864331|FG002|Overall Study|Withdrawal by Subject|1|||
105784462|NCT02777554|364864332|FG003|Overall Study|Withdrawal by Subject|0|||
105784463|NCT02777554|364864333|FG004|Overall Study|Withdrawal by Subject|0|||
105784464|NCT02777554|364864334|FG005|Overall Study|Withdrawal by Subject|0|||
105784465|NCT02777554|364864329|FG000|Overall Study|Discharged early due to hurricane|22|||
105784466|NCT02777554|364864330|FG001|Overall Study|Discharged early due to hurricane|20|||
105784467|NCT02777554|364864331|FG002|Overall Study|Discharged early due to hurricane|0|||
105784468|NCT02777554|364864332|FG003|Overall Study|Discharged early due to hurricane|0|||
105784469|NCT02777554|364864333|FG004|Overall Study|Discharged early due to hurricane|0|||
105784470|NCT02777554|364864334|FG005|Overall Study|Discharged early due to hurricane|0|||
105784471|NCT02777554|364864329|FG000|Overall Study|Other - Miscellaneous|1|||
105784472|NCT02777554|364864330|FG001|Overall Study|Other - Miscellaneous|0|||
105784473|NCT02777554|364864331|FG002|Overall Study|Other - Miscellaneous|0|||
105784474|NCT02777554|364864332|FG003|Overall Study|Other - Miscellaneous|0|||
105784475|NCT02777554|364864333|FG004|Overall Study|Other - Miscellaneous|0|||
105784476|NCT02777554|364864334|FG005|Overall Study|Other - Miscellaneous|0|||
105784477|NCT04177862|364864335|FG000|Overall Study|Protocol Violation|2|||
105784478|NCT04177862|364864336|FG001|Overall Study|Protocol Violation|7|||
105784479|NCT01846039|364864337|FG000|Overall Study|Protocol Violation|1|||
105784480|NCT01846039|364864337|FG000|Overall Study|Subject Withdrew Consent|1|||
105784481|NCT03233009|364864340|FG000|Overall Study|Lost to Follow-up|1|||
105784482|NCT03039686|364864342|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
105784483|NCT03039686|364864343|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
105784484|NCT03039686|364864344|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
105784485|NCT03039686|364864342|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
105784486|NCT03039686|364864343|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
105784487|NCT03039686|364864344|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
105784488|NCT03039686|364864342|FG000|Double-blind Period|Withdrawal by Subject|2|||
105784489|NCT03039686|364864343|FG001|Double-blind Period|Withdrawal by Subject|2|||
105784490|NCT03039686|364864344|FG002|Double-blind Period|Withdrawal by Subject|1|||
105784491|NCT03039686|364864342|FG000|Double-blind Period|Death|0|||
105784492|NCT03039686|364864343|FG001|Double-blind Period|Death|0|||
105784493|NCT03039686|364864344|FG002|Double-blind Period|Death|1|||
105452991|NCT02648204|363667474|FG002|Overall Study|Withdrawal by Subject|2|||
105452992|NCT02648204|363667475|FG003|Overall Study|Withdrawal by Subject|6|||
105452993|NCT02648204|363667472|FG000|Overall Study|Lost to Follow-up|5|||
105452994|NCT02648204|363667473|FG001|Overall Study|Lost to Follow-up|8|||
105452995|NCT02648204|363667474|FG002|Overall Study|Lost to Follow-up|4|||
105784494|NCT03039686|364864342|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
105784495|NCT03039686|364864343|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
105784496|NCT03039686|364864344|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
105784497|NCT03039686|364864342|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
105784498|NCT03039686|364864343|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
105784499|NCT03039686|364864344|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
105784500|NCT03039686|364864342|FG000|Open Label Period|Withdrawal by Subject|0|||
105784501|NCT03039686|364864343|FG001|Open Label Period|Withdrawal by Subject|3|||
105784502|NCT03039686|364864344|FG002|Open Label Period|Withdrawal by Subject|1|||
105784503|NCT04854421|364864345|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
105784504|NCT04854421|364864346|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
105784505|NCT02158949|364864347|FG000|Overall Study|Withdrawal by Subject|1|||
105784506|NCT02158949|364864348|FG001|Overall Study|Withdrawal by Subject|0|||
105784507|NCT02158949|364864347|FG000|Overall Study|Lost to Follow-up|5|||
105784508|NCT02158949|364864348|FG001|Overall Study|Lost to Follow-up|11|||
105784509|NCT02322866|364864350|FG000|Overall Study|Adverse Event|6|||
105784510|NCT02322866|364864351|FG001|Overall Study|Adverse Event|11|||
105784511|NCT02322866|364864350|FG000|Overall Study|Withdrawal of Consent|16|||
105784512|NCT02322866|364864351|FG001|Overall Study|Withdrawal of Consent|25|||
105784513|NCT02322866|364864350|FG000|Overall Study|Lost to Follow-up|36|||
105784514|NCT02322866|364864351|FG001|Overall Study|Lost to Follow-up|39|||
105784515|NCT02322866|364864350|FG000|Overall Study|Protocol Violation|1|||
105784516|NCT02322866|364864351|FG001|Overall Study|Protocol Violation|0|||
105784517|NCT02322866|364864350|FG000|Overall Study|Noncompliance with Treatment|3|||
105784518|NCT02322866|364864351|FG001|Overall Study|Noncompliance with Treatment|4|||
105784519|NCT02322866|364864350|FG000|Overall Study|Lack of Efficacy|3|||
105784520|NCT02322866|364864351|FG001|Overall Study|Lack of Efficacy|1|||
105784521|NCT02322866|364864350|FG000|Overall Study|Other Miscellaneous Reasons|6|||
105784522|NCT02322866|364864351|FG001|Overall Study|Other Miscellaneous Reasons|6|||
105784523|NCT02708524|364864354|FG000|Overall Study|Adverse Event|0|||
105784524|NCT02708524|364864355|FG001|Overall Study|Adverse Event|1|||
105784525|NCT02708524|364864356|FG002|Overall Study|Adverse Event|0|||
105784526|NCT02708524|364864357|FG003|Overall Study|Adverse Event|0|||
105784527|NCT02708524|364864354|FG000|Overall Study|Lens Discomfort|1|||
105784528|NCT02708524|364864355|FG001|Overall Study|Lens Discomfort|0|||
105784529|NCT02708524|364864356|FG002|Overall Study|Lens Discomfort|1|||
105784530|NCT02708524|364864357|FG003|Overall Study|Lens Discomfort|0|||
105784531|NCT02708524|364864354|FG000|Overall Study|Lost to Follow-up|1|||
105784532|NCT02708524|364864355|FG001|Overall Study|Lost to Follow-up|1|||
105784533|NCT02708524|364864356|FG002|Overall Study|Lost to Follow-up|1|||
105784534|NCT02708524|364864357|FG003|Overall Study|Lost to Follow-up|0|||
105784535|NCT02708524|364864354|FG000|Overall Study|Protocol Violation|0|||
105784536|NCT02708524|364864355|FG001|Overall Study|Protocol Violation|1|||
105784537|NCT02708524|364864356|FG002|Overall Study|Protocol Violation|0|||
105784538|NCT02708524|364864357|FG003|Overall Study|Protocol Violation|0|||
105784539|NCT02708524|364864354|FG000|Overall Study|Withdrawal by Subject|1|||
105784540|NCT02708524|364864355|FG001|Overall Study|Withdrawal by Subject|1|||
105784541|NCT02708524|364864356|FG002|Overall Study|Withdrawal by Subject|0|||
105784542|NCT02708524|364864357|FG003|Overall Study|Withdrawal by Subject|0|||
105784543|NCT02708524|364864354|FG000|Overall Study|Dispensed incorrect study lens|0|||
105784544|NCT02708524|364864355|FG001|Overall Study|Dispensed incorrect study lens|1|||
105784545|NCT02708524|364864356|FG002|Overall Study|Dispensed incorrect study lens|1|||
105784546|NCT02708524|364864357|FG003|Overall Study|Dispensed incorrect study lens|0|||
105784547|NCT02708524|364864354|FG000|Overall Study|Did not wear lens at final visit|0|||
105784548|NCT02708524|364864355|FG001|Overall Study|Did not wear lens at final visit|1|||
105784549|NCT02708524|364864356|FG002|Overall Study|Did not wear lens at final visit|0|||
105784550|NCT02708524|364864357|FG003|Overall Study|Did not wear lens at final visit|0|||
105784551|NCT02708524|364864354|FG000|Overall Study|Subject lost study lens|1|||
105784552|NCT02708524|364864355|FG001|Overall Study|Subject lost study lens|0|||
105784553|NCT02708524|364864356|FG002|Overall Study|Subject lost study lens|0|||
105784554|NCT02708524|364864357|FG003|Overall Study|Subject lost study lens|0|||
105784555|NCT02059265|364864360|FG000|Overall Study|Ineligible|4|||
105784556|NCT00761735|364864361|FG000|Overall Study|Lost to Follow-up|6|||
105784557|NCT00761735|364864361|FG000|Overall Study|Withdrawal by Subject|6|||
105784558|NCT00761735|364864361|FG000|Overall Study|Non-compliance with protocol|1|||
105784559|NCT00761735|364864361|FG000|Overall Study|Administrative|1|||
105784560|NCT00381680|364864362|FG000|Overall Study|Adverse Event|9|||
105784561|NCT00381680|364864363|FG001|Overall Study|Adverse Event|3|||
105452996|NCT02648204|363667475|FG003|Overall Study|Lost to Follow-up|6|||
105452997|NCT02648204|363667472|FG000|Overall Study|Missing follow-up information|4|||
105784562|NCT00381680|364864362|FG000|Overall Study|Death|10|||
105784563|NCT00381680|364864363|FG001|Overall Study|Death|7|||
105784564|NCT00381680|364864362|FG000|Overall Study|Lost to Follow-up|3|||
105784565|NCT00381680|364864363|FG001|Overall Study|Lost to Follow-up|2|||
105784566|NCT00381680|364864362|FG000|Overall Study|Physician Decision|25|||
105784567|NCT00381680|364864363|FG001|Overall Study|Physician Decision|6|||
105784568|NCT00381680|364864362|FG000|Overall Study|Withdrawal by Subject|3|||
105784569|NCT00381680|364864363|FG001|Overall Study|Withdrawal by Subject|1|||
105784570|NCT00381680|364864362|FG000|Overall Study|Entry onto another COG Trial|1|||
105784571|NCT00381680|364864363|FG001|Overall Study|Entry onto another COG Trial|2|||
105784572|NCT00381680|364864362|FG000|Overall Study|Alternative Therapy|11|||
105784573|NCT00381680|364864363|FG001|Overall Study|Alternative Therapy|5|||
105784574|NCT00381680|364864362|FG000|Overall Study|Secondary Malignancy|3|||
105784575|NCT00381680|364864363|FG001|Overall Study|Secondary Malignancy|0|||
105784576|NCT00381680|364864362|FG000|Overall Study|Delay initiation|1|||
105784577|NCT00381680|364864363|FG001|Overall Study|Delay initiation|0|||
105784578|NCT00381680|364864362|FG000|Overall Study|Stem Cell Transplant|26|||
105784579|NCT00381680|364864363|FG001|Overall Study|Stem Cell Transplant|10|||
105784580|NCT00381680|364864362|FG000|Overall Study|Relapse|18|||
105784581|NCT00381680|364864363|FG001|Overall Study|Relapse|9|||
105784582|NCT00381680|364864362|FG000|Overall Study|Induction Failure|4|||
105784583|NCT00381680|364864363|FG001|Overall Study|Induction Failure|1|||
105784584|NCT00381680|364864362|FG000|Overall Study|Progression|1|||
105784585|NCT00381680|364864363|FG001|Overall Study|Progression|1|||
105784586|NCT00381680|364864362|FG000|Overall Study|Other not otherwise specified|7|||
105784587|NCT00381680|364864363|FG001|Overall Study|Other not otherwise specified|2|||
105784588|NCT00381680|364864362|FG000|Overall Study|Ineligible|3|||
105784589|NCT00381680|364864363|FG001|Overall Study|Ineligible|1|||
105784590|NCT03290131|364864364|FG000|Overall Study|Adverse Event|22|||
105784591|NCT03290131|364864365|FG001|Overall Study|Adverse Event|57|||
105784592|NCT03290131|364864366|FG002|Overall Study|Adverse Event|11|||
105784593|NCT03290131|364864364|FG000|Overall Study|Withdrawal by Subject|18|||
105784594|NCT03290131|364864365|FG001|Overall Study|Withdrawal by Subject|13|||
105784595|NCT03290131|364864366|FG002|Overall Study|Withdrawal by Subject|8|||
105784596|NCT03290131|364864364|FG000|Overall Study|MS Relapse|2|||
105784597|NCT03290131|364864365|FG001|Overall Study|MS Relapse|1|||
105784598|NCT03290131|364864366|FG002|Overall Study|MS Relapse|0|||
105784599|NCT03290131|364864364|FG000|Overall Study|Unknown reason|0|||
105784600|NCT03290131|364864365|FG001|Overall Study|Unknown reason|1|||
105784601|NCT03290131|364864366|FG002|Overall Study|Unknown reason|0|||
105784602|NCT00465101|364864367|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
105784603|NCT00465101|364864367|FG000|Overall Study|Change in health precluded follow up|4|||
105784604|NCT00465101|364864367|FG000|Overall Study|Did not meet study criteria|4|||
105784605|NCT00465101|364864367|FG000|Overall Study|Lost to Follow-up|5|||
105784606|NCT00465101|364864367|FG000|Overall Study|Other|6|||
105784607|NCT00465101|364864367|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
105784608|NCT00465101|364864367|FG000|Overall Study|Patient postponed procedure|1|||
105784609|NCT00465101|364864367|FG000|Overall Study|Site closed due to IRB expiration|1|||
105784610|NCT00465101|364864367|FG000|Overall Study|Unable to obtain IRB approval|1|||
105784611|NCT00465101|364864367|FG000|Overall Study|Death|3|||
105784612|NCT00465101|364864367|FG000|Overall Study|Withdrawal by Subject|25|||
105784613|NCT00465101|364864367|FG000|Overall Study|Physician Decision|1|||
105784614|NCT00465101|364864367|FG000|Overall Study|Withdrew consent prior to procedure|3|||
105784615|NCT00483574|364864368|FG000|Overall Study|Adverse Event|6|||
105784616|NCT00483574|364864369|FG001|Overall Study|Adverse Event|0|||
105784617|NCT00483574|364864368|FG000|Overall Study|Protocol Violation|28|||
105784618|NCT00483574|364864369|FG001|Overall Study|Protocol Violation|9|||
105784619|NCT00483574|364864368|FG000|Overall Study|Lost to Follow-up|16|||
105784620|NCT00483574|364864369|FG001|Overall Study|Lost to Follow-up|4|||
105784621|NCT00483574|364864368|FG000|Overall Study|Withdrawal by Subject|52|||
105784622|NCT00483574|364864369|FG001|Overall Study|Withdrawal by Subject|0|||
105784623|NCT02369874|364864377|FG000|Overall Study|Lost to Follow-up|2|||
105784624|NCT02369874|364864378|FG001|Overall Study|Lost to Follow-up|2|||
105784625|NCT02369874|364864379|FG002|Overall Study|Lost to Follow-up|2|||
105784626|NCT02369874|364864377|FG000|Overall Study|Withdrawal by Subject|7|||
105784627|NCT02369874|364864378|FG001|Overall Study|Withdrawal by Subject|9|||
105784628|NCT02369874|364864379|FG002|Overall Study|Withdrawal by Subject|27|||
105784629|NCT02369874|364864377|FG000|Overall Study|Miscellaneous|1|||
105784630|NCT02369874|364864378|FG001|Overall Study|Miscellaneous|1|||
105784631|NCT02369874|364864379|FG002|Overall Study|Miscellaneous|0|||
105784632|NCT02369874|364864377|FG000|Overall Study|On Treatment/Off Study|34|||
105784633|NCT02369874|364864378|FG001|Overall Study|On Treatment/Off Study|45|||
105784634|NCT02369874|364864379|FG002|Overall Study|On Treatment/Off Study|32|||
105784635|NCT01049360|364864382|FG000|Period 1|Adverse Event|0|||
105784636|NCT01049360|364864383|FG001|Period 1|Adverse Event|1|||
105784637|NCT01049360|364864384|FG002|Period 1|Adverse Event|0|||
105784638|NCT01049360|364864385|FG003|Period 1|Adverse Event|1|||
105784639|NCT01049360|364864386|FG004|Period 1|Adverse Event|0|||
105452998|NCT02648204|363667473|FG001|Overall Study|Missing follow-up information|4|||
105452999|NCT02648204|363667474|FG002|Overall Study|Missing follow-up information|4|||
105453000|NCT02648204|363667475|FG003|Overall Study|Missing follow-up information|2|||
105453001|NCT02648204|363667472|FG000|Overall Study|Death|1|||
105453002|NCT02648204|363667473|FG001|Overall Study|Death|1|||
105453003|NCT02648204|363667474|FG002|Overall Study|Death|2|||
105453004|NCT02648204|363667475|FG003|Overall Study|Death|2|||
105453005|NCT02648204|363667472|FG000|Overall Study|Adverse Event|0|||
105453006|NCT02648204|363667473|FG001|Overall Study|Adverse Event|0|||
105453007|NCT02648204|363667474|FG002|Overall Study|Adverse Event|1|||
105453008|NCT02648204|363667475|FG003|Overall Study|Adverse Event|0|||
105453009|NCT01453140|363667477|FG000|Overall Study|Adverse Event|3|||
105453010|NCT02634333|363667478|FG000|Overall Study|Completed out of Window|3|||
105453011|NCT02634333|363667479|FG001|Overall Study|Completed out of Window|2|||
105453012|NCT02634333|363667478|FG000|Overall Study|Missed Visit|5|||
105453013|NCT02634333|363667479|FG001|Overall Study|Missed Visit|2|||
105453014|NCT02634333|363667478|FG000|Overall Study|Lost to Follow-up|12|||
105453015|NCT02634333|363667479|FG001|Overall Study|Lost to Follow-up|7|||
105453016|NCT02634333|363667478|FG000|Overall Study|Withdrawal by Subject|9|||
105453017|NCT02634333|363667479|FG001|Overall Study|Withdrawal by Subject|13|||
105453018|NCT02634333|363667478|FG000|Overall Study|Death|11|||
105453019|NCT02634333|363667479|FG001|Overall Study|Death|8|||
105453020|NCT01960140|363667480|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
105453021|NCT00231777|363667481|FG000|Overall Study|Lost to Follow-up|3|||
105453022|NCT00231777|363667482|FG001|Overall Study|Lost to Follow-up|0|||
105453023|NCT00231777|363667481|FG000|Overall Study|Other|3|||
105453024|NCT00231777|363667482|FG001|Overall Study|Other|2|||
105453025|NCT04486235|363667484|FG000|Overall Study|Pregnancy|1|||
105453026|NCT04486235|363667485|FG001|Overall Study|Pregnancy|0|||
105453027|NCT04486235|363667484|FG000|Overall Study|Lost to Follow-up|1|||
105453028|NCT04486235|363667485|FG001|Overall Study|Lost to Follow-up|0|||
105453029|NCT00626275|363667486|FG000|Part A - Treatment Period 1|Adverse Event|1|||
105453030|NCT00626275|363667487|FG001|Part A - Treatment Period 1|Adverse Event|0|||
105453031|NCT00626275|363667488|FG002|Part A - Treatment Period 1|Adverse Event|0|||
105453032|NCT00626275|363667489|FG003|Part A - Treatment Period 1|Adverse Event|0|||
105453033|NCT00626275|363667490|FG004|Part A - Treatment Period 1|Adverse Event|0|||
105453034|NCT00626275|363667491|FG005|Part A - Treatment Period 1|Adverse Event|0|||
105453035|NCT00626275|363667492|FG006|Part A - Treatment Period 1|Adverse Event|0|||
105453036|NCT00626275|363667493|FG007|Part A - Treatment Period 1|Adverse Event|0|||
105453037|NCT00626275|363667486|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
105453038|NCT00626275|363667487|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
105453039|NCT00626275|363667488|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
105453040|NCT00626275|363667489|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
105453041|NCT00626275|363667490|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
105453042|NCT00626275|363667491|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
105453043|NCT00626275|363667492|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
105453044|NCT00626275|363667493|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
105453045|NCT00626275|363667486|FG000|Part B|Lost to Follow-up|0|||
105453046|NCT00626275|363667487|FG001|Part B|Lost to Follow-up|0|||
105453047|NCT00626275|363667488|FG002|Part B|Lost to Follow-up|0|||
105453048|NCT00626275|363667489|FG003|Part B|Lost to Follow-up|0|||
105453049|NCT00626275|363667490|FG004|Part B|Lost to Follow-up|0|||
105453050|NCT00626275|363667491|FG005|Part B|Lost to Follow-up|0|||
105453051|NCT00626275|363667492|FG006|Part B|Lost to Follow-up|1|||
105453052|NCT00626275|363667493|FG007|Part B|Lost to Follow-up|0|||
105453053|NCT00626275|363667486|FG000|Part B|Withdrawal by Subject|0|||
105453054|NCT00626275|363667487|FG001|Part B|Withdrawal by Subject|0|||
105453055|NCT00626275|363667488|FG002|Part B|Withdrawal by Subject|0|||
105453056|NCT00626275|363667489|FG003|Part B|Withdrawal by Subject|0|||
105453057|NCT00626275|363667490|FG004|Part B|Withdrawal by Subject|0|||
105453058|NCT00626275|363667491|FG005|Part B|Withdrawal by Subject|0|||
105453059|NCT00626275|363667492|FG006|Part B|Withdrawal by Subject|0|||
105453060|NCT00626275|363667493|FG007|Part B|Withdrawal by Subject|1|||
105453061|NCT04590014|363667494|FG000|Overall Study|Withdrawal by Subject|1|||
105453062|NCT04590014|363667495|FG001|Overall Study|Withdrawal by Subject|0|||
105453063|NCT03546621|363667496|FG000|Overall Study|Withdrawal by Subject|0|||
105453064|NCT03546621|363667497|FG001|Overall Study|Withdrawal by Subject|1|||
105453065|NCT03546621|363667498|FG002|Overall Study|Withdrawal by Subject|2|||
105453066|NCT03546621|363667499|FG003|Overall Study|Withdrawal by Subject|1|||
105453067|NCT03546621|363667496|FG000|Overall Study|Lost to Follow-up|0|||
105453068|NCT03546621|363667497|FG001|Overall Study|Lost to Follow-up|1|||
105453069|NCT03546621|363667498|FG002|Overall Study|Lost to Follow-up|0|||
105453070|NCT03546621|363667499|FG003|Overall Study|Lost to Follow-up|0|||
105453071|NCT03546621|363667496|FG000|Overall Study|Adverse Event|0|||
105453072|NCT03546621|363667497|FG001|Overall Study|Adverse Event|1|||
105453073|NCT03546621|363667498|FG002|Overall Study|Adverse Event|0|||
105453074|NCT03546621|363667499|FG003|Overall Study|Adverse Event|1|||
105453075|NCT03546621|363667496|FG000|Overall Study|Progressive disease|0|||
105453076|NCT03546621|363667497|FG001|Overall Study|Progressive disease|0|||
105784640|NCT01049360|364864387|FG005|Period 1|Adverse Event|0|||
105784641|NCT01049360|364864388|FG006|Period 1|Adverse Event|0|||
105784642|NCT01049360|364864389|FG007|Period 1|Adverse Event|1|||
105784643|NCT01049360|364864390|FG008|Period 1|Adverse Event|0|||
105784644|NCT01049360|364864391|FG009|Period 1|Adverse Event|0|||
105784645|NCT01049360|364864392|FG010|Period 1|Adverse Event|0|||
105453077|NCT03546621|363667498|FG002|Overall Study|Progressive disease|0|||
105453078|NCT03546621|363667499|FG003|Overall Study|Progressive disease|1|||
105453079|NCT00377520|363667501|FG000|Overall Study|Ineligible (Prior radiation)|1|||
105784646|NCT01049360|364864393|FG011|Period 1|Adverse Event|0|||
105784647|NCT01049360|364864394|FG012|Period 1|Adverse Event|1|||
105784648|NCT01049360|364864395|FG013|Period 1|Adverse Event|1|||
105784649|NCT01049360|364864396|FG014|Period 1|Adverse Event|0|||
105784650|NCT01049360|364864397|FG015|Period 1|Adverse Event|0|||
105784651|NCT01049360|364864398|FG016|Period 1|Adverse Event|1|||
105784652|NCT01049360|364864399|FG017|Period 1|Adverse Event|0|||
105784653|NCT01049360|364864400|FG018|Period 1|Adverse Event|1|||
105784654|NCT01049360|364864401|FG019|Period 1|Adverse Event|0|||
105784655|NCT01049360|364864382|FG000|Period 1|Did not meet inc/exc criteria|0|||
105784656|NCT01049360|364864383|FG001|Period 1|Did not meet inc/exc criteria|0|||
105784657|NCT01049360|364864384|FG002|Period 1|Did not meet inc/exc criteria|0|||
105784658|NCT01049360|364864385|FG003|Period 1|Did not meet inc/exc criteria|0|||
105784659|NCT01049360|364864386|FG004|Period 1|Did not meet inc/exc criteria|0|||
105784660|NCT01049360|364864387|FG005|Period 1|Did not meet inc/exc criteria|0|||
105784661|NCT01049360|364864388|FG006|Period 1|Did not meet inc/exc criteria|0|||
105784662|NCT01049360|364864389|FG007|Period 1|Did not meet inc/exc criteria|1|||
105784663|NCT01049360|364864390|FG008|Period 1|Did not meet inc/exc criteria|1|||
105784664|NCT01049360|364864391|FG009|Period 1|Did not meet inc/exc criteria|0|||
105784665|NCT01049360|364864392|FG010|Period 1|Did not meet inc/exc criteria|0|||
105784666|NCT01049360|364864393|FG011|Period 1|Did not meet inc/exc criteria|0|||
105784667|NCT01049360|364864394|FG012|Period 1|Did not meet inc/exc criteria|0|||
105784668|NCT01049360|364864395|FG013|Period 1|Did not meet inc/exc criteria|0|||
105784669|NCT01049360|364864396|FG014|Period 1|Did not meet inc/exc criteria|0|||
105784670|NCT01049360|364864397|FG015|Period 1|Did not meet inc/exc criteria|0|||
105784671|NCT01049360|364864398|FG016|Period 1|Did not meet inc/exc criteria|0|||
105784672|NCT01049360|364864399|FG017|Period 1|Did not meet inc/exc criteria|0|||
105784673|NCT01049360|364864400|FG018|Period 1|Did not meet inc/exc criteria|0|||
105784674|NCT01049360|364864401|FG019|Period 1|Did not meet inc/exc criteria|0|||
105784675|NCT01049360|364864382|FG000|Period 1|Withdrawal by Subject|0|||
105784676|NCT01049360|364864383|FG001|Period 1|Withdrawal by Subject|0|||
105784677|NCT01049360|364864384|FG002|Period 1|Withdrawal by Subject|0|||
105784678|NCT01049360|364864385|FG003|Period 1|Withdrawal by Subject|0|||
105784679|NCT01049360|364864386|FG004|Period 1|Withdrawal by Subject|0|||
105784680|NCT01049360|364864387|FG005|Period 1|Withdrawal by Subject|0|||
105784681|NCT01049360|364864388|FG006|Period 1|Withdrawal by Subject|0|||
105784682|NCT01049360|364864389|FG007|Period 1|Withdrawal by Subject|0|||
105784683|NCT01049360|364864390|FG008|Period 1|Withdrawal by Subject|1|||
105784684|NCT01049360|364864391|FG009|Period 1|Withdrawal by Subject|0|||
105784685|NCT01049360|364864392|FG010|Period 1|Withdrawal by Subject|1|||
105784686|NCT01049360|364864393|FG011|Period 1|Withdrawal by Subject|0|||
105784687|NCT01049360|364864394|FG012|Period 1|Withdrawal by Subject|1|||
105784688|NCT01049360|364864395|FG013|Period 1|Withdrawal by Subject|0|||
105784689|NCT01049360|364864396|FG014|Period 1|Withdrawal by Subject|0|||
105784690|NCT01049360|364864397|FG015|Period 1|Withdrawal by Subject|0|||
105453080|NCT00614380|363667506|FG000|Overall Study|Adverse Event|14|||
105784691|NCT01049360|364864398|FG016|Period 1|Withdrawal by Subject|0|||
105784692|NCT01049360|364864399|FG017|Period 1|Withdrawal by Subject|0|||
105784693|NCT01049360|364864400|FG018|Period 1|Withdrawal by Subject|0|||
105784694|NCT01049360|364864401|FG019|Period 1|Withdrawal by Subject|0|||
105784695|NCT01049360|364864382|FG000|Period 2|Protocol Violation|0|||
105784696|NCT01049360|364864383|FG001|Period 2|Protocol Violation|0|||
105784697|NCT01049360|364864384|FG002|Period 2|Protocol Violation|0|||
105784698|NCT01049360|364864385|FG003|Period 2|Protocol Violation|1|||
105784699|NCT01049360|364864386|FG004|Period 2|Protocol Violation|0|||
105784700|NCT01049360|364864387|FG005|Period 2|Protocol Violation|0|||
105784701|NCT01049360|364864388|FG006|Period 2|Protocol Violation|0|||
105784702|NCT01049360|364864389|FG007|Period 2|Protocol Violation|0|||
105784703|NCT01049360|364864390|FG008|Period 2|Protocol Violation|0|||
105784704|NCT01049360|364864391|FG009|Period 2|Protocol Violation|0|||
105784705|NCT01049360|364864392|FG010|Period 2|Protocol Violation|0|||
105784706|NCT01049360|364864393|FG011|Period 2|Protocol Violation|0|||
105784707|NCT01049360|364864394|FG012|Period 2|Protocol Violation|0|||
105453081|NCT00614380|363667507|FG001|Overall Study|Adverse Event|4|||
105453082|NCT00614380|363667508|FG002|Overall Study|Adverse Event|0|||
105453083|NCT00614380|363667509|FG003|Overall Study|Adverse Event|0|||
105336981|NCT00090220|363234762|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
105336982|NCT00090220|363234763|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
105453084|NCT00614380|363667506|FG000|Overall Study|Lost to Follow-up|6|||
105453085|NCT00614380|363667507|FG001|Overall Study|Lost to Follow-up|1|||
105453086|NCT00614380|363667508|FG002|Overall Study|Lost to Follow-up|0|||
105784708|NCT01049360|364864395|FG013|Period 2|Protocol Violation|0|||
105784709|NCT01049360|364864396|FG014|Period 2|Protocol Violation|1|||
105784710|NCT01049360|364864397|FG015|Period 2|Protocol Violation|1|||
105784711|NCT01049360|364864398|FG016|Period 2|Protocol Violation|0|||
105784712|NCT01049360|364864399|FG017|Period 2|Protocol Violation|0|||
105784713|NCT01049360|364864400|FG018|Period 2|Protocol Violation|0|||
105784714|NCT01049360|364864401|FG019|Period 2|Protocol Violation|0|||
105784715|NCT01049360|364864382|FG000|Period 2|Adverse Event|0|||
105784716|NCT01049360|364864383|FG001|Period 2|Adverse Event|1|||
105784717|NCT01049360|364864384|FG002|Period 2|Adverse Event|0|||
105784718|NCT01049360|364864385|FG003|Period 2|Adverse Event|0|||
105784719|NCT01049360|364864386|FG004|Period 2|Adverse Event|0|||
105784720|NCT01049360|364864387|FG005|Period 2|Adverse Event|0|||
105784721|NCT01049360|364864388|FG006|Period 2|Adverse Event|0|||
105784722|NCT01049360|364864389|FG007|Period 2|Adverse Event|0|||
105784723|NCT01049360|364864390|FG008|Period 2|Adverse Event|1|||
105784724|NCT01049360|364864391|FG009|Period 2|Adverse Event|0|||
105784725|NCT01049360|364864392|FG010|Period 2|Adverse Event|0|||
105784726|NCT01049360|364864393|FG011|Period 2|Adverse Event|0|||
105784727|NCT01049360|364864394|FG012|Period 2|Adverse Event|0|||
105784728|NCT01049360|364864395|FG013|Period 2|Adverse Event|0|||
105784729|NCT01049360|364864396|FG014|Period 2|Adverse Event|0|||
105784730|NCT01049360|364864397|FG015|Period 2|Adverse Event|0|||
105784731|NCT01049360|364864398|FG016|Period 2|Adverse Event|0|||
105784732|NCT01049360|364864399|FG017|Period 2|Adverse Event|0|||
105784733|NCT01049360|364864400|FG018|Period 2|Adverse Event|0|||
105784734|NCT01049360|364864401|FG019|Period 2|Adverse Event|1|||
105784735|NCT01049360|364864382|FG000|Period 2|Withdrawal by Subject|0|||
105784736|NCT01049360|364864383|FG001|Period 2|Withdrawal by Subject|0|||
105784737|NCT01049360|364864384|FG002|Period 2|Withdrawal by Subject|0|||
105784738|NCT01049360|364864385|FG003|Period 2|Withdrawal by Subject|1|||
105784739|NCT01049360|364864386|FG004|Period 2|Withdrawal by Subject|0|||
105784740|NCT01049360|364864387|FG005|Period 2|Withdrawal by Subject|0|||
105784741|NCT01049360|364864388|FG006|Period 2|Withdrawal by Subject|0|||
105784742|NCT01049360|364864389|FG007|Period 2|Withdrawal by Subject|0|||
105784743|NCT01049360|364864390|FG008|Period 2|Withdrawal by Subject|0|||
105784744|NCT01049360|364864391|FG009|Period 2|Withdrawal by Subject|0|||
105784745|NCT01049360|364864392|FG010|Period 2|Withdrawal by Subject|0|||
105784746|NCT01049360|364864393|FG011|Period 2|Withdrawal by Subject|0|||
105784747|NCT01049360|364864394|FG012|Period 2|Withdrawal by Subject|0|||
105784748|NCT01049360|364864395|FG013|Period 2|Withdrawal by Subject|0|||
105784749|NCT01049360|364864396|FG014|Period 2|Withdrawal by Subject|1|||
105784750|NCT01049360|364864397|FG015|Period 2|Withdrawal by Subject|0|||
105784751|NCT01049360|364864398|FG016|Period 2|Withdrawal by Subject|0|||
105784752|NCT01049360|364864399|FG017|Period 2|Withdrawal by Subject|0|||
105784753|NCT01049360|364864400|FG018|Period 2|Withdrawal by Subject|0|||
105784754|NCT01049360|364864401|FG019|Period 2|Withdrawal by Subject|1|||
105784755|NCT01049360|364864382|FG000|Period 2|Lack of Efficacy|0|||
105784756|NCT01049360|364864383|FG001|Period 2|Lack of Efficacy|0|||
105784757|NCT01049360|364864384|FG002|Period 2|Lack of Efficacy|0|||
105784758|NCT01049360|364864385|FG003|Period 2|Lack of Efficacy|0|||
105784759|NCT01049360|364864386|FG004|Period 2|Lack of Efficacy|0|||
105784760|NCT01049360|364864387|FG005|Period 2|Lack of Efficacy|1|||
105784761|NCT01049360|364864388|FG006|Period 2|Lack of Efficacy|0|||
105784762|NCT01049360|364864389|FG007|Period 2|Lack of Efficacy|0|||
105784763|NCT01049360|364864390|FG008|Period 2|Lack of Efficacy|0|||
105784764|NCT01049360|364864391|FG009|Period 2|Lack of Efficacy|0|||
105784765|NCT01049360|364864392|FG010|Period 2|Lack of Efficacy|0|||
105784766|NCT01049360|364864393|FG011|Period 2|Lack of Efficacy|0|||
105784767|NCT01049360|364864394|FG012|Period 2|Lack of Efficacy|0|||
105784768|NCT01049360|364864395|FG013|Period 2|Lack of Efficacy|0|||
105784769|NCT01049360|364864396|FG014|Period 2|Lack of Efficacy|0|||
105784770|NCT01049360|364864397|FG015|Period 2|Lack of Efficacy|0|||
105784771|NCT01049360|364864398|FG016|Period 2|Lack of Efficacy|0|||
105784772|NCT01049360|364864399|FG017|Period 2|Lack of Efficacy|0|||
105784773|NCT01049360|364864400|FG018|Period 2|Lack of Efficacy|0|||
105784774|NCT01049360|364864401|FG019|Period 2|Lack of Efficacy|0|||
105784775|NCT01049360|364864382|FG000|Period 4|Protocol Violation|0|||
105784776|NCT01049360|364864383|FG001|Period 4|Protocol Violation|0|||
105784777|NCT01049360|364864384|FG002|Period 4|Protocol Violation|0|||
105784778|NCT01049360|364864385|FG003|Period 4|Protocol Violation|0|||
105784779|NCT01049360|364864386|FG004|Period 4|Protocol Violation|0|||
105784780|NCT01049360|364864387|FG005|Period 4|Protocol Violation|0|||
105784781|NCT01049360|364864388|FG006|Period 4|Protocol Violation|0|||
105784782|NCT01049360|364864389|FG007|Period 4|Protocol Violation|0|||
105784783|NCT01049360|364864390|FG008|Period 4|Protocol Violation|0|||
105784784|NCT01049360|364864391|FG009|Period 4|Protocol Violation|0|||
105784785|NCT01049360|364864392|FG010|Period 4|Protocol Violation|0|||
105784786|NCT01049360|364864393|FG011|Period 4|Protocol Violation|0|||
105784787|NCT01049360|364864394|FG012|Period 4|Protocol Violation|0|||
105784788|NCT01049360|364864395|FG013|Period 4|Protocol Violation|0|||
105453087|NCT00614380|363667509|FG003|Overall Study|Lost to Follow-up|0|||
105453088|NCT00614380|363667506|FG000|Overall Study|Non compliant with the protocol|12|||
105453089|NCT00614380|363667507|FG001|Overall Study|Non compliant with the protocol|2|||
105453090|NCT00614380|363667508|FG002|Overall Study|Non compliant with the protocol|1|||
105453091|NCT00614380|363667509|FG003|Overall Study|Non compliant with the protocol|2|||
105453092|NCT00614380|363667506|FG000|Overall Study|Consent withdrawn|3|||
105453093|NCT00614380|363667507|FG001|Overall Study|Consent withdrawn|1|||
105453094|NCT00614380|363667508|FG002|Overall Study|Consent withdrawn|0|||
105453095|NCT00614380|363667509|FG003|Overall Study|Consent withdrawn|0|||
105453096|NCT01290523|363667514|FG000|Overall Study|Death|3|||
105453097|NCT03071263|363667515|FG000|Overall Study|Adverse Event|1|||
105453098|NCT03071263|363667516|FG001|Overall Study|Adverse Event|3|||
105453099|NCT03071263|363667515|FG000|Overall Study|Withdrawal by Subject|1|||
105784789|NCT01049360|364864396|FG014|Period 4|Protocol Violation|0|||
105784790|NCT01049360|364864397|FG015|Period 4|Protocol Violation|0|||
105784791|NCT01049360|364864398|FG016|Period 4|Protocol Violation|0|||
105784792|NCT01049360|364864399|FG017|Period 4|Protocol Violation|1|||
105784793|NCT01049360|364864400|FG018|Period 4|Protocol Violation|0|||
105784794|NCT01049360|364864401|FG019|Period 4|Protocol Violation|0|||
105784795|NCT01049360|364864382|FG000|Period 4|Withdrawal by Subject|0|||
105784796|NCT01049360|364864383|FG001|Period 4|Withdrawal by Subject|0|||
105784797|NCT01049360|364864384|FG002|Period 4|Withdrawal by Subject|0|||
105784798|NCT01049360|364864385|FG003|Period 4|Withdrawal by Subject|1|||
105784799|NCT01049360|364864386|FG004|Period 4|Withdrawal by Subject|0|||
105784800|NCT01049360|364864387|FG005|Period 4|Withdrawal by Subject|0|||
105784801|NCT01049360|364864388|FG006|Period 4|Withdrawal by Subject|0|||
105784802|NCT01049360|364864389|FG007|Period 4|Withdrawal by Subject|0|||
105784803|NCT01049360|364864390|FG008|Period 4|Withdrawal by Subject|0|||
105784804|NCT01049360|364864391|FG009|Period 4|Withdrawal by Subject|0|||
105784805|NCT01049360|364864392|FG010|Period 4|Withdrawal by Subject|0|||
105784806|NCT01049360|364864393|FG011|Period 4|Withdrawal by Subject|0|||
105784807|NCT01049360|364864394|FG012|Period 4|Withdrawal by Subject|0|||
105784808|NCT01049360|364864395|FG013|Period 4|Withdrawal by Subject|0|||
105784809|NCT01049360|364864396|FG014|Period 4|Withdrawal by Subject|0|||
105784810|NCT01049360|364864397|FG015|Period 4|Withdrawal by Subject|0|||
105784811|NCT01049360|364864398|FG016|Period 4|Withdrawal by Subject|0|||
105784812|NCT01049360|364864399|FG017|Period 4|Withdrawal by Subject|0|||
105784813|NCT01049360|364864400|FG018|Period 4|Withdrawal by Subject|0|||
105784814|NCT01049360|364864401|FG019|Period 4|Withdrawal by Subject|0|||
105784815|NCT00429026|364864402|FG000|Overall Study|Inevaluable for response.|40|||
105784816|NCT00920582|364864403|FG000|Overall Study|Lost to Follow-up|5|||
105784817|NCT00920582|364864404|FG001|Overall Study|Lost to Follow-up|1|||
105784818|NCT00920582|364864405|FG002|Overall Study|Lost to Follow-up|2|||
105784819|NCT00920582|364864406|FG003|Overall Study|Lost to Follow-up|0|||
105784820|NCT00920582|364864403|FG000|Overall Study|Withdrawal by Subject|5|||
105784821|NCT00920582|364864404|FG001|Overall Study|Withdrawal by Subject|4|||
105784822|NCT00920582|364864405|FG002|Overall Study|Withdrawal by Subject|6|||
105784823|NCT00920582|364864406|FG003|Overall Study|Withdrawal by Subject|3|||
105784824|NCT00920582|364864403|FG000|Overall Study|Protocol Violation|1|||
105784825|NCT00920582|364864404|FG001|Overall Study|Protocol Violation|0|||
105784826|NCT00920582|364864405|FG002|Overall Study|Protocol Violation|0|||
105784827|NCT00920582|364864406|FG003|Overall Study|Protocol Violation|0|||
105784828|NCT00920582|364864403|FG000|Overall Study|Other|2|||
105784829|NCT00920582|364864404|FG001|Overall Study|Other|1|||
105784830|NCT00920582|364864405|FG002|Overall Study|Other|3|||
105784831|NCT00920582|364864406|FG003|Overall Study|Other|2|||
105784832|NCT01012765|364864410|FG000|Treatment Period 1|Adverse Event|1|||
105784833|NCT01012765|364864411|FG001|Treatment Period 1|Adverse Event|0|||
105784834|NCT01012765|364864412|FG002|Treatment Period 1|Adverse Event|1|||
105784835|NCT01012765|364864413|FG003|Treatment Period 1|Adverse Event|0|||
105784836|NCT01012765|364864414|FG004|Treatment Period 1|Adverse Event|0|||
105784837|NCT01012765|364864415|FG005|Treatment Period 1|Adverse Event|0|||
105784838|NCT01012765|364864410|FG000|Treatment Period 1|Withdrawal by Subject|2|||
105784839|NCT01012765|364864411|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105784840|NCT01012765|364864412|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105784841|NCT01012765|364864413|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105784842|NCT01012765|364864414|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105784843|NCT01012765|364864415|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105784844|NCT01012765|364864410|FG000|Treatment Period 1|Administrative problems|0|||
105784845|NCT01012765|364864411|FG001|Treatment Period 1|Administrative problems|0|||
105784846|NCT01012765|364864412|FG002|Treatment Period 1|Administrative problems|1|||
105784847|NCT01012765|364864413|FG003|Treatment Period 1|Administrative problems|1|||
105784848|NCT01012765|364864414|FG004|Treatment Period 1|Administrative problems|1|||
105784849|NCT01012765|364864415|FG005|Treatment Period 1|Administrative problems|0|||
105784850|NCT01012765|364864410|FG000|Treatment Period 1|Protocol Violation|0|||
105784851|NCT01012765|364864411|FG001|Treatment Period 1|Protocol Violation|0|||
105784852|NCT01012765|364864412|FG002|Treatment Period 1|Protocol Violation|0|||
105784853|NCT01012765|364864413|FG003|Treatment Period 1|Protocol Violation|2|||
105784854|NCT01012765|364864414|FG004|Treatment Period 1|Protocol Violation|1|||
105784855|NCT01012765|364864415|FG005|Treatment Period 1|Protocol Violation|0|||
105784856|NCT01012765|364864410|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
105784857|NCT01012765|364864411|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
105784858|NCT01012765|364864412|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
105784859|NCT01012765|364864413|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
105784860|NCT01012765|364864414|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
105784861|NCT01012765|364864415|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
105784862|NCT01012765|364864410|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105784863|NCT01012765|364864411|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105336983|NCT00090220|363234764|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
105453100|NCT03071263|363667516|FG001|Overall Study|Withdrawal by Subject|3|||
105453101|NCT03071263|363667515|FG000|Overall Study|Physician Decision|1|||
105453102|NCT03071263|363667516|FG001|Overall Study|Physician Decision|0|||
105453103|NCT03071263|363667515|FG000|Overall Study|Participant moved to another city|0|||
105453104|NCT03071263|363667516|FG001|Overall Study|Participant moved to another city|1|||
105453105|NCT00525512|363667517|FG000|Double-Blind Phase|Adverse Event|48|||
105453106|NCT00525512|363667518|FG001|Double-Blind Phase|Adverse Event|28|||
105453107|NCT00525512|363667519|FG002|Double-Blind Phase|Adverse Event|0|||
105453108|NCT00525512|363667520|FG003|Double-Blind Phase|Adverse Event|0|||
105453109|NCT00525512|363667517|FG000|Double-Blind Phase|Protocol Violation|3|||
105453110|NCT00525512|363667518|FG001|Double-Blind Phase|Protocol Violation|1|||
105453111|NCT00525512|363667519|FG002|Double-Blind Phase|Protocol Violation|0|||
105453112|NCT00525512|363667520|FG003|Double-Blind Phase|Protocol Violation|0|||
105453113|NCT00525512|363667517|FG000|Double-Blind Phase|Lost to Follow-up|3|||
105453114|NCT00525512|363667518|FG001|Double-Blind Phase|Lost to Follow-up|7|||
105453115|NCT00525512|363667519|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105453116|NCT00525512|363667520|FG003|Double-Blind Phase|Lost to Follow-up|0|||
105453117|NCT00525512|363667517|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
105453118|NCT00525512|363667518|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
105453119|NCT00525512|363667519|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
105453120|NCT00525512|363667520|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
105453121|NCT00525512|363667517|FG000|Double-Blind Phase|Lack of Efficacy|13|||
105453122|NCT00525512|363667518|FG001|Double-Blind Phase|Lack of Efficacy|5|||
105453123|NCT00525512|363667519|FG002|Double-Blind Phase|Lack of Efficacy|0|||
105453124|NCT00525512|363667520|FG003|Double-Blind Phase|Lack of Efficacy|0|||
105453125|NCT00525512|363667517|FG000|Double-Blind Phase|Other reason (not specified)|12|||
105453126|NCT00525512|363667518|FG001|Double-Blind Phase|Other reason (not specified)|13|||
105453127|NCT00525512|363667519|FG002|Double-Blind Phase|Other reason (not specified)|0|||
105453128|NCT00525512|363667520|FG003|Double-Blind Phase|Other reason (not specified)|0|||
105453129|NCT00525512|363667517|FG000|Open-Label Phase|Adverse Event|0|||
105453130|NCT00525512|363667518|FG001|Open-Label Phase|Adverse Event|0|||
105453131|NCT00525512|363667519|FG002|Open-Label Phase|Adverse Event|1|||
105453132|NCT00525512|363667520|FG003|Open-Label Phase|Adverse Event|0|||
105453133|NCT00525512|363667517|FG000|Open-Label Phase|Lost to Follow-up|0|||
105453134|NCT00525512|363667518|FG001|Open-Label Phase|Lost to Follow-up|0|||
105453135|NCT00525512|363667519|FG002|Open-Label Phase|Lost to Follow-up|1|||
105453136|NCT00525512|363667520|FG003|Open-Label Phase|Lost to Follow-up|0|||
105453137|NCT00525512|363667517|FG000|Open-Label Phase|Other reason (not specified)|0|||
105453138|NCT00525512|363667518|FG001|Open-Label Phase|Other reason (not specified)|0|||
105453139|NCT00525512|363667519|FG002|Open-Label Phase|Other reason (not specified)|4|||
105453140|NCT00525512|363667520|FG003|Open-Label Phase|Other reason (not specified)|5|||
105453141|NCT00510835|363667521|FG000|Overall Study|Withdrawal by Subject|6|||
105453142|NCT00510835|363667522|FG001|Overall Study|Withdrawal by Subject|2|||
105453143|NCT00510835|363667523|FG002|Overall Study|Withdrawal by Subject|2|||
105453144|NCT00647296|363667524|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
105453145|NCT00647296|363667525|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
105453146|NCT00647296|363667526|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
105453147|NCT00647296|363667527|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
105453148|NCT00647296|363667524|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
105453149|NCT00647296|363667525|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
105453150|NCT00647296|363667526|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
105453151|NCT00647296|363667527|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
105453152|NCT00647296|363667524|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
105453153|NCT00647296|363667525|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
105453154|NCT00647296|363667526|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
105453155|NCT00647296|363667527|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
105453156|NCT00647296|363667524|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
105453157|NCT00647296|363667525|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
105453158|NCT00647296|363667526|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
105453159|NCT00647296|363667527|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
105453160|NCT00647296|363667524|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
105453161|NCT00647296|363667525|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
105453162|NCT00647296|363667526|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
105453163|NCT00647296|363667527|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
105550199|NCT00467870|364014374|FG000|Overall Study|Withdrawal by Subject|14|||
105453164|NCT00647296|363667524|FG000|Part 2: 4-week Placebo Washout|Death|3|||
105453165|NCT00647296|363667525|FG001|Part 2: 4-week Placebo Washout|Death|0|||
105453166|NCT00647296|363667526|FG002|Part 2: 4-week Placebo Washout|Death|0|||
105453167|NCT00647296|363667527|FG003|Part 2: 4-week Placebo Washout|Death|0|||
105453168|NCT00647296|363667524|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
105453169|NCT00647296|363667525|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
105453170|NCT00647296|363667526|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
105453171|NCT00647296|363667527|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
105453172|NCT00647296|363667524|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
105453173|NCT00647296|363667525|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
105453174|NCT00647296|363667526|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
105453175|NCT00647296|363667527|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
105453176|NCT00647296|363667524|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
105453177|NCT00647296|363667525|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
105453178|NCT00647296|363667526|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
105453179|NCT00647296|363667527|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
105453180|NCT00647296|363667524|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
105453181|NCT00647296|363667525|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
105453182|NCT00647296|363667526|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
105453183|NCT00647296|363667527|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
105453184|NCT00647296|363667524|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
105453185|NCT00647296|363667525|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
105453186|NCT00647296|363667526|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
105453187|NCT00647296|363667527|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
105453188|NCT01917747|363667528|FG000|Overall Study|Withdrawal by Subject|1|||
105453189|NCT01917747|363667529|FG001|Overall Study|Withdrawal by Subject|2|||
105453190|NCT01917747|363667528|FG000|Overall Study|Lost to Follow-up|18|||
105453191|NCT01917747|363667529|FG001|Overall Study|Lost to Follow-up|9|||
105453192|NCT00402168|363667530|FG000|Randomized|Lost to Follow-up|1|||
105453193|NCT00402168|363667531|FG001|Randomized|Lost to Follow-up|0|||
105453194|NCT00402168|363667530|FG000|Randomized|Withdrawal by Subject|0|||
105453195|NCT00402168|363667531|FG001|Randomized|Withdrawal by Subject|1|||
105453196|NCT00402168|363667530|FG000|Treatment (up to 12 Months)|Death|0|||
105453197|NCT00402168|363667531|FG001|Treatment (up to 12 Months)|Death|1|||
105453198|NCT00402168|363667530|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
105453199|NCT00402168|363667531|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
105453200|NCT00402168|363667530|FG000|Treatment (up to 12 Months)|non-specified|0|||
105453201|NCT00402168|363667531|FG001|Treatment (up to 12 Months)|non-specified|1|||
105453202|NCT00402168|363667530|FG000|Long Term (LT)|Adverse Event|1|||
105453203|NCT00402168|363667531|FG001|Long Term (LT)|Adverse Event|5|||
105453204|NCT00402168|363667530|FG000|Long Term (LT)|Withdrawal by Subject|4|||
105453205|NCT00402168|363667531|FG001|Long Term (LT)|Withdrawal by Subject|7|||
105453206|NCT00402168|363667530|FG000|Long Term (LT)|Pregnancy|0|||
105453207|NCT00402168|363667531|FG001|Long Term (LT)|Pregnancy|1|||
105453208|NCT00402168|363667530|FG000|Long Term (LT)|Lost to Follow-up|1|||
105453209|NCT00402168|363667531|FG001|Long Term (LT)|Lost to Follow-up|0|||
105453210|NCT00402168|363667530|FG000|Long Term (LT)|Death|4|||
105453211|NCT00402168|363667531|FG001|Long Term (LT)|Death|0|||
105453212|NCT00402168|363667530|FG000|Long Term (LT)|Lack of Efficacy|0|||
105453213|NCT00402168|363667531|FG001|Long Term (LT)|Lack of Efficacy|2|||
105453214|NCT00402168|363667530|FG000|Long Term (LT)|non-specified|1|||
105453215|NCT00402168|363667531|FG001|Long Term (LT)|non-specified|2|||
105453216|NCT00402168|363667530|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
105453217|NCT00402168|363667531|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
105453218|NCT00402168|363667530|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
105453219|NCT00402168|363667531|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
105453220|NCT02922725|363667532|FG000|Overall Study|Withdrawal by Subject|1|||
105453221|NCT02922725|363667533|FG001|Overall Study|Withdrawal by Subject|0|||
105453222|NCT02922725|363667534|FG002|Overall Study|Withdrawal by Subject|0|||
105453223|NCT01300234|363667535|FG000|Overall Study|Adverse Event|1|||
105453224|NCT01300234|363667536|FG001|Overall Study|Adverse Event|1|||
105453225|NCT01300234|363667535|FG000|Overall Study|Protocol Violation|2|||
105453226|NCT01300234|363667536|FG001|Overall Study|Protocol Violation|3|||
105453227|NCT01300234|363667535|FG000|Overall Study|Withdrawal by Subject|5|||
105453228|NCT01300234|363667536|FG001|Overall Study|Withdrawal by Subject|9|||
105453229|NCT01300234|363667535|FG000|Overall Study|Lost to Follow-up|14|||
105453230|NCT01300234|363667536|FG001|Overall Study|Lost to Follow-up|12|||
105453231|NCT01300234|363667535|FG000|Overall Study|Pregnancy|2|||
105453232|NCT01300234|363667536|FG001|Overall Study|Pregnancy|1|||
105453233|NCT01300234|363667535|FG000|Overall Study|Participant reached stopping critera|2|||
105453234|NCT01300234|363667536|FG001|Overall Study|Participant reached stopping critera|0|||
105453235|NCT01300234|363667535|FG000|Overall Study|Participant stopped medication|1|||
105453236|NCT01300234|363667536|FG001|Overall Study|Participant stopped medication|1|||
105453237|NCT01300234|363667535|FG000|Overall Study|Participant refused return to hospital|1|||
105453238|NCT01300234|363667536|FG001|Overall Study|Participant refused return to hospital|0|||
105453239|NCT03253679|363667537|FG000|Overall Study|Screen Failure|1|||
105453240|NCT01774799|363667538|FG000|Overall Study|Lost to Follow-up|1|||
105453241|NCT01774799|363667539|FG001|Overall Study|Lost to Follow-up|1|||
105453242|NCT01774799|363667540|FG002|Overall Study|Lost to Follow-up|0|||
105453243|NCT01774799|363667541|FG003|Overall Study|Lost to Follow-up|0|||
105453244|NCT00584415|363667542|FG000|Overall Study|Adverse Event|7|||
105453245|NCT02370420|363667543|FG000|Overall Study|Physician Decision|3|||
105453246|NCT02370420|363667544|FG001|Overall Study|Physician Decision|3|||
105453247|NCT02370420|363667543|FG000|Overall Study|Lost to Follow-up|11|||
105453248|NCT02370420|363667544|FG001|Overall Study|Lost to Follow-up|9|||
105453249|NCT03980730|363667545|FG000|Overall Study|Study Terminated by Sponsor|0|||
105453250|NCT03980730|363667546|FG001|Overall Study|Study Terminated by Sponsor|3|||
105453251|NCT03980730|363667545|FG000|Overall Study|Adverse Event|2|||
105453252|NCT03980730|363667546|FG001|Overall Study|Adverse Event|0|||
105453253|NCT03980730|363667545|FG000|Overall Study|Sponsor Request|0|||
105453254|NCT03980730|363667546|FG001|Overall Study|Sponsor Request|1|||
105453255|NCT05051579|363667547|FG000|Overall Study|Withdrawal by Subject|3|||
105453256|NCT05051579|363667548|FG001|Overall Study|Withdrawal by Subject|5|||
105453257|NCT05051579|363667549|FG002|Overall Study|Withdrawal by Subject|2|||
105453258|NCT05051579|363667550|FG003|Overall Study|Withdrawal by Subject|1|||
105453259|NCT05051579|363667551|FG004|Overall Study|Withdrawal by Subject|4|||
105453260|NCT05051579|363667552|FG005|Overall Study|Withdrawal by Subject|0|||
105453261|NCT05051579|363667553|FG006|Overall Study|Withdrawal by Subject|4|||
105453262|NCT05051579|363667547|FG000|Overall Study|Lost to Follow-up|1|||
105453263|NCT05051579|363667548|FG001|Overall Study|Lost to Follow-up|0|||
105453264|NCT05051579|363667549|FG002|Overall Study|Lost to Follow-up|0|||
105453265|NCT05051579|363667550|FG003|Overall Study|Lost to Follow-up|0|||
105453266|NCT05051579|363667551|FG004|Overall Study|Lost to Follow-up|1|||
105453267|NCT05051579|363667552|FG005|Overall Study|Lost to Follow-up|0|||
105453268|NCT05051579|363667553|FG006|Overall Study|Lost to Follow-up|1|||
105453269|NCT05051579|363667547|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
105453270|NCT05051579|363667548|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
105453271|NCT05051579|363667549|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
105453272|NCT05051579|363667550|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
105453273|NCT05051579|363667551|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
105453274|NCT05051579|363667552|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
105453275|NCT05051579|363667553|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
105453276|NCT05051579|363667547|FG000|Overall Study|Adverse Event|2|||
105453277|NCT05051579|363667548|FG001|Overall Study|Adverse Event|1|||
105453278|NCT05051579|363667549|FG002|Overall Study|Adverse Event|0|||
105453279|NCT05051579|363667550|FG003|Overall Study|Adverse Event|4|||
105453280|NCT05051579|363667551|FG004|Overall Study|Adverse Event|1|||
105453281|NCT05051579|363667552|FG005|Overall Study|Adverse Event|2|||
105453282|NCT05051579|363667553|FG006|Overall Study|Adverse Event|0|||
105453283|NCT05051579|363667547|FG000|Overall Study|Inadvertent Enrollment|0|||
105453284|NCT05051579|363667548|FG001|Overall Study|Inadvertent Enrollment|0|||
105453285|NCT05051579|363667549|FG002|Overall Study|Inadvertent Enrollment|0|||
105453286|NCT05051579|363667550|FG003|Overall Study|Inadvertent Enrollment|0|||
105453287|NCT05051579|363667551|FG004|Overall Study|Inadvertent Enrollment|0|||
105453288|NCT05051579|363667552|FG005|Overall Study|Inadvertent Enrollment|0|||
105453289|NCT05051579|363667553|FG006|Overall Study|Inadvertent Enrollment|1|||
105453290|NCT05051579|363667547|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
105453291|NCT05051579|363667548|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
105453292|NCT05051579|363667549|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
105453293|NCT05051579|363667550|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
105453294|NCT05051579|363667551|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
105453295|NCT05051579|363667552|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
105453296|NCT05051579|363667553|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
105453297|NCT05051579|363667547|FG000|Overall Study|Sponsor Decision|0|||
105453298|NCT05051579|363667548|FG001|Overall Study|Sponsor Decision|0|||
105550200|NCT00467870|364014375|FG001|Overall Study|Withdrawal by Subject|21|||
105453299|NCT05051579|363667549|FG002|Overall Study|Sponsor Decision|0|||
105453300|NCT05051579|363667550|FG003|Overall Study|Sponsor Decision|0|||
105453301|NCT05051579|363667551|FG004|Overall Study|Sponsor Decision|1|||
105453302|NCT05051579|363667552|FG005|Overall Study|Sponsor Decision|0|||
105453303|NCT05051579|363667553|FG006|Overall Study|Sponsor Decision|0|||
105453304|NCT05051579|363667547|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
105453305|NCT05051579|363667548|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
105453306|NCT05051579|363667549|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
105453307|NCT05051579|363667550|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
105453308|NCT05051579|363667551|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
105453309|NCT05051579|363667552|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
105453310|NCT05051579|363667553|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
105453311|NCT00141102|363667554|FG000|Overall Study|Adverse Event|233|||
105453312|NCT00141102|363667555|FG001|Overall Study|Adverse Event|305|||
105453313|NCT00141102|363667554|FG000|Overall Study|Laboratory Abnormality|9|||
105453314|NCT00141102|363667555|FG001|Overall Study|Laboratory Abnormality|33|||
105453315|NCT00141102|363667554|FG000|Overall Study|Lack of Efficacy|21|||
105453316|NCT00141102|363667555|FG001|Overall Study|Lack of Efficacy|26|||
105453317|NCT00141102|363667554|FG000|Overall Study|Lost to Follow-up|29|||
105453318|NCT00141102|363667555|FG001|Overall Study|Lost to Follow-up|32|||
105453319|NCT00141102|363667554|FG000|Overall Study|Other|87|||
105453320|NCT00141102|363667555|FG001|Overall Study|Other|76|||
105453321|NCT00141102|363667554|FG000|Overall Study|Withdrawal by Subject|112|||
105453322|NCT00141102|363667555|FG001|Overall Study|Withdrawal by Subject|142|||
105453323|NCT00141102|363667554|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
105453324|NCT00141102|363667555|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
105453325|NCT00141102|363667554|FG000|Overall Study|Death|2|||
105453326|NCT00141102|363667555|FG001|Overall Study|Death|2|||
105453327|NCT00990106|363667556|FG000|Overall Study|"too busy to continue"|1|||
105453328|NCT00990106|363667557|FG001|Overall Study|"too busy to continue"|2|||
105453329|NCT00990106|363667556|FG000|Overall Study|Lost to Follow-up|1|||
105453330|NCT00990106|363667557|FG001|Overall Study|Lost to Follow-up|3|||
105453331|NCT00990106|363667556|FG000|Overall Study|Withdrawal by Subject|2|||
105453332|NCT00990106|363667557|FG001|Overall Study|Withdrawal by Subject|1|||
105453333|NCT00990106|363667556|FG000|Overall Study|opted for open label prazosin|1|||
105453334|NCT00990106|363667557|FG001|Overall Study|opted for open label prazosin|1|||
105453335|NCT00990106|363667556|FG000|Overall Study|relocation/deployment|4|||
105453336|NCT00990106|363667557|FG001|Overall Study|relocation/deployment|1|||
105453337|NCT00990106|363667556|FG000|Overall Study|started exclusionary medication|0|||
105453338|NCT00990106|363667557|FG001|Overall Study|started exclusionary medication|1|||
105453339|NCT00990106|363667556|FG000|Overall Study|planned major surgery|0|||
105453340|NCT00990106|363667557|FG001|Overall Study|planned major surgery|1|||
105453341|NCT00990106|363667556|FG000|Overall Study|scheduling conflicts|0|||
105453342|NCT00990106|363667557|FG001|Overall Study|scheduling conflicts|2|||
105453343|NCT02926638|363667558|FG000|Overall Study|Progression|2|||
105453344|NCT02926638|363667559|FG001|Overall Study|Progression|5|||
105453345|NCT02926638|363667558|FG000|Overall Study|Ineligible|1|||
105453346|NCT02926638|363667559|FG001|Overall Study|Ineligible|0|||
105453347|NCT02926638|363667558|FG000|Overall Study|Not protocol specified|1|||
105453348|NCT02926638|363667559|FG001|Overall Study|Not protocol specified|0|||
105453349|NCT01928927|363667560|FG000|Overall Study|Lost to Follow-up|1|||
105453350|NCT01928927|363667561|FG001|Overall Study|Lost to Follow-up|0|||
105453351|NCT01928927|363667560|FG000|Overall Study|Withdrawal by Subject|1|||
105453352|NCT01928927|363667561|FG001|Overall Study|Withdrawal by Subject|1|||
105453353|NCT00445549|363669391|FG000|Overall Study|progressive disease|12|||
105453354|NCT00383552|363669397|FG000|Overall Study|Adverse Event|7|||
105453355|NCT00383552|363669398|FG001|Overall Study|Adverse Event|6|||
105453356|NCT00383552|363669399|FG002|Overall Study|Adverse Event|9|||
105453357|NCT00383552|363669400|FG003|Overall Study|Adverse Event|6|||
105453358|NCT00383552|363669397|FG000|Overall Study|Lack of Efficacy|4|||
105453359|NCT00383552|363669398|FG001|Overall Study|Lack of Efficacy|13|||
105453360|NCT00383552|363669399|FG002|Overall Study|Lack of Efficacy|29|||
105453361|NCT00383552|363669400|FG003|Overall Study|Lack of Efficacy|42|||
105453362|NCT00383552|363669397|FG000|Overall Study|Lost to Follow-up|0|||
105453363|NCT00383552|363669398|FG001|Overall Study|Lost to Follow-up|1|||
105453364|NCT00383552|363669399|FG002|Overall Study|Lost to Follow-up|5|||
105453365|NCT00383552|363669400|FG003|Overall Study|Lost to Follow-up|1|||
105453366|NCT00383552|363669397|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
105453367|NCT00383552|363669398|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
105453368|NCT00383552|363669399|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
105453369|NCT00383552|363669400|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
105453370|NCT00383552|363669397|FG000|Overall Study|Did not wish to continue (related)|1|||
105453371|NCT00383552|363669398|FG001|Overall Study|Did not wish to continue (related)|0|||
105453372|NCT00383552|363669399|FG002|Overall Study|Did not wish to continue (related)|2|||
105453373|NCT00383552|363669400|FG003|Overall Study|Did not wish to continue (related)|3|||
105453374|NCT00383552|363669397|FG000|Overall Study|Noncompliance with the protocol|11|||
105453375|NCT00383552|363669398|FG001|Overall Study|Noncompliance with the protocol|6|||
105453376|NCT00383552|363669399|FG002|Overall Study|Noncompliance with the protocol|8|||
105453377|NCT00383552|363669400|FG003|Overall Study|Noncompliance with the protocol|10|||
105453378|NCT00383552|363669397|FG000|Overall Study|Did not meet protocol eligibility|8|||
105453379|NCT00383552|363669398|FG001|Overall Study|Did not meet protocol eligibility|6|||
105453380|NCT00383552|363669399|FG002|Overall Study|Did not meet protocol eligibility|2|||
105453381|NCT00383552|363669400|FG003|Overall Study|Did not meet protocol eligibility|3|||
105453382|NCT00383552|363669397|FG000|Overall Study|Administrative|1|||
105453383|NCT00383552|363669398|FG001|Overall Study|Administrative|0|||
105453384|NCT00383552|363669399|FG002|Overall Study|Administrative|1|||
105453385|NCT00383552|363669400|FG003|Overall Study|Administrative|1|||
105453386|NCT00280917|363669401|FG000|Overall Study|Adverse Event|1|||
105453387|NCT00280917|363669402|FG001|Overall Study|Adverse Event|1|||
105453388|NCT00280917|363669403|FG002|Overall Study|Adverse Event|4|||
105453389|NCT00280917|363669404|FG003|Overall Study|Adverse Event|1|||
105453390|NCT00280917|363669401|FG000|Overall Study|Change Therapy|1|||
105453391|NCT00280917|363669402|FG001|Overall Study|Change Therapy|2|||
105453392|NCT00280917|363669403|FG002|Overall Study|Change Therapy|0|||
105453393|NCT00280917|363669404|FG003|Overall Study|Change Therapy|0|||
105453394|NCT00280917|363669401|FG000|Overall Study|Withdrawal by Subject|0|||
105453395|NCT00280917|363669402|FG001|Overall Study|Withdrawal by Subject|2|||
105453396|NCT00280917|363669403|FG002|Overall Study|Withdrawal by Subject|0|||
105453397|NCT00280917|363669404|FG003|Overall Study|Withdrawal by Subject|1|||
105453398|NCT00280917|363669401|FG000|Overall Study|Noncompliance|0|||
105453399|NCT00280917|363669402|FG001|Overall Study|Noncompliance|1|||
105453400|NCT00280917|363669403|FG002|Overall Study|Noncompliance|2|||
105453401|NCT00280917|363669404|FG003|Overall Study|Noncompliance|0|||
105453402|NCT03096834|363669405|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
105453403|NCT03096834|363669406|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
105453404|NCT03096834|363669407|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
105453405|NCT03096834|363669408|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
105453406|NCT03096834|363669405|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
105453407|NCT03096834|363669406|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
105453408|NCT03096834|363669407|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
105453409|NCT03096834|363669408|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
105453410|NCT03096834|363669405|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
105453411|NCT03096834|363669406|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
105453412|NCT03096834|363669407|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
105453413|NCT03096834|363669408|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
105453414|NCT03096834|363669405|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
105453415|NCT03096834|363669406|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
105453416|NCT03096834|363669407|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
105453417|NCT03096834|363669408|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
105453418|NCT03096834|363669405|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
105453419|NCT03096834|363669406|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
105453420|NCT03096834|363669407|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
105453421|NCT03096834|363669408|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
105453422|NCT03096834|363669405|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
105453423|NCT03096834|363669406|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
105453424|NCT03096834|363669407|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
105453425|NCT03096834|363669408|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
105453426|NCT03096834|363669405|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
105453427|NCT03096834|363669406|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
105453428|NCT03096834|363669407|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
105453429|NCT03096834|363669408|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
105453430|NCT03096834|363669405|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
105453431|NCT03096834|363669406|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
105453432|NCT03096834|363669407|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
105453433|NCT03096834|363669408|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
105453434|NCT03096834|363669405|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
105453435|NCT03096834|363669406|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
105453436|NCT03096834|363669407|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
105453437|NCT03096834|363669408|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
105453438|NCT03096834|363669405|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
105453439|NCT03096834|363669406|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
105453440|NCT03096834|363669407|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
105453441|NCT03096834|363669408|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
105453442|NCT03096834|363669405|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
105453443|NCT03096834|363669406|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
105453444|NCT03096834|363669407|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
105453445|NCT03096834|363669408|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
105453446|NCT03096834|363669405|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
105453447|NCT03096834|363669406|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
105453448|NCT03096834|363669407|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
105453449|NCT03096834|363669408|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
105453450|NCT02173769|363669417|FG000|Overall Study|Protocol Violation|4|||
105453451|NCT02421172|363669420|FG000|Period 1|Adverse Event|1|||
105453452|NCT02421172|363669421|FG001|Period 1|Adverse Event|0|||
105453453|NCT02421172|363669422|FG002|Period 1|Adverse Event|0|||
105453454|NCT02421172|363669423|FG003|Period 1|Adverse Event|0|||
105453455|NCT02421172|363669424|FG004|Period 1|Adverse Event|0|||
105453456|NCT02421172|363669420|FG000|Period 1|Lost to Follow-up|3|||
105453457|NCT02421172|363669421|FG001|Period 1|Lost to Follow-up|1|||
105453458|NCT02421172|363669422|FG002|Period 1|Lost to Follow-up|0|||
105453459|NCT02421172|363669423|FG003|Period 1|Lost to Follow-up|0|||
105453460|NCT02421172|363669424|FG004|Period 1|Lost to Follow-up|0|||
105453461|NCT02421172|363669420|FG000|Period 1|Patient/guardian decision|0|||
105453462|NCT02421172|363669421|FG001|Period 1|Patient/guardian decision|1|||
105453463|NCT02421172|363669422|FG002|Period 1|Patient/guardian decision|0|||
105453464|NCT02421172|363669423|FG003|Period 1|Patient/guardian decision|0|||
105453465|NCT02421172|363669424|FG004|Period 1|Patient/guardian decision|0|||
105453466|NCT02421172|363669420|FG000|Period 2|Adverse Event|0|||
105453467|NCT02421172|363669421|FG001|Period 2|Adverse Event|0|||
105453468|NCT02421172|363669422|FG002|Period 2|Adverse Event|4|||
105453469|NCT02421172|363669423|FG003|Period 2|Adverse Event|0|||
105453470|NCT02421172|363669424|FG004|Period 2|Adverse Event|0|||
105453471|NCT02421172|363669420|FG000|Period 2|Lost to Follow-up|0|||
105453472|NCT02421172|363669421|FG001|Period 2|Lost to Follow-up|0|||
105453473|NCT02421172|363669422|FG002|Period 2|Lost to Follow-up|0|||
105453474|NCT02421172|363669423|FG003|Period 2|Lost to Follow-up|1|||
105453475|NCT02421172|363669424|FG004|Period 2|Lost to Follow-up|0|||
105453476|NCT02421172|363669420|FG000|Period 2|Patient/guardian decision|0|||
105453477|NCT02421172|363669421|FG001|Period 2|Patient/guardian decision|0|||
105453478|NCT02421172|363669422|FG002|Period 2|Patient/guardian decision|3|||
105453479|NCT02421172|363669423|FG003|Period 2|Patient/guardian decision|2|||
105453480|NCT02421172|363669424|FG004|Period 2|Patient/guardian decision|1|||
105453481|NCT00882440|363669425|FG000|Overall Study|Adverse Event|2|||
105453482|NCT00882440|363669426|FG001|Overall Study|Adverse Event|2|||
105453483|NCT00882440|363669427|FG002|Overall Study|Adverse Event|2|||
105453484|NCT00882440|363669428|FG003|Overall Study|Adverse Event|1|||
105453485|NCT00882440|363669429|FG004|Overall Study|Adverse Event|1|||
105453486|NCT00882440|363669430|FG005|Overall Study|Adverse Event|4|||
105453487|NCT00882440|363669431|FG006|Overall Study|Adverse Event|2|||
105453488|NCT00882440|363669425|FG000|Overall Study|Lack of Efficacy|3|||
105453489|NCT00882440|363669426|FG001|Overall Study|Lack of Efficacy|5|||
105453490|NCT00882440|363669427|FG002|Overall Study|Lack of Efficacy|2|||
105453491|NCT00882440|363669428|FG003|Overall Study|Lack of Efficacy|0|||
105453492|NCT00882440|363669429|FG004|Overall Study|Lack of Efficacy|0|||
105453493|NCT00882440|363669430|FG005|Overall Study|Lack of Efficacy|3|||
105453494|NCT00882440|363669431|FG006|Overall Study|Lack of Efficacy|0|||
105453495|NCT00882440|363669425|FG000|Overall Study|Lost to Follow-up|2|||
105453496|NCT00882440|363669426|FG001|Overall Study|Lost to Follow-up|0|||
105453497|NCT00882440|363669427|FG002|Overall Study|Lost to Follow-up|1|||
105453498|NCT00882440|363669428|FG003|Overall Study|Lost to Follow-up|1|||
105453499|NCT00882440|363669429|FG004|Overall Study|Lost to Follow-up|1|||
105453500|NCT00882440|363669430|FG005|Overall Study|Lost to Follow-up|0|||
105453501|NCT00882440|363669431|FG006|Overall Study|Lost to Follow-up|1|||
105453502|NCT00882440|363669425|FG000|Overall Study|Protocol Violation|0|||
105453503|NCT00882440|363669426|FG001|Overall Study|Protocol Violation|0|||
105453504|NCT00882440|363669427|FG002|Overall Study|Protocol Violation|1|||
105453505|NCT00882440|363669428|FG003|Overall Study|Protocol Violation|1|||
105453506|NCT00882440|363669429|FG004|Overall Study|Protocol Violation|1|||
105453507|NCT00882440|363669430|FG005|Overall Study|Protocol Violation|0|||
105453508|NCT00882440|363669431|FG006|Overall Study|Protocol Violation|0|||
105453509|NCT00882440|363669425|FG000|Overall Study|Withdrawal by Subject|2|||
105453510|NCT00882440|363669426|FG001|Overall Study|Withdrawal by Subject|1|||
105453511|NCT00882440|363669427|FG002|Overall Study|Withdrawal by Subject|1|||
105453512|NCT00882440|363669428|FG003|Overall Study|Withdrawal by Subject|0|||
105453513|NCT00882440|363669429|FG004|Overall Study|Withdrawal by Subject|6|||
105453514|NCT00882440|363669430|FG005|Overall Study|Withdrawal by Subject|0|||
105453515|NCT00882440|363669431|FG006|Overall Study|Withdrawal by Subject|1|||
105453516|NCT00882440|363669425|FG000|Overall Study|Patient Uncooperative|2|||
105453517|NCT00882440|363669426|FG001|Overall Study|Patient Uncooperative|0|||
105453518|NCT00882440|363669427|FG002|Overall Study|Patient Uncooperative|0|||
105453519|NCT00882440|363669428|FG003|Overall Study|Patient Uncooperative|0|||
105453520|NCT00882440|363669429|FG004|Overall Study|Patient Uncooperative|1|||
105453521|NCT00882440|363669430|FG005|Overall Study|Patient Uncooperative|0|||
105453522|NCT00882440|363669431|FG006|Overall Study|Patient Uncooperative|0|||
105453523|NCT00683878|363669435|FG000|Overall Study|Lack of Efficacy|3|||
105453524|NCT00683878|363669436|FG001|Overall Study|Lack of Efficacy|0|||
105453525|NCT00683878|363669437|FG002|Overall Study|Lack of Efficacy|1|||
105453526|NCT00683878|363669435|FG000|Overall Study|Adverse Event|4|||
105453527|NCT00683878|363669436|FG001|Overall Study|Adverse Event|3|||
105453528|NCT00683878|363669437|FG002|Overall Study|Adverse Event|3|||
105453529|NCT00683878|363669435|FG000|Overall Study|Withdrawal by Subject|9|||
105453530|NCT00683878|363669436|FG001|Overall Study|Withdrawal by Subject|8|||
105453531|NCT00683878|363669437|FG002|Overall Study|Withdrawal by Subject|6|||
105453532|NCT00683878|363669435|FG000|Overall Study|Death|0|||
105453533|NCT00683878|363669436|FG001|Overall Study|Death|1|||
105453534|NCT00683878|363669437|FG002|Overall Study|Death|0|||
105453535|NCT00683878|363669435|FG000|Overall Study|Lost to Follow-up|4|||
105453536|NCT00683878|363669436|FG001|Overall Study|Lost to Follow-up|2|||
105453537|NCT00683878|363669437|FG002|Overall Study|Lost to Follow-up|4|||
105453538|NCT00683878|363669435|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
105453539|NCT00683878|363669436|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
105453540|NCT00683878|363669437|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
105453541|NCT03016312|363669438|FG000|Overall Study|discontinued before the treatment started|0|||
105453542|NCT03016312|363669439|FG001|Overall Study|discontinued before the treatment started|1|||
105453543|NCT03016312|363669438|FG000|Overall Study|Withdrawal by Subject|37|||
105453544|NCT03016312|363669439|FG001|Overall Study|Withdrawal by Subject|44|||
105453545|NCT03016312|363669438|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
105453546|NCT03016312|363669439|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
105453547|NCT03016312|363669438|FG000|Overall Study|Physician Decision|1|||
105453548|NCT03016312|363669439|FG001|Overall Study|Physician Decision|3|||
105453549|NCT03016312|363669438|FG000|Overall Study|Lost to Follow-up|12|||
105453550|NCT03016312|363669439|FG001|Overall Study|Lost to Follow-up|12|||
105453551|NCT03016312|363669438|FG000|Overall Study|Death|210|||
105453552|NCT03016312|363669439|FG001|Overall Study|Death|184|||
105453553|NCT03016312|363669438|FG000|Overall Study|loss to contact|1|||
105453554|NCT03016312|363669439|FG001|Overall Study|loss to contact|0|||
105453555|NCT03016312|363669438|FG000|Overall Study|started a new cancer therapy|1|||
105453556|NCT03016312|363669439|FG001|Overall Study|started a new cancer therapy|0|||
105453557|NCT01451723|363669441|FG000|Overall Study|study halted|6|||
105453558|NCT01451723|363669442|FG001|Overall Study|study halted|5|||
105453559|NCT00833040|363669443|FG000|Overall Study|Adverse Event|0|||
105453560|NCT00833040|363669444|FG001|Overall Study|Adverse Event|0|||
105453561|NCT00833040|363669445|FG002|Overall Study|Adverse Event|0|||
105453562|NCT00833040|363669446|FG003|Overall Study|Adverse Event|0|||
105453563|NCT00833040|363669447|FG004|Overall Study|Adverse Event|0|||
105453564|NCT00833040|363669448|FG005|Overall Study|Adverse Event|1|||
105453565|NCT03489863|363669449|FG000|Overall Study|Withdrawal by Subject|0|||
105453566|NCT03489863|363669450|FG001|Overall Study|Withdrawal by Subject|1|||
105453567|NCT01005251|363669451|FG000|Overall Study|Withdrawal by Subject|2|||
105453568|NCT01005251|363669452|FG001|Overall Study|Withdrawal by Subject|5|||
105453569|NCT01005251|363669453|FG002|Overall Study|Withdrawal by Subject|3|||
105453570|NCT01005251|363669454|FG003|Overall Study|Withdrawal by Subject|4|||
105453571|NCT01005251|363669455|FG004|Overall Study|Withdrawal by Subject|9|||
105453572|NCT01005251|363669451|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
105453573|NCT01005251|363669452|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105453574|NCT01005251|363669453|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
105453575|NCT01005251|363669454|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
105453576|NCT01005251|363669455|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
105453577|NCT01005251|363669451|FG000|Overall Study|Adverse Event|2|||
105453578|NCT01005251|363669452|FG001|Overall Study|Adverse Event|6|||
105453579|NCT01005251|363669453|FG002|Overall Study|Adverse Event|8|||
105453580|NCT01005251|363669454|FG003|Overall Study|Adverse Event|5|||
105453581|NCT01005251|363669455|FG004|Overall Study|Adverse Event|4|||
105453582|NCT01005251|363669451|FG000|Overall Study|Protocol Violation|1|||
105453583|NCT01005251|363669452|FG001|Overall Study|Protocol Violation|0|||
105453584|NCT01005251|363669453|FG002|Overall Study|Protocol Violation|0|||
105453585|NCT01005251|363669454|FG003|Overall Study|Protocol Violation|0|||
105453586|NCT01005251|363669455|FG004|Overall Study|Protocol Violation|2|||
105453587|NCT01005251|363669451|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
105453588|NCT01005251|363669452|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
105453589|NCT01005251|363669453|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
105453590|NCT01005251|363669454|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
105453591|NCT01005251|363669455|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
105453592|NCT01005251|363669451|FG000|Overall Study|Lost to Follow-up|1|||
105453593|NCT01005251|363669452|FG001|Overall Study|Lost to Follow-up|4|||
105453594|NCT01005251|363669453|FG002|Overall Study|Lost to Follow-up|2|||
105453595|NCT01005251|363669454|FG003|Overall Study|Lost to Follow-up|0|||
105453596|NCT01005251|363669455|FG004|Overall Study|Lost to Follow-up|0|||
105453597|NCT01005251|363669451|FG000|Overall Study|Physician Decision|0|||
105453598|NCT01005251|363669452|FG001|Overall Study|Physician Decision|0|||
105453599|NCT01005251|363669453|FG002|Overall Study|Physician Decision|0|||
105453600|NCT01005251|363669454|FG003|Overall Study|Physician Decision|0|||
105453601|NCT01005251|363669455|FG004|Overall Study|Physician Decision|2|||
105453602|NCT01005251|363669451|FG000|Overall Study|Patient moved|1|||
105453603|NCT01005251|363669452|FG001|Overall Study|Patient moved|0|||
105453604|NCT01005251|363669453|FG002|Overall Study|Patient moved|0|||
105453605|NCT01005251|363669454|FG003|Overall Study|Patient moved|0|||
105453606|NCT01005251|363669455|FG004|Overall Study|Patient moved|0|||
105453607|NCT01005251|363669451|FG000|Overall Study|Wrong drug dispensed|0|||
105453608|NCT01005251|363669452|FG001|Overall Study|Wrong drug dispensed|1|||
105453609|NCT01005251|363669453|FG002|Overall Study|Wrong drug dispensed|0|||
105453610|NCT01005251|363669454|FG003|Overall Study|Wrong drug dispensed|0|||
105453611|NCT01005251|363669455|FG004|Overall Study|Wrong drug dispensed|0|||
105453612|NCT01005251|363669451|FG000|Overall Study|Randomized in error|0|||
105453613|NCT01005251|363669452|FG001|Overall Study|Randomized in error|0|||
105453614|NCT01005251|363669453|FG002|Overall Study|Randomized in error|1|||
105453615|NCT01005251|363669454|FG003|Overall Study|Randomized in error|1|||
105453616|NCT01005251|363669455|FG004|Overall Study|Randomized in error|0|||
105453617|NCT01005251|363669451|FG000|Overall Study|Lack of Efficacy|0|||
105453618|NCT01005251|363669452|FG001|Overall Study|Lack of Efficacy|0|||
105453619|NCT01005251|363669453|FG002|Overall Study|Lack of Efficacy|1|||
105453620|NCT01005251|363669454|FG003|Overall Study|Lack of Efficacy|1|||
105453621|NCT01005251|363669455|FG004|Overall Study|Lack of Efficacy|0|||
105453622|NCT00791388|363669457|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
105453623|NCT00791388|363669458|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
105453624|NCT00791388|363669459|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
105453625|NCT00791388|363669460|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
105453626|NCT00791388|363669461|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
105453627|NCT00791388|363669457|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
105453628|NCT00791388|363669458|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
105453629|NCT00791388|363669459|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
105453630|NCT00791388|363669460|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
105453631|NCT00791388|363669461|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
105453632|NCT00791388|363669457|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
105453633|NCT00791388|363669458|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
105453634|NCT00791388|363669459|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
105336984|NCT00090220|363234765|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
105453635|NCT00791388|363669460|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
105453636|NCT00791388|363669461|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
105453637|NCT00346216|363669462|FG000|Overall Study|Other|181|||
105453638|NCT00346216|363669463|FG001|Overall Study|Other|231|||
105453639|NCT00346216|363669464|FG002|Overall Study|Other|205|||
105453640|NCT00346216|363669462|FG000|Overall Study|No longer willing to participate|600|||
105453641|NCT00346216|363669463|FG001|Overall Study|No longer willing to participate|606|||
105453642|NCT00346216|363669464|FG002|Overall Study|No longer willing to participate|585|||
105453643|NCT00346216|363669462|FG000|Overall Study|Withdrawal by Subject|661|||
105453644|NCT00346216|363669463|FG001|Overall Study|Withdrawal by Subject|692|||
105453645|NCT00346216|363669464|FG002|Overall Study|Withdrawal by Subject|651|||
105453646|NCT00346216|363669462|FG000|Overall Study|Lost to Follow-up|611|||
105453647|NCT00346216|363669463|FG001|Overall Study|Lost to Follow-up|588|||
105453648|NCT00346216|363669464|FG002|Overall Study|Lost to Follow-up|542|||
105453649|NCT00346216|363669462|FG000|Overall Study|Physician Decision|80|||
105453650|NCT00346216|363669463|FG001|Overall Study|Physician Decision|76|||
105453651|NCT00346216|363669464|FG002|Overall Study|Physician Decision|59|||
105453652|NCT00346216|363669462|FG000|Overall Study|Does not meet entrance criteria|13|||
105453653|NCT00346216|363669463|FG001|Overall Study|Does not meet entrance criteria|10|||
105453654|NCT00346216|363669464|FG002|Overall Study|Does not meet entrance criteria|8|||
105453655|NCT00346216|363669462|FG000|Overall Study|Death|189|||
105453656|NCT00346216|363669463|FG001|Overall Study|Death|192|||
105453657|NCT00346216|363669464|FG002|Overall Study|Death|228|||
105453658|NCT00346216|363669462|FG000|Overall Study|Study terminated by sponsor|11|||
105453659|NCT00346216|363669463|FG001|Overall Study|Study terminated by sponsor|4|||
105453660|NCT00346216|363669464|FG002|Overall Study|Study terminated by sponsor|8|||
105453661|NCT00346216|363669462|FG000|Overall Study|Missing Subject Summary Status|62|||
105453662|NCT00346216|363669463|FG001|Overall Study|Missing Subject Summary Status|61|||
105453663|NCT00346216|363669464|FG002|Overall Study|Missing Subject Summary Status|62|||
105453664|NCT00657540|363669474|FG000|Overall Study|Lost to Follow-up|1|||
105453665|NCT00657540|363669475|FG001|Overall Study|Lost to Follow-up|4|||
105453666|NCT01731912|363669478|FG000|Overall Study|noncompliance|2|||
105453667|NCT02043938|363669479|FG000|Overall Study|Withdrawal by Subject|7|||
105453668|NCT02043938|363669479|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
105453669|NCT02043938|363669479|FG000|Overall Study|No show by subject|1|||
105453670|NCT02043938|363669479|FG000|Overall Study|Investigator decision|1|||
105453671|NCT01054456|363669485|FG000|Overall Study|Other|1|||
105453672|NCT03535974|363669486|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
105453673|NCT03535974|363669487|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
105453674|NCT03535974|363669488|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
105453675|NCT03535974|363669486|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
105453676|NCT03535974|363669487|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
105453677|NCT03535974|363669488|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
105453678|NCT04621448|363669489|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
105453679|NCT04621448|363669490|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
105453680|NCT04621448|363669491|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
105453681|NCT04621448|363669492|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
105453682|NCT04621448|363669489|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
105453683|NCT04621448|363669490|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
105453684|NCT04621448|363669491|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
105453685|NCT04621448|363669492|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
105453686|NCT04621448|363669489|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
105453687|NCT04621448|363669490|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
105453688|NCT04621448|363669491|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
105453689|NCT04621448|363669492|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
105453690|NCT04621448|363669489|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
105453691|NCT04621448|363669490|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
105453692|NCT04621448|363669491|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
105453693|NCT04621448|363669492|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
105453694|NCT03935126|363669493|FG000|Overall Study|Study termination by sponsor|3|||
105453695|NCT01721161|363669494|FG000|Overall Study|Adverse Event|2|||
105453696|NCT01721161|363669495|FG001|Overall Study|Adverse Event|3|||
105453697|NCT01721161|363669494|FG000|Overall Study|Lost to Follow-up|1|||
105453698|NCT01721161|363669495|FG001|Overall Study|Lost to Follow-up|2|||
105453699|NCT01721161|363669494|FG000|Overall Study|Withdrawal by Subject|1|||
105453700|NCT01721161|363669495|FG001|Overall Study|Withdrawal by Subject|1|||
105453701|NCT01721161|363669494|FG000|Overall Study|Other|0|||
105453702|NCT01721161|363669495|FG001|Overall Study|Other|1|||
105453703|NCT00399516|363669496|FG000|Overall Study|Lost to Follow-up|2|||
105453704|NCT02365649|363669501|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
105453705|NCT02365649|363669502|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
105453706|NCT02365649|363669503|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
105453707|NCT02365649|363669504|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
105453708|NCT02365649|363669505|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
105453709|NCT02365649|363669506|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
105453710|NCT02365649|363669507|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
105453711|NCT02365649|363669508|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
105453712|NCT02365649|363669509|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
105453713|NCT02365649|363669510|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
105453714|NCT02365649|363669501|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
105453715|NCT02365649|363669502|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
105453716|NCT02365649|363669503|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
105453717|NCT02365649|363669504|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
105453718|NCT02365649|363669505|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
105453719|NCT02365649|363669506|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
105453720|NCT02365649|363669507|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
105453721|NCT02365649|363669508|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
105453722|NCT02365649|363669509|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
105453723|NCT02365649|363669510|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
105453724|NCT02365649|363669501|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
105453725|NCT02365649|363669502|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
105453726|NCT02365649|363669503|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
105453727|NCT02365649|363669504|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
105453728|NCT02365649|363669505|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
105453729|NCT02365649|363669506|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
105453730|NCT02365649|363669507|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
105453731|NCT02365649|363669508|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
105453732|NCT02365649|363669509|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
105453733|NCT02365649|363669510|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
105453734|NCT02365649|363669501|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
105453735|NCT02365649|363669502|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
105453736|NCT02365649|363669503|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
105453737|NCT02365649|363669504|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
105453738|NCT02365649|363669505|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
105661746|NCT04913948|364425129|FG000|Overall Study|Withdrawal by Subject|2|||
105453739|NCT02365649|363669506|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
105453740|NCT02365649|363669507|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
105453741|NCT02365649|363669508|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
105661747|NCT04913948|364425129|FG000|Overall Study|Sample processing issues|1|||
105453742|NCT02365649|363669509|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
105453743|NCT02365649|363669510|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
105453744|NCT02365649|363669501|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
105453745|NCT02365649|363669502|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
105453746|NCT02365649|363669503|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
105453747|NCT02365649|363669504|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
105453748|NCT02365649|363669505|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
105453749|NCT02365649|363669506|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
105453750|NCT02365649|363669507|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
105453751|NCT02365649|363669508|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
105453752|NCT02365649|363669509|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
105453753|NCT02365649|363669510|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
105453754|NCT02365649|363669501|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
105453755|NCT02365649|363669502|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
105453756|NCT02365649|363669503|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
105453757|NCT02365649|363669504|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
105453758|NCT02365649|363669505|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
105453759|NCT02365649|363669506|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
105453760|NCT02365649|363669507|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
105453761|NCT02365649|363669508|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
105453762|NCT02365649|363669509|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
105453763|NCT02365649|363669510|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
105453764|NCT02365649|363669501|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
105453765|NCT02365649|363669502|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
105453766|NCT02365649|363669503|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
105453767|NCT02365649|363669504|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
105453768|NCT02365649|363669505|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
105453769|NCT02365649|363669506|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
105453770|NCT02365649|363669507|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
105453771|NCT02365649|363669508|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
105453772|NCT02365649|363669509|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
105453773|NCT02365649|363669510|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
105453774|NCT02365649|363669501|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
105453775|NCT02365649|363669502|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
105453776|NCT02365649|363669503|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
105453777|NCT02365649|363669504|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
105453778|NCT02365649|363669505|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
105453779|NCT02365649|363669506|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
105453780|NCT02365649|363669507|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
105453781|NCT02365649|363669508|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
105453782|NCT02365649|363669509|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
105453783|NCT02365649|363669510|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
105453784|NCT02365649|363669501|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
105453785|NCT02365649|363669502|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
105453786|NCT02365649|363669503|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
105453787|NCT02365649|363669504|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
105453788|NCT02365649|363669505|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
105453789|NCT02365649|363669506|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
105453790|NCT02365649|363669507|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
105336985|NCT00090220|363234766|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
105336986|NCT00090220|363234761|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
105336987|NCT00090220|363234762|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
105336988|NCT00090220|363234763|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
105453791|NCT02365649|363669508|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
105453792|NCT02365649|363669509|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
105453793|NCT02365649|363669510|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
105453794|NCT02365649|363669501|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
105453795|NCT02365649|363669502|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
105453796|NCT02365649|363669503|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
105453797|NCT02365649|363669504|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
105453798|NCT02365649|363669505|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
105453799|NCT02365649|363669506|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
105453800|NCT02365649|363669507|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
105453801|NCT02365649|363669508|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
105453802|NCT02365649|363669509|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
105453803|NCT02365649|363669510|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
105453804|NCT02365649|363669501|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
105453805|NCT02365649|363669502|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
105453806|NCT02365649|363669503|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
105453807|NCT02365649|363669504|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
105453808|NCT02365649|363669505|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
105453809|NCT02365649|363669506|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
105453810|NCT02365649|363669507|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
105453811|NCT02365649|363669508|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
105453812|NCT02365649|363669509|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
105453813|NCT02365649|363669510|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
105453814|NCT02365649|363669501|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
105453815|NCT02365649|363669502|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
105453816|NCT02365649|363669503|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
105453817|NCT02365649|363669504|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
105453818|NCT02365649|363669505|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
105453819|NCT02365649|363669506|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
105453820|NCT02365649|363669507|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
105453821|NCT02365649|363669508|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
105453822|NCT02365649|363669509|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
105453823|NCT02365649|363669510|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
105453824|NCT00689390|363669518|FG000|Overall Study|Adverse Event|19|||
105453825|NCT00689390|363669519|FG001|Overall Study|Adverse Event|0|||
105453826|NCT00689390|363669518|FG000|Overall Study|Lost to Follow-up|179|||
105453827|NCT00689390|363669519|FG001|Overall Study|Lost to Follow-up|7|||
105453828|NCT00689390|363669518|FG000|Overall Study|Withdrawal by Subject|117|||
105453829|NCT00689390|363669519|FG001|Overall Study|Withdrawal by Subject|3|||
105453830|NCT00689390|363669518|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
105453831|NCT00689390|363669519|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
105453832|NCT00689390|363669518|FG000|Overall Study|Non-Compliance With Protocol|21|||
105453833|NCT00689390|363669519|FG001|Overall Study|Non-Compliance With Protocol|0|||
105453834|NCT00689390|363669518|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
105453835|NCT00689390|363669519|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
105453836|NCT00689390|363669518|FG000|Overall Study|Administrative|37|||
105453837|NCT00689390|363669519|FG001|Overall Study|Administrative|0|||
105453838|NCT03473236|363669522|FG000|Overall Study|Withdrawal by Subject|0|||
105453839|NCT03473236|363669523|FG001|Overall Study|Withdrawal by Subject|0|||
105453840|NCT03473236|363669524|FG002|Overall Study|Withdrawal by Subject|0|||
105453841|NCT03473236|363669525|FG003|Overall Study|Withdrawal by Subject|0|||
105453842|NCT03473236|363669526|FG004|Overall Study|Withdrawal by Subject|0|||
105453843|NCT03473236|363669527|FG005|Overall Study|Withdrawal by Subject|1|||
105453844|NCT03473236|363669528|FG006|Overall Study|Withdrawal by Subject|0|||
105453845|NCT03473236|363669529|FG007|Overall Study|Withdrawal by Subject|0|||
105453846|NCT03473236|363669530|FG008|Overall Study|Withdrawal by Subject|1|||
105453847|NCT03473236|363669531|FG009|Overall Study|Withdrawal by Subject|0|||
105453848|NCT00462306|363669532|FG000|Overall Study|insufficient data|0|||
105453849|NCT00462306|363669533|FG001|Overall Study|insufficient data|13|||
105453850|NCT00871871|363669536|FG000|Part I|Adverse Event|0|||
105453851|NCT00871871|363669537|FG001|Part I|Adverse Event|2|||
105453852|NCT00871871|363669538|FG002|Part I|Adverse Event|0|||
105453853|NCT00871871|363669539|FG003|Part I|Adverse Event|0|||
105453854|NCT00871871|363669536|FG000|Part I|Withdrawal by Subject|3|||
105453855|NCT00871871|363669537|FG001|Part I|Withdrawal by Subject|0|||
105453856|NCT00871871|363669538|FG002|Part I|Withdrawal by Subject|0|||
105453857|NCT00871871|363669539|FG003|Part I|Withdrawal by Subject|0|||
105453858|NCT00871871|363669536|FG000|Part I|Laboratory abnormality|0|||
105453859|NCT00871871|363669537|FG001|Part I|Laboratory abnormality|1|||
105453860|NCT00871871|363669538|FG002|Part I|Laboratory abnormality|0|||
105453861|NCT00871871|363669539|FG003|Part I|Laboratory abnormality|0|||
105453862|NCT00871871|363669536|FG000|Part II|Lack of Efficacy|0|||
105453863|NCT00871871|363669537|FG001|Part II|Lack of Efficacy|0|||
105453864|NCT00871871|363669538|FG002|Part II|Lack of Efficacy|1|||
105453865|NCT00871871|363669539|FG003|Part II|Lack of Efficacy|0|||
105453866|NCT00871871|363669536|FG000|Part II|Withdrawal by Subject|0|||
105453867|NCT00871871|363669537|FG001|Part II|Withdrawal by Subject|0|||
105453868|NCT00871871|363669538|FG002|Part II|Withdrawal by Subject|2|||
105453869|NCT00871871|363669539|FG003|Part II|Withdrawal by Subject|1|||
105453870|NCT00871871|363669536|FG000|Part II|Adverse Event|0|||
105453871|NCT00871871|363669537|FG001|Part II|Adverse Event|0|||
105453872|NCT00871871|363669538|FG002|Part II|Adverse Event|1|||
105453873|NCT00871871|363669539|FG003|Part II|Adverse Event|2|||
105453874|NCT00871871|363669536|FG000|Part II|Protocol Violation|0|||
105453875|NCT00871871|363669537|FG001|Part II|Protocol Violation|0|||
105453876|NCT00871871|363669538|FG002|Part II|Protocol Violation|0|||
105453877|NCT00871871|363669539|FG003|Part II|Protocol Violation|1|||
105453878|NCT03883581|363669540|FG000|Overall Study|Withdrawal by Subject|4|||
105453879|NCT04612725|363669544|FG000|Overall Study|Adverse Event|1|||
105453880|NCT04612725|363669545|FG001|Overall Study|Adverse Event|3|||
105453881|NCT04612725|363669546|FG002|Overall Study|Adverse Event|1|||
105453882|NCT04612725|363669547|FG003|Overall Study|Adverse Event|0|||
105453883|NCT04612725|363669548|FG004|Overall Study|Adverse Event|1|||
105453884|NCT04612725|363669544|FG000|Overall Study|Lost to Follow-up|0|||
105453885|NCT04612725|363669545|FG001|Overall Study|Lost to Follow-up|1|||
105453886|NCT04612725|363669546|FG002|Overall Study|Lost to Follow-up|0|||
105453887|NCT04612725|363669547|FG003|Overall Study|Lost to Follow-up|0|||
105453888|NCT04612725|363669548|FG004|Overall Study|Lost to Follow-up|0|||
105453889|NCT04612725|363669544|FG000|Overall Study|Physician Decision|2|||
105453890|NCT04612725|363669545|FG001|Overall Study|Physician Decision|0|||
105453891|NCT04612725|363669546|FG002|Overall Study|Physician Decision|0|||
105453892|NCT04612725|363669547|FG003|Overall Study|Physician Decision|0|||
105453893|NCT04612725|363669548|FG004|Overall Study|Physician Decision|0|||
105453894|NCT04612725|363669544|FG000|Overall Study|Study terminated by sponsor|3|||
105453895|NCT04612725|363669545|FG001|Overall Study|Study terminated by sponsor|1|||
105453896|NCT04612725|363669546|FG002|Overall Study|Study terminated by sponsor|2|||
105453897|NCT04612725|363669547|FG003|Overall Study|Study terminated by sponsor|4|||
105453898|NCT04612725|363669548|FG004|Overall Study|Study terminated by sponsor|5|||
105453899|NCT04612725|363669544|FG000|Overall Study|Withdrawal by Subject|8|||
105453900|NCT04612725|363669545|FG001|Overall Study|Withdrawal by Subject|3|||
105453901|NCT04612725|363669546|FG002|Overall Study|Withdrawal by Subject|5|||
105453902|NCT04612725|363669547|FG003|Overall Study|Withdrawal by Subject|1|||
105453903|NCT04612725|363669548|FG004|Overall Study|Withdrawal by Subject|9|||
105453904|NCT04612725|363669544|FG000|Overall Study|Other|0|||
105453905|NCT04612725|363669545|FG001|Overall Study|Other|0|||
105453906|NCT04612725|363669546|FG002|Overall Study|Other|0|||
105453907|NCT04612725|363669547|FG003|Overall Study|Other|0|||
105453908|NCT04612725|363669548|FG004|Overall Study|Other|1|||
105453909|NCT01808196|363669549|FG000|Overall Study|Lost to Follow-up|1|||
105453910|NCT03863509|363669553|FG000|Overall Study|COVID-19 shutdown period|0|||
105453911|NCT03863509|363669554|FG001|Overall Study|COVID-19 shutdown period|4|||
105453912|NCT03863509|363669555|FG002|Overall Study|COVID-19 shutdown period|0|||
105453913|NCT03863509|363669553|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
105453914|NCT03863509|363669554|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
105453915|NCT03863509|363669555|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
105453916|NCT03863509|363669553|FG000|Overall Study|Lost to Follow-up|8|||
105453917|NCT03863509|363669554|FG001|Overall Study|Lost to Follow-up|0|||
105453918|NCT03863509|363669555|FG002|Overall Study|Lost to Follow-up|2|||
105453919|NCT03863509|363669553|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
105453920|NCT03863509|363669554|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
105453921|NCT03863509|363669555|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
105453922|NCT03863509|363669553|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
105453923|NCT03863509|363669554|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
105453924|NCT03863509|363669555|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
105453925|NCT05893862|363669558|FG000|Overall Study|Physician Decision|0|||
105453926|NCT05893862|363669559|FG001|Overall Study|Physician Decision|1|||
105453927|NCT05893862|363669560|FG002|Overall Study|Physician Decision|0|||
105453928|NCT05893862|363669561|FG003|Overall Study|Physician Decision|0|||
105453929|NCT05893862|363669562|FG004|Overall Study|Physician Decision|1|||
105453930|NCT05893862|363669563|FG005|Overall Study|Physician Decision|0|||
105453931|NCT05893862|363669558|FG000|Overall Study|Withdrawal by Subject|1|||
105453932|NCT05893862|363669559|FG001|Overall Study|Withdrawal by Subject|7|||
105453933|NCT05893862|363669560|FG002|Overall Study|Withdrawal by Subject|1|||
105453934|NCT05893862|363669561|FG003|Overall Study|Withdrawal by Subject|3|||
105453935|NCT05893862|363669562|FG004|Overall Study|Withdrawal by Subject|3|||
105453936|NCT05893862|363669563|FG005|Overall Study|Withdrawal by Subject|2|||
105453937|NCT05893862|363669558|FG000|Overall Study|Adverse Event|1|||
105453938|NCT05893862|363669559|FG001|Overall Study|Adverse Event|4|||
105453939|NCT05893862|363669560|FG002|Overall Study|Adverse Event|2|||
105453940|NCT05893862|363669561|FG003|Overall Study|Adverse Event|2|||
105453941|NCT05893862|363669562|FG004|Overall Study|Adverse Event|1|||
105453942|NCT05893862|363669563|FG005|Overall Study|Adverse Event|0|||
105453943|NCT04750642|363669566|FG000|Overall Study|Adverse Event|1|||
105453944|NCT04750642|363669567|FG001|Overall Study|Adverse Event|0|||
105453945|NCT04750642|363669566|FG000|Overall Study|Withdrawal by Subject|0|||
105453946|NCT04750642|363669567|FG001|Overall Study|Withdrawal by Subject|1|||
105453947|NCT04750642|363669566|FG000|Overall Study|Protocol Violation|0|||
105453948|NCT04750642|363669567|FG001|Overall Study|Protocol Violation|1|||
105453949|NCT02919761|363669568|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
105453950|NCT02919761|363669569|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
105453951|NCT02919761|363669570|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
105453952|NCT02919761|363669568|FG000|Part 1: Open Label|Adverse Event|1|||
105453953|NCT02919761|363669569|FG001|Part 1: Open Label|Adverse Event|0|||
105453954|NCT02919761|363669570|FG002|Part 1: Open Label|Adverse Event|0|||
105453955|NCT02919761|363669568|FG000|Part 1: Open Label|Lost to Follow-up|1|||
105453956|NCT02919761|363669569|FG001|Part 1: Open Label|Lost to Follow-up|0|||
105453957|NCT02919761|363669570|FG002|Part 1: Open Label|Lost to Follow-up|0|||
105453958|NCT02919761|363669568|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
105453959|NCT02919761|363669569|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
105453960|NCT02919761|363669570|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
105453961|NCT02919761|363669568|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
105453962|NCT02919761|363669569|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
105453963|NCT02919761|363669570|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
105453964|NCT02919761|363669568|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
105453965|NCT02919761|363669569|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
105453966|NCT02919761|363669570|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
105453967|NCT02919761|363669568|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
105453968|NCT02919761|363669569|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
105453969|NCT02919761|363669570|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
105453970|NCT02919761|363669568|FG000|Part 1: Open Label|Termination by Sponsor|1|||
105453971|NCT02919761|363669569|FG001|Part 1: Open Label|Termination by Sponsor|0|||
105453972|NCT02919761|363669570|FG002|Part 1: Open Label|Termination by Sponsor|0|||
105453973|NCT02919761|363669568|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
105453974|NCT02919761|363669569|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
105453975|NCT02919761|363669570|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
105453976|NCT02919761|363669568|FG000|Part 2: Double-blind|Adverse Event|0|||
105453977|NCT02919761|363669569|FG001|Part 2: Double-blind|Adverse Event|1|||
105453978|NCT02919761|363669570|FG002|Part 2: Double-blind|Adverse Event|0|||
105453979|NCT02919761|363669568|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
105453980|NCT02919761|363669569|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
105453981|NCT02919761|363669570|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
105453982|NCT02919761|363669568|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
105453983|NCT02919761|363669569|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
105453984|NCT02919761|363669570|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
105453985|NCT02919761|363669568|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
105453986|NCT02919761|363669569|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
105453987|NCT02919761|363669570|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
105453988|NCT02919761|363669568|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
105453989|NCT02919761|363669569|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
105453990|NCT02919761|363669570|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
105453991|NCT02919761|363669568|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
105453992|NCT02919761|363669569|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
105453993|NCT02919761|363669570|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
105453994|NCT02919761|363669568|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
105453995|NCT02919761|363669569|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
105453996|NCT02919761|363669570|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
105453997|NCT01702844|363671175|FG000|Overall Study|Adverse Event|9|||
105453998|NCT01702844|363671175|FG000|Overall Study|Death|1|||
105453999|NCT01702844|363671175|FG000|Overall Study|Withdrawal by Subject|3|||
105454000|NCT01702844|363671175|FG000|Overall Study|Physician Decision|6|||
105454001|NCT02193776|363671176|FG000|Overall Study|Consent withdrawn|1|||
105454002|NCT02193776|363671177|FG001|Overall Study|Consent withdrawn|0|||
105454003|NCT02193776|363671178|FG002|Overall Study|Consent withdrawn|0|||
105454004|NCT02193776|363671179|FG003|Overall Study|Consent withdrawn|0|||
105454005|NCT02193776|363671176|FG000|Overall Study|Failure to comply with protocol|0|||
105454006|NCT02193776|363671177|FG001|Overall Study|Failure to comply with protocol|1|||
105454007|NCT02193776|363671178|FG002|Overall Study|Failure to comply with protocol|0|||
105454008|NCT02193776|363671179|FG003|Overall Study|Failure to comply with protocol|0|||
105454009|NCT02193776|363671176|FG000|Overall Study|Investigator/Sponsor decision|1|||
105454010|NCT02193776|363671177|FG001|Overall Study|Investigator/Sponsor decision|1|||
105454011|NCT02193776|363671178|FG002|Overall Study|Investigator/Sponsor decision|0|||
105454012|NCT02193776|363671179|FG003|Overall Study|Investigator/Sponsor decision|0|||
105454013|NCT02193776|363671176|FG000|Overall Study|Death|1|||
105454014|NCT02193776|363671177|FG001|Overall Study|Death|0|||
105454015|NCT02193776|363671178|FG002|Overall Study|Death|0|||
105454016|NCT02193776|363671179|FG003|Overall Study|Death|0|||
105454017|NCT02193776|363671176|FG000|Overall Study|Adverse event/Specific toxicity|5|||
105454018|NCT02193776|363671177|FG001|Overall Study|Adverse event/Specific toxicity|5|||
105454019|NCT02193776|363671178|FG002|Overall Study|Adverse event/Specific toxicity|2|||
105454020|NCT02193776|363671179|FG003|Overall Study|Adverse event/Specific toxicity|2|||
105454021|NCT03924622|363671182|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
105454022|NCT03924622|363671183|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
105454023|NCT03924622|363671184|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
105454024|NCT03924622|363671185|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
105454025|NCT03924622|363671186|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
105454026|NCT03924622|363671187|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
105454027|NCT00962208|363671188|FG000|Overall Study|Could not achieve good vision|9|||
105454028|NCT00962208|363671189|FG001|Overall Study|Could not achieve good vision|0|||
105454029|NCT00962208|363671188|FG000|Overall Study|Contraindicated to continue study|5|||
105454030|NCT00962208|363671189|FG001|Overall Study|Contraindicated to continue study|1|||
105454031|NCT00962208|363671188|FG000|Overall Study|Lost to Follow-up|0|||
105454032|NCT00962208|363671189|FG001|Overall Study|Lost to Follow-up|9|||
105454033|NCT00768989|363671190|FG000|Prior to Week 24|Withdrawal by Subject|1|||
105454034|NCT00768989|363671191|FG001|Prior to Week 24|Withdrawal by Subject|0|||
105454035|NCT00768989|363671190|FG000|Prior to Week 24|Adverse Event|3|||
105454036|NCT00768989|363671191|FG001|Prior to Week 24|Adverse Event|0|||
105454037|NCT00768989|363671190|FG000|Prior to Week 24|Lost to Follow-up|0|||
105454038|NCT00768989|363671191|FG001|Prior to Week 24|Lost to Follow-up|1|||
105454039|NCT00768989|363671190|FG000|Prior to Week 24|Protocol Violation|0|||
105454040|NCT00768989|363671191|FG001|Prior to Week 24|Protocol Violation|2|||
105454041|NCT00768989|363671190|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
105454042|NCT00768989|363671191|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
105454043|NCT00768989|363671190|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
105454044|NCT00768989|363671191|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
105454045|NCT00768989|363671190|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
105454046|NCT00768989|363671191|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
105454047|NCT00768989|363671190|FG000|On or After Week 36|Lack of Efficacy|1|||
105454048|NCT00768989|363671191|FG001|On or After Week 36|Lack of Efficacy|0|||
105454049|NCT00768989|363671190|FG000|On or After Week 36|Adverse Event|0|||
105454050|NCT00768989|363671191|FG001|On or After Week 36|Adverse Event|1|||
105454051|NCT00768989|363671190|FG000|On or After Week 36|Lost to Follow-up|1|||
105454052|NCT00768989|363671191|FG001|On or After Week 36|Lost to Follow-up|0|||
105454053|NCT00768989|363671190|FG000|On or After Week 36|Poor Compliance|1|||
105454054|NCT00768989|363671191|FG001|On or After Week 36|Poor Compliance|0|||
105454055|NCT00768989|363671190|FG000|On or After Week 36|Protocol Violation|1|||
105454056|NCT00768989|363671191|FG001|On or After Week 36|Protocol Violation|0|||
105454057|NCT00768989|363671190|FG000|On or After Week 36|Did not attend termination visit|2|||
105454058|NCT00768989|363671191|FG001|On or After Week 36|Did not attend termination visit|0|||
105454059|NCT00768989|363671190|FG000|On or After Week 36|Sponsor Termination|45|||
105454060|NCT00768989|363671191|FG001|On or After Week 36|Sponsor Termination|26|||
105454061|NCT03431441|363671192|FG000|Overall Study|Withdrawal by Subject|2|||
105454062|NCT03431441|363671192|FG000|Overall Study|Adverse Event|2|||
105454063|NCT03431441|363671192|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
105454064|NCT02995980|363671193|FG000|Overall Study|Lost to Follow-up|14|||
105454065|NCT03040999|363671195|FG000|Overall Study|Lost to Follow-up|1|||
105454066|NCT03040999|363671196|FG001|Overall Study|Lost to Follow-up|0|||
105454067|NCT03040999|363671195|FG000|Overall Study|Withdrawal by Subject|7|||
105454068|NCT03040999|363671196|FG001|Overall Study|Withdrawal by Subject|12|||
105454069|NCT03040999|363671195|FG000|Overall Study|Death|128|||
105454070|NCT03040999|363671196|FG001|Overall Study|Death|138|||
105454071|NCT03040999|363671195|FG000|Overall Study|Participants Ongoing in Trial|266|||
105454072|NCT03040999|363671196|FG001|Overall Study|Participants Ongoing in Trial|252|||
105454073|NCT01458639|363671197|FG000|Overall Study|Physician Decision|4|||
105454074|NCT01458639|363671197|FG000|Overall Study|Equipment issue|1|||
105454075|NCT01458639|363671197|FG000|Overall Study|Inability to obtain subject blood sample|1|||
105454076|NCT00764699|363671198|FG000|Overall Study|PI left and study terminated|3|||
105454077|NCT03070392|363671199|FG000|Overall Study|Not Treated|7|||
105454078|NCT03070392|363671200|FG001|Overall Study|Not Treated|0|||
105454079|NCT03070392|363671201|FG002|Overall Study|Not Treated|3|||
105454080|NCT03070392|363671202|FG003|Overall Study|Not Treated|12|||
105454081|NCT03070392|363671199|FG000|Overall Study|Death|3|||
105454082|NCT03070392|363671200|FG001|Overall Study|Death|0|||
105454083|NCT03070392|363671201|FG002|Overall Study|Death|0|||
105454084|NCT03070392|363671202|FG003|Overall Study|Death|1|||
105454085|NCT03070392|363671199|FG000|Overall Study|Withdrawal by Subject|7|||
105454086|NCT03070392|363671200|FG001|Overall Study|Withdrawal by Subject|0|||
105454087|NCT03070392|363671201|FG002|Overall Study|Withdrawal by Subject|0|||
105454088|NCT03070392|363671202|FG003|Overall Study|Withdrawal by Subject|3|||
105454089|NCT03070392|363671199|FG000|Overall Study|Physician Decision|1|||
105454090|NCT03070392|363671200|FG001|Overall Study|Physician Decision|0|||
105454091|NCT03070392|363671201|FG002|Overall Study|Physician Decision|0|||
105454092|NCT03070392|363671202|FG003|Overall Study|Physician Decision|2|||
105454093|NCT03070392|363671199|FG000|Overall Study|Progressive Disease|154|||
105454094|NCT03070392|363671200|FG001|Overall Study|Progressive Disease|6|||
105454095|NCT03070392|363671201|FG002|Overall Study|Progressive Disease|2|||
105454096|NCT03070392|363671202|FG003|Overall Study|Progressive Disease|70|||
105454097|NCT03070392|363671199|FG000|Overall Study|Adverse Event|6|||
105454098|NCT03070392|363671200|FG001|Overall Study|Adverse Event|1|||
105454099|NCT03070392|363671201|FG002|Overall Study|Adverse Event|1|||
105454100|NCT03070392|363671202|FG003|Overall Study|Adverse Event|3|||
105454101|NCT03070392|363671199|FG000|Overall Study|Alternate anticancer treatment|1|||
105454102|NCT03070392|363671200|FG001|Overall Study|Alternate anticancer treatment|0|||
105454103|NCT03070392|363671201|FG002|Overall Study|Alternate anticancer treatment|0|||
105454104|NCT03070392|363671202|FG003|Overall Study|Alternate anticancer treatment|1|||
105454105|NCT03070392|363671199|FG000|Overall Study|Ongoing|73|||
105454106|NCT03070392|363671200|FG001|Overall Study|Ongoing|0|||
105454107|NCT03070392|363671201|FG002|Overall Study|Ongoing|0|||
105454108|NCT03070392|363671202|FG003|Overall Study|Ongoing|11|||
105454109|NCT03985761|363671204|FG000|Overall Study|Withdrawal by Subject|2|||
105454110|NCT03985761|363671205|FG001|Overall Study|Withdrawal by Subject|3|||
105454111|NCT02792231|363671210|FG000|Overall Study|Patient/guardian decision|32|||
105454112|NCT02792231|363671211|FG001|Overall Study|Patient/guardian decision|42|||
105454113|NCT02792231|363671210|FG000|Overall Study|Adverse Event|15|||
105454114|NCT02792231|363671211|FG001|Overall Study|Adverse Event|11|||
105454115|NCT02792231|363671210|FG000|Overall Study|Physician Decision|14|||
105454116|NCT02792231|363671211|FG001|Overall Study|Physician Decision|12|||
105454117|NCT02792231|363671210|FG000|Overall Study|Lack of Efficacy|7|||
105454118|NCT02792231|363671211|FG001|Overall Study|Lack of Efficacy|9|||
105454119|NCT02792231|363671210|FG000|Overall Study|Lost to Follow-up|9|||
105454120|NCT02792231|363671211|FG001|Overall Study|Lost to Follow-up|5|||
105454121|NCT02792231|363671210|FG000|Overall Study|Pregnancy|1|||
105454122|NCT02792231|363671211|FG001|Overall Study|Pregnancy|3|||
105454123|NCT02792231|363671210|FG000|Overall Study|Non-compliance with study treatment|2|||
105454124|NCT02792231|363671211|FG001|Overall Study|Non-compliance with study treatment|1|||
105454125|NCT02792231|363671210|FG000|Overall Study|Protocol deviation|2|||
105454126|NCT02792231|363671211|FG001|Overall Study|Protocol deviation|0|||
105454127|NCT02792231|363671210|FG000|Overall Study|Technical problems|0|||
105454128|NCT02792231|363671211|FG001|Overall Study|Technical problems|1|||
105454129|NCT05196828|363671212|FG000|Overall Study|Withdrawal by Subject|2|||
105454130|NCT05196828|363671213|FG001|Overall Study|Withdrawal by Subject|0|||
105454131|NCT05196828|363671212|FG000|Overall Study|Lost to Follow-up|0|||
105454132|NCT05196828|363671213|FG001|Overall Study|Lost to Follow-up|4|||
105454133|NCT05196828|363671212|FG000|Overall Study|Adverse Event|1|||
105454134|NCT05196828|363671213|FG001|Overall Study|Adverse Event|0|||
105454135|NCT00667628|363671222|FG000|Overall Study|Lost to Follow-up|1|||
105454136|NCT00667628|363671223|FG001|Overall Study|Lost to Follow-up|0|||
105454137|NCT00667628|363671222|FG000|Overall Study|Death|6|||
105454138|NCT00667628|363671223|FG001|Overall Study|Death|6|||
105454139|NCT00667628|363671222|FG000|Overall Study|Investigator Considers in Best Interest|1|||
105454140|NCT00667628|363671223|FG001|Overall Study|Investigator Considers in Best Interest|0|||
105454141|NCT00667628|363671222|FG000|Overall Study|Sponsor Terminated Study|17|||
105454142|NCT00667628|363671223|FG001|Overall Study|Sponsor Terminated Study|21|||
105454143|NCT04244253|363671224|FG000|Overall Study|Adverse Event|2|||
105454144|NCT04244253|363671225|FG001|Overall Study|Adverse Event|2|||
105454145|NCT04244253|363671226|FG002|Overall Study|Adverse Event|4|||
105454146|NCT04244253|363671224|FG000|Overall Study|Protocol Violation|1|||
105454147|NCT04244253|363671225|FG001|Overall Study|Protocol Violation|2|||
105454148|NCT04244253|363671226|FG002|Overall Study|Protocol Violation|1|||
105454149|NCT04244253|363671224|FG000|Overall Study|Withdrawal by Subject|0|||
105454150|NCT04244253|363671225|FG001|Overall Study|Withdrawal by Subject|1|||
105454151|NCT04244253|363671226|FG002|Overall Study|Withdrawal by Subject|6|||
105454152|NCT04244253|363671224|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105454153|NCT04244253|363671225|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105454154|NCT04244253|363671226|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105454155|NCT02055898|363671227|FG000|First Intervention (5 Days)|Physician Decision|2|||
105454156|NCT02055898|363671228|FG001|First Intervention (5 Days)|Physician Decision|0|||
105454157|NCT02055898|363671227|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
105454158|NCT02055898|363671228|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
105454159|NCT02611479|363671229|FG000|Baseline Enrollment|Exited study|13|||
105454160|NCT02611479|363671229|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
105454161|NCT02611479|363671229|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
105454162|NCT02611479|363671229|FG000|Data Cleaning|No baseline function or pain metrics|2|||
105454163|NCT01794000|363671230|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
105454164|NCT01794000|363671231|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
105454165|NCT01794000|363671230|FG000|Double-Blind Phase (DBP)|Death|1|||
105454166|NCT01794000|363671231|FG001|Double-Blind Phase (DBP)|Death|2|||
105454167|NCT01794000|363671230|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
105454168|NCT01794000|363671231|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
105454169|NCT01794000|363671230|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
105454170|NCT01794000|363671231|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
105454171|NCT01794000|363671230|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
105454172|NCT01794000|363671231|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
105454173|NCT01794000|363671230|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
105454174|NCT01794000|363671231|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
105454175|NCT01794000|363671230|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
105454176|NCT01794000|363671231|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
105454177|NCT01794000|363671230|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
105454178|NCT01794000|363671231|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
105454179|NCT02159066|363671235|FG000|Part I|Adverse Event|7|||
105454180|NCT02159066|363671236|FG001|Part I|Adverse Event|5|||
105454181|NCT02159066|363671237|FG002|Part I|Adverse Event|0|||
105454182|NCT02159066|363671238|FG003|Part I|Adverse Event|0|||
105454183|NCT02159066|363671239|FG004|Part I|Adverse Event|0|||
105454184|NCT02159066|363671240|FG005|Part I|Adverse Event|0|||
105454185|NCT02159066|363671235|FG000|Part I|Death|11|||
105454186|NCT02159066|363671236|FG001|Part I|Death|9|||
105454187|NCT02159066|363671237|FG002|Part I|Death|0|||
105454188|NCT02159066|363671238|FG003|Part I|Death|0|||
105454189|NCT02159066|363671239|FG004|Part I|Death|0|||
105454190|NCT02159066|363671240|FG005|Part I|Death|0|||
105454191|NCT02159066|363671235|FG000|Part I|Progressive Disease|37|||
105454192|NCT02159066|363671236|FG001|Part I|Progressive Disease|46|||
105454193|NCT02159066|363671237|FG002|Part I|Progressive Disease|0|||
105454194|NCT02159066|363671238|FG003|Part I|Progressive Disease|0|||
105454195|NCT02159066|363671239|FG004|Part I|Progressive Disease|0|||
105454196|NCT02159066|363671240|FG005|Part I|Progressive Disease|0|||
105454197|NCT02159066|363671235|FG000|Part I|New Therapy for Study Indication|5|||
105454198|NCT02159066|363671236|FG001|Part I|New Therapy for Study Indication|4|||
105454199|NCT02159066|363671237|FG002|Part I|New Therapy for Study Indication|0|||
105454200|NCT02159066|363671238|FG003|Part I|New Therapy for Study Indication|0|||
105454201|NCT02159066|363671239|FG004|Part I|New Therapy for Study Indication|0|||
105454202|NCT02159066|363671240|FG005|Part I|New Therapy for Study Indication|0|||
105454203|NCT02159066|363671235|FG000|Part I|Termination of participants from the study|3|||
105454204|NCT02159066|363671236|FG001|Part I|Termination of participants from the study|3|||
105454205|NCT02159066|363671237|FG002|Part I|Termination of participants from the study|0|||
105454206|NCT02159066|363671238|FG003|Part I|Termination of participants from the study|0|||
105454207|NCT02159066|363671239|FG004|Part I|Termination of participants from the study|0|||
105454208|NCT02159066|363671240|FG005|Part I|Termination of participants from the study|0|||
105454209|NCT02159066|363671235|FG000|Part I|Physician Decision|2|||
105454210|NCT02159066|363671236|FG001|Part I|Physician Decision|9|||
105454211|NCT02159066|363671237|FG002|Part I|Physician Decision|0|||
105454212|NCT02159066|363671238|FG003|Part I|Physician Decision|0|||
105454213|NCT02159066|363671239|FG004|Part I|Physician Decision|0|||
105454214|NCT02159066|363671240|FG005|Part I|Physician Decision|0|||
105454215|NCT02159066|363671235|FG000|Part I|Participant/Guardian Decision|9|||
105454216|NCT02159066|363671236|FG001|Part I|Participant/Guardian Decision|3|||
105454217|NCT02159066|363671237|FG002|Part I|Participant/Guardian Decision|0|||
105454218|NCT02159066|363671238|FG003|Part I|Participant/Guardian Decision|0|||
105454219|NCT02159066|363671239|FG004|Part I|Participant/Guardian Decision|0|||
105454220|NCT02159066|363671240|FG005|Part I|Participant/Guardian Decision|0|||
105454221|NCT02159066|363671235|FG000|Part I|Missing Data|1|||
105454222|NCT02159066|363671236|FG001|Part I|Missing Data|0|||
105454223|NCT02159066|363671237|FG002|Part I|Missing Data|0|||
105454224|NCT02159066|363671238|FG003|Part I|Missing Data|0|||
105454225|NCT02159066|363671239|FG004|Part I|Missing Data|0|||
105454226|NCT02159066|363671240|FG005|Part I|Missing Data|0|||
105454227|NCT02159066|363671235|FG000|Part II|Adverse Event|0|||
105454228|NCT02159066|363671236|FG001|Part II|Adverse Event|0|||
105454229|NCT02159066|363671237|FG002|Part II|Adverse Event|1|||
105454230|NCT02159066|363671238|FG003|Part II|Adverse Event|0|||
105454231|NCT02159066|363671239|FG004|Part II|Adverse Event|1|||
105454232|NCT02159066|363671240|FG005|Part II|Adverse Event|1|||
105454233|NCT02159066|363671235|FG000|Part II|Death|0|||
105454234|NCT02159066|363671236|FG001|Part II|Death|0|||
105454235|NCT02159066|363671237|FG002|Part II|Death|1|||
105454236|NCT02159066|363671238|FG003|Part II|Death|0|||
105454237|NCT02159066|363671239|FG004|Part II|Death|2|||
105454238|NCT02159066|363671240|FG005|Part II|Death|1|||
105454239|NCT02159066|363671235|FG000|Part II|Progressive Disease|0|||
105454240|NCT02159066|363671236|FG001|Part II|Progressive Disease|0|||
105454241|NCT02159066|363671237|FG002|Part II|Progressive Disease|35|||
105454242|NCT02159066|363671238|FG003|Part II|Progressive Disease|1|||
105454243|NCT02159066|363671239|FG004|Part II|Progressive Disease|7|||
105454244|NCT02159066|363671240|FG005|Part II|Progressive Disease|4|||
105454245|NCT02159066|363671235|FG000|Part II|New Therapy for Study Indication|0|||
105454246|NCT02159066|363671236|FG001|Part II|New Therapy for Study Indication|0|||
105454247|NCT02159066|363671237|FG002|Part II|New Therapy for Study Indication|0|||
105454248|NCT02159066|363671238|FG003|Part II|New Therapy for Study Indication|0|||
105454249|NCT02159066|363671239|FG004|Part II|New Therapy for Study Indication|1|||
105454250|NCT02159066|363671240|FG005|Part II|New Therapy for Study Indication|0|||
105454251|NCT02159066|363671235|FG000|Part II|Physician Decision|0|||
105454252|NCT02159066|363671236|FG001|Part II|Physician Decision|0|||
105454253|NCT02159066|363671237|FG002|Part II|Physician Decision|1|||
105454254|NCT02159066|363671238|FG003|Part II|Physician Decision|0|||
105454255|NCT02159066|363671239|FG004|Part II|Physician Decision|0|||
105454256|NCT02159066|363671240|FG005|Part II|Physician Decision|0|||
105454257|NCT02159066|363671235|FG000|Part II|Participant/Guardian Decision|0|||
105454258|NCT02159066|363671236|FG001|Part II|Participant/Guardian Decision|0|||
105454259|NCT02159066|363671237|FG002|Part II|Participant/Guardian Decision|0|||
105454260|NCT02159066|363671238|FG003|Part II|Participant/Guardian Decision|0|||
105454261|NCT02159066|363671239|FG004|Part II|Participant/Guardian Decision|2|||
105454262|NCT02159066|363671240|FG005|Part II|Participant/Guardian Decision|0|||
105454263|NCT00423657|363671241|FG000|Overall Study|Withdrew consent|10|||
105454264|NCT00423657|363671242|FG001|Overall Study|Withdrew consent|8|||
105454265|NCT00423657|363671241|FG000|Overall Study|Non-compliance|0|||
105454266|NCT00423657|363671242|FG001|Overall Study|Non-compliance|1|||
105454267|NCT00423657|363671241|FG000|Overall Study|Other|15|||
105454268|NCT00423657|363671242|FG001|Overall Study|Other|16|||
105454269|NCT00423657|363671241|FG000|Overall Study|Request of sponsor/investigator|1|||
105454270|NCT00423657|363671242|FG001|Overall Study|Request of sponsor/investigator|0|||
105454271|NCT02314052|363671243|FG000|Cycle One|Adverse Event|0|||
105454272|NCT02314052|363671244|FG001|Cycle One|Adverse Event|0|||
105454273|NCT02314052|363671245|FG002|Cycle One|Adverse Event|0|||
105454274|NCT02314052|363671246|FG003|Cycle One|Adverse Event|1|||
105454275|NCT02314052|363671247|FG004|Cycle One|Adverse Event|0|||
105454276|NCT02314052|363671248|FG005|Cycle One|Adverse Event|0|||
105454277|NCT02422498|363671253|FG000|Overall Study|Inevaluable|4|||
105454278|NCT03206216|363671254|FG000|Overall Study|Withdrawal by Subject|0|||
105454279|NCT03206216|363671255|FG001|Overall Study|Withdrawal by Subject|1|||
105454280|NCT01620060|363671256|FG000|Overall Study|Adverse Event|9|||
105454281|NCT01620060|363671256|FG000|Overall Study|Protocol Violation|1|||
105454282|NCT01620060|363671256|FG000|Overall Study|Withdrawal by Subject|1|||
105454283|NCT01620060|363671256|FG000|Overall Study|Did not comply with Study Produre|1|||
105454284|NCT01620060|363671256|FG000|Overall Study|Family emergency|1|||
105454285|NCT01620060|363671256|FG000|Overall Study|Per Sponsor Decision|2|||
105454286|NCT04551989|363671259|FG000|Overall Study|Adverse Event|4|||
105454287|NCT04551989|363671259|FG000|Overall Study|Protocol Violation|3|||
105454288|NCT04551989|363671259|FG000|Overall Study|Lost to Follow-up|1|||
105454289|NCT04551989|363671259|FG000|Overall Study|Physician Decision|3|||
105454290|NCT04698343|363671260|FG000|Overall Study|Withdrawal by Subject|6|||
105454291|NCT04698343|363671260|FG000|Overall Study|Physician Decision|2|||
105454292|NCT04698343|363671260|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
105454293|NCT04698343|363671260|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
105454294|NCT04698343|363671260|FG000|Overall Study|Personal reasons|3|||
105454295|NCT04698343|363671260|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
105454296|NCT00730158|363671261|FG000|Overall Study|Withdrawal by Subject|1|||
105454297|NCT00730158|363671262|FG001|Overall Study|Withdrawal by Subject|1|||
105454298|NCT04678115|363671263|FG000|Overall Study|Lost to Follow-up|1|||
105454299|NCT04678115|363671264|FG001|Overall Study|Lost to Follow-up|0|||
105454300|NCT04059549|363671265|FG000|Overall Study|Withdrawal by Subject|2|||
105454301|NCT04059549|363671266|FG001|Overall Study|Withdrawal by Subject|0|||
105454302|NCT02678351|363671268|FG000|Overall Study|Withdrawal by Subject|1|||
105454303|NCT00988884|363671269|FG000|Overall Study|Adverse Event|0|||
105454304|NCT00988884|363671270|FG001|Overall Study|Adverse Event|1|||
105454305|NCT00988884|363671269|FG000|Overall Study|Lost to Follow-up|20|||
105454306|NCT00988884|363671270|FG001|Overall Study|Lost to Follow-up|16|||
105454307|NCT00988884|363671269|FG000|Overall Study|Protocol Violation|0|||
105454308|NCT00988884|363671270|FG001|Overall Study|Protocol Violation|1|||
105454309|NCT00988884|363671269|FG000|Overall Study|Withdrawal by Subject|15|||
105454310|NCT00988884|363671270|FG001|Overall Study|Withdrawal by Subject|18|||
105454311|NCT01919229|363671271|FG000|Overall Study|Subject/guardian decision|0|||
105454312|NCT01919229|363671272|FG001|Overall Study|Subject/guardian decision|0|||
105454313|NCT01919229|363671273|FG002|Overall Study|Subject/guardian decision|1|||
105454314|NCT01011673|363671274|FG000|Randomized|Secondary headache|2|||
105454315|NCT01011673|363671275|FG001|Randomized|Secondary headache|1|||
105454316|NCT01011673|363671274|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
105454317|NCT01011673|363671275|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
105454318|NCT02738008|363671277|FG000|Overall Study|Study Terminated by Sponsor|1|||
105454319|NCT02738008|363671278|FG001|Overall Study|Study Terminated by Sponsor|5|||
105454320|NCT02738008|363671279|FG002|Overall Study|Study Terminated by Sponsor|3|||
105454321|NCT02738008|363671277|FG000|Overall Study|Adverse Event|0|||
105454322|NCT02738008|363671278|FG001|Overall Study|Adverse Event|1|||
105454323|NCT02738008|363671279|FG002|Overall Study|Adverse Event|2|||
105454324|NCT02552966|363671289|FG000|Overall Study|Lost to Follow-up|2|||
105454325|NCT02552966|363671289|FG000|Overall Study|Withdrawal by Subject|3|||
105454326|NCT04999839|363671292|FG000|Overall Study|Adverse Event|1|||
105454327|NCT04999839|363671293|FG001|Overall Study|Adverse Event|1|||
105454328|NCT04999839|363671294|FG002|Overall Study|Adverse Event|1|||
105454329|NCT04999839|363671295|FG003|Overall Study|Adverse Event|1|||
105454330|NCT04999839|363671296|FG004|Overall Study|Adverse Event|1|||
105454331|NCT04999839|363671292|FG000|Overall Study|Lost to Follow-up|2|||
105454332|NCT04999839|363671293|FG001|Overall Study|Lost to Follow-up|0|||
105550201|NCT00467870|364014376|FG002|Overall Study|Withdrawal by Subject|0|||
105454333|NCT04999839|363671294|FG002|Overall Study|Lost to Follow-up|2|||
105454334|NCT04999839|363671295|FG003|Overall Study|Lost to Follow-up|4|||
105454335|NCT04999839|363671296|FG004|Overall Study|Lost to Follow-up|1|||
105454336|NCT04999839|363671292|FG000|Overall Study|Withdrawal by Subject|6|||
105454337|NCT04999839|363671293|FG001|Overall Study|Withdrawal by Subject|5|||
105454338|NCT04999839|363671294|FG002|Overall Study|Withdrawal by Subject|3|||
105454339|NCT04999839|363671295|FG003|Overall Study|Withdrawal by Subject|2|||
105454340|NCT04999839|363671296|FG004|Overall Study|Withdrawal by Subject|2|||
105454341|NCT04999839|363671292|FG000|Overall Study|Lack of Efficacy|0|||
105454342|NCT04999839|363671293|FG001|Overall Study|Lack of Efficacy|1|||
105454343|NCT04999839|363671294|FG002|Overall Study|Lack of Efficacy|0|||
105454344|NCT04999839|363671295|FG003|Overall Study|Lack of Efficacy|0|||
105454345|NCT04999839|363671296|FG004|Overall Study|Lack of Efficacy|0|||
105454346|NCT04999839|363671292|FG000|Overall Study|Physician Decision|0|||
105454347|NCT04999839|363671293|FG001|Overall Study|Physician Decision|0|||
105454348|NCT04999839|363671294|FG002|Overall Study|Physician Decision|0|||
105454349|NCT04999839|363671295|FG003|Overall Study|Physician Decision|0|||
105454350|NCT04999839|363671296|FG004|Overall Study|Physician Decision|1|||
105454351|NCT04999839|363671292|FG000|Overall Study|Sponsor request|0|||
105454352|NCT04999839|363671293|FG001|Overall Study|Sponsor request|1|||
105454353|NCT04999839|363671294|FG002|Overall Study|Sponsor request|0|||
105454354|NCT04999839|363671295|FG003|Overall Study|Sponsor request|0|||
105454355|NCT04999839|363671296|FG004|Overall Study|Sponsor request|0|||
105454356|NCT04999839|363671292|FG000|Overall Study|Other|0|||
105454357|NCT04999839|363671293|FG001|Overall Study|Other|0|||
105454358|NCT04999839|363671294|FG002|Overall Study|Other|1|||
105454359|NCT04999839|363671295|FG003|Overall Study|Other|0|||
105454360|NCT04999839|363671296|FG004|Overall Study|Other|0|||
105454361|NCT01216202|363671297|FG000|Overall Study|Withdrawal by Subject|8|||
105454362|NCT01216202|363671298|FG001|Overall Study|Withdrawal by Subject|0|||
105454363|NCT01216202|363671297|FG000|Overall Study|Death|0|||
105454364|NCT01216202|363671298|FG001|Overall Study|Death|2|||
105454365|NCT01216202|363671297|FG000|Overall Study|Lost to Follow-up|14|||
105454366|NCT01216202|363671298|FG001|Overall Study|Lost to Follow-up|0|||
105454367|NCT00660192|363671303|FG000|Overall Study|Lost to Follow-up|2|||
105454368|NCT00660192|363671304|FG001|Overall Study|Lost to Follow-up|3|||
105454369|NCT00982735|363671305|FG000|Overall Study|Lost to Follow-up|6|||
105454370|NCT00982735|363671305|FG000|Overall Study|Patient ineligible for trial|224|||
105454371|NCT00539981|363671310|FG000|Overall Study|Adverse events (AE)|3|||
105454372|NCT00539981|363671311|FG001|Overall Study|Adverse events (AE)|3|||
105454373|NCT00539981|363671310|FG000|Overall Study|Lost to Follow-up|260|||
105454374|NCT00539981|363671311|FG001|Overall Study|Lost to Follow-up|251|||
105454375|NCT00539981|363671310|FG000|Overall Study|Withdrew consent|22|||
105454376|NCT00539981|363671311|FG001|Overall Study|Withdrew consent|14|||
105454377|NCT00539981|363671310|FG000|Overall Study|Death|1|||
105454378|NCT00539981|363671311|FG001|Overall Study|Death|1|||
105454379|NCT00539981|363671310|FG000|Overall Study|Other reason-unspecified|9|||
105454380|NCT00539981|363671311|FG001|Overall Study|Other reason-unspecified|13|||
105454381|NCT02675907|363671312|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
105454382|NCT02675907|363671313|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
105454383|NCT02675907|363671312|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
105454384|NCT02675907|363671313|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
105454385|NCT02675907|363671312|FG000|Study Overall|Lack of Efficacy|1|||
105454386|NCT02675907|363671313|FG001|Study Overall|Lack of Efficacy|0|||
105454387|NCT02675907|363671312|FG000|Study Overall|Withdrawal by Subject|2|||
105454388|NCT02675907|363671313|FG001|Study Overall|Withdrawal by Subject|2|||
105454389|NCT02675907|363671312|FG000|Study Overall|Lost to Follow-up|0|||
105454390|NCT02675907|363671313|FG001|Study Overall|Lost to Follow-up|2|||
105454391|NCT03416868|363671316|FG000|Overall Study|Withdrawal by Subject|2|||
105454392|NCT03416868|363671316|FG000|Overall Study|Lost to Follow-up|1|||
105454393|NCT02898454|363671319|FG000|Overall Study|Adverse Event|4|||
105454394|NCT02898454|363671320|FG001|Overall Study|Adverse Event|1|||
105454395|NCT02898454|363671321|FG002|Overall Study|Adverse Event|2|||
105454396|NCT02898454|363671319|FG000|Overall Study|Protocol Violation|1|||
105454397|NCT02898454|363671320|FG001|Overall Study|Protocol Violation|0|||
105454398|NCT02898454|363671321|FG002|Overall Study|Protocol Violation|1|||
105454399|NCT02898454|363671319|FG000|Overall Study|Lack of Efficacy|4|||
105454400|NCT02898454|363671320|FG001|Overall Study|Lack of Efficacy|1|||
105454401|NCT02898454|363671321|FG002|Overall Study|Lack of Efficacy|0|||
105454402|NCT02898454|363671319|FG000|Overall Study|Withdrawal by Subject|6|||
105454403|NCT02898454|363671320|FG001|Overall Study|Withdrawal by Subject|3|||
105454404|NCT02898454|363671321|FG002|Overall Study|Withdrawal by Subject|3|||
105454405|NCT02898454|363671319|FG000|Overall Study|Lost to Follow-up|1|||
105454406|NCT02898454|363671320|FG001|Overall Study|Lost to Follow-up|0|||
105454407|NCT02898454|363671321|FG002|Overall Study|Lost to Follow-up|0|||
105454408|NCT02898454|363671319|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
105454409|NCT02898454|363671320|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
105454410|NCT02898454|363671321|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
105454411|NCT02782949|363671329|FG000|Overall Study|Protocol Violation|1|||
105454412|NCT02782949|363671330|FG001|Overall Study|Protocol Violation|0|||
105454413|NCT02782949|363671329|FG000|Overall Study|Withdrawal by Subject|0|||
105454414|NCT02782949|363671330|FG001|Overall Study|Withdrawal by Subject|1|||
105454415|NCT02741128|363673486|FG000|Overall Study|Protocol Violation|4|||
105454416|NCT02741128|363673487|FG001|Overall Study|Protocol Violation|1|||
105454417|NCT02741128|363673486|FG000|Overall Study|Withdrawal by Subject|2|||
105454418|NCT02741128|363673487|FG001|Overall Study|Withdrawal by Subject|0|||
105454419|NCT02741128|363673486|FG000|Overall Study|Lost to Follow-up|1|||
105454420|NCT02741128|363673487|FG001|Overall Study|Lost to Follow-up|0|||
105454421|NCT01519323|363673488|FG000|Overall Study|Death|3|||
105454422|NCT01519323|363673489|FG001|Overall Study|Death|2|||
105454423|NCT01519323|363673488|FG000|Overall Study|Study terminated by sponsor|0|||
105454424|NCT01519323|363673489|FG001|Overall Study|Study terminated by sponsor|1|||
105454425|NCT00966654|363673497|FG000|Overall Study|Study was terminated,PI left institution|12|||
105454426|NCT04416204|363673498|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
105454427|NCT04416204|363673499|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
105454428|NCT04416204|363673500|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
105454429|NCT04416204|363673501|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
105454430|NCT03858049|363673502|FG000|Overall Study|Adverse Event|16|||
105454431|NCT03858049|363673503|FG001|Overall Study|Adverse Event|9|||
105454432|NCT03858049|363673502|FG000|Overall Study|Other|1|||
105454433|NCT03858049|363673503|FG001|Overall Study|Other|1|||
105454434|NCT00762359|363673506|FG000|Overall Study|Adverse Event|20|||
105454435|NCT00762359|363673507|FG001|Overall Study|Adverse Event|23|||
105454436|NCT00762359|363673506|FG000|Overall Study|Protocol Violation|21|||
105454437|NCT00762359|363673507|FG001|Overall Study|Protocol Violation|13|||
105454438|NCT00762359|363673506|FG000|Overall Study|Withdrawal by Subject|13|||
105454439|NCT00762359|363673507|FG001|Overall Study|Withdrawal by Subject|10|||
105454440|NCT00762359|363673506|FG000|Overall Study|Lack of Efficacy|0|||
105454441|NCT00762359|363673507|FG001|Overall Study|Lack of Efficacy|4|||
105454442|NCT00762359|363673506|FG000|Overall Study|Institution closed|2|||
105454443|NCT00762359|363673507|FG001|Overall Study|Institution closed|3|||
105454444|NCT00762359|363673506|FG000|Overall Study|Physician Decision|2|||
105454445|NCT00762359|363673507|FG001|Overall Study|Physician Decision|3|||
105454446|NCT00762359|363673506|FG000|Overall Study|Removal|0|||
105454447|NCT00762359|363673507|FG001|Overall Study|Removal|1|||
105454448|NCT00762359|363673506|FG000|Overall Study|Withdrew consent|1|||
105454449|NCT00762359|363673507|FG001|Overall Study|Withdrew consent|0|||
105454450|NCT02869633|363673508|FG000|Overall Study|Death|2|||
105454451|NCT02869633|363673509|FG001|Overall Study|Death|1|||
105454452|NCT02869633|363673508|FG000|Overall Study|Patient refused follow-up|1|||
105454453|NCT02869633|363673509|FG001|Overall Study|Patient refused follow-up|0|||
105454454|NCT02869633|363673508|FG000|Overall Study|Provider discretion|1|||
105454455|NCT02869633|363673509|FG001|Overall Study|Provider discretion|0|||
105454456|NCT02869633|363673508|FG000|Overall Study|Investigator decision|1|||
105454457|NCT02869633|363673509|FG001|Overall Study|Investigator decision|0|||
105454458|NCT02869633|363673508|FG000|Overall Study|Lost to Follow-up|0|||
105454459|NCT02869633|363673509|FG001|Overall Study|Lost to Follow-up|1|||
105454460|NCT02869633|363673508|FG000|Overall Study|Not eligible|6|||
105454461|NCT02869633|363673509|FG001|Overall Study|Not eligible|1|||
105454462|NCT02869633|363673508|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
105454463|NCT02869633|363673509|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
105454464|NCT02869633|363673508|FG000|Overall Study|Withdrawal by Subject|0|||
105454465|NCT02869633|363673509|FG001|Overall Study|Withdrawal by Subject|1|||
105454466|NCT03095651|363673512|FG000|Overall Study|Lost to Follow-up|1|||
105550202|NCT00467870|364014377|FG003|Overall Study|Withdrawal by Subject|9|||
105550203|NCT00467870|364014378|FG004|Overall Study|Withdrawal by Subject|10|||
105454467|NCT03095651|363673513|FG001|Overall Study|Lost to Follow-up|1|||
105454468|NCT03095651|363673514|FG002|Overall Study|Lost to Follow-up|0|||
105454469|NCT03095651|363673515|FG003|Overall Study|Lost to Follow-up|1|||
105454470|NCT03095651|363673516|FG004|Overall Study|Lost to Follow-up|0|||
105454471|NCT03095651|363673517|FG005|Overall Study|Lost to Follow-up|0|||
105454472|NCT03095651|363673518|FG006|Overall Study|Lost to Follow-up|0|||
105454473|NCT03095651|363673519|FG007|Overall Study|Lost to Follow-up|0|||
105454474|NCT03095651|363673512|FG000|Overall Study|Withdrawal by Subject|0|||
105454475|NCT03095651|363673513|FG001|Overall Study|Withdrawal by Subject|0|||
105454476|NCT03095651|363673514|FG002|Overall Study|Withdrawal by Subject|0|||
105454477|NCT03095651|363673515|FG003|Overall Study|Withdrawal by Subject|0|||
105454478|NCT03095651|363673516|FG004|Overall Study|Withdrawal by Subject|0|||
105454479|NCT03095651|363673517|FG005|Overall Study|Withdrawal by Subject|1|||
105454480|NCT03095651|363673518|FG006|Overall Study|Withdrawal by Subject|0|||
105454481|NCT03095651|363673519|FG007|Overall Study|Withdrawal by Subject|0|||
105454482|NCT00453154|363673520|FG000|Double BIind Maintenance|Adverse Event|0|||
105454483|NCT00453154|363673521|FG001|Double BIind Maintenance|Adverse Event|0|||
105454484|NCT00453154|363673522|FG002|Double BIind Maintenance|Adverse Event|3|||
105454485|NCT00453154|363673523|FG003|Double BIind Maintenance|Adverse Event|12|||
105454486|NCT00453154|363673520|FG000|Double BIind Maintenance|Death|0|||
105454487|NCT00453154|363673521|FG001|Double BIind Maintenance|Death|0|||
105454488|NCT00453154|363673522|FG002|Double BIind Maintenance|Death|2|||
105454489|NCT00453154|363673523|FG003|Double BIind Maintenance|Death|1|||
105454490|NCT00453154|363673520|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
105454491|NCT00453154|363673521|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
105454492|NCT00453154|363673522|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
105454493|NCT00453154|363673523|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
105454494|NCT00453154|363673520|FG000|Double BIind Maintenance|Progression|0|||
105454495|NCT00453154|363673521|FG001|Double BIind Maintenance|Progression|0|||
105454496|NCT00453154|363673522|FG002|Double BIind Maintenance|Progression|29|||
105454497|NCT00453154|363673523|FG003|Double BIind Maintenance|Progression|26|||
105454498|NCT00453154|363673520|FG000|Double BIind Maintenance|Medical Issues|0|||
105454499|NCT00453154|363673521|FG001|Double BIind Maintenance|Medical Issues|0|||
105454500|NCT00453154|363673522|FG002|Double BIind Maintenance|Medical Issues|3|||
105454501|NCT00453154|363673523|FG003|Double BIind Maintenance|Medical Issues|1|||
105454502|NCT00453154|363673520|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
105454503|NCT00453154|363673521|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
105454504|NCT00453154|363673522|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
105454505|NCT00453154|363673523|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
105454506|NCT01381016|363673525|FG000|Overall Study|Lost to Follow-up|1|||
105454507|NCT01381016|363673526|FG001|Overall Study|Lost to Follow-up|1|||
105454508|NCT01381016|363673525|FG000|Overall Study|Screen Failure|2|||
105454509|NCT01381016|363673526|FG001|Overall Study|Screen Failure|2|||
105454510|NCT01381016|363673525|FG000|Overall Study|Withdrawal by Subject|0|||
105454511|NCT01381016|363673526|FG001|Overall Study|Withdrawal by Subject|1|||
105454512|NCT01381016|363673525|FG000|Overall Study|Physician Decision|0|||
105454513|NCT01381016|363673526|FG001|Overall Study|Physician Decision|2|||
105454514|NCT01693029|363673527|FG000|Overall Study|Withdrawal by Subject|15|||
105454515|NCT01693029|363673528|FG001|Overall Study|Withdrawal by Subject|22|||
105454516|NCT01693029|363673527|FG000|Overall Study|Kidney transplantation|7|||
105454517|NCT01693029|363673528|FG001|Overall Study|Kidney transplantation|7|||
105454518|NCT01693029|363673527|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
105454519|NCT01693029|363673528|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
105454520|NCT01693029|363673527|FG000|Overall Study|Protocol Violation|6|||
105454521|NCT01693029|363673528|FG001|Overall Study|Protocol Violation|7|||
105454522|NCT01693029|363673527|FG000|Overall Study|Change in dialysis modality|2|||
105454523|NCT01693029|363673528|FG001|Overall Study|Change in dialysis modality|1|||
105454524|NCT01693029|363673527|FG000|Overall Study|Physician Decision|0|||
105454525|NCT01693029|363673528|FG001|Overall Study|Physician Decision|2|||
105454526|NCT01693029|363673527|FG000|Overall Study|Lost to Follow-up|0|||
105454527|NCT01693029|363673528|FG001|Overall Study|Lost to Follow-up|1|||
105454528|NCT01693029|363673527|FG000|Overall Study|Adverse Event|1|||
105454529|NCT01693029|363673528|FG001|Overall Study|Adverse Event|6|||
105454530|NCT01693029|363673527|FG000|Overall Study|Death|5|||
105454531|NCT01693029|363673528|FG001|Overall Study|Death|8|||
105454532|NCT01693029|363673527|FG000|Overall Study|Non-compliance|2|||
105454533|NCT01693029|363673528|FG001|Overall Study|Non-compliance|1|||
105454534|NCT05801991|363673529|FG000|Overall Study|Lost to Follow-up|1|||
105454535|NCT05801991|363673530|FG001|Overall Study|Lost to Follow-up|0|||
105454536|NCT06308822|363673531|FG000|Overall Study|Mutation Status Not Confirmed|17|||
105454537|NCT06308822|363673531|FG000|Overall Study|Adverse Event|1|||
105454538|NCT06308822|363673531|FG000|Overall Study|Death|5|||
105454539|NCT06308822|363673531|FG000|Overall Study|Disease progression|8|||
105454540|NCT06308822|363673531|FG000|Overall Study|Withdrawal by Subject|1|||
105454541|NCT06308822|363673531|FG000|Overall Study|Physician Decision|3|||
105454542|NCT00866177|363673541|FG000|Overall Study|Withdrawal by Subject|1|||
105454543|NCT00866177|363673541|FG000|Overall Study|Not Treated|151|||
105454544|NCT01706458|363673546|FG000|Overall Study|Physician Decision|3|||
105454545|NCT01706458|363673547|FG001|Overall Study|Physician Decision|4|||
105454546|NCT03192176|363673548|FG000|Overall Study|Adverse Event|1|||
105454547|NCT03192176|363673549|FG001|Overall Study|Adverse Event|0|||
105454548|NCT03192176|363673550|FG002|Overall Study|Adverse Event|4|||
105454549|NCT03192176|363673551|FG003|Overall Study|Adverse Event|5|||
105454550|NCT03192176|363673552|FG004|Overall Study|Adverse Event|3|||
105454551|NCT03192176|363673553|FG005|Overall Study|Adverse Event|2|||
105454552|NCT03192176|363673554|FG006|Overall Study|Adverse Event|3|||
105454553|NCT03192176|363673555|FG007|Overall Study|Adverse Event|3|||
105454554|NCT03192176|363673548|FG000|Overall Study|Lost to Follow-up|0|||
105454555|NCT03192176|363673549|FG001|Overall Study|Lost to Follow-up|0|||
105454556|NCT03192176|363673550|FG002|Overall Study|Lost to Follow-up|1|||
105454557|NCT03192176|363673551|FG003|Overall Study|Lost to Follow-up|2|||
105454558|NCT03192176|363673552|FG004|Overall Study|Lost to Follow-up|3|||
105454559|NCT03192176|363673553|FG005|Overall Study|Lost to Follow-up|1|||
105454560|NCT03192176|363673554|FG006|Overall Study|Lost to Follow-up|1|||
105454561|NCT03192176|363673555|FG007|Overall Study|Lost to Follow-up|1|||
105454562|NCT03192176|363673548|FG000|Overall Study|Physician Decision|1|||
105454563|NCT03192176|363673549|FG001|Overall Study|Physician Decision|0|||
105454564|NCT03192176|363673550|FG002|Overall Study|Physician Decision|0|||
105454565|NCT03192176|363673551|FG003|Overall Study|Physician Decision|0|||
105454566|NCT03192176|363673552|FG004|Overall Study|Physician Decision|0|||
105454567|NCT03192176|363673553|FG005|Overall Study|Physician Decision|2|||
105454568|NCT03192176|363673554|FG006|Overall Study|Physician Decision|1|||
105454569|NCT03192176|363673555|FG007|Overall Study|Physician Decision|0|||
105454570|NCT03192176|363673548|FG000|Overall Study|Protocol Deviation|1|||
105454571|NCT03192176|363673549|FG001|Overall Study|Protocol Deviation|1|||
105454572|NCT03192176|363673550|FG002|Overall Study|Protocol Deviation|0|||
105454573|NCT03192176|363673551|FG003|Overall Study|Protocol Deviation|0|||
105454574|NCT03192176|363673552|FG004|Overall Study|Protocol Deviation|2|||
105454575|NCT03192176|363673553|FG005|Overall Study|Protocol Deviation|0|||
105454576|NCT03192176|363673554|FG006|Overall Study|Protocol Deviation|0|||
105454577|NCT03192176|363673555|FG007|Overall Study|Protocol Deviation|0|||
105454578|NCT03192176|363673548|FG000|Overall Study|Withdrawal by Subject|3|||
105454579|NCT03192176|363673549|FG001|Overall Study|Withdrawal by Subject|4|||
105454580|NCT03192176|363673550|FG002|Overall Study|Withdrawal by Subject|0|||
105454581|NCT03192176|363673551|FG003|Overall Study|Withdrawal by Subject|4|||
105454582|NCT03192176|363673552|FG004|Overall Study|Withdrawal by Subject|3|||
105454583|NCT03192176|363673553|FG005|Overall Study|Withdrawal by Subject|4|||
105454584|NCT03192176|363673554|FG006|Overall Study|Withdrawal by Subject|4|||
105454585|NCT03192176|363673555|FG007|Overall Study|Withdrawal by Subject|2|||
105454586|NCT03192176|363673548|FG000|Overall Study|Miscellaneous|1|||
105454587|NCT03192176|363673549|FG001|Overall Study|Miscellaneous|0|||
105454588|NCT03192176|363673550|FG002|Overall Study|Miscellaneous|1|||
105454589|NCT03192176|363673551|FG003|Overall Study|Miscellaneous|1|||
105454590|NCT03192176|363673552|FG004|Overall Study|Miscellaneous|1|||
105454591|NCT03192176|363673553|FG005|Overall Study|Miscellaneous|2|||
105454592|NCT03192176|363673554|FG006|Overall Study|Miscellaneous|0|||
105454593|NCT03192176|363673555|FG007|Overall Study|Miscellaneous|1|||
105454594|NCT04349891|363673556|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
105454595|NCT04349891|363673557|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
105454596|NCT04349891|363673556|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
105454597|NCT04349891|363673557|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
105454598|NCT04349891|363673556|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
105454599|NCT04349891|363673557|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
105454600|NCT04349891|363673556|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
105454601|NCT04349891|363673557|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
105454602|NCT00718510|363673563|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
105454603|NCT00718510|363673564|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
105454604|NCT00718510|363673563|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
105454605|NCT00718510|363673564|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
105454606|NCT00286442|363673571|FG000|Overall Study|Hyperglycemic Rescue|19|||
105454607|NCT00286442|363673572|FG001|Overall Study|Hyperglycemic Rescue|17|||
105454608|NCT00286442|363673573|FG002|Overall Study|Hyperglycemic Rescue|25|||
105454609|NCT00286442|363673571|FG000|Overall Study|Adverse Event|7|||
105454610|NCT00286442|363673572|FG001|Overall Study|Adverse Event|6|||
105454611|NCT00286442|363673573|FG002|Overall Study|Adverse Event|1|||
105454612|NCT00286442|363673571|FG000|Overall Study|Protocol Violation|2|||
105454613|NCT00286442|363673572|FG001|Overall Study|Protocol Violation|4|||
105454614|NCT00286442|363673573|FG002|Overall Study|Protocol Violation|2|||
105454615|NCT00286442|363673571|FG000|Overall Study|Lost to Follow-up|5|||
105454616|NCT00286442|363673572|FG001|Overall Study|Lost to Follow-up|2|||
105454617|NCT00286442|363673573|FG002|Overall Study|Lost to Follow-up|1|||
105454618|NCT00286442|363673571|FG000|Overall Study|Physician Decision|1|||
105454619|NCT00286442|363673572|FG001|Overall Study|Physician Decision|1|||
105454620|NCT00286442|363673573|FG002|Overall Study|Physician Decision|1|||
105454621|NCT00286442|363673571|FG000|Overall Study|Administrative Error|1|||
105454622|NCT00286442|363673572|FG001|Overall Study|Administrative Error|1|||
105454623|NCT00286442|363673573|FG002|Overall Study|Administrative Error|0|||
105454624|NCT00286442|363673571|FG000|Overall Study|Withdrawal by Subject|2|||
105454625|NCT00286442|363673572|FG001|Overall Study|Withdrawal by Subject|14|||
105454626|NCT00286442|363673573|FG002|Overall Study|Withdrawal by Subject|2|||
105454627|NCT02756338|363673574|FG000|Overall Study|Withdrawn by Investigator|1|||
105454628|NCT02756338|363673574|FG000|Overall Study|Device Replaced with Pacemaker|4|||
105454629|NCT00667888|363673575|FG000|Overall Study|Death|1|||
105454630|NCT00667888|363673576|FG001|Overall Study|Death|1|||
105454631|NCT00667888|363673575|FG000|Overall Study|Withdrawal by Subject|6|||
105454632|NCT00667888|363673576|FG001|Overall Study|Withdrawal by Subject|3|||
105454633|NCT00667888|363673575|FG000|Overall Study|Proceed with other treatment|3|||
105454634|NCT00667888|363673576|FG001|Overall Study|Proceed with other treatment|3|||
105454635|NCT00667888|363673575|FG000|Overall Study|Ineligible after SIM|0|||
105454636|NCT00667888|363673576|FG001|Overall Study|Ineligible after SIM|2|||
105454637|NCT01945021|363673577|FG000|Overall Study|Adverse Event|1|||
105454638|NCT01945021|363673577|FG000|Overall Study|Withdrawal of consent|12|||
105454639|NCT01945021|363673577|FG000|Overall Study|Lost to Follow-up|5|||
105454640|NCT01945021|363673577|FG000|Overall Study|Death|65|||
105454641|NCT00467740|363673581|FG000|Overall Study|Adverse Event|0|||
105454642|NCT00467740|363673582|FG001|Overall Study|Adverse Event|0|||
105454643|NCT00467740|363673583|FG002|Overall Study|Adverse Event|1|||
105454644|NCT00467740|363673584|FG003|Overall Study|Adverse Event|0|||
105454645|NCT00467740|363673585|FG004|Overall Study|Adverse Event|0|||
105454646|NCT00467740|363673581|FG000|Overall Study|Protocol Violation|0|||
105454647|NCT00467740|363673582|FG001|Overall Study|Protocol Violation|0|||
105454648|NCT00467740|363673583|FG002|Overall Study|Protocol Violation|1|||
105454649|NCT00467740|363673584|FG003|Overall Study|Protocol Violation|0|||
105454650|NCT00467740|363673585|FG004|Overall Study|Protocol Violation|0|||
105454651|NCT00467740|363673581|FG000|Overall Study|Lost to Follow-up|0|||
105454652|NCT00467740|363673582|FG001|Overall Study|Lost to Follow-up|1|||
105454653|NCT00467740|363673583|FG002|Overall Study|Lost to Follow-up|0|||
105454654|NCT00467740|363673584|FG003|Overall Study|Lost to Follow-up|0|||
105454655|NCT00467740|363673585|FG004|Overall Study|Lost to Follow-up|0|||
105454656|NCT00467740|363673581|FG000|Overall Study|Withdrawal by Subject|1|||
105454657|NCT00467740|363673582|FG001|Overall Study|Withdrawal by Subject|1|||
105454658|NCT00467740|363673583|FG002|Overall Study|Withdrawal by Subject|0|||
105454659|NCT00467740|363673584|FG003|Overall Study|Withdrawal by Subject|1|||
105454660|NCT00467740|363673585|FG004|Overall Study|Withdrawal by Subject|0|||
105454661|NCT00467740|363673581|FG000|Overall Study|Lack of Efficacy|0|||
105454662|NCT00467740|363673582|FG001|Overall Study|Lack of Efficacy|1|||
105454663|NCT00467740|363673583|FG002|Overall Study|Lack of Efficacy|0|||
105454664|NCT00467740|363673584|FG003|Overall Study|Lack of Efficacy|0|||
105454665|NCT00467740|363673585|FG004|Overall Study|Lack of Efficacy|0|||
105454666|NCT00953667|363673586|FG000|Overall Study|Lost to Follow-up|11|||
105454667|NCT00953667|363673586|FG000|Overall Study|Physician Decision|35|||
105454668|NCT00953667|363673586|FG000|Overall Study|Withdrawal by Subject|63|||
105454669|NCT00953667|363673586|FG000|Overall Study|Adverse Event|10|||
105454670|NCT00953667|363673586|FG000|Overall Study|poor venous access,unable to draw blood|4|||
105454671|NCT04819945|363673587|FG000|Overall Study|Lost to Follow-up|1|||
105454672|NCT02004236|363673588|FG000|Overall Study|Lack of Efficacy|0|||
105454673|NCT02004236|363673589|FG001|Overall Study|Lack of Efficacy|0|||
105454674|NCT02004236|363673590|FG002|Overall Study|Lack of Efficacy|16|||
105454675|NCT00844376|363673591|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
105454676|NCT00844376|363673592|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
105454677|NCT01632020|363673593|FG000|Overall Study|Withdrawal by Subject|1|||
105454678|NCT01632020|363673594|FG001|Overall Study|Withdrawal by Subject|0|||
105454679|NCT01632020|363673593|FG000|Overall Study|Adverse Event|1|||
105454680|NCT01632020|363673594|FG001|Overall Study|Adverse Event|0|||
105454681|NCT01069484|363673596|FG000|Overall Study|Death-in-near-family|1|||
105336989|NCT00090220|363234764|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
105454682|NCT01069484|363673597|FG001|Overall Study|Death-in-near-family|0|||
105454683|NCT01069484|363673596|FG000|Overall Study|No specific reason|8|||
105454684|NCT01069484|363673597|FG001|Overall Study|No specific reason|2|||
105454685|NCT01069484|363673596|FG000|Overall Study|Illness mother or child|3|||
105454686|NCT01069484|363673597|FG001|Overall Study|Illness mother or child|1|||
105454687|NCT01506271|363673598|FG000|Overall Study|Progressive disease|0|||
105454688|NCT01506271|363673599|FG001|Overall Study|Progressive disease|1|||
105454689|NCT01506271|363673600|FG002|Overall Study|Progressive disease|0|||
105454690|NCT01506271|363673598|FG000|Overall Study|Protocol Violation|3|||
105454691|NCT01506271|363673599|FG001|Overall Study|Protocol Violation|1|||
105454692|NCT01506271|363673600|FG002|Overall Study|Protocol Violation|0|||
105454693|NCT01506271|363673598|FG000|Overall Study|Death|0|||
105454694|NCT01506271|363673599|FG001|Overall Study|Death|1|||
105454695|NCT01506271|363673600|FG002|Overall Study|Death|0|||
105454696|NCT01506271|363673598|FG000|Overall Study|Adverse Event|0|||
105454697|NCT01506271|363673599|FG001|Overall Study|Adverse Event|2|||
105454698|NCT01506271|363673600|FG002|Overall Study|Adverse Event|0|||
105454699|NCT01506271|363673598|FG000|Overall Study|Insufficient supply of study drug|1|||
105454700|NCT01506271|363673599|FG001|Overall Study|Insufficient supply of study drug|0|||
105454701|NCT01506271|363673600|FG002|Overall Study|Insufficient supply of study drug|0|||
105454702|NCT01506271|363673598|FG000|Overall Study|Withdrawal by Subject|0|||
105454703|NCT01506271|363673599|FG001|Overall Study|Withdrawal by Subject|1|||
105454704|NCT01506271|363673600|FG002|Overall Study|Withdrawal by Subject|1|||
105454705|NCT01506271|363673598|FG000|Overall Study|Lost to Follow-up|0|||
105454706|NCT01506271|363673599|FG001|Overall Study|Lost to Follow-up|1|||
105454707|NCT01506271|363673600|FG002|Overall Study|Lost to Follow-up|2|||
105454708|NCT00651924|363673607|FG000|Overall Study|Withdrawal by PI|0|||
105454709|NCT00651924|363673608|FG001|Overall Study|Withdrawal by PI|2|||
105454710|NCT00651924|363673607|FG000|Overall Study|Withdrawal by Subject|0|||
105454711|NCT00651924|363673608|FG001|Overall Study|Withdrawal by Subject|5|||
105454712|NCT00960063|363673609|FG000|Overall Study|Adverse Event|1|||
105454713|NCT00960063|363673610|FG001|Overall Study|Adverse Event|0|||
105454714|NCT00960063|363673611|FG002|Overall Study|Adverse Event|0|||
105454715|NCT00960063|363673609|FG000|Overall Study|Progression of Disease|0|||
105454716|NCT00960063|363673610|FG001|Overall Study|Progression of Disease|0|||
105454717|NCT00960063|363673611|FG002|Overall Study|Progression of Disease|3|||
105454718|NCT00528957|363673612|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
105454719|NCT00528957|363673613|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
105454720|NCT00528957|363673612|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
105454721|NCT00528957|363673613|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
105454722|NCT00528957|363673612|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
105454723|NCT00528957|363673613|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
105454724|NCT00528957|363673612|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
105454725|NCT00528957|363673613|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
105454726|NCT00528957|363673612|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
105454727|NCT00528957|363673613|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
105454728|NCT00528957|363673612|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
105454729|NCT00528957|363673613|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
105454730|NCT00528957|363673612|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
105454731|NCT00528957|363673613|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
105454732|NCT00528957|363673612|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
105454733|NCT00528957|363673613|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
105454734|NCT00528957|363673612|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
105454735|NCT00528957|363673613|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
105454736|NCT00528957|363673612|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
105454737|NCT00528957|363673613|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
105454738|NCT00528957|363673612|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
105454739|NCT00528957|363673613|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
105454740|NCT00528957|363673612|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
105454741|NCT00528957|363673613|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
105454742|NCT00528957|363673612|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
105454743|NCT00528957|363673613|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
105454744|NCT00528957|363673612|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
105454745|NCT00528957|363673613|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
105454746|NCT00528957|363673612|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
105454747|NCT00528957|363673613|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
105454748|NCT00528957|363673612|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
105454749|NCT00528957|363673613|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
105454750|NCT05083351|363673617|FG000|Overall Study|Adverse Event|3|||
105454751|NCT05083351|363673617|FG000|Overall Study|Did not meet data inclusion criteria|8|||
105454752|NCT05083351|363673617|FG000|Overall Study|Did not meet eligibility criteria|19|||
105454753|NCT05083351|363673617|FG000|Overall Study|Study Staff Decision|19|||
105454754|NCT01611792|363673618|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
105454755|NCT01611792|363673619|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
105454756|NCT01611792|363673618|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
105454757|NCT01611792|363673619|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
105454758|NCT01323582|363673620|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
105454759|NCT01323582|363673621|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
105454760|NCT01323582|363673620|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
105454761|NCT01323582|363673621|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
105454762|NCT01323582|363673620|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
105454763|NCT01323582|363673621|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
105454764|NCT01759420|363673623|FG000|Overall Study|Screen failure|5|||
105454765|NCT01759420|363673623|FG000|Overall Study|Inaccurate EKG machine readings|1|||
105454766|NCT01129622|363673624|FG000|Overall Study|Withdrawal by Subject|2|||
105454767|NCT00960375|363673625|FG000|Overall Study|Lost to Follow-up|20|||
105454768|NCT00960375|363673626|FG001|Overall Study|Lost to Follow-up|22|||
105454769|NCT01601535|363673627|FG000|Phase 1|Adverse Event|1|||
105454770|NCT01601535|363673628|FG001|Phase 1|Adverse Event|0|||
105454771|NCT01601535|363673629|FG002|Phase 1|Adverse Event|2|||
105454772|NCT01601535|363673630|FG003|Phase 1|Adverse Event|1|||
105454773|NCT01601535|363673631|FG004|Phase 1|Adverse Event|0|||
105454774|NCT01601535|363673632|FG005|Phase 1|Adverse Event|0|||
105454775|NCT01601535|363673627|FG000|Phase 1|Withdrawal by Subject|2|||
105454776|NCT01601535|363673628|FG001|Phase 1|Withdrawal by Subject|1|||
105454777|NCT01601535|363673629|FG002|Phase 1|Withdrawal by Subject|1|||
105454778|NCT01601535|363673630|FG003|Phase 1|Withdrawal by Subject|2|||
105454779|NCT01601535|363673631|FG004|Phase 1|Withdrawal by Subject|0|||
105454780|NCT01601535|363673632|FG005|Phase 1|Withdrawal by Subject|0|||
105454781|NCT01601535|363673627|FG000|Phase 1|Progressive Disease|2|||
105454782|NCT01601535|363673628|FG001|Phase 1|Progressive Disease|3|||
105454783|NCT01601535|363673629|FG002|Phase 1|Progressive Disease|2|||
105454784|NCT01601535|363673630|FG003|Phase 1|Progressive Disease|1|||
105454785|NCT01601535|363673631|FG004|Phase 1|Progressive Disease|0|||
105454786|NCT01601535|363673632|FG005|Phase 1|Progressive Disease|0|||
105454787|NCT01601535|363673627|FG000|Phase 1|Started Another Treatment|1|||
105454788|NCT01601535|363673628|FG001|Phase 1|Started Another Treatment|2|||
105454789|NCT01601535|363673629|FG002|Phase 1|Started Another Treatment|0|||
105454790|NCT01601535|363673630|FG003|Phase 1|Started Another Treatment|0|||
105454791|NCT01601535|363673631|FG004|Phase 1|Started Another Treatment|0|||
105454792|NCT01601535|363673632|FG005|Phase 1|Started Another Treatment|0|||
105454793|NCT01601535|363673627|FG000|Phase 2|Adverse Event|0|||
105454794|NCT01601535|363673628|FG001|Phase 2|Adverse Event|0|||
105454795|NCT01601535|363673629|FG002|Phase 2|Adverse Event|0|||
105454796|NCT01601535|363673630|FG003|Phase 2|Adverse Event|0|||
105454797|NCT01601535|363673631|FG004|Phase 2|Adverse Event|5|||
105454798|NCT01601535|363673632|FG005|Phase 2|Adverse Event|1|||
105454799|NCT01601535|363673627|FG000|Phase 2|Withdrawal by Subject|0|||
105454800|NCT01601535|363673628|FG001|Phase 2|Withdrawal by Subject|0|||
105454801|NCT01601535|363673629|FG002|Phase 2|Withdrawal by Subject|0|||
105454802|NCT01601535|363673630|FG003|Phase 2|Withdrawal by Subject|0|||
105454803|NCT01601535|363673631|FG004|Phase 2|Withdrawal by Subject|8|||
105454804|NCT01601535|363673632|FG005|Phase 2|Withdrawal by Subject|2|||
105454805|NCT01601535|363673627|FG000|Phase 2|Progressive Disease|0|||
105454806|NCT01601535|363673628|FG001|Phase 2|Progressive Disease|0|||
105454807|NCT01601535|363673629|FG002|Phase 2|Progressive Disease|0|||
105454808|NCT01601535|363673630|FG003|Phase 2|Progressive Disease|0|||
105454809|NCT01601535|363673631|FG004|Phase 2|Progressive Disease|5|||
105454810|NCT01601535|363673632|FG005|Phase 2|Progressive Disease|7|||
105454811|NCT01601535|363673627|FG000|Phase 2|Started Another Treatment|0|||
105454812|NCT01601535|363673628|FG001|Phase 2|Started Another Treatment|0|||
105454813|NCT01601535|363673629|FG002|Phase 2|Started Another Treatment|0|||
105454814|NCT01601535|363673630|FG003|Phase 2|Started Another Treatment|0|||
105454815|NCT01601535|363673631|FG004|Phase 2|Started Another Treatment|1|||
105454816|NCT01601535|363673632|FG005|Phase 2|Started Another Treatment|2|||
105454817|NCT00321789|363673634|FG000|Overall Study|Lost to Follow-up|4|||
105454818|NCT00321789|363673635|FG001|Overall Study|Lost to Follow-up|7|||
105454819|NCT00321789|363673634|FG000|Overall Study|Withdrawal by Subject|6|||
105454820|NCT00321789|363673635|FG001|Overall Study|Withdrawal by Subject|6|||
105454821|NCT00321789|363673634|FG000|Overall Study|Protocol Violation|5|||
105454822|NCT00321789|363673635|FG001|Overall Study|Protocol Violation|3|||
105454823|NCT00152503|363673640|FG000|Overall Study|Adverse Event|4|||
105454824|NCT00154297|363673641|FG000|Overall Study|Death|5|||
105454825|NCT00154297|363673642|FG001|Overall Study|Death|2|||
105454826|NCT00154297|363673641|FG000|Overall Study|Withdrawal by Subject|0|||
105454827|NCT00154297|363673642|FG001|Overall Study|Withdrawal by Subject|5|||
105454828|NCT00154297|363673641|FG000|Overall Study|Lost to Follow-up|3|||
105454829|NCT00154297|363673642|FG001|Overall Study|Lost to Follow-up|0|||
105454830|NCT03077542|363673643|FG000|Overall Study|Death|4|||
105454831|NCT03077542|363673644|FG001|Overall Study|Death|0|||
105454832|NCT03077542|363673643|FG000|Overall Study|Physician Decision|6|||
105454833|NCT03077542|363673644|FG001|Overall Study|Physician Decision|1|||
105454834|NCT03077542|363673643|FG000|Overall Study|Withdrawal by Subject|0|||
105454835|NCT03077542|363673644|FG001|Overall Study|Withdrawal by Subject|1|||
105454836|NCT03649074|363673645|FG000|Overall Study|Lost to Follow-up|2|||
105454837|NCT03649074|363673646|FG001|Overall Study|Lost to Follow-up|1|||
105454838|NCT03649074|363673645|FG000|Overall Study|Adverse Event|1|||
105454839|NCT03649074|363673646|FG001|Overall Study|Adverse Event|0|||
105454840|NCT03649074|363673645|FG000|Overall Study|Physician Decision|1|||
105454841|NCT03649074|363673646|FG001|Overall Study|Physician Decision|0|||
105454842|NCT03649074|363673645|FG000|Overall Study|Withdrawal by Subject|0|||
105454843|NCT03649074|363673646|FG001|Overall Study|Withdrawal by Subject|2|||
105454844|NCT03649074|363673645|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
105454845|NCT03649074|363673646|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
105454846|NCT03649074|363673645|FG000|Overall Study|Other|1|||
105454847|NCT03649074|363673646|FG001|Overall Study|Other|0|||
105454848|NCT01300728|363673647|FG000|Overall Study|Withdrawal by Subject|1|||
105454849|NCT01300728|363673648|FG001|Overall Study|Withdrawal by Subject|1|||
105454850|NCT01300728|363673647|FG000|Overall Study|Physician Decision|1|||
105454851|NCT01300728|363673648|FG001|Overall Study|Physician Decision|0|||
105454852|NCT00880620|363673652|FG000|Overall Study|Adverse Event|4|||
105454853|NCT00880620|363673653|FG001|Overall Study|Adverse Event|5|||
105454854|NCT00880620|363673654|FG002|Overall Study|Adverse Event|15|||
105454855|NCT00880620|363673655|FG003|Overall Study|Adverse Event|15|||
105454856|NCT00880620|363673652|FG000|Overall Study|Death|0|||
105454857|NCT00880620|363673653|FG001|Overall Study|Death|0|||
105454858|NCT00880620|363673654|FG002|Overall Study|Death|1|||
105454859|NCT00880620|363673655|FG003|Overall Study|Death|0|||
105454860|NCT00880620|363673652|FG000|Overall Study|Lack of Efficacy|12|||
105454861|NCT00880620|363673653|FG001|Overall Study|Lack of Efficacy|4|||
105454862|NCT00880620|363673654|FG002|Overall Study|Lack of Efficacy|0|||
105454863|NCT00880620|363673655|FG003|Overall Study|Lack of Efficacy|1|||
105454864|NCT00880620|363673652|FG000|Overall Study|Lost to Follow-up|0|||
105454865|NCT00880620|363673653|FG001|Overall Study|Lost to Follow-up|1|||
105454866|NCT00880620|363673654|FG002|Overall Study|Lost to Follow-up|1|||
105454867|NCT00880620|363673655|FG003|Overall Study|Lost to Follow-up|0|||
105454868|NCT00880620|363673652|FG000|Overall Study|Protocol Violation|0|||
105454869|NCT00880620|363673653|FG001|Overall Study|Protocol Violation|1|||
105454870|NCT00880620|363673654|FG002|Overall Study|Protocol Violation|0|||
105454871|NCT00880620|363673655|FG003|Overall Study|Protocol Violation|2|||
105454872|NCT00880620|363673652|FG000|Overall Study|Withdrawal by Subject|4|||
105454873|NCT00880620|363673653|FG001|Overall Study|Withdrawal by Subject|3|||
105454874|NCT00880620|363673654|FG002|Overall Study|Withdrawal by Subject|1|||
105454875|NCT00880620|363673655|FG003|Overall Study|Withdrawal by Subject|3|||
105454876|NCT00880620|363673652|FG000|Overall Study|Noncompliance|0|||
105454877|NCT00880620|363673653|FG001|Overall Study|Noncompliance|0|||
105454878|NCT00880620|363673654|FG002|Overall Study|Noncompliance|1|||
105454879|NCT00880620|363673655|FG003|Overall Study|Noncompliance|1|||
105454880|NCT00880620|363673652|FG000|Overall Study|Other|1|||
105454881|NCT00880620|363673653|FG001|Overall Study|Other|1|||
105454882|NCT00880620|363673654|FG002|Overall Study|Other|2|||
105454883|NCT00880620|363673655|FG003|Overall Study|Other|2|||
105454884|NCT00301808|363673656|FG000|Overall Study|Adverse Event|5|||
105454885|NCT00301808|363673656|FG000|Overall Study|Death|3|||
105454886|NCT00301808|363673656|FG000|Overall Study|Lack of Efficacy|4|||
105454887|NCT03291067|363675067|FG000|Overall Study|Adverse Event|0|||
105454888|NCT03291067|363675068|FG001|Overall Study|Adverse Event|2|||
105454889|NCT03291067|363675069|FG002|Overall Study|Adverse Event|17|||
105454890|NCT03291067|363675070|FG003|Overall Study|Adverse Event|3|||
105454891|NCT03291067|363675067|FG000|Overall Study|Lost to Follow-up|2|||
105454892|NCT03291067|363675068|FG001|Overall Study|Lost to Follow-up|1|||
105454893|NCT03291067|363675069|FG002|Overall Study|Lost to Follow-up|0|||
105454894|NCT03291067|363675070|FG003|Overall Study|Lost to Follow-up|1|||
105454895|NCT03291067|363675067|FG000|Overall Study|Physician Decision|0|||
105454896|NCT03291067|363675068|FG001|Overall Study|Physician Decision|0|||
105454897|NCT03291067|363675069|FG002|Overall Study|Physician Decision|1|||
105454898|NCT03291067|363675070|FG003|Overall Study|Physician Decision|0|||
105454899|NCT03291067|363675067|FG000|Overall Study|Protocol Violation|5|||
105454900|NCT03291067|363675068|FG001|Overall Study|Protocol Violation|3|||
105454901|NCT03291067|363675069|FG002|Overall Study|Protocol Violation|4|||
105454902|NCT03291067|363675070|FG003|Overall Study|Protocol Violation|2|||
105454903|NCT03291067|363675067|FG000|Overall Study|Withdrawal by Subject|3|||
105454904|NCT03291067|363675068|FG001|Overall Study|Withdrawal by Subject|4|||
105454905|NCT03291067|363675069|FG002|Overall Study|Withdrawal by Subject|7|||
105454906|NCT03291067|363675070|FG003|Overall Study|Withdrawal by Subject|5|||
105454907|NCT03291067|363675067|FG000|Overall Study|Other|0|||
105454908|NCT03291067|363675068|FG001|Overall Study|Other|4|||
105454909|NCT03291067|363675069|FG002|Overall Study|Other|4|||
105454910|NCT03291067|363675070|FG003|Overall Study|Other|6|||
105454911|NCT02250326|363675074|FG000|Treatment|Death|1|||
105454912|NCT02250326|363675075|FG001|Treatment|Death|13|||
105454913|NCT02250326|363675076|FG002|Treatment|Death|2|||
105454914|NCT02250326|363675074|FG000|Treatment|Adverse Event|8|||
105454915|NCT02250326|363675075|FG001|Treatment|Adverse Event|8|||
105454916|NCT02250326|363675076|FG002|Treatment|Adverse Event|9|||
105454917|NCT02250326|363675074|FG000|Treatment|Progressive Disease|42|||
105454918|NCT02250326|363675075|FG001|Treatment|Progressive Disease|40|||
105454919|NCT02250326|363675076|FG002|Treatment|Progressive Disease|47|||
105454920|NCT02250326|363675074|FG000|Treatment|Symptomatic Deterioration|9|||
105454921|NCT02250326|363675075|FG001|Treatment|Symptomatic Deterioration|4|||
105454922|NCT02250326|363675076|FG002|Treatment|Symptomatic Deterioration|10|||
105454923|NCT02250326|363675074|FG000|Treatment|Withdrawal by Subject|11|||
105454924|NCT02250326|363675075|FG001|Treatment|Withdrawal by Subject|6|||
105454925|NCT02250326|363675076|FG002|Treatment|Withdrawal by Subject|4|||
105454926|NCT02250326|363675074|FG000|Treatment|Other reasons|8|||
105454927|NCT02250326|363675075|FG001|Treatment|Other reasons|7|||
105454928|NCT02250326|363675076|FG002|Treatment|Other reasons|7|||
105454929|NCT02250326|363675074|FG000|Extension Period|Progressive Disease|0|||
105454930|NCT02250326|363675075|FG001|Extension Period|Progressive Disease|2|||
105454931|NCT02250326|363675076|FG002|Extension Period|Progressive Disease|0|||
105454932|NCT02250326|363675074|FG000|Extension Period|Withdrawal by Subject|0|||
105454933|NCT02250326|363675075|FG001|Extension Period|Withdrawal by Subject|1|||
105454934|NCT02250326|363675076|FG002|Extension Period|Withdrawal by Subject|0|||
105454935|NCT02250326|363675074|FG000|Extension Period|Withdrawal by investigator|0|||
105454936|NCT02250326|363675075|FG001|Extension Period|Withdrawal by investigator|1|||
105454937|NCT02250326|363675076|FG002|Extension Period|Withdrawal by investigator|0|||
105454938|NCT03585660|363675077|FG000|Overall Study|operator error|1|||
105454939|NCT03585660|363675077|FG000|Overall Study|technical error|2|||
105454940|NCT03585660|363675077|FG000|Overall Study|hip prosthesis|2|||
105454941|NCT03585660|363675077|FG000|Overall Study|did not undergo biopsy|8|||
105454942|NCT03585660|363675077|FG000|Overall Study|scanner problem|2|||
105454943|NCT04245111|363675078|FG000|Overall Study|Lost to Follow-up|5|||
105454944|NCT04245111|363675079|FG001|Overall Study|Lost to Follow-up|1|||
105454945|NCT04245111|363675080|FG002|Overall Study|Lost to Follow-up|1|||
105454946|NCT00435409|363675081|FG000|Overall Study|Protocol Violation|1|||
105454947|NCT00435409|363675082|FG001|Overall Study|Protocol Violation|2|||
105454948|NCT00435409|363675083|FG002|Overall Study|Protocol Violation|0|||
105454949|NCT00435409|363675081|FG000|Overall Study|Lost to Follow-up|1|||
105454950|NCT00435409|363675082|FG001|Overall Study|Lost to Follow-up|2|||
105454951|NCT00435409|363675083|FG002|Overall Study|Lost to Follow-up|0|||
105454952|NCT00435409|363675081|FG000|Overall Study|Death|8|||
105454953|NCT00435409|363675082|FG001|Overall Study|Death|6|||
105454954|NCT00435409|363675083|FG002|Overall Study|Death|6|||
105454955|NCT00435409|363675081|FG000|Overall Study|Objective progression or relapse|158|||
105454956|NCT00435409|363675082|FG001|Overall Study|Objective progression or relapse|93|||
105454957|NCT00435409|363675083|FG002|Overall Study|Objective progression or relapse|58|||
105454958|NCT00435409|363675081|FG000|Overall Study|Global deterioration of health status|0|||
105454959|NCT00435409|363675082|FG001|Overall Study|Global deterioration of health status|0|||
105454960|NCT00435409|363675083|FG002|Overall Study|Global deterioration of health status|4|||
105454961|NCT00435409|363675081|FG000|Overall Study|Withdrawal by Subject|8|||
105454962|NCT00435409|363675082|FG001|Overall Study|Withdrawal by Subject|7|||
105454963|NCT00435409|363675083|FG002|Overall Study|Withdrawal by Subject|1|||
105454964|NCT00435409|363675081|FG000|Overall Study|Other|45|||
105454965|NCT00435409|363675082|FG001|Overall Study|Other|30|||
105454966|NCT00435409|363675083|FG002|Overall Study|Other|1|||
105454967|NCT00435409|363675081|FG000|Overall Study|Adverse Event|0|||
105454968|NCT00435409|363675082|FG001|Overall Study|Adverse Event|0|||
105454969|NCT00435409|363675083|FG002|Overall Study|Adverse Event|8|||
105454970|NCT00435409|363675081|FG000|Overall Study|Sponsor decision|0|||
105454971|NCT00435409|363675082|FG001|Overall Study|Sponsor decision|3|||
105454972|NCT00435409|363675083|FG002|Overall Study|Sponsor decision|0|||
105454973|NCT05106959|363675084|FG000|Overall Study|Lost to Follow-up|1|||
105454974|NCT02542865|363675087|FG000|Overall Study|Identified as screen failure|1|||
105454975|NCT02542865|363675088|FG001|Overall Study|Identified as screen failure|0|||
105454976|NCT02542865|363675087|FG000|Overall Study|Withdrawal by Subject|16|||
105454977|NCT02542865|363675088|FG001|Overall Study|Withdrawal by Subject|0|||
105454978|NCT01339689|363675091|FG000|Overall Study|Adverse Event|1|||
105454979|NCT01339689|363675092|FG001|Overall Study|Adverse Event|2|||
105454980|NCT01339689|363675091|FG000|Overall Study|Lost to Follow-up|9|||
105454981|NCT01339689|363675092|FG001|Overall Study|Lost to Follow-up|3|||
105454982|NCT01339689|363675091|FG000|Overall Study|Withdrawal by Subject|3|||
105336990|NCT00090220|363234765|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
105454983|NCT01339689|363675092|FG001|Overall Study|Withdrawal by Subject|0|||
105454984|NCT01339689|363675091|FG000|Overall Study|Noncompliance|1|||
105454985|NCT01339689|363675092|FG001|Overall Study|Noncompliance|0|||
105454986|NCT01339689|363675091|FG000|Overall Study|Relocated out of area|0|||
105454987|NCT01339689|363675092|FG001|Overall Study|Relocated out of area|1|||
105454988|NCT01339689|363675091|FG000|Overall Study|Other|2|||
105454989|NCT01339689|363675092|FG001|Overall Study|Other|2|||
105454990|NCT01339689|363675091|FG000|Overall Study|multiple reasons|1|||
105454991|NCT01339689|363675092|FG001|Overall Study|multiple reasons|1|||
105454992|NCT04571944|363675095|FG000|Overall Study|Death|1|||
105454993|NCT04571944|363675096|FG001|Overall Study|Death|0|||
105454994|NCT04571944|363675095|FG000|Overall Study|Withdrawal by Subject|3|||
105454995|NCT04571944|363675096|FG001|Overall Study|Withdrawal by Subject|0|||
105454996|NCT04571944|363675095|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
105454997|NCT04571944|363675096|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
105454998|NCT02694744|363675097|FG000|Overall Study|Adverse Event|2|||
105454999|NCT02694744|363675098|FG001|Overall Study|Adverse Event|1|||
105455000|NCT02694744|363675097|FG000|Overall Study|Withdrawal by Subject|2|||
105455001|NCT02694744|363675098|FG001|Overall Study|Withdrawal by Subject|1|||
105455002|NCT02694744|363675097|FG000|Overall Study|Physician Decision|1|||
105455003|NCT02694744|363675098|FG001|Overall Study|Physician Decision|2|||
105336991|NCT00090220|363234766|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
105455004|NCT02694744|363675097|FG000|Overall Study|Lost to Follow-up|1|||
105455005|NCT02694744|363675098|FG001|Overall Study|Lost to Follow-up|0|||
105455006|NCT02694744|363675097|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
105455007|NCT02694744|363675098|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
105455008|NCT02140047|363675099|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105455009|NCT02140047|363675100|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105455010|NCT02140047|363675101|FG002|Overall Study|Withdrawal by parent/guardian|0|||
105455011|NCT02174731|363675102|FG000|Overall Study|Participant decision|67|||
105455012|NCT02174731|363675103|FG001|Overall Study|Participant decision|64|||
105455013|NCT02174731|363675102|FG000|Overall Study|Incorrect enrolment before randomization|0|||
105455014|NCT02174731|363675103|FG001|Overall Study|Incorrect enrolment before randomization|1|||
105455015|NCT02174731|363675102|FG000|Overall Study|Missing|2|||
105455016|NCT02174731|363675103|FG001|Overall Study|Missing|0|||
105455017|NCT00079040|363675104|FG000|Overall Study|Withdrew before treatment|1|||
105455018|NCT00079040|363675104|FG000|Overall Study|Ineligible|1|||
105455019|NCT00739401|363675109|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
105455020|NCT00739401|363675109|FG000|Overall Study|Death|3|||
105455021|NCT00739401|363675109|FG000|Overall Study|Withdrawal by Subject|4|||
105455022|NCT04739982|363675112|FG000|Overall Study|Lost to Follow-up|176|||
105455023|NCT04739982|363675113|FG001|Overall Study|Lost to Follow-up|65|||
105455024|NCT04739982|363675112|FG000|Overall Study|Withdrawal by Subject|19|||
105455025|NCT04739982|363675113|FG001|Overall Study|Withdrawal by Subject|0|||
105455026|NCT04739982|363675112|FG000|Overall Study|Protocol Violation|0|||
105455027|NCT04739982|363675113|FG001|Overall Study|Protocol Violation|5|||
105455028|NCT04575155|363675114|FG000|2 Month|Withdrawal by Subject|1|||
105455029|NCT04575155|363675115|FG001|2 Month|Withdrawal by Subject|1|||
105455030|NCT04575155|363675114|FG000|2 Month|Lost to Follow-up|5|||
105455031|NCT04575155|363675115|FG001|2 Month|Lost to Follow-up|3|||
105455032|NCT04575155|363675114|FG000|2 Month|Ineligible|1|||
105455033|NCT04575155|363675115|FG001|2 Month|Ineligible|0|||
105455034|NCT03915717|363675118|FG000|Overall Study|EchoMark Not Implanted|6|||
105455035|NCT01664910|363675120|FG000|Overall Study|Adverse Event|0|||
105455036|NCT01664910|363675121|FG001|Overall Study|Adverse Event|0|||
105455037|NCT01664910|363675122|FG002|Overall Study|Adverse Event|1|||
105455038|NCT00702702|363675123|FG000|Overall Study|Study prematurely terminated|56|||
105455039|NCT00475670|363675128|FG000|Overall Study|Death|0|||
105455040|NCT00475670|363675129|FG001|Overall Study|Death|1|||
105455041|NCT00475670|363675128|FG000|Overall Study|Lack of Efficacy|3|||
105455042|NCT00475670|363675129|FG001|Overall Study|Lack of Efficacy|34|||
105455043|NCT00475670|363675128|FG000|Overall Study|Refused treatment|0|||
105455044|NCT00475670|363675129|FG001|Overall Study|Refused treatment|2|||
105455045|NCT00475670|363675128|FG000|Overall Study|Failure to Return|0|||
105455046|NCT00475670|363675129|FG001|Overall Study|Failure to Return|1|||
105455047|NCT00475670|363675128|FG000|Overall Study|Other|0|||
105455048|NCT00475670|363675129|FG001|Overall Study|Other|3|||
105455049|NCT00591006|363675134|FG000|Overall Study|Withdrawal by Subject|0|||
105455050|NCT00591006|363675135|FG001|Overall Study|Withdrawal by Subject|0|||
105455051|NCT00591006|363675136|FG002|Overall Study|Withdrawal by Subject|0|||
105455052|NCT00591006|363675137|FG003|Overall Study|Withdrawal by Subject|0|||
105455053|NCT00591006|363675138|FG004|Overall Study|Withdrawal by Subject|0|||
105455054|NCT00591006|363675139|FG005|Overall Study|Withdrawal by Subject|0|||
105455055|NCT00591006|363675140|FG006|Overall Study|Withdrawal by Subject|0|||
105455056|NCT00591006|363675141|FG007|Overall Study|Withdrawal by Subject|0|||
105455057|NCT00591006|363675142|FG008|Overall Study|Withdrawal by Subject|0|||
105455058|NCT00591006|363675143|FG009|Overall Study|Withdrawal by Subject|0|||
105455059|NCT00591006|363675144|FG010|Overall Study|Withdrawal by Subject|0|||
105455060|NCT00591006|363675145|FG011|Overall Study|Withdrawal by Subject|0|||
105455061|NCT00591006|363675146|FG012|Overall Study|Withdrawal by Subject|0|||
105455062|NCT00591006|363675147|FG013|Overall Study|Withdrawal by Subject|0|||
105455063|NCT00591006|363675148|FG014|Overall Study|Withdrawal by Subject|0|||
105455064|NCT00591006|363675149|FG015|Overall Study|Withdrawal by Subject|1|||
105455065|NCT00591006|363675150|FG016|Overall Study|Withdrawal by Subject|0|||
105455066|NCT00591006|363675151|FG017|Overall Study|Withdrawal by Subject|0|||
105455067|NCT00591006|363675152|FG018|Overall Study|Withdrawal by Subject|0|||
105455068|NCT00591006|363675153|FG019|Overall Study|Withdrawal by Subject|0|||
105455069|NCT00591006|363675154|FG020|Overall Study|Withdrawal by Subject|0|||
105455070|NCT00591006|363675155|FG021|Overall Study|Withdrawal by Subject|0|||
105455071|NCT00591006|363675156|FG022|Overall Study|Withdrawal by Subject|0|||
105455072|NCT00591006|363675157|FG023|Overall Study|Withdrawal by Subject|1|||
105455073|NCT00591006|363675134|FG000|Overall Study|Adverse Event|0|||
105455074|NCT00591006|363675135|FG001|Overall Study|Adverse Event|0|||
105455075|NCT00591006|363675136|FG002|Overall Study|Adverse Event|0|||
105455076|NCT00591006|363675137|FG003|Overall Study|Adverse Event|0|||
105455077|NCT00591006|363675138|FG004|Overall Study|Adverse Event|0|||
105455078|NCT00591006|363675139|FG005|Overall Study|Adverse Event|0|||
105455079|NCT00591006|363675140|FG006|Overall Study|Adverse Event|0|||
105455080|NCT00591006|363675141|FG007|Overall Study|Adverse Event|0|||
105455081|NCT00591006|363675142|FG008|Overall Study|Adverse Event|0|||
105455082|NCT00591006|363675143|FG009|Overall Study|Adverse Event|0|||
105455083|NCT00591006|363675144|FG010|Overall Study|Adverse Event|0|||
105455084|NCT00591006|363675145|FG011|Overall Study|Adverse Event|0|||
105455085|NCT00591006|363675146|FG012|Overall Study|Adverse Event|0|||
105455086|NCT00591006|363675147|FG013|Overall Study|Adverse Event|0|||
105455087|NCT00591006|363675148|FG014|Overall Study|Adverse Event|0|||
105455088|NCT00591006|363675149|FG015|Overall Study|Adverse Event|0|||
105455089|NCT00591006|363675150|FG016|Overall Study|Adverse Event|0|||
105455090|NCT00591006|363675151|FG017|Overall Study|Adverse Event|0|||
105455091|NCT00591006|363675152|FG018|Overall Study|Adverse Event|0|||
105455092|NCT00591006|363675153|FG019|Overall Study|Adverse Event|0|||
105455093|NCT00591006|363675154|FG020|Overall Study|Adverse Event|0|||
105455094|NCT00591006|363675155|FG021|Overall Study|Adverse Event|0|||
105455095|NCT00591006|363675156|FG022|Overall Study|Adverse Event|1|||
105455096|NCT00591006|363675157|FG023|Overall Study|Adverse Event|0|||
105455097|NCT03557970|363675158|FG000|Overall Study|Study closure|1|||
105455098|NCT03557970|363675159|FG001|Overall Study|Study closure|0|||
105455099|NCT03557970|363675158|FG000|Overall Study|Physician Decision|0|||
105455100|NCT03557970|363675159|FG001|Overall Study|Physician Decision|1|||
105455101|NCT03557970|363675158|FG000|Overall Study|Death|0|||
105455102|NCT03557970|363675159|FG001|Overall Study|Death|1|||
105455103|NCT00112736|363675160|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
105455104|NCT00112736|363675161|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
105455105|NCT05435339|363675162|FG000|Overall Study|Death|1|||
105455106|NCT05435339|363675163|FG001|Overall Study|Death|0|||
105455107|NCT05435339|363675164|FG002|Overall Study|Death|3|||
105455108|NCT05435339|363675165|FG003|Overall Study|Death|1|||
105455109|NCT05435339|363675166|FG004|Overall Study|Death|3|||
105455110|NCT05435339|363675167|FG005|Overall Study|Death|2|||
105455111|NCT05435339|363675168|FG006|Overall Study|Death|4|||
105455112|NCT05435339|363675169|FG007|Overall Study|Death|6|||
105455113|NCT05435339|363675162|FG000|Overall Study|Sponsor Decision|0|||
105455114|NCT05435339|363675163|FG001|Overall Study|Sponsor Decision|1|||
105455115|NCT05435339|363675164|FG002|Overall Study|Sponsor Decision|0|||
105455116|NCT05435339|363675165|FG003|Overall Study|Sponsor Decision|0|||
105455117|NCT05435339|363675166|FG004|Overall Study|Sponsor Decision|2|||
105455118|NCT05435339|363675167|FG005|Overall Study|Sponsor Decision|1|||
105455119|NCT05435339|363675168|FG006|Overall Study|Sponsor Decision|2|||
105455120|NCT05435339|363675169|FG007|Overall Study|Sponsor Decision|2|||
105455121|NCT05435339|363675162|FG000|Overall Study|Withdrawal by Subject|0|||
105455122|NCT05435339|363675163|FG001|Overall Study|Withdrawal by Subject|0|||
105455123|NCT05435339|363675164|FG002|Overall Study|Withdrawal by Subject|0|||
105455124|NCT05435339|363675165|FG003|Overall Study|Withdrawal by Subject|0|||
105455125|NCT05435339|363675166|FG004|Overall Study|Withdrawal by Subject|1|||
105455126|NCT05435339|363675167|FG005|Overall Study|Withdrawal by Subject|0|||
105455127|NCT05435339|363675168|FG006|Overall Study|Withdrawal by Subject|1|||
105455128|NCT05435339|363675169|FG007|Overall Study|Withdrawal by Subject|1|||
105455129|NCT02343263|363675170|FG000|Overall Study|Physician Decision|5|||
105455130|NCT02343263|363675171|FG001|Overall Study|Physician Decision|3|||
105455131|NCT02343263|363675172|FG002|Overall Study|Physician Decision|1|||
105455132|NCT03040141|363675182|FG000|Overall Study|Death|1|||
105455133|NCT03040141|363675183|FG001|Overall Study|Death|2|||
105455134|NCT03040141|363675184|FG002|Overall Study|Death|3|||
105455135|NCT03040141|363675182|FG000|Overall Study|Withdrawal by Subject|3|||
105455136|NCT03040141|363675183|FG001|Overall Study|Withdrawal by Subject|1|||
105455137|NCT03040141|363675184|FG002|Overall Study|Withdrawal by Subject|1|||
105455138|NCT03040141|363675182|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
105455139|NCT03040141|363675183|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
105455140|NCT03040141|363675184|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
105455141|NCT03040141|363675182|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
105455142|NCT03040141|363675183|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
105455143|NCT03040141|363675184|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
105455144|NCT03155724|363675185|FG000|Overall Study|Death|3|||
105455145|NCT03155724|363675185|FG000|Overall Study|Physician Decision|1|||
105455146|NCT03155724|363675185|FG000|Overall Study|Study closure|7|||
105455147|NCT05135871|363675191|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
105455148|NCT05135871|363675192|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
105455149|NCT05135871|363675193|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
105455150|NCT05135871|363675194|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
105455151|NCT03289208|363675201|FG000|Overall Study|Adverse Event|1|||
105455152|NCT03289208|363675202|FG001|Overall Study|Adverse Event|0|||
105455153|NCT03289208|363675203|FG002|Overall Study|Adverse Event|0|||
105455154|NCT04258423|363675204|FG000|Overall Study|Study Closure|2|||
105455155|NCT04258423|363675205|FG001|Overall Study|Study Closure|2|||
105455156|NCT02354235|363675208|FG000|Overall Study|Adverse Event|2|||
105455157|NCT02354235|363675209|FG001|Overall Study|Adverse Event|2|||
105455158|NCT02354235|363675208|FG000|Overall Study|Physician Decision|0|||
105455159|NCT02354235|363675209|FG001|Overall Study|Physician Decision|1|||
105455160|NCT02354235|363675208|FG000|Overall Study|Withdrawal by Subject|1|||
105455161|NCT02354235|363675209|FG001|Overall Study|Withdrawal by Subject|3|||
105455162|NCT02354235|363675208|FG000|Overall Study|Conflict with the stopping criteria|0|||
105455163|NCT02354235|363675209|FG001|Overall Study|Conflict with the stopping criteria|1|||
105455164|NCT02656017|363677270|FG000|Overall Study|Study burden|3|||
105455165|NCT02656017|363677271|FG001|Overall Study|Study burden|3|||
105455166|NCT02656017|363677270|FG000|Overall Study|Adverse Event|2|||
105455167|NCT02656017|363677271|FG001|Overall Study|Adverse Event|1|||
105455168|NCT02656017|363677270|FG000|Overall Study|Unable/unwilling to take study medication|2|||
105455169|NCT02656017|363677271|FG001|Overall Study|Unable/unwilling to take study medication|1|||
105455170|NCT02656017|363677270|FG000|Overall Study|Began Tolvaptan|1|||
105455171|NCT02656017|363677271|FG001|Overall Study|Began Tolvaptan|1|||
105455172|NCT02656017|363677270|FG000|Overall Study|Withdrawal by Subject|1|||
105455173|NCT02656017|363677271|FG001|Overall Study|Withdrawal by Subject|0|||
105455174|NCT03661723|363677277|FG000|Overall Study|Disease Progression|4|||
105455175|NCT03661723|363677278|FG001|Overall Study|Disease Progression|24|||
105455176|NCT03661723|363677279|FG002|Overall Study|Disease Progression|4|||
105455177|NCT03661723|363677280|FG003|Overall Study|Disease Progression|19|||
105455178|NCT03661723|363677277|FG000|Overall Study|Withdrawal by Subject|1|||
105455179|NCT03661723|363677278|FG001|Overall Study|Withdrawal by Subject|0|||
105455180|NCT03661723|363677279|FG002|Overall Study|Withdrawal by Subject|2|||
105455181|NCT03661723|363677280|FG003|Overall Study|Withdrawal by Subject|4|||
105455182|NCT03661723|363677277|FG000|Overall Study|Physician Decision|1|||
105455183|NCT03661723|363677278|FG001|Overall Study|Physician Decision|0|||
105455184|NCT03661723|363677279|FG002|Overall Study|Physician Decision|0|||
105455185|NCT03661723|363677280|FG003|Overall Study|Physician Decision|0|||
105455186|NCT03661723|363677277|FG000|Overall Study|Clinical Deterioration|0|||
105455187|NCT03661723|363677278|FG001|Overall Study|Clinical Deterioration|0|||
105455188|NCT03661723|363677279|FG002|Overall Study|Clinical Deterioration|0|||
105455189|NCT03661723|363677280|FG003|Overall Study|Clinical Deterioration|1|||
105455190|NCT03760029|363677281|FG000|Overall Study|Death|1|||
105455191|NCT03760029|363677282|FG001|Overall Study|Death|0|||
105455192|NCT03760029|363677283|FG002|Overall Study|Death|0|||
105455193|NCT03760029|363677281|FG000|Overall Study|Lost to Follow-up|0|||
105455194|NCT03760029|363677282|FG001|Overall Study|Lost to Follow-up|2|||
105455195|NCT03760029|363677283|FG002|Overall Study|Lost to Follow-up|1|||
105455196|NCT03760029|363677281|FG000|Overall Study|Withdrawal by Subject|1|||
105455197|NCT03760029|363677282|FG001|Overall Study|Withdrawal by Subject|4|||
105455198|NCT03760029|363677283|FG002|Overall Study|Withdrawal by Subject|1|||
105455199|NCT03760029|363677281|FG000|Overall Study|Withdrawal by parent/guardian|4|||
105455200|NCT03760029|363677282|FG001|Overall Study|Withdrawal by parent/guardian|4|||
105455201|NCT03760029|363677283|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105455202|NCT03760029|363677281|FG000|Overall Study|Other|2|||
105455203|NCT03760029|363677282|FG001|Overall Study|Other|1|||
105455204|NCT03760029|363677283|FG002|Overall Study|Other|0|||
105455205|NCT02927301|363677289|FG000|Overall Study|Death|39|||
105455206|NCT02927301|363677289|FG000|Overall Study|Lost to Follow-up|8|||
105455207|NCT02927301|363677289|FG000|Overall Study|Physician Decision|2|||
105455208|NCT02927301|363677289|FG000|Overall Study|Withdrawal by Subject|12|||
105455209|NCT02927301|363677289|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
105455210|NCT04663321|363677290|FG000|Overall Study|Study terminated by Sponsor|2|||
105455211|NCT04663321|363677291|FG001|Overall Study|Study terminated by Sponsor|1|||
105455212|NCT04663321|363677292|FG002|Overall Study|Study terminated by Sponsor|2|||
105455213|NCT04663321|363677290|FG000|Overall Study|Withdrawal by Subject|10|||
105455214|NCT04663321|363677291|FG001|Overall Study|Withdrawal by Subject|3|||
105455215|NCT04663321|363677292|FG002|Overall Study|Withdrawal by Subject|2|||
105455216|NCT04663321|363677290|FG000|Overall Study|Not provided|0|||
105455217|NCT04663321|363677291|FG001|Overall Study|Not provided|0|||
105455218|NCT04663321|363677292|FG002|Overall Study|Not provided|1|||
105455219|NCT04247347|363677295|FG000|Overall Study|Withdrawal by Subject|2|||
105455220|NCT04247347|363677296|FG001|Overall Study|Withdrawal by Subject|3|||
105455221|NCT04247347|363677297|FG002|Overall Study|Withdrawal by Subject|3|||
105455222|NCT04247347|363677295|FG000|Overall Study|Lost to Follow-up|1|||
105455223|NCT04247347|363677296|FG001|Overall Study|Lost to Follow-up|1|||
105455224|NCT04247347|363677297|FG002|Overall Study|Lost to Follow-up|1|||
105455225|NCT03562195|363677298|FG000|Overall Study|Adverse Event|0|||
105455226|NCT03562195|363677299|FG001|Overall Study|Adverse Event|6|||
105455227|NCT03562195|363677298|FG000|Overall Study|Lack of Efficacy|0|||
105455228|NCT03562195|363677299|FG001|Overall Study|Lack of Efficacy|5|||
105455229|NCT03562195|363677298|FG000|Overall Study|Protocol Violation|0|||
105455230|NCT03562195|363677299|FG001|Overall Study|Protocol Violation|1|||
105455231|NCT03562195|363677298|FG000|Overall Study|Lost to Follow-up|0|||
105455232|NCT03562195|363677299|FG001|Overall Study|Lost to Follow-up|1|||
105455233|NCT03562195|363677298|FG000|Overall Study|Physician Decision|1|||
105455234|NCT03562195|363677299|FG001|Overall Study|Physician Decision|0|||
105455235|NCT03562195|363677298|FG000|Overall Study|Withdrawal by Subject|3|||
105455236|NCT03562195|363677299|FG001|Overall Study|Withdrawal by Subject|0|||
105455237|NCT02529852|363677300|FG000|Overall Study|Withdrawal by Subject|2|||
105455238|NCT03532542|363677301|FG000|Overall Study|Death|1|||
105455239|NCT03532542|363677302|FG001|Overall Study|Death|0|||
105455240|NCT03532542|363677301|FG000|Overall Study|Study Terminated by Sponsor|41|||
105455241|NCT03532542|363677302|FG001|Overall Study|Study Terminated by Sponsor|65|||
105455242|NCT03532542|363677301|FG000|Overall Study|Withdrawal by Subject|6|||
105336992|NCT00090220|363234761|FG000|Base Study Follow-up Period|Patient Moved|20|||
105455243|NCT03532542|363677302|FG001|Overall Study|Withdrawal by Subject|5|||
105455244|NCT01962441|363677303|FG000|Randomized Period|Randomized but Never Treated|4|||
105455245|NCT01962441|363677304|FG001|Randomized Period|Randomized but Never Treated|2|||
105455246|NCT01962441|363677305|FG002|Randomized Period|Randomized but Never Treated|3|||
105455247|NCT01962441|363677303|FG000|Randomized Period|Lost to Follow-up|2|||
105455248|NCT01962441|363677304|FG001|Randomized Period|Lost to Follow-up|4|||
105455249|NCT01962441|363677305|FG002|Randomized Period|Lost to Follow-up|4|||
105455250|NCT01962441|363677303|FG000|Randomized Period|Withdrew Consent|3|||
105455251|NCT01962441|363677304|FG001|Randomized Period|Withdrew Consent|3|||
105455252|NCT01962441|363677305|FG002|Randomized Period|Withdrew Consent|2|||
105455253|NCT01962441|363677303|FG000|Randomized Period|Adverse Event|1|||
105455254|NCT01962441|363677304|FG001|Randomized Period|Adverse Event|1|||
105455255|NCT01962441|363677305|FG002|Randomized Period|Adverse Event|0|||
105455256|NCT01962441|363677303|FG000|Randomized Period|Death|0|||
105455257|NCT01962441|363677304|FG001|Randomized Period|Death|0|||
105455258|NCT01962441|363677305|FG002|Randomized Period|Death|2|||
105455259|NCT01962441|363677303|FG000|Randomized Period|Protocol Violation|0|||
105455260|NCT01962441|363677304|FG001|Randomized Period|Protocol Violation|1|||
105455261|NCT01962441|363677305|FG002|Randomized Period|Protocol Violation|0|||
105455262|NCT01962441|363677303|FG000|Retreatment Substudy|Lack of Efficacy|1|||
105455263|NCT01962441|363677304|FG001|Retreatment Substudy|Lack of Efficacy|0|||
105455264|NCT01962441|363677305|FG002|Retreatment Substudy|Lack of Efficacy|0|||
105455265|NCT01962441|363677303|FG000|Retreatment Substudy|Lost to Follow-up|1|||
105455266|NCT01962441|363677304|FG001|Retreatment Substudy|Lost to Follow-up|0|||
105455267|NCT01962441|363677305|FG002|Retreatment Substudy|Lost to Follow-up|0|||
105455268|NCT00117637|363677306|FG000|First Intervention (Period 1)|Adverse Event|11|||
105455269|NCT00117637|363677307|FG001|First Intervention (Period 1)|Adverse Event|16|||
105455270|NCT00117637|363677306|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
105455271|NCT00117637|363677307|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
105455272|NCT00117637|363677306|FG000|First Intervention (Period 1)|Protocol Violation|1|||
105455273|NCT00117637|363677307|FG001|First Intervention (Period 1)|Protocol Violation|0|||
105455274|NCT00117637|363677306|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
105455275|NCT00117637|363677307|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
105455276|NCT00117637|363677306|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
105455277|NCT00117637|363677307|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
105455278|NCT00117637|363677306|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
105455279|NCT00117637|363677307|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
105455280|NCT00117637|363677306|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
105455281|NCT00117637|363677307|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
105455282|NCT00117637|363677306|FG000|First Intervention (Period 1)|reason not reported|0|||
105455283|NCT00117637|363677307|FG001|First Intervention (Period 1)|reason not reported|1|||
105455284|NCT00117637|363677306|FG000|Second Intervention (Period 2)|Adverse Event|0|||
105455285|NCT00117637|363677307|FG001|Second Intervention (Period 2)|Adverse Event|9|||
105455286|NCT00117637|363677306|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
105455287|NCT00117637|363677307|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
105455288|NCT00117637|363677306|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
105455289|NCT00117637|363677307|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
105455290|NCT00117637|363677306|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
105455291|NCT00117637|363677307|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
105455292|NCT00117637|363677306|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
105455293|NCT00117637|363677307|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
105455294|NCT00117637|363677306|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
105455295|NCT00117637|363677307|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
105455296|NCT00117637|363677306|FG000|Second Intervention (Period 2)|reason not reported|1|||
105455297|NCT00117637|363677307|FG001|Second Intervention (Period 2)|reason not reported|0|||
105455298|NCT02269124|363677313|FG000|Overall Study|Lost to Follow-up|1|||
105455299|NCT02269124|363677314|FG001|Overall Study|Lost to Follow-up|0|||
105336993|NCT00090220|363234762|FG001|Base Study Follow-up Period|Patient Moved|28|||
105336994|NCT00090220|363234763|FG002|Base Study Follow-up Period|Patient Moved|0|||
105336995|NCT00090220|363234764|FG003|Base Study Follow-up Period|Patient Moved|0|||
105336996|NCT00090220|363234765|FG004|Base Study Follow-up Period|Patient Moved|0|||
105336997|NCT00090220|363234766|FG005|Base Study Follow-up Period|Patient Moved|0|||
105336998|NCT00090220|363234761|FG000|Base Study Follow-up Period|Other|19|||
105336999|NCT00090220|363234762|FG001|Base Study Follow-up Period|Other|21|||
105455300|NCT02269124|363677313|FG000|Overall Study|Withdrawal by Subject|0|||
105455301|NCT02269124|363677314|FG001|Overall Study|Withdrawal by Subject|2|||
105455302|NCT00097500|363677315|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
105455303|NCT00097500|363677316|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
105455304|NCT00097500|363677315|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
105455305|NCT00097500|363677316|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
105455306|NCT00097500|363677315|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
105455307|NCT00097500|363677316|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
105455308|NCT00097500|363677315|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
105337000|NCT00090220|363234763|FG002|Base Study Follow-up Period|Other|0|||
105337001|NCT00090220|363234764|FG003|Base Study Follow-up Period|Other|0|||
105337002|NCT00090220|363234765|FG004|Base Study Follow-up Period|Other|0|||
105337003|NCT00090220|363234766|FG005|Base Study Follow-up Period|Other|0|||
105337004|NCT00090220|363234761|FG000|Extension 1 (EXT1)|Adverse Event|0|||
105337005|NCT00090220|363234762|FG001|Extension 1 (EXT1)|Adverse Event|0|||
105337006|NCT00090220|363234763|FG002|Extension 1 (EXT1)|Adverse Event|4|||
105337007|NCT00090220|363234764|FG003|Extension 1 (EXT1)|Adverse Event|0|||
105337008|NCT00090220|363234765|FG004|Extension 1 (EXT1)|Adverse Event|0|||
105337009|NCT00090220|363234766|FG005|Extension 1 (EXT1)|Adverse Event|0|||
105337010|NCT00090220|363234761|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
105337011|NCT00090220|363234762|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
105337012|NCT00090220|363234763|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
105337013|NCT00090220|363234764|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
105337014|NCT00090220|363234765|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
105337015|NCT00090220|363234766|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
105337016|NCT00090220|363234761|FG000|Extension 1 (EXT1)|Moved|0|||
105337017|NCT00090220|363234762|FG001|Extension 1 (EXT1)|Moved|0|||
105337018|NCT00090220|363234763|FG002|Extension 1 (EXT1)|Moved|2|||
105337019|NCT00090220|363234764|FG003|Extension 1 (EXT1)|Moved|1|||
105337020|NCT00090220|363234765|FG004|Extension 1 (EXT1)|Moved|0|||
105337021|NCT00090220|363234766|FG005|Extension 1 (EXT1)|Moved|0|||
105337022|NCT00090220|363234761|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
105337023|NCT00090220|363234762|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
105337024|NCT00090220|363234763|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
105337025|NCT00090220|363234764|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
105337026|NCT00090220|363234765|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
105337027|NCT00090220|363234766|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
105337028|NCT00090220|363234761|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
105337029|NCT00090220|363234762|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
105337030|NCT00090220|363234763|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
105455309|NCT00097500|363677316|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
105455310|NCT00097500|363677315|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
105455311|NCT00097500|363677316|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
105455312|NCT00097500|363677315|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
105455313|NCT00097500|363677316|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
105455314|NCT00097500|363677315|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
105455315|NCT00097500|363677316|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
105455316|NCT00642356|363677323|FG000|Overall Study|Adverse Event|1|||
105455317|NCT00642356|363677324|FG001|Overall Study|Adverse Event|0|||
105455318|NCT00642356|363677323|FG000|Overall Study|Protocol Violation|0|||
105455319|NCT00642356|363677324|FG001|Overall Study|Protocol Violation|3|||
105455320|NCT00642356|363677323|FG000|Overall Study|Lack of Efficacy|1|||
105455321|NCT00642356|363677324|FG001|Overall Study|Lack of Efficacy|0|||
105455322|NCT00686777|363677327|FG000|Overall Study|Adverse Event|2|||
105455323|NCT00686777|363677327|FG000|Overall Study|Pregnancy|1|||
105455324|NCT00686777|363677327|FG000|Overall Study|Withdrawal by Subject|2|||
105455325|NCT00686777|363677327|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
105455326|NCT00686777|363677327|FG000|Overall Study|No Visit|1|||
105455327|NCT00883779|363677328|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
105455328|NCT00883779|363677329|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
105455329|NCT00883779|363677328|FG000|Primary Study Treatment Phase|Disease progression|75|||
105455330|NCT00883779|363677329|FG001|Primary Study Treatment Phase|Disease progression|59|||
105455331|NCT00883779|363677328|FG000|Primary Study Treatment Phase|Adverse Event|16|||
105455332|NCT00883779|363677329|FG001|Primary Study Treatment Phase|Adverse Event|16|||
105455333|NCT00883779|363677328|FG000|Primary Study Treatment Phase|Death|2|||
105337031|NCT00090220|363234764|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
105337032|NCT00090220|363234765|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
105337033|NCT00090220|363234766|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
105455334|NCT00883779|363677329|FG001|Primary Study Treatment Phase|Death|3|||
105455335|NCT00883779|363677328|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
105337034|NCT00090220|363234761|FG000|Extension 1 (EXT1)|Other reason|0|||
105337035|NCT00090220|363234762|FG001|Extension 1 (EXT1)|Other reason|0|||
105455336|NCT00883779|363677329|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
105455337|NCT00883779|363677328|FG000|Primary Study Treatment Phase|Other|3|||
105455338|NCT00883779|363677329|FG001|Primary Study Treatment Phase|Other|0|||
105455339|NCT00883779|363677328|FG000|Post-Study Treatment Phase|Adverse Event|2|||
105455340|NCT00883779|363677329|FG001|Post-Study Treatment Phase|Adverse Event|3|||
105455341|NCT00883779|363677328|FG000|Post-Study Treatment Phase|Death|1|||
105455342|NCT00883779|363677329|FG001|Post-Study Treatment Phase|Death|3|||
105455343|NCT00883779|363677328|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
105455344|NCT00883779|363677329|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
105455345|NCT00883779|363677328|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
105455346|NCT00883779|363677329|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
105455347|NCT00883779|363677328|FG000|Post-Study Treatment Phase|Disease progression|103|||
105455348|NCT00883779|363677329|FG001|Post-Study Treatment Phase|Disease progression|122|||
105455349|NCT00883779|363677328|FG000|Post-Study Treatment Phase|Other|3|||
105455350|NCT00883779|363677329|FG001|Post-Study Treatment Phase|Other|0|||
105455351|NCT00883779|363677328|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
105455352|NCT00883779|363677329|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
105455353|NCT00883779|363677328|FG000|Off-study Phase|Death|185|||
105455354|NCT00883779|363677329|FG001|Off-study Phase|Death|174|||
105455355|NCT00883779|363677328|FG000|Off-study Phase|Refused treatment|1|||
105455356|NCT00883779|363677329|FG001|Off-study Phase|Refused treatment|1|||
105455357|NCT00883779|363677328|FG000|Off-study Phase|Failure to return|5|||
105455358|NCT00883779|363677329|FG001|Off-study Phase|Failure to return|6|||
105455359|NCT00883779|363677328|FG000|Off-study Phase|Other|18|||
105455360|NCT00883779|363677329|FG001|Off-study Phase|Other|21|||
105455361|NCT04913610|363677330|FG000|Randomized Participants|Did Not Receive Treatment|0|||
105455362|NCT04913610|363677331|FG001|Randomized Participants|Did Not Receive Treatment|0|||
105455363|NCT04913610|363677332|FG002|Randomized Participants|Did Not Receive Treatment|1|||
105455364|NCT04913610|363677333|FG003|Randomized Participants|Did Not Receive Treatment|1|||
105455365|NCT04913610|363677334|FG004|Randomized Participants|Did Not Receive Treatment|0|||
105455366|NCT04913610|363677330|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
105455367|NCT04913610|363677331|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
105455368|NCT04913610|363677332|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
105455369|NCT04913610|363677333|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
105455370|NCT04913610|363677334|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
105455371|NCT02913482|363677335|FG000|Overall Study|Death|0|||
105455372|NCT02913482|363677336|FG001|Overall Study|Death|2|||
105455373|NCT02913482|363677337|FG002|Overall Study|Death|2|||
105455374|NCT02913482|363677335|FG000|Overall Study|Progressive Disease|1|||
105455375|NCT02913482|363677336|FG001|Overall Study|Progressive Disease|1|||
105455376|NCT02913482|363677337|FG002|Overall Study|Progressive Disease|1|||
105455377|NCT02913482|363677335|FG000|Overall Study|Reason not specified|0|||
105455378|NCT02913482|363677336|FG001|Overall Study|Reason not specified|0|||
105455379|NCT02913482|363677337|FG002|Overall Study|Reason not specified|1|||
105455380|NCT02913482|363677335|FG000|Overall Study|Withdrawal by Subject|0|||
105455381|NCT02913482|363677336|FG001|Overall Study|Withdrawal by Subject|1|||
105455382|NCT02913482|363677337|FG002|Overall Study|Withdrawal by Subject|1|||
105455383|NCT00549640|363677338|FG000|Overall Study|Withdrawal by Subject|6|||
105455384|NCT00549640|363677339|FG001|Overall Study|Withdrawal by Subject|12|||
105455385|NCT00549640|363677338|FG000|Overall Study|Adverse Event|5|||
105455386|NCT00549640|363677339|FG001|Overall Study|Adverse Event|0|||
105455387|NCT00549640|363677338|FG000|Overall Study|Lost to Follow-up|7|||
105455388|NCT00549640|363677339|FG001|Overall Study|Lost to Follow-up|4|||
105455389|NCT01046565|363677340|FG000|Overall Study|Adverse Event|2|||
105455390|NCT01046565|363677340|FG000|Overall Study|Withdrawal by Subject|7|||
105455391|NCT01476722|363677341|FG000|Overall Study|Adverse Event|1|||
105455392|NCT02978417|363677342|FG000|Overall Study|Lost to Follow-up|2|||
105455393|NCT02978417|363677343|FG001|Overall Study|Lost to Follow-up|2|||
105455394|NCT00317473|363677346|FG000|Overall Study|Withdrawal by Subject|2|||
105455395|NCT00317473|363677347|FG001|Overall Study|Withdrawal by Subject|1|||
105455396|NCT00317473|363677348|FG002|Overall Study|Withdrawal by Subject|2|||
105455397|NCT00317473|363677349|FG003|Overall Study|Withdrawal by Subject|1|||
105455398|NCT00317473|363677350|FG004|Overall Study|Withdrawal by Subject|3|||
105455399|NCT00317473|363677351|FG005|Overall Study|Withdrawal by Subject|1|||
105455400|NCT00317473|363677346|FG000|Overall Study|Relocation|1|||
105455401|NCT00317473|363677347|FG001|Overall Study|Relocation|0|||
105455402|NCT00317473|363677348|FG002|Overall Study|Relocation|1|||
105455403|NCT00317473|363677349|FG003|Overall Study|Relocation|1|||
105455404|NCT00317473|363677350|FG004|Overall Study|Relocation|5|||
105455405|NCT00317473|363677351|FG005|Overall Study|Relocation|2|||
105455406|NCT00317473|363677346|FG000|Overall Study|Death|1|||
105455407|NCT00317473|363677347|FG001|Overall Study|Death|0|||
105455408|NCT00317473|363677348|FG002|Overall Study|Death|0|||
105455409|NCT00317473|363677349|FG003|Overall Study|Death|0|||
105455410|NCT00317473|363677350|FG004|Overall Study|Death|0|||
105455411|NCT00317473|363677351|FG005|Overall Study|Death|0|||
105455412|NCT00317473|363677346|FG000|Overall Study|Other|0|||
105455413|NCT00317473|363677347|FG001|Overall Study|Other|2|||
105455414|NCT00317473|363677348|FG002|Overall Study|Other|0|||
105455415|NCT00317473|363677349|FG003|Overall Study|Other|0|||
105455416|NCT00317473|363677350|FG004|Overall Study|Other|0|||
105455417|NCT00317473|363677351|FG005|Overall Study|Other|0|||
105455418|NCT02051764|363677352|FG000|Overall Study|Study terminated by sponsor|0|||
105455419|NCT02051764|363677353|FG001|Overall Study|Study terminated by sponsor|7|||
105455420|NCT00685165|363677354|FG000|Washout Period of 14 Days|Adverse Event|1|||
105784864|NCT01012765|364864412|FG002|Treatment Period 2|Withdrawal by Subject|1|||
105455421|NCT00685165|363677355|FG001|Washout Period of 14 Days|Adverse Event|0|||
105455422|NCT00795535|363677364|FG000|Overall Study|incomplete data and technical problems|20|||
105455423|NCT03353675|363677366|FG000|Overall Study|Adverse Event|4|||
105455424|NCT03309020|363677367|FG000|Overall Study|Death|1|||
105784865|NCT01012765|364864413|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105784866|NCT01012765|364864414|FG004|Treatment Period 2|Withdrawal by Subject|1|||
105784867|NCT01012765|364864415|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105784868|NCT01012765|364864410|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
105784869|NCT01012765|364864411|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
105784870|NCT01012765|364864412|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
105784871|NCT01012765|364864413|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
105784872|NCT01012765|364864414|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
105784873|NCT01012765|364864415|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
105784874|NCT01012765|364864410|FG000|Treatment Period 2|Adverse Event|0|||
105784875|NCT01012765|364864411|FG001|Treatment Period 2|Adverse Event|1|||
105784876|NCT01012765|364864412|FG002|Treatment Period 2|Adverse Event|1|||
105784877|NCT01012765|364864413|FG003|Treatment Period 2|Adverse Event|0|||
105784878|NCT01012765|364864414|FG004|Treatment Period 2|Adverse Event|0|||
105784879|NCT01012765|364864415|FG005|Treatment Period 2|Adverse Event|0|||
105784880|NCT01012765|364864410|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
105784881|NCT01012765|364864411|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
105784882|NCT01012765|364864412|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
105784883|NCT01012765|364864413|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
105784884|NCT01012765|364864414|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
105784885|NCT01012765|364864415|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
105784886|NCT02219477|364864416|FG000|Overall Study|Adverse Event|0|||
105784887|NCT02219477|364864417|FG001|Overall Study|Adverse Event|1|||
105784888|NCT02219477|364864418|FG002|Overall Study|Adverse Event|1|||
105784889|NCT02219477|364864416|FG000|Overall Study|Withdrawal by Subject|0|||
105784890|NCT02219477|364864417|FG001|Overall Study|Withdrawal by Subject|1|||
105784891|NCT02219477|364864418|FG002|Overall Study|Withdrawal by Subject|0|||
105784892|NCT05147311|364864419|FG000|Overall Study|Did not complete survey|2|||
105784893|NCT05147311|364864420|FG001|Overall Study|Did not complete survey|1|||
105784894|NCT05147311|364864419|FG000|Overall Study|Patient too sick|1|||
105784895|NCT05147311|364864420|FG001|Overall Study|Patient too sick|2|||
105784896|NCT05147311|364864419|FG000|Overall Study|Death|0|||
105784897|NCT05147311|364864420|FG001|Overall Study|Death|1|||
105784898|NCT05147311|364864419|FG000|Overall Study|Declined survey|1|||
105784899|NCT05147311|364864420|FG001|Overall Study|Declined survey|0|||
105784900|NCT00499694|364864423|FG000|Overall Study|Patient never received treatment.|1|||
105784901|NCT02304484|364864424|FG000|Overall Study|Death|9|||
105784902|NCT02304484|364864424|FG000|Overall Study|Withdrawal by Subject|14|||
105784903|NCT02304484|364864424|FG000|Overall Study|Lost to Follow-up|2|||
105784904|NCT02967055|364864425|FG000|Overall Study|Excluded|40|||
105784905|NCT02967055|364864425|FG000|Overall Study|Screen fail|3|||
105784906|NCT02967055|364864425|FG000|Overall Study|Lost to Follow-up|2|||
105784907|NCT02967055|364864425|FG000|Overall Study|Stopped due to side effects|3|||
105455425|NCT03309020|363677368|FG001|Overall Study|Death|0|||
105455426|NCT03309020|363677367|FG000|Overall Study|Did not undergo surgery|2|||
105455427|NCT03309020|363677368|FG001|Overall Study|Did not undergo surgery|1|||
105455428|NCT02741245|363677369|FG000|Overall Study|Adverse Event|0|||
105455429|NCT02741245|363677370|FG001|Overall Study|Adverse Event|0|||
105455430|NCT02741245|363677371|FG002|Overall Study|Adverse Event|0|||
105455431|NCT02741245|363677372|FG003|Overall Study|Adverse Event|2|||
105455432|NCT02741245|363677373|FG004|Overall Study|Adverse Event|2|||
105455433|NCT02741245|363677369|FG000|Overall Study|Protocol Violation|0|||
105455434|NCT02741245|363677370|FG001|Overall Study|Protocol Violation|1|||
105455435|NCT02741245|363677371|FG002|Overall Study|Protocol Violation|0|||
105455436|NCT02741245|363677372|FG003|Overall Study|Protocol Violation|1|||
105455437|NCT02741245|363677373|FG004|Overall Study|Protocol Violation|0|||
105455438|NCT02741245|363677369|FG000|Overall Study|Withdrawal by Subject|0|||
105455439|NCT02741245|363677370|FG001|Overall Study|Withdrawal by Subject|0|||
105455440|NCT02741245|363677371|FG002|Overall Study|Withdrawal by Subject|0|||
105455441|NCT02741245|363677372|FG003|Overall Study|Withdrawal by Subject|1|||
105455442|NCT02741245|363677373|FG004|Overall Study|Withdrawal by Subject|0|||
105455443|NCT00601835|363677376|FG000|Overall Study|Withdrawal by Subject|9|||
105455444|NCT00601835|363677377|FG001|Overall Study|Withdrawal by Subject|6|||
105455445|NCT00601835|363677376|FG000|Overall Study|Physician Decision|1|||
105455446|NCT00601835|363677377|FG001|Overall Study|Physician Decision|0|||
105455447|NCT00601835|363677376|FG000|Overall Study|Lost to Follow-up|37|||
105455448|NCT00601835|363677377|FG001|Overall Study|Lost to Follow-up|5|||
105455449|NCT00601835|363677376|FG000|Overall Study|Adverse Event|1|||
105455450|NCT00601835|363677377|FG001|Overall Study|Adverse Event|1|||
105455451|NCT00601835|363677376|FG000|Overall Study|Relocate|12|||
105455452|NCT00601835|363677377|FG001|Overall Study|Relocate|2|||
105455453|NCT03361137|363677380|FG000|Overall Study|Reason not specified|1|||
105455454|NCT03361137|363677381|FG001|Overall Study|Reason not specified|0|||
105455455|NCT03361137|363677382|FG002|Overall Study|Reason not specified|0|||
105455456|NCT03361137|363677383|FG003|Overall Study|Reason not specified|0|||
105455457|NCT03361137|363677384|FG004|Overall Study|Reason not specified|0|||
105455458|NCT01253291|363677385|FG000|Overall Study|Withdrawal by Subject|1|||
105455459|NCT01253291|363677386|FG001|Overall Study|Withdrawal by Subject|1|||
105455460|NCT01253291|363677387|FG002|Overall Study|Withdrawal by Subject|0|||
105455461|NCT01253291|363677388|FG003|Overall Study|Withdrawal by Subject|0|||
105455462|NCT01253291|363677389|FG004|Overall Study|Withdrawal by Subject|0|||
105455463|NCT01253291|363677385|FG000|Overall Study|Adverse Event|0|||
105455464|NCT01253291|363677386|FG001|Overall Study|Adverse Event|1|||
105455465|NCT01253291|363677387|FG002|Overall Study|Adverse Event|0|||
105455466|NCT01253291|363677388|FG003|Overall Study|Adverse Event|0|||
105455467|NCT01253291|363677389|FG004|Overall Study|Adverse Event|0|||
105455468|NCT01253291|363677385|FG000|Overall Study|Lack of Efficacy|1|||
105455469|NCT01253291|363677386|FG001|Overall Study|Lack of Efficacy|0|||
105455470|NCT01253291|363677387|FG002|Overall Study|Lack of Efficacy|0|||
105455471|NCT01253291|363677388|FG003|Overall Study|Lack of Efficacy|0|||
105455472|NCT01253291|363677389|FG004|Overall Study|Lack of Efficacy|0|||
105455473|NCT01253291|363677385|FG000|Overall Study|Physician Decision|2|||
105455474|NCT01253291|363677386|FG001|Overall Study|Physician Decision|0|||
105455475|NCT01253291|363677387|FG002|Overall Study|Physician Decision|0|||
105455476|NCT01253291|363677388|FG003|Overall Study|Physician Decision|0|||
105455477|NCT01253291|363677389|FG004|Overall Study|Physician Decision|2|||
105455478|NCT01486966|363677390|FG000|Overall Study|Adverse Event|0|||
105455479|NCT01486966|363677391|FG001|Overall Study|Adverse Event|1|||
105455480|NCT01486966|363677390|FG000|Overall Study|Withdrawal by Subject|0|||
105455481|NCT01486966|363677391|FG001|Overall Study|Withdrawal by Subject|1|||
105455482|NCT00506350|363677399|FG000|Overall Study|Serious Adverse Event|1|||
105455483|NCT00506350|363677400|FG001|Overall Study|Serious Adverse Event|0|||
105455484|NCT00506350|363677401|FG002|Overall Study|Serious Adverse Event|0|||
105455485|NCT00506350|363677402|FG003|Overall Study|Serious Adverse Event|0|||
105455486|NCT00506350|363677403|FG004|Overall Study|Serious Adverse Event|0|||
105455487|NCT00506350|363677404|FG005|Overall Study|Serious Adverse Event|0|||
105455488|NCT00506350|363677405|FG006|Overall Study|Serious Adverse Event|0|||
105455489|NCT00506350|363677406|FG007|Overall Study|Serious Adverse Event|0|||
105455490|NCT00506350|363677407|FG008|Overall Study|Serious Adverse Event|0|||
105455491|NCT00506350|363677399|FG000|Overall Study|Adverse Event|0|||
105455492|NCT00506350|363677400|FG001|Overall Study|Adverse Event|0|||
105455493|NCT00506350|363677401|FG002|Overall Study|Adverse Event|0|||
105455494|NCT00506350|363677402|FG003|Overall Study|Adverse Event|0|||
105455495|NCT00506350|363677403|FG004|Overall Study|Adverse Event|0|||
105455496|NCT00506350|363677404|FG005|Overall Study|Adverse Event|0|||
105455497|NCT00506350|363677405|FG006|Overall Study|Adverse Event|0|||
105455498|NCT00506350|363677406|FG007|Overall Study|Adverse Event|1|||
105455499|NCT00506350|363677407|FG008|Overall Study|Adverse Event|1|||
105455500|NCT00506350|363677399|FG000|Overall Study|Protocol Violation|0|||
105455501|NCT00506350|363677400|FG001|Overall Study|Protocol Violation|0|||
105455502|NCT00506350|363677401|FG002|Overall Study|Protocol Violation|1|||
105455503|NCT00506350|363677402|FG003|Overall Study|Protocol Violation|0|||
105455504|NCT00506350|363677403|FG004|Overall Study|Protocol Violation|0|||
105455505|NCT00506350|363677404|FG005|Overall Study|Protocol Violation|0|||
105455506|NCT00506350|363677405|FG006|Overall Study|Protocol Violation|1|||
105455507|NCT00506350|363677406|FG007|Overall Study|Protocol Violation|0|||
105455508|NCT00506350|363677407|FG008|Overall Study|Protocol Violation|0|||
105455509|NCT00506350|363677399|FG000|Overall Study|Withdrawal by Subject|0|||
105455510|NCT00506350|363677400|FG001|Overall Study|Withdrawal by Subject|1|||
105455511|NCT00506350|363677401|FG002|Overall Study|Withdrawal by Subject|1|||
105455512|NCT00506350|363677402|FG003|Overall Study|Withdrawal by Subject|1|||
105455513|NCT00506350|363677403|FG004|Overall Study|Withdrawal by Subject|4|||
105455514|NCT00506350|363677404|FG005|Overall Study|Withdrawal by Subject|1|||
105455515|NCT00506350|363677405|FG006|Overall Study|Withdrawal by Subject|1|||
105455516|NCT00506350|363677406|FG007|Overall Study|Withdrawal by Subject|2|||
105455517|NCT00506350|363677407|FG008|Overall Study|Withdrawal by Subject|0|||
105455518|NCT00506350|363677399|FG000|Overall Study|Lost to Follow-up|1|||
105455519|NCT00506350|363677400|FG001|Overall Study|Lost to Follow-up|1|||
105455520|NCT00506350|363677401|FG002|Overall Study|Lost to Follow-up|1|||
105455521|NCT00506350|363677402|FG003|Overall Study|Lost to Follow-up|1|||
105455522|NCT00506350|363677403|FG004|Overall Study|Lost to Follow-up|2|||
105455523|NCT00506350|363677404|FG005|Overall Study|Lost to Follow-up|1|||
105455524|NCT00506350|363677405|FG006|Overall Study|Lost to Follow-up|0|||
105455525|NCT00506350|363677406|FG007|Overall Study|Lost to Follow-up|0|||
105455526|NCT00506350|363677407|FG008|Overall Study|Lost to Follow-up|2|||
105455527|NCT00506350|363677399|FG000|Overall Study|Medical Reason|0|||
105455528|NCT00506350|363677400|FG001|Overall Study|Medical Reason|0|||
105455529|NCT00506350|363677401|FG002|Overall Study|Medical Reason|0|||
105455530|NCT00506350|363677402|FG003|Overall Study|Medical Reason|0|||
105455531|NCT00506350|363677403|FG004|Overall Study|Medical Reason|1|||
105455532|NCT00506350|363677404|FG005|Overall Study|Medical Reason|0|||
105455533|NCT00506350|363677405|FG006|Overall Study|Medical Reason|0|||
105455534|NCT00506350|363677406|FG007|Overall Study|Medical Reason|0|||
105455535|NCT00506350|363677407|FG008|Overall Study|Medical Reason|0|||
105455536|NCT00506350|363677399|FG000|Overall Study|Other|1|||
105455537|NCT00506350|363677400|FG001|Overall Study|Other|1|||
105455538|NCT00506350|363677401|FG002|Overall Study|Other|3|||
105455539|NCT00506350|363677402|FG003|Overall Study|Other|0|||
105455540|NCT00506350|363677403|FG004|Overall Study|Other|3|||
105455541|NCT00506350|363677404|FG005|Overall Study|Other|0|||
105455542|NCT00506350|363677405|FG006|Overall Study|Other|0|||
105455543|NCT00506350|363677406|FG007|Overall Study|Other|2|||
105455544|NCT00506350|363677407|FG008|Overall Study|Other|2|||
105455545|NCT04972786|363677408|FG000|First Intervention (1 Day)|Adverse Event|1|||
105455546|NCT04972786|363677409|FG001|First Intervention (1 Day)|Adverse Event|0|||
105550204|NCT00467870|364014379|FG005|Overall Study|Withdrawal by Subject|1|||
105455547|NCT01419236|363679465|FG000|Overall Study|Adverse Event|1|||
105455548|NCT01419236|363679466|FG001|Overall Study|Adverse Event|0|||
105455549|NCT01419236|363679465|FG000|Overall Study|Lack of Efficacy|0|||
105455550|NCT01419236|363679466|FG001|Overall Study|Lack of Efficacy|1|||
105455551|NCT01419236|363679465|FG000|Overall Study|Lost to Follow-up|1|||
105455552|NCT01419236|363679466|FG001|Overall Study|Lost to Follow-up|0|||
105455553|NCT01419236|363679465|FG000|Overall Study|Physician Decision|1|||
105337036|NCT00090220|363234763|FG002|Extension 1 (EXT1)|Other reason|2|||
105337037|NCT00090220|363234764|FG003|Extension 1 (EXT1)|Other reason|0|||
105455554|NCT01419236|363679466|FG001|Overall Study|Physician Decision|0|||
105455555|NCT01419236|363679465|FG000|Overall Study|Withdrawal by Subject|1|||
105455556|NCT01419236|363679466|FG001|Overall Study|Withdrawal by Subject|4|||
105455557|NCT01419236|363679465|FG000|Overall Study|Entry Criteria Not Met|1|||
105455558|NCT01419236|363679466|FG001|Overall Study|Entry Criteria Not Met|0|||
105455559|NCT01405768|363679467|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
105455560|NCT01405768|363679468|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
105455561|NCT01393158|363679469|FG000|Overall Study|Adverse Event|1|||
105455562|NCT01393158|363679470|FG001|Overall Study|Adverse Event|0|||
105455563|NCT01690052|363679473|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
105455564|NCT01690052|363679474|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
105455565|NCT01453049|363679475|FG000|Overall Study|Protocol Violation|2|||
105455566|NCT01453049|363679476|FG001|Overall Study|Protocol Violation|5|||
105455567|NCT01453049|363679475|FG000|Overall Study|Lost to Follow-up|2|||
105455568|NCT01453049|363679476|FG001|Overall Study|Lost to Follow-up|1|||
105455569|NCT01453049|363679475|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
105455570|NCT01453049|363679476|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
105455571|NCT01453049|363679475|FG000|Overall Study|Withdrawal by Subject|1|||
105455572|NCT01453049|363679476|FG001|Overall Study|Withdrawal by Subject|0|||
105455573|NCT01453049|363679475|FG000|Overall Study|Randomized in Error|1|||
105337038|NCT00090220|363234765|FG004|Extension 1 (EXT1)|Other reason|0|||
105337039|NCT00090220|363234766|FG005|Extension 1 (EXT1)|Other reason|0|||
105455574|NCT01453049|363679476|FG001|Overall Study|Randomized in Error|0|||
105455575|NCT03287791|363679482|FG000|Overall Study|Insufficient Therapeutic Response|0|||
105455576|NCT03287791|363679483|FG001|Overall Study|Insufficient Therapeutic Response|0|||
105455577|NCT03287791|363679484|FG002|Overall Study|Insufficient Therapeutic Response|1|||
105455578|NCT03287791|363679482|FG000|Overall Study|Adverse Event|0|||
105455579|NCT03287791|363679483|FG001|Overall Study|Adverse Event|4|||
105455580|NCT03287791|363679484|FG002|Overall Study|Adverse Event|3|||
105455581|NCT03287791|363679482|FG000|Overall Study|Withdrawal by Subject|12|||
105455582|NCT03287791|363679483|FG001|Overall Study|Withdrawal by Subject|12|||
105455583|NCT03287791|363679484|FG002|Overall Study|Withdrawal by Subject|17|||
105455584|NCT03287791|363679482|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
105455585|NCT03287791|363679483|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
105455586|NCT03287791|363679484|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
105455587|NCT03287791|363679482|FG000|Overall Study|Lost to Follow-up|8|||
105455588|NCT03287791|363679483|FG001|Overall Study|Lost to Follow-up|14|||
105455589|NCT03287791|363679484|FG002|Overall Study|Lost to Follow-up|11|||
105455590|NCT03287791|363679482|FG000|Overall Study|Protocol Violation|7|||
105455591|NCT03287791|363679483|FG001|Overall Study|Protocol Violation|2|||
105455592|NCT03287791|363679484|FG002|Overall Study|Protocol Violation|1|||
105455593|NCT03287791|363679482|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
105455594|NCT03287791|363679483|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
105455595|NCT03287791|363679484|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
105455596|NCT03287791|363679482|FG000|Overall Study|Too much time between 2 visits|0|||
105455597|NCT03287791|363679483|FG001|Overall Study|Too much time between 2 visits|1|||
105455598|NCT03287791|363679484|FG002|Overall Study|Too much time between 2 visits|0|||
105455599|NCT03287791|363679482|FG000|Overall Study|Non-compliance|0|||
105455600|NCT03287791|363679483|FG001|Overall Study|Non-compliance|1|||
105455601|NCT03287791|363679484|FG002|Overall Study|Non-compliance|0|||
105455602|NCT03287791|363679482|FG000|Overall Study|Did not meet inclusion criteria|1|||
105455603|NCT03287791|363679483|FG001|Overall Study|Did not meet inclusion criteria|0|||
105455604|NCT03287791|363679484|FG002|Overall Study|Did not meet inclusion criteria|0|||
105455605|NCT01474317|363679487|FG000|Overall Study|Adverse Event|1|||
105455606|NCT01474317|363679487|FG000|Overall Study|Subject ineligible for study|1|||
105455607|NCT05482308|363679491|FG000|Overall Study|Withdrawal by Subject|1|||
105455608|NCT05482308|363679492|FG001|Overall Study|Withdrawal by Subject|0|||
105455609|NCT05482308|363679491|FG000|Overall Study|No longer meets eligibility criteria|0|||
105455610|NCT05482308|363679492|FG001|Overall Study|No longer meets eligibility criteria|1|||
105455611|NCT02891174|363679498|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
105455612|NCT02891174|363679499|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
105455613|NCT02891174|363679498|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
105455614|NCT02891174|363679499|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
105455615|NCT02891174|363679498|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
105455616|NCT02891174|363679499|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
105550205|NCT00467870|364014374|FG000|Overall Study|Lost to Follow-up|5|||
105455617|NCT02891174|363679498|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
105455618|NCT02891174|363679499|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
105455619|NCT02891174|363679498|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
105455620|NCT02891174|363679499|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
105455621|NCT02891174|363679498|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
105455622|NCT02891174|363679499|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
105455623|NCT02891174|363679498|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
105455624|NCT02891174|363679499|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
105455625|NCT02647281|363679500|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
105455626|NCT02647281|363679501|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
105455627|NCT02647281|363679502|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
105455628|NCT02647281|363679503|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
105455629|NCT02647281|363679504|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
105455630|NCT02647281|363679505|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
105455631|NCT02647281|363679506|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
105455632|NCT02647281|363679507|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
105455633|NCT02647281|363679508|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
105455634|NCT01838694|363679509|FG000|Overall Study|Adverse Event|0|||
105455635|NCT01838694|363679510|FG001|Overall Study|Adverse Event|1|||
105455636|NCT00419393|363679511|FG000|Overall Study|Adverse Event|5|||
105455637|NCT00419393|363679511|FG000|Overall Study|Protocol Violation|5|||
105455638|NCT00419393|363679511|FG000|Overall Study|Withdrawal by Subject|7|||
105455639|NCT00419393|363679511|FG000|Overall Study|Other: Sponsor request|3|||
105455640|NCT00419393|363679511|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
105455641|NCT00419393|363679511|FG000|Overall Study|Other: Site closure|1|||
105455642|NCT00419393|363679511|FG000|Overall Study|Other: Other health problems|1|||
105455643|NCT00419393|363679511|FG000|Overall Study|Other: Investigator decision|1|||
105455644|NCT04516746|363679512|FG000|Overall Study|Randomized but not Treated|51|||
105455645|NCT04516746|363679513|FG001|Overall Study|Randomized but not Treated|19|||
105455646|NCT04516746|363679512|FG000|Overall Study|Adverse Event|0|||
105455647|NCT04516746|363679513|FG001|Overall Study|Adverse Event|1|||
105455648|NCT04516746|363679512|FG000|Overall Study|Death|62|||
105455649|NCT04516746|363679513|FG001|Overall Study|Death|32|||
105455650|NCT04516746|363679512|FG000|Overall Study|Lost to Follow-up|3431|||
105455651|NCT04516746|363679513|FG001|Overall Study|Lost to Follow-up|1831|||
105455652|NCT04516746|363679512|FG000|Overall Study|Withdrawal by Subject|1946|||
105455653|NCT04516746|363679513|FG001|Overall Study|Withdrawal by Subject|1696|||
105455654|NCT04516746|363679512|FG000|Overall Study|Physician Decision|10|||
105455655|NCT04516746|363679513|FG001|Overall Study|Physician Decision|8|||
105455656|NCT04516746|363679512|FG000|Overall Study|Other|35|||
105455657|NCT04516746|363679513|FG001|Overall Study|Other|16|||
105455658|NCT00416624|363679514|FG000|Overall Study|Withdrawal by Subject|1|||
105455659|NCT00416624|363679515|FG001|Overall Study|Withdrawal by Subject|6|||
105455660|NCT00416624|363679516|FG002|Overall Study|Withdrawal by Subject|4|||
105455661|NCT00416624|363679517|FG003|Overall Study|Withdrawal by Subject|9|||
105455662|NCT00416624|363679514|FG000|Overall Study|Death|4|||
105455663|NCT00416624|363679515|FG001|Overall Study|Death|7|||
105455664|NCT00416624|363679516|FG002|Overall Study|Death|7|||
105455665|NCT00416624|363679517|FG003|Overall Study|Death|1|||
105455666|NCT00416624|363679514|FG000|Overall Study|Adverse Event|8|||
105455667|NCT00416624|363679515|FG001|Overall Study|Adverse Event|3|||
105455668|NCT00416624|363679516|FG002|Overall Study|Adverse Event|2|||
105455669|NCT00416624|363679517|FG003|Overall Study|Adverse Event|2|||
105455670|NCT00416624|363679514|FG000|Overall Study|Other|8|||
105455671|NCT00416624|363679515|FG001|Overall Study|Other|11|||
105455672|NCT00416624|363679516|FG002|Overall Study|Other|5|||
105455673|NCT00416624|363679517|FG003|Overall Study|Other|5|||
105455674|NCT00416624|363679514|FG000|Overall Study|Cancel|1|||
105455675|NCT00416624|363679515|FG001|Overall Study|Cancel|0|||
105455676|NCT00416624|363679516|FG002|Overall Study|Cancel|0|||
105455677|NCT00416624|363679517|FG003|Overall Study|Cancel|0|||
105455678|NCT00979901|363679518|FG000|Overall Study|Adverse Event|1|||
105455679|NCT00979901|363679519|FG001|Overall Study|Adverse Event|3|||
105455680|NCT00979901|363679520|FG002|Overall Study|Adverse Event|9|||
105455681|NCT00979901|363679521|FG003|Overall Study|Adverse Event|2|||
105455682|NCT00979901|363679518|FG000|Overall Study|Lack of Efficacy|8|||
105455683|NCT00979901|363679519|FG001|Overall Study|Lack of Efficacy|4|||
105455684|NCT00979901|363679520|FG002|Overall Study|Lack of Efficacy|9|||
105455685|NCT00979901|363679521|FG003|Overall Study|Lack of Efficacy|0|||
105455686|NCT00979901|363679518|FG000|Overall Study|Lost to Follow-up|1|||
105455687|NCT00979901|363679519|FG001|Overall Study|Lost to Follow-up|1|||
105455688|NCT00979901|363679520|FG002|Overall Study|Lost to Follow-up|2|||
105455689|NCT00979901|363679521|FG003|Overall Study|Lost to Follow-up|0|||
105455690|NCT00979901|363679518|FG000|Overall Study|Protocol Violation|2|||
105455691|NCT00979901|363679519|FG001|Overall Study|Protocol Violation|2|||
105455692|NCT00979901|363679520|FG002|Overall Study|Protocol Violation|7|||
105455693|NCT00979901|363679521|FG003|Overall Study|Protocol Violation|1|||
105455694|NCT00979901|363679518|FG000|Overall Study|Withdrawal by Subject|2|||
105455695|NCT00979901|363679519|FG001|Overall Study|Withdrawal by Subject|1|||
105455696|NCT00979901|363679520|FG002|Overall Study|Withdrawal by Subject|1|||
105455697|NCT00979901|363679521|FG003|Overall Study|Withdrawal by Subject|1|||
105455698|NCT00979901|363679518|FG000|Overall Study|Noncompliance|1|||
105455699|NCT00979901|363679519|FG001|Overall Study|Noncompliance|0|||
105455700|NCT00979901|363679520|FG002|Overall Study|Noncompliance|0|||
105455701|NCT00979901|363679521|FG003|Overall Study|Noncompliance|0|||
105455702|NCT00979901|363679518|FG000|Overall Study|out-of-state|1|||
105455703|NCT00979901|363679519|FG001|Overall Study|out-of-state|0|||
105455704|NCT00979901|363679520|FG002|Overall Study|out-of-state|0|||
105455705|NCT00979901|363679521|FG003|Overall Study|out-of-state|0|||
105455706|NCT00979901|363679518|FG000|Overall Study|vacation|1|||
105455707|NCT00979901|363679519|FG001|Overall Study|vacation|0|||
105455708|NCT00979901|363679520|FG002|Overall Study|vacation|0|||
105455709|NCT00979901|363679521|FG003|Overall Study|vacation|0|||
105455710|NCT00979901|363679518|FG000|Overall Study|elevated lab values pre-randomization|1|||
105455711|NCT00979901|363679519|FG001|Overall Study|elevated lab values pre-randomization|0|||
105455712|NCT00979901|363679520|FG002|Overall Study|elevated lab values pre-randomization|0|||
105455713|NCT00979901|363679521|FG003|Overall Study|elevated lab values pre-randomization|0|||
105455714|NCT00979901|363679518|FG000|Overall Study|Discontinued in Error|0|||
105455715|NCT00979901|363679519|FG001|Overall Study|Discontinued in Error|1|||
105455716|NCT00979901|363679520|FG002|Overall Study|Discontinued in Error|0|||
105455717|NCT00979901|363679521|FG003|Overall Study|Discontinued in Error|0|||
105455718|NCT00979901|363679518|FG000|Overall Study|Left Country|0|||
105455719|NCT00979901|363679519|FG001|Overall Study|Left Country|0|||
105455720|NCT00979901|363679520|FG002|Overall Study|Left Country|1|||
105455721|NCT00979901|363679521|FG003|Overall Study|Left Country|0|||
105455722|NCT00979901|363679518|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
105455723|NCT00979901|363679519|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
105455724|NCT00979901|363679520|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
105455725|NCT00979901|363679521|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
105455726|NCT01751061|363679522|FG000|Overall Study|Death|1|||
105455727|NCT01751061|363679523|FG001|Overall Study|Death|0|||
105455728|NCT01751061|363679522|FG000|Overall Study|patient death|5|||
105455729|NCT01751061|363679523|FG001|Overall Study|patient death|0|||
105455730|NCT01751061|363679522|FG000|Overall Study|Lost to Follow-up|40|||
105455731|NCT01751061|363679523|FG001|Overall Study|Lost to Follow-up|25|||
105455732|NCT01751061|363679522|FG000|Overall Study|patient regained decisional capacity|4|||
105455733|NCT01751061|363679523|FG001|Overall Study|patient regained decisional capacity|8|||
105455734|NCT01751061|363679522|FG000|Overall Study|Withdrawal by Subject|4|||
105455735|NCT01751061|363679523|FG001|Overall Study|Withdrawal by Subject|1|||
105455736|NCT01751061|363679522|FG000|Overall Study|Physician Decision|2|||
105455737|NCT01751061|363679523|FG001|Overall Study|Physician Decision|0|||
105455738|NCT01194830|363679527|FG000|Overall Study|Adverse Event|3|||
105455739|NCT01194830|363679528|FG001|Overall Study|Adverse Event|2|||
105455740|NCT01194830|363679527|FG000|Overall Study|Protocol Violation|5|||
105455741|NCT01194830|363679528|FG001|Overall Study|Protocol Violation|4|||
105455742|NCT01194830|363679527|FG000|Overall Study|Lost to Follow-up|9|||
105455743|NCT01194830|363679528|FG001|Overall Study|Lost to Follow-up|7|||
105455744|NCT01194830|363679527|FG000|Overall Study|Withdrawal by Subject|2|||
105455745|NCT01194830|363679528|FG001|Overall Study|Withdrawal by Subject|1|||
105455746|NCT01194830|363679527|FG000|Overall Study|Lack of Efficacy|1|||
105455747|NCT01194830|363679528|FG001|Overall Study|Lack of Efficacy|1|||
105455748|NCT01194830|363679527|FG000|Overall Study|Non-compliance issues|4|||
105455749|NCT01194830|363679528|FG001|Overall Study|Non-compliance issues|4|||
105455750|NCT01194830|363679527|FG000|Overall Study|Other Reason|12|||
105455751|NCT01194830|363679528|FG001|Overall Study|Other Reason|8|||
105455752|NCT03115359|363679529|FG000|Overall Study|Withdrawal by Subject|29|||
105455753|NCT03115359|363679530|FG001|Overall Study|Withdrawal by Subject|39|||
105455754|NCT03115359|363679529|FG000|Overall Study|Scheduling conflict|25|||
105455755|NCT03115359|363679530|FG001|Overall Study|Scheduling conflict|23|||
105455756|NCT03115359|363679529|FG000|Overall Study|Personal reasons including health|12|||
105455757|NCT03115359|363679530|FG001|Overall Study|Personal reasons including health|9|||
105455758|NCT03115359|363679529|FG000|Overall Study|Transportation barriers|3|||
105455759|NCT03115359|363679530|FG001|Overall Study|Transportation barriers|0|||
105455760|NCT03115359|363679529|FG000|Overall Study|No longer interested|5|||
105455761|NCT03115359|363679530|FG001|Overall Study|No longer interested|4|||
105455762|NCT03115359|363679529|FG000|Overall Study|No reason provided|45|||
105455763|NCT03115359|363679530|FG001|Overall Study|No reason provided|47|||
105455764|NCT03284710|363679535|FG000|Overall Study|Withdrawal by Subject|1|||
105455765|NCT03284710|363679536|FG001|Overall Study|Withdrawal by Subject|0|||
105455766|NCT03284710|363679537|FG002|Overall Study|Withdrawal by Subject|1|||
105455767|NCT03284710|363679538|FG003|Overall Study|Withdrawal by Subject|6|||
105455768|NCT03284710|363679535|FG000|Overall Study|Lost to Follow-up|3|||
105455769|NCT03284710|363679536|FG001|Overall Study|Lost to Follow-up|3|||
105455770|NCT03284710|363679537|FG002|Overall Study|Lost to Follow-up|1|||
105455771|NCT03284710|363679538|FG003|Overall Study|Lost to Follow-up|0|||
105455772|NCT03284710|363679535|FG000|Overall Study|Physician Decision|1|||
105455773|NCT03284710|363679536|FG001|Overall Study|Physician Decision|0|||
105455774|NCT03284710|363679537|FG002|Overall Study|Physician Decision|0|||
105455775|NCT03284710|363679538|FG003|Overall Study|Physician Decision|0|||
105455776|NCT03284710|363679535|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
105455777|NCT03284710|363679536|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
105455778|NCT03284710|363679537|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
105455779|NCT03284710|363679538|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
105455780|NCT03284710|363679535|FG000|Overall Study|HIV Infection|0|||
105455781|NCT03284710|363679536|FG001|Overall Study|HIV Infection|2|||
105455782|NCT03284710|363679537|FG002|Overall Study|HIV Infection|2|||
105455783|NCT03284710|363679538|FG003|Overall Study|HIV Infection|1|||
105455784|NCT00141453|363679540|FG000|Overall Study|Protocol Violation|6|||
105455785|NCT00141453|363679541|FG001|Overall Study|Protocol Violation|5|||
105455786|NCT00443040|363679544|FG000|Overall Study|Withdrawal by Subject|1|||
105455787|NCT00443040|363679545|FG001|Overall Study|Withdrawal by Subject|0|||
105455788|NCT00443040|363679546|FG002|Overall Study|Withdrawal by Subject|0|||
105455789|NCT00443040|363679544|FG000|Overall Study|Converted to an open laparotomy|3|||
105455790|NCT00443040|363679545|FG001|Overall Study|Converted to an open laparotomy|0|||
105455791|NCT00443040|363679546|FG002|Overall Study|Converted to an open laparotomy|1|||
105455792|NCT00614575|363679551|FG000|Overall Study|Adverse Event|106|||
105455793|NCT00614575|363679551|FG000|Overall Study|Lost to Follow-up|55|||
105455794|NCT00614575|363679551|FG000|Overall Study|Lack of Efficacy|14|||
105455795|NCT00614575|363679551|FG000|Overall Study|Withdrawal by Subject|6|||
105455796|NCT00614575|363679551|FG000|Overall Study|Death|3|||
105455797|NCT00614575|363679551|FG000|Overall Study|Physician Decision|2|||
105455798|NCT00614575|363679551|FG000|Overall Study|No data were collected.|18|||
105455799|NCT00614575|363679551|FG000|Overall Study|Irregularly enrolled patients|23|||
105337040|NCT00090220|363234761|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105337041|NCT00090220|363234762|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105337042|NCT00090220|363234763|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105455800|NCT00614575|363679551|FG000|Overall Study|No treatment|1|||
105455801|NCT03452540|363679552|FG000|Overall Study|Adverse Event|1|||
105337043|NCT00090220|363234764|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105455802|NCT03452540|363679552|FG000|Overall Study|Withdrawal by Subject|1|||
105455803|NCT03452540|363679552|FG000|Overall Study|Other SAE and AE|2|||
105455804|NCT04529083|363679556|FG000|Overall Study|Withdrawal by Subject|3|||
105455805|NCT03305666|363679557|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
105455806|NCT03305666|363679558|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
105455807|NCT00914849|363679559|FG000|Overall Study|Withdrawal by Subject|1|||
105455808|NCT00914849|363679560|FG001|Overall Study|Withdrawal by Subject|0|||
105455809|NCT00914849|363679559|FG000|Overall Study|Not eligible|0|||
105455810|NCT00914849|363679560|FG001|Overall Study|Not eligible|1|||
105455811|NCT01001221|363679561|FG000|Overall Study|Adverse Event|1|||
105455812|NCT01001221|363679562|FG001|Overall Study|Adverse Event|2|||
105455813|NCT01001221|363679563|FG002|Overall Study|Adverse Event|0|||
105455814|NCT01001221|363679564|FG003|Overall Study|Adverse Event|2|||
105455815|NCT01001221|363679565|FG004|Overall Study|Adverse Event|0|||
105455816|NCT01001221|363679561|FG000|Overall Study|Disease progression|3|||
105455817|NCT01001221|363679562|FG001|Overall Study|Disease progression|2|||
105455818|NCT01001221|363679563|FG002|Overall Study|Disease progression|2|||
105455819|NCT01001221|363679564|FG003|Overall Study|Disease progression|4|||
105455820|NCT01001221|363679565|FG004|Overall Study|Disease progression|0|||
105455821|NCT01001221|363679561|FG000|Overall Study|Other|1|||
105455822|NCT01001221|363679562|FG001|Overall Study|Other|1|||
105455823|NCT01001221|363679563|FG002|Overall Study|Other|0|||
105455824|NCT01001221|363679564|FG003|Overall Study|Other|0|||
105455825|NCT01001221|363679565|FG004|Overall Study|Other|0|||
105455826|NCT01001221|363679561|FG000|Overall Study|Not treated; protocol exclusion|0|||
105455827|NCT01001221|363679562|FG001|Overall Study|Not treated; protocol exclusion|0|||
105455828|NCT01001221|363679563|FG002|Overall Study|Not treated; protocol exclusion|1|||
105455829|NCT01001221|363679564|FG003|Overall Study|Not treated; protocol exclusion|0|||
105455830|NCT01001221|363679565|FG004|Overall Study|Not treated; protocol exclusion|0|||
105455831|NCT00265564|363679568|FG000|Overall Study|Lost to Follow-up|5|||
105455832|NCT00265564|363679569|FG001|Overall Study|Lost to Follow-up|7|||
105455833|NCT00265564|363679568|FG000|Overall Study|met exclusion criteria|5|||
105455834|NCT00265564|363679569|FG001|Overall Study|met exclusion criteria|2|||
105455835|NCT01176032|363679573|FG000|Overall Study|Adverse Event|1|||
105455836|NCT01176032|363679574|FG001|Overall Study|Adverse Event|0|||
105455837|NCT01176032|363679573|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105455838|NCT01176032|363679574|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105455839|NCT01176032|363679573|FG000|Overall Study|Protocol Violation|1|||
105337044|NCT00090220|363234765|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
105455840|NCT01176032|363679574|FG001|Overall Study|Protocol Violation|0|||
105337045|NCT00090220|363234766|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
105337046|NCT00090220|363234761|FG000|Long-term Follow-up (EXT2)|Death|0|||
105337047|NCT00090220|363234762|FG001|Long-term Follow-up (EXT2)|Death|0|||
105337048|NCT00090220|363234763|FG002|Long-term Follow-up (EXT2)|Death|0|||
105337049|NCT00090220|363234764|FG003|Long-term Follow-up (EXT2)|Death|0|||
105337050|NCT00090220|363234765|FG004|Long-term Follow-up (EXT2)|Death|1|||
105337051|NCT00090220|363234766|FG005|Long-term Follow-up (EXT2)|Death|1|||
105337052|NCT00090220|363234761|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105337053|NCT00090220|363234762|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105337054|NCT00090220|363234763|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105337055|NCT00090220|363234764|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105455841|NCT01176032|363679573|FG000|Overall Study|Informed consent withdrawn|3|||
105337056|NCT00090220|363234765|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
105337057|NCT00090220|363234766|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
105337058|NCT00090220|363234761|FG000|Long-term Follow-up (EXT2)|Other|0|||
105337059|NCT00090220|363234762|FG001|Long-term Follow-up (EXT2)|Other|0|||
105337060|NCT00090220|363234763|FG002|Long-term Follow-up (EXT2)|Other|0|||
105337061|NCT00090220|363234764|FG003|Long-term Follow-up (EXT2)|Other|0|||
105337062|NCT00090220|363234765|FG004|Long-term Follow-up (EXT2)|Other|1|||
105337063|NCT00090220|363234766|FG005|Long-term Follow-up (EXT2)|Other|0|||
105337064|NCT02429778|363234767|FG000|Overall Study|Lost to Follow-up|2|||
105337065|NCT02429778|363234768|FG001|Overall Study|Lost to Follow-up|0|||
105337066|NCT02429778|363234767|FG000|Overall Study|Withdrawal by Subject|5|||
105337067|NCT02429778|363234768|FG001|Overall Study|Withdrawal by Subject|0|||
105337068|NCT03655470|363234769|FG000|Overall Study|Lost to Follow-up|6|||
105337069|NCT03655470|363234770|FG001|Overall Study|Lost to Follow-up|7|||
105337070|NCT01082211|363234775|FG000|Overall Study|Protocol Violation|4|||
105337071|NCT01082211|363234775|FG000|Overall Study|No protocol treatment received|3|||
105337072|NCT03702010|363234780|FG000|Follow-up (30days)|Lack of Efficacy|2|||
105337073|NCT03702010|363234781|FG001|Follow-up (30days)|Lack of Efficacy|2|||
105337074|NCT01254318|363234782|FG000|Overall Study|Lost to Follow-up|5|||
105337075|NCT01254318|363234782|FG000|Overall Study|Death|47|||
105337076|NCT02394340|363234796|FG000|Overall Study|Failed drug screen test|1|||
105337077|NCT02394340|363234796|FG000|Overall Study|Adverse Event|1|||
105337078|NCT06586788|363234797|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
105337079|NCT03514485|363234798|FG000|Overall Study|Lost to Follow-up|5|||
105337080|NCT03514485|363234799|FG001|Overall Study|Lost to Follow-up|3|||
105455842|NCT01176032|363679574|FG001|Overall Study|Informed consent withdrawn|0|||
105455843|NCT01176032|363679573|FG000|Overall Study|Other|1|||
105455844|NCT01176032|363679574|FG001|Overall Study|Other|0|||
105455845|NCT01469221|363679575|FG000|Double Blind Phase|Protocol Violation|1|||
105337081|NCT03514485|363234800|FG002|Overall Study|Lost to Follow-up|2|||
105337082|NCT03514485|363234801|FG003|Overall Study|Lost to Follow-up|0|||
105337083|NCT03514485|363234802|FG004|Overall Study|Lost to Follow-up|1|||
105337084|NCT03514485|363234803|FG005|Overall Study|Lost to Follow-up|4|||
105337085|NCT03514485|363234798|FG000|Overall Study|Withdrawal by Subject|0|||
105337086|NCT03514485|363234799|FG001|Overall Study|Withdrawal by Subject|1|||
105455846|NCT01469221|363679576|FG001|Double Blind Phase|Protocol Violation|0|||
105455847|NCT01469221|363679577|FG002|Double Blind Phase|Protocol Violation|0|||
105455848|NCT01469221|363679575|FG000|Double Blind Phase|Physician Decision|1|||
105455849|NCT01469221|363679576|FG001|Double Blind Phase|Physician Decision|1|||
105455850|NCT01469221|363679577|FG002|Double Blind Phase|Physician Decision|0|||
105455851|NCT01469221|363679575|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
105455852|NCT01469221|363679576|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
105337087|NCT03514485|363234800|FG002|Overall Study|Withdrawal by Subject|3|||
105455853|NCT01469221|363679577|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
105455854|NCT03582215|363679578|FG000|Overall Study|Adverse Event|1|||
105455855|NCT03582215|363679579|FG001|Overall Study|Adverse Event|0|||
105455856|NCT03582215|363679580|FG002|Overall Study|Adverse Event|0|||
105455857|NCT03582215|363679581|FG003|Overall Study|Adverse Event|0|||
105455858|NCT03582215|363679582|FG004|Overall Study|Adverse Event|0|||
105455859|NCT03582215|363679583|FG005|Overall Study|Adverse Event|0|||
105455860|NCT03582215|363679584|FG006|Overall Study|Adverse Event|2|||
105455861|NCT03582215|363679585|FG007|Overall Study|Adverse Event|2|||
105455862|NCT02163902|363679586|FG000|Overall Study|Subject's Request|3|||
105455863|NCT02163902|363679587|FG001|Overall Study|Subject's Request|4|||
105455864|NCT02163902|363679586|FG000|Overall Study|Lost to Follow-up|6|||
105455865|NCT02163902|363679587|FG001|Overall Study|Lost to Follow-up|7|||
105455866|NCT02163902|363679586|FG000|Overall Study|Administrative Decision|2|||
105455867|NCT02163902|363679587|FG001|Overall Study|Administrative Decision|2|||
105455868|NCT00499681|363679588|FG000|Overall Study|toxicity|0|||
105455869|NCT00499681|363679589|FG001|Overall Study|toxicity|1|||
105455870|NCT00499681|363679588|FG000|Overall Study|disease progression|0|||
105455871|NCT00499681|363679589|FG001|Overall Study|disease progression|1|||
105455872|NCT00659061|363679590|FG000|Overall Study|Migration due to political unrest|21|||
105455873|NCT00659061|363679591|FG001|Overall Study|Migration due to political unrest|15|||
105455874|NCT03119259|363679596|FG000|Overall Study|Withdrawn as no longer eligible|1|||
105455875|NCT03119259|363679597|FG001|Overall Study|Withdrawn as no longer eligible|0|||
105455876|NCT03119259|363679596|FG000|Overall Study|Withdrawal by Subject|4|||
105455877|NCT03119259|363679597|FG001|Overall Study|Withdrawal by Subject|2|||
105455878|NCT03119259|363679596|FG000|Overall Study|Lost to Follow-up|0|||
105455879|NCT03119259|363679597|FG001|Overall Study|Lost to Follow-up|1|||
105455880|NCT01277744|363679599|FG000|Overall Study|Physician Decision|2|||
105455881|NCT03740048|363679600|FG000|Overall Study|Withdrawal by Subject|1|||
105455882|NCT03740048|363679601|FG001|Overall Study|Withdrawal by Subject|1|||
105455883|NCT03740048|363679600|FG000|Overall Study|Death|1|||
105455884|NCT03740048|363679601|FG001|Overall Study|Death|6|||
105455885|NCT03740048|363679600|FG000|Overall Study|Switched to thrice-weekly HD|2|||
105455886|NCT03740048|363679601|FG001|Overall Study|Switched to thrice-weekly HD|0|||
105455887|NCT03740048|363679600|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
105455888|NCT03740048|363679601|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
105455889|NCT03740048|363679600|FG000|Overall Study|Lost to Follow-up|0|||
105455890|NCT03740048|363679601|FG001|Overall Study|Lost to Follow-up|1|||
105455891|NCT03740048|363679600|FG000|Overall Study|Non-compliance with HD|0|||
105455892|NCT03740048|363679601|FG001|Overall Study|Non-compliance with HD|1|||
105455893|NCT00918281|363679602|FG000|Overall Study|Physician Decision|29|||
105455894|NCT00083889|363679605|FG000|Overall Study|Adverse Event|76|||
105455895|NCT00083889|363679606|FG001|Overall Study|Adverse Event|86|||
105455896|NCT00083889|363679605|FG000|Overall Study|Protocol Violation|2|||
105455897|NCT00083889|363679606|FG001|Overall Study|Protocol Violation|2|||
105455898|NCT00083889|363679605|FG000|Overall Study|Withdrawal by Subject|22|||
105455899|NCT00083889|363679606|FG001|Overall Study|Withdrawal by Subject|24|||
105455900|NCT00083889|363679605|FG000|Overall Study|Lack of Efficacy|240|||
105455901|NCT00083889|363679606|FG001|Overall Study|Lack of Efficacy|219|||
105455902|NCT00083889|363679605|FG000|Overall Study|Decision of sponsor|32|||
105455903|NCT00083889|363679606|FG001|Overall Study|Decision of sponsor|4|||
105455904|NCT00083889|363679605|FG000|Overall Study|Randomized: did not take study drug|0|||
105455905|NCT00083889|363679606|FG001|Overall Study|Randomized: did not take study drug|15|||
105455906|NCT00083889|363679605|FG000|Overall Study|Completed on marketed sunitinub|3|||
105455907|NCT00083889|363679606|FG001|Overall Study|Completed on marketed sunitinub|0|||
105455908|NCT00083889|363679605|FG000|Overall Study|Crossover to SU011248|0|||
105455909|NCT00083889|363679606|FG001|Overall Study|Crossover to SU011248|25|||
105455910|NCT00168844|363679607|FG000|Overall Study|Adverse Event|31|||
105455911|NCT00168844|363679608|FG001|Overall Study|Adverse Event|32|||
105455912|NCT00168844|363679609|FG002|Overall Study|Adverse Event|48|||
105455913|NCT00168844|363679607|FG000|Overall Study|Lost to Follow-up|4|||
105337088|NCT03514485|363234801|FG003|Overall Study|Withdrawal by Subject|1|||
105337089|NCT03514485|363234802|FG004|Overall Study|Withdrawal by Subject|2|||
105337090|NCT03514485|363234803|FG005|Overall Study|Withdrawal by Subject|1|||
105337091|NCT01878084|363234805|FG000|Overall Study|Physician Decision|2|||
105455914|NCT00168844|363679608|FG001|Overall Study|Lost to Follow-up|5|||
105455915|NCT00168844|363679609|FG002|Overall Study|Lost to Follow-up|11|||
105455916|NCT00168844|363679607|FG000|Overall Study|Withdrawal by Subject|12|||
105455917|NCT00168844|363679608|FG001|Overall Study|Withdrawal by Subject|9|||
105455918|NCT00168844|363679609|FG002|Overall Study|Withdrawal by Subject|19|||
105455919|NCT00168844|363679607|FG000|Overall Study|Protocol Violation|2|||
105455920|NCT00168844|363679608|FG001|Overall Study|Protocol Violation|2|||
105455921|NCT00168844|363679609|FG002|Overall Study|Protocol Violation|4|||
105455922|NCT00168844|363679607|FG000|Overall Study|Other|6|||
105455923|NCT00168844|363679608|FG001|Overall Study|Other|7|||
105455924|NCT00168844|363679609|FG002|Overall Study|Other|9|||
105455925|NCT01339832|363679614|FG000|Overall Study|Lost to Follow-up|3|||
105455926|NCT01339832|363679614|FG000|Overall Study|Death|11|||
105455927|NCT02025179|363679618|FG000|Overall Study|Lost to Follow-up|0|||
105455928|NCT02025179|363679619|FG001|Overall Study|Lost to Follow-up|0|||
105455929|NCT02025179|363679620|FG002|Overall Study|Lost to Follow-up|1|||
105455930|NCT02362724|363679621|FG000|Overall Study|Withdrawal by Subject|3|||
105455931|NCT02362724|363679622|FG001|Overall Study|Withdrawal by Subject|1|||
105455932|NCT02362724|363679621|FG000|Overall Study|Adverse Event|3|||
105455933|NCT02362724|363679622|FG001|Overall Study|Adverse Event|0|||
105337092|NCT03891862|363234806|FG000|Open-label Period|Adverse Event|2|||
105337093|NCT03891862|363234807|FG001|Open-label Period|Adverse Event|0|||
105337094|NCT03891862|363234808|FG002|Open-label Period|Adverse Event|0|||
105337095|NCT03891862|363234806|FG000|Open-label Period|Protocol Violation|5|||
105337096|NCT03891862|363234807|FG001|Open-label Period|Protocol Violation|0|||
105337097|NCT03891862|363234808|FG002|Open-label Period|Protocol Violation|0|||
105337098|NCT03891862|363234806|FG000|Open-label Period|Withdrawal by Subject|6|||
105337099|NCT03891862|363234807|FG001|Open-label Period|Withdrawal by Subject|0|||
105337100|NCT03891862|363234808|FG002|Open-label Period|Withdrawal by Subject|0|||
105337101|NCT03891862|363234806|FG000|Open-label Period|Death|1|||
105337102|NCT03891862|363234807|FG001|Open-label Period|Death|0|||
105337103|NCT03891862|363234808|FG002|Open-label Period|Death|0|||
105337104|NCT03891862|363234806|FG000|Open-label Period|Lost to Follow-up|2|||
105337105|NCT03891862|363234807|FG001|Open-label Period|Lost to Follow-up|0|||
105337106|NCT03891862|363234808|FG002|Open-label Period|Lost to Follow-up|0|||
105337107|NCT03891862|363234806|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
105337108|NCT03891862|363234807|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
105337109|NCT03891862|363234808|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
105337110|NCT03891862|363234806|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
105337111|NCT03891862|363234807|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
105337112|NCT03891862|363234808|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
105337113|NCT03891862|363234806|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
105337114|NCT03891862|363234807|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
105337115|NCT03891862|363234808|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
105337116|NCT03891862|363234806|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
105337117|NCT03891862|363234807|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
105337118|NCT03891862|363234808|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
105337119|NCT01054196|363234810|FG000|Overall Study|Physician Decision|0|||
105337120|NCT01054196|363234811|FG001|Overall Study|Physician Decision|0|||
105337121|NCT01054196|363234812|FG002|Overall Study|Physician Decision|0|||
105337122|NCT01054196|363234813|FG003|Overall Study|Physician Decision|1|||
105337123|NCT01054196|363234814|FG004|Overall Study|Physician Decision|0|||
105337124|NCT01054196|363234815|FG005|Overall Study|Physician Decision|0|||
105337125|NCT01054196|363234816|FG006|Overall Study|Physician Decision|1|||
105337126|NCT03382834|363234817|FG000|Step 1|Lost to Follow-up|0|||
105337127|NCT03382834|363234818|FG001|Step 1|Lost to Follow-up|1|||
105337128|NCT03382834|363234817|FG000|Step 2|Death|1|||
105337129|NCT03382834|363234818|FG001|Step 2|Death|0|||
105337130|NCT03382834|363234817|FG000|Step 2|Lost to Follow-up|2|||
105337131|NCT03382834|363234818|FG001|Step 2|Lost to Follow-up|2|||
105337132|NCT03382834|363234817|FG000|Step 2|Site Terminated by Sponsor|1|||
105337133|NCT03382834|363234818|FG001|Step 2|Site Terminated by Sponsor|0|||
105337134|NCT02387957|363234819|FG000|Overall Study|The study was discontinued|21|||
105337135|NCT02387957|363234820|FG001|Overall Study|The study was discontinued|21|||
105337136|NCT02387957|363234821|FG002|Overall Study|The study was discontinued|20|||
105337137|NCT00675428|363234822|FG000|Overall Study|Disease Progression|2|||
105337138|NCT00675428|363234823|FG001|Overall Study|Disease Progression|2|||
105337139|NCT00675428|363234822|FG000|Overall Study|No Disease Response After Cycle 6|0|||
105337140|NCT00675428|363234823|FG001|Overall Study|No Disease Response After Cycle 6|1|||
105337141|NCT00675428|363234822|FG000|Overall Study|Physician Decision|1|||
105337142|NCT00675428|363234823|FG001|Overall Study|Physician Decision|0|||
105337143|NCT01046903|363234832|FG000|Overall Study|Lost to Follow-up|16|||
105337144|NCT01046903|363234832|FG000|Overall Study|Adverse Event|4|||
105337145|NCT01046903|363234832|FG000|Overall Study|Withdrawal by Subject|3|||
105337146|NCT01046903|363234832|FG000|Overall Study|Other|5|||
105337147|NCT02107859|363234833|FG000|Overall Study|Withdrawal by Subject|14|||
105337148|NCT02107859|363234833|FG000|Overall Study|Adverse Event|3|||
105337149|NCT02107859|363234833|FG000|Overall Study|Study closure|41|||
105337150|NCT02107859|363234833|FG000|Overall Study|Other than specified|3|||
105337151|NCT02964208|363234839|FG000|Overall Study|Death|103|||
105337152|NCT02964208|363234839|FG000|Overall Study|Withdrawal by Subject|6|||
105337153|NCT02964208|363234839|FG000|Overall Study|Lost to Follow-up|6|||
105337154|NCT02964208|363234839|FG000|Overall Study|Unsuccessful Procedure|5|||
105337155|NCT02964208|363234839|FG000|Overall Study|Device Explant|1|||
105337156|NCT02964208|363234839|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
105455934|NCT01927497|363679623|FG000|Overall Study|Death|0|||
105337157|NCT00586820|363234843|FG000|Overall Study|Unsuccessful PCI|1|||
105337158|NCT00586820|363234844|FG001|Overall Study|Unsuccessful PCI|0|||
105337159|NCT01868022|363234847|FG000|Overall Study|Withdrawal by Subject|0|||
105337160|NCT01868022|363234848|FG001|Overall Study|Withdrawal by Subject|0|||
105337161|NCT01868022|363234849|FG002|Overall Study|Withdrawal by Subject|1|||
105337162|NCT01868022|363234850|FG003|Overall Study|Withdrawal by Subject|1|||
105337163|NCT01868022|363234851|FG004|Overall Study|Withdrawal by Subject|0|||
105337164|NCT01868022|363234852|FG005|Overall Study|Withdrawal by Subject|0|||
105337165|NCT01868022|363234853|FG006|Overall Study|Withdrawal by Subject|0|||
105337166|NCT01868022|363234854|FG007|Overall Study|Withdrawal by Subject|1|||
105455935|NCT01927497|363679624|FG001|Overall Study|Death|1|||
105455936|NCT01927497|363679623|FG000|Overall Study|Protocol Violation|2|||
105455937|NCT01927497|363679624|FG001|Overall Study|Protocol Violation|0|||
105455938|NCT03137992|363679625|FG000|Washout Period 1|Adverse Event|1|||
105455939|NCT03137992|363679626|FG001|Washout Period 1|Adverse Event|1|||
105455940|NCT03137992|363679627|FG002|Washout Period 1|Adverse Event|0|||
105455941|NCT03137992|363679628|FG003|Washout Period 1|Adverse Event|0|||
105455942|NCT03137992|363679629|FG004|Washout Period 1|Adverse Event|0|||
105455943|NCT03137992|363679630|FG005|Washout Period 1|Adverse Event|1|||
105455944|NCT03137992|363679625|FG000|Washout Period 1|Withdrawal by Subject|0|||
105455945|NCT03137992|363679626|FG001|Washout Period 1|Withdrawal by Subject|1|||
105455946|NCT03137992|363679627|FG002|Washout Period 1|Withdrawal by Subject|1|||
105455947|NCT03137992|363679628|FG003|Washout Period 1|Withdrawal by Subject|0|||
105455948|NCT03137992|363679629|FG004|Washout Period 1|Withdrawal by Subject|0|||
105455949|NCT03137992|363679630|FG005|Washout Period 1|Withdrawal by Subject|0|||
105455950|NCT03137992|363679625|FG000|Washout Period 1|Principal Investigator Discretion|0|||
105455951|NCT03137992|363679626|FG001|Washout Period 1|Principal Investigator Discretion|1|||
105455952|NCT03137992|363679627|FG002|Washout Period 1|Principal Investigator Discretion|0|||
105455953|NCT03137992|363679628|FG003|Washout Period 1|Principal Investigator Discretion|0|||
105455954|NCT03137992|363679629|FG004|Washout Period 1|Principal Investigator Discretion|0|||
105337167|NCT01868022|363234855|FG008|Overall Study|Withdrawal by Subject|0|||
105337168|NCT01868022|363234847|FG000|Overall Study|Adverse Event|0|||
105337169|NCT01868022|363234848|FG001|Overall Study|Adverse Event|0|||
105337170|NCT01868022|363234849|FG002|Overall Study|Adverse Event|0|||
105455955|NCT03137992|363679630|FG005|Washout Period 1|Principal Investigator Discretion|0|||
105455956|NCT03137992|363679625|FG000|Washout Period 1|COPD Exacerbation|1|||
105455957|NCT03137992|363679626|FG001|Washout Period 1|COPD Exacerbation|1|||
105337171|NCT01868022|363234850|FG003|Overall Study|Adverse Event|0|||
105337172|NCT01868022|363234851|FG004|Overall Study|Adverse Event|2|||
105337173|NCT01868022|363234852|FG005|Overall Study|Adverse Event|0|||
105337174|NCT01868022|363234853|FG006|Overall Study|Adverse Event|0|||
105337175|NCT01868022|363234854|FG007|Overall Study|Adverse Event|2|||
105337176|NCT01868022|363234855|FG008|Overall Study|Adverse Event|2|||
105337177|NCT01868022|363234847|FG000|Overall Study|Physician Decision|0|||
105337178|NCT01868022|363234848|FG001|Overall Study|Physician Decision|0|||
105337179|NCT01868022|363234849|FG002|Overall Study|Physician Decision|0|||
105337180|NCT01868022|363234850|FG003|Overall Study|Physician Decision|0|||
105337181|NCT01868022|363234851|FG004|Overall Study|Physician Decision|0|||
105337182|NCT01868022|363234852|FG005|Overall Study|Physician Decision|1|||
105337183|NCT01868022|363234853|FG006|Overall Study|Physician Decision|0|||
105337184|NCT01868022|363234854|FG007|Overall Study|Physician Decision|2|||
105337185|NCT01868022|363234855|FG008|Overall Study|Physician Decision|0|||
105337186|NCT01868022|363234847|FG000|Overall Study|Study closed/terminated|0|||
105337187|NCT01868022|363234848|FG001|Overall Study|Study closed/terminated|0|||
105337188|NCT01868022|363234849|FG002|Overall Study|Study closed/terminated|0|||
105337189|NCT01868022|363234850|FG003|Overall Study|Study closed/terminated|0|||
105337190|NCT01868022|363234851|FG004|Overall Study|Study closed/terminated|0|||
105337191|NCT01868022|363234852|FG005|Overall Study|Study closed/terminated|0|||
105337192|NCT01868022|363234853|FG006|Overall Study|Study closed/terminated|0|||
105337193|NCT01868022|363234854|FG007|Overall Study|Study closed/terminated|1|||
105337194|NCT01868022|363234855|FG008|Overall Study|Study closed/terminated|0|||
105337195|NCT01868022|363234847|FG000|Overall Study|Ongoing|0|||
105337196|NCT01868022|363234848|FG001|Overall Study|Ongoing|0|||
105337197|NCT01868022|363234849|FG002|Overall Study|Ongoing|0|||
105337198|NCT01868022|363234850|FG003|Overall Study|Ongoing|0|||
105337199|NCT01868022|363234851|FG004|Overall Study|Ongoing|0|||
105337200|NCT01868022|363234852|FG005|Overall Study|Ongoing|0|||
105337201|NCT01868022|363234853|FG006|Overall Study|Ongoing|0|||
105337202|NCT01868022|363234854|FG007|Overall Study|Ongoing|3|||
105337203|NCT01868022|363234855|FG008|Overall Study|Ongoing|0|||
105337204|NCT00746564|363234856|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
105337205|NCT01743560|363234857|FG000|Overall Study|Disease progression|26|||
105337206|NCT01743560|363234857|FG000|Overall Study|Adverse Event|8|||
105337207|NCT01743560|363234857|FG000|Overall Study|Death|3|||
105337208|NCT01743560|363234857|FG000|Overall Study|Withdrawal by Subject|2|||
105337209|NCT01743560|363234857|FG000|Overall Study|Protocol Violation|1|||
105337210|NCT01743560|363234857|FG000|Overall Study|>1 dose of study drug|3|||
105337211|NCT02727777|363234860|FG000|Overall Study|Screen Failure|2|||
105337212|NCT02727777|363234861|FG001|Overall Study|Screen Failure|0|||
105337213|NCT02727777|363234862|FG002|Overall Study|Screen Failure|0|||
105337214|NCT02727777|363234860|FG000|Overall Study|Progressive disease|2|||
105337215|NCT02727777|363234861|FG001|Overall Study|Progressive disease|0|||
105337216|NCT02727777|363234862|FG002|Overall Study|Progressive disease|0|||
105337217|NCT01435018|363236850|FG000|Overall Study|Death|37|||
105455958|NCT03137992|363679627|FG002|Washout Period 1|COPD Exacerbation|1|||
105455959|NCT03137992|363679628|FG003|Washout Period 1|COPD Exacerbation|0|||
105455960|NCT03137992|363679629|FG004|Washout Period 1|COPD Exacerbation|1|||
105455961|NCT03137992|363679630|FG005|Washout Period 1|COPD Exacerbation|1|||
105455962|NCT03137992|363679625|FG000|Washout Period 1|Subject Noncompliance|1|||
105455963|NCT03137992|363679626|FG001|Washout Period 1|Subject Noncompliance|0|||
105455964|NCT03137992|363679627|FG002|Washout Period 1|Subject Noncompliance|0|||
105455965|NCT03137992|363679628|FG003|Washout Period 1|Subject Noncompliance|0|||
105455966|NCT03137992|363679629|FG004|Washout Period 1|Subject Noncompliance|1|||
105455967|NCT03137992|363679630|FG005|Washout Period 1|Subject Noncompliance|0|||
105455968|NCT03137992|363679625|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
105455969|NCT03137992|363679626|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
105455970|NCT03137992|363679627|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
105455971|NCT03137992|363679628|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
105455972|NCT03137992|363679629|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
105337218|NCT01435018|363236851|FG001|Overall Study|Death|18|||
105337219|NCT01435018|363236852|FG002|Overall Study|Death|25|||
105337220|NCT01435018|363236850|FG000|Overall Study|Site is closing|4|||
105337221|NCT01435018|363236851|FG001|Overall Study|Site is closing|9|||
105337222|NCT01435018|363236852|FG002|Overall Study|Site is closing|7|||
105337223|NCT01435018|363236850|FG000|Overall Study|Withdrew consent|0|||
105337224|NCT01435018|363236851|FG001|Overall Study|Withdrew consent|3|||
105337225|NCT01435018|363236852|FG002|Overall Study|Withdrew consent|1|||
105337226|NCT01435018|363236850|FG000|Overall Study|Not willing to adhere to requirements|0|||
105455973|NCT03137992|363679630|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
105337227|NCT01435018|363236851|FG001|Overall Study|Not willing to adhere to requirements|2|||
105337228|NCT01435018|363236852|FG002|Overall Study|Not willing to adhere to requirements|3|||
105337229|NCT01435018|363236850|FG000|Overall Study|Not able to get to clinic|2|||
105337230|NCT01435018|363236851|FG001|Overall Study|Not able to get to clinic|0|||
105337231|NCT01435018|363236852|FG002|Overall Study|Not able to get to clinic|2|||
105337232|NCT01435018|363236850|FG000|Overall Study|Severe debilitation, unable to continue|0|||
105550206|NCT00467870|364014375|FG001|Overall Study|Lost to Follow-up|3|||
105455974|NCT03137992|363679625|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
105455975|NCT03137992|363679626|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
105455976|NCT03137992|363679627|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
105455977|NCT03137992|363679628|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
105455978|NCT03137992|363679629|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
105455979|NCT03137992|363679630|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
105455980|NCT03137992|363679625|FG000|Period 2 (Visit 3)|Adverse Event|0|||
105455981|NCT03137992|363679626|FG001|Period 2 (Visit 3)|Adverse Event|1|||
105455982|NCT03137992|363679627|FG002|Period 2 (Visit 3)|Adverse Event|0|||
105455983|NCT03137992|363679628|FG003|Period 2 (Visit 3)|Adverse Event|0|||
105455984|NCT03137992|363679629|FG004|Period 2 (Visit 3)|Adverse Event|0|||
105455985|NCT03137992|363679630|FG005|Period 2 (Visit 3)|Adverse Event|0|||
105455986|NCT03137992|363679625|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
105455987|NCT03137992|363679626|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
105455988|NCT03137992|363679627|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
105455989|NCT03137992|363679628|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
105455990|NCT03137992|363679629|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
105455991|NCT03137992|363679630|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
105455992|NCT03137992|363679625|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
105455993|NCT03137992|363679626|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
105455994|NCT03137992|363679627|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
105455995|NCT03137992|363679628|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
105455996|NCT03137992|363679629|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
105455997|NCT03137992|363679630|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
105455998|NCT03137992|363679625|FG000|Washout Period 2|COPD Exacerbation|1|||
105455999|NCT03137992|363679626|FG001|Washout Period 2|COPD Exacerbation|1|||
105456000|NCT03137992|363679627|FG002|Washout Period 2|COPD Exacerbation|0|||
105456001|NCT03137992|363679628|FG003|Washout Period 2|COPD Exacerbation|0|||
105456002|NCT03137992|363679629|FG004|Washout Period 2|COPD Exacerbation|1|||
105456003|NCT03137992|363679630|FG005|Washout Period 2|COPD Exacerbation|0|||
105456004|NCT03137992|363679625|FG000|Washout Period 2|Subject Non-compliance|0|||
105456005|NCT03137992|363679626|FG001|Washout Period 2|Subject Non-compliance|1|||
105456006|NCT03137992|363679627|FG002|Washout Period 2|Subject Non-compliance|0|||
105456007|NCT03137992|363679628|FG003|Washout Period 2|Subject Non-compliance|0|||
105456008|NCT03137992|363679629|FG004|Washout Period 2|Subject Non-compliance|0|||
105456009|NCT03137992|363679630|FG005|Washout Period 2|Subject Non-compliance|0|||
105456010|NCT03137992|363679625|FG000|Washout Period 2|Adverse Event|0|||
105456011|NCT03137992|363679626|FG001|Washout Period 2|Adverse Event|0|||
105456012|NCT03137992|363679627|FG002|Washout Period 2|Adverse Event|0|||
105456013|NCT03137992|363679628|FG003|Washout Period 2|Adverse Event|1|||
105456014|NCT03137992|363679629|FG004|Washout Period 2|Adverse Event|1|||
105456015|NCT03137992|363679630|FG005|Washout Period 2|Adverse Event|0|||
105456016|NCT03137992|363679625|FG000|Washout Period 2|Withdrawal by Subject|1|||
105456017|NCT03137992|363679626|FG001|Washout Period 2|Withdrawal by Subject|0|||
105456018|NCT03137992|363679627|FG002|Washout Period 2|Withdrawal by Subject|0|||
105456019|NCT03137992|363679628|FG003|Washout Period 2|Withdrawal by Subject|0|||
105456020|NCT03137992|363679629|FG004|Washout Period 2|Withdrawal by Subject|1|||
105456021|NCT03137992|363679630|FG005|Washout Period 2|Withdrawal by Subject|0|||
105456022|NCT03137992|363679625|FG000|Washout Period 2|Sponsor Decision|0|||
105456023|NCT03137992|363679626|FG001|Washout Period 2|Sponsor Decision|0|||
105456024|NCT03137992|363679627|FG002|Washout Period 2|Sponsor Decision|0|||
105456025|NCT03137992|363679628|FG003|Washout Period 2|Sponsor Decision|0|||
105456026|NCT03137992|363679629|FG004|Washout Period 2|Sponsor Decision|0|||
105456027|NCT03137992|363679630|FG005|Washout Period 2|Sponsor Decision|1|||
105456028|NCT03137992|363679625|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
105456029|NCT03137992|363679626|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
105456030|NCT03137992|363679627|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
105456031|NCT03137992|363679628|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
105456032|NCT03137992|363679629|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
105456033|NCT03137992|363679630|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
105456034|NCT03137992|363679625|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
105456035|NCT03137992|363679626|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
105456036|NCT03137992|363679627|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
105456037|NCT03137992|363679628|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
105456038|NCT03137992|363679629|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
105456039|NCT03137992|363679630|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
105456040|NCT03137992|363679625|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
105456041|NCT03137992|363679626|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
105456042|NCT03137992|363679627|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
105456043|NCT03137992|363679628|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
105456044|NCT03137992|363679629|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
105456045|NCT03137992|363679630|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
105456046|NCT03137992|363679625|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
105456047|NCT03137992|363679626|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
105456048|NCT03137992|363679627|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
105456049|NCT03137992|363679628|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
105456050|NCT03137992|363679629|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
105456051|NCT03137992|363679630|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
105456052|NCT03137992|363679625|FG000|Part 2 (Open-label Extension)|Per study team|1|||
105456053|NCT03137992|363679626|FG001|Part 2 (Open-label Extension)|Per study team|0|||
105456054|NCT03137992|363679627|FG002|Part 2 (Open-label Extension)|Per study team|0|||
105456055|NCT03137992|363679628|FG003|Part 2 (Open-label Extension)|Per study team|0|||
105456056|NCT03137992|363679629|FG004|Part 2 (Open-label Extension)|Per study team|0|||
105456057|NCT03137992|363679630|FG005|Part 2 (Open-label Extension)|Per study team|0|||
105456058|NCT03137992|363679625|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
105456059|NCT03137992|363679626|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
105456060|NCT03137992|363679627|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
105456061|NCT03137992|363679628|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
105456062|NCT03137992|363679629|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
105456063|NCT03137992|363679630|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
105456064|NCT03905096|363679631|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
105456065|NCT03905096|363679632|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
105456066|NCT01350999|363679633|FG000|Overall Study|Adverse Event|4|||
105456067|NCT01350999|363679634|FG001|Overall Study|Adverse Event|9|||
105456068|NCT01350999|363679635|FG002|Overall Study|Adverse Event|10|||
105456069|NCT01350999|363679633|FG000|Overall Study|Voluntary withdrawal|3|||
105456070|NCT01350999|363679634|FG001|Overall Study|Voluntary withdrawal|4|||
105456071|NCT01350999|363679635|FG002|Overall Study|Voluntary withdrawal|6|||
105456072|NCT01350999|363679633|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
105456073|NCT01350999|363679634|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
105456074|NCT01350999|363679635|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
105456075|NCT03724942|363679636|FG000|Overall Study|Adverse Event|20|||
105456076|NCT03724942|363679637|FG001|Overall Study|Adverse Event|14|||
105456077|NCT03724942|363679636|FG000|Overall Study|Lack of Efficacy|0|||
105456078|NCT03724942|363679637|FG001|Overall Study|Lack of Efficacy|1|||
105456079|NCT03724942|363679636|FG000|Overall Study|Physician Decision|5|||
105456080|NCT03724942|363679637|FG001|Overall Study|Physician Decision|2|||
105456081|NCT03724942|363679636|FG000|Overall Study|Protocol Violation|1|||
105456082|NCT03724942|363679637|FG001|Overall Study|Protocol Violation|0|||
105456083|NCT03724942|363679636|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
105456084|NCT03724942|363679637|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
105456085|NCT03724942|363679636|FG000|Overall Study|Withdrawal by Legal Representative|3|||
105456086|NCT03724942|363679637|FG001|Overall Study|Withdrawal by Legal Representative|0|||
105456087|NCT01602224|363681562|FG000|Overall Study|Adverse Event|0|||
105456088|NCT01602224|363681563|FG001|Overall Study|Adverse Event|1|||
105456089|NCT01602224|363681564|FG002|Overall Study|Adverse Event|0|||
105456090|NCT01602224|363681562|FG000|Overall Study|Investigator Decison|1|||
105456091|NCT01602224|363681563|FG001|Overall Study|Investigator Decison|0|||
105456092|NCT01602224|363681564|FG002|Overall Study|Investigator Decison|0|||
105456093|NCT01602224|363681562|FG000|Overall Study|Lost to Follow-up|0|||
105456094|NCT01602224|363681563|FG001|Overall Study|Lost to Follow-up|0|||
105337233|NCT01435018|363236851|FG001|Overall Study|Severe debilitation, unable to continue|0|||
105456095|NCT01602224|363681564|FG002|Overall Study|Lost to Follow-up|1|||
105456096|NCT01602224|363681562|FG000|Overall Study|Protocol Violation|0|||
105456097|NCT01602224|363681563|FG001|Overall Study|Protocol Violation|1|||
105456098|NCT01602224|363681564|FG002|Overall Study|Protocol Violation|0|||
105456099|NCT01602224|363681562|FG000|Overall Study|Sponsor Decision|2|||
105337234|NCT01435018|363236852|FG002|Overall Study|Severe debilitation, unable to continue|1|||
105337235|NCT01435018|363236850|FG000|Overall Study|Unable to contact participant/parent|1|||
105456100|NCT01602224|363681563|FG001|Overall Study|Sponsor Decision|3|||
105456101|NCT01602224|363681564|FG002|Overall Study|Sponsor Decision|2|||
105456102|NCT01602224|363681562|FG000|Overall Study|Withdrawal by Subject|5|||
105456103|NCT01602224|363681563|FG001|Overall Study|Withdrawal by Subject|3|||
105456104|NCT01602224|363681564|FG002|Overall Study|Withdrawal by Subject|3|||
105456105|NCT00770653|363681565|FG000|Overall Study|Adverse Event|13|||
105456106|NCT00770653|363681566|FG001|Overall Study|Adverse Event|5|||
105456107|NCT00770653|363681565|FG000|Overall Study|Protocol Violation|8|||
105456108|NCT00770653|363681566|FG001|Overall Study|Protocol Violation|6|||
105456109|NCT00770653|363681565|FG000|Overall Study|Withdrawal by Subject|4|||
105456110|NCT00770653|363681566|FG001|Overall Study|Withdrawal by Subject|7|||
105456111|NCT00770653|363681565|FG000|Overall Study|Lack of Compliance|1|||
105456112|NCT00770653|363681566|FG001|Overall Study|Lack of Compliance|4|||
105456113|NCT00770653|363681565|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
105456114|NCT00770653|363681566|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
105456115|NCT00770653|363681565|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
105456116|NCT00770653|363681566|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
105456117|NCT00770653|363681565|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
105456118|NCT00770653|363681566|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
105456119|NCT00770653|363681565|FG000|Overall Study|Lost to Follow-up|1|||
105337236|NCT01435018|363236851|FG001|Overall Study|Unable to contact participant/parent|1|||
105337237|NCT01435018|363236852|FG002|Overall Study|Unable to contact participant/parent|1|||
105337238|NCT01435018|363236850|FG000|Overall Study|Enrollment Violation|0|||
105337239|NCT01435018|363236851|FG001|Overall Study|Enrollment Violation|1|||
105337240|NCT01435018|363236852|FG002|Overall Study|Enrollment Violation|0|||
105337241|NCT01435018|363236850|FG000|Overall Study|Never started chemotherapy|3|||
105337242|NCT01435018|363236851|FG001|Overall Study|Never started chemotherapy|0|||
105337243|NCT01435018|363236852|FG002|Overall Study|Never started chemotherapy|1|||
105337244|NCT00378508|363236853|FG000|Overall Study|Withdrawal by Subject|1|||
105337245|NCT00378508|363236854|FG001|Overall Study|Withdrawal by Subject|3|||
105337246|NCT00378508|363236853|FG000|Overall Study|Lost to Follow-up|1|||
105337247|NCT00378508|363236854|FG001|Overall Study|Lost to Follow-up|0|||
105337248|NCT01841762|363236855|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
105337249|NCT01841762|363236855|FG000|Treatment Period|Adverse Event|16|||
105337250|NCT01841762|363236855|FG000|Treatment Period|Death|1|||
105337251|NCT01841762|363236855|FG000|Treatment Period|Withdrawal by Subject|7|||
105337252|NCT01841762|363236855|FG000|Treatment Period|Lost to Follow-up|1|||
105337253|NCT01841762|363236855|FG000|Treatment Period|Physician Decision|2|||
105337254|NCT01841762|363236855|FG000|Treatment Period|Other, including non-compliance|5|||
105337255|NCT01841762|363236855|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
105337256|NCT01841762|363236855|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
105337257|NCT01841762|363236855|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
105337258|NCT01841762|363236855|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
105337259|NCT01177293|363236856|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
105337260|NCT01177293|363236857|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
105337261|NCT03528369|363236858|FG000|Overall Study|Withdrawal by Subject|2|||
105337262|NCT03528369|363236859|FG001|Overall Study|Withdrawal by Subject|0|||
105337263|NCT03528369|363236860|FG002|Overall Study|Withdrawal by Subject|0|||
105337264|NCT03528369|363236858|FG000|Overall Study|Lost to Follow-up|1|||
105337265|NCT03528369|363236859|FG001|Overall Study|Lost to Follow-up|0|||
105337266|NCT03528369|363236860|FG002|Overall Study|Lost to Follow-up|0|||
105337267|NCT03528369|363236858|FG000|Overall Study|Adverse Event|0|||
105337268|NCT03528369|363236859|FG001|Overall Study|Adverse Event|1|||
105337269|NCT03528369|363236860|FG002|Overall Study|Adverse Event|0|||
105337270|NCT03214380|363236861|FG000|Lead-in|Adverse Event|3|||
105337271|NCT03214380|363236862|FG001|Lead-in|Adverse Event|0|||
105337272|NCT03214380|363236863|FG002|Lead-in|Adverse Event|0|||
105337273|NCT03214380|363236864|FG003|Lead-in|Adverse Event|1|||
105337274|NCT03214380|363236865|FG004|Lead-in|Adverse Event|0|||
105337275|NCT03214380|363236866|FG005|Lead-in|Adverse Event|0|||
105337276|NCT03214380|363236861|FG000|Lead-in|Lost to Follow-up|4|||
105337277|NCT03214380|363236862|FG001|Lead-in|Lost to Follow-up|0|||
105337278|NCT03214380|363236863|FG002|Lead-in|Lost to Follow-up|0|||
105337279|NCT03214380|363236864|FG003|Lead-in|Lost to Follow-up|1|||
105337280|NCT03214380|363236865|FG004|Lead-in|Lost to Follow-up|0|||
105337281|NCT03214380|363236866|FG005|Lead-in|Lost to Follow-up|0|||
105337282|NCT03214380|363236861|FG000|Lead-in|Eligibility Criteria|3|||
105337283|NCT03214380|363236862|FG001|Lead-in|Eligibility Criteria|0|||
105337284|NCT03214380|363236863|FG002|Lead-in|Eligibility Criteria|0|||
105337285|NCT03214380|363236864|FG003|Lead-in|Eligibility Criteria|0|||
105337286|NCT03214380|363236865|FG004|Lead-in|Eligibility Criteria|0|||
105337287|NCT03214380|363236866|FG005|Lead-in|Eligibility Criteria|0|||
105337288|NCT03214380|363236861|FG000|Lead-in|Physician Decision|6|||
105337289|NCT03214380|363236862|FG001|Lead-in|Physician Decision|0|||
105337290|NCT03214380|363236863|FG002|Lead-in|Physician Decision|0|||
105337291|NCT03214380|363236864|FG003|Lead-in|Physician Decision|0|||
105456120|NCT00770653|363681566|FG001|Overall Study|Lost to Follow-up|2|||
105456121|NCT00770653|363681565|FG000|Overall Study|Physician Decision|1|||
105456122|NCT00770653|363681566|FG001|Overall Study|Physician Decision|0|||
105456123|NCT00644423|363681567|FG000|Overall Study|Lost to Follow-up|1|||
105456124|NCT00644423|363681568|FG001|Overall Study|Lost to Follow-up|1|||
105456125|NCT01908426|363681569|FG000|Overall Study|Adverse Event|98|||
105456126|NCT01908426|363681570|FG001|Overall Study|Adverse Event|11|||
105456127|NCT01908426|363681569|FG000|Overall Study|Clinical Deterioration|72|||
105456128|NCT01908426|363681570|FG001|Overall Study|Clinical Deterioration|38|||
105456129|NCT01908426|363681569|FG000|Overall Study|Lack of Efficacy|3|||
105456130|NCT01908426|363681570|FG001|Overall Study|Lack of Efficacy|0|||
105337292|NCT03214380|363236865|FG004|Lead-in|Physician Decision|0|||
105337293|NCT03214380|363236866|FG005|Lead-in|Physician Decision|0|||
105337294|NCT03214380|363236861|FG000|Lead-in|Protocol Deviation|7|||
105337295|NCT03214380|363236862|FG001|Lead-in|Protocol Deviation|0|||
105337296|NCT03214380|363236863|FG002|Lead-in|Protocol Deviation|0|||
105337297|NCT03214380|363236864|FG003|Lead-in|Protocol Deviation|3|||
105337298|NCT03214380|363236865|FG004|Lead-in|Protocol Deviation|0|||
105337299|NCT03214380|363236866|FG005|Lead-in|Protocol Deviation|0|||
105337300|NCT03214380|363236861|FG000|Lead-in|Withdrawal by Subject|41|||
105337301|NCT03214380|363236862|FG001|Lead-in|Withdrawal by Subject|0|||
105337302|NCT03214380|363236863|FG002|Lead-in|Withdrawal by Subject|0|||
105337303|NCT03214380|363236864|FG003|Lead-in|Withdrawal by Subject|14|||
105456131|NCT01908426|363681569|FG000|Overall Study|Lost to Follow-up|0|||
105456132|NCT01908426|363681570|FG001|Overall Study|Lost to Follow-up|1|||
105456133|NCT01908426|363681569|FG000|Overall Study|Physician Decision|3|||
105456134|NCT01908426|363681570|FG001|Overall Study|Physician Decision|3|||
105456135|NCT01908426|363681569|FG000|Overall Study|Withdrawal by Subject|11|||
105456136|NCT01908426|363681570|FG001|Overall Study|Withdrawal by Subject|6|||
105456137|NCT01908426|363681569|FG000|Overall Study|Progressive Disease|206|||
105456138|NCT01908426|363681570|FG001|Overall Study|Progressive Disease|152|||
105456139|NCT01908426|363681569|FG000|Overall Study|Protocol Violation|1|||
105456140|NCT01908426|363681570|FG001|Overall Study|Protocol Violation|0|||
105456141|NCT01908426|363681569|FG000|Overall Study|No Study Treatment Given|3|||
105456142|NCT01908426|363681570|FG001|Overall Study|No Study Treatment Given|0|||
105456143|NCT03346434|363681571|FG000|Overall Study|Randomized in Error|0|||
105456144|NCT03346434|363681572|FG001|Overall Study|Randomized in Error|0|||
105456145|NCT03346434|363681573|FG002|Overall Study|Randomized in Error|0|||
105456146|NCT03346434|363681574|FG003|Overall Study|Randomized in Error|0|||
105456147|NCT03346434|363681575|FG004|Overall Study|Randomized in Error|1|||
105456148|NCT03346434|363681576|FG005|Overall Study|Randomized in Error|0|||
105456149|NCT03346434|363681571|FG000|Overall Study|Withdrawal by Subject|0|||
105456150|NCT03346434|363681572|FG001|Overall Study|Withdrawal by Subject|0|||
105456151|NCT03346434|363681573|FG002|Overall Study|Withdrawal by Subject|1|||
105456152|NCT03346434|363681574|FG003|Overall Study|Withdrawal by Subject|0|||
105456153|NCT03346434|363681575|FG004|Overall Study|Withdrawal by Subject|1|||
105456154|NCT03346434|363681576|FG005|Overall Study|Withdrawal by Subject|0|||
105456155|NCT03346434|363681571|FG000|Overall Study|Lost to Follow-up|0|||
105456156|NCT03346434|363681572|FG001|Overall Study|Lost to Follow-up|0|||
105456157|NCT03346434|363681573|FG002|Overall Study|Lost to Follow-up|0|||
105456158|NCT03346434|363681574|FG003|Overall Study|Lost to Follow-up|0|||
105456159|NCT03346434|363681575|FG004|Overall Study|Lost to Follow-up|1|||
105456160|NCT03346434|363681576|FG005|Overall Study|Lost to Follow-up|1|||
105456161|NCT03346434|363681571|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
105456162|NCT03346434|363681572|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
105456163|NCT03346434|363681573|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
105456164|NCT03346434|363681574|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
105456165|NCT03346434|363681575|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
105456166|NCT03346434|363681576|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
105456167|NCT03525444|363681580|FG000|Overall Study|Adverse Event|0|||
105456168|NCT03525444|363681581|FG001|Overall Study|Adverse Event|1|||
105456169|NCT03525444|363681580|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
105456170|NCT03525444|363681581|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
105456171|NCT03525444|363681580|FG000|Overall Study|Other|0|||
105456172|NCT03525444|363681581|FG001|Overall Study|Other|1|||
105456173|NCT00262860|363681584|FG000|Overall Study|Adverse Event|2|||
105456174|NCT02973100|363681587|FG000|Overall Study|Adverse Event|1|||
105456175|NCT02973100|363681588|FG001|Overall Study|Adverse Event|2|||
105456176|NCT02973100|363681589|FG002|Overall Study|Adverse Event|1|||
105456177|NCT02973100|363681590|FG003|Overall Study|Adverse Event|2|||
105456178|NCT02973100|363681587|FG000|Overall Study|Lost to Follow-up|3|||
105456179|NCT02973100|363681588|FG001|Overall Study|Lost to Follow-up|1|||
105456180|NCT02973100|363681589|FG002|Overall Study|Lost to Follow-up|1|||
105456181|NCT02973100|363681590|FG003|Overall Study|Lost to Follow-up|0|||
105456182|NCT02973100|363681587|FG000|Overall Study|Withdrawal by Subject|3|||
105456183|NCT02973100|363681588|FG001|Overall Study|Withdrawal by Subject|5|||
105456184|NCT02973100|363681589|FG002|Overall Study|Withdrawal by Subject|1|||
105456185|NCT02973100|363681590|FG003|Overall Study|Withdrawal by Subject|4|||
105456186|NCT02973100|363681587|FG000|Overall Study|Notification of change in address|0|||
105456187|NCT02973100|363681588|FG001|Overall Study|Notification of change in address|0|||
105456188|NCT02973100|363681589|FG002|Overall Study|Notification of change in address|0|||
105456189|NCT02973100|363681590|FG003|Overall Study|Notification of change in address|1|||
105456190|NCT02973100|363681587|FG000|Overall Study|Failed to attend Safety followup period|0|||
105456191|NCT02973100|363681588|FG001|Overall Study|Failed to attend Safety followup period|0|||
105337304|NCT03214380|363236865|FG004|Lead-in|Withdrawal by Subject|0|||
105337305|NCT03214380|363236866|FG005|Lead-in|Withdrawal by Subject|0|||
105337306|NCT03214380|363236861|FG000|Lead-in|Family Emergency|1|||
105337307|NCT03214380|363236862|FG001|Lead-in|Family Emergency|0|||
105337308|NCT03214380|363236863|FG002|Lead-in|Family Emergency|0|||
105337309|NCT03214380|363236864|FG003|Lead-in|Family Emergency|0|||
105337310|NCT03214380|363236865|FG004|Lead-in|Family Emergency|0|||
105337311|NCT03214380|363236866|FG005|Lead-in|Family Emergency|0|||
105337312|NCT03214380|363236861|FG000|Lead-in|Natural Disaster|9|||
105337313|NCT03214380|363236862|FG001|Lead-in|Natural Disaster|0|||
105337314|NCT03214380|363236863|FG002|Lead-in|Natural Disaster|0|||
105337315|NCT03214380|363236864|FG003|Lead-in|Natural Disaster|0|||
105337316|NCT03214380|363236865|FG004|Lead-in|Natural Disaster|0|||
105337317|NCT03214380|363236866|FG005|Lead-in|Natural Disaster|0|||
105337318|NCT03214380|363236861|FG000|Lead-in|Non Compliance|1|||
105337319|NCT03214380|363236862|FG001|Lead-in|Non Compliance|0|||
105337320|NCT03214380|363236863|FG002|Lead-in|Non Compliance|0|||
105337321|NCT03214380|363236864|FG003|Lead-in|Non Compliance|0|||
105337322|NCT03214380|363236865|FG004|Lead-in|Non Compliance|0|||
105337323|NCT03214380|363236866|FG005|Lead-in|Non Compliance|0|||
105337324|NCT03214380|363236861|FG000|Lead-in|Participant Schedule|2|||
105337325|NCT03214380|363236862|FG001|Lead-in|Participant Schedule|0|||
105337326|NCT03214380|363236863|FG002|Lead-in|Participant Schedule|0|||
105337327|NCT03214380|363236864|FG003|Lead-in|Participant Schedule|0|||
105337328|NCT03214380|363236865|FG004|Lead-in|Participant Schedule|0|||
105337329|NCT03214380|363236866|FG005|Lead-in|Participant Schedule|0|||
105337330|NCT03214380|363236861|FG000|Treatment Period|Adverse Event|0|||
105337331|NCT03214380|363236862|FG001|Treatment Period|Adverse Event|1|||
105337332|NCT03214380|363236863|FG002|Treatment Period|Adverse Event|1|||
105337333|NCT03214380|363236864|FG003|Treatment Period|Adverse Event|0|||
105337334|NCT03214380|363236865|FG004|Treatment Period|Adverse Event|1|||
105337335|NCT03214380|363236866|FG005|Treatment Period|Adverse Event|0|||
105337336|NCT03214380|363236861|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
105337337|NCT03214380|363236862|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
105337338|NCT03214380|363236863|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
105337339|NCT03214380|363236864|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
105337340|NCT03214380|363236865|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
105337341|NCT03214380|363236866|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
105337342|NCT03214380|363236861|FG000|Treatment Period|Withdrawal by Subject|0|||
105337343|NCT03214380|363236862|FG001|Treatment Period|Withdrawal by Subject|10|||
105337344|NCT03214380|363236863|FG002|Treatment Period|Withdrawal by Subject|8|||
105337345|NCT03214380|363236864|FG003|Treatment Period|Withdrawal by Subject|0|||
105337346|NCT03214380|363236865|FG004|Treatment Period|Withdrawal by Subject|7|||
105337347|NCT03214380|363236866|FG005|Treatment Period|Withdrawal by Subject|11|||
105337348|NCT03214380|363236861|FG000|Treatment Period|Death|0|||
105337349|NCT03214380|363236862|FG001|Treatment Period|Death|1|||
105337350|NCT03214380|363236863|FG002|Treatment Period|Death|2|||
105337351|NCT03214380|363236864|FG003|Treatment Period|Death|0|||
105337352|NCT03214380|363236865|FG004|Treatment Period|Death|0|||
105337353|NCT03214380|363236866|FG005|Treatment Period|Death|0|||
105337354|NCT03214380|363236861|FG000|Treatment Period|Lost to Follow-up|0|||
105337355|NCT03214380|363236862|FG001|Treatment Period|Lost to Follow-up|6|||
105337356|NCT03214380|363236863|FG002|Treatment Period|Lost to Follow-up|3|||
105337357|NCT03214380|363236864|FG003|Treatment Period|Lost to Follow-up|0|||
105337358|NCT03214380|363236865|FG004|Treatment Period|Lost to Follow-up|0|||
105337359|NCT03214380|363236866|FG005|Treatment Period|Lost to Follow-up|0|||
105337360|NCT03214380|363236861|FG000|Treatment Period|Participant schedule|0|||
105337361|NCT03214380|363236862|FG001|Treatment Period|Participant schedule|0|||
105337362|NCT03214380|363236863|FG002|Treatment Period|Participant schedule|1|||
105337363|NCT03214380|363236864|FG003|Treatment Period|Participant schedule|0|||
105337364|NCT03214380|363236865|FG004|Treatment Period|Participant schedule|0|||
105337365|NCT03214380|363236866|FG005|Treatment Period|Participant schedule|0|||
105337366|NCT03214380|363236861|FG000|Treatment Period|Treatment Interruption|0|||
105337367|NCT03214380|363236862|FG001|Treatment Period|Treatment Interruption|0|||
105337368|NCT03214380|363236863|FG002|Treatment Period|Treatment Interruption|1|||
105337369|NCT03214380|363236864|FG003|Treatment Period|Treatment Interruption|0|||
105337370|NCT03214380|363236865|FG004|Treatment Period|Treatment Interruption|0|||
105337371|NCT03214380|363236866|FG005|Treatment Period|Treatment Interruption|0|||
105337372|NCT03962790|363236874|FG000|Period 1|Adverse Event|0|||
105337373|NCT03962790|363236875|FG001|Period 1|Adverse Event|1|||
105337374|NCT03962790|363236874|FG000|Period 1|Failed to meet all eligibility criteria|1|||
105337375|NCT03962790|363236875|FG001|Period 1|Failed to meet all eligibility criteria|1|||
105337376|NCT03962790|363236874|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
105337377|NCT03962790|363236875|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
105337378|NCT03962790|363236874|FG000|Period 1|Withdrawal by Subject|1|||
105337379|NCT03962790|363236875|FG001|Period 1|Withdrawal by Subject|0|||
105337380|NCT00076752|363236876|FG000|Overall Study|Death|2|||
105337381|NCT00076752|363236876|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
105550207|NCT00467870|364014376|FG002|Overall Study|Lost to Follow-up|1|||
105456192|NCT02973100|363681589|FG002|Overall Study|Failed to attend Safety followup period|1|||
105456193|NCT02973100|363681590|FG003|Overall Study|Failed to attend Safety followup period|0|||
105456194|NCT02426580|363681591|FG000|Overall Study|Death|2|||
105456195|NCT02426580|363681592|FG001|Overall Study|Death|2|||
105456196|NCT02426580|363681591|FG000|Overall Study|Lost to Follow-up|0|||
105456197|NCT02426580|363681592|FG001|Overall Study|Lost to Follow-up|9|||
105456198|NCT02426580|363681591|FG000|Overall Study|transfer to hemodialysis|5|||
105456199|NCT02426580|363681592|FG001|Overall Study|transfer to hemodialysis|5|||
105456200|NCT02426580|363681591|FG000|Overall Study|Kidney transplant|3|||
105456201|NCT02426580|363681592|FG001|Overall Study|Kidney transplant|0|||
105456202|NCT02426580|363681591|FG000|Overall Study|Allergic to egg white|1|||
105456203|NCT02426580|363681592|FG001|Overall Study|Allergic to egg white|0|||
105456204|NCT01419769|363681593|FG000|Overall Study|Did not receive the AXIOS stent|3|||
105456205|NCT01419769|363681593|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
105456206|NCT01600326|363681597|FG000|Overall Study|Lost to Follow-up|1|||
105456207|NCT01600326|363681598|FG001|Overall Study|Lost to Follow-up|1|||
105337382|NCT00452673|363236879|FG000|Dose Escalation Period|Disease Progression|6|||
105337383|NCT00452673|363236880|FG001|Dose Escalation Period|Disease Progression|6|||
105337384|NCT00452673|363236881|FG002|Dose Escalation Period|Disease Progression|2|||
105337385|NCT00452673|363236882|FG003|Dose Escalation Period|Disease Progression|6|||
105337386|NCT00452673|363236883|FG004|Dose Escalation Period|Disease Progression|0|||
105337387|NCT00452673|363236879|FG000|Dose Escalation Period|study drug toxicity|1|||
105337388|NCT00452673|363236880|FG001|Dose Escalation Period|study drug toxicity|3|||
105337389|NCT00452673|363236881|FG002|Dose Escalation Period|study drug toxicity|3|||
105337390|NCT00452673|363236882|FG003|Dose Escalation Period|study drug toxicity|1|||
105337391|NCT00452673|363236883|FG004|Dose Escalation Period|study drug toxicity|0|||
105337392|NCT00452673|363236879|FG000|Dose Escalation Period|Other|0|||
105337393|NCT00452673|363236880|FG001|Dose Escalation Period|Other|0|||
105337394|NCT00452673|363236881|FG002|Dose Escalation Period|Other|1|||
105337395|NCT00452673|363236882|FG003|Dose Escalation Period|Other|0|||
105337396|NCT00452673|363236883|FG004|Dose Escalation Period|Other|0|||
105337397|NCT00452673|363236879|FG000|Dose Escalation Period|Adverse Event|0|||
105337398|NCT00452673|363236880|FG001|Dose Escalation Period|Adverse Event|0|||
105337399|NCT00452673|363236881|FG002|Dose Escalation Period|Adverse Event|0|||
105337400|NCT00452673|363236882|FG003|Dose Escalation Period|Adverse Event|1|||
105337401|NCT00452673|363236883|FG004|Dose Escalation Period|Adverse Event|0|||
105337402|NCT00452673|363236879|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
105337403|NCT00452673|363236880|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
105337404|NCT00452673|363236881|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
105337405|NCT00452673|363236882|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
105337406|NCT00452673|363236883|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
105337407|NCT00452673|363236879|FG000|Dose Expansion Period|Disease Progression|0|||
105337408|NCT00452673|363236880|FG001|Dose Expansion Period|Disease Progression|0|||
105337409|NCT00452673|363236881|FG002|Dose Expansion Period|Disease Progression|0|||
105337410|NCT00452673|363236882|FG003|Dose Expansion Period|Disease Progression|0|||
105337411|NCT00452673|363236883|FG004|Dose Expansion Period|Disease Progression|19|||
105337412|NCT00452673|363236879|FG000|Dose Expansion Period|Other|0|||
105337413|NCT00452673|363236880|FG001|Dose Expansion Period|Other|0|||
105456208|NCT04456504|363681599|FG000|Overall Study|Lost to Follow-up|2|||
105456209|NCT01131507|363681601|FG000|Overall Study|Adverse Event|1|||
105456210|NCT01131507|363681601|FG000|Overall Study|Lost to Follow-up|1|||
105456211|NCT01131507|363681601|FG000|Overall Study|Withdrawal by Subject|1|||
105456212|NCT03224130|363681608|FG000|Overall Study|consent issue|0|||
105456213|NCT03224130|363681609|FG001|Overall Study|consent issue|1|||
105456214|NCT04750824|363681615|FG000|Overall Study|Toxicity/intolerability|3|||
105456215|NCT04750824|363681616|FG001|Overall Study|Toxicity/intolerability|1|||
105456216|NCT04750824|363681615|FG000|Overall Study|Death|1|||
105456217|NCT04750824|363681616|FG001|Overall Study|Death|3|||
105456218|NCT04750824|363681615|FG000|Overall Study|Scheduled duration of therapy complete|1|||
105456219|NCT04750824|363681616|FG001|Overall Study|Scheduled duration of therapy complete|9|||
105456220|NCT04750824|363681615|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
105456221|NCT04750824|363681616|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
105456222|NCT03547518|363681617|FG000|Overall Study|Lost to Follow-up|2|||
105456223|NCT03547518|363681618|FG001|Overall Study|Lost to Follow-up|0|||
105456224|NCT01018030|363681620|FG000|Overall Study|Adverse Event|10|||
105456225|NCT01018030|363681621|FG001|Overall Study|Adverse Event|5|||
105456226|NCT01018030|363681622|FG002|Overall Study|Adverse Event|5|||
105456227|NCT01018030|363681620|FG000|Overall Study|Withdrawal by Subject|2|||
105456228|NCT01018030|363681621|FG001|Overall Study|Withdrawal by Subject|2|||
105456229|NCT01018030|363681622|FG002|Overall Study|Withdrawal by Subject|4|||
105456230|NCT01018030|363681620|FG000|Overall Study|Lost to Follow-up|2|||
105456231|NCT01018030|363681621|FG001|Overall Study|Lost to Follow-up|0|||
105456232|NCT01018030|363681622|FG002|Overall Study|Lost to Follow-up|3|||
105456233|NCT01018030|363681620|FG000|Overall Study|Protocol Violation|2|||
105456234|NCT01018030|363681621|FG001|Overall Study|Protocol Violation|1|||
105456235|NCT01018030|363681622|FG002|Overall Study|Protocol Violation|0|||
105456236|NCT01018030|363681620|FG000|Overall Study|Physician Decision|1|||
105456237|NCT01018030|363681621|FG001|Overall Study|Physician Decision|0|||
105456238|NCT01018030|363681622|FG002|Overall Study|Physician Decision|1|||
105456239|NCT01018030|363681620|FG000|Overall Study|Lack of Efficacy|1|||
105456240|NCT01018030|363681621|FG001|Overall Study|Lack of Efficacy|0|||
105456241|NCT01018030|363681622|FG002|Overall Study|Lack of Efficacy|0|||
105456242|NCT01018030|363681620|FG000|Overall Study|Did Not Receive Study Drug|1|||
105456243|NCT01018030|363681621|FG001|Overall Study|Did Not Receive Study Drug|3|||
105456244|NCT01018030|363681622|FG002|Overall Study|Did Not Receive Study Drug|0|||
105456245|NCT01600885|363681639|FG000|First Period|Adverse Event|1|||
105456246|NCT01600885|363681640|FG001|First Period|Adverse Event|1|||
105456247|NCT01600885|363681639|FG000|First Period|moved out of area|1|||
105456248|NCT01600885|363681640|FG001|First Period|moved out of area|0|||
105456249|NCT01903356|363681646|FG000|Overall Study|Lost to Follow-up|7|||
105456250|NCT01903356|363681646|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
105337414|NCT00452673|363236881|FG002|Dose Expansion Period|Other|0|||
105456251|NCT01903356|363681646|FG000|Overall Study|Violated the dosage and administration|3|||
105456252|NCT01009060|363681647|FG000|Overall Study|Adverse Event|1|||
105456253|NCT01009060|363681648|FG001|Overall Study|Adverse Event|2|||
105456254|NCT01009060|363681647|FG000|Overall Study|Protocol Violation|0|||
105456255|NCT01009060|363681648|FG001|Overall Study|Protocol Violation|1|||
105456256|NCT01009060|363681647|FG000|Overall Study|Lost to Follow-up|1|||
105456257|NCT01009060|363681648|FG001|Overall Study|Lost to Follow-up|0|||
105456258|NCT01009060|363681647|FG000|Overall Study|Physician Decision|1|||
105456259|NCT01009060|363681648|FG001|Overall Study|Physician Decision|1|||
105456260|NCT01009060|363681647|FG000|Overall Study|Withdrawal by Subject|1|||
105456261|NCT01009060|363681648|FG001|Overall Study|Withdrawal by Subject|1|||
105456262|NCT00005906|363681649|FG000|Overall Study|Lack of Efficacy|3|||
105337415|NCT00452673|363236882|FG003|Dose Expansion Period|Other|0|||
105337416|NCT00452673|363236883|FG004|Dose Expansion Period|Other|2|||
105456263|NCT04196686|363681651|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
105456264|NCT04196686|363681652|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
105456265|NCT02587221|363681657|FG000|Overall Study|Adverse Event|3|||
105456266|NCT02587221|363681658|FG001|Overall Study|Adverse Event|3|||
105456267|NCT02587221|363681657|FG000|Overall Study|Death|33|||
105456268|NCT02587221|363681658|FG001|Overall Study|Death|34|||
105456269|NCT02587221|363681657|FG000|Overall Study|Withdrawal by Subject|66|||
105456270|NCT02587221|363681658|FG001|Overall Study|Withdrawal by Subject|61|||
105456271|NCT02587221|363681657|FG000|Overall Study|Lost to Follow-up|21|||
105456272|NCT02587221|363681658|FG001|Overall Study|Lost to Follow-up|19|||
105337417|NCT02656290|363236884|FG000|Overall Study|Lost to Follow-up|1|||
105337418|NCT02656290|363236884|FG000|Overall Study|Reintervention|3|||
105337419|NCT00394836|363236887|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
105661748|NCT04913948|364425129|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
105456273|NCT02587221|363681657|FG000|Overall Study|Protocol Violation|6|||
105456274|NCT02587221|363681658|FG001|Overall Study|Protocol Violation|5|||
105456275|NCT02587221|363681657|FG000|Overall Study|Other Reason or Unspecified|2|||
105456276|NCT02587221|363681658|FG001|Overall Study|Other Reason or Unspecified|1|||
105456277|NCT02546609|363681659|FG000|Overall Study|Withdrawal by Subject|0|||
105337420|NCT00394836|363236888|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
105456278|NCT02546609|363681660|FG001|Overall Study|Withdrawal by Subject|1|||
105456279|NCT02546609|363681661|FG002|Overall Study|Withdrawal by Subject|2|||
105456280|NCT02546609|363681659|FG000|Overall Study|Adverse Event|0|||
105456281|NCT02546609|363681660|FG001|Overall Study|Adverse Event|6|||
105456282|NCT02546609|363681661|FG002|Overall Study|Adverse Event|1|||
105456283|NCT02546609|363681659|FG000|Overall Study|Protocol Violation|0|||
105456284|NCT02546609|363681660|FG001|Overall Study|Protocol Violation|1|||
105456285|NCT02546609|363681661|FG002|Overall Study|Protocol Violation|1|||
105456286|NCT02546609|363681659|FG000|Overall Study|Lost to Follow-up|2|||
105456287|NCT02546609|363681660|FG001|Overall Study|Lost to Follow-up|3|||
105456288|NCT02546609|363681661|FG002|Overall Study|Lost to Follow-up|1|||
105456289|NCT02546609|363681659|FG000|Overall Study|travel or work schedule restriction|0|||
105456290|NCT02546609|363681660|FG001|Overall Study|travel or work schedule restriction|0|||
105456291|NCT02546609|363681661|FG002|Overall Study|travel or work schedule restriction|2|||
105456292|NCT03796728|363681666|FG000|Overall Study|Lost to Follow-up|8|||
105456293|NCT03796728|363681666|FG000|Overall Study|Reason not Specified|16|||
105456294|NCT01149096|363681668|FG000|Overall Study|Lost to Follow-up|0|||
105456295|NCT01149096|363681669|FG001|Overall Study|Lost to Follow-up|1|||
105456296|NCT00325897|363681670|FG000|Overall Study|Lost to Follow-up|12|||
105456297|NCT00325897|363681671|FG001|Overall Study|Lost to Follow-up|13|||
105456298|NCT04079296|363681672|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
105456299|NCT04079296|363681673|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
105456300|NCT04079296|363681674|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
105456301|NCT04079296|363681675|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
105456302|NCT04079296|363681676|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
105456303|NCT04079296|363681672|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
105456304|NCT04079296|363681673|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
105456305|NCT04079296|363681674|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
105456306|NCT04079296|363681675|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
105456307|NCT04079296|363681676|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
105456308|NCT04079296|363681672|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
105456309|NCT04079296|363681673|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
105456310|NCT04079296|363681674|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
105456311|NCT04079296|363681675|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
105456312|NCT04079296|363681676|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
105456313|NCT04079296|363681672|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
105456314|NCT04079296|363681673|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
105456315|NCT04079296|363681674|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
105456316|NCT04079296|363681675|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
105456317|NCT04079296|363681676|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
105456318|NCT04079296|363681672|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
105456319|NCT04079296|363681673|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
105456320|NCT04079296|363681674|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
105456321|NCT04079296|363681675|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
105456322|NCT04079296|363681676|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
105456323|NCT04079296|363681672|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
105456324|NCT04079296|363681673|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
105456325|NCT04079296|363681674|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
105456326|NCT04079296|363681675|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
105456327|NCT04079296|363681676|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
105456328|NCT04079296|363681672|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
105456329|NCT04079296|363681673|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
105456330|NCT04079296|363681674|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
105456331|NCT04079296|363681675|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
105456332|NCT04079296|363681676|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
105456333|NCT04079296|363681672|FG000|Dose Expansion Phase (168 Days)|Death|0|||
105456334|NCT04079296|363681673|FG001|Dose Expansion Phase (168 Days)|Death|0|||
105456335|NCT04079296|363681674|FG002|Dose Expansion Phase (168 Days)|Death|0|||
105456336|NCT04079296|363681675|FG003|Dose Expansion Phase (168 Days)|Death|1|||
105456337|NCT04079296|363681676|FG004|Dose Expansion Phase (168 Days)|Death|0|||
105456338|NCT03748823|363681677|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
105456339|NCT03748823|363681678|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
105456340|NCT03748823|363681677|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
105456341|NCT03748823|363681678|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
105456342|NCT03748823|363681677|FG000|Extension Period|Withdrawal by Subject|9|||
105456343|NCT03748823|363681678|FG001|Extension Period|Withdrawal by Subject|12|||
105456344|NCT03748823|363681677|FG000|Extension Period|Death|2|||
105456345|NCT03748823|363681678|FG001|Extension Period|Death|2|||
105456346|NCT03748823|363681677|FG000|Extension Period|Other than Specified|0|||
105456347|NCT03748823|363681678|FG001|Extension Period|Other than Specified|1|||
105456348|NCT03748823|363681677|FG000|Extension Period|Protocol Violation|1|||
105456349|NCT03748823|363681678|FG001|Extension Period|Protocol Violation|0|||
105456350|NCT03748823|363681677|FG000|Extension Period|Lost to Follow-up|0|||
105456351|NCT03748823|363681678|FG001|Extension Period|Lost to Follow-up|1|||
105456352|NCT03748823|363681677|FG000|Extension Period|Lack of Efficacy|0|||
105456353|NCT03748823|363681678|FG001|Extension Period|Lack of Efficacy|1|||
105456354|NCT03748823|363681677|FG000|Extension Period|Physician Decision|1|||
105456355|NCT03748823|363681678|FG001|Extension Period|Physician Decision|2|||
105456356|NCT02240485|363681679|FG000|3 Months Post-admission|Lost to Follow-up|1|||
105456357|NCT02240485|363681680|FG001|3 Months Post-admission|Lost to Follow-up|5|||
105456358|NCT02240485|363681679|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
105456359|NCT02240485|363681680|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
105456360|NCT02240485|363681679|FG000|9 Months Post-admission|Lost to Follow-up|3|||
105456361|NCT02240485|363681680|FG001|9 Months Post-admission|Lost to Follow-up|1|||
105456362|NCT02240485|363681679|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
105456363|NCT02240485|363681680|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
105456364|NCT02240485|363681679|FG000|18 Months Post-admission|Lost to Follow-up|1|||
105456365|NCT02240485|363681680|FG001|18 Months Post-admission|Lost to Follow-up|1|||
105456366|NCT02240485|363681679|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
105456367|NCT02240485|363681680|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
105456368|NCT00703014|363681681|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
105456369|NCT00703014|363681682|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
105456370|NCT00703014|363681683|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
105456371|NCT00703014|363681684|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
105456372|NCT00703014|363681681|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
105456373|NCT00703014|363681682|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
105456374|NCT00703014|363681683|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
105456375|NCT00703014|363681684|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
105456376|NCT05121766|363681685|FG000|Overall Study|Covid reinfection|3|||
105456377|NCT05121766|363681686|FG001|Overall Study|Covid reinfection|0|||
105456378|NCT05121766|363681685|FG000|Overall Study|Withdrawal by Subject|3|||
105456379|NCT05121766|363681686|FG001|Overall Study|Withdrawal by Subject|1|||
105456380|NCT05121766|363681685|FG000|Overall Study|Adverse Event|2|||
105456381|NCT05121766|363681686|FG001|Overall Study|Adverse Event|4|||
105456382|NCT05121766|363681685|FG000|Overall Study|Lost to Follow-up|0|||
105456383|NCT05121766|363681686|FG001|Overall Study|Lost to Follow-up|1|||
105456384|NCT02960217|363681688|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
105456385|NCT02960217|363681689|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
105456386|NCT02960217|363681688|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
105456387|NCT02960217|363681689|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
105456388|NCT02960217|363681688|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
105456389|NCT02960217|363681689|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
105456390|NCT02960217|363681688|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
105456391|NCT02960217|363681689|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
105456392|NCT02960217|363681688|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
105456393|NCT02960217|363681689|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
105456394|NCT02960217|363681688|FG000|Open-Label Extension Phase|Adverse Event|1|||
105456395|NCT02960217|363681689|FG001|Open-Label Extension Phase|Adverse Event|0|||
105456396|NCT02960217|363681688|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
105456397|NCT02960217|363681689|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
105456398|NCT02960217|363681688|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
105456399|NCT02960217|363681689|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
105456400|NCT02960217|363681688|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
105456401|NCT02960217|363681689|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
105456402|NCT03624881|363681690|FG000|Overall Study|Screen Failure|14|||
105456403|NCT03624881|363681691|FG001|Overall Study|Screen Failure|0|||
105456404|NCT03624881|363681690|FG000|Overall Study|No Catheter Inserted|6|||
105456405|NCT03624881|363681691|FG001|Overall Study|No Catheter Inserted|1|||
105456406|NCT03624881|363681690|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
105456407|NCT03624881|363681691|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
105456408|NCT03624881|363681690|FG000|Overall Study|Death|2|||
105456409|NCT03624881|363681691|FG001|Overall Study|Death|0|||
105456410|NCT03624881|363681690|FG000|Overall Study|Lost to Follow-up|10|||
105456411|NCT03624881|363681691|FG001|Overall Study|Lost to Follow-up|4|||
105456412|NCT03624881|363681690|FG000|Overall Study|Withdrawal by Subject|12|||
105456413|NCT03624881|363681691|FG001|Overall Study|Withdrawal by Subject|1|||
105456414|NCT00388349|363681692|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
105456415|NCT00388349|363681693|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
105456416|NCT02657889|363681696|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
105456417|NCT02657889|363681697|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
105456418|NCT02657889|363681698|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
105456419|NCT02657889|363681699|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
105456420|NCT02657889|363681696|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
105456421|NCT02657889|363681697|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
105456422|NCT02657889|363681698|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
105456423|NCT02657889|363681699|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
105456424|NCT02657889|363681696|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
105456425|NCT02657889|363681697|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
105456426|NCT02657889|363681698|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
105456427|NCT02657889|363681699|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
105456428|NCT02657889|363681696|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
105456429|NCT02657889|363681697|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
105456430|NCT02657889|363681698|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
105456431|NCT02657889|363681699|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
105456432|NCT02657889|363681696|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
105456433|NCT02657889|363681697|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
105456434|NCT02657889|363681698|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
105456435|NCT02657889|363681699|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
105456436|NCT02657889|363681696|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
105456437|NCT02657889|363681697|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
105456438|NCT02657889|363681698|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
105456439|NCT02657889|363681699|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
105456440|NCT02657889|363681696|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
105456441|NCT02657889|363681697|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
105456442|NCT02657889|363681698|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
105456443|NCT02657889|363681699|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
105456444|NCT02657889|363681696|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
105456445|NCT02657889|363681697|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
105456446|NCT02657889|363681698|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
105456447|NCT02657889|363681699|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
105456448|NCT02657889|363681696|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
105456449|NCT02657889|363681697|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
105456450|NCT02657889|363681698|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
105456451|NCT02657889|363681699|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
105456452|NCT02657889|363681696|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
105456453|NCT02657889|363681697|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
105456454|NCT02657889|363681698|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
105456455|NCT02657889|363681699|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
105456456|NCT02657889|363681696|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
105456457|NCT02657889|363681697|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
105456458|NCT02657889|363681698|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
105456459|NCT02657889|363681699|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
105456460|NCT02657889|363681696|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
105456461|NCT02657889|363681697|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
105456462|NCT02657889|363681698|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
105456463|NCT02657889|363681699|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
105456464|NCT00556075|363681702|FG000|Overall Study|Lost to Follow-up|3|||
105456465|NCT00556075|363681703|FG001|Overall Study|Lost to Follow-up|0|||
105456466|NCT00556075|363681704|FG002|Overall Study|Lost to Follow-up|3|||
105456467|NCT00556075|363681702|FG000|Overall Study|Withdrawal by Subject|3|||
105456468|NCT00556075|363681703|FG001|Overall Study|Withdrawal by Subject|3|||
105456469|NCT00556075|363681704|FG002|Overall Study|Withdrawal by Subject|0|||
105456470|NCT00556075|363681702|FG000|Overall Study|Protocol Violation|1|||
105456471|NCT00556075|363681703|FG001|Overall Study|Protocol Violation|1|||
105456472|NCT00556075|363681704|FG002|Overall Study|Protocol Violation|3|||
105456473|NCT00556075|363681702|FG000|Overall Study|Not eligible|1|||
105456474|NCT00556075|363681703|FG001|Overall Study|Not eligible|1|||
105456475|NCT00556075|363681704|FG002|Overall Study|Not eligible|2|||
105456476|NCT00556075|363681702|FG000|Overall Study|Adverse Event|1|||
105456477|NCT00556075|363681703|FG001|Overall Study|Adverse Event|2|||
105456478|NCT00556075|363681704|FG002|Overall Study|Adverse Event|0|||
105456479|NCT00556075|363681702|FG000|Overall Study|Personal issues|4|||
105456480|NCT00556075|363681703|FG001|Overall Study|Personal issues|1|||
105456481|NCT00556075|363681704|FG002|Overall Study|Personal issues|0|||
105456482|NCT00556075|363681702|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
105456483|NCT00556075|363681703|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
105456484|NCT00556075|363681704|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
105456485|NCT00395746|363681705|FG000|Overall Study|Adverse Event|5|||
105456486|NCT00395746|363681706|FG001|Overall Study|Adverse Event|2|||
105456487|NCT00395746|363681707|FG002|Overall Study|Adverse Event|2|||
105456488|NCT00395746|363681705|FG000|Overall Study|Protocol Violation|0|||
105456489|NCT00395746|363681706|FG001|Overall Study|Protocol Violation|1|||
105456490|NCT00395746|363681707|FG002|Overall Study|Protocol Violation|0|||
105456491|NCT00395746|363681705|FG000|Overall Study|Lack of Efficacy|2|||
105456492|NCT00395746|363681706|FG001|Overall Study|Lack of Efficacy|0|||
105456493|NCT00395746|363681707|FG002|Overall Study|Lack of Efficacy|17|||
105456494|NCT00395746|363681705|FG000|Overall Study|Hypoglycaemia|2|||
105456495|NCT00395746|363681706|FG001|Overall Study|Hypoglycaemia|1|||
105456496|NCT00395746|363681707|FG002|Overall Study|Hypoglycaemia|0|||
105456497|NCT00395746|363681705|FG000|Overall Study|Subject decision|0|||
105337421|NCT00394836|363236887|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
105337422|NCT00394836|363236888|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
105456498|NCT00395746|363681706|FG001|Overall Study|Subject decision|0|||
105456499|NCT00395746|363681707|FG002|Overall Study|Subject decision|1|||
105456500|NCT00395746|363681705|FG000|Overall Study|Withdrawal of consent|0|||
105456501|NCT00395746|363681706|FG001|Overall Study|Withdrawal of consent|0|||
105456502|NCT00395746|363681707|FG002|Overall Study|Withdrawal of consent|1|||
105456503|NCT00395746|363681705|FG000|Overall Study|Difficultulty in use of device|0|||
105456504|NCT00395746|363681706|FG001|Overall Study|Difficultulty in use of device|0|||
105456505|NCT00395746|363681707|FG002|Overall Study|Difficultulty in use of device|1|||
105456506|NCT00395746|363681705|FG000|Overall Study|Unable to visit site on schedule|1|||
105456507|NCT00395746|363681706|FG001|Overall Study|Unable to visit site on schedule|0|||
105456508|NCT00395746|363681707|FG002|Overall Study|Unable to visit site on schedule|0|||
105456509|NCT03914417|363681708|FG000|Overall Study|Withdrawal by Subject|2|||
105456510|NCT01420861|363681715|FG000|Overall Study|Adverse Event|2|||
105456511|NCT01420861|363681715|FG000|Overall Study|Study terminated by Sponsor|7|||
105456512|NCT01420861|363681715|FG000|Overall Study|Screen failure|7|||
105456513|NCT01420861|363681715|FG000|Overall Study|Randomized not Treated|2|||
105456514|NCT01247324|363681719|FG000|Overall Study|Death|6|||
105456515|NCT01247324|363681720|FG001|Overall Study|Death|10|||
105456516|NCT01247324|363681719|FG000|Overall Study|Physician Decision|2|||
105456517|NCT01247324|363681720|FG001|Overall Study|Physician Decision|3|||
105456518|NCT01247324|363681719|FG000|Overall Study|Non-compliance with study drug|3|||
105456519|NCT01247324|363681720|FG001|Overall Study|Non-compliance with study drug|0|||
105456520|NCT01247324|363681719|FG000|Overall Study|Lack of Efficacy|24|||
105456521|NCT01247324|363681720|FG001|Overall Study|Lack of Efficacy|14|||
105456522|NCT01247324|363681719|FG000|Overall Study|Non-compliance|3|||
105456523|NCT01247324|363681720|FG001|Overall Study|Non-compliance|2|||
105337423|NCT00394836|363236887|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
105337424|NCT00394836|363236888|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
105337425|NCT00394836|363236887|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
105337426|NCT00394836|363236888|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
105337427|NCT00394836|363236887|FG000|Teatment or Follow-up Phase|Death|0|||
105337428|NCT00394836|363236888|FG001|Teatment or Follow-up Phase|Death|1|||
105337429|NCT00394836|363236887|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
105337430|NCT00394836|363236888|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
105337431|NCT00394836|363236887|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
105337432|NCT00394836|363236888|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
105337433|NCT00394836|363236887|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
105337434|NCT00394836|363236888|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
105337435|NCT00394836|363236887|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
105337436|NCT00394836|363236888|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
105337437|NCT00394836|363236887|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
105337438|NCT00394836|363236888|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
105337439|NCT00394836|363236887|FG000|Teatment or Follow-up Phase|Non compliance|0|||
105337440|NCT00394836|363236888|FG001|Teatment or Follow-up Phase|Non compliance|1|||
105337441|NCT00394836|363236887|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
105337442|NCT00394836|363236888|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
105337443|NCT00394836|363236887|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
105337444|NCT00394836|363236888|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
105337445|NCT00394836|363236887|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
105337446|NCT00394836|363236888|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
105337447|NCT00394836|363236887|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
105337448|NCT00394836|363236888|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
105337449|NCT04725812|363236889|FG000|Overall Study|Withdrawal by Subject|1|||
105337450|NCT02461524|363236893|FG000|Overall Study|Death|16|||
105456524|NCT01247324|363681719|FG000|Overall Study|Pregnancy|5|||
105456525|NCT01247324|363681720|FG001|Overall Study|Pregnancy|10|||
105456526|NCT01247324|363681719|FG000|Overall Study|Protocol Violation|1|||
105456527|NCT01247324|363681720|FG001|Overall Study|Protocol Violation|1|||
105456528|NCT01247324|363681719|FG000|Overall Study|Reason not specified|42|||
105456529|NCT01247324|363681720|FG001|Overall Study|Reason not specified|32|||
105456530|NCT01247324|363681719|FG000|Overall Study|Consent withdrawn by participant|41|||
105456531|NCT01247324|363681720|FG001|Overall Study|Consent withdrawn by participant|56|||
105456532|NCT01247324|363681719|FG000|Overall Study|Adverse Event|49|||
105456533|NCT01247324|363681720|FG001|Overall Study|Adverse Event|35|||
105456534|NCT01247324|363681719|FG000|Overall Study|Lost to Follow-up|3|||
105456535|NCT01247324|363681720|FG001|Overall Study|Lost to Follow-up|6|||
105456536|NCT01247324|363681719|FG000|Overall Study|Study Terminated by Sponsor|4|||
105456537|NCT01247324|363681720|FG001|Overall Study|Study Terminated by Sponsor|1|||
105456538|NCT01247324|363681719|FG000|Overall Study|Missing|2|||
105456539|NCT01247324|363681720|FG001|Overall Study|Missing|1|||
105456540|NCT00948064|363683372|FG000|Phase I|No treatment received|1|||
105456541|NCT00948064|363683373|FG001|Phase I|No treatment received|0|||
105456542|NCT00948064|363683374|FG002|Phase I|No treatment received|0|||
105456543|NCT00948064|363683372|FG000|Phase II|Physician Decision|0|||
105456544|NCT00948064|363683373|FG001|Phase II|Physician Decision|0|||
105456545|NCT00948064|363683374|FG002|Phase II|Physician Decision|1|||
105456546|NCT00948064|363683372|FG000|Phase II|Withdrawal by Subject|0|||
105456547|NCT00948064|363683373|FG001|Phase II|Withdrawal by Subject|1|||
105456548|NCT00948064|363683374|FG002|Phase II|Withdrawal by Subject|0|||
105456549|NCT03409796|363683377|FG000|Overall Study|Adverse Event|2|||
105456550|NCT03409796|363683378|FG001|Overall Study|Adverse Event|0|||
105456551|NCT03409796|363683377|FG000|Overall Study|Other|0|||
105456552|NCT03409796|363683378|FG001|Overall Study|Other|1|||
105456553|NCT01352117|363683379|FG000|Overall Study|Death|15|||
105456554|NCT01352117|363683380|FG001|Overall Study|Death|16|||
105456555|NCT01352117|363683379|FG000|Overall Study|Withdrawal by Subject|1|||
105456556|NCT01352117|363683380|FG001|Overall Study|Withdrawal by Subject|0|||
105456557|NCT01352117|363683379|FG000|Overall Study|Lost to Follow-up|2|||
105456558|NCT01352117|363683380|FG001|Overall Study|Lost to Follow-up|7|||
105456559|NCT01352117|363683379|FG000|Overall Study|Non-adherent to study requirements|1|||
105456560|NCT01352117|363683380|FG001|Overall Study|Non-adherent to study requirements|1|||
105456561|NCT01352117|363683379|FG000|Overall Study|Did not initiate study treatment|1|||
105456562|NCT01352117|363683380|FG001|Overall Study|Did not initiate study treatment|0|||
105456563|NCT01352117|363683379|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
105456564|NCT01352117|363683380|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
105456565|NCT00633477|363683381|FG000|Overall Study|Death|1|||
105456566|NCT00633477|363683382|FG001|Overall Study|Death|0|||
105456567|NCT00633477|363683381|FG000|Overall Study|Randomized but not treated|1|||
105456568|NCT00633477|363683382|FG001|Overall Study|Randomized but not treated|0|||
105456569|NCT04906499|363683391|FG000|Overall Study|Lack of time|1|||
105456570|NCT01766050|363683392|FG000|Overall Study|Adverse Event|1|||
105456571|NCT01766050|363683392|FG000|Overall Study|Lost to Follow-up|1|||
105456572|NCT01766050|363683392|FG000|Overall Study|Withdrawal by Subject|2|||
105456573|NCT00179621|363683393|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
105456574|NCT00179621|363683394|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
105456575|NCT00179621|363683395|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
105456576|NCT00179621|363683396|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
105456577|NCT00179621|363683393|FG000|Double-Blind Period|Adverse Event|2|||
105456578|NCT00179621|363683394|FG001|Double-Blind Period|Adverse Event|7|||
105456579|NCT00179621|363683395|FG002|Double-Blind Period|Adverse Event|4|||
105456580|NCT00179621|363683396|FG003|Double-Blind Period|Adverse Event|0|||
105456581|NCT00179621|363683393|FG000|Double-Blind Period|Withdrawal by Subject|2|||
105456582|NCT00179621|363683394|FG001|Double-Blind Period|Withdrawal by Subject|1|||
105456583|NCT00179621|363683395|FG002|Double-Blind Period|Withdrawal by Subject|3|||
105456584|NCT00179621|363683396|FG003|Double-Blind Period|Withdrawal by Subject|0|||
105456585|NCT00179621|363683393|FG000|Double-Blind Period|Death|0|||
105456586|NCT00179621|363683394|FG001|Double-Blind Period|Death|1|||
105337451|NCT02461524|363236893|FG000|Overall Study|Withdrawal by Subject|4|||
105337452|NCT02461524|363236893|FG000|Overall Study|Device Explanted|5|||
105337453|NCT02461524|363236893|FG000|Overall Study|Missed Visit|6|||
105337454|NCT02653170|363236896|FG000|Overall Study|Withdrawal by Subject|3|||
105337455|NCT02653170|363236897|FG001|Overall Study|Withdrawal by Subject|8|||
105337456|NCT02653170|363236898|FG002|Overall Study|Withdrawal by Subject|3|||
105337457|NCT02653170|363236896|FG000|Overall Study|withdrawn by study team|2|||
105337458|NCT02653170|363236897|FG001|Overall Study|withdrawn by study team|4|||
105337459|NCT02653170|363236898|FG002|Overall Study|withdrawn by study team|5|||
105337460|NCT02653170|363236896|FG000|Overall Study|Lost to Follow-up|12|||
105337461|NCT02653170|363236897|FG001|Overall Study|Lost to Follow-up|4|||
105337462|NCT02653170|363236898|FG002|Overall Study|Lost to Follow-up|10|||
105456587|NCT00179621|363683395|FG002|Double-Blind Period|Death|2|||
105456588|NCT00179621|363683396|FG003|Double-Blind Period|Death|0|||
105456589|NCT00179621|363683393|FG000|Double-Blind Period|Protocol Violation|1|||
105456590|NCT00179621|363683394|FG001|Double-Blind Period|Protocol Violation|0|||
105456591|NCT00179621|363683395|FG002|Double-Blind Period|Protocol Violation|0|||
105337463|NCT03969901|363236903|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105337464|NCT03969901|363236904|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105337465|NCT03969901|363236905|FG002|Overall Study|Withdrawal by parent/guardian|0|||
105456592|NCT00179621|363683396|FG003|Double-Blind Period|Protocol Violation|0|||
105456593|NCT00179621|363683393|FG000|Double-Blind Period|Other|0|||
105337466|NCT03969901|363236906|FG003|Overall Study|Withdrawal by parent/guardian|0|||
105337467|NCT03969901|363236907|FG004|Overall Study|Withdrawal by parent/guardian|1|||
105337468|NCT03969901|363236908|FG005|Overall Study|Withdrawal by parent/guardian|0|||
105337469|NCT03969901|363236909|FG006|Overall Study|Withdrawal by parent/guardian|0|||
105456594|NCT00179621|363683394|FG001|Double-Blind Period|Other|2|||
105456595|NCT00179621|363683395|FG002|Double-Blind Period|Other|2|||
105456596|NCT00179621|363683396|FG003|Double-Blind Period|Other|0|||
105337470|NCT03969901|363236910|FG007|Overall Study|Withdrawal by parent/guardian|1|||
105337471|NCT03969901|363236911|FG008|Overall Study|Withdrawal by parent/guardian|1|||
105337472|NCT03969901|363236912|FG009|Overall Study|Withdrawal by parent/guardian|0|||
105337473|NCT00712881|363236918|FG000|Overall Study|Adverse Event|3|||
105337474|NCT00712881|363236919|FG001|Overall Study|Adverse Event|3|||
105337475|NCT00712881|363236918|FG000|Overall Study|Withdrawal by Subject|1|||
105337476|NCT00712881|363236919|FG001|Overall Study|Withdrawal by Subject|1|||
105337477|NCT00712881|363236918|FG000|Overall Study|Disease Progression|2|||
105337478|NCT00712881|363236919|FG001|Overall Study|Disease Progression|1|||
105456597|NCT00179621|363683393|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
105337479|NCT00712881|363236918|FG000|Overall Study|Lost to Follow-up|1|||
105456598|NCT00179621|363683394|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
105456599|NCT00179621|363683395|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
105456600|NCT00179621|363683396|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
105456601|NCT00179621|363683393|FG000|Open-Label Period|Adverse Event|0|||
105456602|NCT00179621|363683394|FG001|Open-Label Period|Adverse Event|6|||
105456603|NCT00179621|363683395|FG002|Open-Label Period|Adverse Event|5|||
105337480|NCT00712881|363236919|FG001|Overall Study|Lost to Follow-up|1|||
105337481|NCT00712881|363236918|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
105456604|NCT00179621|363683396|FG003|Open-Label Period|Adverse Event|6|||
105456605|NCT00179621|363683393|FG000|Open-Label Period|Withdrawal by Subject|0|||
105456606|NCT00179621|363683394|FG001|Open-Label Period|Withdrawal by Subject|2|||
105456607|NCT00179621|363683395|FG002|Open-Label Period|Withdrawal by Subject|2|||
105337482|NCT00712881|363236919|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
105337483|NCT00712881|363236918|FG000|Overall Study|Protocol Violation|1|||
105337484|NCT00712881|363236919|FG001|Overall Study|Protocol Violation|1|||
105337485|NCT00712881|363236918|FG000|Overall Study|Randomized but not treated|1|||
105337486|NCT00712881|363236919|FG001|Overall Study|Randomized but not treated|0|||
105337487|NCT00507819|363236922|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
105337488|NCT00507819|363236923|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
105337489|NCT02244463|363236924|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
105337490|NCT02244463|363236925|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
105337491|NCT02244463|363236926|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
105337492|NCT02244463|363236927|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
105337493|NCT02244463|363236928|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
105337494|NCT02244463|363236929|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
105337495|NCT02244463|363236924|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
105456608|NCT00179621|363683396|FG003|Open-Label Period|Withdrawal by Subject|2|||
105456609|NCT00179621|363683393|FG000|Open-Label Period|Death|0|||
105456610|NCT00179621|363683394|FG001|Open-Label Period|Death|0|||
105456611|NCT00179621|363683395|FG002|Open-Label Period|Death|1|||
105456612|NCT00179621|363683396|FG003|Open-Label Period|Death|2|||
105456613|NCT00179621|363683393|FG000|Open-Label Period|Other|0|||
105456614|NCT00179621|363683394|FG001|Open-Label Period|Other|1|||
105456615|NCT00179621|363683395|FG002|Open-Label Period|Other|1|||
105456616|NCT00179621|363683396|FG003|Open-Label Period|Other|2|||
105456617|NCT00878501|363683407|FG000|Overall Study|Adverse Event|11|||
105456618|NCT00878501|363683408|FG001|Overall Study|Adverse Event|3|||
105456619|NCT00878501|363683409|FG002|Overall Study|Adverse Event|3|||
105456620|NCT00878501|363683407|FG000|Overall Study|Lack of Efficacy|2|||
105456621|NCT00878501|363683408|FG001|Overall Study|Lack of Efficacy|1|||
105456622|NCT00878501|363683409|FG002|Overall Study|Lack of Efficacy|0|||
105456623|NCT00878501|363683407|FG000|Overall Study|Withdrawal by Subject|2|||
105456624|NCT00878501|363683408|FG001|Overall Study|Withdrawal by Subject|1|||
105456625|NCT00878501|363683409|FG002|Overall Study|Withdrawal by Subject|2|||
105456626|NCT00878501|363683407|FG000|Overall Study|Protocol Violation|0|||
105456627|NCT00878501|363683408|FG001|Overall Study|Protocol Violation|0|||
105456628|NCT00878501|363683409|FG002|Overall Study|Protocol Violation|1|||
105456629|NCT00878501|363683407|FG000|Overall Study|Incorrect enrolment|1|||
105456630|NCT00878501|363683408|FG001|Overall Study|Incorrect enrolment|2|||
105456631|NCT00878501|363683409|FG002|Overall Study|Incorrect enrolment|0|||
105456632|NCT00878501|363683407|FG000|Overall Study|Intake of prohibited concom. medication|0|||
105456633|NCT00878501|363683408|FG001|Overall Study|Intake of prohibited concom. medication|0|||
105456634|NCT00878501|363683409|FG002|Overall Study|Intake of prohibited concom. medication|1|||
105456635|NCT00878501|363683407|FG000|Overall Study|Mis-randomisation of patient|1|||
105456636|NCT00878501|363683408|FG001|Overall Study|Mis-randomisation of patient|0|||
105456637|NCT00878501|363683409|FG002|Overall Study|Mis-randomisation of patient|0|||
105456638|NCT00878501|363683407|FG000|Overall Study|Administrative|0|||
105456639|NCT00878501|363683408|FG001|Overall Study|Administrative|0|||
105456640|NCT00878501|363683409|FG002|Overall Study|Administrative|1|||
105456641|NCT02412306|363683418|FG000|Overall Study|Lost to Follow-up|0|||
105456642|NCT02412306|363683419|FG001|Overall Study|Lost to Follow-up|1|||
105456643|NCT02412306|363683420|FG002|Overall Study|Lost to Follow-up|0|||
105456644|NCT02412306|363683421|FG003|Overall Study|Lost to Follow-up|0|||
105456645|NCT02412306|363683422|FG004|Overall Study|Lost to Follow-up|0|||
105456646|NCT02412306|363683418|FG000|Overall Study|Withdrawal by Subject|0|||
105456647|NCT02412306|363683419|FG001|Overall Study|Withdrawal by Subject|0|||
105456648|NCT02412306|363683420|FG002|Overall Study|Withdrawal by Subject|1|||
105456649|NCT02412306|363683421|FG003|Overall Study|Withdrawal by Subject|0|||
105456650|NCT02412306|363683422|FG004|Overall Study|Withdrawal by Subject|0|||
105456651|NCT02412306|363683418|FG000|Overall Study|Death|5|||
105456652|NCT02412306|363683419|FG001|Overall Study|Death|7|||
105456653|NCT02412306|363683420|FG002|Overall Study|Death|15|||
105456654|NCT02412306|363683421|FG003|Overall Study|Death|0|||
105456655|NCT02412306|363683422|FG004|Overall Study|Death|2|||
105456656|NCT02953652|363683430|FG000|Overall Study|Adverse Event|18|||
105456657|NCT02953652|363683430|FG000|Overall Study|Withdrawal by Subject|6|||
105456658|NCT02953652|363683430|FG000|Overall Study|Protocol Violation|1|||
105456659|NCT02953652|363683430|FG000|Overall Study|Disease Progression|27|||
105456660|NCT04742556|363683435|FG000|Overall Study|Withdrawal by Subject|0|||
105456661|NCT04742556|363683436|FG001|Overall Study|Withdrawal by Subject|1|||
105456662|NCT04742556|363683437|FG002|Overall Study|Withdrawal by Subject|0|||
105456663|NCT04742556|363683435|FG000|Overall Study|Adverse Event|0|||
105456664|NCT04742556|363683436|FG001|Overall Study|Adverse Event|0|||
105456665|NCT04742556|363683437|FG002|Overall Study|Adverse Event|2|||
105337496|NCT02244463|363236925|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
105456666|NCT04742556|363683435|FG000|Overall Study|Clinical disease progression|0|||
105456667|NCT04742556|363683436|FG001|Overall Study|Clinical disease progression|1|||
105456668|NCT04742556|363683437|FG002|Overall Study|Clinical disease progression|2|||
105456669|NCT04742556|363683435|FG000|Overall Study|Objective disease progression|3|||
105456670|NCT04742556|363683436|FG001|Overall Study|Objective disease progression|2|||
105456671|NCT04742556|363683437|FG002|Overall Study|Objective disease progression|4|||
105456672|NCT01488045|363683442|FG000|Overall Study|Withdrawal by Subject|6|||
105456673|NCT01488045|363683443|FG001|Overall Study|Withdrawal by Subject|11|||
105456674|NCT01488045|363683442|FG000|Overall Study|Failure to present for colonoscopy|3|||
105456675|NCT01488045|363683443|FG001|Overall Study|Failure to present for colonoscopy|6|||
105456676|NCT01488045|363683442|FG000|Overall Study|Failure to report exclusion criteria|0|||
105456677|NCT01488045|363683443|FG001|Overall Study|Failure to report exclusion criteria|1|||
105456678|NCT04664153|363683446|FG000|Overall Study|Lack of Efficacy|0|||
105456679|NCT04664153|363683447|FG001|Overall Study|Lack of Efficacy|0|||
105456680|NCT04664153|363683448|FG002|Overall Study|Lack of Efficacy|1|||
105456681|NCT04664153|363683449|FG003|Overall Study|Lack of Efficacy|0|||
105456682|NCT04664153|363683446|FG000|Overall Study|Physician Decision|0|||
105456683|NCT04664153|363683447|FG001|Overall Study|Physician Decision|0|||
105456684|NCT04664153|363683448|FG002|Overall Study|Physician Decision|1|||
105456685|NCT04664153|363683449|FG003|Overall Study|Physician Decision|0|||
105456686|NCT04664153|363683446|FG000|Overall Study|Withdrawal by Subject|3|||
105456687|NCT04664153|363683447|FG001|Overall Study|Withdrawal by Subject|2|||
105456688|NCT04664153|363683448|FG002|Overall Study|Withdrawal by Subject|1|||
105456689|NCT04664153|363683449|FG003|Overall Study|Withdrawal by Subject|2|||
105456690|NCT04664153|363683446|FG000|Overall Study|Other|0|||
105456691|NCT04664153|363683447|FG001|Overall Study|Other|1|||
105456692|NCT04664153|363683448|FG002|Overall Study|Other|0|||
105456693|NCT04664153|363683449|FG003|Overall Study|Other|0|||
105456694|NCT04664153|363683446|FG000|Overall Study|Adverse Event|4|||
105456695|NCT04664153|363683447|FG001|Overall Study|Adverse Event|0|||
105456696|NCT04664153|363683448|FG002|Overall Study|Adverse Event|1|||
105456697|NCT04664153|363683449|FG003|Overall Study|Adverse Event|0|||
105456698|NCT00524485|363683455|FG000|Overall Study|Withdrawal by Subject|5|||
105456699|NCT02399215|363683456|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
105456700|NCT02399215|363683456|FG000|Overall Study|Withdrawal by Subject|1|||
105456701|NCT00436332|363683457|FG000|Overall Study|Adverse Event|9|||
105456702|NCT00436332|363683457|FG000|Overall Study|Withdrawal by Subject|2|||
105456703|NCT00436332|363683457|FG000|Overall Study|Progression|59|||
105456704|NCT00436332|363683457|FG000|Overall Study|Death|2|||
105456705|NCT00436332|363683457|FG000|Overall Study|Not Protocol Specified|6|||
105456706|NCT00436332|363683457|FG000|Overall Study|Ineligible|2|||
105456707|NCT00436332|363683457|FG000|Overall Study|Never Received Treatment|3|||
105456708|NCT03617172|363683458|FG000|Overall Study|Lost to Follow-up|1|||
105456709|NCT03617172|363683459|FG001|Overall Study|Lost to Follow-up|0|||
105456710|NCT00472108|363683460|FG000|Overall Study|Lost to Follow-up|0|||
105456711|NCT00472108|363683461|FG001|Overall Study|Lost to Follow-up|1|||
105456712|NCT00189540|363683462|FG000|Overall Study|Withdrawal by Subject|3|||
105456713|NCT00189540|363683463|FG001|Overall Study|Withdrawal by Subject|0|||
105456714|NCT00189540|363683462|FG000|Overall Study|Death|4|||
105456715|NCT00189540|363683463|FG001|Overall Study|Death|1|||
105456716|NCT00062439|363683464|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
105456717|NCT00062439|363683464|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
105456718|NCT00062439|363683464|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
105456719|NCT00062439|363683464|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
105456720|NCT00062439|363683464|FG000|Post Chemoradiation Assessment|Death|1|||
105456721|NCT00062439|363683464|FG000|Post Chemoradiation Assessment|Disease progression|2|||
105456722|NCT00062439|363683464|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
105456723|NCT00062439|363683464|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
105456724|NCT00062439|363683464|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
105456725|NCT00062439|363683464|FG000|Surgery|Physician Decision|4|||
105456726|NCT00062439|363683464|FG000|Surgery|Death|1|||
105456727|NCT00062439|363683464|FG000|Surgery|Adverse Event|2|||
105456728|NCT00062439|363683464|FG000|Consolidation Chemotherapy|Adverse Event|2|||
105456729|NCT01924845|363683465|FG000|Overall Study|Adverse Event|3|||
105456730|NCT01924845|363683465|FG000|Overall Study|Withdrawal by Subject|2|||
105456731|NCT01924845|363683465|FG000|Overall Study|Protocol Violation|1|||
105456732|NCT00713609|363683466|FG000|Overall Study|Adverse Event|2|||
105456733|NCT00713609|363683467|FG001|Overall Study|Adverse Event|0|||
105456734|NCT00713609|363683468|FG002|Overall Study|Adverse Event|2|||
105456735|NCT00713609|363683469|FG003|Overall Study|Adverse Event|2|||
105456736|NCT00713609|363683470|FG004|Overall Study|Adverse Event|3|||
105456737|NCT00713609|363683471|FG005|Overall Study|Adverse Event|1|||
105456738|NCT00713609|363683466|FG000|Overall Study|Lost to Follow-up|5|||
105456739|NCT00713609|363683467|FG001|Overall Study|Lost to Follow-up|7|||
105456740|NCT00713609|363683468|FG002|Overall Study|Lost to Follow-up|5|||
105456741|NCT00713609|363683469|FG003|Overall Study|Lost to Follow-up|5|||
105456742|NCT00713609|363683470|FG004|Overall Study|Lost to Follow-up|7|||
105456743|NCT00713609|363683471|FG005|Overall Study|Lost to Follow-up|0|||
105456744|NCT00713609|363683466|FG000|Overall Study|Lack of Efficacy|1|||
105456745|NCT00713609|363683467|FG001|Overall Study|Lack of Efficacy|3|||
105456746|NCT00713609|363683468|FG002|Overall Study|Lack of Efficacy|0|||
105456747|NCT00713609|363683469|FG003|Overall Study|Lack of Efficacy|0|||
105456748|NCT00713609|363683470|FG004|Overall Study|Lack of Efficacy|1|||
105456749|NCT00713609|363683471|FG005|Overall Study|Lack of Efficacy|0|||
105456750|NCT00713609|363683466|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
105456751|NCT00713609|363683467|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
105337497|NCT02244463|363236926|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
105337498|NCT02244463|363236927|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
105337499|NCT02244463|363236928|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
105337500|NCT02244463|363236929|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
105337501|NCT02244463|363236924|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
105337502|NCT02244463|363236925|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
105337503|NCT02244463|363236926|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
105337504|NCT02244463|363236927|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
105337505|NCT02244463|363236928|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
105337506|NCT02244463|363236929|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
105337507|NCT02244463|363236924|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
105337508|NCT02244463|363236925|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
105337509|NCT02244463|363236926|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
105337510|NCT02244463|363236927|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
105337511|NCT02244463|363236928|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
105337512|NCT02244463|363236929|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
105337513|NCT02244463|363236924|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
105337514|NCT02244463|363236925|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
105337515|NCT02244463|363236926|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
105337516|NCT02244463|363236927|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
105337517|NCT02244463|363236928|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
105337518|NCT02244463|363236929|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
105337519|NCT02244463|363236924|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
105337520|NCT02244463|363236925|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
105337521|NCT02244463|363236926|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
105337522|NCT02244463|363236927|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
105337523|NCT02244463|363236928|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
105337524|NCT02244463|363236929|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
105337525|NCT02244463|363236924|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
105337526|NCT02244463|363236925|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
105337527|NCT02244463|363236926|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
105337528|NCT02244463|363236927|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
105337529|NCT02244463|363236928|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
105337530|NCT02244463|363236929|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
105337531|NCT02244463|363236924|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
105337532|NCT02244463|363236925|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
105337533|NCT02244463|363236926|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
105337534|NCT02244463|363236927|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
105337535|NCT02244463|363236928|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
105337536|NCT02244463|363236929|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
105337537|NCT02244463|363236924|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
105456752|NCT00713609|363683468|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
105456753|NCT00713609|363683469|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
105456754|NCT00713609|363683470|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
105337538|NCT02244463|363236925|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
105337539|NCT02244463|363236926|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
105337540|NCT02244463|363236927|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
105337541|NCT02244463|363236928|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
105337542|NCT02244463|363236929|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
105337543|NCT02244463|363236924|FG000|Period 5: Phase II|Disease Progression|0|||
105337544|NCT02244463|363236925|FG001|Period 5: Phase II|Disease Progression|0|||
105337545|NCT02244463|363236926|FG002|Period 5: Phase II|Disease Progression|0|||
105337546|NCT02244463|363236927|FG003|Period 5: Phase II|Disease Progression|0|||
105337547|NCT02244463|363236928|FG004|Period 5: Phase II|Disease Progression|10|||
105337548|NCT02244463|363236929|FG005|Period 5: Phase II|Disease Progression|11|||
105337549|NCT02244463|363236924|FG000|Period 5: Phase II|Physician Decision|0|||
105337550|NCT02244463|363236925|FG001|Period 5: Phase II|Physician Decision|0|||
105337551|NCT02244463|363236926|FG002|Period 5: Phase II|Physician Decision|0|||
105337552|NCT02244463|363236927|FG003|Period 5: Phase II|Physician Decision|0|||
105337553|NCT02244463|363236928|FG004|Period 5: Phase II|Physician Decision|3|||
105337554|NCT02244463|363236929|FG005|Period 5: Phase II|Physician Decision|2|||
105337555|NCT02244463|363236924|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
105337556|NCT02244463|363236925|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
105337557|NCT02244463|363236926|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
105337558|NCT02244463|363236927|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
105337559|NCT02244463|363236928|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
105337560|NCT02244463|363236929|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
105337561|NCT02244463|363236924|FG000|Period 5: Phase II|Intercurrent Illness|0|||
105337562|NCT02244463|363236925|FG001|Period 5: Phase II|Intercurrent Illness|0|||
105456755|NCT00713609|363683471|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
105456756|NCT00713609|363683466|FG000|Overall Study|Withdrawal by Subject|6|||
105337563|NCT02244463|363236926|FG002|Period 5: Phase II|Intercurrent Illness|0|||
105337564|NCT02244463|363236927|FG003|Period 5: Phase II|Intercurrent Illness|0|||
105337565|NCT02244463|363236928|FG004|Period 5: Phase II|Intercurrent Illness|2|||
105456757|NCT00713609|363683467|FG001|Overall Study|Withdrawal by Subject|1|||
105337566|NCT02244463|363236929|FG005|Period 5: Phase II|Intercurrent Illness|0|||
105337567|NCT02244463|363236924|FG000|Period 5: Phase II|Adverse Event|0|||
105337568|NCT02244463|363236925|FG001|Period 5: Phase II|Adverse Event|0|||
105337569|NCT02244463|363236926|FG002|Period 5: Phase II|Adverse Event|0|||
105337570|NCT02244463|363236927|FG003|Period 5: Phase II|Adverse Event|0|||
105337571|NCT02244463|363236928|FG004|Period 5: Phase II|Adverse Event|0|||
105337572|NCT02244463|363236929|FG005|Period 5: Phase II|Adverse Event|2|||
105337573|NCT02244463|363236924|FG000|Period 5: Phase II|Still On treatment|0|||
105337574|NCT02244463|363236925|FG001|Period 5: Phase II|Still On treatment|0|||
105456758|NCT00713609|363683468|FG002|Overall Study|Withdrawal by Subject|5|||
105337575|NCT02244463|363236926|FG002|Period 5: Phase II|Still On treatment|0|||
105456759|NCT00713609|363683469|FG003|Overall Study|Withdrawal by Subject|1|||
105456760|NCT00713609|363683470|FG004|Overall Study|Withdrawal by Subject|5|||
105456761|NCT00713609|363683471|FG005|Overall Study|Withdrawal by Subject|7|||
105337576|NCT02244463|363236927|FG003|Period 5: Phase II|Still On treatment|0|||
105337577|NCT02244463|363236928|FG004|Period 5: Phase II|Still On treatment|0|||
105337578|NCT02244463|363236929|FG005|Period 5: Phase II|Still On treatment|3|||
105337579|NCT01769508|363236930|FG000|Overall Study|Death|3|||
105337580|NCT01769508|363236930|FG000|Overall Study|Withdrawal by Subject|1|||
105337581|NCT01769508|363236930|FG000|Overall Study|Adverse Event|1|||
105456762|NCT00713609|363683466|FG000|Overall Study|Protocol Violation|6|||
105456763|NCT00713609|363683467|FG001|Overall Study|Protocol Violation|3|||
105661749|NCT01068210|364425130|FG000|Overall Study|Lost to Follow-up|1|||
105456764|NCT00713609|363683468|FG002|Overall Study|Protocol Violation|1|||
105456765|NCT00713609|363683469|FG003|Overall Study|Protocol Violation|1|||
105456766|NCT00713609|363683470|FG004|Overall Study|Protocol Violation|2|||
105456767|NCT00713609|363683471|FG005|Overall Study|Protocol Violation|0|||
105456768|NCT01546857|363683476|FG000|Overall Study|Withdrawal by Subject|2|||
105456769|NCT01546857|363683477|FG001|Overall Study|Withdrawal by Subject|3|||
105456770|NCT00333775|363683480|FG000|Overall Study|Death|144|||
105456771|NCT00333775|363683481|FG001|Overall Study|Death|149|||
105456772|NCT00333775|363683482|FG002|Overall Study|Death|143|||
105456773|NCT00333775|363683480|FG000|Overall Study|In Follow-up When Study Stopped|87|||
105456774|NCT00333775|363683481|FG001|Overall Study|In Follow-up When Study Stopped|92|||
105456775|NCT00333775|363683482|FG002|Overall Study|In Follow-up When Study Stopped|96|||
105456776|NCT00333775|363683480|FG000|Overall Study|Lost to Follow-up|10|||
105456777|NCT00333775|363683481|FG001|Overall Study|Lost to Follow-up|7|||
105456778|NCT00333775|363683482|FG002|Overall Study|Lost to Follow-up|8|||
105456779|NCT01791244|363683483|FG000|Overall Study|Adverse Event|5|||
105456780|NCT01791244|363683484|FG001|Overall Study|Adverse Event|7|||
105456781|NCT01791244|363683483|FG000|Overall Study|Insufficient clinical response|10|||
105456782|NCT01791244|363683484|FG001|Overall Study|Insufficient clinical response|10|||
105456783|NCT01791244|363683483|FG000|Overall Study|Laboratory Abnormality|0|||
105456784|NCT01791244|363683484|FG001|Overall Study|Laboratory Abnormality|1|||
105456785|NCT01383928|363683487|FG000|Overall Study|Initiation of ASCT|2|||
105456786|NCT01383928|363683488|FG001|Overall Study|Initiation of ASCT|1|||
105456787|NCT01383928|363683489|FG002|Overall Study|Initiation of ASCT|18|||
105456788|NCT01383928|363683487|FG000|Overall Study|Adverse Event|1|||
105456789|NCT01383928|363683488|FG001|Overall Study|Adverse Event|2|||
105456790|NCT01383928|363683489|FG002|Overall Study|Adverse Event|8|||
105456791|NCT01383928|363683487|FG000|Overall Study|Other|1|||
105456792|NCT01383928|363683488|FG001|Overall Study|Other|3|||
105456793|NCT01383928|363683489|FG002|Overall Study|Other|4|||
105456794|NCT01383928|363683487|FG000|Overall Study|Progressive Disease|1|||
105456795|NCT01383928|363683488|FG001|Overall Study|Progressive Disease|1|||
105456796|NCT01383928|363683489|FG002|Overall Study|Progressive Disease|5|||
105456797|NCT01383928|363683487|FG000|Overall Study|Withdrawal by Subject|0|||
105337582|NCT01769508|363236930|FG000|Overall Study|Lost to Follow-up|1|||
105337583|NCT04016779|363236931|FG000|Overall Study|Adverse Event|9|||
105337584|NCT04016779|363236932|FG001|Overall Study|Adverse Event|17|||
105337585|NCT04016779|363236931|FG000|Overall Study|Lack of Efficacy|4|||
105337586|NCT04016779|363236932|FG001|Overall Study|Lack of Efficacy|1|||
105337587|NCT04016779|363236931|FG000|Overall Study|Lost to Follow-up|5|||
105337588|NCT04016779|363236932|FG001|Overall Study|Lost to Follow-up|14|||
105337589|NCT04016779|363236931|FG000|Overall Study|Physician Decision|1|||
105337590|NCT04016779|363236932|FG001|Overall Study|Physician Decision|3|||
105337591|NCT04016779|363236931|FG000|Overall Study|Withdrawal by Subject|6|||
105337592|NCT04016779|363236932|FG001|Overall Study|Withdrawal by Subject|8|||
105337593|NCT04016779|363236931|FG000|Overall Study|Non-compliance with Study Drug|2|||
105337594|NCT04016779|363236932|FG001|Overall Study|Non-compliance with Study Drug|3|||
105337595|NCT04016779|363236931|FG000|Overall Study|Other, Multiple categories|17|||
105337596|NCT04016779|363236932|FG001|Overall Study|Other, Multiple categories|17|||
105337597|NCT01137110|363236935|FG000|Overall Study|Protocol Violation|1|||
105337598|NCT01137110|363236936|FG001|Overall Study|Protocol Violation|0|||
105337599|NCT02828124|363236937|FG000|Overall Study|Disease Progression|1|||
105337600|NCT02828124|363236938|FG001|Overall Study|Disease Progression|2|||
105337601|NCT02828124|363236939|FG002|Overall Study|Disease Progression|1|||
105337602|NCT02828124|363236940|FG003|Overall Study|Disease Progression|4|||
105337603|NCT02828124|363236937|FG000|Overall Study|AE Unrelated to Study Drug|0|||
105337604|NCT02828124|363236938|FG001|Overall Study|AE Unrelated to Study Drug|0|||
105337605|NCT02828124|363236939|FG002|Overall Study|AE Unrelated to Study Drug|0|||
105456798|NCT01383928|363683488|FG001|Overall Study|Withdrawal by Subject|0|||
105337606|NCT02828124|363236940|FG003|Overall Study|AE Unrelated to Study Drug|1|||
105456799|NCT01383928|363683489|FG002|Overall Study|Withdrawal by Subject|4|||
105456800|NCT01383928|363683487|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
105456801|NCT01383928|363683488|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
105456802|NCT01383928|363683489|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
105456803|NCT04423718|363683490|FG000|Overall Study|Adverse Event|6|||
105456804|NCT04423718|363683491|FG001|Overall Study|Adverse Event|2|||
105456805|NCT04423718|363683492|FG002|Overall Study|Adverse Event|5|||
105456806|NCT04423718|363683490|FG000|Overall Study|Physician Decision|1|||
105456807|NCT04423718|363683491|FG001|Overall Study|Physician Decision|4|||
105456808|NCT04423718|363683492|FG002|Overall Study|Physician Decision|1|||
105456809|NCT04423718|363683490|FG000|Overall Study|Protocol Violation|0|||
105456810|NCT04423718|363683491|FG001|Overall Study|Protocol Violation|1|||
105456811|NCT04423718|363683492|FG002|Overall Study|Protocol Violation|1|||
105456812|NCT04423718|363683490|FG000|Overall Study|Lost to Follow-up|1|||
105456813|NCT04423718|363683491|FG001|Overall Study|Lost to Follow-up|1|||
105456814|NCT04423718|363683492|FG002|Overall Study|Lost to Follow-up|2|||
105456815|NCT04423718|363683490|FG000|Overall Study|Lack of Efficacy|2|||
105456816|NCT04423718|363683491|FG001|Overall Study|Lack of Efficacy|0|||
105456817|NCT04423718|363683492|FG002|Overall Study|Lack of Efficacy|0|||
105456818|NCT04423718|363683490|FG000|Overall Study|Withdrawal by Subject|6|||
105456819|NCT04423718|363683491|FG001|Overall Study|Withdrawal by Subject|8|||
105456820|NCT04423718|363683492|FG002|Overall Study|Withdrawal by Subject|14|||
105456821|NCT04423718|363683490|FG000|Overall Study|Death|5|||
105456822|NCT04423718|363683491|FG001|Overall Study|Death|3|||
105456823|NCT04423718|363683492|FG002|Overall Study|Death|2|||
105456824|NCT04423718|363683490|FG000|Overall Study|COVID-19 pandemic|2|||
105456825|NCT04423718|363683491|FG001|Overall Study|COVID-19 pandemic|2|||
105456826|NCT04423718|363683492|FG002|Overall Study|COVID-19 pandemic|2|||
105456827|NCT04423718|363683490|FG000|Overall Study|Other|6|||
105456828|NCT04423718|363683491|FG001|Overall Study|Other|2|||
105456829|NCT04423718|363683492|FG002|Overall Study|Other|2|||
105456830|NCT04423718|363683490|FG000|Overall Study|Unknown if completed study treatment until Week 60|3|||
105456831|NCT04423718|363683491|FG001|Overall Study|Unknown if completed study treatment until Week 60|3|||
105456832|NCT04423718|363683492|FG002|Overall Study|Unknown if completed study treatment until Week 60|1|||
105456833|NCT01346358|363683493|FG000|Overall Study|Withdrawal by Subject|1|||
105456834|NCT01346358|363683494|FG001|Overall Study|Withdrawal by Subject|0|||
105456835|NCT01346358|363683495|FG002|Overall Study|Withdrawal by Subject|1|||
105456836|NCT01346358|363683496|FG003|Overall Study|Withdrawal by Subject|1|||
105456837|NCT01346358|363683497|FG004|Overall Study|Withdrawal by Subject|0|||
105456838|NCT01346358|363683498|FG005|Overall Study|Withdrawal by Subject|2|||
105456839|NCT01346358|363683499|FG006|Overall Study|Withdrawal by Subject|1|||
105456840|NCT01346358|363683500|FG007|Overall Study|Withdrawal by Subject|1|||
105784908|NCT02967055|364864425|FG000|Overall Study|Stopped due to drug cost|1|||
105456841|NCT01346358|363683501|FG008|Overall Study|Withdrawal by Subject|1|||
105456842|NCT01346358|363683493|FG000|Overall Study|Adverse Event|1|||
105456843|NCT01346358|363683494|FG001|Overall Study|Adverse Event|0|||
105456844|NCT01346358|363683495|FG002|Overall Study|Adverse Event|0|||
105456845|NCT01346358|363683496|FG003|Overall Study|Adverse Event|0|||
105456846|NCT01346358|363683497|FG004|Overall Study|Adverse Event|1|||
105456847|NCT01346358|363683498|FG005|Overall Study|Adverse Event|0|||
105456848|NCT01346358|363683499|FG006|Overall Study|Adverse Event|0|||
105456849|NCT01346358|363683500|FG007|Overall Study|Adverse Event|0|||
105456850|NCT01346358|363683501|FG008|Overall Study|Adverse Event|1|||
105456851|NCT01346358|363683493|FG000|Overall Study|Non-Compliance|0|||
105456852|NCT01346358|363683494|FG001|Overall Study|Non-Compliance|0|||
105456853|NCT01346358|363683495|FG002|Overall Study|Non-Compliance|0|||
105456854|NCT01346358|363683496|FG003|Overall Study|Non-Compliance|0|||
105456855|NCT01346358|363683497|FG004|Overall Study|Non-Compliance|0|||
105456856|NCT01346358|363683498|FG005|Overall Study|Non-Compliance|0|||
105456857|NCT01346358|363683499|FG006|Overall Study|Non-Compliance|0|||
105456858|NCT01346358|363683500|FG007|Overall Study|Non-Compliance|2|||
105456859|NCT01346358|363683501|FG008|Overall Study|Non-Compliance|0|||
105456860|NCT01346358|363683493|FG000|Overall Study|Physician Decision|0|||
105456861|NCT01346358|363683494|FG001|Overall Study|Physician Decision|1|||
105456862|NCT01346358|363683495|FG002|Overall Study|Physician Decision|0|||
105456863|NCT01346358|363683496|FG003|Overall Study|Physician Decision|0|||
105456864|NCT01346358|363683497|FG004|Overall Study|Physician Decision|0|||
105456865|NCT01346358|363683498|FG005|Overall Study|Physician Decision|0|||
105456866|NCT01346358|363683499|FG006|Overall Study|Physician Decision|0|||
105456867|NCT01346358|363683500|FG007|Overall Study|Physician Decision|1|||
105456868|NCT01346358|363683501|FG008|Overall Study|Physician Decision|1|||
105456869|NCT01643668|363683504|FG000|Overall Study|Death|1|||
105456870|NCT01650558|363683505|FG000|Overall Study|Migration out of study area|61|||
105456871|NCT01650558|363683506|FG001|Overall Study|Migration out of study area|71|||
105456872|NCT01650558|363683507|FG002|Overall Study|Migration out of study area|56|||
105456873|NCT01650558|363683505|FG000|Overall Study|Lost to Follow-up|10|||
105456874|NCT01650558|363683506|FG001|Overall Study|Lost to Follow-up|13|||
105456875|NCT01650558|363683507|FG002|Overall Study|Lost to Follow-up|6|||
105456876|NCT01650558|363683505|FG000|Overall Study|Death|10|||
105456877|NCT01650558|363683506|FG001|Overall Study|Death|6|||
105456878|NCT01650558|363683507|FG002|Overall Study|Death|8|||
105456879|NCT01650558|363683505|FG000|Overall Study|Withdrawal by Subject|1|||
105456880|NCT01650558|363683506|FG001|Overall Study|Withdrawal by Subject|1|||
105456881|NCT01650558|363683507|FG002|Overall Study|Withdrawal by Subject|3|||
105456882|NCT01650558|363683505|FG000|Overall Study|Non-compliant participant|1|||
105456883|NCT01650558|363683506|FG001|Overall Study|Non-compliant participant|0|||
105456884|NCT01650558|363683507|FG002|Overall Study|Non-compliant participant|2|||
105456885|NCT01650558|363683505|FG000|Overall Study|Physician Decision|0|||
105456886|NCT01650558|363683506|FG001|Overall Study|Physician Decision|1|||
105456887|NCT01650558|363683507|FG002|Overall Study|Physician Decision|0|||
105456888|NCT00918385|363683508|FG000|Monotherapy|Adverse Event|1|||
105456889|NCT00918385|363683509|FG001|Monotherapy|Adverse Event|6|||
105456890|NCT00918385|363683508|FG000|Monotherapy|Complicating illness|1|||
105456891|NCT00918385|363683509|FG001|Monotherapy|Complicating illness|0|||
105456892|NCT00918385|363683508|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
105456893|NCT00918385|363683509|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
105456894|NCT00918385|363683508|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
105784909|NCT00903357|364864426|FG000|First Intervention|Withdrawal by Subject|5|||
105784910|NCT00903357|364864427|FG001|First Intervention|Withdrawal by Subject|3|||
105784911|NCT00903357|364864426|FG000|First Intervention|Flu|0|||
105784912|NCT00903357|364864427|FG001|First Intervention|Flu|1|||
105784913|NCT00903357|364864426|FG000|Wash Out Period of 2 Weeks|Flu|0|||
105784914|NCT00903357|364864427|FG001|Wash Out Period of 2 Weeks|Flu|1|||
105784915|NCT00903357|364864426|FG000|Second Intervention|Lost to Follow-up|1|||
105784916|NCT00903357|364864427|FG001|Second Intervention|Lost to Follow-up|0|||
105784917|NCT01484691|364864428|FG000|Overall Study|Withdrawal by Subject|1|||
105784918|NCT01484691|364864429|FG001|Overall Study|Withdrawal by Subject|1|||
105784919|NCT01484691|364864430|FG002|Overall Study|Withdrawal by Subject|1|||
105784920|NCT01484691|364864428|FG000|Overall Study|Physician Decision|0|||
105337607|NCT02828124|363236937|FG000|Overall Study|Subject Withdrew Consent|0|||
105337608|NCT02828124|363236938|FG001|Overall Study|Subject Withdrew Consent|0|||
105337609|NCT02828124|363236939|FG002|Overall Study|Subject Withdrew Consent|0|||
105337610|NCT02828124|363236940|FG003|Overall Study|Subject Withdrew Consent|1|||
105337611|NCT00281632|363236942|FG000|Overall Study|Adverse Event|7|||
105337612|NCT00281632|363236942|FG000|Overall Study|Withdrawal by Subject|2|||
105337613|NCT00281632|363236942|FG000|Overall Study|Disease Progression|22|||
105337614|NCT00281632|363236942|FG000|Overall Study|Death|1|||
105337615|NCT00281632|363236942|FG000|Overall Study|Physician Decision|1|||
105337616|NCT00281632|363236942|FG000|Overall Study|Ongoing|3|||
105337617|NCT03614078|363236951|FG000|Overall Study|Withdrawal by Subject|2|||
105337618|NCT03614078|363236952|FG001|Overall Study|Withdrawal by Subject|2|||
105337619|NCT03614078|363236953|FG002|Overall Study|Withdrawal by Subject|3|||
105337620|NCT03614078|363236951|FG000|Overall Study|Participant Did Not Return for Visit|0|||
105337621|NCT03614078|363236952|FG001|Overall Study|Participant Did Not Return for Visit|1|||
105337622|NCT03614078|363236953|FG002|Overall Study|Participant Did Not Return for Visit|0|||
105337623|NCT03614078|363236951|FG000|Overall Study|High Neutrophils|0|||
105337624|NCT03614078|363236952|FG001|Overall Study|High Neutrophils|0|||
105337625|NCT03614078|363236953|FG002|Overall Study|High Neutrophils|2|||
105337626|NCT03614078|363236951|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
105337627|NCT03614078|363236952|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
105337628|NCT03614078|363236953|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
105337629|NCT03614078|363236951|FG000|Overall Study|Exacerbation of Psoriasis|0|||
105337630|NCT03614078|363236952|FG001|Overall Study|Exacerbation of Psoriasis|1|||
105337631|NCT03614078|363236953|FG002|Overall Study|Exacerbation of Psoriasis|0|||
105337632|NCT03614078|363236951|FG000|Overall Study|Adverse Event|0|||
105456895|NCT00918385|363683509|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
105456896|NCT00918385|363683508|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
105456897|NCT00918385|363683509|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
105337633|NCT03614078|363236952|FG001|Overall Study|Adverse Event|2|||
105337634|NCT03614078|363236953|FG002|Overall Study|Adverse Event|0|||
105337635|NCT03614078|363236951|FG000|Overall Study|Dizziness and Rash|0|||
105337636|NCT03614078|363236952|FG001|Overall Study|Dizziness and Rash|1|||
105337637|NCT03614078|363236953|FG002|Overall Study|Dizziness and Rash|0|||
105456898|NCT00918385|363683508|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
105456899|NCT00918385|363683509|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
105456900|NCT02734693|363683510|FG000|Overall Study|Adverse Event|1|||
105337638|NCT02004886|363236954|FG000|Overall Study|Adverse Event|0|||
105337639|NCT02004886|363236955|FG001|Overall Study|Adverse Event|1|||
105337640|NCT02004886|363236956|FG002|Overall Study|Adverse Event|0|||
105337641|NCT02004886|363236957|FG003|Overall Study|Adverse Event|0|||
105456901|NCT02734693|363683511|FG001|Overall Study|Adverse Event|3|||
105456902|NCT02734693|363683512|FG002|Overall Study|Adverse Event|3|||
105456903|NCT02734693|363683510|FG000|Overall Study|Lack of Efficacy|1|||
105456904|NCT02734693|363683511|FG001|Overall Study|Lack of Efficacy|0|||
105456905|NCT02734693|363683512|FG002|Overall Study|Lack of Efficacy|0|||
105456906|NCT02734693|363683510|FG000|Overall Study|Lost to Follow-up|2|||
105456907|NCT02734693|363683511|FG001|Overall Study|Lost to Follow-up|0|||
105456908|NCT02734693|363683512|FG002|Overall Study|Lost to Follow-up|0|||
105456909|NCT02734693|363683510|FG000|Overall Study|Protocol Violation|1|||
105661750|NCT01068210|364425131|FG001|Overall Study|Lost to Follow-up|2|||
105456910|NCT02734693|363683511|FG001|Overall Study|Protocol Violation|0|||
105456911|NCT02734693|363683512|FG002|Overall Study|Protocol Violation|0|||
105456912|NCT02734693|363683510|FG000|Overall Study|Withdrawal by Subject|1|||
105456913|NCT02734693|363683511|FG001|Overall Study|Withdrawal by Subject|0|||
105456914|NCT02734693|363683512|FG002|Overall Study|Withdrawal by Subject|0|||
105456915|NCT03261336|363683514|FG000|Overall Study|Adverse Event|1|||
105456916|NCT00292942|363683516|FG000|Overall Study|Withdrawal by Subject|0|||
105456917|NCT00292942|363683517|FG001|Overall Study|Withdrawal by Subject|0|||
105456918|NCT00292942|363683518|FG002|Overall Study|Withdrawal by Subject|1|||
105456919|NCT00292942|363683519|FG003|Overall Study|Withdrawal by Subject|0|||
105456920|NCT00292942|363683516|FG000|Overall Study|Adverse Event|0|||
105456921|NCT00292942|363683517|FG001|Overall Study|Adverse Event|0|||
105456922|NCT00292942|363683518|FG002|Overall Study|Adverse Event|0|||
105456923|NCT00292942|363683519|FG003|Overall Study|Adverse Event|1|||
105456924|NCT00644358|363683520|FG000|Overall Study|Adverse Event|124|||
105456925|NCT00644358|363683520|FG000|Overall Study|Lost to Follow-up|105|||
105456926|NCT00644358|363683520|FG000|Overall Study|Consent Withdrawal|64|||
105456927|NCT00644358|363683520|FG000|Overall Study|Lack of Effectiveness|39|||
105456928|NCT00644358|363683520|FG000|Overall Study|Protocol Violation|5|||
105456929|NCT00644358|363683520|FG000|Overall Study|Noncompliance|14|||
105456930|NCT00644358|363683520|FG000|Overall Study|Other Unspecified|11|||
105456931|NCT00758771|363683523|FG000|Overall Study|Withdrawal by Subject|1|||
105456932|NCT00758771|363683524|FG001|Overall Study|Withdrawal by Subject|1|||
105456933|NCT00758771|363683523|FG000|Overall Study|Did not meet eligibility criteria|2|||
105456934|NCT00758771|363683524|FG001|Overall Study|Did not meet eligibility criteria|4|||
105456935|NCT01451606|363683532|FG000|Overall Study|Withdrawal by Subject|4|||
105456936|NCT01451606|363683533|FG001|Overall Study|Withdrawal by Subject|3|||
105456937|NCT04011540|363683535|FG000|Overall Study|Lost to Follow-up|9|||
105456938|NCT04011540|363683536|FG001|Overall Study|Lost to Follow-up|6|||
105456939|NCT02138890|363683537|FG000|Overall Study|Adverse Event|1|||
105456940|NCT02138890|363683538|FG001|Overall Study|Adverse Event|0|||
105456941|NCT00537394|363683539|FG000|First Year of Follow-up|Death|7|||
105456942|NCT00537394|363683540|FG001|First Year of Follow-up|Death|0|||
105456943|NCT00537394|363683541|FG002|First Year of Follow-up|Death|0|||
105456944|NCT00537394|363683539|FG000|First Year of Follow-up|Severe debilitation|1|||
105456945|NCT00537394|363683540|FG001|First Year of Follow-up|Severe debilitation|0|||
105456946|NCT00537394|363683541|FG002|First Year of Follow-up|Severe debilitation|1|||
105456947|NCT00537394|363683539|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
105456948|NCT00537394|363683540|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
105456949|NCT00537394|363683541|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
105456950|NCT00537394|363683539|FG000|First Year of Follow-up|Lost to Follow-up|1|||
105456951|NCT00537394|363683540|FG001|First Year of Follow-up|Lost to Follow-up|5|||
105456952|NCT00537394|363683541|FG002|First Year of Follow-up|Lost to Follow-up|1|||
105456953|NCT00537394|363683539|FG000|2nd Year of Follow-up|Death|4|||
105456954|NCT00537394|363683540|FG001|2nd Year of Follow-up|Death|1|||
105456955|NCT00537394|363683541|FG002|2nd Year of Follow-up|Death|2|||
105456956|NCT00537394|363683539|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
105456957|NCT00537394|363683540|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
105661751|NCT01068210|364425132|FG002|Overall Study|Lost to Follow-up|2|||
105456958|NCT00537394|363683541|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
105456959|NCT00537394|363683539|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
105456960|NCT00537394|363683540|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
105456961|NCT00537394|363683541|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
105456962|NCT00537394|363683539|FG000|2nd Year of Follow-up|Clinic site closure|1|||
105456963|NCT00537394|363683540|FG001|2nd Year of Follow-up|Clinic site closure|0|||
105456964|NCT00537394|363683541|FG002|2nd Year of Follow-up|Clinic site closure|0|||
105456965|NCT03668873|363683542|FG000|Overall Study|Lost to Follow-up|6|||
105456966|NCT03668873|363683543|FG001|Overall Study|Lost to Follow-up|3|||
105456967|NCT02485691|363683550|FG000|Overall Study|Adverse Event|25|||
105456968|NCT02485691|363683551|FG001|Overall Study|Adverse Event|11|||
105456969|NCT02485691|363683550|FG000|Overall Study|Poor compliance to protocol|0|||
105456970|NCT02485691|363683551|FG001|Overall Study|Poor compliance to protocol|1|||
105456971|NCT02485691|363683550|FG000|Overall Study|Disease progression|57|||
105456972|NCT02485691|363683551|FG001|Overall Study|Disease progression|92|||
105456973|NCT02485691|363683550|FG000|Overall Study|Investigator's decision|23|||
105456974|NCT02485691|363683551|FG001|Overall Study|Investigator's decision|5|||
105456975|NCT02485691|363683550|FG000|Overall Study|Participant's request|13|||
105456976|NCT02485691|363683551|FG001|Overall Study|Participant's request|6|||
105456977|NCT02485691|363683550|FG000|Overall Study|Other reason|8|||
105456978|NCT02485691|363683551|FG001|Overall Study|Other reason|9|||
105456979|NCT02485691|363683550|FG000|Overall Study|Randomized and not treated|3|||
105456980|NCT02485691|363683551|FG001|Overall Study|Randomized and not treated|2|||
105456981|NCT03836625|363683554|FG000|Overall Study|Lost to Follow-up|9|||
105456982|NCT03836625|363683555|FG001|Overall Study|Lost to Follow-up|9|||
105337642|NCT02004886|363236954|FG000|Overall Study|Unable to attend future visits|1|||
105456983|NCT03836625|363683554|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
105456984|NCT03836625|363683555|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
105456985|NCT03836625|363683554|FG000|Overall Study|Death|0|||
105456986|NCT03836625|363683555|FG001|Overall Study|Death|1|||
105456987|NCT03836625|363683554|FG000|Overall Study|Refused follow-up|0|||
105456988|NCT03836625|363683555|FG001|Overall Study|Refused follow-up|1|||
105456989|NCT04515771|363685034|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
105456990|NCT04515771|363685035|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
105337643|NCT02004886|363236955|FG001|Overall Study|Unable to attend future visits|0|||
105337644|NCT02004886|363236956|FG002|Overall Study|Unable to attend future visits|0|||
105337645|NCT02004886|363236957|FG003|Overall Study|Unable to attend future visits|0|||
105337646|NCT00749684|363236958|FG000|Overall Study|Death|1|||
105337647|NCT00749684|363236958|FG000|Overall Study|Adverse Event|27|||
105337648|NCT00749684|363236958|FG000|Overall Study|Participant's Wish|10|||
105337649|NCT00749684|363236958|FG000|Overall Study|Not Documented|1|||
105337650|NCT00749684|363236958|FG000|Overall Study|Progressive Desease|31|||
105337651|NCT00749684|363236958|FG000|Overall Study|Therapy according to protocol + AE|2|||
105337652|NCT00749684|363236958|FG000|Overall Study|AE+discontinuation on participants wish|1|||
105337653|NCT00749684|363236958|FG000|Overall Study|Missing|9|||
105337654|NCT00679289|363236959|FG000|Overall Study|Progressive disease|4|||
105337655|NCT00679289|363236960|FG001|Overall Study|Progressive disease|5|||
105337656|NCT00679289|363236961|FG002|Overall Study|Progressive disease|18|||
105337657|NCT00679289|363236959|FG000|Overall Study|Withdrawal by Subject|0|||
105337658|NCT00679289|363236960|FG001|Overall Study|Withdrawal by Subject|1|||
105337659|NCT00679289|363236961|FG002|Overall Study|Withdrawal by Subject|1|||
105337660|NCT00679289|363236959|FG000|Overall Study|Adverse Event|0|||
105337661|NCT00679289|363236960|FG001|Overall Study|Adverse Event|0|||
105337662|NCT00679289|363236961|FG002|Overall Study|Adverse Event|3|||
105337663|NCT00679289|363236959|FG000|Overall Study|Physician Decision|1|||
105456991|NCT04515771|363685034|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
105456992|NCT04515771|363685035|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
105456993|NCT04515771|363685034|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
105337664|NCT00679289|363236960|FG001|Overall Study|Physician Decision|0|||
105337665|NCT00679289|363236961|FG002|Overall Study|Physician Decision|1|||
105456994|NCT04515771|363685035|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
105456995|NCT00948246|363685038|FG000|Overall Study|Lost to Follow-up|11|||
105456996|NCT00948246|363685038|FG000|Overall Study|Adverse Event|11|||
105456997|NCT00948246|363685038|FG000|Overall Study|Death|1|||
105456998|NCT00948246|363685038|FG000|Overall Study|Withdrawal by Subject|1|||
105456999|NCT03598036|363685039|FG000|Overall Study|Withdrawal by Subject|1|||
105457000|NCT03598036|363685040|FG001|Overall Study|Withdrawal by Subject|0|||
105457001|NCT04124939|363685041|FG000|Overall Study|Lost to Follow-up|1|||
105457002|NCT04124939|363685042|FG001|Overall Study|Lost to Follow-up|3|||
105457003|NCT02587520|363685043|FG000|Overall Study|Protocol Violation|2|||
105457004|NCT02587520|363685044|FG001|Overall Study|Protocol Violation|0|||
105457005|NCT02587520|363685045|FG002|Overall Study|Protocol Violation|0|||
105457006|NCT02587520|363685046|FG003|Overall Study|Protocol Violation|2|||
105457007|NCT02587520|363685047|FG004|Overall Study|Protocol Violation|0|||
105457008|NCT02587520|363685048|FG005|Overall Study|Protocol Violation|1|||
105457009|NCT02587520|363685049|FG006|Overall Study|Protocol Violation|1|||
105457010|NCT02587520|363685050|FG007|Overall Study|Protocol Violation|1|||
105457011|NCT02587520|363685051|FG008|Overall Study|Protocol Violation|3|||
105457012|NCT02587520|363685052|FG009|Overall Study|Protocol Violation|3|||
105457013|NCT02587520|363685053|FG010|Overall Study|Protocol Violation|1|||
105457014|NCT02587520|363685054|FG011|Overall Study|Protocol Violation|2|||
105457015|NCT02587520|363685055|FG012|Overall Study|Protocol Violation|0|||
105457016|NCT02587520|363685056|FG013|Overall Study|Protocol Violation|0|||
105457017|NCT02587520|363685057|FG014|Overall Study|Protocol Violation|0|||
105457018|NCT02587520|363685058|FG015|Overall Study|Protocol Violation|0|||
105457019|NCT02587520|363685059|FG016|Overall Study|Protocol Violation|0|||
105457020|NCT02587520|363685060|FG017|Overall Study|Protocol Violation|0|||
105457021|NCT02587520|363685043|FG000|Overall Study|Adverse Event|0|||
105457022|NCT02587520|363685044|FG001|Overall Study|Adverse Event|0|||
105457023|NCT02587520|363685045|FG002|Overall Study|Adverse Event|0|||
105457024|NCT02587520|363685046|FG003|Overall Study|Adverse Event|0|||
105457025|NCT02587520|363685047|FG004|Overall Study|Adverse Event|0|||
105457026|NCT02587520|363685048|FG005|Overall Study|Adverse Event|0|||
105457027|NCT02587520|363685049|FG006|Overall Study|Adverse Event|0|||
105457028|NCT02587520|363685050|FG007|Overall Study|Adverse Event|0|||
105457029|NCT02587520|363685051|FG008|Overall Study|Adverse Event|0|||
105457030|NCT02587520|363685052|FG009|Overall Study|Adverse Event|0|||
105457031|NCT02587520|363685053|FG010|Overall Study|Adverse Event|0|||
105457032|NCT02587520|363685054|FG011|Overall Study|Adverse Event|1|||
105457033|NCT02587520|363685055|FG012|Overall Study|Adverse Event|0|||
105457034|NCT02587520|363685056|FG013|Overall Study|Adverse Event|0|||
105457035|NCT02587520|363685057|FG014|Overall Study|Adverse Event|0|||
105457036|NCT02587520|363685058|FG015|Overall Study|Adverse Event|0|||
105457037|NCT02587520|363685059|FG016|Overall Study|Adverse Event|0|||
105457038|NCT02587520|363685060|FG017|Overall Study|Adverse Event|0|||
105457039|NCT02587520|363685043|FG000|Overall Study|Withdrawal by Subject|0|||
105457040|NCT02587520|363685044|FG001|Overall Study|Withdrawal by Subject|0|||
105457041|NCT02587520|363685045|FG002|Overall Study|Withdrawal by Subject|1|||
105457042|NCT02587520|363685046|FG003|Overall Study|Withdrawal by Subject|1|||
105457043|NCT02587520|363685047|FG004|Overall Study|Withdrawal by Subject|0|||
105457044|NCT02587520|363685048|FG005|Overall Study|Withdrawal by Subject|1|||
105457045|NCT02587520|363685049|FG006|Overall Study|Withdrawal by Subject|1|||
105457046|NCT02587520|363685050|FG007|Overall Study|Withdrawal by Subject|0|||
105457047|NCT02587520|363685051|FG008|Overall Study|Withdrawal by Subject|0|||
105457048|NCT02587520|363685052|FG009|Overall Study|Withdrawal by Subject|0|||
105457049|NCT02587520|363685053|FG010|Overall Study|Withdrawal by Subject|0|||
105457050|NCT02587520|363685054|FG011|Overall Study|Withdrawal by Subject|0|||
105457051|NCT02587520|363685055|FG012|Overall Study|Withdrawal by Subject|0|||
105457052|NCT02587520|363685056|FG013|Overall Study|Withdrawal by Subject|1|||
105457053|NCT02587520|363685057|FG014|Overall Study|Withdrawal by Subject|0|||
105457054|NCT02587520|363685058|FG015|Overall Study|Withdrawal by Subject|0|||
105457055|NCT02587520|363685059|FG016|Overall Study|Withdrawal by Subject|0|||
105457056|NCT02587520|363685060|FG017|Overall Study|Withdrawal by Subject|0|||
105457057|NCT02587520|363685043|FG000|Overall Study|Lost to Follow-up|0|||
105457058|NCT02587520|363685044|FG001|Overall Study|Lost to Follow-up|2|||
105457059|NCT02587520|363685045|FG002|Overall Study|Lost to Follow-up|0|||
105457060|NCT02587520|363685046|FG003|Overall Study|Lost to Follow-up|2|||
105457061|NCT02587520|363685047|FG004|Overall Study|Lost to Follow-up|0|||
105457062|NCT02587520|363685048|FG005|Overall Study|Lost to Follow-up|1|||
105457063|NCT02587520|363685049|FG006|Overall Study|Lost to Follow-up|1|||
105457064|NCT02587520|363685050|FG007|Overall Study|Lost to Follow-up|1|||
105457065|NCT02587520|363685051|FG008|Overall Study|Lost to Follow-up|0|||
105457066|NCT02587520|363685052|FG009|Overall Study|Lost to Follow-up|2|||
105457067|NCT02587520|363685053|FG010|Overall Study|Lost to Follow-up|2|||
105457068|NCT02587520|363685054|FG011|Overall Study|Lost to Follow-up|1|||
105457069|NCT02587520|363685055|FG012|Overall Study|Lost to Follow-up|0|||
105457070|NCT02587520|363685056|FG013|Overall Study|Lost to Follow-up|0|||
105457071|NCT02587520|363685057|FG014|Overall Study|Lost to Follow-up|0|||
105457072|NCT02587520|363685058|FG015|Overall Study|Lost to Follow-up|0|||
105457073|NCT02587520|363685059|FG016|Overall Study|Lost to Follow-up|0|||
105457074|NCT02587520|363685060|FG017|Overall Study|Lost to Follow-up|0|||
105457075|NCT03623243|363685061|FG000|Overall Study|Adverse Event|15|||
105457076|NCT03623243|363685061|FG000|Overall Study|Guardian Decision|1|||
105457077|NCT03623243|363685061|FG000|Overall Study|New Therapy for Study Indication|1|||
105457078|NCT03623243|363685061|FG000|Overall Study|Protocol Deviation|3|||
105457079|NCT03623243|363685061|FG000|Overall Study|Physician Decision|4|||
105457080|NCT03623243|363685061|FG000|Overall Study|Patient Decision|15|||
105457081|NCT03182374|363685064|FG000|Overall Study|Lost to Follow-up|3|||
105457082|NCT03182374|363685065|FG001|Overall Study|Lost to Follow-up|2|||
105457083|NCT03182374|363685064|FG000|Overall Study|Lack of Efficacy|8|||
105457084|NCT03182374|363685065|FG001|Overall Study|Lack of Efficacy|14|||
105457085|NCT03182374|363685064|FG000|Overall Study|Withdrawal by Subject|1|||
105457086|NCT03182374|363685065|FG001|Overall Study|Withdrawal by Subject|1|||
105457087|NCT03182374|363685064|FG000|Overall Study|exit for non-compliance|1|||
105457088|NCT03182374|363685065|FG001|Overall Study|exit for non-compliance|1|||
105457089|NCT03182374|363685064|FG000|Overall Study|one subject was randomized but not treated|1|||
105457090|NCT03182374|363685065|FG001|Overall Study|one subject was randomized but not treated|0|||
105457091|NCT03182374|363685064|FG000|Overall Study|Other reasons|0|||
105457092|NCT03182374|363685065|FG001|Overall Study|Other reasons|3|||
105457093|NCT05635461|363685066|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
105457094|NCT05635461|363685067|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
105457095|NCT05635461|363685068|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
105457096|NCT05635461|363685069|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
105457097|NCT05635461|363685070|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
105457098|NCT05635461|363685071|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
105457099|NCT05635461|363685066|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
105457100|NCT05635461|363685067|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
105457101|NCT05635461|363685068|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
105457102|NCT05635461|363685069|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
105457103|NCT05635461|363685070|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
105457104|NCT05635461|363685071|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
105457105|NCT05635461|363685066|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
105457106|NCT05635461|363685067|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
105457107|NCT05635461|363685068|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
105457108|NCT05635461|363685069|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
105457109|NCT05635461|363685070|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
105457110|NCT05635461|363685071|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
105457111|NCT04890652|363685074|FG000|Overall Study|Withdrawal by Subject|2|||
105457112|NCT05543265|363685077|FG000|Overall Study|Lost to Follow-up|3|||
105457113|NCT05543265|363685078|FG001|Overall Study|Lost to Follow-up|3|||
105457114|NCT05543265|363685077|FG000|Overall Study|Withdrawal by Subject|0|||
105457115|NCT05543265|363685078|FG001|Overall Study|Withdrawal by Subject|1|||
105457116|NCT05316597|363685079|FG000|First Session|Withdrawal by Subject|0|||
105457117|NCT05316597|363685080|FG001|First Session|Withdrawal by Subject|1|||
105457118|NCT05316597|363685079|FG000|Washout Period|Lost to Follow-up|1|||
105457119|NCT05316597|363685080|FG001|Washout Period|Lost to Follow-up|2|||
105457120|NCT05316597|363685079|FG000|Washout Period|Physician Decision|1|||
105457121|NCT05316597|363685080|FG001|Washout Period|Physician Decision|1|||
105337666|NCT01508130|363236962|FG000|Overall Study|Adverse Event|81|||
105337667|NCT01508130|363236963|FG001|Overall Study|Adverse Event|28|||
105337668|NCT01508130|363236962|FG000|Overall Study|Death|3|||
105337669|NCT01508130|363236963|FG001|Overall Study|Death|1|||
105337670|NCT01508130|363236962|FG000|Overall Study|Protocol Violation|2|||
105337671|NCT01508130|363236963|FG001|Overall Study|Protocol Violation|0|||
105337672|NCT01508130|363236962|FG000|Overall Study|Lost to Follow-up|25|||
105337673|NCT01508130|363236963|FG001|Overall Study|Lost to Follow-up|2|||
105337674|NCT01508130|363236962|FG000|Overall Study|Withdrawal by Subject|3|||
105337675|NCT01508130|363236963|FG001|Overall Study|Withdrawal by Subject|3|||
105337676|NCT01508130|363236962|FG000|Overall Study|Subject's substantial non-compliance|25|||
105337677|NCT01508130|363236963|FG001|Overall Study|Subject's substantial non-compliance|9|||
105337678|NCT01508130|363236962|FG000|Overall Study|Insufficient therapeutic response|74|||
105337679|NCT01508130|363236963|FG001|Overall Study|Insufficient therapeutic response|23|||
105337680|NCT01508130|363236962|FG000|Overall Study|Administrative|14|||
105337681|NCT01508130|363236963|FG001|Overall Study|Administrative|3|||
105337682|NCT03613649|363236964|FG000|Second Treatment|Lost to Follow-up|0|||
105457122|NCT05316597|363685079|FG000|Washout Period|Excluded before second session|1|||
105457123|NCT05316597|363685080|FG001|Washout Period|Excluded before second session|1|||
105457124|NCT05316597|363685079|FG000|Washout Period|Withdrawal by Subject|0|||
105457125|NCT05316597|363685080|FG001|Washout Period|Withdrawal by Subject|4|||
105457126|NCT05526716|363685081|FG000|Overall Study|Death|1|||
105457127|NCT05526716|363685082|FG001|Overall Study|Death|2|||
105457128|NCT05526716|363685081|FG000|Overall Study|Lost to Follow-up|17|||
105457129|NCT05526716|363685082|FG001|Overall Study|Lost to Follow-up|15|||
105457130|NCT05526716|363685081|FG000|Overall Study|Physician Decision|0|||
105457131|NCT05526716|363685082|FG001|Overall Study|Physician Decision|1|||
105457132|NCT05526716|363685081|FG000|Overall Study|Randomized by mistake without study treatment|0|||
105457133|NCT05526716|363685082|FG001|Overall Study|Randomized by mistake without study treatment|1|||
105457134|NCT05526716|363685081|FG000|Overall Study|Withdrawal by Subject|12|||
105457135|NCT05526716|363685082|FG001|Overall Study|Withdrawal by Subject|12|||
105457136|NCT05526716|363685081|FG000|Overall Study|Not reported|0|||
105457137|NCT05526716|363685082|FG001|Overall Study|Not reported|2|||
105457138|NCT02384551|363685090|FG000|Overall Study|Lost to Follow-up|13|||
105457139|NCT02384551|363685091|FG001|Overall Study|Lost to Follow-up|14|||
105457140|NCT02384551|363685092|FG002|Overall Study|Lost to Follow-up|14|||
105457141|NCT02384551|363685093|FG003|Overall Study|Lost to Follow-up|14|||
105457142|NCT03035032|363685096|FG000|Overall Study|Adverse Event|2|||
105457143|NCT03035032|363685096|FG000|Overall Study|Death|9|||
105457144|NCT03035032|363685096|FG000|Overall Study|Lost to Follow-up|1|||
105457145|NCT03035032|363685096|FG000|Overall Study|Progressive Disease|22|||
105457146|NCT03035032|363685096|FG000|Overall Study|Protocol Violation|2|||
105457147|NCT03035032|363685096|FG000|Overall Study|Withdrawal by Subject|2|||
105457148|NCT03035032|363685096|FG000|Overall Study|Physician Decision|5|||
105457149|NCT02201524|363685097|FG000|Overall Study|Adverse Event|0|||
105457150|NCT02201524|363685098|FG001|Overall Study|Adverse Event|2|||
105457151|NCT02201524|363685099|FG002|Overall Study|Adverse Event|1|||
105457152|NCT02201524|363685100|FG003|Overall Study|Adverse Event|0|||
105457153|NCT02201524|363685097|FG000|Overall Study|Insufficient clinical response|1|||
105457154|NCT02201524|363685098|FG001|Overall Study|Insufficient clinical response|0|||
105457155|NCT02201524|363685099|FG002|Overall Study|Insufficient clinical response|0|||
105457156|NCT02201524|363685100|FG003|Overall Study|Insufficient clinical response|0|||
105457157|NCT02201524|363685097|FG000|Overall Study|Lost to Follow-up|0|||
105457158|NCT02201524|363685098|FG001|Overall Study|Lost to Follow-up|0|||
105457159|NCT02201524|363685099|FG002|Overall Study|Lost to Follow-up|2|||
105457160|NCT02201524|363685100|FG003|Overall Study|Lost to Follow-up|0|||
105457161|NCT02201524|363685097|FG000|Overall Study|No longer meets eligibility criteria|0|||
105457162|NCT02201524|363685098|FG001|Overall Study|No longer meets eligibility criteria|0|||
105457163|NCT02201524|363685099|FG002|Overall Study|No longer meets eligibility criteria|0|||
105457164|NCT02201524|363685100|FG003|Overall Study|No longer meets eligibility criteria|2|||
105457165|NCT02201524|363685097|FG000|Overall Study|Protocol Violation|0|||
105457166|NCT02201524|363685098|FG001|Overall Study|Protocol Violation|0|||
105457167|NCT02201524|363685099|FG002|Overall Study|Protocol Violation|0|||
105457168|NCT02201524|363685100|FG003|Overall Study|Protocol Violation|1|||
105457169|NCT02201524|363685097|FG000|Overall Study|Withdrawal by Subject|0|||
105457170|NCT02201524|363685098|FG001|Overall Study|Withdrawal by Subject|0|||
105457171|NCT02201524|363685099|FG002|Overall Study|Withdrawal by Subject|1|||
105457172|NCT02201524|363685100|FG003|Overall Study|Withdrawal by Subject|1|||
105457173|NCT02201524|363685097|FG000|Overall Study|Other|1|||
105457174|NCT02201524|363685098|FG001|Overall Study|Other|1|||
105457175|NCT02201524|363685099|FG002|Overall Study|Other|0|||
105457176|NCT02201524|363685100|FG003|Overall Study|Other|0|||
105457177|NCT02914639|363685101|FG000|Overall Study|Withdrawal by Subject|0|||
105457178|NCT02914639|363685102|FG001|Overall Study|Withdrawal by Subject|2|||
105457179|NCT01045460|363685106|FG000|Overall Study|Physician Decision|3|||
105457180|NCT01045460|363685107|FG001|Overall Study|Physician Decision|2|||
105457181|NCT01045460|363685106|FG000|Overall Study|Lost to Follow-up|0|||
105457182|NCT01045460|363685107|FG001|Overall Study|Lost to Follow-up|1|||
105457183|NCT01045460|363685106|FG000|Overall Study|Lack of Efficacy|3|||
105457184|NCT01045460|363685107|FG001|Overall Study|Lack of Efficacy|0|||
105457185|NCT00001832|363685108|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
105457186|NCT00001832|363685109|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
105457187|NCT00001832|363685110|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
105457188|NCT00001832|363685111|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
105457189|NCT00001832|363685112|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
105457190|NCT00001832|363685113|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
105457191|NCT00001832|363685114|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
105457192|NCT00001832|363685115|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
105457193|NCT00001832|363685116|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
105457194|NCT00001832|363685117|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
105457195|NCT00001832|363685118|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
105457196|NCT00001832|363685119|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
105457197|NCT00001832|363685120|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
105457198|NCT00001832|363685121|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
105457199|NCT00001832|363685122|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
105457200|NCT00001832|363685108|FG000|Treatment Period|Death during treatment|0|||
105457201|NCT00001832|363685109|FG001|Treatment Period|Death during treatment|0|||
105457202|NCT00001832|363685110|FG002|Treatment Period|Death during treatment|0|||
105457203|NCT00001832|363685111|FG003|Treatment Period|Death during treatment|0|||
105457204|NCT00001832|363685112|FG004|Treatment Period|Death during treatment|0|||
105457205|NCT00001832|363685113|FG005|Treatment Period|Death during treatment|1|||
105457206|NCT00001832|363685114|FG006|Treatment Period|Death during treatment|0|||
105457207|NCT00001832|363685115|FG007|Treatment Period|Death during treatment|0|||
105457208|NCT00001832|363685116|FG008|Treatment Period|Death during treatment|0|||
105457209|NCT00001832|363685117|FG009|Treatment Period|Death during treatment|0|||
105457210|NCT00001832|363685118|FG010|Treatment Period|Death during treatment|0|||
105457211|NCT00001832|363685119|FG011|Treatment Period|Death during treatment|0|||
105457212|NCT00001832|363685120|FG012|Treatment Period|Death during treatment|0|||
105457213|NCT00001832|363685121|FG013|Treatment Period|Death during treatment|0|||
105457214|NCT00001832|363685122|FG014|Treatment Period|Death during treatment|0|||
105457215|NCT00001832|363685108|FG000|Treatment Period|Not treated|0|||
105457216|NCT00001832|363685109|FG001|Treatment Period|Not treated|0|||
105457217|NCT00001832|363685110|FG002|Treatment Period|Not treated|0|||
105457218|NCT00001832|363685111|FG003|Treatment Period|Not treated|0|||
105457219|NCT00001832|363685112|FG004|Treatment Period|Not treated|0|||
105457220|NCT00001832|363685113|FG005|Treatment Period|Not treated|0|||
105457221|NCT00001832|363685114|FG006|Treatment Period|Not treated|0|||
105457222|NCT00001832|363685115|FG007|Treatment Period|Not treated|1|||
105457223|NCT00001832|363685116|FG008|Treatment Period|Not treated|0|||
105457224|NCT00001832|363685117|FG009|Treatment Period|Not treated|0|||
105457225|NCT00001832|363685118|FG010|Treatment Period|Not treated|0|||
105457226|NCT00001832|363685119|FG011|Treatment Period|Not treated|0|||
105457227|NCT00001832|363685120|FG012|Treatment Period|Not treated|0|||
105457228|NCT00001832|363685121|FG013|Treatment Period|Not treated|0|||
105457229|NCT00001832|363685122|FG014|Treatment Period|Not treated|0|||
105457230|NCT02358473|363685126|FG000|Overall Study|Disease Progession|6|||
105457231|NCT02358473|363685126|FG000|Overall Study|Adverse Event|3|||
105457232|NCT02358473|363685126|FG000|Overall Study|Withdrawal by Subject|2|||
105457233|NCT02358473|363685126|FG000|Overall Study|Physician Decision|2|||
105457234|NCT04038359|363685139|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
105457235|NCT04038359|363685140|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
105457236|NCT04038359|363685139|FG000|Overall Study|Death|8|||
105457237|NCT04038359|363685140|FG001|Overall Study|Death|7|||
105457238|NCT04038359|363685139|FG000|Overall Study|Lost to Follow-up|3|||
105457239|NCT04038359|363685140|FG001|Overall Study|Lost to Follow-up|0|||
105457240|NCT04038359|363685139|FG000|Overall Study|Participant Moved|1|||
105457241|NCT04038359|363685140|FG001|Overall Study|Participant Moved|0|||
105457242|NCT04038359|363685139|FG000|Overall Study|Withdrawal by Subject|4|||
105457243|NCT04038359|363685140|FG001|Overall Study|Withdrawal by Subject|3|||
105457244|NCT04038359|363685139|FG000|Overall Study|Physician Decision|3|||
105457245|NCT04038359|363685140|FG001|Overall Study|Physician Decision|2|||
105457246|NCT04038359|363685139|FG000|Overall Study|Adverse Event|0|||
105457247|NCT04038359|363685140|FG001|Overall Study|Adverse Event|2|||
105457248|NCT04038359|363685139|FG000|Overall Study|Progressive Disease|0|||
105457249|NCT04038359|363685140|FG001|Overall Study|Progressive Disease|1|||
105457250|NCT04949191|363685141|FG000|Overall Study|Non-compliance with Study Drug|1|||
105457251|NCT04949191|363685142|FG001|Overall Study|Non-compliance with Study Drug|0|||
105457252|NCT04949191|363685143|FG002|Overall Study|Non-compliance with Study Drug|0|||
105457253|NCT04949191|363685144|FG003|Overall Study|Non-compliance with Study Drug|0|||
105457254|NCT04949191|363685141|FG000|Overall Study|Progressive Disease|0|||
105457255|NCT04949191|363685142|FG001|Overall Study|Progressive Disease|1|||
105457256|NCT04949191|363685143|FG002|Overall Study|Progressive Disease|0|||
105457257|NCT04949191|363685144|FG003|Overall Study|Progressive Disease|0|||
105457258|NCT04949191|363685141|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
105457259|NCT04949191|363685142|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
105457260|NCT04949191|363685143|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
105457261|NCT04949191|363685144|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
105457262|NCT04949191|363685141|FG000|Overall Study|Sponsor Terminated Study|0|||
105457263|NCT04949191|363685142|FG001|Overall Study|Sponsor Terminated Study|0|||
105457264|NCT04949191|363685143|FG002|Overall Study|Sponsor Terminated Study|1|||
105457265|NCT04949191|363685144|FG003|Overall Study|Sponsor Terminated Study|1|||
105457266|NCT03259230|363685147|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
105457267|NCT03259230|363685148|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
105457268|NCT01033240|363685149|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
105457269|NCT01033240|363685150|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
105457270|NCT01033240|363685151|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
105457271|NCT01033240|363685149|FG000|Overall Study|Death|2|||
105457272|NCT01033240|363685150|FG001|Overall Study|Death|0|||
105457273|NCT01033240|363685151|FG002|Overall Study|Death|0|||
105457274|NCT01033240|363685149|FG000|Overall Study|Withdrew Consent|2|||
105457275|NCT01033240|363685150|FG001|Overall Study|Withdrew Consent|9|||
105457276|NCT01033240|363685151|FG002|Overall Study|Withdrew Consent|2|||
105457277|NCT01033240|363685149|FG000|Overall Study|Disease Progression|35|||
105457278|NCT01033240|363685150|FG001|Overall Study|Disease Progression|32|||
105457279|NCT01033240|363685151|FG002|Overall Study|Disease Progression|41|||
105457280|NCT01033240|363685149|FG000|Overall Study|Investigator Discretion|0|||
105457281|NCT01033240|363685150|FG001|Overall Study|Investigator Discretion|0|||
105457282|NCT01033240|363685151|FG002|Overall Study|Investigator Discretion|2|||
105457283|NCT01033240|363685149|FG000|Overall Study|Other|0|||
105661752|NCT01068210|364425133|FG003|Overall Study|Lost to Follow-up|1|||
105457284|NCT01033240|363685150|FG001|Overall Study|Other|1|||
105457285|NCT01033240|363685151|FG002|Overall Study|Other|2|||
105337683|NCT03613649|363236965|FG001|Second Treatment|Lost to Follow-up|0|||
105337684|NCT03613649|363236966|FG002|Second Treatment|Lost to Follow-up|1|||
105337685|NCT03613649|363236967|FG003|Second Treatment|Lost to Follow-up|0|||
105337686|NCT03613649|363236968|FG004|Second Treatment|Lost to Follow-up|0|||
105337687|NCT03613649|363236969|FG005|Second Treatment|Lost to Follow-up|0|||
105337688|NCT03613649|363236970|FG006|Second Treatment|Lost to Follow-up|0|||
105337689|NCT03613649|363236971|FG007|Second Treatment|Lost to Follow-up|0|||
105337690|NCT03613649|363236972|FG008|Second Treatment|Lost to Follow-up|0|||
105337691|NCT03613649|363236973|FG009|Second Treatment|Lost to Follow-up|0|||
105337692|NCT03613649|363236974|FG010|Second Treatment|Lost to Follow-up|0|||
105337693|NCT03613649|363236975|FG011|Second Treatment|Lost to Follow-up|0|||
105337694|NCT03613649|363236964|FG000|Second Treatment|Withdrawal by Subject|0|||
105337695|NCT03613649|363236965|FG001|Second Treatment|Withdrawal by Subject|0|||
105337696|NCT03613649|363236966|FG002|Second Treatment|Withdrawal by Subject|0|||
105337697|NCT03613649|363236967|FG003|Second Treatment|Withdrawal by Subject|0|||
105337698|NCT03613649|363236968|FG004|Second Treatment|Withdrawal by Subject|1|||
105337699|NCT03613649|363236969|FG005|Second Treatment|Withdrawal by Subject|0|||
105337700|NCT03613649|363236970|FG006|Second Treatment|Withdrawal by Subject|0|||
105337701|NCT03613649|363236971|FG007|Second Treatment|Withdrawal by Subject|0|||
105337702|NCT03613649|363236972|FG008|Second Treatment|Withdrawal by Subject|0|||
105337703|NCT03613649|363236973|FG009|Second Treatment|Withdrawal by Subject|0|||
105337704|NCT03613649|363236974|FG010|Second Treatment|Withdrawal by Subject|0|||
105457286|NCT05468814|363685152|FG000|Overall Study|Lost to Follow-up|5|||
105457287|NCT05468814|363685153|FG001|Overall Study|Lost to Follow-up|6|||
105457288|NCT04716426|363685155|FG000|Overall Study|Vaccination|1|||
105457289|NCT04716426|363685156|FG001|Overall Study|Vaccination|1|||
105457290|NCT04716426|363685155|FG000|Overall Study|Contamination|1|||
105457291|NCT04716426|363685156|FG001|Overall Study|Contamination|0|||
105457292|NCT00551759|363685157|FG000|Overall Study|Adverse Event|7|||
105457293|NCT00551759|363685157|FG000|Overall Study|Death|5|||
105457294|NCT00551759|363685157|FG000|Overall Study|Ineligible|1|||
105457295|NCT00625131|363685161|FG000|Overall Study|Lost to Follow-up|3|||
105457296|NCT00625131|363685162|FG001|Overall Study|Lost to Follow-up|2|||
105457297|NCT00625131|363685163|FG002|Overall Study|Lost to Follow-up|0|||
105457298|NCT00625131|363685161|FG000|Overall Study|Withdrawal by Subject|1|||
105457299|NCT00625131|363685162|FG001|Overall Study|Withdrawal by Subject|0|||
105457300|NCT00625131|363685163|FG002|Overall Study|Withdrawal by Subject|5|||
105457301|NCT00771914|363685164|FG000|Overall Study|Physician Decision|0|||
105457302|NCT00771914|363685165|FG001|Overall Study|Physician Decision|0|||
105457303|NCT00771914|363685166|FG002|Overall Study|Physician Decision|0|||
105457304|NCT00771914|363685167|FG003|Overall Study|Physician Decision|1|||
105457305|NCT00771914|363685164|FG000|Overall Study|Lost to Follow-up|0|||
105457306|NCT00771914|363685165|FG001|Overall Study|Lost to Follow-up|0|||
105457307|NCT00771914|363685166|FG002|Overall Study|Lost to Follow-up|0|||
105457308|NCT00771914|363685167|FG003|Overall Study|Lost to Follow-up|1|||
105457309|NCT01743469|363685170|FG000|Active Treatment Phase|Adverse Event|10|||
105457310|NCT01743469|363685171|FG001|Active Treatment Phase|Adverse Event|5|||
105457311|NCT01743469|363685172|FG002|Active Treatment Phase|Adverse Event|8|||
105457312|NCT01743469|363685173|FG003|Active Treatment Phase|Adverse Event|1|||
105457313|NCT01743469|363685170|FG000|Active Treatment Phase|Disease Progression|40|||
105457314|NCT01743469|363685171|FG001|Active Treatment Phase|Disease Progression|47|||
105457315|NCT01743469|363685172|FG002|Active Treatment Phase|Disease Progression|30|||
105457316|NCT01743469|363685173|FG003|Active Treatment Phase|Disease Progression|20|||
105457317|NCT01743469|363685170|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
105457318|NCT01743469|363685171|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
105457319|NCT01743469|363685172|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
105457320|NCT01743469|363685173|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
105457321|NCT01743469|363685170|FG000|Active Treatment Phase|Missing|1|||
105457322|NCT01743469|363685171|FG001|Active Treatment Phase|Missing|0|||
105457323|NCT01743469|363685172|FG002|Active Treatment Phase|Missing|0|||
105457324|NCT01743469|363685173|FG003|Active Treatment Phase|Missing|0|||
105457325|NCT01743469|363685170|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
105457326|NCT01743469|363685171|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
105457327|NCT01743469|363685172|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
105457328|NCT01743469|363685173|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
105457329|NCT01743469|363685170|FG000|Follow-up Period - Post-Treatment|Death|43|||
105457330|NCT01743469|363685171|FG001|Follow-up Period - Post-Treatment|Death|47|||
105457331|NCT01743469|363685172|FG002|Follow-up Period - Post-Treatment|Death|22|||
105457332|NCT01743469|363685173|FG003|Follow-up Period - Post-Treatment|Death|16|||
105457333|NCT01743469|363685170|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
105457334|NCT01743469|363685171|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
105457335|NCT01743469|363685172|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
105457336|NCT01743469|363685173|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
105337705|NCT03613649|363236975|FG011|Second Treatment|Withdrawal by Subject|0|||
105337706|NCT03613649|363236964|FG000|Third Treatment|Lost to Follow-up|0|||
105337707|NCT03613649|363236965|FG001|Third Treatment|Lost to Follow-up|0|||
105457337|NCT02559622|363685176|FG000|Overall Study|Progressive disease|0|||
105457338|NCT02559622|363685177|FG001|Overall Study|Progressive disease|1|||
105457339|NCT02559622|363685178|FG002|Overall Study|Progressive disease|0|||
105457340|NCT02559622|363685179|FG003|Overall Study|Progressive disease|0|||
105457341|NCT02559622|363685176|FG000|Overall Study|Adverse Event|0|||
105457342|NCT02559622|363685177|FG001|Overall Study|Adverse Event|2|||
105457343|NCT02559622|363685178|FG002|Overall Study|Adverse Event|2|||
105457344|NCT02559622|363685179|FG003|Overall Study|Adverse Event|2|||
105457345|NCT02559622|363685176|FG000|Overall Study|Patient/guardian decision|1|||
105457346|NCT02559622|363685177|FG001|Overall Study|Patient/guardian decision|2|||
105457347|NCT02559622|363685178|FG002|Overall Study|Patient/guardian decision|0|||
105457348|NCT02559622|363685179|FG003|Overall Study|Patient/guardian decision|1|||
105457349|NCT00231816|363685182|FG000|Overall Study|Adverse Event|1|||
105457350|NCT00231816|363685183|FG001|Overall Study|Adverse Event|0|||
105457351|NCT00231816|363685182|FG000|Overall Study|Lost to Follow-up|8|||
105457352|NCT00231816|363685183|FG001|Overall Study|Lost to Follow-up|5|||
105457353|NCT00231816|363685182|FG000|Overall Study|Protocol Violation|2|||
105457354|NCT00231816|363685183|FG001|Overall Study|Protocol Violation|3|||
105457355|NCT00231816|363685182|FG000|Overall Study|Withdrawal by Subject|3|||
105457356|NCT00231816|363685183|FG001|Overall Study|Withdrawal by Subject|3|||
105457357|NCT00231816|363685182|FG000|Overall Study|Other|2|||
105457358|NCT00231816|363685183|FG001|Overall Study|Other|1|||
105457359|NCT03341299|363685185|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
105457360|NCT03341299|363685186|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
105457361|NCT03341299|363685187|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
105457362|NCT03341299|363685188|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
105457363|NCT03009058|363685191|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
105457364|NCT02234843|363685197|FG000|Overall Study|Death|1|||
105457365|NCT02234843|363685198|FG001|Overall Study|Death|0|||
105457366|NCT02234843|363685199|FG002|Overall Study|Death|0|||
105457367|NCT02234843|363685200|FG003|Overall Study|Death|0|||
105457368|NCT02234843|363685201|FG004|Overall Study|Death|0|||
105457369|NCT02234843|363685202|FG005|Overall Study|Death|0|||
105457370|NCT02234843|363685203|FG006|Overall Study|Death|0|||
105457371|NCT02234843|363685204|FG007|Overall Study|Death|0|||
105457372|NCT02234843|363685205|FG008|Overall Study|Death|0|||
105457373|NCT02234843|363685206|FG009|Overall Study|Death|0|||
105457374|NCT02234843|363685197|FG000|Overall Study|Protocol Violation|1|||
105457375|NCT02234843|363685198|FG001|Overall Study|Protocol Violation|0|||
105457376|NCT02234843|363685199|FG002|Overall Study|Protocol Violation|1|||
105457377|NCT02234843|363685200|FG003|Overall Study|Protocol Violation|0|||
105457378|NCT02234843|363685201|FG004|Overall Study|Protocol Violation|0|||
105457379|NCT02234843|363685202|FG005|Overall Study|Protocol Violation|0|||
105457380|NCT02234843|363685203|FG006|Overall Study|Protocol Violation|0|||
105457381|NCT02234843|363685204|FG007|Overall Study|Protocol Violation|0|||
105457382|NCT02234843|363685205|FG008|Overall Study|Protocol Violation|0|||
105457383|NCT02234843|363685206|FG009|Overall Study|Protocol Violation|0|||
105457384|NCT02234843|363685197|FG000|Overall Study|Efficacy outcome reached|2|||
105457385|NCT02234843|363685198|FG001|Overall Study|Efficacy outcome reached|0|||
105457386|NCT02234843|363685199|FG002|Overall Study|Efficacy outcome reached|0|||
105457387|NCT02234843|363685200|FG003|Overall Study|Efficacy outcome reached|0|||
105457388|NCT02234843|363685201|FG004|Overall Study|Efficacy outcome reached|0|||
105457389|NCT02234843|363685202|FG005|Overall Study|Efficacy outcome reached|2|||
105457390|NCT02234843|363685203|FG006|Overall Study|Efficacy outcome reached|0|||
105457391|NCT02234843|363685204|FG007|Overall Study|Efficacy outcome reached|0|||
105457392|NCT02234843|363685205|FG008|Overall Study|Efficacy outcome reached|0|||
105457393|NCT02234843|363685206|FG009|Overall Study|Efficacy outcome reached|0|||
105457394|NCT02234843|363685197|FG000|Overall Study|Patient convenience|2|||
105457395|NCT02234843|363685198|FG001|Overall Study|Patient convenience|0|||
105457396|NCT02234843|363685199|FG002|Overall Study|Patient convenience|0|||
105457397|NCT02234843|363685200|FG003|Overall Study|Patient convenience|0|||
105457398|NCT02234843|363685201|FG004|Overall Study|Patient convenience|0|||
105457399|NCT02234843|363685202|FG005|Overall Study|Patient convenience|1|||
105457400|NCT02234843|363685203|FG006|Overall Study|Patient convenience|0|||
105457401|NCT02234843|363685204|FG007|Overall Study|Patient convenience|0|||
105457402|NCT02234843|363685205|FG008|Overall Study|Patient convenience|0|||
105457403|NCT02234843|363685206|FG009|Overall Study|Patient convenience|0|||
105457404|NCT02234843|363685197|FG000|Overall Study|Withdrawal by Subject|5|||
105457405|NCT02234843|363685198|FG001|Overall Study|Withdrawal by Subject|1|||
105457406|NCT02234843|363685199|FG002|Overall Study|Withdrawal by Subject|1|||
105457407|NCT02234843|363685200|FG003|Overall Study|Withdrawal by Subject|0|||
105457408|NCT02234843|363685201|FG004|Overall Study|Withdrawal by Subject|0|||
105457409|NCT02234843|363685202|FG005|Overall Study|Withdrawal by Subject|7|||
105457410|NCT02234843|363685203|FG006|Overall Study|Withdrawal by Subject|0|||
105457411|NCT02234843|363685204|FG007|Overall Study|Withdrawal by Subject|0|||
105457412|NCT02234843|363685205|FG008|Overall Study|Withdrawal by Subject|0|||
105457413|NCT02234843|363685206|FG009|Overall Study|Withdrawal by Subject|0|||
105457414|NCT02234843|363685197|FG000|Overall Study|Recovery|1|||
105457415|NCT02234843|363685198|FG001|Overall Study|Recovery|0|||
105457416|NCT02234843|363685199|FG002|Overall Study|Recovery|0|||
105457417|NCT02234843|363685200|FG003|Overall Study|Recovery|0|||
105457418|NCT02234843|363685201|FG004|Overall Study|Recovery|0|||
105457419|NCT02234843|363685202|FG005|Overall Study|Recovery|0|||
105457420|NCT02234843|363685203|FG006|Overall Study|Recovery|0|||
105457421|NCT02234843|363685204|FG007|Overall Study|Recovery|0|||
105457422|NCT02234843|363685205|FG008|Overall Study|Recovery|0|||
105457423|NCT02234843|363685206|FG009|Overall Study|Recovery|0|||
105457424|NCT02234843|363685197|FG000|Overall Study|Other|0|||
105457425|NCT02234843|363685198|FG001|Overall Study|Other|2|||
105457426|NCT02234843|363685199|FG002|Overall Study|Other|0|||
105457427|NCT02234843|363685200|FG003|Overall Study|Other|1|||
105457428|NCT02234843|363685201|FG004|Overall Study|Other|0|||
105457429|NCT02234843|363685202|FG005|Overall Study|Other|1|||
105457430|NCT02234843|363685203|FG006|Overall Study|Other|0|||
105457431|NCT02234843|363685204|FG007|Overall Study|Other|1|||
105457432|NCT02234843|363685205|FG008|Overall Study|Other|0|||
105457433|NCT02234843|363685206|FG009|Overall Study|Other|0|||
105457434|NCT02234843|363685197|FG000|Overall Study|Physician Decision|4|||
105457435|NCT02234843|363685198|FG001|Overall Study|Physician Decision|1|||
105457436|NCT02234843|363685199|FG002|Overall Study|Physician Decision|0|||
105457437|NCT02234843|363685200|FG003|Overall Study|Physician Decision|1|||
105457438|NCT02234843|363685201|FG004|Overall Study|Physician Decision|0|||
105457439|NCT02234843|363685202|FG005|Overall Study|Physician Decision|0|||
105457440|NCT02234843|363685203|FG006|Overall Study|Physician Decision|0|||
105457441|NCT02234843|363685204|FG007|Overall Study|Physician Decision|1|||
105457442|NCT02234843|363685205|FG008|Overall Study|Physician Decision|0|||
105457443|NCT02234843|363685206|FG009|Overall Study|Physician Decision|0|||
105457444|NCT02234843|363685197|FG000|Overall Study|Adverse Event|5|||
105457445|NCT02234843|363685198|FG001|Overall Study|Adverse Event|1|||
105457446|NCT02234843|363685199|FG002|Overall Study|Adverse Event|1|||
105457447|NCT02234843|363685200|FG003|Overall Study|Adverse Event|3|||
105457448|NCT02234843|363685201|FG004|Overall Study|Adverse Event|2|||
105457449|NCT02234843|363685202|FG005|Overall Study|Adverse Event|1|||
105457450|NCT02234843|363685203|FG006|Overall Study|Adverse Event|0|||
105457451|NCT02234843|363685204|FG007|Overall Study|Adverse Event|0|||
105457452|NCT02234843|363685205|FG008|Overall Study|Adverse Event|1|||
105457453|NCT02234843|363685206|FG009|Overall Study|Adverse Event|0|||
105457454|NCT02234843|363685197|FG000|Overall Study|Non-compliance with study drug|1|||
105457455|NCT02234843|363685198|FG001|Overall Study|Non-compliance with study drug|0|||
105457456|NCT02234843|363685199|FG002|Overall Study|Non-compliance with study drug|0|||
105457457|NCT02234843|363685200|FG003|Overall Study|Non-compliance with study drug|0|||
105457458|NCT02234843|363685201|FG004|Overall Study|Non-compliance with study drug|0|||
105457459|NCT02234843|363685202|FG005|Overall Study|Non-compliance with study drug|1|||
105457460|NCT02234843|363685203|FG006|Overall Study|Non-compliance with study drug|1|||
105457461|NCT02234843|363685204|FG007|Overall Study|Non-compliance with study drug|0|||
105457462|NCT02234843|363685205|FG008|Overall Study|Non-compliance with study drug|0|||
105457463|NCT02234843|363685206|FG009|Overall Study|Non-compliance with study drug|0|||
105457464|NCT02234843|363685197|FG000|Overall Study|Lost to Follow-up|0|||
105457465|NCT02234843|363685198|FG001|Overall Study|Lost to Follow-up|1|||
105457466|NCT02234843|363685199|FG002|Overall Study|Lost to Follow-up|0|||
105457467|NCT02234843|363685200|FG003|Overall Study|Lost to Follow-up|0|||
105457468|NCT02234843|363685201|FG004|Overall Study|Lost to Follow-up|0|||
105457469|NCT02234843|363685202|FG005|Overall Study|Lost to Follow-up|0|||
105457470|NCT02234843|363685203|FG006|Overall Study|Lost to Follow-up|1|||
105457471|NCT02234843|363685204|FG007|Overall Study|Lost to Follow-up|0|||
105457472|NCT02234843|363685205|FG008|Overall Study|Lost to Follow-up|0|||
105457473|NCT02234843|363685206|FG009|Overall Study|Lost to Follow-up|0|||
105457474|NCT01691794|363685207|FG000|Overall Study|Poor/Non-Compliance|1|||
105457475|NCT01691794|363685208|FG001|Overall Study|Poor/Non-Compliance|4|||
105457476|NCT01691794|363685209|FG002|Overall Study|Poor/Non-Compliance|1|||
105457477|NCT01691794|363685207|FG000|Overall Study|Death|0|||
105457478|NCT01691794|363685208|FG001|Overall Study|Death|0|||
105457479|NCT01691794|363685209|FG002|Overall Study|Death|1|||
105457480|NCT01691794|363685207|FG000|Overall Study|Lack of Efficacy|0|||
105457481|NCT01691794|363685208|FG001|Overall Study|Lack of Efficacy|7|||
105457482|NCT01691794|363685209|FG002|Overall Study|Lack of Efficacy|1|||
105457483|NCT01691794|363685207|FG000|Overall Study|Participant request to discontinue|0|||
105457484|NCT01691794|363685208|FG001|Overall Study|Participant request to discontinue|1|||
105457485|NCT01691794|363685209|FG002|Overall Study|Participant request to discontinue|0|||
105457486|NCT01691794|363685207|FG000|Overall Study|Adverse Event|0|||
105457487|NCT01691794|363685208|FG001|Overall Study|Adverse Event|1|||
105457488|NCT01691794|363685209|FG002|Overall Study|Adverse Event|1|||
105457489|NCT01691794|363685207|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
105457490|NCT01691794|363685208|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
105457491|NCT01691794|363685209|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
105457492|NCT01691794|363685207|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
105457493|NCT01691794|363685208|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
105457494|NCT01691794|363685209|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
105337708|NCT03613649|363236966|FG002|Third Treatment|Lost to Follow-up|0|||
105337709|NCT03613649|363236967|FG003|Third Treatment|Lost to Follow-up|0|||
105337710|NCT03613649|363236968|FG004|Third Treatment|Lost to Follow-up|1|||
105337711|NCT03613649|363236969|FG005|Third Treatment|Lost to Follow-up|0|||
105337712|NCT03613649|363236970|FG006|Third Treatment|Lost to Follow-up|0|||
105337713|NCT03613649|363236971|FG007|Third Treatment|Lost to Follow-up|0|||
105337714|NCT03613649|363236972|FG008|Third Treatment|Lost to Follow-up|0|||
105337715|NCT03613649|363236973|FG009|Third Treatment|Lost to Follow-up|0|||
105337716|NCT03613649|363236974|FG010|Third Treatment|Lost to Follow-up|0|||
105337717|NCT03613649|363236975|FG011|Third Treatment|Lost to Follow-up|1|||
105337718|NCT03613649|363236964|FG000|Third Treatment|Protocol Violation|0|||
105337719|NCT03613649|363236965|FG001|Third Treatment|Protocol Violation|0|||
105337720|NCT03613649|363236966|FG002|Third Treatment|Protocol Violation|0|||
105337721|NCT03613649|363236967|FG003|Third Treatment|Protocol Violation|0|||
105337722|NCT03613649|363236968|FG004|Third Treatment|Protocol Violation|0|||
105337723|NCT03613649|363236969|FG005|Third Treatment|Protocol Violation|0|||
105337724|NCT03613649|363236970|FG006|Third Treatment|Protocol Violation|1|||
105337725|NCT03613649|363236971|FG007|Third Treatment|Protocol Violation|0|||
105337726|NCT03613649|363236972|FG008|Third Treatment|Protocol Violation|0|||
105337727|NCT03613649|363236973|FG009|Third Treatment|Protocol Violation|0|||
105337728|NCT03613649|363236974|FG010|Third Treatment|Protocol Violation|0|||
105337729|NCT03613649|363236975|FG011|Third Treatment|Protocol Violation|1|||
105337730|NCT03613649|363236964|FG000|Fourth Treatment|Protocol Violation|1|||
105337731|NCT03613649|363236965|FG001|Fourth Treatment|Protocol Violation|0|||
105337732|NCT03613649|363236966|FG002|Fourth Treatment|Protocol Violation|0|||
105337733|NCT03613649|363236967|FG003|Fourth Treatment|Protocol Violation|0|||
105337734|NCT03613649|363236968|FG004|Fourth Treatment|Protocol Violation|1|||
105337735|NCT03613649|363236969|FG005|Fourth Treatment|Protocol Violation|0|||
105457495|NCT00844844|363685210|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
105457496|NCT00844844|363685210|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
105457497|NCT00844844|363685210|FG000|Extension Treatment Period|Adverse Event|2|||
105457498|NCT00844844|363685210|FG000|Post Treatment Period|Withdrawal by Subject|1|||
105457499|NCT02016781|363685214|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
105457500|NCT02016781|363685215|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
105457501|NCT02016781|363685214|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
105457502|NCT02016781|363685215|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
105457503|NCT02016781|363685214|FG000|Final Database Lock|Withdrawal by Subject|2|||
105457504|NCT02016781|363685215|FG001|Final Database Lock|Withdrawal by Subject|1|||
105457505|NCT02016781|363685214|FG000|Final Database Lock|Lost to Follow-up|11|||
105457506|NCT02016781|363685215|FG001|Final Database Lock|Lost to Follow-up|4|||
105457507|NCT02016781|363685214|FG000|Final Database Lock|Missing data|0|||
105457508|NCT02016781|363685215|FG001|Final Database Lock|Missing data|3|||
105457509|NCT01400698|363685226|FG000|Overall Study|Lost to Follow-up|2|||
105457510|NCT01400698|363685227|FG001|Overall Study|Lost to Follow-up|5|||
105457511|NCT01400698|363685228|FG002|Overall Study|Lost to Follow-up|2|||
105457512|NCT01400698|363685229|FG003|Overall Study|Lost to Follow-up|1|||
105457513|NCT01400698|363685230|FG004|Overall Study|Lost to Follow-up|4|||
105457514|NCT01400698|363685231|FG005|Overall Study|Lost to Follow-up|3|||
105457515|NCT01400698|363685226|FG000|Overall Study|Withdrawal by Subject|8|||
105457516|NCT01400698|363685227|FG001|Overall Study|Withdrawal by Subject|2|||
105457517|NCT01400698|363685228|FG002|Overall Study|Withdrawal by Subject|0|||
105457518|NCT01400698|363685229|FG003|Overall Study|Withdrawal by Subject|4|||
105457519|NCT01400698|363685230|FG004|Overall Study|Withdrawal by Subject|1|||
105457520|NCT01400698|363685231|FG005|Overall Study|Withdrawal by Subject|3|||
105457521|NCT01400698|363685226|FG000|Overall Study|Protocol Violation|0|||
105457522|NCT01400698|363685227|FG001|Overall Study|Protocol Violation|1|||
105457523|NCT01400698|363685228|FG002|Overall Study|Protocol Violation|0|||
105457524|NCT01400698|363685229|FG003|Overall Study|Protocol Violation|0|||
105457525|NCT01400698|363685230|FG004|Overall Study|Protocol Violation|1|||
105457526|NCT01400698|363685231|FG005|Overall Study|Protocol Violation|0|||
105457527|NCT01400698|363685226|FG000|Overall Study|Non-compliance|0|||
105337736|NCT03613649|363236970|FG006|Fourth Treatment|Protocol Violation|0|||
105337737|NCT03613649|363236971|FG007|Fourth Treatment|Protocol Violation|0|||
105457528|NCT01400698|363685227|FG001|Overall Study|Non-compliance|1|||
105457529|NCT01400698|363685228|FG002|Overall Study|Non-compliance|0|||
105457530|NCT01400698|363685229|FG003|Overall Study|Non-compliance|1|||
105457531|NCT01400698|363685230|FG004|Overall Study|Non-compliance|0|||
105337738|NCT03613649|363236972|FG008|Fourth Treatment|Protocol Violation|0|||
105337739|NCT03613649|363236973|FG009|Fourth Treatment|Protocol Violation|0|||
105457532|NCT01400698|363685231|FG005|Overall Study|Non-compliance|0|||
105457533|NCT01400698|363685226|FG000|Overall Study|Adverse Event|1|||
105457534|NCT01400698|363685227|FG001|Overall Study|Adverse Event|0|||
105337740|NCT03613649|363236974|FG010|Fourth Treatment|Protocol Violation|0|||
105337741|NCT03613649|363236975|FG011|Fourth Treatment|Protocol Violation|0|||
105337742|NCT03613649|363236964|FG000|Fourth Treatment|Physician Decision|0|||
105337743|NCT03613649|363236965|FG001|Fourth Treatment|Physician Decision|0|||
105337744|NCT03613649|363236966|FG002|Fourth Treatment|Physician Decision|0|||
105457535|NCT01400698|363685228|FG002|Overall Study|Adverse Event|0|||
105457536|NCT01400698|363685229|FG003|Overall Study|Adverse Event|0|||
105457537|NCT01400698|363685230|FG004|Overall Study|Adverse Event|0|||
105457538|NCT01400698|363685231|FG005|Overall Study|Adverse Event|0|||
105457539|NCT01400698|363685226|FG000|Overall Study|Other|4|||
105457540|NCT01400698|363685227|FG001|Overall Study|Other|2|||
105457541|NCT01400698|363685228|FG002|Overall Study|Other|0|||
105457542|NCT01400698|363685229|FG003|Overall Study|Other|2|||
105457543|NCT01400698|363685230|FG004|Overall Study|Other|1|||
105457544|NCT01400698|363685231|FG005|Overall Study|Other|0|||
105457545|NCT05472090|363685232|FG000|Overall Study|Adverse Event|2|||
105457546|NCT05472090|363685233|FG001|Overall Study|Adverse Event|3|||
105457547|NCT05472090|363685232|FG000|Overall Study|Lack of Efficacy|1|||
105457548|NCT05472090|363685233|FG001|Overall Study|Lack of Efficacy|0|||
105457549|NCT05472090|363685232|FG000|Overall Study|Physician Decision|1|||
105457550|NCT05472090|363685233|FG001|Overall Study|Physician Decision|0|||
105457551|NCT05472090|363685232|FG000|Overall Study|Withdrawal by Subject|2|||
105457552|NCT05472090|363685233|FG001|Overall Study|Withdrawal by Subject|0|||
105457553|NCT05472090|363685232|FG000|Overall Study|Lost to Follow-up|0|||
105457554|NCT05472090|363685233|FG001|Overall Study|Lost to Follow-up|3|||
105457555|NCT00740220|363687092|FG000|Overall Study|screen failures (non-COPD patients)|9|||
105457556|NCT00812708|363687097|FG000|Overall Study|Device could not be implanted|2|||
105457557|NCT00812708|363687097|FG000|Overall Study|Lack of medical insurance|1|||
105457558|NCT00812708|363687097|FG000|Overall Study|Switched to another study|1|||
105457559|NCT00812708|363687097|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
105457560|NCT00812708|363687097|FG000|Overall Study|Signed consent but later withdrew|3|||
105457561|NCT01959503|363687098|FG000|Overall Study|Death|2|||
105457562|NCT01959503|363687099|FG001|Overall Study|Death|1|||
105457563|NCT01959503|363687098|FG000|Overall Study|Randomized but not treated|1|||
105457564|NCT01959503|363687099|FG001|Overall Study|Randomized but not treated|1|||
105457565|NCT04235140|363687108|FG000|Overall Study|Adverse Event|2|||
105457566|NCT04235140|363687108|FG000|Overall Study|Lost to Follow-up|1|||
105457567|NCT04235140|363687108|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
105457568|NCT04235140|363687108|FG000|Overall Study|Commercial drug is available for participants|7|||
105457569|NCT00672555|363687109|FG000|Overall Study|Lost to Follow-up|4|||
105457570|NCT00672555|363687109|FG000|Overall Study|Did not want to answer questionnaire|2|||
105457571|NCT00474487|363687110|FG000|Overall Study|Withdrawal by Subject|6|||
105457572|NCT00474487|363687111|FG001|Overall Study|Withdrawal by Subject|0|||
105457573|NCT00474487|363687112|FG002|Overall Study|Withdrawal by Subject|0|||
105457574|NCT00474487|363687113|FG003|Overall Study|Withdrawal by Subject|0|||
105457575|NCT00474487|363687110|FG000|Overall Study|Lost to Follow-up|20|||
105457576|NCT00474487|363687111|FG001|Overall Study|Lost to Follow-up|1|||
105457577|NCT00474487|363687112|FG002|Overall Study|Lost to Follow-up|7|||
105457578|NCT00474487|363687113|FG003|Overall Study|Lost to Follow-up|0|||
105457579|NCT00474487|363687110|FG000|Overall Study|Inappropriate enrollment|4|||
105457580|NCT00474487|363687111|FG001|Overall Study|Inappropriate enrollment|0|||
105457581|NCT00474487|363687112|FG002|Overall Study|Inappropriate enrollment|7|||
105457582|NCT00474487|363687113|FG003|Overall Study|Inappropriate enrollment|0|||
105457583|NCT00474487|363687110|FG000|Overall Study|Death|0|||
105457584|NCT00474487|363687111|FG001|Overall Study|Death|1|||
105457585|NCT00474487|363687112|FG002|Overall Study|Death|0|||
105457586|NCT00474487|363687113|FG003|Overall Study|Death|0|||
105457587|NCT02153086|363687117|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
105457588|NCT02153086|363687117|FG000|Overall Study|Other|2|||
105457589|NCT00248625|363687118|FG000|Overall Study|Withdrawal by Subject|0|||
105457590|NCT00248625|363687119|FG001|Overall Study|Withdrawal by Subject|2|||
105457591|NCT02182895|363687123|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
105457592|NCT02182895|363687124|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
105457593|NCT00836589|363687130|FG000|Overall Study|Lost to Follow-up|246|||
105457594|NCT00836589|363687130|FG000|Overall Study|Death|429|||
105457595|NCT00836589|363687130|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
105457596|NCT00074711|363687132|FG000|Overall Study|Withdrawal by Subject|1|||
105457597|NCT00074711|363687133|FG001|Overall Study|Withdrawal by Subject|1|||
105457598|NCT00074711|363687132|FG000|Overall Study|Lost to Follow-up|10|||
105457599|NCT00074711|363687133|FG001|Overall Study|Lost to Follow-up|8|||
105457600|NCT00074711|363687132|FG000|Overall Study|Participant stopped study drug|4|||
105457601|NCT00074711|363687133|FG001|Overall Study|Participant stopped study drug|6|||
105457602|NCT04201431|363687136|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
105457603|NCT04201431|363687137|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
105457604|NCT04201431|363687138|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
105457605|NCT04629508|363687139|FG000|Overall Study|Adverse Event|1|||
105457606|NCT04629508|363687139|FG000|Overall Study|Death|2|||
105457607|NCT04629508|363687139|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
105457608|NCT03253796|363687144|FG000|Period 1: Run-In|Adverse Event|4|||
105457609|NCT03253796|363687145|FG001|Period 1: Run-In|Adverse Event|0|||
105457610|NCT03253796|363687146|FG002|Period 1: Run-In|Adverse Event|0|||
105457611|NCT03253796|363687147|FG003|Period 1: Run-In|Adverse Event|0|||
105457612|NCT03253796|363687148|FG004|Period 1: Run-In|Adverse Event|0|||
105457613|NCT03253796|363687144|FG000|Period 1: Run-In|Lack of Efficacy|1|||
105457614|NCT03253796|363687145|FG001|Period 1: Run-In|Lack of Efficacy|0|||
105457615|NCT03253796|363687146|FG002|Period 1: Run-In|Lack of Efficacy|0|||
105457616|NCT03253796|363687147|FG003|Period 1: Run-In|Lack of Efficacy|0|||
105457617|NCT03253796|363687148|FG004|Period 1: Run-In|Lack of Efficacy|0|||
105457618|NCT03253796|363687144|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
105457619|NCT03253796|363687145|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
105457620|NCT03253796|363687146|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
105457621|NCT03253796|363687147|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
105457622|NCT03253796|363687148|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
105457623|NCT03253796|363687144|FG000|Period 1: Run-In|Protocol Violation|5|||
105457624|NCT03253796|363687145|FG001|Period 1: Run-In|Protocol Violation|0|||
105457625|NCT03253796|363687146|FG002|Period 1: Run-In|Protocol Violation|0|||
105457626|NCT03253796|363687147|FG003|Period 1: Run-In|Protocol Violation|0|||
105457627|NCT03253796|363687148|FG004|Period 1: Run-In|Protocol Violation|0|||
105457628|NCT03253796|363687144|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
105457629|NCT03253796|363687145|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
105457630|NCT03253796|363687146|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
105457631|NCT03253796|363687147|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
105457632|NCT03253796|363687148|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
105457633|NCT03253796|363687144|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
105457634|NCT03253796|363687145|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
105457635|NCT03253796|363687146|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
105457636|NCT03253796|363687147|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
105457637|NCT03253796|363687148|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
105457638|NCT03253796|363687144|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
105457639|NCT03253796|363687145|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
105457640|NCT03253796|363687146|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
105457641|NCT03253796|363687147|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
105457642|NCT03253796|363687148|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
105457643|NCT03253796|363687144|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
105457644|NCT03253796|363687145|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
105457645|NCT03253796|363687146|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
105457646|NCT03253796|363687147|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
105457647|NCT03253796|363687148|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
105457648|NCT03253796|363687144|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
105457649|NCT03253796|363687145|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
105457650|NCT03253796|363687146|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
105457651|NCT03253796|363687147|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
105457652|NCT03253796|363687148|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
105457653|NCT03253796|363687144|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
105457654|NCT03253796|363687145|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
105457655|NCT03253796|363687146|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
105457656|NCT03253796|363687147|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
105457657|NCT03253796|363687148|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
105457658|NCT03253796|363687144|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
105457659|NCT03253796|363687145|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
105457660|NCT03253796|363687146|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
105457661|NCT03253796|363687147|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
105457662|NCT03253796|363687148|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
105457663|NCT02163538|363687151|FG000|Overall Study|Protocol Violation|1|||
105457664|NCT02163538|363687152|FG001|Overall Study|Protocol Violation|0|||
105457665|NCT02163538|363687151|FG000|Overall Study|Physician Decision|0|||
105457666|NCT02163538|363687152|FG001|Overall Study|Physician Decision|1|||
105457667|NCT01056822|363687162|FG000|Overall Study|Adverse Event|0|||
105457668|NCT01056822|363687163|FG001|Overall Study|Adverse Event|1|||
105457669|NCT01056822|363687162|FG000|Overall Study|Protocol Violation|6|||
105457670|NCT01056822|363687163|FG001|Overall Study|Protocol Violation|5|||
105457671|NCT01056822|363687162|FG000|Overall Study|Withdrawal by Subject|1|||
105457672|NCT01056822|363687163|FG001|Overall Study|Withdrawal by Subject|1|||
105457673|NCT01056822|363687162|FG000|Overall Study|Lost to Follow-up|1|||
105457674|NCT01056822|363687163|FG001|Overall Study|Lost to Follow-up|0|||
105457675|NCT02761330|363687169|FG000|Treatment Week 1|Withdrawal by Subject|0|||
105457676|NCT02761330|363687170|FG001|Treatment Week 1|Withdrawal by Subject|0|||
105457677|NCT02761330|363687171|FG002|Treatment Week 1|Withdrawal by Subject|0|||
105457678|NCT02761330|363687172|FG003|Treatment Week 1|Withdrawal by Subject|1|||
105457679|NCT02761330|363687173|FG004|Treatment Week 1|Withdrawal by Subject|0|||
105457680|NCT02761330|363687174|FG005|Treatment Week 1|Withdrawal by Subject|1|||
105457681|NCT03043313|363687177|FG000|Overall Study|Withdrawal by Subject|5|||
105457682|NCT03043313|363687178|FG001|Overall Study|Withdrawal by Subject|1|||
105457683|NCT03043313|363687179|FG002|Overall Study|Withdrawal by Subject|1|||
105457684|NCT03043313|363687177|FG000|Overall Study|Lost to Follow-up|1|||
105457685|NCT03043313|363687178|FG001|Overall Study|Lost to Follow-up|1|||
105457686|NCT03043313|363687179|FG002|Overall Study|Lost to Follow-up|0|||
105457687|NCT03043313|363687177|FG000|Overall Study|Death|28|||
105457688|NCT03043313|363687178|FG001|Overall Study|Death|26|||
105457689|NCT03043313|363687179|FG002|Overall Study|Death|17|||
105457690|NCT03043313|363687177|FG000|Overall Study|Participation terminated by sponsor|11|||
105457691|NCT03043313|363687178|FG001|Overall Study|Participation terminated by sponsor|13|||
105457692|NCT03043313|363687179|FG002|Overall Study|Participation terminated by sponsor|13|||
105457693|NCT00980954|363687180|FG000|Overall Study|Protocol Violation|9|||
105457694|NCT00980954|363687181|FG001|Overall Study|Protocol Violation|15|||
105457695|NCT00849940|363687182|FG000|Overall Study|Physician Decision|4|||
105457696|NCT04292535|363687187|FG000|Overall Study|Withdrawal by Subject|0|||
105457697|NCT04292535|363687188|FG001|Overall Study|Withdrawal by Subject|0|||
105457698|NCT04292535|363687189|FG002|Overall Study|Withdrawal by Subject|0|||
105457699|NCT04292535|363687190|FG003|Overall Study|Withdrawal by Subject|0|||
105457700|NCT04292535|363687191|FG004|Overall Study|Withdrawal by Subject|0|||
105457701|NCT04292535|363687192|FG005|Overall Study|Withdrawal by Subject|0|||
105457702|NCT04292535|363687193|FG006|Overall Study|Withdrawal by Subject|0|||
105457703|NCT04292535|363687194|FG007|Overall Study|Withdrawal by Subject|1|||
105457704|NCT04292535|363687195|FG008|Overall Study|Withdrawal by Subject|0|||
105457705|NCT04292535|363687196|FG009|Overall Study|Withdrawal by Subject|0|||
105457706|NCT04292535|363687197|FG010|Overall Study|Withdrawal by Subject|0|||
105457707|NCT04292535|363687198|FG011|Overall Study|Withdrawal by Subject|0|||
105457708|NCT04292535|363687199|FG012|Overall Study|Withdrawal by Subject|0|||
105457709|NCT04292535|363687200|FG013|Overall Study|Withdrawal by Subject|0|||
105457710|NCT04292535|363687187|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105457711|NCT04292535|363687188|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105457712|NCT04292535|363687189|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105457713|NCT04292535|363687190|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105457714|NCT04292535|363687191|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105457715|NCT04292535|363687192|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105457716|NCT04292535|363687193|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105457717|NCT04292535|363687194|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
105457718|NCT04292535|363687195|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105457719|NCT04292535|363687196|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105457720|NCT04292535|363687197|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105457721|NCT04292535|363687198|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105457722|NCT04292535|363687199|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
105457723|NCT04292535|363687200|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
105457724|NCT04292535|363687187|FG000|Overall Study|Report of Dizziness|0|||
105457725|NCT04292535|363687188|FG001|Overall Study|Report of Dizziness|0|||
105457726|NCT04292535|363687189|FG002|Overall Study|Report of Dizziness|0|||
105457727|NCT04292535|363687190|FG003|Overall Study|Report of Dizziness|0|||
105337745|NCT03613649|363236967|FG003|Fourth Treatment|Physician Decision|0|||
105337746|NCT03613649|363236968|FG004|Fourth Treatment|Physician Decision|0|||
105337747|NCT03613649|363236969|FG005|Fourth Treatment|Physician Decision|0|||
105337748|NCT03613649|363236970|FG006|Fourth Treatment|Physician Decision|1|||
105337749|NCT03613649|363236971|FG007|Fourth Treatment|Physician Decision|0|||
105337750|NCT03613649|363236972|FG008|Fourth Treatment|Physician Decision|0|||
105337751|NCT03613649|363236973|FG009|Fourth Treatment|Physician Decision|0|||
105337752|NCT03613649|363236974|FG010|Fourth Treatment|Physician Decision|0|||
105337753|NCT03613649|363236975|FG011|Fourth Treatment|Physician Decision|0|||
105337754|NCT01880086|363236977|FG000|Overall Study|Lost to Follow-up|1|||
105337755|NCT01880086|363236978|FG001|Overall Study|Lost to Follow-up|1|||
105337756|NCT03429244|363236981|FG000|Overall Study|Withdrawal by Subject|2|||
105337757|NCT03429244|363236982|FG001|Overall Study|Withdrawal by Subject|1|||
105337758|NCT03429244|363236983|FG002|Overall Study|Withdrawal by Subject|1|||
105337759|NCT01500187|363236985|FG000|Overall Study|Lost to Follow-up|6|||
105457728|NCT04292535|363687191|FG004|Overall Study|Report of Dizziness|0|||
105457729|NCT04292535|363687192|FG005|Overall Study|Report of Dizziness|0|||
105457730|NCT04292535|363687193|FG006|Overall Study|Report of Dizziness|0|||
105457731|NCT04292535|363687194|FG007|Overall Study|Report of Dizziness|0|||
105457732|NCT04292535|363687195|FG008|Overall Study|Report of Dizziness|0|||
105457733|NCT04292535|363687196|FG009|Overall Study|Report of Dizziness|0|||
105457734|NCT04292535|363687197|FG010|Overall Study|Report of Dizziness|0|||
105457735|NCT04292535|363687198|FG011|Overall Study|Report of Dizziness|0|||
105337760|NCT01500187|363236986|FG001|Overall Study|Lost to Follow-up|0|||
105457736|NCT04292535|363687199|FG012|Overall Study|Report of Dizziness|0|||
105457737|NCT04292535|363687200|FG013|Overall Study|Report of Dizziness|1|||
105457738|NCT04292535|363687187|FG000|Overall Study|Equipment Failure|0|||
105457739|NCT04292535|363687188|FG001|Overall Study|Equipment Failure|0|||
105457740|NCT04292535|363687189|FG002|Overall Study|Equipment Failure|0|||
105457741|NCT04292535|363687190|FG003|Overall Study|Equipment Failure|0|||
105457742|NCT04292535|363687191|FG004|Overall Study|Equipment Failure|0|||
105457743|NCT04292535|363687192|FG005|Overall Study|Equipment Failure|0|||
105457744|NCT04292535|363687193|FG006|Overall Study|Equipment Failure|0|||
105457745|NCT04292535|363687194|FG007|Overall Study|Equipment Failure|0|||
105457746|NCT04292535|363687195|FG008|Overall Study|Equipment Failure|0|||
105457747|NCT04292535|363687196|FG009|Overall Study|Equipment Failure|0|||
105457748|NCT04292535|363687197|FG010|Overall Study|Equipment Failure|0|||
105337761|NCT03843632|363236987|FG000|Overall Study|Withdrawal by Subject|1|||
105337762|NCT03843632|363236988|FG001|Overall Study|Withdrawal by Subject|0|||
105337763|NCT03843632|363236989|FG002|Overall Study|Withdrawal by Subject|0|||
105337764|NCT03843632|363236990|FG003|Overall Study|Withdrawal by Subject|0|||
105337765|NCT00595517|363236991|FG000|Overall Study|Adverse Event|6|||
105337766|NCT00595517|363236991|FG000|Overall Study|Withdrawal by Subject|4|||
105337767|NCT00595517|363236991|FG000|Overall Study|Protocol Violation|2|||
105337768|NCT00595517|363236991|FG000|Overall Study|Recurrence of ulcer|5|||
105337769|NCT00595517|363236991|FG000|Overall Study|usage of prohibited treatment|1|||
105337770|NCT00595517|363236991|FG000|Overall Study|No intention to attend regularly|1|||
105337771|NCT01992653|363237000|FG000|Overall Study|Death|0|||
105337772|NCT01992653|363237001|FG001|Overall Study|Death|0|||
105337773|NCT01992653|363237002|FG002|Overall Study|Death|1|||
105337774|NCT01992653|363237003|FG003|Overall Study|Death|0|||
105337775|NCT01992653|363237004|FG004|Overall Study|Death|1|||
105337776|NCT01992653|363237005|FG005|Overall Study|Death|0|||
105337777|NCT01992653|363237006|FG006|Overall Study|Death|4|||
105337778|NCT01992653|363237007|FG007|Overall Study|Death|2|||
105337779|NCT01992653|363237000|FG000|Overall Study|Lost to Follow-up|0|||
105337780|NCT01992653|363237001|FG001|Overall Study|Lost to Follow-up|0|||
105337781|NCT01992653|363237002|FG002|Overall Study|Lost to Follow-up|0|||
105337782|NCT01992653|363237003|FG003|Overall Study|Lost to Follow-up|0|||
105337783|NCT01992653|363237004|FG004|Overall Study|Lost to Follow-up|0|||
105337784|NCT01992653|363237005|FG005|Overall Study|Lost to Follow-up|0|||
105337785|NCT01992653|363237006|FG006|Overall Study|Lost to Follow-up|0|||
105337786|NCT01992653|363237007|FG007|Overall Study|Lost to Follow-up|1|||
105457749|NCT04292535|363687198|FG011|Overall Study|Equipment Failure|1|||
105457750|NCT04292535|363687199|FG012|Overall Study|Equipment Failure|0|||
105457751|NCT04292535|363687200|FG013|Overall Study|Equipment Failure|0|||
105457752|NCT03605667|363687201|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
105457753|NCT03605667|363687202|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
105457754|NCT03605667|363687201|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
105457755|NCT03605667|363687202|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
105457756|NCT03605667|363687201|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
105457757|NCT03605667|363687202|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
105457758|NCT03605667|363687201|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
105457759|NCT03605667|363687202|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
105457760|NCT03605667|363687201|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
105457761|NCT03605667|363687202|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
105457762|NCT03605667|363687201|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
105457763|NCT03605667|363687202|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
105457764|NCT03605667|363687201|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
105457765|NCT03605667|363687202|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
105457766|NCT03605667|363687201|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
105457767|NCT03605667|363687202|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
105457768|NCT03605667|363687201|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
105457769|NCT03605667|363687202|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
105457770|NCT03605667|363687201|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
105457771|NCT03605667|363687202|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
105457772|NCT03605667|363687201|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
105457773|NCT03605667|363687202|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
105457774|NCT03605667|363687201|FG000|OLE Phase (48 Weeks)|Other|6|||
105337787|NCT01992653|363237000|FG000|Overall Study|Study Completed|0|||
105337788|NCT01992653|363237001|FG001|Overall Study|Study Completed|0|||
105337789|NCT01992653|363237002|FG002|Overall Study|Study Completed|0|||
105337790|NCT01992653|363237003|FG003|Overall Study|Study Completed|0|||
105337791|NCT01992653|363237004|FG004|Overall Study|Study Completed|0|||
105337792|NCT01992653|363237005|FG005|Overall Study|Study Completed|0|||
105337793|NCT01992653|363237006|FG006|Overall Study|Study Completed|0|||
105337794|NCT01992653|363237007|FG007|Overall Study|Study Completed|1|||
105337795|NCT01992653|363237000|FG000|Overall Study|Disease Progression|0|||
105337796|NCT01992653|363237001|FG001|Overall Study|Disease Progression|0|||
105337797|NCT01992653|363237002|FG002|Overall Study|Disease Progression|0|||
105457775|NCT03605667|363687202|FG001|OLE Phase (48 Weeks)|Other|8|||
105457776|NCT03605667|363687201|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
105457777|NCT03605667|363687202|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
105457778|NCT03605667|363687201|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
105457779|NCT03605667|363687202|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
105457780|NCT03605667|363687201|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
105457781|NCT03605667|363687202|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
105457782|NCT03605667|363687201|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
105457783|NCT03605667|363687202|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
105457784|NCT03605667|363687201|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
105457785|NCT03605667|363687202|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
105457786|NCT03605667|363687201|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
105457787|NCT03605667|363687202|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
105457788|NCT03605667|363687201|FG000|OLE Phase (48 Weeks)|Death|0|||
105457789|NCT03605667|363687202|FG001|OLE Phase (48 Weeks)|Death|2|||
105457790|NCT03605667|363687201|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
105457791|NCT03605667|363687202|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
105457792|NCT04528641|363687203|FG000|Overall Study|Withdrawal by Subject|0|||
105457793|NCT04528641|363687204|FG001|Overall Study|Withdrawal by Subject|0|||
105457794|NCT04528641|363687205|FG002|Overall Study|Withdrawal by Subject|0|||
105457795|NCT04528641|363687206|FG003|Overall Study|Withdrawal by Subject|1|||
105457796|NCT04528641|363687207|FG004|Overall Study|Withdrawal by Subject|0|||
105457797|NCT04528641|363687208|FG005|Overall Study|Withdrawal by Subject|1|||
105457798|NCT04607005|363687209|FG000|Overall Study|Adverse Event|0|||
105457799|NCT04607005|363687210|FG001|Overall Study|Adverse Event|1|||
105457800|NCT04607005|363687209|FG000|Overall Study|Lack of Efficacy|1|||
105457801|NCT04607005|363687210|FG001|Overall Study|Lack of Efficacy|6|||
105457802|NCT04607005|363687209|FG000|Overall Study|Withdrawal by Subject|4|||
105457803|NCT04607005|363687210|FG001|Overall Study|Withdrawal by Subject|9|||
105457804|NCT04607005|363687209|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
105457805|NCT04607005|363687210|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
105457806|NCT04886154|363687211|FG000|Overall Study|Adverse Event|0|||
105457807|NCT04886154|363687212|FG001|Overall Study|Adverse Event|0|||
105457808|NCT04886154|363687213|FG002|Overall Study|Adverse Event|0|||
105457809|NCT04886154|363687214|FG003|Overall Study|Adverse Event|0|||
105457810|NCT04886154|363687215|FG004|Overall Study|Adverse Event|1|||
105457811|NCT04886154|363687216|FG005|Overall Study|Adverse Event|0|||
105457812|NCT04886154|363687217|FG006|Overall Study|Adverse Event|0|||
105457813|NCT04886154|363687218|FG007|Overall Study|Adverse Event|1|||
105457814|NCT04886154|363687219|FG008|Overall Study|Adverse Event|1|||
105457815|NCT04886154|363687220|FG009|Overall Study|Adverse Event|0|||
105457816|NCT04886154|363687221|FG010|Overall Study|Adverse Event|0|||
105457817|NCT04886154|363687222|FG011|Overall Study|Adverse Event|1|||
105457818|NCT04886154|363687223|FG012|Overall Study|Adverse Event|0|||
105457819|NCT04886154|363687224|FG013|Overall Study|Adverse Event|0|||
105457820|NCT04886154|363687225|FG014|Overall Study|Adverse Event|3|||
105457821|NCT04886154|363687211|FG000|Overall Study|Lost to Follow-up|1|||
105457822|NCT04886154|363687212|FG001|Overall Study|Lost to Follow-up|0|||
105457823|NCT04886154|363687213|FG002|Overall Study|Lost to Follow-up|2|||
105457824|NCT04886154|363687214|FG003|Overall Study|Lost to Follow-up|0|||
105457825|NCT04886154|363687215|FG004|Overall Study|Lost to Follow-up|17|||
105457826|NCT04886154|363687216|FG005|Overall Study|Lost to Follow-up|7|||
105457827|NCT04886154|363687217|FG006|Overall Study|Lost to Follow-up|8|||
105457828|NCT04886154|363687218|FG007|Overall Study|Lost to Follow-up|7|||
105457829|NCT04886154|363687219|FG008|Overall Study|Lost to Follow-up|8|||
105457830|NCT04886154|363687220|FG009|Overall Study|Lost to Follow-up|0|||
105457831|NCT04886154|363687221|FG010|Overall Study|Lost to Follow-up|2|||
105457832|NCT04886154|363687222|FG011|Overall Study|Lost to Follow-up|0|||
105457833|NCT04886154|363687223|FG012|Overall Study|Lost to Follow-up|0|||
105457834|NCT04886154|363687224|FG013|Overall Study|Lost to Follow-up|0|||
105457835|NCT04886154|363687225|FG014|Overall Study|Lost to Follow-up|0|||
105457836|NCT04886154|363687211|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105457837|NCT04886154|363687212|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105457838|NCT04886154|363687213|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105457839|NCT04886154|363687214|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105457840|NCT04886154|363687215|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105457841|NCT04886154|363687216|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105457842|NCT04886154|363687217|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
105457843|NCT04886154|363687218|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105457844|NCT04886154|363687219|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105457845|NCT04886154|363687220|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105457846|NCT04886154|363687221|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105457847|NCT04886154|363687222|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105457848|NCT04886154|363687223|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105457849|NCT04886154|363687224|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105457850|NCT04886154|363687225|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105457851|NCT04886154|363687211|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105457852|NCT04886154|363687212|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105457853|NCT04886154|363687213|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105457854|NCT04886154|363687214|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105457855|NCT04886154|363687215|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105457856|NCT04886154|363687216|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105457857|NCT04886154|363687217|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
105457858|NCT04886154|363687218|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105457859|NCT04886154|363687219|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105457860|NCT04886154|363687220|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105457861|NCT04886154|363687221|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105457862|NCT04886154|363687222|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105457863|NCT04886154|363687223|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105457864|NCT04886154|363687224|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105457865|NCT04886154|363687225|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105457866|NCT04886154|363687211|FG000|Overall Study|Other, Not Specified|0|||
105457867|NCT04886154|363687212|FG001|Overall Study|Other, Not Specified|0|||
105457868|NCT04886154|363687213|FG002|Overall Study|Other, Not Specified|0|||
105457869|NCT04886154|363687214|FG003|Overall Study|Other, Not Specified|0|||
105457870|NCT04886154|363687215|FG004|Overall Study|Other, Not Specified|11|||
105457871|NCT04886154|363687216|FG005|Overall Study|Other, Not Specified|8|||
105457872|NCT04886154|363687217|FG006|Overall Study|Other, Not Specified|9|||
105457873|NCT04886154|363687218|FG007|Overall Study|Other, Not Specified|10|||
105457874|NCT04886154|363687219|FG008|Overall Study|Other, Not Specified|6|||
105457875|NCT04886154|363687220|FG009|Overall Study|Other, Not Specified|1|||
105457876|NCT04886154|363687221|FG010|Overall Study|Other, Not Specified|1|||
105457877|NCT04886154|363687222|FG011|Overall Study|Other, Not Specified|2|||
105457878|NCT04886154|363687223|FG012|Overall Study|Other, Not Specified|1|||
105457879|NCT04886154|363687224|FG013|Overall Study|Other, Not Specified|2|||
105457880|NCT04886154|363687225|FG014|Overall Study|Other, Not Specified|3|||
105457881|NCT00668148|363687230|FG000|Overall Study|Adverse Event|5|||
105457882|NCT00668148|363687230|FG000|Overall Study|Subject Non-compliance|1|||
105457883|NCT00668148|363687230|FG000|Overall Study|Progressive Disease Before Treatment|2|||
105457884|NCT00668148|363687230|FG000|Overall Study|Withdrawal of Consent|2|||
105457885|NCT03253393|363687231|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
105457886|NCT03253393|363687232|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
105457887|NCT03253393|363687233|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
105457888|NCT00446849|363689060|FG000|Acute Phase|Lack of Efficacy|64|||
105661753|NCT01068210|364425130|FG000|Overall Study|Second cancer|0|||
105337798|NCT01992653|363237003|FG003|Overall Study|Disease Progression|0|||
105337799|NCT01992653|363237004|FG004|Overall Study|Disease Progression|0|||
105337800|NCT01992653|363237005|FG005|Overall Study|Disease Progression|0|||
105337801|NCT01992653|363237006|FG006|Overall Study|Disease Progression|4|||
105337802|NCT01992653|363237007|FG007|Overall Study|Disease Progression|0|||
105337803|NCT00977314|363237008|FG000|Overall Study|Withdrawal by Subject|1|||
105337804|NCT00977314|363237009|FG001|Overall Study|Withdrawal by Subject|0|||
105337805|NCT00977314|363237008|FG000|Overall Study|Physician Decision|1|||
105337806|NCT00977314|363237009|FG001|Overall Study|Physician Decision|0|||
105337807|NCT02537431|363237011|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
105337808|NCT01817582|363237016|FG000|Overall Study|Withdrawal by Subject|0|||
105337809|NCT01817582|363237017|FG001|Overall Study|Withdrawal by Subject|1|||
105337810|NCT01817582|363237018|FG002|Overall Study|Withdrawal by Subject|0|||
105337811|NCT01817582|363237016|FG000|Overall Study|Participant revealed masked treatment|1|||
105337812|NCT01817582|363237017|FG001|Overall Study|Participant revealed masked treatment|0|||
105337813|NCT01817582|363237018|FG002|Overall Study|Participant revealed masked treatment|0|||
105337814|NCT01817582|363237016|FG000|Overall Study|Randomized but exclusion criteria met|1|||
105337815|NCT01817582|363237017|FG001|Overall Study|Randomized but exclusion criteria met|0|||
105337816|NCT01817582|363237018|FG002|Overall Study|Randomized but exclusion criteria met|0|||
105337817|NCT01294696|363237021|FG000|Overall Study|Screening failures|7|||
105337818|NCT01294696|363237021|FG000|Overall Study|Protocol Violation|8|||
105337819|NCT01294696|363237021|FG000|Overall Study|Missing BPI Response|7|||
105337820|NCT01294696|363237021|FG000|Overall Study|Site closure|52|||
105337821|NCT01190410|363239109|FG000|Overall Study|Adverse Event|0|||
105337822|NCT01190410|363239110|FG001|Overall Study|Adverse Event|3|||
105337823|NCT01190410|363239109|FG000|Overall Study|Lack of Efficacy|0|||
105337824|NCT01190410|363239110|FG001|Overall Study|Lack of Efficacy|2|||
105337825|NCT01190410|363239109|FG000|Overall Study|Withdrawal by Subject|0|||
105337826|NCT01190410|363239110|FG001|Overall Study|Withdrawal by Subject|2|||
105337827|NCT01190410|363239109|FG000|Overall Study|Administrative decision|1|||
105337828|NCT01190410|363239110|FG001|Overall Study|Administrative decision|0|||
105337829|NCT01190410|363239109|FG000|Overall Study|PI discretion|0|||
105337830|NCT01190410|363239110|FG001|Overall Study|PI discretion|2|||
105337831|NCT01399047|363239111|FG000|Overall Study|Withdrawal by Subject|0|||
105457889|NCT00446849|363689060|FG000|Acute Phase|Protocol Violation|10|||
105457890|NCT00446849|363689060|FG000|Acute Phase|Consent withdrawn|4|||
105457891|NCT00446849|363689060|FG000|Acute Phase|Lost to Follow-up|2|||
105457892|NCT00446849|363689060|FG000|Acute Phase|Physician Decision|1|||
105457893|NCT00446849|363689060|FG000|Acute Phase|noncompliance|1|||
105457894|NCT00446849|363689060|FG000|Maintenance Phase|Lack of Efficacy|40|||
105457895|NCT00446849|363689060|FG000|Maintenance Phase|Protocol Violation|7|||
105457896|NCT00446849|363689060|FG000|Maintenance Phase|Adverse Event|6|||
105457897|NCT00446849|363689060|FG000|Maintenance Phase|Consent withdrawn|5|||
105457898|NCT00446849|363689060|FG000|Maintenance Phase|Lost to Follow-up|3|||
105457899|NCT00446849|363689060|FG000|Maintenance Phase|Pregnancy|1|||
105457900|NCT00446849|363689060|FG000|Maintenance Phase|noncompliance|2|||
105457901|NCT00446849|363689060|FG000|Maintenance Phase|prohibited medication use|2|||
105457902|NCT00446849|363689060|FG000|Maintenance Phase|antibiotic use|1|||
105457903|NCT00446849|363689060|FG000|Maintenance Phase|study closure|1|||
105457904|NCT00446849|363689060|FG000|Maintenance Phase|hydrocodone use|1|||
105457905|NCT00446849|363689060|FG000|Maintenance Phase|concomitant medication use|1|||
105457906|NCT02443688|363689061|FG000|Overall Study|Adverse Event|2|||
105457907|NCT02443688|363689062|FG001|Overall Study|Adverse Event|3|||
105337832|NCT01399047|363239112|FG001|Overall Study|Withdrawal by Subject|1|||
105337833|NCT03652636|363239121|FG000|Overall Study|Withdrawal by Subject|7|||
105337834|NCT01397786|363239122|FG000|Phase A|Lost to Follow-up|0|||
105337835|NCT01397786|363239123|FG001|Phase A|Lost to Follow-up|0|||
105337836|NCT01397786|363239124|FG002|Phase A|Lost to Follow-up|6|||
105337837|NCT01397786|363239122|FG000|Phase A|Adverse Event|0|||
105337838|NCT01397786|363239123|FG001|Phase A|Adverse Event|0|||
105457908|NCT02443688|363689063|FG002|Overall Study|Adverse Event|2|||
105457909|NCT02443688|363689061|FG000|Overall Study|Lost to Follow-up|1|||
105337839|NCT01397786|363239124|FG002|Phase A|Adverse Event|8|||
105337840|NCT01397786|363239122|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
105337841|NCT01397786|363239123|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
105337842|NCT01397786|363239124|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
105337843|NCT01397786|363239122|FG000|Phase A|Physician Decision|0|||
105337844|NCT01397786|363239123|FG001|Phase A|Physician Decision|0|||
105337845|NCT01397786|363239124|FG002|Phase A|Physician Decision|1|||
105337846|NCT01397786|363239122|FG000|Phase A|Withdrawal by Subject|0|||
105457910|NCT02443688|363689062|FG001|Overall Study|Lost to Follow-up|0|||
105457911|NCT02443688|363689063|FG002|Overall Study|Lost to Follow-up|0|||
105457912|NCT02443688|363689061|FG000|Overall Study|Physician Decision|3|||
105337847|NCT01397786|363239123|FG001|Phase A|Withdrawal by Subject|0|||
105337848|NCT01397786|363239124|FG002|Phase A|Withdrawal by Subject|5|||
105457913|NCT02443688|363689062|FG001|Overall Study|Physician Decision|0|||
105457914|NCT02443688|363689063|FG002|Overall Study|Physician Decision|1|||
105457915|NCT02443688|363689061|FG000|Overall Study|Pregnancy|0|||
105337849|NCT01397786|363239122|FG000|Phase A|Lack of Efficacy|0|||
105337850|NCT01397786|363239123|FG001|Phase A|Lack of Efficacy|0|||
105457916|NCT02443688|363689062|FG001|Overall Study|Pregnancy|0|||
105457917|NCT02443688|363689063|FG002|Overall Study|Pregnancy|1|||
105457918|NCT02443688|363689061|FG000|Overall Study|Withdrawal by Subject|3|||
105457919|NCT02443688|363689062|FG001|Overall Study|Withdrawal by Subject|3|||
105457920|NCT02443688|363689063|FG002|Overall Study|Withdrawal by Subject|4|||
105457921|NCT02443688|363689061|FG000|Overall Study|Non-compliance with study drug|1|||
105457922|NCT02443688|363689062|FG001|Overall Study|Non-compliance with study drug|2|||
105457923|NCT02443688|363689063|FG002|Overall Study|Non-compliance with study drug|4|||
105457924|NCT02443688|363689061|FG000|Overall Study|Sponsor Request|2|||
105457925|NCT02443688|363689062|FG001|Overall Study|Sponsor Request|1|||
105457926|NCT02443688|363689063|FG002|Overall Study|Sponsor Request|0|||
105457927|NCT01317472|363689066|FG000|Overall Study|Withdrawal by Subject|1|||
105457928|NCT01317472|363689067|FG001|Overall Study|Withdrawal by Subject|0|||
105457929|NCT01317472|363689066|FG000|Overall Study|Unrelated hospitalization|1|||
105457930|NCT01317472|363689067|FG001|Overall Study|Unrelated hospitalization|0|||
105457931|NCT01815918|363689068|FG000|Overall Study|Patient samples not analyzable|3|||
105457932|NCT01815918|363689069|FG001|Overall Study|Patient samples not analyzable|4|||
105457933|NCT01815918|363689068|FG000|Overall Study|Lack of Efficacy|15|||
105457934|NCT01815918|363689069|FG001|Overall Study|Lack of Efficacy|15|||
105457935|NCT05546476|363689071|FG000|Period 1: Part A|Adverse Event|2|||
105457936|NCT05546476|363689072|FG001|Period 1: Part A|Adverse Event|0|||
105337851|NCT01397786|363239124|FG002|Phase A|Lack of Efficacy|1|||
105337852|NCT01397786|363239122|FG000|Phase B|Lost to Follow-up|22|||
105337853|NCT01397786|363239123|FG001|Phase B|Lost to Follow-up|12|||
105337854|NCT01397786|363239124|FG002|Phase B|Lost to Follow-up|22|||
105337855|NCT01397786|363239122|FG000|Phase B|Adverse Event|109|||
105337856|NCT01397786|363239123|FG001|Phase B|Adverse Event|23|||
105337857|NCT01397786|363239124|FG002|Phase B|Adverse Event|27|||
105337858|NCT01397786|363239122|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
105337859|NCT01397786|363239123|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
105337860|NCT01397786|363239124|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
105337861|NCT01397786|363239122|FG000|Phase B|Physician Decision|9|||
105337862|NCT01397786|363239123|FG001|Phase B|Physician Decision|1|||
105337863|NCT01397786|363239124|FG002|Phase B|Physician Decision|3|||
105337864|NCT01397786|363239122|FG000|Phase B|Withdrawal by Subject|102|||
105337865|NCT01397786|363239123|FG001|Phase B|Withdrawal by Subject|45|||
105337866|NCT01397786|363239124|FG002|Phase B|Withdrawal by Subject|30|||
105337867|NCT01397786|363239122|FG000|Phase B|Protocol Deviation|1|||
105337868|NCT01397786|363239123|FG001|Phase B|Protocol Deviation|2|||
105337869|NCT01397786|363239124|FG002|Phase B|Protocol Deviation|4|||
105337870|NCT01397786|363239122|FG000|Phase B|Lack of Efficacy|22|||
105337871|NCT01397786|363239123|FG001|Phase B|Lack of Efficacy|7|||
105337872|NCT01397786|363239124|FG002|Phase B|Lack of Efficacy|14|||
105337873|NCT02836236|363239131|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
105337874|NCT02836236|363239132|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
105337875|NCT02836236|363239133|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
105337876|NCT02836236|363239134|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
105337877|NCT02836236|363239131|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
105337878|NCT02836236|363239132|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
105457937|NCT05546476|363689073|FG002|Period 1: Part A|Adverse Event|0|||
105457938|NCT05546476|363689074|FG003|Period 1: Part A|Adverse Event|1|||
105457939|NCT05546476|363689071|FG000|Period 1: Part A|Death|4|||
105457940|NCT05546476|363689072|FG001|Period 1: Part A|Death|4|||
105457941|NCT05546476|363689073|FG002|Period 1: Part A|Death|5|||
105457942|NCT05546476|363689074|FG003|Period 1: Part A|Death|6|||
105457943|NCT05546476|363689071|FG000|Period 1: Part A|Lack of Efficacy|0|||
105457944|NCT05546476|363689072|FG001|Period 1: Part A|Lack of Efficacy|0|||
105457945|NCT05546476|363689073|FG002|Period 1: Part A|Lack of Efficacy|0|||
105457946|NCT05546476|363689074|FG003|Period 1: Part A|Lack of Efficacy|1|||
105457947|NCT05546476|363689071|FG000|Period 1: Part A|Lost to Follow-up|0|||
105457948|NCT05546476|363689072|FG001|Period 1: Part A|Lost to Follow-up|0|||
105457949|NCT05546476|363689073|FG002|Period 1: Part A|Lost to Follow-up|0|||
105457950|NCT05546476|363689074|FG003|Period 1: Part A|Lost to Follow-up|1|||
105457951|NCT05546476|363689071|FG000|Period 1: Part A|Physician Decision|1|||
105457952|NCT05546476|363689072|FG001|Period 1: Part A|Physician Decision|0|||
105457953|NCT05546476|363689073|FG002|Period 1: Part A|Physician Decision|0|||
105337879|NCT02836236|363239133|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
105337880|NCT02836236|363239134|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
105457954|NCT05546476|363689074|FG003|Period 1: Part A|Physician Decision|0|||
105337881|NCT02836236|363239131|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
105337882|NCT02836236|363239132|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
105337883|NCT02836236|363239133|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
105337884|NCT02836236|363239134|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
105457955|NCT05546476|363689071|FG000|Period 1: Part A|Progressive disease|3|||
105457956|NCT05546476|363689072|FG001|Period 1: Part A|Progressive disease|5|||
105457957|NCT05546476|363689073|FG002|Period 1: Part A|Progressive disease|0|||
105457958|NCT05546476|363689074|FG003|Period 1: Part A|Progressive disease|1|||
105457959|NCT05546476|363689071|FG000|Period 1: Part A|Withdrawal by Subject|1|||
105457960|NCT05546476|363689072|FG001|Period 1: Part A|Withdrawal by Subject|1|||
105457961|NCT05546476|363689073|FG002|Period 1: Part A|Withdrawal by Subject|1|||
105457962|NCT05546476|363689074|FG003|Period 1: Part A|Withdrawal by Subject|2|||
105457963|NCT05546476|363689071|FG000|Period 1: Part A|Global deterioration of health status|2|||
105457964|NCT05546476|363689072|FG001|Period 1: Part A|Global deterioration of health status|2|||
105457965|NCT05546476|363689073|FG002|Period 1: Part A|Global deterioration of health status|1|||
105457966|NCT05546476|363689074|FG003|Period 1: Part A|Global deterioration of health status|4|||
105457967|NCT05546476|363689071|FG000|Period 1: Part A|Other: Unspecified|0|||
105457968|NCT05546476|363689072|FG001|Period 1: Part A|Other: Unspecified|2|||
105457969|NCT05546476|363689073|FG002|Period 1: Part A|Other: Unspecified|0|||
105457970|NCT05546476|363689074|FG003|Period 1: Part A|Other: Unspecified|0|||
105457971|NCT05546476|363689071|FG000|Period 2: Part B|Ongoing|26|||
105457972|NCT05546476|363689072|FG001|Period 2: Part B|Ongoing|27|||
105457973|NCT05546476|363689073|FG002|Period 2: Part B|Ongoing|35|||
105457974|NCT05546476|363689074|FG003|Period 2: Part B|Ongoing|29|||
105457975|NCT02814916|363689077|FG000|Overall Study|Withdrawal of consent|0|||
105457976|NCT02814916|363689078|FG001|Overall Study|Withdrawal of consent|2|||
105457977|NCT02814916|363689079|FG002|Overall Study|Withdrawal of consent|0|||
105457978|NCT02814916|363689077|FG000|Overall Study|Lost to Follow-up|0|||
105457979|NCT02814916|363689078|FG001|Overall Study|Lost to Follow-up|1|||
105457980|NCT02814916|363689079|FG002|Overall Study|Lost to Follow-up|0|||
105457981|NCT02814916|363689077|FG000|Overall Study|Other, not specified|0|||
105457982|NCT02814916|363689078|FG001|Overall Study|Other, not specified|1|||
105457983|NCT02814916|363689079|FG002|Overall Study|Other, not specified|0|||
105457984|NCT04205812|363689082|FG000|Randomized Treatment Period|Ongoing|28|||
105457985|NCT04205812|363689083|FG001|Randomized Treatment Period|Ongoing|138|||
105457986|NCT04205812|363689082|FG000|Randomized Treatment Period|Death|94|||
105457987|NCT04205812|363689083|FG001|Randomized Treatment Period|Death|226|||
105457988|NCT04205812|363689082|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
105457989|NCT04205812|363689083|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
105457990|NCT04205812|363689082|FG000|Randomized Treatment Period|Physician Decision|1|||
105457991|NCT04205812|363689083|FG001|Randomized Treatment Period|Physician Decision|4|||
105457992|NCT04205812|363689082|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
105457993|NCT04205812|363689083|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
105457994|NCT04205812|363689082|FG000|Randomized Treatment Period|Progressive Disease|0|||
105457995|NCT04205812|363689083|FG001|Randomized Treatment Period|Progressive Disease|1|||
105457996|NCT04205812|363689082|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
105457997|NCT04205812|363689083|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
105457998|NCT04205812|363689082|FG000|Monotherapy Treatment Period|Ongoing|17|||
105457999|NCT04205812|363689083|FG001|Monotherapy Treatment Period|Ongoing|0|||
105458000|NCT04205812|363689082|FG000|Monotherapy Treatment Period|Death|39|||
105458001|NCT04205812|363689083|FG001|Monotherapy Treatment Period|Death|0|||
105458002|NCT04205812|363689082|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
105458003|NCT04205812|363689083|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
105458004|NCT04205812|363689082|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
105458005|NCT04205812|363689083|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
105458006|NCT04613362|363689086|FG000|3 Month Follow-up|Lost to Follow-up|1|||
105458007|NCT04613362|363689087|FG001|3 Month Follow-up|Lost to Follow-up|2|||
105458008|NCT04613362|363689086|FG000|6 Month Follow-up|Lost to Follow-up|0|||
105458009|NCT04613362|363689087|FG001|6 Month Follow-up|Lost to Follow-up|1|||
105458010|NCT05365217|363689089|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105458011|NCT05365217|363689090|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105458012|NCT03882021|363689092|FG000|Enrollment|Procedure aborted/cancelled|2|||
105458013|NCT03882021|363689092|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
105458014|NCT03882021|363689092|FG000|Enrollment to 3-Month|Death|1|||
105458015|NCT03882021|363689092|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
105458016|NCT03882021|363689092|FG000|Enrollment to 3-Month|Missed Visit|4|||
105458017|NCT03882021|363689092|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
105458018|NCT03882021|363689092|FG000|6-Month to 12-Month Visit|Death|1|||
105458019|NCT03882021|363689092|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
105458020|NCT03186209|363689093|FG000|Overall Study|Withdrawal by Subject|11|||
105458021|NCT03186209|363689094|FG001|Overall Study|Withdrawal by Subject|22|||
105458022|NCT03186209|363689093|FG000|Overall Study|Pregnancy|1|||
105458023|NCT03186209|363689094|FG001|Overall Study|Pregnancy|0|||
105458024|NCT03186209|363689093|FG000|Overall Study|Adverse Event|4|||
105458025|NCT03186209|363689094|FG001|Overall Study|Adverse Event|0|||
105458026|NCT03186209|363689093|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
105458027|NCT03186209|363689094|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
105458028|NCT03186209|363689093|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
105458029|NCT03186209|363689094|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
105458030|NCT03186209|363689093|FG000|Overall Study|Fail to meet randomization criteria|0|||
105337885|NCT02836236|363239131|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
105337886|NCT02836236|363239132|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
105337887|NCT02836236|363239133|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
105337888|NCT02836236|363239134|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
105337889|NCT02836236|363239131|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
105337890|NCT02836236|363239132|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
105337891|NCT02836236|363239133|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
105337892|NCT02836236|363239134|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
105337893|NCT02836236|363239131|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
105337894|NCT02836236|363239132|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
105337895|NCT02836236|363239133|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
105337896|NCT02836236|363239134|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
105337897|NCT02836236|363239131|FG000|Open-Label TAF Treatment Phase|Death|0|||
105337898|NCT02836236|363239132|FG001|Open-Label TAF Treatment Phase|Death|0|||
105337899|NCT02836236|363239133|FG002|Open-Label TAF Treatment Phase|Death|1|||
105337900|NCT02836236|363239134|FG003|Open-Label TAF Treatment Phase|Death|1|||
105337901|NCT02836236|363239131|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
105337902|NCT02836236|363239132|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
105337903|NCT02836236|363239133|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
105337904|NCT02836236|363239134|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
105337905|NCT02282631|363239137|FG000|Overall Study|Lost to Follow-up|2|||
105337906|NCT02282631|363239138|FG001|Overall Study|Lost to Follow-up|0|||
105337907|NCT03233529|363239140|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
105337908|NCT03233529|363239140|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
105337909|NCT00601172|363239141|FG000|Overall Study|Adverse Event|43|||
105458031|NCT03186209|363689094|FG001|Overall Study|Fail to meet randomization criteria|1|||
105458032|NCT03186209|363689093|FG000|Overall Study|Lost to Follow-up|0|||
105458033|NCT03186209|363689094|FG001|Overall Study|Lost to Follow-up|1|||
105458034|NCT05236270|363689098|FG000|Overall Study|Lost to Follow-up|3|||
105458035|NCT05236270|363689099|FG001|Overall Study|Lost to Follow-up|2|||
105458036|NCT05236270|363689100|FG002|Overall Study|Lost to Follow-up|0|||
105458037|NCT05236270|363689101|FG003|Overall Study|Lost to Follow-up|0|||
105458038|NCT05236270|363689102|FG004|Overall Study|Lost to Follow-up|2|||
105458039|NCT05236270|363689103|FG005|Overall Study|Lost to Follow-up|0|||
105458040|NCT05236270|363689104|FG006|Overall Study|Lost to Follow-up|1|||
105458041|NCT05236270|363689105|FG007|Overall Study|Lost to Follow-up|3|||
105458042|NCT00322881|363689106|FG000|Overall Study|Death|2|||
105458043|NCT00322881|363689106|FG000|Overall Study|Adverse Event|1|||
105458044|NCT00322881|363689106|FG000|Overall Study|Disease Progression|2|||
105458045|NCT00528112|363689107|FG000|Treatment up to 3 Years|Adverse Event|313|||
105458046|NCT00528112|363689108|FG001|Treatment up to 3 Years|Adverse Event|278|||
105458047|NCT00528112|363689107|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
105458048|NCT00528112|363689108|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
105458049|NCT00528112|363689107|FG000|Treatment up to 3 Years|Protocol Violation|16|||
105458050|NCT00528112|363689108|FG001|Treatment up to 3 Years|Protocol Violation|16|||
105458051|NCT00528112|363689107|FG000|Treatment up to 3 Years|Death|0|||
105458052|NCT00528112|363689108|FG001|Treatment up to 3 Years|Death|1|||
105458053|NCT00528112|363689107|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
105458054|NCT00528112|363689108|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
105458055|NCT00528112|363689107|FG000|Treatment up to 3 Years|Pregnancy|9|||
105661754|NCT01068210|364425131|FG001|Overall Study|Second cancer|1|||
105337910|NCT00601172|363239142|FG001|Overall Study|Adverse Event|32|||
105337911|NCT00601172|363239141|FG000|Overall Study|Lack of Efficacy|11|||
105337912|NCT00601172|363239142|FG001|Overall Study|Lack of Efficacy|12|||
105337913|NCT00601172|363239141|FG000|Overall Study|Protocol Violation|2|||
105458056|NCT00528112|363689108|FG001|Treatment up to 3 Years|Pregnancy|10|||
105458057|NCT00528112|363689107|FG000|Treatment up to 3 Years|Other reasons|186|||
105458058|NCT00528112|363689108|FG001|Treatment up to 3 Years|Other reasons|186|||
105458059|NCT00528112|363689107|FG000|Extension Phase|Withdrawal by Subject|0|||
105458060|NCT00528112|363689108|FG001|Extension Phase|Withdrawal by Subject|3|||
105458061|NCT00528112|363689107|FG000|Extension Phase|Other reasons|0|||
105458062|NCT00528112|363689108|FG001|Extension Phase|Other reasons|100|||
105458063|NCT00528112|363689107|FG000|Extension Phase|Pregnancy|0|||
105458064|NCT00528112|363689108|FG001|Extension Phase|Pregnancy|3|||
105458065|NCT00528112|363689107|FG000|Extension Phase|Lost to Follow-up|0|||
105458066|NCT00528112|363689108|FG001|Extension Phase|Lost to Follow-up|12|||
105458067|NCT00528112|363689107|FG000|Extension Phase|Death|0|||
105458068|NCT00528112|363689108|FG001|Extension Phase|Death|1|||
105458069|NCT00528112|363689107|FG000|Extension Phase|Adverse Event|0|||
105458070|NCT00528112|363689108|FG001|Extension Phase|Adverse Event|36|||
105458071|NCT00528112|363689107|FG000|Extension Phase|Protocol Violation|0|||
105458072|NCT00528112|363689108|FG001|Extension Phase|Protocol Violation|2|||
105458073|NCT01075243|363689109|FG000|Overall Study|Lost to Follow-up|5|||
105458074|NCT01075243|363689110|FG001|Overall Study|Lost to Follow-up|2|||
105458075|NCT01075243|363689111|FG002|Overall Study|Lost to Follow-up|0|||
105458076|NCT01075243|363689109|FG000|Overall Study|Withdrawal by Subject|1|||
105458077|NCT01075243|363689110|FG001|Overall Study|Withdrawal by Subject|1|||
105458078|NCT01075243|363689111|FG002|Overall Study|Withdrawal by Subject|0|||
105458079|NCT00627393|363689114|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
105458080|NCT00627393|363689115|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
105458081|NCT00627393|363689114|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
105458082|NCT00627393|363689115|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
105458083|NCT00627393|363689114|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
105458084|NCT00627393|363689115|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
105458085|NCT00627393|363689114|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
105458086|NCT00627393|363689115|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
105458087|NCT01521117|363689116|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
105458088|NCT01521117|363689117|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
105458089|NCT01521117|363689116|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
105458090|NCT01521117|363689117|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
105458091|NCT01521117|363689116|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
105458092|NCT01521117|363689117|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
105458093|NCT03337308|363689118|FG000|Overall Study|Adverse Event|2|||
105458094|NCT03337308|363689119|FG001|Overall Study|Adverse Event|3|||
105458095|NCT03337308|363689120|FG002|Overall Study|Adverse Event|3|||
105458096|NCT03337308|363689121|FG003|Overall Study|Adverse Event|1|||
105458097|NCT03337308|363689118|FG000|Overall Study|Lost to Follow-up|1|||
105458098|NCT03337308|363689119|FG001|Overall Study|Lost to Follow-up|2|||
105458099|NCT03337308|363689120|FG002|Overall Study|Lost to Follow-up|0|||
105458100|NCT03337308|363689121|FG003|Overall Study|Lost to Follow-up|0|||
105458101|NCT03337308|363689118|FG000|Overall Study|Withdrawal by Subject|2|||
105458102|NCT03337308|363689119|FG001|Overall Study|Withdrawal by Subject|1|||
105458103|NCT03337308|363689120|FG002|Overall Study|Withdrawal by Subject|2|||
105458104|NCT03337308|363689121|FG003|Overall Study|Withdrawal by Subject|1|||
105458105|NCT03337308|363689118|FG000|Overall Study|Protocol Violation|0|||
105458106|NCT03337308|363689119|FG001|Overall Study|Protocol Violation|1|||
105458107|NCT03337308|363689120|FG002|Overall Study|Protocol Violation|0|||
105458108|NCT03337308|363689121|FG003|Overall Study|Protocol Violation|0|||
105458109|NCT05498649|363689123|FG000|Overall Study|Lost to Follow-up|1|||
105458110|NCT01668784|363689124|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
105458111|NCT01668784|363689125|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
105458112|NCT01668784|363689124|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
105458113|NCT01668784|363689125|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
105458114|NCT01668784|363689124|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
105458115|NCT01668784|363689125|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
105458116|NCT01668784|363689124|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
105458117|NCT01668784|363689125|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
105458118|NCT01668784|363689124|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
105458119|NCT01668784|363689125|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
105458120|NCT01668784|363689124|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
105458121|NCT01668784|363689125|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
105458122|NCT01668784|363689124|FG000|Treatment Period|Disease Progression|316|||
105458123|NCT01668784|363689125|FG001|Treatment Period|Disease Progression|293|||
105458124|NCT01668784|363689124|FG000|Treatment Period|Study Drug Toxicity|46|||
105458125|NCT01668784|363689125|FG001|Treatment Period|Study Drug Toxicity|53|||
105458126|NCT01668784|363689124|FG000|Treatment Period|Death|1|||
105458127|NCT01668784|363689125|FG001|Treatment Period|Death|1|||
105458128|NCT01668784|363689124|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
105458129|NCT01668784|363689125|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
105458130|NCT01668784|363689124|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
105458131|NCT01668784|363689125|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
105458132|NCT01668784|363689124|FG000|Treatment Period|Withdrawal by Subject|5|||
105458133|NCT01668784|363689125|FG001|Treatment Period|Withdrawal by Subject|3|||
105458134|NCT01668784|363689124|FG000|Treatment Period|Maximal Clinical Benefit|3|||
105458135|NCT01668784|363689125|FG001|Treatment Period|Maximal Clinical Benefit|3|||
105458136|NCT01668784|363689124|FG000|Treatment Period|Other|2|||
105458137|NCT01668784|363689125|FG001|Treatment Period|Other|8|||
105458138|NCT01668784|363689124|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
105458139|NCT01668784|363689125|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
105458140|NCT00617734|363689127|FG000|Overall Study|Withdrew Consent|2|||
105458141|NCT00617734|363689128|FG001|Overall Study|Withdrew Consent|0|||
105458142|NCT00617734|363689127|FG000|Overall Study|Adverse Event|4|||
105458143|NCT00617734|363689128|FG001|Overall Study|Adverse Event|1|||
105458144|NCT00617734|363689127|FG000|Overall Study|Protocol Violation|1|||
105458145|NCT00617734|363689128|FG001|Overall Study|Protocol Violation|0|||
105458146|NCT00617734|363689127|FG000|Overall Study|Found Ineligible After Randomization|1|||
105458147|NCT00617734|363689128|FG001|Overall Study|Found Ineligible After Randomization|4|||
105458148|NCT00617734|363689127|FG000|Overall Study|Lost to Follow-up|0|||
105458149|NCT00617734|363689128|FG001|Overall Study|Lost to Follow-up|1|||
105458150|NCT00604565|363689130|FG000|Overall Study|Study terminated|0|||
105458151|NCT00604565|363689131|FG001|Overall Study|Study terminated|3|||
105458152|NCT02260934|363689132|FG000|Overall Study|Lost to Follow-up|2|||
105458153|NCT02260934|363689133|FG001|Overall Study|Lost to Follow-up|1|||
105458154|NCT02260934|363689132|FG000|Overall Study|Withdrawal by Subject|0|||
105458155|NCT02260934|363689133|FG001|Overall Study|Withdrawal by Subject|2|||
105458156|NCT02260934|363689132|FG000|Overall Study|Participant Relocated|1|||
105458157|NCT02260934|363689133|FG001|Overall Study|Participant Relocated|0|||
105458158|NCT02260934|363689132|FG000|Overall Study|Site error|0|||
105458159|NCT02260934|363689133|FG001|Overall Study|Site error|1|||
105458160|NCT00517296|363689134|FG000|Overall Study|Withdrawal by Subject|1|||
105458161|NCT00517296|363689135|FG001|Overall Study|Withdrawal by Subject|0|||
105458162|NCT04366349|363689136|FG000|Overall Study|Withdrawal by Subject|1|||
105458163|NCT04366349|363689137|FG001|Overall Study|Withdrawal by Subject|0|||
105458164|NCT04366349|363689138|FG002|Overall Study|Withdrawal by Subject|0|||
105458165|NCT04366349|363689139|FG003|Overall Study|Withdrawal by Subject|0|||
105458166|NCT04366349|363689140|FG004|Overall Study|Withdrawal by Subject|0|||
105458167|NCT04366349|363689141|FG005|Overall Study|Withdrawal by Subject|0|||
105458168|NCT03413891|363689145|FG000|Overall Study|Lost to Follow-up|2|||
105458169|NCT03413891|363689146|FG001|Overall Study|Lost to Follow-up|1|||
105458170|NCT03413891|363689145|FG000|Overall Study|Protocol Violation|0|||
105458171|NCT03413891|363689146|FG001|Overall Study|Protocol Violation|1|||
105458172|NCT03474588|363689150|FG000|Overall Study|Withdrawal by Subject|4|||
105458173|NCT03474588|363689151|FG001|Overall Study|Withdrawal by Subject|3|||
105337914|NCT00601172|363239142|FG001|Overall Study|Protocol Violation|5|||
105337915|NCT00601172|363239141|FG000|Overall Study|Lost to Follow-up|4|||
105337916|NCT00601172|363239142|FG001|Overall Study|Lost to Follow-up|3|||
105337917|NCT00601172|363239141|FG000|Overall Study|Physician Decision|27|||
105458174|NCT03474588|363689150|FG000|Overall Study|Death|0|||
105458175|NCT03474588|363689151|FG001|Overall Study|Death|1|||
105458176|NCT01607957|363689153|FG000|Overall Study|Not treated|1|||
105337918|NCT00601172|363239142|FG001|Overall Study|Physician Decision|28|||
105337919|NCT00601172|363239141|FG000|Overall Study|Withdrawal by Subject|35|||
105337920|NCT00601172|363239142|FG001|Overall Study|Withdrawal by Subject|27|||
105458177|NCT01607957|363689154|FG001|Overall Study|Not treated|1|||
105458178|NCT01607957|363689153|FG000|Overall Study|Death|367|||
105458179|NCT01607957|363689154|FG001|Overall Study|Death|211|||
105458180|NCT01607957|363689153|FG000|Overall Study|Lost to Follow-up|3|||
105458181|NCT01607957|363689154|FG001|Overall Study|Lost to Follow-up|3|||
105458182|NCT01607957|363689153|FG000|Overall Study|Participant refusal|1|||
105458183|NCT01607957|363689154|FG001|Overall Study|Participant refusal|0|||
105458184|NCT00945009|363689163|FG000|Overall Study|Lack of Efficacy|10|||
105458185|NCT00945009|363689164|FG001|Overall Study|Lack of Efficacy|0|||
105458186|NCT00945009|363689165|FG002|Overall Study|Lack of Efficacy|0|||
105458187|NCT00945009|363689163|FG000|Overall Study|Physician Decision|21|||
105458188|NCT00945009|363689164|FG001|Overall Study|Physician Decision|4|||
105458189|NCT00945009|363689165|FG002|Overall Study|Physician Decision|3|||
105458190|NCT00945009|363689163|FG000|Overall Study|Protocol Violation|6|||
105458191|NCT00945009|363689164|FG001|Overall Study|Protocol Violation|1|||
105458192|NCT00945009|363689165|FG002|Overall Study|Protocol Violation|0|||
105458193|NCT00945009|363689163|FG000|Overall Study|Withdrawal by Subject|1|||
105458194|NCT00945009|363689164|FG001|Overall Study|Withdrawal by Subject|0|||
105458195|NCT00945009|363689165|FG002|Overall Study|Withdrawal by Subject|0|||
105458196|NCT00945009|363689163|FG000|Overall Study|Ineligible|6|||
105458197|NCT00945009|363689164|FG001|Overall Study|Ineligible|1|||
105458198|NCT00945009|363689165|FG002|Overall Study|Ineligible|0|||
105458199|NCT00945009|363689163|FG000|Overall Study|Inevaluable|0|||
105458200|NCT00945009|363689164|FG001|Overall Study|Inevaluable|1|||
105458201|NCT00945009|363689165|FG002|Overall Study|Inevaluable|0|||
105458202|NCT00945009|363689163|FG000|Overall Study|Refusal of further protocol|1|||
105458203|NCT00945009|363689164|FG001|Overall Study|Refusal of further protocol|0|||
105458204|NCT00945009|363689165|FG002|Overall Study|Refusal of further protocol|0|||
105458205|NCT03919773|363689166|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
105458206|NCT03919773|363689167|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
105458207|NCT03919773|363689166|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
105458208|NCT03919773|363689167|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
105458209|NCT04659044|363689168|FG000|Induction|Physician Decision|1|||
105458210|NCT04659044|363689168|FG000|Induction|Adverse Event|2|||
105458211|NCT05177354|363689169|FG000|Implant to 30-day Visit|Physician Decision|1|||
105458212|NCT05177354|363689169|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
105458213|NCT05177354|363689169|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
105458214|NCT05177354|363689169|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
105458215|NCT02331134|363689170|FG000|Overall Study|Withdrawal by Subject|1|||
105337921|NCT00601172|363239141|FG000|Overall Study|Did not meet continuation criteria|19|||
105337922|NCT00601172|363239142|FG001|Overall Study|Did not meet continuation criteria|20|||
105458216|NCT04825574|363689174|FG000|Overall Study|Commercial treatment became available|1|||
105458217|NCT04825574|363689174|FG000|Overall Study|Disease progression|1|||
105337923|NCT01905553|363239145|FG000|Period 2|Adverse Event|1|||
105337924|NCT01905553|363239146|FG001|Period 2|Adverse Event|0|||
105337925|NCT02759055|363239147|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
105337926|NCT02759055|363239148|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
105337927|NCT00723255|363239149|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
105337928|NCT00723255|363239149|FG000|Overall Study|Ineligible: Second primary|1|||
105337929|NCT00723255|363239149|FG000|Overall Study|Ineligible: Wrong Primary|2|||
105337930|NCT01424514|363239152|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
105337931|NCT01424514|363239153|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
105337932|NCT01424514|363239152|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
105337933|NCT01424514|363239153|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
105337934|NCT02002533|363239156|FG000|Overall Study|Withdrawal by Subject|6|||
105337935|NCT02002533|363239157|FG001|Overall Study|Withdrawal by Subject|13|||
105337936|NCT02002533|363239156|FG000|Overall Study|Protocol Violation|0|||
105337937|NCT02002533|363239157|FG001|Overall Study|Protocol Violation|1|||
105337938|NCT02002533|363239156|FG000|Overall Study|Adverse Event|0|||
105337939|NCT02002533|363239157|FG001|Overall Study|Adverse Event|3|||
105337940|NCT02002533|363239156|FG000|Overall Study|Lost to Follow-up|0|||
105337941|NCT02002533|363239157|FG001|Overall Study|Lost to Follow-up|1|||
105337942|NCT03991299|363239168|FG000|Overall Study|Study closed, sponsor decision|3|||
105337943|NCT03991299|363239168|FG000|Overall Study|Withdrawal by Subject|1|||
105337944|NCT04304235|363239169|FG000|Overall Study|incomplete triage data|0|||
105337945|NCT04304235|363239170|FG001|Overall Study|incomplete triage data|69|||
105337946|NCT04304235|363239171|FG002|Overall Study|incomplete triage data|0|||
105337947|NCT04304235|363239172|FG003|Overall Study|incomplete triage data|0|||
105337948|NCT04304235|363239173|FG004|Overall Study|incomplete triage data|289|||
105337949|NCT04304235|363239174|FG005|Overall Study|incomplete triage data|123|||
105337950|NCT04304235|363239175|FG006|Overall Study|incomplete triage data|65|||
105337951|NCT04429555|363239181|FG000|Overall Study|Death|0|||
105337952|NCT04429555|363239182|FG001|Overall Study|Death|2|||
105458218|NCT05417438|363689175|FG000|Overall Study|Withdrawal by Subject|3|||
105458219|NCT02702492|363689178|FG000|Overall Study|Disease progression|3|||
105458220|NCT02702492|363689179|FG001|Overall Study|Disease progression|3|||
105458221|NCT02702492|363689180|FG002|Overall Study|Disease progression|2|||
105458222|NCT02702492|363689181|FG003|Overall Study|Disease progression|4|||
105458223|NCT02702492|363689182|FG004|Overall Study|Disease progression|4|||
105337953|NCT04429555|363239181|FG000|Overall Study|Other|2|||
105337954|NCT04429555|363239182|FG001|Overall Study|Other|0|||
105337955|NCT00231114|363239183|FG000|Randomized|Withdrawal by Subject|6|||
105337956|NCT00231114|363239184|FG001|Randomized|Withdrawal by Subject|3|||
105337957|NCT00231114|363239183|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
105337958|NCT00231114|363239184|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
105337959|NCT00231114|363239183|FG000|Post-Treatment Period|Lost to Follow-up|6|||
105337960|NCT00231114|363239184|FG001|Post-Treatment Period|Lost to Follow-up|1|||
105337961|NCT00231114|363239183|FG000|Post-Treatment Period|Physician Decision|1|||
105337962|NCT00231114|363239184|FG001|Post-Treatment Period|Physician Decision|0|||
105337963|NCT00231114|363239183|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
105337964|NCT00231114|363239184|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
105337965|NCT02703272|363239185|FG000|Overall Study|Death|4|||
105337966|NCT02703272|363239186|FG001|Overall Study|Death|9|||
105337967|NCT02703272|363239187|FG002|Overall Study|Death|19|||
105337968|NCT02703272|363239188|FG003|Overall Study|Death|10|||
105337969|NCT02703272|363239185|FG000|Overall Study|Withdrawal by Subject|0|||
105458224|NCT02702492|363689183|FG005|Overall Study|Disease progression|1|||
105458225|NCT02702492|363689184|FG006|Overall Study|Disease progression|2|||
105458226|NCT02702492|363689185|FG007|Overall Study|Disease progression|8|||
105458227|NCT02702492|363689186|FG008|Overall Study|Disease progression|5|||
105458228|NCT02702492|363689187|FG009|Overall Study|Disease progression|1|||
105458229|NCT02702492|363689188|FG010|Overall Study|Disease progression|0|||
105458230|NCT02702492|363689189|FG011|Overall Study|Disease progression|3|||
105458231|NCT02702492|363689190|FG012|Overall Study|Disease progression|2|||
105458232|NCT02702492|363689178|FG000|Overall Study|Clinical progression|0|||
105458233|NCT02702492|363689179|FG001|Overall Study|Clinical progression|0|||
105458234|NCT02702492|363689180|FG002|Overall Study|Clinical progression|2|||
105458235|NCT02702492|363689181|FG003|Overall Study|Clinical progression|1|||
105458236|NCT02702492|363689182|FG004|Overall Study|Clinical progression|0|||
105458237|NCT02702492|363689183|FG005|Overall Study|Clinical progression|2|||
105458238|NCT02702492|363689184|FG006|Overall Study|Clinical progression|1|||
105337970|NCT02703272|363239186|FG001|Overall Study|Withdrawal by Subject|0|||
105337971|NCT02703272|363239187|FG002|Overall Study|Withdrawal by Subject|4|||
105337972|NCT02703272|363239188|FG003|Overall Study|Withdrawal by Subject|2|||
105337973|NCT02703272|363239185|FG000|Overall Study|Study Terminated by Sponsor|6|||
105337974|NCT02703272|363239186|FG001|Overall Study|Study Terminated by Sponsor|1|||
105337975|NCT02703272|363239187|FG002|Overall Study|Study Terminated by Sponsor|12|||
105337976|NCT02703272|363239188|FG003|Overall Study|Study Terminated by Sponsor|4|||
105458239|NCT02702492|363689185|FG007|Overall Study|Clinical progression|4|||
105458240|NCT02702492|363689186|FG008|Overall Study|Clinical progression|0|||
105458241|NCT02702492|363689187|FG009|Overall Study|Clinical progression|0|||
105458242|NCT02702492|363689188|FG010|Overall Study|Clinical progression|1|||
105458243|NCT02702492|363689189|FG011|Overall Study|Clinical progression|2|||
105458244|NCT02702492|363689190|FG012|Overall Study|Clinical progression|0|||
105458245|NCT02702492|363689178|FG000|Overall Study|Adverse Event|0|||
105458246|NCT02702492|363689179|FG001|Overall Study|Adverse Event|0|||
105458247|NCT02702492|363689180|FG002|Overall Study|Adverse Event|1|||
105458248|NCT02702492|363689181|FG003|Overall Study|Adverse Event|2|||
105458249|NCT02702492|363689182|FG004|Overall Study|Adverse Event|1|||
105458250|NCT02702492|363689183|FG005|Overall Study|Adverse Event|0|||
105458251|NCT02702492|363689184|FG006|Overall Study|Adverse Event|1|||
105458252|NCT02702492|363689185|FG007|Overall Study|Adverse Event|0|||
105458253|NCT02702492|363689186|FG008|Overall Study|Adverse Event|2|||
105458254|NCT02702492|363689187|FG009|Overall Study|Adverse Event|0|||
105458255|NCT02702492|363689188|FG010|Overall Study|Adverse Event|0|||
105458256|NCT02702492|363689189|FG011|Overall Study|Adverse Event|0|||
105458257|NCT02702492|363689190|FG012|Overall Study|Adverse Event|1|||
105458258|NCT02702492|363689178|FG000|Overall Study|Other|0|||
105458259|NCT02702492|363689179|FG001|Overall Study|Other|0|||
105458260|NCT02702492|363689180|FG002|Overall Study|Other|0|||
105458261|NCT02702492|363689181|FG003|Overall Study|Other|0|||
105458262|NCT02702492|363689182|FG004|Overall Study|Other|0|||
105458263|NCT02702492|363689183|FG005|Overall Study|Other|0|||
105458264|NCT02702492|363689184|FG006|Overall Study|Other|0|||
105458265|NCT02702492|363689185|FG007|Overall Study|Other|0|||
105458266|NCT02702492|363689186|FG008|Overall Study|Other|0|||
105458267|NCT02702492|363689187|FG009|Overall Study|Other|0|||
105458268|NCT02702492|363689188|FG010|Overall Study|Other|0|||
105458269|NCT02702492|363689189|FG011|Overall Study|Other|0|||
105458270|NCT02702492|363689190|FG012|Overall Study|Other|1|||
105458271|NCT00089297|363690352|FG000|Overall Study|Adverse Event|9|||
105458272|NCT00089297|363690352|FG000|Overall Study|Death|1|||
105458273|NCT00089297|363690352|FG000|Overall Study|Withdrawal by Subject|12|||
105458274|NCT00089297|363690352|FG000|Overall Study|Disease progression|2|||
105458275|NCT00089297|363690352|FG000|Overall Study|Ineligible|11|||
105458276|NCT00089297|363690352|FG000|Overall Study|Secondary malignancy|1|||
105458277|NCT00089297|363690352|FG000|Overall Study|IRB approval not ready|1|||
105458278|NCT00089297|363690352|FG000|Overall Study|Non-compliance|1|||
105458279|NCT01775501|363690356|FG000|Overall Study|Discontinued prior to treatment|1|||
105458280|NCT04607668|363690366|FG000|Overall Study|Death|49|||
105458281|NCT04607668|363690367|FG001|Overall Study|Death|26|||
105458282|NCT04607668|363690366|FG000|Overall Study|Lost to Follow-up|3|||
105337977|NCT02703272|363239185|FG000|Overall Study|Other|1|||
105458283|NCT04607668|363690367|FG001|Overall Study|Lost to Follow-up|4|||
105458284|NCT04607668|363690366|FG000|Overall Study|Study terminated by Sponsor|92|||
105458285|NCT04607668|363690367|FG001|Overall Study|Study terminated by Sponsor|114|||
105458286|NCT04607668|363690366|FG000|Overall Study|Withdrawal by Subject|12|||
105458287|NCT04607668|363690367|FG001|Overall Study|Withdrawal by Subject|11|||
105458288|NCT04607668|363690366|FG000|Overall Study|Other, unspecified|8|||
105458289|NCT04607668|363690367|FG001|Overall Study|Other, unspecified|7|||
105458290|NCT04199351|363690368|FG000|Overall Study|Decision by sponsor|0|||
105458291|NCT04199351|363690369|FG001|Overall Study|Decision by sponsor|0|||
105458292|NCT04199351|363690370|FG002|Overall Study|Decision by sponsor|0|||
105458293|NCT04199351|363690371|FG003|Overall Study|Decision by sponsor|2|||
105458294|NCT04199351|363690372|FG004|Overall Study|Decision by sponsor|0|||
105458295|NCT04199351|363690373|FG005|Overall Study|Decision by sponsor|0|||
105458296|NCT04199351|363690374|FG006|Overall Study|Decision by sponsor|0|||
105458297|NCT04199351|363690375|FG007|Overall Study|Decision by sponsor|0|||
105458298|NCT04199351|363690376|FG008|Overall Study|Decision by sponsor|0|||
105458299|NCT04199351|363690377|FG009|Overall Study|Decision by sponsor|6|||
105458300|NCT04199351|363690368|FG000|Overall Study|Lost to Follow-up|0|||
105458301|NCT04199351|363690369|FG001|Overall Study|Lost to Follow-up|0|||
105458302|NCT04199351|363690370|FG002|Overall Study|Lost to Follow-up|1|||
105458303|NCT04199351|363690371|FG003|Overall Study|Lost to Follow-up|0|||
105458304|NCT04199351|363690372|FG004|Overall Study|Lost to Follow-up|0|||
105458305|NCT04199351|363690373|FG005|Overall Study|Lost to Follow-up|1|||
105458306|NCT04199351|363690374|FG006|Overall Study|Lost to Follow-up|0|||
105458307|NCT04199351|363690375|FG007|Overall Study|Lost to Follow-up|0|||
105458308|NCT04199351|363690376|FG008|Overall Study|Lost to Follow-up|0|||
105458309|NCT04199351|363690377|FG009|Overall Study|Lost to Follow-up|0|||
105458310|NCT04199351|363690368|FG000|Overall Study|Withdrawal by Subject|0|||
105458311|NCT04199351|363690369|FG001|Overall Study|Withdrawal by Subject|1|||
105458312|NCT04199351|363690370|FG002|Overall Study|Withdrawal by Subject|0|||
105458313|NCT04199351|363690371|FG003|Overall Study|Withdrawal by Subject|0|||
105458314|NCT04199351|363690372|FG004|Overall Study|Withdrawal by Subject|1|||
105458315|NCT04199351|363690373|FG005|Overall Study|Withdrawal by Subject|4|||
105458316|NCT04199351|363690374|FG006|Overall Study|Withdrawal by Subject|2|||
105458317|NCT04199351|363690375|FG007|Overall Study|Withdrawal by Subject|0|||
105458318|NCT04199351|363690376|FG008|Overall Study|Withdrawal by Subject|3|||
105458319|NCT04199351|363690377|FG009|Overall Study|Withdrawal by Subject|0|||
105458320|NCT03007966|363690379|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
105458321|NCT03007966|363690380|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
105458322|NCT01428258|363690381|FG000|Intervention 1|Withdrawal by Subject|2|||
105458323|NCT01428258|363690382|FG001|Intervention 1|Withdrawal by Subject|0|||
105458324|NCT02177695|363690383|FG000|ITT Analysis|Ineligible|5|||
105458325|NCT02177695|363690384|FG001|ITT Analysis|Ineligible|5|||
105458326|NCT02177695|363690383|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
105458327|NCT02177695|363690384|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
105458328|NCT02177695|363690383|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
105458329|NCT02177695|363690384|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
105458330|NCT02177695|363690383|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
105458331|NCT02177695|363690384|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
105458332|NCT03466658|363690394|FG000|Overall Study|Withdrawal by Subject|3|||
105458333|NCT00772538|363690395|FG000|Overall Study|Adverse Event|6|||
105458334|NCT00772538|363690396|FG001|Overall Study|Adverse Event|6|||
105458335|NCT00772538|363690395|FG000|Overall Study|Protocol Violation|3|||
105458336|NCT00772538|363690396|FG001|Overall Study|Protocol Violation|3|||
105458337|NCT00772538|363690395|FG000|Overall Study|Lost to Follow-up|1|||
105458338|NCT00772538|363690396|FG001|Overall Study|Lost to Follow-up|1|||
105458339|NCT00772538|363690395|FG000|Overall Study|Withdrawal by Subject|3|||
105337978|NCT02703272|363239186|FG001|Overall Study|Other|0|||
105337979|NCT02703272|363239187|FG002|Overall Study|Other|0|||
105458340|NCT00772538|363690396|FG001|Overall Study|Withdrawal by Subject|8|||
105458341|NCT00772538|363690395|FG000|Overall Study|Lack of Efficacy|0|||
105458342|NCT00772538|363690396|FG001|Overall Study|Lack of Efficacy|1|||
105458343|NCT00772538|363690395|FG000|Overall Study|Other|7|||
105458344|NCT00772538|363690396|FG001|Overall Study|Other|7|||
105458345|NCT01089504|363690397|FG000|Overall Study|Lost to Follow-up|1|||
105458346|NCT01089504|363690398|FG001|Overall Study|Lost to Follow-up|1|||
105458347|NCT01089504|363690397|FG000|Overall Study|Withdrawal by Subject|2|||
105458348|NCT01089504|363690398|FG001|Overall Study|Withdrawal by Subject|0|||
105458349|NCT01680341|363690403|FG000|Overall Study|Adverse Event|3|||
105458350|NCT01680341|363690404|FG001|Overall Study|Adverse Event|2|||
105458351|NCT01680341|363690403|FG000|Overall Study|Unclassified|18|||
105458352|NCT01680341|363690404|FG001|Overall Study|Unclassified|15|||
105458353|NCT02230410|363690405|FG000|Overall Study|Screen Failure|3|||
105458354|NCT00499486|363690406|FG000|Overall Study|Withdrawal by Subject|16|||
105458355|NCT00656513|363690407|FG000|Overall Study|Protocol Violation|1|||
105458356|NCT00656513|363690408|FG001|Overall Study|Protocol Violation|0|||
105458357|NCT00656513|363690409|FG002|Overall Study|Protocol Violation|2|||
105458358|NCT00656513|363690407|FG000|Overall Study|Withdrawal by Subject|0|||
105458359|NCT00656513|363690408|FG001|Overall Study|Withdrawal by Subject|11|||
105458360|NCT00656513|363690409|FG002|Overall Study|Withdrawal by Subject|4|||
105458361|NCT00656513|363690407|FG000|Overall Study|Death|0|||
105458362|NCT00656513|363690408|FG001|Overall Study|Death|0|||
105458363|NCT00656513|363690409|FG002|Overall Study|Death|1|||
105458364|NCT00656513|363690407|FG000|Overall Study|Missing data|0|||
105458365|NCT00656513|363690408|FG001|Overall Study|Missing data|11|||
105458366|NCT00656513|363690409|FG002|Overall Study|Missing data|9|||
105458367|NCT00656513|363690407|FG000|Overall Study|Incomplete treatment|3|||
105458368|NCT00656513|363690408|FG001|Overall Study|Incomplete treatment|0|||
105458369|NCT00656513|363690409|FG002|Overall Study|Incomplete treatment|0|||
105458370|NCT00656513|363690407|FG000|Overall Study|Treatment completed outside of timeframe|0|||
105458371|NCT00656513|363690408|FG001|Overall Study|Treatment completed outside of timeframe|3|||
105337980|NCT02703272|363239188|FG003|Overall Study|Other|0|||
105337981|NCT02048826|363239189|FG000|Overall Study|Withdrawal by Subject|1|||
105337982|NCT02048826|363239190|FG001|Overall Study|Withdrawal by Subject|0|||
105337983|NCT04470544|363239191|FG000|Overall Study|Withdrawal by Subject|4|||
105337984|NCT04470544|363239192|FG001|Overall Study|Withdrawal by Subject|6|||
105458372|NCT00656513|363690409|FG002|Overall Study|Treatment completed outside of timeframe|1|||
105458373|NCT00656513|363690407|FG000|Overall Study|Missing baseline form|0|||
105458374|NCT00656513|363690408|FG001|Overall Study|Missing baseline form|5|||
105458375|NCT00656513|363690409|FG002|Overall Study|Missing baseline form|5|||
105458376|NCT03780452|363690410|FG000|Overall Study|Screening failure|2|||
105458377|NCT00087152|363690411|FG000|Overall Study|Ineligible|6|||
105458378|NCT03379818|363690414|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
105458379|NCT03379818|363690415|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
105661755|NCT01068210|364425132|FG002|Overall Study|Second cancer|0|||
105337985|NCT02829723|363239196|FG000|Overall Study|Adverse Event|0|||
105458380|NCT03379818|363690414|FG000|Overall Study|Withdrawal by Subject|2|||
105458381|NCT03379818|363690415|FG001|Overall Study|Withdrawal by Subject|3|||
105458382|NCT03379818|363690414|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
105458383|NCT03379818|363690415|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
105661756|NCT01068210|364425133|FG003|Overall Study|Second cancer|0|||
105458384|NCT03199976|363690417|FG000|Overall Study|Lack of Efficacy|3|||
105458385|NCT03199976|363690418|FG001|Overall Study|Lack of Efficacy|6|||
105337986|NCT02829723|363239197|FG001|Overall Study|Adverse Event|0|||
105337987|NCT02829723|363239198|FG002|Overall Study|Adverse Event|1|||
105337988|NCT02829723|363239199|FG003|Overall Study|Adverse Event|1|||
105337989|NCT02829723|363239200|FG004|Overall Study|Adverse Event|0|||
105337990|NCT02829723|363239201|FG005|Overall Study|Adverse Event|0|||
105337991|NCT02829723|363239202|FG006|Overall Study|Adverse Event|0|||
105337992|NCT02829723|363239203|FG007|Overall Study|Adverse Event|1|||
105337993|NCT02829723|363239204|FG008|Overall Study|Adverse Event|0|||
105337994|NCT02829723|363239205|FG009|Overall Study|Adverse Event|0|||
105337995|NCT02829723|363239206|FG010|Overall Study|Adverse Event|0|||
105337996|NCT02829723|363239207|FG011|Overall Study|Adverse Event|0|||
105337997|NCT02829723|363239208|FG012|Overall Study|Adverse Event|0|||
105337998|NCT02829723|363239209|FG013|Overall Study|Adverse Event|0|||
105458386|NCT03199976|363690419|FG002|Overall Study|Lack of Efficacy|13|||
105458387|NCT03199976|363690417|FG000|Overall Study|Withdrawal by Subject|1|||
105458388|NCT03199976|363690418|FG001|Overall Study|Withdrawal by Subject|0|||
105458389|NCT03199976|363690419|FG002|Overall Study|Withdrawal by Subject|0|||
105458390|NCT03199976|363690417|FG000|Overall Study|Lost to Follow-up|0|||
105458391|NCT03199976|363690418|FG001|Overall Study|Lost to Follow-up|1|||
105458392|NCT03199976|363690419|FG002|Overall Study|Lost to Follow-up|1|||
105458393|NCT04602390|363690420|FG000|Overall Study|Withdrawal by Subject|0|||
105458394|NCT04602390|363690421|FG001|Overall Study|Withdrawal by Subject|0|||
105458395|NCT04602390|363690422|FG002|Overall Study|Withdrawal by Subject|0|||
105458396|NCT04602390|363690423|FG003|Overall Study|Withdrawal by Subject|0|||
105458397|NCT04602390|363690424|FG004|Overall Study|Withdrawal by Subject|1|||
105458398|NCT04602390|363690425|FG005|Overall Study|Withdrawal by Subject|0|||
105458399|NCT04602390|363690420|FG000|Overall Study|Adverse Event|0|||
105458400|NCT04602390|363690421|FG001|Overall Study|Adverse Event|0|||
105458401|NCT04602390|363690422|FG002|Overall Study|Adverse Event|0|||
105458402|NCT04602390|363690423|FG003|Overall Study|Adverse Event|0|||
105458403|NCT04602390|363690424|FG004|Overall Study|Adverse Event|0|||
105458404|NCT04602390|363690425|FG005|Overall Study|Adverse Event|1|||
105458405|NCT03988400|363690427|FG000|Overall Study|Adverse Event|1|||
105458406|NCT03988400|363690428|FG001|Overall Study|Adverse Event|0|||
105458407|NCT03988400|363690427|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
105458408|NCT03988400|363690428|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
105458409|NCT03988400|363690427|FG000|Overall Study|Lost to Follow-up|0|||
105458410|NCT03988400|363690428|FG001|Overall Study|Lost to Follow-up|1|||
105458411|NCT03486912|363690433|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
105458412|NCT03486912|363690434|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
105458413|NCT03486912|363690435|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
105458414|NCT03486912|363690436|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
105458415|NCT03486912|363690433|FG000|Treatment Period|Withdrawal by Subject|3|||
105458416|NCT03486912|363690434|FG001|Treatment Period|Withdrawal by Subject|3|||
105458417|NCT03486912|363690435|FG002|Treatment Period|Withdrawal by Subject|3|||
105458418|NCT03486912|363690436|FG003|Treatment Period|Withdrawal by Subject|2|||
105458419|NCT03486912|363690433|FG000|Treatment Period|Other Reasons|0|||
105458420|NCT03486912|363690434|FG001|Treatment Period|Other Reasons|2|||
105458421|NCT03486912|363690435|FG002|Treatment Period|Other Reasons|1|||
105458422|NCT03486912|363690436|FG003|Treatment Period|Other Reasons|1|||
105458423|NCT03486912|363690433|FG000|Treatment Period|Adverse Event|0|||
105458424|NCT03486912|363690434|FG001|Treatment Period|Adverse Event|1|||
105458425|NCT03486912|363690435|FG002|Treatment Period|Adverse Event|1|||
105458426|NCT03486912|363690436|FG003|Treatment Period|Adverse Event|0|||
105458427|NCT03486912|363690433|FG000|Treatment Period|Lost to Follow-up|1|||
105458428|NCT03486912|363690434|FG001|Treatment Period|Lost to Follow-up|0|||
105458429|NCT03486912|363690435|FG002|Treatment Period|Lost to Follow-up|0|||
105458430|NCT03486912|363690436|FG003|Treatment Period|Lost to Follow-up|2|||
105458431|NCT02242942|363690439|FG000|Overall Study|Death|17|||
105458432|NCT02242942|363690440|FG001|Overall Study|Death|20|||
105458433|NCT02242942|363690441|FG002|Overall Study|Death|2|||
105458434|NCT02242942|363690439|FG000|Overall Study|Physician Decision|1|||
105458435|NCT02242942|363690440|FG001|Overall Study|Physician Decision|0|||
105458436|NCT02242942|363690441|FG002|Overall Study|Physician Decision|0|||
105458437|NCT02242942|363690439|FG000|Overall Study|Withdrawal by Subject|8|||
105458438|NCT02242942|363690440|FG001|Overall Study|Withdrawal by Subject|10|||
105458439|NCT02242942|363690441|FG002|Overall Study|Withdrawal by Subject|0|||
105458440|NCT02242942|363690439|FG000|Overall Study|On-going in Study|190|||
105458441|NCT02242942|363690440|FG001|Overall Study|On-going in Study|186|||
105458442|NCT02242942|363690441|FG002|Overall Study|On-going in Study|11|||
105458443|NCT04842747|363690442|FG000|Overall Study|Withdrawal by Subject|6|||
105458444|NCT04842747|363690443|FG001|Overall Study|Withdrawal by Subject|2|||
105458445|NCT04842747|363690442|FG000|Overall Study|Lost to Follow-up|1|||
105458446|NCT04842747|363690443|FG001|Overall Study|Lost to Follow-up|2|||
105458447|NCT04842747|363690442|FG000|Overall Study|Physician Decision|1|||
105337999|NCT02829723|363239210|FG014|Overall Study|Adverse Event|1|||
105338000|NCT02829723|363239211|FG015|Overall Study|Adverse Event|1|||
105338001|NCT02829723|363239212|FG016|Overall Study|Adverse Event|1|||
105458448|NCT04842747|363690443|FG001|Overall Study|Physician Decision|0|||
105458449|NCT04842747|363690442|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
105458450|NCT04842747|363690443|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
105458451|NCT02285855|363690444|FG000|Overall Study|Withdrawal by Subject|2|||
105458452|NCT02285855|363690445|FG001|Overall Study|Withdrawal by Subject|1|||
105458453|NCT01446159|363690447|FG000|Overall Study|Withdrawal by Subject|1|||
105458454|NCT01446159|363690448|FG001|Overall Study|Withdrawal by Subject|0|||
105458455|NCT01446159|363690449|FG002|Overall Study|Withdrawal by Subject|14|||
105458456|NCT01446159|363690450|FG003|Overall Study|Withdrawal by Subject|11|||
105458457|NCT01446159|363690447|FG000|Overall Study|Lost to Follow-up|0|||
105458458|NCT01446159|363690448|FG001|Overall Study|Lost to Follow-up|0|||
105458459|NCT01446159|363690449|FG002|Overall Study|Lost to Follow-up|1|||
105458460|NCT01446159|363690450|FG003|Overall Study|Lost to Follow-up|2|||
105458461|NCT01446159|363690447|FG000|Overall Study|Death|2|||
105458462|NCT01446159|363690448|FG001|Overall Study|Death|3|||
105458463|NCT01446159|363690449|FG002|Overall Study|Death|43|||
105458464|NCT01446159|363690450|FG003|Overall Study|Death|36|||
105458465|NCT01446159|363690447|FG000|Overall Study|Other|0|||
105458466|NCT01446159|363690448|FG001|Overall Study|Other|0|||
105458467|NCT01446159|363690449|FG002|Overall Study|Other|13|||
105458468|NCT01446159|363690450|FG003|Overall Study|Other|13|||
105458469|NCT02183675|363690451|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
105458470|NCT02183675|363690452|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
105458471|NCT02183675|363690453|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
105458472|NCT02183675|363690454|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
105458473|NCT02183675|363690455|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
105458474|NCT02183675|363690456|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
105458475|NCT01614249|363690457|FG000|Overall Study|Lost to Follow-up|11|||
105458476|NCT01614249|363690458|FG001|Overall Study|Lost to Follow-up|23|||
105458477|NCT02954536|363690459|FG000|Overall Study|Adverse Event|2|||
105458478|NCT02954536|363690459|FG000|Overall Study|Death|12|||
105338002|NCT02829723|363239213|FG017|Overall Study|Adverse Event|2|||
105338003|NCT02829723|363239214|FG018|Overall Study|Adverse Event|1|||
105338004|NCT02829723|363239215|FG019|Overall Study|Adverse Event|1|||
105338005|NCT02829723|363239216|FG020|Overall Study|Adverse Event|3|||
105338006|NCT02829723|363239217|FG021|Overall Study|Adverse Event|0|||
105338007|NCT02829723|363239218|FG022|Overall Study|Adverse Event|0|||
105338008|NCT02829723|363239219|FG023|Overall Study|Adverse Event|1|||
105338009|NCT02829723|363239220|FG024|Overall Study|Adverse Event|1|||
105338010|NCT02829723|363239221|FG025|Overall Study|Adverse Event|3|||
105338011|NCT02829723|363239222|FG026|Overall Study|Adverse Event|5|||
105338012|NCT02829723|363239196|FG000|Overall Study|Death|1|||
105338013|NCT02829723|363239197|FG001|Overall Study|Death|0|||
105338014|NCT02829723|363239198|FG002|Overall Study|Death|1|||
105338015|NCT02829723|363239199|FG003|Overall Study|Death|1|||
105338016|NCT02829723|363239200|FG004|Overall Study|Death|0|||
105338017|NCT02829723|363239201|FG005|Overall Study|Death|0|||
105338018|NCT02829723|363239202|FG006|Overall Study|Death|2|||
105338019|NCT02829723|363239203|FG007|Overall Study|Death|0|||
105338020|NCT02829723|363239204|FG008|Overall Study|Death|1|||
105338021|NCT02829723|363239205|FG009|Overall Study|Death|0|||
105338022|NCT02829723|363239206|FG010|Overall Study|Death|0|||
105338023|NCT02829723|363239207|FG011|Overall Study|Death|0|||
105338024|NCT02829723|363239208|FG012|Overall Study|Death|2|||
105338025|NCT02829723|363239209|FG013|Overall Study|Death|1|||
105338026|NCT02829723|363239210|FG014|Overall Study|Death|0|||
105338027|NCT02829723|363239211|FG015|Overall Study|Death|0|||
105338028|NCT02829723|363239212|FG016|Overall Study|Death|0|||
105338029|NCT02829723|363239213|FG017|Overall Study|Death|0|||
105338030|NCT02829723|363239214|FG018|Overall Study|Death|0|||
105338031|NCT02829723|363239215|FG019|Overall Study|Death|0|||
105338032|NCT02829723|363239216|FG020|Overall Study|Death|0|||
105338033|NCT02829723|363239217|FG021|Overall Study|Death|2|||
105338034|NCT02829723|363239218|FG022|Overall Study|Death|0|||
105458479|NCT03600909|363690463|FG000|Overall Study|Not treated|0|||
105458480|NCT03600909|363690464|FG001|Overall Study|Not treated|3|||
105458481|NCT03600909|363690465|FG002|Overall Study|Not treated|0|||
105338035|NCT02829723|363239219|FG023|Overall Study|Death|0|||
105338036|NCT02829723|363239220|FG024|Overall Study|Death|0|||
105458482|NCT00374140|363690466|FG000|Overall Study|Lost to Follow-up|1|||
105338037|NCT02829723|363239221|FG025|Overall Study|Death|1|||
105338038|NCT02829723|363239222|FG026|Overall Study|Death|2|||
105338039|NCT02829723|363239196|FG000|Overall Study|Physician Decision|0|||
105338040|NCT02829723|363239197|FG001|Overall Study|Physician Decision|0|||
105338041|NCT02829723|363239198|FG002|Overall Study|Physician Decision|0|||
105338042|NCT02829723|363239199|FG003|Overall Study|Physician Decision|0|||
105338043|NCT02829723|363239200|FG004|Overall Study|Physician Decision|0|||
105338044|NCT02829723|363239201|FG005|Overall Study|Physician Decision|0|||
105338045|NCT02829723|363239202|FG006|Overall Study|Physician Decision|0|||
105338046|NCT02829723|363239203|FG007|Overall Study|Physician Decision|0|||
105458483|NCT00374140|363690466|FG000|Overall Study|Protocol Violation|1|||
105458484|NCT01576341|363690467|FG000|Overall Study|Withdrawal by Subject|24|||
105458485|NCT01576341|363690467|FG000|Overall Study|Adverse Event|10|||
105458486|NCT01576341|363690467|FG000|Overall Study|Death|21|||
105458487|NCT01576341|363690467|FG000|Overall Study|Physician Decision|2|||
105458488|NCT01576341|363690467|FG000|Overall Study|Lost to Follow-up|2|||
105458489|NCT01576341|363690467|FG000|Overall Study|Kidney transplantation|10|||
105458490|NCT01576341|363690467|FG000|Overall Study|Protocol Violation|12|||
105458491|NCT01576341|363690467|FG000|Overall Study|Other|12|||
105458492|NCT01844765|363690468|FG000|Overall Study|Adverse Event|6|||
105458493|NCT01844765|363690469|FG001|Overall Study|Adverse Event|8|||
105458494|NCT01844765|363690468|FG000|Overall Study|Withdrawal by Subject|2|||
105458495|NCT01844765|363690469|FG001|Overall Study|Withdrawal by Subject|3|||
105458496|NCT01844765|363690468|FG000|Overall Study|Disease progression|1|||
105458497|NCT01844765|363690469|FG001|Overall Study|Disease progression|0|||
105458498|NCT01844765|363690468|FG000|Overall Study|Administrative problems|3|||
105458499|NCT01844765|363690469|FG001|Overall Study|Administrative problems|4|||
105458500|NCT01844765|363690468|FG000|Overall Study|Protocol deviation|2|||
105458501|NCT01844765|363690469|FG001|Overall Study|Protocol deviation|0|||
105458502|NCT01844765|363690468|FG000|Overall Study|Untreated|1|||
105458503|NCT01844765|363690469|FG001|Overall Study|Untreated|0|||
105458504|NCT04764162|363690475|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
105458505|NCT04764162|363690476|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
105458506|NCT02783690|363690477|FG000|Overall Study|Withdrawal by Subject|3|||
105458507|NCT02783690|363690478|FG001|Overall Study|Withdrawal by Subject|3|||
105458508|NCT03589859|363690479|FG000|Overall Study|Withdrawal by Subject|0|||
105458509|NCT03589859|363690480|FG001|Overall Study|Withdrawal by Subject|6|||
105458510|NCT04966013|363690481|FG000|Overall Study|Withdrawal by Subject|0|||
105458511|NCT04966013|363690482|FG001|Overall Study|Withdrawal by Subject|2|||
105458512|NCT04966013|363690483|FG002|Overall Study|Withdrawal by Subject|1|||
105458513|NCT04966013|363690481|FG000|Overall Study|Adverse Event|2|||
105458514|NCT04966013|363690482|FG001|Overall Study|Adverse Event|1|||
105458515|NCT04966013|363690483|FG002|Overall Study|Adverse Event|1|||
105458516|NCT03518086|363690484|FG000|Overall Study|Adverse Event|23|||
105458517|NCT03518086|363690485|FG001|Overall Study|Adverse Event|15|||
105458518|NCT03518086|363690486|FG002|Overall Study|Adverse Event|3|||
105458519|NCT03518086|363690487|FG003|Overall Study|Adverse Event|2|||
105458520|NCT03518086|363690484|FG000|Overall Study|Withdrawal by Subject|8|||
105458521|NCT03518086|363690485|FG001|Overall Study|Withdrawal by Subject|5|||
105458522|NCT03518086|363690486|FG002|Overall Study|Withdrawal by Subject|1|||
105458523|NCT03518086|363690487|FG003|Overall Study|Withdrawal by Subject|0|||
105458524|NCT03518086|363690484|FG000|Overall Study|Lack of Efficacy|5|||
105458525|NCT03518086|363690485|FG001|Overall Study|Lack of Efficacy|5|||
105458526|NCT03518086|363690486|FG002|Overall Study|Lack of Efficacy|0|||
105458527|NCT03518086|363690487|FG003|Overall Study|Lack of Efficacy|2|||
105458528|NCT03518086|363690484|FG000|Overall Study|Protocol Violation|1|||
105458529|NCT03518086|363690485|FG001|Overall Study|Protocol Violation|5|||
105458530|NCT03518086|363690486|FG002|Overall Study|Protocol Violation|1|||
105458531|NCT03518086|363690487|FG003|Overall Study|Protocol Violation|3|||
105458532|NCT03518086|363690484|FG000|Overall Study|Lost to Follow-up|0|||
105458533|NCT03518086|363690485|FG001|Overall Study|Lost to Follow-up|3|||
105458534|NCT03518086|363690486|FG002|Overall Study|Lost to Follow-up|0|||
105458535|NCT03518086|363690487|FG003|Overall Study|Lost to Follow-up|0|||
105458536|NCT03518086|363690484|FG000|Overall Study|Insufficient Diary Data|0|||
105458537|NCT03518086|363690485|FG001|Overall Study|Insufficient Diary Data|2|||
105458538|NCT03518086|363690486|FG002|Overall Study|Insufficient Diary Data|0|||
105458539|NCT03518086|363690487|FG003|Overall Study|Insufficient Diary Data|0|||
105458540|NCT03518086|363690484|FG000|Overall Study|Non- compliance to Protocol|0|||
105458541|NCT03518086|363690485|FG001|Overall Study|Non- compliance to Protocol|1|||
105458542|NCT03518086|363690486|FG002|Overall Study|Non- compliance to Protocol|0|||
105458543|NCT03518086|363690487|FG003|Overall Study|Non- compliance to Protocol|0|||
105458544|NCT03518086|363690484|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
105458545|NCT03518086|363690485|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
105458546|NCT03518086|363690486|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
105458547|NCT03518086|363690487|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
105458548|NCT03518086|363690484|FG000|Overall Study|Site Terminated by Sponsor|0|||
105458549|NCT03518086|363690485|FG001|Overall Study|Site Terminated by Sponsor|1|||
105458550|NCT03518086|363690486|FG002|Overall Study|Site Terminated by Sponsor|0|||
105458551|NCT03518086|363690487|FG003|Overall Study|Site Terminated by Sponsor|0|||
105458552|NCT03518086|363690484|FG000|Overall Study|Pregnancy|0|||
105458553|NCT03518086|363690485|FG001|Overall Study|Pregnancy|0|||
105458554|NCT03518086|363690486|FG002|Overall Study|Pregnancy|0|||
105458555|NCT03518086|363690487|FG003|Overall Study|Pregnancy|2|||
105458556|NCT05967260|363690488|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
105458557|NCT05967260|363690489|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
105458558|NCT02336282|363690490|FG000|Overall Study|Unrelated illness|1|||
105338047|NCT02829723|363239204|FG008|Overall Study|Physician Decision|0|||
105338048|NCT02829723|363239205|FG009|Overall Study|Physician Decision|1|||
105338049|NCT02829723|363239206|FG010|Overall Study|Physician Decision|1|||
105338050|NCT02829723|363239207|FG011|Overall Study|Physician Decision|0|||
105338051|NCT02829723|363239208|FG012|Overall Study|Physician Decision|0|||
105338052|NCT02829723|363239209|FG013|Overall Study|Physician Decision|1|||
105338053|NCT02829723|363239210|FG014|Overall Study|Physician Decision|0|||
105338054|NCT02829723|363239211|FG015|Overall Study|Physician Decision|0|||
105338055|NCT02829723|363239212|FG016|Overall Study|Physician Decision|2|||
105338056|NCT02829723|363239213|FG017|Overall Study|Physician Decision|0|||
105338057|NCT02829723|363239214|FG018|Overall Study|Physician Decision|0|||
105338058|NCT02829723|363239215|FG019|Overall Study|Physician Decision|0|||
105338059|NCT02829723|363239216|FG020|Overall Study|Physician Decision|0|||
105338060|NCT02829723|363239217|FG021|Overall Study|Physician Decision|0|||
105338061|NCT02829723|363239218|FG022|Overall Study|Physician Decision|1|||
105338062|NCT02829723|363239219|FG023|Overall Study|Physician Decision|1|||
105338063|NCT02829723|363239220|FG024|Overall Study|Physician Decision|1|||
105338064|NCT02829723|363239221|FG025|Overall Study|Physician Decision|1|||
105338065|NCT02829723|363239222|FG026|Overall Study|Physician Decision|3|||
105338066|NCT02829723|363239196|FG000|Overall Study|Progressive disease|4|||
105338067|NCT02829723|363239197|FG001|Overall Study|Progressive disease|6|||
105338068|NCT02829723|363239198|FG002|Overall Study|Progressive disease|3|||
105338069|NCT02829723|363239199|FG003|Overall Study|Progressive disease|3|||
105338070|NCT02829723|363239200|FG004|Overall Study|Progressive disease|3|||
105338071|NCT02829723|363239201|FG005|Overall Study|Progressive disease|5|||
105338072|NCT02829723|363239202|FG006|Overall Study|Progressive disease|4|||
105338073|NCT02829723|363239203|FG007|Overall Study|Progressive disease|6|||
105338074|NCT02829723|363239204|FG008|Overall Study|Progressive disease|8|||
105338075|NCT02829723|363239205|FG009|Overall Study|Progressive disease|4|||
105338076|NCT02829723|363239206|FG010|Overall Study|Progressive disease|9|||
105338077|NCT02829723|363239207|FG011|Overall Study|Progressive disease|0|||
105338078|NCT02829723|363239208|FG012|Overall Study|Progressive disease|3|||
105338079|NCT02829723|363239209|FG013|Overall Study|Progressive disease|4|||
105338080|NCT02829723|363239210|FG014|Overall Study|Progressive disease|2|||
105338081|NCT02829723|363239211|FG015|Overall Study|Progressive disease|4|||
105338082|NCT02829723|363239212|FG016|Overall Study|Progressive disease|5|||
105338083|NCT02829723|363239213|FG017|Overall Study|Progressive disease|3|||
105338084|NCT02829723|363239214|FG018|Overall Study|Progressive disease|4|||
105338085|NCT02829723|363239215|FG019|Overall Study|Progressive disease|4|||
105338086|NCT02829723|363239216|FG020|Overall Study|Progressive disease|7|||
105338087|NCT02829723|363239217|FG021|Overall Study|Progressive disease|6|||
105338088|NCT02829723|363239218|FG022|Overall Study|Progressive disease|3|||
105338089|NCT02829723|363239219|FG023|Overall Study|Progressive disease|3|||
105338090|NCT02829723|363239220|FG024|Overall Study|Progressive disease|3|||
105338091|NCT02829723|363239221|FG025|Overall Study|Progressive disease|16|||
105338092|NCT02829723|363239222|FG026|Overall Study|Progressive disease|10|||
105338093|NCT02829723|363239196|FG000|Overall Study|Subject/guardian decision|0|||
105338094|NCT02829723|363239197|FG001|Overall Study|Subject/guardian decision|1|||
105338095|NCT02829723|363239198|FG002|Overall Study|Subject/guardian decision|0|||
105338096|NCT02829723|363239199|FG003|Overall Study|Subject/guardian decision|1|||
105338097|NCT02829723|363239200|FG004|Overall Study|Subject/guardian decision|0|||
105338098|NCT02829723|363239201|FG005|Overall Study|Subject/guardian decision|0|||
105338099|NCT02829723|363239202|FG006|Overall Study|Subject/guardian decision|0|||
105338100|NCT02829723|363239203|FG007|Overall Study|Subject/guardian decision|1|||
105338101|NCT02829723|363239204|FG008|Overall Study|Subject/guardian decision|0|||
105338102|NCT02829723|363239205|FG009|Overall Study|Subject/guardian decision|0|||
105338103|NCT02829723|363239206|FG010|Overall Study|Subject/guardian decision|0|||
105338104|NCT02829723|363239207|FG011|Overall Study|Subject/guardian decision|0|||
105338105|NCT02829723|363239208|FG012|Overall Study|Subject/guardian decision|0|||
105338106|NCT02829723|363239209|FG013|Overall Study|Subject/guardian decision|0|||
105338107|NCT02829723|363239210|FG014|Overall Study|Subject/guardian decision|1|||
105338108|NCT02829723|363239211|FG015|Overall Study|Subject/guardian decision|0|||
105338109|NCT02829723|363239212|FG016|Overall Study|Subject/guardian decision|1|||
105338110|NCT02829723|363239213|FG017|Overall Study|Subject/guardian decision|0|||
105338111|NCT02829723|363239214|FG018|Overall Study|Subject/guardian decision|1|||
105338112|NCT02829723|363239215|FG019|Overall Study|Subject/guardian decision|0|||
105338113|NCT02829723|363239216|FG020|Overall Study|Subject/guardian decision|1|||
105338114|NCT02829723|363239217|FG021|Overall Study|Subject/guardian decision|0|||
105338115|NCT02829723|363239218|FG022|Overall Study|Subject/guardian decision|0|||
105338116|NCT02829723|363239219|FG023|Overall Study|Subject/guardian decision|1|||
105338117|NCT02829723|363239220|FG024|Overall Study|Subject/guardian decision|0|||
105458559|NCT02336282|363690490|FG000|Overall Study|Uncomfortable with technology|1|||
105458560|NCT02336282|363690490|FG000|Overall Study|Lost to Follow-up|1|||
105338118|NCT02829723|363239221|FG025|Overall Study|Subject/guardian decision|1|||
105338119|NCT02829723|363239222|FG026|Overall Study|Subject/guardian decision|1|||
105338120|NCT02829723|363239196|FG000|Overall Study|Study terminated by sponsor|0|||
105458561|NCT02336282|363690490|FG000|Overall Study|Not enough time to complete sessions|2|||
105458562|NCT04875975|363690491|FG000|Overall Study|Adverse Event|1|||
105458563|NCT04875975|363690492|FG001|Overall Study|Adverse Event|2|||
105458564|NCT04875975|363690491|FG000|Overall Study|Lack of Efficacy|2|||
105458565|NCT04875975|363690492|FG001|Overall Study|Lack of Efficacy|2|||
105458566|NCT04875975|363690491|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
105458567|NCT04875975|363690492|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
105458568|NCT04875975|363690491|FG000|Overall Study|Relapse With Insults|0|||
105458569|NCT04875975|363690492|FG001|Overall Study|Relapse With Insults|1|||
105458570|NCT04875975|363690491|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
105458571|NCT04875975|363690492|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
105458572|NCT00781768|363692020|FG000|Overall Study|Not transplanted.|0|||
105458573|NCT00781768|363692021|FG001|Overall Study|Not transplanted.|2|||
105458574|NCT02458313|363692022|FG000|Overall Study|Withdrawal by Subject|6|||
105458575|NCT02458313|363692023|FG001|Overall Study|Withdrawal by Subject|8|||
105458576|NCT02458313|363692022|FG000|Overall Study|Excluded for motion during MRI|1|||
105458577|NCT02458313|363692023|FG001|Overall Study|Excluded for motion during MRI|2|||
105458578|NCT00904969|363692024|FG000|Overall Study|Lost to Follow-up|4|||
105458579|NCT00904969|363692024|FG000|Overall Study|Withdrawal by Subject|3|||
105458580|NCT00904969|363692024|FG000|Overall Study|Additional Treatments|11|||
105458581|NCT00904969|363692024|FG000|Overall Study|Case Aborted; Subject Exited|1|||
105458582|NCT01097668|363692025|FG000|Overall Study|Withdrawal by Subject|1|||
105458583|NCT01097668|363692026|FG001|Overall Study|Withdrawal by Subject|2|||
105458584|NCT01097668|363692025|FG000|Overall Study|Lost to Follow-up|1|||
105458585|NCT01097668|363692026|FG001|Overall Study|Lost to Follow-up|0|||
105458586|NCT03037385|363692027|FG000|Overall Study|Adverse Event|0|||
105458587|NCT03037385|363692028|FG001|Overall Study|Adverse Event|0|||
105458588|NCT03037385|363692029|FG002|Overall Study|Adverse Event|1|||
105458589|NCT03037385|363692030|FG003|Overall Study|Adverse Event|0|||
105458590|NCT03037385|363692031|FG004|Overall Study|Adverse Event|0|||
105458591|NCT03037385|363692032|FG005|Overall Study|Adverse Event|0|||
105458592|NCT03037385|363692033|FG006|Overall Study|Adverse Event|0|||
105458593|NCT03037385|363692034|FG007|Overall Study|Adverse Event|0|||
105458594|NCT03037385|363692035|FG008|Overall Study|Adverse Event|0|||
105458595|NCT03037385|363692036|FG009|Overall Study|Adverse Event|6|||
105458596|NCT03037385|363692027|FG000|Overall Study|Death|1|||
105458597|NCT03037385|363692028|FG001|Overall Study|Death|4|||
105458598|NCT03037385|363692029|FG002|Overall Study|Death|2|||
105458599|NCT03037385|363692030|FG003|Overall Study|Death|2|||
105458600|NCT03037385|363692031|FG004|Overall Study|Death|5|||
105458601|NCT03037385|363692032|FG005|Overall Study|Death|2|||
105458602|NCT03037385|363692033|FG006|Overall Study|Death|1|||
105458603|NCT03037385|363692034|FG007|Overall Study|Death|4|||
105458604|NCT03037385|363692035|FG008|Overall Study|Death|3|||
105458605|NCT03037385|363692036|FG009|Overall Study|Death|240|||
105458606|NCT03037385|363692027|FG000|Overall Study|Initiation of Another Therapy|1|||
105458607|NCT03037385|363692028|FG001|Overall Study|Initiation of Another Therapy|0|||
105458608|NCT03037385|363692029|FG002|Overall Study|Initiation of Another Therapy|0|||
105458609|NCT03037385|363692030|FG003|Overall Study|Initiation of Another Therapy|0|||
105458610|NCT03037385|363692031|FG004|Overall Study|Initiation of Another Therapy|0|||
105458611|NCT03037385|363692032|FG005|Overall Study|Initiation of Another Therapy|0|||
105458612|NCT03037385|363692033|FG006|Overall Study|Initiation of Another Therapy|0|||
105458613|NCT03037385|363692034|FG007|Overall Study|Initiation of Another Therapy|1|||
105458614|NCT03037385|363692035|FG008|Overall Study|Initiation of Another Therapy|0|||
105458615|NCT03037385|363692036|FG009|Overall Study|Initiation of Another Therapy|2|||
105458616|NCT03037385|363692027|FG000|Overall Study|Lost to Follow-up|0|||
105458617|NCT03037385|363692028|FG001|Overall Study|Lost to Follow-up|0|||
105458618|NCT03037385|363692029|FG002|Overall Study|Lost to Follow-up|0|||
105458619|NCT03037385|363692030|FG003|Overall Study|Lost to Follow-up|0|||
105458620|NCT03037385|363692031|FG004|Overall Study|Lost to Follow-up|0|||
105458621|NCT03037385|363692032|FG005|Overall Study|Lost to Follow-up|1|||
105458622|NCT03037385|363692033|FG006|Overall Study|Lost to Follow-up|0|||
105458623|NCT03037385|363692034|FG007|Overall Study|Lost to Follow-up|0|||
105458624|NCT03037385|363692035|FG008|Overall Study|Lost to Follow-up|0|||
105458625|NCT03037385|363692036|FG009|Overall Study|Lost to Follow-up|16|||
105458626|NCT03037385|363692027|FG000|Overall Study|Physician Decision|0|||
105458627|NCT03037385|363692028|FG001|Overall Study|Physician Decision|0|||
105458628|NCT03037385|363692029|FG002|Overall Study|Physician Decision|0|||
105458629|NCT03037385|363692030|FG003|Overall Study|Physician Decision|0|||
105458630|NCT03037385|363692031|FG004|Overall Study|Physician Decision|0|||
105458631|NCT03037385|363692032|FG005|Overall Study|Physician Decision|0|||
105458632|NCT03037385|363692033|FG006|Overall Study|Physician Decision|0|||
105458633|NCT03037385|363692034|FG007|Overall Study|Physician Decision|0|||
105458634|NCT03037385|363692035|FG008|Overall Study|Physician Decision|0|||
105458635|NCT03037385|363692036|FG009|Overall Study|Physician Decision|1|||
105458636|NCT03037385|363692027|FG000|Overall Study|Progressive Disease|0|||
105458637|NCT03037385|363692028|FG001|Overall Study|Progressive Disease|1|||
105458638|NCT03037385|363692029|FG002|Overall Study|Progressive Disease|1|||
105458639|NCT03037385|363692030|FG003|Overall Study|Progressive Disease|5|||
105458640|NCT03037385|363692031|FG004|Overall Study|Progressive Disease|2|||
105458641|NCT03037385|363692032|FG005|Overall Study|Progressive Disease|0|||
105458642|NCT03037385|363692033|FG006|Overall Study|Progressive Disease|1|||
105458643|NCT03037385|363692034|FG007|Overall Study|Progressive Disease|0|||
105458644|NCT03037385|363692035|FG008|Overall Study|Progressive Disease|0|||
105458645|NCT03037385|363692036|FG009|Overall Study|Progressive Disease|30|||
105458646|NCT03037385|363692027|FG000|Overall Study|Withdrawal by Subject|0|||
105458647|NCT03037385|363692028|FG001|Overall Study|Withdrawal by Subject|0|||
105458648|NCT03037385|363692029|FG002|Overall Study|Withdrawal by Subject|1|||
105458649|NCT03037385|363692030|FG003|Overall Study|Withdrawal by Subject|2|||
105458650|NCT03037385|363692031|FG004|Overall Study|Withdrawal by Subject|1|||
105458651|NCT03037385|363692032|FG005|Overall Study|Withdrawal by Subject|3|||
105458652|NCT03037385|363692033|FG006|Overall Study|Withdrawal by Subject|0|||
105458653|NCT03037385|363692034|FG007|Overall Study|Withdrawal by Subject|0|||
105458654|NCT03037385|363692035|FG008|Overall Study|Withdrawal by Subject|0|||
105458655|NCT03037385|363692036|FG009|Overall Study|Withdrawal by Subject|52|||
105458656|NCT03037385|363692027|FG000|Overall Study|Reason Not Specified|0|||
105458657|NCT03037385|363692028|FG001|Overall Study|Reason Not Specified|1|||
105458658|NCT03037385|363692029|FG002|Overall Study|Reason Not Specified|0|||
105458659|NCT03037385|363692030|FG003|Overall Study|Reason Not Specified|4|||
105458660|NCT03037385|363692031|FG004|Overall Study|Reason Not Specified|3|||
105458661|NCT03037385|363692032|FG005|Overall Study|Reason Not Specified|6|||
105458662|NCT03037385|363692033|FG006|Overall Study|Reason Not Specified|2|||
105458663|NCT03037385|363692034|FG007|Overall Study|Reason Not Specified|0|||
105458664|NCT03037385|363692035|FG008|Overall Study|Reason Not Specified|1|||
105458665|NCT03037385|363692036|FG009|Overall Study|Reason Not Specified|181|||
105458666|NCT01702311|363692037|FG000|Overall Study|Withdrawal by Subject|3|||
105458667|NCT01702311|363692038|FG001|Overall Study|Withdrawal by Subject|2|||
105458668|NCT01702311|363692037|FG000|Overall Study|Discharge less than 24 hours|10|||
105458669|NCT01702311|363692038|FG001|Overall Study|Discharge less than 24 hours|7|||
105458670|NCT01702311|363692037|FG000|Overall Study|Physician Decision|3|||
105458671|NCT01702311|363692038|FG001|Overall Study|Physician Decision|4|||
105458672|NCT01473134|363692048|FG000|Overall Study|Lost to Follow-up|21|||
105458673|NCT01473134|363692049|FG001|Overall Study|Lost to Follow-up|13|||
105458674|NCT01473134|363692048|FG000|Overall Study|Protocol Violation|32|||
105458675|NCT01473134|363692049|FG001|Overall Study|Protocol Violation|19|||
105458676|NCT01473134|363692048|FG000|Overall Study|Withdrawal by Subject|1|||
105458677|NCT01473134|363692049|FG001|Overall Study|Withdrawal by Subject|2|||
105458678|NCT01473134|363692048|FG000|Overall Study|Death|0|||
105458679|NCT01473134|363692049|FG001|Overall Study|Death|1|||
105458680|NCT01473134|363692048|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
105550208|NCT00467870|364014377|FG003|Overall Study|Lost to Follow-up|1|||
105458681|NCT01473134|363692049|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
105458682|NCT05176314|363692051|FG000|Overall Study|Lost to Follow-up|2|||
105458683|NCT05176314|363692051|FG000|Overall Study|Physician Decision|1|||
105458684|NCT05176314|363692051|FG000|Overall Study|Adverse Event|1|||
105458685|NCT00807911|363692052|FG000|Overall Study|Withdrawal by Subject|12|||
105458686|NCT00807911|363692053|FG001|Overall Study|Withdrawal by Subject|10|||
105458687|NCT00807911|363692052|FG000|Overall Study|Ineligible|0|||
105458688|NCT00807911|363692053|FG001|Overall Study|Ineligible|4|||
105458689|NCT03041038|363692054|FG000|Overall Study|Withdrawal by Subject|4|||
105458690|NCT03041038|363692055|FG001|Overall Study|Withdrawal by Subject|0|||
105458691|NCT03041038|363692054|FG000|Overall Study|Lost to Follow-up|1|||
105458692|NCT03041038|363692055|FG001|Overall Study|Lost to Follow-up|1|||
105458693|NCT03041038|363692054|FG000|Overall Study|Protocol Violation|1|||
105458694|NCT03041038|363692055|FG001|Overall Study|Protocol Violation|1|||
105458695|NCT02388269|363692056|FG000|Overall Study|Adverse Event|2|||
105458696|NCT02388269|363692057|FG001|Overall Study|Adverse Event|0|||
105458697|NCT02388269|363692058|FG002|Overall Study|Adverse Event|0|||
105458698|NCT02388269|363692056|FG000|Overall Study|Withdrawal by Subject|1|||
105458699|NCT02388269|363692057|FG001|Overall Study|Withdrawal by Subject|2|||
105458700|NCT02388269|363692058|FG002|Overall Study|Withdrawal by Subject|0|||
105458701|NCT02388269|363692056|FG000|Overall Study|less than 50% stimulations|1|||
105458702|NCT02388269|363692057|FG001|Overall Study|less than 50% stimulations|0|||
105458703|NCT02388269|363692058|FG002|Overall Study|less than 50% stimulations|0|||
105458704|NCT02388269|363692056|FG000|Overall Study|no diary data|3|||
105458705|NCT02388269|363692057|FG001|Overall Study|no diary data|0|||
105458706|NCT02388269|363692058|FG002|Overall Study|no diary data|0|||
105458707|NCT02388269|363692056|FG000|Overall Study|Protocol Violation|2|||
105458708|NCT02388269|363692057|FG001|Overall Study|Protocol Violation|0|||
105458709|NCT02388269|363692058|FG002|Overall Study|Protocol Violation|0|||
105458710|NCT02388269|363692056|FG000|Overall Study|Screen Failure|0|||
105458711|NCT02388269|363692057|FG001|Overall Study|Screen Failure|0|||
105458712|NCT02388269|363692058|FG002|Overall Study|Screen Failure|10|||
105458713|NCT01553084|363692060|FG000|Overall Study|Withdrawal by Subject|15|||
105458714|NCT01553084|363692061|FG001|Overall Study|Withdrawal by Subject|13|||
105458715|NCT01553084|363692062|FG002|Overall Study|Withdrawal by Subject|35|||
105458716|NCT03962491|363692063|FG000|Overall Study|Lost to Follow-up|4|||
105458717|NCT03962491|363692064|FG001|Overall Study|Lost to Follow-up|5|||
105338121|NCT02829723|363239197|FG001|Overall Study|Study terminated by sponsor|0|||
105458718|NCT03651765|363692072|FG000|Overall Study|Adverse Event|6|||
105458719|NCT03651765|363692072|FG000|Overall Study|Lack of Efficacy|18|||
105458720|NCT03651765|363692072|FG000|Overall Study|Lost to Follow-up|5|||
105458721|NCT03651765|363692072|FG000|Overall Study|Non-Compliance with Study Drug|4|||
105458722|NCT03651765|363692072|FG000|Overall Study|Physician Decision|6|||
105458723|NCT03651765|363692072|FG000|Overall Study|Pregnancy|1|||
105458724|NCT03651765|363692072|FG000|Overall Study|Discontinued by Sponsor|40|||
105458725|NCT03651765|363692072|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
105458726|NCT03651765|363692072|FG000|Overall Study|Withdrawal by Subject|24|||
105458727|NCT03651765|363692072|FG000|Overall Study|Miscellaneous|6|||
105458728|NCT04852302|363692088|FG000|Overall Study|Withdrawal by Subject|2|||
105458729|NCT04852302|363692088|FG000|Overall Study|Did not complete CALM therapy.|2|||
105458730|NCT01263769|363692089|FG000|Overall Study|Non-Compliant with treatment|1|||
105458731|NCT03267277|363692090|FG000|Overall Study|Withdrawal by Subject|1|||
105458732|NCT05058365|363692091|FG000|Overall Study|Migration|1|||
105458733|NCT05058365|363692092|FG001|Overall Study|Migration|1|||
105458734|NCT04849364|363692093|FG000|Overall Study|Eligibility criteria not meet|0|||
105458735|NCT04849364|363692094|FG001|Overall Study|Eligibility criteria not meet|1|||
105458736|NCT04849364|363692095|FG002|Overall Study|Eligibility criteria not meet|0|||
105458737|NCT04298697|363692098|FG000|Overall Study|Lost to Follow-up|5|||
105458738|NCT04298697|363692099|FG001|Overall Study|Lost to Follow-up|5|||
105458739|NCT04298697|363692100|FG002|Overall Study|Lost to Follow-up|1|||
105458740|NCT04298697|363692101|FG003|Overall Study|Lost to Follow-up|0|||
105458741|NCT04298697|363692098|FG000|Overall Study|Withdrawal by Subject|0|||
105458742|NCT04298697|363692099|FG001|Overall Study|Withdrawal by Subject|3|||
105458743|NCT04298697|363692100|FG002|Overall Study|Withdrawal by Subject|2|||
105458744|NCT04298697|363692101|FG003|Overall Study|Withdrawal by Subject|3|||
105458745|NCT00449696|363692102|FG000|Overall Study|Other Treatment Required|6|||
105458746|NCT00449696|363692103|FG001|Overall Study|Other Treatment Required|1|||
105458747|NCT00449696|363692102|FG000|Overall Study|Withdrawal by Subject|5|||
105458748|NCT00449696|363692103|FG001|Overall Study|Withdrawal by Subject|5|||
105458749|NCT00449696|363692102|FG000|Overall Study|Lost to Follow-up|2|||
105458750|NCT00449696|363692103|FG001|Overall Study|Lost to Follow-up|3|||
105458751|NCT00449696|363692102|FG000|Overall Study|Others|7|||
105458752|NCT00449696|363692103|FG001|Overall Study|Others|0|||
105458753|NCT00468169|363692107|FG000|Overall Study|Withdrawal by Subject|1|||
105458754|NCT00468169|363692108|FG001|Overall Study|Withdrawal by Subject|0|||
105458755|NCT01126749|363692113|FG000|Phase 1b|Other|0|||
105458756|NCT01126749|363692114|FG001|Phase 1b|Other|1|||
105458757|NCT01126749|363692115|FG002|Phase 1b|Other|0|||
105338122|NCT02829723|363239198|FG002|Overall Study|Study terminated by sponsor|0|||
105338123|NCT02829723|363239199|FG003|Overall Study|Study terminated by sponsor|0|||
105338124|NCT02829723|363239200|FG004|Overall Study|Study terminated by sponsor|0|||
105338125|NCT02829723|363239201|FG005|Overall Study|Study terminated by sponsor|0|||
105458758|NCT01126749|363692116|FG003|Phase 1b|Other|0|||
105458759|NCT01126749|363692113|FG000|Phase 1b|Withdrawal by Subject|0|||
105338126|NCT02829723|363239202|FG006|Overall Study|Study terminated by sponsor|0|||
105338127|NCT02829723|363239203|FG007|Overall Study|Study terminated by sponsor|0|||
105338128|NCT02829723|363239204|FG008|Overall Study|Study terminated by sponsor|0|||
105338129|NCT02829723|363239205|FG009|Overall Study|Study terminated by sponsor|0|||
105338130|NCT02829723|363239206|FG010|Overall Study|Study terminated by sponsor|0|||
105338131|NCT02829723|363239207|FG011|Overall Study|Study terminated by sponsor|0|||
105338132|NCT02829723|363239208|FG012|Overall Study|Study terminated by sponsor|0|||
105338133|NCT02829723|363239209|FG013|Overall Study|Study terminated by sponsor|0|||
105338134|NCT02829723|363239210|FG014|Overall Study|Study terminated by sponsor|0|||
105338135|NCT02829723|363239211|FG015|Overall Study|Study terminated by sponsor|0|||
105338136|NCT02829723|363239212|FG016|Overall Study|Study terminated by sponsor|0|||
105338137|NCT02829723|363239213|FG017|Overall Study|Study terminated by sponsor|0|||
105338138|NCT02829723|363239214|FG018|Overall Study|Study terminated by sponsor|0|||
105338139|NCT02829723|363239215|FG019|Overall Study|Study terminated by sponsor|0|||
105338140|NCT02829723|363239216|FG020|Overall Study|Study terminated by sponsor|0|||
105338141|NCT02829723|363239217|FG021|Overall Study|Study terminated by sponsor|1|||
105338142|NCT02829723|363239218|FG022|Overall Study|Study terminated by sponsor|0|||
105338143|NCT02829723|363239219|FG023|Overall Study|Study terminated by sponsor|0|||
105338144|NCT02829723|363239220|FG024|Overall Study|Study terminated by sponsor|0|||
105338145|NCT02829723|363239221|FG025|Overall Study|Study terminated by sponsor|0|||
105338146|NCT02829723|363239222|FG026|Overall Study|Study terminated by sponsor|0|||
105458760|NCT01126749|363692114|FG001|Phase 1b|Withdrawal by Subject|1|||
105338147|NCT03990571|363239223|FG000|Overall Study|Withdrawal by Subject|1|||
105338148|NCT03990571|363239223|FG000|Overall Study|Insurance Issues|3|||
105338149|NCT03990571|363239223|FG000|Overall Study|Covid Restrictions|2|||
105338150|NCT03696108|363239226|FG000|Overall Study|Physician Decision|1|||
105338151|NCT03696108|363239227|FG001|Overall Study|Physician Decision|0|||
105338152|NCT03696108|363239226|FG000|Overall Study|Withdrawal by Subject|3|||
105338153|NCT03696108|363239227|FG001|Overall Study|Withdrawal by Subject|6|||
105338154|NCT02892422|363239229|FG000|Overall Study|Enrolled not treated|4|||
105338155|NCT02892422|363239229|FG000|Overall Study|Adverse Event|38|||
105458761|NCT01126749|363692115|FG002|Phase 1b|Withdrawal by Subject|0|||
105458762|NCT01126749|363692116|FG003|Phase 1b|Withdrawal by Subject|0|||
105458763|NCT01126749|363692113|FG000|Phase 1b|Death|3|||
105458764|NCT01126749|363692114|FG001|Phase 1b|Death|4|||
105458765|NCT01126749|363692115|FG002|Phase 1b|Death|0|||
105458766|NCT01126749|363692116|FG003|Phase 1b|Death|0|||
105458767|NCT01126749|363692113|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
105458768|NCT01126749|363692114|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
105458769|NCT01126749|363692115|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
105458770|NCT01126749|363692116|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
105458771|NCT01126749|363692113|FG000|Phase 2|Study Termination by Sponsor|0|||
105458772|NCT01126749|363692114|FG001|Phase 2|Study Termination by Sponsor|0|||
105338156|NCT02892422|363239229|FG000|Overall Study|Lack of Efficacy|32|||
105338157|NCT02892422|363239229|FG000|Overall Study|Non-compliance with study drug|11|||
105458773|NCT01126749|363692115|FG002|Phase 2|Study Termination by Sponsor|12|||
105458774|NCT01126749|363692116|FG003|Phase 2|Study Termination by Sponsor|6|||
105458775|NCT01126749|363692113|FG000|Phase 2|Other|0|||
105458776|NCT01126749|363692114|FG001|Phase 2|Other|0|||
105458777|NCT01126749|363692115|FG002|Phase 2|Other|4|||
105458778|NCT01126749|363692116|FG003|Phase 2|Other|2|||
105458779|NCT01126749|363692113|FG000|Phase 2|Withdrawal by Subject|0|||
105458780|NCT01126749|363692114|FG001|Phase 2|Withdrawal by Subject|0|||
105458781|NCT01126749|363692115|FG002|Phase 2|Withdrawal by Subject|0|||
105458782|NCT01126749|363692116|FG003|Phase 2|Withdrawal by Subject|2|||
105458783|NCT01126749|363692113|FG000|Phase 2|Lost to Follow-up|0|||
105458784|NCT01126749|363692114|FG001|Phase 2|Lost to Follow-up|0|||
105458785|NCT01126749|363692115|FG002|Phase 2|Lost to Follow-up|0|||
105458786|NCT01126749|363692116|FG003|Phase 2|Lost to Follow-up|1|||
105458787|NCT01126749|363692113|FG000|Phase 2|Death|0|||
105458788|NCT01126749|363692114|FG001|Phase 2|Death|0|||
105458789|NCT01126749|363692115|FG002|Phase 2|Death|22|||
105458790|NCT01126749|363692116|FG003|Phase 2|Death|22|||
105458791|NCT01126749|363692113|FG000|Phase 2|Adverse Event|0|||
105458792|NCT01126749|363692114|FG001|Phase 2|Adverse Event|0|||
105338158|NCT02892422|363239229|FG000|Overall Study|Protocol Violation|4|||
105338159|NCT02892422|363239229|FG000|Overall Study|Withdrawal by Subject|56|||
105338160|NCT02892422|363239229|FG000|Overall Study|Lost to Follow-up|5|||
105458793|NCT01126749|363692115|FG002|Phase 2|Adverse Event|0|||
105458794|NCT01126749|363692116|FG003|Phase 2|Adverse Event|1|||
105458795|NCT01283139|363692117|FG000|Overall Study|Lost to Follow-up|5|||
105458796|NCT01283139|363692118|FG001|Overall Study|Lost to Follow-up|2|||
105458797|NCT01283139|363692119|FG002|Overall Study|Lost to Follow-up|3|||
105458798|NCT01283139|363692120|FG003|Overall Study|Lost to Follow-up|1|||
105458799|NCT01283139|363692117|FG000|Overall Study|Withdrawal by Subject|8|||
105458800|NCT01283139|363692118|FG001|Overall Study|Withdrawal by Subject|8|||
105458801|NCT01283139|363692119|FG002|Overall Study|Withdrawal by Subject|6|||
105458802|NCT01283139|363692120|FG003|Overall Study|Withdrawal by Subject|8|||
105458803|NCT01283139|363692117|FG000|Overall Study|Death|2|||
105458804|NCT01283139|363692118|FG001|Overall Study|Death|0|||
105458805|NCT01283139|363692119|FG002|Overall Study|Death|2|||
105458806|NCT01283139|363692120|FG003|Overall Study|Death|2|||
105458807|NCT01283139|363692117|FG000|Overall Study|Lack of Efficacy|1|||
105458808|NCT01283139|363692118|FG001|Overall Study|Lack of Efficacy|2|||
105458809|NCT01283139|363692119|FG002|Overall Study|Lack of Efficacy|2|||
105458810|NCT01283139|363692120|FG003|Overall Study|Lack of Efficacy|1|||
105458811|NCT01283139|363692117|FG000|Overall Study|Early termination due to AE/SAE|1|||
105458812|NCT01283139|363692118|FG001|Overall Study|Early termination due to AE/SAE|1|||
105458813|NCT01283139|363692119|FG002|Overall Study|Early termination due to AE/SAE|0|||
105458814|NCT01283139|363692120|FG003|Overall Study|Early termination due to AE/SAE|0|||
105458815|NCT01283139|363692117|FG000|Overall Study|Participant's refusal to continue|0|||
105458816|NCT01283139|363692118|FG001|Overall Study|Participant's refusal to continue|3|||
105458817|NCT01283139|363692119|FG002|Overall Study|Participant's refusal to continue|1|||
105458818|NCT01283139|363692120|FG003|Overall Study|Participant's refusal to continue|1|||
105458819|NCT01283139|363692117|FG000|Overall Study|Pregnancy|0|||
105458820|NCT01283139|363692118|FG001|Overall Study|Pregnancy|1|||
105458821|NCT01283139|363692119|FG002|Overall Study|Pregnancy|1|||
105458822|NCT01283139|363692120|FG003|Overall Study|Pregnancy|0|||
105458823|NCT01283139|363692117|FG000|Overall Study|Missed follow-up visit|0|||
105458824|NCT01283139|363692118|FG001|Overall Study|Missed follow-up visit|1|||
105458825|NCT01283139|363692119|FG002|Overall Study|Missed follow-up visit|2|||
105458826|NCT01283139|363692120|FG003|Overall Study|Missed follow-up visit|2|||
105458827|NCT01283139|363692117|FG000|Overall Study|Participant randomized in error|0|||
105458828|NCT01283139|363692118|FG001|Overall Study|Participant randomized in error|0|||
105458829|NCT01283139|363692119|FG002|Overall Study|Participant randomized in error|1|||
105458830|NCT01283139|363692120|FG003|Overall Study|Participant randomized in error|0|||
105458831|NCT00976274|363692121|FG000|Overall Study|Lost to Follow-up|5|||
105458832|NCT00976274|363692122|FG001|Overall Study|Lost to Follow-up|5|||
105458833|NCT00976274|363692121|FG000|Overall Study|Withdrawal by Subject|1|||
105458834|NCT00976274|363692122|FG001|Overall Study|Withdrawal by Subject|1|||
105458835|NCT00976274|363692121|FG000|Overall Study|Physician Decision|1|||
105458836|NCT00976274|363692122|FG001|Overall Study|Physician Decision|2|||
105458837|NCT00004563|363692123|FG000|Overall Study|Withdrawal by Subject|20|||
105458838|NCT00004563|363692124|FG001|Overall Study|Withdrawal by Subject|16|||
105458839|NCT00004563|363692123|FG000|Overall Study|Lack of Efficacy|3|||
105458840|NCT00004563|363692124|FG001|Overall Study|Lack of Efficacy|5|||
105458841|NCT00004563|363692123|FG000|Overall Study|Death|2|||
105458842|NCT00004563|363692124|FG001|Overall Study|Death|3|||
105458843|NCT00784563|363692125|FG000|Years 1 & 2|Withdrawal by Subject|3|||
105458844|NCT00784563|363692126|FG001|Years 1 & 2|Withdrawal by Subject|2|||
105458845|NCT00784563|363692127|FG002|Years 1 & 2|Withdrawal by Subject|0|||
105458846|NCT00784563|363692125|FG000|Years 1 & 2|Adverse Event|0|||
105458847|NCT00784563|363692126|FG001|Years 1 & 2|Adverse Event|3|||
105458848|NCT00784563|363692127|FG002|Years 1 & 2|Adverse Event|0|||
105458849|NCT00784563|363692125|FG000|Year 3|Withdrawal by Subject|0|||
105458850|NCT00784563|363692126|FG001|Year 3|Withdrawal by Subject|0|||
105458851|NCT00784563|363692127|FG002|Year 3|Withdrawal by Subject|2|||
105458852|NCT00784563|363692125|FG000|Year 3|Adverse Event|0|||
105458853|NCT00784563|363692126|FG001|Year 3|Adverse Event|0|||
105458854|NCT00784563|363692127|FG002|Year 3|Adverse Event|1|||
105458855|NCT03050801|363692132|FG000|Experiment 1|Lost to Follow-up|0|||
105458856|NCT03050801|363692133|FG001|Experiment 1|Lost to Follow-up|1|||
105458857|NCT03050801|363692134|FG002|Experiment 1|Lost to Follow-up|0|||
105458858|NCT03050801|363692135|FG003|Experiment 1|Lost to Follow-up|0|||
105458859|NCT03050801|363692136|FG004|Experiment 1|Lost to Follow-up|0|||
105458860|NCT03050801|363692137|FG005|Experiment 1|Lost to Follow-up|0|||
105458861|NCT03050801|363692132|FG000|Experiment 1|Physician Decision|0|||
105458862|NCT03050801|363692133|FG001|Experiment 1|Physician Decision|3|||
105458863|NCT03050801|363692134|FG002|Experiment 1|Physician Decision|0|||
105458864|NCT03050801|363692135|FG003|Experiment 1|Physician Decision|0|||
105458865|NCT03050801|363692136|FG004|Experiment 1|Physician Decision|0|||
105458866|NCT03050801|363692137|FG005|Experiment 1|Physician Decision|0|||
105458867|NCT03050801|363692132|FG000|Experiment 1|Change of experimental design|0|||
105458868|NCT03050801|363692133|FG001|Experiment 1|Change of experimental design|3|||
105458869|NCT03050801|363692134|FG002|Experiment 1|Change of experimental design|0|||
105458870|NCT03050801|363692135|FG003|Experiment 1|Change of experimental design|0|||
105458871|NCT03050801|363692136|FG004|Experiment 1|Change of experimental design|0|||
105458872|NCT03050801|363692137|FG005|Experiment 1|Change of experimental design|0|||
105458873|NCT03050801|363692132|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
105458874|NCT03050801|363692133|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
105458875|NCT03050801|363692134|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
105458876|NCT03050801|363692135|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
105458877|NCT03050801|363692136|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
105458878|NCT03050801|363692137|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
105458879|NCT03050801|363692132|FG000|Experiment 2|Lost to Follow-up|0|||
105458880|NCT03050801|363692133|FG001|Experiment 2|Lost to Follow-up|0|||
105458881|NCT03050801|363692134|FG002|Experiment 2|Lost to Follow-up|0|||
105458882|NCT03050801|363692135|FG003|Experiment 2|Lost to Follow-up|1|||
105458883|NCT03050801|363692136|FG004|Experiment 2|Lost to Follow-up|1|||
105458884|NCT03050801|363692137|FG005|Experiment 2|Lost to Follow-up|0|||
105458885|NCT03050801|363692132|FG000|Experiment 2|Physician Decision|0|||
105458886|NCT03050801|363692133|FG001|Experiment 2|Physician Decision|0|||
105458887|NCT03050801|363692134|FG002|Experiment 2|Physician Decision|0|||
105458888|NCT03050801|363692135|FG003|Experiment 2|Physician Decision|0|||
105458889|NCT03050801|363692136|FG004|Experiment 2|Physician Decision|1|||
105458890|NCT03050801|363692137|FG005|Experiment 2|Physician Decision|0|||
105458891|NCT03050801|363692132|FG000|Experiment 2|Pregnancy|0|||
105458892|NCT03050801|363692133|FG001|Experiment 2|Pregnancy|0|||
105458893|NCT03050801|363692134|FG002|Experiment 2|Pregnancy|0|||
105458894|NCT03050801|363692135|FG003|Experiment 2|Pregnancy|0|||
105458895|NCT03050801|363692136|FG004|Experiment 2|Pregnancy|1|||
105458896|NCT03050801|363692137|FG005|Experiment 2|Pregnancy|0|||
105458897|NCT03050801|363692132|FG000|Experiment 2|Withdrawal by Subject|0|||
105458898|NCT03050801|363692133|FG001|Experiment 2|Withdrawal by Subject|0|||
105458899|NCT03050801|363692134|FG002|Experiment 2|Withdrawal by Subject|0|||
105458900|NCT03050801|363692135|FG003|Experiment 2|Withdrawal by Subject|1|||
105458901|NCT03050801|363692136|FG004|Experiment 2|Withdrawal by Subject|0|||
105458902|NCT03050801|363692137|FG005|Experiment 2|Withdrawal by Subject|0|||
105458903|NCT03050801|363692132|FG000|Experiment 2|Poor data quality|0|||
105458904|NCT03050801|363692133|FG001|Experiment 2|Poor data quality|0|||
105458905|NCT03050801|363692134|FG002|Experiment 2|Poor data quality|0|||
105458906|NCT03050801|363692135|FG003|Experiment 2|Poor data quality|4|||
105458907|NCT03050801|363692136|FG004|Experiment 2|Poor data quality|1|||
105458908|NCT03050801|363692137|FG005|Experiment 2|Poor data quality|0|||
105458909|NCT03050801|363692132|FG000|Experiment 2|Discomfort during stimulation|0|||
105458910|NCT03050801|363692133|FG001|Experiment 2|Discomfort during stimulation|0|||
105458911|NCT03050801|363692134|FG002|Experiment 2|Discomfort during stimulation|0|||
105458912|NCT03050801|363692135|FG003|Experiment 2|Discomfort during stimulation|0|||
105458913|NCT03050801|363692136|FG004|Experiment 2|Discomfort during stimulation|0|||
105458914|NCT03050801|363692137|FG005|Experiment 2|Discomfort during stimulation|2|||
105458915|NCT00005780|363692138|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
105458916|NCT00521079|363692140|FG000|Overall Study|Adverse Event|7|||
105458917|NCT00521079|363692141|FG001|Overall Study|Adverse Event|1|||
105458918|NCT00521079|363692140|FG000|Overall Study|Lost to Follow-up|2|||
105458919|NCT00521079|363692141|FG001|Overall Study|Lost to Follow-up|1|||
105458920|NCT00521079|363692140|FG000|Overall Study|Withdrawal by Subject|5|||
105458921|NCT00521079|363692141|FG001|Overall Study|Withdrawal by Subject|3|||
105458922|NCT04576988|363692142|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
105458923|NCT04576988|363692143|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
105458924|NCT04576988|363692142|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
105458925|NCT04576988|363692143|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
105458926|NCT04576988|363692142|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
105458927|NCT04576988|363692143|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
105458928|NCT04576988|363692142|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
105458929|NCT04576988|363692143|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
105458930|NCT04576988|363692142|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
105458931|NCT04576988|363692143|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
105458932|NCT04576988|363692142|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
105458933|NCT04576988|363692143|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
105458934|NCT04576988|363692142|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
105458935|NCT04576988|363692143|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
105458936|NCT04576988|363692142|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
105458937|NCT04576988|363692143|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
105458938|NCT04576988|363692142|FG000|Long Term Double Blind (LTDB)|Death|2|||
105338161|NCT02892422|363239229|FG000|Overall Study|sponsor information 16159A results|21|||
105458939|NCT04576988|363692143|FG001|Long Term Double Blind (LTDB)|Death|1|||
105458940|NCT04576988|363692142|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
105458941|NCT04576988|363692143|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
105458942|NCT04905134|363692149|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
105458943|NCT04905134|363692149|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
105458944|NCT04583618|363692150|FG000|Overall Study|Adverse Event|0|||
105458945|NCT04583618|363692151|FG001|Overall Study|Adverse Event|0|||
105458946|NCT04583618|363692152|FG002|Overall Study|Adverse Event|1|||
105458947|NCT04583618|363692153|FG003|Overall Study|Adverse Event|0|||
105338162|NCT02892422|363239229|FG000|Overall Study|withdrawal of consent|13|||
105458948|NCT04583618|363692154|FG004|Overall Study|Adverse Event|0|||
105458949|NCT04583618|363692150|FG000|Overall Study|Protocol deviation|1|||
105458950|NCT04583618|363692151|FG001|Overall Study|Protocol deviation|1|||
105458951|NCT04583618|363692152|FG002|Overall Study|Protocol deviation|1|||
105458952|NCT04583618|363692153|FG003|Overall Study|Protocol deviation|0|||
105458953|NCT04583618|363692154|FG004|Overall Study|Protocol deviation|0|||
105458954|NCT04583618|363692150|FG000|Overall Study|Withdrawal by Subject|2|||
105458955|NCT04583618|363692151|FG001|Overall Study|Withdrawal by Subject|1|||
105458956|NCT04583618|363692152|FG002|Overall Study|Withdrawal by Subject|3|||
105458957|NCT04583618|363692153|FG003|Overall Study|Withdrawal by Subject|1|||
105458958|NCT04583618|363692154|FG004|Overall Study|Withdrawal by Subject|1|||
105458959|NCT04583618|363692150|FG000|Overall Study|Lost to Follow-up|0|||
105458960|NCT04583618|363692151|FG001|Overall Study|Lost to Follow-up|1|||
105458961|NCT04583618|363692152|FG002|Overall Study|Lost to Follow-up|3|||
105458962|NCT04583618|363692153|FG003|Overall Study|Lost to Follow-up|1|||
105458963|NCT04583618|363692154|FG004|Overall Study|Lost to Follow-up|1|||
105458964|NCT03642873|363692155|FG000|Third Intervention (1 Day)|Screen failure|0|||
105458965|NCT03642873|363692156|FG001|Third Intervention (1 Day)|Screen failure|0|||
105458966|NCT03642873|363692157|FG002|Third Intervention (1 Day)|Screen failure|0|||
105458967|NCT03642873|363692158|FG003|Third Intervention (1 Day)|Screen failure|0|||
105458968|NCT03642873|363692159|FG004|Third Intervention (1 Day)|Screen failure|1|||
105458969|NCT03642873|363692160|FG005|Third Intervention (1 Day)|Screen failure|0|||
105458970|NCT05556265|363692161|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
105458971|NCT05556265|363692162|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
105458972|NCT05556265|363692163|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
105458973|NCT05556265|363692164|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
105458974|NCT05556265|363692165|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
105458975|NCT05556265|363692161|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
105458976|NCT05556265|363692162|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
105458977|NCT05556265|363692163|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
105458978|NCT05556265|363692164|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
105458979|NCT05556265|363692165|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
105458980|NCT05556265|363692161|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
105458981|NCT05556265|363692162|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
105458982|NCT05556265|363692163|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
105458983|NCT05556265|363692164|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
105458984|NCT05556265|363692165|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
105458985|NCT05556265|363692161|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
105458986|NCT05556265|363692162|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
105458987|NCT05556265|363692163|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
105458988|NCT05556265|363692164|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
105458989|NCT05556265|363692165|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
105458990|NCT05556265|363692161|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
105458991|NCT05556265|363692162|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
105458992|NCT05556265|363692163|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
105458993|NCT05556265|363692164|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
105458994|NCT05556265|363692165|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
105458995|NCT05556265|363692161|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
105458996|NCT05556265|363692162|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
105458997|NCT05556265|363692163|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
105458998|NCT05556265|363692164|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
105458999|NCT05556265|363692165|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
105459000|NCT05556265|363692161|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
105459001|NCT05556265|363692162|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
105459002|NCT05556265|363692163|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
105459003|NCT05556265|363692164|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
105459004|NCT05556265|363692165|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
105459005|NCT05556265|363692161|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
105459006|NCT05556265|363692162|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
105459007|NCT05556265|363692163|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
105459008|NCT05556265|363692164|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
105459009|NCT05556265|363692165|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
105459010|NCT05556265|363692161|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
105459011|NCT05556265|363692162|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
105459012|NCT05556265|363692163|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
105550209|NCT00467870|364014378|FG004|Overall Study|Lost to Follow-up|3|||
105661757|NCT01068210|364425130|FG000|Overall Study|Disease progression|0|||
105459013|NCT05556265|363692164|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
105459014|NCT05556265|363692165|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
105459015|NCT04609319|363692166|FG000|Overall Study|Death|64|||
105459016|NCT04609319|363692167|FG001|Overall Study|Death|49|||
105459017|NCT04609319|363692168|FG002|Overall Study|Death|1|||
105459018|NCT04609319|363692166|FG000|Overall Study|Withdrawal of consent|15|||
105459019|NCT04609319|363692167|FG001|Overall Study|Withdrawal of consent|3|||
105459020|NCT04609319|363692168|FG002|Overall Study|Withdrawal of consent|0|||
105459021|NCT04609319|363692166|FG000|Overall Study|Lost to Follow-up|20|||
105459022|NCT04609319|363692167|FG001|Overall Study|Lost to Follow-up|33|||
105459023|NCT04609319|363692168|FG002|Overall Study|Lost to Follow-up|0|||
105459024|NCT04609319|363692166|FG000|Overall Study|Alive until end of follow-up|60|||
105459025|NCT04609319|363692167|FG001|Overall Study|Alive until end of follow-up|53|||
105459026|NCT04609319|363692168|FG002|Overall Study|Alive until end of follow-up|1|||
105459027|NCT03221556|363692169|FG000|Allocation|post-randomization exclusion|0|||
105459028|NCT03221556|363692170|FG001|Allocation|post-randomization exclusion|1|||
105459029|NCT03221556|363692169|FG000|Follow-Up|Withdrawal by Subject|0|||
105459030|NCT03221556|363692170|FG001|Follow-Up|Withdrawal by Subject|1|||
105459031|NCT00626106|363692174|FG000|Overall Study|Withdrawal by Subject|2|||
105459032|NCT00626106|363692175|FG001|Overall Study|Withdrawal by Subject|1|||
105459033|NCT00626106|363692174|FG000|Overall Study|Lost to Follow-up|1|||
105459034|NCT00626106|363692175|FG001|Overall Study|Lost to Follow-up|4|||
105459035|NCT00626106|363692174|FG000|Overall Study|Death|64|||
105459036|NCT00626106|363692175|FG001|Overall Study|Death|19|||
105459037|NCT04272242|363692176|FG000|Overall Study|Withdrawal by Subject|3|||
105459038|NCT04272242|363692176|FG000|Overall Study|Lost to Follow-up|1|||
105459039|NCT04272242|363692176|FG000|Overall Study|Adverse Event|1|||
105459040|NCT00199381|363693799|FG000|Overall Study|Withdrawal by Subject|38|||
105459041|NCT00199381|363693799|FG000|Overall Study|Adverse Event|73|||
105459042|NCT00199381|363693799|FG000|Overall Study|Protocol Violation|6|||
105459043|NCT00199381|363693799|FG000|Overall Study|Lack of Efficacy|27|||
105459044|NCT00199381|363693799|FG000|Overall Study|Not including due to early termination|37|||
105459045|NCT00199381|363693799|FG000|Overall Study|Study termination by Sponsor|323|||
105459046|NCT01910298|363693800|FG000|Overall Study|Adverse Event|1|||
105459047|NCT01910298|363693801|FG001|Overall Study|Adverse Event|0|||
105459048|NCT01910298|363693800|FG000|Overall Study|Withdrawal by Subject|2|||
105459049|NCT01910298|363693801|FG001|Overall Study|Withdrawal by Subject|7|||
105459050|NCT01910298|363693800|FG000|Overall Study|Protocol Deviation|0|||
105459051|NCT01910298|363693801|FG001|Overall Study|Protocol Deviation|5|||
105459052|NCT01910298|363693800|FG000|Overall Study|Lost to Follow-up|1|||
105459053|NCT01910298|363693801|FG001|Overall Study|Lost to Follow-up|1|||
105459054|NCT01910298|363693800|FG000|Overall Study|Study Terminated by Sponsor|1|||
105459055|NCT01910298|363693801|FG001|Overall Study|Study Terminated by Sponsor|17|||
105459056|NCT01910298|363693800|FG000|Overall Study|Other Miscellaneous Reasons|0|||
105459057|NCT01910298|363693801|FG001|Overall Study|Other Miscellaneous Reasons|2|||
105459058|NCT03175367|363693807|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
105459059|NCT03175367|363693808|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
105459060|NCT03175367|363693809|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
105459061|NCT03175367|363693810|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
105459062|NCT03175367|363693811|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
105459063|NCT03175367|363693812|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
105459064|NCT03175367|363693813|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
105459065|NCT03175367|363693807|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
105459066|NCT03175367|363693808|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
105459067|NCT03175367|363693809|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
105459068|NCT03175367|363693810|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
105459069|NCT03175367|363693811|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
105459070|NCT03175367|363693812|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
105459071|NCT03175367|363693813|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
105459072|NCT03175367|363693807|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
105459073|NCT03175367|363693808|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
105459074|NCT03175367|363693809|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
105459075|NCT03175367|363693810|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
105459076|NCT03175367|363693811|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
105459077|NCT03175367|363693812|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
105459078|NCT03175367|363693813|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
105459079|NCT03175367|363693807|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
105459080|NCT03175367|363693808|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
105459081|NCT03175367|363693809|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
105459082|NCT03175367|363693810|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
105459083|NCT03175367|363693811|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
105459084|NCT03175367|363693812|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
105338163|NCT02892422|363239229|FG000|Overall Study|exclusion criteria met|3|||
105338164|NCT02892422|363239229|FG000|Overall Study|moving elsewhere|4|||
105338165|NCT02892422|363239229|FG000|Overall Study|non-compliance|10|||
105338166|NCT02892422|363239229|FG000|Overall Study|patient legally incapable|1|||
105338167|NCT02892422|363239229|FG000|Overall Study|patient decision|7|||
105338168|NCT02892422|363239229|FG000|Overall Study|Investigator decision|1|||
105338169|NCT01475851|363239230|FG000|Overall Study|Protocol defined stopping criteria|1|||
105338170|NCT01475851|363239231|FG001|Overall Study|Protocol defined stopping criteria|0|||
105338171|NCT00319592|363239238|FG000|Overall Study|Protocol Violation|1|||
105338172|NCT00319592|363239239|FG001|Overall Study|Protocol Violation|0|||
105338173|NCT00319592|363239238|FG000|Overall Study|Physician Decision|0|||
105338174|NCT00319592|363239239|FG001|Overall Study|Physician Decision|1|||
105338175|NCT01190267|363239243|FG000|Overall Study|Adverse Event|10|||
105338176|NCT01190267|363239244|FG001|Overall Study|Adverse Event|0|||
105338177|NCT01190267|363239243|FG000|Overall Study|Treatment Failure|8|||
105338178|NCT01190267|363239244|FG001|Overall Study|Treatment Failure|2|||
105338179|NCT01190267|363239243|FG000|Overall Study|Lost to Follow-up|2|||
105338180|NCT01190267|363239244|FG001|Overall Study|Lost to Follow-up|0|||
105338181|NCT01190267|363239243|FG000|Overall Study|Withdrawal by Subject|13|||
105338182|NCT01190267|363239244|FG001|Overall Study|Withdrawal by Subject|1|||
105338183|NCT01190267|363239243|FG000|Overall Study|Protocol Violation|8|||
105338184|NCT01190267|363239244|FG001|Overall Study|Protocol Violation|1|||
105338185|NCT04687072|363239245|FG000|Overall Study|Adverse Event|2|||
105338186|NCT04687072|363239246|FG001|Overall Study|Adverse Event|0|||
105338187|NCT04687072|363239245|FG000|Overall Study|Death|1|||
105338188|NCT04687072|363239246|FG001|Overall Study|Death|0|||
105338189|NCT04687072|363239245|FG000|Overall Study|Lack of Efficacy|2|||
105338190|NCT04687072|363239246|FG001|Overall Study|Lack of Efficacy|1|||
105338191|NCT04687072|363239245|FG000|Overall Study|Physician Decision|1|||
105338192|NCT04687072|363239246|FG001|Overall Study|Physician Decision|0|||
105338193|NCT04687072|363239245|FG000|Overall Study|Pregnancy|1|||
105338194|NCT04687072|363239246|FG001|Overall Study|Pregnancy|0|||
105338195|NCT04687072|363239245|FG000|Overall Study|Requires Prohibited Medication|2|||
105459085|NCT03175367|363693813|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
105459086|NCT03175367|363693807|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
105459087|NCT03175367|363693808|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
105459088|NCT03175367|363693809|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
105459089|NCT03175367|363693810|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
105459090|NCT03175367|363693811|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
105459091|NCT03175367|363693812|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
105459092|NCT03175367|363693813|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
105459093|NCT03175367|363693807|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
105459094|NCT03175367|363693808|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
105459095|NCT03175367|363693809|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
105459096|NCT03175367|363693810|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
105459097|NCT03175367|363693811|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
105459098|NCT03175367|363693812|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
105459099|NCT03175367|363693813|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
105459100|NCT03175367|363693807|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
105459101|NCT03175367|363693808|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
105459102|NCT03175367|363693809|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
105459103|NCT03175367|363693810|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
105459104|NCT03175367|363693811|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
105459105|NCT03175367|363693812|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
105459106|NCT03175367|363693813|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
105459107|NCT03085095|363693819|FG000|Overall Study|Adverse Event|23|||
105459108|NCT03085095|363693820|FG001|Overall Study|Adverse Event|8|||
105459109|NCT03085095|363693819|FG000|Overall Study|Protocol Violation|0|||
105459110|NCT03085095|363693820|FG001|Overall Study|Protocol Violation|1|||
105459111|NCT03085095|363693819|FG000|Overall Study|Lost to Follow-up|2|||
105459112|NCT03085095|363693820|FG001|Overall Study|Lost to Follow-up|1|||
105459113|NCT03085095|363693819|FG000|Overall Study|Withdrawal by Subject|17|||
105459114|NCT03085095|363693820|FG001|Overall Study|Withdrawal by Subject|6|||
105459115|NCT03085095|363693819|FG000|Overall Study|Physician Decision|9|||
105459116|NCT03085095|363693820|FG001|Overall Study|Physician Decision|3|||
105459117|NCT03085095|363693819|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
105459118|NCT03085095|363693820|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
105459119|NCT03085095|363693819|FG000|Overall Study|Did not Receive Study Drug|2|||
105459120|NCT03085095|363693820|FG001|Overall Study|Did not Receive Study Drug|2|||
105338196|NCT04687072|363239246|FG001|Overall Study|Requires Prohibited Medication|0|||
105338197|NCT04687072|363239245|FG000|Overall Study|Withdrawal of Consent|11|||
105338198|NCT04687072|363239246|FG001|Overall Study|Withdrawal of Consent|6|||
105338199|NCT04687072|363239245|FG000|Overall Study|Miscellaneous|4|||
105338200|NCT04687072|363239246|FG001|Overall Study|Miscellaneous|1|||
105459121|NCT03085095|363693819|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
105459122|NCT03085095|363693820|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
105459123|NCT03459079|363693821|FG000|Overall Study|Adverse Event|4|||
105459124|NCT03459079|363693822|FG001|Overall Study|Adverse Event|2|||
105459125|NCT03459079|363693823|FG002|Overall Study|Adverse Event|0|||
105459126|NCT03459079|363693821|FG000|Overall Study|Withdrawal by Subject|2|||
105459127|NCT03459079|363693822|FG001|Overall Study|Withdrawal by Subject|2|||
105459128|NCT03459079|363693823|FG002|Overall Study|Withdrawal by Subject|0|||
105459129|NCT02220920|363693824|FG000|Overall Study|Adverse Event|1|||
105459130|NCT02220920|363693825|FG001|Overall Study|Adverse Event|0|||
105459131|NCT02220920|363693824|FG000|Overall Study|Lack of Efficacy|0|||
105459132|NCT02220920|363693825|FG001|Overall Study|Lack of Efficacy|1|||
105459133|NCT02220920|363693824|FG000|Overall Study|Withdrawal by Subject|1|||
105459134|NCT02220920|363693825|FG001|Overall Study|Withdrawal by Subject|0|||
105459135|NCT02220920|363693824|FG000|Overall Study|Conflict with the stopping criteria|1|||
105459136|NCT02220920|363693825|FG001|Overall Study|Conflict with the stopping criteria|2|||
105459137|NCT03198715|363693826|FG000|Overall Study|Death|0|||
105459138|NCT03198715|363693827|FG001|Overall Study|Death|0|||
105459139|NCT03198715|363693828|FG002|Overall Study|Death|1|||
105459140|NCT03198715|363693829|FG003|Overall Study|Death|0|||
105459141|NCT03198715|363693830|FG004|Overall Study|Death|2|||
105459142|NCT03198715|363693826|FG000|Overall Study|Other|0|||
105459143|NCT03198715|363693827|FG001|Overall Study|Other|1|||
105459144|NCT03198715|363693828|FG002|Overall Study|Other|1|||
105459145|NCT03198715|363693829|FG003|Overall Study|Other|0|||
105459146|NCT03198715|363693830|FG004|Overall Study|Other|0|||
105459147|NCT06271993|363693831|FG000|Overall Study|Not reactive to histamine|5|||
105459148|NCT06271993|363693832|FG001|Overall Study|Not reactive to histamine|5|||
105459149|NCT06271993|363693833|FG002|Overall Study|Not reactive to histamine|5|||
105459150|NCT00286468|363693834|FG000|Overall Study|Hyperglycemic Rescue|28|||
105459151|NCT00286468|363693835|FG001|Overall Study|Hyperglycemic Rescue|30|||
105338201|NCT02572076|363239247|FG000|Overall Study|Protocol Violation|1|||
105338202|NCT02496091|363239248|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
105338203|NCT05033262|363239251|FG000|Overall Study|Lost to Follow-up|1|||
105459152|NCT00286468|363693836|FG002|Overall Study|Hyperglycemic Rescue|31|||
105459153|NCT00286468|363693834|FG000|Overall Study|Adverse Event|2|||
105459154|NCT00286468|363693835|FG001|Overall Study|Adverse Event|6|||
105338204|NCT05033262|363239252|FG001|Overall Study|Lost to Follow-up|0|||
105338205|NCT05033262|363239253|FG002|Overall Study|Lost to Follow-up|0|||
105338206|NCT05033262|363239254|FG003|Overall Study|Lost to Follow-up|1|||
105338207|NCT03489707|363239257|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
105338208|NCT03489707|363239258|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
105338209|NCT03489707|363239257|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
105338210|NCT03489707|363239258|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
105338211|NCT01806961|363241062|FG000|Overall Study|sponsor decision|16|||
105338212|NCT01106677|363241066|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
105338213|NCT01106677|363241067|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
105338214|NCT01106677|363241068|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
105338215|NCT01106677|363241069|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
105338216|NCT01106677|363241066|FG000|Core Period: Baseline to Week 26|Death|0|||
105459155|NCT00286468|363693836|FG002|Overall Study|Adverse Event|4|||
105459156|NCT00286468|363693834|FG000|Overall Study|Protocol Violation|0|||
105459157|NCT00286468|363693835|FG001|Overall Study|Protocol Violation|3|||
105338217|NCT01106677|363241067|FG001|Core Period: Baseline to Week 26|Death|0|||
105338218|NCT01106677|363241068|FG002|Core Period: Baseline to Week 26|Death|1|||
105459158|NCT00286468|363693836|FG002|Overall Study|Protocol Violation|1|||
105459159|NCT00286468|363693834|FG000|Overall Study|Lost to Follow-up|1|||
105459160|NCT00286468|363693835|FG001|Overall Study|Lost to Follow-up|1|||
105459161|NCT00286468|363693836|FG002|Overall Study|Lost to Follow-up|2|||
105459162|NCT00286468|363693834|FG000|Overall Study|Withdrawal by Subject|3|||
105459163|NCT00286468|363693835|FG001|Overall Study|Withdrawal by Subject|8|||
105459164|NCT00286468|363693836|FG002|Overall Study|Withdrawal by Subject|11|||
105459165|NCT00286468|363693834|FG000|Overall Study|Physician Decision|3|||
105459166|NCT00286468|363693835|FG001|Overall Study|Physician Decision|2|||
105459167|NCT00286468|363693836|FG002|Overall Study|Physician Decision|1|||
105459168|NCT03103542|363693837|FG000|Overall Study|Physician Decision|2|||
105459169|NCT03103542|363693837|FG000|Overall Study|Adverse Event|2|||
105459170|NCT03103542|363693837|FG000|Overall Study|Other|2|||
105459171|NCT03103542|363693837|FG000|Overall Study|Withdrawal by Subject|1|||
105459172|NCT05137041|363693838|FG000|Overall Study|Lost to Follow-up|1|||
105459173|NCT05137041|363693839|FG001|Overall Study|Lost to Follow-up|1|||
105459174|NCT05137041|363693838|FG000|Overall Study|Withdrawal by Subject|0|||
105459175|NCT05137041|363693839|FG001|Overall Study|Withdrawal by Subject|2|||
105459176|NCT05137041|363693838|FG000|Overall Study|Reason not Specified|0|||
105459177|NCT05137041|363693839|FG001|Overall Study|Reason not Specified|1|||
105459178|NCT00981656|363693841|FG000|Overall Study|Protocol Violation|1|||
105459179|NCT00981656|363693841|FG000|Overall Study|Did not start protocol treatment|2|||
105459180|NCT00687596|363693842|FG000|Overall Study|Adverse Event (AE)|10|||
105459181|NCT00687596|363693843|FG001|Overall Study|Adverse Event (AE)|3|||
105459182|NCT00687596|363693842|FG000|Overall Study|Radiological Disease Progression|6|||
105459183|NCT00687596|363693843|FG001|Overall Study|Radiological Disease Progression|2|||
105459184|NCT00687596|363693842|FG000|Overall Study|Clinical Disease Progression|1|||
105459185|NCT00687596|363693843|FG001|Overall Study|Clinical Disease Progression|3|||
105459186|NCT00687596|363693842|FG000|Overall Study|Investigator Discretion|3|||
105459187|NCT00687596|363693843|FG001|Overall Study|Investigator Discretion|1|||
105459188|NCT00687596|363693842|FG000|Overall Study|Sponsor Terminated Study|6|||
105459189|NCT00687596|363693843|FG001|Overall Study|Sponsor Terminated Study|17|||
105459190|NCT02218372|363693845|FG000|Overall Study|Adverse Event|1|||
105459191|NCT02218372|363693846|FG001|Overall Study|Adverse Event|1|||
105459192|NCT02218372|363693845|FG000|Overall Study|Miscellaneous|2|||
105459193|NCT02218372|363693846|FG001|Overall Study|Miscellaneous|1|||
105459194|NCT02218372|363693845|FG000|Overall Study|Randomized but did not receive treatment|2|||
105459195|NCT02218372|363693846|FG001|Overall Study|Randomized but did not receive treatment|3|||
105459196|NCT02218372|363693845|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105459197|NCT02218372|363693846|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
105459198|NCT03405792|363693867|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
105459199|NCT03405792|363693868|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
105459200|NCT03405792|363693867|FG000|Overall Study|o Did not receive pembrolizumab|1|||
105459201|NCT03405792|363693868|FG001|Overall Study|o Did not receive pembrolizumab|0|||
105459202|NCT02476617|363693869|FG000|Overall Study|Adverse Event|1|||
105459203|NCT02476617|363693869|FG000|Overall Study|Lost to Follow-up|1|||
105459204|NCT00561652|363693876|FG000|Overall Study|Withdrawal by Subject|0|||
105459205|NCT00561652|363693877|FG001|Overall Study|Withdrawal by Subject|1|||
105459206|NCT02718898|363693882|FG000|Blinded Treatment Period|Adverse Event|5|||
105459207|NCT02718898|363693883|FG001|Blinded Treatment Period|Adverse Event|1|||
105459208|NCT02718898|363693884|FG002|Blinded Treatment Period|Adverse Event|0|||
105459209|NCT02718898|363693885|FG003|Blinded Treatment Period|Adverse Event|0|||
105459210|NCT02718898|363693886|FG004|Blinded Treatment Period|Adverse Event|0|||
105459211|NCT02718898|363693887|FG005|Blinded Treatment Period|Adverse Event|0|||
105459212|NCT02718898|363693888|FG006|Blinded Treatment Period|Adverse Event|0|||
105459213|NCT02718898|363693882|FG000|Blinded Treatment Period|Physician Decision|1|||
105459214|NCT02718898|363693883|FG001|Blinded Treatment Period|Physician Decision|0|||
105459215|NCT02718898|363693884|FG002|Blinded Treatment Period|Physician Decision|0|||
105459216|NCT02718898|363693885|FG003|Blinded Treatment Period|Physician Decision|0|||
105459217|NCT02718898|363693886|FG004|Blinded Treatment Period|Physician Decision|0|||
105459218|NCT02718898|363693887|FG005|Blinded Treatment Period|Physician Decision|0|||
105459219|NCT02718898|363693888|FG006|Blinded Treatment Period|Physician Decision|0|||
105459220|NCT02718898|363693882|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
105459221|NCT02718898|363693883|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
105459222|NCT02718898|363693884|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
105459223|NCT02718898|363693885|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
105459224|NCT02718898|363693886|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
105459225|NCT02718898|363693887|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
105459226|NCT02718898|363693888|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
105459227|NCT02718898|363693882|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
105459228|NCT02718898|363693883|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
105459229|NCT02718898|363693884|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
105459230|NCT02718898|363693885|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
105459231|NCT02718898|363693886|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
105459232|NCT02718898|363693887|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
105459233|NCT02718898|363693888|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
105459234|NCT02718898|363693882|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
105459235|NCT02718898|363693883|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
105459236|NCT02718898|363693884|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
105459237|NCT02718898|363693885|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
105459238|NCT02718898|363693886|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
105459239|NCT02718898|363693887|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
105459240|NCT02718898|363693888|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
105459241|NCT02718898|363693882|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
105661758|NCT01068210|364425131|FG001|Overall Study|Disease progression|0|||
105661759|NCT01068210|364425132|FG002|Overall Study|Disease progression|0|||
105459242|NCT02718898|363693883|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
105459243|NCT02718898|363693884|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
105459244|NCT02718898|363693885|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
105459245|NCT02718898|363693886|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
105459246|NCT02718898|363693887|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
105661760|NCT01068210|364425133|FG003|Overall Study|Disease progression|2|||
105338219|NCT01106677|363241069|FG003|Core Period: Baseline to Week 26|Death|0|||
105338220|NCT01106677|363241066|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
105338221|NCT01106677|363241067|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
105338222|NCT01106677|363241068|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
105338223|NCT01106677|363241069|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
105338224|NCT01106677|363241066|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
105338225|NCT01106677|363241067|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
105338226|NCT01106677|363241068|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
105338227|NCT01106677|363241069|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
105338228|NCT01106677|363241066|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
105338229|NCT01106677|363241067|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
105338230|NCT01106677|363241068|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
105338231|NCT01106677|363241069|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
105338232|NCT01106677|363241066|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
105338233|NCT01106677|363241067|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
105338234|NCT01106677|363241068|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
105459247|NCT02718898|363693888|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
105459248|NCT02718898|363693882|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
105459249|NCT02718898|363693883|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
105459250|NCT02718898|363693884|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
105459251|NCT02718898|363693885|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
105459252|NCT02718898|363693886|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
105459253|NCT02718898|363693887|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
105459254|NCT02718898|363693888|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
105459255|NCT02718898|363693882|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
105459256|NCT02718898|363693883|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
105459257|NCT02718898|363693884|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
105459258|NCT02718898|363693885|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
105459259|NCT02718898|363693886|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
105459260|NCT02718898|363693887|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
105459261|NCT02718898|363693888|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
105459262|NCT02718898|363693882|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
105459263|NCT02718898|363693883|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
105459264|NCT02718898|363693884|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
105459265|NCT02718898|363693885|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
105459266|NCT02718898|363693886|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
105459267|NCT02718898|363693887|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
105459268|NCT02718898|363693888|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
105459269|NCT02718898|363693882|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
105459270|NCT02718898|363693883|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
105459271|NCT02718898|363693884|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
105459272|NCT02718898|363693885|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
105459273|NCT02718898|363693886|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
105459274|NCT02718898|363693887|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
105459275|NCT02718898|363693888|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
105459276|NCT02718898|363693882|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
105459277|NCT02718898|363693883|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
105459278|NCT02718898|363693884|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
105459279|NCT02718898|363693885|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
105459280|NCT02718898|363693886|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
105459281|NCT02718898|363693887|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
105459282|NCT02718898|363693888|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
105459283|NCT02718898|363693882|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
105459284|NCT02718898|363693883|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
105459285|NCT02718898|363693884|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
105459286|NCT02718898|363693885|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
105459287|NCT02718898|363693886|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
105459288|NCT02718898|363693887|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
105459289|NCT02718898|363693888|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
105459290|NCT02718898|363693882|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
105459291|NCT02718898|363693883|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
105459292|NCT02718898|363693884|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
105459293|NCT02718898|363693885|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
105459294|NCT02718898|363693886|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
105338235|NCT01106677|363241069|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
105459295|NCT02718898|363693887|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
105459296|NCT02718898|363693888|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
105459297|NCT00894803|363693891|FG000|Overall Study|Death|20|||
105459298|NCT00894803|363693892|FG001|Overall Study|Death|4|||
105459299|NCT00894803|363693891|FG000|Overall Study|Lost to Follow-up|0|||
105459300|NCT00894803|363693892|FG001|Overall Study|Lost to Follow-up|1|||
105459301|NCT04484961|363693893|FG000|Overall Study|Lost to Follow-up|9|||
105459302|NCT04484961|363693894|FG001|Overall Study|Lost to Follow-up|9|||
105459303|NCT01710345|363693895|FG000|Overall Study|Adverse Event|0|||
105459304|NCT01710345|363693896|FG001|Overall Study|Adverse Event|2|||
105459305|NCT01710345|363693897|FG002|Overall Study|Adverse Event|0|||
105459306|NCT01710345|363693895|FG000|Overall Study|Lack of Efficacy|2|||
105459307|NCT01710345|363693896|FG001|Overall Study|Lack of Efficacy|3|||
105459308|NCT01710345|363693897|FG002|Overall Study|Lack of Efficacy|1|||
105459309|NCT01710345|363693895|FG000|Overall Study|Drug Dosing Error|1|||
105459310|NCT01710345|363693896|FG001|Overall Study|Drug Dosing Error|0|||
105459311|NCT01710345|363693897|FG002|Overall Study|Drug Dosing Error|0|||
105459312|NCT01667900|363693900|FG000|Part B|Death|0|||
105459313|NCT01667900|363693901|FG001|Part B|Death|0|||
105459314|NCT01667900|363693902|FG002|Part B|Death|0|||
105459315|NCT01667900|363693903|FG003|Part B|Death|0|||
105459316|NCT01667900|363693904|FG004|Part B|Death|0|||
105459317|NCT01667900|363693905|FG005|Part B|Death|0|||
105459318|NCT01667900|363693906|FG006|Part B|Death|0|||
105459319|NCT01667900|363693907|FG007|Part B|Death|0|||
105459320|NCT01667900|363693908|FG008|Part B|Death|0|||
105459321|NCT01667900|363693909|FG009|Part B|Death|0|||
105459322|NCT01667900|363693910|FG010|Part B|Death|0|||
105459323|NCT01667900|363693911|FG011|Part B|Death|0|||
105459324|NCT01667900|363693912|FG012|Part B|Death|0|||
105459325|NCT01667900|363693913|FG013|Part B|Death|0|||
105459326|NCT01667900|363693914|FG014|Part B|Death|0|||
105459327|NCT01667900|363693915|FG015|Part B|Death|0|||
105459328|NCT01667900|363693916|FG016|Part B|Death|1|||
105459329|NCT01667900|363693917|FG017|Part B|Death|0|||
105459330|NCT01667900|363693918|FG018|Part B|Death|0|||
105459331|NCT01667900|363693919|FG019|Part B|Death|0|||
105459332|NCT01345240|363693920|FG000|Overall Study|Adverse Event|3|||
105459333|NCT01345240|363693921|FG001|Overall Study|Adverse Event|5|||
105459334|NCT01345240|363693922|FG002|Overall Study|Adverse Event|4|||
105459335|NCT01345240|363693923|FG003|Overall Study|Adverse Event|2|||
105459336|NCT01345240|363693924|FG004|Overall Study|Adverse Event|1|||
105459337|NCT01345240|363693920|FG000|Overall Study|Lost to Follow-up|8|||
105459338|NCT01345240|363693921|FG001|Overall Study|Lost to Follow-up|9|||
105459339|NCT01345240|363693922|FG002|Overall Study|Lost to Follow-up|14|||
105459340|NCT01345240|363693923|FG003|Overall Study|Lost to Follow-up|7|||
105459341|NCT01345240|363693924|FG004|Overall Study|Lost to Follow-up|9|||
105459342|NCT03597347|363693927|FG000|Overall Study|Withdrawal by Subject|1|||
105459343|NCT03597347|363693928|FG001|Overall Study|Withdrawal by Subject|1|||
105459344|NCT03597347|363693929|FG002|Overall Study|Withdrawal by Subject|0|||
105459345|NCT03597347|363693927|FG000|Overall Study|Withdrawal due to Covid-19|3|||
105459346|NCT03597347|363693928|FG001|Overall Study|Withdrawal due to Covid-19|0|||
105459347|NCT03597347|363693929|FG002|Overall Study|Withdrawal due to Covid-19|0|||
105459348|NCT03597347|363693927|FG000|Overall Study|Sponsor decision to terminate study|3|||
105459349|NCT03597347|363693928|FG001|Overall Study|Sponsor decision to terminate study|2|||
105459350|NCT03597347|363693929|FG002|Overall Study|Sponsor decision to terminate study|4|||
105459351|NCT00107653|363693930|FG000|Overall Study|Adverse Event|24|||
105459352|NCT00107653|363693931|FG001|Overall Study|Adverse Event|43|||
105459353|NCT00107653|363693930|FG000|Overall Study|Insufficient Therapeutic Response|25|||
105459354|NCT00107653|363693931|FG001|Overall Study|Insufficient Therapeutic Response|11|||
105459355|NCT00107653|363693930|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
105459356|NCT00107653|363693931|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
105459357|NCT00107653|363693930|FG000|Overall Study|Protocol Violation|1|||
105459358|NCT00107653|363693931|FG001|Overall Study|Protocol Violation|0|||
105459359|NCT00107653|363693930|FG000|Overall Study|Withdrawal by Subject|12|||
105459360|NCT00107653|363693931|FG001|Overall Study|Withdrawal by Subject|13|||
105459361|NCT00107653|363693930|FG000|Overall Study|Lost to Follow-up|13|||
105459362|NCT00107653|363693931|FG001|Overall Study|Lost to Follow-up|5|||
105459363|NCT00107653|363693930|FG000|Overall Study|Administrative Reasons|3|||
105459364|NCT00107653|363693931|FG001|Overall Study|Administrative Reasons|3|||
105459365|NCT01535040|363693932|FG000|Overall Study|Physician Decision|0|||
105459366|NCT01535040|363693933|FG001|Overall Study|Physician Decision|1|||
105459367|NCT01535040|363693932|FG000|Overall Study|Withdrawal by Subject|13|||
105459368|NCT01535040|363693933|FG001|Overall Study|Withdrawal by Subject|10|||
105459369|NCT01535040|363693932|FG000|Overall Study|Never Started|9|||
105459370|NCT01535040|363693933|FG001|Overall Study|Never Started|4|||
105459371|NCT01535040|363693932|FG000|Overall Study|Toxicity|7|||
105459372|NCT01535040|363693933|FG001|Overall Study|Toxicity|5|||
105459373|NCT01535040|363693932|FG000|Overall Study|Multiple Reasons|1|||
105459374|NCT01535040|363693933|FG001|Overall Study|Multiple Reasons|1|||
105459375|NCT01074970|363693934|FG000|Overall Study|Never Treated|0|||
105459376|NCT01074970|363693935|FG001|Overall Study|Never Treated|0|||
105459377|NCT01074970|363693936|FG002|Overall Study|Never Treated|8|||
105459378|NCT01074970|363693937|FG003|Overall Study|Never Treated|1|||
105459379|NCT01074970|363693934|FG000|Overall Study|Adverse Event|1|||
105459380|NCT01074970|363693935|FG001|Overall Study|Adverse Event|0|||
105459381|NCT01074970|363693936|FG002|Overall Study|Adverse Event|4|||
105459382|NCT01074970|363693937|FG003|Overall Study|Adverse Event|3|||
105459383|NCT01074970|363693934|FG000|Overall Study|Disease progression during treatment|3|||
105459384|NCT01074970|363693935|FG001|Overall Study|Disease progression during treatment|1|||
105459385|NCT01074970|363693936|FG002|Overall Study|Disease progression during treatment|2|||
105459386|NCT01074970|363693937|FG003|Overall Study|Disease progression during treatment|9|||
105459387|NCT01074970|363693934|FG000|Overall Study|Lost to Follow-up|0|||
105459388|NCT01074970|363693935|FG001|Overall Study|Lost to Follow-up|0|||
105459389|NCT01074970|363693936|FG002|Overall Study|Lost to Follow-up|1|||
105459390|NCT01074970|363693937|FG003|Overall Study|Lost to Follow-up|0|||
105459391|NCT01074970|363693934|FG000|Overall Study|Withdrawal by Subject|0|||
105459392|NCT01074970|363693935|FG001|Overall Study|Withdrawal by Subject|0|||
105459393|NCT01074970|363693936|FG002|Overall Study|Withdrawal by Subject|6|||
105459394|NCT01074970|363693937|FG003|Overall Study|Withdrawal by Subject|4|||
105459395|NCT01652235|363693942|FG000|Overall Study|Death|9|||
105459396|NCT01652235|363693942|FG000|Overall Study|Lost to Follow-up|5|||
105459397|NCT01652235|363693942|FG000|Overall Study|Withdrawal by Subject|2|||
105459398|NCT01824836|363693943|FG000|Overall Study|Adverse Event|48|||
105459399|NCT01824836|363693943|FG000|Overall Study|Withdrawal by Subject|63|||
105459400|NCT01824836|363693943|FG000|Overall Study|Other complicating disease|116|||
105459401|NCT01824836|363693943|FG000|Overall Study|Disease progression|5|||
105459402|NCT01824836|363693943|FG000|Overall Study|Alternative therapy|2|||
105459403|NCT01824836|363693943|FG000|Overall Study|Depression|1|||
105459404|NCT01824836|363693943|FG000|Overall Study|Non-compliance|3|||
105459405|NCT01824836|363693943|FG000|Overall Study|Patient regained ovarian function|3|||
105459406|NCT01824836|363693943|FG000|Overall Study|Lost to Follow-up|8|||
105459407|NCT01824836|363693943|FG000|Overall Study|Physician Decision|2|||
105459408|NCT01824836|363693943|FG000|Overall Study|Research office was closed|3|||
105459409|NCT01824836|363693943|FG000|Overall Study|Relocation|3|||
105459410|NCT01824836|363693943|FG000|Overall Study|Insurance-related issue|1|||
105459411|NCT01824836|363693943|FG000|Overall Study|Transportation issue|1|||
105459412|NCT01824836|363693943|FG000|Overall Study|Patient transferred care|1|||
105459413|NCT01824836|363693943|FG000|Overall Study|Unknown reasons|4|||
105459414|NCT01824836|363693943|FG000|Overall Study|Never started treatment|16|||
105459415|NCT01844986|363693948|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
105459416|NCT01844986|363693949|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
105459417|NCT01844986|363693948|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
105459418|NCT01844986|363693949|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
105459419|NCT01844986|363693948|FG000|Overall Study (Global Cohort)|Death|55|||
105459420|NCT01844986|363693949|FG001|Overall Study (Global Cohort)|Death|26|||
105459421|NCT01844986|363693948|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
105459422|NCT01844986|363693949|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
105459423|NCT01844986|363693948|FG000|Overall Study (China Cohort)|Death|10|||
105459424|NCT01844986|363693949|FG001|Overall Study (China Cohort)|Death|6|||
105459425|NCT02994108|363695823|FG000|Intervention Messages|Withdrawal by Subject|2|||
105459426|NCT02994108|363695824|FG001|Intervention Messages|Withdrawal by Subject|0|||
105459427|NCT02994108|363695823|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
105459428|NCT02994108|363695824|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
105459429|NCT02994108|363695823|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
105459430|NCT02994108|363695824|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
105459431|NCT02994108|363695823|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
105459432|NCT02994108|363695824|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
105459433|NCT00079417|363695825|FG000|Overall Study|Physician Decision|2|||
105459434|NCT00079417|363695825|FG000|Overall Study|Ineligible|7|||
105459435|NCT00385671|363695826|FG000|Overall Study|Adverse Event|14|||
105459436|NCT00385671|363695827|FG001|Overall Study|Adverse Event|27|||
105459437|NCT00385671|363695828|FG002|Overall Study|Adverse Event|18|||
105459438|NCT00385671|363695826|FG000|Overall Study|Lack of Efficacy|5|||
105459439|NCT00385671|363695827|FG001|Overall Study|Lack of Efficacy|9|||
105459440|NCT00385671|363695828|FG002|Overall Study|Lack of Efficacy|5|||
105459441|NCT00385671|363695826|FG000|Overall Study|Lost to Follow-up|6|||
105459442|NCT00385671|363695827|FG001|Overall Study|Lost to Follow-up|6|||
105459443|NCT00385671|363695828|FG002|Overall Study|Lost to Follow-up|5|||
105459444|NCT00385671|363695826|FG000|Overall Study|Physician Decision|2|||
105459445|NCT00385671|363695827|FG001|Overall Study|Physician Decision|1|||
105459446|NCT00385671|363695828|FG002|Overall Study|Physician Decision|2|||
105459447|NCT00385671|363695826|FG000|Overall Study|Protocol Violation|5|||
105459448|NCT00385671|363695827|FG001|Overall Study|Protocol Violation|2|||
105459449|NCT00385671|363695828|FG002|Overall Study|Protocol Violation|1|||
105459450|NCT00385671|363695826|FG000|Overall Study|Sponsor Decision|2|||
105459451|NCT00385671|363695827|FG001|Overall Study|Sponsor Decision|2|||
105459452|NCT00385671|363695828|FG002|Overall Study|Sponsor Decision|1|||
105459453|NCT00385671|363695826|FG000|Overall Study|Withdrawal by Subject|4|||
105338236|NCT01106677|363241066|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
105338237|NCT01106677|363241067|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
105338238|NCT01106677|363241068|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
105338239|NCT01106677|363241069|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
105338240|NCT01106677|363241066|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
105338241|NCT01106677|363241067|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
105338242|NCT01106677|363241068|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
105338243|NCT01106677|363241069|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
105338244|NCT01106677|363241066|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
105338245|NCT01106677|363241067|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
105338246|NCT01106677|363241068|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
105338247|NCT01106677|363241069|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
105338248|NCT01106677|363241066|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
105338249|NCT01106677|363241067|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
105338250|NCT01106677|363241068|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
105338251|NCT01106677|363241069|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
105338252|NCT01106677|363241066|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
105338253|NCT01106677|363241067|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
105338254|NCT01106677|363241068|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
105338255|NCT01106677|363241069|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
105338256|NCT01106677|363241066|FG000|Core Period: Baseline to Week 26|Other|8|||
105338257|NCT01106677|363241067|FG001|Core Period: Baseline to Week 26|Other|14|||
105338258|NCT01106677|363241068|FG002|Core Period: Baseline to Week 26|Other|8|||
105338259|NCT01106677|363241069|FG003|Core Period: Baseline to Week 26|Other|23|||
105338260|NCT01106677|363241066|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
105338261|NCT01106677|363241067|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
105338262|NCT01106677|363241068|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
105338263|NCT01106677|363241069|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
105338264|NCT01106677|363241066|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
105338265|NCT01106677|363241067|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
105338266|NCT01106677|363241068|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
105338267|NCT01106677|363241069|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
105338268|NCT01106677|363241066|FG000|Extension Period: Week 26 to Week 52|Death|0|||
105338269|NCT01106677|363241067|FG001|Extension Period: Week 26 to Week 52|Death|0|||
105338270|NCT01106677|363241068|FG002|Extension Period: Week 26 to Week 52|Death|0|||
105338271|NCT01106677|363241069|FG003|Extension Period: Week 26 to Week 52|Death|1|||
105338272|NCT01106677|363241066|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
105338273|NCT01106677|363241067|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
105338274|NCT01106677|363241068|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
105338275|NCT01106677|363241069|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
105338276|NCT01106677|363241066|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
105338277|NCT01106677|363241067|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
105338278|NCT01106677|363241068|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
105338279|NCT01106677|363241069|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
105338280|NCT01106677|363241066|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
105338281|NCT01106677|363241067|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
105338282|NCT01106677|363241068|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
105338283|NCT01106677|363241069|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
105338284|NCT01106677|363241066|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
105338285|NCT01106677|363241067|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105338286|NCT01106677|363241068|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105459454|NCT00385671|363695827|FG001|Overall Study|Withdrawal by Subject|4|||
105459455|NCT00385671|363695828|FG002|Overall Study|Withdrawal by Subject|4|||
105459456|NCT00092417|363695829|FG000|Overall Study|Lost to Follow-up|2|||
105459457|NCT00092417|363695830|FG001|Overall Study|Lost to Follow-up|0|||
105459458|NCT00092417|363695829|FG000|Overall Study|Withdrawal by Subject|2|||
105459459|NCT00092417|363695830|FG001|Overall Study|Withdrawal by Subject|1|||
105459460|NCT00092417|363695829|FG000|Overall Study|Other|1|||
105459461|NCT00092417|363695830|FG001|Overall Study|Other|0|||
105459462|NCT01972217|363695831|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
105459463|NCT01972217|363695832|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
105459464|NCT01972217|363695833|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
105459465|NCT01972217|363695834|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
105459466|NCT01972217|363695831|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
105459467|NCT01972217|363695832|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
105338287|NCT01106677|363241069|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105459468|NCT01972217|363695833|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
105459469|NCT01972217|363695834|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
105459470|NCT01972217|363695831|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
105459471|NCT01972217|363695832|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
105459472|NCT01972217|363695833|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
105459473|NCT01972217|363695834|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
105459474|NCT01972217|363695831|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
105459475|NCT01972217|363695832|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
105459476|NCT01972217|363695833|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
105459477|NCT01972217|363695834|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
105459478|NCT01972217|363695831|FG000|Part B Double-blind, Randomised Period|Death|0|||
105459479|NCT01972217|363695832|FG001|Part B Double-blind, Randomised Period|Death|0|||
105459480|NCT01972217|363695833|FG002|Part B Double-blind, Randomised Period|Death|43|||
105459481|NCT01972217|363695834|FG003|Part B Double-blind, Randomised Period|Death|44|||
105459482|NCT01972217|363695831|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
105459483|NCT01972217|363695832|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
105459484|NCT01972217|363695833|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
105459485|NCT01972217|363695834|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
105459486|NCT01972217|363695831|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
105459487|NCT01972217|363695832|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
105459488|NCT01972217|363695833|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
105459489|NCT01972217|363695834|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
105459490|NCT01972217|363695831|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
105459491|NCT01972217|363695832|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
105459492|NCT01972217|363695833|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
105459493|NCT01972217|363695834|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
105459494|NCT01972217|363695831|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
105459495|NCT01972217|363695832|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
105459496|NCT01972217|363695833|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
105459497|NCT01972217|363695834|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
105459498|NCT01074502|363695836|FG000|Overall Study|Withdrawal by Subject|1|||
105459499|NCT00473564|363695837|FG000|Overall Study|robot surgery aborted in OR|23|||
105459500|NCT00674817|363695838|FG000|Period 1|Withdrawal by Subject|2|||
105459501|NCT00674817|363695838|FG000|Period 1|Protocol Violation|1|||
105459502|NCT00674817|363695838|FG000|Period 3|Adverse Event|1|||
105459503|NCT00674817|363695838|FG000|Period 3|Protocol Violation|1|||
105459504|NCT00674817|363695838|FG000|Period 4|Adverse Event|1|||
105459505|NCT03131219|363695841|FG000|Initial Evaluation Period|Adverse Event|2|||
105459506|NCT03131219|363695842|FG001|Initial Evaluation Period|Adverse Event|0|||
105459507|NCT03131219|363695841|FG000|Initial Evaluation Period|Protocol Violation|1|||
105459508|NCT03131219|363695842|FG001|Initial Evaluation Period|Protocol Violation|0|||
105459509|NCT03131219|363695841|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
105459510|NCT03131219|363695842|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
105459511|NCT03131219|363695841|FG000|Initial Evaluation Period|Physician Decision|1|||
105459512|NCT03131219|363695842|FG001|Initial Evaluation Period|Physician Decision|0|||
105459513|NCT03131219|363695841|FG000|Extension Period|Physician Decision|1|||
105459514|NCT03131219|363695842|FG001|Extension Period|Physician Decision|0|||
105459515|NCT00616759|363695843|FG000|Overall Study|Physician Decision|2|||
105459516|NCT00616759|363695844|FG001|Overall Study|Physician Decision|0|||
105459517|NCT00616759|363695843|FG000|Overall Study|Withdrawal by Subject|1|||
105459518|NCT00616759|363695844|FG001|Overall Study|Withdrawal by Subject|2|||
105459519|NCT02177123|363695846|FG000|Overall Study|Lost to Follow-up|6|||
105459520|NCT02177123|363695846|FG000|Overall Study|Withdrawal by Subject|4|||
105459521|NCT02177123|363695846|FG000|Overall Study|Adverse Event|4|||
105459522|NCT02177123|363695846|FG000|Overall Study|Physician Decision|3|||
105459523|NCT02177123|363695846|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
105459524|NCT02177123|363695846|FG000|Overall Study|Excluded for medical reasons|2|||
105459525|NCT02177123|363695846|FG000|Overall Study|Death|1|||
105459526|NCT02177123|363695846|FG000|Overall Study|Other|1|||
105459527|NCT02177123|363695846|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
105459528|NCT00671658|363695852|FG000|Overall Study|Physician Decision|5|||
105459529|NCT01921205|363695853|FG000|Overall Study|Adverse Event|12|||
105459530|NCT01921205|363695854|FG001|Overall Study|Adverse Event|7|||
105459531|NCT01921205|363695853|FG000|Overall Study|Lack of Efficacy|1|||
105459532|NCT01921205|363695854|FG001|Overall Study|Lack of Efficacy|0|||
105459533|NCT01921205|363695853|FG000|Overall Study|Protocol Violation|1|||
105459534|NCT01921205|363695854|FG001|Overall Study|Protocol Violation|3|||
105459535|NCT01921205|363695853|FG000|Overall Study|Lost to Follow-up|1|||
105459536|NCT01921205|363695854|FG001|Overall Study|Lost to Follow-up|1|||
105459537|NCT01921205|363695853|FG000|Overall Study|Withdrawal by Subject|6|||
105459538|NCT01921205|363695854|FG001|Overall Study|Withdrawal by Subject|5|||
105459539|NCT01921205|363695853|FG000|Overall Study|Use Of Prohibited Medication|0|||
105459540|NCT01921205|363695854|FG001|Overall Study|Use Of Prohibited Medication|1|||
105459541|NCT01921205|363695853|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
105459542|NCT01921205|363695854|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
105459543|NCT01921205|363695853|FG000|Overall Study|Non Compliance Of The Parent|0|||
105459544|NCT01921205|363695854|FG001|Overall Study|Non Compliance Of The Parent|1|||
105459545|NCT01921205|363695853|FG000|Overall Study|Non Compliance Of Child|0|||
105459546|NCT01921205|363695854|FG001|Overall Study|Non Compliance Of Child|1|||
105459547|NCT01527149|363695855|FG000|Overall Study|Death|2|||
105459548|NCT00360230|363695856|FG000|Overall Study|Withdrawal by Subject|1|||
105459549|NCT00360230|363695857|FG001|Overall Study|Withdrawal by Subject|1|||
105459550|NCT00360230|363695858|FG002|Overall Study|Withdrawal by Subject|0|||
105459551|NCT00360230|363695859|FG003|Overall Study|Withdrawal by Subject|1|||
105459552|NCT00360230|363695860|FG004|Overall Study|Withdrawal by Subject|1|||
105459553|NCT00360230|363695861|FG005|Overall Study|Withdrawal by Subject|1|||
105459554|NCT00360230|363695862|FG006|Overall Study|Withdrawal by Subject|0|||
105459555|NCT00360230|363695856|FG000|Overall Study|Migrated|4|||
105459556|NCT00360230|363695857|FG001|Overall Study|Migrated|1|||
105459557|NCT00360230|363695858|FG002|Overall Study|Migrated|3|||
105459558|NCT00360230|363695859|FG003|Overall Study|Migrated|1|||
105459559|NCT00360230|363695860|FG004|Overall Study|Migrated|4|||
105459560|NCT00360230|363695861|FG005|Overall Study|Migrated|1|||
105459561|NCT00360230|363695862|FG006|Overall Study|Migrated|1|||
105459562|NCT00360230|363695856|FG000|Overall Study|Other|1|||
105459563|NCT00360230|363695857|FG001|Overall Study|Other|0|||
105459564|NCT00360230|363695858|FG002|Overall Study|Other|0|||
105459565|NCT00360230|363695859|FG003|Overall Study|Other|0|||
105459566|NCT00360230|363695860|FG004|Overall Study|Other|0|||
105459567|NCT00360230|363695861|FG005|Overall Study|Other|0|||
105459568|NCT00360230|363695862|FG006|Overall Study|Other|0|||
105459569|NCT00360230|363695856|FG000|Overall Study|Protocol Violation|0|||
105459570|NCT00360230|363695857|FG001|Overall Study|Protocol Violation|0|||
105459571|NCT00360230|363695858|FG002|Overall Study|Protocol Violation|0|||
105459572|NCT00360230|363695859|FG003|Overall Study|Protocol Violation|0|||
105459573|NCT00360230|363695860|FG004|Overall Study|Protocol Violation|0|||
105459574|NCT00360230|363695861|FG005|Overall Study|Protocol Violation|1|||
105459575|NCT00360230|363695862|FG006|Overall Study|Protocol Violation|0|||
105459576|NCT00360230|363695856|FG000|Overall Study|Death|0|||
105459577|NCT00360230|363695857|FG001|Overall Study|Death|1|||
105459578|NCT00360230|363695858|FG002|Overall Study|Death|0|||
105459579|NCT00360230|363695859|FG003|Overall Study|Death|0|||
105459580|NCT00360230|363695860|FG004|Overall Study|Death|0|||
105459581|NCT00360230|363695861|FG005|Overall Study|Death|1|||
105459582|NCT00360230|363695862|FG006|Overall Study|Death|1|||
105459583|NCT00481832|363695864|FG000|Enrollment|Physician Decision|8|||
105459584|NCT00481832|363695864|FG000|Enrollment|Unable to collect enough stem cells|2|||
105459585|NCT00481832|363695864|FG000|Inter-transplant Period|Adverse Event|4|||
105459586|NCT00481832|363695864|FG000|Inter-transplant Period|Death|3|||
105459587|NCT00481832|363695864|FG000|Inter-transplant Period|Physician Decision|4|||
105459588|NCT00481832|363695864|FG000|Inter-transplant Period|Disease relapse|11|||
105459589|NCT00481832|363695864|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
105459590|NCT02558894|363695865|FG000|Overall Study|Death; any cause, entire study duration|28|||
105459591|NCT02558894|363695866|FG001|Overall Study|Death; any cause, entire study duration|31|||
105459592|NCT02558894|363695865|FG000|Overall Study|Withdrawal by Subject|2|||
105459593|NCT02558894|363695866|FG001|Overall Study|Withdrawal by Subject|1|||
105459594|NCT02558894|363695865|FG000|Overall Study|Closure of Part A|2|||
105459595|NCT02558894|363695866|FG001|Overall Study|Closure of Part A|1|||
105459596|NCT01527370|363695868|FG000|Overall Study|Withdrawal by Subject|4|||
105459597|NCT01527370|363695868|FG000|Overall Study|Physician Decision|1|||
105459598|NCT01527370|363695868|FG000|Overall Study|Death|1|||
105459599|NCT02340026|363695877|FG000|Treatment Phase|Withdrawal by Subject|2|||
105459600|NCT02340026|363695878|FG001|Treatment Phase|Withdrawal by Subject|2|||
105459601|NCT02340026|363695877|FG000|Follow-up Phase|Lost to Follow-up|1|||
105459602|NCT02340026|363695878|FG001|Follow-up Phase|Lost to Follow-up|0|||
105459603|NCT01436149|363695879|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
105661761|NCT03569891|364425134|FG000|Lead-in|Ineligible during lead-in|8|||
105459604|NCT01436149|363695880|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
105459605|NCT01436149|363695881|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
105459606|NCT01436149|363695879|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
105459607|NCT01436149|363695880|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
105459608|NCT01436149|363695881|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
105459609|NCT01436149|363695879|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
105459610|NCT01436149|363695880|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
105459611|NCT01436149|363695881|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
105459612|NCT01436149|363695879|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
105459613|NCT01436149|363695880|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
105459614|NCT01436149|363695881|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
105459615|NCT01436149|363695879|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
105459616|NCT01436149|363695880|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
105459617|NCT01436149|363695881|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
105459618|NCT01436149|363695879|FG000|Antidepressant Lead-in Phase|Other|119|||
105459619|NCT01436149|363695880|FG001|Antidepressant Lead-in Phase|Other|0|||
105459620|NCT01436149|363695881|FG002|Antidepressant Lead-in Phase|Other|0|||
105459621|NCT01436149|363695879|FG000|Randomized Phase|Adverse Event|9|||
105459622|NCT01436149|363695880|FG001|Randomized Phase|Adverse Event|10|||
105459623|NCT01436149|363695881|FG002|Randomized Phase|Adverse Event|11|||
105459624|NCT01436149|363695879|FG000|Randomized Phase|Protocol Violation|4|||
105459625|NCT01436149|363695880|FG001|Randomized Phase|Protocol Violation|5|||
105459626|NCT01436149|363695881|FG002|Randomized Phase|Protocol Violation|0|||
105459627|NCT01436149|363695879|FG000|Randomized Phase|Withdrawal by Subject|16|||
105459628|NCT01436149|363695880|FG001|Randomized Phase|Withdrawal by Subject|10|||
105459629|NCT01436149|363695881|FG002|Randomized Phase|Withdrawal by Subject|10|||
105459630|NCT01436149|363695879|FG000|Randomized Phase|Lost to Follow-up|34|||
105459631|NCT01436149|363695880|FG001|Randomized Phase|Lost to Follow-up|5|||
105459632|NCT01436149|363695881|FG002|Randomized Phase|Lost to Follow-up|6|||
105459633|NCT01436149|363695879|FG000|Randomized Phase|Lack of Efficacy|0|||
105459634|NCT01436149|363695880|FG001|Randomized Phase|Lack of Efficacy|0|||
105459635|NCT01436149|363695881|FG002|Randomized Phase|Lack of Efficacy|1|||
105459636|NCT01436149|363695879|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
105459637|NCT01436149|363695880|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
105459638|NCT01436149|363695881|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
105459639|NCT01436149|363695879|FG000|Randomized Phase|Other|12|||
105459640|NCT01436149|363695880|FG001|Randomized Phase|Other|5|||
105459641|NCT01436149|363695881|FG002|Randomized Phase|Other|11|||
105459642|NCT03019406|363695888|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
105459643|NCT03019406|363695889|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
105459644|NCT03019406|363695890|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
105459645|NCT03019406|363695891|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
105459646|NCT02946580|363695895|FG000|Overall Study|Withdrawal by Subject|1|||
105459647|NCT02946580|363695896|FG001|Overall Study|Withdrawal by Subject|2|||
105459648|NCT02946580|363695895|FG000|Overall Study|Adverse Event|0|||
105459649|NCT02946580|363695896|FG001|Overall Study|Adverse Event|2|||
105459650|NCT02946580|363695895|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
105459651|NCT02946580|363695896|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
105459652|NCT01903460|363695897|FG000|Overall Study|Adverse Event|0|||
105459653|NCT01903460|363695898|FG001|Overall Study|Adverse Event|0|||
105459654|NCT01903460|363695899|FG002|Overall Study|Adverse Event|0|||
105459655|NCT01903460|363695900|FG003|Overall Study|Adverse Event|1|||
105459656|NCT05712460|363695901|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
105459657|NCT05712460|363695902|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
105459658|NCT05712460|363695903|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
105459659|NCT05712460|363695904|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
105459660|NCT05712460|363695905|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
105459661|NCT05712460|363695906|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
105459662|NCT05712460|363695907|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
105459663|NCT05712460|363695908|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
105459664|NCT05712460|363695909|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
105459665|NCT05712460|363695910|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
105459666|NCT05712460|363695911|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
105459667|NCT05712460|363695912|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
105459668|NCT04408989|363695917|FG000|Overall Study|Lost to Follow-up|0|||
105459669|NCT04408989|363695918|FG001|Overall Study|Lost to Follow-up|0|||
105459670|NCT04408989|363695919|FG002|Overall Study|Lost to Follow-up|1|||
105459671|NCT04408989|363695917|FG000|Overall Study|Withdrawal by Subject|0|||
105459672|NCT04408989|363695918|FG001|Overall Study|Withdrawal by Subject|0|||
105459673|NCT04408989|363695919|FG002|Overall Study|Withdrawal by Subject|2|||
105459674|NCT04672239|363695920|FG000|Week 2 Survey|Failed survey check items|1|||
105459675|NCT04672239|363695921|FG001|Week 2 Survey|Failed survey check items|2|||
105459676|NCT04672239|363695922|FG002|Week 2 Survey|Failed survey check items|3|||
105459677|NCT04672239|363695920|FG000|Week 2 Survey|Partially completed survey|7|||
105459678|NCT04672239|363695921|FG001|Week 2 Survey|Partially completed survey|1|||
105459679|NCT04672239|363695922|FG002|Week 2 Survey|Partially completed survey|4|||
105459680|NCT04672239|363695920|FG000|Week 2 Survey|Withdrawal by Subject|0|||
105459681|NCT04672239|363695921|FG001|Week 2 Survey|Withdrawal by Subject|1|||
105459682|NCT04672239|363695922|FG002|Week 2 Survey|Withdrawal by Subject|0|||
105459683|NCT04672239|363695920|FG000|Week 2 Survey|Lost to Follow-up|3|||
105459684|NCT04672239|363695921|FG001|Week 2 Survey|Lost to Follow-up|2|||
105459685|NCT04672239|363695922|FG002|Week 2 Survey|Lost to Follow-up|5|||
105459686|NCT04672239|363695920|FG000|Week 6 Survey|Failed survey check items|2|||
105459687|NCT04672239|363695921|FG001|Week 6 Survey|Failed survey check items|2|||
105459688|NCT04672239|363695922|FG002|Week 6 Survey|Failed survey check items|2|||
105459689|NCT04672239|363695920|FG000|Week 6 Survey|Partially completed survey|3|||
105459690|NCT04672239|363695921|FG001|Week 6 Survey|Partially completed survey|3|||
105459691|NCT04672239|363695922|FG002|Week 6 Survey|Partially completed survey|2|||
105459692|NCT04672239|363695920|FG000|Week 6 Survey|Withdrawal by Subject|1|||
105459693|NCT04672239|363695921|FG001|Week 6 Survey|Withdrawal by Subject|1|||
105459694|NCT04672239|363695922|FG002|Week 6 Survey|Withdrawal by Subject|1|||
105459695|NCT04672239|363695920|FG000|Week 6 Survey|Withdrawn by PI|0|||
105459696|NCT04672239|363695921|FG001|Week 6 Survey|Withdrawn by PI|1|||
105459697|NCT04672239|363695922|FG002|Week 6 Survey|Withdrawn by PI|0|||
105459698|NCT04672239|363695920|FG000|Week 6 Survey|Lost to Follow-up|12|||
105459699|NCT04672239|363695921|FG001|Week 6 Survey|Lost to Follow-up|2|||
105459700|NCT04672239|363695922|FG002|Week 6 Survey|Lost to Follow-up|5|||
105459701|NCT04672239|363695920|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
105459702|NCT04672239|363695921|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
105459703|NCT04672239|363695922|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
105459704|NCT04672239|363695920|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
105459705|NCT04672239|363695921|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
105459706|NCT04672239|363695922|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
105459707|NCT04672239|363695920|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
105459708|NCT04672239|363695921|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
105459709|NCT04672239|363695922|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
105459710|NCT04672239|363695920|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
105459711|NCT04672239|363695921|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
105459712|NCT04672239|363695922|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
105459713|NCT04672239|363695920|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
105459714|NCT04672239|363695921|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
105459715|NCT04672239|363695922|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
105459716|NCT04672239|363695920|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
105459717|NCT04672239|363695921|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
105459718|NCT04672239|363695922|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
105459719|NCT04672239|363695920|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
105459720|NCT04672239|363695921|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
105459721|NCT04672239|363695922|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
105459722|NCT02018562|363695923|FG000|Overall Study|Withdrawal by Subject|2|||
105459723|NCT02018562|363695924|FG001|Overall Study|Withdrawal by Subject|0|||
105459724|NCT02018562|363695923|FG000|Overall Study|Discharged prior to study completion|1|||
105459725|NCT02018562|363695924|FG001|Overall Study|Discharged prior to study completion|0|||
105459726|NCT05194124|363695925|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
105459727|NCT05194124|363695926|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
105459728|NCT05194124|363695927|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
105459729|NCT05194124|363695928|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
105459730|NCT05194124|363695929|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
105459731|NCT05194124|363695930|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
105459732|NCT05194124|363695931|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
105459733|NCT05194124|363695932|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
105459734|NCT05194124|363695933|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
105459735|NCT05194124|363695934|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
105459736|NCT05194124|363695925|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
105459737|NCT05194124|363695926|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
105459738|NCT05194124|363695927|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
105459739|NCT05194124|363695928|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
105459740|NCT05194124|363695929|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
105459741|NCT05194124|363695930|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
105459742|NCT05194124|363695931|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
105459743|NCT05194124|363695932|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
105459744|NCT05194124|363695933|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
105459745|NCT05194124|363695934|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
105459746|NCT05720897|363695935|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
105459747|NCT05720897|363695936|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
105459748|NCT00400179|363695937|FG000|Overall Study|Adverse Event|2|||
105459749|NCT00400179|363695938|FG001|Overall Study|Adverse Event|2|||
105459750|NCT00400179|363695937|FG000|Overall Study|Death|1|||
105459751|NCT00400179|363695938|FG001|Overall Study|Death|2|||
105459752|NCT00400179|363695937|FG000|Overall Study|Withdrew Consent|1|||
105459753|NCT00400179|363695938|FG001|Overall Study|Withdrew Consent|5|||
105459754|NCT00400179|363695937|FG000|Overall Study|Disease progression|1|||
105459755|NCT00400179|363695938|FG001|Overall Study|Disease progression|1|||
105459756|NCT00400179|363695937|FG000|Overall Study|Intercurrent illness|0|||
105459757|NCT00400179|363695938|FG001|Overall Study|Intercurrent illness|1|||
105338288|NCT01106677|363241066|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
105338289|NCT01106677|363241067|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
105338290|NCT01106677|363241068|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
105338291|NCT01106677|363241069|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
105338292|NCT01106677|363241066|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
105338293|NCT01106677|363241067|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
105338294|NCT01106677|363241068|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
105338295|NCT01106677|363241069|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
105338296|NCT01106677|363241066|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
105338297|NCT01106677|363241067|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
105338298|NCT01106677|363241068|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
105338299|NCT01106677|363241069|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
105338300|NCT01106677|363241066|FG000|Extension Period: Week 26 to Week 52|Other|6|||
105338301|NCT01106677|363241067|FG001|Extension Period: Week 26 to Week 52|Other|5|||
105338302|NCT01106677|363241068|FG002|Extension Period: Week 26 to Week 52|Other|8|||
105338303|NCT01106677|363241069|FG003|Extension Period: Week 26 to Week 52|Other|5|||
105338304|NCT01283334|363241070|FG000|Overall Study|Withdrawal by Subject|1|||
105338305|NCT01283334|363241070|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
105338306|NCT01283334|363241070|FG000|Overall Study|Adverse Event|4|||
105338307|NCT01283334|363241070|FG000|Overall Study|Physician Decision|1|||
105338308|NCT03937908|363241071|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
105338309|NCT03937908|363241072|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
105338310|NCT04420585|363241073|FG000|Overall Study|Adverse Event|1|||
105459758|NCT00400179|363695937|FG000|Overall Study|Investigator judgment|0|||
105459759|NCT00400179|363695938|FG001|Overall Study|Investigator judgment|1|||
105459760|NCT00400179|363695937|FG000|Overall Study|Randomization error/patient ineligible|1|||
105459761|NCT00400179|363695938|FG001|Overall Study|Randomization error/patient ineligible|6|||
105459762|NCT04780061|363695939|FG000|Overall Study|Withdrawal by Subject|5|||
105459763|NCT04780061|363695940|FG001|Overall Study|Withdrawal by Subject|8|||
105459764|NCT04780061|363695939|FG000|Overall Study|Adverse Event|2|||
105459765|NCT04780061|363695940|FG001|Overall Study|Adverse Event|2|||
105459766|NCT04780061|363695939|FG000|Overall Study|Lost to Follow-up|1|||
105459767|NCT04780061|363695940|FG001|Overall Study|Lost to Follow-up|5|||
105459768|NCT05138653|363695947|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
105459769|NCT05138653|363695948|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
105459770|NCT05138653|363695949|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
105459771|NCT05138653|363695950|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
105459772|NCT05138653|363695951|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
105459773|NCT05138653|363695952|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
105459774|NCT05138653|363695953|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
105459775|NCT05138653|363695954|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
105459776|NCT05138653|363695955|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
105459777|NCT05138653|363695956|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
105459778|NCT05138653|363695957|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
105459779|NCT05138653|363695958|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
105459780|NCT05138653|363695959|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
105459781|NCT05138653|363695960|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
105459782|NCT05138653|363695961|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
105459783|NCT05138653|363695962|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
105459784|NCT05138653|363695947|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105459785|NCT05138653|363695948|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
105459786|NCT05138653|363695949|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105459787|NCT05138653|363695950|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105459788|NCT05138653|363695951|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105459789|NCT05138653|363695952|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105459790|NCT05138653|363695953|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105459791|NCT05138653|363695954|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105459792|NCT05138653|363695955|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
105459793|NCT05138653|363695956|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105459794|NCT05138653|363695957|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105459795|NCT05138653|363695958|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105459796|NCT05138653|363695959|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105459797|NCT05138653|363695960|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105459798|NCT05138653|363695961|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105459799|NCT05138653|363695962|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105338311|NCT04420585|363241073|FG000|Overall Study|Never initiated medication|2|||
105338312|NCT04114357|363241074|FG000|Baseline-Randomization|Adverse Event|2|||
105338313|NCT04114357|363241075|FG001|Baseline-Randomization|Adverse Event|1|||
105338314|NCT04114357|363241074|FG000|Baseline-Randomization|Lost to Follow-up|1|||
105338315|NCT04114357|363241075|FG001|Baseline-Randomization|Lost to Follow-up|1|||
105338316|NCT04114357|363241074|FG000|Cross-over|Adverse Event|0|||
105338317|NCT04114357|363241075|FG001|Cross-over|Adverse Event|1|||
105338318|NCT03693612|363241078|FG000|Overall Study|Lost to Follow-up|0|||
105338319|NCT03693612|363241079|FG001|Overall Study|Lost to Follow-up|0|||
105338320|NCT03693612|363241080|FG002|Overall Study|Lost to Follow-up|0|||
105338321|NCT03693612|363241081|FG003|Overall Study|Lost to Follow-up|0|||
105338322|NCT03693612|363241082|FG004|Overall Study|Lost to Follow-up|1|||
105338323|NCT03693612|363241083|FG005|Overall Study|Lost to Follow-up|0|||
105338324|NCT03693612|363241084|FG006|Overall Study|Lost to Follow-up|0|||
105338325|NCT03693612|363241078|FG000|Overall Study|Withdrawal by Subject|0|||
105338326|NCT03693612|363241079|FG001|Overall Study|Withdrawal by Subject|0|||
105338327|NCT03693612|363241080|FG002|Overall Study|Withdrawal by Subject|1|||
105338328|NCT03693612|363241081|FG003|Overall Study|Withdrawal by Subject|0|||
105338329|NCT03693612|363241082|FG004|Overall Study|Withdrawal by Subject|2|||
105338330|NCT03693612|363241083|FG005|Overall Study|Withdrawal by Subject|0|||
105459800|NCT05138653|363695947|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
105459801|NCT05138653|363695948|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
105459802|NCT05138653|363695949|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
105459803|NCT05138653|363695950|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
105459804|NCT05138653|363695951|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
105459805|NCT05138653|363695952|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
105459806|NCT05138653|363695953|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
105459807|NCT05138653|363695954|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
105459808|NCT05138653|363695955|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
105459809|NCT05138653|363695956|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
105459810|NCT05138653|363695957|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
105459811|NCT05138653|363695958|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
105459812|NCT05138653|363695959|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
105459813|NCT05138653|363695960|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
105459814|NCT05138653|363695961|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
105459815|NCT05138653|363695962|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
105459816|NCT05138653|363695947|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
105459817|NCT05138653|363695948|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
105459818|NCT05138653|363695949|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
105459819|NCT05138653|363695950|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
105459820|NCT05138653|363695951|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
105459821|NCT05138653|363695952|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
105459822|NCT05138653|363695953|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
105459823|NCT05138653|363695954|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
105459824|NCT05138653|363695955|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
105459825|NCT05138653|363695956|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
105459826|NCT05138653|363695957|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
105459827|NCT05138653|363695958|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
105459828|NCT05138653|363695959|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
105459829|NCT05138653|363695960|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
105459830|NCT05138653|363695961|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
105459831|NCT05138653|363695962|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
105459832|NCT05138653|363695947|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
105459833|NCT05138653|363695948|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
105459834|NCT05138653|363695949|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
105459835|NCT05138653|363695950|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
105459836|NCT05138653|363695951|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
105459837|NCT05138653|363695952|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
105459838|NCT05138653|363695953|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
105459839|NCT05138653|363695954|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
105459840|NCT05138653|363695955|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
105459841|NCT05138653|363695956|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
105459842|NCT05138653|363695957|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
105459843|NCT05138653|363695958|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
105459844|NCT05138653|363695959|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
105459845|NCT05138653|363695960|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
105459846|NCT05138653|363695961|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
105459847|NCT05138653|363695962|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
105459848|NCT05138653|363695947|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105338331|NCT03693612|363241084|FG006|Overall Study|Withdrawal by Subject|0|||
105338332|NCT03693612|363241078|FG000|Overall Study|Study Terminated by Sponsor|0|||
105338333|NCT03693612|363241079|FG001|Overall Study|Study Terminated by Sponsor|1|||
105338334|NCT03693612|363241080|FG002|Overall Study|Study Terminated by Sponsor|0|||
105338335|NCT03693612|363241081|FG003|Overall Study|Study Terminated by Sponsor|0|||
105338336|NCT03693612|363241082|FG004|Overall Study|Study Terminated by Sponsor|3|||
105338337|NCT03693612|363241083|FG005|Overall Study|Study Terminated by Sponsor|0|||
105338338|NCT03693612|363241084|FG006|Overall Study|Study Terminated by Sponsor|0|||
105338339|NCT05318092|363241085|FG000|Overall Study|Lost to Follow-up|3|||
105338340|NCT05318092|363241085|FG000|Overall Study|Withdrawal by Subject|1|||
105338341|NCT03917472|363241089|FG000|Overall Study|Physician Decision|4|||
105338342|NCT03917472|363241090|FG001|Overall Study|Physician Decision|0|||
105338343|NCT03917472|363241089|FG000|Overall Study|Adverse Event|3|||
105338344|NCT03917472|363241090|FG001|Overall Study|Adverse Event|1|||
105338345|NCT03917472|363241089|FG000|Overall Study|Death|7|||
105338346|NCT03917472|363241090|FG001|Overall Study|Death|5|||
105338347|NCT03917472|363241089|FG000|Overall Study|Withdrawal by Subject|11|||
105338348|NCT03917472|363241090|FG001|Overall Study|Withdrawal by Subject|4|||
105338349|NCT03917472|363241089|FG000|Overall Study|Lost to Follow-up|10|||
105338350|NCT03917472|363241090|FG001|Overall Study|Lost to Follow-up|5|||
105338351|NCT01669174|363241091|FG000|Overall Study|Subject withdrew consent|2|||
105338352|NCT01669174|363241092|FG001|Overall Study|Subject withdrew consent|2|||
105338353|NCT01669174|363241091|FG000|Overall Study|Lost to Follow-up|1|||
105338354|NCT01669174|363241092|FG001|Overall Study|Lost to Follow-up|0|||
105338355|NCT01669174|363241091|FG000|Overall Study|Adverse Event|2|||
105338356|NCT01669174|363241092|FG001|Overall Study|Adverse Event|2|||
105338357|NCT01669174|363241091|FG000|Overall Study|Administrative problems|1|||
105338358|NCT01669174|363241092|FG001|Overall Study|Administrative problems|2|||
105338359|NCT01154296|363241093|FG000|Randomization and Intervention|Decided to decline|1|||
105338360|NCT01154296|363241094|FG001|Randomization and Intervention|Decided to decline|1|||
105338361|NCT01154296|363241093|FG000|Randomization and Intervention|Declined by staff|1|||
105338362|NCT01154296|363241094|FG001|Randomization and Intervention|Declined by staff|0|||
105338363|NCT01154296|363241093|FG000|Randomization and Intervention|Did not return|1|||
105338364|NCT01154296|363241094|FG001|Randomization and Intervention|Did not return|0|||
105338365|NCT01154296|363241093|FG000|Randomization and Intervention|Left before test|0|||
105338366|NCT01154296|363241094|FG001|Randomization and Intervention|Left before test|1|||
105338367|NCT01154296|363241093|FG000|Randomization and Intervention|Left clinic early|2|||
105338368|NCT01154296|363241094|FG001|Randomization and Intervention|Left clinic early|0|||
105338369|NCT01154296|363241093|FG000|6-month Follow-up|Lost contact|269|||
105338370|NCT01154296|363241094|FG001|6-month Follow-up|Lost contact|275|||
105338371|NCT01154296|363241093|FG000|6-month Follow-up|Incarcerated|37|||
105338372|NCT01154296|363241094|FG001|6-month Follow-up|Incarcerated|32|||
105338373|NCT01154296|363241093|FG000|6-month Follow-up|Withdrew consent|14|||
105459849|NCT05138653|363695948|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105459850|NCT05138653|363695949|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105459851|NCT05138653|363695950|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105459852|NCT05138653|363695951|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105459853|NCT05138653|363695952|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105459854|NCT05138653|363695953|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105459855|NCT05138653|363695954|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105459856|NCT05138653|363695955|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105459857|NCT05138653|363695956|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105459858|NCT05138653|363695957|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105459859|NCT05138653|363695958|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105459860|NCT05138653|363695959|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105459861|NCT05138653|363695960|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105459862|NCT05138653|363695961|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105459863|NCT05138653|363695962|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
105459864|NCT05138653|363695947|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105459865|NCT05138653|363695948|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105459866|NCT05138653|363695949|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105459867|NCT05138653|363695950|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105459868|NCT05138653|363695951|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105459869|NCT05138653|363695952|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105338374|NCT01154296|363241094|FG001|6-month Follow-up|Withdrew consent|15|||
105338375|NCT01154296|363241093|FG000|6-month Follow-up|Death|3|||
105459870|NCT05138653|363695953|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105459871|NCT05138653|363695954|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105338376|NCT01154296|363241094|FG001|6-month Follow-up|Death|2|||
105338377|NCT01154296|363241093|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
105338378|NCT01154296|363241094|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
105338379|NCT03854370|363241095|FG000|Overall Study|samples not collected|1|||
105338380|NCT03854370|363241096|FG001|Overall Study|samples not collected|1|||
105338381|NCT03854370|363241097|FG002|Overall Study|samples not collected|1|||
105338382|NCT03854370|363241098|FG003|Overall Study|samples not collected|1|||
105338383|NCT00941863|363241101|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
105338384|NCT00941863|363241102|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
105338385|NCT00941863|363241103|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
105338386|NCT00941863|363241104|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
105459872|NCT05138653|363695955|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105459873|NCT05138653|363695956|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105459874|NCT05138653|363695957|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105459875|NCT05138653|363695958|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105459876|NCT05138653|363695959|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105459877|NCT05138653|363695960|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
105459878|NCT05138653|363695961|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105459879|NCT05138653|363695962|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105459880|NCT02023086|363695965|FG000|Overall Study|Withdrawal by Subject|2|||
105459881|NCT02023086|363695966|FG001|Overall Study|Withdrawal by Subject|0|||
105459882|NCT05523089|363695969|FG000|Overall Study|Withdrawal by Subject|1|||
105459883|NCT05523089|363695970|FG001|Overall Study|Withdrawal by Subject|0|||
105459884|NCT05523089|363695971|FG002|Overall Study|Withdrawal by Subject|0|||
105459885|NCT05523089|363695969|FG000|Overall Study|Lost to Follow-up|1|||
105459886|NCT05523089|363695970|FG001|Overall Study|Lost to Follow-up|0|||
105459887|NCT05523089|363695971|FG002|Overall Study|Lost to Follow-up|0|||
105459888|NCT05050318|363697656|FG000|Overall Study|Protocol Deviation|1|||
105459889|NCT05050318|363697657|FG001|Overall Study|Protocol Deviation|0|||
105459890|NCT05050318|363697658|FG002|Overall Study|Protocol Deviation|0|||
105459891|NCT01112917|363697661|FG000|Overall Study|Death|2|||
105459892|NCT01112917|363697662|FG001|Overall Study|Death|11|||
105459893|NCT01112917|363697661|FG000|Overall Study|Lost to Follow-up|1|||
105459894|NCT01112917|363697662|FG001|Overall Study|Lost to Follow-up|1|||
105459895|NCT01112917|363697661|FG000|Overall Study|Withdrawal by Subject|1|||
105459896|NCT01112917|363697662|FG001|Overall Study|Withdrawal by Subject|3|||
105459897|NCT01112917|363697661|FG000|Overall Study|Unable to Convert Filter|3|||
105459898|NCT01112917|363697662|FG001|Overall Study|Unable to Convert Filter|0|||
105459899|NCT02766023|363697665|FG000|Overall Study|Lost to Follow-up|23|||
105459900|NCT02766023|363697666|FG001|Overall Study|Lost to Follow-up|11|||
105459901|NCT02766023|363697665|FG000|Overall Study|Pregnancy|1|||
105459902|NCT02766023|363697666|FG001|Overall Study|Pregnancy|0|||
105459903|NCT02766023|363697665|FG000|Overall Study|Adverse Event|1|||
105459904|NCT02766023|363697666|FG001|Overall Study|Adverse Event|0|||
105459905|NCT02766023|363697665|FG000|Overall Study|Withdrawal by Subject|4|||
105459906|NCT02766023|363697666|FG001|Overall Study|Withdrawal by Subject|5|||
105459907|NCT02766023|363697665|FG000|Overall Study|Physician Decision|1|||
105459908|NCT02766023|363697666|FG001|Overall Study|Physician Decision|0|||
105459909|NCT02766023|363697665|FG000|Overall Study|Not Eligible at Enrollment|0|||
105459910|NCT02766023|363697666|FG001|Overall Study|Not Eligible at Enrollment|1|||
105459911|NCT03566511|363697667|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
105459912|NCT03566511|363697668|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
105459913|NCT04026113|363697673|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
105459914|NCT04026113|363697674|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
105459915|NCT04026113|363697675|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
105459916|NCT04026113|363697676|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
105459917|NCT04026113|363697673|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
105459918|NCT04026113|363697674|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
105459919|NCT04026113|363697675|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
105459920|NCT04026113|363697676|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
105459921|NCT04026113|363697673|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
105459922|NCT04026113|363697674|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
105459923|NCT04026113|363697675|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
105459924|NCT04026113|363697676|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
105459925|NCT04026113|363697673|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
105459926|NCT04026113|363697674|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
105459927|NCT04026113|363697675|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
105459928|NCT04026113|363697676|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
105459929|NCT04026113|363697673|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
105459930|NCT04026113|363697674|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
105459931|NCT04026113|363697675|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
105459932|NCT04026113|363697676|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
105459933|NCT04026113|363697673|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
105338387|NCT00941863|363241105|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
105338388|NCT00941863|363241101|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
105338389|NCT00941863|363241102|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
105338390|NCT00941863|363241103|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
105338391|NCT00941863|363241104|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
105338392|NCT00941863|363241105|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
105338393|NCT00941863|363241101|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
105338394|NCT00941863|363241102|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
105338395|NCT00941863|363241103|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
105338396|NCT00941863|363241104|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
105338397|NCT00941863|363241105|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
105338398|NCT00941863|363241101|FG000|Until Primary Completion Date (PCD)|Death|0|||
105338399|NCT00941863|363241102|FG001|Until Primary Completion Date (PCD)|Death|0|||
105338400|NCT00941863|363241103|FG002|Until Primary Completion Date (PCD)|Death|1|||
105338401|NCT00941863|363241104|FG003|Until Primary Completion Date (PCD)|Death|2|||
105338402|NCT00941863|363241105|FG004|Until Primary Completion Date (PCD)|Death|7|||
105338403|NCT00941863|363241101|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
105338404|NCT00941863|363241102|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
105338405|NCT00941863|363241103|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
105338406|NCT00941863|363241104|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
105459934|NCT04026113|363697674|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
105459935|NCT04026113|363697675|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
105459936|NCT04026113|363697676|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
105459937|NCT04026113|363697673|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
105459938|NCT04026113|363697674|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
105459939|NCT04026113|363697675|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
105459940|NCT04026113|363697676|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
105459941|NCT04026113|363697673|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
105459942|NCT04026113|363697674|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
105459943|NCT04026113|363697675|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
105459944|NCT04026113|363697676|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
105459945|NCT04026113|363697673|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
105459946|NCT04026113|363697674|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
105459947|NCT04026113|363697675|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
105459948|NCT04026113|363697676|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
105459949|NCT02923726|363697678|FG000|Overall Study|Death|196|||
105459950|NCT02923726|363697679|FG001|Overall Study|Death|175|||
105459951|NCT02923726|363697678|FG000|Overall Study|Withdrawal by Subject|337|||
105459952|NCT02923726|363697679|FG001|Overall Study|Withdrawal by Subject|307|||
105459953|NCT00837434|363697682|FG000|Overall Study|Physician Decision|3|||
105459954|NCT00837434|363697683|FG001|Overall Study|Physician Decision|0|||
105459955|NCT00837434|363697682|FG000|Overall Study|Lost to Follow-up|1|||
105459956|NCT00837434|363697683|FG001|Overall Study|Lost to Follow-up|1|||
105459957|NCT00837434|363697682|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
105459958|NCT00837434|363697683|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
105459959|NCT00837434|363697682|FG000|Overall Study|Noncompliant|2|||
105459960|NCT00837434|363697683|FG001|Overall Study|Noncompliant|0|||
105459961|NCT00837434|363697682|FG000|Overall Study|Baseline assessments not done in time|1|||
105459962|NCT00837434|363697683|FG001|Overall Study|Baseline assessments not done in time|0|||
105459963|NCT00837434|363697682|FG000|Overall Study|Unable to obtain study drug|1|||
105459964|NCT00837434|363697683|FG001|Overall Study|Unable to obtain study drug|0|||
105459965|NCT00129402|363697684|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
105459966|NCT00129402|363697685|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
105459967|NCT00129402|363697686|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
105459968|NCT00129402|363697687|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
105459969|NCT00129402|363697688|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
105459970|NCT00129402|363697689|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
105459971|NCT00129402|363697690|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
105459972|NCT00129402|363697684|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
105459973|NCT00129402|363697685|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
105459974|NCT00129402|363697686|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
105459975|NCT00129402|363697687|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
105459976|NCT00129402|363697688|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
105459977|NCT00129402|363697689|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
105459978|NCT00129402|363697690|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
105459979|NCT00129402|363697684|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
105459980|NCT00129402|363697685|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
105550210|NCT00467870|364014379|FG005|Overall Study|Lost to Follow-up|0|||
105459981|NCT00129402|363697686|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
105459982|NCT00129402|363697687|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
105459983|NCT00129402|363697688|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
105459984|NCT00129402|363697689|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
105459985|NCT00129402|363697690|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
105459986|NCT00129402|363697684|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
105459987|NCT00129402|363697685|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
105459988|NCT00129402|363697686|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
105459989|NCT00129402|363697687|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
105459990|NCT00129402|363697688|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
105459991|NCT00129402|363697689|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
105459992|NCT00129402|363697690|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
105459993|NCT00129402|363697684|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
105459994|NCT00129402|363697685|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
105459995|NCT00129402|363697686|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
105459996|NCT00129402|363697687|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
105459997|NCT00129402|363697688|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
105459998|NCT00129402|363697689|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
105459999|NCT00129402|363697690|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
105460000|NCT00129402|363697684|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
105460001|NCT00129402|363697685|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
105460002|NCT00129402|363697686|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
105460003|NCT00129402|363697687|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
105460004|NCT00129402|363697688|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
105460005|NCT00129402|363697689|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
105460006|NCT00129402|363697690|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
105460007|NCT00129402|363697684|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
105460008|NCT00129402|363697685|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
105460009|NCT00129402|363697686|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
105460010|NCT00129402|363697687|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
105460011|NCT00129402|363697688|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
105460012|NCT00129402|363697689|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
105460013|NCT00129402|363697690|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
105460014|NCT00129402|363697684|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
105460015|NCT00129402|363697685|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
105460016|NCT00129402|363697686|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
105460017|NCT00129402|363697687|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
105460018|NCT00129402|363697688|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
105460019|NCT00129402|363697689|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
105460020|NCT00129402|363697690|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
105460021|NCT00129402|363697684|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
105460022|NCT00129402|363697685|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
105460023|NCT00129402|363697686|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
105460024|NCT00129402|363697687|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
105460025|NCT00129402|363697688|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
105460026|NCT00129402|363697689|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
105460027|NCT00129402|363697690|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
105460028|NCT00129402|363697684|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
105460029|NCT00129402|363697685|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
105460030|NCT00129402|363697686|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
105460031|NCT00129402|363697687|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
105460032|NCT00129402|363697688|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
105460033|NCT00129402|363697689|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
105460034|NCT00129402|363697690|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
105460035|NCT00129402|363697684|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
105460036|NCT00129402|363697685|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
105460037|NCT00129402|363697686|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
105460038|NCT00129402|363697687|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
105460039|NCT00129402|363697688|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
105460040|NCT00129402|363697689|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
105460041|NCT00129402|363697690|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
105460042|NCT00129402|363697684|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
105460043|NCT00129402|363697685|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
105460044|NCT00129402|363697686|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
105460045|NCT00129402|363697687|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
105460046|NCT00129402|363697688|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
105460047|NCT00129402|363697689|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
105460048|NCT00129402|363697690|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
105460049|NCT00129402|363697684|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
105460050|NCT00129402|363697685|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
105460051|NCT00129402|363697686|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
105460052|NCT00129402|363697687|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
105460053|NCT00129402|363697688|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
105460054|NCT00129402|363697689|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
105460055|NCT00129402|363697690|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
105460056|NCT02992288|363697695|FG000|Overall Study|Adverse Event|8|||
105460057|NCT02992288|363697696|FG001|Overall Study|Adverse Event|2|||
105460058|NCT02992288|363697697|FG002|Overall Study|Adverse Event|2|||
105460059|NCT02992288|363697698|FG003|Overall Study|Adverse Event|2|||
105460060|NCT02992288|363697699|FG004|Overall Study|Adverse Event|2|||
105460061|NCT02992288|363697700|FG005|Overall Study|Adverse Event|7|||
105460062|NCT02992288|363697695|FG000|Overall Study|Non-compliance with study drug|0|||
105460063|NCT02992288|363697696|FG001|Overall Study|Non-compliance with study drug|1|||
105460064|NCT02992288|363697697|FG002|Overall Study|Non-compliance with study drug|1|||
105460065|NCT02992288|363697698|FG003|Overall Study|Non-compliance with study drug|0|||
105460066|NCT02992288|363697699|FG004|Overall Study|Non-compliance with study drug|1|||
105460067|NCT02992288|363697700|FG005|Overall Study|Non-compliance with study drug|0|||
105460068|NCT02992288|363697695|FG000|Overall Study|Physician Decision|3|||
105460069|NCT02992288|363697696|FG001|Overall Study|Physician Decision|0|||
105460070|NCT02992288|363697697|FG002|Overall Study|Physician Decision|1|||
105460071|NCT02992288|363697698|FG003|Overall Study|Physician Decision|0|||
105460072|NCT02992288|363697699|FG004|Overall Study|Physician Decision|0|||
105460073|NCT02992288|363697700|FG005|Overall Study|Physician Decision|1|||
105460074|NCT02992288|363697695|FG000|Overall Study|Death|2|||
105460075|NCT02992288|363697696|FG001|Overall Study|Death|0|||
105460076|NCT02992288|363697697|FG002|Overall Study|Death|2|||
105460077|NCT02992288|363697698|FG003|Overall Study|Death|1|||
105460078|NCT02992288|363697699|FG004|Overall Study|Death|2|||
105460079|NCT02992288|363697700|FG005|Overall Study|Death|0|||
105460080|NCT02992288|363697695|FG000|Overall Study|Lost to Follow-up|0|||
105460081|NCT02992288|363697696|FG001|Overall Study|Lost to Follow-up|0|||
105460082|NCT02992288|363697697|FG002|Overall Study|Lost to Follow-up|0|||
105460083|NCT02992288|363697698|FG003|Overall Study|Lost to Follow-up|1|||
105460084|NCT02992288|363697699|FG004|Overall Study|Lost to Follow-up|0|||
105460085|NCT02992288|363697700|FG005|Overall Study|Lost to Follow-up|0|||
105460086|NCT02992288|363697695|FG000|Overall Study|Protocol Violation|0|||
105460087|NCT02992288|363697696|FG001|Overall Study|Protocol Violation|0|||
105460088|NCT02992288|363697697|FG002|Overall Study|Protocol Violation|0|||
105460089|NCT02992288|363697698|FG003|Overall Study|Protocol Violation|0|||
105460090|NCT02992288|363697699|FG004|Overall Study|Protocol Violation|0|||
105460091|NCT02992288|363697700|FG005|Overall Study|Protocol Violation|1|||
105460092|NCT02992288|363697695|FG000|Overall Study|Withdrawal by Subject|4|||
105460093|NCT02992288|363697696|FG001|Overall Study|Withdrawal by Subject|2|||
105460094|NCT02992288|363697697|FG002|Overall Study|Withdrawal by Subject|1|||
105460095|NCT02992288|363697698|FG003|Overall Study|Withdrawal by Subject|5|||
105460096|NCT02992288|363697699|FG004|Overall Study|Withdrawal by Subject|3|||
105460097|NCT02992288|363697700|FG005|Overall Study|Withdrawal by Subject|4|||
105460098|NCT00456846|363697701|FG000|Overall Study|Adverse Event|2|||
105460099|NCT00456846|363697702|FG001|Overall Study|Adverse Event|15|||
105460100|NCT00456846|363697701|FG000|Overall Study|Physician Decision|11|||
105460101|NCT00456846|363697702|FG001|Overall Study|Physician Decision|6|||
105460102|NCT00456846|363697701|FG000|Overall Study|Protocol Deviation|2|||
105460103|NCT00456846|363697702|FG001|Overall Study|Protocol Deviation|0|||
105460104|NCT00456846|363697701|FG000|Overall Study|Participant Discretion|1|||
105460105|NCT00456846|363697702|FG001|Overall Study|Participant Discretion|5|||
105460106|NCT00456846|363697701|FG000|Overall Study|Other|0|||
105460107|NCT00456846|363697702|FG001|Overall Study|Other|2|||
105460108|NCT02006472|363697706|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
105460109|NCT02006472|363697707|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
105460110|NCT02006472|363697708|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
105460111|NCT02006472|363697709|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
105460112|NCT02006472|363697710|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
105460113|NCT02006472|363697706|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
105460114|NCT02006472|363697707|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
105460115|NCT02006472|363697708|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
105460116|NCT02006472|363697709|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
105460117|NCT02006472|363697710|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
105661762|NCT03569891|364425134|FG000|Lead-in|Withdrawal by Subject|3|||
105661763|NCT03569891|364425134|FG000|Lead-in|Risks related to COVID-19|2|||
105661764|NCT03569891|364425134|FG000|AMT-061|Adverse Event|1|||
105661765|NCT03023423|364425138|FG000|Overall Study|Death|5|||
105661766|NCT03023423|364425139|FG001|Overall Study|Death|12|||
105661767|NCT03023423|364425140|FG002|Overall Study|Death|20|||
105661768|NCT03023423|364425138|FG000|Overall Study|Other|0|||
105661769|NCT03023423|364425139|FG001|Overall Study|Other|2|||
105661770|NCT03023423|364425140|FG002|Overall Study|Other|2|||
105661771|NCT03023423|364425138|FG000|Overall Study|Ongoing|2|||
105661772|NCT03023423|364425139|FG001|Overall Study|Ongoing|32|||
105661773|NCT03023423|364425140|FG002|Overall Study|Ongoing|24|||
105661774|NCT03371823|364425141|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
105661775|NCT03371823|364425142|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
105460118|NCT02006472|363697706|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
105460119|NCT02006472|363697707|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
105460120|NCT02006472|363697708|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
105460121|NCT02006472|363697709|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
105460122|NCT02006472|363697710|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
105460123|NCT02006472|363697706|FG000|Period 1 (Through Week 26)|Other|1|||
105460124|NCT02006472|363697707|FG001|Period 1 (Through Week 26)|Other|5|||
105460125|NCT02006472|363697708|FG002|Period 1 (Through Week 26)|Other|0|||
105460126|NCT02006472|363697709|FG003|Period 1 (Through Week 26)|Other|2|||
105460127|NCT02006472|363697710|FG004|Period 1 (Through Week 26)|Other|3|||
105460128|NCT02006472|363697706|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
105460129|NCT02006472|363697707|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
105460130|NCT02006472|363697708|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
105460131|NCT02006472|363697709|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
105460132|NCT02006472|363697710|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
105460133|NCT02006472|363697706|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
105460134|NCT02006472|363697707|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
105460135|NCT02006472|363697708|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
105460136|NCT02006472|363697709|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
105460137|NCT02006472|363697710|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
105460138|NCT02006472|363697706|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
105460139|NCT02006472|363697707|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
105460140|NCT02006472|363697708|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
105460141|NCT02006472|363697709|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
105460142|NCT02006472|363697710|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
105460143|NCT02006472|363697706|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
105460144|NCT02006472|363697707|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
105460145|NCT02006472|363697708|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
105460146|NCT02006472|363697709|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
105460147|NCT02006472|363697710|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
105460148|NCT02006472|363697706|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
105460149|NCT02006472|363697707|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
105460150|NCT02006472|363697708|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
105460151|NCT02006472|363697709|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
105460152|NCT02006472|363697710|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
105460153|NCT02006472|363697706|FG000|Period 2 (Through Week 52)|Other|0|||
105460154|NCT02006472|363697707|FG001|Period 2 (Through Week 52)|Other|1|||
105460155|NCT02006472|363697708|FG002|Period 2 (Through Week 52)|Other|0|||
105460156|NCT02006472|363697709|FG003|Period 2 (Through Week 52)|Other|1|||
105460157|NCT02006472|363697710|FG004|Period 2 (Through Week 52)|Other|0|||
105460158|NCT02006472|363697706|FG000|Period 2 (Through Week 52)|Not treated|0|||
105460159|NCT02006472|363697707|FG001|Period 2 (Through Week 52)|Not treated|0|||
105460160|NCT02006472|363697708|FG002|Period 2 (Through Week 52)|Not treated|2|||
105460161|NCT02006472|363697709|FG003|Period 2 (Through Week 52)|Not treated|0|||
105460162|NCT02006472|363697710|FG004|Period 2 (Through Week 52)|Not treated|0|||
105460163|NCT02006472|363697706|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
105460164|NCT02006472|363697707|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
105460165|NCT02006472|363697708|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
105460166|NCT02006472|363697709|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
105460167|NCT02006472|363697710|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
105460168|NCT02006472|363697706|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
105460169|NCT02006472|363697707|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
105460170|NCT02006472|363697708|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
105460171|NCT02006472|363697709|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
105460172|NCT02006472|363697710|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
105460173|NCT00886379|363697711|FG000|Overall Study|Transferred Schools|0|||
105460174|NCT00886379|363697712|FG001|Overall Study|Transferred Schools|0|||
105661776|NCT01466790|364425145|FG000|Overall Study|Adverse Event|1|||
105661777|NCT01466790|364425146|FG001|Overall Study|Adverse Event|0|||
105661778|NCT01466790|364425147|FG002|Overall Study|Adverse Event|0|||
105661779|NCT01466790|364425148|FG003|Overall Study|Adverse Event|0|||
105661780|NCT01466790|364425149|FG004|Overall Study|Adverse Event|2|||
105661781|NCT01466790|364425150|FG005|Overall Study|Adverse Event|0|||
105661782|NCT01466790|364425151|FG006|Overall Study|Adverse Event|0|||
105460175|NCT00886379|363697713|FG002|Overall Study|Transferred Schools|2|||
105460176|NCT00886379|363697714|FG003|Overall Study|Transferred Schools|1|||
105460177|NCT00886379|363697715|FG004|Overall Study|Transferred Schools|1|||
105460178|NCT00886379|363697711|FG000|Overall Study|Final blood draw not obtained|3|||
105460179|NCT00886379|363697712|FG001|Overall Study|Final blood draw not obtained|3|||
105460180|NCT00886379|363697713|FG002|Overall Study|Final blood draw not obtained|4|||
105460181|NCT00886379|363697714|FG003|Overall Study|Final blood draw not obtained|2|||
105460182|NCT00886379|363697715|FG004|Overall Study|Final blood draw not obtained|2|||
105460183|NCT01614886|363697721|FG000|Overall Study|Adverse Event|15|||
105460184|NCT01614886|363697722|FG001|Overall Study|Adverse Event|20|||
105460185|NCT01614886|363697721|FG000|Overall Study|Withdrawal by Subject|4|||
105460186|NCT01614886|363697722|FG001|Overall Study|Withdrawal by Subject|4|||
105460187|NCT01614886|363697721|FG000|Overall Study|Death|1|||
105460188|NCT01614886|363697722|FG001|Overall Study|Death|0|||
105460189|NCT01614886|363697721|FG000|Overall Study|Protocol deviation|0|||
105460190|NCT01614886|363697722|FG001|Overall Study|Protocol deviation|2|||
105460191|NCT01207414|363697724|FG000|Overall Study|Adverse Event|25|||
105460192|NCT01207414|363697725|FG001|Overall Study|Adverse Event|39|||
105460193|NCT01207414|363697724|FG000|Overall Study|Abnormal test procedure results|0|||
105460194|NCT01207414|363697725|FG001|Overall Study|Abnormal test procedure results|1|||
105460195|NCT01207414|363697724|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
105460196|NCT01207414|363697725|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
105460197|NCT01207414|363697724|FG000|Overall Study|Patient withdrew consent|14|||
105460198|NCT01207414|363697725|FG001|Overall Study|Patient withdrew consent|11|||
105460199|NCT01207414|363697724|FG000|Overall Study|Lost to Follow-up|15|||
105460200|NCT01207414|363697725|FG001|Overall Study|Lost to Follow-up|17|||
105460201|NCT01207414|363697724|FG000|Overall Study|Administrative problems|1|||
105460202|NCT01207414|363697725|FG001|Overall Study|Administrative problems|1|||
105460203|NCT01207414|363697724|FG000|Overall Study|Protocol deviation|12|||
105460204|NCT01207414|363697725|FG001|Overall Study|Protocol deviation|9|||
105460205|NCT01207414|363697724|FG000|Overall Study|Randomized in error|1|||
105460206|NCT01207414|363697725|FG001|Overall Study|Randomized in error|0|||
105460207|NCT03448406|363697728|FG000|Overall Study|Noncompliance of scheduled visits|1|||
105460208|NCT03448406|363697729|FG001|Overall Study|Noncompliance of scheduled visits|2|||
105460209|NCT03448406|363697728|FG000|Overall Study|Withdrawal by Subject|1|||
105460210|NCT03448406|363697729|FG001|Overall Study|Withdrawal by Subject|2|||
105460211|NCT03448406|363697728|FG000|Overall Study|Protocol Violation|1|||
105460212|NCT03448406|363697729|FG001|Overall Study|Protocol Violation|0|||
105460213|NCT03448406|363697728|FG000|Overall Study|Adverse Event|8|||
105460214|NCT03448406|363697729|FG001|Overall Study|Adverse Event|9|||
105460215|NCT01292486|363697730|FG000|Overall Study|Protocol Violation|2|||
105460216|NCT01292486|363697730|FG000|Overall Study|Did not meet screening criteria|2|||
105460217|NCT01292486|363697730|FG000|Overall Study|Adverse Event|1|||
105460218|NCT01292486|363697730|FG000|Overall Study|Physician Decision|1|||
105460219|NCT01435382|363697733|FG000|Overall Study|Lost to Follow-up|1|||
105460220|NCT01435382|363697734|FG001|Overall Study|Lost to Follow-up|0|||
105460221|NCT01435382|363697735|FG002|Overall Study|Lost to Follow-up|1|||
105460222|NCT01435382|363697736|FG003|Overall Study|Lost to Follow-up|0|||
105460223|NCT01435382|363697733|FG000|Overall Study|Withdrawal by Subject|0|||
105460224|NCT01435382|363697734|FG001|Overall Study|Withdrawal by Subject|2|||
105460225|NCT01435382|363697735|FG002|Overall Study|Withdrawal by Subject|0|||
105460226|NCT01435382|363697736|FG003|Overall Study|Withdrawal by Subject|1|||
105460227|NCT02435992|363697737|FG000|Overall Study|non compliance with protocol|2|||
105460228|NCT02435992|363697738|FG001|Overall Study|non compliance with protocol|0|||
105460229|NCT02435992|363697739|FG002|Overall Study|non compliance with protocol|1|||
105460230|NCT02435992|363697740|FG003|Overall Study|non compliance with protocol|0|||
105460231|NCT02435992|363697741|FG004|Overall Study|non compliance with protocol|0|||
105460232|NCT02435992|363697737|FG000|Overall Study|Adverse Event|11|||
105460233|NCT02435992|363697738|FG001|Overall Study|Adverse Event|6|||
105460234|NCT02435992|363697739|FG002|Overall Study|Adverse Event|12|||
105460235|NCT02435992|363697740|FG003|Overall Study|Adverse Event|0|||
105460236|NCT02435992|363697741|FG004|Overall Study|Adverse Event|0|||
105460237|NCT02435992|363697737|FG000|Overall Study|Lack of Efficacy|4|||
105460238|NCT02435992|363697738|FG001|Overall Study|Lack of Efficacy|10|||
105460239|NCT02435992|363697739|FG002|Overall Study|Lack of Efficacy|9|||
105460240|NCT02435992|363697740|FG003|Overall Study|Lack of Efficacy|0|||
105460241|NCT02435992|363697741|FG004|Overall Study|Lack of Efficacy|0|||
105460242|NCT02435992|363697737|FG000|Overall Study|Withdrawal by Subject|10|||
105460243|NCT02435992|363697738|FG001|Overall Study|Withdrawal by Subject|8|||
105460244|NCT02435992|363697739|FG002|Overall Study|Withdrawal by Subject|20|||
105460245|NCT02435992|363697740|FG003|Overall Study|Withdrawal by Subject|0|||
105460246|NCT02435992|363697741|FG004|Overall Study|Withdrawal by Subject|0|||
105460247|NCT02435992|363697737|FG000|Overall Study|Other Reason|1|||
105661783|NCT01466790|364425152|FG007|Overall Study|Adverse Event|0|||
105460248|NCT02435992|363697738|FG001|Overall Study|Other Reason|0|||
105460249|NCT02435992|363697739|FG002|Overall Study|Other Reason|0|||
105460250|NCT02435992|363697740|FG003|Overall Study|Other Reason|0|||
105460251|NCT02435992|363697741|FG004|Overall Study|Other Reason|0|||
105460252|NCT02435992|363697737|FG000|Overall Study|Physician Decision|0|||
105460253|NCT02435992|363697738|FG001|Overall Study|Physician Decision|0|||
105460254|NCT02435992|363697739|FG002|Overall Study|Physician Decision|1|||
105460255|NCT02435992|363697740|FG003|Overall Study|Physician Decision|0|||
105460256|NCT02435992|363697741|FG004|Overall Study|Physician Decision|0|||
105460257|NCT00260533|363697742|FG000|Overall Study|Other|3|||
105460258|NCT00260533|363697743|FG001|Overall Study|Other|3|||
105460259|NCT01310777|363697744|FG000|Overall Study|Adverse Event|23|||
105460260|NCT01310777|363697745|FG001|Overall Study|Adverse Event|1|||
105460261|NCT01310777|363697746|FG002|Overall Study|Adverse Event|15|||
105460262|NCT01310777|363697744|FG000|Overall Study|Lost to Follow-up|0|||
105460263|NCT01310777|363697745|FG001|Overall Study|Lost to Follow-up|4|||
105460264|NCT01310777|363697746|FG002|Overall Study|Lost to Follow-up|1|||
105460265|NCT01310777|363697744|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
105460266|NCT01310777|363697745|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
105460267|NCT01310777|363697746|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
105460268|NCT01310777|363697744|FG000|Overall Study|Inadequate Control of IOP|5|||
105460269|NCT01310777|363697745|FG001|Overall Study|Inadequate Control of IOP|7|||
105460270|NCT01310777|363697746|FG002|Overall Study|Inadequate Control of IOP|10|||
105460271|NCT01310777|363697744|FG000|Overall Study|Other|4|||
105460272|NCT01310777|363697745|FG001|Overall Study|Other|1|||
105460273|NCT01310777|363697746|FG002|Overall Study|Other|2|||
105460274|NCT02491684|363697747|FG000|Treatment Phase|Adverse Event|2|||
105460275|NCT02491684|363697748|FG001|Treatment Phase|Adverse Event|2|||
105460276|NCT02491684|363697747|FG000|Treatment Phase|Incorrect randomisation|1|||
105460277|NCT02491684|363697748|FG001|Treatment Phase|Incorrect randomisation|0|||
105460278|NCT02491684|363697747|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
105460279|NCT02491684|363697748|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
105460280|NCT02383576|363697749|FG000|Overall Study|Death|53|||
105460281|NCT02383576|363697750|FG001|Overall Study|Death|33|||
105460282|NCT02383576|363697749|FG000|Overall Study|Lost to Follow-up|7|||
105460283|NCT02383576|363697750|FG001|Overall Study|Lost to Follow-up|1|||
105460284|NCT02383576|363697749|FG000|Overall Study|Withdrew Consent|1|||
105460285|NCT02383576|363697750|FG001|Overall Study|Withdrew Consent|6|||
105460286|NCT02383576|363697749|FG000|Overall Study|Investigator's Decision|0|||
105460287|NCT02383576|363697750|FG001|Overall Study|Investigator's Decision|1|||
105460288|NCT02383576|363697749|FG000|Overall Study|Administrative/Other|2|||
105460289|NCT02383576|363697750|FG001|Overall Study|Administrative/Other|4|||
105460290|NCT04914364|363697751|FG000|Overall Study|No longer eligible for study|1|||
105460291|NCT04914364|363697751|FG000|Overall Study|Lost to Follow-up|2|||
105460292|NCT02435212|363697754|FG000|Core Phase|Adverse Event|8|||
105460293|NCT02435212|363697755|FG001|Core Phase|Adverse Event|5|||
105460294|NCT02435212|363697754|FG000|Core Phase|Withdrawal by Subject|3|||
105460295|NCT02435212|363697755|FG001|Core Phase|Withdrawal by Subject|0|||
105460296|NCT02435212|363697754|FG000|Core Phase|Withdrawal by parent/guardian|9|||
105460297|NCT02435212|363697755|FG001|Core Phase|Withdrawal by parent/guardian|4|||
105460298|NCT02435212|363697754|FG000|Core Phase|Protocol Violation|1|||
105460299|NCT02435212|363697755|FG001|Core Phase|Protocol Violation|2|||
105460300|NCT02435212|363697754|FG000|Core Phase|Physician Decision|3|||
105460301|NCT02435212|363697755|FG001|Core Phase|Physician Decision|0|||
105460302|NCT02435212|363697754|FG000|Core Phase|Lost to Follow-up|0|||
105460303|NCT02435212|363697755|FG001|Core Phase|Lost to Follow-up|1|||
105460304|NCT02435212|363697754|FG000|Core Phase|Lack of Efficacy|0|||
105460305|NCT02435212|363697755|FG001|Core Phase|Lack of Efficacy|1|||
105460306|NCT02435212|363697754|FG000|Core Phase|Recovery|1|||
105460307|NCT02435212|363697755|FG001|Core Phase|Recovery|0|||
105460308|NCT02435212|363697754|FG000|Optional Extension Phase|Adverse Event|3|||
105460309|NCT02435212|363697755|FG001|Optional Extension Phase|Adverse Event|9|||
105460310|NCT02435212|363697754|FG000|Optional Extension Phase|Physician Decision|6|||
105460311|NCT02435212|363697755|FG001|Optional Extension Phase|Physician Decision|8|||
105460312|NCT02435212|363697754|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
105460313|NCT02435212|363697755|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
105460314|NCT02435212|363697754|FG000|Optional Extension Phase|Lack of Efficacy|2|||
105460315|NCT02435212|363697755|FG001|Optional Extension Phase|Lack of Efficacy|3|||
105460316|NCT02435212|363697754|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
105460317|NCT02435212|363697755|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
105460318|NCT02435212|363697754|FG000|Optional Extension Phase|Protocol Violation|0|||
105460319|NCT02435212|363697755|FG001|Optional Extension Phase|Protocol Violation|1|||
105460320|NCT02435212|363697754|FG000|Optional Extension Phase|Recovery|1|||
105460321|NCT02435212|363697755|FG001|Optional Extension Phase|Recovery|1|||
105460322|NCT02435212|363697754|FG000|Optional Extension Phase|Death|1|||
105460323|NCT02435212|363697755|FG001|Optional Extension Phase|Death|0|||
105460324|NCT02435212|363697754|FG000|Optional Extension Phase|Technical problems|2|||
105460325|NCT02435212|363697755|FG001|Optional Extension Phase|Technical problems|0|||
105661784|NCT01466790|364425145|FG000|Overall Study|Lost to Follow-up|2|||
105661785|NCT01466790|364425146|FG001|Overall Study|Lost to Follow-up|0|||
105661786|NCT01466790|364425147|FG002|Overall Study|Lost to Follow-up|0|||
105661787|NCT01466790|364425148|FG003|Overall Study|Lost to Follow-up|0|||
105661788|NCT01466790|364425149|FG004|Overall Study|Lost to Follow-up|0|||
105661789|NCT01466790|364425150|FG005|Overall Study|Lost to Follow-up|0|||
105661790|NCT01466790|364425151|FG006|Overall Study|Lost to Follow-up|0|||
105661791|NCT01466790|364425152|FG007|Overall Study|Lost to Follow-up|0|||
105661792|NCT01466790|364425145|FG000|Overall Study|Withdrawal by Subject|1|||
105661793|NCT01466790|364425146|FG001|Overall Study|Withdrawal by Subject|1|||
105661794|NCT01466790|364425147|FG002|Overall Study|Withdrawal by Subject|0|||
105661795|NCT01466790|364425148|FG003|Overall Study|Withdrawal by Subject|0|||
105661796|NCT01466790|364425149|FG004|Overall Study|Withdrawal by Subject|1|||
105661797|NCT01466790|364425150|FG005|Overall Study|Withdrawal by Subject|0|||
105661798|NCT01466790|364425151|FG006|Overall Study|Withdrawal by Subject|1|||
105661799|NCT01466790|364425152|FG007|Overall Study|Withdrawal by Subject|1|||
105661800|NCT01263054|364425156|FG000|Overall Study|Death|1|||
105661801|NCT01263054|364425157|FG001|Overall Study|Death|0|||
105661802|NCT01263054|364425156|FG000|Overall Study|Lost to Follow-up|2|||
105661803|NCT01263054|364425157|FG001|Overall Study|Lost to Follow-up|2|||
105661804|NCT01263054|364425156|FG000|Overall Study|Withdrawal by Subject|1|||
105661805|NCT01263054|364425157|FG001|Overall Study|Withdrawal by Subject|3|||
105661806|NCT01263054|364425156|FG000|Overall Study|Qualification Violation|1|||
105661807|NCT01263054|364425157|FG001|Overall Study|Qualification Violation|0|||
105661808|NCT01263054|364425156|FG000|Overall Study|Other|0|||
105661809|NCT01263054|364425157|FG001|Overall Study|Other|1|||
105661810|NCT02242643|364425158|FG000|Overall Study|Protocol Violation|1|||
105661811|NCT02242643|364425159|FG001|Overall Study|Protocol Violation|2|||
105661812|NCT02242643|364425158|FG000|Overall Study|Withdrawal by Subject|15|||
105661813|NCT02242643|364425159|FG001|Overall Study|Withdrawal by Subject|10|||
105661814|NCT02242643|364425158|FG000|Overall Study|Migrated/moved from study area|1|||
105661815|NCT02242643|364425159|FG001|Overall Study|Migrated/moved from study area|3|||
105661816|NCT02242643|364425158|FG000|Overall Study|Lost to Follow-up|54|||
105661817|NCT02242643|364425159|FG001|Overall Study|Lost to Follow-up|61|||
105661818|NCT02242643|364425158|FG000|Overall Study|Child placed in foster care by family|0|||
105661819|NCT02242643|364425159|FG001|Overall Study|Child placed in foster care by family|1|||
105661820|NCT02242643|364425158|FG000|Overall Study|Non-compliance|1|||
105661821|NCT02242643|364425159|FG001|Overall Study|Non-compliance|0|||
105661822|NCT02242643|364425158|FG000|Overall Study|Consent withdrawal by parent|1|||
105661823|NCT02242643|364425159|FG001|Overall Study|Consent withdrawal by parent|0|||
105661824|NCT02242643|364425158|FG000|Overall Study|Protocol requirements not followed|1|||
105661825|NCT02242643|364425159|FG001|Overall Study|Protocol requirements not followed|0|||
105661826|NCT02242643|364425158|FG000|Overall Study|Language barrier|1|||
105661827|NCT02242643|364425159|FG001|Overall Study|Language barrier|0|||
105661828|NCT02242643|364425158|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
105661829|NCT02242643|364425159|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
105661830|NCT05093504|364425162|FG000|Overall Study|Death|0|||
105661831|NCT05093504|364425163|FG001|Overall Study|Death|1|||
105661832|NCT06385483|364425164|FG000|Overall Study|Withdrawal by Subject|2|||
105661833|NCT06385483|364425164|FG000|Overall Study|Never start protocol therapy|2|||
105661834|NCT06385483|364425164|FG000|Overall Study|Disease progression|15|||
105661835|NCT04535544|364425166|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
105661836|NCT04535544|364425167|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
105661837|NCT04535544|364425168|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
105661838|NCT04535544|364425169|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
105661839|NCT04535544|364425166|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
105661840|NCT04535544|364425167|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
105661841|NCT04535544|364425168|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
105661842|NCT04535544|364425169|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
105661843|NCT04535544|364425166|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
105661844|NCT04535544|364425167|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
105661845|NCT04535544|364425168|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
105661846|NCT04535544|364425169|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
105661847|NCT04535544|364425166|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
105661848|NCT04535544|364425167|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
105460326|NCT00107198|363697756|FG000|Overall Study|Lack of Efficacy|28|||
105661849|NCT04535544|364425168|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
105661850|NCT04535544|364425169|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
105661851|NCT04535544|364425166|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
105661852|NCT04535544|364425167|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
105661853|NCT04535544|364425168|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
105661854|NCT04535544|364425169|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
105661855|NCT04535544|364425166|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
105661856|NCT04535544|364425167|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
105661857|NCT04535544|364425168|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
105661858|NCT04535544|364425169|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
105661859|NCT04535544|364425166|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
105661860|NCT04535544|364425167|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
105661861|NCT04535544|364425168|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
105661862|NCT04535544|364425169|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
105661863|NCT04535544|364425166|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
105661864|NCT04535544|364425167|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
105661865|NCT04535544|364425168|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
105661866|NCT04535544|364425169|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
105661867|NCT00344032|364425170|FG000|Overall Study|Adverse Event|0|||
105661868|NCT00344032|364425171|FG001|Overall Study|Adverse Event|1|||
105661869|NCT00344032|364425170|FG000|Overall Study|Withdrawal by Subject|6|||
105661870|NCT00344032|364425171|FG001|Overall Study|Withdrawal by Subject|2|||
105661871|NCT00344032|364425170|FG000|Overall Study|Lost to Follow-up|4|||
105661872|NCT00344032|364425171|FG001|Overall Study|Lost to Follow-up|6|||
105661873|NCT00344032|364425170|FG000|Overall Study|Physician Decision|4|||
105661874|NCT00344032|364425171|FG001|Overall Study|Physician Decision|1|||
105661875|NCT01124838|364425176|FG000|Overall Study|Miscellaneous|4|||
105661876|NCT01124838|364425177|FG001|Overall Study|Miscellaneous|2|||
105661877|NCT01124838|364425176|FG000|Overall Study|Adverse Event|7|||
105661878|NCT01124838|364425177|FG001|Overall Study|Adverse Event|11|||
105661879|NCT01124838|364425176|FG000|Overall Study|Lack of Efficacy|2|||
105661880|NCT01124838|364425177|FG001|Overall Study|Lack of Efficacy|0|||
105661881|NCT01124838|364425176|FG000|Overall Study|Withdrawal by Subject|3|||
105661882|NCT01124838|364425177|FG001|Overall Study|Withdrawal by Subject|2|||
105661883|NCT01124838|364425176|FG000|Overall Study|Lost to Follow-up|2|||
105661884|NCT01124838|364425177|FG001|Overall Study|Lost to Follow-up|0|||
105661885|NCT04297618|364425180|FG000|Overall Study|Adverse Event|1|||
105661886|NCT04297618|364425180|FG000|Overall Study|Withdrawal by Subject|1|||
105661887|NCT02104505|364426787|FG000|First Intervention (14 Days)|Adverse Event|2|||
105661888|NCT02104505|364426788|FG001|First Intervention (14 Days)|Adverse Event|0|||
105661889|NCT02104505|364426787|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
105661890|NCT02104505|364426788|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
105661891|NCT02104505|364426787|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
105661892|NCT02104505|364426788|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
105661893|NCT02104505|364426787|FG000|First Intervention (14 Days)|exclusionary condition|0|||
105661894|NCT02104505|364426788|FG001|First Intervention (14 Days)|exclusionary condition|1|||
105661895|NCT02104505|364426787|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
105661896|NCT02104505|364426788|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
105661897|NCT02104505|364426787|FG000|Second Intervention (14 Days)|Adverse Event|2|||
105661898|NCT02104505|364426788|FG001|Second Intervention (14 Days)|Adverse Event|0|||
105661899|NCT01845805|364426789|FG000|Overall Study|Withdrawal by Subject|1|||
105661900|NCT01845805|364426790|FG001|Overall Study|Withdrawal by Subject|2|||
105661901|NCT01845805|364426789|FG000|Overall Study|Disease Progression|13|||
105661902|NCT01845805|364426790|FG001|Overall Study|Disease Progression|14|||
105661903|NCT01845805|364426789|FG000|Overall Study|Drug-related Toxicity|4|||
105661904|NCT01845805|364426790|FG001|Overall Study|Drug-related Toxicity|0|||
105661905|NCT02366143|364426793|FG000|Overall Study|Death|307|||
105661906|NCT02366143|364426794|FG001|Overall Study|Death|278|||
105661907|NCT02366143|364426795|FG002|Overall Study|Death|280|||
105661908|NCT02366143|364426793|FG000|Overall Study|Lost to Follow-up|2|||
105661909|NCT02366143|364426794|FG001|Overall Study|Lost to Follow-up|4|||
105661910|NCT02366143|364426795|FG002|Overall Study|Lost to Follow-up|2|||
105661911|NCT02366143|364426793|FG000|Overall Study|Physician Decision|1|||
105661912|NCT02366143|364426794|FG001|Overall Study|Physician Decision|2|||
105661913|NCT02366143|364426795|FG002|Overall Study|Physician Decision|1|||
105661914|NCT02366143|364426793|FG000|Overall Study|Protocol Violation|0|||
105661915|NCT02366143|364426794|FG001|Overall Study|Protocol Violation|0|||
105661916|NCT02366143|364426795|FG002|Overall Study|Protocol Violation|2|||
105661917|NCT02366143|364426793|FG000|Overall Study|Withdrawal by Subject|16|||
105661918|NCT02366143|364426794|FG001|Overall Study|Withdrawal by Subject|17|||
105661919|NCT02366143|364426795|FG002|Overall Study|Withdrawal by Subject|22|||
105661920|NCT02366143|364426793|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
105661921|NCT02366143|364426794|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
105661922|NCT02366143|364426795|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
105661923|NCT02366143|364426793|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
105661924|NCT02366143|364426794|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
105661925|NCT02366143|364426795|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
105460327|NCT00107198|363697756|FG000|Overall Study|Lost to Follow-up|12|||
105661926|NCT02366143|364426793|FG000|Overall Study|Randomization Error|1|||
105661927|NCT02366143|364426794|FG001|Overall Study|Randomization Error|0|||
105661928|NCT02366143|364426795|FG002|Overall Study|Randomization Error|0|||
105661929|NCT02366143|364426793|FG000|Overall Study|PI Move and Site Closure|1|||
105661930|NCT02366143|364426794|FG001|Overall Study|PI Move and Site Closure|0|||
105338407|NCT00941863|363241105|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
105338408|NCT00941863|363241101|FG000|Continued After PCD|Withdrawal by Subject|0|||
105338409|NCT00941863|363241102|FG001|Continued After PCD|Withdrawal by Subject|0|||
105338410|NCT00941863|363241103|FG002|Continued After PCD|Withdrawal by Subject|0|||
105338411|NCT00941863|363241104|FG003|Continued After PCD|Withdrawal by Subject|0|||
105460328|NCT00107198|363697756|FG000|Overall Study|Protocol Violation|1|||
105460329|NCT00107198|363697756|FG000|Overall Study|Withdrawal by Subject|6|||
105460330|NCT00107198|363697756|FG000|Overall Study|Ineligible|5|||
105460331|NCT04711850|363697757|FG000|Overall Study|Graft loss|2|||
105661931|NCT02366143|364426795|FG002|Overall Study|PI Move and Site Closure|1|||
105661932|NCT02366143|364426793|FG000|Overall Study|Study Terminated By Sponsor|0|||
105661933|NCT02366143|364426794|FG001|Overall Study|Study Terminated By Sponsor|0|||
105661934|NCT02366143|364426795|FG002|Overall Study|Study Terminated By Sponsor|2|||
105661935|NCT02366143|364426793|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
105661936|NCT02366143|364426794|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
105661937|NCT02366143|364426795|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
105661938|NCT02366143|364426793|FG000|Overall Study|Patient moved to roll-over study|1|||
105661939|NCT02366143|364426794|FG001|Overall Study|Patient moved to roll-over study|19|||
105661940|NCT02366143|364426795|FG002|Overall Study|Patient moved to roll-over study|28|||
105661941|NCT02366143|364426793|FG000|Overall Study|Patient moved to commercial stock|0|||
105661942|NCT02366143|364426794|FG001|Overall Study|Patient moved to commercial stock|0|||
105661943|NCT02366143|364426795|FG002|Overall Study|Patient moved to commercial stock|1|||
105661944|NCT02366143|364426793|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
105661945|NCT02366143|364426794|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
105661946|NCT02366143|364426795|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
105661947|NCT02366143|364426793|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
105661948|NCT02366143|364426794|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
105661949|NCT02366143|364426795|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
105661950|NCT02366143|364426793|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
105661951|NCT02366143|364426794|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
105661952|NCT02366143|364426795|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
105661953|NCT02366143|364426793|FG000|Overall Study|Requester's instructions|1|||
105661954|NCT02366143|364426794|FG001|Overall Study|Requester's instructions|1|||
105661955|NCT02366143|364426795|FG002|Overall Study|Requester's instructions|1|||
105661956|NCT02366143|364426793|FG000|Overall Study|Uneligible|0|||
105661957|NCT02366143|364426794|FG001|Overall Study|Uneligible|1|||
105661958|NCT02366143|364426795|FG002|Overall Study|Uneligible|0|||
105661959|NCT02366143|364426793|FG000|Overall Study|Post Trial Migration|0|||
105661960|NCT02366143|364426794|FG001|Overall Study|Post Trial Migration|1|||
105661961|NCT02366143|364426795|FG002|Overall Study|Post Trial Migration|0|||
105661962|NCT02366143|364426793|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
105338412|NCT00941863|363241105|FG004|Continued After PCD|Withdrawal by Subject|1|||
105338413|NCT00941863|363241101|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
105460332|NCT04711850|363697758|FG001|Overall Study|Graft loss|1|||
105460333|NCT04711850|363697757|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
105460334|NCT04711850|363697758|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
105460335|NCT04711850|363697757|FG000|Overall Study|Study terminated by sponsor|5|||
105460336|NCT04711850|363697758|FG001|Overall Study|Study terminated by sponsor|3|||
105460337|NCT04711850|363697757|FG000|Overall Study|Sponsor decision|0|||
105460338|NCT04711850|363697758|FG001|Overall Study|Sponsor decision|2|||
105460339|NCT03094416|363697782|FG000|Run-in|Screening failure|8|||
105460340|NCT03094416|363697782|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
105460341|NCT03094416|363697782|FG000|Run-in|Withdrawal by Subject|3|||
105460342|NCT03094416|363697782|FG000|Treatment Period|Withdrawal by Subject|2|||
105460343|NCT03104868|363697783|FG000|6 Week Follow up|Lost to Follow-up|5|||
105460344|NCT03104868|363697784|FG001|6 Week Follow up|Lost to Follow-up|8|||
105460345|NCT03104868|363697783|FG000|6 Week Follow up|Death|1|||
105460346|NCT03104868|363697784|FG001|6 Week Follow up|Death|1|||
105460347|NCT03104868|363697783|FG000|6 Week Follow up|Withdrawal by Subject|7|||
105460348|NCT03104868|363697784|FG001|6 Week Follow up|Withdrawal by Subject|6|||
105460349|NCT03104868|363697783|FG000|6 Week Follow up|Completed Later Timepoint|24|||
105460350|NCT03104868|363697784|FG001|6 Week Follow up|Completed Later Timepoint|22|||
105460351|NCT03104868|363697783|FG000|6 Month Follow up|Lost to Follow-up|2|||
105460352|NCT03104868|363697784|FG001|6 Month Follow up|Lost to Follow-up|2|||
105460353|NCT03104868|363697783|FG000|6 Month Follow up|Death|0|||
105661963|NCT02366143|364426794|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
105338414|NCT00941863|363241102|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
105460354|NCT03104868|363697784|FG001|6 Month Follow up|Death|1|||
105460355|NCT03104868|363697783|FG000|6 Month Follow up|Completed Later Timepoint|22|||
105661964|NCT02366143|364426795|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
105661965|NCT02366143|364426793|FG000|Overall Study|Patient switched to PTAP|0|||
105661966|NCT02366143|364426794|FG001|Overall Study|Patient switched to PTAP|1|||
105661967|NCT02366143|364426795|FG002|Overall Study|Patient switched to PTAP|0|||
105661968|NCT02366143|364426793|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
105661969|NCT02366143|364426794|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
105661970|NCT02366143|364426795|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
105661971|NCT04411186|364426796|FG000|Overall Study|Withdrawn due to protocol violation|0|||
105661972|NCT04411186|364426797|FG001|Overall Study|Withdrawn due to protocol violation|1|||
105661973|NCT00575042|364426798|FG000|Overall Study|Adverse Event|2|||
105661974|NCT00575042|364426798|FG000|Overall Study|Lost to Follow-up|1|||
105661975|NCT04795336|364426799|FG000|Overall Study|Withdrawal by Subject|3|||
105661976|NCT04795336|364426800|FG001|Overall Study|Withdrawal by Subject|4|||
105784921|NCT01484691|364864429|FG001|Overall Study|Physician Decision|2|||
105338415|NCT00941863|363241103|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
105338416|NCT00941863|363241104|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
105338417|NCT00941863|363241105|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
105338418|NCT00537316|363241108|FG000|Part 1|Adverse Event|7|||
105338419|NCT00537316|363241109|FG001|Part 1|Adverse Event|11|||
105338420|NCT00537316|363241110|FG002|Part 1|Adverse Event|8|||
105460356|NCT03104868|363697784|FG001|6 Month Follow up|Completed Later Timepoint|32|||
105460357|NCT03104868|363697783|FG000|12 Month Follow up|Lost to Follow-up|1|||
105460358|NCT03104868|363697784|FG001|12 Month Follow up|Lost to Follow-up|2|||
105460359|NCT03104868|363697783|FG000|12 Month Follow up|Death|0|||
105460360|NCT03104868|363697784|FG001|12 Month Follow up|Death|1|||
105460361|NCT03104868|363697783|FG000|12 Month Follow up|Withdrawal by Subject|0|||
105460362|NCT03104868|363697784|FG001|12 Month Follow up|Withdrawal by Subject|3|||
105460363|NCT03104868|363697783|FG000|12 Month Follow up|Completed Later Timepoint|32|||
105460364|NCT03104868|363697784|FG001|12 Month Follow up|Completed Later Timepoint|29|||
105460365|NCT03104868|363697783|FG000|18 Month Follow up|Lost to Follow-up|7|||
105460366|NCT03104868|363697784|FG001|18 Month Follow up|Lost to Follow-up|11|||
105460367|NCT03104868|363697783|FG000|18 Month Follow up|Death|2|||
105460368|NCT03104868|363697784|FG001|18 Month Follow up|Death|1|||
105460369|NCT03104868|363697783|FG000|18 Month Follow up|Withdrawal by Subject|1|||
105460370|NCT03104868|363697784|FG001|18 Month Follow up|Withdrawal by Subject|2|||
105460371|NCT03104868|363697783|FG000|18 Month Follow up|Graft Loss|1|||
105460372|NCT03104868|363697784|FG001|18 Month Follow up|Graft Loss|1|||
105460373|NCT03104868|363697783|FG000|18 Month Follow up|Completed Later Timepoint|19|||
105460374|NCT03104868|363697784|FG001|18 Month Follow up|Completed Later Timepoint|20|||
105460375|NCT03104868|363697783|FG000|24 Month Follow up|Lost to Follow-up|15|||
105460376|NCT03104868|363697784|FG001|24 Month Follow up|Lost to Follow-up|16|||
105460377|NCT03104868|363697783|FG000|24 Month Follow up|Death|3|||
105460378|NCT03104868|363697784|FG001|24 Month Follow up|Death|2|||
105460379|NCT03104868|363697783|FG000|24 Month Follow up|Withdrawal by Subject|1|||
105460380|NCT03104868|363697784|FG001|24 Month Follow up|Withdrawal by Subject|0|||
105460381|NCT03104868|363697783|FG000|24 Month Follow up|Graft Loss|2|||
105460382|NCT03104868|363697784|FG001|24 Month Follow up|Graft Loss|0|||
105460383|NCT00829426|363697788|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
105460384|NCT00829426|363697789|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
105460385|NCT04606134|363697804|FG000|Overall Study|Adverse Event|0|||
105460386|NCT04606134|363697805|FG001|Overall Study|Adverse Event|1|||
105460387|NCT01099267|363697806|FG000|MDS-003 Study|Adverse Event|37|||
105460388|NCT01099267|363697806|FG000|MDS-003 Study|Lack of Efficacy|52|||
105460389|NCT01099267|363697806|FG000|MDS-003 Study|Withdrawal by Subject|8|||
105460390|NCT01099267|363697806|FG000|MDS-003 Study|Lost to Follow-up|1|||
105460391|NCT01099267|363697806|FG000|MDS-003 Study|Death|11|||
105460392|NCT01099267|363697806|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
105460393|NCT01099267|363697806|FG000|MDS-003 Study|Disease Progression|7|||
105460394|NCT01099267|363697806|FG000|MDS-003 Study|Investigator Decision|2|||
105460395|NCT01099267|363697806|FG000|MDS-003 Study|Non-Compliance|2|||
105460396|NCT01099267|363697806|FG000|MDS-003 Study|Loss of Response|1|||
105460397|NCT01099267|363697806|FG000|MDS-003 Study|Secondary Malign Disease|1|||
105460398|NCT05477108|363697809|FG000|Overall Study|Participants randomized, not treated|1|||
105460399|NCT05477108|363697810|FG001|Overall Study|Participants randomized, not treated|1|||
105460400|NCT05477108|363697811|FG002|Overall Study|Participants randomized, not treated|1|||
105460401|NCT05477108|363697809|FG000|Overall Study|Physician Decision|0|||
105460402|NCT05477108|363697810|FG001|Overall Study|Physician Decision|0|||
105460403|NCT05477108|363697811|FG002|Overall Study|Physician Decision|1|||
105460404|NCT05477108|363697809|FG000|Overall Study|withdrawn from study|0|||
105460405|NCT05477108|363697810|FG001|Overall Study|withdrawn from study|0|||
105460406|NCT05477108|363697811|FG002|Overall Study|withdrawn from study|1|||
105460407|NCT01838395|363697815|FG000|Overall Study|Withdrawal by Subject|0|||
105460408|NCT01838395|363697816|FG001|Overall Study|Withdrawal by Subject|0|||
105460409|NCT01838395|363697817|FG002|Overall Study|Withdrawal by Subject|0|||
105460410|NCT01838395|363697818|FG003|Overall Study|Withdrawal by Subject|0|||
105338421|NCT00537316|363241111|FG003|Part 1|Adverse Event|0|||
105661977|NCT04795336|364426801|FG002|Overall Study|Withdrawal by Subject|3|||
105661978|NCT04795336|364426802|FG003|Overall Study|Withdrawal by Subject|12|||
105661979|NCT04795336|364426799|FG000|Overall Study|Lost study logs|0|||
105661980|NCT04795336|364426800|FG001|Overall Study|Lost study logs|1|||
105661981|NCT04795336|364426801|FG002|Overall Study|Lost study logs|0|||
105661982|NCT04795336|364426802|FG003|Overall Study|Lost study logs|2|||
105661983|NCT04795336|364426799|FG000|Overall Study|Did not take study medication|2|||
105661984|NCT04795336|364426800|FG001|Overall Study|Did not take study medication|0|||
105661985|NCT04795336|364426801|FG002|Overall Study|Did not take study medication|0|||
105661986|NCT04795336|364426802|FG003|Overall Study|Did not take study medication|0|||
105661987|NCT03898700|364426803|FG000|Overall Study|Withdrawal by Subject|2|||
105661988|NCT00701909|364426807|FG000|Overall Study|Withdrawal by Subject|0|||
105661989|NCT00701909|364426808|FG001|Overall Study|Withdrawal by Subject|1|||
105661990|NCT03616964|364426814|FG000|Overall Study|Adverse Event|15|||
105661991|NCT03616964|364426815|FG001|Overall Study|Adverse Event|10|||
105661992|NCT03616964|364426816|FG002|Overall Study|Adverse Event|16|||
105661993|NCT03616964|364426814|FG000|Overall Study|Death|3|||
105661994|NCT03616964|364426815|FG001|Overall Study|Death|0|||
105661995|NCT03616964|364426816|FG002|Overall Study|Death|4|||
105661996|NCT03616964|364426814|FG000|Overall Study|Lack of Efficacy|4|||
105661997|NCT03616964|364426815|FG001|Overall Study|Lack of Efficacy|8|||
105661998|NCT03616964|364426816|FG002|Overall Study|Lack of Efficacy|8|||
105661999|NCT03616964|364426814|FG000|Overall Study|Lost to Follow-up|2|||
105662000|NCT03616964|364426815|FG001|Overall Study|Lost to Follow-up|1|||
105662001|NCT03616964|364426816|FG002|Overall Study|Lost to Follow-up|3|||
105662002|NCT03616964|364426814|FG000|Overall Study|Withdrawal by Subject|18|||
105662003|NCT03616964|364426815|FG001|Overall Study|Withdrawal by Subject|14|||
105662004|NCT03616964|364426816|FG002|Overall Study|Withdrawal by Subject|21|||
105662005|NCT03616964|364426814|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
105662006|NCT03616964|364426815|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
105338422|NCT00537316|363241112|FG004|Part 1|Adverse Event|0|||
105338423|NCT00537316|363241113|FG005|Part 1|Adverse Event|0|||
105662007|NCT03616964|364426816|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
105662008|NCT03616964|364426814|FG000|Overall Study|Sponsor's Decision|1|||
105662009|NCT03616964|364426815|FG001|Overall Study|Sponsor's Decision|0|||
105338424|NCT00537316|363241114|FG006|Part 1|Adverse Event|0|||
105662010|NCT03616964|364426816|FG002|Overall Study|Sponsor's Decision|0|||
105662011|NCT03616964|364426814|FG000|Overall Study|Physician Decision|0|||
105662012|NCT03616964|364426815|FG001|Overall Study|Physician Decision|2|||
105460411|NCT01838395|363697819|FG004|Overall Study|Withdrawal by Subject|1|||
105662013|NCT03616964|364426816|FG002|Overall Study|Physician Decision|0|||
105460412|NCT01838395|363697820|FG005|Overall Study|Withdrawal by Subject|0|||
105460413|NCT01838395|363697815|FG000|Overall Study|Death|0|||
105784922|NCT01484691|364864430|FG002|Overall Study|Physician Decision|1|||
105460414|NCT01838395|363697816|FG001|Overall Study|Death|0|||
105460415|NCT01838395|363697817|FG002|Overall Study|Death|1|||
105460416|NCT01838395|363697818|FG003|Overall Study|Death|0|||
105460417|NCT01838395|363697819|FG004|Overall Study|Death|0|||
105460418|NCT01838395|363697820|FG005|Overall Study|Death|0|||
105460419|NCT01838395|363697815|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
105460420|NCT01838395|363697816|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
105460421|NCT01838395|363697817|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
105460422|NCT01838395|363697818|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
105460423|NCT01838395|363697819|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
105460424|NCT01838395|363697820|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
105460425|NCT02532517|363697821|FG000|Overall Study|Did not complete 24-Month visit|4|||
105460426|NCT02532517|363697821|FG000|Overall Study|Failed Angiographic eligibility|1|||
105460427|NCT02532517|363697821|FG000|Overall Study|Lost to Follow-up|4|||
105460428|NCT02532517|363697821|FG000|Overall Study|Withdrawal by Subject|4|||
105460429|NCT02532517|363697821|FG000|Overall Study|Death|4|||
105460430|NCT03312231|363697822|FG000|Overall Study|Lost to Follow-up|2|||
105460431|NCT03312231|363697823|FG001|Overall Study|Lost to Follow-up|6|||
105460432|NCT03312231|363697824|FG002|Overall Study|Lost to Follow-up|1|||
105460433|NCT03312231|363697825|FG003|Overall Study|Lost to Follow-up|3|||
105460434|NCT03312231|363697826|FG004|Overall Study|Lost to Follow-up|1|||
105460435|NCT03312231|363697822|FG000|Overall Study|Withdrawal by Subject|0|||
105460436|NCT03312231|363697823|FG001|Overall Study|Withdrawal by Subject|3|||
105460437|NCT03312231|363697824|FG002|Overall Study|Withdrawal by Subject|1|||
105460438|NCT03312231|363697825|FG003|Overall Study|Withdrawal by Subject|0|||
105460439|NCT03312231|363697826|FG004|Overall Study|Withdrawal by Subject|0|||
105460440|NCT03312231|363697822|FG000|Overall Study|Death|0|||
105460441|NCT03312231|363697823|FG001|Overall Study|Death|1|||
105460442|NCT03312231|363697824|FG002|Overall Study|Death|1|||
105460443|NCT03312231|363697825|FG003|Overall Study|Death|0|||
105460444|NCT03312231|363697826|FG004|Overall Study|Death|0|||
105784923|NCT05807464|364864432|FG000|Overall Study|Adverse Event|1|||
105784924|NCT04298229|364864437|FG000|Overall Study|Physician Decision|1|||
105784925|NCT04298229|364864438|FG001|Overall Study|Physician Decision|1|||
105784926|NCT04298229|364864437|FG000|Overall Study|Withdrawal by Subject|1|||
105784927|NCT04298229|364864438|FG001|Overall Study|Withdrawal by Subject|1|||
105784928|NCT04298229|364864437|FG000|Overall Study|Did not receive IV loop diuretics|2|||
105784929|NCT04298229|364864438|FG001|Overall Study|Did not receive IV loop diuretics|0|||
105460445|NCT03312231|363697822|FG000|Overall Study|Study Vaccination not Received|1|||
105460446|NCT03312231|363697823|FG001|Overall Study|Study Vaccination not Received|1|||
105460447|NCT03312231|363697824|FG002|Overall Study|Study Vaccination not Received|1|||
105460448|NCT03312231|363697825|FG003|Overall Study|Study Vaccination not Received|0|||
105460449|NCT03312231|363697826|FG004|Overall Study|Study Vaccination not Received|0|||
105460450|NCT03157830|363697827|FG000|Overall Study|Lost to Follow-up|1|||
105460451|NCT03157830|363697827|FG000|Overall Study|Withdrawal by Subject|1|||
105460452|NCT03694353|363697831|FG000|Overall Study|Withdrawal by Subject|1|||
105460453|NCT03694353|363697831|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
105784930|NCT02283411|364864439|FG000|Overall Study|Withdrawal by Subject|3|||
105784931|NCT02283411|364864439|FG000|Overall Study|Screen Failed|28|||
105784932|NCT00383292|364864440|FG000|Overall Study|Adverse Event|4|||
105784933|NCT00383292|364864441|FG001|Overall Study|Adverse Event|1|||
105784934|NCT00383292|364864442|FG002|Overall Study|Adverse Event|2|||
105784935|NCT00383292|364864440|FG000|Overall Study|Death|3|||
105784936|NCT00383292|364864441|FG001|Overall Study|Death|3|||
105784937|NCT00383292|364864442|FG002|Overall Study|Death|3|||
105784938|NCT00383292|364864440|FG000|Overall Study|Physician Decision|4|||
105784939|NCT00383292|364864441|FG001|Overall Study|Physician Decision|0|||
105784940|NCT00383292|364864442|FG002|Overall Study|Physician Decision|1|||
105784941|NCT00383292|364864440|FG000|Overall Study|Withdrawal by Subject|3|||
105784942|NCT00383292|364864441|FG001|Overall Study|Withdrawal by Subject|2|||
105784943|NCT00383292|364864442|FG002|Overall Study|Withdrawal by Subject|2|||
105784944|NCT00383292|364864440|FG000|Overall Study|Other|1|||
105784945|NCT00383292|364864441|FG001|Overall Study|Other|0|||
105784946|NCT00383292|364864442|FG002|Overall Study|Other|0|||
105784947|NCT05261126|364864443|FG000|Overall Study|Death|0|||
105784948|NCT05261126|364864444|FG001|Overall Study|Death|0|||
105784949|NCT05261126|364864445|FG002|Overall Study|Death|1|||
105784950|NCT05261126|364864446|FG003|Overall Study|Death|0|||
105784951|NCT05261126|364864447|FG004|Overall Study|Death|0|||
105784952|NCT05261126|364864443|FG000|Overall Study|Lost to Follow-up|0|||
105784953|NCT05261126|364864444|FG001|Overall Study|Lost to Follow-up|0|||
105784954|NCT05261126|364864445|FG002|Overall Study|Lost to Follow-up|0|||
105784955|NCT05261126|364864446|FG003|Overall Study|Lost to Follow-up|0|||
105784956|NCT05261126|364864447|FG004|Overall Study|Lost to Follow-up|1|||
105784957|NCT05261126|364864443|FG000|Overall Study|Physician Decision|1|||
105784958|NCT05261126|364864444|FG001|Overall Study|Physician Decision|0|||
105784959|NCT05261126|364864445|FG002|Overall Study|Physician Decision|0|||
105784960|NCT05261126|364864446|FG003|Overall Study|Physician Decision|0|||
105784961|NCT05261126|364864447|FG004|Overall Study|Physician Decision|0|||
105784962|NCT05261126|364864443|FG000|Overall Study|Screen Failure|0|||
105460454|NCT03804528|363697832|FG000|Overall Study|Time Commitment|18|||
105460455|NCT03804528|363697832|FG000|Overall Study|Health Reasons|5|||
105460456|NCT00651742|363697833|FG000|Overall Study|Objective Disease Progression|22|||
105460457|NCT00651742|363697833|FG000|Overall Study|Toxicity|3|||
105784963|NCT05261126|364864444|FG001|Overall Study|Screen Failure|0|||
105784964|NCT05261126|364864445|FG002|Overall Study|Screen Failure|0|||
105784965|NCT05261126|364864446|FG003|Overall Study|Screen Failure|0|||
105784966|NCT05261126|364864447|FG004|Overall Study|Screen Failure|1|||
105784967|NCT05261126|364864443|FG000|Overall Study|Withdrawal by Subject|1|||
105784968|NCT05261126|364864444|FG001|Overall Study|Withdrawal by Subject|0|||
105662014|NCT03616964|364426814|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
105662015|NCT03616964|364426815|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
105662016|NCT03616964|364426816|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
105662017|NCT03616964|364426814|FG000|Overall Study|Protocol Violation|0|||
105662018|NCT03616964|364426815|FG001|Overall Study|Protocol Violation|1|||
105662019|NCT03616964|364426816|FG002|Overall Study|Protocol Violation|0|||
105662020|NCT03616964|364426814|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
105460458|NCT00651742|363697833|FG000|Overall Study|Investigator Judgment|1|||
105460459|NCT00651742|363697833|FG000|Overall Study|Withdrawal of Consent|1|||
105460460|NCT00651742|363697833|FG000|Overall Study|Enrolled but not treated|1|||
105460461|NCT04050553|363697834|FG000|Period 1|Physician Decision|2|||
105460462|NCT04050553|363697835|FG001|Period 1|Physician Decision|2|||
105460463|NCT04050553|363697834|FG000|Period 1|Adverse Event|1|||
105460464|NCT04050553|363697835|FG001|Period 1|Adverse Event|1|||
105460465|NCT04050553|363697834|FG000|Period 1|Withdrawal by Subject|0|||
105460466|NCT04050553|363697835|FG001|Period 1|Withdrawal by Subject|1|||
105460467|NCT04050553|363697834|FG000|Wash-out|Adverse Event|0|||
105460468|NCT04050553|363697835|FG001|Wash-out|Adverse Event|1|||
105460469|NCT04050553|363697834|FG000|Wash-out|Withdrawal by Subject|0|||
105460470|NCT04050553|363697835|FG001|Wash-out|Withdrawal by Subject|1|||
105460471|NCT05430854|363697836|FG000|Overall Study|Trial terminated by Sponsor|39|||
105460472|NCT05430854|363697837|FG001|Overall Study|Trial terminated by Sponsor|50|||
105460473|NCT05430854|363697838|FG002|Overall Study|Trial terminated by Sponsor|46|||
105460474|NCT05430854|363697836|FG000|Overall Study|Withdrawal by Subject|0|||
105460475|NCT05430854|363697837|FG001|Overall Study|Withdrawal by Subject|3|||
105460476|NCT05430854|363697838|FG002|Overall Study|Withdrawal by Subject|0|||
105784969|NCT05261126|364864445|FG002|Overall Study|Withdrawal by Subject|1|||
105784970|NCT05261126|364864446|FG003|Overall Study|Withdrawal by Subject|1|||
105460477|NCT04314284|363697839|FG000|Overall Study|Withdrawal by Subject|4|||
105460478|NCT04314284|363697840|FG001|Overall Study|Withdrawal by Subject|7|||
105460479|NCT04314284|363697839|FG000|Overall Study|Consented but did not complete survey|0|||
105460480|NCT04314284|363697840|FG001|Overall Study|Consented but did not complete survey|6|||
105460481|NCT01295814|363699251|FG000|Overall Study|Lack of Efficacy|0|||
105460482|NCT01295814|363699252|FG001|Overall Study|Lack of Efficacy|2|||
105460483|NCT01295814|363699251|FG000|Overall Study|Withdrawal by Subject|2|||
105460484|NCT01295814|363699252|FG001|Overall Study|Withdrawal by Subject|0|||
105662021|NCT03616964|364426815|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
105662022|NCT03616964|364426816|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
105662023|NCT03616964|364426814|FG000|Overall Study|Randomized but Never Treated|1|||
105662024|NCT03616964|364426815|FG001|Overall Study|Randomized but Never Treated|1|||
105662025|NCT03616964|364426816|FG002|Overall Study|Randomized but Never Treated|1|||
105662026|NCT04843579|364426822|FG000|Overall Study|Adverse Event|1|||
105662027|NCT04843579|364426822|FG000|Overall Study|Disease Progression|1|||
105662028|NCT04009629|364426823|FG000|Overall Study|Withdrawal by Subject|2|||
105662029|NCT04009629|364426824|FG001|Overall Study|Withdrawal by Subject|0|||
105662030|NCT04398368|364426828|FG000|Overall Study|Withdrawal by Subject|2|||
105662031|NCT00416598|364426829|FG000|Induction & Intensification|Adverse Event|38|||
105662032|NCT00416598|364426829|FG000|Induction & Intensification|Death|32|||
105662033|NCT00416598|364426829|FG000|Induction & Intensification|Withdrawal by Subject|46|||
105662034|NCT00416598|364426829|FG000|Induction & Intensification|Alternative Treatment|135|||
105662035|NCT00416598|364426829|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
105662036|NCT00416598|364426829|FG000|Induction & Intensification|Relapse/progression|29|||
105662037|NCT00416598|364426829|FG000|Induction & Intensification|Failed induction|87|||
105662038|NCT00416598|364426829|FG000|Decitabine Maintenance|Adverse Event|5|||
105662039|NCT00416598|364426829|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
105662040|NCT00416598|364426829|FG000|Decitabine Maintenance|Progression/relapse|38|||
105662041|NCT00416598|364426829|FG000|Decitabine Maintenance|Alternative treatment|2|||
105662042|NCT00416598|364426829|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
105662043|NCT02641587|364426846|FG000|Confinement Period|Adverse Event|1|||
105662044|NCT02641587|364426847|FG001|Confinement Period|Adverse Event|0|||
105662045|NCT02641587|364426846|FG000|Confinement Period|Withdrawal by Subject|2|||
105662046|NCT02641587|364426847|FG001|Confinement Period|Withdrawal by Subject|1|||
105662047|NCT02641587|364426846|FG000|Ambulatory Period|Withdrawal by Subject|1|||
105662048|NCT02641587|364426847|FG001|Ambulatory Period|Withdrawal by Subject|0|||
105662049|NCT01165177|364426848|FG000|Overall Study|Serious Adverse Event|227|||
105662050|NCT01165177|364426849|FG001|Overall Study|Serious Adverse Event|235|||
105662051|NCT01165177|364426848|FG000|Overall Study|Withdrawal by Subject|368|||
105784971|NCT05261126|364864447|FG004|Overall Study|Withdrawal by Subject|0|||
105460485|NCT00751296|363699254|FG000|Overall Study|Adverse Event|2|||
105662052|NCT01165177|364426849|FG001|Overall Study|Withdrawal by Subject|354|||
105662053|NCT01165177|364426848|FG000|Overall Study|Protocol Violation|19|||
105784972|NCT05261126|364864443|FG000|Overall Study|Not Recorded|0|||
105784973|NCT05261126|364864444|FG001|Overall Study|Not Recorded|0|||
105784974|NCT05261126|364864445|FG002|Overall Study|Not Recorded|0|||
105784975|NCT05261126|364864446|FG003|Overall Study|Not Recorded|1|||
105784976|NCT05261126|364864447|FG004|Overall Study|Not Recorded|0|||
105784977|NCT01333501|364864453|FG000|Overall Study|Adverse Event|3|||
105784978|NCT01333501|364864454|FG001|Overall Study|Adverse Event|1|||
105784979|NCT01333501|364864453|FG000|Overall Study|Abnormal laboratory value|2|||
105784980|NCT01333501|364864454|FG001|Overall Study|Abnormal laboratory value|1|||
105784981|NCT01333501|364864453|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105784982|NCT01333501|364864454|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
105784983|NCT01333501|364864453|FG000|Overall Study|Withdrawn consent|3|||
105784984|NCT01333501|364864454|FG001|Overall Study|Withdrawn consent|12|||
105784985|NCT00938366|364864455|FG000|Overall Study|Withdrawal by Subject|1|||
105784986|NCT00938366|364864456|FG001|Overall Study|Withdrawal by Subject|0|||
105784987|NCT00674440|364864457|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
105784988|NCT00674440|364864457|FG000|Overall Study|did not have surgery, so unevaluable|7|||
105784989|NCT00674440|364864457|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
105784990|NCT03329404|364864458|FG000|Overall Study|The study was suspended.|1|||
105784991|NCT03329404|364864459|FG001|Overall Study|The study was suspended.|4|||
105784992|NCT00796367|364864460|FG000|Overall Study|Adverse Event|6|||
105784993|NCT00796367|364864461|FG001|Overall Study|Adverse Event|4|||
105784994|NCT00796367|364864462|FG002|Overall Study|Adverse Event|7|||
105784995|NCT00796367|364864460|FG000|Overall Study|Lost to Follow-up|5|||
105784996|NCT00796367|364864461|FG001|Overall Study|Lost to Follow-up|4|||
105784997|NCT00796367|364864462|FG002|Overall Study|Lost to Follow-up|21|||
105784998|NCT00796367|364864460|FG000|Overall Study|Withdrawal by Subject|9|||
105784999|NCT00796367|364864461|FG001|Overall Study|Withdrawal by Subject|11|||
105460486|NCT01456039|363699257|FG000|Phase 1 (First Step)|Disease Progression|1|||
105460487|NCT01456039|363699258|FG001|Phase 1 (First Step)|Disease Progression|1|||
105460488|NCT01456039|363699259|FG002|Phase 1 (First Step)|Disease Progression|0|||
105460489|NCT01456039|363699257|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
105460490|NCT01456039|363699258|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
105460491|NCT01456039|363699259|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
105460492|NCT01456039|363699257|FG000|Phase 1 (First Step)|Adverse Event|0|||
105460493|NCT01456039|363699258|FG001|Phase 1 (First Step)|Adverse Event|3|||
105460494|NCT01456039|363699259|FG002|Phase 1 (First Step)|Adverse Event|0|||
105662054|NCT01165177|364426849|FG001|Overall Study|Protocol Violation|21|||
105460495|NCT01456039|363699257|FG000|Phase 1 (First Step)|Other|0|||
105785000|NCT00796367|364864462|FG002|Overall Study|Withdrawal by Subject|12|||
105785001|NCT00796367|364864460|FG000|Overall Study|Lack of Efficacy|2|||
105785002|NCT00796367|364864461|FG001|Overall Study|Lack of Efficacy|1|||
105785003|NCT00796367|364864462|FG002|Overall Study|Lack of Efficacy|0|||
105785004|NCT00796367|364864460|FG000|Overall Study|non compliance|3|||
105785005|NCT00796367|364864461|FG001|Overall Study|non compliance|1|||
105785006|NCT00796367|364864462|FG002|Overall Study|non compliance|1|||
105785007|NCT00796367|364864460|FG000|Overall Study|Pregnancy|1|||
105460496|NCT01456039|363699258|FG001|Phase 1 (First Step)|Other|1|||
105460497|NCT01456039|363699259|FG002|Phase 1 (First Step)|Other|0|||
105460498|NCT01456039|363699257|FG000|Phase 2 (Second Step)|Disease Progression|0|||
105460499|NCT01456039|363699258|FG001|Phase 2 (Second Step)|Disease Progression|0|||
105460500|NCT01456039|363699259|FG002|Phase 2 (Second Step)|Disease Progression|17|||
105785008|NCT00796367|364864461|FG001|Overall Study|Pregnancy|0|||
105785009|NCT00796367|364864462|FG002|Overall Study|Pregnancy|1|||
105785010|NCT00796367|364864460|FG000|Overall Study|Requirement for restricted medication|2|||
105785011|NCT00796367|364864461|FG001|Overall Study|Requirement for restricted medication|0|||
105785012|NCT00796367|364864462|FG002|Overall Study|Requirement for restricted medication|2|||
105785013|NCT00796367|364864460|FG000|Overall Study|other|2|||
105785014|NCT00796367|364864461|FG001|Overall Study|other|4|||
105785015|NCT00796367|364864462|FG002|Overall Study|other|3|||
105785016|NCT01288911|364864463|FG000|Double-blind Period|Death|11|||
105785017|NCT01288911|364864464|FG001|Double-blind Period|Death|7|||
105338425|NCT00537316|363241108|FG000|Part 1|Protocol defined clinical event|1|||
105338426|NCT00537316|363241109|FG001|Part 1|Protocol defined clinical event|0|||
105338427|NCT00537316|363241110|FG002|Part 1|Protocol defined clinical event|0|||
105785018|NCT01288911|364864463|FG000|Double-blind Period|Lost to Follow-up|0|||
105785019|NCT01288911|364864464|FG001|Double-blind Period|Lost to Follow-up|2|||
105785020|NCT01288911|364864463|FG000|Double-blind Period|Progressive Disease|75|||
105785021|NCT01288911|364864464|FG001|Double-blind Period|Progressive Disease|103|||
105338428|NCT00537316|363241111|FG003|Part 1|Protocol defined clinical event|0|||
105338429|NCT00537316|363241112|FG004|Part 1|Protocol defined clinical event|0|||
105338430|NCT00537316|363241113|FG005|Part 1|Protocol defined clinical event|0|||
105338431|NCT00537316|363241114|FG006|Part 1|Protocol defined clinical event|0|||
105338432|NCT00537316|363241108|FG000|Part 1|Lost to Follow-up|1|||
105338433|NCT00537316|363241109|FG001|Part 1|Lost to Follow-up|0|||
105338434|NCT00537316|363241110|FG002|Part 1|Lost to Follow-up|0|||
105338435|NCT00537316|363241111|FG003|Part 1|Lost to Follow-up|0|||
105338436|NCT00537316|363241112|FG004|Part 1|Lost to Follow-up|0|||
105338437|NCT00537316|363241113|FG005|Part 1|Lost to Follow-up|0|||
105338438|NCT00537316|363241114|FG006|Part 1|Lost to Follow-up|0|||
105338439|NCT00537316|363241108|FG000|Part 1|Withdrawal by Subject|3|||
105338440|NCT00537316|363241109|FG001|Part 1|Withdrawal by Subject|8|||
105338441|NCT00537316|363241110|FG002|Part 1|Withdrawal by Subject|4|||
105338442|NCT00537316|363241111|FG003|Part 1|Withdrawal by Subject|0|||
105338443|NCT00537316|363241112|FG004|Part 1|Withdrawal by Subject|0|||
105338444|NCT00537316|363241113|FG005|Part 1|Withdrawal by Subject|0|||
105338445|NCT00537316|363241114|FG006|Part 1|Withdrawal by Subject|0|||
105785022|NCT01288911|364864463|FG000|Double-blind Period|Protocol Violation|1|||
105785023|NCT01288911|364864464|FG001|Double-blind Period|Protocol Violation|0|||
105785024|NCT01288911|364864463|FG000|Double-blind Period|Withdrawal by Subject|25|||
105338446|NCT00537316|363241108|FG000|Part 1|Protocol Violation|1|||
105338447|NCT00537316|363241109|FG001|Part 1|Protocol Violation|5|||
105338448|NCT00537316|363241110|FG002|Part 1|Protocol Violation|1|||
105338449|NCT00537316|363241111|FG003|Part 1|Protocol Violation|0|||
105338450|NCT00537316|363241112|FG004|Part 1|Protocol Violation|0|||
105338451|NCT00537316|363241113|FG005|Part 1|Protocol Violation|0|||
105338452|NCT00537316|363241114|FG006|Part 1|Protocol Violation|0|||
105338453|NCT00537316|363241108|FG000|Part 1|Did not meet protocol eligibility|1|||
105338454|NCT00537316|363241109|FG001|Part 1|Did not meet protocol eligibility|3|||
105338455|NCT00537316|363241110|FG002|Part 1|Did not meet protocol eligibility|2|||
105460501|NCT01456039|363699257|FG000|Phase 2 (Second Step)|Adverse Event|0|||
105460502|NCT01456039|363699258|FG001|Phase 2 (Second Step)|Adverse Event|0|||
105785025|NCT01288911|364864464|FG001|Double-blind Period|Withdrawal by Subject|26|||
105785026|NCT01288911|364864463|FG000|Double-blind Period|Miscellaneous Reason|29|||
105785027|NCT01288911|364864464|FG001|Double-blind Period|Miscellaneous Reason|42|||
105338456|NCT00537316|363241111|FG003|Part 1|Did not meet protocol eligibility|0|||
105338457|NCT00537316|363241112|FG004|Part 1|Did not meet protocol eligibility|0|||
105338458|NCT00537316|363241113|FG005|Part 1|Did not meet protocol eligibility|0|||
105338459|NCT00537316|363241114|FG006|Part 1|Did not meet protocol eligibility|0|||
105460503|NCT01456039|363699259|FG002|Phase 2 (Second Step)|Adverse Event|10|||
105460504|NCT01456039|363699257|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
105785028|NCT01288911|364864463|FG000|Double-blind Period|Randomized but never received study drug|1|||
105785029|NCT01288911|364864464|FG001|Double-blind Period|Randomized but never received study drug|2|||
105785030|NCT01288911|364864463|FG000|Open-label Period (All Enzalutamide)|Death|0|||
105785031|NCT01288911|364864464|FG001|Open-label Period (All Enzalutamide)|Death|1|||
105338460|NCT00537316|363241108|FG000|Part 1|Administrative|0|||
105338461|NCT00537316|363241109|FG001|Part 1|Administrative|0|||
105338462|NCT00537316|363241110|FG002|Part 1|Administrative|2|||
105460505|NCT01456039|363699258|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
105460506|NCT01456039|363699259|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
105460507|NCT01456039|363699257|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
105460508|NCT01456039|363699258|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
105460509|NCT01456039|363699259|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
105460510|NCT01456039|363699257|FG000|Phase 2 (Second Step)|Other|0|||
105460511|NCT01456039|363699258|FG001|Phase 2 (Second Step)|Other|0|||
105460512|NCT01456039|363699259|FG002|Phase 2 (Second Step)|Other|1|||
105460513|NCT01021020|363699260|FG000|Period I|Protocol Violation|1|||
105460514|NCT01021020|363699260|FG000|Period I|Withdrawal by Subject|1|||
105460515|NCT01021020|363699260|FG000|14 Day Washout Period A|Physician Decision|1|||
105460516|NCT00992108|363699268|FG000|Overall Study|Lost to Follow-up|0|||
105460517|NCT00992108|363699269|FG001|Overall Study|Lost to Follow-up|1|||
105460518|NCT04106557|363699271|FG000|Overall Study|Physician Decision|0|||
105460519|NCT04106557|363699272|FG001|Overall Study|Physician Decision|1|||
105460520|NCT04106557|363699273|FG002|Overall Study|Physician Decision|0|||
105460521|NCT04106557|363699271|FG000|Overall Study|Protocol Violation|0|||
105460522|NCT04106557|363699272|FG001|Overall Study|Protocol Violation|1|||
105460523|NCT04106557|363699273|FG002|Overall Study|Protocol Violation|0|||
105460524|NCT03780244|363699276|FG000|Overall Study|Lost to Follow-up|1|||
105460525|NCT03780244|363699277|FG001|Overall Study|Lost to Follow-up|0|||
105460526|NCT02151058|363699279|FG000|Overall Study|Withdrawal by Subject|1|||
105460527|NCT02151058|363699280|FG001|Overall Study|Withdrawal by Subject|1|||
105460528|NCT02151058|363699281|FG002|Overall Study|Withdrawal by Subject|3|||
105460529|NCT02151058|363699279|FG000|Overall Study|Lost to Follow-up|1|||
105460530|NCT02151058|363699280|FG001|Overall Study|Lost to Follow-up|0|||
105460531|NCT02151058|363699281|FG002|Overall Study|Lost to Follow-up|2|||
105460532|NCT01280903|363699284|FG000|Overall Study|Lost to Follow-up|23|||
105460533|NCT01280903|363699285|FG001|Overall Study|Lost to Follow-up|16|||
105460534|NCT03453164|363699286|FG000|Overall Study|Lack of Efficacy|16|||
105460535|NCT03453164|363699286|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
105460536|NCT01942837|363699287|FG000|Overall Study|Death|1|||
105460537|NCT01942837|363699287|FG000|Overall Study|Symptomatic or radiographic progression|49|||
105460538|NCT01942837|363699287|FG000|Overall Study|Adverse Event|6|||
105460539|NCT01942837|363699287|FG000|Overall Study|Physician Decision|3|||
105460540|NCT01942837|363699287|FG000|Overall Study|Withdrawal by Subject|2|||
105460541|NCT01942837|363699287|FG000|Overall Study|Intercurrent Illness|1|||
105460542|NCT01942837|363699287|FG000|Overall Study|On treatment|3|||
105460543|NCT01942837|363699287|FG000|Overall Study|Never initiate the treatment|2|||
105460544|NCT00124943|363699290|FG000|Phase II|Adverse Event|0|||
105460545|NCT00124943|363699291|FG001|Phase II|Adverse Event|2|||
105460546|NCT00124943|363699292|FG002|Phase II|Adverse Event|0|||
105460547|NCT00124943|363699293|FG003|Phase II|Adverse Event|1|||
105460548|NCT00124943|363699290|FG000|Phase II|Protocol Violation|0|||
105460549|NCT00124943|363699291|FG001|Phase II|Protocol Violation|0|||
105460550|NCT00124943|363699292|FG002|Phase II|Protocol Violation|0|||
105460551|NCT00124943|363699293|FG003|Phase II|Protocol Violation|1|||
105460552|NCT00124943|363699290|FG000|Phase II|Lost to Follow-up|0|||
105460553|NCT00124943|363699291|FG001|Phase II|Lost to Follow-up|0|||
105460554|NCT00124943|363699292|FG002|Phase II|Lost to Follow-up|0|||
105460555|NCT00124943|363699293|FG003|Phase II|Lost to Follow-up|1|||
105460556|NCT00124943|363699290|FG000|Phase II|Withdrawal by Subject|0|||
105460557|NCT00124943|363699291|FG001|Phase II|Withdrawal by Subject|0|||
105460558|NCT00124943|363699292|FG002|Phase II|Withdrawal by Subject|0|||
105460559|NCT00124943|363699293|FG003|Phase II|Withdrawal by Subject|2|||
105460560|NCT03304626|363699300|FG000|Overall Study|Adverse Event|1|||
105460561|NCT03304626|363699301|FG001|Overall Study|Adverse Event|0|||
105460562|NCT03304626|363699300|FG000|Overall Study|Lack of Efficacy|1|||
105460563|NCT03304626|363699301|FG001|Overall Study|Lack of Efficacy|1|||
105460564|NCT00853307|363699304|FG000|Overall Study|Adverse Event|1|||
105460565|NCT00853307|363699305|FG001|Overall Study|Adverse Event|2|||
105460566|NCT00853307|363699304|FG000|Overall Study|Withdrawal by Subject|1|||
105460567|NCT00853307|363699305|FG001|Overall Study|Withdrawal by Subject|2|||
105460568|NCT00853307|363699304|FG000|Overall Study|Reason Not Specified|0|||
105460569|NCT00853307|363699305|FG001|Overall Study|Reason Not Specified|1|||
105460570|NCT04945733|363699309|FG000|Overall Study|Physician Decision|1|||
105460571|NCT04945733|363699310|FG001|Overall Study|Physician Decision|3|||
105460572|NCT04945733|363699311|FG002|Overall Study|Physician Decision|0|||
105460573|NCT04945733|363699309|FG000|Overall Study|Withdrawal by Subject|3|||
105460574|NCT04945733|363699310|FG001|Overall Study|Withdrawal by Subject|3|||
105460575|NCT04945733|363699311|FG002|Overall Study|Withdrawal by Subject|0|||
105460576|NCT00726063|363699312|FG000|Overall Study|Adverse Event|9|||
105460577|NCT00726063|363699313|FG001|Overall Study|Adverse Event|7|||
105460578|NCT02007096|363699314|FG000|Overall Study|medication not available|2|||
105460579|NCT02007096|363699315|FG001|Overall Study|medication not available|0|||
105460580|NCT02007096|363699314|FG000|Overall Study|did not inject saline|0|||
105460581|NCT02007096|363699315|FG001|Overall Study|did not inject saline|3|||
105662055|NCT01165177|364426848|FG000|Overall Study|Non-serious adverse event|30|||
105662056|NCT01165177|364426849|FG001|Overall Study|Non-serious adverse event|18|||
105662057|NCT01165177|364426848|FG000|Overall Study|Other unspecified reasons|47|||
105662058|NCT01165177|364426849|FG001|Overall Study|Other unspecified reasons|35|||
105662059|NCT01165177|364426848|FG000|Overall Study|Suspected HZ episode|0|||
105662060|NCT01165177|364426849|FG001|Overall Study|Suspected HZ episode|2|||
105662061|NCT01165177|364426848|FG000|Overall Study|Lost to Follow-up|183|||
105662062|NCT01165177|364426849|FG001|Overall Study|Lost to Follow-up|194|||
105662063|NCT01165177|364426848|FG000|Overall Study|Migrated/ moved from study area|48|||
105662064|NCT01165177|364426849|FG001|Overall Study|Migrated/ moved from study area|43|||
105662065|NCT00781937|364426851|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
105662066|NCT00781937|364426852|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
105662067|NCT00781937|364426851|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
105662068|NCT00781937|364426852|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
105662069|NCT00781937|364426851|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
105662070|NCT00781937|364426852|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
105662071|NCT00781937|364426851|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
105662072|NCT00781937|364426852|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
105662073|NCT00781937|364426851|FG000|Main Trial Period Through Week 56|Unclassified|10|||
105662074|NCT00781937|364426852|FG001|Main Trial Period Through Week 56|Unclassified|15|||
105662075|NCT00781937|364426851|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
105662076|NCT00781937|364426852|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
105662077|NCT00781937|364426851|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
105662078|NCT00781937|364426852|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
105662079|NCT03194867|364426856|FG000|Overall Study|Incorrect completion of end of study form|0|||
105662080|NCT03194867|364426857|FG001|Overall Study|Incorrect completion of end of study form|0|||
105662081|NCT03194867|364426858|FG002|Overall Study|Incorrect completion of end of study form|1|||
105662082|NCT03194867|364426859|FG003|Overall Study|Incorrect completion of end of study form|0|||
105662083|NCT00543062|364426860|FG000|Overall Study|Withdrawal by Subject|1|||
105662084|NCT00543062|364426861|FG001|Overall Study|Withdrawal by Subject|0|||
105662085|NCT00543062|364426862|FG002|Overall Study|Withdrawal by Subject|2|||
105662086|NCT00543062|364426863|FG003|Overall Study|Withdrawal by Subject|0|||
105662087|NCT00543062|364426860|FG000|Overall Study|Adverse Event|0|||
105662088|NCT00543062|364426861|FG001|Overall Study|Adverse Event|1|||
105662089|NCT00543062|364426862|FG002|Overall Study|Adverse Event|1|||
105662090|NCT00543062|364426863|FG003|Overall Study|Adverse Event|1|||
105662091|NCT00543062|364426860|FG000|Overall Study|Protocol Violation|1|||
105662092|NCT00543062|364426861|FG001|Overall Study|Protocol Violation|0|||
105662093|NCT00543062|364426862|FG002|Overall Study|Protocol Violation|0|||
105662094|NCT00543062|364426863|FG003|Overall Study|Protocol Violation|0|||
105662095|NCT01663506|364426864|FG000|Overall Study|Lack of Efficacy|3|||
105662096|NCT01663506|364426864|FG000|Overall Study|Consent Withdrawal by Subject|1|||
105662097|NCT01663506|364426864|FG000|Overall Study|Lost to Follow-up|1|||
105662098|NCT01663506|364426864|FG000|Overall Study|Adverse Event|1|||
105662099|NCT01663506|364426864|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
105662100|NCT05382039|364426865|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
105662101|NCT05382039|364426866|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
105662102|NCT05382039|364426867|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
105662103|NCT05382039|364426865|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
105662104|NCT05382039|364426866|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
105662105|NCT05382039|364426867|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
105662106|NCT05382039|364426865|FG000|Overall Study|waiting for confirmation|0|||
105662107|NCT05382039|364426866|FG001|Overall Study|waiting for confirmation|0|||
105662108|NCT05382039|364426867|FG002|Overall Study|waiting for confirmation|1|||
105662109|NCT00328562|364426868|FG000|Overall Study|Disease progression|1|||
105662110|NCT04504630|364426871|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
105662111|NCT04504630|364426872|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
105662112|NCT04504630|364426871|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
105662113|NCT04504630|364426872|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
105662114|NCT01519778|364426873|FG000|Overall Study|Withdrawal by Subject|3|||
105662115|NCT01519778|364426873|FG000|Overall Study|Lost to Follow-up|10|||
105338463|NCT00537316|363241111|FG003|Part 1|Administrative|0|||
105662116|NCT01519778|364426873|FG000|Overall Study|Physician Decision|1|||
105460582|NCT02007096|363699314|FG000|Overall Study|did not follow postoperative protocol|8|||
105460583|NCT02007096|363699315|FG001|Overall Study|did not follow postoperative protocol|11|||
105460584|NCT02007096|363699314|FG000|Overall Study|converted to open surgery|1|||
105460585|NCT02007096|363699315|FG001|Overall Study|converted to open surgery|1|||
105460586|NCT02007096|363699314|FG000|Overall Study|no mesh placed|0|||
105460587|NCT02007096|363699315|FG001|Overall Study|no mesh placed|1|||
105460588|NCT01231984|363699318|FG000|Study Period 1|Withdrawal by Subject|0|||
105460589|NCT01231984|363699319|FG001|Study Period 1|Withdrawal by Subject|0|||
105460590|NCT01231984|363699320|FG002|Study Period 1|Withdrawal by Subject|0|||
105460591|NCT01231984|363699321|FG003|Study Period 1|Withdrawal by Subject|1|||
105460592|NCT01231984|363699318|FG000|Study Period 1|Lost to Follow-up|1|||
105460593|NCT01231984|363699319|FG001|Study Period 1|Lost to Follow-up|1|||
105460594|NCT01231984|363699320|FG002|Study Period 1|Lost to Follow-up|1|||
105460595|NCT01231984|363699321|FG003|Study Period 1|Lost to Follow-up|0|||
105460596|NCT01231984|363699318|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
105460597|NCT01231984|363699319|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
105460598|NCT01231984|363699320|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
105460599|NCT01231984|363699321|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
105460600|NCT01231984|363699318|FG000|Study Period 1|Screen Failure|0|||
105460601|NCT01231984|363699319|FG001|Study Period 1|Screen Failure|0|||
105460602|NCT01231984|363699320|FG002|Study Period 1|Screen Failure|0|||
105662117|NCT01375751|364426881|FG000|Overall Study|Other|0|||
105662118|NCT01375751|364426882|FG001|Overall Study|Other|1|||
105662119|NCT01375751|364426883|FG002|Overall Study|Other|0|||
105662120|NCT03865953|364426884|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
105662121|NCT03865953|364426885|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
105662122|NCT03865953|364426884|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
105662123|NCT03865953|364426885|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
105662124|NCT03865953|364426884|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
105662125|NCT03865953|364426885|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
105662126|NCT00882115|364426886|FG000|Overall Study|Withdrawal by Subject|3|||
105662127|NCT00882115|364426886|FG000|Overall Study|did not respond to DEP challe|6|||
105662128|NCT01271504|364426887|FG000|Overall Study|Death|7|||
105662129|NCT01271504|364426888|FG001|Overall Study|Death|6|||
105662130|NCT01271504|364426889|FG002|Overall Study|Death|32|||
105662131|NCT01271504|364426890|FG003|Overall Study|Death|32|||
105662132|NCT01271504|364426887|FG000|Overall Study|Lost to Follow-up|0|||
105662133|NCT01271504|364426888|FG001|Overall Study|Lost to Follow-up|1|||
105662134|NCT01271504|364426889|FG002|Overall Study|Lost to Follow-up|3|||
105662135|NCT01271504|364426890|FG003|Overall Study|Lost to Follow-up|1|||
105662136|NCT01271504|364426887|FG000|Overall Study|Protocol Violation|0|||
105662137|NCT01271504|364426888|FG001|Overall Study|Protocol Violation|0|||
105662138|NCT01271504|364426889|FG002|Overall Study|Protocol Violation|0|||
105662139|NCT01271504|364426890|FG003|Overall Study|Protocol Violation|2|||
105662140|NCT01271504|364426887|FG000|Overall Study|Administrative Reasons|0|||
105662141|NCT01271504|364426888|FG001|Overall Study|Administrative Reasons|0|||
105662142|NCT01271504|364426889|FG002|Overall Study|Administrative Reasons|6|||
105662143|NCT01271504|364426890|FG003|Overall Study|Administrative Reasons|5|||
105662144|NCT01271504|364426887|FG000|Overall Study|Withdrawal by Subject|0|||
105662145|NCT01271504|364426888|FG001|Overall Study|Withdrawal by Subject|0|||
105662146|NCT01271504|364426889|FG002|Overall Study|Withdrawal by Subject|1|||
105662147|NCT01271504|364426890|FG003|Overall Study|Withdrawal by Subject|3|||
105662148|NCT01271504|364426887|FG000|Overall Study|Other|0|||
105662149|NCT01271504|364426888|FG001|Overall Study|Other|1|||
105460603|NCT01231984|363699321|FG003|Study Period 1|Screen Failure|1|||
105460604|NCT01231984|363699318|FG000|Study Period 1|Non-compliance with study requirements|5|||
105460605|NCT01231984|363699319|FG001|Study Period 1|Non-compliance with study requirements|0|||
105460606|NCT01231984|363699320|FG002|Study Period 1|Non-compliance with study requirements|2|||
105460607|NCT01231984|363699321|FG003|Study Period 1|Non-compliance with study requirements|1|||
105460608|NCT01231984|363699318|FG000|Study Period 1|Protocol Violation|3|||
105460609|NCT01231984|363699319|FG001|Study Period 1|Protocol Violation|4|||
105460610|NCT01231984|363699320|FG002|Study Period 1|Protocol Violation|2|||
105460611|NCT01231984|363699321|FG003|Study Period 1|Protocol Violation|3|||
105460612|NCT01231984|363699318|FG000|Study Period 1|Adverse Event|1|||
105460613|NCT01231984|363699319|FG001|Study Period 1|Adverse Event|0|||
105460614|NCT01231984|363699320|FG002|Study Period 1|Adverse Event|0|||
105460615|NCT01231984|363699321|FG003|Study Period 1|Adverse Event|0|||
105460616|NCT01231984|363699318|FG000|Study Period 1|Other|0|||
105460617|NCT01231984|363699319|FG001|Study Period 1|Other|0|||
105460618|NCT01231984|363699320|FG002|Study Period 1|Other|0|||
105460619|NCT01231984|363699321|FG003|Study Period 1|Other|1|||
105460620|NCT01231984|363699318|FG000|Study Period 2|Withdrawal by Subject|1|||
105460621|NCT01231984|363699319|FG001|Study Period 2|Withdrawal by Subject|1|||
105460622|NCT01231984|363699320|FG002|Study Period 2|Withdrawal by Subject|0|||
105460623|NCT01231984|363699321|FG003|Study Period 2|Withdrawal by Subject|0|||
105460624|NCT01231984|363699318|FG000|Study Period 2|Lost to Follow-up|1|||
105460625|NCT01231984|363699319|FG001|Study Period 2|Lost to Follow-up|0|||
105460626|NCT01231984|363699320|FG002|Study Period 2|Lost to Follow-up|0|||
105460627|NCT01231984|363699321|FG003|Study Period 2|Lost to Follow-up|3|||
105460628|NCT01231984|363699318|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
105460629|NCT01231984|363699319|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
105460630|NCT01231984|363699320|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
105460631|NCT01231984|363699321|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
105460632|NCT04385277|363699322|FG000|Overall Study|Physician Decision|2|||
105460633|NCT04385277|363699322|FG000|Overall Study|Ineligible|1|||
105460634|NCT04385277|363699322|FG000|Overall Study|Patient/Parent Refusal|2|||
105460635|NCT03363841|363699323|FG000|Overall Study|Adverse Event|1|||
105460636|NCT03363841|363699323|FG000|Overall Study|Withdrawal by Subject|1|||
105460637|NCT03363841|363699323|FG000|Overall Study|Death|7|||
105460638|NCT03363841|363699323|FG000|Overall Study|Physician Decision|1|||
105460639|NCT02939287|363699326|FG000|Overall Study|met exclusion criteria|1|||
105460640|NCT02939287|363699327|FG001|Overall Study|met exclusion criteria|1|||
105460641|NCT02939287|363699328|FG002|Overall Study|met exclusion criteria|1|||
105662150|NCT01271504|364426889|FG002|Overall Study|Other|2|||
105662151|NCT01271504|364426890|FG003|Overall Study|Other|0|||
105662152|NCT01790295|364426891|FG000|Overall Study|Adverse Event|1|||
105662153|NCT01790295|364426891|FG000|Overall Study|Death|4|||
105662154|NCT01790295|364426891|FG000|Overall Study|Lack of Efficacy|2|||
105662155|NCT01790295|364426891|FG000|Overall Study|Study closure|4|||
105460642|NCT02939287|363699326|FG000|Overall Study|Did not complete survey|2|||
105460643|NCT02939287|363699327|FG001|Overall Study|Did not complete survey|2|||
105460644|NCT02939287|363699328|FG002|Overall Study|Did not complete survey|0|||
105460645|NCT02939287|363699326|FG000|Overall Study|Withdrawal by Subject|1|||
105460646|NCT02939287|363699327|FG001|Overall Study|Withdrawal by Subject|1|||
105460647|NCT02939287|363699328|FG002|Overall Study|Withdrawal by Subject|0|||
105460648|NCT02903771|363699329|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
105460649|NCT02903771|363699330|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
105460650|NCT02903771|363699331|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
105460651|NCT02903771|363699332|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
105460652|NCT02903771|363699333|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
105460653|NCT02903771|363699334|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
105460654|NCT02903771|363699335|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
105460655|NCT02903771|363699329|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
105460656|NCT02903771|363699330|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
105460657|NCT02903771|363699331|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
105460658|NCT02903771|363699332|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
105460659|NCT02903771|363699333|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
105460660|NCT02903771|363699334|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
105460661|NCT02903771|363699335|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
105460662|NCT02903771|363699329|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
105460663|NCT02903771|363699330|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
105460664|NCT02903771|363699331|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
105460665|NCT02903771|363699332|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
105460666|NCT02903771|363699333|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
105460667|NCT02903771|363699334|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
105460668|NCT02903771|363699335|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
105460669|NCT02903771|363699329|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
105460670|NCT02903771|363699330|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
105460671|NCT02903771|363699331|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
105460672|NCT02903771|363699332|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
105460673|NCT02903771|363699333|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
105460674|NCT02903771|363699334|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
105460675|NCT02903771|363699335|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
105460676|NCT02903771|363699329|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
105460677|NCT02903771|363699330|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
105460678|NCT02903771|363699331|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
105460679|NCT02903771|363699332|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
105460680|NCT02903771|363699333|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
105460681|NCT02903771|363699334|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
105460682|NCT02903771|363699335|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
105460683|NCT02903771|363699329|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
105460684|NCT02903771|363699330|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
105460685|NCT02903771|363699331|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
105460686|NCT02903771|363699332|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
105460687|NCT02903771|363699333|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
105460688|NCT02903771|363699334|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
105460689|NCT02903771|363699335|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
105460690|NCT02903771|363699329|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
105460691|NCT02903771|363699330|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
105460692|NCT02903771|363699331|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
105460693|NCT02903771|363699332|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
105460694|NCT02903771|363699333|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
105460695|NCT02903771|363699334|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
105460696|NCT02903771|363699335|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
105460697|NCT02903771|363699329|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
105460698|NCT02903771|363699330|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
105460699|NCT02903771|363699331|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
105460700|NCT02903771|363699332|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
105662156|NCT01646385|364426892|FG000|Overall Study|Death|202|||
105662157|NCT01646385|364426893|FG001|Overall Study|Death|222|||
105662158|NCT01646385|364426892|FG000|Overall Study|Switched to alternate biologic|636|||
105662159|NCT01646385|364426893|FG001|Overall Study|Switched to alternate biologic|649|||
105662160|NCT02706951|364426894|FG000|Period 1|Adverse Event|1|||
105662161|NCT02706951|364426895|FG001|Period 1|Adverse Event|5|||
105662162|NCT02706951|364426896|FG002|Period 1|Adverse Event|3|||
105338464|NCT00537316|363241112|FG004|Part 1|Administrative|0|||
105338465|NCT00537316|363241113|FG005|Part 1|Administrative|0|||
105662163|NCT02706951|364426897|FG003|Period 1|Adverse Event|0|||
105662164|NCT02706951|364426898|FG004|Period 1|Adverse Event|0|||
105662165|NCT02706951|364426894|FG000|Period 1|Withdrawal by Subject|10|||
105662166|NCT02706951|364426895|FG001|Period 1|Withdrawal by Subject|6|||
105662167|NCT02706951|364426896|FG002|Period 1|Withdrawal by Subject|6|||
105662168|NCT02706951|364426897|FG003|Period 1|Withdrawal by Subject|0|||
105662169|NCT02706951|364426898|FG004|Period 1|Withdrawal by Subject|0|||
105662170|NCT02706951|364426894|FG000|Period 1|Lost to Follow-up|0|||
105338466|NCT00537316|363241114|FG006|Part 1|Administrative|0|||
105338467|NCT00537316|363241108|FG000|Part 2|Never entered follow-up|0|||
105338468|NCT00537316|363241109|FG001|Part 2|Never entered follow-up|0|||
105338469|NCT00537316|363241110|FG002|Part 2|Never entered follow-up|0|||
105338470|NCT00537316|363241111|FG003|Part 2|Never entered follow-up|0|||
105338471|NCT00537316|363241112|FG004|Part 2|Never entered follow-up|0|||
105338472|NCT00537316|363241113|FG005|Part 2|Never entered follow-up|0|||
105662171|NCT02706951|364426895|FG001|Period 1|Lost to Follow-up|4|||
105662172|NCT02706951|364426896|FG002|Period 1|Lost to Follow-up|1|||
105662173|NCT02706951|364426897|FG003|Period 1|Lost to Follow-up|0|||
105662174|NCT02706951|364426898|FG004|Period 1|Lost to Follow-up|0|||
105338473|NCT00537316|363241114|FG006|Part 2|Never entered follow-up|1|||
105338474|NCT00537316|363241108|FG000|Part 2|Adverse Event|4|||
105338475|NCT00537316|363241109|FG001|Part 2|Adverse Event|0|||
105338476|NCT00537316|363241110|FG002|Part 2|Adverse Event|2|||
105662175|NCT02706951|364426894|FG000|Period 1|Other|2|||
105662176|NCT02706951|364426895|FG001|Period 1|Other|1|||
105662177|NCT02706951|364426896|FG002|Period 1|Other|0|||
105338477|NCT00537316|363241111|FG003|Part 2|Adverse Event|0|||
105338478|NCT00537316|363241112|FG004|Part 2|Adverse Event|0|||
105338479|NCT00537316|363241113|FG005|Part 2|Adverse Event|0|||
105338480|NCT00537316|363241114|FG006|Part 2|Adverse Event|0|||
105338481|NCT00537316|363241108|FG000|Part 2|Lost to Follow-up|1|||
105338482|NCT00537316|363241109|FG001|Part 2|Lost to Follow-up|0|||
105662178|NCT02706951|364426897|FG003|Period 1|Other|0|||
105662179|NCT02706951|364426898|FG004|Period 1|Other|0|||
105662180|NCT02706951|364426894|FG000|Period 2|Adverse Event|0|||
105662181|NCT02706951|364426895|FG001|Period 2|Adverse Event|0|||
105662182|NCT02706951|364426896|FG002|Period 2|Adverse Event|0|||
105338483|NCT00537316|363241110|FG002|Part 2|Lost to Follow-up|2|||
105338484|NCT00537316|363241111|FG003|Part 2|Lost to Follow-up|0|||
105460701|NCT02903771|363699333|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
105460702|NCT02903771|363699334|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
105460703|NCT02903771|363699335|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
105460704|NCT02903771|363699329|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
105460705|NCT02903771|363699330|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
105460706|NCT02903771|363699331|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
105460707|NCT02903771|363699332|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
105460708|NCT02903771|363699333|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
105460709|NCT02903771|363699334|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
105460710|NCT02903771|363699335|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
105460711|NCT02903771|363699329|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
105460712|NCT02903771|363699330|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
105460713|NCT02903771|363699331|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
105460714|NCT02903771|363699332|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
105460715|NCT02903771|363699333|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
105460716|NCT02903771|363699334|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
105460717|NCT02903771|363699335|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
105460718|NCT02903771|363699329|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
105460719|NCT02903771|363699330|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
105460720|NCT02903771|363699331|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
105460721|NCT02903771|363699332|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
105460722|NCT02903771|363699333|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
105460723|NCT02903771|363699334|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
105460724|NCT02903771|363699335|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
105460725|NCT00581308|363699336|FG000|Pre Discharge|Lost to Follow-up|1|||
105460726|NCT00581308|363699336|FG000|Pre Discharge|Device Removed|1|||
105662183|NCT02706951|364426897|FG003|Period 2|Adverse Event|25|||
105662184|NCT02706951|364426898|FG004|Period 2|Adverse Event|34|||
105662185|NCT02706951|364426894|FG000|Period 2|Withdrawal by Subject|0|||
105460727|NCT00581308|363699336|FG000|Month 1|Lost to Follow-up|3|||
105662186|NCT02706951|364426895|FG001|Period 2|Withdrawal by Subject|0|||
105662187|NCT02706951|364426896|FG002|Period 2|Withdrawal by Subject|0|||
105662188|NCT02706951|364426897|FG003|Period 2|Withdrawal by Subject|38|||
105662189|NCT02706951|364426898|FG004|Period 2|Withdrawal by Subject|44|||
105662190|NCT02706951|364426894|FG000|Period 2|Lost to Follow-up|0|||
105662191|NCT02706951|364426895|FG001|Period 2|Lost to Follow-up|0|||
105662192|NCT02706951|364426896|FG002|Period 2|Lost to Follow-up|0|||
105662193|NCT02706951|364426897|FG003|Period 2|Lost to Follow-up|17|||
105662194|NCT02706951|364426898|FG004|Period 2|Lost to Follow-up|9|||
105662195|NCT02706951|364426894|FG000|Period 2|COVID-19 Related|0|||
105662196|NCT02706951|364426895|FG001|Period 2|COVID-19 Related|0|||
105662197|NCT02706951|364426896|FG002|Period 2|COVID-19 Related|0|||
105662198|NCT02706951|364426897|FG003|Period 2|COVID-19 Related|1|||
105662199|NCT02706951|364426898|FG004|Period 2|COVID-19 Related|2|||
105662200|NCT02706951|364426894|FG000|Period 2|Other|0|||
105662201|NCT02706951|364426895|FG001|Period 2|Other|0|||
105662202|NCT02706951|364426896|FG002|Period 2|Other|0|||
105662203|NCT02706951|364426897|FG003|Period 2|Other|37|||
105662204|NCT02706951|364426898|FG004|Period 2|Other|31|||
105662205|NCT03721172|364426900|FG000|Placebo-controlled Phase|Adverse Event|7|||
105662206|NCT03721172|364426901|FG001|Placebo-controlled Phase|Adverse Event|7|||
105662207|NCT03721172|364426902|FG002|Placebo-controlled Phase|Adverse Event|0|||
105662208|NCT03721172|364426900|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
105662209|NCT03721172|364426901|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
105662210|NCT03721172|364426902|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
105662211|NCT03721172|364426900|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
105662212|NCT03721172|364426901|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
105662213|NCT03721172|364426902|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
105662214|NCT03721172|364426900|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
105662215|NCT03721172|364426901|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
105662216|NCT03721172|364426902|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
105662217|NCT03721172|364426900|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
105662218|NCT03721172|364426901|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
105662219|NCT03721172|364426902|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
105662220|NCT03721172|364426900|FG000|Placebo-controlled Phase|Other|3|||
105662221|NCT03721172|364426901|FG001|Placebo-controlled Phase|Other|0|||
105662222|NCT03721172|364426902|FG002|Placebo-controlled Phase|Other|0|||
105662223|NCT03721172|364426900|FG000|Apremilast Extension Phase|Adverse Event|0|||
105662224|NCT03721172|364426901|FG001|Apremilast Extension Phase|Adverse Event|0|||
105662225|NCT03721172|364426902|FG002|Apremilast Extension Phase|Adverse Event|10|||
105662226|NCT03721172|364426900|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
105662227|NCT03721172|364426901|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
105662228|NCT03721172|364426902|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
105662229|NCT03721172|364426900|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
105662230|NCT03721172|364426901|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
105662231|NCT03721172|364426902|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
105662232|NCT03721172|364426900|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
105662233|NCT03721172|364426901|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
105662234|NCT03721172|364426902|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
105662235|NCT03721172|364426900|FG000|Apremilast Extension Phase|Protocol Violation|0|||
105662236|NCT03721172|364426901|FG001|Apremilast Extension Phase|Protocol Violation|0|||
105662237|NCT03721172|364426902|FG002|Apremilast Extension Phase|Protocol Violation|1|||
105662238|NCT03721172|364426900|FG000|Apremilast Extension Phase|Physician Decision|0|||
105662239|NCT03721172|364426901|FG001|Apremilast Extension Phase|Physician Decision|0|||
105662240|NCT03721172|364426902|FG002|Apremilast Extension Phase|Physician Decision|1|||
105662241|NCT03721172|364426900|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
105662242|NCT03721172|364426901|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
105662243|NCT03721172|364426902|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
105662244|NCT03721172|364426900|FG000|Apremilast Extension Phase|Other|0|||
105662245|NCT03721172|364426901|FG001|Apremilast Extension Phase|Other|0|||
105662246|NCT03721172|364426902|FG002|Apremilast Extension Phase|Other|3|||
105662247|NCT03721172|364426900|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
105662248|NCT03721172|364426901|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
105460728|NCT00581308|363699336|FG000|Month 1|Withdrawal by Subject|2|||
105662249|NCT03721172|364426902|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
105662250|NCT01777334|364426906|FG000|Overall Study|Adverse Event|18|||
105662251|NCT01777334|364426907|FG001|Overall Study|Adverse Event|14|||
105662252|NCT01777334|364426906|FG000|Overall Study|Lack of Efficacy|15|||
105662253|NCT01777334|364426907|FG001|Overall Study|Lack of Efficacy|29|||
105662254|NCT01777334|364426906|FG000|Overall Study|Protocol Violation|3|||
105662255|NCT01777334|364426907|FG001|Overall Study|Protocol Violation|7|||
105662256|NCT01777334|364426906|FG000|Overall Study|Lost to Follow-up|3|||
105460729|NCT00581308|363699336|FG000|Month 1|Device Removed|2|||
105662257|NCT01777334|364426907|FG001|Overall Study|Lost to Follow-up|2|||
105662258|NCT01777334|364426906|FG000|Overall Study|Withdrawal by Subject|14|||
105662259|NCT01777334|364426907|FG001|Overall Study|Withdrawal by Subject|11|||
105338485|NCT00537316|363241112|FG004|Part 2|Lost to Follow-up|0|||
105662260|NCT01216072|364426913|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
105460730|NCT00581308|363699336|FG000|Month 1|Uknown|1|||
105460731|NCT00581308|363699336|FG000|Month 6|Lost to Follow-up|1|||
105460732|NCT00581308|363699336|FG000|Month 6|Withdrawal by Subject|2|||
105460733|NCT00581308|363699336|FG000|Month 12|Death|1|||
105460734|NCT00581308|363699336|FG000|Month 12|Lost to Follow-up|14|||
105460735|NCT00581308|363699336|FG000|Month 12|Withdrawal by Subject|3|||
105460736|NCT00581308|363699336|FG000|Month 12|Device Removed|1|||
105460737|NCT00581308|363699336|FG000|Month 12|Other|1|||
105460738|NCT04558125|363699337|FG000|Overall Study|Death|1|||
105460739|NCT02738801|363699341|FG000|Overall Study|Adverse Event|1|||
105460740|NCT02738801|363699342|FG001|Overall Study|Adverse Event|1|||
105460741|NCT02738801|363699341|FG000|Overall Study|Withdrawal by Subject|0|||
105460742|NCT02738801|363699342|FG001|Overall Study|Withdrawal by Subject|1|||
105460743|NCT03279081|363699343|FG000|Overall Study|Withdrawal by Subject|12|||
105460744|NCT03279081|363699344|FG001|Overall Study|Withdrawal by Subject|20|||
105460745|NCT03279081|363699343|FG000|Overall Study|Physician Decision|4|||
105460746|NCT03279081|363699344|FG001|Overall Study|Physician Decision|1|||
105460747|NCT03279081|363699343|FG000|Overall Study|Lost to Follow-up|8|||
105460748|NCT03279081|363699344|FG001|Overall Study|Lost to Follow-up|8|||
105460749|NCT03279081|363699343|FG000|Overall Study|Death|0|||
105460750|NCT03279081|363699344|FG001|Overall Study|Death|1|||
105460751|NCT03279081|363699343|FG000|Overall Study|Adverse Event|1|||
105460752|NCT03279081|363699344|FG001|Overall Study|Adverse Event|0|||
105460753|NCT03279081|363699343|FG000|Overall Study|Reason not Specified|14|||
105460754|NCT03279081|363699344|FG001|Overall Study|Reason not Specified|4|||
105460755|NCT04531176|363699345|FG000|Overall Study|Study was stopped early|24|||
105460756|NCT04531176|363699346|FG001|Overall Study|Study was stopped early|26|||
105460757|NCT04531176|363699347|FG002|Overall Study|Study was stopped early|24|||
105460758|NCT03773978|363699348|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
105460759|NCT03773978|363699349|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
105460760|NCT03773978|363699348|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
105460761|NCT03773978|363699349|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
105460762|NCT03773978|363699348|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
105460763|NCT03773978|363699349|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
105460764|NCT03773978|363699348|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
105460765|NCT03773978|363699349|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
105460766|NCT03773978|363699348|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
105460767|NCT03773978|363699349|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
105460768|NCT03773978|363699348|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
105460769|NCT03773978|363699349|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
105460770|NCT03773978|363699348|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
105460771|NCT03773978|363699349|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
105460772|NCT03773978|363699348|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
105460773|NCT03773978|363699349|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
105460774|NCT03773978|363699348|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
105662261|NCT01216072|364426914|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
105662262|NCT01216072|364426913|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
105662263|NCT01216072|364426914|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
105662264|NCT01216072|364426913|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
105662265|NCT01216072|364426914|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
105662266|NCT01216072|364426913|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
105662267|NCT01216072|364426914|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
105662268|NCT01216072|364426913|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
105662269|NCT01216072|364426914|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
105662270|NCT01216072|364426913|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
105662271|NCT01216072|364426914|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
105662272|NCT01216072|364426913|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
105662273|NCT01216072|364426914|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
105662274|NCT01216072|364426913|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
105662275|NCT01216072|364426914|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
105662276|NCT01216072|364426913|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
105662277|NCT01216072|364426914|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
105662278|NCT01216072|364426913|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
105662279|NCT01216072|364426914|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
105662280|NCT04294667|364426919|FG000|Overall Study|Lack of Efficacy|4|||
105662281|NCT04294667|364426920|FG001|Overall Study|Lack of Efficacy|4|||
105662282|NCT04294667|364426919|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
105662283|NCT04294667|364426920|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
105662284|NCT04294667|364426919|FG000|Overall Study|Patient has a Renal Flare|1|||
105662285|NCT04294667|364426920|FG001|Overall Study|Patient has a Renal Flare|0|||
105662286|NCT04294667|364426919|FG000|Overall Study|SLE Worsening|0|||
105662287|NCT04294667|364426920|FG001|Overall Study|SLE Worsening|1|||
105662288|NCT04294667|364426919|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
105662289|NCT04294667|364426920|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
105662290|NCT04294667|364426919|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
105662291|NCT04294667|364426920|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
105662292|NCT04294667|364426919|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
105662293|NCT04294667|364426920|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
105662294|NCT04294667|364426919|FG000|Overall Study|Subject Moved to Another State|0|||
105662295|NCT04294667|364426920|FG001|Overall Study|Subject Moved to Another State|1|||
105662296|NCT04294667|364426919|FG000|Overall Study|Adverse event, serious fatal|0|||
105662297|NCT04294667|364426920|FG001|Overall Study|Adverse event, serious fatal|1|||
105662298|NCT04294667|364426919|FG000|Overall Study|Adverse event, non-fatal|3|||
105662299|NCT04294667|364426920|FG001|Overall Study|Adverse event, non-fatal|4|||
105662300|NCT03016598|364426921|FG000|Overall Study|Lost to Follow-up|0|||
105662301|NCT03016598|364426922|FG001|Overall Study|Lost to Follow-up|2|||
105662302|NCT00756457|364426923|FG000|Overall Study|Lost to Follow-up|1|||
105662303|NCT00756457|364426924|FG001|Overall Study|Lost to Follow-up|2|||
105662304|NCT00822770|364426927|FG000|Overall Study|Not treated|1|||
105662305|NCT00822770|364426928|FG001|Overall Study|Not treated|0|||
105662306|NCT00822770|364426927|FG000|Overall Study|Complication/Incomplete treatment|1|||
105662307|NCT00822770|364426928|FG001|Overall Study|Complication/Incomplete treatment|0|||
105662308|NCT00822770|364426927|FG000|Overall Study|Death|1|||
105662309|NCT00822770|364426928|FG001|Overall Study|Death|1|||
105662310|NCT02402322|364426929|FG000|Pretreatment|Withdrawal by Subject|3|||
105662311|NCT02402322|364426930|FG001|Pretreatment|Withdrawal by Subject|1|||
105662312|NCT02402322|364426931|FG002|Pretreatment|Withdrawal by Subject|1|||
105662313|NCT02402322|364426929|FG000|Follow-up|Withdrawal by Subject|6|||
105662314|NCT02402322|364426930|FG001|Follow-up|Withdrawal by Subject|3|||
105662315|NCT02402322|364426931|FG002|Follow-up|Withdrawal by Subject|24|||
105662316|NCT01772563|364426932|FG000|Cycle 1|Dose limiting toxicity|2|||
105662317|NCT01772563|364426932|FG000|Cycle 1|Progressive disease|2|||
105662318|NCT01772563|364426932|FG000|Cycle 2 and Beyond|Progressive disease|17|||
105662319|NCT01772563|364426932|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
105662320|NCT01772563|364426932|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
105662321|NCT01192776|364426933|FG000|Overall Study|Death|8|||
105662322|NCT01192776|364426934|FG001|Overall Study|Death|15|||
105662323|NCT01192776|364426935|FG002|Overall Study|Death|18|||
105662324|NCT01192776|364426936|FG003|Overall Study|Death|15|||
105662325|NCT01192776|364426933|FG000|Overall Study|Lost to Follow-up|3|||
105662326|NCT01192776|364426934|FG001|Overall Study|Lost to Follow-up|6|||
105662327|NCT01192776|364426935|FG002|Overall Study|Lost to Follow-up|3|||
105662328|NCT01192776|364426936|FG003|Overall Study|Lost to Follow-up|5|||
105662329|NCT02993523|364426941|FG000|Overall Study|Withdrew Consent|0|||
105662330|NCT02993523|364426942|FG001|Overall Study|Withdrew Consent|0|||
105662331|NCT02993523|364426943|FG002|Overall Study|Withdrew Consent|2|||
105662332|NCT02993523|364426944|FG003|Overall Study|Withdrew Consent|9|||
105662333|NCT02993523|364426945|FG004|Overall Study|Withdrew Consent|0|||
105662334|NCT02993523|364426941|FG000|Overall Study|Lost to Follow-up|0|||
105662335|NCT02993523|364426942|FG001|Overall Study|Lost to Follow-up|0|||
105662336|NCT02993523|364426943|FG002|Overall Study|Lost to Follow-up|3|||
105662337|NCT02993523|364426944|FG003|Overall Study|Lost to Follow-up|6|||
105662338|NCT02993523|364426945|FG004|Overall Study|Lost to Follow-up|0|||
105662339|NCT02993523|364426941|FG000|Overall Study|Death|1|||
105662340|NCT02993523|364426942|FG001|Overall Study|Death|1|||
105662341|NCT02993523|364426943|FG002|Overall Study|Death|138|||
105662342|NCT02993523|364426944|FG003|Overall Study|Death|222|||
105662343|NCT02993523|364426945|FG004|Overall Study|Death|6|||
105662344|NCT02993523|364426941|FG000|Overall Study|Reason not Specified|0|||
105662345|NCT02993523|364426942|FG001|Overall Study|Reason not Specified|0|||
105662346|NCT02993523|364426943|FG002|Overall Study|Reason not Specified|1|||
105662347|NCT02993523|364426944|FG003|Overall Study|Reason not Specified|1|||
105662348|NCT02993523|364426945|FG004|Overall Study|Reason not Specified|0|||
105662349|NCT04978350|364428081|FG000|Overall Study|Lost to Follow-up|6|||
105662350|NCT05765435|364428083|FG000|Overall Study|Lost to Follow-up|0|||
105662351|NCT05765435|364428084|FG001|Overall Study|Lost to Follow-up|1|||
105662352|NCT05765435|364428085|FG002|Overall Study|Lost to Follow-up|0|||
105662353|NCT05765435|364428083|FG000|Overall Study|Withdrawal by Subject|0|||
105662354|NCT05765435|364428084|FG001|Overall Study|Withdrawal by Subject|0|||
105662355|NCT05765435|364428085|FG002|Overall Study|Withdrawal by Subject|1|||
105662356|NCT03065933|364428087|FG000|Overall Study|study terminated|5|||
105662357|NCT02375347|364428092|FG000|Overall Study|Protocol Violation|1|||
105662358|NCT01547598|364428097|FG000|Overall Study|Withdrew consent|1|||
105662359|NCT01547598|364428098|FG001|Overall Study|Withdrew consent|1|||
105662360|NCT01547598|364428097|FG000|Overall Study|Lost to Follow-up|1|||
105662361|NCT01547598|364428098|FG001|Overall Study|Lost to Follow-up|1|||
105662362|NCT01547598|364428097|FG000|Overall Study|Adverse Event|1|||
105662363|NCT01547598|364428098|FG001|Overall Study|Adverse Event|1|||
105662364|NCT01547598|364428097|FG000|Overall Study|Protocol Violation|1|||
105662365|NCT01547598|364428098|FG001|Overall Study|Protocol Violation|1|||
105662366|NCT01547598|364428097|FG000|Overall Study|Other Miscellaneous Reasons|2|||
105662367|NCT01547598|364428098|FG001|Overall Study|Other Miscellaneous Reasons|1|||
105662368|NCT01288209|364428099|FG000|Overall Study|Withdrawal by Subject|1|||
105662369|NCT01288209|364428100|FG001|Overall Study|Withdrawal by Subject|3|||
105662370|NCT01288209|364428099|FG000|Overall Study|Other|1|||
105662371|NCT01288209|364428100|FG001|Overall Study|Other|0|||
105662372|NCT01841697|364428110|FG000|Overall Study|Death|0|||
105662373|NCT01841697|364428111|FG001|Overall Study|Death|1|||
105662374|NCT01841697|364428110|FG000|Overall Study|Lost to Follow-up|4|||
105662375|NCT01841697|364428111|FG001|Overall Study|Lost to Follow-up|1|||
105662376|NCT01841697|364428110|FG000|Overall Study|Withdrawal by Subject|16|||
105662377|NCT01841697|364428111|FG001|Overall Study|Withdrawal by Subject|16|||
105662378|NCT01777490|364428112|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
105662379|NCT01777490|364428113|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
105662380|NCT01777490|364428114|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
105662381|NCT01777490|364428115|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
105662382|NCT02947100|364428116|FG000|Overall Study|study terminated early|3|||
105662383|NCT02947100|364428116|FG000|Overall Study|did not meet inclusion criteria|1|||
105662384|NCT00992992|364428119|FG000|Overall Study|Lost to Follow-up|3|||
105662385|NCT00992992|364428119|FG000|Overall Study|Death|16|||
105662386|NCT00992992|364428119|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
105662387|NCT00992992|364428119|FG000|Overall Study|Sponsor Closed the Study|4|||
105662388|NCT01776008|364428120|FG000|Overall Study|ineligible|2|||
105662389|NCT02287233|364428124|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
105662390|NCT02287233|364428125|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
105662391|NCT02287233|364428126|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
105662392|NCT02287233|364428124|FG000|Overall Study|Adverse Event Related to Progression|0|||
105662393|NCT02287233|364428125|FG001|Overall Study|Adverse Event Related to Progression|2|||
105662394|NCT02287233|364428126|FG002|Overall Study|Adverse Event Related to Progression|8|||
105662395|NCT02287233|364428124|FG000|Overall Study|Physician Decision|1|||
105662396|NCT02287233|364428125|FG001|Overall Study|Physician Decision|2|||
105662397|NCT02287233|364428126|FG002|Overall Study|Physician Decision|4|||
105662398|NCT02287233|364428124|FG000|Overall Study|Progressive Disease with Death|0|||
105662399|NCT02287233|364428125|FG001|Overall Study|Progressive Disease with Death|0|||
105662400|NCT02287233|364428126|FG002|Overall Study|Progressive Disease with Death|10|||
105662401|NCT02287233|364428124|FG000|Overall Study|Progressive Disease Without Death|2|||
105662402|NCT02287233|364428125|FG001|Overall Study|Progressive Disease Without Death|3|||
105662403|NCT02287233|364428126|FG002|Overall Study|Progressive Disease Without Death|20|||
105662404|NCT02287233|364428124|FG000|Overall Study|Withdrawal by Subject|1|||
105662405|NCT02287233|364428125|FG001|Overall Study|Withdrawal by Subject|1|||
105662406|NCT02287233|364428126|FG002|Overall Study|Withdrawal by Subject|7|||
105662407|NCT02287233|364428124|FG000|Overall Study|Other|3|||
105662408|NCT02287233|364428125|FG001|Overall Study|Other|0|||
105662409|NCT02287233|364428126|FG002|Overall Study|Other|15|||
105662410|NCT02287233|364428124|FG000|Overall Study|Did Not Receive Treatment|0|||
105662411|NCT02287233|364428125|FG001|Overall Study|Did Not Receive Treatment|0|||
105662412|NCT02287233|364428126|FG002|Overall Study|Did Not Receive Treatment|2|||
105662413|NCT02031536|364428129|FG000|Overall Study|ineligible|1|||
105662414|NCT02031536|364428130|FG001|Overall Study|ineligible|0|||
105662415|NCT01850030|364428131|FG000|Overall Study|Adverse Event|64|||
105662416|NCT01850030|364428132|FG001|Overall Study|Adverse Event|82|||
105662417|NCT01850030|364428131|FG000|Overall Study|Lack of Efficacy|3|||
105662418|NCT01850030|364428132|FG001|Overall Study|Lack of Efficacy|1|||
105662419|NCT01850030|364428131|FG000|Overall Study|Lost to Follow-up|5|||
105662420|NCT01850030|364428132|FG001|Overall Study|Lost to Follow-up|5|||
105662421|NCT01850030|364428131|FG000|Overall Study|Withdrawal by Subject|3|||
105662422|NCT01850030|364428132|FG001|Overall Study|Withdrawal by Subject|4|||
105662423|NCT01850030|364428131|FG000|Overall Study|Protocol Violation|24|||
105662424|NCT01850030|364428132|FG001|Overall Study|Protocol Violation|28|||
105662425|NCT01850030|364428131|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
105662426|NCT01850030|364428132|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
105662427|NCT05594589|364428134|FG000|Overall Study|Other|0|||
105662428|NCT05594589|364428135|FG001|Overall Study|Other|1|||
105662429|NCT05594589|364428136|FG002|Overall Study|Other|0|||
105662430|NCT04462289|364428137|FG000|Overall Study|Lost to Follow-up|4|||
105662431|NCT04462289|364428138|FG001|Overall Study|Lost to Follow-up|5|||
105662432|NCT04462289|364428137|FG000|Overall Study|Death|0|||
105662433|NCT04462289|364428138|FG001|Overall Study|Death|3|||
105662434|NCT04462289|364428137|FG000|Overall Study|Withdrawal by Subject|1|||
105662435|NCT04462289|364428138|FG001|Overall Study|Withdrawal by Subject|3|||
105662436|NCT01056263|364428145|FG000|Overall Study|Adverse Event|12|||
105662437|NCT01056263|364428145|FG000|Overall Study|Death|1|||
105662438|NCT01056263|364428145|FG000|Overall Study|Withdrawal by Subject|1|||
105662439|NCT01056263|364428145|FG000|Overall Study|Lack of Efficacy|29|||
105662440|NCT01056263|364428145|FG000|Overall Study|Progressive disease|2|||
105662441|NCT01056263|364428145|FG000|Overall Study|Neoplasm progression|1|||
105662442|NCT01056263|364428145|FG000|Overall Study|Objective progression or relapse|1|||
105662443|NCT01056263|364428145|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
105662444|NCT04905849|364428149|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
105662445|NCT04905849|364428150|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
105662446|NCT03912532|364428151|FG000|Overall Study|Adverse Event|3|||
105662447|NCT03912532|364428152|FG001|Overall Study|Adverse Event|3|||
105662448|NCT03912532|364428153|FG002|Overall Study|Adverse Event|2|||
105662449|NCT03912532|364428154|FG003|Overall Study|Adverse Event|2|||
105662450|NCT03912532|364428151|FG000|Overall Study|Lost to Follow-up|3|||
105662451|NCT03912532|364428152|FG001|Overall Study|Lost to Follow-up|2|||
105662452|NCT03912532|364428153|FG002|Overall Study|Lost to Follow-up|1|||
105662453|NCT03912532|364428154|FG003|Overall Study|Lost to Follow-up|2|||
105662454|NCT03912532|364428151|FG000|Overall Study|Withdrawal by Subject|1|||
105662455|NCT03912532|364428152|FG001|Overall Study|Withdrawal by Subject|1|||
105662456|NCT03912532|364428153|FG002|Overall Study|Withdrawal by Subject|2|||
105662457|NCT03912532|364428154|FG003|Overall Study|Withdrawal by Subject|0|||
105662458|NCT03912532|364428151|FG000|Overall Study|Physician Decision|1|||
105662459|NCT03912532|364428152|FG001|Overall Study|Physician Decision|0|||
105662460|NCT03912532|364428153|FG002|Overall Study|Physician Decision|0|||
105662461|NCT03912532|364428154|FG003|Overall Study|Physician Decision|3|||
105662462|NCT03912532|364428151|FG000|Overall Study|Other|0|||
105662463|NCT03912532|364428152|FG001|Overall Study|Other|1|||
105662464|NCT03912532|364428153|FG002|Overall Study|Other|1|||
105662465|NCT03912532|364428154|FG003|Overall Study|Other|0|||
105662466|NCT04199052|364428159|FG000|Overall Study|Lost to Follow-up|11|||
105662467|NCT04199052|364428160|FG001|Overall Study|Lost to Follow-up|18|||
105662468|NCT05990387|364428161|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
105662469|NCT05990387|364428162|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
105662470|NCT04907357|364428163|FG000|Overall Study|Death|0|||
105662471|NCT04907357|364428164|FG001|Overall Study|Death|1|||
105662472|NCT04907357|364428163|FG000|Overall Study|Lost to Follow-up|9|||
105662473|NCT04907357|364428164|FG001|Overall Study|Lost to Follow-up|18|||
105662474|NCT04907357|364428163|FG000|Overall Study|Physician Decision|1|||
105662475|NCT04907357|364428164|FG001|Overall Study|Physician Decision|0|||
105662476|NCT04907357|364428163|FG000|Overall Study|Withdrawal by Subject|0|||
105662477|NCT04907357|364428164|FG001|Overall Study|Withdrawal by Subject|1|||
105662478|NCT04907357|364428163|FG000|Overall Study|Unable to attend visits|1|||
105662479|NCT04907357|364428164|FG001|Overall Study|Unable to attend visits|0|||
105662480|NCT04907357|364428163|FG000|Overall Study|Incarcerated|1|||
105662481|NCT04907357|364428164|FG001|Overall Study|Incarcerated|1|||
105662482|NCT03522389|364428165|FG000|Overall Study|Lost to Follow-up|1|||
105338486|NCT00537316|363241113|FG005|Part 2|Lost to Follow-up|0|||
105338487|NCT00537316|363241114|FG006|Part 2|Lost to Follow-up|0|||
105338488|NCT00537316|363241108|FG000|Part 2|Withdrawal by Subject|5|||
105338489|NCT00537316|363241109|FG001|Part 2|Withdrawal by Subject|1|||
105338490|NCT00537316|363241110|FG002|Part 2|Withdrawal by Subject|4|||
105338491|NCT00537316|363241111|FG003|Part 2|Withdrawal by Subject|0|||
105338492|NCT00537316|363241112|FG004|Part 2|Withdrawal by Subject|0|||
105338493|NCT00537316|363241113|FG005|Part 2|Withdrawal by Subject|0|||
105338494|NCT00537316|363241114|FG006|Part 2|Withdrawal by Subject|0|||
105338495|NCT00537316|363241108|FG000|Part 2|Administrative|16|||
105338496|NCT00537316|363241109|FG001|Part 2|Administrative|8|||
105338497|NCT00537316|363241110|FG002|Part 2|Administrative|24|||
105338498|NCT00537316|363241111|FG003|Part 2|Administrative|3|||
105338499|NCT00537316|363241112|FG004|Part 2|Administrative|1|||
105338500|NCT00537316|363241113|FG005|Part 2|Administrative|4|||
105338501|NCT00537316|363241114|FG006|Part 2|Administrative|1|||
105338502|NCT01867710|363241115|FG000|Overall Study|Death|25|||
105338503|NCT01867710|363241116|FG001|Overall Study|Death|15|||
105338504|NCT01867710|363241117|FG002|Overall Study|Death|27|||
105338505|NCT01867710|363241118|FG003|Overall Study|Death|20|||
105338506|NCT01867710|363241115|FG000|Overall Study|Lost to Follow-up|3|||
105338507|NCT01867710|363241116|FG001|Overall Study|Lost to Follow-up|4|||
105338508|NCT01867710|363241117|FG002|Overall Study|Lost to Follow-up|3|||
105338509|NCT01867710|363241118|FG003|Overall Study|Lost to Follow-up|2|||
105338510|NCT01867710|363241115|FG000|Overall Study|Withdrawal of consent|2|||
105338511|NCT01867710|363241116|FG001|Overall Study|Withdrawal of consent|5|||
105338512|NCT01867710|363241117|FG002|Overall Study|Withdrawal of consent|1|||
105338513|NCT01867710|363241118|FG003|Overall Study|Withdrawal of consent|2|||
105338514|NCT01867710|363241115|FG000|Overall Study|Study Terminated by Sponsor|9|||
105338515|NCT01867710|363241116|FG001|Overall Study|Study Terminated by Sponsor|13|||
105338516|NCT01867710|363241117|FG002|Overall Study|Study Terminated by Sponsor|8|||
105338517|NCT01867710|363241118|FG003|Overall Study|Study Terminated by Sponsor|16|||
105338518|NCT01867710|363241115|FG000|Overall Study|Biochemical progression|0|||
105338519|NCT01867710|363241116|FG001|Overall Study|Biochemical progression|1|||
105338520|NCT01867710|363241117|FG002|Overall Study|Biochemical progression|0|||
105460775|NCT03773978|363699349|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
105460776|NCT03773978|363699348|FG000|DBW Period|Adverse Event|2|||
105460777|NCT03773978|363699349|FG001|DBW Period|Adverse Event|2|||
105460778|NCT03773978|363699348|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
105460779|NCT03773978|363699349|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
105460780|NCT03773978|363699348|FG000|DBW Period|Withdrawal by Subject|2|||
105460781|NCT03773978|363699349|FG001|DBW Period|Withdrawal by Subject|1|||
105460782|NCT03773978|363699348|FG000|DBW Period|Due to epidemic or pandemic|5|||
105460783|NCT03773978|363699349|FG001|DBW Period|Due to epidemic or pandemic|6|||
105460784|NCT03773978|363699348|FG000|DBW Period|Study team decision|1|||
105460785|NCT03773978|363699349|FG001|DBW Period|Study team decision|0|||
105460786|NCT01502293|363699352|FG000|Overall Study|Progressive Disease|20|||
105460787|NCT01502293|363699353|FG001|Overall Study|Progressive Disease|12|||
105460788|NCT01502293|363699354|FG002|Overall Study|Progressive Disease|2|||
105460789|NCT01502293|363699352|FG000|Overall Study|Withdrawal by Subject|3|||
105460790|NCT01502293|363699353|FG001|Overall Study|Withdrawal by Subject|3|||
105338521|NCT01867710|363241118|FG003|Overall Study|Biochemical progression|0|||
105338522|NCT01867710|363241115|FG000|Overall Study|Clinical progression|0|||
105338523|NCT01867710|363241116|FG001|Overall Study|Clinical progression|0|||
105460791|NCT01502293|363699354|FG002|Overall Study|Withdrawal by Subject|1|||
105460792|NCT01502293|363699352|FG000|Overall Study|Adverse Event|0|||
105460793|NCT01502293|363699353|FG001|Overall Study|Adverse Event|2|||
105460794|NCT01502293|363699354|FG002|Overall Study|Adverse Event|0|||
105460795|NCT01502293|363699352|FG000|Overall Study|Reason Not Specified|2|||
105460796|NCT01502293|363699353|FG001|Overall Study|Reason Not Specified|0|||
105460797|NCT01502293|363699354|FG002|Overall Study|Reason Not Specified|0|||
105662483|NCT03522389|364428166|FG001|Overall Study|Lost to Follow-up|1|||
105338524|NCT01867710|363241117|FG002|Overall Study|Clinical progression|1|||
105460798|NCT01502293|363699352|FG000|Overall Study|Physician Decision|0|||
105460799|NCT01502293|363699353|FG001|Overall Study|Physician Decision|0|||
105460800|NCT01502293|363699354|FG002|Overall Study|Physician Decision|1|||
105460801|NCT00774046|363699358|FG000|Screening|Not eligible|56|||
105460802|NCT00774046|363699358|FG000|Enrollment|Desired other therapy/refused|28|||
105460803|NCT00774046|363699358|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
105460804|NCT00762164|363699359|FG000|Overall Study|Lost to Follow-up|1|||
105460805|NCT00762164|363699360|FG001|Overall Study|Lost to Follow-up|1|||
105460806|NCT00762164|363699359|FG000|Overall Study|Discontinued medication|2|||
105460807|NCT00762164|363699360|FG001|Overall Study|Discontinued medication|0|||
105460808|NCT00762164|363699359|FG000|Overall Study|Withdrawal by Subject|0|||
105460809|NCT00762164|363699360|FG001|Overall Study|Withdrawal by Subject|1|||
105460810|NCT02246530|363699372|FG000|Overall Study|Lost to Follow-up|4|||
105460811|NCT02246530|363699373|FG001|Overall Study|Lost to Follow-up|0|||
105460812|NCT02201953|363699375|FG000|Overall Study|Randomized but Never Treated|1|||
105460813|NCT02201953|363699376|FG001|Overall Study|Randomized but Never Treated|5|||
105460814|NCT02201953|363699375|FG000|Overall Study|Lack of Efficacy|9|||
105460815|NCT02201953|363699376|FG001|Overall Study|Lack of Efficacy|30|||
105460816|NCT02201953|363699375|FG000|Overall Study|Lost to Follow-up|8|||
105460817|NCT02201953|363699376|FG001|Overall Study|Lost to Follow-up|8|||
105460818|NCT02201953|363699375|FG000|Overall Study|Withdrew Consent|2|||
105460819|NCT02201953|363699376|FG001|Overall Study|Withdrew Consent|5|||
105460820|NCT02201953|363699375|FG000|Overall Study|Adverse Event|0|||
105460821|NCT02201953|363699376|FG001|Overall Study|Adverse Event|5|||
105460822|NCT02201953|363699375|FG000|Overall Study|Death|0|||
105460823|NCT02201953|363699376|FG001|Overall Study|Death|3|||
105460824|NCT00489307|363699377|FG000|Overall Study|Death|1|||
105460825|NCT00489307|363699378|FG001|Overall Study|Death|1|||
105460826|NCT00489307|363699377|FG000|Overall Study|Lost to Follow-up|2|||
105460827|NCT00489307|363699378|FG001|Overall Study|Lost to Follow-up|2|||
105460828|NCT00489307|363699377|FG000|Overall Study|Physician Decision|1|||
105460829|NCT00489307|363699378|FG001|Overall Study|Physician Decision|0|||
105460830|NCT00489307|363699377|FG000|Overall Study|Withdrawal by Subject|2|||
105460831|NCT00489307|363699378|FG001|Overall Study|Withdrawal by Subject|4|||
105460832|NCT00489307|363699377|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
105460833|NCT00489307|363699378|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
105460834|NCT00489307|363699377|FG000|Overall Study|Surgery after assignment|1|||
105460835|NCT00489307|363699378|FG001|Overall Study|Surgery after assignment|0|||
105460836|NCT00489307|363699377|FG000|Overall Study|Did not fill up the forms|2|||
105460837|NCT00489307|363699378|FG001|Overall Study|Did not fill up the forms|1|||
105460838|NCT00489307|363699377|FG000|Overall Study|Patient or family refusal|5|||
105460839|NCT00489307|363699378|FG001|Overall Study|Patient or family refusal|9|||
105460840|NCT03204188|363699379|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
105460841|NCT03204188|363699379|FG000|Immunotherapy Phase (1 Year)|Death|1|||
105460842|NCT03204188|363699379|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
105460843|NCT03204188|363699379|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
105460844|NCT02118584|363700830|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
105460845|NCT02118584|363700831|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
105460846|NCT02118584|363700832|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
105460847|NCT02118584|363700830|FG000|Part 1: Open Label Extension Period|Death|9|||
105460848|NCT02118584|363700831|FG001|Part 1: Open Label Extension Period|Death|0|||
105460849|NCT02118584|363700832|FG002|Part 1: Open Label Extension Period|Death|0|||
105460850|NCT02118584|363700830|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
105460851|NCT02118584|363700831|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
105460852|NCT02118584|363700832|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
105460853|NCT02118584|363700830|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
105460854|NCT02118584|363700831|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
105460855|NCT02118584|363700832|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
105460856|NCT02118584|363700830|FG000|Part 1: Open Label Extension Period|Other|135|||
105460857|NCT02118584|363700831|FG001|Part 1: Open Label Extension Period|Other|0|||
105460858|NCT02118584|363700832|FG002|Part 1: Open Label Extension Period|Other|0|||
105460859|NCT02118584|363700830|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
105460860|NCT02118584|363700831|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
105460861|NCT02118584|363700832|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
105662484|NCT03522389|364428167|FG002|Overall Study|Lost to Follow-up|2|||
105460862|NCT02118584|363700830|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
105460863|NCT02118584|363700831|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
105460864|NCT02118584|363700832|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
105460865|NCT02118584|363700830|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
105460866|NCT02118584|363700831|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
105460867|NCT02118584|363700832|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
105460868|NCT02118584|363700830|FG000|Part 1: Open Label Extension Period|Other|3|||
105460869|NCT02118584|363700831|FG001|Part 1: Open Label Extension Period|Other|0|||
105460870|NCT02118584|363700832|FG002|Part 1: Open Label Extension Period|Other|0|||
105460871|NCT02118584|363700830|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
105460872|NCT02118584|363700831|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
105460873|NCT02118584|363700832|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
105460874|NCT02118584|363700830|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
105460875|NCT02118584|363700831|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
105460876|NCT02118584|363700832|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
105460877|NCT02118584|363700830|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
105460878|NCT02118584|363700831|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
105460879|NCT02118584|363700832|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
105460880|NCT02118584|363700830|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
105460881|NCT02118584|363700831|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
105460882|NCT02118584|363700832|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
105460883|NCT02118584|363700830|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
105460884|NCT02118584|363700831|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
105460885|NCT02118584|363700832|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
105460886|NCT02118584|363700830|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
105460887|NCT02118584|363700831|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
105460888|NCT02118584|363700832|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
105460889|NCT02118584|363700830|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
105460890|NCT02118584|363700831|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
105460891|NCT02118584|363700832|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
105460892|NCT02118584|363700830|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
105460893|NCT02118584|363700831|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
105460894|NCT02118584|363700832|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
105338525|NCT01867710|363241118|FG003|Overall Study|Clinical progression|0|||
105338526|NCT01867710|363241115|FG000|Overall Study|Disease progression|1|||
105338527|NCT01867710|363241116|FG001|Overall Study|Disease progression|0|||
105338528|NCT01867710|363241117|FG002|Overall Study|Disease progression|0|||
105338529|NCT01867710|363241118|FG003|Overall Study|Disease progression|0|||
105338530|NCT01867710|363241115|FG000|Overall Study|Patient decision|0|||
105338531|NCT01867710|363241116|FG001|Overall Study|Patient decision|0|||
105338532|NCT01867710|363241117|FG002|Overall Study|Patient decision|0|||
105338533|NCT01867710|363241118|FG003|Overall Study|Patient decision|1|||
105338534|NCT01867710|363241115|FG000|Overall Study|Patient to follow subsequent treatment|0|||
105785032|NCT01288911|364864463|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
105785033|NCT01288911|364864464|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
105785034|NCT01288911|364864463|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
105785035|NCT01288911|364864464|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
105785036|NCT01288911|364864463|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
105785037|NCT01288911|364864464|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
105785038|NCT01288911|364864463|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
105785039|NCT01288911|364864464|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
105785040|NCT01288911|364864463|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
105785041|NCT01288911|364864464|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
105785042|NCT02950831|364864473|FG000|Overall Study|Lost to Follow-up|1|||
105785043|NCT02950831|364864473|FG000|Overall Study|Withdrawal by Subject|3|||
105785044|NCT02950831|364864473|FG000|Overall Study|stimulation trail failure|5|||
105785045|NCT02576951|364864478|FG000|Overall Study|Lost to Follow-up|0|||
105785046|NCT02576951|364864479|FG001|Overall Study|Lost to Follow-up|0|||
105785047|NCT02576951|364864480|FG002|Overall Study|Lost to Follow-up|2|||
105785048|NCT02576951|364864481|FG003|Overall Study|Lost to Follow-up|2|||
105785049|NCT02576951|364864478|FG000|Overall Study|Withdrawal by Subject|1|||
105785050|NCT02576951|364864479|FG001|Overall Study|Withdrawal by Subject|0|||
105785051|NCT02576951|364864480|FG002|Overall Study|Withdrawal by Subject|0|||
105785052|NCT02576951|364864481|FG003|Overall Study|Withdrawal by Subject|2|||
105785053|NCT02576951|364864478|FG000|Overall Study|Protocol Violation|0|||
105785054|NCT02576951|364864479|FG001|Overall Study|Protocol Violation|0|||
105785055|NCT02576951|364864480|FG002|Overall Study|Protocol Violation|0|||
105785056|NCT02576951|364864481|FG003|Overall Study|Protocol Violation|1|||
105785057|NCT01786707|364866356|FG000|Overall Study|Lost to Follow-up|1|||
105785058|NCT01786707|364866357|FG001|Overall Study|Lost to Follow-up|1|||
105785059|NCT00869362|364866370|FG000|Overall Study|Death|0|||
105785060|NCT00869362|364866371|FG001|Overall Study|Death|2|||
105338535|NCT01867710|363241116|FG001|Overall Study|Patient to follow subsequent treatment|1|||
105338536|NCT01867710|363241117|FG002|Overall Study|Patient to follow subsequent treatment|0|||
105338537|NCT01867710|363241118|FG003|Overall Study|Patient to follow subsequent treatment|0|||
105338538|NCT01867710|363241115|FG000|Overall Study|Progressive disease|1|||
105338539|NCT01867710|363241116|FG001|Overall Study|Progressive disease|0|||
105338540|NCT01867710|363241117|FG002|Overall Study|Progressive disease|0|||
105338541|NCT01867710|363241118|FG003|Overall Study|Progressive disease|0|||
105338542|NCT01867710|363241115|FG000|Overall Study|Protocol Violation|0|||
105338543|NCT01867710|363241116|FG001|Overall Study|Protocol Violation|0|||
105338544|NCT01867710|363241117|FG002|Overall Study|Protocol Violation|0|||
105338545|NCT01867710|363241118|FG003|Overall Study|Protocol Violation|1|||
105338546|NCT01867710|363241115|FG000|Overall Study|PSA-progression|0|||
105338547|NCT01867710|363241116|FG001|Overall Study|PSA-progression|1|||
105338548|NCT01867710|363241117|FG002|Overall Study|PSA-progression|0|||
105338549|NCT01867710|363241118|FG003|Overall Study|PSA-progression|0|||
105338550|NCT01867710|363241115|FG000|Overall Study|Study medication no longer effective|0|||
105338551|NCT01867710|363241116|FG001|Overall Study|Study medication no longer effective|1|||
105338552|NCT01867710|363241117|FG002|Overall Study|Study medication no longer effective|0|||
105338553|NCT01867710|363241118|FG003|Overall Study|Study medication no longer effective|0|||
105338554|NCT03452488|363241119|FG000|Overall Study|Adverse Event|4|||
105338555|NCT03452488|363241120|FG001|Overall Study|Adverse Event|6|||
105338556|NCT03452488|363241121|FG002|Overall Study|Adverse Event|1|||
105338557|NCT03452488|363241119|FG000|Overall Study|Death|0|||
105785061|NCT00869362|364866370|FG000|Overall Study|Lost to Follow-up|1|||
105338558|NCT03452488|363241120|FG001|Overall Study|Death|0|||
105338559|NCT03452488|363241121|FG002|Overall Study|Death|1|||
105338560|NCT03452488|363241119|FG000|Overall Study|Lost to Follow-up|1|||
105338561|NCT03452488|363241120|FG001|Overall Study|Lost to Follow-up|2|||
105338562|NCT03452488|363241121|FG002|Overall Study|Lost to Follow-up|0|||
105338563|NCT03452488|363241119|FG000|Overall Study|PI Decision|1|||
105785062|NCT00869362|364866371|FG001|Overall Study|Lost to Follow-up|3|||
105785063|NCT01241591|364866372|FG000|Overall Study|Lack of Efficacy|5|||
105338564|NCT03452488|363241120|FG001|Overall Study|PI Decision|0|||
105338565|NCT03452488|363241121|FG002|Overall Study|PI Decision|0|||
105338566|NCT03452488|363241119|FG000|Overall Study|Withdrew consent|4|||
105785064|NCT01241591|364866373|FG001|Overall Study|Lack of Efficacy|2|||
105785065|NCT01241591|364866374|FG002|Overall Study|Lack of Efficacy|2|||
105338567|NCT03452488|363241120|FG001|Overall Study|Withdrew consent|2|||
105338568|NCT03452488|363241121|FG002|Overall Study|Withdrew consent|2|||
105338569|NCT03452488|363241119|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
105338570|NCT03452488|363241120|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
105338571|NCT03452488|363241121|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
105338572|NCT03452488|363241119|FG000|Overall Study|Other|0|||
105338573|NCT03452488|363241120|FG001|Overall Study|Other|2|||
105338574|NCT03452488|363241121|FG002|Overall Study|Other|2|||
105338575|NCT00623935|363241122|FG000|Overall Study|Death|1|||
105338576|NCT00623935|363241122|FG000|Overall Study|Patient Declined Transplant|1|||
105338577|NCT00355147|363241123|FG000|Overall Study|Lost to Follow-up|10|||
105338578|NCT00355147|363241124|FG001|Overall Study|Lost to Follow-up|8|||
105338579|NCT00355147|363241123|FG000|Overall Study|Withdrawal by Subject|8|||
105338580|NCT00355147|363241124|FG001|Overall Study|Withdrawal by Subject|12|||
105338581|NCT00747474|363241131|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105338582|NCT00747474|363241132|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105338583|NCT00747474|363241133|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105338584|NCT00747474|363241134|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105338585|NCT00747474|363241135|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105338586|NCT00747474|363241136|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105338587|NCT00747474|363241137|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105338588|NCT00747474|363241138|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
105338589|NCT00747474|363241139|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105338590|NCT00747474|363241140|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105338591|NCT00747474|363241141|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105338592|NCT00747474|363241142|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105460895|NCT02118584|363700830|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
105460896|NCT02118584|363700831|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
105460897|NCT02118584|363700832|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
105460898|NCT03331315|363700838|FG000|Overall Study|Physician Decision|18|||
105460899|NCT03331315|363700839|FG001|Overall Study|Physician Decision|14|||
105460900|NCT03137381|363700840|FG000|Overall Study|Adverse Event|3|||
105460901|NCT03137381|363700841|FG001|Overall Study|Adverse Event|0|||
105460902|NCT03137381|363700842|FG002|Overall Study|Adverse Event|2|||
105460903|NCT03137381|363700843|FG003|Overall Study|Adverse Event|0|||
105460904|NCT03137381|363700840|FG000|Overall Study|Lost to Follow-up|2|||
105460905|NCT03137381|363700841|FG001|Overall Study|Lost to Follow-up|1|||
105460906|NCT03137381|363700842|FG002|Overall Study|Lost to Follow-up|1|||
105460907|NCT03137381|363700843|FG003|Overall Study|Lost to Follow-up|0|||
105460908|NCT03137381|363700840|FG000|Overall Study|Protocol deviation|1|||
105460909|NCT03137381|363700841|FG001|Overall Study|Protocol deviation|1|||
105460910|NCT03137381|363700842|FG002|Overall Study|Protocol deviation|0|||
105460911|NCT03137381|363700843|FG003|Overall Study|Protocol deviation|1|||
105460912|NCT03137381|363700840|FG000|Overall Study|Withdrawal by Investigator|0|||
105460913|NCT03137381|363700841|FG001|Overall Study|Withdrawal by Investigator|1|||
105460914|NCT03137381|363700842|FG002|Overall Study|Withdrawal by Investigator|1|||
105460915|NCT03137381|363700843|FG003|Overall Study|Withdrawal by Investigator|0|||
105460916|NCT03137381|363700840|FG000|Overall Study|Withdrawal by Subject|3|||
105460917|NCT03137381|363700841|FG001|Overall Study|Withdrawal by Subject|4|||
105460918|NCT03137381|363700842|FG002|Overall Study|Withdrawal by Subject|3|||
105460919|NCT03137381|363700843|FG003|Overall Study|Withdrawal by Subject|0|||
105460920|NCT03137381|363700840|FG000|Overall Study|Pregnancy|0|||
105460921|NCT03137381|363700841|FG001|Overall Study|Pregnancy|0|||
105460922|NCT03137381|363700842|FG002|Overall Study|Pregnancy|1|||
105460923|NCT03137381|363700843|FG003|Overall Study|Pregnancy|0|||
105460924|NCT00459316|363700848|FG000|Steps 1 & 2|Other eligibility failure|1|||
105460925|NCT00459316|363700849|FG001|Steps 1 & 2|Other eligibility failure|1|||
105460926|NCT00459316|363700850|FG002|Steps 1 & 2|Other eligibility failure|0|||
105460927|NCT00459316|363700848|FG000|Steps 1 & 2|Death|1|||
105460928|NCT00459316|363700849|FG001|Steps 1 & 2|Death|1|||
105460929|NCT00459316|363700850|FG002|Steps 1 & 2|Death|0|||
105460930|NCT00459316|363700848|FG000|Steps 1 & 2|Not able to get to clinic|7|||
105460931|NCT00459316|363700849|FG001|Steps 1 & 2|Not able to get to clinic|4|||
105338593|NCT02989649|363241143|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
105338594|NCT02989649|363241143|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
105460932|NCT00459316|363700850|FG002|Steps 1 & 2|Not able to get to clinic|0|||
105460933|NCT00459316|363700848|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
105460934|NCT00459316|363700849|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
105460935|NCT00459316|363700850|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
105460936|NCT00459316|363700848|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
105460937|NCT00459316|363700849|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
105460938|NCT00459316|363700850|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
105460939|NCT00459316|363700848|FG000|Steps 1 & 2|Lost to Follow-up|5|||
105460940|NCT00459316|363700849|FG001|Steps 1 & 2|Lost to Follow-up|0|||
105460941|NCT00459316|363700850|FG002|Steps 1 & 2|Lost to Follow-up|2|||
105338595|NCT02989649|363241143|FG000|Overall Study|Lost For Observation During Study|3|||
105338596|NCT02989649|363241143|FG000|Overall Study|Reason Not Specified|13|||
105338597|NCT00330343|363241144|FG000|Overall Study|Lost to Follow-up|5|||
105338598|NCT00782184|363241145|FG000|Overall Study|Adverse Event|1|||
105338599|NCT00782184|363241146|FG001|Overall Study|Adverse Event|2|||
105338600|NCT00782184|363241145|FG000|Overall Study|Protocol Violation|0|||
105338601|NCT00782184|363241146|FG001|Overall Study|Protocol Violation|1|||
105338602|NCT00782184|363241145|FG000|Overall Study|Withdrawal by Subject|3|||
105338603|NCT00782184|363241146|FG001|Overall Study|Withdrawal by Subject|2|||
105338604|NCT01053962|363241148|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
105338605|NCT01053962|363241149|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
105338606|NCT01053962|363241150|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
105338607|NCT01053962|363241151|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
105338608|NCT01053962|363241152|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
105338609|NCT01053962|363241148|FG000|Pretreatment Period|Venipuncture Failure|0|||
105338610|NCT01053962|363241149|FG001|Pretreatment Period|Venipuncture Failure|0|||
105338611|NCT01053962|363241150|FG002|Pretreatment Period|Venipuncture Failure|1|||
105338612|NCT01053962|363241151|FG003|Pretreatment Period|Venipuncture Failure|0|||
105338613|NCT01053962|363241152|FG004|Pretreatment Period|Venipuncture Failure|0|||
105338614|NCT01053962|363241148|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
105338615|NCT01053962|363241149|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
105460942|NCT00459316|363700848|FG000|Step 3|Withdrawal by Subject|3|||
105460943|NCT00459316|363700849|FG001|Step 3|Withdrawal by Subject|0|||
105460944|NCT00459316|363700850|FG002|Step 3|Withdrawal by Subject|1|||
105460945|NCT01748292|363700851|FG000|Overall Study|Adverse Event|2|||
105460946|NCT01748292|363700852|FG001|Overall Study|Adverse Event|4|||
105460947|NCT01748292|363700851|FG000|Overall Study|Lost to Follow-up|0|||
105460948|NCT01748292|363700852|FG001|Overall Study|Lost to Follow-up|3|||
105460949|NCT01748292|363700851|FG000|Overall Study|Death|0|||
105460950|NCT01748292|363700852|FG001|Overall Study|Death|3|||
105460951|NCT01748292|363700851|FG000|Overall Study|Withdrawal by Subject|0|||
105460952|NCT01748292|363700852|FG001|Overall Study|Withdrawal by Subject|2|||
105460953|NCT00910650|363700855|FG000|Overall Study|Death|2|||
105460954|NCT03367793|363700856|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
105460955|NCT03367793|363700857|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
105460956|NCT03367793|363700858|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
105460957|NCT03367793|363700859|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
105460958|NCT03367793|363700860|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
105460959|NCT03367793|363700861|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
105460960|NCT00423579|363700862|FG000|Overall Study|Lost to Follow-up|3|||
105460961|NCT00423579|363700863|FG001|Overall Study|Lost to Follow-up|0|||
105460962|NCT00423579|363700862|FG000|Overall Study|Protocol Violation|1|||
105460963|NCT00423579|363700863|FG001|Overall Study|Protocol Violation|3|||
105460964|NCT00423579|363700862|FG000|Overall Study|Diagnosis of diabetes|0|||
105460965|NCT00423579|363700863|FG001|Overall Study|Diagnosis of diabetes|1|||
105460966|NCT01761877|363700864|FG000|Overall Study|Adverse Event|7|||
105460967|NCT01761877|363700865|FG001|Overall Study|Adverse Event|0|||
105460968|NCT01761877|363700864|FG000|Overall Study|Withdrawal by Subject|6|||
105460969|NCT01761877|363700865|FG001|Overall Study|Withdrawal by Subject|4|||
105460970|NCT01761877|363700864|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
105460971|NCT01761877|363700865|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
105460972|NCT01761877|363700864|FG000|Overall Study|Death|0|||
105460973|NCT01761877|363700865|FG001|Overall Study|Death|1|||
105460974|NCT01761877|363700864|FG000|Overall Study|MRI intolerant|1|||
105460975|NCT01761877|363700865|FG001|Overall Study|MRI intolerant|6|||
105460976|NCT03879772|363700866|FG000|Overall Study|Adverse Event|2|||
105460977|NCT03879772|363700867|FG001|Overall Study|Adverse Event|2|||
105460978|NCT03879772|363700868|FG002|Overall Study|Adverse Event|3|||
105460979|NCT03879772|363700869|FG003|Overall Study|Adverse Event|4|||
105460980|NCT03879772|363700870|FG004|Overall Study|Adverse Event|3|||
105460981|NCT03879772|363700866|FG000|Overall Study|Treatment Failure|1|||
105460982|NCT03879772|363700867|FG001|Overall Study|Treatment Failure|0|||
105460983|NCT03879772|363700868|FG002|Overall Study|Treatment Failure|0|||
105460984|NCT03879772|363700869|FG003|Overall Study|Treatment Failure|2|||
105460985|NCT03879772|363700870|FG004|Overall Study|Treatment Failure|1|||
105460986|NCT03879772|363700866|FG000|Overall Study|Lost to Follow-up|0|||
105460987|NCT03879772|363700867|FG001|Overall Study|Lost to Follow-up|0|||
105460988|NCT03879772|363700868|FG002|Overall Study|Lost to Follow-up|0|||
105460989|NCT03879772|363700869|FG003|Overall Study|Lost to Follow-up|0|||
105460990|NCT03879772|363700870|FG004|Overall Study|Lost to Follow-up|1|||
105460991|NCT03879772|363700866|FG000|Overall Study|Withdrawal by Subject|0|||
105460992|NCT03879772|363700867|FG001|Overall Study|Withdrawal by Subject|1|||
105460993|NCT03879772|363700868|FG002|Overall Study|Withdrawal by Subject|3|||
105460994|NCT03879772|363700869|FG003|Overall Study|Withdrawal by Subject|1|||
105460995|NCT03879772|363700870|FG004|Overall Study|Withdrawal by Subject|1|||
105460996|NCT03879772|363700866|FG000|Overall Study|Protocol Violation|0|||
105460997|NCT03879772|363700867|FG001|Overall Study|Protocol Violation|0|||
105460998|NCT03879772|363700868|FG002|Overall Study|Protocol Violation|3|||
105460999|NCT03879772|363700869|FG003|Overall Study|Protocol Violation|1|||
105461000|NCT03879772|363700870|FG004|Overall Study|Protocol Violation|2|||
105461001|NCT03879772|363700866|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
105461002|NCT03879772|363700867|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
105461003|NCT03879772|363700868|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
105461004|NCT03879772|363700869|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
105461005|NCT03879772|363700870|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
105461006|NCT03697252|363700872|FG000|Overall Study|Adverse Event|3|||
105461007|NCT03697252|363700873|FG001|Overall Study|Adverse Event|2|||
105461008|NCT03697252|363700872|FG000|Overall Study|Withdrawal by Subject|14|||
105461009|NCT03697252|363700873|FG001|Overall Study|Withdrawal by Subject|14|||
105461010|NCT03697252|363700872|FG000|Overall Study|Lost to Follow-up|0|||
105461011|NCT03697252|363700873|FG001|Overall Study|Lost to Follow-up|1|||
105461012|NCT03697252|363700872|FG000|Overall Study|Physician Decision|1|||
105461013|NCT03697252|363700873|FG001|Overall Study|Physician Decision|1|||
105461014|NCT03697252|363700872|FG000|Overall Study|Other|0|||
105461015|NCT03697252|363700873|FG001|Overall Study|Other|1|||
105461016|NCT03125395|363700874|FG000|Overall Study|Adverse Event|2|||
105461017|NCT03125395|363700874|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
105461018|NCT03125395|363700874|FG000|Overall Study|Physician Decision|2|||
105461019|NCT03125395|363700874|FG000|Overall Study|Commercial drug is available|5|||
105461020|NCT01780506|363700875|FG000|Double-Blind Phase|Randomized but not Treated|3|||
105461021|NCT01780506|363700876|FG001|Double-Blind Phase|Randomized but not Treated|2|||
105461022|NCT01780506|363700875|FG000|Double-Blind Phase|Adverse Event|4|||
105461023|NCT01780506|363700876|FG001|Double-Blind Phase|Adverse Event|14|||
105461024|NCT01780506|363700875|FG000|Double-Blind Phase|Death|1|||
105461025|NCT01780506|363700876|FG001|Double-Blind Phase|Death|2|||
105461026|NCT01780506|363700875|FG000|Double-Blind Phase|Pregnancy|2|||
105461027|NCT01780506|363700876|FG001|Double-Blind Phase|Pregnancy|1|||
105461028|NCT01780506|363700875|FG000|Double-Blind Phase|Lack of Efficacy|1|||
105461029|NCT01780506|363700876|FG001|Double-Blind Phase|Lack of Efficacy|1|||
105461030|NCT01780506|363700875|FG000|Double-Blind Phase|Investigator's Discretion|5|||
105461031|NCT01780506|363700876|FG001|Double-Blind Phase|Investigator's Discretion|2|||
105461032|NCT01780506|363700875|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
105461033|NCT01780506|363700876|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
105461034|NCT01780506|363700875|FG000|Double-Blind Phase|Protocol Violation|4|||
105461035|NCT01780506|363700876|FG001|Double-Blind Phase|Protocol Violation|3|||
105461036|NCT01780506|363700875|FG000|Double-Blind Phase|Withdrew Consent|23|||
105461037|NCT01780506|363700876|FG001|Double-Blind Phase|Withdrew Consent|24|||
105461038|NCT01780506|363700875|FG000|Double-Blind Phase|Lost to Follow-up|23|||
105461039|NCT01780506|363700876|FG001|Double-Blind Phase|Lost to Follow-up|26|||
105461040|NCT01780506|363700875|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
105461041|NCT01780506|363700876|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
105461042|NCT02224560|363700880|FG000|Overall Study|Protocol Deviation|1|||
105461043|NCT02224560|363700881|FG001|Overall Study|Protocol Deviation|0|||
105461044|NCT02224560|363700882|FG002|Overall Study|Protocol Deviation|0|||
105461045|NCT02224560|363700880|FG000|Overall Study|Withdrawal by Subject|2|||
105461046|NCT02224560|363700881|FG001|Overall Study|Withdrawal by Subject|0|||
105461047|NCT02224560|363700882|FG002|Overall Study|Withdrawal by Subject|1|||
105461048|NCT02224560|363700880|FG000|Overall Study|Met Withdrawal Criteria|1|||
105461049|NCT02224560|363700881|FG001|Overall Study|Met Withdrawal Criteria|0|||
105461050|NCT02224560|363700882|FG002|Overall Study|Met Withdrawal Criteria|0|||
105461051|NCT02224560|363700880|FG000|Overall Study|Adverse Event|4|||
105461052|NCT02224560|363700881|FG001|Overall Study|Adverse Event|1|||
105461053|NCT02224560|363700882|FG002|Overall Study|Adverse Event|1|||
105461054|NCT02224560|363700880|FG000|Overall Study|Withdrawn by Investigator|1|||
105461055|NCT02224560|363700881|FG001|Overall Study|Withdrawn by Investigator|1|||
105461056|NCT02224560|363700882|FG002|Overall Study|Withdrawn by Investigator|0|||
105461057|NCT02461758|363700883|FG000|Overall Study|Lost to Follow-up|0|||
105461058|NCT02461758|363700884|FG001|Overall Study|Lost to Follow-up|1|||
105461059|NCT02461758|363700885|FG002|Overall Study|Lost to Follow-up|1|||
105461060|NCT02461758|363700886|FG003|Overall Study|Lost to Follow-up|0|||
105461061|NCT04030143|363700887|FG000|Overall Study|Adverse Event|5|||
105461062|NCT04030143|363700888|FG001|Overall Study|Adverse Event|10|||
105461063|NCT04030143|363700887|FG000|Overall Study|Lost to Follow-up|3|||
105461064|NCT04030143|363700888|FG001|Overall Study|Lost to Follow-up|7|||
105461065|NCT04030143|363700887|FG000|Overall Study|Protocol Deviation|2|||
105461066|NCT04030143|363700888|FG001|Overall Study|Protocol Deviation|2|||
105461067|NCT04030143|363700887|FG000|Overall Study|Withdrawal by Subject|16|||
105461068|NCT04030143|363700888|FG001|Overall Study|Withdrawal by Subject|18|||
105461069|NCT04030143|363700887|FG000|Overall Study|Physician Decision|1|||
105461070|NCT04030143|363700888|FG001|Overall Study|Physician Decision|1|||
105461071|NCT04030143|363700887|FG000|Overall Study|Due to Covid-19|2|||
105461072|NCT04030143|363700888|FG001|Overall Study|Due to Covid-19|3|||
105461073|NCT04030143|363700887|FG000|Overall Study|Not Due to Covid-19|1|||
105461074|NCT04030143|363700888|FG001|Overall Study|Not Due to Covid-19|1|||
105461075|NCT00412984|363700889|FG000|Overall Study|Death|331|||
105461076|NCT00412984|363700890|FG001|Overall Study|Death|349|||
105461077|NCT00412984|363700889|FG000|Overall Study|Adverse Event|679|||
105461078|NCT00412984|363700890|FG001|Overall Study|Adverse Event|738|||
105461079|NCT00412984|363700889|FG000|Overall Study|Withdrawal by Subject|921|||
105461080|NCT00412984|363700890|FG001|Overall Study|Withdrawal by Subject|989|||
105461081|NCT00412984|363700889|FG000|Overall Study|Lost to Follow-up|51|||
105461082|NCT00412984|363700890|FG001|Overall Study|Lost to Follow-up|39|||
105461083|NCT00412984|363700889|FG000|Overall Study|Poor/Noncompliance|57|||
105461084|NCT00412984|363700890|FG001|Overall Study|Poor/Noncompliance|77|||
105461085|NCT00412984|363700889|FG000|Overall Study|Pregnancy|1|||
105461086|NCT00412984|363700890|FG001|Overall Study|Pregnancy|0|||
105461087|NCT00412984|363700889|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
105461088|NCT00412984|363700890|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
105461089|NCT00412984|363700889|FG000|Overall Study|Administrative Reason by Sponsor|11|||
105461090|NCT00412984|363700890|FG001|Overall Study|Administrative Reason by Sponsor|8|||
105461091|NCT00412984|363700889|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
105461092|NCT00412984|363700890|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
105461093|NCT00412984|363700889|FG000|Overall Study|Other Reason|80|||
105461094|NCT00412984|363700890|FG001|Overall Study|Other Reason|92|||
105461095|NCT00412984|363700889|FG000|Overall Study|Not Reported|11|||
105461096|NCT00412984|363700890|FG001|Overall Study|Not Reported|12|||
105461097|NCT01550003|363700891|FG000|Overall Study|Adverse Event|0|||
105461098|NCT01550003|363700892|FG001|Overall Study|Adverse Event|9|||
105461099|NCT01550003|363700893|FG002|Overall Study|Adverse Event|15|||
105461100|NCT01550003|363700891|FG000|Overall Study|Lack of Efficacy|4|||
105461101|NCT01550003|363700892|FG001|Overall Study|Lack of Efficacy|11|||
105461102|NCT01550003|363700893|FG002|Overall Study|Lack of Efficacy|15|||
105461103|NCT01550003|363700891|FG000|Overall Study|Protocol Violation|0|||
105461104|NCT01550003|363700892|FG001|Overall Study|Protocol Violation|3|||
105461105|NCT01550003|363700893|FG002|Overall Study|Protocol Violation|2|||
105461106|NCT01550003|363700891|FG000|Overall Study|Lost to Follow-up|1|||
105461107|NCT01550003|363700892|FG001|Overall Study|Lost to Follow-up|4|||
105461108|NCT01550003|363700893|FG002|Overall Study|Lost to Follow-up|8|||
105461109|NCT01550003|363700891|FG000|Overall Study|Consent withdrawn|2|||
105461110|NCT01550003|363700892|FG001|Overall Study|Consent withdrawn|11|||
105461111|NCT01550003|363700893|FG002|Overall Study|Consent withdrawn|23|||
105461112|NCT01550003|363700891|FG000|Overall Study|Missing|1|||
105461113|NCT01550003|363700892|FG001|Overall Study|Missing|0|||
105461114|NCT01550003|363700893|FG002|Overall Study|Missing|2|||
105461115|NCT01550003|363700891|FG000|Overall Study|Study closure as announced by sponsor|7|||
105461116|NCT01550003|363700892|FG001|Overall Study|Study closure as announced by sponsor|6|||
105461117|NCT01550003|363700893|FG002|Overall Study|Study closure as announced by sponsor|24|||
105461118|NCT01550003|363700891|FG000|Overall Study|Protocol Noncompliance|1|||
105461119|NCT01550003|363700892|FG001|Overall Study|Protocol Noncompliance|0|||
105461120|NCT01550003|363700893|FG002|Overall Study|Protocol Noncompliance|0|||
105461121|NCT01550003|363700891|FG000|Overall Study|Study closure|0|||
105461122|NCT01550003|363700892|FG001|Overall Study|Study closure|1|||
105461123|NCT01550003|363700893|FG002|Overall Study|Study closure|1|||
105461124|NCT01550003|363700891|FG000|Overall Study|Patient reached adulthood|0|||
105461125|NCT01550003|363700892|FG001|Overall Study|Patient reached adulthood|1|||
105461126|NCT01550003|363700893|FG002|Overall Study|Patient reached adulthood|0|||
105461127|NCT01550003|363700891|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
105461128|NCT01550003|363700892|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
105461129|NCT01550003|363700893|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
105461130|NCT01550003|363700891|FG000|Overall Study|Sponsor's order|0|||
105461131|NCT01550003|363700892|FG001|Overall Study|Sponsor's order|3|||
105461132|NCT01550003|363700893|FG002|Overall Study|Sponsor's order|3|||
105461133|NCT01550003|363700891|FG000|Overall Study|Sponsor's decision|1|||
105461134|NCT01550003|363700892|FG001|Overall Study|Sponsor's decision|5|||
105461135|NCT01550003|363700893|FG002|Overall Study|Sponsor's decision|4|||
105461136|NCT01550003|363700891|FG000|Overall Study|Subject mother passed away|0|||
105461137|NCT01550003|363700892|FG001|Overall Study|Subject mother passed away|1|||
105461138|NCT01550003|363700893|FG002|Overall Study|Subject mother passed away|0|||
105461139|NCT01550003|363700891|FG000|Overall Study|Discontinuation|0|||
105461140|NCT01550003|363700892|FG001|Overall Study|Discontinuation|1|||
105461141|NCT01550003|363700893|FG002|Overall Study|Discontinuation|0|||
105461142|NCT01550003|363700891|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
105662485|NCT03522389|364428165|FG000|Overall Study|had herniated nucleus pulposus|0|||
105662486|NCT03522389|364428166|FG001|Overall Study|had herniated nucleus pulposus|1|||
105662487|NCT03522389|364428167|FG002|Overall Study|had herniated nucleus pulposus|0|||
105662488|NCT03522389|364428165|FG000|Overall Study|go to work in other province|1|||
105662489|NCT03522389|364428166|FG001|Overall Study|go to work in other province|0|||
105662490|NCT03522389|364428167|FG002|Overall Study|go to work in other province|0|||
105662491|NCT04428476|364428168|FG000|Overall Study|Withdrawal by Subject|1|||
105338616|NCT01053962|363241150|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
105338617|NCT01053962|363241151|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
105338618|NCT01053962|363241152|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
105338619|NCT01053962|363241148|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
105338620|NCT01053962|363241149|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
105338621|NCT01053962|363241150|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
105338622|NCT01053962|363241151|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
105338623|NCT01053962|363241152|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
105338624|NCT01053962|363241148|FG000|Treatment Period|Lack of Efficacy|0|||
105338625|NCT01053962|363241149|FG001|Treatment Period|Lack of Efficacy|0|||
105338626|NCT01053962|363241150|FG002|Treatment Period|Lack of Efficacy|0|||
105338627|NCT01053962|363241151|FG003|Treatment Period|Lack of Efficacy|0|||
105338628|NCT01053962|363241152|FG004|Treatment Period|Lack of Efficacy|1|||
105338629|NCT01053962|363241148|FG000|Treatment Period|Adverse Event|0|||
105338630|NCT01053962|363241149|FG001|Treatment Period|Adverse Event|0|||
105338631|NCT01053962|363241150|FG002|Treatment Period|Adverse Event|0|||
105338632|NCT01053962|363241151|FG003|Treatment Period|Adverse Event|0|||
105338633|NCT01053962|363241152|FG004|Treatment Period|Adverse Event|1|||
105338634|NCT01053962|363241148|FG000|Treatment Period|Withdrawal by Subject|0|||
105338635|NCT01053962|363241149|FG001|Treatment Period|Withdrawal by Subject|0|||
105338636|NCT01053962|363241150|FG002|Treatment Period|Withdrawal by Subject|0|||
105338637|NCT01053962|363241151|FG003|Treatment Period|Withdrawal by Subject|0|||
105461143|NCT01550003|363700892|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
105461144|NCT01550003|363700893|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
105461145|NCT01550003|363700891|FG000|Overall Study|Site closure|0|||
105461146|NCT01550003|363700892|FG001|Overall Study|Site closure|2|||
105461147|NCT01550003|363700893|FG002|Overall Study|Site closure|0|||
105461148|NCT01550003|363700891|FG000|Overall Study|Pregnancy|0|||
105461149|NCT01550003|363700892|FG001|Overall Study|Pregnancy|1|||
105461150|NCT01550003|363700893|FG002|Overall Study|Pregnancy|0|||
105461151|NCT01550003|363700891|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
105461152|NCT01550003|363700892|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
105461153|NCT01550003|363700893|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
105662492|NCT04428476|364428168|FG000|Overall Study|Still on treatment|12|||
105662493|NCT01151423|364428169|FG000|Overall Study|Study terminated by Sponsor|9|||
105338638|NCT01053962|363241152|FG004|Treatment Period|Withdrawal by Subject|1|||
105338639|NCT01053962|363241148|FG000|Treatment Period|Noncompliance with protocol|1|||
105338640|NCT01053962|363241149|FG001|Treatment Period|Noncompliance with protocol|0|||
105461154|NCT01550003|363700891|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
105662494|NCT01151423|364428170|FG001|Overall Study|Study terminated by Sponsor|10|||
105338641|NCT01053962|363241150|FG002|Treatment Period|Noncompliance with protocol|0|||
105338642|NCT01053962|363241151|FG003|Treatment Period|Noncompliance with protocol|0|||
105338643|NCT01053962|363241152|FG004|Treatment Period|Noncompliance with protocol|0|||
105338644|NCT03155178|363241153|FG000|Overall Study|Did not meet treatment day baseline|7|||
105338645|NCT03155178|363241154|FG001|Overall Study|Did not meet treatment day baseline|7|||
105338646|NCT03155178|363241155|FG002|Overall Study|Did not meet treatment day baseline|7|||
105338647|NCT03155178|363241156|FG003|Overall Study|Did not meet treatment day baseline|7|||
105338648|NCT00638443|363241159|FG000|First Intervention|Adverse Event|2|||
105338649|NCT00638443|363241160|FG001|First Intervention|Adverse Event|1|||
105338650|NCT01343277|363241161|FG000|Overall Study|Other|3|||
105338651|NCT01343277|363241162|FG001|Overall Study|Other|3|||
105338652|NCT01343277|363241161|FG000|Overall Study|Withdrawal by Subject|18|||
105338653|NCT01343277|363241162|FG001|Overall Study|Withdrawal by Subject|13|||
105338654|NCT01343277|363241161|FG000|Overall Study|Physician Decision|1|||
105338655|NCT01343277|363241162|FG001|Overall Study|Physician Decision|2|||
105338656|NCT01343277|363241161|FG000|Overall Study|Death|10|||
105338657|NCT01343277|363241162|FG001|Overall Study|Death|1|||
105338658|NCT01343277|363241161|FG000|Overall Study|Adverse Event|67|||
105338659|NCT01343277|363241162|FG001|Overall Study|Adverse Event|13|||
105338660|NCT01343277|363241161|FG000|Overall Study|Disease progression|270|||
105338661|NCT01343277|363241162|FG001|Overall Study|Disease progression|138|||
105338662|NCT01343277|363241161|FG000|Overall Study|Randomized not treated|6|||
105338663|NCT01343277|363241162|FG001|Overall Study|Randomized not treated|21|||
105338664|NCT01343277|363241161|FG000|Overall Study|Treatment ongoing|8|||
105338665|NCT01343277|363241162|FG001|Overall Study|Treatment ongoing|2|||
105338666|NCT01343277|363241161|FG000|Overall Study|Subsequent anticancer therapy|1|||
105338667|NCT01343277|363241162|FG001|Overall Study|Subsequent anticancer therapy|0|||
105338668|NCT01582178|363241168|FG000|Overall Study|Physician Decision|6|||
105338669|NCT01582178|363241169|FG001|Overall Study|Physician Decision|5|||
105338670|NCT03852628|363241170|FG000|Overall Study|Lost to Follow-up|7|||
105338671|NCT03852628|363241171|FG001|Overall Study|Lost to Follow-up|6|||
105338672|NCT03852628|363241170|FG000|Overall Study|Lack of Efficacy|6|||
105338673|NCT03852628|363241171|FG001|Overall Study|Lack of Efficacy|6|||
105338674|NCT02847494|363241172|FG000|Overall Study|Lost to Follow-up|8|||
105338675|NCT02847494|363241173|FG001|Overall Study|Lost to Follow-up|5|||
105338676|NCT02841280|363241174|FG000|Overall Study|Adverse Event|2|||
105338677|NCT02841280|363241175|FG001|Overall Study|Adverse Event|1|||
105338678|NCT02841280|363241174|FG000|Overall Study|Death|1|||
105338679|NCT02841280|363241175|FG001|Overall Study|Death|0|||
105338680|NCT02841280|363241174|FG000|Overall Study|Lost to Follow-up|2|||
105338681|NCT02841280|363241175|FG001|Overall Study|Lost to Follow-up|2|||
105338682|NCT02841280|363241174|FG000|Overall Study|Withdrawal by Subject|7|||
105338683|NCT02841280|363241175|FG001|Overall Study|Withdrawal by Subject|3|||
105338684|NCT02841280|363241174|FG000|Overall Study|Stop Point: BP above threshold|2|||
105338685|NCT02841280|363241175|FG001|Overall Study|Stop Point: BP above threshold|0|||
105338686|NCT03003494|363241176|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
105338687|NCT01340027|363241177|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
105338688|NCT01340027|363241178|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
105338689|NCT01340027|363241179|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
105338690|NCT01340027|363241180|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
105338691|NCT01340027|363241181|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
105338692|NCT01340027|363241182|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
105338693|NCT01340027|363241183|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
105338694|NCT01340027|363241184|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
105338695|NCT01340027|363241185|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
105338696|NCT01340027|363241186|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
105338697|NCT01340027|363241187|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
105338698|NCT01340027|363241188|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
105338699|NCT01340027|363241177|FG000|Overall Study|Adverse Event|0|||
105338700|NCT01340027|363241178|FG001|Overall Study|Adverse Event|1|||
105338701|NCT01340027|363241179|FG002|Overall Study|Adverse Event|2|||
105338702|NCT01340027|363241180|FG003|Overall Study|Adverse Event|0|||
105338703|NCT01340027|363241181|FG004|Overall Study|Adverse Event|1|||
105338704|NCT01340027|363241182|FG005|Overall Study|Adverse Event|2|||
105338705|NCT01340027|363241183|FG006|Overall Study|Adverse Event|2|||
105338706|NCT01340027|363241184|FG007|Overall Study|Adverse Event|1|||
105338707|NCT01340027|363241185|FG008|Overall Study|Adverse Event|4|||
105338708|NCT01340027|363241186|FG009|Overall Study|Adverse Event|1|||
105338709|NCT01340027|363241187|FG010|Overall Study|Adverse Event|1|||
105338710|NCT01340027|363241188|FG011|Overall Study|Adverse Event|3|||
105338711|NCT01340027|363241177|FG000|Overall Study|Lack of Efficacy|0|||
105338712|NCT01340027|363241178|FG001|Overall Study|Lack of Efficacy|0|||
105338713|NCT01340027|363241179|FG002|Overall Study|Lack of Efficacy|0|||
105338714|NCT01340027|363241180|FG003|Overall Study|Lack of Efficacy|0|||
105338715|NCT01340027|363241181|FG004|Overall Study|Lack of Efficacy|0|||
105338716|NCT01340027|363241182|FG005|Overall Study|Lack of Efficacy|0|||
105662495|NCT01151423|364428169|FG000|Overall Study|Protocol Violation|0|||
105662496|NCT01151423|364428170|FG001|Overall Study|Protocol Violation|1|||
105662497|NCT01151423|364428169|FG000|Overall Study|Physician Decision|1|||
105662498|NCT01151423|364428170|FG001|Overall Study|Physician Decision|1|||
105338717|NCT01340027|363241183|FG006|Overall Study|Lack of Efficacy|1|||
105662499|NCT01151423|364428169|FG000|Overall Study|Pregnancy|0|||
105662500|NCT01151423|364428170|FG001|Overall Study|Pregnancy|1|||
105662501|NCT01151423|364428169|FG000|Overall Study|Death|0|||
105662502|NCT01151423|364428170|FG001|Overall Study|Death|1|||
105662503|NCT01151423|364428169|FG000|Overall Study|Adverse Event|3|||
105662504|NCT01151423|364428170|FG001|Overall Study|Adverse Event|0|||
105662505|NCT01151423|364428169|FG000|Overall Study|Withdrawal by Subject|1|||
105662506|NCT01151423|364428170|FG001|Overall Study|Withdrawal by Subject|3|||
105662507|NCT01151423|364428169|FG000|Overall Study|Lost to Follow-up|1|||
105662508|NCT01151423|364428170|FG001|Overall Study|Lost to Follow-up|0|||
105662509|NCT01151423|364428169|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
105662510|NCT01151423|364428170|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
105662511|NCT01151423|364428169|FG000|Overall Study|Participated in other clinical trial|1|||
105662512|NCT01151423|364428170|FG001|Overall Study|Participated in other clinical trial|0|||
105662513|NCT01310699|364428172|FG000|Overall Study|Patients did not complete tandem.|4|||
105662514|NCT01310699|364428173|FG001|Overall Study|Patients did not complete tandem.|6|||
105662515|NCT00936598|364428174|FG000|Overall Study|Withdrawal by Subject|1|||
105662516|NCT00936598|364428175|FG001|Overall Study|Withdrawal by Subject|0|||
105662517|NCT00936598|364428174|FG000|Overall Study|Ineligible after consent|1|||
105662518|NCT00936598|364428175|FG001|Overall Study|Ineligible after consent|0|||
105662519|NCT02201901|364428179|FG000|Overall Study|Randomized but never treated|0|||
105662520|NCT02201901|364428180|FG001|Overall Study|Randomized but never treated|1|||
105662521|NCT02201901|364428181|FG002|Overall Study|Randomized but never treated|0|||
105662522|NCT02201901|364428179|FG000|Overall Study|Lack of Efficacy|7|||
105662523|NCT02201901|364428180|FG001|Overall Study|Lack of Efficacy|1|||
105662524|NCT02201901|364428181|FG002|Overall Study|Lack of Efficacy|6|||
105662525|NCT02201901|364428179|FG000|Overall Study|Death|3|||
105338718|NCT01340027|363241184|FG007|Overall Study|Lack of Efficacy|1|||
105338719|NCT01340027|363241185|FG008|Overall Study|Lack of Efficacy|1|||
105338720|NCT01340027|363241186|FG009|Overall Study|Lack of Efficacy|0|||
105338721|NCT01340027|363241187|FG010|Overall Study|Lack of Efficacy|0|||
105338722|NCT01340027|363241188|FG011|Overall Study|Lack of Efficacy|0|||
105338723|NCT01340027|363241177|FG000|Overall Study|Lost to Follow-up|0|||
105338724|NCT01340027|363241178|FG001|Overall Study|Lost to Follow-up|1|||
105338725|NCT01340027|363241179|FG002|Overall Study|Lost to Follow-up|0|||
105338726|NCT01340027|363241180|FG003|Overall Study|Lost to Follow-up|0|||
105338727|NCT01340027|363241181|FG004|Overall Study|Lost to Follow-up|0|||
105338728|NCT01340027|363241182|FG005|Overall Study|Lost to Follow-up|0|||
105338729|NCT01340027|363241183|FG006|Overall Study|Lost to Follow-up|1|||
105338730|NCT01340027|363241184|FG007|Overall Study|Lost to Follow-up|0|||
105338731|NCT01340027|363241185|FG008|Overall Study|Lost to Follow-up|0|||
105338732|NCT01340027|363241186|FG009|Overall Study|Lost to Follow-up|1|||
105338733|NCT01340027|363241187|FG010|Overall Study|Lost to Follow-up|0|||
105338734|NCT01340027|363241188|FG011|Overall Study|Lost to Follow-up|0|||
105338735|NCT01340027|363241177|FG000|Overall Study|Protocol Violation|1|||
105338736|NCT01340027|363241178|FG001|Overall Study|Protocol Violation|2|||
105338737|NCT01340027|363241179|FG002|Overall Study|Protocol Violation|0|||
105338738|NCT01340027|363241180|FG003|Overall Study|Protocol Violation|0|||
105338739|NCT01340027|363241181|FG004|Overall Study|Protocol Violation|6|||
105338740|NCT01340027|363241182|FG005|Overall Study|Protocol Violation|0|||
105338741|NCT01340027|363241183|FG006|Overall Study|Protocol Violation|0|||
105338742|NCT01340027|363241184|FG007|Overall Study|Protocol Violation|1|||
105338743|NCT01340027|363241185|FG008|Overall Study|Protocol Violation|2|||
105338744|NCT01340027|363241186|FG009|Overall Study|Protocol Violation|2|||
105338745|NCT01340027|363241187|FG010|Overall Study|Protocol Violation|0|||
105338746|NCT01340027|363241188|FG011|Overall Study|Protocol Violation|0|||
105338747|NCT01340027|363241177|FG000|Overall Study|Withdrawal by Subject|4|||
105338748|NCT01340027|363241178|FG001|Overall Study|Withdrawal by Subject|3|||
105338749|NCT01340027|363241179|FG002|Overall Study|Withdrawal by Subject|1|||
105338750|NCT01340027|363241180|FG003|Overall Study|Withdrawal by Subject|3|||
105338751|NCT01340027|363241181|FG004|Overall Study|Withdrawal by Subject|3|||
105338752|NCT01340027|363241182|FG005|Overall Study|Withdrawal by Subject|2|||
105338753|NCT01340027|363241183|FG006|Overall Study|Withdrawal by Subject|3|||
105338754|NCT01340027|363241184|FG007|Overall Study|Withdrawal by Subject|4|||
105338755|NCT01340027|363241185|FG008|Overall Study|Withdrawal by Subject|1|||
105338756|NCT01340027|363241186|FG009|Overall Study|Withdrawal by Subject|2|||
105662526|NCT02201901|364428180|FG001|Overall Study|Death|3|||
105662527|NCT02201901|364428181|FG002|Overall Study|Death|3|||
105338757|NCT01340027|363241187|FG010|Overall Study|Withdrawal by Subject|0|||
105338758|NCT01340027|363241188|FG011|Overall Study|Withdrawal by Subject|1|||
105338759|NCT01340027|363241177|FG000|Overall Study|Miscellaneous|0|||
105338760|NCT01340027|363241178|FG001|Overall Study|Miscellaneous|0|||
105338761|NCT01340027|363241179|FG002|Overall Study|Miscellaneous|0|||
105662528|NCT02201901|364428179|FG000|Overall Study|Lost to Follow-up|2|||
105461155|NCT01550003|363700892|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
105461156|NCT01550003|363700893|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
105461157|NCT01550003|363700891|FG000|Overall Study|Switching to adult rheumatologist|0|||
105461158|NCT01550003|363700892|FG001|Overall Study|Switching to adult rheumatologist|0|||
105461159|NCT01550003|363700893|FG002|Overall Study|Switching to adult rheumatologist|1|||
105461160|NCT01550003|363700891|FG000|Overall Study|Patient transition to adult care|0|||
105461161|NCT01550003|363700892|FG001|Overall Study|Patient transition to adult care|0|||
105461162|NCT01550003|363700893|FG002|Overall Study|Patient transition to adult care|1|||
105461163|NCT01550003|363700891|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
105461164|NCT01550003|363700892|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
105461165|NCT01550003|363700893|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
105461166|NCT01550003|363700891|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
105461167|NCT01550003|363700892|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
105461168|NCT01550003|363700893|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
105461169|NCT01550003|363700891|FG000|Overall Study|Per Sponsor request|1|||
105461170|NCT01550003|363700892|FG001|Overall Study|Per Sponsor request|0|||
105461171|NCT01550003|363700893|FG002|Overall Study|Per Sponsor request|1|||
105461172|NCT01550003|363700891|FG000|Overall Study|Patient not compliance|0|||
105461173|NCT01550003|363700892|FG001|Overall Study|Patient not compliance|0|||
105461174|NCT01550003|363700893|FG002|Overall Study|Patient not compliance|1|||
105461175|NCT01550003|363700891|FG000|Overall Study|Non-compliance|0|||
105461176|NCT01550003|363700892|FG001|Overall Study|Non-compliance|0|||
105461177|NCT01550003|363700893|FG002|Overall Study|Non-compliance|1|||
105461178|NCT01550003|363700891|FG000|Overall Study|Study closed|0|||
105461179|NCT01550003|363700892|FG001|Overall Study|Study closed|1|||
105461180|NCT01550003|363700893|FG002|Overall Study|Study closed|0|||
105461181|NCT01550003|363700891|FG000|Overall Study|Transitioned to adult rheumatology|0|||
105461182|NCT01550003|363700892|FG001|Overall Study|Transitioned to adult rheumatology|0|||
105461183|NCT01550003|363700893|FG002|Overall Study|Transitioned to adult rheumatology|1|||
105461184|NCT00871975|363700894|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
105461185|NCT00871975|363700894|FG000|Overall Study|Catheters could not be inserted|1|||
105461186|NCT00871975|363700894|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
105461187|NCT00871975|363700894|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
105461188|NCT04189952|363700895|FG000|Follow-up Period|Death|1|||
105461189|NCT04189952|363700895|FG000|Follow-up Period|Withdrawal by Subject|1|||
105461190|NCT00453206|363700903|FG000|Overall Study|Death|1|||
105461191|NCT00888173|363700906|FG000|Overall Study|Wrong Primary|1|||
105461192|NCT00888173|363700906|FG000|Overall Study|Ineligible: required test not done|1|||
105461193|NCT01488890|363700909|FG000|Overall Study|Serious adverse event|2|||
105461194|NCT01488890|363700910|FG001|Overall Study|Serious adverse event|0|||
105461195|NCT01488890|363700911|FG002|Overall Study|Serious adverse event|0|||
105461196|NCT01488890|363700912|FG003|Overall Study|Serious adverse event|0|||
105461197|NCT01488890|363700909|FG000|Overall Study|Protocol Violation|3|||
105461198|NCT01488890|363700910|FG001|Overall Study|Protocol Violation|0|||
105461199|NCT01488890|363700911|FG002|Overall Study|Protocol Violation|4|||
105461200|NCT01488890|363700912|FG003|Overall Study|Protocol Violation|0|||
105461201|NCT01488890|363700909|FG000|Overall Study|Lost to Follow-up|13|||
105461202|NCT01488890|363700910|FG001|Overall Study|Lost to Follow-up|10|||
105461203|NCT01488890|363700911|FG002|Overall Study|Lost to Follow-up|20|||
105461204|NCT01488890|363700912|FG003|Overall Study|Lost to Follow-up|3|||
105461205|NCT01488890|363700909|FG000|Overall Study|Withdrawal by Subject|14|||
105461206|NCT01488890|363700910|FG001|Overall Study|Withdrawal by Subject|10|||
105461207|NCT01488890|363700911|FG002|Overall Study|Withdrawal by Subject|11|||
105461208|NCT01488890|363700912|FG003|Overall Study|Withdrawal by Subject|2|||
105461209|NCT02694185|363700913|FG000|Overall Study|Withdrawal by Subject|45|||
105461210|NCT02694185|363700914|FG001|Overall Study|Withdrawal by Subject|0|||
105461211|NCT05082857|363700915|FG000|Overall Study|participants relocated and could not continue|2|||
105461212|NCT05082857|363700916|FG001|Overall Study|participants relocated and could not continue|1|||
105461213|NCT05082857|363700915|FG000|Overall Study|Lost to Follow-up|1|||
105461214|NCT05082857|363700916|FG001|Overall Study|Lost to Follow-up|3|||
105461215|NCT00791934|363700920|FG000|Overall Study|Withdrawal by Subject|2|||
105461216|NCT00791934|363700920|FG000|Overall Study|Did not consent for extended follow-up|13|||
105461217|NCT02195518|363700923|FG000|Overall Study|Adverse Event|1|||
105461218|NCT02195518|363700923|FG000|Overall Study|Protocol Violation|4|||
105461219|NCT02195518|363700923|FG000|Overall Study|Pregnancy|2|||
105461220|NCT02195518|363700923|FG000|Overall Study|Withdrawal by Subject|1|||
105461221|NCT02195518|363700923|FG000|Overall Study|Lost to Follow-up|1|||
105461222|NCT04825678|363700924|FG000|Overall Study|Decision by Sponsor|2|||
105461223|NCT04825678|363700925|FG001|Overall Study|Decision by Sponsor|3|||
105461224|NCT04825678|363700924|FG000|Overall Study|Withdrawal of Consent From Study|7|||
105461225|NCT04825678|363700925|FG001|Overall Study|Withdrawal of Consent From Study|9|||
105461226|NCT04825678|363700924|FG000|Overall Study|Lost to Follow-up|3|||
105461227|NCT04825678|363700925|FG001|Overall Study|Lost to Follow-up|4|||
105461228|NCT04825678|363700924|FG000|Overall Study|Never Received Investigational Product|1|||
105461229|NCT04825678|363700925|FG001|Overall Study|Never Received Investigational Product|1|||
105461230|NCT00734149|363700926|FG000|Overall Study|Withdrawal by Subject|1|||
105461231|NCT04482647|363700929|FG000|Overall Study|Time constraints|2|||
105461232|NCT04482647|363700929|FG000|Overall Study|Health issues|1|||
105461233|NCT04482647|363700929|FG000|Overall Study|Death in the family|1|||
105461234|NCT04482647|363700929|FG000|Overall Study|Disliked the intervention|1|||
105461235|NCT04482647|363700929|FG000|Overall Study|No reasons specified|7|||
105461236|NCT02855125|363700930|FG000|Overall Study|Withdrawal by Subject|2|||
105461237|NCT02855125|363700931|FG001|Overall Study|Withdrawal by Subject|2|||
105461238|NCT02855125|363700930|FG000|Overall Study|Clinical Disease Progression|5|||
105461239|NCT02855125|363700931|FG001|Overall Study|Clinical Disease Progression|4|||
105461240|NCT02855125|363700930|FG000|Overall Study|Radiologic Disease Progression|36|||
105461241|NCT02855125|363700931|FG001|Overall Study|Radiologic Disease Progression|39|||
105461242|NCT02855125|363700930|FG000|Overall Study|Adverse Event|11|||
105461243|NCT02855125|363700931|FG001|Overall Study|Adverse Event|7|||
105461244|NCT02855125|363700930|FG000|Overall Study|Physician Decision|1|||
105461245|NCT02855125|363700931|FG001|Overall Study|Physician Decision|0|||
105461246|NCT02855125|363700930|FG000|Overall Study|On Treatment|9|||
105461247|NCT02855125|363700931|FG001|Overall Study|On Treatment|11|||
105461248|NCT02855125|363700930|FG000|Overall Study|Randomized but not treated|0|||
105461249|NCT02855125|363700931|FG001|Overall Study|Randomized but not treated|1|||
105461250|NCT03472885|363700933|FG000|24-Week Treatment Period|Adverse Event|1|||
105461251|NCT04467905|363700934|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
105461252|NCT04467905|363700935|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
105461253|NCT04467905|363700936|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
105461254|NCT04467905|363700934|FG000|Overall Study|Conversion to SR|0|||
105461255|NCT04467905|363700935|FG001|Overall Study|Conversion to SR|0|||
105461256|NCT04467905|363700936|FG002|Overall Study|Conversion to SR|3|||
105461257|NCT04467905|363700934|FG000|Overall Study|Technical issue with Holter ECG|0|||
105461258|NCT04467905|363700935|FG001|Overall Study|Technical issue with Holter ECG|0|||
105461259|NCT04467905|363700936|FG002|Overall Study|Technical issue with Holter ECG|3|||
105461260|NCT04467905|363700934|FG000|Overall Study|Hemodynamic instability|0|||
105461261|NCT04467905|363700935|FG001|Overall Study|Hemodynamic instability|0|||
105461262|NCT04467905|363700936|FG002|Overall Study|Hemodynamic instability|1|||
105461263|NCT04467905|363700934|FG000|Overall Study|Site misinterpretation of protocol|0|||
105461264|NCT04467905|363700935|FG001|Overall Study|Site misinterpretation of protocol|0|||
105461265|NCT04467905|363700936|FG002|Overall Study|Site misinterpretation of protocol|1|||
105461266|NCT04586205|363700939|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
105461267|NCT04586205|363700940|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
105461268|NCT04944992|363702589|FG000|Overall Study|Lost to Follow-up|1|||
105461269|NCT04944992|363702590|FG001|Overall Study|Lost to Follow-up|1|||
105461270|NCT04944992|363702589|FG000|Overall Study|Physician Decision|1|||
105461271|NCT04944992|363702590|FG001|Overall Study|Physician Decision|0|||
105461272|NCT04944992|363702589|FG000|Overall Study|Withdrawal by Subject|6|||
105461273|NCT04944992|363702590|FG001|Overall Study|Withdrawal by Subject|1|||
105461274|NCT00303069|363702591|FG000|Overall Study|Lost to Follow-up|1|||
105461275|NCT00303069|363702592|FG001|Overall Study|Lost to Follow-up|0|||
105461276|NCT00303069|363702593|FG002|Overall Study|Lost to Follow-up|0|||
105461277|NCT00303069|363702594|FG003|Overall Study|Lost to Follow-up|2|||
105461278|NCT00303069|363702591|FG000|Overall Study|subject moved|1|||
105461279|NCT00303069|363702592|FG001|Overall Study|subject moved|0|||
105461280|NCT00303069|363702593|FG002|Overall Study|subject moved|0|||
105461281|NCT00303069|363702594|FG003|Overall Study|subject moved|0|||
105461282|NCT00303069|363702591|FG000|Overall Study|Recruitment into Army Reserves|0|||
105461283|NCT00303069|363702592|FG001|Overall Study|Recruitment into Army Reserves|0|||
105461284|NCT00303069|363702593|FG002|Overall Study|Recruitment into Army Reserves|1|||
105785066|NCT01241591|364866375|FG003|Overall Study|Lack of Efficacy|3|||
105461285|NCT00303069|363702594|FG003|Overall Study|Recruitment into Army Reserves|0|||
105461286|NCT00425269|363702595|FG000|Overall Study|Pregnancy|5|||
105461287|NCT00425269|363702596|FG001|Overall Study|Pregnancy|7|||
105785067|NCT01241591|364866372|FG000|Overall Study|Protocol Violation|5|||
105662529|NCT02201901|364428180|FG001|Overall Study|Lost to Follow-up|3|||
105662530|NCT02201901|364428181|FG002|Overall Study|Lost to Follow-up|2|||
105662531|NCT02201901|364428179|FG000|Overall Study|Withdrew Consent|2|||
105662532|NCT02201901|364428180|FG001|Overall Study|Withdrew Consent|0|||
105662533|NCT02201901|364428181|FG002|Overall Study|Withdrew Consent|2|||
105662534|NCT02201901|364428179|FG000|Overall Study|Adverse Event|1|||
105662535|NCT02201901|364428180|FG001|Overall Study|Adverse Event|1|||
105662536|NCT02201901|364428181|FG002|Overall Study|Adverse Event|0|||
105662537|NCT03358238|364428184|FG000|Overall Study|Withdrawal by Subject|0|||
105662538|NCT03358238|364428185|FG001|Overall Study|Withdrawal by Subject|1|||
105662539|NCT02559310|364428188|FG000|Overall Study|Death|4|||
105662540|NCT02559310|364428189|FG001|Overall Study|Death|3|||
105662541|NCT02559310|364428188|FG000|Overall Study|Lost to Follow-up|5|||
105662542|NCT02559310|364428189|FG001|Overall Study|Lost to Follow-up|3|||
105662543|NCT02559310|364428188|FG000|Overall Study|Physician Decision|2|||
105662544|NCT02559310|364428189|FG001|Overall Study|Physician Decision|1|||
105662545|NCT02559310|364428188|FG000|Overall Study|Withdrawal by Subject|13|||
105662546|NCT02559310|364428189|FG001|Overall Study|Withdrawal by Subject|9|||
105662547|NCT02559310|364428188|FG000|Overall Study|Sponsor Decision|0|||
105662548|NCT02559310|364428189|FG001|Overall Study|Sponsor Decision|1|||
105662549|NCT02559310|364428188|FG000|Overall Study|Randomized but not treated|3|||
105662550|NCT02559310|364428189|FG001|Overall Study|Randomized but not treated|2|||
105662551|NCT01740154|364428190|FG000|Overall Study|Adverse Event|1|||
105662552|NCT00469859|364428191|FG000|Overall Study|Inevaluable|0|||
105785068|NCT01241591|364866373|FG001|Overall Study|Protocol Violation|2|||
105785069|NCT01241591|364866374|FG002|Overall Study|Protocol Violation|3|||
105785070|NCT01241591|364866375|FG003|Overall Study|Protocol Violation|0|||
105785071|NCT01241591|364866372|FG000|Overall Study|Lost to Follow-up|1|||
105785072|NCT01241591|364866373|FG001|Overall Study|Lost to Follow-up|2|||
105785073|NCT01241591|364866374|FG002|Overall Study|Lost to Follow-up|2|||
105785074|NCT01241591|364866375|FG003|Overall Study|Lost to Follow-up|2|||
105785075|NCT01241591|364866372|FG000|Overall Study|Screen Failure|3|||
105785076|NCT01241591|364866373|FG001|Overall Study|Screen Failure|2|||
105785077|NCT01241591|364866374|FG002|Overall Study|Screen Failure|1|||
105785078|NCT01241591|364866375|FG003|Overall Study|Screen Failure|0|||
105785079|NCT01241591|364866372|FG000|Overall Study|Withdrawal by Subject|6|||
105461288|NCT00425269|363702595|FG000|Overall Study|Lost to Follow-up|9|||
105461289|NCT00425269|363702596|FG001|Overall Study|Lost to Follow-up|9|||
105461290|NCT00425269|363702595|FG000|Overall Study|moved or medical reason|5|||
105662553|NCT00469859|364428192|FG001|Overall Study|Inevaluable|2|||
105662554|NCT04855734|364428193|FG000|Overall Study|Lost to Follow-up|2|||
105662555|NCT04855734|364428194|FG001|Overall Study|Lost to Follow-up|2|||
105785080|NCT01241591|364866373|FG001|Overall Study|Withdrawal by Subject|4|||
105461291|NCT00425269|363702596|FG001|Overall Study|moved or medical reason|4|||
105461292|NCT04218240|363702597|FG000|Overall Study|Withdrawal by Subject|6|||
105461293|NCT04218240|363702598|FG001|Overall Study|Withdrawal by Subject|0|||
105461294|NCT04218240|363702597|FG000|Overall Study|Lack of Efficacy|24|||
105461295|NCT04218240|363702598|FG001|Overall Study|Lack of Efficacy|19|||
105461296|NCT04218240|363702597|FG000|Overall Study|Physician Decision|0|||
105461297|NCT04218240|363702598|FG001|Overall Study|Physician Decision|1|||
105461298|NCT04218240|363702597|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
105461299|NCT04218240|363702598|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
105461300|NCT04097678|363702599|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
105461301|NCT04097678|363702600|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
105461302|NCT03694678|363702601|FG000|Overall Study|Withdrawal by Subject|2|||
105461303|NCT03694678|363702602|FG001|Overall Study|Withdrawal by Subject|0|||
105461304|NCT03694678|363702601|FG000|Overall Study|Lost to Follow-up|2|||
105461305|NCT03694678|363702602|FG001|Overall Study|Lost to Follow-up|3|||
105461306|NCT05966142|363702603|FG000|Overall Study|Death|3|||
105461307|NCT05966142|363702604|FG001|Overall Study|Death|3|||
105461308|NCT05966142|363702603|FG000|Overall Study|Lost to Follow-up|55|||
105461309|NCT05966142|363702604|FG001|Overall Study|Lost to Follow-up|52|||
105461310|NCT05966142|363702603|FG000|Overall Study|Physician Decision|1|||
105461311|NCT05966142|363702604|FG001|Overall Study|Physician Decision|0|||
105461312|NCT05966142|363702603|FG000|Overall Study|Withdrawal by Subject|9|||
105461313|NCT05966142|363702604|FG001|Overall Study|Withdrawal by Subject|8|||
105662556|NCT02520310|364428195|FG000|At 6 Months Clinical Follow-up|Death|1|||
105662557|NCT02520310|364428195|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
105662558|NCT02520310|364428195|FG000|AT 3 Year Clinical Follow-up|Death|2|||
105662559|NCT02520310|364428195|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
105662560|NCT02520310|364428195|FG000|AT 4 Year Clinical Follow-up|Death|1|||
105785081|NCT01241591|364866374|FG002|Overall Study|Withdrawal by Subject|2|||
105785082|NCT01241591|364866375|FG003|Overall Study|Withdrawal by Subject|2|||
105785083|NCT01241591|364866372|FG000|Overall Study|Other|0|||
105461314|NCT05966142|363702603|FG000|Overall Study|Duplicate Enrollment|1|||
105461315|NCT05966142|363702604|FG001|Overall Study|Duplicate Enrollment|0|||
105461316|NCT05966142|363702603|FG000|Overall Study|Study Logistical Reason|1|||
105662561|NCT02520310|364428195|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
105785084|NCT01241591|364866373|FG001|Overall Study|Other|1|||
105461317|NCT05966142|363702604|FG001|Overall Study|Study Logistical Reason|0|||
105461318|NCT05966142|363702603|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
105461319|NCT05966142|363702604|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
105461320|NCT01210313|363702609|FG000|Overall Study|Withdrawal by Subject|3|||
105461321|NCT01210313|363702609|FG000|Overall Study|Adverse Event|2|||
105461322|NCT01210313|363702609|FG000|Overall Study|Distant recurrence|4|||
105461323|NCT01210313|363702609|FG000|Overall Study|Non-compliance|7|||
105785085|NCT01241591|364866374|FG002|Overall Study|Other|0|||
105461324|NCT00283296|363702612|FG000|Overall Study|in-home trial not completed|5|||
105461325|NCT02589938|363702615|FG000|Overall Study|Withdrawal by Subject|11|||
105461326|NCT02589938|363702616|FG001|Overall Study|Withdrawal by Subject|5|||
105461327|NCT02589938|363702617|FG002|Overall Study|Withdrawal by Subject|6|||
105461328|NCT02589938|363702615|FG000|Overall Study|Lost to Follow-up|3|||
105461329|NCT02589938|363702616|FG001|Overall Study|Lost to Follow-up|3|||
105461330|NCT02589938|363702617|FG002|Overall Study|Lost to Follow-up|3|||
105461331|NCT02589938|363702615|FG000|Overall Study|Death|1|||
105461332|NCT02589938|363702616|FG001|Overall Study|Death|0|||
105461333|NCT02589938|363702617|FG002|Overall Study|Death|1|||
105461334|NCT02589938|363702615|FG000|Overall Study|Protocol Violation|6|||
105461335|NCT02589938|363702616|FG001|Overall Study|Protocol Violation|2|||
105461336|NCT02589938|363702617|FG002|Overall Study|Protocol Violation|3|||
105461337|NCT02589938|363702615|FG000|Overall Study|Physician Decision|1|||
105461338|NCT02589938|363702616|FG001|Overall Study|Physician Decision|0|||
105461339|NCT02589938|363702617|FG002|Overall Study|Physician Decision|0|||
105461340|NCT02589938|363702615|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
105461341|NCT02589938|363702616|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
105461342|NCT02589938|363702617|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
105461343|NCT03558737|363702618|FG000|Overall Study|Death|1|||
105461344|NCT03558737|363702619|FG001|Overall Study|Death|1|||
105461345|NCT01318915|363702622|FG000|Overall Study|Lost to Follow-up|1|||
105461346|NCT00632229|363702623|FG000|Overall Study|Adverse Event|6|||
105461347|NCT00632229|363702624|FG001|Overall Study|Adverse Event|0|||
105461348|NCT00632229|363702623|FG000|Overall Study|Lost to Follow-up|0|||
105461349|NCT00632229|363702624|FG001|Overall Study|Lost to Follow-up|3|||
105461350|NCT00632229|363702623|FG000|Overall Study|Lack of Efficacy|0|||
105461351|NCT00632229|363702624|FG001|Overall Study|Lack of Efficacy|2|||
105461352|NCT00632229|363702623|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
105461353|NCT00632229|363702624|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
105461354|NCT05386329|363702628|FG000|Overall Study|Lost to Follow-up|3|||
105461355|NCT00888134|363702629|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
105461356|NCT00888134|363702629|FG000|Follow-up|being followed for long-term survival|1|||
105461357|NCT03224819|363702633|FG000|Overall Study|Withdrawal by Subject|0|||
105461358|NCT03224819|363702634|FG001|Overall Study|Withdrawal by Subject|0|||
105461359|NCT03224819|363702635|FG002|Overall Study|Withdrawal by Subject|0|||
105461360|NCT03224819|363702636|FG003|Overall Study|Withdrawal by Subject|0|||
105461361|NCT03224819|363702637|FG004|Overall Study|Withdrawal by Subject|0|||
105461362|NCT03224819|363702638|FG005|Overall Study|Withdrawal by Subject|0|||
105461363|NCT03224819|363702639|FG006|Overall Study|Withdrawal by Subject|0|||
105461364|NCT03224819|363702640|FG007|Overall Study|Withdrawal by Subject|0|||
105461365|NCT03224819|363702641|FG008|Overall Study|Withdrawal by Subject|0|||
105461366|NCT03224819|363702642|FG009|Overall Study|Withdrawal by Subject|0|||
105461367|NCT03224819|363702643|FG010|Overall Study|Withdrawal by Subject|0|||
105461368|NCT03224819|363702644|FG011|Overall Study|Withdrawal by Subject|0|||
105461369|NCT03224819|363702645|FG012|Overall Study|Withdrawal by Subject|1|||
105461370|NCT03224819|363702646|FG013|Overall Study|Withdrawal by Subject|0|||
105461371|NCT03224819|363702633|FG000|Overall Study|Sponsor Decision|0|||
105461372|NCT03224819|363702634|FG001|Overall Study|Sponsor Decision|0|||
105461373|NCT03224819|363702635|FG002|Overall Study|Sponsor Decision|0|||
105461374|NCT03224819|363702636|FG003|Overall Study|Sponsor Decision|1|||
105461375|NCT03224819|363702637|FG004|Overall Study|Sponsor Decision|1|||
105461376|NCT03224819|363702638|FG005|Overall Study|Sponsor Decision|2|||
105785086|NCT01241591|364866375|FG003|Overall Study|Other|1|||
105785087|NCT01241591|364866372|FG000|Overall Study|Adverse Event|3|||
105785088|NCT01241591|364866373|FG001|Overall Study|Adverse Event|11|||
105785089|NCT01241591|364866374|FG002|Overall Study|Adverse Event|12|||
105785090|NCT01241591|364866375|FG003|Overall Study|Adverse Event|4|||
105785091|NCT01798056|364866376|FG000|Overall Study|Serious Adverse Event|13|||
105785092|NCT01798056|364866377|FG001|Overall Study|Serious Adverse Event|12|||
105785093|NCT01798056|364866376|FG000|Overall Study|Withdrawal by Subject|12|||
105785094|NCT01798056|364866377|FG001|Overall Study|Withdrawal by Subject|9|||
105785095|NCT01798056|364866376|FG000|Overall Study|Migrated/moved from study area|1|||
105785096|NCT01798056|364866377|FG001|Overall Study|Migrated/moved from study area|1|||
105785097|NCT01798056|364866376|FG000|Overall Study|Lost to Follow-up|1|||
105785098|NCT01798056|364866377|FG001|Overall Study|Lost to Follow-up|1|||
105785099|NCT01798056|364866376|FG000|Overall Study|Other|0|||
105785100|NCT01798056|364866377|FG001|Overall Study|Other|2|||
105662562|NCT01340014|364428196|FG000|Period 1, First 7 Days|Adverse Event|1|||
105662563|NCT01340014|364428197|FG001|Period 1, First 7 Days|Adverse Event|0|||
105662564|NCT01340014|364428196|FG000|Period 1, First 7 Days|Personal Reasons|1|||
105662565|NCT01340014|364428197|FG001|Period 1, First 7 Days|Personal Reasons|0|||
105662566|NCT01340014|364428196|FG000|Period 2, Second 7 Days|Adverse Event|0|||
105662567|NCT01340014|364428197|FG001|Period 2, Second 7 Days|Adverse Event|1|||
105662568|NCT01053247|364429951|FG000|Overall Study|Withdrawal by Subject|9|||
105662569|NCT01053247|364429952|FG001|Overall Study|Withdrawal by Subject|4|||
105662570|NCT01053247|364429953|FG002|Overall Study|Withdrawal by Subject|15|||
105662571|NCT01053247|364429951|FG000|Overall Study|Lack of Efficacy|1|||
105662572|NCT01053247|364429952|FG001|Overall Study|Lack of Efficacy|0|||
105662573|NCT01053247|364429953|FG002|Overall Study|Lack of Efficacy|1|||
105662574|NCT01053247|364429951|FG000|Overall Study|Protocol Violation|2|||
105662575|NCT01053247|364429952|FG001|Overall Study|Protocol Violation|1|||
105662576|NCT01053247|364429953|FG002|Overall Study|Protocol Violation|2|||
105662577|NCT01053247|364429951|FG000|Overall Study|Lost to Follow-up|8|||
105662578|NCT01053247|364429952|FG001|Overall Study|Lost to Follow-up|5|||
105662579|NCT01053247|364429953|FG002|Overall Study|Lost to Follow-up|7|||
105662580|NCT01053247|364429951|FG000|Overall Study|Adverse Event|0|||
105662581|NCT01053247|364429952|FG001|Overall Study|Adverse Event|9|||
105662582|NCT01053247|364429953|FG002|Overall Study|Adverse Event|3|||
105662583|NCT02354651|364429954|FG000|Overall Study|Withdrawal by Subject|2|||
105662584|NCT02354651|364429954|FG000|Overall Study|Physician Decision|1|||
105662585|NCT01266018|364429958|FG000|Overall Study|Physician Decision|1|||
105662586|NCT01266018|364429959|FG001|Overall Study|Physician Decision|0|||
105662587|NCT01266018|364429958|FG000|Overall Study|Progressive disease|0|||
105662588|NCT01266018|364429959|FG001|Overall Study|Progressive disease|1|||
105662589|NCT01458522|364429960|FG000|Overall Study|Withdrawal by Subject|2|||
105662590|NCT01458522|364429961|FG001|Overall Study|Withdrawal by Subject|2|||
105662591|NCT01458522|364429960|FG000|Overall Study|Physician Decision|1|||
105662592|NCT01458522|364429961|FG001|Overall Study|Physician Decision|9|||
105662593|NCT02684123|364429962|FG000|Phase 1|Lack of Efficacy|5|||
105662594|NCT02684123|364429963|FG001|Phase 1|Lack of Efficacy|0|||
105662595|NCT02684123|364429962|FG000|Phase 1|Adverse Event|3|||
105662596|NCT02684123|364429963|FG001|Phase 1|Adverse Event|0|||
105662597|NCT02684123|364429962|FG000|Phase 1|Lost to Follow-up|0|||
105662598|NCT02684123|364429963|FG001|Phase 1|Lost to Follow-up|1|||
105662599|NCT02684123|364429962|FG000|Phase 2|Lack of Efficacy|1|||
105662600|NCT02684123|364429963|FG001|Phase 2|Lack of Efficacy|8|||
105662601|NCT00589303|364429970|FG000|Overall Study|Withdrawal by Subject|2|||
105662602|NCT00589303|364429971|FG001|Overall Study|Withdrawal by Subject|1|||
105662603|NCT03382561|364429972|FG000|Overall Study|Disease progression|47|||
105662604|NCT03382561|364429973|FG001|Overall Study|Disease progression|6|||
105662605|NCT03382561|364429972|FG000|Overall Study|Adverse Event|10|||
105662606|NCT03382561|364429973|FG001|Overall Study|Adverse Event|2|||
105662607|NCT03382561|364429972|FG000|Overall Study|Death|8|||
105662608|NCT03382561|364429973|FG001|Overall Study|Death|3|||
105662609|NCT03382561|364429972|FG000|Overall Study|Withdrawal by Subject|6|||
105662610|NCT03382561|364429973|FG001|Overall Study|Withdrawal by Subject|5|||
105662611|NCT03382561|364429972|FG000|Overall Study|Alternative therapy|2|||
105662612|NCT03382561|364429973|FG001|Overall Study|Alternative therapy|8|||
105662613|NCT03382561|364429972|FG000|Overall Study|Never started treatment|3|||
105662614|NCT03382561|364429973|FG001|Overall Study|Never started treatment|6|||
105662615|NCT03382561|364429972|FG000|Overall Study|Lack of Efficacy|0|||
105662616|NCT03382561|364429973|FG001|Overall Study|Lack of Efficacy|1|||
105662617|NCT03382561|364429972|FG000|Overall Study|Physician Decision|0|||
105662618|NCT03382561|364429973|FG001|Overall Study|Physician Decision|1|||
105662619|NCT03382561|364429972|FG000|Overall Study|Other complicating disease|0|||
105662620|NCT03382561|364429973|FG001|Overall Study|Other complicating disease|1|||
105662621|NCT02635360|364429974|FG000|Overall Study|Adverse Event|0|||
105662622|NCT02635360|364429975|FG001|Overall Study|Adverse Event|3|||
105662623|NCT02635360|364429974|FG000|Overall Study|Withdrawal by Subject|2|||
105662624|NCT02635360|364429975|FG001|Overall Study|Withdrawal by Subject|0|||
105662625|NCT02635360|364429974|FG000|Overall Study|Non-Compliance|3|||
105662626|NCT02635360|364429975|FG001|Overall Study|Non-Compliance|1|||
105662627|NCT02635360|364429974|FG000|Overall Study|Disease Progression|0|||
105662628|NCT02635360|364429975|FG001|Overall Study|Disease Progression|2|||
105662629|NCT02635360|364429974|FG000|Overall Study|Lost to Follow-up|1|||
105662630|NCT02635360|364429975|FG001|Overall Study|Lost to Follow-up|1|||
105662631|NCT00334542|364429976|FG000|Overall Study|Adverse Event|3|||
105662632|NCT00334542|364429976|FG000|Overall Study|Withdrawal by Subject|1|||
105662633|NCT00334542|364429976|FG000|Overall Study|New cancer diagnosis|1|||
105662634|NCT02370251|364429977|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
105662635|NCT02370251|364429977|FG000|Overall Study|Death|4|||
105662636|NCT00592293|364429979|FG000|Overall Study|Withdrawal by Subject|1|||
105662637|NCT02094898|364429983|FG000|Overall Study|Clinical Worsening|2|||
105662638|NCT02094898|364429983|FG000|Overall Study|Adverse Event|2|||
105662639|NCT02094898|364429983|FG000|Overall Study|Lack of Efficacy|1|||
105662640|NCT03520075|364429984|FG000|Phase 1 (Dose Escalation)|Death|2|||
105662641|NCT03520075|364429985|FG001|Phase 1 (Dose Escalation)|Death|2|||
105461377|NCT03224819|363702639|FG006|Overall Study|Sponsor Decision|1|||
105461378|NCT03224819|363702640|FG007|Overall Study|Sponsor Decision|1|||
105461379|NCT03224819|363702641|FG008|Overall Study|Sponsor Decision|1|||
105461380|NCT03224819|363702642|FG009|Overall Study|Sponsor Decision|2|||
105461381|NCT03224819|363702643|FG010|Overall Study|Sponsor Decision|1|||
105461382|NCT03224819|363702644|FG011|Overall Study|Sponsor Decision|1|||
105461383|NCT03224819|363702645|FG012|Overall Study|Sponsor Decision|1|||
105461384|NCT03224819|363702646|FG013|Overall Study|Sponsor Decision|0|||
105461385|NCT03224819|363702633|FG000|Overall Study|Lost to Follow-up|0|||
105461386|NCT03224819|363702634|FG001|Overall Study|Lost to Follow-up|0|||
105461387|NCT03224819|363702635|FG002|Overall Study|Lost to Follow-up|0|||
105461388|NCT03224819|363702636|FG003|Overall Study|Lost to Follow-up|0|||
105461389|NCT03224819|363702637|FG004|Overall Study|Lost to Follow-up|0|||
105461390|NCT03224819|363702638|FG005|Overall Study|Lost to Follow-up|0|||
105461391|NCT03224819|363702639|FG006|Overall Study|Lost to Follow-up|0|||
105461392|NCT03224819|363702640|FG007|Overall Study|Lost to Follow-up|0|||
105461393|NCT03224819|363702641|FG008|Overall Study|Lost to Follow-up|1|||
105461394|NCT03224819|363702642|FG009|Overall Study|Lost to Follow-up|0|||
105461395|NCT03224819|363702643|FG010|Overall Study|Lost to Follow-up|0|||
105461396|NCT03224819|363702644|FG011|Overall Study|Lost to Follow-up|0|||
105461397|NCT03224819|363702645|FG012|Overall Study|Lost to Follow-up|0|||
105461398|NCT03224819|363702646|FG013|Overall Study|Lost to Follow-up|0|||
105461399|NCT03224819|363702633|FG000|Overall Study|Death|0|||
105338762|NCT01340027|363241180|FG003|Overall Study|Miscellaneous|1|||
105338763|NCT01340027|363241181|FG004|Overall Study|Miscellaneous|0|||
105461400|NCT03224819|363702634|FG001|Overall Study|Death|1|||
105461401|NCT03224819|363702635|FG002|Overall Study|Death|0|||
105461402|NCT03224819|363702636|FG003|Overall Study|Death|0|||
105461403|NCT03224819|363702637|FG004|Overall Study|Death|0|||
105461404|NCT03224819|363702638|FG005|Overall Study|Death|0|||
105461405|NCT03224819|363702639|FG006|Overall Study|Death|0|||
105461406|NCT03224819|363702640|FG007|Overall Study|Death|1|||
105461407|NCT03224819|363702641|FG008|Overall Study|Death|0|||
105461408|NCT03224819|363702642|FG009|Overall Study|Death|0|||
105461409|NCT03224819|363702643|FG010|Overall Study|Death|0|||
105461410|NCT03224819|363702644|FG011|Overall Study|Death|1|||
105461411|NCT03224819|363702645|FG012|Overall Study|Death|0|||
105461412|NCT03224819|363702646|FG013|Overall Study|Death|0|||
105461413|NCT03783078|363702647|FG000|Overall Study|Death|31|||
105461414|NCT03783078|363702647|FG000|Overall Study|Sponsor Decision|23|||
105461415|NCT03783078|363702647|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105461416|NCT04973449|363702650|FG000|Overall Study|Withdrawal by Subject|3|||
105461417|NCT04973449|363702651|FG001|Overall Study|Withdrawal by Subject|3|||
105461418|NCT04973449|363702652|FG002|Overall Study|Withdrawal by Subject|2|||
105461419|NCT04973449|363702653|FG003|Overall Study|Withdrawal by Subject|5|||
105461420|NCT04973449|363702654|FG004|Overall Study|Withdrawal by Subject|5|||
105461421|NCT04973449|363702655|FG005|Overall Study|Withdrawal by Subject|4|||
105461422|NCT04973449|363702656|FG006|Overall Study|Withdrawal by Subject|7|||
105461423|NCT04973449|363702657|FG007|Overall Study|Withdrawal by Subject|5|||
105461424|NCT04973449|363702650|FG000|Overall Study|Lost to Follow-up|15|||
105461425|NCT04973449|363702651|FG001|Overall Study|Lost to Follow-up|16|||
105461426|NCT04973449|363702652|FG002|Overall Study|Lost to Follow-up|16|||
105461427|NCT04973449|363702653|FG003|Overall Study|Lost to Follow-up|13|||
105461428|NCT04973449|363702654|FG004|Overall Study|Lost to Follow-up|5|||
105461429|NCT04973449|363702655|FG005|Overall Study|Lost to Follow-up|6|||
105461430|NCT04973449|363702656|FG006|Overall Study|Lost to Follow-up|10|||
105461431|NCT04973449|363702657|FG007|Overall Study|Lost to Follow-up|6|||
105461432|NCT04973449|363702650|FG000|Overall Study|Death|1|||
105461433|NCT04973449|363702651|FG001|Overall Study|Death|0|||
105461434|NCT04973449|363702652|FG002|Overall Study|Death|0|||
105461435|NCT04973449|363702653|FG003|Overall Study|Death|0|||
105461436|NCT04973449|363702654|FG004|Overall Study|Death|0|||
105461437|NCT04973449|363702655|FG005|Overall Study|Death|1|||
105461438|NCT04973449|363702656|FG006|Overall Study|Death|0|||
105461439|NCT04973449|363702657|FG007|Overall Study|Death|0|||
105461440|NCT04973449|363702650|FG000|Overall Study|Other|1|||
105461441|NCT04973449|363702651|FG001|Overall Study|Other|1|||
105461442|NCT04973449|363702652|FG002|Overall Study|Other|2|||
105461443|NCT04973449|363702653|FG003|Overall Study|Other|1|||
105461444|NCT04973449|363702654|FG004|Overall Study|Other|4|||
105338764|NCT01340027|363241182|FG005|Overall Study|Miscellaneous|0|||
105338765|NCT01340027|363241183|FG006|Overall Study|Miscellaneous|0|||
105461445|NCT04973449|363702655|FG005|Overall Study|Other|0|||
105461446|NCT04973449|363702656|FG006|Overall Study|Other|2|||
105461447|NCT04973449|363702657|FG007|Overall Study|Other|2|||
105461448|NCT02651675|363702658|FG000|Overall Study|Death|0|||
105461449|NCT02651675|363702659|FG001|Overall Study|Death|0|||
105461450|NCT02651675|363702660|FG002|Overall Study|Death|1|||
105461451|NCT03674411|363702661|FG000|Overall Study|Non-treatment|4|||
105461452|NCT00474812|363702662|FG000|Overall Study|Withdrawal by Subject|5|||
105461453|NCT00474812|363702662|FG000|Overall Study|No Initiation of treatment|2|||
105461454|NCT01506596|363702665|FG000|Overall Study|ineligible pathology|1|||
105461455|NCT00771758|363702667|FG000|Overall Study|Adverse Event|2|||
105461456|NCT00771758|363702668|FG001|Overall Study|Adverse Event|8|||
105461457|NCT00771758|363702669|FG002|Overall Study|Adverse Event|1|||
105461458|NCT00771758|363702667|FG000|Overall Study|Lack of Efficacy|0|||
105461459|NCT00771758|363702668|FG001|Overall Study|Lack of Efficacy|2|||
105461460|NCT00771758|363702669|FG002|Overall Study|Lack of Efficacy|1|||
105461461|NCT00771758|363702667|FG000|Overall Study|Lost to Follow-up|1|||
105461462|NCT00771758|363702668|FG001|Overall Study|Lost to Follow-up|0|||
105461463|NCT00771758|363702669|FG002|Overall Study|Lost to Follow-up|0|||
105461464|NCT00771758|363702667|FG000|Overall Study|Protocol Violation|1|||
105461465|NCT00771758|363702668|FG001|Overall Study|Protocol Violation|0|||
105461466|NCT00771758|363702669|FG002|Overall Study|Protocol Violation|0|||
105461467|NCT00771758|363702667|FG000|Overall Study|Withdrawal by Subject|1|||
105461468|NCT00771758|363702668|FG001|Overall Study|Withdrawal by Subject|0|||
105461469|NCT00771758|363702669|FG002|Overall Study|Withdrawal by Subject|0|||
105461470|NCT00771758|363702667|FG000|Overall Study|Other|3|||
105461471|NCT00771758|363702668|FG001|Overall Study|Other|2|||
105461472|NCT00771758|363702669|FG002|Overall Study|Other|0|||
105461473|NCT00935584|363702670|FG000|Overall Study|Withdrawal by Subject|9|||
105461474|NCT00935584|363702671|FG001|Overall Study|Withdrawal by Subject|0|||
105461475|NCT00935584|363702670|FG000|Overall Study|Death|3|||
105461476|NCT00935584|363702671|FG001|Overall Study|Death|0|||
105461477|NCT00935584|363702670|FG000|Overall Study|Lost to Follow-up|8|||
105461478|NCT00935584|363702671|FG001|Overall Study|Lost to Follow-up|0|||
105461479|NCT00935584|363702670|FG000|Overall Study|No show|9|||
105461480|NCT00935584|363702671|FG001|Overall Study|No show|0|||
105461481|NCT00935584|363702670|FG000|Overall Study|Relocated|3|||
105461482|NCT00935584|363702671|FG001|Overall Study|Relocated|0|||
105461483|NCT00935584|363702670|FG000|Overall Study|Patient changed provider|3|||
105461484|NCT00935584|363702671|FG001|Overall Study|Patient changed provider|0|||
105461485|NCT00935584|363702670|FG000|Overall Study|Provider dropped out of study|14|||
105461486|NCT00935584|363702671|FG001|Overall Study|Provider dropped out of study|4|||
105461487|NCT05408429|363702685|FG000|Overall Study|Lost to Follow-up|1|||
105461488|NCT05408429|363702686|FG001|Overall Study|Lost to Follow-up|1|||
105461489|NCT05408429|363702687|FG002|Overall Study|Lost to Follow-up|0|||
105461490|NCT05408429|363702685|FG000|Overall Study|Withdrawal by Subject|5|||
105461491|NCT05408429|363702686|FG001|Overall Study|Withdrawal by Subject|0|||
105461492|NCT05408429|363702687|FG002|Overall Study|Withdrawal by Subject|1|||
105461493|NCT05972993|363702690|FG000|Overall Study|Lost to Follow-up|2|||
105461494|NCT05972993|363702691|FG001|Overall Study|Lost to Follow-up|0|||
105461495|NCT05972993|363702692|FG002|Overall Study|Lost to Follow-up|1|||
105461496|NCT05972993|363702693|FG003|Overall Study|Lost to Follow-up|0|||
105461497|NCT05972993|363702694|FG004|Overall Study|Lost to Follow-up|0|||
105461498|NCT05972993|363702695|FG005|Overall Study|Lost to Follow-up|0|||
105461499|NCT05972993|363702696|FG006|Overall Study|Lost to Follow-up|0|||
105461500|NCT05972993|363702697|FG007|Overall Study|Lost to Follow-up|2|||
105461501|NCT05972993|363702698|FG008|Overall Study|Lost to Follow-up|0|||
105461502|NCT05565742|363702708|FG000|Overall Study|Withdrawal by Subject|0|||
105461503|NCT05565742|363702709|FG001|Overall Study|Withdrawal by Subject|0|||
105461504|NCT05565742|363702710|FG002|Overall Study|Withdrawal by Subject|2|||
105461505|NCT05565742|363702711|FG003|Overall Study|Withdrawal by Subject|2|||
105461506|NCT05565742|363702712|FG004|Overall Study|Withdrawal by Subject|2|||
105461507|NCT05565742|363702708|FG000|Overall Study|Death|1|||
105338766|NCT01340027|363241184|FG007|Overall Study|Miscellaneous|0|||
105461508|NCT05565742|363702709|FG001|Overall Study|Death|0|||
105461509|NCT05565742|363702710|FG002|Overall Study|Death|0|||
105461510|NCT05565742|363702711|FG003|Overall Study|Death|0|||
105461511|NCT05565742|363702712|FG004|Overall Study|Death|0|||
105461512|NCT05565742|363702708|FG000|Overall Study|Participant Travelled Abroad|0|||
105461513|NCT05565742|363702709|FG001|Overall Study|Participant Travelled Abroad|0|||
105461514|NCT05565742|363702710|FG002|Overall Study|Participant Travelled Abroad|0|||
105461515|NCT05565742|363702711|FG003|Overall Study|Participant Travelled Abroad|0|||
105461516|NCT05565742|363702712|FG004|Overall Study|Participant Travelled Abroad|1|||
105461517|NCT01231906|363702713|FG000|Overall Study|Lack of Efficacy|75|||
105461518|NCT01231906|363702714|FG001|Overall Study|Lack of Efficacy|68|||
105461519|NCT01231906|363702713|FG000|Overall Study|Lost to Follow-up|1|||
105461520|NCT01231906|363702714|FG001|Overall Study|Lost to Follow-up|0|||
105461521|NCT01231906|363702713|FG000|Overall Study|Physician Decision|34|||
105461522|NCT01231906|363702714|FG001|Overall Study|Physician Decision|24|||
105461523|NCT01231906|363702713|FG000|Overall Study|Withdrawal by Subject|0|||
105461524|NCT01231906|363702714|FG001|Overall Study|Withdrawal by Subject|4|||
105461525|NCT01231906|363702713|FG000|Overall Study|Ineligible|10|||
105461526|NCT01231906|363702714|FG001|Overall Study|Ineligible|3|||
105461527|NCT01231906|363702713|FG000|Overall Study|No treatment|1|||
105461528|NCT01231906|363702714|FG001|Overall Study|No treatment|2|||
105461529|NCT02681523|363702717|FG000|Overall Study|Adverse Event|1|||
105461530|NCT02681523|363702717|FG000|Overall Study|Patient Non-compliance|1|||
105461531|NCT04988477|363702721|FG000|Overall Study|Death|1|||
105461532|NCT04988477|363702722|FG001|Overall Study|Death|0|||
105461533|NCT04988477|363702723|FG002|Overall Study|Death|0|||
105461534|NCT04988477|363702721|FG000|Overall Study|Lost to Follow-up|5|||
105461535|NCT04988477|363702722|FG001|Overall Study|Lost to Follow-up|2|||
105461536|NCT04988477|363702723|FG002|Overall Study|Lost to Follow-up|0|||
105461537|NCT04988477|363702721|FG000|Overall Study|Withdrawal by Subject|2|||
105461538|NCT04988477|363702722|FG001|Overall Study|Withdrawal by Subject|0|||
105461539|NCT04988477|363702723|FG002|Overall Study|Withdrawal by Subject|0|||
105461540|NCT02318706|363704069|FG000|Double-blind Phase|Adverse Event|7|||
105461541|NCT02318706|363704070|FG001|Double-blind Phase|Adverse Event|4|||
105461542|NCT02318706|363704071|FG002|Double-blind Phase|Adverse Event|3|||
105461543|NCT02318706|363704072|FG003|Double-blind Phase|Adverse Event|10|||
105461544|NCT02318706|363704073|FG004|Double-blind Phase|Adverse Event|0|||
105461545|NCT02318706|363704069|FG000|Double-blind Phase|Lost to Follow-up|1|||
105461546|NCT02318706|363704070|FG001|Double-blind Phase|Lost to Follow-up|0|||
105461547|NCT02318706|363704071|FG002|Double-blind Phase|Lost to Follow-up|0|||
105461548|NCT02318706|363704072|FG003|Double-blind Phase|Lost to Follow-up|0|||
105461549|NCT02318706|363704073|FG004|Double-blind Phase|Lost to Follow-up|0|||
105461550|NCT02318706|363704069|FG000|Double-blind Phase|Protocol Violation|4|||
105461551|NCT02318706|363704070|FG001|Double-blind Phase|Protocol Violation|2|||
105461552|NCT02318706|363704071|FG002|Double-blind Phase|Protocol Violation|4|||
105461553|NCT02318706|363704072|FG003|Double-blind Phase|Protocol Violation|3|||
105461554|NCT02318706|363704073|FG004|Double-blind Phase|Protocol Violation|0|||
105461555|NCT02318706|363704069|FG000|Double-blind Phase|Withdrawal by Subject|9|||
105461556|NCT02318706|363704070|FG001|Double-blind Phase|Withdrawal by Subject|5|||
105461557|NCT02318706|363704071|FG002|Double-blind Phase|Withdrawal by Subject|7|||
105461558|NCT02318706|363704072|FG003|Double-blind Phase|Withdrawal by Subject|10|||
105461559|NCT02318706|363704073|FG004|Double-blind Phase|Withdrawal by Subject|0|||
105461560|NCT02318706|363704069|FG000|Double-blind Phase|Other|4|||
105461561|NCT02318706|363704070|FG001|Double-blind Phase|Other|1|||
105461562|NCT02318706|363704071|FG002|Double-blind Phase|Other|2|||
105461563|NCT02318706|363704072|FG003|Double-blind Phase|Other|1|||
105461564|NCT02318706|363704073|FG004|Double-blind Phase|Other|0|||
105461565|NCT02318706|363704069|FG000|Double-blind Phase|Death|0|||
105461566|NCT02318706|363704070|FG001|Double-blind Phase|Death|0|||
105461567|NCT02318706|363704071|FG002|Double-blind Phase|Death|2|||
105461568|NCT02318706|363704072|FG003|Double-blind Phase|Death|0|||
105461569|NCT02318706|363704073|FG004|Double-blind Phase|Death|0|||
105461570|NCT02318706|363704069|FG000|Open-label Extension Phase|Adverse Event|0|||
105461571|NCT02318706|363704070|FG001|Open-label Extension Phase|Adverse Event|0|||
105461572|NCT02318706|363704071|FG002|Open-label Extension Phase|Adverse Event|0|||
105461573|NCT02318706|363704072|FG003|Open-label Extension Phase|Adverse Event|0|||
105461574|NCT02318706|363704073|FG004|Open-label Extension Phase|Adverse Event|21|||
105461575|NCT02318706|363704069|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
105461576|NCT02318706|363704070|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
105461577|NCT02318706|363704071|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
105461578|NCT02318706|363704072|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
105461579|NCT02318706|363704073|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
105461580|NCT02318706|363704069|FG000|Open-label Extension Phase|Death|0|||
105461581|NCT02318706|363704070|FG001|Open-label Extension Phase|Death|0|||
105461582|NCT02318706|363704071|FG002|Open-label Extension Phase|Death|0|||
105461583|NCT02318706|363704072|FG003|Open-label Extension Phase|Death|0|||
105461584|NCT02318706|363704073|FG004|Open-label Extension Phase|Death|1|||
105461585|NCT02318706|363704069|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
105461586|NCT02318706|363704070|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
105461587|NCT02318706|363704071|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
105461588|NCT02318706|363704072|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
105461589|NCT02318706|363704073|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
105461590|NCT00906204|363704076|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
105461591|NCT00906204|363704077|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
105461592|NCT00906204|363704076|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
105461593|NCT00906204|363704077|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
105461594|NCT00906204|363704076|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
105461595|NCT00906204|363704077|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
105662642|NCT03520075|364429986|FG002|Phase 1 (Dose Escalation)|Death|3|||
105338767|NCT01340027|363241185|FG008|Overall Study|Miscellaneous|0|||
105338768|NCT01340027|363241186|FG009|Overall Study|Miscellaneous|0|||
105338769|NCT01340027|363241187|FG010|Overall Study|Miscellaneous|1|||
105338770|NCT01340027|363241188|FG011|Overall Study|Miscellaneous|0|||
105338771|NCT01758731|363241189|FG000|Overall Study|Physician Decision|1|||
105338772|NCT05238025|363241190|FG000|Overall Study|Adverse Event|2|||
105338773|NCT05238025|363241191|FG001|Overall Study|Adverse Event|2|||
105338774|NCT05238025|363241190|FG000|Overall Study|Lost to Follow-up|334|||
105338775|NCT05238025|363241191|FG001|Overall Study|Lost to Follow-up|339|||
105338776|NCT05238025|363241190|FG000|Overall Study|Withdrawal by Subject|203|||
105338777|NCT05238025|363241191|FG001|Overall Study|Withdrawal by Subject|222|||
105338778|NCT05238025|363241190|FG000|Overall Study|Physician Decision|20|||
105338779|NCT05238025|363241191|FG001|Overall Study|Physician Decision|8|||
105338780|NCT05238025|363241190|FG000|Overall Study|Protocol Violation|6|||
105338781|NCT05238025|363241191|FG001|Overall Study|Protocol Violation|2|||
105338782|NCT05238025|363241190|FG000|Overall Study|Death|38|||
105338783|NCT05238025|363241191|FG001|Overall Study|Death|32|||
105338784|NCT05238025|363241190|FG000|Overall Study|Study terminated by Sponsor|6358|||
105338785|NCT05238025|363241191|FG001|Overall Study|Study terminated by Sponsor|6358|||
105338786|NCT05238025|363241190|FG000|Overall Study|Other Reason|669|||
105461596|NCT00906204|363704076|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
105461597|NCT00906204|363704077|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
105338787|NCT05238025|363241191|FG001|Overall Study|Other Reason|690|||
105338788|NCT03626363|363241195|FG000|Overall Study|Protocol Violation|4|||
105338789|NCT03626363|363241196|FG001|Overall Study|Protocol Violation|0|||
105338790|NCT03626363|363241195|FG000|Overall Study|Lost to Follow-up|5|||
105338791|NCT03626363|363241196|FG001|Overall Study|Lost to Follow-up|7|||
105662643|NCT03520075|364429987|FG003|Phase 1 (Dose Escalation)|Death|2|||
105662644|NCT03520075|364429988|FG004|Phase 1 (Dose Escalation)|Death|6|||
105662645|NCT03520075|364429989|FG005|Phase 1 (Dose Escalation)|Death|5|||
105662646|NCT03520075|364429990|FG006|Phase 1 (Dose Escalation)|Death|3|||
105662647|NCT03520075|364429991|FG007|Phase 1 (Dose Escalation)|Death|2|||
105662648|NCT03520075|364429992|FG008|Phase 1 (Dose Escalation)|Death|3|||
105662649|NCT03520075|364429993|FG009|Phase 1 (Dose Escalation)|Death|1|||
105662650|NCT03520075|364429994|FG010|Phase 1 (Dose Escalation)|Death|5|||
105662651|NCT03520075|364429995|FG011|Phase 1 (Dose Escalation)|Death|7|||
105662652|NCT03520075|364429996|FG012|Phase 1 (Dose Escalation)|Death|11|||
105662653|NCT03520075|364429997|FG013|Phase 1 (Dose Escalation)|Death|0|||
105662654|NCT03520075|364429998|FG014|Phase 1 (Dose Escalation)|Death|0|||
105662655|NCT03520075|364429999|FG015|Phase 1 (Dose Escalation)|Death|0|||
105662656|NCT03520075|364430000|FG016|Phase 1 (Dose Escalation)|Death|0|||
105662657|NCT03520075|364430001|FG017|Phase 1 (Dose Escalation)|Death|0|||
105662658|NCT03520075|364430002|FG018|Phase 1 (Dose Escalation)|Death|0|||
105662659|NCT03520075|364429984|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
105662660|NCT03520075|364429985|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662661|NCT03520075|364429986|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662662|NCT03520075|364429987|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
105662663|NCT03520075|364429988|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
105662664|NCT03520075|364429989|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
105662665|NCT03520075|364429990|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662666|NCT03520075|364429991|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
105662667|NCT03520075|364429992|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662668|NCT03520075|364429993|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
105662669|NCT03520075|364429994|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662670|NCT03520075|364429995|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662671|NCT03520075|364429996|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
105662672|NCT03520075|364429997|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662673|NCT03520075|364429998|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662674|NCT03520075|364429999|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662675|NCT03520075|364430000|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662676|NCT03520075|364430001|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662677|NCT03520075|364430002|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662678|NCT03520075|364429984|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662679|NCT03520075|364429985|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
105662680|NCT03520075|364429986|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662681|NCT03520075|364429987|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
105662682|NCT03520075|364429988|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
105662683|NCT03520075|364429989|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662684|NCT03520075|364429990|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662685|NCT03520075|364429991|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662686|NCT03520075|364429992|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662687|NCT03520075|364429993|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662688|NCT03520075|364429994|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
105662689|NCT03520075|364429995|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662690|NCT03520075|364429996|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
105662691|NCT03520075|364429997|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662692|NCT03520075|364429998|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662693|NCT03520075|364429999|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662694|NCT03520075|364430000|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662695|NCT03520075|364430001|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662696|NCT03520075|364430002|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662697|NCT03520075|364429984|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662698|NCT03520075|364429985|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662699|NCT03520075|364429986|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662700|NCT03520075|364429987|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105338792|NCT00533702|363241197|FG000|Overall Study|Withdrawal by Subject|3|||
105662701|NCT03520075|364429988|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662702|NCT03520075|364429989|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105785101|NCT05637515|364866378|FG000|Overall Study|Withdrawal by Subject|17|||
105785102|NCT05637515|364866379|FG001|Overall Study|Withdrawal by Subject|17|||
105785103|NCT01269346|364866380|FG000|Treatment Phase|Disease progression|3|||
105785104|NCT01269346|364866380|FG000|Treatment Phase|Adverse Event|3|||
105785105|NCT01269346|364866380|FG000|Treatment Phase|Withdrawal by Subject|1|||
105785106|NCT01269346|364866380|FG000|Treatment Phase|Other|2|||
105785107|NCT01269346|364866380|FG000|Extension Phase|Adverse Event|6|||
105785108|NCT01269346|364866380|FG000|Extension Phase|Withdrawal by Subject|4|||
105785109|NCT01269346|364866380|FG000|Extension Phase|Disease progression|22|||
105338793|NCT00533702|363241198|FG001|Overall Study|Withdrawal by Subject|1|||
105338794|NCT00533702|363241197|FG000|Overall Study|Found ineligible after randomization|2|||
105338795|NCT00533702|363241198|FG001|Overall Study|Found ineligible after randomization|1|||
105338796|NCT03395184|363241199|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
105338797|NCT03395184|363241200|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
105338798|NCT03395184|363241201|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
105338799|NCT03395184|363241202|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
105338800|NCT03395184|363241203|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
105338801|NCT03395184|363241204|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
105338802|NCT03395184|363241205|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
105338803|NCT03395184|363241199|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
105338804|NCT03395184|363241200|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
105461598|NCT00906204|363704076|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
105461599|NCT00906204|363704077|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
105461600|NCT04328077|363704078|FG000|Overall Study|Lost to Follow-up|0|||
105461601|NCT04328077|363704079|FG001|Overall Study|Lost to Follow-up|1|||
105461602|NCT04328077|363704080|FG002|Overall Study|Lost to Follow-up|0|||
105461603|NCT04328077|363704081|FG003|Overall Study|Lost to Follow-up|0|||
105461604|NCT04328077|363704078|FG000|Overall Study|Withdrawal by Subject|0|||
105461605|NCT04328077|363704079|FG001|Overall Study|Withdrawal by Subject|1|||
105461606|NCT04328077|363704080|FG002|Overall Study|Withdrawal by Subject|1|||
105461607|NCT04328077|363704081|FG003|Overall Study|Withdrawal by Subject|3|||
105461608|NCT05291520|363704082|FG000|Overall Study|Lost to Follow-up|0|||
105461609|NCT05291520|363704083|FG001|Overall Study|Lost to Follow-up|0|||
105461610|NCT05291520|363704084|FG002|Overall Study|Lost to Follow-up|1|||
105461611|NCT01347112|363704085|FG000|Overall Study|Withdrawal by Subject|1|||
105461612|NCT01347112|363704086|FG001|Overall Study|Withdrawal by Subject|7|||
105461613|NCT01347112|363704085|FG000|Overall Study|Lost to Follow-up|3|||
105461614|NCT01347112|363704086|FG001|Overall Study|Lost to Follow-up|5|||
105461615|NCT00696072|363704091|FG000|Overall Study|continuing active treatment|10|||
105461616|NCT00696072|363704092|FG001|Overall Study|continuing active treatment|13|||
105461617|NCT00696072|363704091|FG000|Overall Study|Adverse Event|10|||
105461618|NCT00696072|363704092|FG001|Overall Study|Adverse Event|6|||
105461619|NCT00696072|363704091|FG000|Overall Study|Patient Request|3|||
105461620|NCT00696072|363704092|FG001|Overall Study|Patient Request|7|||
105461621|NCT00696072|363704091|FG000|Overall Study|Investigator Request|1|||
105461622|NCT00696072|363704092|FG001|Overall Study|Investigator Request|4|||
105461623|NCT00696072|363704091|FG000|Overall Study|Sponsor Request|0|||
105461624|NCT00696072|363704092|FG001|Overall Study|Sponsor Request|1|||
105461625|NCT00696072|363704091|FG000|Overall Study|Disease Progression|32|||
105461626|NCT00696072|363704092|FG001|Overall Study|Disease Progression|30|||
105461627|NCT00696072|363704091|FG000|Overall Study|Non-specified|1|||
105461628|NCT00696072|363704092|FG001|Overall Study|Non-specified|2|||
105461629|NCT00148317|363704105|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
105461630|NCT00148317|363704105|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
105461631|NCT00148317|363704105|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
105461632|NCT04639245|363704106|FG000|Overall Study|Death|1|||
105461633|NCT02419001|363704107|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
105461634|NCT02419001|363704108|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
105461635|NCT02326155|363704109|FG000|Overall Study|Adverse Event|21|||
105461636|NCT02326155|363704110|FG001|Overall Study|Adverse Event|5|||
105461637|NCT02326155|363704109|FG000|Overall Study|Death|3|||
105461638|NCT02326155|363704110|FG001|Overall Study|Death|0|||
105461639|NCT02326155|363704109|FG000|Overall Study|Lack of Efficacy|49|||
105461640|NCT02326155|363704110|FG001|Overall Study|Lack of Efficacy|5|||
105461641|NCT02326155|363704109|FG000|Overall Study|Lost to Follow-up|14|||
105461642|NCT02326155|363704110|FG001|Overall Study|Lost to Follow-up|3|||
105662703|NCT03520075|364429990|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662704|NCT03520075|364429991|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662705|NCT03520075|364429992|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662706|NCT03520075|364429993|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
105662707|NCT03520075|364429994|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662708|NCT03520075|364429995|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662709|NCT03520075|364429996|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
105461643|NCT02326155|363704109|FG000|Overall Study|Protocol Violation|2|||
105461644|NCT02326155|363704110|FG001|Overall Study|Protocol Violation|0|||
105461645|NCT02326155|363704109|FG000|Overall Study|Withdrawal by Subject|34|||
105461646|NCT02326155|363704110|FG001|Overall Study|Withdrawal by Subject|11|||
105461647|NCT02326155|363704109|FG000|Overall Study|Disease progression|37|||
105461648|NCT02326155|363704110|FG001|Overall Study|Disease progression|4|||
105461649|NCT02326155|363704109|FG000|Overall Study|Study close|188|||
105461650|NCT02326155|363704110|FG001|Overall Study|Study close|21|||
105461651|NCT02326155|363704109|FG000|Overall Study|except for study close|46|||
105461652|NCT02326155|363704110|FG001|Overall Study|except for study close|13|||
105662710|NCT03520075|364429997|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662711|NCT03520075|364429998|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662712|NCT03520075|364429999|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662713|NCT03520075|364430000|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662714|NCT03520075|364430001|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662715|NCT03520075|364430002|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662716|NCT03520075|364429984|FG000|Phase 2 (Dose Expansion)|Death|0|||
105662717|NCT03520075|364429985|FG001|Phase 2 (Dose Expansion)|Death|0|||
105662718|NCT03520075|364429986|FG002|Phase 2 (Dose Expansion)|Death|0|||
105662719|NCT03520075|364429987|FG003|Phase 2 (Dose Expansion)|Death|0|||
105662720|NCT03520075|364429988|FG004|Phase 2 (Dose Expansion)|Death|0|||
105662721|NCT03520075|364429989|FG005|Phase 2 (Dose Expansion)|Death|0|||
105662722|NCT03520075|364429990|FG006|Phase 2 (Dose Expansion)|Death|0|||
105662723|NCT03520075|364429991|FG007|Phase 2 (Dose Expansion)|Death|0|||
105662724|NCT03520075|364429992|FG008|Phase 2 (Dose Expansion)|Death|0|||
105662725|NCT03520075|364429993|FG009|Phase 2 (Dose Expansion)|Death|0|||
105662726|NCT03520075|364429994|FG010|Phase 2 (Dose Expansion)|Death|0|||
105662727|NCT03520075|364429995|FG011|Phase 2 (Dose Expansion)|Death|0|||
105662728|NCT03520075|364429996|FG012|Phase 2 (Dose Expansion)|Death|0|||
105662729|NCT03520075|364429997|FG013|Phase 2 (Dose Expansion)|Death|20|||
105662730|NCT03520075|364429998|FG014|Phase 2 (Dose Expansion)|Death|13|||
105662731|NCT03520075|364429999|FG015|Phase 2 (Dose Expansion)|Death|9|||
105662732|NCT03520075|364430000|FG016|Phase 2 (Dose Expansion)|Death|5|||
105662733|NCT03520075|364430001|FG017|Phase 2 (Dose Expansion)|Death|14|||
105662734|NCT03520075|364430002|FG018|Phase 2 (Dose Expansion)|Death|12|||
105662735|NCT03520075|364429984|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662736|NCT03520075|364429985|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662737|NCT03520075|364429986|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662738|NCT03520075|364429987|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662739|NCT03520075|364429988|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662740|NCT03520075|364429989|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662741|NCT03520075|364429990|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662742|NCT03520075|364429991|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662743|NCT03520075|364429992|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662744|NCT03520075|364429993|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662745|NCT03520075|364429994|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662746|NCT03520075|364429995|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662747|NCT03520075|364429996|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662748|NCT03520075|364429997|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662749|NCT03520075|364429998|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
105662750|NCT03520075|364429999|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
105662751|NCT03520075|364430000|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
105662752|NCT03520075|364430001|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
105662753|NCT03520075|364430002|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
105662754|NCT03520075|364429984|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662755|NCT03520075|364429985|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662756|NCT03520075|364429986|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662757|NCT03520075|364429987|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662758|NCT03520075|364429988|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662759|NCT03520075|364429989|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662760|NCT03520075|364429990|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662761|NCT03520075|364429991|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662762|NCT03520075|364429992|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662763|NCT03520075|364429993|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662764|NCT03520075|364429994|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662765|NCT03520075|364429995|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662766|NCT03520075|364429996|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105461653|NCT01209689|363704111|FG000|Overall Study|Insufficient Therapeutic Response|7|||
105461654|NCT01209689|363704112|FG001|Overall Study|Insufficient Therapeutic Response|2|||
105461655|NCT01209689|363704111|FG000|Overall Study|Refused Treatment|8|||
105461656|NCT01209689|363704112|FG001|Overall Study|Refused Treatment|3|||
105461657|NCT01209689|363704111|FG000|Overall Study|Adverse Event|4|||
105461658|NCT01209689|363704112|FG001|Overall Study|Adverse Event|0|||
105461659|NCT01209689|363704111|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
105461660|NCT01209689|363704112|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
105461661|NCT01209689|363704111|FG000|Overall Study|Failure to Return|3|||
105461662|NCT01209689|363704112|FG001|Overall Study|Failure to Return|0|||
105461663|NCT01209689|363704111|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
105461664|NCT01209689|363704112|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
105461665|NCT03591406|363704113|FG000|Overall Study|Adverse Event|5|||
105461666|NCT03591406|363704114|FG001|Overall Study|Adverse Event|3|||
105461667|NCT03591406|363704113|FG000|Overall Study|Protocol Violation|2|||
105785110|NCT01269346|364866380|FG000|Extension Phase|Physician decision or participant choice|9|||
105338805|NCT03395184|363241201|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
105338806|NCT03395184|363241202|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
105338807|NCT03395184|363241203|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
105338808|NCT03395184|363241204|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
105338809|NCT03395184|363241205|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
105338810|NCT03395184|363241199|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
105338811|NCT03395184|363241200|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
105338812|NCT03395184|363241201|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
105338813|NCT03395184|363241202|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
105338814|NCT03395184|363241203|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
105338815|NCT03395184|363241204|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
105338816|NCT03395184|363241205|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
105338817|NCT03395184|363241199|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
105338818|NCT03395184|363241200|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
105785111|NCT01269346|364866380|FG000|Extension Phase|Clinical progression|1|||
105338819|NCT03395184|363241201|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
105338820|NCT03395184|363241202|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
105338821|NCT03395184|363241203|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
105338822|NCT03395184|363241204|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
105338823|NCT03395184|363241205|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
105338824|NCT03395184|363241199|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
105338825|NCT03395184|363241200|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105338826|NCT03395184|363241201|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
105338827|NCT03395184|363241202|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105338828|NCT03395184|363241203|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105338829|NCT03395184|363241204|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105338830|NCT03395184|363241205|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105338831|NCT03395184|363241199|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
105338832|NCT03395184|363241200|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
105338833|NCT03395184|363241201|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
105338834|NCT03395184|363241202|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
105338835|NCT03395184|363241203|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
105338836|NCT03395184|363241204|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
105338837|NCT03395184|363241205|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
105338838|NCT03395184|363241199|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
105338839|NCT03395184|363241200|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
105338840|NCT03395184|363241201|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
105338841|NCT03395184|363241202|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
105338842|NCT03395184|363241203|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
105338843|NCT03395184|363241204|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
105338844|NCT03395184|363241205|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
105338845|NCT03395184|363241199|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
105338846|NCT03395184|363241200|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
105338847|NCT03395184|363241201|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
105338848|NCT03395184|363241202|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
105338849|NCT03395184|363241203|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
105338850|NCT03395184|363241204|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
105338851|NCT03395184|363241205|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
105338852|NCT03395184|363241199|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
105338853|NCT03395184|363241200|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
105338854|NCT03395184|363241201|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
105338855|NCT03395184|363241202|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
105338856|NCT03395184|363241203|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
105338857|NCT03395184|363241204|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
105338858|NCT03395184|363241205|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
105338859|NCT03395184|363241199|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
105338860|NCT03395184|363241200|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
105461668|NCT03591406|363704114|FG001|Overall Study|Protocol Violation|1|||
105338861|NCT03395184|363241201|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
105338862|NCT03395184|363241202|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
105461669|NCT03591406|363704113|FG000|Overall Study|Withdrawal by Subject|0|||
105461670|NCT03591406|363704114|FG001|Overall Study|Withdrawal by Subject|5|||
105461671|NCT01083771|363704115|FG000|Overall Study|non-compliant|2|||
105461672|NCT01083771|363704115|FG000|Overall Study|Withdrawal by Subject|3|||
105461673|NCT00371150|363704121|FG000|Overall Study|Lost to Follow-up|3|||
105461674|NCT00371150|363704122|FG001|Overall Study|Lost to Follow-up|2|||
105461675|NCT02536976|363704123|FG000|Overall Study|Physician Decision|0|||
105461676|NCT02536976|363704124|FG001|Overall Study|Physician Decision|1|||
105785112|NCT01269346|364866380|FG000|Extension Phase|Started a prohibited con med|1|||
105785113|NCT00278473|364866381|FG000|Overall Study|drop out|4|||
105785114|NCT00278473|364866382|FG001|Overall Study|drop out|3|||
105785115|NCT04516291|364866383|FG000|Treatment Period (24 Weeks)|Other|1|||
105785116|NCT04516291|364866384|FG001|Treatment Period (24 Weeks)|Other|0|||
105785117|NCT04516291|364866385|FG002|Treatment Period (24 Weeks)|Other|0|||
105785118|NCT04516291|364866386|FG003|Treatment Period (24 Weeks)|Other|2|||
105785119|NCT04516291|364866387|FG004|Treatment Period (24 Weeks)|Other|2|||
105785120|NCT04516291|364866388|FG005|Treatment Period (24 Weeks)|Other|4|||
105785121|NCT04516291|364866389|FG006|Treatment Period (24 Weeks)|Other|2|||
105785122|NCT04516291|364866390|FG007|Treatment Period (24 Weeks)|Other|0|||
105785123|NCT04516291|364866383|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105785124|NCT04516291|364866384|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
105785125|NCT04516291|364866385|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
105662767|NCT03520075|364429997|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105785126|NCT04516291|364866386|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105785127|NCT04516291|364866387|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
105461677|NCT00804908|363704125|FG000|Overall Study|Other|115|||
105461678|NCT00804908|363704126|FG001|Overall Study|Other|116|||
105785128|NCT04516291|364866388|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105662768|NCT03520075|364429998|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
105662769|NCT03520075|364429999|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
105662770|NCT03520075|364430000|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662771|NCT03520075|364430001|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662772|NCT03520075|364430002|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
105662773|NCT03520075|364429984|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662774|NCT03520075|364429985|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662775|NCT03520075|364429986|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662776|NCT03520075|364429987|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662777|NCT03520075|364429988|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662778|NCT03520075|364429989|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662779|NCT03520075|364429990|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662780|NCT03520075|364429991|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662781|NCT03520075|364429992|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662782|NCT03520075|364429993|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662783|NCT03520075|364429994|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662784|NCT03520075|364429995|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662785|NCT03520075|364429996|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662786|NCT03520075|364429997|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
105662787|NCT03520075|364429998|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662788|NCT03520075|364429999|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662789|NCT03520075|364430000|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
105662790|NCT03520075|364430001|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
105662791|NCT03520075|364430002|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662792|NCT05144945|364430003|FG000|Overall Study|Withdrawal by Subject|1|||
105662793|NCT05144945|364430004|FG001|Overall Study|Withdrawal by Subject|0|||
105662794|NCT01432626|364430007|FG000|Overall Study|LV function recovered|2|||
105662795|NCT01432626|364430007|FG000|Overall Study|Withdrawal by Subject|2|||
105662796|NCT01432626|364430007|FG000|Overall Study|Only 1 image competed|2|||
105662797|NCT01432626|364430007|FG000|Overall Study|Imaging agent not available|1|||
105662798|NCT02536742|364430011|FG000|Overall Study|Did not start protocol therapy|1|||
105662799|NCT02536742|364430011|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
105662800|NCT01513330|364430012|FG000|SenSura Mio First,|Adverse Event|2|||
105785129|NCT04516291|364866389|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105785130|NCT04516291|364866390|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105785131|NCT04516291|364866383|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
105785132|NCT04516291|364866384|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
105785133|NCT04516291|364866385|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
105785134|NCT04516291|364866386|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
105662801|NCT01513330|364430013|FG001|SenSura Mio First,|Adverse Event|0|||
105662802|NCT01513330|364430012|FG000|SenSura Mio First,|Lack of Efficacy|0|||
105662803|NCT01513330|364430013|FG001|SenSura Mio First,|Lack of Efficacy|1|||
105662804|NCT01513330|364430012|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
105662805|NCT01513330|364430013|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
105662806|NCT01513330|364430012|FG000|SenSura Mio First,|Other|1|||
105662807|NCT01513330|364430013|FG001|SenSura Mio First,|Other|0|||
105662808|NCT01513330|364430012|FG000|Standard Care First,|Lack of Efficacy|2|||
105662809|NCT01513330|364430013|FG001|Standard Care First,|Lack of Efficacy|2|||
105662810|NCT01513330|364430012|FG000|Standard Care First,|Withdrawal by Subject|1|||
105662811|NCT01513330|364430013|FG001|Standard Care First,|Withdrawal by Subject|2|||
105662812|NCT01513330|364430012|FG000|Standard Care First,|Other|1|||
105662813|NCT01513330|364430013|FG001|Standard Care First,|Other|0|||
105662814|NCT05878873|364430014|FG000|Overall Study|Lost to Follow-up|2|||
105785135|NCT04516291|364866387|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
105785136|NCT04516291|364866388|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
105785137|NCT04516291|364866389|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
105785138|NCT04516291|364866390|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
105785139|NCT04516291|364866383|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105338863|NCT03395184|363241203|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
105338864|NCT03395184|363241204|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
105338865|NCT03395184|363241205|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
105338866|NCT03395184|363241199|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
105338867|NCT03395184|363241200|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
105338868|NCT03395184|363241201|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
105338869|NCT03395184|363241202|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
105338870|NCT03395184|363241203|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
105338871|NCT03395184|363241204|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
105338872|NCT03395184|363241205|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
105338873|NCT03395184|363241199|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
105338874|NCT03395184|363241200|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
105338875|NCT03395184|363241201|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
105338876|NCT03395184|363241202|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
105338877|NCT03395184|363241203|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
105338878|NCT03395184|363241204|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
105338879|NCT03395184|363241205|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
105338880|NCT05723328|363241209|FG000|Overall Study|Investigator's Decision|5|||
105338881|NCT05723328|363241210|FG001|Overall Study|Investigator's Decision|2|||
105338882|NCT00199797|363243495|FG000|Overall Study|Progressive Disease|1|||
105338883|NCT00199797|363243495|FG000|Overall Study|Adverse Event|1|||
105338884|NCT00199797|363243495|FG000|Overall Study|Physician Decision|1|||
105461679|NCT00804908|363704127|FG002|Overall Study|Other|114|||
105461680|NCT00321620|363704131|FG000|Overall Study|Death|269|||
105461681|NCT00321620|363704132|FG001|Overall Study|Death|294|||
105785140|NCT04516291|364866384|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105785141|NCT04516291|364866385|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105785142|NCT04516291|364866386|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105461682|NCT00321620|363704131|FG000|Overall Study|Withdrawal by Subject|164|||
105461683|NCT00321620|363704132|FG001|Overall Study|Withdrawal by Subject|147|||
105461684|NCT00321620|363704131|FG000|Overall Study|Disease progression|113|||
105461685|NCT00321620|363704132|FG001|Overall Study|Disease progression|117|||
105461686|NCT00321620|363704131|FG000|Overall Study|Adverse Event|43|||
105461687|NCT00321620|363704132|FG001|Overall Study|Adverse Event|56|||
105461688|NCT00321620|363704131|FG000|Overall Study|Lost to Follow-up|13|||
105461689|NCT00321620|363704132|FG001|Overall Study|Lost to Follow-up|9|||
105461690|NCT00321620|363704131|FG000|Overall Study|Physician Decision|4|||
105461691|NCT00321620|363704132|FG001|Overall Study|Physician Decision|1|||
105461692|NCT00321620|363704131|FG000|Overall Study|Noncompliance|14|||
105461693|NCT00321620|363704132|FG001|Overall Study|Noncompliance|7|||
105461694|NCT00321620|363704131|FG000|Overall Study|Protocol deviation|4|||
105461695|NCT00321620|363704132|FG001|Overall Study|Protocol deviation|3|||
105461696|NCT00321620|363704131|FG000|Overall Study|Ineligibility determined|2|||
105461697|NCT00321620|363704132|FG001|Overall Study|Ineligibility determined|3|||
105461698|NCT00321620|363704131|FG000|Overall Study|Participant request|75|||
105461699|NCT00321620|363704132|FG001|Overall Study|Participant request|52|||
105461700|NCT00321620|363704131|FG000|Overall Study|Other|42|||
105461701|NCT00321620|363704132|FG001|Overall Study|Other|33|||
105461702|NCT03337477|363704133|FG000|Overall Study|not categorized into the listed ones|11|||
105461703|NCT03337477|363704134|FG001|Overall Study|not categorized into the listed ones|9|||
105461704|NCT03337477|363704133|FG000|Overall Study|Withdrawal by Subject|0|||
105461705|NCT03337477|363704134|FG001|Overall Study|Withdrawal by Subject|1|||
105461706|NCT03337477|363704133|FG000|Overall Study|Death|0|||
105461707|NCT03337477|363704134|FG001|Overall Study|Death|1|||
105461708|NCT03337477|363704133|FG000|Overall Study|Lost to Follow-up|0|||
105461709|NCT03337477|363704134|FG001|Overall Study|Lost to Follow-up|2|||
105461710|NCT03819114|363704138|FG000|Overall Study|Protocol Violation|0|||
105461711|NCT03819114|363704139|FG001|Overall Study|Protocol Violation|1|||
105461712|NCT03819114|363704140|FG002|Overall Study|Protocol Violation|1|||
105461713|NCT03819114|363704141|FG003|Overall Study|Protocol Violation|0|||
105461714|NCT03819114|363704138|FG000|Overall Study|Lost to Follow-up|0|||
105461715|NCT03819114|363704139|FG001|Overall Study|Lost to Follow-up|0|||
105461716|NCT03819114|363704140|FG002|Overall Study|Lost to Follow-up|1|||
105461717|NCT03819114|363704141|FG003|Overall Study|Lost to Follow-up|0|||
105461718|NCT00408317|363704142|FG000|First Intervention Period|Adverse Event|0|||
105461719|NCT00408317|363704143|FG001|First Intervention Period|Adverse Event|1|||
105461720|NCT00408317|363704142|FG000|Second Intervention Period|Adverse Event|2|||
105461721|NCT00408317|363704143|FG001|Second Intervention Period|Adverse Event|0|||
105785143|NCT04516291|364866387|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105461722|NCT00408317|363704142|FG000|Second Intervention Period|Protocol Violation|0|||
105461723|NCT00408317|363704143|FG001|Second Intervention Period|Protocol Violation|1|||
105461724|NCT00408317|363704142|FG000|Second Intervention Period|Withdrawal of consent|0|||
105461725|NCT00408317|363704143|FG001|Second Intervention Period|Withdrawal of consent|1|||
105461726|NCT01747876|363704145|FG000|Overall Study|Adverse Event|1|||
105461727|NCT01747876|363704146|FG001|Overall Study|Adverse Event|0|||
105785144|NCT04516291|364866388|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105461728|NCT01747876|363704147|FG002|Overall Study|Adverse Event|2|||
105461729|NCT01747876|363704145|FG000|Overall Study|Withdrawal by Subject|0|||
105461730|NCT01747876|363704146|FG001|Overall Study|Withdrawal by Subject|1|||
105461731|NCT01747876|363704147|FG002|Overall Study|Withdrawal by Subject|1|||
105461732|NCT01747876|363704145|FG000|Overall Study|Disease progression|4|||
105461733|NCT01747876|363704146|FG001|Overall Study|Disease progression|13|||
105461734|NCT01747876|363704147|FG002|Overall Study|Disease progression|8|||
105461735|NCT01747876|363704145|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
105461736|NCT01747876|363704146|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
105461737|NCT01747876|363704147|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
105461738|NCT03822117|363704148|FG000|Overall Study|Death|18|||
105461739|NCT03822117|363704149|FG001|Overall Study|Death|17|||
105461740|NCT03822117|363704150|FG002|Overall Study|Death|12|||
105461741|NCT03822117|363704151|FG003|Overall Study|Death|4|||
105461742|NCT03822117|363704148|FG000|Overall Study|Lost to Follow-up|1|||
105461743|NCT03822117|363704149|FG001|Overall Study|Lost to Follow-up|2|||
105461744|NCT03822117|363704150|FG002|Overall Study|Lost to Follow-up|3|||
105461745|NCT03822117|363704151|FG003|Overall Study|Lost to Follow-up|0|||
105461746|NCT03822117|363704148|FG000|Overall Study|Study Terminated by Sponsor|25|||
105461747|NCT03822117|363704149|FG001|Overall Study|Study Terminated by Sponsor|11|||
105461748|NCT03822117|363704150|FG002|Overall Study|Study Terminated by Sponsor|6|||
105461749|NCT03822117|363704151|FG003|Overall Study|Study Terminated by Sponsor|0|||
105461750|NCT03822117|363704148|FG000|Overall Study|Withdrawal by Subject|4|||
105461751|NCT03822117|363704149|FG001|Overall Study|Withdrawal by Subject|0|||
105461752|NCT03822117|363704150|FG002|Overall Study|Withdrawal by Subject|3|||
105461753|NCT03822117|363704151|FG003|Overall Study|Withdrawal by Subject|0|||
105461754|NCT03822117|363704148|FG000|Overall Study|Disease Progression|1|||
105461755|NCT03822117|363704149|FG001|Overall Study|Disease Progression|2|||
105461756|NCT03822117|363704150|FG002|Overall Study|Disease Progression|1|||
105461757|NCT03822117|363704151|FG003|Overall Study|Disease Progression|0|||
105461758|NCT03822117|363704148|FG000|Overall Study|Never Returned to Hospital|0|||
105461759|NCT03822117|363704149|FG001|Overall Study|Never Returned to Hospital|0|||
105461760|NCT03822117|363704150|FG002|Overall Study|Never Returned to Hospital|1|||
105461761|NCT03822117|363704151|FG003|Overall Study|Never Returned to Hospital|0|||
105461762|NCT00914316|363704152|FG000|Phase 1|Physician Decision|4|||
105461763|NCT00914316|363704153|FG001|Phase 1|Physician Decision|0|||
105461764|NCT00914316|363704154|FG002|Phase 1|Physician Decision|1|||
105461765|NCT00914316|363704155|FG003|Phase 1|Physician Decision|2|||
105461766|NCT00914316|363704152|FG000|Phase 1|Withdrawal by Subject|0|||
105461767|NCT00914316|363704153|FG001|Phase 1|Withdrawal by Subject|2|||
105662815|NCT05878873|364430015|FG001|Overall Study|Lost to Follow-up|0|||
105662816|NCT00943787|364430016|FG000|Overall Study|Physician Decision|4|||
105662817|NCT00943787|364430016|FG000|Overall Study|Withdrawal by Subject|3|||
105662818|NCT02229227|364430021|FG000|Overall Study|Adverse Event|14|||
105662819|NCT02229227|364430022|FG001|Overall Study|Adverse Event|9|||
105662820|NCT02229227|364430021|FG000|Overall Study|Lack of Efficacy|3|||
105662821|NCT02229227|364430022|FG001|Overall Study|Lack of Efficacy|3|||
105662822|NCT02229227|364430021|FG000|Overall Study|Protocol Violation|6|||
105662823|NCT02229227|364430022|FG001|Overall Study|Protocol Violation|8|||
105662824|NCT02229227|364430021|FG000|Overall Study|Protocol defined stopping criteria|1|||
105662825|NCT02229227|364430022|FG001|Overall Study|Protocol defined stopping criteria|3|||
105662826|NCT02229227|364430021|FG000|Overall Study|Lost to Follow-up|3|||
105662827|NCT02229227|364430022|FG001|Overall Study|Lost to Follow-up|3|||
105662828|NCT02229227|364430021|FG000|Overall Study|Study terminated by sponsor|11|||
105662829|NCT02229227|364430022|FG001|Overall Study|Study terminated by sponsor|11|||
105662830|NCT02229227|364430021|FG000|Overall Study|Withdrawal by Subject|8|||
105662831|NCT02229227|364430022|FG001|Overall Study|Withdrawal by Subject|12|||
105662832|NCT02229227|364430021|FG000|Overall Study|Other|0|||
105662833|NCT02229227|364430022|FG001|Overall Study|Other|1|||
105662834|NCT02229227|364430021|FG000|Overall Study|Physician Decision|5|||
105662835|NCT02229227|364430022|FG001|Overall Study|Physician Decision|12|||
105662836|NCT00121667|364430023|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
105662837|NCT00121667|364430024|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
105662838|NCT00121667|364430025|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
105662839|NCT00121667|364430026|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
105662840|NCT00121667|364430023|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
105662841|NCT00121667|364430024|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
105662842|NCT00121667|364430025|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
105662843|NCT00121667|364430026|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
105461768|NCT00914316|363704154|FG002|Phase 1|Withdrawal by Subject|4|||
105461769|NCT00914316|363704155|FG003|Phase 1|Withdrawal by Subject|0|||
105461770|NCT00914316|363704152|FG000|Phase 1|Adverse Event|1|||
105461771|NCT00914316|363704153|FG001|Phase 1|Adverse Event|0|||
105461772|NCT00914316|363704154|FG002|Phase 1|Adverse Event|0|||
105461773|NCT00914316|363704155|FG003|Phase 1|Adverse Event|0|||
105461774|NCT00914316|363704152|FG000|Phase 2|Withdrawal by Subject|1|||
105461775|NCT00914316|363704153|FG001|Phase 2|Withdrawal by Subject|0|||
105461776|NCT00914316|363704154|FG002|Phase 2|Withdrawal by Subject|1|||
105785145|NCT04516291|364866389|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105785146|NCT04516291|364866390|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105785147|NCT04516291|364866383|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
105785148|NCT04516291|364866384|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
105785149|NCT04516291|364866385|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
105785150|NCT04516291|364866386|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
105785151|NCT04516291|364866387|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
105785152|NCT04516291|364866388|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
105785153|NCT04516291|364866389|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
105785154|NCT04516291|364866390|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
105785155|NCT04516291|364866383|FG000|Follow-up Period (12 Weeks)|Other|0|||
105662844|NCT00121667|364430023|FG000|Short Term (ST) Period|Adverse Event|5|||
105662845|NCT00121667|364430024|FG001|Short Term (ST) Period|Adverse Event|6|||
105662846|NCT00121667|364430025|FG002|Short Term (ST) Period|Adverse Event|5|||
105662847|NCT00121667|364430026|FG003|Short Term (ST) Period|Adverse Event|3|||
105662848|NCT00121667|364430023|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
105662849|NCT00121667|364430024|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
105662850|NCT00121667|364430025|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
105662851|NCT00121667|364430026|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
105662852|NCT00121667|364430023|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
105662853|NCT00121667|364430024|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
105662854|NCT00121667|364430025|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
105662855|NCT00121667|364430026|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
105662856|NCT00121667|364430023|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
105662857|NCT00121667|364430024|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
105662858|NCT00121667|364430025|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
105662859|NCT00121667|364430026|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
105662860|NCT00121667|364430023|FG000|Short Term (ST) Period|Other Reason|3|||
105662861|NCT00121667|364430024|FG001|Short Term (ST) Period|Other Reason|0|||
105662862|NCT00121667|364430025|FG002|Short Term (ST) Period|Other Reason|0|||
105662863|NCT00121667|364430026|FG003|Short Term (ST) Period|Other Reason|0|||
105662864|NCT00121667|364430023|FG000|Short Term (ST) Period|Death|0|||
105662865|NCT00121667|364430024|FG001|Short Term (ST) Period|Death|0|||
105662866|NCT00121667|364430025|FG002|Short Term (ST) Period|Death|0|||
105662867|NCT00121667|364430026|FG003|Short Term (ST) Period|Death|1|||
105662868|NCT00121667|364430023|FG000|Short Term (ST) Period|Pregnancy|0|||
105662869|NCT00121667|364430024|FG001|Short Term (ST) Period|Pregnancy|0|||
105785156|NCT04516291|364866384|FG001|Follow-up Period (12 Weeks)|Other|1|||
105785157|NCT04516291|364866385|FG002|Follow-up Period (12 Weeks)|Other|0|||
105785158|NCT04516291|364866386|FG003|Follow-up Period (12 Weeks)|Other|2|||
105785159|NCT04516291|364866387|FG004|Follow-up Period (12 Weeks)|Other|0|||
105785160|NCT04516291|364866388|FG005|Follow-up Period (12 Weeks)|Other|0|||
105785161|NCT04516291|364866389|FG006|Follow-up Period (12 Weeks)|Other|0|||
105785162|NCT04516291|364866390|FG007|Follow-up Period (12 Weeks)|Other|0|||
105662870|NCT00121667|364430025|FG002|Short Term (ST) Period|Pregnancy|0|||
105662871|NCT00121667|364430026|FG003|Short Term (ST) Period|Pregnancy|1|||
105662872|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
105785163|NCT04516291|364866383|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105785164|NCT04516291|364866384|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105785165|NCT04516291|364866385|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105461777|NCT00914316|363704155|FG003|Phase 2|Withdrawal by Subject|0|||
105461778|NCT01213472|363704162|FG000|Overall Study|Recurrence/Progressive disease|25|||
105461779|NCT01213472|363704162|FG000|Overall Study|Withdrawal by Subject|1|||
105461780|NCT01213472|363704162|FG000|Overall Study|Physician Decision|1|||
105461781|NCT03406780|363704163|FG000|Overall Study|Withdrawal by Subject|1|||
105461782|NCT03406780|363704164|FG001|Overall Study|Withdrawal by Subject|1|||
105461783|NCT03406780|363704163|FG000|Overall Study|Other|0|||
105461784|NCT03406780|363704164|FG001|Overall Study|Other|2|||
105461785|NCT02085460|363704166|FG000|Overall Study|Adverse Event|2|||
105461786|NCT02085460|363704167|FG001|Overall Study|Adverse Event|2|||
105461787|NCT02085460|363704168|FG002|Overall Study|Adverse Event|1|||
105461788|NCT02085460|363704166|FG000|Overall Study|Physician Decision|1|||
105461789|NCT02085460|363704167|FG001|Overall Study|Physician Decision|1|||
105461790|NCT02085460|363704168|FG002|Overall Study|Physician Decision|2|||
105461791|NCT02085460|363704166|FG000|Overall Study|Withdrawal by Subject|11|||
105461792|NCT02085460|363704167|FG001|Overall Study|Withdrawal by Subject|5|||
105461793|NCT02085460|363704168|FG002|Overall Study|Withdrawal by Subject|7|||
105461794|NCT01709721|363704169|FG000|Open Label Phase|Withdrawal by Subject|0|||
105461795|NCT01709721|363704170|FG001|Open Label Phase|Withdrawal by Subject|0|||
105461796|NCT01709721|363704171|FG002|Open Label Phase|Withdrawal by Subject|5|||
105461797|NCT01709721|363704169|FG000|Open Label Phase|Adverse Event|0|||
105461798|NCT01709721|363704170|FG001|Open Label Phase|Adverse Event|0|||
105461799|NCT01709721|363704171|FG002|Open Label Phase|Adverse Event|8|||
105461800|NCT01709721|363704169|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
105461801|NCT01709721|363704170|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
105461802|NCT01709721|363704171|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
105461803|NCT01709721|363704169|FG000|Open Label Phase|Investigator Decision|0|||
105461804|NCT01709721|363704170|FG001|Open Label Phase|Investigator Decision|0|||
105461805|NCT01709721|363704171|FG002|Open Label Phase|Investigator Decision|1|||
105461806|NCT01709721|363704169|FG000|Open Label Phase|Sponsor Decision|0|||
105461807|NCT01709721|363704170|FG001|Open Label Phase|Sponsor Decision|0|||
105461808|NCT01709721|363704171|FG002|Open Label Phase|Sponsor Decision|2|||
105461809|NCT01709721|363704169|FG000|Open Label Phase|Protocol Violation|0|||
105461810|NCT01709721|363704170|FG001|Open Label Phase|Protocol Violation|0|||
105461811|NCT01709721|363704171|FG002|Open Label Phase|Protocol Violation|1|||
105461812|NCT01709721|363704169|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
105461813|NCT01709721|363704170|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
105461814|NCT01709721|363704171|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
105461815|NCT01709721|363704169|FG000|Open Label Phase|Inadequate Pain Control|0|||
105461816|NCT01709721|363704170|FG001|Open Label Phase|Inadequate Pain Control|0|||
105461817|NCT01709721|363704171|FG002|Open Label Phase|Inadequate Pain Control|37|||
105461818|NCT01709721|363704169|FG000|Open Label Phase|Other, Specify in text field in database|0|||
105461819|NCT01709721|363704170|FG001|Open Label Phase|Other, Specify in text field in database|0|||
105461820|NCT01709721|363704171|FG002|Open Label Phase|Other, Specify in text field in database|14|||
105461821|NCT01709721|363704169|FG000|Randomized Phase|Adverse Event|0|||
105461822|NCT01709721|363704170|FG001|Randomized Phase|Adverse Event|1|||
105461823|NCT01709721|363704171|FG002|Randomized Phase|Adverse Event|0|||
105461824|NCT01709721|363704169|FG000|Randomized Phase|Lost to Follow-up|1|||
105461825|NCT01709721|363704170|FG001|Randomized Phase|Lost to Follow-up|0|||
105461826|NCT01709721|363704171|FG002|Randomized Phase|Lost to Follow-up|0|||
105461827|NCT01709721|363704169|FG000|Randomized Phase|Inadequate Pain Control|1|||
105461828|NCT01709721|363704170|FG001|Randomized Phase|Inadequate Pain Control|2|||
105461829|NCT01709721|363704171|FG002|Randomized Phase|Inadequate Pain Control|0|||
105461830|NCT01709721|363704169|FG000|Randomized Phase|Other, Specify text field in database|1|||
105461831|NCT01709721|363704170|FG001|Randomized Phase|Other, Specify text field in database|3|||
105461832|NCT01709721|363704171|FG002|Randomized Phase|Other, Specify text field in database|0|||
105461833|NCT01499940|363704172|FG000|Overall Study|Study was withdrawn before completion.|9|||
105461834|NCT05249582|363704173|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
105461835|NCT05249582|363704174|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
105461836|NCT05249582|363704173|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
105461837|NCT05249582|363704174|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
105461838|NCT05249582|363704173|FG000|Overall Study|Declined to use virtual reality headset|1|||
105461839|NCT05249582|363704174|FG001|Overall Study|Declined to use virtual reality headset|0|||
105461840|NCT03675126|363704175|FG000|Overall Study|Study Terminated by Sponsor|9|||
105461841|NCT03675126|363704175|FG000|Overall Study|Death|2|||
105785166|NCT04516291|364866386|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105785167|NCT04516291|364866387|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
105461842|NCT03675126|363704175|FG000|Overall Study|Withdrawal by Subject|4|||
105461843|NCT00001959|363704176|FG000|Overall Study|newly diagnosed colon cancer|1|||
105461844|NCT00001959|363704176|FG000|Overall Study|disabling sedation|1|||
105461845|NCT00001959|363704176|FG000|Overall Study|non-compliance|1|||
105461846|NCT01353898|363704180|FG000|Overall Study|Study site terminated|0|||
105461847|NCT01353898|363704181|FG001|Overall Study|Study site terminated|0|||
105461848|NCT01353898|363704182|FG002|Overall Study|Study site terminated|0|||
105461849|NCT01353898|363704183|FG003|Overall Study|Study site terminated|0|||
105461850|NCT01353898|363704184|FG004|Overall Study|Study site terminated|0|||
105461851|NCT01353898|363704185|FG005|Overall Study|Study site terminated|1|||
105461852|NCT05135767|363704186|FG000|Baseline|Lost to Follow-up|1|||
105461853|NCT05135767|363704187|FG001|Baseline|Lost to Follow-up|1|||
105461854|NCT05135767|363704186|FG000|Baseline|Withdrawal by Subject|0|||
105461855|NCT05135767|363704187|FG001|Baseline|Withdrawal by Subject|2|||
105461856|NCT05135767|363704186|FG000|Active Study Phase|Lost to Follow-up|2|||
105461857|NCT05135767|363704187|FG001|Active Study Phase|Lost to Follow-up|0|||
105461858|NCT03818256|363704193|FG000|Overall Study|Withdrawal by Subject|2|||
105461859|NCT03818256|363704194|FG001|Overall Study|Withdrawal by Subject|2|||
105461860|NCT03818256|363704193|FG000|Overall Study|Adverse Event|3|||
105461861|NCT03818256|363704194|FG001|Overall Study|Adverse Event|1|||
105461862|NCT03818256|363704193|FG000|Overall Study|Lost to Follow-up|0|||
105461863|NCT03818256|363704194|FG001|Overall Study|Lost to Follow-up|5|||
105461864|NCT03818256|363704193|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
105461865|NCT03818256|363704194|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
105461866|NCT03818256|363704193|FG000|Overall Study|Not reporting for scheduled visits|1|||
105461867|NCT03818256|363704194|FG001|Overall Study|Not reporting for scheduled visits|0|||
105461868|NCT03818256|363704193|FG000|Overall Study|Non-compliant with investigational product|1|||
105461869|NCT03818256|363704194|FG001|Overall Study|Non-compliant with investigational product|0|||
105461870|NCT04163341|363704200|FG000|Overall Study|Withdrawal by Subject|2|||
105461871|NCT04163341|363704201|FG001|Overall Study|Withdrawal by Subject|0|||
105461872|NCT04163341|363704200|FG000|Overall Study|Lost to Follow-up|3|||
105461873|NCT04163341|363704201|FG001|Overall Study|Lost to Follow-up|4|||
105461874|NCT02484391|363704202|FG000|Overall Study|Lack of Efficacy|15|||
105461875|NCT02484391|363704203|FG001|Overall Study|Lack of Efficacy|14|||
105461876|NCT02484391|363704204|FG002|Overall Study|Lack of Efficacy|3|||
105461877|NCT02484391|363704202|FG000|Overall Study|Lost to Follow-up|0|||
105461878|NCT02484391|363704203|FG001|Overall Study|Lost to Follow-up|0|||
105461879|NCT02484391|363704204|FG002|Overall Study|Lost to Follow-up|2|||
105461880|NCT02484391|363704202|FG000|Overall Study|Physician Decision|1|||
105461881|NCT02484391|363704203|FG001|Overall Study|Physician Decision|3|||
105461882|NCT02484391|363704204|FG002|Overall Study|Physician Decision|0|||
105461883|NCT02484391|363704202|FG000|Overall Study|Went to Transplant|5|||
105461884|NCT02484391|363704203|FG001|Overall Study|Went to Transplant|3|||
105461885|NCT02484391|363704204|FG002|Overall Study|Went to Transplant|2|||
105461886|NCT01899040|363704205|FG000|Overall Study|Randomized in error|0|||
105461887|NCT01899040|363704206|FG001|Overall Study|Randomized in error|1|||
105461888|NCT01899040|363704207|FG002|Overall Study|Randomized in error|1|||
105461889|NCT01899040|363704205|FG000|Overall Study|Adverse Event|3|||
105461890|NCT01899040|363704206|FG001|Overall Study|Adverse Event|1|||
105461891|NCT01899040|363704207|FG002|Overall Study|Adverse Event|2|||
105461892|NCT01899040|363704205|FG000|Overall Study|Unspecified reasons|4|||
105461893|NCT01899040|363704206|FG001|Overall Study|Unspecified reasons|4|||
105461894|NCT01899040|363704207|FG002|Overall Study|Unspecified reasons|0|||
105461895|NCT01899040|363704205|FG000|Overall Study|Compliance issues|1|||
105461896|NCT01899040|363704206|FG001|Overall Study|Compliance issues|2|||
105461897|NCT01899040|363704207|FG002|Overall Study|Compliance issues|0|||
105461898|NCT02638220|363704213|FG000|Overall Study|Lost to Follow-up|6|||
105461899|NCT02638220|363704213|FG000|Overall Study|Withdrawal by Subject|3|||
105461900|NCT02638220|363704213|FG000|Overall Study|Physician Decision|1|||
105461901|NCT02638220|363704213|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
105461902|NCT04730804|363704218|FG000|Overall Study|Physician Decision|0|||
105461903|NCT04730804|363704219|FG001|Overall Study|Physician Decision|0|||
105461904|NCT04730804|363704220|FG002|Overall Study|Physician Decision|0|||
105461905|NCT04730804|363704221|FG003|Overall Study|Physician Decision|0|||
105461906|NCT04730804|363704222|FG004|Overall Study|Physician Decision|0|||
105461907|NCT04730804|363704223|FG005|Overall Study|Physician Decision|1|||
105461908|NCT04730804|363704218|FG000|Overall Study|Withdrawal by Subject|0|||
105461909|NCT04730804|363704219|FG001|Overall Study|Withdrawal by Subject|0|||
105461910|NCT04730804|363704220|FG002|Overall Study|Withdrawal by Subject|0|||
105461911|NCT04730804|363704221|FG003|Overall Study|Withdrawal by Subject|0|||
105461912|NCT04730804|363704222|FG004|Overall Study|Withdrawal by Subject|1|||
105461913|NCT04730804|363704223|FG005|Overall Study|Withdrawal by Subject|2|||
105461914|NCT02081677|363705577|FG000|Overall Study|Adverse Event|0|||
105461915|NCT02081677|363705578|FG001|Overall Study|Adverse Event|0|||
105461916|NCT02081677|363705579|FG002|Overall Study|Adverse Event|1|||
105461917|NCT02081677|363705580|FG003|Overall Study|Adverse Event|0|||
105461918|NCT02081677|363705577|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
105461919|NCT02081677|363705578|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
105662873|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
105662874|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
105662875|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
105662876|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
105662877|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
105662878|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
105662879|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
105662880|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
105461920|NCT02081677|363705579|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
105461921|NCT02081677|363705580|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
105461922|NCT02081677|363705577|FG000|Overall Study|Not comfortable with lens care system|1|||
105461923|NCT02081677|363705578|FG001|Overall Study|Not comfortable with lens care system|0|||
105461924|NCT02081677|363705579|FG002|Overall Study|Not comfortable with lens care system|0|||
105461925|NCT02081677|363705580|FG003|Overall Study|Not comfortable with lens care system|0|||
105461926|NCT02081677|363705577|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
105550211|NCT00467870|364014374|FG000|Overall Study|Subject Non-compliance|3|||
105550212|NCT00467870|364014375|FG001|Overall Study|Subject Non-compliance|4|||
105550213|NCT00467870|364014376|FG002|Overall Study|Subject Non-compliance|0|||
105550214|NCT00467870|364014377|FG003|Overall Study|Subject Non-compliance|1|||
105550215|NCT00467870|364014378|FG004|Overall Study|Subject Non-compliance|5|||
105550216|NCT00467870|364014379|FG005|Overall Study|Subject Non-compliance|0|||
105550217|NCT00467870|364014374|FG000|Overall Study|Other/Unknown|8|||
105550218|NCT00467870|364014375|FG001|Overall Study|Other/Unknown|5|||
105550219|NCT00467870|364014376|FG002|Overall Study|Other/Unknown|1|||
105550220|NCT00467870|364014377|FG003|Overall Study|Other/Unknown|5|||
105550221|NCT00467870|364014378|FG004|Overall Study|Other/Unknown|4|||
105550222|NCT00467870|364014379|FG005|Overall Study|Other/Unknown|0|||
105550223|NCT02624804|364014380|FG000|Overall Study|Screen Failure|5|||
105550224|NCT01917526|364014381|FG000|Overall Study|Protocol Violation|1|||
105550225|NCT01917526|364014382|FG001|Overall Study|Protocol Violation|1|||
105550226|NCT02261363|364014383|FG000|Overall Study|Lost to Follow-up|21|||
105550227|NCT01517802|364014384|FG000|Overall Study|Death|1|||
105550228|NCT02590354|364014388|FG000|Phase 1|Active hepatitis B or C infection|1|||
105550229|NCT02590354|364014388|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
105550230|NCT02590354|364014388|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
105550231|NCT02590354|364014388|FG000|Phase 1|Subject does not want to participate|20|||
105550232|NCT02590354|364014388|FG000|Phase 1|Lost to Follow-up|1|||
105550233|NCT02590354|364014388|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
105550234|NCT00996996|364014389|FG000|Overall Study|Progressive Disease|10|||
105550235|NCT00996996|364014389|FG000|Overall Study|Non-compliance|8|||
105550236|NCT00996996|364014389|FG000|Overall Study|Lost to Follow-up|9|||
105550237|NCT00996996|364014389|FG000|Overall Study|Death|5|||
105550238|NCT00996996|364014389|FG000|Overall Study|Did Not Receive Study Medications|1|||
105550239|NCT00760929|364014390|FG000|Overall Study|Adverse Event|2|||
105550240|NCT00760929|364014391|FG001|Overall Study|Adverse Event|0|||
105550241|NCT00760929|364014392|FG002|Overall Study|Adverse Event|6|||
105550242|NCT00760929|364014393|FG003|Overall Study|Adverse Event|10|||
105550243|NCT00760929|364014390|FG000|Overall Study|Lack of Efficacy|0|||
105550244|NCT00760929|364014391|FG001|Overall Study|Lack of Efficacy|2|||
105550245|NCT00760929|364014392|FG002|Overall Study|Lack of Efficacy|1|||
105550246|NCT00760929|364014393|FG003|Overall Study|Lack of Efficacy|0|||
105550247|NCT00760929|364014390|FG000|Overall Study|Withdrawal by Subject|1|||
105550248|NCT00760929|364014391|FG001|Overall Study|Withdrawal by Subject|0|||
105550249|NCT00760929|364014392|FG002|Overall Study|Withdrawal by Subject|9|||
105550250|NCT00760929|364014393|FG003|Overall Study|Withdrawal by Subject|1|||
105550251|NCT00760929|364014390|FG000|Overall Study|Lost to Follow-up|0|||
105550252|NCT00760929|364014391|FG001|Overall Study|Lost to Follow-up|0|||
105550253|NCT00760929|364014392|FG002|Overall Study|Lost to Follow-up|1|||
105550254|NCT00760929|364014393|FG003|Overall Study|Lost to Follow-up|0|||
105550255|NCT00760929|364014390|FG000|Overall Study|Progression of Disease|21|||
105550256|NCT00760929|364014391|FG001|Overall Study|Progression of Disease|26|||
105550257|NCT00760929|364014392|FG002|Overall Study|Progression of Disease|38|||
105550258|NCT00760929|364014393|FG003|Overall Study|Progression of Disease|42|||
105550259|NCT00760929|364014390|FG000|Overall Study|Other|2|||
105550260|NCT00760929|364014391|FG001|Overall Study|Other|0|||
105550261|NCT00760929|364014392|FG002|Overall Study|Other|2|||
105550262|NCT00760929|364014393|FG003|Overall Study|Other|1|||
105550263|NCT00760929|364014390|FG000|Overall Study|Death|0|||
105550264|NCT00760929|364014391|FG001|Overall Study|Death|0|||
105550265|NCT00760929|364014392|FG002|Overall Study|Death|1|||
105550266|NCT00760929|364014393|FG003|Overall Study|Death|0|||
105550267|NCT00760929|364014390|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
105550268|NCT00760929|364014391|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
105550269|NCT00760929|364014392|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
105550270|NCT00760929|364014393|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
105550271|NCT03268811|364014396|FG000|Overall Study|Adverse Event|0|||
105550272|NCT03268811|364014397|FG001|Overall Study|Adverse Event|1|||
105550273|NCT02348216|364014399|FG000|Overall Study|Death|5|||
105550274|NCT02348216|364014400|FG001|Overall Study|Death|53|||
105550275|NCT02348216|364014401|FG002|Overall Study|Death|11|||
105550276|NCT02348216|364014402|FG003|Overall Study|Death|20|||
105550277|NCT02348216|364014403|FG004|Overall Study|Death|16|||
105550278|NCT02348216|364014404|FG005|Overall Study|Death|32|||
105550279|NCT02348216|364014405|FG006|Overall Study|Death|17|||
105550280|NCT02348216|364014399|FG000|Overall Study|Full consent withdrawal|0|||
105550281|NCT02348216|364014400|FG001|Overall Study|Full consent withdrawal|0|||
105550282|NCT02348216|364014401|FG002|Overall Study|Full consent withdrawal|0|||
105662881|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
105550283|NCT02348216|364014402|FG003|Overall Study|Full consent withdrawal|1|||
105550284|NCT02348216|364014403|FG004|Overall Study|Full consent withdrawal|3|||
105550285|NCT02348216|364014404|FG005|Overall Study|Full consent withdrawal|0|||
105785168|NCT04516291|364866388|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105785169|NCT04516291|364866389|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105785170|NCT04516291|364866390|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105785171|NCT04516291|364866383|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
105785172|NCT04516291|364866384|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
105785173|NCT04516291|364866385|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
105785174|NCT04516291|364866386|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
105785175|NCT04516291|364866387|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
105785176|NCT04516291|364866388|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
105785177|NCT04516291|364866389|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
105785178|NCT04516291|364866390|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
105785179|NCT00798161|364866391|FG000|Overall Study|Adverse Event|3|||
105785180|NCT00798161|364866392|FG001|Overall Study|Adverse Event|4|||
105785181|NCT00798161|364866393|FG002|Overall Study|Adverse Event|6|||
105785182|NCT00798161|364866394|FG003|Overall Study|Adverse Event|6|||
105785183|NCT00798161|364866395|FG004|Overall Study|Adverse Event|5|||
105785184|NCT00798161|364866396|FG005|Overall Study|Adverse Event|2|||
105785185|NCT00798161|364866397|FG006|Overall Study|Adverse Event|4|||
105785186|NCT00798161|364866391|FG000|Overall Study|Protocol Violation|2|||
105785187|NCT00798161|364866392|FG001|Overall Study|Protocol Violation|1|||
105785188|NCT00798161|364866393|FG002|Overall Study|Protocol Violation|3|||
105785189|NCT00798161|364866394|FG003|Overall Study|Protocol Violation|3|||
105785190|NCT00798161|364866395|FG004|Overall Study|Protocol Violation|3|||
105785191|NCT00798161|364866396|FG005|Overall Study|Protocol Violation|2|||
105785192|NCT00798161|364866397|FG006|Overall Study|Protocol Violation|0|||
105785193|NCT00798161|364866391|FG000|Overall Study|Lost to Follow-up|1|||
105785194|NCT00798161|364866392|FG001|Overall Study|Lost to Follow-up|3|||
105785195|NCT00798161|364866393|FG002|Overall Study|Lost to Follow-up|4|||
105785196|NCT00798161|364866394|FG003|Overall Study|Lost to Follow-up|3|||
105785197|NCT00798161|364866395|FG004|Overall Study|Lost to Follow-up|4|||
105785198|NCT00798161|364866396|FG005|Overall Study|Lost to Follow-up|0|||
105785199|NCT00798161|364866397|FG006|Overall Study|Lost to Follow-up|0|||
105785200|NCT00798161|364866391|FG000|Overall Study|Withdrawal by Subject|5|||
105785201|NCT00798161|364866392|FG001|Overall Study|Withdrawal by Subject|4|||
105785202|NCT00798161|364866393|FG002|Overall Study|Withdrawal by Subject|5|||
105785203|NCT00798161|364866394|FG003|Overall Study|Withdrawal by Subject|4|||
105785204|NCT00798161|364866395|FG004|Overall Study|Withdrawal by Subject|2|||
105785205|NCT00798161|364866396|FG005|Overall Study|Withdrawal by Subject|3|||
105785206|NCT00798161|364866397|FG006|Overall Study|Withdrawal by Subject|1|||
105785207|NCT00798161|364866391|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
105785208|NCT00798161|364866392|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
105785209|NCT00798161|364866393|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
105785210|NCT00798161|364866394|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
105785211|NCT00798161|364866395|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
105785212|NCT00798161|364866396|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
105785213|NCT00798161|364866397|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
105785214|NCT03472586|364866402|FG000|Overall Study|Physician Decision|6|||
105785215|NCT03472586|364866402|FG000|Overall Study|Death|6|||
105785216|NCT03472586|364866402|FG000|Overall Study|Adverse Event|1|||
105785217|NCT02528331|364866404|FG000|Overall Study|Withdrawal by Subject|2|||
105785218|NCT02392078|364866405|FG000|Overall Study|Did not have procedure|32|||
105785219|NCT02392078|364866406|FG001|Overall Study|Did not have procedure|43|||
105785220|NCT02392078|364866407|FG002|Overall Study|Did not have procedure|20|||
105785221|NCT02392078|364866408|FG003|Overall Study|Did not have procedure|1|||
105662882|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
105662883|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
105662884|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
105662885|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
105662886|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
105662887|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
105662888|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
105662889|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
105662890|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
105662891|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
105461927|NCT02081677|363705578|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
105662892|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
105662893|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
105662894|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
105662895|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
105662896|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
105662897|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
105662898|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
105662899|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
105662900|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
105662901|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
105662902|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
105662903|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
105662904|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
105662905|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
105662906|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
105662907|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
105662908|NCT02125279|364430027|FG000|Overall Study|Lack of Efficacy|2|||
105662909|NCT02125279|364430027|FG000|Overall Study|Withdrawal by Subject|6|||
105662910|NCT02125279|364430027|FG000|Overall Study|Protocol Violation|1|||
105662911|NCT02125279|364430027|FG000|Overall Study|Lost to Follow-up|4|||
105662912|NCT03721705|364430040|FG000|Overall Study|Adverse Event|2|||
105662913|NCT03721705|364430041|FG001|Overall Study|Adverse Event|0|||
105662914|NCT03721705|364430040|FG000|Overall Study|Withdrawal by Subject|4|||
105662915|NCT03721705|364430041|FG001|Overall Study|Withdrawal by Subject|10|||
105662916|NCT03721705|364430040|FG000|Overall Study|No Suitable Study Partner|1|||
105662917|NCT03721705|364430041|FG001|Overall Study|No Suitable Study Partner|0|||
105662918|NCT03721705|364430040|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
105662919|NCT03721705|364430041|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
105461928|NCT02081677|363705579|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
105662920|NCT03721705|364430040|FG000|Overall Study|Death|0|||
105662921|NCT03721705|364430041|FG001|Overall Study|Death|1|||
105338885|NCT05413369|363243496|FG000|Overall Study|Adverse Event|1|||
105338886|NCT05413369|363243497|FG001|Overall Study|Adverse Event|1|||
105338887|NCT05413369|363243496|FG000|Overall Study|Withdrawal by Subject|13|||
105338888|NCT05413369|363243497|FG001|Overall Study|Withdrawal by Subject|4|||
105338889|NCT05413369|363243496|FG000|Overall Study|Non-compliance with study schedule|2|||
105338890|NCT05413369|363243497|FG001|Overall Study|Non-compliance with study schedule|1|||
105338891|NCT05413369|363243496|FG000|Overall Study|Other|1|||
105338892|NCT05413369|363243497|FG001|Overall Study|Other|1|||
105785222|NCT03868410|364866411|FG000|Overall Study|Physician Decision|0|||
105785223|NCT03868410|364866412|FG001|Overall Study|Physician Decision|1|||
105338893|NCT00769067|363243498|FG000|Overall Study|Death|89|||
105550286|NCT02348216|364014405|FG006|Overall Study|Full consent withdrawal|3|||
105550287|NCT02348216|364014399|FG000|Overall Study|Lost to Follow-up|0|||
105550288|NCT02348216|364014400|FG001|Overall Study|Lost to Follow-up|5|||
105550289|NCT02348216|364014401|FG002|Overall Study|Lost to Follow-up|2|||
105550290|NCT02348216|364014402|FG003|Overall Study|Lost to Follow-up|0|||
105550291|NCT02348216|364014403|FG004|Overall Study|Lost to Follow-up|1|||
105550292|NCT02348216|364014404|FG005|Overall Study|Lost to Follow-up|1|||
105550293|NCT02348216|364014405|FG006|Overall Study|Lost to Follow-up|1|||
105550294|NCT02348216|364014399|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
105550295|NCT02348216|364014400|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
105550296|NCT02348216|364014401|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
105550297|NCT02348216|364014402|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
105550298|NCT02348216|364014403|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
105550299|NCT02348216|364014404|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
105550300|NCT02348216|364014405|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
105550301|NCT02348216|364014399|FG000|Overall Study|Reason not specified|2|||
105550302|NCT02348216|364014400|FG001|Overall Study|Reason not specified|19|||
105550303|NCT02348216|364014401|FG002|Overall Study|Reason not specified|11|||
105550304|NCT02348216|364014402|FG003|Overall Study|Reason not specified|17|||
105550305|NCT02348216|364014403|FG004|Overall Study|Reason not specified|21|||
105550306|NCT02348216|364014404|FG005|Overall Study|Reason not specified|17|||
105550307|NCT02348216|364014405|FG006|Overall Study|Reason not specified|19|||
105550308|NCT00434057|364014415|FG000|Overall Study|Withdrawal by Subject|1|||
105550309|NCT03073603|364014416|FG000|Overall Study|Noncompliance|3|||
105550310|NCT03073603|364014417|FG001|Overall Study|Noncompliance|1|||
105550311|NCT03073603|364014416|FG000|Overall Study|Adverse Event|5|||
105550312|NCT03073603|364014417|FG001|Overall Study|Adverse Event|3|||
105550313|NCT03073603|364014416|FG000|Overall Study|Physician Decision|1|||
105550314|NCT03073603|364014417|FG001|Overall Study|Physician Decision|2|||
105550315|NCT03073603|364014416|FG000|Overall Study|Required treatment not allowed by protocol|1|||
105550316|NCT03073603|364014417|FG001|Overall Study|Required treatment not allowed by protocol|0|||
105550317|NCT03073603|364014416|FG000|Overall Study|Financial or insurance-related|8|||
105550318|NCT03073603|364014417|FG001|Overall Study|Financial or insurance-related|0|||
105550319|NCT03073603|364014416|FG000|Overall Study|Withdrawal by Subject|0|||
105550320|NCT03073603|364014417|FG001|Overall Study|Withdrawal by Subject|1|||
105550321|NCT03073603|364014416|FG000|Overall Study|Discontinued DMT|4|||
105550322|NCT03073603|364014417|FG001|Overall Study|Discontinued DMT|0|||
105550323|NCT03073603|364014416|FG000|Overall Study|Restarted DMT|0|||
105550324|NCT03073603|364014417|FG001|Overall Study|Restarted DMT|1|||
105550325|NCT00455195|364014420|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
105550326|NCT00455195|364014421|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
105550327|NCT00455195|364014420|FG000|Double-blind Study AGLU02704|Death|1|||
105550328|NCT00455195|364014421|FG001|Double-blind Study AGLU02704|Death|0|||
105550329|NCT00455195|364014420|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
105550330|NCT00455195|364014421|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
105550331|NCT00455195|364014420|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
105550332|NCT00455195|364014421|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
105550333|NCT02117570|364014424|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
105550334|NCT02117570|364014425|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
105550335|NCT02117570|364014426|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
105785224|NCT02213666|364866415|FG000|Overall Study|Withdrawal by Subject|1|||
105338894|NCT00769067|363243499|FG001|Overall Study|Death|86|||
105338895|NCT00769067|363243498|FG000|Overall Study|Lost to Follow-up|3|||
105338896|NCT00769067|363243499|FG001|Overall Study|Lost to Follow-up|1|||
105461929|NCT02081677|363705580|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
105461930|NCT01615939|363705581|FG000|Overall Study|Lost to Follow-up|5|||
105461931|NCT01615939|363705582|FG001|Overall Study|Lost to Follow-up|0|||
105461932|NCT03414983|363705589|FG000|Pre-Treatment|Other reasons|1|||
105461933|NCT03414983|363705590|FG001|Pre-Treatment|Other reasons|0|||
105461934|NCT03414983|363705589|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
105461935|NCT03414983|363705590|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
105461936|NCT03414983|363705589|FG000|Pre-Treatment|Participant withdrew consent|1|||
105662922|NCT03657576|364430050|FG000|Overall Study|Death|0|||
105662923|NCT03657576|364430051|FG001|Overall Study|Death|1|||
105662924|NCT03657576|364430052|FG002|Overall Study|Death|1|||
105662925|NCT03657576|364430053|FG003|Overall Study|Death|0|||
105662926|NCT03657576|364430054|FG004|Overall Study|Death|0|||
105461937|NCT03414983|363705590|FG001|Pre-Treatment|Participant withdrew consent|3|||
105461938|NCT03414983|363705589|FG000|Treatment|Participant withdrew consent|4|||
105461939|NCT03414983|363705590|FG001|Treatment|Participant withdrew consent|3|||
105461940|NCT03414983|363705589|FG000|Treatment|Participant request to discontinue study treatment|8|||
105461941|NCT03414983|363705590|FG001|Treatment|Participant request to discontinue study treatment|10|||
105461942|NCT03414983|363705589|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
105461943|NCT03414983|363705590|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
105461944|NCT03414983|363705589|FG000|Treatment|Death|0|||
105461945|NCT03414983|363705590|FG001|Treatment|Death|1|||
105461946|NCT03414983|363705589|FG000|Treatment|Study Drug Toxicity|10|||
105461947|NCT03414983|363705590|FG001|Treatment|Study Drug Toxicity|5|||
105461948|NCT03414983|363705589|FG000|Treatment|Disease Progression|75|||
105461949|NCT03414983|363705590|FG001|Treatment|Disease Progression|29|||
105461950|NCT03414983|363705589|FG000|Treatment|Not reported|1|||
105461951|NCT03414983|363705590|FG001|Treatment|Not reported|0|||
105461952|NCT03414983|363705589|FG000|Treatment|Other reasons|3|||
105461953|NCT03414983|363705590|FG001|Treatment|Other reasons|2|||
105461954|NCT03414983|363705589|FG000|Treatment|Poor/non-compliance|2|||
105461955|NCT03414983|363705590|FG001|Treatment|Poor/non-compliance|0|||
105461956|NCT03414983|363705589|FG000|Treatment|Maximum clinical benefit|5|||
105461957|NCT03414983|363705590|FG001|Treatment|Maximum clinical benefit|9|||
105461958|NCT03414983|363705589|FG000|Treatment|Lost to Follow-up|0|||
105461959|NCT03414983|363705590|FG001|Treatment|Lost to Follow-up|1|||
105461960|NCT03414983|363705589|FG000|Treatment|Administrative reasons by sponsor|1|||
105461961|NCT03414983|363705590|FG001|Treatment|Administrative reasons by sponsor|0|||
105461962|NCT02608684|363705591|FG000|Overall Study|Physician Decision|2|||
105461963|NCT02608684|363705591|FG000|Overall Study|Withdrawal by Subject|1|||
105461964|NCT01084655|363705596|FG000|Overall Study|Radiographic disease progression|3|||
105461965|NCT01084655|363705597|FG001|Overall Study|Radiographic disease progression|2|||
105461966|NCT01084655|363705598|FG002|Overall Study|Radiographic disease progression|8|||
105461967|NCT01084655|363705596|FG000|Overall Study|Withdrawal by Subject|1|||
105461968|NCT01084655|363705597|FG001|Overall Study|Withdrawal by Subject|0|||
105461969|NCT01084655|363705598|FG002|Overall Study|Withdrawal by Subject|4|||
105662927|NCT03657576|364430055|FG005|Overall Study|Death|0|||
105461970|NCT01084655|363705596|FG000|Overall Study|Adverse Event|2|||
105461971|NCT01084655|363705597|FG001|Overall Study|Adverse Event|1|||
105461972|NCT01084655|363705598|FG002|Overall Study|Adverse Event|2|||
105461973|NCT01084655|363705596|FG000|Overall Study|Other|0|||
105461974|NCT01084655|363705597|FG001|Overall Study|Other|3|||
105461975|NCT01084655|363705598|FG002|Overall Study|Other|2|||
105785225|NCT00727246|364866416|FG000|Overall Study|could not complete MRI|0|||
105785226|NCT00727246|364866417|FG001|Overall Study|could not complete MRI|1|||
105785227|NCT00727246|364866418|FG002|Overall Study|could not complete MRI|0|||
105785228|NCT00727246|364866419|FG003|Overall Study|could not complete MRI|1|||
105461976|NCT01084655|363705596|FG000|Overall Study|Symptomatic deterioration|0|||
105461977|NCT01084655|363705597|FG001|Overall Study|Symptomatic deterioration|0|||
105461978|NCT01084655|363705598|FG002|Overall Study|Symptomatic deterioration|2|||
105461979|NCT01084655|363705596|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
105461980|NCT01084655|363705597|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
105461981|NCT01084655|363705598|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
105461982|NCT03829228|363705599|FG000|Overall Study|Protocol Violation|1|||
105461983|NCT03181932|363705605|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
105461984|NCT03181932|363705606|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
105461985|NCT03181932|363705605|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
105461986|NCT03181932|363705606|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
105461987|NCT03181932|363705605|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
105461988|NCT03181932|363705606|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
105461989|NCT03181932|363705605|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
105461990|NCT03181932|363705606|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
105461991|NCT03181932|363705605|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
105461992|NCT03181932|363705606|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
105461993|NCT03181932|363705605|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
105461994|NCT03181932|363705606|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
105461995|NCT03181932|363705605|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
105461996|NCT03181932|363705606|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
105461997|NCT03181932|363705605|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
105461998|NCT03181932|363705606|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
105461999|NCT03181932|363705605|FG000|Period 2 (Open-label Period)|Reason missing|2|||
105462000|NCT03181932|363705606|FG001|Period 2 (Open-label Period)|Reason missing|0|||
105462001|NCT01198795|363705607|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
105462002|NCT01198795|363705607|FG000|Overall Study|Withdrawal by Subject|17|||
105462003|NCT01198795|363705607|FG000|Overall Study|Lost to Follow-up|15|||
105462004|NCT01198795|363705607|FG000|Overall Study|Adverse Event|9|||
105462005|NCT01198795|363705607|FG000|Overall Study|Lack of Efficacy|5|||
105462006|NCT01198795|363705607|FG000|Overall Study|Protocol Violation|2|||
105462007|NCT01198795|363705607|FG000|Overall Study|Other Reason|4|||
105462008|NCT03038100|363705608|FG000|Overall Study|Death|289|||
105462009|NCT03038100|363705609|FG001|Overall Study|Death|272|||
105462010|NCT03038100|363705608|FG000|Overall Study|Lost to Follow-up|9|||
105462011|NCT03038100|363705609|FG001|Overall Study|Lost to Follow-up|10|||
105462012|NCT03038100|363705608|FG000|Overall Study|Protocol Deviation|1|||
105462013|NCT03038100|363705609|FG001|Overall Study|Protocol Deviation|4|||
105462014|NCT03038100|363705608|FG000|Overall Study|Withdrawal by Subject|45|||
105462015|NCT03038100|363705609|FG001|Overall Study|Withdrawal by Subject|51|||
105462016|NCT03038100|363705608|FG000|Overall Study|Study Terminated By Sponsor|305|||
105462017|NCT03038100|363705609|FG001|Overall Study|Study Terminated By Sponsor|311|||
105462018|NCT03038100|363705608|FG000|Overall Study|Physician Decision|1|||
105462019|NCT03038100|363705609|FG001|Overall Study|Physician Decision|3|||
105462020|NCT00744497|363705610|FG000|Overall Study|Withdrawal by Subject|21|||
105462021|NCT00744497|363705611|FG001|Overall Study|Withdrawal by Subject|18|||
105462022|NCT00744497|363705610|FG000|Overall Study|Death|11|||
105462023|NCT00744497|363705611|FG001|Overall Study|Death|9|||
105462024|NCT00744497|363705610|FG000|Overall Study|Lost to Follow-up|4|||
105462025|NCT00744497|363705611|FG001|Overall Study|Lost to Follow-up|2|||
105462026|NCT00744497|363705610|FG000|Overall Study|Poor compliance/noncompliance|9|||
105462027|NCT00744497|363705611|FG001|Overall Study|Poor compliance/noncompliance|5|||
105462028|NCT00744497|363705610|FG000|Overall Study|No longer meets study criteria|7|||
105462029|NCT00744497|363705611|FG001|Overall Study|No longer meets study criteria|3|||
105462030|NCT00744497|363705610|FG000|Overall Study|Administrative Reason By Sponsor|25|||
105462031|NCT00744497|363705611|FG001|Overall Study|Administrative Reason By Sponsor|8|||
105785229|NCT00727246|364866416|FG000|Overall Study|incidental finding|0|||
105785230|NCT00727246|364866417|FG001|Overall Study|incidental finding|0|||
105785231|NCT00727246|364866418|FG002|Overall Study|incidental finding|0|||
105785232|NCT00727246|364866419|FG003|Overall Study|incidental finding|1|||
105785233|NCT00727246|364866416|FG000|Overall Study|withdrawn|0|||
105785234|NCT00727246|364866417|FG001|Overall Study|withdrawn|0|||
105785235|NCT00727246|364866418|FG002|Overall Study|withdrawn|1|||
105785236|NCT00727246|364866419|FG003|Overall Study|withdrawn|0|||
105785237|NCT00812968|364866422|FG000|Overall Study|Relapse after erythroid response|6|||
105785238|NCT00812968|364866422|FG000|Overall Study|Disease progression|1|||
105785239|NCT00812968|364866422|FG000|Overall Study|No further treatment required|1|||
105785240|NCT00812968|364866422|FG000|Overall Study|Study closed due to marketing approval|3|||
105785241|NCT02696382|364866424|FG000|Overall Study|Death|7|||
105785242|NCT02696382|364866425|FG001|Overall Study|Death|2|||
105785243|NCT02696382|364866424|FG000|Overall Study|Withdrawal by Subject|5|||
105338897|NCT00769067|363243498|FG000|Overall Study|Study terminated by sponsor|1|||
105338898|NCT00769067|363243499|FG001|Overall Study|Study terminated by sponsor|3|||
105338899|NCT00769067|363243498|FG000|Overall Study|Other|1|||
105338900|NCT00769067|363243499|FG001|Overall Study|Other|3|||
105338901|NCT00769067|363243498|FG000|Overall Study|Withdrawal by Subject|0|||
105338902|NCT00769067|363243499|FG001|Overall Study|Withdrawal by Subject|1|||
105338903|NCT00972816|363243500|FG000|Overall Study|Adverse Event|0|||
105338904|NCT00972816|363243501|FG001|Overall Study|Adverse Event|0|||
105338905|NCT00972816|363243502|FG002|Overall Study|Adverse Event|1|||
105338906|NCT00972816|363243503|FG003|Overall Study|Adverse Event|0|||
105338907|NCT00972816|363243504|FG004|Overall Study|Adverse Event|0|||
105338908|NCT00972816|363243505|FG005|Overall Study|Adverse Event|0|||
105338909|NCT00972816|363243506|FG006|Overall Study|Adverse Event|0|||
105338910|NCT00972816|363243507|FG007|Overall Study|Adverse Event|0|||
105338911|NCT00972816|363243500|FG000|Overall Study|Withdrawal by Subject|4|||
105338912|NCT00972816|363243501|FG001|Overall Study|Withdrawal by Subject|2|||
105338913|NCT00972816|363243502|FG002|Overall Study|Withdrawal by Subject|1|||
105338914|NCT00972816|363243503|FG003|Overall Study|Withdrawal by Subject|3|||
105338915|NCT00972816|363243504|FG004|Overall Study|Withdrawal by Subject|0|||
105338916|NCT00972816|363243505|FG005|Overall Study|Withdrawal by Subject|1|||
105338917|NCT00972816|363243506|FG006|Overall Study|Withdrawal by Subject|1|||
105338918|NCT00972816|363243507|FG007|Overall Study|Withdrawal by Subject|2|||
105338919|NCT00972816|363243500|FG000|Overall Study|Lost to Follow-up|11|||
105338920|NCT00972816|363243501|FG001|Overall Study|Lost to Follow-up|9|||
105462032|NCT00744497|363705610|FG000|Overall Study|Disease progression|312|||
105462033|NCT00744497|363705611|FG001|Overall Study|Disease progression|219|||
105462034|NCT00744497|363705610|FG000|Overall Study|Study drug toxicity|68|||
105462035|NCT00744497|363705611|FG001|Overall Study|Study drug toxicity|141|||
105462036|NCT00744497|363705610|FG000|Overall Study|Adverse event unrelated to study drug|78|||
105550336|NCT02117570|364014424|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
105550337|NCT02117570|364014425|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
105550338|NCT02117570|364014426|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
105550339|NCT02117570|364014424|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
105550340|NCT02117570|364014425|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
105462037|NCT00744497|363705611|FG001|Overall Study|Adverse event unrelated to study drug|122|||
105462038|NCT00744497|363705610|FG000|Overall Study|Patient requested to stop study drug|65|||
105462039|NCT00744497|363705611|FG001|Overall Study|Patient requested to stop study drug|80|||
105462040|NCT00744497|363705610|FG000|Overall Study|Maximum clinical benefit|141|||
105550341|NCT02117570|364014426|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
105550342|NCT02117570|364014424|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
105550343|NCT02117570|364014425|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
105550344|NCT02117570|364014426|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
105550345|NCT02117570|364014424|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
105550346|NCT02117570|364014425|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
105550347|NCT02117570|364014426|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
105550348|NCT02117570|364014424|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
105550349|NCT02117570|364014425|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
105550350|NCT02117570|364014426|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
105550351|NCT02117570|364014424|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
105550352|NCT02117570|364014425|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
105550353|NCT02117570|364014426|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
105550354|NCT02370602|364014427|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
105550355|NCT02370602|364014428|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
105550356|NCT02370602|364014429|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
105550357|NCT02370602|364014430|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
105550358|NCT02370602|364014431|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
105550359|NCT02370602|364014432|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
105550360|NCT00237744|364014433|FG000|Overall Study|Withdrawal by Subject|3|||
105550361|NCT00237744|364014434|FG001|Overall Study|Withdrawal by Subject|1|||
105662928|NCT03657576|364430050|FG000|Overall Study|Withdrawal by Subject|0|||
105662929|NCT03657576|364430051|FG001|Overall Study|Withdrawal by Subject|0|||
105662930|NCT03657576|364430052|FG002|Overall Study|Withdrawal by Subject|0|||
105662931|NCT03657576|364430053|FG003|Overall Study|Withdrawal by Subject|1|||
105785244|NCT02696382|364866425|FG001|Overall Study|Withdrawal by Subject|12|||
105462041|NCT00744497|363705611|FG001|Overall Study|Maximum clinical benefit|142|||
105462042|NCT00744497|363705610|FG000|Overall Study|Not defined|19|||
105462043|NCT00744497|363705611|FG001|Overall Study|Not defined|13|||
105462044|NCT03250273|363705615|FG000|Overall Study|Disease Progression|2|||
105462045|NCT03250273|363705616|FG001|Overall Study|Disease Progression|11|||
105462046|NCT03250273|363705615|FG000|Overall Study|Death|0|||
105462047|NCT03250273|363705616|FG001|Overall Study|Death|1|||
105338921|NCT00972816|363243502|FG002|Overall Study|Lost to Follow-up|7|||
105338922|NCT00972816|363243503|FG003|Overall Study|Lost to Follow-up|5|||
105338923|NCT00972816|363243504|FG004|Overall Study|Lost to Follow-up|11|||
105338924|NCT00972816|363243505|FG005|Overall Study|Lost to Follow-up|10|||
105338925|NCT00972816|363243506|FG006|Overall Study|Lost to Follow-up|7|||
105338926|NCT00972816|363243507|FG007|Overall Study|Lost to Follow-up|7|||
105338927|NCT00972816|363243500|FG000|Overall Study|Inappropriate enrolment|0|||
105338928|NCT00972816|363243501|FG001|Overall Study|Inappropriate enrolment|0|||
105338929|NCT00972816|363243502|FG002|Overall Study|Inappropriate enrolment|0|||
105338930|NCT00972816|363243503|FG003|Overall Study|Inappropriate enrolment|0|||
105338931|NCT00972816|363243504|FG004|Overall Study|Inappropriate enrolment|0|||
105338932|NCT00972816|363243505|FG005|Overall Study|Inappropriate enrolment|0|||
105338933|NCT00972816|363243506|FG006|Overall Study|Inappropriate enrolment|2|||
105338934|NCT00972816|363243507|FG007|Overall Study|Inappropriate enrolment|0|||
105338935|NCT00972816|363243500|FG000|Overall Study|Unable to classify|2|||
105338936|NCT00972816|363243501|FG001|Overall Study|Unable to classify|0|||
105462048|NCT02392624|363705617|FG000|Overall Study|Withdrawal by Subject|15|||
105462049|NCT02392624|363705618|FG001|Overall Study|Withdrawal by Subject|12|||
105785245|NCT02696382|364866424|FG000|Overall Study|Lost to Follow-up|4|||
105785246|NCT02696382|364866425|FG001|Overall Study|Lost to Follow-up|7|||
105785247|NCT03417245|364866426|FG000|Overall Study|Adverse Event|1|||
105785248|NCT03417245|364866427|FG001|Overall Study|Adverse Event|0|||
105785249|NCT03417245|364866426|FG000|Overall Study|Protocol Violation|1|||
105785250|NCT03417245|364866427|FG001|Overall Study|Protocol Violation|0|||
105785251|NCT03417245|364866426|FG000|Overall Study|Withdrawal by Subject|1|||
105785252|NCT03417245|364866427|FG001|Overall Study|Withdrawal by Subject|1|||
105785253|NCT00229931|364866432|FG000|Overall Study|Death|1|||
105785254|NCT00229931|364866433|FG001|Overall Study|Death|0|||
105785255|NCT00229931|364866432|FG000|Overall Study|Lost to Follow-up|3|||
105462050|NCT02392624|363705619|FG002|Overall Study|Withdrawal by Subject|9|||
105462051|NCT02392624|363705617|FG000|Overall Study|Adverse Event|4|||
105462052|NCT02392624|363705618|FG001|Overall Study|Adverse Event|1|||
105462053|NCT02392624|363705619|FG002|Overall Study|Adverse Event|2|||
105462054|NCT02392624|363705617|FG000|Overall Study|Pregnancy|1|||
105462055|NCT02392624|363705618|FG001|Overall Study|Pregnancy|0|||
105462056|NCT02392624|363705619|FG002|Overall Study|Pregnancy|0|||
105462057|NCT02392624|363705617|FG000|Overall Study|Protocol Violation|0|||
105550362|NCT00237744|364014435|FG002|Overall Study|Withdrawal by Subject|0|||
105550363|NCT00574080|364014438|FG000|Overall Study|Death|10|||
105550364|NCT00574080|364014439|FG001|Overall Study|Death|10|||
105550365|NCT04258020|364014448|FG000|Overall Study|Withdrawal by Subject|1|||
105550366|NCT04258020|364014449|FG001|Overall Study|Withdrawal by Subject|0|||
105550367|NCT02097472|364014450|FG000|Received Vaccination 2|Adverse Event|0|||
105550368|NCT02097472|364014451|FG001|Received Vaccination 2|Adverse Event|0|||
105550369|NCT02097472|364014452|FG002|Received Vaccination 2|Adverse Event|0|||
105550370|NCT02097472|364014453|FG003|Received Vaccination 2|Adverse Event|0|||
105550371|NCT02097472|364014454|FG004|Received Vaccination 2|Adverse Event|0|||
105550372|NCT02097472|364014455|FG005|Received Vaccination 2|Adverse Event|0|||
105550373|NCT02097472|364014456|FG006|Received Vaccination 2|Adverse Event|1|||
105550374|NCT02097472|364014457|FG007|Received Vaccination 2|Adverse Event|0|||
105550375|NCT00784810|364014458|FG000|Overall Study|Adverse Event|32|||
105550376|NCT00784810|364014459|FG001|Overall Study|Adverse Event|20|||
105550377|NCT00784810|364014458|FG000|Overall Study|Lack of Efficacy|14|||
105550378|NCT00784810|364014459|FG001|Overall Study|Lack of Efficacy|11|||
105550379|NCT00784810|364014458|FG000|Overall Study|Withdrawal by Subject|11|||
105550380|NCT00784810|364014459|FG001|Overall Study|Withdrawal by Subject|9|||
105550381|NCT00784810|364014458|FG000|Overall Study|Administrative|5|||
105550382|NCT00784810|364014459|FG001|Overall Study|Administrative|8|||
105550383|NCT00784810|364014458|FG000|Overall Study|Lost to Follow-up|1|||
105550384|NCT00784810|364014459|FG001|Overall Study|Lost to Follow-up|1|||
105550385|NCT03305016|364014460|FG000|Overall Study|Withdrawal by Subject|2|||
105550386|NCT02828111|364014465|FG000|Overall Study|Withdrawal by Subject|0|||
105785256|NCT00229931|364866433|FG001|Overall Study|Lost to Follow-up|2|||
105785257|NCT01374516|364866448|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
105785258|NCT01374516|364866449|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
105550387|NCT02828111|364014466|FG001|Overall Study|Withdrawal by Subject|0|||
105550388|NCT02828111|364014467|FG002|Overall Study|Withdrawal by Subject|2|||
105550389|NCT02828111|364014468|FG003|Overall Study|Withdrawal by Subject|0|||
105338937|NCT00972816|363243502|FG002|Overall Study|Unable to classify|0|||
105550390|NCT02828111|364014469|FG004|Overall Study|Withdrawal by Subject|0|||
105550391|NCT02828111|364014465|FG000|Overall Study|Lost to Follow-up|0|||
105550392|NCT02828111|364014466|FG001|Overall Study|Lost to Follow-up|0|||
105550393|NCT02828111|364014467|FG002|Overall Study|Lost to Follow-up|0|||
105550394|NCT02828111|364014468|FG003|Overall Study|Lost to Follow-up|1|||
105785259|NCT01374516|364866448|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
105785260|NCT01374516|364866449|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
105462058|NCT02392624|363705618|FG001|Overall Study|Protocol Violation|0|||
105785261|NCT01374516|364866448|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
105785262|NCT01374516|364866449|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
105550395|NCT02828111|364014469|FG004|Overall Study|Lost to Follow-up|1|||
105550396|NCT00148343|364014470|FG000|Overall Study|Withdrawal by Subject|12|||
105550397|NCT00148343|364014471|FG001|Overall Study|Withdrawal by Subject|7|||
105550398|NCT00148343|364014470|FG000|Overall Study|Physician Decision|3|||
105550399|NCT00148343|364014471|FG001|Overall Study|Physician Decision|4|||
105550400|NCT02844946|364014472|FG000|Overall Study|Lost to Follow-up|7|||
105550401|NCT02844946|364014473|FG001|Overall Study|Lost to Follow-up|0|||
105550402|NCT00407537|364014479|FG000|Overall Study|Death|5|||
105550403|NCT00407537|364014480|FG001|Overall Study|Death|2|||
105550404|NCT00407537|364014479|FG000|Overall Study|Adverse Event|36|||
105550405|NCT00407537|364014480|FG001|Overall Study|Adverse Event|0|||
105550406|NCT00407537|364014479|FG000|Overall Study|Lost to Follow-up|12|||
105550407|NCT00407537|364014480|FG001|Overall Study|Lost to Follow-up|19|||
105550408|NCT00407537|364014479|FG000|Overall Study|Other|6|||
105550409|NCT00407537|364014480|FG001|Overall Study|Other|7|||
105550410|NCT00407537|364014479|FG000|Overall Study|Withdrawal by Subject|34|||
105550411|NCT00407537|364014480|FG001|Overall Study|Withdrawal by Subject|16|||
105550412|NCT03879798|364014481|FG000|Overall Study|Adverse Event|0|||
105550413|NCT03879798|364014482|FG001|Overall Study|Adverse Event|0|||
105550414|NCT03879798|364014483|FG002|Overall Study|Adverse Event|0|||
105550415|NCT03879798|364014484|FG003|Overall Study|Adverse Event|0|||
105550416|NCT03879798|364014485|FG004|Overall Study|Adverse Event|0|||
105550417|NCT03879798|364014486|FG005|Overall Study|Adverse Event|1|||
105550418|NCT03879798|364014481|FG000|Overall Study|Lack of Efficacy|0|||
105550419|NCT03879798|364014482|FG001|Overall Study|Lack of Efficacy|0|||
105550420|NCT03879798|364014483|FG002|Overall Study|Lack of Efficacy|0|||
105550421|NCT03879798|364014484|FG003|Overall Study|Lack of Efficacy|0|||
105550422|NCT03879798|364014485|FG004|Overall Study|Lack of Efficacy|0|||
105550423|NCT03879798|364014486|FG005|Overall Study|Lack of Efficacy|1|||
105550424|NCT03879798|364014481|FG000|Overall Study|Withdrawal by Subject|0|||
105550425|NCT03879798|364014482|FG001|Overall Study|Withdrawal by Subject|0|||
105550426|NCT03879798|364014483|FG002|Overall Study|Withdrawal by Subject|0|||
105550427|NCT03879798|364014484|FG003|Overall Study|Withdrawal by Subject|0|||
105550428|NCT03879798|364014485|FG004|Overall Study|Withdrawal by Subject|0|||
105550429|NCT03879798|364014486|FG005|Overall Study|Withdrawal by Subject|1|||
105550430|NCT03759873|364014487|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
105550431|NCT03759873|364014488|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
105550432|NCT03759873|364014489|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
105550433|NCT03759873|364014490|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
105550434|NCT03759873|364014487|FG000|Overall Study|Moved outside eligible area|0|||
105550435|NCT03759873|364014488|FG001|Overall Study|Moved outside eligible area|2|||
105550436|NCT03759873|364014489|FG002|Overall Study|Moved outside eligible area|0|||
105550437|NCT03759873|364014490|FG003|Overall Study|Moved outside eligible area|0|||
105550438|NCT03759873|364014487|FG000|Overall Study|Withdrawal by Subject|0|||
105550439|NCT03759873|364014488|FG001|Overall Study|Withdrawal by Subject|0|||
105550440|NCT03759873|364014489|FG002|Overall Study|Withdrawal by Subject|1|||
105550441|NCT03759873|364014490|FG003|Overall Study|Withdrawal by Subject|0|||
105550442|NCT01715805|364014491|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
105550443|NCT01715805|364014492|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
105550444|NCT01715805|364014493|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
105550445|NCT01715805|364014494|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
105550446|NCT01715805|364014491|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
105550447|NCT01715805|364014492|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
105550448|NCT01715805|364014493|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
105550449|NCT01715805|364014494|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
105550450|NCT01715805|364014491|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
105550451|NCT01715805|364014492|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
105550452|NCT01715805|364014493|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
105550453|NCT01715805|364014494|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
105662932|NCT03657576|364430054|FG004|Overall Study|Withdrawal by Subject|0|||
105662933|NCT03657576|364430055|FG005|Overall Study|Withdrawal by Subject|0|||
105662934|NCT03657576|364430050|FG000|Overall Study|Screen Fail|0|||
105662935|NCT03657576|364430051|FG001|Overall Study|Screen Fail|0|||
105662936|NCT03657576|364430052|FG002|Overall Study|Screen Fail|0|||
105662937|NCT03657576|364430053|FG003|Overall Study|Screen Fail|0|||
105662938|NCT03657576|364430054|FG004|Overall Study|Screen Fail|0|||
105662939|NCT03657576|364430055|FG005|Overall Study|Screen Fail|5|||
105662940|NCT03657576|364430050|FG000|Overall Study|Disease Progression|1|||
105550454|NCT01715805|364014491|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
105662941|NCT03657576|364430051|FG001|Overall Study|Disease Progression|1|||
105662942|NCT03657576|364430052|FG002|Overall Study|Disease Progression|0|||
105662943|NCT03657576|364430053|FG003|Overall Study|Disease Progression|5|||
105662944|NCT03657576|364430054|FG004|Overall Study|Disease Progression|0|||
105662945|NCT03657576|364430055|FG005|Overall Study|Disease Progression|0|||
105550455|NCT01715805|364014492|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
105662946|NCT03657576|364430050|FG000|Overall Study|Insurance Coverage|0|||
105662947|NCT03657576|364430051|FG001|Overall Study|Insurance Coverage|0|||
105462059|NCT02392624|363705619|FG002|Overall Study|Protocol Violation|1|||
105462060|NCT02392624|363705617|FG000|Overall Study|Sponsor/Investigator Decision|2|||
105462061|NCT02392624|363705618|FG001|Overall Study|Sponsor/Investigator Decision|1|||
105462062|NCT02392624|363705619|FG002|Overall Study|Sponsor/Investigator Decision|0|||
105462063|NCT02392624|363705617|FG000|Overall Study|Other|49|||
105462064|NCT02392624|363705618|FG001|Overall Study|Other|1|||
105462065|NCT02392624|363705619|FG002|Overall Study|Other|1|||
105462066|NCT00936715|363705620|FG000|Overall Study|Investigators Discretion|1|||
105462067|NCT00936715|363705620|FG000|Overall Study|Protocol Violation|1|||
105462068|NCT00936715|363705620|FG000|Overall Study|Safety or Tolerability Reasons|4|||
105462069|NCT01462370|363705621|FG000|Overall Study|Lack of Qualifying Event|1|||
105462070|NCT01462370|363705622|FG001|Overall Study|Lack of Qualifying Event|1|||
105462071|NCT01462370|363705621|FG000|Overall Study|Physician Decision|0|||
105462072|NCT01462370|363705622|FG001|Overall Study|Physician Decision|1|||
105462073|NCT01462370|363705621|FG000|Overall Study|Withdrawal by Subject|0|||
105462074|NCT01462370|363705622|FG001|Overall Study|Withdrawal by Subject|3|||
105462075|NCT01337960|363705623|FG000|Overall Study|Lost to Follow-up|1|||
105462076|NCT01337960|363705624|FG001|Overall Study|Lost to Follow-up|0|||
105462077|NCT01337960|363705625|FG002|Overall Study|Lost to Follow-up|0|||
105462078|NCT01337960|363705623|FG000|Overall Study|Withdrawal by Subject|1|||
105462079|NCT01337960|363705624|FG001|Overall Study|Withdrawal by Subject|0|||
105462080|NCT01337960|363705625|FG002|Overall Study|Withdrawal by Subject|0|||
105462081|NCT05101122|363705626|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
105462082|NCT05101122|363705626|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
105462083|NCT05101122|363705626|FG000|AD313 80/5|Withdrawal by Subject|1|||
105462084|NCT05101122|363705626|FG000|AD313 80/10|Physician Decision|1|||
105462085|NCT02703597|363705636|FG000|Assignment to Baseline|Lost to Follow-up|17|||
105462086|NCT02703597|363705637|FG001|Assignment to Baseline|Lost to Follow-up|16|||
105462087|NCT02703597|363705636|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
105462088|NCT02703597|363705637|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
105462089|NCT02703597|363705636|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
105462090|NCT02703597|363705637|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
105462091|NCT02703597|363705636|FG000|First Post-test to First Follow-up|Site drop out|0|||
105462092|NCT02703597|363705637|FG001|First Post-test to First Follow-up|Site drop out|58|||
105462093|NCT02703597|363705636|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
105462094|NCT02703597|363705637|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
105462095|NCT02703597|363705636|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
105462096|NCT02703597|363705637|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
105462097|NCT02703597|363705636|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
105462098|NCT02703597|363705637|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
105785263|NCT01374516|364866448|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
105785264|NCT01374516|364866449|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
105785265|NCT01374516|364866448|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
105785266|NCT01374516|364866449|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
105785267|NCT01374516|364866448|FG000|Surveillance Expansion Period|Protocol Violation|386|||
105785268|NCT01374516|364866449|FG001|Surveillance Expansion Period|Protocol Violation|217|||
105785269|NCT01374516|364866448|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
105338938|NCT00972816|363243503|FG003|Overall Study|Unable to classify|0|||
105338939|NCT00972816|363243504|FG004|Overall Study|Unable to classify|1|||
105338940|NCT00972816|363243505|FG005|Overall Study|Unable to classify|0|||
105338941|NCT00972816|363243506|FG006|Overall Study|Unable to classify|0|||
105785270|NCT01374516|364866449|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
105785271|NCT01374516|364866448|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
105785272|NCT01374516|364866449|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
105785273|NCT01374516|364866448|FG000|Surveillance Expansion Period|Serious adverse event|20|||
105785274|NCT01374516|364866449|FG001|Surveillance Expansion Period|Serious adverse event|5|||
105785275|NCT00505765|364866453|FG000|Overall Study|Withdrawal by Subject|1|||
105785276|NCT00505765|364866454|FG001|Overall Study|Withdrawal by Subject|0|||
105785277|NCT00505765|364866455|FG002|Overall Study|Withdrawal by Subject|0|||
105785278|NCT00505765|364866453|FG000|Overall Study|Adverse Event|1|||
105785279|NCT00505765|364866454|FG001|Overall Study|Adverse Event|2|||
105785280|NCT00505765|364866455|FG002|Overall Study|Adverse Event|0|||
105785281|NCT00505765|364866453|FG000|Overall Study|Noncompliance|0|||
105785282|NCT00505765|364866454|FG001|Overall Study|Noncompliance|1|||
105785283|NCT00505765|364866455|FG002|Overall Study|Noncompliance|3|||
105785284|NCT03219372|364866456|FG000|Overall Study|Withdrawal by Subject|1|||
105785285|NCT03219372|364866457|FG001|Overall Study|Withdrawal by Subject|0|||
105785286|NCT04145531|364866461|FG000|Part A|Adverse Event|2|||
105785287|NCT04145531|364866462|FG001|Part A|Adverse Event|12|||
105785288|NCT04145531|364866463|FG002|Part A|Adverse Event|6|||
105785289|NCT04145531|364866464|FG003|Part A|Adverse Event|0|||
105785290|NCT04145531|364866461|FG000|Part A|Death|1|||
105785291|NCT04145531|364866462|FG001|Part A|Death|2|||
105785292|NCT04145531|364866463|FG002|Part A|Death|0|||
105785293|NCT04145531|364866464|FG003|Part A|Death|0|||
105785294|NCT04145531|364866461|FG000|Part A|Physician Decision|2|||
105785295|NCT04145531|364866462|FG001|Part A|Physician Decision|5|||
105785296|NCT04145531|364866463|FG002|Part A|Physician Decision|2|||
105785297|NCT04145531|364866464|FG003|Part A|Physician Decision|0|||
105785298|NCT04145531|364866461|FG000|Part A|Progressive disease|0|||
105785299|NCT04145531|364866462|FG001|Part A|Progressive disease|2|||
105785300|NCT04145531|364866463|FG002|Part A|Progressive disease|1|||
105785301|NCT04145531|364866464|FG003|Part A|Progressive disease|0|||
105338942|NCT00972816|363243507|FG007|Overall Study|Unable to classify|0|||
105462099|NCT00763035|363705638|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
105462100|NCT00763035|363705639|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
105462101|NCT00763035|363705638|FG000|First Intervention|Adverse Event|0|||
105462102|NCT00763035|363705639|FG001|First Intervention|Adverse Event|1|||
105462103|NCT00763035|363705638|FG000|Second Intervention|Adverse Event|1|||
105462104|NCT00763035|363705639|FG001|Second Intervention|Adverse Event|0|||
105462105|NCT00763035|363705638|FG000|Second Intervention|Physician Decision|2|||
105462106|NCT00763035|363705639|FG001|Second Intervention|Physician Decision|0|||
105462107|NCT02606643|363705640|FG000|Overall Study|did not meet inclusion criteria|1|||
105462108|NCT02606643|363705641|FG001|Overall Study|did not meet inclusion criteria|3|||
105462109|NCT02131259|363705642|FG000|Overall Study|Progressive disease|751|||
105462110|NCT02131259|363705642|FG000|Overall Study|Adverse Event|341|||
105462111|NCT02131259|363705642|FG000|Overall Study|Lost to Follow-up|7|||
105462112|NCT02131259|363705642|FG000|Overall Study|Relocation|32|||
105462113|NCT02131259|363705642|FG000|Overall Study|Other|63|||
105462114|NCT02131259|363705642|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
105462115|NCT02131259|363705642|FG000|Overall Study|Progressive disease/relocation|1|||
105462116|NCT02131259|363705642|FG000|Overall Study|Progressive disease/other|2|||
105462117|NCT02131259|363705642|FG000|Overall Study|AE/lost to follow-up|1|||
105462118|NCT02131259|363705642|FG000|Overall Study|AE/other|1|||
105462119|NCT02131259|363705642|FG000|Overall Study|Progressive disease/AE/other|1|||
105462120|NCT02131259|363705642|FG000|Overall Study|Missing|3|||
105785302|NCT04145531|364866461|FG000|Part A|Protocol deviation|0|||
105785303|NCT04145531|364866462|FG001|Part A|Protocol deviation|0|||
105785304|NCT04145531|364866463|FG002|Part A|Protocol deviation|1|||
105785305|NCT04145531|364866464|FG003|Part A|Protocol deviation|0|||
105785306|NCT04145531|364866461|FG000|Part A|Withdrawal by parent or guardian|1|||
105462121|NCT03219723|363705645|FG000|Overall Study|Case Report Forms Uncollected|6|||
105462122|NCT03219723|363705645|FG000|Overall Study|Protocol Deviation|4|||
105462123|NCT02351817|363705646|FG000|Period 1|Adverse Event|1|||
105785307|NCT04145531|364866462|FG001|Part A|Withdrawal by parent or guardian|0|||
105785308|NCT04145531|364866463|FG002|Part A|Withdrawal by parent or guardian|0|||
105785309|NCT04145531|364866464|FG003|Part A|Withdrawal by parent or guardian|0|||
105785310|NCT04145531|364866461|FG000|Part A|Withdrawal by participant|0|||
105462124|NCT02351817|363705647|FG001|Period 1|Adverse Event|2|||
105462125|NCT02351817|363705646|FG000|Period 1|Lack of Efficacy|0|||
105462126|NCT02351817|363705647|FG001|Period 1|Lack of Efficacy|1|||
105462127|NCT02351817|363705646|FG000|Period 2|Adverse Event|0|||
105462128|NCT02351817|363705647|FG001|Period 2|Adverse Event|2|||
105462129|NCT02351817|363705646|FG000|Period 2|Protocol Violation|1|||
105462130|NCT02351817|363705647|FG001|Period 2|Protocol Violation|0|||
105462131|NCT02488915|363705648|FG000|Overall Study|Death|21|||
105462132|NCT02488915|363705648|FG000|Overall Study|Lost to Follow-up|4|||
105462133|NCT02488915|363705648|FG000|Overall Study|Withdrawal by Subject|1|||
105462134|NCT01980017|363705649|FG000|Overall Study|Lost to Follow-up|30|||
105462135|NCT01980017|363705650|FG001|Overall Study|Lost to Follow-up|21|||
105462136|NCT01980017|363705649|FG000|Overall Study|Death|0|||
105462137|NCT01980017|363705650|FG001|Overall Study|Death|1|||
105462138|NCT03044106|363705651|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
105462139|NCT03044106|363705652|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
105462140|NCT02057250|363705653|FG000|AID Assessment Phase|Adverse Event|3|||
105462141|NCT02057250|363705654|FG001|AID Assessment Phase|Adverse Event|2|||
105462142|NCT02057250|363705655|FG002|AID Assessment Phase|Adverse Event|6|||
105462143|NCT02057250|363705656|FG003|AID Assessment Phase|Adverse Event|1|||
105462144|NCT02057250|363705657|FG004|AID Assessment Phase|Adverse Event|0|||
105462145|NCT02057250|363705653|FG000|AID Assessment Phase|Other than specified above|1|||
105462146|NCT02057250|363705654|FG001|AID Assessment Phase|Other than specified above|1|||
105462147|NCT02057250|363705655|FG002|AID Assessment Phase|Other than specified above|1|||
105462148|NCT02057250|363705656|FG003|AID Assessment Phase|Other than specified above|1|||
105462149|NCT02057250|363705657|FG004|AID Assessment Phase|Other than specified above|0|||
105462150|NCT02057250|363705653|FG000|Extension Phase|Adverse Event|0|||
105462151|NCT02057250|363705654|FG001|Extension Phase|Adverse Event|0|||
105462152|NCT02057250|363705655|FG002|Extension Phase|Adverse Event|0|||
105462153|NCT02057250|363705656|FG003|Extension Phase|Adverse Event|0|||
105462154|NCT02057250|363705657|FG004|Extension Phase|Adverse Event|15|||
105462155|NCT02057250|363705653|FG000|Extension Phase|Lack of Efficacy|0|||
105462156|NCT02057250|363705654|FG001|Extension Phase|Lack of Efficacy|0|||
105462157|NCT02057250|363705655|FG002|Extension Phase|Lack of Efficacy|0|||
105462158|NCT02057250|363705656|FG003|Extension Phase|Lack of Efficacy|0|||
105462159|NCT02057250|363705657|FG004|Extension Phase|Lack of Efficacy|10|||
105462160|NCT02057250|363705653|FG000|Extension Phase|Entered in this period but not treated|0|||
105462161|NCT02057250|363705654|FG001|Extension Phase|Entered in this period but not treated|0|||
105462162|NCT02057250|363705655|FG002|Extension Phase|Entered in this period but not treated|0|||
105462163|NCT02057250|363705656|FG003|Extension Phase|Entered in this period but not treated|0|||
105462164|NCT02057250|363705657|FG004|Extension Phase|Entered in this period but not treated|4|||
105462165|NCT02057250|363705653|FG000|Extension Phase|Other than specified above|0|||
105462166|NCT02057250|363705654|FG001|Extension Phase|Other than specified above|0|||
105462167|NCT02057250|363705655|FG002|Extension Phase|Other than specified above|0|||
105462168|NCT02057250|363705656|FG003|Extension Phase|Other than specified above|0|||
105462169|NCT02057250|363705657|FG004|Extension Phase|Other than specified above|7|||
105462170|NCT00684021|363705659|FG000|Overall Study|MRI Contraindicated|1|||
105462171|NCT00684021|363705660|FG001|Overall Study|MRI Contraindicated|1|||
105462172|NCT00684021|363705661|FG002|Overall Study|MRI Contraindicated|1|||
105462173|NCT00684021|363705662|FG003|Overall Study|MRI Contraindicated|0|||
105462174|NCT00684021|363705659|FG000|Overall Study|MRI not performed|0|||
105462175|NCT00684021|363705660|FG001|Overall Study|MRI not performed|1|||
105462176|NCT00684021|363705661|FG002|Overall Study|MRI not performed|1|||
105462177|NCT00684021|363705662|FG003|Overall Study|MRI not performed|2|||
105462178|NCT00684021|363705659|FG000|Overall Study|Death|1|||
105462179|NCT00684021|363705660|FG001|Overall Study|Death|0|||
105462180|NCT00684021|363705661|FG002|Overall Study|Death|0|||
105462181|NCT00684021|363705662|FG003|Overall Study|Death|0|||
105462182|NCT04596267|363705667|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
105462183|NCT04596267|363705668|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
105462184|NCT04596267|363705667|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
105462185|NCT04596267|363705668|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
105462186|NCT00071058|363705669|FG000|Overall Study|brain tumor-removed from study|1|||
105462187|NCT01188343|363705670|FG000|Overall Study|Not vaccinated|0|||
105662948|NCT03657576|364430052|FG002|Overall Study|Insurance Coverage|0|||
105785311|NCT04145531|364866462|FG001|Part A|Withdrawal by participant|0|||
105785312|NCT04145531|364866463|FG002|Part A|Withdrawal by participant|1|||
105462188|NCT01188343|363705671|FG001|Overall Study|Not vaccinated|2|||
105462189|NCT01188343|363705672|FG002|Overall Study|Not vaccinated|1|||
105462190|NCT01188343|363705670|FG000|Overall Study|Withdrawal by Subject|1|||
105462191|NCT01188343|363705671|FG001|Overall Study|Withdrawal by Subject|24|||
105462192|NCT01188343|363705672|FG002|Overall Study|Withdrawal by Subject|0|||
105462193|NCT03521570|363705675|FG000|Overall Study|Not eligible|11|||
105462194|NCT01033019|363705676|FG000|Overall Study|Withdrawal by Subject|1|||
105462195|NCT01033019|363705677|FG001|Overall Study|Withdrawal by Subject|0|||
105462196|NCT03592186|363705678|FG000|Overall Study|Withdrawal by Subject|1|||
105462197|NCT03592186|363705679|FG001|Overall Study|Withdrawal by Subject|0|||
105462198|NCT03592186|363705678|FG000|Overall Study|Lost to Follow-up|16|||
105462199|NCT03592186|363705679|FG001|Overall Study|Lost to Follow-up|11|||
105462200|NCT01052493|363705682|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
105462201|NCT01052493|363705683|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
105462202|NCT01052493|363705684|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
105462203|NCT01498068|363705687|FG000|Overall Study|Withdrawal by Subject|1|||
105462204|NCT01498068|363705688|FG001|Overall Study|Withdrawal by Subject|1|||
105462205|NCT03866577|363705695|FG000|Overall Study|Protocol Violation|0|||
105462206|NCT03866577|363705696|FG001|Overall Study|Protocol Violation|0|||
105462207|NCT03866577|363705697|FG002|Overall Study|Protocol Violation|0|||
105462208|NCT03866577|363705698|FG003|Overall Study|Protocol Violation|0|||
105462209|NCT03866577|363705699|FG004|Overall Study|Protocol Violation|0|||
105462210|NCT03866577|363705700|FG005|Overall Study|Protocol Violation|0|||
105462211|NCT03866577|363705701|FG006|Overall Study|Protocol Violation|0|||
105462212|NCT03866577|363705702|FG007|Overall Study|Protocol Violation|0|||
105462213|NCT03866577|363705703|FG008|Overall Study|Protocol Violation|0|||
105462214|NCT03866577|363705704|FG009|Overall Study|Protocol Violation|0|||
105462215|NCT03866577|363705705|FG010|Overall Study|Protocol Violation|0|||
105462216|NCT03866577|363705706|FG011|Overall Study|Protocol Violation|1|||
105462217|NCT03866577|363705707|FG012|Overall Study|Protocol Violation|0|||
105462218|NCT03866577|363705695|FG000|Overall Study|Withdrawal by Subject|0|||
105462219|NCT03866577|363705696|FG001|Overall Study|Withdrawal by Subject|0|||
105462220|NCT03866577|363705697|FG002|Overall Study|Withdrawal by Subject|0|||
105462221|NCT03866577|363705698|FG003|Overall Study|Withdrawal by Subject|0|||
105462222|NCT03866577|363705699|FG004|Overall Study|Withdrawal by Subject|0|||
105462223|NCT03866577|363705700|FG005|Overall Study|Withdrawal by Subject|0|||
105462224|NCT03866577|363705701|FG006|Overall Study|Withdrawal by Subject|0|||
105462225|NCT03866577|363705702|FG007|Overall Study|Withdrawal by Subject|0|||
105462226|NCT03866577|363705703|FG008|Overall Study|Withdrawal by Subject|1|||
105462227|NCT03866577|363705704|FG009|Overall Study|Withdrawal by Subject|1|||
105462228|NCT03866577|363705705|FG010|Overall Study|Withdrawal by Subject|0|||
105462229|NCT03866577|363705706|FG011|Overall Study|Withdrawal by Subject|0|||
105462230|NCT03866577|363705707|FG012|Overall Study|Withdrawal by Subject|0|||
105462231|NCT03866577|363705695|FG000|Overall Study|Not qualified for IVIg infusion|0|||
105462232|NCT03866577|363705696|FG001|Overall Study|Not qualified for IVIg infusion|0|||
105462233|NCT03866577|363705697|FG002|Overall Study|Not qualified for IVIg infusion|0|||
105462234|NCT03866577|363705698|FG003|Overall Study|Not qualified for IVIg infusion|0|||
105462235|NCT03866577|363705699|FG004|Overall Study|Not qualified for IVIg infusion|0|||
105462236|NCT03866577|363705700|FG005|Overall Study|Not qualified for IVIg infusion|0|||
105462237|NCT03866577|363705701|FG006|Overall Study|Not qualified for IVIg infusion|0|||
105462238|NCT03866577|363705702|FG007|Overall Study|Not qualified for IVIg infusion|0|||
105462239|NCT03866577|363705703|FG008|Overall Study|Not qualified for IVIg infusion|0|||
105462240|NCT03866577|363705704|FG009|Overall Study|Not qualified for IVIg infusion|1|||
105462241|NCT03866577|363705705|FG010|Overall Study|Not qualified for IVIg infusion|0|||
105462242|NCT03866577|363705706|FG011|Overall Study|Not qualified for IVIg infusion|0|||
105462243|NCT03866577|363705707|FG012|Overall Study|Not qualified for IVIg infusion|0|||
105462244|NCT05530252|363705708|FG000|Overall Study|Lost to Follow-up|1|||
105462245|NCT05530252|363705709|FG001|Overall Study|Lost to Follow-up|1|||
105462246|NCT05530252|363705710|FG002|Overall Study|Lost to Follow-up|1|||
105462247|NCT05615922|363705711|FG000|Overall Study|Lost to Follow-up|1|||
105462248|NCT03043794|363705712|FG000|Overall Study|Lost to Follow-up|1|||
105462249|NCT02514083|363705713|FG000|Overall Study|Adverse Event|1|||
105462250|NCT02892344|363707204|FG000|Overall Study|Protocol deviation|3|||
105462251|NCT02892344|363707205|FG001|Overall Study|Protocol deviation|4|||
105462252|NCT02892344|363707204|FG000|Overall Study|Adverse Event|1|||
105462253|NCT02892344|363707205|FG001|Overall Study|Adverse Event|8|||
105462254|NCT02892344|363707204|FG000|Overall Study|Lost to Follow-up|0|||
105462255|NCT02892344|363707205|FG001|Overall Study|Lost to Follow-up|1|||
105462256|NCT02892344|363707204|FG000|Overall Study|Non-compliance with study treatment|0|||
105338943|NCT03558152|363243509|FG000|Overall Study|Adverse Event|0|||
105462257|NCT02892344|363707205|FG001|Overall Study|Non-compliance with study treatment|1|||
105462258|NCT02892344|363707204|FG000|Overall Study|Physician Decision|0|||
105462259|NCT02892344|363707205|FG001|Overall Study|Physician Decision|2|||
105462260|NCT02892344|363707204|FG000|Overall Study|Subject/guardian decision|0|||
105462261|NCT02892344|363707205|FG001|Overall Study|Subject/guardian decision|4|||
105462262|NCT02892344|363707204|FG000|Overall Study|Technical problems|0|||
105462263|NCT02892344|363707205|FG001|Overall Study|Technical problems|1|||
105462264|NCT01586364|363707206|FG000|Overall Study|Withdrawal by Subject|40|||
105338944|NCT03558152|363243510|FG001|Overall Study|Adverse Event|0|||
105338945|NCT03558152|363243511|FG002|Overall Study|Adverse Event|1|||
105338946|NCT03558152|363243512|FG003|Overall Study|Adverse Event|1|||
105338947|NCT03558152|363243513|FG004|Overall Study|Adverse Event|2|||
105338948|NCT03558152|363243514|FG005|Overall Study|Adverse Event|1|||
105338949|NCT03558152|363243515|FG006|Overall Study|Adverse Event|1|||
105338950|NCT03558152|363243516|FG007|Overall Study|Adverse Event|0|||
105338951|NCT03558152|363243509|FG000|Overall Study|Death|0|||
105338952|NCT03558152|363243510|FG001|Overall Study|Death|0|||
105338953|NCT03558152|363243511|FG002|Overall Study|Death|0|||
105338954|NCT03558152|363243512|FG003|Overall Study|Death|0|||
105338955|NCT03558152|363243513|FG004|Overall Study|Death|1|||
105338956|NCT03558152|363243514|FG005|Overall Study|Death|0|||
105338957|NCT03558152|363243515|FG006|Overall Study|Death|0|||
105338958|NCT03558152|363243516|FG007|Overall Study|Death|0|||
105338959|NCT03558152|363243509|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
105338960|NCT03558152|363243510|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
105338961|NCT03558152|363243511|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
105338962|NCT03558152|363243512|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
105338963|NCT03558152|363243513|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
105338964|NCT03558152|363243514|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
105338965|NCT03558152|363243515|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
105338966|NCT03558152|363243516|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
105338967|NCT03558152|363243509|FG000|Overall Study|Miscalculation in mmcs|0|||
105338968|NCT03558152|363243510|FG001|Overall Study|Miscalculation in mmcs|0|||
105338969|NCT03558152|363243511|FG002|Overall Study|Miscalculation in mmcs|0|||
105338970|NCT03558152|363243512|FG003|Overall Study|Miscalculation in mmcs|0|||
105338971|NCT03558152|363243513|FG004|Overall Study|Miscalculation in mmcs|0|||
105338972|NCT03558152|363243514|FG005|Overall Study|Miscalculation in mmcs|0|||
105338973|NCT03558152|363243515|FG006|Overall Study|Miscalculation in mmcs|1|||
105338974|NCT03558152|363243516|FG007|Overall Study|Miscalculation in mmcs|0|||
105338975|NCT03558152|363243509|FG000|Overall Study|Mistake in calculation|0|||
105338976|NCT03558152|363243510|FG001|Overall Study|Mistake in calculation|0|||
105338977|NCT03558152|363243511|FG002|Overall Study|Mistake in calculation|0|||
105338978|NCT03558152|363243512|FG003|Overall Study|Mistake in calculation|1|||
105338979|NCT03558152|363243513|FG004|Overall Study|Mistake in calculation|0|||
105338980|NCT03558152|363243514|FG005|Overall Study|Mistake in calculation|0|||
105338981|NCT03558152|363243515|FG006|Overall Study|Mistake in calculation|0|||
105338982|NCT03558152|363243516|FG007|Overall Study|Mistake in calculation|0|||
105338983|NCT03558152|363243509|FG000|Overall Study|Mistake in evaluation of disease status|0|||
105338984|NCT03558152|363243510|FG001|Overall Study|Mistake in evaluation of disease status|0|||
105338985|NCT03558152|363243511|FG002|Overall Study|Mistake in evaluation of disease status|0|||
105338986|NCT03558152|363243512|FG003|Overall Study|Mistake in evaluation of disease status|0|||
105338987|NCT03558152|363243513|FG004|Overall Study|Mistake in evaluation of disease status|0|||
105338988|NCT03558152|363243514|FG005|Overall Study|Mistake in evaluation of disease status|0|||
105338989|NCT03558152|363243515|FG006|Overall Study|Mistake in evaluation of disease status|0|||
105338990|NCT03558152|363243516|FG007|Overall Study|Mistake in evaluation of disease status|1|||
105338991|NCT03558152|363243509|FG000|Overall Study|Physician Decision|0|||
105338992|NCT03558152|363243510|FG001|Overall Study|Physician Decision|0|||
105338993|NCT03558152|363243511|FG002|Overall Study|Physician Decision|0|||
105338994|NCT03558152|363243512|FG003|Overall Study|Physician Decision|0|||
105338995|NCT03558152|363243513|FG004|Overall Study|Physician Decision|0|||
105338996|NCT03558152|363243514|FG005|Overall Study|Physician Decision|0|||
105338997|NCT03558152|363243515|FG006|Overall Study|Physician Decision|1|||
105338998|NCT03558152|363243516|FG007|Overall Study|Physician Decision|0|||
105338999|NCT03558152|363243509|FG000|Overall Study|Withdrawal by Subject|2|||
105339000|NCT03558152|363243510|FG001|Overall Study|Withdrawal by Subject|3|||
105462265|NCT01586364|363707206|FG000|Overall Study|Adverse Event|37|||
105462266|NCT01586364|363707206|FG000|Overall Study|Lost to Follow-up|17|||
105462267|NCT01586364|363707206|FG000|Overall Study|Protocol Violation|16|||
105462268|NCT01586364|363707206|FG000|Overall Study|Lack of Efficacy|1|||
105462269|NCT01586364|363707206|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
105462270|NCT01586364|363707206|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
105462271|NCT01586364|363707206|FG000|Overall Study|Other-Site closure due to PI illness|1|||
105462272|NCT01586364|363707206|FG000|Overall Study|Other-PI discretion, site closing|2|||
105462273|NCT01586364|363707206|FG000|Overall Study|Other-Not specified|1|||
105462274|NCT02121535|363707207|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
105462275|NCT02121535|363707208|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
105462276|NCT02121535|363707207|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
105462277|NCT02121535|363707208|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
105462278|NCT00091949|363707209|FG000|Overall Study|Withdrawal by Subject|117|||
105462279|NCT00091949|363707210|FG001|Overall Study|Withdrawal by Subject|110|||
105462280|NCT00091949|363707209|FG000|Overall Study|Lost to Follow-up|58|||
105462281|NCT00091949|363707210|FG001|Overall Study|Lost to Follow-up|41|||
105339001|NCT03558152|363243511|FG002|Overall Study|Withdrawal by Subject|2|||
105339002|NCT03558152|363243512|FG003|Overall Study|Withdrawal by Subject|1|||
105339003|NCT03558152|363243513|FG004|Overall Study|Withdrawal by Subject|1|||
105339004|NCT03558152|363243514|FG005|Overall Study|Withdrawal by Subject|1|||
105339005|NCT03558152|363243515|FG006|Overall Study|Withdrawal by Subject|3|||
105339006|NCT03558152|363243516|FG007|Overall Study|Withdrawal by Subject|2|||
105339007|NCT03558152|363243509|FG000|Overall Study|Lack of Efficacy|11|||
105339008|NCT03558152|363243510|FG001|Overall Study|Lack of Efficacy|11|||
105339009|NCT03558152|363243511|FG002|Overall Study|Lack of Efficacy|10|||
105339010|NCT03558152|363243512|FG003|Overall Study|Lack of Efficacy|11|||
105339011|NCT03558152|363243513|FG004|Overall Study|Lack of Efficacy|14|||
105339012|NCT03558152|363243514|FG005|Overall Study|Lack of Efficacy|12|||
105339013|NCT03558152|363243515|FG006|Overall Study|Lack of Efficacy|14|||
105339014|NCT03558152|363243516|FG007|Overall Study|Lack of Efficacy|13|||
105339015|NCT03558152|363243509|FG000|Overall Study|Protocol Violation|1|||
105339016|NCT03558152|363243510|FG001|Overall Study|Protocol Violation|1|||
105339017|NCT03558152|363243511|FG002|Overall Study|Protocol Violation|0|||
105339018|NCT03558152|363243512|FG003|Overall Study|Protocol Violation|1|||
105339019|NCT03558152|363243513|FG004|Overall Study|Protocol Violation|1|||
105339020|NCT03558152|363243514|FG005|Overall Study|Protocol Violation|0|||
105339021|NCT03558152|363243515|FG006|Overall Study|Protocol Violation|2|||
105339022|NCT03558152|363243516|FG007|Overall Study|Protocol Violation|0|||
105339023|NCT00784238|363243517|FG000|Overall Study|Adverse Event|14|||
105339024|NCT00784238|363243517|FG000|Overall Study|Death|2|||
105339025|NCT00784238|363243517|FG000|Overall Study|Lack of Efficacy|33|||
105339026|NCT00784238|363243517|FG000|Overall Study|Lost to Follow-up|29|||
105339027|NCT00784238|363243517|FG000|Overall Study|Pregnancy|1|||
105339028|NCT00784238|363243517|FG000|Overall Study|Withdrawal by Subject|26|||
105339029|NCT00784238|363243517|FG000|Overall Study|Other|14|||
105339030|NCT04310397|363243529|FG000|Overall Study|Lack of Efficacy|3|||
105339031|NCT04310397|363243529|FG000|Overall Study|Withdrawal by Subject|1|||
105339032|NCT00614523|363243532|FG000|Overall Study|Adverse Event|4|||
105339033|NCT00614523|363243533|FG001|Overall Study|Adverse Event|20|||
105339034|NCT00614523|363243532|FG000|Overall Study|Death|5|||
105339035|NCT00614523|363243533|FG001|Overall Study|Death|8|||
105339036|NCT00614523|363243532|FG000|Overall Study|Lack of Efficacy|9|||
105339037|NCT00614523|363243533|FG001|Overall Study|Lack of Efficacy|11|||
105339038|NCT00614523|363243532|FG000|Overall Study|Lost to Follow-up|0|||
105339039|NCT00614523|363243533|FG001|Overall Study|Lost to Follow-up|1|||
105339040|NCT00614523|363243532|FG000|Overall Study|Protocol Violation|3|||
105462282|NCT01520506|363707211|FG000|Overall Study|Missed Visit|4|||
105462283|NCT01520506|363707211|FG000|Overall Study|Lost to Follow-up|1|||
105462284|NCT01520506|363707211|FG000|Overall Study|Withdrawal by Subject|1|||
105462285|NCT01256788|363707212|FG000|Overall Study|Lost to Follow-up|5|||
105462286|NCT01256788|363707213|FG001|Overall Study|Lost to Follow-up|8|||
105462287|NCT01256788|363707214|FG002|Overall Study|Lost to Follow-up|3|||
105462288|NCT02083354|363707215|FG000|Overall Study|Withdrawal by Subject|9|||
105462289|NCT02083354|363707215|FG000|Overall Study|Lost to Follow-up|1|||
105462290|NCT02083354|363707215|FG000|Overall Study|Adverse Event|3|||
105462291|NCT02083354|363707215|FG000|Overall Study|Disease progression|46|||
105462292|NCT02083354|363707215|FG000|Overall Study|Study closed/terminated|5|||
105462293|NCT03312634|363707216|FG000|Overall Study|Adverse Event|11|||
105462294|NCT03312634|363707217|FG001|Overall Study|Adverse Event|0|||
105462295|NCT03312634|363707216|FG000|Overall Study|Sponsor request|2|||
105462296|NCT03312634|363707217|FG001|Overall Study|Sponsor request|0|||
105462297|NCT03312634|363707216|FG000|Overall Study|Withdrawal by Subject|31|||
105462298|NCT03312634|363707217|FG001|Overall Study|Withdrawal by Subject|9|||
105462299|NCT03312634|363707216|FG000|Overall Study|Enrolled in an interventional study|0|||
105462300|NCT03312634|363707217|FG001|Overall Study|Enrolled in an interventional study|52|||
105462301|NCT03312634|363707216|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
105462302|NCT03312634|363707217|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
105462303|NCT03312634|363707216|FG000|Overall Study|Death|0|||
105339041|NCT00614523|363243533|FG001|Overall Study|Protocol Violation|2|||
105339042|NCT00614523|363243532|FG000|Overall Study|Withdrawal by Subject|12|||
105339043|NCT00614523|363243533|FG001|Overall Study|Withdrawal by Subject|22|||
105462304|NCT03312634|363707217|FG001|Overall Study|Death|1|||
105662949|NCT03657576|364430053|FG003|Overall Study|Insurance Coverage|1|||
105339044|NCT00614523|363243532|FG000|Overall Study|Other|6|||
105339045|NCT00614523|363243533|FG001|Overall Study|Other|11|||
105339046|NCT00614523|363243532|FG000|Overall Study|Ineligibility Determined|1|||
105339047|NCT00614523|363243533|FG001|Overall Study|Ineligibility Determined|2|||
105462305|NCT03312634|363707216|FG000|Overall Study|Non-compliance|0|||
105462306|NCT03312634|363707217|FG001|Overall Study|Non-compliance|2|||
105462307|NCT03312634|363707216|FG000|Overall Study|Lost to Follow-up|0|||
105462308|NCT03312634|363707217|FG001|Overall Study|Lost to Follow-up|1|||
105339048|NCT00614523|363243532|FG000|Overall Study|Disease Progression|0|||
105339049|NCT00614523|363243533|FG001|Overall Study|Disease Progression|8|||
105339050|NCT00614523|363243532|FG000|Overall Study|Administrative Decision|23|||
105339051|NCT00614523|363243533|FG001|Overall Study|Administrative Decision|46|||
105662950|NCT03657576|364430054|FG004|Overall Study|Insurance Coverage|0|||
105662951|NCT03657576|364430055|FG005|Overall Study|Insurance Coverage|0|||
105662952|NCT00409409|364430058|FG000|Overall Study|Adverse Event|7|||
105662953|NCT00409409|364430059|FG001|Overall Study|Adverse Event|2|||
105662954|NCT00409409|364430058|FG000|Overall Study|Withdrawal by Subject|1|||
105662955|NCT00409409|364430059|FG001|Overall Study|Withdrawal by Subject|1|||
105662956|NCT00409409|364430058|FG000|Overall Study|Any other reason not above-mentioned|0|||
105662957|NCT00409409|364430059|FG001|Overall Study|Any other reason not above-mentioned|1|||
105662958|NCT02196077|364430060|FG000|Overall Study|Adverse Event|4|||
105662959|NCT02196077|364430060|FG000|Overall Study|Lack of Efficacy|1|||
105662960|NCT02196077|364430060|FG000|Overall Study|Withdrawal by Subject|14|||
105662961|NCT02196077|364430060|FG000|Overall Study|Physician Decision|1|||
105662962|NCT02196077|364430060|FG000|Overall Study|Lost to Follow-up|3|||
105662963|NCT02196077|364430060|FG000|Overall Study|Protocol Violation|24|||
105662964|NCT01407276|364430063|FG000|Overall Study|Withdrawal by Subject|0|||
105662965|NCT01407276|364430064|FG001|Overall Study|Withdrawal by Subject|0|||
105662966|NCT01407276|364430065|FG002|Overall Study|Withdrawal by Subject|0|||
105662967|NCT01407276|364430066|FG003|Overall Study|Withdrawal by Subject|0|||
105662968|NCT01407276|364430067|FG004|Overall Study|Withdrawal by Subject|0|||
105662969|NCT01407276|364430068|FG005|Overall Study|Withdrawal by Subject|0|||
105662970|NCT01407276|364430069|FG006|Overall Study|Withdrawal by Subject|0|||
105662971|NCT01407276|364430070|FG007|Overall Study|Withdrawal by Subject|1|||
105339052|NCT01936181|363243540|FG000|Randomised, Double-blind|Adverse Event|27|||
105339053|NCT01936181|363243541|FG001|Randomised, Double-blind|Adverse Event|21|||
105339054|NCT01936181|363243542|FG002|Randomised, Double-blind|Adverse Event|0|||
105339055|NCT01936181|363243543|FG003|Randomised, Double-blind|Adverse Event|0|||
105339056|NCT01936181|363243540|FG000|Randomised, Double-blind|Protocol Violation|1|||
105339057|NCT01936181|363243541|FG001|Randomised, Double-blind|Protocol Violation|5|||
105662972|NCT03513068|364430071|FG000|Overall Study|Death|1|||
105662973|NCT03513068|364430072|FG001|Overall Study|Death|0|||
105662974|NCT03513068|364430071|FG000|Overall Study|Withdrawal by Subject|4|||
105662975|NCT03513068|364430072|FG001|Overall Study|Withdrawal by Subject|6|||
105662976|NCT04887506|364430086|FG000|Overall Study|Death|1|||
105662977|NCT04887506|364430087|FG001|Overall Study|Death|1|||
105339058|NCT01936181|363243542|FG002|Randomised, Double-blind|Protocol Violation|0|||
105339059|NCT01936181|363243543|FG003|Randomised, Double-blind|Protocol Violation|0|||
105339060|NCT01936181|363243540|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
105339061|NCT01936181|363243541|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
105339062|NCT01936181|363243542|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
105339063|NCT01936181|363243543|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
105339064|NCT01936181|363243540|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
105662978|NCT04887506|364430086|FG000|Overall Study|Withdrawal by Subject|0|||
105339065|NCT01936181|363243541|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
105339066|NCT01936181|363243542|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
105339067|NCT01936181|363243543|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
105339068|NCT01936181|363243540|FG000|Randomised, Double-blind|Pregnancy|0|||
105339069|NCT01936181|363243541|FG001|Randomised, Double-blind|Pregnancy|1|||
105339070|NCT01936181|363243542|FG002|Randomised, Double-blind|Pregnancy|0|||
105339071|NCT01936181|363243543|FG003|Randomised, Double-blind|Pregnancy|0|||
105339072|NCT01936181|363243540|FG000|Randomised, Double-blind|Physician Decision|4|||
105339073|NCT01936181|363243541|FG001|Randomised, Double-blind|Physician Decision|4|||
105339074|NCT01936181|363243542|FG002|Randomised, Double-blind|Physician Decision|0|||
105339075|NCT01936181|363243543|FG003|Randomised, Double-blind|Physician Decision|0|||
105339076|NCT01936181|363243540|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
105339077|NCT01936181|363243541|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
105339078|NCT01936181|363243542|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
105339079|NCT01936181|363243543|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
105339080|NCT01936181|363243540|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
105339081|NCT01936181|363243541|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
105339082|NCT01936181|363243542|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
105339083|NCT01936181|363243543|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
105339084|NCT01936181|363243540|FG000|Transition-extension|Adverse Event|3|||
105339085|NCT01936181|363243541|FG001|Transition-extension|Adverse Event|0|||
105662979|NCT04887506|364430087|FG001|Overall Study|Withdrawal by Subject|3|||
105662980|NCT04887506|364430086|FG000|Overall Study|Adverse Event|4|||
105662981|NCT04887506|364430087|FG001|Overall Study|Adverse Event|3|||
105662982|NCT04887506|364430086|FG000|Overall Study|Other - Not Reported|1|||
105662983|NCT04887506|364430087|FG001|Overall Study|Other - Not Reported|1|||
105339086|NCT01936181|363243542|FG002|Transition-extension|Adverse Event|3|||
105339087|NCT01936181|363243543|FG003|Transition-extension|Adverse Event|1|||
105662984|NCT01262092|364430088|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
105662985|NCT01262092|364430089|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
105462309|NCT03312634|363707216|FG000|Overall Study|Enrolled into non-interventional study|0|||
105662986|NCT01262092|364430088|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
105462310|NCT03312634|363707217|FG001|Overall Study|Enrolled into non-interventional study|5|||
105462311|NCT03312634|363707216|FG000|Overall Study|Worsening clinical condition|0|||
105462312|NCT03312634|363707217|FG001|Overall Study|Worsening clinical condition|1|||
105462313|NCT03312634|363707216|FG000|Overall Study|Participant did not want to travel|0|||
105462314|NCT03312634|363707217|FG001|Overall Study|Participant did not want to travel|1|||
105462315|NCT03312634|363707216|FG000|Overall Study|Physician Decision|1|||
105462316|NCT03312634|363707217|FG001|Overall Study|Physician Decision|0|||
105462317|NCT03312634|363707216|FG000|Overall Study|Other|13|||
105462318|NCT03312634|363707217|FG001|Overall Study|Other|0|||
105462319|NCT05366738|363707218|FG000|Overall Study|Adverse Event|0|||
105462320|NCT05366738|363707219|FG001|Overall Study|Adverse Event|1|||
105462321|NCT05366738|363707220|FG002|Overall Study|Adverse Event|0|||
105462322|NCT00755183|363707227|FG000|Overall Study|Adverse Event|5|||
105462323|NCT00755183|363707228|FG001|Overall Study|Adverse Event|2|||
105462324|NCT00755183|363707227|FG000|Overall Study|Protocol Violation|0|||
105462325|NCT00755183|363707228|FG001|Overall Study|Protocol Violation|1|||
105462326|NCT00755183|363707227|FG000|Overall Study|Withdrawal by Subject|0|||
105462327|NCT00755183|363707228|FG001|Overall Study|Withdrawal by Subject|2|||
105462328|NCT00755183|363707227|FG000|Overall Study|Administrative|2|||
105662987|NCT01262092|364430089|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
105662988|NCT01262092|364430088|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
105662989|NCT01262092|364430089|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
105662990|NCT01262092|364430088|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
105662991|NCT01262092|364430089|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
105662992|NCT03784820|364430090|FG000|Overall Study|Lost to Follow-up|5|||
105662993|NCT03784820|364430091|FG001|Overall Study|Lost to Follow-up|5|||
105662994|NCT03784820|364430092|FG002|Overall Study|Lost to Follow-up|3|||
105662995|NCT03784820|364430093|FG003|Overall Study|Lost to Follow-up|3|||
105662996|NCT05613088|364430096|FG000|Treatment|Ongoing Study Treatment|9|||
105662997|NCT05613088|364430097|FG001|Treatment|Ongoing Study Treatment|2|||
105662998|NCT05613088|364430096|FG000|Treatment|Adverse Event|3|||
105662999|NCT05613088|364430097|FG001|Treatment|Adverse Event|1|||
105663000|NCT05613088|364430096|FG000|Treatment|Other Reasons|0|||
105663001|NCT05613088|364430097|FG001|Treatment|Other Reasons|1|||
105663002|NCT05613088|364430096|FG000|Treatment|Progressive Disease|58|||
105663003|NCT05613088|364430097|FG001|Treatment|Progressive Disease|26|||
105663004|NCT05613088|364430096|FG000|Treatment|Withdrawal by Subject|0|||
105663005|NCT05613088|364430097|FG001|Treatment|Withdrawal by Subject|4|||
105663006|NCT03842436|364430098|FG000|Overall Study|Lost to Follow-up|1|||
105663007|NCT04277507|364430099|FG000|Overall Study|Lost to Follow-up|17|||
105663008|NCT04277507|364430099|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
105663009|NCT04277507|364430099|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
105663010|NCT04277507|364430099|FG000|Overall Study|Withdrawal by Subject|3|||
105663011|NCT04277507|364430099|FG000|Overall Study|Death due to COVID-19|1|||
105663012|NCT04277507|364430099|FG000|Overall Study|Data missing for full evaluation|5|||
105663013|NCT03732677|364430103|FG000|Overall Study|Terminated the study|154|||
105663014|NCT03732677|364430104|FG001|Overall Study|Terminated the study|197|||
105663015|NCT03732677|364430103|FG000|Overall Study|Continuing study off treatment|379|||
105663016|NCT03732677|364430104|FG001|Overall Study|Continuing study off treatment|333|||
105663017|NCT04013971|364430105|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
105663018|NCT04013971|364430106|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
105663019|NCT04013971|364430105|FG000|Overall Study|Missing biomechanical data|0|||
105663020|NCT04013971|364430106|FG001|Overall Study|Missing biomechanical data|1|||
105663021|NCT02194829|364430115|FG000|Overall Study|Adverse Event|2|||
105663022|NCT02194829|364430116|FG001|Overall Study|Adverse Event|2|||
105663023|NCT02194829|364430115|FG000|Overall Study|Death|0|||
105663024|NCT02194829|364430116|FG001|Overall Study|Death|1|||
105663025|NCT02194829|364430115|FG000|Overall Study|Disease progression|0|||
105663026|NCT02194829|364430116|FG001|Overall Study|Disease progression|1|||
105663027|NCT02194829|364430115|FG000|Overall Study|Withdrawal by Subject|0|||
105663028|NCT02194829|364430116|FG001|Overall Study|Withdrawal by Subject|1|||
105663029|NCT02194829|364430115|FG000|Overall Study|Never started protocol therapy|0|||
105663030|NCT02194829|364430116|FG001|Overall Study|Never started protocol therapy|1|||
105663031|NCT02065882|364430119|FG000|Part I: PK/PD|Screening failure|5|||
105663032|NCT02065882|364430119|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
105785313|NCT04145531|364866464|FG003|Part A|Withdrawal by participant|0|||
105663033|NCT02065882|364430119|FG000|Part I: PK/PD|Adverse Event|1|||
105663034|NCT02065882|364430119|FG000|Part II: Clinical Efficacy|Screening failure|7|||
105663035|NCT02065882|364430119|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
105663036|NCT02065882|364430119|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
105663037|NCT02065882|364430119|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
105663038|NCT02065882|364430119|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
105663039|NCT02065882|364430119|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
105663040|NCT06719986|364430120|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
105785314|NCT04145531|364866461|FG000|Part A|Other|0|||
105785315|NCT04145531|364866462|FG001|Part A|Other|0|||
105785316|NCT04145531|364866463|FG002|Part A|Other|1|||
105785317|NCT04145531|364866464|FG003|Part A|Other|0|||
105785318|NCT04145531|364866461|FG000|Part B|Adverse Event|0|||
105785319|NCT04145531|364866462|FG001|Part B|Adverse Event|0|||
105785320|NCT04145531|364866463|FG002|Part B|Adverse Event|0|||
105785321|NCT04145531|364866464|FG003|Part B|Adverse Event|21|||
105785322|NCT04145531|364866461|FG000|Part B|Physician Decision|0|||
105785323|NCT04145531|364866462|FG001|Part B|Physician Decision|0|||
105785324|NCT04145531|364866463|FG002|Part B|Physician Decision|0|||
105785325|NCT04145531|364866464|FG003|Part B|Physician Decision|7|||
105785326|NCT04145531|364866461|FG000|Part B|Progressive disease|0|||
105785327|NCT04145531|364866462|FG001|Part B|Progressive disease|0|||
105785328|NCT04145531|364866463|FG002|Part B|Progressive disease|0|||
105785329|NCT04145531|364866464|FG003|Part B|Progressive disease|1|||
105785330|NCT04145531|364866461|FG000|Part B|Recurrent disease|0|||
105785331|NCT04145531|364866462|FG001|Part B|Recurrent disease|0|||
105785332|NCT04145531|364866463|FG002|Part B|Recurrent disease|0|||
105785333|NCT04145531|364866464|FG003|Part B|Recurrent disease|1|||
105785334|NCT04145531|364866461|FG000|Part B|Withdrawal by parent or guardian|0|||
105785335|NCT04145531|364866462|FG001|Part B|Withdrawal by parent or guardian|0|||
105462329|NCT00755183|363707228|FG001|Overall Study|Administrative|1|||
105462330|NCT00535496|363707229|FG000|Overall Study|Lost to Follow-up|0|||
105462331|NCT00535496|363707230|FG001|Overall Study|Lost to Follow-up|1|||
105462332|NCT00535496|363707231|FG002|Overall Study|Lost to Follow-up|0|||
105462333|NCT00535496|363707232|FG003|Overall Study|Lost to Follow-up|0|||
105462334|NCT00535496|363707229|FG000|Overall Study|Not treated with sugammadex|0|||
105462335|NCT00535496|363707230|FG001|Overall Study|Not treated with sugammadex|1|||
105462336|NCT00535496|363707231|FG002|Overall Study|Not treated with sugammadex|0|||
105462337|NCT00535496|363707232|FG003|Overall Study|Not treated with sugammadex|0|||
105462338|NCT05024032|363707233|FG000|Overall Study|Withdrawal by Subject|0|||
105462339|NCT05024032|363707234|FG001|Overall Study|Withdrawal by Subject|3|||
105462340|NCT05024032|363707235|FG002|Overall Study|Withdrawal by Subject|4|||
105339088|NCT01936181|363243540|FG000|Transition-extension|Lost to Follow-up|3|||
105462341|NCT05024032|363707233|FG000|Overall Study|Adverse Event|0|||
105462342|NCT05024032|363707234|FG001|Overall Study|Adverse Event|1|||
105462343|NCT05024032|363707235|FG002|Overall Study|Adverse Event|0|||
105462344|NCT05024032|363707233|FG000|Overall Study|Protocol Deviation|1|||
105462345|NCT05024032|363707234|FG001|Overall Study|Protocol Deviation|0|||
105462346|NCT05024032|363707235|FG002|Overall Study|Protocol Deviation|0|||
105462347|NCT02066181|363707236|FG000|Overall Study|Withdrawal by Subject|1|||
105462348|NCT02066181|363707237|FG001|Overall Study|Withdrawal by Subject|1|||
105462349|NCT02851615|363707240|FG000|Overall Study|Cognitive Issue|1|||
105462350|NCT02851615|363707241|FG001|Overall Study|Cognitive Issue|0|||
105462351|NCT02851615|363707240|FG000|Overall Study|Lost to Follow-up|0|||
105462352|NCT02851615|363707241|FG001|Overall Study|Lost to Follow-up|4|||
105462353|NCT00313014|363707242|FG000|Overall Study|Withdrawal by Subject|11|||
105462354|NCT00313014|363707243|FG001|Overall Study|Withdrawal by Subject|7|||
105462355|NCT00313014|363707244|FG002|Overall Study|Withdrawal by Subject|5|||
105462356|NCT00313014|363707242|FG000|Overall Study|Adverse Event|14|||
105462357|NCT00313014|363707243|FG001|Overall Study|Adverse Event|29|||
105462358|NCT00313014|363707244|FG002|Overall Study|Adverse Event|16|||
105462359|NCT00313014|363707242|FG000|Overall Study|Lost to Follow-up|7|||
105462360|NCT00313014|363707243|FG001|Overall Study|Lost to Follow-up|6|||
105462361|NCT00313014|363707244|FG002|Overall Study|Lost to Follow-up|10|||
105462362|NCT00313014|363707242|FG000|Overall Study|Administrative|9|||
105462363|NCT00313014|363707243|FG001|Overall Study|Administrative|6|||
105785336|NCT04145531|364866463|FG002|Part B|Withdrawal by parent or guardian|0|||
105462364|NCT00313014|363707244|FG002|Overall Study|Administrative|14|||
105462365|NCT00313014|363707242|FG000|Overall Study|Lack of Efficacy|52|||
105462366|NCT00313014|363707243|FG001|Overall Study|Lack of Efficacy|25|||
105462367|NCT00313014|363707244|FG002|Overall Study|Lack of Efficacy|16|||
105462368|NCT02141295|363707248|FG000|Overall Study|Adverse Event|1|||
105462369|NCT02141295|363707249|FG001|Overall Study|Adverse Event|18|||
105462370|NCT02141295|363707250|FG002|Overall Study|Adverse Event|11|||
105462371|NCT02141295|363707248|FG000|Overall Study|Physician Decision|2|||
105785337|NCT04145531|364866464|FG003|Part B|Withdrawal by parent or guardian|3|||
105785338|NCT04145531|364866461|FG000|Part B|Withdrawal by participant|0|||
105785339|NCT04145531|364866462|FG001|Part B|Withdrawal by participant|0|||
105785340|NCT04145531|364866463|FG002|Part B|Withdrawal by participant|0|||
105785341|NCT04145531|364866464|FG003|Part B|Withdrawal by participant|1|||
105785342|NCT04145531|364866461|FG000|Part B|Other|0|||
105785343|NCT04145531|364866462|FG001|Part B|Other|0|||
105785344|NCT04145531|364866463|FG002|Part B|Other|0|||
105785345|NCT04145531|364866464|FG003|Part B|Other|1|||
105785346|NCT02985996|364866465|FG000|Overall Study|Withdrawal by Subject|0|||
105785347|NCT02985996|364866466|FG001|Overall Study|Withdrawal by Subject|0|||
105785348|NCT02985996|364866467|FG002|Overall Study|Withdrawal by Subject|1|||
105785349|NCT02985996|364866468|FG003|Overall Study|Withdrawal by Subject|0|||
105785350|NCT02985996|364866469|FG004|Overall Study|Withdrawal by Subject|0|||
105785351|NCT02985996|364866465|FG000|Overall Study|Protocol Violation|0|||
105785352|NCT02985996|364866466|FG001|Overall Study|Protocol Violation|1|||
105785353|NCT02985996|364866467|FG002|Overall Study|Protocol Violation|0|||
105785354|NCT02985996|364866468|FG003|Overall Study|Protocol Violation|0|||
105785355|NCT02985996|364866469|FG004|Overall Study|Protocol Violation|0|||
105785356|NCT04837807|364866471|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
105785357|NCT04837807|364866472|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
105785358|NCT03732534|364866473|FG000|Overall Study|Study terminated by Sponsor|6|||
105785359|NCT02058849|364866476|FG000|Overall Study|Hospitalization|1|||
105785360|NCT02058849|364866477|FG001|Overall Study|Hospitalization|1|||
105785361|NCT02058849|364866476|FG000|Overall Study|Death|1|||
105785362|NCT02058849|364866477|FG001|Overall Study|Death|0|||
105785363|NCT02058849|364866476|FG000|Overall Study|Lost to Follow-up|1|||
105785364|NCT02058849|364866477|FG001|Overall Study|Lost to Follow-up|0|||
105785365|NCT02058849|364866476|FG000|Overall Study|Withdrawal by Subject|4|||
105785366|NCT02058849|364866477|FG001|Overall Study|Withdrawal by Subject|0|||
105785367|NCT00976989|364866484|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
105785368|NCT00976989|364866485|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
105785369|NCT00976989|364866486|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
105462372|NCT02141295|363707249|FG001|Overall Study|Physician Decision|19|||
105462373|NCT02141295|363707250|FG002|Overall Study|Physician Decision|14|||
105462374|NCT02141295|363707248|FG000|Overall Study|Study terminated by sponsor|0|||
105462375|NCT02141295|363707249|FG001|Overall Study|Study terminated by sponsor|6|||
105462376|NCT02141295|363707250|FG002|Overall Study|Study terminated by sponsor|6|||
105462377|NCT02141295|363707248|FG000|Overall Study|Non-compliance|0|||
105462378|NCT02141295|363707249|FG001|Overall Study|Non-compliance|1|||
105462379|NCT02141295|363707250|FG002|Overall Study|Non-compliance|0|||
105462380|NCT02141295|363707248|FG000|Overall Study|Progressive disease|3|||
105462381|NCT02141295|363707249|FG001|Overall Study|Progressive disease|32|||
105462382|NCT02141295|363707250|FG002|Overall Study|Progressive disease|50|||
105462383|NCT02141295|363707248|FG000|Overall Study|Reason not specified|0|||
105462384|NCT02141295|363707249|FG001|Overall Study|Reason not specified|9|||
105462385|NCT02141295|363707250|FG002|Overall Study|Reason not specified|10|||
105462386|NCT02141295|363707248|FG000|Overall Study|Withdrawal by Subject|0|||
105462387|NCT02141295|363707249|FG001|Overall Study|Withdrawal by Subject|9|||
105462388|NCT02141295|363707250|FG002|Overall Study|Withdrawal by Subject|4|||
105462389|NCT02345070|363707252|FG000|Overall Study|Adverse Event|12|||
105462390|NCT02345070|363707253|FG001|Overall Study|Adverse Event|8|||
105462391|NCT02345070|363707254|FG002|Overall Study|Adverse Event|16|||
105462392|NCT02345070|363707252|FG000|Overall Study|Poor compliance to protocol|2|||
105462393|NCT02345070|363707253|FG001|Overall Study|Poor compliance to protocol|0|||
105462394|NCT02345070|363707254|FG002|Overall Study|Poor compliance to protocol|0|||
105462395|NCT02345070|363707252|FG000|Overall Study|Other than specified above|6|||
105462396|NCT02345070|363707253|FG001|Overall Study|Other than specified above|3|||
105785370|NCT00976989|364866484|FG000|Overall Study|Death|5|||
105785371|NCT00976989|364866485|FG001|Overall Study|Death|7|||
105785372|NCT00976989|364866486|FG002|Overall Study|Death|10|||
105339089|NCT01936181|363243541|FG001|Transition-extension|Lost to Follow-up|0|||
105339090|NCT01936181|363243542|FG002|Transition-extension|Lost to Follow-up|1|||
105339091|NCT01936181|363243543|FG003|Transition-extension|Lost to Follow-up|2|||
105339092|NCT01936181|363243540|FG000|Transition-extension|Physician Decision|2|||
105339093|NCT01936181|363243541|FG001|Transition-extension|Physician Decision|0|||
105339094|NCT01936181|363243542|FG002|Transition-extension|Physician Decision|0|||
105339095|NCT01936181|363243543|FG003|Transition-extension|Physician Decision|1|||
105339096|NCT01936181|363243540|FG000|Transition-extension|Withdrawal by Subject|7|||
105339097|NCT01936181|363243541|FG001|Transition-extension|Withdrawal by Subject|0|||
105339098|NCT01936181|363243542|FG002|Transition-extension|Withdrawal by Subject|2|||
105339099|NCT01936181|363243543|FG003|Transition-extension|Withdrawal by Subject|1|||
105339100|NCT02817516|363243544|FG000|Overall Study|Other|0|||
105339101|NCT02817516|363243545|FG001|Overall Study|Other|0|||
105339102|NCT02817516|363243546|FG002|Overall Study|Other|1|||
105339103|NCT02817516|363243547|FG003|Overall Study|Other|0|||
105339104|NCT01943851|363243548|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105339105|NCT01943851|363243549|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105339106|NCT01943851|363243550|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105339107|NCT01943851|363243551|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
105339108|NCT01943851|363243552|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105339109|NCT01943851|363243553|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105339110|NCT01943851|363243554|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
105339111|NCT01943851|363243555|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
105339112|NCT01943851|363243556|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
105339113|NCT01943851|363243557|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105339114|NCT01943851|363243558|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105339115|NCT01943851|363243559|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105339116|NCT01943851|363243560|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105339117|NCT01943851|363243561|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105339118|NCT01943851|363243562|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105339119|NCT01943851|363243563|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105339120|NCT01943851|363243564|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105462397|NCT02345070|363707254|FG002|Overall Study|Other than specified above|7|||
105462398|NCT01710501|363707255|FG000|Overall Study|Lost to Follow-up|2|||
105462399|NCT01710501|363707256|FG001|Overall Study|Lost to Follow-up|0|||
105462400|NCT01710501|363707257|FG002|Overall Study|Lost to Follow-up|0|||
105462401|NCT01389596|363707260|FG000|Overall Study|Protocol Violation|3|||
105462402|NCT01389596|363707261|FG001|Overall Study|Protocol Violation|4|||
105462403|NCT01389596|363707262|FG002|Overall Study|Protocol Violation|3|||
105462404|NCT01389596|363707260|FG000|Overall Study|Withdrawal by Subject|1|||
105462405|NCT01389596|363707261|FG001|Overall Study|Withdrawal by Subject|2|||
105462406|NCT01389596|363707262|FG002|Overall Study|Withdrawal by Subject|2|||
105462407|NCT01389596|363707260|FG000|Overall Study|Insufficient Clinical Response|3|||
105462408|NCT01389596|363707261|FG001|Overall Study|Insufficient Clinical Response|4|||
105462409|NCT01389596|363707262|FG002|Overall Study|Insufficient Clinical Response|5|||
105462410|NCT01389596|363707260|FG000|Overall Study|Adverse Event|1|||
105462411|NCT01389596|363707261|FG001|Overall Study|Adverse Event|4|||
105462412|NCT01389596|363707262|FG002|Overall Study|Adverse Event|0|||
105462413|NCT01389596|363707260|FG000|Overall Study|Death|0|||
105462414|NCT01389596|363707261|FG001|Overall Study|Death|1|||
105462415|NCT01389596|363707262|FG002|Overall Study|Death|0|||
105462416|NCT01389596|363707260|FG000|Overall Study|Other Unspecified|2|||
105462417|NCT01389596|363707261|FG001|Overall Study|Other Unspecified|1|||
105462418|NCT01389596|363707262|FG002|Overall Study|Other Unspecified|0|||
105462419|NCT01709084|363707263|FG000|Overall Study|Lost to Follow-up|4|||
105462420|NCT01709084|363707264|FG001|Overall Study|Lost to Follow-up|7|||
105462421|NCT01709084|363707263|FG000|Overall Study|Withdrawal by Subject|2|||
105462422|NCT01709084|363707264|FG001|Overall Study|Withdrawal by Subject|2|||
105462423|NCT01709084|363707263|FG000|Overall Study|Adverse Event|5|||
105462424|NCT01709084|363707264|FG001|Overall Study|Adverse Event|0|||
105462425|NCT01709084|363707263|FG000|Overall Study|Other|5|||
105462426|NCT01709084|363707264|FG001|Overall Study|Other|3|||
105462427|NCT01709084|363707263|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
105462428|NCT01709084|363707264|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
105785373|NCT00976989|364866484|FG000|Overall Study|Refused Treatment|4|||
105785374|NCT00976989|364866485|FG001|Overall Study|Refused Treatment|3|||
105785375|NCT00976989|364866486|FG002|Overall Study|Refused Treatment|5|||
105339121|NCT01943851|363243565|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105339122|NCT01943851|363243548|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105339123|NCT01943851|363243549|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105339124|NCT01943851|363243550|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105339125|NCT01943851|363243551|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105462429|NCT01709084|363707263|FG000|Overall Study|Not Treated|0|||
105462430|NCT01709084|363707264|FG001|Overall Study|Not Treated|2|||
105462431|NCT01281124|363707272|FG000|Overall Study|Death|1|||
105462432|NCT04154904|363707273|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
105462433|NCT04154904|363707274|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
105462434|NCT04154904|363707275|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
105462435|NCT01285323|363707278|FG000|Overall Study|Adverse Event|9|||
105462436|NCT01285323|363707279|FG001|Overall Study|Adverse Event|8|||
105462437|NCT01285323|363707278|FG000|Overall Study|Lack of Efficacy|4|||
105462438|NCT01285323|363707279|FG001|Overall Study|Lack of Efficacy|2|||
105462439|NCT01285323|363707278|FG000|Overall Study|Withdrawal by Subject|15|||
105462440|NCT01285323|363707279|FG001|Overall Study|Withdrawal by Subject|11|||
105462441|NCT01285323|363707278|FG000|Overall Study|Protocol Violation|1|||
105462442|NCT01285323|363707279|FG001|Overall Study|Protocol Violation|2|||
105462443|NCT01285323|363707278|FG000|Overall Study|Non-compliance with study procedures|2|||
105462444|NCT01285323|363707279|FG001|Overall Study|Non-compliance with study procedures|3|||
105462445|NCT01285323|363707278|FG000|Overall Study|Lost to Follow-up|1|||
105462446|NCT01285323|363707279|FG001|Overall Study|Lost to Follow-up|1|||
105462447|NCT01285323|363707278|FG000|Overall Study|Other|1|||
105462448|NCT01285323|363707279|FG001|Overall Study|Other|3|||
105462449|NCT00003475|363707280|FG000|Overall Study|Not evaluable|13|||
105462450|NCT03818321|363707283|FG000|Overall Study|Withdrawal by Subject|1|||
105462451|NCT03818321|363707284|FG001|Overall Study|Withdrawal by Subject|2|||
105462452|NCT03345784|363707285|FG000|Overall Study|Withdrawal by Subject|2|||
105462453|NCT03345784|363707286|FG001|Overall Study|Withdrawal by Subject|1|||
105462454|NCT00929695|363707297|FG000|Overall Study|Death|2|||
105462455|NCT00929695|363707298|FG001|Overall Study|Death|1|||
105462456|NCT00929695|363707297|FG000|Overall Study|Withdrawal by Subject|0|||
105462457|NCT00929695|363707298|FG001|Overall Study|Withdrawal by Subject|2|||
105462458|NCT00929695|363707297|FG000|Overall Study|discharge home|4|||
105462459|NCT00929695|363707298|FG001|Overall Study|discharge home|3|||
105462460|NCT00929695|363707297|FG000|Overall Study|incorrect stratification|2|||
105462461|NCT00929695|363707298|FG001|Overall Study|incorrect stratification|0|||
105462462|NCT00389610|363707299|FG000|Overall Study|Disease Progression|0|||
105462463|NCT00389610|363707300|FG001|Overall Study|Disease Progression|19|||
105462464|NCT00389610|363707299|FG000|Overall Study|Death|0|||
105462465|NCT00389610|363707300|FG001|Overall Study|Death|1|||
105462466|NCT00389610|363707299|FG000|Overall Study|Physician Decision|0|||
105462467|NCT00389610|363707300|FG001|Overall Study|Physician Decision|1|||
105462468|NCT00389610|363707299|FG000|Overall Study|Withdrawal by Subject|0|||
105462469|NCT00389610|363707300|FG001|Overall Study|Withdrawal by Subject|1|||
105462470|NCT00887809|363707301|FG000|Overall Study|Patient Not Treated|3|||
105462471|NCT00887809|363707302|FG001|Overall Study|Patient Not Treated|0|||
105462472|NCT00887809|363707301|FG000|Overall Study|Death|1|||
105462473|NCT00887809|363707302|FG001|Overall Study|Death|0|||
105462474|NCT02000440|363707303|FG000|Overall Study|Adverse Event|3|||
105462475|NCT02000440|363707303|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
105462476|NCT01690143|363707306|FG000|Overall Study|Withdrawal by Subject|1|||
105462477|NCT03995368|363707307|FG000|Overall Study|Lost to Follow-up|1|||
105462478|NCT03995368|363707308|FG001|Overall Study|Lost to Follow-up|4|||
105462479|NCT03995368|363707309|FG002|Overall Study|Lost to Follow-up|1|||
105462480|NCT03995368|363707307|FG000|Overall Study|Did not meet inclusion criteria|1|||
105462481|NCT03995368|363707308|FG001|Overall Study|Did not meet inclusion criteria|6|||
105462482|NCT03995368|363707309|FG002|Overall Study|Did not meet inclusion criteria|3|||
105462483|NCT03995368|363707307|FG000|Overall Study|Withdrawal by Subject|0|||
105462484|NCT03995368|363707308|FG001|Overall Study|Withdrawal by Subject|1|||
105462485|NCT03995368|363707309|FG002|Overall Study|Withdrawal by Subject|1|||
105462486|NCT00307801|363707310|FG000|Overall Study|Adverse Event|12|||
105550456|NCT01715805|364014493|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
105550457|NCT01715805|364014494|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
105550458|NCT01715805|364014491|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
105550459|NCT01715805|364014492|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
105550460|NCT01715805|364014493|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
105550461|NCT01715805|364014494|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
105550462|NCT01715805|364014491|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
105550463|NCT01715805|364014492|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
105550464|NCT01715805|364014493|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
105550465|NCT01715805|364014494|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
105550466|NCT01715805|364014491|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
105550467|NCT01715805|364014492|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
105550468|NCT01715805|364014493|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
105550469|NCT01715805|364014494|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
105550470|NCT01715805|364014491|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
105550471|NCT01715805|364014492|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
105550472|NCT01715805|364014493|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
105550473|NCT01715805|364014494|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
105550474|NCT01715805|364014491|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
105550475|NCT01715805|364014492|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
105550476|NCT01715805|364014493|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
105550477|NCT01715805|364014494|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
105550478|NCT01715805|364014491|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
105550479|NCT01715805|364014492|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
105550480|NCT01715805|364014493|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
105550481|NCT01715805|364014494|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
105550482|NCT01715805|364014491|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
105550483|NCT01715805|364014492|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
105550484|NCT01715805|364014493|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
105550485|NCT01715805|364014494|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
105550486|NCT01715805|364014491|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
105550487|NCT01715805|364014492|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
105550488|NCT01715805|364014493|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
105550489|NCT01715805|364014494|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
105550490|NCT01715805|364014491|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
105785376|NCT00976989|364866484|FG000|Overall Study|Failure to Return|2|||
105785377|NCT00976989|364866485|FG001|Overall Study|Failure to Return|1|||
105462487|NCT00307801|363707311|FG001|Overall Study|Adverse Event|4|||
105462488|NCT00307801|363707310|FG000|Overall Study|Withdrawal by Subject|9|||
105462489|NCT00307801|363707311|FG001|Overall Study|Withdrawal by Subject|4|||
105462490|NCT00307801|363707310|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
105550491|NCT01715805|364014492|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
105550492|NCT01715805|364014493|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
105550493|NCT01715805|364014494|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
105550494|NCT01715805|364014491|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
105550495|NCT01715805|364014492|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
105550496|NCT01715805|364014493|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
105550497|NCT01715805|364014494|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
105550498|NCT02647359|364014495|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
105550499|NCT02647359|364014496|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
105550500|NCT02647359|364014495|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
105550501|NCT02647359|364014496|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
105550502|NCT02647359|364014495|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
105550503|NCT02647359|364014496|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
105550504|NCT02647359|364014495|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
105550505|NCT02647359|364014496|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
105550506|NCT02647359|364014495|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
105550507|NCT02647359|364014496|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
105550508|NCT02647359|364014495|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
105550509|NCT02647359|364014496|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
105550510|NCT01310036|364014497|FG000|Overall Study|Administrative/other|10|||
105550511|NCT01310036|364014497|FG000|Overall Study|Withdrew Consent|11|||
105550512|NCT01310036|364014497|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
105550513|NCT01310036|364014497|FG000|Overall Study|Progression of Disease|164|||
105550514|NCT01310036|364014497|FG000|Overall Study|Death|1|||
105550515|NCT01310036|364014497|FG000|Overall Study|Adverse event or intercurrent illness|12|||
105550516|NCT02043782|364014498|FG000|Period 1|Adverse Event|0|||
105550517|NCT02043782|364014499|FG001|Period 1|Adverse Event|0|||
105550518|NCT02043782|364014500|FG002|Period 1|Adverse Event|1|||
105550519|NCT02043782|364014501|FG003|Period 1|Adverse Event|0|||
105550520|NCT02043782|364014502|FG004|Period 1|Adverse Event|0|||
105550521|NCT02043782|364014503|FG005|Period 1|Adverse Event|0|||
105550522|NCT04667117|364014504|FG000|Investigational Period|Lost to Follow-up|0|||
105550523|NCT04667117|364014505|FG001|Investigational Period|Lost to Follow-up|0|||
105550524|NCT04667117|364014506|FG002|Investigational Period|Lost to Follow-up|1|||
105550525|NCT04667117|364014504|FG000|Investigational Period|Protocol Deviation|0|||
105550526|NCT04667117|364014505|FG001|Investigational Period|Protocol Deviation|1|||
105550527|NCT04667117|364014506|FG002|Investigational Period|Protocol Deviation|0|||
105550528|NCT04667117|364014504|FG000|Extension Period|Lost to Follow-up|1|||
105550529|NCT04667117|364014505|FG001|Extension Period|Lost to Follow-up|0|||
105550530|NCT04667117|364014506|FG002|Extension Period|Lost to Follow-up|0|||
105550531|NCT00874029|364014507|FG000|Overall Study|Withdrawal by Subject|10|||
105550532|NCT00874029|364014507|FG000|Overall Study|Pregnancy|4|||
105550533|NCT00874029|364014507|FG000|Overall Study|Physician Decision|1|||
105550534|NCT00874029|364014507|FG000|Overall Study|Adverse Event|1|||
105550535|NCT00874029|364014507|FG000|Overall Study|Lost to Follow-up|5|||
105550536|NCT03359096|364014508|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
105550537|NCT03359096|364014509|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
105550538|NCT03359096|364014508|FG000|First Intervention (4 Weeks)|Death|1|||
105550539|NCT03359096|364014509|FG001|First Intervention (4 Weeks)|Death|0|||
105550540|NCT03359096|364014508|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
105550541|NCT03359096|364014509|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
105550542|NCT02007577|364014512|FG000|Overall Study|Adverse Event|1|||
105550543|NCT02007577|364014513|FG001|Overall Study|Adverse Event|0|||
105550544|NCT02007577|364014512|FG000|Overall Study|Withdrawal by Subject|0|||
105550545|NCT02007577|364014513|FG001|Overall Study|Withdrawal by Subject|1|||
105550546|NCT02504294|364014514|FG000|Overall Study|Adverse Event|15|||
105550547|NCT02504294|364014515|FG001|Overall Study|Adverse Event|12|||
105550548|NCT02504294|364014514|FG000|Overall Study|Withdrawal by Subject|7|||
105550549|NCT02504294|364014515|FG001|Overall Study|Withdrawal by Subject|1|||
105550550|NCT02504294|364014514|FG000|Overall Study|Protocol Violation|27|||
105550551|NCT02504294|364014515|FG001|Overall Study|Protocol Violation|26|||
105550552|NCT02504294|364014514|FG000|Overall Study|Physician Decision|1|||
105550553|NCT02504294|364014515|FG001|Overall Study|Physician Decision|2|||
105550554|NCT02504294|364014514|FG000|Overall Study|Lost to Follow-up|6|||
105550555|NCT02504294|364014515|FG001|Overall Study|Lost to Follow-up|7|||
105663041|NCT06719986|364430121|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
105663042|NCT06719986|364430122|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
105663043|NCT06719986|364430120|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
105550556|NCT00214136|364014522|FG000|Overall Study|Death|5|||
105785378|NCT00976989|364866486|FG002|Overall Study|Failure to Return|0|||
105785379|NCT00976989|364866484|FG000|Overall Study|Recurrence of Disease|0|||
105785380|NCT00976989|364866485|FG001|Overall Study|Recurrence of Disease|1|||
105785381|NCT00976989|364866486|FG002|Overall Study|Recurrence of Disease|0|||
105785382|NCT00976989|364866484|FG000|Overall Study|Other|1|||
105663044|NCT06719986|364430121|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
105663045|NCT06719986|364430122|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
105663046|NCT00966264|364432352|FG000|Overall Study|Lost to Follow-up|4|||
105663047|NCT00966264|364432353|FG001|Overall Study|Lost to Follow-up|3|||
105663048|NCT01867047|364432354|FG000|Overall Study|Lost to Follow-up|3|||
105785383|NCT00976989|364866485|FG001|Overall Study|Other|0|||
105785384|NCT00976989|364866486|FG002|Overall Study|Other|1|||
105550557|NCT02310750|364014523|FG000|HP Period 1|Lost to Follow-up|0|||
105550558|NCT02310750|364014524|FG001|HP Period 1|Lost to Follow-up|0|||
105550559|NCT02310750|364014525|FG002|HP Period 1|Lost to Follow-up|0|||
105550560|NCT02310750|364014526|FG003|HP Period 1|Lost to Follow-up|0|||
105550561|NCT02310750|364014527|FG004|HP Period 1|Lost to Follow-up|0|||
105550562|NCT02310750|364014528|FG005|HP Period 1|Lost to Follow-up|0|||
105550563|NCT02310750|364014529|FG006|HP Period 1|Lost to Follow-up|1|||
105550564|NCT02310750|364014530|FG007|HP Period 1|Lost to Follow-up|0|||
105550565|NCT02310750|364014531|FG008|HP Period 1|Lost to Follow-up|0|||
105550566|NCT02310750|364014532|FG009|HP Period 1|Lost to Follow-up|0|||
105550567|NCT02310750|364014533|FG010|HP Period 1|Lost to Follow-up|0|||
105550568|NCT02310750|364014534|FG011|HP Period 1|Lost to Follow-up|0|||
105550569|NCT02310750|364014535|FG012|HP Period 1|Lost to Follow-up|0|||
105550570|NCT02310750|364014536|FG013|HP Period 1|Lost to Follow-up|0|||
105550571|NCT02310750|364014537|FG014|HP Period 1|Lost to Follow-up|0|||
105550572|NCT02310750|364014538|FG015|HP Period 1|Lost to Follow-up|0|||
105550573|NCT02310750|364014523|FG000|HP Period 1|Withdrawal by Subject|1|||
105550574|NCT02310750|364014524|FG001|HP Period 1|Withdrawal by Subject|0|||
105550575|NCT02310750|364014525|FG002|HP Period 1|Withdrawal by Subject|0|||
105550576|NCT02310750|364014526|FG003|HP Period 1|Withdrawal by Subject|1|||
105550577|NCT02310750|364014527|FG004|HP Period 1|Withdrawal by Subject|0|||
105550578|NCT02310750|364014528|FG005|HP Period 1|Withdrawal by Subject|0|||
105550579|NCT02310750|364014529|FG006|HP Period 1|Withdrawal by Subject|0|||
105550580|NCT02310750|364014530|FG007|HP Period 1|Withdrawal by Subject|0|||
105550581|NCT02310750|364014531|FG008|HP Period 1|Withdrawal by Subject|0|||
105550582|NCT02310750|364014532|FG009|HP Period 1|Withdrawal by Subject|0|||
105550583|NCT02310750|364014533|FG010|HP Period 1|Withdrawal by Subject|0|||
105550584|NCT02310750|364014534|FG011|HP Period 1|Withdrawal by Subject|0|||
105550585|NCT02310750|364014535|FG012|HP Period 1|Withdrawal by Subject|0|||
105550586|NCT02310750|364014536|FG013|HP Period 1|Withdrawal by Subject|0|||
105550587|NCT02310750|364014537|FG014|HP Period 1|Withdrawal by Subject|0|||
105550588|NCT02310750|364014538|FG015|HP Period 1|Withdrawal by Subject|0|||
105550589|NCT02310750|364014523|FG000|HP Washout 1|Lost to Follow-up|0|||
105550590|NCT02310750|364014524|FG001|HP Washout 1|Lost to Follow-up|0|||
105550591|NCT02310750|364014525|FG002|HP Washout 1|Lost to Follow-up|1|||
105550592|NCT02310750|364014526|FG003|HP Washout 1|Lost to Follow-up|1|||
105550593|NCT02310750|364014527|FG004|HP Washout 1|Lost to Follow-up|2|||
105550594|NCT02310750|364014528|FG005|HP Washout 1|Lost to Follow-up|2|||
105550595|NCT02310750|364014529|FG006|HP Washout 1|Lost to Follow-up|3|||
105550596|NCT02310750|364014530|FG007|HP Washout 1|Lost to Follow-up|0|||
105550597|NCT02310750|364014531|FG008|HP Washout 1|Lost to Follow-up|0|||
105550598|NCT02310750|364014532|FG009|HP Washout 1|Lost to Follow-up|0|||
105550599|NCT02310750|364014533|FG010|HP Washout 1|Lost to Follow-up|0|||
105550600|NCT02310750|364014534|FG011|HP Washout 1|Lost to Follow-up|0|||
105550601|NCT02310750|364014535|FG012|HP Washout 1|Lost to Follow-up|0|||
105550602|NCT02310750|364014536|FG013|HP Washout 1|Lost to Follow-up|0|||
105550603|NCT02310750|364014537|FG014|HP Washout 1|Lost to Follow-up|0|||
105550604|NCT02310750|364014538|FG015|HP Washout 1|Lost to Follow-up|0|||
105550605|NCT02310750|364014523|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
105550606|NCT02310750|364014524|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
105550607|NCT02310750|364014525|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
105663049|NCT01867047|364432355|FG001|Overall Study|Lost to Follow-up|3|||
105785385|NCT01016912|364866487|FG000|End of Treatment Period|Lack of Efficacy|0|||
105785386|NCT01016912|364866488|FG001|End of Treatment Period|Lack of Efficacy|1|||
105550608|NCT02310750|364014526|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
105550609|NCT02310750|364014527|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
105550610|NCT02310750|364014528|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
105550611|NCT02310750|364014529|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
105550612|NCT02310750|364014530|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
105550613|NCT02310750|364014531|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
105550614|NCT02310750|364014532|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
105663050|NCT01867047|364432354|FG000|Overall Study|Withdrawal by Subject|2|||
105785387|NCT01016912|364866489|FG002|End of Treatment Period|Lack of Efficacy|0|||
105550615|NCT02310750|364014533|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
105550616|NCT02310750|364014534|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
105550617|NCT02310750|364014535|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
105550618|NCT02310750|364014536|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
105550619|NCT02310750|364014537|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
105550620|NCT02310750|364014538|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
105550621|NCT02310750|364014523|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
105550622|NCT02310750|364014524|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
105550623|NCT02310750|364014525|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
105550624|NCT02310750|364014526|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
105550625|NCT02310750|364014527|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
105550626|NCT02310750|364014528|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
105550627|NCT02310750|364014529|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
105550628|NCT02310750|364014530|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
105550629|NCT02310750|364014531|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
105550630|NCT02310750|364014532|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
105550631|NCT02310750|364014533|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
105550632|NCT02310750|364014534|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
105550633|NCT02310750|364014535|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
105550634|NCT02310750|364014536|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
105550635|NCT02310750|364014537|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
105550636|NCT02310750|364014538|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
105550637|NCT02310750|364014523|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
105550638|NCT02310750|364014524|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
105550639|NCT02310750|364014525|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
105550640|NCT02310750|364014526|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
105550641|NCT02310750|364014527|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
105550642|NCT02310750|364014528|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
105550643|NCT02310750|364014529|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
105550644|NCT02310750|364014530|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
105550645|NCT02310750|364014531|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
105550646|NCT02310750|364014532|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
105550647|NCT02310750|364014533|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
105550648|NCT02310750|364014534|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
105550649|NCT02310750|364014535|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
105550650|NCT02310750|364014536|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
105550651|NCT02310750|364014537|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
105550652|NCT02310750|364014538|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
105550653|NCT02310750|364014523|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
105550654|NCT02310750|364014524|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
105550655|NCT02310750|364014525|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
105550656|NCT02310750|364014526|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
105550657|NCT02310750|364014527|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
105550658|NCT02310750|364014528|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
105550659|NCT02310750|364014529|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
105550660|NCT02310750|364014530|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
105550661|NCT02310750|364014531|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
105550662|NCT02310750|364014532|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
105550663|NCT02310750|364014533|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
105550664|NCT02310750|364014534|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
105550665|NCT02310750|364014535|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
105550666|NCT02310750|364014536|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
105550667|NCT02310750|364014537|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
105550668|NCT02310750|364014538|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
105550669|NCT02310750|364014523|FG000|HP Washout 2|Lost to Follow-up|0|||
105550670|NCT02310750|364014524|FG001|HP Washout 2|Lost to Follow-up|0|||
105663051|NCT01867047|364432355|FG001|Overall Study|Withdrawal by Subject|0|||
105663052|NCT01867047|364432354|FG000|Overall Study|Physician Decision|2|||
105663053|NCT01867047|364432355|FG001|Overall Study|Physician Decision|0|||
105663054|NCT01867047|364432354|FG000|Overall Study|surgery not indicated in protocol|1|||
105663055|NCT01867047|364432355|FG001|Overall Study|surgery not indicated in protocol|2|||
105663056|NCT04650698|364432356|FG000|Overall Study|Protocol Violation|2|||
105663057|NCT04650698|364432357|FG001|Overall Study|Protocol Violation|1|||
105550671|NCT02310750|364014525|FG002|HP Washout 2|Lost to Follow-up|0|||
105663058|NCT04650698|364432356|FG000|Overall Study|Withdrawal by Subject|0|||
105663059|NCT04650698|364432357|FG001|Overall Study|Withdrawal by Subject|1|||
105663060|NCT01090011|364432358|FG000|Overall Study|Progressive disease|128|||
105663061|NCT01090011|364432358|FG000|Overall Study|Adverse Event|32|||
105663062|NCT01090011|364432358|FG000|Overall Study|Protocol Violation|1|||
105663063|NCT01090011|364432358|FG000|Overall Study|Refusal to start/continue medication|5|||
105663064|NCT01090011|364432358|FG000|Overall Study|Other reason not defined above|5|||
105663065|NCT02820597|364432359|FG000|Overall Study|Lost to Follow-up|12|||
105663066|NCT01638390|364432360|FG000|Overall Study|screening failures|21|||
105663067|NCT02666664|364432361|FG000|Overall Study|Physician Decision|0|||
105663068|NCT02666664|364432362|FG001|Overall Study|Physician Decision|1|||
105663069|NCT02666664|364432361|FG000|Overall Study|Protocol Violation|0|||
105663070|NCT02666664|364432362|FG001|Overall Study|Protocol Violation|2|||
105663071|NCT02666664|364432361|FG000|Overall Study|Other|0|||
105663072|NCT02666664|364432362|FG001|Overall Study|Other|1|||
105663073|NCT02666664|364432361|FG000|Overall Study|Adverse Event|12|||
105663074|NCT02666664|364432362|FG001|Overall Study|Adverse Event|37|||
105663075|NCT02666664|364432361|FG000|Overall Study|Withdrawal by participant|23|||
105663076|NCT02666664|364432362|FG001|Overall Study|Withdrawal by participant|40|||
105663077|NCT02666664|364432361|FG000|Overall Study|Sponsor decision|0|||
105663078|NCT02666664|364432362|FG001|Overall Study|Sponsor decision|1|||
105663079|NCT02666664|364432361|FG000|Overall Study|Lost to Follow-up|1|||
105663080|NCT02666664|364432362|FG001|Overall Study|Lost to Follow-up|2|||
105663081|NCT01385748|364432363|FG000|Overall Study|Withdrawal by Subject|7|||
105663082|NCT01385748|364432364|FG001|Overall Study|Withdrawal by Subject|4|||
105663083|NCT01385748|364432365|FG002|Overall Study|Withdrawal by Subject|5|||
105663084|NCT01385748|364432363|FG000|Overall Study|Noncompliance|3|||
105663085|NCT01385748|364432364|FG001|Overall Study|Noncompliance|1|||
105663086|NCT01385748|364432365|FG002|Overall Study|Noncompliance|6|||
105663087|NCT01385748|364432363|FG000|Overall Study|Other|1|||
105663088|NCT01385748|364432364|FG001|Overall Study|Other|7|||
105663089|NCT01385748|364432365|FG002|Overall Study|Other|1|||
105663090|NCT01385748|364432363|FG000|Overall Study|Adverse Event|4|||
105663091|NCT01385748|364432364|FG001|Overall Study|Adverse Event|2|||
105663092|NCT01385748|364432365|FG002|Overall Study|Adverse Event|1|||
105663093|NCT01377389|364432366|FG000|Overall Study|Withdrawal by Subject|1|||
105663094|NCT01377389|364432366|FG000|Overall Study|Screen failure|2|||
105663095|NCT03167151|364432368|FG000|Overall Study|Withdrawal by Subject|1|||
105663096|NCT03167151|364432369|FG001|Overall Study|Withdrawal by Subject|0|||
105663097|NCT03167151|364432370|FG002|Overall Study|Withdrawal by Subject|0|||
105663098|NCT03167151|364432368|FG000|Overall Study|No evidence of tumour at surgery|0|||
105663099|NCT03167151|364432369|FG001|Overall Study|No evidence of tumour at surgery|1|||
105663100|NCT03167151|364432370|FG002|Overall Study|No evidence of tumour at surgery|1|||
105663101|NCT04836559|364432371|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
105663102|NCT04836559|364432372|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
105663103|NCT04836559|364432373|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
105663104|NCT04836559|364432374|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
105663105|NCT04836559|364432375|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
105663106|NCT04836559|364432376|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
105663107|NCT04836559|364432377|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
105663108|NCT04836559|364432378|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
105663109|NCT04836559|364432371|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
105663110|NCT04836559|364432372|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
105663111|NCT04836559|364432373|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
105663112|NCT04836559|364432374|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
105663113|NCT04836559|364432375|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
105663114|NCT04836559|364432376|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
105663115|NCT04836559|364432377|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
105663116|NCT04836559|364432378|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
105663117|NCT04836559|364432371|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
105663118|NCT04836559|364432372|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
105663119|NCT04836559|364432373|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
105663120|NCT04836559|364432374|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
105663121|NCT04836559|364432375|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
105663122|NCT04836559|364432376|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
105663123|NCT04836559|364432377|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
105663124|NCT04836559|364432378|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
105663125|NCT04836559|364432371|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
105663126|NCT04836559|364432372|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
105663127|NCT04836559|364432373|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
105663128|NCT04836559|364432374|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
105663129|NCT04836559|364432375|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
105663130|NCT04836559|364432376|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
105663131|NCT04836559|364432377|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
105663132|NCT04836559|364432378|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
105785388|NCT01016912|364866490|FG003|End of Treatment Period|Lack of Efficacy|4|||
105785389|NCT01016912|364866491|FG004|End of Treatment Period|Lack of Efficacy|4|||
105785390|NCT01016912|364866487|FG000|End of Treatment Period|Adverse Event|0|||
105785391|NCT01016912|364866488|FG001|End of Treatment Period|Adverse Event|1|||
105550672|NCT02310750|364014526|FG003|HP Washout 2|Lost to Follow-up|0|||
105550673|NCT02310750|364014527|FG004|HP Washout 2|Lost to Follow-up|1|||
105550674|NCT02310750|364014528|FG005|HP Washout 2|Lost to Follow-up|0|||
105550675|NCT02310750|364014529|FG006|HP Washout 2|Lost to Follow-up|7|||
105550676|NCT02310750|364014530|FG007|HP Washout 2|Lost to Follow-up|0|||
105550677|NCT02310750|364014531|FG008|HP Washout 2|Lost to Follow-up|0|||
105550678|NCT02310750|364014532|FG009|HP Washout 2|Lost to Follow-up|0|||
105550679|NCT02310750|364014533|FG010|HP Washout 2|Lost to Follow-up|0|||
105550680|NCT02310750|364014534|FG011|HP Washout 2|Lost to Follow-up|0|||
105550681|NCT02310750|364014535|FG012|HP Washout 2|Lost to Follow-up|0|||
105550682|NCT02310750|364014536|FG013|HP Washout 2|Lost to Follow-up|0|||
105550683|NCT02310750|364014537|FG014|HP Washout 2|Lost to Follow-up|0|||
105550684|NCT02310750|364014538|FG015|HP Washout 2|Lost to Follow-up|0|||
105550685|NCT01435577|364014541|FG000|Overall Study|Adverse Event|10|||
105550686|NCT01435577|364014542|FG001|Overall Study|Adverse Event|0|||
105550687|NCT01435577|364014541|FG000|Overall Study|Lack of Efficacy|7|||
105550688|NCT01435577|364014542|FG001|Overall Study|Lack of Efficacy|51|||
105550689|NCT01435577|364014541|FG000|Overall Study|Alternative treatment started|0|||
105550690|NCT01435577|364014542|FG001|Overall Study|Alternative treatment started|1|||
105550691|NCT01220557|364014548|FG000|Overall Study|Lost to Follow-up|5|||
105550692|NCT01220557|364014549|FG001|Overall Study|Lost to Follow-up|3|||
105550693|NCT01220557|364014548|FG000|Overall Study|attended less than 6 lessons|1|||
105550694|NCT01220557|364014549|FG001|Overall Study|attended less than 6 lessons|2|||
105550695|NCT00355082|364014552|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
105550696|NCT00355082|364014553|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
105550697|NCT00355082|364014554|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
105663133|NCT04836559|364432371|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
105663134|NCT04836559|364432372|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
105663135|NCT04836559|364432373|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
105663136|NCT04836559|364432374|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
105663137|NCT04836559|364432375|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
105663138|NCT04836559|364432376|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
105663139|NCT04836559|364432377|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
105663140|NCT04836559|364432378|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
105663141|NCT04836559|364432371|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
105663142|NCT04836559|364432372|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
105663143|NCT04836559|364432373|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
105663144|NCT04836559|364432374|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
105663145|NCT04836559|364432375|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
105663146|NCT04836559|364432376|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
105663147|NCT04836559|364432377|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
105663148|NCT04836559|364432378|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
105663149|NCT04836559|364432371|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
105663150|NCT04836559|364432372|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
105663151|NCT04836559|364432373|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
105663152|NCT04836559|364432374|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
105663153|NCT04836559|364432375|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
105663154|NCT04836559|364432376|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
105663155|NCT04836559|364432377|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
105663156|NCT04836559|364432378|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
105663157|NCT04836559|364432371|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
105663158|NCT04836559|364432372|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
105663159|NCT04836559|364432373|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
105663160|NCT04836559|364432374|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
105663161|NCT04836559|364432375|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
105785392|NCT01016912|364866489|FG002|End of Treatment Period|Adverse Event|1|||
105785393|NCT01016912|364866490|FG003|End of Treatment Period|Adverse Event|0|||
105785394|NCT01016912|364866491|FG004|End of Treatment Period|Adverse Event|0|||
105550698|NCT00355082|364014552|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
105550699|NCT00355082|364014553|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
105550700|NCT00355082|364014554|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
105550701|NCT00355082|364014552|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
105550702|NCT00355082|364014553|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
105550703|NCT00355082|364014554|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
105663162|NCT04836559|364432376|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
105663163|NCT04836559|364432377|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
105550704|NCT00355082|364014552|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
105550705|NCT00355082|364014553|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
105663164|NCT04836559|364432378|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
105663165|NCT04836559|364432371|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
105663166|NCT04836559|364432372|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
105663167|NCT04836559|364432373|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
105663168|NCT04836559|364432374|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
105663169|NCT04836559|364432375|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
105663170|NCT04836559|364432376|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
105663171|NCT04836559|364432377|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
105663172|NCT04836559|364432378|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
105663173|NCT04698915|364432382|FG000|Overall Study|Adverse Event|2|||
105663174|NCT04698915|364432383|FG001|Overall Study|Adverse Event|0|||
105663175|NCT04698915|364432382|FG000|Overall Study|Death|23|||
105663176|NCT04698915|364432383|FG001|Overall Study|Death|20|||
105663177|NCT04698915|364432382|FG000|Overall Study|Physician Decision|1|||
105663178|NCT04698915|364432383|FG001|Overall Study|Physician Decision|1|||
105663179|NCT04698915|364432382|FG000|Overall Study|Lost to Follow-up|1|||
105663180|NCT04698915|364432383|FG001|Overall Study|Lost to Follow-up|0|||
105663181|NCT04698915|364432382|FG000|Overall Study|Study Terminated by Sponsor|55|||
105663182|NCT04698915|364432383|FG001|Overall Study|Study Terminated by Sponsor|60|||
105663183|NCT04698915|364432382|FG000|Overall Study|Withdrawal by Subject|2|||
105663184|NCT04698915|364432383|FG001|Overall Study|Withdrawal by Subject|3|||
105663185|NCT00013611|364432384|FG000|Overall Study|Lost to Follow-up|91|||
105663186|NCT00013611|364432385|FG001|Overall Study|Lost to Follow-up|100|||
105663187|NCT01437423|364432391|FG000|Overall Study|Lost to Follow-up|12|||
105663188|NCT01437423|364432391|FG000|Overall Study|Off label usage|3|||
105663189|NCT00633945|364432392|FG000|Overall Study|Physician Decision|2|||
105663190|NCT02552147|364432403|FG000|First Intervention (7 Days)|Protocol Violation|1|||
105663191|NCT02552147|364432404|FG001|First Intervention (7 Days)|Protocol Violation|0|||
105663192|NCT02552147|364432403|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
105663193|NCT02552147|364432404|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
105663194|NCT00940875|364432405|FG000|Treatment Phase|Adverse Event|9|||
105550706|NCT00355082|364014554|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
105550707|NCT00355082|364014552|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
105550708|NCT00355082|364014553|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
105550709|NCT00355082|364014554|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
105550710|NCT00355082|364014552|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
105550711|NCT00355082|364014553|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
105550712|NCT00355082|364014554|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
105550713|NCT00355082|364014552|FG000|Continuation Phase|Adverse Event|2|||
105550714|NCT00355082|364014553|FG001|Continuation Phase|Adverse Event|0|||
105550715|NCT00355082|364014554|FG002|Continuation Phase|Adverse Event|1|||
105550716|NCT00355082|364014552|FG000|Continuation Phase|Lost to Follow-up|2|||
105550717|NCT00355082|364014553|FG001|Continuation Phase|Lost to Follow-up|0|||
105550718|NCT00355082|364014554|FG002|Continuation Phase|Lost to Follow-up|1|||
105550719|NCT00355082|364014552|FG000|Continuation Phase|Protocol Violation|1|||
105550720|NCT00355082|364014553|FG001|Continuation Phase|Protocol Violation|0|||
105550721|NCT00355082|364014554|FG002|Continuation Phase|Protocol Violation|1|||
105550722|NCT00355082|364014552|FG000|Continuation Phase|Withdrawal by Subject|4|||
105550723|NCT00355082|364014553|FG001|Continuation Phase|Withdrawal by Subject|0|||
105550724|NCT00355082|364014554|FG002|Continuation Phase|Withdrawal by Subject|0|||
105550725|NCT00355082|364014552|FG000|Continuation Phase|Lack of Efficacy|5|||
105550726|NCT00355082|364014553|FG001|Continuation Phase|Lack of Efficacy|0|||
105550727|NCT00355082|364014554|FG002|Continuation Phase|Lack of Efficacy|0|||
105550728|NCT00355082|364014552|FG000|Continuation Phase|Site Closed by Sponsor|8|||
105550729|NCT00355082|364014553|FG001|Continuation Phase|Site Closed by Sponsor|0|||
105550730|NCT00355082|364014554|FG002|Continuation Phase|Site Closed by Sponsor|0|||
105550731|NCT00355082|364014552|FG000|Continuation Phase|Scheduling Error|1|||
105550732|NCT00355082|364014553|FG001|Continuation Phase|Scheduling Error|0|||
105550733|NCT00355082|364014554|FG002|Continuation Phase|Scheduling Error|0|||
105550734|NCT00355082|364014552|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
105550735|NCT00355082|364014553|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
105663195|NCT00940875|364432406|FG001|Treatment Phase|Adverse Event|3|||
105663196|NCT00940875|364432405|FG000|Treatment Phase|Death|3|||
105663197|NCT00940875|364432406|FG001|Treatment Phase|Death|5|||
105550736|NCT00355082|364014554|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
105550737|NCT01297062|364014555|FG000|Overall Study|Adverse Event|2|||
105550738|NCT01297062|364014556|FG001|Overall Study|Adverse Event|0|||
105550739|NCT01297062|364014557|FG002|Overall Study|Adverse Event|1|||
105550740|NCT01297062|364014558|FG003|Overall Study|Adverse Event|0|||
105550741|NCT01297062|364014559|FG004|Overall Study|Adverse Event|0|||
105550742|NCT01297062|364014560|FG005|Overall Study|Adverse Event|0|||
105550743|NCT01297062|364014561|FG006|Overall Study|Adverse Event|0|||
105550744|NCT01297062|364014555|FG000|Overall Study|Physician Decision|1|||
105550745|NCT01297062|364014556|FG001|Overall Study|Physician Decision|0|||
105550746|NCT01297062|364014557|FG002|Overall Study|Physician Decision|1|||
105550747|NCT01297062|364014558|FG003|Overall Study|Physician Decision|0|||
105550748|NCT01297062|364014559|FG004|Overall Study|Physician Decision|0|||
105550749|NCT01297062|364014560|FG005|Overall Study|Physician Decision|0|||
105550750|NCT01297062|364014561|FG006|Overall Study|Physician Decision|6|||
105550751|NCT01297062|364014555|FG000|Overall Study|Protocol Violation|0|||
105550752|NCT01297062|364014556|FG001|Overall Study|Protocol Violation|0|||
105550753|NCT01297062|364014557|FG002|Overall Study|Protocol Violation|0|||
105550754|NCT01297062|364014558|FG003|Overall Study|Protocol Violation|0|||
105550755|NCT01297062|364014559|FG004|Overall Study|Protocol Violation|1|||
105550756|NCT01297062|364014560|FG005|Overall Study|Protocol Violation|0|||
105550757|NCT01297062|364014561|FG006|Overall Study|Protocol Violation|0|||
105550758|NCT01297062|364014555|FG000|Overall Study|Subject Decision|1|||
105550759|NCT01297062|364014556|FG001|Overall Study|Subject Decision|1|||
105550760|NCT01297062|364014557|FG002|Overall Study|Subject Decision|0|||
105550761|NCT01297062|364014558|FG003|Overall Study|Subject Decision|1|||
105550762|NCT01297062|364014559|FG004|Overall Study|Subject Decision|1|||
105550763|NCT01297062|364014560|FG005|Overall Study|Subject Decision|1|||
105550764|NCT01297062|364014561|FG006|Overall Study|Subject Decision|2|||
105550765|NCT00074282|364017103|FG000|Step 1|Adverse Event|32|||
105550766|NCT00074282|364017104|FG001|Step 1|Adverse Event|0|||
105550767|NCT00074282|364017105|FG002|Step 1|Adverse Event|0|||
105550768|NCT00074282|364017103|FG000|Step 1|Death|6|||
105550769|NCT00074282|364017104|FG001|Step 1|Death|0|||
105550770|NCT00074282|364017105|FG002|Step 1|Death|0|||
105550771|NCT00074282|364017103|FG000|Step 1|Withdrawal by Subject|7|||
105550772|NCT00074282|364017104|FG001|Step 1|Withdrawal by Subject|0|||
105550773|NCT00074282|364017105|FG002|Step 1|Withdrawal by Subject|0|||
105550774|NCT00074282|364017103|FG000|Step 1|Disease progression|2|||
105550775|NCT00074282|364017104|FG001|Step 1|Disease progression|0|||
105550776|NCT00074282|364017105|FG002|Step 1|Disease progression|0|||
105550777|NCT00074282|364017103|FG000|Step 1|Alternative therapy|2|||
105550778|NCT00074282|364017104|FG001|Step 1|Alternative therapy|0|||
105550779|NCT00074282|364017105|FG002|Step 1|Alternative therapy|0|||
105550780|NCT00074282|364017103|FG000|Step 1|Other complicating disease|2|||
105550781|NCT00074282|364017104|FG001|Step 1|Other complicating disease|0|||
105550782|NCT00074282|364017105|FG002|Step 1|Other complicating disease|0|||
105550783|NCT00074282|364017103|FG000|Step 1|Physician Decision|1|||
105550784|NCT00074282|364017104|FG001|Step 1|Physician Decision|0|||
105550785|NCT00074282|364017105|FG002|Step 1|Physician Decision|0|||
105550786|NCT00074282|364017103|FG000|Step 1|Ineligible|4|||
105550787|NCT00074282|364017104|FG001|Step 1|Ineligible|0|||
105550788|NCT00074282|364017105|FG002|Step 1|Ineligible|0|||
105550789|NCT00074282|364017103|FG000|Step 1|Never started treatment|2|||
105550790|NCT00074282|364017104|FG001|Step 1|Never started treatment|0|||
105550791|NCT00074282|364017105|FG002|Step 1|Never started treatment|0|||
105550792|NCT00074282|364017103|FG000|Step 2|Adverse Event|0|||
105550793|NCT00074282|364017104|FG001|Step 2|Adverse Event|2|||
105550794|NCT00074282|364017105|FG002|Step 2|Adverse Event|12|||
105550795|NCT00074282|364017103|FG000|Step 2|Disease progression|0|||
105550796|NCT00074282|364017104|FG001|Step 2|Disease progression|0|||
105550797|NCT00074282|364017105|FG002|Step 2|Disease progression|5|||
105550798|NCT00074282|364017103|FG000|Step 2|Death|0|||
105550799|NCT00074282|364017104|FG001|Step 2|Death|0|||
105550800|NCT00074282|364017105|FG002|Step 2|Death|3|||
105550801|NCT00074282|364017103|FG000|Step 2|Withdrawal by Subject|0|||
105550802|NCT00074282|364017104|FG001|Step 2|Withdrawal by Subject|0|||
105550803|NCT00074282|364017105|FG002|Step 2|Withdrawal by Subject|2|||
105550804|NCT00074282|364017103|FG000|Step 2|Physician Decision|0|||
105550805|NCT00074282|364017104|FG001|Step 2|Physician Decision|0|||
105550806|NCT00074282|364017105|FG002|Step 2|Physician Decision|1|||
105663198|NCT00940875|364432405|FG000|Treatment Phase|Lack of Efficacy|1|||
105550807|NCT00074282|364017103|FG000|Step 2|Ineligible|0|||
105550808|NCT00074282|364017104|FG001|Step 2|Ineligible|0|||
105550809|NCT00074282|364017105|FG002|Step 2|Ineligible|1|||
105550810|NCT00724282|364017111|FG000|Overall Study|Withdrawal by Subject|3|||
105550811|NCT00724282|364017111|FG000|Overall Study|Physician Decision|1|||
105550812|NCT00489970|364017113|FG000|Persistence Year 9|Lost to Follow-up|2|||
105550813|NCT00489970|364017114|FG001|Persistence Year 9|Lost to Follow-up|2|||
105550814|NCT00489970|364017115|FG002|Persistence Year 9|Lost to Follow-up|3|||
105550815|NCT00489970|364017113|FG000|Persistence Year 9|Other|1|||
105550816|NCT00489970|364017114|FG001|Persistence Year 9|Other|0|||
105550817|NCT00489970|364017115|FG002|Persistence Year 9|Other|2|||
105550818|NCT02395120|364017116|FG000|Overall Study|Missed follow-up dental exam|57|||
105550819|NCT02395120|364017117|FG001|Overall Study|Missed follow-up dental exam|62|||
105550820|NCT02395120|364017118|FG002|Overall Study|Missed follow-up dental exam|6|||
105550821|NCT02395120|364017119|FG003|Overall Study|Missed follow-up dental exam|6|||
105550822|NCT02395120|364017120|FG004|Overall Study|Missed follow-up dental exam|51|||
105550823|NCT02053350|364017121|FG000|Overall Study|Withdrawal by Subject|1|||
105550824|NCT02053350|364017121|FG000|Overall Study|Adverse Event|4|||
105550825|NCT01159691|364017124|FG000|Overall Study|Lost to Follow-up|2|||
105550826|NCT01159691|364017124|FG000|Overall Study|Unknown reasons|1|||
105550827|NCT01159691|364017124|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
105550828|NCT01159691|364017124|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
105550829|NCT01159691|364017124|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
105550830|NCT01159691|364017124|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
105550831|NCT01159691|364017124|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
105550832|NCT01159691|364017124|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
105550833|NCT02367911|364017125|FG000|Overall Study|Withdrawal by Subject|3|||
105550834|NCT02367911|364017126|FG001|Overall Study|Withdrawal by Subject|2|||
105550835|NCT02367911|364017125|FG000|Overall Study|Lost to Follow-up|2|||
105550836|NCT02367911|364017126|FG001|Overall Study|Lost to Follow-up|2|||
105550837|NCT02492100|364017132|FG000|Overall Study|Death|1|||
105550838|NCT00352365|364017133|FG000|Induction Therapy|Adverse Event|7|||
105550839|NCT00352365|364017133|FG000|Induction Therapy|Progression/Relapse|8|||
105550840|NCT00352365|364017133|FG000|Induction Therapy|Death|7|||
105550841|NCT00352365|364017133|FG000|Induction Therapy|Not protocol specified|1|||
105550842|NCT00352365|364017133|FG000|Induction Therapy|Not eligible|3|||
105550843|NCT00352365|364017133|FG000|Induction Therapy|Death before starting protocol therapy|1|||
105550844|NCT00352365|364017133|FG000|Maintenance Therapy|Progression/Relapse|3|||
105550845|NCT00352365|364017133|FG000|Maintenance Therapy|Death|2|||
105550846|NCT00352365|364017133|FG000|Maintenance Therapy|Not protocol specified|3|||
105550847|NCT00352365|364017133|FG000|Maintenance Therapy|Not eligible|4|||
105550848|NCT02646423|364017134|FG000|Overall Study|Adverse Event|5|||
105550849|NCT02646423|364017135|FG001|Overall Study|Adverse Event|7|||
105550850|NCT02646423|364017134|FG000|Overall Study|Ineligible|2|||
105550851|NCT02646423|364017135|FG001|Overall Study|Ineligible|1|||
105550852|NCT00377819|364017136|FG000|Overall Study|Adverse Event|2|||
105550853|NCT00377819|364017137|FG001|Overall Study|Adverse Event|3|||
105550854|NCT00377819|364017136|FG000|Overall Study|Withdrawal by Subject|10|||
105550855|NCT00377819|364017137|FG001|Overall Study|Withdrawal by Subject|4|||
105550856|NCT00377819|364017136|FG000|Overall Study|Death|0|||
105550857|NCT00377819|364017137|FG001|Overall Study|Death|1|||
105550858|NCT00377819|364017136|FG000|Overall Study|Lost to Follow-up|0|||
105550859|NCT00377819|364017137|FG001|Overall Study|Lost to Follow-up|1|||
105550860|NCT00377819|364017136|FG000|Overall Study|Protocol Violation|1|||
105550861|NCT00377819|364017137|FG001|Overall Study|Protocol Violation|1|||
105550862|NCT03727750|364017138|FG000|Overall Study|Death|45|||
105550863|NCT03727750|364017138|FG000|Overall Study|Withdrawal by Subject|2|||
105550864|NCT03727750|364017138|FG000|Overall Study|Lost to Follow-up|1|||
105550865|NCT03727750|364017138|FG000|Overall Study|Other|1|||
105550866|NCT00321919|364017139|FG000|Overall Study|Adverse Event|17|||
105550867|NCT00321919|364017140|FG001|Overall Study|Adverse Event|10|||
105550868|NCT00321919|364017139|FG000|Overall Study|Death|21|||
105550869|NCT00321919|364017140|FG001|Overall Study|Death|17|||
105550870|NCT00321919|364017139|FG000|Overall Study|Insufficient Therapeutic Response|1|||
105550871|NCT00321919|364017140|FG001|Overall Study|Insufficient Therapeutic Response|0|||
105550872|NCT00321919|364017139|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
105550873|NCT00321919|364017140|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
105550874|NCT00321919|364017139|FG000|Overall Study|Refused Treatment|23|||
105550875|NCT00321919|364017140|FG001|Overall Study|Refused Treatment|14|||
105550876|NCT00321919|364017139|FG000|Overall Study|Other Protocol Violation|2|||
105550877|NCT00321919|364017140|FG001|Overall Study|Other Protocol Violation|3|||
105550878|NCT00321919|364017139|FG000|Overall Study|Failure to Return|3|||
105550879|NCT00321919|364017140|FG001|Overall Study|Failure to Return|1|||
105550880|NCT00321919|364017139|FG000|Overall Study|Other withdrawal reason|7|||
105550881|NCT00321919|364017140|FG001|Overall Study|Other withdrawal reason|6|||
105550882|NCT02460991|364017144|FG000|Overall Study|Withdrawal by Subject|0|||
105550883|NCT02460991|364017145|FG001|Overall Study|Withdrawal by Subject|2|||
105550884|NCT00856856|364017146|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
105550885|NCT00856856|364017146|FG000|4-year Clinical Follow-up|Missed visit|1|||
105550886|NCT02148250|364017148|FG000|Screening|Withdrawal by Subject|5|||
105550887|NCT02148250|364017149|FG001|Screening|Withdrawal by Subject|0|||
105550888|NCT00922428|364017152|FG000|Overall Study|retrospective/extremely implausible data|2|||
105550889|NCT00922428|364017152|FG000|Overall Study|no medication use or questionable use|13|||
105550890|NCT03701555|364017154|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
105550891|NCT03701555|364017155|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
105339126|NCT01943851|363243552|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
105339127|NCT01943851|363243553|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105339128|NCT01943851|363243554|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105339129|NCT01943851|363243555|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
105339130|NCT01943851|363243556|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105339131|NCT01943851|363243557|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105339132|NCT01943851|363243558|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105339133|NCT01943851|363243559|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105339134|NCT01943851|363243560|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105339135|NCT01943851|363243561|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105339136|NCT01943851|363243562|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105339137|NCT01943851|363243563|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105339138|NCT01943851|363243564|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105339139|NCT01943851|363243565|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105339140|NCT01943851|363243548|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339141|NCT01943851|363243549|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339142|NCT01943851|363243550|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339143|NCT01943851|363243551|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339144|NCT01943851|363243552|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339145|NCT01943851|363243553|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339146|NCT01943851|363243554|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339147|NCT01943851|363243555|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339148|NCT01943851|363243556|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339149|NCT01943851|363243557|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339150|NCT01943851|363243558|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339151|NCT01943851|363243559|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339152|NCT01943851|363243560|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339153|NCT01943851|363243561|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
105339154|NCT01943851|363243562|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339155|NCT01943851|363243563|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339156|NCT01943851|363243564|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339157|NCT01943851|363243565|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105339158|NCT01943851|363243548|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339159|NCT01943851|363243549|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339160|NCT01943851|363243550|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339161|NCT01943851|363243551|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339162|NCT01943851|363243552|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339163|NCT01943851|363243553|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339164|NCT01943851|363243554|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339165|NCT01943851|363243555|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339166|NCT01943851|363243556|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339167|NCT01943851|363243557|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339168|NCT01943851|363243558|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339169|NCT01943851|363243559|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339170|NCT01943851|363243560|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339171|NCT01943851|363243561|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339172|NCT01943851|363243562|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339173|NCT01943851|363243563|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
105339174|NCT01943851|363243564|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339175|NCT01943851|363243565|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105339176|NCT01943851|363243548|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105339177|NCT01943851|363243549|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105339178|NCT01943851|363243550|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105339179|NCT01943851|363243551|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105339180|NCT01943851|363243552|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105339181|NCT01943851|363243553|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105339182|NCT01943851|363243554|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105339183|NCT01943851|363243555|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105339184|NCT01943851|363243556|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105663199|NCT00940875|364432406|FG001|Treatment Phase|Lack of Efficacy|0|||
105663200|NCT00940875|364432405|FG000|Treatment Phase|Withdrawal by Subject|3|||
105663201|NCT00940875|364432406|FG001|Treatment Phase|Withdrawal by Subject|0|||
105663202|NCT00940875|364432405|FG000|Treatment Phase|Disease progression|9|||
105663203|NCT00940875|364432406|FG001|Treatment Phase|Disease progression|11|||
105663204|NCT00940875|364432405|FG000|Treatment Phase|Physician Decision|1|||
105663205|NCT00940875|364432406|FG001|Treatment Phase|Physician Decision|0|||
105663206|NCT00940875|364432405|FG000|Post-Study Treatment|Death|0|||
105663207|NCT00940875|364432406|FG001|Post-Study Treatment|Death|1|||
105663208|NCT00940875|364432405|FG000|Post-Study Treatment|Disease Progression|0|||
105663209|NCT00940875|364432406|FG001|Post-Study Treatment|Disease Progression|2|||
105663210|NCT04071301|364432412|FG000|Overall Study|Withdrawal by Subject|6|||
105663211|NCT04071301|364432412|FG000|Overall Study|Death|1|||
105663212|NCT01453023|364432413|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
105663213|NCT01453023|364432414|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
105663214|NCT01453023|364432413|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
105462491|NCT00307801|363707311|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
105462492|NCT00307801|363707310|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
105462493|NCT00307801|363707311|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
105462494|NCT00307801|363707310|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
105462495|NCT00307801|363707311|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
105462496|NCT00307801|363707310|FG000|Overall Study|Wrong Randomization|1|||
105462497|NCT00307801|363707311|FG001|Overall Study|Wrong Randomization|0|||
105663215|NCT01453023|364432414|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
105785395|NCT01016912|364866487|FG000|End of Treatment Period|Completed double-blind period only|0|||
105462498|NCT00307801|363707310|FG000|Overall Study|Lack of Efficacy|0|||
105462499|NCT00307801|363707311|FG001|Overall Study|Lack of Efficacy|2|||
105550892|NCT03701555|364017156|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
105785396|NCT01016912|364866488|FG001|End of Treatment Period|Completed double-blind period only|1|||
105785397|NCT01016912|364866489|FG002|End of Treatment Period|Completed double-blind period only|0|||
105785398|NCT01016912|364866490|FG003|End of Treatment Period|Completed double-blind period only|0|||
105785399|NCT01016912|364866491|FG004|End of Treatment Period|Completed double-blind period only|0|||
105785400|NCT01016912|364866487|FG000|Follow-up Period|Other reason|0|||
105785401|NCT01016912|364866488|FG001|Follow-up Period|Other reason|0|||
105785402|NCT01016912|364866489|FG002|Follow-up Period|Other reason|1|||
105785403|NCT01016912|364866490|FG003|Follow-up Period|Other reason|1|||
105785404|NCT01016912|364866491|FG004|Follow-up Period|Other reason|0|||
105785405|NCT01119118|364866492|FG000|Overall Study|Adverse Event|1|||
105785406|NCT01003691|364866494|FG000|Overall Study|Adverse Event|0|||
105785407|NCT01003691|364866495|FG001|Overall Study|Adverse Event|0|||
105785408|NCT01003691|364866496|FG002|Overall Study|Adverse Event|0|||
105785409|NCT01003691|364866497|FG003|Overall Study|Adverse Event|1|||
105785410|NCT01875731|364866498|FG000|Overall Study|Fail to obtain lab sample|1|||
105785411|NCT01875731|364866499|FG001|Overall Study|Fail to obtain lab sample|0|||
105785412|NCT03417102|364866500|FG000|Overall Study|Adverse Event|0|||
105785413|NCT03417102|364866501|FG001|Overall Study|Adverse Event|1|||
105785414|NCT03417102|364866500|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
105785415|NCT03417102|364866501|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
105785416|NCT03417102|364866500|FG000|Overall Study|Other|0|||
105785417|NCT03417102|364866501|FG001|Overall Study|Other|1|||
105785418|NCT03418727|364866502|FG000|Overall Study|Adverse Event|1|||
105785419|NCT03418727|364866503|FG001|Overall Study|Adverse Event|2|||
105785420|NCT03418727|364866504|FG002|Overall Study|Adverse Event|0|||
105785421|NCT03418727|364866502|FG000|Overall Study|Withdrawal by Subject|0|||
105785422|NCT03418727|364866503|FG001|Overall Study|Withdrawal by Subject|0|||
105785423|NCT03418727|364866504|FG002|Overall Study|Withdrawal by Subject|2|||
105785424|NCT01018680|364868458|FG000|Overall Study|Adverse Event|23|||
105785425|NCT01018680|364868459|FG001|Overall Study|Adverse Event|40|||
105785426|NCT01018680|364868458|FG000|Overall Study|Withdrawal by Subject|10|||
105785427|NCT01018680|364868459|FG001|Overall Study|Withdrawal by Subject|10|||
105785428|NCT01018680|364868458|FG000|Overall Study|Protocol Violation|5|||
105785429|NCT01018680|364868459|FG001|Overall Study|Protocol Violation|8|||
105785430|NCT01018680|364868458|FG000|Overall Study|Sponsor Decision|6|||
105785431|NCT01018680|364868459|FG001|Overall Study|Sponsor Decision|7|||
105785432|NCT01018680|364868458|FG000|Overall Study|Lack of Efficacy|8|||
105785433|NCT01018680|364868459|FG001|Overall Study|Lack of Efficacy|2|||
105785434|NCT01018680|364868458|FG000|Overall Study|Lost to Follow-up|5|||
105785435|NCT01018680|364868459|FG001|Overall Study|Lost to Follow-up|3|||
105785436|NCT01018680|364868458|FG000|Overall Study|Entry Criteria Not Met|1|||
105785437|NCT01018680|364868459|FG001|Overall Study|Entry Criteria Not Met|4|||
105785438|NCT01018680|364868458|FG000|Overall Study|Physician Decision|3|||
105785439|NCT01018680|364868459|FG001|Overall Study|Physician Decision|1|||
105785440|NCT02930889|364868460|FG000|Overall Study|Lost to Follow-up|2|||
105785441|NCT02930889|364868460|FG000|Overall Study|Withdrawal by Subject|6|||
105663216|NCT01453023|364432413|FG000|Treatment Period 2|Protocol Violation|0|||
105663217|NCT01453023|364432414|FG001|Treatment Period 2|Protocol Violation|1|||
105663218|NCT04468230|364432420|FG000|Overall Study|Adverse Event|2|||
105663219|NCT00420784|364432421|FG000|Overall Study|Adverse Event|11|||
105663220|NCT00420784|364432422|FG001|Overall Study|Adverse Event|29|||
105663221|NCT00420784|364432423|FG002|Overall Study|Adverse Event|10|||
105663222|NCT00420784|364432424|FG003|Overall Study|Adverse Event|5|||
105663223|NCT00420784|364432421|FG000|Overall Study|Withdrawal by Subject|0|||
105663224|NCT00420784|364432422|FG001|Overall Study|Withdrawal by Subject|1|||
105663225|NCT00420784|364432423|FG002|Overall Study|Withdrawal by Subject|0|||
105663226|NCT00420784|364432424|FG003|Overall Study|Withdrawal by Subject|0|||
105663227|NCT00420784|364432421|FG000|Overall Study|Lost to Follow-up|0|||
105663228|NCT00420784|364432422|FG001|Overall Study|Lost to Follow-up|0|||
105663229|NCT00420784|364432423|FG002|Overall Study|Lost to Follow-up|2|||
105663230|NCT00420784|364432424|FG003|Overall Study|Lost to Follow-up|1|||
105663231|NCT00420784|364432421|FG000|Overall Study|Virologic Stopping Rule|17|||
105663232|NCT00420784|364432422|FG001|Overall Study|Virologic Stopping Rule|26|||
105663233|NCT00420784|364432423|FG002|Overall Study|Virologic Stopping Rule|41|||
105663234|NCT00420784|364432424|FG003|Overall Study|Virologic Stopping Rule|67|||
105663235|NCT00420784|364432421|FG000|Overall Study|Other|1|||
105663236|NCT00420784|364432422|FG001|Overall Study|Other|2|||
105663237|NCT00420784|364432423|FG002|Overall Study|Other|0|||
105663238|NCT00420784|364432424|FG003|Overall Study|Other|5|||
105663239|NCT04799418|364432425|FG000|Overall Study|Death|1|||
105663240|NCT04799418|364432426|FG001|Overall Study|Death|1|||
105663241|NCT04799418|364432425|FG000|Overall Study|Lack of Efficacy|14|||
105663242|NCT04799418|364432426|FG001|Overall Study|Lack of Efficacy|14|||
105663243|NCT04799418|364432425|FG000|Overall Study|Withdrawal by Subject|10|||
105663244|NCT04799418|364432426|FG001|Overall Study|Withdrawal by Subject|7|||
105663245|NCT04799418|364432425|FG000|Overall Study|Adverse Event|3|||
105663246|NCT04799418|364432426|FG001|Overall Study|Adverse Event|2|||
105663247|NCT02844777|364432438|FG000|Overall Study|Withdrawal by Subject|2|||
105663248|NCT02844777|364432439|FG001|Overall Study|Withdrawal by Subject|0|||
105663249|NCT02844777|364432440|FG002|Overall Study|Withdrawal by Subject|0|||
105663250|NCT04092452|364432442|FG000|Overall Study|Adverse Event|1|||
105663251|NCT04092452|364432443|FG001|Overall Study|Adverse Event|3|||
105663252|NCT04092452|364432444|FG002|Overall Study|Adverse Event|3|||
105663253|NCT04092452|364432445|FG003|Overall Study|Adverse Event|7|||
105663254|NCT04092452|364432442|FG000|Overall Study|Lack of Efficacy|1|||
105663255|NCT04092452|364432443|FG001|Overall Study|Lack of Efficacy|1|||
105663256|NCT04092452|364432444|FG002|Overall Study|Lack of Efficacy|1|||
105663257|NCT04092452|364432445|FG003|Overall Study|Lack of Efficacy|0|||
105663258|NCT04092452|364432442|FG000|Overall Study|Lost to Follow-up|4|||
105663259|NCT04092452|364432443|FG001|Overall Study|Lost to Follow-up|3|||
105663260|NCT04092452|364432444|FG002|Overall Study|Lost to Follow-up|5|||
105663261|NCT04092452|364432445|FG003|Overall Study|Lost to Follow-up|1|||
105663262|NCT04092452|364432442|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105663263|NCT04092452|364432443|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105663264|NCT04092452|364432444|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105663265|NCT04092452|364432445|FG003|Overall Study|Non-Compliance With Study Drug|1|||
105663266|NCT04092452|364432442|FG000|Overall Study|Physician Decision|1|||
105663267|NCT04092452|364432443|FG001|Overall Study|Physician Decision|0|||
105663268|NCT04092452|364432444|FG002|Overall Study|Physician Decision|1|||
105663269|NCT04092452|364432445|FG003|Overall Study|Physician Decision|0|||
105663270|NCT04092452|364432442|FG000|Overall Study|Pregnancy|2|||
105663271|NCT04092452|364432443|FG001|Overall Study|Pregnancy|0|||
105663272|NCT04092452|364432444|FG002|Overall Study|Pregnancy|0|||
105663273|NCT04092452|364432445|FG003|Overall Study|Pregnancy|0|||
105663274|NCT04092452|364432442|FG000|Overall Study|Protocol Deviation|1|||
105663275|NCT04092452|364432443|FG001|Overall Study|Protocol Deviation|0|||
105663276|NCT04092452|364432444|FG002|Overall Study|Protocol Deviation|0|||
105663277|NCT04092452|364432445|FG003|Overall Study|Protocol Deviation|0|||
105663278|NCT04092452|364432442|FG000|Overall Study|Withdrawal by Subject|3|||
105663279|NCT04092452|364432443|FG001|Overall Study|Withdrawal by Subject|10|||
105663280|NCT04092452|364432444|FG002|Overall Study|Withdrawal by Subject|3|||
105663281|NCT04092452|364432445|FG003|Overall Study|Withdrawal by Subject|5|||
105663282|NCT04092452|364432442|FG000|Overall Study|Other|0|||
105663283|NCT04092452|364432443|FG001|Overall Study|Other|0|||
105663284|NCT04092452|364432444|FG002|Overall Study|Other|1|||
105550893|NCT03701555|364017157|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
105550894|NCT03701555|364017158|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
105550895|NCT03701555|364017159|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
105550896|NCT03701555|364017160|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
105550897|NCT03701555|364017161|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
105550898|NCT03701555|364017162|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
105550899|NCT03701555|364017163|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
105550900|NCT03701555|364017164|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
105550901|NCT03701555|364017165|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
105550902|NCT03701555|364017166|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
105550903|NCT03701555|364017167|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
105550904|NCT03701555|364017168|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
105550905|NCT03701555|364017169|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
105550906|NCT03701555|364017170|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
105550907|NCT03701555|364017171|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
105550908|NCT03701555|364017172|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
105550909|NCT03701555|364017173|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
105550910|NCT03701555|364017174|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
105550911|NCT03701555|364017175|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
105550912|NCT03701555|364017176|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
105550913|NCT03701555|364017177|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
105550914|NCT03701555|364017178|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
105550915|NCT03701555|364017179|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
105550916|NCT03701555|364017180|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
105550917|NCT03701555|364017181|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
105550918|NCT03701555|364017182|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
105550919|NCT03701555|364017183|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
105550920|NCT03701555|364017184|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
105550921|NCT03701555|364017185|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
105550922|NCT03701555|364017186|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
105550923|NCT03701555|364017187|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
105550924|NCT03701555|364017188|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
105550925|NCT03701555|364017189|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
105550926|NCT03701555|364017154|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
105550927|NCT03701555|364017155|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
105550928|NCT03701555|364017156|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
105550929|NCT03701555|364017157|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
105550930|NCT03701555|364017158|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
105550931|NCT03701555|364017159|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
105550932|NCT03701555|364017160|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
105550933|NCT03701555|364017161|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
105550934|NCT03701555|364017162|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
105550935|NCT03701555|364017163|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
105550936|NCT03701555|364017164|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
105663285|NCT04092452|364432445|FG003|Overall Study|Other|2|||
105663286|NCT04016272|364432446|FG000|Overall Study|Withdrawal by Subject|1|||
105663287|NCT04016272|364432447|FG001|Overall Study|Withdrawal by Subject|2|||
105663288|NCT03355209|364432448|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
105663289|NCT03355209|364432449|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
105663290|NCT03355209|364432450|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
105663291|NCT03355209|364432451|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
105663292|NCT03355209|364432452|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
105663293|NCT03355209|364432453|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
105663294|NCT03355209|364432448|FG000|Part 1: Double-Blind Period|Death|0|||
105663295|NCT03355209|364432449|FG001|Part 1: Double-Blind Period|Death|0|||
105663296|NCT03355209|364432450|FG002|Part 1: Double-Blind Period|Death|1|||
105663297|NCT03355209|364432451|FG003|Part 1: Double-Blind Period|Death|0|||
105663298|NCT03355209|364432452|FG004|Part 1: Double-Blind Period|Death|0|||
105663299|NCT03355209|364432453|FG005|Part 1: Double-Blind Period|Death|0|||
105663300|NCT03355209|364432448|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
105663301|NCT03355209|364432449|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
105663302|NCT03355209|364432450|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
105663303|NCT03355209|364432451|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
105663304|NCT03355209|364432452|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
105663305|NCT03355209|364432453|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
105663306|NCT03355209|364432448|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
105663307|NCT03355209|364432449|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
105663308|NCT03355209|364432450|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
105663309|NCT03355209|364432451|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
105663310|NCT03355209|364432452|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
105663311|NCT03355209|364432453|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
105663312|NCT03355209|364432448|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
105663313|NCT03355209|364432449|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
105663314|NCT03355209|364432450|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
105663315|NCT03355209|364432451|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
105663316|NCT03355209|364432452|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
105663317|NCT03355209|364432453|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
105663318|NCT03355209|364432448|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
105663319|NCT03355209|364432449|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
105663320|NCT03355209|364432450|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
105663321|NCT03355209|364432451|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
105663322|NCT03355209|364432452|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
105663323|NCT03355209|364432453|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
105663324|NCT03355209|364432448|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
105462500|NCT00307801|363707310|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
105462501|NCT00307801|363707311|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
105462502|NCT00307801|363707310|FG000|Overall Study|Frustration with e-diary|1|||
105462503|NCT00307801|363707311|FG001|Overall Study|Frustration with e-diary|0|||
105462504|NCT00307801|363707310|FG000|Overall Study|Protocol Violation|3|||
105462505|NCT00307801|363707311|FG001|Overall Study|Protocol Violation|2|||
105462506|NCT00307801|363707310|FG000|Overall Study|No reason specified|2|||
105462507|NCT00307801|363707311|FG001|Overall Study|No reason specified|0|||
105462508|NCT00307801|363707310|FG000|Overall Study|Pregnancy|0|||
105462509|NCT00307801|363707311|FG001|Overall Study|Pregnancy|1|||
105462510|NCT00551642|363707314|FG000|Treatment Period|Protocol Deviation|6|||
105462511|NCT00551642|363707315|FG001|Treatment Period|Protocol Deviation|11|||
105462512|NCT00551642|363707314|FG000|Treatment Period|Delivery device failure|1|||
105663325|NCT03355209|364432449|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
105663326|NCT03355209|364432450|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
105663327|NCT03355209|364432451|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
105663328|NCT03355209|364432452|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
105462513|NCT00551642|363707315|FG001|Treatment Period|Delivery device failure|3|||
105462514|NCT00551642|363707314|FG000|Treatment Period|Physician Decision|0|||
105339185|NCT01943851|363243557|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105339186|NCT01943851|363243558|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105339187|NCT01943851|363243559|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105339188|NCT01943851|363243560|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105339189|NCT01943851|363243561|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105339190|NCT01943851|363243562|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105339191|NCT01943851|363243563|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
105339192|NCT01943851|363243564|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
105339193|NCT01943851|363243565|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
105339194|NCT00348595|363243566|FG000|Overall Study|Adverse Event|5|||
105339195|NCT00348595|363243567|FG001|Overall Study|Adverse Event|8|||
105339196|NCT00900757|363243568|FG000|Overall Study|screen failure|19|||
105339197|NCT01942486|363243569|FG000|Overall Study|Lost to Follow-up|27|||
105339198|NCT02005692|363243572|FG000|Overall Study|Protocol Violation|1|||
105339199|NCT02005692|363243572|FG000|Overall Study|Withdrawal by Subject|1|||
105339200|NCT02005692|363243572|FG000|Overall Study|Discharged earlier than anticipated|5|||
105339201|NCT02651155|363243573|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
105339202|NCT02651155|363243574|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
105339203|NCT02651155|363243573|FG000|Overall Study|Voluntary Withdrawal|5|||
105339204|NCT02651155|363243574|FG001|Overall Study|Voluntary Withdrawal|0|||
105339205|NCT05113979|363243580|FG000|Overall Study|Death|2|||
105339206|NCT05113979|363243580|FG000|Overall Study|Lost to Follow-up|1|||
105339207|NCT01489254|363243585|FG000|Double-blind Part|Adverse Event|7|||
105339208|NCT01489254|363243586|FG001|Double-blind Part|Adverse Event|2|||
105339209|NCT01489254|363243587|FG002|Double-blind Part|Adverse Event|2|||
105339210|NCT01489254|363243588|FG003|Double-blind Part|Adverse Event|0|||
105339211|NCT01489254|363243585|FG000|Double-blind Part|Pregnancy|1|||
105339212|NCT01489254|363243586|FG001|Double-blind Part|Pregnancy|3|||
105339213|NCT01489254|363243587|FG002|Double-blind Part|Pregnancy|0|||
105339214|NCT01489254|363243588|FG003|Double-blind Part|Pregnancy|0|||
105339215|NCT01489254|363243585|FG000|Double-blind Part|Withdrawal by Subject|12|||
105339216|NCT01489254|363243586|FG001|Double-blind Part|Withdrawal by Subject|20|||
105339217|NCT01489254|363243587|FG002|Double-blind Part|Withdrawal by Subject|1|||
105663329|NCT03355209|364432453|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
105663330|NCT03355209|364432448|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
105663331|NCT03355209|364432449|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
105663332|NCT03355209|364432450|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
105663333|NCT03355209|364432451|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
105663334|NCT03355209|364432452|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
105663335|NCT03355209|364432453|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
105339218|NCT01489254|363243588|FG003|Double-blind Part|Withdrawal by Subject|0|||
105339219|NCT01489254|363243585|FG000|Double-blind Part|Lost to Follow-up|1|||
105339220|NCT01489254|363243586|FG001|Double-blind Part|Lost to Follow-up|2|||
105339221|NCT01489254|363243587|FG002|Double-blind Part|Lost to Follow-up|0|||
105339222|NCT01489254|363243588|FG003|Double-blind Part|Lost to Follow-up|0|||
105339223|NCT01489254|363243585|FG000|Double-blind Part|Other reasons for not completing study|4|||
105462515|NCT00551642|363707315|FG001|Treatment Period|Physician Decision|1|||
105462516|NCT00551642|363707314|FG000|Treatment Period|Death|33|||
105462517|NCT00551642|363707315|FG001|Treatment Period|Death|31|||
105462518|NCT00551642|363707314|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
105462519|NCT00551642|363707315|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
105462520|NCT00551642|363707314|FG000|Treatment Period|Adverse Event|15|||
105462521|NCT00551642|363707315|FG001|Treatment Period|Adverse Event|12|||
105462522|NCT00551642|363707314|FG000|Treatment Period|Withdrawal by Subject|2|||
105462523|NCT00551642|363707315|FG001|Treatment Period|Withdrawal by Subject|1|||
105462524|NCT00904982|363707318|FG000|Overall Study|Withdrawal by Subject|2|||
105462525|NCT00904982|363707319|FG001|Overall Study|Withdrawal by Subject|0|||
105462526|NCT00904982|363707320|FG002|Overall Study|Withdrawal by Subject|0|||
105462527|NCT00904982|363707321|FG003|Overall Study|Withdrawal by Subject|0|||
105462528|NCT03011099|363707327|FG000|Overall Study|Withdrawal by Subject|0|||
105462529|NCT03011099|363707328|FG001|Overall Study|Withdrawal by Subject|2|||
105462530|NCT02072668|363707331|FG000|Second Intervention|Lost to Follow-up|1|||
105462531|NCT02072668|363707332|FG001|Second Intervention|Lost to Follow-up|0|||
105462532|NCT02668653|363707333|FG000|Overall Study|Refractory disease|41|||
105462533|NCT02668653|363707334|FG001|Overall Study|Refractory disease|70|||
105462534|NCT02668653|363707333|FG000|Overall Study|Relapse|44|||
105462535|NCT02668653|363707334|FG001|Overall Study|Relapse|65|||
105462536|NCT02668653|363707333|FG000|Overall Study|Adverse Event|58|||
105339224|NCT01489254|363243586|FG001|Double-blind Part|Other reasons for not completing study|6|||
105462537|NCT02668653|363707334|FG001|Overall Study|Adverse Event|23|||
105462538|NCT02668653|363707333|FG000|Overall Study|Subject decision to stop study drug|25|||
105462539|NCT02668653|363707334|FG001|Overall Study|Subject decision to stop study drug|23|||
105462540|NCT02668653|363707333|FG000|Overall Study|Other reasons not specified|16|||
105462541|NCT02668653|363707334|FG001|Overall Study|Other reasons not specified|11|||
105339225|NCT01489254|363243587|FG002|Double-blind Part|Other reasons for not completing study|0|||
105339226|NCT01489254|363243588|FG003|Double-blind Part|Other reasons for not completing study|0|||
105339227|NCT01489254|363243585|FG000|Open-label Extension Part|Adverse Event|0|||
105339228|NCT01489254|363243586|FG001|Open-label Extension Part|Adverse Event|0|||
105339229|NCT01489254|363243587|FG002|Open-label Extension Part|Adverse Event|0|||
105339230|NCT01489254|363243588|FG003|Open-label Extension Part|Adverse Event|10|||
105339231|NCT01489254|363243585|FG000|Open-label Extension Part|Pregnancy|0|||
105339232|NCT01489254|363243586|FG001|Open-label Extension Part|Pregnancy|0|||
105339233|NCT01489254|363243587|FG002|Open-label Extension Part|Pregnancy|0|||
105339234|NCT01489254|363243588|FG003|Open-label Extension Part|Pregnancy|3|||
105339235|NCT01489254|363243585|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
105339236|NCT01489254|363243586|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
105339237|NCT01489254|363243587|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
105339238|NCT01489254|363243588|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
105339239|NCT01489254|363243585|FG000|Open-label Extension Part|Protocol Violation|0|||
105339240|NCT01489254|363243586|FG001|Open-label Extension Part|Protocol Violation|0|||
105339241|NCT01489254|363243587|FG002|Open-label Extension Part|Protocol Violation|0|||
105339242|NCT01489254|363243588|FG003|Open-label Extension Part|Protocol Violation|1|||
105339243|NCT01489254|363243585|FG000|Open-label Extension Part|Lost to Follow-up|0|||
105339244|NCT01489254|363243586|FG001|Open-label Extension Part|Lost to Follow-up|0|||
105339245|NCT01489254|363243587|FG002|Open-label Extension Part|Lost to Follow-up|0|||
105339246|NCT01489254|363243588|FG003|Open-label Extension Part|Lost to Follow-up|9|||
105339247|NCT01489254|363243585|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
105339248|NCT01489254|363243586|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
105339249|NCT01489254|363243587|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
105339250|NCT01489254|363243588|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
105339251|NCT01609543|363243589|FG000|Overall Study|Disease Progression|28|||
105339252|NCT01609543|363243589|FG000|Overall Study|Adverse Event|5|||
105339253|NCT01609543|363243589|FG000|Overall Study|Withdrawal by Subject|1|||
105339254|NCT01609543|363243589|FG000|Overall Study|Protocol Violation|1|||
105339255|NCT01609543|363243589|FG000|Overall Study|Death|7|||
105339256|NCT03843541|363243593|FG000|Overall Study|Adverse Event|4|||
105339257|NCT03843541|363243594|FG001|Overall Study|Adverse Event|2|||
105339258|NCT03843541|363243595|FG002|Overall Study|Adverse Event|3|||
105462542|NCT02668653|363707333|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
105462543|NCT02668653|363707334|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
105462544|NCT02668653|363707333|FG000|Overall Study|Investigator decision|10|||
105462545|NCT02668653|363707334|FG001|Overall Study|Investigator decision|7|||
105462546|NCT02668653|363707333|FG000|Overall Study|Failure to meet continuation criteria|5|||
105462547|NCT02668653|363707334|FG001|Overall Study|Failure to meet continuation criteria|12|||
105462548|NCT02668653|363707333|FG000|Overall Study|Lost to Follow-up|1|||
105462549|NCT02668653|363707334|FG001|Overall Study|Lost to Follow-up|0|||
105462550|NCT02668653|363707333|FG000|Overall Study|Pregnancy|0|||
105462551|NCT02668653|363707334|FG001|Overall Study|Pregnancy|1|||
105462552|NCT02668653|363707333|FG000|Overall Study|Death|0|||
105462553|NCT02668653|363707334|FG001|Overall Study|Death|1|||
105462554|NCT03987503|363707335|FG000|Overall Study|Lost to Follow-up|20|||
105462555|NCT03987503|363707335|FG000|Overall Study|Withdrawal by Subject|2|||
105462556|NCT00926237|363707336|FG000|Overall Study|Withdrawal by Subject|2|||
105462557|NCT00926237|363707337|FG001|Overall Study|Withdrawal by Subject|1|||
105462558|NCT04949490|363707339|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
105462559|NCT04949490|363707340|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
105550937|NCT03701555|364017165|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
105550938|NCT03701555|364017166|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
105550939|NCT03701555|364017167|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
105663336|NCT03355209|364432448|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
105339259|NCT03843541|363243593|FG000|Overall Study|Death|1|||
105339260|NCT03843541|363243594|FG001|Overall Study|Death|0|||
105339261|NCT03843541|363243595|FG002|Overall Study|Death|0|||
105339262|NCT03843541|363243593|FG000|Overall Study|Lack of adherence to study medication|0|||
105462560|NCT04949490|363707341|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
105462561|NCT04949490|363707342|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
105339263|NCT03843541|363243594|FG001|Overall Study|Lack of adherence to study medication|0|||
105339264|NCT03843541|363243595|FG002|Overall Study|Lack of adherence to study medication|1|||
105339265|NCT03843541|363243593|FG000|Overall Study|Physician Decision|1|||
105339266|NCT03843541|363243594|FG001|Overall Study|Physician Decision|2|||
105339267|NCT03843541|363243595|FG002|Overall Study|Physician Decision|2|||
105339268|NCT03843541|363243593|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
105339269|NCT03843541|363243594|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
105339270|NCT03843541|363243595|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
105339271|NCT03843541|363243593|FG000|Overall Study|Withdrawal by Subject|6|||
105339272|NCT03843541|363243594|FG001|Overall Study|Withdrawal by Subject|9|||
105339273|NCT03843541|363243595|FG002|Overall Study|Withdrawal by Subject|7|||
105339274|NCT03843541|363243593|FG000|Overall Study|Administration of rescue mucolytic|0|||
105339275|NCT03843541|363243594|FG001|Overall Study|Administration of rescue mucolytic|0|||
105339276|NCT03843541|363243595|FG002|Overall Study|Administration of rescue mucolytic|1|||
105339277|NCT03843541|363243593|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
105339278|NCT03843541|363243594|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
105339279|NCT03843541|363243595|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
105339280|NCT02691013|363243598|FG000|Overall Study|Withdrawal by Subject|3|||
105339281|NCT02691013|363243599|FG001|Overall Study|Withdrawal by Subject|0|||
105339282|NCT01075646|363243600|FG000|Overall Study|Lost to Follow-up|4|||
105339283|NCT01075646|363243601|FG001|Overall Study|Lost to Follow-up|3|||
105339284|NCT01075646|363243602|FG002|Overall Study|Lost to Follow-up|1|||
105339285|NCT01075646|363243603|FG003|Overall Study|Lost to Follow-up|2|||
105339286|NCT01023256|363243604|FG000|Overall Study|Protocol Violation|2|||
105339287|NCT01023256|363243605|FG001|Overall Study|Protocol Violation|3|||
105339288|NCT01023256|363243606|FG002|Overall Study|Protocol Violation|0|||
105339289|NCT01023256|363243607|FG003|Overall Study|Protocol Violation|0|||
105339290|NCT01023256|363243604|FG000|Overall Study|Randomized but not treated|1|||
105339291|NCT01023256|363243605|FG001|Overall Study|Randomized but not treated|0|||
105339292|NCT01023256|363243606|FG002|Overall Study|Randomized but not treated|1|||
105339293|NCT01023256|363243607|FG003|Overall Study|Randomized but not treated|0|||
105339294|NCT01023256|363243604|FG000|Overall Study|Other|1|||
105339295|NCT01023256|363243605|FG001|Overall Study|Other|0|||
105339296|NCT01023256|363243606|FG002|Overall Study|Other|0|||
105339297|NCT01023256|363243607|FG003|Overall Study|Other|2|||
105339298|NCT01023256|363243604|FG000|Overall Study|Adverse Event|0|||
105339299|NCT01023256|363243605|FG001|Overall Study|Adverse Event|0|||
105339300|NCT01023256|363243606|FG002|Overall Study|Adverse Event|0|||
105339301|NCT01023256|363243607|FG003|Overall Study|Adverse Event|1|||
105339302|NCT01023256|363243604|FG000|Overall Study|Withdrawal by Subject|0|||
105339303|NCT01023256|363243605|FG001|Overall Study|Withdrawal by Subject|0|||
105339304|NCT01023256|363243606|FG002|Overall Study|Withdrawal by Subject|0|||
105339305|NCT01023256|363243607|FG003|Overall Study|Withdrawal by Subject|2|||
105339306|NCT03089697|363243608|FG000|Overall Study|Adverse Event|1|||
105339307|NCT03089697|363243609|FG001|Overall Study|Adverse Event|2|||
105339308|NCT03089697|363243608|FG000|Overall Study|Withdrawal by Subject|1|||
105339309|NCT03089697|363243609|FG001|Overall Study|Withdrawal by Subject|0|||
105339310|NCT00937040|363243610|FG000|Overall Study|Adverse Event|5|||
105339311|NCT00937040|363243611|FG001|Overall Study|Adverse Event|8|||
105339312|NCT00937040|363243610|FG000|Overall Study|Lost to Follow-up|12|||
105339313|NCT00937040|363243611|FG001|Overall Study|Lost to Follow-up|12|||
105339314|NCT00937040|363243610|FG000|Overall Study|Protocol Violation|3|||
105339315|NCT00937040|363243611|FG001|Overall Study|Protocol Violation|0|||
105339316|NCT00937040|363243610|FG000|Overall Study|Withdrawal by Subject|13|||
105339317|NCT00937040|363243611|FG001|Overall Study|Withdrawal by Subject|7|||
105339318|NCT00937040|363243610|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
105339319|NCT00937040|363243611|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
105339320|NCT00937040|363243610|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
105339321|NCT00937040|363243611|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
105339322|NCT03403751|363243613|FG000|Overall Study|Death|5|||
105339323|NCT03403751|363243614|FG001|Overall Study|Death|6|||
105339324|NCT03403751|363243613|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
105339325|NCT03403751|363243614|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
105339326|NCT01820572|363243615|FG000|Randomization|Not Treated|2|||
105339327|NCT01820572|363243616|FG001|Randomization|Not Treated|1|||
105339328|NCT01820572|363243615|FG000|Treatment Period|Adverse Event|12|||
105339329|NCT01820572|363243616|FG001|Treatment Period|Adverse Event|7|||
105339330|NCT01820572|363243615|FG000|Treatment Period|Death|3|||
105339331|NCT01820572|363243616|FG001|Treatment Period|Death|3|||
105339332|NCT01820572|363243615|FG000|Treatment Period|Lack of Efficacy|1|||
105339333|NCT01820572|363243616|FG001|Treatment Period|Lack of Efficacy|0|||
105339334|NCT01820572|363243615|FG000|Treatment Period|poor/non compliance|0|||
105339335|NCT01820572|363243616|FG001|Treatment Period|poor/non compliance|3|||
105339336|NCT01820572|363243615|FG000|Treatment Period|request to discontinue|6|||
105663337|NCT03355209|364432449|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
105663338|NCT03355209|364432450|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
105663339|NCT03355209|364432451|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105663340|NCT03355209|364432452|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
105663341|NCT03355209|364432453|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105663342|NCT03355209|364432448|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
105663343|NCT03355209|364432449|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
105663344|NCT03355209|364432450|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
105663345|NCT03355209|364432451|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
105663346|NCT03355209|364432452|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
105663347|NCT03355209|364432453|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
105663348|NCT03355209|364432448|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
105663349|NCT03355209|364432449|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
105663350|NCT03355209|364432450|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
105663351|NCT03355209|364432451|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
105663352|NCT03355209|364432452|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
105663353|NCT03355209|364432453|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
105663354|NCT01825577|364432454|FG000|Overall Study|Physician Decision|2|||
105663355|NCT01825577|364432454|FG000|Overall Study|Withdrawal by Subject|1|||
105663356|NCT01825577|364432454|FG000|Overall Study|Withdrawn by family members|2|||
105663357|NCT01825577|364432454|FG000|Overall Study|Lack of Efficacy|3|||
105663358|NCT02734004|364432455|FG000|Overall Study|Death|36|||
105663359|NCT02734004|364432456|FG001|Overall Study|Death|24|||
105663360|NCT02734004|364432457|FG002|Overall Study|Death|26|||
105663361|NCT02734004|364432458|FG003|Overall Study|Death|35|||
105663362|NCT02734004|364432459|FG004|Overall Study|Death|13|||
105663363|NCT02734004|364432460|FG005|Overall Study|Death|17|||
105663364|NCT02734004|364432461|FG006|Overall Study|Death|20|||
105663365|NCT02734004|364432455|FG000|Overall Study|Lost to Follow-up|1|||
105663366|NCT02734004|364432456|FG001|Overall Study|Lost to Follow-up|1|||
105663367|NCT02734004|364432457|FG002|Overall Study|Lost to Follow-up|0|||
105663368|NCT02734004|364432458|FG003|Overall Study|Lost to Follow-up|0|||
105663369|NCT02734004|364432459|FG004|Overall Study|Lost to Follow-up|1|||
105663370|NCT02734004|364432460|FG005|Overall Study|Lost to Follow-up|0|||
105462562|NCT04949490|363707343|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
105663371|NCT02734004|364432461|FG006|Overall Study|Lost to Follow-up|0|||
105663372|NCT02734004|364432455|FG000|Overall Study|Withdrawal by Subject|3|||
105663373|NCT02734004|364432456|FG001|Overall Study|Withdrawal by Subject|1|||
105663374|NCT02734004|364432457|FG002|Overall Study|Withdrawal by Subject|1|||
105663375|NCT02734004|364432458|FG003|Overall Study|Withdrawal by Subject|1|||
105663376|NCT02734004|364432459|FG004|Overall Study|Withdrawal by Subject|3|||
105663377|NCT02734004|364432460|FG005|Overall Study|Withdrawal by Subject|0|||
105663378|NCT02734004|364432461|FG006|Overall Study|Withdrawal by Subject|2|||
105663379|NCT02734004|364432455|FG000|Overall Study|Other|0|||
105663380|NCT02734004|364432456|FG001|Overall Study|Other|8|||
105663381|NCT02734004|364432457|FG002|Overall Study|Other|7|||
105663382|NCT02734004|364432458|FG003|Overall Study|Other|4|||
105663383|NCT02734004|364432459|FG004|Overall Study|Other|34|||
105663384|NCT02734004|364432460|FG005|Overall Study|Other|14|||
105663385|NCT02734004|364432461|FG006|Overall Study|Other|10|||
105663389|NCT00926575|364432468|FG000|Overall Study|Adverse Event|1|||
105663390|NCT00926575|364432469|FG001|Overall Study|Adverse Event|1|||
105663391|NCT00926575|364432468|FG000|Overall Study|Death|4|||
105663392|NCT00926575|364432469|FG001|Overall Study|Death|4|||
105663393|NCT00926575|364432468|FG000|Overall Study|Lost to Follow-up|1|||
105663394|NCT00926575|364432469|FG001|Overall Study|Lost to Follow-up|1|||
105663395|NCT00926575|364432468|FG000|Overall Study|Physician Decision|1|||
105663396|NCT00926575|364432469|FG001|Overall Study|Physician Decision|2|||
105663397|NCT00926575|364432468|FG000|Overall Study|Protocol Violation|1|||
105663398|NCT00926575|364432469|FG001|Overall Study|Protocol Violation|0|||
105663399|NCT00926575|364432468|FG000|Overall Study|Withdrawal by Subject|8|||
105663400|NCT00926575|364432469|FG001|Overall Study|Withdrawal by Subject|9|||
105663401|NCT01431950|364432470|FG000|Overall Study|Study Site Closed/Terminated|7|||
105663402|NCT01431950|364432471|FG001|Overall Study|Study Site Closed/Terminated|3|||
105550940|NCT03701555|364017168|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
105550941|NCT03701555|364017169|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
105550942|NCT03701555|364017170|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
105550943|NCT03701555|364017171|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
105550944|NCT03701555|364017172|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
105550945|NCT03701555|364017173|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
105550946|NCT03701555|364017174|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
105550947|NCT03701555|364017175|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
105550948|NCT03701555|364017176|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
105550949|NCT03701555|364017177|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
105550950|NCT03701555|364017178|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
105550951|NCT03701555|364017179|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
105550952|NCT03701555|364017180|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
105550953|NCT03701555|364017181|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
105550954|NCT03701555|364017182|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
105550955|NCT03701555|364017183|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
105550956|NCT03701555|364017184|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
105550957|NCT03701555|364017185|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
105550958|NCT03701555|364017186|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
105550959|NCT03701555|364017187|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
105663403|NCT01431950|364432470|FG000|Overall Study|Withdrawal by Subject|4|||
105663404|NCT01431950|364432471|FG001|Overall Study|Withdrawal by Subject|3|||
105663405|NCT01431950|364432470|FG000|Overall Study|Protocol Violation|2|||
105663406|NCT01431950|364432471|FG001|Overall Study|Protocol Violation|3|||
105663407|NCT01431950|364432470|FG000|Overall Study|Adverse Event|2|||
105663408|NCT01431950|364432471|FG001|Overall Study|Adverse Event|2|||
105663409|NCT01431950|364432470|FG000|Overall Study|Physician Decision|2|||
105663410|NCT01431950|364432471|FG001|Overall Study|Physician Decision|1|||
105663411|NCT01431950|364432470|FG000|Overall Study|Lack of Efficacy|2|||
105663412|NCT01431950|364432471|FG001|Overall Study|Lack of Efficacy|1|||
105663413|NCT01431950|364432470|FG000|Overall Study|Lost to Follow-up|0|||
105663414|NCT01431950|364432471|FG001|Overall Study|Lost to Follow-up|1|||
105663415|NCT01431950|364432470|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
105663416|NCT01431950|364432471|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105663417|NCT01210651|364432472|FG000|Overall Study|Lost to Follow-up|1|||
105663418|NCT01210651|364432473|FG001|Overall Study|Lost to Follow-up|1|||
105663419|NCT01210651|364432472|FG000|Overall Study|schedule conflicts|1|||
105663420|NCT01210651|364432473|FG001|Overall Study|schedule conflicts|5|||
105339337|NCT01820572|363243616|FG001|Treatment Period|request to discontinue|11|||
105339338|NCT01820572|363243615|FG000|Treatment Period|No longer meets study criteria|3|||
105550960|NCT03701555|364017188|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
105550961|NCT03701555|364017189|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
105550962|NCT03701555|364017154|FG000|Part 2 (Day 1)|Other|0|||
105550963|NCT03701555|364017155|FG001|Part 2 (Day 1)|Other|0|||
105550964|NCT03701555|364017156|FG002|Part 2 (Day 1)|Other|0|||
105550965|NCT03701555|364017157|FG003|Part 2 (Day 1)|Other|0|||
105339339|NCT01820572|363243616|FG001|Treatment Period|No longer meets study criteria|10|||
105339340|NCT01820572|363243615|FG000|Treatment Period|withdrew consent|1|||
105339341|NCT01820572|363243616|FG001|Treatment Period|withdrew consent|2|||
105339342|NCT00125242|363243619|FG000|Overall Study|did not qualify|7|||
105339343|NCT00125242|363243620|FG001|Overall Study|did not qualify|2|||
105339344|NCT01738503|363243621|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
105339345|NCT01738503|363243622|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
105339346|NCT01738503|363243623|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
105339347|NCT01738503|363243624|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
105339348|NCT01738503|363243625|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
105339349|NCT01738503|363243626|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
105339350|NCT01738503|363243627|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
105339351|NCT01738503|363243621|FG000|Treatment Period|Adverse Event|0|||
105339352|NCT01738503|363243622|FG001|Treatment Period|Adverse Event|1|||
105339353|NCT01738503|363243623|FG002|Treatment Period|Adverse Event|0|||
105339354|NCT01738503|363243624|FG003|Treatment Period|Adverse Event|1|||
105339355|NCT01738503|363243625|FG004|Treatment Period|Adverse Event|2|||
105339356|NCT01738503|363243626|FG005|Treatment Period|Adverse Event|2|||
105339357|NCT01738503|363243627|FG006|Treatment Period|Adverse Event|2|||
105339358|NCT01738503|363243621|FG000|Treatment Period|Lost to Follow-up|0|||
105339359|NCT01738503|363243622|FG001|Treatment Period|Lost to Follow-up|0|||
105339360|NCT01738503|363243623|FG002|Treatment Period|Lost to Follow-up|3|||
105550966|NCT03701555|364017158|FG004|Part 2 (Day 1)|Other|0|||
105550967|NCT03701555|364017159|FG005|Part 2 (Day 1)|Other|0|||
105550968|NCT03701555|364017160|FG006|Part 2 (Day 1)|Other|0|||
105550969|NCT03701555|364017161|FG007|Part 2 (Day 1)|Other|0|||
105550970|NCT03701555|364017162|FG008|Part 2 (Day 1)|Other|0|||
105550971|NCT03701555|364017163|FG009|Part 2 (Day 1)|Other|0|||
105550972|NCT03701555|364017164|FG010|Part 2 (Day 1)|Other|3|||
105663421|NCT01210651|364432472|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
105663422|NCT01210651|364432473|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
105339361|NCT01738503|363243624|FG003|Treatment Period|Lost to Follow-up|4|||
105339362|NCT01738503|363243625|FG004|Treatment Period|Lost to Follow-up|1|||
105339363|NCT01738503|363243626|FG005|Treatment Period|Lost to Follow-up|1|||
105339364|NCT01738503|363243627|FG006|Treatment Period|Lost to Follow-up|5|||
105339365|NCT01738503|363243621|FG000|Treatment Period|Withdrawal by Subject|0|||
105339366|NCT01738503|363243622|FG001|Treatment Period|Withdrawal by Subject|1|||
105339367|NCT01738503|363243623|FG002|Treatment Period|Withdrawal by Subject|0|||
105339368|NCT01738503|363243624|FG003|Treatment Period|Withdrawal by Subject|1|||
105339369|NCT01738503|363243625|FG004|Treatment Period|Withdrawal by Subject|1|||
105339370|NCT01738503|363243626|FG005|Treatment Period|Withdrawal by Subject|1|||
105339371|NCT01738503|363243627|FG006|Treatment Period|Withdrawal by Subject|1|||
105339372|NCT01738503|363243621|FG000|Treatment Period|Protocol Violation|0|||
105339373|NCT01738503|363243622|FG001|Treatment Period|Protocol Violation|3|||
105339374|NCT01738503|363243623|FG002|Treatment Period|Protocol Violation|1|||
105339375|NCT01738503|363243624|FG003|Treatment Period|Protocol Violation|0|||
105339376|NCT01738503|363243625|FG004|Treatment Period|Protocol Violation|4|||
105339377|NCT01738503|363243626|FG005|Treatment Period|Protocol Violation|2|||
105339378|NCT01738503|363243627|FG006|Treatment Period|Protocol Violation|0|||
105339379|NCT01738503|363243621|FG000|Treatment Period|Other|0|||
105339380|NCT01738503|363243622|FG001|Treatment Period|Other|0|||
105339381|NCT01738503|363243623|FG002|Treatment Period|Other|1|||
105339382|NCT01738503|363243624|FG003|Treatment Period|Other|0|||
105339383|NCT01738503|363243625|FG004|Treatment Period|Other|0|||
105339384|NCT01738503|363243626|FG005|Treatment Period|Other|0|||
105339385|NCT01738503|363243627|FG006|Treatment Period|Other|0|||
105339386|NCT01738503|363243621|FG000|PET Imaging Sub-study|Adverse Event|0|||
105339387|NCT01738503|363243622|FG001|PET Imaging Sub-study|Adverse Event|0|||
105339388|NCT01738503|363243623|FG002|PET Imaging Sub-study|Adverse Event|0|||
105339389|NCT01738503|363243624|FG003|PET Imaging Sub-study|Adverse Event|0|||
105339390|NCT01738503|363243625|FG004|PET Imaging Sub-study|Adverse Event|0|||
105339391|NCT01738503|363243626|FG005|PET Imaging Sub-study|Adverse Event|1|||
105339392|NCT01738503|363243627|FG006|PET Imaging Sub-study|Adverse Event|0|||
105339393|NCT01738503|363243621|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
105339394|NCT01738503|363243622|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
105462563|NCT04949490|363707344|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
105462564|NCT04949490|363707339|FG000|Group A and Group B|Withdrawal by Subject|0|||
105462565|NCT04949490|363707340|FG001|Group A and Group B|Withdrawal by Subject|0|||
105462566|NCT04949490|363707341|FG002|Group A and Group B|Withdrawal by Subject|1|||
105462567|NCT04949490|363707342|FG003|Group A and Group B|Withdrawal by Subject|0|||
105462568|NCT04949490|363707343|FG004|Group A and Group B|Withdrawal by Subject|0|||
105462569|NCT04949490|363707344|FG005|Group A and Group B|Withdrawal by Subject|0|||
105462570|NCT04949490|363707339|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
105462571|NCT04949490|363707340|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
105462572|NCT04949490|363707341|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
105462573|NCT04949490|363707342|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
105462574|NCT04949490|363707343|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
105462575|NCT04949490|363707344|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
105462576|NCT04949490|363707339|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
105462577|NCT04949490|363707340|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
105462578|NCT04949490|363707341|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
105462579|NCT04949490|363707342|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
105462580|NCT04949490|363707343|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
105462581|NCT04949490|363707344|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
105462582|NCT04721977|363707345|FG000|Overall Study|Death|15|||
105462583|NCT04721977|363707345|FG000|Overall Study|Ongoing|51|||
105462584|NCT02864394|363707347|FG000|Overall Study|Death|184|||
105462585|NCT02864394|363707348|FG001|Overall Study|Death|189|||
105462586|NCT02864394|363707347|FG000|Overall Study|Lost to Follow-up|0|||
105462587|NCT02864394|363707348|FG001|Overall Study|Lost to Follow-up|2|||
105462588|NCT02864394|363707347|FG000|Overall Study|Sponsor Decision|26|||
105462589|NCT02864394|363707348|FG001|Overall Study|Sponsor Decision|11|||
105462590|NCT02864394|363707347|FG000|Overall Study|Withdrawal by Subject|3|||
105462591|NCT02864394|363707348|FG001|Overall Study|Withdrawal by Subject|10|||
105462592|NCT01597596|363709566|FG000|Overall Study|Study terminated by sponsor|1|||
105462593|NCT01597596|363709567|FG001|Overall Study|Study terminated by sponsor|0|||
105462594|NCT01597596|363709566|FG000|Overall Study|Physician Decision|0|||
105462595|NCT01597596|363709567|FG001|Overall Study|Physician Decision|1|||
105462596|NCT00939393|363709573|FG000|Overall Study|Withdrawal by Subject|1|||
105462597|NCT00939393|363709574|FG001|Overall Study|Withdrawal by Subject|0|||
105339395|NCT01738503|363243623|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
105339396|NCT01738503|363243624|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
105339397|NCT01738503|363243625|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
105462598|NCT00939393|363709573|FG000|Overall Study|Lost to Follow-up|3|||
105462599|NCT00939393|363709574|FG001|Overall Study|Lost to Follow-up|0|||
105462600|NCT02144610|363709579|FG000|Overall Study|Physician Decision|1|||
105462601|NCT02144610|363709580|FG001|Overall Study|Physician Decision|0|||
105462602|NCT02144610|363709579|FG000|Overall Study|Withdrawal by Subject|1|||
105462603|NCT02144610|363709580|FG001|Overall Study|Withdrawal by Subject|5|||
105462604|NCT02144610|363709579|FG000|Overall Study|Death|2|||
105462605|NCT02144610|363709580|FG001|Overall Study|Death|2|||
105462606|NCT02144610|363709579|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
105462607|NCT02144610|363709580|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
105462608|NCT02144610|363709579|FG000|Overall Study|Other|0|||
105462609|NCT02144610|363709580|FG001|Overall Study|Other|1|||
105462610|NCT01054885|363709581|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
105462611|NCT01054885|363709582|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105462612|NCT01054885|363709583|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105462613|NCT01054885|363709584|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105462614|NCT01054885|363709585|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105462615|NCT01054885|363709586|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105462616|NCT01054885|363709587|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105462617|NCT01054885|363709581|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
105462618|NCT01054885|363709582|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
105462619|NCT01054885|363709583|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
105462620|NCT01054885|363709584|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
105462621|NCT01054885|363709585|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
105462622|NCT01054885|363709586|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
105462623|NCT01054885|363709587|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
105462624|NCT01054885|363709581|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
105462625|NCT01054885|363709582|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105462626|NCT01054885|363709583|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105462627|NCT01054885|363709584|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105462628|NCT01054885|363709585|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105462629|NCT01054885|363709586|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105462630|NCT01054885|363709587|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105462631|NCT01054885|363709581|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
105462632|NCT01054885|363709582|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105462633|NCT01054885|363709583|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105462634|NCT01054885|363709584|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105462635|NCT01054885|363709585|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105462636|NCT01054885|363709586|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105462637|NCT01054885|363709587|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105462638|NCT01054885|363709581|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
105462639|NCT01054885|363709582|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
105462640|NCT01054885|363709583|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
105462641|NCT01054885|363709584|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
105462642|NCT01054885|363709585|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
105462643|NCT01054885|363709586|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
105339398|NCT01738503|363243626|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
105339399|NCT01738503|363243627|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
105339400|NCT02272842|363243630|FG000|Overall Study|Lost to Follow-up|8|||
105550973|NCT03701555|364017165|FG011|Part 2 (Day 1)|Other|1|||
105462644|NCT01054885|363709587|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
105462645|NCT01054885|363709581|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
105462646|NCT01054885|363709582|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
105462647|NCT01054885|363709583|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
105462648|NCT01054885|363709584|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
105462649|NCT01054885|363709585|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
105462650|NCT01054885|363709586|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
105462651|NCT01054885|363709587|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
105462652|NCT01054885|363709581|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
105462653|NCT01054885|363709582|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
105462654|NCT01054885|363709583|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
105462655|NCT01054885|363709584|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
105462656|NCT01054885|363709585|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
105462657|NCT01054885|363709586|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
105462658|NCT01054885|363709587|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
105462659|NCT01054885|363709581|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
105462660|NCT01054885|363709582|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
105462661|NCT01054885|363709583|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
105462662|NCT01054885|363709584|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
105462663|NCT01054885|363709585|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
105462664|NCT01054885|363709586|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
105462665|NCT01054885|363709587|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
105462666|NCT01054885|363709581|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
105462667|NCT01054885|363709582|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
105462668|NCT01054885|363709583|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
105462669|NCT01054885|363709584|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
105462670|NCT01054885|363709585|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
105462671|NCT01054885|363709586|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
105462672|NCT01054885|363709587|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
105462673|NCT01054885|363709581|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
105462674|NCT01054885|363709582|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
105462675|NCT01054885|363709583|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
105462676|NCT01054885|363709584|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
105462677|NCT01054885|363709585|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
105462678|NCT01054885|363709586|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
105462679|NCT01054885|363709587|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
105462680|NCT01054885|363709581|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
105462681|NCT01054885|363709582|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
105462682|NCT01054885|363709583|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
105462683|NCT01054885|363709584|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
105462684|NCT01054885|363709585|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
105462685|NCT01054885|363709586|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
105462686|NCT01054885|363709587|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
105462687|NCT01054885|363709581|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
105462688|NCT01054885|363709582|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
105462689|NCT01054885|363709583|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
105462690|NCT01054885|363709584|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
105462691|NCT01054885|363709585|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
105462692|NCT01054885|363709586|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
105462693|NCT01054885|363709587|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
105462694|NCT01054885|363709581|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105462695|NCT01054885|363709582|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
105462696|NCT01054885|363709583|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
105462697|NCT01054885|363709584|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105462698|NCT01054885|363709585|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105462699|NCT01054885|363709586|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
105462700|NCT01054885|363709587|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
105550974|NCT03701555|364017166|FG012|Part 2 (Day 1)|Other|0|||
105550975|NCT03701555|364017167|FG013|Part 2 (Day 1)|Other|1|||
105550976|NCT03701555|364017168|FG014|Part 2 (Day 1)|Other|0|||
105462701|NCT01054885|363709581|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
105462702|NCT01054885|363709582|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
105462703|NCT01054885|363709583|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
105462704|NCT01054885|363709584|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
105462705|NCT01054885|363709585|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
105462706|NCT01054885|363709586|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
105462707|NCT01054885|363709587|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
105462708|NCT01054885|363709581|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
105462709|NCT01054885|363709582|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
105462710|NCT01054885|363709583|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
105462711|NCT01054885|363709584|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
105462712|NCT01054885|363709585|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
105462713|NCT01054885|363709586|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
105462714|NCT01054885|363709587|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
105462715|NCT01399372|363709588|FG000|Overall Study|Protocol Violation|3|||
105462716|NCT01399372|363709589|FG001|Overall Study|Protocol Violation|1|||
105462717|NCT01421719|363709590|FG000|Overall Study|Withdrawal by Subject|4|||
105462718|NCT01803607|363709596|FG000|Overall Study|Adverse Event|5|||
105462719|NCT01803607|363709597|FG001|Overall Study|Adverse Event|3|||
105462720|NCT01803607|363709596|FG000|Overall Study|Lack of Efficacy|0|||
105663423|NCT01210651|364432472|FG000|Overall Study|Withdrawal by Subject|1|||
105663424|NCT01210651|364432473|FG001|Overall Study|Withdrawal by Subject|1|||
105663425|NCT01210651|364432472|FG000|Overall Study|Injury outside study|2|||
105663426|NCT01210651|364432473|FG001|Overall Study|Injury outside study|0|||
105663427|NCT02592707|364432477|FG000|Overall Study|Consent Withdrawn|0|||
105663428|NCT02592707|364432478|FG001|Overall Study|Consent Withdrawn|1|||
105663429|NCT02592707|364432479|FG002|Overall Study|Consent Withdrawn|2|||
105663430|NCT02592707|364432480|FG003|Overall Study|Consent Withdrawn|0|||
105663431|NCT02592707|364432477|FG000|Overall Study|Death|1|||
105663432|NCT02592707|364432478|FG001|Overall Study|Death|0|||
105663433|NCT02592707|364432479|FG002|Overall Study|Death|0|||
105663434|NCT02592707|364432480|FG003|Overall Study|Death|0|||
105663435|NCT02592707|364432477|FG000|Overall Study|Progressive Disease|4|||
105663436|NCT02592707|364432478|FG001|Overall Study|Progressive Disease|4|||
105663437|NCT02592707|364432479|FG002|Overall Study|Progressive Disease|3|||
105663438|NCT02592707|364432480|FG003|Overall Study|Progressive Disease|3|||
105663439|NCT02592707|364432477|FG000|Overall Study|Other|0|||
105663440|NCT02592707|364432478|FG001|Overall Study|Other|0|||
105663441|NCT02592707|364432479|FG002|Overall Study|Other|1|||
105663442|NCT02592707|364432480|FG003|Overall Study|Other|2|||
105663443|NCT02592707|364432477|FG000|Overall Study|Never entered LTFU period|1|||
105663444|NCT02592707|364432478|FG001|Overall Study|Never entered LTFU period|0|||
105663445|NCT02592707|364432479|FG002|Overall Study|Never entered LTFU period|0|||
105663446|NCT02592707|364432480|FG003|Overall Study|Never entered LTFU period|2|||
105663447|NCT02282059|364432482|FG000|Overall Study|Other|15|||
105663448|NCT02282059|364432483|FG001|Overall Study|Other|3|||
105663449|NCT02282059|364432482|FG000|Overall Study|Participant refused further follow-up|8|||
105663450|NCT02282059|364432483|FG001|Overall Study|Participant refused further follow-up|4|||
105663451|NCT02282059|364432482|FG000|Overall Study|Lost to Follow-up|19|||
105663452|NCT02282059|364432483|FG001|Overall Study|Lost to Follow-up|3|||
105663453|NCT02282059|364432482|FG000|Overall Study|Death|40|||
105663454|NCT02282059|364432483|FG001|Overall Study|Death|8|||
105663455|NCT05131477|364432484|FG000|PART 1|Withdrawal by Subject|2|||
105663456|NCT05131477|364432485|FG001|PART 1|Withdrawal by Subject|9|||
105663457|NCT05131477|364432486|FG002|PART 1|Withdrawal by Subject|6|||
105663458|NCT05131477|364432487|FG003|PART 1|Withdrawal by Subject|2|||
105663459|NCT05131477|364432488|FG004|PART 1|Withdrawal by Subject|8|||
105663460|NCT05131477|364432489|FG005|PART 1|Withdrawal by Subject|0|||
105663461|NCT05131477|364432490|FG006|PART 1|Withdrawal by Subject|0|||
105663462|NCT05131477|364432491|FG007|PART 1|Withdrawal by Subject|0|||
105462721|NCT01803607|363709597|FG001|Overall Study|Lack of Efficacy|1|||
105663463|NCT05131477|364432492|FG008|PART 1|Withdrawal by Subject|0|||
105663464|NCT05131477|364432493|FG009|PART 1|Withdrawal by Subject|0|||
105663465|NCT05131477|364432494|FG010|PART 1|Withdrawal by Subject|0|||
105663466|NCT05131477|364432495|FG011|PART 1|Withdrawal by Subject|0|||
105663467|NCT05131477|364432496|FG012|PART 1|Withdrawal by Subject|0|||
105663468|NCT05131477|364432497|FG013|PART 1|Withdrawal by Subject|0|||
105663469|NCT05131477|364432484|FG000|PART 1|Physician Decision|1|||
105663470|NCT05131477|364432485|FG001|PART 1|Physician Decision|0|||
105663471|NCT05131477|364432486|FG002|PART 1|Physician Decision|0|||
105663472|NCT05131477|364432487|FG003|PART 1|Physician Decision|0|||
105663473|NCT05131477|364432488|FG004|PART 1|Physician Decision|0|||
105462722|NCT01803607|363709596|FG000|Overall Study|Protocol Violation|3|||
105663474|NCT05131477|364432489|FG005|PART 1|Physician Decision|0|||
105663475|NCT05131477|364432490|FG006|PART 1|Physician Decision|0|||
105663476|NCT05131477|364432491|FG007|PART 1|Physician Decision|0|||
105663477|NCT05131477|364432492|FG008|PART 1|Physician Decision|0|||
105339401|NCT02272842|363243631|FG001|Overall Study|Lost to Follow-up|8|||
105663478|NCT05131477|364432493|FG009|PART 1|Physician Decision|0|||
105663479|NCT05131477|364432494|FG010|PART 1|Physician Decision|0|||
105663480|NCT05131477|364432495|FG011|PART 1|Physician Decision|0|||
105663481|NCT05131477|364432496|FG012|PART 1|Physician Decision|0|||
105663482|NCT05131477|364432497|FG013|PART 1|Physician Decision|0|||
105663483|NCT05131477|364432484|FG000|PART 1|Adverse Event|3|||
105663484|NCT05131477|364432485|FG001|PART 1|Adverse Event|5|||
105663485|NCT05131477|364432486|FG002|PART 1|Adverse Event|1|||
105663486|NCT05131477|364432487|FG003|PART 1|Adverse Event|6|||
105663487|NCT05131477|364432488|FG004|PART 1|Adverse Event|4|||
105663488|NCT05131477|364432489|FG005|PART 1|Adverse Event|0|||
105663489|NCT05131477|364432490|FG006|PART 1|Adverse Event|0|||
105663490|NCT05131477|364432491|FG007|PART 1|Adverse Event|0|||
105663491|NCT05131477|364432492|FG008|PART 1|Adverse Event|0|||
105663492|NCT05131477|364432493|FG009|PART 1|Adverse Event|0|||
105663493|NCT05131477|364432494|FG010|PART 1|Adverse Event|0|||
105663494|NCT05131477|364432495|FG011|PART 1|Adverse Event|0|||
105663495|NCT05131477|364432496|FG012|PART 1|Adverse Event|0|||
105663496|NCT05131477|364432497|FG013|PART 1|Adverse Event|0|||
105663497|NCT05131477|364432484|FG000|PART 1|unclassified|1|||
105663498|NCT05131477|364432485|FG001|PART 1|unclassified|1|||
105663499|NCT05131477|364432486|FG002|PART 1|unclassified|0|||
105663500|NCT05131477|364432487|FG003|PART 1|unclassified|0|||
105663501|NCT05131477|364432488|FG004|PART 1|unclassified|4|||
105663502|NCT05131477|364432489|FG005|PART 1|unclassified|0|||
105663503|NCT05131477|364432490|FG006|PART 1|unclassified|0|||
105663504|NCT05131477|364432491|FG007|PART 1|unclassified|0|||
105663505|NCT05131477|364432492|FG008|PART 1|unclassified|0|||
105663506|NCT05131477|364432493|FG009|PART 1|unclassified|0|||
105663507|NCT05131477|364432494|FG010|PART 1|unclassified|0|||
105663508|NCT05131477|364432495|FG011|PART 1|unclassified|0|||
105663509|NCT05131477|364432496|FG012|PART 1|unclassified|0|||
105663510|NCT05131477|364432497|FG013|PART 1|unclassified|0|||
105663511|NCT05131477|364432484|FG000|PART 1|Randomized and not treated|0|||
105663512|NCT05131477|364432485|FG001|PART 1|Randomized and not treated|0|||
105663513|NCT05131477|364432486|FG002|PART 1|Randomized and not treated|0|||
105663514|NCT05131477|364432487|FG003|PART 1|Randomized and not treated|1|||
105663515|NCT05131477|364432488|FG004|PART 1|Randomized and not treated|1|||
105663516|NCT05131477|364432489|FG005|PART 1|Randomized and not treated|0|||
105663517|NCT05131477|364432490|FG006|PART 1|Randomized and not treated|0|||
105663518|NCT05131477|364432491|FG007|PART 1|Randomized and not treated|0|||
105663519|NCT05131477|364432492|FG008|PART 1|Randomized and not treated|0|||
105663520|NCT05131477|364432493|FG009|PART 1|Randomized and not treated|0|||
105663521|NCT05131477|364432494|FG010|PART 1|Randomized and not treated|0|||
105663522|NCT05131477|364432495|FG011|PART 1|Randomized and not treated|0|||
105663523|NCT05131477|364432496|FG012|PART 1|Randomized and not treated|0|||
105663524|NCT05131477|364432497|FG013|PART 1|Randomized and not treated|0|||
105663525|NCT05131477|364432484|FG000|PART 1|Protocol Violation|2|||
105663526|NCT05131477|364432485|FG001|PART 1|Protocol Violation|0|||
105663527|NCT05131477|364432486|FG002|PART 1|Protocol Violation|0|||
105663528|NCT05131477|364432487|FG003|PART 1|Protocol Violation|1|||
105663529|NCT05131477|364432488|FG004|PART 1|Protocol Violation|0|||
105663530|NCT05131477|364432489|FG005|PART 1|Protocol Violation|0|||
105663531|NCT05131477|364432490|FG006|PART 1|Protocol Violation|0|||
105663532|NCT05131477|364432491|FG007|PART 1|Protocol Violation|0|||
105663533|NCT05131477|364432492|FG008|PART 1|Protocol Violation|0|||
105663534|NCT05131477|364432493|FG009|PART 1|Protocol Violation|0|||
105663535|NCT05131477|364432494|FG010|PART 1|Protocol Violation|0|||
105663536|NCT05131477|364432495|FG011|PART 1|Protocol Violation|0|||
105663537|NCT05131477|364432496|FG012|PART 1|Protocol Violation|0|||
105663538|NCT05131477|364432497|FG013|PART 1|Protocol Violation|0|||
105663539|NCT05131477|364432484|FG000|PART 1|Lack of Efficacy|0|||
105663540|NCT05131477|364432485|FG001|PART 1|Lack of Efficacy|1|||
105663541|NCT05131477|364432486|FG002|PART 1|Lack of Efficacy|1|||
105663542|NCT05131477|364432487|FG003|PART 1|Lack of Efficacy|2|||
105663543|NCT05131477|364432488|FG004|PART 1|Lack of Efficacy|5|||
105663544|NCT05131477|364432489|FG005|PART 1|Lack of Efficacy|0|||
105663545|NCT05131477|364432490|FG006|PART 1|Lack of Efficacy|0|||
105663546|NCT05131477|364432491|FG007|PART 1|Lack of Efficacy|0|||
105663547|NCT05131477|364432492|FG008|PART 1|Lack of Efficacy|0|||
105663548|NCT05131477|364432493|FG009|PART 1|Lack of Efficacy|0|||
105663549|NCT05131477|364432494|FG010|PART 1|Lack of Efficacy|0|||
105663550|NCT05131477|364432495|FG011|PART 1|Lack of Efficacy|0|||
105663551|NCT05131477|364432496|FG012|PART 1|Lack of Efficacy|0|||
105663552|NCT05131477|364432497|FG013|PART 1|Lack of Efficacy|0|||
105663553|NCT05131477|364432484|FG000|PART 2|Withdrawal by Subject|0|||
105663554|NCT05131477|364432485|FG001|PART 2|Withdrawal by Subject|0|||
105663555|NCT05131477|364432486|FG002|PART 2|Withdrawal by Subject|0|||
105663556|NCT05131477|364432487|FG003|PART 2|Withdrawal by Subject|0|||
105663557|NCT05131477|364432488|FG004|PART 2|Withdrawal by Subject|0|||
105663558|NCT05131477|364432489|FG005|PART 2|Withdrawal by Subject|0|||
105663559|NCT05131477|364432490|FG006|PART 2|Withdrawal by Subject|2|||
105663560|NCT05131477|364432491|FG007|PART 2|Withdrawal by Subject|0|||
105663561|NCT05131477|364432492|FG008|PART 2|Withdrawal by Subject|0|||
105663562|NCT05131477|364432493|FG009|PART 2|Withdrawal by Subject|0|||
105663563|NCT05131477|364432494|FG010|PART 2|Withdrawal by Subject|2|||
105663564|NCT05131477|364432495|FG011|PART 2|Withdrawal by Subject|0|||
105663565|NCT05131477|364432496|FG012|PART 2|Withdrawal by Subject|2|||
105663566|NCT05131477|364432497|FG013|PART 2|Withdrawal by Subject|2|||
105663567|NCT05131477|364432484|FG000|PART 2|Other|0|||
105663568|NCT05131477|364432485|FG001|PART 2|Other|0|||
105663569|NCT05131477|364432486|FG002|PART 2|Other|0|||
105663570|NCT05131477|364432487|FG003|PART 2|Other|0|||
105663571|NCT05131477|364432488|FG004|PART 2|Other|0|||
105663572|NCT05131477|364432489|FG005|PART 2|Other|0|||
105663573|NCT05131477|364432490|FG006|PART 2|Other|0|||
105663574|NCT05131477|364432491|FG007|PART 2|Other|0|||
105462723|NCT01803607|363709597|FG001|Overall Study|Protocol Violation|2|||
105462724|NCT01803607|363709596|FG000|Overall Study|Study terminated by sponsor|54|||
105462725|NCT01803607|363709597|FG001|Overall Study|Study terminated by sponsor|56|||
105462726|NCT01803607|363709596|FG000|Overall Study|Withdrawal by Subject|6|||
105462727|NCT01803607|363709597|FG001|Overall Study|Withdrawal by Subject|5|||
105462728|NCT00918255|363709601|FG000|Overall Study|Adverse Event|1|||
105462729|NCT00918255|363709602|FG001|Overall Study|Adverse Event|0|||
105462730|NCT00918255|363709603|FG002|Overall Study|Adverse Event|0|||
105663575|NCT05131477|364432492|FG008|PART 2|Other|1|||
105462731|NCT00918255|363709601|FG000|Overall Study|Withdrawal by Subject|1|||
105462732|NCT00918255|363709602|FG001|Overall Study|Withdrawal by Subject|0|||
105462733|NCT00918255|363709603|FG002|Overall Study|Withdrawal by Subject|2|||
105462734|NCT00918255|363709601|FG000|Overall Study|Lack of Efficacy|1|||
105462735|NCT00918255|363709602|FG001|Overall Study|Lack of Efficacy|0|||
105462736|NCT00918255|363709603|FG002|Overall Study|Lack of Efficacy|0|||
105550977|NCT03701555|364017169|FG015|Part 2 (Day 1)|Other|2|||
105550978|NCT03701555|364017170|FG016|Part 2 (Day 1)|Other|2|||
105550979|NCT03701555|364017171|FG017|Part 2 (Day 1)|Other|0|||
105550980|NCT03701555|364017172|FG018|Part 2 (Day 1)|Other|0|||
105550981|NCT03701555|364017173|FG019|Part 2 (Day 1)|Other|0|||
105550982|NCT03701555|364017174|FG020|Part 2 (Day 1)|Other|0|||
105550983|NCT03701555|364017175|FG021|Part 2 (Day 1)|Other|0|||
105550984|NCT03701555|364017176|FG022|Part 2 (Day 1)|Other|0|||
105550985|NCT03701555|364017177|FG023|Part 2 (Day 1)|Other|0|||
105550986|NCT03701555|364017178|FG024|Part 2 (Day 1)|Other|0|||
105550987|NCT03701555|364017179|FG025|Part 2 (Day 1)|Other|0|||
105550988|NCT03701555|364017180|FG026|Part 2 (Day 1)|Other|0|||
105550989|NCT03701555|364017181|FG027|Part 2 (Day 1)|Other|0|||
105550990|NCT03701555|364017182|FG028|Part 2 (Day 1)|Other|0|||
105550991|NCT03701555|364017183|FG029|Part 2 (Day 1)|Other|0|||
105550992|NCT03701555|364017184|FG030|Part 2 (Day 1)|Other|0|||
105550993|NCT03701555|364017185|FG031|Part 2 (Day 1)|Other|0|||
105550994|NCT03701555|364017186|FG032|Part 2 (Day 1)|Other|0|||
105550995|NCT03701555|364017187|FG033|Part 2 (Day 1)|Other|0|||
105550996|NCT03701555|364017188|FG034|Part 2 (Day 1)|Other|0|||
105550997|NCT03701555|364017189|FG035|Part 2 (Day 1)|Other|0|||
105550998|NCT03701555|364017154|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
105550999|NCT03701555|364017155|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
105663576|NCT05131477|364432493|FG009|PART 2|Other|1|||
105663577|NCT05131477|364432494|FG010|PART 2|Other|0|||
105663578|NCT05131477|364432495|FG011|PART 2|Other|0|||
105462737|NCT00918255|363709601|FG000|Overall Study|Lost to Follow-up|1|||
105462738|NCT00918255|363709602|FG001|Overall Study|Lost to Follow-up|0|||
105785442|NCT02930889|364868460|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
105785443|NCT00509223|364868463|FG000|Overall Study|Lost to Follow-up|1|||
105462739|NCT00918255|363709603|FG002|Overall Study|Lost to Follow-up|2|||
105462740|NCT00918255|363709601|FG000|Overall Study|Exceeded allowed number of interventions|0|||
105551000|NCT03701555|364017156|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
105551001|NCT03701555|364017157|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
105551002|NCT03701555|364017158|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
105551003|NCT03701555|364017159|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
105551004|NCT03701555|364017160|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
105551005|NCT03701555|364017161|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
105551006|NCT03701555|364017162|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
105551007|NCT03701555|364017163|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
105551008|NCT03701555|364017164|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
105663579|NCT05131477|364432496|FG012|PART 2|Other|1|||
105663580|NCT05131477|364432497|FG013|PART 2|Other|0|||
105663581|NCT05131477|364432484|FG000|PART 2|Lack of Efficacy|0|||
105663582|NCT05131477|364432485|FG001|PART 2|Lack of Efficacy|0|||
105663583|NCT05131477|364432486|FG002|PART 2|Lack of Efficacy|0|||
105663584|NCT05131477|364432487|FG003|PART 2|Lack of Efficacy|0|||
105663585|NCT05131477|364432488|FG004|PART 2|Lack of Efficacy|0|||
105663586|NCT05131477|364432489|FG005|PART 2|Lack of Efficacy|1|||
105663587|NCT05131477|364432490|FG006|PART 2|Lack of Efficacy|1|||
105663588|NCT05131477|364432491|FG007|PART 2|Lack of Efficacy|0|||
105663589|NCT05131477|364432492|FG008|PART 2|Lack of Efficacy|3|||
105663590|NCT05131477|364432493|FG009|PART 2|Lack of Efficacy|0|||
105663591|NCT05131477|364432494|FG010|PART 2|Lack of Efficacy|1|||
105663592|NCT05131477|364432495|FG011|PART 2|Lack of Efficacy|0|||
105663593|NCT05131477|364432496|FG012|PART 2|Lack of Efficacy|2|||
105663594|NCT05131477|364432497|FG013|PART 2|Lack of Efficacy|0|||
105663595|NCT05131477|364432484|FG000|PART 2|Unclassified|0|||
105663596|NCT05131477|364432485|FG001|PART 2|Unclassified|0|||
105663597|NCT05131477|364432486|FG002|PART 2|Unclassified|0|||
105663598|NCT05131477|364432487|FG003|PART 2|Unclassified|0|||
105663599|NCT05131477|364432488|FG004|PART 2|Unclassified|0|||
105663600|NCT05131477|364432489|FG005|PART 2|Unclassified|0|||
105663601|NCT05131477|364432490|FG006|PART 2|Unclassified|0|||
105663602|NCT05131477|364432491|FG007|PART 2|Unclassified|0|||
105663603|NCT05131477|364432492|FG008|PART 2|Unclassified|0|||
105663604|NCT05131477|364432493|FG009|PART 2|Unclassified|0|||
105663605|NCT05131477|364432494|FG010|PART 2|Unclassified|1|||
105663606|NCT05131477|364432495|FG011|PART 2|Unclassified|0|||
105663607|NCT05131477|364432496|FG012|PART 2|Unclassified|0|||
105663608|NCT05131477|364432497|FG013|PART 2|Unclassified|0|||
105663609|NCT05131477|364432484|FG000|PART 2|Re-randomized and not treated|0|||
105663610|NCT05131477|364432485|FG001|PART 2|Re-randomized and not treated|0|||
105663611|NCT05131477|364432486|FG002|PART 2|Re-randomized and not treated|0|||
105663612|NCT05131477|364432487|FG003|PART 2|Re-randomized and not treated|0|||
105663613|NCT05131477|364432488|FG004|PART 2|Re-randomized and not treated|0|||
105663614|NCT05131477|364432489|FG005|PART 2|Re-randomized and not treated|0|||
105663615|NCT05131477|364432490|FG006|PART 2|Re-randomized and not treated|0|||
105663616|NCT05131477|364432491|FG007|PART 2|Re-randomized and not treated|1|||
105663617|NCT05131477|364432492|FG008|PART 2|Re-randomized and not treated|0|||
105663618|NCT05131477|364432493|FG009|PART 2|Re-randomized and not treated|0|||
105663619|NCT05131477|364432494|FG010|PART 2|Re-randomized and not treated|1|||
105663620|NCT05131477|364432495|FG011|PART 2|Re-randomized and not treated|0|||
105663621|NCT05131477|364432496|FG012|PART 2|Re-randomized and not treated|1|||
105663622|NCT05131477|364432497|FG013|PART 2|Re-randomized and not treated|1|||
105663623|NCT01246999|364434712|FG000|Overall Study|Lost to Follow-up|0|||
105663624|NCT01246999|364434713|FG001|Overall Study|Lost to Follow-up|1|||
105663625|NCT01246999|364434714|FG002|Overall Study|Lost to Follow-up|0|||
105663626|NCT01246999|364434715|FG003|Overall Study|Lost to Follow-up|0|||
105663627|NCT01246999|364434712|FG000|Overall Study|Withdrawal by Subject|0|||
105663628|NCT01246999|364434713|FG001|Overall Study|Withdrawal by Subject|0|||
105663629|NCT01246999|364434714|FG002|Overall Study|Withdrawal by Subject|0|||
105663630|NCT01246999|364434715|FG003|Overall Study|Withdrawal by Subject|2|||
105663631|NCT00307047|364434716|FG000|Overall Study|Lost to Follow-up|35|||
105663632|NCT00307047|364434717|FG001|Overall Study|Lost to Follow-up|24|||
105663633|NCT00307047|364434716|FG000|Overall Study|Withdrawal by Subject|6|||
105663634|NCT00307047|364434717|FG001|Overall Study|Withdrawal by Subject|6|||
105663635|NCT00307047|364434716|FG000|Overall Study|Physician Decision|1|||
105663636|NCT00307047|364434717|FG001|Overall Study|Physician Decision|2|||
105663637|NCT00307047|364434716|FG000|Overall Study|Lost to follow-up for other reasons|0|||
105663638|NCT00307047|364434717|FG001|Overall Study|Lost to follow-up for other reasons|1|||
105663639|NCT00307047|364434716|FG000|Overall Study|All death, all MI, all Revascularization|27|||
105663640|NCT00307047|364434717|FG001|Overall Study|All death, all MI, all Revascularization|16|||
105663641|NCT00903760|364434718|FG000|Overall Study|Disease Progression/Death|8|||
105663642|NCT00903760|364434719|FG001|Overall Study|Disease Progression/Death|6|||
105663643|NCT00903760|364434718|FG000|Overall Study|Stem Cell Transplant|8|||
105663644|NCT00903760|364434719|FG001|Overall Study|Stem Cell Transplant|4|||
105663645|NCT00903760|364434718|FG000|Overall Study|Physician Decision|1|||
105663646|NCT00903760|364434719|FG001|Overall Study|Physician Decision|2|||
105663647|NCT00903760|364434718|FG000|Overall Study|Death|0|||
105663648|NCT00903760|364434719|FG001|Overall Study|Death|1|||
105663649|NCT00903760|364434718|FG000|Overall Study|Lost to Follow-up|1|||
105663650|NCT00903760|364434719|FG001|Overall Study|Lost to Follow-up|0|||
105663651|NCT00903760|364434718|FG000|Overall Study|Withdrawal by Subject|1|||
105663652|NCT00903760|364434719|FG001|Overall Study|Withdrawal by Subject|2|||
105663653|NCT00903760|364434718|FG000|Overall Study|Off treatment for long period|0|||
105663654|NCT00903760|364434719|FG001|Overall Study|Off treatment for long period|1|||
105663655|NCT00379769|364434720|FG000|Main Study|Death|57|||
105663656|NCT00379769|364434721|FG001|Main Study|Death|67|||
105663657|NCT00379769|364434722|FG002|Main Study|Death|54|||
105663658|NCT00379769|364434723|FG003|Main Study|Death|72|||
105663659|NCT00379769|364434724|FG004|Main Study|Death|0|||
105663660|NCT00379769|364434725|FG005|Main Study|Death|0|||
105663661|NCT00379769|364434720|FG000|Main Study|Adverse Event|5|||
105663662|NCT00379769|364434721|FG001|Main Study|Adverse Event|8|||
105663663|NCT00379769|364434722|FG002|Main Study|Adverse Event|10|||
105663664|NCT00379769|364434723|FG003|Main Study|Adverse Event|11|||
105663665|NCT00379769|364434724|FG004|Main Study|Adverse Event|0|||
105663666|NCT00379769|364434725|FG005|Main Study|Adverse Event|0|||
105663667|NCT00379769|364434720|FG000|Main Study|Lost to Follow-up|29|||
105663668|NCT00379769|364434721|FG001|Main Study|Lost to Follow-up|29|||
105663669|NCT00379769|364434722|FG002|Main Study|Lost to Follow-up|25|||
105663670|NCT00379769|364434723|FG003|Main Study|Lost to Follow-up|26|||
105663671|NCT00379769|364434724|FG004|Main Study|Lost to Follow-up|0|||
105551009|NCT03701555|364017165|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
105551010|NCT03701555|364017166|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
105551011|NCT03701555|364017167|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
105551012|NCT03701555|364017168|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
105551013|NCT03701555|364017169|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
105551014|NCT03701555|364017170|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
105551015|NCT03701555|364017171|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
105551016|NCT03701555|364017172|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
105551017|NCT03701555|364017173|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
105551018|NCT03701555|364017174|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
105551019|NCT03701555|364017175|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
105551020|NCT03701555|364017176|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
105551021|NCT03701555|364017177|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
105551022|NCT03701555|364017178|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
105551023|NCT03701555|364017179|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
105551024|NCT03701555|364017180|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
105551025|NCT03701555|364017181|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
105551026|NCT03701555|364017182|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
105551027|NCT03701555|364017183|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
105551028|NCT03701555|364017184|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
105551029|NCT03701555|364017185|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
105551030|NCT03701555|364017186|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
105551031|NCT03701555|364017187|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
105551032|NCT03701555|364017188|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
105551033|NCT03701555|364017189|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
105551034|NCT03701555|364017154|FG000|Part 3 (Day 1)|Subject Decision|0|||
105551035|NCT03701555|364017155|FG001|Part 3 (Day 1)|Subject Decision|0|||
105551036|NCT03701555|364017156|FG002|Part 3 (Day 1)|Subject Decision|0|||
105663672|NCT00379769|364434725|FG005|Main Study|Lost to Follow-up|0|||
105663673|NCT00379769|364434720|FG000|Main Study|Withdrawal by Subject|46|||
105663674|NCT00379769|364434721|FG001|Main Study|Withdrawal by Subject|56|||
105663675|NCT00379769|364434722|FG002|Main Study|Withdrawal by Subject|72|||
105663676|NCT00379769|364434723|FG003|Main Study|Withdrawal by Subject|70|||
105663677|NCT00379769|364434724|FG004|Main Study|Withdrawal by Subject|0|||
105462741|NCT00918255|363709602|FG001|Overall Study|Exceeded allowed number of interventions|0|||
105462742|NCT00918255|363709603|FG002|Overall Study|Exceeded allowed number of interventions|1|||
105462743|NCT00918255|363709601|FG000|Overall Study|Non-compliance|1|||
105462744|NCT00918255|363709602|FG001|Overall Study|Non-compliance|0|||
105462745|NCT00918255|363709603|FG002|Overall Study|Non-compliance|0|||
105462746|NCT00918255|363709601|FG000|Overall Study|Investigator discretion|1|||
105462747|NCT00918255|363709602|FG001|Overall Study|Investigator discretion|0|||
105462748|NCT00918255|363709603|FG002|Overall Study|Investigator discretion|0|||
105462749|NCT02038933|363709636|FG000|Overall Study|Disease progression|104|||
105462750|NCT02038933|363709636|FG000|Overall Study|Study drug toxicity|6|||
105462751|NCT02038933|363709636|FG000|Overall Study|Adverse event unrelated to study drug|6|||
105462752|NCT02038933|363709636|FG000|Overall Study|Participant request to discontinue treatment|2|||
105462753|NCT02038933|363709636|FG000|Overall Study|Lost to Follow-up|1|||
105462754|NCT02038933|363709636|FG000|Overall Study|Other reasons|2|||
105339402|NCT02272842|363243630|FG000|Overall Study|Withdrawal by Subject|8|||
105339403|NCT02272842|363243631|FG001|Overall Study|Withdrawal by Subject|2|||
105339404|NCT01493284|363243634|FG000|Overall Study|Death|29|||
105339405|NCT01493284|363243634|FG000|Overall Study|Withdrawal by Subject|32|||
105339406|NCT03814720|363243635|FG000|Overall Study|Lost to Follow-up|0|||
105339407|NCT03814720|363243636|FG001|Overall Study|Lost to Follow-up|1|||
105339408|NCT03814720|363243637|FG002|Overall Study|Lost to Follow-up|0|||
105339409|NCT03814720|363243638|FG003|Overall Study|Lost to Follow-up|0|||
105339410|NCT03814720|363243639|FG004|Overall Study|Lost to Follow-up|0|||
105339411|NCT03053063|363243648|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
105339412|NCT03053063|363243649|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
105339413|NCT03053063|363243650|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
105339414|NCT03053063|363243651|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
105339415|NCT03053063|363243648|FG000|Randomized Phase|Withdrew consent|8|||
105339416|NCT03053063|363243649|FG001|Randomized Phase|Withdrew consent|11|||
105339417|NCT03053063|363243650|FG002|Randomized Phase|Withdrew consent|5|||
105339418|NCT03053063|363243651|FG003|Randomized Phase|Withdrew consent|0|||
105339419|NCT03053063|363243648|FG000|Randomized Phase|Investigator's Discretion|8|||
105339420|NCT03053063|363243649|FG001|Randomized Phase|Investigator's Discretion|6|||
105339421|NCT03053063|363243650|FG002|Randomized Phase|Investigator's Discretion|2|||
105339422|NCT03053063|363243651|FG003|Randomized Phase|Investigator's Discretion|0|||
105339423|NCT03053063|363243648|FG000|Randomized Phase|Lost to Follow-up|3|||
105339424|NCT03053063|363243649|FG001|Randomized Phase|Lost to Follow-up|5|||
105339425|NCT03053063|363243650|FG002|Randomized Phase|Lost to Follow-up|1|||
105339426|NCT03053063|363243651|FG003|Randomized Phase|Lost to Follow-up|0|||
105339427|NCT03053063|363243648|FG000|Randomized Phase|Adverse Event|0|||
105339428|NCT03053063|363243649|FG001|Randomized Phase|Adverse Event|1|||
105339429|NCT03053063|363243650|FG002|Randomized Phase|Adverse Event|0|||
105339430|NCT03053063|363243651|FG003|Randomized Phase|Adverse Event|0|||
105339431|NCT03053063|363243648|FG000|Randomized Phase|Randomized but Never Treated|1|||
105339432|NCT03053063|363243649|FG001|Randomized Phase|Randomized but Never Treated|3|||
105339433|NCT03053063|363243650|FG002|Randomized Phase|Randomized but Never Treated|2|||
105339434|NCT03053063|363243651|FG003|Randomized Phase|Randomized but Never Treated|0|||
105339435|NCT03053063|363243648|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
105462755|NCT02492763|363709639|FG000|Overall Study|Withdrawal by Subject|0|||
105462756|NCT02492763|363709640|FG001|Overall Study|Withdrawal by Subject|2|||
105462757|NCT02492763|363709641|FG002|Overall Study|Withdrawal by Subject|1|||
105462758|NCT02492763|363709642|FG003|Overall Study|Withdrawal by Subject|0|||
105462759|NCT02492763|363709639|FG000|Overall Study|Adverse Event|3|||
105462760|NCT02492763|363709640|FG001|Overall Study|Adverse Event|1|||
105339436|NCT03053063|363243649|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
105462761|NCT02492763|363709641|FG002|Overall Study|Adverse Event|1|||
105462762|NCT02492763|363709642|FG003|Overall Study|Adverse Event|2|||
105462763|NCT02492763|363709639|FG000|Overall Study|Death|0|||
105339437|NCT03053063|363243650|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
105339438|NCT03053063|363243651|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
105339439|NCT03053063|363243648|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
105339440|NCT03053063|363243649|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
105339441|NCT03053063|363243650|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
105339442|NCT03053063|363243651|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
105339443|NCT03053063|363243648|FG000|Open-Label Phase|Death|0|||
105339444|NCT03053063|363243649|FG001|Open-Label Phase|Death|0|||
105339445|NCT03053063|363243650|FG002|Open-Label Phase|Death|0|||
105339446|NCT03053063|363243651|FG003|Open-Label Phase|Death|2|||
105339447|NCT03053063|363243648|FG000|Open-Label Phase|Investigator's discretion|0|||
105339448|NCT03053063|363243649|FG001|Open-Label Phase|Investigator's discretion|0|||
105339449|NCT03053063|363243650|FG002|Open-Label Phase|Investigator's discretion|0|||
105462764|NCT02492763|363709640|FG001|Overall Study|Death|0|||
105462765|NCT02492763|363709641|FG002|Overall Study|Death|1|||
105462766|NCT02492763|363709642|FG003|Overall Study|Death|0|||
105462767|NCT02492763|363709639|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
105462768|NCT02492763|363709640|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
105663678|NCT00379769|364434725|FG005|Main Study|Withdrawal by Subject|0|||
105663679|NCT00379769|364434720|FG000|Main Study|Moved to survival status follow-up only|27|||
105663680|NCT00379769|364434721|FG001|Main Study|Moved to survival status follow-up only|25|||
105663681|NCT00379769|364434722|FG002|Main Study|Moved to survival status follow-up only|32|||
105663682|NCT00379769|364434723|FG003|Main Study|Moved to survival status follow-up only|36|||
105663683|NCT00379769|364434724|FG004|Main Study|Moved to survival status follow-up only|0|||
105663684|NCT00379769|364434725|FG005|Main Study|Moved to survival status follow-up only|0|||
105663685|NCT00379769|364434720|FG000|Main Study|Participant moved|3|||
105663686|NCT00379769|364434721|FG001|Main Study|Participant moved|2|||
105663687|NCT00379769|364434722|FG002|Main Study|Participant moved|3|||
105663688|NCT00379769|364434723|FG003|Main Study|Participant moved|3|||
105663689|NCT00379769|364434724|FG004|Main Study|Participant moved|0|||
105663690|NCT00379769|364434725|FG005|Main Study|Participant moved|0|||
105663691|NCT00379769|364434720|FG000|Main Study|Poor compliance|3|||
105663692|NCT00379769|364434721|FG001|Main Study|Poor compliance|2|||
105663693|NCT00379769|364434722|FG002|Main Study|Poor compliance|2|||
105663694|NCT00379769|364434723|FG003|Main Study|Poor compliance|1|||
105663695|NCT00379769|364434724|FG004|Main Study|Poor compliance|0|||
105663696|NCT00379769|364434725|FG005|Main Study|Poor compliance|0|||
105663697|NCT00379769|364434720|FG000|Main Study|Prohibited glucose lowering medication|0|||
105663698|NCT00379769|364434721|FG001|Main Study|Prohibited glucose lowering medication|3|||
105663699|NCT00379769|364434722|FG002|Main Study|Prohibited glucose lowering medication|0|||
105663700|NCT00379769|364434723|FG003|Main Study|Prohibited glucose lowering medication|1|||
105663701|NCT00379769|364434724|FG004|Main Study|Prohibited glucose lowering medication|0|||
105663702|NCT00379769|364434725|FG005|Main Study|Prohibited glucose lowering medication|0|||
105663703|NCT00379769|364434720|FG000|Main Study|Site closed|4|||
105663704|NCT00379769|364434721|FG001|Main Study|Site closed|4|||
105663705|NCT00379769|364434722|FG002|Main Study|Site closed|4|||
105663706|NCT00379769|364434723|FG003|Main Study|Site closed|8|||
105663707|NCT00379769|364434724|FG004|Main Study|Site closed|0|||
105663708|NCT00379769|364434725|FG005|Main Study|Site closed|0|||
105663709|NCT00379769|364434720|FG000|Main Study|Entry criteria violation|0|||
105663710|NCT00379769|364434721|FG001|Main Study|Entry criteria violation|0|||
105663711|NCT00379769|364434722|FG002|Main Study|Entry criteria violation|1|||
105663712|NCT00379769|364434723|FG003|Main Study|Entry criteria violation|1|||
105663713|NCT00379769|364434724|FG004|Main Study|Entry criteria violation|0|||
105663714|NCT00379769|364434725|FG005|Main Study|Entry criteria violation|0|||
105663715|NCT00379769|364434720|FG000|Main Study|Participant did not take study drug|0|||
105663716|NCT00379769|364434721|FG001|Main Study|Participant did not take study drug|0|||
105663717|NCT00379769|364434722|FG002|Main Study|Participant did not take study drug|1|||
105663718|NCT00379769|364434723|FG003|Main Study|Participant did not take study drug|0|||
105663719|NCT00379769|364434724|FG004|Main Study|Participant did not take study drug|0|||
105663720|NCT00379769|364434725|FG005|Main Study|Participant did not take study drug|0|||
105663721|NCT00379769|364434720|FG000|Main Study|Physician Decision|2|||
105663722|NCT00379769|364434721|FG001|Main Study|Physician Decision|2|||
105663723|NCT00379769|364434722|FG002|Main Study|Physician Decision|1|||
105663724|NCT00379769|364434723|FG003|Main Study|Physician Decision|1|||
105663725|NCT00379769|364434724|FG004|Main Study|Physician Decision|0|||
105663726|NCT00379769|364434725|FG005|Main Study|Physician Decision|0|||
105663727|NCT00379769|364434720|FG000|Main Study|Participant completed study at visit 27|1|||
105663728|NCT00379769|364434721|FG001|Main Study|Participant completed study at visit 27|0|||
105663729|NCT00379769|364434722|FG002|Main Study|Participant completed study at visit 27|0|||
105663730|NCT00379769|364434723|FG003|Main Study|Participant completed study at visit 27|0|||
105663731|NCT00379769|364434724|FG004|Main Study|Participant completed study at visit 27|0|||
105663732|NCT00379769|364434725|FG005|Main Study|Participant completed study at visit 27|0|||
105663733|NCT00379769|364434720|FG000|Main Study|Personal reasons|1|||
105663734|NCT00379769|364434721|FG001|Main Study|Personal reasons|0|||
105663735|NCT00379769|364434722|FG002|Main Study|Personal reasons|0|||
105663736|NCT00379769|364434723|FG003|Main Study|Personal reasons|0|||
105663737|NCT00379769|364434724|FG004|Main Study|Personal reasons|0|||
105663738|NCT00379769|364434725|FG005|Main Study|Personal reasons|0|||
105663739|NCT00379769|364434720|FG000|Main Study|Risk of heart failure|0|||
105663740|NCT00379769|364434721|FG001|Main Study|Risk of heart failure|1|||
105663741|NCT00379769|364434722|FG002|Main Study|Risk of heart failure|0|||
105663742|NCT00379769|364434723|FG003|Main Study|Risk of heart failure|0|||
105663743|NCT00379769|364434724|FG004|Main Study|Risk of heart failure|0|||
105663744|NCT00379769|364434725|FG005|Main Study|Risk of heart failure|0|||
105663745|NCT00379769|364434720|FG000|Main Study|Investigator refused to log temperature|0|||
105663746|NCT00379769|364434721|FG001|Main Study|Investigator refused to log temperature|0|||
105663747|NCT00379769|364434722|FG002|Main Study|Investigator refused to log temperature|1|||
105663748|NCT00379769|364434723|FG003|Main Study|Investigator refused to log temperature|0|||
105663749|NCT00379769|364434724|FG004|Main Study|Investigator refused to log temperature|0|||
105663750|NCT00379769|364434725|FG005|Main Study|Investigator refused to log temperature|0|||
105663751|NCT00379769|364434720|FG000|Main Study|Reason unspecified|0|||
105663752|NCT00379769|364434721|FG001|Main Study|Reason unspecified|0|||
105663753|NCT00379769|364434722|FG002|Main Study|Reason unspecified|1|||
105663754|NCT00379769|364434723|FG003|Main Study|Reason unspecified|0|||
105663755|NCT00379769|364434724|FG004|Main Study|Reason unspecified|0|||
105663756|NCT00379769|364434725|FG005|Main Study|Reason unspecified|0|||
105663757|NCT00379769|364434720|FG000|Observational Follow-up|Death|0|||
105663758|NCT00379769|364434721|FG001|Observational Follow-up|Death|0|||
105663759|NCT00379769|364434722|FG002|Observational Follow-up|Death|0|||
105663760|NCT00379769|364434723|FG003|Observational Follow-up|Death|0|||
105663761|NCT00379769|364434724|FG004|Observational Follow-up|Death|78|||
105663762|NCT00379769|364434725|FG005|Observational Follow-up|Death|70|||
105663763|NCT00379769|364434720|FG000|Observational Follow-up|Adverse Event|0|||
105663764|NCT00379769|364434721|FG001|Observational Follow-up|Adverse Event|0|||
105663765|NCT00379769|364434722|FG002|Observational Follow-up|Adverse Event|0|||
105663766|NCT00379769|364434723|FG003|Observational Follow-up|Adverse Event|0|||
105462769|NCT02492763|363709641|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
105462770|NCT02492763|363709642|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
105663767|NCT00379769|364434724|FG004|Observational Follow-up|Adverse Event|1|||
105663768|NCT00379769|364434725|FG005|Observational Follow-up|Adverse Event|0|||
105663769|NCT00379769|364434720|FG000|Observational Follow-up|Lost to Follow-up|0|||
105663770|NCT00379769|364434721|FG001|Observational Follow-up|Lost to Follow-up|0|||
105663771|NCT00379769|364434722|FG002|Observational Follow-up|Lost to Follow-up|0|||
105663772|NCT00379769|364434723|FG003|Observational Follow-up|Lost to Follow-up|0|||
105663773|NCT00379769|364434724|FG004|Observational Follow-up|Lost to Follow-up|25|||
105663774|NCT00379769|364434725|FG005|Observational Follow-up|Lost to Follow-up|27|||
105663775|NCT00379769|364434720|FG000|Observational Follow-up|Withdrawal by Subject|0|||
105663776|NCT00379769|364434721|FG001|Observational Follow-up|Withdrawal by Subject|0|||
105663777|NCT00379769|364434722|FG002|Observational Follow-up|Withdrawal by Subject|0|||
105663778|NCT00379769|364434723|FG003|Observational Follow-up|Withdrawal by Subject|0|||
105663779|NCT00379769|364434724|FG004|Observational Follow-up|Withdrawal by Subject|12|||
105663780|NCT00379769|364434725|FG005|Observational Follow-up|Withdrawal by Subject|12|||
105663781|NCT00379769|364434720|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
105663782|NCT00379769|364434721|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
105663783|NCT00379769|364434722|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
105663784|NCT00379769|364434723|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
105663785|NCT00379769|364434724|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
105663786|NCT00379769|364434725|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
105663787|NCT00379769|364434720|FG000|Observational Follow-up|Physician Decision|0|||
105462771|NCT02492763|363709639|FG000|Overall Study|Lost to Follow-up|0|||
105663788|NCT00379769|364434721|FG001|Observational Follow-up|Physician Decision|0|||
105462772|NCT02492763|363709640|FG001|Overall Study|Lost to Follow-up|0|||
105462773|NCT02492763|363709641|FG002|Overall Study|Lost to Follow-up|1|||
105462774|NCT02492763|363709642|FG003|Overall Study|Lost to Follow-up|0|||
105663789|NCT00379769|364434722|FG002|Observational Follow-up|Physician Decision|0|||
105663790|NCT00379769|364434723|FG003|Observational Follow-up|Physician Decision|0|||
105663791|NCT00379769|364434724|FG004|Observational Follow-up|Physician Decision|8|||
105663792|NCT00379769|364434725|FG005|Observational Follow-up|Physician Decision|8|||
105663793|NCT00379769|364434720|FG000|Observational Follow-up|Site Closed Early|0|||
105663794|NCT00379769|364434721|FG001|Observational Follow-up|Site Closed Early|0|||
105663795|NCT00379769|364434722|FG002|Observational Follow-up|Site Closed Early|0|||
105663796|NCT00379769|364434723|FG003|Observational Follow-up|Site Closed Early|0|||
105663797|NCT00379769|364434724|FG004|Observational Follow-up|Site Closed Early|6|||
105462775|NCT02492763|363709639|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105462776|NCT02492763|363709640|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105551037|NCT03701555|364017157|FG003|Part 3 (Day 1)|Subject Decision|0|||
105551038|NCT03701555|364017158|FG004|Part 3 (Day 1)|Subject Decision|0|||
105551039|NCT03701555|364017159|FG005|Part 3 (Day 1)|Subject Decision|0|||
105551040|NCT03701555|364017160|FG006|Part 3 (Day 1)|Subject Decision|0|||
105551041|NCT03701555|364017161|FG007|Part 3 (Day 1)|Subject Decision|0|||
105551042|NCT03701555|364017162|FG008|Part 3 (Day 1)|Subject Decision|0|||
105551043|NCT03701555|364017163|FG009|Part 3 (Day 1)|Subject Decision|0|||
105551044|NCT03701555|364017164|FG010|Part 3 (Day 1)|Subject Decision|0|||
105551045|NCT03701555|364017165|FG011|Part 3 (Day 1)|Subject Decision|0|||
105551046|NCT03701555|364017166|FG012|Part 3 (Day 1)|Subject Decision|0|||
105551047|NCT03701555|364017167|FG013|Part 3 (Day 1)|Subject Decision|0|||
105551048|NCT03701555|364017168|FG014|Part 3 (Day 1)|Subject Decision|0|||
105551049|NCT03701555|364017169|FG015|Part 3 (Day 1)|Subject Decision|0|||
105551050|NCT03701555|364017170|FG016|Part 3 (Day 1)|Subject Decision|0|||
105551051|NCT03701555|364017171|FG017|Part 3 (Day 1)|Subject Decision|0|||
105551052|NCT03701555|364017172|FG018|Part 3 (Day 1)|Subject Decision|0|||
105551053|NCT03701555|364017173|FG019|Part 3 (Day 1)|Subject Decision|0|||
105551054|NCT03701555|364017174|FG020|Part 3 (Day 1)|Subject Decision|0|||
105551055|NCT03701555|364017175|FG021|Part 3 (Day 1)|Subject Decision|0|||
105551056|NCT03701555|364017176|FG022|Part 3 (Day 1)|Subject Decision|0|||
105551057|NCT03701555|364017177|FG023|Part 3 (Day 1)|Subject Decision|0|||
105551058|NCT03701555|364017178|FG024|Part 3 (Day 1)|Subject Decision|0|||
105551059|NCT03701555|364017179|FG025|Part 3 (Day 1)|Subject Decision|0|||
105551060|NCT03701555|364017180|FG026|Part 3 (Day 1)|Subject Decision|1|||
105551061|NCT03701555|364017181|FG027|Part 3 (Day 1)|Subject Decision|0|||
105663798|NCT00379769|364434725|FG005|Observational Follow-up|Site Closed Early|7|||
105339450|NCT03053063|363243651|FG003|Open-Label Phase|Investigator's discretion|2|||
105339451|NCT02600845|363243652|FG000|Overall Study|Reason Not Specified|3|||
105339452|NCT02600845|363243652|FG000|Overall Study|Non-compliance with Study Procedures|10|||
105339453|NCT02600845|363243652|FG000|Overall Study|Consent Withdrawal|5|||
105339454|NCT04413552|363243653|FG000|Overall Study|Adverse Event|0|||
105663799|NCT00379769|364434720|FG000|Observational Follow-up|Participant Moved|0|||
105663800|NCT00379769|364434721|FG001|Observational Follow-up|Participant Moved|0|||
105663801|NCT00379769|364434722|FG002|Observational Follow-up|Participant Moved|0|||
105663802|NCT00379769|364434723|FG003|Observational Follow-up|Participant Moved|0|||
105663803|NCT00379769|364434724|FG004|Observational Follow-up|Participant Moved|0|||
105339455|NCT04413552|363243654|FG001|Overall Study|Adverse Event|0|||
105339456|NCT04413552|363243655|FG002|Overall Study|Adverse Event|0|||
105339457|NCT04413552|363243656|FG003|Overall Study|Adverse Event|0|||
105339458|NCT04413552|363243657|FG004|Overall Study|Adverse Event|0|||
105339459|NCT04413552|363243658|FG005|Overall Study|Adverse Event|0|||
105339460|NCT04413552|363243659|FG006|Overall Study|Adverse Event|1|||
105339461|NCT04413552|363243660|FG007|Overall Study|Adverse Event|0|||
105339462|NCT04413552|363243661|FG008|Overall Study|Adverse Event|0|||
105339463|NCT04413552|363243662|FG009|Overall Study|Adverse Event|0|||
105339464|NCT05685732|363243663|FG000|Overall Study|Withdrawal by Subject|2|||
105339465|NCT05685732|363243664|FG001|Overall Study|Withdrawal by Subject|0|||
105339466|NCT05685732|363243665|FG002|Overall Study|Withdrawal by Subject|2|||
105339467|NCT05685732|363243666|FG003|Overall Study|Withdrawal by Subject|3|||
105339468|NCT05685732|363243663|FG000|Overall Study|Protocol Violation|1|||
105339469|NCT05685732|363243664|FG001|Overall Study|Protocol Violation|2|||
105339470|NCT05685732|363243665|FG002|Overall Study|Protocol Violation|4|||
105339471|NCT05685732|363243666|FG003|Overall Study|Protocol Violation|1|||
105339472|NCT05685732|363243663|FG000|Overall Study|Lost to Follow-up|5|||
105339473|NCT05685732|363243664|FG001|Overall Study|Lost to Follow-up|1|||
105339474|NCT05685732|363243665|FG002|Overall Study|Lost to Follow-up|3|||
105339475|NCT05685732|363243666|FG003|Overall Study|Lost to Follow-up|1|||
105339476|NCT05685732|363243663|FG000|Overall Study|Adverse Event|2|||
105339477|NCT05685732|363243664|FG001|Overall Study|Adverse Event|1|||
105339478|NCT05685732|363243665|FG002|Overall Study|Adverse Event|0|||
105339479|NCT05685732|363243666|FG003|Overall Study|Adverse Event|0|||
105339480|NCT05685732|363243663|FG000|Overall Study|Physician Decision|1|||
105339481|NCT05685732|363243664|FG001|Overall Study|Physician Decision|0|||
105339482|NCT05685732|363243665|FG002|Overall Study|Physician Decision|0|||
105339483|NCT05685732|363243666|FG003|Overall Study|Physician Decision|0|||
105339484|NCT02100670|363243667|FG000|Overall Study|Adverse Event|10|||
105339485|NCT02100670|363243668|FG001|Overall Study|Adverse Event|3|||
105339486|NCT02100670|363243669|FG002|Overall Study|Adverse Event|3|||
105339487|NCT02100670|363243670|FG003|Overall Study|Adverse Event|0|||
105339488|NCT02100670|363243667|FG000|Overall Study|Lost to Follow-up|1|||
105339489|NCT02100670|363243668|FG001|Overall Study|Lost to Follow-up|0|||
105339490|NCT02100670|363243669|FG002|Overall Study|Lost to Follow-up|0|||
105339491|NCT02100670|363243670|FG003|Overall Study|Lost to Follow-up|0|||
105339492|NCT02100670|363243667|FG000|Overall Study|Protocol Violation|0|||
105551062|NCT03701555|364017182|FG028|Part 3 (Day 1)|Subject Decision|0|||
105551063|NCT03701555|364017183|FG029|Part 3 (Day 1)|Subject Decision|0|||
105339493|NCT02100670|363243668|FG001|Overall Study|Protocol Violation|1|||
105339494|NCT02100670|363243669|FG002|Overall Study|Protocol Violation|0|||
105339495|NCT02100670|363243670|FG003|Overall Study|Protocol Violation|1|||
105339496|NCT02100670|363243667|FG000|Overall Study|Withdrawal of Consent|0|||
105551064|NCT03701555|364017184|FG030|Part 3 (Day 1)|Subject Decision|0|||
105663804|NCT00379769|364434725|FG005|Observational Follow-up|Participant Moved|1|||
105339497|NCT02100670|363243668|FG001|Overall Study|Withdrawal of Consent|1|||
105339498|NCT02100670|363243669|FG002|Overall Study|Withdrawal of Consent|1|||
105339499|NCT02100670|363243670|FG003|Overall Study|Withdrawal of Consent|0|||
105339500|NCT02100670|363243667|FG000|Overall Study|No swelling no pain|1|||
105339501|NCT02100670|363243668|FG001|Overall Study|No swelling no pain|0|||
105551065|NCT03701555|364017185|FG031|Part 3 (Day 1)|Subject Decision|2|||
105663805|NCT00379769|364434720|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
105663806|NCT00379769|364434721|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
105663807|NCT00379769|364434722|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
105663808|NCT00379769|364434723|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
105663809|NCT00379769|364434724|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
105663810|NCT00379769|364434725|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
105663811|NCT03778294|364434726|FG000|Overall Study|Death|1|||
105663812|NCT03778294|364434726|FG000|Overall Study|Issues with insurance|1|||
105663813|NCT03778294|364434726|FG000|Overall Study|disease progression before treatment|2|||
105663814|NCT02388347|364434727|FG000|Overall Study|Withdrawal by Subject|0|||
105663815|NCT02388347|364434728|FG001|Overall Study|Withdrawal by Subject|0|||
105663816|NCT02388347|364434729|FG002|Overall Study|Withdrawal by Subject|1|||
105663817|NCT02388347|364434730|FG003|Overall Study|Withdrawal by Subject|0|||
105663818|NCT02388347|364434731|FG004|Overall Study|Withdrawal by Subject|0|||
105663819|NCT02825251|364434734|FG000|Overall Study|Adverse Event|0|||
105663820|NCT02825251|364434735|FG001|Overall Study|Adverse Event|1|||
105663821|NCT02825251|364434734|FG000|Overall Study|Lost to Follow-up|0|||
105663822|NCT02825251|364434735|FG001|Overall Study|Lost to Follow-up|1|||
105663823|NCT02825251|364434734|FG000|Overall Study|Withdrawal by Subject|1|||
105663824|NCT02825251|364434735|FG001|Overall Study|Withdrawal by Subject|4|||
105663825|NCT02825251|364434734|FG000|Overall Study|Unclassified|2|||
105663826|NCT02825251|364434735|FG001|Overall Study|Unclassified|0|||
105663827|NCT01689363|364434742|FG000|Overall Study|Protocol Violation|0|||
105663828|NCT01689363|364434743|FG001|Overall Study|Protocol Violation|1|||
105663829|NCT01689363|364434744|FG002|Overall Study|Protocol Violation|0|||
105663830|NCT01689363|364434745|FG003|Overall Study|Protocol Violation|0|||
105663831|NCT01689363|364434746|FG004|Overall Study|Protocol Violation|0|||
105663832|NCT01689363|364434747|FG005|Overall Study|Protocol Violation|0|||
105663833|NCT01689363|364434748|FG006|Overall Study|Protocol Violation|0|||
105663834|NCT01689363|364434749|FG007|Overall Study|Protocol Violation|0|||
105663835|NCT02859064|364434750|FG000|Overall Study|Progressive Disease|3|||
105663836|NCT02859064|364434750|FG000|Overall Study|Physician Decision|1|||
105663837|NCT02859064|364434750|FG000|Overall Study|Withdrawal by Subject|1|||
105663838|NCT02859064|364434750|FG000|Overall Study|Death|1|||
105663839|NCT00321685|364434751|FG000|Overall Study|Adverse Event|18|||
105663840|NCT00321685|364434751|FG000|Overall Study|Death|2|||
105663841|NCT00321685|364434751|FG000|Overall Study|Withdrawal by Subject|8|||
105663842|NCT00321685|364434751|FG000|Overall Study|Alternative therapy|1|||
105663843|NCT00321685|364434751|FG000|Overall Study|Complicating disese|1|||
105663844|NCT00321685|364434751|FG000|Overall Study|Other|5|||
105663845|NCT00321685|364434751|FG000|Overall Study|Not start protocol therapy|2|||
105663846|NCT00321685|364434751|FG000|Overall Study|Ineligible|2|||
105663847|NCT02172911|364434756|FG000|Overall Study|Serious Adverse Event|0|||
105339502|NCT02100670|363243669|FG002|Overall Study|No swelling no pain|0|||
105339503|NCT02100670|363243670|FG003|Overall Study|No swelling no pain|0|||
105339504|NCT02100670|363243667|FG000|Overall Study|Poor Efficacy|0|||
105663848|NCT02172911|364434757|FG001|Overall Study|Serious Adverse Event|1|||
105663849|NCT02172911|364434756|FG000|Overall Study|Progression of Disease|0|||
105663850|NCT02172911|364434757|FG001|Overall Study|Progression of Disease|1|||
105663851|NCT02172911|364434756|FG000|Overall Study|Loss of insurance coverage|1|||
105663852|NCT02172911|364434757|FG001|Overall Study|Loss of insurance coverage|0|||
105663853|NCT00127842|364434758|FG000|Overall Study|Adverse Event|15|||
105663854|NCT00127842|364434758|FG000|Overall Study|Withdrawal by Subject|3|||
105663855|NCT00127842|364434758|FG000|Overall Study|Lost to Follow-up|1|||
105663856|NCT00127842|364434758|FG000|Overall Study|Lack of Efficacy|12|||
105663857|NCT00127842|364434758|FG000|Overall Study|Noncompliance|2|||
105663858|NCT00127842|364434758|FG000|Overall Study|Protocol Violation|1|||
105663859|NCT00127842|364434758|FG000|Overall Study|Other|5|||
105663860|NCT01536587|364434761|FG000|Overall Study|Adverse Event|2|||
105663861|NCT03023722|364434762|FG000|Overall Study|No follow-up assessment|4|||
105663862|NCT00129935|364434763|FG000|Overall Study|Adverse Event|18|||
105462777|NCT02492763|363709641|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105462778|NCT02492763|363709642|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105462779|NCT02492763|363709639|FG000|Overall Study|Screen Failure|0|||
105462780|NCT02492763|363709640|FG001|Overall Study|Screen Failure|0|||
105663863|NCT00129935|364434764|FG001|Overall Study|Adverse Event|56|||
105663864|NCT00129935|364434763|FG000|Overall Study|Death|1|||
105663865|NCT00129935|364434764|FG001|Overall Study|Death|1|||
105339505|NCT02100670|363243668|FG001|Overall Study|Poor Efficacy|1|||
105339506|NCT02100670|363243669|FG002|Overall Study|Poor Efficacy|0|||
105663866|NCT00129935|364434763|FG000|Overall Study|Withdrawal by Subject|7|||
105663867|NCT00129935|364434764|FG001|Overall Study|Withdrawal by Subject|20|||
105663868|NCT00129935|364434763|FG000|Overall Study|Protocol Violation|0|||
105462781|NCT02492763|363709641|FG002|Overall Study|Screen Failure|0|||
105462782|NCT02492763|363709642|FG003|Overall Study|Screen Failure|1|||
105462783|NCT02492763|363709639|FG000|Overall Study|Study Terminated by Sponsor|13|||
105462784|NCT02492763|363709640|FG001|Overall Study|Study Terminated by Sponsor|10|||
105462785|NCT02492763|363709641|FG002|Overall Study|Study Terminated by Sponsor|6|||
105462786|NCT02492763|363709642|FG003|Overall Study|Study Terminated by Sponsor|10|||
105462787|NCT02113982|363709643|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
105462788|NCT02113982|363709644|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
105462789|NCT02113982|363709645|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
105462790|NCT02113982|363709646|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
105462791|NCT02113982|363709647|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
105462792|NCT02113982|363709648|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
105462793|NCT02113982|363709649|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
105462794|NCT02113982|363709650|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
105462795|NCT02113982|363709651|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
105462796|NCT02113982|363709652|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
105462797|NCT02113982|363709653|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
105462798|NCT02113982|363709654|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
105462799|NCT02113982|363709655|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
105462800|NCT02113982|363709656|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
105462801|NCT02113982|363709643|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
105462802|NCT02113982|363709644|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
105462803|NCT02113982|363709645|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
105462804|NCT02113982|363709646|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
105462805|NCT02113982|363709647|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
105462806|NCT02113982|363709648|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
105462807|NCT02113982|363709649|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
105462808|NCT02113982|363709650|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
105462809|NCT02113982|363709651|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
105462810|NCT02113982|363709652|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
105462811|NCT02113982|363709653|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
105462812|NCT02113982|363709654|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
105462813|NCT02113982|363709655|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
105462814|NCT02113982|363709656|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
105462815|NCT02113982|363709643|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
105462816|NCT02113982|363709644|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
105339507|NCT02100670|363243670|FG003|Overall Study|Poor Efficacy|0|||
105339508|NCT02100670|363243667|FG000|Overall Study|Physician Decision|0|||
105462817|NCT02113982|363709645|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
105462818|NCT02113982|363709646|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
105462819|NCT02113982|363709647|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
105462820|NCT02113982|363709648|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
105462821|NCT02113982|363709649|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
105663869|NCT00129935|364434764|FG001|Overall Study|Protocol Violation|4|||
105663870|NCT00129935|364434763|FG000|Overall Study|Physician Decision|3|||
105339509|NCT02100670|363243668|FG001|Overall Study|Physician Decision|1|||
105339510|NCT02100670|363243669|FG002|Overall Study|Physician Decision|0|||
105339511|NCT02100670|363243670|FG003|Overall Study|Physician Decision|0|||
105339512|NCT02100670|363243667|FG000|Overall Study|Withdrawal by Subject|1|||
105339513|NCT02100670|363243668|FG001|Overall Study|Withdrawal by Subject|0|||
105339514|NCT02100670|363243669|FG002|Overall Study|Withdrawal by Subject|0|||
105339515|NCT02100670|363243670|FG003|Overall Study|Withdrawal by Subject|0|||
105339516|NCT03467217|363245172|FG000|Overall Study|Trial stopped early|5|||
105339517|NCT03467217|363245173|FG001|Overall Study|Trial stopped early|2|||
105339518|NCT03467217|363245172|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
105462822|NCT02113982|363709650|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
105462823|NCT02113982|363709651|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
105339519|NCT03467217|363245173|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
105339520|NCT03467217|363245172|FG000|Overall Study|Lost to Follow-up|0|||
105339521|NCT03467217|363245173|FG001|Overall Study|Lost to Follow-up|2|||
105462824|NCT02113982|363709652|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
105462825|NCT02113982|363709653|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
105462826|NCT02113982|363709654|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
105462827|NCT02113982|363709655|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
105462828|NCT02113982|363709656|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
105462829|NCT02113982|363709643|FG000|Stage 1: Dose Escalation|Transplant|0|||
105462830|NCT02113982|363709644|FG001|Stage 1: Dose Escalation|Transplant|1|||
105462831|NCT02113982|363709645|FG002|Stage 1: Dose Escalation|Transplant|0|||
105462832|NCT02113982|363709646|FG003|Stage 1: Dose Escalation|Transplant|0|||
105462833|NCT02113982|363709647|FG004|Stage 1: Dose Escalation|Transplant|0|||
105462834|NCT02113982|363709648|FG005|Stage 1: Dose Escalation|Transplant|1|||
105462835|NCT02113982|363709649|FG006|Stage 1: Dose Escalation|Transplant|0|||
105462836|NCT02113982|363709650|FG007|Stage 1: Dose Escalation|Transplant|0|||
105462837|NCT02113982|363709651|FG008|Stage 1: Dose Escalation|Transplant|0|||
105663871|NCT00129935|364434764|FG001|Overall Study|Physician Decision|4|||
105663872|NCT00129935|364434763|FG000|Overall Study|Recurrence|1|||
105663873|NCT00129935|364434764|FG001|Overall Study|Recurrence|3|||
105663874|NCT00129935|364434763|FG000|Overall Study|Second primary|0|||
105663875|NCT00129935|364434764|FG001|Overall Study|Second primary|1|||
105663876|NCT00129935|364434763|FG000|Overall Study|Other|3|||
105663877|NCT00129935|364434764|FG001|Overall Study|Other|2|||
105663878|NCT00129935|364434763|FG000|Overall Study|Crossed to the other arm|2|||
105663879|NCT00129935|364434764|FG001|Overall Study|Crossed to the other arm|1|||
105663880|NCT00129935|364434763|FG000|Overall Study|Incorrect study treatment|1|||
105663881|NCT00129935|364434764|FG001|Overall Study|Incorrect study treatment|0|||
105663882|NCT00590564|364434766|FG000|Overall Study|Withdrawal by Subject|4|||
105663883|NCT00590564|364434766|FG000|Overall Study|Lost to Follow-up|6|||
105663884|NCT00590564|364434766|FG000|Overall Study|Protocol Violation|1|||
105663885|NCT00590564|364434766|FG000|Overall Study|Patient Found to be Ineligible|1|||
105663886|NCT00590564|364434766|FG000|Overall Study|Patient Non-compliance|6|||
105663887|NCT01434680|364434769|FG000|Overall Study|Withdrawal by Subject|1|||
105663888|NCT01434680|364434770|FG001|Overall Study|Withdrawal by Subject|0|||
105339522|NCT03030989|363245175|FG000|Overall Study|Fever|2|||
105663889|NCT01434680|364434771|FG002|Overall Study|Withdrawal by Subject|2|||
105663890|NCT01434680|364434772|FG003|Overall Study|Withdrawal by Subject|0|||
105663891|NCT01434680|364434769|FG000|Overall Study|Lost to Follow-up|1|||
105663892|NCT01434680|364434770|FG001|Overall Study|Lost to Follow-up|1|||
105663893|NCT01434680|364434771|FG002|Overall Study|Lost to Follow-up|0|||
105663894|NCT01434680|364434772|FG003|Overall Study|Lost to Follow-up|0|||
105663895|NCT01434680|364434769|FG000|Overall Study|Protocol Violation|1|||
105462838|NCT02113982|363709652|FG009|Stage 1: Dose Escalation|Transplant|0|||
105663896|NCT01434680|364434770|FG001|Overall Study|Protocol Violation|1|||
105663897|NCT01434680|364434771|FG002|Overall Study|Protocol Violation|0|||
105663898|NCT01434680|364434772|FG003|Overall Study|Protocol Violation|0|||
105663899|NCT03020069|364434776|FG000|Overall Study|Lost to Follow-up|0|||
105663900|NCT03020069|364434777|FG001|Overall Study|Lost to Follow-up|1|||
105663901|NCT01367847|364434778|FG000|Overall Study|Withdrawal by Subject|2|||
105462839|NCT02113982|363709653|FG010|Stage 1: Dose Escalation|Transplant|0|||
105462840|NCT02113982|363709654|FG011|Stage 1: Dose Escalation|Transplant|0|||
105462841|NCT02113982|363709655|FG012|Stage 1: Dose Escalation|Transplant|0|||
105462842|NCT02113982|363709656|FG013|Stage 1: Dose Escalation|Transplant|0|||
105462843|NCT02113982|363709643|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
105462844|NCT02113982|363709644|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
105462845|NCT02113982|363709645|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
105462846|NCT02113982|363709646|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
105462847|NCT02113982|363709647|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
105462848|NCT02113982|363709648|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
105462849|NCT02113982|363709649|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
105462850|NCT02113982|363709650|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
105462851|NCT02113982|363709651|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
105462852|NCT02113982|363709652|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
105462853|NCT02113982|363709653|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
105462854|NCT02113982|363709654|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
105462855|NCT02113982|363709655|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
105462856|NCT02113982|363709656|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
105462857|NCT02113982|363709643|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
105462858|NCT02113982|363709644|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
105462859|NCT02113982|363709645|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
105462860|NCT02113982|363709646|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
105462861|NCT02113982|363709647|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
105462862|NCT02113982|363709648|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
105462863|NCT02113982|363709649|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
105462864|NCT02113982|363709650|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
105462865|NCT02113982|363709651|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
105462866|NCT02113982|363709652|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
105462867|NCT02113982|363709653|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
105462868|NCT02113982|363709654|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
105462869|NCT02113982|363709655|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
105462870|NCT02113982|363709656|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
105462871|NCT02113982|363709643|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
105663902|NCT01367847|364434779|FG001|Overall Study|Withdrawal by Subject|2|||
105663903|NCT00953147|364434780|FG000|Overall Study|Adverse Event|8|||
105785444|NCT00509223|364868464|FG001|Overall Study|Lost to Follow-up|1|||
105663904|NCT00953147|364434781|FG001|Overall Study|Adverse Event|16|||
105785445|NCT00509223|364868463|FG000|Overall Study|Adverse Event|1|||
105785446|NCT00509223|364868464|FG001|Overall Study|Adverse Event|1|||
105785447|NCT00509223|364868463|FG000|Overall Study|Withdrawal by Subject|25|||
105785448|NCT00509223|364868464|FG001|Overall Study|Withdrawal by Subject|6|||
105785449|NCT00509223|364868463|FG000|Overall Study|Including: subject change of address|5|||
105785450|NCT00509223|364868464|FG001|Overall Study|Including: subject change of address|2|||
105785451|NCT00509223|364868463|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
105785452|NCT00509223|364868464|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
105785453|NCT00198107|364868465|FG000|Double-Blind Period|Adverse Event|1|||
105785454|NCT00198107|364868466|FG001|Double-Blind Period|Adverse Event|1|||
105785455|NCT00198107|364868467|FG002|Double-Blind Period|Adverse Event|0|||
105785456|NCT00198107|364868465|FG000|Double-Blind Period|Lack of Efficacy|2|||
105785457|NCT00198107|364868466|FG001|Double-Blind Period|Lack of Efficacy|0|||
105785458|NCT00198107|364868467|FG002|Double-Blind Period|Lack of Efficacy|0|||
105785459|NCT00198107|364868465|FG000|Double-Blind Period|Lost to Follow-up|2|||
105785460|NCT00198107|364868466|FG001|Double-Blind Period|Lost to Follow-up|1|||
105785461|NCT00198107|364868467|FG002|Double-Blind Period|Lost to Follow-up|0|||
105785462|NCT00198107|364868465|FG000|Double-Blind Period|Physician Decision|1|||
105785463|NCT00198107|364868466|FG001|Double-Blind Period|Physician Decision|0|||
105785464|NCT00198107|364868467|FG002|Double-Blind Period|Physician Decision|0|||
105785465|NCT00198107|364868465|FG000|Double-Blind Period|Withdrawal by Subject|0|||
105785466|NCT00198107|364868466|FG001|Double-Blind Period|Withdrawal by Subject|1|||
105785467|NCT00198107|364868467|FG002|Double-Blind Period|Withdrawal by Subject|0|||
105785468|NCT00198107|364868465|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
105785469|NCT00198107|364868466|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
105785470|NCT00198107|364868467|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
105785471|NCT02513732|364868468|FG000|Overall Study|Lost to Follow-up|11|||
105785472|NCT02513732|364868468|FG000|Overall Study|Death|9|||
105551066|NCT03701555|364017186|FG032|Part 3 (Day 1)|Subject Decision|1|||
105551067|NCT03701555|364017187|FG033|Part 3 (Day 1)|Subject Decision|1|||
105551068|NCT03701555|364017188|FG034|Part 3 (Day 1)|Subject Decision|0|||
105551069|NCT03701555|364017189|FG035|Part 3 (Day 1)|Subject Decision|0|||
105551070|NCT03701555|364017154|FG000|Part 3 (Day 1)|Other|0|||
105551071|NCT03701555|364017155|FG001|Part 3 (Day 1)|Other|0|||
105551072|NCT03701555|364017156|FG002|Part 3 (Day 1)|Other|0|||
105551073|NCT03701555|364017157|FG003|Part 3 (Day 1)|Other|0|||
105551074|NCT03701555|364017158|FG004|Part 3 (Day 1)|Other|0|||
105551075|NCT03701555|364017159|FG005|Part 3 (Day 1)|Other|0|||
105551076|NCT03701555|364017160|FG006|Part 3 (Day 1)|Other|0|||
105551077|NCT03701555|364017161|FG007|Part 3 (Day 1)|Other|0|||
105551078|NCT03701555|364017162|FG008|Part 3 (Day 1)|Other|0|||
105551079|NCT03701555|364017163|FG009|Part 3 (Day 1)|Other|0|||
105551080|NCT03701555|364017164|FG010|Part 3 (Day 1)|Other|0|||
105551081|NCT03701555|364017165|FG011|Part 3 (Day 1)|Other|0|||
105551082|NCT03701555|364017166|FG012|Part 3 (Day 1)|Other|0|||
105551083|NCT03701555|364017167|FG013|Part 3 (Day 1)|Other|0|||
105551084|NCT03701555|364017168|FG014|Part 3 (Day 1)|Other|0|||
105551085|NCT03701555|364017169|FG015|Part 3 (Day 1)|Other|0|||
105551086|NCT03701555|364017170|FG016|Part 3 (Day 1)|Other|0|||
105551087|NCT03701555|364017171|FG017|Part 3 (Day 1)|Other|0|||
105551088|NCT03701555|364017172|FG018|Part 3 (Day 1)|Other|0|||
105551089|NCT03701555|364017173|FG019|Part 3 (Day 1)|Other|0|||
105551090|NCT03701555|364017174|FG020|Part 3 (Day 1)|Other|0|||
105551091|NCT03701555|364017175|FG021|Part 3 (Day 1)|Other|0|||
105551092|NCT03701555|364017176|FG022|Part 3 (Day 1)|Other|0|||
105551093|NCT03701555|364017177|FG023|Part 3 (Day 1)|Other|0|||
105551094|NCT03701555|364017178|FG024|Part 3 (Day 1)|Other|1|||
105551095|NCT03701555|364017179|FG025|Part 3 (Day 1)|Other|1|||
105663905|NCT00953147|364434782|FG002|Overall Study|Adverse Event|6|||
105663906|NCT00953147|364434780|FG000|Overall Study|Protocol Violation|2|||
105663907|NCT00953147|364434781|FG001|Overall Study|Protocol Violation|8|||
105663908|NCT00953147|364434782|FG002|Overall Study|Protocol Violation|4|||
105663909|NCT00953147|364434780|FG000|Overall Study|Withdrawal by Subject|13|||
105663910|NCT00953147|364434781|FG001|Overall Study|Withdrawal by Subject|15|||
105663911|NCT00953147|364434782|FG002|Overall Study|Withdrawal by Subject|12|||
105663912|NCT00953147|364434780|FG000|Overall Study|Lost to Follow-up|8|||
105663913|NCT00953147|364434781|FG001|Overall Study|Lost to Follow-up|9|||
105663914|NCT00953147|364434782|FG002|Overall Study|Lost to Follow-up|4|||
105663915|NCT00953147|364434780|FG000|Overall Study|Physician Decision|2|||
105663916|NCT00953147|364434781|FG001|Overall Study|Physician Decision|7|||
105663917|NCT00953147|364434782|FG002|Overall Study|Physician Decision|3|||
105663918|NCT00953147|364434780|FG000|Overall Study|Other|4|||
105663919|NCT00953147|364434781|FG001|Overall Study|Other|11|||
105663920|NCT00953147|364434782|FG002|Overall Study|Other|13|||
105663921|NCT04367480|364434783|FG000|Overall Study|Adverse Event|1|||
105663922|NCT04367480|364434784|FG001|Overall Study|Adverse Event|1|||
105663923|NCT04367480|364434783|FG000|Overall Study|Death|1|||
105663924|NCT04367480|364434784|FG001|Overall Study|Death|0|||
105663925|NCT04367480|364434783|FG000|Overall Study|Lost to Follow-up|1|||
105663926|NCT04367480|364434784|FG001|Overall Study|Lost to Follow-up|1|||
105663927|NCT04367480|364434783|FG000|Overall Study|Withdrawal by Subject|0|||
105663928|NCT04367480|364434784|FG001|Overall Study|Withdrawal by Subject|3|||
105663929|NCT04367480|364434783|FG000|Overall Study|App glitch during the study|1|||
105663930|NCT04367480|364434784|FG001|Overall Study|App glitch during the study|0|||
105663931|NCT04367480|364434783|FG000|Overall Study|Device Distribution Error|0|||
105663932|NCT04367480|364434784|FG001|Overall Study|Device Distribution Error|2|||
105663933|NCT04367480|364434783|FG000|Overall Study|Ineligible after Randomization|0|||
105663934|NCT04367480|364434784|FG001|Overall Study|Ineligible after Randomization|1|||
105663935|NCT04367480|364434783|FG000|Overall Study|Other Medical Reasons|0|||
105663936|NCT04367480|364434784|FG001|Overall Study|Other Medical Reasons|2|||
105663937|NCT01245140|364434789|FG000|Overall Study|Adverse Event|1|||
105663938|NCT01245140|364434790|FG001|Overall Study|Adverse Event|3|||
105663939|NCT01245140|364434789|FG000|Overall Study|Lack of Efficacy|2|||
105663940|NCT01245140|364434790|FG001|Overall Study|Lack of Efficacy|4|||
105663941|NCT01245140|364434789|FG000|Overall Study|Protocol Violation|0|||
105663942|NCT01245140|364434790|FG001|Overall Study|Protocol Violation|1|||
105663943|NCT01245140|364434789|FG000|Overall Study|Withdrawal by Subject|0|||
105663944|NCT01245140|364434790|FG001|Overall Study|Withdrawal by Subject|1|||
105663945|NCT01245140|364434789|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
105663946|NCT01245140|364434790|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
105663947|NCT01150045|364434793|FG000|Overall Study|Protocol Violation|0|||
105663948|NCT01150045|364434794|FG001|Overall Study|Protocol Violation|1|||
105663949|NCT01150045|364434795|FG002|Overall Study|Protocol Violation|0|||
105663950|NCT01150045|364434796|FG003|Overall Study|Protocol Violation|1|||
105663951|NCT00634842|364434797|FG000|Overall Study|Adverse Event|2|||
105663952|NCT00634842|364434798|FG001|Overall Study|Adverse Event|3|||
105663953|NCT00634842|364434797|FG000|Overall Study|Protocol Violation|8|||
105663954|NCT00634842|364434798|FG001|Overall Study|Protocol Violation|4|||
105663955|NCT00634842|364434797|FG000|Overall Study|Move to another state|1|||
105663956|NCT00634842|364434798|FG001|Overall Study|Move to another state|0|||
105663957|NCT00634842|364434797|FG000|Overall Study|Inclusion criteria were not met|1|||
105663958|NCT00634842|364434798|FG001|Overall Study|Inclusion criteria were not met|0|||
105663959|NCT00634842|364434797|FG000|Overall Study|Lost to Follow-up|1|||
105663960|NCT00634842|364434798|FG001|Overall Study|Lost to Follow-up|2|||
105663961|NCT00634842|364434797|FG000|Overall Study|Physician Decision|1|||
105663962|NCT00634842|364434798|FG001|Overall Study|Physician Decision|0|||
105663963|NCT00634842|364434797|FG000|Overall Study|Withdrawal by Subject|1|||
105663964|NCT00634842|364434798|FG001|Overall Study|Withdrawal by Subject|3|||
105663965|NCT00634842|364434797|FG000|Overall Study|Lack of time and intolerance to drug|0|||
105663966|NCT00634842|364434798|FG001|Overall Study|Lack of time and intolerance to drug|1|||
105663967|NCT00634842|364434797|FG000|Overall Study|Discontinued due to injection|0|||
105551096|NCT03701555|364017180|FG026|Part 3 (Day 1)|Other|0|||
105551097|NCT03701555|364017181|FG027|Part 3 (Day 1)|Other|0|||
105551098|NCT03701555|364017182|FG028|Part 3 (Day 1)|Other|0|||
105551099|NCT03701555|364017183|FG029|Part 3 (Day 1)|Other|1|||
105551100|NCT03701555|364017184|FG030|Part 3 (Day 1)|Other|1|||
105551101|NCT03701555|364017185|FG031|Part 3 (Day 1)|Other|0|||
105551102|NCT03701555|364017186|FG032|Part 3 (Day 1)|Other|1|||
105551103|NCT03701555|364017187|FG033|Part 3 (Day 1)|Other|1|||
105551104|NCT03701555|364017188|FG034|Part 3 (Day 1)|Other|0|||
105551105|NCT03701555|364017189|FG035|Part 3 (Day 1)|Other|0|||
105551106|NCT04757649|364017190|FG000|Overall Study|Withdrawal by Subject|1|||
105551107|NCT04757649|364017190|FG000|Overall Study|Adverse Event|1|||
105551108|NCT01659021|364017193|FG000|Main Study|Adverse Event|2|||
105551109|NCT01659021|364017194|FG001|Main Study|Adverse Event|3|||
105551110|NCT01659021|364017193|FG000|Main Study|Lost to Follow-up|1|||
105551111|NCT01659021|364017194|FG001|Main Study|Lost to Follow-up|0|||
105551112|NCT01659021|364017193|FG000|Main Study|Unknown Reasons|2|||
105551113|NCT01659021|364017194|FG001|Main Study|Unknown Reasons|1|||
105551114|NCT01659021|364017193|FG000|Main Study|Physician Decision|34|||
105551115|NCT01659021|364017194|FG001|Main Study|Physician Decision|16|||
105551116|NCT01659021|364017193|FG000|Main Study|Withdrawal by Subject|19|||
105551117|NCT01659021|364017194|FG001|Main Study|Withdrawal by Subject|16|||
105551118|NCT01659021|364017193|FG000|Main Study|Study Terminated by Sponsor|16|||
105551119|NCT01659021|364017194|FG001|Main Study|Study Terminated by Sponsor|1|||
105551120|NCT01659021|364017193|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
105339523|NCT03030989|363245176|FG001|Overall Study|Fever|2|||
105339524|NCT03030989|363245175|FG000|Overall Study|Rash|2|||
105551121|NCT01659021|364017194|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
105551122|NCT01659021|364017193|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
105339525|NCT03030989|363245176|FG001|Overall Study|Rash|1|||
105551123|NCT01659021|364017194|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
105551124|NCT02508311|364017195|FG000|Overall Study|Withdrawal by Subject|1|||
105551125|NCT02508311|364017196|FG001|Overall Study|Withdrawal by Subject|0|||
105551126|NCT03551938|364017197|FG000|3-Month Follow Up|Lost to Follow-up|39|||
105785473|NCT02513732|364868468|FG000|Overall Study|Changing hospital|2|||
105785474|NCT00934661|364868469|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
105785475|NCT00934661|364868470|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
105785476|NCT00467051|364868471|FG000|Overall Study|Adverse Event|2|||
105785477|NCT01740297|364868472|FG000|Overall Study|Withdrawal by Subject|4|||
105785478|NCT01740297|364868473|FG001|Overall Study|Withdrawal by Subject|16|||
105785479|NCT01740297|364868474|FG002|Overall Study|Withdrawal by Subject|17|||
105785480|NCT01740297|364868472|FG000|Overall Study|Death|8|||
105785481|NCT01740297|364868473|FG001|Overall Study|Death|46|||
105785482|NCT01740297|364868474|FG002|Overall Study|Death|40|||
105785483|NCT01740297|364868472|FG000|Overall Study|Lost to Follow-up|1|||
105785484|NCT01740297|364868473|FG001|Overall Study|Lost to Follow-up|2|||
105785485|NCT01740297|364868474|FG002|Overall Study|Lost to Follow-up|4|||
105785486|NCT00761462|364868478|FG000|Treatment|Subjects never received study medication|23|||
105785487|NCT00761462|364868479|FG001|Treatment|Subjects never received study medication|12|||
105785488|NCT00761462|364868478|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
105785489|NCT00761462|364868479|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
105785490|NCT00761462|364868478|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
105785491|NCT00761462|364868479|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
105785492|NCT00761462|364868478|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
105785493|NCT00761462|364868479|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
105785494|NCT02383966|364868486|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
105785495|NCT02383966|364868487|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
105785496|NCT02383966|364868486|FG000|Overall Study|Randomized, but not treated|1|||
105785497|NCT02383966|364868487|FG001|Overall Study|Randomized, but not treated|3|||
105785498|NCT02163759|364868488|FG000|Overall Study|Withdrawal by Subject|1|||
105785499|NCT02163759|364868489|FG001|Overall Study|Withdrawal by Subject|5|||
105785500|NCT02163759|364868490|FG002|Overall Study|Withdrawal by Subject|1|||
105785501|NCT02163759|364868488|FG000|Overall Study|Adverse Event|0|||
105785502|NCT02163759|364868489|FG001|Overall Study|Adverse Event|0|||
105785503|NCT02163759|364868490|FG002|Overall Study|Adverse Event|1|||
105785504|NCT02163759|364868488|FG000|Overall Study|Death|0|||
105785505|NCT02163759|364868489|FG001|Overall Study|Death|0|||
105785506|NCT02163759|364868490|FG002|Overall Study|Death|1|||
105785507|NCT03996694|364868492|FG000|First Washout (7 Days)|positive urine drug screen|0|||
105785508|NCT03996694|364868493|FG001|First Washout (7 Days)|positive urine drug screen|0|||
105785509|NCT03996694|364868494|FG002|First Washout (7 Days)|positive urine drug screen|1|||
105785510|NCT03996694|364868495|FG003|First Washout (7 Days)|positive urine drug screen|0|||
105785511|NCT03996694|364868496|FG004|First Washout (7 Days)|positive urine drug screen|0|||
105785512|NCT03996694|364868497|FG005|First Washout (7 Days)|positive urine drug screen|0|||
105785513|NCT03996694|364868492|FG000|First Washout (7 Days)|Adverse Event|0|||
105785514|NCT03996694|364868493|FG001|First Washout (7 Days)|Adverse Event|1|||
105462872|NCT02113982|363709644|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
105462873|NCT02113982|363709645|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
105462874|NCT02113982|363709646|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
105462875|NCT02113982|363709647|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
105462876|NCT02113982|363709648|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
105462877|NCT02113982|363709649|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
105462878|NCT02113982|363709650|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
105462879|NCT02113982|363709651|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
105462880|NCT02113982|363709652|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
105462881|NCT02113982|363709653|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
105462882|NCT02113982|363709654|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
105462883|NCT02113982|363709655|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
105462884|NCT02113982|363709656|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
105462885|NCT02113982|363709643|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
105462886|NCT02113982|363709644|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
105462887|NCT02113982|363709645|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
105462888|NCT02113982|363709646|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
105462889|NCT02113982|363709647|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
105462890|NCT02113982|363709648|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
105462891|NCT02113982|363709649|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
105462892|NCT02113982|363709650|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
105462893|NCT02113982|363709651|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
105462894|NCT02113982|363709652|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
105462895|NCT02113982|363709653|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
105462896|NCT02113982|363709654|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
105462897|NCT02113982|363709655|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
105462898|NCT02113982|363709656|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
105462899|NCT02113982|363709643|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
105462900|NCT02113982|363709644|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
105462901|NCT02113982|363709645|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
105462902|NCT02113982|363709646|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
105462903|NCT02113982|363709647|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
105462904|NCT02113982|363709648|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
105462905|NCT02113982|363709649|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
105462906|NCT02113982|363709650|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
105462907|NCT02113982|363709651|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
105462908|NCT02113982|363709652|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
105462909|NCT02113982|363709653|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
105462910|NCT02113982|363709654|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
105462911|NCT02113982|363709655|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
105462912|NCT02113982|363709656|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
105462913|NCT02113982|363709643|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
105462914|NCT02113982|363709644|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
105462915|NCT02113982|363709645|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
105462916|NCT02113982|363709646|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
105462917|NCT02113982|363709647|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
105462918|NCT02113982|363709648|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
105462919|NCT02113982|363709649|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
105462920|NCT02113982|363709650|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
105462921|NCT02113982|363709651|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
105462922|NCT02113982|363709652|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
105462923|NCT02113982|363709653|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
105462924|NCT02113982|363709654|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
105462925|NCT02113982|363709655|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
105462926|NCT02113982|363709656|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
105462927|NCT02113982|363709643|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
105462928|NCT02113982|363709644|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
105462929|NCT02113982|363709645|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
105462930|NCT02113982|363709646|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
105462931|NCT02113982|363709647|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
105462932|NCT02113982|363709648|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
105462933|NCT02113982|363709649|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
105339526|NCT03030989|363245175|FG000|Overall Study|Fatigue/Overwhelmed|1|||
105339527|NCT03030989|363245176|FG001|Overall Study|Fatigue/Overwhelmed|5|||
105339528|NCT03030989|363245175|FG000|Overall Study|Positive Blood Cultures|2|||
105339529|NCT03030989|363245176|FG001|Overall Study|Positive Blood Cultures|1|||
105339530|NCT03030989|363245175|FG000|Overall Study|Line Removed|0|||
105339531|NCT03030989|363245176|FG001|Overall Study|Line Removed|2|||
105339532|NCT03030989|363245175|FG000|Overall Study|No longer interested|5|||
105339533|NCT03030989|363245176|FG001|Overall Study|No longer interested|3|||
105339534|NCT02706886|363245177|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
105339535|NCT02706886|363245178|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
105339536|NCT02706886|363245179|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
105339537|NCT02706886|363245180|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
105339538|NCT02706886|363245181|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
105339539|NCT02706886|363245182|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
105339540|NCT02706886|363245183|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
105339541|NCT02706886|363245184|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
105339542|NCT02706886|363245185|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
105339543|NCT01608087|363245193|FG000|Overall Study|Lost to Follow-up|0|||
105339544|NCT01608087|363245194|FG001|Overall Study|Lost to Follow-up|1|||
105339545|NCT01608087|363245195|FG002|Overall Study|Lost to Follow-up|0|||
105339546|NCT01608087|363245193|FG000|Overall Study|Other Reason|0|||
105339547|NCT01608087|363245194|FG001|Overall Study|Other Reason|1|||
105339548|NCT01608087|363245195|FG002|Overall Study|Other Reason|0|||
105339549|NCT00970632|363245196|FG000|Overall Study|Adverse Event|2|||
105339550|NCT00970632|363245197|FG001|Overall Study|Adverse Event|2|||
105339551|NCT00970632|363245198|FG002|Overall Study|Adverse Event|1|||
105339552|NCT00970632|363245196|FG000|Overall Study|Lack of Efficacy|3|||
105339553|NCT00970632|363245197|FG001|Overall Study|Lack of Efficacy|0|||
105339554|NCT00970632|363245198|FG002|Overall Study|Lack of Efficacy|0|||
105339555|NCT00970632|363245196|FG000|Overall Study|Lost to Follow-up|3|||
105339556|NCT00970632|363245197|FG001|Overall Study|Lost to Follow-up|0|||
105339557|NCT00970632|363245198|FG002|Overall Study|Lost to Follow-up|2|||
105462934|NCT02113982|363709650|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
105462935|NCT02113982|363709651|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
105462936|NCT02113982|363709652|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
105462937|NCT02113982|363709653|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
105663968|NCT00634842|364434798|FG001|Overall Study|Discontinued due to injection|2|||
105663969|NCT00634842|364434797|FG000|Overall Study|No need of study drug to treat diabetes|0|||
105663970|NCT00634842|364434798|FG001|Overall Study|No need of study drug to treat diabetes|1|||
105339558|NCT00970632|363245196|FG000|Overall Study|Protocol Violation|8|||
105339559|NCT00970632|363245197|FG001|Overall Study|Protocol Violation|5|||
105339560|NCT00970632|363245198|FG002|Overall Study|Protocol Violation|8|||
105339561|NCT00970632|363245196|FG000|Overall Study|Withdrawal by Subject|7|||
105462938|NCT02113982|363709654|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
105339562|NCT00970632|363245197|FG001|Overall Study|Withdrawal by Subject|6|||
105339563|NCT00970632|363245198|FG002|Overall Study|Withdrawal by Subject|4|||
105339564|NCT00970632|363245196|FG000|Overall Study|Entry criteria not met|0|||
105462939|NCT02113982|363709655|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
105462940|NCT02113982|363709656|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
105462941|NCT02113982|363709643|FG000|Stage 2: Cohort Expansion|Transplant|0|||
105462942|NCT02113982|363709644|FG001|Stage 2: Cohort Expansion|Transplant|0|||
105462943|NCT02113982|363709645|FG002|Stage 2: Cohort Expansion|Transplant|0|||
105462944|NCT02113982|363709646|FG003|Stage 2: Cohort Expansion|Transplant|0|||
105462945|NCT02113982|363709647|FG004|Stage 2: Cohort Expansion|Transplant|0|||
105462946|NCT02113982|363709648|FG005|Stage 2: Cohort Expansion|Transplant|0|||
105462947|NCT02113982|363709649|FG006|Stage 2: Cohort Expansion|Transplant|0|||
105462948|NCT02113982|363709650|FG007|Stage 2: Cohort Expansion|Transplant|0|||
105462949|NCT02113982|363709651|FG008|Stage 2: Cohort Expansion|Transplant|0|||
105462950|NCT02113982|363709652|FG009|Stage 2: Cohort Expansion|Transplant|4|||
105462951|NCT02113982|363709653|FG010|Stage 2: Cohort Expansion|Transplant|2|||
105462952|NCT02113982|363709654|FG011|Stage 2: Cohort Expansion|Transplant|0|||
105462953|NCT02113982|363709655|FG012|Stage 2: Cohort Expansion|Transplant|0|||
105462954|NCT02113982|363709656|FG013|Stage 2: Cohort Expansion|Transplant|0|||
105462955|NCT02113982|363709643|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
105462956|NCT02113982|363709644|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
105462957|NCT02113982|363709645|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
105462958|NCT02113982|363709646|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
105462959|NCT02113982|363709647|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
105462960|NCT02113982|363709648|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
105462961|NCT02113982|363709649|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
105462962|NCT02113982|363709650|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
105462963|NCT02113982|363709651|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
105462964|NCT02113982|363709652|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
105663971|NCT00634842|364434797|FG000|Overall Study|No wish to keep taking Avandia|0|||
105785515|NCT03996694|364868494|FG002|First Washout (7 Days)|Adverse Event|0|||
105785516|NCT03996694|364868495|FG003|First Washout (7 Days)|Adverse Event|0|||
105462965|NCT02113982|363709653|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
105462966|NCT02113982|363709654|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
105462967|NCT02113982|363709655|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
105462968|NCT02113982|363709656|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
105785517|NCT03996694|364868496|FG004|First Washout (7 Days)|Adverse Event|0|||
105785518|NCT03996694|364868497|FG005|First Washout (7 Days)|Adverse Event|0|||
105785519|NCT03996694|364868492|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
105785520|NCT03996694|364868493|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
105785521|NCT03996694|364868494|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
105785522|NCT03996694|364868495|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
105785523|NCT03996694|364868496|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
105785524|NCT03996694|364868497|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
105785525|NCT03996694|364868492|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
105785526|NCT03996694|364868493|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
105785527|NCT03996694|364868494|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
105785528|NCT03996694|364868495|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
105785529|NCT03996694|364868496|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
105785530|NCT03996694|364868497|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
105785531|NCT00665366|364868506|FG000|Overall Study|Lack of Efficacy|11|||
105785532|NCT00665366|364868507|FG001|Overall Study|Lack of Efficacy|10|||
105785533|NCT00665366|364868506|FG000|Overall Study|Adverse Event|25|||
105785534|NCT00665366|364868507|FG001|Overall Study|Adverse Event|23|||
105785535|NCT00665366|364868506|FG000|Overall Study|Withdrawal by Subject|11|||
105785536|NCT00665366|364868507|FG001|Overall Study|Withdrawal by Subject|14|||
105785537|NCT00665366|364868506|FG000|Overall Study|Lost to Follow-up|3|||
105785538|NCT00665366|364868507|FG001|Overall Study|Lost to Follow-up|5|||
105785539|NCT00665366|364868506|FG000|Overall Study|Poor compliance/noncompliance|3|||
105785540|NCT00665366|364868507|FG001|Overall Study|Poor compliance/noncompliance|5|||
105785541|NCT00665366|364868506|FG000|Overall Study|Pregnancy|1|||
105785542|NCT00665366|364868507|FG001|Overall Study|Pregnancy|0|||
105785543|NCT00665366|364868506|FG000|Overall Study|No longer meets study criteria|0|||
105785544|NCT00665366|364868507|FG001|Overall Study|No longer meets study criteria|1|||
105785545|NCT00665366|364868506|FG000|Overall Study|Other reasons|4|||
105785546|NCT00665366|364868507|FG001|Overall Study|Other reasons|1|||
105785547|NCT03628781|364868511|FG000|Overall Study|Lost to Follow-up|16|||
105785548|NCT03628781|364868512|FG001|Overall Study|Lost to Follow-up|8|||
105785549|NCT03628781|364868511|FG000|Overall Study|Withdrawal by Subject|16|||
105785550|NCT03628781|364868512|FG001|Overall Study|Withdrawal by Subject|1|||
105785551|NCT03575806|364868517|FG000|Overall Study|Withdrawal by Subject|0|||
105785552|NCT03575806|364868518|FG001|Overall Study|Withdrawal by Subject|2|||
105339565|NCT00970632|363245197|FG001|Overall Study|Entry criteria not met|2|||
105339566|NCT00970632|363245198|FG002|Overall Study|Entry criteria not met|2|||
105339567|NCT00970632|363245196|FG000|Overall Study|Sponsor decision|1|||
105339568|NCT00970632|363245197|FG001|Overall Study|Sponsor decision|0|||
105663972|NCT00634842|364434798|FG001|Overall Study|No wish to keep taking Avandia|1|||
105339569|NCT00970632|363245198|FG002|Overall Study|Sponsor decision|1|||
105339570|NCT02222545|363245211|FG000|Overall Study|Adverse Event|1|||
105339571|NCT02222545|363245212|FG001|Overall Study|Adverse Event|0|||
105339572|NCT02222545|363245213|FG002|Overall Study|Adverse Event|2|||
105339573|NCT02222545|363245211|FG000|Overall Study|Death|0|||
105339574|NCT02222545|363245212|FG001|Overall Study|Death|0|||
105339575|NCT02222545|363245213|FG002|Overall Study|Death|9|||
105339576|NCT02222545|363245211|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
105339577|NCT02222545|363245212|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
105339578|NCT02222545|363245213|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
105339579|NCT02222545|363245211|FG000|Overall Study|Withdrawal by Subject|0|||
105339580|NCT02222545|363245212|FG001|Overall Study|Withdrawal by Subject|0|||
105339581|NCT02222545|363245213|FG002|Overall Study|Withdrawal by Subject|3|||
105339582|NCT02222545|363245211|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
105339583|NCT02222545|363245212|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
105339584|NCT02222545|363245213|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
105339585|NCT03875482|363245214|FG000|Overall Study|Adverse Event|0|||
105339586|NCT03875482|363245215|FG001|Overall Study|Adverse Event|1|||
105339587|NCT03875482|363245214|FG000|Overall Study|Withdrew consent|5|||
105339588|NCT03875482|363245215|FG001|Overall Study|Withdrew consent|6|||
105339589|NCT03875482|363245214|FG000|Overall Study|Lost to Follow-up|8|||
105339590|NCT03875482|363245215|FG001|Overall Study|Lost to Follow-up|2|||
105339591|NCT03875482|363245214|FG000|Overall Study|Lack of Efficacy|0|||
105339592|NCT03875482|363245215|FG001|Overall Study|Lack of Efficacy|11|||
105339593|NCT02137850|363245216|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
105339594|NCT02137850|363245217|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
105339595|NCT02137850|363245218|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
105663973|NCT00634842|364434797|FG000|Overall Study|Subject off study drug for too long|0|||
105339596|NCT02137850|363245216|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
105339597|NCT02137850|363245217|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
105339598|NCT02137850|363245218|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
105339599|NCT02137850|363245216|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
105339600|NCT02137850|363245217|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
105339601|NCT02137850|363245218|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
105339602|NCT02137850|363245216|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
105339603|NCT02137850|363245217|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
105339604|NCT02137850|363245218|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
105339605|NCT02137850|363245216|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
105339606|NCT02137850|363245217|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
105339607|NCT02137850|363245218|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
105339608|NCT02137850|363245216|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
105339609|NCT02137850|363245217|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
105339610|NCT02137850|363245218|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
105339611|NCT02137850|363245216|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
105339612|NCT02137850|363245217|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
105339613|NCT02137850|363245218|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
105339614|NCT02137850|363245216|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
105339615|NCT02137850|363245217|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
105339616|NCT02137850|363245218|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
105339617|NCT02137850|363245216|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
105663974|NCT00634842|364434798|FG001|Overall Study|Subject off study drug for too long|1|||
105663975|NCT01594827|364434800|FG000|Overall Study|Adverse Event|1|||
105663976|NCT01594827|364434801|FG001|Overall Study|Adverse Event|0|||
105663977|NCT01594827|364434800|FG000|Overall Study|Physician Decision|3|||
105663978|NCT01594827|364434801|FG001|Overall Study|Physician Decision|0|||
105663979|NCT03210519|364434802|FG000|Overall Study|Adverse Event|2|||
105663980|NCT03210519|364434803|FG001|Overall Study|Adverse Event|0|||
105663981|NCT04351269|364434804|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
105663982|NCT04351269|364434805|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
105663983|NCT04351269|364434806|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
105663984|NCT04351269|364434804|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
105663985|NCT04351269|364434805|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
105663986|NCT04351269|364434806|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
105663987|NCT04351269|364434804|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
105663988|NCT04351269|364434805|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
105663989|NCT04351269|364434806|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
105663990|NCT04351269|364434804|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
105663991|NCT04351269|364434805|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
105663992|NCT04351269|364434806|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
105663993|NCT04351269|364434804|FG000|Overall Study|Lost to Follow-up|1|||
105663994|NCT04351269|364434805|FG001|Overall Study|Lost to Follow-up|3|||
105663995|NCT04351269|364434806|FG002|Overall Study|Lost to Follow-up|0|||
105663996|NCT01677299|364434807|FG000|Overall Study|Adverse Event|0|||
105663997|NCT01677299|364434808|FG001|Overall Study|Adverse Event|2|||
105663998|NCT01677299|364434809|FG002|Overall Study|Adverse Event|1|||
105663999|NCT01677299|364434810|FG003|Overall Study|Adverse Event|0|||
105664000|NCT01677299|364434807|FG000|Overall Study|Withdrawal by Subject|0|||
105664001|NCT01677299|364434808|FG001|Overall Study|Withdrawal by Subject|1|||
105664002|NCT01677299|364434809|FG002|Overall Study|Withdrawal by Subject|0|||
105664003|NCT01677299|364434810|FG003|Overall Study|Withdrawal by Subject|1|||
105664004|NCT00174447|364434816|FG000|Overall Study|Adverse Event|19|||
105664005|NCT00174447|364434816|FG000|Overall Study|Withdrawal by Subject|15|||
105664006|NCT00174447|364434816|FG000|Overall Study|Protocol Violation|1|||
105664007|NCT00174447|364434816|FG000|Overall Study|Lack of Efficacy|1|||
105664008|NCT00174447|364434816|FG000|Overall Study|Administrative reason/Other|2|||
105664009|NCT01013961|364434817|FG000|Overall Study|Adverse Event|2|||
105664010|NCT01013961|364434818|FG001|Overall Study|Adverse Event|2|||
105664011|NCT01013961|364434817|FG000|Overall Study|Withdrawal by Subject|1|||
105664012|NCT01013961|364434818|FG001|Overall Study|Withdrawal by Subject|0|||
105664013|NCT01013961|364434817|FG000|Overall Study|Physician Decision|0|||
105664014|NCT01013961|364434818|FG001|Overall Study|Physician Decision|1|||
105664015|NCT02879383|364434819|FG000|First 24 Weeks|Physician Decision|0|||
105664016|NCT02879383|364434820|FG001|First 24 Weeks|Physician Decision|1|||
105664017|NCT02879383|364434821|FG002|First 24 Weeks|Physician Decision|0|||
105664018|NCT02879383|364434822|FG003|First 24 Weeks|Physician Decision|0|||
105664019|NCT00609947|364434825|FG000|Overall Study|Death|1|||
105664020|NCT03603639|364434826|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
105664021|NCT03603639|364434827|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
105664022|NCT03603639|364434828|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
105664023|NCT03603639|364434829|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
105664024|NCT03603639|364434830|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
105664025|NCT03603639|364434831|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
105664026|NCT03603639|364434826|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
105664027|NCT03603639|364434827|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
105664028|NCT03603639|364434828|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
105664029|NCT03603639|364434829|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
105664030|NCT03603639|364434830|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
105664031|NCT03603639|364434831|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
105664032|NCT02643628|364434835|FG000|Overall Study|Lost to Follow-up|1|||
105664033|NCT02643628|364434836|FG001|Overall Study|Lost to Follow-up|4|||
105664034|NCT02643628|364434835|FG000|Overall Study|Withdrawal by Subject|0|||
105664035|NCT02643628|364434836|FG001|Overall Study|Withdrawal by Subject|1|||
105664036|NCT02643628|364434835|FG000|Overall Study|Relocated out of state|0|||
105664037|NCT02643628|364434836|FG001|Overall Study|Relocated out of state|1|||
105664038|NCT04042077|364434838|FG000|Overall Study|Adverse Event|0|||
105664039|NCT04042077|364434839|FG001|Overall Study|Adverse Event|1|||
105664040|NCT04042077|364434838|FG000|Overall Study|Death|2|||
105664041|NCT04042077|364434839|FG001|Overall Study|Death|1|||
105664042|NCT04042077|364434838|FG000|Overall Study|Physician Decision|2|||
105664043|NCT04042077|364434839|FG001|Overall Study|Physician Decision|0|||
105664044|NCT04042077|364434838|FG000|Overall Study|Withdrawal by Subject|3|||
105664045|NCT04042077|364434839|FG001|Overall Study|Withdrawal by Subject|2|||
105664046|NCT04042077|364434838|FG000|Overall Study|Lack of Efficacy|0|||
105664047|NCT04042077|364434839|FG001|Overall Study|Lack of Efficacy|1|||
105664048|NCT03482752|364434840|FG000|Overall Study|Withdrawal by Subject|2|||
105664049|NCT03482752|364434840|FG000|Overall Study|Lost to Follow-up|1|||
105664050|NCT03482752|364434840|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
105664051|NCT01807182|364434841|FG000|Overall Study|Death|1|||
105664052|NCT01807182|364434841|FG000|Overall Study|New therapy|1|||
105664053|NCT01807182|364434841|FG000|Overall Study|Moved to hospice care|1|||
105664054|NCT00478205|364434843|FG000|Overall Study|Adverse Event|182|||
105664055|NCT00478205|364434844|FG001|Overall Study|Adverse Event|39|||
105664056|NCT00478205|364434843|FG000|Overall Study|Medication Non-compliance|9|||
105664057|NCT00478205|364434844|FG001|Overall Study|Medication Non-compliance|4|||
105664058|NCT00478205|364434843|FG000|Overall Study|Protocol Violation|15|||
105664059|NCT00478205|364434844|FG001|Overall Study|Protocol Violation|5|||
105664060|NCT00478205|364434843|FG000|Overall Study|Request of Investigator or Sponsor|4|||
105664061|NCT00478205|364434844|FG001|Overall Study|Request of Investigator or Sponsor|5|||
105664062|NCT00478205|364434843|FG000|Overall Study|Withdrawal by Subject|61|||
105664063|NCT00478205|364434844|FG001|Overall Study|Withdrawal by Subject|22|||
105664064|NCT00478205|364434843|FG000|Overall Study|Lack of Efficacy|1|||
105664065|NCT00478205|364434844|FG001|Overall Study|Lack of Efficacy|0|||
105664066|NCT00478205|364434843|FG000|Overall Study|Other|24|||
105664067|NCT00478205|364434844|FG001|Overall Study|Other|12|||
105664068|NCT02344342|364434847|FG000|Overall Study|Industry partner dropped out|11|||
105664069|NCT02344342|364434848|FG001|Overall Study|Industry partner dropped out|9|||
105664070|NCT02344342|364434849|FG002|Overall Study|Industry partner dropped out|14|||
105551127|NCT03551938|364017198|FG001|3-Month Follow Up|Lost to Follow-up|38|||
105551128|NCT03551938|364017197|FG000|6-Month Follow Up|Lost to Follow-up|46|||
105551129|NCT03551938|364017198|FG001|6-Month Follow Up|Lost to Follow-up|42|||
105551130|NCT03551938|364017197|FG000|9-Month Follow Up|Lost to Follow-up|44|||
105551131|NCT03551938|364017198|FG001|9-Month Follow Up|Lost to Follow-up|43|||
105551132|NCT02169674|364017199|FG000|Overall Study|Withdrawal by Subject|2|||
105551133|NCT02169674|364017200|FG001|Overall Study|Withdrawal by Subject|1|||
105551134|NCT02169674|364017199|FG000|Overall Study|Seroprotected|30|||
105551135|NCT02169674|364017200|FG001|Overall Study|Seroprotected|76|||
105551136|NCT02169674|364017199|FG000|Overall Study|Lost to Follow-up|0|||
105551137|NCT02169674|364017200|FG001|Overall Study|Lost to Follow-up|1|||
105551138|NCT00695903|364017201|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
105551139|NCT00695903|364017202|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
105551140|NCT00695903|364017201|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
105551141|NCT00695903|364017202|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
105551142|NCT00695903|364017201|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
105551143|NCT00695903|364017202|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
105551144|NCT00695903|364017201|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
105551145|NCT00695903|364017202|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
105551146|NCT00695903|364017201|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
105551147|NCT00695903|364017202|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
105551148|NCT00695903|364017201|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
105551149|NCT00695903|364017202|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
105551150|NCT00695903|364017201|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
105551151|NCT00695903|364017202|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
105551152|NCT00695903|364017201|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
105551153|NCT00695903|364017202|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
105551154|NCT00695903|364017201|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
105551155|NCT00695903|364017202|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
105551156|NCT01296568|364017203|FG000|Continued Access Phase|Lost to Follow-up|1|||
105551157|NCT01296568|364017203|FG000|Continued Access Phase|Withdrawal by Subject|1|||
105551158|NCT01296568|364017203|FG000|Continued Access Phase|Disease Progression|1|||
105551159|NCT04137380|364017208|FG000|Overall Study|Physician Decision|0|||
105551160|NCT04137380|364017209|FG001|Overall Study|Physician Decision|0|||
105551161|NCT04137380|364017210|FG002|Overall Study|Physician Decision|0|||
105551162|NCT04137380|364017211|FG003|Overall Study|Physician Decision|1|||
105551163|NCT04137380|364017212|FG004|Overall Study|Physician Decision|0|||
105664071|NCT02344342|364434850|FG003|Overall Study|Industry partner dropped out|10|||
105664072|NCT00762476|364434851|FG000|Overall Study|Adverse Event|7|||
105664073|NCT00762476|364434852|FG001|Overall Study|Adverse Event|1|||
105664074|NCT00762476|364434851|FG000|Overall Study|Lost to Follow-up|2|||
105664075|NCT00762476|364434852|FG001|Overall Study|Lost to Follow-up|0|||
105664076|NCT00762476|364434851|FG000|Overall Study|Protocol Violation|5|||
105664077|NCT00762476|364434852|FG001|Overall Study|Protocol Violation|6|||
105664078|NCT00762476|364434851|FG000|Overall Study|Physician Decision|2|||
105664079|NCT00762476|364434852|FG001|Overall Study|Physician Decision|14|||
105664080|NCT00762476|364434851|FG000|Overall Study|Withdrawal by Subject|6|||
105664081|NCT00762476|364434852|FG001|Overall Study|Withdrawal by Subject|12|||
105664082|NCT00762476|364434851|FG000|Overall Study|antibiotic use|0|||
105664083|NCT00762476|364434852|FG001|Overall Study|antibiotic use|1|||
105664084|NCT00762476|364434851|FG000|Overall Study|non-compliance with study visits|0|||
105664085|NCT00762476|364434852|FG001|Overall Study|non-compliance with study visits|2|||
105664086|NCT00762476|364434851|FG000|Overall Study|Seasonal allergies|1|||
105664087|NCT00762476|364434852|FG001|Overall Study|Seasonal allergies|0|||
105664088|NCT02838134|364434854|FG000|Overall Study|Lost to Follow-up|1|||
105664089|NCT02838134|364434855|FG001|Overall Study|Lost to Follow-up|2|||
105664090|NCT02838134|364434854|FG000|Overall Study|logistic problems|1|||
105664091|NCT02838134|364434855|FG001|Overall Study|logistic problems|1|||
105664092|NCT00794924|364434856|FG000|Overall Study|Lost to Follow-up|6|||
105664093|NCT00794924|364434857|FG001|Overall Study|Lost to Follow-up|8|||
105664094|NCT00794924|364434856|FG000|Overall Study|Withdrawal by Subject|48|||
105664095|NCT00794924|364434857|FG001|Overall Study|Withdrawal by Subject|60|||
105664096|NCT00794924|364434856|FG000|Overall Study|Adverse Event|6|||
105664097|NCT00794924|364434857|FG001|Overall Study|Adverse Event|2|||
105664098|NCT01594970|364434858|FG000|Overall Study|Non-Adverse Event Related|4|||
105664099|NCT01594970|364434859|FG001|Overall Study|Non-Adverse Event Related|5|||
105664100|NCT01594970|364434860|FG002|Overall Study|Non-Adverse Event Related|6|||
105664101|NCT01594970|364434858|FG000|Overall Study|Adverse Event|17|||
105664102|NCT01594970|364434859|FG001|Overall Study|Adverse Event|23|||
105664103|NCT01594970|364434860|FG002|Overall Study|Adverse Event|23|||
105664104|NCT01594970|364434858|FG000|Overall Study|Lost to Follow-up|54|||
105664105|NCT01594970|364434859|FG001|Overall Study|Lost to Follow-up|54|||
105664106|NCT01594970|364434860|FG002|Overall Study|Lost to Follow-up|37|||
105664107|NCT00617929|364434861|FG000|Overall Study|Physician Decision|1|||
105664108|NCT03229486|364434862|FG000|Overall Study|Protocol Violation|0|||
105664109|NCT03229486|364434863|FG001|Overall Study|Protocol Violation|1|||
105664110|NCT02296892|364434864|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
105664111|NCT02296892|364434865|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
105664112|NCT02296892|364434866|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
105664113|NCT02296892|364434864|FG000|Overall Study|Lost to Follow-up|5|||
105664114|NCT02296892|364434865|FG001|Overall Study|Lost to Follow-up|0|||
105664115|NCT02296892|364434866|FG002|Overall Study|Lost to Follow-up|1|||
105664116|NCT00585078|364434867|FG000|Overall Study|Withdrawal by Subject|4|||
105664117|NCT00585078|364434867|FG000|Overall Study|Poor performance status|1|||
105664118|NCT00585078|364434867|FG000|Overall Study|Disease Progression|24|||
105664119|NCT00585078|364434867|FG000|Overall Study|Adverse Event|10|||
105664120|NCT00585078|364434867|FG000|Overall Study|Death|1|||
105664121|NCT00455741|364434868|FG000|Overall Study|Physician Decision|0|||
105664122|NCT00455741|364434869|FG001|Overall Study|Physician Decision|1|||
105664123|NCT00243074|364434870|FG000|Overall Study|Ineligible|6|||
105664124|NCT00243074|364434870|FG000|Overall Study|Adverse Event|6|||
105664125|NCT00243074|364434870|FG000|Overall Study|Withdrawal by Subject|2|||
105664126|NCT00243074|364434870|FG000|Overall Study|Lack of Efficacy|36|||
105664127|NCT00243074|364434870|FG000|Overall Study|Death|2|||
105664128|NCT00243074|364434870|FG000|Overall Study|not protocol specified|1|||
105664129|NCT00243074|364434870|FG000|Overall Study|Did not receive any treatment|1|||
105664130|NCT02336425|364434871|FG000|Overall Study|Study terminated.|2|||
105664131|NCT02336425|364434872|FG001|Overall Study|Study terminated.|2|||
105664132|NCT02336425|364434873|FG002|Overall Study|Study terminated.|3|||
105664133|NCT02336425|364434874|FG003|Overall Study|Study terminated.|3|||
105664134|NCT04641962|364434875|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
105664135|NCT04641962|364434876|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
105664136|NCT04641962|364434877|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
105664137|NCT04641962|364434878|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
105664138|NCT04641962|364434879|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
105664139|NCT04641962|364434875|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
105664140|NCT04641962|364434876|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
105664141|NCT04641962|364434877|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
105664142|NCT04641962|364434878|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
105664143|NCT04641962|364434879|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
105664144|NCT04641962|364434875|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
105664145|NCT04641962|364434876|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
105664146|NCT04641962|364434877|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
105664147|NCT04641962|364434878|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
105664148|NCT04641962|364434879|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
105664149|NCT04641962|364434875|FG000|DBT Period: Up to 52 Weeks|Death|1|||
105664150|NCT04641962|364434876|FG001|DBT Period: Up to 52 Weeks|Death|0|||
105664151|NCT04641962|364434877|FG002|DBT Period: Up to 52 Weeks|Death|0|||
105339618|NCT02137850|363245217|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
105339619|NCT02137850|363245218|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
105339620|NCT02137850|363245216|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
105339621|NCT02137850|363245217|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
105339622|NCT02137850|363245218|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
105339623|NCT02137850|363245216|FG000|Main Phase: Prophylaxis|Other|0|||
105339624|NCT02137850|363245217|FG001|Main Phase: Prophylaxis|Other|1|||
105664152|NCT04641962|364434878|FG003|DBT Period: Up to 52 Weeks|Death|0|||
105664153|NCT04641962|364434879|FG004|DBT Period: Up to 52 Weeks|Death|0|||
105664154|NCT04641962|364434875|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
105339625|NCT02137850|363245218|FG002|Main Phase: Prophylaxis|Other|0|||
105339626|NCT02137850|363245216|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
105339627|NCT02137850|363245217|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
105664155|NCT04641962|364434876|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
105664156|NCT04641962|364434877|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
105664157|NCT04641962|364434878|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
105664158|NCT04641962|364434879|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
105664159|NCT04641962|364434875|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
105664160|NCT04641962|364434876|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
105664161|NCT04641962|364434877|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
105664162|NCT04641962|364434878|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
105664163|NCT04641962|364434879|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
105339628|NCT02137850|363245218|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
105339629|NCT02137850|363245216|FG000|Main Phase: Prophylaxis|Early site closure|0|||
105664164|NCT04641962|364434875|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
105664165|NCT04641962|364434876|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
105664166|NCT04641962|364434877|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
105664167|NCT04641962|364434878|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
105339630|NCT02137850|363245217|FG001|Main Phase: Prophylaxis|Early site closure|2|||
105339631|NCT02137850|363245218|FG002|Main Phase: Prophylaxis|Early site closure|0|||
105551164|NCT04137380|364017213|FG005|Overall Study|Physician Decision|0|||
105551165|NCT04137380|364017214|FG006|Overall Study|Physician Decision|0|||
105664168|NCT04641962|364434879|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
105664169|NCT00583947|364434882|FG000|Cross-over Period|Adverse Event|2|||
105664170|NCT00583947|364434883|FG001|Cross-over Period|Adverse Event|0|||
105664171|NCT00583947|364434882|FG000|Cross-over Period|Withdrawal by Subject|2|||
105664172|NCT00583947|364434883|FG001|Cross-over Period|Withdrawal by Subject|0|||
105664173|NCT00583947|364434882|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
105664174|NCT00583947|364434883|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
105664175|NCT00583947|364434882|FG000|Cross-over Period|Other|1|||
105664176|NCT00583947|364434883|FG001|Cross-over Period|Other|1|||
105664177|NCT05101993|364434884|FG000|Overall Study|Withdrawal by Subject|1|||
105664178|NCT06926673|364434886|FG000|Overall Study|Lost to Follow-up|0|||
105664179|NCT06926673|364434887|FG001|Overall Study|Lost to Follow-up|0|||
105664180|NCT06926673|364434888|FG002|Overall Study|Lost to Follow-up|0|||
105664181|NCT06926673|364434889|FG003|Overall Study|Lost to Follow-up|1|||
105664182|NCT06926673|364434890|FG004|Overall Study|Lost to Follow-up|0|||
105664183|NCT06926673|364434891|FG005|Overall Study|Lost to Follow-up|0|||
105664184|NCT06926673|364434892|FG006|Overall Study|Lost to Follow-up|0|||
105664185|NCT06926673|364434886|FG000|Overall Study|Physician Decision|0|||
105664186|NCT06926673|364434887|FG001|Overall Study|Physician Decision|0|||
105664187|NCT06926673|364434888|FG002|Overall Study|Physician Decision|0|||
105664188|NCT06926673|364434889|FG003|Overall Study|Physician Decision|0|||
105664189|NCT06926673|364434890|FG004|Overall Study|Physician Decision|0|||
105664190|NCT06926673|364434891|FG005|Overall Study|Physician Decision|0|||
105664191|NCT06926673|364434892|FG006|Overall Study|Physician Decision|1|||
105664192|NCT06926673|364434886|FG000|Overall Study|Withdrawal by Subject|0|||
105664193|NCT06926673|364434887|FG001|Overall Study|Withdrawal by Subject|3|||
105664194|NCT06926673|364434888|FG002|Overall Study|Withdrawal by Subject|2|||
105664195|NCT06926673|364434889|FG003|Overall Study|Withdrawal by Subject|1|||
105664196|NCT06926673|364434890|FG004|Overall Study|Withdrawal by Subject|0|||
105664197|NCT06926673|364434891|FG005|Overall Study|Withdrawal by Subject|2|||
105664198|NCT06926673|364434892|FG006|Overall Study|Withdrawal by Subject|0|||
105664199|NCT02797522|364436565|FG000|Overall Study|Study Terminated by Sponsor|0|||
105664200|NCT02797522|364436566|FG001|Overall Study|Study Terminated by Sponsor|0|||
105664201|NCT02797522|364436567|FG002|Overall Study|Study Terminated by Sponsor|0|||
105664202|NCT02797522|364436568|FG003|Overall Study|Study Terminated by Sponsor|0|||
105664203|NCT02797522|364436569|FG004|Overall Study|Study Terminated by Sponsor|0|||
105664204|NCT02797522|364436570|FG005|Overall Study|Study Terminated by Sponsor|0|||
105664205|NCT02797522|364436571|FG006|Overall Study|Study Terminated by Sponsor|0|||
105664206|NCT02797522|364436572|FG007|Overall Study|Study Terminated by Sponsor|4|||
105664207|NCT02797522|364436573|FG008|Overall Study|Study Terminated by Sponsor|2|||
105664208|NCT02797522|364436574|FG009|Overall Study|Study Terminated by Sponsor|4|||
105664209|NCT02797522|364436575|FG010|Overall Study|Study Terminated by Sponsor|1|||
105664210|NCT00516139|364436577|FG000|Overall Study|Adverse Event|27|||
105664211|NCT00516139|364436577|FG000|Overall Study|Lost to Follow-up|1|||
105664212|NCT00516139|364436577|FG000|Overall Study|Protocol Violation|1|||
105551166|NCT01343407|364017215|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
105664213|NCT00516139|364436577|FG000|Overall Study|Withdrawal by Subject|8|||
105664214|NCT00516139|364436577|FG000|Overall Study|Lack of Efficacy|1|||
105664215|NCT01439867|364436578|FG000|Overall Study|Non-compliance|0|||
105664216|NCT01439867|364436579|FG001|Overall Study|Non-compliance|1|||
105664217|NCT01439867|364436578|FG000|Overall Study|Withdrawal by Subject|1|||
105664218|NCT01439867|364436579|FG001|Overall Study|Withdrawal by Subject|2|||
105664219|NCT01439867|364436578|FG000|Overall Study|Administrative Decision|4|||
105664220|NCT01439867|364436579|FG001|Overall Study|Administrative Decision|5|||
105664221|NCT01439867|364436578|FG000|Overall Study|Protocol-specified Criteria|1|||
105664222|NCT01439867|364436579|FG001|Overall Study|Protocol-specified Criteria|0|||
105664223|NCT01888874|364436580|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
105664224|NCT01888874|364436581|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
105664225|NCT01888874|364436582|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
105664226|NCT01888874|364436583|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
105664227|NCT01888874|364436584|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
105664228|NCT01888874|364436585|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
105664229|NCT01888874|364436586|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
105664230|NCT01888874|364436580|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
105664231|NCT01888874|364436581|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
105664232|NCT01888874|364436582|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
105664233|NCT01888874|364436583|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
105664234|NCT01888874|364436584|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
105664235|NCT01888874|364436585|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
105664236|NCT01888874|364436586|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
105664237|NCT01888874|364436580|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
105664238|NCT01888874|364436581|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
105664239|NCT01888874|364436582|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
105664240|NCT01888874|364436583|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
105664241|NCT01888874|364436584|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
105664242|NCT01888874|364436585|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
105664243|NCT01888874|364436586|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
105664244|NCT01888874|364436580|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
105664245|NCT01888874|364436581|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
105664246|NCT01888874|364436582|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
105664247|NCT01888874|364436583|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
105664248|NCT01888874|364436584|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
105664249|NCT01888874|364436585|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
105785553|NCT03575806|364868517|FG000|Overall Study|Protocol Violation|0|||
105785554|NCT03575806|364868518|FG001|Overall Study|Protocol Violation|2|||
105785555|NCT00219349|364868519|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
105785556|NCT00219349|364868519|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
105785557|NCT00219349|364868519|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
105785558|NCT00219349|364868519|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
105785559|NCT02079740|364868520|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
105785560|NCT02079740|364868521|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
105785561|NCT02079740|364868522|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
105785562|NCT02079740|364868523|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
105785563|NCT02079740|364868524|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
105785564|NCT02079740|364868525|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
105785565|NCT02079740|364868526|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
105785566|NCT02079740|364868527|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
105785567|NCT02079740|364868528|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
105785568|NCT02079740|364868529|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
105785569|NCT02079740|364868530|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
105785570|NCT02079740|364868531|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
105785571|NCT02079740|364868532|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
105785572|NCT02079740|364868520|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
105785573|NCT02079740|364868521|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
105785574|NCT02079740|364868522|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
105785575|NCT02079740|364868523|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
105785576|NCT02079740|364868524|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
105785577|NCT02079740|364868525|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
105785578|NCT02079740|364868526|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
105785579|NCT02079740|364868527|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
105785580|NCT02079740|364868528|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
105785581|NCT02079740|364868529|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
105785582|NCT02079740|364868530|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
105785583|NCT02079740|364868531|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
105785584|NCT02079740|364868532|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
105664250|NCT01888874|364436586|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
105664251|NCT01888874|364436580|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105664252|NCT01888874|364436581|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105664253|NCT01888874|364436582|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105664254|NCT01888874|364436583|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105664255|NCT01888874|364436584|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
105664256|NCT01888874|364436585|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105664257|NCT01888874|364436586|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105664258|NCT01888874|364436580|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
105664259|NCT01888874|364436581|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
105664260|NCT01888874|364436582|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
105664261|NCT01888874|364436583|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
105664262|NCT01888874|364436584|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
105664263|NCT01888874|364436585|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
105664264|NCT01888874|364436586|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
105664265|NCT01888874|364436580|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
105664266|NCT01888874|364436581|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
105664267|NCT01888874|364436582|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
105664268|NCT01888874|364436583|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
105664269|NCT01888874|364436584|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
105664270|NCT01888874|364436585|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
105664271|NCT01888874|364436586|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
105664272|NCT01888874|364436580|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
105664273|NCT01888874|364436581|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
105664274|NCT01888874|364436582|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
105664275|NCT01888874|364436583|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
105664276|NCT01888874|364436584|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
105664277|NCT01888874|364436585|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
105664278|NCT01888874|364436586|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
105664279|NCT01888874|364436580|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
105664280|NCT01888874|364436581|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
105664281|NCT01888874|364436582|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
105664282|NCT01888874|364436583|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
105664283|NCT01888874|364436584|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
105664284|NCT01888874|364436585|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
105664285|NCT01888874|364436586|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
105664286|NCT01888874|364436580|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
105664287|NCT01888874|364436581|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
105664288|NCT01888874|364436582|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
105664289|NCT01888874|364436583|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
105664290|NCT01888874|364436584|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
105664291|NCT01888874|364436585|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
105664292|NCT01888874|364436586|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
105664293|NCT01888874|364436580|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
105664294|NCT01888874|364436581|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
105664295|NCT01888874|364436582|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
105664296|NCT01888874|364436583|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
105664297|NCT01888874|364436584|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
105664298|NCT01888874|364436585|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
105664299|NCT01888874|364436586|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
105664300|NCT01888874|364436580|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
105664301|NCT01888874|364436581|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
105664302|NCT01888874|364436582|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
105664303|NCT01888874|364436583|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
105664304|NCT01888874|364436584|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
105664305|NCT01888874|364436585|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
105664306|NCT01888874|364436586|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
105664307|NCT01888874|364436580|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
105664308|NCT01888874|364436581|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
105664309|NCT01888874|364436582|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
105664310|NCT01888874|364436583|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
105664311|NCT01888874|364436584|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
105664312|NCT01888874|364436585|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
105664313|NCT01888874|364436586|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
105664314|NCT02980042|364436587|FG000|Overall Study|Lost to Follow-up|5|||
105664315|NCT02980042|364436588|FG001|Overall Study|Lost to Follow-up|0|||
105664316|NCT02980042|364436587|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
105664317|NCT02980042|364436588|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
105664318|NCT01131104|364436589|FG000|Overall Study|Withdrawal by Subject|3|||
105664319|NCT01131104|364436589|FG000|Overall Study|Physician Decision|4|||
105664320|NCT01131104|364436589|FG000|Overall Study|Information Not Available|5|||
105664321|NCT01131104|364436589|FG000|Overall Study|No Information on Index Date of Onset|1|||
105664322|NCT00863512|364436590|FG000|Overall Study|Adverse Event|2|||
105664323|NCT00863512|364436591|FG001|Overall Study|Adverse Event|0|||
105664324|NCT00863512|364436590|FG000|Overall Study|Withdrawal by Subject|11|||
105664325|NCT00863512|364436591|FG001|Overall Study|Withdrawal by Subject|0|||
105664326|NCT00863512|364436590|FG000|Overall Study|Physician Decision|1|||
105664327|NCT00863512|364436591|FG001|Overall Study|Physician Decision|0|||
105664328|NCT02037477|364436592|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
105664329|NCT02037477|364436593|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
105664330|NCT02037477|364436594|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
105339632|NCT02137850|363245216|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
105339633|NCT02137850|363245217|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
105339634|NCT02137850|363245218|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
105664331|NCT02037477|364436595|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
105664332|NCT00983749|364436597|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
105664333|NCT00983749|364436598|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
105664334|NCT01270828|364436599|FG000|Pregabalin CR SB|Reason Unspecified|0|||
105664335|NCT01270828|364436600|FG001|Pregabalin CR SB|Reason Unspecified|0|||
105664336|NCT01270828|364436601|FG002|Pregabalin CR SB|Reason Unspecified|8|||
105664337|NCT01270828|364436599|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
105664338|NCT01270828|364436600|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
105664339|NCT01270828|364436601|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
105664340|NCT01270828|364436599|FG000|Pregabalin CR SB|Related adverse event|0|||
105664341|NCT01270828|364436600|FG001|Pregabalin CR SB|Related adverse event|0|||
105664342|NCT01270828|364436601|FG002|Pregabalin CR SB|Related adverse event|46|||
105664343|NCT01270828|364436599|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
105664344|NCT01270828|364436600|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
105664345|NCT01270828|364436601|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
105664346|NCT01270828|364436599|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
105664347|NCT01270828|364436600|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
105664348|NCT01270828|364436601|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
105664349|NCT01270828|364436599|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
105664350|NCT01270828|364436600|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
105664351|NCT01270828|364436601|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
105664352|NCT01270828|364436599|FG000|Pregabalin CR SB|Unrelated AE|0|||
105664353|NCT01270828|364436600|FG001|Pregabalin CR SB|Unrelated AE|0|||
105664354|NCT01270828|364436601|FG002|Pregabalin CR SB|Unrelated AE|8|||
105664355|NCT01270828|364436599|FG000|Pregabalin CR SB|Protocol Violation|0|||
105664356|NCT01270828|364436600|FG001|Pregabalin CR SB|Protocol Violation|0|||
105664357|NCT01270828|364436601|FG002|Pregabalin CR SB|Protocol Violation|8|||
105664358|NCT01270828|364436599|FG000|Double Blind Phase|Death|0|||
105664359|NCT01270828|364436600|FG001|Double Blind Phase|Death|1|||
105664360|NCT01270828|364436601|FG002|Double Blind Phase|Death|0|||
105664361|NCT01270828|364436599|FG000|Double Blind Phase|Protocol Violation|0|||
105664362|NCT01270828|364436600|FG001|Double Blind Phase|Protocol Violation|1|||
105664363|NCT01270828|364436601|FG002|Double Blind Phase|Protocol Violation|0|||
105664364|NCT01270828|364436599|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
105664365|NCT01270828|364436600|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
105664366|NCT01270828|364436601|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
105664367|NCT01270828|364436599|FG000|Double Blind Phase|Reason Unspecified|7|||
105664368|NCT01270828|364436600|FG001|Double Blind Phase|Reason Unspecified|4|||
105664369|NCT01270828|364436601|FG002|Double Blind Phase|Reason Unspecified|0|||
105664370|NCT01270828|364436599|FG000|Double Blind Phase|Withdrawal by Subject|6|||
105664371|NCT01270828|364436600|FG001|Double Blind Phase|Withdrawal by Subject|15|||
105664372|NCT01270828|364436601|FG002|Double Blind Phase|Withdrawal by Subject|0|||
105664373|NCT01270828|364436599|FG000|Double Blind Phase|Lost to Follow-up|1|||
105664374|NCT01270828|364436600|FG001|Double Blind Phase|Lost to Follow-up|2|||
105664375|NCT01270828|364436601|FG002|Double Blind Phase|Lost to Follow-up|0|||
105664376|NCT01270828|364436599|FG000|Double Blind Phase|Lack of Efficacy|2|||
105664377|NCT01270828|364436600|FG001|Double Blind Phase|Lack of Efficacy|11|||
105664378|NCT01270828|364436601|FG002|Double Blind Phase|Lack of Efficacy|0|||
105664379|NCT01270828|364436599|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
105664380|NCT01270828|364436600|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
105664381|NCT01270828|364436601|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
105664382|NCT01270828|364436599|FG000|Double Blind Phase|Adverse event related to study drug|5|||
105664383|NCT01270828|364436600|FG001|Double Blind Phase|Adverse event related to study drug|7|||
105664384|NCT01270828|364436601|FG002|Double Blind Phase|Adverse event related to study drug|0|||
105664385|NCT04292470|364436602|FG000|Overall Study|Withdrawal by Subject|0|||
105664386|NCT04292470|364436603|FG001|Overall Study|Withdrawal by Subject|1|||
105664387|NCT01454739|364436604|FG000|Overall Study|Protocol Violation|2|||
105664388|NCT01454739|364436605|FG001|Overall Study|Protocol Violation|3|||
105664389|NCT01454739|364436604|FG000|Overall Study|Withdrawal by Subject|2|||
105664390|NCT01454739|364436605|FG001|Overall Study|Withdrawal by Subject|6|||
105664391|NCT01454739|364436604|FG000|Overall Study|Other|3|||
105664392|NCT01454739|364436605|FG001|Overall Study|Other|5|||
105664393|NCT01454739|364436604|FG000|Overall Study|Physician Decision|0|||
105664394|NCT01454739|364436605|FG001|Overall Study|Physician Decision|5|||
105664395|NCT01454739|364436604|FG000|Overall Study|Lost to Follow-up|0|||
105664396|NCT01454739|364436605|FG001|Overall Study|Lost to Follow-up|1|||
105664397|NCT01454739|364436604|FG000|Overall Study|Adverse Event|0|||
105462969|NCT02113982|363709643|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
105664398|NCT01454739|364436605|FG001|Overall Study|Adverse Event|1|||
105664399|NCT00884650|364436619|FG000|Overall Study|Did not return complete pain diaries|7|||
105664400|NCT00884650|364436620|FG001|Overall Study|Did not return complete pain diaries|7|||
105664401|NCT00884650|364436619|FG000|Overall Study|Admitted Post-Op|1|||
105664402|NCT00884650|364436620|FG001|Overall Study|Admitted Post-Op|0|||
105664403|NCT00884650|364436619|FG000|Overall Study|Femoral Stress Fracture|1|||
105664404|NCT00884650|364436620|FG001|Overall Study|Femoral Stress Fracture|0|||
105664405|NCT00884650|364436619|FG000|Overall Study|Pain Pump Complication|0|||
105664406|NCT00884650|364436620|FG001|Overall Study|Pain Pump Complication|1|||
105664407|NCT01124097|364436622|FG000|Overall Study|Withdrawal by Subject|4|||
105664408|NCT01124097|364436623|FG001|Overall Study|Withdrawal by Subject|3|||
105664409|NCT01124097|364436624|FG002|Overall Study|Withdrawal by Subject|2|||
105664410|NCT01124097|364436625|FG003|Overall Study|Withdrawal by Subject|3|||
105664411|NCT01124097|364436622|FG000|Overall Study|Lack of Efficacy|2|||
105462970|NCT02113982|363709644|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
105664412|NCT01124097|364436623|FG001|Overall Study|Lack of Efficacy|3|||
105664413|NCT01124097|364436624|FG002|Overall Study|Lack of Efficacy|1|||
105664414|NCT01124097|364436625|FG003|Overall Study|Lack of Efficacy|3|||
105664415|NCT01124097|364436622|FG000|Overall Study|Adverse Event|24|||
105664416|NCT01124097|364436623|FG001|Overall Study|Adverse Event|15|||
105664417|NCT01124097|364436624|FG002|Overall Study|Adverse Event|15|||
105664418|NCT01124097|364436625|FG003|Overall Study|Adverse Event|7|||
105664419|NCT01124097|364436622|FG000|Overall Study|Protocol Violation|2|||
105664420|NCT01124097|364436623|FG001|Overall Study|Protocol Violation|0|||
105664421|NCT01124097|364436624|FG002|Overall Study|Protocol Violation|2|||
105664422|NCT01124097|364436625|FG003|Overall Study|Protocol Violation|1|||
105664423|NCT01124097|364436622|FG000|Overall Study|Physician Decision|2|||
105664424|NCT01124097|364436623|FG001|Overall Study|Physician Decision|1|||
105664425|NCT01124097|364436624|FG002|Overall Study|Physician Decision|0|||
105664426|NCT01124097|364436625|FG003|Overall Study|Physician Decision|0|||
105664427|NCT01821937|364436626|FG000|Overall Study|Adverse Event|0|||
105664428|NCT01821937|364436627|FG001|Overall Study|Adverse Event|3|||
105664429|NCT02270671|364436628|FG000|Overall Study|Withdrawal by Subject|1|||
105664430|NCT02270671|364436629|FG001|Overall Study|Withdrawal by Subject|1|||
105664431|NCT02270671|364436628|FG000|Overall Study|Protocol Violation|0|||
105664432|NCT02270671|364436629|FG001|Overall Study|Protocol Violation|1|||
105664433|NCT02270671|364436628|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
105664434|NCT02270671|364436629|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
105664435|NCT02270671|364436628|FG000|Overall Study|Lost to Follow-up|2|||
105664436|NCT02270671|364436629|FG001|Overall Study|Lost to Follow-up|1|||
105664437|NCT02980523|364436634|FG000|Overall Study|Lost to Follow-up|1|||
105664438|NCT02980523|364436635|FG001|Overall Study|Lost to Follow-up|4|||
105664439|NCT02980523|364436636|FG002|Overall Study|Lost to Follow-up|1|||
105664440|NCT02980523|364436637|FG003|Overall Study|Lost to Follow-up|2|||
105664441|NCT02980523|364436638|FG004|Overall Study|Lost to Follow-up|1|||
105664442|NCT02980523|364436634|FG000|Overall Study|Excluded from analysis|1|||
105664443|NCT02980523|364436635|FG001|Overall Study|Excluded from analysis|3|||
105664444|NCT02980523|364436636|FG002|Overall Study|Excluded from analysis|1|||
105664445|NCT02980523|364436637|FG003|Overall Study|Excluded from analysis|1|||
105664446|NCT02980523|364436638|FG004|Overall Study|Excluded from analysis|1|||
105664447|NCT02980523|364436634|FG000|Overall Study|Lack of Efficacy|1|||
105664448|NCT02980523|364436635|FG001|Overall Study|Lack of Efficacy|4|||
105664449|NCT02980523|364436636|FG002|Overall Study|Lack of Efficacy|4|||
105664450|NCT02980523|364436637|FG003|Overall Study|Lack of Efficacy|5|||
105664451|NCT02980523|364436638|FG004|Overall Study|Lack of Efficacy|8|||
105664452|NCT02980523|364436634|FG000|Overall Study|Did not receive intervention|0|||
105664453|NCT02980523|364436635|FG001|Overall Study|Did not receive intervention|0|||
105664454|NCT02980523|364436636|FG002|Overall Study|Did not receive intervention|0|||
105664455|NCT02980523|364436637|FG003|Overall Study|Did not receive intervention|1|||
105462971|NCT02113982|363709645|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
105462972|NCT02113982|363709646|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
105664456|NCT02980523|364436638|FG004|Overall Study|Did not receive intervention|0|||
105664457|NCT02153905|364436639|FG000|Overall Study|Death|1|||
105664458|NCT02153905|364436640|FG001|Overall Study|Death|0|||
105664459|NCT00193479|364436645|FG000|Induction Chemotherapy|Adverse Event|2|||
105664460|NCT00193479|364436645|FG000|Induction Chemotherapy|Disease Progression|1|||
105664461|NCT00193479|364436645|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
105664462|NCT00193479|364436645|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
105664463|NCT02229578|364436646|FG000|Overall Study|Withdrawal by Subject|1|||
105664464|NCT02229578|364436647|FG001|Overall Study|Withdrawal by Subject|3|||
105462973|NCT02113982|363709647|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
105664465|NCT02229578|364436646|FG000|Overall Study|Protocol Violation|2|||
105551167|NCT01343407|364017216|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
105551168|NCT01343407|364017217|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
105551169|NCT01343407|364017218|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
105551170|NCT01343407|364017219|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
105551171|NCT01343407|364017220|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
105551172|NCT01343407|364017215|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
105551173|NCT01343407|364017216|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
105551174|NCT01343407|364017217|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
105551175|NCT01343407|364017218|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
105551176|NCT01343407|364017219|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
105551177|NCT01343407|364017220|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
105551178|NCT03950739|364017221|FG000|Treatment Phase|Adverse Event|2|||
105551179|NCT03950739|364017221|FG000|Optional Extension Phase|Death|1|||
105551180|NCT03950739|364017221|FG000|Optional Extension Phase|Progressive Disease|5|||
105551181|NCT03950739|364017221|FG000|Optional Extension Phase|Adverse Event|7|||
105551182|NCT03950739|364017221|FG000|Optional Extension Phase|Lost to Follow-up|2|||
105551183|NCT03950739|364017221|FG000|Optional Extension Phase|Site Closure|2|||
105551184|NCT03950739|364017221|FG000|Optional Extension Phase|Pregnancy|1|||
105551185|NCT04139317|364017222|FG000|Overall Study|Adverse Event|10|||
105551186|NCT04139317|364017223|FG001|Overall Study|Adverse Event|2|||
105551187|NCT04139317|364017222|FG000|Overall Study|Death|6|||
105551188|NCT04139317|364017223|FG001|Overall Study|Death|4|||
105551189|NCT04139317|364017222|FG000|Overall Study|Lost to Follow-up|1|||
105551190|NCT04139317|364017223|FG001|Overall Study|Lost to Follow-up|0|||
105551191|NCT04139317|364017222|FG000|Overall Study|Physician Decision|3|||
105551192|NCT04139317|364017223|FG001|Overall Study|Physician Decision|1|||
105551193|NCT04139317|364017222|FG000|Overall Study|Progressive Disease|19|||
105551194|NCT04139317|364017223|FG001|Overall Study|Progressive Disease|9|||
105551195|NCT04139317|364017222|FG000|Overall Study|Subject Decision|2|||
105551196|NCT04139317|364017223|FG001|Overall Study|Subject Decision|2|||
105551197|NCT01949480|364017226|FG000|Overall Study|Physician Decision|5|||
105551198|NCT01949480|364017227|FG001|Overall Study|Physician Decision|8|||
105551199|NCT00965523|364017232|FG000|Study 221|Progressive Disease|4|||
105551200|NCT00965523|364017232|FG000|Study 221|Physician Decision|3|||
105551201|NCT00965523|364017232|FG000|Study 224|Progressive Disease|5|||
105551202|NCT00965523|364017232|FG000|Study 224|Physician Decision|1|||
105551203|NCT02232893|364017237|FG000|Overall Study|Withdrawal by Subject|4|||
105551204|NCT02232893|364017238|FG001|Overall Study|Withdrawal by Subject|1|||
105551205|NCT02232893|364017237|FG000|Overall Study|Adverse Event|0|||
105551206|NCT02232893|364017238|FG001|Overall Study|Adverse Event|1|||
105551207|NCT02232893|364017237|FG000|Overall Study|Sponsor request early termination|0|||
105551208|NCT02232893|364017238|FG001|Overall Study|Sponsor request early termination|1|||
105551209|NCT02232893|364017237|FG000|Overall Study|Developed exclusion criteria|0|||
105551210|NCT02232893|364017238|FG001|Overall Study|Developed exclusion criteria|1|||
105551211|NCT02232893|364017237|FG000|Overall Study|Other|0|||
105551212|NCT02232893|364017238|FG001|Overall Study|Other|3|||
105551213|NCT01196975|364017242|FG000|Overall Study|Adverse Event|2|||
105551214|NCT01196975|364017243|FG001|Overall Study|Adverse Event|2|||
105551215|NCT01196975|364017244|FG002|Overall Study|Adverse Event|0|||
105551216|NCT01196975|364017245|FG003|Overall Study|Adverse Event|0|||
105551217|NCT01196975|364017246|FG004|Overall Study|Adverse Event|2|||
105551218|NCT01196975|364017242|FG000|Overall Study|Withdrawal by Subject|2|||
105551219|NCT01196975|364017243|FG001|Overall Study|Withdrawal by Subject|1|||
105551220|NCT01196975|364017244|FG002|Overall Study|Withdrawal by Subject|0|||
105551221|NCT01196975|364017245|FG003|Overall Study|Withdrawal by Subject|1|||
105551222|NCT01196975|364017246|FG004|Overall Study|Withdrawal by Subject|0|||
105551223|NCT01196975|364017242|FG000|Overall Study|Lost to Follow-up|11|||
105551224|NCT01196975|364017243|FG001|Overall Study|Lost to Follow-up|6|||
105551225|NCT01196975|364017244|FG002|Overall Study|Lost to Follow-up|5|||
105551226|NCT01196975|364017245|FG003|Overall Study|Lost to Follow-up|5|||
105551227|NCT01196975|364017246|FG004|Overall Study|Lost to Follow-up|11|||
105551228|NCT01365494|364017247|FG000|Overall Study|Adverse Event|1|||
105551229|NCT01365494|364017248|FG001|Overall Study|Adverse Event|0|||
105551230|NCT01365494|364017247|FG000|Overall Study|Withdrawal by Subject|0|||
105551231|NCT01365494|364017248|FG001|Overall Study|Withdrawal by Subject|1|||
105551232|NCT01365494|364017247|FG000|Overall Study|Lost to Follow-up|1|||
105551233|NCT01365494|364017248|FG001|Overall Study|Lost to Follow-up|2|||
105551234|NCT01664078|364017249|FG000|Overall Study|Death|9|||
105551235|NCT01664078|364017249|FG000|Overall Study|Withdrawal by Subject|4|||
105551236|NCT01664078|364017249|FG000|Overall Study|Lost to Follow-up|2|||
105551237|NCT01664078|364017249|FG000|Overall Study|missed 5 year visit|1|||
105551238|NCT01664078|364017249|FG000|Overall Study|Other|53|||
105551239|NCT04782323|364017250|FG000|Overall Study|Death|1|||
105551240|NCT04782323|364017251|FG001|Overall Study|Death|0|||
105551241|NCT04782323|364017252|FG002|Overall Study|Death|0|||
105551242|NCT04782323|364017253|FG003|Overall Study|Death|0|||
105551243|NCT04782323|364017254|FG004|Overall Study|Death|1|||
105551244|NCT04782323|364017255|FG005|Overall Study|Death|1|||
105339635|NCT02137850|363245216|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
105664466|NCT02229578|364436647|FG001|Overall Study|Protocol Violation|0|||
105664467|NCT00559377|364436649|FG000|Overall Study|Withdrawal by Subject|9|||
105664468|NCT00872001|364436650|FG000|Overall Study|Adverse Event|34|||
105664469|NCT00872001|364436651|FG001|Overall Study|Adverse Event|23|||
105664470|NCT00872001|364436650|FG000|Overall Study|Protocol Defined Clinical Event|5|||
105664471|NCT00872001|364436651|FG001|Overall Study|Protocol Defined Clinical Event|7|||
105664472|NCT00872001|364436650|FG000|Overall Study|Lost to Follow-up|13|||
105664473|NCT00872001|364436651|FG001|Overall Study|Lost to Follow-up|12|||
105664474|NCT00872001|364436650|FG000|Overall Study|Withdrawal by Subject|18|||
105664475|NCT00872001|364436651|FG001|Overall Study|Withdrawal by Subject|30|||
105664476|NCT00872001|364436650|FG000|Overall Study|Protocol Violation|5|||
105664477|NCT00872001|364436651|FG001|Overall Study|Protocol Violation|8|||
105664478|NCT00872001|364436650|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
105664479|NCT00872001|364436651|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
105664480|NCT00872001|364436650|FG000|Overall Study|Administrative|23|||
105664481|NCT00872001|364436651|FG001|Overall Study|Administrative|15|||
105664482|NCT00340704|364436652|FG000|PK Study|Adverse Event|0|||
105664483|NCT00340704|364436653|FG001|PK Study|Adverse Event|1|||
105664484|NCT00340704|364436654|FG002|PK Study|Adverse Event|0|||
105664485|NCT00340704|364436655|FG003|PK Study|Adverse Event|0|||
105664486|NCT00340704|364436656|FG004|PK Study|Adverse Event|0|||
105664487|NCT00340704|364436657|FG005|PK Study|Adverse Event|0|||
105664488|NCT00340704|364436658|FG006|PK Study|Adverse Event|0|||
105664489|NCT00340704|364436659|FG007|PK Study|Adverse Event|0|||
105664490|NCT00340704|364436660|FG008|PK Study|Adverse Event|0|||
105664491|NCT00340704|364436652|FG000|PK Study|Not treated|0|||
105664492|NCT00340704|364436653|FG001|PK Study|Not treated|0|||
105664493|NCT00340704|364436654|FG002|PK Study|Not treated|1|||
105664494|NCT00340704|364436655|FG003|PK Study|Not treated|0|||
105664495|NCT00340704|364436656|FG004|PK Study|Not treated|0|||
105664496|NCT00340704|364436657|FG005|PK Study|Not treated|0|||
105664497|NCT00340704|364436658|FG006|PK Study|Not treated|0|||
105664498|NCT00340704|364436659|FG007|PK Study|Not treated|0|||
105664499|NCT00340704|364436660|FG008|PK Study|Not treated|0|||
105664500|NCT00340704|364436652|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
105664501|NCT00340704|364436653|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
105664502|NCT00340704|364436654|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
105664503|NCT00340704|364436655|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
105664504|NCT00340704|364436656|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
105664505|NCT00340704|364436657|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
105664506|NCT00340704|364436658|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
105664507|NCT00340704|364436659|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
105664508|NCT00340704|364436660|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
105664509|NCT00340704|364436652|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105664510|NCT00340704|364436653|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105664511|NCT00340704|364436654|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105664512|NCT00340704|364436655|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105664513|NCT00340704|364436656|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105664514|NCT00340704|364436657|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
105339636|NCT02137850|363245217|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
105664515|NCT00340704|364436658|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105664516|NCT00340704|364436659|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105664517|NCT00340704|364436660|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105339637|NCT02137850|363245218|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
105339638|NCT02137850|363245216|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
105664518|NCT00340704|364436652|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
105664519|NCT00340704|364436653|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
105664520|NCT00340704|364436654|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
105664521|NCT00340704|364436655|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
105664522|NCT00340704|364436656|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
105664523|NCT00340704|364436657|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
105664524|NCT00340704|364436658|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
105462974|NCT02113982|363709648|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
105462975|NCT02113982|363709649|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
105462976|NCT02113982|363709650|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
105664525|NCT00340704|364436659|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
105664526|NCT00340704|364436660|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
105664527|NCT00340704|364436652|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
105664528|NCT00340704|364436653|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
105664529|NCT00340704|364436654|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
105664530|NCT00340704|364436655|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
105664531|NCT00340704|364436656|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
105664532|NCT00340704|364436657|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
105664533|NCT00340704|364436658|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
105664534|NCT00340704|364436659|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
105664535|NCT00340704|364436660|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
105551245|NCT04782323|364017256|FG006|Overall Study|Death|1|||
105551246|NCT04782323|364017257|FG007|Overall Study|Death|0|||
105551247|NCT04782323|364017250|FG000|Overall Study|Withdrawal by Subject|0|||
105551248|NCT04782323|364017251|FG001|Overall Study|Withdrawal by Subject|0|||
105551249|NCT04782323|364017252|FG002|Overall Study|Withdrawal by Subject|1|||
105551250|NCT04782323|364017253|FG003|Overall Study|Withdrawal by Subject|0|||
105551251|NCT04782323|364017254|FG004|Overall Study|Withdrawal by Subject|0|||
105551252|NCT04782323|364017255|FG005|Overall Study|Withdrawal by Subject|1|||
105551253|NCT04782323|364017256|FG006|Overall Study|Withdrawal by Subject|0|||
105551254|NCT04782323|364017257|FG007|Overall Study|Withdrawal by Subject|1|||
105551255|NCT04782323|364017250|FG000|Overall Study|Lost to Follow-up|0|||
105551256|NCT04782323|364017251|FG001|Overall Study|Lost to Follow-up|1|||
105551257|NCT04782323|364017252|FG002|Overall Study|Lost to Follow-up|1|||
105551258|NCT04782323|364017253|FG003|Overall Study|Lost to Follow-up|0|||
105551259|NCT04782323|364017254|FG004|Overall Study|Lost to Follow-up|0|||
105551260|NCT04782323|364017255|FG005|Overall Study|Lost to Follow-up|1|||
105551261|NCT04782323|364017256|FG006|Overall Study|Lost to Follow-up|1|||
105551262|NCT04782323|364017257|FG007|Overall Study|Lost to Follow-up|2|||
105551263|NCT04782323|364017250|FG000|Overall Study|randomization in error|1|||
105551264|NCT04782323|364017251|FG001|Overall Study|randomization in error|0|||
105551265|NCT04782323|364017252|FG002|Overall Study|randomization in error|0|||
105551266|NCT04782323|364017253|FG003|Overall Study|randomization in error|0|||
105551267|NCT04782323|364017254|FG004|Overall Study|randomization in error|0|||
105551268|NCT04782323|364017255|FG005|Overall Study|randomization in error|0|||
105551269|NCT04782323|364017256|FG006|Overall Study|randomization in error|0|||
105551270|NCT04782323|364017257|FG007|Overall Study|randomization in error|0|||
105551271|NCT04598152|364017262|FG000|Overall Study|Lost to Follow-up|0|||
105551272|NCT04598152|364017263|FG001|Overall Study|Lost to Follow-up|1|||
105551273|NCT03394924|364017264|FG000|Overall Study|Adverse Event|0|||
105551274|NCT03394924|364017265|FG001|Overall Study|Adverse Event|5|||
105551275|NCT03394924|364017266|FG002|Overall Study|Adverse Event|0|||
105551276|NCT03394924|364017264|FG000|Overall Study|Withdrawal by Subject|2|||
105551277|NCT03394924|364017265|FG001|Overall Study|Withdrawal by Subject|0|||
105551278|NCT03394924|364017266|FG002|Overall Study|Withdrawal by Subject|0|||
105551279|NCT03394924|364017264|FG000|Overall Study|Lost to Follow-up|0|||
105551280|NCT03394924|364017265|FG001|Overall Study|Lost to Follow-up|1|||
105551281|NCT03394924|364017266|FG002|Overall Study|Lost to Follow-up|0|||
105551282|NCT03394924|364017264|FG000|Overall Study|Did not meet all inclusion criteria|1|||
105551283|NCT03394924|364017265|FG001|Overall Study|Did not meet all inclusion criteria|0|||
105551284|NCT03394924|364017266|FG002|Overall Study|Did not meet all inclusion criteria|0|||
105551285|NCT02194621|364017277|FG000|Overall Study|6 withdrew prior to randomization|2|||
105551286|NCT02194621|364017278|FG001|Overall Study|6 withdrew prior to randomization|2|||
105551287|NCT02194621|364017279|FG002|Overall Study|6 withdrew prior to randomization|2|||
105551288|NCT02194621|364017277|FG000|Overall Study|Withdrawal by Subject|4|||
105551289|NCT02194621|364017278|FG001|Overall Study|Withdrawal by Subject|4|||
105551290|NCT02194621|364017279|FG002|Overall Study|Withdrawal by Subject|7|||
105551291|NCT02121847|364017280|FG000|Overall Study|Administrative Reasons|1|||
105551292|NCT02121847|364017280|FG000|Overall Study|Adverse Event|2|||
105551293|NCT01174342|364017281|FG000|Overall Study|Conversion to cesarean section|4|||
105551294|NCT01410448|364017282|FG000|Overall Study|No conversion to everolimus|0|||
105551295|NCT01410448|364017283|FG001|Overall Study|No conversion to everolimus|24|||
105551296|NCT01410448|364017282|FG000|Overall Study|Graft loss|4|||
105551297|NCT01410448|364017283|FG001|Overall Study|Graft loss|1|||
105551298|NCT01410448|364017282|FG000|Overall Study|Administrative issues|2|||
105551299|NCT01410448|364017283|FG001|Overall Study|Administrative issues|1|||
105551300|NCT01410448|364017282|FG000|Overall Study|Lost to Follow-up|1|||
105551301|NCT01410448|364017283|FG001|Overall Study|Lost to Follow-up|0|||
105551302|NCT01410448|364017282|FG000|Overall Study|Withdrawal by Subject|3|||
105551303|NCT01410448|364017283|FG001|Overall Study|Withdrawal by Subject|2|||
105551304|NCT01410448|364017282|FG000|Overall Study|Protocol Violation|0|||
105551305|NCT01410448|364017283|FG001|Overall Study|Protocol Violation|4|||
105551306|NCT01410448|364017282|FG000|Overall Study|Death|2|||
105551307|NCT01410448|364017283|FG001|Overall Study|Death|3|||
105551308|NCT00360529|364017284|FG000|Overall Study|Adverse Event|10|||
105551309|NCT00360529|364017285|FG001|Overall Study|Adverse Event|23|||
105551310|NCT00360529|364017286|FG002|Overall Study|Adverse Event|33|||
105551311|NCT00360529|364017284|FG000|Overall Study|Protocol Violation|3|||
105551312|NCT00360529|364017285|FG001|Overall Study|Protocol Violation|3|||
105551313|NCT00360529|364017286|FG002|Overall Study|Protocol Violation|11|||
105551314|NCT00360529|364017284|FG000|Overall Study|Lost to Follow-up|14|||
105551315|NCT00360529|364017285|FG001|Overall Study|Lost to Follow-up|10|||
105551316|NCT00360529|364017286|FG002|Overall Study|Lost to Follow-up|13|||
105551317|NCT00360529|364017284|FG000|Overall Study|Withdrawal by Subject|22|||
105551318|NCT00360529|364017285|FG001|Overall Study|Withdrawal by Subject|14|||
105551319|NCT00360529|364017286|FG002|Overall Study|Withdrawal by Subject|18|||
105551320|NCT00360529|364017284|FG000|Overall Study|Lack of Efficacy|8|||
105551321|NCT00360529|364017285|FG001|Overall Study|Lack of Efficacy|6|||
105551322|NCT00360529|364017286|FG002|Overall Study|Lack of Efficacy|5|||
105785585|NCT02079740|364868520|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785586|NCT02079740|364868521|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785587|NCT02079740|364868522|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785588|NCT02079740|364868523|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785589|NCT02079740|364868524|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785590|NCT02079740|364868525|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785591|NCT02079740|364868526|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785592|NCT02079740|364868527|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
105785593|NCT02079740|364868528|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785594|NCT02079740|364868529|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785595|NCT02079740|364868530|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785596|NCT02079740|364868531|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785597|NCT02079740|364868532|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785598|NCT02079740|364868520|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785599|NCT02079740|364868521|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785600|NCT02079740|364868522|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785601|NCT02079740|364868523|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785602|NCT02079740|364868524|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785603|NCT02079740|364868525|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785604|NCT02079740|364868526|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785605|NCT02079740|364868527|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
105785606|NCT02079740|364868528|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785607|NCT02079740|364868529|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785608|NCT02079740|364868530|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785609|NCT02079740|364868531|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785610|NCT02079740|364868532|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785611|NCT02079740|364868520|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785612|NCT02079740|364868521|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785613|NCT02079740|364868522|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785614|NCT02079740|364868523|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785615|NCT02079740|364868524|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785616|NCT02079740|364868525|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785617|NCT02079740|364868526|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785618|NCT02079740|364868527|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785619|NCT02079740|364868528|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785620|NCT02079740|364868529|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
105785621|NCT02079740|364868530|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785622|NCT02079740|364868531|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
105785623|NCT02079740|364868532|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
105785624|NCT02842736|364868535|FG000|Overall Study|Lost to Follow-up|13|||
105785625|NCT02842736|364868535|FG000|Overall Study|Intervention for menstrual bleeding|17|||
105785626|NCT02842736|364868535|FG000|Overall Study|Withdrawal by Subject|4|||
105785627|NCT02842736|364868535|FG000|Overall Study|Pregnancy|3|||
105785628|NCT02842736|364868535|FG000|Overall Study|Hysterectomy for fibroids|2|||
105785629|NCT02842736|364868535|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
105785630|NCT02842736|364868535|FG000|Overall Study|IUD: Mirena|1|||
105785631|NCT01238861|364868537|FG000|Overall Study|Lost to Follow-up|4|||
105785632|NCT01238861|364868538|FG001|Overall Study|Lost to Follow-up|2|||
105785633|NCT01238861|364868539|FG002|Overall Study|Lost to Follow-up|3|||
105785634|NCT01238861|364868540|FG003|Overall Study|Lost to Follow-up|1|||
105785635|NCT01238861|364868541|FG004|Overall Study|Lost to Follow-up|1|||
105785636|NCT01238861|364868542|FG005|Overall Study|Lost to Follow-up|2|||
105785637|NCT01238861|364868537|FG000|Overall Study|Unplanned surgery|1|||
105785638|NCT01238861|364868538|FG001|Overall Study|Unplanned surgery|0|||
105785639|NCT01238861|364868539|FG002|Overall Study|Unplanned surgery|0|||
105785640|NCT01238861|364868540|FG003|Overall Study|Unplanned surgery|0|||
105785641|NCT01238861|364868541|FG004|Overall Study|Unplanned surgery|0|||
105785642|NCT01238861|364868542|FG005|Overall Study|Unplanned surgery|0|||
105785643|NCT01238861|364868537|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
105785644|NCT01238861|364868538|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
105785645|NCT01238861|364868539|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
105785646|NCT01238861|364868540|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
105785647|NCT01238861|364868541|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
105785648|NCT01238861|364868542|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
105785649|NCT01238861|364868537|FG000|Overall Study|Incorrect enrollment/randomization|0|||
105785650|NCT01238861|364868538|FG001|Overall Study|Incorrect enrollment/randomization|0|||
105785651|NCT01238861|364868539|FG002|Overall Study|Incorrect enrollment/randomization|1|||
105339639|NCT02137850|363245217|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
105339640|NCT02137850|363245218|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
105339641|NCT02137850|363245216|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
105339642|NCT02137850|363245217|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
105339643|NCT02137850|363245218|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
105339644|NCT02137850|363245216|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
105339645|NCT02137850|363245217|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
105339646|NCT02137850|363245218|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
105339647|NCT02137850|363245216|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
105339648|NCT02137850|363245217|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
105339649|NCT02137850|363245218|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
105339650|NCT02137850|363245216|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
105339651|NCT02137850|363245217|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
105339652|NCT02137850|363245218|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
105339653|NCT02137850|363245216|FG000|Extension Phase: Prophylaxis|Other|0|||
105339654|NCT02137850|363245217|FG001|Extension Phase: Prophylaxis|Other|1|||
105339655|NCT02137850|363245218|FG002|Extension Phase: Prophylaxis|Other|0|||
105339656|NCT02137850|363245216|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
105462977|NCT02113982|363709651|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
105462978|NCT02113982|363709652|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
105462979|NCT02113982|363709653|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
105462980|NCT02113982|363709654|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
105462981|NCT02113982|363709655|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
105462982|NCT02113982|363709656|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
105462983|NCT02113982|363709643|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
105462984|NCT02113982|363709644|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
105462985|NCT02113982|363709645|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
105462986|NCT02113982|363709646|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
105462987|NCT02113982|363709647|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
105462988|NCT02113982|363709648|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
105462989|NCT02113982|363709649|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
105664536|NCT01732549|364436661|FG000|Overall Study|Adverse Event|13|||
105462990|NCT02113982|363709650|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
105462991|NCT02113982|363709651|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
105664537|NCT01732549|364436662|FG001|Overall Study|Adverse Event|3|||
105664538|NCT01732549|364436661|FG000|Overall Study|Consent withdrawn|13|||
105664539|NCT01732549|364436662|FG001|Overall Study|Consent withdrawn|6|||
105664540|NCT01732549|364436661|FG000|Overall Study|Disease progression|37|||
105339657|NCT02137850|363245217|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
105339658|NCT02137850|363245218|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
105339659|NCT01730534|363245220|FG000|Overall Study|Withdrawal by Subject|97|||
105339660|NCT01730534|363245221|FG001|Overall Study|Withdrawal by Subject|127|||
105339661|NCT01730534|363245220|FG000|Overall Study|Lost to Follow-up|12|||
105339662|NCT01730534|363245221|FG001|Overall Study|Lost to Follow-up|18|||
105339663|NCT01647516|363245222|FG000|Induction Period (IP)|Physician Decision|2|||
105339664|NCT01647516|363245223|FG001|Induction Period (IP)|Physician Decision|0|||
105339665|NCT01647516|363245224|FG002|Induction Period (IP)|Physician Decision|0|||
105462992|NCT02113982|363709652|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
105339666|NCT01647516|363245225|FG003|Induction Period (IP)|Physician Decision|0|||
105339667|NCT01647516|363245226|FG004|Induction Period (IP)|Physician Decision|0|||
105551323|NCT00360529|364017284|FG000|Overall Study|Reason discontinued not explained above|4|||
105551324|NCT00360529|364017285|FG001|Overall Study|Reason discontinued not explained above|9|||
105551325|NCT00360529|364017286|FG002|Overall Study|Reason discontinued not explained above|11|||
105551326|NCT01218438|364017288|FG000|Epoch 1|Physician Decision|2|||
105551327|NCT01218438|364017288|FG000|Epoch 1|Adverse Event|1|||
105551328|NCT01218438|364017288|FG000|Epoch 3|Withdrawal by Subject|3|||
105551329|NCT01218438|364017288|FG000|Epoch 3|Adverse Event|1|||
105551330|NCT01218438|364017288|FG000|Epoch 4|Physician Decision|1|||
105551331|NCT01218438|364017288|FG000|Epoch 4|Withdrawal by Subject|2|||
105339668|NCT01647516|363245227|FG005|Induction Period (IP)|Physician Decision|0|||
105339669|NCT01647516|363245222|FG000|Induction Period (IP)|Adverse Event|1|||
105339670|NCT01647516|363245223|FG001|Induction Period (IP)|Adverse Event|2|||
105339671|NCT01647516|363245224|FG002|Induction Period (IP)|Adverse Event|0|||
105339672|NCT01647516|363245225|FG003|Induction Period (IP)|Adverse Event|0|||
105339673|NCT01647516|363245226|FG004|Induction Period (IP)|Adverse Event|0|||
105339674|NCT01647516|363245227|FG005|Induction Period (IP)|Adverse Event|0|||
105339675|NCT01647516|363245222|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
105339676|NCT01647516|363245223|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
105339677|NCT01647516|363245224|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
105339678|NCT01647516|363245225|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
105339679|NCT01647516|363245226|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
105339680|NCT01647516|363245227|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
105339681|NCT01647516|363245222|FG000|Induction Period (IP)|Participant Choice|0|||
105339682|NCT01647516|363245223|FG001|Induction Period (IP)|Participant Choice|0|||
105339683|NCT01647516|363245224|FG002|Induction Period (IP)|Participant Choice|1|||
105339684|NCT01647516|363245225|FG003|Induction Period (IP)|Participant Choice|0|||
105339685|NCT01647516|363245226|FG004|Induction Period (IP)|Participant Choice|0|||
105339686|NCT01647516|363245227|FG005|Induction Period (IP)|Participant Choice|0|||
105339687|NCT01647516|363245222|FG000|Induction Period (IP)|Lack of Efficacy|1|||
105339688|NCT01647516|363245223|FG001|Induction Period (IP)|Lack of Efficacy|0|||
105339689|NCT01647516|363245224|FG002|Induction Period (IP)|Lack of Efficacy|0|||
105339690|NCT01647516|363245225|FG003|Induction Period (IP)|Lack of Efficacy|0|||
105462993|NCT02113982|363709653|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
105462994|NCT02113982|363709654|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
105462995|NCT02113982|363709655|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
105462996|NCT02113982|363709656|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
105462997|NCT02113982|363709643|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
105462998|NCT02113982|363709644|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
105462999|NCT02113982|363709645|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
105463000|NCT02113982|363709646|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
105339691|NCT01647516|363245226|FG004|Induction Period (IP)|Lack of Efficacy|0|||
105463001|NCT02113982|363709647|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
105463002|NCT02113982|363709648|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
105785652|NCT01238861|364868540|FG003|Overall Study|Incorrect enrollment/randomization|0|||
105785653|NCT01238861|364868541|FG004|Overall Study|Incorrect enrollment/randomization|1|||
105785654|NCT01238861|364868542|FG005|Overall Study|Incorrect enrollment/randomization|0|||
105339692|NCT01647516|363245227|FG005|Induction Period (IP)|Lack of Efficacy|0|||
105463003|NCT02113982|363709649|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
105463004|NCT02113982|363709650|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
105785655|NCT01238861|364868537|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
105785656|NCT01238861|364868538|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
105785657|NCT01238861|364868539|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
105785658|NCT01238861|364868540|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
105785659|NCT01238861|364868541|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
105785660|NCT01238861|364868542|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
105785661|NCT01238861|364868537|FG000|Overall Study|Subject moved out of state/area|0|||
105785662|NCT01238861|364868538|FG001|Overall Study|Subject moved out of state/area|0|||
105785663|NCT01238861|364868539|FG002|Overall Study|Subject moved out of state/area|1|||
105785664|NCT01238861|364868540|FG003|Overall Study|Subject moved out of state/area|1|||
105785665|NCT01238861|364868541|FG004|Overall Study|Subject moved out of state/area|0|||
105785666|NCT01238861|364868542|FG005|Overall Study|Subject moved out of state/area|0|||
105785667|NCT01238861|364868537|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
105785668|NCT01238861|364868538|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
105785669|NCT01238861|364868539|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
105785670|NCT01238861|364868540|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
105785671|NCT01238861|364868541|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
105785672|NCT01238861|364868542|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
105785673|NCT01238861|364868537|FG000|Overall Study|Personal problems|0|||
105785674|NCT01238861|364868538|FG001|Overall Study|Personal problems|0|||
105785675|NCT01238861|364868539|FG002|Overall Study|Personal problems|0|||
105785676|NCT01238861|364868540|FG003|Overall Study|Personal problems|1|||
105664541|NCT01732549|364436662|FG001|Overall Study|Disease progression|50|||
105664542|NCT01732549|364436661|FG000|Overall Study|Other|8|||
105664543|NCT01732549|364436662|FG001|Overall Study|Other|14|||
105664544|NCT05186311|364436663|FG000|Part A: Serum|Withdrawal by Subject|1|||
105664545|NCT01850589|364436664|FG000|Overall Study|Withdrawal by Subject|8|||
105664546|NCT01850589|364436665|FG001|Overall Study|Withdrawal by Subject|0|||
105664547|NCT01592045|364436666|FG000|Overall Study|Disease Progression|1|||
105664548|NCT01592045|364436667|FG001|Overall Study|Disease Progression|1|||
105664549|NCT01592045|364436666|FG000|Overall Study|Adverse Event|1|||
105664550|NCT01592045|364436667|FG001|Overall Study|Adverse Event|1|||
105664551|NCT01592045|364436666|FG000|Overall Study|Withdrawal by Subject|1|||
105664552|NCT01592045|364436667|FG001|Overall Study|Withdrawal by Subject|0|||
105664553|NCT01592045|364436666|FG000|Overall Study|Moved out of country|2|||
105664554|NCT01592045|364436667|FG001|Overall Study|Moved out of country|0|||
105551332|NCT01218646|364017291|FG000|Overall Study|Adverse Event|0|||
105664555|NCT02417441|364436668|FG000|Overall Study|Inconclusive due to missing data|52|||
105664556|NCT02417441|364436669|FG001|Overall Study|Inconclusive due to missing data|19|||
105664557|NCT00983853|364436672|FG000|Overall Study|Lost to Follow-up|1|||
105664558|NCT00983853|364436673|FG001|Overall Study|Lost to Follow-up|1|||
105664559|NCT00983853|364436674|FG002|Overall Study|Lost to Follow-up|2|||
105664560|NCT00983853|364436675|FG003|Overall Study|Lost to Follow-up|2|||
105664561|NCT00983853|364436676|FG004|Overall Study|Lost to Follow-up|2|||
105664562|NCT00983853|364436677|FG005|Overall Study|Lost to Follow-up|1|||
105664563|NCT00983853|364436672|FG000|Overall Study|Withdrawal by Subject|0|||
105664564|NCT00983853|364436673|FG001|Overall Study|Withdrawal by Subject|0|||
105664565|NCT00983853|364436674|FG002|Overall Study|Withdrawal by Subject|1|||
105664566|NCT00983853|364436675|FG003|Overall Study|Withdrawal by Subject|0|||
105664567|NCT00983853|364436676|FG004|Overall Study|Withdrawal by Subject|1|||
105664568|NCT00983853|364436677|FG005|Overall Study|Withdrawal by Subject|0|||
105664569|NCT00983853|364436672|FG000|Overall Study|Unable to come to study follow-up visits|0|||
105664570|NCT00983853|364436673|FG001|Overall Study|Unable to come to study follow-up visits|1|||
105664571|NCT00983853|364436674|FG002|Overall Study|Unable to come to study follow-up visits|0|||
105664572|NCT00983853|364436675|FG003|Overall Study|Unable to come to study follow-up visits|0|||
105664573|NCT00983853|364436676|FG004|Overall Study|Unable to come to study follow-up visits|0|||
105664574|NCT00983853|364436677|FG005|Overall Study|Unable to come to study follow-up visits|0|||
105664575|NCT02159040|364436685|FG000|Overall Study|Death|1|||
105664576|NCT02472145|364436686|FG000|Overall Study|Death|10|||
105664577|NCT02472145|364436687|FG001|Overall Study|Death|101|||
105664578|NCT02472145|364436688|FG002|Overall Study|Death|99|||
105664579|NCT02472145|364436686|FG000|Overall Study|Lost to Follow-up|0|||
105664580|NCT02472145|364436687|FG001|Overall Study|Lost to Follow-up|1|||
105339693|NCT01647516|363245222|FG000|Induction Period (IP)|No study drug received|1|||
105339694|NCT01647516|363245223|FG001|Induction Period (IP)|No study drug received|1|||
105339695|NCT01647516|363245224|FG002|Induction Period (IP)|No study drug received|0|||
105339696|NCT01647516|363245225|FG003|Induction Period (IP)|No study drug received|0|||
105339697|NCT01647516|363245226|FG004|Induction Period (IP)|No study drug received|0|||
105551333|NCT01218646|364017292|FG001|Overall Study|Adverse Event|0|||
105551334|NCT01218646|364017293|FG002|Overall Study|Adverse Event|1|||
105551335|NCT01218646|364017294|FG003|Overall Study|Adverse Event|0|||
105551336|NCT01218646|364017291|FG000|Overall Study|Lost to Follow-up|1|||
105463005|NCT02113982|363709651|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
105463006|NCT02113982|363709652|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
105463007|NCT02113982|363709653|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
105463008|NCT02113982|363709654|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
105463009|NCT02113982|363709655|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
105463010|NCT02113982|363709656|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
105463011|NCT02113982|363709643|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
105463012|NCT02113982|363709644|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
105463013|NCT02113982|363709645|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
105463014|NCT02113982|363709646|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
105463015|NCT02113982|363709647|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
105463016|NCT02113982|363709648|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
105463017|NCT02113982|363709649|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
105463018|NCT02113982|363709650|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
105463019|NCT02113982|363709651|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
105463020|NCT02113982|363709652|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
105463021|NCT02113982|363709653|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
105463022|NCT02113982|363709654|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
105463023|NCT02113982|363709655|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
105463024|NCT02113982|363709656|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
105463025|NCT02113982|363709643|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
105463026|NCT02113982|363709644|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
105463027|NCT02113982|363709645|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
105463028|NCT02113982|363709646|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
105463029|NCT02113982|363709647|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
105463030|NCT02113982|363709648|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
105463031|NCT02113982|363709649|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
105463032|NCT02113982|363709650|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
105463033|NCT02113982|363709651|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
105463034|NCT02113982|363709652|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
105463035|NCT02113982|363709653|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
105463036|NCT02113982|363709654|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
105463037|NCT02113982|363709655|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
105463038|NCT02113982|363709656|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
105463039|NCT02113982|363709643|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
105463040|NCT02113982|363709644|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
105463041|NCT02113982|363709645|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
105463042|NCT02113982|363709646|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
105463043|NCT02113982|363709647|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
105463044|NCT02113982|363709648|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
105463045|NCT02113982|363709649|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
105463046|NCT02113982|363709650|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
105463047|NCT02113982|363709651|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
105463048|NCT02113982|363709652|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
105463049|NCT02113982|363709653|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
105463050|NCT02113982|363709654|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
105463051|NCT02113982|363709655|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
105463052|NCT02113982|363709656|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
105463053|NCT02113982|363709643|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
105551337|NCT01218646|364017292|FG001|Overall Study|Lost to Follow-up|0|||
105551338|NCT01218646|364017293|FG002|Overall Study|Lost to Follow-up|0|||
105551339|NCT01218646|364017294|FG003|Overall Study|Lost to Follow-up|0|||
105551340|NCT01218646|364017291|FG000|Overall Study|Protocol Violation|0|||
105551341|NCT01218646|364017292|FG001|Overall Study|Protocol Violation|0|||
105551342|NCT01218646|364017293|FG002|Overall Study|Protocol Violation|1|||
105551343|NCT01218646|364017294|FG003|Overall Study|Protocol Violation|1|||
105551344|NCT03156023|364017295|FG000|Overall Study|Withdrawal by Subject|1|||
105551345|NCT03156023|364017296|FG001|Overall Study|Withdrawal by Subject|0|||
105551346|NCT03156023|364017297|FG002|Overall Study|Withdrawal by Subject|2|||
105664581|NCT02472145|364436688|FG002|Overall Study|Lost to Follow-up|0|||
105664582|NCT02472145|364436686|FG000|Overall Study|Withdrawal by Subject|0|||
105664583|NCT02472145|364436687|FG001|Overall Study|Withdrawal by Subject|9|||
105664584|NCT02472145|364436688|FG002|Overall Study|Withdrawal by Subject|13|||
105664585|NCT02472145|364436686|FG000|Overall Study|Sponsor decision|0|||
105664586|NCT02472145|364436687|FG001|Overall Study|Sponsor decision|3|||
105664587|NCT02472145|364436688|FG002|Overall Study|Sponsor decision|2|||
105664588|NCT02472145|364436686|FG000|Overall Study|Other|0|||
105664589|NCT02472145|364436687|FG001|Overall Study|Other|45|||
105664590|NCT02472145|364436688|FG002|Overall Study|Other|43|||
105664591|NCT01318876|364436689|FG000|Day 8 Survey|email address invalid|96|||
105664592|NCT01318876|364436689|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
105664593|NCT01318876|364436689|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
105664594|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
105664595|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
105664596|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
105664597|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
105664598|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
105339698|NCT01647516|363245227|FG005|Induction Period (IP)|No study drug received|0|||
105339699|NCT01647516|363245222|FG000|Maintenance Period (MP)|Adverse Event|2|||
105339700|NCT01647516|363245223|FG001|Maintenance Period (MP)|Adverse Event|1|||
105339701|NCT01647516|363245224|FG002|Maintenance Period (MP)|Adverse Event|0|||
105339702|NCT01647516|363245225|FG003|Maintenance Period (MP)|Adverse Event|0|||
105339703|NCT01647516|363245226|FG004|Maintenance Period (MP)|Adverse Event|0|||
105339704|NCT01647516|363245227|FG005|Maintenance Period (MP)|Adverse Event|0|||
105339705|NCT01647516|363245222|FG000|Maintenance Period (MP)|Non-compliance|1|||
105339706|NCT01647516|363245223|FG001|Maintenance Period (MP)|Non-compliance|0|||
105339707|NCT01647516|363245224|FG002|Maintenance Period (MP)|Non-compliance|0|||
105339708|NCT01647516|363245225|FG003|Maintenance Period (MP)|Non-compliance|0|||
105339709|NCT01647516|363245226|FG004|Maintenance Period (MP)|Non-compliance|0|||
105339710|NCT01647516|363245227|FG005|Maintenance Period (MP)|Non-compliance|0|||
105339711|NCT01647516|363245222|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
105339712|NCT01647516|363245223|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
105339713|NCT01647516|363245224|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
105339714|NCT01647516|363245225|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
105463054|NCT02113982|363709644|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
105463055|NCT02113982|363709645|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
105463056|NCT02113982|363709646|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
105463057|NCT02113982|363709647|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
105463058|NCT02113982|363709648|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
105463059|NCT02113982|363709649|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
105463060|NCT02113982|363709650|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
105463061|NCT02113982|363709651|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
105463062|NCT02113982|363709652|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
105463063|NCT02113982|363709653|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
105463064|NCT02113982|363709654|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
105463065|NCT02113982|363709655|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
105463066|NCT02113982|363709656|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
105463067|NCT02113982|363709643|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
105463068|NCT02113982|363709644|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
105463069|NCT02113982|363709645|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
105463070|NCT02113982|363709646|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
105463071|NCT02113982|363709647|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
105463072|NCT02113982|363709648|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
105463073|NCT02113982|363709649|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
105463074|NCT02113982|363709650|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
105463075|NCT02113982|363709651|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
105463076|NCT02113982|363709652|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
105463077|NCT02113982|363709653|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
105463078|NCT02113982|363709654|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
105463079|NCT02113982|363709655|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
105463080|NCT02113982|363709656|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
105339715|NCT01647516|363245226|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
105339716|NCT01647516|363245227|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
105339717|NCT01647516|363245222|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
105339718|NCT01647516|363245223|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
105551347|NCT03156023|364017298|FG003|Overall Study|Withdrawal by Subject|1|||
105551348|NCT03156023|364017299|FG004|Overall Study|Withdrawal by Subject|1|||
105551349|NCT03156023|364017295|FG000|Overall Study|Lost to Follow-up|0|||
105551350|NCT03156023|364017296|FG001|Overall Study|Lost to Follow-up|0|||
105551351|NCT03156023|364017297|FG002|Overall Study|Lost to Follow-up|0|||
105551352|NCT03156023|364017298|FG003|Overall Study|Lost to Follow-up|0|||
105551353|NCT03156023|364017299|FG004|Overall Study|Lost to Follow-up|1|||
105551354|NCT02075593|364017300|FG000|Overall Study|Withdrawal by Subject|1|||
105551355|NCT00710424|364017301|FG000|Overall Study|Adverse Event|30|||
105551356|NCT00710424|364017302|FG001|Overall Study|Adverse Event|12|||
105551357|NCT00710424|364017301|FG000|Overall Study|Lack of Efficacy|4|||
105339719|NCT01647516|363245224|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
105339720|NCT01647516|363245225|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
105339721|NCT01647516|363245226|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
105551358|NCT00710424|364017302|FG001|Overall Study|Lack of Efficacy|5|||
105551359|NCT00710424|364017301|FG000|Overall Study|Withdrawal by Subject|5|||
105551360|NCT00710424|364017302|FG001|Overall Study|Withdrawal by Subject|3|||
105551361|NCT00710424|364017301|FG000|Overall Study|Lost to Follow-up|0|||
105551362|NCT00710424|364017302|FG001|Overall Study|Lost to Follow-up|1|||
105551363|NCT00710424|364017301|FG000|Overall Study|Refused medication, no side effects|1|||
105551364|NCT00710424|364017302|FG001|Overall Study|Refused medication, no side effects|0|||
105551365|NCT00710424|364017301|FG000|Overall Study|Non-compliance with stable analgesia|1|||
105551366|NCT00710424|364017302|FG001|Overall Study|Non-compliance with stable analgesia|0|||
105551367|NCT00710424|364017301|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
105551368|NCT00710424|364017302|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
105551369|NCT00710424|364017301|FG000|Overall Study|Subject thought medication changed|1|||
105551370|NCT00710424|364017302|FG001|Overall Study|Subject thought medication changed|0|||
105551371|NCT00710424|364017301|FG000|Overall Study|Ceased treatment due to travel|1|||
105551372|NCT00710424|364017302|FG001|Overall Study|Ceased treatment due to travel|0|||
105551373|NCT00710424|364017301|FG000|Overall Study|Subject preferred paracetamol|0|||
105551374|NCT00710424|364017302|FG001|Overall Study|Subject preferred paracetamol|1|||
105551375|NCT00710424|364017301|FG000|Overall Study|Felt good so stopped treatment|0|||
105551376|NCT00710424|364017302|FG001|Overall Study|Felt good so stopped treatment|1|||
105551377|NCT05819749|364017303|FG000|Overall Study|Lost to Follow-up|1|||
105551378|NCT03120624|364017304|FG000|Overall Study|Withdrawal by Subject|0|||
105551379|NCT03120624|364017305|FG001|Overall Study|Withdrawal by Subject|1|||
105551380|NCT03120624|364017306|FG002|Overall Study|Withdrawal by Subject|0|||
105551381|NCT03120624|364017307|FG003|Overall Study|Withdrawal by Subject|0|||
105551382|NCT03120624|364017308|FG004|Overall Study|Withdrawal by Subject|0|||
105339722|NCT01647516|363245227|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
105339723|NCT01647516|363245222|FG000|Open-Label Period|Adverse Event|0|||
105664599|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
105664600|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
105664601|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
105664602|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
105664603|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
105664604|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
105664605|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
105664606|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
105664607|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
105664608|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
105664609|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
105339724|NCT01647516|363245223|FG001|Open-Label Period|Adverse Event|0|||
105463081|NCT02113982|363709643|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
105664610|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
105339725|NCT01647516|363245224|FG002|Open-Label Period|Adverse Event|0|||
105339726|NCT01647516|363245225|FG003|Open-Label Period|Adverse Event|5|||
105339727|NCT01647516|363245226|FG004|Open-Label Period|Adverse Event|6|||
105463082|NCT02113982|363709644|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
105463083|NCT02113982|363709645|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
105463084|NCT02113982|363709646|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
105463085|NCT02113982|363709647|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
105463086|NCT02113982|363709648|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
105463087|NCT02113982|363709649|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
105463088|NCT02113982|363709650|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
105463089|NCT02113982|363709651|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
105463090|NCT02113982|363709652|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
105463091|NCT02113982|363709653|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
105463092|NCT02113982|363709654|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
105463093|NCT02113982|363709655|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
105463094|NCT02113982|363709656|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
105463095|NCT02113982|363709643|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
105463096|NCT02113982|363709644|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
105463097|NCT02113982|363709645|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
105463098|NCT02113982|363709646|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
105463099|NCT02113982|363709647|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
105463100|NCT02113982|363709648|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
105463101|NCT02113982|363709649|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
105463102|NCT02113982|363709650|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
105463103|NCT02113982|363709651|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
105463104|NCT02113982|363709652|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
105463105|NCT02113982|363709653|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
105463106|NCT02113982|363709654|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
105463107|NCT02113982|363709655|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
105463108|NCT02113982|363709656|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
105463109|NCT02113982|363709643|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
105463110|NCT02113982|363709644|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
105463111|NCT02113982|363709645|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
105463112|NCT02113982|363709646|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
105463113|NCT02113982|363709647|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
105463114|NCT02113982|363709648|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
105785677|NCT01238861|364868541|FG004|Overall Study|Personal problems|0|||
105785678|NCT01238861|364868542|FG005|Overall Study|Personal problems|0|||
105785679|NCT01238861|364868537|FG000|Overall Study|Unable to continue visits|0|||
105785680|NCT01238861|364868538|FG001|Overall Study|Unable to continue visits|0|||
105785681|NCT01238861|364868539|FG002|Overall Study|Unable to continue visits|0|||
105785682|NCT01238861|364868540|FG003|Overall Study|Unable to continue visits|1|||
105785683|NCT01238861|364868541|FG004|Overall Study|Unable to continue visits|0|||
105785684|NCT01238861|364868542|FG005|Overall Study|Unable to continue visits|1|||
105785685|NCT01238861|364868537|FG000|Overall Study|Serious adverse event|0|||
105785686|NCT01238861|364868538|FG001|Overall Study|Serious adverse event|0|||
105785687|NCT01238861|364868539|FG002|Overall Study|Serious adverse event|0|||
105785688|NCT01238861|364868540|FG003|Overall Study|Serious adverse event|0|||
105785689|NCT01238861|364868541|FG004|Overall Study|Serious adverse event|0|||
105785690|NCT01238861|364868542|FG005|Overall Study|Serious adverse event|1|||
105785691|NCT01238861|364868537|FG000|Overall Study|Lack of compliance|0|||
105785692|NCT01238861|364868538|FG001|Overall Study|Lack of compliance|0|||
105785693|NCT01238861|364868539|FG002|Overall Study|Lack of compliance|0|||
105785694|NCT01238861|364868540|FG003|Overall Study|Lack of compliance|0|||
105785695|NCT01238861|364868541|FG004|Overall Study|Lack of compliance|0|||
105785696|NCT01238861|364868542|FG005|Overall Study|Lack of compliance|1|||
105785697|NCT01238861|364868537|FG000|Overall Study|Adverse Event|0|||
105785698|NCT01238861|364868538|FG001|Overall Study|Adverse Event|1|||
105785699|NCT01238861|364868539|FG002|Overall Study|Adverse Event|0|||
105785700|NCT01238861|364868540|FG003|Overall Study|Adverse Event|0|||
105785701|NCT01238861|364868541|FG004|Overall Study|Adverse Event|0|||
105785702|NCT01238861|364868542|FG005|Overall Study|Adverse Event|0|||
105785703|NCT01238861|364868537|FG000|Overall Study|Withdrawal by Subject|6|||
105785704|NCT01238861|364868538|FG001|Overall Study|Withdrawal by Subject|5|||
105785705|NCT01238861|364868539|FG002|Overall Study|Withdrawal by Subject|4|||
105785706|NCT01238861|364868540|FG003|Overall Study|Withdrawal by Subject|8|||
105785707|NCT01238861|364868541|FG004|Overall Study|Withdrawal by Subject|10|||
105785708|NCT01238861|364868542|FG005|Overall Study|Withdrawal by Subject|9|||
105785709|NCT00247416|364868543|FG000|Overall Study|3 patients were found to be ineligible|1|||
105785710|NCT00247416|364868544|FG001|Overall Study|3 patients were found to be ineligible|2|||
105785711|NCT06104423|364868545|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
105785712|NCT06104423|364868546|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
105785713|NCT06104423|364868547|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
105664611|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
105664612|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Missing|2|||
105664613|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Missing|1|||
105664614|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
105664615|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
105664616|NCT00443209|364436690|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
105664617|NCT00443209|364436691|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
105664618|NCT00443209|364436690|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
105664619|NCT00443209|364436691|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
105664620|NCT00443209|364436690|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
105664621|NCT00443209|364436691|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
105664622|NCT00443209|364436690|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
105664623|NCT00443209|364436691|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
105664624|NCT00443209|364436690|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
105664625|NCT00443209|364436691|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
105664626|NCT00443209|364436690|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
105664627|NCT00443209|364436691|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
105664628|NCT01296555|364436692|FG000|Overall Study|Adverse Event|0|||
105664629|NCT01296555|364436693|FG001|Overall Study|Adverse Event|0|||
105664630|NCT01296555|364436694|FG002|Overall Study|Adverse Event|1|||
105664631|NCT01296555|364436695|FG003|Overall Study|Adverse Event|1|||
105664632|NCT01296555|364436696|FG004|Overall Study|Adverse Event|2|||
105664633|NCT01296555|364436697|FG005|Overall Study|Adverse Event|4|||
105664634|NCT01296555|364436698|FG006|Overall Study|Adverse Event|1|||
105664635|NCT01296555|364436699|FG007|Overall Study|Adverse Event|4|||
105664636|NCT01296555|364436700|FG008|Overall Study|Adverse Event|3|||
105664637|NCT01296555|364436701|FG009|Overall Study|Adverse Event|1|||
105664638|NCT01296555|364436702|FG010|Overall Study|Adverse Event|0|||
105664639|NCT01296555|364436703|FG011|Overall Study|Adverse Event|4|||
105664640|NCT01296555|364436704|FG012|Overall Study|Adverse Event|1|||
105664641|NCT01296555|364436705|FG013|Overall Study|Adverse Event|4|||
105664642|NCT01296555|364436706|FG014|Overall Study|Adverse Event|0|||
105664643|NCT01296555|364436707|FG015|Overall Study|Adverse Event|0|||
105664644|NCT01296555|364436708|FG016|Overall Study|Adverse Event|0|||
105664645|NCT01296555|364436709|FG017|Overall Study|Adverse Event|0|||
105664646|NCT01296555|364436710|FG018|Overall Study|Adverse Event|0|||
105664647|NCT01296555|364436711|FG019|Overall Study|Adverse Event|1|||
105664648|NCT01296555|364436712|FG020|Overall Study|Adverse Event|0|||
105664649|NCT01296555|364436713|FG021|Overall Study|Adverse Event|0|||
105664650|NCT01296555|364436714|FG022|Overall Study|Adverse Event|0|||
105664651|NCT01296555|364436715|FG023|Overall Study|Adverse Event|0|||
105664652|NCT01296555|364436716|FG024|Overall Study|Adverse Event|0|||
105664653|NCT01296555|364436717|FG025|Overall Study|Adverse Event|0|||
105664654|NCT01296555|364436718|FG026|Overall Study|Adverse Event|0|||
105664655|NCT01296555|364436719|FG027|Overall Study|Adverse Event|0|||
105664656|NCT01296555|364436720|FG028|Overall Study|Adverse Event|0|||
105664657|NCT01296555|364436692|FG000|Overall Study|Reason Not Specified|0|||
105664658|NCT01296555|364436693|FG001|Overall Study|Reason Not Specified|0|||
105664659|NCT01296555|364436694|FG002|Overall Study|Reason Not Specified|0|||
105664660|NCT01296555|364436695|FG003|Overall Study|Reason Not Specified|0|||
105664661|NCT01296555|364436696|FG004|Overall Study|Reason Not Specified|0|||
105664662|NCT01296555|364436697|FG005|Overall Study|Reason Not Specified|0|||
105664663|NCT01296555|364436698|FG006|Overall Study|Reason Not Specified|0|||
105664664|NCT01296555|364436699|FG007|Overall Study|Reason Not Specified|0|||
105664665|NCT01296555|364436700|FG008|Overall Study|Reason Not Specified|0|||
105664666|NCT01296555|364436701|FG009|Overall Study|Reason Not Specified|0|||
105664667|NCT01296555|364436702|FG010|Overall Study|Reason Not Specified|0|||
105664668|NCT01296555|364436703|FG011|Overall Study|Reason Not Specified|0|||
105664669|NCT01296555|364436704|FG012|Overall Study|Reason Not Specified|0|||
105664670|NCT01296555|364436705|FG013|Overall Study|Reason Not Specified|1|||
105664671|NCT01296555|364436706|FG014|Overall Study|Reason Not Specified|2|||
105664672|NCT01296555|364436707|FG015|Overall Study|Reason Not Specified|3|||
105664673|NCT01296555|364436708|FG016|Overall Study|Reason Not Specified|7|||
105664674|NCT01296555|364436709|FG017|Overall Study|Reason Not Specified|4|||
105664675|NCT01296555|364436710|FG018|Overall Study|Reason Not Specified|3|||
105664676|NCT01296555|364436711|FG019|Overall Study|Reason Not Specified|7|||
105664677|NCT01296555|364436712|FG020|Overall Study|Reason Not Specified|11|||
105664678|NCT01296555|364436713|FG021|Overall Study|Reason Not Specified|5|||
105551383|NCT03120624|364017309|FG005|Overall Study|Withdrawal by Subject|0|||
105551384|NCT03120624|364017310|FG006|Overall Study|Withdrawal by Subject|0|||
105551385|NCT03120624|364017311|FG007|Overall Study|Withdrawal by Subject|0|||
105551386|NCT05437510|364017312|FG000|Overall Study|Adverse Event|1|||
105551387|NCT05437510|364017313|FG001|Overall Study|Adverse Event|1|||
105551388|NCT05437510|364017312|FG000|Overall Study|Protocol Deviation|1|||
105664679|NCT01296555|364436714|FG022|Overall Study|Reason Not Specified|5|||
105664680|NCT01296555|364436715|FG023|Overall Study|Reason Not Specified|7|||
105664681|NCT01296555|364436716|FG024|Overall Study|Reason Not Specified|2|||
105664682|NCT01296555|364436717|FG025|Overall Study|Reason Not Specified|2|||
105664683|NCT01296555|364436718|FG026|Overall Study|Reason Not Specified|19|||
105664684|NCT01296555|364436719|FG027|Overall Study|Reason Not Specified|11|||
105664685|NCT01296555|364436720|FG028|Overall Study|Reason Not Specified|9|||
105664686|NCT01296555|364436692|FG000|Overall Study|Physician Decision|0|||
105664687|NCT01296555|364436693|FG001|Overall Study|Physician Decision|0|||
105664688|NCT01296555|364436694|FG002|Overall Study|Physician Decision|0|||
105664689|NCT01296555|364436695|FG003|Overall Study|Physician Decision|0|||
105664690|NCT01296555|364436696|FG004|Overall Study|Physician Decision|1|||
105664691|NCT01296555|364436697|FG005|Overall Study|Physician Decision|0|||
105664692|NCT01296555|364436698|FG006|Overall Study|Physician Decision|0|||
105664693|NCT01296555|364436699|FG007|Overall Study|Physician Decision|0|||
105664694|NCT01296555|364436700|FG008|Overall Study|Physician Decision|0|||
105339728|NCT01647516|363245227|FG005|Open-Label Period|Adverse Event|3|||
105339729|NCT01647516|363245222|FG000|Open-Label Period|Pregnancy|0|||
105339730|NCT01647516|363245223|FG001|Open-Label Period|Pregnancy|0|||
105339731|NCT01647516|363245224|FG002|Open-Label Period|Pregnancy|0|||
105339732|NCT01647516|363245225|FG003|Open-Label Period|Pregnancy|0|||
105339733|NCT01647516|363245226|FG004|Open-Label Period|Pregnancy|0|||
105339734|NCT01647516|363245227|FG005|Open-Label Period|Pregnancy|1|||
105339735|NCT01647516|363245222|FG000|Open-Label Period|Non-compliance|0|||
105339736|NCT01647516|363245223|FG001|Open-Label Period|Non-compliance|0|||
105339737|NCT01647516|363245224|FG002|Open-Label Period|Non-compliance|0|||
105339738|NCT01647516|363245225|FG003|Open-Label Period|Non-compliance|1|||
105339739|NCT01647516|363245226|FG004|Open-Label Period|Non-compliance|0|||
105339740|NCT01647516|363245227|FG005|Open-Label Period|Non-compliance|1|||
105339741|NCT01647516|363245222|FG000|Open-Label Period|Physician Decision|0|||
105339742|NCT01647516|363245223|FG001|Open-Label Period|Physician Decision|0|||
105339743|NCT01647516|363245224|FG002|Open-Label Period|Physician Decision|0|||
105339744|NCT01647516|363245225|FG003|Open-Label Period|Physician Decision|1|||
105339745|NCT01647516|363245226|FG004|Open-Label Period|Physician Decision|1|||
105339746|NCT01647516|363245227|FG005|Open-Label Period|Physician Decision|0|||
105339747|NCT01647516|363245222|FG000|Open-Label Period|Withdrawal by Subject|0|||
105339748|NCT01647516|363245223|FG001|Open-Label Period|Withdrawal by Subject|0|||
105339749|NCT01647516|363245224|FG002|Open-Label Period|Withdrawal by Subject|0|||
105339750|NCT01647516|363245225|FG003|Open-Label Period|Withdrawal by Subject|9|||
105339751|NCT01647516|363245226|FG004|Open-Label Period|Withdrawal by Subject|11|||
105339752|NCT01647516|363245227|FG005|Open-Label Period|Withdrawal by Subject|6|||
105339753|NCT01647516|363245222|FG000|Open-Label Period|Lost to Follow-up|0|||
105339754|NCT01647516|363245223|FG001|Open-Label Period|Lost to Follow-up|0|||
105339755|NCT01647516|363245224|FG002|Open-Label Period|Lost to Follow-up|0|||
105339756|NCT01647516|363245225|FG003|Open-Label Period|Lost to Follow-up|1|||
105339757|NCT01647516|363245226|FG004|Open-Label Period|Lost to Follow-up|0|||
105339758|NCT01647516|363245227|FG005|Open-Label Period|Lost to Follow-up|1|||
105339759|NCT01647516|363245222|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
105339760|NCT01647516|363245223|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
105339761|NCT01647516|363245224|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
105664695|NCT01296555|364436701|FG009|Overall Study|Physician Decision|0|||
105664696|NCT01296555|364436702|FG010|Overall Study|Physician Decision|0|||
105664697|NCT01296555|364436703|FG011|Overall Study|Physician Decision|0|||
105664698|NCT01296555|364436704|FG012|Overall Study|Physician Decision|0|||
105664699|NCT01296555|364436705|FG013|Overall Study|Physician Decision|1|||
105664700|NCT01296555|364436706|FG014|Overall Study|Physician Decision|0|||
105664701|NCT01296555|364436707|FG015|Overall Study|Physician Decision|0|||
105664702|NCT01296555|364436708|FG016|Overall Study|Physician Decision|0|||
105664703|NCT01296555|364436709|FG017|Overall Study|Physician Decision|0|||
105664704|NCT01296555|364436710|FG018|Overall Study|Physician Decision|0|||
105664705|NCT01296555|364436711|FG019|Overall Study|Physician Decision|1|||
105664706|NCT01296555|364436712|FG020|Overall Study|Physician Decision|0|||
105664707|NCT01296555|364436713|FG021|Overall Study|Physician Decision|0|||
105664708|NCT01296555|364436714|FG022|Overall Study|Physician Decision|0|||
105664709|NCT01296555|364436715|FG023|Overall Study|Physician Decision|0|||
105664710|NCT01296555|364436716|FG024|Overall Study|Physician Decision|0|||
105664711|NCT01296555|364436717|FG025|Overall Study|Physician Decision|0|||
105664712|NCT01296555|364436718|FG026|Overall Study|Physician Decision|0|||
105664713|NCT01296555|364436719|FG027|Overall Study|Physician Decision|0|||
105664714|NCT01296555|364436720|FG028|Overall Study|Physician Decision|0|||
105664715|NCT01296555|364436692|FG000|Overall Study|Progressive Disease|6|||
105664716|NCT01296555|364436693|FG001|Overall Study|Progressive Disease|3|||
105664717|NCT01296555|364436694|FG002|Overall Study|Progressive Disease|3|||
105339762|NCT01647516|363245225|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
105339763|NCT01647516|363245226|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
105339764|NCT01647516|363245227|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
105339765|NCT01647516|363245222|FG000|Open-Label Period|Lack of Efficacy|0|||
105664718|NCT01296555|364436695|FG003|Overall Study|Progressive Disease|7|||
105664719|NCT01296555|364436696|FG004|Overall Study|Progressive Disease|6|||
105664720|NCT01296555|364436697|FG005|Overall Study|Progressive Disease|16|||
105664721|NCT01296555|364436698|FG006|Overall Study|Progressive Disease|16|||
105339766|NCT01647516|363245223|FG001|Open-Label Period|Lack of Efficacy|0|||
105339767|NCT01647516|363245224|FG002|Open-Label Period|Lack of Efficacy|0|||
105339768|NCT01647516|363245225|FG003|Open-Label Period|Lack of Efficacy|7|||
105664722|NCT01296555|364436699|FG007|Overall Study|Progressive Disease|8|||
105664723|NCT01296555|364436700|FG008|Overall Study|Progressive Disease|7|||
105664724|NCT01296555|364436701|FG009|Overall Study|Progressive Disease|18|||
105664725|NCT01296555|364436702|FG010|Overall Study|Progressive Disease|7|||
105664726|NCT01296555|364436703|FG011|Overall Study|Progressive Disease|14|||
105551389|NCT05437510|364017313|FG001|Overall Study|Protocol Deviation|6|||
105551390|NCT05437510|364017312|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
105551391|NCT05437510|364017313|FG001|Overall Study|Withdrawal by Parent/Guardian|22|||
105551392|NCT05437510|364017312|FG000|Overall Study|Lost to Follow-up|219|||
105551393|NCT05437510|364017313|FG001|Overall Study|Lost to Follow-up|289|||
105551394|NCT05437510|364017312|FG000|Overall Study|Ongoing in the Study Extension|1387|||
105664727|NCT01296555|364436704|FG012|Overall Study|Progressive Disease|5|||
105463115|NCT02113982|363709649|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
105463116|NCT02113982|363709650|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
105463117|NCT02113982|363709651|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
105463118|NCT02113982|363709652|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
105463119|NCT02113982|363709653|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
105463120|NCT02113982|363709654|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
105463121|NCT02113982|363709655|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
105463122|NCT02113982|363709656|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
105664728|NCT01296555|364436705|FG013|Overall Study|Progressive Disease|12|||
105664729|NCT01296555|364436706|FG014|Overall Study|Progressive Disease|1|||
105664730|NCT01296555|364436707|FG015|Overall Study|Progressive Disease|1|||
105664731|NCT01296555|364436708|FG016|Overall Study|Progressive Disease|0|||
105664732|NCT01296555|364436709|FG017|Overall Study|Progressive Disease|0|||
105664733|NCT01296555|364436710|FG018|Overall Study|Progressive Disease|0|||
105664734|NCT01296555|364436711|FG019|Overall Study|Progressive Disease|1|||
105664735|NCT01296555|364436712|FG020|Overall Study|Progressive Disease|0|||
105664736|NCT01296555|364436713|FG021|Overall Study|Progressive Disease|0|||
105664737|NCT01296555|364436714|FG022|Overall Study|Progressive Disease|0|||
105664738|NCT01296555|364436715|FG023|Overall Study|Progressive Disease|0|||
105664739|NCT01296555|364436716|FG024|Overall Study|Progressive Disease|1|||
105664740|NCT01296555|364436717|FG025|Overall Study|Progressive Disease|0|||
105664741|NCT01296555|364436718|FG026|Overall Study|Progressive Disease|5|||
105664742|NCT01296555|364436719|FG027|Overall Study|Progressive Disease|1|||
105664743|NCT01296555|364436720|FG028|Overall Study|Progressive Disease|0|||
105664744|NCT01296555|364436692|FG000|Overall Study|Protocol Violation|0|||
105664745|NCT01296555|364436693|FG001|Overall Study|Protocol Violation|0|||
105664746|NCT01296555|364436694|FG002|Overall Study|Protocol Violation|0|||
105664747|NCT01296555|364436695|FG003|Overall Study|Protocol Violation|0|||
105664748|NCT01296555|364436696|FG004|Overall Study|Protocol Violation|0|||
105664749|NCT01296555|364436697|FG005|Overall Study|Protocol Violation|0|||
105664750|NCT01296555|364436698|FG006|Overall Study|Protocol Violation|0|||
105664751|NCT01296555|364436699|FG007|Overall Study|Protocol Violation|0|||
105664752|NCT01296555|364436700|FG008|Overall Study|Protocol Violation|0|||
105664753|NCT01296555|364436701|FG009|Overall Study|Protocol Violation|0|||
105664754|NCT01296555|364436702|FG010|Overall Study|Protocol Violation|0|||
105664755|NCT01296555|364436703|FG011|Overall Study|Protocol Violation|0|||
105664756|NCT01296555|364436704|FG012|Overall Study|Protocol Violation|0|||
105664757|NCT01296555|364436705|FG013|Overall Study|Protocol Violation|1|||
105664758|NCT01296555|364436706|FG014|Overall Study|Protocol Violation|0|||
105664759|NCT01296555|364436707|FG015|Overall Study|Protocol Violation|0|||
105664760|NCT01296555|364436708|FG016|Overall Study|Protocol Violation|0|||
105664761|NCT01296555|364436709|FG017|Overall Study|Protocol Violation|0|||
105664762|NCT01296555|364436710|FG018|Overall Study|Protocol Violation|0|||
105664763|NCT01296555|364436711|FG019|Overall Study|Protocol Violation|0|||
105664764|NCT01296555|364436712|FG020|Overall Study|Protocol Violation|0|||
105664765|NCT01296555|364436713|FG021|Overall Study|Protocol Violation|0|||
105664766|NCT01296555|364436714|FG022|Overall Study|Protocol Violation|0|||
105664767|NCT01296555|364436715|FG023|Overall Study|Protocol Violation|0|||
105664768|NCT01296555|364436716|FG024|Overall Study|Protocol Violation|0|||
105463123|NCT02113982|363709643|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
105463124|NCT02113982|363709644|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
105463125|NCT02113982|363709645|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
105463126|NCT02113982|363709646|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
105463127|NCT02113982|363709647|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
105463128|NCT02113982|363709648|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
105463129|NCT02113982|363709649|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
105463130|NCT02113982|363709650|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
105463131|NCT02113982|363709651|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
105463132|NCT02113982|363709652|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
105463133|NCT02113982|363709653|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
105463134|NCT02113982|363709654|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
105463135|NCT02113982|363709655|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
105463136|NCT02113982|363709656|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
105463137|NCT01936870|363709659|FG000|Overall Study|No Visit After Treatment|176|||
105463138|NCT01936870|363709659|FG000|Overall Study|Protocol Violation|12|||
105463139|NCT01936870|363709659|FG000|Overall Study|No Drug Administration|1|||
105463140|NCT01600716|363709662|FG000|Overall Study|Other Reasons|3|||
105551395|NCT05437510|364017313|FG001|Overall Study|Ongoing in the Study Extension|1352|||
105551396|NCT00920426|364019124|FG000|ITZ111451|Adverse Event|1|||
105551397|NCT00920426|364019125|FG001|ITZ111451|Adverse Event|0|||
105551398|NCT00920426|364019126|FG002|ITZ111451|Adverse Event|0|||
105551399|NCT00920426|364019127|FG003|ITZ111451|Adverse Event|0|||
105551400|NCT00773968|364019128|FG000|Overall Study|Adverse Event|2|||
105785714|NCT06104423|364868545|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
105785715|NCT06104423|364868546|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
105785716|NCT06104423|364868547|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
105785717|NCT00145795|364868550|FG000|Overall Study|Adverse Event|1|||
105785718|NCT00145795|364868551|FG001|Overall Study|Adverse Event|0|||
105785719|NCT00570492|364868552|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
105785720|NCT00570492|364868553|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
105785721|NCT00570492|364868554|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
105785722|NCT00570492|364868552|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
105785723|NCT00570492|364868553|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
105785724|NCT00570492|364868554|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
105785725|NCT00570492|364868552|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
105785726|NCT00570492|364868553|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
105785727|NCT00570492|364868554|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
105785728|NCT00570492|364868552|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
105785729|NCT00570492|364868553|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
105785730|NCT00570492|364868554|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
105785731|NCT00570492|364868552|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
105785732|NCT00570492|364868553|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
105785733|NCT00570492|364868554|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
105785734|NCT00570492|364868552|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
105785735|NCT00570492|364868553|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
105785736|NCT00570492|364868554|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
105785737|NCT00570492|364868552|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
105785738|NCT00570492|364868553|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
105785739|NCT00570492|364868554|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
105785740|NCT00570492|364868552|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
105785741|NCT00570492|364868553|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
105785742|NCT00570492|364868554|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
105785743|NCT00570492|364868552|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
105785744|NCT00570492|364868553|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
105785745|NCT00570492|364868554|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
105785746|NCT00570492|364868552|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
105785747|NCT00570492|364868553|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
105785748|NCT00570492|364868554|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
105785749|NCT00570492|364868552|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
105785750|NCT00570492|364868553|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
105785751|NCT00570492|364868554|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
105785752|NCT00570492|364868552|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
105785753|NCT00570492|364868553|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
105664769|NCT01296555|364436717|FG025|Overall Study|Protocol Violation|0|||
105664770|NCT01296555|364436718|FG026|Overall Study|Protocol Violation|0|||
105664771|NCT01296555|364436719|FG027|Overall Study|Protocol Violation|0|||
105551401|NCT00773968|364019128|FG000|Overall Study|Death|1|||
105551402|NCT00773968|364019128|FG000|Overall Study|Failure to Return|2|||
105339769|NCT01647516|363245226|FG004|Open-Label Period|Lack of Efficacy|9|||
105339770|NCT01647516|363245227|FG005|Open-Label Period|Lack of Efficacy|10|||
105339771|NCT01647516|363245222|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
105339772|NCT01647516|363245223|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
105339773|NCT01647516|363245224|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
105339774|NCT01647516|363245225|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
105339775|NCT01647516|363245226|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
105339776|NCT01647516|363245227|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
105339777|NCT01647516|363245222|FG000|Open-Label Period|No completion / discontinuation visit|0|||
105664772|NCT01296555|364436720|FG028|Overall Study|Protocol Violation|0|||
105339778|NCT01647516|363245223|FG001|Open-Label Period|No completion / discontinuation visit|0|||
105339779|NCT01647516|363245224|FG002|Open-Label Period|No completion / discontinuation visit|0|||
105339780|NCT01647516|363245225|FG003|Open-Label Period|No completion / discontinuation visit|0|||
105339781|NCT01647516|363245226|FG004|Open-Label Period|No completion / discontinuation visit|2|||
105339782|NCT01647516|363245227|FG005|Open-Label Period|No completion / discontinuation visit|1|||
105339783|NCT01676896|363245228|FG000|Overall Study|Withdrawal by Subject|12|||
105339784|NCT01676896|363245229|FG001|Overall Study|Withdrawal by Subject|7|||
105339785|NCT01676896|363245230|FG002|Overall Study|Withdrawal by Subject|19|||
105339786|NCT02980341|363245231|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
105339787|NCT02980341|363245232|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
105339788|NCT02980341|363245233|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
105339789|NCT02980341|363245234|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
105339790|NCT02980341|363245235|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
105339791|NCT02980341|363245236|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
105339792|NCT02980341|363245237|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
105339793|NCT02980341|363245238|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
105339794|NCT02980341|363245239|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
105339795|NCT02980341|363245240|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
105339796|NCT02980341|363245241|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
105339797|NCT02980341|363245231|FG000|Dose Escalation|Clinical progression|0|||
105339798|NCT02980341|363245232|FG001|Dose Escalation|Clinical progression|0|||
105339799|NCT02980341|363245233|FG002|Dose Escalation|Clinical progression|2|||
105339800|NCT02980341|363245234|FG003|Dose Escalation|Clinical progression|1|||
105339801|NCT02980341|363245235|FG004|Dose Escalation|Clinical progression|0|||
105339802|NCT02980341|363245236|FG005|Dose Escalation|Clinical progression|0|||
105339803|NCT02980341|363245237|FG006|Dose Escalation|Clinical progression|0|||
105339804|NCT02980341|363245238|FG007|Dose Escalation|Clinical progression|0|||
105339805|NCT02980341|363245239|FG008|Dose Escalation|Clinical progression|0|||
105339806|NCT02980341|363245240|FG009|Dose Escalation|Clinical progression|0|||
105339807|NCT02980341|363245241|FG010|Dose Escalation|Clinical progression|0|||
105339808|NCT02980341|363245231|FG000|Dose Escalation|Adverse Event|0|||
105339809|NCT02980341|363245232|FG001|Dose Escalation|Adverse Event|0|||
105339810|NCT02980341|363245233|FG002|Dose Escalation|Adverse Event|1|||
105339811|NCT02980341|363245234|FG003|Dose Escalation|Adverse Event|2|||
105339812|NCT02980341|363245235|FG004|Dose Escalation|Adverse Event|2|||
105339813|NCT02980341|363245236|FG005|Dose Escalation|Adverse Event|0|||
105664773|NCT01296555|364436692|FG000|Overall Study|Study Terminated By Sponsor|0|||
105339814|NCT02980341|363245237|FG006|Dose Escalation|Adverse Event|0|||
105339815|NCT02980341|363245238|FG007|Dose Escalation|Adverse Event|0|||
105339816|NCT02980341|363245239|FG008|Dose Escalation|Adverse Event|0|||
105339817|NCT02980341|363245240|FG009|Dose Escalation|Adverse Event|0|||
105339818|NCT02980341|363245241|FG010|Dose Escalation|Adverse Event|0|||
105664774|NCT01296555|364436693|FG001|Overall Study|Study Terminated By Sponsor|0|||
105551403|NCT00773968|364019128|FG000|Overall Study|Lack of Efficacy|3|||
105551404|NCT00773968|364019128|FG000|Overall Study|Protocol Violation|1|||
105551405|NCT00773968|364019128|FG000|Overall Study|Withdrawal by Subject|11|||
105551406|NCT00773968|364019128|FG000|Overall Study|Screen Failure|17|||
105551407|NCT00773968|364019128|FG000|Overall Study|Other|8|||
105551408|NCT00896168|364019129|FG000|Overall Study|Adverse Event|4|||
105551409|NCT00896168|364019130|FG001|Overall Study|Adverse Event|7|||
105551410|NCT00896168|364019129|FG000|Overall Study|Treatment failure|8|||
105551411|NCT00896168|364019130|FG001|Overall Study|Treatment failure|10|||
105551412|NCT00896168|364019129|FG000|Overall Study|Lost to Follow-up|1|||
105551413|NCT00896168|364019130|FG001|Overall Study|Lost to Follow-up|1|||
105551414|NCT00896168|364019129|FG000|Overall Study|Other|1|||
105551415|NCT00896168|364019130|FG001|Overall Study|Other|1|||
105664775|NCT01296555|364436694|FG002|Overall Study|Study Terminated By Sponsor|0|||
105664776|NCT01296555|364436695|FG003|Overall Study|Study Terminated By Sponsor|0|||
105664777|NCT01296555|364436696|FG004|Overall Study|Study Terminated By Sponsor|0|||
105664778|NCT01296555|364436697|FG005|Overall Study|Study Terminated By Sponsor|0|||
105664779|NCT01296555|364436698|FG006|Overall Study|Study Terminated By Sponsor|0|||
105664780|NCT01296555|364436699|FG007|Overall Study|Study Terminated By Sponsor|0|||
105664781|NCT01296555|364436700|FG008|Overall Study|Study Terminated By Sponsor|0|||
105664782|NCT01296555|364436701|FG009|Overall Study|Study Terminated By Sponsor|0|||
105664783|NCT01296555|364436702|FG010|Overall Study|Study Terminated By Sponsor|0|||
105664784|NCT01296555|364436703|FG011|Overall Study|Study Terminated By Sponsor|0|||
105664785|NCT01296555|364436704|FG012|Overall Study|Study Terminated By Sponsor|0|||
105664786|NCT01296555|364436705|FG013|Overall Study|Study Terminated By Sponsor|0|||
105664787|NCT01296555|364436706|FG014|Overall Study|Study Terminated By Sponsor|0|||
105664788|NCT01296555|364436707|FG015|Overall Study|Study Terminated By Sponsor|0|||
105551416|NCT00321854|364019137|FG000|Overall Study|Adverse Event|41|||
105551417|NCT00321854|364019138|FG001|Overall Study|Adverse Event|43|||
105551418|NCT00321854|364019137|FG000|Overall Study|Lack of Efficacy|9|||
105551419|NCT00321854|364019138|FG001|Overall Study|Lack of Efficacy|14|||
105551420|NCT00321854|364019137|FG000|Overall Study|Protocol Violation|6|||
105551421|NCT00321854|364019138|FG001|Overall Study|Protocol Violation|5|||
105551422|NCT00321854|364019137|FG000|Overall Study|Lost to Follow-up|0|||
105551423|NCT00321854|364019138|FG001|Overall Study|Lost to Follow-up|2|||
105551424|NCT00321854|364019137|FG000|Overall Study|Withdrawal by Subject|6|||
105551425|NCT00321854|364019138|FG001|Overall Study|Withdrawal by Subject|17|||
105551426|NCT00321854|364019137|FG000|Overall Study|Other|1|||
105551427|NCT00321854|364019138|FG001|Overall Study|Other|1|||
105551428|NCT02372396|364019140|FG000|Overall Study|Lost to Follow-up|7|||
105551429|NCT02372396|364019141|FG001|Overall Study|Lost to Follow-up|9|||
105551430|NCT01226745|364019142|FG000|Overall Study|Did not complete schedule of assessments|8|||
105551431|NCT01226745|364019143|FG001|Overall Study|Did not complete schedule of assessments|3|||
105551432|NCT01226745|364019144|FG002|Overall Study|Did not complete schedule of assessments|6|||
105551433|NCT01226745|364019145|FG003|Overall Study|Did not complete schedule of assessments|0|||
105664789|NCT01296555|364436708|FG016|Overall Study|Study Terminated By Sponsor|0|||
105664790|NCT01296555|364436709|FG017|Overall Study|Study Terminated By Sponsor|0|||
105664791|NCT01296555|364436710|FG018|Overall Study|Study Terminated By Sponsor|0|||
105664792|NCT01296555|364436711|FG019|Overall Study|Study Terminated By Sponsor|0|||
105664793|NCT01296555|364436712|FG020|Overall Study|Study Terminated By Sponsor|0|||
105664794|NCT01296555|364436713|FG021|Overall Study|Study Terminated By Sponsor|0|||
105664795|NCT01296555|364436714|FG022|Overall Study|Study Terminated By Sponsor|0|||
105664796|NCT01296555|364436715|FG023|Overall Study|Study Terminated By Sponsor|0|||
105664797|NCT01296555|364436716|FG024|Overall Study|Study Terminated By Sponsor|0|||
105664798|NCT01296555|364436717|FG025|Overall Study|Study Terminated By Sponsor|1|||
105664799|NCT01296555|364436718|FG026|Overall Study|Study Terminated By Sponsor|0|||
105664800|NCT01296555|364436719|FG027|Overall Study|Study Terminated By Sponsor|0|||
105664801|NCT01296555|364436720|FG028|Overall Study|Study Terminated By Sponsor|0|||
105664802|NCT01296555|364436692|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664803|NCT01296555|364436693|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664804|NCT01296555|364436694|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664805|NCT01296555|364436695|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664806|NCT01296555|364436696|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664807|NCT01296555|364436697|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664808|NCT01296555|364436698|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664809|NCT01296555|364436699|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664810|NCT01296555|364436700|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664811|NCT01296555|364436701|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664812|NCT01296555|364436702|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664813|NCT01296555|364436703|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664814|NCT01296555|364436704|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664815|NCT01296555|364436705|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664816|NCT01296555|364436706|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664817|NCT01296555|364436707|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664818|NCT01296555|364436708|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105551434|NCT01226745|364019146|FG004|Overall Study|Did not complete schedule of assessments|0|||
105551435|NCT01226745|364019147|FG005|Overall Study|Did not complete schedule of assessments|1|||
105551436|NCT01226745|364019142|FG000|Overall Study|Lost to Follow-up|2|||
105664819|NCT01296555|364436709|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664820|NCT01296555|364436710|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664821|NCT01296555|364436711|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
105664822|NCT01296555|364436712|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664823|NCT01296555|364436713|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664824|NCT01296555|364436714|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664825|NCT01296555|364436715|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664826|NCT01296555|364436716|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664827|NCT01296555|364436717|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664828|NCT01296555|364436718|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664829|NCT01296555|364436719|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664830|NCT01296555|364436720|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664831|NCT01296555|364436692|FG000|Overall Study|Death|0|||
105664832|NCT01296555|364436693|FG001|Overall Study|Death|0|||
105463141|NCT01600716|363709663|FG001|Overall Study|Other Reasons|1|||
105463142|NCT01600716|363709662|FG000|Overall Study|Personal Reasons|0|||
105664833|NCT01296555|364436694|FG002|Overall Study|Death|0|||
105664834|NCT01296555|364436695|FG003|Overall Study|Death|2|||
105664835|NCT01296555|364436696|FG004|Overall Study|Death|1|||
105664836|NCT01296555|364436697|FG005|Overall Study|Death|0|||
105664837|NCT01296555|364436698|FG006|Overall Study|Death|2|||
105664838|NCT01296555|364436699|FG007|Overall Study|Death|0|||
105664839|NCT01296555|364436700|FG008|Overall Study|Death|0|||
105664840|NCT01296555|364436701|FG009|Overall Study|Death|1|||
105664841|NCT01296555|364436702|FG010|Overall Study|Death|0|||
105664842|NCT01296555|364436703|FG011|Overall Study|Death|1|||
105664843|NCT01296555|364436704|FG012|Overall Study|Death|0|||
105664844|NCT01296555|364436705|FG013|Overall Study|Death|2|||
105664845|NCT01296555|364436706|FG014|Overall Study|Death|27|||
105664846|NCT01296555|364436707|FG015|Overall Study|Death|15|||
105664847|NCT01296555|364436708|FG016|Overall Study|Death|11|||
105664848|NCT01296555|364436709|FG017|Overall Study|Death|11|||
105664849|NCT01296555|364436710|FG018|Overall Study|Death|17|||
105664850|NCT01296555|364436711|FG019|Overall Study|Death|12|||
105664851|NCT01296555|364436712|FG020|Overall Study|Death|13|||
105664852|NCT01296555|364436713|FG021|Overall Study|Death|12|||
105664853|NCT01296555|364436714|FG022|Overall Study|Death|12|||
105664854|NCT01296555|364436715|FG023|Overall Study|Death|13|||
105664855|NCT01296555|364436716|FG024|Overall Study|Death|7|||
105664856|NCT01296555|364436717|FG025|Overall Study|Death|7|||
105664857|NCT01296555|364436718|FG026|Overall Study|Death|35|||
105664858|NCT01296555|364436719|FG027|Overall Study|Death|92|||
105664859|NCT01296555|364436720|FG028|Overall Study|Death|44|||
105664860|NCT01296555|364436692|FG000|Overall Study|Lost to Follow-up|0|||
105664861|NCT01296555|364436693|FG001|Overall Study|Lost to Follow-up|0|||
105664862|NCT01296555|364436694|FG002|Overall Study|Lost to Follow-up|0|||
105664863|NCT01296555|364436695|FG003|Overall Study|Lost to Follow-up|0|||
105664864|NCT01296555|364436696|FG004|Overall Study|Lost to Follow-up|0|||
105664865|NCT01296555|364436697|FG005|Overall Study|Lost to Follow-up|0|||
105664866|NCT01296555|364436698|FG006|Overall Study|Lost to Follow-up|0|||
105664867|NCT01296555|364436699|FG007|Overall Study|Lost to Follow-up|0|||
105664868|NCT01296555|364436700|FG008|Overall Study|Lost to Follow-up|0|||
105664869|NCT01296555|364436701|FG009|Overall Study|Lost to Follow-up|0|||
105664870|NCT01296555|364436702|FG010|Overall Study|Lost to Follow-up|0|||
105664871|NCT01296555|364436703|FG011|Overall Study|Lost to Follow-up|0|||
105664872|NCT01296555|364436704|FG012|Overall Study|Lost to Follow-up|0|||
105463143|NCT01600716|363709663|FG001|Overall Study|Personal Reasons|2|||
105463144|NCT01600716|363709662|FG000|Overall Study|Lost to Follow-up|0|||
105463145|NCT01600716|363709663|FG001|Overall Study|Lost to Follow-up|2|||
105463146|NCT01600716|363709662|FG000|Overall Study|Pregnancy|1|||
105463147|NCT01600716|363709663|FG001|Overall Study|Pregnancy|0|||
105463148|NCT01600716|363709662|FG000|Overall Study|Lack of Efficacy|2|||
105664873|NCT01296555|364436705|FG013|Overall Study|Lost to Follow-up|0|||
105551437|NCT01226745|364019143|FG001|Overall Study|Lost to Follow-up|6|||
105551438|NCT01226745|364019144|FG002|Overall Study|Lost to Follow-up|6|||
105551439|NCT01226745|364019145|FG003|Overall Study|Lost to Follow-up|1|||
105551440|NCT01226745|364019146|FG004|Overall Study|Lost to Follow-up|1|||
105551441|NCT01226745|364019147|FG005|Overall Study|Lost to Follow-up|2|||
105551442|NCT01226745|364019142|FG000|Overall Study|Death|1|||
105551443|NCT01226745|364019143|FG001|Overall Study|Death|0|||
105551444|NCT01226745|364019144|FG002|Overall Study|Death|0|||
105551445|NCT01226745|364019145|FG003|Overall Study|Death|0|||
105664874|NCT01296555|364436706|FG014|Overall Study|Lost to Follow-up|2|||
105664875|NCT01296555|364436707|FG015|Overall Study|Lost to Follow-up|1|||
105664876|NCT01296555|364436708|FG016|Overall Study|Lost to Follow-up|0|||
105664877|NCT01296555|364436709|FG017|Overall Study|Lost to Follow-up|2|||
105664878|NCT01296555|364436710|FG018|Overall Study|Lost to Follow-up|0|||
105664879|NCT01296555|364436711|FG019|Overall Study|Lost to Follow-up|2|||
105664880|NCT01296555|364436712|FG020|Overall Study|Lost to Follow-up|3|||
105664881|NCT01296555|364436713|FG021|Overall Study|Lost to Follow-up|2|||
105664882|NCT01296555|364436714|FG022|Overall Study|Lost to Follow-up|0|||
105664883|NCT01296555|364436715|FG023|Overall Study|Lost to Follow-up|0|||
105664884|NCT01296555|364436716|FG024|Overall Study|Lost to Follow-up|0|||
105664885|NCT01296555|364436717|FG025|Overall Study|Lost to Follow-up|0|||
105664886|NCT01296555|364436718|FG026|Overall Study|Lost to Follow-up|3|||
105664887|NCT01296555|364436719|FG027|Overall Study|Lost to Follow-up|13|||
105664888|NCT01296555|364436720|FG028|Overall Study|Lost to Follow-up|5|||
105664889|NCT01296555|364436692|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105664890|NCT01296555|364436693|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105664891|NCT01296555|364436694|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105664892|NCT01296555|364436695|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105664893|NCT01296555|364436696|FG004|Overall Study|Non-Compliance With Study Drug|0|||
105664894|NCT01296555|364436697|FG005|Overall Study|Non-Compliance With Study Drug|0|||
105664895|NCT01296555|364436698|FG006|Overall Study|Non-Compliance With Study Drug|0|||
105664896|NCT01296555|364436699|FG007|Overall Study|Non-Compliance With Study Drug|1|||
105664897|NCT01296555|364436700|FG008|Overall Study|Non-Compliance With Study Drug|0|||
105664898|NCT01296555|364436701|FG009|Overall Study|Non-Compliance With Study Drug|0|||
105664899|NCT01296555|364436702|FG010|Overall Study|Non-Compliance With Study Drug|0|||
105664900|NCT01296555|364436703|FG011|Overall Study|Non-Compliance With Study Drug|0|||
105664901|NCT01296555|364436704|FG012|Overall Study|Non-Compliance With Study Drug|0|||
105664902|NCT01296555|364436705|FG013|Overall Study|Non-Compliance With Study Drug|0|||
105664903|NCT01296555|364436706|FG014|Overall Study|Non-Compliance With Study Drug|0|||
105664904|NCT01296555|364436707|FG015|Overall Study|Non-Compliance With Study Drug|0|||
105664905|NCT01296555|364436708|FG016|Overall Study|Non-Compliance With Study Drug|0|||
105664906|NCT01296555|364436709|FG017|Overall Study|Non-Compliance With Study Drug|0|||
105664907|NCT01296555|364436710|FG018|Overall Study|Non-Compliance With Study Drug|0|||
105664908|NCT01296555|364436711|FG019|Overall Study|Non-Compliance With Study Drug|0|||
105664909|NCT01296555|364436712|FG020|Overall Study|Non-Compliance With Study Drug|0|||
105664910|NCT01296555|364436713|FG021|Overall Study|Non-Compliance With Study Drug|0|||
105664911|NCT01296555|364436714|FG022|Overall Study|Non-Compliance With Study Drug|0|||
105664912|NCT01296555|364436715|FG023|Overall Study|Non-Compliance With Study Drug|0|||
105664913|NCT01296555|364436716|FG024|Overall Study|Non-Compliance With Study Drug|0|||
105664914|NCT01296555|364436717|FG025|Overall Study|Non-Compliance With Study Drug|0|||
105664915|NCT01296555|364436718|FG026|Overall Study|Non-Compliance With Study Drug|0|||
105664916|NCT01296555|364436719|FG027|Overall Study|Non-Compliance With Study Drug|0|||
105664917|NCT01296555|364436720|FG028|Overall Study|Non-Compliance With Study Drug|0|||
105664918|NCT01296555|364436692|FG000|Overall Study|Withdrawal by Subject|0|||
105664919|NCT01296555|364436693|FG001|Overall Study|Withdrawal by Subject|0|||
105664920|NCT01296555|364436694|FG002|Overall Study|Withdrawal by Subject|0|||
105664921|NCT01296555|364436695|FG003|Overall Study|Withdrawal by Subject|0|||
105664922|NCT01296555|364436696|FG004|Overall Study|Withdrawal by Subject|1|||
105664923|NCT01296555|364436697|FG005|Overall Study|Withdrawal by Subject|0|||
105664924|NCT01296555|364436698|FG006|Overall Study|Withdrawal by Subject|1|||
105664925|NCT01296555|364436699|FG007|Overall Study|Withdrawal by Subject|0|||
105664926|NCT01296555|364436700|FG008|Overall Study|Withdrawal by Subject|0|||
105664927|NCT01296555|364436701|FG009|Overall Study|Withdrawal by Subject|0|||
105664928|NCT01296555|364436702|FG010|Overall Study|Withdrawal by Subject|1|||
105664929|NCT01296555|364436703|FG011|Overall Study|Withdrawal by Subject|1|||
105664930|NCT01296555|364436704|FG012|Overall Study|Withdrawal by Subject|0|||
105664931|NCT01296555|364436705|FG013|Overall Study|Withdrawal by Subject|0|||
105664932|NCT01296555|364436706|FG014|Overall Study|Withdrawal by Subject|3|||
105339819|NCT02980341|363245231|FG000|Dose Escalation|Withdrawal by Subject|0|||
105664933|NCT01296555|364436707|FG015|Overall Study|Withdrawal by Subject|0|||
105664934|NCT01296555|364436708|FG016|Overall Study|Withdrawal by Subject|2|||
105664935|NCT01296555|364436709|FG017|Overall Study|Withdrawal by Subject|1|||
105664936|NCT01296555|364436710|FG018|Overall Study|Withdrawal by Subject|0|||
105785754|NCT00570492|364868554|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
105785755|NCT00570492|364868552|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
105785756|NCT00570492|364868553|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
105785757|NCT00570492|364868554|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
105785758|NCT00570492|364868552|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
105785759|NCT00570492|364868553|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
105785760|NCT00570492|364868554|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
105785761|NCT01539512|364868556|FG000|Overall Study|Adverse Event|9|||
105785762|NCT01539512|364868557|FG001|Overall Study|Adverse Event|7|||
105785763|NCT01539512|364868556|FG000|Overall Study|Physician Decision|1|||
105785764|NCT01539512|364868557|FG001|Overall Study|Physician Decision|1|||
105785765|NCT01539512|364868556|FG000|Overall Study|Withdrawal by Subject|12|||
105785766|NCT01539512|364868557|FG001|Overall Study|Withdrawal by Subject|5|||
105785767|NCT01539512|364868556|FG000|Overall Study|Richter's Transformation|1|||
105785768|NCT01539512|364868557|FG001|Overall Study|Richter's Transformation|0|||
105785769|NCT05146999|364868560|FG000|Overall Study|Withdrew consent|6|||
105785770|NCT05146999|364868561|FG001|Overall Study|Withdrew consent|1|||
105785771|NCT05146999|364868560|FG000|Overall Study|Lost to Follow-up|3|||
105785772|NCT05146999|364868561|FG001|Overall Study|Lost to Follow-up|2|||
105785773|NCT05146999|364868560|FG000|Overall Study|Other|1|||
105785774|NCT05146999|364868561|FG001|Overall Study|Other|3|||
105785775|NCT04668157|364868562|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
105785776|NCT04668157|364868563|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
105785777|NCT04668157|364868562|FG000|Treatment Period (52 Weeks)|Other|0|||
105785778|NCT04668157|364868563|FG001|Treatment Period (52 Weeks)|Other|2|||
105785779|NCT03958045|364868564|FG000|Overall Study|Withdrawal by Subject|1|||
105785780|NCT04479358|364868567|FG000|Overall Study|Withdrawal by Subject|0|||
105785781|NCT04479358|364868568|FG001|Overall Study|Withdrawal by Subject|0|||
105785782|NCT04479358|364868569|FG002|Overall Study|Withdrawal by Subject|1|||
105785783|NCT04479358|364868570|FG003|Overall Study|Withdrawal by Subject|0|||
105785784|NCT04479358|364868571|FG004|Overall Study|Withdrawal by Subject|0|||
105785785|NCT04479358|364868572|FG005|Overall Study|Withdrawal by Subject|1|||
105785786|NCT05437211|364868574|FG000|Overall Study|Patient's decision|1|||
105785787|NCT05437211|364868575|FG001|Overall Study|Patient's decision|1|||
105785788|NCT01463631|364868585|FG000|Overall Study|Withdrawal by Subject|0|||
105463149|NCT01600716|363709663|FG001|Overall Study|Lack of Efficacy|1|||
105463150|NCT01600716|363709662|FG000|Overall Study|Adverse Event|1|||
105463151|NCT01600716|363709663|FG001|Overall Study|Adverse Event|1|||
105463152|NCT02379728|363709664|FG000|Overall Study|Lost to Follow-up|1|||
105463153|NCT02379728|363709665|FG001|Overall Study|Lost to Follow-up|0|||
105463154|NCT02379728|363709666|FG002|Overall Study|Lost to Follow-up|3|||
105463155|NCT02379728|363709667|FG003|Overall Study|Lost to Follow-up|0|||
105463156|NCT02379728|363709664|FG000|Overall Study|Withdrawal by Subject|5|||
105463157|NCT02379728|363709665|FG001|Overall Study|Withdrawal by Subject|0|||
105463158|NCT02379728|363709666|FG002|Overall Study|Withdrawal by Subject|5|||
105463159|NCT02379728|363709667|FG003|Overall Study|Withdrawal by Subject|3|||
105463160|NCT02379728|363709664|FG000|Overall Study|Protocol Violation|0|||
105463161|NCT02379728|363709665|FG001|Overall Study|Protocol Violation|0|||
105463162|NCT02379728|363709666|FG002|Overall Study|Protocol Violation|2|||
105463163|NCT02379728|363709667|FG003|Overall Study|Protocol Violation|0|||
105463164|NCT01907854|363709668|FG000|Overall Study|Protocol Violation|1|||
105463165|NCT01907854|363709669|FG001|Overall Study|Protocol Violation|1|||
105463166|NCT01907854|363709668|FG000|Overall Study|Withdrawal by Subject|9|||
105463167|NCT01907854|363709669|FG001|Overall Study|Withdrawal by Subject|7|||
105463168|NCT01907854|363709668|FG000|Overall Study|Lost to Follow-up|2|||
105463169|NCT01907854|363709669|FG001|Overall Study|Lost to Follow-up|2|||
105463170|NCT01907854|363709668|FG000|Overall Study|Unclassified|4|||
105463171|NCT01907854|363709669|FG001|Overall Study|Unclassified|3|||
105463172|NCT02796170|363709670|FG000|Overall Study|Lost to Follow-up|3|||
105463173|NCT02796170|363709671|FG001|Overall Study|Lost to Follow-up|0|||
105463174|NCT04313244|363709674|FG000|Overall Study|Withdrawal of Consent|3|||
105463175|NCT04313244|363709675|FG001|Overall Study|Withdrawal of Consent|3|||
105463176|NCT04313244|363709674|FG000|Overall Study|Met Exclusion Criteria|1|||
105463177|NCT04313244|363709675|FG001|Overall Study|Met Exclusion Criteria|0|||
105463178|NCT04313244|363709674|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
105463179|NCT04313244|363709675|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
105463180|NCT01472289|363709676|FG000|Overall Study|Death|2|||
105463181|NCT03112603|363709677|FG000|End of Randomization Period|Lost to Follow-up|3|||
105463182|NCT03112603|363709678|FG001|End of Randomization Period|Lost to Follow-up|0|||
105463183|NCT03112603|363709679|FG002|End of Randomization Period|Lost to Follow-up|0|||
105463184|NCT03112603|363709677|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
105463185|NCT03112603|363709678|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
105463186|NCT03112603|363709679|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
105463187|NCT03112603|363709677|FG000|End of Randomization Period|Physician Decision|43|||
105463188|NCT03112603|363709678|FG001|End of Randomization Period|Physician Decision|18|||
105463189|NCT03112603|363709679|FG002|End of Randomization Period|Physician Decision|0|||
105463190|NCT03112603|363709677|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
105463191|NCT03112603|363709678|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
105463192|NCT03112603|363709679|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
105463193|NCT03112603|363709677|FG000|End of Randomization Period|Death|10|||
105463194|NCT03112603|363709678|FG001|End of Randomization Period|Death|7|||
105463195|NCT03112603|363709679|FG002|End of Randomization Period|Death|0|||
105463196|NCT03112603|363709677|FG000|End of Randomization Period|Disease Relapse|12|||
105463197|NCT03112603|363709678|FG001|End of Randomization Period|Disease Relapse|7|||
105463198|NCT03112603|363709679|FG002|End of Randomization Period|Disease Relapse|0|||
105463199|NCT03112603|363709677|FG000|End of Randomization Period|Lack of Efficacy|25|||
105463200|NCT03112603|363709678|FG001|End of Randomization Period|Lack of Efficacy|77|||
105463201|NCT03112603|363709679|FG002|End of Randomization Period|Lack of Efficacy|0|||
105463202|NCT03112603|363709677|FG000|End of Randomization Period|Adverse Event|32|||
105463203|NCT03112603|363709678|FG001|End of Randomization Period|Adverse Event|12|||
105463204|NCT03112603|363709679|FG002|End of Randomization Period|Adverse Event|0|||
105463205|NCT03112603|363709677|FG000|End of Cross Over Period|Death|0|||
105463206|NCT03112603|363709678|FG001|End of Cross Over Period|Death|0|||
105463207|NCT03112603|363709679|FG002|End of Cross Over Period|Death|2|||
105463208|NCT03112603|363709677|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
105463209|NCT03112603|363709678|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
105463210|NCT03112603|363709679|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
105463211|NCT03112603|363709677|FG000|End of Cross Over Period|Physician Decision|0|||
105463212|NCT03112603|363709678|FG001|End of Cross Over Period|Physician Decision|0|||
105463213|NCT03112603|363709679|FG002|End of Cross Over Period|Physician Decision|29|||
105551446|NCT01226745|364019146|FG004|Overall Study|Death|0|||
105551447|NCT01226745|364019147|FG005|Overall Study|Death|1|||
105551448|NCT01226745|364019142|FG000|Overall Study|Other|6|||
105551449|NCT01226745|364019143|FG001|Overall Study|Other|7|||
105551450|NCT01226745|364019144|FG002|Overall Study|Other|8|||
105551451|NCT01226745|364019145|FG003|Overall Study|Other|4|||
105551452|NCT01226745|364019146|FG004|Overall Study|Other|3|||
105551453|NCT01226745|364019147|FG005|Overall Study|Other|1|||
105785789|NCT01463631|364868586|FG001|Overall Study|Withdrawal by Subject|0|||
105551454|NCT01587651|364019148|FG000|Overall Study|Adverse Event|0|||
105785790|NCT01463631|364868587|FG002|Overall Study|Withdrawal by Subject|0|||
105785791|NCT01463631|364868588|FG003|Overall Study|Withdrawal by Subject|1|||
105785792|NCT01463631|364868585|FG000|Overall Study|Death|0|||
105785793|NCT01463631|364868586|FG001|Overall Study|Death|0|||
105785794|NCT01463631|364868587|FG002|Overall Study|Death|1|||
105785795|NCT01463631|364868588|FG003|Overall Study|Death|0|||
105785796|NCT01463631|364868585|FG000|Overall Study|Progressive Disease|0|||
105785797|NCT01463631|364868586|FG001|Overall Study|Progressive Disease|0|||
105785798|NCT01463631|364868587|FG002|Overall Study|Progressive Disease|0|||
105785799|NCT01463631|364868588|FG003|Overall Study|Progressive Disease|5|||
105785800|NCT05966129|364868591|FG000|Overall Study|Death|1|||
105785801|NCT05966129|364868592|FG001|Overall Study|Death|2|||
105785802|NCT05966129|364868591|FG000|Overall Study|Lost to Follow-up|63|||
105785803|NCT05966129|364868592|FG001|Overall Study|Lost to Follow-up|66|||
105785804|NCT05966129|364868591|FG000|Overall Study|Protocol Violation|1|||
105785805|NCT05966129|364868592|FG001|Overall Study|Protocol Violation|0|||
105785806|NCT05966129|364868591|FG000|Overall Study|Withdrawal by Subject|26|||
105785807|NCT05966129|364868592|FG001|Overall Study|Withdrawal by Subject|25|||
105785808|NCT05966129|364868591|FG000|Overall Study|Surgery not completed|63|||
105785809|NCT05966129|364868592|FG001|Overall Study|Surgery not completed|69|||
105785810|NCT05966129|364868591|FG000|Overall Study|Surgery logistics issue|2|||
105785811|NCT05966129|364868592|FG001|Overall Study|Surgery logistics issue|1|||
105785812|NCT01298323|364868593|FG000|Overall Study|Adverse Event|2|||
105785813|NCT01298323|364868594|FG001|Overall Study|Adverse Event|4|||
105785814|NCT01298323|364868593|FG000|Overall Study|Death|11|||
105785815|NCT01298323|364868594|FG001|Overall Study|Death|16|||
105785816|NCT01298323|364868593|FG000|Overall Study|Lost to Follow-up|1|||
105785817|NCT01298323|364868594|FG001|Overall Study|Lost to Follow-up|0|||
105785818|NCT01298323|364868593|FG000|Overall Study|Withdrawal by Subject|6|||
105785819|NCT01298323|364868594|FG001|Overall Study|Withdrawal by Subject|3|||
105785820|NCT01298323|364868593|FG000|Overall Study|Protocol Violation|1|||
105785821|NCT01298323|364868594|FG001|Overall Study|Protocol Violation|0|||
105785822|NCT01298323|364868593|FG000|Overall Study|Other|10|||
105785823|NCT01298323|364868594|FG001|Overall Study|Other|9|||
105785824|NCT01298323|364868593|FG000|Overall Study|Ongoing|55|||
105785825|NCT01298323|364868594|FG001|Overall Study|Ongoing|55|||
105785826|NCT01298323|364868593|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105785827|NCT01298323|364868594|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
105785828|NCT04502862|364868598|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
105785829|NCT04502862|364868599|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
105785830|NCT04502862|364868598|FG000|Overall Study|Withdrawal by Subject|1|||
105785831|NCT04502862|364868599|FG001|Overall Study|Withdrawal by Subject|0|||
105785832|NCT04502862|364868598|FG000|Overall Study|Adverse Event|1|||
105785833|NCT04502862|364868599|FG001|Overall Study|Adverse Event|1|||
105785834|NCT02646566|364870354|FG000|Overall Study|Lost to Follow-up|5|||
105785835|NCT02646566|364870355|FG001|Overall Study|Lost to Follow-up|4|||
105785836|NCT02646566|364870356|FG002|Overall Study|Lost to Follow-up|5|||
105785837|NCT02646566|364870354|FG000|Overall Study|Treatment failure|1|||
105785838|NCT02646566|364870355|FG001|Overall Study|Treatment failure|0|||
105785839|NCT02646566|364870356|FG002|Overall Study|Treatment failure|0|||
105785840|NCT02222246|364870357|FG000|Overall Study|No Emergency Department Visits|27|||
105785841|NCT02222246|364870358|FG001|Overall Study|No Emergency Department Visits|26|||
105785842|NCT02222246|364870357|FG000|Overall Study|Physician Decision|0|||
105785843|NCT02222246|364870358|FG001|Overall Study|Physician Decision|1|||
105785844|NCT00474994|364870359|FG000|Overall Study|Patient Not treated|1|||
105785845|NCT00474994|364870359|FG000|Overall Study|Patient evaluable for toxicity only|3|||
105785846|NCT00474994|364870359|FG000|Overall Study|Patient found to be ineligible|1|||
105785847|NCT02064231|364870360|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
105785848|NCT02064231|364870361|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
105785849|NCT02064231|364870362|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
105785850|NCT02064231|364870363|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
105785851|NCT02064231|364870360|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
105785852|NCT02064231|364870361|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
105785853|NCT02064231|364870362|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
105785854|NCT02064231|364870363|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
105551455|NCT01587651|364019149|FG001|Overall Study|Adverse Event|1|||
105551456|NCT01587651|364019150|FG002|Overall Study|Adverse Event|0|||
105551457|NCT01587651|364019148|FG000|Overall Study|Protocol Violation|0|||
105551458|NCT01587651|364019149|FG001|Overall Study|Protocol Violation|1|||
105551459|NCT01587651|364019150|FG002|Overall Study|Protocol Violation|1|||
105551460|NCT01587651|364019148|FG000|Overall Study|Withdrawal by Subject|0|||
105551461|NCT01587651|364019149|FG001|Overall Study|Withdrawal by Subject|1|||
105551462|NCT01587651|364019150|FG002|Overall Study|Withdrawal by Subject|0|||
105551463|NCT01650259|364019151|FG000|Overall Study|Improvement|105|||
105551464|NCT01650259|364019152|FG001|Overall Study|Improvement|0|||
105551465|NCT01650259|364019151|FG000|Overall Study|Adverse Event|127|||
105551466|NCT01650259|364019152|FG001|Overall Study|Adverse Event|0|||
105551467|NCT01650259|364019151|FG000|Overall Study|Lack of Efficacy|143|||
105551468|NCT01650259|364019152|FG001|Overall Study|Lack of Efficacy|0|||
105551469|NCT01650259|364019151|FG000|Overall Study|Lost to Follow-up|435|||
105551470|NCT01650259|364019152|FG001|Overall Study|Lost to Follow-up|0|||
105551471|NCT01650259|364019151|FG000|Overall Study|Patients had no visit after entry|70|||
105664937|NCT01296555|364436711|FG019|Overall Study|Withdrawal by Subject|1|||
105664938|NCT01296555|364436712|FG020|Overall Study|Withdrawal by Subject|1|||
105785855|NCT02064231|364870360|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
105551472|NCT01650259|364019152|FG001|Overall Study|Patients had no visit after entry|0|||
105551473|NCT01650259|364019151|FG000|Overall Study|CRF not collected|98|||
105551474|NCT01650259|364019152|FG001|Overall Study|CRF not collected|82|||
105551475|NCT01650259|364019151|FG000|Overall Study|Not treated|1|||
105785856|NCT02064231|364870361|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
105785857|NCT02064231|364870362|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
105785858|NCT02064231|364870363|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
105785859|NCT02064231|364870360|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
105785860|NCT02064231|364870361|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
105785861|NCT02064231|364870362|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
105785862|NCT02064231|364870363|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
105785863|NCT04887922|364870364|FG000|1st Randomization|Decided not to have surgery|0|||
105785864|NCT04887922|364870365|FG001|1st Randomization|Decided not to have surgery|1|||
105785865|NCT04887922|364870366|FG002|1st Randomization|Decided not to have surgery|0|||
105785866|NCT04887922|364870367|FG003|1st Randomization|Decided not to have surgery|0|||
105785867|NCT04887922|364870368|FG004|1st Randomization|Decided not to have surgery|0|||
105785868|NCT00536991|364870369|FG000|Overall Study|Withdrawal by Subject|10|||
105785869|NCT00536991|364870369|FG000|Overall Study|Physician Decision|1|||
105785870|NCT00536991|364870369|FG000|Overall Study|patient ineligible|2|||
105785871|NCT04576702|364870370|FG000|Overall Study|Death|1|||
105785872|NCT04576702|364870371|FG001|Overall Study|Death|0|||
105785873|NCT04576702|364870372|FG002|Overall Study|Death|0|||
105785874|NCT04576702|364870373|FG003|Overall Study|Death|0|||
105785875|NCT04576702|364870370|FG000|Overall Study|Withdrawal by Subject|0|||
105785876|NCT04576702|364870371|FG001|Overall Study|Withdrawal by Subject|2|||
105785877|NCT04576702|364870372|FG002|Overall Study|Withdrawal by Subject|1|||
105785878|NCT04576702|364870373|FG003|Overall Study|Withdrawal by Subject|0|||
105785879|NCT04576702|364870370|FG000|Overall Study|Lost to Follow-up|3|||
105785880|NCT04576702|364870371|FG001|Overall Study|Lost to Follow-up|3|||
105785881|NCT04576702|364870372|FG002|Overall Study|Lost to Follow-up|3|||
105785882|NCT04576702|364870373|FG003|Overall Study|Lost to Follow-up|4|||
105785883|NCT03471507|364870377|FG000|Overall Study|Lost to Follow-up|1|||
105785884|NCT03471507|364870378|FG001|Overall Study|Lost to Follow-up|3|||
105785885|NCT03471507|364870377|FG000|Overall Study|Physician Decision|0|||
105785886|NCT03471507|364870378|FG001|Overall Study|Physician Decision|1|||
105785887|NCT03471507|364870377|FG000|Overall Study|Withdrawal by Subject|2|||
105785888|NCT03471507|364870378|FG001|Overall Study|Withdrawal by Subject|1|||
105785889|NCT00998166|364870379|FG000|Overall Study|Early Study Termination|8|||
105785890|NCT03841331|364870380|FG000|Overall Study|Withdrawal by Subject|4|||
105785891|NCT03841331|364870381|FG001|Overall Study|Withdrawal by Subject|9|||
105785892|NCT03841331|364870380|FG000|Overall Study|Lost to Follow-up|5|||
105785893|NCT03841331|364870381|FG001|Overall Study|Lost to Follow-up|1|||
105785894|NCT04988035|364870382|FG000|Overall Study|Death|19|||
105785895|NCT04988035|364870383|FG001|Overall Study|Death|13|||
105785896|NCT04988035|364870382|FG000|Overall Study|Lost to Follow-up|12|||
105785897|NCT04988035|364870383|FG001|Overall Study|Lost to Follow-up|6|||
105785898|NCT04988035|364870382|FG000|Overall Study|Protocol Violation|0|||
105785899|NCT04988035|364870383|FG001|Overall Study|Protocol Violation|1|||
105785900|NCT04988035|364870382|FG000|Overall Study|Withdrawal by Subject|2|||
105785901|NCT04988035|364870383|FG001|Overall Study|Withdrawal by Subject|4|||
105785902|NCT04988035|364870382|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
105785903|NCT04988035|364870383|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
105785904|NCT03602976|364870384|FG000|Overall Study|Withdrawal by Subject|1|||
105785905|NCT00442572|364870386|FG000|Overall Study|Relapse|8|||
105785906|NCT00442572|364870387|FG001|Overall Study|Relapse|1|||
105551476|NCT01650259|364019152|FG001|Overall Study|Not treated|7|||
105664939|NCT01296555|364436713|FG021|Overall Study|Withdrawal by Subject|1|||
105664940|NCT01296555|364436714|FG022|Overall Study|Withdrawal by Subject|3|||
105664941|NCT01296555|364436715|FG023|Overall Study|Withdrawal by Subject|0|||
105664942|NCT01296555|364436716|FG024|Overall Study|Withdrawal by Subject|0|||
105664943|NCT01296555|364436717|FG025|Overall Study|Withdrawal by Subject|0|||
105664944|NCT01296555|364436718|FG026|Overall Study|Withdrawal by Subject|8|||
105664945|NCT01296555|364436719|FG027|Overall Study|Withdrawal by Subject|4|||
105339820|NCT02980341|363245232|FG001|Dose Escalation|Withdrawal by Subject|0|||
105339821|NCT02980341|363245233|FG002|Dose Escalation|Withdrawal by Subject|1|||
105339822|NCT02980341|363245234|FG003|Dose Escalation|Withdrawal by Subject|0|||
105339823|NCT02980341|363245235|FG004|Dose Escalation|Withdrawal by Subject|0|||
105339824|NCT02980341|363245236|FG005|Dose Escalation|Withdrawal by Subject|0|||
105339825|NCT02980341|363245237|FG006|Dose Escalation|Withdrawal by Subject|0|||
105339826|NCT02980341|363245238|FG007|Dose Escalation|Withdrawal by Subject|0|||
105339827|NCT02980341|363245239|FG008|Dose Escalation|Withdrawal by Subject|0|||
105339828|NCT02980341|363245240|FG009|Dose Escalation|Withdrawal by Subject|0|||
105339829|NCT02980341|363245241|FG010|Dose Escalation|Withdrawal by Subject|0|||
105339830|NCT02980341|363245231|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
105339831|NCT02980341|363245232|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
105339832|NCT02980341|363245233|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
105339833|NCT02980341|363245234|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
105339834|NCT02980341|363245235|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
105339835|NCT02980341|363245236|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
105339836|NCT02980341|363245237|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
105339837|NCT02980341|363245238|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
105339838|NCT02980341|363245239|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
105339839|NCT02980341|363245240|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
105339840|NCT02980341|363245241|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
105339841|NCT02980341|363245231|FG000|Dose Escalation|Due to investigator's decision|0|||
105339842|NCT02980341|363245232|FG001|Dose Escalation|Due to investigator's decision|0|||
105339843|NCT02980341|363245233|FG002|Dose Escalation|Due to investigator's decision|0|||
105339844|NCT02980341|363245234|FG003|Dose Escalation|Due to investigator's decision|0|||
105339845|NCT02980341|363245235|FG004|Dose Escalation|Due to investigator's decision|1|||
105339846|NCT02980341|363245236|FG005|Dose Escalation|Due to investigator's decision|0|||
105339847|NCT02980341|363245237|FG006|Dose Escalation|Due to investigator's decision|0|||
105339848|NCT02980341|363245238|FG007|Dose Escalation|Due to investigator's decision|0|||
105339849|NCT02980341|363245239|FG008|Dose Escalation|Due to investigator's decision|0|||
105339850|NCT02980341|363245240|FG009|Dose Escalation|Due to investigator's decision|0|||
105339851|NCT02980341|363245241|FG010|Dose Escalation|Due to investigator's decision|0|||
105339852|NCT02980341|363245231|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
105339853|NCT02980341|363245232|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
105339854|NCT02980341|363245233|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
105664946|NCT01296555|364436720|FG028|Overall Study|Withdrawal by Subject|2|||
105664947|NCT01358331|364436721|FG000|Overall Study|Lost to Follow-up|0|||
105664948|NCT01358331|364436722|FG001|Overall Study|Lost to Follow-up|0|||
105339855|NCT02980341|363245234|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
105339856|NCT02980341|363245235|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
105339857|NCT02980341|363245236|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
105339858|NCT02980341|363245237|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
105339859|NCT02980341|363245238|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
105339860|NCT02980341|363245239|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
105339861|NCT02980341|363245240|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
105339862|NCT02980341|363245241|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
105339863|NCT02980341|363245231|FG000|Dose Finding|Adverse Event|0|||
105339864|NCT02980341|363245232|FG001|Dose Finding|Adverse Event|0|||
105339865|NCT02980341|363245233|FG002|Dose Finding|Adverse Event|0|||
105339866|NCT02980341|363245234|FG003|Dose Finding|Adverse Event|0|||
105339867|NCT02980341|363245235|FG004|Dose Finding|Adverse Event|0|||
105339868|NCT02980341|363245236|FG005|Dose Finding|Adverse Event|3|||
105339869|NCT02980341|363245237|FG006|Dose Finding|Adverse Event|0|||
105339870|NCT02980341|363245238|FG007|Dose Finding|Adverse Event|0|||
105339871|NCT02980341|363245239|FG008|Dose Finding|Adverse Event|0|||
105339872|NCT02980341|363245240|FG009|Dose Finding|Adverse Event|0|||
105339873|NCT02980341|363245241|FG010|Dose Finding|Adverse Event|0|||
105339874|NCT02980341|363245231|FG000|Dose Finding|Withdrawal by Subject|0|||
105339875|NCT02980341|363245232|FG001|Dose Finding|Withdrawal by Subject|0|||
105339876|NCT02980341|363245233|FG002|Dose Finding|Withdrawal by Subject|0|||
105339877|NCT02980341|363245234|FG003|Dose Finding|Withdrawal by Subject|0|||
105339878|NCT02980341|363245235|FG004|Dose Finding|Withdrawal by Subject|0|||
105339879|NCT02980341|363245236|FG005|Dose Finding|Withdrawal by Subject|1|||
105339880|NCT02980341|363245237|FG006|Dose Finding|Withdrawal by Subject|1|||
105339881|NCT02980341|363245238|FG007|Dose Finding|Withdrawal by Subject|0|||
105339882|NCT02980341|363245239|FG008|Dose Finding|Withdrawal by Subject|0|||
105339883|NCT02980341|363245240|FG009|Dose Finding|Withdrawal by Subject|0|||
105339884|NCT02980341|363245241|FG010|Dose Finding|Withdrawal by Subject|0|||
105339885|NCT02980341|363245231|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
105339886|NCT02980341|363245232|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
105339887|NCT02980341|363245233|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
105339888|NCT02980341|363245234|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
105339889|NCT02980341|363245235|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
105339890|NCT02980341|363245236|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
105339891|NCT02980341|363245237|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
105339892|NCT02980341|363245238|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
105339893|NCT02980341|363245239|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
105339894|NCT02980341|363245240|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
105339895|NCT02980341|363245241|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
105339896|NCT02980341|363245231|FG000|Dose Expansion|Clinical progression|0|||
105339897|NCT02980341|363245232|FG001|Dose Expansion|Clinical progression|0|||
105339898|NCT02980341|363245233|FG002|Dose Expansion|Clinical progression|0|||
105339899|NCT02980341|363245234|FG003|Dose Expansion|Clinical progression|0|||
105339900|NCT02980341|363245235|FG004|Dose Expansion|Clinical progression|0|||
105339901|NCT02980341|363245236|FG005|Dose Expansion|Clinical progression|0|||
105339902|NCT02980341|363245237|FG006|Dose Expansion|Clinical progression|0|||
105339903|NCT02980341|363245238|FG007|Dose Expansion|Clinical progression|4|||
105339904|NCT02980341|363245239|FG008|Dose Expansion|Clinical progression|3|||
105551477|NCT01650259|364019151|FG000|Overall Study|Other than listed|64|||
105551478|NCT01650259|364019152|FG001|Overall Study|Other than listed|146|||
105551479|NCT00092131|364019153|FG000|Treatment Period I|Adverse Event|1|||
105551480|NCT00092131|364019154|FG001|Treatment Period I|Adverse Event|0|||
105551481|NCT00092131|364019153|FG000|Treatment Period II|Adverse Event|0|||
105551482|NCT00092131|364019154|FG001|Treatment Period II|Adverse Event|1|||
105551483|NCT04403698|364019155|FG000|Overall Study|Adverse Event|1|||
105551484|NCT04403698|364019156|FG001|Overall Study|Adverse Event|1|||
105551485|NCT04403698|364019155|FG000|Overall Study|Lost to Follow-up|1|||
105339905|NCT02980341|363245240|FG009|Dose Expansion|Clinical progression|1|||
105339906|NCT02980341|363245241|FG010|Dose Expansion|Clinical progression|4|||
105339907|NCT02980341|363245231|FG000|Dose Expansion|Adverse Event|0|||
105339908|NCT02980341|363245232|FG001|Dose Expansion|Adverse Event|0|||
105551486|NCT04403698|364019156|FG001|Overall Study|Lost to Follow-up|0|||
105551487|NCT04403698|364019155|FG000|Overall Study|Protocol Violation|0|||
105339909|NCT02980341|363245233|FG002|Dose Expansion|Adverse Event|0|||
105339910|NCT02980341|363245234|FG003|Dose Expansion|Adverse Event|0|||
105339911|NCT02980341|363245235|FG004|Dose Expansion|Adverse Event|0|||
105339912|NCT02980341|363245236|FG005|Dose Expansion|Adverse Event|0|||
105339913|NCT02980341|363245237|FG006|Dose Expansion|Adverse Event|0|||
105339914|NCT02980341|363245238|FG007|Dose Expansion|Adverse Event|3|||
105551488|NCT04403698|364019156|FG001|Overall Study|Protocol Violation|1|||
105551489|NCT04323436|364019159|FG000|Overall Study|Adverse Event|7|||
105551490|NCT04323436|364019160|FG001|Overall Study|Adverse Event|0|||
105339915|NCT02980341|363245239|FG008|Dose Expansion|Adverse Event|0|||
105551491|NCT04323436|364019161|FG002|Overall Study|Adverse Event|0|||
105664949|NCT01358331|364436723|FG002|Overall Study|Lost to Follow-up|0|||
105664950|NCT01358331|364436724|FG003|Overall Study|Lost to Follow-up|1|||
105664951|NCT01358331|364436725|FG004|Overall Study|Lost to Follow-up|0|||
105664952|NCT01358331|364436726|FG005|Overall Study|Lost to Follow-up|0|||
105664953|NCT01358331|364436721|FG000|Overall Study|Withdrawal by Subject|0|||
105664954|NCT01358331|364436722|FG001|Overall Study|Withdrawal by Subject|0|||
105664955|NCT01358331|364436723|FG002|Overall Study|Withdrawal by Subject|0|||
105664956|NCT01358331|364436724|FG003|Overall Study|Withdrawal by Subject|1|||
105664957|NCT01358331|364436725|FG004|Overall Study|Withdrawal by Subject|1|||
105664958|NCT01358331|364436726|FG005|Overall Study|Withdrawal by Subject|1|||
105664959|NCT01358331|364436721|FG000|Overall Study|Adverse Events|1|||
105664960|NCT01358331|364436722|FG001|Overall Study|Adverse Events|1|||
105664961|NCT01358331|364436723|FG002|Overall Study|Adverse Events|1|||
105664962|NCT01358331|364436724|FG003|Overall Study|Adverse Events|0|||
105664963|NCT01358331|364436725|FG004|Overall Study|Adverse Events|1|||
105463214|NCT03112603|363709677|FG000|End of Cross Over Period|Lack of Efficacy|0|||
105463215|NCT03112603|363709678|FG001|End of Cross Over Period|Lack of Efficacy|0|||
105463216|NCT03112603|363709679|FG002|End of Cross Over Period|Lack of Efficacy|8|||
105463217|NCT03112603|363709677|FG000|End of Cross Over Period|Adverse Event|0|||
105463218|NCT03112603|363709678|FG001|End of Cross Over Period|Adverse Event|0|||
105463219|NCT03112603|363709679|FG002|End of Cross Over Period|Adverse Event|6|||
105463220|NCT03112603|363709677|FG000|End of Cross Over Period|Disease Relapse|0|||
105463221|NCT03112603|363709678|FG001|End of Cross Over Period|Disease Relapse|0|||
105463222|NCT03112603|363709679|FG002|End of Cross Over Period|Disease Relapse|2|||
105463223|NCT02161016|363709680|FG000|Overall Study|withdrawn by IRB|1|||
105463224|NCT00912808|363709681|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
105463225|NCT00912808|363709682|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
105463226|NCT00912808|363709681|FG000|Washout|Withdrawal by Subject|0|||
105463227|NCT00912808|363709682|FG001|Washout|Withdrawal by Subject|1|||
105463228|NCT00912808|363709681|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
105463229|NCT00912808|363709682|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
105463230|NCT00912808|363709681|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
105463231|NCT00912808|363709682|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
105463232|NCT03873116|363709683|FG000|Part 1|Study drug discontinuation due to rash|0|||
105463233|NCT03873116|363709684|FG001|Part 1|Study drug discontinuation due to rash|0|||
105463234|NCT03873116|363709685|FG002|Part 1|Study drug discontinuation due to rash|0|||
105463235|NCT03873116|363709686|FG003|Part 1|Study drug discontinuation due to rash|0|||
105463236|NCT03873116|363709687|FG004|Part 1|Study drug discontinuation due to rash|0|||
105463237|NCT03873116|363709688|FG005|Part 1|Study drug discontinuation due to rash|1|||
105463238|NCT03873116|363709683|FG000|Part 2|Withdrawal by Subject|0|||
105463239|NCT03873116|363709684|FG001|Part 2|Withdrawal by Subject|0|||
105463240|NCT03873116|363709685|FG002|Part 2|Withdrawal by Subject|1|||
105551492|NCT04323436|364019159|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
105551493|NCT04323436|364019160|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
105551494|NCT04323436|364019161|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
105551495|NCT04323436|364019159|FG000|Overall Study|Death|1|||
105551496|NCT04323436|364019160|FG001|Overall Study|Death|0|||
105551497|NCT04323436|364019161|FG002|Overall Study|Death|0|||
105551498|NCT04323436|364019159|FG000|Overall Study|Physician Decision|2|||
105551499|NCT04323436|364019160|FG001|Overall Study|Physician Decision|0|||
105551500|NCT04323436|364019161|FG002|Overall Study|Physician Decision|0|||
105664964|NCT01358331|364436726|FG005|Overall Study|Adverse Events|5|||
105664965|NCT01358331|364436721|FG000|Overall Study|Symptomatic Deterioration|0|||
105664966|NCT01358331|364436722|FG001|Overall Study|Symptomatic Deterioration|0|||
105664967|NCT01358331|364436723|FG002|Overall Study|Symptomatic Deterioration|0|||
105463241|NCT03873116|363709686|FG003|Part 2|Withdrawal by Subject|0|||
105551501|NCT04323436|364019159|FG000|Overall Study|Progressive disease|10|||
105551502|NCT04323436|364019160|FG001|Overall Study|Progressive disease|0|||
105551503|NCT04323436|364019161|FG002|Overall Study|Progressive disease|0|||
105664968|NCT01358331|364436724|FG003|Overall Study|Symptomatic Deterioration|0|||
105339916|NCT02980341|363245240|FG009|Dose Expansion|Adverse Event|1|||
105339917|NCT02980341|363245241|FG010|Dose Expansion|Adverse Event|3|||
105339918|NCT02980341|363245231|FG000|Dose Expansion|Death|0|||
105339919|NCT02980341|363245232|FG001|Dose Expansion|Death|0|||
105339920|NCT02980341|363245233|FG002|Dose Expansion|Death|0|||
105339921|NCT02980341|363245234|FG003|Dose Expansion|Death|0|||
105339922|NCT02980341|363245235|FG004|Dose Expansion|Death|0|||
105339923|NCT02980341|363245236|FG005|Dose Expansion|Death|0|||
105339924|NCT02980341|363245237|FG006|Dose Expansion|Death|0|||
105339925|NCT02980341|363245238|FG007|Dose Expansion|Death|0|||
105339926|NCT02980341|363245239|FG008|Dose Expansion|Death|2|||
105339927|NCT02980341|363245240|FG009|Dose Expansion|Death|1|||
105339928|NCT02980341|363245241|FG010|Dose Expansion|Death|0|||
105339929|NCT02980341|363245231|FG000|Dose Expansion|Withdrawal by Subject|0|||
105339930|NCT02980341|363245232|FG001|Dose Expansion|Withdrawal by Subject|0|||
105339931|NCT02980341|363245233|FG002|Dose Expansion|Withdrawal by Subject|0|||
105339932|NCT02980341|363245234|FG003|Dose Expansion|Withdrawal by Subject|0|||
105664969|NCT01358331|364436725|FG004|Overall Study|Symptomatic Deterioration|1|||
105664970|NCT01358331|364436726|FG005|Overall Study|Symptomatic Deterioration|0|||
105664971|NCT01358331|364436721|FG000|Overall Study|Participants did not wish to continue|0|||
105664972|NCT01358331|364436722|FG001|Overall Study|Participants did not wish to continue|0|||
105664973|NCT01358331|364436723|FG002|Overall Study|Participants did not wish to continue|0|||
105664974|NCT01358331|364436724|FG003|Overall Study|Participants did not wish to continue|0|||
105664975|NCT01358331|364436725|FG004|Overall Study|Participants did not wish to continue|1|||
105664976|NCT01358331|364436726|FG005|Overall Study|Participants did not wish to continue|0|||
105664977|NCT01358331|364436721|FG000|Overall Study|Progress of disease under investigation|1|||
105664978|NCT01358331|364436722|FG001|Overall Study|Progress of disease under investigation|2|||
105664979|NCT01358331|364436723|FG002|Overall Study|Progress of disease under investigation|3|||
105664980|NCT01358331|364436724|FG003|Overall Study|Progress of disease under investigation|1|||
105664981|NCT01358331|364436725|FG004|Overall Study|Progress of disease under investigation|3|||
105664982|NCT01358331|364436726|FG005|Overall Study|Progress of disease under investigation|0|||
105664983|NCT01637077|364436727|FG000|Overall Study|Cancel|1|||
105664984|NCT01637077|364436728|FG001|Overall Study|Cancel|1|||
105664985|NCT01637077|364436727|FG000|Overall Study|Withdrawal by Subject|1|||
105664986|NCT01637077|364436728|FG001|Overall Study|Withdrawal by Subject|0|||
105664987|NCT01637077|364436727|FG000|Overall Study|No cycle 1 questionnaire data|2|||
105664988|NCT01637077|364436728|FG001|Overall Study|No cycle 1 questionnaire data|0|||
105664989|NCT02595372|364436729|FG000|Overall Study|Adverse Event|6|||
105664990|NCT02595372|364436729|FG000|Overall Study|Physician Decision|2|||
105664991|NCT02595372|364436729|FG000|Overall Study|Disease Progression|1|||
105664992|NCT01889069|364436732|FG000|Overall Study|Death|18|||
105664993|NCT01889069|364436732|FG000|Overall Study|Progression of Disease|14|||
105664994|NCT01889069|364436732|FG000|Overall Study|Lost to Follow-up|6|||
105664995|NCT01889069|364436732|FG000|Overall Study|Other|4|||
105664996|NCT01889069|364436732|FG000|Overall Study|Consent Withdrawal|3|||
105664997|NCT00658606|364436734|FG000|Overall Study|Adverse Event|2|||
105664998|NCT00658606|364436735|FG001|Overall Study|Adverse Event|1|||
105664999|NCT00658606|364436734|FG000|Overall Study|Lack of Efficacy|6|||
105665000|NCT00658606|364436735|FG001|Overall Study|Lack of Efficacy|3|||
105665001|NCT00658606|364436734|FG000|Overall Study|Lost to Follow-up|1|||
105665002|NCT00658606|364436735|FG001|Overall Study|Lost to Follow-up|0|||
105665003|NCT00658606|364436734|FG000|Overall Study|Withdrawal by Subject|7|||
105665004|NCT00658606|364436735|FG001|Overall Study|Withdrawal by Subject|16|||
105665005|NCT00658606|364436734|FG000|Overall Study|Lack of Compliance|0|||
105665006|NCT00658606|364436735|FG001|Overall Study|Lack of Compliance|3|||
105665007|NCT04982575|364436736|FG000|Overall Study|Withdrawal by Subject|2|||
105665008|NCT04982575|364436737|FG001|Overall Study|Withdrawal by Subject|0|||
105665009|NCT04982575|364436738|FG002|Overall Study|Withdrawal by Subject|2|||
105665010|NCT03075527|364436739|FG000|Overall Study|Death|1|||
105665011|NCT03075527|364436739|FG000|Overall Study|Withdrawal by Subject|1|||
105665012|NCT03075527|364436739|FG000|Overall Study|Physician Decision|3|||
105665013|NCT03075527|364436739|FG000|Overall Study|Progression/Relapse|14|||
105665014|NCT04946942|364436740|FG000|Overall Study|Lost to Follow-up|6|||
105785907|NCT00442572|364870386|FG000|Overall Study|Lost to Follow-up|0|||
105785908|NCT00442572|364870387|FG001|Overall Study|Lost to Follow-up|1|||
105785909|NCT00442572|364870386|FG000|Overall Study|Withdrawal by Subject|0|||
105785910|NCT00442572|364870387|FG001|Overall Study|Withdrawal by Subject|1|||
105785911|NCT03532048|364870388|FG000|Overall Study|Lost to Follow-up|12|||
105785912|NCT03532048|364870389|FG001|Overall Study|Lost to Follow-up|17|||
105785913|NCT03532048|364870388|FG000|Overall Study|Withdrawal by Subject|7|||
105785914|NCT03532048|364870389|FG001|Overall Study|Withdrawal by Subject|0|||
105785915|NCT02190604|364870392|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785916|NCT02190604|364870393|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785917|NCT02190604|364870394|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785918|NCT02190604|364870395|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785919|NCT02190604|364870396|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785920|NCT02190604|364870397|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785921|NCT02190604|364870398|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785922|NCT02190604|364870399|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785923|NCT02190604|364870400|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785924|NCT02190604|364870401|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785925|NCT02190604|364870402|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785926|NCT02190604|364870403|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785927|NCT02190604|364870404|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785928|NCT02190604|364870405|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785929|NCT02190604|364870406|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
105785930|NCT02190604|364870407|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785931|NCT02190604|364870408|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785932|NCT02190604|364870409|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785933|NCT02190604|364870410|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785934|NCT02190604|364870392|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785935|NCT02190604|364870393|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785936|NCT02190604|364870394|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785937|NCT02190604|364870395|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785938|NCT02190604|364870396|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785939|NCT02190604|364870397|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785940|NCT02190604|364870398|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785941|NCT02190604|364870399|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785942|NCT02190604|364870400|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785943|NCT02190604|364870401|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785944|NCT02190604|364870402|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785945|NCT02190604|364870403|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785946|NCT02190604|364870404|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785947|NCT02190604|364870405|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
105785948|NCT02190604|364870406|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785949|NCT02190604|364870407|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785950|NCT02190604|364870408|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785951|NCT02190604|364870409|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785952|NCT02190604|364870410|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785953|NCT02797951|364870413|FG000|Overall Study|Adverse Event|4|||
105785954|NCT02797951|364870413|FG000|Overall Study|Death|1|||
105785955|NCT02797951|364870413|FG000|Overall Study|Lack of Efficacy|19|||
105785956|NCT02797951|364870413|FG000|Overall Study|Lost to Follow-up|4|||
105785957|NCT02797951|364870413|FG000|Overall Study|Physician Decision|6|||
105785958|NCT02797951|364870413|FG000|Overall Study|Withdrawal by Subject|15|||
105785959|NCT00814502|364870414|FG000|Overall Study|Adverse Event|1|||
105785960|NCT00814502|364870415|FG001|Overall Study|Adverse Event|0|||
105785961|NCT00814502|364870414|FG000|Overall Study|Withdrawal by Subject|0|||
105785962|NCT00814502|364870415|FG001|Overall Study|Withdrawal by Subject|2|||
105785963|NCT03735849|364870419|FG000|Overall Study|Lost to Follow-up|1|||
105785964|NCT03735849|364870420|FG001|Overall Study|Lost to Follow-up|0|||
105785965|NCT03735849|364870421|FG002|Overall Study|Lost to Follow-up|0|||
105785966|NCT03735849|364870419|FG000|Overall Study|Participant unable to adhere to visit|1|||
105463242|NCT03873116|363709687|FG004|Part 2|Withdrawal by Subject|0|||
105463243|NCT03873116|363709688|FG005|Part 2|Withdrawal by Subject|0|||
105463244|NCT03873116|363709683|FG000|Part 2|Lab abnormality or AE|0|||
105463245|NCT03873116|363709684|FG001|Part 2|Lab abnormality or AE|0|||
105463246|NCT03873116|363709685|FG002|Part 2|Lab abnormality or AE|0|||
105665015|NCT04946942|364436741|FG001|Overall Study|Lost to Follow-up|2|||
105463247|NCT03873116|363709686|FG003|Part 2|Lab abnormality or AE|0|||
105463248|NCT03873116|363709687|FG004|Part 2|Lab abnormality or AE|1|||
105665016|NCT04946942|364436742|FG002|Overall Study|Lost to Follow-up|0|||
105760663|NCT02999100|364776121|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
105463249|NCT03873116|363709688|FG005|Part 2|Lab abnormality or AE|0|||
105463250|NCT03873116|363709683|FG000|Part 3|Withdrawal by Subject|0|||
105463251|NCT03873116|363709684|FG001|Part 3|Withdrawal by Subject|0|||
105760664|NCT00293241|364776123|FG000|Overall Study|Lost to Follow-up|9|||
105339933|NCT02980341|363245235|FG004|Dose Expansion|Withdrawal by Subject|0|||
105339934|NCT02980341|363245236|FG005|Dose Expansion|Withdrawal by Subject|0|||
105339935|NCT02980341|363245237|FG006|Dose Expansion|Withdrawal by Subject|0|||
105339936|NCT02980341|363245238|FG007|Dose Expansion|Withdrawal by Subject|2|||
105339937|NCT02980341|363245239|FG008|Dose Expansion|Withdrawal by Subject|0|||
105339938|NCT02980341|363245240|FG009|Dose Expansion|Withdrawal by Subject|1|||
105339939|NCT02980341|363245241|FG010|Dose Expansion|Withdrawal by Subject|0|||
105339940|NCT02980341|363245231|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105339941|NCT02980341|363245232|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105339942|NCT02980341|363245233|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105339943|NCT02980341|363245234|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105339944|NCT02980341|363245235|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105339945|NCT02980341|363245236|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105339946|NCT02980341|363245237|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105339947|NCT02980341|363245238|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
105339948|NCT02980341|363245239|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105339949|NCT02980341|363245240|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105339950|NCT02980341|363245241|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105339951|NCT02980341|363245231|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105339952|NCT02980341|363245232|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105339953|NCT02980341|363245233|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105339954|NCT02980341|363245234|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105339955|NCT02980341|363245235|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105339956|NCT02980341|363245236|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105339957|NCT02980341|363245237|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105339958|NCT02980341|363245238|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105339959|NCT02980341|363245239|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
105339960|NCT02980341|363245240|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105339961|NCT02980341|363245241|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105339962|NCT02980341|363245231|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105339963|NCT02980341|363245232|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105339964|NCT02980341|363245233|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105339965|NCT02980341|363245234|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105339966|NCT02980341|363245235|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105339967|NCT02980341|363245236|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105339968|NCT02980341|363245237|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105339969|NCT02980341|363245238|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105339970|NCT02980341|363245239|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
105339971|NCT02980341|363245240|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105339972|NCT02980341|363245241|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105339973|NCT02980341|363245231|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105339974|NCT02980341|363245232|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105339975|NCT02980341|363245233|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105339976|NCT02980341|363245234|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105339977|NCT02980341|363245235|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105339978|NCT02980341|363245236|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105339979|NCT02980341|363245237|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105339980|NCT02980341|363245238|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105339981|NCT02980341|363245239|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105339982|NCT02980341|363245240|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105339983|NCT02980341|363245241|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
105339984|NCT01895608|363245246|FG000|Overall Study|change in health status|0|||
105339985|NCT01895608|363245247|FG001|Overall Study|change in health status|1|||
105339986|NCT01895608|363245248|FG002|Overall Study|change in health status|1|||
105339987|NCT01895608|363245249|FG003|Overall Study|change in health status|0|||
105665017|NCT00487825|364438532|FG000|Overall Study|Adverse Event|2|||
105665018|NCT00487825|364438533|FG001|Overall Study|Adverse Event|2|||
105665019|NCT00487825|364438532|FG000|Overall Study|Lack of Efficacy|1|||
105463252|NCT03873116|363709685|FG002|Part 3|Withdrawal by Subject|0|||
105463253|NCT03873116|363709686|FG003|Part 3|Withdrawal by Subject|0|||
105463254|NCT03873116|363709687|FG004|Part 3|Withdrawal by Subject|1|||
105463255|NCT03873116|363709688|FG005|Part 3|Withdrawal by Subject|0|||
105463256|NCT04682366|363709689|FG000|Overall Study|Lost to Follow-up|1|||
105463257|NCT04682366|363709690|FG001|Overall Study|Lost to Follow-up|1|||
105463258|NCT00702221|363709691|FG000|Overall Study|Adverse Event|4|||
105463259|NCT00702221|363709692|FG001|Overall Study|Adverse Event|3|||
105463260|NCT00106704|363709693|FG000|Overall Study|Adverse Event|10|||
105463261|NCT00106704|363709694|FG001|Overall Study|Adverse Event|7|||
105551504|NCT04323436|364019159|FG000|Overall Study|Subject decision|3|||
105551505|NCT04323436|364019160|FG001|Overall Study|Subject decision|0|||
105551506|NCT04323436|364019161|FG002|Overall Study|Subject decision|0|||
105551507|NCT01808313|364019162|FG000|Overall Study|Adverse Event|5|||
105551508|NCT01808313|364019162|FG000|Overall Study|Protocol Violation|2|||
105551509|NCT01808313|364019162|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105551510|NCT01808313|364019162|FG000|Overall Study|Lost to Follow-up|1|||
105551511|NCT01808313|364019162|FG000|Overall Study|Physician Decision|1|||
105551512|NCT03325712|364019163|FG000|Overall Study|Protocol Violation|0|||
105551513|NCT03325712|364019164|FG001|Overall Study|Protocol Violation|0|||
105551514|NCT03325712|364019165|FG002|Overall Study|Protocol Violation|0|||
105551515|NCT03325712|364019166|FG003|Overall Study|Protocol Violation|0|||
105551516|NCT03325712|364019167|FG004|Overall Study|Protocol Violation|1|||
105551517|NCT03325712|364019168|FG005|Overall Study|Protocol Violation|0|||
105551518|NCT03325712|364019169|FG006|Overall Study|Protocol Violation|0|||
105551519|NCT03325712|364019170|FG007|Overall Study|Protocol Violation|0|||
105551520|NCT03325712|364019163|FG000|Overall Study|Adverse Event|0|||
105551521|NCT03325712|364019164|FG001|Overall Study|Adverse Event|0|||
105551522|NCT03325712|364019165|FG002|Overall Study|Adverse Event|0|||
105551523|NCT03325712|364019166|FG003|Overall Study|Adverse Event|0|||
105551524|NCT03325712|364019167|FG004|Overall Study|Adverse Event|1|||
105551525|NCT03325712|364019168|FG005|Overall Study|Adverse Event|0|||
105551526|NCT03325712|364019169|FG006|Overall Study|Adverse Event|0|||
105551527|NCT03325712|364019170|FG007|Overall Study|Adverse Event|0|||
105551528|NCT02265237|364019172|FG000|As Treated (Overall Study)|Adverse Event|1|||
105551529|NCT02265237|364019173|FG001|As Treated (Overall Study)|Adverse Event|1|||
105551530|NCT02265237|364019174|FG002|As Treated (Overall Study)|Adverse Event|0|||
105551531|NCT02265237|364019175|FG003|As Treated (Overall Study)|Adverse Event|0|||
105551532|NCT02265237|364019172|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
105551533|NCT02265237|364019173|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
105551534|NCT02265237|364019174|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
105551535|NCT02265237|364019175|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
105551536|NCT02265237|364019172|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
105551537|NCT02265237|364019173|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
105551538|NCT02265237|364019174|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
105551539|NCT02265237|364019175|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
105551540|NCT02265237|364019172|FG000|As Treated (Overall Study)|Other|2|||
105551541|NCT02265237|364019173|FG001|As Treated (Overall Study)|Other|0|||
105551542|NCT02265237|364019174|FG002|As Treated (Overall Study)|Other|3|||
105551543|NCT02265237|364019175|FG003|As Treated (Overall Study)|Other|1|||
105551544|NCT01178853|364019178|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
105551545|NCT01178853|364019179|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
105551546|NCT01178853|364019178|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
105551547|NCT01178853|364019179|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
105463262|NCT00106704|363709693|FG000|Overall Study|Death|2|||
105463263|NCT00106704|363709694|FG001|Overall Study|Death|1|||
105463264|NCT00106704|363709693|FG000|Overall Study|Lack of Efficacy|67|||
105463265|NCT00106704|363709694|FG001|Overall Study|Lack of Efficacy|69|||
105463266|NCT00106704|363709693|FG000|Overall Study|Lost to Follow-up|7|||
105463267|NCT00106704|363709694|FG001|Overall Study|Lost to Follow-up|3|||
105551548|NCT01178853|364019178|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
105551549|NCT01178853|364019179|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
105551550|NCT01178853|364019178|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
105551551|NCT01178853|364019179|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
105551552|NCT01178853|364019178|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
105551553|NCT01178853|364019179|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
105551554|NCT03550313|364019180|FG000|Overall Study|Adverse Event|0|||
105551555|NCT03550313|364019181|FG001|Overall Study|Adverse Event|1|||
105551556|NCT03550313|364019182|FG002|Overall Study|Adverse Event|0|||
105339988|NCT01895608|363245246|FG000|Overall Study|Withdrawal by Subject|0|||
105339989|NCT01895608|363245247|FG001|Overall Study|Withdrawal by Subject|0|||
105551557|NCT03550313|364019180|FG000|Overall Study|Lost to Follow-up|5|||
105551558|NCT03550313|364019181|FG001|Overall Study|Lost to Follow-up|7|||
105665020|NCT00487825|364438533|FG001|Overall Study|Lack of Efficacy|1|||
105665021|NCT00487825|364438532|FG000|Overall Study|Other|3|||
105665022|NCT00487825|364438533|FG001|Overall Study|Other|2|||
105665023|NCT04596995|364438538|FG000|Overall Study|Lack of Efficacy|8|||
105665024|NCT04596995|364438538|FG000|Overall Study|Lost to Follow-up|3|||
105665025|NCT04596995|364438538|FG000|Overall Study|Withdrawal by Subject|12|||
105665026|NCT04596995|364438538|FG000|Overall Study|Sponsor decision|3|||
105665027|NCT04596995|364438538|FG000|Overall Study|Enrolled in managed access program|3|||
105665028|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
105665029|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
105665030|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
105665031|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Death|4|||
105339990|NCT01895608|363245248|FG002|Overall Study|Withdrawal by Subject|2|||
105339991|NCT01895608|363245249|FG003|Overall Study|Withdrawal by Subject|0|||
105339992|NCT03505593|363245250|FG000|Overall Study|Withdrawal by Subject|1|||
105339993|NCT03505593|363245250|FG000|Overall Study|Died before procedure|1|||
105339994|NCT03505593|363245250|FG000|Overall Study|Anatomical abnormality|1|||
105339995|NCT03505593|363245250|FG000|Overall Study|Unable to pass through esophagus|1|||
105339996|NCT03505593|363245250|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
105339997|NCT02275780|363245251|FG000|Base Study: 96 Weeks|Adverse Event|6|||
105339998|NCT02275780|363245252|FG001|Base Study: 96 Weeks|Adverse Event|14|||
105339999|NCT02275780|363245251|FG000|Base Study: 96 Weeks|Death|3|||
105665032|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Death|2|||
105665033|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Death|3|||
105665034|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
105665035|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
105665036|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
105760665|NCT00293241|364776124|FG001|Overall Study|Lost to Follow-up|16|||
105340000|NCT02275780|363245252|FG001|Base Study: 96 Weeks|Death|1|||
105463268|NCT00106704|363709693|FG000|Overall Study|Pregnancy|1|||
105463269|NCT00106704|363709694|FG001|Overall Study|Pregnancy|0|||
105463270|NCT00106704|363709693|FG000|Overall Study|Protocol Violation|4|||
105463271|NCT00106704|363709694|FG001|Overall Study|Protocol Violation|7|||
105463272|NCT00106704|363709693|FG000|Overall Study|Withdrawal by Subject|14|||
105463273|NCT00106704|363709694|FG001|Overall Study|Withdrawal by Subject|21|||
105463274|NCT00106704|363709693|FG000|Overall Study|Patient moved|1|||
105463275|NCT00106704|363709694|FG001|Overall Study|Patient moved|0|||
105463276|NCT00106704|363709693|FG000|Overall Study|Site terminated|0|||
105463277|NCT00106704|363709694|FG001|Overall Study|Site terminated|1|||
105463278|NCT00106704|363709693|FG000|Overall Study|Planned major surgery|1|||
105340001|NCT02275780|363245251|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
105340002|NCT02275780|363245252|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
105340003|NCT02275780|363245251|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
105340004|NCT02275780|363245252|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
105665037|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
105665038|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
105665039|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
105665040|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
105665041|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
105665042|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
105665043|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
105665044|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
105665045|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
105665046|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
105665047|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
105665048|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
105665049|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
105665050|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
105665051|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
105665052|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
105665053|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
105665054|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
105665055|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
105665056|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
105665057|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
105665058|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
105665059|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
105665060|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
105665061|NCT02783573|364438539|FG000|Delayed-Start Period|Sponsor Decision|0|||
105665062|NCT02783573|364438540|FG001|Delayed-Start Period|Sponsor Decision|17|||
105665063|NCT02783573|364438541|FG002|Delayed-Start Period|Sponsor Decision|12|||
105665064|NCT01375673|364438542|FG000|Overall Study|Withdrawal by Subject|0|||
105665065|NCT01375673|364438543|FG001|Overall Study|Withdrawal by Subject|1|||
105665066|NCT01784523|364438544|FG000|Overall Study|Study closed early|7|||
105665067|NCT01784523|364438545|FG001|Overall Study|Study closed early|4|||
105665068|NCT01907906|364438548|FG000|Overall Study|Withdrawal by Subject|1|||
105665069|NCT01907906|364438549|FG001|Overall Study|Withdrawal by Subject|0|||
105665070|NCT01907906|364438548|FG000|Overall Study|Physician Decision|3|||
105665071|NCT01907906|364438549|FG001|Overall Study|Physician Decision|1|||
105665072|NCT04334278|364438555|FG000|Overall Study|Lost to Follow-up|0|||
105340005|NCT02275780|363245251|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
105340006|NCT02275780|363245252|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
105340007|NCT02275780|363245251|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
105340008|NCT02275780|363245252|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
105340009|NCT02275780|363245251|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
105340010|NCT02275780|363245252|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
105340011|NCT02275780|363245251|FG000|Base Study: 96 Weeks|Physician Decision|2|||
105340012|NCT02275780|363245252|FG001|Base Study: 96 Weeks|Physician Decision|4|||
105340013|NCT02275780|363245251|FG000|Base Study: 96 Weeks|Pregnancy|2|||
105463279|NCT00106704|363709694|FG001|Overall Study|Planned major surgery|0|||
105463280|NCT00106704|363709693|FG000|Overall Study|Patient Received Glycemic Medication|22|||
105463281|NCT00106704|363709694|FG001|Overall Study|Patient Received Glycemic Medication|41|||
105463282|NCT00106704|363709693|FG000|Overall Study|Unable to re-enter US|1|||
105463283|NCT00106704|363709694|FG001|Overall Study|Unable to re-enter US|0|||
105463284|NCT00106704|363709693|FG000|Overall Study|Laboratory test|1|||
105463285|NCT00106704|363709694|FG001|Overall Study|Laboratory test|1|||
105463286|NCT04798196|363709695|FG000|Overall Study|Lost to Follow-up|3|||
105463287|NCT04798196|363709696|FG001|Overall Study|Lost to Follow-up|1|||
105463288|NCT04798196|363709697|FG002|Overall Study|Lost to Follow-up|3|||
105463289|NCT01249261|363709700|FG000|Overall Study|Withdrawal by Subject|1|||
105463290|NCT01249261|363709701|FG001|Overall Study|Withdrawal by Subject|0|||
105463291|NCT00728689|363709703|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
105463292|NCT00728689|363709704|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
105463293|NCT01523366|363709705|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105463294|NCT01523366|363709706|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105463295|NCT01523366|363709705|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
105463296|NCT01523366|363709706|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
105463297|NCT04543279|363709711|FG000|Overall Study|Withdrawal by Subject|1|||
105463298|NCT04543279|363709712|FG001|Overall Study|Withdrawal by Subject|0|||
105463299|NCT04543279|363709711|FG000|Overall Study|Adverse Event|1|||
105463300|NCT04543279|363709712|FG001|Overall Study|Adverse Event|0|||
105463301|NCT04543279|363709711|FG000|Overall Study|Physician Decision|1|||
105463302|NCT04543279|363709712|FG001|Overall Study|Physician Decision|0|||
105463303|NCT04885998|363709715|FG000|Overall Study|Ongoing in study|3|||
105463304|NCT04885998|363709716|FG001|Overall Study|Ongoing in study|2|||
105463305|NCT04885998|363709717|FG002|Overall Study|Ongoing in study|2|||
105463306|NCT04885998|363709718|FG003|Overall Study|Ongoing in study|6|||
105463307|NCT04885998|363709715|FG000|Overall Study|Withdrawal by Subject|0|||
105463308|NCT04885998|363709716|FG001|Overall Study|Withdrawal by Subject|2|||
105463309|NCT04885998|363709717|FG002|Overall Study|Withdrawal by Subject|1|||
105463310|NCT04885998|363709718|FG003|Overall Study|Withdrawal by Subject|1|||
105463311|NCT04885998|363709715|FG000|Overall Study|Lost to Follow-up|1|||
105463312|NCT04885998|363709716|FG001|Overall Study|Lost to Follow-up|0|||
105463313|NCT04885998|363709717|FG002|Overall Study|Lost to Follow-up|0|||
105463314|NCT04885998|363709718|FG003|Overall Study|Lost to Follow-up|0|||
105463315|NCT04885998|363709715|FG000|Overall Study|Death|2|||
105463316|NCT04885998|363709716|FG001|Overall Study|Death|1|||
105463317|NCT04885998|363709717|FG002|Overall Study|Death|1|||
105463318|NCT04885998|363709718|FG003|Overall Study|Death|0|||
105463319|NCT00734539|363709721|FG000|Main Study|Death|33|||
105463320|NCT00734539|363709722|FG001|Main Study|Death|32|||
105463321|NCT00734539|363709721|FG000|Main Study|Physician Decision|2|||
105463322|NCT00734539|363709722|FG001|Main Study|Physician Decision|0|||
105463323|NCT00734539|363709721|FG000|Main Study|Withdrawal by Subject|1|||
105463324|NCT00734539|363709722|FG001|Main Study|Withdrawal by Subject|3|||
105463325|NCT00734539|363709721|FG000|Main Study|Enrolled in error; ineligible|1|||
105463326|NCT00734539|363709722|FG001|Main Study|Enrolled in error; ineligible|0|||
105463327|NCT03216226|363709725|FG000|Overall Study|Adverse Event|3|||
105551559|NCT03550313|364019182|FG002|Overall Study|Lost to Follow-up|12|||
105463328|NCT03216226|363709726|FG001|Overall Study|Adverse Event|0|||
105463329|NCT03216226|363709725|FG000|Overall Study|Protocol Violation|1|||
105463330|NCT03216226|363709726|FG001|Overall Study|Protocol Violation|3|||
105463331|NCT03216226|363709725|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
105484892|NCT02038829|363786992|FG001|Washout Period 2|Withdrawal by Subject|0|||
105484893|NCT02038829|363786993|FG002|Washout Period 2|Withdrawal by Subject|0|||
105484894|NCT02038829|363786994|FG003|Washout Period 2|Withdrawal by Subject|0|||
105484895|NCT02038829|363786995|FG004|Washout Period 2|Withdrawal by Subject|0|||
105484896|NCT02038829|363786996|FG005|Washout Period 2|Withdrawal by Subject|1|||
105665073|NCT04334278|364438556|FG001|Overall Study|Lost to Follow-up|3|||
105665074|NCT04334278|364438555|FG000|Overall Study|Withdrawal by Subject|4|||
105665075|NCT04334278|364438556|FG001|Overall Study|Withdrawal by Subject|2|||
105665076|NCT02577003|364438557|FG000|Overall Study|Adverse Event|2|||
105665077|NCT02577003|364438558|FG001|Overall Study|Adverse Event|4|||
105665078|NCT02577003|364438557|FG000|Overall Study|Withdrawal by Subject|0|||
105665079|NCT02577003|364438558|FG001|Overall Study|Withdrawal by Subject|1|||
105665080|NCT02786004|364438559|FG000|Overall Study|Withdrawal by Subject|0|||
105665081|NCT02786004|364438560|FG001|Overall Study|Withdrawal by Subject|1|||
105665082|NCT01234883|364438561|FG000|Overall Study|Early treatment release|8|||
105665083|NCT01234883|364438562|FG001|Overall Study|Early treatment release|10|||
105665084|NCT01234883|364438561|FG000|Overall Study|Parent/guardian withdrew consent|1|||
105665085|NCT01234883|364438562|FG001|Overall Study|Parent/guardian withdrew consent|2|||
105665086|NCT01234883|364438561|FG000|Overall Study|Technical difficulties with IV infusion|0|||
105665087|NCT01234883|364438562|FG001|Overall Study|Technical difficulties with IV infusion|1|||
105665088|NCT01234883|364438561|FG000|Overall Study|Inclusion/exclusion failure|1|||
105665089|NCT01234883|364438562|FG001|Overall Study|Inclusion/exclusion failure|0|||
105665090|NCT00126659|364438566|FG000|Overall Study|Adverse Event|0|||
105665091|NCT00126659|364438567|FG001|Overall Study|Adverse Event|0|||
105665092|NCT00126659|364438568|FG002|Overall Study|Adverse Event|2|||
105665093|NCT02367352|364438569|FG000|Overall Study|Progressive disease|7|||
105665094|NCT02367352|364438570|FG001|Overall Study|Progressive disease|0|||
105665095|NCT02367352|364438571|FG002|Overall Study|Progressive disease|0|||
105665096|NCT02367352|364438569|FG000|Overall Study|Participant Received Alternative Therapy|1|||
105665097|NCT02367352|364438570|FG001|Overall Study|Participant Received Alternative Therapy|0|||
105665098|NCT02367352|364438571|FG002|Overall Study|Participant Received Alternative Therapy|0|||
105665099|NCT02367352|364438569|FG000|Overall Study|Adverse Event|1|||
105665100|NCT02367352|364438570|FG001|Overall Study|Adverse Event|0|||
105665101|NCT02367352|364438571|FG002|Overall Study|Adverse Event|0|||
105665102|NCT00490945|364438576|FG000|Overall Study|Adverse Event|0|||
105665103|NCT00490945|364438577|FG001|Overall Study|Adverse Event|1|||
105665104|NCT00490945|364438578|FG002|Overall Study|Adverse Event|0|||
105665105|NCT00490945|364438579|FG003|Overall Study|Adverse Event|0|||
105665106|NCT00490945|364438580|FG004|Overall Study|Adverse Event|0|||
105665107|NCT00520845|364438581|FG000|Overall Study|Death|3|||
105665108|NCT00520845|364438581|FG000|Overall Study|Adverse Event|4|||
105665109|NCT00520845|364438581|FG000|Overall Study|Disease Progression, relapse|13|||
105665110|NCT00520845|364438581|FG000|Overall Study|Withdrawal by Subject|1|||
105665111|NCT00520845|364438581|FG000|Overall Study|Alternative Therapy|1|||
105665112|NCT03334253|364438582|FG000|Overall Study|Withdrawal by Subject|1|||
105665113|NCT03334253|364438583|FG001|Overall Study|Withdrawal by Subject|0|||
105665114|NCT03334253|364438582|FG000|Overall Study|Lost to Follow-up|4|||
105665115|NCT03334253|364438583|FG001|Overall Study|Lost to Follow-up|3|||
105665116|NCT03334253|364438582|FG000|Overall Study|Moved residence|2|||
105665117|NCT03334253|364438583|FG001|Overall Study|Moved residence|2|||
105665118|NCT00203047|364438584|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
105665119|NCT00203047|364438585|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
105665120|NCT00203047|364438584|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
105665121|NCT00203047|364438585|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
105665122|NCT00203047|364438584|FG000|Overall Study|Withdrawal by Subject|13|||
105665123|NCT00203047|364438585|FG001|Overall Study|Withdrawal by Subject|47|||
105665124|NCT00203047|364438584|FG000|Overall Study|Teva requested participant withdrawal|1|||
105665125|NCT00203047|364438585|FG001|Overall Study|Teva requested participant withdrawal|1|||
105665126|NCT00203047|364438584|FG000|Overall Study|Physician Decision|8|||
105665127|NCT00203047|364438585|FG001|Overall Study|Physician Decision|7|||
105665128|NCT00203047|364438584|FG000|Overall Study|Non-compliance|4|||
105665129|NCT00203047|364438585|FG001|Overall Study|Non-compliance|8|||
105665130|NCT00203047|364438584|FG000|Overall Study|Protocol Violation|1|||
105665131|NCT00203047|364438585|FG001|Overall Study|Protocol Violation|0|||
105551560|NCT03550313|364019180|FG000|Overall Study|Study terminated by sponsor|44|||
105665132|NCT00203047|364438584|FG000|Overall Study|Lost to Follow-up|11|||
105665133|NCT00203047|364438585|FG001|Overall Study|Lost to Follow-up|5|||
105665134|NCT00203047|364438584|FG000|Overall Study|Adverse Event|8|||
105665135|NCT00203047|364438585|FG001|Overall Study|Adverse Event|18|||
105665136|NCT00203047|364438584|FG000|Overall Study|Death|1|||
105665137|NCT00203047|364438585|FG001|Overall Study|Death|2|||
105665138|NCT00203047|364438584|FG000|Overall Study|Pregnancy|3|||
105665139|NCT00203047|364438585|FG001|Overall Study|Pregnancy|0|||
105665140|NCT00203047|364438584|FG000|Overall Study|Other|5|||
105665141|NCT00203047|364438585|FG001|Overall Study|Other|5|||
105665142|NCT03994731|364438594|FG000|Pegloticase + IMM Period|Death|2|||
105665143|NCT03994731|364438595|FG001|Pegloticase + IMM Period|Death|0|||
105665144|NCT03994731|364438594|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
105665145|NCT03994731|364438595|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
105665146|NCT03994731|364438594|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
105665147|NCT03994731|364438595|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
105665148|NCT00742326|364438600|FG000|Overall Study|Physician Decision|0|||
105665149|NCT00742326|364438601|FG001|Overall Study|Physician Decision|1|||
105665150|NCT00790205|364438602|FG000|Overall Study|Lost to Follow-up|61|||
105665151|NCT00790205|364438603|FG001|Overall Study|Lost to Follow-up|71|||
105665152|NCT00790205|364438602|FG000|Overall Study|Withdrawal by Subject|299|||
105665153|NCT00790205|364438603|FG001|Overall Study|Withdrawal by Subject|363|||
105665154|NCT01080326|364438604|FG000|Overall Study|Patient deterioration prior to procedure|3|||
105665155|NCT01080326|364438604|FG000|Overall Study|Surgeon decision|1|||
105665156|NCT03080493|364438605|FG000|Overall Study|Did not provide NRS pain results|1|||
105665157|NCT03080493|364438606|FG001|Overall Study|Did not provide NRS pain results|0|||
105665158|NCT03080493|364438605|FG000|Overall Study|Adverse Event|0|||
105665159|NCT03080493|364438606|FG001|Overall Study|Adverse Event|1|||
105665160|NCT03080493|364438605|FG000|Overall Study|Randomization error (parity group)|0|||
105665161|NCT03080493|364438606|FG001|Overall Study|Randomization error (parity group)|1|||
105665162|NCT00755417|364438607|FG000|Overall Study|Adverse Event|28|||
105665163|NCT00755417|364438608|FG001|Overall Study|Adverse Event|20|||
105665164|NCT00755417|364438609|FG002|Overall Study|Adverse Event|7|||
105665165|NCT00755417|364438607|FG000|Overall Study|Lack of Efficacy|8|||
105665166|NCT00755417|364438608|FG001|Overall Study|Lack of Efficacy|4|||
105665167|NCT00755417|364438609|FG002|Overall Study|Lack of Efficacy|9|||
105665168|NCT00755417|364438607|FG000|Overall Study|Protocol Violation|2|||
105665169|NCT00755417|364438608|FG001|Overall Study|Protocol Violation|1|||
105665170|NCT00755417|364438609|FG002|Overall Study|Protocol Violation|1|||
105665171|NCT00755417|364438607|FG000|Overall Study|Lost to Follow-up|3|||
105665172|NCT00755417|364438608|FG001|Overall Study|Lost to Follow-up|0|||
105665173|NCT00755417|364438609|FG002|Overall Study|Lost to Follow-up|1|||
105665174|NCT00755417|364438607|FG000|Overall Study|Withdrawal by Subject|12|||
105665175|NCT00755417|364438608|FG001|Overall Study|Withdrawal by Subject|12|||
105665176|NCT00755417|364438609|FG002|Overall Study|Withdrawal by Subject|12|||
105665177|NCT00755417|364438607|FG000|Overall Study|Not specified or missing data|9|||
105760666|NCT00293241|364776123|FG000|Overall Study|Physician Decision|23|||
105463332|NCT03216226|363709726|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
105463333|NCT03216226|363709725|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
105463334|NCT03216226|363709726|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
105463335|NCT03216226|363709725|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
105463336|NCT03216226|363709726|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
105463337|NCT00538902|363709727|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
105463338|NCT00538902|363709728|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
105463339|NCT00538902|363709729|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
105463340|NCT00538902|363709727|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
105463341|NCT00538902|363709728|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
105463342|NCT00538902|363709729|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
105463343|NCT00538902|363709727|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
105463344|NCT00538902|363709728|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
105463345|NCT00538902|363709729|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
105463346|NCT00538902|363709727|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
105463347|NCT00538902|363709728|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
105463348|NCT00538902|363709729|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
105463349|NCT00538902|363709727|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
105463350|NCT00538902|363709728|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
105463351|NCT00538902|363709729|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
105463352|NCT00538902|363709727|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
105463353|NCT00538902|363709728|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
105463354|NCT00538902|363709729|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
105463355|NCT00538902|363709727|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
105463356|NCT00538902|363709728|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
105463357|NCT00538902|363709729|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
105463358|NCT00538902|363709727|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
105463359|NCT00538902|363709728|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
105463360|NCT00538902|363709729|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
105463361|NCT04109547|363709735|FG000|Overall Study|Withdrawal by Subject|3|||
105463362|NCT04109547|363709736|FG001|Overall Study|Withdrawal by Subject|2|||
105463363|NCT04109547|363709737|FG002|Overall Study|Withdrawal by Subject|6|||
105463364|NCT04109547|363709738|FG003|Overall Study|Withdrawal by Subject|6|||
105463365|NCT04109547|363709735|FG000|Overall Study|Lost to Follow-up|0|||
105463366|NCT04109547|363709736|FG001|Overall Study|Lost to Follow-up|0|||
105463367|NCT04109547|363709737|FG002|Overall Study|Lost to Follow-up|0|||
105463368|NCT04109547|363709738|FG003|Overall Study|Lost to Follow-up|1|||
105463369|NCT04109547|363709735|FG000|Overall Study|Physician Decision|1|||
105463370|NCT04109547|363709736|FG001|Overall Study|Physician Decision|2|||
105463371|NCT04109547|363709737|FG002|Overall Study|Physician Decision|0|||
105463372|NCT04109547|363709738|FG003|Overall Study|Physician Decision|0|||
105463373|NCT03777982|363709743|FG000|Overall Study|Physician Decision|0|||
105463374|NCT03777982|363709744|FG001|Overall Study|Physician Decision|1|||
105463375|NCT00870740|363709745|FG000|Overall Study|Adverse Event|2|||
105463376|NCT00870740|363709746|FG001|Overall Study|Adverse Event|1|||
105463377|NCT00870740|363709747|FG002|Overall Study|Adverse Event|3|||
105463378|NCT00870740|363709748|FG003|Overall Study|Adverse Event|2|||
105463379|NCT00870740|363709749|FG004|Overall Study|Adverse Event|1|||
105463380|NCT00870740|363709750|FG005|Overall Study|Adverse Event|6|||
105463381|NCT00870740|363709745|FG000|Overall Study|Consent Withdrawn|6|||
105760667|NCT00293241|364776124|FG001|Overall Study|Physician Decision|17|||
105665178|NCT00755417|364438608|FG001|Overall Study|Not specified or missing data|18|||
105665179|NCT00755417|364438609|FG002|Overall Study|Not specified or missing data|12|||
105665180|NCT01834586|364438612|FG000|Overall Study|Adverse Event|1|||
105665181|NCT00825305|364438614|FG000|Overall Study|Adverse Event|1|||
105665182|NCT00825305|364438615|FG001|Overall Study|Adverse Event|1|||
105665183|NCT00825305|364438614|FG000|Overall Study|Withdrawal by Subject|6|||
105665184|NCT00825305|364438615|FG001|Overall Study|Withdrawal by Subject|12|||
105665185|NCT00825305|364438614|FG000|Overall Study|Inappropriate inclusion|1|||
105665186|NCT00825305|364438615|FG001|Overall Study|Inappropriate inclusion|0|||
105665187|NCT00825305|364438614|FG000|Overall Study|Protocol Violation|9|||
105665188|NCT00825305|364438615|FG001|Overall Study|Protocol Violation|9|||
105665189|NCT00825305|364438614|FG000|Overall Study|Can not be classified|0|||
105665190|NCT00825305|364438615|FG001|Overall Study|Can not be classified|1|||
105340014|NCT02275780|363245252|FG001|Base Study: 96 Weeks|Pregnancy|1|||
105463382|NCT00870740|363709746|FG001|Overall Study|Consent Withdrawn|3|||
105463383|NCT00870740|363709747|FG002|Overall Study|Consent Withdrawn|4|||
105463384|NCT00870740|363709748|FG003|Overall Study|Consent Withdrawn|6|||
105463385|NCT00870740|363709749|FG004|Overall Study|Consent Withdrawn|6|||
105463386|NCT00870740|363709750|FG005|Overall Study|Consent Withdrawn|5|||
105463387|NCT00870740|363709745|FG000|Overall Study|Investigator Decision|2|||
105463388|NCT00870740|363709746|FG001|Overall Study|Investigator Decision|0|||
105463389|NCT00870740|363709747|FG002|Overall Study|Investigator Decision|1|||
105463390|NCT00870740|363709748|FG003|Overall Study|Investigator Decision|0|||
105463391|NCT00870740|363709749|FG004|Overall Study|Investigator Decision|0|||
105463392|NCT00870740|363709750|FG005|Overall Study|Investigator Decision|0|||
105463393|NCT00870740|363709745|FG000|Overall Study|Subject Non-compliance|0|||
105463394|NCT00870740|363709746|FG001|Overall Study|Subject Non-compliance|0|||
105463395|NCT00870740|363709747|FG002|Overall Study|Subject Non-compliance|0|||
105463396|NCT00870740|363709748|FG003|Overall Study|Subject Non-compliance|0|||
105463397|NCT00870740|363709749|FG004|Overall Study|Subject Non-compliance|0|||
105463398|NCT00870740|363709750|FG005|Overall Study|Subject Non-compliance|1|||
105463399|NCT00870740|363709745|FG000|Overall Study|Death|0|||
105463400|NCT00870740|363709746|FG001|Overall Study|Death|0|||
105463401|NCT00870740|363709747|FG002|Overall Study|Death|0|||
105463402|NCT00870740|363709748|FG003|Overall Study|Death|0|||
105463403|NCT00870740|363709749|FG004|Overall Study|Death|1|||
105463404|NCT00870740|363709750|FG005|Overall Study|Death|0|||
105463405|NCT00870740|363709745|FG000|Overall Study|Other|2|||
105463406|NCT00870740|363709746|FG001|Overall Study|Other|5|||
105463407|NCT00870740|363709747|FG002|Overall Study|Other|2|||
105463408|NCT00870740|363709748|FG003|Overall Study|Other|4|||
105463409|NCT00870740|363709749|FG004|Overall Study|Other|3|||
105463410|NCT00870740|363709750|FG005|Overall Study|Other|5|||
105463411|NCT03755934|363709751|FG000|Overall Study|Adverse Event|4|||
105463412|NCT03755934|363709752|FG001|Overall Study|Adverse Event|1|||
105463413|NCT03755934|363709753|FG002|Overall Study|Adverse Event|1|||
105463414|NCT03755934|363709754|FG003|Overall Study|Adverse Event|3|||
105463415|NCT03755934|363709751|FG000|Overall Study|Physician Decision|2|||
105463416|NCT03755934|363709752|FG001|Overall Study|Physician Decision|0|||
105463417|NCT03755934|363709753|FG002|Overall Study|Physician Decision|0|||
105463418|NCT03755934|363709754|FG003|Overall Study|Physician Decision|1|||
105463419|NCT03755934|363709751|FG000|Overall Study|Withdrawal by Subject|5|||
105463420|NCT03755934|363709752|FG001|Overall Study|Withdrawal by Subject|0|||
105463421|NCT03755934|363709753|FG002|Overall Study|Withdrawal by Subject|0|||
105463422|NCT03755934|363709754|FG003|Overall Study|Withdrawal by Subject|1|||
105463423|NCT03755934|363709751|FG000|Overall Study|Other|3|||
105463424|NCT03755934|363709752|FG001|Overall Study|Other|1|||
105463425|NCT03755934|363709753|FG002|Overall Study|Other|3|||
105463426|NCT03755934|363709754|FG003|Overall Study|Other|1|||
105463427|NCT00198822|363709758|FG000|Overall Study|Lost to Follow-up|14|||
105463428|NCT00198822|363709759|FG001|Overall Study|Lost to Follow-up|20|||
105463429|NCT00198822|363709760|FG002|Overall Study|Lost to Follow-up|21|||
105463430|NCT02158442|363709761|FG000|Overall Study|Withdrawal by Subject|1|||
105463431|NCT02158442|363709762|FG001|Overall Study|Withdrawal by Subject|0|||
105463432|NCT02158442|363709761|FG000|Overall Study|Perfusion staff not available|1|||
105463433|NCT02158442|363709762|FG001|Overall Study|Perfusion staff not available|0|||
105463434|NCT00686712|363709763|FG000|Overall Study|Protocol Violation|8|||
105463435|NCT00686712|363709764|FG001|Overall Study|Protocol Violation|8|||
105463436|NCT00686712|363709765|FG002|Overall Study|Protocol Violation|10|||
105463437|NCT00686712|363709763|FG000|Overall Study|Lost to Follow-up|1|||
105463438|NCT00686712|363709764|FG001|Overall Study|Lost to Follow-up|2|||
105463439|NCT00686712|363709765|FG002|Overall Study|Lost to Follow-up|3|||
105463440|NCT00686712|363709763|FG000|Overall Study|Adverse Event|1|||
105463441|NCT00686712|363709764|FG001|Overall Study|Adverse Event|1|||
105463442|NCT00686712|363709765|FG002|Overall Study|Adverse Event|0|||
105463443|NCT04119414|363709767|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
105463444|NCT01352793|363709778|FG000|Overall Study|Lost to Follow-up|289|||
105463445|NCT01352793|363709779|FG001|Overall Study|Lost to Follow-up|125|||
105463446|NCT01352793|363709778|FG000|Overall Study|Withdrawal by Subject|120|||
105340015|NCT02275780|363245251|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
105340016|NCT02275780|363245252|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
105340017|NCT02275780|363245251|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
105340018|NCT02275780|363245252|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
105340019|NCT02275780|363245251|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
105340020|NCT02275780|363245252|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
105340021|NCT02275780|363245251|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
105340022|NCT02275780|363245252|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
105340023|NCT02275780|363245251|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
105340024|NCT02275780|363245252|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
105340025|NCT02275780|363245251|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
105340026|NCT02275780|363245252|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
105340027|NCT02275780|363245251|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
105340028|NCT02275780|363245252|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
105340029|NCT02275780|363245251|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
105340030|NCT02275780|363245252|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
105340031|NCT02275780|363245251|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
105340032|NCT02275780|363245252|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
105340033|NCT02275780|363245251|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
105665191|NCT01721954|364438618|FG000|Overall Study|Death|58|||
105340034|NCT02275780|363245252|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
105360867|NCT04547140|363328094|FG000|Overall Study|Reason Not Specified|4|||
105360868|NCT04547140|363328095|FG001|Overall Study|Reason Not Specified|1|||
105665192|NCT01721954|364438619|FG001|Overall Study|Death|64|||
105665193|NCT01721954|364438618|FG000|Overall Study|Withdrawal by Subject|8|||
105665194|NCT01721954|364438619|FG001|Overall Study|Withdrawal by Subject|4|||
105665195|NCT01721954|364438618|FG000|Overall Study|Adverse Event|2|||
105665196|NCT01721954|364438619|FG001|Overall Study|Adverse Event|0|||
105665197|NCT01721954|364438618|FG000|Overall Study|Lost to Follow-up|2|||
105665198|NCT01721954|364438619|FG001|Overall Study|Lost to Follow-up|1|||
105665199|NCT00965497|364438625|FG000|Overall Study|Physician Decision|1|||
105665200|NCT02638103|364438627|FG000|Overall Study|Adverse Event|13|||
105665201|NCT02638103|364438628|FG001|Overall Study|Adverse Event|12|||
105665202|NCT02638103|364438629|FG002|Overall Study|Adverse Event|19|||
105665203|NCT02638103|364438630|FG003|Overall Study|Adverse Event|12|||
105665204|NCT02638103|364438627|FG000|Overall Study|Withdrawal by Subject|43|||
105665205|NCT02638103|364438628|FG001|Overall Study|Withdrawal by Subject|53|||
105665206|NCT02638103|364438629|FG002|Overall Study|Withdrawal by Subject|30|||
105665207|NCT02638103|364438630|FG003|Overall Study|Withdrawal by Subject|61|||
105665208|NCT02638103|364438627|FG000|Overall Study|Protocol Violation|1|||
105665209|NCT02638103|364438628|FG001|Overall Study|Protocol Violation|2|||
105665210|NCT02638103|364438629|FG002|Overall Study|Protocol Violation|1|||
105665211|NCT02638103|364438630|FG003|Overall Study|Protocol Violation|4|||
105665212|NCT02638103|364438627|FG000|Overall Study|Pregnancy|2|||
105665213|NCT02638103|364438628|FG001|Overall Study|Pregnancy|3|||
105463447|NCT01352793|363709779|FG001|Overall Study|Withdrawal by Subject|55|||
105463448|NCT01352793|363709778|FG000|Overall Study|Protocol Violation|44|||
105463449|NCT01352793|363709779|FG001|Overall Study|Protocol Violation|23|||
105463450|NCT01352793|363709778|FG000|Overall Study|Adverse Event|44|||
105463451|NCT01352793|363709779|FG001|Overall Study|Adverse Event|10|||
105463452|NCT01352793|363709778|FG000|Overall Study|Physician Decision|1|||
105463453|NCT01352793|363709779|FG001|Overall Study|Physician Decision|0|||
105463454|NCT01352793|363709778|FG000|Overall Study|Pregnancy|26|||
105463455|NCT01352793|363709779|FG001|Overall Study|Pregnancy|8|||
105463456|NCT01352793|363709778|FG000|Overall Study|Other|25|||
105463457|NCT01352793|363709779|FG001|Overall Study|Other|7|||
105463458|NCT01352793|363709778|FG000|Overall Study|Medication error|2|||
105463459|NCT01352793|363709779|FG001|Overall Study|Medication error|2|||
105463460|NCT01352793|363709778|FG000|Overall Study|Death|1|||
105463461|NCT01352793|363709779|FG001|Overall Study|Death|0|||
105463462|NCT01352793|363709778|FG000|Overall Study|Randomized but not vaccinated|8|||
105463463|NCT01352793|363709779|FG001|Overall Study|Randomized but not vaccinated|0|||
105463464|NCT01352793|363709778|FG000|Overall Study|No longer meets eligibility criteria|25|||
105463465|NCT01352793|363709779|FG001|Overall Study|No longer meets eligibility criteria|15|||
105463466|NCT02839200|363709786|FG000|Overall Study|Withdrawal by Subject|2|||
105463467|NCT02839200|363709787|FG001|Overall Study|Withdrawal by Subject|0|||
105463468|NCT02839200|363709788|FG002|Overall Study|Withdrawal by Subject|1|||
105463469|NCT02839200|363709789|FG003|Overall Study|Withdrawal by Subject|0|||
105463470|NCT02839200|363709790|FG004|Overall Study|Withdrawal by Subject|0|||
105463471|NCT02839200|363709791|FG005|Overall Study|Withdrawal by Subject|1|||
105463472|NCT02839200|363709786|FG000|Overall Study|Lost to Follow-up|2|||
105463473|NCT02839200|363709787|FG001|Overall Study|Lost to Follow-up|0|||
105463474|NCT02839200|363709788|FG002|Overall Study|Lost to Follow-up|0|||
105463475|NCT02839200|363709789|FG003|Overall Study|Lost to Follow-up|0|||
105463476|NCT02839200|363709790|FG004|Overall Study|Lost to Follow-up|1|||
105463477|NCT02839200|363709791|FG005|Overall Study|Lost to Follow-up|0|||
105463478|NCT02839200|363709786|FG000|Overall Study|Adverse Event|0|||
105463479|NCT02839200|363709787|FG001|Overall Study|Adverse Event|0|||
105463480|NCT02839200|363709788|FG002|Overall Study|Adverse Event|0|||
105463481|NCT02839200|363709789|FG003|Overall Study|Adverse Event|0|||
105463482|NCT02839200|363709790|FG004|Overall Study|Adverse Event|1|||
105463483|NCT02839200|363709791|FG005|Overall Study|Adverse Event|0|||
105463484|NCT02839200|363709786|FG000|Overall Study|Randomized in error|0|||
105463485|NCT02839200|363709787|FG001|Overall Study|Randomized in error|1|||
105463486|NCT02839200|363709788|FG002|Overall Study|Randomized in error|0|||
105551561|NCT03550313|364019181|FG001|Overall Study|Study terminated by sponsor|37|||
105551562|NCT03550313|364019182|FG002|Overall Study|Study terminated by sponsor|48|||
105551563|NCT03550313|364019180|FG000|Overall Study|No longer met eligibility criteria|3|||
105551564|NCT03550313|364019181|FG001|Overall Study|No longer met eligibility criteria|5|||
105463487|NCT02839200|363709789|FG003|Overall Study|Randomized in error|0|||
105463488|NCT02839200|363709790|FG004|Overall Study|Randomized in error|0|||
105463489|NCT02839200|363709791|FG005|Overall Study|Randomized in error|0|||
105463490|NCT01929317|363709792|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
105463491|NCT01929317|363709793|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
105463492|NCT01929317|363709792|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
105463493|NCT01929317|363709793|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
105463494|NCT01929317|363709792|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
105463495|NCT01929317|363709793|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
105463496|NCT01929317|363709792|FG000|Long-term Phase|Adverse Event|5|||
105463497|NCT01929317|363709793|FG001|Long-term Phase|Adverse Event|1|||
105463498|NCT01929317|363709792|FG000|Long-term Phase|Physician Decision|3|||
105463499|NCT01929317|363709793|FG001|Long-term Phase|Physician Decision|0|||
105463500|NCT01929317|363709792|FG000|Long-term Phase|Withdrawal by Subject|4|||
105463501|NCT01929317|363709793|FG001|Long-term Phase|Withdrawal by Subject|0|||
105463502|NCT01929317|363709792|FG000|Long-term Phase|Protocol Violation|1|||
105463503|NCT01929317|363709793|FG001|Long-term Phase|Protocol Violation|0|||
105463504|NCT01929317|363709792|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
105463505|NCT01929317|363709793|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
105463506|NCT01929317|363709792|FG000|Long-term Phase|Study Closed/Terminated|5|||
105463507|NCT01929317|363709793|FG001|Long-term Phase|Study Closed/Terminated|3|||
105463508|NCT00577889|363709796|FG000|Overall Study|Withdrawal by Subject|1|||
105463509|NCT00577889|363709797|FG001|Overall Study|Withdrawal by Subject|0|||
105551565|NCT03550313|364019182|FG002|Overall Study|No longer met eligibility criteria|6|||
105551566|NCT03550313|364019180|FG000|Overall Study|Withdrawal by parent/guardian|20|||
105551567|NCT03550313|364019181|FG001|Overall Study|Withdrawal by parent/guardian|18|||
105551568|NCT03550313|364019182|FG002|Overall Study|Withdrawal by parent/guardian|26|||
105551569|NCT03550313|364019180|FG000|Overall Study|Other|4|||
105551570|NCT03550313|364019181|FG001|Overall Study|Other|2|||
105551571|NCT03550313|364019182|FG002|Overall Study|Other|2|||
105551572|NCT03550313|364019180|FG000|Overall Study|Randomized but not vaccinated|3|||
105551573|NCT03550313|364019181|FG001|Overall Study|Randomized but not vaccinated|23|||
105551574|NCT03550313|364019182|FG002|Overall Study|Randomized but not vaccinated|2|||
105551575|NCT03550313|364019180|FG000|Overall Study|Sites terminated due to quality issues|18|||
105551576|NCT03550313|364019181|FG001|Overall Study|Sites terminated due to quality issues|17|||
105551577|NCT03550313|364019182|FG002|Overall Study|Sites terminated due to quality issues|18|||
105551578|NCT00839072|364019183|FG000|First Intervention Period|Withdrawal by Subject|1|||
105551579|NCT00839072|364019184|FG001|First Intervention Period|Withdrawal by Subject|0|||
105551580|NCT00839072|364019183|FG000|First Intervention Period|Adverse Event|1|||
105551581|NCT00839072|364019184|FG001|First Intervention Period|Adverse Event|1|||
105340035|NCT02275780|363245251|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
105551582|NCT00839072|364019183|FG000|Second Intervention Period|Withdrawal by Subject|1|||
105551583|NCT00839072|364019184|FG001|Second Intervention Period|Withdrawal by Subject|0|||
105551584|NCT01458574|364019185|FG000|Overall Study|Adverse Event|5|||
105551585|NCT01458574|364019186|FG001|Overall Study|Adverse Event|9|||
105551586|NCT01458574|364019187|FG002|Overall Study|Adverse Event|7|||
105551587|NCT01458574|364019185|FG000|Overall Study|Lack of Efficacy|70|||
105551588|NCT01458574|364019186|FG001|Overall Study|Lack of Efficacy|53|||
105551589|NCT01458574|364019187|FG002|Overall Study|Lack of Efficacy|132|||
105551590|NCT01458574|364019185|FG000|Overall Study|Lost to Follow-up|3|||
105551591|NCT01458574|364019186|FG001|Overall Study|Lost to Follow-up|2|||
105551592|NCT01458574|364019187|FG002|Overall Study|Lost to Follow-up|1|||
105551593|NCT01458574|364019185|FG000|Overall Study|Pregnancy|1|||
105551594|NCT01458574|364019186|FG001|Overall Study|Pregnancy|1|||
105551595|NCT01458574|364019187|FG002|Overall Study|Pregnancy|0|||
105551596|NCT01458574|364019185|FG000|Overall Study|Protocol Violation|0|||
105551597|NCT01458574|364019186|FG001|Overall Study|Protocol Violation|1|||
105551598|NCT01458574|364019187|FG002|Overall Study|Protocol Violation|0|||
105551599|NCT01458574|364019185|FG000|Overall Study|Withdrawal by Subject|6|||
105665214|NCT02638103|364438629|FG002|Overall Study|Pregnancy|0|||
105665215|NCT02638103|364438630|FG003|Overall Study|Pregnancy|1|||
105665216|NCT02638103|364438627|FG000|Overall Study|Non-compliance to Study Procedures|2|||
105551600|NCT01458574|364019186|FG001|Overall Study|Withdrawal by Subject|3|||
105665217|NCT02638103|364438628|FG001|Overall Study|Non-compliance to Study Procedures|1|||
105665218|NCT02638103|364438629|FG002|Overall Study|Non-compliance to Study Procedures|1|||
105665219|NCT02638103|364438630|FG003|Overall Study|Non-compliance to Study Procedures|1|||
105463510|NCT00577889|363709798|FG002|Overall Study|Withdrawal by Subject|0|||
105463511|NCT03041181|363709802|FG000|Overall Study|Disease Progression|1|||
105463512|NCT03041181|363709803|FG001|Overall Study|Disease Progression|2|||
105463513|NCT02667119|363709804|FG000|Overall Study|Lost to Follow-up|3|||
105463514|NCT02667119|363709805|FG001|Overall Study|Lost to Follow-up|0|||
105463515|NCT02760498|363709806|FG000|Overall Study|Adverse Event|3|||
105463516|NCT02760498|363709807|FG001|Overall Study|Adverse Event|3|||
105463517|NCT02760498|363709808|FG002|Overall Study|Adverse Event|1|||
105463518|NCT02760498|363709809|FG003|Overall Study|Adverse Event|1|||
105463519|NCT02760498|363709810|FG004|Overall Study|Adverse Event|0|||
105463520|NCT02760498|363709811|FG005|Overall Study|Adverse Event|6|||
105463521|NCT02760498|363709806|FG000|Overall Study|Death|7|||
105463522|NCT02760498|363709807|FG001|Overall Study|Death|5|||
105463523|NCT02760498|363709808|FG002|Overall Study|Death|5|||
105463524|NCT02760498|363709809|FG003|Overall Study|Death|7|||
105463525|NCT02760498|363709810|FG004|Overall Study|Death|0|||
105463526|NCT02760498|363709811|FG005|Overall Study|Death|23|||
105463527|NCT02760498|363709806|FG000|Overall Study|Lost to Follow-up|0|||
105463528|NCT02760498|363709807|FG001|Overall Study|Lost to Follow-up|0|||
105463529|NCT02760498|363709808|FG002|Overall Study|Lost to Follow-up|0|||
105463530|NCT02760498|363709809|FG003|Overall Study|Lost to Follow-up|0|||
105463531|NCT02760498|363709810|FG004|Overall Study|Lost to Follow-up|0|||
105463532|NCT02760498|363709811|FG005|Overall Study|Lost to Follow-up|3|||
105463533|NCT02760498|363709806|FG000|Overall Study|Non-compliance with study drug|0|||
105463534|NCT02760498|363709807|FG001|Overall Study|Non-compliance with study drug|2|||
105463535|NCT02760498|363709808|FG002|Overall Study|Non-compliance with study drug|0|||
105463536|NCT02760498|363709809|FG003|Overall Study|Non-compliance with study drug|0|||
105463537|NCT02760498|363709810|FG004|Overall Study|Non-compliance with study drug|0|||
105463538|NCT02760498|363709811|FG005|Overall Study|Non-compliance with study drug|0|||
105463539|NCT02760498|363709806|FG000|Overall Study|Participant decision|1|||
105463540|NCT02760498|363709807|FG001|Overall Study|Participant decision|4|||
105463541|NCT02760498|363709808|FG002|Overall Study|Participant decision|2|||
105463542|NCT02760498|363709809|FG003|Overall Study|Participant decision|2|||
105463543|NCT02760498|363709810|FG004|Overall Study|Participant decision|1|||
105463544|NCT02760498|363709811|FG005|Overall Study|Participant decision|6|||
105463545|NCT02760498|363709806|FG000|Overall Study|Sponsor decision|0|||
105463546|NCT02760498|363709807|FG001|Overall Study|Sponsor decision|0|||
105463547|NCT02760498|363709808|FG002|Overall Study|Sponsor decision|0|||
105463548|NCT02760498|363709809|FG003|Overall Study|Sponsor decision|3|||
105463549|NCT02760498|363709810|FG004|Overall Study|Sponsor decision|0|||
105665220|NCT02638103|364438627|FG000|Overall Study|Lost to Follow-up|26|||
105463550|NCT02760498|363709811|FG005|Overall Study|Sponsor decision|0|||
105463551|NCT02760498|363709806|FG000|Overall Study|Physician Decision|3|||
105463552|NCT02760498|363709807|FG001|Overall Study|Physician Decision|4|||
105463553|NCT02760498|363709808|FG002|Overall Study|Physician Decision|1|||
105463554|NCT02760498|363709809|FG003|Overall Study|Physician Decision|4|||
105463555|NCT02760498|363709810|FG004|Overall Study|Physician Decision|0|||
105665221|NCT02638103|364438628|FG001|Overall Study|Lost to Follow-up|33|||
105665222|NCT02638103|364438629|FG002|Overall Study|Lost to Follow-up|20|||
105665223|NCT02638103|364438630|FG003|Overall Study|Lost to Follow-up|37|||
105665224|NCT02638103|364438627|FG000|Overall Study|Lack of Efficacy|14|||
105665225|NCT02638103|364438628|FG001|Overall Study|Lack of Efficacy|10|||
105665226|NCT02638103|364438629|FG002|Overall Study|Lack of Efficacy|12|||
105665227|NCT02638103|364438630|FG003|Overall Study|Lack of Efficacy|22|||
105665228|NCT02638103|364438627|FG000|Overall Study|Other than specified|5|||
105665229|NCT02638103|364438628|FG001|Overall Study|Other than specified|4|||
105665230|NCT02638103|364438629|FG002|Overall Study|Other than specified|2|||
105665231|NCT02638103|364438630|FG003|Overall Study|Other than specified|4|||
105665232|NCT00358644|364438631|FG000|Overall Study|Progressive Disease|21|||
105665233|NCT00358644|364438631|FG000|Overall Study|Adverse Event|7|||
105665234|NCT00358644|364438631|FG000|Overall Study|Death|11|||
105665235|NCT00358644|364438631|FG000|Overall Study|Withdrawal by Subject|4|||
105463556|NCT02760498|363709811|FG005|Overall Study|Physician Decision|2|||
105665236|NCT00358644|364438631|FG000|Overall Study|Physician Decision|6|||
105665237|NCT00358644|364438631|FG000|Overall Study|Patient not eligible for study|1|||
105665238|NCT00513708|364438632|FG000|Overall Study|Lost to Follow-up|4|||
105665239|NCT00513708|364438633|FG001|Overall Study|Lost to Follow-up|4|||
105665240|NCT00513708|364438634|FG002|Overall Study|Lost to Follow-up|4|||
105665241|NCT03327831|364438635|FG000|Overall Study|Lost to Follow-up|2|||
105665242|NCT04674189|364438636|FG000|Overall Study|Adverse Event|0|||
105665243|NCT04674189|364438637|FG001|Overall Study|Adverse Event|0|||
105665244|NCT04674189|364438638|FG002|Overall Study|Adverse Event|1|||
105551601|NCT01458574|364019187|FG002|Overall Study|Withdrawal by Subject|5|||
105551602|NCT01458574|364019185|FG000|Overall Study|Other|2|||
105551603|NCT01458574|364019186|FG001|Overall Study|Other|1|||
105551604|NCT01458574|364019187|FG002|Overall Study|Other|0|||
105551605|NCT01458574|364019185|FG000|Overall Study|Randomized but not treated|0|||
105551606|NCT01458574|364019186|FG001|Overall Study|Randomized but not treated|1|||
105551607|NCT01458574|364019187|FG002|Overall Study|Randomized but not treated|0|||
105551608|NCT02125786|364019188|FG000|Overall Study|Still in Follow-up|3|||
105551609|NCT02125786|364019188|FG000|Overall Study|Screen Failure|2|||
105551610|NCT02125786|364019188|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
105551611|NCT02125786|364019188|FG000|Overall Study|Progressive Disease|44|||
105551612|NCT02125786|364019188|FG000|Overall Study|Death|8|||
105551613|NCT03832946|364019199|FG000|Overall Study|Adverse Event|3|||
105551614|NCT03832946|364019200|FG001|Overall Study|Adverse Event|1|||
105551615|NCT03832946|364019199|FG000|Overall Study|Lost to Follow-up|1|||
105551616|NCT03832946|364019200|FG001|Overall Study|Lost to Follow-up|0|||
105551617|NCT03832946|364019199|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
105551618|NCT03832946|364019200|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
105551619|NCT03832946|364019199|FG000|Overall Study|Lack of Efficacy|1|||
105551620|NCT03832946|364019200|FG001|Overall Study|Lack of Efficacy|0|||
105551621|NCT03832946|364019199|FG000|Overall Study|Withdrawal by Subject|12|||
105551622|NCT03832946|364019200|FG001|Overall Study|Withdrawal by Subject|9|||
105665245|NCT04674189|364438636|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
105665246|NCT04674189|364438637|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
105665247|NCT04674189|364438638|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
105665248|NCT04674189|364438636|FG000|Overall Study|Physician Decision|1|||
105551623|NCT01954017|364019202|FG000|Overall Study|Adverse Event|0|||
105551624|NCT01954017|364019203|FG001|Overall Study|Adverse Event|0|||
105551625|NCT01954017|364019204|FG002|Overall Study|Adverse Event|1|||
105551626|NCT01954017|364019202|FG000|Overall Study|Death|2|||
105551627|NCT01954017|364019203|FG001|Overall Study|Death|1|||
105665249|NCT04674189|364438637|FG001|Overall Study|Physician Decision|0|||
105551628|NCT01954017|364019204|FG002|Overall Study|Death|1|||
105551629|NCT01954017|364019202|FG000|Overall Study|Withdrawal by Subject|0|||
105665250|NCT04674189|364438638|FG002|Overall Study|Physician Decision|0|||
105551630|NCT01954017|364019203|FG001|Overall Study|Withdrawal by Subject|1|||
105551631|NCT01954017|364019204|FG002|Overall Study|Withdrawal by Subject|0|||
105551632|NCT01954017|364019202|FG000|Overall Study|Protocol Violation|0|||
105665251|NCT04674189|364438636|FG000|Overall Study|Withdrawal by Participant|83|||
105665252|NCT04674189|364438637|FG001|Overall Study|Withdrawal by Participant|71|||
105665253|NCT04674189|364438638|FG002|Overall Study|Withdrawal by Participant|142|||
105340036|NCT02275780|363245252|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
105551633|NCT01954017|364019203|FG001|Overall Study|Protocol Violation|3|||
105665254|NCT04674189|364438636|FG000|Overall Study|Lost to Follow-up|55|||
105665255|NCT04674189|364438637|FG001|Overall Study|Lost to Follow-up|53|||
105665256|NCT04674189|364438638|FG002|Overall Study|Lost to Follow-up|44|||
105463557|NCT02760498|363709806|FG000|Overall Study|Disease progression|21|||
105463558|NCT02760498|363709807|FG001|Overall Study|Disease progression|19|||
105463559|NCT02760498|363709808|FG002|Overall Study|Disease progression|20|||
105463560|NCT02760498|363709809|FG003|Overall Study|Disease progression|18|||
105463561|NCT02760498|363709810|FG004|Overall Study|Disease progression|4|||
105463562|NCT02760498|363709811|FG005|Overall Study|Disease progression|55|||
105463563|NCT02760498|363709806|FG000|Overall Study|Withdrawal by Subject|4|||
105463564|NCT02760498|363709807|FG001|Overall Study|Withdrawal by Subject|7|||
105463565|NCT02760498|363709808|FG002|Overall Study|Withdrawal by Subject|5|||
105463566|NCT02760498|363709809|FG003|Overall Study|Withdrawal by Subject|1|||
105463567|NCT02760498|363709810|FG004|Overall Study|Withdrawal by Subject|0|||
105463568|NCT02760498|363709811|FG005|Overall Study|Withdrawal by Subject|6|||
105463569|NCT02760498|363709806|FG000|Overall Study|Other than specified|1|||
105463570|NCT02760498|363709807|FG001|Overall Study|Other than specified|6|||
105463571|NCT02760498|363709808|FG002|Overall Study|Other than specified|0|||
105463572|NCT02760498|363709809|FG003|Overall Study|Other than specified|3|||
105463573|NCT02760498|363709810|FG004|Overall Study|Other than specified|1|||
105463574|NCT02760498|363709811|FG005|Overall Study|Other than specified|0|||
105463575|NCT02760498|363709806|FG000|Overall Study|Not treated|0|||
105463576|NCT02760498|363709807|FG001|Overall Study|Not treated|0|||
105463577|NCT02760498|363709808|FG002|Overall Study|Not treated|0|||
105463578|NCT02760498|363709809|FG003|Overall Study|Not treated|0|||
105463579|NCT02760498|363709810|FG004|Overall Study|Not treated|0|||
105463580|NCT02760498|363709811|FG005|Overall Study|Not treated|2|||
105463581|NCT02059278|363709812|FG000|Overall Study|Adverse Event|1|||
105463582|NCT02059278|363709813|FG001|Overall Study|Adverse Event|1|||
105463583|NCT02059278|363709812|FG000|Overall Study|Lost to Follow-up|1|||
105463584|NCT02059278|363709813|FG001|Overall Study|Lost to Follow-up|0|||
105463585|NCT02059278|363709812|FG000|Overall Study|Withdrawal by Subject|0|||
105463586|NCT02059278|363709813|FG001|Overall Study|Withdrawal by Subject|3|||
105463587|NCT02059278|363709812|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
105463588|NCT02059278|363709813|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
105463589|NCT04363320|363709814|FG000|Overall Study|Lost to Follow-up|43|||
105463590|NCT04363320|363709815|FG001|Overall Study|Lost to Follow-up|42|||
105463591|NCT04363320|363709816|FG002|Overall Study|Lost to Follow-up|24|||
105665257|NCT04674189|364438636|FG000|Overall Study|Miscellaneous|27|||
105665258|NCT04674189|364438637|FG001|Overall Study|Miscellaneous|23|||
105665259|NCT04674189|364438638|FG002|Overall Study|Miscellaneous|207|||
105665260|NCT04674189|364438636|FG000|Overall Study|Did Not Receive Treatment|3|||
105665261|NCT04674189|364438637|FG001|Overall Study|Did Not Receive Treatment|1|||
105665262|NCT04674189|364438638|FG002|Overall Study|Did Not Receive Treatment|2|||
105665263|NCT01564277|364438639|FG000|Overall Study|Protocol Violation|0|||
105665264|NCT01564277|364438640|FG001|Overall Study|Protocol Violation|1|||
105665265|NCT01564277|364438639|FG000|Overall Study|Physician Decision|1|||
105665266|NCT01564277|364438640|FG001|Overall Study|Physician Decision|0|||
105665267|NCT03332784|364438647|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665268|NCT03332784|364438648|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
105665269|NCT03332784|364438649|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665270|NCT03332784|364438650|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665271|NCT03332784|364438651|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665272|NCT03332784|364438652|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665273|NCT03332784|364438653|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665274|NCT03332784|364438654|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665275|NCT03332784|364438655|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665276|NCT03332784|364438656|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665277|NCT03332784|364438657|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665278|NCT03332784|364438658|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105551634|NCT01954017|364019204|FG002|Overall Study|Protocol Violation|2|||
105551635|NCT01954017|364019202|FG000|Overall Study|Necrotizing enterocolitis|1|||
105551636|NCT01954017|364019203|FG001|Overall Study|Necrotizing enterocolitis|0|||
105551637|NCT01954017|364019204|FG002|Overall Study|Necrotizing enterocolitis|1|||
105551638|NCT01954017|364019202|FG000|Overall Study|Enteral intake stopped >7 days|0|||
105551639|NCT01954017|364019203|FG001|Overall Study|Enteral intake stopped >7 days|1|||
105551640|NCT01954017|364019204|FG002|Overall Study|Enteral intake stopped >7 days|1|||
105551641|NCT01954017|364019202|FG000|Overall Study|All other reasons|2|||
105551642|NCT01954017|364019203|FG001|Overall Study|All other reasons|2|||
105551643|NCT01954017|364019204|FG002|Overall Study|All other reasons|7|||
105551644|NCT03346759|364019205|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
105551645|NCT03346759|364019206|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
105551646|NCT03346759|364019205|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
105551647|NCT03346759|364019206|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
105551648|NCT03346759|364019205|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
105551649|NCT03346759|364019206|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
105551650|NCT01165281|364019212|FG000|Overall Study|Adverse Event|12|||
105551651|NCT01165281|364019213|FG001|Overall Study|Adverse Event|14|||
105551652|NCT01165281|364019212|FG000|Overall Study|Death|3|||
105551653|NCT01165281|364019213|FG001|Overall Study|Death|4|||
105551654|NCT01165281|364019212|FG000|Overall Study|Lack of Efficacy|4|||
105340037|NCT02275780|363245251|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
105665279|NCT03332784|364438659|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665280|NCT03332784|364438660|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665281|NCT03332784|364438661|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
105665282|NCT03332784|364438662|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665283|NCT03332784|364438663|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665284|NCT03332784|364438664|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665285|NCT03332784|364438665|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665286|NCT03332784|364438666|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665287|NCT01969851|364438676|FG000|Overall Study|Adverse Event|0|||
105665288|NCT01969851|364438677|FG001|Overall Study|Adverse Event|0|||
105665289|NCT01969851|364438678|FG002|Overall Study|Adverse Event|3|||
105665290|NCT01969851|364438676|FG000|Overall Study|Lack of Efficacy|0|||
105665291|NCT01969851|364438677|FG001|Overall Study|Lack of Efficacy|3|||
105665292|NCT01969851|364438678|FG002|Overall Study|Lack of Efficacy|1|||
105665293|NCT01969851|364438676|FG000|Overall Study|Withdrawal by Subject|1|||
105665294|NCT01969851|364438677|FG001|Overall Study|Withdrawal by Subject|0|||
105665295|NCT01969851|364438678|FG002|Overall Study|Withdrawal by Subject|1|||
105665296|NCT01969851|364438676|FG000|Overall Study|No effective dose in Titration period|0|||
105665297|NCT01969851|364438677|FG001|Overall Study|No effective dose in Titration period|0|||
105665298|NCT01969851|364438678|FG002|Overall Study|No effective dose in Titration period|1|||
105665299|NCT01969851|364438676|FG000|Overall Study|Sponsor decision|0|||
105665300|NCT01969851|364438677|FG001|Overall Study|Sponsor decision|0|||
105665301|NCT01969851|364438678|FG002|Overall Study|Sponsor decision|1|||
105665302|NCT01299480|364438679|FG000|Overall Study|No longer willing to participate|19|||
105665303|NCT01299480|364438680|FG001|Overall Study|No longer willing to participate|17|||
105665304|NCT01299480|364438681|FG002|Overall Study|No longer willing to participate|14|||
105665305|NCT01299480|364438682|FG003|Overall Study|No longer willing to participate|13|||
105665306|NCT01299480|364438683|FG004|Overall Study|No longer willing to participate|10|||
105665307|NCT01299480|364438679|FG000|Overall Study|Protocol Violation|7|||
105665308|NCT01299480|364438680|FG001|Overall Study|Protocol Violation|5|||
105665309|NCT01299480|364438681|FG002|Overall Study|Protocol Violation|8|||
105665310|NCT01299480|364438682|FG003|Overall Study|Protocol Violation|1|||
105665311|NCT01299480|364438683|FG004|Overall Study|Protocol Violation|1|||
105665312|NCT01299480|364438679|FG000|Overall Study|Withdrawal by Subject|3|||
105665313|NCT01299480|364438680|FG001|Overall Study|Withdrawal by Subject|4|||
105665314|NCT01299480|364438681|FG002|Overall Study|Withdrawal by Subject|7|||
105665315|NCT01299480|364438682|FG003|Overall Study|Withdrawal by Subject|3|||
105665316|NCT01299480|364438683|FG004|Overall Study|Withdrawal by Subject|4|||
105665317|NCT01299480|364438679|FG000|Overall Study|Adverse Event|6|||
105665318|NCT01299480|364438680|FG001|Overall Study|Adverse Event|4|||
105665319|NCT01299480|364438681|FG002|Overall Study|Adverse Event|5|||
105665320|NCT01299480|364438682|FG003|Overall Study|Adverse Event|4|||
105665321|NCT01299480|364438683|FG004|Overall Study|Adverse Event|0|||
105665322|NCT01299480|364438679|FG000|Overall Study|Withdrawal due to pregnancy|0|||
105665323|NCT01299480|364438680|FG001|Overall Study|Withdrawal due to pregnancy|1|||
105665324|NCT01299480|364438681|FG002|Overall Study|Withdrawal due to pregnancy|1|||
105665325|NCT01299480|364438682|FG003|Overall Study|Withdrawal due to pregnancy|0|||
105665326|NCT01299480|364438683|FG004|Overall Study|Withdrawal due to pregnancy|0|||
105665327|NCT01299480|364438679|FG000|Overall Study|Physician Decision|1|||
105665328|NCT01299480|364438680|FG001|Overall Study|Physician Decision|1|||
105340038|NCT02275780|363245252|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
105340039|NCT02275780|363245251|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
105360869|NCT00003483|363328096|FG000|Overall Study|Not evaluable|1|||
105360870|NCT02609386|363328097|FG000|Overall Study|Withdrawal by Subject|6|||
105360871|NCT02609386|363328098|FG001|Overall Study|Withdrawal by Subject|1|||
105360872|NCT02609386|363328097|FG000|Overall Study|Lost to Follow-up|3|||
105360873|NCT02609386|363328098|FG001|Overall Study|Lost to Follow-up|5|||
105360874|NCT02609386|363328097|FG000|Overall Study|Death|19|||
105360875|NCT02609386|363328098|FG001|Overall Study|Death|9|||
105360876|NCT02609386|363328097|FG000|Overall Study|Physician Decision|0|||
105360877|NCT02609386|363328098|FG001|Overall Study|Physician Decision|2|||
105665329|NCT01299480|364438681|FG002|Overall Study|Physician Decision|0|||
105665330|NCT01299480|364438682|FG003|Overall Study|Physician Decision|2|||
105665331|NCT01299480|364438683|FG004|Overall Study|Physician Decision|0|||
105665332|NCT01299480|364438679|FG000|Overall Study|Lost to Follow-up|3|||
105665333|NCT01299480|364438680|FG001|Overall Study|Lost to Follow-up|1|||
105665334|NCT01299480|364438681|FG002|Overall Study|Lost to Follow-up|2|||
105665335|NCT01299480|364438682|FG003|Overall Study|Lost to Follow-up|1|||
105665336|NCT01299480|364438683|FG004|Overall Study|Lost to Follow-up|2|||
105665337|NCT01299480|364438679|FG000|Overall Study|Other|3|||
105665338|NCT01299480|364438680|FG001|Overall Study|Other|2|||
105665339|NCT01299480|364438681|FG002|Overall Study|Other|3|||
105665340|NCT01299480|364438682|FG003|Overall Study|Other|0|||
105665341|NCT01299480|364438683|FG004|Overall Study|Other|3|||
105665342|NCT01299480|364438679|FG000|Overall Study|Started, but not vaccinated|0|||
105665343|NCT01299480|364438680|FG001|Overall Study|Started, but not vaccinated|0|||
105665344|NCT01299480|364438681|FG002|Overall Study|Started, but not vaccinated|1|||
105665345|NCT01299480|364438682|FG003|Overall Study|Started, but not vaccinated|1|||
105665346|NCT01299480|364438683|FG004|Overall Study|Started, but not vaccinated|0|||
105665347|NCT01827046|364438684|FG000|Overall Study|Lost to Follow-up|1|||
105665348|NCT01827046|364438685|FG001|Overall Study|Lost to Follow-up|5|||
105665349|NCT01827046|364438684|FG000|Overall Study|Withdrawal by Subject|0|||
105665350|NCT01827046|364438685|FG001|Overall Study|Withdrawal by Subject|4|||
105665351|NCT02498236|364438692|FG000|Overall Study|Did not show for testing|1|||
105665352|NCT02498236|364438693|FG001|Overall Study|Did not show for testing|0|||
105665353|NCT02498236|364438694|FG002|Overall Study|Did not show for testing|0|||
105665354|NCT02498236|364438695|FG003|Overall Study|Did not show for testing|0|||
105665355|NCT02498236|364438696|FG004|Overall Study|Did not show for testing|0|||
105665356|NCT02498236|364438697|FG005|Overall Study|Did not show for testing|0|||
105665357|NCT02498236|364438698|FG006|Overall Study|Did not show for testing|0|||
105665358|NCT02498236|364438699|FG007|Overall Study|Did not show for testing|1|||
105665359|NCT02498236|364438692|FG000|Overall Study|Equipment failure|0|||
105665360|NCT02498236|364438693|FG001|Overall Study|Equipment failure|0|||
105665361|NCT02498236|364438694|FG002|Overall Study|Equipment failure|0|||
105665362|NCT02498236|364438695|FG003|Overall Study|Equipment failure|0|||
105665363|NCT02498236|364438696|FG004|Overall Study|Equipment failure|0|||
105665364|NCT02498236|364438697|FG005|Overall Study|Equipment failure|0|||
105665365|NCT02498236|364438698|FG006|Overall Study|Equipment failure|1|||
105665366|NCT02498236|364438699|FG007|Overall Study|Equipment failure|0|||
105665367|NCT02498236|364438692|FG000|Overall Study|Withdrawal by Subject|0|||
105665368|NCT02498236|364438693|FG001|Overall Study|Withdrawal by Subject|0|||
105665369|NCT02498236|364438694|FG002|Overall Study|Withdrawal by Subject|0|||
105665370|NCT02498236|364438695|FG003|Overall Study|Withdrawal by Subject|0|||
105665371|NCT02498236|364438696|FG004|Overall Study|Withdrawal by Subject|1|||
105665372|NCT02498236|364438697|FG005|Overall Study|Withdrawal by Subject|0|||
105665373|NCT02498236|364438698|FG006|Overall Study|Withdrawal by Subject|0|||
105665374|NCT02498236|364438699|FG007|Overall Study|Withdrawal by Subject|0|||
105665375|NCT01426347|364438700|FG000|Overall Study|Lost to Follow-up|0|||
105665376|NCT01426347|364438701|FG001|Overall Study|Lost to Follow-up|3|||
105665377|NCT01426347|364438700|FG000|Overall Study|Protocol Violation|2|||
105665378|NCT01426347|364438701|FG001|Overall Study|Protocol Violation|0|||
105665379|NCT01426347|364438700|FG000|Overall Study|Withdrawal by Subject|5|||
105340040|NCT02275780|363245252|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
105665380|NCT01426347|364438701|FG001|Overall Study|Withdrawal by Subject|0|||
105665381|NCT01948076|364438704|FG000|Overall Study|Withdrawal by Subject|0|||
105463592|NCT04363320|363709817|FG003|Overall Study|Lost to Follow-up|29|||
105340041|NCT02275780|363245251|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
105340042|NCT02275780|363245252|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
105463593|NCT04363320|363709814|FG000|Overall Study|Death|0|||
105463594|NCT04363320|363709815|FG001|Overall Study|Death|0|||
105463595|NCT04363320|363709816|FG002|Overall Study|Death|1|||
105463596|NCT04363320|363709817|FG003|Overall Study|Death|0|||
105340043|NCT02275780|363245251|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
105463597|NCT03435211|363709820|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
105463598|NCT01198977|363709821|FG000|Overall Study|Lost to Follow-up|1|||
105463599|NCT01198977|363709822|FG001|Overall Study|Lost to Follow-up|0|||
105463600|NCT03863080|363709823|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
105463601|NCT03863080|363709824|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
105463602|NCT03863080|363709825|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
105463603|NCT03863080|363709826|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
105463604|NCT03863080|363709823|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
105463605|NCT03863080|363709824|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
105463606|NCT03863080|363709825|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
105463607|NCT03863080|363709826|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
105463608|NCT03863080|363709823|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
105463609|NCT03863080|363709824|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
105463610|NCT03863080|363709825|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
105463611|NCT03863080|363709826|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
105463612|NCT01342211|363709827|FG000|Overall Study|Lost to Follow-up|0|||
105463613|NCT01342211|363709828|FG001|Overall Study|Lost to Follow-up|0|||
105463614|NCT01342211|363709829|FG002|Overall Study|Lost to Follow-up|0|||
105463615|NCT01342211|363709830|FG003|Overall Study|Lost to Follow-up|1|||
105551655|NCT01165281|364019213|FG001|Overall Study|Lack of Efficacy|1|||
105340044|NCT02275780|363245252|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
105340045|NCT02275780|363245251|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
105463616|NCT01342211|363709831|FG004|Overall Study|Lost to Follow-up|0|||
105463617|NCT01342211|363709827|FG000|Overall Study|Adverse Event|0|||
105551656|NCT01165281|364019212|FG000|Overall Study|Lost to Follow-up|0|||
105360878|NCT00873730|363328099|FG000|Overall Study|Protocol Deviation|5|||
105665382|NCT01948076|364438705|FG001|Overall Study|Withdrawal by Subject|1|||
105665383|NCT00475228|364438708|FG000|Overall Study|Lost to Follow-up|17|||
105665384|NCT00475228|364438709|FG001|Overall Study|Lost to Follow-up|17|||
105665385|NCT00738283|364438713|FG000|Overall Study|Death|1|||
105340046|NCT02275780|363245252|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
105340047|NCT02275780|363245251|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
105665386|NCT00738283|364438713|FG000|Overall Study|Transfer to another facility|2|||
105551657|NCT01165281|364019213|FG001|Overall Study|Lost to Follow-up|1|||
105551658|NCT01165281|364019212|FG000|Overall Study|Physician Decision|8|||
105551659|NCT01165281|364019213|FG001|Overall Study|Physician Decision|1|||
105551660|NCT01165281|364019212|FG000|Overall Study|Protocol Violation|6|||
105551661|NCT01165281|364019213|FG001|Overall Study|Protocol Violation|5|||
105551662|NCT01165281|364019212|FG000|Overall Study|Withdrawal by Subject|8|||
105551663|NCT01165281|364019213|FG001|Overall Study|Withdrawal by Subject|7|||
105463618|NCT01342211|363709828|FG001|Overall Study|Adverse Event|0|||
105463619|NCT01342211|363709829|FG002|Overall Study|Adverse Event|0|||
105463620|NCT01342211|363709830|FG003|Overall Study|Adverse Event|0|||
105463621|NCT01342211|363709831|FG004|Overall Study|Adverse Event|1|||
105463622|NCT01342211|363709827|FG000|Overall Study|Withdrawal by Subject|0|||
105463623|NCT01342211|363709828|FG001|Overall Study|Withdrawal by Subject|0|||
105463624|NCT01342211|363709829|FG002|Overall Study|Withdrawal by Subject|0|||
105463625|NCT01342211|363709830|FG003|Overall Study|Withdrawal by Subject|1|||
105463626|NCT01342211|363709831|FG004|Overall Study|Withdrawal by Subject|0|||
105463627|NCT01342211|363709827|FG000|Overall Study|Randomized, but not Treated|0|||
105463628|NCT01342211|363709828|FG001|Overall Study|Randomized, but not Treated|2|||
105463629|NCT01342211|363709829|FG002|Overall Study|Randomized, but not Treated|0|||
105463630|NCT01342211|363709830|FG003|Overall Study|Randomized, but not Treated|0|||
105463631|NCT01342211|363709831|FG004|Overall Study|Randomized, but not Treated|1|||
105463632|NCT05660577|363711528|FG000|Overall Study|Discontinued|9|||
105340048|NCT02275780|363245252|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
105340049|NCT02275780|363245251|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
105340050|NCT02275780|363245252|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
105340051|NCT02275780|363245251|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
105340052|NCT02275780|363245252|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
105340053|NCT02275780|363245251|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
105340054|NCT02275780|363245252|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
105340055|NCT02275780|363245251|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
105340056|NCT02275780|363245252|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
105340057|NCT02275780|363245251|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
105340058|NCT02275780|363245252|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
105340059|NCT02833844|363245257|FG000|Double-Blind Period|Withdrawal by Subject|2|||
105340060|NCT02833844|363245258|FG001|Double-Blind Period|Withdrawal by Subject|3|||
105340061|NCT02833844|363245257|FG000|Double-Blind Period|Protocol Violation|0|||
105340062|NCT02833844|363245258|FG001|Double-Blind Period|Protocol Violation|4|||
105340063|NCT02833844|363245257|FG000|Open-Label Period|Death|0|||
105340064|NCT02833844|363245258|FG001|Open-Label Period|Death|2|||
105340065|NCT02833844|363245257|FG000|Open-Label Period|Lost to Follow-up|1|||
105340066|NCT02833844|363245258|FG001|Open-Label Period|Lost to Follow-up|0|||
105340067|NCT02833844|363245257|FG000|Open-Label Period|Withdrawal by Subject|1|||
105340068|NCT02833844|363245258|FG001|Open-Label Period|Withdrawal by Subject|0|||
105340069|NCT02662764|363245259|FG000|Overall Study|Adverse Event|6|||
105340070|NCT02662764|363245259|FG000|Overall Study|Lack of Efficacy|8|||
105340071|NCT02662764|363245259|FG000|Overall Study|Protocol Violation|1|||
105340072|NCT02662764|363245259|FG000|Overall Study|Withdrawal by Subject|5|||
105340073|NCT02662764|363245259|FG000|Overall Study|Device failure|4|||
105340074|NCT02662764|363245259|FG000|Overall Study|Patient changed treatment|1|||
105340075|NCT02662764|363245259|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
105340076|NCT00348790|363245260|FG000|Completed Treatment|Withdrawal by Subject|4|||
105340077|NCT00348790|363245260|FG000|Completed Treatment|Disease progression|14|||
105340078|NCT00348790|363245260|FG000|Completed Treatment|Adverse Event|4|||
105340079|NCT00348790|363245260|FG000|Completed Treatment|Required surgery|2|||
105340080|NCT00348790|363245260|FG000|Completed Treatment|Unable to travel to study site|1|||
105340081|NCT01282164|363245261|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
105340082|NCT01282164|363245262|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
105340083|NCT00834639|363245263|FG000|Second Intervention|Physician Decision|0|||
105340084|NCT00834639|363245264|FG001|Second Intervention|Physician Decision|2|||
105340085|NCT02658734|363245265|FG000|Overall Study|Adverse Event|2|||
105665387|NCT00738283|364438713|FG000|Overall Study|Discharge home prior to end of study|1|||
105665388|NCT04463680|364438714|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
105665389|NCT04463680|364438714|FG000|Overall Study|Not eligible due to implant duration of use|1|||
105665390|NCT04463680|364438714|FG000|Overall Study|Withdrawal by Subject|3|||
105665391|NCT05239598|364438715|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
105665392|NCT05239598|364438716|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
105665393|NCT05239598|364438715|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
105665394|NCT05239598|364438716|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
105665395|NCT04124471|364438717|FG000|Overall Study|screen failure|1|||
105665396|NCT05226130|364438718|FG000|Overall Study|Lost to Follow-up|0|||
105665397|NCT05226130|364438719|FG001|Overall Study|Lost to Follow-up|1|||
105665398|NCT05226130|364438718|FG000|Overall Study|Not treatment adherent|0|||
105665399|NCT05226130|364438719|FG001|Overall Study|Not treatment adherent|2|||
105665400|NCT03358472|364438720|FG000|Overall Study|Death|6|||
105665401|NCT03358472|364438721|FG001|Overall Study|Death|3|||
105665402|NCT03358472|364438722|FG002|Overall Study|Death|10|||
105665403|NCT03358472|364438720|FG000|Overall Study|Physician Decision|0|||
105665404|NCT03358472|364438721|FG001|Overall Study|Physician Decision|1|||
105665405|NCT03358472|364438722|FG002|Overall Study|Physician Decision|0|||
105665406|NCT03358472|364438720|FG000|Overall Study|Withdrawal by Subject|0|||
105665407|NCT03358472|364438721|FG001|Overall Study|Withdrawal by Subject|0|||
105665408|NCT03358472|364438722|FG002|Overall Study|Withdrawal by Subject|1|||
105665409|NCT03358472|364438720|FG000|Overall Study|On-going at clinical cut off date|9|||
105665410|NCT03358472|364438721|FG001|Overall Study|On-going at clinical cut off date|6|||
105665411|NCT03358472|364438722|FG002|Overall Study|On-going at clinical cut off date|5|||
105665412|NCT00078377|364440732|FG000|Overall Study|Adverse Event|2|||
105665413|NCT00078377|364440733|FG001|Overall Study|Adverse Event|5|||
105665414|NCT00078377|364440734|FG002|Overall Study|Adverse Event|1|||
105665415|NCT00078377|364440732|FG000|Overall Study|Lack of Efficacy|2|||
105463633|NCT01744977|363711529|FG000|Overall Study|Withdrawal by Subject|1|||
105463634|NCT01744977|363711530|FG001|Overall Study|Withdrawal by Subject|2|||
105463635|NCT01744977|363711529|FG000|Overall Study|Death|2|||
105463636|NCT01744977|363711530|FG001|Overall Study|Death|3|||
105463637|NCT01744977|363711529|FG000|Overall Study|Lost to Follow-up|2|||
105463638|NCT01744977|363711530|FG001|Overall Study|Lost to Follow-up|0|||
105463639|NCT01744977|363711529|FG000|Overall Study|No longer meets inclusion|6|||
105463640|NCT01744977|363711530|FG001|Overall Study|No longer meets inclusion|0|||
105463641|NCT02156076|363711531|FG000|Treatment Period|no longer meets study criteria|0|||
105463642|NCT02156076|363711532|FG001|Treatment Period|no longer meets study criteria|0|||
105463643|NCT02156076|363711533|FG002|Treatment Period|no longer meets study criteria|1|||
105463644|NCT02156076|363711534|FG003|Treatment Period|no longer meets study criteria|0|||
105463645|NCT02156076|363711531|FG000|Treatment Period|Poor/non-compliance|0|||
105463646|NCT02156076|363711532|FG001|Treatment Period|Poor/non-compliance|1|||
105463647|NCT02156076|363711533|FG002|Treatment Period|Poor/non-compliance|0|||
105463648|NCT02156076|363711534|FG003|Treatment Period|Poor/non-compliance|0|||
105463649|NCT02156076|363711531|FG000|Treatment Period|Lost to Follow-up|0|||
105665416|NCT00078377|364440733|FG001|Overall Study|Lack of Efficacy|0|||
105463650|NCT02156076|363711532|FG001|Treatment Period|Lost to Follow-up|0|||
105463651|NCT02156076|363711533|FG002|Treatment Period|Lost to Follow-up|0|||
105665417|NCT00078377|364440734|FG002|Overall Study|Lack of Efficacy|2|||
105340086|NCT02658734|363245265|FG000|Overall Study|Death|4|||
105340087|NCT02658734|363245265|FG000|Overall Study|Lost to Follow-up|7|||
105340088|NCT02658734|363245265|FG000|Overall Study|Withdrawal of Consent|16|||
105340089|NCT02658734|363245265|FG000|Overall Study|Disease Progression|28|||
105340090|NCT01552915|363245266|FG000|Overall Study|Adverse Event|3|||
105340091|NCT01552915|363245267|FG001|Overall Study|Adverse Event|14|||
105340092|NCT01552915|363245268|FG002|Overall Study|Adverse Event|3|||
105340093|NCT01552915|363245266|FG000|Overall Study|Lost to Follow-up|4|||
105340094|NCT01552915|363245267|FG001|Overall Study|Lost to Follow-up|6|||
105340095|NCT01552915|363245268|FG002|Overall Study|Lost to Follow-up|5|||
105340096|NCT01552915|363245266|FG000|Overall Study|Withdrawal by Subject|6|||
105340097|NCT01552915|363245267|FG001|Overall Study|Withdrawal by Subject|4|||
105340098|NCT01552915|363245268|FG002|Overall Study|Withdrawal by Subject|5|||
105340099|NCT01552915|363245266|FG000|Overall Study|Protocol Violation|0|||
105340100|NCT01552915|363245267|FG001|Overall Study|Protocol Violation|4|||
105340101|NCT01552915|363245268|FG002|Overall Study|Protocol Violation|4|||
105340102|NCT01552915|363245266|FG000|Overall Study|Lack of Efficacy|8|||
105340103|NCT01552915|363245267|FG001|Overall Study|Lack of Efficacy|1|||
105340104|NCT01552915|363245268|FG002|Overall Study|Lack of Efficacy|4|||
105340105|NCT01552915|363245266|FG000|Overall Study|Other|2|||
105340106|NCT01552915|363245267|FG001|Overall Study|Other|0|||
105340107|NCT01552915|363245268|FG002|Overall Study|Other|6|||
105340108|NCT01252563|363245270|FG000|Overall Study|Contract Deviation|41|||
105340109|NCT01252563|363245270|FG000|Overall Study|Centralized Registration Deviation|30|||
105340110|NCT01252563|363245270|FG000|Overall Study|Lost to Follow-up|161|||
105340111|NCT01252563|363245270|FG000|Overall Study|No visit after first day of treatment|194|||
105340112|NCT01252563|363245270|FG000|Overall Study|No drug administration|6|||
105340113|NCT03973918|363245282|FG000|Overall Study|Adverse Event|0|||
105340114|NCT03973918|363245283|FG001|Overall Study|Adverse Event|0|||
105340115|NCT03973918|363245284|FG002|Overall Study|Adverse Event|0|||
105340116|NCT03973918|363245285|FG003|Overall Study|Adverse Event|1|||
105340117|NCT03973918|363245282|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
105340118|NCT03973918|363245283|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
105340119|NCT03973918|363245284|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
105340120|NCT03973918|363245285|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
105340121|NCT02253316|363245286|FG000|Consolidation|Progression|4|||
105340122|NCT02253316|363245287|FG001|Consolidation|Progression|0|||
105340123|NCT02253316|363245288|FG002|Consolidation|Progression|0|||
105340124|NCT02253316|363245286|FG000|Consolidation|Non-Compliance|1|||
105340125|NCT02253316|363245287|FG001|Consolidation|Non-Compliance|0|||
105340126|NCT02253316|363245288|FG002|Consolidation|Non-Compliance|0|||
105340127|NCT02253316|363245286|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
105340128|NCT02253316|363245287|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
105340129|NCT02253316|363245288|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
105340130|NCT02253316|363245286|FG000|Consolidation|Secondary Malignancy|2|||
105340131|NCT02253316|363245287|FG001|Consolidation|Secondary Malignancy|0|||
105551664|NCT01165281|364019212|FG000|Overall Study|Noncompliance with Study Drug|1|||
105340132|NCT02253316|363245288|FG002|Consolidation|Secondary Malignancy|0|||
105340133|NCT02253316|363245286|FG000|Consolidation|Adverse Event|7|||
105340134|NCT02253316|363245287|FG001|Consolidation|Adverse Event|0|||
105340135|NCT02253316|363245288|FG002|Consolidation|Adverse Event|0|||
105340136|NCT02253316|363245286|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
105463652|NCT02156076|363711534|FG003|Treatment Period|Lost to Follow-up|1|||
105665418|NCT00078377|364440732|FG000|Overall Study|Lost to Follow-up|0|||
105463653|NCT02156076|363711531|FG000|Treatment Period|Withdrawal by Subject|0|||
105463654|NCT02156076|363711532|FG001|Treatment Period|Withdrawal by Subject|0|||
105463655|NCT02156076|363711533|FG002|Treatment Period|Withdrawal by Subject|1|||
105463656|NCT02156076|363711534|FG003|Treatment Period|Withdrawal by Subject|0|||
105463657|NCT02156076|363711531|FG000|Treatment Period|Subject request to discontinue treatment|0|||
105463658|NCT02156076|363711532|FG001|Treatment Period|Subject request to discontinue treatment|1|||
105463659|NCT02156076|363711533|FG002|Treatment Period|Subject request to discontinue treatment|0|||
105665419|NCT00078377|364440733|FG001|Overall Study|Lost to Follow-up|1|||
105665420|NCT00078377|364440734|FG002|Overall Study|Lost to Follow-up|1|||
105665421|NCT00078377|364440732|FG000|Overall Study|Physician Decision|2|||
105665422|NCT00078377|364440733|FG001|Overall Study|Physician Decision|0|||
105665423|NCT00078377|364440734|FG002|Overall Study|Physician Decision|0|||
105665424|NCT00078377|364440732|FG000|Overall Study|Withdrawal by Subject|3|||
105665425|NCT00078377|364440733|FG001|Overall Study|Withdrawal by Subject|4|||
105665426|NCT00078377|364440734|FG002|Overall Study|Withdrawal by Subject|4|||
105665427|NCT00078377|364440732|FG000|Overall Study|Miscellaneous|2|||
105665428|NCT00078377|364440733|FG001|Overall Study|Miscellaneous|6|||
105665429|NCT00078377|364440734|FG002|Overall Study|Miscellaneous|1|||
105665430|NCT02568397|364440735|FG000|Period 2|Withdrawal by Subject|0|||
105665431|NCT02568397|364440736|FG001|Period 2|Withdrawal by Subject|1|||
105551665|NCT01165281|364019213|FG001|Overall Study|Noncompliance with Study Drug|4|||
105551666|NCT01165281|364019212|FG000|Overall Study|Progressive Disease|10|||
105551667|NCT01165281|364019213|FG001|Overall Study|Progressive Disease|14|||
105551668|NCT01165281|364019212|FG000|Overall Study|Other|6|||
105551669|NCT01165281|364019213|FG001|Overall Study|Other|0|||
105551670|NCT03277313|364019216|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
105551671|NCT03277313|364019217|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
105551672|NCT03277313|364019216|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
105551673|NCT03277313|364019217|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
105551674|NCT03277313|364019216|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
105551675|NCT03277313|364019217|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
105551676|NCT03277313|364019216|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
105551677|NCT03277313|364019217|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
105551678|NCT03277313|364019216|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
105551679|NCT03277313|364019217|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
105551680|NCT02005471|364019218|FG000|Main Study|Adverse Event|0|||
105551681|NCT02005471|364019219|FG001|Main Study|Adverse Event|1|||
105551682|NCT02005471|364019220|FG002|Main Study|Adverse Event|0|||
105551683|NCT02005471|364019221|FG003|Main Study|Adverse Event|0|||
105551684|NCT02005471|364019218|FG000|Main Study|Death|83|||
105551685|NCT02005471|364019219|FG001|Main Study|Death|52|||
105551686|NCT02005471|364019220|FG002|Main Study|Death|0|||
105551687|NCT02005471|364019221|FG003|Main Study|Death|0|||
105551688|NCT02005471|364019218|FG000|Main Study|Lost to Follow-up|4|||
105551689|NCT02005471|364019219|FG001|Main Study|Lost to Follow-up|5|||
105551690|NCT02005471|364019220|FG002|Main Study|Lost to Follow-up|0|||
105551691|NCT02005471|364019221|FG003|Main Study|Lost to Follow-up|0|||
105551692|NCT02005471|364019218|FG000|Main Study|Physician Decision|3|||
105551693|NCT02005471|364019219|FG001|Main Study|Physician Decision|1|||
105551694|NCT02005471|364019220|FG002|Main Study|Physician Decision|0|||
105551695|NCT02005471|364019221|FG003|Main Study|Physician Decision|0|||
105551696|NCT02005471|364019218|FG000|Main Study|Withdrawal by Subject|26|||
105551697|NCT02005471|364019219|FG001|Main Study|Withdrawal by Subject|11|||
105551698|NCT02005471|364019220|FG002|Main Study|Withdrawal by Subject|0|||
105551699|NCT02005471|364019221|FG003|Main Study|Withdrawal by Subject|0|||
105551700|NCT02005471|364019218|FG000|Main Study|Reason not Specified|0|||
105551701|NCT02005471|364019219|FG001|Main Study|Reason not Specified|6|||
105551702|NCT02005471|364019220|FG002|Main Study|Reason not Specified|0|||
105551703|NCT02005471|364019221|FG003|Main Study|Reason not Specified|0|||
105551704|NCT02005471|364019218|FG000|Main Study|Randomized but not Dosed|8|||
105551705|NCT02005471|364019219|FG001|Main Study|Randomized but not Dosed|0|||
105551706|NCT02005471|364019220|FG002|Main Study|Randomized but not Dosed|0|||
105551707|NCT02005471|364019221|FG003|Main Study|Randomized but not Dosed|0|||
105551708|NCT02005471|364019218|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
105551709|NCT02005471|364019219|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
105551710|NCT02005471|364019220|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
105551711|NCT02005471|364019221|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
105551712|NCT02005471|364019218|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
105551713|NCT02005471|364019219|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
105551714|NCT02005471|364019220|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
105551715|NCT02005471|364019221|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
105551716|NCT02005471|364019218|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
105665432|NCT02568397|364440735|FG000|Period 2|Physician Decision|0|||
105551717|NCT02005471|364019219|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
105551718|NCT02005471|364019220|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
105551719|NCT02005471|364019221|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
105551720|NCT03943095|364019223|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
105551721|NCT03943095|364019224|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
105551722|NCT03943095|364019223|FG000|Overall Study|Withdrawal by Subject|1|||
105551723|NCT03943095|364019224|FG001|Overall Study|Withdrawal by Subject|0|||
105551724|NCT03674177|364019225|FG000|Overall Study|Lost to Follow-up|2|||
105551725|NCT03674177|364019226|FG001|Overall Study|Lost to Follow-up|1|||
105551726|NCT03674177|364019227|FG002|Overall Study|Lost to Follow-up|0|||
105785967|NCT03735849|364870420|FG001|Overall Study|Participant unable to adhere to visit|0|||
105360879|NCT00873730|363328100|FG001|Overall Study|Protocol Deviation|2|||
105551727|NCT03674177|364019228|FG003|Overall Study|Lost to Follow-up|2|||
105785968|NCT03735849|364870421|FG002|Overall Study|Participant unable to adhere to visit|0|||
105785969|NCT03735849|364870419|FG000|Overall Study|Not Randomized|0|||
105785970|NCT03735849|364870420|FG001|Overall Study|Not Randomized|0|||
105785971|NCT03735849|364870421|FG002|Overall Study|Not Randomized|4|||
105340137|NCT02253316|363245287|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
105340138|NCT02253316|363245288|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
105340139|NCT02253316|363245286|FG000|Maintenance|Physician Decision|0|||
105463660|NCT02156076|363711534|FG003|Treatment Period|Subject request to discontinue treatment|0|||
105463661|NCT02156076|363711531|FG000|Treatment Period|Adverse Event|0|||
105463662|NCT02156076|363711532|FG001|Treatment Period|Adverse Event|0|||
105463663|NCT02156076|363711533|FG002|Treatment Period|Adverse Event|0|||
105463664|NCT02156076|363711534|FG003|Treatment Period|Adverse Event|1|||
105463665|NCT02156076|363711531|FG000|Follow-up Period|Withdrawal by Subject|1|||
105463666|NCT02156076|363711532|FG001|Follow-up Period|Withdrawal by Subject|0|||
105463667|NCT02156076|363711533|FG002|Follow-up Period|Withdrawal by Subject|0|||
105463668|NCT02156076|363711534|FG003|Follow-up Period|Withdrawal by Subject|0|||
105340140|NCT02253316|363245287|FG001|Maintenance|Physician Decision|7|||
105340141|NCT02253316|363245288|FG002|Maintenance|Physician Decision|16|||
105340142|NCT02253316|363245286|FG000|Maintenance|Non-Compliance|0|||
105340143|NCT02253316|363245287|FG001|Maintenance|Non-Compliance|1|||
105340144|NCT02253316|363245288|FG002|Maintenance|Non-Compliance|1|||
105340145|NCT02253316|363245286|FG000|Maintenance|Secondary Malignancy|0|||
105340146|NCT02253316|363245287|FG001|Maintenance|Secondary Malignancy|2|||
105340147|NCT02253316|363245288|FG002|Maintenance|Secondary Malignancy|6|||
105340148|NCT02253316|363245286|FG000|Maintenance|Adverse Event|0|||
105340149|NCT02253316|363245287|FG001|Maintenance|Adverse Event|8|||
105340150|NCT02253316|363245288|FG002|Maintenance|Adverse Event|12|||
105551728|NCT03387852|364019229|FG000|Overall Study|Adverse event (AE)|3|||
105551729|NCT03387852|364019230|FG001|Overall Study|Adverse event (AE)|0|||
105551730|NCT03387852|364019231|FG002|Overall Study|Adverse event (AE)|2|||
105551731|NCT03387852|364019232|FG003|Overall Study|Adverse event (AE)|0|||
105551732|NCT03387852|364019229|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
105551733|NCT03387852|364019230|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
105551734|NCT03387852|364019231|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
105551735|NCT03387852|364019232|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
105551736|NCT03387852|364019229|FG000|Overall Study|Withdrawal by participant|1|||
105340151|NCT02253316|363245286|FG000|Maintenance|Still receiving active treatment|0|||
105340152|NCT02253316|363245287|FG001|Maintenance|Still receiving active treatment|5|||
105340153|NCT02253316|363245288|FG002|Maintenance|Still receiving active treatment|0|||
105551737|NCT03387852|364019230|FG001|Overall Study|Withdrawal by participant|1|||
105340154|NCT00520481|363245289|FG000|Overall Study|Adverse Event|4|||
105665433|NCT02568397|364440736|FG001|Period 2|Physician Decision|1|||
105665434|NCT00971997|364440737|FG000|Overall Study|Adverse Event|2|||
105665435|NCT00971997|364440737|FG000|Overall Study|Death|1|||
105665436|NCT00971997|364440737|FG000|Overall Study|Protocol Violation|4|||
105665437|NCT00971997|364440737|FG000|Overall Study|Withdrawal by Subject|5|||
105665438|NCT00971997|364440737|FG000|Overall Study|Physician Decision|7|||
105665439|NCT00725712|364440738|FG000|Overall Study|Withdrawal by Subject|2|||
105665440|NCT00725712|364440739|FG001|Overall Study|Withdrawal by Subject|1|||
105665441|NCT00725712|364440738|FG000|Overall Study|Protocol Violation|1|||
105665442|NCT00725712|364440739|FG001|Overall Study|Protocol Violation|0|||
105665443|NCT00725712|364440738|FG000|Overall Study|Progressive disease|37|||
105551738|NCT03387852|364019231|FG002|Overall Study|Withdrawal by participant|3|||
105551739|NCT03387852|364019232|FG003|Overall Study|Withdrawal by participant|2|||
105551740|NCT03387852|364019229|FG000|Overall Study|Other- Unspecified|1|||
105551741|NCT03387852|364019230|FG001|Overall Study|Other- Unspecified|1|||
105551742|NCT03387852|364019231|FG002|Overall Study|Other- Unspecified|2|||
105551743|NCT03387852|364019232|FG003|Overall Study|Other- Unspecified|1|||
105551744|NCT03387852|364019229|FG000|Overall Study|Poor compliance to protocol|0|||
105551745|NCT03387852|364019230|FG001|Overall Study|Poor compliance to protocol|0|||
105551746|NCT03387852|364019231|FG002|Overall Study|Poor compliance to protocol|0|||
105551747|NCT03387852|364019232|FG003|Overall Study|Poor compliance to protocol|1|||
105551748|NCT03387852|364019229|FG000|Overall Study|Randomized and not treated|0|||
105551749|NCT03387852|364019230|FG001|Overall Study|Randomized and not treated|0|||
105551750|NCT03387852|364019231|FG002|Overall Study|Randomized and not treated|0|||
105551751|NCT03387852|364019232|FG003|Overall Study|Randomized and not treated|1|||
105551752|NCT02493127|364019236|FG000|Overall Study|Lost to Follow-up|1|||
105551753|NCT02493127|364019237|FG001|Overall Study|Lost to Follow-up|1|||
105551754|NCT02763384|364019238|FG000|Overall Study|Physician Decision|1|||
105551755|NCT02763384|364019238|FG000|Overall Study|Rapid decline - went on hospice|1|||
105551756|NCT03034577|364019243|FG000|Overall Study|Withdrawal by Subject|6|||
105340155|NCT00520481|363245290|FG001|Overall Study|Adverse Event|1|||
105551757|NCT03034577|364019244|FG001|Overall Study|Withdrawal by Subject|9|||
105551758|NCT03034577|364019243|FG000|Overall Study|Lost to Follow-up|25|||
105551759|NCT03034577|364019244|FG001|Overall Study|Lost to Follow-up|26|||
105551760|NCT04177758|364019245|FG000|Overall Study|Lost to Follow-up|19|||
105340156|NCT00520481|363245289|FG000|Overall Study|Withdrawal by Subject|3|||
105340157|NCT00520481|363245290|FG001|Overall Study|Withdrawal by Subject|0|||
105340158|NCT02548351|363245300|FG000|Overall Study|Withdrawal by Subject|149|||
105340159|NCT02548351|363245301|FG001|Overall Study|Withdrawal by Subject|154|||
105463669|NCT00927953|363711537|FG000|Overall Study|Death|2|||
105463670|NCT00927953|363711538|FG001|Overall Study|Death|1|||
105463671|NCT02976038|363711539|FG000|Overall Study|Physician Decision|22|||
105463672|NCT02976038|363711539|FG000|Overall Study|Withdrawal by Subject|3|||
105463673|NCT02976038|363711539|FG000|Overall Study|Lost to Follow-up|2|||
105463674|NCT02976038|363711539|FG000|Overall Study|Adverse Event|1|||
105463675|NCT00346697|363711541|FG000|Overall Study|Lost to Follow-up|0|||
105463676|NCT00346697|363711542|FG001|Overall Study|Lost to Follow-up|1|||
105463677|NCT01867671|363711543|FG000|Overall Study|Adverse Event|5|||
105463678|NCT01867671|363711544|FG001|Overall Study|Adverse Event|3|||
105340160|NCT02548351|363245302|FG002|Overall Study|Withdrawal by Subject|152|||
105340161|NCT02548351|363245300|FG000|Overall Study|Death|11|||
105463679|NCT01867671|363711543|FG000|Overall Study|Anaphylaxis|0|||
105551761|NCT04177758|364019246|FG001|Overall Study|Lost to Follow-up|11|||
105551762|NCT01308580|364019247|FG000|Overall Study|Lost to Follow-up|12|||
105551763|NCT01308580|364019248|FG001|Overall Study|Lost to Follow-up|7|||
105551764|NCT02535065|364019249|FG000|Overall Study|Death|13|||
105551765|NCT02535065|364019249|FG000|Overall Study|Lost to Follow-up|1|||
105551766|NCT02535065|364019249|FG000|Overall Study|Withdrawal by Subject|6|||
105551767|NCT01128413|364019255|FG000|Overall Study|Withdrawal by Subject|1|||
105340162|NCT02548351|363245301|FG001|Overall Study|Death|15|||
105340163|NCT02548351|363245302|FG002|Overall Study|Death|12|||
105340164|NCT02548351|363245300|FG000|Overall Study|Adverse Event|22|||
105340165|NCT02548351|363245301|FG001|Overall Study|Adverse Event|56|||
105340166|NCT02548351|363245302|FG002|Overall Study|Adverse Event|36|||
105340167|NCT02548351|363245300|FG000|Overall Study|Study Terminated by Sponsor|549|||
105340168|NCT02548351|363245301|FG001|Overall Study|Study Terminated by Sponsor|509|||
105340169|NCT02548351|363245302|FG002|Overall Study|Study Terminated by Sponsor|528|||
105340170|NCT02548351|363245300|FG000|Overall Study|Site Closure|14|||
105340171|NCT02548351|363245301|FG001|Overall Study|Site Closure|5|||
105340172|NCT02548351|363245302|FG002|Overall Study|Site Closure|7|||
105340173|NCT02548351|363245300|FG000|Overall Study|Non-compliance with Study Drug|4|||
105340174|NCT02548351|363245301|FG001|Overall Study|Non-compliance with Study Drug|2|||
105340175|NCT02548351|363245302|FG002|Overall Study|Non-compliance with Study Drug|0|||
105340176|NCT02548351|363245300|FG000|Overall Study|Protocol Violation|2|||
105340177|NCT02548351|363245301|FG001|Overall Study|Protocol Violation|1|||
105340178|NCT02548351|363245302|FG002|Overall Study|Protocol Violation|2|||
105340179|NCT02548351|363245300|FG000|Overall Study|Physician Decision|11|||
105340180|NCT02548351|363245301|FG001|Overall Study|Physician Decision|18|||
105340181|NCT02548351|363245302|FG002|Overall Study|Physician Decision|11|||
105551768|NCT01128413|364019256|FG001|Overall Study|Withdrawal by Subject|0|||
105340182|NCT02548351|363245300|FG000|Overall Study|Lost to Follow-up|43|||
105340183|NCT02548351|363245301|FG001|Overall Study|Lost to Follow-up|50|||
105340184|NCT02548351|363245302|FG002|Overall Study|Lost to Follow-up|57|||
105340185|NCT02548351|363245300|FG000|Overall Study|Other|19|||
105551769|NCT01128413|364019255|FG000|Overall Study|NICOM Monitor Problems|2|||
105551770|NCT01128413|364019256|FG001|Overall Study|NICOM Monitor Problems|1|||
105551771|NCT01128413|364019255|FG000|Overall Study|Pt made DNR|1|||
105551772|NCT01128413|364019256|FG001|Overall Study|Pt made DNR|0|||
105551773|NCT00045110|364019258|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
105551774|NCT00045110|364019259|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
105551775|NCT00045110|364019260|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
105551776|NCT00045110|364019258|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
105551777|NCT00045110|364019259|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
105551778|NCT00045110|364019260|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
105551779|NCT00045110|364019258|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
105551780|NCT00045110|364019259|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
105551781|NCT00045110|364019260|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
105551782|NCT04602624|364019261|FG000|Overall Study|Protocol Deviation|1|||
105551783|NCT04602624|364019261|FG000|Overall Study|Withdrawal by Participant|1|||
105551784|NCT00613951|364019262|FG000|Overall Study|Adverse Event|1|||
105551785|NCT00613951|364019263|FG001|Overall Study|Adverse Event|0|||
105551786|NCT00613951|364019264|FG002|Overall Study|Adverse Event|1|||
105551787|NCT00613951|364019262|FG000|Overall Study|Lack of Efficacy|0|||
105551788|NCT00613951|364019263|FG001|Overall Study|Lack of Efficacy|1|||
105551789|NCT00613951|364019264|FG002|Overall Study|Lack of Efficacy|1|||
105551790|NCT00613951|364019262|FG000|Overall Study|Protocol Violation|1|||
105551791|NCT00613951|364019263|FG001|Overall Study|Protocol Violation|1|||
105551792|NCT00613951|364019264|FG002|Overall Study|Protocol Violation|1|||
105551793|NCT00613951|364019262|FG000|Overall Study|Unclassified|5|||
105551794|NCT00613951|364019263|FG001|Overall Study|Unclassified|3|||
105551795|NCT00613951|364019264|FG002|Overall Study|Unclassified|2|||
105551796|NCT03069482|364020995|FG000|Overall Study|Lost to Follow-up|0|||
105665444|NCT00725712|364440739|FG001|Overall Study|Progressive disease|16|||
105665445|NCT00725712|364440738|FG000|Overall Study|Clinical progression not based on RECIST|0|||
105551797|NCT03069482|364020996|FG001|Overall Study|Lost to Follow-up|1|||
105551798|NCT03069482|364020995|FG000|Overall Study|Physician Decision|1|||
105665446|NCT00725712|364440739|FG001|Overall Study|Clinical progression not based on RECIST|3|||
105463680|NCT01867671|363711544|FG001|Overall Study|Anaphylaxis|1|||
105463681|NCT01867671|363711543|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
105463682|NCT01867671|363711544|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
105463683|NCT01867671|363711543|FG000|Overall Study|Lost to Follow-up|0|||
105463684|NCT01867671|363711544|FG001|Overall Study|Lost to Follow-up|1|||
105463685|NCT01867671|363711543|FG000|Overall Study|Non-compliance with Study Drug|1|||
105463686|NCT01867671|363711544|FG001|Overall Study|Non-compliance with Study Drug|2|||
105463687|NCT01867671|363711543|FG000|Overall Study|Withdrawal by Subject|21|||
105463688|NCT01867671|363711544|FG001|Overall Study|Withdrawal by Subject|21|||
105463689|NCT02420821|363711545|FG000|Overall Study|Lost to Follow-up|6|||
105463690|NCT02420821|363711546|FG001|Overall Study|Lost to Follow-up|6|||
105463691|NCT02420821|363711545|FG000|Overall Study|Non-compliance|0|||
105463692|NCT02420821|363711546|FG001|Overall Study|Non-compliance|2|||
105463693|NCT02420821|363711545|FG000|Overall Study|Physician Decision|6|||
105463694|NCT02420821|363711546|FG001|Overall Study|Physician Decision|2|||
105463695|NCT02420821|363711545|FG000|Overall Study|Withdrawal by Subject|32|||
105463696|NCT02420821|363711546|FG001|Overall Study|Withdrawal by Subject|25|||
105463697|NCT02420821|363711545|FG000|Overall Study|Death|270|||
105463698|NCT02420821|363711546|FG001|Overall Study|Death|263|||
105463699|NCT02420821|363711545|FG000|Overall Study|Study Terminated By Sponsor|145|||
105463700|NCT02420821|363711546|FG001|Overall Study|Study Terminated By Sponsor|149|||
105463701|NCT02420821|363711545|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
105463702|NCT02420821|363711546|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
105463703|NCT02420821|363711545|FG000|Overall Study|Adverse Event|0|||
105463704|NCT02420821|363711546|FG001|Overall Study|Adverse Event|1|||
105463705|NCT02420821|363711545|FG000|Overall Study|Protinuria|0|||
105463706|NCT02420821|363711546|FG001|Overall Study|Protinuria|1|||
105463707|NCT02420821|363711545|FG000|Overall Study|Progressive Disease|1|||
105463708|NCT02420821|363711546|FG001|Overall Study|Progressive Disease|1|||
105463709|NCT02420821|363711545|FG000|Overall Study|Disease Progression|0|||
105463710|NCT02420821|363711546|FG001|Overall Study|Disease Progression|1|||
105463711|NCT02420821|363711545|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
105463712|NCT02420821|363711546|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
105463713|NCT01409707|363711547|FG000|Overall Study|Withdrawal by Subject|5|||
105463714|NCT01409707|363711548|FG001|Overall Study|Withdrawal by Subject|17|||
105463715|NCT01409707|363711549|FG002|Overall Study|Withdrawal by Subject|16|||
105463716|NCT01294553|363711551|FG000|Overall Study|Duplicated Participants|1|||
105463717|NCT01294553|363711551|FG000|Overall Study|Protocol Violation|268|||
105463718|NCT03058146|363711552|FG000|Overall Study|Withdrawal by Subject|4|||
105463719|NCT03058146|363711553|FG001|Overall Study|Withdrawal by Subject|1|||
105463720|NCT03058146|363711552|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
105463721|NCT03058146|363711553|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
105463722|NCT04322526|363711555|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
105463723|NCT04322526|363711556|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
105463724|NCT04322526|363711555|FG000|Washout (1 Week)|Lost to Follow-up|1|||
105463725|NCT04322526|363711556|FG001|Washout (1 Week)|Lost to Follow-up|2|||
105463726|NCT03486834|363711558|FG000|Overall Study|Withdrawal by Subject|46|||
105463727|NCT03486834|363711559|FG001|Overall Study|Withdrawal by Subject|46|||
105463728|NCT03486834|363711560|FG002|Overall Study|Withdrawal by Subject|52|||
105463729|NCT03486834|363711558|FG000|Overall Study|Adverse Event|8|||
105463730|NCT03486834|363711559|FG001|Overall Study|Adverse Event|7|||
105463731|NCT03486834|363711560|FG002|Overall Study|Adverse Event|0|||
105463732|NCT03486834|363711558|FG000|Overall Study|Lost to Follow-up|41|||
105463733|NCT03486834|363711559|FG001|Overall Study|Lost to Follow-up|24|||
105463734|NCT03486834|363711560|FG002|Overall Study|Lost to Follow-up|39|||
105665447|NCT00725712|364440738|FG000|Overall Study|Adverse Event|5|||
105463735|NCT03486834|363711558|FG000|Overall Study|Non-compliance with Study Drug|2|||
105463736|NCT03486834|363711559|FG001|Overall Study|Non-compliance with Study Drug|2|||
105463737|NCT03486834|363711560|FG002|Overall Study|Non-compliance with Study Drug|0|||
105463738|NCT03486834|363711558|FG000|Overall Study|Physician Decision|5|||
105463739|NCT03486834|363711559|FG001|Overall Study|Physician Decision|2|||
105463740|NCT03486834|363711560|FG002|Overall Study|Physician Decision|3|||
105463741|NCT03486834|363711558|FG000|Overall Study|Pregnancy|10|||
105665448|NCT00725712|364440739|FG001|Overall Study|Adverse Event|5|||
105665449|NCT00725712|364440738|FG000|Overall Study|Death|2|||
105340186|NCT02548351|363245301|FG001|Overall Study|Other|16|||
105340187|NCT02548351|363245302|FG002|Overall Study|Other|20|||
105340188|NCT02548351|363245300|FG000|Overall Study|Missing|1|||
105340189|NCT02548351|363245301|FG001|Overall Study|Missing|1|||
105340190|NCT02548351|363245302|FG002|Overall Study|Missing|0|||
105340191|NCT00325156|363245305|FG000|Overall Study|Protocol Violation|8|||
105340192|NCT00325156|363245305|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
105340193|NCT00325156|363245305|FG000|Overall Study|Migrated/moved from study area|12|||
105340194|NCT00325156|363245305|FG000|Overall Study|Adverse event, non-fatal|3|||
105340195|NCT00325156|363245305|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
105340196|NCT00325156|363245305|FG000|Overall Study|Other|1|||
105340197|NCT00325156|363245305|FG000|Overall Study|Withdrawal by Subject|31|||
105340198|NCT00519428|363245306|FG000|Overall Study|Adverse Event|5|||
105340199|NCT00519428|363245307|FG001|Overall Study|Adverse Event|2|||
105340200|NCT00519428|363245308|FG002|Overall Study|Adverse Event|10|||
105340201|NCT00519428|363245306|FG000|Overall Study|Lost to Follow-up|7|||
105340202|NCT00519428|363245307|FG001|Overall Study|Lost to Follow-up|7|||
105340203|NCT00519428|363245308|FG002|Overall Study|Lost to Follow-up|6|||
105340204|NCT00519428|363245306|FG000|Overall Study|Withdrawal by Subject|8|||
105340205|NCT00519428|363245307|FG001|Overall Study|Withdrawal by Subject|3|||
105340206|NCT00519428|363245308|FG002|Overall Study|Withdrawal by Subject|7|||
105340207|NCT00519428|363245306|FG000|Overall Study|unstated|1|||
105340208|NCT00519428|363245307|FG001|Overall Study|unstated|3|||
105340209|NCT00519428|363245308|FG002|Overall Study|unstated|2|||
105340210|NCT04064411|363245309|FG000|Overall Study|Adverse Event|29|||
105340211|NCT04064411|363245310|FG001|Overall Study|Adverse Event|19|||
105340212|NCT04064411|363245309|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
105340213|NCT04064411|363245310|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
105463742|NCT03486834|363711559|FG001|Overall Study|Pregnancy|12|||
105463743|NCT03486834|363711560|FG002|Overall Study|Pregnancy|12|||
105463744|NCT03486834|363711558|FG000|Overall Study|Protocol Deviation|2|||
105340214|NCT04064411|363245309|FG000|Overall Study|Protocol Deviation|0|||
105340215|NCT04064411|363245310|FG001|Overall Study|Protocol Deviation|2|||
105340216|NCT04064411|363245309|FG000|Overall Study|Withdrawal by Subject|25|||
105340217|NCT04064411|363245310|FG001|Overall Study|Withdrawal by Subject|29|||
105340218|NCT04064411|363245309|FG000|Overall Study|Lost to Follow-up|5|||
105463745|NCT03486834|363711559|FG001|Overall Study|Protocol Deviation|3|||
105463746|NCT03486834|363711560|FG002|Overall Study|Protocol Deviation|3|||
105463747|NCT03486834|363711558|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105463748|NCT03486834|363711559|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
105463749|NCT03486834|363711560|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
105463750|NCT03486834|363711558|FG000|Overall Study|Randomized but not treated|4|||
105463751|NCT03486834|363711559|FG001|Overall Study|Randomized but not treated|4|||
105463752|NCT03486834|363711560|FG002|Overall Study|Randomized but not treated|1|||
105463753|NCT04476797|363711561|FG000|Overall Study|Withdrawal by Subject|1|||
105463754|NCT04476797|363711562|FG001|Overall Study|Withdrawal by Subject|0|||
105463755|NCT04476797|363711563|FG002|Overall Study|Withdrawal by Subject|0|||
105463756|NCT04476797|363711561|FG000|Overall Study|Death|0|||
105463757|NCT04476797|363711562|FG001|Overall Study|Death|1|||
105463758|NCT04476797|363711563|FG002|Overall Study|Death|2|||
105463759|NCT04476797|363711561|FG000|Overall Study|Sponsor Terminated Study|0|||
105463760|NCT04476797|363711562|FG001|Overall Study|Sponsor Terminated Study|18|||
105551799|NCT03069482|364020996|FG001|Overall Study|Physician Decision|0|||
105340219|NCT04064411|363245310|FG001|Overall Study|Lost to Follow-up|2|||
105340220|NCT04064411|363245309|FG000|Overall Study|Other than Specified|4|||
105340221|NCT04064411|363245310|FG001|Overall Study|Other than Specified|1|||
105340222|NCT04064411|363245309|FG000|Overall Study|Death|1|||
105340223|NCT04064411|363245310|FG001|Overall Study|Death|0|||
105340224|NCT04464720|363245311|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
105340225|NCT00954512|363245318|FG000|Overall Study|Withdrawal by Subject|0|||
105340226|NCT00954512|363245319|FG001|Overall Study|Withdrawal by Subject|0|||
105340227|NCT00954512|363245320|FG002|Overall Study|Withdrawal by Subject|0|||
105340228|NCT00954512|363245321|FG003|Overall Study|Withdrawal by Subject|0|||
105340229|NCT00954512|363245322|FG004|Overall Study|Withdrawal by Subject|0|||
105340230|NCT00954512|363245323|FG005|Overall Study|Withdrawal by Subject|1|||
105340231|NCT00954512|363245318|FG000|Overall Study|Adverse Event|0|||
105340232|NCT00954512|363245319|FG001|Overall Study|Adverse Event|0|||
105340233|NCT00954512|363245320|FG002|Overall Study|Adverse Event|0|||
105340234|NCT00954512|363245321|FG003|Overall Study|Adverse Event|0|||
105340235|NCT00954512|363245322|FG004|Overall Study|Adverse Event|1|||
105340236|NCT00954512|363245323|FG005|Overall Study|Adverse Event|2|||
105340237|NCT00954512|363245318|FG000|Overall Study|Physician Decision|0|||
105340238|NCT00954512|363245319|FG001|Overall Study|Physician Decision|1|||
105340239|NCT00954512|363245320|FG002|Overall Study|Physician Decision|0|||
105340240|NCT00954512|363245321|FG003|Overall Study|Physician Decision|1|||
105340241|NCT00954512|363245322|FG004|Overall Study|Physician Decision|0|||
105340242|NCT00954512|363245323|FG005|Overall Study|Physician Decision|0|||
105340243|NCT00954512|363245318|FG000|Overall Study|Symptomatic Deterioration|0|||
105340244|NCT00954512|363245319|FG001|Overall Study|Symptomatic Deterioration|1|||
105340245|NCT00954512|363245320|FG002|Overall Study|Symptomatic Deterioration|0|||
105340246|NCT00954512|363245321|FG003|Overall Study|Symptomatic Deterioration|0|||
105340247|NCT00954512|363245322|FG004|Overall Study|Symptomatic Deterioration|2|||
105340248|NCT00954512|363245323|FG005|Overall Study|Symptomatic Deterioration|0|||
105340249|NCT00954512|363245318|FG000|Overall Study|Progression of Disease|2|||
105340250|NCT00954512|363245319|FG001|Overall Study|Progression of Disease|1|||
105340251|NCT00954512|363245320|FG002|Overall Study|Progression of Disease|0|||
105340252|NCT00954512|363245321|FG003|Overall Study|Progression of Disease|1|||
105340253|NCT00954512|363245322|FG004|Overall Study|Progression of Disease|1|||
105340254|NCT00954512|363245323|FG005|Overall Study|Progression of Disease|1|||
105340255|NCT01794793|363245324|FG000|Treatment Period|Withdrawal by Subject|24|||
105340256|NCT01794793|363245324|FG000|Treatment Period|Lack of Efficacy|22|||
105340257|NCT01794793|363245324|FG000|Treatment Period|Adverse Event|17|||
105340258|NCT01794793|363245324|FG000|Treatment Period|Physician Decision|14|||
105340259|NCT01794793|363245324|FG000|Treatment Period|Lost to Follow-up|7|||
105340260|NCT01794793|363245324|FG000|Treatment Period|Death|6|||
105340261|NCT01794793|363245324|FG000|Treatment Period|Protocol Violation|5|||
105340262|NCT01794793|363245324|FG000|Treatment Period|administrative problem|3|||
105340263|NCT01794793|363245324|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
105340264|NCT01794793|363245324|FG000|Post-treatment Follow-up|Adverse Event|8|||
105340265|NCT01794793|363245324|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
105340266|NCT01794793|363245324|FG000|Post-treatment Follow-up|administrative problem|5|||
105463761|NCT04476797|363711563|FG002|Overall Study|Sponsor Terminated Study|17|||
105463762|NCT01716234|363711566|FG000|Overall Study|Protocol Violation|0|||
105340267|NCT01794793|363245324|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
105340268|NCT01794793|363245324|FG000|Post-treatment Follow-up|Protocol Violation|3|||
105340269|NCT02640404|363245325|FG000|Overall Study|Protocol Violation|1|||
105340270|NCT02640404|363245326|FG001|Overall Study|Protocol Violation|0|||
105340271|NCT02640404|363245325|FG000|Overall Study|Withdrawal by Subject|1|||
105340272|NCT02640404|363245326|FG001|Overall Study|Withdrawal by Subject|0|||
105340273|NCT05397171|363245327|FG000|Overall Study|Death|2|||
105340274|NCT05397171|363245328|FG001|Overall Study|Death|3|||
105340275|NCT05397171|363245329|FG002|Overall Study|Death|3|||
105340276|NCT05397171|363245327|FG000|Overall Study|Study Terminated By Sponsor|1|||
105463763|NCT01716234|363711567|FG001|Overall Study|Protocol Violation|0|||
105463764|NCT01716234|363711568|FG002|Overall Study|Protocol Violation|0|||
105463765|NCT01716234|363711569|FG003|Overall Study|Protocol Violation|1|||
105463766|NCT01716234|363711570|FG004|Overall Study|Protocol Violation|1|||
105463767|NCT01716234|363711571|FG005|Overall Study|Protocol Violation|1|||
105463768|NCT01716234|363711572|FG006|Overall Study|Protocol Violation|0|||
105463769|NCT01716234|363711566|FG000|Overall Study|Lack of Efficacy|0|||
105340277|NCT05397171|363245328|FG001|Overall Study|Study Terminated By Sponsor|2|||
105340278|NCT05397171|363245329|FG002|Overall Study|Study Terminated By Sponsor|3|||
105340279|NCT05397171|363245327|FG000|Overall Study|Withdrawal by Subject|0|||
105340280|NCT05397171|363245328|FG001|Overall Study|Withdrawal by Subject|1|||
105340281|NCT05397171|363245329|FG002|Overall Study|Withdrawal by Subject|1|||
105340282|NCT04250350|363248157|FG000|Overall Study|Withdrawal by Subject|13|||
105340283|NCT04250350|363248157|FG000|Overall Study|Lost to Follow-up|8|||
105340284|NCT04250350|363248157|FG000|Overall Study|Adverse Event|5|||
105340285|NCT04250350|363248157|FG000|Overall Study|Lack of Efficacy|4|||
105340286|NCT04250350|363248157|FG000|Overall Study|Physician Decision|1|||
105665450|NCT00725712|364440739|FG001|Overall Study|Death|0|||
105665451|NCT00725712|364440738|FG000|Overall Study|Other: Death|1|||
105665452|NCT00725712|364440739|FG001|Overall Study|Other: Death|0|||
105340287|NCT04250350|363248157|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
105340288|NCT01275755|363248163|FG000|Double-blind Treatment Period|Adverse Event|0|||
105340289|NCT01275755|363248164|FG001|Double-blind Treatment Period|Adverse Event|2|||
105340290|NCT01275755|363248163|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
105665453|NCT00725712|364440738|FG000|Overall Study|Hospitalized, unable to continue|0|||
105463770|NCT01716234|363711567|FG001|Overall Study|Lack of Efficacy|0|||
105463771|NCT01716234|363711568|FG002|Overall Study|Lack of Efficacy|0|||
105463772|NCT01716234|363711569|FG003|Overall Study|Lack of Efficacy|1|||
105463773|NCT01716234|363711570|FG004|Overall Study|Lack of Efficacy|0|||
105463774|NCT01716234|363711571|FG005|Overall Study|Lack of Efficacy|0|||
105463775|NCT01716234|363711572|FG006|Overall Study|Lack of Efficacy|0|||
105665454|NCT00725712|364440739|FG001|Overall Study|Hospitalized, unable to continue|1|||
105665455|NCT02763215|364440740|FG000|Overall Study|Participants withdrew from study|3|||
105665456|NCT02763215|364440740|FG000|Overall Study|Missed visit|1|||
105665457|NCT02763215|364440740|FG000|Overall Study|Visit outside visit-window|1|||
105665458|NCT02763215|364440740|FG000|Overall Study|Death|1|||
105665459|NCT02763215|364440740|FG000|Overall Study|Lost to Follow-up|1|||
105665460|NCT01667926|364440741|FG000|Overall Study|Withdrawal by Subject|1|||
105665461|NCT01667926|364440742|FG001|Overall Study|Withdrawal by Subject|2|||
105665462|NCT01667926|364440743|FG002|Overall Study|Withdrawal by Subject|2|||
105665463|NCT01667926|364440741|FG000|Overall Study|Physician Decision|0|||
105665464|NCT01667926|364440742|FG001|Overall Study|Physician Decision|0|||
105665465|NCT01667926|364440743|FG002|Overall Study|Physician Decision|1|||
105665466|NCT01667926|364440741|FG000|Overall Study|Time committment|0|||
105665467|NCT01667926|364440742|FG001|Overall Study|Time committment|0|||
105665468|NCT01667926|364440743|FG002|Overall Study|Time committment|2|||
105665469|NCT01667926|364440741|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
105665470|NCT01667926|364440742|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
105665471|NCT01667926|364440743|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
105665472|NCT01667926|364440741|FG000|Overall Study|Lost to Follow-up|1|||
105665473|NCT01667926|364440742|FG001|Overall Study|Lost to Follow-up|2|||
105665474|NCT01667926|364440743|FG002|Overall Study|Lost to Follow-up|1|||
105340291|NCT01275755|363248164|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
105340292|NCT01275755|363248163|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
105340293|NCT01275755|363248164|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
105340294|NCT01275755|363248163|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
105340295|NCT01275755|363248164|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
105340296|NCT00174967|363248165|FG000|Overall Study|Adverse Event|1|||
105340297|NCT00174967|363248166|FG001|Overall Study|Adverse Event|2|||
105340298|NCT00174967|363248167|FG002|Overall Study|Adverse Event|2|||
105340299|NCT00174967|363248168|FG003|Overall Study|Adverse Event|1|||
105340300|NCT00174967|363248165|FG000|Overall Study|Gout Flare|0|||
105340301|NCT00174967|363248166|FG001|Overall Study|Gout Flare|0|||
105340302|NCT00174967|363248167|FG002|Overall Study|Gout Flare|0|||
105340303|NCT00174967|363248168|FG003|Overall Study|Gout Flare|1|||
105340304|NCT00174967|363248165|FG000|Overall Study|Other|0|||
105340305|NCT00174967|363248166|FG001|Overall Study|Other|1|||
105340306|NCT00174967|363248167|FG002|Overall Study|Other|0|||
105340307|NCT00174967|363248168|FG003|Overall Study|Other|0|||
105340308|NCT03104400|363248169|FG000|Overall Study|Adverse Event|5|||
105340309|NCT03104400|363248170|FG001|Overall Study|Adverse Event|7|||
105340310|NCT03104400|363248171|FG002|Overall Study|Adverse Event|11|||
105340311|NCT03104400|363248172|FG003|Overall Study|Adverse Event|9|||
105340312|NCT03104400|363248173|FG004|Overall Study|Adverse Event|21|||
105340313|NCT03104400|363248169|FG000|Overall Study|Withdrawal by Subject|17|||
105340314|NCT03104400|363248170|FG001|Overall Study|Withdrawal by Subject|19|||
105340315|NCT03104400|363248171|FG002|Overall Study|Withdrawal by Subject|29|||
105340316|NCT03104400|363248172|FG003|Overall Study|Withdrawal by Subject|25|||
105340317|NCT03104400|363248173|FG004|Overall Study|Withdrawal by Subject|24|||
105340318|NCT03104400|363248169|FG000|Overall Study|Lost to Follow-up|4|||
105340319|NCT03104400|363248170|FG001|Overall Study|Lost to Follow-up|1|||
105340320|NCT03104400|363248171|FG002|Overall Study|Lost to Follow-up|4|||
105340321|NCT03104400|363248172|FG003|Overall Study|Lost to Follow-up|8|||
105340322|NCT03104400|363248173|FG004|Overall Study|Lost to Follow-up|7|||
105340323|NCT03104400|363248169|FG000|Overall Study|Lack of Efficacy|6|||
105340324|NCT03104400|363248170|FG001|Overall Study|Lack of Efficacy|3|||
105340325|NCT03104400|363248171|FG002|Overall Study|Lack of Efficacy|8|||
105340326|NCT03104400|363248172|FG003|Overall Study|Lack of Efficacy|2|||
105340327|NCT03104400|363248173|FG004|Overall Study|Lack of Efficacy|1|||
105340328|NCT03104400|363248169|FG000|Overall Study|COVID Logistical Restrictions|0|||
105463776|NCT01716234|363711566|FG000|Overall Study|Did not meet protocol eligibility|0|||
105463777|NCT01716234|363711567|FG001|Overall Study|Did not meet protocol eligibility|0|||
105463778|NCT01716234|363711568|FG002|Overall Study|Did not meet protocol eligibility|1|||
105463779|NCT01716234|363711569|FG003|Overall Study|Did not meet protocol eligibility|0|||
105463780|NCT01716234|363711570|FG004|Overall Study|Did not meet protocol eligibility|0|||
105463781|NCT01716234|363711571|FG005|Overall Study|Did not meet protocol eligibility|4|||
105463782|NCT01716234|363711572|FG006|Overall Study|Did not meet protocol eligibility|0|||
105463783|NCT01716234|363711566|FG000|Overall Study|Adverse Event|7|||
105463784|NCT01716234|363711567|FG001|Overall Study|Adverse Event|10|||
105463785|NCT01716234|363711568|FG002|Overall Study|Adverse Event|2|||
105463786|NCT01716234|363711569|FG003|Overall Study|Adverse Event|8|||
105463787|NCT01716234|363711570|FG004|Overall Study|Adverse Event|3|||
105463788|NCT01716234|363711571|FG005|Overall Study|Adverse Event|6|||
105463789|NCT01716234|363711572|FG006|Overall Study|Adverse Event|0|||
105463790|NCT01716234|363711566|FG000|Overall Study|Withdrawal by Subject|3|||
105463791|NCT01716234|363711567|FG001|Overall Study|Withdrawal by Subject|0|||
105463792|NCT01716234|363711568|FG002|Overall Study|Withdrawal by Subject|2|||
105463793|NCT01716234|363711569|FG003|Overall Study|Withdrawal by Subject|2|||
105463794|NCT01716234|363711570|FG004|Overall Study|Withdrawal by Subject|1|||
105463795|NCT01716234|363711571|FG005|Overall Study|Withdrawal by Subject|3|||
105463796|NCT01716234|363711572|FG006|Overall Study|Withdrawal by Subject|0|||
105463797|NCT03815929|363711576|FG000|Overall Study|Lost to Follow-up|2|||
105463798|NCT03815929|363711577|FG001|Overall Study|Lost to Follow-up|1|||
105463799|NCT03815929|363711578|FG002|Overall Study|Lost to Follow-up|0|||
105463800|NCT03815929|363711576|FG000|Overall Study|Physician Decision|2|||
105463801|NCT03815929|363711577|FG001|Overall Study|Physician Decision|2|||
105463802|NCT03815929|363711578|FG002|Overall Study|Physician Decision|0|||
105463803|NCT03815929|363711576|FG000|Overall Study|Withdrawal by Subject|0|||
105463804|NCT03815929|363711577|FG001|Overall Study|Withdrawal by Subject|0|||
105463805|NCT03815929|363711578|FG002|Overall Study|Withdrawal by Subject|1|||
105463806|NCT02205736|363711579|FG000|Overall Study|Lost to Follow-up|106|||
105340329|NCT03104400|363248170|FG001|Overall Study|COVID Logistical Restrictions|0|||
105340330|NCT03104400|363248171|FG002|Overall Study|COVID Logistical Restrictions|0|||
105340331|NCT03104400|363248172|FG003|Overall Study|COVID Logistical Restrictions|1|||
105340332|NCT03104400|363248173|FG004|Overall Study|COVID Logistical Restrictions|0|||
105340333|NCT03104400|363248169|FG000|Overall Study|Other|2|||
105340334|NCT03104400|363248170|FG001|Overall Study|Other|3|||
105340335|NCT03104400|363248171|FG002|Overall Study|Other|7|||
105340336|NCT03104400|363248172|FG003|Overall Study|Other|6|||
105340337|NCT03104400|363248173|FG004|Overall Study|Other|4|||
105463807|NCT01467960|363711580|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
105463808|NCT01467960|363711581|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
105463809|NCT01467960|363711582|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
105463810|NCT01467960|363711583|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
105463811|NCT01467960|363711584|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
105463812|NCT01467960|363711585|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
105463813|NCT03326713|363711586|FG000|Overall Study|Death|2|||
105463814|NCT03326713|363711587|FG001|Overall Study|Death|1|||
105463815|NCT03326713|363711588|FG002|Overall Study|Death|0|||
105463816|NCT03326713|363711586|FG000|Overall Study|Lost to Follow-up|20|||
105463817|NCT03326713|363711587|FG001|Overall Study|Lost to Follow-up|21|||
105463818|NCT03326713|363711588|FG002|Overall Study|Lost to Follow-up|33|||
105463819|NCT03326713|363711586|FG000|Overall Study|Withdrawal by Subject|1|||
105463820|NCT03326713|363711587|FG001|Overall Study|Withdrawal by Subject|2|||
105463821|NCT03326713|363711588|FG002|Overall Study|Withdrawal by Subject|11|||
105463822|NCT03326713|363711586|FG000|Overall Study|Found Ineligible|11|||
105463823|NCT03326713|363711587|FG001|Overall Study|Found Ineligible|11|||
105463824|NCT03326713|363711588|FG002|Overall Study|Found Ineligible|8|||
105463825|NCT00687193|363711591|FG000|Overall Study|Adverse Event|0|||
105463826|NCT00687193|363711592|FG001|Overall Study|Adverse Event|1|||
105463827|NCT00687193|363711593|FG002|Overall Study|Adverse Event|2|||
105463828|NCT00687193|363711594|FG003|Overall Study|Adverse Event|3|||
105463829|NCT00687193|363711595|FG004|Overall Study|Adverse Event|0|||
105463830|NCT00687193|363711596|FG005|Overall Study|Adverse Event|2|||
105463831|NCT00687193|363711591|FG000|Overall Study|Lack of Efficacy|1|||
105463832|NCT00687193|363711592|FG001|Overall Study|Lack of Efficacy|1|||
105463833|NCT00687193|363711593|FG002|Overall Study|Lack of Efficacy|0|||
105463834|NCT00687193|363711594|FG003|Overall Study|Lack of Efficacy|0|||
105463835|NCT00687193|363711595|FG004|Overall Study|Lack of Efficacy|0|||
105463836|NCT00687193|363711596|FG005|Overall Study|Lack of Efficacy|2|||
105463837|NCT00687193|363711591|FG000|Overall Study|Protocol Violation|1|||
105463838|NCT00687193|363711592|FG001|Overall Study|Protocol Violation|2|||
105463839|NCT00687193|363711593|FG002|Overall Study|Protocol Violation|0|||
105463840|NCT00687193|363711594|FG003|Overall Study|Protocol Violation|1|||
105551800|NCT02891187|364020999|FG000|Overall Study|Lost to Follow-up|1|||
105551801|NCT02891187|364021000|FG001|Overall Study|Lost to Follow-up|2|||
105551802|NCT03836053|364021001|FG000|Overall Study|Protocol-specified criteria|0|||
105551803|NCT03836053|364021002|FG001|Overall Study|Protocol-specified criteria|2|||
105551804|NCT03836053|364021003|FG002|Overall Study|Protocol-specified criteria|1|||
105551805|NCT03836053|364021001|FG000|Overall Study|Death|1|||
105551806|NCT03836053|364021002|FG001|Overall Study|Death|6|||
105551807|NCT03836053|364021003|FG002|Overall Study|Death|4|||
105551808|NCT03836053|364021001|FG000|Overall Study|Withdrawal of consent from study|0|||
105551809|NCT03836053|364021002|FG001|Overall Study|Withdrawal of consent from study|0|||
105551810|NCT03836053|364021003|FG002|Overall Study|Withdrawal of consent from study|1|||
105551811|NCT03836053|364021001|FG000|Overall Study|Decision by sponsor|0|||
105551812|NCT03836053|364021002|FG001|Overall Study|Decision by sponsor|2|||
105551813|NCT03836053|364021003|FG002|Overall Study|Decision by sponsor|4|||
105551814|NCT02041195|364021006|FG000|Overall Study|Adverse Event|1|||
105551815|NCT02041195|364021007|FG001|Overall Study|Adverse Event|2|||
105551816|NCT02041195|364021008|FG002|Overall Study|Adverse Event|0|||
105551817|NCT02041195|364021009|FG003|Overall Study|Adverse Event|0|||
105551818|NCT02041195|364021010|FG004|Overall Study|Adverse Event|0|||
105551819|NCT02041195|364021011|FG005|Overall Study|Adverse Event|0|||
105551820|NCT02041195|364021012|FG006|Overall Study|Adverse Event|3|||
105551821|NCT02041195|364021013|FG007|Overall Study|Adverse Event|0|||
105551822|NCT02041195|364021006|FG000|Overall Study|Withdrawal by Subject|1|||
105463841|NCT00687193|363711595|FG004|Overall Study|Protocol Violation|2|||
105463842|NCT00687193|363711596|FG005|Overall Study|Protocol Violation|0|||
105463843|NCT00737672|363711603|FG000|Overall Study|Graft Abandonment|48|||
105463844|NCT00737672|363711604|FG001|Overall Study|Graft Abandonment|56|||
105551823|NCT02041195|364021007|FG001|Overall Study|Withdrawal by Subject|0|||
105551824|NCT02041195|364021008|FG002|Overall Study|Withdrawal by Subject|0|||
105551825|NCT02041195|364021009|FG003|Overall Study|Withdrawal by Subject|0|||
105551826|NCT02041195|364021010|FG004|Overall Study|Withdrawal by Subject|0|||
105551827|NCT02041195|364021011|FG005|Overall Study|Withdrawal by Subject|0|||
105551828|NCT02041195|364021012|FG006|Overall Study|Withdrawal by Subject|4|||
105665475|NCT01667926|364440741|FG000|Overall Study|Side effects|3|||
105665476|NCT01667926|364440742|FG001|Overall Study|Side effects|0|||
105665477|NCT01667926|364440743|FG002|Overall Study|Side effects|0|||
105665478|NCT00475644|364440745|FG000|Overall Study|Protocol Violation|13|||
105665479|NCT01411241|364440746|FG000|Overall Study|Protocol Violation|0|||
105665480|NCT01411241|364440747|FG001|Overall Study|Protocol Violation|5|||
105665481|NCT01411241|364440746|FG000|Overall Study|Withdrawal by Subject|9|||
105665482|NCT01411241|364440747|FG001|Overall Study|Withdrawal by Subject|10|||
105665483|NCT01411241|364440746|FG000|Overall Study|Serious Adverse Event|0|||
105665484|NCT01411241|364440747|FG001|Overall Study|Serious Adverse Event|3|||
105665485|NCT01411241|364440746|FG000|Overall Study|Lost to Follow-up|2|||
105665486|NCT01411241|364440747|FG001|Overall Study|Lost to Follow-up|4|||
105665487|NCT00078338|364440748|FG000|Overall Study|Adverse Event|31|||
105665488|NCT00078338|364440749|FG001|Overall Study|Adverse Event|24|||
105665489|NCT00078338|364440748|FG000|Overall Study|Lost to Follow-up|17|||
105665490|NCT00078338|364440749|FG001|Overall Study|Lost to Follow-up|2|||
105665491|NCT00078338|364440748|FG000|Overall Study|Protocol Violation|2|||
105665492|NCT00078338|364440749|FG001|Overall Study|Protocol Violation|2|||
105340338|NCT03104400|363248169|FG000|Overall Study|Other|0|||
105340339|NCT03104400|363248170|FG001|Overall Study|Other|1|||
105340340|NCT03104400|363248171|FG002|Overall Study|Other|0|||
105340341|NCT03104400|363248172|FG003|Overall Study|Other|0|||
105551829|NCT02041195|364021013|FG007|Overall Study|Withdrawal by Subject|3|||
105551830|NCT02041195|364021006|FG000|Overall Study|Unable to comply with study visits|0|||
105551831|NCT02041195|364021007|FG001|Overall Study|Unable to comply with study visits|1|||
105551832|NCT02041195|364021008|FG002|Overall Study|Unable to comply with study visits|0|||
105551833|NCT02041195|364021009|FG003|Overall Study|Unable to comply with study visits|0|||
105551834|NCT02041195|364021010|FG004|Overall Study|Unable to comply with study visits|1|||
105551835|NCT02041195|364021011|FG005|Overall Study|Unable to comply with study visits|0|||
105551836|NCT02041195|364021012|FG006|Overall Study|Unable to comply with study visits|0|||
105551837|NCT02041195|364021013|FG007|Overall Study|Unable to comply with study visits|0|||
105551838|NCT00907153|364021016|FG000|Overall Study|Lost to Follow-up|1|||
105551839|NCT00907153|364021017|FG001|Overall Study|Lost to Follow-up|1|||
105551840|NCT00907153|364021016|FG000|Overall Study|Withdrawal by Subject|1|||
105551841|NCT00907153|364021017|FG001|Overall Study|Withdrawal by Subject|3|||
105551842|NCT01928719|364021018|FG000|Overall Study|Lost to Follow-up|26|||
105551843|NCT01928719|364021019|FG001|Overall Study|Lost to Follow-up|11|||
105551844|NCT01928719|364021018|FG000|Overall Study|Withdrawal by Subject|22|||
105551845|NCT01928719|364021019|FG001|Overall Study|Withdrawal by Subject|7|||
105551846|NCT01928719|364021018|FG000|Overall Study|Protocol Violation|3|||
105551847|NCT01928719|364021019|FG001|Overall Study|Protocol Violation|1|||
105551848|NCT01928719|364021018|FG000|Overall Study|Adverse Event|1|||
105551849|NCT01928719|364021019|FG001|Overall Study|Adverse Event|0|||
105551850|NCT01490632|364021023|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
105551851|NCT01490632|364021024|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
105551852|NCT01490632|364021025|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
105551853|NCT01490632|364021026|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
105551854|NCT01490632|364021027|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
105551855|NCT01490632|364021028|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
105551856|NCT01490632|364021029|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
105551857|NCT01490632|364021030|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
105551858|NCT01490632|364021031|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
105551859|NCT01490632|364021032|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
105551860|NCT01490632|364021033|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
105551861|NCT01490632|364021034|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
105551862|NCT01490632|364021035|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
105551863|NCT01490632|364021036|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
105551864|NCT01490632|364021037|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
105551865|NCT01490632|364021038|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
105551866|NCT01490632|364021039|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
105551867|NCT01490632|364021040|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
105551868|NCT01490632|364021041|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
105551869|NCT01490632|364021042|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
105551870|NCT01490632|364021023|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
105551871|NCT01490632|364021024|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
105551872|NCT01490632|364021025|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
105551873|NCT01490632|364021026|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
105551874|NCT01490632|364021027|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105551875|NCT01490632|364021028|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105551876|NCT01490632|364021029|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105551877|NCT01490632|364021030|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105340342|NCT03104400|363248173|FG004|Overall Study|Other|0|||
105340343|NCT02752165|363248179|FG000|Overall Study|Withdrawal by Subject|6|||
105340344|NCT02752165|363248180|FG001|Overall Study|Withdrawal by Subject|6|||
105340345|NCT02752165|363248179|FG000|Overall Study|Protocol Violation|6|||
105340346|NCT02752165|363248180|FG001|Overall Study|Protocol Violation|5|||
105340347|NCT02752165|363248179|FG000|Overall Study|Lost to Follow-up|33|||
105340348|NCT02752165|363248180|FG001|Overall Study|Lost to Follow-up|38|||
105340349|NCT01953601|363248181|FG000|Part 1 (Base Study)|Adverse Event|24|||
105340350|NCT01953601|363248182|FG001|Part 1 (Base Study)|Adverse Event|37|||
105340351|NCT01953601|363248183|FG002|Part 1 (Base Study)|Adverse Event|15|||
105340352|NCT01953601|363248181|FG000|Part 1 (Base Study)|Death|2|||
105340353|NCT01953601|363248182|FG001|Part 1 (Base Study)|Death|0|||
105340354|NCT01953601|363248183|FG002|Part 1 (Base Study)|Death|3|||
105340355|NCT01953601|363248181|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
105340356|NCT01953601|363248182|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
105340357|NCT01953601|363248183|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
105340358|NCT01953601|363248181|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
105340359|NCT01953601|363248182|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
105340360|NCT01953601|363248183|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
105340361|NCT01953601|363248181|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
105340362|NCT01953601|363248182|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
105340363|NCT01953601|363248183|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
105340364|NCT01953601|363248181|FG000|Part 1 (Base Study)|Physician Decision|3|||
105340365|NCT01953601|363248182|FG001|Part 1 (Base Study)|Physician Decision|7|||
105340366|NCT01953601|363248183|FG002|Part 1 (Base Study)|Physician Decision|4|||
105340367|NCT01953601|363248181|FG000|Part 1 (Base Study)|Screen failure|1|||
105340368|NCT01953601|363248182|FG001|Part 1 (Base Study)|Screen failure|0|||
105340369|NCT01953601|363248183|FG002|Part 1 (Base Study)|Screen failure|1|||
105340370|NCT01953601|363248181|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
105340371|NCT01953601|363248182|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
105340372|NCT01953601|363248183|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
105340373|NCT01953601|363248181|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
105340374|NCT01953601|363248182|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
105340375|NCT01953601|363248183|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
105340376|NCT01953601|363248181|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
105340377|NCT01953601|363248182|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
105340378|NCT01953601|363248183|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
105340379|NCT01953601|363248181|FG000|Part 1 (Base Study)|Subject moved|2|||
105340380|NCT01953601|363248182|FG001|Part 1 (Base Study)|Subject moved|2|||
105340381|NCT01953601|363248183|FG002|Part 1 (Base Study)|Subject moved|1|||
105340382|NCT01953601|363248181|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
105340383|NCT01953601|363248182|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
105340384|NCT01953601|363248183|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
105340385|NCT01953601|363248181|FG000|Part 2 (Extension Study)|Adverse Event|1|||
105340386|NCT01953601|363248182|FG001|Part 2 (Extension Study)|Adverse Event|1|||
105340387|NCT01953601|363248183|FG002|Part 2 (Extension Study)|Adverse Event|10|||
105340388|NCT01953601|363248181|FG000|Part 2 (Extension Study)|Death|0|||
105340389|NCT01953601|363248182|FG001|Part 2 (Extension Study)|Death|3|||
105340390|NCT01953601|363248183|FG002|Part 2 (Extension Study)|Death|0|||
105340391|NCT01953601|363248181|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
105340392|NCT01953601|363248182|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
105340393|NCT01953601|363248183|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
105340394|NCT01953601|363248181|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
105340395|NCT01953601|363248182|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
105340396|NCT01953601|363248183|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
105340397|NCT01953601|363248181|FG000|Part 2 (Extension Study)|Physician Decision|2|||
105340398|NCT01953601|363248182|FG001|Part 2 (Extension Study)|Physician Decision|0|||
105340399|NCT01953601|363248183|FG002|Part 2 (Extension Study)|Physician Decision|2|||
105340400|NCT01953601|363248181|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
105340401|NCT01953601|363248182|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
105340402|NCT01953601|363248183|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
105340403|NCT01953601|363248181|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
105340404|NCT01953601|363248182|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
105340405|NCT01953601|363248183|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
105340406|NCT01953601|363248181|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
105340407|NCT01953601|363248182|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
105340408|NCT01953601|363248183|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
105340409|NCT01953601|363248181|FG000|Part 2 (Extension Study)|Subject moved|0|||
105340410|NCT01953601|363248182|FG001|Part 2 (Extension Study)|Subject moved|0|||
105340411|NCT01953601|363248183|FG002|Part 2 (Extension Study)|Subject moved|1|||
105340412|NCT01953601|363248181|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
105551878|NCT01490632|364021031|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105551879|NCT01490632|364021032|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105551880|NCT01490632|364021033|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105551881|NCT01490632|364021034|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105551882|NCT01490632|364021035|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105551883|NCT01490632|364021036|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105551884|NCT01490632|364021037|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105551885|NCT01490632|364021038|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105551886|NCT01490632|364021039|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105551887|NCT01490632|364021040|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105551888|NCT01490632|364021041|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105551889|NCT01490632|364021042|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
105551890|NCT01490632|364021023|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551891|NCT01490632|364021024|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551892|NCT01490632|364021025|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
105551893|NCT01490632|364021026|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
105665493|NCT00078338|364440748|FG000|Overall Study|Disease Progression|4|||
105551894|NCT01490632|364021027|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
105340413|NCT01953601|363248182|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
105340414|NCT01953601|363248183|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
105463845|NCT00737672|363711603|FG000|Overall Study|Death|23|||
105463846|NCT00737672|363711604|FG001|Overall Study|Death|22|||
105463847|NCT00737672|363711603|FG000|Overall Study|Withdrawal by Subject|1|||
105463848|NCT00737672|363711604|FG001|Overall Study|Withdrawal by Subject|2|||
105463849|NCT00737672|363711603|FG000|Overall Study|Lost to Follow-up|1|||
105463850|NCT00737672|363711604|FG001|Overall Study|Lost to Follow-up|0|||
105463851|NCT00737672|363711603|FG000|Overall Study|Miscellaneous|7|||
105463852|NCT00737672|363711604|FG001|Overall Study|Miscellaneous|1|||
105463853|NCT00737672|363711603|FG000|Overall Study|Physician Decision|0|||
105463854|NCT00737672|363711604|FG001|Overall Study|Physician Decision|2|||
105463855|NCT01394016|363711606|FG000|Overall Study|Progressive Disease|2|||
105463856|NCT01394016|363711607|FG001|Overall Study|Progressive Disease|0|||
105463857|NCT01394016|363711608|FG002|Overall Study|Progressive Disease|0|||
105463858|NCT01394016|363711609|FG003|Overall Study|Progressive Disease|0|||
105551895|NCT01490632|364021028|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551896|NCT01490632|364021029|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551897|NCT01490632|364021030|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551898|NCT01490632|364021031|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551899|NCT01490632|364021032|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551900|NCT01490632|364021033|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551901|NCT01490632|364021034|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551902|NCT01490632|364021035|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551903|NCT01490632|364021036|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551904|NCT01490632|364021037|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551905|NCT01490632|364021038|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551906|NCT01490632|364021039|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551907|NCT01490632|364021040|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551908|NCT01490632|364021041|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105551909|NCT01490632|364021042|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
105463859|NCT01394016|363711610|FG004|Overall Study|Progressive Disease|0|||
105463860|NCT01394016|363711611|FG005|Overall Study|Progressive Disease|0|||
105463861|NCT01394016|363711612|FG006|Overall Study|Progressive Disease|0|||
105551910|NCT01490632|364021023|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
105551911|NCT01490632|364021024|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
105551912|NCT01490632|364021025|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
105551913|NCT01490632|364021026|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
105551914|NCT01490632|364021027|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
105551915|NCT01490632|364021028|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
105551916|NCT01490632|364021029|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
105551917|NCT01490632|364021030|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
105551918|NCT01490632|364021031|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
105551919|NCT01490632|364021032|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
105551920|NCT01490632|364021033|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
105551921|NCT01490632|364021034|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
105551922|NCT01490632|364021035|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
105551923|NCT01490632|364021036|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
105551924|NCT01490632|364021037|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
105551925|NCT01490632|364021038|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
105551926|NCT01490632|364021039|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
105551927|NCT01490632|364021040|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
105551928|NCT01490632|364021041|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
105551929|NCT01490632|364021042|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
105551930|NCT01490632|364021023|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
105551931|NCT01490632|364021024|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551932|NCT01490632|364021025|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551933|NCT01490632|364021026|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551934|NCT01490632|364021027|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551935|NCT01490632|364021028|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551936|NCT01490632|364021029|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551937|NCT01490632|364021030|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551938|NCT01490632|364021031|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551939|NCT01490632|364021032|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551940|NCT01490632|364021033|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551941|NCT01490632|364021034|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551942|NCT01490632|364021035|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551943|NCT01490632|364021036|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551944|NCT01490632|364021037|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551945|NCT01490632|364021038|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551946|NCT01490632|364021039|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551947|NCT01490632|364021040|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551948|NCT01490632|364021041|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551949|NCT01490632|364021042|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
105551950|NCT01490632|364021023|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
105551951|NCT01490632|364021024|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
105551952|NCT01490632|364021025|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105551953|NCT01490632|364021026|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
105551954|NCT01490632|364021027|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
105551955|NCT01490632|364021028|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105665494|NCT00078338|364440749|FG001|Overall Study|Disease Progression|7|||
105340415|NCT03692325|363248192|FG000|Overall Study|Adverse Event|2|||
105340416|NCT03692325|363248192|FG000|Overall Study|Progression/Recurrence|2|||
105340417|NCT01300338|363248193|FG000|Overall Study|Lost to Follow-up|5|||
105463862|NCT01394016|363711613|FG007|Overall Study|Progressive Disease|0|||
105463863|NCT01394016|363711614|FG008|Overall Study|Progressive Disease|0|||
105551956|NCT01490632|364021029|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105463864|NCT01394016|363711615|FG009|Overall Study|Progressive Disease|0|||
105463865|NCT01394016|363711616|FG010|Overall Study|Progressive Disease|0|||
105463866|NCT01394016|363711617|FG011|Overall Study|Progressive Disease|0|||
105463867|NCT01394016|363711618|FG012|Overall Study|Progressive Disease|0|||
105463868|NCT01394016|363711619|FG013|Overall Study|Progressive Disease|0|||
105463869|NCT01394016|363711620|FG014|Overall Study|Progressive Disease|0|||
105463870|NCT01394016|363711621|FG015|Overall Study|Progressive Disease|0|||
105463871|NCT01394016|363711622|FG016|Overall Study|Progressive Disease|0|||
105463872|NCT01394016|363711623|FG017|Overall Study|Progressive Disease|0|||
105463873|NCT01394016|363711624|FG018|Overall Study|Progressive Disease|0|||
105463874|NCT01394016|363711606|FG000|Overall Study|Withdrawal by Subject|0|||
105463875|NCT01394016|363711607|FG001|Overall Study|Withdrawal by Subject|0|||
105463876|NCT01394016|363711608|FG002|Overall Study|Withdrawal by Subject|0|||
105463877|NCT01394016|363711609|FG003|Overall Study|Withdrawal by Subject|0|||
105463878|NCT01394016|363711610|FG004|Overall Study|Withdrawal by Subject|0|||
105463879|NCT01394016|363711611|FG005|Overall Study|Withdrawal by Subject|0|||
105463880|NCT01394016|363711612|FG006|Overall Study|Withdrawal by Subject|0|||
105463881|NCT01394016|363711613|FG007|Overall Study|Withdrawal by Subject|1|||
105463882|NCT01394016|363711614|FG008|Overall Study|Withdrawal by Subject|1|||
105463883|NCT01394016|363711615|FG009|Overall Study|Withdrawal by Subject|1|||
105463884|NCT01394016|363711616|FG010|Overall Study|Withdrawal by Subject|4|||
105463885|NCT01394016|363711617|FG011|Overall Study|Withdrawal by Subject|0|||
105463886|NCT01394016|363711618|FG012|Overall Study|Withdrawal by Subject|0|||
105463887|NCT01394016|363711619|FG013|Overall Study|Withdrawal by Subject|3|||
105463888|NCT01394016|363711620|FG014|Overall Study|Withdrawal by Subject|1|||
105463889|NCT01394016|363711621|FG015|Overall Study|Withdrawal by Subject|3|||
105463890|NCT01394016|363711622|FG016|Overall Study|Withdrawal by Subject|1|||
105463891|NCT01394016|363711623|FG017|Overall Study|Withdrawal by Subject|1|||
105463892|NCT01394016|363711624|FG018|Overall Study|Withdrawal by Subject|2|||
105463893|NCT01394016|363711606|FG000|Overall Study|Adverse Event|0|||
105463894|NCT01394016|363711607|FG001|Overall Study|Adverse Event|0|||
105463895|NCT01394016|363711608|FG002|Overall Study|Adverse Event|0|||
105463896|NCT01394016|363711609|FG003|Overall Study|Adverse Event|0|||
105463897|NCT01394016|363711610|FG004|Overall Study|Adverse Event|0|||
105463898|NCT01394016|363711611|FG005|Overall Study|Adverse Event|0|||
105463899|NCT01394016|363711612|FG006|Overall Study|Adverse Event|0|||
105463900|NCT01394016|363711613|FG007|Overall Study|Adverse Event|0|||
105463901|NCT01394016|363711614|FG008|Overall Study|Adverse Event|0|||
105463902|NCT01394016|363711615|FG009|Overall Study|Adverse Event|1|||
105463903|NCT01394016|363711616|FG010|Overall Study|Adverse Event|0|||
105463904|NCT01394016|363711617|FG011|Overall Study|Adverse Event|0|||
105463905|NCT01394016|363711618|FG012|Overall Study|Adverse Event|0|||
105463906|NCT01394016|363711619|FG013|Overall Study|Adverse Event|0|||
105463907|NCT01394016|363711620|FG014|Overall Study|Adverse Event|0|||
105463908|NCT01394016|363711621|FG015|Overall Study|Adverse Event|0|||
105463909|NCT01394016|363711622|FG016|Overall Study|Adverse Event|1|||
105463910|NCT01394016|363711623|FG017|Overall Study|Adverse Event|1|||
105463911|NCT01394016|363711624|FG018|Overall Study|Adverse Event|0|||
105463912|NCT01394016|363711606|FG000|Overall Study|Sponsor Decision|0|||
105463913|NCT01394016|363711607|FG001|Overall Study|Sponsor Decision|0|||
105463914|NCT01394016|363711608|FG002|Overall Study|Sponsor Decision|0|||
105463915|NCT01394016|363711609|FG003|Overall Study|Sponsor Decision|0|||
105463916|NCT01394016|363711610|FG004|Overall Study|Sponsor Decision|0|||
105463917|NCT01394016|363711611|FG005|Overall Study|Sponsor Decision|0|||
105463918|NCT01394016|363711612|FG006|Overall Study|Sponsor Decision|0|||
105665495|NCT00078338|364440748|FG000|Overall Study|Other|28|||
105665496|NCT00078338|364440749|FG001|Overall Study|Other|16|||
105665497|NCT00078338|364440748|FG000|Overall Study|Subjects randomized, but not treated|3|||
105665498|NCT00078338|364440749|FG001|Overall Study|Subjects randomized, but not treated|3|||
105665499|NCT03258723|364440750|FG000|Overall Study|COVID Interruption of study|54|||
105665500|NCT03258723|364440750|FG000|Overall Study|Lost to Follow-up|8|||
105665501|NCT00944229|364440751|FG000|Overall Study|Withdrawal by Subject|11|||
105665502|NCT00944229|364440751|FG000|Overall Study|Physician Decision|14|||
105665503|NCT01606319|364440752|FG000|Overall Study|Lost to Follow-up|17|||
105665504|NCT01606319|364440753|FG001|Overall Study|Lost to Follow-up|14|||
105665505|NCT01606319|364440752|FG000|Overall Study|Withdrawal by Subject|9|||
105665506|NCT01606319|364440753|FG001|Overall Study|Withdrawal by Subject|12|||
105665507|NCT01606319|364440752|FG000|Overall Study|Physician Decision|1|||
105665508|NCT01606319|364440753|FG001|Overall Study|Physician Decision|2|||
105665509|NCT01606319|364440752|FG000|Overall Study|Lack of Efficacy|6|||
105665510|NCT01606319|364440753|FG001|Overall Study|Lack of Efficacy|8|||
105665511|NCT01606319|364440752|FG000|Overall Study|Adverse Event|1|||
105665512|NCT01606319|364440753|FG001|Overall Study|Adverse Event|4|||
105665513|NCT02906020|364440758|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
105665514|NCT02906020|364440759|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
105665515|NCT02906020|364440760|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
105665516|NCT02906020|364440761|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
105665517|NCT02906020|364440762|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
105665518|NCT02906020|364440763|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
105665519|NCT02906020|364440764|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
105665520|NCT02906020|364440765|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
105665521|NCT02906020|364440766|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
105665522|NCT02906020|364440767|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
105665523|NCT02906020|364440768|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
105665524|NCT02906020|364440769|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
105665525|NCT02906020|364440770|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
105665526|NCT02906020|364440771|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
105665527|NCT02906020|364440772|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
105665528|NCT02906020|364440773|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
105665529|NCT02906020|364440758|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665530|NCT02906020|364440759|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665531|NCT02906020|364440760|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665532|NCT02906020|364440761|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665533|NCT02906020|364440762|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665534|NCT02906020|364440763|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665535|NCT02906020|364440764|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665536|NCT02906020|364440765|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665537|NCT02906020|364440766|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
105665538|NCT02906020|364440767|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
105665539|NCT02906020|364440768|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665540|NCT02906020|364440769|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665541|NCT02906020|364440770|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665542|NCT02906020|364440771|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665543|NCT02906020|364440772|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665544|NCT02906020|364440773|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665545|NCT02906020|364440758|FG000|Part 2: Double-blind Treatment Period|Other|0|||
105665546|NCT02906020|364440759|FG001|Part 2: Double-blind Treatment Period|Other|0|||
105665547|NCT02906020|364440760|FG002|Part 2: Double-blind Treatment Period|Other|0|||
105665548|NCT02906020|364440761|FG003|Part 2: Double-blind Treatment Period|Other|0|||
105665549|NCT02906020|364440762|FG004|Part 2: Double-blind Treatment Period|Other|0|||
105340418|NCT01300338|363248194|FG001|Overall Study|Lost to Follow-up|0|||
105340419|NCT00664859|363248196|FG000|Overall Study|Adverse Event|2|||
105340420|NCT00664859|363248197|FG001|Overall Study|Adverse Event|1|||
105551957|NCT01490632|364021030|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105551958|NCT01490632|364021031|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105551959|NCT01490632|364021032|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105551960|NCT01490632|364021033|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105551961|NCT01490632|364021034|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105551962|NCT01490632|364021035|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105551963|NCT01490632|364021036|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105551964|NCT01490632|364021037|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105340421|NCT00664859|363248198|FG002|Overall Study|Adverse Event|3|||
105360880|NCT00873730|363328099|FG000|Overall Study|Adverse Event|0|||
105340422|NCT00664859|363248196|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
105340423|NCT00664859|363248197|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
105340424|NCT00664859|363248198|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
105463919|NCT01394016|363711613|FG007|Overall Study|Sponsor Decision|0|||
105463920|NCT01394016|363711614|FG008|Overall Study|Sponsor Decision|0|||
105463921|NCT01394016|363711615|FG009|Overall Study|Sponsor Decision|0|||
105463922|NCT01394016|363711616|FG010|Overall Study|Sponsor Decision|0|||
105463923|NCT01394016|363711617|FG011|Overall Study|Sponsor Decision|0|||
105463924|NCT01394016|363711618|FG012|Overall Study|Sponsor Decision|1|||
105463925|NCT01394016|363711619|FG013|Overall Study|Sponsor Decision|0|||
105463926|NCT01394016|363711620|FG014|Overall Study|Sponsor Decision|0|||
105463927|NCT01394016|363711621|FG015|Overall Study|Sponsor Decision|0|||
105463928|NCT01394016|363711622|FG016|Overall Study|Sponsor Decision|0|||
105463929|NCT01394016|363711623|FG017|Overall Study|Sponsor Decision|0|||
105463930|NCT01394016|363711624|FG018|Overall Study|Sponsor Decision|0|||
105463931|NCT01394016|363711606|FG000|Overall Study|Lost to Follow-up|0|||
105463932|NCT01394016|363711607|FG001|Overall Study|Lost to Follow-up|0|||
105463933|NCT01394016|363711608|FG002|Overall Study|Lost to Follow-up|0|||
105463934|NCT01394016|363711609|FG003|Overall Study|Lost to Follow-up|0|||
105463935|NCT01394016|363711610|FG004|Overall Study|Lost to Follow-up|0|||
105463936|NCT01394016|363711611|FG005|Overall Study|Lost to Follow-up|0|||
105463937|NCT01394016|363711612|FG006|Overall Study|Lost to Follow-up|0|||
105463938|NCT01394016|363711613|FG007|Overall Study|Lost to Follow-up|0|||
105463939|NCT01394016|363711614|FG008|Overall Study|Lost to Follow-up|0|||
105463940|NCT01394016|363711615|FG009|Overall Study|Lost to Follow-up|0|||
105463941|NCT01394016|363711616|FG010|Overall Study|Lost to Follow-up|0|||
105463942|NCT01394016|363711617|FG011|Overall Study|Lost to Follow-up|0|||
105463943|NCT01394016|363711618|FG012|Overall Study|Lost to Follow-up|0|||
105463944|NCT01394016|363711619|FG013|Overall Study|Lost to Follow-up|0|||
105463945|NCT01394016|363711620|FG014|Overall Study|Lost to Follow-up|0|||
105463946|NCT01394016|363711621|FG015|Overall Study|Lost to Follow-up|0|||
105463947|NCT01394016|363711622|FG016|Overall Study|Lost to Follow-up|0|||
105463948|NCT01394016|363711623|FG017|Overall Study|Lost to Follow-up|0|||
105463949|NCT01394016|363711624|FG018|Overall Study|Lost to Follow-up|1|||
105665550|NCT02906020|364440763|FG005|Part 2: Double-blind Treatment Period|Other|0|||
105665551|NCT02906020|364440764|FG006|Part 2: Double-blind Treatment Period|Other|0|||
105665552|NCT02906020|364440765|FG007|Part 2: Double-blind Treatment Period|Other|0|||
105665553|NCT02906020|364440766|FG008|Part 2: Double-blind Treatment Period|Other|6|||
105665554|NCT02906020|364440767|FG009|Part 2: Double-blind Treatment Period|Other|10|||
105665555|NCT02906020|364440768|FG010|Part 2: Double-blind Treatment Period|Other|0|||
105665556|NCT02906020|364440769|FG011|Part 2: Double-blind Treatment Period|Other|0|||
105665557|NCT02906020|364440770|FG012|Part 2: Double-blind Treatment Period|Other|0|||
105665558|NCT02906020|364440771|FG013|Part 2: Double-blind Treatment Period|Other|0|||
105665559|NCT02906020|364440772|FG014|Part 2: Double-blind Treatment Period|Other|0|||
105665560|NCT02906020|364440773|FG015|Part 2: Double-blind Treatment Period|Other|0|||
105665561|NCT02906020|364440758|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665562|NCT02906020|364440759|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665563|NCT02906020|364440760|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665564|NCT02906020|364440761|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665565|NCT02906020|364440762|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665566|NCT02906020|364440763|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665567|NCT02906020|364440764|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665568|NCT02906020|364440765|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665569|NCT02906020|364440766|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665570|NCT02906020|364440767|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665571|NCT02906020|364440768|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665572|NCT02906020|364440769|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665573|NCT02906020|364440770|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
105665574|NCT02906020|364440771|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
105665575|NCT02906020|364440772|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665576|NCT02906020|364440773|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665577|NCT02906020|364440758|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665578|NCT02906020|364440759|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665579|NCT02906020|364440760|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665580|NCT02906020|364440761|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665581|NCT02906020|364440762|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665582|NCT02906020|364440763|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665583|NCT02906020|364440764|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665584|NCT02906020|364440765|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665585|NCT02906020|364440766|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665586|NCT02906020|364440767|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665587|NCT02906020|364440768|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105340425|NCT00664859|363248196|FG000|Overall Study|Noncompliance with protocol|1|||
105340426|NCT00664859|363248197|FG001|Overall Study|Noncompliance with protocol|0|||
105340427|NCT00664859|363248198|FG002|Overall Study|Noncompliance with protocol|4|||
105551965|NCT01490632|364021038|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105551966|NCT01490632|364021039|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105551967|NCT01490632|364021040|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105551968|NCT01490632|364021041|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105551969|NCT01490632|364021042|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
105551970|NCT01490632|364021023|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551971|NCT01490632|364021024|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551972|NCT01490632|364021025|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551973|NCT01490632|364021026|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551974|NCT01490632|364021027|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
105785972|NCT04626947|364870422|FG000|Overall Study|Study terminated|14|||
105665588|NCT02906020|364440769|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665589|NCT02906020|364440770|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
105665590|NCT02906020|364440771|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
105665591|NCT02906020|364440772|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665592|NCT02906020|364440773|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
105665593|NCT02906020|364440758|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665594|NCT02906020|364440759|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665595|NCT02906020|364440760|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665596|NCT02906020|364440761|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665597|NCT02906020|364440762|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665598|NCT02906020|364440763|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665599|NCT02906020|364440764|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665600|NCT02906020|364440765|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665601|NCT02906020|364440766|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665602|NCT02906020|364440767|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665603|NCT02906020|364440768|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665604|NCT02906020|364440769|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665605|NCT02906020|364440770|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
105665606|NCT02906020|364440771|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
105665607|NCT02906020|364440772|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665608|NCT02906020|364440773|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665609|NCT02906020|364440758|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665610|NCT02906020|364440759|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665611|NCT02906020|364440760|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665612|NCT02906020|364440761|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665613|NCT02906020|364440762|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665614|NCT02906020|364440763|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105340428|NCT00664859|363248196|FG000|Overall Study|Laboratory abnormality|2|||
105340429|NCT00664859|363248197|FG001|Overall Study|Laboratory abnormality|1|||
105463950|NCT03534804|363711625|FG000|Overall Study|Withdrawal by Subject|1|||
105551975|NCT01490632|364021028|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105463951|NCT03955146|363711626|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
105463952|NCT03955146|363711627|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
105463953|NCT03955146|363711628|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
105463954|NCT03955146|363711629|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
105463955|NCT03955146|363711626|FG000|DB Period (48 Weeks)|Adverse Event|2|||
105463956|NCT03955146|363711627|FG001|DB Period (48 Weeks)|Adverse Event|5|||
105463957|NCT03955146|363711628|FG002|DB Period (48 Weeks)|Adverse Event|1|||
105463958|NCT03955146|363711629|FG003|DB Period (48 Weeks)|Adverse Event|2|||
105463959|NCT03955146|363711626|FG000|DB Period (48 Weeks)|Death|13|||
105463960|NCT03955146|363711627|FG001|DB Period (48 Weeks)|Death|17|||
105463961|NCT03955146|363711628|FG002|DB Period (48 Weeks)|Death|1|||
105463962|NCT03955146|363711629|FG003|DB Period (48 Weeks)|Death|0|||
105463963|NCT03955146|363711626|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
105463964|NCT03955146|363711627|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
105463965|NCT03955146|363711628|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
105463966|NCT03955146|363711629|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
105463967|NCT03955146|363711626|FG000|DB Period (48 Weeks)|Disease Progression|2|||
105463968|NCT03955146|363711627|FG001|DB Period (48 Weeks)|Disease Progression|0|||
105463969|NCT03955146|363711628|FG002|DB Period (48 Weeks)|Disease Progression|0|||
105463970|NCT03955146|363711629|FG003|DB Period (48 Weeks)|Disease Progression|0|||
105463971|NCT03955146|363711626|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
105463972|NCT03955146|363711627|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
105463973|NCT03955146|363711628|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
105463974|NCT03955146|363711629|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
105551976|NCT01490632|364021029|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551977|NCT01490632|364021030|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105340430|NCT00664859|363248198|FG002|Overall Study|Laboratory abnormality|4|||
105340431|NCT00664859|363248196|FG000|Overall Study|Withdrawal by Subject|4|||
105463975|NCT03955146|363711626|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
105463976|NCT03955146|363711627|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
105463977|NCT03955146|363711628|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
105463978|NCT03955146|363711629|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
105463979|NCT03955146|363711626|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
105463980|NCT03955146|363711627|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
105463981|NCT03955146|363711628|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
105463982|NCT03955146|363711629|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
105463983|NCT03955146|363711626|FG000|DB Period (48 Weeks)|Participant Decision|9|||
105665615|NCT02906020|364440764|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105463984|NCT03955146|363711627|FG001|DB Period (48 Weeks)|Participant Decision|12|||
105463985|NCT03955146|363711628|FG002|DB Period (48 Weeks)|Participant Decision|1|||
105463986|NCT03955146|363711629|FG003|DB Period (48 Weeks)|Participant Decision|1|||
105340432|NCT00664859|363248197|FG001|Overall Study|Withdrawal by Subject|1|||
105340433|NCT00664859|363248198|FG002|Overall Study|Withdrawal by Subject|3|||
105340434|NCT00664859|363248196|FG000|Overall Study|Lost to Follow-up|2|||
105340435|NCT00664859|363248197|FG001|Overall Study|Lost to Follow-up|2|||
105340436|NCT00664859|363248198|FG002|Overall Study|Lost to Follow-up|1|||
105340437|NCT00664859|363248196|FG000|Overall Study|Other|0|||
105340438|NCT00664859|363248197|FG001|Overall Study|Other|1|||
105340439|NCT00664859|363248198|FG002|Overall Study|Other|2|||
105340440|NCT00748189|363248199|FG000|Overall Study|Death|99|||
105340441|NCT00748189|363248200|FG001|Overall Study|Death|84|||
105340442|NCT00748189|363248199|FG000|Overall Study|Withdrawal by Subject|23|||
105340443|NCT00748189|363248200|FG001|Overall Study|Withdrawal by Subject|29|||
105340444|NCT00748189|363248199|FG000|Overall Study|Physician Decision|16|||
105551978|NCT01490632|364021031|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551979|NCT01490632|364021032|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551980|NCT01490632|364021033|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551981|NCT01490632|364021034|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551982|NCT01490632|364021035|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551983|NCT01490632|364021036|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551984|NCT01490632|364021037|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551985|NCT01490632|364021038|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551986|NCT01490632|364021039|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551987|NCT01490632|364021040|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551988|NCT01490632|364021041|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551989|NCT01490632|364021042|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105551990|NCT01490632|364021023|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
105551991|NCT01490632|364021024|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
105551992|NCT01490632|364021025|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
105551993|NCT01490632|364021026|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
105551994|NCT01490632|364021027|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
105551995|NCT01490632|364021028|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
105551996|NCT01490632|364021029|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
105551997|NCT01490632|364021030|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
105551998|NCT01490632|364021031|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
105551999|NCT01490632|364021032|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
105552000|NCT01490632|364021033|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
105552001|NCT01490632|364021034|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
105552002|NCT01490632|364021035|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
105552003|NCT01490632|364021036|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
105552004|NCT01490632|364021037|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
105552005|NCT01490632|364021038|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
105552006|NCT01490632|364021039|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
105552007|NCT01490632|364021040|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
105552008|NCT01490632|364021041|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
105552009|NCT01490632|364021042|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
105552010|NCT01490632|364021023|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552011|NCT01490632|364021024|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552012|NCT01490632|364021025|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552013|NCT01490632|364021026|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552014|NCT01490632|364021027|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552015|NCT01490632|364021028|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552016|NCT01490632|364021029|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
105340445|NCT00748189|363248200|FG001|Overall Study|Physician Decision|5|||
105340446|NCT00748189|363248199|FG000|Overall Study|Lost to Follow-up|8|||
105340447|NCT00748189|363248200|FG001|Overall Study|Lost to Follow-up|15|||
105340448|NCT00748189|363248199|FG000|Overall Study|Study terminated by Sponsor|70|||
105340449|NCT00748189|363248200|FG001|Overall Study|Study terminated by Sponsor|79|||
105665616|NCT02906020|364440765|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665617|NCT02906020|364440766|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665618|NCT02906020|364440767|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665619|NCT02906020|364440768|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665620|NCT02906020|364440769|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665621|NCT02906020|364440770|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
105665622|NCT02906020|364440771|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
105665623|NCT02906020|364440772|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665624|NCT02906020|364440773|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665625|NCT02906020|364440758|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665626|NCT02906020|364440759|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105340450|NCT04598451|363248201|FG000|Overall Study|Adverse Event|3|||
105552017|NCT01490632|364021030|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552018|NCT01490632|364021031|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
105552019|NCT01490632|364021032|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
105552020|NCT01490632|364021033|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
105552021|NCT01490632|364021034|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552022|NCT01490632|364021035|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552023|NCT01490632|364021036|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552024|NCT01490632|364021037|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552025|NCT01490632|364021038|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552026|NCT01490632|364021039|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552027|NCT01490632|364021040|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552028|NCT01490632|364021041|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552029|NCT01490632|364021042|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
105552030|NCT01490632|364021023|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552031|NCT01490632|364021024|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552032|NCT01490632|364021025|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552033|NCT01490632|364021026|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552034|NCT01490632|364021027|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552035|NCT01490632|364021028|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552036|NCT01490632|364021029|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
105552037|NCT01490632|364021030|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552038|NCT01490632|364021031|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552039|NCT01490632|364021032|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
105552040|NCT01490632|364021033|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552041|NCT01490632|364021034|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552042|NCT01490632|364021035|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552043|NCT01490632|364021036|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552044|NCT01490632|364021037|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552045|NCT01490632|364021038|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552046|NCT01490632|364021039|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552047|NCT01490632|364021040|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552048|NCT01490632|364021041|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552049|NCT01490632|364021042|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105552050|NCT01490632|364021023|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552051|NCT01490632|364021024|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552052|NCT01490632|364021025|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552053|NCT01490632|364021026|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552054|NCT01490632|364021027|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
105665627|NCT02906020|364440760|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665628|NCT02906020|364440761|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665629|NCT02906020|364440762|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665630|NCT02906020|364440763|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665631|NCT02906020|364440764|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665632|NCT02906020|364440765|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665633|NCT02906020|364440766|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665634|NCT02906020|364440767|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665635|NCT02906020|364440768|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665636|NCT02906020|364440769|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665637|NCT02906020|364440770|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
105665638|NCT02906020|364440771|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
105665639|NCT02906020|364440772|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
105665640|NCT02906020|364440773|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
105665641|NCT02906020|364440758|FG000|Part 2: Long-term Follow-up Period|Other|0|||
105665642|NCT02906020|364440759|FG001|Part 2: Long-term Follow-up Period|Other|0|||
105665643|NCT02906020|364440760|FG002|Part 2: Long-term Follow-up Period|Other|0|||
105665644|NCT02906020|364440761|FG003|Part 2: Long-term Follow-up Period|Other|0|||
105665645|NCT02906020|364440762|FG004|Part 2: Long-term Follow-up Period|Other|0|||
105665646|NCT02906020|364440763|FG005|Part 2: Long-term Follow-up Period|Other|0|||
105665647|NCT02906020|364440764|FG006|Part 2: Long-term Follow-up Period|Other|0|||
105665648|NCT02906020|364440765|FG007|Part 2: Long-term Follow-up Period|Other|0|||
105665649|NCT02906020|364440766|FG008|Part 2: Long-term Follow-up Period|Other|0|||
105665650|NCT02906020|364440767|FG009|Part 2: Long-term Follow-up Period|Other|0|||
105665651|NCT02906020|364440768|FG010|Part 2: Long-term Follow-up Period|Other|0|||
105665652|NCT02906020|364440769|FG011|Part 2: Long-term Follow-up Period|Other|0|||
105665653|NCT02906020|364440770|FG012|Part 2: Long-term Follow-up Period|Other|13|||
105665654|NCT02906020|364440771|FG013|Part 2: Long-term Follow-up Period|Other|8|||
105665655|NCT02906020|364440772|FG014|Part 2: Long-term Follow-up Period|Other|3|||
105665656|NCT02906020|364440773|FG015|Part 2: Long-term Follow-up Period|Other|2|||
105665657|NCT01810939|364440774|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
105665658|NCT01810939|364440775|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
105665659|NCT01810939|364440776|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
105665660|NCT01810939|364440774|FG000|Part A Treatment Period|Protocol Violation|2|||
105665661|NCT01810939|364440775|FG001|Part A Treatment Period|Protocol Violation|0|||
105665662|NCT01810939|364440776|FG002|Part A Treatment Period|Protocol Violation|0|||
105665663|NCT01810939|364440774|FG000|Part A Treatment Period|Adverse Event|10|||
105665664|NCT01810939|364440775|FG001|Part A Treatment Period|Adverse Event|0|||
105665665|NCT01810939|364440776|FG002|Part A Treatment Period|Adverse Event|0|||
105665666|NCT01810939|364440774|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
105665667|NCT01810939|364440775|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
105665668|NCT01810939|364440776|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
105665669|NCT01810939|364440774|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
105665670|NCT01810939|364440775|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
105665671|NCT01810939|364440776|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
105665672|NCT01810939|364440774|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
105665673|NCT01810939|364440775|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
105665674|NCT01810939|364440776|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
105665675|NCT01810939|364440774|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
105665676|NCT01810939|364440775|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
105665677|NCT01810939|364440776|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
105665678|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
105665679|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
105665680|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
105665681|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
105665682|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
105665683|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
105340451|NCT04598451|363248202|FG001|Overall Study|Adverse Event|2|||
105665684|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
105665685|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
105665686|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
105665687|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
105665688|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
105665689|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
105665690|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
105665691|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
105340452|NCT04598451|363248201|FG000|Overall Study|Withdrawal by Subject|3|||
105665692|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
105665693|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
105665694|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
105665695|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
105665696|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
105665697|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
105665698|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
105665699|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
105665700|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
105665701|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
105665702|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
105665703|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
105665704|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
105665705|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
105665706|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
105552055|NCT01490632|364021028|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552056|NCT01490632|364021029|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
105552057|NCT01490632|364021030|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552058|NCT01490632|364021031|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552059|NCT01490632|364021032|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552060|NCT01490632|364021033|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552061|NCT01490632|364021034|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552062|NCT01490632|364021035|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552063|NCT01490632|364021036|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552064|NCT01490632|364021037|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552065|NCT01490632|364021038|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552066|NCT01490632|364021039|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552067|NCT01490632|364021040|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552068|NCT01490632|364021041|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552069|NCT01490632|364021042|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
105552070|NCT01490632|364021023|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552071|NCT01490632|364021024|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552072|NCT01490632|364021025|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552073|NCT01490632|364021026|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552074|NCT01490632|364021027|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552075|NCT01490632|364021028|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
105552076|NCT01490632|364021029|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552077|NCT01490632|364021030|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552078|NCT01490632|364021031|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552079|NCT01490632|364021032|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552080|NCT01490632|364021033|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552081|NCT01490632|364021034|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552082|NCT01490632|364021035|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552083|NCT01490632|364021036|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552084|NCT01490632|364021037|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552085|NCT01490632|364021038|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552086|NCT01490632|364021039|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552087|NCT01490632|364021040|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552088|NCT01490632|364021041|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552089|NCT01490632|364021042|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105552090|NCT01490632|364021023|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105552091|NCT01490632|364021024|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105552092|NCT01490632|364021025|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105552093|NCT01490632|364021026|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105552094|NCT01490632|364021027|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105552095|NCT01490632|364021028|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105552096|NCT01490632|364021029|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
105552097|NCT01490632|364021030|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105552098|NCT01490632|364021031|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
105552099|NCT01490632|364021032|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105463987|NCT03955146|363711626|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
105463988|NCT03955146|363711627|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
105463989|NCT03955146|363711628|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
105463990|NCT03955146|363711629|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
105463991|NCT03955146|363711626|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
105463992|NCT03955146|363711627|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
105463993|NCT03955146|363711628|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
105463994|NCT03955146|363711629|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
105463995|NCT03955146|363711626|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
105463996|NCT03955146|363711627|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
105463997|NCT03955146|363711628|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
105463998|NCT03955146|363711629|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
105463999|NCT03955146|363711626|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
105464000|NCT03955146|363711627|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
105464001|NCT03955146|363711628|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
105464002|NCT03955146|363711629|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
105464003|NCT03955146|363711626|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
105464004|NCT03955146|363711627|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
105464005|NCT03955146|363711628|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
105464006|NCT03955146|363711629|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
105464007|NCT03955146|363711626|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
105464008|NCT03955146|363711627|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
105464009|NCT03955146|363711628|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
105464010|NCT03955146|363711629|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
105464011|NCT03955146|363711626|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
105464012|NCT03955146|363711627|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
105464013|NCT03955146|363711628|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
105464014|NCT03955146|363711629|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
105464015|NCT03955146|363711626|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
105464016|NCT03955146|363711627|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
105464017|NCT03955146|363711628|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
105464018|NCT03955146|363711629|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
105464019|NCT03955146|363711626|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
105464020|NCT03955146|363711627|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
105464021|NCT03955146|363711628|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
105464022|NCT03955146|363711629|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
105464023|NCT03955146|363711626|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
105464024|NCT03955146|363711627|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
105464025|NCT03955146|363711628|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
105464026|NCT03955146|363711629|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
105464027|NCT03955146|363711626|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
105464028|NCT03955146|363711627|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
105464029|NCT03955146|363711628|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
105464030|NCT03955146|363711629|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
105464031|NCT02002598|363711632|FG000|Dose Level 1|Withdrawal by Subject|1|||
105464032|NCT02002598|363711633|FG001|Dose Level 1|Withdrawal by Subject|0|||
105464033|NCT02002598|363711634|FG002|Dose Level 1|Withdrawal by Subject|0|||
105464034|NCT02002598|363711635|FG003|Dose Level 1|Withdrawal by Subject|0|||
105464035|NCT02002598|363711636|FG004|Dose Level 1|Withdrawal by Subject|0|||
105464036|NCT05632211|363711637|FG000|Overall Study|Withdrawal by Subject|2|||
105464037|NCT05632211|363711638|FG001|Overall Study|Withdrawal by Subject|0|||
105464038|NCT05632211|363711639|FG002|Overall Study|Withdrawal by Subject|2|||
105464039|NCT05632211|363711637|FG000|Overall Study|Other reasons|1|||
105464040|NCT05632211|363711638|FG001|Overall Study|Other reasons|1|||
105464041|NCT05632211|363711639|FG002|Overall Study|Other reasons|1|||
105464042|NCT02628873|363711642|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
105340453|NCT04598451|363248202|FG001|Overall Study|Withdrawal by Subject|7|||
105340454|NCT04598451|363248201|FG000|Overall Study|Lost to Follow-up|2|||
105340455|NCT04598451|363248202|FG001|Overall Study|Lost to Follow-up|0|||
105340456|NCT04598451|363248201|FG000|Overall Study|Physician Decision|4|||
105340457|NCT04598451|363248202|FG001|Overall Study|Physician Decision|1|||
105552100|NCT01490632|364021033|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
105552101|NCT01490632|364021034|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
105552102|NCT01490632|364021035|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105552103|NCT01490632|364021036|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105552104|NCT01490632|364021037|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105552105|NCT01490632|364021038|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105552106|NCT01490632|364021039|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105552107|NCT01490632|364021040|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105552108|NCT01490632|364021041|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105552109|NCT01490632|364021042|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
105552110|NCT01490632|364021023|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
105552111|NCT01490632|364021024|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
105552112|NCT01490632|364021025|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
105552113|NCT01490632|364021026|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
105552114|NCT01490632|364021027|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
105552115|NCT01490632|364021028|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
105552116|NCT01490632|364021029|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
105552117|NCT01490632|364021030|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
105552118|NCT01490632|364021031|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
105552119|NCT01490632|364021032|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
105552120|NCT01490632|364021033|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
105552121|NCT01490632|364021034|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
105552122|NCT01490632|364021035|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
105552123|NCT01490632|364021036|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
105552124|NCT01490632|364021037|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
105552125|NCT01490632|364021038|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
105552126|NCT01490632|364021039|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
105552127|NCT01490632|364021040|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
105552128|NCT01490632|364021041|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
105552129|NCT01490632|364021042|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
105552130|NCT01490632|364021023|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552131|NCT01490632|364021024|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552132|NCT01490632|364021025|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552133|NCT01490632|364021026|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552134|NCT01490632|364021027|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
105340458|NCT04598451|363248201|FG000|Overall Study|Requires Prohibited Medication|1|||
105360881|NCT00873730|363328100|FG001|Overall Study|Adverse Event|2|||
105464043|NCT02628873|363711643|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
105552135|NCT01490632|364021028|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552136|NCT01490632|364021029|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552137|NCT01490632|364021030|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552138|NCT01490632|364021031|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552139|NCT01490632|364021032|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552140|NCT01490632|364021033|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552141|NCT01490632|364021034|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552142|NCT01490632|364021035|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
105464044|NCT02628873|363711642|FG000|Second Test (1 Hour)|Physician Decision|1|||
105464045|NCT02628873|363711643|FG001|Second Test (1 Hour)|Physician Decision|0|||
105464046|NCT00630838|363711644|FG000|Overall Study|Death|0|||
105464047|NCT00630838|363711645|FG001|Overall Study|Death|1|||
105464048|NCT00630838|363711644|FG000|Overall Study|Lost to Follow-up|0|||
105464049|NCT00630838|363711645|FG001|Overall Study|Lost to Follow-up|1|||
105464050|NCT00541658|363711646|FG000|Overall Study|Adverse Event|28|||
105464051|NCT00541658|363711647|FG001|Overall Study|Adverse Event|37|||
105464052|NCT00541658|363711648|FG002|Overall Study|Adverse Event|25|||
105464053|NCT00541658|363711646|FG000|Overall Study|Physician Decision|0|||
105464054|NCT00541658|363711647|FG001|Overall Study|Physician Decision|0|||
105552143|NCT01490632|364021036|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552144|NCT01490632|364021037|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
105552145|NCT01490632|364021038|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
105552146|NCT01490632|364021039|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552147|NCT01490632|364021040|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552148|NCT01490632|364021041|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552149|NCT01490632|364021042|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
105552150|NCT01490632|364021023|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552151|NCT01490632|364021024|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552152|NCT01490632|364021025|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552153|NCT01490632|364021026|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552154|NCT01490632|364021027|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552155|NCT01490632|364021028|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552156|NCT01490632|364021029|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552157|NCT01490632|364021030|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552158|NCT01490632|364021031|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552159|NCT01490632|364021032|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552160|NCT01490632|364021033|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552161|NCT01490632|364021034|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552162|NCT01490632|364021035|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552163|NCT01490632|364021036|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
105552164|NCT01490632|364021037|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552165|NCT01490632|364021038|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552166|NCT01490632|364021039|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552167|NCT01490632|364021040|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552168|NCT01490632|364021041|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552169|NCT01490632|364021042|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
105552170|NCT01490632|364021023|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552171|NCT01490632|364021024|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552172|NCT01490632|364021025|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552173|NCT01490632|364021026|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552174|NCT01490632|364021027|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552175|NCT01490632|364021028|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552176|NCT01490632|364021029|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552177|NCT01490632|364021030|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552178|NCT01490632|364021031|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552179|NCT01490632|364021032|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552180|NCT01490632|364021033|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552181|NCT01490632|364021034|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552182|NCT01490632|364021035|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552183|NCT01490632|364021036|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552184|NCT01490632|364021037|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
105552185|NCT01490632|364021038|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
105552186|NCT01490632|364021039|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105785973|NCT04246593|364870423|FG000|Overall Study|Withdrawal by Subject|14|||
105464055|NCT00541658|363711648|FG002|Overall Study|Physician Decision|4|||
105464056|NCT00541658|363711646|FG000|Overall Study|Lost to Follow-up|3|||
105665707|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
105665708|NCT01952847|364440777|FG000|Overall Study|Ineligible|1|||
105665709|NCT01952847|364440778|FG001|Overall Study|Ineligible|0|||
105665710|NCT01952847|364440779|FG002|Overall Study|Ineligible|0|||
105665711|NCT01952847|364440780|FG003|Overall Study|Ineligible|0|||
105665712|NCT01952847|364440777|FG000|Overall Study|Lack of Insurance Coverage|0|||
105665713|NCT01952847|364440778|FG001|Overall Study|Lack of Insurance Coverage|1|||
105665714|NCT01952847|364440779|FG002|Overall Study|Lack of Insurance Coverage|0|||
105665715|NCT01952847|364440780|FG003|Overall Study|Lack of Insurance Coverage|0|||
105665716|NCT01952847|364440777|FG000|Overall Study|Withdrawal by Subject|1|||
105665717|NCT01952847|364440778|FG001|Overall Study|Withdrawal by Subject|1|||
105665718|NCT01952847|364440779|FG002|Overall Study|Withdrawal by Subject|0|||
105665719|NCT01952847|364440780|FG003|Overall Study|Withdrawal by Subject|1|||
105665720|NCT01661205|364440785|FG000|Overall Study|Physician Decision|2|||
105665721|NCT02803593|364440786|FG000|Overall Study|Lost to Follow-up|17|||
105665722|NCT02803593|364440787|FG001|Overall Study|Lost to Follow-up|35|||
105665723|NCT04245345|364440798|FG000|Overall Study|Death|1|||
105665724|NCT04245345|364440798|FG000|Overall Study|Exited prior to implant|5|||
105665725|NCT04245345|364440798|FG000|Overall Study|Exited prior to 1-month|9|||
105665726|NCT04245345|364440798|FG000|Overall Study|Missed 1-month visit|3|||
105665727|NCT04245345|364440798|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
105665728|NCT04245345|364440798|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
105665729|NCT01667549|364440800|FG000|Overall Study|Withdrawal by Subject|3|||
105665730|NCT01667549|364440801|FG001|Overall Study|Withdrawal by Subject|5|||
105665731|NCT01667549|364440802|FG002|Overall Study|Withdrawal by Subject|7|||
105665732|NCT01667549|364440803|FG003|Overall Study|Withdrawal by Subject|6|||
105665733|NCT01667549|364440804|FG004|Overall Study|Withdrawal by Subject|1|||
105665734|NCT01080300|364440807|FG000|Overall Study|Adverse Event|49|||
105665735|NCT01080300|364440808|FG001|Overall Study|Adverse Event|35|||
105665736|NCT01080300|364440807|FG000|Overall Study|Lack of Efficacy|12|||
105665737|NCT01080300|364440808|FG001|Overall Study|Lack of Efficacy|15|||
105665738|NCT01080300|364440807|FG000|Overall Study|Protocol Violation|7|||
105665739|NCT01080300|364440808|FG001|Overall Study|Protocol Violation|13|||
105665740|NCT01080300|364440807|FG000|Overall Study|Lost to Follow-up|10|||
105665741|NCT01080300|364440808|FG001|Overall Study|Lost to Follow-up|6|||
105665742|NCT01080300|364440807|FG000|Overall Study|Death|0|||
105665743|NCT01080300|364440808|FG001|Overall Study|Death|1|||
105665744|NCT01080300|364440807|FG000|Overall Study|Withdrawal by Subject|12|||
105665745|NCT01080300|364440808|FG001|Overall Study|Withdrawal by Subject|28|||
105665746|NCT01080300|364440807|FG000|Overall Study|Reasons not specified|4|||
105665747|NCT01080300|364440808|FG001|Overall Study|Reasons not specified|6|||
105665748|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
105665749|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
105665750|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
105665751|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
105665752|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
105665753|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
105665754|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
105665755|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
105665756|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
105665757|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
105665758|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
105665759|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
105665760|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
105665761|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
105665762|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
105665763|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
105665764|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
105665765|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
105665766|NCT04210843|364440809|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
105665767|NCT04210843|364440810|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
105665768|NCT04210843|364440809|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
105665769|NCT04210843|364440810|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
105665770|NCT04210843|364440809|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
105665771|NCT04210843|364440810|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
105665772|NCT04210843|364440809|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
105665773|NCT04210843|364440810|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
105464057|NCT00541658|363711647|FG001|Overall Study|Lost to Follow-up|3|||
105665774|NCT04210843|364440809|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
105665775|NCT04210843|364440810|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
105552187|NCT01490632|364021040|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552188|NCT01490632|364021041|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552189|NCT01490632|364021042|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
105552190|NCT01490632|364021023|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552191|NCT01490632|364021024|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552192|NCT01490632|364021025|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552193|NCT01490632|364021026|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552194|NCT01490632|364021027|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552195|NCT01490632|364021028|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552196|NCT01490632|364021029|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552197|NCT01490632|364021030|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552198|NCT01490632|364021031|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552199|NCT01490632|364021032|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552200|NCT01490632|364021033|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552201|NCT01490632|364021034|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552202|NCT01490632|364021035|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
105665776|NCT04210843|364440809|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
105552203|NCT01490632|364021036|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
105552204|NCT01490632|364021037|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
105552205|NCT01490632|364021038|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
105552206|NCT01490632|364021039|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552207|NCT01490632|364021040|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552208|NCT01490632|364021041|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552209|NCT01490632|364021042|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105552210|NCT01490632|364021023|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
105552211|NCT01490632|364021024|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
105552212|NCT01490632|364021025|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
105552213|NCT01490632|364021026|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
105552214|NCT01490632|364021027|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
105552215|NCT01490632|364021028|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
105552216|NCT01490632|364021029|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
105785974|NCT04246593|364870424|FG001|Overall Study|Withdrawal by Subject|13|||
105340459|NCT04598451|363248202|FG001|Overall Study|Requires Prohibited Medication|0|||
105340460|NCT04598451|363248201|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
105340461|NCT04598451|363248202|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
105340462|NCT00843037|363248205|FG000|Overall Study|Lost to Follow-up|1|||
105340463|NCT04594941|363248206|FG000|Overall Study|Other|0|||
105340464|NCT04594941|363248207|FG001|Overall Study|Other|3|||
105340465|NCT04594941|363248208|FG002|Overall Study|Other|1|||
105340466|NCT04594941|363248209|FG003|Overall Study|Other|0|||
105665777|NCT04210843|364440810|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
105665778|NCT04210843|364440809|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
105665779|NCT04210843|364440810|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
105665780|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
105665781|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
105665782|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
105665783|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
105665784|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
105665785|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
105665786|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
105665787|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
105665788|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
105340467|NCT01482065|363248210|FG000|Overall Study|Withdrawal by Subject|0|||
105665789|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
105665790|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
105665791|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
105665792|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
105665793|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
105665794|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
105665795|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
105665796|NCT00150618|364440811|FG000|Overall Study|Adverse Event|2|||
105665797|NCT00150618|364440812|FG001|Overall Study|Adverse Event|2|||
105665798|NCT00150618|364440813|FG002|Overall Study|Adverse Event|6|||
105665799|NCT00150618|364440814|FG003|Overall Study|Adverse Event|9|||
105665800|NCT00150618|364440815|FG004|Overall Study|Adverse Event|5|||
105665801|NCT00150618|364440811|FG000|Overall Study|Withdrawal by Subject|6|||
105665802|NCT00150618|364440812|FG001|Overall Study|Withdrawal by Subject|8|||
105665803|NCT00150618|364440813|FG002|Overall Study|Withdrawal by Subject|8|||
105665804|NCT00150618|364440814|FG003|Overall Study|Withdrawal by Subject|4|||
105340468|NCT01482065|363248211|FG001|Overall Study|Withdrawal by Subject|1|||
105340469|NCT02424630|363248212|FG000|Overall Study|No rotator cuff tear|1|||
105340470|NCT02424630|363248213|FG001|Overall Study|No rotator cuff tear|2|||
105340471|NCT02424630|363248212|FG000|Overall Study|Open procedure|0|||
105340472|NCT02424630|363248213|FG001|Overall Study|Open procedure|1|||
105340473|NCT02031640|363248214|FG000|Screening Period|Adverse Event|1|||
105464058|NCT00541658|363711648|FG002|Overall Study|Lost to Follow-up|6|||
105464059|NCT00541658|363711646|FG000|Overall Study|Protocol Violation|0|||
105464060|NCT00541658|363711647|FG001|Overall Study|Protocol Violation|1|||
105464061|NCT00541658|363711648|FG002|Overall Study|Protocol Violation|1|||
105464062|NCT00541658|363711646|FG000|Overall Study|Withdrawal by Subject|28|||
105665805|NCT00150618|364440815|FG004|Overall Study|Withdrawal by Subject|5|||
105665806|NCT00150618|364440811|FG000|Overall Study|Lost to Follow-up|4|||
105665807|NCT00150618|364440812|FG001|Overall Study|Lost to Follow-up|1|||
105665808|NCT00150618|364440813|FG002|Overall Study|Lost to Follow-up|5|||
105665809|NCT00150618|364440814|FG003|Overall Study|Lost to Follow-up|8|||
105665810|NCT00150618|364440815|FG004|Overall Study|Lost to Follow-up|4|||
105340474|NCT02031640|363248215|FG001|Screening Period|Adverse Event|0|||
105464063|NCT00541658|363711647|FG001|Overall Study|Withdrawal by Subject|32|||
105464064|NCT00541658|363711648|FG002|Overall Study|Withdrawal by Subject|32|||
105552217|NCT01490632|364021030|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
105552218|NCT01490632|364021031|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
105552219|NCT01490632|364021032|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
105552220|NCT01490632|364021033|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
105552221|NCT01490632|364021034|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
105552222|NCT01490632|364021035|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
105552223|NCT01490632|364021036|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
105552224|NCT01490632|364021037|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
105552225|NCT01490632|364021038|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
105552226|NCT01490632|364021039|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
105552227|NCT01490632|364021040|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
105552228|NCT01490632|364021041|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
105552229|NCT01490632|364021042|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
105552230|NCT01490632|364021023|FG000|Part D: Re-Treatment Period|Death|0|||
105552231|NCT01490632|364021024|FG001|Part D: Re-Treatment Period|Death|0|||
105552232|NCT01490632|364021025|FG002|Part D: Re-Treatment Period|Death|0|||
105552233|NCT01490632|364021026|FG003|Part D: Re-Treatment Period|Death|0|||
105552234|NCT01490632|364021027|FG004|Part D: Re-Treatment Period|Death|0|||
105552235|NCT01490632|364021028|FG005|Part D: Re-Treatment Period|Death|0|||
105552236|NCT01490632|364021029|FG006|Part D: Re-Treatment Period|Death|0|||
105552237|NCT01490632|364021030|FG007|Part D: Re-Treatment Period|Death|0|||
105552238|NCT01490632|364021031|FG008|Part D: Re-Treatment Period|Death|0|||
105552239|NCT01490632|364021032|FG009|Part D: Re-Treatment Period|Death|0|||
105552240|NCT01490632|364021033|FG010|Part D: Re-Treatment Period|Death|0|||
105552241|NCT01490632|364021034|FG011|Part D: Re-Treatment Period|Death|0|||
105552242|NCT01490632|364021035|FG012|Part D: Re-Treatment Period|Death|0|||
105552243|NCT01490632|364021036|FG013|Part D: Re-Treatment Period|Death|0|||
105552244|NCT01490632|364021037|FG014|Part D: Re-Treatment Period|Death|0|||
105552245|NCT01490632|364021038|FG015|Part D: Re-Treatment Period|Death|0|||
105552246|NCT01490632|364021039|FG016|Part D: Re-Treatment Period|Death|0|||
105552247|NCT01490632|364021040|FG017|Part D: Re-Treatment Period|Death|0|||
105552248|NCT01490632|364021041|FG018|Part D: Re-Treatment Period|Death|1|||
105552249|NCT01490632|364021042|FG019|Part D: Re-Treatment Period|Death|0|||
105552250|NCT01490632|364021023|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552251|NCT01490632|364021024|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552252|NCT01490632|364021025|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552253|NCT01490632|364021026|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552254|NCT01490632|364021027|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552255|NCT01490632|364021028|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552256|NCT01490632|364021029|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552257|NCT01490632|364021030|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552258|NCT01490632|364021031|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552259|NCT01490632|364021032|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552260|NCT01490632|364021033|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552261|NCT01490632|364021034|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552262|NCT01490632|364021035|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552263|NCT01490632|364021036|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552264|NCT01490632|364021037|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552265|NCT01490632|364021038|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105552266|NCT01490632|364021039|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
105665811|NCT00150618|364440811|FG000|Overall Study|Protocol Violation|1|||
105665812|NCT00150618|364440812|FG001|Overall Study|Protocol Violation|0|||
105665813|NCT00150618|364440813|FG002|Overall Study|Protocol Violation|0|||
105665814|NCT00150618|364440814|FG003|Overall Study|Protocol Violation|0|||
105665815|NCT00150618|364440815|FG004|Overall Study|Protocol Violation|1|||
105665816|NCT00150618|364440811|FG000|Overall Study|Lack of Efficacy|1|||
105665817|NCT00150618|364440812|FG001|Overall Study|Lack of Efficacy|4|||
105665818|NCT00150618|364440813|FG002|Overall Study|Lack of Efficacy|7|||
105665819|NCT00150618|364440814|FG003|Overall Study|Lack of Efficacy|4|||
105665820|NCT00150618|364440815|FG004|Overall Study|Lack of Efficacy|6|||
105665821|NCT00150618|364440811|FG000|Overall Study|No study meds|0|||
105665822|NCT00150618|364440812|FG001|Overall Study|No study meds|0|||
105665823|NCT00150618|364440813|FG002|Overall Study|No study meds|0|||
105665824|NCT00150618|364440814|FG003|Overall Study|No study meds|0|||
105665825|NCT00150618|364440815|FG004|Overall Study|No study meds|2|||
105665826|NCT00150618|364440811|FG000|Overall Study|Physician Decision|0|||
105665827|NCT00150618|364440812|FG001|Overall Study|Physician Decision|2|||
105665828|NCT00150618|364440813|FG002|Overall Study|Physician Decision|0|||
105665829|NCT00150618|364440814|FG003|Overall Study|Physician Decision|0|||
105665830|NCT00150618|364440815|FG004|Overall Study|Physician Decision|1|||
105665831|NCT00150618|364440811|FG000|Overall Study|Lack of compliance|2|||
105665832|NCT00150618|364440812|FG001|Overall Study|Lack of compliance|1|||
105665833|NCT00150618|364440813|FG002|Overall Study|Lack of compliance|1|||
105665834|NCT00150618|364440814|FG003|Overall Study|Lack of compliance|0|||
105665835|NCT00150618|364440815|FG004|Overall Study|Lack of compliance|1|||
105665836|NCT00150618|364440811|FG000|Overall Study|Abnormal ECG|1|||
105665837|NCT00150618|364440812|FG001|Overall Study|Abnormal ECG|0|||
105665838|NCT00150618|364440813|FG002|Overall Study|Abnormal ECG|0|||
105665839|NCT00150618|364440814|FG003|Overall Study|Abnormal ECG|0|||
105665840|NCT00150618|364440815|FG004|Overall Study|Abnormal ECG|0|||
105665841|NCT00150618|364440811|FG000|Overall Study|Sponsor's decision|0|||
105665842|NCT00150618|364440812|FG001|Overall Study|Sponsor's decision|0|||
105665843|NCT00150618|364440813|FG002|Overall Study|Sponsor's decision|0|||
105665844|NCT00150618|364440814|FG003|Overall Study|Sponsor's decision|1|||
105665845|NCT00150618|364440815|FG004|Overall Study|Sponsor's decision|0|||
105665846|NCT01012947|364440816|FG000|Overall Study|Lost to Follow-up|131|||
105665847|NCT01012947|364440817|FG001|Overall Study|Lost to Follow-up|135|||
105665848|NCT01012947|364440818|FG002|Overall Study|Lost to Follow-up|130|||
105665849|NCT01012947|364440819|FG003|Overall Study|Lost to Follow-up|118|||
105665850|NCT01012947|364440820|FG004|Overall Study|Lost to Follow-up|142|||
105665851|NCT01791413|364440821|FG000|Overall Study|Lost to Follow-up|5|||
105665852|NCT01791413|364440822|FG001|Overall Study|Lost to Follow-up|1|||
105665853|NCT02493946|364440823|FG000|DB Period|Withdrawal by Subject|8|||
105665854|NCT02493946|364440824|FG001|DB Period|Withdrawal by Subject|5|||
105665855|NCT02493946|364440825|FG002|DB Period|Withdrawal by Subject|0|||
105665856|NCT02493946|364440823|FG000|Open Label Period|Withdrawal by Subject|0|||
105665857|NCT02493946|364440824|FG001|Open Label Period|Withdrawal by Subject|0|||
105665858|NCT02493946|364440825|FG002|Open Label Period|Withdrawal by Subject|74|||
105665859|NCT02493946|364440823|FG000|Open Label Period|Adverse Event|0|||
105665860|NCT02493946|364440824|FG001|Open Label Period|Adverse Event|0|||
105665861|NCT02493946|364440825|FG002|Open Label Period|Adverse Event|4|||
105665862|NCT02493946|364440823|FG000|Open Label Period|Lost to Follow-up|0|||
105665863|NCT02493946|364440824|FG001|Open Label Period|Lost to Follow-up|0|||
105665864|NCT02493946|364440825|FG002|Open Label Period|Lost to Follow-up|1|||
105665865|NCT02493946|364440823|FG000|Open Label Period|Investigator decision, non-compliance|0|||
105665866|NCT02493946|364440824|FG001|Open Label Period|Investigator decision, non-compliance|0|||
105665867|NCT02493946|364440825|FG002|Open Label Period|Investigator decision, non-compliance|2|||
105665868|NCT02493946|364440823|FG000|Open Label Period|Investigator decision, non-availability|0|||
105665869|NCT02493946|364440824|FG001|Open Label Period|Investigator decision, non-availability|0|||
105665870|NCT02493946|364440825|FG002|Open Label Period|Investigator decision, non-availability|1|||
105665871|NCT02493946|364440823|FG000|Open Label Period|Pregnancy|0|||
105665872|NCT02493946|364440824|FG001|Open Label Period|Pregnancy|0|||
105665873|NCT02493946|364440825|FG002|Open Label Period|Pregnancy|3|||
105665874|NCT02493946|364440823|FG000|Open Label Period|Site error|0|||
105665875|NCT02493946|364440824|FG001|Open Label Period|Site error|0|||
105665876|NCT02493946|364440825|FG002|Open Label Period|Site error|1|||
105665877|NCT01575873|364440826|FG000|Overall Study|Withdrawal by Subject|15|||
105665878|NCT01575873|364440827|FG001|Overall Study|Withdrawal by Subject|20|||
105665879|NCT01575873|364440828|FG002|Overall Study|Withdrawal by Subject|34|||
105665880|NCT01575873|364440829|FG003|Overall Study|Withdrawal by Subject|34|||
105665881|NCT01575873|364440826|FG000|Overall Study|Adverse Event|7|||
105665882|NCT01575873|364440827|FG001|Overall Study|Adverse Event|7|||
105665883|NCT01575873|364440828|FG002|Overall Study|Adverse Event|9|||
105665884|NCT01575873|364440829|FG003|Overall Study|Adverse Event|12|||
105665885|NCT01575873|364440826|FG000|Overall Study|Lost to Follow-up|1|||
105665886|NCT01575873|364440827|FG001|Overall Study|Lost to Follow-up|3|||
105665887|NCT01575873|364440828|FG002|Overall Study|Lost to Follow-up|13|||
105665888|NCT01575873|364440829|FG003|Overall Study|Lost to Follow-up|5|||
105665889|NCT01575873|364440826|FG000|Overall Study|Death|3|||
105665890|NCT01575873|364440827|FG001|Overall Study|Death|2|||
105665891|NCT01575873|364440828|FG002|Overall Study|Death|8|||
105665892|NCT01575873|364440829|FG003|Overall Study|Death|9|||
105665893|NCT01575873|364440826|FG000|Overall Study|Noncompliance|1|||
105665894|NCT01575873|364440827|FG001|Overall Study|Noncompliance|2|||
105665895|NCT01575873|364440828|FG002|Overall Study|Noncompliance|4|||
105665896|NCT01575873|364440829|FG003|Overall Study|Noncompliance|3|||
105665897|NCT01575873|364440826|FG000|Overall Study|Administrative decision|1|||
105665898|NCT01575873|364440827|FG001|Overall Study|Administrative decision|1|||
105665899|NCT01575873|364440828|FG002|Overall Study|Administrative decision|1|||
105665900|NCT01575873|364440829|FG003|Overall Study|Administrative decision|0|||
105665901|NCT01575873|364440826|FG000|Overall Study|Protocol deviation|0|||
105665902|NCT01575873|364440827|FG001|Overall Study|Protocol deviation|1|||
105665903|NCT01575873|364440828|FG002|Overall Study|Protocol deviation|0|||
105665904|NCT01575873|364440829|FG003|Overall Study|Protocol deviation|1|||
105665905|NCT01575873|364440826|FG000|Overall Study|Requirement for Alternative Therapy|0|||
105665906|NCT01575873|364440827|FG001|Overall Study|Requirement for Alternative Therapy|0|||
105665907|NCT01575873|364440828|FG002|Overall Study|Requirement for Alternative Therapy|1|||
105665908|NCT01575873|364440829|FG003|Overall Study|Requirement for Alternative Therapy|1|||
105665909|NCT01575873|364440826|FG000|Overall Study|Other|0|||
105665910|NCT01575873|364440827|FG001|Overall Study|Other|0|||
105665911|NCT01575873|364440828|FG002|Overall Study|Other|4|||
105665912|NCT01575873|364440829|FG003|Overall Study|Other|2|||
105665913|NCT03017742|364440831|FG000|Overall Study|Protocol Violation|36|||
105665914|NCT03017742|364440831|FG000|Overall Study|Withdrawal by Subject|37|||
105665915|NCT01151215|364440832|FG000|Overall Study|Worsening of condition under study|1|||
105665916|NCT01151215|364440833|FG001|Overall Study|Worsening of condition under study|1|||
105665917|NCT01151215|364440834|FG002|Overall Study|Worsening of condition under study|1|||
105665918|NCT01151215|364440832|FG000|Overall Study|Death|16|||
105665919|NCT01151215|364440833|FG001|Overall Study|Death|20|||
105665920|NCT01151215|364440834|FG002|Overall Study|Death|11|||
105665921|NCT01151215|364440832|FG000|Overall Study|Lost to Follow-up|0|||
105665922|NCT01151215|364440833|FG001|Overall Study|Lost to Follow-up|0|||
105665923|NCT01151215|364440834|FG002|Overall Study|Lost to Follow-up|3|||
105665924|NCT01151215|364440832|FG000|Overall Study|Withdrawal by Subject|3|||
105665925|NCT01151215|364440833|FG001|Overall Study|Withdrawal by Subject|1|||
105665926|NCT01151215|364440834|FG002|Overall Study|Withdrawal by Subject|2|||
105665927|NCT01151215|364440832|FG000|Overall Study|Disease progression|0|||
105665928|NCT01151215|364440833|FG001|Overall Study|Disease progression|1|||
105665929|NCT01151215|364440834|FG002|Overall Study|Disease progression|1|||
105665930|NCT01151215|364440832|FG000|Overall Study|Safety as judged by the investigator|0|||
105665931|NCT01151215|364440833|FG001|Overall Study|Safety as judged by the investigator|0|||
105665932|NCT01151215|364440834|FG002|Overall Study|Safety as judged by the investigator|1|||
105665933|NCT02956837|364440838|FG000|Overall Study|Serious Adverse Events|0|||
105665934|NCT02956837|364440839|FG001|Overall Study|Serious Adverse Events|1|||
105665935|NCT02956837|364440840|FG002|Overall Study|Serious Adverse Events|0|||
105665936|NCT02956837|364440841|FG003|Overall Study|Serious Adverse Events|0|||
105665937|NCT02956837|364440838|FG000|Overall Study|Withdrawal by Subject|0|||
105665938|NCT02956837|364440839|FG001|Overall Study|Withdrawal by Subject|1|||
105665939|NCT02956837|364440840|FG002|Overall Study|Withdrawal by Subject|0|||
105665940|NCT02956837|364440841|FG003|Overall Study|Withdrawal by Subject|3|||
105665941|NCT02956837|364440838|FG000|Overall Study|Lost to Follow-up|0|||
105665942|NCT02956837|364440839|FG001|Overall Study|Lost to Follow-up|1|||
105665943|NCT02956837|364440840|FG002|Overall Study|Lost to Follow-up|2|||
105665944|NCT02956837|364440841|FG003|Overall Study|Lost to Follow-up|0|||
105665945|NCT01727505|364440842|FG000|First 24 Hours|Adverse Event|0|||
105665946|NCT01727505|364440843|FG001|First 24 Hours|Adverse Event|1|||
105665947|NCT01727505|364440842|FG000|Second 24 Hours|Missing data|0|||
105665948|NCT01727505|364440843|FG001|Second 24 Hours|Missing data|1|||
105665949|NCT01441635|364440844|FG000|Overall Study|Adverse Event|4|||
105665950|NCT01441635|364440845|FG001|Overall Study|Adverse Event|3|||
105665951|NCT01441635|364440846|FG002|Overall Study|Adverse Event|1|||
105665952|NCT01441635|364440847|FG003|Overall Study|Adverse Event|5|||
105665953|NCT01441635|364440848|FG004|Overall Study|Adverse Event|1|||
105552267|NCT01490632|364021040|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
105552268|NCT01490632|364021041|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
105552269|NCT01490632|364021042|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
105552270|NCT01490632|364021023|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552271|NCT01490632|364021024|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552272|NCT01490632|364021025|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552273|NCT01490632|364021026|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552274|NCT01490632|364021027|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552275|NCT01490632|364021028|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552276|NCT01490632|364021029|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552277|NCT01490632|364021030|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552278|NCT01490632|364021031|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552279|NCT01490632|364021032|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552280|NCT01490632|364021033|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552281|NCT01490632|364021034|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552282|NCT01490632|364021035|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552283|NCT01490632|364021036|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552284|NCT01490632|364021037|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552285|NCT01490632|364021038|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552286|NCT01490632|364021039|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552287|NCT01490632|364021040|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552288|NCT01490632|364021041|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
105552289|NCT01490632|364021042|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105552290|NCT01490632|364021023|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
105552291|NCT01490632|364021024|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
105552292|NCT01490632|364021025|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
105552293|NCT01490632|364021026|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
105552294|NCT01490632|364021027|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
105552295|NCT01490632|364021028|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
105552296|NCT01490632|364021029|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
105552297|NCT01490632|364021030|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
105552298|NCT01490632|364021031|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
105552299|NCT01490632|364021032|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
105552300|NCT01490632|364021033|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
105552301|NCT01490632|364021034|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
105552302|NCT01490632|364021035|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
105552303|NCT01490632|364021036|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
105552304|NCT01490632|364021037|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
105552305|NCT01490632|364021038|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
105552306|NCT01490632|364021039|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
105552307|NCT01490632|364021040|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
105552308|NCT01490632|364021041|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
105552309|NCT01490632|364021042|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
105552310|NCT01490632|364021023|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
105552311|NCT01490632|364021024|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
105552312|NCT01490632|364021025|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
105552313|NCT01490632|364021026|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
105552314|NCT01490632|364021027|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
105552315|NCT01490632|364021028|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
105552316|NCT01490632|364021029|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
105552317|NCT01490632|364021030|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
105552318|NCT01490632|364021031|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
105552319|NCT01490632|364021032|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
105552320|NCT01490632|364021033|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
105552321|NCT01490632|364021034|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
105552322|NCT01490632|364021035|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
105552323|NCT01490632|364021036|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
105552324|NCT01490632|364021037|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
105552325|NCT01490632|364021038|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
105552326|NCT01490632|364021039|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
105552327|NCT01490632|364021040|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
105665954|NCT01441635|364440849|FG005|Overall Study|Adverse Event|2|||
105665955|NCT01441635|364440850|FG006|Overall Study|Adverse Event|2|||
105665956|NCT01441635|364440851|FG007|Overall Study|Adverse Event|2|||
105665957|NCT01441635|364440852|FG008|Overall Study|Adverse Event|1|||
105665958|NCT01441635|364440853|FG009|Overall Study|Adverse Event|0|||
105665959|NCT01441635|364440844|FG000|Overall Study|Withdrawal by Subject|1|||
105665960|NCT01441635|364440845|FG001|Overall Study|Withdrawal by Subject|1|||
105665961|NCT01441635|364440846|FG002|Overall Study|Withdrawal by Subject|0|||
105665962|NCT01441635|364440847|FG003|Overall Study|Withdrawal by Subject|1|||
105665963|NCT01441635|364440848|FG004|Overall Study|Withdrawal by Subject|0|||
105665964|NCT01441635|364440849|FG005|Overall Study|Withdrawal by Subject|0|||
105665965|NCT01441635|364440850|FG006|Overall Study|Withdrawal by Subject|2|||
105665966|NCT01441635|364440851|FG007|Overall Study|Withdrawal by Subject|0|||
105665967|NCT01441635|364440852|FG008|Overall Study|Withdrawal by Subject|1|||
105665968|NCT01441635|364440853|FG009|Overall Study|Withdrawal by Subject|1|||
105665969|NCT01441635|364440844|FG000|Overall Study|Lost to Follow-up|0|||
105665970|NCT01441635|364440845|FG001|Overall Study|Lost to Follow-up|1|||
105665971|NCT01441635|364440846|FG002|Overall Study|Lost to Follow-up|1|||
105665972|NCT01441635|364440847|FG003|Overall Study|Lost to Follow-up|1|||
105665973|NCT01441635|364440848|FG004|Overall Study|Lost to Follow-up|1|||
105665974|NCT01441635|364440849|FG005|Overall Study|Lost to Follow-up|3|||
105665975|NCT01441635|364440850|FG006|Overall Study|Lost to Follow-up|1|||
105665976|NCT01441635|364440851|FG007|Overall Study|Lost to Follow-up|1|||
105665977|NCT01441635|364440852|FG008|Overall Study|Lost to Follow-up|0|||
105665978|NCT01441635|364440853|FG009|Overall Study|Lost to Follow-up|1|||
105665979|NCT01441635|364440844|FG000|Overall Study|Noncompliance|0|||
105665980|NCT01441635|364440845|FG001|Overall Study|Noncompliance|1|||
105665981|NCT01441635|364440846|FG002|Overall Study|Noncompliance|0|||
105665982|NCT01441635|364440847|FG003|Overall Study|Noncompliance|0|||
105665983|NCT01441635|364440848|FG004|Overall Study|Noncompliance|0|||
105665984|NCT01441635|364440849|FG005|Overall Study|Noncompliance|0|||
105665985|NCT01441635|364440850|FG006|Overall Study|Noncompliance|1|||
105665986|NCT01441635|364440851|FG007|Overall Study|Noncompliance|0|||
105665987|NCT01441635|364440852|FG008|Overall Study|Noncompliance|0|||
105665988|NCT01441635|364440853|FG009|Overall Study|Noncompliance|0|||
105665989|NCT01441635|364440844|FG000|Overall Study|Surgery or Invasive Intervention|0|||
105665990|NCT01441635|364440845|FG001|Overall Study|Surgery or Invasive Intervention|0|||
105665991|NCT01441635|364440846|FG002|Overall Study|Surgery or Invasive Intervention|1|||
105665992|NCT01441635|364440847|FG003|Overall Study|Surgery or Invasive Intervention|0|||
105665993|NCT01441635|364440848|FG004|Overall Study|Surgery or Invasive Intervention|0|||
105665994|NCT01441635|364440849|FG005|Overall Study|Surgery or Invasive Intervention|0|||
105665995|NCT01441635|364440850|FG006|Overall Study|Surgery or Invasive Intervention|0|||
105665996|NCT01441635|364440851|FG007|Overall Study|Surgery or Invasive Intervention|0|||
105665997|NCT01441635|364440852|FG008|Overall Study|Surgery or Invasive Intervention|0|||
105665998|NCT01441635|364440853|FG009|Overall Study|Surgery or Invasive Intervention|0|||
105665999|NCT01441635|364440844|FG000|Overall Study|Received Exclusionary Medication|1|||
105666000|NCT01441635|364440845|FG001|Overall Study|Received Exclusionary Medication|0|||
105666001|NCT01441635|364440846|FG002|Overall Study|Received Exclusionary Medication|0|||
105666002|NCT01441635|364440847|FG003|Overall Study|Received Exclusionary Medication|0|||
105666003|NCT01441635|364440848|FG004|Overall Study|Received Exclusionary Medication|0|||
105666004|NCT01441635|364440849|FG005|Overall Study|Received Exclusionary Medication|0|||
105666005|NCT01441635|364440850|FG006|Overall Study|Received Exclusionary Medication|0|||
105666006|NCT01441635|364440851|FG007|Overall Study|Received Exclusionary Medication|0|||
105666007|NCT01441635|364440852|FG008|Overall Study|Received Exclusionary Medication|0|||
105666008|NCT01441635|364440853|FG009|Overall Study|Received Exclusionary Medication|0|||
105666009|NCT01441635|364440844|FG000|Overall Study|Other|0|||
105666010|NCT01441635|364440845|FG001|Overall Study|Other|0|||
105666011|NCT01441635|364440846|FG002|Overall Study|Other|0|||
105666012|NCT01441635|364440847|FG003|Overall Study|Other|0|||
105666013|NCT01441635|364440848|FG004|Overall Study|Other|0|||
105666014|NCT01441635|364440849|FG005|Overall Study|Other|0|||
105666015|NCT01441635|364440850|FG006|Overall Study|Other|0|||
105666016|NCT01441635|364440851|FG007|Overall Study|Other|1|||
105666017|NCT01441635|364440852|FG008|Overall Study|Other|0|||
105666018|NCT01441635|364440853|FG009|Overall Study|Other|0|||
105666019|NCT02878603|364440854|FG000|Overall Study|Lost to Follow-up|4|||
105666020|NCT02878603|364440855|FG001|Overall Study|Lost to Follow-up|1|||
105666021|NCT02878603|364440854|FG000|Overall Study|Withdrawal by Subject|1|||
105666022|NCT02878603|364440855|FG001|Overall Study|Withdrawal by Subject|1|||
105666023|NCT02878603|364440854|FG000|Overall Study|Death|1|||
105666024|NCT02878603|364440855|FG001|Overall Study|Death|0|||
105666025|NCT02878603|364440854|FG000|Overall Study|Physician Decision|0|||
105666026|NCT02878603|364440855|FG001|Overall Study|Physician Decision|3|||
105666027|NCT02637323|364440856|FG000|Overall Study|Lost to Follow-up|2|||
105666028|NCT02637323|364440857|FG001|Overall Study|Lost to Follow-up|0|||
105666029|NCT02637323|364440856|FG000|Overall Study|Protocol Violation|0|||
105552328|NCT01490632|364021041|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
105552329|NCT01490632|364021042|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
105552330|NCT01490632|364021023|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552331|NCT01490632|364021024|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552332|NCT01490632|364021025|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552333|NCT01490632|364021026|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552334|NCT01490632|364021027|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552335|NCT01490632|364021028|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552336|NCT01490632|364021029|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552337|NCT01490632|364021030|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552338|NCT01490632|364021031|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552339|NCT01490632|364021032|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552340|NCT01490632|364021033|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552341|NCT01490632|364021034|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552342|NCT01490632|364021035|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552343|NCT01490632|364021036|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552344|NCT01490632|364021037|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552345|NCT01490632|364021038|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552346|NCT01490632|364021039|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
105552347|NCT01490632|364021040|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
105552348|NCT01490632|364021041|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
105464065|NCT00541658|363711646|FG000|Overall Study|Took No Study Drug|1|||
105464066|NCT00541658|363711647|FG001|Overall Study|Took No Study Drug|0|||
105464067|NCT00541658|363711648|FG002|Overall Study|Took No Study Drug|0|||
105464068|NCT04986904|363711649|FG000|Overall Study|Lost to Follow-up|11|||
105464069|NCT04986904|363711649|FG000|Overall Study|Withdrawal by Subject|1|||
105464070|NCT04123470|363711650|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
105464071|NCT04123470|363711651|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
105464072|NCT04123470|363711650|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
105464073|NCT04123470|363711651|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
105464074|NCT04123470|363711650|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
105464075|NCT04123470|363711651|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
105464076|NCT04123470|363711650|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
105464077|NCT04123470|363711651|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
105464078|NCT00759941|363711652|FG000|Overall Study|Use of medication|1|||
105464079|NCT00759941|363711653|FG001|Overall Study|Use of medication|0|||
105464080|NCT00759941|363711652|FG000|Overall Study|Adverse Event|1|||
105464081|NCT00759941|363711653|FG001|Overall Study|Adverse Event|0|||
105464082|NCT00759941|363711652|FG000|Overall Study|Exited in error by site|1|||
105464083|NCT00759941|363711653|FG001|Overall Study|Exited in error by site|1|||
105464084|NCT03467750|363711665|FG000|Overall Study|Surgery canceled|1|||
105464085|NCT03467750|363711666|FG001|Overall Study|Surgery canceled|0|||
105464086|NCT03467750|363711665|FG000|Overall Study|Protocol Violation|1|||
105464087|NCT03467750|363711666|FG001|Overall Study|Protocol Violation|1|||
105464088|NCT03467750|363711665|FG000|Overall Study|Withdrawal by Subject|0|||
105464089|NCT03467750|363711666|FG001|Overall Study|Withdrawal by Subject|1|||
105464090|NCT05673876|363711667|FG000|Overall Study|Death|3|||
105464091|NCT05673876|363711668|FG001|Overall Study|Death|1|||
105464092|NCT05673876|363711667|FG000|Overall Study|Study Terminated by Sponsor|0|||
105464093|NCT05673876|363711668|FG001|Overall Study|Study Terminated by Sponsor|1|||
105464094|NCT05673876|363711667|FG000|Overall Study|Physician Decision|0|||
105464095|NCT05673876|363711668|FG001|Overall Study|Physician Decision|1|||
105464096|NCT04500158|363711674|FG000|Overall Study|Physician Decision|17|||
105464097|NCT04500158|363711675|FG001|Overall Study|Physician Decision|11|||
105464098|NCT03205423|363711676|FG000|Overall Study|Personal|1|||
105464099|NCT03205423|363711677|FG001|Overall Study|Personal|1|||
105464100|NCT03205423|363711676|FG000|Overall Study|Physician Decision|0|||
105464101|NCT03205423|363711677|FG001|Overall Study|Physician Decision|2|||
105464102|NCT05786651|363711682|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
105464103|NCT04390763|363711683|FG000|Safety run-in Part|Adverse Event|4|||
105464104|NCT04390763|363711684|FG001|Safety run-in Part|Adverse Event|0|||
105464105|NCT04390763|363711685|FG002|Safety run-in Part|Adverse Event|0|||
105464106|NCT04390763|363711686|FG003|Safety run-in Part|Adverse Event|0|||
105464107|NCT04390763|363711683|FG000|Safety run-in Part|Physician Decision|1|||
105464108|NCT04390763|363711684|FG001|Safety run-in Part|Physician Decision|0|||
105464109|NCT04390763|363711685|FG002|Safety run-in Part|Physician Decision|0|||
105464110|NCT04390763|363711686|FG003|Safety run-in Part|Physician Decision|0|||
105464111|NCT04390763|363711683|FG000|Safety run-in Part|Progressive Disease|6|||
105464112|NCT04390763|363711684|FG001|Safety run-in Part|Progressive Disease|0|||
105464113|NCT04390763|363711685|FG002|Safety run-in Part|Progressive Disease|0|||
105464114|NCT04390763|363711686|FG003|Safety run-in Part|Progressive Disease|0|||
105552349|NCT01490632|364021042|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
105552350|NCT05706506|364021047|FG000|Overall Study|Adverse Event|1|||
105552351|NCT05706506|364021047|FG000|Overall Study|Withdrawal by Subject|4|||
105552352|NCT05706506|364021047|FG000|Overall Study|Lost to Follow-up|2|||
105552353|NCT05706506|364021047|FG000|Overall Study|Inadvertent Enrolment|12|||
105552354|NCT05706506|364021047|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
105552355|NCT05706506|364021047|FG000|Overall Study|Participant Moved Out of State|1|||
105552356|NCT05732454|364021048|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
105552357|NCT05732454|364021049|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
105552358|NCT05732454|364021048|FG000|Part 1: DB Period|Adverse Event|1|||
105552359|NCT05732454|364021049|FG001|Part 1: DB Period|Adverse Event|0|||
105552360|NCT05732454|364021048|FG000|Part 1: DB Period|Lost to Follow-up|1|||
105552361|NCT05732454|364021049|FG001|Part 1: DB Period|Lost to Follow-up|0|||
105552362|NCT05732454|364021048|FG000|Part 1: DB Period|Protocol Violation|0|||
105552363|NCT05732454|364021049|FG001|Part 1: DB Period|Protocol Violation|1|||
105552364|NCT05732454|364021048|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
105552365|NCT05732454|364021049|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
105552366|NCT05732454|364021048|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
105552367|NCT05732454|364021049|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
105464115|NCT04390763|363711683|FG000|Randomized Part|Adverse Event|0|||
105464116|NCT04390763|363711684|FG001|Randomized Part|Adverse Event|11|||
105464117|NCT04390763|363711685|FG002|Randomized Part|Adverse Event|5|||
105464118|NCT04390763|363711686|FG003|Randomized Part|Adverse Event|5|||
105464119|NCT04390763|363711683|FG000|Randomized Part|Death|0|||
105464120|NCT04390763|363711684|FG001|Randomized Part|Death|3|||
105464121|NCT04390763|363711685|FG002|Randomized Part|Death|4|||
105552368|NCT05732454|364021048|FG000|Part 1: OLE Period|Adverse Event|0|||
105464122|NCT04390763|363711686|FG003|Randomized Part|Death|2|||
105464123|NCT04390763|363711683|FG000|Randomized Part|Physician Decision|0|||
105464124|NCT04390763|363711684|FG001|Randomized Part|Physician Decision|2|||
105464125|NCT04390763|363711685|FG002|Randomized Part|Physician Decision|2|||
105464126|NCT04390763|363711686|FG003|Randomized Part|Physician Decision|9|||
105464127|NCT04390763|363711683|FG000|Randomized Part|Progressive Disease|0|||
105464128|NCT04390763|363711684|FG001|Randomized Part|Progressive Disease|24|||
105464129|NCT04390763|363711685|FG002|Randomized Part|Progressive Disease|31|||
105464130|NCT04390763|363711686|FG003|Randomized Part|Progressive Disease|23|||
105464131|NCT04390763|363711683|FG000|Randomized Part|Study terminated by sponsor|0|||
105464132|NCT04390763|363711684|FG001|Randomized Part|Study terminated by sponsor|1|||
105464133|NCT04390763|363711685|FG002|Randomized Part|Study terminated by sponsor|0|||
105464134|NCT04390763|363711686|FG003|Randomized Part|Study terminated by sponsor|0|||
105464135|NCT04390763|363711683|FG000|Randomized Part|Participant Decision|0|||
105464136|NCT04390763|363711684|FG001|Randomized Part|Participant Decision|5|||
105464137|NCT04390763|363711685|FG002|Randomized Part|Participant Decision|7|||
105464138|NCT04390763|363711686|FG003|Randomized Part|Participant Decision|6|||
105464139|NCT04390763|363711683|FG000|Randomized Part|Not treated|0|||
105464140|NCT04390763|363711684|FG001|Randomized Part|Not treated|4|||
105464141|NCT04390763|363711685|FG002|Randomized Part|Not treated|2|||
105464142|NCT04390763|363711686|FG003|Randomized Part|Not treated|7|||
105464143|NCT00911170|363711687|FG000|Treatment Period|Randomized in error|1|||
105464144|NCT00911170|363711688|FG001|Treatment Period|Randomized in error|1|||
105464145|NCT00911170|363711687|FG000|Treatment Period|Ineligibility determined|1|||
105464146|NCT00911170|363711688|FG001|Treatment Period|Ineligibility determined|3|||
105464147|NCT00911170|363711687|FG000|Treatment Period|Protocol deviation|1|||
105464148|NCT00911170|363711688|FG001|Treatment Period|Protocol deviation|2|||
105464149|NCT00911170|363711687|FG000|Treatment Period|Adverse Event|9|||
105464150|NCT00911170|363711688|FG001|Treatment Period|Adverse Event|10|||
105464151|NCT00911170|363711687|FG000|Treatment Period|Withdrawal by Subject|4|||
105464152|NCT00911170|363711688|FG001|Treatment Period|Withdrawal by Subject|4|||
105464153|NCT00911170|363711687|FG000|Treatment Period|Disease progression|0|||
105464154|NCT00911170|363711688|FG001|Treatment Period|Disease progression|2|||
105464155|NCT00911170|363711687|FG000|Treatment Period|Physician Decision|5|||
105464156|NCT00911170|363711688|FG001|Treatment Period|Physician Decision|5|||
105464157|NCT00911170|363711687|FG000|Treatment Period|Lost to Follow-up|0|||
105464158|NCT00911170|363711688|FG001|Treatment Period|Lost to Follow-up|1|||
105464159|NCT00911170|363711687|FG000|Treatment Period|Death|6|||
105464160|NCT00911170|363711688|FG001|Treatment Period|Death|9|||
105464161|NCT00911170|363711687|FG000|Long Term Follow-Up|Continuing in study|274|||
105464162|NCT00911170|363711688|FG001|Long Term Follow-Up|Continuing in study|269|||
105464163|NCT00911170|363711687|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
105464164|NCT00911170|363711688|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
105464165|NCT00911170|363711687|FG000|Long Term Follow-Up|Physician Decision|5|||
105464166|NCT00911170|363711688|FG001|Long Term Follow-Up|Physician Decision|4|||
105464167|NCT00911170|363711687|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
105464168|NCT00911170|363711688|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
105464169|NCT00911170|363711687|FG000|Long Term Follow-Up|Death|116|||
105464170|NCT00911170|363711688|FG001|Long Term Follow-Up|Death|121|||
105464171|NCT00335777|363713984|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
105464172|NCT00335777|363713984|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
105464173|NCT00335777|363713984|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
105464174|NCT00335777|363713984|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
105464175|NCT00335777|363713984|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
105464176|NCT02079246|363713985|FG000|OLEX|Withdrawal before treatment|1|||
105464177|NCT02079246|363713986|FG001|OLEX|Withdrawal before treatment|0|||
105464178|NCT02079246|363713985|FG000|OLEX|Death|11|||
105464179|NCT02079246|363713986|FG001|OLEX|Death|0|||
105464180|NCT02079246|363713985|FG000|OLEX|Adverse Event|66|||
105464181|NCT02079246|363713986|FG001|OLEX|Adverse Event|0|||
105464182|NCT02079246|363713985|FG000|OLEX|Withdrawal by Subject|60|||
105464183|NCT02079246|363713986|FG001|OLEX|Withdrawal by Subject|0|||
105464184|NCT02079246|363713985|FG000|OLEX|Lost to Follow-up|6|||
105464185|NCT02079246|363713986|FG001|OLEX|Lost to Follow-up|0|||
105464186|NCT02079246|363713985|FG000|OLEX|Protocol Violation|6|||
105464187|NCT02079246|363713986|FG001|OLEX|Protocol Violation|0|||
105464188|NCT02079246|363713985|FG000|OLEX|Lack of Efficacy|3|||
105464189|NCT02079246|363713986|FG001|OLEX|Lack of Efficacy|0|||
105464190|NCT02079246|363713985|FG000|OLEX|Results of the lead-in studies|58|||
105464191|NCT02079246|363713986|FG001|OLEX|Results of the lead-in studies|0|||
105464192|NCT02079246|363713985|FG000|OLEX|Other: Disallowed medication|8|||
105464193|NCT02079246|363713986|FG001|OLEX|Other: Disallowed medication|0|||
105464194|NCT02079246|363713985|FG000|OLEX|Other: Insufficient compliance|2|||
105464195|NCT02079246|363713986|FG001|OLEX|Other: Insufficient compliance|0|||
105464196|NCT02079246|363713985|FG000|OLEX|Other: Caregiver unavailable|3|||
105464197|NCT02079246|363713986|FG001|OLEX|Other: Caregiver unavailable|0|||
105464198|NCT02079246|363713985|FG000|OLEX|Other: Coordinator decision|1|||
105464199|NCT02079246|363713986|FG001|OLEX|Other: Coordinator decision|0|||
105464200|NCT02079246|363713985|FG000|OLEX|Other: Worsening of condition|1|||
105464201|NCT02079246|363713986|FG001|OLEX|Other: Worsening of condition|0|||
105464202|NCT02079246|363713985|FG000|OLEX|Other: Moved to nursing home|1|||
105464203|NCT02079246|363713986|FG001|OLEX|Other: Moved to nursing home|0|||
105464204|NCT02079246|363713985|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
105464205|NCT02079246|363713986|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
105464206|NCT02079246|363713985|FG000|OLEX-MEM|Adverse Event|0|||
105464207|NCT02079246|363713986|FG001|OLEX-MEM|Adverse Event|6|||
105464208|NCT02079246|363713985|FG000|OLEX-MEM|Withdrawal by Subject|0|||
105464209|NCT02079246|363713986|FG001|OLEX-MEM|Withdrawal by Subject|7|||
105464210|NCT02079246|363713985|FG000|OLEX-MEM|Protocol Violation|0|||
105464211|NCT02079246|363713986|FG001|OLEX-MEM|Protocol Violation|2|||
105464212|NCT02079246|363713985|FG000|OLEX-MEM|Lost to Follow-up|0|||
105464213|NCT02079246|363713986|FG001|OLEX-MEM|Lost to Follow-up|1|||
105464214|NCT02079246|363713985|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
105464215|NCT02079246|363713986|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
105464216|NCT03714672|363713991|FG000|Overall Study|Adverse Event|0|||
105464217|NCT03714672|363713992|FG001|Overall Study|Adverse Event|0|||
105464218|NCT03714672|363713993|FG002|Overall Study|Adverse Event|3|||
105464219|NCT03714672|363713994|FG003|Overall Study|Adverse Event|0|||
105464220|NCT03714672|363713991|FG000|Overall Study|Physician Decision|0|||
105464221|NCT03714672|363713992|FG001|Overall Study|Physician Decision|1|||
105464222|NCT03714672|363713993|FG002|Overall Study|Physician Decision|0|||
105464223|NCT03714672|363713994|FG003|Overall Study|Physician Decision|0|||
105464224|NCT03714672|363713991|FG000|Overall Study|Other Reason|1|||
105464225|NCT03714672|363713992|FG001|Overall Study|Other Reason|2|||
105464226|NCT03714672|363713993|FG002|Overall Study|Other Reason|1|||
105464227|NCT03714672|363713994|FG003|Overall Study|Other Reason|1|||
105464228|NCT03714672|363713991|FG000|Overall Study|Lost to Follow-up|1|||
105464229|NCT03714672|363713992|FG001|Overall Study|Lost to Follow-up|1|||
105464230|NCT03714672|363713993|FG002|Overall Study|Lost to Follow-up|0|||
105464231|NCT03714672|363713994|FG003|Overall Study|Lost to Follow-up|0|||
105464232|NCT01671319|363713995|FG000|Overall Study|Withdrawal by Subject|1|||
105464233|NCT01432730|363714000|FG000|Period 1|Adverse Event|2|||
105464234|NCT01432730|363714001|FG001|Period 1|Adverse Event|0|||
105464235|NCT01432730|363714000|FG000|Period 2|Adverse Event|0|||
105464236|NCT01432730|363714001|FG001|Period 2|Adverse Event|4|||
105464237|NCT01298648|363714004|FG000|Overall Study|Withdrawal by Subject|2|||
105464238|NCT01298648|363714004|FG000|Overall Study|Lost to Follow-up|21|||
105464239|NCT03077412|363714005|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
105464240|NCT03077412|363714006|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
105464241|NCT03077412|363714007|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
105464242|NCT03077412|363714005|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
105464243|NCT03077412|363714006|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
105464244|NCT03077412|363714007|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
105464245|NCT03077412|363714005|FG000|Overall Study|Adverse Event|1|||
105464246|NCT03077412|363714006|FG001|Overall Study|Adverse Event|2|||
105464247|NCT03077412|363714007|FG002|Overall Study|Adverse Event|2|||
105464248|NCT03077412|363714005|FG000|Overall Study|Investigator's Discretion|0|||
105666030|NCT02637323|364440857|FG001|Overall Study|Protocol Violation|1|||
105666031|NCT00246090|364440858|FG000|Overall Study|Adverse Event|25|||
105666032|NCT00246090|364440858|FG000|Overall Study|Withdrawal by Subject|7|||
105666033|NCT00246090|364440858|FG000|Overall Study|Progressive Disease|212|||
105666034|NCT00246090|364440858|FG000|Overall Study|Clinical Progression|30|||
105666035|NCT00246090|364440858|FG000|Overall Study|Physician Decision|11|||
105666036|NCT00246090|364440858|FG000|Overall Study|Not Otherwise Specified|10|||
105666037|NCT01162486|364440860|FG000|Overall Study|low ANC|1|||
105666038|NCT01162486|364440861|FG001|Overall Study|low ANC|0|||
105666039|NCT01162486|364440862|FG002|Overall Study|low ANC|0|||
105666040|NCT01162486|364440863|FG003|Overall Study|low ANC|0|||
105666041|NCT01162486|364440864|FG004|Overall Study|low ANC|0|||
105666042|NCT01162486|364440860|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
105666043|NCT01162486|364440861|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
105666044|NCT01162486|364440862|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
105666045|NCT01162486|364440863|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
105666046|NCT01162486|364440864|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
105666047|NCT01162486|364440860|FG000|Overall Study|elevated LFTs|0|||
105666048|NCT01162486|364440861|FG001|Overall Study|elevated LFTs|0|||
105666049|NCT01162486|364440862|FG002|Overall Study|elevated LFTs|1|||
105666050|NCT01162486|364440863|FG003|Overall Study|elevated LFTs|0|||
105666051|NCT01162486|364440864|FG004|Overall Study|elevated LFTs|0|||
105666052|NCT01162486|364440860|FG000|Overall Study|Pregnancy|0|||
105666053|NCT01162486|364440861|FG001|Overall Study|Pregnancy|0|||
105666054|NCT01162486|364440862|FG002|Overall Study|Pregnancy|0|||
105666055|NCT01162486|364440863|FG003|Overall Study|Pregnancy|1|||
105666056|NCT01162486|364440864|FG004|Overall Study|Pregnancy|0|||
105666057|NCT00953615|364440870|FG000|Overall Study|Adverse Event|1|||
105666058|NCT01461005|364440874|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
105666059|NCT01814072|364440879|FG000|Overall Study|Lost to Follow-up|2|||
105666060|NCT01814072|364440880|FG001|Overall Study|Lost to Follow-up|2|||
105666061|NCT01814072|364440881|FG002|Overall Study|Lost to Follow-up|2|||
105666062|NCT01814072|364440882|FG003|Overall Study|Lost to Follow-up|0|||
105666063|NCT01814072|364440883|FG004|Overall Study|Lost to Follow-up|2|||
105464249|NCT03077412|363714006|FG001|Overall Study|Investigator's Discretion|1|||
105785975|NCT04246593|364870423|FG000|Overall Study|Lost to Follow-up|124|||
105464250|NCT03077412|363714007|FG002|Overall Study|Investigator's Discretion|1|||
105666064|NCT01814072|364440884|FG005|Overall Study|Lost to Follow-up|3|||
105464251|NCT03077412|363714005|FG000|Overall Study|Withdrew Consent|0|||
105666065|NCT01814072|364440885|FG006|Overall Study|Lost to Follow-up|3|||
105666066|NCT01814072|364440886|FG007|Overall Study|Lost to Follow-up|1|||
105666067|NCT01814072|364440887|FG008|Overall Study|Lost to Follow-up|2|||
105666068|NCT01814072|364440888|FG009|Overall Study|Lost to Follow-up|3|||
105666069|NCT01814072|364440889|FG010|Overall Study|Lost to Follow-up|1|||
105666070|NCT01814072|364440890|FG011|Overall Study|Lost to Follow-up|2|||
105552369|NCT05732454|364021049|FG001|Part 1: OLE Period|Adverse Event|1|||
105552370|NCT05732454|364021048|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
105552371|NCT05732454|364021049|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
105552372|NCT02091726|364021052|FG000|Overall Study|Lost to Follow-up|6|||
105552373|NCT06111742|364021061|FG000|Overall Study|Did not receive intervention|1|||
105552374|NCT06111742|364021062|FG001|Overall Study|Did not receive intervention|0|||
105552375|NCT06111742|364021063|FG002|Overall Study|Did not receive intervention|0|||
105552376|NCT06111742|364021061|FG000|Overall Study|Withdrawal by Subject|2|||
105552377|NCT06111742|364021062|FG001|Overall Study|Withdrawal by Subject|0|||
105552378|NCT06111742|364021063|FG002|Overall Study|Withdrawal by Subject|0|||
105552379|NCT01914926|364021064|FG000|Overall Study|Adverse Event|1|||
105552380|NCT01914926|364021065|FG001|Overall Study|Adverse Event|0|||
105552381|NCT01914926|364021064|FG000|Overall Study|uncooperative, agitated and removed|0|||
105552382|NCT01914926|364021065|FG001|Overall Study|uncooperative, agitated and removed|1|||
105552383|NCT02605954|364021066|FG000|Overall Study|Adverse Event|5|||
105552384|NCT02605954|364021067|FG001|Overall Study|Adverse Event|1|||
105552385|NCT02605954|364021066|FG000|Overall Study|Investigator's Discretion|1|||
105552386|NCT02605954|364021067|FG001|Overall Study|Investigator's Discretion|0|||
105552387|NCT02605954|364021066|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105552388|NCT02605954|364021067|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105552389|NCT02605954|364021066|FG000|Overall Study|Withdrew Consent|2|||
105552390|NCT02605954|364021067|FG001|Overall Study|Withdrew Consent|2|||
105552391|NCT02605954|364021066|FG000|Overall Study|Lost to Follow-up|3|||
105552392|NCT02605954|364021067|FG001|Overall Study|Lost to Follow-up|0|||
105552393|NCT02605954|364021066|FG000|Overall Study|Randomized but not treated|0|||
105552394|NCT02605954|364021067|FG001|Overall Study|Randomized but not treated|1|||
105552395|NCT04717596|364021068|FG000|Overall Study|Withdrawal by Subject|4|||
105552396|NCT03555396|364021069|FG000|Overall Study|Death|3|||
105552397|NCT03555396|364021070|FG001|Overall Study|Death|1|||
105552398|NCT03555396|364021069|FG000|Overall Study|Lost to Follow-up|0|||
105552399|NCT03555396|364021070|FG001|Overall Study|Lost to Follow-up|2|||
105552400|NCT02896855|364021072|FG000|Overall Study|Death|50|||
105552401|NCT02896855|364021073|FG001|Overall Study|Death|40|||
105552402|NCT02896855|364021072|FG000|Overall Study|Lost to Follow-up|15|||
105552403|NCT02896855|364021073|FG001|Overall Study|Lost to Follow-up|9|||
105552404|NCT02896855|364021072|FG000|Overall Study|Withdrawal by Subject|7|||
105552405|NCT02896855|364021073|FG001|Overall Study|Withdrawal by Subject|4|||
105552406|NCT02696317|364021076|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
105552407|NCT02696317|364021077|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
105552408|NCT02696317|364021076|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
105552409|NCT02696317|364021077|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
105552410|NCT01369342|364021078|FG000|Overall Study|Withdrawal by Subject|7|||
105552411|NCT01369342|364021079|FG001|Overall Study|Withdrawal by Subject|7|||
105552412|NCT01369342|364021080|FG002|Overall Study|Withdrawal by Subject|2|||
105552413|NCT01369342|364021078|FG000|Overall Study|Lost to Follow-up|5|||
105552414|NCT01369342|364021079|FG001|Overall Study|Lost to Follow-up|2|||
105552415|NCT01369342|364021080|FG002|Overall Study|Lost to Follow-up|1|||
105552416|NCT01369342|364021078|FG000|Overall Study|Not Treated|1|||
105552417|NCT01369342|364021079|FG001|Overall Study|Not Treated|0|||
105552418|NCT01369342|364021080|FG002|Overall Study|Not Treated|0|||
105552419|NCT04723576|364021081|FG000|Overall Study|Withdrawal by Subject|2133|||
105552420|NCT04723576|364021082|FG001|Overall Study|Withdrawal by Subject|3234|||
105552421|NCT03732209|364021083|FG000|Overall Study|Lost to Follow-up|4|||
105552422|NCT03732209|364021084|FG001|Overall Study|Lost to Follow-up|4|||
105552423|NCT03732209|364021083|FG000|Overall Study|Withdrawal by Subject|8|||
105552424|NCT03732209|364021084|FG001|Overall Study|Withdrawal by Subject|9|||
105552425|NCT05046795|364021085|FG000|Overall Study|Adverse Event|13|||
105552426|NCT05046795|364021086|FG001|Overall Study|Adverse Event|15|||
105552427|NCT05046795|364021085|FG000|Overall Study|Withdrawal by Subject|4|||
105552428|NCT05046795|364021086|FG001|Overall Study|Withdrawal by Subject|7|||
105552429|NCT05046795|364021085|FG000|Overall Study|Physician Decision|1|||
105552430|NCT05046795|364021086|FG001|Overall Study|Physician Decision|2|||
105552431|NCT05046795|364021085|FG000|Overall Study|Protocol Violation|1|||
105552432|NCT05046795|364021086|FG001|Overall Study|Protocol Violation|2|||
105552433|NCT05046795|364021085|FG000|Overall Study|Death|1|||
105552434|NCT05046795|364021086|FG001|Overall Study|Death|0|||
105552435|NCT05046795|364021085|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
105552436|NCT05046795|364021086|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
105552437|NCT01127178|364021087|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
105552438|NCT01127178|364021088|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
105552439|NCT01127178|364021087|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
105666071|NCT01814072|364440891|FG012|Overall Study|Lost to Follow-up|2|||
105552440|NCT01127178|364021088|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
105552441|NCT01127178|364021087|FG000|Dose Escalation: Treatment Phase|Other|2|||
105552442|NCT01127178|364021088|FG001|Dose Escalation: Treatment Phase|Other|0|||
105552443|NCT01127178|364021087|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
105666072|NCT01814072|364440892|FG013|Overall Study|Lost to Follow-up|1|||
105340475|NCT02031640|363248216|FG002|Screening Period|Adverse Event|0|||
105340476|NCT02031640|363248217|FG003|Screening Period|Adverse Event|0|||
105340477|NCT02031640|363248218|FG004|Screening Period|Adverse Event|0|||
105340478|NCT02031640|363248219|FG005|Screening Period|Adverse Event|0|||
105552444|NCT01127178|364021088|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
105552445|NCT01127178|364021087|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
105552446|NCT01127178|364021088|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
105552447|NCT01127178|364021087|FG000|Dose Escalation: Extension Phase|Other|1|||
105552448|NCT01127178|364021088|FG001|Dose Escalation: Extension Phase|Other|0|||
105552449|NCT06027216|364021091|FG000|Overall Study|Did not qualify|8|||
105552450|NCT00709722|364021092|FG000|Overall Study|Adverse Event|1|||
105552451|NCT04818346|364021093|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
105552452|NCT04818346|364021094|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
105552453|NCT04818346|364021095|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
105552454|NCT04818346|364021096|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
105552455|NCT04818346|364021093|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
105552456|NCT04818346|364021094|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
105552457|NCT04818346|364021095|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
105552458|NCT04818346|364021096|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
105552459|NCT04818346|364021093|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
105552460|NCT04818346|364021094|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
105552461|NCT04818346|364021095|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
105552462|NCT04818346|364021096|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
105552463|NCT04818346|364021093|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
105552464|NCT04818346|364021094|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
105552465|NCT04818346|364021095|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
105552466|NCT04818346|364021096|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
105552467|NCT04818346|364021093|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
105552468|NCT04818346|364021094|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
105552469|NCT04818346|364021095|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
105552470|NCT04818346|364021096|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
105552471|NCT04818346|364021093|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
105552472|NCT04818346|364021094|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
105552473|NCT04818346|364021095|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
105552474|NCT04818346|364021096|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
105552475|NCT04818346|364021093|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
105552476|NCT04818346|364021094|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
105552477|NCT04818346|364021095|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
105552478|NCT04818346|364021096|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
105552479|NCT04818346|364021093|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
105552480|NCT04818346|364021094|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
105552481|NCT04818346|364021095|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
105552482|NCT04818346|364021096|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
105552483|NCT04818346|364021093|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
105666073|NCT01814072|364440893|FG014|Overall Study|Lost to Follow-up|2|||
105464252|NCT03077412|363714006|FG001|Overall Study|Withdrew Consent|2|||
105464253|NCT03077412|363714007|FG002|Overall Study|Withdrew Consent|0|||
105464254|NCT02266888|363714008|FG000|Overall Study|Death|2|||
105464255|NCT02266888|363714009|FG001|Overall Study|Death|2|||
105464256|NCT02266888|363714010|FG002|Overall Study|Death|4|||
105464257|NCT02266888|363714011|FG003|Overall Study|Death|2|||
105464258|NCT02266888|363714008|FG000|Overall Study|Physician Decision|0|||
105464259|NCT02266888|363714009|FG001|Overall Study|Physician Decision|1|||
105464260|NCT02266888|363714010|FG002|Overall Study|Physician Decision|2|||
105464261|NCT02266888|363714011|FG003|Overall Study|Physician Decision|2|||
105464262|NCT02266888|363714008|FG000|Overall Study|Study Terminated|5|||
105464263|NCT02266888|363714009|FG001|Overall Study|Study Terminated|1|||
105464264|NCT02266888|363714010|FG002|Overall Study|Study Terminated|0|||
105464265|NCT02266888|363714011|FG003|Overall Study|Study Terminated|0|||
105464266|NCT02266888|363714008|FG000|Overall Study|No Longer Eligible|0|||
105464267|NCT02266888|363714009|FG001|Overall Study|No Longer Eligible|0|||
105464268|NCT02266888|363714010|FG002|Overall Study|No Longer Eligible|0|||
105464269|NCT02266888|363714011|FG003|Overall Study|No Longer Eligible|2|||
105464270|NCT02266888|363714008|FG000|Overall Study|Randomization Closed|0|||
105464271|NCT02266888|363714009|FG001|Overall Study|Randomization Closed|0|||
105464272|NCT02266888|363714010|FG002|Overall Study|Randomization Closed|4|||
105464273|NCT02266888|363714011|FG003|Overall Study|Randomization Closed|0|||
105464274|NCT02266888|363714008|FG000|Overall Study|Personnel unavailable at transplant|0|||
105666074|NCT01814072|364440894|FG015|Overall Study|Lost to Follow-up|1|||
105666075|NCT01814072|364440895|FG016|Overall Study|Lost to Follow-up|3|||
105666076|NCT01814072|364440896|FG017|Overall Study|Lost to Follow-up|1|||
105666077|NCT01814072|364440897|FG018|Overall Study|Lost to Follow-up|3|||
105666078|NCT01814072|364440898|FG019|Overall Study|Lost to Follow-up|3|||
105464275|NCT02266888|363714009|FG001|Overall Study|Personnel unavailable at transplant|0|||
105464276|NCT02266888|363714010|FG002|Overall Study|Personnel unavailable at transplant|0|||
105464277|NCT02266888|363714011|FG003|Overall Study|Personnel unavailable at transplant|1|||
105464278|NCT02266888|363714008|FG000|Overall Study|Transfer of care|0|||
105464279|NCT02266888|363714009|FG001|Overall Study|Transfer of care|0|||
105464280|NCT02266888|363714010|FG002|Overall Study|Transfer of care|1|||
105464281|NCT02266888|363714011|FG003|Overall Study|Transfer of care|0|||
105464282|NCT04226742|363714014|FG000|Overall Study|Lost to Follow-up|16|||
105464283|NCT04226742|363714015|FG001|Overall Study|Lost to Follow-up|13|||
105464284|NCT04226742|363714014|FG000|Overall Study|Withdrawal by Subject|5|||
105464285|NCT04226742|363714015|FG001|Overall Study|Withdrawal by Subject|3|||
105464286|NCT01772316|363714018|FG000|Overall Study|Serious adverse event|1|||
105464287|NCT01772316|363714018|FG000|Overall Study|Inform consent withdrawn|1|||
105464288|NCT01772316|363714018|FG000|Overall Study|Withdrawn by sponsor decision|5|||
105464289|NCT01774721|363714020|FG000|Overall Study|Death|133|||
105464290|NCT01774721|363714021|FG001|Overall Study|Death|152|||
105464291|NCT01774721|363714020|FG000|Overall Study|Withdrawal by Subject|20|||
105464292|NCT01774721|363714021|FG001|Overall Study|Withdrawal by Subject|14|||
105464293|NCT01774721|363714020|FG000|Overall Study|Lost to Follow-up|6|||
105464294|NCT01774721|363714021|FG001|Overall Study|Lost to Follow-up|7|||
105464295|NCT01774721|363714020|FG000|Overall Study|Did not meet eligibility criteria|0|||
105464296|NCT01774721|363714021|FG001|Overall Study|Did not meet eligibility criteria|3|||
105464297|NCT01774721|363714020|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
105464298|NCT01774721|363714021|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
105464299|NCT01774721|363714020|FG000|Overall Study|Study terminated by sponsor|5|||
105464300|NCT01774721|363714021|FG001|Overall Study|Study terminated by sponsor|0|||
105464301|NCT01774721|363714020|FG000|Overall Study|Disease progression|5|||
105464302|NCT01774721|363714021|FG001|Overall Study|Disease progression|0|||
105464303|NCT03848832|363714023|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
105464304|NCT03848832|363714024|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
105464305|NCT03848832|363714025|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
105464306|NCT03848832|363714023|FG000|Overall Study|Withdrawal by Subject|0|||
105464307|NCT03848832|363714024|FG001|Overall Study|Withdrawal by Subject|0|||
105464308|NCT03848832|363714025|FG002|Overall Study|Withdrawal by Subject|1|||
105464309|NCT03848832|363714023|FG000|Overall Study|Withdrawal (Covid-19)|0|||
105464310|NCT03848832|363714024|FG001|Overall Study|Withdrawal (Covid-19)|2|||
105464311|NCT03848832|363714025|FG002|Overall Study|Withdrawal (Covid-19)|0|||
105464312|NCT03848832|363714023|FG000|Overall Study|Physician Decision|2|||
105464313|NCT03848832|363714024|FG001|Overall Study|Physician Decision|1|||
105464314|NCT03848832|363714025|FG002|Overall Study|Physician Decision|3|||
105464315|NCT03848832|363714023|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
105464316|NCT03848832|363714024|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
105464317|NCT03848832|363714025|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
105464318|NCT03848832|363714023|FG000|Overall Study|Adverse Event|1|||
105464319|NCT03848832|363714024|FG001|Overall Study|Adverse Event|0|||
105464320|NCT03848832|363714025|FG002|Overall Study|Adverse Event|0|||
105464321|NCT01759446|363714026|FG000|Overall Study|Protocol Violation|1|||
105464322|NCT01759446|363714027|FG001|Overall Study|Protocol Violation|0|||
105464323|NCT01759446|363714028|FG002|Overall Study|Protocol Violation|1|||
105464324|NCT01759446|363714029|FG003|Overall Study|Protocol Violation|0|||
105464325|NCT01759446|363714030|FG004|Overall Study|Protocol Violation|0|||
105464326|NCT01759446|363714026|FG000|Overall Study|Withdrawal by Subject|0|||
105464327|NCT01759446|363714027|FG001|Overall Study|Withdrawal by Subject|1|||
105464328|NCT01759446|363714028|FG002|Overall Study|Withdrawal by Subject|0|||
105464329|NCT01759446|363714029|FG003|Overall Study|Withdrawal by Subject|1|||
105464330|NCT01759446|363714030|FG004|Overall Study|Withdrawal by Subject|0|||
105464331|NCT00719472|363714031|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
105464332|NCT00719472|363714031|FG000|Enrolled in Study|Subject decision to withdraw|8|||
105464333|NCT00719472|363714031|FG000|Enrolled in Study|Various Reasons|17|||
105464334|NCT00719472|363714031|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
105464335|NCT00719472|363714031|FG000|Received Cycle 1 Treatment|Death|5|||
105464336|NCT00719472|363714031|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
105464337|NCT00719472|363714031|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
105666079|NCT01814072|364440899|FG020|Overall Study|Lost to Follow-up|2|||
105464338|NCT00719472|363714031|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
105464339|NCT00719472|363714031|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
105464340|NCT00719472|363714031|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
105464341|NCT00719472|363714031|FG000|Received Cycle 2 Treatment|Death|6|||
105464342|NCT00719472|363714031|FG000|Received Cycle 2 Treatment|Disease progression|3|||
105666080|NCT01814072|364440900|FG021|Overall Study|Lost to Follow-up|1|||
105666081|NCT01814072|364440901|FG022|Overall Study|Lost to Follow-up|3|||
105666082|NCT01814072|364440902|FG023|Overall Study|Lost to Follow-up|1|||
105666083|NCT01814072|364440903|FG024|Overall Study|Lost to Follow-up|4|||
105666084|NCT01814072|364440904|FG025|Overall Study|Lost to Follow-up|1|||
105666085|NCT01814072|364440905|FG026|Overall Study|Lost to Follow-up|1|||
105666086|NCT01814072|364440906|FG027|Overall Study|Lost to Follow-up|2|||
105666087|NCT01814072|364440907|FG028|Overall Study|Lost to Follow-up|3|||
105666088|NCT01814072|364440908|FG029|Overall Study|Lost to Follow-up|3|||
105666089|NCT01814072|364440909|FG030|Overall Study|Lost to Follow-up|2|||
105666090|NCT01814072|364440910|FG031|Overall Study|Lost to Follow-up|0|||
105666091|NCT01814072|364440879|FG000|Overall Study|Withdrawal by Subject|2|||
105666092|NCT01814072|364440880|FG001|Overall Study|Withdrawal by Subject|0|||
105666093|NCT01814072|364440881|FG002|Overall Study|Withdrawal by Subject|1|||
105666094|NCT01814072|364440882|FG003|Overall Study|Withdrawal by Subject|0|||
105666095|NCT01814072|364440883|FG004|Overall Study|Withdrawal by Subject|2|||
105666096|NCT01814072|364440884|FG005|Overall Study|Withdrawal by Subject|3|||
105666097|NCT01814072|364440885|FG006|Overall Study|Withdrawal by Subject|1|||
105666098|NCT01814072|364440886|FG007|Overall Study|Withdrawal by Subject|0|||
105666099|NCT01814072|364440887|FG008|Overall Study|Withdrawal by Subject|1|||
105666100|NCT01814072|364440888|FG009|Overall Study|Withdrawal by Subject|2|||
105666101|NCT01814072|364440889|FG010|Overall Study|Withdrawal by Subject|0|||
105666102|NCT01814072|364440890|FG011|Overall Study|Withdrawal by Subject|0|||
105666103|NCT01814072|364440891|FG012|Overall Study|Withdrawal by Subject|1|||
105666104|NCT01814072|364440892|FG013|Overall Study|Withdrawal by Subject|1|||
105666105|NCT01814072|364440893|FG014|Overall Study|Withdrawal by Subject|1|||
105666106|NCT01814072|364440894|FG015|Overall Study|Withdrawal by Subject|1|||
105666107|NCT01814072|364440895|FG016|Overall Study|Withdrawal by Subject|0|||
105666108|NCT01814072|364440896|FG017|Overall Study|Withdrawal by Subject|0|||
105666109|NCT01814072|364440897|FG018|Overall Study|Withdrawal by Subject|0|||
105666110|NCT01814072|364440898|FG019|Overall Study|Withdrawal by Subject|2|||
105666111|NCT01814072|364440899|FG020|Overall Study|Withdrawal by Subject|0|||
105666112|NCT01814072|364440900|FG021|Overall Study|Withdrawal by Subject|0|||
105666113|NCT01814072|364440901|FG022|Overall Study|Withdrawal by Subject|1|||
105666114|NCT01814072|364440902|FG023|Overall Study|Withdrawal by Subject|0|||
105666115|NCT01814072|364440903|FG024|Overall Study|Withdrawal by Subject|2|||
105666116|NCT01814072|364440904|FG025|Overall Study|Withdrawal by Subject|1|||
105666117|NCT01814072|364440905|FG026|Overall Study|Withdrawal by Subject|1|||
105666118|NCT01814072|364440906|FG027|Overall Study|Withdrawal by Subject|2|||
105666119|NCT01814072|364440907|FG028|Overall Study|Withdrawal by Subject|1|||
105666120|NCT01814072|364440908|FG029|Overall Study|Withdrawal by Subject|0|||
105666121|NCT01814072|364440909|FG030|Overall Study|Withdrawal by Subject|0|||
105666122|NCT01814072|364440910|FG031|Overall Study|Withdrawal by Subject|0|||
105666123|NCT00760747|364440913|FG000|Study Period II|Adverse Event|3|||
105666124|NCT00760747|364440914|FG001|Study Period II|Adverse Event|4|||
105666125|NCT00760747|364440913|FG000|Study Period II|Lack of Efficacy|0|||
105666126|NCT00760747|364440914|FG001|Study Period II|Lack of Efficacy|6|||
105666127|NCT00760747|364440913|FG000|Study Period II|Parent/Caregiver Decision|3|||
105666128|NCT00760747|364440914|FG001|Study Period II|Parent/Caregiver Decision|0|||
105666129|NCT00760747|364440913|FG000|Study Period II|Protocol Violation|6|||
105666130|NCT00760747|364440914|FG001|Study Period II|Protocol Violation|3|||
105666131|NCT00760747|364440913|FG000|Study Period II|Withdrawal by Subject|1|||
105666132|NCT00760747|364440914|FG001|Study Period II|Withdrawal by Subject|0|||
105666133|NCT00760747|364440913|FG000|Study Period II|No drug administered|0|||
105666134|NCT00760747|364440914|FG001|Study Period II|No drug administered|1|||
105666135|NCT00760747|364440913|FG000|Study Period III|Adverse Event|1|||
105666136|NCT00760747|364440914|FG001|Study Period III|Adverse Event|0|||
105666137|NCT00760747|364440913|FG000|Study Period III|Lack of Efficacy|1|||
105666138|NCT00760747|364440914|FG001|Study Period III|Lack of Efficacy|0|||
105464343|NCT00719472|363714031|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
105666139|NCT00760747|364440913|FG000|Study Period III|Parent/Caregiver Decision|0|||
105666140|NCT00760747|364440914|FG001|Study Period III|Parent/Caregiver Decision|1|||
105666141|NCT00760747|364440913|FG000|Study Period III|Protocol Violation|1|||
105666142|NCT00760747|364440914|FG001|Study Period III|Protocol Violation|1|||
105666143|NCT00760747|364440913|FG000|Study Period III|Physician Decision|0|||
105666144|NCT00760747|364440914|FG001|Study Period III|Physician Decision|1|||
105666145|NCT01443923|364440915|FG000|Overall Study|Adverse Event|1|||
105666146|NCT01443923|364440916|FG001|Overall Study|Adverse Event|0|||
105666147|NCT00250432|364440917|FG000|Overall Study|Adverse Event|25|||
105666148|NCT00250432|364440918|FG001|Overall Study|Adverse Event|29|||
105666149|NCT00250432|364440917|FG000|Overall Study|Lack of Efficacy|2|||
105464344|NCT00719472|363714031|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
105666150|NCT00250432|364440918|FG001|Overall Study|Lack of Efficacy|1|||
105666151|NCT00250432|364440917|FG000|Overall Study|Lost to Follow-up|6|||
105464345|NCT00719472|363714031|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
105464346|NCT00719472|363714031|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
105666152|NCT00250432|364440918|FG001|Overall Study|Lost to Follow-up|5|||
105666153|NCT00250432|364440917|FG000|Overall Study|Patient Moved|0|||
105666154|NCT00250432|364440918|FG001|Overall Study|Patient Moved|1|||
105666155|NCT00250432|364440917|FG000|Overall Study|Protocol Violation|0|||
105666156|NCT00250432|364440918|FG001|Overall Study|Protocol Violation|3|||
105666157|NCT00250432|364440917|FG000|Overall Study|Withdrawal by Subject|6|||
105666158|NCT00250432|364440918|FG001|Overall Study|Withdrawal by Subject|2|||
105666159|NCT00250432|364440917|FG000|Overall Study|Pt died out of posttherapy report period|6|||
105666160|NCT00250432|364440918|FG001|Overall Study|Pt died out of posttherapy report period|5|||
105666161|NCT00250432|364440917|FG000|Overall Study|Pt was considered untreatable|0|||
105666162|NCT00250432|364440918|FG001|Overall Study|Pt was considered untreatable|1|||
105666163|NCT00935532|364440922|FG000|Overall Study|Adverse Event|11|||
105666164|NCT00935532|364440923|FG001|Overall Study|Adverse Event|6|||
105666165|NCT00935532|364440922|FG000|Overall Study|Death|1|||
105666166|NCT00935532|364440923|FG001|Overall Study|Death|0|||
105666167|NCT00935532|364440922|FG000|Overall Study|Lost to Follow-up|1|||
105666168|NCT00935532|364440923|FG001|Overall Study|Lost to Follow-up|0|||
105666169|NCT00935532|364440922|FG000|Overall Study|Physician Decision|1|||
105666170|NCT00935532|364440923|FG001|Overall Study|Physician Decision|2|||
105666171|NCT00935532|364440922|FG000|Overall Study|Protocol Violation|2|||
105666172|NCT00935532|364440923|FG001|Overall Study|Protocol Violation|1|||
105666173|NCT00935532|364440922|FG000|Overall Study|Subject Decision|2|||
105666174|NCT00935532|364440923|FG001|Overall Study|Subject Decision|1|||
105666175|NCT00935532|364440922|FG000|Overall Study|Sponsor Decision|0|||
105666176|NCT00935532|364440923|FG001|Overall Study|Sponsor Decision|1|||
105666177|NCT00935532|364440922|FG000|Overall Study|Loss Glucose Control|4|||
105666178|NCT00935532|364440923|FG001|Overall Study|Loss Glucose Control|0|||
105666179|NCT04954326|364440924|FG000|Overall Study|Protocol Violation|0|||
105666180|NCT04954326|364440925|FG001|Overall Study|Protocol Violation|1|||
105666181|NCT04954326|364440924|FG000|Overall Study|Death|0|||
105666182|NCT04954326|364440925|FG001|Overall Study|Death|2|||
105464347|NCT01244893|363714032|FG000|Baseline|Protocol Violation|0|||
105464348|NCT01244893|363714033|FG001|Baseline|Protocol Violation|1|||
105464349|NCT01244893|363714032|FG000|1-Week Follow Up|Lost to Follow-up|1|||
105464350|NCT01244893|363714033|FG001|1-Week Follow Up|Lost to Follow-up|0|||
105666183|NCT04954326|364440924|FG000|Overall Study|Physician Decision|0|||
105666184|NCT04954326|364440925|FG001|Overall Study|Physician Decision|1|||
105666185|NCT01782690|364440926|FG000|Overall Study|Not reported|7|||
105666186|NCT01782690|364440926|FG000|Overall Study|Toxicity of gemcitabine|1|||
105666187|NCT01782690|364440926|FG000|Overall Study|Toxicity of erlotinib|1|||
105666188|NCT01782690|364440926|FG000|Overall Study|Lost to Follow-up|31|||
105666189|NCT01782690|364440926|FG000|Overall Study|Withdrawal of informed consent|2|||
105666190|NCT01782690|364440926|FG000|Overall Study|Absent rash|9|||
105666191|NCT01782690|364440926|FG000|Overall Study|Physician Decision|13|||
105666192|NCT01782690|364440926|FG000|Overall Study|Patient's wish|21|||
105666193|NCT01782690|364440926|FG000|Overall Study|Tumor progression|74|||
105666194|NCT01782690|364440926|FG000|Overall Study|Death|133|||
105666195|NCT01782690|364440926|FG000|Overall Study|Study completion unknown|7|||
105666196|NCT00277095|364440927|FG000|Overall Study|Death|2|||
105666197|NCT00277095|364440927|FG000|Overall Study|Explanted|7|||
105666198|NCT00277095|364440927|FG000|Overall Study|Lost to Follow-up|2|||
105666199|NCT00277095|364440927|FG000|Overall Study|Missed Follow-up|9|||
105666200|NCT00277095|364440927|FG000|Overall Study|Physician Decision|1|||
105666201|NCT01806389|364440929|FG000|Overall Study|Withdrawal by Subject|4|||
105666202|NCT00681668|364440930|FG000|Overall Study|Protocol Violation|1|||
105666203|NCT00681668|364440930|FG000|Overall Study|Withdrawal by Subject|1|||
105666204|NCT02209181|364440931|FG000|Overall Study|Adverse Event|1|||
105666205|NCT02209181|364440932|FG001|Overall Study|Adverse Event|0|||
105666206|NCT02209181|364440933|FG002|Overall Study|Adverse Event|1|||
105666207|NCT02209181|364440934|FG003|Overall Study|Adverse Event|0|||
105666208|NCT02209181|364440931|FG000|Overall Study|Withdrawal by Subject|0|||
105666209|NCT02209181|364440932|FG001|Overall Study|Withdrawal by Subject|1|||
105666210|NCT02209181|364440933|FG002|Overall Study|Withdrawal by Subject|0|||
105666211|NCT02209181|364440934|FG003|Overall Study|Withdrawal by Subject|0|||
105666212|NCT02548078|364440935|FG000|Overall Study|Serious adverse event/Adverse event|1|||
105666213|NCT02548078|364440936|FG001|Overall Study|Serious adverse event/Adverse event|0|||
105666214|NCT02548078|364440935|FG000|Overall Study|Moved from study area|3|||
105666215|NCT02548078|364440936|FG001|Overall Study|Moved from study area|3|||
105666216|NCT02548078|364440935|FG000|Overall Study|Lost to Follow-up|1|||
105666217|NCT02548078|364440936|FG001|Overall Study|Lost to Follow-up|3|||
105666218|NCT00490698|364440937|FG000|Overall Study|Withdrawal by Subject|1|||
105666219|NCT00490698|364440937|FG000|Overall Study|Disease Progression|7|||
105666220|NCT00490698|364440937|FG000|Overall Study|Physician Decision|2|||
105666221|NCT02963090|364442136|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
105666222|NCT02963090|364442137|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
105666223|NCT03445533|364442138|FG000|Overall Study|Progressive Disease|48|||
105666224|NCT03445533|364442139|FG001|Overall Study|Progressive Disease|81|||
105666225|NCT03445533|364442138|FG000|Overall Study|Adverse Event|60|||
105666226|NCT03445533|364442139|FG001|Overall Study|Adverse Event|64|||
105666227|NCT03445533|364442138|FG000|Overall Study|Death|9|||
105666228|NCT03445533|364442139|FG001|Overall Study|Death|19|||
105666229|NCT03445533|364442138|FG000|Overall Study|Miscellaneous|0|||
105666230|NCT03445533|364442139|FG001|Overall Study|Miscellaneous|16|||
105666231|NCT03445533|364442138|FG000|Overall Study|Withdrawal by Subject|3|||
105666232|NCT03445533|364442139|FG001|Overall Study|Withdrawal by Subject|4|||
105666233|NCT03445533|364442138|FG000|Overall Study|Physician Decision|1|||
105666234|NCT03445533|364442139|FG001|Overall Study|Physician Decision|3|||
105666235|NCT03445533|364442138|FG000|Overall Study|Sponsor Decision|0|||
105666236|NCT03445533|364442139|FG001|Overall Study|Sponsor Decision|1|||
105666237|NCT03445533|364442138|FG000|Overall Study|Lost to Follow-up|0|||
105666238|NCT03445533|364442139|FG001|Overall Study|Lost to Follow-up|1|||
105666239|NCT03445533|364442138|FG000|Overall Study|Never Received any Study Treatment|7|||
105666240|NCT03445533|364442139|FG001|Overall Study|Never Received any Study Treatment|4|||
105666241|NCT00079339|364442140|FG000|Overall Study|Adverse Event|1|||
105666242|NCT00079339|364442141|FG001|Overall Study|Adverse Event|7|||
105666243|NCT00079339|364442142|FG002|Overall Study|Adverse Event|2|||
105666244|NCT00079339|364442140|FG000|Overall Study|Death|1|||
105666245|NCT00079339|364442141|FG001|Overall Study|Death|0|||
105666246|NCT00079339|364442142|FG002|Overall Study|Death|0|||
105666247|NCT00079339|364442140|FG000|Overall Study|Non-compliance|0|||
105666248|NCT00079339|364442141|FG001|Overall Study|Non-compliance|0|||
105666249|NCT00079339|364442142|FG002|Overall Study|Non-compliance|1|||
105666250|NCT00079339|364442140|FG000|Overall Study|Withdrawal by Subject|0|||
105666251|NCT00079339|364442141|FG001|Overall Study|Withdrawal by Subject|4|||
105666252|NCT00079339|364442142|FG002|Overall Study|Withdrawal by Subject|1|||
105666253|NCT00079339|364442140|FG000|Overall Study|Disease progression|3|||
105666254|NCT00079339|364442141|FG001|Overall Study|Disease progression|28|||
105340479|NCT02031640|363248214|FG000|Screening Period|Withdrawal by Subject|29|||
105340480|NCT02031640|363248215|FG001|Screening Period|Withdrawal by Subject|0|||
105340481|NCT02031640|363248216|FG002|Screening Period|Withdrawal by Subject|0|||
105340482|NCT02031640|363248217|FG003|Screening Period|Withdrawal by Subject|0|||
105340483|NCT02031640|363248218|FG004|Screening Period|Withdrawal by Subject|0|||
105340484|NCT02031640|363248219|FG005|Screening Period|Withdrawal by Subject|0|||
105340485|NCT02031640|363248214|FG000|Screening Period|Inclusion criteria not met|312|||
105340486|NCT02031640|363248215|FG001|Screening Period|Inclusion criteria not met|0|||
105340487|NCT02031640|363248216|FG002|Screening Period|Inclusion criteria not met|0|||
105666255|NCT00079339|364442142|FG002|Overall Study|Disease progression|2|||
105340488|NCT02031640|363248217|FG003|Screening Period|Inclusion criteria not met|0|||
105666256|NCT02563548|364442143|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
105666257|NCT02563548|364442144|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
105666258|NCT02563548|364442145|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
105666259|NCT02563548|364442146|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
105666260|NCT02563548|364442147|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
105666261|NCT02563548|364442148|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
105340489|NCT02031640|363248218|FG004|Screening Period|Inclusion criteria not met|0|||
105340490|NCT02031640|363248219|FG005|Screening Period|Inclusion criteria not met|0|||
105340491|NCT02031640|363248214|FG000|Screening Period|Exclusion criteria met|30|||
105340492|NCT02031640|363248215|FG001|Screening Period|Exclusion criteria met|0|||
105340493|NCT02031640|363248216|FG002|Screening Period|Exclusion criteria met|0|||
105340494|NCT02031640|363248217|FG003|Screening Period|Exclusion criteria met|0|||
105340495|NCT02031640|363248218|FG004|Screening Period|Exclusion criteria met|0|||
105340496|NCT02031640|363248219|FG005|Screening Period|Exclusion criteria met|0|||
105340497|NCT02031640|363248214|FG000|Screening Period|Lost to Follow-up|14|||
105340498|NCT02031640|363248215|FG001|Screening Period|Lost to Follow-up|0|||
105340499|NCT02031640|363248216|FG002|Screening Period|Lost to Follow-up|0|||
105340500|NCT02031640|363248217|FG003|Screening Period|Lost to Follow-up|0|||
105340501|NCT02031640|363248218|FG004|Screening Period|Lost to Follow-up|0|||
105340502|NCT02031640|363248219|FG005|Screening Period|Lost to Follow-up|0|||
105340503|NCT02031640|363248214|FG000|Screening Period|Enrollment closed|26|||
105464351|NCT02399163|363714035|FG000|Overall Study|Adverse Event|2|||
105464352|NCT02399163|363714035|FG000|Overall Study|Protocol Deviation|2|||
105464353|NCT02399163|363714035|FG000|Overall Study|Withdrawal by Participant|5|||
105464354|NCT04646044|363714037|FG000|Overall Study|Lost to Follow-up|0|||
105464355|NCT04646044|363714038|FG001|Overall Study|Lost to Follow-up|0|||
105464356|NCT04646044|363714039|FG002|Overall Study|Lost to Follow-up|1|||
105464357|NCT04646044|363714040|FG003|Overall Study|Lost to Follow-up|0|||
105464358|NCT04646044|363714037|FG000|Overall Study|Withdrawal by Subject|0|||
105464359|NCT04646044|363714038|FG001|Overall Study|Withdrawal by Subject|1|||
105464360|NCT04646044|363714039|FG002|Overall Study|Withdrawal by Subject|0|||
105464361|NCT04646044|363714040|FG003|Overall Study|Withdrawal by Subject|0|||
105340504|NCT02031640|363248215|FG001|Screening Period|Enrollment closed|0|||
105340505|NCT02031640|363248216|FG002|Screening Period|Enrollment closed|0|||
105340506|NCT02031640|363248217|FG003|Screening Period|Enrollment closed|0|||
105340507|NCT02031640|363248218|FG004|Screening Period|Enrollment closed|0|||
105340508|NCT02031640|363248219|FG005|Screening Period|Enrollment closed|0|||
105340509|NCT02031640|363248214|FG000|Run-In Period|Adverse Event|4|||
105340510|NCT02031640|363248215|FG001|Run-In Period|Adverse Event|0|||
105464362|NCT01391546|363714043|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
105464363|NCT01391546|363714044|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
105464364|NCT01524796|363714045|FG000|Overall Study|Adverse Event|13|||
105464365|NCT01524796|363714045|FG000|Overall Study|Lack of Efficacy|3|||
105666262|NCT02563548|364442143|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
105666263|NCT02563548|364442144|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
105666264|NCT02563548|364442145|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
105666265|NCT02563548|364442146|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
105666266|NCT02563548|364442147|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
105666267|NCT02563548|364442148|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
105666268|NCT02563548|364442143|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
105666269|NCT02563548|364442144|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
105666270|NCT02563548|364442145|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
105666271|NCT02563548|364442146|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
105666272|NCT02563548|364442147|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
105666273|NCT02563548|364442148|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
105666274|NCT02563548|364442143|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
105666275|NCT02563548|364442144|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
105666276|NCT02563548|364442145|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
105666277|NCT02563548|364442146|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
105666278|NCT02563548|364442147|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
105666279|NCT02563548|364442148|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
105666280|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
105666281|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
105666282|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
105666283|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
105666284|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
105666285|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
105666286|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
105666287|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
105666288|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
105666289|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
105666290|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
105666291|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
105666292|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
105666293|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
105666294|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
105666295|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
105666296|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
105666297|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
105666298|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
105666299|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
105666300|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
105666301|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
105666302|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
105666303|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
105666304|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
105666305|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
105666306|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
105666307|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
105666308|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
105666309|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
105666310|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
105666311|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
105666312|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
105666313|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
105666314|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
105666315|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
105666316|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
105666317|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
105666318|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
105666319|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
105666320|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
105666321|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
105666322|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
105666323|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
105666324|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
105666325|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
105666326|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
105666327|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
105666328|NCT01023958|364442151|FG000|Overall Study|Progressive disease|48|||
105666329|NCT01023958|364442151|FG000|Overall Study|Other adverse event|1|||
105666330|NCT01023958|364442151|FG000|Overall Study|Refused to continue medication|1|||
105666331|NCT01099917|364442158|FG000|Overall Study|Adverse Event|3|||
105666332|NCT01099917|364442158|FG000|Overall Study|Not Treated|24|||
105666333|NCT01266161|364442159|FG000|Overall Study|Ineligible|1|||
105666334|NCT01266161|364442160|FG001|Overall Study|Ineligible|0|||
105666335|NCT01266161|364442159|FG000|Overall Study|Lack of Efficacy|0|||
105666336|NCT01266161|364442160|FG001|Overall Study|Lack of Efficacy|1|||
105666337|NCT01266161|364442159|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
105666338|NCT01266161|364442160|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
105666339|NCT01485120|364442161|FG000|Overall Study|Withdrawal by Subject|2|||
105666340|NCT00422734|364442162|FG000|Overall Study|Physician Decision|1|||
105666341|NCT00422734|364442163|FG001|Overall Study|Physician Decision|1|||
105666342|NCT00422734|364442162|FG000|Overall Study|Protocol Violation|1|||
105666343|NCT00422734|364442163|FG001|Overall Study|Protocol Violation|6|||
105666344|NCT00422734|364442162|FG000|Overall Study|Withdrawal by Subject|12|||
105666345|NCT00422734|364442163|FG001|Overall Study|Withdrawal by Subject|8|||
105666346|NCT00422734|364442162|FG000|Overall Study|Adverse Event|0|||
105666347|NCT00422734|364442163|FG001|Overall Study|Adverse Event|3|||
105666348|NCT00422734|364442162|FG000|Overall Study|Partner Decision|0|||
105666349|NCT00422734|364442163|FG001|Overall Study|Partner Decision|3|||
105666350|NCT02353468|364442164|FG000|Overall Study|Study terminated|3|||
105666351|NCT00848484|364442165|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
105666352|NCT00848484|364442166|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
105666353|NCT00848484|364442165|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
105666354|NCT00848484|364442166|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
105666355|NCT00848484|364442165|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
105666356|NCT00848484|364442166|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
105666357|NCT00848484|364442165|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
105666358|NCT00848484|364442166|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
105666359|NCT00848484|364442165|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
105666360|NCT00848484|364442166|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
105666361|NCT00706654|364442174|FG000|Conversion Phase|Lost to Follow-up|4|||
105666362|NCT00706654|364442175|FG001|Conversion Phase|Lost to Follow-up|0|||
105666363|NCT00706654|364442176|FG002|Conversion Phase|Lost to Follow-up|0|||
105666364|NCT00706654|364442177|FG003|Conversion Phase|Lost to Follow-up|0|||
105666365|NCT00706654|364442174|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
105666366|NCT00706654|364442175|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
105666367|NCT00706654|364442176|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
105666368|NCT00706654|364442177|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
105666369|NCT00706654|364442174|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
105666370|NCT00706654|364442175|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
105666371|NCT00706654|364442176|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
105666372|NCT00706654|364442177|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
105340511|NCT02031640|363248216|FG002|Run-In Period|Adverse Event|0|||
105666373|NCT00706654|364442174|FG000|Conversion Phase|Withdrawn by Investigator|14|||
105666374|NCT00706654|364442175|FG001|Conversion Phase|Withdrawn by Investigator|0|||
105666375|NCT00706654|364442176|FG002|Conversion Phase|Withdrawn by Investigator|0|||
105666376|NCT00706654|364442177|FG003|Conversion Phase|Withdrawn by Investigator|0|||
105666377|NCT00706654|364442174|FG000|Conversion Phase|Withdrew Consent|38|||
105666378|NCT00706654|364442175|FG001|Conversion Phase|Withdrew Consent|0|||
105666379|NCT00706654|364442176|FG002|Conversion Phase|Withdrew Consent|0|||
105666380|NCT00706654|364442177|FG003|Conversion Phase|Withdrew Consent|0|||
105666381|NCT00706654|364442174|FG000|Conversion Phase|Adverse Event|18|||
105666382|NCT00706654|364442175|FG001|Conversion Phase|Adverse Event|0|||
105666383|NCT00706654|364442176|FG002|Conversion Phase|Adverse Event|0|||
105666384|NCT00706654|364442177|FG003|Conversion Phase|Adverse Event|0|||
105666385|NCT00706654|364442174|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
105666386|NCT00706654|364442175|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
105666387|NCT00706654|364442176|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
105666388|NCT00706654|364442177|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
105666389|NCT00706654|364442174|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
105785976|NCT04246593|364870424|FG001|Overall Study|Lost to Follow-up|71|||
105340512|NCT02031640|363248217|FG003|Run-In Period|Adverse Event|0|||
105340513|NCT02031640|363248218|FG004|Run-In Period|Adverse Event|0|||
105340514|NCT02031640|363248219|FG005|Run-In Period|Adverse Event|0|||
105340515|NCT02031640|363248214|FG000|Run-In Period|Withdrawal by Subject|17|||
105340516|NCT02031640|363248215|FG001|Run-In Period|Withdrawal by Subject|0|||
105340517|NCT02031640|363248216|FG002|Run-In Period|Withdrawal by Subject|0|||
105340518|NCT02031640|363248217|FG003|Run-In Period|Withdrawal by Subject|0|||
105340519|NCT02031640|363248218|FG004|Run-In Period|Withdrawal by Subject|0|||
105340520|NCT02031640|363248219|FG005|Run-In Period|Withdrawal by Subject|0|||
105340521|NCT02031640|363248214|FG000|Run-In Period|Inclusion criteria not met|38|||
105340522|NCT02031640|363248215|FG001|Run-In Period|Inclusion criteria not met|0|||
105340523|NCT02031640|363248216|FG002|Run-In Period|Inclusion criteria not met|0|||
105552484|NCT04818346|364021094|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
105552485|NCT04818346|364021095|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
105552486|NCT04818346|364021096|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
105552487|NCT04818346|364021093|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
105552488|NCT04818346|364021094|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
105552489|NCT04818346|364021095|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
105552490|NCT04818346|364021096|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
105552491|NCT04818346|364021093|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
105552492|NCT04818346|364021094|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
105552493|NCT04818346|364021095|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
105552494|NCT04818346|364021096|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
105552495|NCT04818346|364021093|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
105552496|NCT04818346|364021094|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
105552497|NCT04818346|364021095|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
105552498|NCT04818346|364021096|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
105552499|NCT04818346|364021093|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
105552500|NCT04818346|364021094|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
105552501|NCT04818346|364021095|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
105552502|NCT04818346|364021096|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
105552503|NCT04818346|364021093|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
105552504|NCT04818346|364021094|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
105552505|NCT04818346|364021095|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
105552506|NCT04818346|364021096|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
105552507|NCT04818346|364021093|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
105552508|NCT04818346|364021094|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
105552509|NCT04818346|364021095|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
105552510|NCT04818346|364021096|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
105552511|NCT01953926|364021102|FG000|Overall Study|Withdrawal by Subject|23|||
105552512|NCT01953926|364021103|FG001|Overall Study|Withdrawal by Subject|3|||
105552513|NCT01953926|364021104|FG002|Overall Study|Withdrawal by Subject|3|||
105552514|NCT01953926|364021105|FG003|Overall Study|Withdrawal by Subject|5|||
105552515|NCT01953926|364021106|FG004|Overall Study|Withdrawal by Subject|6|||
105552516|NCT01953926|364021107|FG005|Overall Study|Withdrawal by Subject|0|||
105552517|NCT01953926|364021108|FG006|Overall Study|Withdrawal by Subject|1|||
105552518|NCT01953926|364021102|FG000|Overall Study|Physician Decision|1|||
105552519|NCT01953926|364021103|FG001|Overall Study|Physician Decision|0|||
105552520|NCT01953926|364021104|FG002|Overall Study|Physician Decision|0|||
105552521|NCT01953926|364021105|FG003|Overall Study|Physician Decision|0|||
105552522|NCT01953926|364021106|FG004|Overall Study|Physician Decision|2|||
105552523|NCT01953926|364021107|FG005|Overall Study|Physician Decision|0|||
105552524|NCT01953926|364021108|FG006|Overall Study|Physician Decision|0|||
105552525|NCT01953926|364021102|FG000|Overall Study|Lost to Follow-up|18|||
105552526|NCT01953926|364021103|FG001|Overall Study|Lost to Follow-up|3|||
105552527|NCT01953926|364021104|FG002|Overall Study|Lost to Follow-up|0|||
105552528|NCT01953926|364021105|FG003|Overall Study|Lost to Follow-up|5|||
105552529|NCT01953926|364021106|FG004|Overall Study|Lost to Follow-up|3|||
105552530|NCT01953926|364021107|FG005|Overall Study|Lost to Follow-up|0|||
105552531|NCT01953926|364021108|FG006|Overall Study|Lost to Follow-up|0|||
105666390|NCT00706654|364442175|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
105340524|NCT02031640|363248217|FG003|Run-In Period|Inclusion criteria not met|0|||
105340525|NCT02031640|363248218|FG004|Run-In Period|Inclusion criteria not met|0|||
105340526|NCT02031640|363248219|FG005|Run-In Period|Inclusion criteria not met|0|||
105340527|NCT02031640|363248214|FG000|Run-In Period|Exclusion criteria met|8|||
105340528|NCT02031640|363248215|FG001|Run-In Period|Exclusion criteria met|0|||
105552532|NCT01953926|364021102|FG000|Overall Study|Protocol Violation|1|||
105552533|NCT01953926|364021103|FG001|Overall Study|Protocol Violation|0|||
105552534|NCT01953926|364021104|FG002|Overall Study|Protocol Violation|0|||
105552535|NCT01953926|364021105|FG003|Overall Study|Protocol Violation|0|||
105464366|NCT01524796|363714045|FG000|Overall Study|Lost to Follow-up|1|||
105464367|NCT01524796|363714045|FG000|Overall Study|The price|1|||
105464368|NCT01524796|363714045|FG000|Overall Study|Withdrawal by Subject|4|||
105464369|NCT01524796|363714045|FG000|Overall Study|Move|1|||
105464370|NCT01524796|363714045|FG000|Overall Study|Deterioration of pains|1|||
105464371|NCT01524796|363714045|FG000|Overall Study|Gall stone surgery|1|||
105464372|NCT01524796|363714045|FG000|Overall Study|Nervous about confidentiality|1|||
105464373|NCT01524796|363714045|FG000|Overall Study|Switch to carbamazapine|1|||
105464374|NCT01524796|363714045|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
105464375|NCT01746901|363714048|FG000|Naloxone Challenge Phase|Adverse Event|2|||
105464376|NCT01746901|363714049|FG001|Naloxone Challenge Phase|Adverse Event|0|||
105464377|NCT01746901|363714050|FG002|Naloxone Challenge Phase|Adverse Event|0|||
105464378|NCT01746901|363714051|FG003|Naloxone Challenge Phase|Adverse Event|0|||
105464379|NCT01746901|363714052|FG004|Naloxone Challenge Phase|Adverse Event|0|||
105464380|NCT01746901|363714053|FG005|Naloxone Challenge Phase|Adverse Event|0|||
105464381|NCT01746901|363714054|FG006|Naloxone Challenge Phase|Adverse Event|0|||
105464382|NCT01746901|363714055|FG007|Naloxone Challenge Phase|Adverse Event|0|||
105464383|NCT01746901|363714056|FG008|Naloxone Challenge Phase|Adverse Event|0|||
105464384|NCT01746901|363714048|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
105464385|NCT01746901|363714049|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
105464386|NCT01746901|363714050|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
105464387|NCT01746901|363714051|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
105464388|NCT01746901|363714052|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
105464389|NCT01746901|363714053|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
105464390|NCT01746901|363714054|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
105464391|NCT01746901|363714055|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
105464392|NCT01746901|363714056|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
105464393|NCT01746901|363714048|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105666391|NCT00706654|364442176|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
105666392|NCT00706654|364442177|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
105666393|NCT00706654|364442174|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
105666394|NCT00706654|364442175|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
105666395|NCT00706654|364442176|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
105666396|NCT00706654|364442177|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
105666397|NCT00706654|364442174|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
105666398|NCT00706654|364442175|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
105666399|NCT00706654|364442176|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
105666400|NCT00706654|364442177|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
105666401|NCT00706654|364442174|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
105666402|NCT00706654|364442175|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
105666403|NCT00706654|364442176|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
105666404|NCT00706654|364442177|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
105666405|NCT00706654|364442174|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
105666406|NCT00706654|364442175|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
105666407|NCT00706654|364442176|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
105666408|NCT00706654|364442177|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
105666409|NCT00706654|364442174|FG000|Oral Stabilization Phase|Withdrew consent|55|||
105666410|NCT00706654|364442175|FG001|Oral Stabilization Phase|Withdrew consent|0|||
105666411|NCT00706654|364442176|FG002|Oral Stabilization Phase|Withdrew consent|0|||
105666412|NCT00706654|364442177|FG003|Oral Stabilization Phase|Withdrew consent|0|||
105666413|NCT00706654|364442174|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
105666414|NCT00706654|364442175|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
105666415|NCT00706654|364442176|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
105666416|NCT00706654|364442177|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
105666417|NCT00706654|364442174|FG000|Oral Stabilization Phase|Adverse Event|21|||
105666418|NCT00706654|364442175|FG001|Oral Stabilization Phase|Adverse Event|0|||
105666419|NCT00706654|364442176|FG002|Oral Stabilization Phase|Adverse Event|0|||
105666420|NCT00706654|364442177|FG003|Oral Stabilization Phase|Adverse Event|0|||
105666421|NCT00706654|364442174|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
105666422|NCT00706654|364442175|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
105666423|NCT00706654|364442176|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
105666424|NCT00706654|364442177|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
105666425|NCT00706654|364442174|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
105666426|NCT00706654|364442175|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
105666427|NCT00706654|364442176|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
105666428|NCT00706654|364442177|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
105552536|NCT01953926|364021106|FG004|Overall Study|Protocol Violation|0|||
105552537|NCT01953926|364021107|FG005|Overall Study|Protocol Violation|0|||
105552538|NCT01953926|364021108|FG006|Overall Study|Protocol Violation|0|||
105552539|NCT01953926|364021102|FG000|Overall Study|Other, Disease progression|2|||
105552540|NCT01953926|364021103|FG001|Overall Study|Other, Disease progression|1|||
105552541|NCT01953926|364021104|FG002|Overall Study|Other, Disease progression|0|||
105552542|NCT01953926|364021105|FG003|Overall Study|Other, Disease progression|0|||
105552543|NCT01953926|364021106|FG004|Overall Study|Other, Disease progression|1|||
105552544|NCT01953926|364021107|FG005|Overall Study|Other, Disease progression|0|||
105552545|NCT01953926|364021108|FG006|Overall Study|Other, Disease progression|0|||
105552546|NCT01953926|364021102|FG000|Overall Study|Discontinuation of study by sponsor|41|||
105552547|NCT01953926|364021103|FG001|Overall Study|Discontinuation of study by sponsor|7|||
105552548|NCT01953926|364021104|FG002|Overall Study|Discontinuation of study by sponsor|5|||
105552549|NCT01953926|364021105|FG003|Overall Study|Discontinuation of study by sponsor|12|||
105552550|NCT01953926|364021106|FG004|Overall Study|Discontinuation of study by sponsor|46|||
105552551|NCT01953926|364021107|FG005|Overall Study|Discontinuation of study by sponsor|5|||
105552552|NCT01953926|364021108|FG006|Overall Study|Discontinuation of study by sponsor|6|||
105552553|NCT01953926|364021102|FG000|Overall Study|Not Treated|1|||
105666429|NCT00706654|364442174|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
105666430|NCT00706654|364442175|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
105552554|NCT01953926|364021103|FG001|Overall Study|Not Treated|0|||
105552555|NCT01953926|364021104|FG002|Overall Study|Not Treated|1|||
105552556|NCT01953926|364021105|FG003|Overall Study|Not Treated|0|||
105552557|NCT01953926|364021106|FG004|Overall Study|Not Treated|0|||
105666431|NCT00706654|364442176|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
105666432|NCT00706654|364442177|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
105666433|NCT00706654|364442174|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
105666434|NCT00706654|364442175|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
105666435|NCT00706654|364442176|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
105666436|NCT00706654|364442177|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
105666437|NCT00706654|364442174|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
105666438|NCT00706654|364442175|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
105666439|NCT00706654|364442176|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
105666440|NCT00706654|364442177|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
105666441|NCT00706654|364442174|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
105666442|NCT00706654|364442175|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
105666443|NCT00706654|364442176|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
105666444|NCT00706654|364442177|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
105666445|NCT00706654|364442174|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
105666446|NCT00706654|364442175|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
105666447|NCT00706654|364442176|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
105666448|NCT00706654|364442177|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
105666449|NCT00706654|364442174|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
105666450|NCT00706654|364442175|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
105666451|NCT00706654|364442176|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
105666452|NCT00706654|364442177|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
105666453|NCT00706654|364442174|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
105666454|NCT00706654|364442175|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
105666455|NCT00706654|364442176|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
105666456|NCT00706654|364442177|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
105666457|NCT00706654|364442174|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
105666458|NCT00706654|364442175|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
105666459|NCT00706654|364442176|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
105666460|NCT00706654|364442177|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
105666461|NCT02975102|364442183|FG000|Overall Study|Adverse Event|2|||
105666462|NCT02975102|364442184|FG001|Overall Study|Adverse Event|1|||
105666463|NCT01001390|364442190|FG000|Overall Study|Failure to wear AFO device|2|||
105666464|NCT01001390|364442191|FG001|Overall Study|Failure to wear AFO device|0|||
105666465|NCT01430468|364442199|FG000|Overall Study|Physician Decision|2|||
105666466|NCT01430468|364442200|FG001|Overall Study|Physician Decision|1|||
105666467|NCT01430468|364442199|FG000|Overall Study|Withdrawal by Subject|5|||
105666468|NCT01430468|364442200|FG001|Overall Study|Withdrawal by Subject|5|||
105666469|NCT01294436|364442201|FG000|Overall Study|Adverse Event|10|||
105666470|NCT01294436|364442202|FG001|Overall Study|Adverse Event|17|||
105666471|NCT01294436|364442201|FG000|Overall Study|Withdrawal by Subject|11|||
105666472|NCT01294436|364442202|FG001|Overall Study|Withdrawal by Subject|28|||
105666473|NCT01294436|364442201|FG000|Overall Study|subject no longer meets study criteria|5|||
105666474|NCT01294436|364442202|FG001|Overall Study|subject no longer meets study criteria|20|||
105666475|NCT01294436|364442201|FG000|Overall Study|poor/non-compliance|2|||
105666476|NCT01294436|364442202|FG001|Overall Study|poor/non-compliance|5|||
105666477|NCT02389764|364442203|FG000|Overall Study|Lack of Efficacy|9|||
105666478|NCT04978090|364442204|FG000|Overall Study|unable to adequately fit device|2|||
105666479|NCT00996606|364442206|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
105666480|NCT00996606|364442206|FG000|Overall Study|Insufficient Therapeutic Response|2|||
105666481|NCT00996606|364442206|FG000|Overall Study|Protocol Violation|1|||
105666482|NCT00996606|364442206|FG000|Overall Study|Withdrawal by Subject|3|||
105666483|NCT00978562|364442211|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
105666484|NCT00632502|364442212|FG000|Overall Study|Adverse Event|0|||
105666485|NCT00632502|364442213|FG001|Overall Study|Adverse Event|1|||
105666486|NCT00632502|364442212|FG000|Overall Study|Randomized not treated|3|||
105666487|NCT00632502|364442213|FG001|Overall Study|Randomized not treated|0|||
105666488|NCT01213524|364442214|FG000|Baseline|Withdrawal by Subject|5|||
105464394|NCT01746901|363714049|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
105464395|NCT01746901|363714050|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105464396|NCT01746901|363714051|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105464397|NCT01746901|363714052|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105464398|NCT01746901|363714053|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105666489|NCT01213524|364442214|FG000|Baseline|high breath alcohol levels|1|||
105666490|NCT01213524|364442214|FG000|Baseline|Physician Decision|1|||
105666491|NCT01213524|364442214|FG000|Session 2|Withdrawal by Subject|5|||
105666492|NCT01213524|364442214|FG000|Session 3|Withdrawal by Subject|4|||
105464399|NCT01746901|363714054|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105666493|NCT01213524|364442214|FG000|Session 4|Physician Decision|1|||
105666494|NCT01213524|364442214|FG000|Session 4|Withdrawal by Subject|2|||
105666495|NCT00281320|364442215|FG000|Overall Study|Adverse Event|12|||
105666496|NCT00281320|364442216|FG001|Overall Study|Adverse Event|9|||
105666497|NCT00281320|364442215|FG000|Overall Study|Lack of Efficacy|4|||
105666498|NCT00281320|364442216|FG001|Overall Study|Lack of Efficacy|3|||
105666499|NCT00281320|364442215|FG000|Overall Study|Withdrawal by Subject|5|||
105666500|NCT00281320|364442216|FG001|Overall Study|Withdrawal by Subject|6|||
105666501|NCT00281320|364442215|FG000|Overall Study|Lost to Follow-up|1|||
105666502|NCT00281320|364442216|FG001|Overall Study|Lost to Follow-up|2|||
105666503|NCT00281320|364442215|FG000|Overall Study|Other|3|||
105666504|NCT00281320|364442216|FG001|Overall Study|Other|1|||
105666505|NCT03128671|364442221|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
105666506|NCT03128671|364442222|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
105666507|NCT03128671|364442221|FG000|Allocation|Death|1|||
105666508|NCT03128671|364442222|FG001|Allocation|Death|0|||
105666509|NCT03128671|364442221|FG000|Allocation|Withdrawal by Subject|4|||
105666510|NCT03128671|364442222|FG001|Allocation|Withdrawal by Subject|0|||
105666511|NCT03128671|364442221|FG000|Intervention|Withdrawal by Subject|11|||
105666512|NCT03128671|364442222|FG001|Intervention|Withdrawal by Subject|10|||
105666513|NCT03128671|364442221|FG000|Intervention|Palliative/hospice care initiated|9|||
105666514|NCT03128671|364442222|FG001|Intervention|Palliative/hospice care initiated|10|||
105666515|NCT03128671|364442221|FG000|Intervention|Death|13|||
105666516|NCT03128671|364442222|FG001|Intervention|Death|11|||
105666517|NCT03128671|364442221|FG000|Intervention|Interrupted by hurricane|1|||
105666518|NCT03128671|364442222|FG001|Intervention|Interrupted by hurricane|0|||
105666519|NCT03128671|364442221|FG000|Intervention|Physician Decision|2|||
105666520|NCT03128671|364442222|FG001|Intervention|Physician Decision|3|||
105666521|NCT00862836|364442224|FG000|Overall Study|Withdrawal by Subject|1|||
105666522|NCT00486252|364442226|FG000|Overall Study|Adverse Event|7|||
105666523|NCT00486252|364442226|FG000|Overall Study|Lack of Efficacy|9|||
105666524|NCT00486252|364442226|FG000|Overall Study|Lost to Follow-up|24|||
105666525|NCT00486252|364442226|FG000|Overall Study|Other|18|||
105666526|NCT01261247|364442227|FG000|Overall Study|Ineligible|2|||
105666527|NCT03277352|364442234|FG000|Overall Study|Study Terminated By Sponsor|2|||
105666528|NCT03277352|364442234|FG000|Overall Study|Withdrawal by Subject|4|||
105666529|NCT03277352|364442234|FG000|Overall Study|Death|4|||
105666530|NCT02397447|364442236|FG000|Overall Study|Lost to Follow-up|2|||
105666531|NCT02397447|364442237|FG001|Overall Study|Lost to Follow-up|2|||
105666532|NCT01435772|364442238|FG000|Overall Study|Adverse Event|1|||
105666533|NCT01435772|364442239|FG001|Overall Study|Adverse Event|0|||
105666534|NCT01435772|364442240|FG002|Overall Study|Adverse Event|2|||
105666535|NCT01435772|364442238|FG000|Overall Study|Withdrawal by Subject|0|||
105666536|NCT01435772|364442239|FG001|Overall Study|Withdrawal by Subject|1|||
105666537|NCT01435772|364442240|FG002|Overall Study|Withdrawal by Subject|3|||
105666538|NCT01435772|364442238|FG000|Overall Study|Other - study termination|2|||
105666539|NCT01435772|364442239|FG001|Overall Study|Other - study termination|2|||
105666540|NCT01435772|364442240|FG002|Overall Study|Other - study termination|10|||
105666541|NCT05823012|364442241|FG000|Titration Period|Adverse Event|1|||
105666542|NCT05823012|364442241|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
105666543|NCT05823012|364442241|FG000|Maintenance Period|Adverse Event|1|||
105666544|NCT05823012|364442241|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
105666545|NCT05823012|364442241|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
105666546|NCT02419417|364443974|FG000|Overall Study|Disease progression|5|||
105666547|NCT02419417|364443975|FG001|Overall Study|Disease progression|4|||
105464400|NCT01746901|363714055|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105464401|NCT01746901|363714056|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105666548|NCT02419417|364443976|FG002|Overall Study|Disease progression|13|||
105666549|NCT02419417|364443977|FG003|Overall Study|Disease progression|10|||
105666550|NCT02419417|364443978|FG004|Overall Study|Disease progression|10|||
105464402|NCT01746901|363714048|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
105464403|NCT01746901|363714049|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
105666551|NCT02419417|364443979|FG005|Overall Study|Disease progression|3|||
105666552|NCT02419417|364443980|FG006|Overall Study|Disease progression|4|||
105666553|NCT02419417|364443981|FG007|Overall Study|Disease progression|5|||
105666554|NCT02419417|364443982|FG008|Overall Study|Disease progression|13|||
105666555|NCT02419417|364443983|FG009|Overall Study|Disease progression|9|||
105666556|NCT02419417|364443984|FG010|Overall Study|Disease progression|0|||
105666557|NCT02419417|364443974|FG000|Overall Study|Study drug toxicity|0|||
105666558|NCT02419417|364443975|FG001|Overall Study|Study drug toxicity|0|||
105464404|NCT01746901|363714050|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
105464405|NCT01746901|363714051|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
105666559|NCT02419417|364443976|FG002|Overall Study|Study drug toxicity|0|||
105666560|NCT02419417|364443977|FG003|Overall Study|Study drug toxicity|0|||
105666561|NCT02419417|364443978|FG004|Overall Study|Study drug toxicity|1|||
105666562|NCT02419417|364443979|FG005|Overall Study|Study drug toxicity|0|||
105666563|NCT02419417|364443980|FG006|Overall Study|Study drug toxicity|0|||
105666564|NCT02419417|364443981|FG007|Overall Study|Study drug toxicity|0|||
105552558|NCT01953926|364021107|FG005|Overall Study|Not Treated|0|||
105552559|NCT01953926|364021108|FG006|Overall Study|Not Treated|0|||
105552560|NCT00833989|364021110|FG000|Overall Study|Physician Decision|0|||
105552561|NCT00833989|364021111|FG001|Overall Study|Physician Decision|0|||
105552562|NCT00833989|364021112|FG002|Overall Study|Physician Decision|0|||
105552563|NCT00833989|364021113|FG003|Overall Study|Physician Decision|1|||
105552564|NCT00833989|364021110|FG000|Overall Study|Withdrawal by Subject|3|||
105552565|NCT00833989|364021111|FG001|Overall Study|Withdrawal by Subject|0|||
105552566|NCT00833989|364021112|FG002|Overall Study|Withdrawal by Subject|1|||
105552567|NCT00833989|364021113|FG003|Overall Study|Withdrawal by Subject|1|||
105552568|NCT03998618|364021115|FG000|Overall Study|Death|7|||
105552569|NCT03998618|364021116|FG001|Overall Study|Death|11|||
105552570|NCT03998618|364021115|FG000|Overall Study|hospice enrollment|3|||
105552571|NCT03998618|364021116|FG001|Overall Study|hospice enrollment|3|||
105552572|NCT03998618|364021115|FG000|Overall Study|Not feeling well/health problems|3|||
105552573|NCT03998618|364021116|FG001|Overall Study|Not feeling well/health problems|5|||
105552574|NCT03998618|364021115|FG000|Overall Study|Lost to Follow-up|6|||
105552575|NCT03998618|364021116|FG001|Overall Study|Lost to Follow-up|6|||
105552576|NCT03998618|364021115|FG000|Overall Study|Withdrawal by Subject|0|||
105552577|NCT03998618|364021116|FG001|Overall Study|Withdrawal by Subject|4|||
105552578|NCT01910129|364021120|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
105552579|NCT01910129|364021121|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
105552580|NCT01910129|364021122|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
105552581|NCT01910129|364021120|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
105552582|NCT01910129|364021121|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
105552583|NCT01910129|364021122|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
105552584|NCT02105948|364021127|FG000|Overall Study|Adverse Event|10|||
105552585|NCT02105948|364021128|FG001|Overall Study|Adverse Event|7|||
105552586|NCT02105948|364021129|FG002|Overall Study|Adverse Event|11|||
105552587|NCT02105948|364021130|FG003|Overall Study|Adverse Event|11|||
105552588|NCT02105948|364021127|FG000|Overall Study|Lack of Efficacy|0|||
105552589|NCT02105948|364021128|FG001|Overall Study|Lack of Efficacy|1|||
105552590|NCT02105948|364021129|FG002|Overall Study|Lack of Efficacy|3|||
105552591|NCT02105948|364021130|FG003|Overall Study|Lack of Efficacy|2|||
105552592|NCT02105948|364021127|FG000|Overall Study|Lost to Follow-up|0|||
105552593|NCT02105948|364021128|FG001|Overall Study|Lost to Follow-up|0|||
105552594|NCT02105948|364021129|FG002|Overall Study|Lost to Follow-up|2|||
105552595|NCT02105948|364021130|FG003|Overall Study|Lost to Follow-up|1|||
105552596|NCT02105948|364021127|FG000|Overall Study|Physician Decision|2|||
105552597|NCT02105948|364021128|FG001|Overall Study|Physician Decision|2|||
105552598|NCT02105948|364021129|FG002|Overall Study|Physician Decision|2|||
105552599|NCT02105948|364021130|FG003|Overall Study|Physician Decision|2|||
105552600|NCT02105948|364021127|FG000|Overall Study|Withdrawal by Subject|15|||
105552601|NCT02105948|364021128|FG001|Overall Study|Withdrawal by Subject|10|||
105552602|NCT02105948|364021129|FG002|Overall Study|Withdrawal by Subject|10|||
105552603|NCT02105948|364021130|FG003|Overall Study|Withdrawal by Subject|11|||
105552604|NCT02187991|364021133|FG000|Overall Study|Adverse Event|13|||
105552605|NCT02187991|364021134|FG001|Overall Study|Adverse Event|14|||
105552606|NCT02187991|364021135|FG002|Overall Study|Adverse Event|3|||
105552607|NCT02187991|364021136|FG003|Overall Study|Adverse Event|2|||
105666565|NCT02419417|364443982|FG008|Overall Study|Study drug toxicity|0|||
105552608|NCT02187991|364021133|FG000|Overall Study|Withdrawal by Subject|9|||
105552609|NCT02187991|364021134|FG001|Overall Study|Withdrawal by Subject|6|||
105552610|NCT02187991|364021135|FG002|Overall Study|Withdrawal by Subject|3|||
105552611|NCT02187991|364021136|FG003|Overall Study|Withdrawal by Subject|2|||
105552612|NCT02187991|364021133|FG000|Overall Study|Physician Decision|4|||
105552613|NCT02187991|364021134|FG001|Overall Study|Physician Decision|4|||
105552614|NCT02187991|364021135|FG002|Overall Study|Physician Decision|0|||
105552615|NCT02187991|364021136|FG003|Overall Study|Physician Decision|2|||
105552616|NCT02187991|364021133|FG000|Overall Study|Other, unrelated complication|7|||
105552617|NCT02187991|364021134|FG001|Overall Study|Other, unrelated complication|1|||
105552618|NCT02187991|364021135|FG002|Overall Study|Other, unrelated complication|1|||
105552619|NCT02187991|364021136|FG003|Overall Study|Other, unrelated complication|2|||
105552620|NCT02187991|364021133|FG000|Overall Study|Death|1|||
105552621|NCT02187991|364021134|FG001|Overall Study|Death|3|||
105552622|NCT02187991|364021135|FG002|Overall Study|Death|0|||
105552623|NCT02187991|364021136|FG003|Overall Study|Death|0|||
105552624|NCT01939028|364021141|FG000|Overall Study|Withdrawal by Subject|5|||
105666566|NCT02419417|364443983|FG009|Overall Study|Study drug toxicity|0|||
105552625|NCT01939028|364021141|FG000|Overall Study|Physician Decision|7|||
105552626|NCT00936858|364021142|FG000|Overall Study|Death|3|||
105552627|NCT00936858|364021142|FG000|Overall Study|Progression|29|||
105552628|NCT00936858|364021142|FG000|Overall Study|Withdrawal by Subject|5|||
105552629|NCT00936858|364021142|FG000|Overall Study|Adverse Event|1|||
105552630|NCT00936858|364021142|FG000|Overall Study|Physician Decision|7|||
105552631|NCT00936858|364021142|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
105666567|NCT02419417|364443984|FG010|Overall Study|Study drug toxicity|0|||
105666568|NCT02419417|364443974|FG000|Overall Study|Adverse event unrelated to study drug|0|||
105666569|NCT02419417|364443975|FG001|Overall Study|Adverse event unrelated to study drug|0|||
105666570|NCT02419417|364443976|FG002|Overall Study|Adverse event unrelated to study drug|0|||
105666571|NCT02419417|364443977|FG003|Overall Study|Adverse event unrelated to study drug|0|||
105666572|NCT02419417|364443978|FG004|Overall Study|Adverse event unrelated to study drug|2|||
105666573|NCT02419417|364443979|FG005|Overall Study|Adverse event unrelated to study drug|1|||
105666574|NCT02419417|364443980|FG006|Overall Study|Adverse event unrelated to study drug|0|||
105666575|NCT02419417|364443981|FG007|Overall Study|Adverse event unrelated to study drug|1|||
105666576|NCT02419417|364443982|FG008|Overall Study|Adverse event unrelated to study drug|0|||
105666577|NCT02419417|364443983|FG009|Overall Study|Adverse event unrelated to study drug|0|||
105666578|NCT02419417|364443984|FG010|Overall Study|Adverse event unrelated to study drug|0|||
105666579|NCT02419417|364443974|FG000|Overall Study|Participant request to discontinue|0|||
105666580|NCT02419417|364443975|FG001|Overall Study|Participant request to discontinue|0|||
105666581|NCT02419417|364443976|FG002|Overall Study|Participant request to discontinue|0|||
105666582|NCT02419417|364443977|FG003|Overall Study|Participant request to discontinue|0|||
105666583|NCT02419417|364443978|FG004|Overall Study|Participant request to discontinue|0|||
105666584|NCT02419417|364443979|FG005|Overall Study|Participant request to discontinue|0|||
105666585|NCT02419417|364443980|FG006|Overall Study|Participant request to discontinue|0|||
105666586|NCT02419417|364443981|FG007|Overall Study|Participant request to discontinue|0|||
105666587|NCT02419417|364443982|FG008|Overall Study|Participant request to discontinue|0|||
105666588|NCT02419417|364443983|FG009|Overall Study|Participant request to discontinue|1|||
105666589|NCT02419417|364443984|FG010|Overall Study|Participant request to discontinue|0|||
105666590|NCT02419417|364443974|FG000|Overall Study|Withdrawal by Subject|0|||
105666591|NCT02419417|364443975|FG001|Overall Study|Withdrawal by Subject|0|||
105666592|NCT02419417|364443976|FG002|Overall Study|Withdrawal by Subject|0|||
105666593|NCT02419417|364443977|FG003|Overall Study|Withdrawal by Subject|0|||
105666594|NCT02419417|364443978|FG004|Overall Study|Withdrawal by Subject|0|||
105666595|NCT02419417|364443979|FG005|Overall Study|Withdrawal by Subject|0|||
105666596|NCT02419417|364443980|FG006|Overall Study|Withdrawal by Subject|0|||
105666597|NCT02419417|364443981|FG007|Overall Study|Withdrawal by Subject|0|||
105666598|NCT02419417|364443982|FG008|Overall Study|Withdrawal by Subject|0|||
105666599|NCT02419417|364443983|FG009|Overall Study|Withdrawal by Subject|0|||
105666600|NCT02419417|364443984|FG010|Overall Study|Withdrawal by Subject|1|||
105666601|NCT01730950|364443992|FG000|Overall Study|Protocol Violation|6|||
105666602|NCT01730950|364443993|FG001|Overall Study|Protocol Violation|6|||
105666603|NCT00667459|364443994|FG000|Overall Study|Death|0|||
105666604|NCT00667459|364443995|FG001|Overall Study|Death|2|||
105666605|NCT00667459|364443994|FG000|Overall Study|Lost to Follow-up|8|||
105666606|NCT00667459|364443995|FG001|Overall Study|Lost to Follow-up|43|||
105666607|NCT00132678|364444004|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
105666608|NCT00132678|364444005|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
105666609|NCT00132678|364444006|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
105666610|NCT00132678|364444004|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
105666611|NCT00132678|364444005|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
105666612|NCT00132678|364444006|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
105666613|NCT00132678|364444004|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
105666614|NCT00132678|364444005|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
105666615|NCT00132678|364444006|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
105666616|NCT00132678|364444004|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
105666617|NCT00132678|364444005|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
105666618|NCT00132678|364444006|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
105666619|NCT00132678|364444004|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
105666620|NCT00132678|364444005|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
105666621|NCT00132678|364444006|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
105666622|NCT00132678|364444004|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
105666623|NCT00132678|364444005|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
105666624|NCT00132678|364444006|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
105666625|NCT00132678|364444004|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
105666626|NCT00132678|364444005|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
105666627|NCT00132678|364444006|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
105666628|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Death|2|||
105552632|NCT00936858|364021142|FG000|Overall Study|Lost to Follow-up|1|||
105552633|NCT02576067|364021145|FG000|Overall Study|Death|0|||
105552634|NCT02576067|364021146|FG001|Overall Study|Death|1|||
105552635|NCT02576067|364021145|FG000|Overall Study|Lack of Efficacy|1|||
105552636|NCT02576067|364021146|FG001|Overall Study|Lack of Efficacy|0|||
105552637|NCT02576067|364021145|FG000|Overall Study|Lost to Follow-up|11|||
105552638|NCT02576067|364021146|FG001|Overall Study|Lost to Follow-up|0|||
105552639|NCT02576067|364021145|FG000|Overall Study|Withdrawal by Subject|11|||
105552640|NCT02576067|364021146|FG001|Overall Study|Withdrawal by Subject|2|||
105552641|NCT02576067|364021145|FG000|Overall Study|study closure of main CIRT trial)|0|||
105552642|NCT02576067|364021146|FG001|Overall Study|study closure of main CIRT trial)|8|||
105552643|NCT02576067|364021145|FG000|Overall Study|not randomized, failed run-in|7|||
105552644|NCT02576067|364021146|FG001|Overall Study|not randomized, failed run-in|0|||
105552645|NCT02576067|364021145|FG000|Overall Study|screen failure/ re-enrolled|0|||
105552646|NCT02576067|364021146|FG001|Overall Study|screen failure/ re-enrolled|25|||
105552647|NCT02576067|364021145|FG000|Overall Study|Physician Decision|4|||
105552648|NCT02576067|364021146|FG001|Overall Study|Physician Decision|0|||
105552649|NCT04773587|364021147|FG000|Overall Study|Lost to Follow-up|11|||
105552650|NCT04773587|364021148|FG001|Overall Study|Lost to Follow-up|3|||
105552651|NCT04773587|364021147|FG000|Overall Study|Adverse Event|6|||
105552652|NCT04773587|364021148|FG001|Overall Study|Adverse Event|3|||
105552653|NCT04773587|364021147|FG000|Overall Study|Lack of Efficacy|5|||
105552654|NCT04773587|364021148|FG001|Overall Study|Lack of Efficacy|2|||
105552655|NCT04773587|364021147|FG000|Overall Study|Withdrawal by Subject|4|||
105552656|NCT04773587|364021148|FG001|Overall Study|Withdrawal by Subject|5|||
105552657|NCT04773587|364021147|FG000|Overall Study|Noncompliance|1|||
105552658|NCT04773587|364021148|FG001|Overall Study|Noncompliance|0|||
105552659|NCT04773587|364021147|FG000|Overall Study|Protocol Violation|1|||
105552660|NCT04773587|364021148|FG001|Overall Study|Protocol Violation|0|||
105552661|NCT04773587|364021147|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
105552662|NCT04773587|364021148|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
105552663|NCT02372409|364021149|FG000|Overall Study|Lost to Follow-up|1|||
105552664|NCT02372409|364021150|FG001|Overall Study|Lost to Follow-up|0|||
105552665|NCT02372409|364021149|FG000|Overall Study|Disease progression|1|||
105552666|NCT02372409|364021150|FG001|Overall Study|Disease progression|1|||
105552667|NCT00047879|364021151|FG000|Overall Study|Progressive disease|4|||
105552668|NCT00047879|364021152|FG001|Overall Study|Progressive disease|3|||
105552669|NCT00714168|364021155|FG000|Overall Study|Pregnancy|5|||
105552670|NCT00714168|364021156|FG001|Overall Study|Pregnancy|4|||
105552671|NCT00714168|364021155|FG000|Overall Study|Lost to Follow-up|32|||
105552672|NCT00714168|364021156|FG001|Overall Study|Lost to Follow-up|50|||
105552673|NCT00714168|364021155|FG000|Overall Study|Relocation|4|||
105552674|NCT00714168|364021156|FG001|Overall Study|Relocation|3|||
105552675|NCT00714168|364021155|FG000|Overall Study|Non-study medical condition|3|||
105552676|NCT00714168|364021156|FG001|Overall Study|Non-study medical condition|2|||
105552677|NCT02096900|364021157|FG000|Overall Study|Did not receive medication|3|||
105552678|NCT02096900|364021158|FG001|Overall Study|Did not receive medication|1|||
105552679|NCT02096900|364021157|FG000|Overall Study|Surgery cancelled- medication received|1|||
105552680|NCT02096900|364021158|FG001|Overall Study|Surgery cancelled- medication received|1|||
105552681|NCT04764396|364021170|FG000|Overall Study|Physician Decision|1|||
105552682|NCT04764396|364021171|FG001|Overall Study|Physician Decision|0|||
105552683|NCT03077724|364021173|FG000|Overall Study|Lost to Follow-up|5|||
105552684|NCT03077724|364021174|FG001|Overall Study|Lost to Follow-up|1|||
105552685|NCT03077724|364021173|FG000|Overall Study|Withdrawal by Subject|3|||
105552686|NCT03077724|364021174|FG001|Overall Study|Withdrawal by Subject|1|||
105552687|NCT04827576|364023256|FG000|Overall Study|Death|5|||
105552688|NCT04827576|364023257|FG001|Overall Study|Death|17|||
105552689|NCT04827576|364023258|FG002|Overall Study|Death|17|||
105552690|NCT04827576|364023259|FG003|Overall Study|Death|32|||
105552691|NCT04827576|364023256|FG000|Overall Study|Study Terminated by Sponsor|2|||
105552692|NCT04827576|364023257|FG001|Overall Study|Study Terminated by Sponsor|9|||
105552693|NCT04827576|364023258|FG002|Overall Study|Study Terminated by Sponsor|7|||
105552694|NCT04827576|364023259|FG003|Overall Study|Study Terminated by Sponsor|5|||
105552695|NCT04827576|364023256|FG000|Overall Study|Investigator's Discretion|1|||
105552696|NCT04827576|364023257|FG001|Overall Study|Investigator's Discretion|0|||
105552697|NCT04827576|364023258|FG002|Overall Study|Investigator's Discretion|2|||
105552698|NCT04827576|364023259|FG003|Overall Study|Investigator's Discretion|5|||
105552699|NCT04827576|364023256|FG000|Overall Study|Withdrew Consent|0|||
105552700|NCT04827576|364023257|FG001|Overall Study|Withdrew Consent|3|||
105552701|NCT04827576|364023258|FG002|Overall Study|Withdrew Consent|0|||
105552702|NCT04827576|364023259|FG003|Overall Study|Withdrew Consent|0|||
105552703|NCT04827576|364023256|FG000|Overall Study|Lost to Follow-up|1|||
105552704|NCT04827576|364023257|FG001|Overall Study|Lost to Follow-up|0|||
105552705|NCT04827576|364023258|FG002|Overall Study|Lost to Follow-up|0|||
105552706|NCT04827576|364023259|FG003|Overall Study|Lost to Follow-up|0|||
105552707|NCT00791765|364023260|FG000|Weeks 1 to 12|Adverse Event|0|||
105464406|NCT01746901|363714052|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
105464407|NCT01746901|363714053|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
105464408|NCT01746901|363714054|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
105464409|NCT01746901|363714055|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
105464410|NCT01746901|363714056|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
105464411|NCT01746901|363714048|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
105464412|NCT01746901|363714049|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
105464413|NCT01746901|363714050|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
105464414|NCT01746901|363714051|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
105464415|NCT01746901|363714052|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
105464416|NCT01746901|363714053|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
105464417|NCT01746901|363714054|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
105464418|NCT01746901|363714055|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
105464419|NCT01746901|363714056|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
105464420|NCT01746901|363714048|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105464421|NCT01746901|363714049|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
105464422|NCT01746901|363714050|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
105464423|NCT01746901|363714051|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105464424|NCT01746901|363714052|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105464425|NCT01746901|363714053|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105464426|NCT01746901|363714054|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105464427|NCT01746901|363714055|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105464428|NCT01746901|363714056|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105464429|NCT01746901|363714048|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
105464430|NCT01746901|363714049|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
105464431|NCT01746901|363714050|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
105464432|NCT01746901|363714051|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
105464433|NCT01746901|363714052|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
105464434|NCT01746901|363714053|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
105464435|NCT01746901|363714054|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
105464436|NCT01746901|363714055|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
105464437|NCT01746901|363714056|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
105552708|NCT00791765|364023261|FG001|Weeks 1 to 12|Adverse Event|1|||
105552709|NCT00791765|364023260|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
105464438|NCT01746901|363714048|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
105464439|NCT01746901|363714049|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
105464440|NCT01746901|363714050|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
105464441|NCT01746901|363714051|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
105464442|NCT01746901|363714052|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
105464443|NCT01746901|363714053|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
105464444|NCT01746901|363714054|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
105464445|NCT01746901|363714055|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
105464446|NCT01746901|363714056|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
105464447|NCT01746901|363714048|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
105464448|NCT01746901|363714049|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
105464449|NCT01746901|363714050|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
105464450|NCT01746901|363714051|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
105464451|NCT01746901|363714052|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
105464452|NCT01746901|363714053|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
105464453|NCT01746901|363714054|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
105464454|NCT01746901|363714055|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
105464455|NCT01746901|363714056|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
105464456|NCT01746901|363714048|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
105464457|NCT01746901|363714049|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
105464458|NCT01746901|363714050|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
105464459|NCT01746901|363714051|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
105464460|NCT01746901|363714052|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
105464461|NCT01746901|363714053|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
105464462|NCT01746901|363714054|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
105464463|NCT01746901|363714055|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
105464464|NCT01746901|363714056|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
105552710|NCT00791765|364023261|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
105552711|NCT00791765|364023260|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
105552712|NCT00791765|364023261|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
105552713|NCT00791765|364023260|FG000|Weeks 1 to 12|Physician Decision|1|||
105552714|NCT00791765|364023261|FG001|Weeks 1 to 12|Physician Decision|0|||
105552715|NCT00791765|364023260|FG000|Weeks 1 to 12|Disease progression|3|||
105552716|NCT00791765|364023261|FG001|Weeks 1 to 12|Disease progression|0|||
105552717|NCT00791765|364023260|FG000|Weeks 1 to 12|Ineligibility determined|0|||
105552718|NCT00791765|364023261|FG001|Weeks 1 to 12|Ineligibility determined|3|||
105552719|NCT00791765|364023260|FG000|Weeks 13 to 24|Protocol deviation|2|||
105552720|NCT00791765|364023261|FG001|Weeks 13 to 24|Protocol deviation|0|||
105552721|NCT00791765|364023260|FG000|Weeks 13 to 24|Adverse Event|0|||
105552722|NCT00791765|364023261|FG001|Weeks 13 to 24|Adverse Event|3|||
105552723|NCT00791765|364023260|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
105552724|NCT00791765|364023261|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
105552725|NCT00791765|364023260|FG000|Weeks 13 to 24|Disease progression|0|||
105552726|NCT00791765|364023261|FG001|Weeks 13 to 24|Disease progression|1|||
105552727|NCT00791765|364023260|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
105552728|NCT00791765|364023261|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
105552729|NCT00791765|364023260|FG000|Weeks 13 to 24|Other|0|||
105552730|NCT00791765|364023261|FG001|Weeks 13 to 24|Other|1|||
105552731|NCT01261611|364023263|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
105552732|NCT01261611|364023264|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
105552733|NCT01261611|364023265|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
105552734|NCT01261611|364023263|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
105552735|NCT01261611|364023264|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
105552736|NCT01261611|364023265|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
105552737|NCT01261611|364023263|FG000|Treatment Cycle 1|Adverse Event|0|||
105552738|NCT01261611|364023264|FG001|Treatment Cycle 1|Adverse Event|1|||
105552739|NCT01261611|364023265|FG002|Treatment Cycle 1|Adverse Event|0|||
105552740|NCT01261611|364023263|FG000|Treatment Cycle 1|Protocol Violation|0|||
105552741|NCT01261611|364023264|FG001|Treatment Cycle 1|Protocol Violation|0|||
105552742|NCT01261611|364023265|FG002|Treatment Cycle 1|Protocol Violation|2|||
105552743|NCT01261611|364023263|FG000|Treatment Cycle 2|Completed study|4|||
105552744|NCT01261611|364023264|FG001|Treatment Cycle 2|Completed study|0|||
105552745|NCT01261611|364023265|FG002|Treatment Cycle 2|Completed study|0|||
105552746|NCT01261611|364023263|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
105552747|NCT01261611|364023264|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
105552748|NCT01261611|364023265|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
105552749|NCT01261611|364023263|FG000|Treatment Cycle 2|Adverse Event|1|||
105552750|NCT01261611|364023264|FG001|Treatment Cycle 2|Adverse Event|0|||
105552751|NCT01261611|364023265|FG002|Treatment Cycle 2|Adverse Event|0|||
105552752|NCT01261611|364023263|FG000|Treatment Cycle 2|Protocol Violation|2|||
105552753|NCT01261611|364023264|FG001|Treatment Cycle 2|Protocol Violation|0|||
105552754|NCT01261611|364023265|FG002|Treatment Cycle 2|Protocol Violation|0|||
105552755|NCT01261611|364023263|FG000|Treatment Cycle 2|Not otherwise specified|2|||
105552756|NCT01261611|364023264|FG001|Treatment Cycle 2|Not otherwise specified|0|||
105552757|NCT01261611|364023265|FG002|Treatment Cycle 2|Not otherwise specified|0|||
105552758|NCT01261611|364023263|FG000|Treatment Cycle 3|Completed study|24|||
105552759|NCT01261611|364023264|FG001|Treatment Cycle 3|Completed study|0|||
105552760|NCT01261611|364023265|FG002|Treatment Cycle 3|Completed study|0|||
105552761|NCT01261611|364023263|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
105552762|NCT01261611|364023264|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
105552763|NCT01261611|364023265|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
105552764|NCT01261611|364023263|FG000|Treatment Cycle 3|Adverse Event|1|||
105552765|NCT01261611|364023264|FG001|Treatment Cycle 3|Adverse Event|0|||
105552766|NCT01261611|364023265|FG002|Treatment Cycle 3|Adverse Event|0|||
105552767|NCT01261611|364023263|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
105552768|NCT01261611|364023264|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
105552769|NCT01261611|364023265|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
105552770|NCT01261611|364023263|FG000|Treatment Cycle 4|Completed study|87|||
105552771|NCT01261611|364023264|FG001|Treatment Cycle 4|Completed study|0|||
105552772|NCT01261611|364023265|FG002|Treatment Cycle 4|Completed study|0|||
105552773|NCT01261611|364023263|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
105552774|NCT01261611|364023264|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
105552775|NCT01261611|364023265|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
105552776|NCT01261611|364023263|FG000|Treatment Cycle 4|Adverse Event|1|||
105552777|NCT01261611|364023264|FG001|Treatment Cycle 4|Adverse Event|0|||
105552778|NCT01261611|364023265|FG002|Treatment Cycle 4|Adverse Event|0|||
105552779|NCT01261611|364023263|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
105552780|NCT01261611|364023264|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
105552781|NCT01261611|364023265|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
105552782|NCT01261611|364023263|FG000|Treatment Cycle 4|Not otherwise specified|3|||
105552783|NCT01261611|364023264|FG001|Treatment Cycle 4|Not otherwise specified|0|||
105552784|NCT01261611|364023265|FG002|Treatment Cycle 4|Not otherwise specified|0|||
105552785|NCT01261611|364023263|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
105552786|NCT01261611|364023264|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
105552787|NCT01261611|364023265|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
105552788|NCT01261611|364023263|FG000|Treatment Cycle 5|Adverse Event|1|||
105552789|NCT01261611|364023264|FG001|Treatment Cycle 5|Adverse Event|0|||
105552790|NCT01261611|364023265|FG002|Treatment Cycle 5|Adverse Event|0|||
105552791|NCT01261611|364023263|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
105666629|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Death|0|||
105666630|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Death|0|||
105666631|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
105666632|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
105666633|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
105552792|NCT01261611|364023264|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
105552793|NCT01261611|364023265|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
105552794|NCT05349617|364023269|FG000|Overall Study|Death|1|||
105552795|NCT05349617|364023270|FG001|Overall Study|Death|1|||
105552796|NCT05349617|364023269|FG000|Overall Study|Lost to Follow-up|3|||
105552797|NCT05349617|364023270|FG001|Overall Study|Lost to Follow-up|8|||
105552798|NCT05349617|364023269|FG000|Overall Study|Withdrawal by Subject|2|||
105552799|NCT05349617|364023270|FG001|Overall Study|Withdrawal by Subject|10|||
105552800|NCT01432366|364023271|FG000|Overall Study|Non-Responder|7|||
105552801|NCT01432366|364023271|FG000|Overall Study|Adverse Event|8|||
105552802|NCT01432366|364023271|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
105552803|NCT01432366|364023271|FG000|Overall Study|Pregnancy|1|||
105552804|NCT01432366|364023271|FG000|Overall Study|Lost to Follow-up|13|||
105552805|NCT01432366|364023271|FG000|Overall Study|Lack of Efficacy|1|||
105552806|NCT01432366|364023271|FG000|Overall Study|Site Closed|20|||
105552807|NCT01432366|364023271|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
105552808|NCT01432366|364023271|FG000|Overall Study|Other|14|||
105552809|NCT01808690|364023272|FG000|Overall Study|Withdrawal by Subject|1|||
105552810|NCT01808690|364023273|FG001|Overall Study|Withdrawal by Subject|2|||
105552811|NCT03870763|364023274|FG000|Overall Study|Study terminated by sponsor|0|||
105552812|NCT03870763|364023275|FG001|Overall Study|Study terminated by sponsor|2|||
105552813|NCT03870763|364023276|FG002|Overall Study|Study terminated by sponsor|0|||
105552814|NCT03870763|364023274|FG000|Overall Study|Withdrawal by Subject|0|||
105552815|NCT03870763|364023275|FG001|Overall Study|Withdrawal by Subject|1|||
105552816|NCT03870763|364023276|FG002|Overall Study|Withdrawal by Subject|0|||
105552817|NCT03870763|364023274|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
105552818|NCT03870763|364023275|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
105552819|NCT03870763|364023276|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
105552820|NCT02332720|364023285|FG000|Part A and Part B|Lost to Follow-up|1|||
105552821|NCT02332720|364023286|FG001|Part A and Part B|Lost to Follow-up|0|||
105552822|NCT02332720|364023287|FG002|Part A and Part B|Lost to Follow-up|0|||
105552823|NCT02332720|364023288|FG003|Part A and Part B|Lost to Follow-up|0|||
105552824|NCT02332720|364023289|FG004|Part A and Part B|Lost to Follow-up|0|||
105552825|NCT02332720|364023290|FG005|Part A and Part B|Lost to Follow-up|2|||
105552826|NCT02332720|364023291|FG006|Part A and Part B|Lost to Follow-up|1|||
105552827|NCT02332720|364023292|FG007|Part A and Part B|Lost to Follow-up|1|||
105552828|NCT02332720|364023293|FG008|Part A and Part B|Lost to Follow-up|0|||
105552829|NCT02332720|364023294|FG009|Part A and Part B|Lost to Follow-up|0|||
105552830|NCT02332720|364023295|FG010|Part A and Part B|Lost to Follow-up|0|||
105552831|NCT02332720|364023296|FG011|Part A and Part B|Lost to Follow-up|0|||
105552832|NCT02332720|364023297|FG012|Part A and Part B|Lost to Follow-up|0|||
105552833|NCT02332720|364023298|FG013|Part A and Part B|Lost to Follow-up|0|||
105552834|NCT02332720|364023299|FG014|Part A and Part B|Lost to Follow-up|0|||
105552835|NCT02332720|364023300|FG015|Part A and Part B|Lost to Follow-up|1|||
105552836|NCT02332720|364023301|FG016|Part A and Part B|Lost to Follow-up|0|||
105552837|NCT02332720|364023302|FG017|Part A and Part B|Lost to Follow-up|0|||
105552838|NCT02332720|364023303|FG018|Part A and Part B|Lost to Follow-up|0|||
105552839|NCT02332720|364023304|FG019|Part A and Part B|Lost to Follow-up|0|||
105552840|NCT02332720|364023305|FG020|Part A and Part B|Lost to Follow-up|0|||
105552841|NCT02332720|364023306|FG021|Part A and Part B|Lost to Follow-up|0|||
105552842|NCT02332720|364023307|FG022|Part A and Part B|Lost to Follow-up|0|||
105552843|NCT02332720|364023285|FG000|Part A and Part B|Adverse Event|0|||
105552844|NCT02332720|364023286|FG001|Part A and Part B|Adverse Event|0|||
105552845|NCT02332720|364023287|FG002|Part A and Part B|Adverse Event|0|||
105552846|NCT02332720|364023288|FG003|Part A and Part B|Adverse Event|0|||
105666634|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
105552847|NCT02332720|364023289|FG004|Part A and Part B|Adverse Event|0|||
105552848|NCT02332720|364023290|FG005|Part A and Part B|Adverse Event|0|||
105552849|NCT02332720|364023291|FG006|Part A and Part B|Adverse Event|0|||
105464465|NCT01746901|363714048|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
105464466|NCT01746901|363714049|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
105464467|NCT01746901|363714050|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
105464468|NCT01746901|363714051|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
105464469|NCT01746901|363714052|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
105464470|NCT01746901|363714053|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
105464471|NCT01746901|363714054|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
105464472|NCT01746901|363714055|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
105464473|NCT01746901|363714056|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
105464474|NCT01746901|363714048|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
105464475|NCT01746901|363714049|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
105464476|NCT01746901|363714050|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
105464477|NCT01746901|363714051|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
105464478|NCT01746901|363714052|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
105464479|NCT01746901|363714053|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
105464480|NCT01746901|363714054|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
105464481|NCT01746901|363714055|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
105464482|NCT01746901|363714056|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
105464483|NCT04225897|363714057|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
105464484|NCT04225897|363714058|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
105464485|NCT04225897|363714059|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
105464486|NCT04225897|363714060|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
105464487|NCT04225897|363714061|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
105552850|NCT02332720|364023292|FG007|Part A and Part B|Adverse Event|0|||
105552851|NCT02332720|364023293|FG008|Part A and Part B|Adverse Event|0|||
105552852|NCT02332720|364023294|FG009|Part A and Part B|Adverse Event|0|||
105552853|NCT02332720|364023295|FG010|Part A and Part B|Adverse Event|0|||
105552854|NCT02332720|364023296|FG011|Part A and Part B|Adverse Event|0|||
105552855|NCT02332720|364023297|FG012|Part A and Part B|Adverse Event|0|||
105552856|NCT02332720|364023298|FG013|Part A and Part B|Adverse Event|0|||
105552857|NCT02332720|364023299|FG014|Part A and Part B|Adverse Event|0|||
105552858|NCT02332720|364023300|FG015|Part A and Part B|Adverse Event|0|||
105552859|NCT02332720|364023301|FG016|Part A and Part B|Adverse Event|0|||
105552860|NCT02332720|364023302|FG017|Part A and Part B|Adverse Event|1|||
105552861|NCT02332720|364023303|FG018|Part A and Part B|Adverse Event|0|||
105552862|NCT02332720|364023304|FG019|Part A and Part B|Adverse Event|0|||
105552863|NCT02332720|364023305|FG020|Part A and Part B|Adverse Event|0|||
105552864|NCT02332720|364023306|FG021|Part A and Part B|Adverse Event|0|||
105552865|NCT02332720|364023307|FG022|Part A and Part B|Adverse Event|0|||
105552866|NCT02332720|364023285|FG000|Part A and Part B|Physician Decision|0|||
105552867|NCT02332720|364023286|FG001|Part A and Part B|Physician Decision|0|||
105552868|NCT02332720|364023287|FG002|Part A and Part B|Physician Decision|0|||
105552869|NCT02332720|364023288|FG003|Part A and Part B|Physician Decision|0|||
105552870|NCT02332720|364023289|FG004|Part A and Part B|Physician Decision|0|||
105552871|NCT02332720|364023290|FG005|Part A and Part B|Physician Decision|0|||
105552872|NCT02332720|364023291|FG006|Part A and Part B|Physician Decision|0|||
105552873|NCT02332720|364023292|FG007|Part A and Part B|Physician Decision|0|||
105552874|NCT02332720|364023293|FG008|Part A and Part B|Physician Decision|0|||
105552875|NCT02332720|364023294|FG009|Part A and Part B|Physician Decision|0|||
105552876|NCT02332720|364023295|FG010|Part A and Part B|Physician Decision|0|||
105552877|NCT02332720|364023296|FG011|Part A and Part B|Physician Decision|0|||
105552878|NCT02332720|364023297|FG012|Part A and Part B|Physician Decision|0|||
105552879|NCT02332720|364023298|FG013|Part A and Part B|Physician Decision|0|||
105552880|NCT02332720|364023299|FG014|Part A and Part B|Physician Decision|0|||
105552881|NCT02332720|364023300|FG015|Part A and Part B|Physician Decision|0|||
105552882|NCT02332720|364023301|FG016|Part A and Part B|Physician Decision|0|||
105552883|NCT02332720|364023302|FG017|Part A and Part B|Physician Decision|0|||
105552884|NCT02332720|364023303|FG018|Part A and Part B|Physician Decision|1|||
105552885|NCT02332720|364023304|FG019|Part A and Part B|Physician Decision|0|||
105552886|NCT02332720|364023305|FG020|Part A and Part B|Physician Decision|0|||
105552887|NCT02332720|364023306|FG021|Part A and Part B|Physician Decision|0|||
105552888|NCT02332720|364023307|FG022|Part A and Part B|Physician Decision|0|||
105552889|NCT02332720|364023285|FG000|Part A and Part B|Withdrawal by Subject|0|||
105552890|NCT02332720|364023286|FG001|Part A and Part B|Withdrawal by Subject|0|||
105552891|NCT02332720|364023287|FG002|Part A and Part B|Withdrawal by Subject|0|||
105552892|NCT02332720|364023288|FG003|Part A and Part B|Withdrawal by Subject|0|||
105552893|NCT02332720|364023289|FG004|Part A and Part B|Withdrawal by Subject|0|||
105552894|NCT02332720|364023290|FG005|Part A and Part B|Withdrawal by Subject|1|||
105552895|NCT02332720|364023291|FG006|Part A and Part B|Withdrawal by Subject|0|||
105552896|NCT02332720|364023292|FG007|Part A and Part B|Withdrawal by Subject|0|||
105552897|NCT02332720|364023293|FG008|Part A and Part B|Withdrawal by Subject|0|||
105552898|NCT02332720|364023294|FG009|Part A and Part B|Withdrawal by Subject|0|||
105552899|NCT02332720|364023295|FG010|Part A and Part B|Withdrawal by Subject|0|||
105552900|NCT02332720|364023296|FG011|Part A and Part B|Withdrawal by Subject|0|||
105552901|NCT02332720|364023297|FG012|Part A and Part B|Withdrawal by Subject|0|||
105552902|NCT02332720|364023298|FG013|Part A and Part B|Withdrawal by Subject|0|||
105552903|NCT02332720|364023299|FG014|Part A and Part B|Withdrawal by Subject|0|||
105552904|NCT02332720|364023300|FG015|Part A and Part B|Withdrawal by Subject|0|||
105552905|NCT02332720|364023301|FG016|Part A and Part B|Withdrawal by Subject|0|||
105552906|NCT02332720|364023302|FG017|Part A and Part B|Withdrawal by Subject|0|||
105552907|NCT02332720|364023303|FG018|Part A and Part B|Withdrawal by Subject|0|||
105552908|NCT02332720|364023304|FG019|Part A and Part B|Withdrawal by Subject|1|||
105552909|NCT02332720|364023305|FG020|Part A and Part B|Withdrawal by Subject|0|||
105552910|NCT02332720|364023306|FG021|Part A and Part B|Withdrawal by Subject|0|||
105552911|NCT02332720|364023307|FG022|Part A and Part B|Withdrawal by Subject|0|||
105552912|NCT05912400|364023308|FG000|Overall Study|Lost to Follow-up|1|||
105552913|NCT05912400|364023309|FG001|Overall Study|Lost to Follow-up|0|||
105552914|NCT05912400|364023308|FG000|Overall Study|Physician Decision|6|||
105552915|NCT05912400|364023309|FG001|Overall Study|Physician Decision|0|||
105552916|NCT05912400|364023308|FG000|Overall Study|Withdrawal by Subject|1|||
105552917|NCT05912400|364023309|FG001|Overall Study|Withdrawal by Subject|0|||
105552918|NCT00838110|364023311|FG000|Overall Study|Death|0|||
105552919|NCT00838110|364023312|FG001|Overall Study|Death|0|||
105552920|NCT00838110|364023313|FG002|Overall Study|Death|1|||
105552921|NCT00838110|364023314|FG003|Overall Study|Death|2|||
105552922|NCT00838110|364023311|FG000|Overall Study|Adverse Event|11|||
105552923|NCT00838110|364023312|FG001|Overall Study|Adverse Event|10|||
105552924|NCT00838110|364023313|FG002|Overall Study|Adverse Event|8|||
105552925|NCT00838110|364023314|FG003|Overall Study|Adverse Event|7|||
105552926|NCT00838110|364023311|FG000|Overall Study|Withdrawal by Subject|5|||
105552927|NCT00838110|364023312|FG001|Overall Study|Withdrawal by Subject|6|||
105552928|NCT00838110|364023313|FG002|Overall Study|Withdrawal by Subject|3|||
105552929|NCT00838110|364023314|FG003|Overall Study|Withdrawal by Subject|4|||
105552930|NCT00838110|364023311|FG000|Overall Study|Other|3|||
105552931|NCT00838110|364023312|FG001|Overall Study|Other|3|||
105552932|NCT00838110|364023313|FG002|Overall Study|Other|3|||
105552933|NCT00838110|364023314|FG003|Overall Study|Other|2|||
105552934|NCT00838110|364023311|FG000|Overall Study|Protocol Violation|0|||
105552935|NCT00838110|364023312|FG001|Overall Study|Protocol Violation|2|||
105552936|NCT00838110|364023313|FG002|Overall Study|Protocol Violation|1|||
105552937|NCT00838110|364023314|FG003|Overall Study|Protocol Violation|1|||
105552938|NCT00838110|364023311|FG000|Overall Study|Lost to Follow-up|3|||
105552939|NCT00838110|364023312|FG001|Overall Study|Lost to Follow-up|0|||
105552940|NCT00838110|364023313|FG002|Overall Study|Lost to Follow-up|0|||
105552941|NCT00838110|364023314|FG003|Overall Study|Lost to Follow-up|0|||
105552942|NCT00838110|364023311|FG000|Overall Study|Did not meet eligibility criteria|0|||
105552943|NCT00838110|364023312|FG001|Overall Study|Did not meet eligibility criteria|0|||
105552944|NCT00838110|364023313|FG002|Overall Study|Did not meet eligibility criteria|1|||
105552945|NCT00838110|364023314|FG003|Overall Study|Did not meet eligibility criteria|2|||
105552946|NCT00838110|364023311|FG000|Overall Study|Randomized but not treated|0|||
105552947|NCT00838110|364023312|FG001|Overall Study|Randomized but not treated|1|||
105666635|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
105666636|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
105464488|NCT04225897|363714062|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
105464489|NCT04225897|363714063|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
105464490|NCT04225897|363714064|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
105464491|NCT04225897|363714065|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
105464492|NCT04225897|363714066|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
105464493|NCT04225897|363714067|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
105666637|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
105666638|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
105666639|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
105666640|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
105666641|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
105666642|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
105666643|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
105666644|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
105666645|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
105666646|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
105666647|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
105666648|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
105666649|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
105666650|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
105666651|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
105666652|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
105666653|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
105666654|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
105666655|NCT00132678|364444004|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
105666656|NCT00132678|364444005|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
105666657|NCT00132678|364444006|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
105666658|NCT00132678|364444004|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
105666659|NCT00132678|364444005|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
105666660|NCT00132678|364444006|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
105666661|NCT00132678|364444004|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
105666662|NCT00132678|364444005|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
105666663|NCT00132678|364444006|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
105666664|NCT00132678|364444004|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
105666665|NCT00132678|364444005|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
105666666|NCT00132678|364444006|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
105666667|NCT00132678|364444004|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
105666668|NCT00132678|364444005|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
105666669|NCT00132678|364444006|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
105666670|NCT00132678|364444004|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
105666671|NCT00132678|364444005|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
105666672|NCT00132678|364444006|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
105666673|NCT00132678|364444004|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
105666674|NCT00132678|364444005|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
105666675|NCT00132678|364444006|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
105666676|NCT02056626|364444011|FG000|Overall Study|patient did not follow directions|3|||
105666677|NCT02056626|364444012|FG001|Overall Study|patient did not follow directions|1|||
105666678|NCT02056626|364444013|FG002|Overall Study|patient did not follow directions|0|||
105666679|NCT02056626|364444014|FG003|Overall Study|patient did not follow directions|0|||
105666680|NCT00790400|364444015|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
105666681|NCT00790400|364444016|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
105666682|NCT00790400|364444015|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
105666683|NCT00790400|364444016|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
105666684|NCT00790400|364444015|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
105666685|NCT00790400|364444016|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
105666686|NCT00790400|364444015|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
105666687|NCT00790400|364444016|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
105666688|NCT00790400|364444015|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
105666689|NCT00790400|364444016|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
105666690|NCT00790400|364444015|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
105666691|NCT00790400|364444016|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
105666692|NCT00790400|364444015|FG000|Double-blind Period (Core Phase)|Death|1|||
105666693|NCT00790400|364444016|FG001|Double-blind Period (Core Phase)|Death|0|||
105464494|NCT04225897|363714068|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
105464495|NCT04225897|363714057|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
105552948|NCT00838110|364023313|FG002|Overall Study|Randomized but not treated|0|||
105464496|NCT04225897|363714058|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
105464497|NCT04225897|363714059|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
105666694|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
105666695|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
105666696|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
105666697|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
105666698|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
105666699|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
105666700|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
105666701|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
105666702|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
105666703|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
105666704|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Death|1|||
105666705|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Death|0|||
105666706|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
105666707|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
105666708|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
105666709|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
105666710|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
105666711|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
105666712|NCT01483144|364444017|FG000|Overall Study|Adverse Event|9|||
105666713|NCT01483144|364444018|FG001|Overall Study|Adverse Event|4|||
105666714|NCT01483144|364444019|FG002|Overall Study|Adverse Event|6|||
105666715|NCT01483144|364444017|FG000|Overall Study|Withdrawal by Subject|0|||
105666716|NCT01483144|364444018|FG001|Overall Study|Withdrawal by Subject|2|||
105666717|NCT01483144|364444019|FG002|Overall Study|Withdrawal by Subject|5|||
105666718|NCT01483144|364444017|FG000|Overall Study|Physician Decision|1|||
105666719|NCT01483144|364444018|FG001|Overall Study|Physician Decision|0|||
105666720|NCT01483144|364444019|FG002|Overall Study|Physician Decision|0|||
105666721|NCT01483144|364444017|FG000|Overall Study|Lost to Follow-up|2|||
105666722|NCT01483144|364444018|FG001|Overall Study|Lost to Follow-up|4|||
105666723|NCT01483144|364444019|FG002|Overall Study|Lost to Follow-up|1|||
105666724|NCT01483144|364444017|FG000|Overall Study|Protocol Violation|3|||
105666725|NCT01483144|364444018|FG001|Overall Study|Protocol Violation|3|||
105666726|NCT01483144|364444019|FG002|Overall Study|Protocol Violation|3|||
105666727|NCT01107899|364444020|FG000|Overall Study|Physician Decision|5|||
105666728|NCT01107899|364444021|FG001|Overall Study|Physician Decision|0|||
105666729|NCT01107899|364444022|FG002|Overall Study|Physician Decision|3|||
105666730|NCT01107899|364444020|FG000|Overall Study|Withdrawal by Subject|0|||
105666731|NCT01107899|364444021|FG001|Overall Study|Withdrawal by Subject|0|||
105666732|NCT01107899|364444022|FG002|Overall Study|Withdrawal by Subject|1|||
105666733|NCT02179177|364444023|FG000|Overall Study|Lost to Follow-up|1|||
105666734|NCT02179177|364444024|FG001|Overall Study|Lost to Follow-up|1|||
105666735|NCT02179177|364444023|FG000|Overall Study|Withdrawal by Subject|1|||
105666736|NCT02179177|364444024|FG001|Overall Study|Withdrawal by Subject|1|||
105666737|NCT03274453|364444027|FG000|Overall Study|Lost to Follow-up|2|||
105666738|NCT03274453|364444028|FG001|Overall Study|Lost to Follow-up|5|||
105666739|NCT03274453|364444029|FG002|Overall Study|Lost to Follow-up|4|||
105666740|NCT03274453|364444030|FG003|Overall Study|Lost to Follow-up|1|||
105340529|NCT02031640|363248216|FG002|Run-In Period|Exclusion criteria met|0|||
105340530|NCT02031640|363248217|FG003|Run-In Period|Exclusion criteria met|0|||
105340531|NCT02031640|363248218|FG004|Run-In Period|Exclusion criteria met|0|||
105340532|NCT02031640|363248219|FG005|Run-In Period|Exclusion criteria met|0|||
105464498|NCT04225897|363714060|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
105464499|NCT04225897|363714061|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
105666741|NCT03274453|364444027|FG000|Overall Study|Physician Decision|2|||
105666742|NCT03274453|364444028|FG001|Overall Study|Physician Decision|0|||
105666743|NCT03274453|364444029|FG002|Overall Study|Physician Decision|0|||
105666744|NCT03274453|364444030|FG003|Overall Study|Physician Decision|3|||
105666745|NCT03274453|364444027|FG000|Overall Study|Surgery Cancelled|0|||
105666746|NCT03274453|364444028|FG001|Overall Study|Surgery Cancelled|1|||
105666747|NCT03274453|364444029|FG002|Overall Study|Surgery Cancelled|0|||
105666748|NCT03274453|364444030|FG003|Overall Study|Surgery Cancelled|0|||
105666749|NCT01516749|364444031|FG000|Active Therapy|Lost to Follow-up|1|||
105666750|NCT01516749|364444031|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
105666751|NCT00351377|364444032|FG000|Overall Study|Adverse Event|5|||
105666752|NCT00351377|364444032|FG000|Overall Study|Death|1|||
105666753|NCT00351377|364444032|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105666754|NCT03845140|364444034|FG000|Overall Study|Participant travelled outside study area|0|||
105666755|NCT03845140|364444035|FG001|Overall Study|Participant travelled outside study area|1|||
105666756|NCT03845140|364444036|FG002|Overall Study|Participant travelled outside study area|0|||
105666757|NCT03845140|364444037|FG003|Overall Study|Participant travelled outside study area|0|||
105666758|NCT03845140|364444038|FG004|Overall Study|Participant travelled outside study area|0|||
105666759|NCT03845140|364444039|FG005|Overall Study|Participant travelled outside study area|0|||
105666760|NCT02030002|364444040|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
105666761|NCT02030002|364444040|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
105666762|NCT02030002|364444040|FG000|Follow-up|Lost to Follow-up|2|||
105666763|NCT00447590|364444041|FG000|Overall Study|Withdrawal by Subject|26|||
105464500|NCT04225897|363714062|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
105464501|NCT04225897|363714063|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
105464502|NCT04225897|363714064|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
105464503|NCT04225897|363714065|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
105464504|NCT04225897|363714066|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
105464505|NCT04225897|363714067|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
105464506|NCT04225897|363714068|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
105666764|NCT00447590|364444041|FG000|Overall Study|Lost to Follow-up|24|||
105666765|NCT00447590|364444041|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
105666766|NCT01967069|364444042|FG000|Overall Study|Adverse Event|2|||
105666767|NCT01967069|364444043|FG001|Overall Study|Adverse Event|2|||
105666768|NCT01967069|364444042|FG000|Overall Study|Lost to Follow-up|5|||
105666769|NCT01967069|364444043|FG001|Overall Study|Lost to Follow-up|2|||
105666770|NCT01967069|364444042|FG000|Overall Study|Withdrawal by Subject|1|||
105666771|NCT01967069|364444043|FG001|Overall Study|Withdrawal by Subject|3|||
105666772|NCT01967069|364444042|FG000|Overall Study|Lack of Efficacy|0|||
105666773|NCT01967069|364444043|FG001|Overall Study|Lack of Efficacy|1|||
105666774|NCT00504075|364444046|FG000|Overall Study|Adverse Event|1|||
105666775|NCT00504075|364444046|FG000|Overall Study|Lost to Follow-up|5|||
105666776|NCT00504075|364444046|FG000|Overall Study|Withdrawal by Subject|1|||
105666777|NCT00504075|364444046|FG000|Overall Study|Required other therapeutic intervention|1|||
105666778|NCT02406248|364444047|FG000|Overall Study|Death|7|||
105666779|NCT02406248|364444047|FG000|Overall Study|Withdrawal by Subject|2|||
105666780|NCT01689857|364444049|FG000|Overall Study|Lost to Follow-up|5|||
105666781|NCT01689857|364444050|FG001|Overall Study|Lost to Follow-up|2|||
105666782|NCT01730378|364444051|FG000|Overall Study|Lost to Follow-up|1|||
105666783|NCT01730378|364444052|FG001|Overall Study|Lost to Follow-up|0|||
105666784|NCT01736540|364444056|FG000|Overall Study|Did not complete scan within 45 days|2|||
105666785|NCT01736540|364444056|FG000|Overall Study|Death|1|||
105666786|NCT01736540|364444056|FG000|Overall Study|Abnormal test procedure|1|||
105666787|NCT01736540|364444056|FG000|Overall Study|Withdrawal by Subject|5|||
105666788|NCT01736540|364444056|FG000|Overall Study|Protocol Violation|1|||
105666789|NCT01736540|364444056|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
105666790|NCT01736540|364444056|FG000|Overall Study|No show for MRI appointment|1|||
105666791|NCT01736540|364444056|FG000|Overall Study|Unable to make MRI appointment|3|||
105464507|NCT04225897|363714057|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
105464508|NCT04225897|363714058|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
105464509|NCT04225897|363714059|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
105464510|NCT04225897|363714060|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
105666792|NCT03812029|364444061|FG000|Overall Study|Protocol Violation|1|||
105666793|NCT03812029|364444062|FG001|Overall Study|Protocol Violation|0|||
105666794|NCT03812029|364444063|FG002|Overall Study|Protocol Violation|0|||
105666795|NCT03812029|364444064|FG003|Overall Study|Protocol Violation|1|||
105666796|NCT03812029|364444065|FG004|Overall Study|Protocol Violation|0|||
105666797|NCT03812029|364444061|FG000|Overall Study|Withdrawal by Subject|1|||
105666798|NCT03812029|364444062|FG001|Overall Study|Withdrawal by Subject|0|||
105666799|NCT03812029|364444063|FG002|Overall Study|Withdrawal by Subject|0|||
105666800|NCT03812029|364444064|FG003|Overall Study|Withdrawal by Subject|2|||
105666801|NCT03812029|364444065|FG004|Overall Study|Withdrawal by Subject|2|||
105666802|NCT03812029|364444061|FG000|Overall Study|Stopping rules|0|||
105552949|NCT00838110|364023314|FG003|Overall Study|Randomized but not treated|0|||
105552950|NCT01003899|364023315|FG000|Overall Study|Other Adverse Event|8|||
105552951|NCT01003899|364023315|FG000|Overall Study|Not entered|4|||
105552952|NCT01003899|364023315|FG000|Overall Study|Not treated|1|||
105552953|NCT01003899|364023315|FG000|Overall Study|Progressive disease|34|||
105552954|NCT01262651|364023316|FG000|Overall Study|Adverse Event|40|||
105552955|NCT01262651|364023317|FG001|Overall Study|Adverse Event|35|||
105552956|NCT01262651|364023316|FG000|Overall Study|Withdrawal by Subject|15|||
105552957|NCT01262651|364023317|FG001|Overall Study|Withdrawal by Subject|11|||
105552958|NCT01262651|364023316|FG000|Overall Study|Withdrawal by Investigator|2|||
105552959|NCT01262651|364023317|FG001|Overall Study|Withdrawal by Investigator|2|||
105552960|NCT01262651|364023316|FG000|Overall Study|Met Withdrawal Criteria|1|||
105552961|NCT01262651|364023317|FG001|Overall Study|Met Withdrawal Criteria|0|||
105552962|NCT03822533|364023320|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
105552963|NCT03822533|364023321|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
105552964|NCT03822533|364023320|FG000|3 Month Follow-up|Lost to Follow-up|2|||
105552965|NCT03822533|364023321|FG001|3 Month Follow-up|Lost to Follow-up|2|||
105552966|NCT03822533|364023320|FG000|6 Month Follow-up|Lost to Follow-up|3|||
105552967|NCT03822533|364023321|FG001|6 Month Follow-up|Lost to Follow-up|0|||
105552968|NCT03822533|364023320|FG000|12 Month Follow-up|Lost to Follow-up|2|||
105552969|NCT03822533|364023321|FG001|12 Month Follow-up|Lost to Follow-up|3|||
105552970|NCT03822533|364023320|FG000|12 Month Follow-up|Pregnancy|0|||
105552971|NCT03822533|364023321|FG001|12 Month Follow-up|Pregnancy|1|||
105552972|NCT03822533|364023320|FG000|12 Month Follow-up|Surgery|2|||
105552973|NCT03822533|364023321|FG001|12 Month Follow-up|Surgery|0|||
105552974|NCT03822533|364023320|FG000|12 Month Follow-up|Wrong address|1|||
105552975|NCT03822533|364023321|FG001|12 Month Follow-up|Wrong address|0|||
105552976|NCT03822533|364023320|FG000|12 Month Follow-up|No symptoms|1|||
105552977|NCT03822533|364023321|FG001|12 Month Follow-up|No symptoms|0|||
105552978|NCT03822533|364023320|FG000|12 Month Follow-up|Changed primary care center|0|||
105552979|NCT03822533|364023321|FG001|12 Month Follow-up|Changed primary care center|1|||
105552980|NCT04969783|364023322|FG000|Overall Study|Lost to Follow-up|2|||
105552981|NCT04969783|364023323|FG001|Overall Study|Lost to Follow-up|0|||
105666803|NCT03812029|364444062|FG001|Overall Study|Stopping rules|1|||
105666804|NCT03812029|364444063|FG002|Overall Study|Stopping rules|0|||
105666805|NCT03812029|364444064|FG003|Overall Study|Stopping rules|0|||
105666806|NCT03812029|364444065|FG004|Overall Study|Stopping rules|0|||
105666807|NCT03812029|364444061|FG000|Overall Study|Adverse Event|0|||
105666808|NCT03812029|364444062|FG001|Overall Study|Adverse Event|9|||
105666809|NCT03812029|364444063|FG002|Overall Study|Adverse Event|0|||
105666810|NCT03812029|364444064|FG003|Overall Study|Adverse Event|3|||
105552982|NCT04969783|364023322|FG000|Overall Study|Withdrawal by Subject|4|||
105552983|NCT04969783|364023323|FG001|Overall Study|Withdrawal by Subject|0|||
105552984|NCT04969783|364023322|FG000|Overall Study|Physician Decision|6|||
105666811|NCT03812029|364444065|FG004|Overall Study|Adverse Event|5|||
105552985|NCT04969783|364023323|FG001|Overall Study|Physician Decision|0|||
105552986|NCT00328510|364023324|FG000|Overall Study|Gag disorder, could not use frame|4|||
105666812|NCT03812029|364444061|FG000|Overall Study|Lost to Follow-up|0|||
105666813|NCT03812029|364444062|FG001|Overall Study|Lost to Follow-up|0|||
105666814|NCT03812029|364444063|FG002|Overall Study|Lost to Follow-up|0|||
105666815|NCT03812029|364444064|FG003|Overall Study|Lost to Follow-up|0|||
105666816|NCT03812029|364444065|FG004|Overall Study|Lost to Follow-up|3|||
105666817|NCT00479882|364444066|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
105666818|NCT00479882|364444067|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
105666819|NCT00479882|364444068|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
105666820|NCT00479882|364444069|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
105666821|NCT00479882|364444066|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
105666822|NCT00479882|364444067|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
105666823|NCT00479882|364444068|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
105666824|NCT00479882|364444069|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
105666825|NCT00479882|364444066|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
105666826|NCT00479882|364444067|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
105666827|NCT00479882|364444068|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
105666828|NCT00479882|364444069|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
105666829|NCT00479882|364444066|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
105666830|NCT00479882|364444067|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
105666831|NCT00479882|364444068|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
105666832|NCT00479882|364444069|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
105666833|NCT00479882|364444066|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
105666834|NCT00479882|364444067|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
105666835|NCT00479882|364444068|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
105666836|NCT00479882|364444069|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
105666837|NCT00479882|364444066|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
105666838|NCT00479882|364444067|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
105666839|NCT00479882|364444068|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
105666840|NCT00479882|364444069|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
105666841|NCT00479882|364444066|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
105666842|NCT00479882|364444067|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
105666843|NCT00479882|364444068|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
105666844|NCT00479882|364444069|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
105666845|NCT00479882|364444066|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
105666846|NCT00479882|364444067|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
105666847|NCT00479882|364444068|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
105666848|NCT00479882|364444069|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
105666849|NCT00479882|364444066|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
105666850|NCT00479882|364444067|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
105666851|NCT00479882|364444068|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
105666852|NCT00479882|364444069|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
105666853|NCT00479882|364444066|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
105666854|NCT00479882|364444067|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
105666855|NCT00479882|364444068|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
105666856|NCT00479882|364444069|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
105666857|NCT00479882|364444066|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
105666858|NCT00479882|364444067|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
105666859|NCT00479882|364444068|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
105666860|NCT00479882|364444069|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
105666861|NCT00479882|364444066|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
105666862|NCT00479882|364444067|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
105666863|NCT00479882|364444068|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
105666864|NCT00479882|364444069|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
105666865|NCT00479882|364444066|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
105666866|NCT00479882|364444067|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
105666867|NCT00479882|364444068|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
105666868|NCT00479882|364444069|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
105666869|NCT00479882|364444066|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
105666870|NCT00479882|364444067|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
105666871|NCT00479882|364444068|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
105666872|NCT00479882|364444069|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
105666873|NCT03738475|364444070|FG000|Overall Study|Participant Non-Compliance|1|||
105666874|NCT03738475|364444071|FG001|Overall Study|Participant Non-Compliance|0|||
105666875|NCT03106753|364444072|FG000|Overall Study|Withdrawal by Subject|0|||
105666876|NCT03106753|364444073|FG001|Overall Study|Withdrawal by Subject|1|||
105666877|NCT03149042|364444074|FG000|Overall Study|Invasive FFR not performed|21|||
105666878|NCT03149042|364444074|FG000|Overall Study|Poor CT Image Quality|1|||
105666879|NCT03149042|364444074|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
105666880|NCT01735175|364444075|FG000|Overall Study|Withdrawal by Subject|9|||
105464511|NCT04225897|363714061|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
105464512|NCT04225897|363714062|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
105464513|NCT04225897|363714063|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
105464514|NCT04225897|363714064|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
105464515|NCT04225897|363714065|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
105464516|NCT04225897|363714066|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
105464517|NCT04225897|363714067|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
105464518|NCT04225897|363714068|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
105464519|NCT04225897|363714057|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
105464520|NCT04225897|363714058|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
105666881|NCT01735175|364444076|FG001|Overall Study|Withdrawal by Subject|2|||
105666882|NCT01735175|364444075|FG000|Overall Study|Lost to Follow-up|4|||
105666883|NCT01735175|364444076|FG001|Overall Study|Lost to Follow-up|2|||
105666884|NCT01735175|364444075|FG000|Overall Study|Death|3|||
105666885|NCT01735175|364444076|FG001|Overall Study|Death|2|||
105666886|NCT01735175|364444075|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
105666887|NCT01735175|364444076|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
105666888|NCT04593823|364444079|FG000|Overall Study|Withdrawal by Subject|1|||
105666889|NCT04593823|364444080|FG001|Overall Study|Withdrawal by Subject|1|||
105666890|NCT04593823|364444079|FG000|Overall Study|Lost to Follow-up|0|||
105666891|NCT04593823|364444080|FG001|Overall Study|Lost to Follow-up|1|||
105666892|NCT01304498|364444081|FG000|Overall Study|Adverse Event|1|||
105666893|NCT01304498|364444082|FG001|Overall Study|Adverse Event|1|||
105666894|NCT01304498|364444081|FG000|Overall Study|Withdrawal by Subject|2|||
105666895|NCT01304498|364444082|FG001|Overall Study|Withdrawal by Subject|3|||
105666896|NCT01304498|364444081|FG000|Overall Study|Protocol Violation|1|||
105666897|NCT01304498|364444082|FG001|Overall Study|Protocol Violation|0|||
105666898|NCT01304498|364444081|FG000|Overall Study|Lost to Follow-up|2|||
105666899|NCT01304498|364444082|FG001|Overall Study|Lost to Follow-up|1|||
105666900|NCT03443414|364444083|FG000|Overall Study|Adverse Event|6|||
105666901|NCT03443414|364444084|FG001|Overall Study|Adverse Event|0|||
105666902|NCT03443414|364444085|FG002|Overall Study|Adverse Event|4|||
105666903|NCT03443414|364444086|FG003|Overall Study|Adverse Event|2|||
105666904|NCT03443414|364444087|FG004|Overall Study|Adverse Event|3|||
105666905|NCT03443414|364444083|FG000|Overall Study|Withdrawal by Subject|3|||
105666906|NCT03443414|364444084|FG001|Overall Study|Withdrawal by Subject|2|||
105666907|NCT03443414|364444085|FG002|Overall Study|Withdrawal by Subject|2|||
105666908|NCT03443414|364444086|FG003|Overall Study|Withdrawal by Subject|2|||
105666909|NCT03443414|364444087|FG004|Overall Study|Withdrawal by Subject|1|||
105666910|NCT03443414|364444083|FG000|Overall Study|Death|0|||
105464521|NCT04225897|363714059|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
105464522|NCT04225897|363714060|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
105464523|NCT04225897|363714061|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
105464524|NCT04225897|363714062|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
105464525|NCT04225897|363714063|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
105464526|NCT04225897|363714064|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
105464527|NCT04225897|363714065|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
105464528|NCT04225897|363714066|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
105464529|NCT04225897|363714067|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
105666911|NCT03443414|364444084|FG001|Overall Study|Death|1|||
105666912|NCT03443414|364444085|FG002|Overall Study|Death|0|||
105666913|NCT03443414|364444086|FG003|Overall Study|Death|1|||
105666914|NCT03443414|364444087|FG004|Overall Study|Death|0|||
105666915|NCT03443414|364444083|FG000|Overall Study|Reason not specified|2|||
105666916|NCT03443414|364444084|FG001|Overall Study|Reason not specified|0|||
105666917|NCT03443414|364444085|FG002|Overall Study|Reason not specified|0|||
105666918|NCT03443414|364444086|FG003|Overall Study|Reason not specified|0|||
105666919|NCT03443414|364444087|FG004|Overall Study|Reason not specified|1|||
105666920|NCT00732992|364444088|FG000|Overall Study|Adverse Event|1|||
105666921|NCT00732992|364444089|FG001|Overall Study|Adverse Event|1|||
105666922|NCT00732992|364444088|FG000|Overall Study|Objective Progression or Relapse|3|||
105666923|NCT00732992|364444089|FG001|Overall Study|Objective Progression or Relapse|5|||
105464530|NCT04225897|363714068|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
105666924|NCT00732992|364444088|FG000|Overall Study|Global Deterioration of Health Status|1|||
105785977|NCT04246593|364870423|FG000|Overall Study|Moved out of area/became ineligible|3|||
105666925|NCT00732992|364444089|FG001|Overall Study|Global Deterioration of Health Status|0|||
105666926|NCT00732992|364444088|FG000|Overall Study|Withdrawal by Subject|1|||
105666927|NCT00732992|364444089|FG001|Overall Study|Withdrawal by Subject|0|||
105666928|NCT03933462|364444090|FG000|Overall Study|Adverse Event|2|||
105666929|NCT03933462|364444091|FG001|Overall Study|Adverse Event|0|||
105666930|NCT02522728|364444092|FG000|Overall Study|Withdrawal by Subject|6|||
105666931|NCT02522728|364444093|FG001|Overall Study|Withdrawal by Subject|6|||
105666932|NCT02522728|364444092|FG000|Overall Study|Death|4|||
105666933|NCT02522728|364444093|FG001|Overall Study|Death|3|||
105666934|NCT02522728|364444092|FG000|Overall Study|Adverse Event|2|||
105666935|NCT02522728|364444093|FG001|Overall Study|Adverse Event|1|||
105666936|NCT02522728|364444092|FG000|Overall Study|Did not receive randomized study device|0|||
105666937|NCT02522728|364444093|FG001|Overall Study|Did not receive randomized study device|1|||
105666938|NCT00967005|364444094|FG000|Overall Study|Lost to Follow-up|7|||
105666939|NCT00967005|364444095|FG001|Overall Study|Lost to Follow-up|10|||
105666940|NCT02127125|364444096|FG000|Overall Study|Lost to Follow-up|0|||
105666941|NCT02127125|364444097|FG001|Overall Study|Lost to Follow-up|0|||
105666942|NCT02127125|364444098|FG002|Overall Study|Lost to Follow-up|0|||
105666943|NCT02127125|364444099|FG003|Overall Study|Lost to Follow-up|0|||
105666944|NCT02127125|364444100|FG004|Overall Study|Lost to Follow-up|2|||
105666945|NCT02127125|364444101|FG005|Overall Study|Lost to Follow-up|1|||
105666946|NCT02127125|364444102|FG006|Overall Study|Lost to Follow-up|0|||
105666947|NCT02127125|364444103|FG007|Overall Study|Lost to Follow-up|0|||
105666948|NCT02127125|364444104|FG008|Overall Study|Lost to Follow-up|0|||
105666949|NCT02127125|364444096|FG000|Overall Study|Withdrawal by Subject|0|||
105666950|NCT02127125|364444097|FG001|Overall Study|Withdrawal by Subject|0|||
105666951|NCT02127125|364444098|FG002|Overall Study|Withdrawal by Subject|0|||
105666952|NCT02127125|364444099|FG003|Overall Study|Withdrawal by Subject|1|||
105666953|NCT02127125|364444100|FG004|Overall Study|Withdrawal by Subject|0|||
105666954|NCT02127125|364444101|FG005|Overall Study|Withdrawal by Subject|0|||
105666955|NCT02127125|364444102|FG006|Overall Study|Withdrawal by Subject|0|||
105666956|NCT02127125|364444103|FG007|Overall Study|Withdrawal by Subject|0|||
105666957|NCT02127125|364444104|FG008|Overall Study|Withdrawal by Subject|0|||
105666958|NCT02127125|364444096|FG000|Overall Study|Physician Decision|0|||
105666959|NCT02127125|364444097|FG001|Overall Study|Physician Decision|0|||
105666960|NCT02127125|364444098|FG002|Overall Study|Physician Decision|1|||
105340533|NCT02031640|363248214|FG000|Run-In Period|Randomization criteria not met|85|||
105340534|NCT02031640|363248215|FG001|Run-In Period|Randomization criteria not met|0|||
105340535|NCT02031640|363248216|FG002|Run-In Period|Randomization criteria not met|0|||
105340536|NCT02031640|363248217|FG003|Run-In Period|Randomization criteria not met|0|||
105340537|NCT02031640|363248218|FG004|Run-In Period|Randomization criteria not met|0|||
105340538|NCT02031640|363248219|FG005|Run-In Period|Randomization criteria not met|0|||
105340539|NCT02031640|363248214|FG000|Run-In Period|Various administrative reasons|17|||
105340540|NCT02031640|363248215|FG001|Run-In Period|Various administrative reasons|0|||
105340541|NCT02031640|363248216|FG002|Run-In Period|Various administrative reasons|0|||
105340542|NCT02031640|363248217|FG003|Run-In Period|Various administrative reasons|0|||
105666961|NCT02127125|364444099|FG003|Overall Study|Physician Decision|0|||
105666962|NCT02127125|364444100|FG004|Overall Study|Physician Decision|1|||
105666963|NCT02127125|364444101|FG005|Overall Study|Physician Decision|2|||
105666964|NCT02127125|364444102|FG006|Overall Study|Physician Decision|0|||
105666965|NCT02127125|364444103|FG007|Overall Study|Physician Decision|0|||
105340543|NCT02031640|363248218|FG004|Run-In Period|Various administrative reasons|0|||
105340544|NCT02031640|363248219|FG005|Run-In Period|Various administrative reasons|0|||
105666966|NCT02127125|364444104|FG008|Overall Study|Physician Decision|0|||
105666967|NCT00856245|364444110|FG000|Overall Study|Was not transplanted|5|||
105666968|NCT00844597|364444111|FG000|Overall Study|Adverse Event|0|||
105666969|NCT00844597|364444112|FG001|Overall Study|Adverse Event|0|||
105666970|NCT00844597|364444113|FG002|Overall Study|Adverse Event|0|||
105666971|NCT00844597|364444114|FG003|Overall Study|Adverse Event|1|||
105666972|NCT00844597|364444115|FG004|Overall Study|Adverse Event|0|||
105666973|NCT00844597|364444116|FG005|Overall Study|Adverse Event|0|||
105666974|NCT03566979|364444117|FG000|Overall Study|Withdrawal by Subject|2|||
105666975|NCT03566979|364444118|FG001|Overall Study|Withdrawal by Subject|0|||
105666976|NCT03566979|364444119|FG002|Overall Study|Withdrawal by Subject|1|||
105666977|NCT03566979|364444120|FG003|Overall Study|Withdrawal by Subject|1|||
105666978|NCT03566979|364444117|FG000|Overall Study|Lost to Follow-up|2|||
105666979|NCT03566979|364444118|FG001|Overall Study|Lost to Follow-up|7|||
105666980|NCT03566979|364444119|FG002|Overall Study|Lost to Follow-up|9|||
105666981|NCT03566979|364444120|FG003|Overall Study|Lost to Follow-up|5|||
105666982|NCT03566979|364444117|FG000|Overall Study|Adverse Event|1|||
105666983|NCT03566979|364444118|FG001|Overall Study|Adverse Event|0|||
105666984|NCT03566979|364444119|FG002|Overall Study|Adverse Event|0|||
105666985|NCT03566979|364444120|FG003|Overall Study|Adverse Event|0|||
105666986|NCT02762903|364444121|FG000|Overall Study|Lost to Follow-up|0|||
105666987|NCT02762903|364444122|FG001|Overall Study|Lost to Follow-up|1|||
105666988|NCT00108745|364444123|FG000|Overall Study|Withdrawal by Subject|19|||
105666989|NCT00108745|364444124|FG001|Overall Study|Withdrawal by Subject|12|||
105666990|NCT00108745|364444125|FG002|Overall Study|Withdrawal by Subject|12|||
105666991|NCT00108745|364444123|FG000|Overall Study|Never Treated|8|||
105666992|NCT00108745|364444124|FG001|Overall Study|Never Treated|10|||
105666993|NCT00108745|364444125|FG002|Overall Study|Never Treated|12|||
105666994|NCT00108745|364444123|FG000|Overall Study|Ineligible|7|||
105666995|NCT00108745|364444124|FG001|Overall Study|Ineligible|13|||
105666996|NCT00108745|364444125|FG002|Overall Study|Ineligible|13|||
105666997|NCT02473965|364445950|FG000|Overall Study|Adverse Event|6|||
105666998|NCT02473965|364445951|FG001|Overall Study|Adverse Event|4|||
105666999|NCT02473965|364445950|FG000|Overall Study|MG worsening|4|||
105667000|NCT02473965|364445951|FG001|Overall Study|MG worsening|1|||
105667001|NCT02473965|364445950|FG000|Overall Study|Withdrawal by Subject|2|||
105667002|NCT02473965|364445951|FG001|Overall Study|Withdrawal by Subject|3|||
105667003|NCT02473965|364445950|FG000|Overall Study|Physician Decision|0|||
105667004|NCT02473965|364445951|FG001|Overall Study|Physician Decision|2|||
105667005|NCT03192462|364445952|FG000|Overall Study|Death|13|||
105667006|NCT03192462|364445953|FG001|Overall Study|Death|11|||
105667007|NCT03192462|364445954|FG002|Overall Study|Death|9|||
105667008|NCT03192462|364445952|FG000|Overall Study|Lost to Follow-up|0|||
105667009|NCT03192462|364445953|FG001|Overall Study|Lost to Follow-up|1|||
105667010|NCT03192462|364445954|FG002|Overall Study|Lost to Follow-up|0|||
105667011|NCT03192462|364445952|FG000|Overall Study|On follow up|0|||
105667012|NCT03192462|364445953|FG001|Overall Study|On follow up|0|||
105667013|NCT03192462|364445954|FG002|Overall Study|On follow up|3|||
105667014|NCT01183390|364445955|FG000|First Intervention|Adverse Event|0|||
105667015|NCT01183390|364445956|FG001|First Intervention|Adverse Event|1|||
105667016|NCT03816761|364445957|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
105667017|NCT03816761|364445958|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
105667018|NCT03816761|364445959|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
105667019|NCT03816761|364445960|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
105667020|NCT03816761|364445961|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
105667021|NCT03816761|364445962|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
105667022|NCT03816761|364445957|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
105667023|NCT03816761|364445958|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
105667024|NCT03816761|364445959|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
105667025|NCT03816761|364445960|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
105667026|NCT03816761|364445961|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
105667027|NCT03816761|364445962|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
105667028|NCT02358668|364445963|FG000|Overall Study|Adverse Event|2|||
105667029|NCT02358668|364445964|FG001|Overall Study|Adverse Event|0|||
105667030|NCT02358668|364445965|FG002|Overall Study|Adverse Event|0|||
105667031|NCT02358668|364445963|FG000|Overall Study|Withdrawal by Subject|0|||
105667032|NCT02358668|364445964|FG001|Overall Study|Withdrawal by Subject|1|||
105667033|NCT02358668|364445965|FG002|Overall Study|Withdrawal by Subject|0|||
105667034|NCT02737826|364445966|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
105667035|NCT02737826|364445967|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
105667036|NCT02737826|364445968|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
105667037|NCT00581893|364445969|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
105667038|NCT00581893|364445970|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
105667039|NCT01381575|364445971|FG000|Overall Study|Serious Adverse Event|1|||
105340545|NCT02031640|363248214|FG000|Double-blind Treatment Period|Protocol deviation|0|||
105340546|NCT02031640|363248215|FG001|Double-blind Treatment Period|Protocol deviation|2|||
105340547|NCT02031640|363248216|FG002|Double-blind Treatment Period|Protocol deviation|0|||
105340548|NCT02031640|363248217|FG003|Double-blind Treatment Period|Protocol deviation|1|||
105340549|NCT02031640|363248218|FG004|Double-blind Treatment Period|Protocol deviation|3|||
105340550|NCT02031640|363248219|FG005|Double-blind Treatment Period|Protocol deviation|1|||
105340551|NCT02031640|363248214|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
105340552|NCT02031640|363248215|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
105340553|NCT02031640|363248216|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
105464531|NCT01046396|363714069|FG000|Overall Study|Withdrawal by Subject|5|||
105464532|NCT00174187|363714070|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
105464533|NCT00174187|363714071|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
105667040|NCT01381575|364445972|FG001|Overall Study|Serious Adverse Event|0|||
105464534|NCT00174187|363714072|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
105464535|NCT00174187|363714070|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
105464536|NCT00174187|363714071|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
105464537|NCT00174187|363714072|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
105464538|NCT00174187|363714070|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
105464539|NCT00174187|363714071|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
105464540|NCT00174187|363714072|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
105464541|NCT00174187|363714070|FG000|Period 1 (up to 3 Years)|Other|0|||
105464542|NCT00174187|363714071|FG001|Period 1 (up to 3 Years)|Other|1|||
105464543|NCT00174187|363714072|FG002|Period 1 (up to 3 Years)|Other|0|||
105464544|NCT00174187|363714070|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
105464545|NCT00174187|363714071|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
105667041|NCT01381575|364445973|FG002|Overall Study|Serious Adverse Event|0|||
105667042|NCT01381575|364445971|FG000|Overall Study|Non-Serious Adverse Event|0|||
105464546|NCT00174187|363714072|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
105464547|NCT00174187|363714070|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
105464548|NCT00174187|363714071|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
105464549|NCT00174187|363714072|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
105464550|NCT00174187|363714070|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
105464551|NCT00174187|363714071|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
105464552|NCT00174187|363714072|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
105464553|NCT00174187|363714070|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
105464554|NCT00174187|363714071|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
105464555|NCT00174187|363714072|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
105464556|NCT00174187|363714070|FG000|Period 2 (After 3 Years)|Other|0|||
105464557|NCT00174187|363714071|FG001|Period 2 (After 3 Years)|Other|0|||
105464558|NCT00174187|363714072|FG002|Period 2 (After 3 Years)|Other|5|||
105464559|NCT01285557|363714073|FG000|Overall Study|Death|173|||
105464560|NCT01285557|363714074|FG001|Overall Study|Death|90|||
105464561|NCT01285557|363714073|FG000|Overall Study|Lost to Follow-up|6|||
105464562|NCT01285557|363714074|FG001|Overall Study|Lost to Follow-up|2|||
105464563|NCT01285557|363714073|FG000|Overall Study|Withdrew Consent|6|||
105667043|NCT01381575|364445972|FG001|Overall Study|Non-Serious Adverse Event|0|||
105464564|NCT01285557|363714074|FG001|Overall Study|Withdrew Consent|1|||
105667044|NCT01381575|364445973|FG002|Overall Study|Non-Serious Adverse Event|1|||
105667045|NCT01381575|364445971|FG000|Overall Study|Protocol Violation|0|||
105667046|NCT01381575|364445972|FG001|Overall Study|Protocol Violation|1|||
105667047|NCT01381575|364445973|FG002|Overall Study|Protocol Violation|1|||
105667048|NCT01381575|364445971|FG000|Overall Study|Withdrawal by Subject|15|||
105667049|NCT01381575|364445972|FG001|Overall Study|Withdrawal by Subject|9|||
105667050|NCT01381575|364445973|FG002|Overall Study|Withdrawal by Subject|7|||
105667051|NCT01381575|364445971|FG000|Overall Study|Migrated/moved from study area|2|||
105667052|NCT01381575|364445972|FG001|Overall Study|Migrated/moved from study area|12|||
105667053|NCT01381575|364445973|FG002|Overall Study|Migrated/moved from study area|2|||
105667054|NCT01381575|364445971|FG000|Overall Study|Lost to Follow-up|8|||
105667055|NCT01381575|364445972|FG001|Overall Study|Lost to Follow-up|17|||
105667056|NCT01381575|364445973|FG002|Overall Study|Lost to Follow-up|9|||
105667057|NCT01200342|364445974|FG000|Overall Study|Disease Progression|1|||
105667058|NCT02271984|364445983|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667059|NCT02271984|364445984|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105552987|NCT00328510|364023325|FG001|Overall Study|Gag disorder, could not use frame|0|||
105552988|NCT00328510|364023324|FG000|Overall Study|Dentition problems, could not use frame|1|||
105552989|NCT00328510|364023325|FG001|Overall Study|Dentition problems, could not use frame|0|||
105552990|NCT00328510|364023324|FG000|Overall Study|Withdrawal by Subject|4|||
105552991|NCT00328510|364023325|FG001|Overall Study|Withdrawal by Subject|2|||
105552992|NCT00328510|364023324|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
105552993|NCT00328510|364023325|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
105552994|NCT00328510|364023324|FG000|Overall Study|Treatment changed to a single fraction|1|||
105552995|NCT00328510|364023325|FG001|Overall Study|Treatment changed to a single fraction|1|||
105552996|NCT02349295|364023327|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
105552997|NCT02349295|364023328|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
105552998|NCT02349295|364023329|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
105552999|NCT02349295|364023330|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
105553000|NCT02349295|364023331|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
105553001|NCT02349295|364023332|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
105553002|NCT02349295|364023333|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
105553003|NCT02349295|364023334|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
105553004|NCT02349295|364023335|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
105553005|NCT02349295|364023336|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
105553006|NCT02349295|364023337|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
105553007|NCT02349295|364023338|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
105553008|NCT02349295|364023339|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
105553009|NCT02349295|364023340|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
105553010|NCT02349295|364023327|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
105553011|NCT02349295|364023328|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
105553012|NCT02349295|364023329|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
105553013|NCT02349295|364023330|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
105553014|NCT02349295|364023331|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
105553015|NCT02349295|364023332|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
105553016|NCT02349295|364023333|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
105553017|NCT02349295|364023334|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
105553018|NCT02349295|364023335|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
105553019|NCT02349295|364023336|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
105553020|NCT02349295|364023337|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
105553021|NCT02349295|364023338|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
105553022|NCT02349295|364023339|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
105553023|NCT02349295|364023340|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
105553024|NCT02349295|364023327|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
105553025|NCT02349295|364023328|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
105667060|NCT02271984|364445985|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667061|NCT02271984|364445986|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667062|NCT02271984|364445987|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667063|NCT02271984|364445988|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
105667064|NCT02271984|364445989|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667065|NCT02271984|364445990|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
105667066|NCT02271984|364445991|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667067|NCT02271984|364445992|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667068|NCT02271984|364445993|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667069|NCT02271984|364445994|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667070|NCT02460575|364445995|FG000|Overall Study|Lost to Follow-up|1|||
105667071|NCT02460575|364445996|FG001|Overall Study|Lost to Follow-up|0|||
105667072|NCT04307940|364445997|FG000|Overall Study|Adverse Event|1|||
105667073|NCT04307940|364445998|FG001|Overall Study|Adverse Event|0|||
105667074|NCT04307940|364445999|FG002|Overall Study|Adverse Event|0|||
105667075|NCT04307940|364445997|FG000|Overall Study|Withdrawal by Subject|2|||
105667076|NCT04307940|364445998|FG001|Overall Study|Withdrawal by Subject|3|||
105667077|NCT04307940|364445999|FG002|Overall Study|Withdrawal by Subject|1|||
105667078|NCT04307940|364445997|FG000|Overall Study|Lost to Follow-up|2|||
105667079|NCT04307940|364445998|FG001|Overall Study|Lost to Follow-up|0|||
105667080|NCT04307940|364445999|FG002|Overall Study|Lost to Follow-up|1|||
105667081|NCT00974259|364446005|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
105667082|NCT00974259|364446006|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
105667083|NCT02870972|364446013|FG000|Overall Study|Adverse Event|1|||
105667084|NCT02870972|364446014|FG001|Overall Study|Adverse Event|0|||
105667085|NCT02870972|364446015|FG002|Overall Study|Adverse Event|0|||
105667086|NCT02870972|364446016|FG003|Overall Study|Adverse Event|0|||
105667087|NCT02870972|364446017|FG004|Overall Study|Adverse Event|0|||
105667088|NCT04497389|364446018|FG000|Overall Study|Withdrawal by Subject|1|||
105667089|NCT04497389|364446019|FG001|Overall Study|Withdrawal by Subject|0|||
105667090|NCT04400487|364446022|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
105667091|NCT04400487|364446022|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
105667092|NCT04400487|364446022|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
105667093|NCT00979953|364446023|FG000|Overall Study|Adverse Event|5|||
105667094|NCT00979953|364446024|FG001|Overall Study|Adverse Event|2|||
105667095|NCT00979953|364446025|FG002|Overall Study|Adverse Event|17|||
105667096|NCT00979953|364446026|FG003|Overall Study|Adverse Event|4|||
105667097|NCT00979953|364446023|FG000|Overall Study|Lack of Efficacy|1|||
105667098|NCT00979953|364446024|FG001|Overall Study|Lack of Efficacy|2|||
105667099|NCT00979953|364446025|FG002|Overall Study|Lack of Efficacy|0|||
105667100|NCT00979953|364446026|FG003|Overall Study|Lack of Efficacy|0|||
105667101|NCT00979953|364446023|FG000|Overall Study|Lost to Follow-up|1|||
105667102|NCT00979953|364446024|FG001|Overall Study|Lost to Follow-up|1|||
105667103|NCT00979953|364446025|FG002|Overall Study|Lost to Follow-up|1|||
105667104|NCT00979953|364446026|FG003|Overall Study|Lost to Follow-up|0|||
105667105|NCT00979953|364446023|FG000|Overall Study|Withdrawal by Subject|0|||
105667106|NCT00979953|364446024|FG001|Overall Study|Withdrawal by Subject|0|||
105667107|NCT00979953|364446025|FG002|Overall Study|Withdrawal by Subject|2|||
105667108|NCT00979953|364446026|FG003|Overall Study|Withdrawal by Subject|1|||
105667109|NCT00979953|364446023|FG000|Overall Study|Protocol Violation|1|||
105667110|NCT00979953|364446024|FG001|Overall Study|Protocol Violation|0|||
105667111|NCT00979953|364446025|FG002|Overall Study|Protocol Violation|2|||
105667112|NCT00979953|364446026|FG003|Overall Study|Protocol Violation|2|||
105667113|NCT04829747|364446029|FG000|Overall Study|Protocol Violation|1|||
105667114|NCT02615509|364446030|FG000|Overall Study|Lost to Follow-up|134|||
105667115|NCT02615509|364446030|FG000|Overall Study|Death|4|||
105667116|NCT02615509|364446030|FG000|Overall Study|Withdrawal by Subject|8|||
105667117|NCT00425607|364446031|FG000|Overall Study|Death|1|||
105667118|NCT00425607|364446031|FG000|Overall Study|Withdrawal by Subject|1|||
105667119|NCT01706705|364446033|FG000|Overall Study|Death|1|||
105667120|NCT01706705|364446033|FG000|Overall Study|Lack of Efficacy|13|||
105667121|NCT01706705|364446033|FG000|Overall Study|Non-clinical|6|||
105667122|NCT00968526|364446034|FG000|Overall Study|Adverse Event|2|||
105667123|NCT00968526|364446035|FG001|Overall Study|Adverse Event|0|||
105667124|NCT00968526|364446034|FG000|Overall Study|Migrated/moved from study area|1|||
105667125|NCT00968526|364446035|FG001|Overall Study|Migrated/moved from study area|0|||
105667126|NCT01607879|364446036|FG000|Overall Study|Death|1|||
105667127|NCT01607879|364446037|FG001|Overall Study|Death|0|||
105667128|NCT03054337|364446038|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
105667129|NCT03054337|364446039|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
105667130|NCT03054337|364446040|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
105667131|NCT03054337|364446041|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
105667132|NCT03054337|364446042|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
105667133|NCT03054337|364446043|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
105667134|NCT02088957|364446044|FG000|Overall Study|Lack of Efficacy|1|||
105667135|NCT02088957|364446045|FG001|Overall Study|Lack of Efficacy|0|||
105667136|NCT00678301|364446046|FG000|Overall Study|Non-compliance with study procedures|0|||
105667137|NCT00678301|364446047|FG001|Overall Study|Non-compliance with study procedures|1|||
105667138|NCT00678301|364446046|FG000|Overall Study|Adverse Event|1|||
105667139|NCT00678301|364446047|FG001|Overall Study|Adverse Event|0|||
105667140|NCT00678301|364446046|FG000|Overall Study|Withdrawal by Subject|4|||
105667141|NCT00678301|364446047|FG001|Overall Study|Withdrawal by Subject|0|||
105667142|NCT00678301|364446046|FG000|Overall Study|Lost to Follow-up|3|||
105667143|NCT00678301|364446047|FG001|Overall Study|Lost to Follow-up|1|||
105667144|NCT01132820|364446050|FG000|Overall Study|Ineligible: wrong cell type|1|||
105667145|NCT01132820|364446050|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
105667146|NCT01132820|364446050|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
105667147|NCT01132820|364446050|FG000|Overall Study|Never treated|1|||
105667148|NCT01132820|364446050|FG000|Overall Study|Inadequate data|1|||
105667149|NCT02224703|364446055|FG000|Overall Study|Adverse Event|0|||
105667150|NCT02224703|364446056|FG001|Overall Study|Adverse Event|5|||
105667151|NCT02224703|364446057|FG002|Overall Study|Adverse Event|0|||
105667152|NCT02224703|364446055|FG000|Overall Study|Withdrawn by investigator|1|||
105667153|NCT02224703|364446056|FG001|Overall Study|Withdrawn by investigator|0|||
105667154|NCT02224703|364446057|FG002|Overall Study|Withdrawn by investigator|0|||
105667155|NCT02224703|364446055|FG000|Overall Study|Advised by medical monitor|1|||
105667156|NCT02224703|364446056|FG001|Overall Study|Advised by medical monitor|0|||
105667157|NCT02224703|364446057|FG002|Overall Study|Advised by medical monitor|0|||
105667158|NCT02224703|364446055|FG000|Overall Study|Withdrawn by parent/guardian|0|||
105667159|NCT02224703|364446056|FG001|Overall Study|Withdrawn by parent/guardian|1|||
105667160|NCT02224703|364446057|FG002|Overall Study|Withdrawn by parent/guardian|0|||
105667161|NCT02224703|364446055|FG000|Overall Study|Lack of Efficacy|1|||
105667162|NCT02224703|364446056|FG001|Overall Study|Lack of Efficacy|0|||
105667163|NCT02224703|364446057|FG002|Overall Study|Lack of Efficacy|0|||
105667164|NCT02990468|364446062|FG000|Phase 2: MTD|Change in treatment|0|||
105667165|NCT02990468|364446063|FG001|Phase 2: MTD|Change in treatment|0|||
105667166|NCT02990468|364446064|FG002|Phase 2: MTD|Change in treatment|1|||
105667167|NCT01602510|364446067|FG000|Open Label Phase|Adverse Event|46|||
105667168|NCT01602510|364446068|FG001|Open Label Phase|Adverse Event|0|||
105667169|NCT01602510|364446069|FG002|Open Label Phase|Adverse Event|0|||
105667170|NCT01602510|364446067|FG000|Open Label Phase|Lack of Efficacy|22|||
105667171|NCT01602510|364446068|FG001|Open Label Phase|Lack of Efficacy|0|||
105667172|NCT01602510|364446069|FG002|Open Label Phase|Lack of Efficacy|0|||
105667173|NCT01602510|364446067|FG000|Open Label Phase|Protocol Violation|15|||
105667174|NCT01602510|364446068|FG001|Open Label Phase|Protocol Violation|0|||
105667175|NCT01602510|364446069|FG002|Open Label Phase|Protocol Violation|0|||
105667176|NCT01602510|364446067|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
105667177|NCT01602510|364446068|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
105667178|NCT01602510|364446069|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
105667179|NCT01602510|364446067|FG000|Open Label Phase|Lost to Follow-up|22|||
105667180|NCT01602510|364446068|FG001|Open Label Phase|Lost to Follow-up|0|||
105667181|NCT01602510|364446069|FG002|Open Label Phase|Lost to Follow-up|0|||
105667182|NCT01602510|364446067|FG000|Open Label Phase|Physician Decision|19|||
105667183|NCT01602510|364446068|FG001|Open Label Phase|Physician Decision|0|||
105667184|NCT01602510|364446069|FG002|Open Label Phase|Physician Decision|0|||
105667185|NCT01602510|364446067|FG000|Open Label Phase|Withdrawal by Subject|57|||
105667186|NCT01602510|364446068|FG001|Open Label Phase|Withdrawal by Subject|0|||
105553026|NCT02349295|364023329|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
105553027|NCT02349295|364023330|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
105553028|NCT02349295|364023331|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
105553029|NCT02349295|364023332|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
105553030|NCT02349295|364023333|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
105553031|NCT02349295|364023334|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
105553032|NCT02349295|364023335|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
105553033|NCT02349295|364023336|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
105553034|NCT02349295|364023337|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
105553035|NCT02349295|364023338|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
105553036|NCT02349295|364023339|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
105553037|NCT02349295|364023340|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
105553038|NCT02349295|364023327|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
105553039|NCT02349295|364023328|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
105553040|NCT02349295|364023329|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
105553041|NCT02349295|364023330|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
105553042|NCT02349295|364023331|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
105553043|NCT02349295|364023332|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
105553044|NCT02349295|364023333|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
105553045|NCT02349295|364023334|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
105553046|NCT02349295|364023335|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
105553047|NCT02349295|364023336|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
105553048|NCT02349295|364023337|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
105553049|NCT02349295|364023338|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
105553050|NCT02349295|364023339|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
105553051|NCT02349295|364023340|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
105553052|NCT02349295|364023327|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
105553053|NCT02349295|364023328|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
105553054|NCT02349295|364023329|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
105553055|NCT02349295|364023330|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
105553056|NCT02349295|364023331|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
105553057|NCT02349295|364023332|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
105553058|NCT02349295|364023333|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
105553059|NCT02349295|364023334|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
105553060|NCT02349295|364023335|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
105553061|NCT02349295|364023336|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
105553062|NCT02349295|364023337|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
105553063|NCT02349295|364023338|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
105553064|NCT02349295|364023339|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
105553065|NCT02349295|364023340|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
105553066|NCT02349295|364023327|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
105553067|NCT02349295|364023328|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
105553068|NCT02349295|364023329|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
105553069|NCT02349295|364023330|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
105553070|NCT02349295|364023331|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
105553071|NCT02349295|364023332|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
105667187|NCT01602510|364446069|FG002|Open Label Phase|Withdrawal by Subject|0|||
105667188|NCT01602510|364446067|FG000|Randomized Phase|Adverse Event|0|||
105667189|NCT01602510|364446068|FG001|Randomized Phase|Adverse Event|2|||
105667190|NCT01602510|364446069|FG002|Randomized Phase|Adverse Event|6|||
105667191|NCT01602510|364446067|FG000|Randomized Phase|Lack of Efficacy|0|||
105667192|NCT01602510|364446068|FG001|Randomized Phase|Lack of Efficacy|4|||
105667193|NCT01602510|364446069|FG002|Randomized Phase|Lack of Efficacy|4|||
105667194|NCT01602510|364446067|FG000|Randomized Phase|Protocol Violation|0|||
105667195|NCT01602510|364446068|FG001|Randomized Phase|Protocol Violation|3|||
105667196|NCT01602510|364446069|FG002|Randomized Phase|Protocol Violation|3|||
105667197|NCT01602510|364446067|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
105667198|NCT01602510|364446068|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
105667199|NCT01602510|364446069|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
105667200|NCT01602510|364446067|FG000|Randomized Phase|Lost to Follow-up|0|||
105667201|NCT01602510|364446068|FG001|Randomized Phase|Lost to Follow-up|1|||
105667202|NCT01602510|364446069|FG002|Randomized Phase|Lost to Follow-up|3|||
105667203|NCT01602510|364446067|FG000|Randomized Phase|Physician Decision|0|||
105667204|NCT01602510|364446068|FG001|Randomized Phase|Physician Decision|0|||
105667205|NCT01602510|364446069|FG002|Randomized Phase|Physician Decision|2|||
105667206|NCT01602510|364446067|FG000|Randomized Phase|Withdrawal by Subject|0|||
105667207|NCT01602510|364446068|FG001|Randomized Phase|Withdrawal by Subject|6|||
105667208|NCT01602510|364446069|FG002|Randomized Phase|Withdrawal by Subject|7|||
105667209|NCT02992691|364446071|FG000|Overall Study|Adverse Event|2|||
105667210|NCT02992691|364446071|FG000|Overall Study|Withdrawal by Subject|1|||
105667211|NCT04276051|364446073|FG000|Overall Study|Lost to Follow-up|0|||
105667212|NCT04276051|364446074|FG001|Overall Study|Lost to Follow-up|1|||
105667213|NCT04276051|364446073|FG000|Overall Study|Physician Decision|0|||
105667214|NCT04276051|364446074|FG001|Overall Study|Physician Decision|1|||
105667215|NCT04276051|364446073|FG000|Overall Study|Withdrawal by Subject|1|||
105667216|NCT04276051|364446074|FG001|Overall Study|Withdrawal by Subject|1|||
105785978|NCT04246593|364870424|FG001|Overall Study|Moved out of area/became ineligible|1|||
105785979|NCT04246593|364870423|FG000|Overall Study|Reason unknown|4|||
105785980|NCT04246593|364870424|FG001|Overall Study|Reason unknown|2|||
105785981|NCT04338685|364870433|FG000|Overall Study|Death|3|||
105667217|NCT03552523|364446075|FG000|Overall Study|Withdrawal by Subject|1|||
105667218|NCT03552523|364446076|FG001|Overall Study|Withdrawal by Subject|1|||
105667219|NCT03995316|364446078|FG000|Overall Study|Lost to Follow-up|10|||
105667220|NCT03995316|364446079|FG001|Overall Study|Lost to Follow-up|3|||
105667221|NCT01281839|364446080|FG000|Overall Study|Lost to Follow-up|6|||
105667222|NCT01281839|364446081|FG001|Overall Study|Lost to Follow-up|3|||
105667223|NCT01281839|364446080|FG000|Overall Study|Withdrawal by Subject|4|||
105667224|NCT01281839|364446081|FG001|Overall Study|Withdrawal by Subject|10|||
105667225|NCT01281839|364446080|FG000|Overall Study|Reason not specified|0|||
105667226|NCT01281839|364446081|FG001|Overall Study|Reason not specified|1|||
105667227|NCT01305239|364446082|FG000|Overall Study|Adverse Event|22|||
105667228|NCT01305239|364446082|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
105667229|NCT01518153|364446088|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
105667230|NCT01518153|364446089|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
105667231|NCT01518153|364446090|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
105667232|NCT01518153|364446088|FG000|Stem Cell Transplant|Death|2|||
105667233|NCT01518153|364446089|FG001|Stem Cell Transplant|Death|0|||
105667234|NCT01518153|364446090|FG002|Stem Cell Transplant|Death|0|||
105667235|NCT01518153|364446088|FG000|Stem Cell Transplant|Secondary graft failure|1|||
105667236|NCT01518153|364446089|FG001|Stem Cell Transplant|Secondary graft failure|0|||
105785982|NCT04338685|364870434|FG001|Overall Study|Death|4|||
105785983|NCT04338685|364870435|FG002|Overall Study|Death|2|||
105667237|NCT01518153|364446090|FG002|Stem Cell Transplant|Secondary graft failure|0|||
105667238|NCT01518153|364446088|FG000|Stem Cell Transplant|Adverse Event|1|||
105667239|NCT01518153|364446089|FG001|Stem Cell Transplant|Adverse Event|0|||
105667240|NCT01518153|364446090|FG002|Stem Cell Transplant|Adverse Event|0|||
105785984|NCT04338685|364870436|FG003|Overall Study|Death|4|||
105667241|NCT01518153|364446088|FG000|Donor Lymphocyte Infusion|Death|0|||
105667242|NCT01518153|364446089|FG001|Donor Lymphocyte Infusion|Death|2|||
105667243|NCT01518153|364446090|FG002|Donor Lymphocyte Infusion|Death|1|||
105340554|NCT02031640|363248217|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
105340555|NCT02031640|363248218|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
105553072|NCT02349295|364023333|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
105553073|NCT02349295|364023334|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
105553074|NCT02349295|364023335|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
105553075|NCT02349295|364023336|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
105553076|NCT02349295|364023337|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
105553077|NCT02349295|364023338|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
105553078|NCT02349295|364023339|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
105553079|NCT02349295|364023340|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
105553080|NCT02349295|364023327|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
105553081|NCT02349295|364023328|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
105553082|NCT02349295|364023329|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
105553083|NCT02349295|364023330|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
105553084|NCT02349295|364023331|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
105553085|NCT02349295|364023332|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
105553086|NCT02349295|364023333|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
105553087|NCT02349295|364023334|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
105553088|NCT02349295|364023335|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
105553089|NCT02349295|364023336|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
105553090|NCT02349295|364023337|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
105553091|NCT02349295|364023338|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
105553092|NCT02349295|364023339|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
105553093|NCT02349295|364023340|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
105553094|NCT02349295|364023327|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
105553095|NCT02349295|364023328|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
105553096|NCT02349295|364023329|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
105553097|NCT02349295|364023330|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
105553098|NCT02349295|364023331|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
105553099|NCT02349295|364023332|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
105553100|NCT02349295|364023333|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
105553101|NCT02349295|364023334|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
105553102|NCT02349295|364023335|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
105553103|NCT02349295|364023336|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
105553104|NCT02349295|364023337|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
105553105|NCT02349295|364023338|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
105553106|NCT02349295|364023339|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
105553107|NCT02349295|364023340|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
105553108|NCT02349295|364023327|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
105553109|NCT02349295|364023328|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
105553110|NCT02349295|364023329|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
105553111|NCT02349295|364023330|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
105553112|NCT02349295|364023331|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
105553113|NCT02349295|364023332|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
105553114|NCT02349295|364023333|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
105553115|NCT02349295|364023334|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
105553116|NCT02349295|364023335|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
105553117|NCT02349295|364023336|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
105553118|NCT02349295|364023337|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
105553119|NCT02349295|364023338|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
105553120|NCT02349295|364023339|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
105553121|NCT02349295|364023340|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
105553122|NCT02349295|364023327|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
105553123|NCT02349295|364023328|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
105553124|NCT02349295|364023329|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
105553125|NCT02349295|364023330|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
105553126|NCT02349295|364023331|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
105553127|NCT02349295|364023332|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
105553128|NCT02349295|364023333|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
105553129|NCT02349295|364023334|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
105553130|NCT02349295|364023335|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
105553131|NCT02349295|364023336|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
105553132|NCT02349295|364023337|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
105340556|NCT02031640|363248219|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
105340557|NCT02031640|363248214|FG000|Double-blind Treatment Period|Non-compliance|0|||
105667244|NCT02670122|364446093|FG000|Overall Study|Lost to Follow-up|4|||
105667245|NCT01011868|364446096|FG000|After Week 18 Follow-up|Adverse Event|8|||
105667246|NCT01011868|364446097|FG001|After Week 18 Follow-up|Adverse Event|6|||
105667247|NCT01011868|364446098|FG002|After Week 18 Follow-up|Adverse Event|13|||
105667248|NCT01011868|364446096|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
105667249|NCT01011868|364446097|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
105667250|NCT01011868|364446098|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
105667251|NCT01011868|364446096|FG000|After Week 18 Follow-up|Protocol Violation|1|||
105667252|NCT01011868|364446097|FG001|After Week 18 Follow-up|Protocol Violation|1|||
105667253|NCT01011868|364446098|FG002|After Week 18 Follow-up|Protocol Violation|1|||
105667254|NCT01011868|364446096|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
105667255|NCT01011868|364446097|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
105667256|NCT01011868|364446098|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
105667257|NCT01011868|364446096|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
105667258|NCT01011868|364446097|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
105667259|NCT01011868|364446098|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
105667260|NCT01011868|364446096|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
105667261|NCT01011868|364446097|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
105667262|NCT01011868|364446098|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
105667263|NCT01011868|364446096|FG000|After Week 78 Follow-up|Adverse Event|14|||
105667264|NCT01011868|364446097|FG001|After Week 78 Follow-up|Adverse Event|18|||
105667265|NCT01011868|364446098|FG002|After Week 78 Follow-up|Adverse Event|21|||
105667266|NCT01011868|364446096|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
105667267|NCT01011868|364446097|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
105667268|NCT01011868|364446098|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
105667269|NCT01011868|364446096|FG000|After Week 78 Follow-up|Protocol Violation|9|||
105667270|NCT01011868|364446097|FG001|After Week 78 Follow-up|Protocol Violation|1|||
105667271|NCT01011868|364446098|FG002|After Week 78 Follow-up|Protocol Violation|2|||
105667272|NCT01011868|364446096|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
105667273|NCT01011868|364446097|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
105667274|NCT01011868|364446098|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
105667275|NCT01011868|364446096|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
105667276|NCT01011868|364446097|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
105667277|NCT01011868|364446098|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
105667278|NCT01011868|364446096|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
105667279|NCT01011868|364446097|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
105340558|NCT02031640|363248215|FG001|Double-blind Treatment Period|Non-compliance|1|||
105340559|NCT02031640|363248216|FG002|Double-blind Treatment Period|Non-compliance|0|||
105340560|NCT02031640|363248217|FG003|Double-blind Treatment Period|Non-compliance|1|||
105340561|NCT02031640|363248218|FG004|Double-blind Treatment Period|Non-compliance|1|||
105340562|NCT02031640|363248219|FG005|Double-blind Treatment Period|Non-compliance|0|||
105340563|NCT02031640|363248214|FG000|Double-blind Treatment Period|Adverse Event|0|||
105340564|NCT02031640|363248215|FG001|Double-blind Treatment Period|Adverse Event|0|||
105340565|NCT02031640|363248216|FG002|Double-blind Treatment Period|Adverse Event|0|||
105340566|NCT02031640|363248217|FG003|Double-blind Treatment Period|Adverse Event|2|||
105340567|NCT02031640|363248218|FG004|Double-blind Treatment Period|Adverse Event|0|||
105340568|NCT02031640|363248219|FG005|Double-blind Treatment Period|Adverse Event|0|||
105340569|NCT02031640|363248214|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
105340570|NCT02031640|363248215|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
105340571|NCT02031640|363248216|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
105340572|NCT02031640|363248217|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
105340573|NCT02031640|363248218|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
105340574|NCT02031640|363248219|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
105340575|NCT02031640|363248214|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
105340576|NCT02031640|363248215|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
105340577|NCT02031640|363248216|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
105340578|NCT02031640|363248217|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
105340579|NCT02031640|363248218|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
105340580|NCT02031640|363248219|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
105340581|NCT02091375|363248222|FG000|Overall Study|Adverse Event|8|||
105340582|NCT02091375|363248223|FG001|Overall Study|Adverse Event|1|||
105340583|NCT02091375|363248222|FG000|Overall Study|Lost to Follow-up|0|||
105340584|NCT02091375|363248223|FG001|Overall Study|Lost to Follow-up|1|||
105667280|NCT01011868|364446098|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
105667281|NCT01228175|364446099|FG000|Overall Study|Lost to Follow-up|64|||
105667282|NCT01228175|364446100|FG001|Overall Study|Lost to Follow-up|50|||
105340585|NCT02091375|363248222|FG000|Overall Study|Withdrawal by Subject|0|||
105340586|NCT02091375|363248223|FG001|Overall Study|Withdrawal by Subject|1|||
105667283|NCT01228175|364446099|FG000|Overall Study|Withdrawal by Subject|1|||
105667284|NCT01228175|364446100|FG001|Overall Study|Withdrawal by Subject|2|||
105667285|NCT01228175|364446099|FG000|Overall Study|Physician Decision|1|||
105667286|NCT01228175|364446100|FG001|Overall Study|Physician Decision|1|||
105667287|NCT03041792|364446103|FG000|Overall Study|Adverse Event|4|||
105667288|NCT03041792|364446104|FG001|Overall Study|Adverse Event|0|||
105667289|NCT03041792|364446103|FG000|Overall Study|Death in the family|0|||
105667290|NCT03041792|364446104|FG001|Overall Study|Death in the family|2|||
105667291|NCT03041792|364446103|FG000|Overall Study|Randomized but not treated|0|||
105667292|NCT03041792|364446104|FG001|Overall Study|Randomized but not treated|1|||
105667293|NCT01647542|364446105|FG000|Overall Study|Major Protocol Deviation|1|||
105667294|NCT01647542|364446106|FG001|Overall Study|Major Protocol Deviation|0|||
105667295|NCT01647542|364446107|FG002|Overall Study|Major Protocol Deviation|0|||
105667296|NCT01647542|364446105|FG000|Overall Study|Adverse Event|4|||
105667297|NCT01647542|364446106|FG001|Overall Study|Adverse Event|5|||
105667298|NCT01647542|364446107|FG002|Overall Study|Adverse Event|4|||
105667299|NCT01647542|364446105|FG000|Overall Study|Lost to Follow-up|0|||
105667300|NCT01647542|364446106|FG001|Overall Study|Lost to Follow-up|2|||
105667301|NCT01647542|364446107|FG002|Overall Study|Lost to Follow-up|2|||
105667302|NCT01647542|364446105|FG000|Overall Study|Withdrawal by Subject|6|||
105667303|NCT01647542|364446106|FG001|Overall Study|Withdrawal by Subject|4|||
105667304|NCT01647542|364446107|FG002|Overall Study|Withdrawal by Subject|0|||
105667305|NCT01647542|364446105|FG000|Overall Study|Study Termination|64|||
105667306|NCT01647542|364446106|FG001|Overall Study|Study Termination|61|||
105667307|NCT01647542|364446107|FG002|Overall Study|Study Termination|65|||
105667308|NCT01647542|364446105|FG000|Overall Study|Lack of Efficacy|1|||
105667309|NCT01647542|364446106|FG001|Overall Study|Lack of Efficacy|1|||
105667310|NCT01647542|364446107|FG002|Overall Study|Lack of Efficacy|0|||
105667311|NCT01647542|364446105|FG000|Overall Study|Death|0|||
105667312|NCT01647542|364446106|FG001|Overall Study|Death|0|||
105667313|NCT01647542|364446107|FG002|Overall Study|Death|1|||
105464565|NCT01285557|363714073|FG000|Overall Study|Sponsor Study Termination|23|||
105667314|NCT00975676|364446112|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
105667315|NCT00975676|364446113|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
105667316|NCT01424813|364446117|FG000|Overall Study|Withdrawal by Subject|3|||
105667317|NCT01424813|364446118|FG001|Overall Study|Withdrawal by Subject|0|||
105667318|NCT01424813|364446117|FG000|Overall Study|Protocol Violation|1|||
105667319|NCT01424813|364446118|FG001|Overall Study|Protocol Violation|0|||
105667320|NCT01424813|364446117|FG000|Overall Study|Other|1|||
105667321|NCT01424813|364446118|FG001|Overall Study|Other|2|||
105667322|NCT01484431|364448086|FG000|Period 1: High Dose|Physician Decision|0|||
105667323|NCT01484431|364448087|FG001|Period 1: High Dose|Physician Decision|1|||
105667324|NCT01484431|364448088|FG002|Period 1: High Dose|Physician Decision|0|||
105667325|NCT01484431|364448086|FG000|Period 2|Death|0|||
105667326|NCT01484431|364448087|FG001|Period 2|Death|1|||
105667327|NCT01484431|364448088|FG002|Period 2|Death|1|||
105667328|NCT01484431|364448086|FG000|Period 2|Physician Decision|0|||
105667329|NCT01484431|364448087|FG001|Period 2|Physician Decision|0|||
105667330|NCT01484431|364448088|FG002|Period 2|Physician Decision|1|||
105667331|NCT01484431|364448086|FG000|Period 2|Non-Compliance with Study Drug|1|||
105464566|NCT01285557|363714074|FG001|Overall Study|Sponsor Study Termination|13|||
105464567|NCT01285557|363714073|FG000|Overall Study|Randomized but not treated|1|||
105464568|NCT01285557|363714074|FG001|Overall Study|Randomized but not treated|1|||
105464569|NCT01285557|363714073|FG000|Overall Study|Study follow-up ongoing|28|||
105464570|NCT01285557|363714074|FG001|Overall Study|Study follow-up ongoing|14|||
105464571|NCT01285557|363714073|FG000|Overall Study|Sponsor Decision|2|||
105464572|NCT01285557|363714074|FG001|Overall Study|Sponsor Decision|1|||
105464573|NCT03173248|363714081|FG000|Overall Study|Death|28|||
105464574|NCT03173248|363714082|FG001|Overall Study|Death|46|||
105464575|NCT03173248|363714081|FG000|Overall Study|Lost to Follow-up|0|||
105464576|NCT03173248|363714082|FG001|Overall Study|Lost to Follow-up|1|||
105464577|NCT03173248|363714081|FG000|Overall Study|Withdrawal by Subject|6|||
105667332|NCT01484431|364448087|FG001|Period 2|Non-Compliance with Study Drug|0|||
105667333|NCT01484431|364448088|FG002|Period 2|Non-Compliance with Study Drug|0|||
105667334|NCT01251770|364448089|FG000|Overall Study|Protocol Violation|13|||
105667335|NCT01251770|364448090|FG001|Overall Study|Protocol Violation|7|||
105667336|NCT00426127|364448093|FG000|Overall Study|Adverse Event|1|||
105667337|NCT00426127|364448093|FG000|Overall Study|Removed due to disease progression|1|||
105667338|NCT01016262|364448095|FG000|Double-blind Phase|Adverse Event|0|||
105667339|NCT01016262|364448096|FG001|Double-blind Phase|Adverse Event|0|||
105667340|NCT01016262|364448097|FG002|Double-blind Phase|Adverse Event|1|||
105785985|NCT04338685|364870437|FG004|Overall Study|Death|4|||
105464578|NCT03173248|363714082|FG001|Overall Study|Withdrawal by Subject|4|||
105667341|NCT01016262|364448098|FG003|Double-blind Phase|Adverse Event|0|||
105667342|NCT01016262|364448099|FG004|Double-blind Phase|Adverse Event|0|||
105667343|NCT01016262|364448100|FG005|Double-blind Phase|Adverse Event|0|||
105667344|NCT01016262|364448095|FG000|Double-blind Phase|Lack of Efficacy|1|||
105667345|NCT01016262|364448096|FG001|Double-blind Phase|Lack of Efficacy|0|||
105667346|NCT01016262|364448097|FG002|Double-blind Phase|Lack of Efficacy|5|||
105464579|NCT03173248|363714081|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
105464580|NCT03173248|363714082|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
105464581|NCT01648751|363714083|FG000|Overall Study|Withdrawal by Subject|2|||
105464582|NCT01648751|363714084|FG001|Overall Study|Withdrawal by Subject|3|||
105464583|NCT01588522|363714086|FG000|Overall Study|Withdrawal by Subject|1|||
105464584|NCT01588522|363714087|FG001|Overall Study|Withdrawal by Subject|5|||
105464585|NCT01588522|363714088|FG002|Overall Study|Withdrawal by Subject|3|||
105464586|NCT01588522|363714089|FG003|Overall Study|Withdrawal by Subject|1|||
105464587|NCT01588522|363714090|FG004|Overall Study|Withdrawal by Subject|2|||
105464588|NCT01588522|363714091|FG005|Overall Study|Withdrawal by Subject|0|||
105464589|NCT01588522|363714086|FG000|Overall Study|Lack of Efficacy|0|||
105464590|NCT01588522|363714087|FG001|Overall Study|Lack of Efficacy|0|||
105464591|NCT01588522|363714088|FG002|Overall Study|Lack of Efficacy|0|||
105464592|NCT01588522|363714089|FG003|Overall Study|Lack of Efficacy|0|||
105464593|NCT01588522|363714090|FG004|Overall Study|Lack of Efficacy|1|||
105464594|NCT01588522|363714091|FG005|Overall Study|Lack of Efficacy|0|||
105464595|NCT01588522|363714086|FG000|Overall Study|Adverse Event|0|||
105464596|NCT01588522|363714087|FG001|Overall Study|Adverse Event|0|||
105464597|NCT01588522|363714088|FG002|Overall Study|Adverse Event|0|||
105464598|NCT01588522|363714089|FG003|Overall Study|Adverse Event|1|||
105464599|NCT01588522|363714090|FG004|Overall Study|Adverse Event|0|||
105464600|NCT01588522|363714091|FG005|Overall Study|Adverse Event|0|||
105464601|NCT01588522|363714086|FG000|Overall Study|Grade 2 alopecia|1|||
105464602|NCT01588522|363714087|FG001|Overall Study|Grade 2 alopecia|0|||
105464603|NCT01588522|363714088|FG002|Overall Study|Grade 2 alopecia|0|||
105464604|NCT01588522|363714089|FG003|Overall Study|Grade 2 alopecia|0|||
105464605|NCT01588522|363714090|FG004|Overall Study|Grade 2 alopecia|0|||
105464606|NCT01588522|363714091|FG005|Overall Study|Grade 2 alopecia|0|||
105464607|NCT01588522|363714086|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
105464608|NCT01588522|363714087|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
105464609|NCT01588522|363714088|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
105464610|NCT01588522|363714089|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
105464611|NCT01588522|363714090|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
105464612|NCT01588522|363714091|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
105464613|NCT01588522|363714086|FG000|Overall Study|Taken off taxane-based regimen|0|||
105464614|NCT01588522|363714087|FG001|Overall Study|Taken off taxane-based regimen|0|||
105464615|NCT01588522|363714088|FG002|Overall Study|Taken off taxane-based regimen|0|||
105464616|NCT01588522|363714089|FG003|Overall Study|Taken off taxane-based regimen|1|||
105464617|NCT01588522|363714090|FG004|Overall Study|Taken off taxane-based regimen|0|||
105464618|NCT01588522|363714091|FG005|Overall Study|Taken off taxane-based regimen|0|||
105464619|NCT01588522|363714086|FG000|Overall Study|Did not initiate chemotherapy|0|||
105464620|NCT01588522|363714087|FG001|Overall Study|Did not initiate chemotherapy|0|||
105464621|NCT01588522|363714088|FG002|Overall Study|Did not initiate chemotherapy|0|||
105464622|NCT01588522|363714089|FG003|Overall Study|Did not initiate chemotherapy|0|||
105464623|NCT01588522|363714090|FG004|Overall Study|Did not initiate chemotherapy|1|||
105464624|NCT01588522|363714091|FG005|Overall Study|Did not initiate chemotherapy|0|||
105464625|NCT02991768|363714092|FG000|Overall Study|Physician Decision|4|||
105464626|NCT02749422|363714093|FG000|Overall Study|Lost to Follow-up|0|||
105464627|NCT02749422|363714094|FG001|Overall Study|Lost to Follow-up|2|||
105464628|NCT02749422|363714093|FG000|Overall Study|Ineligible|0|||
105464629|NCT02749422|363714094|FG001|Overall Study|Ineligible|1|||
105464630|NCT02594124|363714095|FG000|Overall Study|Adverse Event|0|||
105464631|NCT02594124|363714096|FG001|Overall Study|Adverse Event|5|||
105464632|NCT02594124|363714097|FG002|Overall Study|Adverse Event|8|||
105464633|NCT02594124|363714098|FG003|Overall Study|Adverse Event|1|||
105464634|NCT02594124|363714099|FG004|Overall Study|Adverse Event|0|||
105464635|NCT02594124|363714100|FG005|Overall Study|Adverse Event|0|||
105464636|NCT02594124|363714101|FG006|Overall Study|Adverse Event|2|||
105464637|NCT02594124|363714102|FG007|Overall Study|Adverse Event|2|||
105464638|NCT02594124|363714103|FG008|Overall Study|Adverse Event|0|||
105464639|NCT02594124|363714095|FG000|Overall Study|Withdrawal by Subject|2|||
105464640|NCT02594124|363714096|FG001|Overall Study|Withdrawal by Subject|3|||
105464641|NCT02594124|363714097|FG002|Overall Study|Withdrawal by Subject|5|||
105667347|NCT01016262|364448098|FG003|Double-blind Phase|Lack of Efficacy|0|||
105667348|NCT01016262|364448099|FG004|Double-blind Phase|Lack of Efficacy|0|||
105667349|NCT01016262|364448100|FG005|Double-blind Phase|Lack of Efficacy|0|||
105667350|NCT01016262|364448095|FG000|Double-blind Phase|Disease Progression|0|||
105667351|NCT01016262|364448096|FG001|Double-blind Phase|Disease Progression|1|||
105667352|NCT01016262|364448097|FG002|Double-blind Phase|Disease Progression|2|||
105667353|NCT01016262|364448098|FG003|Double-blind Phase|Disease Progression|0|||
105667354|NCT01016262|364448099|FG004|Double-blind Phase|Disease Progression|0|||
105667355|NCT01016262|364448100|FG005|Double-blind Phase|Disease Progression|0|||
105667356|NCT01016262|364448095|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
105667357|NCT01016262|364448096|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
105464642|NCT02594124|363714098|FG003|Overall Study|Withdrawal by Subject|1|||
105464643|NCT02594124|363714099|FG004|Overall Study|Withdrawal by Subject|8|||
105464644|NCT02594124|363714100|FG005|Overall Study|Withdrawal by Subject|4|||
105464645|NCT02594124|363714101|FG006|Overall Study|Withdrawal by Subject|13|||
105464646|NCT02594124|363714102|FG007|Overall Study|Withdrawal by Subject|19|||
105464647|NCT02594124|363714103|FG008|Overall Study|Withdrawal by Subject|0|||
105464648|NCT02594124|363714095|FG000|Overall Study|Physician Decision|0|||
105464649|NCT02594124|363714096|FG001|Overall Study|Physician Decision|2|||
105464650|NCT02594124|363714097|FG002|Overall Study|Physician Decision|0|||
105464651|NCT02594124|363714098|FG003|Overall Study|Physician Decision|0|||
105464652|NCT02594124|363714099|FG004|Overall Study|Physician Decision|0|||
105464653|NCT02594124|363714100|FG005|Overall Study|Physician Decision|0|||
105464654|NCT02594124|363714101|FG006|Overall Study|Physician Decision|0|||
105464655|NCT02594124|363714102|FG007|Overall Study|Physician Decision|1|||
105464656|NCT02594124|363714103|FG008|Overall Study|Physician Decision|0|||
105464657|NCT02594124|363714095|FG000|Overall Study|Commercial drug|0|||
105464658|NCT02594124|363714096|FG001|Overall Study|Commercial drug|1|||
105464659|NCT02594124|363714097|FG002|Overall Study|Commercial drug|6|||
105464660|NCT02594124|363714098|FG003|Overall Study|Commercial drug|3|||
105464661|NCT02594124|363714099|FG004|Overall Study|Commercial drug|0|||
105464662|NCT02594124|363714100|FG005|Overall Study|Commercial drug|0|||
105464663|NCT02594124|363714101|FG006|Overall Study|Commercial drug|7|||
105464664|NCT02594124|363714102|FG007|Overall Study|Commercial drug|11|||
105464665|NCT02594124|363714103|FG008|Overall Study|Commercial drug|2|||
105464666|NCT02594124|363714095|FG000|Overall Study|Reason Not Specified|1|||
105464667|NCT02594124|363714096|FG001|Overall Study|Reason Not Specified|3|||
105464668|NCT02594124|363714097|FG002|Overall Study|Reason Not Specified|4|||
105464669|NCT02594124|363714098|FG003|Overall Study|Reason Not Specified|0|||
105464670|NCT02594124|363714099|FG004|Overall Study|Reason Not Specified|0|||
105464671|NCT02594124|363714100|FG005|Overall Study|Reason Not Specified|1|||
105464672|NCT02594124|363714101|FG006|Overall Study|Reason Not Specified|1|||
105464673|NCT02594124|363714102|FG007|Overall Study|Reason Not Specified|6|||
105464674|NCT02594124|363714103|FG008|Overall Study|Reason Not Specified|1|||
105464675|NCT02017405|363714106|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
105464676|NCT02017405|363714107|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
105464677|NCT02017405|363714108|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
105464678|NCT02017405|363714109|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
105464679|NCT02017405|363714110|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
105464680|NCT02017405|363714111|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
105464681|NCT02017405|363714106|FG000|Open-label Phase|Adverse Event|1|||
105464682|NCT02017405|363714107|FG001|Open-label Phase|Adverse Event|1|||
105464683|NCT02017405|363714108|FG002|Open-label Phase|Adverse Event|0|||
105464684|NCT02017405|363714109|FG003|Open-label Phase|Adverse Event|0|||
105464685|NCT02017405|363714110|FG004|Open-label Phase|Adverse Event|0|||
105464686|NCT02017405|363714111|FG005|Open-label Phase|Adverse Event|0|||
105464687|NCT04774094|363714112|FG000|Overall Study|Other|2|||
105464688|NCT04774094|363714112|FG000|Overall Study|Withdrawal by Subject|9|||
105464689|NCT04774094|363714112|FG000|Overall Study|Lost to Follow-up|7|||
105464690|NCT04774094|363714112|FG000|Overall Study|Lack of Efficacy|5|||
105464691|NCT04774094|363714112|FG000|Overall Study|Death|17|||
105464692|NCT04774094|363714112|FG000|Overall Study|Adverse Event|4|||
105464693|NCT02374450|363714113|FG000|Overall Study|Protocol Violation|0|||
105464694|NCT02374450|363714114|FG001|Overall Study|Protocol Violation|1|||
105464695|NCT02374450|363714115|FG002|Overall Study|Protocol Violation|0|||
105464696|NCT02374450|363714113|FG000|Overall Study|Withdrawal by Subject|91|||
105464697|NCT02374450|363714114|FG001|Overall Study|Withdrawal by Subject|110|||
105464698|NCT02374450|363714115|FG002|Overall Study|Withdrawal by Subject|4|||
105464699|NCT02374450|363714113|FG000|Overall Study|Lost to Follow-up|168|||
105464700|NCT02374450|363714114|FG001|Overall Study|Lost to Follow-up|194|||
105464701|NCT02374450|363714115|FG002|Overall Study|Lost to Follow-up|138|||
105464702|NCT02374450|363714113|FG000|Overall Study|Death|173|||
105464703|NCT02374450|363714114|FG001|Overall Study|Death|185|||
105464704|NCT02374450|363714115|FG002|Overall Study|Death|81|||
105464705|NCT02374450|363714113|FG000|Overall Study|Migrated from the study area|538|||
105464706|NCT02374450|363714114|FG001|Overall Study|Migrated from the study area|648|||
105464707|NCT02374450|363714115|FG002|Overall Study|Migrated from the study area|181|||
105464708|NCT02374450|363714113|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
105464709|NCT02374450|363714114|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
105464710|NCT02374450|363714115|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
105464711|NCT02374450|363714113|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
105464712|NCT02374450|363714114|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
105464713|NCT02374450|363714115|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
105464714|NCT02374450|363714113|FG000|Overall Study|Other|0|||
105464715|NCT02374450|363714114|FG001|Overall Study|Other|21|||
105464716|NCT02374450|363714115|FG002|Overall Study|Other|79|||
105464717|NCT05232682|363714116|FG000|Overall Study|Lost to Follow-up|2|||
105464718|NCT04323124|363714117|FG000|Overall Study|Adverse Event|0|||
105464719|NCT04323124|363714118|FG001|Overall Study|Adverse Event|0|||
105464720|NCT04323124|363714119|FG002|Overall Study|Adverse Event|0|||
105464721|NCT04323124|363714120|FG003|Overall Study|Adverse Event|0|||
105464722|NCT04323124|363714121|FG004|Overall Study|Adverse Event|0|||
105553133|NCT02349295|364023338|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
105553134|NCT02349295|364023339|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
105553135|NCT02349295|364023340|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
105553136|NCT02349295|364023327|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
105553137|NCT02349295|364023328|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
105553138|NCT02349295|364023329|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
105553139|NCT02349295|364023330|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
105553140|NCT02349295|364023331|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
105553141|NCT02349295|364023332|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
105553142|NCT02349295|364023333|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
105553143|NCT02349295|364023334|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
105553144|NCT02349295|364023335|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
105667358|NCT01016262|364448097|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
105464723|NCT04323124|363714122|FG005|Overall Study|Adverse Event|1|||
105464724|NCT04323124|363714123|FG006|Overall Study|Adverse Event|0|||
105464725|NCT04323124|363714124|FG007|Overall Study|Adverse Event|1|||
105464726|NCT04323124|363714125|FG008|Overall Study|Adverse Event|1|||
105464727|NCT04323124|363714126|FG009|Overall Study|Adverse Event|0|||
105464728|NCT04323124|363714127|FG010|Overall Study|Adverse Event|0|||
105464729|NCT04323124|363714128|FG011|Overall Study|Adverse Event|0|||
105464730|NCT04323124|363714129|FG012|Overall Study|Adverse Event|0|||
105340587|NCT02091375|363248222|FG000|Overall Study|Withdrawn by the investigator|1|||
105340588|NCT02091375|363248223|FG001|Overall Study|Withdrawn by the investigator|0|||
105340589|NCT01741792|363248224|FG000|Overall Study|Death|6|||
105553145|NCT02349295|364023336|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
105553146|NCT02349295|364023337|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
105553147|NCT02349295|364023338|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
105553148|NCT02349295|364023339|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
105553149|NCT02349295|364023340|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
105553150|NCT02349295|364023327|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
105553151|NCT02349295|364023328|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
105667359|NCT01016262|364448098|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
105667360|NCT01016262|364448099|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
105667361|NCT01016262|364448100|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
105667362|NCT01016262|364448095|FG000|Open-Label Phase|Adverse Event|0|||
105667363|NCT01016262|364448096|FG001|Open-Label Phase|Adverse Event|0|||
105667364|NCT01016262|364448097|FG002|Open-Label Phase|Adverse Event|0|||
105667365|NCT01016262|364448098|FG003|Open-Label Phase|Adverse Event|1|||
105667366|NCT01016262|364448099|FG004|Open-Label Phase|Adverse Event|0|||
105667367|NCT01016262|364448100|FG005|Open-Label Phase|Adverse Event|0|||
105667368|NCT01016262|364448095|FG000|Open-Label Phase|Lost to Follow-up|0|||
105667369|NCT01016262|364448096|FG001|Open-Label Phase|Lost to Follow-up|0|||
105667370|NCT01016262|364448097|FG002|Open-Label Phase|Lost to Follow-up|0|||
105667371|NCT01016262|364448098|FG003|Open-Label Phase|Lost to Follow-up|0|||
105667372|NCT01016262|364448099|FG004|Open-Label Phase|Lost to Follow-up|1|||
105667373|NCT01016262|364448100|FG005|Open-Label Phase|Lost to Follow-up|0|||
105667374|NCT01016262|364448095|FG000|Open-Label Phase|Lack of Efficacy|0|||
105667375|NCT01016262|364448096|FG001|Open-Label Phase|Lack of Efficacy|0|||
105667376|NCT01016262|364448097|FG002|Open-Label Phase|Lack of Efficacy|0|||
105667377|NCT01016262|364448098|FG003|Open-Label Phase|Lack of Efficacy|1|||
105667378|NCT01016262|364448099|FG004|Open-Label Phase|Lack of Efficacy|0|||
105667379|NCT01016262|364448100|FG005|Open-Label Phase|Lack of Efficacy|0|||
105667380|NCT01016262|364448095|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
105667381|NCT01016262|364448096|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
105667382|NCT01016262|364448097|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
105667383|NCT01016262|364448098|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
105667384|NCT01016262|364448099|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
105667385|NCT01016262|364448100|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
105667386|NCT01725126|364448101|FG000|Overall Study|Protocol Violation|0|||
105667387|NCT01725126|364448102|FG001|Overall Study|Protocol Violation|1|||
105667388|NCT01725126|364448103|FG002|Overall Study|Protocol Violation|0|||
105667389|NCT01725126|364448104|FG003|Overall Study|Protocol Violation|0|||
105667390|NCT01725126|364448105|FG004|Overall Study|Protocol Violation|0|||
105667391|NCT01725126|364448106|FG005|Overall Study|Protocol Violation|0|||
105667392|NCT01725126|364448101|FG000|Overall Study|Withdrawal by Subject|0|||
105667393|NCT01725126|364448102|FG001|Overall Study|Withdrawal by Subject|0|||
105667394|NCT01725126|364448103|FG002|Overall Study|Withdrawal by Subject|0|||
105667395|NCT01725126|364448104|FG003|Overall Study|Withdrawal by Subject|1|||
105667396|NCT01725126|364448105|FG004|Overall Study|Withdrawal by Subject|0|||
105667397|NCT01725126|364448106|FG005|Overall Study|Withdrawal by Subject|0|||
105667398|NCT00581477|364448110|FG000|Overall Study|Physician Decision|2|||
105667399|NCT00667394|364448112|FG000|Overall Study|Adverse Event|3|||
105667400|NCT00667394|364448113|FG001|Overall Study|Adverse Event|0|||
105667401|NCT00667394|364448112|FG000|Overall Study|Progressive disease|1|||
105667402|NCT00667394|364448113|FG001|Overall Study|Progressive disease|0|||
105340590|NCT01741792|363248225|FG001|Overall Study|Death|1|||
105340591|NCT01741792|363248226|FG002|Overall Study|Death|12|||
105340592|NCT00761280|363248227|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
105340593|NCT00761280|363248228|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
105340594|NCT00761280|363248227|FG000|Randomization to First Dose|Sponsor decision|1|||
105340595|NCT00761280|363248228|FG001|Randomization to First Dose|Sponsor decision|0|||
105340596|NCT00761280|363248227|FG000|Randomization to First Dose|Other|1|||
105340597|NCT00761280|363248228|FG001|Randomization to First Dose|Other|0|||
105340598|NCT00761280|363248227|FG000|First Dose to End of Study|End of trial|5|||
105340599|NCT00761280|363248228|FG001|First Dose to End of Study|End of trial|5|||
105340600|NCT00761280|363248227|FG000|First Dose to End of Study|Progressive disease|5|||
105340601|NCT00761280|363248228|FG001|First Dose to End of Study|Progressive disease|3|||
105340602|NCT00761280|363248227|FG000|First Dose to End of Study|Sponsor decision|1|||
105340603|NCT00761280|363248228|FG001|First Dose to End of Study|Sponsor decision|2|||
105667403|NCT02057575|364448115|FG000|Overall Study|Adverse Event|0|||
105667404|NCT02057575|364448116|FG001|Overall Study|Adverse Event|2|||
105667405|NCT02057575|364448117|FG002|Overall Study|Adverse Event|0|||
105667406|NCT02057575|364448118|FG003|Overall Study|Adverse Event|1|||
105667407|NCT02057575|364448115|FG000|Overall Study|Withdrawal by Subject|1|||
105340604|NCT00761280|363248227|FG000|First Dose to End of Study|Death|1|||
105340605|NCT00761280|363248228|FG001|First Dose to End of Study|Death|0|||
105667408|NCT02057575|364448116|FG001|Overall Study|Withdrawal by Subject|0|||
105667409|NCT02057575|364448117|FG002|Overall Study|Withdrawal by Subject|0|||
105340606|NCT00761280|363248227|FG000|First Dose to End of Study|Lost to Follow-up|0|||
105667410|NCT02057575|364448118|FG003|Overall Study|Withdrawal by Subject|0|||
105667411|NCT02057575|364448115|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
105667412|NCT02057575|364448116|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
105667413|NCT02057575|364448117|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
105667414|NCT02057575|364448118|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
105667415|NCT02057575|364448115|FG000|Overall Study|Protocol Violation|0|||
105667416|NCT02057575|364448116|FG001|Overall Study|Protocol Violation|1|||
105667417|NCT02057575|364448117|FG002|Overall Study|Protocol Violation|0|||
105667418|NCT02057575|364448118|FG003|Overall Study|Protocol Violation|0|||
105667419|NCT01643044|364448119|FG000|Overall Study|Lost to Follow-up|1|||
105667420|NCT01643044|364448120|FG001|Overall Study|Lost to Follow-up|1|||
105667421|NCT01643044|364448119|FG000|Overall Study|Miscarried baby|2|||
105667422|NCT01643044|364448120|FG001|Overall Study|Miscarried baby|2|||
105667423|NCT01643044|364448119|FG000|Overall Study|Delivered outside of hospital|1|||
105667424|NCT01643044|364448120|FG001|Overall Study|Delivered outside of hospital|2|||
105667425|NCT00863681|364448121|FG000|Overall Study|Other|2|||
105667426|NCT00863681|364448122|FG001|Overall Study|Other|0|||
105667427|NCT00863681|364448123|FG002|Overall Study|Other|0|||
105667428|NCT00863681|364448121|FG000|Overall Study|Missing|1|||
105667429|NCT00863681|364448122|FG001|Overall Study|Missing|0|||
105667430|NCT00863681|364448123|FG002|Overall Study|Missing|0|||
105667431|NCT00863681|364448121|FG000|Overall Study|Death|40|||
105667432|NCT00863681|364448122|FG001|Overall Study|Death|23|||
105667433|NCT00863681|364448123|FG002|Overall Study|Death|6|||
105667434|NCT00863681|364448121|FG000|Overall Study|Withdrawal by Subject|12|||
105667435|NCT00863681|364448122|FG001|Overall Study|Withdrawal by Subject|5|||
105667436|NCT00863681|364448123|FG002|Overall Study|Withdrawal by Subject|2|||
105667437|NCT00863681|364448121|FG000|Overall Study|Protocol Violation|2|||
105667438|NCT00863681|364448122|FG001|Overall Study|Protocol Violation|0|||
105667439|NCT00863681|364448123|FG002|Overall Study|Protocol Violation|0|||
105667440|NCT00863681|364448121|FG000|Overall Study|Lost to Follow-up|3|||
105667441|NCT00863681|364448122|FG001|Overall Study|Lost to Follow-up|0|||
105667442|NCT00863681|364448123|FG002|Overall Study|Lost to Follow-up|3|||
105667443|NCT00863681|364448121|FG000|Overall Study|Adverse Event|28|||
105667444|NCT00863681|364448122|FG001|Overall Study|Adverse Event|10|||
105667445|NCT00863681|364448123|FG002|Overall Study|Adverse Event|6|||
105667446|NCT00863681|364448121|FG000|Overall Study|Lack of Efficacy|2|||
105667447|NCT00863681|364448122|FG001|Overall Study|Lack of Efficacy|2|||
105667448|NCT00863681|364448123|FG002|Overall Study|Lack of Efficacy|1|||
105667449|NCT00863681|364448121|FG000|Overall Study|Non-compliance with study drug|1|||
105667450|NCT00863681|364448122|FG001|Overall Study|Non-compliance with study drug|3|||
105667451|NCT00863681|364448123|FG002|Overall Study|Non-compliance with study drug|0|||
105667452|NCT03325777|364448129|FG000|Overall Study|Lost to Follow-up|9|||
105667453|NCT03325777|364448130|FG001|Overall Study|Lost to Follow-up|12|||
105667454|NCT03004404|364448131|FG000|Period 2|Adverse Event|0|||
105667455|NCT03004404|364448132|FG001|Period 2|Adverse Event|0|||
105667456|NCT03004404|364448133|FG002|Period 2|Adverse Event|0|||
105667457|NCT03004404|364448134|FG003|Period 2|Adverse Event|0|||
105667458|NCT03004404|364448135|FG004|Period 2|Adverse Event|0|||
105667459|NCT03004404|364448136|FG005|Period 2|Adverse Event|0|||
105667460|NCT03004404|364448137|FG006|Period 2|Adverse Event|0|||
105667461|NCT03004404|364448138|FG007|Period 2|Adverse Event|0|||
105667462|NCT03004404|364448139|FG008|Period 2|Adverse Event|1|||
105667463|NCT03004404|364448140|FG009|Period 2|Adverse Event|0|||
105667464|NCT03004404|364448141|FG010|Period 2|Adverse Event|0|||
105667465|NCT03004404|364448142|FG011|Period 2|Adverse Event|0|||
105667466|NCT03004404|364448143|FG012|Period 2|Adverse Event|0|||
105667467|NCT03004404|364448144|FG013|Period 2|Adverse Event|0|||
105667468|NCT03004404|364448145|FG014|Period 2|Adverse Event|0|||
105667469|NCT03004404|364448146|FG015|Period 2|Adverse Event|1|||
105667470|NCT03126110|364448151|FG000|Phase 1|Death|2|||
105667471|NCT03126110|364448152|FG001|Phase 1|Death|2|||
105667472|NCT03126110|364448153|FG002|Phase 1|Death|4|||
105667473|NCT03126110|364448154|FG003|Phase 1|Death|3|||
105667474|NCT03126110|364448155|FG004|Phase 1|Death|4|||
105667475|NCT03126110|364448156|FG005|Phase 1|Death|4|||
105667476|NCT03126110|364448157|FG006|Phase 1|Death|3|||
105667477|NCT03126110|364448158|FG007|Phase 1|Death|4|||
105667478|NCT03126110|364448159|FG008|Phase 1|Death|5|||
105667479|NCT03126110|364448160|FG009|Phase 1|Death|2|||
105667480|NCT03126110|364448161|FG010|Phase 1|Death|6|||
105667481|NCT03126110|364448162|FG011|Phase 1|Death|0|||
105667482|NCT03126110|364448163|FG012|Phase 1|Death|0|||
105667483|NCT03126110|364448164|FG013|Phase 1|Death|0|||
105667484|NCT03126110|364448165|FG014|Phase 1|Death|0|||
105667485|NCT03126110|364448166|FG015|Phase 1|Death|0|||
105667486|NCT03126110|364448167|FG016|Phase 1|Death|0|||
105667487|NCT03126110|364448151|FG000|Phase 1|Lost to Follow-up|0|||
105667488|NCT03126110|364448152|FG001|Phase 1|Lost to Follow-up|1|||
105667489|NCT03126110|364448153|FG002|Phase 1|Lost to Follow-up|0|||
105667490|NCT03126110|364448154|FG003|Phase 1|Lost to Follow-up|0|||
105667491|NCT03126110|364448155|FG004|Phase 1|Lost to Follow-up|0|||
105667492|NCT03126110|364448156|FG005|Phase 1|Lost to Follow-up|0|||
105667493|NCT03126110|364448157|FG006|Phase 1|Lost to Follow-up|0|||
105667494|NCT03126110|364448158|FG007|Phase 1|Lost to Follow-up|0|||
105667495|NCT03126110|364448159|FG008|Phase 1|Lost to Follow-up|1|||
105667496|NCT03126110|364448160|FG009|Phase 1|Lost to Follow-up|0|||
105667497|NCT03126110|364448161|FG010|Phase 1|Lost to Follow-up|0|||
105667498|NCT03126110|364448162|FG011|Phase 1|Lost to Follow-up|0|||
105667499|NCT03126110|364448163|FG012|Phase 1|Lost to Follow-up|0|||
105667500|NCT03126110|364448164|FG013|Phase 1|Lost to Follow-up|0|||
105667501|NCT03126110|364448165|FG014|Phase 1|Lost to Follow-up|0|||
105667502|NCT03126110|364448166|FG015|Phase 1|Lost to Follow-up|0|||
105667503|NCT03126110|364448167|FG016|Phase 1|Lost to Follow-up|0|||
105667504|NCT03126110|364448151|FG000|Phase 1|Withdrawal by Subject|1|||
105667505|NCT03126110|364448152|FG001|Phase 1|Withdrawal by Subject|0|||
105667506|NCT03126110|364448153|FG002|Phase 1|Withdrawal by Subject|0|||
105667507|NCT03126110|364448154|FG003|Phase 1|Withdrawal by Subject|1|||
105667508|NCT03126110|364448155|FG004|Phase 1|Withdrawal by Subject|1|||
105667509|NCT03126110|364448156|FG005|Phase 1|Withdrawal by Subject|0|||
105667510|NCT03126110|364448157|FG006|Phase 1|Withdrawal by Subject|0|||
105667511|NCT03126110|364448158|FG007|Phase 1|Withdrawal by Subject|0|||
105667512|NCT03126110|364448159|FG008|Phase 1|Withdrawal by Subject|2|||
105667513|NCT03126110|364448160|FG009|Phase 1|Withdrawal by Subject|1|||
105667514|NCT03126110|364448161|FG010|Phase 1|Withdrawal by Subject|0|||
105667515|NCT03126110|364448162|FG011|Phase 1|Withdrawal by Subject|0|||
105667516|NCT03126110|364448163|FG012|Phase 1|Withdrawal by Subject|0|||
105667517|NCT03126110|364448164|FG013|Phase 1|Withdrawal by Subject|0|||
105667518|NCT03126110|364448165|FG014|Phase 1|Withdrawal by Subject|0|||
105667519|NCT03126110|364448166|FG015|Phase 1|Withdrawal by Subject|0|||
105667520|NCT03126110|364448167|FG016|Phase 1|Withdrawal by Subject|0|||
105667521|NCT03126110|364448151|FG000|Phase 1|Safety follow-up no longer necessary|1|||
105667522|NCT03126110|364448152|FG001|Phase 1|Safety follow-up no longer necessary|0|||
105667523|NCT03126110|364448153|FG002|Phase 1|Safety follow-up no longer necessary|0|||
105667524|NCT03126110|364448154|FG003|Phase 1|Safety follow-up no longer necessary|0|||
105667525|NCT03126110|364448155|FG004|Phase 1|Safety follow-up no longer necessary|0|||
105667526|NCT03126110|364448156|FG005|Phase 1|Safety follow-up no longer necessary|0|||
105667527|NCT03126110|364448157|FG006|Phase 1|Safety follow-up no longer necessary|0|||
105667528|NCT03126110|364448158|FG007|Phase 1|Safety follow-up no longer necessary|0|||
105667529|NCT03126110|364448159|FG008|Phase 1|Safety follow-up no longer necessary|0|||
105667530|NCT03126110|364448160|FG009|Phase 1|Safety follow-up no longer necessary|0|||
105667531|NCT03126110|364448161|FG010|Phase 1|Safety follow-up no longer necessary|0|||
105667532|NCT03126110|364448162|FG011|Phase 1|Safety follow-up no longer necessary|0|||
105667533|NCT03126110|364448163|FG012|Phase 1|Safety follow-up no longer necessary|0|||
105667534|NCT03126110|364448164|FG013|Phase 1|Safety follow-up no longer necessary|0|||
105667535|NCT03126110|364448165|FG014|Phase 1|Safety follow-up no longer necessary|0|||
105667536|NCT03126110|364448166|FG015|Phase 1|Safety follow-up no longer necessary|0|||
105667537|NCT03126110|364448167|FG016|Phase 1|Safety follow-up no longer necessary|0|||
105667538|NCT03126110|364448151|FG000|Phase 1|Survival follow-up no longer necessary|0|||
105667539|NCT03126110|364448152|FG001|Phase 1|Survival follow-up no longer necessary|0|||
105667540|NCT03126110|364448153|FG002|Phase 1|Survival follow-up no longer necessary|1|||
105667541|NCT03126110|364448154|FG003|Phase 1|Survival follow-up no longer necessary|0|||
105667542|NCT03126110|364448155|FG004|Phase 1|Survival follow-up no longer necessary|0|||
105667543|NCT03126110|364448156|FG005|Phase 1|Survival follow-up no longer necessary|0|||
105667544|NCT03126110|364448157|FG006|Phase 1|Survival follow-up no longer necessary|0|||
105667545|NCT03126110|364448158|FG007|Phase 1|Survival follow-up no longer necessary|0|||
105667546|NCT03126110|364448159|FG008|Phase 1|Survival follow-up no longer necessary|0|||
105667547|NCT03126110|364448160|FG009|Phase 1|Survival follow-up no longer necessary|0|||
105667548|NCT03126110|364448161|FG010|Phase 1|Survival follow-up no longer necessary|0|||
105667549|NCT03126110|364448162|FG011|Phase 1|Survival follow-up no longer necessary|0|||
105667550|NCT03126110|364448163|FG012|Phase 1|Survival follow-up no longer necessary|0|||
105667551|NCT03126110|364448164|FG013|Phase 1|Survival follow-up no longer necessary|0|||
105667552|NCT03126110|364448165|FG014|Phase 1|Survival follow-up no longer necessary|0|||
105667553|NCT03126110|364448166|FG015|Phase 1|Survival follow-up no longer necessary|0|||
105667554|NCT03126110|364448167|FG016|Phase 1|Survival follow-up no longer necessary|0|||
105667555|NCT03126110|364448151|FG000|Phase 2|Study terminated by the sponsor|0|||
105667556|NCT03126110|364448152|FG001|Phase 2|Study terminated by the sponsor|0|||
105667557|NCT03126110|364448153|FG002|Phase 2|Study terminated by the sponsor|0|||
105667558|NCT03126110|364448154|FG003|Phase 2|Study terminated by the sponsor|0|||
105667559|NCT03126110|364448155|FG004|Phase 2|Study terminated by the sponsor|0|||
105667560|NCT03126110|364448156|FG005|Phase 2|Study terminated by the sponsor|0|||
105667561|NCT03126110|364448157|FG006|Phase 2|Study terminated by the sponsor|0|||
105667562|NCT03126110|364448158|FG007|Phase 2|Study terminated by the sponsor|0|||
105667563|NCT03126110|364448159|FG008|Phase 2|Study terminated by the sponsor|0|||
105667564|NCT03126110|364448160|FG009|Phase 2|Study terminated by the sponsor|0|||
105667565|NCT03126110|364448161|FG010|Phase 2|Study terminated by the sponsor|0|||
105667566|NCT03126110|364448162|FG011|Phase 2|Study terminated by the sponsor|0|||
105667567|NCT03126110|364448163|FG012|Phase 2|Study terminated by the sponsor|0|||
105667568|NCT03126110|364448164|FG013|Phase 2|Study terminated by the sponsor|4|||
105667569|NCT03126110|364448165|FG014|Phase 2|Study terminated by the sponsor|0|||
105667570|NCT03126110|364448166|FG015|Phase 2|Study terminated by the sponsor|0|||
105667571|NCT03126110|364448167|FG016|Phase 2|Study terminated by the sponsor|0|||
105667572|NCT03126110|364448151|FG000|Phase 2|Withdrawal by Subject|0|||
105667573|NCT03126110|364448152|FG001|Phase 2|Withdrawal by Subject|0|||
105667574|NCT03126110|364448153|FG002|Phase 2|Withdrawal by Subject|0|||
105667575|NCT03126110|364448154|FG003|Phase 2|Withdrawal by Subject|0|||
105667576|NCT03126110|364448155|FG004|Phase 2|Withdrawal by Subject|0|||
105667577|NCT03126110|364448156|FG005|Phase 2|Withdrawal by Subject|0|||
105667578|NCT03126110|364448157|FG006|Phase 2|Withdrawal by Subject|0|||
105667579|NCT03126110|364448158|FG007|Phase 2|Withdrawal by Subject|0|||
105667580|NCT03126110|364448159|FG008|Phase 2|Withdrawal by Subject|0|||
105667581|NCT03126110|364448160|FG009|Phase 2|Withdrawal by Subject|0|||
105667582|NCT03126110|364448161|FG010|Phase 2|Withdrawal by Subject|0|||
105667583|NCT03126110|364448162|FG011|Phase 2|Withdrawal by Subject|1|||
105667584|NCT03126110|364448163|FG012|Phase 2|Withdrawal by Subject|3|||
105667585|NCT03126110|364448164|FG013|Phase 2|Withdrawal by Subject|3|||
105667586|NCT03126110|364448165|FG014|Phase 2|Withdrawal by Subject|2|||
105667587|NCT03126110|364448166|FG015|Phase 2|Withdrawal by Subject|1|||
105667588|NCT03126110|364448167|FG016|Phase 2|Withdrawal by Subject|0|||
105667589|NCT03126110|364448151|FG000|Phase 2|Lost to Follow-up|0|||
105785986|NCT04338685|364870438|FG005|Overall Study|Death|8|||
105667590|NCT03126110|364448152|FG001|Phase 2|Lost to Follow-up|0|||
105667591|NCT03126110|364448153|FG002|Phase 2|Lost to Follow-up|0|||
105667592|NCT03126110|364448154|FG003|Phase 2|Lost to Follow-up|0|||
105785987|NCT04338685|364870439|FG006|Overall Study|Death|1|||
105785988|NCT04338685|364870440|FG007|Overall Study|Death|0|||
105785989|NCT04338685|364870441|FG008|Overall Study|Death|0|||
105785990|NCT04338685|364870433|FG000|Overall Study|Study terminated by Sponsor|0|||
105785991|NCT04338685|364870434|FG001|Overall Study|Study terminated by Sponsor|0|||
105785992|NCT04338685|364870435|FG002|Overall Study|Study terminated by Sponsor|1|||
105785993|NCT04338685|364870436|FG003|Overall Study|Study terminated by Sponsor|4|||
105667593|NCT03126110|364448155|FG004|Phase 2|Lost to Follow-up|0|||
105667594|NCT03126110|364448156|FG005|Phase 2|Lost to Follow-up|0|||
105667595|NCT03126110|364448157|FG006|Phase 2|Lost to Follow-up|0|||
105667596|NCT03126110|364448158|FG007|Phase 2|Lost to Follow-up|0|||
105785994|NCT04338685|364870437|FG004|Overall Study|Study terminated by Sponsor|0|||
105667597|NCT03126110|364448159|FG008|Phase 2|Lost to Follow-up|0|||
105667598|NCT03126110|364448160|FG009|Phase 2|Lost to Follow-up|0|||
105667599|NCT03126110|364448161|FG010|Phase 2|Lost to Follow-up|0|||
105667600|NCT03126110|364448162|FG011|Phase 2|Lost to Follow-up|1|||
105667601|NCT03126110|364448163|FG012|Phase 2|Lost to Follow-up|1|||
105667602|NCT03126110|364448164|FG013|Phase 2|Lost to Follow-up|1|||
105667603|NCT03126110|364448165|FG014|Phase 2|Lost to Follow-up|2|||
105667604|NCT03126110|364448166|FG015|Phase 2|Lost to Follow-up|0|||
105667605|NCT03126110|364448167|FG016|Phase 2|Lost to Follow-up|0|||
105667606|NCT03126110|364448151|FG000|Phase 2|Death|0|||
105667607|NCT03126110|364448152|FG001|Phase 2|Death|0|||
105667608|NCT03126110|364448153|FG002|Phase 2|Death|0|||
105667609|NCT03126110|364448154|FG003|Phase 2|Death|0|||
105667610|NCT03126110|364448155|FG004|Phase 2|Death|0|||
105667611|NCT03126110|364448156|FG005|Phase 2|Death|0|||
105667612|NCT03126110|364448157|FG006|Phase 2|Death|0|||
105464731|NCT04323124|363714130|FG013|Overall Study|Adverse Event|0|||
105464732|NCT04323124|363714131|FG014|Overall Study|Adverse Event|0|||
105464733|NCT04323124|363714117|FG000|Overall Study|Other|0|||
105464734|NCT04323124|363714118|FG001|Overall Study|Other|0|||
105464735|NCT04323124|363714119|FG002|Overall Study|Other|0|||
105464736|NCT04323124|363714120|FG003|Overall Study|Other|0|||
105464737|NCT04323124|363714121|FG004|Overall Study|Other|1|||
105464738|NCT04323124|363714122|FG005|Overall Study|Other|0|||
105464739|NCT04323124|363714123|FG006|Overall Study|Other|0|||
105464740|NCT04323124|363714124|FG007|Overall Study|Other|0|||
105464741|NCT04323124|363714125|FG008|Overall Study|Other|1|||
105667613|NCT03126110|364448158|FG007|Phase 2|Death|0|||
105667614|NCT03126110|364448159|FG008|Phase 2|Death|0|||
105667615|NCT03126110|364448160|FG009|Phase 2|Death|0|||
105667616|NCT03126110|364448161|FG010|Phase 2|Death|0|||
105667617|NCT03126110|364448162|FG011|Phase 2|Death|6|||
105667618|NCT03126110|364448163|FG012|Phase 2|Death|12|||
105667619|NCT03126110|364448164|FG013|Phase 2|Death|25|||
105667620|NCT03126110|364448165|FG014|Phase 2|Death|11|||
105667621|NCT03126110|364448166|FG015|Phase 2|Death|3|||
105667622|NCT03126110|364448167|FG016|Phase 2|Death|2|||
105667623|NCT03126110|364448151|FG000|Phase 2|Progressive Disease|0|||
105667624|NCT03126110|364448152|FG001|Phase 2|Progressive Disease|0|||
105667625|NCT03126110|364448153|FG002|Phase 2|Progressive Disease|0|||
105667626|NCT03126110|364448154|FG003|Phase 2|Progressive Disease|0|||
105667627|NCT03126110|364448155|FG004|Phase 2|Progressive Disease|0|||
105667628|NCT03126110|364448156|FG005|Phase 2|Progressive Disease|0|||
105667629|NCT03126110|364448157|FG006|Phase 2|Progressive Disease|0|||
105667630|NCT03126110|364448158|FG007|Phase 2|Progressive Disease|0|||
105667631|NCT03126110|364448159|FG008|Phase 2|Progressive Disease|0|||
105667632|NCT03126110|364448160|FG009|Phase 2|Progressive Disease|0|||
105667633|NCT03126110|364448161|FG010|Phase 2|Progressive Disease|0|||
105667634|NCT03126110|364448162|FG011|Phase 2|Progressive Disease|0|||
105667635|NCT03126110|364448163|FG012|Phase 2|Progressive Disease|0|||
105667636|NCT03126110|364448164|FG013|Phase 2|Progressive Disease|1|||
105667637|NCT03126110|364448165|FG014|Phase 2|Progressive Disease|0|||
105667638|NCT03126110|364448166|FG015|Phase 2|Progressive Disease|0|||
105667639|NCT03126110|364448167|FG016|Phase 2|Progressive Disease|0|||
105667640|NCT03126110|364448151|FG000|Phase 2|Started new treatment|0|||
105667641|NCT03126110|364448152|FG001|Phase 2|Started new treatment|0|||
105667642|NCT03126110|364448153|FG002|Phase 2|Started new treatment|0|||
105667643|NCT03126110|364448154|FG003|Phase 2|Started new treatment|0|||
105667644|NCT03126110|364448155|FG004|Phase 2|Started new treatment|0|||
105667645|NCT03126110|364448156|FG005|Phase 2|Started new treatment|0|||
105667646|NCT03126110|364448157|FG006|Phase 2|Started new treatment|0|||
105464742|NCT04323124|363714126|FG009|Overall Study|Other|0|||
105464743|NCT04323124|363714127|FG010|Overall Study|Other|0|||
105667647|NCT03126110|364448158|FG007|Phase 2|Started new treatment|0|||
105667648|NCT03126110|364448159|FG008|Phase 2|Started new treatment|0|||
105667649|NCT03126110|364448160|FG009|Phase 2|Started new treatment|0|||
105667650|NCT03126110|364448161|FG010|Phase 2|Started new treatment|0|||
105667651|NCT03126110|364448162|FG011|Phase 2|Started new treatment|0|||
105464744|NCT04323124|363714128|FG011|Overall Study|Other|0|||
105464745|NCT04323124|363714129|FG012|Overall Study|Other|0|||
105667652|NCT03126110|364448163|FG012|Phase 2|Started new treatment|0|||
105667653|NCT03126110|364448164|FG013|Phase 2|Started new treatment|0|||
105667654|NCT03126110|364448165|FG014|Phase 2|Started new treatment|1|||
105667655|NCT03126110|364448166|FG015|Phase 2|Started new treatment|0|||
105667656|NCT03126110|364448167|FG016|Phase 2|Started new treatment|0|||
105464746|NCT04323124|363714130|FG013|Overall Study|Other|0|||
105667657|NCT01263509|364448168|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
105667658|NCT01263509|364448169|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
105667659|NCT01263509|364448170|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
105667660|NCT01263509|364448171|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
105667661|NCT01263509|364448168|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
105667662|NCT01263509|364448169|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
105667663|NCT01263509|364448170|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
105667664|NCT01263509|364448171|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
105667665|NCT01263509|364448168|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105667666|NCT01263509|364448169|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105667667|NCT01263509|364448170|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
105667668|NCT01263509|364448171|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
105667669|NCT01263509|364448168|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
105667670|NCT01263509|364448169|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
105667671|NCT01263509|364448170|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105667672|NCT01263509|364448171|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105667673|NCT01263509|364448168|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
105667674|NCT01263509|364448169|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
105667675|NCT01263509|364448170|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
105667676|NCT01263509|364448171|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
105667677|NCT01436305|364448179|FG000|Overall Study|Death|1|||
105667678|NCT01436305|364448180|FG001|Overall Study|Death|0|||
105667679|NCT01436305|364448181|FG002|Overall Study|Death|0|||
105667680|NCT01436305|364448179|FG000|Overall Study|Lost to Follow-up|0|||
105667681|NCT01436305|364448180|FG001|Overall Study|Lost to Follow-up|1|||
105667682|NCT01436305|364448181|FG002|Overall Study|Lost to Follow-up|0|||
105667683|NCT01436305|364448179|FG000|Overall Study|Withdrawal by Subject|1|||
105667684|NCT01436305|364448180|FG001|Overall Study|Withdrawal by Subject|3|||
105667685|NCT01436305|364448181|FG002|Overall Study|Withdrawal by Subject|0|||
105667686|NCT01081886|364448182|FG000|Overall Study|Study termination|11|||
105667687|NCT01081886|364448183|FG001|Overall Study|Study termination|13|||
105667688|NCT02567708|364448184|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
105667689|NCT02567708|364448185|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
105667690|NCT02567708|364448184|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
105667691|NCT02567708|364448185|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
105667692|NCT02567708|364448184|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
105667693|NCT02567708|364448185|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
105667694|NCT02567708|364448184|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
105667695|NCT02567708|364448185|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
105667696|NCT04148651|364448186|FG000|Overall Study|Lost to Follow-up|2|||
105667697|NCT01371825|364448187|FG000|Overall Study|Death|4|||
105667698|NCT05262751|364448188|FG000|Washout Period 2|Adverse Event|1|||
105667699|NCT05262751|364448189|FG001|Washout Period 2|Adverse Event|0|||
105667700|NCT05262751|364448190|FG002|Washout Period 2|Adverse Event|0|||
105667701|NCT05262751|364448191|FG003|Washout Period 2|Adverse Event|0|||
105667702|NCT05262751|364448192|FG004|Washout Period 2|Adverse Event|0|||
105667703|NCT05262751|364448193|FG005|Washout Period 2|Adverse Event|0|||
105667704|NCT05262751|364448188|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
105667705|NCT05262751|364448189|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
105667706|NCT05262751|364448190|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
105667707|NCT05262751|364448191|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
105667708|NCT05262751|364448192|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
105667709|NCT05262751|364448193|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
105667710|NCT00895895|364448196|FG000|Period 1|Adverse Event|7|||
105667711|NCT00895895|364448197|FG001|Period 1|Adverse Event|6|||
105667712|NCT00895895|364448198|FG002|Period 1|Adverse Event|4|||
105667713|NCT00895895|364448199|FG003|Period 1|Adverse Event|6|||
105667714|NCT00895895|364448200|FG004|Period 1|Adverse Event|7|||
105667715|NCT00895895|364448196|FG000|Period 1|Death|0|||
105667716|NCT00895895|364448197|FG001|Period 1|Death|0|||
105464747|NCT04323124|363714131|FG014|Overall Study|Other|0|||
105667717|NCT00895895|364448198|FG002|Period 1|Death|0|||
105667718|NCT00895895|364448199|FG003|Period 1|Death|0|||
105667719|NCT00895895|364448200|FG004|Period 1|Death|1|||
105667720|NCT00895895|364448196|FG000|Period 1|discontinued by sponsor|2|||
105667721|NCT00895895|364448197|FG001|Period 1|discontinued by sponsor|1|||
105667722|NCT00895895|364448198|FG002|Period 1|discontinued by sponsor|2|||
105667723|NCT00895895|364448199|FG003|Period 1|discontinued by sponsor|1|||
105667724|NCT00895895|364448200|FG004|Period 1|discontinued by sponsor|1|||
105667725|NCT00895895|364448196|FG000|Period 1|failed to return|0|||
105667726|NCT00895895|364448197|FG001|Period 1|failed to return|0|||
105667727|NCT00895895|364448198|FG002|Period 1|failed to return|1|||
105667728|NCT00895895|364448199|FG003|Period 1|failed to return|0|||
105667729|NCT00895895|364448200|FG004|Period 1|failed to return|1|||
105667730|NCT00895895|364448196|FG000|Period 1|investigator request|0|||
105667731|NCT00895895|364448197|FG001|Period 1|investigator request|1|||
105667732|NCT00895895|364448198|FG002|Period 1|investigator request|0|||
105667733|NCT00895895|364448199|FG003|Period 1|investigator request|0|||
105667734|NCT00895895|364448200|FG004|Period 1|investigator request|0|||
105667735|NCT00895895|364448196|FG000|Period 1|Lost to Follow-up|2|||
105667736|NCT00895895|364448197|FG001|Period 1|Lost to Follow-up|1|||
105667737|NCT00895895|364448198|FG002|Period 1|Lost to Follow-up|3|||
105667738|NCT00895895|364448199|FG003|Period 1|Lost to Follow-up|2|||
105667739|NCT00895895|364448200|FG004|Period 1|Lost to Follow-up|3|||
105667740|NCT00895895|364448196|FG000|Period 1|Other|1|||
105667741|NCT00895895|364448197|FG001|Period 1|Other|2|||
105667742|NCT00895895|364448198|FG002|Period 1|Other|1|||
105667743|NCT00895895|364448199|FG003|Period 1|Other|1|||
105667744|NCT00895895|364448200|FG004|Period 1|Other|1|||
105667745|NCT00895895|364448196|FG000|Period 1|Protocol Violation|0|||
105667746|NCT00895895|364448197|FG001|Period 1|Protocol Violation|1|||
105667747|NCT00895895|364448198|FG002|Period 1|Protocol Violation|0|||
105667748|NCT00895895|364448199|FG003|Period 1|Protocol Violation|0|||
105667749|NCT00895895|364448200|FG004|Period 1|Protocol Violation|0|||
105667750|NCT00895895|364448196|FG000|Period 1|Withdrawal by Subject|6|||
105667751|NCT00895895|364448197|FG001|Period 1|Withdrawal by Subject|6|||
105667752|NCT00895895|364448198|FG002|Period 1|Withdrawal by Subject|8|||
105667753|NCT00895895|364448199|FG003|Period 1|Withdrawal by Subject|2|||
105667754|NCT00895895|364448200|FG004|Period 1|Withdrawal by Subject|4|||
105667755|NCT00895895|364448196|FG000|Period 1|unsatisfactory response-efficacy|2|||
105667756|NCT00895895|364448197|FG001|Period 1|unsatisfactory response-efficacy|0|||
105667757|NCT00895895|364448198|FG002|Period 1|unsatisfactory response-efficacy|0|||
105667758|NCT00895895|364448199|FG003|Period 1|unsatisfactory response-efficacy|0|||
105667759|NCT00895895|364448200|FG004|Period 1|unsatisfactory response-efficacy|0|||
105667760|NCT00895895|364448196|FG000|Period 1|randomized and not treated|1|||
105667761|NCT00895895|364448197|FG001|Period 1|randomized and not treated|3|||
105667762|NCT00895895|364448198|FG002|Period 1|randomized and not treated|1|||
105667763|NCT00895895|364448199|FG003|Period 1|randomized and not treated|1|||
105667764|NCT00895895|364448200|FG004|Period 1|randomized and not treated|2|||
105667765|NCT00895895|364448196|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
105667766|NCT00895895|364448197|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
105667767|NCT00895895|364448198|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
105667768|NCT00895895|364448199|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
105667769|NCT00895895|364448200|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
105667770|NCT00895895|364448196|FG000|After Period 1, Prior to Period 2|Other|0|||
105667771|NCT00895895|364448197|FG001|After Period 1, Prior to Period 2|Other|0|||
105667772|NCT00895895|364448198|FG002|After Period 1, Prior to Period 2|Other|1|||
105667773|NCT00895895|364448199|FG003|After Period 1, Prior to Period 2|Other|0|||
105667774|NCT00895895|364448200|FG004|After Period 1, Prior to Period 2|Other|0|||
105667775|NCT00895895|364448196|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
105667776|NCT00895895|364448197|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
105667777|NCT00895895|364448198|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
105667778|NCT00895895|364448199|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
105464748|NCT04323124|363714117|FG000|Overall Study|Coming from a red zone (COVID)|0|||
105667779|NCT00895895|364448200|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
105667780|NCT00895895|364448196|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
105667781|NCT00895895|364448197|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
105667782|NCT00895895|364448198|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
105667783|NCT00895895|364448199|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
105667784|NCT00895895|364448200|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
105667785|NCT00895895|364448196|FG000|Period 2|Adverse Event|3|||
105667786|NCT00895895|364448197|FG001|Period 2|Adverse Event|3|||
105667787|NCT00895895|364448198|FG002|Period 2|Adverse Event|5|||
105667788|NCT00895895|364448199|FG003|Period 2|Adverse Event|2|||
105667789|NCT00895895|364448200|FG004|Period 2|Adverse Event|5|||
105667790|NCT00895895|364448196|FG000|Period 2|Death|0|||
105667791|NCT00895895|364448197|FG001|Period 2|Death|0|||
105667792|NCT00895895|364448198|FG002|Period 2|Death|1|||
105667793|NCT00895895|364448199|FG003|Period 2|Death|0|||
105667794|NCT00895895|364448200|FG004|Period 2|Death|0|||
105667795|NCT00895895|364448196|FG000|Period 2|discontinued by sponsor|44|||
105667796|NCT00895895|364448197|FG001|Period 2|discontinued by sponsor|44|||
105667797|NCT00895895|364448198|FG002|Period 2|discontinued by sponsor|38|||
105667798|NCT00895895|364448199|FG003|Period 2|discontinued by sponsor|46|||
105667799|NCT00895895|364448200|FG004|Period 2|discontinued by sponsor|37|||
105667800|NCT00895895|364448196|FG000|Period 2|failed to return|2|||
105667801|NCT00895895|364448197|FG001|Period 2|failed to return|0|||
105667802|NCT00895895|364448198|FG002|Period 2|failed to return|0|||
105667803|NCT00895895|364448199|FG003|Period 2|failed to return|0|||
105667804|NCT00895895|364448200|FG004|Period 2|failed to return|0|||
105667805|NCT00895895|364448196|FG000|Period 2|investigator request|2|||
105667806|NCT00895895|364448197|FG001|Period 2|investigator request|0|||
105667807|NCT00895895|364448198|FG002|Period 2|investigator request|0|||
105667808|NCT00895895|364448199|FG003|Period 2|investigator request|0|||
105667809|NCT00895895|364448200|FG004|Period 2|investigator request|0|||
105667810|NCT00895895|364448196|FG000|Period 2|Lost to Follow-up|1|||
105667811|NCT00895895|364448197|FG001|Period 2|Lost to Follow-up|2|||
105667812|NCT00895895|364448198|FG002|Period 2|Lost to Follow-up|1|||
105667813|NCT00895895|364448199|FG003|Period 2|Lost to Follow-up|1|||
105667814|NCT00895895|364448200|FG004|Period 2|Lost to Follow-up|0|||
105667815|NCT00895895|364448196|FG000|Period 2|Other|1|||
105553152|NCT02349295|364023329|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
105553153|NCT02349295|364023330|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
105553154|NCT02349295|364023331|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
105553155|NCT02349295|364023332|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
105553156|NCT02349295|364023333|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
105553157|NCT02349295|364023334|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
105553158|NCT02349295|364023335|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
105553159|NCT02349295|364023336|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
105553160|NCT02349295|364023337|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
105553161|NCT02349295|364023338|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
105553162|NCT02349295|364023339|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
105553163|NCT02349295|364023340|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
105553164|NCT02349295|364023327|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
105553165|NCT02349295|364023328|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
105553166|NCT02349295|364023329|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
105553167|NCT02349295|364023330|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
105553168|NCT02349295|364023331|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
105553169|NCT02349295|364023332|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
105553170|NCT02349295|364023333|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
105553171|NCT02349295|364023334|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
105553172|NCT02349295|364023335|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
105553173|NCT02349295|364023336|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
105553174|NCT02349295|364023337|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
105553175|NCT02349295|364023338|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
105553176|NCT02349295|364023339|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
105553177|NCT02349295|364023340|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
105553178|NCT02349295|364023327|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
105553179|NCT02349295|364023328|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
105553180|NCT02349295|364023329|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
105553181|NCT02349295|364023330|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
105553182|NCT02349295|364023331|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
105553183|NCT02349295|364023332|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
105553184|NCT02349295|364023333|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
105553185|NCT02349295|364023334|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
105553186|NCT02349295|364023335|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
105553187|NCT02349295|364023336|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
105553188|NCT02349295|364023337|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
105553189|NCT02349295|364023338|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
105667816|NCT00895895|364448197|FG001|Period 2|Other|1|||
105667817|NCT00895895|364448198|FG002|Period 2|Other|3|||
105667818|NCT00895895|364448199|FG003|Period 2|Other|1|||
105667819|NCT00895895|364448200|FG004|Period 2|Other|1|||
105667820|NCT00895895|364448196|FG000|Period 2|Protocol Violation|1|||
105667821|NCT00895895|364448197|FG001|Period 2|Protocol Violation|0|||
105667822|NCT00895895|364448198|FG002|Period 2|Protocol Violation|1|||
105667823|NCT00895895|364448199|FG003|Period 2|Protocol Violation|1|||
105667824|NCT00895895|364448200|FG004|Period 2|Protocol Violation|1|||
105464749|NCT04323124|363714118|FG001|Overall Study|Coming from a red zone (COVID)|0|||
105464750|NCT04323124|363714119|FG002|Overall Study|Coming from a red zone (COVID)|0|||
105464751|NCT04323124|363714120|FG003|Overall Study|Coming from a red zone (COVID)|0|||
105464752|NCT04323124|363714121|FG004|Overall Study|Coming from a red zone (COVID)|1|||
105464753|NCT04323124|363714122|FG005|Overall Study|Coming from a red zone (COVID)|1|||
105464754|NCT04323124|363714123|FG006|Overall Study|Coming from a red zone (COVID)|0|||
105464755|NCT04323124|363714124|FG007|Overall Study|Coming from a red zone (COVID)|0|||
105464756|NCT04323124|363714125|FG008|Overall Study|Coming from a red zone (COVID)|0|||
105464757|NCT04323124|363714126|FG009|Overall Study|Coming from a red zone (COVID)|0|||
105464758|NCT04323124|363714127|FG010|Overall Study|Coming from a red zone (COVID)|0|||
105464759|NCT04323124|363714128|FG011|Overall Study|Coming from a red zone (COVID)|0|||
105464760|NCT04323124|363714129|FG012|Overall Study|Coming from a red zone (COVID)|0|||
105464761|NCT04323124|363714130|FG013|Overall Study|Coming from a red zone (COVID)|0|||
105464762|NCT04323124|363714131|FG014|Overall Study|Coming from a red zone (COVID)|0|||
105464763|NCT04323124|363714117|FG000|Overall Study|No longer meets eligibility criteria|0|||
105464764|NCT04323124|363714118|FG001|Overall Study|No longer meets eligibility criteria|0|||
105464765|NCT04323124|363714119|FG002|Overall Study|No longer meets eligibility criteria|0|||
105464766|NCT04323124|363714120|FG003|Overall Study|No longer meets eligibility criteria|0|||
105464767|NCT04323124|363714121|FG004|Overall Study|No longer meets eligibility criteria|0|||
105464768|NCT04323124|363714122|FG005|Overall Study|No longer meets eligibility criteria|0|||
105464769|NCT04323124|363714123|FG006|Overall Study|No longer meets eligibility criteria|0|||
105464770|NCT04323124|363714124|FG007|Overall Study|No longer meets eligibility criteria|1|||
105464771|NCT04323124|363714125|FG008|Overall Study|No longer meets eligibility criteria|0|||
105464772|NCT04323124|363714126|FG009|Overall Study|No longer meets eligibility criteria|0|||
105464773|NCT04323124|363714127|FG010|Overall Study|No longer meets eligibility criteria|0|||
105464774|NCT04323124|363714128|FG011|Overall Study|No longer meets eligibility criteria|0|||
105464775|NCT04323124|363714129|FG012|Overall Study|No longer meets eligibility criteria|0|||
105464776|NCT04323124|363714130|FG013|Overall Study|No longer meets eligibility criteria|1|||
105464777|NCT04323124|363714131|FG014|Overall Study|No longer meets eligibility criteria|1|||
105464778|NCT04323124|363714117|FG000|Overall Study|Study terminated by sponsor|0|||
105464779|NCT04323124|363714118|FG001|Overall Study|Study terminated by sponsor|0|||
105464780|NCT04323124|363714119|FG002|Overall Study|Study terminated by sponsor|0|||
105464781|NCT04323124|363714120|FG003|Overall Study|Study terminated by sponsor|0|||
105464782|NCT04323124|363714121|FG004|Overall Study|Study terminated by sponsor|0|||
105464783|NCT04323124|363714122|FG005|Overall Study|Study terminated by sponsor|0|||
105464784|NCT04323124|363714123|FG006|Overall Study|Study terminated by sponsor|0|||
105464785|NCT04323124|363714124|FG007|Overall Study|Study terminated by sponsor|0|||
105464786|NCT04323124|363714125|FG008|Overall Study|Study terminated by sponsor|0|||
105464787|NCT04323124|363714126|FG009|Overall Study|Study terminated by sponsor|0|||
105464788|NCT04323124|363714127|FG010|Overall Study|Study terminated by sponsor|0|||
105464789|NCT04323124|363714128|FG011|Overall Study|Study terminated by sponsor|2|||
105464790|NCT04323124|363714129|FG012|Overall Study|Study terminated by sponsor|1|||
105464791|NCT04323124|363714130|FG013|Overall Study|Study terminated by sponsor|0|||
105464792|NCT04323124|363714131|FG014|Overall Study|Study terminated by sponsor|0|||
105464793|NCT00905164|363714132|FG000|Period 1|Protocol Violation|0|||
105464794|NCT00905164|363714133|FG001|Period 1|Protocol Violation|1|||
105464795|NCT02202759|363716075|FG000|Overall Study|Study Terminated by Sponsor|3|||
105464796|NCT02202759|363716076|FG001|Overall Study|Study Terminated by Sponsor|3|||
105464797|NCT02202759|363716077|FG002|Overall Study|Study Terminated by Sponsor|3|||
105464798|NCT02202759|363716075|FG000|Overall Study|Withdrawal by Subject|2|||
105464799|NCT02202759|363716076|FG001|Overall Study|Withdrawal by Subject|1|||
105464800|NCT02202759|363716077|FG002|Overall Study|Withdrawal by Subject|1|||
105464801|NCT02202759|363716075|FG000|Overall Study|Reason not Specified|4|||
105464802|NCT02202759|363716076|FG001|Overall Study|Reason not Specified|11|||
105464803|NCT02202759|363716077|FG002|Overall Study|Reason not Specified|10|||
105464804|NCT00214201|363716078|FG000|Overall Study|Withdrawal by Subject|2|||
105464805|NCT00214201|363716079|FG001|Overall Study|Withdrawal by Subject|0|||
105464806|NCT00214201|363716078|FG000|Overall Study|Death|0|||
105464807|NCT00214201|363716079|FG001|Overall Study|Death|2|||
105464808|NCT01124006|363716080|FG000|Overall Study|Withdrawal by Subject|2|||
105464809|NCT01124006|363716081|FG001|Overall Study|Withdrawal by Subject|2|||
105464810|NCT01124006|363716082|FG002|Overall Study|Withdrawal by Subject|0|||
105464811|NCT01124006|363716080|FG000|Overall Study|Lost to Follow-up|1|||
105464812|NCT01124006|363716081|FG001|Overall Study|Lost to Follow-up|0|||
105464813|NCT01124006|363716082|FG002|Overall Study|Lost to Follow-up|1|||
105464814|NCT01124006|363716080|FG000|Overall Study|Other|0|||
105464815|NCT01124006|363716081|FG001|Overall Study|Other|0|||
105464816|NCT01124006|363716082|FG002|Overall Study|Other|1|||
105464817|NCT01712399|363716084|FG000|Overall Study|Lost to Follow-up|1|||
105464818|NCT01712399|363716084|FG000|Overall Study|Withdrawal by Subject|39|||
105464819|NCT01712399|363716084|FG000|Overall Study|Death|1|||
105464820|NCT01712399|363716084|FG000|Overall Study|Adverse Event|11|||
105340607|NCT00761280|363248228|FG001|First Dose to End of Study|Lost to Follow-up|1|||
105340608|NCT01938430|363248232|FG000|Overall Study|Randomized but Not Treated|0|||
105464821|NCT01712399|363716084|FG000|Overall Study|Study closure|345|||
105464822|NCT00706238|363716090|FG000|Overall Study|Disease progression|4|||
105464823|NCT00706238|363716090|FG000|Overall Study|Other|1|||
105340609|NCT01938430|363248233|FG001|Overall Study|Randomized but Not Treated|0|||
105340610|NCT01938430|363248234|FG002|Overall Study|Randomized but Not Treated|0|||
105340611|NCT01938430|363248235|FG003|Overall Study|Randomized but Not Treated|0|||
105464824|NCT00753506|363716091|FG000|Overall Study|Withdrawal by Subject|4|||
105464825|NCT00753506|363716092|FG001|Overall Study|Withdrawal by Subject|1|||
105667825|NCT00895895|364448196|FG000|Period 2|Withdrawal by Subject|0|||
105667826|NCT00895895|364448197|FG001|Period 2|Withdrawal by Subject|2|||
105553190|NCT02349295|364023339|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
105553191|NCT02349295|364023340|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
105553192|NCT02349295|364023327|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
105553193|NCT02349295|364023328|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
105553194|NCT02349295|364023329|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
105553195|NCT02349295|364023330|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
105553196|NCT02349295|364023331|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
105553197|NCT02349295|364023332|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
105553198|NCT02349295|364023333|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
105553199|NCT02349295|364023334|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
105667827|NCT00895895|364448198|FG002|Period 2|Withdrawal by Subject|0|||
105464826|NCT00753506|363716091|FG000|Overall Study|Lost to Follow-up|2|||
105464827|NCT00753506|363716092|FG001|Overall Study|Lost to Follow-up|0|||
105340612|NCT01938430|363248236|FG004|Overall Study|Randomized but Not Treated|0|||
105340613|NCT01938430|363248237|FG005|Overall Study|Randomized but Not Treated|0|||
105340614|NCT01938430|363248238|FG006|Overall Study|Randomized but Not Treated|0|||
105340615|NCT01938430|363248239|FG007|Overall Study|Randomized but Not Treated|0|||
105340616|NCT01938430|363248240|FG008|Overall Study|Randomized but Not Treated|0|||
105340617|NCT01938430|363248241|FG009|Overall Study|Randomized but Not Treated|0|||
105340618|NCT01938430|363248242|FG010|Overall Study|Randomized but Not Treated|1|||
105340619|NCT01938430|363248243|FG011|Overall Study|Randomized but Not Treated|0|||
105340620|NCT01938430|363248244|FG012|Overall Study|Randomized but Not Treated|0|||
105340621|NCT01938430|363248245|FG013|Overall Study|Randomized but Not Treated|1|||
105340622|NCT01938430|363248232|FG000|Overall Study|Adverse Event|0|||
105340623|NCT01938430|363248233|FG001|Overall Study|Adverse Event|0|||
105340624|NCT01938430|363248234|FG002|Overall Study|Adverse Event|0|||
105340625|NCT01938430|363248235|FG003|Overall Study|Adverse Event|0|||
105340626|NCT01938430|363248236|FG004|Overall Study|Adverse Event|0|||
105340627|NCT01938430|363248237|FG005|Overall Study|Adverse Event|0|||
105340628|NCT01938430|363248238|FG006|Overall Study|Adverse Event|1|||
105340629|NCT01938430|363248239|FG007|Overall Study|Adverse Event|0|||
105340630|NCT01938430|363248240|FG008|Overall Study|Adverse Event|0|||
105340631|NCT01938430|363248241|FG009|Overall Study|Adverse Event|0|||
105340632|NCT01938430|363248242|FG010|Overall Study|Adverse Event|0|||
105340633|NCT01938430|363248243|FG011|Overall Study|Adverse Event|0|||
105340634|NCT01938430|363248244|FG012|Overall Study|Adverse Event|0|||
105340635|NCT01938430|363248245|FG013|Overall Study|Adverse Event|0|||
105340636|NCT01938430|363248232|FG000|Overall Study|Death|1|||
105340637|NCT01938430|363248233|FG001|Overall Study|Death|2|||
105340638|NCT01938430|363248234|FG002|Overall Study|Death|2|||
105340639|NCT01938430|363248235|FG003|Overall Study|Death|1|||
105340640|NCT01938430|363248236|FG004|Overall Study|Death|0|||
105340641|NCT01938430|363248237|FG005|Overall Study|Death|0|||
105464828|NCT00753506|363716091|FG000|Overall Study|Other reason|1|||
105464829|NCT00753506|363716092|FG001|Overall Study|Other reason|1|||
105340642|NCT01938430|363248238|FG006|Overall Study|Death|1|||
105340643|NCT01938430|363248239|FG007|Overall Study|Death|1|||
105464830|NCT01193244|363716093|FG000|Overall Study|Withdrawal by Subject|79|||
105464831|NCT01193244|363716094|FG001|Overall Study|Withdrawal by Subject|97|||
105464832|NCT01193244|363716093|FG000|Overall Study|Other|303|||
105464833|NCT01193244|363716094|FG001|Overall Study|Other|278|||
105464834|NCT01193244|363716093|FG000|Overall Study|Lost to Follow-up|6|||
105464835|NCT01193244|363716094|FG001|Overall Study|Lost to Follow-up|15|||
105464836|NCT03877510|363716095|FG000|Overall Study|Death|6|||
105464837|NCT03877510|363716095|FG000|Overall Study|Lost to Follow-up|2|||
105464838|NCT03877510|363716095|FG000|Overall Study|Non-compliance with study drug|2|||
105464839|NCT03877510|363716095|FG000|Overall Study|Lack of Efficacy|14|||
105464840|NCT03877510|363716095|FG000|Overall Study|Adverse Event|20|||
105464841|NCT03877510|363716095|FG000|Overall Study|Withdrawal by Subject|22|||
105464842|NCT03877510|363716095|FG000|Overall Study|Miscellaneous|1|||
105464843|NCT01417377|363716096|FG000|Overall Study|Lost to Follow-up|12|||
105464844|NCT01417377|363716096|FG000|Overall Study|Enrolled, but not treated|1|||
105464845|NCT02085161|363716098|FG000|Overall Study|Not Treated|1|||
105464846|NCT02085161|363716099|FG001|Overall Study|Not Treated|0|||
105464847|NCT02085161|363716100|FG002|Overall Study|Not Treated|0|||
105464848|NCT02085161|363716101|FG003|Overall Study|Not Treated|0|||
105464849|NCT02085161|363716098|FG000|Overall Study|Adverse Event|8|||
105785995|NCT04338685|364870438|FG005|Overall Study|Study terminated by Sponsor|5|||
105785996|NCT04338685|364870439|FG006|Overall Study|Study terminated by Sponsor|2|||
105785997|NCT04338685|364870440|FG007|Overall Study|Study terminated by Sponsor|4|||
105785998|NCT04338685|364870441|FG008|Overall Study|Study terminated by Sponsor|1|||
105785999|NCT04338685|364870433|FG000|Overall Study|Withdrawal by Subject|1|||
105786000|NCT04338685|364870434|FG001|Overall Study|Withdrawal by Subject|2|||
105786001|NCT04338685|364870435|FG002|Overall Study|Withdrawal by Subject|0|||
105786002|NCT04338685|364870436|FG003|Overall Study|Withdrawal by Subject|2|||
105786003|NCT04338685|364870437|FG004|Overall Study|Withdrawal by Subject|0|||
105786004|NCT04338685|364870438|FG005|Overall Study|Withdrawal by Subject|5|||
105786005|NCT04338685|364870439|FG006|Overall Study|Withdrawal by Subject|1|||
105786006|NCT04338685|364870440|FG007|Overall Study|Withdrawal by Subject|1|||
105786007|NCT04338685|364870441|FG008|Overall Study|Withdrawal by Subject|0|||
105786008|NCT00234533|364870442|FG000|Overall Study|Withdrawal by Subject|6|||
105340644|NCT01938430|363248240|FG008|Overall Study|Death|2|||
105340645|NCT01938430|363248241|FG009|Overall Study|Death|3|||
105340646|NCT01938430|363248242|FG010|Overall Study|Death|0|||
105340647|NCT01938430|363248243|FG011|Overall Study|Death|0|||
105340648|NCT01938430|363248244|FG012|Overall Study|Death|0|||
105340649|NCT01938430|363248245|FG013|Overall Study|Death|0|||
105786009|NCT00234533|364870442|FG000|Overall Study|Adverse Event|2|||
105340650|NCT01938430|363248232|FG000|Overall Study|Investigator's Discretion|0|||
105340651|NCT01938430|363248233|FG001|Overall Study|Investigator's Discretion|0|||
105340652|NCT01938430|363248234|FG002|Overall Study|Investigator's Discretion|1|||
105464850|NCT02085161|363716099|FG001|Overall Study|Adverse Event|5|||
105464851|NCT02085161|363716100|FG002|Overall Study|Adverse Event|4|||
105340653|NCT01938430|363248235|FG003|Overall Study|Investigator's Discretion|0|||
105340654|NCT01938430|363248236|FG004|Overall Study|Investigator's Discretion|0|||
105340655|NCT01938430|363248237|FG005|Overall Study|Investigator's Discretion|0|||
105340656|NCT01938430|363248238|FG006|Overall Study|Investigator's Discretion|0|||
105464852|NCT02085161|363716101|FG003|Overall Study|Adverse Event|5|||
105464853|NCT02085161|363716098|FG000|Overall Study|Protocol Violation|0|||
105464854|NCT02085161|363716099|FG001|Overall Study|Protocol Violation|1|||
105464855|NCT02085161|363716100|FG002|Overall Study|Protocol Violation|0|||
105464856|NCT02085161|363716101|FG003|Overall Study|Protocol Violation|1|||
105464857|NCT02085161|363716098|FG000|Overall Study|Withdrawal by Subject|2|||
105464858|NCT02085161|363716099|FG001|Overall Study|Withdrawal by Subject|4|||
105464859|NCT02085161|363716100|FG002|Overall Study|Withdrawal by Subject|0|||
105464860|NCT02085161|363716101|FG003|Overall Study|Withdrawal by Subject|3|||
105464861|NCT02085161|363716098|FG000|Overall Study|Other Reason|1|||
105464862|NCT02085161|363716099|FG001|Overall Study|Other Reason|0|||
105464863|NCT02085161|363716100|FG002|Overall Study|Other Reason|1|||
105464864|NCT02085161|363716101|FG003|Overall Study|Other Reason|1|||
105464865|NCT03763877|363716110|FG000|Overall Study|Withdrawal by Subject|3|||
105464866|NCT03763877|363716111|FG001|Overall Study|Withdrawal by Subject|1|||
105464867|NCT03763877|363716112|FG002|Overall Study|Withdrawal by Subject|3|||
105464868|NCT03763877|363716113|FG003|Overall Study|Withdrawal by Subject|4|||
105464869|NCT03763877|363716110|FG000|Overall Study|Adverse Event|1|||
105464870|NCT03763877|363716111|FG001|Overall Study|Adverse Event|1|||
105464871|NCT03763877|363716112|FG002|Overall Study|Adverse Event|3|||
105464872|NCT03763877|363716113|FG003|Overall Study|Adverse Event|1|||
105464873|NCT03763877|363716110|FG000|Overall Study|Protocol Violation|1|||
105464874|NCT03763877|363716111|FG001|Overall Study|Protocol Violation|1|||
105464875|NCT03763877|363716112|FG002|Overall Study|Protocol Violation|0|||
105464876|NCT03763877|363716113|FG003|Overall Study|Protocol Violation|0|||
105464877|NCT03763877|363716110|FG000|Overall Study|Lost to Follow-up|0|||
105464878|NCT03763877|363716111|FG001|Overall Study|Lost to Follow-up|1|||
105464879|NCT03763877|363716112|FG002|Overall Study|Lost to Follow-up|1|||
105464880|NCT03763877|363716113|FG003|Overall Study|Lost to Follow-up|0|||
105464881|NCT03040336|363716114|FG000|Overall Study|Death|1|||
105464882|NCT03040336|363716115|FG001|Overall Study|Death|0|||
105464883|NCT03040336|363716114|FG000|Overall Study|Withdrawal by Subject|2|||
105464884|NCT03040336|363716115|FG001|Overall Study|Withdrawal by Subject|3|||
105464885|NCT00068692|363716124|FG000|Step 1: Registration|Disese progression/relapse|5|||
105464886|NCT00068692|363716125|FG001|Step 1: Registration|Disese progression/relapse|0|||
105464887|NCT00068692|363716126|FG002|Step 1: Registration|Disese progression/relapse|0|||
105464888|NCT00068692|363716127|FG003|Step 1: Registration|Disese progression/relapse|0|||
105464889|NCT00068692|363716128|FG004|Step 1: Registration|Disese progression/relapse|0|||
105464890|NCT00068692|363716129|FG005|Step 1: Registration|Disese progression/relapse|0|||
105464891|NCT00068692|363716130|FG006|Step 1: Registration|Disese progression/relapse|0|||
105464892|NCT00068692|363716131|FG007|Step 1: Registration|Disese progression/relapse|0|||
105464893|NCT00068692|363716124|FG000|Step 1: Registration|Adverse Event|7|||
105464894|NCT00068692|363716125|FG001|Step 1: Registration|Adverse Event|0|||
105464895|NCT00068692|363716126|FG002|Step 1: Registration|Adverse Event|0|||
105464896|NCT00068692|363716127|FG003|Step 1: Registration|Adverse Event|0|||
105464897|NCT00068692|363716128|FG004|Step 1: Registration|Adverse Event|0|||
105464898|NCT00068692|363716129|FG005|Step 1: Registration|Adverse Event|0|||
105464899|NCT00068692|363716130|FG006|Step 1: Registration|Adverse Event|0|||
105464900|NCT00068692|363716131|FG007|Step 1: Registration|Adverse Event|0|||
105786010|NCT00234533|364870442|FG000|Overall Study|Enrolled but not treated|3|||
105464901|NCT00068692|363716124|FG000|Step 1: Registration|Death|1|||
105464902|NCT00068692|363716125|FG001|Step 1: Registration|Death|0|||
105464903|NCT00068692|363716126|FG002|Step 1: Registration|Death|0|||
105464904|NCT00068692|363716127|FG003|Step 1: Registration|Death|0|||
105464905|NCT00068692|363716128|FG004|Step 1: Registration|Death|0|||
105464906|NCT00068692|363716129|FG005|Step 1: Registration|Death|0|||
105464907|NCT00068692|363716130|FG006|Step 1: Registration|Death|0|||
105464908|NCT00068692|363716131|FG007|Step 1: Registration|Death|0|||
105340657|NCT01938430|363248239|FG007|Overall Study|Investigator's Discretion|0|||
105553200|NCT02349295|364023335|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
105553201|NCT02349295|364023336|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
105553202|NCT02349295|364023337|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
105553203|NCT02349295|364023338|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
105553204|NCT02349295|364023339|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
105553205|NCT02349295|364023340|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
105553206|NCT02349295|364023327|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
105553207|NCT02349295|364023328|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
105553208|NCT02349295|364023329|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
105553209|NCT02349295|364023330|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
105553210|NCT02349295|364023331|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
105553211|NCT02349295|364023332|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
105553212|NCT02349295|364023333|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
105553213|NCT02349295|364023334|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
105553214|NCT02349295|364023335|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
105553215|NCT02349295|364023336|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
105553216|NCT02349295|364023337|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
105553217|NCT02349295|364023338|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
105553218|NCT02349295|364023339|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
105553219|NCT02349295|364023340|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
105553220|NCT02349295|364023327|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
105553221|NCT02349295|364023328|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
105553222|NCT02349295|364023329|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
105553223|NCT02349295|364023330|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
105553224|NCT02349295|364023331|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
105553225|NCT02349295|364023332|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
105553226|NCT02349295|364023333|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
105553227|NCT02349295|364023334|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
105553228|NCT02349295|364023335|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
105553229|NCT02349295|364023336|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
105553230|NCT02349295|364023337|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
105553231|NCT02349295|364023338|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
105553232|NCT02349295|364023339|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
105553233|NCT02349295|364023340|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
105553234|NCT02349295|364023327|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
105553235|NCT02349295|364023328|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
105553236|NCT02349295|364023329|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
105553237|NCT02349295|364023330|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
105553238|NCT02349295|364023331|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
105553239|NCT02349295|364023332|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
105553240|NCT02349295|364023333|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
105553241|NCT02349295|364023334|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
105667828|NCT00895895|364448199|FG003|Period 2|Withdrawal by Subject|3|||
105667829|NCT00895895|364448200|FG004|Period 2|Withdrawal by Subject|5|||
105667830|NCT00895895|364448196|FG000|Period 2|unsatisfactory response-efficacy|2|||
105667831|NCT00895895|364448197|FG001|Period 2|unsatisfactory response-efficacy|1|||
105667832|NCT00895895|364448198|FG002|Period 2|unsatisfactory response-efficacy|0|||
105667833|NCT00895895|364448199|FG003|Period 2|unsatisfactory response-efficacy|0|||
105667834|NCT00895895|364448200|FG004|Period 2|unsatisfactory response-efficacy|0|||
105553242|NCT02349295|364023335|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
105553243|NCT02349295|364023336|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
105553244|NCT02349295|364023337|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
105553245|NCT02349295|364023338|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
105553246|NCT02349295|364023339|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
105553247|NCT02349295|364023340|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
105553248|NCT02863926|364023341|FG000|Overall Study|Physician Decision|1|||
105553249|NCT02863926|364023342|FG001|Overall Study|Physician Decision|0|||
105553250|NCT02863926|364023341|FG000|Overall Study|Lost to Follow-up|1|||
105553251|NCT02863926|364023342|FG001|Overall Study|Lost to Follow-up|1|||
105553252|NCT03240588|364023343|FG000|Overall Study|Death|3|||
105553253|NCT03240588|364023344|FG001|Overall Study|Death|0|||
105553254|NCT03240588|364023345|FG002|Overall Study|Death|0|||
105553255|NCT03240588|364023343|FG000|Overall Study|Adverse Event|5|||
105553256|NCT03240588|364023344|FG001|Overall Study|Adverse Event|4|||
105553257|NCT03240588|364023345|FG002|Overall Study|Adverse Event|0|||
105553258|NCT03240588|364023343|FG000|Overall Study|Lost to Follow-up|9|||
105553259|NCT03240588|364023344|FG001|Overall Study|Lost to Follow-up|4|||
105553260|NCT03240588|364023345|FG002|Overall Study|Lost to Follow-up|0|||
105553261|NCT03240588|364023343|FG000|Overall Study|Physician Decision|3|||
105553262|NCT03240588|364023344|FG001|Overall Study|Physician Decision|2|||
105553263|NCT03240588|364023345|FG002|Overall Study|Physician Decision|0|||
105553264|NCT03240588|364023343|FG000|Overall Study|Did not meet eligibility criteria|0|||
105553265|NCT03240588|364023344|FG001|Overall Study|Did not meet eligibility criteria|6|||
105553266|NCT03240588|364023345|FG002|Overall Study|Did not meet eligibility criteria|0|||
105553267|NCT03240588|364023343|FG000|Overall Study|No longer meets protocol criteria|12|||
105553268|NCT03240588|364023344|FG001|Overall Study|No longer meets protocol criteria|7|||
105553269|NCT03240588|364023345|FG002|Overall Study|No longer meets protocol criteria|0|||
105553270|NCT03240588|364023343|FG000|Overall Study|Withdrawal by Subject|60|||
105553271|NCT03240588|364023344|FG001|Overall Study|Withdrawal by Subject|52|||
105553272|NCT03240588|364023345|FG002|Overall Study|Withdrawal by Subject|7|||
105553273|NCT03240588|364023343|FG000|Overall Study|Other, additional details not available.|0|||
105553274|NCT03240588|364023344|FG001|Overall Study|Other, additional details not available.|12|||
105553275|NCT03240588|364023345|FG002|Overall Study|Other, additional details not available.|1|||
105553276|NCT03240588|364023343|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
105553277|NCT03240588|364023344|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
105553278|NCT03240588|364023345|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
105553279|NCT03240588|364023343|FG000|Overall Study|Closure of study|55|||
105553280|NCT03240588|364023344|FG001|Overall Study|Closure of study|3|||
105553281|NCT03240588|364023345|FG002|Overall Study|Closure of study|0|||
105553282|NCT03240588|364023343|FG000|Overall Study|Subject non-compliance|23|||
105553283|NCT03240588|364023344|FG001|Overall Study|Subject non-compliance|2|||
105553284|NCT03240588|364023345|FG002|Overall Study|Subject non-compliance|1|||
105553285|NCT03240588|364023343|FG000|Overall Study|Device Deficiency|1|||
105553286|NCT03240588|364023344|FG001|Overall Study|Device Deficiency|0|||
105553287|NCT03240588|364023345|FG002|Overall Study|Device Deficiency|0|||
105667835|NCT01261000|364448201|FG000|Overall Study|Screen failure|1|||
105667836|NCT03690427|364448202|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
105667837|NCT03690427|364448203|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
105667838|NCT03519204|364448204|FG000|Overall Study|Lost to Follow-up|3|||
105667839|NCT03519204|364448205|FG001|Overall Study|Lost to Follow-up|8|||
105667840|NCT03519204|364448204|FG000|Overall Study|Withdrawal by Subject|9|||
105667841|NCT03519204|364448205|FG001|Overall Study|Withdrawal by Subject|7|||
105667842|NCT03519204|364448204|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105667843|NCT03519204|364448205|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105667844|NCT03392168|364448206|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
105667845|NCT03392168|364448207|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
105667846|NCT03392168|364448208|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
105667847|NCT03392168|364448209|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
105340658|NCT01938430|363248240|FG008|Overall Study|Investigator's Discretion|0|||
105340659|NCT01938430|363248241|FG009|Overall Study|Investigator's Discretion|0|||
105340660|NCT01938430|363248242|FG010|Overall Study|Investigator's Discretion|0|||
105340661|NCT01938430|363248243|FG011|Overall Study|Investigator's Discretion|0|||
105340662|NCT01938430|363248244|FG012|Overall Study|Investigator's Discretion|0|||
105340663|NCT01938430|363248245|FG013|Overall Study|Investigator's Discretion|0|||
105340664|NCT01938430|363248232|FG000|Overall Study|Lack of Efficacy|3|||
105340665|NCT01938430|363248233|FG001|Overall Study|Lack of Efficacy|1|||
105340666|NCT01938430|363248234|FG002|Overall Study|Lack of Efficacy|1|||
105340667|NCT01938430|363248235|FG003|Overall Study|Lack of Efficacy|1|||
105340668|NCT01938430|363248236|FG004|Overall Study|Lack of Efficacy|0|||
105340669|NCT01938430|363248237|FG005|Overall Study|Lack of Efficacy|0|||
105340670|NCT01938430|363248238|FG006|Overall Study|Lack of Efficacy|0|||
105340671|NCT01938430|363248239|FG007|Overall Study|Lack of Efficacy|0|||
105340672|NCT01938430|363248240|FG008|Overall Study|Lack of Efficacy|1|||
105340673|NCT01938430|363248241|FG009|Overall Study|Lack of Efficacy|0|||
105340674|NCT01938430|363248242|FG010|Overall Study|Lack of Efficacy|2|||
105340675|NCT01938430|363248243|FG011|Overall Study|Lack of Efficacy|1|||
105340676|NCT01938430|363248244|FG012|Overall Study|Lack of Efficacy|0|||
105340677|NCT01938430|363248245|FG013|Overall Study|Lack of Efficacy|0|||
105340678|NCT01938430|363248232|FG000|Overall Study|Lost to Follow-up|0|||
105340679|NCT01938430|363248233|FG001|Overall Study|Lost to Follow-up|0|||
105340680|NCT01938430|363248234|FG002|Overall Study|Lost to Follow-up|1|||
105340681|NCT01938430|363248235|FG003|Overall Study|Lost to Follow-up|0|||
105340682|NCT01938430|363248236|FG004|Overall Study|Lost to Follow-up|0|||
105340683|NCT01938430|363248237|FG005|Overall Study|Lost to Follow-up|1|||
105340684|NCT01938430|363248238|FG006|Overall Study|Lost to Follow-up|0|||
105340685|NCT01938430|363248239|FG007|Overall Study|Lost to Follow-up|0|||
105340686|NCT01938430|363248240|FG008|Overall Study|Lost to Follow-up|0|||
105667848|NCT03392168|364448206|FG000|Period 2: Cohort 2|Other|0|||
105667849|NCT03392168|364448207|FG001|Period 2: Cohort 2|Other|1|||
105667850|NCT03392168|364448208|FG002|Period 2: Cohort 2|Other|0|||
105667851|NCT03392168|364448209|FG003|Period 2: Cohort 2|Other|0|||
105340687|NCT01938430|363248241|FG009|Overall Study|Lost to Follow-up|0|||
105340688|NCT01938430|363248242|FG010|Overall Study|Lost to Follow-up|0|||
105340689|NCT01938430|363248243|FG011|Overall Study|Lost to Follow-up|0|||
105340690|NCT01938430|363248244|FG012|Overall Study|Lost to Follow-up|0|||
105340691|NCT01938430|363248245|FG013|Overall Study|Lost to Follow-up|0|||
105340692|NCT01938430|363248232|FG000|Overall Study|Withdrew Consent|0|||
105340693|NCT01938430|363248233|FG001|Overall Study|Withdrew Consent|0|||
105340694|NCT01938430|363248234|FG002|Overall Study|Withdrew Consent|0|||
105340695|NCT01938430|363248235|FG003|Overall Study|Withdrew Consent|0|||
105340696|NCT01938430|363248236|FG004|Overall Study|Withdrew Consent|0|||
105667852|NCT02609672|364448210|FG000|Overall Study|Lost to Follow-up|3|||
105667853|NCT02609672|364448211|FG001|Overall Study|Lost to Follow-up|1|||
105667854|NCT02597712|364448212|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
105340697|NCT01938430|363248237|FG005|Overall Study|Withdrew Consent|0|||
105667855|NCT02597712|364448213|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
105340698|NCT01938430|363248238|FG006|Overall Study|Withdrew Consent|0|||
105340699|NCT01938430|363248239|FG007|Overall Study|Withdrew Consent|0|||
105340700|NCT01938430|363248240|FG008|Overall Study|Withdrew Consent|1|||
105340701|NCT01938430|363248241|FG009|Overall Study|Withdrew Consent|0|||
105340702|NCT01938430|363248242|FG010|Overall Study|Withdrew Consent|0|||
105340703|NCT01938430|363248243|FG011|Overall Study|Withdrew Consent|0|||
105340704|NCT01938430|363248244|FG012|Overall Study|Withdrew Consent|0|||
105340705|NCT01938430|363248245|FG013|Overall Study|Withdrew Consent|0|||
105340706|NCT04533412|363248246|FG000|Overall Study|Withdrawal by Subject|1|||
105340707|NCT04533412|363248247|FG001|Overall Study|Withdrawal by Subject|1|||
105340708|NCT04533412|363248246|FG000|Overall Study|Lost to Follow-up|1|||
105340709|NCT04533412|363248247|FG001|Overall Study|Lost to Follow-up|4|||
105340710|NCT00976820|363248248|FG000|Overall Study|Lost to Follow-up|5|||
105340711|NCT00976820|363248249|FG001|Overall Study|Lost to Follow-up|16|||
105340712|NCT00976820|363248250|FG002|Overall Study|Lost to Follow-up|2|||
105340713|NCT00976820|363248251|FG003|Overall Study|Lost to Follow-up|3|||
105340714|NCT00976820|363248248|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
105340715|NCT00976820|363248249|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
105786011|NCT00596466|364870443|FG000|Overall Study|Lack of Efficacy|5|||
105786012|NCT00596466|364870443|FG000|Overall Study|Adverse Event|4|||
105340716|NCT00976820|363248250|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
105340717|NCT00976820|363248251|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
105340718|NCT00976820|363248248|FG000|Overall Study|Withdrawal by Subject|2|||
105340719|NCT00976820|363248249|FG001|Overall Study|Withdrawal by Subject|4|||
105667856|NCT02597712|364448212|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
105464909|NCT00068692|363716124|FG000|Step 1: Registration|Withdrawal by Subject|11|||
105464910|NCT00068692|363716125|FG001|Step 1: Registration|Withdrawal by Subject|0|||
105464911|NCT00068692|363716126|FG002|Step 1: Registration|Withdrawal by Subject|0|||
105464912|NCT00068692|363716127|FG003|Step 1: Registration|Withdrawal by Subject|0|||
105464913|NCT00068692|363716128|FG004|Step 1: Registration|Withdrawal by Subject|0|||
105464914|NCT00068692|363716129|FG005|Step 1: Registration|Withdrawal by Subject|0|||
105464915|NCT00068692|363716130|FG006|Step 1: Registration|Withdrawal by Subject|0|||
105464916|NCT00068692|363716131|FG007|Step 1: Registration|Withdrawal by Subject|0|||
105464917|NCT00068692|363716124|FG000|Step 1: Registration|Alternative therapy|2|||
105464918|NCT00068692|363716125|FG001|Step 1: Registration|Alternative therapy|0|||
105464919|NCT00068692|363716126|FG002|Step 1: Registration|Alternative therapy|0|||
105464920|NCT00068692|363716127|FG003|Step 1: Registration|Alternative therapy|0|||
105464921|NCT00068692|363716128|FG004|Step 1: Registration|Alternative therapy|0|||
105464922|NCT00068692|363716129|FG005|Step 1: Registration|Alternative therapy|0|||
105464923|NCT00068692|363716130|FG006|Step 1: Registration|Alternative therapy|0|||
105464924|NCT00068692|363716131|FG007|Step 1: Registration|Alternative therapy|0|||
105464925|NCT00068692|363716124|FG000|Step 1: Registration|Complicating disease|2|||
105464926|NCT00068692|363716125|FG001|Step 1: Registration|Complicating disease|0|||
105464927|NCT00068692|363716126|FG002|Step 1: Registration|Complicating disease|0|||
105340720|NCT00976820|363248250|FG002|Overall Study|Withdrawal by Subject|1|||
105340721|NCT00976820|363248251|FG003|Overall Study|Withdrawal by Subject|4|||
105340722|NCT00968981|363248254|FG000|Overall Study|Adverse Event|2|||
105340723|NCT00968981|363248255|FG001|Overall Study|Adverse Event|0|||
105340724|NCT00968981|363248256|FG002|Overall Study|Adverse Event|0|||
105340725|NCT00968981|363248254|FG000|Overall Study|Disease Progression|14|||
105340726|NCT00968981|363248255|FG001|Overall Study|Disease Progression|16|||
105340727|NCT00968981|363248256|FG002|Overall Study|Disease Progression|13|||
105340728|NCT00968981|363248254|FG000|Overall Study|Lost to Follow-up|0|||
105340729|NCT00968981|363248255|FG001|Overall Study|Lost to Follow-up|0|||
105340730|NCT00968981|363248256|FG002|Overall Study|Lost to Follow-up|1|||
105340731|NCT00968981|363248254|FG000|Overall Study|Physician Decision|5|||
105340732|NCT00968981|363248255|FG001|Overall Study|Physician Decision|3|||
105340733|NCT00968981|363248256|FG002|Overall Study|Physician Decision|5|||
105340734|NCT00968981|363248254|FG000|Overall Study|Withdrawal by Subject|1|||
105340735|NCT00968981|363248255|FG001|Overall Study|Withdrawal by Subject|3|||
105340736|NCT00968981|363248256|FG002|Overall Study|Withdrawal by Subject|3|||
105340737|NCT03261674|363248257|FG000|Overall Study|Lost to Follow-up|6|||
105340738|NCT03261674|363248258|FG001|Overall Study|Lost to Follow-up|7|||
105340739|NCT03261674|363248257|FG000|Overall Study|Protocol Violation|1|||
105340740|NCT03261674|363248258|FG001|Overall Study|Protocol Violation|4|||
105340741|NCT03261674|363248257|FG000|Overall Study|Withdrawal by Subject|1|||
105340742|NCT03261674|363248258|FG001|Overall Study|Withdrawal by Subject|4|||
105340743|NCT03261674|363248257|FG000|Overall Study|Physician Decision|1|||
105340744|NCT03261674|363248258|FG001|Overall Study|Physician Decision|0|||
105340745|NCT02045862|363248259|FG000|Overall Study|Death|0|||
105340746|NCT02045862|363248260|FG001|Overall Study|Death|0|||
105340747|NCT02045862|363248261|FG002|Overall Study|Death|1|||
105340748|NCT02045862|363248259|FG000|Overall Study|Miscellaneous|5|||
105340749|NCT02045862|363248260|FG001|Overall Study|Miscellaneous|0|||
105340750|NCT02045862|363248261|FG002|Overall Study|Miscellaneous|8|||
105340751|NCT02045862|363248259|FG000|Overall Study|Withdrawal by Patient|18|||
105340752|NCT02045862|363248260|FG001|Overall Study|Withdrawal by Patient|27|||
105340753|NCT02045862|363248261|FG002|Overall Study|Withdrawal by Patient|57|||
105464928|NCT00068692|363716127|FG003|Step 1: Registration|Complicating disease|0|||
105464929|NCT00068692|363716128|FG004|Step 1: Registration|Complicating disease|0|||
105464930|NCT00068692|363716129|FG005|Step 1: Registration|Complicating disease|0|||
105464931|NCT00068692|363716130|FG006|Step 1: Registration|Complicating disease|0|||
105464932|NCT00068692|363716131|FG007|Step 1: Registration|Complicating disease|0|||
105464933|NCT00068692|363716124|FG000|Step 1: Registration|Protocol Violation|1|||
105464934|NCT00068692|363716125|FG001|Step 1: Registration|Protocol Violation|0|||
105464935|NCT00068692|363716126|FG002|Step 1: Registration|Protocol Violation|0|||
105340754|NCT02045862|363248259|FG000|Overall Study|Protocol Violation|0|||
105340755|NCT02045862|363248260|FG001|Overall Study|Protocol Violation|0|||
105340756|NCT02045862|363248261|FG002|Overall Study|Protocol Violation|6|||
105340757|NCT02045862|363248259|FG000|Overall Study|Lack of Efficacy|8|||
105340758|NCT02045862|363248260|FG001|Overall Study|Lack of Efficacy|4|||
105340759|NCT02045862|363248261|FG002|Overall Study|Lack of Efficacy|13|||
105464936|NCT00068692|363716127|FG003|Step 1: Registration|Protocol Violation|0|||
105553288|NCT03240588|364023343|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
105553289|NCT03240588|364023344|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
105340760|NCT02045862|363248259|FG000|Overall Study|Randomized but not Received Study Drug|0|||
105464937|NCT00068692|363716128|FG004|Step 1: Registration|Protocol Violation|0|||
105464938|NCT00068692|363716129|FG005|Step 1: Registration|Protocol Violation|0|||
105553290|NCT03240588|364023345|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
105553291|NCT03912259|364023348|FG000|Overall Study|Adverse Event (AE)|2|||
105553292|NCT03912259|364023349|FG001|Overall Study|Adverse Event (AE)|4|||
105553293|NCT03912259|364023348|FG000|Overall Study|Lack of Efficacy|4|||
105553294|NCT03912259|364023349|FG001|Overall Study|Lack of Efficacy|1|||
105553295|NCT03912259|364023348|FG000|Overall Study|Withdrawal by Subject|11|||
105667857|NCT02597712|364448213|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
105340761|NCT02045862|363248260|FG001|Overall Study|Randomized but not Received Study Drug|2|||
105340762|NCT02045862|363248261|FG002|Overall Study|Randomized but not Received Study Drug|8|||
105464939|NCT00068692|363716130|FG006|Step 1: Registration|Protocol Violation|0|||
105340763|NCT02045862|363248259|FG000|Overall Study|Adverse Event|7|||
105464940|NCT00068692|363716131|FG007|Step 1: Registration|Protocol Violation|0|||
105667858|NCT02597712|364448212|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
105667859|NCT02597712|364448213|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
105667860|NCT00504777|364448218|FG000|Overall Study|Adverse Event|1|||
105667861|NCT01154140|364448223|FG000|Overall Study|Death|71|||
105667862|NCT01154140|364448224|FG001|Overall Study|Death|81|||
105667863|NCT01154140|364448223|FG000|Overall Study|Lost to Follow-up|4|||
105340764|NCT02045862|363248260|FG001|Overall Study|Adverse Event|5|||
105340765|NCT02045862|363248261|FG002|Overall Study|Adverse Event|27|||
105340766|NCT02045862|363248259|FG000|Overall Study|Lost to Follow-up|1|||
105340767|NCT02045862|363248260|FG001|Overall Study|Lost to Follow-up|2|||
105340768|NCT02045862|363248261|FG002|Overall Study|Lost to Follow-up|6|||
105340769|NCT00631410|363248262|FG000|Overall Study|Adverse Event|1|||
105340770|NCT00631410|363248263|FG001|Overall Study|Adverse Event|3|||
105340771|NCT00631410|363248262|FG000|Overall Study|Objective Progression or Relapse|4|||
105340772|NCT00631410|363248263|FG001|Overall Study|Objective Progression or Relapse|3|||
105340773|NCT00631410|363248262|FG000|Overall Study|Surgery|1|||
105340774|NCT00631410|363248263|FG001|Overall Study|Surgery|0|||
105340775|NCT00890084|363248265|FG000|Overall Study|Adverse Event|16|||
105340776|NCT00890084|363248265|FG000|Overall Study|Lost to Follow-up|126|||
105340777|NCT01438294|363248266|FG000|Overall Study|Lost to Follow-up|3|||
105340778|NCT01438294|363248267|FG001|Overall Study|Lost to Follow-up|7|||
105340779|NCT01346189|363248272|FG000|Overall Study|Withdrawal by Subject|7|||
105340780|NCT01346189|363248273|FG001|Overall Study|Withdrawal by Subject|5|||
105340781|NCT01346189|363248274|FG002|Overall Study|Withdrawal by Subject|3|||
105464941|NCT00068692|363716124|FG000|Step 1: Registration|Not eligible|6|||
105464942|NCT00068692|363716125|FG001|Step 1: Registration|Not eligible|0|||
105464943|NCT00068692|363716126|FG002|Step 1: Registration|Not eligible|0|||
105464944|NCT00068692|363716127|FG003|Step 1: Registration|Not eligible|0|||
105340782|NCT01346189|363248275|FG003|Overall Study|Withdrawal by Subject|5|||
105464945|NCT00068692|363716128|FG004|Step 1: Registration|Not eligible|0|||
105340783|NCT01346189|363248272|FG000|Overall Study|Physician Decision|4|||
105340784|NCT01346189|363248273|FG001|Overall Study|Physician Decision|0|||
105340785|NCT01346189|363248274|FG002|Overall Study|Physician Decision|0|||
105340786|NCT01346189|363248275|FG003|Overall Study|Physician Decision|0|||
105340787|NCT01346189|363248272|FG000|Overall Study|Moved|3|||
105786013|NCT00596466|364870443|FG000|Overall Study|Withdrawal by Subject|2|||
105340788|NCT01346189|363248273|FG001|Overall Study|Moved|0|||
105340789|NCT01346189|363248274|FG002|Overall Study|Moved|4|||
105340790|NCT01346189|363248275|FG003|Overall Study|Moved|0|||
105553296|NCT03912259|364023349|FG001|Overall Study|Withdrawal by Subject|1|||
105553297|NCT01259713|364023350|FG000|Overall Study|Adverse Event|54|||
105553298|NCT01259713|364023351|FG001|Overall Study|Adverse Event|23|||
105553299|NCT01259713|364023350|FG000|Overall Study|Death Not Related to IFI|8|||
105553300|NCT01259713|364023351|FG001|Overall Study|Death Not Related to IFI|1|||
105553301|NCT01259713|364023350|FG000|Overall Study|Investigators Discretion|14|||
105553302|NCT01259713|364023351|FG001|Overall Study|Investigators Discretion|6|||
105553303|NCT01259713|364023350|FG000|Overall Study|Lack of Efficacy|2|||
105553304|NCT01259713|364023351|FG001|Overall Study|Lack of Efficacy|0|||
105553305|NCT01259713|364023350|FG000|Overall Study|Protocol Violation|5|||
105553306|NCT01259713|364023351|FG001|Overall Study|Protocol Violation|4|||
105340791|NCT01346189|363248272|FG000|Overall Study|Other|2|||
105553307|NCT01259713|364023350|FG000|Overall Study|Subject Withdrew Consent|12|||
105340792|NCT01346189|363248273|FG001|Overall Study|Other|4|||
105553308|NCT01259713|364023351|FG001|Overall Study|Subject Withdrew Consent|7|||
105553309|NCT04955639|364023352|FG000|Overall Study|Withdrawal by Subject|2|||
105553310|NCT04955639|364023353|FG001|Overall Study|Withdrawal by Subject|2|||
105553311|NCT04955639|364023352|FG000|Overall Study|Week 26 survey not completed|2|||
105667864|NCT01154140|364448224|FG001|Overall Study|Lost to Follow-up|5|||
105340793|NCT01346189|363248274|FG002|Overall Study|Other|7|||
105340794|NCT01346189|363248275|FG003|Overall Study|Other|3|||
105340795|NCT01346189|363248272|FG000|Overall Study|Death|0|||
105340796|NCT01346189|363248273|FG001|Overall Study|Death|3|||
105340797|NCT01346189|363248274|FG002|Overall Study|Death|0|||
105340798|NCT01346189|363248275|FG003|Overall Study|Death|0|||
105340799|NCT01346189|363248272|FG000|Overall Study|Non-health system primary care physician|0|||
105340800|NCT01346189|363248273|FG001|Overall Study|Non-health system primary care physician|5|||
105340801|NCT01346189|363248274|FG002|Overall Study|Non-health system primary care physician|0|||
105340802|NCT01346189|363248275|FG003|Overall Study|Non-health system primary care physician|0|||
105340803|NCT01346189|363248272|FG000|Overall Study|Travel|0|||
105340804|NCT01346189|363248273|FG001|Overall Study|Travel|0|||
105340805|NCT01346189|363248274|FG002|Overall Study|Travel|0|||
105340806|NCT01346189|363248275|FG003|Overall Study|Travel|3|||
105340807|NCT03193801|363248279|FG000|Overall Study|Physician Decision|2|||
105340808|NCT03193801|363248279|FG000|Overall Study|Withdrawal by Subject|1|||
105340809|NCT04964544|363248280|FG000|Overall Study|Screen failure or other uncategorised|10|||
105340810|NCT04964544|363248280|FG000|Overall Study|Physician Decision|4|||
105340811|NCT04964544|363248280|FG000|Overall Study|Lost to Follow-up|9|||
105340812|NCT04964544|363248280|FG000|Overall Study|Withdrawal by Subject|18|||
105340813|NCT04964544|363248280|FG000|Overall Study|Death|1|||
105464946|NCT00068692|363716129|FG005|Step 1: Registration|Not eligible|0|||
105340814|NCT02855359|363248284|FG000|Overall Study|Death|2|||
105340815|NCT02855359|363248285|FG001|Overall Study|Death|2|||
105340816|NCT02855359|363248286|FG002|Overall Study|Death|0|||
105340817|NCT02855359|363248287|FG003|Overall Study|Death|0|||
105464947|NCT00068692|363716130|FG006|Step 1: Registration|Not eligible|0|||
105464948|NCT00068692|363716131|FG007|Step 1: Registration|Not eligible|0|||
105464949|NCT00068692|363716124|FG000|Step 1: Registration|Other|2|||
105464950|NCT00068692|363716125|FG001|Step 1: Registration|Other|0|||
105464951|NCT00068692|363716126|FG002|Step 1: Registration|Other|0|||
105464952|NCT00068692|363716127|FG003|Step 1: Registration|Other|0|||
105464953|NCT00068692|363716128|FG004|Step 1: Registration|Other|0|||
105464954|NCT00068692|363716129|FG005|Step 1: Registration|Other|0|||
105464955|NCT00068692|363716130|FG006|Step 1: Registration|Other|0|||
105464956|NCT00068692|363716131|FG007|Step 1: Registration|Other|0|||
105464957|NCT00068692|363716124|FG000|Step 1: Registration|Not start protocol therapy|3|||
105464958|NCT00068692|363716125|FG001|Step 1: Registration|Not start protocol therapy|0|||
105464959|NCT00068692|363716126|FG002|Step 1: Registration|Not start protocol therapy|0|||
105464960|NCT00068692|363716127|FG003|Step 1: Registration|Not start protocol therapy|0|||
105464961|NCT00068692|363716128|FG004|Step 1: Registration|Not start protocol therapy|0|||
105553312|NCT04955639|364023353|FG001|Overall Study|Week 26 survey not completed|2|||
105553313|NCT00413153|364023354|FG000|Overall Study|Withdrawal by Subject|1|||
105464962|NCT00068692|363716129|FG005|Step 1: Registration|Not start protocol therapy|0|||
105464963|NCT00068692|363716130|FG006|Step 1: Registration|Not start protocol therapy|0|||
105464964|NCT00068692|363716131|FG007|Step 1: Registration|Not start protocol therapy|0|||
105553314|NCT00413153|364023355|FG001|Overall Study|Withdrawal by Subject|1|||
105553315|NCT00413153|364023354|FG000|Overall Study|Adverse Event|1|||
105464965|NCT00068692|363716124|FG000|Step 1: Registration|Registered but not randomized|0|||
105464966|NCT00068692|363716125|FG001|Step 1: Registration|Registered but not randomized|1|||
105464967|NCT00068692|363716126|FG002|Step 1: Registration|Registered but not randomized|0|||
105464968|NCT00068692|363716127|FG003|Step 1: Registration|Registered but not randomized|0|||
105464969|NCT00068692|363716128|FG004|Step 1: Registration|Registered but not randomized|0|||
105464970|NCT00068692|363716129|FG005|Step 1: Registration|Registered but not randomized|0|||
105464971|NCT00068692|363716130|FG006|Step 1: Registration|Registered but not randomized|0|||
105464972|NCT00068692|363716131|FG007|Step 1: Registration|Registered but not randomized|0|||
105464973|NCT00068692|363716124|FG000|Step 2: Randomization|Disesae progression/replase|0|||
105464974|NCT00068692|363716125|FG001|Step 2: Randomization|Disesae progression/replase|0|||
105464975|NCT00068692|363716126|FG002|Step 2: Randomization|Disesae progression/replase|1|||
105464976|NCT00068692|363716127|FG003|Step 2: Randomization|Disesae progression/replase|1|||
105553316|NCT00413153|364023355|FG001|Overall Study|Adverse Event|0|||
105553317|NCT04969250|364023356|FG000|Overall Study|Protocol Violation|0|||
105553318|NCT04969250|364023357|FG001|Overall Study|Protocol Violation|2|||
105553319|NCT04969250|364023358|FG002|Overall Study|Protocol Violation|3|||
105786014|NCT00596466|364870443|FG000|Overall Study|Protocol Violation|2|||
105667865|NCT01154140|364448223|FG000|Overall Study|Withdrawal by Subject|12|||
105667866|NCT01154140|364448224|FG001|Overall Study|Withdrawal by Subject|13|||
105667867|NCT01154140|364448223|FG000|Overall Study|Other|3|||
105667868|NCT01154140|364448224|FG001|Overall Study|Other|1|||
105667869|NCT01154140|364448223|FG000|Overall Study|Randomized but not treated|1|||
105667870|NCT01154140|364448224|FG001|Overall Study|Randomized but not treated|2|||
105667871|NCT00368875|364448225|FG000|Overall Study|Adverse Event|0|||
105464977|NCT00068692|363716128|FG004|Step 2: Randomization|Disesae progression/replase|0|||
105464978|NCT00068692|363716129|FG005|Step 2: Randomization|Disesae progression/replase|0|||
105464979|NCT00068692|363716130|FG006|Step 2: Randomization|Disesae progression/replase|0|||
105464980|NCT00068692|363716131|FG007|Step 2: Randomization|Disesae progression/replase|0|||
105464981|NCT00068692|363716124|FG000|Step 2: Randomization|Adverse Event|0|||
105464982|NCT00068692|363716125|FG001|Step 2: Randomization|Adverse Event|0|||
105464983|NCT00068692|363716126|FG002|Step 2: Randomization|Adverse Event|4|||
105667872|NCT00368875|364448226|FG001|Overall Study|Adverse Event|12|||
105667873|NCT00368875|364448225|FG000|Overall Study|Progressive disease|3|||
105667874|NCT00368875|364448226|FG001|Overall Study|Progressive disease|27|||
105667875|NCT00368875|364448225|FG000|Overall Study|Withdrawal by Subject|2|||
105667876|NCT00368875|364448226|FG001|Overall Study|Withdrawal by Subject|6|||
105667877|NCT00368875|364448225|FG000|Overall Study|Other Reason|0|||
105667878|NCT00368875|364448226|FG001|Overall Study|Other Reason|2|||
105667879|NCT00368875|364448225|FG000|Overall Study|Alternative Therapy|1|||
105667880|NCT00368875|364448226|FG001|Overall Study|Alternative Therapy|1|||
105667881|NCT01572740|364448227|FG000|Overall Study|Adverse Event|1|||
105667882|NCT01572740|364448228|FG001|Overall Study|Adverse Event|1|||
105667883|NCT01572740|364448227|FG000|Overall Study|Withdrawal by Subject|1|||
105667884|NCT01572740|364448228|FG001|Overall Study|Withdrawal by Subject|1|||
105464984|NCT00068692|363716127|FG003|Step 2: Randomization|Adverse Event|2|||
105667885|NCT01572740|364448227|FG000|Overall Study|unclassified|4|||
105667886|NCT01572740|364448228|FG001|Overall Study|unclassified|3|||
105553320|NCT04969250|364023359|FG003|Overall Study|Protocol Violation|8|||
105464985|NCT00068692|363716128|FG004|Step 2: Randomization|Adverse Event|2|||
105553321|NCT04969250|364023356|FG000|Overall Study|Withdrawal by Subject|0|||
105667887|NCT01289210|364448229|FG000|Overall Study|Adverse Event|1|||
105553322|NCT04969250|364023357|FG001|Overall Study|Withdrawal by Subject|1|||
105553323|NCT04969250|364023358|FG002|Overall Study|Withdrawal by Subject|0|||
105553324|NCT04969250|364023359|FG003|Overall Study|Withdrawal by Subject|0|||
105553325|NCT01221597|364023360|FG000|Overall Study|Adverse Event|4|||
105340818|NCT02855359|363248284|FG000|Overall Study|Study Termination by Sponsor|9|||
105340819|NCT02855359|363248285|FG001|Overall Study|Study Termination by Sponsor|11|||
105340820|NCT02855359|363248286|FG002|Overall Study|Study Termination by Sponsor|0|||
105340821|NCT02855359|363248287|FG003|Overall Study|Study Termination by Sponsor|0|||
105340822|NCT01899742|363248290|FG000|Overall Study|Adverse Event|5|||
105340823|NCT01899742|363248291|FG001|Overall Study|Adverse Event|4|||
105340824|NCT01899742|363248290|FG000|Overall Study|Lack of Efficacy|1|||
105340825|NCT01899742|363248291|FG001|Overall Study|Lack of Efficacy|5|||
105340826|NCT01899742|363248290|FG000|Overall Study|Protocol Violation|2|||
105340827|NCT01899742|363248291|FG001|Overall Study|Protocol Violation|2|||
105340828|NCT01899742|363248290|FG000|Overall Study|Withdrawal by Subject|9|||
105340829|NCT01899742|363248291|FG001|Overall Study|Withdrawal by Subject|5|||
105553326|NCT01221597|364023361|FG001|Overall Study|Adverse Event|1|||
105553327|NCT01221597|364023360|FG000|Overall Study|Withdrawal by Subject|20|||
105553328|NCT01221597|364023361|FG001|Overall Study|Withdrawal by Subject|6|||
105553329|NCT01221597|364023360|FG000|Overall Study|Lost to Follow-up|6|||
105464986|NCT00068692|363716129|FG005|Step 2: Randomization|Adverse Event|3|||
105464987|NCT00068692|363716130|FG006|Step 2: Randomization|Adverse Event|4|||
105340830|NCT01044290|363248292|FG000|Follow-up 1|Death|3|||
105464988|NCT00068692|363716131|FG007|Step 2: Randomization|Adverse Event|4|||
105464989|NCT00068692|363716124|FG000|Step 2: Randomization|Death|0|||
105464990|NCT00068692|363716125|FG001|Step 2: Randomization|Death|0|||
105464991|NCT00068692|363716126|FG002|Step 2: Randomization|Death|0|||
105464992|NCT00068692|363716127|FG003|Step 2: Randomization|Death|0|||
105464993|NCT00068692|363716128|FG004|Step 2: Randomization|Death|1|||
105553330|NCT01221597|364023361|FG001|Overall Study|Lost to Follow-up|5|||
105464994|NCT00068692|363716129|FG005|Step 2: Randomization|Death|0|||
105464995|NCT00068692|363716130|FG006|Step 2: Randomization|Death|0|||
105464996|NCT00068692|363716131|FG007|Step 2: Randomization|Death|1|||
105464997|NCT00068692|363716124|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
105464998|NCT00068692|363716125|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
105464999|NCT00068692|363716126|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
105465000|NCT00068692|363716127|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
105465001|NCT00068692|363716128|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
105465002|NCT00068692|363716129|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
105465003|NCT00068692|363716130|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
105465004|NCT00068692|363716131|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
105465005|NCT00068692|363716124|FG000|Step 2: Randomization|alternative therapy|0|||
105465006|NCT00068692|363716125|FG001|Step 2: Randomization|alternative therapy|0|||
105465007|NCT00068692|363716126|FG002|Step 2: Randomization|alternative therapy|0|||
105465008|NCT00068692|363716127|FG003|Step 2: Randomization|alternative therapy|1|||
105465009|NCT00068692|363716128|FG004|Step 2: Randomization|alternative therapy|1|||
105465010|NCT00068692|363716129|FG005|Step 2: Randomization|alternative therapy|0|||
105465011|NCT00068692|363716130|FG006|Step 2: Randomization|alternative therapy|0|||
105465012|NCT00068692|363716131|FG007|Step 2: Randomization|alternative therapy|0|||
105465013|NCT00068692|363716124|FG000|Step 2: Randomization|Physician Decision|0|||
105465014|NCT00068692|363716125|FG001|Step 2: Randomization|Physician Decision|0|||
105465015|NCT00068692|363716126|FG002|Step 2: Randomization|Physician Decision|0|||
105465016|NCT00068692|363716127|FG003|Step 2: Randomization|Physician Decision|1|||
105465017|NCT00068692|363716128|FG004|Step 2: Randomization|Physician Decision|1|||
105465018|NCT00068692|363716129|FG005|Step 2: Randomization|Physician Decision|0|||
105465019|NCT00068692|363716130|FG006|Step 2: Randomization|Physician Decision|0|||
105465020|NCT00068692|363716131|FG007|Step 2: Randomization|Physician Decision|0|||
105465021|NCT00068692|363716124|FG000|Step 2: Randomization|Other|0|||
105465022|NCT00068692|363716125|FG001|Step 2: Randomization|Other|0|||
105465023|NCT00068692|363716126|FG002|Step 2: Randomization|Other|0|||
105340831|NCT01044290|363248293|FG001|Follow-up 1|Death|3|||
105340832|NCT01044290|363248294|FG002|Follow-up 1|Death|1|||
105465024|NCT00068692|363716127|FG003|Step 2: Randomization|Other|1|||
105465025|NCT00068692|363716128|FG004|Step 2: Randomization|Other|0|||
105465026|NCT00068692|363716129|FG005|Step 2: Randomization|Other|1|||
105465027|NCT00068692|363716130|FG006|Step 2: Randomization|Other|0|||
105465028|NCT00068692|363716131|FG007|Step 2: Randomization|Other|0|||
105465029|NCT00068692|363716124|FG000|Step 2: Randomization|never start protocol therapy|0|||
105465030|NCT00068692|363716125|FG001|Step 2: Randomization|never start protocol therapy|0|||
105667888|NCT01818531|364448230|FG000|Overall Study|Withdrawn for case delay after block|1|||
105667889|NCT01818531|364448231|FG001|Overall Study|Withdrawn for case delay after block|0|||
105667890|NCT01818531|364448230|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
105667891|NCT01818531|364448231|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
105667892|NCT01818531|364448230|FG000|Overall Study|Withdrawn for failure to place block|0|||
105667893|NCT01818531|364448231|FG001|Overall Study|Withdrawn for failure to place block|1|||
105340833|NCT01044290|363248292|FG000|Follow-up 1|Withdrawal by Subject|2|||
105340834|NCT01044290|363248293|FG001|Follow-up 1|Withdrawal by Subject|2|||
105667894|NCT00477490|364448234|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
105465031|NCT00068692|363716126|FG002|Step 2: Randomization|never start protocol therapy|1|||
105465032|NCT00068692|363716127|FG003|Step 2: Randomization|never start protocol therapy|0|||
105465033|NCT00068692|363716128|FG004|Step 2: Randomization|never start protocol therapy|1|||
105465034|NCT00068692|363716129|FG005|Step 2: Randomization|never start protocol therapy|0|||
105465035|NCT00068692|363716130|FG006|Step 2: Randomization|never start protocol therapy|0|||
105465036|NCT00068692|363716131|FG007|Step 2: Randomization|never start protocol therapy|0|||
105465037|NCT00248040|363716133|FG000|Overall Study|transplantectomy|2|||
105465038|NCT00248040|363716134|FG001|Overall Study|transplantectomy|1|||
105465039|NCT00248040|363716135|FG002|Overall Study|transplantectomy|3|||
105465040|NCT00248040|363716133|FG000|Overall Study|transplant cancelled post treat start|1|||
105465041|NCT00248040|363716134|FG001|Overall Study|transplant cancelled post treat start|0|||
105465042|NCT00248040|363716135|FG002|Overall Study|transplant cancelled post treat start|0|||
105465043|NCT00248040|363716133|FG000|Overall Study|Death|0|||
105465044|NCT00248040|363716134|FG001|Overall Study|Death|0|||
105465045|NCT00248040|363716135|FG002|Overall Study|Death|1|||
105465046|NCT03557034|363716139|FG000|Overall Study|Withdrawal by Subject|1|||
105340835|NCT01044290|363248294|FG002|Follow-up 1|Withdrawal by Subject|0|||
105340836|NCT01044290|363248292|FG000|Follow-Up 2|Death|0|||
105340837|NCT01044290|363248293|FG001|Follow-Up 2|Death|1|||
105340838|NCT01044290|363248294|FG002|Follow-Up 2|Death|1|||
105340839|NCT01044290|363248292|FG000|Follow-Up 2|Withdrawal by Subject|0|||
105340840|NCT01044290|363248293|FG001|Follow-Up 2|Withdrawal by Subject|1|||
105340841|NCT01044290|363248294|FG002|Follow-Up 2|Withdrawal by Subject|1|||
105340842|NCT04323306|363248295|FG000|Overall Study|Physician Decision|1|||
105340843|NCT04323306|363248296|FG001|Overall Study|Physician Decision|0|||
105340844|NCT04323306|363248297|FG002|Overall Study|Physician Decision|0|||
105340845|NCT04323306|363248298|FG003|Overall Study|Physician Decision|0|||
105340846|NCT04323306|363248299|FG004|Overall Study|Physician Decision|0|||
105340847|NCT04323306|363248300|FG005|Overall Study|Physician Decision|0|||
105340848|NCT04323306|363248301|FG006|Overall Study|Physician Decision|0|||
105340849|NCT04323306|363248302|FG007|Overall Study|Physician Decision|0|||
105340850|NCT04323306|363248303|FG008|Overall Study|Physician Decision|0|||
105340851|NCT04323306|363248295|FG000|Overall Study|Withdrawal by Subject|0|||
105340852|NCT04323306|363248296|FG001|Overall Study|Withdrawal by Subject|0|||
105340853|NCT04323306|363248297|FG002|Overall Study|Withdrawal by Subject|0|||
105340854|NCT04323306|363248298|FG003|Overall Study|Withdrawal by Subject|0|||
105340855|NCT04323306|363248299|FG004|Overall Study|Withdrawal by Subject|0|||
105340856|NCT04323306|363248300|FG005|Overall Study|Withdrawal by Subject|1|||
105340857|NCT04323306|363248301|FG006|Overall Study|Withdrawal by Subject|3|||
105340858|NCT04323306|363248302|FG007|Overall Study|Withdrawal by Subject|0|||
105340859|NCT04323306|363248303|FG008|Overall Study|Withdrawal by Subject|1|||
105340860|NCT04712019|363248304|FG000|Overall Study|Withdrawal by Subject|2|||
105340861|NCT04712019|363248305|FG001|Overall Study|Withdrawal by Subject|2|||
105340862|NCT04712019|363248304|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
105340863|NCT04712019|363248305|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
105340864|NCT01867294|363248308|FG000|Overall Study|Withdrawal by Subject|1|||
105465047|NCT03557034|363716140|FG001|Overall Study|Withdrawal by Subject|0|||
105340865|NCT01867294|363248309|FG001|Overall Study|Withdrawal by Subject|1|||
105465048|NCT00628108|363716146|FG000|Overall Study|Adverse Event|0|||
105465049|NCT00628108|363716147|FG001|Overall Study|Adverse Event|3|||
105465050|NCT00628108|363716146|FG000|Overall Study|Withdrawal by Subject|1|||
105465051|NCT00628108|363716147|FG001|Overall Study|Withdrawal by Subject|0|||
105465052|NCT01002339|363716151|FG000|Overall Study|Withdrawal by Subject|0|||
105465053|NCT01002339|363716152|FG001|Overall Study|Withdrawal by Subject|1|||
105465054|NCT01002339|363716153|FG002|Overall Study|Withdrawal by Subject|0|||
105465055|NCT01002339|363716151|FG000|Overall Study|Incorrect treatment assignment|0|||
105465056|NCT01002339|363716152|FG001|Overall Study|Incorrect treatment assignment|0|||
105465057|NCT01002339|363716153|FG002|Overall Study|Incorrect treatment assignment|1|||
105465058|NCT01002339|363716151|FG000|Overall Study|Protocol Violation|0|||
105465059|NCT01002339|363716152|FG001|Overall Study|Protocol Violation|0|||
105465060|NCT01002339|363716153|FG002|Overall Study|Protocol Violation|2|||
105465061|NCT01002339|363716151|FG000|Overall Study|Lung cancer detected before transplant|0|||
105465062|NCT01002339|363716152|FG001|Overall Study|Lung cancer detected before transplant|0|||
105465063|NCT01002339|363716153|FG002|Overall Study|Lung cancer detected before transplant|1|||
105465064|NCT01002339|363716151|FG000|Overall Study|Randomized. Not transplanted|0|||
105465065|NCT01002339|363716152|FG001|Overall Study|Randomized. Not transplanted|0|||
105465066|NCT01002339|363716153|FG002|Overall Study|Randomized. Not transplanted|1|||
105465067|NCT02215252|363716154|FG000|Overall Study|Adverse Event|1|||
105465068|NCT02215252|363716155|FG001|Overall Study|Adverse Event|5|||
105465069|NCT02215252|363716156|FG002|Overall Study|Adverse Event|2|||
105465070|NCT02215252|363716154|FG000|Overall Study|Lost to Follow-up|0|||
105465071|NCT02215252|363716155|FG001|Overall Study|Lost to Follow-up|0|||
105465072|NCT02215252|363716156|FG002|Overall Study|Lost to Follow-up|1|||
105465073|NCT02215252|363716154|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
105465074|NCT02215252|363716155|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
105465075|NCT02215252|363716156|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
105465076|NCT02215252|363716154|FG000|Overall Study|Protocol Violation|0|||
105465077|NCT02215252|363716155|FG001|Overall Study|Protocol Violation|1|||
105465078|NCT02215252|363716156|FG002|Overall Study|Protocol Violation|0|||
105465079|NCT02215252|363716154|FG000|Overall Study|Withdrawal by Subject|1|||
105465080|NCT02215252|363716155|FG001|Overall Study|Withdrawal by Subject|0|||
105465081|NCT02215252|363716156|FG002|Overall Study|Withdrawal by Subject|0|||
105465082|NCT02215252|363716154|FG000|Overall Study|Other|0|||
105465083|NCT02215252|363716155|FG001|Overall Study|Other|1|||
105465084|NCT02215252|363716156|FG002|Overall Study|Other|1|||
105465085|NCT02633306|363716157|FG000|Overall Study|Withdrawal by Subject|3|||
105465086|NCT03774576|363716158|FG000|Period 2|Adverse Event|1|||
105465087|NCT00790842|363716159|FG000|Dose Level 1|Adverse Event|1|||
105465088|NCT00790842|363716160|FG001|Dose Level 1|Adverse Event|0|||
105465089|NCT00790842|363716161|FG002|Dose Level 1|Adverse Event|0|||
105465090|NCT00790842|363716162|FG003|Dose Level 1|Adverse Event|2|||
105465091|NCT00790842|363716163|FG004|Dose Level 1|Adverse Event|0|||
105465092|NCT00790842|363716164|FG005|Dose Level 1|Adverse Event|0|||
105465093|NCT00790842|363716165|FG006|Dose Level 1|Adverse Event|0|||
105465094|NCT00790842|363716166|FG007|Dose Level 1|Adverse Event|1|||
105465095|NCT00790842|363716167|FG008|Dose Level 1|Adverse Event|0|||
105465096|NCT00790842|363716168|FG009|Dose Level 1|Adverse Event|0|||
105465097|NCT00790842|363716169|FG010|Dose Level 1|Adverse Event|0|||
105465098|NCT00790842|363716159|FG000|Dose Level 1|Physician Decision|1|||
105465099|NCT00790842|363716160|FG001|Dose Level 1|Physician Decision|0|||
105465100|NCT00790842|363716161|FG002|Dose Level 1|Physician Decision|0|||
105465101|NCT00790842|363716162|FG003|Dose Level 1|Physician Decision|0|||
105465102|NCT00790842|363716163|FG004|Dose Level 1|Physician Decision|0|||
105465103|NCT00790842|363716164|FG005|Dose Level 1|Physician Decision|0|||
105465104|NCT00790842|363716165|FG006|Dose Level 1|Physician Decision|0|||
105465105|NCT00790842|363716166|FG007|Dose Level 1|Physician Decision|1|||
105465106|NCT00790842|363716167|FG008|Dose Level 1|Physician Decision|0|||
105465107|NCT00790842|363716168|FG009|Dose Level 1|Physician Decision|0|||
105465108|NCT00790842|363716169|FG010|Dose Level 1|Physician Decision|0|||
105465109|NCT00790842|363716159|FG000|Dose Level 1|Withdrawal by Subject|1|||
105465110|NCT00790842|363716160|FG001|Dose Level 1|Withdrawal by Subject|0|||
105465111|NCT00790842|363716161|FG002|Dose Level 1|Withdrawal by Subject|0|||
105465112|NCT00790842|363716162|FG003|Dose Level 1|Withdrawal by Subject|0|||
105465113|NCT00790842|363716163|FG004|Dose Level 1|Withdrawal by Subject|0|||
105465114|NCT00790842|363716164|FG005|Dose Level 1|Withdrawal by Subject|0|||
105465115|NCT00790842|363716165|FG006|Dose Level 1|Withdrawal by Subject|0|||
105465116|NCT00790842|363716166|FG007|Dose Level 1|Withdrawal by Subject|0|||
105465117|NCT00790842|363716167|FG008|Dose Level 1|Withdrawal by Subject|0|||
105465118|NCT00790842|363716168|FG009|Dose Level 1|Withdrawal by Subject|0|||
105465119|NCT00790842|363716169|FG010|Dose Level 1|Withdrawal by Subject|0|||
105465120|NCT00790842|363716159|FG000|Dose Level 2|Death|0|||
105465121|NCT00790842|363716160|FG001|Dose Level 2|Death|1|||
105465122|NCT00790842|363716161|FG002|Dose Level 2|Death|0|||
105465123|NCT00790842|363716162|FG003|Dose Level 2|Death|0|||
105465124|NCT00790842|363716163|FG004|Dose Level 2|Death|1|||
105465125|NCT00790842|363716164|FG005|Dose Level 2|Death|0|||
105465126|NCT00790842|363716165|FG006|Dose Level 2|Death|0|||
105465127|NCT00790842|363716166|FG007|Dose Level 2|Death|0|||
105465128|NCT00790842|363716167|FG008|Dose Level 2|Death|0|||
105465129|NCT00790842|363716168|FG009|Dose Level 2|Death|0|||
105465130|NCT00790842|363716169|FG010|Dose Level 2|Death|0|||
105465131|NCT00790842|363716159|FG000|Dose Level 2|Physician Decision|0|||
105667895|NCT00477490|364448235|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
105667896|NCT00477490|364448236|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
105667897|NCT00477490|364448237|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
105667898|NCT00477490|364448238|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
105667899|NCT00477490|364448239|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
105667900|NCT00477490|364448240|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
105667901|NCT00477490|364448241|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
105667902|NCT00477490|364448242|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
105667903|NCT00477490|364448234|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
105465132|NCT00790842|363716160|FG001|Dose Level 2|Physician Decision|1|||
105667904|NCT00477490|364448235|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
105465133|NCT00790842|363716161|FG002|Dose Level 2|Physician Decision|0|||
105465134|NCT00790842|363716162|FG003|Dose Level 2|Physician Decision|0|||
105465135|NCT00790842|363716163|FG004|Dose Level 2|Physician Decision|0|||
105465136|NCT00790842|363716164|FG005|Dose Level 2|Physician Decision|0|||
105465137|NCT00790842|363716165|FG006|Dose Level 2|Physician Decision|0|||
105465138|NCT00790842|363716166|FG007|Dose Level 2|Physician Decision|0|||
105465139|NCT00790842|363716167|FG008|Dose Level 2|Physician Decision|0|||
105465140|NCT00790842|363716168|FG009|Dose Level 2|Physician Decision|0|||
105465141|NCT00790842|363716169|FG010|Dose Level 2|Physician Decision|0|||
105465142|NCT00790842|363716159|FG000|Dose Level 2|Withdrawal by Subject|0|||
105667905|NCT00477490|364448236|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
105667906|NCT00477490|364448237|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
105465143|NCT00790842|363716160|FG001|Dose Level 2|Withdrawal by Subject|1|||
105465144|NCT00790842|363716161|FG002|Dose Level 2|Withdrawal by Subject|0|||
105465145|NCT00790842|363716162|FG003|Dose Level 2|Withdrawal by Subject|0|||
105465146|NCT00790842|363716163|FG004|Dose Level 2|Withdrawal by Subject|0|||
105465147|NCT00790842|363716164|FG005|Dose Level 2|Withdrawal by Subject|0|||
105465148|NCT00790842|363716165|FG006|Dose Level 2|Withdrawal by Subject|0|||
105465149|NCT00790842|363716166|FG007|Dose Level 2|Withdrawal by Subject|0|||
105465150|NCT00790842|363716167|FG008|Dose Level 2|Withdrawal by Subject|0|||
105667907|NCT00477490|364448238|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
105465151|NCT00790842|363716168|FG009|Dose Level 2|Withdrawal by Subject|0|||
105465152|NCT00790842|363716169|FG010|Dose Level 2|Withdrawal by Subject|0|||
105553331|NCT01221597|364023360|FG000|Overall Study|Protocol Violation|1|||
105667908|NCT00477490|364448239|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
105667909|NCT00477490|364448240|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
105667910|NCT00477490|364448241|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
105667911|NCT00477490|364448242|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
105667912|NCT00477490|364448234|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
105667913|NCT00477490|364448235|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
105667914|NCT00477490|364448236|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
105667915|NCT00477490|364448237|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
105667916|NCT00477490|364448238|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
105667917|NCT00477490|364448239|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
105667918|NCT00477490|364448240|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
105465153|NCT00790842|363716159|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
105465154|NCT00790842|363716160|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
105465155|NCT00790842|363716161|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
105465156|NCT00790842|363716162|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
105667919|NCT00477490|364448241|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
105667920|NCT00477490|364448242|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
105786015|NCT00596466|364870443|FG000|Overall Study|Unpecified|2|||
105340866|NCT01867294|363248310|FG002|Overall Study|Withdrawal by Subject|0|||
105340867|NCT01867294|363248311|FG003|Overall Study|Withdrawal by Subject|0|||
105340868|NCT02017912|363248312|FG000|Overall Study|Withdrawal by Subject|2|||
105340869|NCT02017912|363248313|FG001|Overall Study|Withdrawal by Subject|1|||
105340870|NCT02017912|363248312|FG000|Overall Study|miscellaneous|1|||
105340871|NCT02017912|363248313|FG001|Overall Study|miscellaneous|1|||
105340872|NCT01322035|363248314|FG000|Overall Study|Lost to Follow-up|8|||
105340873|NCT01322035|363248315|FG001|Overall Study|Lost to Follow-up|3|||
105340874|NCT00535847|363248316|FG000|Overall Study|Adverse Event|5|||
105340875|NCT00535847|363248317|FG001|Overall Study|Adverse Event|3|||
105340876|NCT00535847|363248318|FG002|Overall Study|Adverse Event|2|||
105340877|NCT00535847|363248316|FG000|Overall Study|Non compliance|1|||
105340878|NCT00535847|363248317|FG001|Overall Study|Non compliance|1|||
105340879|NCT00535847|363248318|FG002|Overall Study|Non compliance|0|||
105340880|NCT00535847|363248316|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
105340881|NCT00535847|363248317|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
105340882|NCT00535847|363248318|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
105340883|NCT04569968|363248319|FG000|Overall Study|Lost to Follow-up|2|||
105340884|NCT04569968|363248320|FG001|Overall Study|Lost to Follow-up|5|||
105340885|NCT04569968|363248319|FG000|Overall Study|Story of head and/or neck surgery|2|||
105340886|NCT04569968|363248320|FG001|Overall Study|Story of head and/or neck surgery|2|||
105340887|NCT04569968|363248319|FG000|Overall Study|Time of stroke onset|8|||
105340888|NCT04569968|363248320|FG001|Overall Study|Time of stroke onset|7|||
105340889|NCT04569968|363248319|FG000|Overall Study|Type of strokr|12|||
105340890|NCT04569968|363248320|FG001|Overall Study|Type of strokr|8|||
105340891|NCT04569968|363248319|FG000|Overall Study|Cooperation|8|||
105340892|NCT04569968|363248320|FG001|Overall Study|Cooperation|8|||
105340893|NCT04569968|363248319|FG000|Overall Study|Age interval|17|||
105340894|NCT04569968|363248320|FG001|Overall Study|Age interval|6|||
105340895|NCT04569968|363248319|FG000|Overall Study|Denial of participation to the study|0|||
105340896|NCT04569968|363248320|FG001|Overall Study|Denial of participation to the study|3|||
105340897|NCT04569968|363248319|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
105340898|NCT04569968|363248320|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
105340899|NCT04569968|363248319|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
105340900|NCT04569968|363248320|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
105340901|NCT04569968|363248319|FG000|Overall Study|Quarantine|1|||
105340902|NCT04569968|363248320|FG001|Overall Study|Quarantine|0|||
105340903|NCT04569968|363248319|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
105340904|NCT04569968|363248320|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
105340905|NCT04569968|363248319|FG000|Overall Study|Repetitive stroke|8|||
105340906|NCT04569968|363248320|FG001|Overall Study|Repetitive stroke|0|||
105553332|NCT01221597|364023361|FG001|Overall Study|Protocol Violation|0|||
105340907|NCT04569968|363248319|FG000|Overall Study|Insufficient mastication|1|||
105553333|NCT01221597|364023360|FG000|Overall Study|Other|3|||
105553334|NCT01221597|364023361|FG001|Overall Study|Other|4|||
105553335|NCT01221597|364023360|FG000|Overall Study|Death|2|||
105553336|NCT01221597|364023361|FG001|Overall Study|Death|0|||
105553337|NCT02119416|364023362|FG000|Overall Study|Protocol Violation|1|||
105340908|NCT04569968|363248320|FG001|Overall Study|Insufficient mastication|0|||
105340909|NCT04569968|363248319|FG000|Overall Study|Infection|1|||
105340910|NCT04569968|363248320|FG001|Overall Study|Infection|0|||
105340911|NCT00732758|363248321|FG000|Overall Study|Lost to Follow-up|8|||
105340912|NCT00732758|363248322|FG001|Overall Study|Lost to Follow-up|16|||
105340913|NCT05007041|363248323|FG000|Overall Study|Missing Diary Entries|0|||
105340914|NCT05007041|363248324|FG001|Overall Study|Missing Diary Entries|1|||
105340915|NCT00750139|363248325|FG000|Overall Study|Adverse Event|1|||
105340916|NCT00750139|363248326|FG001|Overall Study|Adverse Event|2|||
105340917|NCT00750139|363248327|FG002|Overall Study|Adverse Event|0|||
105340918|NCT00750139|363248328|FG003|Overall Study|Adverse Event|1|||
105340919|NCT00750139|363248325|FG000|Overall Study|Lost to Follow-up|17|||
105340920|NCT00750139|363248326|FG001|Overall Study|Lost to Follow-up|12|||
105340921|NCT00750139|363248327|FG002|Overall Study|Lost to Follow-up|15|||
105340922|NCT00750139|363248328|FG003|Overall Study|Lost to Follow-up|6|||
105340923|NCT00750139|363248325|FG000|Overall Study|Withdrawal by Subject|3|||
105465157|NCT00790842|363716163|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
105465158|NCT00790842|363716164|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
105465159|NCT00790842|363716165|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
105667921|NCT00477490|364448234|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
105667922|NCT00477490|364448235|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
105667923|NCT00477490|364448236|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
105340924|NCT00750139|363248326|FG001|Overall Study|Withdrawal by Subject|2|||
105340925|NCT00750139|363248327|FG002|Overall Study|Withdrawal by Subject|6|||
105667924|NCT00477490|364448237|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
105667925|NCT00477490|364448238|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
105667926|NCT00477490|364448239|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
105667927|NCT00477490|364448240|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
105667928|NCT00477490|364448241|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
105667929|NCT00477490|364448242|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
105667930|NCT00477490|364448234|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
105667931|NCT00477490|364448235|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
105667932|NCT00477490|364448236|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
105667933|NCT00477490|364448237|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
105667934|NCT00477490|364448238|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
105667935|NCT00477490|364448239|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
105667936|NCT00477490|364448240|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
105667937|NCT00477490|364448241|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
105667938|NCT00477490|364448242|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
105667939|NCT00477490|364448234|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
105667940|NCT00477490|364448235|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
105667941|NCT00477490|364448236|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
105667942|NCT00477490|364448237|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
105667943|NCT00477490|364448238|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
105667944|NCT00477490|364448239|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
105667945|NCT00477490|364448240|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
105667946|NCT00477490|364448241|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
105667947|NCT00477490|364448242|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
105667948|NCT00477490|364448234|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
105667949|NCT00477490|364448235|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
105667950|NCT00477490|364448236|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
105667951|NCT00477490|364448237|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
105667952|NCT00477490|364448238|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
105667953|NCT00477490|364448239|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
105667954|NCT00477490|364448240|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
105667955|NCT00477490|364448241|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
105667956|NCT00477490|364448242|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
105667957|NCT00477490|364448234|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
105667958|NCT00477490|364448235|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
105667959|NCT00477490|364448236|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
105667960|NCT00477490|364448237|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
105667961|NCT00477490|364448238|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
105667962|NCT00477490|364448239|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
105667963|NCT00477490|364448240|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
105667964|NCT00477490|364448241|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
105667965|NCT00477490|364448242|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
105667966|NCT00477490|364448234|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
105667967|NCT00477490|364448235|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
105553338|NCT02119416|364023363|FG001|Overall Study|Protocol Violation|1|||
105667968|NCT00477490|364448236|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
105667969|NCT00477490|364448237|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
105667970|NCT00477490|364448238|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
105465160|NCT00790842|363716166|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
105465161|NCT00790842|363716167|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
105465162|NCT00790842|363716168|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
105465163|NCT00790842|363716169|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
105465164|NCT00790842|363716159|FG000|Dose Level 3|Adverse Event|0|||
105465165|NCT00790842|363716160|FG001|Dose Level 3|Adverse Event|0|||
105465166|NCT00790842|363716161|FG002|Dose Level 3|Adverse Event|1|||
105465167|NCT00790842|363716162|FG003|Dose Level 3|Adverse Event|0|||
105465168|NCT00790842|363716163|FG004|Dose Level 3|Adverse Event|0|||
105465169|NCT00790842|363716164|FG005|Dose Level 3|Adverse Event|0|||
105465170|NCT00790842|363716165|FG006|Dose Level 3|Adverse Event|0|||
105465171|NCT00790842|363716166|FG007|Dose Level 3|Adverse Event|0|||
105465172|NCT00790842|363716167|FG008|Dose Level 3|Adverse Event|0|||
105465173|NCT00790842|363716168|FG009|Dose Level 3|Adverse Event|0|||
105465174|NCT00790842|363716169|FG010|Dose Level 3|Adverse Event|0|||
105465175|NCT00790842|363716159|FG000|Dose Level 3|Withdrawal by Subject|0|||
105465176|NCT00790842|363716160|FG001|Dose Level 3|Withdrawal by Subject|0|||
105465177|NCT00790842|363716161|FG002|Dose Level 3|Withdrawal by Subject|3|||
105465178|NCT00790842|363716162|FG003|Dose Level 3|Withdrawal by Subject|0|||
105465179|NCT00790842|363716163|FG004|Dose Level 3|Withdrawal by Subject|0|||
105465180|NCT00790842|363716164|FG005|Dose Level 3|Withdrawal by Subject|0|||
105465181|NCT00790842|363716165|FG006|Dose Level 3|Withdrawal by Subject|0|||
105465182|NCT00790842|363716166|FG007|Dose Level 3|Withdrawal by Subject|0|||
105553339|NCT02119416|364023364|FG002|Overall Study|Protocol Violation|1|||
105465183|NCT00790842|363716167|FG008|Dose Level 3|Withdrawal by Subject|0|||
105465184|NCT00790842|363716168|FG009|Dose Level 3|Withdrawal by Subject|2|||
105465185|NCT00790842|363716169|FG010|Dose Level 3|Withdrawal by Subject|0|||
105340926|NCT00750139|363248328|FG003|Overall Study|Withdrawal by Subject|2|||
105340927|NCT00750139|363248325|FG000|Overall Study|Physician Decision|1|||
105340928|NCT00750139|363248326|FG001|Overall Study|Physician Decision|1|||
105340929|NCT00750139|363248327|FG002|Overall Study|Physician Decision|0|||
105340930|NCT00750139|363248328|FG003|Overall Study|Physician Decision|0|||
105340931|NCT00750139|363248325|FG000|Overall Study|Non-compliance|1|||
105340932|NCT00750139|363248326|FG001|Overall Study|Non-compliance|0|||
105340933|NCT00750139|363248327|FG002|Overall Study|Non-compliance|1|||
105340934|NCT00750139|363248328|FG003|Overall Study|Non-compliance|3|||
105340935|NCT00750139|363248325|FG000|Overall Study|Termination by sponsor|4|||
105340936|NCT00750139|363248326|FG001|Overall Study|Termination by sponsor|0|||
105340937|NCT00750139|363248327|FG002|Overall Study|Termination by sponsor|0|||
105340938|NCT00750139|363248328|FG003|Overall Study|Termination by sponsor|1|||
105340939|NCT00750139|363248325|FG000|Overall Study|Non-specific|62|||
105340940|NCT00750139|363248326|FG001|Overall Study|Non-specific|42|||
105340941|NCT00750139|363248327|FG002|Overall Study|Non-specific|79|||
105340942|NCT00750139|363248328|FG003|Overall Study|Non-specific|33|||
105340943|NCT05036668|363248331|FG000|Overall Study|lost to follow Up|0|||
105340944|NCT05036668|363248332|FG001|Overall Study|lost to follow Up|0|||
105340945|NCT05036668|363248333|FG002|Overall Study|lost to follow Up|1|||
105340946|NCT00658775|363248334|FG000|Overall Study|Adverse Event|4|||
105340947|NCT00658775|363248335|FG001|Overall Study|Adverse Event|6|||
105340948|NCT00658775|363248334|FG000|Overall Study|Lost to Follow-up|17|||
105340949|NCT00658775|363248335|FG001|Overall Study|Lost to Follow-up|18|||
105340950|NCT00658775|363248334|FG000|Overall Study|Withdrawal by Subject|6|||
105340951|NCT00658775|363248335|FG001|Overall Study|Withdrawal by Subject|4|||
105340952|NCT00658775|363248334|FG000|Overall Study|Withdrawal of consent|8|||
105340953|NCT00658775|363248335|FG001|Overall Study|Withdrawal of consent|7|||
105340954|NCT00658775|363248334|FG000|Overall Study|Other|7|||
105340955|NCT00658775|363248335|FG001|Overall Study|Other|8|||
105340956|NCT00387010|363248336|FG000|Dose Titration Period|Adverse Event|12|||
105340957|NCT00387010|363248336|FG000|Dose Titration Period|Lack of Efficacy|5|||
105340958|NCT00387010|363248336|FG000|Dose Titration Period|Withdrawal by Subject|3|||
105340959|NCT00387010|363248336|FG000|Dose Titration Period|Protocol Violation|1|||
105340960|NCT00387010|363248336|FG000|Dose Titration Period|Lost to Follow-up|2|||
105340961|NCT00387010|363248336|FG000|Dose Titration Period|Noncompliance with study medication|8|||
105340962|NCT00387010|363248336|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
105340963|NCT00387010|363248336|FG000|Treatment Period|Adverse Event|4|||
105340964|NCT00387010|363248336|FG000|Treatment Period|Withdrawal by Subject|1|||
105340965|NCT00387010|363248336|FG000|Treatment Period|Noncompliance with study medication|2|||
105340966|NCT00387010|363248336|FG000|Treatment Period|Noncompliance with study procedures|3|||
105340967|NCT00387010|363248336|FG000|Treatment Period|Participant reported study drug stolen|1|||
105340968|NCT01597375|363248338|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
105340969|NCT01597375|363248339|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
105340970|NCT01597375|363248338|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
105340971|NCT01597375|363248339|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
105340972|NCT01597375|363248338|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
105340973|NCT01597375|363248339|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
105340974|NCT01597375|363248338|FG000|Washout (2 Weeks)|Adverse Event|1|||
105340975|NCT01597375|363248339|FG001|Washout (2 Weeks)|Adverse Event|0|||
105340976|NCT01597375|363248338|FG000|Second Intervention|Failed to react at both Aspirin|1|||
105340977|NCT01597375|363248339|FG001|Second Intervention|Failed to react at both Aspirin|1|||
105465186|NCT00790842|363716159|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
105465187|NCT00790842|363716160|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
105465188|NCT00790842|363716161|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
105465189|NCT00790842|363716162|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
105465190|NCT00790842|363716163|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
105465191|NCT00790842|363716164|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
105465192|NCT00790842|363716165|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
105553340|NCT02119416|364023362|FG000|Overall Study|wrong pubertal stage|1|||
105553341|NCT02119416|364023363|FG001|Overall Study|wrong pubertal stage|0|||
105553342|NCT02119416|364023364|FG002|Overall Study|wrong pubertal stage|1|||
105553343|NCT03834779|364023367|FG000|Overall Study|Death|1|||
105553344|NCT03834779|364023368|FG001|Overall Study|Death|2|||
105340978|NCT01931956|363248344|FG000|Overall Study|Death|42|||
105465193|NCT00790842|363716166|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
105553345|NCT03834779|364023367|FG000|Overall Study|Lost to Follow-up|6|||
105553346|NCT03834779|364023368|FG001|Overall Study|Lost to Follow-up|4|||
105465194|NCT00790842|363716167|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
105465195|NCT00790842|363716168|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
105465196|NCT00790842|363716169|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
105465197|NCT00790842|363716159|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
105465198|NCT00790842|363716160|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
105667971|NCT00477490|364448239|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
105465199|NCT00790842|363716161|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
105465200|NCT00790842|363716162|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
105465201|NCT00790842|363716163|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
105465202|NCT00790842|363716164|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
105340979|NCT01931956|363248345|FG001|Overall Study|Death|7|||
105340980|NCT01931956|363248346|FG002|Overall Study|Death|379|||
105340981|NCT01931956|363248347|FG003|Overall Study|Death|96|||
105340982|NCT01931956|363248344|FG000|Overall Study|Withdrawal by Subject|5|||
105340983|NCT01931956|363248345|FG001|Overall Study|Withdrawal by Subject|0|||
105340984|NCT01931956|363248346|FG002|Overall Study|Withdrawal by Subject|70|||
105340985|NCT01931956|363248347|FG003|Overall Study|Withdrawal by Subject|30|||
105340986|NCT01931956|363248344|FG000|Overall Study|Lost to Follow-up|2|||
105340987|NCT01931956|363248345|FG001|Overall Study|Lost to Follow-up|0|||
105340988|NCT01931956|363248346|FG002|Overall Study|Lost to Follow-up|11|||
105340989|NCT01931956|363248347|FG003|Overall Study|Lost to Follow-up|7|||
105340990|NCT01931956|363248344|FG000|Overall Study|Expected|2|||
105340991|NCT01931956|363248345|FG001|Overall Study|Expected|0|||
105340992|NCT01931956|363248346|FG002|Overall Study|Expected|6|||
105340993|NCT01931956|363248347|FG003|Overall Study|Expected|0|||
105340994|NCT01931956|363248344|FG000|Overall Study|Not due|0|||
105340995|NCT01931956|363248345|FG001|Overall Study|Not due|0|||
105340996|NCT01931956|363248346|FG002|Overall Study|Not due|21|||
105340997|NCT01931956|363248347|FG003|Overall Study|Not due|0|||
105340998|NCT01901653|363248348|FG000|Overall Study|Death|2|||
105340999|NCT01901653|363248349|FG001|Overall Study|Death|1|||
105341000|NCT01901653|363248350|FG002|Overall Study|Death|8|||
105341001|NCT01901653|363248351|FG003|Overall Study|Death|3|||
105341002|NCT01901653|363248352|FG004|Overall Study|Death|2|||
105341003|NCT01901653|363248353|FG005|Overall Study|Death|2|||
105341004|NCT01901653|363248354|FG006|Overall Study|Death|6|||
105341005|NCT01901653|363248355|FG007|Overall Study|Death|9|||
105341006|NCT01901653|363248356|FG008|Overall Study|Death|1|||
105341007|NCT01901653|363248357|FG009|Overall Study|Death|16|||
105341008|NCT01901653|363248358|FG010|Overall Study|Death|2|||
105341009|NCT01901653|363248359|FG011|Overall Study|Death|15|||
105341010|NCT01901653|363248360|FG012|Overall Study|Death|4|||
105341011|NCT01901653|363248348|FG000|Overall Study|Lost to Follow-up|1|||
105341012|NCT01901653|363248349|FG001|Overall Study|Lost to Follow-up|0|||
105341013|NCT01901653|363248350|FG002|Overall Study|Lost to Follow-up|2|||
105465203|NCT00790842|363716165|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
105465204|NCT00790842|363716166|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
105465205|NCT00790842|363716167|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
105465206|NCT00790842|363716168|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
105465207|NCT00790842|363716169|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
105465208|NCT00790842|363716159|FG000|Dose Level 4|Adverse Event|0|||
105465209|NCT00790842|363716160|FG001|Dose Level 4|Adverse Event|0|||
105465210|NCT00790842|363716161|FG002|Dose Level 4|Adverse Event|0|||
105465211|NCT00790842|363716162|FG003|Dose Level 4|Adverse Event|0|||
105465212|NCT00790842|363716163|FG004|Dose Level 4|Adverse Event|0|||
105465213|NCT00790842|363716164|FG005|Dose Level 4|Adverse Event|0|||
105341014|NCT01901653|363248351|FG003|Overall Study|Lost to Follow-up|0|||
105341015|NCT01901653|363248352|FG004|Overall Study|Lost to Follow-up|0|||
105341016|NCT01901653|363248353|FG005|Overall Study|Lost to Follow-up|1|||
105341017|NCT01901653|363248354|FG006|Overall Study|Lost to Follow-up|0|||
105341018|NCT01901653|363248355|FG007|Overall Study|Lost to Follow-up|1|||
105341019|NCT01901653|363248356|FG008|Overall Study|Lost to Follow-up|0|||
105341020|NCT01901653|363248357|FG009|Overall Study|Lost to Follow-up|0|||
105341021|NCT01901653|363248358|FG010|Overall Study|Lost to Follow-up|0|||
105341022|NCT01901653|363248359|FG011|Overall Study|Lost to Follow-up|0|||
105341023|NCT01901653|363248360|FG012|Overall Study|Lost to Follow-up|0|||
105341024|NCT01901653|363248348|FG000|Overall Study|Withdrawal by Subject|0|||
105341025|NCT01901653|363248349|FG001|Overall Study|Withdrawal by Subject|0|||
105341026|NCT01901653|363248350|FG002|Overall Study|Withdrawal by Subject|0|||
105341027|NCT01901653|363248351|FG003|Overall Study|Withdrawal by Subject|0|||
105341028|NCT01901653|363248352|FG004|Overall Study|Withdrawal by Subject|0|||
105341029|NCT01901653|363248353|FG005|Overall Study|Withdrawal by Subject|0|||
105341030|NCT01901653|363248354|FG006|Overall Study|Withdrawal by Subject|1|||
105341031|NCT01901653|363248355|FG007|Overall Study|Withdrawal by Subject|0|||
105341032|NCT01901653|363248356|FG008|Overall Study|Withdrawal by Subject|0|||
105341033|NCT01901653|363248357|FG009|Overall Study|Withdrawal by Subject|0|||
105341034|NCT01901653|363248358|FG010|Overall Study|Withdrawal by Subject|0|||
105341035|NCT01901653|363248359|FG011|Overall Study|Withdrawal by Subject|0|||
105341036|NCT01901653|363248360|FG012|Overall Study|Withdrawal by Subject|0|||
105341037|NCT01901653|363248348|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
105341038|NCT01901653|363248349|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
105341039|NCT01901653|363248350|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
105341040|NCT01901653|363248351|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
105341041|NCT01901653|363248352|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
105341042|NCT01901653|363248353|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
105341043|NCT01901653|363248354|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
105341044|NCT01901653|363248355|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
105341045|NCT01901653|363248356|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
105341046|NCT01901653|363248357|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
105341047|NCT01901653|363248358|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
105341048|NCT01901653|363248359|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
105341049|NCT01901653|363248360|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
105341050|NCT00688701|363249894|FG000|Overall Study|Adverse Event|1|||
105341051|NCT00688701|363249895|FG001|Overall Study|Adverse Event|0|||
105341052|NCT00688701|363249896|FG002|Overall Study|Adverse Event|5|||
105341053|NCT00688701|363249897|FG003|Overall Study|Adverse Event|3|||
105341054|NCT00688701|363249894|FG000|Overall Study|Lack of Efficacy|0|||
105341055|NCT00688701|363249895|FG001|Overall Study|Lack of Efficacy|1|||
105341056|NCT00688701|363249896|FG002|Overall Study|Lack of Efficacy|0|||
105341057|NCT00688701|363249897|FG003|Overall Study|Lack of Efficacy|0|||
105341058|NCT00688701|363249894|FG000|Overall Study|Withdrawal by Subject|3|||
105341059|NCT00688701|363249895|FG001|Overall Study|Withdrawal by Subject|3|||
105341060|NCT00688701|363249896|FG002|Overall Study|Withdrawal by Subject|4|||
105341061|NCT00688701|363249897|FG003|Overall Study|Withdrawal by Subject|8|||
105341062|NCT00688701|363249894|FG000|Overall Study|Poor compliance to protocol|0|||
105341063|NCT00688701|363249895|FG001|Overall Study|Poor compliance to protocol|1|||
105341064|NCT00688701|363249896|FG002|Overall Study|Poor compliance to protocol|1|||
105341065|NCT00688701|363249897|FG003|Overall Study|Poor compliance to protocol|0|||
105341066|NCT03205761|363249905|FG000|Overall Study|Withdrawal by Subject|1|||
105341067|NCT03205761|363249905|FG000|Overall Study|Progressive Disease|10|||
105341068|NCT00636194|363249906|FG000|Overall Study|Study related symptoms and complaints|1|||
105341069|NCT00636194|363249907|FG001|Overall Study|Study related symptoms and complaints|0|||
105341070|NCT00636194|363249906|FG000|Overall Study|Protocol Violation|2|||
105341071|NCT00636194|363249907|FG001|Overall Study|Protocol Violation|0|||
105341072|NCT04934189|363249909|FG000|Overall Study|Lost to Follow-up|4|||
105341073|NCT04934189|363249909|FG000|Overall Study|Withdrawal by Subject|17|||
105465214|NCT00790842|363716165|FG006|Dose Level 4|Adverse Event|1|||
105465215|NCT00790842|363716166|FG007|Dose Level 4|Adverse Event|0|||
105465216|NCT00790842|363716167|FG008|Dose Level 4|Adverse Event|0|||
105465217|NCT00790842|363716168|FG009|Dose Level 4|Adverse Event|0|||
105465218|NCT00790842|363716169|FG010|Dose Level 4|Adverse Event|0|||
105465219|NCT00790842|363716159|FG000|Dose Level 4|Physician Decision|0|||
105465220|NCT00790842|363716160|FG001|Dose Level 4|Physician Decision|0|||
105465221|NCT00790842|363716161|FG002|Dose Level 4|Physician Decision|0|||
105341074|NCT04481191|363249920|FG000|Overall Study|Withdrawn by parent/guardian|15|||
105465222|NCT00790842|363716162|FG003|Dose Level 4|Physician Decision|0|||
105465223|NCT00790842|363716163|FG004|Dose Level 4|Physician Decision|0|||
105465224|NCT00790842|363716164|FG005|Dose Level 4|Physician Decision|0|||
105465225|NCT00790842|363716165|FG006|Dose Level 4|Physician Decision|1|||
105341075|NCT04481191|363249921|FG001|Overall Study|Withdrawn by parent/guardian|10|||
105341076|NCT00546117|363249922|FG000|Overall Study|Withdrawal by Subject|3|||
105465226|NCT00790842|363716166|FG007|Dose Level 4|Physician Decision|0|||
105341077|NCT00546117|363249923|FG001|Overall Study|Withdrawal by Subject|0|||
105341078|NCT00546117|363249922|FG000|Overall Study|Inability to schedule follow-up visit|1|||
105341079|NCT00546117|363249923|FG001|Overall Study|Inability to schedule follow-up visit|0|||
105341080|NCT02487771|363249924|FG000|Overall Study|Lost to Follow-up|2|||
105341081|NCT02487771|363249925|FG001|Overall Study|Lost to Follow-up|3|||
105465227|NCT00790842|363716167|FG008|Dose Level 4|Physician Decision|0|||
105465228|NCT00790842|363716168|FG009|Dose Level 4|Physician Decision|0|||
105465229|NCT00790842|363716169|FG010|Dose Level 4|Physician Decision|1|||
105465230|NCT00790842|363716159|FG000|Dose Level 4|Withdrawal by Subject|0|||
105465231|NCT00790842|363716160|FG001|Dose Level 4|Withdrawal by Subject|0|||
105465232|NCT00790842|363716161|FG002|Dose Level 4|Withdrawal by Subject|0|||
105465233|NCT00790842|363716162|FG003|Dose Level 4|Withdrawal by Subject|0|||
105465234|NCT00790842|363716163|FG004|Dose Level 4|Withdrawal by Subject|0|||
105465235|NCT00790842|363716164|FG005|Dose Level 4|Withdrawal by Subject|0|||
105465236|NCT00790842|363716165|FG006|Dose Level 4|Withdrawal by Subject|0|||
105465237|NCT00790842|363716166|FG007|Dose Level 4|Withdrawal by Subject|0|||
105553347|NCT00476476|364023370|FG000|Overall Study|Adverse Event|2|||
105553348|NCT00476476|364023371|FG001|Overall Study|Adverse Event|7|||
105667972|NCT00477490|364448240|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
105667973|NCT00477490|364448241|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
105667974|NCT00477490|364448242|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
105667975|NCT00477490|364448234|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
105667976|NCT00477490|364448235|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
105667977|NCT00477490|364448236|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
105667978|NCT00477490|364448237|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
105667979|NCT00477490|364448238|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
105667980|NCT00477490|364448239|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
105667981|NCT00477490|364448240|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
105667982|NCT00477490|364448241|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
105667983|NCT00477490|364448242|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
105667984|NCT00477490|364448234|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
105465238|NCT00790842|363716167|FG008|Dose Level 4|Withdrawal by Subject|0|||
105465239|NCT00790842|363716168|FG009|Dose Level 4|Withdrawal by Subject|0|||
105465240|NCT00790842|363716169|FG010|Dose Level 4|Withdrawal by Subject|1|||
105465241|NCT00790842|363716159|FG000|Expansion Cohort|Adverse Event|0|||
105465242|NCT00790842|363716160|FG001|Expansion Cohort|Adverse Event|0|||
105465243|NCT00790842|363716161|FG002|Expansion Cohort|Adverse Event|0|||
105465244|NCT00790842|363716162|FG003|Expansion Cohort|Adverse Event|0|||
105465245|NCT00790842|363716163|FG004|Expansion Cohort|Adverse Event|0|||
105465246|NCT00790842|363716164|FG005|Expansion Cohort|Adverse Event|0|||
105465247|NCT00790842|363716165|FG006|Expansion Cohort|Adverse Event|1|||
105465248|NCT00790842|363716166|FG007|Expansion Cohort|Adverse Event|0|||
105465249|NCT00790842|363716167|FG008|Expansion Cohort|Adverse Event|0|||
105465250|NCT00790842|363716168|FG009|Expansion Cohort|Adverse Event|0|||
105465251|NCT00790842|363716169|FG010|Expansion Cohort|Adverse Event|0|||
105465252|NCT00790842|363716159|FG000|Expansion Cohort|Death|0|||
105465253|NCT00790842|363716160|FG001|Expansion Cohort|Death|0|||
105465254|NCT00790842|363716161|FG002|Expansion Cohort|Death|2|||
105465255|NCT00790842|363716162|FG003|Expansion Cohort|Death|0|||
105465256|NCT00790842|363716163|FG004|Expansion Cohort|Death|0|||
105465257|NCT00790842|363716164|FG005|Expansion Cohort|Death|0|||
105465258|NCT00790842|363716165|FG006|Expansion Cohort|Death|0|||
105465259|NCT00790842|363716166|FG007|Expansion Cohort|Death|0|||
105465260|NCT00790842|363716167|FG008|Expansion Cohort|Death|0|||
105465261|NCT00790842|363716168|FG009|Expansion Cohort|Death|0|||
105465262|NCT00790842|363716169|FG010|Expansion Cohort|Death|0|||
105465263|NCT00790842|363716159|FG000|Expansion Cohort|Physician Decision|0|||
105465264|NCT00790842|363716160|FG001|Expansion Cohort|Physician Decision|0|||
105465265|NCT00790842|363716161|FG002|Expansion Cohort|Physician Decision|1|||
105465266|NCT00790842|363716162|FG003|Expansion Cohort|Physician Decision|0|||
105465267|NCT00790842|363716163|FG004|Expansion Cohort|Physician Decision|0|||
105465268|NCT00790842|363716164|FG005|Expansion Cohort|Physician Decision|0|||
105465269|NCT00790842|363716165|FG006|Expansion Cohort|Physician Decision|0|||
105465270|NCT00790842|363716166|FG007|Expansion Cohort|Physician Decision|0|||
105465271|NCT00790842|363716167|FG008|Expansion Cohort|Physician Decision|0|||
105465272|NCT00790842|363716168|FG009|Expansion Cohort|Physician Decision|0|||
105465273|NCT00790842|363716169|FG010|Expansion Cohort|Physician Decision|0|||
105465274|NCT00790842|363716159|FG000|Expansion Cohort|Withdrawal by Subject|0|||
105465275|NCT00790842|363716160|FG001|Expansion Cohort|Withdrawal by Subject|0|||
105465276|NCT00790842|363716161|FG002|Expansion Cohort|Withdrawal by Subject|3|||
105465277|NCT00790842|363716162|FG003|Expansion Cohort|Withdrawal by Subject|0|||
105465278|NCT00790842|363716163|FG004|Expansion Cohort|Withdrawal by Subject|0|||
105553349|NCT00476476|364023370|FG000|Overall Study|Progressive Disease|0|||
105465279|NCT00790842|363716164|FG005|Expansion Cohort|Withdrawal by Subject|0|||
105465280|NCT00790842|363716165|FG006|Expansion Cohort|Withdrawal by Subject|0|||
105465281|NCT00790842|363716166|FG007|Expansion Cohort|Withdrawal by Subject|0|||
105465282|NCT00790842|363716167|FG008|Expansion Cohort|Withdrawal by Subject|0|||
105465283|NCT00790842|363716168|FG009|Expansion Cohort|Withdrawal by Subject|0|||
105465284|NCT00790842|363716169|FG010|Expansion Cohort|Withdrawal by Subject|0|||
105465285|NCT00790842|363716159|FG000|Expansion Cohort|Study Closure|0|||
105465286|NCT00790842|363716160|FG001|Expansion Cohort|Study Closure|0|||
105465287|NCT00790842|363716161|FG002|Expansion Cohort|Study Closure|1|||
105465288|NCT00790842|363716162|FG003|Expansion Cohort|Study Closure|0|||
105465289|NCT00790842|363716163|FG004|Expansion Cohort|Study Closure|0|||
105465290|NCT00790842|363716164|FG005|Expansion Cohort|Study Closure|0|||
105465291|NCT00790842|363716165|FG006|Expansion Cohort|Study Closure|0|||
105465292|NCT00790842|363716166|FG007|Expansion Cohort|Study Closure|0|||
105465293|NCT00790842|363716167|FG008|Expansion Cohort|Study Closure|0|||
105465294|NCT00790842|363716168|FG009|Expansion Cohort|Study Closure|0|||
105465295|NCT00790842|363716169|FG010|Expansion Cohort|Study Closure|0|||
105465296|NCT03809104|363716170|FG000|Overall Study|Withdrawal by Subject|3|||
105465297|NCT00561925|363716171|FG000|14 Day Lead-In Period|Adverse Event|38|||
105465298|NCT00561925|363716172|FG001|14 Day Lead-In Period|Adverse Event|0|||
105465299|NCT00561925|363716173|FG002|14 Day Lead-In Period|Adverse Event|0|||
105465300|NCT00561925|363716174|FG003|14 Day Lead-In Period|Adverse Event|0|||
105465301|NCT00561925|363716175|FG004|14 Day Lead-In Period|Adverse Event|0|||
105465302|NCT00561925|363716171|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
105465303|NCT00561925|363716172|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
105465304|NCT00561925|363716173|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
105465305|NCT00561925|363716174|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
105465306|NCT00561925|363716175|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
105465307|NCT00561925|363716171|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
105465308|NCT00561925|363716172|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
105465309|NCT00561925|363716173|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
105465310|NCT00561925|363716174|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
105465311|NCT00561925|363716175|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
105465312|NCT00561925|363716171|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
105465313|NCT00561925|363716172|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
105465314|NCT00561925|363716173|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
105465315|NCT00561925|363716174|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
105465316|NCT00561925|363716175|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
105465317|NCT00561925|363716171|FG000|14 Day Lead-In Period|Other|5|||
105465318|NCT00561925|363716172|FG001|14 Day Lead-In Period|Other|0|||
105465319|NCT00561925|363716173|FG002|14 Day Lead-In Period|Other|0|||
105465320|NCT00561925|363716174|FG003|14 Day Lead-In Period|Other|0|||
105465321|NCT00561925|363716175|FG004|14 Day Lead-In Period|Other|0|||
105341082|NCT02487771|363249924|FG000|Overall Study|Moved out of area|5|||
105341083|NCT02487771|363249925|FG001|Overall Study|Moved out of area|6|||
105341084|NCT02487771|363249924|FG000|Overall Study|Withdrawal by Subject|3|||
105341085|NCT02487771|363249925|FG001|Overall Study|Withdrawal by Subject|5|||
105341086|NCT00381238|363249926|FG000|Overall Study|Adverse Event|3|||
105341087|NCT00381238|363249926|FG000|Overall Study|Protocol Violation|1|||
105341088|NCT00381238|363249926|FG000|Overall Study|Withdrawal by Subject|4|||
105341089|NCT00381238|363249926|FG000|Overall Study|Lack of Efficacy|2|||
105341090|NCT00381238|363249926|FG000|Overall Study|Withdrew by physician|1|||
105341091|NCT00381238|363249926|FG000|Overall Study|Disease progression|1|||
105341092|NCT02637895|363249929|FG000|Overall Study|Lost to Follow-up|4|||
105341093|NCT02637895|363249930|FG001|Overall Study|Lost to Follow-up|0|||
105341094|NCT02637895|363249929|FG000|Overall Study|Protocol Violation|0|||
105341095|NCT02637895|363249930|FG001|Overall Study|Protocol Violation|1|||
105341096|NCT02637895|363249929|FG000|Overall Study|Lack of Efficacy|1|||
105341097|NCT02637895|363249930|FG001|Overall Study|Lack of Efficacy|0|||
105341098|NCT02637895|363249929|FG000|Overall Study|Withdrawal by Subject|1|||
105341099|NCT02637895|363249930|FG001|Overall Study|Withdrawal by Subject|1|||
105341100|NCT02637895|363249929|FG000|Overall Study|Abnormal baseline lab|0|||
105341101|NCT02637895|363249930|FG001|Overall Study|Abnormal baseline lab|1|||
105341102|NCT00425061|363249931|FG000|Overall Study|Adverse Event|1|||
105341103|NCT00425061|363249932|FG001|Overall Study|Adverse Event|0|||
105341104|NCT00425061|363249933|FG002|Overall Study|Adverse Event|0|||
105341105|NCT00425061|363249934|FG003|Overall Study|Adverse Event|2|||
105341106|NCT00425061|363249935|FG004|Overall Study|Adverse Event|2|||
105341107|NCT00425061|363249936|FG005|Overall Study|Adverse Event|0|||
105341108|NCT00425061|363249937|FG006|Overall Study|Adverse Event|0|||
105341109|NCT00425061|363249931|FG000|Overall Study|Lost to Follow-up|0|||
105341110|NCT00425061|363249932|FG001|Overall Study|Lost to Follow-up|1|||
105341111|NCT00425061|363249933|FG002|Overall Study|Lost to Follow-up|0|||
105341112|NCT00425061|363249934|FG003|Overall Study|Lost to Follow-up|0|||
105341113|NCT00425061|363249935|FG004|Overall Study|Lost to Follow-up|0|||
105341114|NCT00425061|363249936|FG005|Overall Study|Lost to Follow-up|0|||
105341115|NCT00425061|363249937|FG006|Overall Study|Lost to Follow-up|0|||
105341116|NCT00425061|363249931|FG000|Overall Study|Protocol Violation|1|||
105341117|NCT00425061|363249932|FG001|Overall Study|Protocol Violation|0|||
105465322|NCT00561925|363716171|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
105341118|NCT00425061|363249933|FG002|Overall Study|Protocol Violation|0|||
105341119|NCT00425061|363249934|FG003|Overall Study|Protocol Violation|0|||
105341120|NCT00425061|363249935|FG004|Overall Study|Protocol Violation|0|||
105341121|NCT00425061|363249936|FG005|Overall Study|Protocol Violation|0|||
105465323|NCT00561925|363716172|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
105465324|NCT00561925|363716173|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
105465325|NCT00561925|363716174|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
105465326|NCT00561925|363716175|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
105465327|NCT00561925|363716171|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
105465328|NCT00561925|363716172|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
105465329|NCT00561925|363716173|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
105465330|NCT00561925|363716174|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
105465331|NCT00561925|363716175|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
105465332|NCT00561925|363716171|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
105465333|NCT00561925|363716172|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
105465334|NCT00561925|363716173|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
105553350|NCT00476476|364023371|FG001|Overall Study|Progressive Disease|17|||
105667985|NCT00477490|364448235|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
105667986|NCT00477490|364448236|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
105667987|NCT00477490|364448237|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
105667988|NCT00477490|364448238|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
105667989|NCT00477490|364448239|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
105341122|NCT00425061|363249937|FG006|Overall Study|Protocol Violation|0|||
105667990|NCT00477490|364448240|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
105667991|NCT00477490|364448241|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
105667992|NCT00477490|364448242|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
105667993|NCT00477490|364448234|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105667994|NCT00477490|364448235|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
105667995|NCT00477490|364448236|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105667996|NCT00477490|364448237|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105667997|NCT00477490|364448238|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105667998|NCT00477490|364448239|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105667999|NCT00477490|364448240|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105668000|NCT00477490|364448241|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105668001|NCT00477490|364448242|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105668002|NCT00477490|364448234|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
105668003|NCT00477490|364448235|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
105668004|NCT00477490|364448236|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
105668005|NCT00477490|364448237|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
105668006|NCT00477490|364448238|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
105668007|NCT00477490|364448239|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
105668008|NCT00477490|364448240|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
105668009|NCT00477490|364448241|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
105668010|NCT00477490|364448242|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
105668011|NCT00477490|364448234|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
105668012|NCT00477490|364448235|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
105668013|NCT00477490|364448236|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
105668014|NCT00477490|364448237|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
105668015|NCT00477490|364448238|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
105668016|NCT00477490|364448239|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
105668017|NCT00477490|364448240|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
105668018|NCT00477490|364448241|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
105668019|NCT00477490|364448242|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
105668020|NCT03274895|364448243|FG000|Overall Study|Lack of Efficacy|1|||
105668021|NCT03274895|364448244|FG001|Overall Study|Lack of Efficacy|0|||
105668022|NCT03274895|364448243|FG000|Overall Study|Adverse Event|8|||
105668023|NCT03274895|364448244|FG001|Overall Study|Adverse Event|7|||
105668024|NCT03274895|364448243|FG000|Overall Study|Lost to Follow-up|1|||
105668025|NCT03274895|364448244|FG001|Overall Study|Lost to Follow-up|0|||
105668026|NCT03274895|364448243|FG000|Overall Study|Diagnosis not confirmed|3|||
105668027|NCT03274895|364448244|FG001|Overall Study|Diagnosis not confirmed|4|||
105668028|NCT00401258|364448248|FG000|Overall Study|Adverse Event|7|||
105668029|NCT01110408|364448249|FG000|Overall Study|Protocol Violation|1|||
105668030|NCT01110408|364448250|FG001|Overall Study|Protocol Violation|0|||
105668031|NCT02269423|364448254|FG000|Overall Study|Discontinued due to change in residence|0|||
105668032|NCT02269423|364448255|FG001|Overall Study|Discontinued due to change in residence|1|||
105668033|NCT02269423|364448256|FG002|Overall Study|Discontinued due to change in residence|0|||
105668034|NCT02269423|364448257|FG003|Overall Study|Discontinued due to change in residence|1|||
105668035|NCT00604708|364448258|FG000|Overall Study|Withdrawal by Subject|9|||
105668036|NCT00604708|364448259|FG001|Overall Study|Withdrawal by Subject|10|||
105668037|NCT00604708|364448258|FG000|Overall Study|Protocol Violation|2|||
105668038|NCT00604708|364448259|FG001|Overall Study|Protocol Violation|8|||
105668039|NCT00604708|364448258|FG000|Overall Study|Lost to Follow-up|5|||
105668040|NCT00604708|364448259|FG001|Overall Study|Lost to Follow-up|5|||
105668041|NCT00604708|364448258|FG000|Overall Study|administrative reasons|9|||
105668042|NCT00604708|364448259|FG001|Overall Study|administrative reasons|11|||
105668043|NCT00604708|364448258|FG000|Overall Study|Adverse Event|6|||
105668044|NCT00604708|364448259|FG001|Overall Study|Adverse Event|6|||
105668045|NCT02284009|364448262|FG000|Overall Study|Adverse Event|3|||
105668046|NCT02284009|364448263|FG001|Overall Study|Adverse Event|0|||
105668047|NCT02284009|364448262|FG000|Overall Study|Lost to Follow-up|1|||
105668048|NCT02284009|364448263|FG001|Overall Study|Lost to Follow-up|3|||
105668049|NCT02284009|364448262|FG000|Overall Study|Physician Decision|0|||
105668050|NCT02284009|364448263|FG001|Overall Study|Physician Decision|2|||
105668051|NCT02284009|364448262|FG000|Overall Study|Withdrawal by Subject|2|||
105668052|NCT02284009|364448263|FG001|Overall Study|Withdrawal by Subject|5|||
105668053|NCT04147195|364448264|FG000|Overall Study|Adverse Event|0|||
105668054|NCT04147195|364448265|FG001|Overall Study|Adverse Event|3|||
105668055|NCT04147195|364448264|FG000|Overall Study|Study Terminated by Sponsor|4|||
105668056|NCT04147195|364448265|FG001|Overall Study|Study Terminated by Sponsor|2|||
105668057|NCT04147195|364448264|FG000|Overall Study|Withdrawal by Subject|0|||
105668058|NCT04147195|364448265|FG001|Overall Study|Withdrawal by Subject|1|||
105553351|NCT01026974|364023372|FG000|Overall Study|Withdrawal by Subject|0|||
105553352|NCT01026974|364023373|FG001|Overall Study|Withdrawal by Subject|1|||
105341123|NCT00425061|363249931|FG000|Overall Study|Withdrawal by Subject|0|||
105341124|NCT00425061|363249932|FG001|Overall Study|Withdrawal by Subject|1|||
105553353|NCT01026974|364023374|FG002|Overall Study|Withdrawal by Subject|7|||
105668059|NCT03238963|364448266|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
105553354|NCT01026974|364023375|FG003|Overall Study|Withdrawal by Subject|2|||
105553355|NCT01026974|364023372|FG000|Overall Study|Lost to Follow-up|1|||
105553356|NCT01026974|364023373|FG001|Overall Study|Lost to Follow-up|1|||
105553357|NCT01026974|364023374|FG002|Overall Study|Lost to Follow-up|4|||
105553358|NCT01026974|364023375|FG003|Overall Study|Lost to Follow-up|0|||
105553359|NCT01026974|364023372|FG000|Overall Study|Adverse Event|0|||
105553360|NCT01026974|364023373|FG001|Overall Study|Adverse Event|0|||
105553361|NCT01026974|364023374|FG002|Overall Study|Adverse Event|0|||
105553362|NCT01026974|364023375|FG003|Overall Study|Adverse Event|1|||
105553363|NCT01026974|364023372|FG000|Overall Study|Inappropriate enrollment|0|||
105553364|NCT01026974|364023373|FG001|Overall Study|Inappropriate enrollment|0|||
105553365|NCT01026974|364023374|FG002|Overall Study|Inappropriate enrollment|1|||
105553366|NCT01026974|364023375|FG003|Overall Study|Inappropriate enrollment|0|||
105553367|NCT03043664|364023376|FG000|Overall Study|Lost to Follow-up|1|||
105553368|NCT00971048|364023377|FG000|Overall Study|Protocol Violation|1|||
105553369|NCT00971048|364023378|FG001|Overall Study|Protocol Violation|2|||
105553370|NCT00971048|364023379|FG002|Overall Study|Protocol Violation|0|||
105553371|NCT00971048|364023380|FG003|Overall Study|Protocol Violation|1|||
105341125|NCT00425061|363249933|FG002|Overall Study|Withdrawal by Subject|0|||
105341126|NCT00425061|363249934|FG003|Overall Study|Withdrawal by Subject|0|||
105341127|NCT00425061|363249935|FG004|Overall Study|Withdrawal by Subject|1|||
105341128|NCT00425061|363249936|FG005|Overall Study|Withdrawal by Subject|0|||
105341129|NCT00425061|363249937|FG006|Overall Study|Withdrawal by Subject|3|||
105341130|NCT00425061|363249931|FG000|Overall Study|Sponsor's request|0|||
105341131|NCT00425061|363249932|FG001|Overall Study|Sponsor's request|0|||
105341132|NCT00425061|363249933|FG002|Overall Study|Sponsor's request|0|||
105341133|NCT00425061|363249934|FG003|Overall Study|Sponsor's request|0|||
105341134|NCT00425061|363249935|FG004|Overall Study|Sponsor's request|19|||
105341135|NCT00425061|363249936|FG005|Overall Study|Sponsor's request|4|||
105341136|NCT00425061|363249937|FG006|Overall Study|Sponsor's request|15|||
105341137|NCT00425061|363249931|FG000|Overall Study|Physician Decision|0|||
105341138|NCT00425061|363249932|FG001|Overall Study|Physician Decision|0|||
105341139|NCT00425061|363249933|FG002|Overall Study|Physician Decision|0|||
105341140|NCT00425061|363249934|FG003|Overall Study|Physician Decision|0|||
105341141|NCT00425061|363249935|FG004|Overall Study|Physician Decision|1|||
105341142|NCT00425061|363249936|FG005|Overall Study|Physician Decision|0|||
105341143|NCT00425061|363249937|FG006|Overall Study|Physician Decision|0|||
105341144|NCT00425061|363249931|FG000|Overall Study|Other|0|||
105341145|NCT00425061|363249932|FG001|Overall Study|Other|0|||
105341146|NCT00425061|363249933|FG002|Overall Study|Other|0|||
105341147|NCT00425061|363249934|FG003|Overall Study|Other|0|||
105341148|NCT00425061|363249935|FG004|Overall Study|Other|3|||
105341149|NCT00425061|363249936|FG005|Overall Study|Other|0|||
105341150|NCT00425061|363249937|FG006|Overall Study|Other|1|||
105341151|NCT03085238|363249938|FG000|Overall Study|Adverse Event|2|||
105341152|NCT03085238|363249938|FG000|Overall Study|Death|2|||
105341153|NCT00680901|363249939|FG000|Overall Study|Lost to Follow-up|8|||
105341154|NCT00680901|363249940|FG001|Overall Study|Lost to Follow-up|8|||
105341155|NCT00680901|363249939|FG000|Overall Study|Withdrawal by Subject|4|||
105341156|NCT00680901|363249940|FG001|Overall Study|Withdrawal by Subject|13|||
105341157|NCT00680901|363249939|FG000|Overall Study|Physician Decision|0|||
105341158|NCT00680901|363249940|FG001|Overall Study|Physician Decision|1|||
105341159|NCT00680901|363249939|FG000|Overall Study|Ongoing: On Study Treatment|16|||
105341160|NCT00680901|363249940|FG001|Overall Study|Ongoing: On Study Treatment|13|||
105341161|NCT00680901|363249939|FG000|Overall Study|Ongoing: In Follow Up|45|||
105341162|NCT00680901|363249940|FG001|Overall Study|Ongoing: In Follow Up|41|||
105341163|NCT03164564|363249943|FG000|Overall Study|Death|3|||
105341164|NCT03164564|363249944|FG001|Overall Study|Death|0|||
105341165|NCT03164564|363249943|FG000|Overall Study|Withdrawal by Subject|20|||
105341166|NCT03164564|363249944|FG001|Overall Study|Withdrawal by Subject|15|||
105341167|NCT03164564|363249943|FG000|Overall Study|Lost to Follow-up|2|||
105341168|NCT03164564|363249944|FG001|Overall Study|Lost to Follow-up|0|||
105341169|NCT03164564|363249943|FG000|Overall Study|Physician Decision|0|||
105341170|NCT03164564|363249944|FG001|Overall Study|Physician Decision|1|||
105341171|NCT03164564|363249943|FG000|Overall Study|Adverse Event|0|||
105341172|NCT03164564|363249944|FG001|Overall Study|Adverse Event|1|||
105341173|NCT03164564|363249943|FG000|Overall Study|Ongoing|1586|||
105341174|NCT03164564|363249944|FG001|Overall Study|Ongoing|1586|||
105341175|NCT04507256|363249948|FG000|Overall Study|Withdrawal by Subject|1|||
105341176|NCT04507256|363249949|FG001|Overall Study|Withdrawal by Subject|0|||
105341177|NCT04507256|363249950|FG002|Overall Study|Withdrawal by Subject|0|||
105341178|NCT04507256|363249951|FG003|Overall Study|Withdrawal by Subject|1|||
105341179|NCT04507256|363249952|FG004|Overall Study|Withdrawal by Subject|0|||
105341180|NCT04507256|363249953|FG005|Overall Study|Withdrawal by Subject|0|||
105341181|NCT02822573|363249964|FG000|Overall Study|Lost to Follow-up|5|||
105341182|NCT02822573|363249965|FG001|Overall Study|Lost to Follow-up|3|||
105341183|NCT02822573|363249964|FG000|Overall Study|Physician Decision|1|||
105341184|NCT02822573|363249965|FG001|Overall Study|Physician Decision|1|||
105341185|NCT02822573|363249964|FG000|Overall Study|Withdrawal by Subject|9|||
105341186|NCT02822573|363249965|FG001|Overall Study|Withdrawal by Subject|5|||
105341187|NCT02822573|363249964|FG000|Overall Study|Protocol Violation|6|||
105341188|NCT02822573|363249965|FG001|Overall Study|Protocol Violation|4|||
105341189|NCT02822573|363249964|FG000|Overall Study|Too sick or ill|2|||
105341190|NCT02822573|363249965|FG001|Overall Study|Too sick or ill|1|||
105341191|NCT02822573|363249964|FG000|Overall Study|Disease Progression|1|||
105341192|NCT02822573|363249965|FG001|Overall Study|Disease Progression|1|||
105341193|NCT02822573|363249964|FG000|Overall Study|No reason given|6|||
105341194|NCT02822573|363249965|FG001|Overall Study|No reason given|4|||
105341195|NCT00738881|363249966|FG000|Overall Study|Withdrawal by Subject|0|||
105341196|NCT00738881|363249967|FG001|Overall Study|Withdrawal by Subject|2|||
105341197|NCT02347891|363249970|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
105341198|NCT02347891|363249971|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
105341199|NCT02347891|363249970|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
105341200|NCT02347891|363249971|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
105341201|NCT05845567|363249972|FG000|Overall Study|Withdrawal by Subject|1|||
105341202|NCT02541669|363249978|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
105341203|NCT02541669|363249979|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
105341204|NCT02541669|363249980|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
105341205|NCT02541669|363249981|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
105341206|NCT02541669|363249982|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
105341207|NCT01154088|363249983|FG000|Overall Study|Lost to Follow-up|4|||
105341208|NCT01154088|363249984|FG001|Overall Study|Lost to Follow-up|6|||
105341209|NCT01154088|363249985|FG002|Overall Study|Lost to Follow-up|7|||
105341210|NCT02122770|363249987|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
105341211|NCT02122770|363249988|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
105341212|NCT02122770|363249989|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
105341213|NCT02122770|363249990|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
105341214|NCT02122770|363249991|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
105341215|NCT02122770|363249992|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
105341216|NCT02122770|363249987|FG000|Part A: Drug-drug Interaction 2|Other|0|||
105341217|NCT02122770|363249988|FG001|Part A: Drug-drug Interaction 2|Other|0|||
105341218|NCT02122770|363249989|FG002|Part A: Drug-drug Interaction 2|Other|1|||
105341219|NCT02122770|363249990|FG003|Part A: Drug-drug Interaction 2|Other|0|||
105341220|NCT02122770|363249991|FG004|Part A: Drug-drug Interaction 2|Other|0|||
105341221|NCT02122770|363249992|FG005|Part A: Drug-drug Interaction 2|Other|0|||
105341222|NCT02122770|363249987|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
105341223|NCT02122770|363249988|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
105341224|NCT02122770|363249989|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
105341225|NCT02122770|363249990|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
105341226|NCT02122770|363249991|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
105341227|NCT02122770|363249992|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
105668060|NCT03238963|364448267|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
105668061|NCT03238963|364448266|FG000|Overall Study|Withdrawal by Subject|1|||
105668062|NCT03238963|364448267|FG001|Overall Study|Withdrawal by Subject|1|||
105668063|NCT03238963|364448266|FG000|Overall Study|Lost to Follow-up|1|||
105341228|NCT02122770|363249987|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
105668064|NCT03238963|364448267|FG001|Overall Study|Lost to Follow-up|0|||
105668065|NCT03238963|364448266|FG000|Overall Study|Protocol Violation|1|||
105465335|NCT00561925|363716174|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
105465336|NCT00561925|363716175|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
105465337|NCT00561925|363716171|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
105465338|NCT00561925|363716172|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
105465339|NCT00561925|363716173|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
105465340|NCT00561925|363716174|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
105465341|NCT00561925|363716175|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
105465342|NCT00561925|363716171|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
105465343|NCT00561925|363716172|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
105465344|NCT00561925|363716173|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
105465345|NCT00561925|363716174|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
105465346|NCT00561925|363716175|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
105465347|NCT00561925|363716171|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
105465348|NCT00561925|363716172|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
105465349|NCT00561925|363716173|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
105465350|NCT00561925|363716174|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
105465351|NCT00561925|363716175|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
105465352|NCT00561925|363716171|FG000|144-week Double-blind, Double-dummy|Death|0|||
105465353|NCT00561925|363716172|FG001|144-week Double-blind, Double-dummy|Death|6|||
105465354|NCT00561925|363716173|FG002|144-week Double-blind, Double-dummy|Death|3|||
105465355|NCT00561925|363716174|FG003|144-week Double-blind, Double-dummy|Death|0|||
105465356|NCT00561925|363716175|FG004|144-week Double-blind, Double-dummy|Death|0|||
105465357|NCT00561925|363716171|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
105465358|NCT00561925|363716172|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
105465359|NCT00561925|363716173|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
105465360|NCT00561925|363716174|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
105465361|NCT00561925|363716175|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
105465362|NCT00561925|363716171|FG000|144-week Double-blind, Double-dummy|Other|0|||
105465363|NCT00561925|363716172|FG001|144-week Double-blind, Double-dummy|Other|8|||
105465364|NCT00561925|363716173|FG002|144-week Double-blind, Double-dummy|Other|11|||
105465365|NCT00561925|363716174|FG003|144-week Double-blind, Double-dummy|Other|0|||
105465366|NCT00561925|363716175|FG004|144-week Double-blind, Double-dummy|Other|0|||
105465367|NCT00561925|363716171|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
105465368|NCT00561925|363716172|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
105465369|NCT00561925|363716173|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
105465370|NCT00561925|363716174|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
105465371|NCT00561925|363716175|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
105465372|NCT00891904|363716178|FG000|Overall Study|Death|1|||
105465373|NCT00891904|363716178|FG000|Overall Study|Adverse Event|1|||
105465374|NCT00907335|363716179|FG000|Overall Study|Withdrawal by Subject|2|||
105465375|NCT00907335|363716180|FG001|Overall Study|Withdrawal by Subject|0|||
105465376|NCT00907335|363716179|FG000|Overall Study|Adverse Event|4|||
105465377|NCT00907335|363716180|FG001|Overall Study|Adverse Event|1|||
105465378|NCT00907335|363716179|FG000|Overall Study|Lost to Follow-up|2|||
105465379|NCT00907335|363716180|FG001|Overall Study|Lost to Follow-up|0|||
105465380|NCT03096288|363716183|FG000|Overall Study|Withdrawal by Subject|0|||
105465381|NCT03096288|363716184|FG001|Overall Study|Withdrawal by Subject|1|||
105465382|NCT03096288|363716185|FG002|Overall Study|Withdrawal by Subject|0|||
105465383|NCT03096288|363716186|FG003|Overall Study|Withdrawal by Subject|1|||
105465384|NCT01411891|363716187|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
105465385|NCT01411891|363716188|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
105465386|NCT00930046|363716189|FG000|Overall Study|Wound catheter malfunctioned|1|||
105465387|NCT00930046|363716190|FG001|Overall Study|Wound catheter malfunctioned|2|||
105465388|NCT04004988|363716191|FG000|Period 1|Physician Decision|2|||
105465389|NCT04004988|363716192|FG001|Period 1|Physician Decision|0|||
105465390|NCT04004988|363716191|FG000|Period 1|Withdrawal by Subject|0|||
105465391|NCT04004988|363716192|FG001|Period 1|Withdrawal by Subject|1|||
105465392|NCT04004988|363716191|FG000|Period 1|Adverse Event|1|||
105465393|NCT04004988|363716192|FG001|Period 1|Adverse Event|2|||
105465394|NCT01598532|363716193|FG000|Overall Study|Lost to Follow-up|3|||
105465395|NCT01598532|363716193|FG000|Overall Study|Did not meet inclusion criteria|8|||
105465396|NCT00414596|363716194|FG000|Overall Study|Protocol Violation|2|||
105465397|NCT02900378|363716203|FG000|Randomization (Visit 2)|Adverse Event|14|||
105465398|NCT02900378|363716204|FG001|Randomization (Visit 2)|Adverse Event|11|||
105465399|NCT02900378|363716203|FG000|Randomization (Visit 2)|Death|1|||
105465400|NCT02900378|363716204|FG001|Randomization (Visit 2)|Death|4|||
105465401|NCT02900378|363716203|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
105465402|NCT02900378|363716204|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
105465403|NCT02900378|363716203|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
105465404|NCT02900378|363716204|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
105465405|NCT02900378|363716203|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
105465406|NCT02900378|363716204|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
105668066|NCT03238963|364448267|FG001|Overall Study|Protocol Violation|1|||
105668067|NCT03238963|364448266|FG000|Overall Study|Adverse Event|1|||
105668068|NCT03238963|364448267|FG001|Overall Study|Adverse Event|0|||
105341229|NCT02122770|363249988|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
105465407|NCT02900378|363716203|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
105465408|NCT02900378|363716204|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
105465409|NCT02900378|363716203|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
105465410|NCT02900378|363716204|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
105465411|NCT00297258|363716205|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
105465412|NCT00297258|363716205|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
105465413|NCT00297258|363716205|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
105465414|NCT00297258|363716205|FG000|Overall Study|Intercurrent Illness|3|||
105465415|NCT00297258|363716205|FG000|Overall Study|Intercurrent Death|2|||
105465416|NCT00297258|363716205|FG000|Overall Study|Deteriorization of General Condition|1|||
105465417|NCT00297258|363716205|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
105465418|NCT00297258|363716205|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
105465419|NCT00297258|363716205|FG000|Overall Study|Switch to Commercial Treatment|1|||
105465420|NCT00297258|363716205|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
105465421|NCT02819804|363716211|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
105465422|NCT00482053|363716215|FG000|Inter-treatment Period|Disease progression|1|||
105465423|NCT03131570|363716219|FG000|Overall Study|Adverse Event|1|||
105465424|NCT03131570|363716220|FG001|Overall Study|Adverse Event|0|||
105465425|NCT01782378|363716221|FG000|First Series|Lost to Follow-up|7|||
105465426|NCT01782378|363716222|FG001|First Series|Lost to Follow-up|8|||
105465427|NCT01782378|363716221|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
105465428|NCT01782378|363716222|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
105465429|NCT01782378|363716221|FG000|Second Series|Lost to Follow-up|8|||
105465430|NCT01782378|363716222|FG001|Second Series|Lost to Follow-up|7|||
105465431|NCT01782378|363716221|FG000|Second Series|Did not choose to complete S2 Optional|18|||
105465432|NCT01782378|363716222|FG001|Second Series|Did not choose to complete S2 Optional|0|||
105465433|NCT03023397|363716223|FG000|Run-In|Failed screening allergen challenge|1|||
105465434|NCT03023397|363716224|FG001|Run-In|Failed screening allergen challenge|0|||
105465435|NCT03023397|363716225|FG002|Run-In|Failed screening allergen challenge|0|||
105465436|NCT03023397|363716223|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
105465437|NCT03023397|363716224|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
105465438|NCT03023397|363716225|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
105465439|NCT01656408|363716226|FG000|Overall Study|Adverse Event|0|||
105465440|NCT01656408|363716227|FG001|Overall Study|Adverse Event|0|||
105465441|NCT01656408|363716228|FG002|Overall Study|Adverse Event|1|||
105465442|NCT01656408|363716229|FG003|Overall Study|Adverse Event|0|||
105465443|NCT01656408|363716230|FG004|Overall Study|Adverse Event|0|||
105465444|NCT01656408|363716231|FG005|Overall Study|Adverse Event|1|||
105465445|NCT01656408|363716232|FG006|Overall Study|Adverse Event|1|||
105465446|NCT01656408|363716233|FG007|Overall Study|Adverse Event|0|||
105465447|NCT01656408|363716234|FG008|Overall Study|Adverse Event|1|||
105465448|NCT01656408|363716235|FG009|Overall Study|Adverse Event|0|||
105465449|NCT01656408|363716226|FG000|Overall Study|Physician Decision|1|||
105465450|NCT01656408|363716227|FG001|Overall Study|Physician Decision|0|||
105465451|NCT01656408|363716228|FG002|Overall Study|Physician Decision|1|||
105465452|NCT01656408|363716229|FG003|Overall Study|Physician Decision|0|||
105465453|NCT01656408|363716230|FG004|Overall Study|Physician Decision|1|||
105465454|NCT01656408|363716231|FG005|Overall Study|Physician Decision|1|||
105465455|NCT01656408|363716232|FG006|Overall Study|Physician Decision|0|||
105465456|NCT01656408|363716233|FG007|Overall Study|Physician Decision|1|||
105465457|NCT01656408|363716234|FG008|Overall Study|Physician Decision|1|||
105465458|NCT01656408|363716235|FG009|Overall Study|Physician Decision|3|||
105465459|NCT05567783|363716236|FG000|Overall Study|Death|2|||
105465460|NCT05567783|363716237|FG001|Overall Study|Death|3|||
105465461|NCT05567783|363716238|FG002|Overall Study|Death|0|||
105465462|NCT05567783|363716236|FG000|Overall Study|Lost to Follow-up|25|||
105465463|NCT05567783|363716237|FG001|Overall Study|Lost to Follow-up|19|||
105465464|NCT05567783|363716238|FG002|Overall Study|Lost to Follow-up|17|||
105465465|NCT05567783|363716236|FG000|Overall Study|Physician Decision|10|||
105465466|NCT05567783|363716237|FG001|Overall Study|Physician Decision|7|||
105465467|NCT05567783|363716238|FG002|Overall Study|Physician Decision|9|||
105668069|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Adverse Event|10|||
105465468|NCT05567783|363716236|FG000|Overall Study|Study Terminated by Sponsor|924|||
105465469|NCT05567783|363716237|FG001|Overall Study|Study Terminated by Sponsor|937|||
105465470|NCT05567783|363716238|FG002|Overall Study|Study Terminated by Sponsor|941|||
105465471|NCT05567783|363716236|FG000|Overall Study|Withdrawal by Subject|23|||
105465472|NCT05567783|363716237|FG001|Overall Study|Withdrawal by Subject|27|||
105465473|NCT05567783|363716238|FG002|Overall Study|Withdrawal by Subject|24|||
105465474|NCT05567783|363716236|FG000|Overall Study|Incarcerated|1|||
105465475|NCT05567783|363716237|FG001|Overall Study|Incarcerated|0|||
105668070|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Adverse Event|9|||
105465476|NCT05567783|363716238|FG002|Overall Study|Incarcerated|0|||
105668071|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Adverse Event|7|||
105668072|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
105668073|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
105668074|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
105668075|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
105465477|NCT05567783|363716236|FG000|Overall Study|Participant randomized in error|4|||
105465478|NCT05567783|363716237|FG001|Overall Study|Participant randomized in error|2|||
105465479|NCT05567783|363716238|FG002|Overall Study|Participant randomized in error|2|||
105465480|NCT01457703|363716239|FG000|Overall Study|Screen Failure|5|||
105465481|NCT01457703|363716240|FG001|Overall Study|Screen Failure|7|||
105553372|NCT00971048|364023377|FG000|Overall Study|Adverse Event|0|||
105341230|NCT02122770|363249989|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
105341231|NCT02122770|363249990|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
105553373|NCT00971048|364023378|FG001|Overall Study|Adverse Event|0|||
105465482|NCT01457703|363716239|FG000|Overall Study|Withdrawal by Subject|1|||
105465483|NCT01457703|363716240|FG001|Overall Study|Withdrawal by Subject|4|||
105465484|NCT03278249|363716241|FG000|Overall Study|Withdrawal by Subject|2|||
105465485|NCT03278249|363716241|FG000|Overall Study|Lost to Follow-up|1|||
105465486|NCT03525678|363716243|FG000|Overall Study|Withdrawal by Subject|8|||
105465487|NCT03525678|363716244|FG001|Overall Study|Withdrawal by Subject|2|||
105465488|NCT03525678|363716245|FG002|Overall Study|Withdrawal by Subject|2|||
105465489|NCT03525678|363716243|FG000|Overall Study|Physician Decision|2|||
105465490|NCT03525678|363716244|FG001|Overall Study|Physician Decision|4|||
105465491|NCT03525678|363716245|FG002|Overall Study|Physician Decision|0|||
105465492|NCT03525678|363716243|FG000|Overall Study|Lost to Follow-up|2|||
105668076|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
105668077|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
105668078|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Physician Decision|7|||
105668079|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Physician Decision|3|||
105668080|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Physician Decision|2|||
105668081|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Pregnancy|2|||
105668082|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Pregnancy|1|||
105668083|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Pregnancy|3|||
105668084|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
105668085|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
105668086|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
105668087|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
105668088|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
105668089|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
105668090|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
105668091|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
105668092|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
105668093|NCT02614183|364448268|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
105668094|NCT02614183|364448269|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
105668095|NCT02614183|364448270|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
105668096|NCT02614183|364448268|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
105668097|NCT02614183|364448269|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
105668098|NCT02614183|364448270|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
105668099|NCT02614183|364448268|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
105668100|NCT02614183|364448269|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
105668101|NCT02614183|364448270|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
105668102|NCT02614183|364448268|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
105668103|NCT02614183|364448269|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
105668104|NCT02614183|364448270|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
105668105|NCT04949802|364450153|FG000|Overall Study|Lost to Follow-up|3|||
105668106|NCT01240551|364450154|FG000|Overall Study|Refused further treatment|3|||
105668107|NCT01240551|364450155|FG001|Overall Study|Refused further treatment|2|||
105668108|NCT01240551|364450154|FG000|Overall Study|Lost to Follow-up|1|||
105668109|NCT01240551|364450155|FG001|Overall Study|Lost to Follow-up|1|||
105668110|NCT00233480|364450156|FG000|Overall Study|Underwent status II heart transplant|0|||
105668111|NCT00233480|364450157|FG001|Overall Study|Underwent status II heart transplant|1|||
105668112|NCT01920477|364450158|FG000|Overall Study|Adverse Event|0|||
105668113|NCT01920477|364450159|FG001|Overall Study|Adverse Event|1|||
105668114|NCT01920477|364450158|FG000|Overall Study|Lack of Efficacy|1|||
105668115|NCT01920477|364450159|FG001|Overall Study|Lack of Efficacy|0|||
105668116|NCT01920477|364450158|FG000|Overall Study|Study closed/terminated|14|||
105668117|NCT01920477|364450159|FG001|Overall Study|Study closed/terminated|15|||
105668118|NCT01920477|364450158|FG000|Overall Study|Withdrawal by Subject|0|||
105668119|NCT01920477|364450159|FG001|Overall Study|Withdrawal by Subject|1|||
105668120|NCT01443403|364450160|FG000|Overall Study|Adverse Event|1|||
105668121|NCT01443403|364450161|FG001|Overall Study|Adverse Event|1|||
105668122|NCT01443403|364450162|FG002|Overall Study|Adverse Event|4|||
105668123|NCT01443403|364450163|FG003|Overall Study|Adverse Event|5|||
105668124|NCT01443403|364450160|FG000|Overall Study|Withdrawal by Subject|0|||
105668125|NCT01443403|364450161|FG001|Overall Study|Withdrawal by Subject|1|||
105668126|NCT01443403|364450162|FG002|Overall Study|Withdrawal by Subject|2|||
105668127|NCT01443403|364450163|FG003|Overall Study|Withdrawal by Subject|1|||
105668128|NCT01443403|364450160|FG000|Overall Study|Lost to Follow-up|0|||
105668129|NCT01443403|364450161|FG001|Overall Study|Lost to Follow-up|0|||
105668130|NCT01443403|364450162|FG002|Overall Study|Lost to Follow-up|0|||
105668131|NCT01443403|364450163|FG003|Overall Study|Lost to Follow-up|1|||
105668132|NCT01443403|364450160|FG000|Overall Study|Protocol Violation|2|||
105668133|NCT01443403|364450161|FG001|Overall Study|Protocol Violation|1|||
105668134|NCT01443403|364450162|FG002|Overall Study|Protocol Violation|1|||
105668135|NCT01443403|364450163|FG003|Overall Study|Protocol Violation|1|||
105668136|NCT01443403|364450160|FG000|Overall Study|Use of Prohibited Treatment|2|||
105668137|NCT01443403|364450161|FG001|Overall Study|Use of Prohibited Treatment|3|||
105668138|NCT01443403|364450162|FG002|Overall Study|Use of Prohibited Treatment|0|||
105668139|NCT01443403|364450163|FG003|Overall Study|Use of Prohibited Treatment|0|||
105668140|NCT01443403|364450160|FG000|Overall Study|Other - Miscellaneous|1|||
105668141|NCT01443403|364450161|FG001|Overall Study|Other - Miscellaneous|0|||
105668142|NCT01443403|364450162|FG002|Overall Study|Other - Miscellaneous|0|||
105465493|NCT03525678|363716244|FG001|Overall Study|Lost to Follow-up|1|||
105465494|NCT03525678|363716245|FG002|Overall Study|Lost to Follow-up|2|||
105465495|NCT03525678|363716243|FG000|Overall Study|Death|70|||
105465496|NCT03525678|363716244|FG001|Overall Study|Death|80|||
105465497|NCT03525678|363716245|FG002|Overall Study|Death|16|||
105465498|NCT03525678|363716243|FG000|Overall Study|other reasons|14|||
105465499|NCT03525678|363716244|FG001|Overall Study|other reasons|10|||
105465500|NCT03525678|363716245|FG002|Overall Study|other reasons|5|||
105465501|NCT03525678|363716243|FG000|Overall Study|ongoing at the time of analysis|1|||
105465502|NCT03525678|363716244|FG001|Overall Study|ongoing at the time of analysis|2|||
105465503|NCT03525678|363716245|FG002|Overall Study|ongoing at the time of analysis|0|||
105465504|NCT01177397|363717718|FG000|Overall Study|Protocol Violation|0|||
105465505|NCT01177397|363717719|FG001|Overall Study|Protocol Violation|0|||
105465506|NCT01177397|363717720|FG002|Overall Study|Protocol Violation|0|||
105465507|NCT01177397|363717721|FG003|Overall Study|Protocol Violation|0|||
105465508|NCT01177397|363717722|FG004|Overall Study|Protocol Violation|0|||
105465509|NCT01177397|363717723|FG005|Overall Study|Protocol Violation|1|||
105465510|NCT01177397|363717724|FG006|Overall Study|Protocol Violation|0|||
105465511|NCT01177397|363717725|FG007|Overall Study|Protocol Violation|0|||
105465512|NCT01177397|363717726|FG008|Overall Study|Protocol Violation|0|||
105465513|NCT01177397|363717727|FG009|Overall Study|Protocol Violation|0|||
105465514|NCT01177397|363717728|FG010|Overall Study|Protocol Violation|0|||
105465515|NCT01177397|363717729|FG011|Overall Study|Protocol Violation|0|||
105465516|NCT01177397|363717718|FG000|Overall Study|Lost to Follow-up|0|||
105465517|NCT01177397|363717719|FG001|Overall Study|Lost to Follow-up|0|||
105465518|NCT01177397|363717720|FG002|Overall Study|Lost to Follow-up|0|||
105465519|NCT01177397|363717721|FG003|Overall Study|Lost to Follow-up|0|||
105465520|NCT01177397|363717722|FG004|Overall Study|Lost to Follow-up|1|||
105465521|NCT01177397|363717723|FG005|Overall Study|Lost to Follow-up|0|||
105465522|NCT01177397|363717724|FG006|Overall Study|Lost to Follow-up|0|||
105465523|NCT01177397|363717725|FG007|Overall Study|Lost to Follow-up|2|||
105668143|NCT01443403|364450163|FG003|Overall Study|Other - Miscellaneous|1|||
105668144|NCT01681277|364450164|FG000|Overall Study|Adverse Event|1|||
105668145|NCT01681277|364450165|FG001|Overall Study|Adverse Event|0|||
105668146|NCT01681277|364450166|FG002|Overall Study|Adverse Event|0|||
105668147|NCT01681277|364450167|FG003|Overall Study|Adverse Event|0|||
105668148|NCT01681277|364450168|FG004|Overall Study|Adverse Event|0|||
105668149|NCT00474526|364450169|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
105668150|NCT00474526|364450170|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
105668151|NCT00474526|364450171|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
105668152|NCT00474526|364450172|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
105668153|NCT00474526|364450173|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
105668154|NCT00474526|364450174|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
105465524|NCT01177397|363717726|FG008|Overall Study|Lost to Follow-up|0|||
105465525|NCT01177397|363717727|FG009|Overall Study|Lost to Follow-up|0|||
105465526|NCT01177397|363717728|FG010|Overall Study|Lost to Follow-up|0|||
105465527|NCT01177397|363717729|FG011|Overall Study|Lost to Follow-up|0|||
105668155|NCT00474526|364450175|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
105465528|NCT01177397|363717718|FG000|Overall Study|Death|0|||
105668156|NCT00474526|364450176|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
105668157|NCT00474526|364450177|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
105341232|NCT02122770|363249991|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
105341233|NCT02122770|363249992|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
105341234|NCT02122770|363249987|FG000|Part B: Standard of Care|Adverse Event|0|||
105341235|NCT02122770|363249988|FG001|Part B: Standard of Care|Adverse Event|0|||
105341236|NCT02122770|363249989|FG002|Part B: Standard of Care|Adverse Event|0|||
105341237|NCT02122770|363249990|FG003|Part B: Standard of Care|Adverse Event|0|||
105341238|NCT02122770|363249991|FG004|Part B: Standard of Care|Adverse Event|4|||
105341239|NCT02122770|363249992|FG005|Part B: Standard of Care|Adverse Event|1|||
105341240|NCT02122770|363249987|FG000|Part B: Standard of Care|Other|0|||
105341241|NCT02122770|363249988|FG001|Part B: Standard of Care|Other|0|||
105341242|NCT02122770|363249989|FG002|Part B: Standard of Care|Other|0|||
105341243|NCT02122770|363249990|FG003|Part B: Standard of Care|Other|0|||
105341244|NCT02122770|363249991|FG004|Part B: Standard of Care|Other|0|||
105341245|NCT02122770|363249992|FG005|Part B: Standard of Care|Other|2|||
105341246|NCT02122770|363249987|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
105341247|NCT02122770|363249988|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
105341248|NCT02122770|363249989|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
105341249|NCT02122770|363249990|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
105341250|NCT02122770|363249991|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
105341251|NCT02122770|363249992|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
105341252|NCT02122770|363249987|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
105341253|NCT02122770|363249988|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
105341254|NCT02122770|363249989|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
105341255|NCT02122770|363249990|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
105341256|NCT02122770|363249991|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
105341257|NCT02122770|363249992|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
105341258|NCT02122770|363249987|FG000|Part B: Standard of Care|Progressive Disease|0|||
105341259|NCT02122770|363249988|FG001|Part B: Standard of Care|Progressive Disease|0|||
105341260|NCT02122770|363249989|FG002|Part B: Standard of Care|Progressive Disease|0|||
105341261|NCT02122770|363249990|FG003|Part B: Standard of Care|Progressive Disease|0|||
105465529|NCT01177397|363717719|FG001|Overall Study|Death|0|||
105465530|NCT01177397|363717720|FG002|Overall Study|Death|1|||
105465531|NCT01177397|363717721|FG003|Overall Study|Death|1|||
105465532|NCT01177397|363717722|FG004|Overall Study|Death|0|||
105465533|NCT01177397|363717723|FG005|Overall Study|Death|0|||
105465534|NCT01177397|363717724|FG006|Overall Study|Death|0|||
105465535|NCT01177397|363717725|FG007|Overall Study|Death|5|||
105465536|NCT01177397|363717726|FG008|Overall Study|Death|2|||
105553374|NCT00971048|364023379|FG002|Overall Study|Adverse Event|1|||
105553375|NCT00971048|364023380|FG003|Overall Study|Adverse Event|0|||
105341262|NCT02122770|363249991|FG004|Part B: Standard of Care|Progressive Disease|10|||
105465537|NCT01177397|363717727|FG009|Overall Study|Death|1|||
105465538|NCT01177397|363717728|FG010|Overall Study|Death|0|||
105465539|NCT01177397|363717729|FG011|Overall Study|Death|0|||
105465540|NCT01177397|363717718|FG000|Overall Study|Withdrawal by Subject|0|||
105465541|NCT01177397|363717719|FG001|Overall Study|Withdrawal by Subject|0|||
105465542|NCT01177397|363717720|FG002|Overall Study|Withdrawal by Subject|1|||
105465543|NCT01177397|363717721|FG003|Overall Study|Withdrawal by Subject|1|||
105465544|NCT01177397|363717722|FG004|Overall Study|Withdrawal by Subject|1|||
105465545|NCT01177397|363717723|FG005|Overall Study|Withdrawal by Subject|2|||
105465546|NCT01177397|363717724|FG006|Overall Study|Withdrawal by Subject|0|||
105465547|NCT01177397|363717725|FG007|Overall Study|Withdrawal by Subject|5|||
105465548|NCT01177397|363717726|FG008|Overall Study|Withdrawal by Subject|9|||
105465549|NCT01177397|363717727|FG009|Overall Study|Withdrawal by Subject|1|||
105465550|NCT01177397|363717728|FG010|Overall Study|Withdrawal by Subject|1|||
105465551|NCT01177397|363717729|FG011|Overall Study|Withdrawal by Subject|0|||
105465552|NCT01177397|363717718|FG000|Overall Study|Adverse Event|0|||
105465553|NCT01177397|363717719|FG001|Overall Study|Adverse Event|0|||
105553376|NCT00971048|364023377|FG000|Overall Study|Physician Decision|0|||
105465554|NCT01177397|363717720|FG002|Overall Study|Adverse Event|1|||
105553377|NCT00971048|364023378|FG001|Overall Study|Physician Decision|0|||
105465555|NCT01177397|363717721|FG003|Overall Study|Adverse Event|2|||
105668158|NCT00474526|364450178|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
105668159|NCT00474526|364450179|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
105668160|NCT00474526|364450180|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
105668161|NCT00474526|364450181|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
105465556|NCT01177397|363717722|FG004|Overall Study|Adverse Event|0|||
105465557|NCT01177397|363717723|FG005|Overall Study|Adverse Event|12|||
105465558|NCT01177397|363717724|FG006|Overall Study|Adverse Event|1|||
105465559|NCT01177397|363717725|FG007|Overall Study|Adverse Event|14|||
105465560|NCT01177397|363717726|FG008|Overall Study|Adverse Event|8|||
105465561|NCT01177397|363717727|FG009|Overall Study|Adverse Event|6|||
105465562|NCT01177397|363717728|FG010|Overall Study|Adverse Event|3|||
105465563|NCT01177397|363717729|FG011|Overall Study|Adverse Event|7|||
105668162|NCT00474526|364450182|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
105668163|NCT00474526|364450183|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
105668164|NCT00474526|364450184|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
105668165|NCT00474526|364450185|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
105668166|NCT00474526|364450169|FG000|Overall Study|Adverse Event|2|||
105668167|NCT00474526|364450170|FG001|Overall Study|Adverse Event|0|||
105668168|NCT00474526|364450171|FG002|Overall Study|Adverse Event|2|||
105668169|NCT00474526|364450172|FG003|Overall Study|Adverse Event|4|||
105668170|NCT00474526|364450173|FG004|Overall Study|Adverse Event|2|||
105668171|NCT00474526|364450174|FG005|Overall Study|Adverse Event|1|||
105668172|NCT00474526|364450175|FG006|Overall Study|Adverse Event|1|||
105668173|NCT00474526|364450176|FG007|Overall Study|Adverse Event|0|||
105668174|NCT00474526|364450177|FG008|Overall Study|Adverse Event|0|||
105668175|NCT00474526|364450178|FG009|Overall Study|Adverse Event|0|||
105668176|NCT00474526|364450179|FG010|Overall Study|Adverse Event|0|||
105668177|NCT00474526|364450180|FG011|Overall Study|Adverse Event|0|||
105668178|NCT00474526|364450181|FG012|Overall Study|Adverse Event|0|||
105668179|NCT00474526|364450182|FG013|Overall Study|Adverse Event|0|||
105668180|NCT00474526|364450183|FG014|Overall Study|Adverse Event|1|||
105668181|NCT00474526|364450184|FG015|Overall Study|Adverse Event|1|||
105668182|NCT00474526|364450185|FG016|Overall Study|Adverse Event|0|||
105668183|NCT00474526|364450169|FG000|Overall Study|Death|0|||
105668184|NCT00474526|364450170|FG001|Overall Study|Death|0|||
105668185|NCT00474526|364450171|FG002|Overall Study|Death|0|||
105668186|NCT00474526|364450172|FG003|Overall Study|Death|0|||
105668187|NCT00474526|364450173|FG004|Overall Study|Death|0|||
105668188|NCT00474526|364450174|FG005|Overall Study|Death|0|||
105668189|NCT00474526|364450175|FG006|Overall Study|Death|0|||
105668190|NCT00474526|364450176|FG007|Overall Study|Death|0|||
105668191|NCT00474526|364450177|FG008|Overall Study|Death|0|||
105668192|NCT00474526|364450178|FG009|Overall Study|Death|0|||
105668193|NCT00474526|364450179|FG010|Overall Study|Death|0|||
105668194|NCT00474526|364450180|FG011|Overall Study|Death|0|||
105668195|NCT00474526|364450181|FG012|Overall Study|Death|0|||
105668196|NCT00474526|364450182|FG013|Overall Study|Death|3|||
105668197|NCT00474526|364450183|FG014|Overall Study|Death|0|||
105668198|NCT00474526|364450184|FG015|Overall Study|Death|0|||
105668199|NCT00474526|364450185|FG016|Overall Study|Death|0|||
105668200|NCT00474526|364450169|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668201|NCT00474526|364450170|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
105668202|NCT00474526|364450171|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668203|NCT00474526|364450172|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
105668204|NCT00474526|364450173|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
105553378|NCT00971048|364023379|FG002|Overall Study|Physician Decision|0|||
105553379|NCT00971048|364023380|FG003|Overall Study|Physician Decision|1|||
105553380|NCT00990652|364023383|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
105553381|NCT00990652|364023383|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
105553382|NCT04009291|364023384|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
105553383|NCT04009291|364023385|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
105553384|NCT04009291|364023386|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
105553385|NCT04009291|364023387|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
105553386|NCT04009291|364023388|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
105553387|NCT04009291|364023384|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
105553388|NCT04009291|364023385|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
105668205|NCT00474526|364450174|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668206|NCT00474526|364450175|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105465564|NCT01177397|363717718|FG000|Overall Study|Disease progression|1|||
105465565|NCT01177397|363717719|FG001|Overall Study|Disease progression|2|||
105668207|NCT00474526|364450176|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668208|NCT00474526|364450177|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668209|NCT00474526|364450178|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668210|NCT00474526|364450179|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668211|NCT00474526|364450180|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668212|NCT00474526|364450181|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668213|NCT00474526|364450182|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
105668214|NCT00474526|364450183|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
105668215|NCT00474526|364450184|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668216|NCT00474526|364450185|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668217|NCT00474526|364450169|FG000|Overall Study|Lost to Follow-up|8|||
105668218|NCT00474526|364450170|FG001|Overall Study|Lost to Follow-up|6|||
105668219|NCT00474526|364450171|FG002|Overall Study|Lost to Follow-up|13|||
105668220|NCT00474526|364450172|FG003|Overall Study|Lost to Follow-up|29|||
105668221|NCT00474526|364450173|FG004|Overall Study|Lost to Follow-up|11|||
105668222|NCT00474526|364450174|FG005|Overall Study|Lost to Follow-up|5|||
105668223|NCT00474526|364450175|FG006|Overall Study|Lost to Follow-up|8|||
105668224|NCT00474526|364450176|FG007|Overall Study|Lost to Follow-up|1|||
105668225|NCT00474526|364450177|FG008|Overall Study|Lost to Follow-up|0|||
105668226|NCT00474526|364450178|FG009|Overall Study|Lost to Follow-up|6|||
105668227|NCT00474526|364450179|FG010|Overall Study|Lost to Follow-up|2|||
105668228|NCT00474526|364450180|FG011|Overall Study|Lost to Follow-up|4|||
105668229|NCT00474526|364450181|FG012|Overall Study|Lost to Follow-up|6|||
105668230|NCT00474526|364450182|FG013|Overall Study|Lost to Follow-up|74|||
105668231|NCT00474526|364450183|FG014|Overall Study|Lost to Follow-up|29|||
105668232|NCT00474526|364450184|FG015|Overall Study|Lost to Follow-up|4|||
105668233|NCT00474526|364450185|FG016|Overall Study|Lost to Follow-up|5|||
105668234|NCT00474526|364450169|FG000|Overall Study|Protocol Violation|2|||
105668235|NCT00474526|364450170|FG001|Overall Study|Protocol Violation|6|||
105668236|NCT00474526|364450171|FG002|Overall Study|Protocol Violation|4|||
105668237|NCT00474526|364450172|FG003|Overall Study|Protocol Violation|12|||
105668238|NCT00474526|364450173|FG004|Overall Study|Protocol Violation|3|||
105668239|NCT00474526|364450174|FG005|Overall Study|Protocol Violation|1|||
105668240|NCT00474526|364450175|FG006|Overall Study|Protocol Violation|3|||
105668241|NCT00474526|364450176|FG007|Overall Study|Protocol Violation|0|||
105668242|NCT00474526|364450177|FG008|Overall Study|Protocol Violation|0|||
105668243|NCT00474526|364450178|FG009|Overall Study|Protocol Violation|4|||
105668244|NCT00474526|364450179|FG010|Overall Study|Protocol Violation|2|||
105668245|NCT00474526|364450180|FG011|Overall Study|Protocol Violation|2|||
105668246|NCT00474526|364450181|FG012|Overall Study|Protocol Violation|4|||
105668247|NCT00474526|364450182|FG013|Overall Study|Protocol Violation|19|||
105668248|NCT00474526|364450183|FG014|Overall Study|Protocol Violation|9|||
105668249|NCT00474526|364450184|FG015|Overall Study|Protocol Violation|6|||
105668250|NCT00474526|364450185|FG016|Overall Study|Protocol Violation|2|||
105668251|NCT00474526|364450169|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
105668252|NCT00474526|364450170|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
105668253|NCT00474526|364450171|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
105668254|NCT00474526|364450172|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
105668255|NCT00474526|364450173|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
105668256|NCT00474526|364450174|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
105668257|NCT00474526|364450175|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
105668258|NCT00474526|364450176|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
105668259|NCT00474526|364450177|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
105668260|NCT00474526|364450178|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
105668261|NCT00474526|364450179|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
105668262|NCT00474526|364450180|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
105668263|NCT00474526|364450181|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
105668264|NCT00474526|364450182|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
105668265|NCT00474526|364450183|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
105668266|NCT00474526|364450184|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
105668267|NCT00474526|364450185|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
105668268|NCT00474526|364450169|FG000|Overall Study|Withdrawal by Subject|9|||
105668269|NCT00474526|364450170|FG001|Overall Study|Withdrawal by Subject|24|||
105668270|NCT00474526|364450171|FG002|Overall Study|Withdrawal by Subject|21|||
105668271|NCT00474526|364450172|FG003|Overall Study|Withdrawal by Subject|52|||
105668272|NCT00474526|364450173|FG004|Overall Study|Withdrawal by Subject|38|||
105668273|NCT00474526|364450174|FG005|Overall Study|Withdrawal by Subject|6|||
105668274|NCT00474526|364450175|FG006|Overall Study|Withdrawal by Subject|12|||
105668275|NCT00474526|364450176|FG007|Overall Study|Withdrawal by Subject|4|||
105668276|NCT00474526|364450177|FG008|Overall Study|Withdrawal by Subject|4|||
105668277|NCT00474526|364450178|FG009|Overall Study|Withdrawal by Subject|13|||
105668278|NCT00474526|364450179|FG010|Overall Study|Withdrawal by Subject|5|||
105668279|NCT00474526|364450180|FG011|Overall Study|Withdrawal by Subject|4|||
105668280|NCT00474526|364450181|FG012|Overall Study|Withdrawal by Subject|4|||
105668281|NCT00474526|364450182|FG013|Overall Study|Withdrawal by Subject|37|||
105668282|NCT00474526|364450183|FG014|Overall Study|Withdrawal by Subject|22|||
105668283|NCT00474526|364450184|FG015|Overall Study|Withdrawal by Subject|1|||
105668284|NCT00474526|364450185|FG016|Overall Study|Withdrawal by Subject|1|||
105668285|NCT04546217|364450188|FG000|Overall Study|Withdrawal by Subject|2|||
105668286|NCT04546217|364450189|FG001|Overall Study|Withdrawal by Subject|0|||
105668287|NCT04546217|364450188|FG000|Overall Study|Uncontrolled hypertension|1|||
105668288|NCT04546217|364450189|FG001|Overall Study|Uncontrolled hypertension|0|||
105668289|NCT02550938|364450192|FG000|Overall Study|Lost to Follow-up|8|||
105668290|NCT02550938|364450193|FG001|Overall Study|Lost to Follow-up|7|||
105668291|NCT02550938|364450194|FG002|Overall Study|Lost to Follow-up|12|||
105668292|NCT02550938|364450195|FG003|Overall Study|Lost to Follow-up|11|||
105668293|NCT04491877|364450196|FG000|Overall Study|Protocol Deviation|1|||
105668294|NCT04491877|364450197|FG001|Overall Study|Protocol Deviation|0|||
105668295|NCT04491877|364450198|FG002|Overall Study|Protocol Deviation|2|||
105668296|NCT04491877|364450199|FG003|Overall Study|Protocol Deviation|0|||
105668297|NCT04491877|364450200|FG004|Overall Study|Protocol Deviation|0|||
105668298|NCT04491877|364450201|FG005|Overall Study|Protocol Deviation|0|||
105668299|NCT04491877|364450202|FG006|Overall Study|Protocol Deviation|1|||
105668300|NCT04491877|364450203|FG007|Overall Study|Protocol Deviation|1|||
105668301|NCT04491877|364450204|FG008|Overall Study|Protocol Deviation|0|||
105668302|NCT04491877|364450196|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105668303|NCT04491877|364450197|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105668304|NCT04491877|364450198|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105668305|NCT04491877|364450199|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
105668306|NCT04491877|364450200|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
105668307|NCT04491877|364450201|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
105668308|NCT04491877|364450202|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
105668309|NCT04491877|364450203|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
105668310|NCT04491877|364450204|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
105668311|NCT04491877|364450196|FG000|Overall Study|Lost to Follow-up|0|||
105668312|NCT04491877|364450197|FG001|Overall Study|Lost to Follow-up|2|||
105668313|NCT04491877|364450198|FG002|Overall Study|Lost to Follow-up|0|||
105668314|NCT04491877|364450199|FG003|Overall Study|Lost to Follow-up|0|||
105668315|NCT04491877|364450200|FG004|Overall Study|Lost to Follow-up|0|||
105668316|NCT04491877|364450201|FG005|Overall Study|Lost to Follow-up|0|||
105668317|NCT04491877|364450202|FG006|Overall Study|Lost to Follow-up|2|||
105668318|NCT04491877|364450203|FG007|Overall Study|Lost to Follow-up|1|||
105668319|NCT04491877|364450204|FG008|Overall Study|Lost to Follow-up|1|||
105668320|NCT01020877|364450209|FG000|Second Intervention|Withdrawal by Subject|1|||
105668321|NCT01020877|364450210|FG001|Second Intervention|Withdrawal by Subject|0|||
105668322|NCT00789360|364450212|FG000|Overall Study|Protocol Violation|3|||
105668323|NCT00789360|364450213|FG001|Overall Study|Protocol Violation|1|||
105668324|NCT01077128|364450215|FG000|Overall Study|Adverse Event|8|||
105668325|NCT01077128|364450215|FG000|Overall Study|Lack of Efficacy|1|||
105668326|NCT01077128|364450215|FG000|Overall Study|Disease exacerbation|1|||
105668327|NCT01077128|364450215|FG000|Overall Study|Adverse event and consent withdrawal|1|||
105668328|NCT01077128|364450215|FG000|Overall Study|Adverse event and disease exacerbation|1|||
105668329|NCT01077128|364450215|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
105668330|NCT01077128|364450215|FG000|Overall Study|Other|54|||
105341263|NCT02122770|363249992|FG005|Part B: Standard of Care|Progressive Disease|8|||
105341264|NCT02447497|363249993|FG000|Overall Study|Did not meet treatment day baseline.|6|||
105341265|NCT02447497|363249994|FG001|Overall Study|Did not meet treatment day baseline.|5|||
105341266|NCT02447497|363249995|FG002|Overall Study|Did not meet treatment day baseline.|2|||
105341267|NCT02447497|363249996|FG003|Overall Study|Did not meet treatment day baseline.|2|||
105341268|NCT02447497|363249993|FG000|Overall Study|Dressing was compromised|0|||
105341269|NCT02447497|363249994|FG001|Overall Study|Dressing was compromised|1|||
105341270|NCT02447497|363249995|FG002|Overall Study|Dressing was compromised|0|||
105341271|NCT02447497|363249996|FG003|Overall Study|Dressing was compromised|0|||
105341272|NCT03640481|363249997|FG000|Overall Study|Death|14|||
105341273|NCT03640481|363249998|FG001|Overall Study|Death|14|||
105341274|NCT03640481|363249999|FG002|Overall Study|Death|0|||
105341275|NCT03640481|363250000|FG003|Overall Study|Death|0|||
105341276|NCT03640481|363249997|FG000|Overall Study|Lost to Follow-up|2|||
105341277|NCT03640481|363249998|FG001|Overall Study|Lost to Follow-up|0|||
105341278|NCT03640481|363249999|FG002|Overall Study|Lost to Follow-up|0|||
105341279|NCT03640481|363250000|FG003|Overall Study|Lost to Follow-up|0|||
105341280|NCT03640481|363249997|FG000|Overall Study|Site terminated by sponsor|1|||
105341281|NCT03640481|363249998|FG001|Overall Study|Site terminated by sponsor|3|||
105341282|NCT03640481|363249999|FG002|Overall Study|Site terminated by sponsor|0|||
105341283|NCT03640481|363250000|FG003|Overall Study|Site terminated by sponsor|0|||
105341284|NCT03640481|363249997|FG000|Overall Study|Study terminated by sponsor|29|||
105341285|NCT03640481|363249998|FG001|Overall Study|Study terminated by sponsor|42|||
105341286|NCT03640481|363249999|FG002|Overall Study|Study terminated by sponsor|1|||
105341287|NCT03640481|363250000|FG003|Overall Study|Study terminated by sponsor|0|||
105341288|NCT03640481|363249997|FG000|Overall Study|Withdrawal by Subject|5|||
105341289|NCT03640481|363249998|FG001|Overall Study|Withdrawal by Subject|4|||
105341290|NCT03640481|363249999|FG002|Overall Study|Withdrawal by Subject|0|||
105341291|NCT03640481|363250000|FG003|Overall Study|Withdrawal by Subject|1|||
105341292|NCT03640481|363249997|FG000|Overall Study|Other|26|||
105341293|NCT03640481|363249998|FG001|Overall Study|Other|12|||
105465566|NCT01177397|363717720|FG002|Overall Study|Disease progression|5|||
105465567|NCT01177397|363717721|FG003|Overall Study|Disease progression|5|||
105341294|NCT03640481|363249999|FG002|Overall Study|Other|1|||
105341295|NCT03640481|363250000|FG003|Overall Study|Other|0|||
105341296|NCT03640481|363249997|FG000|Overall Study|Randomized, but not treated|1|||
105341297|NCT03640481|363249998|FG001|Overall Study|Randomized, but not treated|3|||
105341298|NCT03640481|363249999|FG002|Overall Study|Randomized, but not treated|0|||
105341299|NCT03640481|363250000|FG003|Overall Study|Randomized, but not treated|0|||
105341300|NCT00727844|363250001|FG000|Initial Randomization|Physician Decision|2|||
105341301|NCT00727844|363250002|FG001|Initial Randomization|Physician Decision|0|||
105465568|NCT01177397|363717722|FG004|Overall Study|Disease progression|4|||
105341302|NCT00727844|363250003|FG002|Initial Randomization|Physician Decision|0|||
105341303|NCT00727844|363250004|FG003|Initial Randomization|Physician Decision|0|||
105341304|NCT03782298|363250014|FG000|Overall Study|Protocol Deviation|4|||
105465569|NCT01177397|363717723|FG005|Overall Study|Disease progression|10|||
105465570|NCT01177397|363717724|FG006|Overall Study|Disease progression|10|||
105465571|NCT01177397|363717725|FG007|Overall Study|Disease progression|21|||
105465572|NCT01177397|363717726|FG008|Overall Study|Disease progression|18|||
105465573|NCT01177397|363717727|FG009|Overall Study|Disease progression|12|||
105465574|NCT01177397|363717728|FG010|Overall Study|Disease progression|10|||
105465575|NCT01177397|363717729|FG011|Overall Study|Disease progression|8|||
105465576|NCT01177397|363717718|FG000|Overall Study|Other reasons|0|||
105465577|NCT01177397|363717719|FG001|Overall Study|Other reasons|0|||
105465578|NCT01177397|363717720|FG002|Overall Study|Other reasons|1|||
105465579|NCT01177397|363717721|FG003|Overall Study|Other reasons|0|||
105465580|NCT01177397|363717722|FG004|Overall Study|Other reasons|1|||
105465581|NCT01177397|363717723|FG005|Overall Study|Other reasons|1|||
105465582|NCT01177397|363717724|FG006|Overall Study|Other reasons|2|||
105465583|NCT01177397|363717725|FG007|Overall Study|Other reasons|6|||
105465584|NCT01177397|363717726|FG008|Overall Study|Other reasons|10|||
105465585|NCT01177397|363717727|FG009|Overall Study|Other reasons|8|||
105341305|NCT00742508|363250015|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
105465586|NCT01177397|363717728|FG010|Overall Study|Other reasons|0|||
105465587|NCT01177397|363717729|FG011|Overall Study|Other reasons|2|||
105465588|NCT01760733|363717731|FG000|Waiting List|Death|18|||
105465589|NCT01760733|363717731|FG000|Waiting List|Removed from waiting list|41|||
105465590|NCT01760733|363717731|FG000|Waiting List|Not received a transplant yet|13|||
105465591|NCT01760733|363717731|FG000|Transplanted|Not reached 10 years post transplant|184|||
105465592|NCT01760733|363717731|FG000|Transplanted|Death|26|||
105465593|NCT01760733|363717731|FG000|Transplanted|Graft loss|7|||
105465594|NCT00882557|363717734|FG000|Overall Study|Withdrawal by Subject|1|||
105553389|NCT04009291|364023386|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
105553390|NCT04009291|364023387|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
105553391|NCT04009291|364023388|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
105553392|NCT05177770|364023389|FG000|Overall Study|Death|4|||
105553393|NCT05177770|364023389|FG000|Overall Study|Withdrawal by Subject|1|||
105553394|NCT05177770|364023389|FG000|Overall Study|Adverse Event prior to dosing|1|||
105553395|NCT01362140|364023393|FG000|Overall Study|Noncompliance|1|||
105553396|NCT01362140|364023394|FG001|Overall Study|Noncompliance|0|||
105553397|NCT01362140|364023393|FG000|Overall Study|Adverse Event|2|||
105553398|NCT01362140|364023394|FG001|Overall Study|Adverse Event|2|||
105553399|NCT01362140|364023393|FG000|Overall Study|Withdrawal by Subject|3|||
105553400|NCT01362140|364023394|FG001|Overall Study|Withdrawal by Subject|3|||
105553401|NCT01362140|364023393|FG000|Overall Study|Administrative Decision|0|||
105553402|NCT01362140|364023394|FG001|Overall Study|Administrative Decision|1|||
105553403|NCT01362140|364023393|FG000|Overall Study|Death|2|||
105553404|NCT01362140|364023394|FG001|Overall Study|Death|1|||
105553405|NCT01362140|364023393|FG000|Overall Study|Other|1|||
105553406|NCT01362140|364023394|FG001|Overall Study|Other|1|||
105553407|NCT01362140|364023393|FG000|Overall Study|Protocol-specified Criteria|1|||
105553408|NCT01362140|364023394|FG001|Overall Study|Protocol-specified Criteria|2|||
105553409|NCT01362140|364023393|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
105553410|NCT01362140|364023394|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
105553411|NCT01306162|364023395|FG000|Period 1|Adverse Event|0|||
105553412|NCT01306162|364023396|FG001|Period 1|Adverse Event|0|||
105553413|NCT01306162|364023397|FG002|Period 1|Adverse Event|0|||
105553414|NCT01306162|364023398|FG003|Period 1|Adverse Event|1|||
105553415|NCT01306162|364023395|FG000|Washout 1|Non-compliance to protocol|0|||
105553416|NCT01306162|364023396|FG001|Washout 1|Non-compliance to protocol|1|||
105553417|NCT01306162|364023397|FG002|Washout 1|Non-compliance to protocol|0|||
105553418|NCT01306162|364023398|FG003|Washout 1|Non-compliance to protocol|0|||
105553419|NCT00492284|364023400|FG000|Overall Study|Adverse Event|0|||
105553420|NCT00492284|364023401|FG001|Overall Study|Adverse Event|1|||
105553421|NCT00492284|364023402|FG002|Overall Study|Adverse Event|1|||
105553422|NCT00492284|364023403|FG003|Overall Study|Adverse Event|2|||
105553423|NCT00492284|364023400|FG000|Overall Study|Lost to Follow-up|0|||
105553424|NCT00492284|364023401|FG001|Overall Study|Lost to Follow-up|0|||
105553425|NCT00492284|364023402|FG002|Overall Study|Lost to Follow-up|3|||
105553426|NCT00492284|364023403|FG003|Overall Study|Lost to Follow-up|1|||
105668331|NCT00945672|364450216|FG000|Overall Study|Withdrawal by Subject|0|||
105668332|NCT00945672|364450217|FG001|Overall Study|Withdrawal by Subject|0|||
105668333|NCT00945672|364450218|FG002|Overall Study|Withdrawal by Subject|0|||
105668334|NCT00945672|364450219|FG003|Overall Study|Withdrawal by Subject|1|||
105668335|NCT03926195|364450223|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
105668336|NCT03926195|364450224|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
105668337|NCT03926195|364450223|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
105668338|NCT03926195|364450224|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
105668339|NCT03926195|364450223|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
105668340|NCT03926195|364450224|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
105668341|NCT03926195|364450223|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
105668342|NCT03926195|364450224|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
105668343|NCT03926195|364450223|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
105553427|NCT00492284|364023400|FG000|Overall Study|Death|0|||
105553428|NCT00492284|364023401|FG001|Overall Study|Death|3|||
105553429|NCT00492284|364023402|FG002|Overall Study|Death|2|||
105553430|NCT00492284|364023403|FG003|Overall Study|Death|5|||
105553431|NCT00492284|364023400|FG000|Overall Study|Withdrawal by Subject|1|||
105553432|NCT00492284|364023401|FG001|Overall Study|Withdrawal by Subject|0|||
105553433|NCT00492284|364023402|FG002|Overall Study|Withdrawal by Subject|0|||
105465595|NCT00882557|363717735|FG001|Overall Study|Withdrawal by Subject|0|||
105553434|NCT00492284|364023403|FG003|Overall Study|Withdrawal by Subject|2|||
105668344|NCT03926195|364450224|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
105668345|NCT03926195|364450223|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
105668346|NCT03926195|364450224|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
105668347|NCT01294397|364450227|FG000|Overall Study|Withdrawal by Subject|1|||
105668348|NCT01294397|364450227|FG000|Overall Study|Administrative Decision|1|||
105668349|NCT01250925|364450228|FG000|Overall Study|Lost to Follow-up|1|||
105668350|NCT01250925|364450229|FG001|Overall Study|Lost to Follow-up|1|||
105668351|NCT01250925|364450230|FG002|Overall Study|Lost to Follow-up|0|||
105668352|NCT01250925|364450228|FG000|Overall Study|Withdrawal by Subject|2|||
105668353|NCT01250925|364450229|FG001|Overall Study|Withdrawal by Subject|0|||
105668354|NCT01250925|364450230|FG002|Overall Study|Withdrawal by Subject|0|||
105668355|NCT01250925|364450228|FG000|Overall Study|Protocol Violation|2|||
105668356|NCT01250925|364450229|FG001|Overall Study|Protocol Violation|0|||
105668357|NCT01250925|364450230|FG002|Overall Study|Protocol Violation|0|||
105668358|NCT01250925|364450228|FG000|Overall Study|Physician Decision|0|||
105668359|NCT01250925|364450229|FG001|Overall Study|Physician Decision|2|||
105668360|NCT01250925|364450230|FG002|Overall Study|Physician Decision|1|||
105668361|NCT01250925|364450228|FG000|Overall Study|Adverse Event|0|||
105668362|NCT01250925|364450229|FG001|Overall Study|Adverse Event|0|||
105668363|NCT01250925|364450230|FG002|Overall Study|Adverse Event|1|||
105668364|NCT01939353|364450231|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
105668365|NCT01939353|364450231|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
105668366|NCT01939353|364450231|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
105668367|NCT01939353|364450231|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
105668368|NCT01939353|364450231|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
105668369|NCT00737477|364450232|FG000|Overall Study|Adverse Event|9|||
105668370|NCT00737477|364450232|FG000|Overall Study|Death|9|||
105668371|NCT00737477|364450232|FG000|Overall Study|Treatment Refusal|1|||
105668372|NCT00737477|364450232|FG000|Overall Study|Withdrawal by Subject|1|||
105668373|NCT00737477|364450232|FG000|Overall Study|Renal Transplantation|10|||
105668374|NCT00737477|364450232|FG000|Overall Study|Other|4|||
105668375|NCT01370655|364450233|FG000|Period 1|Adverse Event|2|||
105668376|NCT01370655|364450234|FG001|Period 1|Adverse Event|0|||
105668377|NCT01370655|364450235|FG002|Period 1|Adverse Event|0|||
105668378|NCT01370655|364450236|FG003|Period 1|Adverse Event|0|||
105668379|NCT01370655|364450237|FG004|Period 1|Adverse Event|0|||
105668380|NCT01370655|364450238|FG005|Period 1|Adverse Event|0|||
105668381|NCT01370655|364450239|FG006|Period 1|Adverse Event|1|||
105668382|NCT01370655|364450240|FG007|Period 1|Adverse Event|0|||
105668383|NCT01370655|364450241|FG008|Period 1|Adverse Event|0|||
105668384|NCT01370655|364450242|FG009|Period 1|Adverse Event|0|||
105668385|NCT01370655|364450243|FG010|Period 1|Adverse Event|0|||
105465596|NCT00882557|363717734|FG000|Overall Study|Trouble with Vein Access|1|||
105465597|NCT00882557|363717735|FG001|Overall Study|Trouble with Vein Access|0|||
105465598|NCT00882557|363717734|FG000|Overall Study|Randomized Not Treated|0|||
105465599|NCT00882557|363717735|FG001|Overall Study|Randomized Not Treated|1|||
105668386|NCT01370655|364450244|FG011|Period 1|Adverse Event|0|||
105668387|NCT01370655|364450233|FG000|Period 2|Adverse Event|0|||
105668388|NCT01370655|364450234|FG001|Period 2|Adverse Event|0|||
105465600|NCT02282605|363717736|FG000|Overall Study|negative SA result on Day -1|3|||
105465601|NCT02282605|363717737|FG001|Overall Study|negative SA result on Day -1|0|||
105668389|NCT01370655|364450235|FG002|Period 2|Adverse Event|1|||
105668390|NCT01370655|364450236|FG003|Period 2|Adverse Event|0|||
105668391|NCT01370655|364450237|FG004|Period 2|Adverse Event|1|||
105668392|NCT01370655|364450238|FG005|Period 2|Adverse Event|0|||
105668393|NCT01370655|364450239|FG006|Period 2|Adverse Event|0|||
105668394|NCT01370655|364450240|FG007|Period 2|Adverse Event|1|||
105668395|NCT01370655|364450241|FG008|Period 2|Adverse Event|0|||
105668396|NCT01370655|364450242|FG009|Period 2|Adverse Event|0|||
105465602|NCT02282605|363717738|FG002|Overall Study|negative SA result on Day -1|0|||
105465603|NCT01383356|363717739|FG000|Period 1|Adverse Event|5|||
105668397|NCT01370655|364450243|FG010|Period 2|Adverse Event|0|||
105668398|NCT01370655|364450244|FG011|Period 2|Adverse Event|0|||
105668399|NCT01370655|364450233|FG000|Period 2|met protocol specified stopping criteria|0|||
105341306|NCT00742508|363250016|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
105465604|NCT01383356|363717740|FG001|Period 1|Adverse Event|3|||
105668400|NCT01370655|364450234|FG001|Period 2|met protocol specified stopping criteria|0|||
105465605|NCT01383356|363717739|FG000|Period 1|Non-compliance|3|||
105668401|NCT01370655|364450235|FG002|Period 2|met protocol specified stopping criteria|1|||
105465606|NCT01383356|363717740|FG001|Period 1|Non-compliance|0|||
105465607|NCT01383356|363717739|FG000|Period 1|Out of Range Mid-study-Test|0|||
105465608|NCT01383356|363717740|FG001|Period 1|Out of Range Mid-study-Test|1|||
105465609|NCT01383356|363717739|FG000|Period 1|Personal|0|||
105465610|NCT01383356|363717740|FG001|Period 1|Personal|2|||
105465611|NCT02158546|363717744|FG000|Overall Study|Physician Decision|0|||
105465612|NCT02158546|363717745|FG001|Overall Study|Physician Decision|1|||
105465613|NCT02158546|363717746|FG002|Overall Study|Physician Decision|0|||
105465614|NCT02158546|363717747|FG003|Overall Study|Physician Decision|0|||
105465615|NCT02158546|363717744|FG000|Overall Study|Non-compliance|0|||
105465616|NCT02158546|363717745|FG001|Overall Study|Non-compliance|1|||
105465617|NCT02158546|363717746|FG002|Overall Study|Non-compliance|0|||
105465618|NCT02158546|363717747|FG003|Overall Study|Non-compliance|1|||
105465619|NCT02158546|363717744|FG000|Overall Study|Failure to meet eligibility criteria|0|||
105465620|NCT02158546|363717745|FG001|Overall Study|Failure to meet eligibility criteria|1|||
105465621|NCT02158546|363717746|FG002|Overall Study|Failure to meet eligibility criteria|0|||
105465622|NCT02158546|363717747|FG003|Overall Study|Failure to meet eligibility criteria|0|||
105465623|NCT02158546|363717744|FG000|Overall Study|Lack of Efficacy|1|||
105465624|NCT02158546|363717745|FG001|Overall Study|Lack of Efficacy|1|||
105465625|NCT02158546|363717746|FG002|Overall Study|Lack of Efficacy|0|||
105341307|NCT00742508|363250015|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
105341308|NCT00742508|363250016|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
105341309|NCT00742508|363250015|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
105341310|NCT00742508|363250016|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
105341311|NCT00742508|363250015|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
105341312|NCT00742508|363250016|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
105341313|NCT00742508|363250015|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
105341314|NCT00742508|363250016|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
105341315|NCT03339726|363251880|FG000|Overall Study|Withdrawal by Subject|1|||
105341316|NCT03339726|363251881|FG001|Overall Study|Withdrawal by Subject|0|||
105341317|NCT03339726|363251882|FG002|Overall Study|Withdrawal by Subject|0|||
105465626|NCT02158546|363717747|FG003|Overall Study|Lack of Efficacy|0|||
105465627|NCT02158546|363717744|FG000|Overall Study|Adverse Event|2|||
105465628|NCT02158546|363717745|FG001|Overall Study|Adverse Event|2|||
105465629|NCT02158546|363717746|FG002|Overall Study|Adverse Event|0|||
105341318|NCT03339726|363251880|FG000|Overall Study|Lost to Follow-up|0|||
105465630|NCT02158546|363717747|FG003|Overall Study|Adverse Event|0|||
105465631|NCT02158546|363717744|FG000|Overall Study|Withdrawal by Subject|6|||
105465632|NCT02158546|363717745|FG001|Overall Study|Withdrawal by Subject|2|||
105465633|NCT02158546|363717746|FG002|Overall Study|Withdrawal by Subject|1|||
105668402|NCT01370655|364450236|FG003|Period 2|met protocol specified stopping criteria|0|||
105668403|NCT01370655|364450237|FG004|Period 2|met protocol specified stopping criteria|0|||
105668404|NCT01370655|364450238|FG005|Period 2|met protocol specified stopping criteria|0|||
105668405|NCT01370655|364450239|FG006|Period 2|met protocol specified stopping criteria|1|||
105668406|NCT01370655|364450240|FG007|Period 2|met protocol specified stopping criteria|0|||
105668407|NCT01370655|364450241|FG008|Period 2|met protocol specified stopping criteria|1|||
105668408|NCT01370655|364450242|FG009|Period 2|met protocol specified stopping criteria|0|||
105668409|NCT01370655|364450243|FG010|Period 2|met protocol specified stopping criteria|1|||
105668410|NCT01370655|364450244|FG011|Period 2|met protocol specified stopping criteria|0|||
105668411|NCT01370655|364450233|FG000|Period 2|Withdrawal by Subject|0|||
105668412|NCT01370655|364450234|FG001|Period 2|Withdrawal by Subject|0|||
105668413|NCT01370655|364450235|FG002|Period 2|Withdrawal by Subject|0|||
105668414|NCT01370655|364450236|FG003|Period 2|Withdrawal by Subject|0|||
105668415|NCT01370655|364450237|FG004|Period 2|Withdrawal by Subject|0|||
105668416|NCT01370655|364450238|FG005|Period 2|Withdrawal by Subject|0|||
105668417|NCT01370655|364450239|FG006|Period 2|Withdrawal by Subject|0|||
105668418|NCT01370655|364450240|FG007|Period 2|Withdrawal by Subject|0|||
105668419|NCT01370655|364450241|FG008|Period 2|Withdrawal by Subject|1|||
105668420|NCT01370655|364450242|FG009|Period 2|Withdrawal by Subject|0|||
105668421|NCT01370655|364450243|FG010|Period 2|Withdrawal by Subject|0|||
105668422|NCT01370655|364450244|FG011|Period 2|Withdrawal by Subject|0|||
105668423|NCT01465763|364450246|FG000|Overall Study|Withdrawal by Subject|4|||
105668424|NCT01465763|364450247|FG001|Overall Study|Withdrawal by Subject|0|||
105668425|NCT01465763|364450248|FG002|Overall Study|Withdrawal by Subject|1|||
105668426|NCT01465763|364450246|FG000|Overall Study|Insufficient Clinical Response|11|||
105668427|NCT01465763|364450247|FG001|Overall Study|Insufficient Clinical Response|0|||
105668428|NCT01465763|364450248|FG002|Overall Study|Insufficient Clinical Response|1|||
105668429|NCT01465763|364450246|FG000|Overall Study|Adverse Event|9|||
105668430|NCT01465763|364450247|FG001|Overall Study|Adverse Event|0|||
105668431|NCT01465763|364450248|FG002|Overall Study|Adverse Event|1|||
105668432|NCT01465763|364450246|FG000|Overall Study|Other|2|||
105668433|NCT01465763|364450247|FG001|Overall Study|Other|0|||
105668434|NCT01465763|364450248|FG002|Overall Study|Other|0|||
105668435|NCT01465763|364450246|FG000|Overall Study|Protocol Violation|4|||
105668436|NCT01465763|364450247|FG001|Overall Study|Protocol Violation|1|||
105668437|NCT01465763|364450248|FG002|Overall Study|Protocol Violation|1|||
105668438|NCT01465763|364450246|FG000|Overall Study|Death|1|||
105668439|NCT01465763|364450247|FG001|Overall Study|Death|0|||
105668440|NCT01465763|364450248|FG002|Overall Study|Death|0|||
105668441|NCT01427725|364450254|FG000|Overall Study|Lost to Follow-up|17|||
105668442|NCT01427725|364450254|FG000|Overall Study|Protocol Violation|1|||
105668443|NCT01427725|364450254|FG000|Overall Study|Drug not administered|1|||
105668444|NCT01427725|364450254|FG000|Overall Study|Failure to visit|7|||
105668445|NCT01427725|364450254|FG000|Overall Study|Adverse Event|46|||
105341319|NCT03339726|363251881|FG001|Overall Study|Lost to Follow-up|1|||
105341320|NCT03339726|363251882|FG002|Overall Study|Lost to Follow-up|0|||
105668446|NCT01427725|364450254|FG000|Overall Study|Failure to visit after administration|40|||
105668447|NCT01427725|364450254|FG000|Overall Study|Patient's rejection|27|||
105668448|NCT01427725|364450254|FG000|Overall Study|Transfer to a different hospital|17|||
105668449|NCT01427725|364450254|FG000|Overall Study|Lack of Efficacy|8|||
105668450|NCT01427725|364450254|FG000|Overall Study|Death|7|||
105668451|NCT01427725|364450254|FG000|Overall Study|Symptom improvement|6|||
105668452|NCT01427725|364450254|FG000|Overall Study|AE and Patient's rejection|5|||
105668453|NCT01427725|364450254|FG000|Overall Study|Physician Decision|5|||
105668454|NCT01427725|364450254|FG000|Overall Study|Exacerbation of underlying disease|5|||
105668455|NCT01427725|364450254|FG000|Overall Study|Oral feeding difficulty|5|||
105668456|NCT01427725|364450254|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
105668457|NCT01427725|364450254|FG000|Overall Study|Forgetting prescription|1|||
105668458|NCT01427725|364450254|FG000|Overall Study|Other|2|||
105668459|NCT00588692|364450255|FG000|Overall Study|Withdrawal by Subject|4|||
105668460|NCT00588692|364450256|FG001|Overall Study|Withdrawal by Subject|2|||
105668461|NCT00588692|364450255|FG000|Overall Study|Hip Surgery|0|||
105668462|NCT00588692|364450256|FG001|Overall Study|Hip Surgery|1|||
105668463|NCT00588692|364450255|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
105668464|NCT00588692|364450256|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
105668465|NCT00588692|364450255|FG000|Overall Study|Cancer|1|||
105668466|NCT00588692|364450256|FG001|Overall Study|Cancer|0|||
105668467|NCT00588692|364450255|FG000|Overall Study|Death|1|||
105668468|NCT00588692|364450256|FG001|Overall Study|Death|0|||
105668469|NCT01374568|364450257|FG000|Overall Study|Lab unable to analyze BTM|0|||
105668470|NCT01374568|364450258|FG001|Overall Study|Lab unable to analyze BTM|2|||
105668471|NCT00392925|364450259|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
105668472|NCT00392925|364450260|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
105668473|NCT00392925|364450261|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
105668474|NCT00392925|364450262|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
105668475|NCT00392925|364450259|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
105668476|NCT00392925|364450260|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
105341321|NCT03875092|363251883|FG000|Overall Study|Adverse Event|2|||
105465634|NCT02158546|363717747|FG003|Overall Study|Withdrawal by Subject|0|||
105465635|NCT02158546|363717744|FG000|Overall Study|Lost to Follow-up|5|||
105465636|NCT02158546|363717745|FG001|Overall Study|Lost to Follow-up|4|||
105465637|NCT02158546|363717746|FG002|Overall Study|Lost to Follow-up|0|||
105465638|NCT02158546|363717747|FG003|Overall Study|Lost to Follow-up|1|||
105465639|NCT02158546|363717744|FG000|Overall Study|Site Excluded|5|||
105465640|NCT02158546|363717745|FG001|Overall Study|Site Excluded|5|||
105465641|NCT02158546|363717746|FG002|Overall Study|Site Excluded|3|||
105465642|NCT02158546|363717747|FG003|Overall Study|Site Excluded|4|||
105465643|NCT00803569|363717748|FG000|Overall Study|Progressive Disease|3|||
105465644|NCT00803569|363717748|FG000|Overall Study|Noncompliance|1|||
105465645|NCT01208207|363717751|FG000|Part I|Adverse Event|19|||
105465646|NCT01208207|363717752|FG001|Part I|Adverse Event|2|||
105465647|NCT01208207|363717753|FG002|Part I|Adverse Event|6|||
105465648|NCT01208207|363717754|FG003|Part I|Adverse Event|0|||
105465649|NCT01208207|363717755|FG004|Part I|Adverse Event|0|||
105465650|NCT01208207|363717756|FG005|Part I|Adverse Event|0|||
105465651|NCT01208207|363717757|FG006|Part I|Adverse Event|0|||
105465652|NCT01208207|363717751|FG000|Part I|Lack of Efficacy|21|||
105465653|NCT01208207|363717752|FG001|Part I|Lack of Efficacy|3|||
105465654|NCT01208207|363717753|FG002|Part I|Lack of Efficacy|2|||
105465655|NCT01208207|363717754|FG003|Part I|Lack of Efficacy|0|||
105465656|NCT01208207|363717755|FG004|Part I|Lack of Efficacy|0|||
105465657|NCT01208207|363717756|FG005|Part I|Lack of Efficacy|0|||
105465658|NCT01208207|363717757|FG006|Part I|Lack of Efficacy|0|||
105465659|NCT01208207|363717751|FG000|Part I|Lost to Follow-up|6|||
105465660|NCT01208207|363717752|FG001|Part I|Lost to Follow-up|1|||
105465661|NCT01208207|363717753|FG002|Part I|Lost to Follow-up|0|||
105465662|NCT01208207|363717754|FG003|Part I|Lost to Follow-up|0|||
105465663|NCT01208207|363717755|FG004|Part I|Lost to Follow-up|0|||
105465664|NCT01208207|363717756|FG005|Part I|Lost to Follow-up|0|||
105465665|NCT01208207|363717757|FG006|Part I|Lost to Follow-up|0|||
105465666|NCT01208207|363717751|FG000|Part I|Non-Compliance With Study Drug|1|||
105465667|NCT01208207|363717752|FG001|Part I|Non-Compliance With Study Drug|0|||
105465668|NCT01208207|363717753|FG002|Part I|Non-Compliance With Study Drug|1|||
105465669|NCT01208207|363717754|FG003|Part I|Non-Compliance With Study Drug|0|||
105465670|NCT01208207|363717755|FG004|Part I|Non-Compliance With Study Drug|0|||
105465671|NCT01208207|363717756|FG005|Part I|Non-Compliance With Study Drug|0|||
105465672|NCT01208207|363717757|FG006|Part I|Non-Compliance With Study Drug|0|||
105465673|NCT01208207|363717751|FG000|Part I|Physician Decision|0|||
105465674|NCT01208207|363717752|FG001|Part I|Physician Decision|1|||
105465675|NCT01208207|363717753|FG002|Part I|Physician Decision|0|||
105465676|NCT01208207|363717754|FG003|Part I|Physician Decision|0|||
105465677|NCT01208207|363717755|FG004|Part I|Physician Decision|0|||
105465678|NCT01208207|363717756|FG005|Part I|Physician Decision|0|||
105465679|NCT01208207|363717757|FG006|Part I|Physician Decision|0|||
105465680|NCT01208207|363717751|FG000|Part I|Progressive Disease|1|||
105465681|NCT01208207|363717752|FG001|Part I|Progressive Disease|0|||
105465682|NCT01208207|363717753|FG002|Part I|Progressive Disease|0|||
105465683|NCT01208207|363717754|FG003|Part I|Progressive Disease|0|||
105465684|NCT01208207|363717755|FG004|Part I|Progressive Disease|0|||
105465685|NCT01208207|363717756|FG005|Part I|Progressive Disease|0|||
105465686|NCT01208207|363717757|FG006|Part I|Progressive Disease|0|||
105465687|NCT01208207|363717751|FG000|Part I|Protocol Violation|8|||
105465688|NCT01208207|363717752|FG001|Part I|Protocol Violation|0|||
105465689|NCT01208207|363717753|FG002|Part I|Protocol Violation|2|||
105465690|NCT01208207|363717754|FG003|Part I|Protocol Violation|0|||
105465691|NCT01208207|363717755|FG004|Part I|Protocol Violation|0|||
105465692|NCT01208207|363717756|FG005|Part I|Protocol Violation|0|||
105465693|NCT01208207|363717757|FG006|Part I|Protocol Violation|0|||
105465694|NCT01208207|363717751|FG000|Part I|Withdrawal by Subject|14|||
105465695|NCT01208207|363717752|FG001|Part I|Withdrawal by Subject|4|||
105668477|NCT00392925|364450261|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
105465696|NCT01208207|363717753|FG002|Part I|Withdrawal by Subject|4|||
105465697|NCT01208207|363717754|FG003|Part I|Withdrawal by Subject|0|||
105465698|NCT01208207|363717755|FG004|Part I|Withdrawal by Subject|0|||
105465699|NCT01208207|363717756|FG005|Part I|Withdrawal by Subject|0|||
105465700|NCT01208207|363717757|FG006|Part I|Withdrawal by Subject|0|||
105465701|NCT01208207|363717751|FG000|Part II|Withdrawal by Subject|0|||
105668478|NCT00392925|364450262|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
105465702|NCT01208207|363717752|FG001|Part II|Withdrawal by Subject|0|||
105465703|NCT01208207|363717753|FG002|Part II|Withdrawal by Subject|0|||
105465704|NCT01208207|363717754|FG003|Part II|Withdrawal by Subject|10|||
105465705|NCT01208207|363717755|FG004|Part II|Withdrawal by Subject|9|||
105465706|NCT01208207|363717756|FG005|Part II|Withdrawal by Subject|3|||
105465707|NCT01208207|363717757|FG006|Part II|Withdrawal by Subject|5|||
105465708|NCT01208207|363717751|FG000|Part II|Adverse Event|0|||
105465709|NCT01208207|363717752|FG001|Part II|Adverse Event|0|||
105465710|NCT01208207|363717753|FG002|Part II|Adverse Event|0|||
105465711|NCT01208207|363717754|FG003|Part II|Adverse Event|5|||
105465712|NCT01208207|363717755|FG004|Part II|Adverse Event|9|||
105465713|NCT01208207|363717756|FG005|Part II|Adverse Event|4|||
105465714|NCT01208207|363717757|FG006|Part II|Adverse Event|2|||
105465715|NCT01208207|363717751|FG000|Part II|Lack of Efficacy|0|||
105465716|NCT01208207|363717752|FG001|Part II|Lack of Efficacy|0|||
105465717|NCT01208207|363717753|FG002|Part II|Lack of Efficacy|0|||
105465718|NCT01208207|363717754|FG003|Part II|Lack of Efficacy|6|||
105465719|NCT01208207|363717755|FG004|Part II|Lack of Efficacy|4|||
105465720|NCT01208207|363717756|FG005|Part II|Lack of Efficacy|3|||
105465721|NCT01208207|363717757|FG006|Part II|Lack of Efficacy|3|||
105465722|NCT01208207|363717751|FG000|Part II|Lost to Follow-up|0|||
105465723|NCT01208207|363717752|FG001|Part II|Lost to Follow-up|0|||
105465724|NCT01208207|363717753|FG002|Part II|Lost to Follow-up|0|||
105465725|NCT01208207|363717754|FG003|Part II|Lost to Follow-up|4|||
105465726|NCT01208207|363717755|FG004|Part II|Lost to Follow-up|0|||
105465727|NCT01208207|363717756|FG005|Part II|Lost to Follow-up|2|||
105465728|NCT01208207|363717757|FG006|Part II|Lost to Follow-up|1|||
105465729|NCT01208207|363717751|FG000|Part II|Non-Compliance With Study Drug|0|||
105465730|NCT01208207|363717752|FG001|Part II|Non-Compliance With Study Drug|0|||
105465731|NCT01208207|363717753|FG002|Part II|Non-Compliance With Study Drug|0|||
105465732|NCT01208207|363717754|FG003|Part II|Non-Compliance With Study Drug|4|||
105465733|NCT01208207|363717755|FG004|Part II|Non-Compliance With Study Drug|1|||
105465734|NCT01208207|363717756|FG005|Part II|Non-Compliance With Study Drug|1|||
105465735|NCT01208207|363717757|FG006|Part II|Non-Compliance With Study Drug|0|||
105668479|NCT00392925|364450259|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
105668480|NCT00392925|364450260|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
105465736|NCT01208207|363717751|FG000|Part II|Physician Decision|0|||
105668481|NCT00392925|364450261|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
105668482|NCT00392925|364450262|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
105465737|NCT01208207|363717752|FG001|Part II|Physician Decision|0|||
105465738|NCT01208207|363717753|FG002|Part II|Physician Decision|0|||
105668483|NCT00392925|364450259|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
105668484|NCT00392925|364450260|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
105668485|NCT00392925|364450261|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
105465739|NCT01208207|363717754|FG003|Part II|Physician Decision|1|||
105668486|NCT00392925|364450262|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
105668487|NCT00392925|364450259|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
105465740|NCT01208207|363717755|FG004|Part II|Physician Decision|0|||
105465741|NCT01208207|363717756|FG005|Part II|Physician Decision|2|||
105465742|NCT01208207|363717757|FG006|Part II|Physician Decision|0|||
105465743|NCT01208207|363717751|FG000|Part II|Protocol Violation|0|||
105553435|NCT02959437|364023404|FG000|Overall Study|Death|33|||
105465744|NCT01208207|363717752|FG001|Part II|Protocol Violation|0|||
105465745|NCT01208207|363717753|FG002|Part II|Protocol Violation|0|||
105465746|NCT01208207|363717754|FG003|Part II|Protocol Violation|1|||
105465747|NCT01208207|363717755|FG004|Part II|Protocol Violation|0|||
105465748|NCT01208207|363717756|FG005|Part II|Protocol Violation|0|||
105465749|NCT01208207|363717757|FG006|Part II|Protocol Violation|0|||
105465750|NCT01208207|363717751|FG000|Part II|Technical Problems|0|||
105465751|NCT01208207|363717752|FG001|Part II|Technical Problems|0|||
105465752|NCT01208207|363717753|FG002|Part II|Technical Problems|0|||
105465753|NCT01208207|363717754|FG003|Part II|Technical Problems|1|||
105465754|NCT01208207|363717755|FG004|Part II|Technical Problems|0|||
105465755|NCT01208207|363717756|FG005|Part II|Technical Problems|1|||
105465756|NCT01208207|363717757|FG006|Part II|Technical Problems|0|||
105465757|NCT05021978|363717758|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
105465758|NCT05021978|363717759|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
105465759|NCT05021978|363717760|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
105465760|NCT05021978|363717761|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
105465761|NCT05021978|363717758|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
105465762|NCT05021978|363717759|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
105465763|NCT05021978|363717760|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
105465764|NCT05021978|363717761|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
105465765|NCT02177032|363717764|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
105465766|NCT02177032|363717765|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
105465767|NCT02177032|363717766|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
105465768|NCT02177032|363717767|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
105465769|NCT02177032|363717764|FG000|Overall Study|Lost to Follow-up|0|||
105465770|NCT02177032|363717765|FG001|Overall Study|Lost to Follow-up|2|||
105465771|NCT02177032|363717766|FG002|Overall Study|Lost to Follow-up|0|||
105465772|NCT02177032|363717767|FG003|Overall Study|Lost to Follow-up|0|||
105553436|NCT02959437|364023405|FG001|Overall Study|Death|3|||
105553437|NCT02959437|364023406|FG002|Overall Study|Death|0|||
105465773|NCT02177032|363717764|FG000|Overall Study|OTHER|2|||
105465774|NCT02177032|363717765|FG001|Overall Study|OTHER|0|||
105465775|NCT02177032|363717766|FG002|Overall Study|OTHER|1|||
105465776|NCT02177032|363717767|FG003|Overall Study|OTHER|0|||
105465777|NCT02177032|363717764|FG000|Overall Study|Withdrawal by Subject|1|||
105465778|NCT02177032|363717765|FG001|Overall Study|Withdrawal by Subject|0|||
105465779|NCT02177032|363717766|FG002|Overall Study|Withdrawal by Subject|1|||
105465780|NCT02177032|363717767|FG003|Overall Study|Withdrawal by Subject|0|||
105668488|NCT00392925|364450260|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
105668489|NCT00392925|364450261|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
105668490|NCT00392925|364450262|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
105668491|NCT00392925|364450259|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
105668492|NCT00392925|364450260|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
105668493|NCT00392925|364450261|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
105668494|NCT00392925|364450262|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
105668495|NCT00392925|364450259|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
105668496|NCT00392925|364450260|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
105668497|NCT00392925|364450261|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
105668498|NCT00392925|364450262|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
105668499|NCT00392925|364450259|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
105553438|NCT02959437|364023407|FG003|Overall Study|Death|0|||
105553439|NCT02959437|364023404|FG000|Overall Study|Lost to Follow-up|3|||
105553440|NCT02959437|364023405|FG001|Overall Study|Lost to Follow-up|1|||
105553441|NCT02959437|364023406|FG002|Overall Study|Lost to Follow-up|0|||
105553442|NCT02959437|364023407|FG003|Overall Study|Lost to Follow-up|0|||
105553443|NCT02959437|364023404|FG000|Overall Study|Withdrawal by Subject|11|||
105553444|NCT02959437|364023405|FG001|Overall Study|Withdrawal by Subject|3|||
105553445|NCT02959437|364023406|FG002|Overall Study|Withdrawal by Subject|0|||
105553446|NCT02959437|364023407|FG003|Overall Study|Withdrawal by Subject|0|||
105553447|NCT02959437|364023404|FG000|Overall Study|Progressive Disease|9|||
105553448|NCT02959437|364023405|FG001|Overall Study|Progressive Disease|1|||
105553449|NCT02959437|364023406|FG002|Overall Study|Progressive Disease|0|||
105553450|NCT02959437|364023407|FG003|Overall Study|Progressive Disease|0|||
105553451|NCT02959437|364023404|FG000|Overall Study|Study Terminated by Sponsor|4|||
105553452|NCT02959437|364023405|FG001|Overall Study|Study Terminated by Sponsor|0|||
105553453|NCT02959437|364023406|FG002|Overall Study|Study Terminated by Sponsor|0|||
105553454|NCT02959437|364023407|FG003|Overall Study|Study Terminated by Sponsor|0|||
105553455|NCT02959437|364023404|FG000|Overall Study|Other Unspecified|2|||
105668500|NCT00392925|364450260|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
105668501|NCT00392925|364450261|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
105668502|NCT00392925|364450262|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
105668503|NCT00392925|364450259|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
105668504|NCT00392925|364450260|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
105668505|NCT00392925|364450261|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
105668506|NCT00392925|364450262|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
105668507|NCT04160988|364450263|FG000|Overall Study|poor image quality|28|||
105668508|NCT00664534|364450264|FG000|Overall Study|Adverse Event|2|||
105668509|NCT00664534|364450265|FG001|Overall Study|Adverse Event|3|||
105668510|NCT00664534|364450264|FG000|Overall Study|Lost to Follow-up|6|||
105668511|NCT00664534|364450265|FG001|Overall Study|Lost to Follow-up|10|||
105668512|NCT00664534|364450264|FG000|Overall Study|Protocol Violation|10|||
105668513|NCT00664534|364450265|FG001|Overall Study|Protocol Violation|8|||
105668514|NCT00664534|364450264|FG000|Overall Study|Withdrawal by Subject|7|||
105668515|NCT00664534|364450265|FG001|Overall Study|Withdrawal by Subject|6|||
105668516|NCT00664534|364450264|FG000|Overall Study|Physician Decision|8|||
105668517|NCT00664534|364450265|FG001|Overall Study|Physician Decision|0|||
105668518|NCT00664534|364450264|FG000|Overall Study|Sponsor decision|8|||
105668519|NCT00664534|364450265|FG001|Overall Study|Sponsor decision|6|||
105668520|NCT00600613|364450266|FG000|Overall Study|Protocol Deviation|1|||
105668521|NCT01245374|364450268|FG000|Overall Study|Protocol Violation|1|||
105668522|NCT01245374|364450268|FG000|Overall Study|Withdrawal by Subject|3|||
105668523|NCT00839956|364450269|FG000|Overall Study|Adverse Event|2|||
105668524|NCT00839956|364450269|FG000|Overall Study|Lack of Efficacy|6|||
105553456|NCT02959437|364023405|FG001|Overall Study|Other Unspecified|0|||
105553457|NCT02959437|364023406|FG002|Overall Study|Other Unspecified|0|||
105553458|NCT02959437|364023407|FG003|Overall Study|Other Unspecified|0|||
105465781|NCT00665652|363717768|FG000|Overall Study|Adverse Event|4|||
105465782|NCT00665652|363717768|FG000|Overall Study|Death|1|||
105465783|NCT00665652|363717768|FG000|Overall Study|No longer met inclusion criteria.|1|||
105465784|NCT02004093|363717772|FG000|Overall Study|Death|2|||
105465785|NCT02004093|363717773|FG001|Overall Study|Death|1|||
105465786|NCT02004093|363717772|FG000|Overall Study|Lack of Efficacy|66|||
105465787|NCT02004093|363717773|FG001|Overall Study|Lack of Efficacy|62|||
105465788|NCT02004093|363717772|FG000|Overall Study|Protocol Violation|0|||
105465789|NCT02004093|363717773|FG001|Overall Study|Protocol Violation|1|||
105465790|NCT02004093|363717772|FG000|Overall Study|Lost to Follow-up|0|||
105465791|NCT02004093|363717773|FG001|Overall Study|Lost to Follow-up|1|||
105465792|NCT02004093|363717772|FG000|Overall Study|Withdrawal by Subject|3|||
105465793|NCT02004093|363717773|FG001|Overall Study|Withdrawal by Subject|7|||
105465794|NCT02004093|363717772|FG000|Overall Study|Other|3|||
105465795|NCT02004093|363717773|FG001|Overall Study|Other|1|||
105465796|NCT01055197|363717776|FG000|Overall Study|Protocol Violation|7|||
105465797|NCT01055197|363717777|FG001|Overall Study|Protocol Violation|2|||
105465798|NCT01055197|363717776|FG000|Overall Study|Withdrawal by Subject|2|||
105553459|NCT03150056|364023414|FG000|Overall Study|Withdrawal by Subject|0|||
105553460|NCT03150056|364023415|FG001|Overall Study|Withdrawal by Subject|0|||
105553461|NCT03150056|364023416|FG002|Overall Study|Withdrawal by Subject|0|||
105553462|NCT03150056|364023417|FG003|Overall Study|Withdrawal by Subject|0|||
105553463|NCT03150056|364023418|FG004|Overall Study|Withdrawal by Subject|0|||
105553464|NCT03150056|364023419|FG005|Overall Study|Withdrawal by Subject|2|||
105553465|NCT03150056|364023414|FG000|Overall Study|Study terminated by Sponsor|1|||
105553466|NCT03150056|364023415|FG001|Overall Study|Study terminated by Sponsor|3|||
105553467|NCT03150056|364023416|FG002|Overall Study|Study terminated by Sponsor|1|||
105553468|NCT03150056|364023417|FG003|Overall Study|Study terminated by Sponsor|1|||
105553469|NCT03150056|364023418|FG004|Overall Study|Study terminated by Sponsor|5|||
105553470|NCT03150056|364023419|FG005|Overall Study|Study terminated by Sponsor|6|||
105553471|NCT03150056|364023414|FG000|Overall Study|Death|9|||
105553472|NCT03150056|364023415|FG001|Overall Study|Death|2|||
105553473|NCT03150056|364023416|FG002|Overall Study|Death|2|||
105553474|NCT03150056|364023417|FG003|Overall Study|Death|7|||
105553475|NCT03150056|364023418|FG004|Overall Study|Death|8|||
105553476|NCT03150056|364023419|FG005|Overall Study|Death|10|||
105553477|NCT02952924|364023420|FG000|Overall Study|Protocol Violation|0|||
105668525|NCT00839956|364450269|FG000|Overall Study|Physician Decision|1|||
105668526|NCT00839956|364450269|FG000|Overall Study|Withdrawal by Subject|3|||
105668527|NCT02227992|364450270|FG000|Overall Study|Lost to Follow-up|1|||
105668528|NCT02227992|364450271|FG001|Overall Study|Lost to Follow-up|1|||
105668529|NCT01509547|364450274|FG000|Overall Study|Lost to Follow-up|24|||
105668530|NCT01509547|364450275|FG001|Overall Study|Lost to Follow-up|14|||
105668531|NCT01509547|364450274|FG000|Overall Study|Withdrawal by Subject|11|||
105668532|NCT01509547|364450275|FG001|Overall Study|Withdrawal by Subject|24|||
105668533|NCT01509547|364450274|FG000|Overall Study|Physician Decision|0|||
105668534|NCT01509547|364450275|FG001|Overall Study|Physician Decision|1|||
105668535|NCT00402051|364450278|FG000|Overall Study|Progressive Disease|13|||
105668536|NCT00402051|364450279|FG001|Overall Study|Progressive Disease|20|||
105668537|NCT00402051|364450278|FG000|Overall Study|Adverse Event|11|||
105668538|NCT00402051|364450279|FG001|Overall Study|Adverse Event|4|||
105668539|NCT00402051|364450278|FG000|Overall Study|Physician Decision|7|||
105668540|NCT00402051|364450279|FG001|Overall Study|Physician Decision|3|||
105668541|NCT00402051|364450278|FG000|Overall Study|Withdrawal by Subject|3|||
105668542|NCT00402051|364450279|FG001|Overall Study|Withdrawal by Subject|3|||
105668543|NCT00402051|364450278|FG000|Overall Study|Death - Related to Study Drug|1|||
105668544|NCT00402051|364450279|FG001|Overall Study|Death - Related to Study Drug|2|||
105668545|NCT00402051|364450278|FG000|Overall Study|Death Due to Study Disease|2|||
105668546|NCT00402051|364450279|FG001|Overall Study|Death Due to Study Disease|1|||
105668547|NCT00402051|364450278|FG000|Overall Study|Death Due to Adverse Event|0|||
105668548|NCT00402051|364450279|FG001|Overall Study|Death Due to Adverse Event|2|||
105668549|NCT00402051|364450278|FG000|Overall Study|Lost to Follow-up|1|||
105465799|NCT01055197|363717777|FG001|Overall Study|Withdrawal by Subject|0|||
105465800|NCT02504151|363717778|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
105553478|NCT02952924|364023421|FG001|Overall Study|Protocol Violation|0|||
105668550|NCT00402051|364450279|FG001|Overall Study|Lost to Follow-up|0|||
105668551|NCT01254747|364450292|FG000|Overall Study|Unacceptable subjective vision|0|||
105668552|NCT01254747|364450293|FG001|Overall Study|Unacceptable subjective vision|0|||
105465801|NCT02504151|363717779|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
105465802|NCT02504151|363717778|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
105465803|NCT02504151|363717779|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
105465804|NCT02504151|363717778|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
105465805|NCT02504151|363717779|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
105553479|NCT02952924|364023422|FG002|Overall Study|Protocol Violation|0|||
105553480|NCT02952924|364023423|FG003|Overall Study|Protocol Violation|0|||
105553481|NCT02952924|364023424|FG004|Overall Study|Protocol Violation|0|||
105553482|NCT02952924|364023425|FG005|Overall Study|Protocol Violation|0|||
105553483|NCT02952924|364023426|FG006|Overall Study|Protocol Violation|0|||
105668553|NCT01254747|364450294|FG002|Overall Study|Unacceptable subjective vision|0|||
105668554|NCT01254747|364450295|FG003|Overall Study|Unacceptable subjective vision|2|||
105668555|NCT01254747|364450292|FG000|Overall Study|Difficult removal handling|0|||
105668556|NCT01254747|364450293|FG001|Overall Study|Difficult removal handling|0|||
105668557|NCT01254747|364450294|FG002|Overall Study|Difficult removal handling|1|||
105668558|NCT01254747|364450295|FG003|Overall Study|Difficult removal handling|0|||
105668559|NCT01254747|364450292|FG000|Overall Study|Symptoms and problems|0|||
105668560|NCT01254747|364450293|FG001|Overall Study|Symptoms and problems|2|||
105465806|NCT02504151|363717778|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
105465807|NCT02504151|363717779|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
105465808|NCT05038982|363717780|FG000|Overall Study|Withdrawal by Subject|0|||
105465809|NCT05038982|363717781|FG001|Overall Study|Withdrawal by Subject|2|||
105465810|NCT02691507|363717782|FG000|Overall Study|Missed Visit 3|0|||
105465811|NCT02691507|363717783|FG001|Overall Study|Missed Visit 3|1|||
105465812|NCT02557139|363717787|FG000|Overall Study|Significant liver elevation|1|||
105465813|NCT02557139|363717788|FG001|Overall Study|Significant liver elevation|0|||
105465814|NCT02557139|363717789|FG002|Overall Study|Significant liver elevation|1|||
105465815|NCT02557139|363717787|FG000|Overall Study|Withdrawal by Subject|1|||
105465816|NCT02557139|363717788|FG001|Overall Study|Withdrawal by Subject|0|||
105465817|NCT02557139|363717789|FG002|Overall Study|Withdrawal by Subject|0|||
105465818|NCT02557139|363717787|FG000|Overall Study|Illness of prohibited medication|0|||
105465819|NCT02557139|363717788|FG001|Overall Study|Illness of prohibited medication|0|||
105465820|NCT02557139|363717789|FG002|Overall Study|Illness of prohibited medication|1|||
105465821|NCT01352715|363717790|FG000|Overall Study|Death|3|||
105465822|NCT01352715|363717791|FG001|Overall Study|Death|3|||
105465823|NCT01352715|363717790|FG000|Overall Study|Lost to Follow-up|5|||
105465824|NCT01352715|363717791|FG001|Overall Study|Lost to Follow-up|7|||
105465825|NCT01352715|363717790|FG000|Overall Study|Withdrawal by Subject|4|||
105465826|NCT01352715|363717791|FG001|Overall Study|Withdrawal by Subject|8|||
105465827|NCT01352715|363717790|FG000|Overall Study|site closure|16|||
105465828|NCT01352715|363717791|FG001|Overall Study|site closure|15|||
105465829|NCT01352715|363717790|FG000|Overall Study|no final visit in closeout period|15|||
105465830|NCT01352715|363717791|FG001|Overall Study|no final visit in closeout period|12|||
105465831|NCT01352715|363717790|FG000|Overall Study|major ineligibility|2|||
105465832|NCT01352715|363717791|FG001|Overall Study|major ineligibility|1|||
105465833|NCT01663103|363717792|FG000|Overall Study|Withdrawal by Subject|1|||
105465834|NCT01663103|363717793|FG001|Overall Study|Withdrawal by Subject|2|||
105465835|NCT01663103|363717792|FG000|Overall Study|Adverse Event|1|||
105465836|NCT01663103|363717793|FG001|Overall Study|Adverse Event|0|||
105465837|NCT01663103|363717792|FG000|Overall Study|dog bite|1|||
105465838|NCT01663103|363717793|FG001|Overall Study|dog bite|0|||
105465839|NCT03944577|363717794|FG000|Overall Study|Adverse Event|3|||
105465840|NCT00391586|363717795|FG000|Overall Study|Progressive disease|13|||
105465841|NCT00391586|363717795|FG000|Overall Study|Adverse Event|5|||
105465842|NCT00391586|363717795|FG000|Overall Study|Physician Decision|2|||
105465843|NCT00391586|363717795|FG000|Overall Study|Death|4|||
105465844|NCT01658436|363717804|FG000|Overall Study|Adverse Event|6|||
105465845|NCT01658436|363717805|FG001|Overall Study|Adverse Event|5|||
105465846|NCT01658436|363717804|FG000|Overall Study|Physician Decision|1|||
105465847|NCT01658436|363717805|FG001|Overall Study|Physician Decision|0|||
105465848|NCT01658436|363717804|FG000|Overall Study|Progressive disease|12|||
105465849|NCT01658436|363717805|FG001|Overall Study|Progressive disease|4|||
105465850|NCT01658436|363717804|FG000|Overall Study|Study terminated by sponsor|0|||
105465851|NCT01658436|363717805|FG001|Overall Study|Study terminated by sponsor|1|||
105465852|NCT01658436|363717804|FG000|Overall Study|Subject/guardian decision|0|||
105465853|NCT01658436|363717805|FG001|Overall Study|Subject/guardian decision|1|||
105465854|NCT01658436|363717804|FG000|Overall Study|Death|1|||
105465855|NCT01658436|363717805|FG001|Overall Study|Death|0|||
105465856|NCT00949702|363717806|FG000|Overall Study|Death|40|||
105465857|NCT00949702|363717806|FG000|Overall Study|Disease progression|7|||
105465858|NCT00949702|363717806|FG000|Overall Study|Withdrawal of consent|1|||
105668561|NCT01254747|364450294|FG002|Overall Study|Symptoms and problems|1|||
105668562|NCT01254747|364450295|FG003|Overall Study|Symptoms and problems|0|||
105668563|NCT01254747|364450292|FG000|Overall Study|Lost to Follow-up|0|||
105668564|NCT01254747|364450293|FG001|Overall Study|Lost to Follow-up|0|||
105668565|NCT01254747|364450294|FG002|Overall Study|Lost to Follow-up|1|||
105668566|NCT01254747|364450295|FG003|Overall Study|Lost to Follow-up|0|||
105668567|NCT01254747|364450292|FG000|Overall Study|Biomicroscopy|0|||
105465859|NCT01654302|363717807|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
105465860|NCT01654302|363717808|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
105465861|NCT03133793|363717809|FG000|Overall Study|Withdrawal by Subject|0|||
105465862|NCT03133793|363717810|FG001|Overall Study|Withdrawal by Subject|4|||
105465863|NCT03133793|363717811|FG002|Overall Study|Withdrawal by Subject|2|||
105465864|NCT03133793|363717812|FG003|Overall Study|Withdrawal by Subject|4|||
105465865|NCT03133793|363717809|FG000|Overall Study|Lost to Follow-up|1|||
105465866|NCT03133793|363717810|FG001|Overall Study|Lost to Follow-up|0|||
105465867|NCT03133793|363717811|FG002|Overall Study|Lost to Follow-up|2|||
105465868|NCT03133793|363717812|FG003|Overall Study|Lost to Follow-up|0|||
105465869|NCT03133793|363717809|FG000|Overall Study|Death|0|||
105465870|NCT03133793|363717810|FG001|Overall Study|Death|0|||
105465871|NCT03133793|363717811|FG002|Overall Study|Death|0|||
105465872|NCT03133793|363717812|FG003|Overall Study|Death|1|||
105465873|NCT02952820|363717813|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
105465874|NCT02952820|363717814|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
105465875|NCT02952820|363717815|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
105465876|NCT02952820|363717813|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
105465877|NCT02952820|363717814|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
105465878|NCT02952820|363717815|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
105465879|NCT02952820|363717813|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
105465880|NCT02952820|363717814|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
105465881|NCT02952820|363717815|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
105465882|NCT02952820|363717813|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
105465883|NCT02952820|363717814|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
105465884|NCT02952820|363717815|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
105465885|NCT02952820|363717813|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
105465886|NCT02952820|363717814|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
105465887|NCT02952820|363717815|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
105465888|NCT02952820|363717813|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
105465889|NCT02952820|363717814|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
105465890|NCT02952820|363717815|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
105465891|NCT02952820|363717813|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
105465892|NCT02952820|363717814|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
105465893|NCT02952820|363717815|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
105465894|NCT02952820|363717813|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
105465895|NCT02952820|363717814|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
105465896|NCT02952820|363717815|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
105465897|NCT02952820|363717813|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
105465898|NCT02952820|363717814|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
105465899|NCT02952820|363717815|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
105465900|NCT02952820|363717813|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
105465901|NCT02952820|363717814|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
105465902|NCT02952820|363717815|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
105465903|NCT02952820|363717813|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
105465904|NCT02952820|363717814|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
105465905|NCT02952820|363717815|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
105465906|NCT02952820|363717813|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
105465907|NCT02952820|363717814|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
105465908|NCT02952820|363717815|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
105465909|NCT02952820|363717813|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
105465910|NCT02952820|363717814|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
105465911|NCT02952820|363717815|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
105465912|NCT02952820|363717813|FG000|Active Treatment Period (6 Months)|Not treated|0|||
105465913|NCT02952820|363717814|FG001|Active Treatment Period (6 Months)|Not treated|0|||
105465914|NCT02952820|363717815|FG002|Active Treatment Period (6 Months)|Not treated|1|||
105465915|NCT01599637|363717816|FG000|Overall Study|administrative problems|0|||
105465916|NCT01599637|363717817|FG001|Overall Study|administrative problems|2|||
105465917|NCT01599637|363717818|FG002|Overall Study|administrative problems|0|||
105465918|NCT01599637|363717816|FG000|Overall Study|Adverse Event|1|||
105465919|NCT01599637|363717817|FG001|Overall Study|Adverse Event|0|||
105465920|NCT01599637|363717818|FG002|Overall Study|Adverse Event|0|||
105465921|NCT00993967|363717820|FG000|Overall Study|Adverse Event|8|||
105465922|NCT00993967|363717820|FG000|Overall Study|Death|1|||
105465923|NCT00993967|363717820|FG000|Overall Study|Lost to Follow-up|14|||
105465924|NCT00993967|363717820|FG000|Overall Study|Withdrawal by Subject|36|||
105668568|NCT01254747|364450293|FG001|Overall Study|Biomicroscopy|0|||
105668569|NCT01254747|364450294|FG002|Overall Study|Biomicroscopy|1|||
105668570|NCT01254747|364450295|FG003|Overall Study|Biomicroscopy|0|||
105668571|NCT01254747|364450292|FG000|Overall Study|Discomfort|0|||
105668572|NCT01254747|364450293|FG001|Overall Study|Discomfort|4|||
105668573|NCT01254747|364450294|FG002|Overall Study|Discomfort|0|||
105668574|NCT01254747|364450295|FG003|Overall Study|Discomfort|0|||
105668575|NCT00570908|364450296|FG000|Overall Study|Adverse Event|5|||
105668576|NCT00570908|364450296|FG000|Overall Study|Withdrawal by Subject|2|||
105668577|NCT01495598|364450300|FG000|Overall Study|Death during follow up period|2|||
105668578|NCT01495598|364450300|FG000|Overall Study|Death on study|1|||
105668579|NCT01495598|364450300|FG000|Overall Study|Lost to Follow-up|3|||
105668580|NCT01495598|364450300|FG000|Overall Study|Physician Decision|8|||
105668581|NCT02671500|364450306|FG000|Overall Study|Lack of Efficacy|12|||
105668582|NCT02671500|364450306|FG000|Overall Study|Lost to Follow-up|2|||
105668583|NCT00798434|364450307|FG000|Double-Blind|Adverse Event|22|||
105668584|NCT00798434|364450308|FG001|Double-Blind|Adverse Event|46|||
105668585|NCT00798434|364450307|FG000|Double-Blind|Death|0|||
105668586|NCT00798434|364450308|FG001|Double-Blind|Death|1|||
105668587|NCT00798434|364450307|FG000|Double-Blind|Lost to Follow-up|1|||
105668588|NCT00798434|364450308|FG001|Double-Blind|Lost to Follow-up|0|||
105668589|NCT00798434|364450307|FG000|Double-Blind|Lack of Efficacy|8|||
105668590|NCT00798434|364450308|FG001|Double-Blind|Lack of Efficacy|12|||
105668591|NCT00798434|364450307|FG000|Double-Blind|Withdrawal by Subject|17|||
105668592|NCT00798434|364450308|FG001|Double-Blind|Withdrawal by Subject|14|||
105668593|NCT00798434|364450307|FG000|Double-Blind|Protocol Violation|1|||
105668594|NCT00798434|364450308|FG001|Double-Blind|Protocol Violation|4|||
105668595|NCT00798434|364450307|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
105668596|NCT00798434|364450308|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
105668597|NCT00798434|364450307|FG000|Double-Blind|Other|1|||
105668598|NCT00798434|364450308|FG001|Double-Blind|Other|0|||
105668599|NCT00798434|364450307|FG000|Double-Blind|Not Treated|3|||
105668600|NCT00798434|364450308|FG001|Double-Blind|Not Treated|6|||
105668601|NCT00798434|364450307|FG000|Open-Label|Adverse Event|33|||
105668602|NCT00798434|364450308|FG001|Open-Label|Adverse Event|11|||
105668603|NCT00798434|364450307|FG000|Open-Label|Lack of Efficacy|5|||
105668604|NCT00798434|364450308|FG001|Open-Label|Lack of Efficacy|11|||
105668605|NCT00798434|364450307|FG000|Open-Label|Withdrawal by Subject|2|||
105668606|NCT00798434|364450308|FG001|Open-Label|Withdrawal by Subject|7|||
105668607|NCT00798434|364450307|FG000|Open-Label|Protocol Violation|1|||
105668608|NCT00798434|364450308|FG001|Open-Label|Protocol Violation|0|||
105668609|NCT00798434|364450307|FG000|Open-Label|Other|1|||
105668610|NCT00798434|364450308|FG001|Open-Label|Other|2|||
105668611|NCT00798434|364450307|FG000|Open-Label|Not Treated|0|||
105668612|NCT00798434|364450308|FG001|Open-Label|Not Treated|1|||
105668613|NCT01447576|364450313|FG000|Overall Study|Lost to Follow-up|52|||
105668614|NCT01447576|364450313|FG000|Overall Study|Adverse Event|127|||
105668615|NCT01447576|364450313|FG000|Overall Study|Participant met withdrawal criteria|40|||
105668616|NCT01447576|364450313|FG000|Overall Study|Withdrawal by Subject|100|||
105465925|NCT00993967|363717820|FG000|Overall Study|Protocol Violation|2|||
105668617|NCT01447576|364450313|FG000|Overall Study|Protocol deviation|83|||
105668618|NCT01447576|364450313|FG000|Overall Study|Lack of Efficacy|68|||
105668619|NCT01447576|364450313|FG000|Overall Study|Physician Decision|6|||
105668620|NCT02579772|364450314|FG000|Overall Study|Withdrawal by Subject|0|||
105668621|NCT02579772|364450315|FG001|Overall Study|Withdrawal by Subject|1|||
105668622|NCT02579772|364450314|FG000|Overall Study|Usage of additional antioxidants|1|||
105668623|NCT02579772|364450315|FG001|Overall Study|Usage of additional antioxidants|0|||
105668624|NCT02579772|364450314|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
105668625|NCT02579772|364450315|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
105668626|NCT04942366|364452175|FG000|Overall Study|Withdrawal by Subject|5|||
105668627|NCT04942366|364452176|FG001|Overall Study|Withdrawal by Subject|5|||
105668628|NCT02113124|364452177|FG000|Overall Study|Unable to retrieve blood sample|1|||
105668629|NCT02113124|364452178|FG001|Overall Study|Unable to retrieve blood sample|1|||
105553484|NCT02952924|364023427|FG007|Overall Study|Protocol Violation|0|||
105553485|NCT02952924|364023428|FG008|Overall Study|Protocol Violation|0|||
105553486|NCT02952924|364023429|FG009|Overall Study|Protocol Violation|0|||
105553487|NCT02952924|364023430|FG010|Overall Study|Protocol Violation|0|||
105553488|NCT02952924|364023431|FG011|Overall Study|Protocol Violation|0|||
105553489|NCT02952924|364023432|FG012|Overall Study|Protocol Violation|0|||
105553490|NCT02952924|364023433|FG013|Overall Study|Protocol Violation|0|||
105553491|NCT02952924|364023434|FG014|Overall Study|Protocol Violation|0|||
105553492|NCT02952924|364023435|FG015|Overall Study|Protocol Violation|0|||
105553493|NCT02952924|364023436|FG016|Overall Study|Protocol Violation|0|||
105553494|NCT02952924|364023437|FG017|Overall Study|Protocol Violation|0|||
105553495|NCT02952924|364023438|FG018|Overall Study|Protocol Violation|0|||
105553496|NCT02952924|364023439|FG019|Overall Study|Protocol Violation|1|||
105553497|NCT02952924|364023440|FG020|Overall Study|Protocol Violation|0|||
105553498|NCT02952924|364023441|FG021|Overall Study|Protocol Violation|0|||
105553499|NCT02952924|364023420|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
105553500|NCT02952924|364023421|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
105553501|NCT02952924|364023422|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
105553502|NCT02952924|364023423|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
105553503|NCT02952924|364023424|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
105553504|NCT02952924|364023425|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
105668630|NCT02514239|364452179|FG000|Overall Study|Refused to continue trial medication|0|||
105668631|NCT02514239|364452180|FG001|Overall Study|Refused to continue trial medication|0|||
105668632|NCT02514239|364452181|FG002|Overall Study|Refused to continue trial medication|0|||
105668633|NCT02514239|364452182|FG003|Overall Study|Refused to continue trial medication|0|||
105668634|NCT02514239|364452183|FG004|Overall Study|Refused to continue trial medication|0|||
105668635|NCT02514239|364452184|FG005|Overall Study|Refused to continue trial medication|0|||
105668636|NCT02514239|364452185|FG006|Overall Study|Refused to continue trial medication|0|||
105668637|NCT02514239|364452186|FG007|Overall Study|Refused to continue trial medication|0|||
105668638|NCT02514239|364452187|FG008|Overall Study|Refused to continue trial medication|0|||
105668639|NCT02514239|364452188|FG009|Overall Study|Refused to continue trial medication|1|||
105668640|NCT02514239|364452179|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
105341322|NCT03875092|363251884|FG001|Overall Study|Adverse Event|5|||
105465926|NCT00515619|363717821|FG000|Overall Study|Adverse Event|34|||
105465927|NCT00515619|363717821|FG000|Overall Study|Lack of Efficacy|92|||
105341323|NCT03875092|363251883|FG000|Overall Study|Death|44|||
105341324|NCT03875092|363251884|FG001|Overall Study|Death|51|||
105341325|NCT03875092|363251883|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
105465928|NCT00515619|363717821|FG000|Overall Study|Withdrawal by Subject|66|||
105465929|NCT00515619|363717821|FG000|Overall Study|Protocol Violation|3|||
105465930|NCT00515619|363717821|FG000|Overall Study|Lost to Follow-up|4|||
105465931|NCT00515619|363717821|FG000|Overall Study|Unsatisfactory compliance|6|||
105465932|NCT00515619|363717821|FG000|Overall Study|Other: Site discontinuing trials|2|||
105465933|NCT00515619|363717821|FG000|Overall Study|Other: Subject cannot attend visits|2|||
105465934|NCT00515619|363717821|FG000|Overall Study|Other: Subject required surgery|1|||
105465935|NCT00515619|363717821|FG000|Overall Study|Other: Subject moved to another country|1|||
105668641|NCT02514239|364452180|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
105668642|NCT02514239|364452181|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
105668643|NCT02514239|364452182|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
105668644|NCT02514239|364452183|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
105668645|NCT02514239|364452184|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
105668646|NCT02514239|364452185|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
105668647|NCT02514239|364452186|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
105668648|NCT02514239|364452187|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
105668649|NCT02514239|364452188|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
105668650|NCT02514239|364452179|FG000|Overall Study|Not treated|0|||
105668651|NCT02514239|364452180|FG001|Overall Study|Not treated|1|||
105668652|NCT02514239|364452181|FG002|Overall Study|Not treated|0|||
105668653|NCT02514239|364452182|FG003|Overall Study|Not treated|0|||
105668654|NCT02514239|364452183|FG004|Overall Study|Not treated|0|||
105668655|NCT02514239|364452184|FG005|Overall Study|Not treated|0|||
105668656|NCT02514239|364452185|FG006|Overall Study|Not treated|0|||
105668657|NCT02514239|364452186|FG007|Overall Study|Not treated|0|||
105668658|NCT02514239|364452187|FG008|Overall Study|Not treated|0|||
105668659|NCT02514239|364452188|FG009|Overall Study|Not treated|0|||
105668660|NCT02514239|364452179|FG000|Overall Study|Other Adverse Events|2|||
105668661|NCT02514239|364452180|FG001|Overall Study|Other Adverse Events|0|||
105668662|NCT02514239|364452181|FG002|Overall Study|Other Adverse Events|0|||
105553505|NCT02952924|364023426|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
105668663|NCT02514239|364452182|FG003|Overall Study|Other Adverse Events|1|||
105668664|NCT02514239|364452183|FG004|Overall Study|Other Adverse Events|0|||
105668665|NCT02514239|364452184|FG005|Overall Study|Other Adverse Events|1|||
105668666|NCT02514239|364452185|FG006|Overall Study|Other Adverse Events|0|||
105668667|NCT02514239|364452186|FG007|Overall Study|Other Adverse Events|1|||
105465936|NCT00515619|363717821|FG000|Overall Study|Other: Investigator decision|1|||
105465937|NCT00515619|363717821|FG000|Overall Study|Other: Subject became pregnant|1|||
105465938|NCT00515619|363717821|FG000|Overall Study|Other: Request from sponsor|1|||
105341326|NCT03875092|363251884|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
105668668|NCT02514239|364452187|FG008|Overall Study|Other Adverse Events|2|||
105668669|NCT02514239|364452188|FG009|Overall Study|Other Adverse Events|0|||
105668670|NCT02514239|364452179|FG000|Overall Study|Progressive disease|3|||
105668671|NCT02514239|364452180|FG001|Overall Study|Progressive disease|3|||
105668672|NCT02514239|364452181|FG002|Overall Study|Progressive disease|2|||
105668673|NCT02514239|364452182|FG003|Overall Study|Progressive disease|2|||
105668674|NCT02514239|364452183|FG004|Overall Study|Progressive disease|3|||
105668675|NCT02514239|364452184|FG005|Overall Study|Progressive disease|3|||
105668676|NCT02514239|364452185|FG006|Overall Study|Progressive disease|4|||
105668677|NCT02514239|364452186|FG007|Overall Study|Progressive disease|2|||
105668678|NCT02514239|364452187|FG008|Overall Study|Progressive disease|5|||
105668679|NCT02514239|364452188|FG009|Overall Study|Progressive disease|0|||
105465939|NCT00515619|363717821|FG000|Overall Study|Other: Drug available on license|1|||
105465940|NCT00515619|363717821|FG000|Overall Study|Other: Subject interested in other AED|1|||
105465941|NCT03067077|363717822|FG000|Overall Study|Did not receive surgery|4|||
105465942|NCT03067077|363717823|FG001|Overall Study|Did not receive surgery|5|||
105341327|NCT04984278|363251885|FG000|Period 1|Withdrawal by Subject|1|||
105668680|NCT01901419|364452191|FG000|Overall Study|Protocol Violation|2|||
105668681|NCT01901419|364452192|FG001|Overall Study|Protocol Violation|6|||
105668682|NCT01901419|364452191|FG000|Overall Study|unavailable researchers|6|||
105553506|NCT02952924|364023427|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
105553507|NCT02952924|364023428|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
105553508|NCT02952924|364023429|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
105553509|NCT02952924|364023430|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
105553510|NCT02952924|364023431|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
105553511|NCT02952924|364023432|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
105553512|NCT02952924|364023433|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
105553513|NCT02952924|364023434|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
105553514|NCT02952924|364023435|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
105553515|NCT02952924|364023436|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
105553516|NCT02952924|364023437|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
105341328|NCT04984278|363251886|FG001|Period 1|Withdrawal by Subject|0|||
105553517|NCT02952924|364023438|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
105553518|NCT02952924|364023439|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
105553519|NCT02952924|364023440|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
105553520|NCT02952924|364023441|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
105553521|NCT02952924|364023420|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553522|NCT02952924|364023421|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553523|NCT02952924|364023422|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553524|NCT02952924|364023423|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553525|NCT02952924|364023424|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553526|NCT02952924|364023425|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553527|NCT02952924|364023426|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553528|NCT02952924|364023427|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553529|NCT02952924|364023428|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553530|NCT02952924|364023429|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553531|NCT02952924|364023430|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553532|NCT02952924|364023431|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553533|NCT02952924|364023432|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553534|NCT02952924|364023433|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553535|NCT02952924|364023434|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553536|NCT02952924|364023435|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553537|NCT02952924|364023436|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553538|NCT02952924|364023437|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553539|NCT02952924|364023438|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553540|NCT02952924|364023439|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553541|NCT02952924|364023440|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
105553542|NCT02952924|364023441|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
105553543|NCT02952924|364023420|FG000|Overall Study|Noncompliance with study drug|0|||
105553544|NCT02952924|364023421|FG001|Overall Study|Noncompliance with study drug|0|||
105553545|NCT02952924|364023422|FG002|Overall Study|Noncompliance with study drug|0|||
105465943|NCT03067077|363717822|FG000|Overall Study|Lost to Follow-up|3|||
105465944|NCT03067077|363717823|FG001|Overall Study|Lost to Follow-up|2|||
105465945|NCT02170077|363717824|FG000|Overall Study|Withdrawal by Subject|3|||
105465946|NCT02170077|363717825|FG001|Overall Study|Withdrawal by Subject|4|||
105465947|NCT02170077|363717826|FG002|Overall Study|Withdrawal by Subject|2|||
105465948|NCT02170077|363717824|FG000|Overall Study|Adverse Event|4|||
105465949|NCT02170077|363717825|FG001|Overall Study|Adverse Event|4|||
105668683|NCT01901419|364452192|FG001|Overall Study|unavailable researchers|3|||
105668684|NCT03838731|364452197|FG000|Overall Study|Pregnancy|0|||
105668685|NCT03838731|364452198|FG001|Overall Study|Pregnancy|1|||
105668686|NCT03838731|364452197|FG000|Overall Study|Withdrawal of consent|1|||
105668687|NCT03838731|364452198|FG001|Overall Study|Withdrawal of consent|0|||
105668688|NCT01088984|364452203|FG000|Phase 1|Death|2|||
105465950|NCT02170077|363717826|FG002|Overall Study|Adverse Event|4|||
105465951|NCT02170077|363717824|FG000|Overall Study|Lost to Follow-up|0|||
105465952|NCT02170077|363717825|FG001|Overall Study|Lost to Follow-up|1|||
105465953|NCT02170077|363717826|FG002|Overall Study|Lost to Follow-up|0|||
105465954|NCT02170077|363717824|FG000|Overall Study|Exclusion criteria|2|||
105465955|NCT02170077|363717825|FG001|Overall Study|Exclusion criteria|2|||
105465956|NCT02170077|363717826|FG002|Overall Study|Exclusion criteria|5|||
105465957|NCT02170077|363717824|FG000|Overall Study|Exacerbation of seizures|0|||
105465958|NCT02170077|363717825|FG001|Overall Study|Exacerbation of seizures|2|||
105465959|NCT02170077|363717826|FG002|Overall Study|Exacerbation of seizures|1|||
105465960|NCT01958164|363717827|FG000|Overall Study|Adverse Event|0|||
105465961|NCT01958164|363717828|FG001|Overall Study|Adverse Event|2|||
105465962|NCT01958164|363717827|FG000|Overall Study|Lost to Follow-up|2|||
105465963|NCT01958164|363717828|FG001|Overall Study|Lost to Follow-up|3|||
105465964|NCT02963506|363717834|FG000|Double-Blind Period|Adverse Event|0|||
105465965|NCT02963506|363717835|FG001|Double-Blind Period|Adverse Event|0|||
105465966|NCT02963506|363717836|FG002|Double-Blind Period|Adverse Event|1|||
105465967|NCT02963506|363717837|FG003|Double-Blind Period|Adverse Event|0|||
105668689|NCT01088984|364452204|FG001|Phase 1|Death|1|||
105668690|NCT01088984|364452203|FG000|Phase 1|Disease Progression|2|||
105668691|NCT01088984|364452204|FG001|Phase 1|Disease Progression|4|||
105465968|NCT02963506|363717838|FG004|Double-Blind Period|Adverse Event|0|||
105465969|NCT02963506|363717839|FG005|Double-Blind Period|Adverse Event|0|||
105465970|NCT02963506|363717840|FG006|Double-Blind Period|Adverse Event|0|||
105465971|NCT02963506|363717841|FG007|Double-Blind Period|Adverse Event|0|||
105465972|NCT02963506|363717842|FG008|Double-Blind Period|Adverse Event|0|||
105465973|NCT02963506|363717843|FG009|Double-Blind Period|Adverse Event|0|||
105465974|NCT02963506|363717844|FG010|Double-Blind Period|Adverse Event|0|||
105465975|NCT02963506|363717845|FG011|Double-Blind Period|Adverse Event|0|||
105465976|NCT02963506|363717846|FG012|Double-Blind Period|Adverse Event|0|||
105465977|NCT02963506|363717834|FG000|Double-Blind Period|Death|0|||
105465978|NCT02963506|363717835|FG001|Double-Blind Period|Death|0|||
105465979|NCT02963506|363717836|FG002|Double-Blind Period|Death|0|||
105668692|NCT01088984|364452203|FG000|Phase 1|Other|1|||
105668693|NCT01088984|364452204|FG001|Phase 1|Other|1|||
105668694|NCT01088984|364452203|FG000|Phase 2|Death|0|||
105668695|NCT01088984|364452204|FG001|Phase 2|Death|5|||
105668696|NCT01088984|364452203|FG000|Phase 2|Withdrawal by Subject|0|||
105668697|NCT01088984|364452204|FG001|Phase 2|Withdrawal by Subject|1|||
105668698|NCT01088984|364452203|FG000|Phase 2|DIsease Progression|0|||
105668699|NCT01088984|364452204|FG001|Phase 2|DIsease Progression|25|||
105668700|NCT01088984|364452203|FG000|Phase 2|Other|0|||
105668701|NCT01088984|364452204|FG001|Phase 2|Other|1|||
105668702|NCT00699153|364452205|FG000|Overall Study|Lost to Follow-up|1|||
105668703|NCT00699153|364452206|FG001|Overall Study|Lost to Follow-up|0|||
105668704|NCT00699153|364452205|FG000|Overall Study|Adverse Event|0|||
105668705|NCT00699153|364452206|FG001|Overall Study|Adverse Event|2|||
105668706|NCT00699153|364452205|FG000|Overall Study|Protocol Violation|1|||
105668707|NCT00699153|364452206|FG001|Overall Study|Protocol Violation|0|||
105668708|NCT00699153|364452205|FG000|Overall Study|Travel Problem|1|||
105668709|NCT00699153|364452206|FG001|Overall Study|Travel Problem|0|||
105668710|NCT01228318|364452216|FG000|Overall Study|Clinic no show to receive intervention|1|||
105668711|NCT01228318|364452217|FG001|Overall Study|Clinic no show to receive intervention|0|||
105668712|NCT01228318|364452216|FG000|Overall Study|Unable to contact|2|||
105341329|NCT04984278|363251885|FG000|Period 1|Other|0|||
105341330|NCT04984278|363251886|FG001|Period 1|Other|1|||
105465980|NCT02963506|363717837|FG003|Double-Blind Period|Death|1|||
105465981|NCT02963506|363717838|FG004|Double-Blind Period|Death|0|||
105465982|NCT02963506|363717839|FG005|Double-Blind Period|Death|0|||
105465983|NCT02963506|363717840|FG006|Double-Blind Period|Death|0|||
105465984|NCT02963506|363717841|FG007|Double-Blind Period|Death|0|||
105465985|NCT02963506|363717842|FG008|Double-Blind Period|Death|0|||
105465986|NCT02963506|363717843|FG009|Double-Blind Period|Death|0|||
105465987|NCT02963506|363717844|FG010|Double-Blind Period|Death|0|||
105465988|NCT02963506|363717845|FG011|Double-Blind Period|Death|0|||
105465989|NCT02963506|363717846|FG012|Double-Blind Period|Death|0|||
105668713|NCT01228318|364452217|FG001|Overall Study|Unable to contact|5|||
105668714|NCT01228318|364452216|FG000|Overall Study|Moved|0|||
105668715|NCT01228318|364452217|FG001|Overall Study|Moved|2|||
105668716|NCT01228318|364452216|FG000|Overall Study|Incarcerated|1|||
105465990|NCT02963506|363717834|FG000|Double-Blind Period|Lost to Follow-up|0|||
105465991|NCT02963506|363717835|FG001|Double-Blind Period|Lost to Follow-up|1|||
105465992|NCT02963506|363717836|FG002|Double-Blind Period|Lost to Follow-up|0|||
105465993|NCT02963506|363717837|FG003|Double-Blind Period|Lost to Follow-up|0|||
105465994|NCT02963506|363717838|FG004|Double-Blind Period|Lost to Follow-up|0|||
105465995|NCT02963506|363717839|FG005|Double-Blind Period|Lost to Follow-up|0|||
105465996|NCT02963506|363717840|FG006|Double-Blind Period|Lost to Follow-up|0|||
105465997|NCT02963506|363717841|FG007|Double-Blind Period|Lost to Follow-up|0|||
105465998|NCT02963506|363717842|FG008|Double-Blind Period|Lost to Follow-up|0|||
105465999|NCT02963506|363717843|FG009|Double-Blind Period|Lost to Follow-up|0|||
105466000|NCT02963506|363717844|FG010|Double-Blind Period|Lost to Follow-up|0|||
105466001|NCT02963506|363717845|FG011|Double-Blind Period|Lost to Follow-up|0|||
105466002|NCT02963506|363717846|FG012|Double-Blind Period|Lost to Follow-up|0|||
105466003|NCT02963506|363717834|FG000|Double-Blind Period|Withdrawal by Subject|0|||
105466004|NCT02963506|363717835|FG001|Double-Blind Period|Withdrawal by Subject|0|||
105466005|NCT02963506|363717836|FG002|Double-Blind Period|Withdrawal by Subject|1|||
105466006|NCT02963506|363717837|FG003|Double-Blind Period|Withdrawal by Subject|1|||
105466007|NCT02963506|363717838|FG004|Double-Blind Period|Withdrawal by Subject|0|||
105466008|NCT02963506|363717839|FG005|Double-Blind Period|Withdrawal by Subject|0|||
105466009|NCT02963506|363717840|FG006|Double-Blind Period|Withdrawal by Subject|0|||
105466010|NCT02963506|363717841|FG007|Double-Blind Period|Withdrawal by Subject|0|||
105466011|NCT02963506|363717842|FG008|Double-Blind Period|Withdrawal by Subject|0|||
105466012|NCT02963506|363717843|FG009|Double-Blind Period|Withdrawal by Subject|0|||
105466013|NCT02963506|363717844|FG010|Double-Blind Period|Withdrawal by Subject|0|||
105466014|NCT02963506|363717845|FG011|Double-Blind Period|Withdrawal by Subject|0|||
105466015|NCT02963506|363717846|FG012|Double-Blind Period|Withdrawal by Subject|0|||
105466016|NCT02963506|363717834|FG000|Double-Blind Period|No compliance|0|||
105466017|NCT02963506|363717835|FG001|Double-Blind Period|No compliance|1|||
105466018|NCT02963506|363717836|FG002|Double-Blind Period|No compliance|0|||
105466019|NCT02963506|363717837|FG003|Double-Blind Period|No compliance|0|||
105466020|NCT02963506|363717838|FG004|Double-Blind Period|No compliance|0|||
105466021|NCT02963506|363717839|FG005|Double-Blind Period|No compliance|0|||
105466022|NCT02963506|363717840|FG006|Double-Blind Period|No compliance|0|||
105466023|NCT02963506|363717841|FG007|Double-Blind Period|No compliance|0|||
105466024|NCT02963506|363717842|FG008|Double-Blind Period|No compliance|0|||
105466025|NCT02963506|363717843|FG009|Double-Blind Period|No compliance|0|||
105466026|NCT02963506|363717844|FG010|Double-Blind Period|No compliance|0|||
105466027|NCT02963506|363717845|FG011|Double-Blind Period|No compliance|0|||
105466028|NCT02963506|363717846|FG012|Double-Blind Period|No compliance|0|||
105466029|NCT02963506|363717834|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
105466030|NCT02963506|363717835|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
105466031|NCT02963506|363717836|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
105466032|NCT02963506|363717837|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
105466033|NCT02963506|363717838|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
105466034|NCT02963506|363717839|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
105466035|NCT02963506|363717840|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
105466036|NCT02963506|363717841|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
105466037|NCT02963506|363717842|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
105466038|NCT02963506|363717843|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
105466039|NCT02963506|363717844|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
105466040|NCT02963506|363717845|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
105466041|NCT02963506|363717846|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
105466042|NCT02963506|363717834|FG000|Dose-Blind Period|Adverse Event|0|||
105466043|NCT02963506|363717835|FG001|Dose-Blind Period|Adverse Event|0|||
105466044|NCT02963506|363717836|FG002|Dose-Blind Period|Adverse Event|0|||
105466045|NCT02963506|363717837|FG003|Dose-Blind Period|Adverse Event|0|||
105466046|NCT02963506|363717838|FG004|Dose-Blind Period|Adverse Event|0|||
105466047|NCT02963506|363717839|FG005|Dose-Blind Period|Adverse Event|1|||
105466048|NCT02963506|363717840|FG006|Dose-Blind Period|Adverse Event|3|||
105553546|NCT02952924|364023423|FG003|Overall Study|Noncompliance with study drug|0|||
105553547|NCT02952924|364023424|FG004|Overall Study|Noncompliance with study drug|0|||
105341331|NCT04984278|363251885|FG000|Period 2|Adverse Event|1|||
105466049|NCT02963506|363717841|FG007|Dose-Blind Period|Adverse Event|2|||
105466050|NCT02963506|363717842|FG008|Dose-Blind Period|Adverse Event|2|||
105466051|NCT02963506|363717843|FG009|Dose-Blind Period|Adverse Event|2|||
105466052|NCT02963506|363717844|FG010|Dose-Blind Period|Adverse Event|1|||
105466053|NCT02963506|363717845|FG011|Dose-Blind Period|Adverse Event|1|||
105466054|NCT02963506|363717846|FG012|Dose-Blind Period|Adverse Event|6|||
105466055|NCT02963506|363717834|FG000|Dose-Blind Period|Lack of Efficacy|0|||
105466056|NCT02963506|363717835|FG001|Dose-Blind Period|Lack of Efficacy|0|||
105466057|NCT02963506|363717836|FG002|Dose-Blind Period|Lack of Efficacy|0|||
105553548|NCT02952924|364023425|FG005|Overall Study|Noncompliance with study drug|0|||
105466058|NCT02963506|363717837|FG003|Dose-Blind Period|Lack of Efficacy|0|||
105466059|NCT02963506|363717838|FG004|Dose-Blind Period|Lack of Efficacy|0|||
105341332|NCT04984278|363251886|FG001|Period 2|Adverse Event|0|||
105466060|NCT02963506|363717839|FG005|Dose-Blind Period|Lack of Efficacy|0|||
105466061|NCT02963506|363717840|FG006|Dose-Blind Period|Lack of Efficacy|0|||
105466062|NCT02963506|363717841|FG007|Dose-Blind Period|Lack of Efficacy|1|||
105466063|NCT02963506|363717842|FG008|Dose-Blind Period|Lack of Efficacy|0|||
105466064|NCT02963506|363717843|FG009|Dose-Blind Period|Lack of Efficacy|1|||
105466065|NCT02963506|363717844|FG010|Dose-Blind Period|Lack of Efficacy|0|||
105466066|NCT02963506|363717845|FG011|Dose-Blind Period|Lack of Efficacy|0|||
105466067|NCT02963506|363717846|FG012|Dose-Blind Period|Lack of Efficacy|0|||
105466068|NCT02963506|363717834|FG000|Dose-Blind Period|Lost to Follow-up|0|||
105466069|NCT02963506|363717835|FG001|Dose-Blind Period|Lost to Follow-up|0|||
105466070|NCT02963506|363717836|FG002|Dose-Blind Period|Lost to Follow-up|0|||
105466071|NCT02963506|363717837|FG003|Dose-Blind Period|Lost to Follow-up|0|||
105466072|NCT02963506|363717838|FG004|Dose-Blind Period|Lost to Follow-up|0|||
105466073|NCT02963506|363717839|FG005|Dose-Blind Period|Lost to Follow-up|1|||
105466074|NCT02963506|363717840|FG006|Dose-Blind Period|Lost to Follow-up|0|||
105466075|NCT02963506|363717841|FG007|Dose-Blind Period|Lost to Follow-up|0|||
105466076|NCT02963506|363717842|FG008|Dose-Blind Period|Lost to Follow-up|1|||
105466077|NCT02963506|363717843|FG009|Dose-Blind Period|Lost to Follow-up|0|||
105466078|NCT02963506|363717844|FG010|Dose-Blind Period|Lost to Follow-up|0|||
105466079|NCT02963506|363717845|FG011|Dose-Blind Period|Lost to Follow-up|1|||
105466080|NCT02963506|363717846|FG012|Dose-Blind Period|Lost to Follow-up|0|||
105466081|NCT02963506|363717834|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
105466082|NCT02963506|363717835|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
105466083|NCT02963506|363717836|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
105466084|NCT02963506|363717837|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
105466085|NCT02963506|363717838|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
105466086|NCT02963506|363717839|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
105466087|NCT02963506|363717840|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
105466088|NCT02963506|363717841|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
105466089|NCT02963506|363717842|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
105466090|NCT02963506|363717843|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
105466091|NCT02963506|363717844|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
105466092|NCT02963506|363717845|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
105341333|NCT04984278|363251885|FG000|Period 2|Other|0|||
105466093|NCT02963506|363717846|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
105466094|NCT02963506|363717834|FG000|Dose-Blind Period|Sponsor decision|0|||
105466095|NCT02963506|363717835|FG001|Dose-Blind Period|Sponsor decision|0|||
105466096|NCT02963506|363717836|FG002|Dose-Blind Period|Sponsor decision|0|||
105466097|NCT02963506|363717837|FG003|Dose-Blind Period|Sponsor decision|0|||
105466098|NCT02963506|363717838|FG004|Dose-Blind Period|Sponsor decision|0|||
105466099|NCT02963506|363717839|FG005|Dose-Blind Period|Sponsor decision|1|||
105466100|NCT02963506|363717840|FG006|Dose-Blind Period|Sponsor decision|0|||
105466101|NCT02963506|363717841|FG007|Dose-Blind Period|Sponsor decision|0|||
105341334|NCT04984278|363251886|FG001|Period 2|Other|1|||
105466102|NCT02963506|363717842|FG008|Dose-Blind Period|Sponsor decision|0|||
105466103|NCT02963506|363717843|FG009|Dose-Blind Period|Sponsor decision|0|||
105466104|NCT02963506|363717844|FG010|Dose-Blind Period|Sponsor decision|0|||
105341335|NCT01877551|363251891|FG000|Overall Study|Physician Decision|0|||
105668717|NCT01228318|364452217|FG001|Overall Study|Incarcerated|0|||
105668718|NCT00709228|364452220|FG000|Overall Study|Not treated|14|||
105668719|NCT00709228|364452220|FG000|Overall Study|Eligibility criteria not met|281|||
105668720|NCT00709228|364452220|FG000|Overall Study|Adverse events|2|||
105668721|NCT00709228|364452220|FG000|Overall Study|Discontinued treatment|14|||
105668722|NCT00709228|364452220|FG000|Overall Study|Did not enter follow-up|4|||
105668723|NCT00709228|364452220|FG000|Overall Study|Discontinued follow-up|5|||
105668724|NCT00709228|364452220|FG000|Overall Study|Disease progression|1|||
105466105|NCT02963506|363717845|FG011|Dose-Blind Period|Sponsor decision|0|||
105668725|NCT00709228|364452220|FG000|Overall Study|Lost to Follow-up|6|||
105668726|NCT00709228|364452220|FG000|Overall Study|Non-compliance|5|||
105668727|NCT01174446|364452221|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
105668728|NCT01174446|364452222|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
105668729|NCT01174446|364452223|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
105668730|NCT01174446|364452224|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
105668731|NCT01174446|364452221|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
105668732|NCT01174446|364452222|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
105553549|NCT02952924|364023426|FG006|Overall Study|Noncompliance with study drug|0|||
105553550|NCT02952924|364023427|FG007|Overall Study|Noncompliance with study drug|0|||
105553551|NCT02952924|364023428|FG008|Overall Study|Noncompliance with study drug|0|||
105553552|NCT02952924|364023429|FG009|Overall Study|Noncompliance with study drug|0|||
105553553|NCT02952924|364023430|FG010|Overall Study|Noncompliance with study drug|0|||
105553554|NCT02952924|364023431|FG011|Overall Study|Noncompliance with study drug|0|||
105341336|NCT01877551|363251892|FG001|Overall Study|Physician Decision|1|||
105341337|NCT05139303|363251893|FG000|Overall Study|Lost to Follow-up|3|||
105341338|NCT05139303|363251894|FG001|Overall Study|Lost to Follow-up|0|||
105341339|NCT05139303|363251893|FG000|Overall Study|Adverse Event|1|||
105341340|NCT05139303|363251894|FG001|Overall Study|Adverse Event|0|||
105341341|NCT02111785|363251895|FG000|Overall Study|Death|0|||
105341342|NCT02111785|363251896|FG001|Overall Study|Death|1|||
105341343|NCT02111785|363251897|FG002|Overall Study|Death|0|||
105668733|NCT01174446|364452223|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
105668734|NCT01174446|364452224|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
105668735|NCT01174446|364452221|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
105668736|NCT01174446|364452222|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
105668737|NCT01174446|364452223|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
105668738|NCT01174446|364452224|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
105668739|NCT01174446|364452221|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
105668740|NCT01174446|364452222|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
105668741|NCT01174446|364452223|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
105668742|NCT01174446|364452224|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
105668743|NCT00847626|364452227|FG000|Overall Study|Adverse Event|10|||
105668744|NCT00847626|364452228|FG001|Overall Study|Adverse Event|10|||
105668745|NCT00847626|364452229|FG002|Overall Study|Adverse Event|6|||
105668746|NCT00847626|364452230|FG003|Overall Study|Adverse Event|19|||
105668747|NCT00847626|364452231|FG004|Overall Study|Adverse Event|11|||
105668748|NCT00847626|364452232|FG005|Overall Study|Adverse Event|22|||
105668749|NCT00847626|364452233|FG006|Overall Study|Adverse Event|4|||
105668750|NCT00847626|364452234|FG007|Overall Study|Adverse Event|6|||
105668751|NCT00847626|364452235|FG008|Overall Study|Adverse Event|3|||
105668752|NCT00847626|364452236|FG009|Overall Study|Adverse Event|6|||
105668753|NCT00847626|364452237|FG010|Overall Study|Adverse Event|6|||
105668754|NCT00847626|364452227|FG000|Overall Study|Protocol Violation|2|||
105668755|NCT00847626|364452228|FG001|Overall Study|Protocol Violation|1|||
105668756|NCT00847626|364452229|FG002|Overall Study|Protocol Violation|2|||
105668757|NCT00847626|364452230|FG003|Overall Study|Protocol Violation|1|||
105668758|NCT00847626|364452231|FG004|Overall Study|Protocol Violation|1|||
105668759|NCT00847626|364452232|FG005|Overall Study|Protocol Violation|1|||
105668760|NCT00847626|364452233|FG006|Overall Study|Protocol Violation|1|||
105668761|NCT00847626|364452234|FG007|Overall Study|Protocol Violation|1|||
105668762|NCT00847626|364452235|FG008|Overall Study|Protocol Violation|0|||
105668763|NCT00847626|364452236|FG009|Overall Study|Protocol Violation|1|||
105668764|NCT00847626|364452237|FG010|Overall Study|Protocol Violation|1|||
105668765|NCT00847626|364452227|FG000|Overall Study|Lost to Follow-up|0|||
105668766|NCT00847626|364452228|FG001|Overall Study|Lost to Follow-up|1|||
105668767|NCT00847626|364452229|FG002|Overall Study|Lost to Follow-up|1|||
105668768|NCT00847626|364452230|FG003|Overall Study|Lost to Follow-up|1|||
105668769|NCT00847626|364452231|FG004|Overall Study|Lost to Follow-up|0|||
105668770|NCT00847626|364452232|FG005|Overall Study|Lost to Follow-up|3|||
105668771|NCT00847626|364452233|FG006|Overall Study|Lost to Follow-up|1|||
105668772|NCT00847626|364452234|FG007|Overall Study|Lost to Follow-up|3|||
105668773|NCT00847626|364452235|FG008|Overall Study|Lost to Follow-up|1|||
105668774|NCT00847626|364452236|FG009|Overall Study|Lost to Follow-up|0|||
105668775|NCT00847626|364452237|FG010|Overall Study|Lost to Follow-up|1|||
105668776|NCT00847626|364452227|FG000|Overall Study|Withdrawal by Subject|5|||
105668777|NCT00847626|364452228|FG001|Overall Study|Withdrawal by Subject|5|||
105668778|NCT00847626|364452229|FG002|Overall Study|Withdrawal by Subject|3|||
105668779|NCT00847626|364452230|FG003|Overall Study|Withdrawal by Subject|8|||
105668780|NCT00847626|364452231|FG004|Overall Study|Withdrawal by Subject|12|||
105668781|NCT00847626|364452232|FG005|Overall Study|Withdrawal by Subject|9|||
105668782|NCT00847626|364452233|FG006|Overall Study|Withdrawal by Subject|8|||
105668783|NCT00847626|364452234|FG007|Overall Study|Withdrawal by Subject|4|||
105668784|NCT00847626|364452235|FG008|Overall Study|Withdrawal by Subject|4|||
105668785|NCT00847626|364452236|FG009|Overall Study|Withdrawal by Subject|5|||
105668786|NCT00847626|364452237|FG010|Overall Study|Withdrawal by Subject|2|||
105668787|NCT00847626|364452227|FG000|Overall Study|Lack of Efficacy|3|||
105668788|NCT00847626|364452228|FG001|Overall Study|Lack of Efficacy|1|||
105668789|NCT00847626|364452229|FG002|Overall Study|Lack of Efficacy|0|||
105668790|NCT00847626|364452230|FG003|Overall Study|Lack of Efficacy|1|||
105668791|NCT00847626|364452231|FG004|Overall Study|Lack of Efficacy|2|||
105668792|NCT00847626|364452232|FG005|Overall Study|Lack of Efficacy|0|||
105668793|NCT00847626|364452233|FG006|Overall Study|Lack of Efficacy|6|||
105668794|NCT00847626|364452234|FG007|Overall Study|Lack of Efficacy|2|||
105668795|NCT00847626|364452235|FG008|Overall Study|Lack of Efficacy|5|||
105668796|NCT00847626|364452236|FG009|Overall Study|Lack of Efficacy|1|||
105668797|NCT00847626|364452237|FG010|Overall Study|Lack of Efficacy|7|||
105668798|NCT00847626|364452227|FG000|Overall Study|Other|1|||
105668799|NCT00847626|364452228|FG001|Overall Study|Other|5|||
105341344|NCT02111785|363251898|FG003|Overall Study|Death|0|||
105341345|NCT02738879|363251899|FG000|Overall Study|Adverse Event|1|||
105341346|NCT02738879|363251900|FG001|Overall Study|Adverse Event|1|||
105466106|NCT02963506|363717846|FG012|Dose-Blind Period|Sponsor decision|0|||
105786016|NCT00596466|364870443|FG000|Overall Study|Enrolled, not treated|2|||
105341347|NCT02738879|363251899|FG000|Overall Study|Death|0|||
105341348|NCT02738879|363251900|FG001|Overall Study|Death|2|||
105341349|NCT02738879|363251899|FG000|Overall Study|Lost to Follow-up|1|||
105341350|NCT02738879|363251900|FG001|Overall Study|Lost to Follow-up|5|||
105341351|NCT02738879|363251899|FG000|Overall Study|Protocol Violation|1|||
105341352|NCT02738879|363251900|FG001|Overall Study|Protocol Violation|3|||
105341353|NCT02738879|363251899|FG000|Overall Study|Physician Decision|3|||
105341354|NCT02738879|363251900|FG001|Overall Study|Physician Decision|4|||
105341355|NCT02738879|363251899|FG000|Overall Study|Pregnancy|0|||
105341356|NCT02738879|363251900|FG001|Overall Study|Pregnancy|1|||
105341357|NCT02738879|363251899|FG000|Overall Study|Screen Failure|1|||
105341358|NCT02738879|363251900|FG001|Overall Study|Screen Failure|2|||
105341359|NCT02738879|363251899|FG000|Overall Study|Site Discontinued Study Participation|1|||
105341360|NCT02738879|363251900|FG001|Overall Study|Site Discontinued Study Participation|0|||
105341361|NCT02738879|363251899|FG000|Overall Study|Withdrawal by Subject|5|||
105341362|NCT02738879|363251900|FG001|Overall Study|Withdrawal by Subject|7|||
105341363|NCT02256982|363251905|FG000|Overall Study|Disease Progression|0|||
105341364|NCT02256982|363251906|FG001|Overall Study|Disease Progression|1|||
105341365|NCT01613222|363251907|FG000|Overall Study|Physician Decision|1|||
105341366|NCT01613222|363251907|FG000|Overall Study|Unable to place arterial line|1|||
105341367|NCT01613222|363251907|FG000|Overall Study|Reused disposable sensors|10|||
105341368|NCT01054300|363251908|FG000|Period 1|Adverse Event|1|||
105341369|NCT01054300|363251909|FG001|Period 1|Adverse Event|0|||
105341370|NCT01054300|363251910|FG002|Period 1|Adverse Event|0|||
105341371|NCT01054300|363251911|FG003|Period 1|Adverse Event|0|||
105341372|NCT01054300|363251908|FG000|Period 2|Withdrawal by Subject|0|||
105341373|NCT01054300|363251909|FG001|Period 2|Withdrawal by Subject|0|||
105341374|NCT01054300|363251910|FG002|Period 2|Withdrawal by Subject|1|||
105341375|NCT01054300|363251911|FG003|Period 2|Withdrawal by Subject|0|||
105341376|NCT00308087|363251914|FG000|Overall Study|Progressive Disease|19|||
105341377|NCT00308087|363251915|FG001|Overall Study|Progressive Disease|21|||
105341378|NCT00308087|363251914|FG000|Overall Study|Study Closure|11|||
105341379|NCT00308087|363251915|FG001|Overall Study|Study Closure|12|||
105341380|NCT00308087|363251914|FG000|Overall Study|Withdrawal by Subject|2|||
105341381|NCT00308087|363251915|FG001|Overall Study|Withdrawal by Subject|1|||
105341382|NCT00308087|363251914|FG000|Overall Study|Other|4|||
105341383|NCT00308087|363251915|FG001|Overall Study|Other|3|||
105341384|NCT04186806|363251923|FG000|Period 1: 7 Days|Adverse Event|1|||
105341385|NCT04186806|363251924|FG001|Period 1: 7 Days|Adverse Event|0|||
105341386|NCT00759785|363251926|FG000|Overall Study|Participant sample not evaluable|11|||
105341387|NCT00759785|363251927|FG001|Overall Study|Participant sample not evaluable|2|||
105341388|NCT00759785|363251926|FG000|Overall Study|Participant sample lost|0|||
105341389|NCT00759785|363251927|FG001|Overall Study|Participant sample lost|1|||
105341390|NCT00759785|363251926|FG000|Overall Study|Protocol Violation|1|||
105341391|NCT00759785|363251927|FG001|Overall Study|Protocol Violation|0|||
105341392|NCT00759785|363251926|FG000|Overall Study|Physician Decision|0|||
105341393|NCT00759785|363251927|FG001|Overall Study|Physician Decision|1|||
105341394|NCT00759785|363251926|FG000|Overall Study|Withdrawal by Subject|0|||
105553555|NCT02952924|364023432|FG012|Overall Study|Noncompliance with study drug|0|||
105553556|NCT02952924|364023433|FG013|Overall Study|Noncompliance with study drug|0|||
105553557|NCT02952924|364023434|FG014|Overall Study|Noncompliance with study drug|0|||
105553558|NCT02952924|364023435|FG015|Overall Study|Noncompliance with study drug|0|||
105553559|NCT02952924|364023436|FG016|Overall Study|Noncompliance with study drug|0|||
105553560|NCT02952924|364023437|FG017|Overall Study|Noncompliance with study drug|0|||
105553561|NCT02952924|364023438|FG018|Overall Study|Noncompliance with study drug|0|||
105553562|NCT02952924|364023439|FG019|Overall Study|Noncompliance with study drug|0|||
105553563|NCT02952924|364023440|FG020|Overall Study|Noncompliance with study drug|0|||
105553564|NCT02952924|364023441|FG021|Overall Study|Noncompliance with study drug|1|||
105553565|NCT02653482|364023443|FG000|Overall Study|Death|1|||
105553566|NCT02653482|364023444|FG001|Overall Study|Death|1|||
105553567|NCT03230916|364023445|FG000|Overall Study|Withdrawal by Subject|0|||
105553568|NCT03230916|364023446|FG001|Overall Study|Withdrawal by Subject|0|||
105553569|NCT03230916|364023447|FG002|Overall Study|Withdrawal by Subject|0|||
105553570|NCT03230916|364023448|FG003|Overall Study|Withdrawal by Subject|0|||
105553571|NCT03230916|364023449|FG004|Overall Study|Withdrawal by Subject|0|||
105553572|NCT03230916|364023450|FG005|Overall Study|Withdrawal by Subject|1|||
105553573|NCT03230916|364023451|FG006|Overall Study|Withdrawal by Subject|0|||
105553574|NCT03230916|364023452|FG007|Overall Study|Withdrawal by Subject|0|||
105553575|NCT03230916|364023453|FG008|Overall Study|Withdrawal by Subject|0|||
105553576|NCT03230916|364023454|FG009|Overall Study|Withdrawal by Subject|0|||
105553577|NCT03230916|364023455|FG010|Overall Study|Withdrawal by Subject|0|||
105553578|NCT05132699|364023456|FG000|Overall Study|Withdrawal by Subject|3|||
105668800|NCT00847626|364452229|FG002|Overall Study|Other|4|||
105553579|NCT05132699|364023457|FG001|Overall Study|Withdrawal by Subject|0|||
105553580|NCT02899728|364023458|FG000|Overall Study|Withdrawal by Subject|1|||
105553581|NCT02899728|364023459|FG001|Overall Study|Withdrawal by Subject|1|||
105553582|NCT00136955|364025143|FG000|Overall Study|Adverse Event|8|||
105668801|NCT00847626|364452230|FG003|Overall Study|Other|1|||
105668802|NCT00847626|364452231|FG004|Overall Study|Other|2|||
105668803|NCT00847626|364452232|FG005|Overall Study|Other|2|||
105668804|NCT00847626|364452233|FG006|Overall Study|Other|2|||
105668805|NCT00847626|364452234|FG007|Overall Study|Other|3|||
105668806|NCT00847626|364452235|FG008|Overall Study|Other|1|||
105668807|NCT00847626|364452236|FG009|Overall Study|Other|1|||
105668808|NCT00847626|364452237|FG010|Overall Study|Other|3|||
105668809|NCT03057847|364452238|FG000|Overall Study|Lost to Follow-up|16|||
105668810|NCT00731133|364452241|FG000|Overall Study|Withdrawal by Subject|10|||
105668811|NCT02493062|364452242|FG000|Overall Study|Physician Decision|12|||
105668812|NCT01681992|364452249|FG000|Overall Study|Adverse Event|3|||
105668813|NCT01681992|364452250|FG001|Overall Study|Adverse Event|2|||
105668814|NCT01681992|364452251|FG002|Overall Study|Adverse Event|3|||
105668815|NCT01681992|364452249|FG000|Overall Study|Lost to Follow-up|36|||
105668816|NCT01681992|364452250|FG001|Overall Study|Lost to Follow-up|38|||
105668817|NCT01681992|364452251|FG002|Overall Study|Lost to Follow-up|53|||
105668818|NCT01681992|364452249|FG000|Overall Study|As Per Sponsor Decision|0|||
105668819|NCT01681992|364452250|FG001|Overall Study|As Per Sponsor Decision|0|||
105668820|NCT01681992|364452251|FG002|Overall Study|As Per Sponsor Decision|1|||
105668821|NCT01681992|364452249|FG000|Overall Study|Protocol Violation|0|||
105668822|NCT01681992|364452250|FG001|Overall Study|Protocol Violation|0|||
105668823|NCT01681992|364452251|FG002|Overall Study|Protocol Violation|1|||
105668824|NCT01681992|364452249|FG000|Overall Study|Withdrawal by Subject|27|||
105668825|NCT01681992|364452250|FG001|Overall Study|Withdrawal by Subject|30|||
105668826|NCT01681992|364452251|FG002|Overall Study|Withdrawal by Subject|25|||
105668827|NCT01327612|364452252|FG000|Overall Study|Withdrawal by Subject|0|||
105668828|NCT01327612|364452253|FG001|Overall Study|Withdrawal by Subject|0|||
105668829|NCT01327612|364452254|FG002|Overall Study|Withdrawal by Subject|0|||
105668830|NCT01327612|364452255|FG003|Overall Study|Withdrawal by Subject|0|||
105553583|NCT00136955|364025143|FG000|Overall Study|Lost to Follow-up|1|||
105668831|NCT01327612|364452256|FG004|Overall Study|Withdrawal by Subject|0|||
105668832|NCT01327612|364452257|FG005|Overall Study|Withdrawal by Subject|1|||
105668833|NCT01327612|364452258|FG006|Overall Study|Withdrawal by Subject|0|||
105668834|NCT01327612|364452252|FG000|Overall Study|Disease Progression|1|||
105668835|NCT01327612|364452253|FG001|Overall Study|Disease Progression|1|||
105668836|NCT01327612|364452254|FG002|Overall Study|Disease Progression|1|||
105668837|NCT01327612|364452255|FG003|Overall Study|Disease Progression|0|||
105668838|NCT01327612|364452256|FG004|Overall Study|Disease Progression|1|||
105668839|NCT01327612|364452257|FG005|Overall Study|Disease Progression|2|||
105668840|NCT01327612|364452258|FG006|Overall Study|Disease Progression|2|||
105668841|NCT01327612|364452252|FG000|Overall Study|Administrative Decision|0|||
105668842|NCT01327612|364452253|FG001|Overall Study|Administrative Decision|0|||
105668843|NCT01327612|364452254|FG002|Overall Study|Administrative Decision|0|||
105668844|NCT01327612|364452255|FG003|Overall Study|Administrative Decision|1|||
105668845|NCT01327612|364452256|FG004|Overall Study|Administrative Decision|0|||
105668846|NCT01327612|364452257|FG005|Overall Study|Administrative Decision|0|||
105668847|NCT01327612|364452258|FG006|Overall Study|Administrative Decision|0|||
105668848|NCT01327612|364452252|FG000|Overall Study|Death|0|||
105668849|NCT01327612|364452253|FG001|Overall Study|Death|0|||
105668850|NCT01327612|364452254|FG002|Overall Study|Death|0|||
105466107|NCT02963506|363717834|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
105466108|NCT02963506|363717835|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
105466109|NCT02963506|363717836|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
105466110|NCT02963506|363717837|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
105466111|NCT02963506|363717838|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
105466112|NCT02963506|363717839|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
105466113|NCT02963506|363717840|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
105466114|NCT02963506|363717841|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
105466115|NCT02963506|363717842|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
105466116|NCT02963506|363717843|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
105466117|NCT02963506|363717844|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
105466118|NCT02963506|363717845|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
105466119|NCT02963506|363717846|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
105466120|NCT02129699|363717847|FG000|Overall Study|Did not start treatment|3|||
105466121|NCT02129699|363717848|FG001|Overall Study|Did not start treatment|2|||
105466122|NCT00750438|363717852|FG000|Overall Study|Protocol Violation|4|||
105466123|NCT00750438|363717853|FG001|Overall Study|Protocol Violation|1|||
105466124|NCT00750438|363717852|FG000|Overall Study|Physician Decision|2|||
105466125|NCT00750438|363717853|FG001|Overall Study|Physician Decision|2|||
105466126|NCT00750438|363717852|FG000|Overall Study|Withdrawal by Subject|1|||
105466127|NCT00750438|363717853|FG001|Overall Study|Withdrawal by Subject|1|||
105466128|NCT01108185|363717857|FG000|Overall Study|Non-compliance|15|||
105466129|NCT01108185|363717857|FG000|Overall Study|Lost to Follow-up|12|||
105466130|NCT02581410|363717858|FG000|Vaccination Phase|Adverse Event|2|||
105466131|NCT02581410|363717859|FG001|Vaccination Phase|Adverse Event|1|||
105466132|NCT02581410|363717858|FG000|Vaccination Phase|Withdrawal by Subject|0|||
105466133|NCT02581410|363717859|FG001|Vaccination Phase|Withdrawal by Subject|1|||
105466134|NCT02581410|363717858|FG000|Vaccination Phase|Migrated/moved from study area|0|||
105466135|NCT02581410|363717859|FG001|Vaccination Phase|Migrated/moved from study area|1|||
105466136|NCT02581410|363717858|FG000|End of Study Phase|Adverse Event|4|||
105466137|NCT02581410|363717859|FG001|End of Study Phase|Adverse Event|3|||
105466138|NCT02581410|363717858|FG000|End of Study Phase|Withdrawal by Subject|1|||
105466139|NCT02581410|363717859|FG001|End of Study Phase|Withdrawal by Subject|2|||
105466140|NCT02581410|363717858|FG000|End of Study Phase|Migrated/moved from study area|0|||
105466141|NCT02581410|363717859|FG001|End of Study Phase|Migrated/moved from study area|3|||
105466142|NCT02581410|363717858|FG000|End of Study Phase|Lost to Follow-up|0|||
105466143|NCT02581410|363717859|FG001|End of Study Phase|Lost to Follow-up|2|||
105466144|NCT02581410|363717858|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
105466145|NCT02581410|363717859|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
105466146|NCT00670748|363717864|FG000|Overall Study|Death during treatment|1|||
105466147|NCT00670748|363717865|FG001|Overall Study|Death during treatment|1|||
105668851|NCT01327612|364452255|FG003|Overall Study|Death|0|||
105668852|NCT01327612|364452256|FG004|Overall Study|Death|1|||
105668853|NCT01327612|364452257|FG005|Overall Study|Death|0|||
105668854|NCT01327612|364452258|FG006|Overall Study|Death|0|||
105553584|NCT00136955|364025143|FG000|Overall Study|Withdrawal by Subject|2|||
105553585|NCT00136955|364025143|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
105553586|NCT04450264|364025144|FG000|Overall Study|Incomplete survey|13|||
105466148|NCT00670748|363717866|FG002|Overall Study|Death during treatment|1|||
105466149|NCT00670748|363717867|FG003|Overall Study|Death during treatment|0|||
105466150|NCT00670748|363717864|FG000|Overall Study|Not off study|2|||
105466151|NCT00670748|363717865|FG001|Overall Study|Not off study|1|||
105466152|NCT00670748|363717866|FG002|Overall Study|Not off study|1|||
105466153|NCT00670748|363717867|FG003|Overall Study|Not off study|1|||
105466154|NCT03493464|363717884|FG000|Overall Study|Surgery not performed|1|||
105466155|NCT02807402|363717885|FG000|Overall Study|Failure to Return|1|||
105466156|NCT02807402|363717885|FG000|Overall Study|Death|3|||
105466157|NCT02807402|363717885|FG000|Overall Study|Other|2|||
105466158|NCT03938259|363720049|FG000|Overall Study|unable to establish baseline for ventilation|1|||
105466159|NCT03938259|363720050|FG001|Overall Study|unable to establish baseline for ventilation|1|||
105466160|NCT03910244|363720052|FG000|Overall Study|Adverse Event|14|||
105466161|NCT03910244|363720053|FG001|Overall Study|Adverse Event|0|||
105466162|NCT03910244|363720052|FG000|Overall Study|Death|1|||
105466163|NCT03910244|363720053|FG001|Overall Study|Death|0|||
105466164|NCT03910244|363720052|FG000|Overall Study|Lost to Follow-up|0|||
105466165|NCT03910244|363720053|FG001|Overall Study|Lost to Follow-up|2|||
105466166|NCT03910244|363720052|FG000|Overall Study|Joint withdrawal decision|1|||
105466167|NCT03910244|363720053|FG001|Overall Study|Joint withdrawal decision|0|||
105466168|NCT03910244|363720052|FG000|Overall Study|Study Terminated by Sponsor|7|||
105466169|NCT03910244|363720053|FG001|Overall Study|Study Terminated by Sponsor|4|||
105466170|NCT03910244|363720052|FG000|Overall Study|Physician Decision|1|||
105466171|NCT03910244|363720053|FG001|Overall Study|Physician Decision|0|||
105466172|NCT03910244|363720052|FG000|Overall Study|Protocol Violation|1|||
105466173|NCT03910244|363720053|FG001|Overall Study|Protocol Violation|0|||
105466174|NCT03910244|363720052|FG000|Overall Study|Withdrawal by Subject|7|||
105466175|NCT03910244|363720053|FG001|Overall Study|Withdrawal by Subject|2|||
105466176|NCT02489318|363720054|FG000|Randomized|Withdrawal by Subject|0|||
105466177|NCT02489318|363720055|FG001|Randomized|Withdrawal by Subject|1|||
105466178|NCT02489318|363720054|FG000|Treated|Adverse Event|19|||
105466179|NCT02489318|363720055|FG001|Treated|Adverse Event|62|||
105466180|NCT02489318|363720054|FG000|Treated|Death|13|||
105466181|NCT02489318|363720055|FG001|Treated|Death|11|||
105466182|NCT02489318|363720054|FG000|Treated|Physician Decision|4|||
105466183|NCT02489318|363720055|FG001|Treated|Physician Decision|6|||
105466184|NCT02489318|363720054|FG000|Treated|Protocol Violation|1|||
105466185|NCT02489318|363720055|FG001|Treated|Protocol Violation|2|||
105466186|NCT02489318|363720054|FG000|Treated|Withdrawal by Subject|37|||
105466187|NCT02489318|363720055|FG001|Treated|Withdrawal by Subject|36|||
105466188|NCT02489318|363720054|FG000|Treated|Other: Progressive Disease|245|||
105466189|NCT02489318|363720055|FG001|Treated|Other: Progressive Disease|138|||
105466190|NCT02489318|363720054|FG000|Treated|Other|0|||
105466191|NCT02489318|363720055|FG001|Treated|Other|2|||
105466192|NCT02489318|363720054|FG000|Treated|Ongoing|0|||
105466193|NCT02489318|363720055|FG001|Treated|Ongoing|267|||
105341395|NCT00759785|363251927|FG001|Overall Study|Withdrawal by Subject|1|||
105341396|NCT00089778|363251928|FG000|Overall Study|Protocol Violation|0|||
105341397|NCT00089778|363251929|FG001|Overall Study|Protocol Violation|0|||
105341398|NCT00089778|363251930|FG002|Overall Study|Protocol Violation|1|||
105341399|NCT04521621|363251931|FG000|Overall Study|Death|17|||
105341400|NCT04521621|363251932|FG001|Overall Study|Death|8|||
105341401|NCT04521621|363251933|FG002|Overall Study|Death|8|||
105341402|NCT04521621|363251934|FG003|Overall Study|Death|5|||
105341403|NCT04521621|363251935|FG004|Overall Study|Death|2|||
105341404|NCT04521621|363251936|FG005|Overall Study|Death|7|||
105341405|NCT04521621|363251937|FG006|Overall Study|Death|0|||
105341406|NCT04521621|363251938|FG007|Overall Study|Death|0|||
105341407|NCT04521621|363251931|FG000|Overall Study|Study Terminated by Sponsor|4|||
105341408|NCT04521621|363251932|FG001|Overall Study|Study Terminated by Sponsor|6|||
105341409|NCT04521621|363251933|FG002|Overall Study|Study Terminated by Sponsor|8|||
105341410|NCT04521621|363251934|FG003|Overall Study|Study Terminated by Sponsor|0|||
105341411|NCT04521621|363251935|FG004|Overall Study|Study Terminated by Sponsor|1|||
105341412|NCT04521621|363251936|FG005|Overall Study|Study Terminated by Sponsor|7|||
105341413|NCT04521621|363251937|FG006|Overall Study|Study Terminated by Sponsor|0|||
105341414|NCT04521621|363251938|FG007|Overall Study|Study Terminated by Sponsor|0|||
105341415|NCT04521621|363251931|FG000|Overall Study|Withdrawal by Subject|0|||
105341416|NCT04521621|363251932|FG001|Overall Study|Withdrawal by Subject|0|||
105341417|NCT04521621|363251933|FG002|Overall Study|Withdrawal by Subject|1|||
105341418|NCT04521621|363251934|FG003|Overall Study|Withdrawal by Subject|1|||
105341419|NCT04521621|363251935|FG004|Overall Study|Withdrawal by Subject|0|||
105341420|NCT04521621|363251936|FG005|Overall Study|Withdrawal by Subject|0|||
105341421|NCT04521621|363251937|FG006|Overall Study|Withdrawal by Subject|0|||
105341422|NCT04521621|363251938|FG007|Overall Study|Withdrawal by Subject|0|||
105341423|NCT04521621|363251931|FG000|Overall Study|Allocated in error without study intervention|1|||
105466194|NCT00956007|363720056|FG000|Overall Study|Protocol Violation|27|||
105341424|NCT04521621|363251932|FG001|Overall Study|Allocated in error without study intervention|0|||
105341425|NCT04521621|363251933|FG002|Overall Study|Allocated in error without study intervention|0|||
105341426|NCT04521621|363251934|FG003|Overall Study|Allocated in error without study intervention|0|||
105341427|NCT04521621|363251935|FG004|Overall Study|Allocated in error without study intervention|0|||
105466195|NCT00956007|363720057|FG001|Overall Study|Protocol Violation|23|||
105466196|NCT02968004|363720058|FG000|Main Study Phase|Adverse Event|1|||
105466197|NCT02968004|363720059|FG001|Main Study Phase|Adverse Event|0|||
105466198|NCT02968004|363720058|FG000|Main Study Phase|Withdrawal by Subject|0|||
105466199|NCT02968004|363720059|FG001|Main Study Phase|Withdrawal by Subject|1|||
105466200|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
105466201|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
105668855|NCT01199068|364452261|FG000|Overall Study|Unacceptable toxicity|0|||
105668856|NCT01199068|364452262|FG001|Overall Study|Unacceptable toxicity|0|||
105668857|NCT01199068|364452263|FG002|Overall Study|Unacceptable toxicity|2|||
105668858|NCT01199068|364452261|FG000|Overall Study|Progressive disease|3|||
105668859|NCT01199068|364452262|FG001|Overall Study|Progressive disease|3|||
105668860|NCT01199068|364452263|FG002|Overall Study|Progressive disease|6|||
105668861|NCT01199068|364452261|FG000|Overall Study|Withdrawal by Subject|0|||
105668862|NCT01199068|364452262|FG001|Overall Study|Withdrawal by Subject|0|||
105668863|NCT01199068|364452263|FG002|Overall Study|Withdrawal by Subject|1|||
105668864|NCT00874731|364452265|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
105668865|NCT00874731|364452266|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
105668866|NCT00874731|364452267|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
105668867|NCT00874731|364452265|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
105668868|NCT00874731|364452266|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
105668869|NCT00874731|364452267|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
105668870|NCT00874731|364452265|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
105668871|NCT00874731|364452266|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
105668872|NCT00874731|364452267|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
105668873|NCT00955708|364452268|FG000|Overall Study|Death|269|||
105668874|NCT00955708|364452268|FG000|Overall Study|Lost to Follow-up|72|||
105668875|NCT00955708|364452268|FG000|Overall Study|Physician Decision|36|||
105668876|NCT00955708|364452268|FG000|Overall Study|Protocol Violation|134|||
105668877|NCT00955708|364452268|FG000|Overall Study|Registry Conclusion|186|||
105668878|NCT00955708|364452268|FG000|Overall Study|Product removed from service|94|||
105668879|NCT00955708|364452268|FG000|Overall Study|Patient Refused to participate further|116|||
105668880|NCT00955708|364452268|FG000|Overall Study|Closure of study location|60|||
105466202|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
105553587|NCT04450264|364025145|FG001|Overall Study|Incomplete survey|19|||
105553588|NCT04537923|364025146|FG000|Overall Study|Adverse Event|2|||
105553589|NCT04537923|364025147|FG001|Overall Study|Adverse Event|1|||
105553590|NCT04537923|364025148|FG002|Overall Study|Adverse Event|2|||
105553591|NCT04537923|364025149|FG003|Overall Study|Adverse Event|4|||
105553592|NCT04537923|364025146|FG000|Overall Study|Death|3|||
105553593|NCT04537923|364025147|FG001|Overall Study|Death|3|||
105553594|NCT04537923|364025148|FG002|Overall Study|Death|1|||
105553595|NCT04537923|364025149|FG003|Overall Study|Death|11|||
105553596|NCT04537923|364025146|FG000|Overall Study|Lost to Follow-up|1|||
105553597|NCT04537923|364025147|FG001|Overall Study|Lost to Follow-up|2|||
105668881|NCT00955708|364452268|FG000|Overall Study|Patient changed care provider/moved|91|||
105668882|NCT00677534|364452273|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
105668883|NCT00677534|364452273|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
105668884|NCT00677534|364452273|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
105668885|NCT02687035|364452274|FG000|Overall Study|Withdrawal by Subject|1|||
105668886|NCT02687035|364452274|FG000|Overall Study|Death|87|||
105668887|NCT02687035|364452274|FG000|Overall Study|Lost to Follow-up|1|||
105668888|NCT02687035|364452274|FG000|Overall Study|Missed Visit|87|||
105668889|NCT02687035|364452274|FG000|Overall Study|Did not receive Study Device|8|||
105668890|NCT00332462|364452275|FG000|Overall Study|Adverse Event|5|||
105668891|NCT00332462|364452275|FG000|Overall Study|Abnormal Lab Value|1|||
105668892|NCT00332462|364452275|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105668893|NCT00332462|364452275|FG000|Overall Study|no longer requires study drug|1|||
105668894|NCT00332462|364452275|FG000|Overall Study|Death|3|||
105668895|NCT00332462|364452275|FG000|Overall Study|Graft Loss|2|||
105668896|NCT01853475|364452276|FG000|Overall Study|Withdrawal by Subject|0|||
105668897|NCT01853475|364452277|FG001|Overall Study|Withdrawal by Subject|1|||
105668898|NCT01853475|364452278|FG002|Overall Study|Withdrawal by Subject|0|||
105668899|NCT00820170|364452279|FG000|Overall Study|Adverse Event|0|||
105668900|NCT00820170|364452280|FG001|Overall Study|Adverse Event|0|||
105668901|NCT00820170|364452281|FG002|Overall Study|Adverse Event|0|||
105668902|NCT00820170|364452282|FG003|Overall Study|Adverse Event|0|||
105668903|NCT00820170|364452283|FG004|Overall Study|Adverse Event|2|||
105668904|NCT00820170|364452279|FG000|Overall Study|Progressive Disease|0|||
105668905|NCT00820170|364452280|FG001|Overall Study|Progressive Disease|0|||
105668906|NCT00820170|364452281|FG002|Overall Study|Progressive Disease|0|||
105668907|NCT00820170|364452282|FG003|Overall Study|Progressive Disease|0|||
105668908|NCT00820170|364452283|FG004|Overall Study|Progressive Disease|2|||
105668909|NCT03192475|364452284|FG000|Overall Study|Death|0|||
105668910|NCT03192475|364452285|FG001|Overall Study|Death|1|||
105668911|NCT03192475|364452284|FG000|Overall Study|Lost to Follow-up|13|||
105668912|NCT03192475|364452285|FG001|Overall Study|Lost to Follow-up|8|||
105668913|NCT00755105|364452288|FG000|Overall Study|Withdrawal by Subject|9|||
105668914|NCT00755105|364452289|FG001|Overall Study|Withdrawal by Subject|11|||
105341428|NCT04521621|363251936|FG005|Overall Study|Allocated in error without study intervention|0|||
105341429|NCT04521621|363251937|FG006|Overall Study|Allocated in error without study intervention|0|||
105341430|NCT04521621|363251938|FG007|Overall Study|Allocated in error without study intervention|0|||
105341431|NCT02777970|363251949|FG000|Overall Study|Lost to Follow-up|0|||
105341432|NCT02777970|363251950|FG001|Overall Study|Lost to Follow-up|1|||
105341433|NCT02777970|363251951|FG002|Overall Study|Lost to Follow-up|0|||
105341434|NCT02777970|363251949|FG000|Overall Study|Protocol Violation|1|||
105341435|NCT02777970|363251950|FG001|Overall Study|Protocol Violation|0|||
105341436|NCT02777970|363251951|FG002|Overall Study|Protocol Violation|0|||
105341437|NCT01967706|363251952|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
105341438|NCT01967706|363251953|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
105341439|NCT01967706|363251954|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
105341440|NCT01967706|363251955|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
105341441|NCT00725608|363251956|FG000|Overall Study|Lost to Follow-up|60|||
105466203|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
105341442|NCT00725608|363251956|FG000|Overall Study|Adverse Event|14|||
105668915|NCT00755105|364452290|FG002|Overall Study|Withdrawal by Subject|4|||
105668916|NCT02180243|364452291|FG000|Overall Study|Withdrawal by Subject|12|||
105668917|NCT02180243|364452292|FG001|Overall Study|Withdrawal by Subject|12|||
105668918|NCT02180243|364452291|FG000|Overall Study|Lost to Follow-up|12|||
105668919|NCT02180243|364452292|FG001|Overall Study|Lost to Follow-up|2|||
105668920|NCT02202785|364452293|FG000|Overall Study|Study Terminated by Sponsor|1|||
105668921|NCT02202785|364452294|FG001|Overall Study|Study Terminated by Sponsor|6|||
105466204|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
105466205|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
105466206|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
105466207|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
105466208|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
105466209|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
105466210|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
105466211|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
105466212|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
105466213|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
105466214|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
105466215|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
105466216|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
105466217|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
105466218|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
105466219|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
105466220|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
105466221|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
105466222|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
105466223|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
105466224|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
105466225|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
105466226|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
105466227|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
105466228|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
105466229|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
105466230|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
105466231|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
105466232|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
105466233|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
105466234|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
105466235|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
105466236|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
105466237|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
105466238|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
105466239|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
105466240|NCT02968004|363720058|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
105466241|NCT02968004|363720059|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
105466242|NCT05029362|363720060|FG000|Overall Study|Lost to Follow-up|9|||
105466243|NCT03771664|363720070|FG000|Overall Study|Adverse Event|1|||
105466244|NCT03771664|363720071|FG001|Overall Study|Adverse Event|0|||
105466245|NCT03771664|363720070|FG000|Overall Study|Lost to Follow-up|1|||
105466246|NCT03771664|363720071|FG001|Overall Study|Lost to Follow-up|0|||
105466247|NCT03771664|363720070|FG000|Overall Study|Withdrawal by Participant|1|||
105553598|NCT04537923|364025148|FG002|Overall Study|Lost to Follow-up|1|||
105553599|NCT04537923|364025149|FG003|Overall Study|Lost to Follow-up|6|||
105553600|NCT04537923|364025146|FG000|Overall Study|Physician Decision|1|||
105553601|NCT04537923|364025147|FG001|Overall Study|Physician Decision|0|||
105553602|NCT04537923|364025148|FG002|Overall Study|Physician Decision|2|||
105553603|NCT04537923|364025149|FG003|Overall Study|Physician Decision|5|||
105553604|NCT04537923|364025146|FG000|Overall Study|Pregnancy|1|||
105553605|NCT04537923|364025147|FG001|Overall Study|Pregnancy|0|||
105668922|NCT02202785|364452295|FG002|Overall Study|Study Terminated by Sponsor|4|||
105668923|NCT02202785|364452293|FG000|Overall Study|Withdrawal by Subject|0|||
105553606|NCT04537923|364025148|FG002|Overall Study|Pregnancy|0|||
105553607|NCT04537923|364025149|FG003|Overall Study|Pregnancy|0|||
105553608|NCT04537923|364025146|FG000|Overall Study|Withdrawal by Subject|4|||
105553609|NCT04537923|364025147|FG001|Overall Study|Withdrawal by Subject|4|||
105553610|NCT04537923|364025148|FG002|Overall Study|Withdrawal by Subject|4|||
105553611|NCT04537923|364025149|FG003|Overall Study|Withdrawal by Subject|58|||
105553612|NCT04537923|364025146|FG000|Overall Study|Missed study visits|2|||
105553613|NCT04537923|364025147|FG001|Overall Study|Missed study visits|0|||
105553614|NCT04537923|364025148|FG002|Overall Study|Missed study visits|0|||
105553615|NCT04537923|364025149|FG003|Overall Study|Missed study visits|3|||
105553616|NCT04537923|364025146|FG000|Overall Study|Sponsor's decision|0|||
105553617|NCT04537923|364025147|FG001|Overall Study|Sponsor's decision|0|||
105553618|NCT04537923|364025148|FG002|Overall Study|Sponsor's decision|1|||
105553619|NCT04537923|364025149|FG003|Overall Study|Sponsor's decision|1|||
105668924|NCT02202785|364452294|FG001|Overall Study|Withdrawal by Subject|1|||
105553620|NCT04537923|364025146|FG000|Overall Study|Safety reasons|1|||
105553621|NCT04537923|364025147|FG001|Overall Study|Safety reasons|0|||
105553622|NCT04537923|364025148|FG002|Overall Study|Safety reasons|0|||
105553623|NCT04537923|364025149|FG003|Overall Study|Safety reasons|0|||
105341443|NCT00725608|363251956|FG000|Overall Study|Individual reasons|86|||
105341444|NCT00725608|363251956|FG000|Overall Study|Other|7|||
105553624|NCT02527798|364025150|FG000|Overall Study|Physician Decision|1|||
105553625|NCT02527798|364025151|FG001|Overall Study|Physician Decision|0|||
105553626|NCT02527798|364025152|FG002|Overall Study|Physician Decision|1|||
105553627|NCT02527798|364025153|FG003|Overall Study|Physician Decision|1|||
105553628|NCT02527798|364025154|FG004|Overall Study|Physician Decision|0|||
105553629|NCT02527798|364025155|FG005|Overall Study|Physician Decision|0|||
105553630|NCT02527798|364025150|FG000|Overall Study|Death|0|||
105553631|NCT02527798|364025151|FG001|Overall Study|Death|0|||
105553632|NCT02527798|364025152|FG002|Overall Study|Death|1|||
105553633|NCT02527798|364025153|FG003|Overall Study|Death|0|||
105553634|NCT02527798|364025154|FG004|Overall Study|Death|0|||
105553635|NCT02527798|364025155|FG005|Overall Study|Death|0|||
105553636|NCT02527798|364025150|FG000|Overall Study|Withdrawal by Subject|0|||
105553637|NCT02527798|364025151|FG001|Overall Study|Withdrawal by Subject|1|||
105553638|NCT02527798|364025152|FG002|Overall Study|Withdrawal by Subject|2|||
105553639|NCT02527798|364025153|FG003|Overall Study|Withdrawal by Subject|0|||
105553640|NCT02527798|364025154|FG004|Overall Study|Withdrawal by Subject|0|||
105553641|NCT02527798|364025155|FG005|Overall Study|Withdrawal by Subject|0|||
105553642|NCT02527798|364025150|FG000|Overall Study|Reason undisclosed|1|||
105553643|NCT02527798|364025151|FG001|Overall Study|Reason undisclosed|0|||
105553644|NCT02527798|364025152|FG002|Overall Study|Reason undisclosed|1|||
105553645|NCT02527798|364025153|FG003|Overall Study|Reason undisclosed|0|||
105553646|NCT02527798|364025154|FG004|Overall Study|Reason undisclosed|0|||
105553647|NCT02527798|364025155|FG005|Overall Study|Reason undisclosed|0|||
105553648|NCT02527798|364025150|FG000|Overall Study|Did not receive intervention|1|||
105553649|NCT02527798|364025151|FG001|Overall Study|Did not receive intervention|1|||
105553650|NCT02527798|364025152|FG002|Overall Study|Did not receive intervention|0|||
105553651|NCT02527798|364025153|FG003|Overall Study|Did not receive intervention|0|||
105553652|NCT02527798|364025154|FG004|Overall Study|Did not receive intervention|0|||
105553653|NCT02527798|364025155|FG005|Overall Study|Did not receive intervention|0|||
105553654|NCT01682460|364025161|FG000|Overall Study|Withdrawal by Subject|2|||
105553655|NCT01682460|364025161|FG000|Overall Study|Did not meet inclusion criteria|2|||
105553656|NCT01912612|364025164|FG000|Overall Study|Adverse Event|4|||
105553657|NCT01912612|364025165|FG001|Overall Study|Adverse Event|0|||
105553658|NCT01912612|364025166|FG002|Overall Study|Adverse Event|0|||
105553659|NCT01912612|364025164|FG000|Overall Study|Withdrew consent|1|||
105553660|NCT01912612|364025165|FG001|Overall Study|Withdrew consent|0|||
105553661|NCT01912612|364025166|FG002|Overall Study|Withdrew consent|0|||
105553662|NCT01912612|364025164|FG000|Overall Study|Study design change|0|||
105553663|NCT01912612|364025165|FG001|Overall Study|Study design change|0|||
105553664|NCT01912612|364025166|FG002|Overall Study|Study design change|3|||
105553665|NCT04546581|364025167|FG000|Overall Study|Adverse Event|9|||
105553666|NCT04546581|364025168|FG001|Overall Study|Adverse Event|3|||
105553667|NCT04546581|364025167|FG000|Overall Study|Physician Decision|0|||
105553668|NCT04546581|364025168|FG001|Overall Study|Physician Decision|1|||
105553669|NCT04546581|364025167|FG000|Overall Study|Protocol Violation|1|||
105553670|NCT04546581|364025168|FG001|Overall Study|Protocol Violation|2|||
105553671|NCT04546581|364025167|FG000|Overall Study|Withdrawal by Subject|3|||
105553672|NCT04546581|364025168|FG001|Overall Study|Withdrawal by Subject|7|||
105668925|NCT02202785|364452295|FG002|Overall Study|Withdrawal by Subject|0|||
105668926|NCT02202785|364452293|FG000|Overall Study|Lost to Follow-up|0|||
105668927|NCT02202785|364452294|FG001|Overall Study|Lost to Follow-up|1|||
105668928|NCT02202785|364452295|FG002|Overall Study|Lost to Follow-up|0|||
105668929|NCT02202785|364452293|FG000|Overall Study|Reason not Specified|10|||
105668930|NCT02202785|364452294|FG001|Overall Study|Reason not Specified|7|||
105668931|NCT02202785|364452295|FG002|Overall Study|Reason not Specified|13|||
105668932|NCT01361594|364452296|FG000|Overall Study|Withdrawal by Subject|1|||
105668933|NCT01361594|364452297|FG001|Overall Study|Withdrawal by Subject|2|||
105668934|NCT01111240|364452298|FG000|Overall Study|Adverse Event|190|||
105668935|NCT01111240|364452298|FG000|Overall Study|Lack of Efficacy|545|||
105668936|NCT01111240|364452298|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
105668937|NCT01111240|364452298|FG000|Overall Study|Other|312|||
105668938|NCT04343976|364452302|FG000|Overall Study|Withdrawal by Subject|0|||
105553673|NCT02526693|364025169|FG000|Overall Study|Physician Decision|3|||
105553674|NCT02526693|364025170|FG001|Overall Study|Physician Decision|1|||
105553675|NCT01983293|364025171|FG000|Overall Study|Withdrawal by Subject|29|||
105553676|NCT01983293|364025172|FG001|Overall Study|Withdrawal by Subject|15|||
105553677|NCT01983293|364025171|FG000|Overall Study|Missing 12-month visit|3|||
105553678|NCT01983293|364025172|FG001|Overall Study|Missing 12-month visit|3|||
105553679|NCT01983293|364025171|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
105553680|NCT01983293|364025172|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
105553681|NCT01349569|364025173|FG000|Overall Study|Lack of Efficacy|4|||
105553682|NCT03581305|364025174|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
105553683|NCT03581305|364025175|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
105553684|NCT03581305|364025174|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
105553685|NCT03581305|364025175|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
105553686|NCT03581305|364025174|FG000|Serotonergic Study|Withdrawal by Subject|5|||
105553687|NCT03581305|364025175|FG001|Serotonergic Study|Withdrawal by Subject|1|||
105553688|NCT01747772|364025176|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
105553689|NCT01798927|364025177|FG000|Overall Study|Withdrawal by Subject|1|||
105553690|NCT00626522|364025180|FG000|Overall Study|Protocol Violation|0|||
105553691|NCT00626522|364025181|FG001|Overall Study|Protocol Violation|0|||
105553692|NCT00626522|364025182|FG002|Overall Study|Protocol Violation|0|||
105553693|NCT00626522|364025183|FG003|Overall Study|Protocol Violation|0|||
105553694|NCT00626522|364025184|FG004|Overall Study|Protocol Violation|1|||
105553695|NCT00626522|364025185|FG005|Overall Study|Protocol Violation|0|||
105553696|NCT00626522|364025180|FG000|Overall Study|Adverse Event|2|||
105553697|NCT00626522|364025181|FG001|Overall Study|Adverse Event|1|||
105553698|NCT00626522|364025182|FG002|Overall Study|Adverse Event|2|||
105553699|NCT00626522|364025183|FG003|Overall Study|Adverse Event|0|||
105553700|NCT00626522|364025184|FG004|Overall Study|Adverse Event|1|||
105553701|NCT00626522|364025185|FG005|Overall Study|Adverse Event|1|||
105553702|NCT00626522|364025180|FG000|Overall Study|Withdrawal by Subject|2|||
105553703|NCT00626522|364025181|FG001|Overall Study|Withdrawal by Subject|5|||
105553704|NCT00626522|364025182|FG002|Overall Study|Withdrawal by Subject|5|||
105553705|NCT00626522|364025183|FG003|Overall Study|Withdrawal by Subject|0|||
105553706|NCT00626522|364025184|FG004|Overall Study|Withdrawal by Subject|4|||
105668939|NCT04343976|364452303|FG001|Overall Study|Withdrawal by Subject|1|||
105341445|NCT05129137|363251959|FG000|Second Period|Adverse Event|1|||
105553707|NCT00626522|364025185|FG005|Overall Study|Withdrawal by Subject|1|||
105553708|NCT00626522|364025180|FG000|Overall Study|COPD exacerbation|0|||
105553709|NCT00626522|364025181|FG001|Overall Study|COPD exacerbation|0|||
105553710|NCT00626522|364025182|FG002|Overall Study|COPD exacerbation|0|||
105668940|NCT00594880|364452304|FG000|Overall Study|Withdrawal by Subject|1|||
105668941|NCT00594880|364452305|FG001|Overall Study|Withdrawal by Subject|1|||
105668942|NCT00594880|364452304|FG000|Overall Study|Lost to Follow-up|1|||
105668943|NCT00594880|364452305|FG001|Overall Study|Lost to Follow-up|0|||
105668944|NCT01371708|364452308|FG000|Overall Study|Insufficient clinical response|3|||
105668945|NCT01371708|364452309|FG001|Overall Study|Insufficient clinical response|2|||
105668946|NCT01371708|364452310|FG002|Overall Study|Insufficient clinical response|0|||
105668947|NCT01371708|364452308|FG000|Overall Study|Lost to Follow-up|5|||
105668948|NCT01371708|364452309|FG001|Overall Study|Lost to Follow-up|9|||
105668949|NCT01371708|364452310|FG002|Overall Study|Lost to Follow-up|7|||
105668950|NCT01371708|364452308|FG000|Overall Study|Protocol Violation|2|||
105668951|NCT01371708|364452309|FG001|Overall Study|Protocol Violation|1|||
105668952|NCT01371708|364452310|FG002|Overall Study|Protocol Violation|2|||
105668953|NCT01371708|364452308|FG000|Overall Study|No longer willing to participate|7|||
105668954|NCT01371708|364452309|FG001|Overall Study|No longer willing to participate|7|||
105668955|NCT01371708|364452310|FG002|Overall Study|No longer willing to participate|13|||
105668956|NCT01371708|364452308|FG000|Overall Study|Medication error/not related to AE|0|||
105466248|NCT03771664|363720071|FG001|Overall Study|Withdrawal by Participant|4|||
105668957|NCT01371708|364452309|FG001|Overall Study|Medication error/not related to AE|1|||
105668958|NCT01371708|364452310|FG002|Overall Study|Medication error/not related to AE|0|||
105668959|NCT01371708|364452308|FG000|Overall Study|Other|3|||
105668960|NCT01371708|364452309|FG001|Overall Study|Other|2|||
105668961|NCT01371708|364452310|FG002|Overall Study|Other|4|||
105668962|NCT01371708|364452308|FG000|Overall Study|Adverse Event|5|||
105668963|NCT01371708|364452309|FG001|Overall Study|Adverse Event|8|||
105668964|NCT01371708|364452310|FG002|Overall Study|Adverse Event|12|||
105668965|NCT01371708|364452308|FG000|Overall Study|Started but did not receive treatment|1|||
105668966|NCT01371708|364452309|FG001|Overall Study|Started but did not receive treatment|0|||
105668967|NCT01371708|364452310|FG002|Overall Study|Started but did not receive treatment|1|||
105668968|NCT00694109|364452311|FG000|Overall Study|Physician Decision|3|||
105668969|NCT00694109|364452311|FG000|Overall Study|Adverse Event|74|||
105668970|NCT00694109|364452311|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
105668971|NCT00694109|364452311|FG000|Overall Study|Lack of Efficacy|2|||
105668972|NCT00694109|364452311|FG000|Overall Study|Withdrawal by Subject|13|||
105668973|NCT00694109|364452311|FG000|Overall Study|Pregnancy|1|||
105668974|NCT00694109|364452311|FG000|Overall Study|Enrolled but not treated|1|||
105668975|NCT00694109|364452311|FG000|Overall Study|Other|2|||
105668976|NCT00694109|364452311|FG000|Overall Study|Consented but no additional treatment|3|||
105668977|NCT02514551|364452312|FG000|Overall Study|Lost to Follow-up|0|||
105668978|NCT02514551|364452313|FG001|Overall Study|Lost to Follow-up|1|||
105668979|NCT02514551|364452312|FG000|Overall Study|Participant Never Treated|0|||
105668980|NCT02514551|364452313|FG001|Overall Study|Participant Never Treated|2|||
105668981|NCT00245960|364452314|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
105668982|NCT00245960|364452315|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
105668983|NCT00245960|364452314|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
105668984|NCT00245960|364452315|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
105668985|NCT00245960|364452314|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
105668986|NCT00245960|364452315|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
105668987|NCT00245960|364452314|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
105668988|NCT00245960|364452315|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
105668989|NCT00245960|364452314|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
105668990|NCT00245960|364452315|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
105466249|NCT03771664|363720070|FG000|Overall Study|Randomized but not Treated|0|||
105466250|NCT03771664|363720071|FG001|Overall Study|Randomized but not Treated|1|||
105668991|NCT00245960|364452314|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
105668992|NCT00245960|364452315|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
105668993|NCT00245960|364452314|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
105668994|NCT00245960|364452315|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
105668995|NCT00245960|364452314|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
105668996|NCT00245960|364452315|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
105668997|NCT00245960|364452314|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
105668998|NCT00245960|364452315|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
105466251|NCT01662102|363720072|FG000|Overall Study|Sponsor's decision|1|||
105668999|NCT00245960|364452314|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
105466252|NCT01662102|363720073|FG001|Overall Study|Sponsor's decision|0|||
105466253|NCT00724698|363720074|FG000|Overall Study|Adverse Event|9|||
105466254|NCT00724698|363720074|FG000|Overall Study|Failure of Therapy|4|||
105466255|NCT00724698|363720074|FG000|Overall Study|Poor Compliance|16|||
105466256|NCT00724698|363720074|FG000|Overall Study|Lost to Follow-up|36|||
105669000|NCT00245960|364452315|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
105669001|NCT00245960|364452314|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
105669002|NCT00245960|364452315|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
105669003|NCT00245960|364452314|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
105669004|NCT00245960|364452315|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
105669005|NCT03197766|364452316|FG000|Overall Study|Withdrawal by Subject|2|||
105669006|NCT03197766|364452317|FG001|Overall Study|Withdrawal by Subject|0|||
105669007|NCT01607476|364452322|FG000|Overall Study|Withdrawal by Subject|1|||
105669008|NCT01607476|364452323|FG001|Overall Study|Withdrawal by Subject|0|||
105466257|NCT00724698|363720074|FG000|Overall Study|No Info|25|||
105669009|NCT01607476|364452324|FG002|Overall Study|Withdrawal by Subject|1|||
105669010|NCT01607476|364452322|FG000|Overall Study|Lost to Follow-up|0|||
105669011|NCT01607476|364452323|FG001|Overall Study|Lost to Follow-up|0|||
105669012|NCT01607476|364452324|FG002|Overall Study|Lost to Follow-up|2|||
105669013|NCT02833077|364452331|FG000|Overall Study|Adverse Event|1|||
105669014|NCT02833077|364452332|FG001|Overall Study|Adverse Event|2|||
105466258|NCT00043979|363720075|FG000|Period 1|recipient with progressive disease|7|||
105466259|NCT00043979|363720076|FG001|Period 1|recipient with progressive disease|4|||
105466260|NCT00043979|363720077|FG002|Period 1|recipient with progressive disease|3|||
105466261|NCT04041414|363720078|FG000|Overall Study|Lost to Follow-up|1|||
105466262|NCT04041414|363720079|FG001|Overall Study|Lost to Follow-up|2|||
105466263|NCT04639258|363720083|FG000|Overall Study|Screen failure|5|||
105466264|NCT04639258|363720083|FG000|Overall Study|Physician Decision|2|||
105786017|NCT03556202|364870444|FG000|Extension Treatment Period|Adverse Event|18|||
105786018|NCT03556202|364870445|FG001|Extension Treatment Period|Adverse Event|14|||
105786019|NCT03556202|364870446|FG002|Extension Treatment Period|Adverse Event|9|||
105786020|NCT03556202|364870444|FG000|Extension Treatment Period|Death|2|||
105786021|NCT03556202|364870445|FG001|Extension Treatment Period|Death|6|||
105786022|NCT03556202|364870446|FG002|Extension Treatment Period|Death|0|||
105786023|NCT03556202|364870444|FG000|Extension Treatment Period|Lack of Efficacy|5|||
105786024|NCT03556202|364870445|FG001|Extension Treatment Period|Lack of Efficacy|12|||
105786025|NCT03556202|364870446|FG002|Extension Treatment Period|Lack of Efficacy|18|||
105786026|NCT03556202|364870444|FG000|Extension Treatment Period|Lost to Follow-up|9|||
105786027|NCT03556202|364870445|FG001|Extension Treatment Period|Lost to Follow-up|20|||
105786028|NCT03556202|364870446|FG002|Extension Treatment Period|Lost to Follow-up|2|||
105786029|NCT03556202|364870444|FG000|Extension Treatment Period|Pregnancy|2|||
105786030|NCT03556202|364870445|FG001|Extension Treatment Period|Pregnancy|4|||
105786031|NCT03556202|364870446|FG002|Extension Treatment Period|Pregnancy|3|||
105786032|NCT03556202|364870444|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
105786033|NCT03556202|364870445|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
105786034|NCT03556202|364870446|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
105786035|NCT03556202|364870444|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
105786036|NCT03556202|364870445|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
105786037|NCT03556202|364870446|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
105786038|NCT03556202|364870444|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
105786039|NCT03556202|364870445|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
105786040|NCT03556202|364870446|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
105786041|NCT03556202|364870444|FG000|Extension Treatment Period|Physician Decision|0|||
105786042|NCT03556202|364870445|FG001|Extension Treatment Period|Physician Decision|8|||
105786043|NCT03556202|364870446|FG002|Extension Treatment Period|Physician Decision|2|||
105786044|NCT03556202|364870444|FG000|Extension Treatment Period|Protocol Violation|0|||
105786045|NCT03556202|364870445|FG001|Extension Treatment Period|Protocol Violation|1|||
105786046|NCT03556202|364870446|FG002|Extension Treatment Period|Protocol Violation|1|||
105786047|NCT03556202|364870444|FG000|Extension Treatment Period|Sponsor Decision|0|||
105786048|NCT03556202|364870445|FG001|Extension Treatment Period|Sponsor Decision|1|||
105786049|NCT03556202|364870446|FG002|Extension Treatment Period|Sponsor Decision|0|||
105786050|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
105786051|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
105786052|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
105786053|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Death|1|||
105786054|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Death|0|||
105786055|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Death|0|||
105786056|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
105786057|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
105786058|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
105786059|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
105786060|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
105786061|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
105786062|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
105466265|NCT04639258|363720083|FG000|Overall Study|Early study termination|3|||
105341446|NCT05129137|363251960|FG001|Second Period|Adverse Event|0|||
105341447|NCT05129137|363251961|FG002|Second Period|Adverse Event|0|||
105341448|NCT05129137|363251962|FG003|Second Period|Adverse Event|0|||
105341449|NCT05129137|363251959|FG000|Second Period|Protocol Violation|0|||
105341450|NCT05129137|363251960|FG001|Second Period|Protocol Violation|0|||
105341451|NCT05129137|363251961|FG002|Second Period|Protocol Violation|0|||
105341452|NCT05129137|363251962|FG003|Second Period|Protocol Violation|1|||
105341453|NCT05129137|363251959|FG000|Third Period|Protocol Violation|0|||
105341454|NCT05129137|363251960|FG001|Third Period|Protocol Violation|0|||
105341455|NCT05129137|363251961|FG002|Third Period|Protocol Violation|0|||
105341456|NCT05129137|363251962|FG003|Third Period|Protocol Violation|1|||
105341457|NCT05129137|363251959|FG000|Forth Period|Protocol Violation|0|||
105341458|NCT05129137|363251960|FG001|Forth Period|Protocol Violation|1|||
105341459|NCT05129137|363251961|FG002|Forth Period|Protocol Violation|0|||
105341460|NCT05129137|363251962|FG003|Forth Period|Protocol Violation|0|||
105341461|NCT05129137|363251959|FG000|Forth Period|Withdrawal by Subject|0|||
105341462|NCT05129137|363251960|FG001|Forth Period|Withdrawal by Subject|0|||
105341463|NCT05129137|363251961|FG002|Forth Period|Withdrawal by Subject|1|||
105341464|NCT05129137|363251962|FG003|Forth Period|Withdrawal by Subject|0|||
105341465|NCT01084668|363251963|FG000|Overall Study|Lack of Efficacy|5|||
105341466|NCT01084668|363251963|FG000|Overall Study|Withdrawal by Subject|2|||
105341467|NCT01084668|363251963|FG000|Overall Study|Pregnancy|1|||
105341468|NCT01084668|363251963|FG000|Overall Study|Non-compliance|1|||
105341469|NCT00878969|363251967|FG000|Overall Study|Physician Decision|5|||
105341470|NCT00878969|363251968|FG001|Overall Study|Physician Decision|3|||
105341471|NCT00878969|363251969|FG002|Overall Study|Physician Decision|2|||
105341472|NCT00878969|363251967|FG000|Overall Study|Withdrawal by Subject|1|||
105341473|NCT00878969|363251968|FG001|Overall Study|Withdrawal by Subject|6|||
105341474|NCT00878969|363251969|FG002|Overall Study|Withdrawal by Subject|3|||
105341475|NCT00878969|363251967|FG000|Overall Study|kidney transplant|2|||
105341476|NCT00878969|363251968|FG001|Overall Study|kidney transplant|3|||
105341477|NCT00878969|363251969|FG002|Overall Study|kidney transplant|2|||
105341478|NCT00878969|363251967|FG000|Overall Study|Adverse Event|3|||
105341479|NCT00878969|363251968|FG001|Overall Study|Adverse Event|1|||
105341480|NCT00878969|363251969|FG002|Overall Study|Adverse Event|2|||
105553711|NCT00626522|364025183|FG003|Overall Study|COPD exacerbation|1|||
105553712|NCT00626522|364025184|FG004|Overall Study|COPD exacerbation|1|||
105669015|NCT02833077|364452331|FG000|Overall Study|Lost to Follow-up|10|||
105786063|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
105341481|NCT00878969|363251967|FG000|Overall Study|Lost to Follow-up|2|||
105341482|NCT00878969|363251968|FG001|Overall Study|Lost to Follow-up|1|||
105341483|NCT00878969|363251969|FG002|Overall Study|Lost to Follow-up|0|||
105341484|NCT00878969|363251967|FG000|Overall Study|Protocol Violation|2|||
105669016|NCT02833077|364452332|FG001|Overall Study|Lost to Follow-up|1|||
105341485|NCT00878969|363251968|FG001|Overall Study|Protocol Violation|0|||
105466266|NCT04639258|363720083|FG000|Overall Study|Withdrawal by Subject|1|||
105466267|NCT02556177|363720088|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
105466268|NCT02556177|363720089|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
105466269|NCT00658359|363720090|FG000|Overall Study|Death|3|||
105466270|NCT00658359|363720091|FG001|Overall Study|Death|1|||
105466271|NCT00658359|363720092|FG002|Overall Study|Death|2|||
105466272|NCT00658359|363720090|FG000|Overall Study|Adverse Event|13|||
105466273|NCT00658359|363720091|FG001|Overall Study|Adverse Event|6|||
105466274|NCT00658359|363720092|FG002|Overall Study|Adverse Event|9|||
105466275|NCT00658359|363720090|FG000|Overall Study|Protocol Violation|1|||
105466276|NCT00658359|363720091|FG001|Overall Study|Protocol Violation|0|||
105466277|NCT00658359|363720092|FG002|Overall Study|Protocol Violation|0|||
105466278|NCT00658359|363720090|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
105466279|NCT00658359|363720091|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
105466280|NCT00658359|363720092|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
105466281|NCT00658359|363720090|FG000|Overall Study|Withdrawal by Subject|7|||
105466282|NCT00658359|363720091|FG001|Overall Study|Withdrawal by Subject|4|||
105466283|NCT00658359|363720092|FG002|Overall Study|Withdrawal by Subject|2|||
105466284|NCT00658359|363720090|FG000|Overall Study|Lost to Follow-up|2|||
105466285|NCT00658359|363720091|FG001|Overall Study|Lost to Follow-up|2|||
105466286|NCT00658359|363720092|FG002|Overall Study|Lost to Follow-up|4|||
105466287|NCT00658359|363720090|FG000|Overall Study|Lack of Efficacy|0|||
105466288|NCT00658359|363720091|FG001|Overall Study|Lack of Efficacy|1|||
105466289|NCT00658359|363720092|FG002|Overall Study|Lack of Efficacy|0|||
105466290|NCT02558296|363720093|FG000|Completed the Study Through Week 24|Adverse Event|9|||
105466291|NCT02558296|363720094|FG001|Completed the Study Through Week 24|Adverse Event|3|||
105466292|NCT02558296|363720093|FG000|Completed the Study Through Week 24|Death|7|||
105466293|NCT02558296|363720094|FG001|Completed the Study Through Week 24|Death|7|||
105466294|NCT02558296|363720093|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
105669017|NCT02833077|364452331|FG000|Overall Study|Personal Reasons|6|||
105669018|NCT02833077|364452332|FG001|Overall Study|Personal Reasons|4|||
105466295|NCT02558296|363720094|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
105466296|NCT02558296|363720093|FG000|Completed the Study Through Week 24|Physician Decision|1|||
105466297|NCT02558296|363720094|FG001|Completed the Study Through Week 24|Physician Decision|0|||
105466298|NCT02558296|363720093|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
105466299|NCT02558296|363720094|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
105466300|NCT02558296|363720093|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
105466301|NCT02558296|363720094|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
105669019|NCT02833077|364452331|FG000|Overall Study|Protocol Deviation|0|||
105669020|NCT02833077|364452332|FG001|Overall Study|Protocol Deviation|1|||
105669021|NCT01077518|364452333|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
105669022|NCT01077518|364452334|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
105669023|NCT01077518|364452335|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
105669024|NCT01077518|364452333|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
105669025|NCT01077518|364452334|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
105669026|NCT01077518|364452335|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
105669027|NCT01077518|364452333|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
105669028|NCT01077518|364452334|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
105669029|NCT01077518|364452335|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
105669030|NCT01077518|364452333|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
105669031|NCT01077518|364452334|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
105669032|NCT01077518|364452335|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
105669033|NCT01077518|364452333|FG000|Optional Ofa Phase|Physician Decision|0|||
105669034|NCT01077518|364452334|FG001|Optional Ofa Phase|Physician Decision|0|||
105669035|NCT01077518|364452335|FG002|Optional Ofa Phase|Physician Decision|1|||
105669036|NCT01077518|364452333|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
105669037|NCT01077518|364452334|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
105466302|NCT02558296|363720093|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
105466303|NCT02558296|363720094|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
105466304|NCT02558296|363720093|FG000|Completed the Study|Adverse Event|14|||
105669038|NCT01077518|364452335|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
105669039|NCT01077518|364452333|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
105466305|NCT02558296|363720094|FG001|Completed the Study|Adverse Event|5|||
105466306|NCT02558296|363720093|FG000|Completed the Study|Death|39|||
105466307|NCT02558296|363720094|FG001|Completed the Study|Death|25|||
105466308|NCT02558296|363720093|FG000|Completed the Study|Lost to Follow-up|31|||
105466309|NCT02558296|363720094|FG001|Completed the Study|Lost to Follow-up|23|||
105466310|NCT02558296|363720093|FG000|Completed the Study|Physician Decision|6|||
105466311|NCT02558296|363720094|FG001|Completed the Study|Physician Decision|0|||
105553713|NCT00626522|364025185|FG005|Overall Study|COPD exacerbation|0|||
105669040|NCT01077518|364452334|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
105341486|NCT00878969|363251969|FG002|Overall Study|Protocol Violation|0|||
105341487|NCT00878969|363251967|FG000|Overall Study|Death|0|||
105341488|NCT00878969|363251968|FG001|Overall Study|Death|0|||
105341489|NCT00878969|363251969|FG002|Overall Study|Death|2|||
105341490|NCT00878969|363251967|FG000|Overall Study|Pregnancy|0|||
105341491|NCT00878969|363251968|FG001|Overall Study|Pregnancy|1|||
105341492|NCT00878969|363251969|FG002|Overall Study|Pregnancy|0|||
105341493|NCT00655733|363251976|FG000|Overall Study|Lost to Follow-up|2|||
105341494|NCT00655733|363251977|FG001|Overall Study|Lost to Follow-up|2|||
105341495|NCT00655733|363251976|FG000|Overall Study|Adverse Event|2|||
105341496|NCT00655733|363251977|FG001|Overall Study|Adverse Event|2|||
105341497|NCT00655733|363251976|FG000|Overall Study|Withdrawal by Subject|3|||
105341498|NCT00655733|363251977|FG001|Overall Study|Withdrawal by Subject|3|||
105341499|NCT00655733|363251976|FG000|Overall Study|Physician Decision|0|||
105341500|NCT00655733|363251977|FG001|Overall Study|Physician Decision|1|||
105341501|NCT00373958|363251978|FG000|Infant Series|Withdrawal by Subject|13|||
105341502|NCT00373958|363251979|FG001|Infant Series|Withdrawal by Subject|15|||
105341503|NCT00373958|363251978|FG000|Infant Series|Failed to return|8|||
105341504|NCT00373958|363251979|FG001|Infant Series|Failed to return|13|||
105553714|NCT00626522|364025180|FG000|Overall Study|Lost to Follow-up|0|||
105553715|NCT00626522|364025181|FG001|Overall Study|Lost to Follow-up|1|||
105553716|NCT00626522|364025182|FG002|Overall Study|Lost to Follow-up|0|||
105553717|NCT00626522|364025183|FG003|Overall Study|Lost to Follow-up|0|||
105553718|NCT00626522|364025184|FG004|Overall Study|Lost to Follow-up|0|||
105553719|NCT00626522|364025185|FG005|Overall Study|Lost to Follow-up|0|||
105553720|NCT00626522|364025180|FG000|Overall Study|Inconsistent reason reported|1|||
105553721|NCT00626522|364025181|FG001|Overall Study|Inconsistent reason reported|0|||
105553722|NCT00626522|364025182|FG002|Overall Study|Inconsistent reason reported|0|||
105553723|NCT00626522|364025183|FG003|Overall Study|Inconsistent reason reported|0|||
105553724|NCT00626522|364025184|FG004|Overall Study|Inconsistent reason reported|0|||
105553725|NCT00626522|364025185|FG005|Overall Study|Inconsistent reason reported|0|||
105553726|NCT00626522|364025180|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
105553727|NCT00626522|364025181|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
105553728|NCT00626522|364025182|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
105553729|NCT00626522|364025183|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
105553730|NCT00626522|364025184|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
105553731|NCT00626522|364025185|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
105553732|NCT02280044|364025186|FG000|Overall Study|Planned alternate|0|||
105553733|NCT02280044|364025187|FG001|Overall Study|Planned alternate|2|||
105553734|NCT00263666|364025190|FG000|Overall Study|Adverse Event|6|||
105553735|NCT00263666|364025191|FG001|Overall Study|Adverse Event|8|||
105553736|NCT00263666|364025190|FG000|Overall Study|Lost to Follow-up|1|||
105553737|NCT00263666|364025191|FG001|Overall Study|Lost to Follow-up|2|||
105553738|NCT00263666|364025190|FG000|Overall Study|Withdrawal by Subject|0|||
105553739|NCT00263666|364025191|FG001|Overall Study|Withdrawal by Subject|1|||
105553740|NCT03832010|364025197|FG000|Overall Study|Withdrawal by Subject|2|||
105341505|NCT00373958|363251978|FG000|Infant Series|Lost to Follow-up|6|||
105341506|NCT00373958|363251979|FG001|Infant Series|Lost to Follow-up|5|||
105341507|NCT00373958|363251978|FG000|Infant Series|Protocol Violation|3|||
105341508|NCT00373958|363251979|FG001|Infant Series|Protocol Violation|7|||
105786064|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
105786065|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
105786066|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
105341509|NCT00373958|363251978|FG000|Infant Series|Lost Kaiser coverage|4|||
105341510|NCT00373958|363251979|FG001|Infant Series|Lost Kaiser coverage|0|||
105341511|NCT00373958|363251978|FG000|Infant Series|Child relocated|1|||
105553741|NCT03832010|364025198|FG001|Overall Study|Withdrawal by Subject|1|||
105553742|NCT03832010|364025199|FG002|Overall Study|Withdrawal by Subject|0|||
105553743|NCT03832010|364025197|FG000|Overall Study|Lost to Follow-up|2|||
105553744|NCT03832010|364025198|FG001|Overall Study|Lost to Follow-up|1|||
105553745|NCT03832010|364025199|FG002|Overall Study|Lost to Follow-up|1|||
105553746|NCT01944631|364025200|FG000|Overall Study|Adverse Event|1|||
105553747|NCT01944631|364025201|FG001|Overall Study|Adverse Event|0|||
105553748|NCT01944631|364025200|FG000|Overall Study|Lost to Follow-up|3|||
105553749|NCT01944631|364025201|FG001|Overall Study|Lost to Follow-up|1|||
105553750|NCT01944631|364025200|FG000|Overall Study|Withdrawal by Subject|0|||
105553751|NCT01944631|364025201|FG001|Overall Study|Withdrawal by Subject|1|||
105553752|NCT02811861|364025202|FG000|Overall Study|Radiological Disease Progression|123|||
105553753|NCT02811861|364025203|FG001|Overall Study|Radiological Disease Progression|97|||
105553754|NCT02811861|364025204|FG002|Overall Study|Radiological Disease Progression|174|||
105553755|NCT02811861|364025202|FG000|Overall Study|Clinical Disease Progression|20|||
105553756|NCT02811861|364025203|FG001|Overall Study|Clinical Disease Progression|19|||
105553757|NCT02811861|364025204|FG002|Overall Study|Clinical Disease Progression|22|||
105786067|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
105341512|NCT00373958|363251979|FG001|Infant Series|Child relocated|0|||
105553758|NCT02811861|364025202|FG000|Overall Study|Adverse Event|63|||
105669041|NCT01077518|364452335|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
105669042|NCT00972322|364452336|FG000|Overall Study|Adverse Event|2|||
105669043|NCT00972322|364452337|FG001|Overall Study|Adverse Event|1|||
105669044|NCT00972322|364452336|FG000|Overall Study|Positive drug screen|0|||
105669045|NCT00972322|364452337|FG001|Overall Study|Positive drug screen|1|||
105669046|NCT00972322|364452336|FG000|Overall Study|Lost to Follow-up|0|||
105669047|NCT00972322|364452337|FG001|Overall Study|Lost to Follow-up|1|||
105669048|NCT00972322|364452336|FG000|Overall Study|Consistently high glucose values|1|||
105669049|NCT00972322|364452337|FG001|Overall Study|Consistently high glucose values|0|||
105669050|NCT02138786|364453929|FG000|Overall Study|Adverse Event|0|||
105669051|NCT02138786|364453930|FG001|Overall Study|Adverse Event|2|||
105669052|NCT02138786|364453931|FG002|Overall Study|Adverse Event|1|||
105669053|NCT02138786|364453929|FG000|Overall Study|Death|1|||
105669054|NCT02138786|364453930|FG001|Overall Study|Death|7|||
105669055|NCT02138786|364453931|FG002|Overall Study|Death|2|||
105669056|NCT02138786|364453929|FG000|Overall Study|Disease Progression|1|||
105669057|NCT02138786|364453930|FG001|Overall Study|Disease Progression|1|||
105669058|NCT02138786|364453931|FG002|Overall Study|Disease Progression|3|||
105669059|NCT02138786|364453929|FG000|Overall Study|Withdrawal by Subject|1|||
105669060|NCT02138786|364453930|FG001|Overall Study|Withdrawal by Subject|2|||
105669061|NCT02138786|364453931|FG002|Overall Study|Withdrawal by Subject|0|||
105341513|NCT00373958|363251978|FG000|Infant Series|Consent was not received|1|||
105669062|NCT02138786|364453929|FG000|Overall Study|Patient's Wish|0|||
105669063|NCT02138786|364453930|FG001|Overall Study|Patient's Wish|2|||
105669064|NCT02138786|364453931|FG002|Overall Study|Patient's Wish|0|||
105669065|NCT02138786|364453929|FG000|Overall Study|Sponsor Terminated Study|0|||
105669066|NCT02138786|364453930|FG001|Overall Study|Sponsor Terminated Study|1|||
105669067|NCT02138786|364453931|FG002|Overall Study|Sponsor Terminated Study|1|||
105669068|NCT02138786|364453929|FG000|Overall Study|Non-Compliance|0|||
105669069|NCT02138786|364453930|FG001|Overall Study|Non-Compliance|0|||
105669070|NCT02138786|364453931|FG002|Overall Study|Non-Compliance|1|||
105669071|NCT00608868|364453932|FG000|Overall Study|Withdrawal by Subject|7|||
105669072|NCT00608868|364453932|FG000|Overall Study|Protocol Violation|3|||
105669073|NCT00608868|364453932|FG000|Overall Study|Lost to Follow-up|2|||
105669074|NCT00608868|364453932|FG000|Overall Study|Adverse Event|1|||
105669075|NCT00608868|364453932|FG000|Overall Study|Physician Decision|2|||
105669076|NCT00335140|364453935|FG000|Overall Study|Ineligible|1|||
105669077|NCT02922023|364453940|FG000|Overall Study|Lost to Follow-up|2|||
105669078|NCT02922023|364453941|FG001|Overall Study|Lost to Follow-up|0|||
105669079|NCT01125046|364453943|FG000|First 6 Months of Treatment|Death|1|||
105669080|NCT01125046|364453943|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
105669081|NCT01125046|364453943|FG000|First 6 Months of Treatment|Non-compliance|1|||
105669082|NCT01125046|364453943|FG000|First 6 Months of Treatment|Surgery|1|||
105669083|NCT01125046|364453943|FG000|First 6 Months of Treatment|Progressive Disease|7|||
105669084|NCT01125046|364453943|FG000|First 6 Months of Treatment|Adverse Event|2|||
105669085|NCT01125046|364453943|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
105669086|NCT01125046|364453943|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
105669087|NCT01125046|364453943|FG000|Follow-up/Data Cut Off Point|Death|29|||
105669088|NCT01125046|364453943|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
105669089|NCT01240915|364453944|FG000|Overall Study|Adverse Event|0|||
105669090|NCT01240915|364453945|FG001|Overall Study|Adverse Event|0|||
105669091|NCT01240915|364453946|FG002|Overall Study|Adverse Event|0|||
105669092|NCT01240915|364453947|FG003|Overall Study|Adverse Event|1|||
105669093|NCT01240915|364453948|FG004|Overall Study|Adverse Event|0|||
105669094|NCT01240915|364453949|FG005|Overall Study|Adverse Event|2|||
105669095|NCT01240915|364453950|FG006|Overall Study|Adverse Event|0|||
105669096|NCT01240915|364453951|FG007|Overall Study|Adverse Event|0|||
105669097|NCT01240915|364453952|FG008|Overall Study|Adverse Event|1|||
105669098|NCT01240915|364453944|FG000|Overall Study|Lost to Follow-up|0|||
105669099|NCT01240915|364453945|FG001|Overall Study|Lost to Follow-up|0|||
105669100|NCT01240915|364453946|FG002|Overall Study|Lost to Follow-up|0|||
105669101|NCT01240915|364453947|FG003|Overall Study|Lost to Follow-up|0|||
105669102|NCT01240915|364453948|FG004|Overall Study|Lost to Follow-up|1|||
105669103|NCT01240915|364453949|FG005|Overall Study|Lost to Follow-up|1|||
105669104|NCT01240915|364453950|FG006|Overall Study|Lost to Follow-up|0|||
105669105|NCT01240915|364453951|FG007|Overall Study|Lost to Follow-up|1|||
105669106|NCT01240915|364453952|FG008|Overall Study|Lost to Follow-up|1|||
105669107|NCT01240915|364453944|FG000|Overall Study|Withdrawal by Subject|2|||
105669108|NCT01240915|364453945|FG001|Overall Study|Withdrawal by Subject|1|||
105669109|NCT01240915|364453946|FG002|Overall Study|Withdrawal by Subject|0|||
105669110|NCT01240915|364453947|FG003|Overall Study|Withdrawal by Subject|2|||
105669111|NCT01240915|364453948|FG004|Overall Study|Withdrawal by Subject|0|||
105669112|NCT01240915|364453949|FG005|Overall Study|Withdrawal by Subject|4|||
105669113|NCT01240915|364453950|FG006|Overall Study|Withdrawal by Subject|2|||
105669114|NCT01240915|364453951|FG007|Overall Study|Withdrawal by Subject|3|||
105669115|NCT01240915|364453952|FG008|Overall Study|Withdrawal by Subject|3|||
105669116|NCT01240915|364453944|FG000|Overall Study|Other|0|||
105669117|NCT01240915|364453945|FG001|Overall Study|Other|0|||
105669118|NCT01240915|364453946|FG002|Overall Study|Other|0|||
105669119|NCT01240915|364453947|FG003|Overall Study|Other|0|||
105669120|NCT01240915|364453948|FG004|Overall Study|Other|2|||
105669121|NCT01240915|364453949|FG005|Overall Study|Other|0|||
105669122|NCT01240915|364453950|FG006|Overall Study|Other|0|||
105669123|NCT01240915|364453951|FG007|Overall Study|Other|0|||
105669124|NCT01240915|364453952|FG008|Overall Study|Other|0|||
105669125|NCT01240915|364453944|FG000|Overall Study|Insufficient Clinical Response|0|||
105669126|NCT01240915|364453945|FG001|Overall Study|Insufficient Clinical Response|0|||
105669127|NCT01240915|364453946|FG002|Overall Study|Insufficient Clinical Response|0|||
105669128|NCT01240915|364453947|FG003|Overall Study|Insufficient Clinical Response|0|||
105669129|NCT01240915|364453948|FG004|Overall Study|Insufficient Clinical Response|1|||
105669130|NCT01240915|364453949|FG005|Overall Study|Insufficient Clinical Response|3|||
105669131|NCT01240915|364453950|FG006|Overall Study|Insufficient Clinical Response|6|||
105669132|NCT01240915|364453951|FG007|Overall Study|Insufficient Clinical Response|0|||
105669133|NCT01240915|364453952|FG008|Overall Study|Insufficient Clinical Response|3|||
105669134|NCT01685229|364453954|FG000|Overall Study|Subjects missing Study Exit form|3|||
105341514|NCT00373958|363251979|FG001|Infant Series|Consent was not received|0|||
105669135|NCT01685229|364453955|FG001|Overall Study|Subjects missing Study Exit form|1|||
105669136|NCT01685229|364453954|FG000|Overall Study|Lost to Follow-up|16|||
105669137|NCT01685229|364453955|FG001|Overall Study|Lost to Follow-up|10|||
105341515|NCT00373958|363251978|FG000|Infant Series|Adverse Event|3|||
105669138|NCT01685229|364453954|FG000|Overall Study|Withdrawal by Subject|6|||
105669139|NCT01685229|364453955|FG001|Overall Study|Withdrawal by Subject|5|||
105669140|NCT01685229|364453954|FG000|Overall Study|Death|1|||
105669141|NCT01685229|364453955|FG001|Overall Study|Death|0|||
105669142|NCT03868787|364453956|FG000|Overall Study|Withdrawal by Subject|2|||
105669143|NCT03868787|364453957|FG001|Overall Study|Withdrawal by Subject|1|||
105669144|NCT01598662|364453958|FG000|Overall Study|Lost to Follow-up|10|||
105669145|NCT01598662|364453959|FG001|Overall Study|Lost to Follow-up|17|||
105669146|NCT01598662|364453958|FG000|Overall Study|Physician Decision|1|||
105669147|NCT01598662|364453959|FG001|Overall Study|Physician Decision|2|||
105669148|NCT01598662|364453958|FG000|Overall Study|IUD expelled before month 6|0|||
105669149|NCT01598662|364453959|FG001|Overall Study|IUD expelled before month 6|2|||
105669150|NCT01399697|364453972|FG000|Overall Study|Adverse Event|13|||
105669151|NCT01399697|364453973|FG001|Overall Study|Adverse Event|3|||
105669152|NCT01399697|364453974|FG002|Overall Study|Adverse Event|1|||
105669153|NCT01399697|364453972|FG000|Overall Study|Lost to Follow-up|2|||
105669154|NCT01399697|364453973|FG001|Overall Study|Lost to Follow-up|0|||
105669155|NCT01399697|364453974|FG002|Overall Study|Lost to Follow-up|0|||
105669156|NCT01399697|364453972|FG000|Overall Study|Withdrawal by Subject|8|||
105669157|NCT01399697|364453973|FG001|Overall Study|Withdrawal by Subject|0|||
105669158|NCT01399697|364453974|FG002|Overall Study|Withdrawal by Subject|0|||
105669159|NCT01399697|364453972|FG000|Overall Study|Investigator Decisión|1|||
105669160|NCT01399697|364453973|FG001|Overall Study|Investigator Decisión|0|||
105669161|NCT01399697|364453974|FG002|Overall Study|Investigator Decisión|2|||
105669162|NCT01399697|364453972|FG000|Overall Study|Lack of Efficacy|9|||
105669163|NCT01399697|364453973|FG001|Overall Study|Lack of Efficacy|0|||
105669164|NCT01399697|364453974|FG002|Overall Study|Lack of Efficacy|1|||
105669165|NCT01399697|364453972|FG000|Overall Study|Protocol Violation|2|||
105669166|NCT01399697|364453973|FG001|Overall Study|Protocol Violation|0|||
105669167|NCT01399697|364453974|FG002|Overall Study|Protocol Violation|0|||
105669168|NCT01399697|364453972|FG000|Overall Study|Non-Compliant|1|||
105669169|NCT01399697|364453973|FG001|Overall Study|Non-Compliant|0|||
105669170|NCT01399697|364453974|FG002|Overall Study|Non-Compliant|0|||
105669171|NCT01399697|364453972|FG000|Overall Study|Inclusion Error|2|||
105669172|NCT01399697|364453973|FG001|Overall Study|Inclusion Error|0|||
105669173|NCT01399697|364453974|FG002|Overall Study|Inclusion Error|0|||
105669174|NCT01399697|364453972|FG000|Overall Study|Positive result for hepatitis B|1|||
105786068|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
105786069|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
105669175|NCT01399697|364453973|FG001|Overall Study|Positive result for hepatitis B|0|||
105669176|NCT01399697|364453974|FG002|Overall Study|Positive result for hepatitis B|0|||
105786070|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
105341516|NCT00373958|363251979|FG001|Infant Series|Adverse Event|1|||
105669177|NCT01399697|364453972|FG000|Overall Study|Clinical RA remission|1|||
105669178|NCT01399697|364453973|FG001|Overall Study|Clinical RA remission|0|||
105669179|NCT01399697|364453974|FG002|Overall Study|Clinical RA remission|0|||
105669180|NCT01399697|364453972|FG000|Overall Study|Sponsor Decision|1|||
105669181|NCT01399697|364453973|FG001|Overall Study|Sponsor Decision|0|||
105669182|NCT01399697|364453974|FG002|Overall Study|Sponsor Decision|0|||
105669183|NCT00659880|364453979|FG000|Overall Study|Lost to Follow-up|5|||
105669184|NCT03435692|364453980|FG000|Overall Study|Lack of Efficacy|2|||
105669185|NCT03435692|364453981|FG001|Overall Study|Lack of Efficacy|2|||
105669186|NCT03435692|364453982|FG002|Overall Study|Lack of Efficacy|0|||
105669187|NCT02766777|364453986|FG000|Overall Study|Adverse Event|12|||
105669188|NCT02766777|364453986|FG000|Overall Study|Lost to Follow-up|16|||
105669189|NCT02766777|364453986|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105669190|NCT02766777|364453986|FG000|Overall Study|Protocol Violation|1|||
105669191|NCT02766777|364453986|FG000|Overall Study|Withdrawal by Subject|4|||
105669192|NCT04313608|364453994|FG000|Overall Study|Death|12|||
105669193|NCT04313608|364453995|FG001|Overall Study|Death|3|||
105669194|NCT01886287|364453996|FG000|Overall Study|Radiographic disease progression|1|||
105669195|NCT01886287|364453996|FG000|Overall Study|Clinical progression due to disease|1|||
105669196|NCT02233803|364454010|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
105669197|NCT02233803|364454011|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
105669198|NCT02233803|364454010|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
105669199|NCT02233803|364454011|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
105669200|NCT02233803|364454010|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
105669201|NCT02233803|364454011|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
105669202|NCT02233803|364454010|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
105669203|NCT02233803|364454011|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
105669204|NCT02233803|364454010|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
105669205|NCT02233803|364454011|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
105669206|NCT02233803|364454010|FG000|Washout Period (4-Wks)|Physician Decision|1|||
105669207|NCT02233803|364454011|FG001|Washout Period (4-Wks)|Physician Decision|0|||
105669208|NCT02233803|364454010|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
105669209|NCT02233803|364454011|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
105669210|NCT02233803|364454010|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
105669211|NCT02233803|364454011|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
105669212|NCT02233803|364454010|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
105669213|NCT02233803|364454011|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
105669214|NCT00669877|364454012|FG000|Overall Study|Disease Progression/Death|4|||
105669215|NCT01646177|364454013|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
105669216|NCT01646177|364454014|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
105669217|NCT01646177|364454015|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
105669218|NCT01646177|364454016|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
105669219|NCT01646177|364454017|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105669220|NCT01646177|364454018|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105669221|NCT01646177|364454019|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105669222|NCT01646177|364454020|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105669223|NCT01646177|364454021|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105669224|NCT01646177|364454022|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105669225|NCT01646177|364454023|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105669226|NCT01646177|364454024|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105669227|NCT01646177|364454013|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
105669228|NCT01646177|364454014|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
105669229|NCT01646177|364454015|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
105669230|NCT01646177|364454016|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
105669231|NCT01646177|364454017|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669232|NCT01646177|364454018|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669233|NCT01646177|364454019|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669234|NCT01646177|364454020|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669235|NCT01646177|364454021|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669236|NCT01646177|364454022|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669237|NCT01646177|364454023|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669238|NCT01646177|364454024|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669239|NCT01646177|364454013|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
105669240|NCT01646177|364454014|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
105669241|NCT01646177|364454015|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
105669242|NCT01646177|364454016|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
105669243|NCT01646177|364454017|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669244|NCT01646177|364454018|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669245|NCT01646177|364454019|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669246|NCT01646177|364454020|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669247|NCT01646177|364454021|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669248|NCT01646177|364454022|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669249|NCT01646177|364454023|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669250|NCT01646177|364454024|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669251|NCT01646177|364454013|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
105669252|NCT01646177|364454014|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
105669253|NCT01646177|364454015|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
105669254|NCT01646177|364454016|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
105669255|NCT01646177|364454017|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105669256|NCT01646177|364454018|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105669257|NCT01646177|364454019|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105669258|NCT01646177|364454020|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105341517|NCT00373958|363251978|FG000|Infant Series|Physician Decision|1|||
105669259|NCT01646177|364454021|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105669260|NCT01646177|364454022|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105669261|NCT01646177|364454023|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105669262|NCT01646177|364454024|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105669263|NCT01646177|364454013|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669264|NCT01646177|364454014|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669265|NCT01646177|364454015|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
105669266|NCT01646177|364454016|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
105669267|NCT01646177|364454017|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669268|NCT01646177|364454018|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669269|NCT01646177|364454019|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669270|NCT01646177|364454020|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669271|NCT01646177|364454021|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669272|NCT01646177|364454022|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669273|NCT01646177|364454023|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669274|NCT01646177|364454024|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669275|NCT01646177|364454013|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
105669276|NCT01646177|364454014|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
105669277|NCT01646177|364454015|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
105669278|NCT01646177|364454016|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105669279|NCT01646177|364454017|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105669280|NCT01646177|364454018|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105669281|NCT01646177|364454019|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105669282|NCT01646177|364454020|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105553759|NCT02811861|364025203|FG001|Overall Study|Adverse Event|60|||
105341518|NCT00373958|363251979|FG001|Infant Series|Physician Decision|1|||
105341519|NCT00373958|363251978|FG000|Toddler Dose|Lost to Follow-up|5|||
105341520|NCT00373958|363251979|FG001|Toddler Dose|Lost to Follow-up|8|||
105341521|NCT00373958|363251978|FG000|Toddler Dose|Withdrawal by Subject|2|||
105341522|NCT00373958|363251979|FG001|Toddler Dose|Withdrawal by Subject|2|||
105341523|NCT00373958|363251978|FG000|Toddler Dose|Failed to return|1|||
105341524|NCT00373958|363251979|FG001|Toddler Dose|Failed to return|2|||
105341525|NCT00373958|363251978|FG000|Toddler Dose|Protocol Violation|0|||
105341526|NCT00373958|363251979|FG001|Toddler Dose|Protocol Violation|1|||
105341527|NCT00373958|363251978|FG000|Toddler Dose|Withdrawn after infant series|22|||
105341528|NCT00373958|363251979|FG001|Toddler Dose|Withdrawn after infant series|25|||
105341529|NCT02288091|363251983|FG000|Overall Study|Lost to Follow-up|1|||
105341530|NCT02288091|363251983|FG000|Overall Study|Screen fail|7|||
105341531|NCT00656851|363251988|FG000|Overall Study|Withdrawal by Subject|0|||
105341532|NCT00656851|363251989|FG001|Overall Study|Withdrawal by Subject|4|||
105341533|NCT00978250|363251993|FG000|Overall Study|Late determination of ineligibility|0|||
105341534|NCT00978250|363251994|FG001|Overall Study|Late determination of ineligibility|1|||
105341535|NCT00978250|363251995|FG002|Overall Study|Late determination of ineligibility|0|||
105341536|NCT00978250|363251996|FG003|Overall Study|Late determination of ineligibility|1|||
105341537|NCT05174949|363251999|FG000|Overall Study|Physician Decision|1|||
105341538|NCT05174949|363252000|FG001|Overall Study|Physician Decision|2|||
105341539|NCT05174949|363252001|FG002|Overall Study|Physician Decision|0|||
105341540|NCT05174949|363252002|FG003|Overall Study|Physician Decision|1|||
105341541|NCT05174949|363252003|FG004|Overall Study|Physician Decision|0|||
105466312|NCT02558296|363720093|FG000|Completed the Study|Protocol Violation|2|||
105466313|NCT02558296|363720094|FG001|Completed the Study|Protocol Violation|1|||
105341542|NCT05174949|363252004|FG005|Overall Study|Physician Decision|0|||
105341543|NCT05174949|363251999|FG000|Overall Study|Withdrawal by Subject|0|||
105466314|NCT02558296|363720093|FG000|Completed the Study|Withdrawal by Subject|53|||
105466315|NCT02558296|363720094|FG001|Completed the Study|Withdrawal by Subject|31|||
105466316|NCT02558296|363720093|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
105466317|NCT02558296|363720094|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
105466318|NCT02919995|363720095|FG000|Overall Study|Adverse Event|0|||
105466319|NCT02919995|363720096|FG001|Overall Study|Adverse Event|0|||
105466320|NCT02919995|363720097|FG002|Overall Study|Adverse Event|0|||
105466321|NCT02919995|363720098|FG003|Overall Study|Adverse Event|0|||
105466322|NCT02919995|363720099|FG004|Overall Study|Adverse Event|0|||
105341544|NCT05174949|363252000|FG001|Overall Study|Withdrawal by Subject|1|||
105341545|NCT05174949|363252001|FG002|Overall Study|Withdrawal by Subject|0|||
105466323|NCT02919995|363720100|FG005|Overall Study|Adverse Event|1|||
105466324|NCT02531802|363720102|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
105669283|NCT01646177|364454021|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105669284|NCT01646177|364454022|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105669285|NCT01646177|364454023|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105669286|NCT01646177|364454024|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105669287|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105669288|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105669289|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105669290|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105669291|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
105669292|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
105669293|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
105669294|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
105669295|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105669296|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105669297|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105669298|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105669299|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105669300|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105669301|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105669302|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105669303|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
105669304|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
105669305|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
105669306|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
105669307|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105669308|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105669309|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105669310|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105669311|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669312|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669313|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669314|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669315|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
105669316|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
105669317|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
105669318|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
105669319|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669320|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669321|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669322|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669323|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669324|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669325|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669326|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669327|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
105669328|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
105669329|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
105669330|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
105669331|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669332|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669333|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669334|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669335|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105466325|NCT02531802|363720103|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
105669336|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105669337|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105669338|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105669339|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
105669340|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
105669341|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
105669342|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
105669343|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105669344|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105669345|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105669346|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105669347|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105669348|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105669349|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105669350|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105669351|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
105669352|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
105669353|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105669354|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
105669355|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105669356|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105669357|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105466326|NCT02531802|363720104|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
105466327|NCT02531802|363720105|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
105466328|NCT02531802|363720106|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
105466329|NCT02531802|363720107|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
105466330|NCT02531802|363720108|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
105466331|NCT02531802|363720109|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
105466332|NCT02531802|363720110|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
105466333|NCT02531802|363720111|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
105466334|NCT02531802|363720112|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
105466335|NCT02531802|363720113|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
105466336|NCT02531802|363720114|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
105466337|NCT02531802|363720115|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
105466338|NCT02531802|363720116|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
105466339|NCT02531802|363720117|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
105466340|NCT02531802|363720118|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
105466341|NCT02531802|363720119|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
105466342|NCT02531802|363720120|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
105466343|NCT02531802|363720121|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
105466344|NCT02531802|363720122|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
105466345|NCT02531802|363720102|FG000|Received Vaccination 2|Physician Decision|0|||
105466346|NCT02531802|363720103|FG001|Received Vaccination 2|Physician Decision|0|||
105466347|NCT02531802|363720104|FG002|Received Vaccination 2|Physician Decision|0|||
105466348|NCT02531802|363720105|FG003|Received Vaccination 2|Physician Decision|0|||
105466349|NCT02531802|363720106|FG004|Received Vaccination 2|Physician Decision|0|||
105466350|NCT02531802|363720107|FG005|Received Vaccination 2|Physician Decision|1|||
105466351|NCT02531802|363720108|FG006|Received Vaccination 2|Physician Decision|0|||
105466352|NCT02531802|363720109|FG007|Received Vaccination 2|Physician Decision|0|||
105466353|NCT02531802|363720110|FG008|Received Vaccination 2|Physician Decision|0|||
105466354|NCT02531802|363720111|FG009|Received Vaccination 2|Physician Decision|2|||
105466355|NCT02531802|363720112|FG010|Received Vaccination 2|Physician Decision|0|||
105466356|NCT02531802|363720113|FG011|Received Vaccination 2|Physician Decision|0|||
105466357|NCT02531802|363720114|FG012|Received Vaccination 2|Physician Decision|0|||
105466358|NCT02531802|363720115|FG013|Received Vaccination 2|Physician Decision|1|||
105466359|NCT02531802|363720116|FG014|Received Vaccination 2|Physician Decision|0|||
105466360|NCT02531802|363720117|FG015|Received Vaccination 2|Physician Decision|0|||
105341546|NCT05174949|363252002|FG003|Overall Study|Withdrawal by Subject|0|||
105341547|NCT05174949|363252003|FG004|Overall Study|Withdrawal by Subject|0|||
105341548|NCT05174949|363252004|FG005|Overall Study|Withdrawal by Subject|0|||
105341549|NCT05174949|363251999|FG000|Overall Study|Lost to Follow-up|0|||
105553760|NCT02811861|364025204|FG002|Overall Study|Adverse Event|41|||
105553761|NCT02811861|364025202|FG000|Overall Study|Lost to Follow-up|0|||
105553762|NCT02811861|364025203|FG001|Overall Study|Lost to Follow-up|0|||
105553763|NCT02811861|364025204|FG002|Overall Study|Lost to Follow-up|1|||
105553764|NCT02811861|364025202|FG000|Overall Study|Subject Choice|29|||
105553765|NCT02811861|364025203|FG001|Overall Study|Subject Choice|17|||
105553766|NCT02811861|364025204|FG002|Overall Study|Subject Choice|23|||
105553767|NCT02811861|364025202|FG000|Overall Study|Withdrawal by Subject|4|||
105553768|NCT02811861|364025203|FG001|Overall Study|Withdrawal by Subject|4|||
105553769|NCT02811861|364025204|FG002|Overall Study|Withdrawal by Subject|9|||
105553770|NCT02811861|364025202|FG000|Overall Study|Other|4|||
105553771|NCT02811861|364025203|FG001|Overall Study|Other|13|||
105553772|NCT02811861|364025204|FG002|Overall Study|Other|3|||
105553773|NCT02811861|364025202|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
105553774|NCT02811861|364025203|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
105553775|NCT02811861|364025204|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
105553776|NCT02811861|364025202|FG000|Overall Study|Randomized but not treated|2|||
105553777|NCT02811861|364025203|FG001|Overall Study|Randomized but not treated|3|||
105553778|NCT02811861|364025204|FG002|Overall Study|Randomized but not treated|17|||
105553779|NCT02489500|364025207|FG000|Overall Study|Death|1|||
105553780|NCT02489500|364025208|FG001|Overall Study|Death|1|||
105553781|NCT00686166|364025209|FG000|Overall Study|Adverse Event|7|||
105553782|NCT00686166|364025209|FG000|Overall Study|Withdrawal by Subject|1|||
105553783|NCT00686166|364025209|FG000|Overall Study|Progression/Relapse|1|||
105553784|NCT00686166|364025209|FG000|Overall Study|Death|1|||
105553785|NCT00686166|364025209|FG000|Overall Study|Not Protocol Specified|1|||
105553786|NCT00686166|364025209|FG000|Overall Study|Ineligible|5|||
105553787|NCT00686166|364025209|FG000|Overall Study|Did not begin protocol therapy|4|||
105553788|NCT01990950|364025210|FG000|Overall Study|Death|3|||
105553789|NCT01990950|364025210|FG000|Overall Study|Lost to Follow-up|2|||
105553790|NCT01990950|364025210|FG000|Overall Study|Withdrawal by Subject|6|||
105553791|NCT03461003|364025211|FG000|Overall Study|Lost to Follow-up|2|||
105553792|NCT03461003|364025212|FG001|Overall Study|Lost to Follow-up|2|||
105553793|NCT03461003|364025211|FG000|Overall Study|Withdrawal by Subject|3|||
105553794|NCT03461003|364025212|FG001|Overall Study|Withdrawal by Subject|1|||
105341550|NCT05174949|363252000|FG001|Overall Study|Lost to Follow-up|0|||
105341551|NCT05174949|363252001|FG002|Overall Study|Lost to Follow-up|0|||
105341552|NCT05174949|363252002|FG003|Overall Study|Lost to Follow-up|1|||
105341553|NCT05174949|363252003|FG004|Overall Study|Lost to Follow-up|0|||
105553795|NCT03593655|364025238|FG000|First Product Use Period|Withdrawal by Subject|1|||
105341554|NCT05174949|363252004|FG005|Overall Study|Lost to Follow-up|0|||
105341555|NCT02951533|363252005|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
105466361|NCT02531802|363720118|FG016|Received Vaccination 2|Physician Decision|0|||
105669358|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105466362|NCT02531802|363720119|FG017|Received Vaccination 2|Physician Decision|1|||
105553796|NCT03593655|364025239|FG001|First Product Use Period|Withdrawal by Subject|1|||
105553797|NCT03593655|364025238|FG000|First Product Use Period|Lost to Follow-up|1|||
105553798|NCT03593655|364025239|FG001|First Product Use Period|Lost to Follow-up|3|||
105553799|NCT03593655|364025238|FG000|Second Product Use Period|Withdrawal by Subject|1|||
105553800|NCT03593655|364025239|FG001|Second Product Use Period|Withdrawal by Subject|1|||
105553801|NCT03593655|364025238|FG000|Second Product Use Period|Lost to Follow-up|1|||
105553802|NCT03593655|364025239|FG001|Second Product Use Period|Lost to Follow-up|0|||
105553803|NCT03593655|364025238|FG000|Third Product Use Period|Lost to Follow-up|1|||
105553804|NCT03593655|364025239|FG001|Third Product Use Period|Lost to Follow-up|2|||
105553805|NCT03593655|364025238|FG000|Third Product Use Period|Physician Decision|0|||
105553806|NCT03593655|364025239|FG001|Third Product Use Period|Physician Decision|1|||
105553807|NCT03593655|364025238|FG000|Third Product Use Period|Withdrawal by Subject|0|||
105553808|NCT03593655|364025239|FG001|Third Product Use Period|Withdrawal by Subject|1|||
105553809|NCT04420221|364025247|FG000|Overall Study|Withdrawal by Subject|0|||
105553810|NCT04420221|364025248|FG001|Overall Study|Withdrawal by Subject|0|||
105553811|NCT04420221|364025249|FG002|Overall Study|Withdrawal by Subject|0|||
105553812|NCT04420221|364025250|FG003|Overall Study|Withdrawal by Subject|0|||
105553813|NCT04420221|364025251|FG004|Overall Study|Withdrawal by Subject|0|||
105553814|NCT04420221|364025252|FG005|Overall Study|Withdrawal by Subject|20|||
105553815|NCT04420221|364025253|FG006|Overall Study|Withdrawal by Subject|5|||
105553816|NCT04420221|364025247|FG000|Overall Study|Other|0|||
105553817|NCT04420221|364025248|FG001|Overall Study|Other|0|||
105553818|NCT04420221|364025249|FG002|Overall Study|Other|0|||
105553819|NCT04420221|364025250|FG003|Overall Study|Other|0|||
105553820|NCT04420221|364025251|FG004|Overall Study|Other|0|||
105553821|NCT04420221|364025252|FG005|Overall Study|Other|1|||
105553822|NCT04420221|364025253|FG006|Overall Study|Other|1|||
105553823|NCT04420221|364025247|FG000|Overall Study|Lost to Follow-up|0|||
105553824|NCT04420221|364025248|FG001|Overall Study|Lost to Follow-up|0|||
105553825|NCT04420221|364025249|FG002|Overall Study|Lost to Follow-up|0|||
105553826|NCT04420221|364025250|FG003|Overall Study|Lost to Follow-up|0|||
105341556|NCT02951533|363252006|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
105553827|NCT04420221|364025251|FG004|Overall Study|Lost to Follow-up|0|||
105553828|NCT04420221|364025252|FG005|Overall Study|Lost to Follow-up|3|||
105553829|NCT04420221|364025253|FG006|Overall Study|Lost to Follow-up|2|||
105553830|NCT04420221|364025247|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
105553831|NCT04420221|364025248|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
105553832|NCT04420221|364025249|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
105553833|NCT04420221|364025250|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
105553834|NCT04420221|364025251|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
105553835|NCT04420221|364025252|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
105553836|NCT04420221|364025253|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
105553837|NCT02415400|364025256|FG000|Overall Study|Adverse Event|0|||
105553838|NCT02415400|364025257|FG001|Overall Study|Adverse Event|1|||
105553839|NCT02415400|364025258|FG002|Overall Study|Adverse Event|1|||
105553840|NCT02415400|364025259|FG003|Overall Study|Adverse Event|2|||
105553841|NCT02415400|364025256|FG000|Overall Study|Participant request to stop therapy|4|||
105553842|NCT02415400|364025257|FG001|Overall Study|Participant request to stop therapy|3|||
105553843|NCT02415400|364025258|FG002|Overall Study|Participant request to stop therapy|8|||
105553844|NCT02415400|364025259|FG003|Overall Study|Participant request to stop therapy|6|||
105553845|NCT02415400|364025256|FG000|Overall Study|Participant withdrew consent|14|||
105553846|NCT02415400|364025257|FG001|Overall Study|Participant withdrew consent|12|||
105553847|NCT02415400|364025258|FG002|Overall Study|Participant withdrew consent|30|||
105553848|NCT02415400|364025259|FG003|Overall Study|Participant withdrew consent|21|||
105553849|NCT02415400|364025256|FG000|Overall Study|Death|39|||
105553850|NCT02415400|364025257|FG001|Overall Study|Death|41|||
105553851|NCT02415400|364025258|FG002|Overall Study|Death|35|||
105553852|NCT02415400|364025259|FG003|Overall Study|Death|42|||
105553853|NCT02415400|364025256|FG000|Overall Study|Lost to Follow-up|3|||
105553854|NCT02415400|364025257|FG001|Overall Study|Lost to Follow-up|3|||
105553855|NCT02415400|364025258|FG002|Overall Study|Lost to Follow-up|2|||
105553856|NCT02415400|364025259|FG003|Overall Study|Lost to Follow-up|5|||
105553857|NCT02415400|364025256|FG000|Overall Study|Poor/Non-Compliance|0|||
105553858|NCT02415400|364025257|FG001|Overall Study|Poor/Non-Compliance|1|||
105553859|NCT02415400|364025258|FG002|Overall Study|Poor/Non-Compliance|3|||
105553860|NCT02415400|364025259|FG003|Overall Study|Poor/Non-Compliance|4|||
105553861|NCT02415400|364025256|FG000|Overall Study|Participant no longer meets criteria|2|||
105553862|NCT02415400|364025257|FG001|Overall Study|Participant no longer meets criteria|0|||
105553863|NCT02415400|364025258|FG002|Overall Study|Participant no longer meets criteria|0|||
105553864|NCT02415400|364025259|FG003|Overall Study|Participant no longer meets criteria|1|||
105553865|NCT02415400|364025256|FG000|Overall Study|Participant doesn't answer phone|1|||
105553866|NCT02415400|364025257|FG001|Overall Study|Participant doesn't answer phone|0|||
105553867|NCT02415400|364025258|FG002|Overall Study|Participant doesn't answer phone|0|||
105553868|NCT02415400|364025259|FG003|Overall Study|Participant doesn't answer phone|0|||
105553869|NCT02415400|364025256|FG000|Overall Study|Participant wanted home visits|1|||
105553870|NCT02415400|364025257|FG001|Overall Study|Participant wanted home visits|0|||
105553871|NCT02415400|364025258|FG002|Overall Study|Participant wanted home visits|0|||
105553872|NCT02415400|364025259|FG003|Overall Study|Participant wanted home visits|0|||
105553873|NCT02415400|364025256|FG000|Overall Study|Randomized in error|2|||
105669359|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105466363|NCT02531802|363720120|FG018|Received Vaccination 2|Physician Decision|0|||
105466364|NCT02531802|363720121|FG019|Received Vaccination 2|Physician Decision|0|||
105466365|NCT02531802|363720122|FG020|Received Vaccination 2|Physician Decision|0|||
105466366|NCT02531802|363720102|FG000|Received Vaccination 2|Adverse Event|0|||
105669360|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105669361|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105669362|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105669363|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
105669364|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
105669365|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
105669366|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
105669367|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105669368|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105669369|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105669370|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105669371|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
105669372|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
105669373|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
105669374|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
105669375|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
105669376|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
105669377|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
105466367|NCT02531802|363720103|FG001|Received Vaccination 2|Adverse Event|0|||
105466368|NCT02531802|363720104|FG002|Received Vaccination 2|Adverse Event|0|||
105466369|NCT02531802|363720105|FG003|Received Vaccination 2|Adverse Event|0|||
105466370|NCT02531802|363720106|FG004|Received Vaccination 2|Adverse Event|0|||
105553874|NCT02415400|364025257|FG001|Overall Study|Randomized in error|0|||
105553875|NCT02415400|364025258|FG002|Overall Study|Randomized in error|0|||
105553876|NCT02415400|364025259|FG003|Overall Study|Randomized in error|0|||
105553877|NCT02415400|364025256|FG000|Overall Study|No study drug on site|0|||
105553878|NCT02415400|364025257|FG001|Overall Study|No study drug on site|1|||
105553879|NCT02415400|364025258|FG002|Overall Study|No study drug on site|0|||
105553880|NCT02415400|364025259|FG003|Overall Study|No study drug on site|0|||
105553881|NCT02415400|364025256|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
105553882|NCT02415400|364025257|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
105553883|NCT02415400|364025258|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
105553884|NCT02415400|364025259|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
105553885|NCT02415400|364025256|FG000|Overall Study|Coagulation values cannot be set|0|||
105553886|NCT02415400|364025257|FG001|Overall Study|Coagulation values cannot be set|0|||
105553887|NCT02415400|364025258|FG002|Overall Study|Coagulation values cannot be set|1|||
105341557|NCT02951533|363252007|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
105341558|NCT02951533|363252005|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
105341559|NCT02951533|363252006|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
105341560|NCT02951533|363252007|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
105341561|NCT02951533|363252005|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
105341562|NCT02951533|363252006|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
105341563|NCT02951533|363252007|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
105341564|NCT02951533|363252005|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
105341565|NCT02951533|363252006|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
105341566|NCT02951533|363252007|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
105341567|NCT02951533|363252005|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
105341568|NCT02951533|363252006|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
105341569|NCT02951533|363252007|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
105341570|NCT02951533|363252005|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
105341571|NCT02951533|363252006|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
105341572|NCT02951533|363252007|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
105341573|NCT02951533|363252005|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
105341574|NCT02951533|363252006|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
105341575|NCT02951533|363252007|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
105341576|NCT02951533|363252005|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
105341577|NCT02951533|363252006|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
105341578|NCT02951533|363252007|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
105341579|NCT02951533|363252005|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
105341580|NCT02951533|363252006|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
105341581|NCT02951533|363252007|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
105341582|NCT02951533|363252005|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
105341583|NCT02951533|363252006|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
105341584|NCT02951533|363252007|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
105341585|NCT02951533|363252005|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
105341586|NCT02951533|363252006|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
105341587|NCT02951533|363252007|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
105341588|NCT02029989|363252008|FG000|Overall Study|Withdrawal by Subject|1|||
105341589|NCT02029989|363252009|FG001|Overall Study|Withdrawal by Subject|0|||
105341590|NCT02029989|363252008|FG000|Overall Study|Withdrawal: Fear of needles|1|||
105341591|NCT02029989|363252009|FG001|Overall Study|Withdrawal: Fear of needles|0|||
105553888|NCT02415400|364025259|FG003|Overall Study|Coagulation values cannot be set|0|||
105553889|NCT02415400|364025256|FG000|Overall Study|State regulations prevent participation|0|||
105669378|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
105669379|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
105669380|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
105669381|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
105669382|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
105669383|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669384|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669385|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669386|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669387|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
105669388|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
105669389|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
105669390|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
105669391|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669392|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669393|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669394|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669395|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669396|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669397|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669398|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669399|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669400|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669401|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669402|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
105669403|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669404|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669405|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669406|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669407|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105669408|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105669409|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105669410|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105669411|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105669412|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
105669413|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
105669414|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
105669415|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105341592|NCT02029989|363252008|FG000|Overall Study|Change of location|2|||
105341593|NCT02029989|363252009|FG001|Overall Study|Change of location|3|||
105341594|NCT02029989|363252008|FG000|Overall Study|Physician Decision|2|||
105341595|NCT02029989|363252009|FG001|Overall Study|Physician Decision|0|||
105341596|NCT02029989|363252008|FG000|Overall Study|Lost to Follow-up|9|||
105341597|NCT02029989|363252009|FG001|Overall Study|Lost to Follow-up|7|||
105341598|NCT02029989|363252008|FG000|Overall Study|Death|0|||
105341599|NCT02029989|363252009|FG001|Overall Study|Death|1|||
105341600|NCT02029989|363252008|FG000|Overall Study|Protocol Violation|1|||
105341601|NCT02029989|363252009|FG001|Overall Study|Protocol Violation|0|||
105341602|NCT04351373|363252010|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
105466371|NCT02531802|363720107|FG005|Received Vaccination 2|Adverse Event|2|||
105466372|NCT02531802|363720108|FG006|Received Vaccination 2|Adverse Event|0|||
105466373|NCT02531802|363720109|FG007|Received Vaccination 2|Adverse Event|0|||
105466374|NCT02531802|363720110|FG008|Received Vaccination 2|Adverse Event|0|||
105466375|NCT02531802|363720111|FG009|Received Vaccination 2|Adverse Event|0|||
105466376|NCT02531802|363720112|FG010|Received Vaccination 2|Adverse Event|0|||
105466377|NCT02531802|363720113|FG011|Received Vaccination 2|Adverse Event|0|||
105466378|NCT02531802|363720114|FG012|Received Vaccination 2|Adverse Event|0|||
105466379|NCT02531802|363720115|FG013|Received Vaccination 2|Adverse Event|0|||
105466380|NCT02531802|363720116|FG014|Received Vaccination 2|Adverse Event|0|||
105466381|NCT02531802|363720117|FG015|Received Vaccination 2|Adverse Event|0|||
105466382|NCT02531802|363720118|FG016|Received Vaccination 2|Adverse Event|0|||
105466383|NCT02531802|363720119|FG017|Received Vaccination 2|Adverse Event|2|||
105466384|NCT02531802|363720120|FG018|Received Vaccination 2|Adverse Event|1|||
105466385|NCT02531802|363720121|FG019|Received Vaccination 2|Adverse Event|0|||
105466386|NCT02531802|363720122|FG020|Received Vaccination 2|Adverse Event|1|||
105466387|NCT02531802|363720102|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
105466388|NCT02531802|363720103|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
105341603|NCT04601103|363252017|FG000|Overall Study|Needed crown & cleaning|0|||
105341604|NCT04601103|363252018|FG001|Overall Study|Needed crown & cleaning|0|||
105466389|NCT02531802|363720104|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
105341605|NCT04601103|363252019|FG002|Overall Study|Needed crown & cleaning|1|||
105341606|NCT04601103|363252017|FG000|Overall Study|study was terminated|18|||
105341607|NCT04601103|363252018|FG001|Overall Study|study was terminated|18|||
105341608|NCT04601103|363252019|FG002|Overall Study|study was terminated|16|||
105466390|NCT02531802|363720105|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
105466391|NCT02531802|363720106|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
105466392|NCT02531802|363720107|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
105341609|NCT02291601|363252025|FG000|Abdomen|Did not qualify|333|||
105341610|NCT02291601|363252026|FG001|Abdomen|Did not qualify|54|||
105341611|NCT02291601|363252027|FG002|Abdomen|Did not qualify|339|||
105341612|NCT02291601|363252025|FG000|Groin|Did not qualify|183|||
105341613|NCT02291601|363252026|FG001|Groin|Did not qualify|30|||
105341614|NCT02291601|363252027|FG002|Groin|Did not qualify|177|||
105341615|NCT01698879|363252031|FG000|Overall Study|Withdrawal by Subject|1|||
105341616|NCT01698879|363252032|FG001|Overall Study|Withdrawal by Subject|0|||
105466393|NCT02531802|363720108|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
105466394|NCT02531802|363720109|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
105341617|NCT01698879|363252033|FG002|Overall Study|Withdrawal by Subject|0|||
105341618|NCT02091986|363252047|FG000|Overall Study|7 rand in error 1 patient decision|2|||
105669416|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105669417|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105669418|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105341619|NCT02091986|363252048|FG001|Overall Study|7 rand in error 1 patient decision|3|||
105341620|NCT02091986|363252049|FG002|Overall Study|7 rand in error 1 patient decision|3|||
105341621|NCT02091986|363252047|FG000|Overall Study|Lost to Follow-up|1|||
105341622|NCT02091986|363252048|FG001|Overall Study|Lost to Follow-up|0|||
105341623|NCT02091986|363252049|FG002|Overall Study|Lost to Follow-up|0|||
105553890|NCT02415400|364025257|FG001|Overall Study|State regulations prevent participation|0|||
105553891|NCT02415400|364025258|FG002|Overall Study|State regulations prevent participation|1|||
105553892|NCT02415400|364025259|FG003|Overall Study|State regulations prevent participation|0|||
105553893|NCT02415400|364025256|FG000|Overall Study|Poor treatment monitoring|0|||
105466395|NCT02531802|363720110|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
105466396|NCT02531802|363720111|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
105466397|NCT02531802|363720112|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
105466398|NCT02531802|363720113|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
105466399|NCT02531802|363720114|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
105466400|NCT02531802|363720115|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
105466401|NCT02531802|363720116|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
105466402|NCT02531802|363720117|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
105466403|NCT02531802|363720118|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
105466404|NCT02531802|363720119|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
105466405|NCT02531802|363720120|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
105553894|NCT02415400|364025257|FG001|Overall Study|Poor treatment monitoring|0|||
105553895|NCT02415400|364025258|FG002|Overall Study|Poor treatment monitoring|1|||
105466406|NCT02531802|363720121|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
105553896|NCT02415400|364025259|FG003|Overall Study|Poor treatment monitoring|0|||
105669419|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105669420|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105669421|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105669422|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105669423|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105669424|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105669425|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105669426|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105669427|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
105669428|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
105669429|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
105669430|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
105553897|NCT02415400|364025256|FG000|Overall Study|Participant in jail|0|||
105553898|NCT02415400|364025257|FG001|Overall Study|Participant in jail|0|||
105553899|NCT02415400|364025258|FG002|Overall Study|Participant in jail|1|||
105553900|NCT02415400|364025259|FG003|Overall Study|Participant in jail|0|||
105553901|NCT02415400|364025256|FG000|Overall Study|Investigator decision|0|||
105553902|NCT02415400|364025257|FG001|Overall Study|Investigator decision|0|||
105553903|NCT02415400|364025258|FG002|Overall Study|Investigator decision|1|||
105553904|NCT02415400|364025259|FG003|Overall Study|Investigator decision|1|||
105553905|NCT02415400|364025256|FG000|Overall Study|Site closure; participant won't transfer|0|||
105553906|NCT02415400|364025257|FG001|Overall Study|Site closure; participant won't transfer|0|||
105553907|NCT02415400|364025258|FG002|Overall Study|Site closure; participant won't transfer|0|||
105553908|NCT02415400|364025259|FG003|Overall Study|Site closure; participant won't transfer|1|||
105553909|NCT02363738|364025260|FG000|Overall Study|Adverse Event|5|||
105553910|NCT02363738|364025261|FG001|Overall Study|Adverse Event|2|||
105553911|NCT02363738|364025260|FG000|Overall Study|Lack of Efficacy|1|||
105553912|NCT02363738|364025261|FG001|Overall Study|Lack of Efficacy|2|||
105553913|NCT02363738|364025260|FG000|Overall Study|Lost to Follow-up|2|||
105553914|NCT02363738|364025261|FG001|Overall Study|Lost to Follow-up|1|||
105553915|NCT00700401|364025264|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
105553916|NCT00700401|364025264|FG000|Overall Study|Adverse Event|5|||
105553917|NCT00700401|364025264|FG000|Overall Study|Refused Treatment|2|||
105553918|NCT00700401|364025264|FG000|Overall Study|Lost to Follow-up|1|||
105553919|NCT00700401|364025264|FG000|Overall Study|Treatment never started|1|||
105553920|NCT00700401|364025264|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
105553921|NCT00700401|364025264|FG000|Overall Study|Withdrawal by Subject|2|||
105553922|NCT04656847|364025267|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
105553923|NCT03301051|364025268|FG000|Overall Study|Adverse Event|0|||
105553924|NCT03301051|364025269|FG001|Overall Study|Adverse Event|4|||
105553925|NCT03301051|364025268|FG000|Overall Study|Withdrawal by Subject|59|||
105553926|NCT03301051|364025269|FG001|Overall Study|Withdrawal by Subject|65|||
105553927|NCT03301051|364025268|FG000|Overall Study|Lost to Follow-up|263|||
105553928|NCT03301051|364025269|FG001|Overall Study|Lost to Follow-up|282|||
105553929|NCT03301051|364025268|FG000|Overall Study|Protocol Violation|1|||
105553930|NCT03301051|364025269|FG001|Overall Study|Protocol Violation|3|||
105553931|NCT03301051|364025268|FG000|Overall Study|Physician Decision|1|||
105553932|NCT03301051|364025269|FG001|Overall Study|Physician Decision|3|||
105553933|NCT03301051|364025268|FG000|Overall Study|Death|1|||
105553934|NCT03301051|364025269|FG001|Overall Study|Death|1|||
105553935|NCT03301051|364025268|FG000|Overall Study|Miscellaneous|8|||
105553936|NCT03301051|364025269|FG001|Overall Study|Miscellaneous|4|||
105553937|NCT03301051|364025268|FG000|Overall Study|Randomized, not vaccinated|13|||
105553938|NCT03301051|364025269|FG001|Overall Study|Randomized, not vaccinated|10|||
105553939|NCT01300546|364025271|FG000|Overall Study|Withdrawal by Subject|1|||
105553940|NCT01300546|364025272|FG001|Overall Study|Withdrawal by Subject|0|||
105553941|NCT01300546|364025271|FG000|Overall Study|Lost to Follow-up|0|||
105553942|NCT01300546|364025272|FG001|Overall Study|Lost to Follow-up|2|||
105553943|NCT01300546|364025271|FG000|Overall Study|Lack of Efficacy|0|||
105553944|NCT01300546|364025272|FG001|Overall Study|Lack of Efficacy|3|||
105553945|NCT01300546|364025271|FG000|Overall Study|Adverse Event|0|||
105553946|NCT01300546|364025272|FG001|Overall Study|Adverse Event|1|||
105553947|NCT02715765|364025273|FG000|Overall Study|Study Termination|3|||
105669431|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105669432|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105669433|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105669434|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105669435|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105669436|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105669437|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105669438|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105669439|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
105669440|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
105669441|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
105669442|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
105669443|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105669444|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105669445|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105669446|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105669447|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105669448|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105669449|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105669450|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105669451|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
105669452|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
105669453|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
105669454|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
105669455|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669456|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669457|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669458|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669459|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669460|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669461|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669462|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669463|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
105669464|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
105669465|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
105669466|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
105669467|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669468|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669469|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669470|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669471|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669472|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669473|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669474|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669475|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
105669476|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
105669477|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
105669478|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
105466407|NCT02531802|363720122|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
105466408|NCT01263197|363720128|FG000|First Intervention (Period 1)|Adverse Event|0|||
105669479|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
105466409|NCT01263197|363720129|FG001|First Intervention (Period 1)|Adverse Event|0|||
105466410|NCT01263197|363720130|FG002|First Intervention (Period 1)|Adverse Event|0|||
105466411|NCT01263197|363720131|FG003|First Intervention (Period 1)|Adverse Event|0|||
105466412|NCT01263197|363720132|FG004|First Intervention (Period 1)|Adverse Event|0|||
105466413|NCT01263197|363720133|FG005|First Intervention (Period 1)|Adverse Event|1|||
105669480|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
105669481|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
105669482|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
105341624|NCT02091986|363252047|FG000|Overall Study|Withdrawal by Subject|4|||
105466414|NCT01263197|363720128|FG000|Washout Period 1|Protocol Violation|0|||
105669483|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
105669484|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
105669485|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
105669486|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
105669487|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
105466415|NCT01263197|363720129|FG001|Washout Period 1|Protocol Violation|0|||
105669488|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
105669489|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
105669490|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
105553948|NCT02715765|364025274|FG001|Overall Study|Study Termination|0|||
105341625|NCT02091986|363252048|FG001|Overall Study|Withdrawal by Subject|8|||
105341626|NCT02091986|363252049|FG002|Overall Study|Withdrawal by Subject|3|||
105466416|NCT01263197|363720130|FG002|Washout Period 1|Protocol Violation|0|||
105466417|NCT01263197|363720131|FG003|Washout Period 1|Protocol Violation|0|||
105466418|NCT01263197|363720132|FG004|Washout Period 1|Protocol Violation|1|||
105466419|NCT01263197|363720133|FG005|Washout Period 1|Protocol Violation|0|||
105466420|NCT01263197|363720128|FG000|Washout Period 2|Physician Decision|0|||
105466421|NCT01263197|363720129|FG001|Washout Period 2|Physician Decision|0|||
105466422|NCT01263197|363720130|FG002|Washout Period 2|Physician Decision|0|||
105466423|NCT01263197|363720131|FG003|Washout Period 2|Physician Decision|0|||
105466424|NCT01263197|363720132|FG004|Washout Period 2|Physician Decision|0|||
105466425|NCT01263197|363720133|FG005|Washout Period 2|Physician Decision|1|||
105466426|NCT01263197|363720128|FG000|Washout Period 2|Protocol Violation|0|||
105466427|NCT01263197|363720129|FG001|Washout Period 2|Protocol Violation|0|||
105466428|NCT01263197|363720130|FG002|Washout Period 2|Protocol Violation|0|||
105466429|NCT01263197|363720131|FG003|Washout Period 2|Protocol Violation|1|||
105466430|NCT01263197|363720132|FG004|Washout Period 2|Protocol Violation|0|||
105466431|NCT01263197|363720133|FG005|Washout Period 2|Protocol Violation|0|||
105466432|NCT01263197|363720128|FG000|Third Intervention (Period 3)|Adverse Event|0|||
105341627|NCT02091986|363252047|FG000|Overall Study|Adverse Event|0|||
105669491|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669492|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669493|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669494|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669495|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669496|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669497|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669498|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669499|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669500|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
105669501|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
105669502|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
105669503|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669504|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669505|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669506|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669507|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669508|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669509|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669510|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669511|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669512|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
105669513|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
105669514|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
105669515|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669516|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669517|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669518|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669519|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669520|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669521|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669522|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669523|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
105669524|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669525|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
105669526|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
105669527|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669528|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669529|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669530|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669531|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669532|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669533|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669534|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669535|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669536|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669537|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
105669538|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
105669539|NCT00468143|364454028|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
105669540|NCT00468143|364454029|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
105669541|NCT00468143|364454028|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
105669542|NCT00468143|364454029|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
105669543|NCT01711853|364454030|FG000|Overall Study|Not treated|3|||
105669544|NCT01606670|364454031|FG000|Overall Study|Adverse Event|6|||
105669545|NCT01606670|364454031|FG000|Overall Study|Lack of Efficacy|2|||
105669546|NCT01606670|364454031|FG000|Overall Study|Lost to Follow-up|3|||
105669547|NCT01606670|364454031|FG000|Overall Study|Withdrawal by Subject|3|||
105669548|NCT01606670|364454031|FG000|Overall Study|Other Reason|2|||
105669549|NCT02636725|364454033|FG000|Overall Study|Adverse Event|1|||
105669550|NCT01038427|364454034|FG000|Overall Study|Lost to follow up|1|||
105669551|NCT01038427|364454035|FG001|Overall Study|Lost to follow up|1|||
105669552|NCT01038427|364454036|FG002|Overall Study|Lost to follow up|0|||
105669553|NCT01038427|364454034|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
105669554|NCT01038427|364454035|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
105669555|NCT01038427|364454036|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
105466433|NCT01263197|363720129|FG001|Third Intervention (Period 3)|Adverse Event|1|||
105466434|NCT01263197|363720130|FG002|Third Intervention (Period 3)|Adverse Event|0|||
105341628|NCT02091986|363252048|FG001|Overall Study|Adverse Event|0|||
105341629|NCT02091986|363252049|FG002|Overall Study|Adverse Event|2|||
105341630|NCT01664949|363252050|FG000|Overall Study|Adverse Event|11|||
105341631|NCT01664949|363252051|FG001|Overall Study|Adverse Event|12|||
105341632|NCT01664949|363252050|FG000|Overall Study|Lack of Efficacy|1|||
105341633|NCT01664949|363252051|FG001|Overall Study|Lack of Efficacy|1|||
105341634|NCT01664949|363252050|FG000|Overall Study|Lost to Follow-up|1|||
105341635|NCT01664949|363252051|FG001|Overall Study|Lost to Follow-up|2|||
105341636|NCT01664949|363252050|FG000|Overall Study|Personal Reasons|3|||
105341637|NCT01664949|363252051|FG001|Overall Study|Personal Reasons|4|||
105341638|NCT01664949|363252050|FG000|Overall Study|Protocol Violation|5|||
105341639|NCT01664949|363252051|FG001|Overall Study|Protocol Violation|5|||
105341640|NCT01664949|363252050|FG000|Overall Study|Other Miscellaneous Reasons|3|||
105341641|NCT01664949|363252051|FG001|Overall Study|Other Miscellaneous Reasons|1|||
105341642|NCT00957268|363252052|FG000|Overall Study|Voluntary Withdrawal|0|||
105341643|NCT00957268|363252053|FG001|Overall Study|Voluntary Withdrawal|0|||
105341644|NCT00957268|363252054|FG002|Overall Study|Voluntary Withdrawal|1|||
105341645|NCT00957268|363252055|FG003|Overall Study|Voluntary Withdrawal|0|||
105341646|NCT00957268|363252056|FG004|Overall Study|Voluntary Withdrawal|0|||
105341647|NCT00794040|363252057|FG000|Overall Study|Withdrawal by Subject|3|||
105341648|NCT00794040|363252058|FG001|Overall Study|Withdrawal by Subject|4|||
105341649|NCT00794040|363252057|FG000|Overall Study|Physician Decision|0|||
105341650|NCT00794040|363252058|FG001|Overall Study|Physician Decision|1|||
105341651|NCT03005327|363252059|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
105341652|NCT03005327|363252060|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
105341653|NCT03005327|363252061|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
105341654|NCT03005327|363252062|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
105341655|NCT03005327|363252059|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105341656|NCT03005327|363252060|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
105341657|NCT03005327|363252061|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105341658|NCT03005327|363252062|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105341659|NCT02396420|363252065|FG000|Overall Study|Death|1|||
105341660|NCT01273623|363252066|FG000|Overall Study|did not meet IVUS criteria|29|||
105341661|NCT02135107|363252067|FG000|Treatment Period|Withdrawal by Subject|11|||
105341662|NCT02135107|363252068|FG001|Treatment Period|Withdrawal by Subject|0|||
105341663|NCT02135107|363252069|FG002|Treatment Period|Withdrawal by Subject|0|||
105341664|NCT02135107|363252070|FG003|Treatment Period|Withdrawal by Subject|0|||
105341665|NCT02135107|363252067|FG000|Treatment Period|Adverse Event|5|||
105341666|NCT02135107|363252068|FG001|Treatment Period|Adverse Event|2|||
105341667|NCT02135107|363252069|FG002|Treatment Period|Adverse Event|0|||
105341668|NCT02135107|363252070|FG003|Treatment Period|Adverse Event|0|||
105341669|NCT02135107|363252067|FG000|Treatment Period|Pregnancy|1|||
105341670|NCT02135107|363252068|FG001|Treatment Period|Pregnancy|0|||
105341671|NCT02135107|363252069|FG002|Treatment Period|Pregnancy|0|||
105341672|NCT02135107|363252070|FG003|Treatment Period|Pregnancy|0|||
105341673|NCT02135107|363252067|FG000|Treatment Period|Other|115|||
105341674|NCT02135107|363252068|FG001|Treatment Period|Other|24|||
105341675|NCT02135107|363252069|FG002|Treatment Period|Other|0|||
105341676|NCT02135107|363252070|FG003|Treatment Period|Other|0|||
105341677|NCT02135107|363252067|FG000|Maintenance Therapy Period|Adverse Event|0|||
105341678|NCT02135107|363252068|FG001|Maintenance Therapy Period|Adverse Event|0|||
105553949|NCT02715765|364025275|FG002|Overall Study|Study Termination|0|||
105553950|NCT00435370|364025282|FG000|Overall Study|Adverse Event|8|||
105341679|NCT02135107|363252069|FG002|Maintenance Therapy Period|Adverse Event|3|||
105341680|NCT02135107|363252070|FG003|Maintenance Therapy Period|Adverse Event|7|||
105341681|NCT02135107|363252067|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
105341682|NCT02135107|363252068|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
105341683|NCT02135107|363252069|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
105341684|NCT02135107|363252070|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
105341685|NCT02135107|363252067|FG000|Maintenance Therapy Period|Pregnancy|0|||
105341686|NCT02135107|363252068|FG001|Maintenance Therapy Period|Pregnancy|0|||
105341687|NCT02135107|363252069|FG002|Maintenance Therapy Period|Pregnancy|0|||
105341688|NCT02135107|363252070|FG003|Maintenance Therapy Period|Pregnancy|1|||
105553951|NCT00435370|364025283|FG001|Overall Study|Adverse Event|8|||
105341689|NCT02135107|363252067|FG000|Maintenance Therapy Period|Other|0|||
105553952|NCT00435370|364025282|FG000|Overall Study|Withdrawal by Subject|10|||
105553953|NCT00435370|364025283|FG001|Overall Study|Withdrawal by Subject|10|||
105341690|NCT02135107|363252068|FG001|Maintenance Therapy Period|Other|0|||
105341691|NCT02135107|363252069|FG002|Maintenance Therapy Period|Other|7|||
105341692|NCT02135107|363252070|FG003|Maintenance Therapy Period|Other|8|||
105341693|NCT01095978|363252077|FG000|Overall Study|Did not take Klacid SR|2|||
105341694|NCT01095978|363252077|FG000|Overall Study|Adverse Event|1|||
105341695|NCT02009397|363252078|FG000|Overall Study|Protocol Violation|6|||
105341696|NCT02009397|363252078|FG000|Overall Study|Death|8|||
105341697|NCT02009397|363252078|FG000|Overall Study|Lost to Follow-up|6|||
105341698|NCT02278120|363252080|FG000|Treatment Period|Progressive disease|234|||
105341699|NCT02278120|363252081|FG001|Treatment Period|Progressive disease|260|||
105669556|NCT01038427|364454034|FG000|Overall Study|Withdrew consent|0|||
105669557|NCT01038427|364454035|FG001|Overall Study|Withdrew consent|0|||
105669558|NCT01038427|364454036|FG002|Overall Study|Withdrew consent|1|||
105669559|NCT01038427|364454034|FG000|Overall Study|Adverse Event|2|||
105669560|NCT01038427|364454035|FG001|Overall Study|Adverse Event|2|||
105669561|NCT01038427|364454036|FG002|Overall Study|Adverse Event|1|||
105669562|NCT01038427|364454034|FG000|Overall Study|Enrolled in error|0|||
105669563|NCT01038427|364454035|FG001|Overall Study|Enrolled in error|1|||
105669564|NCT01038427|364454036|FG002|Overall Study|Enrolled in error|1|||
105669565|NCT01038427|364454034|FG000|Overall Study|Other|0|||
105669566|NCT01038427|364454035|FG001|Overall Study|Other|2|||
105669567|NCT01038427|364454036|FG002|Overall Study|Other|0|||
105669568|NCT01162863|364454039|FG000|Overall Study|Lack of Efficacy|1|||
105669569|NCT01162863|364454040|FG001|Overall Study|Lack of Efficacy|0|||
105669570|NCT01162863|364454041|FG002|Overall Study|Lack of Efficacy|0|||
105669571|NCT01162863|364454039|FG000|Overall Study|Adverse Event|0|||
105669572|NCT01162863|364454040|FG001|Overall Study|Adverse Event|1|||
105669573|NCT01162863|364454041|FG002|Overall Study|Adverse Event|0|||
105669574|NCT01912404|364454042|FG000|Overall Study|Due to personal reasons|1|||
105669575|NCT01912404|364454043|FG001|Overall Study|Due to personal reasons|0|||
105669576|NCT03538938|364454045|FG000|Overall Study|Death|0|||
105669577|NCT03538938|364454046|FG001|Overall Study|Death|0|||
105669578|NCT03538938|364454047|FG002|Overall Study|Death|2|||
105669579|NCT03538938|364454048|FG003|Overall Study|Death|0|||
105669580|NCT03538938|364454049|FG004|Overall Study|Death|0|||
105669581|NCT03538938|364454050|FG005|Overall Study|Death|1|||
105669582|NCT03538938|364454051|FG006|Overall Study|Death|0|||
105669583|NCT03538938|364454052|FG007|Overall Study|Death|1|||
105669584|NCT03538938|364454053|FG008|Overall Study|Death|1|||
105669585|NCT03538938|364454054|FG009|Overall Study|Death|1|||
105669586|NCT03538938|364454055|FG010|Overall Study|Death|0|||
105669587|NCT03538938|364454056|FG011|Overall Study|Death|0|||
105669588|NCT03538938|364454057|FG012|Overall Study|Death|1|||
105669589|NCT03538938|364454058|FG013|Overall Study|Death|1|||
105669590|NCT03538938|364454059|FG014|Overall Study|Death|0|||
105669591|NCT03538938|364454060|FG015|Overall Study|Death|1|||
105669592|NCT03538938|364454045|FG000|Overall Study|Withdrawal by Subject|4|||
105669593|NCT03538938|364454046|FG001|Overall Study|Withdrawal by Subject|6|||
105669594|NCT03538938|364454047|FG002|Overall Study|Withdrawal by Subject|5|||
105669595|NCT03538938|364454048|FG003|Overall Study|Withdrawal by Subject|3|||
105669596|NCT03538938|364454049|FG004|Overall Study|Withdrawal by Subject|0|||
105669597|NCT03538938|364454050|FG005|Overall Study|Withdrawal by Subject|0|||
105669598|NCT03538938|364454051|FG006|Overall Study|Withdrawal by Subject|3|||
105669599|NCT03538938|364454052|FG007|Overall Study|Withdrawal by Subject|1|||
105669600|NCT03538938|364454053|FG008|Overall Study|Withdrawal by Subject|5|||
105669601|NCT03538938|364454054|FG009|Overall Study|Withdrawal by Subject|1|||
105669602|NCT03538938|364454055|FG010|Overall Study|Withdrawal by Subject|2|||
105669603|NCT03538938|364454056|FG011|Overall Study|Withdrawal by Subject|1|||
105786071|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
105786072|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
105786073|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
105669604|NCT03538938|364454057|FG012|Overall Study|Withdrawal by Subject|3|||
105669605|NCT03538938|364454058|FG013|Overall Study|Withdrawal by Subject|0|||
105669606|NCT03538938|364454059|FG014|Overall Study|Withdrawal by Subject|2|||
105669607|NCT03538938|364454060|FG015|Overall Study|Withdrawal by Subject|4|||
105669608|NCT03538938|364454045|FG000|Overall Study|Incarcerated|0|||
105669609|NCT03538938|364454046|FG001|Overall Study|Incarcerated|0|||
105669610|NCT03538938|364454047|FG002|Overall Study|Incarcerated|0|||
105669611|NCT03538938|364454048|FG003|Overall Study|Incarcerated|0|||
105669612|NCT03538938|364454049|FG004|Overall Study|Incarcerated|0|||
105669613|NCT03538938|364454050|FG005|Overall Study|Incarcerated|0|||
105669614|NCT03538938|364454051|FG006|Overall Study|Incarcerated|0|||
105669615|NCT03538938|364454052|FG007|Overall Study|Incarcerated|0|||
105669616|NCT03538938|364454053|FG008|Overall Study|Incarcerated|0|||
105786074|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
105341700|NCT02278120|363252080|FG000|Treatment Period|Subject/guardian decision|23|||
105341701|NCT02278120|363252081|FG001|Treatment Period|Subject/guardian decision|20|||
105669617|NCT03538938|364454054|FG009|Overall Study|Incarcerated|0|||
105669618|NCT03538938|364454055|FG010|Overall Study|Incarcerated|0|||
105669619|NCT03538938|364454056|FG011|Overall Study|Incarcerated|1|||
105669620|NCT03538938|364454057|FG012|Overall Study|Incarcerated|0|||
105669621|NCT03538938|364454058|FG013|Overall Study|Incarcerated|0|||
105669622|NCT03538938|364454059|FG014|Overall Study|Incarcerated|0|||
105669623|NCT03538938|364454060|FG015|Overall Study|Incarcerated|0|||
105669624|NCT01137578|364454061|FG000|Overall Study|Participant requested to Discontinue|3|||
105669625|NCT01137578|364454062|FG001|Overall Study|Participant requested to Discontinue|0|||
105669626|NCT01137578|364454063|FG002|Overall Study|Participant requested to Discontinue|0|||
105669627|NCT01137578|364454061|FG000|Overall Study|Withdrawal by Subject|1|||
105669628|NCT01137578|364454062|FG001|Overall Study|Withdrawal by Subject|0|||
105669629|NCT01137578|364454063|FG002|Overall Study|Withdrawal by Subject|0|||
105669630|NCT01137578|364454061|FG000|Overall Study|Other|12|||
105669631|NCT01137578|364454062|FG001|Overall Study|Other|2|||
105669632|NCT01137578|364454063|FG002|Overall Study|Other|6|||
105669633|NCT01277887|364454065|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
105669634|NCT01277887|364454066|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
105669635|NCT01277887|364454065|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
105669636|NCT01277887|364454066|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
105669637|NCT01277887|364454065|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
105669638|NCT01277887|364454066|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
105669639|NCT00415051|364454068|FG000|Overall Study|Protocol Violation|1|||
105669640|NCT00780559|364454069|FG000|Overall Study|Lost to Follow-up|2|||
105669641|NCT00780559|364454070|FG001|Overall Study|Lost to Follow-up|7|||
105669642|NCT00780559|364454069|FG000|Overall Study|Death|1|||
105669643|NCT00780559|364454070|FG001|Overall Study|Death|0|||
105786075|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
105341702|NCT02278120|363252080|FG000|Treatment Period|Adverse Event|16|||
105341703|NCT02278120|363252081|FG001|Treatment Period|Adverse Event|14|||
105669644|NCT01399918|364454073|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
105669645|NCT04608773|364454074|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
105669646|NCT04608773|364454075|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
105341704|NCT02278120|363252080|FG000|Treatment Period|Physician Decision|14|||
105341705|NCT02278120|363252081|FG001|Treatment Period|Physician Decision|27|||
105341706|NCT02278120|363252080|FG000|Treatment Period|Death|3|||
105341707|NCT02278120|363252081|FG001|Treatment Period|Death|3|||
105341708|NCT02278120|363252080|FG000|Treatment Period|Lost to Follow-up|2|||
105341709|NCT02278120|363252081|FG001|Treatment Period|Lost to Follow-up|0|||
105341710|NCT02278120|363252080|FG000|Treatment Period|Protocol deviation|0|||
105341711|NCT02278120|363252081|FG001|Treatment Period|Protocol deviation|2|||
105341712|NCT02278120|363252080|FG000|Treatment Period|Study terminated as per protocol|43|||
105341713|NCT02278120|363252081|FG001|Treatment Period|Study terminated as per protocol|11|||
105341714|NCT02278120|363252080|FG000|Post-treatment Efficacy Follow-up|Death|0|||
105341715|NCT02278120|363252081|FG001|Post-treatment Efficacy Follow-up|Death|1|||
105341716|NCT02278120|363252080|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
105341717|NCT02278120|363252081|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
105341718|NCT02278120|363252080|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
105341719|NCT02278120|363252081|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
105466435|NCT01263197|363720131|FG003|Third Intervention (Period 3)|Adverse Event|0|||
105466436|NCT01263197|363720132|FG004|Third Intervention (Period 3)|Adverse Event|0|||
105669647|NCT04608773|364454074|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
105669648|NCT04608773|364454075|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
105669649|NCT04608773|364454074|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
105669650|NCT04608773|364454075|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
105669651|NCT04608773|364454074|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
105669652|NCT04608773|364454075|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
105669653|NCT04608773|364454074|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
105669654|NCT04608773|364454075|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
105669655|NCT01217437|364454089|FG000|Overall Study|Adverse Event|0|||
105669656|NCT01217437|364454090|FG001|Overall Study|Adverse Event|8|||
105669657|NCT01217437|364454089|FG000|Overall Study|Death|5|||
105669658|NCT01217437|364454090|FG001|Overall Study|Death|0|||
105669659|NCT01217437|364454089|FG000|Overall Study|Lack of Efficacy|29|||
105669660|NCT01217437|364454090|FG001|Overall Study|Lack of Efficacy|25|||
105669661|NCT01217437|364454089|FG000|Overall Study|Physician Decision|8|||
105669662|NCT01217437|364454090|FG001|Overall Study|Physician Decision|5|||
105669663|NCT01217437|364454089|FG000|Overall Study|Withdrawal by Subject|0|||
105669664|NCT01217437|364454090|FG001|Overall Study|Withdrawal by Subject|2|||
105669665|NCT01217437|364454089|FG000|Overall Study|Ineligible|1|||
105669666|NCT01217437|364454090|FG001|Overall Study|Ineligible|1|||
105669667|NCT01040169|364454093|FG000|Overall Study|Lost to Follow-up|3|||
105669668|NCT01040169|364454094|FG001|Overall Study|Lost to Follow-up|8|||
105669669|NCT00350727|364454095|FG000|Phase I: Dose Escalation|Adverse Event|4|||
105669670|NCT00350727|364454096|FG001|Phase I: Dose Escalation|Adverse Event|0|||
105669671|NCT00350727|364454097|FG002|Phase I: Dose Escalation|Adverse Event|0|||
105669672|NCT00350727|364454095|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
105669673|NCT00350727|364454096|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
105341720|NCT02278120|363252080|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
105669674|NCT00350727|364454097|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
105669675|NCT00350727|364454095|FG000|Phase I: Dose Escalation|Death|1|||
105669676|NCT00350727|364454096|FG001|Phase I: Dose Escalation|Death|0|||
105669677|NCT00350727|364454097|FG002|Phase I: Dose Escalation|Death|0|||
105669678|NCT00350727|364454095|FG000|Phase I: Dose Escalation|Physician Decision|1|||
105553954|NCT00435370|364025282|FG000|Overall Study|Antipsychotic medication changed|4|||
105553955|NCT00435370|364025283|FG001|Overall Study|Antipsychotic medication changed|2|||
105553956|NCT01965834|364025284|FG000|Overall Study|Lack of Efficacy|4|||
105553957|NCT00744653|364025287|FG000|Overall Study|antineoplastic treatment|11|||
105553958|NCT00744653|364025287|FG000|Overall Study|Death|1|||
105553959|NCT00744653|364025287|FG000|Overall Study|Lost to Follow-up|1|||
105553960|NCT00744653|364025287|FG000|Overall Study|Physician Decision|3|||
105553961|NCT03826667|364025288|FG000|Overall Study|Protocol deviation|21|||
105553962|NCT02298192|364025292|FG000|Overall Study|Unclassified|3|||
105553963|NCT02298192|364025293|FG001|Overall Study|Unclassified|2|||
105553964|NCT02298192|364025292|FG000|Overall Study|Withdrawal criteria|2|||
105553965|NCT02298192|364025293|FG001|Overall Study|Withdrawal criteria|0|||
105553966|NCT02298192|364025292|FG000|Overall Study|Withdrawal by Subject|6|||
105553967|NCT02298192|364025293|FG001|Overall Study|Withdrawal by Subject|1|||
105553968|NCT02298192|364025292|FG000|Overall Study|Lost to Follow-up|2|||
105553969|NCT02298192|364025293|FG001|Overall Study|Lost to Follow-up|1|||
105553970|NCT02298192|364025292|FG000|Overall Study|Adverse Event|6|||
105553971|NCT02298192|364025293|FG001|Overall Study|Adverse Event|2|||
105553972|NCT02352948|364025294|FG000|Overall Study|Death|47|||
105553973|NCT02352948|364025295|FG001|Overall Study|Death|48|||
105553974|NCT02352948|364025296|FG002|Overall Study|Death|114|||
105553975|NCT02352948|364025297|FG003|Overall Study|Death|74|||
105553976|NCT02352948|364025298|FG004|Overall Study|Death|77|||
105553977|NCT02352948|364025299|FG005|Overall Study|Death|44|||
105553978|NCT02352948|364025294|FG000|Overall Study|Lost to Follow-up|1|||
105553979|NCT02352948|364025295|FG001|Overall Study|Lost to Follow-up|0|||
105553980|NCT02352948|364025296|FG002|Overall Study|Lost to Follow-up|2|||
105553981|NCT02352948|364025297|FG003|Overall Study|Lost to Follow-up|1|||
105553982|NCT02352948|364025298|FG004|Overall Study|Lost to Follow-up|2|||
105553983|NCT02352948|364025299|FG005|Overall Study|Lost to Follow-up|1|||
105553984|NCT02352948|364025294|FG000|Overall Study|Withdrawal by Subject|1|||
105341721|NCT02278120|363252081|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
105341722|NCT02278120|363252080|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
105341723|NCT02278120|363252081|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
105341724|NCT00965341|363252082|FG000|Overall Study|Withdrew consent|1|||
105341725|NCT00965341|363252083|FG001|Overall Study|Withdrew consent|5|||
105341726|NCT00965341|363252082|FG000|Overall Study|Lost to Follow-up|1|||
105466437|NCT01263197|363720133|FG005|Third Intervention (Period 3)|Adverse Event|0|||
105466438|NCT03967444|363720134|FG000|Overall Study|Lost to Follow-up|1|||
105466439|NCT03967444|363720135|FG001|Overall Study|Lost to Follow-up|2|||
105466440|NCT05197049|363720136|FG000|Overall Study|Death|0|||
105466441|NCT05197049|363720137|FG001|Overall Study|Death|1|||
105466442|NCT05197049|363720138|FG002|Overall Study|Death|0|||
105466443|NCT05197049|363720136|FG000|Overall Study|Lost to Follow-up|3|||
105466444|NCT05197049|363720137|FG001|Overall Study|Lost to Follow-up|1|||
105466445|NCT05197049|363720138|FG002|Overall Study|Lost to Follow-up|0|||
105466446|NCT05197049|363720136|FG000|Overall Study|Withdrawal by Subject|15|||
105466447|NCT05197049|363720137|FG001|Overall Study|Withdrawal by Subject|3|||
105466448|NCT05197049|363720138|FG002|Overall Study|Withdrawal by Subject|1|||
105466449|NCT05197049|363720136|FG000|Overall Study|GCP non-compliance|1|||
105341727|NCT00965341|363252083|FG001|Overall Study|Lost to Follow-up|0|||
105466450|NCT05197049|363720137|FG001|Overall Study|GCP non-compliance|2|||
105466451|NCT05197049|363720138|FG002|Overall Study|GCP non-compliance|0|||
105466452|NCT01454102|363720139|FG000|Overall Study|Continuing in the treatment period|0|||
105341728|NCT00965341|363252082|FG000|Overall Study|Transportation issues|4|||
105341729|NCT00965341|363252083|FG001|Overall Study|Transportation issues|3|||
105341730|NCT01970475|363252089|FG000|Overall Study|Withdrawal by Subject|11|||
105341731|NCT01970475|363252090|FG001|Overall Study|Withdrawal by Subject|6|||
105341732|NCT01970475|363252089|FG000|Overall Study|Adverse Event|7|||
105341733|NCT01970475|363252090|FG001|Overall Study|Adverse Event|3|||
105341734|NCT01970475|363252089|FG000|Overall Study|Lost to Follow-up|2|||
105341735|NCT01970475|363252090|FG001|Overall Study|Lost to Follow-up|2|||
105341736|NCT01970475|363252089|FG000|Overall Study|Protocol Violation|1|||
105341737|NCT01970475|363252090|FG001|Overall Study|Protocol Violation|0|||
105341738|NCT01077739|363252091|FG000|Overall Study|Premature withdrawal|1|||
105341739|NCT01077739|363252092|FG001|Overall Study|Premature withdrawal|3|||
105341740|NCT01077739|363252091|FG000|Overall Study|Withdrawal by Subject|1|||
105341741|NCT01077739|363252092|FG001|Overall Study|Withdrawal by Subject|0|||
105341742|NCT01077739|363252091|FG000|Overall Study|Death|0|||
105341743|NCT01077739|363252092|FG001|Overall Study|Death|3|||
105341744|NCT01077739|363252091|FG000|Overall Study|Unacceptable toxicity|1|||
105341745|NCT01077739|363252092|FG001|Overall Study|Unacceptable toxicity|2|||
105341746|NCT01077739|363252091|FG000|Overall Study|Other|2|||
105341747|NCT01077739|363252092|FG001|Overall Study|Other|2|||
105341748|NCT00960986|363252093|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
105341749|NCT00960986|363252094|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
105341750|NCT00960986|363252095|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
105341751|NCT00960986|363252096|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
105341752|NCT00960986|363252093|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
105341753|NCT00960986|363252094|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
105341754|NCT00960986|363252095|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
105341755|NCT00960986|363252096|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
105341756|NCT00960986|363252093|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
105341757|NCT00960986|363252094|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
105341758|NCT00960986|363252095|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
105341759|NCT00960986|363252096|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
105341760|NCT00960986|363252093|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
105341761|NCT00960986|363252094|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
105341762|NCT00960986|363252095|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
105341763|NCT00960986|363252096|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
105466453|NCT01454102|363720140|FG001|Overall Study|Continuing in the treatment period|0|||
105466454|NCT01454102|363720141|FG002|Overall Study|Continuing in the treatment period|0|||
105466455|NCT01454102|363720142|FG003|Overall Study|Continuing in the treatment period|0|||
105466456|NCT01454102|363720143|FG004|Overall Study|Continuing in the treatment period|3|||
105466457|NCT01454102|363720144|FG005|Overall Study|Continuing in the treatment period|3|||
105466458|NCT01454102|363720145|FG006|Overall Study|Continuing in the treatment period|2|||
105466459|NCT01454102|363720146|FG007|Overall Study|Continuing in the treatment period|0|||
105466460|NCT01454102|363720147|FG008|Overall Study|Continuing in the treatment period|1|||
105466461|NCT01454102|363720148|FG009|Overall Study|Continuing in the treatment period|0|||
105466462|NCT01454102|363720149|FG010|Overall Study|Continuing in the treatment period|0|||
105466463|NCT01454102|363720150|FG011|Overall Study|Continuing in the treatment period|4|||
105466464|NCT01454102|363720151|FG012|Overall Study|Continuing in the treatment period|7|||
105466465|NCT01454102|363720152|FG013|Overall Study|Continuing in the treatment period|4|||
105466466|NCT01454102|363720153|FG014|Overall Study|Continuing in the treatment period|3|||
105466467|NCT01454102|363720154|FG015|Overall Study|Continuing in the treatment period|1|||
105466468|NCT03739203|363720158|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
105466469|NCT03739203|363720159|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
105466470|NCT03739203|363720160|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
105466471|NCT03739203|363720158|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
105466472|NCT03739203|363720159|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
105466473|NCT03739203|363720160|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
105466474|NCT03739203|363720158|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
105466475|NCT03739203|363720159|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
105341764|NCT00960986|363252093|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
105341765|NCT00960986|363252094|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
105341766|NCT00960986|363252095|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
105341767|NCT00960986|363252096|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
105341768|NCT00960986|363252093|FG000|Period 3 (7-week Therapy Period)|Death|0|||
105341769|NCT00960986|363252094|FG001|Period 3 (7-week Therapy Period)|Death|0|||
105341770|NCT00960986|363252095|FG002|Period 3 (7-week Therapy Period)|Death|1|||
105341771|NCT00960986|363252096|FG003|Period 3 (7-week Therapy Period)|Death|0|||
105341772|NCT00960986|363252093|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
105341773|NCT00960986|363252094|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
105341774|NCT00960986|363252095|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
105341775|NCT00960986|363252096|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
105341776|NCT00960986|363252093|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
105341777|NCT00960986|363252094|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
105341778|NCT00960986|363252095|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
105341779|NCT00960986|363252096|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
105341780|NCT00960986|363252093|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
105341781|NCT00960986|363252094|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
105341782|NCT00960986|363252095|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
105341783|NCT00960986|363252096|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
105341784|NCT00960986|363252093|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
105341785|NCT00960986|363252094|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
105341786|NCT00960986|363252095|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
105341787|NCT00960986|363252096|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
105341788|NCT00877071|363252097|FG000|Overall Study|disease progression|2|||
105341789|NCT02234596|363252098|FG000|Overall Study|Participant not treated|2|||
105341790|NCT04852679|363252101|FG000|Main Intervention Period|Withdrawal by Subject|3|||
105341791|NCT04852679|363252101|FG000|Main Intervention Period|Adverse Event|1|||
105341792|NCT04852679|363252101|FG000|Main Intervention Period|Progressive Disease|16|||
105341793|NCT04852679|363252101|FG000|Main Intervention Period|Refused study visit|1|||
105341794|NCT04852679|363252101|FG000|Independent Injection Period|Missed study visit|1|||
105341795|NCT04542499|363253564|FG000|Overall Study|Adverse Event|23|||
105341796|NCT04542499|363253565|FG001|Overall Study|Adverse Event|43|||
105341797|NCT04542499|363253564|FG000|Overall Study|Lack of Efficacy|5|||
105341798|NCT04542499|363253565|FG001|Overall Study|Lack of Efficacy|2|||
105341799|NCT04542499|363253564|FG000|Overall Study|Lost to Follow-up|3|||
105341800|NCT04542499|363253565|FG001|Overall Study|Lost to Follow-up|4|||
105341801|NCT04542499|363253564|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
105341802|NCT04542499|363253565|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
105341803|NCT04542499|363253564|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
105341804|NCT04542499|363253565|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
105341805|NCT04542499|363253564|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105341806|NCT04542499|363253565|FG001|Overall Study|Non-Compliance with Study Drug|2|||
105466476|NCT03739203|363720160|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
105466477|NCT03739203|363720158|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
105466478|NCT03739203|363720159|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
105466479|NCT03739203|363720160|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
105466480|NCT03739203|363720158|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
105466481|NCT03739203|363720159|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
105466482|NCT03739203|363720160|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
105466483|NCT03739203|363720158|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
105466484|NCT03739203|363720159|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
105466485|NCT03739203|363720160|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
105553985|NCT02352948|364025295|FG001|Overall Study|Withdrawal by Subject|10|||
105553986|NCT02352948|364025296|FG002|Overall Study|Withdrawal by Subject|11|||
105553987|NCT02352948|364025297|FG003|Overall Study|Withdrawal by Subject|23|||
105553988|NCT02352948|364025298|FG004|Overall Study|Withdrawal by Subject|9|||
105553989|NCT02352948|364025299|FG005|Overall Study|Withdrawal by Subject|4|||
105341807|NCT04542499|363253564|FG000|Overall Study|Physician Decision|0|||
105341808|NCT04542499|363253565|FG001|Overall Study|Physician Decision|1|||
105341809|NCT04542499|363253564|FG000|Overall Study|Site Terminated by Sponsor|3|||
105341810|NCT04542499|363253565|FG001|Overall Study|Site Terminated by Sponsor|5|||
105341811|NCT04542499|363253564|FG000|Overall Study|Withdrawal by Subject|12|||
105341812|NCT04542499|363253565|FG001|Overall Study|Withdrawal by Subject|33|||
105341813|NCT04542499|363253564|FG000|Overall Study|Other|2|||
105669679|NCT00350727|364454096|FG001|Phase I: Dose Escalation|Physician Decision|0|||
105669680|NCT00350727|364454097|FG002|Phase I: Dose Escalation|Physician Decision|0|||
105669681|NCT00350727|364454095|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
105669682|NCT00350727|364454096|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
105669683|NCT00350727|364454097|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
105669684|NCT00350727|364454095|FG000|Phase II|Disease Progression|0|||
105669685|NCT00350727|364454096|FG001|Phase II|Disease Progression|15|||
105669686|NCT00350727|364454097|FG002|Phase II|Disease Progression|16|||
105669687|NCT00350727|364454095|FG000|Phase II|Clinical Deterioration|0|||
105669688|NCT00350727|364454096|FG001|Phase II|Clinical Deterioration|1|||
105669689|NCT00350727|364454097|FG002|Phase II|Clinical Deterioration|0|||
105669690|NCT00350727|364454095|FG000|Phase II|Withdrawal by Subject|0|||
105669691|NCT00350727|364454096|FG001|Phase II|Withdrawal by Subject|2|||
105669692|NCT00350727|364454097|FG002|Phase II|Withdrawal by Subject|1|||
105669693|NCT00350727|364454095|FG000|Phase II|Adverse Event|0|||
105669694|NCT00350727|364454096|FG001|Phase II|Adverse Event|1|||
105669695|NCT00350727|364454097|FG002|Phase II|Adverse Event|1|||
105669696|NCT00350727|364454095|FG000|Phase II|Death|0|||
105669697|NCT00350727|364454096|FG001|Phase II|Death|0|||
105669698|NCT00350727|364454097|FG002|Phase II|Death|2|||
105669699|NCT00350727|364454095|FG000|Phase II|Sponsor Terminated Study|0|||
105669700|NCT00350727|364454096|FG001|Phase II|Sponsor Terminated Study|0|||
105669701|NCT00350727|364454097|FG002|Phase II|Sponsor Terminated Study|1|||
105669702|NCT00350727|364454095|FG000|Phase II|Enrolled in Rollover Study|0|||
105669703|NCT00350727|364454096|FG001|Phase II|Enrolled in Rollover Study|0|||
105669704|NCT00350727|364454097|FG002|Phase II|Enrolled in Rollover Study|1|||
105669705|NCT03682185|364454098|FG000|Overall Study|Lost to Follow-up|4|||
105669706|NCT03682185|364454099|FG001|Overall Study|Lost to Follow-up|7|||
105669707|NCT03682185|364454100|FG002|Overall Study|Lost to Follow-up|4|||
105669708|NCT03682185|364454101|FG003|Overall Study|Lost to Follow-up|7|||
105669709|NCT03682185|364454102|FG004|Overall Study|Lost to Follow-up|1|||
105669710|NCT03682185|364454098|FG000|Overall Study|Withdrawal by Subject|7|||
105669711|NCT03682185|364454099|FG001|Overall Study|Withdrawal by Subject|3|||
105669712|NCT03682185|364454100|FG002|Overall Study|Withdrawal by Subject|7|||
105669713|NCT03682185|364454101|FG003|Overall Study|Withdrawal by Subject|3|||
105669714|NCT03682185|364454102|FG004|Overall Study|Withdrawal by Subject|0|||
105669715|NCT03548220|364454107|FG000|Overall Study|Lost to Follow-up|1|||
105669716|NCT03548220|364454108|FG001|Overall Study|Lost to Follow-up|0|||
105669717|NCT03548220|364454109|FG002|Overall Study|Lost to Follow-up|0|||
105669718|NCT03548220|364454110|FG003|Overall Study|Lost to Follow-up|0|||
105669719|NCT03551691|364454113|FG000|Overall Study|Withdrawal by Subject|3|||
105669720|NCT03551691|364454114|FG001|Overall Study|Withdrawal by Subject|3|||
105669721|NCT01123070|364456067|FG000|Part B Double Blind Period|Protocol Violation|0|||
105669722|NCT01123070|364456068|FG001|Part B Double Blind Period|Protocol Violation|0|||
105669723|NCT01123070|364456069|FG002|Part B Double Blind Period|Protocol Violation|0|||
105669724|NCT01123070|364456070|FG003|Part B Double Blind Period|Protocol Violation|1|||
105669725|NCT01123070|364456067|FG000|Part B Double Blind Period|Adverse Event|0|||
105669726|NCT01123070|364456068|FG001|Part B Double Blind Period|Adverse Event|0|||
105669727|NCT01123070|364456069|FG002|Part B Double Blind Period|Adverse Event|2|||
105669728|NCT01123070|364456070|FG003|Part B Double Blind Period|Adverse Event|0|||
105669729|NCT01123070|364456067|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
105669730|NCT01123070|364456068|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
105669731|NCT01123070|364456069|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
105669732|NCT01123070|364456070|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
105669733|NCT02706405|364456071|FG000|Overall Study|Death|3|||
105669734|NCT02706405|364456072|FG001|Overall Study|Death|2|||
105669735|NCT02706405|364456073|FG002|Overall Study|Death|0|||
105669736|NCT02706405|364456074|FG003|Overall Study|Death|1|||
105669737|NCT02706405|364456075|FG004|Overall Study|Death|0|||
105786076|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
105341814|NCT04542499|363253565|FG001|Overall Study|Other|2|||
105341815|NCT02163226|363253570|FG000|Overall Study|Death|2|||
105341816|NCT02163226|363253571|FG001|Overall Study|Death|1|||
105341817|NCT02163226|363253570|FG000|Overall Study|Withdrawal by Subject|5|||
105669738|NCT02706405|364456076|FG005|Overall Study|Death|0|||
105341818|NCT02163226|363253571|FG001|Overall Study|Withdrawal by Subject|2|||
105669739|NCT02706405|364456077|FG006|Overall Study|Death|3|||
105669740|NCT02706405|364456078|FG007|Overall Study|Death|4|||
105669741|NCT02706405|364456071|FG000|Overall Study|Disease progression|0|||
105669742|NCT02706405|364456072|FG001|Overall Study|Disease progression|0|||
105669743|NCT02706405|364456073|FG002|Overall Study|Disease progression|0|||
105669744|NCT02706405|364456074|FG003|Overall Study|Disease progression|0|||
105669745|NCT02706405|364456075|FG004|Overall Study|Disease progression|0|||
105669746|NCT02706405|364456076|FG005|Overall Study|Disease progression|0|||
105669747|NCT02706405|364456077|FG006|Overall Study|Disease progression|0|||
105669748|NCT02706405|364456078|FG007|Overall Study|Disease progression|1|||
105669749|NCT02706405|364456071|FG000|Overall Study|Pt moved to new therapy|0|||
105341819|NCT02163226|363253570|FG000|Overall Study|Returned home, local radiotherapy|3|||
105669750|NCT02706405|364456072|FG001|Overall Study|Pt moved to new therapy|0|||
105669751|NCT02706405|364456073|FG002|Overall Study|Pt moved to new therapy|0|||
105669752|NCT02706405|364456074|FG003|Overall Study|Pt moved to new therapy|0|||
105669753|NCT02706405|364456075|FG004|Overall Study|Pt moved to new therapy|0|||
105669754|NCT02706405|364456076|FG005|Overall Study|Pt moved to new therapy|1|||
105669755|NCT02706405|364456077|FG006|Overall Study|Pt moved to new therapy|0|||
105669756|NCT02706405|364456078|FG007|Overall Study|Pt moved to new therapy|1|||
105669757|NCT02706405|364456071|FG000|Overall Study|Physician Decision|1|||
105669758|NCT02706405|364456072|FG001|Overall Study|Physician Decision|0|||
105669759|NCT02706405|364456073|FG002|Overall Study|Physician Decision|0|||
105669760|NCT02706405|364456074|FG003|Overall Study|Physician Decision|0|||
105669761|NCT02706405|364456075|FG004|Overall Study|Physician Decision|0|||
105669762|NCT02706405|364456076|FG005|Overall Study|Physician Decision|0|||
105669763|NCT02706405|364456077|FG006|Overall Study|Physician Decision|0|||
105669764|NCT02706405|364456078|FG007|Overall Study|Physician Decision|0|||
105669765|NCT01182441|364456079|FG000|Overall Study|Patient Still in Follow-up|152|||
105669766|NCT01182441|364456080|FG001|Overall Study|Patient Still in Follow-up|72|||
105669767|NCT01182441|364456079|FG000|Overall Study|Death|37|||
105669768|NCT01182441|364456080|FG001|Overall Study|Death|25|||
105669769|NCT01182441|364456079|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
105669770|NCT01182441|364456080|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
105669771|NCT01182441|364456079|FG000|Overall Study|Lost to Follow-up|5|||
105669772|NCT01182441|364456080|FG001|Overall Study|Lost to Follow-up|8|||
105669773|NCT01182441|364456079|FG000|Overall Study|Withdrawal by Subject|6|||
105669774|NCT01182441|364456080|FG001|Overall Study|Withdrawal by Subject|13|||
105669775|NCT01182441|364456079|FG000|Overall Study|Implant Not Attempted|4|||
105669776|NCT01182441|364456080|FG001|Overall Study|Implant Not Attempted|0|||
105669777|NCT01182441|364456079|FG000|Overall Study|Adverse Event|2|||
105669778|NCT01182441|364456080|FG001|Overall Study|Adverse Event|0|||
105669779|NCT01182441|364456079|FG000|Overall Study|Physician Decision|1|||
105669780|NCT01182441|364456080|FG001|Overall Study|Physician Decision|1|||
105669781|NCT00515671|364456081|FG000|Overall Study|Lost to Follow-up|13|||
105669782|NCT00515671|364456082|FG001|Overall Study|Lost to Follow-up|10|||
105669783|NCT00515671|364456081|FG000|Overall Study|Withdrawal by Subject|3|||
105669784|NCT00515671|364456082|FG001|Overall Study|Withdrawal by Subject|5|||
105669785|NCT00515671|364456081|FG000|Overall Study|incarcerated|1|||
105669786|NCT00515671|364456082|FG001|Overall Study|incarcerated|2|||
105669787|NCT00603525|364456083|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
105669788|NCT00603525|364456084|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
105669789|NCT00603525|364456085|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105669790|NCT00603525|364456083|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
105669791|NCT00603525|364456084|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
105669792|NCT00603525|364456085|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
105669793|NCT00603525|364456083|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
105669794|NCT00603525|364456084|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
105669795|NCT00603525|364456085|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105669796|NCT00603525|364456083|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105669797|NCT00603525|364456084|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
105669798|NCT00603525|364456085|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105669799|NCT00603525|364456083|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
105669800|NCT00603525|364456084|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
105669801|NCT00603525|364456085|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105669802|NCT00603525|364456083|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
105669803|NCT00603525|364456084|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
105669804|NCT00603525|364456085|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
105669805|NCT00603525|364456083|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
105669806|NCT00603525|364456084|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
105669807|NCT00603525|364456085|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
105669808|NCT00603525|364456083|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
105669809|NCT00603525|364456084|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
105669810|NCT00603525|364456085|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
105669811|NCT00603525|364456083|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
105669812|NCT00603525|364456084|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
105669813|NCT00603525|364456085|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
105669814|NCT00603525|364456083|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
105669815|NCT00603525|364456084|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
105669816|NCT00603525|364456085|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
105669817|NCT00603525|364456083|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
105669818|NCT00603525|364456084|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
105669819|NCT00603525|364456085|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
105669820|NCT00603525|364456083|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
105669821|NCT00603525|364456084|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
105669822|NCT00603525|364456085|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
105669823|NCT00603525|364456083|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
105669824|NCT00603525|364456084|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
105669825|NCT00603525|364456085|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
105669826|NCT00603525|364456083|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
105341820|NCT02163226|363253571|FG001|Overall Study|Returned home, local radiotherapy|0|||
105341821|NCT02163226|363253570|FG000|Overall Study|Repeat imaging showed no disease|2|||
105341822|NCT02163226|363253571|FG001|Overall Study|Repeat imaging showed no disease|0|||
105341823|NCT02163226|363253570|FG000|Overall Study|Incomplete radiotherapy|3|||
105341824|NCT02163226|363253571|FG001|Overall Study|Incomplete radiotherapy|0|||
105341825|NCT02163226|363253570|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
105341826|NCT02163226|363253571|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
105341827|NCT02163226|363253570|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
105341828|NCT02163226|363253571|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
105341829|NCT02163226|363253570|FG000|Overall Study|ineligible|0|||
105341830|NCT02163226|363253571|FG001|Overall Study|ineligible|3|||
105341831|NCT00477750|363253572|FG000|Overall Study|Currently Receiving Treatment|11|||
105341832|NCT04166591|363253573|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
105341833|NCT04166591|363253574|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
105341834|NCT04166591|363253575|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
105341835|NCT04166591|363253576|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
105341836|NCT04166591|363253573|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
105341837|NCT04166591|363253574|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
105341838|NCT04166591|363253575|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
105341839|NCT04166591|363253576|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
105341840|NCT04434469|363253577|FG000|Overall Study|Death|2|||
105341841|NCT04434469|363253578|FG001|Overall Study|Death|3|||
105341842|NCT04434469|363253579|FG002|Overall Study|Death|2|||
105341843|NCT04434469|363253580|FG003|Overall Study|Death|2|||
105341844|NCT04434469|363253581|FG004|Overall Study|Death|2|||
105341845|NCT04434469|363253582|FG005|Overall Study|Death|0|||
105341846|NCT04434469|363253577|FG000|Overall Study|Lost to Follow-up|0|||
105341847|NCT04434469|363253578|FG001|Overall Study|Lost to Follow-up|0|||
105341848|NCT04434469|363253579|FG002|Overall Study|Lost to Follow-up|0|||
105341849|NCT04434469|363253580|FG003|Overall Study|Lost to Follow-up|1|||
105341850|NCT04434469|363253581|FG004|Overall Study|Lost to Follow-up|1|||
105341851|NCT04434469|363253582|FG005|Overall Study|Lost to Follow-up|0|||
105669827|NCT00603525|364456084|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
105669828|NCT00603525|364456085|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
105669829|NCT00603525|364456083|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
105669830|NCT00603525|364456084|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
105669831|NCT00603525|364456085|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
105669832|NCT02815579|364456086|FG000|Overall Study|Non-payment of loan down-payment|16|||
105669833|NCT02815579|364456087|FG001|Overall Study|Non-payment of loan down-payment|0|||
105669834|NCT02815579|364456086|FG000|Overall Study|Withdrawal by Subject|7|||
105466486|NCT03739203|363720158|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
105466487|NCT03739203|363720159|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
105466488|NCT03739203|363720160|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
105466489|NCT03739203|363720158|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
105466490|NCT03739203|363720159|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
105466491|NCT03739203|363720160|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
105466492|NCT03739203|363720158|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
105466493|NCT03739203|363720159|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
105466494|NCT03739203|363720160|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
105466495|NCT03739203|363720158|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
105466496|NCT03739203|363720159|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
105466497|NCT03739203|363720160|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
105466498|NCT03739203|363720158|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
105466499|NCT03739203|363720159|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
105466500|NCT03739203|363720160|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
105466501|NCT00830440|363720163|FG000|Overall Study|Protocol Violation|1|||
105466502|NCT00830440|363720164|FG001|Overall Study|Protocol Violation|0|||
105466503|NCT00830440|363720163|FG000|Overall Study|Withdrawal by Subject|1|||
105466504|NCT00830440|363720164|FG001|Overall Study|Withdrawal by Subject|0|||
105466505|NCT00830440|363720163|FG000|Overall Study|unsuccessful procedure|4|||
105466506|NCT00830440|363720164|FG001|Overall Study|unsuccessful procedure|0|||
105466507|NCT00830440|363720163|FG000|Overall Study|Adverse Event|2|||
105466508|NCT00830440|363720164|FG001|Overall Study|Adverse Event|0|||
105466509|NCT02592798|363720165|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
105466510|NCT02592798|363720166|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
105466511|NCT02592798|363720165|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
105466512|NCT02592798|363720166|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
105466513|NCT02592798|363720165|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
105466514|NCT02592798|363720166|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
105466515|NCT02592798|363720165|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
105466516|NCT02592798|363720166|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
105466517|NCT02592798|363720165|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
105466518|NCT02592798|363720166|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
105466519|NCT02592798|363720165|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
105466520|NCT02592798|363720166|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
105466521|NCT02592798|363720165|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
105466522|NCT02592798|363720166|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
105466523|NCT02592798|363720165|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
105466524|NCT02592798|363720166|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
105466525|NCT02592798|363720165|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
105466526|NCT02592798|363720166|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
105466527|NCT02592798|363720165|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
105466528|NCT02592798|363720166|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
105466529|NCT02592798|363720165|FG000|Transition From DB2 to OLE|Other reasons|1|||
105466530|NCT02592798|363720166|FG001|Transition From DB2 to OLE|Other reasons|0|||
105466531|NCT02592798|363720165|FG000|Open Label Period (OLE)|Other reasons|0|||
105466532|NCT02592798|363720166|FG001|Open Label Period (OLE)|Other reasons|2|||
105466533|NCT02592798|363720165|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
105466534|NCT02592798|363720166|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
105466535|NCT02592798|363720165|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
105466536|NCT02592798|363720166|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
105466537|NCT02592798|363720165|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
105466538|NCT02592798|363720166|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
105669835|NCT02815579|364456087|FG001|Overall Study|Withdrawal by Subject|1|||
105466539|NCT02592798|363720165|FG000|Open Label Period (OLE)|Adverse Event|0|||
105466540|NCT02592798|363720166|FG001|Open Label Period (OLE)|Adverse Event|1|||
105466541|NCT01967940|363720173|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
105466542|NCT01967940|363720174|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
105466543|NCT01967940|363720175|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
105466544|NCT01967940|363720176|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
105466545|NCT01967940|363720173|FG000|Part 2|Adverse Event|0|||
105669836|NCT02815579|364456086|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
105669837|NCT02815579|364456087|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
105669838|NCT02815579|364456086|FG000|Overall Study|Lost to Follow-up|7|||
105669839|NCT02815579|364456087|FG001|Overall Study|Lost to Follow-up|4|||
105669840|NCT02815579|364456086|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
105669841|NCT02815579|364456087|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
105669842|NCT02815579|364456086|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
105669843|NCT02815579|364456087|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
105669844|NCT02815579|364456086|FG000|Overall Study|Death|5|||
105669845|NCT02815579|364456087|FG001|Overall Study|Death|4|||
105669846|NCT02815579|364456086|FG000|Overall Study|Imprisoned|0|||
105669847|NCT02815579|364456087|FG001|Overall Study|Imprisoned|2|||
105669848|NCT02815579|364456086|FG000|Overall Study|Did not meet enrollment criteria|0|||
105669849|NCT02815579|364456087|FG001|Overall Study|Did not meet enrollment criteria|1|||
105669850|NCT01195948|364456090|FG000|Overall Study|Lost to Follow-up|0|||
105669851|NCT01195948|364456091|FG001|Overall Study|Lost to Follow-up|1|||
105669852|NCT01195948|364456092|FG002|Overall Study|Lost to Follow-up|2|||
105669853|NCT04043143|364456093|FG000|Overall Study|Lost to Follow-up|5|||
105669854|NCT04043143|364456094|FG001|Overall Study|Lost to Follow-up|5|||
105669855|NCT04043143|364456093|FG000|Overall Study|screen failure|1|||
105669856|NCT04043143|364456094|FG001|Overall Study|screen failure|0|||
105669857|NCT03480932|364456095|FG000|Overall Study|Death|1|||
105669858|NCT03480932|364456096|FG001|Overall Study|Death|1|||
105669859|NCT03480932|364456097|FG002|Overall Study|Death|0|||
105669860|NCT03480932|364456095|FG000|Overall Study|Lost to Follow-up|0|||
105669861|NCT03480932|364456096|FG001|Overall Study|Lost to Follow-up|2|||
105669862|NCT03480932|364456097|FG002|Overall Study|Lost to Follow-up|3|||
105669863|NCT03480932|364456095|FG000|Overall Study|Incarcerated|2|||
105669864|NCT03480932|364456096|FG001|Overall Study|Incarcerated|2|||
105669865|NCT03480932|364456097|FG002|Overall Study|Incarcerated|2|||
105669866|NCT00667225|364456101|FG000|Overall Study|Subject had no more lesions to treat.|1|||
105669867|NCT00667225|364456102|FG001|Overall Study|Subject had no more lesions to treat.|0|||
105669868|NCT00667225|364456101|FG000|Overall Study|Lost to Follow-up|0|||
105669869|NCT00667225|364456102|FG001|Overall Study|Lost to Follow-up|1|||
105669870|NCT00953771|364456103|FG000|Overall Study|Death|1|||
105669871|NCT00953771|364456104|FG001|Overall Study|Death|0|||
105669872|NCT00527787|364456109|FG000|Overall Study|Adverse Event|14|||
105669873|NCT00527787|364456110|FG001|Overall Study|Adverse Event|24|||
105669874|NCT00527787|364456109|FG000|Overall Study|Withdrawal by Subject|13|||
105669875|NCT00527787|364456110|FG001|Overall Study|Withdrawal by Subject|25|||
105669876|NCT00527787|364456109|FG000|Overall Study|Lost to Follow-up|5|||
105669877|NCT00527787|364456110|FG001|Overall Study|Lost to Follow-up|2|||
105669878|NCT00527787|364456109|FG000|Overall Study|Duodenal Ulcer|1|||
105669879|NCT00527787|364456110|FG001|Overall Study|Duodenal Ulcer|10|||
105669880|NCT00527787|364456109|FG000|Overall Study|misc|5|||
105669881|NCT00527787|364456110|FG001|Overall Study|misc|2|||
105669882|NCT03433677|364456111|FG000|Period 1|Protocol Violation|1|||
105669883|NCT03433677|364456112|FG001|Period 1|Protocol Violation|0|||
105669884|NCT03433677|364456111|FG000|Period 2|Withdrawal by Subject|1|||
105669885|NCT03433677|364456112|FG001|Period 2|Withdrawal by Subject|1|||
105669886|NCT00626197|364456115|FG000|Overall Study|Did not cooperate|2|||
105669887|NCT00626197|364456116|FG001|Overall Study|Did not cooperate|6|||
105669888|NCT00626197|364456117|FG002|Overall Study|Did not cooperate|1|||
105669889|NCT00626197|364456115|FG000|Overall Study|Failure to return|6|||
105669890|NCT00626197|364456116|FG001|Overall Study|Failure to return|5|||
105669891|NCT00626197|364456117|FG002|Overall Study|Failure to return|6|||
105669892|NCT00626197|364456115|FG000|Overall Study|Adverse event, serious fatal|3|||
105669893|NCT00626197|364456116|FG001|Overall Study|Adverse event, serious fatal|6|||
105669894|NCT00626197|364456117|FG002|Overall Study|Adverse event, serious fatal|6|||
105669895|NCT00626197|364456115|FG000|Overall Study|Adverse Event|1|||
105669896|NCT00626197|364456116|FG001|Overall Study|Adverse Event|1|||
105669897|NCT00626197|364456117|FG002|Overall Study|Adverse Event|2|||
105669898|NCT00626197|364456115|FG000|Overall Study|Withdrawal by Subject|17|||
105669899|NCT00626197|364456116|FG001|Overall Study|Withdrawal by Subject|17|||
105669900|NCT00626197|364456117|FG002|Overall Study|Withdrawal by Subject|7|||
105669901|NCT00626197|364456115|FG000|Overall Study|Administrative reasons|15|||
105669902|NCT00626197|364456116|FG001|Overall Study|Administrative reasons|19|||
105669903|NCT00626197|364456117|FG002|Overall Study|Administrative reasons|55|||
105341852|NCT04434469|363253577|FG000|Overall Study|Study terminated by sponsor|1|||
105341853|NCT04434469|363253578|FG001|Overall Study|Study terminated by sponsor|1|||
105466546|NCT01967940|363720174|FG001|Part 2|Adverse Event|0|||
105466547|NCT01967940|363720175|FG002|Part 2|Adverse Event|0|||
105466548|NCT01967940|363720176|FG003|Part 2|Adverse Event|1|||
105466549|NCT01967940|363720173|FG000|Part 2|Unknown Reason|0|||
105466550|NCT01967940|363720174|FG001|Part 2|Unknown Reason|0|||
105466551|NCT01967940|363720175|FG002|Part 2|Unknown Reason|0|||
105341854|NCT04434469|363253579|FG002|Overall Study|Study terminated by sponsor|1|||
105341855|NCT04434469|363253580|FG003|Overall Study|Study terminated by sponsor|2|||
105466552|NCT01967940|363720176|FG003|Part 2|Unknown Reason|1|||
105466553|NCT00942604|363720177|FG000|Overall Study|Protocol Violation|1|||
105466554|NCT00942604|363720178|FG001|Overall Study|Protocol Violation|1|||
105466555|NCT00942604|363720177|FG000|Overall Study|Adverse Event|0|||
105466556|NCT00942604|363720178|FG001|Overall Study|Adverse Event|1|||
105341856|NCT04434469|363253581|FG004|Overall Study|Study terminated by sponsor|3|||
105341857|NCT04434469|363253582|FG005|Overall Study|Study terminated by sponsor|3|||
105341858|NCT04434469|363253577|FG000|Overall Study|Withdrawal by Subject|0|||
105341859|NCT04434469|363253578|FG001|Overall Study|Withdrawal by Subject|0|||
105341860|NCT04434469|363253579|FG002|Overall Study|Withdrawal by Subject|1|||
105466557|NCT00942604|363720177|FG000|Overall Study|Withdrawal by Subject|0|||
105466558|NCT00942604|363720178|FG001|Overall Study|Withdrawal by Subject|1|||
105466559|NCT00942604|363720177|FG000|Overall Study|Patient relocation|1|||
105466560|NCT00942604|363720178|FG001|Overall Study|Patient relocation|1|||
105466561|NCT01146795|363720179|FG000|Overall Study|Withdrawal by Subject|4|||
105466562|NCT01146795|363720179|FG000|Overall Study|Adverse Event|6|||
105466563|NCT01146795|363720179|FG000|Overall Study|Still in treatment at study closure|10|||
105553990|NCT02352948|364025294|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105553991|NCT02352948|364025295|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
105553992|NCT02352948|364025296|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
105553993|NCT02352948|364025297|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
105553994|NCT02352948|364025298|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
105341861|NCT04434469|363253580|FG003|Overall Study|Withdrawal by Subject|0|||
105341862|NCT04434469|363253581|FG004|Overall Study|Withdrawal by Subject|0|||
105341863|NCT04434469|363253582|FG005|Overall Study|Withdrawal by Subject|0|||
105341864|NCT03320850|363253584|FG000|Overall Study|Lost to Follow-up|0|||
105341865|NCT03320850|363253585|FG001|Overall Study|Lost to Follow-up|0|||
105341866|NCT03320850|363253586|FG002|Overall Study|Lost to Follow-up|0|||
105553995|NCT02352948|364025299|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
105553996|NCT02352948|364025294|FG000|Overall Study|Other|0|||
105553997|NCT02352948|364025295|FG001|Overall Study|Other|0|||
105553998|NCT02352948|364025296|FG002|Overall Study|Other|2|||
105553999|NCT02352948|364025297|FG003|Overall Study|Other|0|||
105554000|NCT02352948|364025298|FG004|Overall Study|Other|0|||
105554001|NCT02352948|364025299|FG005|Overall Study|Other|0|||
105554002|NCT01669122|364025300|FG000|Period I|Lost to Follow-up|1|||
105554003|NCT01669122|364025300|FG000|Washout Period II|Protocol Violation|2|||
105554004|NCT03972488|364025301|FG000|Overall Study|Progressive disease|42|||
105554005|NCT03972488|364025302|FG001|Overall Study|Progressive disease|44|||
105554006|NCT03972488|364025301|FG000|Overall Study|Physician Decision|13|||
105554007|NCT03972488|364025302|FG001|Overall Study|Physician Decision|7|||
105554008|NCT03972488|364025301|FG000|Overall Study|Adverse Event|8|||
105554009|NCT03972488|364025302|FG001|Overall Study|Adverse Event|1|||
105554010|NCT03972488|364025301|FG000|Overall Study|Death|4|||
105554011|NCT03972488|364025302|FG001|Overall Study|Death|4|||
105554012|NCT03972488|364025301|FG000|Overall Study|Withdrawal by Subject|3|||
105554013|NCT03972488|364025302|FG001|Overall Study|Withdrawal by Subject|4|||
105554014|NCT03972488|364025301|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
105554015|NCT03972488|364025302|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
105554016|NCT02611037|364025303|FG000|Overall Study|Withdrawal prior to treatment|2|||
105554017|NCT02611037|364025304|FG001|Overall Study|Withdrawal prior to treatment|0|||
105554018|NCT04439110|364025305|FG000|Overall Study|Ineligible|2|||
105669904|NCT03559062|364456118|FG000|Overall Study|Other|0|||
105466564|NCT05375760|363720180|FG000|Overall Study|Adverse Event|1|||
105466565|NCT05375760|363720181|FG001|Overall Study|Adverse Event|0|||
105466566|NCT05375760|363720180|FG000|Overall Study|Death|0|||
105466567|NCT05375760|363720181|FG001|Overall Study|Death|1|||
105466568|NCT05375760|363720180|FG000|Overall Study|Lost to Follow-up|6|||
105466569|NCT05375760|363720181|FG001|Overall Study|Lost to Follow-up|6|||
105341867|NCT03320850|363253587|FG003|Overall Study|Lost to Follow-up|0|||
105341868|NCT03320850|363253588|FG004|Overall Study|Lost to Follow-up|1|||
105341869|NCT03320850|363253589|FG005|Overall Study|Lost to Follow-up|2|||
105341870|NCT03320850|363253590|FG006|Overall Study|Lost to Follow-up|2|||
105341871|NCT03320850|363253591|FG007|Overall Study|Lost to Follow-up|0|||
105341872|NCT03320850|363253592|FG008|Overall Study|Lost to Follow-up|6|||
105341873|NCT03320850|363253593|FG009|Overall Study|Lost to Follow-up|4|||
105341874|NCT03320850|363253584|FG000|Overall Study|Withdrawal by Subject|0|||
105341875|NCT03320850|363253585|FG001|Overall Study|Withdrawal by Subject|0|||
105341876|NCT03320850|363253586|FG002|Overall Study|Withdrawal by Subject|0|||
105341877|NCT03320850|363253587|FG003|Overall Study|Withdrawal by Subject|0|||
105341878|NCT03320850|363253588|FG004|Overall Study|Withdrawal by Subject|1|||
105341879|NCT03320850|363253589|FG005|Overall Study|Withdrawal by Subject|2|||
105341880|NCT03320850|363253590|FG006|Overall Study|Withdrawal by Subject|4|||
105341881|NCT03320850|363253591|FG007|Overall Study|Withdrawal by Subject|5|||
105341882|NCT03320850|363253592|FG008|Overall Study|Withdrawal by Subject|2|||
105341883|NCT03320850|363253593|FG009|Overall Study|Withdrawal by Subject|1|||
105341884|NCT03320850|363253584|FG000|Overall Study|Lack of Efficacy|0|||
105341885|NCT03320850|363253585|FG001|Overall Study|Lack of Efficacy|0|||
105341886|NCT03320850|363253586|FG002|Overall Study|Lack of Efficacy|0|||
105341887|NCT03320850|363253587|FG003|Overall Study|Lack of Efficacy|1|||
105341888|NCT03320850|363253588|FG004|Overall Study|Lack of Efficacy|0|||
105341889|NCT03320850|363253589|FG005|Overall Study|Lack of Efficacy|1|||
105341890|NCT03320850|363253590|FG006|Overall Study|Lack of Efficacy|0|||
105341891|NCT03320850|363253591|FG007|Overall Study|Lack of Efficacy|2|||
105341892|NCT03320850|363253592|FG008|Overall Study|Lack of Efficacy|0|||
105341893|NCT03320850|363253593|FG009|Overall Study|Lack of Efficacy|3|||
105341894|NCT03320850|363253584|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
105341895|NCT03320850|363253585|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
105341896|NCT03320850|363253586|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
105341897|NCT03320850|363253587|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
105341898|NCT03320850|363253588|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
105341899|NCT03320850|363253589|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
105341900|NCT03320850|363253590|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
105341901|NCT03320850|363253591|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
105341902|NCT03320850|363253592|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
105341903|NCT03320850|363253593|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
105341904|NCT03320850|363253584|FG000|Overall Study|Adverse Event|0|||
105341905|NCT03320850|363253585|FG001|Overall Study|Adverse Event|0|||
105341906|NCT03320850|363253586|FG002|Overall Study|Adverse Event|0|||
105341907|NCT03320850|363253587|FG003|Overall Study|Adverse Event|0|||
105341908|NCT03320850|363253588|FG004|Overall Study|Adverse Event|0|||
105341909|NCT03320850|363253589|FG005|Overall Study|Adverse Event|2|||
105341910|NCT03320850|363253590|FG006|Overall Study|Adverse Event|1|||
105341911|NCT03320850|363253591|FG007|Overall Study|Adverse Event|0|||
105341912|NCT03320850|363253592|FG008|Overall Study|Adverse Event|2|||
105341913|NCT03320850|363253593|FG009|Overall Study|Adverse Event|0|||
105341914|NCT03320850|363253584|FG000|Overall Study|Reason Not Specified|0|||
105341915|NCT03320850|363253585|FG001|Overall Study|Reason Not Specified|0|||
105341916|NCT03320850|363253586|FG002|Overall Study|Reason Not Specified|0|||
105341917|NCT03320850|363253587|FG003|Overall Study|Reason Not Specified|0|||
105341918|NCT03320850|363253588|FG004|Overall Study|Reason Not Specified|0|||
105341919|NCT03320850|363253589|FG005|Overall Study|Reason Not Specified|1|||
105341920|NCT03320850|363253590|FG006|Overall Study|Reason Not Specified|0|||
105341921|NCT03320850|363253591|FG007|Overall Study|Reason Not Specified|0|||
105341922|NCT03320850|363253592|FG008|Overall Study|Reason Not Specified|0|||
105341923|NCT03320850|363253593|FG009|Overall Study|Reason Not Specified|1|||
105341924|NCT03361865|363253596|FG000|Overall Study|Death|17|||
105341925|NCT03361865|363253597|FG001|Overall Study|Death|18|||
105341926|NCT03361865|363253596|FG000|Overall Study|Physician Decision|1|||
105341927|NCT03361865|363253597|FG001|Overall Study|Physician Decision|9|||
105341928|NCT03361865|363253596|FG000|Overall Study|Withdrawal by Subject|1|||
105341929|NCT03361865|363253597|FG001|Overall Study|Withdrawal by Subject|0|||
105341930|NCT01632150|363253606|FG000|Overall Study|Disease progression|27|||
105341931|NCT01632150|363253606|FG000|Overall Study|Study drug toxicity|1|||
105341932|NCT01632150|363253606|FG000|Overall Study|Unrelated adverse event|7|||
105341933|NCT01632150|363253606|FG000|Overall Study|Withdrawal by Subject|2|||
105341934|NCT01632150|363253606|FG000|Overall Study|Patient underwent autologous transplant|1|||
105341935|NCT01632150|363253606|FG000|Overall Study|Moved to compassionate program|2|||
105341936|NCT02086448|363253610|FG000|Overall Study|Withdrawal by Subject|1|||
105341937|NCT02086448|363253611|FG001|Overall Study|Withdrawal by Subject|0|||
105341938|NCT02086448|363253612|FG002|Overall Study|Withdrawal by Subject|0|||
105341939|NCT02086448|363253613|FG003|Overall Study|Withdrawal by Subject|2|||
105341940|NCT00401544|363253618|FG000|Overall Study|Adverse Event|5|||
105341941|NCT00401544|363253619|FG001|Overall Study|Adverse Event|1|||
105341942|NCT00401544|363253620|FG002|Overall Study|Adverse Event|1|||
105341943|NCT00401544|363253621|FG003|Overall Study|Adverse Event|1|||
105341944|NCT00401544|363253618|FG000|Overall Study|Death|3|||
105669905|NCT03559062|364456119|FG001|Overall Study|Other|1|||
105341945|NCT00401544|363253619|FG001|Overall Study|Death|6|||
105341946|NCT00401544|363253620|FG002|Overall Study|Death|2|||
105341947|NCT00401544|363253621|FG003|Overall Study|Death|5|||
105341948|NCT00401544|363253618|FG000|Overall Study|Lost to Follow-up|2|||
105341949|NCT00401544|363253619|FG001|Overall Study|Lost to Follow-up|0|||
105341950|NCT00401544|363253620|FG002|Overall Study|Lost to Follow-up|1|||
105341951|NCT00401544|363253621|FG003|Overall Study|Lost to Follow-up|1|||
105341952|NCT00401544|363253618|FG000|Overall Study|Withdrawal by Subject|7|||
105341953|NCT00401544|363253619|FG001|Overall Study|Withdrawal by Subject|6|||
105341954|NCT00401544|363253620|FG002|Overall Study|Withdrawal by Subject|6|||
105341955|NCT00401544|363253621|FG003|Overall Study|Withdrawal by Subject|5|||
105341956|NCT00401544|363253618|FG000|Overall Study|Physician Decision|1|||
105341957|NCT00401544|363253619|FG001|Overall Study|Physician Decision|3|||
105341958|NCT00401544|363253620|FG002|Overall Study|Physician Decision|0|||
105341959|NCT00401544|363253621|FG003|Overall Study|Physician Decision|0|||
105341960|NCT00401544|363253618|FG000|Overall Study|Ineligibility determined|0|||
105341961|NCT00401544|363253619|FG001|Overall Study|Ineligibility determined|1|||
105341962|NCT00401544|363253620|FG002|Overall Study|Ineligibility determined|0|||
105341963|NCT00401544|363253621|FG003|Overall Study|Ineligibility determined|2|||
105341964|NCT00401544|363253618|FG000|Overall Study|Disease progression|0|||
105669906|NCT03559062|364456120|FG002|Overall Study|Other|0|||
105669907|NCT00022659|364456121|FG000|Overall Study|Ineligible: wrong primary|1|||
105669908|NCT00022659|364456121|FG000|Overall Study|Never treated|1|||
105669909|NCT01757197|364456122|FG000|Overall Study|Death|2|||
105669910|NCT03301155|364456129|FG000|Overall Study|Сompliance with exclusion criteria|8|||
105669911|NCT03301155|364456130|FG001|Overall Study|Сompliance with exclusion criteria|7|||
105669912|NCT03510455|364456132|FG000|Overall Study|Physician Decision|1|||
105669913|NCT04939701|364456133|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
105669914|NCT04939701|364456134|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
105669915|NCT04939701|364456135|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
105669916|NCT04939701|364456133|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
105669917|NCT04939701|364456134|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
105669918|NCT04939701|364456135|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
105341965|NCT00401544|363253619|FG001|Overall Study|Disease progression|1|||
105669919|NCT04939701|364456133|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
105669920|NCT04939701|364456134|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
105669921|NCT04939701|364456135|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
105669922|NCT04939701|364456133|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
105669923|NCT04939701|364456134|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
105669924|NCT04939701|364456135|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
105669925|NCT04939701|364456133|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
105669926|NCT04939701|364456134|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
105669927|NCT04939701|364456135|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
105669928|NCT04939701|364456133|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
105669929|NCT04939701|364456134|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
105669930|NCT04939701|364456135|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
105669931|NCT04939701|364456133|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
105669932|NCT04939701|364456134|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
105669933|NCT04939701|364456135|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
105669934|NCT02383940|364456140|FG000|Overall Study|Adverse Event|1|||
105669935|NCT02383940|364456141|FG001|Overall Study|Adverse Event|0|||
105669936|NCT02383940|364456140|FG000|Overall Study|Lost to Follow-up|2|||
105669937|NCT02383940|364456141|FG001|Overall Study|Lost to Follow-up|2|||
105669938|NCT02383940|364456140|FG000|Overall Study|Physician Decision|2|||
105669939|NCT02383940|364456141|FG001|Overall Study|Physician Decision|0|||
105669940|NCT02383940|364456140|FG000|Overall Study|Withdrawal by Subject|1|||
105669941|NCT02383940|364456141|FG001|Overall Study|Withdrawal by Subject|1|||
105669942|NCT02383940|364456140|FG000|Overall Study|Randomized but not treated|2|||
105669943|NCT02383940|364456141|FG001|Overall Study|Randomized but not treated|0|||
105669944|NCT02383940|364456140|FG000|Overall Study|Other than specified above|1|||
105669945|NCT02383940|364456141|FG001|Overall Study|Other than specified above|0|||
105669946|NCT00384189|364456142|FG000|Overall Study|Reason Not Specified|50|||
105669947|NCT00384189|364456143|FG001|Overall Study|Reason Not Specified|57|||
105669948|NCT00384189|364456144|FG002|Overall Study|Reason Not Specified|58|||
105669949|NCT00384189|364456145|FG003|Overall Study|Reason Not Specified|40|||
105669950|NCT02672852|364456146|FG000|Part A1|Disease Worsening|1|||
105669951|NCT02672852|364456147|FG001|Part A1|Disease Worsening|0|||
105669952|NCT02672852|364456148|FG002|Part A1|Disease Worsening|0|||
105669953|NCT02672852|364456149|FG003|Part A1|Disease Worsening|0|||
105554019|NCT04439110|364025305|FG000|Overall Study|Adverse Event|4|||
105554020|NCT04439110|364025305|FG000|Overall Study|Death|2|||
105554021|NCT04439110|364025305|FG000|Overall Study|Disease proression|25|||
105554022|NCT04439110|364025305|FG000|Overall Study|Withdrawal by Subject|1|||
105554023|NCT04439110|364025305|FG000|Overall Study|Alternative therapy|1|||
105554024|NCT04439110|364025305|FG000|Overall Study|Other complicating disease|1|||
105554025|NCT04439110|364025305|FG000|Overall Study|Personal reasons|1|||
105554026|NCT04439110|364025305|FG000|Overall Study|Still on treatment|1|||
105554027|NCT00127608|364025308|FG000|Overall Study|VZV DNA negative|1|||
105554028|NCT05245864|364025309|FG000|Overall Study|Withdrawal by Subject|1|||
105554029|NCT05245864|364025310|FG001|Overall Study|Withdrawal by Subject|1|||
105554030|NCT00680407|364025322|FG000|Overall Study|Lost to Follow-up|3|||
105554031|NCT00680407|364025323|FG001|Overall Study|Lost to Follow-up|3|||
105669954|NCT02672852|364456150|FG004|Part A1|Disease Worsening|0|||
105669955|NCT02672852|364456151|FG005|Part A1|Disease Worsening|0|||
105669956|NCT02672852|364456152|FG006|Part A1|Disease Worsening|0|||
105669957|NCT02672852|364456146|FG000|Part A1|Adverse Event|0|||
105554032|NCT00680407|364025324|FG002|Overall Study|Lost to Follow-up|1|||
105669958|NCT02672852|364456147|FG001|Part A1|Adverse Event|1|||
105669959|NCT02672852|364456148|FG002|Part A1|Adverse Event|0|||
105669960|NCT02672852|364456149|FG003|Part A1|Adverse Event|0|||
105554033|NCT00680407|364025322|FG000|Overall Study|Withdrawal by Subject|5|||
105554034|NCT00680407|364025323|FG001|Overall Study|Withdrawal by Subject|2|||
105554035|NCT00680407|364025324|FG002|Overall Study|Withdrawal by Subject|2|||
105554036|NCT01625897|364027317|FG000|Overall Study|Adverse Event|27|||
105554037|NCT01625897|364027318|FG001|Overall Study|Adverse Event|10|||
105554038|NCT01625897|364027317|FG000|Overall Study|Physician Decision|0|||
105554039|NCT01625897|364027318|FG001|Overall Study|Physician Decision|1|||
105554040|NCT01625897|364027317|FG000|Overall Study|Withdrawal by Subject|25|||
105669961|NCT02672852|364456150|FG004|Part A1|Adverse Event|0|||
105669962|NCT02672852|364456151|FG005|Part A1|Adverse Event|0|||
105669963|NCT02672852|364456152|FG006|Part A1|Adverse Event|0|||
105554041|NCT01625897|364027318|FG001|Overall Study|Withdrawal by Subject|3|||
105554042|NCT02621931|364027320|FG000|Overall Study|Death|0|||
105341966|NCT00401544|363253620|FG002|Overall Study|Disease progression|0|||
105554043|NCT02621931|364027321|FG001|Overall Study|Death|1|||
105554044|NCT02621931|364027322|FG002|Overall Study|Death|0|||
105554045|NCT02621931|364027320|FG000|Overall Study|Adverse Event|8|||
105554046|NCT02621931|364027321|FG001|Overall Study|Adverse Event|5|||
105554047|NCT02621931|364027322|FG002|Overall Study|Adverse Event|7|||
105554048|NCT02621931|364027320|FG000|Overall Study|Withdrawal by Subject|12|||
105554049|NCT02621931|364027321|FG001|Overall Study|Withdrawal by Subject|10|||
105554050|NCT02621931|364027322|FG002|Overall Study|Withdrawal by Subject|11|||
105554051|NCT02621931|364027320|FG000|Overall Study|Protocol Violation|2|||
105554052|NCT02621931|364027321|FG001|Overall Study|Protocol Violation|2|||
105554053|NCT02621931|364027322|FG002|Overall Study|Protocol Violation|2|||
105554054|NCT02621931|364027320|FG000|Overall Study|Pregnancy|2|||
105554055|NCT02621931|364027321|FG001|Overall Study|Pregnancy|0|||
105554056|NCT02621931|364027322|FG002|Overall Study|Pregnancy|0|||
105554057|NCT02621931|364027320|FG000|Overall Study|Noncompliance to study procedures|0|||
105554058|NCT02621931|364027321|FG001|Overall Study|Noncompliance to study procedures|1|||
105554059|NCT02621931|364027322|FG002|Overall Study|Noncompliance to study procedures|2|||
105554060|NCT02621931|364027320|FG000|Overall Study|Lost to Follow-up|8|||
105554061|NCT02621931|364027321|FG001|Overall Study|Lost to Follow-up|7|||
105554062|NCT02621931|364027322|FG002|Overall Study|Lost to Follow-up|10|||
105554063|NCT02621931|364027320|FG000|Overall Study|Lack of Efficacy|0|||
105554064|NCT02621931|364027321|FG001|Overall Study|Lack of Efficacy|0|||
105554065|NCT02621931|364027322|FG002|Overall Study|Lack of Efficacy|1|||
105554066|NCT02621931|364027320|FG000|Overall Study|Other|1|||
105554067|NCT02621931|364027321|FG001|Overall Study|Other|1|||
105554068|NCT02621931|364027322|FG002|Overall Study|Other|3|||
105554069|NCT01292603|364027323|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
105554070|NCT01292603|364027324|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
105554071|NCT01292603|364027325|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
105554072|NCT01292603|364027326|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
105554073|NCT01292603|364027327|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
105554074|NCT01292603|364027328|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
105554075|NCT01292603|364027323|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
105554076|NCT01292603|364027324|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
105554077|NCT01292603|364027325|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
105554078|NCT01292603|364027326|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
105554079|NCT01292603|364027327|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
105554080|NCT01292603|364027328|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
105669964|NCT02672852|364456146|FG000|Part A1|Lost to Follow-up|1|||
105554081|NCT01292603|364027323|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
105554082|NCT01292603|364027324|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
105669965|NCT02672852|364456147|FG001|Part A1|Lost to Follow-up|2|||
105669966|NCT02672852|364456148|FG002|Part A1|Lost to Follow-up|0|||
105669967|NCT02672852|364456149|FG003|Part A1|Lost to Follow-up|0|||
105669968|NCT02672852|364456150|FG004|Part A1|Lost to Follow-up|0|||
105669969|NCT02672852|364456151|FG005|Part A1|Lost to Follow-up|0|||
105669970|NCT02672852|364456152|FG006|Part A1|Lost to Follow-up|0|||
105669971|NCT02672852|364456146|FG000|Part A1|Withdrawal by Subject|1|||
105669972|NCT02672852|364456147|FG001|Part A1|Withdrawal by Subject|1|||
105669973|NCT02672852|364456148|FG002|Part A1|Withdrawal by Subject|0|||
105669974|NCT02672852|364456149|FG003|Part A1|Withdrawal by Subject|0|||
105669975|NCT02672852|364456150|FG004|Part A1|Withdrawal by Subject|0|||
105669976|NCT02672852|364456151|FG005|Part A1|Withdrawal by Subject|0|||
105669977|NCT02672852|364456152|FG006|Part A1|Withdrawal by Subject|0|||
105669978|NCT02672852|364456146|FG000|Part A2|Disease worsening|0|||
105669979|NCT02672852|364456147|FG001|Part A2|Disease worsening|0|||
105669980|NCT02672852|364456148|FG002|Part A2|Disease worsening|1|||
105669981|NCT02672852|364456149|FG003|Part A2|Disease worsening|0|||
105669982|NCT02672852|364456150|FG004|Part A2|Disease worsening|0|||
105669983|NCT02672852|364456151|FG005|Part A2|Disease worsening|0|||
105669984|NCT02672852|364456152|FG006|Part A2|Disease worsening|0|||
105669985|NCT02672852|364456146|FG000|Part A2|Adverse Event|0|||
105669986|NCT02672852|364456147|FG001|Part A2|Adverse Event|0|||
105669987|NCT02672852|364456148|FG002|Part A2|Adverse Event|3|||
105669988|NCT02672852|364456149|FG003|Part A2|Adverse Event|0|||
105669989|NCT02672852|364456150|FG004|Part A2|Adverse Event|0|||
105669990|NCT02672852|364456151|FG005|Part A2|Adverse Event|0|||
105669991|NCT02672852|364456152|FG006|Part A2|Adverse Event|0|||
105669992|NCT02672852|364456146|FG000|Part A2|Lost to Follow-up|0|||
105669993|NCT02672852|364456147|FG001|Part A2|Lost to Follow-up|0|||
105554083|NCT01292603|364027325|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
105554084|NCT01292603|364027326|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
105669994|NCT02672852|364456148|FG002|Part A2|Lost to Follow-up|2|||
105669995|NCT02672852|364456149|FG003|Part A2|Lost to Follow-up|0|||
105341967|NCT00401544|363253621|FG003|Overall Study|Disease progression|0|||
105669996|NCT02672852|364456150|FG004|Part A2|Lost to Follow-up|0|||
105669997|NCT02672852|364456151|FG005|Part A2|Lost to Follow-up|0|||
105669998|NCT02672852|364456152|FG006|Part A2|Lost to Follow-up|0|||
105669999|NCT02672852|364456146|FG000|Part A2|Withdrawal by Subject|0|||
105670000|NCT02672852|364456147|FG001|Part A2|Withdrawal by Subject|0|||
105670001|NCT02672852|364456148|FG002|Part A2|Withdrawal by Subject|1|||
105554085|NCT01292603|364027327|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
105554086|NCT01292603|364027328|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
105554087|NCT01292603|364027323|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
105554088|NCT01292603|364027324|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
105554089|NCT01292603|364027325|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
105554090|NCT01292603|364027326|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
105554091|NCT01292603|364027327|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
105670002|NCT02672852|364456149|FG003|Part A2|Withdrawal by Subject|0|||
105670003|NCT02672852|364456150|FG004|Part A2|Withdrawal by Subject|0|||
105786077|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
105786078|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
105786079|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
105786080|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
105786081|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
105786082|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
105786083|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
105786084|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
105786085|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
105786086|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
105786087|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
105786088|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
105786089|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
105786090|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
105786091|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
105786092|NCT00908375|364870447|FG000|Overall Study|Withdrawal by Subject|2|||
105786093|NCT00908375|364870448|FG001|Overall Study|Withdrawal by Subject|4|||
105786094|NCT00908375|364870447|FG000|Overall Study|Lost to Follow-up|8|||
105786095|NCT00908375|364870448|FG001|Overall Study|Lost to Follow-up|6|||
105786096|NCT04095039|364870449|FG000|Overall Study|Withdrawal by Subject|2|||
105786097|NCT04095039|364870450|FG001|Overall Study|Withdrawal by Subject|16|||
105786098|NCT04095039|364870449|FG000|Overall Study|Transplanted|21|||
105786099|NCT04095039|364870450|FG001|Overall Study|Transplanted|24|||
105786100|NCT04095039|364870449|FG000|Overall Study|Transferred to Non-study Facility|47|||
105786101|NCT04095039|364870450|FG001|Overall Study|Transferred to Non-study Facility|44|||
105786102|NCT04095039|364870449|FG000|Overall Study|Withdrawal from internvention target|0|||
105786103|NCT04095039|364870450|FG001|Overall Study|Withdrawal from internvention target|2|||
105786104|NCT04095039|364870449|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
105786105|NCT04095039|364870450|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
105786106|NCT04095039|364870449|FG000|Overall Study|Cacliphylaxis|0|||
105786107|NCT04095039|364870450|FG001|Overall Study|Cacliphylaxis|1|||
105786108|NCT04095039|364870449|FG000|Overall Study|Pregnancy|1|||
105786109|NCT04095039|364870450|FG001|Overall Study|Pregnancy|0|||
105786110|NCT03635788|364870451|FG000|Step 1|Death|1|||
105786111|NCT03635788|364870452|FG001|Step 1|Death|0|||
105786112|NCT03635788|364870453|FG002|Step 1|Death|0|||
105786113|NCT03635788|364870451|FG000|Step 1|Lost to Follow-up|31|||
105786114|NCT03635788|364870452|FG001|Step 1|Lost to Follow-up|0|||
105786115|NCT03635788|364870453|FG002|Step 1|Lost to Follow-up|0|||
105786116|NCT03635788|364870451|FG000|Step 1|Pregnancy|1|||
105786117|NCT03635788|364870452|FG001|Step 1|Pregnancy|0|||
105786118|NCT03635788|364870453|FG002|Step 1|Pregnancy|0|||
105786119|NCT03635788|364870451|FG000|Step 1|Protocol Violation|8|||
105786120|NCT03635788|364870452|FG001|Step 1|Protocol Violation|0|||
105786121|NCT03635788|364870453|FG002|Step 1|Protocol Violation|0|||
105786122|NCT03635788|364870451|FG000|Step 1|Withdrawal by Subject|13|||
105786123|NCT03635788|364870452|FG001|Step 1|Withdrawal by Subject|0|||
105786124|NCT03635788|364870453|FG002|Step 1|Withdrawal by Subject|0|||
105786125|NCT03635788|364870451|FG000|Step 1|Other reasons|12|||
105786126|NCT03635788|364870452|FG001|Step 1|Other reasons|0|||
105786127|NCT03635788|364870453|FG002|Step 1|Other reasons|0|||
105786128|NCT03635788|364870451|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
105786129|NCT03635788|364870452|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
105786130|NCT03635788|364870453|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
105786131|NCT03635788|364870451|FG000|Step 2|Lost to Follow-up|0|||
105786132|NCT03635788|364870452|FG001|Step 2|Lost to Follow-up|8|||
105786133|NCT03635788|364870453|FG002|Step 2|Lost to Follow-up|15|||
105786134|NCT03635788|364870451|FG000|Step 2|Withdrawal by Subject|0|||
105786135|NCT03635788|364870452|FG001|Step 2|Withdrawal by Subject|6|||
105786136|NCT03635788|364870453|FG002|Step 2|Withdrawal by Subject|6|||
105786137|NCT03635788|364870451|FG000|Step 2|Death|0|||
105786138|NCT03635788|364870452|FG001|Step 2|Death|2|||
105786139|NCT03635788|364870453|FG002|Step 2|Death|0|||
105786140|NCT03635788|364870451|FG000|Step 2|Incarceration|0|||
105786141|NCT03635788|364870452|FG001|Step 2|Incarceration|2|||
105786142|NCT03635788|364870453|FG002|Step 2|Incarceration|0|||
105786143|NCT03635788|364870451|FG000|Step 2|Non-Compliance With Study Requirements|0|||
105786144|NCT03635788|364870452|FG001|Step 2|Non-Compliance With Study Requirements|1|||
105786145|NCT03635788|364870453|FG002|Step 2|Non-Compliance With Study Requirements|1|||
105786146|NCT03635788|364870451|FG000|Step 2|Confounding Medical Condition|0|||
105786147|NCT03635788|364870452|FG001|Step 2|Confounding Medical Condition|0|||
105786148|NCT03635788|364870453|FG002|Step 2|Confounding Medical Condition|1|||
105786149|NCT03635788|364870451|FG000|Step 2|Out Of State With No Plan To Return|0|||
105786150|NCT03635788|364870452|FG001|Step 2|Out Of State With No Plan To Return|1|||
105786151|NCT03635788|364870453|FG002|Step 2|Out Of State With No Plan To Return|0|||
105670004|NCT02672852|364456151|FG005|Part A2|Withdrawal by Subject|0|||
105670005|NCT02672852|364456152|FG006|Part A2|Withdrawal by Subject|0|||
105341968|NCT00401544|363253618|FG000|Overall Study|Other|0|||
105341969|NCT00401544|363253619|FG001|Overall Study|Other|0|||
105341970|NCT00401544|363253620|FG002|Overall Study|Other|2|||
105341971|NCT00401544|363253621|FG003|Overall Study|Other|2|||
105341972|NCT01871402|363253622|FG000|Overall Study|Lost to Follow-up|1|||
105341973|NCT01871402|363253623|FG001|Overall Study|Lost to Follow-up|0|||
105341974|NCT01871402|363253622|FG000|Overall Study|Withdrawal by Subject|0|||
105341975|NCT01871402|363253623|FG001|Overall Study|Withdrawal by Subject|2|||
105341976|NCT01871402|363253622|FG000|Overall Study|Non-compliance|0|||
105341977|NCT01871402|363253623|FG001|Overall Study|Non-compliance|1|||
105341978|NCT00177307|363253633|FG000|Overall Study|Withdrawal by Subject|1|||
105341979|NCT01646021|363253634|FG000|Overall Study|Death|77|||
105341980|NCT01646021|363253635|FG001|Overall Study|Death|83|||
105341981|NCT01646021|363253634|FG000|Overall Study|Study Terminated by Sponsor|50|||
105341982|NCT01646021|363253635|FG001|Overall Study|Study Terminated by Sponsor|41|||
105341983|NCT01646021|363253634|FG000|Overall Study|Lost to Follow-up|2|||
105341984|NCT01646021|363253635|FG001|Overall Study|Lost to Follow-up|2|||
105341985|NCT01646021|363253634|FG000|Overall Study|Withdrawal by Subject|10|||
105341986|NCT01646021|363253635|FG001|Overall Study|Withdrawal by Subject|15|||
105341987|NCT05178641|363253636|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
105341988|NCT05178641|363253637|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
105341989|NCT05178641|363253636|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
105341990|NCT05178641|363253637|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
105341991|NCT01869699|363253639|FG000|Overall Study|Withdrawal by Subject|1|||
105341992|NCT01869699|363253640|FG001|Overall Study|Withdrawal by Subject|0|||
105341993|NCT01083186|363253641|FG000|Overall Study|Lost to Follow-up|48|||
105341994|NCT01083186|363253641|FG000|Overall Study|Consent Withdrawal|7|||
105341995|NCT01083186|363253641|FG000|Overall Study|Death|3|||
105341996|NCT01083186|363253641|FG000|Overall Study|Adverse Event|3|||
105341997|NCT01083186|363253641|FG000|Overall Study|Lack of Efficacy|2|||
105341998|NCT01083186|363253641|FG000|Overall Study|Hemodialysis Initiation|28|||
105341999|NCT01083186|363253641|FG000|Overall Study|Administrative Reasons|2|||
105342000|NCT01083186|363253641|FG000|Overall Study|Non-compliance to Study Treatment|1|||
105342001|NCT00108485|363253642|FG000|Overall Study|Withdrawal by Subject|3|||
105342002|NCT00108485|363253643|FG001|Overall Study|Withdrawal by Subject|0|||
105342003|NCT00108485|363253642|FG000|Overall Study|Lost to Follow-up|0|||
105342004|NCT00108485|363253643|FG001|Overall Study|Lost to Follow-up|2|||
105342005|NCT01097421|363253646|FG000|Overall Study|Adverse Event|8|||
105342006|NCT01097421|363253646|FG000|Overall Study|Protocol Violation|2|||
105342007|NCT01097421|363253646|FG000|Overall Study|Lost to Follow-up|1|||
105342008|NCT01097421|363253646|FG000|Overall Study|Withdrawal by Subject|3|||
105342009|NCT02062944|363253650|FG000|Overall Study|Lost to Follow-up|1|||
105342010|NCT02062944|363253650|FG000|Overall Study|New hemotological disorder identified|1|||
105342011|NCT02062944|363253650|FG000|Overall Study|Uncontrolled Hypertension|1|||
105342012|NCT02062944|363253650|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
105342013|NCT00278148|363253651|FG000|Phase II - Expansion Phase|Disease progression|0|||
105342014|NCT00278148|363253652|FG001|Phase II - Expansion Phase|Disease progression|0|||
105342015|NCT00278148|363253653|FG002|Phase II - Expansion Phase|Disease progression|4|||
105342016|NCT00278148|363253651|FG000|Phase II - Expansion Phase|Adverse Event|0|||
105342017|NCT00278148|363253652|FG001|Phase II - Expansion Phase|Adverse Event|0|||
105342018|NCT00278148|363253653|FG002|Phase II - Expansion Phase|Adverse Event|2|||
105342019|NCT02407457|363253654|FG000|1 Month|Death|3|||
105342020|NCT02407457|363253655|FG001|1 Month|Death|0|||
105342021|NCT02407457|363253654|FG000|1 Month|Lost to Follow-up|1|||
105342022|NCT02407457|363253655|FG001|1 Month|Lost to Follow-up|1|||
105342023|NCT02407457|363253654|FG000|1 Month|missed visit|2|||
105342024|NCT02407457|363253655|FG001|1 Month|missed visit|5|||
105670006|NCT02672852|364456146|FG000|Part A2|Other|0|||
105670007|NCT02672852|364456147|FG001|Part A2|Other|0|||
105670008|NCT02672852|364456148|FG002|Part A2|Other|3|||
105670009|NCT02672852|364456149|FG003|Part A2|Other|0|||
105342025|NCT02407457|363253654|FG000|6-Month|Death|2|||
105342026|NCT02407457|363253655|FG001|6-Month|Death|8|||
105342027|NCT02407457|363253654|FG000|6-Month|Lost to Follow-up|2|||
105342028|NCT02407457|363253655|FG001|6-Month|Lost to Follow-up|2|||
105342029|NCT02407457|363253654|FG000|6-Month|missed visit|16|||
105342030|NCT02407457|363253655|FG001|6-Month|missed visit|14|||
105342031|NCT02407457|363253654|FG000|6-Month|Open Repair|0|||
105342032|NCT02407457|363253655|FG001|6-Month|Open Repair|1|||
105342033|NCT02407457|363253654|FG000|1 Year|Death|6|||
105342034|NCT02407457|363253655|FG001|1 Year|Death|11|||
105342035|NCT02407457|363253654|FG000|1 Year|Lost to Follow-up|3|||
105342036|NCT02407457|363253655|FG001|1 Year|Lost to Follow-up|2|||
105342037|NCT02407457|363253654|FG000|1 Year|Missed Visit|24|||
105342038|NCT02407457|363253655|FG001|1 Year|Missed Visit|14|||
105342039|NCT02407457|363253654|FG000|1 Year|Open Repair|0|||
105342040|NCT02407457|363253655|FG001|1 Year|Open Repair|1|||
105670010|NCT02672852|364456150|FG004|Part A2|Other|0|||
105670011|NCT02672852|364456151|FG005|Part A2|Other|0|||
105670012|NCT02672852|364456152|FG006|Part A2|Other|0|||
105670013|NCT02672852|364456146|FG000|Part A2|Not entered in Part B|0|||
105670014|NCT02672852|364456147|FG001|Part A2|Not entered in Part B|0|||
105670015|NCT02672852|364456148|FG002|Part A2|Not entered in Part B|0|||
105670016|NCT02672852|364456149|FG003|Part A2|Not entered in Part B|4|||
105670017|NCT02672852|364456150|FG004|Part A2|Not entered in Part B|0|||
105670018|NCT02672852|364456151|FG005|Part A2|Not entered in Part B|0|||
105670019|NCT02672852|364456152|FG006|Part A2|Not entered in Part B|0|||
105670020|NCT02672852|364456146|FG000|Part B|Disease worsening|0|||
105670021|NCT02672852|364456147|FG001|Part B|Disease worsening|0|||
105670022|NCT02672852|364456148|FG002|Part B|Disease worsening|0|||
105670023|NCT02672852|364456149|FG003|Part B|Disease worsening|0|||
105670024|NCT02672852|364456150|FG004|Part B|Disease worsening|1|||
105670025|NCT02672852|364456151|FG005|Part B|Disease worsening|0|||
105670026|NCT02672852|364456152|FG006|Part B|Disease worsening|1|||
105670027|NCT02672852|364456146|FG000|Part B|Worsening pre-existing condition|0|||
105670028|NCT02672852|364456147|FG001|Part B|Worsening pre-existing condition|0|||
105670029|NCT02672852|364456148|FG002|Part B|Worsening pre-existing condition|0|||
105670030|NCT02672852|364456149|FG003|Part B|Worsening pre-existing condition|0|||
105670031|NCT02672852|364456150|FG004|Part B|Worsening pre-existing condition|0|||
105670032|NCT02672852|364456151|FG005|Part B|Worsening pre-existing condition|1|||
105670033|NCT02672852|364456152|FG006|Part B|Worsening pre-existing condition|0|||
105670034|NCT02672852|364456146|FG000|Part B|Other adverse event|0|||
105670035|NCT02672852|364456147|FG001|Part B|Other adverse event|0|||
105670036|NCT02672852|364456148|FG002|Part B|Other adverse event|0|||
105670037|NCT02672852|364456149|FG003|Part B|Other adverse event|0|||
105670038|NCT02672852|364456150|FG004|Part B|Other adverse event|3|||
105670039|NCT02672852|364456151|FG005|Part B|Other adverse event|5|||
105670040|NCT02672852|364456152|FG006|Part B|Other adverse event|1|||
105670041|NCT02672852|364456146|FG000|Part B|Lost to Follow-up|0|||
105670042|NCT02672852|364456147|FG001|Part B|Lost to Follow-up|0|||
105670043|NCT02672852|364456148|FG002|Part B|Lost to Follow-up|0|||
105670044|NCT02672852|364456149|FG003|Part B|Lost to Follow-up|0|||
105670045|NCT02672852|364456150|FG004|Part B|Lost to Follow-up|3|||
105670046|NCT02672852|364456151|FG005|Part B|Lost to Follow-up|4|||
105670047|NCT02672852|364456152|FG006|Part B|Lost to Follow-up|1|||
105670048|NCT02672852|364456146|FG000|Part B|Withdrawal by Subject|0|||
105670049|NCT02672852|364456147|FG001|Part B|Withdrawal by Subject|0|||
105670050|NCT02672852|364456148|FG002|Part B|Withdrawal by Subject|0|||
105670051|NCT02672852|364456149|FG003|Part B|Withdrawal by Subject|0|||
105670052|NCT02672852|364456150|FG004|Part B|Withdrawal by Subject|5|||
105670053|NCT02672852|364456151|FG005|Part B|Withdrawal by Subject|0|||
105670054|NCT02672852|364456152|FG006|Part B|Withdrawal by Subject|7|||
105670055|NCT02672852|364456146|FG000|Part B|Other|0|||
105670056|NCT02672852|364456147|FG001|Part B|Other|0|||
105670057|NCT02672852|364456148|FG002|Part B|Other|0|||
105670058|NCT02672852|364456149|FG003|Part B|Other|0|||
105670059|NCT02672852|364456150|FG004|Part B|Other|4|||
105670060|NCT02672852|364456151|FG005|Part B|Other|1|||
105670061|NCT02672852|364456152|FG006|Part B|Other|2|||
105670062|NCT04958642|364456153|FG000|Overall Study|Transferred to OLEX program|3|||
105670063|NCT04958642|364456154|FG001|Overall Study|Transferred to OLEX program|0|||
105670064|NCT04958642|364456155|FG002|Overall Study|Transferred to OLEX program|5|||
105670065|NCT04958642|364456153|FG000|Overall Study|Death|0|||
105670066|NCT04958642|364456154|FG001|Overall Study|Death|0|||
105670067|NCT04958642|364456155|FG002|Overall Study|Death|1|||
105670068|NCT04958642|364456153|FG000|Overall Study|Withdrawal by Subject|4|||
105670069|NCT04958642|364456154|FG001|Overall Study|Withdrawal by Subject|9|||
105670070|NCT04958642|364456155|FG002|Overall Study|Withdrawal by Subject|13|||
105670071|NCT04958642|364456153|FG000|Overall Study|Investigator's Decision|0|||
105670072|NCT04958642|364456154|FG001|Overall Study|Investigator's Decision|0|||
105786152|NCT03635788|364870451|FG000|Step 2|Switched To Injectables|0|||
105670073|NCT04958642|364456155|FG002|Overall Study|Investigator's Decision|1|||
105670074|NCT04958642|364456153|FG000|Overall Study|Adverse Event|1|||
105670075|NCT04958642|364456154|FG001|Overall Study|Adverse Event|0|||
105670076|NCT04958642|364456155|FG002|Overall Study|Adverse Event|1|||
105670077|NCT04958642|364456153|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
105670078|NCT04958642|364456154|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
105670079|NCT04958642|364456155|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
105670080|NCT04958642|364456153|FG000|Overall Study|Lost to Follow-up|1|||
105670081|NCT04958642|364456154|FG001|Overall Study|Lost to Follow-up|0|||
105670082|NCT04958642|364456155|FG002|Overall Study|Lost to Follow-up|0|||
105670083|NCT04958642|364456153|FG000|Overall Study|Transferred to EAP following study termination|0|||
105670084|NCT04958642|364456154|FG001|Overall Study|Transferred to EAP following study termination|0|||
105670085|NCT04958642|364456155|FG002|Overall Study|Transferred to EAP following study termination|1|||
105670086|NCT04958642|364456153|FG000|Overall Study|Transferred to Expanded Access Program|1|||
105786153|NCT03635788|364870452|FG001|Step 2|Switched To Injectables|0|||
105554092|NCT01292603|364027328|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
105786154|NCT03635788|364870453|FG002|Step 2|Switched To Injectables|1|||
105786155|NCT03635788|364870451|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
105786156|NCT03635788|364870452|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
105342041|NCT02407457|363253654|FG000|2-year|Death|14|||
105342042|NCT02407457|363253655|FG001|2-year|Death|8|||
105342043|NCT02407457|363253654|FG000|2-year|Lost to Follow-up|7|||
105342044|NCT02407457|363253655|FG001|2-year|Lost to Follow-up|10|||
105342045|NCT02407457|363253654|FG000|2-year|Missed Visit|13|||
105342046|NCT02407457|363253655|FG001|2-year|Missed Visit|15|||
105342047|NCT02407457|363253654|FG000|2-year|Open Repair|0|||
105342048|NCT02407457|363253655|FG001|2-year|Open Repair|2|||
105342049|NCT02407457|363253654|FG000|3-year|Death|11|||
105342050|NCT02407457|363253655|FG001|3-year|Death|10|||
105342051|NCT02407457|363253654|FG000|3-year|Lost to Follow-up|9|||
105342052|NCT02407457|363253655|FG001|3-year|Lost to Follow-up|10|||
105342053|NCT02407457|363253654|FG000|3-year|Missed Visit|19|||
105342054|NCT02407457|363253655|FG001|3-year|Missed Visit|16|||
105342055|NCT02407457|363253654|FG000|4-year|Death|18|||
105342056|NCT02407457|363253655|FG001|4-year|Death|10|||
105342057|NCT02407457|363253654|FG000|4-year|Lost to Follow-up|10|||
105342058|NCT02407457|363253655|FG001|4-year|Lost to Follow-up|12|||
105342059|NCT02407457|363253654|FG000|4-year|Missed Visit|18|||
105342060|NCT02407457|363253655|FG001|4-year|Missed Visit|16|||
105342061|NCT02407457|363253654|FG000|5-year|Death|10|||
105342062|NCT02407457|363253655|FG001|5-year|Death|3|||
105342063|NCT02407457|363253654|FG000|5-year|Lost to Follow-up|22|||
105342064|NCT02407457|363253655|FG001|5-year|Lost to Follow-up|13|||
105342065|NCT02407457|363253654|FG000|5-year|Missed Visit|9|||
105342066|NCT02407457|363253655|FG001|5-year|Missed Visit|1|||
105342067|NCT03419598|363253656|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
105342068|NCT01740128|363253657|FG000|Overall Study|Pregnancy|0|||
105342069|NCT01740128|363253658|FG001|Overall Study|Pregnancy|1|||
105342070|NCT01740128|363253657|FG000|Overall Study|Protocol Violation|1|||
105342071|NCT01740128|363253658|FG001|Overall Study|Protocol Violation|2|||
105342072|NCT01740128|363253657|FG000|Overall Study|Lost to Follow-up|2|||
105342073|NCT01740128|363253658|FG001|Overall Study|Lost to Follow-up|2|||
105342074|NCT01740128|363253657|FG000|Overall Study|Withdrawal by Subject|1|||
105342075|NCT01740128|363253658|FG001|Overall Study|Withdrawal by Subject|0|||
105342076|NCT01740128|363253657|FG000|Overall Study|Insufficient protocol compliance|2|||
105342077|NCT01740128|363253658|FG001|Overall Study|Insufficient protocol compliance|2|||
105342078|NCT01041976|363253659|FG000|Overall Study|Withdrawal by Subject|3|||
105342079|NCT01041976|363253660|FG001|Overall Study|Withdrawal by Subject|0|||
105342080|NCT01041976|363253659|FG000|Overall Study|Incarceration|2|||
105342081|NCT01041976|363253660|FG001|Overall Study|Incarceration|0|||
105342082|NCT01041976|363253659|FG000|Overall Study|Death|0|||
105342083|NCT01041976|363253660|FG001|Overall Study|Death|4|||
105342084|NCT00380081|363253661|FG000|Overall Study|Withdrawal by Subject|0|||
105342085|NCT00380081|363253662|FG001|Overall Study|Withdrawal by Subject|0|||
105342086|NCT00380081|363253663|FG002|Overall Study|Withdrawal by Subject|0|||
105342087|NCT00380081|363253664|FG003|Overall Study|Withdrawal by Subject|0|||
105342088|NCT00380081|363253665|FG004|Overall Study|Withdrawal by Subject|1|||
105554093|NCT01292603|364027323|FG000|Part 1: Regular Follow-Up Period|Death|3|||
105554094|NCT01292603|364027324|FG001|Part 1: Regular Follow-Up Period|Death|1|||
105554095|NCT01292603|364027325|FG002|Part 1: Regular Follow-Up Period|Death|3|||
105554096|NCT01292603|364027326|FG003|Part 1: Regular Follow-Up Period|Death|1|||
105554097|NCT01292603|364027327|FG004|Part 1: Regular Follow-Up Period|Death|0|||
105554098|NCT01292603|364027328|FG005|Part 1: Regular Follow-Up Period|Death|0|||
105554099|NCT01292603|364027323|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
105554100|NCT01292603|364027324|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
105554101|NCT01292603|364027325|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
105554102|NCT01292603|364027326|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
105554103|NCT01292603|364027327|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
105554104|NCT01292603|364027328|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
105554105|NCT01292603|364027323|FG000|Part 2: Dose Confirmation Period|Death|0|||
105554106|NCT01292603|364027324|FG001|Part 2: Dose Confirmation Period|Death|0|||
105342089|NCT00380081|363253666|FG005|Overall Study|Withdrawal by Subject|0|||
105342090|NCT00380081|363253661|FG000|Overall Study|Family Emergency|0|||
105342091|NCT00380081|363253662|FG001|Overall Study|Family Emergency|0|||
105342092|NCT00380081|363253663|FG002|Overall Study|Family Emergency|0|||
105342093|NCT00380081|363253664|FG003|Overall Study|Family Emergency|0|||
105342094|NCT00380081|363253665|FG004|Overall Study|Family Emergency|0|||
105554107|NCT01292603|364027325|FG002|Part 2: Dose Confirmation Period|Death|0|||
105342095|NCT00380081|363253666|FG005|Overall Study|Family Emergency|1|||
105554108|NCT01292603|364027326|FG003|Part 2: Dose Confirmation Period|Death|0|||
105342096|NCT00189306|363253668|FG000|Treatment Period|Withdrawal by Subject|2|||
105342097|NCT00189306|363253668|FG000|Treatment Period|Adverse Event|2|||
105342098|NCT00189306|363253668|FG000|Treatment Period|Protocol Violation|1|||
105342099|NCT00189306|363253668|FG000|Posttreatment Period|Death|1|||
105670087|NCT04958642|364456154|FG001|Overall Study|Transferred to Expanded Access Program|0|||
105670088|NCT04958642|364456155|FG002|Overall Study|Transferred to Expanded Access Program|0|||
105670089|NCT03853551|364456161|FG000|Overall Study|Death|2|||
105670090|NCT03853551|364456161|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
105670091|NCT03338296|364456162|FG000|Overall Study|Adverse Event|0|||
105670092|NCT03338296|364456163|FG001|Overall Study|Adverse Event|1|||
105670093|NCT03338296|364456162|FG000|Overall Study|Withdrawal by Subject|14|||
105670094|NCT03338296|364456163|FG001|Overall Study|Withdrawal by Subject|13|||
105670095|NCT03338296|364456162|FG000|Overall Study|Lost to Follow-up|10|||
105670096|NCT03338296|364456163|FG001|Overall Study|Lost to Follow-up|10|||
105670097|NCT03338296|364456162|FG000|Overall Study|Study Terminated by Sponsor|77|||
105670098|NCT03338296|364456163|FG001|Overall Study|Study Terminated by Sponsor|76|||
105670099|NCT03338296|364456162|FG000|Overall Study|Other|2|||
105670100|NCT03338296|364456163|FG001|Overall Study|Other|7|||
105670101|NCT03338296|364456162|FG000|Overall Study|Missing|0|||
105670102|NCT03338296|364456163|FG001|Overall Study|Missing|1|||
105670103|NCT01923467|364456166|FG000|Overall Study|Lost to Follow-up|62|||
105670104|NCT01923467|364456166|FG000|Overall Study|Subject non-interest|479|||
105670105|NCT03921723|364456167|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
105670106|NCT03921723|364456167|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
105670107|NCT03015129|364456168|FG000|Overall Study|Death|2|||
105670108|NCT03015129|364456169|FG001|Overall Study|Death|2|||
105670109|NCT03015129|364456168|FG000|Overall Study|Lost to Follow-up|0|||
105670110|NCT03015129|364456169|FG001|Overall Study|Lost to Follow-up|1|||
105670111|NCT03015129|364456168|FG000|Overall Study|Progression of disease|38|||
105670112|NCT03015129|364456169|FG001|Overall Study|Progression of disease|33|||
105670113|NCT03015129|364456168|FG000|Overall Study|Adverse Event|0|||
105670114|NCT03015129|364456169|FG001|Overall Study|Adverse Event|4|||
105786157|NCT03635788|364870453|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
105786158|NCT04089566|364870457|FG000|Overall Study|Death|0|||
105786159|NCT04089566|364870458|FG001|Overall Study|Death|6|||
105670115|NCT04076943|364456176|FG000|Overall Study|Withdrawal by Subject|12|||
105670116|NCT04076943|364456176|FG000|Overall Study|Adverse Event|1|||
105670117|NCT04076943|364456176|FG000|Overall Study|Progressive Disease|2|||
105670118|NCT04076943|364456176|FG000|Overall Study|Death|13|||
105670119|NCT04076943|364456176|FG000|Overall Study|Other than specified|6|||
105670120|NCT01075958|364456180|FG000|Overall Study|Blood sample could not be obtained|44|||
105670121|NCT03596762|364456181|FG000|Overall Study|Protocol Violation|0|||
105670122|NCT03596762|364456182|FG001|Overall Study|Protocol Violation|0|||
105670123|NCT03596762|364456183|FG002|Overall Study|Protocol Violation|0|||
105670124|NCT03596762|364456184|FG003|Overall Study|Protocol Violation|0|||
105670125|NCT03596762|364456185|FG004|Overall Study|Protocol Violation|1|||
105670126|NCT03596762|364456181|FG000|Overall Study|Adverse Event|2|||
105670127|NCT03596762|364456182|FG001|Overall Study|Adverse Event|0|||
105670128|NCT03596762|364456183|FG002|Overall Study|Adverse Event|1|||
105670129|NCT03596762|364456184|FG003|Overall Study|Adverse Event|0|||
105670130|NCT03596762|364456185|FG004|Overall Study|Adverse Event|5|||
105670131|NCT03596762|364456181|FG000|Overall Study|Withdrawal by Subject|2|||
105670132|NCT03596762|364456182|FG001|Overall Study|Withdrawal by Subject|1|||
105670133|NCT03596762|364456183|FG002|Overall Study|Withdrawal by Subject|0|||
105670134|NCT03596762|364456184|FG003|Overall Study|Withdrawal by Subject|1|||
105670135|NCT03596762|364456185|FG004|Overall Study|Withdrawal by Subject|1|||
105670136|NCT02510040|364456186|FG000|Overall Study|Deemed no longer eligible|18|||
105670137|NCT02510040|364456187|FG001|Overall Study|Deemed no longer eligible|3|||
105670138|NCT02510040|364456188|FG002|Overall Study|Deemed no longer eligible|1|||
105786160|NCT04089566|364870459|FG002|Overall Study|Death|10|||
105786161|NCT04089566|364870460|FG003|Overall Study|Death|0|||
105786162|NCT04089566|364870461|FG004|Overall Study|Death|0|||
105786163|NCT04089566|364870462|FG005|Overall Study|Death|0|||
105786164|NCT04089566|364870457|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
105786165|NCT04089566|364870458|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
105786166|NCT04089566|364870459|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
105786167|NCT04089566|364870460|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
105670139|NCT03174431|364456189|FG000|Overall Study|Withdrawal by Subject|14|||
105670140|NCT03174431|364456190|FG001|Overall Study|Withdrawal by Subject|11|||
105670141|NCT03174431|364456189|FG000|Overall Study|alternative treatment|2|||
105670142|NCT03174431|364456190|FG001|Overall Study|alternative treatment|0|||
105670143|NCT03174431|364456189|FG000|Overall Study|Lost to Follow-up|1|||
105670144|NCT03174431|364456190|FG001|Overall Study|Lost to Follow-up|5|||
105670145|NCT01031628|364456191|FG000|Overall Study|Study terminated early|0|||
105670146|NCT01031628|364456192|FG001|Overall Study|Study terminated early|1|||
105670147|NCT01031628|364456193|FG002|Overall Study|Study terminated early|3|||
105670148|NCT01031628|364456194|FG003|Overall Study|Study terminated early|0|||
105670149|NCT00643617|364456195|FG000|Overall Study|Death|6|||
105670150|NCT00643617|364456196|FG001|Overall Study|Death|9|||
105670151|NCT00643617|364456195|FG000|Overall Study|Lost to Follow-up|42|||
105670152|NCT00643617|364456196|FG001|Overall Study|Lost to Follow-up|51|||
105670153|NCT02593123|364456199|FG000|Overall Study|Physician Decision|2|||
105670154|NCT02593123|364456200|FG001|Overall Study|Physician Decision|1|||
105670155|NCT02593123|364456199|FG000|Overall Study|Relapse|1|||
105670156|NCT02593123|364456200|FG001|Overall Study|Relapse|1|||
105670157|NCT00416195|364456201|FG000|Overall Study|Adverse Event|1|||
105670158|NCT00416195|364456202|FG001|Overall Study|Adverse Event|2|||
105670159|NCT00416195|364456201|FG000|Overall Study|Protocol Violation|1|||
105670160|NCT00416195|364456202|FG001|Overall Study|Protocol Violation|1|||
105670161|NCT00416195|364456201|FG000|Overall Study|Other|0|||
105670162|NCT00416195|364456202|FG001|Overall Study|Other|1|||
105670163|NCT01417104|364456205|FG000|Overall Study|Withdrawal by Subject|5|||
105670164|NCT01417104|364456206|FG001|Overall Study|Withdrawal by Subject|1|||
105670165|NCT01417104|364456205|FG000|Overall Study|Failure to make contact|0|||
105670166|NCT01417104|364456206|FG001|Overall Study|Failure to make contact|1|||
105670167|NCT01417104|364456205|FG000|Overall Study|Adverse Event|1|||
105670168|NCT01417104|364456206|FG001|Overall Study|Adverse Event|0|||
105670169|NCT01401153|364456208|FG000|First Test Day|Learning disabilities; illness|1|||
105670170|NCT01401153|364456209|FG001|First Test Day|Learning disabilities; illness|10|||
105670171|NCT01401153|364456208|FG000|Second Test Day|illness|0|||
105670172|NCT01401153|364456209|FG001|Second Test Day|illness|5|||
105670173|NCT01754753|364456214|FG000|Overall Study|Study close|43|||
105670174|NCT01754753|364456215|FG001|Overall Study|Study close|44|||
105670175|NCT01754753|364456214|FG000|Overall Study|Lost to Follow-up|9|||
105670176|NCT01754753|364456215|FG001|Overall Study|Lost to Follow-up|5|||
105670177|NCT01250509|364456216|FG000|Overall Study|Lost to Follow-up|5|||
105670178|NCT01250509|364456217|FG001|Overall Study|Lost to Follow-up|2|||
105670179|NCT01067846|364456221|FG000|Overall Study|Lost to Follow-up|17|||
105670180|NCT01067846|364456222|FG001|Overall Study|Lost to Follow-up|19|||
105670181|NCT01067846|364456221|FG000|Overall Study|Withdrawal by Subject|1|||
105670182|NCT01067846|364456222|FG001|Overall Study|Withdrawal by Subject|0|||
105670183|NCT01067846|364456221|FG000|Overall Study|participation in other tx study|1|||
105670184|NCT01067846|364456222|FG001|Overall Study|participation in other tx study|0|||
105670185|NCT03686423|364456223|FG000|Overall Study|Withdrawal by Subject|9|||
105670186|NCT03686423|364456223|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
105670187|NCT00387426|364457995|FG000|Overall Study|Lack of Response|7|||
105670188|NCT00387426|364457995|FG000|Overall Study|Toxicities|4|||
105670189|NCT00387426|364457995|FG000|Overall Study|Disease Progression|3|||
105670190|NCT02218606|364457996|FG000|Overall Study|Adverse Event|1|||
105670191|NCT02218606|364457997|FG001|Overall Study|Adverse Event|1|||
105670192|NCT02218606|364457996|FG000|Overall Study|Death|15|||
105670193|NCT02218606|364457997|FG001|Overall Study|Death|28|||
105670194|NCT02218606|364457996|FG000|Overall Study|Physician Decision|0|||
105670195|NCT02218606|364457997|FG001|Overall Study|Physician Decision|1|||
105670196|NCT02218606|364457996|FG000|Overall Study|Withdrawal by Subject|4|||
105670197|NCT02218606|364457997|FG001|Overall Study|Withdrawal by Subject|0|||
105670198|NCT02218606|364457996|FG000|Overall Study|Noncompliance|1|||
105670199|NCT02218606|364457997|FG001|Overall Study|Noncompliance|0|||
105670200|NCT02218606|364457996|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
105670201|NCT02218606|364457997|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
105670202|NCT02218606|364457996|FG000|Overall Study|Other|2|||
105670203|NCT02218606|364457997|FG001|Overall Study|Other|1|||
105670204|NCT02218606|364457996|FG000|Overall Study|Never started treatment|0|||
105670205|NCT02218606|364457997|FG001|Overall Study|Never started treatment|1|||
105670206|NCT03203473|364457998|FG000|Induction Phase|Never started primary treatment|2|||
105670207|NCT03203473|364457999|FG001|Induction Phase|Never started primary treatment|0|||
105670208|NCT03203473|364458000|FG002|Induction Phase|Never started primary treatment|0|||
105670209|NCT03203473|364457998|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
105670210|NCT03203473|364457999|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
105670211|NCT03203473|364458000|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
105670212|NCT03203473|364457998|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
105670213|NCT03203473|364457999|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
105670214|NCT03203473|364458000|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
105670215|NCT03203473|364457998|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
105670216|NCT03203473|364457999|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
105670217|NCT03203473|364458000|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
105670218|NCT03203473|364457998|FG000|Arm Allocation Phase|started salvage therapy|0|||
105670219|NCT03203473|364457999|FG001|Arm Allocation Phase|started salvage therapy|5|||
105670220|NCT03203473|364458000|FG002|Arm Allocation Phase|started salvage therapy|0|||
105670221|NCT03203473|364457998|FG000|Arm Allocation Phase|Disease progression|0|||
105670222|NCT03203473|364457999|FG001|Arm Allocation Phase|Disease progression|0|||
105670223|NCT03203473|364458000|FG002|Arm Allocation Phase|Disease progression|37|||
105670224|NCT03203473|364457998|FG000|Arm Allocation Phase|Adverse Event|0|||
105670225|NCT03203473|364457999|FG001|Arm Allocation Phase|Adverse Event|0|||
105670226|NCT03203473|364458000|FG002|Arm Allocation Phase|Adverse Event|11|||
105670227|NCT03203473|364457998|FG000|Arm Allocation Phase|Physician Decision|0|||
105670228|NCT03203473|364457999|FG001|Arm Allocation Phase|Physician Decision|0|||
105670229|NCT03203473|364458000|FG002|Arm Allocation Phase|Physician Decision|3|||
105670230|NCT03203473|364457998|FG000|Arm Allocation Phase|Death|0|||
105670231|NCT03203473|364457999|FG001|Arm Allocation Phase|Death|0|||
105670232|NCT03203473|364458000|FG002|Arm Allocation Phase|Death|1|||
105670233|NCT03203473|364457998|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
105670234|NCT03203473|364457999|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
105670235|NCT03203473|364458000|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
105670236|NCT03203473|364457998|FG000|Arm Allocation Phase|Intercurrent illness|0|||
105670237|NCT03203473|364457999|FG001|Arm Allocation Phase|Intercurrent illness|0|||
105670238|NCT03203473|364458000|FG002|Arm Allocation Phase|Intercurrent illness|1|||
105670239|NCT03203473|364457998|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
105670240|NCT03203473|364457999|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
105670241|NCT03203473|364458000|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
105670242|NCT03554629|364458001|FG000|Overall Study|Inadequate data|6|||
105670243|NCT00918879|364458002|FG000|Overall Study|Withdrawal by Subject|4|||
105670244|NCT00918879|364458003|FG001|Overall Study|Withdrawal by Subject|4|||
105670245|NCT00918879|364458002|FG000|Overall Study|Lost to Follow-up|1|||
105670246|NCT00918879|364458003|FG001|Overall Study|Lost to Follow-up|1|||
105670247|NCT00918879|364458002|FG000|Overall Study|Severe non-compliance to protocol|1|||
105670248|NCT00918879|364458003|FG001|Overall Study|Severe non-compliance to protocol|1|||
105670249|NCT04707664|364458006|FG000|Overall Study|Adverse Event|2|||
105670250|NCT04707664|364458007|FG001|Overall Study|Adverse Event|0|||
105670251|NCT04707664|364458006|FG000|Overall Study|Death|1|||
105670252|NCT04707664|364458007|FG001|Overall Study|Death|2|||
105670253|NCT04707664|364458006|FG000|Overall Study|Withdrawal by Subject|13|||
105670254|NCT04707664|364458007|FG001|Overall Study|Withdrawal by Subject|21|||
105670255|NCT04707664|364458006|FG000|Overall Study|Lost to Follow-up|11|||
105670256|NCT04707664|364458007|FG001|Overall Study|Lost to Follow-up|13|||
105670257|NCT04707664|364458006|FG000|Overall Study|Not treated|2|||
105670258|NCT04707664|364458007|FG001|Overall Study|Not treated|0|||
105670259|NCT02412735|364458008|FG000|Overall Study|Adverse Event|0|||
105670260|NCT02412735|364458009|FG001|Overall Study|Adverse Event|1|||
105670261|NCT02412735|364458010|FG002|Overall Study|Adverse Event|2|||
105670262|NCT02412735|364458008|FG000|Overall Study|Withdrawal by Subject|23|||
105670263|NCT02412735|364458009|FG001|Overall Study|Withdrawal by Subject|27|||
105670264|NCT02412735|364458010|FG002|Overall Study|Withdrawal by Subject|22|||
105670265|NCT02412735|364458008|FG000|Overall Study|Investigator Decision|3|||
105670266|NCT02412735|364458009|FG001|Overall Study|Investigator Decision|3|||
105670267|NCT02412735|364458010|FG002|Overall Study|Investigator Decision|2|||
105670268|NCT02412735|364458008|FG000|Overall Study|Lost to Follow-up|17|||
105670269|NCT02412735|364458009|FG001|Overall Study|Lost to Follow-up|11|||
105670270|NCT02412735|364458010|FG002|Overall Study|Lost to Follow-up|18|||
105670271|NCT02412735|364458008|FG000|Overall Study|Reason not Specified|3|||
105670272|NCT02412735|364458009|FG001|Overall Study|Reason not Specified|2|||
105670273|NCT02412735|364458010|FG002|Overall Study|Reason not Specified|2|||
105670274|NCT05602727|364458018|FG000|Overall Study|Physician Decision|0|||
105670275|NCT05602727|364458019|FG001|Overall Study|Physician Decision|1|||
105670276|NCT05602727|364458020|FG002|Overall Study|Physician Decision|0|||
105670277|NCT05602727|364458018|FG000|Overall Study|Randomized by mistake without study medication|1|||
105670278|NCT05602727|364458019|FG001|Overall Study|Randomized by mistake without study medication|0|||
105670279|NCT05602727|364458020|FG002|Overall Study|Randomized by mistake without study medication|0|||
105670280|NCT05602727|364458018|FG000|Overall Study|Study termination by Sponsor|18|||
105670281|NCT05602727|364458019|FG001|Overall Study|Study termination by Sponsor|15|||
105670282|NCT05602727|364458020|FG002|Overall Study|Study termination by Sponsor|19|||
105670283|NCT05602727|364458018|FG000|Overall Study|Withdrawal by Subject|2|||
105670284|NCT05602727|364458019|FG001|Overall Study|Withdrawal by Subject|1|||
105670285|NCT05602727|364458020|FG002|Overall Study|Withdrawal by Subject|1|||
105670286|NCT05602727|364458018|FG000|Overall Study|Various reasons|1|||
105670287|NCT05602727|364458019|FG001|Overall Study|Various reasons|6|||
105466570|NCT05375760|363720180|FG000|Overall Study|Withdrawal by Subject|17|||
105670288|NCT05602727|364458020|FG002|Overall Study|Various reasons|1|||
105670289|NCT03330405|364458021|FG000|Overall Study|Other|1|||
105670290|NCT03330405|364458022|FG001|Overall Study|Other|3|||
105670291|NCT03330405|364458023|FG002|Overall Study|Other|1|||
105670292|NCT03330405|364458024|FG003|Overall Study|Other|0|||
105670293|NCT03330405|364458025|FG004|Overall Study|Other|2|||
105670294|NCT03330405|364458026|FG005|Overall Study|Other|0|||
105670295|NCT03330405|364458027|FG006|Overall Study|Other|1|||
105670296|NCT03330405|364458028|FG007|Overall Study|Other|0|||
105670297|NCT03330405|364458029|FG008|Overall Study|Other|0|||
105670298|NCT03330405|364458030|FG009|Overall Study|Other|0|||
105670299|NCT03330405|364458031|FG010|Overall Study|Other|0|||
105670300|NCT03330405|364458021|FG000|Overall Study|Progressive disease|8|||
105670301|NCT03330405|364458022|FG001|Overall Study|Progressive disease|27|||
105670302|NCT03330405|364458023|FG002|Overall Study|Progressive disease|4|||
105670303|NCT03330405|364458024|FG003|Overall Study|Progressive disease|18|||
105670304|NCT03330405|364458025|FG004|Overall Study|Progressive disease|16|||
105670305|NCT03330405|364458026|FG005|Overall Study|Progressive disease|14|||
105670306|NCT03330405|364458027|FG006|Overall Study|Progressive disease|7|||
105670307|NCT03330405|364458028|FG007|Overall Study|Progressive disease|29|||
105670308|NCT03330405|364458029|FG008|Overall Study|Progressive disease|9|||
105670309|NCT03330405|364458030|FG009|Overall Study|Progressive disease|11|||
105670310|NCT03330405|364458031|FG010|Overall Study|Progressive disease|5|||
105670311|NCT03330405|364458021|FG000|Overall Study|Withdrawal by Subject|1|||
105670312|NCT03330405|364458022|FG001|Overall Study|Withdrawal by Subject|4|||
105670313|NCT03330405|364458023|FG002|Overall Study|Withdrawal by Subject|0|||
105670314|NCT03330405|364458024|FG003|Overall Study|Withdrawal by Subject|1|||
105670315|NCT03330405|364458025|FG004|Overall Study|Withdrawal by Subject|1|||
105670316|NCT03330405|364458026|FG005|Overall Study|Withdrawal by Subject|1|||
105670317|NCT03330405|364458027|FG006|Overall Study|Withdrawal by Subject|0|||
105670318|NCT03330405|364458028|FG007|Overall Study|Withdrawal by Subject|2|||
105670319|NCT03330405|364458029|FG008|Overall Study|Withdrawal by Subject|2|||
105670320|NCT03330405|364458030|FG009|Overall Study|Withdrawal by Subject|1|||
105670321|NCT03330405|364458031|FG010|Overall Study|Withdrawal by Subject|1|||
105342100|NCT00189306|363253668|FG000|Posttreatment Period|Withdrawal by Subject|2|||
105342101|NCT00189306|363253668|FG000|Posttreatment Period|Noncompliance|1|||
105342102|NCT00189306|363253668|FG000|Posttreatment Period|Target lesion excised|1|||
105342103|NCT00189306|363253668|FG000|Posttreatment Period|Protocol Violation|1|||
105342104|NCT00189306|363253668|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
105342105|NCT00189306|363253668|FG000|Posttreatment Period|Local skin reaction/sign|1|||
105342106|NCT00189306|363253668|FG000|Long-Term Follow-up|Adverse Event|2|||
105342107|NCT00189306|363253668|FG000|Long-Term Follow-up|Death|4|||
105342108|NCT00189306|363253668|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
105342109|NCT00189306|363253668|FG000|Long-Term Follow-up|Intercurrent disease|2|||
105342110|NCT00189306|363253668|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
105342111|NCT00189306|363253668|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
105342112|NCT01258075|363253680|FG000|Overall Study|Adverse Event|8|||
105342113|NCT01258075|363253681|FG001|Overall Study|Adverse Event|3|||
105342114|NCT01258075|363253680|FG000|Overall Study|Lost to Follow-up|11|||
105342115|NCT01258075|363253681|FG001|Overall Study|Lost to Follow-up|6|||
105342116|NCT01258075|363253680|FG000|Overall Study|Withdrawal by Subject|10|||
105342117|NCT01258075|363253681|FG001|Overall Study|Withdrawal by Subject|7|||
105342118|NCT01258075|363253680|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
105342119|NCT01258075|363253681|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
105342120|NCT01258075|363253680|FG000|Overall Study|Other|12|||
105342121|NCT01258075|363253681|FG001|Overall Study|Other|5|||
105342122|NCT02880865|363253684|FG000|Overall Study|Adverse Event|1|||
105342123|NCT02880865|363253685|FG001|Overall Study|Adverse Event|0|||
105342124|NCT02880865|363253684|FG000|Overall Study|Withdrawal by Subject|0|||
105342125|NCT02880865|363253685|FG001|Overall Study|Withdrawal by Subject|2|||
105342126|NCT02880865|363253684|FG000|Overall Study|Physician Decision|0|||
105342127|NCT02880865|363253685|FG001|Overall Study|Physician Decision|1|||
105342128|NCT01032239|363253686|FG000|Overall Study|Lost to Follow-up|3|||
105342129|NCT01032239|363253687|FG001|Overall Study|Lost to Follow-up|2|||
105342130|NCT01032239|363253686|FG000|Overall Study|Withdrawal by Subject|2|||
105342131|NCT01032239|363253687|FG001|Overall Study|Withdrawal by Subject|3|||
105342132|NCT01032239|363253686|FG000|Overall Study|Death|1|||
105342133|NCT01032239|363253687|FG001|Overall Study|Death|0|||
105342134|NCT01032239|363253686|FG000|Overall Study|Protocol Violation|1|||
105342135|NCT01032239|363253687|FG001|Overall Study|Protocol Violation|0|||
105670322|NCT03330405|364458021|FG000|Overall Study|Global deterioration of health status|2|||
105342136|NCT01940900|363253690|FG000|Overall Study|Physician Decision|4|||
105342137|NCT01940900|363253691|FG001|Overall Study|Physician Decision|0|||
105342138|NCT01940900|363253690|FG000|Overall Study|Adverse Event|10|||
105342139|NCT01940900|363253691|FG001|Overall Study|Adverse Event|15|||
105670323|NCT03330405|364458022|FG001|Overall Study|Global deterioration of health status|3|||
105670324|NCT03330405|364458023|FG002|Overall Study|Global deterioration of health status|0|||
105670325|NCT03330405|364458024|FG003|Overall Study|Global deterioration of health status|2|||
105670326|NCT03330405|364458025|FG004|Overall Study|Global deterioration of health status|3|||
105670327|NCT03330405|364458026|FG005|Overall Study|Global deterioration of health status|3|||
105670328|NCT03330405|364458027|FG006|Overall Study|Global deterioration of health status|0|||
105670329|NCT03330405|364458028|FG007|Overall Study|Global deterioration of health status|2|||
105670330|NCT03330405|364458029|FG008|Overall Study|Global deterioration of health status|8|||
105670331|NCT03330405|364458030|FG009|Overall Study|Global deterioration of health status|4|||
105670332|NCT03330405|364458031|FG010|Overall Study|Global deterioration of health status|1|||
105670333|NCT03330405|364458021|FG000|Overall Study|Adverse Event|0|||
105670334|NCT03330405|364458022|FG001|Overall Study|Adverse Event|1|||
105670335|NCT03330405|364458023|FG002|Overall Study|Adverse Event|0|||
105670336|NCT03330405|364458024|FG003|Overall Study|Adverse Event|1|||
105670337|NCT03330405|364458025|FG004|Overall Study|Adverse Event|1|||
105670338|NCT03330405|364458026|FG005|Overall Study|Adverse Event|1|||
105670339|NCT03330405|364458027|FG006|Overall Study|Adverse Event|3|||
105670340|NCT03330405|364458028|FG007|Overall Study|Adverse Event|4|||
105670341|NCT03330405|364458029|FG008|Overall Study|Adverse Event|2|||
105670342|NCT03330405|364458030|FG009|Overall Study|Adverse Event|2|||
105670343|NCT03330405|364458031|FG010|Overall Study|Adverse Event|2|||
105670344|NCT03330405|364458021|FG000|Overall Study|Death|0|||
105670345|NCT03330405|364458022|FG001|Overall Study|Death|4|||
105670346|NCT03330405|364458023|FG002|Overall Study|Death|0|||
105670347|NCT03330405|364458024|FG003|Overall Study|Death|0|||
105670348|NCT03330405|364458025|FG004|Overall Study|Death|0|||
105670349|NCT03330405|364458026|FG005|Overall Study|Death|1|||
105670350|NCT03330405|364458027|FG006|Overall Study|Death|0|||
105670351|NCT03330405|364458028|FG007|Overall Study|Death|2|||
105670352|NCT03330405|364458029|FG008|Overall Study|Death|0|||
105670353|NCT03330405|364458030|FG009|Overall Study|Death|0|||
105670354|NCT03330405|364458031|FG010|Overall Study|Death|0|||
105670355|NCT03330405|364458021|FG000|Overall Study|Physician Decision|0|||
105670356|NCT03330405|364458022|FG001|Overall Study|Physician Decision|0|||
105670357|NCT03330405|364458023|FG002|Overall Study|Physician Decision|0|||
105342140|NCT01940900|363253690|FG000|Overall Study|Withdrawal by Subject|11|||
105670358|NCT03330405|364458024|FG003|Overall Study|Physician Decision|0|||
105670359|NCT03330405|364458025|FG004|Overall Study|Physician Decision|0|||
105670360|NCT03330405|364458026|FG005|Overall Study|Physician Decision|0|||
105670361|NCT03330405|364458027|FG006|Overall Study|Physician Decision|0|||
105670362|NCT03330405|364458028|FG007|Overall Study|Physician Decision|1|||
105670363|NCT03330405|364458029|FG008|Overall Study|Physician Decision|0|||
105670364|NCT03330405|364458030|FG009|Overall Study|Physician Decision|0|||
105670365|NCT03330405|364458031|FG010|Overall Study|Physician Decision|0|||
105670366|NCT03139604|364458032|FG000|Overall Study|Other|7|||
105670367|NCT03139604|364458033|FG001|Overall Study|Other|3|||
105670368|NCT03139604|364458032|FG000|Overall Study|Withdrawal by Subject|16|||
105670369|NCT03139604|364458033|FG001|Overall Study|Withdrawal by Subject|17|||
105670370|NCT03139604|364458032|FG000|Overall Study|Physician Decision|1|||
105670371|NCT03139604|364458033|FG001|Overall Study|Physician Decision|2|||
105670372|NCT03139604|364458032|FG000|Overall Study|Lost to Follow-up|3|||
105670373|NCT03139604|364458033|FG001|Overall Study|Lost to Follow-up|1|||
105670374|NCT03139604|364458032|FG000|Overall Study|Death|65|||
105670375|NCT03139604|364458033|FG001|Overall Study|Death|67|||
105670376|NCT03139604|364458032|FG000|Overall Study|Study Terminated by Sponsor|122|||
105670377|NCT03139604|364458033|FG001|Overall Study|Study Terminated by Sponsor|127|||
105670378|NCT03139604|364458032|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
105670379|NCT03139604|364458033|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
105670380|NCT02476175|364458036|FG000|Overall Study|Adverse Event|2|||
105670381|NCT00821587|364458037|FG000|Overall Study|Physician Decision|0|||
105670382|NCT00821587|364458038|FG001|Overall Study|Physician Decision|1|||
105670383|NCT02964325|364458039|FG000|Overall Study|Lost to Follow-up|3|||
105670384|NCT02964325|364458040|FG001|Overall Study|Lost to Follow-up|3|||
105670385|NCT02964325|364458039|FG000|Overall Study|Physician Decision|5|||
105670386|NCT02964325|364458040|FG001|Overall Study|Physician Decision|4|||
105670387|NCT02964325|364458039|FG000|Overall Study|Death|1|||
105670388|NCT02964325|364458040|FG001|Overall Study|Death|3|||
105670389|NCT02964325|364458039|FG000|Overall Study|Withdrawal by Subject|2|||
105670390|NCT02964325|364458040|FG001|Overall Study|Withdrawal by Subject|1|||
105670391|NCT02964325|364458039|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
105670392|NCT02964325|364458040|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
105670393|NCT01931098|364458041|FG000|Overall Study|Withdrawal by Subject|0|||
105670394|NCT01931098|364458042|FG001|Overall Study|Withdrawal by Subject|1|||
105670395|NCT01931098|364458041|FG000|Overall Study|Enrolled in different protocol|0|||
105786168|NCT04089566|364870461|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
105786169|NCT04089566|364870462|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
105786170|NCT04089566|364870457|FG000|Overall Study|Reason not Specified|0|||
105670396|NCT01931098|364458042|FG001|Overall Study|Enrolled in different protocol|1|||
105670397|NCT01931098|364458041|FG000|Overall Study|Unable to begin trmt:active infection|0|||
105670398|NCT01931098|364458042|FG001|Overall Study|Unable to begin trmt:active infection|1|||
105670399|NCT01931098|364458041|FG000|Overall Study|Refused further treatment|0|||
105670400|NCT01931098|364458042|FG001|Overall Study|Refused further treatment|1|||
105670401|NCT01712061|364458043|FG000|Overall Study|Adverse Event|4|||
105670402|NCT01712061|364458044|FG001|Overall Study|Adverse Event|9|||
105670403|NCT01712061|364458045|FG002|Overall Study|Adverse Event|5|||
105670404|NCT01712061|364458043|FG000|Overall Study|Death|0|||
105670405|NCT01712061|364458044|FG001|Overall Study|Death|0|||
105670406|NCT01712061|364458045|FG002|Overall Study|Death|1|||
105670407|NCT01712061|364458043|FG000|Overall Study|Lost to Follow-up|1|||
105670408|NCT01712061|364458044|FG001|Overall Study|Lost to Follow-up|0|||
105670409|NCT01712061|364458045|FG002|Overall Study|Lost to Follow-up|1|||
105670410|NCT01712061|364458043|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
105670411|NCT01712061|364458044|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
105670412|NCT01712061|364458045|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
105670413|NCT01712061|364458043|FG000|Overall Study|Medication Error Without Associated AE|0|||
105670414|NCT01712061|364458044|FG001|Overall Study|Medication Error Without Associated AE|1|||
105670415|NCT01712061|364458045|FG002|Overall Study|Medication Error Without Associated AE|0|||
105670416|NCT01712061|364458043|FG000|Overall Study|Withdrawal by Subject|1|||
105670417|NCT01712061|364458044|FG001|Overall Study|Withdrawal by Subject|7|||
105670418|NCT01712061|364458045|FG002|Overall Study|Withdrawal by Subject|1|||
105670419|NCT01712061|364458043|FG000|Overall Study|Other|0|||
105786171|NCT04089566|364870458|FG001|Overall Study|Reason not Specified|4|||
105670420|NCT01712061|364458044|FG001|Overall Study|Other|3|||
105670421|NCT01712061|364458045|FG002|Overall Study|Other|0|||
105786172|NCT04089566|364870459|FG002|Overall Study|Reason not Specified|4|||
105786173|NCT04089566|364870460|FG003|Overall Study|Reason not Specified|1|||
105670422|NCT02797080|364458046|FG000|Overall Study|Lost to Follow-up|1|||
105670423|NCT02797080|364458046|FG000|Overall Study|Withdrawal by Subject|1|||
105670424|NCT00879775|364458050|FG000|Overall Study|Lost to Follow-up|2|||
105670425|NCT00879775|364458051|FG001|Overall Study|Lost to Follow-up|1|||
105670426|NCT03819634|364458052|FG000|Overall Study|Physician Decision|2|||
105670427|NCT03019640|364458053|FG000|Overall Study|Screen Failures|4|||
105670428|NCT03019640|364458053|FG000|Overall Study|Adverse Event|3|||
105670429|NCT03019640|364458053|FG000|Overall Study|Participant Relapsed|1|||
105670430|NCT02683785|364458056|FG000|Overall Study|Withdrawal by Subject|1|||
105670431|NCT02683785|364458057|FG001|Overall Study|Withdrawal by Subject|1|||
105670432|NCT02683785|364458056|FG000|Overall Study|Lost to Follow-up|0|||
105670433|NCT02683785|364458057|FG001|Overall Study|Lost to Follow-up|1|||
105786174|NCT04089566|364870461|FG004|Overall Study|Reason not Specified|0|||
105670434|NCT02683785|364458056|FG000|Overall Study|Adverse Event|0|||
105670435|NCT02683785|364458057|FG001|Overall Study|Adverse Event|2|||
105342141|NCT01940900|363253691|FG001|Overall Study|Withdrawal by Subject|15|||
105342142|NCT01940900|363253690|FG000|Overall Study|Lost to Follow-up|1|||
105342143|NCT01940900|363253691|FG001|Overall Study|Lost to Follow-up|0|||
105342144|NCT01940900|363253690|FG000|Overall Study|Sponsor Decision|1|||
105342145|NCT01940900|363253691|FG001|Overall Study|Sponsor Decision|0|||
105342146|NCT01940900|363253690|FG000|Overall Study|subject non-compliance|1|||
105342147|NCT01940900|363253691|FG001|Overall Study|subject non-compliance|1|||
105342148|NCT01940900|363253690|FG000|Overall Study|other|1|||
105342149|NCT01940900|363253691|FG001|Overall Study|other|0|||
105342150|NCT04713592|363253694|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
105342151|NCT04713592|363253695|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
105342152|NCT04713592|363253696|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
105342153|NCT04713592|363253697|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
105342154|NCT04713592|363253694|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
105342155|NCT04713592|363253695|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
105342156|NCT04713592|363253696|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
105342157|NCT04713592|363253697|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
105342158|NCT04713592|363253694|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
105342159|NCT04713592|363253695|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
105342160|NCT04713592|363253696|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
105342161|NCT04713592|363253697|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
105342162|NCT04713592|363253694|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105342163|NCT04713592|363253695|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105342164|NCT04713592|363253696|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
105342165|NCT04713592|363253697|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
105342166|NCT04713592|363253694|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
105342167|NCT04713592|363253695|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
105342168|NCT04713592|363253696|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
105342169|NCT04713592|363253697|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
105342170|NCT04713592|363253694|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105342171|NCT04713592|363253695|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105342172|NCT04713592|363253696|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
105342173|NCT04713592|363253697|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
105342174|NCT04713592|363253694|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
105342175|NCT04713592|363253695|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
105342176|NCT04713592|363253696|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
105342177|NCT04713592|363253697|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
105342178|NCT01263782|363253698|FG000|Overall Study|Death|0|||
105342179|NCT01263782|363253699|FG001|Overall Study|Death|0|||
105342180|NCT01263782|363253700|FG002|Overall Study|Death|1|||
105342181|NCT01263782|363253701|FG003|Overall Study|Death|0|||
105342182|NCT01263782|363253698|FG000|Overall Study|Progressive disease|0|||
105342183|NCT01263782|363253699|FG001|Overall Study|Progressive disease|0|||
105342184|NCT01263782|363253700|FG002|Overall Study|Progressive disease|0|||
105342185|NCT01263782|363253701|FG003|Overall Study|Progressive disease|1|||
105342186|NCT01263782|363253698|FG000|Overall Study|Too early|0|||
105342187|NCT01263782|363253699|FG001|Overall Study|Too early|0|||
105466571|NCT05375760|363720181|FG001|Overall Study|Withdrawal by Subject|19|||
105342188|NCT01263782|363253700|FG002|Overall Study|Too early|1|||
105342189|NCT01263782|363253701|FG003|Overall Study|Too early|0|||
105554109|NCT01292603|364027327|FG004|Part 2: Dose Confirmation Period|Death|1|||
105554110|NCT01292603|364027328|FG005|Part 2: Dose Confirmation Period|Death|0|||
105554111|NCT01292603|364027323|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
105554112|NCT01292603|364027324|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
105554113|NCT01292603|364027325|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
105554114|NCT01292603|364027326|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
105554115|NCT01292603|364027327|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
105554116|NCT01292603|364027328|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
105554117|NCT01292603|364027323|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
105554118|NCT01292603|364027324|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
105554119|NCT01292603|364027325|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
105554120|NCT01292603|364027326|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
105554121|NCT01292603|364027327|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
105554122|NCT01292603|364027328|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
105554123|NCT01292603|364027323|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
105554124|NCT01292603|364027324|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
105554125|NCT01292603|364027325|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
105554126|NCT01292603|364027326|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
105554127|NCT01292603|364027327|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
105554128|NCT01292603|364027328|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
105554129|NCT01292603|364027323|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
105554130|NCT01292603|364027324|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
105554131|NCT01292603|364027325|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
105554132|NCT01292603|364027326|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
105342190|NCT01263782|363253698|FG000|Overall Study|Inevaluable|0|||
105342191|NCT01263782|363253699|FG001|Overall Study|Inevaluable|0|||
105342192|NCT01263782|363253700|FG002|Overall Study|Inevaluable|1|||
105342193|NCT01263782|363253701|FG003|Overall Study|Inevaluable|0|||
105342194|NCT00191282|363253704|FG000|Overall Study|Adverse Event|5|||
105342195|NCT00191282|363253705|FG001|Overall Study|Adverse Event|6|||
105342196|NCT00191282|363253704|FG000|Overall Study|Death|51|||
105342197|NCT00191282|363253705|FG001|Overall Study|Death|51|||
105342198|NCT00191282|363253704|FG000|Overall Study|Lack of Efficacy|11|||
105342199|NCT00191282|363253705|FG001|Overall Study|Lack of Efficacy|6|||
105342200|NCT00191282|363253704|FG000|Overall Study|Noncompliance|14|||
105342201|NCT00191282|363253705|FG001|Overall Study|Noncompliance|17|||
105342202|NCT00191282|363253704|FG000|Overall Study|Patient moved|11|||
105342203|NCT00191282|363253705|FG001|Overall Study|Patient moved|14|||
105342204|NCT00191282|363253704|FG000|Overall Study|Withdrawal by Subject|59|||
105342205|NCT00191282|363253705|FG001|Overall Study|Withdrawal by Subject|44|||
105342206|NCT00191282|363253704|FG000|Overall Study|Physician Decision|18|||
105342207|NCT00191282|363253705|FG001|Overall Study|Physician Decision|15|||
105342208|NCT00191282|363253704|FG000|Overall Study|Protocol entry criteria not met|14|||
105342209|NCT00191282|363253705|FG001|Overall Study|Protocol entry criteria not met|9|||
105342210|NCT00191282|363253704|FG000|Overall Study|Protocol Violation|9|||
105342211|NCT00191282|363253705|FG001|Overall Study|Protocol Violation|12|||
105342212|NCT00191282|363253704|FG000|Overall Study|Severity of outcome|2|||
105342213|NCT00191282|363253705|FG001|Overall Study|Severity of outcome|5|||
105342214|NCT00191282|363253704|FG000|Overall Study|Sponsor's decision|2|||
105342215|NCT00191282|363253705|FG001|Overall Study|Sponsor's decision|2|||
105342216|NCT00191282|363253704|FG000|Overall Study|Lost to Follow-up|24|||
105342217|NCT00191282|363253705|FG001|Overall Study|Lost to Follow-up|31|||
105342218|NCT02730377|363255346|FG000|Overall Study|Other|5|||
105342219|NCT02730377|363255347|FG001|Overall Study|Other|4|||
105342220|NCT02730377|363255346|FG000|Overall Study|Death|1|||
105342221|NCT02730377|363255347|FG001|Overall Study|Death|8|||
105466572|NCT05375760|363720180|FG000|Overall Study|Dosing halted by FDA|96|||
105466573|NCT05375760|363720181|FG001|Overall Study|Dosing halted by FDA|100|||
105466574|NCT05375760|363720180|FG000|Overall Study|Not compliant with study visit|2|||
105466575|NCT05375760|363720181|FG001|Overall Study|Not compliant with study visit|0|||
105466576|NCT05375760|363720180|FG000|Overall Study|Physician Decision|1|||
105466577|NCT05375760|363720181|FG001|Overall Study|Physician Decision|0|||
105466578|NCT05375760|363720180|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
105466579|NCT05375760|363720181|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
105466580|NCT05375760|363720180|FG000|Overall Study|Participant moved|1|||
105466581|NCT05375760|363720181|FG001|Overall Study|Participant moved|0|||
105466582|NCT00363480|363720182|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
105466583|NCT00363480|363720182|FG000|Overall Study|Adverse Event|4|||
105466584|NCT00363480|363720182|FG000|Overall Study|Lost to Follow-up|5|||
105466585|NCT00363480|363720182|FG000|Overall Study|Withdrawal by Subject|5|||
105466586|NCT00363480|363720182|FG000|Overall Study|Non-compliance of subject|1|||
105342222|NCT02730377|363255346|FG000|Overall Study|Inadequate glycaemic control|368|||
105342223|NCT02730377|363255347|FG001|Overall Study|Inadequate glycaemic control|473|||
105342224|NCT02730377|363255346|FG000|Overall Study|Adverse Event|79|||
105670436|NCT00299494|364458058|FG000|Overall Study|Withdrawal by Subject|0|||
105670437|NCT00299494|364458059|FG001|Overall Study|Withdrawal by Subject|0|||
105670438|NCT00299494|364458060|FG002|Overall Study|Withdrawal by Subject|0|||
105670439|NCT00299494|364458061|FG003|Overall Study|Withdrawal by Subject|3|||
105670440|NCT00299494|364458062|FG004|Overall Study|Withdrawal by Subject|1|||
105670441|NCT00299494|364458063|FG005|Overall Study|Withdrawal by Subject|4|||
105670442|NCT00299494|364458058|FG000|Overall Study|Physician Decision|0|||
105670443|NCT00299494|364458059|FG001|Overall Study|Physician Decision|0|||
105670444|NCT00299494|364458060|FG002|Overall Study|Physician Decision|0|||
105670445|NCT00299494|364458061|FG003|Overall Study|Physician Decision|0|||
105670446|NCT00299494|364458062|FG004|Overall Study|Physician Decision|1|||
105670447|NCT00299494|364458063|FG005|Overall Study|Physician Decision|0|||
105670448|NCT00299494|364458058|FG000|Overall Study|Death|3|||
105670449|NCT00299494|364458059|FG001|Overall Study|Death|1|||
105670450|NCT00299494|364458060|FG002|Overall Study|Death|4|||
105670451|NCT00299494|364458061|FG003|Overall Study|Death|6|||
105670452|NCT00299494|364458062|FG004|Overall Study|Death|18|||
105670453|NCT00299494|364458063|FG005|Overall Study|Death|19|||
105670454|NCT00299494|364458058|FG000|Overall Study|Lost to Follow-up|0|||
105670455|NCT00299494|364458059|FG001|Overall Study|Lost to Follow-up|0|||
105670456|NCT00299494|364458060|FG002|Overall Study|Lost to Follow-up|0|||
105670457|NCT00299494|364458061|FG003|Overall Study|Lost to Follow-up|0|||
105670458|NCT00299494|364458062|FG004|Overall Study|Lost to Follow-up|3|||
105670459|NCT00299494|364458063|FG005|Overall Study|Lost to Follow-up|1|||
105670460|NCT00299494|364458058|FG000|Overall Study|Other - Unspecified|0|||
105670461|NCT00299494|364458059|FG001|Overall Study|Other - Unspecified|0|||
105670462|NCT00299494|364458060|FG002|Overall Study|Other - Unspecified|0|||
105670463|NCT00299494|364458061|FG003|Overall Study|Other - Unspecified|0|||
105670464|NCT00299494|364458062|FG004|Overall Study|Other - Unspecified|3|||
105670465|NCT00299494|364458063|FG005|Overall Study|Other - Unspecified|1|||
105670466|NCT00299494|364458058|FG000|Overall Study|Other - site closure|0|||
105670467|NCT00299494|364458059|FG001|Overall Study|Other - site closure|0|||
105670468|NCT00299494|364458060|FG002|Overall Study|Other - site closure|0|||
105670469|NCT00299494|364458061|FG003|Overall Study|Other - site closure|1|||
105670470|NCT00299494|364458062|FG004|Overall Study|Other - site closure|1|||
105670471|NCT00299494|364458063|FG005|Overall Study|Other - site closure|1|||
105670472|NCT01195623|364458064|FG000|Overall Study|Lost to Follow-up|35|||
105670473|NCT01195623|364458065|FG001|Overall Study|Lost to Follow-up|37|||
105670474|NCT00534495|364458068|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
105670475|NCT00534495|364458069|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
105670476|NCT00534495|364458070|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
105670477|NCT00534495|364458068|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
105670478|NCT00534495|364458069|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
105670479|NCT00534495|364458070|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
105670480|NCT00534495|364458068|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
105670481|NCT00534495|364458069|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
105670482|NCT00534495|364458070|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
105670483|NCT00534495|364458068|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
105670484|NCT00534495|364458069|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
105554133|NCT01292603|364027327|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
105554134|NCT01292603|364027328|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
105554135|NCT01292603|364027323|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
105554136|NCT01292603|364027324|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
105554137|NCT01292603|364027325|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
105554138|NCT01292603|364027326|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
105554139|NCT01292603|364027327|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
105554140|NCT01292603|364027328|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
105554141|NCT01292603|364027323|FG000|Part 2: Regular Follow-Up|Death|0|||
105554142|NCT01292603|364027324|FG001|Part 2: Regular Follow-Up|Death|0|||
105554143|NCT01292603|364027325|FG002|Part 2: Regular Follow-Up|Death|0|||
105554144|NCT01292603|364027326|FG003|Part 2: Regular Follow-Up|Death|0|||
105554145|NCT01292603|364027327|FG004|Part 2: Regular Follow-Up|Death|6|||
105554146|NCT01292603|364027328|FG005|Part 2: Regular Follow-Up|Death|3|||
105554147|NCT01292603|364027323|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
105554148|NCT01292603|364027324|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
105554149|NCT01292603|364027325|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
105554150|NCT01292603|364027326|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
105554151|NCT01292603|364027327|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
105554152|NCT01292603|364027328|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
105554153|NCT01292603|364027323|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
105554154|NCT01292603|364027324|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
105554155|NCT01292603|364027325|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
105554156|NCT01292603|364027326|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
105554157|NCT01292603|364027327|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
105554158|NCT01292603|364027328|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
105554159|NCT01292603|364027323|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
105554160|NCT01292603|364027324|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
105554161|NCT01292603|364027325|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
105554162|NCT01292603|364027326|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
105554163|NCT01292603|364027327|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
105554164|NCT01292603|364027328|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
105554165|NCT01292603|364027323|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
105554166|NCT01292603|364027324|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
105554167|NCT01292603|364027325|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
105554168|NCT01292603|364027326|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
105554169|NCT01292603|364027327|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
105554170|NCT01292603|364027328|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
105554171|NCT01292603|364027323|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
105554172|NCT01292603|364027324|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
105554173|NCT01292603|364027325|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
105670485|NCT00534495|364458070|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
105670486|NCT00534495|364458068|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
105670487|NCT00534495|364458069|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
105670488|NCT00534495|364458070|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
105670489|NCT00534495|364458068|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
105670490|NCT00534495|364458069|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
105670491|NCT00534495|364458070|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
105670492|NCT00534495|364458068|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
105670493|NCT00534495|364458069|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
105670494|NCT00534495|364458070|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
105670495|NCT00534495|364458068|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
105342225|NCT02730377|363255347|FG001|Overall Study|Adverse Event|41|||
105342226|NCT02730377|363255346|FG000|Overall Study|Protocol Violation|23|||
105342227|NCT02730377|363255347|FG001|Overall Study|Protocol Violation|30|||
105554174|NCT01292603|364027326|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
105554175|NCT01292603|364027327|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
105554176|NCT01292603|364027328|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
105554177|NCT01292603|364027323|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
105554178|NCT01292603|364027324|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
105554179|NCT01292603|364027325|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
105554180|NCT01292603|364027326|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
105554181|NCT01292603|364027327|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
105554182|NCT01292603|364027328|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
105554183|NCT01292603|364027323|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
105554184|NCT01292603|364027324|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
105554185|NCT01292603|364027325|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
105554186|NCT01292603|364027326|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
105554187|NCT01292603|364027327|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
105554188|NCT01292603|364027328|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
105554189|NCT01292603|364027323|FG000|Overall Survival Status|Death|3|||
105554190|NCT01292603|364027324|FG001|Overall Survival Status|Death|1|||
105554191|NCT01292603|364027325|FG002|Overall Survival Status|Death|3|||
105554192|NCT01292603|364027326|FG003|Overall Survival Status|Death|1|||
105554193|NCT01292603|364027327|FG004|Overall Survival Status|Death|16|||
105554194|NCT01292603|364027328|FG005|Overall Survival Status|Death|10|||
105554195|NCT03586648|364027329|FG000|Period 1|Withdrawal by Subject|0|||
105554196|NCT03586648|364027330|FG001|Period 1|Withdrawal by Subject|1|||
105554197|NCT03586648|364027329|FG000|Period 1|Lost to Follow-up|1|||
105554198|NCT03586648|364027330|FG001|Period 1|Lost to Follow-up|1|||
105554199|NCT03586648|364027329|FG000|Period 1|Adverse Event|1|||
105554200|NCT03586648|364027330|FG001|Period 1|Adverse Event|0|||
105554201|NCT03586648|364027329|FG000|Period 1|Study related symptoms or complaints|2|||
105554202|NCT03586648|364027330|FG001|Period 1|Study related symptoms or complaints|1|||
105554203|NCT03586648|364027329|FG000|Period 1|Physician Decision|0|||
105554204|NCT03586648|364027330|FG001|Period 1|Physician Decision|1|||
105554205|NCT03586648|364027329|FG000|Period 2|Adverse Event|1|||
105554206|NCT03586648|364027330|FG001|Period 2|Adverse Event|0|||
105554207|NCT00674986|364027333|FG000|Overall Study|Adverse Event|2|||
105554208|NCT00674986|364027334|FG001|Overall Study|Adverse Event|1|||
105554209|NCT00674986|364027333|FG000|Overall Study|Subject withdrew consent|12|||
105554210|NCT00674986|364027334|FG001|Overall Study|Subject withdrew consent|19|||
105554211|NCT00674986|364027333|FG000|Overall Study|Lost to Follow-up|25|||
105554212|NCT00674986|364027334|FG001|Overall Study|Lost to Follow-up|53|||
105554213|NCT00674986|364027333|FG000|Overall Study|Other reasons|4|||
105554214|NCT00674986|364027334|FG001|Overall Study|Other reasons|8|||
105554215|NCT00377234|364027335|FG000|Overall Study|Adverse Event|14|||
105554216|NCT00377234|364027336|FG001|Overall Study|Adverse Event|17|||
105554217|NCT00377234|364027335|FG000|Overall Study|Withdrawal by Subject|11|||
105554218|NCT00377234|364027336|FG001|Overall Study|Withdrawal by Subject|9|||
105554219|NCT00377234|364027335|FG000|Overall Study|Lost to Follow-up|4|||
105554220|NCT00377234|364027336|FG001|Overall Study|Lost to Follow-up|2|||
105554221|NCT00377234|364027335|FG000|Overall Study|Administrative|2|||
105554222|NCT00377234|364027336|FG001|Overall Study|Administrative|1|||
105554223|NCT00377234|364027335|FG000|Overall Study|Not assigned|3|||
105554224|NCT00377234|364027336|FG001|Overall Study|Not assigned|2|||
105554225|NCT01880424|364027337|FG000|Overall Study|Adverse Event|7|||
105554226|NCT01880424|364027338|FG001|Overall Study|Adverse Event|6|||
105554227|NCT01880424|364027337|FG000|Overall Study|Lack of Efficacy|1|||
105554228|NCT01880424|364027338|FG001|Overall Study|Lack of Efficacy|4|||
105554229|NCT01880424|364027337|FG000|Overall Study|Lost to Follow-up|3|||
105554230|NCT01880424|364027338|FG001|Overall Study|Lost to Follow-up|2|||
105554231|NCT01880424|364027337|FG000|Overall Study|Protocol Violation|11|||
105554232|NCT01880424|364027338|FG001|Overall Study|Protocol Violation|13|||
105554233|NCT01880424|364027337|FG000|Overall Study|Withdrawal by Subject|10|||
105554234|NCT01880424|364027338|FG001|Overall Study|Withdrawal by Subject|30|||
105554235|NCT01880424|364027337|FG000|Overall Study|Other|1|||
105554236|NCT01880424|364027338|FG001|Overall Study|Other|0|||
105670496|NCT00534495|364458069|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
105554237|NCT01588184|364027344|FG000|Overall Study|Death|1|||
105554238|NCT01588184|364027345|FG001|Overall Study|Death|0|||
105554239|NCT01588184|364027346|FG002|Overall Study|Death|0|||
105554240|NCT01588184|364027347|FG003|Overall Study|Death|1|||
105554241|NCT01588184|364027348|FG004|Overall Study|Death|1|||
105554242|NCT01588184|364027349|FG005|Overall Study|Death|1|||
105554243|NCT01588184|364027344|FG000|Overall Study|Withdrawal by Subject|2|||
105670497|NCT00534495|364458070|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
105670498|NCT00534495|364458068|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
105670499|NCT00534495|364458069|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
105670500|NCT00534495|364458070|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
105670501|NCT01305408|364458071|FG000|Overall Study|Adverse Event|10|||
105670502|NCT01305408|364458072|FG001|Overall Study|Adverse Event|7|||
105466587|NCT00363480|363720182|FG000|Overall Study|Participant discontinued on its own|1|||
105466588|NCT03853109|363720183|FG000|Overall Study|Withdrawal by Subject|0|||
105466589|NCT03853109|363720184|FG001|Overall Study|Withdrawal by Subject|0|||
105466590|NCT03853109|363720185|FG002|Overall Study|Withdrawal by Subject|1|||
105466591|NCT03853109|363720186|FG003|Overall Study|Withdrawal by Subject|2|||
105466592|NCT03853109|363720187|FG004|Overall Study|Withdrawal by Subject|1|||
105466593|NCT03853109|363720188|FG005|Overall Study|Withdrawal by Subject|4|||
105466594|NCT03853109|363720189|FG006|Overall Study|Withdrawal by Subject|5|||
105466595|NCT03853109|363720190|FG007|Overall Study|Withdrawal by Subject|3|||
105466596|NCT03853109|363720183|FG000|Overall Study|Decision by Sponsor|0|||
105466597|NCT03853109|363720184|FG001|Overall Study|Decision by Sponsor|0|||
105466598|NCT03853109|363720185|FG002|Overall Study|Decision by Sponsor|1|||
105466599|NCT03853109|363720186|FG003|Overall Study|Decision by Sponsor|0|||
105466600|NCT03853109|363720187|FG004|Overall Study|Decision by Sponsor|1|||
105466601|NCT03853109|363720188|FG005|Overall Study|Decision by Sponsor|1|||
105466602|NCT03853109|363720189|FG006|Overall Study|Decision by Sponsor|10|||
105466603|NCT03853109|363720190|FG007|Overall Study|Decision by Sponsor|2|||
105466604|NCT03853109|363720183|FG000|Overall Study|Lost to Follow-up|0|||
105466605|NCT03853109|363720184|FG001|Overall Study|Lost to Follow-up|0|||
105466606|NCT03853109|363720185|FG002|Overall Study|Lost to Follow-up|0|||
105466607|NCT03853109|363720186|FG003|Overall Study|Lost to Follow-up|0|||
105466608|NCT03853109|363720187|FG004|Overall Study|Lost to Follow-up|1|||
105466609|NCT03853109|363720188|FG005|Overall Study|Lost to Follow-up|3|||
105466610|NCT03853109|363720189|FG006|Overall Study|Lost to Follow-up|0|||
105466611|NCT03853109|363720190|FG007|Overall Study|Lost to Follow-up|0|||
105466612|NCT03853109|363720183|FG000|Overall Study|Death|2|||
105554244|NCT01588184|364027345|FG001|Overall Study|Withdrawal by Subject|4|||
105554245|NCT01588184|364027346|FG002|Overall Study|Withdrawal by Subject|0|||
105554246|NCT01588184|364027347|FG003|Overall Study|Withdrawal by Subject|1|||
105554247|NCT01588184|364027348|FG004|Overall Study|Withdrawal by Subject|0|||
105554248|NCT01588184|364027349|FG005|Overall Study|Withdrawal by Subject|0|||
105554249|NCT01588184|364027344|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
105554250|NCT01588184|364027345|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
105554251|NCT01588184|364027346|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
105554252|NCT01588184|364027347|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
105554253|NCT01588184|364027348|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
105554254|NCT01588184|364027349|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
105554255|NCT01588184|364027344|FG000|Overall Study|multiple reasons|0|||
105554256|NCT01588184|364027345|FG001|Overall Study|multiple reasons|3|||
105554257|NCT01588184|364027346|FG002|Overall Study|multiple reasons|0|||
105554258|NCT01588184|364027347|FG003|Overall Study|multiple reasons|1|||
105554259|NCT01588184|364027348|FG004|Overall Study|multiple reasons|0|||
105554260|NCT01588184|364027349|FG005|Overall Study|multiple reasons|0|||
105554261|NCT01275625|364027350|FG000|Overall Study|Death|1|||
105554262|NCT01275625|364027350|FG000|Overall Study|Lack of Efficacy|2|||
105554263|NCT01275625|364027350|FG000|Overall Study|Lost to Follow-up|1|||
105554264|NCT01275625|364027350|FG000|Overall Study|Withdrawal by Subject|3|||
105554265|NCT01275625|364027350|FG000|Overall Study|Protocol Violation|1|||
105554266|NCT01275625|364027350|FG000|Overall Study|Adverse Event|4|||
105554267|NCT01275625|364027350|FG000|Overall Study|Other|1|||
105554268|NCT01585103|364027352|FG000|Overall Study|Unable to swallow Cytosponge|6|||
105554269|NCT03147248|364027356|FG000|Overall Study|Adverse Event|0|||
105554270|NCT03147248|364027357|FG001|Overall Study|Adverse Event|2|||
105554271|NCT03147248|364027358|FG002|Overall Study|Adverse Event|2|||
105554272|NCT03147248|364027359|FG003|Overall Study|Adverse Event|2|||
105554273|NCT03147248|364027360|FG004|Overall Study|Adverse Event|6|||
105554274|NCT03147248|364027361|FG005|Overall Study|Adverse Event|11|||
105554275|NCT03147248|364027356|FG000|Overall Study|Disease progression|1|||
105554276|NCT03147248|364027357|FG001|Overall Study|Disease progression|0|||
105554277|NCT03147248|364027358|FG002|Overall Study|Disease progression|0|||
105554278|NCT03147248|364027359|FG003|Overall Study|Disease progression|0|||
105554279|NCT03147248|364027360|FG004|Overall Study|Disease progression|0|||
105554280|NCT03147248|364027361|FG005|Overall Study|Disease progression|2|||
105554281|NCT03147248|364027356|FG000|Overall Study|Withdrawal by Subject|0|||
105554282|NCT03147248|364027357|FG001|Overall Study|Withdrawal by Subject|0|||
105554283|NCT03147248|364027358|FG002|Overall Study|Withdrawal by Subject|0|||
105554284|NCT03147248|364027359|FG003|Overall Study|Withdrawal by Subject|0|||
105554285|NCT03147248|364027360|FG004|Overall Study|Withdrawal by Subject|12|||
105554286|NCT03147248|364027361|FG005|Overall Study|Withdrawal by Subject|9|||
105554287|NCT03147248|364027356|FG000|Overall Study|Protocol Violation|0|||
105554288|NCT03147248|364027357|FG001|Overall Study|Protocol Violation|0|||
105554289|NCT03147248|364027358|FG002|Overall Study|Protocol Violation|0|||
105554290|NCT03147248|364027359|FG003|Overall Study|Protocol Violation|0|||
105554291|NCT03147248|364027360|FG004|Overall Study|Protocol Violation|2|||
105554292|NCT03147248|364027361|FG005|Overall Study|Protocol Violation|0|||
105554293|NCT03147248|364027356|FG000|Overall Study|Lost to Follow-up|0|||
105554294|NCT03147248|364027357|FG001|Overall Study|Lost to Follow-up|0|||
105554295|NCT03147248|364027358|FG002|Overall Study|Lost to Follow-up|0|||
105554296|NCT03147248|364027359|FG003|Overall Study|Lost to Follow-up|0|||
105554297|NCT03147248|364027360|FG004|Overall Study|Lost to Follow-up|2|||
105554298|NCT03147248|364027361|FG005|Overall Study|Lost to Follow-up|0|||
105554299|NCT03147248|364027356|FG000|Overall Study|Pregnancy|0|||
105554300|NCT03147248|364027357|FG001|Overall Study|Pregnancy|0|||
105554301|NCT03147248|364027358|FG002|Overall Study|Pregnancy|0|||
105554302|NCT03147248|364027359|FG003|Overall Study|Pregnancy|0|||
105554303|NCT03147248|364027360|FG004|Overall Study|Pregnancy|1|||
105554304|NCT03147248|364027361|FG005|Overall Study|Pregnancy|0|||
105554305|NCT03147248|364027356|FG000|Overall Study|Death|0|||
105554306|NCT03147248|364027357|FG001|Overall Study|Death|0|||
105554307|NCT03147248|364027358|FG002|Overall Study|Death|0|||
105554308|NCT03147248|364027359|FG003|Overall Study|Death|0|||
105554309|NCT03147248|364027360|FG004|Overall Study|Death|0|||
105554310|NCT03147248|364027361|FG005|Overall Study|Death|4|||
105554311|NCT03147248|364027356|FG000|Overall Study|Physician Decision|0|||
105554312|NCT03147248|364027357|FG001|Overall Study|Physician Decision|0|||
105554313|NCT03147248|364027358|FG002|Overall Study|Physician Decision|0|||
105554314|NCT03147248|364027359|FG003|Overall Study|Physician Decision|0|||
105554315|NCT03147248|364027360|FG004|Overall Study|Physician Decision|2|||
105554316|NCT03147248|364027361|FG005|Overall Study|Physician Decision|4|||
105554317|NCT03147248|364027356|FG000|Overall Study|Prolonged Dosing Interval|0|||
105554318|NCT03147248|364027357|FG001|Overall Study|Prolonged Dosing Interval|0|||
105554319|NCT03147248|364027358|FG002|Overall Study|Prolonged Dosing Interval|0|||
105554320|NCT03147248|364027359|FG003|Overall Study|Prolonged Dosing Interval|0|||
105670503|NCT01305408|364458071|FG000|Overall Study|Lack of Efficacy|3|||
105670504|NCT01305408|364458072|FG001|Overall Study|Lack of Efficacy|4|||
105670505|NCT01305408|364458071|FG000|Overall Study|Withdrawal by Subject|9|||
105670506|NCT01305408|364458072|FG001|Overall Study|Withdrawal by Subject|9|||
105670507|NCT01305408|364458071|FG000|Overall Study|Protocol Violation|4|||
105670508|NCT01305408|364458072|FG001|Overall Study|Protocol Violation|6|||
105670509|NCT01305408|364458071|FG000|Overall Study|Lost to Follow-up|5|||
105670510|NCT01305408|364458072|FG001|Overall Study|Lost to Follow-up|3|||
105670511|NCT01305408|364458071|FG000|Overall Study|Noncompliance with study medication|0|||
105670512|NCT01305408|364458072|FG001|Overall Study|Noncompliance with study medication|1|||
105670513|NCT01305408|364458071|FG000|Overall Study|Noncompliance with study procedures|0|||
105670514|NCT01305408|364458072|FG001|Overall Study|Noncompliance with study procedures|1|||
105670515|NCT01305408|364458071|FG000|Overall Study|Other|1|||
105670516|NCT01305408|364458072|FG001|Overall Study|Other|0|||
105670517|NCT02440425|364458073|FG000|Overall Study|Death likely due to disease progression|1|||
105670518|NCT02440425|364458073|FG000|Overall Study|Withdrawal by Subject|2|||
105670519|NCT02440425|364458073|FG000|Overall Study|Adverse Event|1|||
105670520|NCT02440425|364458073|FG000|Overall Study|Adverse Event/Ineligible|1|||
105670521|NCT03101462|364458074|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
105670522|NCT03101462|364458075|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
105670523|NCT00214019|364458076|FG000|Overall Study|Lost to Follow-up|11|||
105670524|NCT00214019|364458076|FG000|Overall Study|Withdrawal by Subject|2|||
105670525|NCT00214019|364458076|FG000|Overall Study|Screen Failed prior to randomization|17|||
105670526|NCT01677767|364458079|FG000|Overall Study|Adverse Event|1|||
105670527|NCT01677767|364458079|FG000|Overall Study|Death|4|||
105670528|NCT01677767|364458079|FG000|Overall Study|Protocol Violation|4|||
105670529|NCT01677767|364458079|FG000|Overall Study|Withdrawal by Subject|10|||
105670530|NCT01677767|364458079|FG000|Overall Study|Non-compliance by the participants|3|||
105670531|NCT00842244|364458080|FG000|Overall Study|Death|3|||
105670532|NCT00842244|364458080|FG000|Overall Study|Withdrawal by Subject|1|||
105670533|NCT00842244|364458080|FG000|Overall Study|Other|17|||
105670534|NCT03635099|364458081|FG000|Period 1|Adverse Event|1|||
105670535|NCT03635099|364458082|FG001|Period 1|Adverse Event|0|||
105670536|NCT03635099|364458083|FG002|Period 1|Adverse Event|0|||
105670537|NCT03635099|364458084|FG003|Period 1|Adverse Event|1|||
105670538|NCT03635099|364458085|FG004|Period 1|Adverse Event|0|||
105670539|NCT03635099|364458086|FG005|Period 1|Adverse Event|0|||
105670540|NCT03635099|364458087|FG006|Period 1|Adverse Event|0|||
105670541|NCT03635099|364458088|FG007|Period 1|Adverse Event|0|||
105670542|NCT03635099|364458081|FG000|Period 1|Protocol Violation|0|||
105670543|NCT03635099|364458082|FG001|Period 1|Protocol Violation|0|||
105670544|NCT03635099|364458083|FG002|Period 1|Protocol Violation|1|||
105670545|NCT03635099|364458084|FG003|Period 1|Protocol Violation|0|||
105670546|NCT03635099|364458085|FG004|Period 1|Protocol Violation|0|||
105670547|NCT03635099|364458086|FG005|Period 1|Protocol Violation|0|||
105670548|NCT03635099|364458087|FG006|Period 1|Protocol Violation|0|||
105670549|NCT03635099|364458088|FG007|Period 1|Protocol Violation|0|||
105670550|NCT03635099|364458081|FG000|Period 1|Lost to Follow-up|0|||
105670551|NCT03635099|364458082|FG001|Period 1|Lost to Follow-up|0|||
105670552|NCT03635099|364458083|FG002|Period 1|Lost to Follow-up|1|||
105670553|NCT03635099|364458084|FG003|Period 1|Lost to Follow-up|2|||
105670554|NCT03635099|364458085|FG004|Period 1|Lost to Follow-up|1|||
105670555|NCT03635099|364458086|FG005|Period 1|Lost to Follow-up|0|||
105670556|NCT03635099|364458087|FG006|Period 1|Lost to Follow-up|1|||
105670557|NCT03635099|364458088|FG007|Period 1|Lost to Follow-up|2|||
105670558|NCT03635099|364458081|FG000|Period 1|Withdrawal by Subject|3|||
105670559|NCT03635099|364458082|FG001|Period 1|Withdrawal by Subject|3|||
105670560|NCT03635099|364458083|FG002|Period 1|Withdrawal by Subject|5|||
105670561|NCT03635099|364458084|FG003|Period 1|Withdrawal by Subject|2|||
105670562|NCT03635099|364458085|FG004|Period 1|Withdrawal by Subject|2|||
105670563|NCT03635099|364458086|FG005|Period 1|Withdrawal by Subject|0|||
105670564|NCT03635099|364458087|FG006|Period 1|Withdrawal by Subject|3|||
105670565|NCT03635099|364458088|FG007|Period 1|Withdrawal by Subject|0|||
105670566|NCT03635099|364458081|FG000|Period 1|History of suicidal ideation|0|||
105670567|NCT03635099|364458082|FG001|Period 1|History of suicidal ideation|0|||
105670568|NCT03635099|364458083|FG002|Period 1|History of suicidal ideation|1|||
105670569|NCT03635099|364458084|FG003|Period 1|History of suicidal ideation|0|||
105670570|NCT03635099|364458085|FG004|Period 1|History of suicidal ideation|0|||
105670571|NCT03635099|364458086|FG005|Period 1|History of suicidal ideation|0|||
105670572|NCT03635099|364458087|FG006|Period 1|History of suicidal ideation|0|||
105670573|NCT03635099|364458088|FG007|Period 1|History of suicidal ideation|0|||
105670574|NCT03635099|364458081|FG000|Period 1|pursue other treatment options|0|||
105670575|NCT03635099|364458082|FG001|Period 1|pursue other treatment options|0|||
105670576|NCT03635099|364458083|FG002|Period 1|pursue other treatment options|0|||
105670577|NCT03635099|364458084|FG003|Period 1|pursue other treatment options|0|||
105670578|NCT03635099|364458085|FG004|Period 1|pursue other treatment options|0|||
105670579|NCT03635099|364458086|FG005|Period 1|pursue other treatment options|1|||
105670580|NCT03635099|364458087|FG006|Period 1|pursue other treatment options|0|||
105670581|NCT03635099|364458088|FG007|Period 1|pursue other treatment options|0|||
105670582|NCT03635099|364458081|FG000|Not Eligible for Period 2|Pregnancy|0|||
105670583|NCT03635099|364458082|FG001|Not Eligible for Period 2|Pregnancy|0|||
105670584|NCT03635099|364458083|FG002|Not Eligible for Period 2|Pregnancy|0|||
105670585|NCT03635099|364458084|FG003|Not Eligible for Period 2|Pregnancy|1|||
105670586|NCT03635099|364458085|FG004|Not Eligible for Period 2|Pregnancy|0|||
105670587|NCT03635099|364458086|FG005|Not Eligible for Period 2|Pregnancy|0|||
105670588|NCT03635099|364458087|FG006|Not Eligible for Period 2|Pregnancy|0|||
105670589|NCT03635099|364458088|FG007|Not Eligible for Period 2|Pregnancy|0|||
105670590|NCT03635099|364458081|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
105670591|NCT03635099|364458082|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
105670592|NCT03635099|364458083|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
105670593|NCT03635099|364458084|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
105670594|NCT03635099|364458085|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
105670595|NCT03635099|364458086|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
105670596|NCT03635099|364458087|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
105670597|NCT03635099|364458088|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
105670598|NCT03635099|364458081|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
105670599|NCT03635099|364458082|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
105670600|NCT03635099|364458083|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
105670601|NCT03635099|364458084|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
105670602|NCT03635099|364458085|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
105670603|NCT03635099|364458086|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
105670604|NCT03635099|364458087|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
105670605|NCT03635099|364458088|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
105670606|NCT03635099|364458081|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
105670607|NCT03635099|364458082|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
105670608|NCT03635099|364458083|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
105670609|NCT03635099|364458084|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
105670610|NCT03635099|364458085|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
105670611|NCT03635099|364458086|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
105670612|NCT03635099|364458087|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
105670613|NCT03635099|364458088|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
105670614|NCT03635099|364458081|FG000|Period 2|Adverse Event|0|||
105670615|NCT03635099|364458082|FG001|Period 2|Adverse Event|0|||
105670616|NCT03635099|364458083|FG002|Period 2|Adverse Event|1|||
105670617|NCT03635099|364458084|FG003|Period 2|Adverse Event|0|||
105670618|NCT03635099|364458085|FG004|Period 2|Adverse Event|1|||
105670619|NCT03635099|364458086|FG005|Period 2|Adverse Event|0|||
105670620|NCT03635099|364458087|FG006|Period 2|Adverse Event|0|||
105670621|NCT03635099|364458088|FG007|Period 2|Adverse Event|0|||
105670622|NCT03635099|364458081|FG000|Period 2|Lost to Follow-up|0|||
105670623|NCT03635099|364458082|FG001|Period 2|Lost to Follow-up|0|||
105670624|NCT03635099|364458083|FG002|Period 2|Lost to Follow-up|1|||
105670625|NCT03635099|364458084|FG003|Period 2|Lost to Follow-up|0|||
105670626|NCT03635099|364458085|FG004|Period 2|Lost to Follow-up|4|||
105670627|NCT03635099|364458086|FG005|Period 2|Lost to Follow-up|0|||
105670628|NCT03635099|364458087|FG006|Period 2|Lost to Follow-up|0|||
105670629|NCT03635099|364458088|FG007|Period 2|Lost to Follow-up|0|||
105670630|NCT03635099|364458081|FG000|Period 2|Withdrawal by Subject|0|||
105670631|NCT03635099|364458082|FG001|Period 2|Withdrawal by Subject|0|||
105670632|NCT03635099|364458083|FG002|Period 2|Withdrawal by Subject|7|||
105670633|NCT03635099|364458084|FG003|Period 2|Withdrawal by Subject|4|||
105670634|NCT03635099|364458085|FG004|Period 2|Withdrawal by Subject|7|||
105670635|NCT03635099|364458086|FG005|Period 2|Withdrawal by Subject|0|||
105342228|NCT02730377|363255346|FG000|Overall Study|Lack of Efficacy|4|||
105670636|NCT03635099|364458087|FG006|Period 2|Withdrawal by Subject|0|||
105670637|NCT03635099|364458088|FG007|Period 2|Withdrawal by Subject|0|||
105670638|NCT01068665|364458089|FG000|Overall Study|Adverse Event|5|||
105670639|NCT01068665|364458090|FG001|Overall Study|Adverse Event|4|||
105670640|NCT01068665|364458089|FG000|Overall Study|Lack of Efficacy|0|||
105670641|NCT01068665|364458090|FG001|Overall Study|Lack of Efficacy|2|||
105342229|NCT02730377|363255347|FG001|Overall Study|Lack of Efficacy|13|||
105670642|NCT01068665|364458089|FG000|Overall Study|Protocol Violation|5|||
105670643|NCT01068665|364458090|FG001|Overall Study|Protocol Violation|2|||
105670644|NCT01068665|364458089|FG000|Overall Study|Withdrawal Criteria|3|||
105670645|NCT01068665|364458090|FG001|Overall Study|Withdrawal Criteria|9|||
105670646|NCT01068665|364458089|FG000|Overall Study|Other|17|||
105670647|NCT01068665|364458090|FG001|Overall Study|Other|12|||
105670648|NCT02920970|364458091|FG000|First Intervention|Protocol Violation|0|||
105670649|NCT02920970|364458092|FG001|First Intervention|Protocol Violation|1|||
105670650|NCT02920970|364458091|FG000|First Intervention|Adverse Event|0|||
105670651|NCT02920970|364458092|FG001|First Intervention|Adverse Event|1|||
105670652|NCT02920970|364458091|FG000|Second Intervention|Poor Lens Fit|1|||
105670653|NCT02920970|364458092|FG001|Second Intervention|Poor Lens Fit|0|||
105670654|NCT02807272|364458094|FG000|Overall Study|Death|9|||
105670655|NCT02807272|364458095|FG001|Overall Study|Death|5|||
105670656|NCT02807272|364458096|FG002|Overall Study|Death|2|||
105670657|NCT02807272|364458097|FG003|Overall Study|Death|0|||
105670658|NCT02807272|364458098|FG004|Overall Study|Death|1|||
105670659|NCT02807272|364458094|FG000|Overall Study|Lost to Follow-up|1|||
105670660|NCT02807272|364458095|FG001|Overall Study|Lost to Follow-up|0|||
105670661|NCT02807272|364458096|FG002|Overall Study|Lost to Follow-up|0|||
105670662|NCT02807272|364458097|FG003|Overall Study|Lost to Follow-up|0|||
105670663|NCT02807272|364458098|FG004|Overall Study|Lost to Follow-up|0|||
105670664|NCT02807272|364458094|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
105670665|NCT02807272|364458095|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
105670666|NCT02807272|364458096|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
105670667|NCT02807272|364458097|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
105670668|NCT02807272|364458098|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
105670669|NCT02807272|364458094|FG000|Overall Study|Protocol-defined Disease Progression|0|||
105670670|NCT02807272|364458095|FG001|Overall Study|Protocol-defined Disease Progression|1|||
105670671|NCT02807272|364458096|FG002|Overall Study|Protocol-defined Disease Progression|0|||
105670672|NCT02807272|364458097|FG003|Overall Study|Protocol-defined Disease Progression|0|||
105670673|NCT02807272|364458098|FG004|Overall Study|Protocol-defined Disease Progression|1|||
105670674|NCT02807272|364458094|FG000|Overall Study|Study Terminated by Sponsor|1|||
105670675|NCT02807272|364458095|FG001|Overall Study|Study Terminated by Sponsor|0|||
105670676|NCT02807272|364458096|FG002|Overall Study|Study Terminated by Sponsor|0|||
105670677|NCT02807272|364458097|FG003|Overall Study|Study Terminated by Sponsor|1|||
105670678|NCT02807272|364458098|FG004|Overall Study|Study Terminated by Sponsor|0|||
105670679|NCT02807272|364458094|FG000|Overall Study|Other|1|||
105670680|NCT02807272|364458095|FG001|Overall Study|Other|0|||
105670681|NCT02807272|364458096|FG002|Overall Study|Other|0|||
105670682|NCT02807272|364458097|FG003|Overall Study|Other|0|||
105670683|NCT02807272|364458098|FG004|Overall Study|Other|1|||
105670684|NCT00757627|364458099|FG000|Overall Study|Adverse Event|15|||
105670685|NCT00757627|364458099|FG000|Overall Study|Lack of Efficacy|10|||
105670686|NCT00757627|364458099|FG000|Overall Study|Lost to Follow-up|28|||
105670687|NCT00757627|364458099|FG000|Overall Study|Withdrawal by Subject|27|||
105342230|NCT02730377|363255346|FG000|Overall Study|Pregnancy|0|||
105342231|NCT02730377|363255347|FG001|Overall Study|Pregnancy|1|||
105342232|NCT02730377|363255346|FG000|Overall Study|Withdrawal by Subject|45|||
105342233|NCT02730377|363255347|FG001|Overall Study|Withdrawal by Subject|42|||
105342234|NCT02730377|363255346|FG000|Overall Study|Lost to Follow-up|25|||
105342235|NCT02730377|363255347|FG001|Overall Study|Lost to Follow-up|21|||
105342236|NCT01286168|363255350|FG000|Overall Study|Withdrawal by Subject|1|||
105342237|NCT01286168|363255350|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
105342238|NCT02091960|363255351|FG000|Overall Study|Death|7|||
105342239|NCT02091960|363255351|FG000|Overall Study|Withdrawal by Subject|1|||
105342240|NCT02091960|363255351|FG000|Overall Study|Miscellaneous Reasons|37|||
105342241|NCT02677038|363255354|FG000|Overall Study|Physician Decision|1|||
105342242|NCT02677038|363255354|FG000|Overall Study|Withdrawal by Subject|1|||
105342243|NCT03671564|363255356|FG000|Overall Study|Progressive Disease|3|||
105342244|NCT03671564|363255357|FG001|Overall Study|Progressive Disease|5|||
105342245|NCT03671564|363255358|FG002|Overall Study|Progressive Disease|3|||
105342246|NCT03671564|363255356|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
105342247|NCT03671564|363255357|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
105670688|NCT00757627|364458099|FG000|Overall Study|Other|1|||
105670689|NCT00635661|364458100|FG000|Overall Study|Withdrawal by Subject|4|||
105670690|NCT01696955|364458102|FG000|Main Study|Protocol Violation|1|||
105670691|NCT01696955|364458103|FG001|Main Study|Protocol Violation|0|||
105670692|NCT01696955|364458102|FG000|Main Study|Withdrawal by Subject|1|||
105670693|NCT01696955|364458103|FG001|Main Study|Withdrawal by Subject|1|||
105670694|NCT03653208|364458106|FG000|Overall Study|Withdrawal by Subject|0|||
105670695|NCT03653208|364458107|FG001|Overall Study|Withdrawal by Subject|0|||
105670696|NCT03653208|364458108|FG002|Overall Study|Withdrawal by Subject|0|||
105670697|NCT03653208|364458109|FG003|Overall Study|Withdrawal by Subject|0|||
105670698|NCT03653208|364458110|FG004|Overall Study|Withdrawal by Subject|1|||
105670699|NCT03653208|364458111|FG005|Overall Study|Withdrawal by Subject|0|||
105342248|NCT03671564|363255358|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
105670700|NCT03653208|364458112|FG006|Overall Study|Withdrawal by Subject|0|||
105342249|NCT03671564|363255356|FG000|Overall Study|Withdrawal by Subject|1|||
105786175|NCT04089566|364870462|FG005|Overall Study|Reason not Specified|0|||
105786176|NCT01083121|364870463|FG000|Overall Study|Use of Humira outside the approved label|81|||
105786177|NCT04409262|364870466|FG000|Overall Study|Adverse Event|0|||
105786178|NCT04409262|364870467|FG001|Overall Study|Adverse Event|2|||
105786179|NCT04409262|364870466|FG000|Overall Study|Death|55|||
105786180|NCT04409262|364870467|FG001|Overall Study|Death|97|||
105786181|NCT04409262|364870466|FG000|Overall Study|Lost to Follow-up|12|||
105554321|NCT03147248|364027360|FG004|Overall Study|Prolonged Dosing Interval|1|||
105554322|NCT03147248|364027361|FG005|Overall Study|Prolonged Dosing Interval|1|||
105554323|NCT03750552|364027362|FG000|Overall Study|Adverse Event|5|||
105554324|NCT03750552|364027363|FG001|Overall Study|Adverse Event|1|||
105554325|NCT03750552|364027362|FG000|Overall Study|Withdrawal by Subject|1|||
105554326|NCT03750552|364027363|FG001|Overall Study|Withdrawal by Subject|1|||
105554327|NCT03750552|364027362|FG000|Overall Study|Other|2|||
105554328|NCT03750552|364027363|FG001|Overall Study|Other|0|||
105554329|NCT02062632|364027364|FG000|Overall Study|No treatment data|1|||
105554330|NCT02105116|364027365|FG000|Overall Study|not eligible for step 2 of trial|5|||
105554331|NCT02105116|364027365|FG000|Overall Study|Death|1|||
105554332|NCT02522494|364027366|FG000|Overall Study|Lost to Follow-up|6|||
105554333|NCT02522494|364027367|FG001|Overall Study|Lost to Follow-up|2|||
105554334|NCT02522494|364027366|FG000|Overall Study|Withdrawal by Subject|1|||
105554335|NCT02522494|364027367|FG001|Overall Study|Withdrawal by Subject|0|||
105554336|NCT02522494|364027366|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
105554337|NCT02522494|364027367|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
105554338|NCT02522494|364027366|FG000|Overall Study|Participant did not watch the video|1|||
105554339|NCT02522494|364027367|FG001|Overall Study|Participant did not watch the video|0|||
105554340|NCT02522494|364027366|FG000|Overall Study|Death|0|||
105554341|NCT02522494|364027367|FG001|Overall Study|Death|1|||
105554342|NCT01412944|364027368|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
105554343|NCT01412944|364027369|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
105554344|NCT01412944|364027370|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
105554345|NCT01412944|364027371|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
105554346|NCT01412944|364027372|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
105554347|NCT01412944|364027373|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
105554348|NCT01412944|364027368|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
105554349|NCT01412944|364027369|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
105554350|NCT01412944|364027370|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
105554351|NCT01412944|364027371|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
105554352|NCT01412944|364027372|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
105554353|NCT01412944|364027373|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
105554354|NCT01412944|364027368|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
105554355|NCT01412944|364027369|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
105554356|NCT01412944|364027370|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
105554357|NCT01412944|364027371|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
105554358|NCT01412944|364027372|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
105554359|NCT01412944|364027373|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
105554360|NCT01412944|364027368|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
105554361|NCT01412944|364027369|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
105786182|NCT04409262|364870467|FG001|Overall Study|Lost to Follow-up|23|||
105786183|NCT04409262|364870466|FG000|Overall Study|Lack of Staff|0|||
105786184|NCT04409262|364870467|FG001|Overall Study|Lack of Staff|1|||
105786185|NCT04409262|364870466|FG000|Overall Study|Protocol Violation|3|||
105786186|NCT04409262|364870467|FG001|Overall Study|Protocol Violation|1|||
105786187|NCT04409262|364870466|FG000|Overall Study|Withdrawal by Subject|5|||
105786188|NCT04409262|364870467|FG001|Overall Study|Withdrawal by Subject|10|||
105786189|NCT02500732|364870468|FG000|Overall Study|Physician Decision|0|||
105786190|NCT02500732|364870469|FG001|Overall Study|Physician Decision|1|||
105786191|NCT01958619|364870470|FG000|Overall Study|Protocol Violation|2|||
105786192|NCT01958619|364870471|FG001|Overall Study|Protocol Violation|0|||
105786193|NCT01958619|364870472|FG002|Overall Study|Protocol Violation|1|||
105342250|NCT03671564|363255357|FG001|Overall Study|Withdrawal by Subject|1|||
105554362|NCT01412944|364027370|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
105554363|NCT01412944|364027371|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
105554364|NCT01412944|364027372|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
105554365|NCT01412944|364027373|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
105554366|NCT01412944|364027368|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
105554367|NCT01412944|364027369|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
105554368|NCT01412944|364027370|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
105786194|NCT01958619|364870473|FG003|Overall Study|Protocol Violation|0|||
105786195|NCT02396849|364870475|FG000|Overall Study|Lost to Follow-up|1|||
105786196|NCT02396849|364870476|FG001|Overall Study|Lost to Follow-up|1|||
105786197|NCT02396849|364870475|FG000|Overall Study|Did not tolerate intervention|1|||
105786198|NCT02396849|364870476|FG001|Overall Study|Did not tolerate intervention|1|||
105342251|NCT03671564|363255358|FG002|Overall Study|Withdrawal by Subject|0|||
105342252|NCT03535740|363255366|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
105342253|NCT03535740|363255366|FG000|Overall Study|Death|34|||
105342254|NCT03535740|363255366|FG000|Overall Study|Lost to Follow-up|1|||
105342255|NCT03535740|363255366|FG000|Overall Study|Withdrawal by Subject|13|||
105342256|NCT04739722|363255367|FG000|Overall Study|Lost to Follow-up|5301|||
105670701|NCT03653208|364458113|FG007|Overall Study|Withdrawal by Subject|1|||
105670702|NCT03653208|364458114|FG008|Overall Study|Withdrawal by Subject|1|||
105670703|NCT00436605|364458115|FG000|Overall Study|Protocol Violation|3|||
105670704|NCT03752970|364458118|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
105670705|NCT03752970|364458119|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
105670706|NCT03752970|364458120|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
105670707|NCT03752970|364458118|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
105670708|NCT03752970|364458119|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
105670709|NCT03752970|364458120|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
105670710|NCT03752970|364458118|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
105670711|NCT03752970|364458119|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
105670712|NCT03752970|364458120|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
105670713|NCT03752970|364458118|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
105670714|NCT03752970|364458119|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
105670715|NCT03752970|364458120|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
105670716|NCT03752970|364458118|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
105670717|NCT03752970|364458119|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
105670718|NCT03752970|364458120|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
105670719|NCT00573859|364458121|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
105670720|NCT00573859|364458121|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
105670721|NCT00368927|364458122|FG000|Overall Study|Lost to Follow-up|2|||
105670722|NCT00368927|364458123|FG001|Overall Study|Lost to Follow-up|0|||
105670723|NCT00368927|364458122|FG000|Overall Study|Adverse Event|1|||
105342257|NCT04739722|363255367|FG000|Overall Study|Withdrawal by Subject|42|||
105342258|NCT04739722|363255367|FG000|Overall Study|Non Average-risk|1157|||
105342259|NCT03047720|363255371|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
105342260|NCT03047720|363255372|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
105342261|NCT00614120|363255373|FG000|Overall Study|Adverse Event|9|||
105342262|NCT00614120|363255374|FG001|Overall Study|Adverse Event|22|||
105342263|NCT00614120|363255375|FG002|Overall Study|Adverse Event|30|||
105342264|NCT00614120|363255376|FG003|Overall Study|Adverse Event|3|||
105342265|NCT00614120|363255373|FG000|Overall Study|Lack of Efficacy|3|||
105342266|NCT00614120|363255374|FG001|Overall Study|Lack of Efficacy|3|||
105342267|NCT00614120|363255375|FG002|Overall Study|Lack of Efficacy|2|||
105670724|NCT00368927|364458123|FG001|Overall Study|Adverse Event|1|||
105342268|NCT00614120|363255376|FG003|Overall Study|Lack of Efficacy|2|||
105342269|NCT00614120|363255373|FG000|Overall Study|Protocol Violation|2|||
105342270|NCT00614120|363255374|FG001|Overall Study|Protocol Violation|5|||
105342271|NCT00614120|363255375|FG002|Overall Study|Protocol Violation|3|||
105342272|NCT00614120|363255376|FG003|Overall Study|Protocol Violation|1|||
105342273|NCT00614120|363255373|FG000|Overall Study|Withdrawal criteria|1|||
105342274|NCT00614120|363255374|FG001|Overall Study|Withdrawal criteria|0|||
105342275|NCT00614120|363255375|FG002|Overall Study|Withdrawal criteria|0|||
105342276|NCT00614120|363255376|FG003|Overall Study|Withdrawal criteria|0|||
105342277|NCT00614120|363255373|FG000|Overall Study|Withdrawal by Subject|9|||
105342278|NCT00614120|363255374|FG001|Overall Study|Withdrawal by Subject|10|||
105342279|NCT00614120|363255375|FG002|Overall Study|Withdrawal by Subject|16|||
105342280|NCT00614120|363255376|FG003|Overall Study|Withdrawal by Subject|3|||
105342281|NCT00614120|363255373|FG000|Overall Study|Did not meet trial criteria|0|||
105342282|NCT00614120|363255374|FG001|Overall Study|Did not meet trial criteria|1|||
105670725|NCT00368927|364458122|FG000|Overall Study|Withdrawal by Subject|1|||
105670726|NCT00368927|364458123|FG001|Overall Study|Withdrawal by Subject|2|||
105670727|NCT00368927|364458122|FG000|Overall Study|Physician Decision|1|||
105670728|NCT00368927|364458123|FG001|Overall Study|Physician Decision|0|||
105670729|NCT01152814|364458124|FG000|Overall Study|Lost to Follow-up|2|||
105670730|NCT03541200|364458125|FG000|Overall Study|Adverse Event|19|||
105670731|NCT03541200|364458125|FG000|Overall Study|Death|1|||
105670732|NCT03541200|364458125|FG000|Overall Study|Lost to Follow-up|10|||
105670733|NCT03541200|364458125|FG000|Overall Study|Physician Decision|1|||
105670734|NCT03541200|364458125|FG000|Overall Study|Protocol Violation|51|||
105342283|NCT00614120|363255375|FG002|Overall Study|Did not meet trial criteria|1|||
105342284|NCT00614120|363255376|FG003|Overall Study|Did not meet trial criteria|1|||
105342285|NCT00614120|363255373|FG000|Overall Study|hCG positive (not pregnant)|0|||
105342286|NCT00614120|363255374|FG001|Overall Study|hCG positive (not pregnant)|0|||
105670735|NCT03541200|364458125|FG000|Overall Study|Withdrawal by Subject|23|||
105670736|NCT03541200|364458125|FG000|Overall Study|other|8|||
105670737|NCT00818779|364458126|FG000|Overall Study|Protocol Violation|1|||
105670738|NCT00818779|364458127|FG001|Overall Study|Protocol Violation|0|||
105670739|NCT00818779|364458126|FG000|Overall Study|Lost to Follow-up|1|||
105342287|NCT00614120|363255375|FG002|Overall Study|hCG positive (not pregnant)|1|||
105342288|NCT00614120|363255376|FG003|Overall Study|hCG positive (not pregnant)|0|||
105554369|NCT01412944|364027371|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
105554370|NCT01412944|364027372|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
105554371|NCT01412944|364027373|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
105554372|NCT01412944|364027368|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
105554373|NCT01412944|364027369|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
105554374|NCT01412944|364027370|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
105554375|NCT01412944|364027371|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
105342289|NCT00614120|363255373|FG000|Overall Study|Hypoglycaemia|0|||
105342290|NCT00614120|363255374|FG001|Overall Study|Hypoglycaemia|0|||
105670740|NCT00818779|364458127|FG001|Overall Study|Lost to Follow-up|0|||
105670741|NCT00818779|364458126|FG000|Overall Study|Adverse Event|4|||
105670742|NCT00818779|364458127|FG001|Overall Study|Adverse Event|1|||
105670743|NCT03682302|364458128|FG000|Overall Study|Lost to Follow-up|1|||
105670744|NCT03682302|364458129|FG001|Overall Study|Lost to Follow-up|2|||
105670745|NCT03682302|364458130|FG002|Overall Study|Lost to Follow-up|0|||
105670746|NCT03682302|364458131|FG003|Overall Study|Lost to Follow-up|1|||
105670747|NCT03682302|364458128|FG000|Overall Study|Study drug was not administered|0|||
105670748|NCT03682302|364458129|FG001|Overall Study|Study drug was not administered|0|||
105670749|NCT03682302|364458130|FG002|Overall Study|Study drug was not administered|1|||
105670750|NCT03682302|364458131|FG003|Overall Study|Study drug was not administered|1|||
105670751|NCT01036438|364458132|FG000|Overall Study|Adverse Event|7|||
105670752|NCT01036438|364458133|FG001|Overall Study|Adverse Event|8|||
105670753|NCT01036438|364458132|FG000|Overall Study|Death|0|||
105670754|NCT01036438|364458133|FG001|Overall Study|Death|1|||
105670755|NCT01036438|364458132|FG000|Overall Study|No effect of study treatment|3|||
105670756|NCT01036438|364458133|FG001|Overall Study|No effect of study treatment|1|||
105670757|NCT01896726|364458134|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
105670758|NCT01896726|364458134|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
105670759|NCT01128114|364458135|FG000|Overall Study|Treatment Withdrawn|6|||
105670760|NCT01128114|364458135|FG000|Overall Study|Screening Failed|2|||
105670761|NCT00208325|364458139|FG000|Overall Study|Death|18|||
105670762|NCT00208325|364458140|FG001|Overall Study|Death|19|||
105670763|NCT00208325|364458141|FG002|Overall Study|Death|7|||
105670764|NCT00208325|364458142|FG003|Overall Study|Death|5|||
105670765|NCT00208325|364458139|FG000|Overall Study|Withdrawal by Subject|0|||
105670766|NCT00208325|364458140|FG001|Overall Study|Withdrawal by Subject|1|||
105670767|NCT00208325|364458141|FG002|Overall Study|Withdrawal by Subject|0|||
105670768|NCT00208325|364458142|FG003|Overall Study|Withdrawal by Subject|0|||
105670769|NCT00208325|364458139|FG000|Overall Study|Revision|4|||
105670770|NCT00208325|364458140|FG001|Overall Study|Revision|1|||
105670771|NCT00208325|364458141|FG002|Overall Study|Revision|0|||
105670772|NCT00208325|364458142|FG003|Overall Study|Revision|4|||
105670773|NCT00208325|364458139|FG000|Overall Study|Lost to Follow-up|1|||
105670774|NCT00208325|364458140|FG001|Overall Study|Lost to Follow-up|0|||
105670775|NCT00208325|364458141|FG002|Overall Study|Lost to Follow-up|2|||
105670776|NCT00208325|364458142|FG003|Overall Study|Lost to Follow-up|0|||
105670777|NCT00208325|364458139|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
105670778|NCT00208325|364458140|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
105670779|NCT00208325|364458141|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
105670780|NCT00208325|364458142|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
105670781|NCT00208325|364458139|FG000|Overall Study|Does not wish to Continue in Study|5|||
105670782|NCT00208325|364458140|FG001|Overall Study|Does not wish to Continue in Study|8|||
105670783|NCT00208325|364458141|FG002|Overall Study|Does not wish to Continue in Study|3|||
105670784|NCT00208325|364458142|FG003|Overall Study|Does not wish to Continue in Study|2|||
105670785|NCT00208325|364458139|FG000|Overall Study|Other|2|||
105670786|NCT00208325|364458140|FG001|Overall Study|Other|1|||
105670787|NCT00208325|364458141|FG002|Overall Study|Other|1|||
105670788|NCT00208325|364458142|FG003|Overall Study|Other|0|||
105670789|NCT00208325|364458139|FG000|Overall Study|Mis-Randomized|17|||
105670790|NCT00208325|364458140|FG001|Overall Study|Mis-Randomized|20|||
105670791|NCT00208325|364458141|FG002|Overall Study|Mis-Randomized|0|||
105670792|NCT00208325|364458142|FG003|Overall Study|Mis-Randomized|0|||
105670793|NCT01327846|364458143|FG000|Core Phase|Subject decision (vital status: missing)|1|||
105670794|NCT01327846|364458144|FG001|Core Phase|Subject decision (vital status: missing)|2|||
105670795|NCT01327846|364458145|FG002|Core Phase|Subject decision (vital status: missing)|2|||
105670796|NCT01327846|364458146|FG003|Core Phase|Subject decision (vital status: missing)|1|||
105670797|NCT01327846|364458143|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
105670798|NCT01327846|364458144|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
105670799|NCT01327846|364458145|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
105670800|NCT01327846|364458146|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
105670801|NCT01327846|364458143|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
105670802|NCT01327846|364458144|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
105554376|NCT01412944|364027372|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
105670803|NCT01327846|364458145|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
105670804|NCT01327846|364458146|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
105670805|NCT01327846|364458143|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
105670806|NCT01327846|364458144|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
105670807|NCT01327846|364458145|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
105670808|NCT01327846|364458146|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
105670809|NCT01327846|364458143|FG000|Core Phase|Lost to Follow-up|3|||
105670810|NCT01327846|364458144|FG001|Core Phase|Lost to Follow-up|3|||
105670811|NCT01327846|364458145|FG002|Core Phase|Lost to Follow-up|4|||
105670812|NCT01327846|364458146|FG003|Core Phase|Lost to Follow-up|5|||
105670813|NCT01327846|364458143|FG000|Extension Phase|Study terminated by sponsor|1073|||
105670814|NCT01327846|364458144|FG001|Extension Phase|Study terminated by sponsor|1124|||
105670815|NCT01327846|364458145|FG002|Extension Phase|Study terminated by sponsor|1067|||
105670816|NCT01327846|364458146|FG003|Extension Phase|Study terminated by sponsor|1660|||
105670817|NCT01327846|364458143|FG000|Extension Phase|Withdrawal by Subject|20|||
105670818|NCT01327846|364458144|FG001|Extension Phase|Withdrawal by Subject|13|||
105670819|NCT01327846|364458145|FG002|Extension Phase|Withdrawal by Subject|19|||
105670820|NCT01327846|364458146|FG003|Extension Phase|Withdrawal by Subject|37|||
105670821|NCT01327846|364458143|FG000|Extension Phase|Lost to Follow-up|4|||
105670822|NCT01327846|364458144|FG001|Extension Phase|Lost to Follow-up|3|||
105670823|NCT01327846|364458145|FG002|Extension Phase|Lost to Follow-up|4|||
105670824|NCT01327846|364458146|FG003|Extension Phase|Lost to Follow-up|7|||
105670825|NCT01327846|364458143|FG000|Extension Phase|Technical Problems|2|||
105670826|NCT01327846|364458144|FG001|Extension Phase|Technical Problems|4|||
105670827|NCT01327846|364458145|FG002|Extension Phase|Technical Problems|2|||
105670828|NCT01327846|364458146|FG003|Extension Phase|Technical Problems|2|||
105670829|NCT01989169|364458149|FG000|Period 2|Adverse Event|0|||
105670830|NCT01989169|364458150|FG001|Period 2|Adverse Event|1|||
105670831|NCT00203268|364458151|FG000|Early Treatment|only treated one headache|2|||
105670832|NCT00203268|364458151|FG000|Early Treatment|Lost to Follow-up|1|||
105670833|NCT00203268|364458151|FG000|Early Treatment|Withdrawal by Subject|1|||
105670834|NCT00846807|364458152|FG000|Overall Study|Adverse Event|270|||
105670835|NCT00846807|364458152|FG000|Overall Study|Lost to Follow-up|94|||
105670836|NCT00846807|364458152|FG000|Overall Study|Withdrawal by Subject|56|||
105670837|NCT00846807|364458152|FG000|Overall Study|Non compliant with European label|7|||
105670838|NCT00846807|364458152|FG000|Overall Study|Switch to other anticoagulants|89|||
105670839|NCT00846807|364458152|FG000|Overall Study|No prescription after hospital discharge|56|||
105670840|NCT00846807|364458152|FG000|Overall Study|Other|60|||
105670841|NCT00316017|364458159|FG000|Overall Study|Protocol Violation|11|||
105670842|NCT00316017|364458160|FG001|Overall Study|Protocol Violation|13|||
105670843|NCT00316017|364458161|FG002|Overall Study|Protocol Violation|19|||
105670844|NCT02592876|364458162|FG000|Overall Study|Withdrawal by Subject|3|||
105670845|NCT02592876|364458163|FG001|Overall Study|Withdrawal by Subject|3|||
105670846|NCT02592876|364458162|FG000|Overall Study|Study Termination by Sponsor|32|||
105670847|NCT02592876|364458163|FG001|Overall Study|Study Termination by Sponsor|27|||
105670848|NCT02592876|364458162|FG000|Overall Study|Lost to Follow-up|0|||
105670849|NCT02592876|364458163|FG001|Overall Study|Lost to Follow-up|1|||
105670850|NCT02592876|364458162|FG000|Overall Study|Death|6|||
105670851|NCT02592876|364458163|FG001|Overall Study|Death|9|||
105670852|NCT01133418|364458164|FG000|Overall Study|Lost to Follow-up|5|||
105670853|NCT01133418|364458165|FG001|Overall Study|Lost to Follow-up|6|||
105670854|NCT00611975|364458166|FG000|Overall Study|Withdrawal by Subject|3|||
105670855|NCT00611975|364458167|FG001|Overall Study|Withdrawal by Subject|7|||
105670856|NCT00611975|364458166|FG000|Overall Study|Pregnancy|2|||
105670857|NCT00611975|364458167|FG001|Overall Study|Pregnancy|1|||
105670858|NCT03345576|364458172|FG000|Overall Study|Withdrawal by Subject|2|||
105670859|NCT03345576|364458173|FG001|Overall Study|Withdrawal by Subject|2|||
105670860|NCT03345576|364458172|FG000|Overall Study|Adverse Event|1|||
105670861|NCT03345576|364458173|FG001|Overall Study|Adverse Event|0|||
105670862|NCT03829501|364460514|FG000|Overall Study|Withdrawal of Consent|2|||
105670863|NCT03829501|364460515|FG001|Overall Study|Withdrawal of Consent|0|||
105670864|NCT03829501|364460516|FG002|Overall Study|Withdrawal of Consent|3|||
105670865|NCT03829501|364460517|FG003|Overall Study|Withdrawal of Consent|0|||
105670866|NCT03829501|364460518|FG004|Overall Study|Withdrawal of Consent|1|||
105670867|NCT03829501|364460519|FG005|Overall Study|Withdrawal of Consent|1|||
105670868|NCT03829501|364460520|FG006|Overall Study|Withdrawal of Consent|0|||
105670869|NCT03829501|364460521|FG007|Overall Study|Withdrawal of Consent|10|||
105670870|NCT03829501|364460522|FG008|Overall Study|Withdrawal of Consent|10|||
105670871|NCT03829501|364460523|FG009|Overall Study|Withdrawal of Consent|3|||
105670872|NCT03829501|364460524|FG010|Overall Study|Withdrawal of Consent|4|||
105670873|NCT03829501|364460525|FG011|Overall Study|Withdrawal of Consent|4|||
105670874|NCT03829501|364460526|FG012|Overall Study|Withdrawal of Consent|4|||
105670875|NCT03829501|364460527|FG013|Overall Study|Withdrawal of Consent|0|||
105670876|NCT03829501|364460528|FG014|Overall Study|Withdrawal of Consent|3|||
105670877|NCT03829501|364460529|FG015|Overall Study|Withdrawal of Consent|0|||
105670878|NCT03829501|364460530|FG016|Overall Study|Withdrawal of Consent|1|||
105670879|NCT03829501|364460531|FG017|Overall Study|Withdrawal of Consent|1|||
105670880|NCT03829501|364460532|FG018|Overall Study|Withdrawal of Consent|0|||
105670881|NCT03829501|364460533|FG019|Overall Study|Withdrawal of Consent|0|||
105670882|NCT03829501|364460534|FG020|Overall Study|Withdrawal of Consent|3|||
105670883|NCT03829501|364460535|FG021|Overall Study|Withdrawal of Consent|0|||
105670884|NCT03829501|364460536|FG022|Overall Study|Withdrawal of Consent|1|||
105670885|NCT03829501|364460514|FG000|Overall Study|PD|0|||
105670886|NCT03829501|364460515|FG001|Overall Study|PD|0|||
105670887|NCT03829501|364460516|FG002|Overall Study|PD|0|||
105670888|NCT03829501|364460517|FG003|Overall Study|PD|2|||
105670889|NCT03829501|364460518|FG004|Overall Study|PD|0|||
105670890|NCT03829501|364460519|FG005|Overall Study|PD|0|||
105670891|NCT03829501|364460520|FG006|Overall Study|PD|0|||
105670892|NCT03829501|364460521|FG007|Overall Study|PD|0|||
105670893|NCT03829501|364460522|FG008|Overall Study|PD|0|||
105670894|NCT03829501|364460523|FG009|Overall Study|PD|0|||
105670895|NCT03829501|364460524|FG010|Overall Study|PD|0|||
105670896|NCT03829501|364460525|FG011|Overall Study|PD|0|||
105670897|NCT03829501|364460526|FG012|Overall Study|PD|0|||
105670898|NCT03829501|364460527|FG013|Overall Study|PD|0|||
105670899|NCT03829501|364460528|FG014|Overall Study|PD|0|||
105670900|NCT03829501|364460529|FG015|Overall Study|PD|1|||
105670901|NCT03829501|364460530|FG016|Overall Study|PD|0|||
105670902|NCT03829501|364460531|FG017|Overall Study|PD|0|||
105670903|NCT03829501|364460532|FG018|Overall Study|PD|0|||
105670904|NCT03829501|364460533|FG019|Overall Study|PD|0|||
105670905|NCT03829501|364460534|FG020|Overall Study|PD|1|||
105670906|NCT03829501|364460535|FG021|Overall Study|PD|0|||
105670907|NCT03829501|364460536|FG022|Overall Study|PD|0|||
105670908|NCT03829501|364460514|FG000|Overall Study|Study Terminated by Sponsor|0|||
105670909|NCT03829501|364460515|FG001|Overall Study|Study Terminated by Sponsor|0|||
105670910|NCT03829501|364460516|FG002|Overall Study|Study Terminated by Sponsor|0|||
105670911|NCT03829501|364460517|FG003|Overall Study|Study Terminated by Sponsor|0|||
105670912|NCT03829501|364460518|FG004|Overall Study|Study Terminated by Sponsor|0|||
105670913|NCT03829501|364460519|FG005|Overall Study|Study Terminated by Sponsor|0|||
105670914|NCT03829501|364460520|FG006|Overall Study|Study Terminated by Sponsor|0|||
105670915|NCT03829501|364460521|FG007|Overall Study|Study Terminated by Sponsor|3|||
105670916|NCT03829501|364460522|FG008|Overall Study|Study Terminated by Sponsor|1|||
105670917|NCT03829501|364460523|FG009|Overall Study|Study Terminated by Sponsor|0|||
105670918|NCT03829501|364460524|FG010|Overall Study|Study Terminated by Sponsor|0|||
105342291|NCT00614120|363255375|FG002|Overall Study|Hypoglycaemia|0|||
105342292|NCT00614120|363255376|FG003|Overall Study|Hypoglycaemia|1|||
105342293|NCT00614120|363255373|FG000|Overall Study|Lack of trial product|3|||
105342294|NCT00614120|363255374|FG001|Overall Study|Lack of trial product|3|||
105342295|NCT00614120|363255375|FG002|Overall Study|Lack of trial product|2|||
105342296|NCT00614120|363255376|FG003|Overall Study|Lack of trial product|0|||
105342297|NCT00614120|363255373|FG000|Overall Study|Late syphilis, latent|1|||
105342298|NCT00614120|363255374|FG001|Overall Study|Late syphilis, latent|0|||
105342299|NCT00614120|363255375|FG002|Overall Study|Late syphilis, latent|0|||
105342300|NCT00614120|363255376|FG003|Overall Study|Late syphilis, latent|0|||
105342301|NCT00614120|363255373|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
105342302|NCT00614120|363255374|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
105342303|NCT00614120|363255375|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
105342304|NCT00614120|363255376|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
105342305|NCT00614120|363255373|FG000|Overall Study|Lost to Follow-up|1|||
105342306|NCT00614120|363255374|FG001|Overall Study|Lost to Follow-up|2|||
105342307|NCT00614120|363255375|FG002|Overall Study|Lost to Follow-up|3|||
105342308|NCT00614120|363255376|FG003|Overall Study|Lost to Follow-up|4|||
105342309|NCT03409107|363255377|FG000|Overall Study|Withdrawal by Subject|4|||
105342310|NCT03409107|363255378|FG001|Overall Study|Withdrawal by Subject|2|||
105342311|NCT03409107|363255377|FG000|Overall Study|Physician Decision|1|||
105342312|NCT03409107|363255378|FG001|Overall Study|Physician Decision|0|||
105342313|NCT03409107|363255377|FG000|Overall Study|Lost to Follow-up|7|||
105342314|NCT03409107|363255378|FG001|Overall Study|Lost to Follow-up|2|||
105342315|NCT03409107|363255377|FG000|Overall Study|Adverse Event|5|||
105342316|NCT03409107|363255378|FG001|Overall Study|Adverse Event|3|||
105342317|NCT01185509|363255383|FG000|Overall Study|Progression/Relapse|9|||
105342318|NCT01185509|363255384|FG001|Overall Study|Progression/Relapse|15|||
105342319|NCT01185509|363255383|FG000|Overall Study|Physician Decision|2|||
105342320|NCT01185509|363255384|FG001|Overall Study|Physician Decision|2|||
105342321|NCT01185509|363255383|FG000|Overall Study|Withdrawal by Subject|0|||
105342322|NCT01185509|363255384|FG001|Overall Study|Withdrawal by Subject|1|||
105342323|NCT01185509|363255383|FG000|Overall Study|Death|0|||
105342324|NCT01185509|363255384|FG001|Overall Study|Death|1|||
105342325|NCT01185509|363255383|FG000|Overall Study|Intercurrent Illness|0|||
105342326|NCT01185509|363255384|FG001|Overall Study|Intercurrent Illness|1|||
105342327|NCT01104246|363255385|FG000|Overall Study|Withdrawal by Subject|1|||
105342328|NCT01104246|363255385|FG000|Overall Study|did not meet inclusion criteria|4|||
105670919|NCT03829501|364460525|FG011|Overall Study|Study Terminated by Sponsor|0|||
105670920|NCT03829501|364460526|FG012|Overall Study|Study Terminated by Sponsor|0|||
105670921|NCT03829501|364460527|FG013|Overall Study|Study Terminated by Sponsor|0|||
105342329|NCT01701193|363255397|FG000|Overall Study|Withdrawal by Subject|2|||
105342330|NCT01701193|363255398|FG001|Overall Study|Withdrawal by Subject|2|||
105342331|NCT01701193|363255399|FG002|Overall Study|Withdrawal by Subject|1|||
105342332|NCT01701193|363255400|FG003|Overall Study|Withdrawal by Subject|2|||
105342333|NCT01701193|363255397|FG000|Overall Study|Adverse Event|1|||
105342334|NCT01701193|363255398|FG001|Overall Study|Adverse Event|0|||
105342335|NCT01701193|363255399|FG002|Overall Study|Adverse Event|0|||
105554377|NCT01412944|364027373|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
105670922|NCT03829501|364460528|FG014|Overall Study|Study Terminated by Sponsor|3|||
105342336|NCT01701193|363255400|FG003|Overall Study|Adverse Event|0|||
105670923|NCT03829501|364460529|FG015|Overall Study|Study Terminated by Sponsor|2|||
105670924|NCT03829501|364460530|FG016|Overall Study|Study Terminated by Sponsor|2|||
105670925|NCT03829501|364460531|FG017|Overall Study|Study Terminated by Sponsor|0|||
105670926|NCT03829501|364460532|FG018|Overall Study|Study Terminated by Sponsor|0|||
105670927|NCT03829501|364460533|FG019|Overall Study|Study Terminated by Sponsor|0|||
105670928|NCT03829501|364460534|FG020|Overall Study|Study Terminated by Sponsor|1|||
105342337|NCT01546168|363255401|FG000|Overall Study|Lost to Follow-up|1|||
105342338|NCT01546168|363255402|FG001|Overall Study|Lost to Follow-up|0|||
105342339|NCT01546168|363255401|FG000|Overall Study|Withdrawal by Subject|1|||
105342340|NCT01546168|363255402|FG001|Overall Study|Withdrawal by Subject|0|||
105342341|NCT01546168|363255401|FG000|Overall Study|ineligible after signing consent|2|||
105342342|NCT01546168|363255402|FG001|Overall Study|ineligible after signing consent|0|||
105670929|NCT03829501|364460535|FG021|Overall Study|Study Terminated by Sponsor|0|||
105670930|NCT03829501|364460536|FG022|Overall Study|Study Terminated by Sponsor|3|||
105670931|NCT03829501|364460514|FG000|Overall Study|Lost to Follow Up|0|||
105342343|NCT06137703|363255403|FG000|Overall Study|Other|0|||
105342344|NCT06137703|363255404|FG001|Overall Study|Other|1|||
105342345|NCT06137703|363255405|FG002|Overall Study|Other|0|||
105670932|NCT03829501|364460515|FG001|Overall Study|Lost to Follow Up|0|||
105670933|NCT03829501|364460516|FG002|Overall Study|Lost to Follow Up|0|||
105342346|NCT06137703|363255406|FG003|Overall Study|Other|0|||
105342347|NCT06137703|363255403|FG000|Overall Study|Adverse Event|0|||
105670934|NCT03829501|364460517|FG003|Overall Study|Lost to Follow Up|0|||
105670935|NCT03829501|364460518|FG004|Overall Study|Lost to Follow Up|1|||
105670936|NCT03829501|364460519|FG005|Overall Study|Lost to Follow Up|0|||
105670937|NCT03829501|364460520|FG006|Overall Study|Lost to Follow Up|0|||
105670938|NCT03829501|364460521|FG007|Overall Study|Lost to Follow Up|2|||
105670939|NCT03829501|364460522|FG008|Overall Study|Lost to Follow Up|2|||
105670940|NCT03829501|364460523|FG009|Overall Study|Lost to Follow Up|0|||
105670941|NCT03829501|364460524|FG010|Overall Study|Lost to Follow Up|2|||
105670942|NCT03829501|364460525|FG011|Overall Study|Lost to Follow Up|1|||
105670943|NCT03829501|364460526|FG012|Overall Study|Lost to Follow Up|0|||
105670944|NCT03829501|364460527|FG013|Overall Study|Lost to Follow Up|1|||
105670945|NCT03829501|364460528|FG014|Overall Study|Lost to Follow Up|1|||
105670946|NCT03829501|364460529|FG015|Overall Study|Lost to Follow Up|0|||
105670947|NCT03829501|364460530|FG016|Overall Study|Lost to Follow Up|0|||
105670948|NCT03829501|364460531|FG017|Overall Study|Lost to Follow Up|0|||
105670949|NCT03829501|364460532|FG018|Overall Study|Lost to Follow Up|0|||
105670950|NCT03829501|364460533|FG019|Overall Study|Lost to Follow Up|0|||
105670951|NCT03829501|364460534|FG020|Overall Study|Lost to Follow Up|0|||
105670952|NCT03829501|364460535|FG021|Overall Study|Lost to Follow Up|0|||
105670953|NCT03829501|364460536|FG022|Overall Study|Lost to Follow Up|1|||
105670954|NCT03829501|364460514|FG000|Overall Study|Death|2|||
105670955|NCT03829501|364460515|FG001|Overall Study|Death|4|||
105670956|NCT03829501|364460516|FG002|Overall Study|Death|5|||
105670957|NCT03829501|364460517|FG003|Overall Study|Death|6|||
105670958|NCT03829501|364460518|FG004|Overall Study|Death|5|||
105670959|NCT03829501|364460519|FG005|Overall Study|Death|4|||
105670960|NCT03829501|364460520|FG006|Overall Study|Death|5|||
105342348|NCT06137703|363255404|FG001|Overall Study|Adverse Event|0|||
105342349|NCT06137703|363255405|FG002|Overall Study|Adverse Event|1|||
105342350|NCT06137703|363255406|FG003|Overall Study|Adverse Event|0|||
105342351|NCT01618019|363255409|FG000|Overall Study|Withdrawal by Subject|14|||
105342352|NCT01618019|363255410|FG001|Overall Study|Withdrawal by Subject|14|||
105342353|NCT02612610|363255411|FG000|Overall Study|Withdrawal by Subject|1|||
105342354|NCT02612610|363255412|FG001|Overall Study|Withdrawal by Subject|1|||
105342355|NCT02612610|363255413|FG002|Overall Study|Withdrawal by Subject|0|||
105342356|NCT02612610|363255414|FG003|Overall Study|Withdrawal by Subject|2|||
105342357|NCT02612610|363255411|FG000|Overall Study|Adverse Event|2|||
105342358|NCT02612610|363255412|FG001|Overall Study|Adverse Event|2|||
105342359|NCT02612610|363255413|FG002|Overall Study|Adverse Event|3|||
105342360|NCT02612610|363255414|FG003|Overall Study|Adverse Event|10|||
105342361|NCT02612610|363255411|FG000|Overall Study|Lost to Follow-up|0|||
105342362|NCT02612610|363255412|FG001|Overall Study|Lost to Follow-up|1|||
105342363|NCT02612610|363255413|FG002|Overall Study|Lost to Follow-up|0|||
105342364|NCT02612610|363255414|FG003|Overall Study|Lost to Follow-up|0|||
105342365|NCT02612610|363255411|FG000|Overall Study|Protocol Violation|0|||
105342366|NCT02612610|363255412|FG001|Overall Study|Protocol Violation|1|||
105342367|NCT02612610|363255413|FG002|Overall Study|Protocol Violation|1|||
105342368|NCT02612610|363255414|FG003|Overall Study|Protocol Violation|0|||
105342369|NCT02612610|363255411|FG000|Overall Study|Lack of Efficacy|1|||
105342370|NCT02612610|363255412|FG001|Overall Study|Lack of Efficacy|2|||
105342371|NCT02612610|363255413|FG002|Overall Study|Lack of Efficacy|0|||
105342372|NCT02612610|363255414|FG003|Overall Study|Lack of Efficacy|1|||
105342373|NCT02612610|363255411|FG000|Overall Study|Physician Decision|0|||
105342374|NCT02612610|363255412|FG001|Overall Study|Physician Decision|1|||
105342375|NCT02612610|363255413|FG002|Overall Study|Physician Decision|0|||
105342376|NCT02612610|363255414|FG003|Overall Study|Physician Decision|0|||
105670961|NCT03829501|364460521|FG007|Overall Study|Death|24|||
105670962|NCT03829501|364460522|FG008|Overall Study|Death|22|||
105670963|NCT03829501|364460523|FG009|Overall Study|Death|6|||
105670964|NCT03829501|364460524|FG010|Overall Study|Death|3|||
105670965|NCT03829501|364460525|FG011|Overall Study|Death|10|||
105670966|NCT03829501|364460526|FG012|Overall Study|Death|10|||
105670967|NCT03829501|364460527|FG013|Overall Study|Death|5|||
105670968|NCT03829501|364460528|FG014|Overall Study|Death|7|||
105670969|NCT03829501|364460529|FG015|Overall Study|Death|2|||
105670970|NCT03829501|364460530|FG016|Overall Study|Death|2|||
105466613|NCT03853109|363720184|FG001|Overall Study|Death|5|||
105554378|NCT01412944|364027368|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
105554379|NCT01412944|364027369|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
105554380|NCT01412944|364027370|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
105554381|NCT01412944|364027371|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
105554382|NCT01412944|364027372|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
105554383|NCT01412944|364027373|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
105554384|NCT01412944|364027368|FG000|Entire: IV + Maintenance|Adverse Event|0|||
105554385|NCT01412944|364027369|FG001|Entire: IV + Maintenance|Adverse Event|0|||
105554386|NCT01412944|364027370|FG002|Entire: IV + Maintenance|Adverse Event|0|||
105554387|NCT01412944|364027371|FG003|Entire: IV + Maintenance|Adverse Event|0|||
105554388|NCT01412944|364027372|FG004|Entire: IV + Maintenance|Adverse Event|1|||
105554389|NCT01412944|364027373|FG005|Entire: IV + Maintenance|Adverse Event|0|||
105554390|NCT01412944|364027368|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
105554391|NCT01412944|364027369|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
105554392|NCT01412944|364027370|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
105554393|NCT01412944|364027371|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
105554394|NCT01412944|364027372|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
105554395|NCT01412944|364027373|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
105554396|NCT01412944|364027368|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
105554397|NCT01412944|364027369|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
105554398|NCT01412944|364027370|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
105554399|NCT01412944|364027371|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
105554400|NCT01412944|364027372|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
105554401|NCT01412944|364027373|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
105554402|NCT01412944|364027368|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
105554403|NCT01412944|364027369|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
105554404|NCT01412944|364027370|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
105554405|NCT01412944|364027371|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
105554406|NCT01412944|364027372|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
105554407|NCT01412944|364027373|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
105554408|NCT01412944|364027368|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
105554409|NCT01412944|364027369|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
105554410|NCT01412944|364027370|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
105554411|NCT01412944|364027371|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
105554412|NCT01412944|364027372|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
105554413|NCT01412944|364027373|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
105554414|NCT01412944|364027368|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
105554415|NCT01412944|364027369|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
105554416|NCT01412944|364027370|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
105554417|NCT01412944|364027371|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
105554418|NCT01412944|364027372|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
105554419|NCT01412944|364027373|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
105554420|NCT01412944|364027368|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
105554421|NCT01412944|364027369|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
105554422|NCT01412944|364027370|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
105554423|NCT01412944|364027371|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
105554424|NCT01412944|364027372|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
105554425|NCT01412944|364027373|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
105554426|NCT01412944|364027368|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
105554427|NCT01412944|364027369|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
105554428|NCT01412944|364027370|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
105554429|NCT01412944|364027371|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
105554430|NCT01412944|364027372|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
105554431|NCT01412944|364027373|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
105554432|NCT01412944|364027368|FG000|Entire: IV + Maintenance|Adverse Event|0|||
105554433|NCT01412944|364027369|FG001|Entire: IV + Maintenance|Adverse Event|1|||
105554434|NCT01412944|364027370|FG002|Entire: IV + Maintenance|Adverse Event|0|||
105554435|NCT01412944|364027371|FG003|Entire: IV + Maintenance|Adverse Event|0|||
105554436|NCT01412944|364027372|FG004|Entire: IV + Maintenance|Adverse Event|0|||
105554437|NCT01412944|364027373|FG005|Entire: IV + Maintenance|Adverse Event|0|||
105554438|NCT00360308|364027375|FG000|Overall Study|Adverse Event|15|||
105554439|NCT00360308|364027376|FG001|Overall Study|Adverse Event|14|||
105554440|NCT00360308|364027377|FG002|Overall Study|Adverse Event|25|||
105554441|NCT00360308|364027375|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
105554442|NCT00360308|364027376|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
105554443|NCT00360308|364027377|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
105554444|NCT00360308|364027375|FG000|Overall Study|Protocol Violation|2|||
105342377|NCT02612610|363255411|FG000|Overall Study|Noncompliance|1|||
105342378|NCT02612610|363255412|FG001|Overall Study|Noncompliance|0|||
105342379|NCT02612610|363255413|FG002|Overall Study|Noncompliance|0|||
105670971|NCT03829501|364460531|FG017|Overall Study|Death|1|||
105670972|NCT03829501|364460532|FG018|Overall Study|Death|1|||
105670973|NCT03829501|364460533|FG019|Overall Study|Death|1|||
105670974|NCT03829501|364460534|FG020|Overall Study|Death|1|||
105670975|NCT03829501|364460535|FG021|Overall Study|Death|2|||
105670976|NCT03829501|364460536|FG022|Overall Study|Death|3|||
105670977|NCT03829501|364460514|FG000|Overall Study|Miscellaneous|0|||
105670978|NCT03829501|364460515|FG001|Overall Study|Miscellaneous|0|||
105670979|NCT03829501|364460516|FG002|Overall Study|Miscellaneous|1|||
105670980|NCT03829501|364460517|FG003|Overall Study|Miscellaneous|0|||
105670981|NCT03829501|364460518|FG004|Overall Study|Miscellaneous|0|||
105670982|NCT03829501|364460519|FG005|Overall Study|Miscellaneous|0|||
105670983|NCT03829501|364460520|FG006|Overall Study|Miscellaneous|0|||
105670984|NCT03829501|364460521|FG007|Overall Study|Miscellaneous|1|||
105670985|NCT03829501|364460522|FG008|Overall Study|Miscellaneous|0|||
105670986|NCT03829501|364460523|FG009|Overall Study|Miscellaneous|0|||
105670987|NCT03829501|364460524|FG010|Overall Study|Miscellaneous|0|||
105670988|NCT03829501|364460525|FG011|Overall Study|Miscellaneous|0|||
105670989|NCT03829501|364460526|FG012|Overall Study|Miscellaneous|0|||
105670990|NCT03829501|364460527|FG013|Overall Study|Miscellaneous|0|||
105670991|NCT03829501|364460528|FG014|Overall Study|Miscellaneous|0|||
105670992|NCT03829501|364460529|FG015|Overall Study|Miscellaneous|0|||
105670993|NCT03829501|364460530|FG016|Overall Study|Miscellaneous|0|||
105670994|NCT03829501|364460531|FG017|Overall Study|Miscellaneous|0|||
105670995|NCT03829501|364460532|FG018|Overall Study|Miscellaneous|0|||
105670996|NCT03829501|364460533|FG019|Overall Study|Miscellaneous|0|||
105342380|NCT02612610|363255414|FG003|Overall Study|Noncompliance|0|||
105342381|NCT02612610|363255411|FG000|Overall Study|Cough Improvement|0|||
105342382|NCT02612610|363255412|FG001|Overall Study|Cough Improvement|0|||
105342383|NCT02612610|363255413|FG002|Overall Study|Cough Improvement|1|||
105342384|NCT02612610|363255414|FG003|Overall Study|Cough Improvement|0|||
105342385|NCT00471718|363255416|FG000|Overall Study|Adverse Event|3|||
105342386|NCT00471718|363255416|FG000|Overall Study|other complicating disease|1|||
105670997|NCT03829501|364460534|FG020|Overall Study|Miscellaneous|0|||
105342387|NCT00471718|363255416|FG000|Overall Study|disease progression|22|||
105342388|NCT00471718|363255416|FG000|Overall Study|Withdrawal by Subject|1|||
105342389|NCT00347919|363255417|FG000|Overall Study|Lost to Follow-up|11|||
105342390|NCT00347919|363255418|FG001|Overall Study|Lost to Follow-up|13|||
105342391|NCT00347919|363255419|FG002|Overall Study|Lost to Follow-up|0|||
105342392|NCT00347919|363255417|FG000|Overall Study|Withdrawal by Subject|6|||
105342393|NCT00347919|363255418|FG001|Overall Study|Withdrawal by Subject|8|||
105342394|NCT00347919|363255419|FG002|Overall Study|Withdrawal by Subject|0|||
105342395|NCT00347919|363255417|FG000|Overall Study|Physician Decision|1|||
105342396|NCT00347919|363255418|FG001|Overall Study|Physician Decision|1|||
105342397|NCT00347919|363255419|FG002|Overall Study|Physician Decision|0|||
105342398|NCT00347919|363255417|FG000|Overall Study|Sponsor terminated study|15|||
105670998|NCT03829501|364460535|FG021|Overall Study|Miscellaneous|0|||
105670999|NCT03829501|364460536|FG022|Overall Study|Miscellaneous|1|||
105342399|NCT00347919|363255418|FG001|Overall Study|Sponsor terminated study|10|||
105342400|NCT00347919|363255419|FG002|Overall Study|Sponsor terminated study|16|||
105342401|NCT00347919|363255417|FG000|Overall Study|Death|35|||
105671000|NCT00747227|364460537|FG000|Overall Study|Death|3|||
105671001|NCT00747227|364460538|FG001|Overall Study|Death|1|||
105671002|NCT00747227|364460537|FG000|Overall Study|Withdrawal by Subject|1|||
105671003|NCT00747227|364460538|FG001|Overall Study|Withdrawal by Subject|0|||
105671004|NCT00747227|364460537|FG000|Overall Study|Lost to Follow-up|1|||
105671005|NCT00747227|364460538|FG001|Overall Study|Lost to Follow-up|2|||
105671006|NCT00747227|364460537|FG000|Overall Study|Illness|1|||
105671007|NCT00747227|364460538|FG001|Overall Study|Illness|1|||
105554445|NCT00360308|364027376|FG001|Overall Study|Protocol Violation|1|||
105554446|NCT00360308|364027377|FG002|Overall Study|Protocol Violation|2|||
105554447|NCT00360308|364027375|FG000|Overall Study|Withdrawal by Subject|11|||
105554448|NCT00360308|364027376|FG001|Overall Study|Withdrawal by Subject|7|||
105554449|NCT00360308|364027377|FG002|Overall Study|Withdrawal by Subject|14|||
105554450|NCT00360308|364027375|FG000|Overall Study|Lack of Efficacy|3|||
105554451|NCT00360308|364027376|FG001|Overall Study|Lack of Efficacy|0|||
105554452|NCT00360308|364027377|FG002|Overall Study|Lack of Efficacy|2|||
105554453|NCT00360308|364027375|FG000|Overall Study|Other|2|||
105554454|NCT00360308|364027376|FG001|Overall Study|Other|1|||
105554455|NCT00360308|364027377|FG002|Overall Study|Other|1|||
105554456|NCT00360308|364027375|FG000|Overall Study|Study termination by sponsor|43|||
105554457|NCT00360308|364027376|FG001|Overall Study|Study termination by sponsor|55|||
105554458|NCT00360308|364027377|FG002|Overall Study|Study termination by sponsor|44|||
105554459|NCT03422250|364027378|FG000|Intervention|Adverse Event|0|||
105554460|NCT03422250|364027379|FG001|Intervention|Adverse Event|1|||
105554461|NCT03422250|364027380|FG002|Intervention|Adverse Event|0|||
105554462|NCT03422250|364027381|FG003|Intervention|Adverse Event|1|||
105554463|NCT03422250|364027378|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
105554464|NCT03422250|364027379|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
105671008|NCT00379288|364460545|FG000|Overall Study|Adverse Event|5|||
105671009|NCT00379288|364460546|FG001|Overall Study|Adverse Event|6|||
105671010|NCT00379288|364460547|FG002|Overall Study|Adverse Event|2|||
105671011|NCT00379288|364460548|FG003|Overall Study|Adverse Event|0|||
105671012|NCT00379288|364460545|FG000|Overall Study|Treatment Failure|0|||
105671013|NCT00379288|364460546|FG001|Overall Study|Treatment Failure|1|||
105671014|NCT00379288|364460547|FG002|Overall Study|Treatment Failure|0|||
105671015|NCT00379288|364460548|FG003|Overall Study|Treatment Failure|1|||
105671016|NCT00379288|364460545|FG000|Overall Study|Lost to Follow-up|3|||
105671017|NCT00379288|364460546|FG001|Overall Study|Lost to Follow-up|3|||
105671018|NCT00379288|364460547|FG002|Overall Study|Lost to Follow-up|2|||
105671019|NCT00379288|364460548|FG003|Overall Study|Lost to Follow-up|0|||
105671020|NCT00379288|364460545|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
105671021|NCT00379288|364460546|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
105671022|NCT00379288|364460547|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
105671023|NCT00379288|364460548|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
105671024|NCT00379288|364460545|FG000|Overall Study|Subject withdrew-related to study drug|1|||
105671025|NCT00379288|364460546|FG001|Overall Study|Subject withdrew-related to study drug|0|||
105671026|NCT00379288|364460547|FG002|Overall Study|Subject withdrew-related to study drug|0|||
105671027|NCT00379288|364460548|FG003|Overall Study|Subject withdrew-related to study drug|1|||
105671028|NCT00379288|364460545|FG000|Overall Study|Noncompliance with protocol|8|||
105786199|NCT00972309|364870477|FG000|Overall Study|Switched to alternative treatment|0|||
105786200|NCT00972309|364870478|FG001|Overall Study|Switched to alternative treatment|2|||
105671029|NCT00379288|364460546|FG001|Overall Study|Noncompliance with protocol|6|||
105671030|NCT00379288|364460547|FG002|Overall Study|Noncompliance with protocol|2|||
105671031|NCT00379288|364460548|FG003|Overall Study|Noncompliance with protocol|1|||
105342402|NCT00347919|363255418|FG001|Overall Study|Death|42|||
105342403|NCT00347919|363255419|FG002|Overall Study|Death|19|||
105342404|NCT00347919|363255417|FG000|Overall Study|Par. Started Other Treatment|1|||
105342405|NCT00347919|363255418|FG001|Overall Study|Par. Started Other Treatment|1|||
105342406|NCT00347919|363255419|FG002|Overall Study|Par. Started Other Treatment|1|||
105342407|NCT00347919|363255417|FG000|Overall Study|Missing|2|||
105342408|NCT00347919|363255418|FG001|Overall Study|Missing|1|||
105342409|NCT00347919|363255419|FG002|Overall Study|Missing|2|||
105342410|NCT01446237|363255420|FG000|Overall Study|Adverse Event|1|||
105342411|NCT01446237|363255420|FG000|Overall Study|Lost to Follow-up|2|||
105342412|NCT01446237|363255420|FG000|Overall Study|Withdrawal by Subject|7|||
105342413|NCT04017832|363255421|FG000|Overall Study|Withdrawal by Subject|13|||
105342414|NCT04017832|363255422|FG001|Overall Study|Withdrawal by Subject|12|||
105342415|NCT04017832|363255423|FG002|Overall Study|Withdrawal by Subject|21|||
105342416|NCT04017832|363255424|FG003|Overall Study|Withdrawal by Subject|7|||
105342417|NCT04017832|363255421|FG000|Overall Study|Lost to Follow-up|0|||
105342418|NCT04017832|363255422|FG001|Overall Study|Lost to Follow-up|3|||
105554465|NCT03422250|364027380|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
105554466|NCT03422250|364027381|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
105342419|NCT04017832|363255423|FG002|Overall Study|Lost to Follow-up|3|||
105342420|NCT04017832|363255424|FG003|Overall Study|Lost to Follow-up|1|||
105342421|NCT04017832|363255421|FG000|Overall Study|Physician Decision|1|||
105342422|NCT04017832|363255422|FG001|Overall Study|Physician Decision|1|||
105342423|NCT04017832|363255423|FG002|Overall Study|Physician Decision|1|||
105342424|NCT04017832|363255424|FG003|Overall Study|Physician Decision|1|||
105342425|NCT04017832|363255421|FG000|Overall Study|Death|2|||
105342426|NCT04017832|363255422|FG001|Overall Study|Death|2|||
105342427|NCT04017832|363255423|FG002|Overall Study|Death|1|||
105342428|NCT04017832|363255424|FG003|Overall Study|Death|0|||
105342429|NCT02484651|363255427|FG000|Overall Study|Patients' data files were corrupted.|1|||
105342430|NCT02484651|363255428|FG001|Overall Study|Patients' data files were corrupted.|1|||
105342431|NCT02484651|363255427|FG000|Overall Study|BIS monitoring failed.|1|||
105342432|NCT02484651|363255428|FG001|Overall Study|BIS monitoring failed.|1|||
105342433|NCT02484651|363255427|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
105342434|NCT02484651|363255428|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
105342435|NCT00150800|363255429|FG000|Overall Study|Adverse Event|89|||
105342436|NCT00150800|363255429|FG000|Overall Study|Death|18|||
105342437|NCT00150800|363255429|FG000|Overall Study|Lack of Efficacy|166|||
105342438|NCT00150800|363255429|FG000|Overall Study|Lost to Follow-up|58|||
105342439|NCT00150800|363255429|FG000|Overall Study|Subject's choice|90|||
105342440|NCT00150800|363255429|FG000|Overall Study|No compliance|18|||
105342441|NCT00150800|363255429|FG000|Overall Study|IP misshandling|1|||
105342442|NCT00150800|363255429|FG000|Overall Study|Site closure|24|||
105342443|NCT00150800|363255429|FG000|Overall Study|Protocol non-adherence|2|||
105342444|NCT00150800|363255429|FG000|Overall Study|Nobody to accompany patient|1|||
105342445|NCT00150800|363255429|FG000|Overall Study|Distance too long for patient|1|||
105342446|NCT00150800|363255429|FG000|Overall Study|Neurosurgery|2|||
105342447|NCT00150800|363255429|FG000|Overall Study|BRV monotherapy|1|||
105342448|NCT00150800|363255429|FG000|Overall Study|Visit refusal|3|||
105342449|NCT00150800|363255429|FG000|Overall Study|Sponsor's request|2|||
105342450|NCT00150800|363255429|FG000|Overall Study|Generalized Epilepsy|1|||
105342451|NCT00150800|363255429|FG000|Overall Study|Moved from area/country|8|||
105342452|NCT00150800|363255429|FG000|Overall Study|PI retiring|2|||
105342453|NCT00150800|363255429|FG000|Overall Study|PI leaving site|2|||
105342454|NCT00150800|363255429|FG000|Overall Study|Patient insurance|1|||
105342455|NCT00150800|363255429|FG000|Overall Study|Surgical intervention|4|||
105342456|NCT00150800|363255429|FG000|Overall Study|Pregnancy planned|1|||
105342457|NCT00150800|363255429|FG000|Overall Study|PI discontinuation request|1|||
105342458|NCT04696354|363255438|FG000|Overall Study|Study termination|6|||
105342459|NCT04696354|363255439|FG001|Overall Study|Study termination|6|||
105342460|NCT04545567|363255443|FG000|Overall Study|tested positive for SARS-co-V2|1|||
105342461|NCT04545567|363255444|FG001|Overall Study|tested positive for SARS-co-V2|1|||
105342462|NCT04545567|363255443|FG000|Overall Study|Withdrawal by Subject|0|||
105342463|NCT04545567|363255444|FG001|Overall Study|Withdrawal by Subject|1|||
105342464|NCT02419612|363255450|FG000|Short-term Treatment Period|Adverse Event|1|||
105554467|NCT03422250|364027378|FG000|Follow-up|Withdrawal by Subject|0|||
105554468|NCT03422250|364027379|FG001|Follow-up|Withdrawal by Subject|0|||
105554469|NCT03422250|364027380|FG002|Follow-up|Withdrawal by Subject|0|||
105342465|NCT02419612|363255451|FG001|Short-term Treatment Period|Adverse Event|1|||
105342466|NCT02419612|363255450|FG000|Short-term Treatment Period|Death|0|||
105342467|NCT02419612|363255451|FG001|Short-term Treatment Period|Death|2|||
105342468|NCT02419612|363255450|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
105554470|NCT03422250|364027381|FG003|Follow-up|Withdrawal by Subject|1|||
105342469|NCT02419612|363255451|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
105342470|NCT02419612|363255450|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
105342471|NCT02419612|363255451|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
105342472|NCT02419612|363255450|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
105671032|NCT00379288|364460545|FG000|Overall Study|Did not meet protocol eligibility|0|||
105671033|NCT00379288|364460546|FG001|Overall Study|Did not meet protocol eligibility|1|||
105671034|NCT00379288|364460547|FG002|Overall Study|Did not meet protocol eligibility|0|||
105671035|NCT00379288|364460548|FG003|Overall Study|Did not meet protocol eligibility|2|||
105671036|NCT00379288|364460545|FG000|Overall Study|Administrative|2|||
105671037|NCT00379288|364460546|FG001|Overall Study|Administrative|2|||
105671038|NCT00379288|364460547|FG002|Overall Study|Administrative|0|||
105671039|NCT00379288|364460548|FG003|Overall Study|Administrative|1|||
105671040|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
105671041|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
105671042|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
105671043|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
105671044|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Death|13|||
105671045|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Death|12|||
105671046|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Progression|257|||
105671047|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Progression|218|||
105671048|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
105671049|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
105671050|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
105671051|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
105671052|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
105671053|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
105554471|NCT03422250|364027378|FG000|Follow-up|Adverse Event|0|||
105554472|NCT03422250|364027379|FG001|Follow-up|Adverse Event|0|||
105554473|NCT03422250|364027380|FG002|Follow-up|Adverse Event|0|||
105554474|NCT03422250|364027381|FG003|Follow-up|Adverse Event|1|||
105554475|NCT04786444|364027382|FG000|Overall Study|Withdrawal by Subject|4|||
105554476|NCT04786444|364027383|FG001|Overall Study|Withdrawal by Subject|7|||
105554477|NCT04786444|364027384|FG002|Overall Study|Withdrawal by Subject|2|||
105554478|NCT04786444|364027382|FG000|Overall Study|Lost to Follow-up|11|||
105554479|NCT04786444|364027383|FG001|Overall Study|Lost to Follow-up|9|||
105554480|NCT04786444|364027384|FG002|Overall Study|Lost to Follow-up|10|||
105554481|NCT04786444|364027382|FG000|Overall Study|Subject would like to become pregnant|0|||
105554482|NCT04786444|364027383|FG001|Overall Study|Subject would like to become pregnant|1|||
105554483|NCT04786444|364027384|FG002|Overall Study|Subject would like to become pregnant|0|||
105554484|NCT02388724|364027385|FG000|Overall Study|Reason not Specified|0|||
105671054|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
105671055|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
105671056|NCT01006980|364460549|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
105342473|NCT02419612|363255451|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
105342474|NCT02419612|363255450|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
105342475|NCT02419612|363255451|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
105342476|NCT02419612|363255450|FG000|Short-term Treatment Period|Worsening of liver function|0|||
105342477|NCT02419612|363255451|FG001|Short-term Treatment Period|Worsening of liver function|1|||
105342478|NCT02419612|363255450|FG000|Short-term Treatment Period|Subject moved out of state|0|||
105342479|NCT02419612|363255451|FG001|Short-term Treatment Period|Subject moved out of state|1|||
105342480|NCT02419612|363255450|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
105342481|NCT02419612|363255451|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
105342482|NCT02419612|363255450|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
105342483|NCT02419612|363255451|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
105342484|NCT02419612|363255450|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
105342485|NCT02419612|363255451|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
105342486|NCT02419612|363255450|FG000|Long-term Treatment Period|Death|0|||
105342487|NCT02419612|363255451|FG001|Long-term Treatment Period|Death|1|||
105342488|NCT02419612|363255450|FG000|Long-term Treatment Period|Adverse Event|0|||
105342489|NCT02419612|363255451|FG001|Long-term Treatment Period|Adverse Event|5|||
105342490|NCT02419612|363255450|FG000|Long-term Treatment Period|Other|4|||
105342491|NCT02419612|363255451|FG001|Long-term Treatment Period|Other|4|||
105342492|NCT02419612|363255450|FG000|Long-term Treatment Period|Subject Decision|2|||
105342493|NCT02419612|363255451|FG001|Long-term Treatment Period|Subject Decision|4|||
105342494|NCT02419612|363255450|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
105342495|NCT02419612|363255451|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
105342496|NCT00474045|363255452|FG000|Overall Study|Adverse Event|18|||
105342497|NCT00474045|363255453|FG001|Overall Study|Adverse Event|8|||
105342498|NCT00474045|363255452|FG000|Overall Study|Unclassified|1|||
105342499|NCT00474045|363255453|FG001|Overall Study|Unclassified|3|||
105342500|NCT00474045|363255452|FG000|Overall Study|Lack of Efficacy|0|||
105342501|NCT00474045|363255453|FG001|Overall Study|Lack of Efficacy|9|||
105342502|NCT00474045|363255452|FG000|Overall Study|Lost to Follow-up|1|||
105342503|NCT00474045|363255453|FG001|Overall Study|Lost to Follow-up|1|||
105342504|NCT00474045|363255452|FG000|Overall Study|Protocol Violation|10|||
105342505|NCT00474045|363255453|FG001|Overall Study|Protocol Violation|12|||
105342506|NCT00474045|363255452|FG000|Overall Study|Withdrawal by Subject|16|||
105342507|NCT00474045|363255453|FG001|Overall Study|Withdrawal by Subject|18|||
105342508|NCT00474045|363255452|FG000|Overall Study|Withdrawal criteria|60|||
105342509|NCT00474045|363255453|FG001|Overall Study|Withdrawal criteria|50|||
105342510|NCT00808639|363255460|FG000|Overall Study|Disease progression before surgery.|1|||
105342511|NCT03197324|363255463|FG000|Overall Study|Adverse Event|0|||
105342512|NCT03197324|363255464|FG001|Overall Study|Adverse Event|1|||
105342513|NCT03057054|363255467|FG000|Overall Study|Death|4|||
105342514|NCT03057054|363255468|FG001|Overall Study|Death|4|||
105342515|NCT03057054|363255467|FG000|Overall Study|Withdrawal by Subject|6|||
105342516|NCT03057054|363255468|FG001|Overall Study|Withdrawal by Subject|3|||
105342517|NCT03057054|363255467|FG000|Overall Study|Ineligible|1|||
105342518|NCT03057054|363255468|FG001|Overall Study|Ineligible|1|||
105342519|NCT01790828|363255470|FG000|Overall Study|Other|34|||
105342520|NCT01984892|363255471|FG000|Overall Study|Progressive disease|7|||
105554485|NCT02388724|364027386|FG001|Overall Study|Reason not Specified|1|||
105554486|NCT02388724|364027385|FG000|Overall Study|Major Protocol Deviation|3|||
105554487|NCT02388724|364027386|FG001|Overall Study|Major Protocol Deviation|3|||
105554488|NCT02388724|364027385|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
105554489|NCT02388724|364027386|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
105554490|NCT02388724|364027385|FG000|Overall Study|Voluntary Withdrawal|6|||
105554491|NCT02388724|364027386|FG001|Overall Study|Voluntary Withdrawal|5|||
105554492|NCT02388724|364027385|FG000|Overall Study|Randomized but not Treated|0|||
105554493|NCT02388724|364027386|FG001|Overall Study|Randomized but not Treated|2|||
105554494|NCT01217073|364027387|FG000|Base Period|Adverse Event|1|||
105554495|NCT01217073|364027388|FG001|Base Period|Adverse Event|0|||
105554496|NCT01217073|364027389|FG002|Base Period|Adverse Event|1|||
105554497|NCT01217073|364027390|FG003|Base Period|Adverse Event|0|||
105554498|NCT01217073|364027391|FG004|Base Period|Adverse Event|4|||
105554499|NCT01217073|364027392|FG005|Base Period|Adverse Event|1|||
105554500|NCT01217073|364027393|FG006|Base Period|Adverse Event|0|||
105554501|NCT01217073|364027394|FG007|Base Period|Adverse Event|0|||
105554502|NCT01217073|364027387|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
105554503|NCT01217073|364027388|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
105554504|NCT01217073|364027389|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
105554505|NCT01217073|364027390|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
105554506|NCT01217073|364027391|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
105671057|NCT01006980|364460550|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
105671058|NCT01006980|364460549|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
105671059|NCT01006980|364460550|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
105671060|NCT01006980|364460549|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
105671061|NCT01006980|364460550|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
105671062|NCT01006980|364460549|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
105671063|NCT01006980|364460550|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
105671064|NCT01006980|364460549|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
105671065|NCT01006980|364460550|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
105671066|NCT01531673|364460553|FG000|Overall Study|Non-Compliance|0|||
105671067|NCT01531673|364460554|FG001|Overall Study|Non-Compliance|0|||
105671068|NCT01531673|364460555|FG002|Overall Study|Non-Compliance|0|||
105671069|NCT01531673|364460556|FG003|Overall Study|Non-Compliance|0|||
105671070|NCT01531673|364460557|FG004|Overall Study|Non-Compliance|0|||
105671071|NCT01531673|364460558|FG005|Overall Study|Non-Compliance|1|||
105671072|NCT01531673|364460559|FG006|Overall Study|Non-Compliance|0|||
105671073|NCT01531673|364460560|FG007|Overall Study|Non-Compliance|0|||
105671074|NCT01531673|364460561|FG008|Overall Study|Non-Compliance|0|||
105671075|NCT01531673|364460562|FG009|Overall Study|Non-Compliance|0|||
105671076|NCT01531673|364460563|FG010|Overall Study|Non-Compliance|0|||
105671077|NCT01531673|364460564|FG011|Overall Study|Non-Compliance|0|||
105671078|NCT01531673|364460565|FG012|Overall Study|Non-Compliance|0|||
105671079|NCT01531673|364460553|FG000|Overall Study|Adverse Event|0|||
105671080|NCT01531673|364460554|FG001|Overall Study|Adverse Event|1|||
105671081|NCT01531673|364460555|FG002|Overall Study|Adverse Event|0|||
105671082|NCT01531673|364460556|FG003|Overall Study|Adverse Event|0|||
105671083|NCT01531673|364460557|FG004|Overall Study|Adverse Event|0|||
105671084|NCT01531673|364460558|FG005|Overall Study|Adverse Event|0|||
105671085|NCT01531673|364460559|FG006|Overall Study|Adverse Event|0|||
105671086|NCT01531673|364460560|FG007|Overall Study|Adverse Event|0|||
105671087|NCT01531673|364460561|FG008|Overall Study|Adverse Event|0|||
105671088|NCT01531673|364460562|FG009|Overall Study|Adverse Event|0|||
105671089|NCT01531673|364460563|FG010|Overall Study|Adverse Event|0|||
105671090|NCT01531673|364460564|FG011|Overall Study|Adverse Event|0|||
105671091|NCT01531673|364460565|FG012|Overall Study|Adverse Event|0|||
105671092|NCT01531673|364460553|FG000|Overall Study|Lost to Follow-up|0|||
105671093|NCT01531673|364460554|FG001|Overall Study|Lost to Follow-up|0|||
105671094|NCT01531673|364460555|FG002|Overall Study|Lost to Follow-up|0|||
105671095|NCT01531673|364460556|FG003|Overall Study|Lost to Follow-up|0|||
105671096|NCT01531673|364460557|FG004|Overall Study|Lost to Follow-up|1|||
105671097|NCT01531673|364460558|FG005|Overall Study|Lost to Follow-up|0|||
105671098|NCT01531673|364460559|FG006|Overall Study|Lost to Follow-up|0|||
105671099|NCT01531673|364460560|FG007|Overall Study|Lost to Follow-up|0|||
105671100|NCT01531673|364460561|FG008|Overall Study|Lost to Follow-up|0|||
105671101|NCT01531673|364460562|FG009|Overall Study|Lost to Follow-up|0|||
105671102|NCT01531673|364460563|FG010|Overall Study|Lost to Follow-up|0|||
105671103|NCT01531673|364460564|FG011|Overall Study|Lost to Follow-up|0|||
105671104|NCT01531673|364460565|FG012|Overall Study|Lost to Follow-up|0|||
105671105|NCT01531673|364460553|FG000|Overall Study|Other|0|||
105671106|NCT01531673|364460554|FG001|Overall Study|Other|0|||
105786201|NCT00972309|364870477|FG000|Overall Study|Refused further treatment|0|||
105786202|NCT00972309|364870478|FG001|Overall Study|Refused further treatment|1|||
105786203|NCT00972309|364870477|FG000|Overall Study|Late determination of ineligibility|0|||
105786204|NCT00972309|364870478|FG001|Overall Study|Late determination of ineligibility|1|||
105671107|NCT01531673|364460555|FG002|Overall Study|Other|0|||
105671108|NCT01531673|364460556|FG003|Overall Study|Other|1|||
105671109|NCT01531673|364460557|FG004|Overall Study|Other|0|||
105671110|NCT01531673|364460558|FG005|Overall Study|Other|0|||
105671111|NCT01531673|364460559|FG006|Overall Study|Other|0|||
105671112|NCT01531673|364460560|FG007|Overall Study|Other|0|||
105671113|NCT01531673|364460561|FG008|Overall Study|Other|0|||
105671114|NCT01531673|364460562|FG009|Overall Study|Other|1|||
105671115|NCT01531673|364460563|FG010|Overall Study|Other|0|||
105671116|NCT01531673|364460564|FG011|Overall Study|Other|0|||
105671117|NCT01531673|364460565|FG012|Overall Study|Other|0|||
105786205|NCT00972309|364870477|FG000|Overall Study|Second malignancy|1|||
105671118|NCT01008553|364460568|FG000|Period 1 (Titration Period)|Physician Decision|2|||
105671119|NCT01008553|364460569|FG001|Period 1 (Titration Period)|Physician Decision|0|||
105671120|NCT01008553|364460570|FG002|Period 1 (Titration Period)|Physician Decision|0|||
105671121|NCT01008553|364460568|FG000|Period 1 (Titration Period)|Adverse Event|33|||
105554507|NCT01217073|364027392|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
105554508|NCT01217073|364027393|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
105554509|NCT01217073|364027394|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
105554510|NCT01217073|364027387|FG000|Base Period|Excluded medication|0|||
105554511|NCT01217073|364027388|FG001|Base Period|Excluded medication|0|||
105554512|NCT01217073|364027389|FG002|Base Period|Excluded medication|0|||
105554513|NCT01217073|364027390|FG003|Base Period|Excluded medication|0|||
105554514|NCT01217073|364027391|FG004|Base Period|Excluded medication|1|||
105554515|NCT01217073|364027392|FG005|Base Period|Excluded medication|0|||
105554516|NCT01217073|364027393|FG006|Base Period|Excluded medication|0|||
105554517|NCT01217073|364027394|FG007|Base Period|Excluded medication|0|||
105554518|NCT01217073|364027387|FG000|Base Period|Lack of Efficacy|0|||
105554519|NCT01217073|364027388|FG001|Base Period|Lack of Efficacy|0|||
105554520|NCT01217073|364027389|FG002|Base Period|Lack of Efficacy|0|||
105554521|NCT01217073|364027390|FG003|Base Period|Lack of Efficacy|0|||
105554522|NCT01217073|364027391|FG004|Base Period|Lack of Efficacy|0|||
105554523|NCT01217073|364027392|FG005|Base Period|Lack of Efficacy|1|||
105554524|NCT01217073|364027393|FG006|Base Period|Lack of Efficacy|0|||
105554525|NCT01217073|364027394|FG007|Base Period|Lack of Efficacy|0|||
105554526|NCT01217073|364027387|FG000|Base Period|Lost to Follow-up|0|||
105554527|NCT01217073|364027388|FG001|Base Period|Lost to Follow-up|0|||
105554528|NCT01217073|364027389|FG002|Base Period|Lost to Follow-up|1|||
105554529|NCT01217073|364027390|FG003|Base Period|Lost to Follow-up|1|||
105554530|NCT01217073|364027391|FG004|Base Period|Lost to Follow-up|3|||
105554531|NCT01217073|364027392|FG005|Base Period|Lost to Follow-up|0|||
105554532|NCT01217073|364027393|FG006|Base Period|Lost to Follow-up|0|||
105554533|NCT01217073|364027394|FG007|Base Period|Lost to Follow-up|0|||
105554534|NCT01217073|364027387|FG000|Base Period|Physician Decision|0|||
105554535|NCT01217073|364027388|FG001|Base Period|Physician Decision|0|||
105554536|NCT01217073|364027389|FG002|Base Period|Physician Decision|0|||
105554537|NCT01217073|364027390|FG003|Base Period|Physician Decision|0|||
105554538|NCT01217073|364027391|FG004|Base Period|Physician Decision|1|||
105554539|NCT01217073|364027392|FG005|Base Period|Physician Decision|0|||
105554540|NCT01217073|364027393|FG006|Base Period|Physician Decision|0|||
105554541|NCT01217073|364027394|FG007|Base Period|Physician Decision|0|||
105554542|NCT01217073|364027387|FG000|Base Period|Protocol Violation|1|||
105554543|NCT01217073|364027388|FG001|Base Period|Protocol Violation|0|||
105554544|NCT01217073|364027389|FG002|Base Period|Protocol Violation|0|||
105554545|NCT01217073|364027390|FG003|Base Period|Protocol Violation|0|||
105671122|NCT01008553|364460569|FG001|Period 1 (Titration Period)|Adverse Event|0|||
105342521|NCT03721835|363255477|FG000|Overall Study|Participant not able to return|1|||
105554546|NCT01217073|364027391|FG004|Base Period|Protocol Violation|1|||
105554547|NCT01217073|364027392|FG005|Base Period|Protocol Violation|2|||
105554548|NCT01217073|364027393|FG006|Base Period|Protocol Violation|0|||
105554549|NCT01217073|364027394|FG007|Base Period|Protocol Violation|0|||
105671123|NCT01008553|364460570|FG002|Period 1 (Titration Period)|Adverse Event|0|||
105671124|NCT01008553|364460568|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
105671125|NCT01008553|364460569|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
105671126|NCT01008553|364460570|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
105671127|NCT01008553|364460568|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
105671128|NCT01008553|364460569|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
105671129|NCT01008553|364460570|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
105671130|NCT01008553|364460568|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
105671131|NCT01008553|364460569|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
105671132|NCT01008553|364460570|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
105671133|NCT01008553|364460568|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
105671134|NCT01008553|364460569|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
105671135|NCT01008553|364460570|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
105671136|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
105671137|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
105671138|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
105671139|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
105671140|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
105671141|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
105671142|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
105671143|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
105671144|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
105671145|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
105671146|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
105671147|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
105671148|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
105671149|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
105671150|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
105671151|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
105671152|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
105671153|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
105671154|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
105671155|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
105671156|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
105671157|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
105671158|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
105671159|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
105671160|NCT01283152|364460575|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
105671161|NCT01283152|364460576|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
105671162|NCT01283152|364460575|FG000|Overall Study|Refused HESA|1|||
105671163|NCT01283152|364460576|FG001|Overall Study|Refused HESA|0|||
105671164|NCT00567567|364460578|FG000|Overall Study|Adverse Event|0|||
105671165|NCT00567567|364460579|FG001|Overall Study|Adverse Event|2|||
105671166|NCT00567567|364460580|FG002|Overall Study|Adverse Event|5|||
105671167|NCT00567567|364460578|FG000|Overall Study|Death|8|||
105671168|NCT00567567|364460579|FG001|Overall Study|Death|1|||
105671169|NCT00567567|364460580|FG002|Overall Study|Death|5|||
105671170|NCT00567567|364460578|FG000|Overall Study|Lack of Efficacy|16|||
105671171|NCT00567567|364460579|FG001|Overall Study|Lack of Efficacy|17|||
105671172|NCT00567567|364460580|FG002|Overall Study|Lack of Efficacy|48|||
105671173|NCT00567567|364460578|FG000|Overall Study|Lost to Follow-up|0|||
105671174|NCT00567567|364460579|FG001|Overall Study|Lost to Follow-up|0|||
105671175|NCT00567567|364460580|FG002|Overall Study|Lost to Follow-up|1|||
105671176|NCT00567567|364460578|FG000|Overall Study|Physician Decision|16|||
105671177|NCT00567567|364460579|FG001|Overall Study|Physician Decision|18|||
105671178|NCT00567567|364460580|FG002|Overall Study|Physician Decision|84|||
105671179|NCT00567567|364460578|FG000|Overall Study|Withdrawal by Subject|0|||
105671180|NCT00567567|364460579|FG001|Overall Study|Withdrawal by Subject|0|||
105671181|NCT00567567|364460580|FG002|Overall Study|Withdrawal by Subject|2|||
105671182|NCT00567567|364460578|FG000|Overall Study|Ineligible|4|||
105671183|NCT00567567|364460579|FG001|Overall Study|Ineligible|0|||
105671184|NCT00567567|364460580|FG002|Overall Study|Ineligible|9|||
105671185|NCT00567567|364460578|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
105671186|NCT00567567|364460579|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
105671187|NCT00567567|364460580|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
105671188|NCT00567567|364460578|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
105671189|NCT00567567|364460579|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
105671190|NCT00567567|364460580|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
105671191|NCT00567567|364460578|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
105671192|NCT00567567|364460579|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
105671193|NCT00567567|364460580|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
105671194|NCT03889704|364460583|FG000|Overall Study|Study terminated due to pandemic|1|||
105671195|NCT01736189|364460588|FG000|Overall Study|Violation of registration criteria|41|||
105671196|NCT01736189|364460588|FG000|Overall Study|Protocol Violation|4|||
105671197|NCT01736189|364460588|FG000|Overall Study|Criteria and protocol violations|1|||
105671198|NCT02591953|364460589|FG000|Overall Study|Lost to Follow-up|6|||
105671199|NCT02591953|364460590|FG001|Overall Study|Lost to Follow-up|6|||
105671200|NCT01499303|364460591|FG000|Overall Study|Ongoing|2|||
105671201|NCT01499303|364460592|FG001|Overall Study|Ongoing|1|||
105671202|NCT01499303|364460591|FG000|Overall Study|Withdrawal by Subject|0|||
105671203|NCT01499303|364460592|FG001|Overall Study|Withdrawal by Subject|1|||
105671204|NCT01499303|364460591|FG000|Overall Study|Adverse Event|1|||
105671205|NCT01499303|364460592|FG001|Overall Study|Adverse Event|4|||
105671206|NCT01499303|364460591|FG000|Overall Study|Other|0|||
105671207|NCT01499303|364460592|FG001|Overall Study|Other|1|||
105671208|NCT01896557|364460595|FG000|Clopidogrel Alone|Adverse Event|1|||
105671209|NCT01896557|364460596|FG001|Clopidogrel Alone|Adverse Event|0|||
105671210|NCT01896557|364460595|FG000|Clopidogrel + GI Protector|low adherence|1|||
105671211|NCT01896557|364460596|FG001|Clopidogrel + GI Protector|low adherence|1|||
105671212|NCT01896557|364460595|FG000|Clopidogrel + GI Protector|Reading error|1|||
105671213|NCT01896557|364460596|FG001|Clopidogrel + GI Protector|Reading error|3|||
105671214|NCT03809039|364460597|FG000|Part 1|Withdrawal by Subject|1|||
105671215|NCT03809039|364460598|FG001|Part 1|Withdrawal by Subject|0|||
105671216|NCT03809039|364460599|FG002|Part 1|Withdrawal by Subject|0|||
105671217|NCT03809039|364460600|FG003|Part 1|Withdrawal by Subject|1|||
105671218|NCT03809039|364460601|FG004|Part 1|Withdrawal by Subject|0|||
105671219|NCT03809039|364460602|FG005|Part 1|Withdrawal by Subject|0|||
105671220|NCT03809039|364460603|FG006|Part 1|Withdrawal by Subject|0|||
105671221|NCT03809039|364460604|FG007|Part 1|Withdrawal by Subject|0|||
105671222|NCT03809039|364460605|FG008|Part 1|Withdrawal by Subject|0|||
105671223|NCT03809039|364460597|FG000|Part 3|Withdrawn by study termination|0|||
105671224|NCT03809039|364460598|FG001|Part 3|Withdrawn by study termination|0|||
105671225|NCT03809039|364460599|FG002|Part 3|Withdrawn by study termination|0|||
105671226|NCT03809039|364460600|FG003|Part 3|Withdrawn by study termination|0|||
105671227|NCT03809039|364460601|FG004|Part 3|Withdrawn by study termination|0|||
105671228|NCT03809039|364460602|FG005|Part 3|Withdrawn by study termination|0|||
105671229|NCT03809039|364460603|FG006|Part 3|Withdrawn by study termination|0|||
105671230|NCT03809039|364460604|FG007|Part 3|Withdrawn by study termination|2|||
105671231|NCT03809039|364460605|FG008|Part 3|Withdrawn by study termination|6|||
105671232|NCT04798781|364460612|FG000|Overall Study|Withdrawal by Subject|1|||
105671233|NCT00702962|364460613|FG000|Overall Study|Progressive disease|0|||
105671234|NCT00702962|364460614|FG001|Overall Study|Progressive disease|1|||
105671235|NCT00702962|364460613|FG000|Overall Study|Hospitalized for other health disorder|1|||
105671236|NCT00702962|364460614|FG001|Overall Study|Hospitalized for other health disorder|0|||
105671237|NCT01252355|364460615|FG000|Overall Study|Adverse Event|9|||
105671238|NCT01252355|364460616|FG001|Overall Study|Adverse Event|17|||
105671239|NCT01252355|364460617|FG002|Overall Study|Adverse Event|22|||
105671240|NCT01252355|364460615|FG000|Overall Study|Lack of Efficacy|6|||
105671241|NCT01252355|364460616|FG001|Overall Study|Lack of Efficacy|4|||
105671242|NCT01252355|364460617|FG002|Overall Study|Lack of Efficacy|2|||
105671243|NCT01252355|364460615|FG000|Overall Study|Lost to Follow-up|0|||
105671244|NCT01252355|364460616|FG001|Overall Study|Lost to Follow-up|0|||
105671245|NCT01252355|364460617|FG002|Overall Study|Lost to Follow-up|1|||
105671246|NCT01252355|364460615|FG000|Overall Study|Poor Compliance to Protocol|1|||
105671247|NCT01252355|364460616|FG001|Overall Study|Poor Compliance to Protocol|1|||
105671248|NCT01252355|364460617|FG002|Overall Study|Poor Compliance to Protocol|1|||
105671249|NCT01252355|364460615|FG000|Overall Study|Progressive Disease|2|||
105671250|NCT01252355|364460616|FG001|Overall Study|Progressive Disease|0|||
105671251|NCT01252355|364460617|FG002|Overall Study|Progressive Disease|0|||
105671252|NCT01252355|364460615|FG000|Overall Study|Sponsor Early Termination of Study|149|||
105671253|NCT01252355|364460616|FG001|Overall Study|Sponsor Early Termination of Study|149|||
105671254|NCT01252355|364460617|FG002|Overall Study|Sponsor Early Termination of Study|146|||
105671255|NCT01252355|364460615|FG000|Overall Study|Randomized but not Treated|2|||
105671256|NCT01252355|364460616|FG001|Overall Study|Randomized but not Treated|0|||
105671257|NCT01252355|364460617|FG002|Overall Study|Randomized but not Treated|0|||
105671258|NCT01252355|364460615|FG000|Overall Study|Other Than Above|8|||
105671259|NCT01252355|364460616|FG001|Overall Study|Other Than Above|7|||
105671260|NCT01252355|364460617|FG002|Overall Study|Other Than Above|7|||
105671261|NCT03031496|364460619|FG000|Period 1|Adverse Event|2|||
105671262|NCT03031496|364460620|FG001|Period 1|Adverse Event|0|||
105671263|NCT03031496|364460619|FG000|Period 1|Withdrawal by Subject|0|||
105671264|NCT03031496|364460620|FG001|Period 1|Withdrawal by Subject|2|||
105671265|NCT03733314|364460621|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
105671266|NCT03733314|364460622|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
105671267|NCT03733314|364460621|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
105671268|NCT03733314|364460622|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
105671269|NCT03733314|364460621|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
105671270|NCT03733314|364460622|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
105671271|NCT03733314|364460621|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
105671272|NCT03733314|364460622|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
105671273|NCT03733314|364460621|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
105671274|NCT03733314|364460622|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
105671275|NCT03733314|364460621|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
105671276|NCT03733314|364460622|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
105671277|NCT02574845|364460623|FG000|Overall Study|Consent withdrawn further participation|0|||
105671278|NCT02574845|364460624|FG001|Overall Study|Consent withdrawn further participation|0|||
105671279|NCT02574845|364460625|FG002|Overall Study|Consent withdrawn further participation|0|||
105671280|NCT02574845|364460626|FG003|Overall Study|Consent withdrawn further participation|0|||
105671281|NCT02574845|364460627|FG004|Overall Study|Consent withdrawn further participation|1|||
105671282|NCT02574845|364460628|FG005|Overall Study|Consent withdrawn further participation|0|||
105671283|NCT02574845|364460623|FG000|Overall Study|Adverse Event|0|||
105671284|NCT02574845|364460624|FG001|Overall Study|Adverse Event|1|||
105671285|NCT02574845|364460625|FG002|Overall Study|Adverse Event|0|||
105671286|NCT02574845|364460626|FG003|Overall Study|Adverse Event|0|||
105671287|NCT02574845|364460627|FG004|Overall Study|Adverse Event|0|||
105671288|NCT02574845|364460628|FG005|Overall Study|Adverse Event|1|||
105671289|NCT01696045|364460630|FG000|Overall Study|Study drug toxicity|1|||
105671290|NCT01696045|364460631|FG001|Overall Study|Study drug toxicity|5|||
105671291|NCT01696045|364460630|FG000|Overall Study|Disease progression|2|||
105671292|NCT01696045|364460631|FG001|Overall Study|Disease progression|2|||
105671293|NCT04145700|364460633|FG000|Overall Study|Withdrawal by Subject|8|||
105671294|NCT04145700|364460634|FG001|Overall Study|Withdrawal by Subject|3|||
105671295|NCT02229851|364460635|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
105671296|NCT02229851|364460636|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
105671297|NCT02229851|364460637|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
105671298|NCT02229851|364460638|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
105671299|NCT02229851|364460639|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
105671300|NCT02229851|364460640|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
105671301|NCT02229851|364460641|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
105671302|NCT02229851|364460635|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
105671303|NCT02229851|364460636|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
105671304|NCT02229851|364460637|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
105671305|NCT02229851|364460638|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
105671306|NCT02229851|364460639|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
105671307|NCT02229851|364460640|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
105671308|NCT02229851|364460641|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
105671309|NCT02229851|364460635|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
105671310|NCT02229851|364460636|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
105671311|NCT02229851|364460637|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
105671312|NCT02229851|364460638|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
105671313|NCT02229851|364460639|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
105671314|NCT02229851|364460640|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
105671315|NCT02229851|364460641|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
105671316|NCT02229851|364460635|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
105671317|NCT02229851|364460636|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
105671318|NCT02229851|364460637|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
105671319|NCT02229851|364460638|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
105671320|NCT02229851|364460639|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
105671321|NCT02229851|364460640|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
105671322|NCT02229851|364460641|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
105671323|NCT02229851|364460635|FG000|Main Phase (Double-blind Phase)|Death|1|||
105671324|NCT02229851|364460636|FG001|Main Phase (Double-blind Phase)|Death|1|||
105671325|NCT02229851|364460637|FG002|Main Phase (Double-blind Phase)|Death|0|||
105671326|NCT02229851|364460638|FG003|Main Phase (Double-blind Phase)|Death|0|||
105671327|NCT02229851|364460639|FG004|Main Phase (Double-blind Phase)|Death|0|||
105671328|NCT02229851|364460640|FG005|Main Phase (Double-blind Phase)|Death|0|||
105671329|NCT02229851|364460641|FG006|Main Phase (Double-blind Phase)|Death|0|||
105671330|NCT02229851|364460635|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
105671331|NCT02229851|364460636|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
105671332|NCT02229851|364460637|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
105671333|NCT02229851|364460638|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
105671334|NCT02229851|364460639|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
105671335|NCT02229851|364460640|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
105671336|NCT02229851|364460641|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
105671337|NCT02229851|364460635|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
105671338|NCT02229851|364460636|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
105671339|NCT02229851|364460637|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
105671340|NCT02229851|364460638|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
105671341|NCT02229851|364460639|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
105671342|NCT02229851|364460640|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
105671343|NCT02229851|364460641|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
105671344|NCT02229851|364460635|FG000|Extension Phase (Open-label Phase)|Death|0|||
105671345|NCT02229851|364460636|FG001|Extension Phase (Open-label Phase)|Death|0|||
105671346|NCT02229851|364460637|FG002|Extension Phase (Open-label Phase)|Death|0|||
105671347|NCT02229851|364460638|FG003|Extension Phase (Open-label Phase)|Death|1|||
105671348|NCT02229851|364460639|FG004|Extension Phase (Open-label Phase)|Death|0|||
105671349|NCT02229851|364460640|FG005|Extension Phase (Open-label Phase)|Death|1|||
105671350|NCT02229851|364460641|FG006|Extension Phase (Open-label Phase)|Death|1|||
105671351|NCT02045875|364460643|FG000|Overall Study|Lost to Follow-up|3|||
105671352|NCT02045875|364460644|FG001|Overall Study|Lost to Follow-up|0|||
105671353|NCT02045875|364460643|FG000|Overall Study|Withdrawal by Subject|4|||
105671354|NCT02045875|364460644|FG001|Overall Study|Withdrawal by Subject|3|||
105671355|NCT00864253|364460645|FG000|Overall Study|Adverse Event|56|||
105671356|NCT00864253|364460646|FG001|Overall Study|Adverse Event|11|||
105671357|NCT00864253|364460645|FG000|Overall Study|Unrelated Adverse Event|3|||
105671358|NCT00864253|364460646|FG001|Overall Study|Unrelated Adverse Event|1|||
105671359|NCT00864253|364460645|FG000|Overall Study|Physician Decision|11|||
105671360|NCT00864253|364460646|FG001|Overall Study|Physician Decision|15|||
105671361|NCT00864253|364460645|FG000|Overall Study|Protocol Violation|0|||
105671362|NCT00864253|364460646|FG001|Overall Study|Protocol Violation|2|||
105671363|NCT00864253|364460645|FG000|Overall Study|Lost to Follow-up|1|||
105671364|NCT00864253|364460646|FG001|Overall Study|Lost to Follow-up|1|||
105671365|NCT00864253|364460645|FG000|Overall Study|Withdrawal by Subject|18|||
105671366|NCT00864253|364460646|FG001|Overall Study|Withdrawal by Subject|18|||
105671367|NCT00864253|364460645|FG000|Overall Study|Death|1|||
105671368|NCT00864253|364460646|FG001|Overall Study|Death|0|||
105671369|NCT00864253|364460645|FG000|Overall Study|Ongoing|2|||
105671370|NCT00864253|364460646|FG001|Overall Study|Ongoing|3|||
105671371|NCT00864253|364460645|FG000|Overall Study|Untreated|7|||
105671372|NCT00864253|364460646|FG001|Overall Study|Untreated|7|||
105671373|NCT02807883|364460647|FG000|Overall Study|Withdrawal by Subject|2|||
105671374|NCT02206061|364460648|FG000|Overall Study|Withdrawal by Subject|4|||
105671375|NCT02206061|364460649|FG001|Overall Study|Withdrawal by Subject|7|||
105671376|NCT02206061|364460650|FG002|Overall Study|Withdrawal by Subject|1|||
105671377|NCT02206061|364460648|FG000|Overall Study|Lost to Follow-up|14|||
105671378|NCT02206061|364460649|FG001|Overall Study|Lost to Follow-up|7|||
105671379|NCT02206061|364460650|FG002|Overall Study|Lost to Follow-up|20|||
105671380|NCT01743989|364460661|FG000|Treatment Phase|Unstable MR4.0|0|||
105671381|NCT01743989|364460662|FG001|Treatment Phase|Unstable MR4.0|6|||
105671382|NCT01743989|364460663|FG002|Treatment Phase|Unstable MR4.0|263|||
105671383|NCT01743989|364460661|FG000|Treatment Phase|Adverse Event|0|||
105671384|NCT01743989|364460662|FG001|Treatment Phase|Adverse Event|4|||
105671385|NCT01743989|364460663|FG002|Treatment Phase|Adverse Event|67|||
105671386|NCT01743989|364460661|FG000|Treatment Phase|Withdrawal by Subject|1|||
105671387|NCT01743989|364460662|FG001|Treatment Phase|Withdrawal by Subject|3|||
105671388|NCT01743989|364460663|FG002|Treatment Phase|Withdrawal by Subject|28|||
105671389|NCT01743989|364460661|FG000|Treatment Phase|Death|0|||
105671390|NCT01743989|364460662|FG001|Treatment Phase|Death|1|||
105671391|NCT01743989|364460663|FG002|Treatment Phase|Death|3|||
105671392|NCT01743989|364460661|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
105671393|NCT01743989|364460662|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
105671394|NCT01743989|364460663|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
105671395|NCT01743989|364460661|FG000|Treatment Phase|Protocol deviation|0|||
105671396|NCT01743989|364460662|FG001|Treatment Phase|Protocol deviation|0|||
105671397|NCT01743989|364460663|FG002|Treatment Phase|Protocol deviation|3|||
105671398|NCT01743989|364460661|FG000|Treatment Phase|Pregnancy|0|||
105671399|NCT01743989|364460662|FG001|Treatment Phase|Pregnancy|0|||
105671400|NCT01743989|364460663|FG002|Treatment Phase|Pregnancy|2|||
105671401|NCT01743989|364460661|FG000|Treatment Phase|Lost to Follow-up|0|||
105671402|NCT01743989|364460662|FG001|Treatment Phase|Lost to Follow-up|0|||
105671403|NCT01743989|364460663|FG002|Treatment Phase|Lost to Follow-up|2|||
105671404|NCT01743989|364460661|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
105671405|NCT01743989|364460662|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
105671406|NCT01743989|364460663|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
105671407|NCT01743989|364460661|FG000|Treatment Phase|Administrative problems|0|||
105671408|NCT01743989|364460662|FG001|Treatment Phase|Administrative problems|0|||
105671409|NCT01743989|364460663|FG002|Treatment Phase|Administrative problems|1|||
105671410|NCT01743989|364460661|FG000|Treatment Phase|New cancer (CML) therapy|0|||
105671411|NCT01743989|364460662|FG001|Treatment Phase|New cancer (CML) therapy|1|||
105671412|NCT01743989|364460663|FG002|Treatment Phase|New cancer (CML) therapy|0|||
105671413|NCT01743989|364460661|FG000|Treatment Phase|Physician Decision|0|||
105671414|NCT01743989|364460662|FG001|Treatment Phase|Physician Decision|0|||
105671415|NCT01743989|364460663|FG002|Treatment Phase|Physician Decision|3|||
105671416|NCT01743989|364460661|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
105671417|NCT01743989|364460662|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
105671418|NCT01743989|364460663|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
105671419|NCT01743989|364460661|FG000|Treatment Phase|Not randomized by mistake|0|||
105671420|NCT01743989|364460662|FG001|Treatment Phase|Not randomized by mistake|0|||
105671421|NCT01743989|364460663|FG002|Treatment Phase|Not randomized by mistake|1|||
105671422|NCT01743989|364460661|FG000|Treatment Phase|Included by mistake|0|||
105671423|NCT01743989|364460662|FG001|Treatment Phase|Included by mistake|0|||
105671424|NCT01743989|364460663|FG002|Treatment Phase|Included by mistake|1|||
105671425|NCT01743989|364460661|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
105671426|NCT01743989|364460662|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
105671427|NCT01743989|364460663|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
105671428|NCT01743989|364460661|FG000|TFR Phase|Adverse Event|0|||
105671429|NCT01743989|364460662|FG001|TFR Phase|Adverse Event|1|||
105671430|NCT01743989|364460663|FG002|TFR Phase|Adverse Event|0|||
105671431|NCT01743989|364460661|FG000|TFR Phase|Lost to Follow-up|0|||
105671432|NCT01743989|364460662|FG001|TFR Phase|Lost to Follow-up|2|||
105671433|NCT01743989|364460663|FG002|TFR Phase|Lost to Follow-up|0|||
105671434|NCT01743989|364460661|FG000|TFR Phase|Physician Decision|0|||
105671435|NCT01743989|364460662|FG001|TFR Phase|Physician Decision|1|||
105671436|NCT01743989|364460663|FG002|TFR Phase|Physician Decision|0|||
105671437|NCT01743989|364460661|FG000|TFR Phase|Logistical problems|0|||
105671438|NCT01743989|364460662|FG001|TFR Phase|Logistical problems|2|||
105671439|NCT01743989|364460663|FG002|TFR Phase|Logistical problems|0|||
105671440|NCT01743989|364460661|FG000|TFR Phase|Protocol deviation|0|||
105671441|NCT01743989|364460662|FG001|TFR Phase|Protocol deviation|1|||
105671442|NCT01743989|364460663|FG002|TFR Phase|Protocol deviation|0|||
105671443|NCT01743989|364460661|FG000|TFR Phase|Withdrawal by Subject|0|||
105671444|NCT01743989|364460662|FG001|TFR Phase|Withdrawal by Subject|2|||
105671445|NCT01743989|364460663|FG002|TFR Phase|Withdrawal by Subject|0|||
105671446|NCT01743989|364460661|FG000|Re-treatment Phase|Adverse Event|8|||
105671447|NCT01743989|364460662|FG001|Re-treatment Phase|Adverse Event|4|||
105671448|NCT01743989|364460663|FG002|Re-treatment Phase|Adverse Event|0|||
105671449|NCT01743989|364460661|FG000|Re-treatment Phase|Death|1|||
105671450|NCT01743989|364460662|FG001|Re-treatment Phase|Death|1|||
105671451|NCT01743989|364460663|FG002|Re-treatment Phase|Death|0|||
105671452|NCT01743989|364460661|FG000|Re-treatment Phase|Administrative problems|1|||
105671453|NCT01743989|364460662|FG001|Re-treatment Phase|Administrative problems|1|||
105671454|NCT01743989|364460663|FG002|Re-treatment Phase|Administrative problems|0|||
105671455|NCT01743989|364460661|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
105671456|NCT01743989|364460662|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
105671457|NCT01743989|364460663|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
105671458|NCT01743989|364460661|FG000|Re-treatment Phase|Unstable MR|1|||
105671459|NCT01743989|364460662|FG001|Re-treatment Phase|Unstable MR|0|||
105671460|NCT01743989|364460663|FG002|Re-treatment Phase|Unstable MR|0|||
105671461|NCT01743989|364460661|FG000|Re-treatment Phase|Physician Decision|0|||
105671462|NCT01743989|364460662|FG001|Re-treatment Phase|Physician Decision|1|||
105671463|NCT01743989|364460663|FG002|Re-treatment Phase|Physician Decision|0|||
105671464|NCT01743989|364460661|FG000|Re-treatment Phase|Lost to Follow-up|0|||
105671465|NCT01743989|364460662|FG001|Re-treatment Phase|Lost to Follow-up|1|||
105671466|NCT01743989|364460663|FG002|Re-treatment Phase|Lost to Follow-up|0|||
105671467|NCT02235311|364460673|FG000|Overall Study|Lost to Follow-up|0|||
105671468|NCT02235311|364460674|FG001|Overall Study|Lost to Follow-up|1|||
105671469|NCT02235311|364460673|FG000|Overall Study|Protocol Violation|0|||
105671470|NCT02235311|364460674|FG001|Overall Study|Protocol Violation|1|||
105671471|NCT04655027|364460676|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
105671472|NCT04655027|364460677|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
105671473|NCT05543707|364460678|FG000|Overall Study|Study drug non-compliance/|5|||
105671474|NCT05543707|364460679|FG001|Overall Study|Study drug non-compliance/|0|||
105671475|NCT05543707|364460678|FG000|Overall Study|Withdrawal by Subject|1|||
105671476|NCT05543707|364460679|FG001|Overall Study|Withdrawal by Subject|1|||
105671477|NCT05543707|364460678|FG000|Overall Study|Adverse Event|1|||
105671478|NCT05543707|364460679|FG001|Overall Study|Adverse Event|0|||
105671479|NCT05543707|364460678|FG000|Overall Study|concurrent illness|0|||
105671480|NCT05543707|364460679|FG001|Overall Study|concurrent illness|1|||
105671481|NCT05543707|364460678|FG000|Overall Study|Pregnancy|1|||
105671482|NCT05543707|364460679|FG001|Overall Study|Pregnancy|1|||
105671483|NCT02108964|364460680|FG000|Overall Study|Progressive disease|15|||
105671484|NCT02108964|364460681|FG001|Overall Study|Progressive disease|31|||
105671485|NCT02108964|364460682|FG002|Overall Study|Progressive disease|54|||
105671486|NCT02108964|364460683|FG003|Overall Study|Progressive disease|7|||
105671487|NCT02108964|364460684|FG004|Overall Study|Progressive disease|20|||
105671488|NCT02108964|364460685|FG005|Overall Study|Progressive disease|4|||
105671489|NCT02108964|364460686|FG006|Overall Study|Progressive disease|6|||
105671490|NCT02108964|364460687|FG007|Overall Study|Progressive disease|33|||
105671491|NCT02108964|364460680|FG000|Overall Study|Physician Decision|1|||
105671492|NCT02108964|364460681|FG001|Overall Study|Physician Decision|5|||
105671493|NCT02108964|364460682|FG002|Overall Study|Physician Decision|7|||
105671494|NCT02108964|364460683|FG003|Overall Study|Physician Decision|1|||
105671495|NCT02108964|364460684|FG004|Overall Study|Physician Decision|2|||
105671496|NCT02108964|364460685|FG005|Overall Study|Physician Decision|1|||
105671497|NCT02108964|364460686|FG006|Overall Study|Physician Decision|1|||
105671498|NCT02108964|364460687|FG007|Overall Study|Physician Decision|3|||
105671499|NCT02108964|364460680|FG000|Overall Study|Adverse Event|0|||
105671500|NCT02108964|364460681|FG001|Overall Study|Adverse Event|0|||
105671501|NCT02108964|364460682|FG002|Overall Study|Adverse Event|4|||
105671502|NCT02108964|364460683|FG003|Overall Study|Adverse Event|0|||
105671503|NCT02108964|364460684|FG004|Overall Study|Adverse Event|1|||
105671504|NCT02108964|364460685|FG005|Overall Study|Adverse Event|0|||
105671505|NCT02108964|364460686|FG006|Overall Study|Adverse Event|3|||
105671506|NCT02108964|364460687|FG007|Overall Study|Adverse Event|2|||
105671507|NCT02108964|364460680|FG000|Overall Study|Death|1|||
105671508|NCT02108964|364460681|FG001|Overall Study|Death|1|||
105671509|NCT02108964|364460682|FG002|Overall Study|Death|4|||
105671510|NCT02108964|364460683|FG003|Overall Study|Death|0|||
105671511|NCT02108964|364460684|FG004|Overall Study|Death|3|||
105671512|NCT02108964|364460685|FG005|Overall Study|Death|0|||
105554550|NCT01217073|364027387|FG000|Base Period|Withdrawal by Subject|4|||
105554551|NCT01217073|364027388|FG001|Base Period|Withdrawal by Subject|5|||
105554552|NCT01217073|364027389|FG002|Base Period|Withdrawal by Subject|5|||
105554553|NCT01217073|364027390|FG003|Base Period|Withdrawal by Subject|1|||
105554554|NCT01217073|364027391|FG004|Base Period|Withdrawal by Subject|5|||
105554555|NCT01217073|364027392|FG005|Base Period|Withdrawal by Subject|5|||
105554556|NCT01217073|364027393|FG006|Base Period|Withdrawal by Subject|0|||
105554557|NCT01217073|364027394|FG007|Base Period|Withdrawal by Subject|0|||
105554558|NCT01217073|364027387|FG000|Extension Period|Adverse Event|0|||
105554559|NCT01217073|364027388|FG001|Extension Period|Adverse Event|0|||
105554560|NCT01217073|364027389|FG002|Extension Period|Adverse Event|0|||
105554561|NCT01217073|364027390|FG003|Extension Period|Adverse Event|0|||
105554562|NCT01217073|364027391|FG004|Extension Period|Adverse Event|0|||
105554563|NCT01217073|364027392|FG005|Extension Period|Adverse Event|0|||
105554564|NCT01217073|364027393|FG006|Extension Period|Adverse Event|19|||
105554565|NCT01217073|364027394|FG007|Extension Period|Adverse Event|5|||
105554566|NCT01217073|364027387|FG000|Extension Period|ALT/AST|0|||
105554567|NCT01217073|364027388|FG001|Extension Period|ALT/AST|0|||
105554568|NCT01217073|364027389|FG002|Extension Period|ALT/AST|0|||
105554569|NCT01217073|364027390|FG003|Extension Period|ALT/AST|0|||
105554570|NCT01217073|364027391|FG004|Extension Period|ALT/AST|0|||
105554571|NCT01217073|364027392|FG005|Extension Period|ALT/AST|0|||
105554572|NCT01217073|364027393|FG006|Extension Period|ALT/AST|2|||
105554573|NCT01217073|364027394|FG007|Extension Period|ALT/AST|0|||
105554574|NCT01217073|364027387|FG000|Extension Period|Contraindication to study medication|0|||
105554575|NCT01217073|364027388|FG001|Extension Period|Contraindication to study medication|0|||
105554576|NCT01217073|364027389|FG002|Extension Period|Contraindication to study medication|0|||
105554577|NCT01217073|364027390|FG003|Extension Period|Contraindication to study medication|0|||
105554578|NCT01217073|364027391|FG004|Extension Period|Contraindication to study medication|0|||
105554579|NCT01217073|364027392|FG005|Extension Period|Contraindication to study medication|0|||
105554580|NCT01217073|364027393|FG006|Extension Period|Contraindication to study medication|1|||
105554581|NCT01217073|364027394|FG007|Extension Period|Contraindication to study medication|0|||
105554582|NCT01217073|364027387|FG000|Extension Period|Creatinine/eGFR|0|||
105554583|NCT01217073|364027388|FG001|Extension Period|Creatinine/eGFR|0|||
105554584|NCT01217073|364027389|FG002|Extension Period|Creatinine/eGFR|0|||
105554585|NCT01217073|364027390|FG003|Extension Period|Creatinine/eGFR|0|||
105554586|NCT01217073|364027391|FG004|Extension Period|Creatinine/eGFR|0|||
105554587|NCT01217073|364027392|FG005|Extension Period|Creatinine/eGFR|0|||
105554588|NCT01217073|364027393|FG006|Extension Period|Creatinine/eGFR|11|||
105554589|NCT01217073|364027394|FG007|Extension Period|Creatinine/eGFR|1|||
105554590|NCT01217073|364027387|FG000|Extension Period|Death|0|||
105554591|NCT01217073|364027388|FG001|Extension Period|Death|0|||
105554592|NCT01217073|364027389|FG002|Extension Period|Death|0|||
105554593|NCT01217073|364027390|FG003|Extension Period|Death|0|||
105554594|NCT01217073|364027391|FG004|Extension Period|Death|0|||
105554595|NCT01217073|364027392|FG005|Extension Period|Death|0|||
105554596|NCT01217073|364027393|FG006|Extension Period|Death|1|||
105554597|NCT01217073|364027394|FG007|Extension Period|Death|0|||
105554598|NCT01217073|364027387|FG000|Extension Period|Excluded medication|0|||
105554599|NCT01217073|364027388|FG001|Extension Period|Excluded medication|0|||
105554600|NCT01217073|364027389|FG002|Extension Period|Excluded medication|0|||
105554601|NCT01217073|364027390|FG003|Extension Period|Excluded medication|0|||
105554602|NCT01217073|364027391|FG004|Extension Period|Excluded medication|0|||
105342522|NCT03721835|363255477|FG000|Overall Study|Lost to Follow-up|1|||
105342523|NCT03721835|363255477|FG000|Overall Study|Revision of the components of the study device|2|||
105342524|NCT03721835|363255477|FG000|Overall Study|Sponsor terminated study|6|||
105342525|NCT03721835|363255477|FG000|Overall Study|Death|1|||
105342526|NCT03721835|363255477|FG000|Overall Study|Sponsor decision|1|||
105342527|NCT05072964|363255478|FG000|Overall Study|Withdrawal by Subject|4|||
105342528|NCT05072964|363255478|FG000|Overall Study|Death|1|||
105342529|NCT03495154|363255483|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
105342530|NCT03495154|363255483|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
105342531|NCT03495154|363255483|FG000|Overall Study|Screen Failures During Surgery|6|||
105342532|NCT03495154|363255483|FG000|Overall Study|Death|2|||
105342533|NCT03495154|363255483|FG000|Overall Study|Lost to Follow-up|16|||
105342534|NCT03495154|363255483|FG000|Overall Study|Withdrawal by Subject|2|||
105342535|NCT03495154|363255483|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
105342536|NCT01328548|363255485|FG000|Overall Study|Death|3|||
105342537|NCT01328548|363255486|FG001|Overall Study|Death|0|||
105342538|NCT01328548|363255485|FG000|Overall Study|Protocol Violation|1|||
105342539|NCT01328548|363255486|FG001|Overall Study|Protocol Violation|0|||
105342540|NCT00073983|363255487|FG000|Overall Study|not evaluable|1|||
105554603|NCT01217073|364027392|FG005|Extension Period|Excluded medication|0|||
105554604|NCT01217073|364027393|FG006|Extension Period|Excluded medication|2|||
105554605|NCT01217073|364027394|FG007|Extension Period|Excluded medication|0|||
105554606|NCT01217073|364027387|FG000|Extension Period|Lack of Efficacy|0|||
105554607|NCT01217073|364027388|FG001|Extension Period|Lack of Efficacy|0|||
105554608|NCT01217073|364027389|FG002|Extension Period|Lack of Efficacy|0|||
105554609|NCT01217073|364027390|FG003|Extension Period|Lack of Efficacy|0|||
105554610|NCT01217073|364027391|FG004|Extension Period|Lack of Efficacy|0|||
105554611|NCT01217073|364027392|FG005|Extension Period|Lack of Efficacy|0|||
105554612|NCT01217073|364027393|FG006|Extension Period|Lack of Efficacy|3|||
105554613|NCT01217073|364027394|FG007|Extension Period|Lack of Efficacy|0|||
105554614|NCT01217073|364027387|FG000|Extension Period|Lost to Follow-up|0|||
105554615|NCT01217073|364027388|FG001|Extension Period|Lost to Follow-up|0|||
105554616|NCT01217073|364027389|FG002|Extension Period|Lost to Follow-up|0|||
105554617|NCT01217073|364027390|FG003|Extension Period|Lost to Follow-up|0|||
105554618|NCT01217073|364027391|FG004|Extension Period|Lost to Follow-up|0|||
105554619|NCT01217073|364027392|FG005|Extension Period|Lost to Follow-up|0|||
105554620|NCT01217073|364027393|FG006|Extension Period|Lost to Follow-up|9|||
105554621|NCT01217073|364027394|FG007|Extension Period|Lost to Follow-up|1|||
105554622|NCT01217073|364027387|FG000|Extension Period|Non-compliance with study drug|0|||
105554623|NCT01217073|364027388|FG001|Extension Period|Non-compliance with study drug|0|||
105671513|NCT02108964|364460686|FG006|Overall Study|Death|0|||
105554624|NCT01217073|364027389|FG002|Extension Period|Non-compliance with study drug|0|||
105554625|NCT01217073|364027390|FG003|Extension Period|Non-compliance with study drug|0|||
105554626|NCT01217073|364027391|FG004|Extension Period|Non-compliance with study drug|0|||
105342541|NCT00784550|363256670|FG000|Overall Study|Adverse Event|12|||
105342542|NCT00784550|363256671|FG001|Overall Study|Adverse Event|10|||
105671514|NCT02108964|364460687|FG007|Overall Study|Death|2|||
105671515|NCT02108964|364460680|FG000|Overall Study|Subject/Guardian decision|0|||
105671516|NCT02108964|364460681|FG001|Overall Study|Subject/Guardian decision|1|||
105671517|NCT02108964|364460682|FG002|Overall Study|Subject/Guardian decision|4|||
105671518|NCT02108964|364460683|FG003|Overall Study|Subject/Guardian decision|0|||
105671519|NCT02108964|364460684|FG004|Overall Study|Subject/Guardian decision|2|||
105671520|NCT02108964|364460685|FG005|Overall Study|Subject/Guardian decision|0|||
105671521|NCT02108964|364460686|FG006|Overall Study|Subject/Guardian decision|1|||
105671522|NCT02108964|364460687|FG007|Overall Study|Subject/Guardian decision|2|||
105671523|NCT02108964|364460680|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
105671524|NCT02108964|364460681|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
105671525|NCT02108964|364460682|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
105671526|NCT02108964|364460683|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
105671527|NCT02108964|364460684|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
105671528|NCT02108964|364460685|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
105671529|NCT02108964|364460686|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
105671530|NCT02108964|364460687|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
105671531|NCT02626455|364460688|FG000|Overall Study|Other|1|||
105671532|NCT02626455|364460689|FG001|Overall Study|Other|1|||
105671533|NCT02626455|364460690|FG002|Overall Study|Other|0|||
105671534|NCT02626455|364460691|FG003|Overall Study|Other|0|||
105671535|NCT02626455|364460692|FG004|Overall Study|Other|0|||
105671536|NCT02626455|364460693|FG005|Overall Study|Other|17|||
105671537|NCT02626455|364460694|FG006|Overall Study|Other|23|||
105671538|NCT02626455|364460688|FG000|Overall Study|Withdrawal by Subject|1|||
105671539|NCT02626455|364460689|FG001|Overall Study|Withdrawal by Subject|0|||
105671540|NCT02626455|364460690|FG002|Overall Study|Withdrawal by Subject|0|||
105671541|NCT02626455|364460691|FG003|Overall Study|Withdrawal by Subject|0|||
105671542|NCT02626455|364460692|FG004|Overall Study|Withdrawal by Subject|0|||
105671543|NCT02626455|364460693|FG005|Overall Study|Withdrawal by Subject|10|||
105671544|NCT02626455|364460694|FG006|Overall Study|Withdrawal by Subject|6|||
105671545|NCT02626455|364460688|FG000|Overall Study|Physician Decision|0|||
105671546|NCT02626455|364460689|FG001|Overall Study|Physician Decision|2|||
105671547|NCT02626455|364460690|FG002|Overall Study|Physician Decision|2|||
105671548|NCT02626455|364460691|FG003|Overall Study|Physician Decision|2|||
105671549|NCT02626455|364460692|FG004|Overall Study|Physician Decision|1|||
105671550|NCT02626455|364460693|FG005|Overall Study|Physician Decision|10|||
105671551|NCT02626455|364460694|FG006|Overall Study|Physician Decision|3|||
105671552|NCT02626455|364460688|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
105671553|NCT02626455|364460689|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
105671554|NCT02626455|364460690|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
105671555|NCT02626455|364460691|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
105671556|NCT02626455|364460692|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
105671557|NCT02626455|364460693|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
105671558|NCT02626455|364460694|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
105671559|NCT02626455|364460688|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
105671560|NCT02626455|364460689|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
105671561|NCT02626455|364460690|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
105671562|NCT02626455|364460691|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
105671563|NCT02626455|364460692|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
105671564|NCT02626455|364460693|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
105671565|NCT02626455|364460694|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
105671566|NCT02626455|364460688|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
105671567|NCT02626455|364460689|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
105671568|NCT02626455|364460690|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
105671569|NCT02626455|364460691|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
105671570|NCT02626455|364460692|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
105671571|NCT02626455|364460693|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
105671572|NCT02626455|364460694|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
105671573|NCT02626455|364460688|FG000|Overall Study|Patient decision|0|||
105671574|NCT02626455|364460689|FG001|Overall Study|Patient decision|1|||
105671575|NCT02626455|364460690|FG002|Overall Study|Patient decision|0|||
105671576|NCT02626455|364460691|FG003|Overall Study|Patient decision|0|||
105671577|NCT02626455|364460692|FG004|Overall Study|Patient decision|1|||
105671578|NCT02626455|364460693|FG005|Overall Study|Patient decision|36|||
105786206|NCT00972309|364870478|FG001|Overall Study|Second malignancy|1|||
105786207|NCT00972309|364870477|FG000|Overall Study|Visa issues|0|||
105671579|NCT02626455|364460694|FG006|Overall Study|Patient decision|22|||
105671580|NCT02626455|364460688|FG000|Overall Study|Protocol Violation|0|||
105671581|NCT02626455|364460689|FG001|Overall Study|Protocol Violation|0|||
105671582|NCT02626455|364460690|FG002|Overall Study|Protocol Violation|0|||
105671583|NCT02626455|364460691|FG003|Overall Study|Protocol Violation|0|||
105671584|NCT02626455|364460692|FG004|Overall Study|Protocol Violation|0|||
105671585|NCT02626455|364460693|FG005|Overall Study|Protocol Violation|0|||
105671586|NCT02626455|364460694|FG006|Overall Study|Protocol Violation|1|||
105671587|NCT02626455|364460688|FG000|Overall Study|Progressive disease - radiological progression|0|||
105671588|NCT02626455|364460689|FG001|Overall Study|Progressive disease - radiological progression|0|||
105671589|NCT02626455|364460690|FG002|Overall Study|Progressive disease - radiological progression|0|||
105671590|NCT02626455|364460691|FG003|Overall Study|Progressive disease - radiological progression|0|||
105671591|NCT02626455|364460692|FG004|Overall Study|Progressive disease - radiological progression|0|||
105671592|NCT02626455|364460693|FG005|Overall Study|Progressive disease - radiological progression|11|||
105671593|NCT02626455|364460694|FG006|Overall Study|Progressive disease - radiological progression|22|||
105671594|NCT02626455|364460688|FG000|Overall Study|Progressive disease - clinical progression|0|||
105671595|NCT02626455|364460689|FG001|Overall Study|Progressive disease - clinical progression|0|||
105671596|NCT02626455|364460690|FG002|Overall Study|Progressive disease - clinical progression|0|||
105671597|NCT02626455|364460691|FG003|Overall Study|Progressive disease - clinical progression|0|||
105671598|NCT02626455|364460692|FG004|Overall Study|Progressive disease - clinical progression|0|||
105671599|NCT02626455|364460693|FG005|Overall Study|Progressive disease - clinical progression|1|||
105671600|NCT02626455|364460694|FG006|Overall Study|Progressive disease - clinical progression|2|||
105671601|NCT02626455|364460688|FG000|Overall Study|Lost to Follow-up|0|||
105671602|NCT02626455|364460689|FG001|Overall Study|Lost to Follow-up|0|||
105671603|NCT02626455|364460690|FG002|Overall Study|Lost to Follow-up|0|||
105671604|NCT02626455|364460691|FG003|Overall Study|Lost to Follow-up|0|||
105671605|NCT02626455|364460692|FG004|Overall Study|Lost to Follow-up|0|||
105671606|NCT02626455|364460693|FG005|Overall Study|Lost to Follow-up|1|||
105671607|NCT02626455|364460694|FG006|Overall Study|Lost to Follow-up|0|||
105671608|NCT02626455|364460688|FG000|Overall Study|AE not associated with clinical disease progression|1|||
105671609|NCT02626455|364460689|FG001|Overall Study|AE not associated with clinical disease progression|1|||
105671610|NCT02626455|364460690|FG002|Overall Study|AE not associated with clinical disease progression|0|||
105671611|NCT02626455|364460691|FG003|Overall Study|AE not associated with clinical disease progression|2|||
105671612|NCT02626455|364460692|FG004|Overall Study|AE not associated with clinical disease progression|1|||
105671613|NCT02626455|364460693|FG005|Overall Study|AE not associated with clinical disease progression|65|||
105671614|NCT02626455|364460694|FG006|Overall Study|AE not associated with clinical disease progression|21|||
105671615|NCT02626455|364460688|FG000|Overall Study|AE associated with clinical disease progression|0|||
105671616|NCT02626455|364460689|FG001|Overall Study|AE associated with clinical disease progression|0|||
105671617|NCT02626455|364460690|FG002|Overall Study|AE associated with clinical disease progression|0|||
105671618|NCT02626455|364460691|FG003|Overall Study|AE associated with clinical disease progression|0|||
105671619|NCT02626455|364460692|FG004|Overall Study|AE associated with clinical disease progression|0|||
105671620|NCT02626455|364460693|FG005|Overall Study|AE associated with clinical disease progression|1|||
105671621|NCT02626455|364460694|FG006|Overall Study|AE associated with clinical disease progression|2|||
105671622|NCT02626455|364460688|FG000|Overall Study|Study intervention never administered|0|||
105671623|NCT02626455|364460689|FG001|Overall Study|Study intervention never administered|0|||
105671624|NCT02626455|364460690|FG002|Overall Study|Study intervention never administered|0|||
105671625|NCT02626455|364460691|FG003|Overall Study|Study intervention never administered|0|||
105671626|NCT02626455|364460692|FG004|Overall Study|Study intervention never administered|0|||
105671627|NCT02626455|364460693|FG005|Overall Study|Study intervention never administered|1|||
105671628|NCT02626455|364460694|FG006|Overall Study|Study intervention never administered|3|||
105671629|NCT00384397|364460698|FG000|Overall Study|Adverse Event|0|||
105671630|NCT00384397|364460699|FG001|Overall Study|Adverse Event|1|||
105671631|NCT00384397|364460700|FG002|Overall Study|Adverse Event|2|||
105671632|NCT00384397|364460698|FG000|Overall Study|Protocol Violation|7|||
105671633|NCT00384397|364460699|FG001|Overall Study|Protocol Violation|15|||
105671634|NCT00384397|364460700|FG002|Overall Study|Protocol Violation|13|||
105671635|NCT00384397|364460698|FG000|Overall Study|Lost to Follow-up|11|||
105671636|NCT00384397|364460699|FG001|Overall Study|Lost to Follow-up|13|||
105671637|NCT00384397|364460700|FG002|Overall Study|Lost to Follow-up|3|||
105671638|NCT00384397|364460698|FG000|Overall Study|Withdrawal by Subject|14|||
105671639|NCT00384397|364460699|FG001|Overall Study|Withdrawal by Subject|17|||
105671640|NCT00384397|364460700|FG002|Overall Study|Withdrawal by Subject|15|||
105671641|NCT01214642|364460701|FG000|Overall Study|Progressive Disease|3|||
105671642|NCT01214642|364460702|FG001|Overall Study|Progressive Disease|2|||
105671643|NCT01214642|364460703|FG002|Overall Study|Progressive Disease|3|||
105671644|NCT01214642|364460704|FG003|Overall Study|Progressive Disease|5|||
105671645|NCT01214642|364460705|FG004|Overall Study|Progressive Disease|5|||
105671646|NCT01214642|364460706|FG005|Overall Study|Progressive Disease|3|||
105671647|NCT01214642|364460707|FG006|Overall Study|Progressive Disease|5|||
105671648|NCT01214642|364460708|FG007|Overall Study|Progressive Disease|3|||
105671649|NCT01214642|364460709|FG008|Overall Study|Progressive Disease|10|||
105671650|NCT01214642|364460710|FG009|Overall Study|Progressive Disease|2|||
105671651|NCT01214642|364460711|FG010|Overall Study|Progressive Disease|1|||
105671652|NCT01214642|364460712|FG011|Overall Study|Progressive Disease|4|||
105671653|NCT01214642|364460701|FG000|Overall Study|Adverse Event|0|||
105671654|NCT01214642|364460702|FG001|Overall Study|Adverse Event|1|||
105671655|NCT01214642|364460703|FG002|Overall Study|Adverse Event|0|||
105671656|NCT01214642|364460704|FG003|Overall Study|Adverse Event|0|||
105671657|NCT01214642|364460705|FG004|Overall Study|Adverse Event|0|||
105671658|NCT01214642|364460706|FG005|Overall Study|Adverse Event|0|||
105671659|NCT01214642|364460707|FG006|Overall Study|Adverse Event|1|||
105671660|NCT01214642|364460708|FG007|Overall Study|Adverse Event|0|||
105671661|NCT01214642|364460709|FG008|Overall Study|Adverse Event|0|||
105671662|NCT01214642|364460710|FG009|Overall Study|Adverse Event|1|||
105671663|NCT01214642|364460711|FG010|Overall Study|Adverse Event|1|||
105671664|NCT01214642|364460712|FG011|Overall Study|Adverse Event|0|||
105671665|NCT01214642|364460701|FG000|Overall Study|Death|0|||
105671666|NCT01214642|364460702|FG001|Overall Study|Death|0|||
105671667|NCT01214642|364460703|FG002|Overall Study|Death|1|||
105671668|NCT01214642|364460704|FG003|Overall Study|Death|0|||
105671669|NCT01214642|364460705|FG004|Overall Study|Death|0|||
105671670|NCT01214642|364460706|FG005|Overall Study|Death|0|||
105671671|NCT01214642|364460707|FG006|Overall Study|Death|0|||
105671672|NCT01214642|364460708|FG007|Overall Study|Death|0|||
105671673|NCT01214642|364460709|FG008|Overall Study|Death|0|||
105671674|NCT01214642|364460710|FG009|Overall Study|Death|0|||
105671675|NCT01214642|364460711|FG010|Overall Study|Death|1|||
105671676|NCT01214642|364460712|FG011|Overall Study|Death|0|||
105671677|NCT01214642|364460701|FG000|Overall Study|Withdrawal by Subject|0|||
105671678|NCT01214642|364460702|FG001|Overall Study|Withdrawal by Subject|0|||
105671679|NCT01214642|364460703|FG002|Overall Study|Withdrawal by Subject|1|||
105671680|NCT01214642|364460704|FG003|Overall Study|Withdrawal by Subject|0|||
105671681|NCT01214642|364460705|FG004|Overall Study|Withdrawal by Subject|0|||
105671682|NCT01214642|364460706|FG005|Overall Study|Withdrawal by Subject|0|||
105671683|NCT01214642|364460707|FG006|Overall Study|Withdrawal by Subject|0|||
105671684|NCT01214642|364460708|FG007|Overall Study|Withdrawal by Subject|0|||
105671685|NCT01214642|364460709|FG008|Overall Study|Withdrawal by Subject|3|||
105786208|NCT00972309|364870478|FG001|Overall Study|Visa issues|1|||
105786209|NCT00972309|364870477|FG000|Overall Study|Secondary cancer (SCC)|0|||
105786210|NCT00972309|364870478|FG001|Overall Study|Secondary cancer (SCC)|1|||
105671686|NCT01214642|364460710|FG009|Overall Study|Withdrawal by Subject|1|||
105671687|NCT01214642|364460711|FG010|Overall Study|Withdrawal by Subject|1|||
105671688|NCT01214642|364460712|FG011|Overall Study|Withdrawal by Subject|0|||
105671689|NCT01214642|364460701|FG000|Overall Study|Physician Decision|0|||
105671690|NCT01214642|364460702|FG001|Overall Study|Physician Decision|0|||
105671691|NCT01214642|364460703|FG002|Overall Study|Physician Decision|1|||
105671692|NCT01214642|364460704|FG003|Overall Study|Physician Decision|1|||
105786211|NCT00972309|364870477|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
105671693|NCT01214642|364460705|FG004|Overall Study|Physician Decision|1|||
105342543|NCT00784550|363256670|FG000|Overall Study|Lack of Efficacy|0|||
105342544|NCT00784550|363256671|FG001|Overall Study|Lack of Efficacy|1|||
105342545|NCT00784550|363256670|FG000|Overall Study|Protocol Violation|10|||
105342546|NCT00784550|363256671|FG001|Overall Study|Protocol Violation|10|||
105342547|NCT00784550|363256670|FG000|Overall Study|Lost to Follow-up|8|||
105342548|NCT00784550|363256671|FG001|Overall Study|Lost to Follow-up|5|||
105342549|NCT00784550|363256670|FG000|Overall Study|Physician Decision|2|||
105342550|NCT00784550|363256671|FG001|Overall Study|Physician Decision|3|||
105342551|NCT00784550|363256670|FG000|Overall Study|Withdrawal by Subject|4|||
105342552|NCT00784550|363256671|FG001|Overall Study|Withdrawal by Subject|13|||
105342553|NCT00860249|363256672|FG000|Overall Study|trial was terminated prior to completion|21|||
105342554|NCT00860249|363256673|FG001|Overall Study|trial was terminated prior to completion|18|||
105342555|NCT00860249|363256674|FG002|Overall Study|trial was terminated prior to completion|21|||
105342556|NCT01944670|363256675|FG000|Overall Study|Lost to Follow-up|2|||
105342557|NCT02143791|363256678|FG000|Enrolled|Withdrawal by Subject|4|||
105342558|NCT02143791|363256678|FG000|Trial Stimulation|Lack of Efficacy|21|||
105342559|NCT02143791|363256678|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
105342560|NCT02143791|363256678|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
105342561|NCT02143791|363256678|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
105342562|NCT02143791|363256678|FG000|Any Programming (3-6 Months)|Missing Data|1|||
105342563|NCT02143791|363256678|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
105342564|NCT01214252|363256686|FG000|Overall Study|Not eligible per protocol|82|||
105342565|NCT01279070|363256689|FG000|Overall Study|Withdrawal by Subject|2|||
105342566|NCT01279070|363256690|FG001|Overall Study|Withdrawal by Subject|3|||
105342567|NCT01279070|363256689|FG000|Overall Study|Acute exacerbation|3|||
105342568|NCT01279070|363256690|FG001|Overall Study|Acute exacerbation|1|||
105342569|NCT03687372|363256691|FG000|Overall Study|Lost to Follow-up|12|||
105342570|NCT03687372|363256692|FG001|Overall Study|Lost to Follow-up|21|||
105342571|NCT03687372|363256691|FG000|Overall Study|Withdrawal by Subject|4|||
105342572|NCT03687372|363256692|FG001|Overall Study|Withdrawal by Subject|17|||
105342573|NCT03687372|363256691|FG000|Overall Study|Investigator Decision|1|||
105342574|NCT03687372|363256692|FG001|Overall Study|Investigator Decision|1|||
105342575|NCT01482962|363256697|FG000|Overall Study|Progressive Disease|65|||
105342576|NCT01482962|363256698|FG001|Overall Study|Progressive Disease|53|||
105342577|NCT01482962|363256697|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
105342578|NCT01482962|363256698|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
105342579|NCT01482962|363256697|FG000|Overall Study|Adverse Event|18|||
105342580|NCT01482962|363256698|FG001|Overall Study|Adverse Event|22|||
105342581|NCT01482962|363256697|FG000|Overall Study|Withdrawal by Participant|8|||
105342582|NCT01482962|363256698|FG001|Overall Study|Withdrawal by Participant|13|||
105342583|NCT01482962|363256697|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
105342584|NCT01482962|363256698|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
105342585|NCT01482962|363256697|FG000|Overall Study|Other Reason|1|||
105342586|NCT01482962|363256698|FG001|Overall Study|Other Reason|5|||
105342587|NCT01482962|363256697|FG000|Overall Study|Study Terminated by Sponsor|5|||
105342588|NCT01482962|363256698|FG001|Overall Study|Study Terminated by Sponsor|2|||
105342589|NCT01482962|363256697|FG000|Overall Study|Did not Receive Study Drug|1|||
105342590|NCT01482962|363256698|FG001|Overall Study|Did not Receive Study Drug|6|||
105342591|NCT02035748|363256699|FG000|Overall Study|Adverse Event|5|||
105342592|NCT02035748|363256699|FG000|Overall Study|Death|3|||
105554627|NCT01217073|364027392|FG005|Extension Period|Non-compliance with study drug|0|||
105554628|NCT01217073|364027393|FG006|Extension Period|Non-compliance with study drug|0|||
105554629|NCT01217073|364027394|FG007|Extension Period|Non-compliance with study drug|1|||
105554630|NCT01217073|364027387|FG000|Extension Period|Physician Decision|0|||
105554631|NCT01217073|364027388|FG001|Extension Period|Physician Decision|0|||
105554632|NCT01217073|364027389|FG002|Extension Period|Physician Decision|0|||
105554633|NCT01217073|364027390|FG003|Extension Period|Physician Decision|0|||
105671694|NCT01214642|364460706|FG005|Overall Study|Physician Decision|0|||
105671695|NCT01214642|364460707|FG006|Overall Study|Physician Decision|0|||
105671696|NCT01214642|364460708|FG007|Overall Study|Physician Decision|0|||
105671697|NCT01214642|364460709|FG008|Overall Study|Physician Decision|0|||
105671698|NCT01214642|364460710|FG009|Overall Study|Physician Decision|0|||
105671699|NCT01214642|364460711|FG010|Overall Study|Physician Decision|0|||
105342593|NCT02035748|363256699|FG000|Overall Study|Lost to Follow-up|2|||
105786212|NCT00972309|364870478|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
105554634|NCT01217073|364027391|FG004|Extension Period|Physician Decision|0|||
105786213|NCT00972309|364870477|FG000|Overall Study|Lost to Follow-up|1|||
105342594|NCT02035748|363256699|FG000|Overall Study|Physician Decision|3|||
105342595|NCT02035748|363256699|FG000|Overall Study|Withdrawal by Subject|6|||
105342596|NCT02035748|363256699|FG000|Overall Study|Progressive Disease|1|||
105342597|NCT01088243|363256701|FG000|Overall Study|Adverse Event|1|||
105342598|NCT01088243|363256702|FG001|Overall Study|Adverse Event|0|||
105342599|NCT02231879|363256703|FG000|Overall Study|Adverse Event|2|||
105342600|NCT02231879|363256704|FG001|Overall Study|Adverse Event|1|||
105671700|NCT01214642|364460712|FG011|Overall Study|Physician Decision|2|||
105671701|NCT01241604|364460716|FG000|Screening Period|Screen Failure|3|||
105671702|NCT01241604|364460717|FG001|Screening Period|Screen Failure|0|||
105671703|NCT01241604|364460718|FG002|Screening Period|Screen Failure|0|||
105671704|NCT02304705|364462510|FG000|Overall Study|Withdrawal by Subject|2|||
105671705|NCT02304705|364462511|FG001|Overall Study|Withdrawal by Subject|0|||
105671706|NCT02304705|364462510|FG000|Overall Study|Physician Decision|2|||
105671707|NCT02304705|364462511|FG001|Overall Study|Physician Decision|4|||
105671708|NCT02304705|364462510|FG000|Overall Study|Death|0|||
105671709|NCT02304705|364462511|FG001|Overall Study|Death|1|||
105671710|NCT02304705|364462510|FG000|Overall Study|Lost to Follow-up|0|||
105786214|NCT00972309|364870478|FG001|Overall Study|Lost to Follow-up|1|||
105786215|NCT00972309|364870477|FG000|Overall Study|Disease progression on study|10|||
105671711|NCT02304705|364462511|FG001|Overall Study|Lost to Follow-up|2|||
105671712|NCT01014208|364462512|FG000|Overall Study|Lost to Follow-up|2|||
105671713|NCT01014208|364462513|FG001|Overall Study|Lost to Follow-up|5|||
105671714|NCT01014208|364462512|FG000|Overall Study|Participant Withdrew Consent|12|||
105671715|NCT01014208|364462513|FG001|Overall Study|Participant Withdrew Consent|12|||
105671716|NCT01014208|364462512|FG000|Overall Study|Did Not Receive Study Drug|2|||
105671717|NCT01014208|364462513|FG001|Overall Study|Did Not Receive Study Drug|0|||
105671718|NCT01014208|364462512|FG000|Overall Study|Study Closed/terminated|78|||
105671719|NCT01014208|364462513|FG001|Overall Study|Study Closed/terminated|83|||
105671720|NCT00770029|364462517|FG000|Overall Study|Lost to Follow-up|2|||
105671721|NCT00770029|364462518|FG001|Overall Study|Lost to Follow-up|0|||
105671722|NCT00770029|364462517|FG000|Overall Study|Withdrawal by Subject|3|||
105671723|NCT00770029|364462518|FG001|Overall Study|Withdrawal by Subject|3|||
105671724|NCT00770029|364462517|FG000|Overall Study|Adverse Event|1|||
105671725|NCT00770029|364462518|FG001|Overall Study|Adverse Event|0|||
105671726|NCT02124811|364462519|FG000|Overall Study|Early termination|2|||
105671727|NCT02124811|364462520|FG001|Overall Study|Early termination|2|||
105671728|NCT02124811|364462519|FG000|Overall Study|Withdrawal by Subject|1|||
105671729|NCT02124811|364462520|FG001|Overall Study|Withdrawal by Subject|0|||
105671730|NCT00414908|364462521|FG000|Overall Study|Protocol Violation|1|||
105671731|NCT00414908|364462522|FG001|Overall Study|Protocol Violation|1|||
105671732|NCT00818168|364462523|FG000|Overall Study|Lack of Efficacy|18|||
105671733|NCT00818168|364462523|FG000|Overall Study|Pregnancy|2|||
105671734|NCT00818168|364462523|FG000|Overall Study|Withdrawal by Subject|16|||
105671735|NCT00818168|364462523|FG000|Overall Study|Lost to Follow-up|7|||
105671736|NCT00818168|364462523|FG000|Overall Study|Adverse Event|19|||
105671737|NCT00818168|364462523|FG000|Overall Study|Reason for Non-completion Not reported|6|||
105671738|NCT00818168|364462523|FG000|Overall Study|Participant Moved|2|||
105671739|NCT03140280|364462524|FG000|Overall Study|Physician Decision|5|||
105671740|NCT04476251|364462527|FG000|Overall Study|Not treated|1|||
105671741|NCT02248818|364462530|FG000|Screening|Protocol Violation|0|||
105671742|NCT02248818|364462531|FG001|Screening|Protocol Violation|0|||
105671743|NCT02248818|364462532|FG002|Screening|Protocol Violation|0|||
105671744|NCT02248818|364462533|FG003|Screening|Protocol Violation|0|||
105671745|NCT02248818|364462534|FG004|Screening|Protocol Violation|0|||
105671746|NCT02248818|364462535|FG005|Screening|Protocol Violation|0|||
105671747|NCT02248818|364462536|FG006|Screening|Protocol Violation|0|||
105671748|NCT02248818|364462537|FG007|Screening|Protocol Violation|0|||
105671749|NCT02248818|364462538|FG008|Screening|Protocol Violation|7|||
105671750|NCT02248818|364462530|FG000|Screening|Study fully enrolled|0|||
105671751|NCT02248818|364462531|FG001|Screening|Study fully enrolled|0|||
105671752|NCT02248818|364462532|FG002|Screening|Study fully enrolled|0|||
105671753|NCT02248818|364462533|FG003|Screening|Study fully enrolled|0|||
105671754|NCT02248818|364462534|FG004|Screening|Study fully enrolled|0|||
105671755|NCT02248818|364462535|FG005|Screening|Study fully enrolled|0|||
105671756|NCT02248818|364462536|FG006|Screening|Study fully enrolled|0|||
105671757|NCT02248818|364462537|FG007|Screening|Study fully enrolled|0|||
105671758|NCT02248818|364462538|FG008|Screening|Study fully enrolled|14|||
105671759|NCT02248818|364462530|FG000|Screening|Physician Decision|0|||
105671760|NCT02248818|364462531|FG001|Screening|Physician Decision|0|||
105671761|NCT02248818|364462532|FG002|Screening|Physician Decision|0|||
105671762|NCT02248818|364462533|FG003|Screening|Physician Decision|0|||
105671763|NCT02248818|364462534|FG004|Screening|Physician Decision|0|||
105671764|NCT02248818|364462535|FG005|Screening|Physician Decision|0|||
105671765|NCT02248818|364462536|FG006|Screening|Physician Decision|0|||
105671766|NCT02248818|364462537|FG007|Screening|Physician Decision|0|||
105671767|NCT02248818|364462538|FG008|Screening|Physician Decision|73|||
105671768|NCT02248818|364462530|FG000|Screening|Withdrawal by Subject|0|||
105671769|NCT02248818|364462531|FG001|Screening|Withdrawal by Subject|0|||
105671770|NCT02248818|364462532|FG002|Screening|Withdrawal by Subject|0|||
105671771|NCT02248818|364462533|FG003|Screening|Withdrawal by Subject|0|||
105671772|NCT02248818|364462534|FG004|Screening|Withdrawal by Subject|0|||
105671773|NCT02248818|364462535|FG005|Screening|Withdrawal by Subject|0|||
105671774|NCT02248818|364462536|FG006|Screening|Withdrawal by Subject|0|||
105671775|NCT02248818|364462537|FG007|Screening|Withdrawal by Subject|0|||
105671776|NCT02248818|364462538|FG008|Screening|Withdrawal by Subject|6|||
105671777|NCT02248818|364462530|FG000|Screening|Lost to Follow-up|0|||
105671778|NCT02248818|364462531|FG001|Screening|Lost to Follow-up|0|||
105671779|NCT02248818|364462532|FG002|Screening|Lost to Follow-up|0|||
105671780|NCT02248818|364462533|FG003|Screening|Lost to Follow-up|0|||
105671781|NCT02248818|364462534|FG004|Screening|Lost to Follow-up|0|||
105671782|NCT02248818|364462535|FG005|Screening|Lost to Follow-up|0|||
105671783|NCT02248818|364462536|FG006|Screening|Lost to Follow-up|0|||
105671784|NCT02248818|364462537|FG007|Screening|Lost to Follow-up|0|||
105671785|NCT02248818|364462538|FG008|Screening|Lost to Follow-up|7|||
105554635|NCT01217073|364027392|FG005|Extension Period|Physician Decision|0|||
105554636|NCT01217073|364027393|FG006|Extension Period|Physician Decision|4|||
105554637|NCT01217073|364027394|FG007|Extension Period|Physician Decision|1|||
105554638|NCT01217073|364027387|FG000|Extension Period|Protocol Violation|0|||
105554639|NCT01217073|364027388|FG001|Extension Period|Protocol Violation|0|||
105554640|NCT01217073|364027389|FG002|Extension Period|Protocol Violation|0|||
105554641|NCT01217073|364027390|FG003|Extension Period|Protocol Violation|0|||
105554642|NCT01217073|364027391|FG004|Extension Period|Protocol Violation|0|||
105554643|NCT01217073|364027392|FG005|Extension Period|Protocol Violation|0|||
105554644|NCT01217073|364027393|FG006|Extension Period|Protocol Violation|2|||
105554645|NCT01217073|364027394|FG007|Extension Period|Protocol Violation|1|||
105554646|NCT01217073|364027387|FG000|Extension Period|Site discontinued study participation|0|||
105554647|NCT01217073|364027388|FG001|Extension Period|Site discontinued study participation|0|||
105554648|NCT01217073|364027389|FG002|Extension Period|Site discontinued study participation|0|||
105554649|NCT01217073|364027390|FG003|Extension Period|Site discontinued study participation|0|||
105554650|NCT01217073|364027391|FG004|Extension Period|Site discontinued study participation|0|||
105554651|NCT01217073|364027392|FG005|Extension Period|Site discontinued study participation|0|||
105554652|NCT01217073|364027393|FG006|Extension Period|Site discontinued study participation|7|||
105554653|NCT01217073|364027394|FG007|Extension Period|Site discontinued study participation|2|||
105554654|NCT01217073|364027387|FG000|Extension Period|Withdrawal by Subject|0|||
105554655|NCT01217073|364027388|FG001|Extension Period|Withdrawal by Subject|0|||
105554656|NCT01217073|364027389|FG002|Extension Period|Withdrawal by Subject|0|||
105554657|NCT01217073|364027390|FG003|Extension Period|Withdrawal by Subject|0|||
105554658|NCT01217073|364027391|FG004|Extension Period|Withdrawal by Subject|0|||
105554659|NCT01217073|364027392|FG005|Extension Period|Withdrawal by Subject|0|||
105554660|NCT01217073|364027393|FG006|Extension Period|Withdrawal by Subject|30|||
105554661|NCT01217073|364027394|FG007|Extension Period|Withdrawal by Subject|8|||
105554662|NCT02479412|364027395|FG000|Overall Study|Adverse Event|0|||
105554663|NCT02479412|364027396|FG001|Overall Study|Adverse Event|0|||
105554664|NCT02479412|364027397|FG002|Overall Study|Adverse Event|1|||
105554665|NCT02479412|364027398|FG003|Overall Study|Adverse Event|0|||
105554666|NCT02479412|364027399|FG004|Overall Study|Adverse Event|0|||
105554667|NCT02479412|364027400|FG005|Overall Study|Adverse Event|0|||
105554668|NCT02479412|364027401|FG006|Overall Study|Adverse Event|0|||
105554669|NCT02479412|364027402|FG007|Overall Study|Adverse Event|0|||
105554670|NCT02479412|364027403|FG008|Overall Study|Adverse Event|0|||
105554671|NCT02479412|364027395|FG000|Overall Study|Study-specific withdrawal criteria|0|||
105554672|NCT02479412|364027396|FG001|Overall Study|Study-specific withdrawal criteria|0|||
105554673|NCT02479412|364027397|FG002|Overall Study|Study-specific withdrawal criteria|1|||
105554674|NCT02479412|364027398|FG003|Overall Study|Study-specific withdrawal criteria|1|||
105554675|NCT02479412|364027399|FG004|Overall Study|Study-specific withdrawal criteria|0|||
105554676|NCT02479412|364027400|FG005|Overall Study|Study-specific withdrawal criteria|0|||
105554677|NCT02479412|364027401|FG006|Overall Study|Study-specific withdrawal criteria|0|||
105554678|NCT02479412|364027402|FG007|Overall Study|Study-specific withdrawal criteria|1|||
105554679|NCT02479412|364027403|FG008|Overall Study|Study-specific withdrawal criteria|1|||
105554680|NCT02479412|364027395|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
105554681|NCT02479412|364027396|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
105554682|NCT02479412|364027397|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
105554683|NCT02479412|364027398|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
105554684|NCT02479412|364027399|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
105554685|NCT02479412|364027400|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
105554686|NCT02479412|364027401|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
105554687|NCT02479412|364027402|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
105554688|NCT02479412|364027403|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
105554689|NCT03117738|364027407|FG000|Overall Study|Withdrawal by Subject|3|||
105554690|NCT03117738|364027408|FG001|Overall Study|Withdrawal by Subject|1|||
105554691|NCT03117738|364027407|FG000|Overall Study|Lost to Follow-up|1|||
105554692|NCT03117738|364027408|FG001|Overall Study|Lost to Follow-up|4|||
105554693|NCT03667053|364027410|FG000|Overall Study|Withdrawal by Subject|1|||
105554694|NCT03667053|364027411|FG001|Overall Study|Withdrawal by Subject|0|||
105554695|NCT03667053|364027412|FG002|Overall Study|Withdrawal by Subject|0|||
105554696|NCT00487162|364027416|FG000|Overall Study|Adverse Event|0|||
105554697|NCT00487162|364027417|FG001|Overall Study|Adverse Event|1|||
105554698|NCT00487162|364027416|FG000|Overall Study|Physician Decision|0|||
105554699|NCT00487162|364027417|FG001|Overall Study|Physician Decision|1|||
105554700|NCT00487162|364027416|FG000|Overall Study|Withdrawal by Subject|2|||
105554701|NCT00487162|364027417|FG001|Overall Study|Withdrawal by Subject|3|||
105554702|NCT01292928|364027420|FG000|Overall Study|Death|8|||
105554703|NCT01292928|364027420|FG000|Overall Study|Withdrawal by Subject|8|||
105554704|NCT01292928|364027420|FG000|Overall Study|Lost to Follow-up|6|||
105554705|NCT01292928|364027420|FG000|Overall Study|Physician Decision|2|||
105554706|NCT05545072|364027421|FG000|Overall Study|Lost to Follow-up|1|||
105554707|NCT05545072|364027422|FG001|Overall Study|Lost to Follow-up|0|||
105554708|NCT05545072|364027421|FG000|Overall Study|Study ended prematurely due to funding|2|||
105554709|NCT05545072|364027422|FG001|Overall Study|Study ended prematurely due to funding|2|||
105554710|NCT05585307|364027425|FG000|Overall Study|Lost to Follow-up|0|||
105554711|NCT05585307|364027426|FG001|Overall Study|Lost to Follow-up|0|||
105554712|NCT05585307|364027427|FG002|Overall Study|Lost to Follow-up|0|||
105554713|NCT05585307|364027428|FG003|Overall Study|Lost to Follow-up|0|||
105554714|NCT05585307|364027429|FG004|Overall Study|Lost to Follow-up|0|||
105554715|NCT05585307|364027430|FG005|Overall Study|Lost to Follow-up|0|||
105554716|NCT05585307|364027431|FG006|Overall Study|Lost to Follow-up|1|||
105554717|NCT05585307|364027432|FG007|Overall Study|Lost to Follow-up|0|||
105554718|NCT03579563|364027433|FG000|Overall Study|Lost to Follow-up|0|||
105554719|NCT03579563|364027434|FG001|Overall Study|Lost to Follow-up|0|||
105554720|NCT03579563|364027435|FG002|Overall Study|Lost to Follow-up|0|||
105554721|NCT03579563|364027436|FG003|Overall Study|Lost to Follow-up|0|||
105554722|NCT03579563|364027437|FG004|Overall Study|Lost to Follow-up|1|||
105554723|NCT03579563|364027438|FG005|Overall Study|Lost to Follow-up|0|||
105554724|NCT03579563|364027433|FG000|Overall Study|Lack of Efficacy|1|||
105554725|NCT03579563|364027434|FG001|Overall Study|Lack of Efficacy|1|||
105554726|NCT03579563|364027435|FG002|Overall Study|Lack of Efficacy|4|||
105554727|NCT03579563|364027436|FG003|Overall Study|Lack of Efficacy|1|||
105554728|NCT03579563|364027437|FG004|Overall Study|Lack of Efficacy|2|||
105554729|NCT03579563|364027438|FG005|Overall Study|Lack of Efficacy|3|||
105554730|NCT03579563|364027433|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
105554731|NCT03579563|364027434|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
105554732|NCT03579563|364027435|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
105554733|NCT03579563|364027436|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
105554734|NCT03579563|364027437|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
105554735|NCT03579563|364027438|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
105554736|NCT03579563|364027433|FG000|Overall Study|Time/distance concern|0|||
105554737|NCT03579563|364027434|FG001|Overall Study|Time/distance concern|0|||
105554738|NCT03579563|364027435|FG002|Overall Study|Time/distance concern|1|||
105554739|NCT03579563|364027436|FG003|Overall Study|Time/distance concern|0|||
105554740|NCT03579563|364027437|FG004|Overall Study|Time/distance concern|0|||
105554741|NCT03579563|364027438|FG005|Overall Study|Time/distance concern|1|||
105554742|NCT03579563|364027433|FG000|Overall Study|COVID shutdown|2|||
105554743|NCT03579563|364027434|FG001|Overall Study|COVID shutdown|3|||
105554744|NCT03579563|364027435|FG002|Overall Study|COVID shutdown|4|||
105554745|NCT03579563|364027436|FG003|Overall Study|COVID shutdown|3|||
105554746|NCT03579563|364027437|FG004|Overall Study|COVID shutdown|1|||
105554747|NCT03579563|364027438|FG005|Overall Study|COVID shutdown|2|||
105554748|NCT03579563|364027433|FG000|Overall Study|Protocol administration error|1|||
105554749|NCT03579563|364027434|FG001|Overall Study|Protocol administration error|0|||
105554750|NCT03579563|364027435|FG002|Overall Study|Protocol administration error|1|||
105554751|NCT03579563|364027436|FG003|Overall Study|Protocol administration error|0|||
105554752|NCT03579563|364027437|FG004|Overall Study|Protocol administration error|1|||
105554753|NCT03579563|364027438|FG005|Overall Study|Protocol administration error|5|||
105554754|NCT04642638|364027439|FG000|Overall Study|Withdrawal by Subject|23|||
105554755|NCT04642638|364027440|FG001|Overall Study|Withdrawal by Subject|29|||
105671786|NCT02248818|364462530|FG000|Randomised Study|Administrative - randomization error|0|||
105671787|NCT02248818|364462531|FG001|Randomised Study|Administrative - randomization error|0|||
105671788|NCT02248818|364462532|FG002|Randomised Study|Administrative - randomization error|0|||
105671789|NCT02248818|364462533|FG003|Randomised Study|Administrative - randomization error|0|||
105671790|NCT02248818|364462534|FG004|Randomised Study|Administrative - randomization error|0|||
105671791|NCT02248818|364462535|FG005|Randomised Study|Administrative - randomization error|8|||
105671792|NCT02248818|364462536|FG006|Randomised Study|Administrative - randomization error|0|||
105671793|NCT02248818|364462537|FG007|Randomised Study|Administrative - randomization error|0|||
105671794|NCT02248818|364462538|FG008|Randomised Study|Administrative - randomization error|0|||
105671795|NCT04020185|364462542|FG000|Overall Study|Death|0|||
105671796|NCT04020185|364462543|FG001|Overall Study|Death|0|||
105671797|NCT04020185|364462544|FG002|Overall Study|Death|1|||
105671798|NCT04020185|364462545|FG003|Overall Study|Death|2|||
105671799|NCT04020185|364462546|FG004|Overall Study|Death|1|||
105671800|NCT04020185|364462547|FG005|Overall Study|Death|0|||
105671801|NCT04020185|364462548|FG006|Overall Study|Death|1|||
105671802|NCT04020185|364462549|FG007|Overall Study|Death|0|||
105671803|NCT04020185|364462542|FG000|Overall Study|Consent withdrawn|1|||
105671804|NCT04020185|364462543|FG001|Overall Study|Consent withdrawn|0|||
105671805|NCT04020185|364462544|FG002|Overall Study|Consent withdrawn|0|||
105671806|NCT04020185|364462545|FG003|Overall Study|Consent withdrawn|0|||
105671807|NCT04020185|364462546|FG004|Overall Study|Consent withdrawn|2|||
105671808|NCT04020185|364462547|FG005|Overall Study|Consent withdrawn|0|||
105671809|NCT04020185|364462548|FG006|Overall Study|Consent withdrawn|1|||
105671810|NCT04020185|364462549|FG007|Overall Study|Consent withdrawn|1|||
105671811|NCT04020185|364462542|FG000|Overall Study|Patient in hospice|0|||
105671812|NCT04020185|364462543|FG001|Overall Study|Patient in hospice|1|||
105671813|NCT04020185|364462544|FG002|Overall Study|Patient in hospice|0|||
105671814|NCT04020185|364462545|FG003|Overall Study|Patient in hospice|0|||
105671815|NCT04020185|364462546|FG004|Overall Study|Patient in hospice|0|||
105671816|NCT04020185|364462547|FG005|Overall Study|Patient in hospice|0|||
105671817|NCT04020185|364462548|FG006|Overall Study|Patient in hospice|0|||
105671818|NCT04020185|364462549|FG007|Overall Study|Patient in hospice|0|||
105671819|NCT04020185|364462542|FG000|Overall Study|Continuing on expanded access|0|||
105671820|NCT04020185|364462543|FG001|Overall Study|Continuing on expanded access|0|||
105671821|NCT04020185|364462544|FG002|Overall Study|Continuing on expanded access|0|||
105671822|NCT04020185|364462545|FG003|Overall Study|Continuing on expanded access|0|||
105671823|NCT04020185|364462546|FG004|Overall Study|Continuing on expanded access|0|||
105671824|NCT04020185|364462547|FG005|Overall Study|Continuing on expanded access|0|||
105671825|NCT04020185|364462548|FG006|Overall Study|Continuing on expanded access|1|||
105671826|NCT04020185|364462549|FG007|Overall Study|Continuing on expanded access|1|||
105671827|NCT04833127|364462550|FG000|Overall Study|Lost to Follow-up|1|||
105671828|NCT04833127|364462551|FG001|Overall Study|Lost to Follow-up|1|||
105671829|NCT04552899|364462552|FG000|Overall Study|Adverse Event|4|||
105671830|NCT04552899|364462553|FG001|Overall Study|Adverse Event|3|||
105671831|NCT04552899|364462552|FG000|Overall Study|Death|4|||
105671832|NCT04552899|364462553|FG001|Overall Study|Death|4|||
105671833|NCT04552899|364462552|FG000|Overall Study|Lost to Follow-up|8|||
105671834|NCT04552899|364462553|FG001|Overall Study|Lost to Follow-up|13|||
105671835|NCT04552899|364462552|FG000|Overall Study|Lung Transplant|4|||
105671836|NCT04552899|364462553|FG001|Overall Study|Lung Transplant|3|||
105671837|NCT04552899|364462552|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
105671838|NCT04552899|364462553|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
105671839|NCT04552899|364462552|FG000|Overall Study|Physician Decision|3|||
105671840|NCT04552899|364462553|FG001|Overall Study|Physician Decision|4|||
105671841|NCT04552899|364462552|FG000|Overall Study|Study Terminated By Sponsor|237|||
105671842|NCT04552899|364462553|FG001|Overall Study|Study Terminated By Sponsor|239|||
105671843|NCT04552899|364462552|FG000|Overall Study|Withdrawal by Subject|15|||
105671844|NCT04552899|364462553|FG001|Overall Study|Withdrawal by Subject|17|||
105671845|NCT04335591|364462554|FG000|Overall Study|Adverse Event|5|||
105671846|NCT04335591|364462555|FG001|Overall Study|Adverse Event|2|||
105671847|NCT04335591|364462556|FG002|Overall Study|Adverse Event|3|||
105671848|NCT04335591|364462557|FG003|Overall Study|Adverse Event|2|||
105671849|NCT04335591|364462554|FG000|Overall Study|Protocol Violation|1|||
105671850|NCT04335591|364462555|FG001|Overall Study|Protocol Violation|0|||
105671851|NCT04335591|364462556|FG002|Overall Study|Protocol Violation|0|||
105671852|NCT04335591|364462557|FG003|Overall Study|Protocol Violation|0|||
105671853|NCT04335591|364462554|FG000|Overall Study|Withdrawal by Subject|8|||
105671854|NCT04335591|364462555|FG001|Overall Study|Withdrawal by Subject|4|||
105671855|NCT04335591|364462556|FG002|Overall Study|Withdrawal by Subject|4|||
105671856|NCT04335591|364462557|FG003|Overall Study|Withdrawal by Subject|5|||
105671857|NCT04335591|364462554|FG000|Overall Study|Subject planning pregnancy|0|||
105671858|NCT04335591|364462555|FG001|Overall Study|Subject planning pregnancy|1|||
105671859|NCT04335591|364462556|FG002|Overall Study|Subject planning pregnancy|0|||
105671860|NCT04335591|364462557|FG003|Overall Study|Subject planning pregnancy|0|||
105671861|NCT04335591|364462554|FG000|Overall Study|Ukrainian Russian war conflict|4|||
105671862|NCT04335591|364462555|FG001|Overall Study|Ukrainian Russian war conflict|5|||
105671863|NCT04335591|364462556|FG002|Overall Study|Ukrainian Russian war conflict|2|||
105671864|NCT04335591|364462557|FG003|Overall Study|Ukrainian Russian war conflict|0|||
105671865|NCT03268603|364462558|FG000|Overall Study|Withdrawal by Subject|6|||
105671866|NCT03268603|364462558|FG000|Overall Study|Physician Decision|1|||
105671867|NCT03268603|364462558|FG000|Overall Study|Withdrawn due to disease progression|2|||
105671868|NCT00461981|364462559|FG000|Overall Study|Lost to Follow-up|9|||
105671869|NCT00461981|364462560|FG001|Overall Study|Lost to Follow-up|6|||
105671870|NCT00461981|364462559|FG000|Overall Study|Withdrawal by Subject|2|||
105671871|NCT00461981|364462560|FG001|Overall Study|Withdrawal by Subject|3|||
105671872|NCT02071290|364462561|FG000|Overall Study|Death|1|||
105671873|NCT02071290|364462562|FG001|Overall Study|Death|0|||
105671874|NCT02071290|364462561|FG000|Overall Study|Withdrawal by Subject|0|||
105671875|NCT02071290|364462562|FG001|Overall Study|Withdrawal by Subject|1|||
105671876|NCT02071290|364462561|FG000|Overall Study|Protocol Violation|3|||
105671877|NCT02071290|364462562|FG001|Overall Study|Protocol Violation|5|||
105671878|NCT02071290|364462561|FG000|Overall Study|Physician Decision|0|||
105671879|NCT02071290|364462562|FG001|Overall Study|Physician Decision|1|||
105671880|NCT01493427|364462563|FG000|Overall Study|Adverse Event|10|||
105671881|NCT01493427|364462563|FG000|Overall Study|Personal Reasons|4|||
105671882|NCT01493427|364462563|FG000|Overall Study|Lost to Follow-up|2|||
105671883|NCT01493427|364462563|FG000|Overall Study|Inability to Follow Instructions|2|||
105671884|NCT01493427|364462563|FG000|Overall Study|Other|2|||
105671885|NCT00565773|364462564|FG000|Overall Study|Withdrawal by Subject|1|||
105671886|NCT00565773|364462564|FG000|Overall Study|Physician Decision|1|||
105671887|NCT02175641|364462567|FG000|Overall Study|Death|3|||
105671888|NCT02175641|364462568|FG001|Overall Study|Death|4|||
105671889|NCT02175641|364462567|FG000|Overall Study|Lost to Follow-up|4|||
105671890|NCT02175641|364462568|FG001|Overall Study|Lost to Follow-up|4|||
105671891|NCT02175641|364462567|FG000|Overall Study|Withdrawal by Subject|7|||
105671892|NCT02175641|364462568|FG001|Overall Study|Withdrawal by Subject|4|||
105671893|NCT02175641|364462567|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
105671894|NCT02175641|364462568|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
105671895|NCT02175641|364462567|FG000|Overall Study|Developed Contraindicated Condition|8|||
105671896|NCT02175641|364462568|FG001|Overall Study|Developed Contraindicated Condition|0|||
105671897|NCT04546425|364462569|FG000|Overall Study|Protocol Violation|1|||
105671898|NCT04546425|364462570|FG001|Overall Study|Protocol Violation|1|||
105671899|NCT04546425|364462571|FG002|Overall Study|Protocol Violation|0|||
105671900|NCT04546425|364462572|FG003|Overall Study|Protocol Violation|0|||
105671901|NCT04546425|364462569|FG000|Overall Study|Adverse Event|3|||
105671902|NCT04546425|364462570|FG001|Overall Study|Adverse Event|0|||
105671903|NCT04546425|364462571|FG002|Overall Study|Adverse Event|0|||
105671904|NCT04546425|364462572|FG003|Overall Study|Adverse Event|0|||
105671905|NCT04546425|364462569|FG000|Overall Study|Lost to Follow-up|5|||
105671906|NCT04546425|364462570|FG001|Overall Study|Lost to Follow-up|4|||
105671907|NCT04546425|364462571|FG002|Overall Study|Lost to Follow-up|0|||
105671908|NCT04546425|364462572|FG003|Overall Study|Lost to Follow-up|0|||
105671909|NCT04546425|364462569|FG000|Overall Study|No Longer met eligibility criteria|3|||
105342601|NCT02231879|363256703|FG000|Overall Study|Lack of Efficacy|0|||
105671910|NCT04546425|364462570|FG001|Overall Study|No Longer met eligibility criteria|3|||
105671911|NCT04546425|364462571|FG002|Overall Study|No Longer met eligibility criteria|1|||
105671912|NCT04546425|364462572|FG003|Overall Study|No Longer met eligibility criteria|1|||
105671913|NCT04546425|364462569|FG000|Overall Study|Withdrawal by parent/guardian|6|||
105671914|NCT04546425|364462570|FG001|Overall Study|Withdrawal by parent/guardian|5|||
105671915|NCT04546425|364462571|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105671916|NCT04546425|364462572|FG003|Overall Study|Withdrawal by parent/guardian|1|||
105671917|NCT01461811|364462576|FG000|Overall Study|Adverse Event|2|||
105671918|NCT01461811|364462577|FG001|Overall Study|Adverse Event|1|||
105671919|NCT01461811|364462576|FG000|Overall Study|Subject decision unrelated to an AE|1|||
105671920|NCT01461811|364462577|FG001|Overall Study|Subject decision unrelated to an AE|1|||
105671921|NCT01461811|364462576|FG000|Overall Study|Noncompliance|1|||
105671922|NCT01461811|364462577|FG001|Overall Study|Noncompliance|1|||
105671923|NCT02242097|364462579|FG000|Ibrutinib Treatment|Adverse Event|16|||
105671924|NCT02242097|364462579|FG000|Ibrutinib Treatment|Physician Decision|1|||
105671925|NCT02242097|364462579|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
105671926|NCT02242097|364462579|FG000|Ibrutinib Treatment|Death|1|||
105671927|NCT02242097|364462579|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
105671928|NCT02242097|364462579|FG000|Post Therapy Follow Up|Death|3|||
105671929|NCT02242097|364462579|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
105671930|NCT05032872|364462587|FG000|Overall Study|Adverse Event|1|||
105671931|NCT05032872|364462588|FG001|Overall Study|Adverse Event|0|||
105671932|NCT05032872|364462587|FG000|Overall Study|Lost to Follow-up|2|||
105671933|NCT05032872|364462588|FG001|Overall Study|Lost to Follow-up|4|||
105671934|NCT05032872|364462587|FG000|Overall Study|Withdrawal by Subject|4|||
105671935|NCT05032872|364462588|FG001|Overall Study|Withdrawal by Subject|3|||
105671936|NCT01232738|364462589|FG000|Overall Study|Death|3|||
105671937|NCT01232738|364462589|FG000|Overall Study|Physician Decision|2|||
105671938|NCT01232738|364462589|FG000|Overall Study|Lost to Follow-up|1|||
105671939|NCT01232738|364462589|FG000|Overall Study|Withdrawal by Subject|2|||
105671940|NCT01232738|364462589|FG000|Overall Study|Adverse Event|5|||
105671941|NCT02979249|364462590|FG000|Overall Study|Lost to Follow-up|2|||
105671942|NCT02979249|364462590|FG000|Overall Study|Withdrawal by Subject|4|||
105671943|NCT03525392|364462621|FG000|Overall Study|Adverse Event|1|||
105671944|NCT03525392|364462622|FG001|Overall Study|Adverse Event|0|||
105671945|NCT03525392|364462623|FG002|Overall Study|Adverse Event|2|||
105671946|NCT03525392|364462624|FG003|Overall Study|Adverse Event|0|||
105671947|NCT03525392|364462625|FG004|Overall Study|Adverse Event|0|||
105671948|NCT03525392|364462621|FG000|Overall Study|Progressive disease|0|||
105671949|NCT03525392|364462622|FG001|Overall Study|Progressive disease|1|||
105671950|NCT03525392|364462623|FG002|Overall Study|Progressive disease|1|||
105671951|NCT03525392|364462624|FG003|Overall Study|Progressive disease|3|||
105671952|NCT03525392|364462625|FG004|Overall Study|Progressive disease|1|||
105671953|NCT00886795|364462626|FG000|Overall Study|Lack of Efficacy|1|||
105671954|NCT03449901|364462629|FG000|Overall Study|Progression|57|||
105671955|NCT03449901|364462630|FG001|Overall Study|Progression|12|||
105671956|NCT03449901|364462629|FG000|Overall Study|Adverse Event|3|||
105671957|NCT03449901|364462630|FG001|Overall Study|Adverse Event|0|||
105671958|NCT03449901|364462629|FG000|Overall Study|Death|6|||
105671959|NCT03449901|364462630|FG001|Overall Study|Death|2|||
105671960|NCT03449901|364462629|FG000|Overall Study|Withdrawal by Subject|12|||
105671961|NCT03449901|364462630|FG001|Overall Study|Withdrawal by Subject|1|||
105671962|NCT03449901|364462629|FG000|Overall Study|Physician Decision|1|||
105671963|NCT03449901|364462630|FG001|Overall Study|Physician Decision|0|||
105671964|NCT03449901|364462629|FG000|Overall Study|Patient elected for surgical intervention|1|||
105671965|NCT03449901|364462630|FG001|Overall Study|Patient elected for surgical intervention|0|||
105671966|NCT03449901|364462629|FG000|Overall Study|Patient off for other complicating disease|1|||
105671967|NCT03449901|364462630|FG001|Overall Study|Patient off for other complicating disease|0|||
105671968|NCT00743431|364462631|FG000|Overall Study|Toxicity|6|||
105671969|NCT00743431|364462631|FG000|Overall Study|Tumor progression|56|||
105671970|NCT00743431|364462631|FG000|Overall Study|Withdrawal by Subject|13|||
105671971|NCT00743431|364462631|FG000|Overall Study|Death|9|||
105671972|NCT00743431|364462631|FG000|Overall Study|Reason for discontinuation not specified|29|||
105671973|NCT00743431|364462631|FG000|Overall Study|No documentation available|13|||
105671974|NCT04276415|364462632|FG000|Overall Study|Adverse Event|0|||
105671975|NCT04276415|364462633|FG001|Overall Study|Adverse Event|0|||
105671976|NCT04276415|364462634|FG002|Overall Study|Adverse Event|0|||
105671977|NCT04276415|364462635|FG003|Overall Study|Adverse Event|3|||
105671978|NCT04276415|364462636|FG004|Overall Study|Adverse Event|0|||
105342602|NCT02231879|363256704|FG001|Overall Study|Lack of Efficacy|1|||
105342603|NCT02850016|363256707|FG000|Overall Study|Withdrawal by Subject|1|||
105342604|NCT02850016|363256708|FG001|Overall Study|Withdrawal by Subject|2|||
105342605|NCT00705718|363256709|FG000|Overall Study|Death|6|||
105671979|NCT04276415|364462637|FG005|Overall Study|Adverse Event|0|||
105342606|NCT00705718|363256710|FG001|Overall Study|Death|6|||
105671980|NCT04276415|364462632|FG000|Overall Study|Clinical progression|1|||
105342607|NCT00705718|363256709|FG000|Overall Study|Not due for Visit|0|||
105671981|NCT04276415|364462633|FG001|Overall Study|Clinical progression|1|||
105671982|NCT04276415|364462634|FG002|Overall Study|Clinical progression|0|||
105671983|NCT04276415|364462635|FG003|Overall Study|Clinical progression|0|||
105671984|NCT04276415|364462636|FG004|Overall Study|Clinical progression|1|||
105671985|NCT04276415|364462637|FG005|Overall Study|Clinical progression|0|||
105671986|NCT04276415|364462632|FG000|Overall Study|Other|0|||
105671987|NCT04276415|364462633|FG001|Overall Study|Other|0|||
105342608|NCT00705718|363256710|FG001|Overall Study|Not due for Visit|12|||
105671988|NCT04276415|364462634|FG002|Overall Study|Other|0|||
105671989|NCT04276415|364462635|FG003|Overall Study|Other|1|||
105671990|NCT04276415|364462636|FG004|Overall Study|Other|0|||
105671991|NCT04276415|364462637|FG005|Overall Study|Other|0|||
105671992|NCT04276415|364462632|FG000|Overall Study|Physician Decision|0|||
105671993|NCT04276415|364462633|FG001|Overall Study|Physician Decision|0|||
105671994|NCT04276415|364462634|FG002|Overall Study|Physician Decision|1|||
105671995|NCT04276415|364462635|FG003|Overall Study|Physician Decision|3|||
105671996|NCT04276415|364462636|FG004|Overall Study|Physician Decision|2|||
105671997|NCT04276415|364462637|FG005|Overall Study|Physician Decision|0|||
105671998|NCT04276415|364462632|FG000|Overall Study|Progressive disease|3|||
105671999|NCT04276415|364462633|FG001|Overall Study|Progressive disease|3|||
105672000|NCT04276415|364462634|FG002|Overall Study|Progressive disease|4|||
105672001|NCT04276415|364462635|FG003|Overall Study|Progressive disease|5|||
105672002|NCT04276415|364462636|FG004|Overall Study|Progressive disease|1|||
105672003|NCT04276415|364462637|FG005|Overall Study|Progressive disease|2|||
105672004|NCT04276415|364462632|FG000|Overall Study|Withdrawal by patient|0|||
105672005|NCT04276415|364462633|FG001|Overall Study|Withdrawal by patient|0|||
105672006|NCT04276415|364462634|FG002|Overall Study|Withdrawal by patient|0|||
105672007|NCT04276415|364462635|FG003|Overall Study|Withdrawal by patient|1|||
105672008|NCT04276415|364462636|FG004|Overall Study|Withdrawal by patient|2|||
105672009|NCT04276415|364462637|FG005|Overall Study|Withdrawal by patient|0|||
105672010|NCT01840410|364462638|FG000|Overall Study|Physician Decision|1|||
105672011|NCT01840410|364462639|FG001|Overall Study|Physician Decision|2|||
105672012|NCT01840410|364462638|FG000|Overall Study|Pregnancy|1|||
105672013|NCT01840410|364462639|FG001|Overall Study|Pregnancy|0|||
105672014|NCT01840410|364462638|FG000|Overall Study|Protocol deviation|1|||
105672015|NCT01840410|364462639|FG001|Overall Study|Protocol deviation|0|||
105672016|NCT01840410|364462638|FG000|Overall Study|Lost to Follow-up|1|||
105672017|NCT01840410|364462639|FG001|Overall Study|Lost to Follow-up|0|||
105672018|NCT01840410|364462638|FG000|Overall Study|Withdrawal by Subject|2|||
105672019|NCT01840410|364462639|FG001|Overall Study|Withdrawal by Subject|1|||
105672020|NCT01840410|364462638|FG000|Overall Study|Adverse Event|1|||
105672021|NCT01840410|364462639|FG001|Overall Study|Adverse Event|1|||
105672022|NCT01413503|364462640|FG000|Overall Study|Lost to Follow-up|1|||
105672023|NCT02406677|364462641|FG000|Overall Study|Death|16|||
105672024|NCT02406677|364462642|FG001|Overall Study|Death|8|||
105672025|NCT02406677|364462641|FG000|Overall Study|Discharged without P2Y12|1|||
105672026|NCT02406677|364462642|FG001|Overall Study|Discharged without P2Y12|3|||
105672027|NCT02406677|364462641|FG000|Overall Study|Discharged on prasugrel|283|||
105672028|NCT02406677|364462642|FG001|Overall Study|Discharged on prasugrel|587|||
105672029|NCT02406677|364462641|FG000|Overall Study|Withdrawal by Subject|1|||
105672030|NCT02406677|364462642|FG001|Overall Study|Withdrawal by Subject|0|||
105672031|NCT01114880|364462643|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
105672032|NCT01114880|364462644|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
105672033|NCT01114880|364462643|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
105672034|NCT01114880|364462644|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
105672035|NCT01114880|364462643|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
105672036|NCT01114880|364462644|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
105672037|NCT01114880|364462643|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
105672038|NCT01114880|364462644|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
105672039|NCT01114880|364462643|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
105672040|NCT01114880|364462644|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
105672041|NCT01114880|364462643|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
105672042|NCT01114880|364462644|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
105672043|NCT02817906|364462645|FG000|Overall Study|Adverse Event|3|||
105672044|NCT02817906|364462646|FG001|Overall Study|Adverse Event|0|||
105672045|NCT02817906|364462645|FG000|Overall Study|Lack of Efficacy|1|||
105672046|NCT02817906|364462646|FG001|Overall Study|Lack of Efficacy|0|||
105672047|NCT02817906|364462645|FG000|Overall Study|Protocol Violation|1|||
105672048|NCT02817906|364462646|FG001|Overall Study|Protocol Violation|1|||
105672049|NCT02817906|364462645|FG000|Overall Study|Study Terminated by Sponsor|2|||
105672050|NCT02817906|364462646|FG001|Overall Study|Study Terminated by Sponsor|2|||
105672051|NCT02817906|364462645|FG000|Overall Study|Withdrawal by Subject|7|||
105672052|NCT02817906|364462646|FG001|Overall Study|Withdrawal by Subject|0|||
105672053|NCT02817906|364462645|FG000|Overall Study|Other|2|||
105672054|NCT02817906|364462646|FG001|Overall Study|Other|2|||
105786216|NCT00972309|364870478|FG001|Overall Study|Disease progression on study|4|||
105672055|NCT04958200|364462651|FG000|Overall Study|Withdrawal by Subject|0|||
105672056|NCT04958200|364462652|FG001|Overall Study|Withdrawal by Subject|2|||
105786217|NCT04794491|364870479|FG000|Overall Study|Adverse Event|1|||
105342609|NCT00705718|363256709|FG000|Overall Study|Follow up not done|1|||
105672057|NCT04958200|364462651|FG000|Overall Study|Lost to Follow-up|3|||
105672058|NCT04958200|364462652|FG001|Overall Study|Lost to Follow-up|2|||
105672059|NCT04531098|364462653|FG000|Stage I|Adverse Event|0|||
105672060|NCT04531098|364462654|FG001|Stage I|Adverse Event|0|||
105786218|NCT04794491|364870479|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
105672061|NCT04531098|364462655|FG002|Stage I|Adverse Event|3|||
105672062|NCT04531098|364462653|FG000|Stage I|Protocol Violation|0|||
105672063|NCT04531098|364462654|FG001|Stage I|Protocol Violation|0|||
105672064|NCT04531098|364462655|FG002|Stage I|Protocol Violation|5|||
105672065|NCT04531098|364462653|FG000|Stage I|Withdrawal by Subject|0|||
105672066|NCT04531098|364462654|FG001|Stage I|Withdrawal by Subject|5|||
105672067|NCT04531098|364462655|FG002|Stage I|Withdrawal by Subject|10|||
105672068|NCT04531098|364462653|FG000|Stage II|Adverse Event|1|||
105672069|NCT04531098|364462654|FG001|Stage II|Adverse Event|2|||
105672070|NCT04531098|364462655|FG002|Stage II|Adverse Event|0|||
105672071|NCT04531098|364462653|FG000|Stage II|Protocol Violation|1|||
105672072|NCT04531098|364462654|FG001|Stage II|Protocol Violation|2|||
105672073|NCT04531098|364462655|FG002|Stage II|Protocol Violation|0|||
105672074|NCT04531098|364462653|FG000|Stage II|Withdrawal by Subject|3|||
105672075|NCT04531098|364462654|FG001|Stage II|Withdrawal by Subject|1|||
105672076|NCT04531098|364462655|FG002|Stage II|Withdrawal by Subject|0|||
105672077|NCT04531098|364462653|FG000|Stage II|Moved from study area|8|||
105672078|NCT04531098|364462654|FG001|Stage II|Moved from study area|5|||
105672079|NCT04531098|364462655|FG002|Stage II|Moved from study area|0|||
105672080|NCT02628028|364462656|FG000|Dosing Period|Withdrawal by Subject|0|||
105672081|NCT02628028|364462657|FG001|Dosing Period|Withdrawal by Subject|0|||
105672082|NCT02628028|364462658|FG002|Dosing Period|Withdrawal by Subject|1|||
105672083|NCT02628028|364462659|FG003|Dosing Period|Withdrawal by Subject|0|||
105672084|NCT02628028|364462660|FG004|Dosing Period|Withdrawal by Subject|2|||
105672085|NCT02628028|364462661|FG005|Dosing Period|Withdrawal by Subject|4|||
105672086|NCT02628028|364462662|FG006|Dosing Period|Withdrawal by Subject|1|||
105672087|NCT02628028|364462663|FG007|Dosing Period|Withdrawal by Subject|1|||
105672088|NCT02628028|364462656|FG000|Dosing Period|Adverse Event|0|||
105672089|NCT02628028|364462657|FG001|Dosing Period|Adverse Event|0|||
105672090|NCT02628028|364462658|FG002|Dosing Period|Adverse Event|0|||
105672091|NCT02628028|364462659|FG003|Dosing Period|Adverse Event|0|||
105672092|NCT02628028|364462660|FG004|Dosing Period|Adverse Event|2|||
105672093|NCT02628028|364462661|FG005|Dosing Period|Adverse Event|1|||
105672094|NCT02628028|364462662|FG006|Dosing Period|Adverse Event|3|||
105672095|NCT02628028|364462663|FG007|Dosing Period|Adverse Event|2|||
105672096|NCT02628028|364462656|FG000|Dosing Period|Death|0|||
105672097|NCT02628028|364462657|FG001|Dosing Period|Death|0|||
105672098|NCT02628028|364462658|FG002|Dosing Period|Death|0|||
105672099|NCT02628028|364462659|FG003|Dosing Period|Death|0|||
105672100|NCT02628028|364462660|FG004|Dosing Period|Death|0|||
105672101|NCT02628028|364462661|FG005|Dosing Period|Death|0|||
105672102|NCT02628028|364462662|FG006|Dosing Period|Death|0|||
105672103|NCT02628028|364462663|FG007|Dosing Period|Death|1|||
105672104|NCT02628028|364462656|FG000|Dosing Period|Lack of Efficacy|0|||
105672105|NCT02628028|364462657|FG001|Dosing Period|Lack of Efficacy|0|||
105672106|NCT02628028|364462658|FG002|Dosing Period|Lack of Efficacy|0|||
105672107|NCT02628028|364462659|FG003|Dosing Period|Lack of Efficacy|0|||
105672108|NCT02628028|364462660|FG004|Dosing Period|Lack of Efficacy|3|||
105672109|NCT02628028|364462661|FG005|Dosing Period|Lack of Efficacy|0|||
105672110|NCT02628028|364462662|FG006|Dosing Period|Lack of Efficacy|1|||
105672111|NCT02628028|364462663|FG007|Dosing Period|Lack of Efficacy|0|||
105672112|NCT02628028|364462656|FG000|Dosing Period|Study Terminated by Sponsor|0|||
105672113|NCT02628028|364462657|FG001|Dosing Period|Study Terminated by Sponsor|0|||
105672114|NCT02628028|364462658|FG002|Dosing Period|Study Terminated by Sponsor|0|||
105672115|NCT02628028|364462659|FG003|Dosing Period|Study Terminated by Sponsor|0|||
105672116|NCT02628028|364462660|FG004|Dosing Period|Study Terminated by Sponsor|7|||
105672117|NCT02628028|364462661|FG005|Dosing Period|Study Terminated by Sponsor|6|||
105672118|NCT02628028|364462662|FG006|Dosing Period|Study Terminated by Sponsor|7|||
105672119|NCT02628028|364462663|FG007|Dosing Period|Study Terminated by Sponsor|7|||
105672120|NCT02628028|364462656|FG000|Dosing Period|Physician Decision|0|||
105672121|NCT02628028|364462657|FG001|Dosing Period|Physician Decision|0|||
105672122|NCT02628028|364462658|FG002|Dosing Period|Physician Decision|0|||
105672123|NCT02628028|364462659|FG003|Dosing Period|Physician Decision|0|||
105672124|NCT02628028|364462660|FG004|Dosing Period|Physician Decision|0|||
105672125|NCT02628028|364462661|FG005|Dosing Period|Physician Decision|1|||
105672126|NCT02628028|364462662|FG006|Dosing Period|Physician Decision|0|||
105672127|NCT02628028|364462663|FG007|Dosing Period|Physician Decision|0|||
105672128|NCT02628028|364462656|FG000|Dosing Period|Site Terminated by Sponsor|0|||
105672129|NCT02628028|364462657|FG001|Dosing Period|Site Terminated by Sponsor|0|||
105672130|NCT02628028|364462658|FG002|Dosing Period|Site Terminated by Sponsor|0|||
105342610|NCT00705718|363256710|FG001|Overall Study|Follow up not done|4|||
105672131|NCT02628028|364462659|FG003|Dosing Period|Site Terminated by Sponsor|0|||
105672132|NCT02628028|364462660|FG004|Dosing Period|Site Terminated by Sponsor|0|||
105672133|NCT02628028|364462661|FG005|Dosing Period|Site Terminated by Sponsor|1|||
105672134|NCT02628028|364462662|FG006|Dosing Period|Site Terminated by Sponsor|1|||
105672135|NCT02628028|364462663|FG007|Dosing Period|Site Terminated by Sponsor|0|||
105672136|NCT02628028|364462656|FG000|Dosing Period|Lost to Follow-up|0|||
105672137|NCT02628028|364462657|FG001|Dosing Period|Lost to Follow-up|0|||
105672138|NCT02628028|364462658|FG002|Dosing Period|Lost to Follow-up|0|||
105672139|NCT02628028|364462659|FG003|Dosing Period|Lost to Follow-up|0|||
105672140|NCT02628028|364462660|FG004|Dosing Period|Lost to Follow-up|0|||
105672141|NCT02628028|364462661|FG005|Dosing Period|Lost to Follow-up|0|||
105672142|NCT02628028|364462662|FG006|Dosing Period|Lost to Follow-up|1|||
105672143|NCT02628028|364462663|FG007|Dosing Period|Lost to Follow-up|0|||
105672144|NCT02628028|364462656|FG000|Dosing Period|Other|0|||
105672145|NCT02628028|364462657|FG001|Dosing Period|Other|0|||
105672146|NCT02628028|364462658|FG002|Dosing Period|Other|0|||
105672147|NCT02628028|364462659|FG003|Dosing Period|Other|0|||
105672148|NCT02628028|364462660|FG004|Dosing Period|Other|2|||
105672149|NCT02628028|364462661|FG005|Dosing Period|Other|1|||
105672150|NCT02628028|364462662|FG006|Dosing Period|Other|2|||
105672151|NCT02628028|364462663|FG007|Dosing Period|Other|4|||
105672152|NCT02628028|364462656|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
105672153|NCT02628028|364462657|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
105672154|NCT02628028|364462658|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
105672155|NCT02628028|364462659|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
105672156|NCT02628028|364462660|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
105672157|NCT02628028|364462661|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
105672158|NCT02628028|364462662|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
105672159|NCT02628028|364462663|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
105672160|NCT02628028|364462656|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
105672161|NCT02628028|364462657|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
105672162|NCT02628028|364462658|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
105672163|NCT02628028|364462659|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
105672164|NCT02628028|364462660|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
105672165|NCT02628028|364462661|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
105672166|NCT02628028|364462662|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
105672167|NCT02628028|364462663|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
105672168|NCT02628028|364462656|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
105672169|NCT02628028|364462657|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
105672170|NCT02628028|364462658|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
105672171|NCT02628028|364462659|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
105672172|NCT02628028|364462660|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
105672173|NCT02628028|364462661|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
105672174|NCT02628028|364462662|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
105672175|NCT02628028|364462663|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
105672176|NCT02628028|364462656|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
105672177|NCT02628028|364462657|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
105672178|NCT02628028|364462658|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
105672179|NCT02628028|364462659|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
105672180|NCT02628028|364462660|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
105672181|NCT02628028|364462661|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
105672182|NCT02628028|364462662|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
105672183|NCT02628028|364462663|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
105672184|NCT02628028|364462656|FG000|Long-term Extension (LTE) Period|Other|0|||
105672185|NCT02628028|364462657|FG001|Long-term Extension (LTE) Period|Other|0|||
105672186|NCT02628028|364462658|FG002|Long-term Extension (LTE) Period|Other|0|||
105672187|NCT02628028|364462659|FG003|Long-term Extension (LTE) Period|Other|0|||
105672188|NCT02628028|364462660|FG004|Long-term Extension (LTE) Period|Other|0|||
105672189|NCT02628028|364462661|FG005|Long-term Extension (LTE) Period|Other|3|||
105672190|NCT02628028|364462662|FG006|Long-term Extension (LTE) Period|Other|4|||
105672191|NCT02628028|364462663|FG007|Long-term Extension (LTE) Period|Other|3|||
105672192|NCT01436253|364462664|FG000|Overall Study|Lost to Follow-up|182|||
105672193|NCT01436253|364462664|FG000|Overall Study|Not meeting all eligibility criteria|117|||
105786219|NCT04794491|364870479|FG000|Overall Study|Noncompliance With Study Intervention|1|||
105672194|NCT01803282|364462671|FG000|Overall Study|Progressive Disease|4|||
105672195|NCT01803282|364462672|FG001|Overall Study|Progressive Disease|3|||
105672196|NCT01803282|364462673|FG002|Overall Study|Progressive Disease|6|||
105672197|NCT01803282|364462674|FG003|Overall Study|Progressive Disease|22|||
105672198|NCT01803282|364462675|FG004|Overall Study|Progressive Disease|5|||
105672199|NCT01803282|364462676|FG005|Overall Study|Progressive Disease|8|||
105672200|NCT01803282|364462677|FG006|Overall Study|Progressive Disease|23|||
105672201|NCT01803282|364462678|FG007|Overall Study|Progressive Disease|24|||
105672202|NCT01803282|364462679|FG008|Overall Study|Progressive Disease|3|||
105672203|NCT01803282|364462680|FG009|Overall Study|Progressive Disease|29|||
105672204|NCT01803282|364462681|FG010|Overall Study|Progressive Disease|6|||
105672205|NCT01803282|364462682|FG011|Overall Study|Progressive Disease|11|||
105672206|NCT01803282|364462671|FG000|Overall Study|Death|0|||
105672207|NCT01803282|364462672|FG001|Overall Study|Death|0|||
105672208|NCT01803282|364462673|FG002|Overall Study|Death|0|||
105672209|NCT01803282|364462674|FG003|Overall Study|Death|0|||
105672210|NCT01803282|364462675|FG004|Overall Study|Death|2|||
105672211|NCT01803282|364462676|FG005|Overall Study|Death|1|||
105672212|NCT01803282|364462677|FG006|Overall Study|Death|1|||
105672213|NCT01803282|364462678|FG007|Overall Study|Death|5|||
105672214|NCT01803282|364462679|FG008|Overall Study|Death|1|||
105672215|NCT01803282|364462680|FG009|Overall Study|Death|1|||
105672216|NCT01803282|364462681|FG010|Overall Study|Death|0|||
105672217|NCT01803282|364462682|FG011|Overall Study|Death|0|||
105672218|NCT01803282|364462671|FG000|Overall Study|Withdrew Consent|0|||
105672219|NCT01803282|364462672|FG001|Overall Study|Withdrew Consent|0|||
105672220|NCT01803282|364462673|FG002|Overall Study|Withdrew Consent|0|||
105672221|NCT01803282|364462674|FG003|Overall Study|Withdrew Consent|6|||
105672222|NCT01803282|364462675|FG004|Overall Study|Withdrew Consent|1|||
105672223|NCT01803282|364462676|FG005|Overall Study|Withdrew Consent|0|||
105672224|NCT01803282|364462677|FG006|Overall Study|Withdrew Consent|8|||
105672225|NCT01803282|364462678|FG007|Overall Study|Withdrew Consent|3|||
105672226|NCT01803282|364462679|FG008|Overall Study|Withdrew Consent|1|||
105672227|NCT01803282|364462680|FG009|Overall Study|Withdrew Consent|5|||
105672228|NCT01803282|364462681|FG010|Overall Study|Withdrew Consent|0|||
105672229|NCT01803282|364462682|FG011|Overall Study|Withdrew Consent|1|||
105672230|NCT01803282|364462671|FG000|Overall Study|Investigator's Discretion|0|||
105672231|NCT01803282|364462672|FG001|Overall Study|Investigator's Discretion|0|||
105672232|NCT01803282|364462673|FG002|Overall Study|Investigator's Discretion|0|||
105672233|NCT01803282|364462674|FG003|Overall Study|Investigator's Discretion|7|||
105672234|NCT01803282|364462675|FG004|Overall Study|Investigator's Discretion|2|||
105672235|NCT01803282|364462676|FG005|Overall Study|Investigator's Discretion|1|||
105672236|NCT01803282|364462677|FG006|Overall Study|Investigator's Discretion|7|||
105672237|NCT01803282|364462678|FG007|Overall Study|Investigator's Discretion|10|||
105672238|NCT01803282|364462679|FG008|Overall Study|Investigator's Discretion|6|||
105672239|NCT01803282|364462680|FG009|Overall Study|Investigator's Discretion|7|||
105672240|NCT01803282|364462681|FG010|Overall Study|Investigator's Discretion|1|||
105672241|NCT01803282|364462682|FG011|Overall Study|Investigator's Discretion|0|||
105672242|NCT01803282|364462671|FG000|Overall Study|Adverse Event|0|||
105672243|NCT01803282|364462672|FG001|Overall Study|Adverse Event|0|||
105672244|NCT01803282|364462673|FG002|Overall Study|Adverse Event|0|||
105672245|NCT01803282|364462674|FG003|Overall Study|Adverse Event|0|||
105672246|NCT01803282|364462675|FG004|Overall Study|Adverse Event|0|||
105672247|NCT01803282|364462676|FG005|Overall Study|Adverse Event|0|||
105672248|NCT01803282|364462677|FG006|Overall Study|Adverse Event|1|||
105672249|NCT01803282|364462678|FG007|Overall Study|Adverse Event|2|||
105672250|NCT01803282|364462679|FG008|Overall Study|Adverse Event|0|||
105672251|NCT01803282|364462680|FG009|Overall Study|Adverse Event|1|||
105672252|NCT01803282|364462681|FG010|Overall Study|Adverse Event|0|||
105672253|NCT01803282|364462682|FG011|Overall Study|Adverse Event|3|||
105672254|NCT01803282|364462671|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105672255|NCT01803282|364462672|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105672256|NCT01803282|364462673|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105672257|NCT01803282|364462674|FG003|Overall Study|Non-Compliance with Study Drug|1|||
105672258|NCT01803282|364462675|FG004|Overall Study|Non-Compliance with Study Drug|0|||
105672259|NCT01803282|364462676|FG005|Overall Study|Non-Compliance with Study Drug|0|||
105672260|NCT01803282|364462677|FG006|Overall Study|Non-Compliance with Study Drug|0|||
105672261|NCT01803282|364462678|FG007|Overall Study|Non-Compliance with Study Drug|0|||
105672262|NCT01803282|364462679|FG008|Overall Study|Non-Compliance with Study Drug|0|||
105672263|NCT01803282|364462680|FG009|Overall Study|Non-Compliance with Study Drug|0|||
105672264|NCT01803282|364462681|FG010|Overall Study|Non-Compliance with Study Drug|0|||
105672265|NCT01803282|364462682|FG011|Overall Study|Non-Compliance with Study Drug|0|||
105672266|NCT01803282|364462671|FG000|Overall Study|Unknown Reason|0|||
105672267|NCT01803282|364462672|FG001|Overall Study|Unknown Reason|0|||
105672268|NCT01803282|364462673|FG002|Overall Study|Unknown Reason|0|||
105672269|NCT01803282|364462674|FG003|Overall Study|Unknown Reason|0|||
105786220|NCT04794491|364870479|FG000|Overall Study|Withdrawal by Subject|2|||
105672270|NCT01803282|364462675|FG004|Overall Study|Unknown Reason|0|||
105672271|NCT01803282|364462676|FG005|Overall Study|Unknown Reason|0|||
105672272|NCT01803282|364462677|FG006|Overall Study|Unknown Reason|0|||
105672273|NCT01803282|364462678|FG007|Overall Study|Unknown Reason|1|||
105672274|NCT01803282|364462679|FG008|Overall Study|Unknown Reason|0|||
105672275|NCT01803282|364462680|FG009|Overall Study|Unknown Reason|0|||
105672276|NCT01803282|364462681|FG010|Overall Study|Unknown Reason|0|||
105672277|NCT01803282|364462682|FG011|Overall Study|Unknown Reason|0|||
105672278|NCT01803282|364462671|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
105672279|NCT01803282|364462672|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
105672280|NCT01803282|364462673|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
105672281|NCT01803282|364462674|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
105672282|NCT01803282|364462675|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
105672283|NCT01803282|364462676|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
105672284|NCT01803282|364462677|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
105672285|NCT01803282|364462678|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
105672286|NCT01803282|364462679|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
105672287|NCT01803282|364462680|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
105672288|NCT01803282|364462681|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
105672289|NCT01803282|364462682|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
105672290|NCT01803282|364462671|FG000|Overall Study|Enrolled but Never Treated|0|||
105672291|NCT01803282|364462672|FG001|Overall Study|Enrolled but Never Treated|0|||
105672292|NCT01803282|364462673|FG002|Overall Study|Enrolled but Never Treated|0|||
105672293|NCT01803282|364462674|FG003|Overall Study|Enrolled but Never Treated|0|||
105672294|NCT01803282|364462675|FG004|Overall Study|Enrolled but Never Treated|1|||
105672295|NCT01803282|364462676|FG005|Overall Study|Enrolled but Never Treated|0|||
105672296|NCT01803282|364462677|FG006|Overall Study|Enrolled but Never Treated|1|||
105672297|NCT01803282|364462678|FG007|Overall Study|Enrolled but Never Treated|1|||
105672298|NCT01803282|364462679|FG008|Overall Study|Enrolled but Never Treated|0|||
105672299|NCT01803282|364462680|FG009|Overall Study|Enrolled but Never Treated|1|||
105672300|NCT01803282|364462681|FG010|Overall Study|Enrolled but Never Treated|0|||
105672301|NCT01803282|364462682|FG011|Overall Study|Enrolled but Never Treated|0|||
105672302|NCT01008410|364464233|FG000|Overall Study|Adverse Event|13|||
105672303|NCT01008410|364464234|FG001|Overall Study|Adverse Event|7|||
105672304|NCT01008410|364464233|FG000|Overall Study|Withdrawal by Subject|6|||
105672305|NCT01008410|364464234|FG001|Overall Study|Withdrawal by Subject|2|||
105672306|NCT01008410|364464233|FG000|Overall Study|Lost to Follow-up|1|||
105672307|NCT01008410|364464234|FG001|Overall Study|Lost to Follow-up|0|||
105672308|NCT01008410|364464233|FG000|Overall Study|Noncompliance|1|||
105672309|NCT01008410|364464234|FG001|Overall Study|Noncompliance|0|||
105672310|NCT01008410|364464233|FG000|Overall Study|Low Cortisol|2|||
105672311|NCT01008410|364464234|FG001|Overall Study|Low Cortisol|0|||
105672312|NCT01008410|364464233|FG000|Overall Study|Lack of Efficacy|2|||
105672313|NCT01008410|364464234|FG001|Overall Study|Lack of Efficacy|6|||
105672314|NCT01008410|364464233|FG000|Overall Study|Met Exclusion Criterion|0|||
105672315|NCT01008410|364464234|FG001|Overall Study|Met Exclusion Criterion|1|||
105672316|NCT01977677|364464235|FG000|Overall Study|Unrelated Adverse Event|0|||
105672317|NCT01977677|364464236|FG001|Overall Study|Unrelated Adverse Event|0|||
105672318|NCT01977677|364464237|FG002|Overall Study|Unrelated Adverse Event|1|||
105672319|NCT01498887|364464238|FG000|Overall Study|Administrative problems|1|||
105672320|NCT01498887|364464239|FG001|Overall Study|Administrative problems|0|||
105672321|NCT01498887|364464238|FG000|Overall Study|Lost to Follow-up|1|||
105672322|NCT01498887|364464239|FG001|Overall Study|Lost to Follow-up|1|||
105672323|NCT01498887|364464238|FG000|Overall Study|Withdrawal by Subject|1|||
105672324|NCT01498887|364464239|FG001|Overall Study|Withdrawal by Subject|0|||
105672325|NCT01498887|364464238|FG000|Overall Study|Protocol Violation|1|||
105672326|NCT01498887|364464239|FG001|Overall Study|Protocol Violation|3|||
105672327|NCT01498887|364464238|FG000|Overall Study|Lack of Efficacy|5|||
105672328|NCT01498887|364464239|FG001|Overall Study|Lack of Efficacy|3|||
105672329|NCT01498887|364464238|FG000|Overall Study|Abnormal result from test procedure|1|||
105672330|NCT01498887|364464239|FG001|Overall Study|Abnormal result from test procedure|1|||
105672331|NCT01498887|364464238|FG000|Overall Study|Abnormal laboratory value|2|||
105672332|NCT01498887|364464239|FG001|Overall Study|Abnormal laboratory value|2|||
105672333|NCT01498887|364464238|FG000|Overall Study|Adverse Event|4|||
105672334|NCT01498887|364464239|FG001|Overall Study|Adverse Event|1|||
105672335|NCT00574873|364464242|FG000|Overall Study|Withdrawal by Subject|18|||
105672336|NCT00574873|364464243|FG001|Overall Study|Withdrawal by Subject|19|||
105672337|NCT00574873|364464242|FG000|Overall Study|Investigator request|18|||
105672338|NCT00574873|364464243|FG001|Overall Study|Investigator request|8|||
105672339|NCT00574873|364464242|FG000|Overall Study|Death|15|||
105672340|NCT00574873|364464243|FG001|Overall Study|Death|14|||
105672341|NCT00574873|364464242|FG000|Overall Study|Lost to Follow-up|14|||
105672342|NCT00574873|364464243|FG001|Overall Study|Lost to Follow-up|5|||
105672343|NCT00574873|364464242|FG000|Overall Study|Other|40|||
105672344|NCT00574873|364464243|FG001|Overall Study|Other|4|||
105672345|NCT00574873|364464242|FG000|Overall Study|Discontinuation of study by sponsor|5|||
105672346|NCT00574873|364464243|FG001|Overall Study|Discontinuation of study by sponsor|199|||
105672347|NCT00574873|364464242|FG000|Overall Study|Blank, site closed per local regulations|2|||
105672348|NCT00574873|364464243|FG001|Overall Study|Blank, site closed per local regulations|2|||
105672349|NCT00574873|364464242|FG000|Overall Study|Extension Study|126|||
105672350|NCT00574873|364464243|FG001|Overall Study|Extension Study|0|||
105672351|NCT04996004|364464244|FG000|Phase I|Death|1|||
105672352|NCT04996004|364464245|FG001|Phase I|Death|2|||
105672353|NCT04996004|364464246|FG002|Phase I|Death|1|||
105672354|NCT04996004|364464247|FG003|Phase I|Death|0|||
105672355|NCT04996004|364464248|FG004|Phase I|Death|0|||
105672356|NCT04996004|364464249|FG005|Phase I|Death|0|||
105672357|NCT04996004|364464244|FG000|Phase I|Study terminated by sponsor|2|||
105672358|NCT04996004|364464245|FG001|Phase I|Study terminated by sponsor|1|||
105672359|NCT04996004|364464246|FG002|Phase I|Study terminated by sponsor|2|||
105672360|NCT04996004|364464247|FG003|Phase I|Study terminated by sponsor|0|||
105672361|NCT04996004|364464248|FG004|Phase I|Study terminated by sponsor|0|||
105672362|NCT04996004|364464249|FG005|Phase I|Study terminated by sponsor|0|||
105672363|NCT04996004|364464244|FG000|Phase II|Study terminated by sponsor|0|||
105672364|NCT04996004|364464245|FG001|Phase II|Study terminated by sponsor|0|||
105672365|NCT04996004|364464246|FG002|Phase II|Study terminated by sponsor|0|||
105672366|NCT04996004|364464247|FG003|Phase II|Study terminated by sponsor|20|||
105672367|NCT04996004|364464248|FG004|Phase II|Study terminated by sponsor|10|||
105672368|NCT04996004|364464249|FG005|Phase II|Study terminated by sponsor|10|||
105672369|NCT04996004|364464244|FG000|Phase II|Withdrawal by Subject|0|||
105672370|NCT04996004|364464245|FG001|Phase II|Withdrawal by Subject|0|||
105672371|NCT04996004|364464246|FG002|Phase II|Withdrawal by Subject|0|||
105672372|NCT04996004|364464247|FG003|Phase II|Withdrawal by Subject|0|||
105672373|NCT04996004|364464248|FG004|Phase II|Withdrawal by Subject|1|||
105672374|NCT04996004|364464249|FG005|Phase II|Withdrawal by Subject|2|||
105672375|NCT04996004|364464244|FG000|Phase II|Death|0|||
105672376|NCT04996004|364464245|FG001|Phase II|Death|0|||
105672377|NCT04996004|364464246|FG002|Phase II|Death|0|||
105672378|NCT04996004|364464247|FG003|Phase II|Death|12|||
105672379|NCT04996004|364464248|FG004|Phase II|Death|2|||
105672380|NCT04996004|364464249|FG005|Phase II|Death|9|||
105672381|NCT04996004|364464244|FG000|Phase II|Other|0|||
105672382|NCT04996004|364464245|FG001|Phase II|Other|0|||
105672383|NCT04996004|364464246|FG002|Phase II|Other|0|||
105672384|NCT04996004|364464247|FG003|Phase II|Other|0|||
105672385|NCT04996004|364464248|FG004|Phase II|Other|0|||
105672386|NCT04996004|364464249|FG005|Phase II|Other|1|||
105672387|NCT02993406|364464250|FG000|Overall Study|Withdrawal by Subject|170|||
105672388|NCT02993406|364464251|FG001|Overall Study|Withdrawal by Subject|196|||
105672389|NCT02993406|364464250|FG000|Overall Study|Physician Decision|3|||
105672390|NCT02993406|364464251|FG001|Overall Study|Physician Decision|5|||
105672391|NCT02993406|364464250|FG000|Overall Study|Lost to Follow-up|12|||
105672392|NCT02993406|364464251|FG001|Overall Study|Lost to Follow-up|13|||
105672393|NCT02993406|364464250|FG000|Overall Study|Unclassifiable Response|105|||
105672394|NCT02993406|364464251|FG001|Overall Study|Unclassifiable Response|139|||
105672395|NCT02993406|364464250|FG000|Overall Study|Administrative decision|1|||
105786221|NCT00931515|364870481|FG000|Overall Study|Lost to Follow-up|2|||
105672396|NCT02993406|364464251|FG001|Overall Study|Administrative decision|0|||
105672397|NCT02993406|364464250|FG000|Overall Study|Sponsor decision|4|||
105672398|NCT02993406|364464251|FG001|Overall Study|Sponsor decision|5|||
105672399|NCT03563157|364464252|FG000|Overall Study|Progressive Disease|2|||
105672400|NCT00201643|364464253|FG000|Overall Study|Withdrawal by Subject|5|||
105672401|NCT00201643|364464254|FG001|Overall Study|Withdrawal by Subject|4|||
105672402|NCT02942277|364464256|FG000|Year 1|Withdrawal by Subject|0|||
105672403|NCT02942277|364464257|FG001|Year 1|Withdrawal by Subject|0|||
105672404|NCT02942277|364464258|FG002|Year 1|Withdrawal by Subject|0|||
105672405|NCT02942277|364464259|FG003|Year 1|Withdrawal by Subject|0|||
105672406|NCT02942277|364464260|FG004|Year 1|Withdrawal by Subject|1|||
105672407|NCT02942277|364464261|FG005|Year 1|Withdrawal by Subject|3|||
105672408|NCT02942277|364464262|FG006|Year 1|Withdrawal by Subject|0|||
105672409|NCT02942277|364464263|FG007|Year 1|Withdrawal by Subject|1|||
105672410|NCT02942277|364464264|FG008|Year 1|Withdrawal by Subject|0|||
105672411|NCT02942277|364464265|FG009|Year 1|Withdrawal by Subject|0|||
105672412|NCT02942277|364464266|FG010|Year 1|Withdrawal by Subject|3|||
105672413|NCT02942277|364464256|FG000|Year 1|Travel|0|||
105672414|NCT02942277|364464257|FG001|Year 1|Travel|1|||
105672415|NCT02942277|364464258|FG002|Year 1|Travel|0|||
105672416|NCT02942277|364464259|FG003|Year 1|Travel|0|||
105672417|NCT02942277|364464260|FG004|Year 1|Travel|4|||
105672418|NCT02942277|364464261|FG005|Year 1|Travel|5|||
105672419|NCT02942277|364464262|FG006|Year 1|Travel|0|||
105672420|NCT02942277|364464263|FG007|Year 1|Travel|0|||
105672421|NCT02942277|364464264|FG008|Year 1|Travel|0|||
105672422|NCT02942277|364464265|FG009|Year 1|Travel|0|||
105672423|NCT02942277|364464266|FG010|Year 1|Travel|8|||
105672424|NCT02942277|364464256|FG000|Year 1|Joined Army|0|||
105786222|NCT00931515|364870482|FG001|Overall Study|Lost to Follow-up|5|||
105786223|NCT01233284|364870483|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
105786224|NCT01233284|364870484|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
105672425|NCT02942277|364464257|FG001|Year 1|Joined Army|1|||
105672426|NCT02942277|364464258|FG002|Year 1|Joined Army|0|||
105672427|NCT02942277|364464259|FG003|Year 1|Joined Army|0|||
105672428|NCT02942277|364464260|FG004|Year 1|Joined Army|0|||
105672429|NCT02942277|364464261|FG005|Year 1|Joined Army|0|||
105672430|NCT02942277|364464262|FG006|Year 1|Joined Army|0|||
105342611|NCT00423189|363256712|FG000|Overall Study|Death|0|||
105342612|NCT00423189|363256713|FG001|Overall Study|Death|1|||
105342613|NCT00423189|363256714|FG002|Overall Study|Death|0|||
105342614|NCT03787303|363256715|FG000|Overall Study|Death|1|||
105342615|NCT03787303|363256715|FG000|Overall Study|Premature Termination of Study|1|||
105342616|NCT04240457|363256718|FG000|Overall Study|Lost to Follow-up|5|||
105342617|NCT04240457|363256719|FG001|Overall Study|Lost to Follow-up|1|||
105342618|NCT01500213|363256720|FG000|Overall Study|Adverse Event|35|||
105342619|NCT01500213|363256721|FG001|Overall Study|Adverse Event|35|||
105342620|NCT01500213|363256720|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
105342621|NCT01500213|363256721|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
105342622|NCT01500213|363256720|FG000|Overall Study|Withdrawal by Subject|28|||
105342623|NCT01500213|363256721|FG001|Overall Study|Withdrawal by Subject|37|||
105342624|NCT01500213|363256720|FG000|Overall Study|Death|7|||
105342625|NCT01500213|363256721|FG001|Overall Study|Death|3|||
105342626|NCT01500213|363256720|FG000|Overall Study|Disease Progression|13|||
105342627|NCT01500213|363256721|FG001|Overall Study|Disease Progression|21|||
105342628|NCT01500213|363256720|FG000|Overall Study|Protocol Violation|19|||
105342629|NCT01500213|363256721|FG001|Overall Study|Protocol Violation|19|||
105342630|NCT01500213|363256720|FG000|Overall Study|Physician Decision|12|||
105342631|NCT01500213|363256721|FG001|Overall Study|Physician Decision|10|||
105342632|NCT01500213|363256720|FG000|Overall Study|Lack of Efficacy|9|||
105342633|NCT01500213|363256721|FG001|Overall Study|Lack of Efficacy|7|||
105342634|NCT01500213|363256720|FG000|Overall Study|Lost to Follow-up|3|||
105342635|NCT01500213|363256721|FG001|Overall Study|Lost to Follow-up|6|||
105342636|NCT01500213|363256720|FG000|Overall Study|Other Reasons|7|||
105342637|NCT01500213|363256721|FG001|Overall Study|Other Reasons|5|||
105342638|NCT00985959|363256722|FG000|Overall Study|Adverse Event|0|||
105342639|NCT00985959|363256723|FG001|Overall Study|Adverse Event|0|||
105342640|NCT00985959|363256724|FG002|Overall Study|Adverse Event|19|||
105342641|NCT00985959|363256722|FG000|Overall Study|Withdrawal by Subject|0|||
105342642|NCT00985959|363256723|FG001|Overall Study|Withdrawal by Subject|0|||
105342643|NCT00985959|363256724|FG002|Overall Study|Withdrawal by Subject|8|||
105342644|NCT00985959|363256722|FG000|Overall Study|Progressive disease|1|||
105342645|NCT00985959|363256723|FG001|Overall Study|Progressive disease|2|||
105342646|NCT00985959|363256724|FG002|Overall Study|Progressive disease|8|||
105342647|NCT00985959|363256722|FG000|Overall Study|Unrecovered toxicity|0|||
105342648|NCT00985959|363256723|FG001|Overall Study|Unrecovered toxicity|0|||
105342649|NCT00985959|363256724|FG002|Overall Study|Unrecovered toxicity|7|||
105342650|NCT00985959|363256722|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
105342651|NCT00985959|363256723|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
105342652|NCT00985959|363256724|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
105342653|NCT00985959|363256722|FG000|Overall Study|Complete response observed over 2 cycles|0|||
105342654|NCT00985959|363256723|FG001|Overall Study|Complete response observed over 2 cycles|1|||
105342655|NCT00985959|363256724|FG002|Overall Study|Complete response observed over 2 cycles|4|||
105342656|NCT00985959|363256722|FG000|Overall Study|Other|0|||
105342657|NCT00985959|363256723|FG001|Overall Study|Other|0|||
105342658|NCT00985959|363256724|FG002|Overall Study|Other|11|||
105342659|NCT00976209|363256725|FG000|Treatment Period 1|Protocol Violation|1|||
105554756|NCT04642638|364027441|FG002|Overall Study|Withdrawal by Subject|9|||
105554757|NCT04642638|364027442|FG003|Overall Study|Withdrawal by Subject|7|||
105554758|NCT04642638|364027443|FG004|Overall Study|Withdrawal by Subject|61|||
105554759|NCT04642638|364027444|FG005|Overall Study|Withdrawal by Subject|27|||
105554760|NCT04642638|364027439|FG000|Overall Study|Lost to Follow-up|17|||
105554761|NCT04642638|364027440|FG001|Overall Study|Lost to Follow-up|18|||
105554762|NCT04642638|364027441|FG002|Overall Study|Lost to Follow-up|5|||
105554763|NCT04642638|364027442|FG003|Overall Study|Lost to Follow-up|5|||
105554764|NCT04642638|364027443|FG004|Overall Study|Lost to Follow-up|6|||
105554765|NCT04642638|364027444|FG005|Overall Study|Lost to Follow-up|3|||
105554766|NCT04642638|364027439|FG000|Overall Study|Adverse Event|0|||
105554767|NCT04642638|364027440|FG001|Overall Study|Adverse Event|0|||
105554768|NCT04642638|364027441|FG002|Overall Study|Adverse Event|1|||
105554769|NCT04642638|364027442|FG003|Overall Study|Adverse Event|0|||
105342660|NCT00976209|363256726|FG001|Treatment Period 1|Protocol Violation|0|||
105342661|NCT00976209|363256725|FG000|Treatment Period 1|Lost to Follow-up|2|||
105342662|NCT00976209|363256726|FG001|Treatment Period 1|Lost to Follow-up|0|||
105342663|NCT00976209|363256725|FG000|Treatment Period 1|Other|0|||
105342664|NCT00976209|363256726|FG001|Treatment Period 1|Other|1|||
105342665|NCT00976209|363256725|FG000|Wash-out Period|Adverse Event|1|||
105342666|NCT00976209|363256726|FG001|Wash-out Period|Adverse Event|2|||
105554770|NCT04642638|364027443|FG004|Overall Study|Adverse Event|10|||
105342667|NCT00976209|363256725|FG000|Wash-out Period|Lost to Follow-up|1|||
105342668|NCT00976209|363256726|FG001|Wash-out Period|Lost to Follow-up|0|||
105554771|NCT04642638|364027444|FG005|Overall Study|Adverse Event|3|||
105554772|NCT04642638|364027439|FG000|Overall Study|Reason Not Specified|1|||
105342669|NCT00976209|363256725|FG000|Wash-out Period|Protocol Violation|1|||
105342670|NCT00976209|363256726|FG001|Wash-out Period|Protocol Violation|0|||
105342671|NCT00976209|363256725|FG000|Wash-out Period|Other|1|||
105342672|NCT00976209|363256726|FG001|Wash-out Period|Other|0|||
105672431|NCT02942277|364464263|FG007|Year 1|Joined Army|0|||
105672432|NCT02942277|364464264|FG008|Year 1|Joined Army|0|||
105672433|NCT02942277|364464265|FG009|Year 1|Joined Army|0|||
105672434|NCT02942277|364464266|FG010|Year 1|Joined Army|0|||
105672435|NCT02942277|364464256|FG000|Year 1|Subject met withdrawal criteria|0|||
105672436|NCT02942277|364464257|FG001|Year 1|Subject met withdrawal criteria|0|||
105672437|NCT02942277|364464258|FG002|Year 1|Subject met withdrawal criteria|0|||
105554773|NCT04642638|364027440|FG001|Overall Study|Reason Not Specified|4|||
105554774|NCT04642638|364027441|FG002|Overall Study|Reason Not Specified|0|||
105554775|NCT04642638|364027442|FG003|Overall Study|Reason Not Specified|0|||
105554776|NCT04642638|364027443|FG004|Overall Study|Reason Not Specified|38|||
105554777|NCT04642638|364027444|FG005|Overall Study|Reason Not Specified|16|||
105554778|NCT04642638|364027439|FG000|Overall Study|Physician Decision|0|||
105554779|NCT04642638|364027440|FG001|Overall Study|Physician Decision|0|||
105554780|NCT04642638|364027441|FG002|Overall Study|Physician Decision|0|||
105554781|NCT04642638|364027442|FG003|Overall Study|Physician Decision|0|||
105554782|NCT04642638|364027443|FG004|Overall Study|Physician Decision|2|||
105554783|NCT04642638|364027444|FG005|Overall Study|Physician Decision|1|||
105554784|NCT04642638|364027439|FG000|Overall Study|Protocol Deviation|0|||
105554785|NCT04642638|364027440|FG001|Overall Study|Protocol Deviation|0|||
105554786|NCT04642638|364027441|FG002|Overall Study|Protocol Deviation|0|||
105554787|NCT04642638|364027442|FG003|Overall Study|Protocol Deviation|0|||
105554788|NCT04642638|364027443|FG004|Overall Study|Protocol Deviation|1|||
105554789|NCT04642638|364027444|FG005|Overall Study|Protocol Deviation|3|||
105554790|NCT04642638|364027439|FG000|Overall Study|Study Terminated|0|||
105554791|NCT04642638|364027440|FG001|Overall Study|Study Terminated|0|||
105554792|NCT04642638|364027441|FG002|Overall Study|Study Terminated|0|||
105554793|NCT04642638|364027442|FG003|Overall Study|Study Terminated|0|||
105554794|NCT04642638|364027443|FG004|Overall Study|Study Terminated|484|||
105554795|NCT04642638|364027444|FG005|Overall Study|Study Terminated|250|||
105554796|NCT04642638|364027439|FG000|Overall Study|Pregnancy|0|||
105554797|NCT04642638|364027440|FG001|Overall Study|Pregnancy|0|||
105554798|NCT04642638|364027441|FG002|Overall Study|Pregnancy|0|||
105554799|NCT04642638|364027442|FG003|Overall Study|Pregnancy|0|||
105554800|NCT04642638|364027443|FG004|Overall Study|Pregnancy|1|||
105554801|NCT04642638|364027444|FG005|Overall Study|Pregnancy|0|||
105554802|NCT02189798|364027447|FG000|Extended Use Phase|Withdrawal by Subject|0|||
105554803|NCT02189798|364027448|FG001|Extended Use Phase|Withdrawal by Subject|4|||
105554804|NCT02189798|364027447|FG000|Extended Use Phase|Physician Decision|1|||
105554805|NCT02189798|364027448|FG001|Extended Use Phase|Physician Decision|0|||
105554806|NCT02189798|364027447|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
105554807|NCT02189798|364027448|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
105554808|NCT02189798|364027447|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
105554809|NCT02189798|364027448|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
105554810|NCT02189798|364027447|FG000|Extended Use Phase|Travel Issues|2|||
105554811|NCT02189798|364027448|FG001|Extended Use Phase|Travel Issues|1|||
105554812|NCT02189798|364027447|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
105554813|NCT02189798|364027448|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
105554814|NCT01672801|364027449|FG000|Overall Study|Screen Failure|0|||
105554815|NCT01672801|364027450|FG001|Overall Study|Screen Failure|1|||
105554816|NCT01474681|364027451|FG000|Overall Study|Death|0|||
105554817|NCT01474681|364027452|FG001|Overall Study|Death|3|||
105554818|NCT01474681|364027453|FG002|Overall Study|Death|2|||
105554819|NCT01474681|364027454|FG003|Overall Study|Death|6|||
105554820|NCT03595904|364027459|FG000|Overall Study|Protocol Violation|3|||
105554821|NCT03595904|364027460|FG001|Overall Study|Protocol Violation|1|||
105554822|NCT03595904|364027459|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
105554823|NCT03595904|364027460|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
105554824|NCT03595904|364027459|FG000|Overall Study|Insurance complications|1|||
105554825|NCT03595904|364027460|FG001|Overall Study|Insurance complications|0|||
105554826|NCT03595904|364027459|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
105554827|NCT03595904|364027460|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
105554828|NCT01581281|364027461|FG000|Overall Study|Early Study Closure|15|||
105554829|NCT01581281|364027462|FG001|Overall Study|Early Study Closure|6|||
105672438|NCT02942277|364464259|FG003|Year 1|Subject met withdrawal criteria|1|||
105554830|NCT01581281|364027463|FG002|Overall Study|Early Study Closure|12|||
105672439|NCT02942277|364464260|FG004|Year 1|Subject met withdrawal criteria|0|||
105786225|NCT01233284|364870485|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
105554831|NCT01392560|364027464|FG000|Overall Study|Adverse Event|2|||
105554832|NCT01392560|364027464|FG000|Overall Study|not entered|8|||
105672440|NCT02942277|364464261|FG005|Year 1|Subject met withdrawal criteria|0|||
105672441|NCT02942277|364464262|FG006|Year 1|Subject met withdrawal criteria|0|||
105554833|NCT01392560|364027464|FG000|Overall Study|discontinued during placebo run-in|2|||
105554834|NCT01934218|364027465|FG000|Double-blind Phase|Adverse Event|8|||
105554835|NCT01934218|364027466|FG001|Double-blind Phase|Adverse Event|8|||
105672442|NCT02942277|364464263|FG007|Year 1|Subject met withdrawal criteria|0|||
105672443|NCT02942277|364464264|FG008|Year 1|Subject met withdrawal criteria|0|||
105672444|NCT02942277|364464265|FG009|Year 1|Subject met withdrawal criteria|0|||
105672445|NCT02942277|364464266|FG010|Year 1|Subject met withdrawal criteria|0|||
105672446|NCT02942277|364464256|FG000|Year 1|Lost to Follow-up|0|||
105672447|NCT02942277|364464257|FG001|Year 1|Lost to Follow-up|0|||
105672448|NCT02942277|364464258|FG002|Year 1|Lost to Follow-up|0|||
105672449|NCT02942277|364464259|FG003|Year 1|Lost to Follow-up|0|||
105672450|NCT02942277|364464260|FG004|Year 1|Lost to Follow-up|1|||
105672451|NCT02942277|364464261|FG005|Year 1|Lost to Follow-up|0|||
105672452|NCT02942277|364464262|FG006|Year 1|Lost to Follow-up|0|||
105672453|NCT02942277|364464263|FG007|Year 1|Lost to Follow-up|0|||
105672454|NCT02942277|364464264|FG008|Year 1|Lost to Follow-up|0|||
105554836|NCT01934218|364027465|FG000|Double-blind Phase|Lack of Efficacy|6|||
105554837|NCT01934218|364027466|FG001|Double-blind Phase|Lack of Efficacy|7|||
105554838|NCT01934218|364027465|FG000|Double-blind Phase|Lost to Follow-up|7|||
105554839|NCT01934218|364027466|FG001|Double-blind Phase|Lost to Follow-up|14|||
105554840|NCT01934218|364027465|FG000|Double-blind Phase|Physician Decision|1|||
105554841|NCT01934218|364027466|FG001|Double-blind Phase|Physician Decision|2|||
105554842|NCT01934218|364027465|FG000|Double-blind Phase|Protocol Violation|4|||
105554843|NCT01934218|364027466|FG001|Double-blind Phase|Protocol Violation|0|||
105554844|NCT01934218|364027465|FG000|Double-blind Phase|Withdrawal by Subject|16|||
105554845|NCT01934218|364027466|FG001|Double-blind Phase|Withdrawal by Subject|13|||
105554846|NCT01934218|364027465|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
105554847|NCT01934218|364027466|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
105554848|NCT01934218|364027465|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
105554849|NCT01934218|364027466|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
105554850|NCT01934218|364027465|FG000|Open-Label Phase|Adverse Event|2|||
105554851|NCT01934218|364027466|FG001|Open-Label Phase|Adverse Event|4|||
105554852|NCT01934218|364027465|FG000|Open-Label Phase|Lack of Efficacy|1|||
105554853|NCT01934218|364027466|FG001|Open-Label Phase|Lack of Efficacy|4|||
105554854|NCT01934218|364027465|FG000|Open-Label Phase|Lost to Follow-up|4|||
105554855|NCT01934218|364027466|FG001|Open-Label Phase|Lost to Follow-up|2|||
105554856|NCT01934218|364027465|FG000|Open-Label Phase|Physician Decision|1|||
105554857|NCT01934218|364027466|FG001|Open-Label Phase|Physician Decision|0|||
105554858|NCT01934218|364027465|FG000|Open-Label Phase|Protocol Violation|1|||
105554859|NCT01934218|364027466|FG001|Open-Label Phase|Protocol Violation|0|||
105554860|NCT01934218|364027465|FG000|Open-Label Phase|Withdrawal by Subject|13|||
105554861|NCT01934218|364027466|FG001|Open-Label Phase|Withdrawal by Subject|11|||
105554862|NCT01934218|364027465|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
105554863|NCT01934218|364027466|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
105554864|NCT01934218|364027465|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
105554865|NCT01934218|364027466|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
105554866|NCT03273946|364027473|FG000|Overall Study|Withdrawal by Subject|5|||
105554867|NCT03273946|364027473|FG000|Overall Study|Unwillingness of the guardian|1|||
105554868|NCT03273946|364027473|FG000|Overall Study|Participant refused to use the drug|2|||
105554869|NCT03273946|364027473|FG000|Overall Study|Participant relative refused to use drug|1|||
105554870|NCT04330638|364027478|FG000|Overall Study|Adverse Event|9|||
105554871|NCT04330638|364027479|FG001|Overall Study|Adverse Event|10|||
105554872|NCT04330638|364027480|FG002|Overall Study|Adverse Event|15|||
105554873|NCT04330638|364027481|FG003|Overall Study|Adverse Event|6|||
105554874|NCT04330638|364027482|FG004|Overall Study|Adverse Event|10|||
105554875|NCT04330638|364027483|FG005|Overall Study|Adverse Event|5|||
105554876|NCT04330638|364027478|FG000|Overall Study|Other|2|||
105554877|NCT04330638|364027479|FG001|Overall Study|Other|2|||
105554878|NCT04330638|364027480|FG002|Overall Study|Other|5|||
105554879|NCT04330638|364027481|FG003|Overall Study|Other|1|||
105554880|NCT04330638|364027482|FG004|Overall Study|Other|3|||
105554881|NCT04330638|364027483|FG005|Overall Study|Other|2|||
105554882|NCT04330638|364027478|FG000|Overall Study|Withdrawal by Subject|4|||
105554883|NCT04330638|364027479|FG001|Overall Study|Withdrawal by Subject|0|||
105554884|NCT04330638|364027480|FG002|Overall Study|Withdrawal by Subject|0|||
105554885|NCT04330638|364027481|FG003|Overall Study|Withdrawal by Subject|0|||
105554886|NCT04330638|364027482|FG004|Overall Study|Withdrawal by Subject|0|||
105554887|NCT04330638|364027483|FG005|Overall Study|Withdrawal by Subject|0|||
105554888|NCT04330638|364027478|FG000|Overall Study|Lost to Follow-up|3|||
105554889|NCT04330638|364027479|FG001|Overall Study|Lost to Follow-up|2|||
105554890|NCT04330638|364027480|FG002|Overall Study|Lost to Follow-up|3|||
105554891|NCT04330638|364027481|FG003|Overall Study|Lost to Follow-up|2|||
105554892|NCT04330638|364027482|FG004|Overall Study|Lost to Follow-up|3|||
105554893|NCT04330638|364027483|FG005|Overall Study|Lost to Follow-up|0|||
105554894|NCT00295750|364027488|FG000|Overall Study|Adverse Event|19|||
105554895|NCT00295750|364027489|FG001|Overall Study|Adverse Event|15|||
105554896|NCT00295750|364027490|FG002|Overall Study|Adverse Event|12|||
105672455|NCT02942277|364464265|FG009|Year 1|Lost to Follow-up|0|||
105672456|NCT02942277|364464266|FG010|Year 1|Lost to Follow-up|2|||
105672457|NCT02942277|364464256|FG000|Year 1|Protocol Violation|0|||
105672458|NCT02942277|364464257|FG001|Year 1|Protocol Violation|0|||
105672459|NCT02942277|364464258|FG002|Year 1|Protocol Violation|0|||
105672460|NCT02942277|364464259|FG003|Year 1|Protocol Violation|0|||
105672461|NCT02942277|364464260|FG004|Year 1|Protocol Violation|1|||
105672462|NCT02942277|364464261|FG005|Year 1|Protocol Violation|1|||
105672463|NCT02942277|364464262|FG006|Year 1|Protocol Violation|0|||
105672464|NCT02942277|364464263|FG007|Year 1|Protocol Violation|0|||
105672465|NCT02942277|364464264|FG008|Year 1|Protocol Violation|0|||
105672466|NCT02942277|364464265|FG009|Year 1|Protocol Violation|0|||
105672467|NCT02942277|364464266|FG010|Year 1|Protocol Violation|2|||
105672468|NCT02942277|364464256|FG000|Year 1|Pregnancy|0|||
105672469|NCT02942277|364464257|FG001|Year 1|Pregnancy|0|||
105672470|NCT02942277|364464258|FG002|Year 1|Pregnancy|0|||
105672471|NCT02942277|364464259|FG003|Year 1|Pregnancy|0|||
105672472|NCT02942277|364464260|FG004|Year 1|Pregnancy|0|||
105672473|NCT02942277|364464261|FG005|Year 1|Pregnancy|1|||
105672474|NCT02942277|364464262|FG006|Year 1|Pregnancy|0|||
105672475|NCT02942277|364464263|FG007|Year 1|Pregnancy|0|||
105672476|NCT02942277|364464264|FG008|Year 1|Pregnancy|0|||
105672477|NCT02942277|364464265|FG009|Year 1|Pregnancy|0|||
105672478|NCT02942277|364464266|FG010|Year 1|Pregnancy|0|||
105672479|NCT02942277|364464256|FG000|Year 2|Lost to Follow-up|0|||
105672480|NCT02942277|364464257|FG001|Year 2|Lost to Follow-up|0|||
105672481|NCT02942277|364464258|FG002|Year 2|Lost to Follow-up|0|||
105672482|NCT02942277|364464259|FG003|Year 2|Lost to Follow-up|0|||
105672483|NCT02942277|364464260|FG004|Year 2|Lost to Follow-up|2|||
105672484|NCT02942277|364464261|FG005|Year 2|Lost to Follow-up|1|||
105672485|NCT02942277|364464262|FG006|Year 2|Lost to Follow-up|0|||
105672486|NCT02942277|364464263|FG007|Year 2|Lost to Follow-up|0|||
105672487|NCT02942277|364464264|FG008|Year 2|Lost to Follow-up|0|||
105672488|NCT02942277|364464265|FG009|Year 2|Lost to Follow-up|0|||
105672489|NCT02942277|364464266|FG010|Year 2|Lost to Follow-up|0|||
105672490|NCT02942277|364464256|FG000|Year 2|Did not rescreen|0|||
105672491|NCT02942277|364464257|FG001|Year 2|Did not rescreen|0|||
105786226|NCT01233284|364870486|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
105786227|NCT01233284|364870487|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
105786228|NCT01233284|364870483|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
105786229|NCT01233284|364870484|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
105786230|NCT01233284|364870485|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
105786231|NCT01233284|364870486|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
105786232|NCT01233284|364870487|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
105786233|NCT01233284|364870483|FG000|Period 1 (4 Weeks)|Other|0|||
105786234|NCT01233284|364870484|FG001|Period 1 (4 Weeks)|Other|0|||
105786235|NCT01233284|364870485|FG002|Period 1 (4 Weeks)|Other|1|||
105672492|NCT02942277|364464258|FG002|Year 2|Did not rescreen|1|||
105672493|NCT02942277|364464259|FG003|Year 2|Did not rescreen|1|||
105786236|NCT01233284|364870486|FG003|Period 1 (4 Weeks)|Other|0|||
105786237|NCT01233284|364870487|FG004|Period 1 (4 Weeks)|Other|0|||
105786238|NCT01233284|364870483|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105786239|NCT01233284|364870484|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105786240|NCT01233284|364870485|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
105786241|NCT01233284|364870486|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105786242|NCT01233284|364870487|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105786243|NCT01233284|364870483|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
105786244|NCT01233284|364870484|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
105786245|NCT01233284|364870485|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
105786246|NCT01233284|364870486|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
105786247|NCT01233284|364870487|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
105786248|NCT01233284|364870483|FG000|Period 3 (4 Weeks)|Other|0|||
105786249|NCT01233284|364870484|FG001|Period 3 (4 Weeks)|Other|0|||
105786250|NCT01233284|364870485|FG002|Period 3 (4 Weeks)|Other|0|||
105786251|NCT01233284|364870486|FG003|Period 3 (4 Weeks)|Other|1|||
105786252|NCT01233284|364870487|FG004|Period 3 (4 Weeks)|Other|0|||
105786253|NCT01233284|364870483|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
105466614|NCT03853109|363720185|FG002|Overall Study|Death|8|||
105672494|NCT02942277|364464260|FG004|Year 2|Did not rescreen|9|||
105672495|NCT02942277|364464261|FG005|Year 2|Did not rescreen|6|||
105672496|NCT02942277|364464262|FG006|Year 2|Did not rescreen|0|||
105786254|NCT01233284|364870484|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
105672497|NCT02942277|364464263|FG007|Year 2|Did not rescreen|1|||
105672498|NCT02942277|364464264|FG008|Year 2|Did not rescreen|0|||
105672499|NCT02942277|364464265|FG009|Year 2|Did not rescreen|0|||
105672500|NCT02942277|364464266|FG010|Year 2|Did not rescreen|21|||
105786255|NCT01233284|364870485|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
105786256|NCT01233284|364870486|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
105786257|NCT01233284|364870487|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
105786258|NCT01233284|364870483|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
105786259|NCT01233284|364870484|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
105672501|NCT02942277|364464256|FG000|Year 2|Met withdrawal criteria|0|||
105672502|NCT02942277|364464257|FG001|Year 2|Met withdrawal criteria|0|||
105672503|NCT02942277|364464258|FG002|Year 2|Met withdrawal criteria|0|||
105672504|NCT02942277|364464259|FG003|Year 2|Met withdrawal criteria|0|||
105672505|NCT02942277|364464260|FG004|Year 2|Met withdrawal criteria|1|||
105672506|NCT02942277|364464261|FG005|Year 2|Met withdrawal criteria|2|||
105672507|NCT02942277|364464262|FG006|Year 2|Met withdrawal criteria|0|||
105672508|NCT02942277|364464263|FG007|Year 2|Met withdrawal criteria|0|||
105672509|NCT02942277|364464264|FG008|Year 2|Met withdrawal criteria|0|||
105672510|NCT02942277|364464265|FG009|Year 2|Met withdrawal criteria|0|||
105672511|NCT02942277|364464266|FG010|Year 2|Met withdrawal criteria|1|||
105672512|NCT02942277|364464256|FG000|Year 2|Travel|0|||
105672513|NCT02942277|364464257|FG001|Year 2|Travel|1|||
105672514|NCT02942277|364464258|FG002|Year 2|Travel|0|||
105672515|NCT02942277|364464259|FG003|Year 2|Travel|0|||
105672516|NCT02942277|364464260|FG004|Year 2|Travel|0|||
105672517|NCT02942277|364464261|FG005|Year 2|Travel|1|||
105672518|NCT02942277|364464262|FG006|Year 2|Travel|0|||
105672519|NCT02942277|364464263|FG007|Year 2|Travel|0|||
105672520|NCT02942277|364464264|FG008|Year 2|Travel|0|||
105672521|NCT02942277|364464265|FG009|Year 2|Travel|1|||
105672522|NCT02942277|364464266|FG010|Year 2|Travel|3|||
105672523|NCT02942277|364464256|FG000|Year 2|Non-compliant|0|||
105672524|NCT02942277|364464257|FG001|Year 2|Non-compliant|0|||
105672525|NCT02942277|364464258|FG002|Year 2|Non-compliant|0|||
105672526|NCT02942277|364464259|FG003|Year 2|Non-compliant|0|||
105672527|NCT02942277|364464260|FG004|Year 2|Non-compliant|1|||
105672528|NCT02942277|364464261|FG005|Year 2|Non-compliant|1|||
105672529|NCT02942277|364464262|FG006|Year 2|Non-compliant|0|||
105672530|NCT02942277|364464263|FG007|Year 2|Non-compliant|0|||
105672531|NCT02942277|364464264|FG008|Year 2|Non-compliant|0|||
105672532|NCT02942277|364464265|FG009|Year 2|Non-compliant|0|||
105672533|NCT02942277|364464266|FG010|Year 2|Non-compliant|0|||
105672534|NCT02942277|364464256|FG000|Year 2|Withdrawal by Subject|0|||
105672535|NCT02942277|364464257|FG001|Year 2|Withdrawal by Subject|0|||
105672536|NCT02942277|364464258|FG002|Year 2|Withdrawal by Subject|0|||
105672537|NCT02942277|364464259|FG003|Year 2|Withdrawal by Subject|0|||
105672538|NCT02942277|364464260|FG004|Year 2|Withdrawal by Subject|0|||
105672539|NCT02942277|364464261|FG005|Year 2|Withdrawal by Subject|0|||
105672540|NCT02942277|364464262|FG006|Year 2|Withdrawal by Subject|1|||
105672541|NCT02942277|364464263|FG007|Year 2|Withdrawal by Subject|0|||
105672542|NCT02942277|364464264|FG008|Year 2|Withdrawal by Subject|0|||
105672543|NCT02942277|364464265|FG009|Year 2|Withdrawal by Subject|0|||
105672544|NCT02942277|364464266|FG010|Year 2|Withdrawal by Subject|0|||
105672545|NCT02187159|364464274|FG000|Overall Study|Protocol Violation|4|||
105672546|NCT02187159|364464275|FG001|Overall Study|Protocol Violation|6|||
105672547|NCT02187159|364464276|FG002|Overall Study|Protocol Violation|3|||
105672548|NCT02187159|364464277|FG003|Overall Study|Protocol Violation|4|||
105672549|NCT02187159|364464274|FG000|Overall Study|Lack of Efficacy|10|||
105672550|NCT02187159|364464275|FG001|Overall Study|Lack of Efficacy|5|||
105672551|NCT02187159|364464276|FG002|Overall Study|Lack of Efficacy|4|||
105672552|NCT02187159|364464277|FG003|Overall Study|Lack of Efficacy|7|||
105672553|NCT02187159|364464274|FG000|Overall Study|Adverse Event|28|||
105672554|NCT02187159|364464275|FG001|Overall Study|Adverse Event|33|||
105672555|NCT02187159|364464276|FG002|Overall Study|Adverse Event|42|||
105672556|NCT02187159|364464277|FG003|Overall Study|Adverse Event|50|||
105672557|NCT02187159|364464274|FG000|Overall Study|Withdrawal by Subject|24|||
105672558|NCT02187159|364464275|FG001|Overall Study|Withdrawal by Subject|28|||
105672559|NCT02187159|364464276|FG002|Overall Study|Withdrawal by Subject|25|||
105672560|NCT02187159|364464277|FG003|Overall Study|Withdrawal by Subject|26|||
105672561|NCT02187159|364464274|FG000|Overall Study|Other|3|||
105672562|NCT02187159|364464275|FG001|Overall Study|Other|7|||
105672563|NCT02187159|364464276|FG002|Overall Study|Other|3|||
105672564|NCT02187159|364464277|FG003|Overall Study|Other|9|||
105672565|NCT02787044|364464278|FG000|Overall Study|Lost to Follow-up|15|||
105672566|NCT02787044|364464279|FG001|Overall Study|Lost to Follow-up|19|||
105672567|NCT00338962|364464280|FG000|Overall Study|Lost to Follow-up|3|||
105672568|NCT00338962|364464281|FG001|Overall Study|Lost to Follow-up|3|||
105672569|NCT00338962|364464282|FG002|Overall Study|Lost to Follow-up|2|||
105672570|NCT00338962|364464283|FG003|Overall Study|Lost to Follow-up|3|||
105672571|NCT00338962|364464280|FG000|Overall Study|Withdrawal by Subject|1|||
105672572|NCT00338962|364464281|FG001|Overall Study|Withdrawal by Subject|0|||
105672573|NCT00338962|364464282|FG002|Overall Study|Withdrawal by Subject|0|||
105672574|NCT00338962|364464283|FG003|Overall Study|Withdrawal by Subject|0|||
105672575|NCT00338962|364464280|FG000|Overall Study|No Transportation|2|||
105672576|NCT00338962|364464281|FG001|Overall Study|No Transportation|0|||
105672577|NCT00338962|364464282|FG002|Overall Study|No Transportation|0|||
105672578|NCT00338962|364464283|FG003|Overall Study|No Transportation|0|||
105672579|NCT00338962|364464280|FG000|Overall Study|Time Constraint|2|||
105672580|NCT00338962|364464281|FG001|Overall Study|Time Constraint|0|||
105672581|NCT00338962|364464282|FG002|Overall Study|Time Constraint|0|||
105672582|NCT00338962|364464283|FG003|Overall Study|Time Constraint|0|||
105672583|NCT00338962|364464280|FG000|Overall Study|Moved|0|||
105672584|NCT00338962|364464281|FG001|Overall Study|Moved|1|||
105672585|NCT00338962|364464282|FG002|Overall Study|Moved|0|||
105672586|NCT00338962|364464283|FG003|Overall Study|Moved|0|||
105672587|NCT00338962|364464280|FG000|Overall Study|Adverse Event|0|||
105672588|NCT00338962|364464281|FG001|Overall Study|Adverse Event|0|||
105672589|NCT00338962|364464282|FG002|Overall Study|Adverse Event|2|||
105672590|NCT00338962|364464283|FG003|Overall Study|Adverse Event|0|||
105672591|NCT00338962|364464280|FG000|Overall Study|Poor Compliance|0|||
105672592|NCT00338962|364464281|FG001|Overall Study|Poor Compliance|0|||
105672593|NCT00338962|364464282|FG002|Overall Study|Poor Compliance|2|||
105672594|NCT00338962|364464283|FG003|Overall Study|Poor Compliance|0|||
105672595|NCT03046121|364464284|FG000|Overall Study|Death|32|||
105672596|NCT03046121|364464285|FG001|Overall Study|Death|60|||
105672597|NCT03046121|364464284|FG000|Overall Study|Withdrawal by Subject|14|||
105672598|NCT03046121|364464285|FG001|Overall Study|Withdrawal by Subject|12|||
105672599|NCT02781090|364464286|FG000|3-Month Follow-Up|Missed Visit|20|||
105672600|NCT02781090|364464287|FG001|3-Month Follow-Up|Missed Visit|20|||
105672601|NCT02781090|364464286|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
105672602|NCT02781090|364464287|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
105672603|NCT02781090|364464286|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
105672604|NCT02781090|364464287|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
105672605|NCT02781090|364464286|FG000|3-Month Follow-Up|Death|1|||
105672606|NCT02781090|364464287|FG001|3-Month Follow-Up|Death|0|||
105672607|NCT02781090|364464286|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
105672608|NCT02781090|364464287|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
105672609|NCT02781090|364464286|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
105672610|NCT02781090|364464287|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
105672611|NCT02781090|364464286|FG000|6-Month Follow-Up|Death|0|||
105672612|NCT02781090|364464287|FG001|6-Month Follow-Up|Death|1|||
105672613|NCT03361605|364464288|FG000|Overall Study|Analyzable data not available|3|||
105672614|NCT03846453|364464294|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
105672615|NCT03846453|364464295|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
105672616|NCT03846453|364464296|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
105672617|NCT03846453|364464294|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
105672618|NCT03846453|364464295|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
105672619|NCT03846453|364464296|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
105672620|NCT03846453|364464294|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
105672621|NCT03846453|364464295|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
105672622|NCT03846453|364464296|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
105672623|NCT03846453|364464294|FG000|Placebo Run-in (14 Days)|Other|2|||
105672624|NCT03846453|364464295|FG001|Placebo Run-in (14 Days)|Other|0|||
105672625|NCT03846453|364464296|FG002|Placebo Run-in (14 Days)|Other|0|||
105672626|NCT03846453|364464294|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
105672627|NCT03846453|364464295|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
105672628|NCT03846453|364464296|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
105672629|NCT03846453|364464294|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
105672630|NCT03846453|364464295|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
105672631|NCT03846453|364464296|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
105672632|NCT03846453|364464294|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
105672633|NCT03846453|364464295|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
105672634|NCT03846453|364464296|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
105672635|NCT03846453|364464294|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
105672636|NCT03846453|364464295|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
105672637|NCT03846453|364464296|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
105672638|NCT03846453|364464294|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
105672639|NCT03846453|364464295|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
105672640|NCT03846453|364464296|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
105672641|NCT04230122|364464301|FG000|Overall Study|Lost to Follow-up|1|||
105672642|NCT04230122|364464302|FG001|Overall Study|Lost to Follow-up|0|||
105672643|NCT00403767|364464303|FG000|Overall Study|Adverse Event|993|||
105672644|NCT00403767|364464304|FG001|Overall Study|Adverse Event|919|||
105672645|NCT00403767|364464303|FG000|Overall Study|Non-compliant with study medication|134|||
105672646|NCT00403767|364464304|FG001|Overall Study|Non-compliant with study medication|164|||
105672647|NCT00403767|364464303|FG000|Overall Study|Consent withdrawn|671|||
105672648|NCT00403767|364464304|FG001|Overall Study|Consent withdrawn|673|||
105672649|NCT00403767|364464303|FG000|Overall Study|Investigator dec./not protocol-related|191|||
105672650|NCT00403767|364464304|FG001|Overall Study|Investigator dec./not protocol-related|178|||
105672651|NCT00403767|364464303|FG000|Overall Study|Lost to Follow-up|6|||
105672652|NCT00403767|364464304|FG001|Overall Study|Lost to Follow-up|8|||
105672653|NCT00403767|364464303|FG000|Overall Study|Protocol Violation|142|||
105672654|NCT00403767|364464304|FG001|Overall Study|Protocol Violation|124|||
105672655|NCT00403767|364464303|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
105672656|NCT00403767|364464304|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
105672657|NCT00403767|364464303|FG000|Overall Study|Study terminated by sponsor|82|||
105672658|NCT00403767|364464304|FG001|Overall Study|Study terminated by sponsor|69|||
105672659|NCT00403767|364464303|FG000|Overall Study|Missing/incomplete data|1|||
105672660|NCT00403767|364464304|FG001|Overall Study|Missing/incomplete data|1|||
105672661|NCT01641159|364464305|FG000|Overall Study|Lost to Follow-up|2|||
105672662|NCT01641159|364464306|FG001|Overall Study|Lost to Follow-up|1|||
105672663|NCT01641159|364464305|FG000|Overall Study|Withdrawal by Subject|0|||
105786260|NCT01233284|364870485|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
105786261|NCT01233284|364870486|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
105786262|NCT01233284|364870487|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
105786263|NCT00948896|364870488|FG000|Randomization to 24 Months of Age|Death|1|||
105786264|NCT00948896|364870489|FG001|Randomization to 24 Months of Age|Death|0|||
105786265|NCT00948896|364870490|FG002|Randomization to 24 Months of Age|Death|0|||
105786266|NCT00948896|364870491|FG003|Randomization to 24 Months of Age|Death|0|||
105786267|NCT00948896|364870492|FG004|Randomization to 24 Months of Age|Death|2|||
105786268|NCT00948896|364870493|FG005|Randomization to 24 Months of Age|Death|1|||
105786269|NCT00948896|364870494|FG006|Randomization to 24 Months of Age|Death|2|||
105786270|NCT00948896|364870495|FG007|Randomization to 24 Months of Age|Death|1|||
105786271|NCT00948896|364870488|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
105786272|NCT00948896|364870489|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
105786273|NCT00948896|364870490|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
105786274|NCT00948896|364870491|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
105786275|NCT00948896|364870492|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
105786276|NCT00948896|364870493|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
105786277|NCT00948896|364870494|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
105786278|NCT00948896|364870495|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
105786279|NCT00948896|364870488|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
105786280|NCT00948896|364870489|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
105786281|NCT00948896|364870490|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
105786282|NCT00948896|364870491|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
105786283|NCT00948896|364870492|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
105786284|NCT00948896|364870493|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
105786285|NCT00948896|364870494|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
105786286|NCT00948896|364870495|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
105786287|NCT00948896|364870488|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
105786288|NCT00948896|364870489|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
105786289|NCT00948896|364870490|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
105786290|NCT00948896|364870491|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
105672664|NCT01641159|364464306|FG001|Overall Study|Withdrawal by Subject|1|||
105672665|NCT05330676|364464307|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
105672666|NCT05330676|364464308|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
105672667|NCT02416453|364464309|FG000|Overall Study|Adverse Event|0|||
105672668|NCT02416453|364464310|FG001|Overall Study|Adverse Event|0|||
105672669|NCT02416453|364464311|FG002|Overall Study|Adverse Event|0|||
105786291|NCT00948896|364870492|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
105672670|NCT02416453|364464312|FG003|Overall Study|Adverse Event|2|||
105672671|NCT02416453|364464313|FG004|Overall Study|Adverse Event|0|||
105672672|NCT02416453|364464314|FG005|Overall Study|Adverse Event|1|||
105672673|NCT02416453|364464315|FG006|Overall Study|Adverse Event|0|||
105672674|NCT02416453|364464316|FG007|Overall Study|Adverse Event|0|||
105672675|NCT02416453|364464317|FG008|Overall Study|Adverse Event|0|||
105672676|NCT02416453|364464318|FG009|Overall Study|Adverse Event|0|||
105672677|NCT02416453|364464319|FG010|Overall Study|Adverse Event|0|||
105672678|NCT02416453|364464309|FG000|Overall Study|Lost to Follow-up|1|||
105672679|NCT02416453|364464310|FG001|Overall Study|Lost to Follow-up|3|||
105672680|NCT02416453|364464311|FG002|Overall Study|Lost to Follow-up|0|||
105672681|NCT02416453|364464312|FG003|Overall Study|Lost to Follow-up|8|||
105672682|NCT02416453|364464313|FG004|Overall Study|Lost to Follow-up|0|||
105672683|NCT02416453|364464314|FG005|Overall Study|Lost to Follow-up|5|||
105672684|NCT02416453|364464315|FG006|Overall Study|Lost to Follow-up|1|||
105672685|NCT02416453|364464316|FG007|Overall Study|Lost to Follow-up|3|||
105672686|NCT02416453|364464317|FG008|Overall Study|Lost to Follow-up|1|||
105672687|NCT02416453|364464318|FG009|Overall Study|Lost to Follow-up|0|||
105672688|NCT02416453|364464319|FG010|Overall Study|Lost to Follow-up|0|||
105672689|NCT02416453|364464309|FG000|Overall Study|Physician Decision|0|||
105672690|NCT02416453|364464310|FG001|Overall Study|Physician Decision|0|||
105672691|NCT02416453|364464311|FG002|Overall Study|Physician Decision|0|||
105672692|NCT02416453|364464312|FG003|Overall Study|Physician Decision|0|||
105672693|NCT02416453|364464313|FG004|Overall Study|Physician Decision|0|||
105672694|NCT02416453|364464314|FG005|Overall Study|Physician Decision|1|||
105672695|NCT02416453|364464315|FG006|Overall Study|Physician Decision|1|||
105672696|NCT02416453|364464316|FG007|Overall Study|Physician Decision|1|||
105672697|NCT02416453|364464317|FG008|Overall Study|Physician Decision|0|||
105672698|NCT02416453|364464318|FG009|Overall Study|Physician Decision|0|||
105672699|NCT02416453|364464319|FG010|Overall Study|Physician Decision|0|||
105672700|NCT02416453|364464309|FG000|Overall Study|Withdrawal by Subject|2|||
105672701|NCT02416453|364464310|FG001|Overall Study|Withdrawal by Subject|0|||
105672702|NCT02416453|364464311|FG002|Overall Study|Withdrawal by Subject|0|||
105672703|NCT02416453|364464312|FG003|Overall Study|Withdrawal by Subject|5|||
105672704|NCT02416453|364464313|FG004|Overall Study|Withdrawal by Subject|1|||
105672705|NCT02416453|364464314|FG005|Overall Study|Withdrawal by Subject|8|||
105672706|NCT02416453|364464315|FG006|Overall Study|Withdrawal by Subject|0|||
105672707|NCT02416453|364464316|FG007|Overall Study|Withdrawal by Subject|8|||
105672708|NCT02416453|364464317|FG008|Overall Study|Withdrawal by Subject|4|||
105672709|NCT02416453|364464318|FG009|Overall Study|Withdrawal by Subject|0|||
105672710|NCT02416453|364464319|FG010|Overall Study|Withdrawal by Subject|0|||
105672711|NCT02416453|364464309|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672712|NCT02416453|364464310|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672713|NCT02416453|364464311|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
105672714|NCT02416453|364464312|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672715|NCT02416453|364464313|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672716|NCT02416453|364464314|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672717|NCT02416453|364464315|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672718|NCT02416453|364464316|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672719|NCT02416453|364464317|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672720|NCT02416453|364464318|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672721|NCT02416453|364464319|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672722|NCT02416453|364464309|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672723|NCT02416453|364464310|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672724|NCT02416453|364464311|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672725|NCT02416453|364464312|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672726|NCT02416453|364464313|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672727|NCT02416453|364464314|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
105672728|NCT02416453|364464315|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672729|NCT02416453|364464316|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672730|NCT02416453|364464317|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672731|NCT02416453|364464318|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672732|NCT02416453|364464319|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672733|NCT01559129|364464320|FG000|Treatment Phase|Adverse Event|0|||
105672734|NCT01559129|364464321|FG001|Treatment Phase|Adverse Event|2|||
105672735|NCT01559129|364464320|FG000|Treatment Phase|Progressive Disease|1|||
105672736|NCT01559129|364464321|FG001|Treatment Phase|Progressive Disease|1|||
105672737|NCT01559129|364464320|FG000|Treatment Phase|Lack of Efficacy|0|||
105672738|NCT01559129|364464321|FG001|Treatment Phase|Lack of Efficacy|1|||
105672739|NCT01559129|364464320|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
105672740|NCT01559129|364464321|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
105672741|NCT01559129|364464320|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
105672742|NCT01559129|364464321|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
105672743|NCT01559129|364464320|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
105672744|NCT01559129|364464321|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
105672745|NCT01559129|364464320|FG000|Open-label Extension Period|Adverse Event|1|||
105672746|NCT01559129|364464321|FG001|Open-label Extension Period|Adverse Event|0|||
105672747|NCT01559129|364464320|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
105672748|NCT01559129|364464321|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
105672749|NCT01280357|364464322|FG000|Overall Study|Excluded no internal monitoring|14|||
105672750|NCT01280357|364464322|FG000|Overall Study|IInsufficient data/No data supplied|12|||
105672751|NCT01259089|364464323|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
105672752|NCT01259089|364464324|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
105672753|NCT01259089|364464325|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
105672754|NCT01259089|364464326|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
105672755|NCT01259089|364464327|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
105672756|NCT01259089|364464328|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
105672757|NCT01259089|364464323|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
105672758|NCT01259089|364464324|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
105672759|NCT01259089|364464325|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
105672760|NCT01259089|364464326|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
105672761|NCT01259089|364464327|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
105672762|NCT01259089|364464328|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
105672763|NCT01259089|364464323|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
105672764|NCT01259089|364464324|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
105672765|NCT01259089|364464325|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
105672766|NCT01259089|364464326|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
105672767|NCT01259089|364464327|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
105672768|NCT01259089|364464328|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
105672769|NCT01259089|364464323|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
105672770|NCT01259089|364464324|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
105672771|NCT01259089|364464325|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
105786292|NCT00948896|364870493|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
105672772|NCT01259089|364464326|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
105466615|NCT03853109|363720186|FG003|Overall Study|Death|10|||
105672773|NCT01259089|364464327|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
105672774|NCT01259089|364464328|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
105554897|NCT00295750|364027488|FG000|Overall Study|Lack of Efficacy|1|||
105554898|NCT00295750|364027489|FG001|Overall Study|Lack of Efficacy|1|||
105554899|NCT00295750|364027490|FG002|Overall Study|Lack of Efficacy|0|||
105554900|NCT00295750|364027488|FG000|Overall Study|Lost to Follow-up|1|||
105554901|NCT00295750|364027489|FG001|Overall Study|Lost to Follow-up|4|||
105554902|NCT00295750|364027490|FG002|Overall Study|Lost to Follow-up|1|||
105554903|NCT00295750|364027488|FG000|Overall Study|Taking prohibited therapy|2|||
105554904|NCT00295750|364027489|FG001|Overall Study|Taking prohibited therapy|3|||
105554905|NCT00295750|364027490|FG002|Overall Study|Taking prohibited therapy|2|||
105554906|NCT00295750|364027488|FG000|Overall Study|Administrative errors|2|||
105554907|NCT00295750|364027489|FG001|Overall Study|Administrative errors|4|||
105554908|NCT00295750|364027490|FG002|Overall Study|Administrative errors|5|||
105554909|NCT00295750|364027488|FG000|Overall Study|Trial drug errors|1|||
105554910|NCT00295750|364027489|FG001|Overall Study|Trial drug errors|1|||
105554911|NCT00295750|364027490|FG002|Overall Study|Trial drug errors|0|||
105554912|NCT00295750|364027488|FG000|Overall Study|Disease progression|2|||
105554913|NCT00295750|364027489|FG001|Overall Study|Disease progression|1|||
105554914|NCT00295750|364027490|FG002|Overall Study|Disease progression|0|||
105554915|NCT00295750|364027488|FG000|Overall Study|Personal reasons|0|||
105554916|NCT00295750|364027489|FG001|Overall Study|Personal reasons|1|||
105554917|NCT00295750|364027490|FG002|Overall Study|Personal reasons|0|||
105554918|NCT00295750|364027488|FG000|Overall Study|Randomized but never received trial drug|4|||
105554919|NCT00295750|364027489|FG001|Overall Study|Randomized but never received trial drug|3|||
105554920|NCT00295750|364027490|FG002|Overall Study|Randomized but never received trial drug|3|||
105554921|NCT00295750|364027488|FG000|Overall Study|Withdrawal by Subject|9|||
105554922|NCT00295750|364027489|FG001|Overall Study|Withdrawal by Subject|4|||
105554923|NCT00295750|364027490|FG002|Overall Study|Withdrawal by Subject|7|||
105554924|NCT00295750|364027488|FG000|Overall Study|Protocol Violation|2|||
105554925|NCT00295750|364027489|FG001|Overall Study|Protocol Violation|4|||
105554926|NCT00295750|364027490|FG002|Overall Study|Protocol Violation|2|||
105554927|NCT00522275|364027493|FG000|Overall Study|Adverse Event|35|||
105554928|NCT00522275|364027493|FG000|Overall Study|Lack of Efficacy|80|||
105554929|NCT00522275|364027493|FG000|Overall Study|Subject withdrew consent|16|||
105554930|NCT00522275|364027493|FG000|Overall Study|Protocol deviation|1|||
105554931|NCT00522275|364027493|FG000|Overall Study|Unsatisfactory compliance|11|||
105554932|NCT00522275|364027493|FG000|Overall Study|Lost to Follow-up|8|||
105554933|NCT00522275|364027493|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
105554934|NCT00522275|364027493|FG000|Overall Study|Other: Subject is pregnant|2|||
105554935|NCT00522275|364027493|FG000|Overall Study|Other: Subject relocated|2|||
105554936|NCT00522275|364027493|FG000|Overall Study|Other: Subject arrested|1|||
105554937|NCT00522275|364027493|FG000|Overall Study|Other: Site / clinic closed|4|||
105554938|NCT00522275|364027493|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
105554939|NCT00522275|364027493|FG000|Overall Study|Other: Sponsor request|2|||
105554940|NCT00522275|364027493|FG000|Overall Study|Other: Subject ran out of medication|1|||
105554941|NCT00522275|364027493|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
105554942|NCT03152552|364027494|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
105554943|NCT03152552|364027495|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
105554944|NCT03152552|364027496|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
105554945|NCT03152552|364027497|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
105554946|NCT03152552|364027498|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
105554947|NCT03152552|364027494|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
105554948|NCT03152552|364027495|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
105554949|NCT03152552|364027496|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
105554950|NCT03152552|364027497|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
105554951|NCT03152552|364027498|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
105554952|NCT03152552|364027494|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
105554953|NCT03152552|364027495|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
105554954|NCT03152552|364027496|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
105554955|NCT03152552|364027497|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
105554956|NCT03152552|364027498|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
105554957|NCT03152552|364027494|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105554958|NCT03152552|364027495|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105554959|NCT03152552|364027496|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
105672775|NCT01259089|364464323|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
105672776|NCT01259089|364464324|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
105672777|NCT01259089|364464325|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
105672778|NCT01259089|364464326|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
105672779|NCT01259089|364464327|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
105672780|NCT01259089|364464328|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
105672781|NCT01259089|364464323|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
105672782|NCT01259089|364464324|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
105672783|NCT01259089|364464325|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
105672784|NCT01259089|364464326|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
105672785|NCT01259089|364464327|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
105672786|NCT01259089|364464328|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
105672787|NCT01259089|364464323|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
105672788|NCT01259089|364464324|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
105672789|NCT01259089|364464325|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
105672790|NCT01259089|364464326|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
105672791|NCT01259089|364464327|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
105672792|NCT01259089|364464328|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
105672793|NCT01259089|364464323|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
105672794|NCT01259089|364464324|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
105672795|NCT01259089|364464325|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
105672796|NCT01259089|364464326|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
105672797|NCT01259089|364464327|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
105672798|NCT01259089|364464328|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
105672799|NCT01259089|364464323|FG000|Survival Follow up for Two Years|Death|3|||
105672800|NCT01259089|364464324|FG001|Survival Follow up for Two Years|Death|2|||
105672801|NCT01259089|364464325|FG002|Survival Follow up for Two Years|Death|2|||
105672802|NCT01259089|364464326|FG003|Survival Follow up for Two Years|Death|3|||
105672803|NCT01259089|364464327|FG004|Survival Follow up for Two Years|Death|6|||
105672804|NCT01259089|364464328|FG005|Survival Follow up for Two Years|Death|13|||
105672805|NCT01259089|364464323|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
105672806|NCT01259089|364464324|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
105672807|NCT01259089|364464325|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
105672808|NCT01259089|364464326|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
105672809|NCT01259089|364464327|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
105672810|NCT01259089|364464328|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
105672811|NCT01259089|364464323|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
105672812|NCT01259089|364464324|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
105672813|NCT01259089|364464325|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
105672814|NCT01259089|364464326|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
105672815|NCT01259089|364464327|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
105672816|NCT01259089|364464328|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
105672817|NCT03284203|364464329|FG000|Overall Study|Lost to Follow-up|3|||
105672818|NCT01669577|364464330|FG000|Overall Study|Death|22|||
105672819|NCT01669577|364464330|FG000|Overall Study|Lost to Follow-up|78|||
105672820|NCT01669577|364464330|FG000|Overall Study|Physician Decision|34|||
105672821|NCT01253018|364464331|FG000|Overall Study|Lost to Follow-up|1|||
105672822|NCT01253018|364464332|FG001|Overall Study|Lost to Follow-up|1|||
105672823|NCT01253018|364464331|FG000|Overall Study|Robot Repair Issues|2|||
105672824|NCT01253018|364464332|FG001|Overall Study|Robot Repair Issues|0|||
105672825|NCT01253018|364464331|FG000|Overall Study|Withdrawal by Subject|1|||
105672826|NCT01253018|364464332|FG001|Overall Study|Withdrawal by Subject|1|||
105672827|NCT01204710|364464336|FG000|Randomization Treatment|Lost to Follow-up|1|||
105672828|NCT01204710|364464337|FG001|Randomization Treatment|Lost to Follow-up|0|||
105672829|NCT01204710|364464336|FG000|Randomization Treatment|Withdrawal by Subject|6|||
105672830|NCT01204710|364464337|FG001|Randomization Treatment|Withdrawal by Subject|5|||
105672831|NCT01204710|364464336|FG000|Randomization Treatment|Physician Decision|3|||
105672832|NCT01204710|364464337|FG001|Randomization Treatment|Physician Decision|2|||
105672833|NCT01204710|364464336|FG000|Randomization Treatment|Entry criteria not met|0|||
105672834|NCT01204710|364464337|FG001|Randomization Treatment|Entry criteria not met|1|||
105672835|NCT01204710|364464336|FG000|Randomization Treatment|Adverse Event|4|||
105672836|NCT01204710|364464337|FG001|Randomization Treatment|Adverse Event|2|||
105672837|NCT01204710|364464336|FG000|Randomization Treatment|Sponsor Decision|0|||
105672838|NCT01204710|364464337|FG001|Randomization Treatment|Sponsor Decision|1|||
105672839|NCT01204710|364464336|FG000|Randomization Treatment|Worsening of General condition|0|||
105672840|NCT01204710|364464337|FG001|Randomization Treatment|Worsening of General condition|1|||
105672841|NCT01204710|364464336|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
105672842|NCT01204710|364464337|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
105672843|NCT01204710|364464336|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
105672844|NCT01204710|364464337|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
105672845|NCT01204710|364464336|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
105672846|NCT01204710|364464337|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
105672847|NCT01204710|364464336|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
105672848|NCT01204710|364464337|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
105672849|NCT01769326|364464338|FG000|Overall Study|Lost to Follow-up|1|||
105672850|NCT01769326|364464339|FG001|Overall Study|Lost to Follow-up|2|||
105672851|NCT01769326|364464340|FG002|Overall Study|Lost to Follow-up|0|||
105672852|NCT01769326|364464341|FG003|Overall Study|Lost to Follow-up|0|||
105672853|NCT01769326|364464338|FG000|Overall Study|unrelated injry|1|||
105672854|NCT01769326|364464339|FG001|Overall Study|unrelated injry|1|||
105672855|NCT01769326|364464340|FG002|Overall Study|unrelated injry|0|||
105672856|NCT01769326|364464341|FG003|Overall Study|unrelated injry|0|||
105672857|NCT01769326|364464338|FG000|Overall Study|got a job|0|||
105672858|NCT01769326|364464339|FG001|Overall Study|got a job|1|||
105672859|NCT01769326|364464340|FG002|Overall Study|got a job|0|||
105672860|NCT01769326|364464341|FG003|Overall Study|got a job|0|||
105672861|NCT01769326|364464338|FG000|Overall Study|Got sick and could not complete study|0|||
105672862|NCT01769326|364464339|FG001|Overall Study|Got sick and could not complete study|0|||
105672863|NCT01769326|364464340|FG002|Overall Study|Got sick and could not complete study|1|||
105672864|NCT01769326|364464341|FG003|Overall Study|Got sick and could not complete study|0|||
105672865|NCT05132127|364464342|FG000|Overall Study|Adverse Event|1|||
105672866|NCT00737698|364464348|FG000|Overall Study|Withdrawal by Subject|6|||
105672867|NCT00737698|364464349|FG001|Overall Study|Withdrawal by Subject|5|||
105672868|NCT00737698|364464350|FG002|Overall Study|Withdrawal by Subject|3|||
105672869|NCT00737698|364464348|FG000|Overall Study|Death|0|||
105672870|NCT00737698|364464349|FG001|Overall Study|Death|0|||
105672871|NCT00737698|364464350|FG002|Overall Study|Death|1|||
105672872|NCT04445987|364464351|FG000|Overall Study|Adverse Event|0|||
105672873|NCT04445987|364464352|FG001|Overall Study|Adverse Event|0|||
105672874|NCT04445987|364464353|FG002|Overall Study|Adverse Event|1|||
105672875|NCT04445987|364464354|FG003|Overall Study|Adverse Event|0|||
105672876|NCT04445987|364464355|FG004|Overall Study|Adverse Event|4|||
105672877|NCT04445987|364464356|FG005|Overall Study|Adverse Event|0|||
105672878|NCT04445987|364464351|FG000|Overall Study|Lost to Follow-up|4|||
105672879|NCT04445987|364464352|FG001|Overall Study|Lost to Follow-up|3|||
105672880|NCT04445987|364464353|FG002|Overall Study|Lost to Follow-up|1|||
105672881|NCT04445987|364464354|FG003|Overall Study|Lost to Follow-up|1|||
105672882|NCT04445987|364464355|FG004|Overall Study|Lost to Follow-up|29|||
105672883|NCT04445987|364464356|FG005|Overall Study|Lost to Follow-up|0|||
105672884|NCT04445987|364464351|FG000|Overall Study|Physician Decision|0|||
105672885|NCT04445987|364464352|FG001|Overall Study|Physician Decision|0|||
105342673|NCT00976209|363256725|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105342674|NCT00976209|363256726|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105342675|NCT00976209|363256725|FG000|Treatment Period 2|Lost to Follow-up|0|||
105342676|NCT00976209|363256726|FG001|Treatment Period 2|Lost to Follow-up|1|||
105342677|NCT03197870|363256731|FG000|Overall Study|Adverse Event|9|||
105342678|NCT03197870|363256732|FG001|Overall Study|Adverse Event|4|||
105342679|NCT03197870|363256733|FG002|Overall Study|Adverse Event|6|||
105342680|NCT03197870|363256731|FG000|Overall Study|Withdrawal by Subject|2|||
105342681|NCT03197870|363256732|FG001|Overall Study|Withdrawal by Subject|3|||
105342682|NCT03197870|363256733|FG002|Overall Study|Withdrawal by Subject|0|||
105342683|NCT03197870|363256731|FG000|Overall Study|Lost to Follow-up|2|||
105342684|NCT03197870|363256732|FG001|Overall Study|Lost to Follow-up|2|||
105672886|NCT04445987|364464353|FG002|Overall Study|Physician Decision|0|||
105342685|NCT03197870|363256733|FG002|Overall Study|Lost to Follow-up|0|||
105672887|NCT04445987|364464354|FG003|Overall Study|Physician Decision|0|||
105672888|NCT04445987|364464355|FG004|Overall Study|Physician Decision|1|||
105672889|NCT04445987|364464356|FG005|Overall Study|Physician Decision|0|||
105342686|NCT03197870|363256731|FG000|Overall Study|data not available|1|||
105342687|NCT03197870|363256732|FG001|Overall Study|data not available|1|||
105342688|NCT03197870|363256733|FG002|Overall Study|data not available|0|||
105672890|NCT04445987|364464351|FG000|Overall Study|Protocol Violation|1|||
105672891|NCT04445987|364464352|FG001|Overall Study|Protocol Violation|0|||
105672892|NCT04445987|364464353|FG002|Overall Study|Protocol Violation|0|||
105672893|NCT04445987|364464354|FG003|Overall Study|Protocol Violation|0|||
105672894|NCT04445987|364464355|FG004|Overall Study|Protocol Violation|2|||
105672895|NCT04445987|364464356|FG005|Overall Study|Protocol Violation|0|||
105672896|NCT04445987|364464351|FG000|Overall Study|Withdrawal by Subject|4|||
105672897|NCT04445987|364464352|FG001|Overall Study|Withdrawal by Subject|0|||
105672898|NCT04445987|364464353|FG002|Overall Study|Withdrawal by Subject|1|||
105672899|NCT04445987|364464354|FG003|Overall Study|Withdrawal by Subject|0|||
105672900|NCT04445987|364464355|FG004|Overall Study|Withdrawal by Subject|18|||
105672901|NCT04445987|364464356|FG005|Overall Study|Withdrawal by Subject|1|||
105672902|NCT04445987|364464351|FG000|Overall Study|Other reason|0|||
105672903|NCT04445987|364464352|FG001|Overall Study|Other reason|0|||
105672904|NCT04445987|364464353|FG002|Overall Study|Other reason|1|||
105672905|NCT04445987|364464354|FG003|Overall Study|Other reason|0|||
105672906|NCT04445987|364464355|FG004|Overall Study|Other reason|2|||
105672907|NCT04445987|364464356|FG005|Overall Study|Other reason|0|||
105672908|NCT02387970|364464361|FG000|Overall Study|Did not complete 1-year follow up|1|||
105672909|NCT02387970|364464362|FG001|Overall Study|Did not complete 1-year follow up|2|||
105672910|NCT04157400|364464369|FG000|Overall Study|Withdrawal by Subject|1|||
105672911|NCT04157400|364464369|FG000|Overall Study|Lost to Follow-up|3|||
105672912|NCT00623805|364464370|FG000|Overall Study|Adverse Event|9|||
105672913|NCT00623805|364464371|FG001|Overall Study|Adverse Event|6|||
105672914|NCT00623805|364464370|FG000|Overall Study|Death|2|||
105672915|NCT00623805|364464371|FG001|Overall Study|Death|0|||
105672916|NCT00623805|364464370|FG000|Overall Study|Lack of Efficacy|3|||
105672917|NCT00623805|364464371|FG001|Overall Study|Lack of Efficacy|7|||
105672918|NCT00623805|364464370|FG000|Overall Study|Lost to Follow-up|2|||
105672919|NCT00623805|364464371|FG001|Overall Study|Lost to Follow-up|2|||
105672920|NCT00623805|364464370|FG000|Overall Study|Protocol Violation|1|||
105672921|NCT00623805|364464371|FG001|Overall Study|Protocol Violation|1|||
105672922|NCT00623805|364464370|FG000|Overall Study|Reason not Specified|3|||
105672923|NCT00623805|364464371|FG001|Overall Study|Reason not Specified|6|||
105672924|NCT01200290|364464373|FG000|Treatment Period|Adverse Event|1|||
105672925|NCT01200290|364464373|FG000|Post-Treatment Follow-Up Period|Death|2|||
105672926|NCT00607724|364464375|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
105672927|NCT00607724|364464376|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
105672928|NCT00607724|364464377|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
105672929|NCT00607724|364464378|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
105672930|NCT00607724|364464379|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
105672931|NCT00607724|364464380|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
105672932|NCT00607724|364464381|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
105672933|NCT00607724|364464375|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
105672934|NCT00607724|364464376|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
105672935|NCT00607724|364464377|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
105672936|NCT00607724|364464378|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
105672937|NCT00607724|364464379|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
105672938|NCT00607724|364464380|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
105672939|NCT00607724|364464381|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
105672940|NCT00607724|364464375|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
105672941|NCT00607724|364464376|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
105672942|NCT00607724|364464377|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
105672943|NCT00607724|364464378|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
105672944|NCT00607724|364464379|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
105672945|NCT00607724|364464380|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
105672946|NCT00607724|364464381|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
105672947|NCT00607724|364464375|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
105672948|NCT00607724|364464376|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
105672949|NCT00607724|364464377|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
105672950|NCT00607724|364464378|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
105672951|NCT00607724|364464379|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
105672952|NCT00607724|364464380|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
105672953|NCT00607724|364464381|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
105672954|NCT00607724|364464375|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
105672955|NCT00607724|364464376|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
105672956|NCT00607724|364464377|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
105672957|NCT00607724|364464378|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
105672958|NCT00607724|364464379|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
105672959|NCT00607724|364464380|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
105672960|NCT00607724|364464381|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
105672961|NCT02336451|364464382|FG000|Overall Study|Adverse Event|1|||
105672962|NCT02336451|364464383|FG001|Overall Study|Adverse Event|2|||
105672963|NCT02336451|364464384|FG002|Overall Study|Adverse Event|0|||
105672964|NCT02336451|364464385|FG003|Overall Study|Adverse Event|6|||
105672965|NCT02336451|364464386|FG004|Overall Study|Adverse Event|4|||
105672966|NCT02336451|364464382|FG000|Overall Study|Death|6|||
105672967|NCT02336451|364464383|FG001|Overall Study|Death|2|||
105672968|NCT02336451|364464384|FG002|Overall Study|Death|3|||
105672969|NCT02336451|364464385|FG003|Overall Study|Death|6|||
105672970|NCT02336451|364464386|FG004|Overall Study|Death|6|||
105672971|NCT02336451|364464382|FG000|Overall Study|Physician Decision|9|||
105672972|NCT02336451|364464383|FG001|Overall Study|Physician Decision|6|||
105672973|NCT02336451|364464384|FG002|Overall Study|Physician Decision|7|||
105672974|NCT02336451|364464385|FG003|Overall Study|Physician Decision|16|||
105672975|NCT02336451|364464386|FG004|Overall Study|Physician Decision|3|||
105672976|NCT02336451|364464382|FG000|Overall Study|Progressive disease|23|||
105672977|NCT02336451|364464383|FG001|Overall Study|Progressive disease|26|||
105672978|NCT02336451|364464384|FG002|Overall Study|Progressive disease|2|||
105672979|NCT02336451|364464385|FG003|Overall Study|Progressive disease|14|||
105672980|NCT02336451|364464386|FG004|Overall Study|Progressive disease|4|||
105672981|NCT02336451|364464382|FG000|Overall Study|Protocol Violation|1|||
105672982|NCT02336451|364464383|FG001|Overall Study|Protocol Violation|0|||
105672983|NCT02336451|364464384|FG002|Overall Study|Protocol Violation|0|||
105672984|NCT02336451|364464385|FG003|Overall Study|Protocol Violation|0|||
105672985|NCT02336451|364464386|FG004|Overall Study|Protocol Violation|0|||
105672986|NCT02336451|364464382|FG000|Overall Study|Patient/guardian decision|2|||
105672987|NCT02336451|364464383|FG001|Overall Study|Patient/guardian decision|4|||
105672988|NCT02336451|364464384|FG002|Overall Study|Patient/guardian decision|0|||
105672989|NCT02336451|364464385|FG003|Overall Study|Patient/guardian decision|2|||
105672990|NCT02336451|364464386|FG004|Overall Study|Patient/guardian decision|1|||
105672991|NCT04372121|364464388|FG000|Overall Study|Lost to Follow-up|0|||
105672992|NCT04372121|364464389|FG001|Overall Study|Lost to Follow-up|0|||
105672993|NCT04372121|364464390|FG002|Overall Study|Lost to Follow-up|0|||
105672994|NCT04372121|364464391|FG003|Overall Study|Lost to Follow-up|1|||
105672995|NCT04372121|364464388|FG000|Overall Study|Protocol Violation|0|||
105672996|NCT04372121|364464389|FG001|Overall Study|Protocol Violation|0|||
105672997|NCT04372121|364464390|FG002|Overall Study|Protocol Violation|1|||
105672998|NCT04372121|364464391|FG003|Overall Study|Protocol Violation|0|||
105672999|NCT04372121|364464388|FG000|Overall Study|Withdrawal by Subject|3|||
105673000|NCT04372121|364464389|FG001|Overall Study|Withdrawal by Subject|1|||
105673001|NCT04372121|364464390|FG002|Overall Study|Withdrawal by Subject|0|||
105673002|NCT04372121|364464391|FG003|Overall Study|Withdrawal by Subject|0|||
105673003|NCT04372121|364464388|FG000|Overall Study|Study termination|6|||
105673004|NCT04372121|364464389|FG001|Overall Study|Study termination|5|||
105673005|NCT04372121|364464390|FG002|Overall Study|Study termination|1|||
105673006|NCT04372121|364464391|FG003|Overall Study|Study termination|1|||
105673007|NCT04372121|364464388|FG000|Overall Study|Hysterectomy planned|1|||
105673008|NCT04372121|364464389|FG001|Overall Study|Hysterectomy planned|0|||
105673009|NCT04372121|364464390|FG002|Overall Study|Hysterectomy planned|0|||
105673010|NCT04372121|364464391|FG003|Overall Study|Hysterectomy planned|0|||
105673011|NCT05618912|364464392|FG000|Overall Study|Lost to Follow-up|14|||
105673012|NCT05618912|364464393|FG001|Overall Study|Lost to Follow-up|19|||
105673013|NCT04500769|364466260|FG000|Overall Study|Withdrawal by Subject|5|||
105673014|NCT05718466|364466261|FG000|Overall Study|Withdrawal by Subject|1|||
105673015|NCT05718466|364466262|FG001|Overall Study|Withdrawal by Subject|2|||
105673016|NCT05718466|364466261|FG000|Overall Study|Death|0|||
105673017|NCT05718466|364466262|FG001|Overall Study|Death|1|||
105673018|NCT01967147|364466263|FG000|Overall Study|Adverse Event|5|||
105673019|NCT01967147|364466264|FG001|Overall Study|Adverse Event|2|||
105673020|NCT01967147|364466263|FG000|Overall Study|Lack of Efficacy|1|||
105673021|NCT01967147|364466264|FG001|Overall Study|Lack of Efficacy|4|||
105673022|NCT01967147|364466263|FG000|Overall Study|Lost to Follow-up|1|||
105673023|NCT01967147|364466264|FG001|Overall Study|Lost to Follow-up|2|||
105673024|NCT01967147|364466263|FG000|Overall Study|Withdrawal by Subject|2|||
105673025|NCT01967147|364466264|FG001|Overall Study|Withdrawal by Subject|4|||
105673026|NCT01967147|364466263|FG000|Overall Study|Non-compliance with Study Drug|0|||
105673027|NCT01967147|364466264|FG001|Overall Study|Non-compliance with Study Drug|3|||
105673028|NCT01967147|364466263|FG000|Overall Study|Other|4|||
105673029|NCT01967147|364466264|FG001|Overall Study|Other|5|||
105673030|NCT01099215|364466265|FG000|Overall Study|Withdrawal by Subject|1|||
105673031|NCT01099215|364466266|FG001|Overall Study|Withdrawal by Subject|0|||
105673032|NCT01099215|364466265|FG000|Overall Study|Adverse Event|0|||
105673033|NCT01099215|364466266|FG001|Overall Study|Adverse Event|1|||
105673034|NCT00890695|364466274|FG000|Overall Study|Protocol Violation|1|||
105673035|NCT00890695|364466275|FG001|Overall Study|Protocol Violation|0|||
105673036|NCT01253135|364466276|FG000|Original Protocol|Protocol Amendment|15|||
105673037|NCT01253135|364466276|FG000|Amended Protocol|Non-compliance|1|||
105673038|NCT03284229|364466277|FG000|Overall Study|Lost to Follow-up|3|||
105673039|NCT01901432|364466280|FG000|Overall Study|Adverse Event|0|||
105673040|NCT01901432|364466281|FG001|Overall Study|Adverse Event|1|||
105673041|NCT01901432|364466282|FG002|Overall Study|Adverse Event|1|||
105673042|NCT01901432|364466283|FG003|Overall Study|Adverse Event|0|||
105673043|NCT01901432|364466284|FG004|Overall Study|Adverse Event|1|||
105673044|NCT01901432|364466280|FG000|Overall Study|Withdrawal by Subject|0|||
105673045|NCT01901432|364466281|FG001|Overall Study|Withdrawal by Subject|0|||
105673046|NCT01901432|364466282|FG002|Overall Study|Withdrawal by Subject|1|||
105673047|NCT01901432|364466283|FG003|Overall Study|Withdrawal by Subject|0|||
105673048|NCT01901432|364466284|FG004|Overall Study|Withdrawal by Subject|5|||
105673049|NCT01901432|364466280|FG000|Overall Study|Physician Decision|0|||
105673050|NCT01901432|364466281|FG001|Overall Study|Physician Decision|0|||
105673051|NCT01901432|364466282|FG002|Overall Study|Physician Decision|0|||
105673052|NCT01901432|364466283|FG003|Overall Study|Physician Decision|0|||
105673053|NCT01901432|364466284|FG004|Overall Study|Physician Decision|2|||
105673054|NCT01901432|364466280|FG000|Overall Study|Patient decision to stop study drug|0|||
105673055|NCT01901432|364466281|FG001|Overall Study|Patient decision to stop study drug|0|||
105673056|NCT01901432|364466282|FG002|Overall Study|Patient decision to stop study drug|0|||
105673057|NCT01901432|364466283|FG003|Overall Study|Patient decision to stop study drug|0|||
105673058|NCT01901432|364466284|FG004|Overall Study|Patient decision to stop study drug|1|||
105673059|NCT01015560|364466288|FG000|Overall Study|Adverse Event|1|||
105673060|NCT01015560|364466288|FG000|Overall Study|Not protocol specified|1|||
105673061|NCT01015560|364466288|FG000|Overall Study|Withdrawal by Subject|1|||
105673062|NCT01302080|364466293|FG000|Overall Study|Withdrew Consent|92|||
105673063|NCT01302080|364466294|FG001|Overall Study|Withdrew Consent|39|||
105673064|NCT01302080|364466293|FG000|Overall Study|Patient/Family Moved|28|||
105673065|NCT01302080|364466294|FG001|Overall Study|Patient/Family Moved|3|||
105673066|NCT01302080|364466293|FG000|Overall Study|Lost to Follow-up|192|||
105673067|NCT01302080|364466294|FG001|Overall Study|Lost to Follow-up|93|||
105673068|NCT01302080|364466293|FG000|Overall Study|Death|1|||
105673069|NCT01302080|364466294|FG001|Overall Study|Death|0|||
105673070|NCT01302080|364466293|FG000|Overall Study|Other|52|||
105673071|NCT01302080|364466294|FG001|Overall Study|Other|8|||
105673072|NCT01302080|364466293|FG000|Overall Study|Reason Missing For Discontinuation|1|||
105673073|NCT01302080|364466294|FG001|Overall Study|Reason Missing For Discontinuation|0|||
105786293|NCT00948896|364870494|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
105673074|NCT00288639|364466297|FG000|Overall Study|Adverse Event|5|||
105673075|NCT00288639|364466297|FG000|Overall Study|Lack of Efficacy|4|||
105673076|NCT00288639|364466297|FG000|Overall Study|Withdrawal by Subject|2|||
105673077|NCT00288639|364466297|FG000|Overall Study|Other|1|||
105673078|NCT00264303|364466298|FG000|Overall Study|Adverse Event|4|||
105673079|NCT00264303|364466299|FG001|Overall Study|Adverse Event|3|||
105673080|NCT00264303|364466298|FG000|Overall Study|Lack of Efficacy|10|||
105673081|NCT00264303|364466299|FG001|Overall Study|Lack of Efficacy|13|||
105673082|NCT00264303|364466298|FG000|Overall Study|Lost to Follow-up|3|||
105673083|NCT00264303|364466299|FG001|Overall Study|Lost to Follow-up|3|||
105673084|NCT00264303|364466298|FG000|Overall Study|Withdrawal by Subject|2|||
105673085|NCT00264303|364466299|FG001|Overall Study|Withdrawal by Subject|3|||
105673086|NCT00264303|364466298|FG000|Overall Study|Various reasons listed in study report|6|||
105673087|NCT00264303|364466299|FG001|Overall Study|Various reasons listed in study report|7|||
105673088|NCT02389452|364466300|FG000|Overall Study|Lost to Follow-up|13|||
105673089|NCT02389452|364466300|FG000|Overall Study|Adverse Event|1|||
105673090|NCT02389452|364466300|FG000|Overall Study|Withdrawal by Subject|5|||
105673091|NCT02389452|364466300|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
105673092|NCT01076153|364466307|FG000|Overall Study|Symptoms improved/resolved|10|||
105673093|NCT01076153|364466307|FG000|Overall Study|Adverse Event|1|||
105673094|NCT00663702|364466317|FG000|Overall Study|Adverse Event|8|||
105673095|NCT00663702|364466318|FG001|Overall Study|Adverse Event|4|||
105673096|NCT00663702|364466317|FG000|Overall Study|Withdrawal by Subject|3|||
105673097|NCT00663702|364466318|FG001|Overall Study|Withdrawal by Subject|1|||
105673098|NCT00663702|364466317|FG000|Overall Study|Pregnancy|0|||
105673099|NCT00663702|364466318|FG001|Overall Study|Pregnancy|1|||
105673100|NCT00663702|364466317|FG000|Overall Study|Lost to Follow-up|3|||
105673101|NCT00663702|364466318|FG001|Overall Study|Lost to Follow-up|0|||
105673102|NCT00663702|364466317|FG000|Overall Study|Death|1|||
105673103|NCT00663702|364466318|FG001|Overall Study|Death|1|||
105673104|NCT00663702|364466317|FG000|Overall Study|Lack of Efficacy|3|||
105673105|NCT00663702|364466318|FG001|Overall Study|Lack of Efficacy|3|||
105673106|NCT00626990|364466321|FG000|Overall Study|Lack of Efficacy|6|||
105673107|NCT00626990|364466322|FG001|Overall Study|Lack of Efficacy|7|||
105673108|NCT00626990|364466323|FG002|Overall Study|Lack of Efficacy|49|||
105673109|NCT00626990|364466324|FG003|Overall Study|Lack of Efficacy|40|||
105673110|NCT00626990|364466321|FG000|Overall Study|Adverse Event|1|||
105673111|NCT00626990|364466322|FG001|Overall Study|Adverse Event|7|||
105673112|NCT00626990|364466323|FG002|Overall Study|Adverse Event|14|||
105673113|NCT00626990|364466324|FG003|Overall Study|Adverse Event|28|||
105673114|NCT00626990|364466321|FG000|Overall Study|Death|0|||
105673115|NCT00626990|364466322|FG001|Overall Study|Death|1|||
105673116|NCT00626990|364466323|FG002|Overall Study|Death|0|||
105673117|NCT00626990|364466324|FG003|Overall Study|Death|0|||
105673118|NCT00626990|364466321|FG000|Overall Study|Withdrawal by Subject|3|||
105673119|NCT00626990|364466322|FG001|Overall Study|Withdrawal by Subject|1|||
105673120|NCT00626990|364466323|FG002|Overall Study|Withdrawal by Subject|5|||
105673121|NCT00626990|364466324|FG003|Overall Study|Withdrawal by Subject|11|||
105673122|NCT00626990|364466321|FG000|Overall Study|Protocol Violation|0|||
105673123|NCT00626990|364466322|FG001|Overall Study|Protocol Violation|1|||
105673124|NCT00626990|364466323|FG002|Overall Study|Protocol Violation|1|||
105673125|NCT00626990|364466324|FG003|Overall Study|Protocol Violation|0|||
105342689|NCT02998476|363256734|FG000|Overall Study|Lost to Follow-up|1|||
105673126|NCT00626990|364466321|FG000|Overall Study|Various different reasons/missing|4|||
105673127|NCT00626990|364466322|FG001|Overall Study|Various different reasons/missing|8|||
105673128|NCT00626990|364466323|FG002|Overall Study|Various different reasons/missing|8|||
105673129|NCT00626990|364466324|FG003|Overall Study|Various different reasons/missing|16|||
105673130|NCT04138576|364466329|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
105673131|NCT00297427|364466332|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
105673132|NCT00297427|364466333|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
105673133|NCT00297427|364466332|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
105673134|NCT00297427|364466333|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
105673135|NCT00297427|364466332|FG000|Phase 1: Initial Intervention|Death|0|||
105673136|NCT00297427|364466333|FG001|Phase 1: Initial Intervention|Death|1|||
105673137|NCT00297427|364466332|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
105673138|NCT00297427|364466333|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
105673139|NCT00297427|364466332|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
105673140|NCT00297427|364466333|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
105673141|NCT00297427|364466332|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
105673142|NCT00297427|364466333|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
105673143|NCT00297427|364466332|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
105673144|NCT00297427|364466333|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
105673145|NCT00297427|364466332|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
105673146|NCT00297427|364466333|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
105673147|NCT02898077|364466338|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
105673148|NCT02898077|364466339|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
105673149|NCT02898077|364466338|FG000|Overall Study|Lost to Follow-up|4|||
105673150|NCT02898077|364466339|FG001|Overall Study|Lost to Follow-up|3|||
105673151|NCT02898077|364466338|FG000|Overall Study|Physician Decision|0|||
105673152|NCT02898077|364466339|FG001|Overall Study|Physician Decision|2|||
105673153|NCT02898077|364466338|FG000|Overall Study|Sponsor Decision|32|||
105673154|NCT02898077|364466339|FG001|Overall Study|Sponsor Decision|13|||
105673155|NCT02898077|364466338|FG000|Overall Study|Withdrawal by Subject|6|||
105673156|NCT02898077|364466339|FG001|Overall Study|Withdrawal by Subject|3|||
105673157|NCT02898077|364466338|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
105673158|NCT02898077|364466339|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
105673159|NCT02898077|364466338|FG000|Overall Study|Ended extension period|3|||
105673160|NCT02898077|364466339|FG001|Overall Study|Ended extension period|0|||
105673161|NCT02643303|364466341|FG000|Overall Study|Progressive Disease|4|||
105673162|NCT02643303|364466342|FG001|Overall Study|Progressive Disease|4|||
105673163|NCT02643303|364466343|FG002|Overall Study|Progressive Disease|1|||
105673164|NCT02643303|364466344|FG003|Overall Study|Progressive Disease|12|||
105673165|NCT02643303|364466345|FG004|Overall Study|Progressive Disease|6|||
105673166|NCT02643303|364466346|FG005|Overall Study|Progressive Disease|4|||
105673167|NCT02643303|364466347|FG006|Overall Study|Progressive Disease|8|||
105673168|NCT02643303|364466348|FG007|Overall Study|Progressive Disease|2|||
105673169|NCT02643303|364466349|FG008|Overall Study|Progressive Disease|6|||
105673170|NCT02643303|364466341|FG000|Overall Study|Adverse Event|0|||
105673171|NCT02643303|364466342|FG001|Overall Study|Adverse Event|1|||
105673172|NCT02643303|364466343|FG002|Overall Study|Adverse Event|0|||
105673173|NCT02643303|364466344|FG003|Overall Study|Adverse Event|0|||
105673174|NCT02643303|364466345|FG004|Overall Study|Adverse Event|1|||
105673175|NCT02643303|364466346|FG005|Overall Study|Adverse Event|0|||
105673176|NCT02643303|364466347|FG006|Overall Study|Adverse Event|0|||
105673177|NCT02643303|364466348|FG007|Overall Study|Adverse Event|0|||
105673178|NCT02643303|364466349|FG008|Overall Study|Adverse Event|0|||
105673179|NCT02643303|364466341|FG000|Overall Study|Withdrawal by Subject|0|||
105673180|NCT02643303|364466342|FG001|Overall Study|Withdrawal by Subject|0|||
105673181|NCT02643303|364466343|FG002|Overall Study|Withdrawal by Subject|0|||
105673182|NCT02643303|364466344|FG003|Overall Study|Withdrawal by Subject|1|||
105673183|NCT02643303|364466345|FG004|Overall Study|Withdrawal by Subject|0|||
105673184|NCT02643303|364466346|FG005|Overall Study|Withdrawal by Subject|0|||
105673185|NCT02643303|364466347|FG006|Overall Study|Withdrawal by Subject|1|||
105673186|NCT02643303|364466348|FG007|Overall Study|Withdrawal by Subject|1|||
105673187|NCT02643303|364466349|FG008|Overall Study|Withdrawal by Subject|1|||
105673188|NCT00132873|364466353|FG000|Overall Study|Adverse Event|3|||
105673189|NCT00132873|364466353|FG000|Overall Study|Lost to Follow-up|1|||
105673190|NCT00132873|364466353|FG000|Overall Study|Lack of Efficacy|1|||
105673191|NCT00132873|364466353|FG000|Overall Study|Withdrawal by Subject|3|||
105673192|NCT00132873|364466353|FG000|Overall Study|Planned Pregnancy|1|||
105673193|NCT00283244|364466356|FG000|Overall Study|Adverse Event|0|||
105673194|NCT00283244|364466357|FG001|Overall Study|Adverse Event|8|||
105673195|NCT00283244|364466358|FG002|Overall Study|Adverse Event|11|||
105673196|NCT00283244|364466356|FG000|Overall Study|Death|4|||
105673197|NCT00283244|364466357|FG001|Overall Study|Death|3|||
105673198|NCT00283244|364466358|FG002|Overall Study|Death|2|||
105673199|NCT00283244|364466356|FG000|Overall Study|Lack of Efficacy|8|||
105673200|NCT00283244|364466357|FG001|Overall Study|Lack of Efficacy|32|||
105673201|NCT00283244|364466358|FG002|Overall Study|Lack of Efficacy|26|||
105673202|NCT00283244|364466356|FG000|Overall Study|Withdrawal by Subject|1|||
105673203|NCT00283244|364466357|FG001|Overall Study|Withdrawal by Subject|2|||
105673204|NCT00283244|364466358|FG002|Overall Study|Withdrawal by Subject|2|||
105673205|NCT00283244|364466356|FG000|Overall Study|Physician Decision|0|||
105673206|NCT00283244|364466357|FG001|Overall Study|Physician Decision|0|||
105673207|NCT00283244|364466358|FG002|Overall Study|Physician Decision|1|||
105786294|NCT00948896|364870495|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
105673208|NCT00283244|364466356|FG000|Overall Study|Medical illness (other complicating dz)|4|||
105673209|NCT00283244|364466357|FG001|Overall Study|Medical illness (other complicating dz)|3|||
105673210|NCT00283244|364466358|FG002|Overall Study|Medical illness (other complicating dz)|6|||
105673211|NCT00283244|364466356|FG000|Overall Study|Clinical deterioration|1|||
105673212|NCT00283244|364466357|FG001|Overall Study|Clinical deterioration|3|||
105673213|NCT00283244|364466358|FG002|Overall Study|Clinical deterioration|3|||
105673214|NCT02145468|364466359|FG000|Overall Study|Withdrawal by Subject|5|||
105673215|NCT02145468|364466360|FG001|Overall Study|Withdrawal by Subject|8|||
105673216|NCT00586612|364466361|FG000|Primary Phase|Protocol Violation|1|||
105673217|NCT00586612|364466362|FG001|Primary Phase|Protocol Violation|0|||
105673218|NCT00586612|364466361|FG000|Primary Phase|Lost to Follow-up|0|||
105673219|NCT00586612|364466362|FG001|Primary Phase|Lost to Follow-up|1|||
105673220|NCT00586612|364466361|FG000|Primary Phase|Withdrawal by Subject|0|||
105673221|NCT00586612|364466362|FG001|Primary Phase|Withdrawal by Subject|2|||
105673222|NCT00586612|364466361|FG000|Booster Phase|Lost to Follow-up|3|||
105673223|NCT00586612|364466362|FG001|Booster Phase|Lost to Follow-up|1|||
105673224|NCT02001064|364466363|FG000|Overall Study|Withdrawal by Subject|2|||
105673225|NCT02001064|364466364|FG001|Overall Study|Withdrawal by Subject|1|||
105673226|NCT01609062|364466367|FG000|Extension Phase|Terminated by Sponsor|14|||
105673227|NCT01609062|364466368|FG001|Extension Phase|Terminated by Sponsor|9|||
105673228|NCT01609062|364466367|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
105673229|NCT01609062|364466368|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
105673230|NCT01609062|364466367|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
105673231|NCT01609062|364466368|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
105673232|NCT02738853|364466369|FG000|Enrollment|Inclusion/Exclusion not met|21|||
105673233|NCT02738853|364466369|FG000|Enrollment|Withdrawal by Subject|3|||
105673234|NCT02738853|364466369|FG000|Enrollment|Subject treated with commercially available device|6|||
105673235|NCT02738853|364466369|FG000|Enrollment|Study Enrollment Closed|3|||
105673236|NCT02738853|364466369|FG000|Procedure|Death|1|||
105673237|NCT02738853|364466369|FG000|1 Month|Death|2|||
105673238|NCT02738853|364466369|FG000|6 Month|Death|4|||
105673239|NCT02738853|364466369|FG000|6 Month|Withdrawal by Subject|2|||
105673240|NCT02738853|364466369|FG000|1 Year|Death|6|||
105673241|NCT02738853|364466369|FG000|1 Year|Withdrawal by Subject|1|||
105673242|NCT02738853|364466369|FG000|2 Year|Death|2|||
105673243|NCT02738853|364466369|FG000|2 Year|Lost to Follow-up|1|||
105673244|NCT02738853|364466369|FG000|3 Year|Death|2|||
105673245|NCT02738853|364466369|FG000|3 Year|Withdrawal by Subject|1|||
105673246|NCT02738853|364466369|FG000|4 Year|Death|9|||
105673247|NCT02738853|364466369|FG000|5 Year|Lost to Follow-up|4|||
105673248|NCT01585155|364466370|FG000|Overall Study|Adverse Event|1|||
105673249|NCT01585155|364466370|FG000|Overall Study|Lack of Efficacy|2|||
105673250|NCT01585155|364466370|FG000|Overall Study|Worsening ulcerative colitis|2|||
105673251|NCT01468181|364466371|FG000|Overall Study|Adverse Event|8|||
105673252|NCT01468181|364466372|FG001|Overall Study|Adverse Event|1|||
105673253|NCT01468181|364466373|FG002|Overall Study|Adverse Event|6|||
105673254|NCT01468181|364466374|FG003|Overall Study|Adverse Event|2|||
105673255|NCT01468181|364466375|FG004|Overall Study|Adverse Event|2|||
105673256|NCT01468181|364466371|FG000|Overall Study|Protocol Violation|2|||
105673257|NCT01468181|364466372|FG001|Overall Study|Protocol Violation|0|||
105673258|NCT01468181|364466373|FG002|Overall Study|Protocol Violation|1|||
105673259|NCT01468181|364466374|FG003|Overall Study|Protocol Violation|0|||
105673260|NCT01468181|364466375|FG004|Overall Study|Protocol Violation|1|||
105673261|NCT01468181|364466371|FG000|Overall Study|Physician Decision|0|||
105673262|NCT01468181|364466372|FG001|Overall Study|Physician Decision|0|||
105673263|NCT01468181|364466373|FG002|Overall Study|Physician Decision|0|||
105673264|NCT01468181|364466374|FG003|Overall Study|Physician Decision|1|||
105786295|NCT00948896|364870488|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
105786296|NCT00948896|364870489|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
105786297|NCT00948896|364870490|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
105786298|NCT00948896|364870491|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
105786299|NCT00948896|364870492|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
105786300|NCT00948896|364870493|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
105673265|NCT01468181|364466375|FG004|Overall Study|Physician Decision|1|||
105673266|NCT01468181|364466371|FG000|Overall Study|Lost to Follow-up|0|||
105673267|NCT01468181|364466372|FG001|Overall Study|Lost to Follow-up|0|||
105673268|NCT01468181|364466373|FG002|Overall Study|Lost to Follow-up|1|||
105673269|NCT01468181|364466374|FG003|Overall Study|Lost to Follow-up|0|||
105673270|NCT01468181|364466375|FG004|Overall Study|Lost to Follow-up|1|||
105673271|NCT01468181|364466371|FG000|Overall Study|Withdrawal by Subject|0|||
105673272|NCT01468181|364466372|FG001|Overall Study|Withdrawal by Subject|1|||
105673273|NCT01468181|364466373|FG002|Overall Study|Withdrawal by Subject|0|||
105673274|NCT01468181|364466374|FG003|Overall Study|Withdrawal by Subject|0|||
105673275|NCT01468181|364466375|FG004|Overall Study|Withdrawal by Subject|0|||
105673276|NCT00545753|364466376|FG000|Overall Study|Withdrawal by Subject|0|||
105673277|NCT00545753|364466377|FG001|Overall Study|Withdrawal by Subject|1|||
105673278|NCT00545753|364466378|FG002|Overall Study|Withdrawal by Subject|10|||
105673279|NCT00545753|364466376|FG000|Overall Study|Lost to Follow-up|13|||
105673280|NCT00545753|364466377|FG001|Overall Study|Lost to Follow-up|3|||
105673281|NCT00545753|364466378|FG002|Overall Study|Lost to Follow-up|12|||
105673282|NCT00545753|364466376|FG000|Overall Study|Protocol Violation|3|||
105673283|NCT00545753|364466377|FG001|Overall Study|Protocol Violation|1|||
105673284|NCT00545753|364466378|FG002|Overall Study|Protocol Violation|4|||
105673285|NCT03772587|364466379|FG000|Overall Study|COVID-19|0|||
105673286|NCT03772587|364466380|FG001|Overall Study|COVID-19|0|||
105673287|NCT03772587|364466381|FG002|Overall Study|COVID-19|1|||
105673288|NCT03772587|364466382|FG003|Overall Study|COVID-19|1|||
105673289|NCT03772587|364466383|FG004|Overall Study|COVID-19|0|||
105673290|NCT03772587|364466379|FG000|Overall Study|Withdrawal by Subject|1|||
105673291|NCT03772587|364466380|FG001|Overall Study|Withdrawal by Subject|0|||
105673292|NCT03772587|364466381|FG002|Overall Study|Withdrawal by Subject|0|||
105673293|NCT03772587|364466382|FG003|Overall Study|Withdrawal by Subject|0|||
105673294|NCT03772587|364466383|FG004|Overall Study|Withdrawal by Subject|0|||
105673295|NCT00513305|364466384|FG000|Overall Study|Adverse Event|6|||
105673296|NCT00513305|364466385|FG001|Overall Study|Adverse Event|2|||
105673297|NCT00513305|364466384|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
105673298|NCT00513305|364466385|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
105673299|NCT00513305|364466384|FG000|Overall Study|Lack of Efficacy|8|||
105673300|NCT00513305|364466385|FG001|Overall Study|Lack of Efficacy|13|||
105673301|NCT00513305|364466384|FG000|Overall Study|Withdrawal by Subject|1|||
105673302|NCT00513305|364466385|FG001|Overall Study|Withdrawal by Subject|2|||
105673303|NCT00513305|364466384|FG000|Overall Study|Disease progression|8|||
105673304|NCT00513305|364466385|FG001|Overall Study|Disease progression|5|||
105673305|NCT00513305|364466384|FG000|Overall Study|Eligible for stem cell transplant|1|||
105673306|NCT00513305|364466385|FG001|Overall Study|Eligible for stem cell transplant|0|||
105673307|NCT00513305|364466384|FG000|Overall Study|Hematologic counts did not recover|1|||
105673308|NCT00513305|364466385|FG001|Overall Study|Hematologic counts did not recover|0|||
105673309|NCT00513305|364466384|FG000|Overall Study|Physician Decision|1|||
105673310|NCT00513305|364466385|FG001|Overall Study|Physician Decision|0|||
105673311|NCT00513305|364466384|FG000|Overall Study|Persistent hypocellularity|0|||
105673312|NCT00513305|364466385|FG001|Overall Study|Persistent hypocellularity|1|||
105673313|NCT00513305|364466384|FG000|Overall Study|Sponsor Decision|0|||
105673314|NCT00513305|364466385|FG001|Overall Study|Sponsor Decision|2|||
105673315|NCT05384938|364466392|FG000|Overall Study|Withdrawal by Subject|8|||
105673316|NCT05384938|364466392|FG000|Overall Study|Lost to Follow-up|6|||
105673317|NCT05384938|364466392|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
105673318|NCT03798691|364466396|FG000|Overall Study|Lost to Follow-up|2|||
105673319|NCT03798691|364466397|FG001|Overall Study|Lost to Follow-up|2|||
105673320|NCT00552929|364466398|FG000|Overall Study|Lost to Follow-up|0|||
105673321|NCT00552929|364466399|FG001|Overall Study|Lost to Follow-up|0|||
105673322|NCT00552929|364466400|FG002|Overall Study|Lost to Follow-up|0|||
105673323|NCT00552929|364466401|FG003|Overall Study|Lost to Follow-up|0|||
105673324|NCT00552929|364466402|FG004|Overall Study|Lost to Follow-up|0|||
105673325|NCT00552929|364466403|FG005|Overall Study|Lost to Follow-up|0|||
105673326|NCT00552929|364466404|FG006|Overall Study|Lost to Follow-up|0|||
105673327|NCT00552929|364466405|FG007|Overall Study|Lost to Follow-up|0|||
105673328|NCT00552929|364466406|FG008|Overall Study|Lost to Follow-up|1|||
105673329|NCT00552929|364466407|FG009|Overall Study|Lost to Follow-up|0|||
105673330|NCT00552929|364466398|FG000|Overall Study|Not Eligible|0|||
105673331|NCT00552929|364466399|FG001|Overall Study|Not Eligible|0|||
105673332|NCT00552929|364466400|FG002|Overall Study|Not Eligible|0|||
105673333|NCT00552929|364466401|FG003|Overall Study|Not Eligible|0|||
105673334|NCT00552929|364466402|FG004|Overall Study|Not Eligible|0|||
105673335|NCT00552929|364466403|FG005|Overall Study|Not Eligible|1|||
105786301|NCT00948896|364870494|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
105786302|NCT00948896|364870495|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
105673336|NCT00552929|364466404|FG006|Overall Study|Not Eligible|0|||
105673337|NCT00552929|364466405|FG007|Overall Study|Not Eligible|0|||
105673338|NCT00552929|364466406|FG008|Overall Study|Not Eligible|0|||
105673339|NCT00552929|364466407|FG009|Overall Study|Not Eligible|0|||
105786303|NCT00948896|364870488|FG000|24 Months of Age to 36 Months of Age|Death|0|||
105673340|NCT04577001|364466411|FG000|Overall Study|Subject became ineligible|0|||
105673341|NCT04577001|364466412|FG001|Overall Study|Subject became ineligible|1|||
105673342|NCT01593787|364466413|FG000|Overall Study|Adverse Event|1|||
105673343|NCT01593787|364466414|FG001|Overall Study|Adverse Event|0|||
105673344|NCT01593787|364466415|FG002|Overall Study|Adverse Event|0|||
105673345|NCT01865747|364466416|FG000|Overall Study (ITT)|Adverse Event|32|||
105673346|NCT01865747|364466417|FG001|Overall Study (ITT)|Adverse Event|31|||
105554960|NCT03152552|364027497|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105554961|NCT03152552|364027498|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105554962|NCT03152552|364027494|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
105554963|NCT03152552|364027495|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
105554964|NCT03152552|364027496|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
105554965|NCT03152552|364027497|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
105554966|NCT03152552|364027498|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
105554967|NCT03152552|364027494|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
105554968|NCT03152552|364027495|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
105554969|NCT03152552|364027496|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
105554970|NCT03152552|364027497|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
105554971|NCT03152552|364027498|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
105554972|NCT03152552|364027494|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
105554973|NCT03152552|364027495|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
105554974|NCT03152552|364027496|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
105554975|NCT03152552|364027497|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
105786304|NCT00948896|364870489|FG001|24 Months of Age to 36 Months of Age|Death|2|||
105786305|NCT00948896|364870490|FG002|24 Months of Age to 36 Months of Age|Death|2|||
105342690|NCT02998476|363256735|FG001|Overall Study|Lost to Follow-up|0|||
105342691|NCT02998476|363256734|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
105342692|NCT02998476|363256735|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
105342693|NCT02998476|363256734|FG000|Overall Study|Withdrawal by Subject|1|||
105342694|NCT02998476|363256735|FG001|Overall Study|Withdrawal by Subject|2|||
105342695|NCT02998476|363256734|FG000|Overall Study|Death|45|||
105342696|NCT02998476|363256735|FG001|Overall Study|Death|2|||
105342697|NCT02998476|363256734|FG000|Overall Study|Other|6|||
105342698|NCT02998476|363256735|FG001|Overall Study|Other|1|||
105342699|NCT00986986|363256736|FG000|Overall Study|Lost to Follow-up|0|||
105342700|NCT00986986|363256737|FG001|Overall Study|Lost to Follow-up|1|||
105342701|NCT01542034|363256741|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
105342702|NCT01542034|363256742|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
105342703|NCT01542034|363256741|FG000|Overall Study|Administrative decision|0|||
105342704|NCT01542034|363256742|FG001|Overall Study|Administrative decision|3|||
105342705|NCT01542034|363256741|FG000|Overall Study|Subject Noncompliance|1|||
105342706|NCT01542034|363256742|FG001|Overall Study|Subject Noncompliance|0|||
105342707|NCT01542034|363256741|FG000|Overall Study|Adverse Event|2|||
105342708|NCT01542034|363256742|FG001|Overall Study|Adverse Event|2|||
105342709|NCT01542034|363256741|FG000|Overall Study|Lost to Follow-up|7|||
105342710|NCT01542034|363256742|FG001|Overall Study|Lost to Follow-up|6|||
105342711|NCT00478699|363256743|FG000|Overall Study|Inclusion Error|1|||
105342712|NCT00478699|363256744|FG001|Overall Study|Inclusion Error|7|||
105342713|NCT00478699|363256743|FG000|Overall Study|Not receive study treatment|6|||
105342714|NCT00478699|363256744|FG001|Overall Study|Not receive study treatment|30|||
105342715|NCT01801280|363256746|FG000|Period 1|Withdrawal by Subject|0|||
105342716|NCT01801280|363256747|FG001|Period 1|Withdrawal by Subject|1|||
105342717|NCT01801280|363256748|FG002|Period 1|Withdrawal by Subject|0|||
105342718|NCT01801280|363256749|FG003|Period 1|Withdrawal by Subject|0|||
105342719|NCT01801280|363256746|FG000|Period 2|Withdrawal by Subject|1|||
105342720|NCT01801280|363256747|FG001|Period 2|Withdrawal by Subject|0|||
105342721|NCT01801280|363256748|FG002|Period 2|Withdrawal by Subject|0|||
105342722|NCT01801280|363256749|FG003|Period 2|Withdrawal by Subject|0|||
105342723|NCT01801280|363256746|FG000|Period 4|Protocol Violation|0|||
105342724|NCT01801280|363256747|FG001|Period 4|Protocol Violation|0|||
105342725|NCT01801280|363256748|FG002|Period 4|Protocol Violation|1|||
105342726|NCT01801280|363256749|FG003|Period 4|Protocol Violation|0|||
105342727|NCT00176644|363256750|FG000|Overall Study|Withdrawal by Subject|1|||
105342728|NCT02783729|363256751|FG000|Overall Study|Lack of Efficacy|1|||
105342729|NCT02783729|363256752|FG001|Overall Study|Lack of Efficacy|0|||
105342730|NCT02783729|363256753|FG002|Overall Study|Lack of Efficacy|0|||
105342731|NCT02783729|363256754|FG003|Overall Study|Lack of Efficacy|0|||
105342732|NCT02783729|363256751|FG000|Overall Study|Adverse Event|2|||
105342733|NCT02783729|363256752|FG001|Overall Study|Adverse Event|6|||
105342734|NCT02783729|363256753|FG002|Overall Study|Adverse Event|2|||
105342735|NCT02783729|363256754|FG003|Overall Study|Adverse Event|3|||
105342736|NCT02783729|363256751|FG000|Overall Study|Other|1|||
105342737|NCT02783729|363256752|FG001|Overall Study|Other|6|||
105342738|NCT02783729|363256753|FG002|Overall Study|Other|2|||
105554976|NCT03152552|364027498|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
105554977|NCT04899349|364027499|FG000|Overall Study|Study terminated by Sponsor|2|||
105554978|NCT04899349|364027500|FG001|Overall Study|Study terminated by Sponsor|0|||
105554979|NCT00617344|364027504|FG000|Overall Study|Serious adverse event|1|||
105554980|NCT00617344|364027505|FG001|Overall Study|Serious adverse event|0|||
105554981|NCT00617344|364027506|FG002|Overall Study|Serious adverse event|0|||
105554982|NCT00617344|364027504|FG000|Overall Study|Other Adverse Event|1|||
105554983|NCT00617344|364027505|FG001|Overall Study|Other Adverse Event|1|||
105554984|NCT00617344|364027506|FG002|Overall Study|Other Adverse Event|0|||
105554985|NCT00617344|364027504|FG000|Overall Study|Protocol Violation|10|||
105554986|NCT00617344|364027505|FG001|Overall Study|Protocol Violation|8|||
105554987|NCT00617344|364027506|FG002|Overall Study|Protocol Violation|5|||
105554988|NCT00617344|364027504|FG000|Overall Study|Lost to Follow-up|5|||
105554989|NCT00617344|364027505|FG001|Overall Study|Lost to Follow-up|4|||
105554990|NCT00617344|364027506|FG002|Overall Study|Lost to Follow-up|1|||
105342739|NCT02783729|363256754|FG003|Overall Study|Other|3|||
105342740|NCT02783729|363256751|FG000|Overall Study|Withdrawal by Subject|2|||
105342741|NCT02783729|363256752|FG001|Overall Study|Withdrawal by Subject|3|||
105342742|NCT02783729|363256753|FG002|Overall Study|Withdrawal by Subject|1|||
105342743|NCT02783729|363256754|FG003|Overall Study|Withdrawal by Subject|2|||
105342744|NCT02783729|363256751|FG000|Overall Study|Participant's choice|2|||
105342745|NCT02783729|363256752|FG001|Overall Study|Participant's choice|1|||
105342746|NCT02783729|363256753|FG002|Overall Study|Participant's choice|2|||
105554991|NCT00617344|364027504|FG000|Overall Study|Withdrawal by Subject|8|||
105554992|NCT00617344|364027505|FG001|Overall Study|Withdrawal by Subject|9|||
105554993|NCT00617344|364027506|FG002|Overall Study|Withdrawal by Subject|2|||
105554994|NCT00679939|364027507|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
105554995|NCT00679939|364027508|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
105554996|NCT00679939|364027507|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
105342747|NCT02783729|363256754|FG003|Overall Study|Participant's choice|1|||
105673347|NCT01865747|364466416|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
105673348|NCT01865747|364466417|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
105673349|NCT01865747|364466416|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
105673350|NCT01865747|364466417|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
105673351|NCT01865747|364466416|FG000|Overall Study (ITT)|Protocol Violation|1|||
105673352|NCT01865747|364466417|FG001|Overall Study (ITT)|Protocol Violation|1|||
105673353|NCT01865747|364466416|FG000|Overall Study (ITT)|Physician Decision|5|||
105673354|NCT01865747|364466417|FG001|Overall Study (ITT)|Physician Decision|2|||
105673355|NCT01865747|364466416|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
105673356|NCT01865747|364466417|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
105673357|NCT01865747|364466416|FG000|Overall Study (ITT)|Sponsor Decision|0|||
105673358|NCT01865747|364466417|FG001|Overall Study (ITT)|Sponsor Decision|1|||
105673359|NCT01865747|364466416|FG000|Overall Study (ITT)|Progressive Disease|122|||
105673360|NCT01865747|364466417|FG001|Overall Study (ITT)|Progressive Disease|158|||
105673361|NCT01865747|364466416|FG000|Overall Study (ITT)|Reason Not Provided|0|||
105673362|NCT01865747|364466417|FG001|Overall Study (ITT)|Reason Not Provided|1|||
105673363|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
105673364|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
105673365|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
105673366|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
105673367|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
105673368|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
105673369|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
105673370|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
105673371|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
105673372|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
105673373|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
105673374|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
105673375|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
105673376|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
105673377|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Other|0|||
105673378|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Other|1|||
105673379|NCT01732822|364468223|FG000|Overall Study|Withdrawal by Subject|123|||
105673380|NCT01732822|364468224|FG001|Overall Study|Withdrawal by Subject|113|||
105673381|NCT03002220|364468228|FG000|Overall Study|Lack of Efficacy|2|||
105673382|NCT03002220|364468228|FG000|Overall Study|Withdrawal by Subject|3|||
105673383|NCT03002220|364468228|FG000|Overall Study|Adverse Event|2|||
105673384|NCT03002220|364468228|FG000|Overall Study|Disease progression|13|||
105673385|NCT03002220|364468228|FG000|Overall Study|Physician Decision|1|||
105673386|NCT01183260|364468229|FG000|Overall Study|Intraop screen failure|2|||
105673387|NCT01183260|364468230|FG001|Overall Study|Intraop screen failure|0|||
105673388|NCT01183260|364468229|FG000|Overall Study|Withdrawal by Subject|1|||
105673389|NCT01183260|364468230|FG001|Overall Study|Withdrawal by Subject|1|||
105673390|NCT01183260|364468229|FG000|Overall Study|Revised within 30 days|0|||
105673391|NCT01183260|364468230|FG001|Overall Study|Revised within 30 days|1|||
105673392|NCT01183260|364468229|FG000|Overall Study|Death|1|||
105673393|NCT01183260|364468230|FG001|Overall Study|Death|0|||
105673394|NCT00357110|364468233|FG000|Overall Study|Early study termination|5|||
105673395|NCT00357110|364468234|FG001|Overall Study|Early study termination|5|||
105673396|NCT01202903|364468236|FG000|Overall Study|Administrative Probelms|1|||
105673397|NCT01202903|364468237|FG001|Overall Study|Administrative Probelms|4|||
105673398|NCT01202903|364468236|FG000|Overall Study|Protocol Violation|0|||
105673399|NCT01202903|364468237|FG001|Overall Study|Protocol Violation|1|||
105673400|NCT01202903|364468236|FG000|Overall Study|Death|1|||
105673401|NCT01202903|364468237|FG001|Overall Study|Death|0|||
105673402|NCT01202903|364468236|FG000|Overall Study|Lost to Follow-up|1|||
105673403|NCT01202903|364468237|FG001|Overall Study|Lost to Follow-up|1|||
105673404|NCT01202903|364468236|FG000|Overall Study|Lack of Efficacy|1|||
105673405|NCT01202903|364468237|FG001|Overall Study|Lack of Efficacy|3|||
105673406|NCT01202903|364468236|FG000|Overall Study|Adverse Event|3|||
105673407|NCT01202903|364468237|FG001|Overall Study|Adverse Event|3|||
105673408|NCT01202903|364468236|FG000|Overall Study|Withdrawal by Subject|4|||
105673409|NCT01202903|364468237|FG001|Overall Study|Withdrawal by Subject|4|||
105673410|NCT01255631|364468239|FG000|Overall Study|poor enrollment, no data analyzed|9|||
105673411|NCT01255631|364468240|FG001|Overall Study|poor enrollment, no data analyzed|6|||
105673412|NCT00568178|364468250|FG000|Double Blind Base Study|Adverse Event|0|||
105673413|NCT00568178|364468251|FG001|Double Blind Base Study|Adverse Event|2|||
105673414|NCT00568178|364468252|FG002|Double Blind Base Study|Adverse Event|1|||
105673415|NCT00568178|364468253|FG003|Double Blind Base Study|Adverse Event|2|||
105673416|NCT00568178|364468254|FG004|Double Blind Base Study|Adverse Event|0|||
105673417|NCT00568178|364468255|FG005|Double Blind Base Study|Adverse Event|0|||
105673418|NCT00568178|364468250|FG000|Double Blind Base Study|Lost to Follow-up|1|||
105673419|NCT00568178|364468251|FG001|Double Blind Base Study|Lost to Follow-up|0|||
105673420|NCT00568178|364468252|FG002|Double Blind Base Study|Lost to Follow-up|0|||
105673421|NCT00568178|364468253|FG003|Double Blind Base Study|Lost to Follow-up|1|||
105673422|NCT00568178|364468254|FG004|Double Blind Base Study|Lost to Follow-up|0|||
105673423|NCT00568178|364468255|FG005|Double Blind Base Study|Lost to Follow-up|0|||
105673424|NCT00568178|364468250|FG000|Double Blind Base Study|Physician Decision|1|||
105673425|NCT00568178|364468251|FG001|Double Blind Base Study|Physician Decision|1|||
105673426|NCT00568178|364468252|FG002|Double Blind Base Study|Physician Decision|0|||
105673427|NCT00568178|364468253|FG003|Double Blind Base Study|Physician Decision|1|||
105673428|NCT00568178|364468254|FG004|Double Blind Base Study|Physician Decision|0|||
105673429|NCT00568178|364468255|FG005|Double Blind Base Study|Physician Decision|0|||
105673430|NCT00568178|364468250|FG000|Double Blind Base Study|Protocol Violation|3|||
105673431|NCT00568178|364468251|FG001|Double Blind Base Study|Protocol Violation|2|||
105673432|NCT00568178|364468252|FG002|Double Blind Base Study|Protocol Violation|0|||
105342748|NCT02783729|363256751|FG000|Overall Study|Lost to Follow-up|2|||
105342749|NCT02783729|363256752|FG001|Overall Study|Lost to Follow-up|1|||
105342750|NCT02783729|363256753|FG002|Overall Study|Lost to Follow-up|1|||
105342751|NCT02783729|363256754|FG003|Overall Study|Lost to Follow-up|0|||
105342752|NCT03589326|363256755|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
105342753|NCT03589326|363256756|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
105342754|NCT03589326|363256755|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
105342755|NCT03589326|363256756|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
105342756|NCT03589326|363256755|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
105342757|NCT03589326|363256756|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
105342758|NCT03589326|363256755|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
105342759|NCT03589326|363256756|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
105342760|NCT03589326|363256755|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
105342761|NCT03589326|363256756|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
105342762|NCT02693171|363256757|FG000|Overall Study|Adverse Event|1|||
105342763|NCT02693171|363256757|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
105342764|NCT00435487|363256758|FG000|Overall Study|Death|3|||
105342765|NCT00435487|363256759|FG001|Overall Study|Death|4|||
105342766|NCT00435487|363256758|FG000|Overall Study|Adverse Event|0|||
105342767|NCT00435487|363256759|FG001|Overall Study|Adverse Event|3|||
105342768|NCT00435487|363256758|FG000|Overall Study|Lost to Follow-up|2|||
105342769|NCT00435487|363256759|FG001|Overall Study|Lost to Follow-up|2|||
105342770|NCT00435487|363256758|FG000|Overall Study|Other|5|||
105673433|NCT00568178|364468253|FG003|Double Blind Base Study|Protocol Violation|0|||
105673434|NCT00568178|364468254|FG004|Double Blind Base Study|Protocol Violation|0|||
105673435|NCT00568178|364468255|FG005|Double Blind Base Study|Protocol Violation|0|||
105673436|NCT00568178|364468250|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
105673437|NCT00568178|364468251|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
105673438|NCT00568178|364468252|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
105673439|NCT00568178|364468253|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
105673440|NCT00568178|364468254|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
105673441|NCT00568178|364468255|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
105673442|NCT00568178|364468250|FG000|Double Blind Base Study|Progressive Disease|0|||
105673443|NCT00568178|364468251|FG001|Double Blind Base Study|Progressive Disease|0|||
105673444|NCT00568178|364468252|FG002|Double Blind Base Study|Progressive Disease|0|||
105673445|NCT00568178|364468253|FG003|Double Blind Base Study|Progressive Disease|1|||
105673446|NCT00568178|364468254|FG004|Double Blind Base Study|Progressive Disease|0|||
105673447|NCT00568178|364468255|FG005|Double Blind Base Study|Progressive Disease|0|||
105673448|NCT00568178|364468250|FG000|Open Label Extension|Adverse Event|0|||
105673449|NCT00568178|364468251|FG001|Open Label Extension|Adverse Event|0|||
105673450|NCT00568178|364468252|FG002|Open Label Extension|Adverse Event|0|||
105673451|NCT00568178|364468253|FG003|Open Label Extension|Adverse Event|0|||
105673452|NCT00568178|364468254|FG004|Open Label Extension|Adverse Event|11|||
105673453|NCT00568178|364468255|FG005|Open Label Extension|Adverse Event|8|||
105673454|NCT00568178|364468250|FG000|Open Label Extension|Protocol Violation|0|||
105673455|NCT00568178|364468251|FG001|Open Label Extension|Protocol Violation|0|||
105673456|NCT00568178|364468252|FG002|Open Label Extension|Protocol Violation|0|||
105673457|NCT00568178|364468253|FG003|Open Label Extension|Protocol Violation|0|||
105673458|NCT00568178|364468254|FG004|Open Label Extension|Protocol Violation|1|||
105673459|NCT00568178|364468255|FG005|Open Label Extension|Protocol Violation|0|||
105342771|NCT00435487|363256759|FG001|Overall Study|Other|2|||
105342772|NCT00435487|363256758|FG000|Overall Study|Withdrawal by Subject|2|||
105342773|NCT00435487|363256759|FG001|Overall Study|Withdrawal by Subject|1|||
105673460|NCT00568178|364468250|FG000|Open Label Extension|Lost to Follow-up|0|||
105673461|NCT00568178|364468251|FG001|Open Label Extension|Lost to Follow-up|0|||
105673462|NCT00568178|364468252|FG002|Open Label Extension|Lost to Follow-up|0|||
105673463|NCT00568178|364468253|FG003|Open Label Extension|Lost to Follow-up|0|||
105673464|NCT00568178|364468254|FG004|Open Label Extension|Lost to Follow-up|6|||
105673465|NCT00568178|364468255|FG005|Open Label Extension|Lost to Follow-up|11|||
105673466|NCT00568178|364468250|FG000|Open Label Extension|Physician Decision|0|||
105673467|NCT00568178|364468251|FG001|Open Label Extension|Physician Decision|0|||
105673468|NCT00568178|364468252|FG002|Open Label Extension|Physician Decision|0|||
105673469|NCT00568178|364468253|FG003|Open Label Extension|Physician Decision|0|||
105673470|NCT00568178|364468254|FG004|Open Label Extension|Physician Decision|9|||
105673471|NCT00568178|364468255|FG005|Open Label Extension|Physician Decision|8|||
105673472|NCT00568178|364468250|FG000|Open Label Extension|Pregnancy|0|||
105673473|NCT00568178|364468251|FG001|Open Label Extension|Pregnancy|0|||
105673474|NCT00568178|364468252|FG002|Open Label Extension|Pregnancy|0|||
105673475|NCT00568178|364468253|FG003|Open Label Extension|Pregnancy|0|||
105673476|NCT00568178|364468254|FG004|Open Label Extension|Pregnancy|0|||
105673477|NCT00568178|364468255|FG005|Open Label Extension|Pregnancy|1|||
105673478|NCT00568178|364468250|FG000|Open Label Extension|Progressive Disease|0|||
105673479|NCT00568178|364468251|FG001|Open Label Extension|Progressive Disease|0|||
105673480|NCT00568178|364468252|FG002|Open Label Extension|Progressive Disease|0|||
105673481|NCT00568178|364468253|FG003|Open Label Extension|Progressive Disease|0|||
105673482|NCT00568178|364468254|FG004|Open Label Extension|Progressive Disease|3|||
105673483|NCT00568178|364468255|FG005|Open Label Extension|Progressive Disease|1|||
105673484|NCT00568178|364468250|FG000|Open Label Extension|Termination of Trial|0|||
105673485|NCT00568178|364468251|FG001|Open Label Extension|Termination of Trial|0|||
105673486|NCT00568178|364468252|FG002|Open Label Extension|Termination of Trial|0|||
105673487|NCT00568178|364468253|FG003|Open Label Extension|Termination of Trial|0|||
105673488|NCT00568178|364468254|FG004|Open Label Extension|Termination of Trial|45|||
105673489|NCT00568178|364468255|FG005|Open Label Extension|Termination of Trial|47|||
105673490|NCT00568178|364468250|FG000|Open Label Extension|Withdrawal by Subject|0|||
105673491|NCT00568178|364468251|FG001|Open Label Extension|Withdrawal by Subject|0|||
105673492|NCT00568178|364468252|FG002|Open Label Extension|Withdrawal by Subject|0|||
105673493|NCT00568178|364468253|FG003|Open Label Extension|Withdrawal by Subject|0|||
105673494|NCT00568178|364468254|FG004|Open Label Extension|Withdrawal by Subject|4|||
105673495|NCT00568178|364468255|FG005|Open Label Extension|Withdrawal by Subject|4|||
105673496|NCT02311673|364468261|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
105673497|NCT02311673|364468262|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
105673498|NCT02311673|364468263|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
105673499|NCT02311673|364468264|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
105673500|NCT00095056|364468265|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
105673501|NCT00095056|364468266|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
105673502|NCT00095056|364468265|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
105673503|NCT00095056|364468266|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
105673504|NCT00095056|364468265|FG000|Phase A (Weeks 0-12)|Death|1|||
105673505|NCT00095056|364468266|FG001|Phase A (Weeks 0-12)|Death|0|||
105673506|NCT00095056|364468265|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
105673507|NCT00095056|364468266|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
105673508|NCT00095056|364468265|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
105673509|NCT00095056|364468266|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
105673510|NCT00095056|364468265|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
105673511|NCT00095056|364468266|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
105673512|NCT00095056|364468265|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
105673513|NCT00095056|364468266|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
105673514|NCT00095056|364468265|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
105673515|NCT00095056|364468266|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
105673516|NCT00095056|364468265|FG000|Phase B (Weeks 12-54)|Death|3|||
105673517|NCT00095056|364468266|FG001|Phase B (Weeks 12-54)|Death|1|||
105673518|NCT00095056|364468265|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
105673519|NCT00095056|364468266|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
105673520|NCT00095056|364468265|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
105673521|NCT00095056|364468266|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
105673522|NCT01332630|364468267|FG000|Overall Study|Withdrawal by Subject|3|||
105673523|NCT00490490|364468271|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
105673524|NCT00490490|364468271|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
105673525|NCT01638429|364468272|FG000|Overall Study|Withdrawal by Subject|1|||
105673526|NCT03207451|364468273|FG000|Overall Study|scheduling conflict|1|||
105673527|NCT03207451|364468274|FG001|Overall Study|scheduling conflict|0|||
105673528|NCT03207451|364468275|FG002|Overall Study|scheduling conflict|2|||
105673529|NCT03207451|364468276|FG003|Overall Study|scheduling conflict|2|||
105673530|NCT03207451|364468273|FG000|Overall Study|Adverse Event|0|||
105673531|NCT03207451|364468274|FG001|Overall Study|Adverse Event|0|||
105673532|NCT03207451|364468275|FG002|Overall Study|Adverse Event|0|||
105673533|NCT03207451|364468276|FG003|Overall Study|Adverse Event|1|||
105673534|NCT03482466|364468277|FG000|Overall Study|Protocol Violation|2|||
105673535|NCT01239043|364468278|FG000|Overall Study|Protocol Violation|2|||
105673536|NCT01239043|364468279|FG001|Overall Study|Protocol Violation|1|||
105673537|NCT05540717|364468280|FG000|Overall Study|Lost to Follow-up|2|||
105673538|NCT05540717|364468281|FG001|Overall Study|Lost to Follow-up|5|||
105673539|NCT05540717|364468280|FG000|Overall Study|Withdrawal by Subject|6|||
105673540|NCT05540717|364468281|FG001|Overall Study|Withdrawal by Subject|6|||
105673541|NCT05540717|364468280|FG000|Overall Study|Sponsor request|1|||
105673542|NCT05540717|364468281|FG001|Overall Study|Sponsor request|0|||
105673543|NCT05540717|364468280|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
105673544|NCT05540717|364468281|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
105673545|NCT05540717|364468280|FG000|Overall Study|Other|0|||
105673546|NCT05540717|364468281|FG001|Overall Study|Other|1|||
105673547|NCT01940939|364468282|FG000|Overall Study|Withdrawal by Subject|2|||
105673548|NCT01940939|364468283|FG001|Overall Study|Withdrawal by Subject|8|||
105673549|NCT01470001|364468284|FG000|Overall Study|Lost to Follow-up|1|||
105673550|NCT01470001|364468285|FG001|Overall Study|Lost to Follow-up|1|||
105673551|NCT01470001|364468284|FG000|Overall Study|Physician Decision|2|||
105673552|NCT01470001|364468285|FG001|Overall Study|Physician Decision|0|||
105673553|NCT01470001|364468284|FG000|Overall Study|Withdrawal by Subject|2|||
105673554|NCT01470001|364468285|FG001|Overall Study|Withdrawal by Subject|1|||
105673555|NCT02060370|364468288|FG000|Overall Study|Physician Decision|1|||
105673556|NCT03248882|364468289|FG000|Overall Study|Adverse Event|3|||
105673557|NCT03248882|364468290|FG001|Overall Study|Adverse Event|3|||
105673558|NCT03248882|364468291|FG002|Overall Study|Adverse Event|2|||
105673559|NCT03248882|364468292|FG003|Overall Study|Adverse Event|6|||
105673560|NCT03248882|364468293|FG004|Overall Study|Adverse Event|9|||
105673561|NCT03248882|364468289|FG000|Overall Study|Lost to Follow-up|0|||
105673562|NCT03248882|364468290|FG001|Overall Study|Lost to Follow-up|0|||
105673563|NCT03248882|364468291|FG002|Overall Study|Lost to Follow-up|0|||
105673564|NCT03248882|364468292|FG003|Overall Study|Lost to Follow-up|0|||
105673565|NCT03248882|364468293|FG004|Overall Study|Lost to Follow-up|1|||
105673566|NCT03248882|364468289|FG000|Overall Study|Protocol Violation|2|||
105673567|NCT03248882|364468290|FG001|Overall Study|Protocol Violation|0|||
105673568|NCT03248882|364468291|FG002|Overall Study|Protocol Violation|2|||
105673569|NCT03248882|364468292|FG003|Overall Study|Protocol Violation|0|||
105673570|NCT03248882|364468293|FG004|Overall Study|Protocol Violation|1|||
105673571|NCT03248882|364468289|FG000|Overall Study|Withdrawal by Subject|2|||
105673572|NCT03248882|364468290|FG001|Overall Study|Withdrawal by Subject|2|||
105673573|NCT03248882|364468291|FG002|Overall Study|Withdrawal by Subject|3|||
105673574|NCT03248882|364468292|FG003|Overall Study|Withdrawal by Subject|4|||
105673575|NCT03248882|364468293|FG004|Overall Study|Withdrawal by Subject|2|||
105673576|NCT02182947|364468294|FG000|Overall Study|Withdrawal by Subject|7|||
105673577|NCT02182947|364468294|FG000|Overall Study|Lost to Follow-up|3|||
105673578|NCT02182947|364468294|FG000|Overall Study|Failed screening activities|8|||
105673579|NCT03582943|364468295|FG000|Allocated to Groups|Withdrawal by Subject|1|||
105673580|NCT03582943|364468296|FG001|Allocated to Groups|Withdrawal by Subject|1|||
105673581|NCT03582943|364468295|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
105673582|NCT03582943|364468296|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
105673583|NCT03582943|364468295|FG000|Analyzed|Protocol Violation|4|||
105673584|NCT03582943|364468296|FG001|Analyzed|Protocol Violation|1|||
105673585|NCT01656200|364468299|FG000|Overall Study|Withdrawal by Subject|1|||
105673586|NCT02236988|364468300|FG000|Overall Study|Lost to Follow-up|0|||
105673587|NCT02236988|364468301|FG001|Overall Study|Lost to Follow-up|0|||
105673588|NCT02236988|364468302|FG002|Overall Study|Lost to Follow-up|0|||
105673589|NCT02236988|364468303|FG003|Overall Study|Lost to Follow-up|1|||
105673590|NCT02236988|364468300|FG000|Overall Study|Unable to Comply with Study Visits|0|||
105673591|NCT02236988|364468301|FG001|Overall Study|Unable to Comply with Study Visits|0|||
105673592|NCT02236988|364468302|FG002|Overall Study|Unable to Comply with Study Visits|0|||
105673593|NCT02236988|364468303|FG003|Overall Study|Unable to Comply with Study Visits|2|||
105786306|NCT00948896|364870491|FG003|24 Months of Age to 36 Months of Age|Death|0|||
105786307|NCT00948896|364870492|FG004|24 Months of Age to 36 Months of Age|Death|0|||
105786308|NCT00948896|364870493|FG005|24 Months of Age to 36 Months of Age|Death|1|||
105786309|NCT00948896|364870494|FG006|24 Months of Age to 36 Months of Age|Death|0|||
105786310|NCT00948896|364870495|FG007|24 Months of Age to 36 Months of Age|Death|0|||
105673594|NCT00730275|364468304|FG000|Overall Study|Withdrawal by Subject|0|||
105673595|NCT00730275|364468305|FG001|Overall Study|Withdrawal by Subject|0|||
105673596|NCT00730275|364468306|FG002|Overall Study|Withdrawal by Subject|0|||
105673597|NCT00730275|364468307|FG003|Overall Study|Withdrawal by Subject|1|||
105673598|NCT00356408|364468308|FG000|Overall Study|Adverse Event|9|||
105673599|NCT00356408|364468308|FG000|Overall Study|Lack of Efficacy|36|||
105673600|NCT00356408|364468308|FG000|Overall Study|Lost to Follow-up|2|||
105673601|NCT00356408|364468308|FG000|Overall Study|Withdrawal by Subject|6|||
105673602|NCT00356408|364468308|FG000|Overall Study|Other: Principal investigator discretion|3|||
105673603|NCT00356408|364468308|FG000|Overall Study|Other: Sponsor request|1|||
105673604|NCT00356408|364468308|FG000|Overall Study|Other: Azathioprine stopped|1|||
105673605|NCT00356408|364468308|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
105466616|NCT03853109|363720187|FG004|Overall Study|Death|3|||
105673606|NCT00356408|364468308|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
105673607|NCT04032613|364468310|FG000|Overall Study|Did not complete post-program assessment|5|||
105673608|NCT04032613|364468311|FG001|Overall Study|Did not complete post-program assessment|2|||
105673609|NCT04488770|364468312|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673610|NCT04488770|364468313|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673611|NCT04488770|364468314|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673612|NCT04488770|364468315|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
105673613|NCT04488770|364468316|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673614|NCT04488770|364468317|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673615|NCT04488770|364468318|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673616|NCT04488770|364468319|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673617|NCT04488770|364468320|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673618|NCT04488770|364468321|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673619|NCT04488770|364468322|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673620|NCT04488770|364468323|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673621|NCT04488770|364468324|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673622|NCT04488770|364468312|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
105673623|NCT04488770|364468313|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673624|NCT04488770|364468314|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673625|NCT04488770|364468315|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673626|NCT04488770|364468316|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673627|NCT04488770|364468317|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673628|NCT04488770|364468318|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673629|NCT04488770|364468319|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673630|NCT04488770|364468320|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673631|NCT04488770|364468321|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673632|NCT04488770|364468322|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673633|NCT04488770|364468323|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673634|NCT04488770|364468324|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673635|NCT04488770|364468312|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673636|NCT04488770|364468313|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673637|NCT04488770|364468314|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673638|NCT04488770|364468315|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673639|NCT04488770|364468316|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673640|NCT04488770|364468317|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
105673641|NCT04488770|364468318|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
105673642|NCT04488770|364468319|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673643|NCT04488770|364468320|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673644|NCT04488770|364468321|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673645|NCT04488770|364468322|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673646|NCT04488770|364468323|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673647|NCT04488770|364468324|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673648|NCT04488770|364468312|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673649|NCT04488770|364468313|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673650|NCT04488770|364468314|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673651|NCT04488770|364468315|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673652|NCT04488770|364468316|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
105673653|NCT04488770|364468317|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673654|NCT04488770|364468318|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673655|NCT04488770|364468319|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673656|NCT04488770|364468320|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673657|NCT04488770|364468321|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673658|NCT04488770|364468322|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673659|NCT04488770|364468323|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673660|NCT04488770|364468324|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673661|NCT01867333|364468325|FG000|Overall Study|Withdrawal by Subject|1|||
105786311|NCT00948896|364870488|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
105786312|NCT00948896|364870489|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
105786313|NCT00948896|364870490|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
105673662|NCT01867333|364468326|FG001|Overall Study|Withdrawal by Subject|0|||
105673663|NCT01867333|364468325|FG000|Overall Study|Adverse Event|1|||
105673664|NCT01867333|364468326|FG001|Overall Study|Adverse Event|0|||
105673665|NCT01867333|364468325|FG000|Overall Study|Participant choice|1|||
105673666|NCT01867333|364468326|FG001|Overall Study|Participant choice|2|||
105673667|NCT01867333|364468325|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
105673668|NCT01867333|364468326|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
105673669|NCT01867333|364468325|FG000|Overall Study|Death|0|||
105673670|NCT01867333|364468326|FG001|Overall Study|Death|1|||
105673671|NCT01867333|364468325|FG000|Overall Study|Physician Decision|3|||
105673672|NCT01867333|364468326|FG001|Overall Study|Physician Decision|2|||
105673673|NCT01867333|364468325|FG000|Overall Study|Switched to alternative treatment|1|||
105673674|NCT01867333|364468326|FG001|Overall Study|Switched to alternative treatment|0|||
105673675|NCT02075073|364468327|FG000|Overall Study|Withdrawal by Subject|0|||
105673676|NCT02075073|364468328|FG001|Overall Study|Withdrawal by Subject|1|||
105673677|NCT02075073|364468329|FG002|Overall Study|Withdrawal by Subject|0|||
105673678|NCT00951015|364468345|FG000|Randomization Phase 96 Week|Adverse Event|1|||
105673679|NCT00951015|364468346|FG001|Randomization Phase 96 Week|Adverse Event|1|||
105673680|NCT00951015|364468347|FG002|Randomization Phase 96 Week|Adverse Event|2|||
105673681|NCT00951015|364468348|FG003|Randomization Phase 96 Week|Adverse Event|5|||
105673682|NCT00951015|364468349|FG004|Randomization Phase 96 Week|Adverse Event|0|||
105673683|NCT00951015|364468345|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
105673684|NCT00951015|364468346|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
105673685|NCT00951015|364468347|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
105673686|NCT00951015|364468348|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
105673687|NCT00951015|364468349|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
105673688|NCT00951015|364468345|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
105673689|NCT00951015|364468346|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
105673690|NCT00951015|364468347|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
105673691|NCT00951015|364468348|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
105673692|NCT00951015|364468349|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
105673693|NCT00951015|364468345|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
105673694|NCT00951015|364468346|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
105673695|NCT00951015|364468347|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
105673696|NCT00951015|364468348|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
105673697|NCT00951015|364468349|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
105673698|NCT00951015|364468345|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
105673699|NCT00951015|364468346|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
105673700|NCT00951015|364468347|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
105673701|NCT00951015|364468348|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
105673702|NCT00951015|364468349|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
105673703|NCT00951015|364468345|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
105673704|NCT00951015|364468346|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
105673705|NCT00951015|364468347|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
105673706|NCT00951015|364468348|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
105673707|NCT00951015|364468349|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
105673708|NCT00951015|364468345|FG000|Open-label Phase|Adverse Event|0|||
105673709|NCT00951015|364468346|FG001|Open-label Phase|Adverse Event|0|||
105673710|NCT00951015|364468347|FG002|Open-label Phase|Adverse Event|0|||
105673711|NCT00951015|364468348|FG003|Open-label Phase|Adverse Event|0|||
105673712|NCT00951015|364468349|FG004|Open-label Phase|Adverse Event|3|||
105673713|NCT00951015|364468345|FG000|Open-label Phase|Lack of Efficacy|0|||
105673714|NCT00951015|364468346|FG001|Open-label Phase|Lack of Efficacy|0|||
105673715|NCT00951015|364468347|FG002|Open-label Phase|Lack of Efficacy|0|||
105673716|NCT00951015|364468348|FG003|Open-label Phase|Lack of Efficacy|0|||
105673717|NCT00951015|364468349|FG004|Open-label Phase|Lack of Efficacy|1|||
105673718|NCT00951015|364468345|FG000|Open-label Phase|Protocol Violation|0|||
105673719|NCT00951015|364468346|FG001|Open-label Phase|Protocol Violation|0|||
105673720|NCT00951015|364468347|FG002|Open-label Phase|Protocol Violation|0|||
105673721|NCT00951015|364468348|FG003|Open-label Phase|Protocol Violation|0|||
105673722|NCT00951015|364468349|FG004|Open-label Phase|Protocol Violation|12|||
105673723|NCT00951015|364468345|FG000|Open-label Phase|Lost to Follow-up|0|||
105673724|NCT00951015|364468346|FG001|Open-label Phase|Lost to Follow-up|0|||
105673725|NCT00951015|364468347|FG002|Open-label Phase|Lost to Follow-up|0|||
105673726|NCT00951015|364468348|FG003|Open-label Phase|Lost to Follow-up|0|||
105673727|NCT00951015|364468349|FG004|Open-label Phase|Lost to Follow-up|12|||
105673728|NCT00951015|364468345|FG000|Open-label Phase|Withdrawal by Subject|0|||
105673729|NCT00951015|364468346|FG001|Open-label Phase|Withdrawal by Subject|0|||
105673730|NCT00951015|364468347|FG002|Open-label Phase|Withdrawal by Subject|0|||
105673731|NCT00951015|364468348|FG003|Open-label Phase|Withdrawal by Subject|0|||
105673732|NCT00951015|364468349|FG004|Open-label Phase|Withdrawal by Subject|14|||
105673733|NCT00951015|364468345|FG000|Open-label Phase|Physician Decision|0|||
105673734|NCT00951015|364468346|FG001|Open-label Phase|Physician Decision|0|||
105673735|NCT00951015|364468347|FG002|Open-label Phase|Physician Decision|0|||
105673736|NCT00951015|364468348|FG003|Open-label Phase|Physician Decision|0|||
105673737|NCT00951015|364468349|FG004|Open-label Phase|Physician Decision|8|||
105673738|NCT01208103|364468350|FG000|Overall Study|Adverse Event|1|||
105673739|NCT01208103|364468350|FG000|Overall Study|Withdrawal by Subject|1|||
105673740|NCT02530970|364468352|FG000|Overall Study|Adverse Event|8|||
105673741|NCT02530970|364468352|FG000|Overall Study|Lost to Follow-up|88|||
105673742|NCT02530970|364468352|FG000|Overall Study|Physician Decision|5|||
105673743|NCT02530970|364468352|FG000|Overall Study|Withdrawal by Subject|14|||
105673744|NCT02530970|364468352|FG000|Overall Study|Death|6|||
105673745|NCT02530970|364468352|FG000|Overall Study|Hospitalization|1|||
105673746|NCT02530970|364468352|FG000|Overall Study|Insurance|2|||
105673747|NCT02530970|364468352|FG000|Overall Study|Explant|2|||
105673748|NCT02530970|364468352|FG000|Overall Study|Change in Provider|5|||
105673749|NCT02530970|364468352|FG000|Overall Study|Relocation|3|||
105673750|NCT02770612|364468353|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
105673751|NCT01416389|364468354|FG000|Overall Study|Lost to Follow-up|1|||
105673752|NCT01416389|364468355|FG001|Overall Study|Lost to Follow-up|0|||
105673753|NCT01416389|364468354|FG000|Overall Study|Started New Therapy|2|||
105673754|NCT01416389|364468355|FG001|Overall Study|Started New Therapy|0|||
105673755|NCT01012414|364468372|FG000|Overall Study|Withdrawal by Subject|2|||
105673756|NCT01012414|364468372|FG000|Overall Study|Lost to Follow-up|1|||
105673757|NCT01012414|364468372|FG000|Overall Study|Trial was stopped before completed|7|||
105673758|NCT02310100|364468373|FG000|Overall Study|Physician Decision|3|||
105673759|NCT02310100|364468373|FG000|Overall Study|Withdrawal by Subject|10|||
105673760|NCT02310100|364468373|FG000|Overall Study|Enrollment closure|1|||
105673761|NCT02310100|364468373|FG000|Overall Study|Unapproved ablation operator|1|||
105673762|NCT02310100|364468373|FG000|Overall Study|Visit compliance|1|||
105673763|NCT02310100|364468373|FG000|Overall Study|Lost to Follow-up|2|||
105673764|NCT04165031|364470438|FG000|Overall Study|Adverse Event|1|||
105673765|NCT04165031|364470439|FG001|Overall Study|Adverse Event|1|||
105673766|NCT04165031|364470440|FG002|Overall Study|Adverse Event|0|||
105673767|NCT04165031|364470441|FG003|Overall Study|Adverse Event|0|||
105673768|NCT04165031|364470442|FG004|Overall Study|Adverse Event|0|||
105673769|NCT04165031|364470443|FG005|Overall Study|Adverse Event|0|||
105673770|NCT04165031|364470438|FG000|Overall Study|Withdrawal by Subject|0|||
105673771|NCT04165031|364470439|FG001|Overall Study|Withdrawal by Subject|0|||
105673772|NCT04165031|364470440|FG002|Overall Study|Withdrawal by Subject|1|||
105673773|NCT04165031|364470441|FG003|Overall Study|Withdrawal by Subject|0|||
105673774|NCT04165031|364470442|FG004|Overall Study|Withdrawal by Subject|0|||
105673775|NCT04165031|364470443|FG005|Overall Study|Withdrawal by Subject|0|||
105673776|NCT02731690|364470444|FG000|Overall Study|Adverse Event|1|||
105673777|NCT02731690|364470444|FG000|Overall Study|Withdrawal by Subject|3|||
105673778|NCT02731690|364470444|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
105673779|NCT02735577|364470445|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
105673780|NCT02735577|364470445|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
105673781|NCT02040259|364470456|FG000|Overall Study|Death|280|||
105673782|NCT02040259|364470456|FG000|Overall Study|Lost to Follow-up|76|||
105673783|NCT02040259|364470456|FG000|Overall Study|Assessment not completed|3|||
105673784|NCT02040259|364470456|FG000|Overall Study|Withdrawal by Subject|4|||
105673785|NCT00316602|364470458|FG000|Overall Study|Withdrawal by Subject|3|||
105673786|NCT00316602|364470459|FG001|Overall Study|Withdrawal by Subject|2|||
105673787|NCT00316602|364470458|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
105673788|NCT00316602|364470459|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
105673789|NCT00316602|364470458|FG000|Overall Study|Adverse Event|1|||
105673790|NCT00316602|364470459|FG001|Overall Study|Adverse Event|0|||
105673791|NCT00316602|364470458|FG000|Overall Study|Other|3|||
105673792|NCT00316602|364470459|FG001|Overall Study|Other|6|||
105673793|NCT01142232|364470460|FG000|Overall Study|Adverse Event|1|||
105673794|NCT01142232|364470461|FG001|Overall Study|Adverse Event|2|||
105673795|NCT01142232|364470462|FG002|Overall Study|Adverse Event|1|||
105673796|NCT01142232|364470463|FG003|Overall Study|Adverse Event|0|||
105673797|NCT01142232|364470464|FG004|Overall Study|Adverse Event|4|||
105673798|NCT01142232|364470460|FG000|Overall Study|Death|0|||
105673799|NCT01142232|364470461|FG001|Overall Study|Death|0|||
105673800|NCT01142232|364470462|FG002|Overall Study|Death|0|||
105673801|NCT01142232|364470463|FG003|Overall Study|Death|0|||
105673802|NCT01142232|364470464|FG004|Overall Study|Death|1|||
105673803|NCT01142232|364470460|FG000|Overall Study|Disease Progression|2|||
105673804|NCT01142232|364470461|FG001|Overall Study|Disease Progression|0|||
105673805|NCT01142232|364470462|FG002|Overall Study|Disease Progression|1|||
105673806|NCT01142232|364470463|FG003|Overall Study|Disease Progression|2|||
105673807|NCT01142232|364470464|FG004|Overall Study|Disease Progression|12|||
105673808|NCT01142232|364470460|FG000|Overall Study|Withdrawal by Subject|0|||
105673809|NCT01142232|364470461|FG001|Overall Study|Withdrawal by Subject|0|||
105673810|NCT01142232|364470462|FG002|Overall Study|Withdrawal by Subject|0|||
105673811|NCT01142232|364470463|FG003|Overall Study|Withdrawal by Subject|1|||
105673812|NCT01142232|364470464|FG004|Overall Study|Withdrawal by Subject|3|||
105673813|NCT01142232|364470460|FG000|Overall Study|Physician Decision|0|||
105673814|NCT01142232|364470461|FG001|Overall Study|Physician Decision|1|||
105673815|NCT01142232|364470462|FG002|Overall Study|Physician Decision|0|||
105673816|NCT01142232|364470463|FG003|Overall Study|Physician Decision|2|||
105673817|NCT01142232|364470464|FG004|Overall Study|Physician Decision|10|||
105673818|NCT01142232|364470460|FG000|Overall Study|Alternative Therapy|0|||
105673819|NCT01142232|364470461|FG001|Overall Study|Alternative Therapy|1|||
105673820|NCT01142232|364470462|FG002|Overall Study|Alternative Therapy|1|||
105673821|NCT01142232|364470463|FG003|Overall Study|Alternative Therapy|0|||
105673822|NCT01142232|364470464|FG004|Overall Study|Alternative Therapy|1|||
105673823|NCT01142232|364470460|FG000|Overall Study|Off Trt for other complicating disease|0|||
105673824|NCT01142232|364470461|FG001|Overall Study|Off Trt for other complicating disease|0|||
105673825|NCT01142232|364470462|FG002|Overall Study|Off Trt for other complicating disease|0|||
105673826|NCT01142232|364470463|FG003|Overall Study|Off Trt for other complicating disease|0|||
105673827|NCT01142232|364470464|FG004|Overall Study|Off Trt for other complicating disease|1|||
105673828|NCT01142232|364470460|FG000|Overall Study|Noncompliance|0|||
105673829|NCT01142232|364470461|FG001|Overall Study|Noncompliance|0|||
105673830|NCT01142232|364470462|FG002|Overall Study|Noncompliance|0|||
105673831|NCT01142232|364470463|FG003|Overall Study|Noncompliance|0|||
105673832|NCT01142232|364470464|FG004|Overall Study|Noncompliance|2|||
105673833|NCT05262517|364470466|FG000|Overall Study|Randomized but not treated|5|||
105673834|NCT05262517|364470467|FG001|Overall Study|Randomized but not treated|11|||
105673835|NCT01659853|364470474|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
105673836|NCT01659853|364470475|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
105673837|NCT01659853|364470474|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
105673838|NCT01659853|364470475|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
105673839|NCT03053518|364470479|FG000|Overall Study|Withdrawal by Subject|3|||
105673840|NCT03053518|364470479|FG000|Overall Study|Lost to Follow-up|2|||
105673841|NCT03053518|364470479|FG000|Overall Study|Ineligible|5|||
105673842|NCT01156376|364470480|FG000|Overall Study|Adverse Event|1|||
105673843|NCT01156376|364470481|FG001|Overall Study|Adverse Event|0|||
105673844|NCT01156376|364470482|FG002|Overall Study|Adverse Event|1|||
105673845|NCT01156376|364470480|FG000|Overall Study|Withdrawal by Subject|0|||
105673846|NCT01156376|364470481|FG001|Overall Study|Withdrawal by Subject|0|||
105673847|NCT01156376|364470482|FG002|Overall Study|Withdrawal by Subject|3|||
105673848|NCT05775991|364470483|FG000|Overall Study|Withdrawal by Subject|0|||
105673849|NCT05775991|364470484|FG001|Overall Study|Withdrawal by Subject|0|||
105673850|NCT05775991|364470485|FG002|Overall Study|Withdrawal by Subject|2|||
105673851|NCT01072630|364470486|FG000|Overall Study|Adverse Event|11|||
105673852|NCT01072630|364470487|FG001|Overall Study|Adverse Event|19|||
105673853|NCT01072630|364470488|FG002|Overall Study|Adverse Event|2|||
105673854|NCT01072630|364470486|FG000|Overall Study|Lack of Efficacy|10|||
105673855|NCT01072630|364470487|FG001|Overall Study|Lack of Efficacy|10|||
105673856|NCT01072630|364470488|FG002|Overall Study|Lack of Efficacy|1|||
105673857|NCT01072630|364470486|FG000|Overall Study|Withdrawal by Subject|8|||
105673858|NCT01072630|364470487|FG001|Overall Study|Withdrawal by Subject|7|||
105673859|NCT01072630|364470488|FG002|Overall Study|Withdrawal by Subject|2|||
105673860|NCT01072630|364470486|FG000|Overall Study|Protocol Violation|10|||
105673861|NCT01072630|364470487|FG001|Overall Study|Protocol Violation|8|||
105673862|NCT01072630|364470488|FG002|Overall Study|Protocol Violation|4|||
105673863|NCT01072630|364470486|FG000|Overall Study|Lost to Follow-up|11|||
105673864|NCT01072630|364470487|FG001|Overall Study|Lost to Follow-up|11|||
105673865|NCT01072630|364470488|FG002|Overall Study|Lost to Follow-up|1|||
105673866|NCT01072630|364470486|FG000|Overall Study|Noncompliance with study medication|1|||
105673867|NCT01072630|364470487|FG001|Overall Study|Noncompliance with study medication|1|||
105673868|NCT01072630|364470488|FG002|Overall Study|Noncompliance with study medication|1|||
105673869|NCT01072630|364470486|FG000|Overall Study|Noncompliance with study procedures|1|||
105673870|NCT01072630|364470487|FG001|Overall Study|Noncompliance with study procedures|2|||
105673871|NCT01072630|364470488|FG002|Overall Study|Noncompliance with study procedures|1|||
105673872|NCT01072630|364470486|FG000|Overall Study|Other|3|||
105673873|NCT01072630|364470487|FG001|Overall Study|Other|2|||
105673874|NCT01072630|364470488|FG002|Overall Study|Other|1|||
105673875|NCT03214640|364470489|FG000|Overall Study|Protocol Violation|1|||
105673876|NCT03214640|364470490|FG001|Overall Study|Protocol Violation|2|||
105673877|NCT03214640|364470491|FG002|Overall Study|Protocol Violation|1|||
105673878|NCT03214640|364470492|FG003|Overall Study|Protocol Violation|4|||
105673879|NCT04514510|364470495|FG000|Overall Study|Lost to Follow-up|0|||
105673880|NCT04514510|364470496|FG001|Overall Study|Lost to Follow-up|1|||
105673881|NCT04514510|364470495|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
105673882|NCT04514510|364470496|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
105673883|NCT01365481|364470501|FG000|Overall Study|Adverse Event|6|||
105673884|NCT01365481|364470502|FG001|Overall Study|Adverse Event|9|||
105673885|NCT01365481|364470503|FG002|Overall Study|Adverse Event|0|||
105673886|NCT01365481|364470504|FG003|Overall Study|Adverse Event|2|||
105673887|NCT01365481|364470501|FG000|Overall Study|Withdrawal by Subject|0|||
105673888|NCT01365481|364470502|FG001|Overall Study|Withdrawal by Subject|2|||
105673889|NCT01365481|364470503|FG002|Overall Study|Withdrawal by Subject|1|||
105673890|NCT01365481|364470504|FG003|Overall Study|Withdrawal by Subject|1|||
105673891|NCT01365481|364470501|FG000|Overall Study|Lost to Follow-up|1|||
105673892|NCT01365481|364470502|FG001|Overall Study|Lost to Follow-up|1|||
105673893|NCT01365481|364470503|FG002|Overall Study|Lost to Follow-up|2|||
105673894|NCT01365481|364470504|FG003|Overall Study|Lost to Follow-up|3|||
105673895|NCT01365481|364470501|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105673896|NCT01365481|364470502|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105342774|NCT00435487|363256758|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
105342775|NCT00435487|363256759|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
105342776|NCT00435487|363256758|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
105342777|NCT00435487|363256759|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
105342778|NCT04021121|363256762|FG000|Overall Study|Death|3|||
105342779|NCT04021121|363256763|FG001|Overall Study|Death|3|||
105342780|NCT04021121|363256764|FG002|Overall Study|Death|5|||
105342781|NCT04021121|363256765|FG003|Overall Study|Death|4|||
105342782|NCT00819780|363256772|FG000|Overall Study|Did not receive study drug|3|||
105342783|NCT00819780|363256773|FG001|Overall Study|Did not receive study drug|4|||
105342784|NCT00819780|363256772|FG000|Overall Study|Still in treatment|25|||
105342785|NCT00819780|363256773|FG001|Overall Study|Still in treatment|17|||
105342786|NCT02344290|363256774|FG000|Overall Study|Withdrawal by Subject|315|||
105342787|NCT02344290|363256775|FG001|Overall Study|Withdrawal by Subject|324|||
105673897|NCT01365481|364470503|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105673898|NCT01365481|364470504|FG003|Overall Study|Abnormal laboratory value(s)|0|||
105673899|NCT01365481|364470501|FG000|Overall Study|Administrative problems|0|||
105673900|NCT01365481|364470502|FG001|Overall Study|Administrative problems|1|||
105673901|NCT01365481|364470503|FG002|Overall Study|Administrative problems|0|||
105673902|NCT01365481|364470504|FG003|Overall Study|Administrative problems|0|||
105673903|NCT01365481|364470501|FG000|Overall Study|Protocol deviation|0|||
105673904|NCT01365481|364470502|FG001|Overall Study|Protocol deviation|1|||
105673905|NCT01365481|364470503|FG002|Overall Study|Protocol deviation|0|||
105673906|NCT01365481|364470504|FG003|Overall Study|Protocol deviation|1|||
105673907|NCT01365481|364470501|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105673908|NCT01365481|364470502|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105673909|NCT01365481|364470503|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
105673910|NCT01365481|364470504|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
105673911|NCT02535091|364470511|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
105673912|NCT02535091|364470512|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
105673913|NCT02535091|364470513|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
105673914|NCT02535091|364470511|FG000|Overall Study|Withdrawal by Subject|14|||
105673915|NCT02535091|364470512|FG001|Overall Study|Withdrawal by Subject|5|||
105673916|NCT02535091|364470513|FG002|Overall Study|Withdrawal by Subject|121|||
105673917|NCT02535091|364470511|FG000|Overall Study|Adverse Event|9|||
105673918|NCT02535091|364470512|FG001|Overall Study|Adverse Event|4|||
105673919|NCT02535091|364470513|FG002|Overall Study|Adverse Event|170|||
105673920|NCT02535091|364470511|FG000|Overall Study|Other|4|||
105673921|NCT02535091|364470512|FG001|Overall Study|Other|3|||
105673922|NCT02535091|364470513|FG002|Overall Study|Other|81|||
105673923|NCT02535091|364470511|FG000|Overall Study|Lost to Follow-up|0|||
105673924|NCT02535091|364470512|FG001|Overall Study|Lost to Follow-up|1|||
105673925|NCT02535091|364470513|FG002|Overall Study|Lost to Follow-up|19|||
105673926|NCT02535091|364470511|FG000|Overall Study|Protocol Violation|0|||
105673927|NCT02535091|364470512|FG001|Overall Study|Protocol Violation|1|||
105673928|NCT02535091|364470513|FG002|Overall Study|Protocol Violation|11|||
105673929|NCT02535091|364470511|FG000|Overall Study|Pregnancy|0|||
105673930|NCT02535091|364470512|FG001|Overall Study|Pregnancy|0|||
105673931|NCT02535091|364470513|FG002|Overall Study|Pregnancy|7|||
105673932|NCT03459443|364470533|FG000|Overall Study|Lack of Efficacy|3|||
105673933|NCT03459443|364470533|FG000|Overall Study|Adverse Event|1|||
105673934|NCT03459443|364470533|FG000|Overall Study|Sponsor's decision to close the study|18|||
105673935|NCT02153073|364470534|FG000|Overall Study|Case Report Forms Uncollected|230|||
105673936|NCT02153073|364470534|FG000|Overall Study|Protocol Deviation|68|||
105673937|NCT03291288|364470535|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
105673938|NCT03291288|364470536|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
105673939|NCT03291288|364470535|FG000|Drug-drug Interaction Phase|Disease progression|1|||
105342788|NCT02344290|363256774|FG000|Overall Study|Lost to Follow-up|258|||
105342789|NCT02344290|363256775|FG001|Overall Study|Lost to Follow-up|249|||
105342790|NCT02344290|363256774|FG000|Overall Study|Unable to get to clinic|69|||
105342791|NCT02344290|363256775|FG001|Overall Study|Unable to get to clinic|60|||
105342792|NCT02344290|363256774|FG000|Overall Study|Physician Decision|25|||
105673940|NCT03291288|364470536|FG001|Drug-drug Interaction Phase|Disease progression|0|||
105673941|NCT03291288|364470535|FG000|Drug-drug Interaction Phase|Other|3|||
105673942|NCT03291288|364470536|FG001|Drug-drug Interaction Phase|Other|0|||
105673943|NCT03291288|364470535|FG000|Pexidartinib Only|Ongoing|0|||
105673944|NCT03291288|364470536|FG001|Pexidartinib Only|Ongoing|2|||
105673945|NCT01276379|364470537|FG000|Overall Study|Screening failure|40|||
105673946|NCT00287690|364470538|FG000|Overall Study|Protocol Violation|20|||
105673947|NCT00287690|364470539|FG001|Overall Study|Protocol Violation|26|||
105673948|NCT03590366|364470540|FG000|Overall Study|Adverse Event|0|||
105342793|NCT02344290|363256775|FG001|Overall Study|Physician Decision|25|||
105673949|NCT03590366|364470541|FG001|Overall Study|Adverse Event|3|||
105786314|NCT00948896|364870491|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
105342794|NCT02344290|363256774|FG000|Overall Study|Site Closure|15|||
105673950|NCT03590366|364470540|FG000|Overall Study|Lost to Follow-up|3|||
105673951|NCT03590366|364470541|FG001|Overall Study|Lost to Follow-up|3|||
105673952|NCT03590366|364470540|FG000|Overall Study|Withdrawal by Subject|0|||
105673953|NCT03590366|364470541|FG001|Overall Study|Withdrawal by Subject|2|||
105673954|NCT03309813|364470542|FG000|Main Randomized Study|Withdrawal by Subject|1|||
105673955|NCT03309813|364470543|FG001|Main Randomized Study|Withdrawal by Subject|0|||
105673956|NCT01081665|364470545|FG000|Overall Study|Death|41|||
105673957|NCT01081665|364470545|FG000|Overall Study|Lost to Follow-up|18|||
105673958|NCT01081665|364470545|FG000|Overall Study|Withdrawal by Subject|17|||
105673959|NCT01081665|364470545|FG000|Overall Study|Change of dialysis unit|10|||
105673960|NCT01081665|364470545|FG000|Overall Study|Regulation of iPTH|5|||
105673961|NCT01081665|364470545|FG000|Overall Study|Change in renal replacement therapy|2|||
105673962|NCT01081665|364470545|FG000|Overall Study|Adverse Event|1|||
105673963|NCT01081665|364470545|FG000|Overall Study|Lack of Efficacy|1|||
105673964|NCT01747551|364470546|FG000|Overall Study|Progressive Disease|24|||
105673965|NCT01747551|364470547|FG001|Overall Study|Progressive Disease|17|||
105673966|NCT01747551|364470546|FG000|Overall Study|Death|3|||
105673967|NCT01747551|364470547|FG001|Overall Study|Death|1|||
105673968|NCT01747551|364470546|FG000|Overall Study|Adverse Event|7|||
105673969|NCT01747551|364470547|FG001|Overall Study|Adverse Event|1|||
105673970|NCT01747551|364470546|FG000|Overall Study|Prolonged Treatment Delay|2|||
105673971|NCT01747551|364470547|FG001|Overall Study|Prolonged Treatment Delay|0|||
105673972|NCT01747551|364470546|FG000|Overall Study|Withdrawal by Subject|3|||
105673973|NCT01747551|364470547|FG001|Overall Study|Withdrawal by Subject|1|||
105673974|NCT01747551|364470546|FG000|Overall Study|Physician Decision|2|||
105673975|NCT01747551|364470547|FG001|Overall Study|Physician Decision|1|||
105673976|NCT01747551|364470546|FG000|Overall Study|Other|2|||
105673977|NCT01747551|364470547|FG001|Overall Study|Other|0|||
105673978|NCT01142115|364470548|FG000|First Intervention|Lack of Efficacy|1|||
105673979|NCT01142115|364470549|FG001|First Intervention|Lack of Efficacy|1|||
105673980|NCT01142115|364470548|FG000|First Intervention|Adverse Event|1|||
105673981|NCT01142115|364470549|FG001|First Intervention|Adverse Event|0|||
105673982|NCT03406078|364470552|FG000|Overall Study|Death|1|||
105673983|NCT03406078|364470553|FG001|Overall Study|Death|0|||
105673984|NCT03406078|364470552|FG000|Overall Study|Lost to Follow-up|0|||
105673985|NCT03406078|364470553|FG001|Overall Study|Lost to Follow-up|1|||
105673986|NCT03406078|364470552|FG000|Overall Study|Withdrawal by Subject|5|||
105673987|NCT03406078|364470553|FG001|Overall Study|Withdrawal by Subject|2|||
105673988|NCT02546921|364470554|FG000|Overall Study|Adverse Event|0|||
105673989|NCT02546921|364470555|FG001|Overall Study|Adverse Event|5|||
105673990|NCT02546921|364470556|FG002|Overall Study|Adverse Event|2|||
105673991|NCT02546921|364470557|FG003|Overall Study|Adverse Event|0|||
105673992|NCT02546921|364470558|FG004|Overall Study|Adverse Event|0|||
105342795|NCT02344290|363256775|FG001|Overall Study|Site Closure|19|||
105342796|NCT02344290|363256774|FG000|Overall Study|Other|5|||
105342797|NCT02344290|363256775|FG001|Overall Study|Other|3|||
105342798|NCT04972968|363256776|FG000|Overall Study|Adverse Event|3|||
105342799|NCT04972968|363256777|FG001|Overall Study|Adverse Event|1|||
105673993|NCT02546921|364470559|FG005|Overall Study|Adverse Event|0|||
105673994|NCT02546921|364470560|FG006|Overall Study|Adverse Event|0|||
105673995|NCT02546921|364470554|FG000|Overall Study|Evidence of Disease Progression|1|||
105673996|NCT02546921|364470555|FG001|Overall Study|Evidence of Disease Progression|0|||
105673997|NCT02546921|364470556|FG002|Overall Study|Evidence of Disease Progression|0|||
105673998|NCT02546921|364470557|FG003|Overall Study|Evidence of Disease Progression|0|||
105673999|NCT02546921|364470558|FG004|Overall Study|Evidence of Disease Progression|1|||
105674000|NCT02546921|364470559|FG005|Overall Study|Evidence of Disease Progression|0|||
105674001|NCT02546921|364470560|FG006|Overall Study|Evidence of Disease Progression|0|||
105674002|NCT02546921|364470554|FG000|Overall Study|Patient Choice|0|||
105674003|NCT02546921|364470555|FG001|Overall Study|Patient Choice|1|||
105674004|NCT02546921|364470556|FG002|Overall Study|Patient Choice|0|||
105466617|NCT03853109|363720188|FG005|Overall Study|Death|20|||
105466618|NCT03853109|363720189|FG006|Overall Study|Death|10|||
105554997|NCT00679939|364027508|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
105554998|NCT00679939|364027507|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
105554999|NCT00679939|364027508|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
105555000|NCT00679939|364027507|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
105555001|NCT00679939|364027508|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
105555002|NCT00679939|364027507|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
105555003|NCT00679939|364027508|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
105555004|NCT00679939|364027507|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
105555005|NCT00679939|364027508|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
105555006|NCT00679939|364027507|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
105555007|NCT00679939|364027508|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
105555008|NCT00679939|364027507|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
105555009|NCT00679939|364027508|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
105555010|NCT00679939|364027507|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
105555011|NCT00679939|364027508|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
105786315|NCT00948896|364870492|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
105786316|NCT00948896|364870493|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
105786317|NCT00948896|364870494|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
105786318|NCT00948896|364870495|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
105786319|NCT00948896|364870488|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
105786320|NCT00948896|364870489|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
105786321|NCT00948896|364870490|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
105786322|NCT00948896|364870491|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
105786323|NCT00948896|364870492|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
105786324|NCT00948896|364870493|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
105786325|NCT00948896|364870494|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
105786326|NCT00948896|364870495|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
105786327|NCT00948896|364870488|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
105786328|NCT00948896|364870489|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
105786329|NCT00948896|364870490|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
105786330|NCT00948896|364870491|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
105786331|NCT00948896|364870492|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
105786332|NCT00948896|364870493|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
105786333|NCT00948896|364870494|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
105786334|NCT00948896|364870495|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
105786335|NCT00948896|364870488|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
105786336|NCT00948896|364870489|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
105786337|NCT00948896|364870490|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
105786338|NCT00948896|364870491|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
105786339|NCT00948896|364870492|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
105786340|NCT00948896|364870493|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
105786341|NCT00948896|364870494|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
105786342|NCT00948896|364870495|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
105786343|NCT03795233|364870496|FG000|Overall Study|Withdrawal by Subject|2|||
105786344|NCT03795233|364870497|FG001|Overall Study|Withdrawal by Subject|1|||
105786345|NCT03795233|364870496|FG000|Overall Study|Lost to Follow-up|1|||
105786346|NCT03795233|364870497|FG001|Overall Study|Lost to Follow-up|0|||
105786347|NCT03795233|364870496|FG000|Overall Study|Death|1|||
105786348|NCT03795233|364870497|FG001|Overall Study|Death|0|||
105786349|NCT05403502|364870498|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
105786350|NCT05403502|364870498|FG000|Humalog Lead-In Period|Physician Decision|2|||
105786351|NCT05403502|364870498|FG000|Humalog Lead-In Period|Protocol Violation|1|||
105786352|NCT05403502|364870498|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
105786353|NCT05403502|364870498|FG000|Lyumjev Treatment Period|Physician Decision|2|||
105786354|NCT01054443|364870499|FG000|Overall Study|Withdrawal by Subject|0|||
105786355|NCT01054443|364870500|FG001|Overall Study|Withdrawal by Subject|0|||
105786356|NCT01054443|364870501|FG002|Overall Study|Withdrawal by Subject|0|||
105786357|NCT01054443|364870502|FG003|Overall Study|Withdrawal by Subject|1|||
105786358|NCT00985114|364870504|FG000|Overall Study|Adverse Event|1|||
105786359|NCT00985114|364870505|FG001|Overall Study|Adverse Event|0|||
105786360|NCT00985114|364870504|FG000|Overall Study|Withdrawal by Subject|0|||
105786361|NCT00985114|364870505|FG001|Overall Study|Withdrawal by Subject|2|||
105786362|NCT01869959|364870508|FG000|Randomization Period|Physician Decision|0|||
105786363|NCT01869959|364870509|FG001|Randomization Period|Physician Decision|0|||
105786364|NCT01869959|364870510|FG002|Randomization Period|Physician Decision|0|||
105786365|NCT01869959|364870511|FG003|Randomization Period|Physician Decision|0|||
105786366|NCT01869959|364870512|FG004|Randomization Period|Physician Decision|1|||
105786367|NCT01869959|364870508|FG000|Treatment Period|Adverse Event|1|||
105786368|NCT01869959|364870509|FG001|Treatment Period|Adverse Event|0|||
105786369|NCT01869959|364870510|FG002|Treatment Period|Adverse Event|3|||
105786370|NCT01869959|364870511|FG003|Treatment Period|Adverse Event|1|||
105786371|NCT01869959|364870512|FG004|Treatment Period|Adverse Event|0|||
105786372|NCT01869959|364870508|FG000|Treatment Period|Sponsor decision|0|||
105342800|NCT04972968|363256778|FG002|Overall Study|Adverse Event|1|||
105342801|NCT04972968|363256779|FG003|Overall Study|Adverse Event|7|||
105342802|NCT04972968|363256776|FG000|Overall Study|Lack of Efficacy|2|||
105555012|NCT00679939|364027507|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
105786373|NCT01869959|364870509|FG001|Treatment Period|Sponsor decision|1|||
105342803|NCT04972968|363256777|FG001|Overall Study|Lack of Efficacy|1|||
105342804|NCT04972968|363256778|FG002|Overall Study|Lack of Efficacy|0|||
105342805|NCT04972968|363256779|FG003|Overall Study|Lack of Efficacy|0|||
105342806|NCT04972968|363256776|FG000|Overall Study|Withdrawal by Subject|7|||
105342807|NCT04972968|363256777|FG001|Overall Study|Withdrawal by Subject|4|||
105674005|NCT02546921|364470557|FG003|Overall Study|Patient Choice|0|||
105674006|NCT02546921|364470558|FG004|Overall Study|Patient Choice|0|||
105674007|NCT02546921|364470559|FG005|Overall Study|Patient Choice|1|||
105674008|NCT02546921|364470560|FG006|Overall Study|Patient Choice|0|||
105674009|NCT02091206|364470561|FG000|Treatment Period|Adverse Event|0|||
105555013|NCT00679939|364027508|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
105555014|NCT00722761|364027509|FG000|Overall Study|Lost to Follow-up|1|||
105555015|NCT00722761|364027510|FG001|Overall Study|Lost to Follow-up|4|||
105555016|NCT00722761|364027509|FG000|Overall Study|Withdrawal by Subject|5|||
105555017|NCT00722761|364027510|FG001|Overall Study|Withdrawal by Subject|2|||
105555018|NCT00506493|364027514|FG000|Overall Study|Death|6|||
105555019|NCT00506493|364027514|FG000|Overall Study|Withdrawal by Subject|5|||
105555020|NCT02277444|364027515|FG000|Overall Study|Adverse Event|10|||
105555021|NCT02277444|364027515|FG000|Overall Study|Withdrawal by Subject|3|||
105555022|NCT02277444|364027515|FG000|Overall Study|Other|1|||
105555023|NCT02277444|364027515|FG000|Overall Study|Enrolled and not Treated|3|||
105555024|NCT02277444|364027515|FG000|Overall Study|Ongoing|113|||
105555025|NCT00924287|364029124|FG000|Overall Study|Death|1|||
105555026|NCT01877408|364029125|FG000|Overall Study|Lost to Follow-up|0|||
105555027|NCT01877408|364029126|FG001|Overall Study|Lost to Follow-up|2|||
105555028|NCT02239679|364029127|FG000|Overall Study|Lost to Follow-up|1|||
105555029|NCT02239679|364029128|FG001|Overall Study|Lost to Follow-up|0|||
105555030|NCT02239679|364029129|FG002|Overall Study|Lost to Follow-up|0|||
105555031|NCT02239679|364029127|FG000|Overall Study|Withdrawal by Subject|2|||
105555032|NCT02239679|364029128|FG001|Overall Study|Withdrawal by Subject|3|||
105555033|NCT02239679|364029129|FG002|Overall Study|Withdrawal by Subject|1|||
105555034|NCT02462876|364029133|FG000|Overall Study|Death|3|||
105555035|NCT02462876|364029133|FG000|Overall Study|Lost to Follow-up|7|||
105555036|NCT02462876|364029133|FG000|Overall Study|Surgical Bypass|9|||
105555037|NCT02462876|364029133|FG000|Overall Study|Amputation Above the Metatarsals|1|||
105555038|NCT02462876|364029133|FG000|Overall Study|36 months follow-up visit missed|1|||
105555039|NCT02462876|364029133|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
105555040|NCT02462876|364029133|FG000|Overall Study|Patient did not come back to the vascular department|1|||
105555041|NCT02462876|364029133|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
105555042|NCT02462876|364029133|FG000|Overall Study|Patient refused to come back|1|||
105555043|NCT02462876|364029133|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
105555044|NCT02462876|364029133|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
105555045|NCT00130533|364029137|FG000|Overall Study|Withdrawal by Subject|33|||
105555046|NCT00130533|364029138|FG001|Overall Study|Withdrawal by Subject|6|||
105555047|NCT00130533|364029137|FG000|Overall Study|Adverse Event|34|||
105555048|NCT00130533|364029138|FG001|Overall Study|Adverse Event|1|||
105555049|NCT00130533|364029137|FG000|Overall Study|Disease relapse|9|||
105555050|NCT00130533|364029138|FG001|Overall Study|Disease relapse|13|||
105555051|NCT00130533|364029137|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
105555052|NCT00130533|364029138|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
105555053|NCT00130533|364029137|FG000|Overall Study|Death|4|||
105555054|NCT00130533|364029138|FG001|Overall Study|Death|2|||
105555055|NCT00130533|364029137|FG000|Overall Study|Protocol Violation|5|||
105555056|NCT00130533|364029138|FG001|Overall Study|Protocol Violation|1|||
105555057|NCT00130533|364029137|FG000|Overall Study|Lost to Follow-up|1|||
105555058|NCT00130533|364029138|FG001|Overall Study|Lost to Follow-up|1|||
105555059|NCT00130533|364029137|FG000|Overall Study|Sponsor´s decision|2|||
105555060|NCT00130533|364029138|FG001|Overall Study|Sponsor´s decision|0|||
105555061|NCT00130533|364029137|FG000|Overall Study|Second Primary Malignancy|0|||
105555062|NCT00130533|364029138|FG001|Overall Study|Second Primary Malignancy|1|||
105555063|NCT00130533|364029137|FG000|Overall Study|Other|12|||
105555064|NCT00130533|364029138|FG001|Overall Study|Other|5|||
105555065|NCT01059565|364029139|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
105555066|NCT01059565|364029140|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
105555067|NCT01059565|364029139|FG000|24-Week Randomized Phase|Adverse Event|5|||
105555068|NCT01059565|364029140|FG001|24-Week Randomized Phase|Adverse Event|0|||
105555069|NCT01059565|364029139|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
105555070|NCT01059565|364029140|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
105555071|NCT01059565|364029139|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
105555072|NCT01059565|364029140|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
105555073|NCT01059565|364029139|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
105555074|NCT01059565|364029140|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
105674010|NCT02091206|364470562|FG001|Treatment Period|Adverse Event|1|||
105674011|NCT02091206|364470563|FG002|Treatment Period|Adverse Event|0|||
105674012|NCT02091206|364470564|FG003|Treatment Period|Adverse Event|0|||
105555075|NCT01059565|364029139|FG000|24-Week Open-Label Phase|Adverse Event|2|||
105555076|NCT01059565|364029140|FG001|24-Week Open-Label Phase|Adverse Event|0|||
105555077|NCT01059565|364029139|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
105555078|NCT01059565|364029140|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
105555079|NCT01059565|364029139|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
105555080|NCT01059565|364029140|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
105555081|NCT01059565|364029139|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
105555082|NCT01059565|364029140|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
105786374|NCT01869959|364870510|FG002|Treatment Period|Sponsor decision|0|||
105674013|NCT02091206|364470561|FG000|Treatment Period|Met withdrawal criteria|0|||
105674014|NCT02091206|364470562|FG001|Treatment Period|Met withdrawal criteria|0|||
105786375|NCT01869959|364870511|FG003|Treatment Period|Sponsor decision|1|||
105786376|NCT01869959|364870512|FG004|Treatment Period|Sponsor decision|0|||
105342808|NCT04972968|363256778|FG002|Overall Study|Withdrawal by Subject|3|||
105342809|NCT04972968|363256779|FG003|Overall Study|Withdrawal by Subject|2|||
105342810|NCT04972968|363256776|FG000|Overall Study|Study Terminated by Sponsor|25|||
105342811|NCT04972968|363256777|FG001|Overall Study|Study Terminated by Sponsor|28|||
105342812|NCT04972968|363256778|FG002|Overall Study|Study Terminated by Sponsor|32|||
105342813|NCT04972968|363256779|FG003|Overall Study|Study Terminated by Sponsor|27|||
105342814|NCT04972968|363256776|FG000|Overall Study|Other|1|||
105342815|NCT04972968|363256777|FG001|Overall Study|Other|0|||
105342816|NCT04972968|363256778|FG002|Overall Study|Other|1|||
105342817|NCT04972968|363256779|FG003|Overall Study|Other|1|||
105342818|NCT02375555|363256784|FG000|Induction Period|Adverse Event|7|||
105342819|NCT02375555|363256784|FG000|Induction Period|Withdrawal by Subject|2|||
105342820|NCT02375555|363256784|FG000|Induction Period|Other|1|||
105342821|NCT02375555|363256784|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
105342822|NCT02375555|363256784|FG000|Maintenance Period|Adverse Event|2|||
105342823|NCT02375555|363256784|FG000|Maintenance Period|Withdrawal by Subject|4|||
105342824|NCT02375555|363256784|FG000|Maintenance Period|Death|1|||
105342825|NCT02375555|363256784|FG000|Maintenance Period|Disease Progression|5|||
105342826|NCT02375555|363256784|FG000|Maintenance Period|Patient Non-compliance|1|||
105342827|NCT02375555|363256784|FG000|Maintenance Period|Still on maintenance|16|||
105342828|NCT02294175|363256786|FG000|Overall Study|Withdrawal by Subject|1|||
105342829|NCT02294175|363256787|FG001|Overall Study|Withdrawal by Subject|2|||
105342830|NCT02294175|363256786|FG000|Overall Study|pt taking excluded medication|3|||
105342831|NCT02294175|363256787|FG001|Overall Study|pt taking excluded medication|1|||
105342832|NCT02294175|363256786|FG000|Overall Study|Protocol Violation|1|||
105342833|NCT02294175|363256787|FG001|Overall Study|Protocol Violation|0|||
105342834|NCT02294175|363256786|FG000|Overall Study|Lost to Follow-up|0|||
105342835|NCT02294175|363256787|FG001|Overall Study|Lost to Follow-up|1|||
105342836|NCT02294175|363256786|FG000|Overall Study|wound healed|0|||
105342837|NCT02294175|363256787|FG001|Overall Study|wound healed|2|||
105342838|NCT00948506|363256788|FG000|Overall Study|Withdrawal by Subject|3|||
105342839|NCT00948506|363256789|FG001|Overall Study|Withdrawal by Subject|1|||
105342840|NCT01744184|363256790|FG000|Overall Study|Adverse Event|1|||
105342841|NCT01744184|363256791|FG001|Overall Study|Adverse Event|0|||
105342842|NCT01744184|363256790|FG000|Overall Study|Withdrawal by Subject|0|||
105342843|NCT01744184|363256791|FG001|Overall Study|Withdrawal by Subject|1|||
105342844|NCT00514904|363256799|FG000|Overall Study|Withdrawal by Subject|3|||
105342845|NCT00514904|363256800|FG001|Overall Study|Withdrawal by Subject|2|||
105342846|NCT00514904|363256799|FG000|Overall Study|Lost to Follow-up|21|||
105342847|NCT00514904|363256800|FG001|Overall Study|Lost to Follow-up|3|||
105342848|NCT03430895|363256801|FG000|Overall Study|Not Treated|2|||
105342849|NCT01173055|363256802|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
105342850|NCT01173055|363256803|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
105342851|NCT01173055|363256802|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
105342852|NCT01173055|363256803|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
105342853|NCT04253782|363256804|FG000|Overall Study|Death|2|||
105342854|NCT04253782|363256805|FG001|Overall Study|Death|0|||
105342855|NCT00962091|363256806|FG000|Overall Study|Withdrawal by Subject|1|||
105342856|NCT00962091|363256807|FG001|Overall Study|Withdrawal by Subject|2|||
105342857|NCT00962091|363256808|FG002|Overall Study|Withdrawal by Subject|1|||
105342858|NCT00962091|363256809|FG003|Overall Study|Withdrawal by Subject|1|||
105342859|NCT00962091|363256810|FG004|Overall Study|Withdrawal by Subject|0|||
105342860|NCT00962091|363256811|FG005|Overall Study|Withdrawal by Subject|1|||
105342861|NCT00962091|363256812|FG006|Overall Study|Withdrawal by Subject|0|||
105342862|NCT00962091|363256806|FG000|Overall Study|Adverse Event|0|||
105342863|NCT00962091|363256807|FG001|Overall Study|Adverse Event|0|||
105342864|NCT00962091|363256808|FG002|Overall Study|Adverse Event|0|||
105342865|NCT00962091|363256809|FG003|Overall Study|Adverse Event|0|||
105342866|NCT00962091|363256810|FG004|Overall Study|Adverse Event|0|||
105342867|NCT00962091|363256811|FG005|Overall Study|Adverse Event|0|||
105342868|NCT00962091|363256812|FG006|Overall Study|Adverse Event|1|||
105342869|NCT02044874|363256813|FG000|Overall Study|Adverse Event|5|||
105342870|NCT02044874|363256814|FG001|Overall Study|Adverse Event|6|||
105342871|NCT02044874|363256815|FG002|Overall Study|Adverse Event|6|||
105342872|NCT02044874|363256813|FG000|Overall Study|Withdrawal by Subject|8|||
105342873|NCT02044874|363256814|FG001|Overall Study|Withdrawal by Subject|16|||
105342874|NCT02044874|363256815|FG002|Overall Study|Withdrawal by Subject|23|||
105342875|NCT02044874|363256813|FG000|Overall Study|Physician Decision|0|||
105342876|NCT02044874|363256814|FG001|Overall Study|Physician Decision|2|||
105342877|NCT02044874|363256815|FG002|Overall Study|Physician Decision|1|||
105342878|NCT02044874|363256813|FG000|Overall Study|Lost to Follow-up|10|||
105342879|NCT02044874|363256814|FG001|Overall Study|Lost to Follow-up|27|||
105342880|NCT02044874|363256815|FG002|Overall Study|Lost to Follow-up|21|||
105342881|NCT02044874|363256813|FG000|Overall Study|Sponsor Decision|0|||
105342882|NCT02044874|363256814|FG001|Overall Study|Sponsor Decision|1|||
105342883|NCT02044874|363256815|FG002|Overall Study|Sponsor Decision|1|||
105342884|NCT02044874|363256813|FG000|Overall Study|Other|7|||
105342885|NCT02044874|363256814|FG001|Overall Study|Other|3|||
105342886|NCT02044874|363256815|FG002|Overall Study|Other|8|||
105342887|NCT03634033|363258183|FG000|Overall Study|Did not have a post-assessment|384|||
105342888|NCT03634033|363258184|FG001|Overall Study|Did not have a post-assessment|291|||
105342889|NCT03634033|363258185|FG002|Overall Study|Did not have a post-assessment|114|||
105342890|NCT03634033|363258186|FG003|Overall Study|Did not have a post-assessment|161|||
105342891|NCT03634033|363258187|FG004|Overall Study|Did not have a post-assessment|5|||
105342892|NCT03634033|363258188|FG005|Overall Study|Did not have a post-assessment|0|||
105342893|NCT03634033|363258189|FG006|Overall Study|Did not have a post-assessment|0|||
105342894|NCT03634033|363258183|FG000|Overall Study|Death|0|||
105342895|NCT03634033|363258184|FG001|Overall Study|Death|0|||
105342896|NCT03634033|363258185|FG002|Overall Study|Death|0|||
105342897|NCT03634033|363258186|FG003|Overall Study|Death|0|||
105342898|NCT03634033|363258187|FG004|Overall Study|Death|0|||
105342899|NCT03634033|363258188|FG005|Overall Study|Death|7|||
105342900|NCT03634033|363258189|FG006|Overall Study|Death|7|||
105342901|NCT03634033|363258183|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
105342902|NCT03634033|363258184|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
105342903|NCT03634033|363258185|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
105342904|NCT03634033|363258186|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
105342905|NCT03634033|363258187|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
105342906|NCT03634033|363258188|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
105342907|NCT03634033|363258189|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
105342908|NCT03634033|363258183|FG000|Overall Study|Lost to Follow-up|0|||
105342909|NCT03634033|363258184|FG001|Overall Study|Lost to Follow-up|0|||
105342910|NCT03634033|363258185|FG002|Overall Study|Lost to Follow-up|0|||
105342911|NCT03634033|363258186|FG003|Overall Study|Lost to Follow-up|0|||
105342912|NCT03634033|363258187|FG004|Overall Study|Lost to Follow-up|0|||
105342913|NCT03634033|363258188|FG005|Overall Study|Lost to Follow-up|1|||
105342914|NCT03634033|363258189|FG006|Overall Study|Lost to Follow-up|2|||
105342915|NCT03634033|363258183|FG000|Overall Study|Withdrawal by Subject|0|||
105342916|NCT03634033|363258184|FG001|Overall Study|Withdrawal by Subject|0|||
105342917|NCT03634033|363258185|FG002|Overall Study|Withdrawal by Subject|0|||
105342918|NCT03634033|363258186|FG003|Overall Study|Withdrawal by Subject|0|||
105342919|NCT03634033|363258187|FG004|Overall Study|Withdrawal by Subject|0|||
105342920|NCT03634033|363258188|FG005|Overall Study|Withdrawal by Subject|0|||
105342921|NCT03634033|363258189|FG006|Overall Study|Withdrawal by Subject|1|||
105342922|NCT05897827|363258190|FG000|Overall Study|Lost to Follow-up|33|||
105342923|NCT05897827|363258191|FG001|Overall Study|Lost to Follow-up|14|||
105342924|NCT05897827|363258190|FG000|Overall Study|Withdrawal by Subject|1|||
105342925|NCT05897827|363258191|FG001|Overall Study|Withdrawal by Subject|1|||
105342926|NCT00197002|363258192|FG000|Overall Study|Adverse Event|0|||
105342927|NCT00197002|363258193|FG001|Overall Study|Adverse Event|1|||
105342928|NCT00197002|363258194|FG002|Overall Study|Adverse Event|0|||
105342929|NCT00197002|363258192|FG000|Overall Study|Protocol Violation|1|||
105342930|NCT00197002|363258193|FG001|Overall Study|Protocol Violation|0|||
105342931|NCT00197002|363258194|FG002|Overall Study|Protocol Violation|2|||
105342932|NCT00197002|363258192|FG000|Overall Study|Withdrawal by Subject|9|||
105342933|NCT00197002|363258193|FG001|Overall Study|Withdrawal by Subject|5|||
105342934|NCT00197002|363258194|FG002|Overall Study|Withdrawal by Subject|7|||
105342935|NCT00197002|363258192|FG000|Overall Study|Migrated/moved from study area|3|||
105342936|NCT00197002|363258193|FG001|Overall Study|Migrated/moved from study area|5|||
105342937|NCT00197002|363258194|FG002|Overall Study|Migrated/moved from study area|1|||
105342938|NCT00197002|363258192|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
105342939|NCT00197002|363258193|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
105342940|NCT00197002|363258194|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
105342941|NCT00197002|363258192|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
105342942|NCT00197002|363258193|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
105342943|NCT00197002|363258194|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
105342944|NCT00197002|363258192|FG000|Overall Study|Others|3|||
105342945|NCT00197002|363258193|FG001|Overall Study|Others|1|||
105342946|NCT00197002|363258194|FG002|Overall Study|Others|1|||
105342947|NCT02017717|363258195|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105342948|NCT02017717|363258196|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105342949|NCT02017717|363258197|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105342950|NCT02017717|363258198|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105342951|NCT02017717|363258199|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105342952|NCT02017717|363258200|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105342953|NCT02017717|363258201|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105342954|NCT02017717|363258202|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
105342955|NCT02017717|363258203|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105342956|NCT02017717|363258195|FG000|Before Treatment Period|Participant request to stop therapy|0|||
105342957|NCT02017717|363258196|FG001|Before Treatment Period|Participant request to stop therapy|0|||
105342958|NCT02017717|363258197|FG002|Before Treatment Period|Participant request to stop therapy|0|||
105342959|NCT02017717|363258198|FG003|Before Treatment Period|Participant request to stop therapy|0|||
105342960|NCT02017717|363258199|FG004|Before Treatment Period|Participant request to stop therapy|0|||
105342961|NCT02017717|363258200|FG005|Before Treatment Period|Participant request to stop therapy|0|||
105342962|NCT02017717|363258201|FG006|Before Treatment Period|Participant request to stop therapy|0|||
105342963|NCT02017717|363258202|FG007|Before Treatment Period|Participant request to stop therapy|0|||
105342964|NCT02017717|363258203|FG008|Before Treatment Period|Participant request to stop therapy|5|||
105342965|NCT02017717|363258195|FG000|Before Treatment Period|Participant withdrew consent|0|||
105342966|NCT02017717|363258196|FG001|Before Treatment Period|Participant withdrew consent|0|||
105342967|NCT02017717|363258197|FG002|Before Treatment Period|Participant withdrew consent|0|||
105342968|NCT02017717|363258198|FG003|Before Treatment Period|Participant withdrew consent|0|||
105342969|NCT02017717|363258199|FG004|Before Treatment Period|Participant withdrew consent|0|||
105342970|NCT02017717|363258200|FG005|Before Treatment Period|Participant withdrew consent|0|||
105342971|NCT02017717|363258201|FG006|Before Treatment Period|Participant withdrew consent|2|||
105342972|NCT02017717|363258202|FG007|Before Treatment Period|Participant withdrew consent|0|||
105342973|NCT02017717|363258203|FG008|Before Treatment Period|Participant withdrew consent|11|||
105342974|NCT02017717|363258195|FG000|Before Treatment Period|Lost to Follow-up|0|||
105342975|NCT02017717|363258196|FG001|Before Treatment Period|Lost to Follow-up|0|||
105342976|NCT02017717|363258197|FG002|Before Treatment Period|Lost to Follow-up|0|||
105342977|NCT02017717|363258198|FG003|Before Treatment Period|Lost to Follow-up|0|||
105342978|NCT02017717|363258199|FG004|Before Treatment Period|Lost to Follow-up|0|||
105342979|NCT02017717|363258200|FG005|Before Treatment Period|Lost to Follow-up|0|||
105342980|NCT02017717|363258201|FG006|Before Treatment Period|Lost to Follow-up|0|||
105342981|NCT02017717|363258202|FG007|Before Treatment Period|Lost to Follow-up|0|||
105342982|NCT02017717|363258203|FG008|Before Treatment Period|Lost to Follow-up|1|||
105342983|NCT02017717|363258195|FG000|Before Treatment Period|Participant no longer met criteria|0|||
105555083|NCT01059565|364029139|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
105342984|NCT02017717|363258196|FG001|Before Treatment Period|Participant no longer met criteria|0|||
105342985|NCT02017717|363258197|FG002|Before Treatment Period|Participant no longer met criteria|0|||
105342986|NCT02017717|363258198|FG003|Before Treatment Period|Participant no longer met criteria|0|||
105342987|NCT02017717|363258199|FG004|Before Treatment Period|Participant no longer met criteria|0|||
105342988|NCT02017717|363258200|FG005|Before Treatment Period|Participant no longer met criteria|1|||
105342989|NCT02017717|363258201|FG006|Before Treatment Period|Participant no longer met criteria|0|||
105342990|NCT02017717|363258202|FG007|Before Treatment Period|Participant no longer met criteria|1|||
105342991|NCT02017717|363258203|FG008|Before Treatment Period|Participant no longer met criteria|2|||
105342992|NCT02017717|363258195|FG000|Before Treatment Period|other reason|0|||
105342993|NCT02017717|363258196|FG001|Before Treatment Period|other reason|0|||
105342994|NCT02017717|363258197|FG002|Before Treatment Period|other reason|0|||
105342995|NCT02017717|363258198|FG003|Before Treatment Period|other reason|0|||
105342996|NCT02017717|363258199|FG004|Before Treatment Period|other reason|0|||
105342997|NCT02017717|363258200|FG005|Before Treatment Period|other reason|0|||
105342998|NCT02017717|363258201|FG006|Before Treatment Period|other reason|0|||
105342999|NCT02017717|363258202|FG007|Before Treatment Period|other reason|0|||
105343000|NCT02017717|363258203|FG008|Before Treatment Period|other reason|1|||
105343001|NCT02017717|363258195|FG000|Treatment Period|Disease progression|7|||
105343002|NCT02017717|363258196|FG001|Treatment Period|Disease progression|9|||
105343003|NCT02017717|363258197|FG002|Treatment Period|Disease progression|12|||
105343004|NCT02017717|363258198|FG003|Treatment Period|Disease progression|20|||
105343005|NCT02017717|363258199|FG004|Treatment Period|Disease progression|26|||
105343006|NCT02017717|363258200|FG005|Treatment Period|Disease progression|16|||
105343007|NCT02017717|363258201|FG006|Treatment Period|Disease progression|22|||
105343008|NCT02017717|363258202|FG007|Treatment Period|Disease progression|165|||
105343009|NCT02017717|363258203|FG008|Treatment Period|Disease progression|135|||
105343010|NCT02017717|363258195|FG000|Treatment Period|Study drug toxicity|3|||
105343011|NCT02017717|363258196|FG001|Treatment Period|Study drug toxicity|0|||
105343012|NCT02017717|363258197|FG002|Treatment Period|Study drug toxicity|1|||
105343013|NCT02017717|363258198|FG003|Treatment Period|Study drug toxicity|4|||
105343014|NCT02017717|363258199|FG004|Treatment Period|Study drug toxicity|4|||
105343015|NCT02017717|363258200|FG005|Treatment Period|Study drug toxicity|5|||
105343016|NCT02017717|363258201|FG006|Treatment Period|Study drug toxicity|3|||
105343017|NCT02017717|363258202|FG007|Treatment Period|Study drug toxicity|7|||
105343018|NCT02017717|363258203|FG008|Treatment Period|Study drug toxicity|11|||
105343019|NCT02017717|363258195|FG000|Treatment Period|Death|0|||
105343020|NCT02017717|363258196|FG001|Treatment Period|Death|0|||
105343021|NCT02017717|363258197|FG002|Treatment Period|Death|1|||
105343022|NCT02017717|363258198|FG003|Treatment Period|Death|0|||
105343023|NCT02017717|363258199|FG004|Treatment Period|Death|0|||
105343024|NCT02017717|363258200|FG005|Treatment Period|Death|2|||
105343025|NCT02017717|363258201|FG006|Treatment Period|Death|0|||
105343026|NCT02017717|363258202|FG007|Treatment Period|Death|0|||
105343027|NCT02017717|363258203|FG008|Treatment Period|Death|0|||
105343028|NCT02017717|363258195|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
105343029|NCT02017717|363258196|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
105343030|NCT02017717|363258197|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
105343031|NCT02017717|363258198|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
105343032|NCT02017717|363258199|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
105343033|NCT02017717|363258200|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
105343034|NCT02017717|363258201|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
105343035|NCT02017717|363258202|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
105343036|NCT02017717|363258203|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
105343037|NCT02017717|363258195|FG000|Treatment Period|Participant request to stop therapy|0|||
105343038|NCT02017717|363258196|FG001|Treatment Period|Participant request to stop therapy|0|||
105343039|NCT02017717|363258197|FG002|Treatment Period|Participant request to stop therapy|3|||
105343040|NCT02017717|363258198|FG003|Treatment Period|Participant request to stop therapy|6|||
105343041|NCT02017717|363258199|FG004|Treatment Period|Participant request to stop therapy|0|||
105343042|NCT02017717|363258200|FG005|Treatment Period|Participant request to stop therapy|2|||
105343043|NCT02017717|363258201|FG006|Treatment Period|Participant request to stop therapy|1|||
105343044|NCT02017717|363258202|FG007|Treatment Period|Participant request to stop therapy|4|||
105343045|NCT02017717|363258203|FG008|Treatment Period|Participant request to stop therapy|7|||
105343046|NCT02017717|363258195|FG000|Treatment Period|Participant withdrew consent|0|||
105343047|NCT02017717|363258196|FG001|Treatment Period|Participant withdrew consent|0|||
105343048|NCT02017717|363258197|FG002|Treatment Period|Participant withdrew consent|1|||
105343049|NCT02017717|363258198|FG003|Treatment Period|Participant withdrew consent|0|||
105343050|NCT02017717|363258199|FG004|Treatment Period|Participant withdrew consent|0|||
105343051|NCT02017717|363258200|FG005|Treatment Period|Participant withdrew consent|2|||
105343052|NCT02017717|363258201|FG006|Treatment Period|Participant withdrew consent|0|||
105343053|NCT02017717|363258202|FG007|Treatment Period|Participant withdrew consent|1|||
105343054|NCT02017717|363258203|FG008|Treatment Period|Participant withdrew consent|4|||
105466619|NCT03853109|363720190|FG007|Overall Study|Death|5|||
105674015|NCT02091206|364470563|FG002|Treatment Period|Met withdrawal criteria|1|||
105674016|NCT02091206|364470564|FG003|Treatment Period|Met withdrawal criteria|0|||
105674017|NCT02091206|364470561|FG000|Taper Period|Participant refused study drug|1|||
105674018|NCT02091206|364470562|FG001|Taper Period|Participant refused study drug|0|||
105674019|NCT02091206|364470563|FG002|Taper Period|Participant refused study drug|0|||
105674020|NCT02091206|364470564|FG003|Taper Period|Participant refused study drug|1|||
105674021|NCT02091206|364470561|FG000|Taper Period|Lost to Follow-up|0|||
105674022|NCT02091206|364470562|FG001|Taper Period|Lost to Follow-up|0|||
105674023|NCT02091206|364470563|FG002|Taper Period|Lost to Follow-up|0|||
105674024|NCT02091206|364470564|FG003|Taper Period|Lost to Follow-up|1|||
105674025|NCT03381339|364470565|FG000|Overall Study|Protocol Violation|4|||
105674026|NCT03381339|364470566|FG001|Overall Study|Protocol Violation|3|||
105674027|NCT03381339|364470565|FG000|Overall Study|Lost to Follow-up|0|||
105674028|NCT03381339|364470566|FG001|Overall Study|Lost to Follow-up|1|||
105674029|NCT04531904|364470569|FG000|Overall Study|Lost to Follow-up|1|||
105674030|NCT04531904|364470569|FG000|Overall Study|Death|14|||
105674031|NCT03117998|364470570|FG000|Overall Study|Adverse Event|1|||
105674032|NCT03117998|364470571|FG001|Overall Study|Adverse Event|0|||
105674033|NCT03117998|364470572|FG002|Overall Study|Adverse Event|0|||
105674034|NCT03117998|364470573|FG003|Overall Study|Adverse Event|0|||
105674035|NCT03117998|364470574|FG004|Overall Study|Adverse Event|0|||
105786377|NCT01869959|364870508|FG000|Treatment Period|Withdrawal by Subject|0|||
105786378|NCT01869959|364870509|FG001|Treatment Period|Withdrawal by Subject|1|||
105786379|NCT01869959|364870510|FG002|Treatment Period|Withdrawal by Subject|0|||
105786380|NCT01869959|364870511|FG003|Treatment Period|Withdrawal by Subject|0|||
105786381|NCT01869959|364870512|FG004|Treatment Period|Withdrawal by Subject|0|||
105786382|NCT01965600|364870513|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
105786383|NCT01965600|364870514|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
105786384|NCT01965600|364870515|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
105786385|NCT01965600|364870516|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
105786386|NCT01965600|364870513|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
105786387|NCT01965600|364870514|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
105786388|NCT01965600|364870515|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
105786389|NCT01965600|364870516|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
105786390|NCT01965600|364870513|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
105786391|NCT01965600|364870514|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
105555084|NCT01059565|364029140|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
105555085|NCT01059565|364029139|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
105555086|NCT01059565|364029140|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
105555087|NCT01605617|364029141|FG000|First Intervention|Adverse Event|0|||
105555088|NCT01605617|364029142|FG001|First Intervention|Adverse Event|1|||
105555089|NCT01605617|364029141|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
105555090|NCT01605617|364029142|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
105555091|NCT01613248|364029143|FG000|Overall Study|Adverse Event|0|||
105555092|NCT01613248|364029144|FG001|Overall Study|Adverse Event|0|||
105555093|NCT01613248|364029145|FG002|Overall Study|Adverse Event|0|||
105555094|NCT01613248|364029146|FG003|Overall Study|Adverse Event|1|||
105555095|NCT01613248|364029147|FG004|Overall Study|Adverse Event|0|||
105555096|NCT01613248|364029148|FG005|Overall Study|Adverse Event|0|||
105555097|NCT01613248|364029143|FG000|Overall Study|Withdrawal by Subject|3|||
105555098|NCT01613248|364029144|FG001|Overall Study|Withdrawal by Subject|2|||
105555099|NCT01613248|364029145|FG002|Overall Study|Withdrawal by Subject|2|||
105555100|NCT01613248|364029146|FG003|Overall Study|Withdrawal by Subject|5|||
105343055|NCT02017717|363258195|FG000|Treatment Period|Participant no longer met criteria|0|||
105343056|NCT02017717|363258196|FG001|Treatment Period|Participant no longer met criteria|0|||
105466620|NCT02731638|363720191|FG000|Overall Study|Lost to Follow-up|6|||
105343057|NCT02017717|363258197|FG002|Treatment Period|Participant no longer met criteria|0|||
105555101|NCT01613248|364029147|FG004|Overall Study|Withdrawal by Subject|0|||
105343058|NCT02017717|363258198|FG003|Treatment Period|Participant no longer met criteria|0|||
105555102|NCT01613248|364029148|FG005|Overall Study|Withdrawal by Subject|1|||
105343059|NCT02017717|363258199|FG004|Treatment Period|Participant no longer met criteria|0|||
105343060|NCT02017717|363258200|FG005|Treatment Period|Participant no longer met criteria|0|||
105343061|NCT02017717|363258201|FG006|Treatment Period|Participant no longer met criteria|0|||
105343062|NCT02017717|363258202|FG007|Treatment Period|Participant no longer met criteria|0|||
105343063|NCT02017717|363258203|FG008|Treatment Period|Participant no longer met criteria|1|||
105343064|NCT02017717|363258195|FG000|Treatment Period|Other reasons|0|||
105343065|NCT02017717|363258196|FG001|Treatment Period|Other reasons|0|||
105674036|NCT03117998|364470575|FG005|Overall Study|Adverse Event|0|||
105674037|NCT03117998|364470570|FG000|Overall Study|Withdrawal by Subject|0|||
105343066|NCT02017717|363258197|FG002|Treatment Period|Other reasons|0|||
105343067|NCT02017717|363258198|FG003|Treatment Period|Other reasons|1|||
105674038|NCT03117998|364470571|FG001|Overall Study|Withdrawal by Subject|0|||
105674039|NCT03117998|364470572|FG002|Overall Study|Withdrawal by Subject|2|||
105786392|NCT01965600|364870515|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
105466621|NCT02731638|363720192|FG001|Overall Study|Lost to Follow-up|9|||
105674040|NCT03117998|364470573|FG003|Overall Study|Withdrawal by Subject|3|||
105674041|NCT03117998|364470574|FG004|Overall Study|Withdrawal by Subject|3|||
105674042|NCT03117998|364470575|FG005|Overall Study|Withdrawal by Subject|0|||
105674043|NCT03117998|364470570|FG000|Overall Study|Physician Decision|0|||
105674044|NCT03117998|364470571|FG001|Overall Study|Physician Decision|1|||
105674045|NCT03117998|364470572|FG002|Overall Study|Physician Decision|1|||
105674046|NCT03117998|364470573|FG003|Overall Study|Physician Decision|0|||
105674047|NCT03117998|364470574|FG004|Overall Study|Physician Decision|0|||
105674048|NCT03117998|364470575|FG005|Overall Study|Physician Decision|0|||
105674049|NCT03117998|364470570|FG000|Overall Study|Lost to Follow-up|0|||
105674050|NCT03117998|364470571|FG001|Overall Study|Lost to Follow-up|0|||
105674051|NCT03117998|364470572|FG002|Overall Study|Lost to Follow-up|0|||
105674052|NCT03117998|364470573|FG003|Overall Study|Lost to Follow-up|1|||
105674053|NCT03117998|364470574|FG004|Overall Study|Lost to Follow-up|4|||
105674054|NCT03117998|364470575|FG005|Overall Study|Lost to Follow-up|0|||
105674055|NCT03117998|364470570|FG000|Overall Study|Subject noncompliance|0|||
105674056|NCT03117998|364470571|FG001|Overall Study|Subject noncompliance|0|||
105674057|NCT03117998|364470572|FG002|Overall Study|Subject noncompliance|1|||
105674058|NCT03117998|364470573|FG003|Overall Study|Subject noncompliance|0|||
105674059|NCT03117998|364470574|FG004|Overall Study|Subject noncompliance|0|||
105674060|NCT03117998|364470575|FG005|Overall Study|Subject noncompliance|2|||
105674061|NCT03117998|364470570|FG000|Overall Study|Protocol Violation|0|||
105674062|NCT03117998|364470571|FG001|Overall Study|Protocol Violation|0|||
105674063|NCT03117998|364470572|FG002|Overall Study|Protocol Violation|0|||
105674064|NCT03117998|364470573|FG003|Overall Study|Protocol Violation|0|||
105674065|NCT03117998|364470574|FG004|Overall Study|Protocol Violation|0|||
105674066|NCT03117998|364470575|FG005|Overall Study|Protocol Violation|1|||
105674067|NCT00293059|364470576|FG000|Overall Study|Adverse Event|12|||
105674068|NCT00293059|364470577|FG001|Overall Study|Adverse Event|4|||
105674069|NCT00293059|364470576|FG000|Overall Study|Lack of Efficacy|2|||
105674070|NCT00293059|364470577|FG001|Overall Study|Lack of Efficacy|0|||
105674071|NCT00293059|364470576|FG000|Overall Study|Lost to Follow-up|2|||
105674072|NCT00293059|364470577|FG001|Overall Study|Lost to Follow-up|3|||
105674073|NCT00293059|364470576|FG000|Overall Study|Pregnancy|1|||
105674074|NCT00293059|364470577|FG001|Overall Study|Pregnancy|1|||
105674075|NCT00293059|364470576|FG000|Overall Study|Protocol Violation|2|||
105674076|NCT00293059|364470577|FG001|Overall Study|Protocol Violation|0|||
105674077|NCT00293059|364470576|FG000|Overall Study|Withdrawal by Subject|11|||
105674078|NCT00293059|364470577|FG001|Overall Study|Withdrawal by Subject|5|||
105674079|NCT00293059|364470576|FG000|Overall Study|Participant moved out of state|1|||
105674080|NCT00293059|364470577|FG001|Overall Study|Participant moved out of state|0|||
105674081|NCT00293059|364470576|FG000|Overall Study|Participant stopped study drug|1|||
105674082|NCT00293059|364470577|FG001|Overall Study|Participant stopped study drug|0|||
105674083|NCT00293059|364470576|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
105674084|NCT00293059|364470577|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
105674085|NCT00293059|364470576|FG000|Overall Study|missing|3|||
105674086|NCT00293059|364470577|FG001|Overall Study|missing|5|||
105674087|NCT00438672|364470579|FG000|Overall Study|Lost to Follow-up|7|||
105674088|NCT00438672|364470580|FG001|Overall Study|Lost to Follow-up|9|||
105674089|NCT00680992|364470581|FG000|Overall Study|Complete Resection (as per protocol)|25|||
105674090|NCT00680992|364470582|FG001|Overall Study|Complete Resection (as per protocol)|121|||
105674091|NCT00680992|364470583|FG002|Overall Study|Complete Resection (as per protocol)|0|||
105674092|NCT00680992|364470581|FG000|Overall Study|Administrative Decision|83|||
105674093|NCT00680992|364470582|FG001|Overall Study|Administrative Decision|42|||
105674094|NCT00680992|364470583|FG002|Overall Study|Administrative Decision|5|||
105674095|NCT00680992|364470581|FG000|Overall Study|End of Trial|32|||
105674096|NCT00680992|364470582|FG001|Overall Study|End of Trial|12|||
105674097|NCT00680992|364470583|FG002|Overall Study|End of Trial|3|||
105674098|NCT00680992|364470581|FG000|Overall Study|Withdrawal by Subject|33|||
105674099|NCT00680992|364470582|FG001|Overall Study|Withdrawal by Subject|11|||
105674100|NCT00680992|364470583|FG002|Overall Study|Withdrawal by Subject|1|||
105674101|NCT00680992|364470581|FG000|Overall Study|Adverse Event|21|||
105674102|NCT00680992|364470582|FG001|Overall Study|Adverse Event|19|||
105674103|NCT00680992|364470583|FG002|Overall Study|Adverse Event|1|||
105674104|NCT00680992|364470581|FG000|Overall Study|Other|19|||
105674105|NCT00680992|364470582|FG001|Overall Study|Other|14|||
105674106|NCT00680992|364470583|FG002|Overall Study|Other|1|||
105674107|NCT00680992|364470581|FG000|Overall Study|Disease Progression|21|||
105674108|NCT00680992|364470582|FG001|Overall Study|Disease Progression|9|||
105674109|NCT00680992|364470583|FG002|Overall Study|Disease Progression|0|||
105674110|NCT00680992|364470581|FG000|Overall Study|Lost to Follow-up|12|||
105674111|NCT00680992|364470582|FG001|Overall Study|Lost to Follow-up|14|||
105674112|NCT00680992|364470583|FG002|Overall Study|Lost to Follow-up|0|||
105674113|NCT00680992|364470581|FG000|Overall Study|Noncompliance|4|||
105674114|NCT00680992|364470582|FG001|Overall Study|Noncompliance|6|||
105674115|NCT00680992|364470583|FG002|Overall Study|Noncompliance|0|||
105674116|NCT00680992|364470581|FG000|Overall Study|Requirement for Alternative Therapy|8|||
105674117|NCT00680992|364470582|FG001|Overall Study|Requirement for Alternative Therapy|2|||
105674118|NCT00680992|364470583|FG002|Overall Study|Requirement for Alternative Therapy|0|||
105674119|NCT00680992|364470581|FG000|Overall Study|Pregnancy|5|||
105674120|NCT00680992|364470582|FG001|Overall Study|Pregnancy|0|||
105674121|NCT00680992|364470583|FG002|Overall Study|Pregnancy|1|||
105674122|NCT00680992|364470581|FG000|Overall Study|Death|5|||
105674123|NCT00680992|364470582|FG001|Overall Study|Death|1|||
105674124|NCT00680992|364470583|FG002|Overall Study|Death|0|||
105674125|NCT00680992|364470581|FG000|Overall Study|Ineligibility Determined|0|||
105674126|NCT00680992|364470582|FG001|Overall Study|Ineligibility Determined|1|||
105674127|NCT00680992|364470583|FG002|Overall Study|Ineligibility Determined|0|||
105674128|NCT04828837|364470584|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
105674129|NCT04828837|364470585|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
105674130|NCT04828837|364470584|FG000|Overall Study|Lost to Follow-up|2|||
105674131|NCT04828837|364470585|FG001|Overall Study|Lost to Follow-up|6|||
105674132|NCT04828837|364470584|FG000|Overall Study|Lack of Efficacy|1|||
105674133|NCT04828837|364470585|FG001|Overall Study|Lack of Efficacy|0|||
105674134|NCT04828837|364470584|FG000|Overall Study|Admitted due to pneumothorax.|1|||
105674135|NCT04828837|364470585|FG001|Overall Study|Admitted due to pneumothorax.|0|||
105674136|NCT04828837|364470584|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
105674137|NCT04828837|364470585|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
105674138|NCT00320528|364470586|FG000|Study Period II|Adverse Event|3|||
105674139|NCT00320528|364470587|FG001|Study Period II|Adverse Event|4|||
105674140|NCT00320528|364470588|FG002|Study Period II|Adverse Event|8|||
105674141|NCT00320528|364470586|FG000|Study Period II|Parent/Caregiver Decision|8|||
105674142|NCT00320528|364470587|FG001|Study Period II|Parent/Caregiver Decision|3|||
105674143|NCT00320528|364470588|FG002|Study Period II|Parent/Caregiver Decision|11|||
105674144|NCT00320528|364470586|FG000|Study Period II|Withdrawal by Subject|0|||
105674145|NCT00320528|364470587|FG001|Study Period II|Withdrawal by Subject|1|||
105674146|NCT00320528|364470588|FG002|Study Period II|Withdrawal by Subject|1|||
105674147|NCT00320528|364470586|FG000|Study Period II|Entry Criteria Exclusion|0|||
105674148|NCT00320528|364470587|FG001|Study Period II|Entry Criteria Exclusion|2|||
105674149|NCT00320528|364470588|FG002|Study Period II|Entry Criteria Exclusion|2|||
105674150|NCT00320528|364470586|FG000|Study Period III|Adverse Event|1|||
105674151|NCT00320528|364470587|FG001|Study Period III|Adverse Event|0|||
105674152|NCT00320528|364470588|FG002|Study Period III|Adverse Event|0|||
105674153|NCT00320528|364470586|FG000|Study Period III|Lost to Follow-up|1|||
105674154|NCT00320528|364470587|FG001|Study Period III|Lost to Follow-up|0|||
105674155|NCT00320528|364470588|FG002|Study Period III|Lost to Follow-up|0|||
105674156|NCT00320528|364470586|FG000|Study Period III|Withdrawal by Subject|1|||
105674157|NCT00320528|364470587|FG001|Study Period III|Withdrawal by Subject|1|||
105674158|NCT00320528|364470588|FG002|Study Period III|Withdrawal by Subject|2|||
105674159|NCT00320528|364470586|FG000|Study Period III|Lack of Efficacy|2|||
105674160|NCT00320528|364470587|FG001|Study Period III|Lack of Efficacy|0|||
105674161|NCT00320528|364470588|FG002|Study Period III|Lack of Efficacy|0|||
105674162|NCT00320528|364470586|FG000|Study Period III|Parent/Caregiver Decision|14|||
105674163|NCT00320528|364470587|FG001|Study Period III|Parent/Caregiver Decision|3|||
105674164|NCT00320528|364470588|FG002|Study Period III|Parent/Caregiver Decision|11|||
105674165|NCT00320528|364470586|FG000|Study Period III|Protocol Violation|0|||
105674166|NCT00320528|364470587|FG001|Study Period III|Protocol Violation|1|||
105674167|NCT00320528|364470588|FG002|Study Period III|Protocol Violation|0|||
105674168|NCT00320528|364470586|FG000|Study Period III|Physician Decision|0|||
105674169|NCT00320528|364470587|FG001|Study Period III|Physician Decision|1|||
105674170|NCT00320528|364470588|FG002|Study Period III|Physician Decision|2|||
105674171|NCT00320528|364470586|FG000|Study Period III|Sponsor Decision|0|||
105674172|NCT00320528|364470587|FG001|Study Period III|Sponsor Decision|0|||
105674173|NCT00320528|364470588|FG002|Study Period III|Sponsor Decision|1|||
105674174|NCT00320528|364470586|FG000|Study Period III|Atomoxetine Commercially Available|68|||
105674175|NCT00320528|364470587|FG001|Study Period III|Atomoxetine Commercially Available|25|||
105674176|NCT00320528|364470588|FG002|Study Period III|Atomoxetine Commercially Available|90|||
105674177|NCT00925353|364470589|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
105674178|NCT01022112|364470590|FG000|Overall Study|Adverse Event|1|||
105674179|NCT01022112|364470591|FG001|Overall Study|Adverse Event|2|||
105674180|NCT01022112|364470592|FG002|Overall Study|Adverse Event|0|||
105674181|NCT01022112|364470593|FG003|Overall Study|Adverse Event|1|||
105674182|NCT01022112|364470594|FG004|Overall Study|Adverse Event|0|||
105674183|NCT01022112|364470590|FG000|Overall Study|Lack of Efficacy|1|||
105674184|NCT01022112|364470591|FG001|Overall Study|Lack of Efficacy|0|||
105674185|NCT01022112|364470592|FG002|Overall Study|Lack of Efficacy|0|||
105674186|NCT01022112|364470593|FG003|Overall Study|Lack of Efficacy|0|||
105674187|NCT01022112|364470594|FG004|Overall Study|Lack of Efficacy|1|||
105674188|NCT01022112|364470590|FG000|Overall Study|Physician Decision|0|||
105674189|NCT01022112|364470591|FG001|Overall Study|Physician Decision|0|||
105674190|NCT01022112|364470592|FG002|Overall Study|Physician Decision|1|||
105674191|NCT01022112|364470593|FG003|Overall Study|Physician Decision|0|||
105674192|NCT01022112|364470594|FG004|Overall Study|Physician Decision|1|||
105674193|NCT01022112|364470590|FG000|Overall Study|Withdrawal by Subject|0|||
105674194|NCT01022112|364470591|FG001|Overall Study|Withdrawal by Subject|1|||
105674195|NCT01022112|364470592|FG002|Overall Study|Withdrawal by Subject|2|||
105674196|NCT01022112|364470593|FG003|Overall Study|Withdrawal by Subject|2|||
105674197|NCT01022112|364470594|FG004|Overall Study|Withdrawal by Subject|1|||
105674198|NCT01022112|364470590|FG000|Overall Study|Fasting plasma glucose level increased|1|||
105674199|NCT01022112|364470591|FG001|Overall Study|Fasting plasma glucose level increased|0|||
105674200|NCT01022112|364470592|FG002|Overall Study|Fasting plasma glucose level increased|0|||
105674201|NCT01022112|364470593|FG003|Overall Study|Fasting plasma glucose level increased|0|||
105674202|NCT01022112|364470594|FG004|Overall Study|Fasting plasma glucose level increased|7|||
105674203|NCT04664400|364470595|FG000|Overall Study|Withdrawal by Subject|2|||
105674204|NCT00515853|364470596|FG000|Overall Study|Lost to Follow-up|9|||
105674205|NCT00515853|364470597|FG001|Overall Study|Lost to Follow-up|13|||
105674206|NCT00515853|364470596|FG000|Overall Study|Withdrawal by Subject|6|||
105674207|NCT00515853|364470597|FG001|Overall Study|Withdrawal by Subject|4|||
105674208|NCT03014479|364470599|FG000|Overall Study|Adverse Event|0|||
105674209|NCT03014479|364470600|FG001|Overall Study|Adverse Event|1|||
105674210|NCT03014479|364470599|FG000|Overall Study|Voluntary Withdrawal|0|||
105674211|NCT03014479|364470600|FG001|Overall Study|Voluntary Withdrawal|2|||
105674212|NCT03014479|364470599|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
105674213|NCT03014479|364470600|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
105674214|NCT00653523|364470601|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
105674215|NCT00653523|364470601|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
105674216|NCT00653523|364470601|FG000|Overall Study|Adverse Event|7|||
105674217|NCT00653523|364470601|FG000|Overall Study|Withdrawal by Subject|6|||
105674218|NCT00653523|364470601|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
105674219|NCT00653523|364470601|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
105674220|NCT01942785|364470605|FG000|Overall Study|Adverse Event|2|||
105674221|NCT01942785|364470605|FG000|Overall Study|Withdrawal by Subject|1|||
105674222|NCT01942785|364470605|FG000|Overall Study|Protocol Violation|1|||
105674223|NCT05597787|364470606|FG000|Overall Study|Withdrawal by Subject|0|||
105674224|NCT05597787|364470607|FG001|Overall Study|Withdrawal by Subject|0|||
105674225|NCT05597787|364470608|FG002|Overall Study|Withdrawal by Subject|1|||
105674226|NCT05148962|364470609|FG000|Overall Study|Withdrawal by Subject|1|||
105674227|NCT05148962|364470610|FG001|Overall Study|Withdrawal by Subject|1|||
105674228|NCT05148962|364470611|FG002|Overall Study|Withdrawal by Subject|0|||
105674229|NCT05148962|364470612|FG003|Overall Study|Withdrawal by Subject|1|||
105674230|NCT05148962|364470613|FG004|Overall Study|Withdrawal by Subject|0|||
105674231|NCT05148962|364470609|FG000|Overall Study|Participant was early terminated per protocol|0|||
105674232|NCT05148962|364470610|FG001|Overall Study|Participant was early terminated per protocol|0|||
105674233|NCT05148962|364470611|FG002|Overall Study|Participant was early terminated per protocol|3|||
105674234|NCT05148962|364470612|FG003|Overall Study|Participant was early terminated per protocol|5|||
105674235|NCT05148962|364470613|FG004|Overall Study|Participant was early terminated per protocol|2|||
105674236|NCT05148962|364470609|FG000|Overall Study|Miscellaneous|0|||
105674237|NCT05148962|364470610|FG001|Overall Study|Miscellaneous|0|||
105674238|NCT05148962|364470611|FG002|Overall Study|Miscellaneous|0|||
105674239|NCT05148962|364470612|FG003|Overall Study|Miscellaneous|1|||
105674240|NCT05148962|364470613|FG004|Overall Study|Miscellaneous|0|||
105674241|NCT01144377|364470616|FG000|52 Week Treatment Period|Adverse Event|0|||
105674242|NCT01144377|364470617|FG001|52 Week Treatment Period|Adverse Event|0|||
105674243|NCT01144377|364470618|FG002|52 Week Treatment Period|Adverse Event|3|||
105674244|NCT01144377|364470619|FG003|52 Week Treatment Period|Adverse Event|2|||
105674245|NCT01144377|364470620|FG004|52 Week Treatment Period|Adverse Event|1|||
105674246|NCT01144377|364470616|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
105674247|NCT01144377|364470617|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
105674248|NCT01144377|364470618|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
105674249|NCT01144377|364470619|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
105674250|NCT01144377|364470620|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
105674251|NCT01144377|364470616|FG000|52 Week Treatment Period|Protocol Violation|0|||
105674252|NCT01144377|364470617|FG001|52 Week Treatment Period|Protocol Violation|0|||
105674253|NCT01144377|364470618|FG002|52 Week Treatment Period|Protocol Violation|0|||
105674254|NCT01144377|364470619|FG003|52 Week Treatment Period|Protocol Violation|0|||
105674255|NCT01144377|364470620|FG004|52 Week Treatment Period|Protocol Violation|1|||
105674256|NCT01144377|364470616|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
105674257|NCT01144377|364470617|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
105674258|NCT01144377|364470618|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
105674259|NCT01144377|364470619|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
105674260|NCT01144377|364470620|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
105674261|NCT01144377|364470616|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
105674262|NCT01144377|364470617|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
105674263|NCT01144377|364470618|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
105674264|NCT01144377|364470619|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
105674265|NCT01144377|364470620|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
105674266|NCT01144377|364470616|FG000|52 Week Treatment Period|Sponsor Decision|0|||
105674267|NCT01144377|364470617|FG001|52 Week Treatment Period|Sponsor Decision|0|||
105674268|NCT01144377|364470618|FG002|52 Week Treatment Period|Sponsor Decision|0|||
105674269|NCT01144377|364470619|FG003|52 Week Treatment Period|Sponsor Decision|0|||
105674270|NCT01144377|364470620|FG004|52 Week Treatment Period|Sponsor Decision|1|||
105674271|NCT01144377|364470616|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
105674272|NCT01144377|364470617|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
105674273|NCT01144377|364470618|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
105674274|NCT01144377|364470619|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
105674275|NCT01144377|364470620|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
105674276|NCT01144377|364470616|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
105674277|NCT01144377|364470617|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
105674278|NCT01144377|364470618|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
105674279|NCT01144377|364470619|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
105674280|NCT01144377|364470620|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
105674281|NCT01144377|364470616|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
105786393|NCT01965600|364870516|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
105786394|NCT01965600|364870513|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
105786395|NCT01965600|364870514|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
105466622|NCT00361296|363720193|FG000|Overall Study|Physician Decision|1|||
105555103|NCT01613248|364029143|FG000|Overall Study|Lost to Follow-up|5|||
105555104|NCT01613248|364029144|FG001|Overall Study|Lost to Follow-up|7|||
105555105|NCT01613248|364029145|FG002|Overall Study|Lost to Follow-up|4|||
105555106|NCT01613248|364029146|FG003|Overall Study|Lost to Follow-up|8|||
105555107|NCT01613248|364029147|FG004|Overall Study|Lost to Follow-up|4|||
105555108|NCT01613248|364029148|FG005|Overall Study|Lost to Follow-up|2|||
105555109|NCT01613248|364029143|FG000|Overall Study|Study Terminated by Sponsor|4|||
105555110|NCT01613248|364029144|FG001|Overall Study|Study Terminated by Sponsor|6|||
105555111|NCT01613248|364029145|FG002|Overall Study|Study Terminated by Sponsor|8|||
105555112|NCT01613248|364029146|FG003|Overall Study|Study Terminated by Sponsor|8|||
105555113|NCT01613248|364029147|FG004|Overall Study|Study Terminated by Sponsor|9|||
105555114|NCT01613248|364029148|FG005|Overall Study|Study Terminated by Sponsor|11|||
105555115|NCT01613248|364029143|FG000|Overall Study|Physician Decision|8|||
105555116|NCT01613248|364029144|FG001|Overall Study|Physician Decision|8|||
105555117|NCT01613248|364029145|FG002|Overall Study|Physician Decision|9|||
105555118|NCT01613248|364029146|FG003|Overall Study|Physician Decision|4|||
105555119|NCT01613248|364029147|FG004|Overall Study|Physician Decision|7|||
105555120|NCT01613248|364029148|FG005|Overall Study|Physician Decision|6|||
105555121|NCT01613248|364029143|FG000|Overall Study|Lack of Qualifying Event|9|||
105555122|NCT01613248|364029144|FG001|Overall Study|Lack of Qualifying Event|11|||
105555123|NCT01613248|364029145|FG002|Overall Study|Lack of Qualifying Event|10|||
105555124|NCT01613248|364029146|FG003|Overall Study|Lack of Qualifying Event|11|||
105555125|NCT01613248|364029147|FG004|Overall Study|Lack of Qualifying Event|15|||
105555126|NCT01613248|364029148|FG005|Overall Study|Lack of Qualifying Event|18|||
105555127|NCT01613248|364029143|FG000|Overall Study|Pregnancy|0|||
105555128|NCT01613248|364029144|FG001|Overall Study|Pregnancy|0|||
105555129|NCT01613248|364029145|FG002|Overall Study|Pregnancy|0|||
105555130|NCT01613248|364029146|FG003|Overall Study|Pregnancy|1|||
105555131|NCT01613248|364029147|FG004|Overall Study|Pregnancy|0|||
105555132|NCT01613248|364029148|FG005|Overall Study|Pregnancy|0|||
105555133|NCT01491854|364029149|FG000|Overall Study|mainly due to premature termination|93|||
105555134|NCT01491854|364029149|FG000|Overall Study|Death|1|||
105555135|NCT01491854|364029149|FG000|Overall Study|Withdrawal by Subject|3|||
105555136|NCT01491854|364029149|FG000|Overall Study|Lost to Follow-up|33|||
105555137|NCT00121238|364029150|FG000|Overall Study|disease progression before intervention|1|||
105555138|NCT00121238|364029150|FG000|Overall Study|Protocol Violation|2|||
105555139|NCT00868439|364029151|FG000|Overall Study|Adverse Event|4|||
105555140|NCT00868439|364029152|FG001|Overall Study|Adverse Event|3|||
105555141|NCT00868439|364029151|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
105555142|NCT00868439|364029152|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
105674282|NCT01144377|364470617|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
105674283|NCT01144377|364470618|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
105674284|NCT01144377|364470619|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
105674285|NCT01144377|364470620|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
105674286|NCT01147536|364470621|FG000|Overall Study|Administrative study close|2|||
105674287|NCT01147536|364470621|FG000|Overall Study|Death|1|||
105674288|NCT02489968|364470622|FG000|Open-label Treatment Period|Adverse Event|14|||
105674289|NCT02489968|364470623|FG001|Open-label Treatment Period|Adverse Event|7|||
105674290|NCT02489968|364470624|FG002|Open-label Treatment Period|Adverse Event|0|||
105674291|NCT02489968|364470625|FG003|Open-label Treatment Period|Adverse Event|0|||
105674292|NCT02489968|364470626|FG004|Open-label Treatment Period|Adverse Event|0|||
105674293|NCT02489968|364470627|FG005|Open-label Treatment Period|Adverse Event|0|||
105674294|NCT02489968|364470622|FG000|Open-label Treatment Period|Protocol Violation|2|||
105674295|NCT02489968|364470623|FG001|Open-label Treatment Period|Protocol Violation|2|||
105674296|NCT02489968|364470624|FG002|Open-label Treatment Period|Protocol Violation|0|||
105674297|NCT02489968|364470625|FG003|Open-label Treatment Period|Protocol Violation|0|||
105674298|NCT02489968|364470626|FG004|Open-label Treatment Period|Protocol Violation|0|||
105674299|NCT02489968|364470627|FG005|Open-label Treatment Period|Protocol Violation|0|||
105674300|NCT02489968|364470622|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
105674301|NCT02489968|364470623|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
105674302|NCT02489968|364470624|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
105674303|NCT02489968|364470625|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
105674304|NCT02489968|364470626|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
105555143|NCT00868439|364029151|FG000|Overall Study|Death|0|||
105555144|NCT00868439|364029152|FG001|Overall Study|Death|1|||
105555145|NCT00868439|364029151|FG000|Overall Study|Protocol Violation|1|||
105555146|NCT00868439|364029152|FG001|Overall Study|Protocol Violation|1|||
105555147|NCT00868439|364029151|FG000|Overall Study|Physician Decision|1|||
105555148|NCT00868439|364029152|FG001|Overall Study|Physician Decision|0|||
105555149|NCT00868439|364029151|FG000|Overall Study|Withdrawal by Subject|0|||
105555150|NCT00868439|364029152|FG001|Overall Study|Withdrawal by Subject|1|||
105674305|NCT02489968|364470627|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
105674306|NCT02489968|364470622|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
105674307|NCT02489968|364470623|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
105555151|NCT03280121|364029155|FG000|Overall Study|Physician Decision|1|||
105674308|NCT02489968|364470624|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
105674309|NCT02489968|364470625|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
105674310|NCT02489968|364470626|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
105674311|NCT02489968|364470627|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
105674312|NCT02489968|364470622|FG000|Open-label Treatment Period|Other than specified above|204|||
105674313|NCT02489968|364470623|FG001|Open-label Treatment Period|Other than specified above|189|||
105674314|NCT02489968|364470624|FG002|Open-label Treatment Period|Other than specified above|0|||
105674315|NCT02489968|364470625|FG003|Open-label Treatment Period|Other than specified above|0|||
105674316|NCT02489968|364470626|FG004|Open-label Treatment Period|Other than specified above|0|||
105674317|NCT02489968|364470627|FG005|Open-label Treatment Period|Other than specified above|0|||
105674318|NCT02489968|364470622|FG000|Double-blind Treatment Period|Adverse Event|0|||
105674319|NCT02489968|364470623|FG001|Double-blind Treatment Period|Adverse Event|0|||
105674320|NCT02489968|364470624|FG002|Double-blind Treatment Period|Adverse Event|2|||
105674321|NCT02489968|364470625|FG003|Double-blind Treatment Period|Adverse Event|6|||
105674322|NCT02489968|364470626|FG004|Double-blind Treatment Period|Adverse Event|4|||
105674323|NCT02489968|364470627|FG005|Double-blind Treatment Period|Adverse Event|5|||
105674324|NCT02489968|364470622|FG000|Double-blind Treatment Period|Protocol Violation|0|||
105674325|NCT02489968|364470623|FG001|Double-blind Treatment Period|Protocol Violation|0|||
105674326|NCT02489968|364470624|FG002|Double-blind Treatment Period|Protocol Violation|0|||
105674327|NCT02489968|364470625|FG003|Double-blind Treatment Period|Protocol Violation|0|||
105674328|NCT02489968|364470626|FG004|Double-blind Treatment Period|Protocol Violation|1|||
105674329|NCT02489968|364470627|FG005|Double-blind Treatment Period|Protocol Violation|1|||
105674330|NCT02489968|364470622|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
105674331|NCT02489968|364470623|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
105674332|NCT02489968|364470624|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105674333|NCT02489968|364470625|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
105674334|NCT02489968|364470626|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
105674335|NCT02489968|364470627|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
105674336|NCT02489968|364470622|FG000|Double-blind Treatment Period|Other than specified above|0|||
105674337|NCT02489968|364470623|FG001|Double-blind Treatment Period|Other than specified above|0|||
105674338|NCT02489968|364470624|FG002|Double-blind Treatment Period|Other than specified above|0|||
105674339|NCT02489968|364470625|FG003|Double-blind Treatment Period|Other than specified above|0|||
105674340|NCT02489968|364470626|FG004|Double-blind Treatment Period|Other than specified above|1|||
105674341|NCT02489968|364470627|FG005|Double-blind Treatment Period|Other than specified above|0|||
105674342|NCT01525238|364470628|FG000|Overall Study|Withdrawal by Subject|1|||
105674343|NCT01525238|364470629|FG001|Overall Study|Withdrawal by Subject|0|||
105674344|NCT01525238|364470630|FG002|Overall Study|Withdrawal by Subject|0|||
105674345|NCT03446781|364471891|FG000|Overall Study|Lost to Follow-up|11|||
105674346|NCT03446781|364471892|FG001|Overall Study|Lost to Follow-up|5|||
105674347|NCT03446781|364471891|FG000|Overall Study|Withdrawal by Subject|9|||
105674348|NCT03446781|364471892|FG001|Overall Study|Withdrawal by Subject|7|||
105674349|NCT03446781|364471891|FG000|Overall Study|Adverse Event|8|||
105674350|NCT03446781|364471892|FG001|Overall Study|Adverse Event|2|||
105674351|NCT03446781|364471891|FG000|Overall Study|Protocol Violation|0|||
105674352|NCT03446781|364471892|FG001|Overall Study|Protocol Violation|3|||
105674353|NCT00836745|364471893|FG000|Overall Study|Death|2|||
105674354|NCT00836745|364471893|FG000|Overall Study|Lost to Follow-up|10|||
105674355|NCT00836745|364471893|FG000|Overall Study|Adverse Event|3|||
105674356|NCT00836745|364471893|FG000|Overall Study|Objective progression or relapse|4|||
105674357|NCT00836745|364471893|FG000|Overall Study|Other|2|||
105674358|NCT01552603|364471897|FG000|Overall Study|Physician Decision|1|||
105674359|NCT00224887|364471901|FG000|Overall Study|Pregnancy|6|||
105674360|NCT00224887|364471902|FG001|Overall Study|Pregnancy|6|||
105674361|NCT05560243|364471905|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
105674362|NCT00939822|364471906|FG000|Overall Study|Lost to Follow-up|1|||
105674363|NCT00939822|364471907|FG001|Overall Study|Lost to Follow-up|0|||
105674364|NCT00939822|364471906|FG000|Overall Study|withdrew from study due to busy schedule|1|||
105674365|NCT00939822|364471907|FG001|Overall Study|withdrew from study due to busy schedule|1|||
105674366|NCT00939822|364471906|FG000|Overall Study|Mental health issues|0|||
105674367|NCT00939822|364471907|FG001|Overall Study|Mental health issues|2|||
105674368|NCT00910039|364471908|FG000|Overall Study|Physician Decision|1|||
105674369|NCT03231800|364471912|FG000|Overall Study|Lost to Follow-up|0|||
105674370|NCT03231800|364471913|FG001|Overall Study|Lost to Follow-up|2|||
105674371|NCT03231800|364471912|FG000|Overall Study|Protocol Violation|1|||
105674372|NCT03231800|364471913|FG001|Overall Study|Protocol Violation|1|||
105674373|NCT03231800|364471912|FG000|Overall Study|reason not provided|2|||
105674374|NCT03231800|364471913|FG001|Overall Study|reason not provided|0|||
105674375|NCT00859222|364471915|FG000|Overall Study|Adverse Event|2|||
105674376|NCT00859222|364471916|FG001|Overall Study|Adverse Event|3|||
105674377|NCT00859222|364471917|FG002|Overall Study|Adverse Event|6|||
105674378|NCT00859222|364471918|FG003|Overall Study|Adverse Event|24|||
105786396|NCT01965600|364870515|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
105343068|NCT02017717|363258199|FG004|Treatment Period|Other reasons|0|||
105343069|NCT02017717|363258200|FG005|Treatment Period|Other reasons|1|||
105343070|NCT02017717|363258201|FG006|Treatment Period|Other reasons|1|||
105555152|NCT03280121|364029155|FG000|Overall Study|Lost to Follow-up|1|||
105555153|NCT03280121|364029155|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
105555154|NCT01933932|364029163|FG000|Overall Study|Death|173|||
105555155|NCT01933932|364029164|FG001|Overall Study|Death|163|||
105555156|NCT01933932|364029163|FG000|Overall Study|Withdrawal by Subject|11|||
105555157|NCT01933932|364029164|FG001|Overall Study|Withdrawal by Subject|14|||
105555158|NCT01933932|364029163|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105555159|NCT01933932|364029164|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
105555160|NCT04969198|364029165|FG000|Overall Study|Withdrawal by Subject|20|||
105555161|NCT04969198|364029165|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
105555162|NCT04969198|364029165|FG000|Overall Study|Lost to Follow-up|20|||
105555163|NCT03526250|364029166|FG000|Overall Study|Adverse Event|4|||
105555164|NCT03526250|364029166|FG000|Overall Study|Progressive Disease|16|||
105555165|NCT03526250|364029166|FG000|Overall Study|No Treatment|3|||
105555166|NCT00511004|364029167|FG000|Overall Study|Lost to Follow-up|0|||
105555167|NCT00511004|364029168|FG001|Overall Study|Lost to Follow-up|0|||
105555168|NCT00511004|364029169|FG002|Overall Study|Lost to Follow-up|4|||
105555169|NCT01869491|364029170|FG000|Overall Study|Adverse Event|3|||
105555170|NCT01869491|364029171|FG001|Overall Study|Adverse Event|5|||
105555171|NCT01869491|364029170|FG000|Overall Study|Lack of Efficacy|0|||
105555172|NCT01869491|364029171|FG001|Overall Study|Lack of Efficacy|3|||
105555173|NCT01869491|364029170|FG000|Overall Study|Withdrawal by Subject|6|||
105555174|NCT01869491|364029171|FG001|Overall Study|Withdrawal by Subject|7|||
105555175|NCT01869491|364029170|FG000|Overall Study|Lost to Follow-up|11|||
105555176|NCT01869491|364029171|FG001|Overall Study|Lost to Follow-up|9|||
105555177|NCT01869491|364029170|FG000|Overall Study|No further need of investigational product|1|||
105555178|NCT01869491|364029171|FG001|Overall Study|No further need of investigational product|0|||
105555179|NCT02085408|364029172|FG000|Step 1: Induction|Disease Progression|19|||
105555180|NCT02085408|364029173|FG001|Step 1: Induction|Disease Progression|19|||
105555181|NCT02085408|364029172|FG000|Step 1: Induction|Adverse Event|18|||
105555182|NCT02085408|364029173|FG001|Step 1: Induction|Adverse Event|17|||
105555183|NCT02085408|364029172|FG000|Step 1: Induction|Death|33|||
105555184|NCT02085408|364029173|FG001|Step 1: Induction|Death|30|||
105555185|NCT02085408|364029172|FG000|Step 1: Induction|Withdrawal by Subject|16|||
105555186|NCT02085408|364029173|FG001|Step 1: Induction|Withdrawal by Subject|8|||
105555187|NCT02085408|364029172|FG000|Step 1: Induction|Alternative Therapy|15|||
105555188|NCT02085408|364029173|FG001|Step 1: Induction|Alternative Therapy|19|||
105555189|NCT02085408|364029172|FG000|Step 1: Induction|Complicating Disease|2|||
105555190|NCT02085408|364029173|FG001|Step 1: Induction|Complicating Disease|3|||
105555191|NCT02085408|364029172|FG000|Step 1: Induction|Other|27|||
105555192|NCT02085408|364029173|FG001|Step 1: Induction|Other|39|||
105555193|NCT02085408|364029172|FG000|Step 1: Induction|Never started treatment|6|||
105555194|NCT02085408|364029173|FG001|Step 1: Induction|Never started treatment|4|||
105555195|NCT02085408|364029172|FG000|Step 2: Consolidation|Disease Progression|5|||
105555196|NCT02085408|364029173|FG001|Step 2: Consolidation|Disease Progression|20|||
105555197|NCT02085408|364029172|FG000|Step 2: Consolidation|Adverse Event|9|||
105555198|NCT02085408|364029173|FG001|Step 2: Consolidation|Adverse Event|8|||
105555199|NCT02085408|364029172|FG000|Step 2: Consolidation|Death|4|||
105555200|NCT02085408|364029173|FG001|Step 2: Consolidation|Death|3|||
105555201|NCT02085408|364029172|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
105555202|NCT02085408|364029173|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
105555203|NCT02085408|364029172|FG000|Step 2: Consolidation|Alternative Therapy|9|||
105555204|NCT02085408|364029173|FG001|Step 2: Consolidation|Alternative Therapy|3|||
105555205|NCT02085408|364029172|FG000|Step 2: Consolidation|Complicating Disease|0|||
105555206|NCT02085408|364029173|FG001|Step 2: Consolidation|Complicating Disease|2|||
105555207|NCT02085408|364029172|FG000|Step 2: Consolidation|Other|6|||
105555208|NCT02085408|364029173|FG001|Step 2: Consolidation|Other|6|||
105555209|NCT02085408|364029172|FG000|Step 2: Consolidation|Never started treatment|4|||
105555210|NCT02085408|364029173|FG001|Step 2: Consolidation|Never started treatment|3|||
105555211|NCT02085408|364029172|FG000|Step 3: Maintenance|Disease Progression|13|||
105555212|NCT02085408|364029173|FG001|Step 3: Maintenance|Disease Progression|11|||
105555213|NCT02085408|364029172|FG000|Step 3: Maintenance|Adverse Event|2|||
105555214|NCT02085408|364029173|FG001|Step 3: Maintenance|Adverse Event|4|||
105555215|NCT02085408|364029172|FG000|Step 3: Maintenance|Death|1|||
105555216|NCT02085408|364029173|FG001|Step 3: Maintenance|Death|2|||
105343071|NCT02017717|363258202|FG007|Treatment Period|Other reasons|1|||
105343072|NCT02017717|363258203|FG008|Treatment Period|Other reasons|1|||
105555217|NCT02085408|364029172|FG000|Step 3: Maintenance|Alternative Therapy|1|||
105555218|NCT02085408|364029173|FG001|Step 3: Maintenance|Alternative Therapy|1|||
105555219|NCT02085408|364029172|FG000|Step 3: Maintenance|Complicating Disease|0|||
105555220|NCT02085408|364029173|FG001|Step 3: Maintenance|Complicating Disease|1|||
105555221|NCT02085408|364029172|FG000|Step 3: Maintenance|Other|3|||
105555222|NCT02085408|364029173|FG001|Step 3: Maintenance|Other|2|||
105555223|NCT02085408|364029172|FG000|Step 3: Maintenance|Never started treatment|5|||
105674379|NCT00859222|364471919|FG004|Overall Study|Adverse Event|15|||
105674380|NCT00859222|364471915|FG000|Overall Study|DLT|1|||
105674381|NCT00859222|364471916|FG001|Overall Study|DLT|0|||
105674382|NCT00859222|364471917|FG002|Overall Study|DLT|0|||
105674383|NCT00859222|364471918|FG003|Overall Study|DLT|0|||
105674384|NCT00859222|364471919|FG004|Overall Study|DLT|0|||
105674385|NCT00488475|364471920|FG000|Overall Study|Other|1754|||
105674386|NCT01941719|364471927|FG000|Overall Study|Lost to Follow-up|20|||
105674387|NCT01941719|364471928|FG001|Overall Study|Lost to Follow-up|19|||
105674388|NCT00958841|364471929|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105674389|NCT00958841|364471929|FG000|Overall Study|Abnormal test procedure result(s)|3|||
105674390|NCT00958841|364471929|FG000|Overall Study|Administrative problems|1|||
105674391|NCT00958841|364471929|FG000|Overall Study|Adverse Event|8|||
105674392|NCT00958841|364471929|FG000|Overall Study|New cancer therapy|5|||
105674393|NCT00958841|364471929|FG000|Overall Study|Withdrawal by Subject|1|||
105674394|NCT00958841|364471929|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
105674395|NCT00958841|364471929|FG000|Overall Study|Completed M6/did not enter extension|27|||
105674396|NCT00958841|364471929|FG000|Overall Study|Discontinued prior to M*|28|||
105674397|NCT01125514|364471930|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
105674398|NCT01125514|364471930|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
105674399|NCT01125514|364471930|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
105674400|NCT01125514|364471930|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
105674401|NCT01125514|364471930|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
105674402|NCT01125514|364471930|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
105674403|NCT01163292|364471932|FG000|Overall Study|Lack of Efficacy|9|||
105674404|NCT01163292|364471933|FG001|Overall Study|Lack of Efficacy|0|||
105674405|NCT01163292|364471932|FG000|Overall Study|Adverse Event|6|||
105674406|NCT01163292|364471933|FG001|Overall Study|Adverse Event|0|||
105674407|NCT01163292|364471932|FG000|Overall Study|Initiation of biological therapy|0|||
105674408|NCT01163292|364471933|FG001|Overall Study|Initiation of biological therapy|15|||
105674409|NCT01163292|364471932|FG000|Overall Study|Sufficient response to adalimumab|8|||
105674410|NCT01163292|364471933|FG001|Overall Study|Sufficient response to adalimumab|0|||
105674411|NCT01163292|364471932|FG000|Overall Study|Refusal to receive adalimumab|7|||
105674412|NCT01163292|364471933|FG001|Overall Study|Refusal to receive adalimumab|0|||
105674413|NCT01163292|364471932|FG000|Overall Study|Economic reasons|6|||
105674414|NCT01163292|364471933|FG001|Overall Study|Economic reasons|0|||
105674415|NCT01163292|364471932|FG000|Overall Study|No further visits|5|||
105674416|NCT01163292|364471933|FG001|Overall Study|No further visits|7|||
105674417|NCT00506441|364471934|FG000|Period 1; Open-label Period|Adverse Event|21|||
105674418|NCT00506441|364471935|FG001|Period 1; Open-label Period|Adverse Event|0|||
105674419|NCT00506441|364471934|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
105674420|NCT00506441|364471935|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
105674421|NCT00506441|364471934|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
105674422|NCT00506441|364471935|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
105674423|NCT00506441|364471934|FG000|Period 1; Open-label Period|Physician Decision|5|||
105674424|NCT00506441|364471935|FG001|Period 1; Open-label Period|Physician Decision|0|||
105343073|NCT02017717|363258195|FG000|Treatment Period|Maximum clinical benefit|0|||
105343074|NCT02017717|363258196|FG001|Treatment Period|Maximum clinical benefit|0|||
105343075|NCT02017717|363258197|FG002|Treatment Period|Maximum clinical benefit|0|||
105343076|NCT02017717|363258198|FG003|Treatment Period|Maximum clinical benefit|0|||
105343077|NCT02017717|363258199|FG004|Treatment Period|Maximum clinical benefit|0|||
105343078|NCT02017717|363258200|FG005|Treatment Period|Maximum clinical benefit|0|||
105674425|NCT00506441|364471934|FG000|Period 1; Open-label Period|Protocol Violation|9|||
105674426|NCT00506441|364471935|FG001|Period 1; Open-label Period|Protocol Violation|0|||
105674427|NCT00506441|364471934|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
105674428|NCT00506441|364471935|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
105674429|NCT00506441|364471934|FG000|Period 1; Open-label Period|Other Reasons|13|||
105674430|NCT00506441|364471935|FG001|Period 1; Open-label Period|Other Reasons|0|||
105674431|NCT00506441|364471934|FG000|Period 2; Double-blind Period|Adverse Event|0|||
105674432|NCT00506441|364471935|FG001|Period 2; Double-blind Period|Adverse Event|1|||
105674433|NCT00506441|364471934|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
105674434|NCT00506441|364471935|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
105674435|NCT00506441|364471934|FG000|Period 2; Double-blind Period|Physician Decision|1|||
105343079|NCT02017717|363258201|FG006|Treatment Period|Maximum clinical benefit|0|||
105343080|NCT02017717|363258202|FG007|Treatment Period|Maximum clinical benefit|0|||
105343081|NCT02017717|363258203|FG008|Treatment Period|Maximum clinical benefit|1|||
105343082|NCT02017717|363258195|FG000|Treatment Period|Not reported|0|||
105343083|NCT02017717|363258196|FG001|Treatment Period|Not reported|1|||
105343084|NCT02017717|363258197|FG002|Treatment Period|Not reported|0|||
105343085|NCT02017717|363258198|FG003|Treatment Period|Not reported|0|||
105674436|NCT00506441|364471935|FG001|Period 2; Double-blind Period|Physician Decision|1|||
105674437|NCT00506441|364471934|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
105343086|NCT02017717|363258199|FG004|Treatment Period|Not reported|0|||
105343087|NCT02017717|363258200|FG005|Treatment Period|Not reported|0|||
105343088|NCT02017717|363258201|FG006|Treatment Period|Not reported|0|||
105343089|NCT02017717|363258202|FG007|Treatment Period|Not reported|0|||
105674438|NCT00506441|364471935|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
105674439|NCT00506441|364471934|FG000|Period 2; Double-blind Period|Other Reason|1|||
105674440|NCT00506441|364471935|FG001|Period 2; Double-blind Period|Other Reason|1|||
105674441|NCT01215188|364471936|FG000|Overall Study|Lost to Follow-up|22|||
105674442|NCT01215188|364471937|FG001|Overall Study|Lost to Follow-up|22|||
105674443|NCT01215188|364471938|FG002|Overall Study|Lost to Follow-up|16|||
105674444|NCT01215188|364471936|FG000|Overall Study|Adverse Event|1|||
105674445|NCT01215188|364471937|FG001|Overall Study|Adverse Event|1|||
105343090|NCT02017717|363258203|FG008|Treatment Period|Not reported|0|||
105343091|NCT06366087|363258204|FG000|Overall Study|Withdrawal by Subject|0|||
105343092|NCT06366087|363258205|FG001|Overall Study|Withdrawal by Subject|1|||
105343093|NCT03839459|363258210|FG000|Overall Study|Withdrawal by Subject|2|||
105343094|NCT03839459|363258210|FG000|Overall Study|progression of disease|3|||
105343095|NCT02276053|363258212|FG000|Overall Study|Death|2|||
105343096|NCT02276053|363258212|FG000|Overall Study|Adverse Event|5|||
105343097|NCT02276053|363258212|FG000|Overall Study|Lack of Efficacy|2|||
105343098|NCT02276053|363258212|FG000|Overall Study|Withdrawal by Subject|1|||
105343099|NCT02276053|363258212|FG000|Overall Study|Patient does not meet selection criteria|3|||
105343100|NCT02276053|363258212|FG000|Overall Study|Patient needs to increase baseline AED|1|||
105343101|NCT00743288|363258217|FG000|Overall Study|Adverse Event|1|||
105343102|NCT00743288|363258218|FG001|Overall Study|Adverse Event|1|||
105343103|NCT00743288|363258219|FG002|Overall Study|Adverse Event|2|||
105674446|NCT01215188|364471938|FG002|Overall Study|Adverse Event|3|||
105674447|NCT01215188|364471936|FG000|Overall Study|Physician Decision|2|||
105674448|NCT01215188|364471937|FG001|Overall Study|Physician Decision|1|||
105674449|NCT01215188|364471938|FG002|Overall Study|Physician Decision|0|||
105674450|NCT01215188|364471936|FG000|Overall Study|Lack of Efficacy|0|||
105674451|NCT01215188|364471937|FG001|Overall Study|Lack of Efficacy|0|||
105674452|NCT01215188|364471938|FG002|Overall Study|Lack of Efficacy|1|||
105674453|NCT01215188|364471936|FG000|Overall Study|Protocol Violation|1|||
105674454|NCT01215188|364471937|FG001|Overall Study|Protocol Violation|1|||
105674455|NCT01215188|364471938|FG002|Overall Study|Protocol Violation|1|||
105674456|NCT01215188|364471936|FG000|Overall Study|Withdrawal by Subject|32|||
105674457|NCT01215188|364471937|FG001|Overall Study|Withdrawal by Subject|34|||
105674458|NCT01215188|364471938|FG002|Overall Study|Withdrawal by Subject|31|||
105674459|NCT01127763|364471941|FG000|Overall Study|Adverse Event|2|||
105674460|NCT01127763|364471941|FG000|Overall Study|Withdrawal by Subject|1|||
105674461|NCT01127763|364471941|FG000|Overall Study|Physician Decision|2|||
105674462|NCT00831129|364471942|FG000|Overall Study|Adverse Event|0|||
105674463|NCT00831129|364471943|FG001|Overall Study|Adverse Event|1|||
105674464|NCT00831129|364471942|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
105674465|NCT00831129|364471943|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
105674466|NCT01877239|364471944|FG000|Overall Study|Adverse Event|4|||
105674467|NCT01877239|364471944|FG000|Overall Study|Disease Remission|1|||
105674468|NCT01877239|364471944|FG000|Overall Study|Withdrawal by Subject|4|||
105674469|NCT01877239|364471944|FG000|Overall Study|Other|2|||
105674470|NCT01877239|364471944|FG000|Overall Study|Lack of Efficacy|4|||
105674471|NCT01877239|364471944|FG000|Overall Study|Data not available|35|||
105674472|NCT03466073|364471946|FG000|Overall Study|Death|1|||
105674473|NCT03466073|364471947|FG001|Overall Study|Death|0|||
105674474|NCT03466073|364471948|FG002|Overall Study|Death|0|||
105674475|NCT03466073|364471949|FG003|Overall Study|Death|0|||
105674476|NCT03466073|364471950|FG004|Overall Study|Death|0|||
105343104|NCT00743288|363258220|FG003|Overall Study|Adverse Event|2|||
105343105|NCT00743288|363258221|FG004|Overall Study|Adverse Event|1|||
105343106|NCT00743288|363258222|FG005|Overall Study|Adverse Event|1|||
105343107|NCT00743288|363258223|FG006|Overall Study|Adverse Event|2|||
105343108|NCT00743288|363258217|FG000|Overall Study|Withdrawal by Subject|0|||
105674477|NCT03466073|364471951|FG005|Overall Study|Death|1|||
105674478|NCT01283516|364471952|FG000|Overall Study|Adverse Event|0|||
105674479|NCT01283516|364471953|FG001|Overall Study|Adverse Event|0|||
105674480|NCT01283516|364471954|FG002|Overall Study|Adverse Event|0|||
105343109|NCT00743288|363258218|FG001|Overall Study|Withdrawal by Subject|0|||
105343110|NCT00743288|363258219|FG002|Overall Study|Withdrawal by Subject|1|||
105343111|NCT00743288|363258220|FG003|Overall Study|Withdrawal by Subject|0|||
105674481|NCT01283516|364471955|FG003|Overall Study|Adverse Event|0|||
105674482|NCT01283516|364471956|FG004|Overall Study|Adverse Event|0|||
105674483|NCT01283516|364471957|FG005|Overall Study|Adverse Event|0|||
105674484|NCT01283516|364471958|FG006|Overall Study|Adverse Event|2|||
105674485|NCT01283516|364471959|FG007|Overall Study|Adverse Event|0|||
105674486|NCT01283516|364471960|FG008|Overall Study|Adverse Event|28|||
105343112|NCT00743288|363258221|FG004|Overall Study|Withdrawal by Subject|0|||
105343113|NCT00743288|363258222|FG005|Overall Study|Withdrawal by Subject|1|||
105466623|NCT00361296|363720193|FG000|Overall Study|Lack of Efficacy|2|||
105674487|NCT01283516|364471952|FG000|Overall Study|Death|0|||
105674488|NCT01283516|364471953|FG001|Overall Study|Death|0|||
105674489|NCT01283516|364471954|FG002|Overall Study|Death|0|||
105674490|NCT01283516|364471955|FG003|Overall Study|Death|0|||
105674491|NCT01283516|364471956|FG004|Overall Study|Death|0|||
105674492|NCT01283516|364471957|FG005|Overall Study|Death|1|||
105674493|NCT01283516|364471958|FG006|Overall Study|Death|0|||
105674494|NCT01283516|364471959|FG007|Overall Study|Death|1|||
105674495|NCT01283516|364471960|FG008|Overall Study|Death|12|||
105674496|NCT01283516|364471952|FG000|Overall Study|Disease Progression|2|||
105674497|NCT01283516|364471953|FG001|Overall Study|Disease Progression|2|||
105674498|NCT01283516|364471954|FG002|Overall Study|Disease Progression|3|||
105674499|NCT01283516|364471955|FG003|Overall Study|Disease Progression|3|||
105674500|NCT01283516|364471956|FG004|Overall Study|Disease Progression|13|||
105674501|NCT01283516|364471957|FG005|Overall Study|Disease Progression|8|||
105674502|NCT01283516|364471958|FG006|Overall Study|Disease Progression|6|||
105674503|NCT01283516|364471959|FG007|Overall Study|Disease Progression|3|||
105674504|NCT01283516|364471960|FG008|Overall Study|Disease Progression|139|||
105674505|NCT01283516|364471952|FG000|Overall Study|Withdrawal by Subject|0|||
105674506|NCT01283516|364471953|FG001|Overall Study|Withdrawal by Subject|0|||
105674507|NCT01283516|364471954|FG002|Overall Study|Withdrawal by Subject|0|||
105674508|NCT01283516|364471955|FG003|Overall Study|Withdrawal by Subject|0|||
105674509|NCT01283516|364471956|FG004|Overall Study|Withdrawal by Subject|1|||
105674510|NCT01283516|364471957|FG005|Overall Study|Withdrawal by Subject|0|||
105674511|NCT01283516|364471958|FG006|Overall Study|Withdrawal by Subject|1|||
105674512|NCT01283516|364471959|FG007|Overall Study|Withdrawal by Subject|0|||
105674513|NCT01283516|364471960|FG008|Overall Study|Withdrawal by Subject|36|||
105674514|NCT01283516|364471952|FG000|Overall Study|Administrative problems|0|||
105674515|NCT01283516|364471953|FG001|Overall Study|Administrative problems|0|||
105674516|NCT01283516|364471954|FG002|Overall Study|Administrative problems|0|||
105674517|NCT01283516|364471955|FG003|Overall Study|Administrative problems|0|||
105674518|NCT01283516|364471956|FG004|Overall Study|Administrative problems|0|||
105674519|NCT01283516|364471957|FG005|Overall Study|Administrative problems|1|||
105674520|NCT01283516|364471958|FG006|Overall Study|Administrative problems|1|||
105674521|NCT01283516|364471959|FG007|Overall Study|Administrative problems|1|||
105674522|NCT01283516|364471960|FG008|Overall Study|Administrative problems|39|||
105674523|NCT01283516|364471952|FG000|Overall Study|Lost to Follow-up|0|||
105674524|NCT01283516|364471953|FG001|Overall Study|Lost to Follow-up|0|||
105674525|NCT01283516|364471954|FG002|Overall Study|Lost to Follow-up|0|||
105674526|NCT01283516|364471955|FG003|Overall Study|Lost to Follow-up|0|||
105674527|NCT01283516|364471956|FG004|Overall Study|Lost to Follow-up|0|||
105674528|NCT01283516|364471957|FG005|Overall Study|Lost to Follow-up|0|||
105674529|NCT01283516|364471958|FG006|Overall Study|Lost to Follow-up|0|||
105674530|NCT01283516|364471959|FG007|Overall Study|Lost to Follow-up|0|||
105674531|NCT01283516|364471960|FG008|Overall Study|Lost to Follow-up|1|||
105674532|NCT00444275|364471961|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
105674533|NCT00444275|364471962|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
105674534|NCT00444275|364471963|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
105674535|NCT00444275|364471964|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
105674536|NCT00444275|364471965|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
105674537|NCT00444275|364471961|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
105674538|NCT00444275|364471962|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
105674539|NCT00444275|364471963|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
105674540|NCT00444275|364471964|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
105674541|NCT00444275|364471965|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
105674542|NCT00444275|364471961|FG000|Maintenance Treatment Phase|Adverse Event|0|||
105674543|NCT00444275|364471962|FG001|Maintenance Treatment Phase|Adverse Event|0|||
105674544|NCT00444275|364471963|FG002|Maintenance Treatment Phase|Adverse Event|3|||
105674545|NCT00444275|364471964|FG003|Maintenance Treatment Phase|Adverse Event|2|||
105674546|NCT00444275|364471965|FG004|Maintenance Treatment Phase|Adverse Event|13|||
105674547|NCT00444275|364471961|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
105674548|NCT00444275|364471962|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
105674549|NCT00444275|364471963|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
105674550|NCT00444275|364471964|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
105674551|NCT00444275|364471965|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
105674552|NCT00444275|364471961|FG000|Maintenance Treatment Phase|Patient's wish|0|||
105674553|NCT00444275|364471962|FG001|Maintenance Treatment Phase|Patient's wish|0|||
105674554|NCT00444275|364471963|FG002|Maintenance Treatment Phase|Patient's wish|19|||
105674555|NCT00444275|364471964|FG003|Maintenance Treatment Phase|Patient's wish|9|||
105674556|NCT00444275|364471965|FG004|Maintenance Treatment Phase|Patient's wish|20|||
105674557|NCT00444275|364471961|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
105674558|NCT00444275|364471962|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
105674559|NCT00444275|364471963|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
105674560|NCT00444275|364471964|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
105674561|NCT00444275|364471965|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
105674562|NCT00444275|364471961|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
105674563|NCT00444275|364471962|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
105674564|NCT00444275|364471963|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
105674565|NCT00444275|364471964|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
105674566|NCT00444275|364471965|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
105466624|NCT01217229|363720194|FG000|Overall Study|Adverse Event|1|||
105674567|NCT00658788|364471966|FG000|Overall Study|Adverse Event|11|||
105674568|NCT00658788|364471966|FG000|Overall Study|Withdrawal by Subject|13|||
105674569|NCT00658788|364471966|FG000|Overall Study|Lost to Follow-up|18|||
105674570|NCT00658788|364471966|FG000|Overall Study|Treatment Discontinuation|32|||
105674571|NCT02297139|364471967|FG000|Overall Study|Disease progression|0|||
105674572|NCT02297139|364471968|FG001|Overall Study|Disease progression|1|||
105674573|NCT02297139|364471967|FG000|Overall Study|Study drug toxicity|0|||
105674574|NCT02297139|364471968|FG001|Overall Study|Study drug toxicity|4|||
105674575|NCT02297139|364471967|FG000|Overall Study|Participant request to discontinue study treatment|0|||
105674576|NCT02297139|364471968|FG001|Overall Study|Participant request to discontinue study treatment|1|||
105674577|NCT02297139|364471967|FG000|Overall Study|Maximum clinical benefit|1|||
105674578|NCT02297139|364471968|FG001|Overall Study|Maximum clinical benefit|0|||
105674579|NCT02297139|364471967|FG000|Overall Study|Administrative reason by sponsor|0|||
105343114|NCT00743288|363258223|FG006|Overall Study|Withdrawal by Subject|1|||
105343115|NCT00743288|363258217|FG000|Overall Study|Progressive disease (PD)|2|||
105343116|NCT00743288|363258218|FG001|Overall Study|Progressive disease (PD)|0|||
105343117|NCT00743288|363258219|FG002|Overall Study|Progressive disease (PD)|1|||
105343118|NCT00743288|363258220|FG003|Overall Study|Progressive disease (PD)|4|||
105343119|NCT00743288|363258221|FG004|Overall Study|Progressive disease (PD)|5|||
105343120|NCT00743288|363258222|FG005|Overall Study|Progressive disease (PD)|3|||
105343121|NCT00743288|363258223|FG006|Overall Study|Progressive disease (PD)|6|||
105343122|NCT00743288|363258217|FG000|Overall Study|Worsening of condition (Not PD)|0|||
105343123|NCT00743288|363258218|FG001|Overall Study|Worsening of condition (Not PD)|2|||
105343124|NCT00743288|363258219|FG002|Overall Study|Worsening of condition (Not PD)|1|||
105343125|NCT00743288|363258220|FG003|Overall Study|Worsening of condition (Not PD)|1|||
105343126|NCT00743288|363258221|FG004|Overall Study|Worsening of condition (Not PD)|0|||
105343127|NCT00743288|363258222|FG005|Overall Study|Worsening of condition (Not PD)|0|||
105343128|NCT00743288|363258223|FG006|Overall Study|Worsening of condition (Not PD)|0|||
105343129|NCT04338269|363258224|FG000|Overall Study|Death|86|||
105343130|NCT04338269|363258225|FG001|Overall Study|Death|89|||
105343131|NCT04338269|363258224|FG000|Overall Study|Lost to Follow-up|1|||
105343132|NCT04338269|363258225|FG001|Overall Study|Lost to Follow-up|2|||
105343133|NCT04338269|363258224|FG000|Overall Study|Physician Decision|1|||
105343134|NCT04338269|363258225|FG001|Overall Study|Physician Decision|0|||
105343135|NCT04338269|363258224|FG000|Overall Study|Withdrawal by Subject|14|||
105343136|NCT04338269|363258225|FG001|Overall Study|Withdrawal by Subject|11|||
105343137|NCT03617861|363258226|FG000|Second Intervention (1 Day)|Adverse Event|0|||
105343138|NCT03617861|363258227|FG001|Second Intervention (1 Day)|Adverse Event|0|||
105343139|NCT03617861|363258228|FG002|Second Intervention (1 Day)|Adverse Event|1|||
105343140|NCT03617861|363258229|FG003|Second Intervention (1 Day)|Adverse Event|0|||
105343141|NCT04045132|363258237|FG000|Overall Study|Lost to Follow-up|3|||
105343142|NCT04045132|363258238|FG001|Overall Study|Lost to Follow-up|6|||
105343143|NCT04327661|363258243|FG000|Overall Study|Withdrawal by Subject|1|||
105343144|NCT04327661|363258244|FG001|Overall Study|Withdrawal by Subject|0|||
105674580|NCT02297139|364471968|FG001|Overall Study|Administrative reason by sponsor|2|||
105674581|NCT02297139|364471967|FG000|Overall Study|Other reasons|0|||
105674582|NCT02297139|364471968|FG001|Overall Study|Other reasons|8|||
105674583|NCT05038163|364471969|FG000|Stage 1|Did not complete survey|374|||
105674584|NCT05038163|364471970|FG001|Stage 1|Did not complete survey|0|||
105674585|NCT05038163|364471971|FG002|Stage 1|Did not complete survey|0|||
105674586|NCT05038163|364471972|FG003|Stage 1|Did not complete survey|0|||
105674587|NCT05038163|364471973|FG004|Stage 1|Did not complete survey|0|||
105674588|NCT05038163|364471974|FG005|Stage 1|Did not complete survey|0|||
105674589|NCT05038163|364471969|FG000|Stage 2|Did not complete Stage 2 survey|0|||
105674590|NCT05038163|364471970|FG001|Stage 2|Did not complete Stage 2 survey|29|||
105674591|NCT05038163|364471971|FG002|Stage 2|Did not complete Stage 2 survey|30|||
105674592|NCT05038163|364471972|FG003|Stage 2|Did not complete Stage 2 survey|24|||
105674593|NCT05038163|364471973|FG004|Stage 2|Did not complete Stage 2 survey|21|||
105674594|NCT05038163|364471974|FG005|Stage 2|Did not complete Stage 2 survey|100|||
105674595|NCT05453201|364471975|FG000|Overall Study|Withdrawal by Subject|1|||
105674596|NCT01934790|364471976|FG000|Treatment|Adverse Event|3|||
105674597|NCT01934790|364471976|FG000|Treatment|Clinical progression|6|||
105674598|NCT01934790|364471976|FG000|Treatment|Radiological progression|4|||
105674599|NCT01934790|364471976|FG000|Treatment|Withdrawal by Subject|2|||
105674600|NCT01934790|364471976|FG000|Treatment|Study drug never administered|1|||
105674601|NCT01934790|364471976|FG000|Active Follow up|Death|20|||
105674602|NCT01934790|364471976|FG000|Active Follow up|Physician Decision|2|||
105674603|NCT01934790|364471976|FG000|Active Follow up|Progressive disease|1|||
105674604|NCT01934790|364471976|FG000|Active Follow up|Other reason|1|||
105674605|NCT03762200|364471984|FG000|Overall Study|Death|2|||
105674606|NCT02631577|364471985|FG000|Overall Study|Death|1|||
105674607|NCT02631577|364471986|FG001|Overall Study|Death|7|||
105674608|NCT02631577|364471985|FG000|Overall Study|Withdrawal by Subject|0|||
105674609|NCT02631577|364471986|FG001|Overall Study|Withdrawal by Subject|3|||
105674610|NCT03738423|364471987|FG000|Overall Study|Withdrawal by Subject|9|||
105674611|NCT03738423|364471988|FG001|Overall Study|Withdrawal by Subject|12|||
105674612|NCT03738423|364471989|FG002|Overall Study|Withdrawal by Subject|9|||
105674613|NCT03738423|364471990|FG003|Overall Study|Withdrawal by Subject|12|||
105674614|NCT03738423|364471991|FG004|Overall Study|Withdrawal by Subject|10|||
105674615|NCT03738423|364471987|FG000|Overall Study|Lack of Efficacy|3|||
105674616|NCT03738423|364471988|FG001|Overall Study|Lack of Efficacy|1|||
105674617|NCT03738423|364471989|FG002|Overall Study|Lack of Efficacy|1|||
105674618|NCT03738423|364471990|FG003|Overall Study|Lack of Efficacy|1|||
105674619|NCT03738423|364471991|FG004|Overall Study|Lack of Efficacy|2|||
105674620|NCT03738423|364471987|FG000|Overall Study|Lost to Follow-up|1|||
105674621|NCT03738423|364471988|FG001|Overall Study|Lost to Follow-up|0|||
105674622|NCT03738423|364471989|FG002|Overall Study|Lost to Follow-up|1|||
105674623|NCT03738423|364471990|FG003|Overall Study|Lost to Follow-up|1|||
105674624|NCT03738423|364471991|FG004|Overall Study|Lost to Follow-up|0|||
105674625|NCT03738423|364471987|FG000|Overall Study|Protocol Violation|1|||
105674626|NCT03738423|364471988|FG001|Overall Study|Protocol Violation|0|||
105674627|NCT03738423|364471989|FG002|Overall Study|Protocol Violation|0|||
105674628|NCT03738423|364471990|FG003|Overall Study|Protocol Violation|0|||
105674629|NCT03738423|364471991|FG004|Overall Study|Protocol Violation|1|||
105674630|NCT03738423|364471987|FG000|Overall Study|Physician Decision|0|||
105674631|NCT03738423|364471988|FG001|Overall Study|Physician Decision|0|||
105674632|NCT03738423|364471989|FG002|Overall Study|Physician Decision|1|||
105674633|NCT03738423|364471990|FG003|Overall Study|Physician Decision|0|||
105674634|NCT03738423|364471991|FG004|Overall Study|Physician Decision|1|||
105674635|NCT03738423|364471987|FG000|Overall Study|Death|0|||
105674636|NCT03738423|364471988|FG001|Overall Study|Death|0|||
105674637|NCT03738423|364471989|FG002|Overall Study|Death|0|||
105674638|NCT03738423|364471990|FG003|Overall Study|Death|0|||
105674639|NCT03738423|364471991|FG004|Overall Study|Death|1|||
105674640|NCT03738423|364471987|FG000|Overall Study|Randomized but never treated|0|||
105674641|NCT03738423|364471988|FG001|Overall Study|Randomized but never treated|0|||
105674642|NCT03738423|364471989|FG002|Overall Study|Randomized but never treated|1|||
105674643|NCT03738423|364471990|FG003|Overall Study|Randomized but never treated|1|||
105674644|NCT03738423|364471991|FG004|Overall Study|Randomized but never treated|0|||
105674645|NCT05110690|364471994|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
105674646|NCT05110690|364471994|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
105674647|NCT05110690|364471994|FG000|Completion of Intervention|Lost to Follow-up|1|||
105674648|NCT05110690|364471994|FG000|Completion of Intervention|Death|1|||
105674649|NCT05110690|364471994|FG000|Completion of Intervention|Withdrawal by Subject|2|||
105674650|NCT03992846|364471997|FG000|Overall Study|Adverse Event|8|||
105674651|NCT03992846|364471998|FG001|Overall Study|Adverse Event|6|||
105674652|NCT03992846|364471999|FG002|Overall Study|Adverse Event|3|||
105674653|NCT03992846|364471997|FG000|Overall Study|Lost to Follow-up|0|||
105674654|NCT03992846|364471998|FG001|Overall Study|Lost to Follow-up|1|||
105674655|NCT03992846|364471999|FG002|Overall Study|Lost to Follow-up|1|||
105674656|NCT03992846|364471997|FG000|Overall Study|Pregnancy|2|||
105674657|NCT03992846|364471998|FG001|Overall Study|Pregnancy|0|||
105674658|NCT03992846|364471999|FG002|Overall Study|Pregnancy|1|||
105674659|NCT03992846|364471997|FG000|Overall Study|Protocol Violation|1|||
105674660|NCT03992846|364471998|FG001|Overall Study|Protocol Violation|2|||
105674661|NCT03992846|364471999|FG002|Overall Study|Protocol Violation|0|||
105674662|NCT03992846|364471997|FG000|Overall Study|Withdrawal by Subject|8|||
105674663|NCT03992846|364471998|FG001|Overall Study|Withdrawal by Subject|10|||
105674664|NCT03992846|364471999|FG002|Overall Study|Withdrawal by Subject|20|||
105674665|NCT03992846|364471997|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
105674666|NCT03992846|364471998|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
105343145|NCT04327661|363258245|FG002|Overall Study|Withdrawal by Subject|0|||
105343146|NCT02370667|363258252|FG000|Overall Study|Lost to Follow-up|0|||
105343147|NCT02370667|363258253|FG001|Overall Study|Lost to Follow-up|1|||
105674667|NCT03992846|364471999|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
105674668|NCT00215137|364473480|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
105674669|NCT00215137|364473481|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
105674670|NCT00215137|364473482|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
105674671|NCT00215137|364473480|FG000|Randomization Period|Lost to Follow-up|0|||
105674672|NCT00215137|364473481|FG001|Randomization Period|Lost to Follow-up|1|||
105674673|NCT00215137|364473482|FG002|Randomization Period|Lost to Follow-up|0|||
105674674|NCT00215137|364473480|FG000|Randomization Period|Withdrawal by Subject|0|||
105674675|NCT00215137|364473481|FG001|Randomization Period|Withdrawal by Subject|1|||
105674676|NCT00215137|364473482|FG002|Randomization Period|Withdrawal by Subject|0|||
105674677|NCT00166712|364473484|FG000|Overall Study|Death|0|||
105674678|NCT00166712|364473485|FG001|Overall Study|Death|1|||
105674679|NCT00166712|364473484|FG000|Overall Study|Adverse Event|1|||
105674680|NCT00166712|364473485|FG001|Overall Study|Adverse Event|0|||
105674681|NCT00166712|364473484|FG000|Overall Study|Withdrawal by Subject|1|||
105674682|NCT00166712|364473485|FG001|Overall Study|Withdrawal by Subject|2|||
105674683|NCT00166712|364473484|FG000|Overall Study|Physician Decision|0|||
105674684|NCT00166712|364473485|FG001|Overall Study|Physician Decision|2|||
105674685|NCT03986944|364473486|FG000|Overall Study|Adverse Event|1|||
105674686|NCT03986944|364473487|FG001|Overall Study|Adverse Event|2|||
105674687|NCT03986944|364473488|FG002|Overall Study|Adverse Event|3|||
105674688|NCT03986944|364473486|FG000|Overall Study|Protocol Violation|0|||
105674689|NCT03986944|364473487|FG001|Overall Study|Protocol Violation|1|||
105674690|NCT03986944|364473488|FG002|Overall Study|Protocol Violation|1|||
105674691|NCT03986944|364473486|FG000|Overall Study|Withdrawal by Subject|3|||
105674692|NCT03986944|364473487|FG001|Overall Study|Withdrawal by Subject|5|||
105674693|NCT03986944|364473488|FG002|Overall Study|Withdrawal by Subject|5|||
105674694|NCT03986944|364473486|FG000|Overall Study|Study termination|10|||
105674695|NCT03986944|364473487|FG001|Overall Study|Study termination|10|||
105674696|NCT03986944|364473488|FG002|Overall Study|Study termination|10|||
105674697|NCT03986944|364473486|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
105674698|NCT03986944|364473487|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
105674699|NCT03986944|364473488|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
105674700|NCT03986944|364473486|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
105674701|NCT03986944|364473487|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
105674702|NCT03986944|364473488|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
105674703|NCT00833261|364473492|FG000|Overall Study|Withdrawal by Subject|4|||
105674704|NCT00503139|364473496|FG000|Overall Study|Case Report Forms were not collected|4|||
105674705|NCT00503139|364473496|FG000|Overall Study|Protocol Violation|4|||
105674706|NCT00616902|364473497|FG000|Overall Study|Termination of study|6|||
105674707|NCT00616902|364473498|FG001|Overall Study|Termination of study|6|||
105674708|NCT01262677|364473499|FG000|Overall Study|Does not meet entrance criteria|0|||
105674709|NCT01262677|364473500|FG001|Overall Study|Does not meet entrance criteria|2|||
105674710|NCT01262677|364473501|FG002|Overall Study|Does not meet entrance criteria|0|||
105674711|NCT01262677|364473499|FG000|Overall Study|Insufficient clinical response|0|||
105674712|NCT01262677|364473500|FG001|Overall Study|Insufficient clinical response|0|||
105674713|NCT01262677|364473501|FG002|Overall Study|Insufficient clinical response|1|||
105674714|NCT01262677|364473499|FG000|Overall Study|Lost to Follow-up|1|||
105674715|NCT01262677|364473500|FG001|Overall Study|Lost to Follow-up|0|||
105674716|NCT01262677|364473501|FG002|Overall Study|Lost to Follow-up|2|||
105674717|NCT01262677|364473499|FG000|Overall Study|No longer willing to participate|3|||
105674718|NCT01262677|364473500|FG001|Overall Study|No longer willing to participate|3|||
105674719|NCT01262677|364473501|FG002|Overall Study|No longer willing to participate|2|||
105674720|NCT01262677|364473499|FG000|Overall Study|Reason not provided|2|||
105674721|NCT01262677|364473500|FG001|Overall Study|Reason not provided|1|||
105674722|NCT01262677|364473501|FG002|Overall Study|Reason not provided|3|||
105674723|NCT01262677|364473499|FG000|Overall Study|Protocol Violation|0|||
105674724|NCT01262677|364473500|FG001|Overall Study|Protocol Violation|1|||
105674725|NCT01262677|364473501|FG002|Overall Study|Protocol Violation|1|||
105674726|NCT01262677|364473499|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
105674727|NCT01262677|364473500|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
105674728|NCT01262677|364473501|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
105674729|NCT03056300|364473502|FG000|Overall Study|Surgical reason per study protocol|3|||
105674730|NCT03828747|364473506|FG000|Double-Blind Treatment Period|Adverse Event|6|||
105674731|NCT03828747|364473507|FG001|Double-Blind Treatment Period|Adverse Event|6|||
105674732|NCT03828747|364473506|FG000|Double-Blind Treatment Period|Death|1|||
105343148|NCT02370667|363258254|FG002|Overall Study|Lost to Follow-up|0|||
105343149|NCT02052596|363258255|FG000|Active Phase|Adverse Event|3|||
105674733|NCT03828747|364473507|FG001|Double-Blind Treatment Period|Death|1|||
105674734|NCT03828747|364473506|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105674735|NCT03828747|364473507|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
105674736|NCT03828747|364473506|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
105674737|NCT03828747|364473507|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
105674738|NCT03828747|364473506|FG000|Double-Blind Treatment Period|Physician Decision|1|||
105343150|NCT02052596|363258256|FG001|Active Phase|Adverse Event|2|||
105674739|NCT03828747|364473507|FG001|Double-Blind Treatment Period|Physician Decision|4|||
105674740|NCT03828747|364473506|FG000|Double-Blind Treatment Period|Various reasons|5|||
105674741|NCT03828747|364473507|FG001|Double-Blind Treatment Period|Various reasons|3|||
105674742|NCT03828747|364473506|FG000|Open-Label Extension|Adverse Event|9|||
105674743|NCT03828747|364473507|FG001|Open-Label Extension|Adverse Event|7|||
105674744|NCT03828747|364473506|FG000|Open-Label Extension|Death|0|||
105674745|NCT03828747|364473507|FG001|Open-Label Extension|Death|2|||
105674746|NCT03828747|364473506|FG000|Open-Label Extension|Lost to Follow-up|4|||
105674747|NCT03828747|364473507|FG001|Open-Label Extension|Lost to Follow-up|0|||
105674748|NCT03828747|364473506|FG000|Open-Label Extension|Withdrawal by Subject|31|||
105674749|NCT03828747|364473507|FG001|Open-Label Extension|Withdrawal by Subject|30|||
105674750|NCT03828747|364473506|FG000|Open-Label Extension|Various reasons|4|||
105674751|NCT03828747|364473507|FG001|Open-Label Extension|Various reasons|4|||
105674752|NCT03828747|364473506|FG000|Open-Label Extension|Physician Decision|6|||
105674753|NCT03828747|364473507|FG001|Open-Label Extension|Physician Decision|2|||
105674754|NCT03900416|364473508|FG000|Six Week Follow-up|Lost to Follow-up|1|||
105674755|NCT03900416|364473509|FG001|Six Week Follow-up|Lost to Follow-up|0|||
105674756|NCT03900416|364473508|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
105674757|NCT03900416|364473509|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
105674758|NCT03900416|364473508|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
105674759|NCT03900416|364473509|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
105674760|NCT03900416|364473508|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
105674761|NCT03900416|364473509|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
105674762|NCT03900416|364473508|FG000|Twelve Week Follow-up|Adverse Event|1|||
105674763|NCT03900416|364473509|FG001|Twelve Week Follow-up|Adverse Event|1|||
105674764|NCT03900416|364473508|FG000|Six Month Follow-up|Lost to Follow-up|4|||
105674765|NCT03900416|364473509|FG001|Six Month Follow-up|Lost to Follow-up|3|||
105674766|NCT03900416|364473508|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
105674767|NCT03900416|364473509|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
105674768|NCT04797650|364473510|FG000|Overall Study|Reason Not Specified|5|||
105674769|NCT04797650|364473511|FG001|Overall Study|Reason Not Specified|12|||
105674770|NCT04797650|364473512|FG002|Overall Study|Reason Not Specified|5|||
105674771|NCT04797650|364473510|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
105674772|NCT04797650|364473511|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
105674773|NCT04797650|364473512|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
105674774|NCT04797650|364473510|FG000|Overall Study|Lack of Efficacy|1|||
105674775|NCT04797650|364473511|FG001|Overall Study|Lack of Efficacy|0|||
105674776|NCT04797650|364473512|FG002|Overall Study|Lack of Efficacy|1|||
105674777|NCT04797650|364473510|FG000|Overall Study|Non-compliance with Study Drug|0|||
105674778|NCT04797650|364473511|FG001|Overall Study|Non-compliance with Study Drug|0|||
105674779|NCT04797650|364473512|FG002|Overall Study|Non-compliance with Study Drug|2|||
105674780|NCT04797650|364473510|FG000|Overall Study|Lost to Follow-up|4|||
105674781|NCT04797650|364473511|FG001|Overall Study|Lost to Follow-up|6|||
105674782|NCT04797650|364473512|FG002|Overall Study|Lost to Follow-up|1|||
105674783|NCT02040584|364473514|FG000|Overall Study|Adverse Event|13|||
105674784|NCT02040584|364473515|FG001|Overall Study|Adverse Event|6|||
105674785|NCT02040584|364473514|FG000|Overall Study|Protocol Violation|9|||
105674786|NCT02040584|364473515|FG001|Overall Study|Protocol Violation|11|||
105674787|NCT02040584|364473514|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105674788|NCT02040584|364473515|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105674789|NCT02040584|364473514|FG000|Overall Study|Death|6|||
105674790|NCT02040584|364473515|FG001|Overall Study|Death|3|||
105674791|NCT02040584|364473514|FG000|Overall Study|Transplant rejection/retransplant|0|||
105674792|NCT02040584|364473515|FG001|Overall Study|Transplant rejection/retransplant|1|||
105674793|NCT02040584|364473514|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
105674794|NCT02040584|364473515|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
105674795|NCT02121301|364473518|FG000|Overall Study|Protocol Violation|1|||
105674796|NCT02121301|364473519|FG001|Overall Study|Protocol Violation|4|||
105674797|NCT02121301|364473520|FG002|Overall Study|Protocol Violation|1|||
105674798|NCT01802567|364473521|FG000|Overall Study|Withdrawal by Subject|2|||
105674799|NCT01802567|364473521|FG000|Overall Study|Physician Decision|1|||
105674800|NCT01802567|364473521|FG000|Overall Study|Lack of Efficacy|7|||
105674801|NCT01802567|364473521|FG000|Overall Study|Consented but did not start therapy|7|||
105674802|NCT01802567|364473521|FG000|Overall Study|Protocol Violation|1|||
105674803|NCT00309959|364473525|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
105674804|NCT01895101|364473526|FG000|Overall Study|OPCAB procedure|1|||
105674805|NCT01895101|364473527|FG001|Overall Study|OPCAB procedure|1|||
105674806|NCT01895101|364473528|FG002|Overall Study|OPCAB procedure|3|||
105674807|NCT01895101|364473526|FG000|Overall Study|Withdrawal by Subject|0|||
105674808|NCT01895101|364473527|FG001|Overall Study|Withdrawal by Subject|1|||
105674809|NCT01895101|364473528|FG002|Overall Study|Withdrawal by Subject|2|||
105674810|NCT01895101|364473526|FG000|Overall Study|another study, enrolled in other study|0|||
105674811|NCT01895101|364473527|FG001|Overall Study|another study, enrolled in other study|1|||
105674812|NCT01895101|364473528|FG002|Overall Study|another study, enrolled in other study|0|||
105674813|NCT01895101|364473526|FG000|Overall Study|Death|0|||
105674814|NCT01895101|364473527|FG001|Overall Study|Death|1|||
105674815|NCT01895101|364473528|FG002|Overall Study|Death|0|||
105674816|NCT01895101|364473526|FG000|Overall Study|coagulation disorder|0|||
105555224|NCT02085408|364029173|FG001|Step 3: Maintenance|Never started treatment|1|||
105555225|NCT01295944|364029178|FG000|Overall Study|Switched to alternative treatment|1|||
105555226|NCT01295944|364029178|FG000|Overall Study|Ineligible|9|||
105555227|NCT01295944|364029178|FG000|Overall Study|Withdrawal by Subject|1|||
105555228|NCT01295944|364029178|FG000|Overall Study|Participant chose to be treated in Peru|1|||
105555229|NCT01295944|364029178|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
105555230|NCT01295944|364029178|FG000|Overall Study|Physician Decision|1|||
105555231|NCT01295944|364029178|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
105555232|NCT01295944|364029178|FG000|Overall Study|Disease progression|4|||
105555233|NCT01295944|364029178|FG000|Overall Study|Transferred care before starting new treatment|1|||
105555234|NCT02273141|364029182|FG000|Overall Study|Adverse Event|0|||
105555235|NCT02273141|364029183|FG001|Overall Study|Adverse Event|1|||
105555236|NCT02273141|364029182|FG000|Overall Study|Lost to Follow-up|1|||
105555237|NCT02273141|364029183|FG001|Overall Study|Lost to Follow-up|3|||
105555238|NCT02273141|364029182|FG000|Overall Study|Withdrawal by Subject|10|||
105555239|NCT02273141|364029183|FG001|Overall Study|Withdrawal by Subject|15|||
105555240|NCT02273141|364029182|FG000|Overall Study|Various|6|||
105555241|NCT02273141|364029183|FG001|Overall Study|Various|6|||
105555242|NCT01556438|364029184|FG000|Overall Study|Adverse Event|4|||
105555243|NCT01556438|364029185|FG001|Overall Study|Adverse Event|2|||
105555244|NCT01556438|364029184|FG000|Overall Study|Sponsor Decision|0|||
105555245|NCT01556438|364029185|FG001|Overall Study|Sponsor Decision|2|||
105555246|NCT01556438|364029184|FG000|Overall Study|Progressive Disease|0|||
105555247|NCT01556438|364029185|FG001|Overall Study|Progressive Disease|6|||
105555248|NCT01556438|364029184|FG000|Overall Study|Death|0|||
105555249|NCT01556438|364029185|FG001|Overall Study|Death|1|||
105555250|NCT00529399|364029186|FG000|Overall Study|Lost to Follow-up|1|||
105555251|NCT00529399|364029187|FG001|Overall Study|Lost to Follow-up|0|||
105555252|NCT00529399|364029188|FG002|Overall Study|Lost to Follow-up|1|||
105555253|NCT00529399|364029186|FG000|Overall Study|Withdrawal by Subject|1|||
105555254|NCT00529399|364029187|FG001|Overall Study|Withdrawal by Subject|0|||
105555255|NCT00529399|364029188|FG002|Overall Study|Withdrawal by Subject|1|||
105555256|NCT00529399|364029186|FG000|Overall Study|Non-compliant|0|||
105555257|NCT00529399|364029187|FG001|Overall Study|Non-compliant|1|||
105555258|NCT00529399|364029188|FG002|Overall Study|Non-compliant|0|||
105555259|NCT01572727|364029190|FG000|Overall Study|Adverse Event|43|||
105555260|NCT01572727|364029191|FG001|Overall Study|Adverse Event|15|||
105555261|NCT01572727|364029190|FG000|Overall Study|Lost to Follow-up|1|||
105555262|NCT01572727|364029191|FG001|Overall Study|Lost to Follow-up|1|||
105555263|NCT01572727|364029190|FG000|Overall Study|Physician Decision|23|||
105555264|NCT01572727|364029191|FG001|Overall Study|Physician Decision|9|||
105555265|NCT01572727|364029190|FG000|Overall Study|Progressive disease|59|||
105555266|NCT01572727|364029191|FG001|Overall Study|Progressive disease|82|||
105555267|NCT01572727|364029190|FG000|Overall Study|Protocol Violation|0|||
105555268|NCT01572727|364029191|FG001|Overall Study|Protocol Violation|1|||
105555269|NCT01572727|364029190|FG000|Overall Study|Study terminated by sponsor|61|||
105555270|NCT01572727|364029191|FG001|Overall Study|Study terminated by sponsor|83|||
105555271|NCT01572727|364029190|FG000|Overall Study|Parent/guardian decision|14|||
105555272|NCT01572727|364029191|FG001|Overall Study|Parent/guardian decision|9|||
105555273|NCT01572727|364029190|FG000|Overall Study|Death|2|||
105555274|NCT01572727|364029191|FG001|Overall Study|Death|2|||
105555275|NCT01572727|364029190|FG000|Overall Study|Untreated|4|||
105674817|NCT01895101|364473527|FG001|Overall Study|coagulation disorder|1|||
105674818|NCT01895101|364473528|FG002|Overall Study|coagulation disorder|0|||
105674819|NCT01144052|364473529|FG000|Overall Study|Withdrawal by Subject|1|||
105555276|NCT01572727|364029191|FG001|Overall Study|Untreated|7|||
105674820|NCT01144052|364473530|FG001|Overall Study|Withdrawal by Subject|1|||
105555277|NCT01328574|364029195|FG000|Overall Study|Refused further treatment|1|||
105555278|NCT00319098|364029203|FG000|Overall Study|Serious adverse event|3|||
105555279|NCT00319098|364029204|FG001|Overall Study|Serious adverse event|0|||
105555280|NCT00319098|364029203|FG000|Overall Study|Adverse Event|20|||
105555281|NCT00319098|364029204|FG001|Overall Study|Adverse Event|1|||
105555282|NCT00319098|364029203|FG000|Overall Study|Withdrawal by Subject|37|||
105674821|NCT03896152|364473531|FG000|Overall Study|Patient/guardian decision|1|||
105674822|NCT03896152|364473532|FG001|Overall Study|Patient/guardian decision|1|||
105674823|NCT03896152|364473531|FG000|Overall Study|Adverse Event|0|||
105674824|NCT03896152|364473532|FG001|Overall Study|Adverse Event|1|||
105674825|NCT03896152|364473531|FG000|Overall Study|Physician Decision|1|||
105674826|NCT03896152|364473532|FG001|Overall Study|Physician Decision|0|||
105674827|NCT03896152|364473531|FG000|Overall Study|Technical problems|1|||
105674828|NCT03896152|364473532|FG001|Overall Study|Technical problems|0|||
105674829|NCT00436852|364473533|FG000|Overall Study|Death|23|||
105674830|NCT00436852|364473534|FG001|Overall Study|Death|34|||
105674831|NCT00436852|364473533|FG000|Overall Study|Lack of Efficacy|9|||
105674832|NCT00436852|364473534|FG001|Overall Study|Lack of Efficacy|7|||
105674833|NCT00436852|364473533|FG000|Overall Study|Withdrawal by Subject|2|||
105674834|NCT00436852|364473534|FG001|Overall Study|Withdrawal by Subject|4|||
105674835|NCT00436852|364473533|FG000|Overall Study|Ineligible|1|||
105674836|NCT00436852|364473534|FG001|Overall Study|Ineligible|0|||
105674837|NCT00370682|364473535|FG000|Overall Study|Moved from area|0|||
105674838|NCT00370682|364473536|FG001|Overall Study|Moved from area|2|||
105674839|NCT00370682|364473537|FG002|Overall Study|Moved from area|0|||
105674840|NCT00370682|364473535|FG000|Overall Study|Lost to Follow-up|0|||
105674841|NCT00370682|364473536|FG001|Overall Study|Lost to Follow-up|1|||
105674842|NCT00370682|364473537|FG002|Overall Study|Lost to Follow-up|1|||
105674843|NCT03167359|364473538|FG000|Overall Study|Physician Decision|1|||
105674844|NCT03167359|364473538|FG000|Overall Study|Lost to Follow-up|1|||
105674845|NCT03339583|364473539|FG000|First Intervention (14 Days)|Adverse Event|1|||
105674846|NCT03339583|364473540|FG001|First Intervention (14 Days)|Adverse Event|0|||
105674847|NCT03339583|364473539|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
105674848|NCT03339583|364473540|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
105674849|NCT03339583|364473539|FG000|Second Intervention (14 Days)|Adverse Event|0|||
105674850|NCT03339583|364473540|FG001|Second Intervention (14 Days)|Adverse Event|1|||
105674851|NCT03339583|364473539|FG000|Follow-up (14 Days)|Physician Decision|6|||
105674852|NCT03339583|364473540|FG001|Follow-up (14 Days)|Physician Decision|3|||
105674853|NCT00943852|364473541|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674854|NCT00943852|364473542|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674855|NCT00943852|364473543|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674856|NCT00943852|364473544|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
105674857|NCT00943852|364473545|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674858|NCT00943852|364473546|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674859|NCT00943852|364473547|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674860|NCT00943852|364473548|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674861|NCT00943852|364473549|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674862|NCT00943852|364473550|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674863|NCT00943852|364473541|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674864|NCT00943852|364473542|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674865|NCT00943852|364473543|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674866|NCT00943852|364473544|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674867|NCT00943852|364473545|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674868|NCT00943852|364473546|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
105674869|NCT00943852|364473547|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674870|NCT00943852|364473548|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674871|NCT00943852|364473549|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674872|NCT00943852|364473550|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674873|NCT00943852|364473541|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674874|NCT00943852|364473542|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674875|NCT00943852|364473543|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674876|NCT00943852|364473544|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674877|NCT00943852|364473545|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674878|NCT00943852|364473546|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674879|NCT00943852|364473547|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
105674880|NCT00943852|364473548|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674881|NCT00943852|364473549|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674882|NCT00943852|364473550|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674883|NCT00943852|364473541|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674884|NCT00943852|364473542|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674885|NCT00943852|364473543|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674886|NCT00943852|364473544|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674887|NCT00943852|364473545|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674888|NCT00943852|364473546|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674889|NCT00943852|364473547|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674890|NCT00943852|364473548|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
105674891|NCT00943852|364473549|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674892|NCT00943852|364473550|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674893|NCT00943852|364473541|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
105674894|NCT00943852|364473542|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
105674895|NCT00943852|364473543|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
105674896|NCT00943852|364473544|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
105674897|NCT00943852|364473545|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
105674898|NCT00943852|364473546|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
105674899|NCT00943852|364473547|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
105674900|NCT00943852|364473548|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
105674901|NCT00943852|364473549|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
105674902|NCT00943852|364473550|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
105674903|NCT02141620|364473551|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
105674904|NCT02141620|364473552|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
105674905|NCT00772330|364473553|FG000|Overall Study|Lost to Follow-up|3|||
105674906|NCT01519089|364473554|FG000|Overall Study|Adverse Event|4|||
105674907|NCT01519089|364473555|FG001|Overall Study|Adverse Event|4|||
105674908|NCT01519089|364473554|FG000|Overall Study|Lack of Efficacy|0|||
105674909|NCT01519089|364473555|FG001|Overall Study|Lack of Efficacy|2|||
105674910|NCT01519089|364473554|FG000|Overall Study|Lost to Follow-up|1|||
105674911|NCT01519089|364473555|FG001|Overall Study|Lost to Follow-up|0|||
105674912|NCT01519089|364473554|FG000|Overall Study|Withdrawal by Subject|0|||
105674913|NCT01519089|364473555|FG001|Overall Study|Withdrawal by Subject|2|||
105674914|NCT01519089|364473554|FG000|Overall Study|Other|2|||
105674915|NCT01519089|364473555|FG001|Overall Study|Other|6|||
105674916|NCT01519089|364473554|FG000|Overall Study|Not received study drug|0|||
105674917|NCT01519089|364473555|FG001|Overall Study|Not received study drug|1|||
105674918|NCT00127205|364473556|FG000|Overall Study|Adverse Event|228|||
105674919|NCT00127205|364473557|FG001|Overall Study|Adverse Event|387|||
105674920|NCT00127205|364473558|FG002|Overall Study|Adverse Event|273|||
105674921|NCT00127205|364473556|FG000|Overall Study|Death|8|||
105674922|NCT00127205|364473557|FG001|Overall Study|Death|6|||
105674923|NCT00127205|364473558|FG002|Overall Study|Death|5|||
105674924|NCT00127205|364473556|FG000|Overall Study|Withdrawal by Subject|318|||
105674925|NCT00127205|364473557|FG001|Overall Study|Withdrawal by Subject|310|||
105674926|NCT00127205|364473558|FG002|Overall Study|Withdrawal by Subject|172|||
105674927|NCT00127205|364473556|FG000|Overall Study|Other-non protocol specified|142|||
105674928|NCT00127205|364473557|FG001|Overall Study|Other-non protocol specified|129|||
105674929|NCT00127205|364473558|FG002|Overall Study|Other-non protocol specified|77|||
105674930|NCT00127205|364473556|FG000|Overall Study|Data not reported|6|||
105674931|NCT00127205|364473557|FG001|Overall Study|Data not reported|10|||
105674932|NCT00127205|364473558|FG002|Overall Study|Data not reported|1|||
105674933|NCT00127205|364473556|FG000|Overall Study|Progression|127|||
105674934|NCT00127205|364473557|FG001|Overall Study|Progression|131|||
105674935|NCT00127205|364473558|FG002|Overall Study|Progression|84|||
105674936|NCT00734591|364473559|FG000|Screening for Prospective Period|Site did not participate|1604|||
105674937|NCT00734591|364473560|FG001|Screening for Prospective Period|Site did not participate|1488|||
105674938|NCT00734591|364473559|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
105674939|NCT00734591|364473560|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
105674940|NCT00734591|364473559|FG000|Prospective Period|Withdrawal by Subject|11|||
105674941|NCT00734591|364473560|FG001|Prospective Period|Withdrawal by Subject|9|||
105674942|NCT00734591|364473559|FG000|Prospective Period|Lost to Follow-up|37|||
105674943|NCT00734591|364473560|FG001|Prospective Period|Lost to Follow-up|33|||
105674944|NCT00734591|364473559|FG000|Prospective Period|Study Terminated|1|||
105674945|NCT00734591|364473560|FG001|Prospective Period|Study Terminated|0|||
105674946|NCT00734591|364473559|FG000|Prospective Period|Other|2|||
105674947|NCT00734591|364473560|FG001|Prospective Period|Other|2|||
105674948|NCT03377699|364473561|FG000|Overall Study|Withdrawal by Subject|2|||
105674949|NCT03377699|364473562|FG001|Overall Study|Withdrawal by Subject|9|||
105674950|NCT03377699|364473561|FG000|Overall Study|Lost to Follow-up|1|||
105674951|NCT03377699|364473562|FG001|Overall Study|Lost to Follow-up|1|||
105674952|NCT03377699|364473561|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
105674953|NCT03377699|364473562|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
105674954|NCT03377699|364473561|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
105674955|NCT03377699|364473562|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
105674956|NCT03377699|364473561|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
105674957|NCT03377699|364473562|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
105674958|NCT03377699|364473561|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
105674959|NCT03377699|364473562|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
105674960|NCT01353859|364473563|FG000|Overall Study|Adverse Event|3|||
105674961|NCT01353859|364473563|FG000|Overall Study|Lack of Efficacy|1|||
105674962|NCT04155047|364473568|FG000|Overall Study|Adverse Event|1|||
105674963|NCT04155047|364473569|FG001|Overall Study|Adverse Event|0|||
105674964|NCT04155047|364473568|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
105674965|NCT04155047|364473569|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
105674966|NCT00406692|364473570|FG000|Overall Study|Withdrawal by Subject|4|||
105674967|NCT00406692|364473570|FG000|Overall Study|Physician Decision|1|||
105674968|NCT00406692|364473570|FG000|Overall Study|Adverse Event|1|||
105674969|NCT00406692|364473570|FG000|Overall Study|Lack of Efficacy|1|||
105674970|NCT00941070|364473573|FG000|Overall Study|Patient non-compliant|1|||
105674971|NCT00400725|364473574|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
105674972|NCT00400725|364473575|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
105674973|NCT00400725|364473576|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
105674974|NCT00400725|364473574|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
105674975|NCT00400725|364473575|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
105674976|NCT00400725|364473576|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
105674977|NCT00400725|364473574|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
105674978|NCT00400725|364473575|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
105674979|NCT00400725|364473576|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
105674980|NCT00400725|364473574|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
105674981|NCT00400725|364473575|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
105674982|NCT00400725|364473576|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
105674983|NCT00400725|364473574|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
105674984|NCT00400725|364473575|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
105674985|NCT00400725|364473576|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
105674986|NCT00400725|364473574|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
105674987|NCT00400725|364473575|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
105674988|NCT00400725|364473576|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
105555283|NCT00319098|364029204|FG001|Overall Study|Withdrawal by Subject|8|||
105555284|NCT00319098|364029203|FG000|Overall Study|Migrated/moved from study area|2|||
105555285|NCT00319098|364029204|FG001|Overall Study|Migrated/moved from study area|1|||
105555286|NCT00319098|364029203|FG000|Overall Study|Lost to Follow-up|37|||
105555287|NCT00319098|364029204|FG001|Overall Study|Lost to Follow-up|13|||
105555288|NCT00319098|364029203|FG000|Overall Study|Others|33|||
105555289|NCT00319098|364029204|FG001|Overall Study|Others|8|||
105555290|NCT00319098|364029203|FG000|Overall Study|Protocol Violation|3|||
105555291|NCT00319098|364029204|FG001|Overall Study|Protocol Violation|1|||
105555292|NCT03449030|364029205|FG000|Overall Study|Withdrawal by Subject|0|||
105674989|NCT00400725|364473574|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
105674990|NCT00400725|364473575|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
105674991|NCT00400725|364473576|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
105674992|NCT00400725|364473574|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
105674993|NCT00400725|364473575|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
105674994|NCT00400725|364473576|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
105674995|NCT00400725|364473574|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
105674996|NCT00400725|364473575|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
105555293|NCT03449030|364029206|FG001|Overall Study|Withdrawal by Subject|0|||
105674997|NCT00400725|364473576|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
105555294|NCT03449030|364029207|FG002|Overall Study|Withdrawal by Subject|0|||
105555295|NCT03449030|364029208|FG003|Overall Study|Withdrawal by Subject|1|||
105555296|NCT03449030|364029209|FG004|Overall Study|Withdrawal by Subject|1|||
105555297|NCT03449030|364029210|FG005|Overall Study|Withdrawal by Subject|1|||
105555298|NCT03449030|364029211|FG006|Overall Study|Withdrawal by Subject|1|||
105555299|NCT03449030|364029212|FG007|Overall Study|Withdrawal by Subject|2|||
105555300|NCT03449030|364029213|FG008|Overall Study|Withdrawal by Subject|0|||
105555301|NCT03449030|364029214|FG009|Overall Study|Withdrawal by Subject|0|||
105555302|NCT03449030|364029205|FG000|Overall Study|Symptomatic Deterioration|0|||
105555303|NCT03449030|364029206|FG001|Overall Study|Symptomatic Deterioration|1|||
105555304|NCT03449030|364029207|FG002|Overall Study|Symptomatic Deterioration|0|||
105555305|NCT03449030|364029208|FG003|Overall Study|Symptomatic Deterioration|0|||
105555306|NCT03449030|364029209|FG004|Overall Study|Symptomatic Deterioration|0|||
105555307|NCT03449030|364029210|FG005|Overall Study|Symptomatic Deterioration|1|||
105555308|NCT03449030|364029211|FG006|Overall Study|Symptomatic Deterioration|1|||
105555309|NCT03449030|364029212|FG007|Overall Study|Symptomatic Deterioration|0|||
105555310|NCT03449030|364029213|FG008|Overall Study|Symptomatic Deterioration|2|||
105555311|NCT03449030|364029214|FG009|Overall Study|Symptomatic Deterioration|0|||
105555312|NCT03449030|364029205|FG000|Overall Study|Progressive Disease|1|||
105555313|NCT03449030|364029206|FG001|Overall Study|Progressive Disease|0|||
105555314|NCT03449030|364029207|FG002|Overall Study|Progressive Disease|1|||
105555315|NCT03449030|364029208|FG003|Overall Study|Progressive Disease|4|||
105555316|NCT03449030|364029209|FG004|Overall Study|Progressive Disease|5|||
105555317|NCT03449030|364029210|FG005|Overall Study|Progressive Disease|3|||
105555318|NCT03449030|364029211|FG006|Overall Study|Progressive Disease|0|||
105555319|NCT03449030|364029212|FG007|Overall Study|Progressive Disease|1|||
105555320|NCT03449030|364029213|FG008|Overall Study|Progressive Disease|1|||
105555321|NCT03449030|364029214|FG009|Overall Study|Progressive Disease|1|||
105555322|NCT03449030|364029205|FG000|Overall Study|Adverse Event|0|||
105555323|NCT03449030|364029206|FG001|Overall Study|Adverse Event|0|||
105555324|NCT03449030|364029207|FG002|Overall Study|Adverse Event|0|||
105555325|NCT03449030|364029208|FG003|Overall Study|Adverse Event|0|||
105555326|NCT03449030|364029209|FG004|Overall Study|Adverse Event|0|||
105555327|NCT03449030|364029210|FG005|Overall Study|Adverse Event|2|||
105555328|NCT03449030|364029211|FG006|Overall Study|Adverse Event|0|||
105555329|NCT03449030|364029212|FG007|Overall Study|Adverse Event|0|||
105555330|NCT03449030|364029213|FG008|Overall Study|Adverse Event|0|||
105555331|NCT03449030|364029214|FG009|Overall Study|Adverse Event|0|||
105555332|NCT03449030|364029205|FG000|Overall Study|Death|0|||
105555333|NCT03449030|364029206|FG001|Overall Study|Death|0|||
105555334|NCT03449030|364029207|FG002|Overall Study|Death|0|||
105555335|NCT03449030|364029208|FG003|Overall Study|Death|0|||
105555336|NCT03449030|364029209|FG004|Overall Study|Death|1|||
105555337|NCT03449030|364029210|FG005|Overall Study|Death|0|||
105555338|NCT03449030|364029211|FG006|Overall Study|Death|0|||
105555339|NCT03449030|364029212|FG007|Overall Study|Death|0|||
105555340|NCT03449030|364029213|FG008|Overall Study|Death|0|||
105555341|NCT03449030|364029214|FG009|Overall Study|Death|0|||
105555342|NCT00322348|364029217|FG000|Overall Study|Adverse Event|0|||
105555343|NCT00322348|364029218|FG001|Overall Study|Adverse Event|1|||
105555344|NCT00322348|364029217|FG000|Overall Study|Withdrawal by Subject|1|||
105555345|NCT00322348|364029218|FG001|Overall Study|Withdrawal by Subject|4|||
105555346|NCT00322348|364029217|FG000|Overall Study|Lost to Follow-up|1|||
105555347|NCT00322348|364029218|FG001|Overall Study|Lost to Follow-up|0|||
105555348|NCT00322348|364029217|FG000|Overall Study|Death|0|||
105555349|NCT00322348|364029218|FG001|Overall Study|Death|2|||
105555350|NCT00322348|364029217|FG000|Overall Study|Disease Progression|30|||
105555351|NCT00322348|364029218|FG001|Overall Study|Disease Progression|25|||
105555352|NCT00322348|364029217|FG000|Overall Study|Reasons not specified|5|||
105555353|NCT00322348|364029218|FG001|Overall Study|Reasons not specified|1|||
105555354|NCT02341417|364029220|FG000|Overall Study|Withdrawal by Subject|0|||
105555355|NCT02341417|364029221|FG001|Overall Study|Withdrawal by Subject|2|||
105555356|NCT02341417|364029222|FG002|Overall Study|Withdrawal by Subject|0|||
105555357|NCT02341417|364029220|FG000|Overall Study|Decision by sponsor|2|||
105555358|NCT02341417|364029221|FG001|Overall Study|Decision by sponsor|0|||
105555359|NCT02341417|364029222|FG002|Overall Study|Decision by sponsor|0|||
105555360|NCT02341417|364029220|FG000|Overall Study|Death|0|||
105555361|NCT02341417|364029221|FG001|Overall Study|Death|0|||
105555362|NCT02341417|364029222|FG002|Overall Study|Death|1|||
105555363|NCT03743038|364029224|FG000|Overall Study|Physician Decision|1|||
105555364|NCT05207813|364029227|FG000|Overall Study|Lost to Follow-up|2|||
105555365|NCT04988308|364029228|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
105555366|NCT04988308|364029229|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
105555367|NCT04988308|364029230|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
105555368|NCT04988308|364029231|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
105555369|NCT04988308|364029232|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
105555370|NCT04988308|364029233|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
105674998|NCT01145898|364473579|FG000|3-year Treatment|medication change by treating physician|3|||
105674999|NCT01145898|364473580|FG001|3-year Treatment|medication change by treating physician|16|||
105675000|NCT00858364|364473583|FG000|Overall Study|Administrative Decision|3|||
105675001|NCT00858364|364473584|FG001|Overall Study|Administrative Decision|2|||
105675002|NCT00858364|364473583|FG000|Overall Study|Adverse Event|5|||
105675003|NCT00858364|364473584|FG001|Overall Study|Adverse Event|2|||
105675004|NCT00858364|364473583|FG000|Overall Study|Withdrawal by Subject|44|||
105675005|NCT00858364|364473584|FG001|Overall Study|Withdrawal by Subject|118|||
105675006|NCT00858364|364473583|FG000|Overall Study|Ineligibility Determined|1|||
105675007|NCT00858364|364473584|FG001|Overall Study|Ineligibility Determined|10|||
105675008|NCT00858364|364473583|FG000|Overall Study|Lost to Follow-up|24|||
105675009|NCT00858364|364473584|FG001|Overall Study|Lost to Follow-up|54|||
105675010|NCT00858364|364473583|FG000|Overall Study|Noncompliance|3|||
105675011|NCT00858364|364473584|FG001|Overall Study|Noncompliance|4|||
105675012|NCT00858364|364473583|FG000|Overall Study|Protocol Deviation|0|||
105675013|NCT00858364|364473584|FG001|Overall Study|Protocol Deviation|2|||
105675014|NCT00858364|364473583|FG000|Overall Study|Other|9|||
105675015|NCT00858364|364473584|FG001|Overall Study|Other|17|||
105675016|NCT00858364|364473583|FG000|Overall Study|Missing|1|||
105786397|NCT01965600|364870516|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
105786398|NCT01965600|364870513|FG000|Second Intervention|Study terminated by Sponsor|0|||
105343151|NCT02052596|363258255|FG000|Active Phase|Lost to Follow-up|8|||
105555371|NCT04988308|364029228|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
105555372|NCT04988308|364029229|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
105555373|NCT04988308|364029230|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
105555374|NCT04988308|364029231|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
105555375|NCT04988308|364029232|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
105555376|NCT04988308|364029233|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
105555377|NCT04988308|364029228|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
105555378|NCT04988308|364029229|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
105555379|NCT04988308|364029230|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
105555380|NCT04988308|364029231|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
105555381|NCT04988308|364029232|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
105555382|NCT04988308|364029233|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
105555383|NCT04988308|364029228|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
105555384|NCT04988308|364029229|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
105555385|NCT04988308|364029230|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
105555386|NCT04988308|364029231|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
105555387|NCT04988308|364029232|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
105555388|NCT04988308|364029233|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
105555389|NCT04988308|364029228|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
105555390|NCT04988308|364029229|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
105555391|NCT04988308|364029230|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
105555392|NCT04988308|364029231|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
105555393|NCT04988308|364029232|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
105555394|NCT04988308|364029233|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
105555395|NCT04988308|364029228|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
105555396|NCT04988308|364029229|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
105555397|NCT04988308|364029230|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
105555398|NCT04988308|364029231|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
105555399|NCT04988308|364029232|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
105555400|NCT04988308|364029233|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
105555401|NCT04988308|364029228|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
105555402|NCT04988308|364029229|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
105555403|NCT04988308|364029230|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
105555404|NCT04988308|364029231|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
105675017|NCT00858364|364473584|FG001|Overall Study|Missing|1|||
105675018|NCT00858364|364473583|FG000|Overall Study|Still on-study|114|||
105675019|NCT00858364|364473584|FG001|Overall Study|Still on-study|247|||
105786399|NCT01965600|364870514|FG001|Second Intervention|Study terminated by Sponsor|0|||
105675020|NCT03980808|364473585|FG000|Overall Study|Lost to Follow-up|2|||
105675021|NCT03980808|364473586|FG001|Overall Study|Lost to Follow-up|2|||
105675022|NCT01655693|364473589|FG000|Overall Study|Progression of Disease|92|||
105675023|NCT01655693|364473590|FG001|Overall Study|Progression of Disease|76|||
105675024|NCT01655693|364473591|FG002|Overall Study|Progression of Disease|58|||
105675025|NCT01655693|364473589|FG000|Overall Study|Death|8|||
105675026|NCT01655693|364473590|FG001|Overall Study|Death|9|||
105675027|NCT01655693|364473591|FG002|Overall Study|Death|12|||
105675028|NCT01655693|364473589|FG000|Overall Study|Serious Adverse Event|3|||
105675029|NCT01655693|364473590|FG001|Overall Study|Serious Adverse Event|15|||
105675030|NCT01655693|364473591|FG002|Overall Study|Serious Adverse Event|11|||
105675031|NCT01655693|364473589|FG000|Overall Study|Withdrawal by Subject|3|||
105675032|NCT01655693|364473590|FG001|Overall Study|Withdrawal by Subject|2|||
105675033|NCT01655693|364473591|FG002|Overall Study|Withdrawal by Subject|20|||
105675034|NCT01655693|364473589|FG000|Overall Study|Adverse Event|3|||
105675035|NCT01655693|364473590|FG001|Overall Study|Adverse Event|11|||
105675036|NCT01655693|364473591|FG002|Overall Study|Adverse Event|3|||
105675037|NCT01655693|364473589|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
105675038|NCT01655693|364473590|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
105675039|NCT01655693|364473591|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
105675040|NCT01655693|364473589|FG000|Overall Study|Non-Compliance|0|||
105675041|NCT01655693|364473590|FG001|Overall Study|Non-Compliance|0|||
105675042|NCT01655693|364473591|FG002|Overall Study|Non-Compliance|7|||
105675043|NCT01655693|364473589|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
105675044|NCT01655693|364473590|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
105675045|NCT01655693|364473591|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
105675046|NCT01655693|364473589|FG000|Overall Study|Protocol Violation|1|||
105675047|NCT01655693|364473590|FG001|Overall Study|Protocol Violation|0|||
105675048|NCT01655693|364473591|FG002|Overall Study|Protocol Violation|3|||
105675049|NCT01655693|364473589|FG000|Overall Study|Lost to Follow-up|1|||
105675050|NCT01655693|364473590|FG001|Overall Study|Lost to Follow-up|0|||
105675051|NCT01655693|364473591|FG002|Overall Study|Lost to Follow-up|1|||
105675052|NCT01655693|364473589|FG000|Overall Study|Screening Failure|1|||
105675053|NCT01655693|364473590|FG001|Overall Study|Screening Failure|0|||
105675054|NCT01655693|364473591|FG002|Overall Study|Screening Failure|0|||
105675055|NCT01655693|364473589|FG000|Overall Study|Other|8|||
105675056|NCT01655693|364473590|FG001|Overall Study|Other|6|||
105675057|NCT01655693|364473591|FG002|Overall Study|Other|15|||
105675058|NCT02755818|364473592|FG000|Overall Study|Withdrawal by Subject|0|||
105675059|NCT02755818|364473593|FG001|Overall Study|Withdrawal by Subject|0|||
105675060|NCT02755818|364473594|FG002|Overall Study|Withdrawal by Subject|0|||
105675061|NCT02755818|364473595|FG003|Overall Study|Withdrawal by Subject|2|||
105675062|NCT02755818|364473592|FG000|Overall Study|withdrawal by PI|0|||
105675063|NCT02755818|364473593|FG001|Overall Study|withdrawal by PI|0|||
105675064|NCT02755818|364473594|FG002|Overall Study|withdrawal by PI|1|||
105675065|NCT02755818|364473595|FG003|Overall Study|withdrawal by PI|1|||
105675066|NCT03014011|364473596|FG000|First Intervention|Withdrawal by Subject|1|||
105675067|NCT03014011|364473597|FG001|First Intervention|Withdrawal by Subject|0|||
105675068|NCT03014011|364473596|FG000|Washout|Withdrawal by Subject|1|||
105675069|NCT03014011|364473597|FG001|Washout|Withdrawal by Subject|0|||
105675070|NCT02643472|364473598|FG000|Overall Study|Death|2|||
105675071|NCT02643472|364473599|FG001|Overall Study|Death|5|||
105675072|NCT02643472|364473598|FG000|Overall Study|Withdrawal by Subject|3|||
105675073|NCT02643472|364473599|FG001|Overall Study|Withdrawal by Subject|2|||
105675074|NCT02643472|364473598|FG000|Overall Study|Protocol Violation|0|||
105675075|NCT02643472|364473599|FG001|Overall Study|Protocol Violation|1|||
105675076|NCT02643472|364473598|FG000|Overall Study|Lost to Follow-up|22|||
105675077|NCT02643472|364473599|FG001|Overall Study|Lost to Follow-up|26|||
105675078|NCT00528931|364473603|FG000|Overall Study|Lost to Follow-up|1|||
105675079|NCT00688870|364473604|FG000|Infant Series|Parent or legal guardian request|4|||
105675080|NCT00688870|364473605|FG001|Infant Series|Parent or legal guardian request|0|||
105675081|NCT00291642|364473607|FG000|Overall Study|Adverse Event|1|||
105675082|NCT00291642|364473608|FG001|Overall Study|Adverse Event|0|||
105675083|NCT00291642|364473609|FG002|Overall Study|Adverse Event|1|||
105675084|NCT00291642|364473610|FG003|Overall Study|Adverse Event|0|||
105675085|NCT00291642|364473611|FG004|Overall Study|Adverse Event|1|||
105675086|NCT00291642|364473607|FG000|Overall Study|Patient missed visit|0|||
105466625|NCT01217229|363720194|FG000|Overall Study|Disease progression, deterioration|2|||
105675087|NCT00291642|364473608|FG001|Overall Study|Patient missed visit|0|||
105675088|NCT00291642|364473609|FG002|Overall Study|Patient missed visit|1|||
105675089|NCT00291642|364473610|FG003|Overall Study|Patient missed visit|0|||
105675090|NCT00291642|364473611|FG004|Overall Study|Patient missed visit|0|||
105675091|NCT00291642|364473607|FG000|Overall Study|Intake of prohibited medication|1|||
105675092|NCT00291642|364473608|FG001|Overall Study|Intake of prohibited medication|0|||
105675093|NCT00291642|364473609|FG002|Overall Study|Intake of prohibited medication|0|||
105675094|NCT00291642|364473610|FG003|Overall Study|Intake of prohibited medication|0|||
105675095|NCT00291642|364473611|FG004|Overall Study|Intake of prohibited medication|0|||
105675096|NCT01278173|364473612|FG000|Overall Study|Lack of Efficacy|13|||
105675097|NCT01278173|364473612|FG000|Overall Study|Adverse Event|8|||
105675098|NCT01278173|364473612|FG000|Overall Study|Administrative or other reason|4|||
105675099|NCT01278173|364473612|FG000|Overall Study|Protocol Violation|1|||
105675100|NCT01278173|364473612|FG000|Overall Study|Withdrawal by Subject|1|||
105675101|NCT03973931|364473613|FG000|Overall Study|Lost to Follow-up|47|||
105675102|NCT03973931|364473614|FG001|Overall Study|Lost to Follow-up|63|||
105675103|NCT03973931|364473615|FG002|Overall Study|Lost to Follow-up|51|||
105675104|NCT03973931|364473616|FG003|Overall Study|Lost to Follow-up|54|||
105675105|NCT03973931|364473613|FG000|Overall Study|opted out|6|||
105675106|NCT03973931|364473614|FG001|Overall Study|opted out|5|||
105675107|NCT03973931|364473615|FG002|Overall Study|opted out|5|||
105675108|NCT03973931|364473616|FG003|Overall Study|opted out|1|||
105675109|NCT00744757|364475537|FG000|Overall Study|Objective disease progression|7|||
105675110|NCT00744757|364475537|FG000|Overall Study|Physician Decision|5|||
105675111|NCT00744757|364475537|FG000|Overall Study|Withdrawal by Subject|1|||
105675112|NCT00744757|364475537|FG000|Overall Study|Death|6|||
105675113|NCT00744757|364475537|FG000|Overall Study|Adverse Event|2|||
105675114|NCT00948766|364475540|FG000|Core Study|Adverse Event|73|||
105675115|NCT00948766|364475541|FG001|Core Study|Adverse Event|51|||
105675116|NCT00948766|364475540|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
105675117|NCT00948766|364475541|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
105675118|NCT00948766|364475540|FG000|Core Study|Patient Withdrew Consent|27|||
105675119|NCT00948766|364475541|FG001|Core Study|Patient Withdrew Consent|46|||
105343152|NCT02052596|363258256|FG001|Active Phase|Lost to Follow-up|11|||
105675120|NCT00948766|364475540|FG000|Core Study|Lost to Follow-up|3|||
105675121|NCT00948766|364475541|FG001|Core Study|Lost to Follow-up|2|||
105675122|NCT00948766|364475540|FG000|Core Study|Administrative Problems|2|||
105675123|NCT00948766|364475541|FG001|Core Study|Administrative Problems|2|||
105675124|NCT00948766|364475540|FG000|Core Study|Death|1|||
105675125|NCT00948766|364475541|FG001|Core Study|Death|1|||
105675126|NCT00948766|364475540|FG000|Core Study|Protocol Deviation|8|||
105675127|NCT00948766|364475541|FG001|Core Study|Protocol Deviation|10|||
105675128|NCT00948766|364475540|FG000|Extension Study|Adverse Event|43|||
105675129|NCT00948766|364475541|FG001|Extension Study|Adverse Event|0|||
105675130|NCT00948766|364475540|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
105675131|NCT00948766|364475541|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
105675132|NCT00948766|364475540|FG000|Extension Study|Study Drug No Longer Required|1|||
105675133|NCT00948766|364475541|FG001|Extension Study|Study Drug No Longer Required|0|||
105675134|NCT00948766|364475540|FG000|Extension Study|Patient Withdrew Consent|32|||
105675135|NCT00948766|364475541|FG001|Extension Study|Patient Withdrew Consent|0|||
105675136|NCT00948766|364475540|FG000|Extension Study|Lost to Follow-up|8|||
105675137|NCT00948766|364475541|FG001|Extension Study|Lost to Follow-up|0|||
105675138|NCT00948766|364475540|FG000|Extension Study|Administrative Problems|1|||
105675139|NCT00948766|364475541|FG001|Extension Study|Administrative Problems|0|||
105675140|NCT00948766|364475540|FG000|Extension Study|Death|4|||
105675141|NCT00948766|364475541|FG001|Extension Study|Death|0|||
105675142|NCT00888927|364475542|FG000|Overall Study|Adverse Event|0|||
105675143|NCT00888927|364475543|FG001|Overall Study|Adverse Event|0|||
105675144|NCT00888927|364475544|FG002|Overall Study|Adverse Event|0|||
105675145|NCT00888927|364475545|FG003|Overall Study|Adverse Event|1|||
105675146|NCT00888927|364475542|FG000|Overall Study|Withdrawal of consent|0|||
105675147|NCT00888927|364475543|FG001|Overall Study|Withdrawal of consent|0|||
105675148|NCT00888927|364475544|FG002|Overall Study|Withdrawal of consent|0|||
105675149|NCT00888927|364475545|FG003|Overall Study|Withdrawal of consent|1|||
105675150|NCT01080716|364475546|FG000|Part 1|Physician Decision|1|||
105675151|NCT01080716|364475547|FG001|Part 1|Physician Decision|0|||
105675152|NCT01080716|364475548|FG002|Part 1|Physician Decision|0|||
105675153|NCT01080716|364475549|FG003|Part 1|Physician Decision|0|||
105675154|NCT01056718|364475550|FG000|Overall Study|Withdrawal by Subject|2|||
105675155|NCT01056718|364475550|FG000|Overall Study|Ischemia on baseline stress test|1|||
105675156|NCT03189745|364475551|FG000|Overall Study|Conflict in work schedule of participant|1|||
105675157|NCT03189745|364475552|FG001|Overall Study|Conflict in work schedule of participant|1|||
105675158|NCT05086276|364475553|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
105675159|NCT05086276|364475554|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
105675160|NCT00895154|364475555|FG000|Overall Study|Lost to Follow-up|1|||
105675161|NCT00895154|364475556|FG001|Overall Study|Lost to Follow-up|1|||
105675162|NCT00895154|364475555|FG000|Overall Study|Withdrawal by Subject|0|||
105675163|NCT00895154|364475556|FG001|Overall Study|Withdrawal by Subject|1|||
105675164|NCT03702231|364475557|FG000|Overall Study|Withdrawal by Subject|1|||
105675165|NCT03702231|364475558|FG001|Overall Study|Withdrawal by Subject|0|||
105675166|NCT03702231|364475559|FG002|Overall Study|Withdrawal by Subject|0|||
105675167|NCT03702231|364475557|FG000|Overall Study|Protocol Violation|0|||
105675168|NCT03702231|364475558|FG001|Overall Study|Protocol Violation|0|||
105675169|NCT03702231|364475559|FG002|Overall Study|Protocol Violation|1|||
105675170|NCT03702231|364475557|FG000|Overall Study|Change in CLL Treatment|0|||
105675171|NCT03702231|364475558|FG001|Overall Study|Change in CLL Treatment|0|||
105675172|NCT03702231|364475559|FG002|Overall Study|Change in CLL Treatment|1|||
105675173|NCT03702231|364475557|FG000|Overall Study|COVID Pandemic|1|||
105675174|NCT03702231|364475558|FG001|Overall Study|COVID Pandemic|4|||
105675175|NCT03702231|364475559|FG002|Overall Study|COVID Pandemic|1|||
105675176|NCT03702231|364475557|FG000|Overall Study|Non-compliance|0|||
105675177|NCT03702231|364475558|FG001|Overall Study|Non-compliance|0|||
105675178|NCT03702231|364475559|FG002|Overall Study|Non-compliance|1|||
105675179|NCT00777088|364475560|FG000|Overall Study|PED Treatment not attempted|1|||
105675180|NCT03592745|364475561|FG000|Overall Study|Adverse Event|0|||
105675181|NCT03592745|364475562|FG001|Overall Study|Adverse Event|2|||
105675182|NCT03592745|364475561|FG000|Overall Study|Lost to Follow-up|2|||
105786400|NCT01965600|364870515|FG002|Second Intervention|Study terminated by Sponsor|2|||
105786401|NCT01965600|364870516|FG003|Second Intervention|Study terminated by Sponsor|2|||
105786402|NCT03145207|364870518|FG000|Overall Study|volunteer started taking allergy shots|1|||
105786403|NCT03145207|364870518|FG000|Overall Study|baseline blood pressure high|1|||
105786404|NCT01302366|364871383|FG000|Overall Study|patient choice or noncompliance|5|||
105675183|NCT03592745|364475562|FG001|Overall Study|Lost to Follow-up|0|||
105675184|NCT03592745|364475561|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
105675185|NCT03592745|364475562|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
105675186|NCT00738894|364475566|FG000|Overall Study|Lost to Follow-up|23|||
105675187|NCT00738894|364475567|FG001|Overall Study|Lost to Follow-up|13|||
105675188|NCT00738894|364475566|FG000|Overall Study|Withdrawal by Subject|10|||
105786405|NCT02957149|364871386|FG000|Overall Study|Withdrawal by Subject|5|||
105555405|NCT04988308|364029232|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
105675189|NCT00738894|364475567|FG001|Overall Study|Withdrawal by Subject|15|||
105675190|NCT00738894|364475566|FG000|Overall Study|Physician Decision|4|||
105675191|NCT00738894|364475567|FG001|Overall Study|Physician Decision|5|||
105675192|NCT00738894|364475566|FG000|Overall Study|Death|2|||
105675193|NCT00738894|364475567|FG001|Overall Study|Death|0|||
105675194|NCT05017103|364475568|FG000|Overall Study|Death|2|||
105675195|NCT02656329|364475569|FG000|Overall Study|Lost to Follow-up|2|||
105675196|NCT02656329|364475570|FG001|Overall Study|Lost to Follow-up|3|||
105675197|NCT02656329|364475569|FG000|Overall Study|Withdrawal by Subject|7|||
105675198|NCT02656329|364475570|FG001|Overall Study|Withdrawal by Subject|6|||
105675199|NCT02656329|364475569|FG000|Overall Study|Study termination by Sponsor|150|||
105675200|NCT02656329|364475570|FG001|Overall Study|Study termination by Sponsor|142|||
105675201|NCT02656329|364475569|FG000|Overall Study|Other than specified above|5|||
105675202|NCT02656329|364475570|FG001|Overall Study|Other than specified above|6|||
105675203|NCT01139580|364475571|FG000|Overall Study|Adverse Event|5|||
105675204|NCT01139580|364475572|FG001|Overall Study|Adverse Event|4|||
105675205|NCT01139580|364475571|FG000|Overall Study|Lost to Follow-up|9|||
105675206|NCT01139580|364475572|FG001|Overall Study|Lost to Follow-up|1|||
105675207|NCT01139580|364475571|FG000|Overall Study|Lack of Efficacy|0|||
105675208|NCT01139580|364475572|FG001|Overall Study|Lack of Efficacy|2|||
105675209|NCT01139580|364475571|FG000|Overall Study|Withdrawal by Subject|6|||
105343153|NCT02052596|363258255|FG000|Active Phase|Protocol Violation|1|||
105343154|NCT02052596|363258256|FG001|Active Phase|Protocol Violation|2|||
105343155|NCT02052596|363258255|FG000|Active Phase|Withdrawal by Subject|3|||
105343156|NCT02052596|363258256|FG001|Active Phase|Withdrawal by Subject|4|||
105343157|NCT02052596|363258255|FG000|Active Phase|Enrolled in error|1|||
105675210|NCT01139580|364475572|FG001|Overall Study|Withdrawal by Subject|9|||
105675211|NCT01139580|364475571|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
105675212|NCT01139580|364475572|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
105675213|NCT01139580|364475571|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
105675214|NCT01139580|364475572|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
105675215|NCT01139580|364475571|FG000|Overall Study|Misrandomized|1|||
105675216|NCT01139580|364475572|FG001|Overall Study|Misrandomized|0|||
105675217|NCT01139580|364475571|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
105675218|NCT01139580|364475572|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
105675219|NCT01139580|364475571|FG000|Overall Study|Participant Randomization in Error|0|||
105675220|NCT01139580|364475572|FG001|Overall Study|Participant Randomization in Error|1|||
105675221|NCT00911768|364475581|FG000|Overall Study|Protocol Violation|5|||
105675222|NCT00911768|364475582|FG001|Overall Study|Protocol Violation|4|||
105675223|NCT00911768|364475581|FG000|Overall Study|Withdrawal by Subject|1|||
105675224|NCT00911768|364475582|FG001|Overall Study|Withdrawal by Subject|0|||
105675225|NCT00633880|364475583|FG000|Open Label Titration|Lack of Efficacy|1|||
105675226|NCT00633880|364475584|FG001|Open Label Titration|Lack of Efficacy|0|||
105675227|NCT00633880|364475585|FG002|Open Label Titration|Lack of Efficacy|0|||
105675228|NCT00633880|364475583|FG000|Open Label Titration|Adverse Event|13|||
105675229|NCT00633880|364475584|FG001|Open Label Titration|Adverse Event|0|||
105675230|NCT00633880|364475585|FG002|Open Label Titration|Adverse Event|0|||
105343158|NCT02052596|363258256|FG001|Active Phase|Enrolled in error|0|||
105343159|NCT02052596|363258255|FG000|Active Phase|Lost due to Crohn's disease|0|||
105343160|NCT02052596|363258256|FG001|Active Phase|Lost due to Crohn's disease|1|||
105343161|NCT02052596|363258255|FG000|Safety Phase|Adverse Event|6|||
105343162|NCT02052596|363258256|FG001|Safety Phase|Adverse Event|3|||
105343163|NCT02052596|363258255|FG000|Safety Phase|Lost to Follow-up|11|||
105343164|NCT02052596|363258256|FG001|Safety Phase|Lost to Follow-up|18|||
105343165|NCT02052596|363258255|FG000|Safety Phase|Protocol Violation|1|||
105343166|NCT02052596|363258256|FG001|Safety Phase|Protocol Violation|2|||
105343167|NCT02052596|363258255|FG000|Safety Phase|Withdrawal by Subject|8|||
105343168|NCT02052596|363258256|FG001|Safety Phase|Withdrawal by Subject|11|||
105343169|NCT02052596|363258255|FG000|Safety Phase|Enrolled in error|1|||
105343170|NCT02052596|363258256|FG001|Safety Phase|Enrolled in error|0|||
105343171|NCT02052596|363258255|FG000|Safety Phase|Lost due to Crohn's disease|0|||
105343172|NCT02052596|363258256|FG001|Safety Phase|Lost due to Crohn's disease|1|||
105343173|NCT00558896|363258257|FG000|Overall Study|Adverse Event|1|||
105343174|NCT00558896|363258258|FG001|Overall Study|Adverse Event|1|||
105343175|NCT00558896|363258259|FG002|Overall Study|Adverse Event|1|||
105343176|NCT00558896|363258260|FG003|Overall Study|Adverse Event|3|||
105675231|NCT00633880|364475583|FG000|Open Label Titration|Treatment Failure|55|||
105675232|NCT00633880|364475584|FG001|Open Label Titration|Treatment Failure|0|||
105675233|NCT00633880|364475585|FG002|Open Label Titration|Treatment Failure|0|||
105675234|NCT00633880|364475583|FG000|Open Label Titration|Protocol Violation|6|||
105343177|NCT00558896|363258261|FG004|Overall Study|Adverse Event|4|||
105675235|NCT00633880|364475584|FG001|Open Label Titration|Protocol Violation|0|||
105555406|NCT04988308|364029233|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
105343178|NCT00558896|363258262|FG005|Overall Study|Adverse Event|10|||
105343179|NCT00558896|363258263|FG006|Overall Study|Adverse Event|3|||
105343180|NCT00558896|363258257|FG000|Overall Study|Death|3|||
105343181|NCT00558896|363258258|FG001|Overall Study|Death|0|||
105343182|NCT00558896|363258259|FG002|Overall Study|Death|2|||
105343183|NCT00558896|363258260|FG003|Overall Study|Death|3|||
105555407|NCT04988308|364029228|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
105555408|NCT04988308|364029229|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
105555409|NCT04988308|364029230|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
105555410|NCT04988308|364029231|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
105555411|NCT04988308|364029232|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
105555412|NCT04988308|364029233|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
105555413|NCT04988308|364029228|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
105555414|NCT04988308|364029229|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
105555415|NCT04988308|364029230|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
105555416|NCT04988308|364029231|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
105555417|NCT04988308|364029232|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
105555418|NCT04988308|364029233|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
105555419|NCT01371851|364029235|FG000|Overall Study|Lost to Follow-up|5|||
105555420|NCT01371851|364029236|FG001|Overall Study|Lost to Follow-up|8|||
105555421|NCT01371851|364029235|FG000|Overall Study|was arrested and put in jail|0|||
105555422|NCT01371851|364029236|FG001|Overall Study|was arrested and put in jail|1|||
105555423|NCT01371851|364029235|FG000|Overall Study|non study related adverse event|1|||
105555424|NCT01371851|364029236|FG001|Overall Study|non study related adverse event|0|||
105786406|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Adverse Event|4|||
105343184|NCT00558896|363258261|FG004|Overall Study|Death|2|||
105555425|NCT01371851|364029235|FG000|Overall Study|Blood Pressure outside study parameters|2|||
105555426|NCT01371851|364029236|FG001|Overall Study|Blood Pressure outside study parameters|0|||
105555427|NCT00833638|364029237|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
105555428|NCT00833638|364029238|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
105555429|NCT00833638|364029239|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
105555430|NCT00833638|364029237|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
105555431|NCT00833638|364029238|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
105555432|NCT00833638|364029239|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
105555433|NCT00833638|364029237|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
105555434|NCT00833638|364029238|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
105555435|NCT00833638|364029239|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
105555436|NCT00833638|364029237|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
105555437|NCT00833638|364029238|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
105555438|NCT00833638|364029239|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
105555439|NCT00833638|364029237|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
105555440|NCT00833638|364029238|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
105555441|NCT00833638|364029239|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
105555442|NCT00833638|364029237|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
105555443|NCT00833638|364029238|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
105555444|NCT00833638|364029239|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
105555445|NCT00833638|364029237|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
105555446|NCT00833638|364029238|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
105555447|NCT00833638|364029239|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
105555448|NCT00833638|364029237|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
105555449|NCT00833638|364029238|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
105555450|NCT00833638|364029239|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
105555451|NCT00833638|364029237|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
105555452|NCT00833638|364029238|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
105555453|NCT00833638|364029239|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
105555454|NCT01864564|364029244|FG000|Overall Study|Lost to Follow-up|17|||
105555455|NCT01864564|364029245|FG001|Overall Study|Lost to Follow-up|23|||
105555456|NCT01864564|364029244|FG000|Overall Study|Withdrawal by Subject|20|||
105555457|NCT01864564|364029245|FG001|Overall Study|Withdrawal by Subject|11|||
105555458|NCT01864564|364029244|FG000|Overall Study|Protocol Violation|0|||
105555459|NCT01864564|364029245|FG001|Overall Study|Protocol Violation|27|||
105555460|NCT01864564|364029244|FG000|Overall Study|not reported|0|||
105555461|NCT01864564|364029245|FG001|Overall Study|not reported|34|||
105555462|NCT02269670|364029246|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
105555463|NCT00941330|364029247|FG000|Overall Study|Other|1|||
105555464|NCT00941330|364029248|FG001|Overall Study|Other|0|||
105555465|NCT00941330|364029247|FG000|Overall Study|Physician Decision|0|||
105555466|NCT00941330|364029248|FG001|Overall Study|Physician Decision|2|||
105555467|NCT02693665|364029249|FG000|Overall Study|Death|3|||
105555468|NCT02693665|364029250|FG001|Overall Study|Death|2|||
105555469|NCT02693665|364029249|FG000|Overall Study|Lost to Follow-up|7|||
105555470|NCT02693665|364029250|FG001|Overall Study|Lost to Follow-up|3|||
105555471|NCT02693665|364029249|FG000|Overall Study|Protocol Violation|1|||
105555472|NCT02693665|364029250|FG001|Overall Study|Protocol Violation|0|||
105555473|NCT02693665|364029249|FG000|Overall Study|Withdrawal by Subject|2|||
105555474|NCT02693665|364029250|FG001|Overall Study|Withdrawal by Subject|0|||
105555475|NCT02693665|364029249|FG000|Overall Study|patient wanted to leave it behind|1|||
105555476|NCT02693665|364029250|FG001|Overall Study|patient wanted to leave it behind|0|||
105555477|NCT02693665|364029249|FG000|Overall Study|anxiety|1|||
105555478|NCT02693665|364029250|FG001|Overall Study|anxiety|0|||
105555479|NCT02693665|364029249|FG000|Overall Study|family issues|1|||
105555480|NCT02693665|364029250|FG001|Overall Study|family issues|0|||
105555481|NCT02693665|364029249|FG000|Overall Study|no reason given|1|||
105555482|NCT02693665|364029250|FG001|Overall Study|no reason given|0|||
105555483|NCT01962493|364029253|FG000|Overall Study|Adverse Event|1|||
105555484|NCT01962493|364029254|FG001|Overall Study|Adverse Event|2|||
105555485|NCT01962493|364029253|FG000|Overall Study|Protocol Violation|0|||
105555486|NCT01962493|364029254|FG001|Overall Study|Protocol Violation|1|||
105555487|NCT01962493|364029253|FG000|Overall Study|Withdrawal by Subject|4|||
105555488|NCT01962493|364029254|FG001|Overall Study|Withdrawal by Subject|2|||
105555489|NCT03776136|364029255|FG000|Overall Study|Death|85|||
105555490|NCT03776136|364029255|FG000|Overall Study|Withdrawal by Subject|3|||
105555491|NCT03776136|364029255|FG000|Overall Study|Sponsor Decision|15|||
105555492|NCT00655980|364029258|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
105555493|NCT00655980|364029259|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
105555494|NCT00655980|364029260|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
105555495|NCT01329029|364029261|FG000|Overall Study|Withdrawal by Subject|117|||
105555496|NCT01329029|364029262|FG001|Overall Study|Withdrawal by Subject|87|||
105675236|NCT00633880|364475585|FG002|Open Label Titration|Protocol Violation|0|||
105675237|NCT00633880|364475583|FG000|Open Label Titration|Physician Decision|1|||
105675238|NCT00633880|364475584|FG001|Open Label Titration|Physician Decision|0|||
105675239|NCT00633880|364475585|FG002|Open Label Titration|Physician Decision|0|||
105675240|NCT00633880|364475583|FG000|Open Label Titration|Withdrawal by Subject|4|||
105675241|NCT00633880|364475584|FG001|Open Label Titration|Withdrawal by Subject|0|||
105675242|NCT00633880|364475585|FG002|Open Label Titration|Withdrawal by Subject|0|||
105675243|NCT00700778|364475586|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
105675244|NCT01373151|364475587|FG000|Period 1|Lack of Efficacy|3|||
105675245|NCT01373151|364475588|FG001|Period 1|Lack of Efficacy|0|||
105675246|NCT01373151|364475589|FG002|Period 1|Lack of Efficacy|0|||
105675247|NCT01373151|364475590|FG003|Period 1|Lack of Efficacy|0|||
105675248|NCT01373151|364475591|FG004|Period 1|Lack of Efficacy|1|||
105675249|NCT01373151|364475592|FG005|Period 1|Lack of Efficacy|0|||
105675250|NCT01373151|364475593|FG006|Period 1|Lack of Efficacy|0|||
105675251|NCT01373151|364475587|FG000|Period 1|Adverse Event|0|||
105675252|NCT01373151|364475588|FG001|Period 1|Adverse Event|0|||
105675253|NCT01373151|364475589|FG002|Period 1|Adverse Event|1|||
105675254|NCT01373151|364475590|FG003|Period 1|Adverse Event|0|||
105675255|NCT01373151|364475591|FG004|Period 1|Adverse Event|4|||
105675256|NCT01373151|364475592|FG005|Period 1|Adverse Event|3|||
105675257|NCT01373151|364475593|FG006|Period 1|Adverse Event|0|||
105675258|NCT01373151|364475587|FG000|Period 1|Withdrawal by Subject|2|||
105675259|NCT01373151|364475588|FG001|Period 1|Withdrawal by Subject|0|||
105675260|NCT01373151|364475589|FG002|Period 1|Withdrawal by Subject|3|||
105675261|NCT01373151|364475590|FG003|Period 1|Withdrawal by Subject|1|||
105675262|NCT01373151|364475591|FG004|Period 1|Withdrawal by Subject|0|||
105675263|NCT01373151|364475592|FG005|Period 1|Withdrawal by Subject|1|||
105675264|NCT01373151|364475593|FG006|Period 1|Withdrawal by Subject|0|||
105675265|NCT01373151|364475587|FG000|Period 2|Lack of Efficacy|9|||
105675266|NCT01373151|364475588|FG001|Period 2|Lack of Efficacy|0|||
105675267|NCT01373151|364475589|FG002|Period 2|Lack of Efficacy|0|||
105675268|NCT01373151|364475590|FG003|Period 2|Lack of Efficacy|1|||
105675269|NCT01373151|364475591|FG004|Period 2|Lack of Efficacy|2|||
105675270|NCT01373151|364475592|FG005|Period 2|Lack of Efficacy|0|||
105675271|NCT01373151|364475593|FG006|Period 2|Lack of Efficacy|3|||
105675272|NCT01373151|364475587|FG000|Period 2|Adverse Event|0|||
105675273|NCT01373151|364475588|FG001|Period 2|Adverse Event|0|||
105675274|NCT01373151|364475589|FG002|Period 2|Adverse Event|3|||
105675275|NCT01373151|364475590|FG003|Period 2|Adverse Event|3|||
105675276|NCT01373151|364475591|FG004|Period 2|Adverse Event|0|||
105675277|NCT01373151|364475592|FG005|Period 2|Adverse Event|0|||
105675278|NCT01373151|364475593|FG006|Period 2|Adverse Event|1|||
105675279|NCT01373151|364475587|FG000|Period 2|subject request to discontinue|0|||
105675280|NCT01373151|364475588|FG001|Period 2|subject request to discontinue|1|||
105675281|NCT01373151|364475589|FG002|Period 2|subject request to discontinue|0|||
105675282|NCT01373151|364475590|FG003|Period 2|subject request to discontinue|0|||
105675283|NCT01373151|364475591|FG004|Period 2|subject request to discontinue|0|||
105675284|NCT01373151|364475592|FG005|Period 2|subject request to discontinue|0|||
105675285|NCT01373151|364475593|FG006|Period 2|subject request to discontinue|0|||
105675286|NCT01373151|364475587|FG000|Period 2|Withdrawal by Subject|0|||
105675287|NCT01373151|364475588|FG001|Period 2|Withdrawal by Subject|0|||
105675288|NCT01373151|364475589|FG002|Period 2|Withdrawal by Subject|0|||
105675289|NCT01373151|364475590|FG003|Period 2|Withdrawal by Subject|1|||
105675290|NCT01373151|364475591|FG004|Period 2|Withdrawal by Subject|0|||
105675291|NCT01373151|364475592|FG005|Period 2|Withdrawal by Subject|0|||
105675292|NCT01373151|364475593|FG006|Period 2|Withdrawal by Subject|0|||
105675293|NCT01373151|364475587|FG000|Period 2|Other|0|||
105675294|NCT01373151|364475588|FG001|Period 2|Other|0|||
105675295|NCT01373151|364475589|FG002|Period 2|Other|1|||
105675296|NCT01373151|364475590|FG003|Period 2|Other|0|||
105675297|NCT01373151|364475591|FG004|Period 2|Other|0|||
105675298|NCT01373151|364475592|FG005|Period 2|Other|0|||
105675299|NCT01373151|364475593|FG006|Period 2|Other|1|||
105675300|NCT03026075|364475597|FG000|Overall Study|Physician Decision|1|||
105675301|NCT04927247|364475598|FG000|Overall Study|Other|2|||
105675302|NCT04927247|364475599|FG001|Overall Study|Other|1|||
105675303|NCT04927247|364475598|FG000|Overall Study|Physician Decision|0|||
105675304|NCT04927247|364475599|FG001|Overall Study|Physician Decision|1|||
105675305|NCT04927247|364475598|FG000|Overall Study|Adverse Event|1|||
105675306|NCT04927247|364475599|FG001|Overall Study|Adverse Event|0|||
105675307|NCT00350103|364475603|FG000|Overall Study|Adverse Event|12|||
105675308|NCT00350103|364475604|FG001|Overall Study|Adverse Event|29|||
105675309|NCT00350103|364475605|FG002|Overall Study|Adverse Event|17|||
105675310|NCT00350103|364475603|FG000|Overall Study|Lack of Efficacy|5|||
105675311|NCT00350103|364475604|FG001|Overall Study|Lack of Efficacy|1|||
105675312|NCT00350103|364475605|FG002|Overall Study|Lack of Efficacy|3|||
105675313|NCT00350103|364475603|FG000|Overall Study|Withdrawal by Subject|6|||
105675314|NCT00350103|364475604|FG001|Overall Study|Withdrawal by Subject|6|||
105675315|NCT00350103|364475605|FG002|Overall Study|Withdrawal by Subject|8|||
105675316|NCT00350103|364475603|FG000|Overall Study|Protocol Violation|0|||
105675317|NCT00350103|364475604|FG001|Overall Study|Protocol Violation|0|||
105675318|NCT00350103|364475605|FG002|Overall Study|Protocol Violation|1|||
105675319|NCT00350103|364475603|FG000|Overall Study|Unsatisfactory Compliance|2|||
105675320|NCT00350103|364475604|FG001|Overall Study|Unsatisfactory Compliance|2|||
105675321|NCT00350103|364475605|FG002|Overall Study|Unsatisfactory Compliance|1|||
105675322|NCT00350103|364475603|FG000|Overall Study|Investigator´s decision|1|||
105675323|NCT00350103|364475604|FG001|Overall Study|Investigator´s decision|1|||
105675324|NCT00350103|364475605|FG002|Overall Study|Investigator´s decision|0|||
105675325|NCT00350103|364475603|FG000|Overall Study|Exclusion criteria met|0|||
105675326|NCT00350103|364475604|FG001|Overall Study|Exclusion criteria met|0|||
105675327|NCT00350103|364475605|FG002|Overall Study|Exclusion criteria met|1|||
105675328|NCT00350103|364475603|FG000|Overall Study|Patient relocated|0|||
105675329|NCT00350103|364475604|FG001|Overall Study|Patient relocated|0|||
105675330|NCT00350103|364475605|FG002|Overall Study|Patient relocated|1|||
105675331|NCT00350103|364475603|FG000|Overall Study|Need for prohibited medication|1|||
105675332|NCT00350103|364475604|FG001|Overall Study|Need for prohibited medication|0|||
105675333|NCT00350103|364475605|FG002|Overall Study|Need for prohibited medication|0|||
105675334|NCT00350103|364475603|FG000|Overall Study|Personal reasons|0|||
105675335|NCT00350103|364475604|FG001|Overall Study|Personal reasons|0|||
105675336|NCT00350103|364475605|FG002|Overall Study|Personal reasons|1|||
105675337|NCT00350103|364475603|FG000|Overall Study|Patient stopped feeling pain|1|||
105675338|NCT00350103|364475604|FG001|Overall Study|Patient stopped feeling pain|0|||
105675339|NCT00350103|364475605|FG002|Overall Study|Patient stopped feeling pain|0|||
105675340|NCT00350103|364475603|FG000|Overall Study|PR greater than 250ms|0|||
105675341|NCT00350103|364475604|FG001|Overall Study|PR greater than 250ms|0|||
105675342|NCT00350103|364475605|FG002|Overall Study|PR greater than 250ms|1|||
105675343|NCT00350103|364475603|FG000|Overall Study|Wrong calculation of QT interval|0|||
105675344|NCT00350103|364475604|FG001|Overall Study|Wrong calculation of QT interval|0|||
105675345|NCT00350103|364475605|FG002|Overall Study|Wrong calculation of QT interval|1|||
105343185|NCT00558896|363258262|FG005|Overall Study|Death|2|||
105343186|NCT00558896|363258263|FG006|Overall Study|Death|6|||
105675346|NCT00350103|364475603|FG000|Overall Study|Sponsor mistake|1|||
105675347|NCT00350103|364475604|FG001|Overall Study|Sponsor mistake|0|||
105675348|NCT00350103|364475605|FG002|Overall Study|Sponsor mistake|0|||
105675349|NCT00350103|364475603|FG000|Overall Study|Randomization mistake|0|||
105675350|NCT00350103|364475604|FG001|Overall Study|Randomization mistake|1|||
105343187|NCT00558896|363258257|FG000|Overall Study|Withdrawal by Subject|2|||
105343188|NCT00558896|363258258|FG001|Overall Study|Withdrawal by Subject|1|||
105343189|NCT00558896|363258259|FG002|Overall Study|Withdrawal by Subject|1|||
105675351|NCT00350103|364475605|FG002|Overall Study|Randomization mistake|1|||
105466626|NCT01217229|363720194|FG000|Overall Study|Disease progression, Cheson criteria|14|||
105675352|NCT00350103|364475603|FG000|Overall Study|Sponsor´s decision|0|||
105675353|NCT00350103|364475604|FG001|Overall Study|Sponsor´s decision|1|||
105675354|NCT00350103|364475605|FG002|Overall Study|Sponsor´s decision|0|||
105675355|NCT00350103|364475603|FG000|Overall Study|Lost, Reason unknown|1|||
105675356|NCT00350103|364475604|FG001|Overall Study|Lost, Reason unknown|1|||
105675357|NCT00350103|364475605|FG002|Overall Study|Lost, Reason unknown|0|||
105675358|NCT02712905|364475606|FG000|Monotherapy|Death|2|||
105675359|NCT02712905|364475607|FG001|Monotherapy|Death|5|||
105675360|NCT02712905|364475608|FG002|Monotherapy|Death|0|||
105675361|NCT02712905|364475609|FG003|Monotherapy|Death|3|||
105675362|NCT02712905|364475610|FG004|Monotherapy|Death|15|||
105675363|NCT02712905|364475611|FG005|Monotherapy|Death|1|||
105675364|NCT02712905|364475612|FG006|Monotherapy|Death|3|||
105675365|NCT02712905|364475613|FG007|Monotherapy|Death|3|||
105675366|NCT02712905|364475614|FG008|Monotherapy|Death|0|||
105675367|NCT02712905|364475615|FG009|Monotherapy|Death|27|||
105675368|NCT02712905|364475616|FG010|Monotherapy|Death|2|||
105675369|NCT02712905|364475617|FG011|Monotherapy|Death|5|||
105786407|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Adverse Event|3|||
105786408|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Adverse Event|0|||
105675370|NCT02712905|364475618|FG012|Monotherapy|Death|0|||
105675371|NCT02712905|364475619|FG013|Monotherapy|Death|0|||
105675372|NCT02712905|364475620|FG014|Monotherapy|Death|0|||
105675373|NCT02712905|364475621|FG015|Monotherapy|Death|0|||
105555497|NCT01329029|364029261|FG000|Overall Study|Adverse Event|82|||
105555498|NCT01329029|364029262|FG001|Overall Study|Adverse Event|29|||
105555499|NCT01329029|364029261|FG000|Overall Study|Death|16|||
105555500|NCT01329029|364029262|FG001|Overall Study|Death|19|||
105555501|NCT01329029|364029261|FG000|Overall Study|Other|14|||
105555502|NCT01329029|364029262|FG001|Overall Study|Other|20|||
105555503|NCT01329029|364029261|FG000|Overall Study|COPD Exacerbation|11|||
105555504|NCT01329029|364029262|FG001|Overall Study|COPD Exacerbation|18|||
105555505|NCT01329029|364029261|FG000|Overall Study|Physician Decision|16|||
105555506|NCT01329029|364029262|FG001|Overall Study|Physician Decision|13|||
105555507|NCT01329029|364029261|FG000|Overall Study|Lost to Follow-up|8|||
105555508|NCT01329029|364029262|FG001|Overall Study|Lost to Follow-up|5|||
105555509|NCT01329029|364029261|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
105555510|NCT01329029|364029262|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
105570234|NCT00405639|364086710|FG000|Overall Study|Seizure prior to receiving BNP|1|||
105570235|NCT00405639|364086711|FG001|Overall Study|Seizure prior to receiving BNP|0|||
105570236|NCT05096208|364086712|FG000|Overall Study|Lost to Follow-up|3|||
105570237|NCT05096208|364086713|FG001|Overall Study|Lost to Follow-up|5|||
105570238|NCT05096208|364086714|FG002|Overall Study|Lost to Follow-up|5|||
105570239|NCT05096208|364086715|FG003|Overall Study|Lost to Follow-up|2|||
105570240|NCT05096208|364086712|FG000|Overall Study|Withdrawal by Subject|0|||
105570241|NCT05096208|364086713|FG001|Overall Study|Withdrawal by Subject|1|||
105570242|NCT05096208|364086714|FG002|Overall Study|Withdrawal by Subject|2|||
105570243|NCT05096208|364086715|FG003|Overall Study|Withdrawal by Subject|3|||
105570244|NCT05096208|364086712|FG000|Overall Study|No longer met eligibility criteria|1|||
105570245|NCT05096208|364086713|FG001|Overall Study|No longer met eligibility criteria|0|||
105570246|NCT05096208|364086714|FG002|Overall Study|No longer met eligibility criteria|0|||
105570247|NCT05096208|364086715|FG003|Overall Study|No longer met eligibility criteria|0|||
105570248|NCT05096208|364086712|FG000|Overall Study|Other|0|||
105570249|NCT05096208|364086713|FG001|Overall Study|Other|0|||
105570250|NCT05096208|364086714|FG002|Overall Study|Other|1|||
105570251|NCT05096208|364086715|FG003|Overall Study|Other|0|||
105570252|NCT00094328|364086717|FG000|Overall Study|Lost to Follow-up|1|||
105570253|NCT00612534|364086719|FG000|Overall Study|Adverse Event|0|||
105570254|NCT00612534|364086720|FG001|Overall Study|Adverse Event|4|||
105570255|NCT00612534|364086721|FG002|Overall Study|Adverse Event|2|||
105570256|NCT00612534|364086722|FG003|Overall Study|Adverse Event|1|||
105570257|NCT00612534|364086719|FG000|Overall Study|Lack of Efficacy|13|||
105570258|NCT00612534|364086720|FG001|Overall Study|Lack of Efficacy|12|||
105570259|NCT00612534|364086721|FG002|Overall Study|Lack of Efficacy|5|||
105570260|NCT00612534|364086722|FG003|Overall Study|Lack of Efficacy|16|||
105570261|NCT00612534|364086719|FG000|Overall Study|Other Reason|0|||
105570262|NCT00612534|364086720|FG001|Overall Study|Other Reason|1|||
105570263|NCT00612534|364086721|FG002|Overall Study|Other Reason|0|||
105570264|NCT00612534|364086722|FG003|Overall Study|Other Reason|0|||
105570265|NCT04615182|364086723|FG000|Overall Study|Re-transplanted|2|||
105570266|NCT04615182|364086723|FG000|Overall Study|Protocol Violation|6|||
105570267|NCT04615182|364086723|FG000|Overall Study|Death|6|||
105570268|NCT04615182|364086723|FG000|Overall Study|Death and protocol violation|1|||
105570269|NCT02821819|364086728|FG000|Overall Study|Protocol Violation|1|||
105570270|NCT01975220|364086729|FG000|Test Period 1|Not treated|0|||
105570271|NCT01975220|364086730|FG001|Test Period 1|Not treated|1|||
105570272|NCT01975220|364086731|FG002|Test Period 1|Not treated|0|||
105570273|NCT01975220|364086732|FG003|Test Period 1|Not treated|0|||
105570274|NCT01975220|364086733|FG004|Test Period 1|Not treated|0|||
105570275|NCT01975220|364086734|FG005|Test Period 1|Not treated|0|||
105570276|NCT03403426|364086735|FG000|Overall Study|Death|1|||
105570277|NCT03403426|364086735|FG000|Overall Study|Lost to Follow-up|2|||
105570278|NCT01806584|364086736|FG000|Overall Study|Adverse Event|2|||
105570279|NCT01806584|364086737|FG001|Overall Study|Adverse Event|1|||
105570280|NCT01806584|364086736|FG000|Overall Study|Death|1|||
105570281|NCT01806584|364086737|FG001|Overall Study|Death|0|||
105675374|NCT02712905|364475622|FG016|Monotherapy|Death|0|||
105675375|NCT02712905|364475623|FG017|Monotherapy|Death|0|||
105675376|NCT02712905|364475606|FG000|Monotherapy|Lost to Follow-up|0|||
105675377|NCT02712905|364475607|FG001|Monotherapy|Lost to Follow-up|1|||
105675378|NCT02712905|364475608|FG002|Monotherapy|Lost to Follow-up|0|||
105675379|NCT02712905|364475609|FG003|Monotherapy|Lost to Follow-up|1|||
105675380|NCT02712905|364475610|FG004|Monotherapy|Lost to Follow-up|0|||
105675381|NCT02712905|364475611|FG005|Monotherapy|Lost to Follow-up|0|||
105675382|NCT02712905|364475612|FG006|Monotherapy|Lost to Follow-up|0|||
105675383|NCT02712905|364475613|FG007|Monotherapy|Lost to Follow-up|0|||
105675384|NCT02712905|364475614|FG008|Monotherapy|Lost to Follow-up|0|||
105675385|NCT02712905|364475615|FG009|Monotherapy|Lost to Follow-up|2|||
105675386|NCT02712905|364475616|FG010|Monotherapy|Lost to Follow-up|0|||
105675387|NCT02712905|364475617|FG011|Monotherapy|Lost to Follow-up|0|||
105675388|NCT02712905|364475618|FG012|Monotherapy|Lost to Follow-up|0|||
105675389|NCT02712905|364475619|FG013|Monotherapy|Lost to Follow-up|0|||
105675390|NCT02712905|364475620|FG014|Monotherapy|Lost to Follow-up|0|||
105675391|NCT02712905|364475621|FG015|Monotherapy|Lost to Follow-up|0|||
105675392|NCT02712905|364475622|FG016|Monotherapy|Lost to Follow-up|0|||
105675393|NCT02712905|364475623|FG017|Monotherapy|Lost to Follow-up|0|||
105675394|NCT02712905|364475606|FG000|Monotherapy|Physician Decision|1|||
105675395|NCT02712905|364475607|FG001|Monotherapy|Physician Decision|0|||
105675396|NCT02712905|364475608|FG002|Monotherapy|Physician Decision|0|||
105675397|NCT02712905|364475609|FG003|Monotherapy|Physician Decision|1|||
105675398|NCT02712905|364475610|FG004|Monotherapy|Physician Decision|0|||
105675399|NCT02712905|364475611|FG005|Monotherapy|Physician Decision|0|||
105675400|NCT02712905|364475612|FG006|Monotherapy|Physician Decision|0|||
105675401|NCT02712905|364475613|FG007|Monotherapy|Physician Decision|0|||
105675402|NCT02712905|364475614|FG008|Monotherapy|Physician Decision|0|||
105675403|NCT02712905|364475615|FG009|Monotherapy|Physician Decision|1|||
105675404|NCT02712905|364475616|FG010|Monotherapy|Physician Decision|0|||
105675405|NCT02712905|364475617|FG011|Monotherapy|Physician Decision|0|||
105675406|NCT02712905|364475618|FG012|Monotherapy|Physician Decision|0|||
105675407|NCT02712905|364475619|FG013|Monotherapy|Physician Decision|0|||
105675408|NCT02712905|364475620|FG014|Monotherapy|Physician Decision|0|||
105675409|NCT02712905|364475621|FG015|Monotherapy|Physician Decision|0|||
105675410|NCT02712905|364475622|FG016|Monotherapy|Physician Decision|0|||
105675411|NCT02712905|364475623|FG017|Monotherapy|Physician Decision|0|||
105675412|NCT02712905|364475606|FG000|Monotherapy|Study Terminated by Sponsor|0|||
105675413|NCT02712905|364475607|FG001|Monotherapy|Study Terminated by Sponsor|0|||
105675414|NCT02712905|364475608|FG002|Monotherapy|Study Terminated by Sponsor|0|||
105675415|NCT02712905|364475609|FG003|Monotherapy|Study Terminated by Sponsor|0|||
105675416|NCT02712905|364475610|FG004|Monotherapy|Study Terminated by Sponsor|1|||
105675417|NCT02712905|364475611|FG005|Monotherapy|Study Terminated by Sponsor|0|||
105675418|NCT02712905|364475612|FG006|Monotherapy|Study Terminated by Sponsor|0|||
105675419|NCT02712905|364475613|FG007|Monotherapy|Study Terminated by Sponsor|0|||
105675420|NCT02712905|364475614|FG008|Monotherapy|Study Terminated by Sponsor|0|||
105675421|NCT02712905|364475615|FG009|Monotherapy|Study Terminated by Sponsor|2|||
105675422|NCT02712905|364475616|FG010|Monotherapy|Study Terminated by Sponsor|0|||
105675423|NCT02712905|364475617|FG011|Monotherapy|Study Terminated by Sponsor|0|||
105675424|NCT02712905|364475618|FG012|Monotherapy|Study Terminated by Sponsor|0|||
105675425|NCT02712905|364475619|FG013|Monotherapy|Study Terminated by Sponsor|0|||
105675426|NCT02712905|364475620|FG014|Monotherapy|Study Terminated by Sponsor|0|||
105675427|NCT02712905|364475621|FG015|Monotherapy|Study Terminated by Sponsor|0|||
105675428|NCT02712905|364475622|FG016|Monotherapy|Study Terminated by Sponsor|0|||
105675429|NCT02712905|364475623|FG017|Monotherapy|Study Terminated by Sponsor|0|||
105675430|NCT02712905|364475606|FG000|Monotherapy|Withdrawal by Subject|0|||
105675431|NCT02712905|364475607|FG001|Monotherapy|Withdrawal by Subject|0|||
105675432|NCT02712905|364475608|FG002|Monotherapy|Withdrawal by Subject|1|||
105675433|NCT02712905|364475609|FG003|Monotherapy|Withdrawal by Subject|0|||
105675434|NCT02712905|364475610|FG004|Monotherapy|Withdrawal by Subject|2|||
105675435|NCT02712905|364475611|FG005|Monotherapy|Withdrawal by Subject|0|||
105675436|NCT02712905|364475612|FG006|Monotherapy|Withdrawal by Subject|0|||
105675437|NCT02712905|364475613|FG007|Monotherapy|Withdrawal by Subject|0|||
105675438|NCT02712905|364475614|FG008|Monotherapy|Withdrawal by Subject|0|||
105675439|NCT02712905|364475615|FG009|Monotherapy|Withdrawal by Subject|4|||
105675440|NCT02712905|364475616|FG010|Monotherapy|Withdrawal by Subject|1|||
105675441|NCT02712905|364475617|FG011|Monotherapy|Withdrawal by Subject|2|||
105675442|NCT02712905|364475618|FG012|Monotherapy|Withdrawal by Subject|0|||
105675443|NCT02712905|364475619|FG013|Monotherapy|Withdrawal by Subject|0|||
105675444|NCT02712905|364475620|FG014|Monotherapy|Withdrawal by Subject|0|||
105675445|NCT02712905|364475621|FG015|Monotherapy|Withdrawal by Subject|0|||
105675446|NCT02712905|364475622|FG016|Monotherapy|Withdrawal by Subject|0|||
105675447|NCT02712905|364475623|FG017|Monotherapy|Withdrawal by Subject|0|||
105675448|NCT02712905|364475606|FG000|Monotherapy|Started New Cancer Drug|0|||
105675449|NCT02712905|364475607|FG001|Monotherapy|Started New Cancer Drug|0|||
105675450|NCT02712905|364475608|FG002|Monotherapy|Started New Cancer Drug|0|||
105675451|NCT02712905|364475609|FG003|Monotherapy|Started New Cancer Drug|0|||
105675452|NCT02712905|364475610|FG004|Monotherapy|Started New Cancer Drug|0|||
105675453|NCT02712905|364475611|FG005|Monotherapy|Started New Cancer Drug|1|||
105675454|NCT02712905|364475612|FG006|Monotherapy|Started New Cancer Drug|0|||
105675455|NCT02712905|364475613|FG007|Monotherapy|Started New Cancer Drug|0|||
105675456|NCT02712905|364475614|FG008|Monotherapy|Started New Cancer Drug|0|||
105675457|NCT02712905|364475615|FG009|Monotherapy|Started New Cancer Drug|0|||
105675458|NCT02712905|364475616|FG010|Monotherapy|Started New Cancer Drug|0|||
105675459|NCT02712905|364475617|FG011|Monotherapy|Started New Cancer Drug|0|||
105675460|NCT02712905|364475618|FG012|Monotherapy|Started New Cancer Drug|0|||
105675461|NCT02712905|364475619|FG013|Monotherapy|Started New Cancer Drug|0|||
105675462|NCT02712905|364475620|FG014|Monotherapy|Started New Cancer Drug|0|||
105675463|NCT02712905|364475621|FG015|Monotherapy|Started New Cancer Drug|0|||
105675464|NCT02712905|364475622|FG016|Monotherapy|Started New Cancer Drug|0|||
105675465|NCT02712905|364475623|FG017|Monotherapy|Started New Cancer Drug|0|||
105675466|NCT02712905|364475606|FG000|Monotherapy|Adverse Event|0|||
105675467|NCT02712905|364475607|FG001|Monotherapy|Adverse Event|0|||
105675468|NCT02712905|364475608|FG002|Monotherapy|Adverse Event|0|||
105675469|NCT02712905|364475609|FG003|Monotherapy|Adverse Event|0|||
105675470|NCT02712905|364475610|FG004|Monotherapy|Adverse Event|0|||
105675471|NCT02712905|364475611|FG005|Monotherapy|Adverse Event|0|||
105675472|NCT02712905|364475612|FG006|Monotherapy|Adverse Event|0|||
105675473|NCT02712905|364475613|FG007|Monotherapy|Adverse Event|0|||
105675474|NCT02712905|364475614|FG008|Monotherapy|Adverse Event|1|||
105675475|NCT02712905|364475615|FG009|Monotherapy|Adverse Event|0|||
105675476|NCT02712905|364475616|FG010|Monotherapy|Adverse Event|0|||
105675477|NCT02712905|364475617|FG011|Monotherapy|Adverse Event|0|||
105675478|NCT02712905|364475618|FG012|Monotherapy|Adverse Event|0|||
105675479|NCT02712905|364475619|FG013|Monotherapy|Adverse Event|0|||
105675480|NCT02712905|364475620|FG014|Monotherapy|Adverse Event|0|||
105675481|NCT02712905|364475621|FG015|Monotherapy|Adverse Event|0|||
105675482|NCT02712905|364475622|FG016|Monotherapy|Adverse Event|0|||
105786409|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Adverse Event|0|||
105786410|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Death|24|||
105786411|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Death|9|||
105675483|NCT02712905|364475623|FG017|Monotherapy|Adverse Event|0|||
105675484|NCT02712905|364475606|FG000|Combination Therapy|Death|0|||
105675485|NCT02712905|364475607|FG001|Combination Therapy|Death|0|||
105675486|NCT02712905|364475608|FG002|Combination Therapy|Death|0|||
105675487|NCT02712905|364475609|FG003|Combination Therapy|Death|0|||
105675488|NCT02712905|364475610|FG004|Combination Therapy|Death|0|||
105675489|NCT02712905|364475611|FG005|Combination Therapy|Death|0|||
105675490|NCT02712905|364475612|FG006|Combination Therapy|Death|0|||
105675491|NCT02712905|364475613|FG007|Combination Therapy|Death|0|||
105786412|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Death|0|||
105675492|NCT02712905|364475614|FG008|Combination Therapy|Death|0|||
105675493|NCT02712905|364475615|FG009|Combination Therapy|Death|0|||
105675494|NCT02712905|364475616|FG010|Combination Therapy|Death|0|||
105675495|NCT02712905|364475617|FG011|Combination Therapy|Death|0|||
105675496|NCT02712905|364475618|FG012|Combination Therapy|Death|5|||
105675497|NCT02712905|364475619|FG013|Combination Therapy|Death|6|||
105675498|NCT02712905|364475620|FG014|Combination Therapy|Death|1|||
105675499|NCT02712905|364475621|FG015|Combination Therapy|Death|3|||
105675500|NCT02712905|364475622|FG016|Combination Therapy|Death|1|||
105786413|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Death|0|||
105786414|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
105786415|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
105343190|NCT00558896|363258260|FG003|Overall Study|Withdrawal by Subject|1|||
105343191|NCT00558896|363258261|FG004|Overall Study|Withdrawal by Subject|1|||
105343192|NCT00558896|363258262|FG005|Overall Study|Withdrawal by Subject|5|||
105343193|NCT00558896|363258263|FG006|Overall Study|Withdrawal by Subject|5|||
105343194|NCT00558896|363258257|FG000|Overall Study|Alternative Treatment|2|||
105343195|NCT00558896|363258258|FG001|Overall Study|Alternative Treatment|2|||
105555511|NCT00156065|364031747|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
105555512|NCT00156065|364031748|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
105555513|NCT00156065|364031749|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
105555514|NCT00156065|364031747|FG000|Overall Study|Adverse Event|8|||
105555515|NCT00156065|364031748|FG001|Overall Study|Adverse Event|11|||
105555516|NCT00156065|364031749|FG002|Overall Study|Adverse Event|4|||
105555517|NCT00156065|364031747|FG000|Overall Study|Lack of Efficacy|2|||
105555518|NCT00156065|364031748|FG001|Overall Study|Lack of Efficacy|9|||
105555519|NCT00156065|364031749|FG002|Overall Study|Lack of Efficacy|3|||
105555520|NCT00156065|364031747|FG000|Overall Study|Withdrawal by Subject|13|||
105555521|NCT00156065|364031748|FG001|Overall Study|Withdrawal by Subject|26|||
105555522|NCT00156065|364031749|FG002|Overall Study|Withdrawal by Subject|16|||
105555523|NCT00156065|364031747|FG000|Overall Study|Lost to Follow-up|5|||
105555524|NCT00156065|364031748|FG001|Overall Study|Lost to Follow-up|7|||
105555525|NCT00156065|364031749|FG002|Overall Study|Lost to Follow-up|1|||
105555526|NCT00156065|364031747|FG000|Overall Study|Other|2|||
105555527|NCT00156065|364031748|FG001|Overall Study|Other|9|||
105555528|NCT00156065|364031749|FG002|Overall Study|Other|3|||
105555529|NCT02985866|364031751|FG000|Overall Study|Poor CGM data|1|||
105555530|NCT02985866|364031752|FG001|Overall Study|Poor CGM data|1|||
105555531|NCT02008890|364031755|FG000|Period 1|Withdrawal by Subject|7|||
105555532|NCT02008890|364031756|FG001|Period 1|Withdrawal by Subject|7|||
105555533|NCT02008890|364031757|FG002|Period 1|Withdrawal by Subject|5|||
105555534|NCT02008890|364031758|FG003|Period 1|Withdrawal by Subject|0|||
105555535|NCT02008890|364031759|FG004|Period 1|Withdrawal by Subject|0|||
105555536|NCT02008890|364031755|FG000|Period 1|Pregnancy|1|||
105555537|NCT02008890|364031756|FG001|Period 1|Pregnancy|0|||
105555538|NCT02008890|364031757|FG002|Period 1|Pregnancy|0|||
105555539|NCT02008890|364031758|FG003|Period 1|Pregnancy|0|||
105555540|NCT02008890|364031759|FG004|Period 1|Pregnancy|0|||
105555541|NCT02008890|364031755|FG000|Period 1|Physician Decision|1|||
105555542|NCT02008890|364031756|FG001|Period 1|Physician Decision|0|||
105555543|NCT02008890|364031757|FG002|Period 1|Physician Decision|1|||
105555544|NCT02008890|364031758|FG003|Period 1|Physician Decision|0|||
105555545|NCT02008890|364031759|FG004|Period 1|Physician Decision|0|||
105555546|NCT02008890|364031755|FG000|Period 1|Adverse Event|6|||
105555547|NCT02008890|364031756|FG001|Period 1|Adverse Event|8|||
105555548|NCT02008890|364031757|FG002|Period 1|Adverse Event|6|||
105555549|NCT02008890|364031758|FG003|Period 1|Adverse Event|0|||
105555550|NCT02008890|364031759|FG004|Period 1|Adverse Event|0|||
105555551|NCT02008890|364031755|FG000|Period 2|Adverse Event|12|||
105555552|NCT02008890|364031756|FG001|Period 2|Adverse Event|7|||
105555553|NCT02008890|364031757|FG002|Period 2|Adverse Event|0|||
105555554|NCT02008890|364031758|FG003|Period 2|Adverse Event|5|||
105555555|NCT02008890|364031759|FG004|Period 2|Adverse Event|5|||
105555556|NCT02008890|364031755|FG000|Period 2|Withdrawal by Subject|11|||
105555557|NCT02008890|364031756|FG001|Period 2|Withdrawal by Subject|8|||
105786416|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
105555558|NCT02008890|364031757|FG002|Period 2|Withdrawal by Subject|0|||
105555559|NCT02008890|364031758|FG003|Period 2|Withdrawal by Subject|7|||
105555560|NCT02008890|364031759|FG004|Period 2|Withdrawal by Subject|2|||
105555561|NCT02008890|364031755|FG000|Period 2|Physician Decision|4|||
105555562|NCT02008890|364031756|FG001|Period 2|Physician Decision|0|||
105555563|NCT02008890|364031757|FG002|Period 2|Physician Decision|0|||
105555564|NCT02008890|364031758|FG003|Period 2|Physician Decision|2|||
105555565|NCT02008890|364031759|FG004|Period 2|Physician Decision|1|||
105555566|NCT02008890|364031755|FG000|Period 2|Lost to Follow-up|0|||
105555567|NCT02008890|364031756|FG001|Period 2|Lost to Follow-up|0|||
105555568|NCT02008890|364031757|FG002|Period 2|Lost to Follow-up|1|||
105555569|NCT02008890|364031758|FG003|Period 2|Lost to Follow-up|0|||
105555570|NCT02008890|364031759|FG004|Period 2|Lost to Follow-up|0|||
105675501|NCT02712905|364475623|FG017|Combination Therapy|Death|3|||
105675502|NCT02712905|364475606|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
105786417|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
105555571|NCT02008890|364031755|FG000|Extension Period|Withdrawal by Subject|3|||
105555572|NCT02008890|364031756|FG001|Extension Period|Withdrawal by Subject|2|||
105555573|NCT02008890|364031757|FG002|Extension Period|Withdrawal by Subject|0|||
105555574|NCT02008890|364031758|FG003|Extension Period|Withdrawal by Subject|4|||
105555575|NCT02008890|364031759|FG004|Extension Period|Withdrawal by Subject|2|||
105555576|NCT02008890|364031755|FG000|Extension Period|Lost to Follow-up|1|||
105555577|NCT02008890|364031756|FG001|Extension Period|Lost to Follow-up|0|||
105555578|NCT02008890|364031757|FG002|Extension Period|Lost to Follow-up|0|||
105555579|NCT02008890|364031758|FG003|Extension Period|Lost to Follow-up|0|||
105555580|NCT02008890|364031759|FG004|Extension Period|Lost to Follow-up|0|||
105555581|NCT02008890|364031755|FG000|Extension Period|Adverse Event|1|||
105555582|NCT02008890|364031756|FG001|Extension Period|Adverse Event|3|||
105555583|NCT02008890|364031757|FG002|Extension Period|Adverse Event|0|||
105555584|NCT02008890|364031758|FG003|Extension Period|Adverse Event|0|||
105555585|NCT02008890|364031759|FG004|Extension Period|Adverse Event|2|||
105555586|NCT02207816|364031760|FG000|Overall Study|Serious Adverse Event|0|||
105555587|NCT02207816|364031761|FG001|Overall Study|Serious Adverse Event|5|||
105555588|NCT02207816|364031762|FG002|Overall Study|Serious Adverse Event|2|||
105555589|NCT02207816|364031760|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
105555590|NCT02207816|364031761|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
105555591|NCT02207816|364031762|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
105555592|NCT02207816|364031760|FG000|Overall Study|Withdrawal by Subject|4|||
105555593|NCT02207816|364031761|FG001|Overall Study|Withdrawal by Subject|9|||
105555594|NCT02207816|364031762|FG002|Overall Study|Withdrawal by Subject|7|||
105555595|NCT02207816|364031760|FG000|Overall Study|Migrated/Moved From Study Area|41|||
105555596|NCT02207816|364031761|FG001|Overall Study|Migrated/Moved From Study Area|60|||
105555597|NCT02207816|364031762|FG002|Overall Study|Migrated/Moved From Study Area|51|||
105555598|NCT02207816|364031760|FG000|Overall Study|Lost to Follow-up|3|||
105555599|NCT02207816|364031761|FG001|Overall Study|Lost to Follow-up|9|||
105555600|NCT02207816|364031762|FG002|Overall Study|Lost to Follow-up|1|||
105555601|NCT02207816|364031760|FG000|Overall Study|Other|1|||
105555602|NCT02207816|364031761|FG001|Overall Study|Other|2|||
105555603|NCT02207816|364031762|FG002|Overall Study|Other|4|||
105555604|NCT02925455|364031763|FG000|Overall Study|Withdrawal by Subject|2|||
105555605|NCT02925455|364031764|FG001|Overall Study|Withdrawal by Subject|0|||
105555606|NCT01549613|364031765|FG000|Overall Study|Lost to Follow-up|11|||
105555607|NCT01549613|364031766|FG001|Overall Study|Lost to Follow-up|11|||
105555608|NCT02216123|364031767|FG000|Overall Study|Lost to Follow-up|4|||
105555609|NCT02216123|364031768|FG001|Overall Study|Lost to Follow-up|2|||
105555610|NCT02216123|364031767|FG000|Overall Study|Withdrawal by Subject|2|||
105555611|NCT02216123|364031768|FG001|Overall Study|Withdrawal by Subject|0|||
105555612|NCT03489304|364031769|FG000|Overall Study|Lost to Follow-up|4|||
105555613|NCT03166618|364031770|FG000|Overall Study|Study was Terminated|0|||
105555614|NCT03166618|364031771|FG001|Overall Study|Study was Terminated|1|||
105555615|NCT00605293|364031772|FG000|Overall Study|Death|2|||
105555616|NCT00605293|364031773|FG001|Overall Study|Death|1|||
105555617|NCT00605293|364031772|FG000|Overall Study|Insufficient Therapeutic Response|2|||
105555618|NCT00605293|364031773|FG001|Overall Study|Insufficient Therapeutic Response|0|||
105555619|NCT00605293|364031772|FG000|Overall Study|Adverse Event|1|||
105555620|NCT00605293|364031773|FG001|Overall Study|Adverse Event|0|||
105555621|NCT00605293|364031772|FG000|Overall Study|Holidays Dialysis Out|1|||
105555622|NCT00605293|364031773|FG001|Overall Study|Holidays Dialysis Out|0|||
105555623|NCT00605293|364031772|FG000|Overall Study|Blood Transfusion|7|||
105555624|NCT00605293|364031773|FG001|Overall Study|Blood Transfusion|1|||
105555625|NCT00605293|364031772|FG000|Overall Study|Renal Transplantation|3|||
105555626|NCT00605293|364031773|FG001|Overall Study|Renal Transplantation|1|||
105555627|NCT00605293|364031772|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
105555628|NCT00605293|364031773|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
105555629|NCT00605293|364031772|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
105555630|NCT00605293|364031773|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
105555631|NCT00605293|364031772|FG000|Overall Study|Principal Investigator Decision|0|||
105555632|NCT00605293|364031773|FG001|Overall Study|Principal Investigator Decision|1|||
105555633|NCT02502266|364031774|FG000|Overall Study|Adverse Event|0|||
105555634|NCT02502266|364031775|FG001|Overall Study|Adverse Event|0|||
105555635|NCT02502266|364031776|FG002|Overall Study|Adverse Event|0|||
105675503|NCT02712905|364475607|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
105675504|NCT02712905|364475608|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
105555636|NCT02502266|364031777|FG003|Overall Study|Adverse Event|0|||
105675505|NCT02712905|364475609|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
105675506|NCT02712905|364475610|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
105555637|NCT02502266|364031778|FG004|Overall Study|Adverse Event|1|||
105555638|NCT02502266|364031779|FG005|Overall Study|Adverse Event|1|||
105555639|NCT02502266|364031780|FG006|Overall Study|Adverse Event|1|||
105555640|NCT02502266|364031774|FG000|Overall Study|Withdrawal by Subject|30|||
105555641|NCT02502266|364031775|FG001|Overall Study|Withdrawal by Subject|15|||
105675507|NCT02712905|364475611|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
105675508|NCT02712905|364475612|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
105675509|NCT02712905|364475613|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
105675510|NCT02712905|364475614|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
105675511|NCT02712905|364475615|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
105675512|NCT02712905|364475616|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
105675513|NCT02712905|364475617|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
105675514|NCT02712905|364475618|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
105675515|NCT02712905|364475619|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
105675516|NCT02712905|364475620|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
105675517|NCT02712905|364475621|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
105675518|NCT02712905|364475622|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
105675519|NCT02712905|364475623|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
105675520|NCT02712905|364475606|FG000|Combination Therapy|Withdrawal by Subject|0|||
105675521|NCT02712905|364475607|FG001|Combination Therapy|Withdrawal by Subject|0|||
105675522|NCT02712905|364475608|FG002|Combination Therapy|Withdrawal by Subject|0|||
105675523|NCT02712905|364475609|FG003|Combination Therapy|Withdrawal by Subject|0|||
105675524|NCT02712905|364475610|FG004|Combination Therapy|Withdrawal by Subject|0|||
105675525|NCT02712905|364475611|FG005|Combination Therapy|Withdrawal by Subject|0|||
105675526|NCT02712905|364475612|FG006|Combination Therapy|Withdrawal by Subject|0|||
105555642|NCT02502266|364031776|FG002|Overall Study|Withdrawal by Subject|16|||
105555643|NCT02502266|364031777|FG003|Overall Study|Withdrawal by Subject|0|||
105555644|NCT02502266|364031778|FG004|Overall Study|Withdrawal by Subject|0|||
105555645|NCT02502266|364031779|FG005|Overall Study|Withdrawal by Subject|0|||
105555646|NCT02502266|364031780|FG006|Overall Study|Withdrawal by Subject|0|||
105555647|NCT02502266|364031774|FG000|Overall Study|Still on Treatment|0|||
105555648|NCT02502266|364031775|FG001|Overall Study|Still on Treatment|0|||
105555649|NCT02502266|364031776|FG002|Overall Study|Still on Treatment|1|||
105555650|NCT02502266|364031777|FG003|Overall Study|Still on Treatment|0|||
105555651|NCT02502266|364031778|FG004|Overall Study|Still on Treatment|0|||
105555652|NCT02502266|364031779|FG005|Overall Study|Still on Treatment|0|||
105555653|NCT02502266|364031780|FG006|Overall Study|Still on Treatment|0|||
105555654|NCT02502266|364031774|FG000|Overall Study|Other Reasons|19|||
105555655|NCT02502266|364031775|FG001|Overall Study|Other Reasons|6|||
105555656|NCT02502266|364031776|FG002|Overall Study|Other Reasons|14|||
105555657|NCT02502266|364031777|FG003|Overall Study|Other Reasons|0|||
105555658|NCT02502266|364031778|FG004|Overall Study|Other Reasons|1|||
105555659|NCT02502266|364031779|FG005|Overall Study|Other Reasons|1|||
105555660|NCT02502266|364031780|FG006|Overall Study|Other Reasons|0|||
105555661|NCT02502266|364031774|FG000|Overall Study|Arm 4 Discontinued|0|||
105555662|NCT02502266|364031775|FG001|Overall Study|Arm 4 Discontinued|0|||
105555663|NCT02502266|364031776|FG002|Overall Study|Arm 4 Discontinued|0|||
105555664|NCT02502266|364031777|FG003|Overall Study|Arm 4 Discontinued|52|||
105555665|NCT02502266|364031778|FG004|Overall Study|Arm 4 Discontinued|0|||
105555666|NCT02502266|364031779|FG005|Overall Study|Arm 4 Discontinued|0|||
105555667|NCT02502266|364031780|FG006|Overall Study|Arm 4 Discontinued|0|||
105555668|NCT02502266|364031774|FG000|Overall Study|Never treated|0|||
105555669|NCT02502266|364031775|FG001|Overall Study|Never treated|0|||
105555670|NCT02502266|364031776|FG002|Overall Study|Never treated|0|||
105555671|NCT02502266|364031777|FG003|Overall Study|Never treated|0|||
105555672|NCT02502266|364031778|FG004|Overall Study|Never treated|0|||
105555673|NCT02502266|364031779|FG005|Overall Study|Never treated|1|||
105555674|NCT02502266|364031780|FG006|Overall Study|Never treated|0|||
105555675|NCT03508843|364031781|FG000|Overall Study|Withdrawal by Subject|1|||
105555676|NCT03508843|364031781|FG000|Overall Study|technical difficulties|2|||
105555677|NCT04154956|364031782|FG000|Overall Study|Death|109|||
105555678|NCT04154956|364031783|FG001|Overall Study|Death|110|||
105555679|NCT04154956|364031782|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
105555680|NCT04154956|364031783|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
105555681|NCT04154956|364031782|FG000|Overall Study|Withdrawal by Subject|1|||
105555682|NCT04154956|364031783|FG001|Overall Study|Withdrawal by Subject|7|||
105555683|NCT04154956|364031782|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
105555684|NCT04154956|364031783|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
105555685|NCT04066114|364031784|FG000|Overall Study|Adverse Event|1|||
105555686|NCT04066114|364031785|FG001|Overall Study|Adverse Event|0|||
105555687|NCT04066114|364031786|FG002|Overall Study|Adverse Event|0|||
105555688|NCT04066114|364031784|FG000|Overall Study|Withdrawal by Subject|1|||
105555689|NCT04066114|364031785|FG001|Overall Study|Withdrawal by Subject|0|||
105555690|NCT04066114|364031786|FG002|Overall Study|Withdrawal by Subject|0|||
105675527|NCT02712905|364475613|FG007|Combination Therapy|Withdrawal by Subject|0|||
105675528|NCT02712905|364475614|FG008|Combination Therapy|Withdrawal by Subject|0|||
105675529|NCT02712905|364475615|FG009|Combination Therapy|Withdrawal by Subject|0|||
105555691|NCT04066114|364031784|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
105555692|NCT04066114|364031785|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
105555693|NCT04066114|364031786|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
105555694|NCT00254982|364031787|FG000|Overall Study|Other|2|||
105555695|NCT00254982|364031788|FG001|Overall Study|Other|1|||
105555696|NCT00254982|364031787|FG000|Overall Study|Lack of Efficacy|5|||
105555697|NCT00254982|364031788|FG001|Overall Study|Lack of Efficacy|3|||
105555698|NCT00254982|364031787|FG000|Overall Study|Lost to Follow-up|5|||
105555699|NCT00254982|364031788|FG001|Overall Study|Lost to Follow-up|3|||
105555700|NCT00254982|364031787|FG000|Overall Study|Adverse Event|18|||
105555701|NCT00254982|364031788|FG001|Overall Study|Adverse Event|16|||
105555702|NCT00254982|364031787|FG000|Overall Study|Withdrawal by Subject|1|||
105555703|NCT00254982|364031788|FG001|Overall Study|Withdrawal by Subject|1|||
105555704|NCT00254982|364031787|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
105555705|NCT00254982|364031788|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
105555706|NCT00254982|364031787|FG000|Overall Study|Protocol deviation|1|||
105555707|NCT00254982|364031788|FG001|Overall Study|Protocol deviation|1|||
105555708|NCT00254982|364031787|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
105555709|NCT00254982|364031788|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
105555710|NCT00254982|364031787|FG000|Overall Study|Malignancy|0|||
105555711|NCT00254982|364031788|FG001|Overall Study|Malignancy|2|||
105555712|NCT00254982|364031787|FG000|Overall Study|Opportunistic infection|1|||
105555713|NCT00254982|364031788|FG001|Overall Study|Opportunistic infection|0|||
105555714|NCT00254982|364031787|FG000|Overall Study|Abnormal liver function tests|2|||
105555715|NCT00254982|364031788|FG001|Overall Study|Abnormal liver function tests|1|||
105555716|NCT02103439|364031796|FG000|Overall Study|Adverse Event|0|||
105555717|NCT02103439|364031797|FG001|Overall Study|Adverse Event|2|||
105555718|NCT02103439|364031796|FG000|Overall Study|Withdrawal by Subject|3|||
105555719|NCT02103439|364031797|FG001|Overall Study|Withdrawal by Subject|1|||
105555720|NCT01816594|364031800|FG000|Overall Study|Local Progress|0|||
105555721|NCT01816594|364031801|FG001|Overall Study|Local Progress|2|||
105555722|NCT01816594|364031800|FG000|Overall Study|Adverse Event|9|||
105555723|NCT01816594|364031801|FG001|Overall Study|Adverse Event|0|||
105555724|NCT01816594|364031800|FG000|Overall Study|Withdrawal by Subject|1|||
105555725|NCT01816594|364031801|FG001|Overall Study|Withdrawal by Subject|0|||
105555726|NCT01816594|364031800|FG000|Overall Study|Physician Decision|1|||
105555727|NCT01816594|364031801|FG001|Overall Study|Physician Decision|0|||
105555728|NCT03905655|364031802|FG000|Overall Study|Adverse Event|1|||
105555729|NCT03905655|364031803|FG001|Overall Study|Adverse Event|0|||
105555730|NCT03905655|364031804|FG002|Overall Study|Adverse Event|1|||
105555731|NCT03905655|364031805|FG003|Overall Study|Adverse Event|1|||
105555732|NCT02566031|364031806|FG000|Overall Study|Patient/guardian decision|14|||
105555733|NCT02566031|364031807|FG001|Overall Study|Patient/guardian decision|7|||
105555734|NCT02566031|364031806|FG000|Overall Study|Protocol deviation|2|||
105555735|NCT02566031|364031807|FG001|Overall Study|Protocol deviation|3|||
105555736|NCT02566031|364031806|FG000|Overall Study|Adverse Event|3|||
105555737|NCT02566031|364031807|FG001|Overall Study|Adverse Event|1|||
105555738|NCT02566031|364031806|FG000|Overall Study|Lost to Follow-up|1|||
105555739|NCT02566031|364031807|FG001|Overall Study|Lost to Follow-up|1|||
105555740|NCT03204279|364031808|FG000|Overall Study|Withdrawal by Subject|0|||
105555741|NCT03204279|364031809|FG001|Overall Study|Withdrawal by Subject|1|||
105555742|NCT02277106|364031810|FG000|Stage 2|Adverse Event|0|||
105555743|NCT02277106|364031811|FG001|Stage 2|Adverse Event|0|||
105555744|NCT02277106|364031812|FG002|Stage 2|Adverse Event|1|||
105555745|NCT01064739|364031813|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
105555746|NCT03031938|364031814|FG000|Overall Study|Death|1|||
105555747|NCT03031938|364031815|FG001|Overall Study|Death|0|||
105555748|NCT01571362|364031818|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
105555749|NCT01571362|364031819|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
105555750|NCT01571362|364031820|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
105555751|NCT01571362|364031818|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
105555752|NCT01571362|364031819|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
105555753|NCT01571362|364031820|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
105555754|NCT01571362|364031818|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
105555755|NCT01571362|364031819|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
105555756|NCT01571362|364031820|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
105555757|NCT01571362|364031818|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
105555758|NCT01571362|364031819|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
105555759|NCT01571362|364031820|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
105555760|NCT01571362|364031818|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
105555761|NCT01571362|364031819|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
105555762|NCT01571362|364031820|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
105555763|NCT01571362|364031818|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
105555764|NCT01571362|364031819|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
105675530|NCT02712905|364475616|FG010|Combination Therapy|Withdrawal by Subject|0|||
105675531|NCT02712905|364475617|FG011|Combination Therapy|Withdrawal by Subject|0|||
105675532|NCT02712905|364475618|FG012|Combination Therapy|Withdrawal by Subject|0|||
105675533|NCT02712905|364475619|FG013|Combination Therapy|Withdrawal by Subject|0|||
105675534|NCT02712905|364475620|FG014|Combination Therapy|Withdrawal by Subject|0|||
105675535|NCT02712905|364475621|FG015|Combination Therapy|Withdrawal by Subject|1|||
105675536|NCT02712905|364475622|FG016|Combination Therapy|Withdrawal by Subject|0|||
105675537|NCT02712905|364475623|FG017|Combination Therapy|Withdrawal by Subject|2|||
105675538|NCT02712905|364475606|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675539|NCT02712905|364475607|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675540|NCT02712905|364475608|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675541|NCT02712905|364475609|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675542|NCT02712905|364475610|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675543|NCT02712905|364475611|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675544|NCT02712905|364475612|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675545|NCT02712905|364475613|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675546|NCT02712905|364475614|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675547|NCT02712905|364475615|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675548|NCT02712905|364475616|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675549|NCT02712905|364475617|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675550|NCT02712905|364475618|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675551|NCT02712905|364475619|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675552|NCT02712905|364475620|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675553|NCT02712905|364475621|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
105675554|NCT02712905|364475622|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675555|NCT02712905|364475623|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675556|NCT01397422|364475624|FG000|Overall Study|Adverse Event|0|||
105675557|NCT01397422|364475625|FG001|Overall Study|Adverse Event|3|||
105675558|NCT01397422|364475626|FG002|Overall Study|Adverse Event|3|||
105675559|NCT01397422|364475627|FG003|Overall Study|Adverse Event|8|||
105675560|NCT01397422|364475624|FG000|Overall Study|Withdrawal by Subject|1|||
105675561|NCT01397422|364475625|FG001|Overall Study|Withdrawal by Subject|0|||
105675562|NCT01397422|364475626|FG002|Overall Study|Withdrawal by Subject|0|||
105675563|NCT01397422|364475627|FG003|Overall Study|Withdrawal by Subject|0|||
105555765|NCT01571362|364031820|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
105555766|NCT01571362|364031818|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105555767|NCT01571362|364031819|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
105555768|NCT01571362|364031820|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
105555769|NCT01571362|364031818|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
105555770|NCT01571362|364031819|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
105555771|NCT01571362|364031820|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
105555772|NCT01571362|364031818|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105555773|NCT01571362|364031819|FG001|Double-Blind Treatment Period|Adverse Event|9|||
105555774|NCT01571362|364031820|FG002|Double-Blind Treatment Period|Adverse Event|14|||
105555775|NCT01571362|364031818|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105555776|NCT01571362|364031819|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
105555777|NCT01571362|364031820|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
105555778|NCT01571362|364031818|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
105555779|NCT01571362|364031819|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
105555780|NCT01571362|364031820|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
105555781|NCT01571362|364031818|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
105555782|NCT01571362|364031819|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
105555783|NCT01571362|364031820|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
105555784|NCT03966157|364031821|FG000|Overall Study|Physician Decision|1|||
105555785|NCT03966157|364031822|FG001|Overall Study|Physician Decision|0|||
105555786|NCT03568318|364031823|FG000|Overall Study|Adverse Event|3|||
105555787|NCT03568318|364031824|FG001|Overall Study|Adverse Event|1|||
105555788|NCT03568318|364031825|FG002|Overall Study|Adverse Event|1|||
105555789|NCT03568318|364031826|FG003|Overall Study|Adverse Event|0|||
105555790|NCT03568318|364031827|FG004|Overall Study|Adverse Event|1|||
105555791|NCT03568318|364031828|FG005|Overall Study|Adverse Event|0|||
105555792|NCT03568318|364031823|FG000|Overall Study|Withdrawal by Subject|6|||
105555793|NCT03568318|364031824|FG001|Overall Study|Withdrawal by Subject|5|||
105555794|NCT03568318|364031825|FG002|Overall Study|Withdrawal by Subject|2|||
105675564|NCT01397422|364475624|FG000|Overall Study|Increased bradykinesia related to PD|1|||
105675565|NCT01397422|364475625|FG001|Overall Study|Increased bradykinesia related to PD|0|||
105675566|NCT01397422|364475626|FG002|Overall Study|Increased bradykinesia related to PD|0|||
105675567|NCT01397422|364475627|FG003|Overall Study|Increased bradykinesia related to PD|0|||
105675568|NCT00760474|364475628|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
105675569|NCT00760474|364475629|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
105675570|NCT00760474|364475628|FG000|Placebo Washout Period|Other|0|||
105675571|NCT00760474|364475629|FG001|Placebo Washout Period|Other|1|||
105675572|NCT00760474|364475628|FG000|Period 2 (P2)|Lost to Follow-up|1|||
105675573|NCT00760474|364475629|FG001|Period 2 (P2)|Lost to Follow-up|0|||
105675574|NCT00760474|364475628|FG000|Period 2 (P2)|Adverse Event|0|||
105675575|NCT00760474|364475629|FG001|Period 2 (P2)|Adverse Event|1|||
105675576|NCT01011153|364475634|FG000|Overall Study|Less than 78 cases completed|8|||
105675577|NCT01011153|364475635|FG001|Overall Study|Less than 78 cases completed|11|||
105675578|NCT01011153|364475636|FG002|Overall Study|Less than 78 cases completed|9|||
105675579|NCT02217501|364475647|FG000|Overall Study|Death|3|||
105675580|NCT02217501|364475648|FG001|Overall Study|Death|4|||
105675581|NCT01394978|364475649|FG000|Overall Study|Withdrawal by Subject|2|||
105675582|NCT01394978|364475650|FG001|Overall Study|Withdrawal by Subject|4|||
105675583|NCT01394978|364475649|FG000|Overall Study|Lost to Follow-up|13|||
105675584|NCT01394978|364475650|FG001|Overall Study|Lost to Follow-up|20|||
105675585|NCT01394978|364475649|FG000|Overall Study|Death|6|||
105675586|NCT01394978|364475650|FG001|Overall Study|Death|7|||
105675587|NCT01081132|364475651|FG000|Overall Study|Lack of Efficacy|25|||
105675588|NCT01081132|364475652|FG001|Overall Study|Lack of Efficacy|9|||
105675589|NCT01081132|364475651|FG000|Overall Study|Withdrawal by Subject|13|||
105675590|NCT01081132|364475652|FG001|Overall Study|Withdrawal by Subject|16|||
105675591|NCT01081132|364475651|FG000|Overall Study|Lost to Follow-up|4|||
105675592|NCT01081132|364475652|FG001|Overall Study|Lost to Follow-up|11|||
105675593|NCT01081132|364475651|FG000|Overall Study|Adverse Event|3|||
105675594|NCT01081132|364475652|FG001|Overall Study|Adverse Event|9|||
105675595|NCT01081132|364475651|FG000|Overall Study|Non Compliance|4|||
105675596|NCT01081132|364475652|FG001|Overall Study|Non Compliance|2|||
105675597|NCT01081132|364475651|FG000|Overall Study|Lack Of Compliance|0|||
105675598|NCT01081132|364475652|FG001|Overall Study|Lack Of Compliance|1|||
105675599|NCT01081132|364475651|FG000|Overall Study|Missed Visits|1|||
105675600|NCT01081132|364475652|FG001|Overall Study|Missed Visits|1|||
105675601|NCT01081132|364475651|FG000|Overall Study|Stopped Taking Meds|2|||
105675602|NCT01081132|364475652|FG001|Overall Study|Stopped Taking Meds|0|||
105675603|NCT01081132|364475651|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
105675604|NCT01081132|364475652|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
105675605|NCT01081132|364475651|FG000|Overall Study|Declined Taper Phase|0|||
105675606|NCT01081132|364475652|FG001|Overall Study|Declined Taper Phase|1|||
105675607|NCT01081132|364475651|FG000|Overall Study|Protocol Violation|3|||
105675608|NCT01081132|364475652|FG001|Overall Study|Protocol Violation|1|||
105675609|NCT02019667|364475653|FG000|First Intervention (6 Months)|Adverse Event|0|||
105675610|NCT02019667|364475654|FG001|First Intervention (6 Months)|Adverse Event|1|||
105675611|NCT02019667|364475653|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
105675612|NCT02019667|364475654|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
105675613|NCT02019667|364475653|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
105675614|NCT02019667|364475654|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
105675615|NCT02101385|364475658|FG000|Study Treatment|Disease Progression|9|||
105675616|NCT02101385|364475659|FG001|Study Treatment|Disease Progression|3|||
105675617|NCT02101385|364475658|FG000|Study Treatment|Alternative therapy|0|||
105675618|NCT02101385|364475659|FG001|Study Treatment|Alternative therapy|1|||
105675619|NCT02101385|364475658|FG000|Study Treatment|No treatment, per protocol criteria|0|||
105675620|NCT02101385|364475659|FG001|Study Treatment|No treatment, per protocol criteria|4|||
105675621|NCT02101385|364475658|FG000|Study Treatment|Patient Non compliance|0|||
105675622|NCT02101385|364475659|FG001|Study Treatment|Patient Non compliance|2|||
105675623|NCT02101385|364475658|FG000|Study Treatment|Withdrawal by Subject|5|||
105675624|NCT02101385|364475659|FG001|Study Treatment|Withdrawal by Subject|2|||
105675625|NCT02101385|364475658|FG000|Study Treatment|screen failure|1|||
105675626|NCT02101385|364475659|FG001|Study Treatment|screen failure|0|||
105675627|NCT02101385|364475658|FG000|Study Treatment|AE/Side Effects/Complications|8|||
105675628|NCT02101385|364475659|FG001|Study Treatment|AE/Side Effects/Complications|0|||
105675629|NCT02101385|364475658|FG000|Study Treatment|Lost to Follow-up|1|||
105675630|NCT02101385|364475659|FG001|Study Treatment|Lost to Follow-up|0|||
105675631|NCT02101385|364475658|FG000|Study Treatment|Disease Progression before treatment|1|||
105675632|NCT02101385|364475659|FG001|Study Treatment|Disease Progression before treatment|0|||
105675633|NCT02101385|364475658|FG000|Study Treatment|Death|1|||
105675634|NCT02101385|364475659|FG001|Study Treatment|Death|0|||
105675635|NCT02101385|364475658|FG000|Follow up|Lost to Follow-up|4|||
105675636|NCT02101385|364475659|FG001|Follow up|Lost to Follow-up|9|||
105675637|NCT02101385|364475658|FG000|Follow up|Refused to follow up|5|||
105786418|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Physician Decision|4|||
105675638|NCT02101385|364475659|FG001|Follow up|Refused to follow up|4|||
105675639|NCT02101385|364475658|FG000|Follow up|Death|21|||
105675640|NCT02101385|364475659|FG001|Follow up|Death|39|||
105675641|NCT02101385|364475658|FG000|Follow up|study completed|33|||
105675642|NCT02101385|364475659|FG001|Follow up|study completed|52|||
105675643|NCT02101385|364475658|FG000|Follow up|screen failure|2|||
105675644|NCT02101385|364475659|FG001|Follow up|screen failure|0|||
105675645|NCT02101385|364475658|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
105675646|NCT02101385|364475659|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
105675647|NCT02101385|364475658|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
105675648|NCT02101385|364475659|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
105675649|NCT02101385|364475658|FG000|Follow up|Withdrawal by Subject|2|||
105675650|NCT02101385|364475659|FG001|Follow up|Withdrawal by Subject|2|||
105675651|NCT02101385|364475658|FG000|Follow up|PI requested closure of site|0|||
105675652|NCT02101385|364475659|FG001|Follow up|PI requested closure of site|5|||
105675653|NCT00847808|364475660|FG000|Overall Study|Adverse Event|7|||
105675654|NCT00847808|364475660|FG000|Overall Study|Protocol Violation|1|||
105675655|NCT00847808|364475660|FG000|Overall Study|Lost to Follow-up|1|||
105675656|NCT00847808|364475660|FG000|Overall Study|Withdrawal by Subject|4|||
105675657|NCT00847808|364475660|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
105675658|NCT00847808|364475660|FG000|Overall Study|Participant Took Excluded Medication|1|||
105675659|NCT02432196|364475661|FG000|Overall Study|Exit - did not receive study device|1|||
105675660|NCT02432196|364475661|FG000|Overall Study|Death|2|||
105675661|NCT02432196|364475661|FG000|Overall Study|Reoperation|3|||
105675662|NCT02227199|364475668|FG000|Overall Study|Physician Decision|0|||
105675663|NCT02227199|364475669|FG001|Overall Study|Physician Decision|0|||
105675664|NCT02227199|364475670|FG002|Overall Study|Physician Decision|1|||
105675665|NCT02227199|364475668|FG000|Overall Study|Adverse Event|0|||
105675666|NCT02227199|364475669|FG001|Overall Study|Adverse Event|0|||
105675667|NCT02227199|364475670|FG002|Overall Study|Adverse Event|3|||
105675668|NCT01905150|364475674|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
105675669|NCT01905150|364475675|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
105675670|NCT05000931|364475676|FG000|Overall Study|Lost to Follow-up|1|||
105675671|NCT01892540|364475680|FG000|Overall Study|Did not complete PET/MRI|0|||
105675672|NCT01892540|364475681|FG001|Overall Study|Did not complete PET/MRI|0|||
105675673|NCT01892540|364475682|FG002|Overall Study|Did not complete PET/MRI|2|||
105675674|NCT01892540|364475680|FG000|Overall Study|Did not fit in scanner|0|||
105675675|NCT01892540|364475681|FG001|Overall Study|Did not fit in scanner|0|||
105675676|NCT01892540|364475682|FG002|Overall Study|Did not fit in scanner|1|||
105675677|NCT01370590|364475683|FG000|Period 1|Adverse Event|8|||
105675678|NCT01370590|364475684|FG001|Period 1|Adverse Event|4|||
105675679|NCT01370590|364475683|FG000|Period 1|Lost to Follow-up|2|||
105675680|NCT01370590|364475684|FG001|Period 1|Lost to Follow-up|2|||
105675681|NCT01370590|364475683|FG000|Period 1|Protocol Violation|2|||
105675682|NCT01370590|364475684|FG001|Period 1|Protocol Violation|2|||
105675683|NCT01370590|364475683|FG000|Period 1|Withdrawal by Subject|4|||
105675684|NCT01370590|364475684|FG001|Period 1|Withdrawal by Subject|2|||
105675685|NCT01370590|364475683|FG000|Period 1|Could not access randomization system|0|||
105675686|NCT01370590|364475684|FG001|Period 1|Could not access randomization system|1|||
105675687|NCT01370590|364475683|FG000|Crossover Washout Period|Adverse Event|1|||
105675688|NCT01370590|364475684|FG001|Crossover Washout Period|Adverse Event|4|||
105675689|NCT01370590|364475683|FG000|Crossover Washout Period|Lost to Follow-up|2|||
105675690|NCT01370590|364475684|FG001|Crossover Washout Period|Lost to Follow-up|0|||
105675691|NCT01370590|364475683|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
105675692|NCT01370590|364475684|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
105675693|NCT01370590|364475683|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
105675694|NCT01370590|364475684|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
105675695|NCT01370590|364475683|FG000|Period 2|Adverse Event|0|||
105675696|NCT01370590|364475684|FG001|Period 2|Adverse Event|1|||
105675697|NCT01370590|364475683|FG000|Period 2|Withdrawal by Subject|1|||
105675698|NCT01370590|364475684|FG001|Period 2|Withdrawal by Subject|1|||
105675699|NCT05172050|364475685|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
105675700|NCT05172050|364475686|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
105675701|NCT05172050|364475687|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
105675702|NCT05172050|364475685|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
105675703|NCT05172050|364475686|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
105675704|NCT05172050|364475687|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
105675705|NCT05172050|364475685|FG000|Overall Study|Other|2|||
105675706|NCT05172050|364475686|FG001|Overall Study|Other|2|||
105343196|NCT00558896|363258259|FG002|Overall Study|Alternative Treatment|0|||
105343197|NCT00558896|363258260|FG003|Overall Study|Alternative Treatment|2|||
105343198|NCT00558896|363258261|FG004|Overall Study|Alternative Treatment|6|||
105343199|NCT00558896|363258262|FG005|Overall Study|Alternative Treatment|7|||
105343200|NCT00558896|363258263|FG006|Overall Study|Alternative Treatment|1|||
105343201|NCT00558896|363258257|FG000|Overall Study|Physician discretion|3|||
105555795|NCT03568318|364031826|FG003|Overall Study|Withdrawal by Subject|1|||
105555796|NCT03568318|364031827|FG004|Overall Study|Withdrawal by Subject|0|||
105555797|NCT03568318|364031828|FG005|Overall Study|Withdrawal by Subject|0|||
105555798|NCT03568318|364031823|FG000|Overall Study|Lost to Follow-up|3|||
105555799|NCT03568318|364031824|FG001|Overall Study|Lost to Follow-up|2|||
105555800|NCT03568318|364031825|FG002|Overall Study|Lost to Follow-up|2|||
105555801|NCT03568318|364031826|FG003|Overall Study|Lost to Follow-up|2|||
105555802|NCT03568318|364031827|FG004|Overall Study|Lost to Follow-up|1|||
105555803|NCT03568318|364031828|FG005|Overall Study|Lost to Follow-up|0|||
105555804|NCT03568318|364031823|FG000|Overall Study|Other|3|||
105555805|NCT03568318|364031824|FG001|Overall Study|Other|1|||
105555806|NCT03568318|364031825|FG002|Overall Study|Other|3|||
105555807|NCT03568318|364031826|FG003|Overall Study|Other|0|||
105555808|NCT03568318|364031827|FG004|Overall Study|Other|0|||
105555809|NCT03568318|364031828|FG005|Overall Study|Other|0|||
105555810|NCT03568318|364031823|FG000|Overall Study|Ongoing at Time of Analysis|5|||
105555811|NCT03568318|364031824|FG001|Overall Study|Ongoing at Time of Analysis|3|||
105555812|NCT03568318|364031825|FG002|Overall Study|Ongoing at Time of Analysis|2|||
105555813|NCT03568318|364031826|FG003|Overall Study|Ongoing at Time of Analysis|1|||
105555814|NCT03568318|364031827|FG004|Overall Study|Ongoing at Time of Analysis|0|||
105555815|NCT03568318|364031828|FG005|Overall Study|Ongoing at Time of Analysis|0|||
105555816|NCT04004611|364031829|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
105555817|NCT04004611|364031830|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
105555818|NCT04004611|364031831|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
105555819|NCT04004611|364031832|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
105555820|NCT04004611|364031833|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
105555821|NCT04004611|364031834|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
105555822|NCT04004611|364031835|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
105555823|NCT04004611|364031836|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
105555824|NCT04004611|364031837|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
105555825|NCT04004611|364031829|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
105555826|NCT04004611|364031830|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
105555827|NCT04004611|364031831|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
105555828|NCT04004611|364031832|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
105555829|NCT04004611|364031833|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
105555830|NCT04004611|364031834|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
105555831|NCT04004611|364031835|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
105555832|NCT04004611|364031836|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
105555833|NCT04004611|364031837|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
105555834|NCT04004611|364031829|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
105555835|NCT04004611|364031830|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
105555836|NCT04004611|364031831|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
105555837|NCT04004611|364031832|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
105555838|NCT04004611|364031833|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
105555839|NCT04004611|364031834|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
105555840|NCT04004611|364031835|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
105555841|NCT04004611|364031836|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
105555842|NCT04004611|364031837|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
105555843|NCT04004611|364031829|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
105555844|NCT04004611|364031830|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
105555845|NCT04004611|364031831|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
105555846|NCT04004611|364031832|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
105555847|NCT04004611|364031833|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
105555848|NCT04004611|364031834|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
105555849|NCT04004611|364031835|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
105555850|NCT04004611|364031836|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
105555851|NCT04004611|364031837|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
105555852|NCT04004611|364031829|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
105555853|NCT04004611|364031830|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
105555854|NCT04004611|364031831|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
105555855|NCT04004611|364031832|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
105555856|NCT04004611|364031833|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
105555857|NCT04004611|364031834|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
105555858|NCT04004611|364031835|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
105343202|NCT00558896|363258258|FG001|Overall Study|Physician discretion|2|||
105675707|NCT05172050|364475687|FG002|Overall Study|Other|1|||
105675708|NCT00151281|364475695|FG000|Overall Study|Not evaluable|3|||
105675709|NCT00604825|364475698|FG000|Overall Study|Adverse Event|2|||
105675710|NCT00604825|364475699|FG001|Overall Study|Adverse Event|6|||
105675711|NCT00604825|364475700|FG002|Overall Study|Adverse Event|7|||
105675712|NCT00604825|364475701|FG003|Overall Study|Adverse Event|4|||
105675713|NCT00604825|364475698|FG000|Overall Study|Lost to Follow-up|0|||
105675714|NCT00604825|364475699|FG001|Overall Study|Lost to Follow-up|3|||
105675715|NCT00604825|364475700|FG002|Overall Study|Lost to Follow-up|1|||
105675716|NCT00604825|364475701|FG003|Overall Study|Lost to Follow-up|0|||
105675717|NCT00604825|364475698|FG000|Overall Study|Protocol Violation|0|||
105675718|NCT00604825|364475699|FG001|Overall Study|Protocol Violation|1|||
105675719|NCT00604825|364475700|FG002|Overall Study|Protocol Violation|0|||
105675720|NCT00604825|364475701|FG003|Overall Study|Protocol Violation|0|||
105675721|NCT00604825|364475698|FG000|Overall Study|Withdrawal by Subject|4|||
105675722|NCT00604825|364475699|FG001|Overall Study|Withdrawal by Subject|3|||
105675723|NCT00604825|364475700|FG002|Overall Study|Withdrawal by Subject|5|||
105675724|NCT00604825|364475701|FG003|Overall Study|Withdrawal by Subject|5|||
105675725|NCT00604825|364475698|FG000|Overall Study|Lack of Efficacy|3|||
105675726|NCT00604825|364475699|FG001|Overall Study|Lack of Efficacy|2|||
105675727|NCT00604825|364475700|FG002|Overall Study|Lack of Efficacy|1|||
105675728|NCT00604825|364475701|FG003|Overall Study|Lack of Efficacy|0|||
105675729|NCT00604825|364475698|FG000|Overall Study|Did not meet eligibility criteria|0|||
105675730|NCT00604825|364475699|FG001|Overall Study|Did not meet eligibility criteria|0|||
105675731|NCT00604825|364475700|FG002|Overall Study|Did not meet eligibility criteria|2|||
105675732|NCT00604825|364475701|FG003|Overall Study|Did not meet eligibility criteria|0|||
105675733|NCT00604825|364475698|FG000|Overall Study|Physician Decision|0|||
105675734|NCT00604825|364475699|FG001|Overall Study|Physician Decision|0|||
105675735|NCT00604825|364475700|FG002|Overall Study|Physician Decision|0|||
105675736|NCT00604825|364475701|FG003|Overall Study|Physician Decision|1|||
105675737|NCT00604825|364475698|FG000|Overall Study|Exclusion criterion met|0|||
105675738|NCT00604825|364475699|FG001|Overall Study|Exclusion criterion met|0|||
105675739|NCT00604825|364475700|FG002|Overall Study|Exclusion criterion met|0|||
105675740|NCT00604825|364475701|FG003|Overall Study|Exclusion criterion met|1|||
105675741|NCT04617275|364475702|FG000|Treatment Period|Adverse Event|1|||
105675742|NCT04617275|364475703|FG001|Treatment Period|Adverse Event|6|||
105675743|NCT04617275|364475704|FG002|Treatment Period|Adverse Event|4|||
105675744|NCT04617275|364475705|FG003|Treatment Period|Adverse Event|6|||
105675745|NCT04617275|364475706|FG004|Treatment Period|Adverse Event|7|||
105675746|NCT04617275|364475707|FG005|Treatment Period|Adverse Event|8|||
105675747|NCT04617275|364475708|FG006|Treatment Period|Adverse Event|0|||
105675748|NCT04617275|364475709|FG007|Treatment Period|Adverse Event|12|||
105675749|NCT04617275|364475702|FG000|Treatment Period|Lost to Follow-up|0|||
105675750|NCT04617275|364475703|FG001|Treatment Period|Lost to Follow-up|0|||
105675751|NCT04617275|364475704|FG002|Treatment Period|Lost to Follow-up|2|||
105675752|NCT04617275|364475705|FG003|Treatment Period|Lost to Follow-up|0|||
105675753|NCT04617275|364475706|FG004|Treatment Period|Lost to Follow-up|0|||
105675754|NCT04617275|364475707|FG005|Treatment Period|Lost to Follow-up|3|||
105675755|NCT04617275|364475708|FG006|Treatment Period|Lost to Follow-up|0|||
105675756|NCT04617275|364475709|FG007|Treatment Period|Lost to Follow-up|2|||
105675757|NCT04617275|364475702|FG000|Treatment Period|No longer meets eligibility criteria|0|||
105675758|NCT04617275|364475703|FG001|Treatment Period|No longer meets eligibility criteria|0|||
105675759|NCT04617275|364475704|FG002|Treatment Period|No longer meets eligibility criteria|0|||
105675760|NCT04617275|364475705|FG003|Treatment Period|No longer meets eligibility criteria|1|||
105675761|NCT04617275|364475706|FG004|Treatment Period|No longer meets eligibility criteria|0|||
105675762|NCT04617275|364475707|FG005|Treatment Period|No longer meets eligibility criteria|0|||
105675763|NCT04617275|364475708|FG006|Treatment Period|No longer meets eligibility criteria|0|||
105675764|NCT04617275|364475709|FG007|Treatment Period|No longer meets eligibility criteria|0|||
105675765|NCT04617275|364475702|FG000|Treatment Period|Other|0|||
105675766|NCT04617275|364475703|FG001|Treatment Period|Other|1|||
105675767|NCT04617275|364475704|FG002|Treatment Period|Other|0|||
105675768|NCT04617275|364475705|FG003|Treatment Period|Other|0|||
105675769|NCT04617275|364475706|FG004|Treatment Period|Other|0|||
105555859|NCT04004611|364031836|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
105555860|NCT04004611|364031837|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
105675770|NCT04617275|364475707|FG005|Treatment Period|Other|0|||
105675771|NCT04617275|364475708|FG006|Treatment Period|Other|0|||
105675772|NCT04617275|364475709|FG007|Treatment Period|Other|0|||
105675773|NCT04617275|364475702|FG000|Treatment Period|Withdrawal by Subject|2|||
105675774|NCT04617275|364475703|FG001|Treatment Period|Withdrawal by Subject|0|||
105675775|NCT04617275|364475704|FG002|Treatment Period|Withdrawal by Subject|0|||
105675776|NCT04617275|364475705|FG003|Treatment Period|Withdrawal by Subject|2|||
105675777|NCT04617275|364475706|FG004|Treatment Period|Withdrawal by Subject|2|||
105675778|NCT04617275|364475707|FG005|Treatment Period|Withdrawal by Subject|0|||
105675779|NCT04617275|364475708|FG006|Treatment Period|Withdrawal by Subject|1|||
105675780|NCT04617275|364475709|FG007|Treatment Period|Withdrawal by Subject|2|||
105343203|NCT00558896|363258259|FG002|Overall Study|Physician discretion|1|||
105343204|NCT00558896|363258260|FG003|Overall Study|Physician discretion|2|||
105343205|NCT00558896|363258261|FG004|Overall Study|Physician discretion|1|||
105343206|NCT00558896|363258262|FG005|Overall Study|Physician discretion|3|||
105343207|NCT00558896|363258263|FG006|Overall Study|Physician discretion|3|||
105343208|NCT00558896|363258257|FG000|Overall Study|Continues on treatment|10|||
105343209|NCT00558896|363258258|FG001|Overall Study|Continues on treatment|1|||
105343210|NCT00558896|363258259|FG002|Overall Study|Continues on treatment|0|||
105343211|NCT00558896|363258260|FG003|Overall Study|Continues on treatment|1|||
105343212|NCT00558896|363258261|FG004|Overall Study|Continues on treatment|9|||
105343213|NCT00558896|363258262|FG005|Overall Study|Continues on treatment|25|||
105343214|NCT00558896|363258263|FG006|Overall Study|Continues on treatment|6|||
105555861|NCT04004611|364031829|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
105555862|NCT04004611|364031830|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
105555863|NCT04004611|364031831|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
105555864|NCT04004611|364031832|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
105555865|NCT04004611|364031833|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
105555866|NCT04004611|364031834|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
105555867|NCT04004611|364031835|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
105555868|NCT04004611|364031836|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
105555869|NCT04004611|364031837|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
105555870|NCT00515502|364031844|FG000|Treatment Period 1|Adverse Event|0|||
105555871|NCT00515502|364031845|FG001|Treatment Period 1|Adverse Event|0|||
105555872|NCT00515502|364031846|FG002|Treatment Period 1|Adverse Event|0|||
105555873|NCT00515502|364031847|FG003|Treatment Period 1|Adverse Event|0|||
105555874|NCT00515502|364031848|FG004|Treatment Period 1|Adverse Event|0|||
105555875|NCT00515502|364031849|FG005|Treatment Period 1|Adverse Event|0|||
105555876|NCT00515502|364031850|FG006|Treatment Period 1|Adverse Event|1|||
105555877|NCT00515502|364031851|FG007|Treatment Period 1|Adverse Event|0|||
105555878|NCT00515502|364031852|FG008|Treatment Period 1|Adverse Event|1|||
105555879|NCT00515502|364031853|FG009|Treatment Period 1|Adverse Event|0|||
105555880|NCT00515502|364031854|FG010|Treatment Period 1|Adverse Event|0|||
105555881|NCT00515502|364031855|FG011|Treatment Period 1|Adverse Event|1|||
105555882|NCT00515502|364031844|FG000|Treatment Period 2|Adverse Event|0|||
105555883|NCT00515502|364031845|FG001|Treatment Period 2|Adverse Event|1|||
105555884|NCT00515502|364031846|FG002|Treatment Period 2|Adverse Event|0|||
105343215|NCT03536949|363258264|FG000|Overall Study|Adverse Event|4|||
105343216|NCT03536949|363258265|FG001|Overall Study|Adverse Event|0|||
105343217|NCT03536949|363258264|FG000|Overall Study|Lost to Follow-up|2|||
105343218|NCT03536949|363258265|FG001|Overall Study|Lost to Follow-up|1|||
105675781|NCT04617275|364475702|FG000|Follow-up Period|Adverse Event|1|||
105675782|NCT04617275|364475703|FG001|Follow-up Period|Adverse Event|1|||
105675783|NCT04617275|364475704|FG002|Follow-up Period|Adverse Event|2|||
105675784|NCT04617275|364475705|FG003|Follow-up Period|Adverse Event|3|||
105675785|NCT04617275|364475706|FG004|Follow-up Period|Adverse Event|4|||
105675786|NCT04617275|364475707|FG005|Follow-up Period|Adverse Event|3|||
105675787|NCT04617275|364475708|FG006|Follow-up Period|Adverse Event|0|||
105675788|NCT04617275|364475709|FG007|Follow-up Period|Adverse Event|3|||
105675789|NCT04617275|364475702|FG000|Follow-up Period|Lost to Follow-up|0|||
105675790|NCT04617275|364475703|FG001|Follow-up Period|Lost to Follow-up|1|||
105675791|NCT04617275|364475704|FG002|Follow-up Period|Lost to Follow-up|2|||
105675792|NCT04617275|364475705|FG003|Follow-up Period|Lost to Follow-up|0|||
105675793|NCT04617275|364475706|FG004|Follow-up Period|Lost to Follow-up|0|||
105675794|NCT04617275|364475707|FG005|Follow-up Period|Lost to Follow-up|4|||
105675795|NCT04617275|364475708|FG006|Follow-up Period|Lost to Follow-up|0|||
105675796|NCT04617275|364475709|FG007|Follow-up Period|Lost to Follow-up|3|||
105675797|NCT04617275|364475702|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
105675798|NCT04617275|364475703|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
105675799|NCT04617275|364475704|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
105675800|NCT04617275|364475705|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
105675801|NCT04617275|364475706|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
105675802|NCT04617275|364475707|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
105675803|NCT04617275|364475708|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
105675804|NCT04617275|364475709|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
105675805|NCT04617275|364475702|FG000|Follow-up Period|Other|0|||
105675806|NCT04617275|364475703|FG001|Follow-up Period|Other|1|||
105675807|NCT04617275|364475704|FG002|Follow-up Period|Other|0|||
105675808|NCT04617275|364475705|FG003|Follow-up Period|Other|0|||
105675809|NCT04617275|364475706|FG004|Follow-up Period|Other|0|||
105675810|NCT04617275|364475707|FG005|Follow-up Period|Other|0|||
105675811|NCT04617275|364475708|FG006|Follow-up Period|Other|0|||
105675812|NCT04617275|364475709|FG007|Follow-up Period|Other|0|||
105675813|NCT04617275|364475702|FG000|Follow-up Period|Withdrawal by Subject|2|||
105675814|NCT04617275|364475703|FG001|Follow-up Period|Withdrawal by Subject|0|||
105675815|NCT04617275|364475704|FG002|Follow-up Period|Withdrawal by Subject|0|||
105675816|NCT04617275|364475705|FG003|Follow-up Period|Withdrawal by Subject|2|||
105675817|NCT04617275|364475706|FG004|Follow-up Period|Withdrawal by Subject|2|||
105675818|NCT04617275|364475707|FG005|Follow-up Period|Withdrawal by Subject|0|||
105675819|NCT04617275|364475708|FG006|Follow-up Period|Withdrawal by Subject|1|||
105675820|NCT04617275|364475709|FG007|Follow-up Period|Withdrawal by Subject|2|||
105675821|NCT03465904|364475710|FG000|Overall Study|Withdrawal by Subject|9|||
105675822|NCT03465904|364475711|FG001|Overall Study|Withdrawal by Subject|5|||
105675823|NCT03465904|364475710|FG000|Overall Study|Lost to Follow-up|11|||
105675824|NCT03465904|364475711|FG001|Overall Study|Lost to Follow-up|9|||
105675825|NCT03465904|364475710|FG000|Overall Study|Protocol Violation|20|||
105675826|NCT03465904|364475711|FG001|Overall Study|Protocol Violation|15|||
105675827|NCT00727311|364475712|FG000|Overall Study|Did not receive drug|316|||
105675828|NCT00727311|364475712|FG000|Overall Study|Missing end of therapy data|205|||
105675829|NCT00727311|364475712|FG000|Overall Study|Adverse Event|58|||
105675830|NCT00727311|364475712|FG000|Overall Study|Lack of Efficacy|242|||
105675831|NCT00727311|364475712|FG000|Overall Study|Lost to Follow-up|73|||
105675832|NCT00727311|364475712|FG000|Overall Study|Withdrawal by Subject|77|||
105675833|NCT00727311|364475712|FG000|Overall Study|Other|97|||
105675834|NCT00727311|364475712|FG000|Overall Study|Multiple reasons|39|||
105675835|NCT02314780|364477105|FG000|Overall Study|organizational reasons|0|||
105675836|NCT02314780|364477106|FG001|Overall Study|organizational reasons|2|||
105675837|NCT02314780|364477107|FG002|Overall Study|organizational reasons|0|||
105675838|NCT02314780|364477105|FG000|Overall Study|Adverse Event|0|||
105675839|NCT02314780|364477106|FG001|Overall Study|Adverse Event|1|||
105675840|NCT02314780|364477107|FG002|Overall Study|Adverse Event|0|||
105675841|NCT03333876|364477108|FG000|Screening Period|Screen Failure|4|||
105675842|NCT03333876|364477108|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
105675843|NCT03333876|364477108|FG000|Mandibular Advancement|Adverse Event|2|||
105675844|NCT03333876|364477108|FG000|Mandibular Advancement|Product Damage|2|||
105675845|NCT00640133|364477109|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
105675846|NCT00640133|364477110|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
105675847|NCT00640133|364477109|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
105675848|NCT00640133|364477110|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
105675849|NCT00640133|364477109|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
105675850|NCT00640133|364477110|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
105675851|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
105675852|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
105675853|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
105675854|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
105675855|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
105675856|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
105675857|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
105675858|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
105675859|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
105675860|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
105675861|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
105675862|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
105675863|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Death|1|||
105675864|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Death|2|||
105675865|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Death|2|||
105675866|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Death|0|||
105675867|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Death|0|||
105675868|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Death|0|||
105675869|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
105675870|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
105675871|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
105675872|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
105675873|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
105675874|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
105675875|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
105675876|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
105675877|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
105675878|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
105675879|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
105675880|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
105675881|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
105675882|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
105675883|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
105675884|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
105675885|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
105675886|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
105675887|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
105675888|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
105675889|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
105675890|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
105675891|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
105675892|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
105675893|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
105675894|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
105675895|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
105675896|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
105675897|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
105675898|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
105675899|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
105675900|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
105675901|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
105675902|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
105675903|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
105675904|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
105675905|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
105675906|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
105675907|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
105675908|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
105675909|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
105675910|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
105675911|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Site closure|0|||
105675912|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Site closure|0|||
105675913|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Site closure|1|||
105675914|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Site closure|0|||
105675915|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Site closure|0|||
105675916|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Site closure|0|||
105675917|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
105675918|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
105675919|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
105675920|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
105675921|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
105675922|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
105675923|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
105675924|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
105675925|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
105675926|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
105675927|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
105675928|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
105675929|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
105675930|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
105675931|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
105343219|NCT03536949|363258264|FG000|Overall Study|Withdrawal by Subject|6|||
105343220|NCT03536949|363258265|FG001|Overall Study|Withdrawal by Subject|0|||
105343221|NCT03536949|363258264|FG000|Overall Study|Non-compliance|2|||
105343222|NCT03536949|363258265|FG001|Overall Study|Non-compliance|1|||
105343223|NCT02954653|363258268|FG000|Overall Study|Death|3|||
105343224|NCT02954653|363258269|FG001|Overall Study|Death|1|||
105343225|NCT02954653|363258270|FG002|Overall Study|Death|0|||
105343226|NCT02954653|363258271|FG003|Overall Study|Death|0|||
105343227|NCT02954653|363258272|FG004|Overall Study|Death|0|||
105343228|NCT02954653|363258273|FG005|Overall Study|Death|0|||
105343229|NCT02954653|363258274|FG006|Overall Study|Death|0|||
105343230|NCT02954653|363258275|FG007|Overall Study|Death|0|||
105343231|NCT02954653|363258276|FG008|Overall Study|Death|0|||
105343232|NCT02954653|363258268|FG000|Overall Study|Randomized but did not receive treatment|1|||
105343233|NCT02954653|363258269|FG001|Overall Study|Randomized but did not receive treatment|0|||
105343234|NCT02954653|363258270|FG002|Overall Study|Randomized but did not receive treatment|0|||
105343235|NCT02954653|363258271|FG003|Overall Study|Randomized but did not receive treatment|0|||
105343236|NCT02954653|363258272|FG004|Overall Study|Randomized but did not receive treatment|0|||
105343237|NCT02954653|363258273|FG005|Overall Study|Randomized but did not receive treatment|0|||
105343238|NCT02954653|363258274|FG006|Overall Study|Randomized but did not receive treatment|0|||
105343239|NCT02954653|363258275|FG007|Overall Study|Randomized but did not receive treatment|0|||
105343240|NCT02954653|363258276|FG008|Overall Study|Randomized but did not receive treatment|0|||
105555885|NCT00515502|364031847|FG003|Treatment Period 2|Adverse Event|0|||
105555886|NCT00515502|364031848|FG004|Treatment Period 2|Adverse Event|0|||
105555887|NCT00515502|364031849|FG005|Treatment Period 2|Adverse Event|0|||
105555888|NCT00515502|364031850|FG006|Treatment Period 2|Adverse Event|0|||
105555889|NCT00515502|364031851|FG007|Treatment Period 2|Adverse Event|0|||
105555890|NCT00515502|364031852|FG008|Treatment Period 2|Adverse Event|0|||
105555891|NCT00515502|364031853|FG009|Treatment Period 2|Adverse Event|0|||
105555892|NCT00515502|364031854|FG010|Treatment Period 2|Adverse Event|0|||
105555893|NCT00515502|364031855|FG011|Treatment Period 2|Adverse Event|0|||
105555894|NCT01814371|364031859|FG000|Overall Study|Lost to Follow-up|30|||
105555895|NCT01814371|364031860|FG001|Overall Study|Lost to Follow-up|27|||
105555896|NCT03263429|364031861|FG000|Overall Study|Withdrawal by Subject|0|||
105555897|NCT03263429|364031862|FG001|Overall Study|Withdrawal by Subject|1|||
105555898|NCT03263429|364031863|FG002|Overall Study|Withdrawal by Subject|0|||
105555899|NCT03263429|364031861|FG000|Overall Study|Follow-Up Period Completed|0|||
105555900|NCT03263429|364031862|FG001|Overall Study|Follow-Up Period Completed|2|||
105555901|NCT03263429|364031863|FG002|Overall Study|Follow-Up Period Completed|0|||
105555902|NCT03263429|364031861|FG000|Overall Study|Death|3|||
105555903|NCT03263429|364031862|FG001|Overall Study|Death|5|||
105555904|NCT03263429|364031863|FG002|Overall Study|Death|16|||
105555905|NCT03263429|364031861|FG000|Overall Study|Participant unable to return|0|||
105555906|NCT03263429|364031862|FG001|Overall Study|Participant unable to return|0|||
105555907|NCT03263429|364031863|FG002|Overall Study|Participant unable to return|1|||
105555908|NCT03263429|364031861|FG000|Overall Study|Study Closed|0|||
105555909|NCT03263429|364031862|FG001|Overall Study|Study Closed|0|||
105555910|NCT03263429|364031863|FG002|Overall Study|Study Closed|1|||
105555911|NCT02384759|364031864|FG000|Overall Study|Patients not treated|3|||
105555912|NCT02384759|364031865|FG001|Overall Study|Patients not treated|2|||
105555913|NCT00325468|364031868|FG000|Overall Study|Adverse Event|1|||
105555914|NCT00325468|364031869|FG001|Overall Study|Adverse Event|1|||
105555915|NCT00325468|364031870|FG002|Overall Study|Adverse Event|0|||
105555916|NCT00325468|364031871|FG003|Overall Study|Adverse Event|5|||
105555917|NCT00325468|364031872|FG004|Overall Study|Adverse Event|1|||
105555918|NCT00325468|364031868|FG000|Overall Study|Death|2|||
105555919|NCT00325468|364031869|FG001|Overall Study|Death|0|||
105555920|NCT00325468|364031870|FG002|Overall Study|Death|2|||
105555921|NCT00325468|364031871|FG003|Overall Study|Death|4|||
105555922|NCT00325468|364031872|FG004|Overall Study|Death|0|||
105555923|NCT00325468|364031868|FG000|Overall Study|Lost to Follow-up|0|||
105555924|NCT00325468|364031869|FG001|Overall Study|Lost to Follow-up|0|||
105555925|NCT00325468|364031870|FG002|Overall Study|Lost to Follow-up|1|||
105555926|NCT00325468|364031871|FG003|Overall Study|Lost to Follow-up|2|||
105555927|NCT00325468|364031872|FG004|Overall Study|Lost to Follow-up|2|||
105555928|NCT00325468|364031868|FG000|Overall Study|Physician Decision|1|||
105555929|NCT00325468|364031869|FG001|Overall Study|Physician Decision|1|||
105555930|NCT00325468|364031870|FG002|Overall Study|Physician Decision|0|||
105343241|NCT02954653|363258268|FG000|Overall Study|Started another anti-cancer therapy|0|||
105343242|NCT02954653|363258269|FG001|Overall Study|Started another anti-cancer therapy|1|||
105343243|NCT02954653|363258270|FG002|Overall Study|Started another anti-cancer therapy|0|||
105555931|NCT00325468|364031871|FG003|Overall Study|Physician Decision|1|||
105555932|NCT00325468|364031872|FG004|Overall Study|Physician Decision|0|||
105555933|NCT00325468|364031868|FG000|Overall Study|Withdrawal by Subject|3|||
105675932|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
105675933|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
105675934|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
105675935|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
105675936|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
105675937|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
105675938|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
105675939|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
105675940|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
105675941|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
105675942|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
105675943|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
105675944|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
105675945|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
105675946|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
105675947|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
105675948|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
105675949|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
105675950|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
105675951|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
105675952|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
105675953|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
105675954|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
105675955|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
105675956|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
105675957|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
105675958|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
105675959|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
105675960|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
105675961|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
105675962|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
105675963|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
105675964|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
105675965|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
105675966|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
105675967|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
105675968|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
105675969|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
105675970|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
105675971|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
105675972|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
105675973|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
105675974|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
105675975|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
105675976|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
105675977|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
105675978|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
105675979|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
105675980|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
105675981|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
105675982|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
105675983|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
105675984|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
105675985|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
105675986|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
105675987|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
105675988|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
105675989|NCT00128102|364477117|FG000|Overall Study|Site Discontinued|3|||
105675990|NCT00128102|364477118|FG001|Overall Study|Site Discontinued|6|||
105675991|NCT00128102|364477117|FG000|Overall Study|Other|0|||
105675992|NCT00128102|364477118|FG001|Overall Study|Other|1|||
105675993|NCT00128102|364477117|FG000|Overall Study|Progressive Disease|255|||
105675994|NCT00128102|364477118|FG001|Overall Study|Progressive Disease|285|||
105675995|NCT00128102|364477117|FG000|Overall Study|Adverse Event|34|||
105675996|NCT00128102|364477118|FG001|Overall Study|Adverse Event|11|||
105675997|NCT00128102|364477117|FG000|Overall Study|Death|12|||
105675998|NCT00128102|364477118|FG001|Overall Study|Death|13|||
105675999|NCT00128102|364477117|FG000|Overall Study|Physician Decision|3|||
105676000|NCT00128102|364477118|FG001|Overall Study|Physician Decision|3|||
105676001|NCT00128102|364477117|FG000|Overall Study|Withdrawal by Subject|19|||
105676002|NCT00128102|364477118|FG001|Overall Study|Withdrawal by Subject|11|||
105676003|NCT00128102|364477117|FG000|Overall Study|Protocol Violation|2|||
105676004|NCT00128102|364477118|FG001|Overall Study|Protocol Violation|2|||
105676005|NCT03339245|364477119|FG000|Overall Study|Adverse Event|1|||
105676006|NCT03339245|364477120|FG001|Overall Study|Adverse Event|1|||
105676007|NCT03339245|364477119|FG000|Overall Study|Withdrawal by Subject|1|||
105676008|NCT03339245|364477120|FG001|Overall Study|Withdrawal by Subject|0|||
105676009|NCT01342341|364477121|FG000|Overall Study|Lost to Follow-up|4|||
105676010|NCT01342341|364477122|FG001|Overall Study|Lost to Follow-up|4|||
105676011|NCT02075476|364477123|FG000|Overall Study|Death|2|||
105676012|NCT02075476|364477124|FG001|Overall Study|Death|2|||
105676013|NCT02075476|364477123|FG000|Overall Study|Lost to Follow-up|1|||
105676014|NCT02075476|364477124|FG001|Overall Study|Lost to Follow-up|3|||
105676015|NCT00837694|364477125|FG000|Overall Study|Lost to Follow-up|2|||
105676016|NCT00837694|364477126|FG001|Overall Study|Lost to Follow-up|0|||
105676017|NCT00837694|364477127|FG002|Overall Study|Lost to Follow-up|2|||
105676018|NCT00837694|364477128|FG003|Overall Study|Lost to Follow-up|1|||
105676019|NCT00837694|364477129|FG004|Overall Study|Lost to Follow-up|1|||
105676020|NCT00837694|364477130|FG005|Overall Study|Lost to Follow-up|1|||
105676021|NCT00306670|364477142|FG000|Overall Study|patients recruited; Genentech, the st|0|||
105676022|NCT00306670|364477143|FG001|Overall Study|patients recruited; Genentech, the st|2|||
105676023|NCT00833833|364477149|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
105676024|NCT00833833|364477150|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
105676025|NCT00833833|364477151|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
105676026|NCT00833833|364477152|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
105676027|NCT00833833|364477153|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
105676028|NCT00833833|364477154|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
105676029|NCT00833833|364477149|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
105676030|NCT00833833|364477150|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
105676031|NCT00833833|364477151|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
105676032|NCT00833833|364477152|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
105676033|NCT00833833|364477153|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
105676034|NCT00833833|364477154|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
105676035|NCT00833833|364477149|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
105676036|NCT00833833|364477150|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
105676037|NCT00833833|364477151|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
105676038|NCT00833833|364477152|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
105676039|NCT00833833|364477153|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
105676040|NCT00833833|364477154|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
105676041|NCT00833833|364477149|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
105676042|NCT00833833|364477150|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
105676043|NCT00833833|364477151|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
105676044|NCT00833833|364477152|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
105676045|NCT00833833|364477153|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
105676046|NCT00833833|364477154|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
105676047|NCT00833833|364477149|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
105676048|NCT00833833|364477150|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676049|NCT00833833|364477151|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
105676050|NCT00833833|364477152|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676051|NCT00833833|364477153|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676052|NCT00833833|364477154|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676053|NCT00833833|364477149|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
105676054|NCT00833833|364477150|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
105676055|NCT00833833|364477151|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
105343244|NCT02954653|363258271|FG003|Overall Study|Started another anti-cancer therapy|0|||
105343245|NCT02954653|363258272|FG004|Overall Study|Started another anti-cancer therapy|0|||
105343246|NCT02954653|363258273|FG005|Overall Study|Started another anti-cancer therapy|0|||
105343247|NCT02954653|363258274|FG006|Overall Study|Started another anti-cancer therapy|0|||
105676056|NCT00833833|364477152|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
105676057|NCT00833833|364477153|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
105676058|NCT00833833|364477154|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
105676059|NCT00833833|364477149|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
105676060|NCT00833833|364477150|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
105676061|NCT00833833|364477151|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
105676062|NCT00833833|364477152|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
105676063|NCT00833833|364477153|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
105676064|NCT00833833|364477154|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
105676065|NCT00833833|364477149|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
105676066|NCT00833833|364477150|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
105676067|NCT00833833|364477151|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
105676068|NCT00833833|364477152|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
105676069|NCT00833833|364477153|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
105676070|NCT00833833|364477154|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
105676071|NCT00833833|364477149|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
105676072|NCT00833833|364477150|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
105676073|NCT00833833|364477151|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
105676074|NCT00833833|364477152|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
105676075|NCT00833833|364477153|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
105676076|NCT00833833|364477154|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
105676077|NCT00833833|364477149|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676078|NCT00833833|364477150|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676079|NCT00833833|364477151|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676080|NCT00833833|364477152|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676081|NCT00833833|364477153|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
105676082|NCT00833833|364477154|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
105676083|NCT00833833|364477149|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
105676084|NCT00833833|364477150|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
105676085|NCT00833833|364477151|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
105676086|NCT00833833|364477152|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
105676087|NCT00833833|364477153|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
105676088|NCT00833833|364477154|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
105676089|NCT00833833|364477149|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
105676090|NCT00833833|364477150|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
105676091|NCT00833833|364477151|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
105676092|NCT00833833|364477152|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
105676093|NCT00833833|364477153|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
105676094|NCT00833833|364477154|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
105676095|NCT00833833|364477149|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
105676096|NCT00833833|364477150|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
105676097|NCT00833833|364477151|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
105676098|NCT00833833|364477152|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
105676099|NCT00833833|364477153|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
105676100|NCT00833833|364477154|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
105676101|NCT01994837|364477155|FG000|Overall Study|Progressive disease per protocol|23|||
105676102|NCT01994837|364477155|FG000|Overall Study|Adv event related to progressive disease|3|||
105676103|NCT01994837|364477155|FG000|Overall Study|Fatal progressive disease|2|||
105676104|NCT01994837|364477155|FG000|Overall Study|Adverse event not related to progression|1|||
105676105|NCT01994837|364477155|FG000|Overall Study|Chose palliative care|1|||
105676106|NCT01994837|364477155|FG000|Overall Study|Proceeded to transplant|1|||
105676107|NCT01994837|364477155|FG000|Overall Study|Removed from study due to no response|1|||
105676108|NCT01302067|364477156|FG000|Overall Study|Death|0|||
105676109|NCT01302067|364477157|FG001|Overall Study|Death|0|||
105676110|NCT01302067|364477158|FG002|Overall Study|Death|1|||
105676111|NCT01302067|364477156|FG000|Overall Study|Physician Decision|9|||
105676112|NCT01302067|364477157|FG001|Overall Study|Physician Decision|5|||
105676113|NCT01302067|364477158|FG002|Overall Study|Physician Decision|14|||
105676114|NCT01302067|364477156|FG000|Overall Study|Lack of Efficacy|8|||
105676115|NCT01302067|364477157|FG001|Overall Study|Lack of Efficacy|4|||
105676116|NCT01302067|364477158|FG002|Overall Study|Lack of Efficacy|2|||
105676117|NCT01302067|364477156|FG000|Overall Study|Lost to Follow-up|9|||
105676118|NCT01302067|364477157|FG001|Overall Study|Lost to Follow-up|4|||
105676119|NCT01302067|364477158|FG002|Overall Study|Lost to Follow-up|15|||
105676120|NCT01302067|364477156|FG000|Overall Study|Withdrawal by Subject|13|||
105676121|NCT01302067|364477157|FG001|Overall Study|Withdrawal by Subject|6|||
105676122|NCT01302067|364477158|FG002|Overall Study|Withdrawal by Subject|10|||
105676123|NCT01302067|364477156|FG000|Overall Study|Other|1|||
105676124|NCT01302067|364477157|FG001|Overall Study|Other|1|||
105676125|NCT01302067|364477158|FG002|Overall Study|Other|3|||
105676126|NCT01302067|364477156|FG000|Overall Study|Protocol Violation|11|||
105676127|NCT01302067|364477157|FG001|Overall Study|Protocol Violation|0|||
105676128|NCT01302067|364477158|FG002|Overall Study|Protocol Violation|8|||
105676129|NCT01302067|364477156|FG000|Overall Study|Adverse Event|27|||
105676130|NCT01302067|364477157|FG001|Overall Study|Adverse Event|14|||
105676131|NCT01302067|364477158|FG002|Overall Study|Adverse Event|45|||
105676132|NCT02738203|364477160|FG000|Overall Study|Failed IUD Insertion|2|||
105676133|NCT02738203|364477161|FG001|Overall Study|Failed IUD Insertion|2|||
105343248|NCT02954653|363258275|FG007|Overall Study|Started another anti-cancer therapy|0|||
105343249|NCT02954653|363258276|FG008|Overall Study|Started another anti-cancer therapy|0|||
105343250|NCT02954653|363258268|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
105343251|NCT02954653|363258269|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
105343252|NCT02954653|363258270|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
105343253|NCT02954653|363258271|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
105343254|NCT02954653|363258272|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
105343255|NCT02954653|363258273|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
105343256|NCT02954653|363258274|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
105343257|NCT02954653|363258275|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
105343258|NCT02954653|363258276|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
105343259|NCT03054064|363258279|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
105343260|NCT03054064|363258279|FG000|Overall Study|Investigator Decision|2|||
105343261|NCT03054064|363258279|FG000|Overall Study|Bladder Issue|1|||
105676134|NCT02738203|364477160|FG000|Overall Study|Protocol Violation|0|||
105676135|NCT02738203|364477161|FG001|Overall Study|Protocol Violation|1|||
105676136|NCT03241927|364477162|FG000|Overall Study|study terminated|1|||
105676137|NCT03241927|364477163|FG001|Overall Study|study terminated|0|||
105343262|NCT03054064|363258279|FG000|Overall Study|High Blood Pressure|1|||
105343263|NCT03054064|363258279|FG000|Overall Study|Change in Status|1|||
105676138|NCT01198756|364477164|FG000|Overall Study|Adverse Event|0|||
105676139|NCT01198756|364477165|FG001|Overall Study|Adverse Event|0|||
105676140|NCT01198756|364477166|FG002|Overall Study|Adverse Event|0|||
105676141|NCT01198756|364477167|FG003|Overall Study|Adverse Event|1|||
105676142|NCT01198756|364477164|FG000|Overall Study|Protocol Violation|0|||
105676143|NCT01198756|364477165|FG001|Overall Study|Protocol Violation|0|||
105676144|NCT01198756|364477166|FG002|Overall Study|Protocol Violation|0|||
105676145|NCT01198756|364477167|FG003|Overall Study|Protocol Violation|2|||
105676146|NCT01198756|364477164|FG000|Overall Study|Withdrawal by Subject|9|||
105676147|NCT01198756|364477165|FG001|Overall Study|Withdrawal by Subject|4|||
105676148|NCT01198756|364477166|FG002|Overall Study|Withdrawal by Subject|7|||
105676149|NCT01198756|364477167|FG003|Overall Study|Withdrawal by Subject|5|||
105676150|NCT01198756|364477164|FG000|Overall Study|Lost to Follow-up|29|||
105676151|NCT01198756|364477165|FG001|Overall Study|Lost to Follow-up|36|||
105676152|NCT01198756|364477166|FG002|Overall Study|Lost to Follow-up|23|||
105676153|NCT01198756|364477167|FG003|Overall Study|Lost to Follow-up|18|||
105676154|NCT01127893|364477168|FG000|Overall Study|Study Termination by the Sponsor|1|||
105676155|NCT02704754|364477169|FG000|Overall Study|Lost to Follow-up|1|||
105343264|NCT01472757|363258284|FG000|Overall Study|Withdrawal by Subject|1|||
105343265|NCT01472757|363258285|FG001|Overall Study|Withdrawal by Subject|2|||
105343266|NCT01472757|363258286|FG002|Overall Study|Withdrawal by Subject|2|||
105343267|NCT01472757|363258287|FG003|Overall Study|Withdrawal by Subject|0|||
105343268|NCT01472757|363258284|FG000|Overall Study|Asthma exacerbation|4|||
105343269|NCT01472757|363258285|FG001|Overall Study|Asthma exacerbation|1|||
105343270|NCT01472757|363258286|FG002|Overall Study|Asthma exacerbation|2|||
105343271|NCT01472757|363258287|FG003|Overall Study|Asthma exacerbation|1|||
105676156|NCT02704754|364477170|FG001|Overall Study|Lost to Follow-up|1|||
105676157|NCT02704754|364477169|FG000|Overall Study|Lack of Efficacy|1|||
105676158|NCT02704754|364477170|FG001|Overall Study|Lack of Efficacy|0|||
105676159|NCT02704754|364477169|FG000|Overall Study|Withdrawal by Subject|1|||
105676160|NCT02704754|364477170|FG001|Overall Study|Withdrawal by Subject|0|||
105676161|NCT00423943|364477171|FG000|Overall Study|Withdrawal by Subject|3|||
105676162|NCT00423943|364477172|FG001|Overall Study|Withdrawal by Subject|1|||
105676163|NCT05816330|364477176|FG000|Overall Study|Withdrawal by Subject|4|||
105343272|NCT01472757|363258284|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
105676164|NCT05816330|364477177|FG001|Overall Study|Withdrawal by Subject|1|||
105676165|NCT03245151|364477178|FG000|Overall Study|Withdrawal by Subject|2|||
105676166|NCT03245151|364477179|FG001|Overall Study|Withdrawal by Subject|0|||
105676167|NCT03245151|364477180|FG002|Overall Study|Withdrawal by Subject|0|||
105343273|NCT01472757|363258285|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
105343274|NCT01472757|363258286|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
105343275|NCT01472757|363258287|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
105343276|NCT01472757|363258284|FG000|Overall Study|Protocol Violation|3|||
105343277|NCT01472757|363258285|FG001|Overall Study|Protocol Violation|2|||
105676168|NCT03245151|364477181|FG003|Overall Study|Withdrawal by Subject|2|||
105676169|NCT03245151|364477182|FG004|Overall Study|Withdrawal by Subject|1|||
105676170|NCT03245151|364477178|FG000|Overall Study|Death|3|||
105676171|NCT03245151|364477179|FG001|Overall Study|Death|14|||
105676172|NCT03245151|364477180|FG002|Overall Study|Death|9|||
105343278|NCT01472757|363258286|FG002|Overall Study|Protocol Violation|4|||
105343279|NCT01472757|363258287|FG003|Overall Study|Protocol Violation|4|||
105676173|NCT03245151|364477181|FG003|Overall Study|Death|16|||
105676174|NCT03245151|364477182|FG004|Overall Study|Death|7|||
105676175|NCT03245151|364477178|FG000|Overall Study|Sponsor's decision|0|||
105676176|NCT03245151|364477179|FG001|Overall Study|Sponsor's decision|1|||
105676177|NCT03245151|364477180|FG002|Overall Study|Sponsor's decision|0|||
105676178|NCT03245151|364477181|FG003|Overall Study|Sponsor's decision|0|||
105676179|NCT03245151|364477182|FG004|Overall Study|Sponsor's decision|0|||
105676180|NCT00621777|364477183|FG000|Open Phase|Adverse Event|20|||
105676181|NCT00621777|364477184|FG001|Open Phase|Adverse Event|0|||
105676182|NCT00621777|364477183|FG000|Open Phase|Did not abstain during open phase|56|||
105676183|NCT00621777|364477184|FG001|Open Phase|Did not abstain during open phase|0|||
105676184|NCT00621777|364477183|FG000|Open Phase|Withdrawal by Subject|17|||
105676185|NCT00621777|364477184|FG001|Open Phase|Withdrawal by Subject|0|||
105676186|NCT00621777|364477183|FG000|Open Phase|administrative|13|||
105676187|NCT00621777|364477184|FG001|Open Phase|administrative|0|||
105676188|NCT00621777|364477183|FG000|Open Phase|Lost to Follow-up|10|||
105676189|NCT00621777|364477184|FG001|Open Phase|Lost to Follow-up|0|||
105676190|NCT00621777|364477183|FG000|Randomized Phase|Adverse Event|3|||
105676191|NCT00621777|364477184|FG001|Randomized Phase|Adverse Event|3|||
105676192|NCT00621777|364477183|FG000|Randomized Phase|Lost to Follow-up|3|||
105676193|NCT00621777|364477184|FG001|Randomized Phase|Lost to Follow-up|3|||
105676194|NCT00621777|364477183|FG000|Randomized Phase|Withdrawal by Subject|1|||
105676195|NCT00621777|364477184|FG001|Randomized Phase|Withdrawal by Subject|9|||
105676196|NCT00621777|364477183|FG000|Randomized Phase|administrative|0|||
105676197|NCT00621777|364477184|FG001|Randomized Phase|administrative|3|||
105676198|NCT00621777|364477183|FG000|Randomized Phase|Death|0|||
105676199|NCT00621777|364477184|FG001|Randomized Phase|Death|1|||
105676200|NCT00996476|364477185|FG000|Overall Study|Withdrawal by Subject|1|||
105676201|NCT00996476|364477186|FG001|Overall Study|Withdrawal by Subject|2|||
105676202|NCT00996476|364477187|FG002|Overall Study|Withdrawal by Subject|1|||
105676203|NCT00996476|364477188|FG003|Overall Study|Withdrawal by Subject|0|||
105676204|NCT00996476|364477189|FG004|Overall Study|Withdrawal by Subject|1|||
105676205|NCT00996476|364477185|FG000|Overall Study|Adverse Event|0|||
105676206|NCT00996476|364477186|FG001|Overall Study|Adverse Event|1|||
105676207|NCT00996476|364477187|FG002|Overall Study|Adverse Event|0|||
105676208|NCT00996476|364477188|FG003|Overall Study|Adverse Event|0|||
105676209|NCT00996476|364477189|FG004|Overall Study|Adverse Event|1|||
105676210|NCT01517295|364477195|FG000|Overall Study|Physician Decision|1|||
105676211|NCT01517295|364477196|FG001|Overall Study|Physician Decision|0|||
105676212|NCT00307684|364477197|FG000|Open Label Phase|Lack of Efficacy|0|||
105676213|NCT00307684|364477198|FG001|Open Label Phase|Lack of Efficacy|0|||
105676214|NCT00307684|364477199|FG002|Open Label Phase|Lack of Efficacy|3|||
105676215|NCT00307684|364477197|FG000|Open Label Phase|Adverse Event|0|||
105676216|NCT00307684|364477198|FG001|Open Label Phase|Adverse Event|0|||
105676217|NCT00307684|364477199|FG002|Open Label Phase|Adverse Event|16|||
105676218|NCT00307684|364477197|FG000|Open Label Phase|Withdrawal by Subject|0|||
105676219|NCT00307684|364477198|FG001|Open Label Phase|Withdrawal by Subject|0|||
105676220|NCT00307684|364477199|FG002|Open Label Phase|Withdrawal by Subject|15|||
105676221|NCT00307684|364477197|FG000|Open Label Phase|Lost to Follow-up|0|||
105676222|NCT00307684|364477198|FG001|Open Label Phase|Lost to Follow-up|0|||
105676223|NCT00307684|364477199|FG002|Open Label Phase|Lost to Follow-up|11|||
105676224|NCT00307684|364477197|FG000|Open Label Phase|non compliance|0|||
105676225|NCT00307684|364477198|FG001|Open Label Phase|non compliance|0|||
105676226|NCT00307684|364477199|FG002|Open Label Phase|non compliance|5|||
105676227|NCT00307684|364477197|FG000|Open Label Phase|other|0|||
105676228|NCT00307684|364477198|FG001|Open Label Phase|other|0|||
105676229|NCT00307684|364477199|FG002|Open Label Phase|other|6|||
105676230|NCT00307684|364477197|FG000|Double Blind Phase|Lack of Efficacy|2|||
105676231|NCT00307684|364477198|FG001|Double Blind Phase|Lack of Efficacy|5|||
105676232|NCT00307684|364477199|FG002|Double Blind Phase|Lack of Efficacy|0|||
105676233|NCT02580305|364477200|FG000|Overall Study|Adverse Event|15|||
105786419|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Physician Decision|1|||
105786420|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Physician Decision|0|||
105676234|NCT02580305|364477201|FG001|Overall Study|Adverse Event|19|||
105676235|NCT02580305|364477202|FG002|Overall Study|Adverse Event|10|||
105676236|NCT02580305|364477200|FG000|Overall Study|Lack of Efficacy|5|||
105676237|NCT02580305|364477201|FG001|Overall Study|Lack of Efficacy|0|||
105676238|NCT02580305|364477202|FG002|Overall Study|Lack of Efficacy|2|||
105676239|NCT02580305|364477200|FG000|Overall Study|Protocol Violation|4|||
105676240|NCT02580305|364477201|FG001|Overall Study|Protocol Violation|9|||
105676241|NCT02580305|364477202|FG002|Overall Study|Protocol Violation|6|||
105676242|NCT02580305|364477200|FG000|Overall Study|Lost to Follow-up|4|||
105676243|NCT02580305|364477201|FG001|Overall Study|Lost to Follow-up|4|||
105676244|NCT02580305|364477202|FG002|Overall Study|Lost to Follow-up|2|||
105676245|NCT02580305|364477200|FG000|Overall Study|Withdrawal by Subject|11|||
105676246|NCT02580305|364477201|FG001|Overall Study|Withdrawal by Subject|9|||
105786421|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Physician Decision|0|||
105786422|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Progressive disease|1|||
105676247|NCT02580305|364477202|FG002|Overall Study|Withdrawal by Subject|7|||
105786423|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Progressive disease|0|||
105343280|NCT01472757|363258284|FG000|Overall Study|Other reasons|1|||
105343281|NCT01472757|363258285|FG001|Overall Study|Other reasons|0|||
105343282|NCT01472757|363258286|FG002|Overall Study|Other reasons|2|||
105343283|NCT01472757|363258287|FG003|Overall Study|Other reasons|2|||
105343284|NCT00574249|363258291|FG000|Overall Study|Adverse Event|6|||
105343285|NCT00574249|363258292|FG001|Overall Study|Adverse Event|18|||
105343286|NCT00574249|363258291|FG000|Overall Study|Lack of Efficacy|5|||
105555934|NCT00325468|364031869|FG001|Overall Study|Withdrawal by Subject|1|||
105555935|NCT00325468|364031870|FG002|Overall Study|Withdrawal by Subject|0|||
105555936|NCT00325468|364031871|FG003|Overall Study|Withdrawal by Subject|14|||
105555937|NCT00325468|364031872|FG004|Overall Study|Withdrawal by Subject|4|||
105555938|NCT00325468|364031868|FG000|Overall Study|site closure etc|4|||
105555939|NCT00325468|364031869|FG001|Overall Study|site closure etc|2|||
105555940|NCT00325468|364031870|FG002|Overall Study|site closure etc|1|||
105555941|NCT00325468|364031871|FG003|Overall Study|site closure etc|8|||
105555942|NCT00325468|364031872|FG004|Overall Study|site closure etc|1|||
105555943|NCT04307004|364031883|FG000|Randomization 1|Withdrawal by Subject|25|||
105555944|NCT04307004|364031884|FG001|Randomization 1|Withdrawal by Subject|26|||
105555945|NCT04307004|364031885|FG002|Randomization 1|Withdrawal by Subject|0|||
105555946|NCT04307004|364031886|FG003|Randomization 1|Withdrawal by Subject|0|||
105555947|NCT04307004|364031883|FG000|Randomization 2|Withdrawal by Subject|0|||
105555948|NCT04307004|364031884|FG001|Randomization 2|Withdrawal by Subject|0|||
105555949|NCT04307004|364031885|FG002|Randomization 2|Withdrawal by Subject|28|||
105555950|NCT04307004|364031886|FG003|Randomization 2|Withdrawal by Subject|23|||
105555951|NCT06390839|364031892|FG000|Overall Study|Ineligible|2|||
105343287|NCT00574249|363258292|FG001|Overall Study|Lack of Efficacy|3|||
105676248|NCT02580305|364477200|FG000|Overall Study|Randomized in error and never treated|4|||
105676249|NCT02580305|364477201|FG001|Overall Study|Randomized in error and never treated|8|||
105676250|NCT02580305|364477202|FG002|Overall Study|Randomized in error and never treated|5|||
105676251|NCT04075994|364477207|FG000|Overall Study|Withdrawal by Subject|8|||
105676252|NCT04075994|364477208|FG001|Overall Study|Withdrawal by Subject|9|||
105676253|NCT04075994|364477207|FG000|Overall Study|Adverse Event|2|||
105676254|NCT04075994|364477208|FG001|Overall Study|Adverse Event|2|||
105676255|NCT04075994|364477207|FG000|Overall Study|Investigator withdrew|3|||
105676256|NCT04075994|364477208|FG001|Overall Study|Investigator withdrew|1|||
105676257|NCT00929110|364477209|FG000|Overall Study|Adverse Event|40|||
105676258|NCT00929110|364477210|FG001|Overall Study|Adverse Event|29|||
105676259|NCT00929110|364477211|FG002|Overall Study|Adverse Event|18|||
105676260|NCT00929110|364477209|FG000|Overall Study|Subject withdrew consent|40|||
105676261|NCT00929110|364477210|FG001|Overall Study|Subject withdrew consent|23|||
105676262|NCT00929110|364477211|FG002|Overall Study|Subject withdrew consent|26|||
105676263|NCT00929110|364477209|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
105676264|NCT00929110|364477210|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
105676265|NCT00929110|364477211|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
105676266|NCT00929110|364477209|FG000|Overall Study|Lost to Follow-up|7|||
105676267|NCT00929110|364477210|FG001|Overall Study|Lost to Follow-up|7|||
105676268|NCT00929110|364477211|FG002|Overall Study|Lost to Follow-up|3|||
105676269|NCT00929110|364477209|FG000|Overall Study|Protocol deviation|5|||
105676270|NCT00929110|364477210|FG001|Overall Study|Protocol deviation|2|||
105676271|NCT00929110|364477211|FG002|Overall Study|Protocol deviation|4|||
105676272|NCT00929110|364477209|FG000|Overall Study|Administrative problems|4|||
105676273|NCT00929110|364477210|FG001|Overall Study|Administrative problems|1|||
105676274|NCT00929110|364477211|FG002|Overall Study|Administrative problems|2|||
105676275|NCT00929110|364477209|FG000|Overall Study|Death|2|||
105676276|NCT00929110|364477210|FG001|Overall Study|Death|2|||
105676277|NCT00929110|364477211|FG002|Overall Study|Death|2|||
105676278|NCT00929110|364477209|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105676279|NCT00929110|364477210|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105676280|NCT00929110|364477211|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105676281|NCT00929110|364477209|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105676282|NCT00929110|364477210|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105676283|NCT00929110|364477211|FG002|Overall Study|Abnormal test procedure result(s)|1|||
105676284|NCT00929110|364477209|FG000|Overall Study|Patient inability to use the device|0|||
105676285|NCT00929110|364477210|FG001|Overall Study|Patient inability to use the device|1|||
105676286|NCT00929110|364477211|FG002|Overall Study|Patient inability to use the device|0|||
105676287|NCT00992225|364477212|FG000|Overall Study|Entry Criteria Not Met|8|||
105676288|NCT00992225|364477212|FG000|Overall Study|Adverse Event|2|||
105676289|NCT03122223|364477213|FG000|Overall Study|Withdrawal by Subject|2|||
105676290|NCT03122223|364477214|FG001|Overall Study|Withdrawal by Subject|2|||
105676291|NCT03122223|364477215|FG002|Overall Study|Withdrawal by Subject|1|||
105676292|NCT03122223|364477216|FG003|Overall Study|Withdrawal by Subject|0|||
105676293|NCT03122223|364477213|FG000|Overall Study|Lost to Follow-up|0|||
105676294|NCT03122223|364477214|FG001|Overall Study|Lost to Follow-up|2|||
105676295|NCT03122223|364477215|FG002|Overall Study|Lost to Follow-up|2|||
105676296|NCT03122223|364477216|FG003|Overall Study|Lost to Follow-up|0|||
105676297|NCT03122223|364477213|FG000|Overall Study|Participant unable to adhere|1|||
105676298|NCT03122223|364477214|FG001|Overall Study|Participant unable to adhere|1|||
105676299|NCT03122223|364477215|FG002|Overall Study|Participant unable to adhere|1|||
105676300|NCT03122223|364477216|FG003|Overall Study|Participant unable to adhere|0|||
105676301|NCT02624791|364477220|FG000|Overall Study|Withdrawal by Subject|2|||
105676302|NCT02624791|364477221|FG001|Overall Study|Withdrawal by Subject|0|||
105676303|NCT02624791|364477222|FG002|Overall Study|Withdrawal by Subject|0|||
105676304|NCT02624791|364477223|FG003|Overall Study|Withdrawal by Subject|0|||
105676305|NCT02624791|364477224|FG004|Overall Study|Withdrawal by Subject|0|||
105676306|NCT02624791|364477225|FG005|Overall Study|Withdrawal by Subject|0|||
105676307|NCT00844532|364477228|FG000|Overall Study|Death|16|||
105676308|NCT00844532|364477228|FG000|Overall Study|Withdrawal by Subject|16|||
105676309|NCT00844532|364477228|FG000|Overall Study|Lost to Follow-up|7|||
105676310|NCT02576587|364477229|FG000|Baseline|Equipment failure|0|||
105676311|NCT02576587|364477230|FG001|Baseline|Equipment failure|1|||
105676312|NCT02576587|364477229|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
105676313|NCT02576587|364477230|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
105676314|NCT02576587|364477229|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
105676315|NCT02576587|364477230|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
105676316|NCT02576587|364477229|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
105676317|NCT02576587|364477230|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
105676318|NCT00532493|364477231|FG000|Overall Study|Death|1|||
105676319|NCT00532493|364477232|FG001|Overall Study|Death|1|||
105676320|NCT00532493|364477231|FG000|Overall Study|Lost to Follow-up|10|||
105676321|NCT00532493|364477232|FG001|Overall Study|Lost to Follow-up|7|||
105676322|NCT00532493|364477231|FG000|Overall Study|Withdrawal by Subject|7|||
105676323|NCT00532493|364477232|FG001|Overall Study|Withdrawal by Subject|9|||
105676324|NCT00532493|364477231|FG000|Overall Study|Physician Decision|1|||
105676325|NCT00532493|364477232|FG001|Overall Study|Physician Decision|6|||
105676326|NCT00532493|364477231|FG000|Overall Study|Adverse Event|6|||
105676327|NCT00532493|364477232|FG001|Overall Study|Adverse Event|5|||
105676328|NCT00532493|364477231|FG000|Overall Study|Protocol Deviation|1|||
105676329|NCT00532493|364477232|FG001|Overall Study|Protocol Deviation|0|||
105676330|NCT00532493|364477231|FG000|Overall Study|Subject Moved Away|3|||
105676331|NCT00532493|364477232|FG001|Overall Study|Subject Moved Away|1|||
105676332|NCT00532493|364477231|FG000|Overall Study|Contraindicative Medication|1|||
105676333|NCT00532493|364477232|FG001|Overall Study|Contraindicative Medication|0|||
105676334|NCT05917470|364477234|FG000|Overall Study|Progressive Disease|1|||
105676335|NCT05917470|364477235|FG001|Overall Study|Progressive Disease|1|||
105676336|NCT05917470|364477236|FG002|Overall Study|Progressive Disease|2|||
105676337|NCT05917470|364477237|FG003|Overall Study|Progressive Disease|3|||
105676338|NCT05917470|364477238|FG004|Overall Study|Progressive Disease|1|||
105676339|NCT05917470|364477239|FG005|Overall Study|Progressive Disease|1|||
105676340|NCT05917470|364477240|FG006|Overall Study|Progressive Disease|0|||
105676341|NCT05917470|364477241|FG007|Overall Study|Progressive Disease|0|||
105676342|NCT05917470|364477234|FG000|Overall Study|Withdrawal by Subject|0|||
105676343|NCT05917470|364477235|FG001|Overall Study|Withdrawal by Subject|0|||
105676344|NCT05917470|364477236|FG002|Overall Study|Withdrawal by Subject|1|||
105676345|NCT05917470|364477237|FG003|Overall Study|Withdrawal by Subject|0|||
105676346|NCT05917470|364477238|FG004|Overall Study|Withdrawal by Subject|0|||
105676347|NCT05917470|364477239|FG005|Overall Study|Withdrawal by Subject|0|||
105676348|NCT05917470|364477240|FG006|Overall Study|Withdrawal by Subject|0|||
105343288|NCT00574249|363258291|FG000|Overall Study|Lost to Follow-up|4|||
105676349|NCT05917470|364477241|FG007|Overall Study|Withdrawal by Subject|0|||
105676350|NCT05917470|364477234|FG000|Overall Study|Sponsor Decision|0|||
105676351|NCT05917470|364477235|FG001|Overall Study|Sponsor Decision|0|||
105676352|NCT05917470|364477236|FG002|Overall Study|Sponsor Decision|1|||
105555952|NCT06390839|364031892|FG000|Overall Study|Never start protocol therapy|3|||
105555953|NCT06390839|364031892|FG000|Overall Study|Adverse Event|1|||
105555954|NCT06390839|364031892|FG000|Overall Study|Alternative therapy|2|||
105555955|NCT06390839|364031892|FG000|Overall Study|Death|3|||
105555956|NCT06390839|364031892|FG000|Overall Study|Disease progression|28|||
105555957|NCT06390839|364031892|FG000|Overall Study|Withdrawal by Subject|2|||
105555958|NCT06390839|364031892|FG000|Overall Study|Complicating disease|1|||
105786424|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Progressive disease|0|||
105676353|NCT05917470|364477237|FG003|Overall Study|Sponsor Decision|0|||
105676354|NCT05917470|364477238|FG004|Overall Study|Sponsor Decision|2|||
105676355|NCT05917470|364477239|FG005|Overall Study|Sponsor Decision|1|||
105676356|NCT05917470|364477240|FG006|Overall Study|Sponsor Decision|3|||
105676357|NCT05917470|364477241|FG007|Overall Study|Sponsor Decision|3|||
105676358|NCT05917470|364477234|FG000|Overall Study|Adverse Event|0|||
105676359|NCT05917470|364477235|FG001|Overall Study|Adverse Event|0|||
105676360|NCT05917470|364477236|FG002|Overall Study|Adverse Event|0|||
105676361|NCT05917470|364477237|FG003|Overall Study|Adverse Event|0|||
105676362|NCT05917470|364477238|FG004|Overall Study|Adverse Event|0|||
105676363|NCT05917470|364477239|FG005|Overall Study|Adverse Event|1|||
105676364|NCT05917470|364477240|FG006|Overall Study|Adverse Event|0|||
105676365|NCT05917470|364477241|FG007|Overall Study|Adverse Event|0|||
105676366|NCT05593445|364477244|FG000|12-Week DBVC Period|Adverse Event|1|||
105676367|NCT05593445|364477245|FG001|12-Week DBVC Period|Adverse Event|0|||
105676368|NCT05593445|364477246|FG002|12-Week DBVC Period|Adverse Event|0|||
105676369|NCT05593445|364477247|FG003|12-Week DBVC Period|Adverse Event|0|||
105676370|NCT05593445|364477244|FG000|12-Week DBVC Period|Physician Decision|0|||
105676371|NCT05593445|364477245|FG001|12-Week DBVC Period|Physician Decision|1|||
105676372|NCT05593445|364477246|FG002|12-Week DBVC Period|Physician Decision|0|||
105676373|NCT05593445|364477247|FG003|12-Week DBVC Period|Physician Decision|0|||
105676374|NCT05593445|364477244|FG000|12-Week DBVC Period|Protocol Violation|0|||
105676375|NCT05593445|364477245|FG001|12-Week DBVC Period|Protocol Violation|1|||
105676376|NCT05593445|364477246|FG002|12-Week DBVC Period|Protocol Violation|0|||
105676377|NCT05593445|364477247|FG003|12-Week DBVC Period|Protocol Violation|0|||
105676378|NCT05593445|364477244|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
105676379|NCT05593445|364477245|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
105676380|NCT05593445|364477246|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
105676381|NCT05593445|364477247|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
105676382|NCT05593445|364477244|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
105676383|NCT05593445|364477245|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
105676384|NCT05593445|364477246|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
105676385|NCT05593445|364477247|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
105676386|NCT05593445|364477244|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
105676387|NCT05593445|364477245|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
105676388|NCT05593445|364477246|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
105676389|NCT05593445|364477247|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
105676390|NCT05593445|364477244|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
105676391|NCT05593445|364477245|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
105676392|NCT05593445|364477246|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
105676393|NCT05593445|364477247|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
105676394|NCT05593445|364477244|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
105676395|NCT05593445|364477245|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
105676396|NCT05593445|364477246|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
105676397|NCT05593445|364477247|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
105676398|NCT03981861|364477248|FG000|Overall Study|Withdrawal by Subject|3|||
105676399|NCT00095498|364479330|FG000|Overall Study|Physician Decision|9|||
105676400|NCT00095498|364479331|FG001|Overall Study|Physician Decision|10|||
105676401|NCT00095498|364479332|FG002|Overall Study|Physician Decision|8|||
105676402|NCT00095498|364479330|FG000|Overall Study|Adverse Event|1|||
105676403|NCT00095498|364479331|FG001|Overall Study|Adverse Event|0|||
105676404|NCT00095498|364479332|FG002|Overall Study|Adverse Event|1|||
105676405|NCT00095498|364479330|FG000|Overall Study|Withdrawal by Subject|15|||
105676406|NCT00095498|364479331|FG001|Overall Study|Withdrawal by Subject|16|||
105676407|NCT00095498|364479332|FG002|Overall Study|Withdrawal by Subject|15|||
105676408|NCT00095498|364479330|FG000|Overall Study|Disease progression|0|||
105676409|NCT00095498|364479331|FG001|Overall Study|Disease progression|1|||
105676410|NCT00095498|364479332|FG002|Overall Study|Disease progression|1|||
105676411|NCT00095498|364479330|FG000|Overall Study|Ineligibility determined|3|||
105676412|NCT00095498|364479331|FG001|Overall Study|Ineligibility determined|0|||
105676413|NCT00095498|364479332|FG002|Overall Study|Ineligibility determined|2|||
105676414|NCT00095498|364479330|FG000|Overall Study|Lost to Follow-up|1|||
105676415|NCT00095498|364479331|FG001|Overall Study|Lost to Follow-up|1|||
105676416|NCT00095498|364479332|FG002|Overall Study|Lost to Follow-up|2|||
105676417|NCT00095498|364479330|FG000|Overall Study|Noncompliance|1|||
105676418|NCT00095498|364479331|FG001|Overall Study|Noncompliance|0|||
105676419|NCT00095498|364479332|FG002|Overall Study|Noncompliance|1|||
105676420|NCT00095498|364479330|FG000|Overall Study|Other|6|||
105676421|NCT00095498|364479331|FG001|Overall Study|Other|7|||
105676422|NCT00095498|364479332|FG002|Overall Study|Other|6|||
105676423|NCT00095498|364479330|FG000|Overall Study|Protocol Violation|0|||
105676424|NCT00095498|364479331|FG001|Overall Study|Protocol Violation|0|||
105676425|NCT00095498|364479332|FG002|Overall Study|Protocol Violation|1|||
105676426|NCT00095498|364479330|FG000|Overall Study|Requirement for alternative therapy|1|||
105676427|NCT00095498|364479331|FG001|Overall Study|Requirement for alternative therapy|0|||
105676428|NCT00095498|364479332|FG002|Overall Study|Requirement for alternative therapy|2|||
105676429|NCT05020327|364479333|FG000|Overall Study|Physician Decision|3|||
105676430|NCT05020327|364479334|FG001|Overall Study|Physician Decision|0|||
105676431|NCT05020327|364479335|FG002|Overall Study|Physician Decision|0|||
105676432|NCT05020327|364479333|FG000|Overall Study|Withdrawal by Subject|1|||
105676433|NCT05020327|364479334|FG001|Overall Study|Withdrawal by Subject|1|||
105676434|NCT05020327|364479335|FG002|Overall Study|Withdrawal by Subject|0|||
105676435|NCT05020327|364479333|FG000|Overall Study|personal/cultural, ineligible|12|||
105676436|NCT05020327|364479334|FG001|Overall Study|personal/cultural, ineligible|0|||
105676437|NCT05020327|364479335|FG002|Overall Study|personal/cultural, ineligible|0|||
105676438|NCT04684394|364479336|FG000|Overall Study|Death|1|||
105676439|NCT04684394|364479337|FG001|Overall Study|Death|2|||
105676440|NCT04684394|364479336|FG000|Overall Study|Lost to Follow-up|1|||
105676441|NCT04684394|364479337|FG001|Overall Study|Lost to Follow-up|0|||
105676442|NCT04684394|364479336|FG000|Overall Study|Withdrawal by Subject|2|||
105676443|NCT04684394|364479337|FG001|Overall Study|Withdrawal by Subject|0|||
105676444|NCT04684394|364479336|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
105676445|NCT04684394|364479337|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
105676446|NCT03037931|364479338|FG000|Overall Study|Death|354|||
105676447|NCT03037931|364479339|FG001|Overall Study|Death|367|||
105676448|NCT03037931|364479338|FG000|Overall Study|Lost to Follow-up|7|||
105676449|NCT03037931|364479339|FG001|Overall Study|Lost to Follow-up|4|||
105676450|NCT03037931|364479338|FG000|Overall Study|Withdrawal by Subject|48|||
105676451|NCT03037931|364479339|FG001|Overall Study|Withdrawal by Subject|41|||
105676452|NCT01775475|364479340|FG000|Overall Study|Death|3|||
105676453|NCT01775475|364479341|FG001|Overall Study|Death|3|||
105676454|NCT04410523|364479345|FG000|Overall Study|Study terminated by sponsor|1|||
105676455|NCT04410523|364479346|FG001|Overall Study|Study terminated by sponsor|3|||
105676456|NCT04410523|364479347|FG002|Overall Study|Study terminated by sponsor|2|||
105676457|NCT04410523|364479348|FG003|Overall Study|Study terminated by sponsor|6|||
105676458|NCT04410523|364479349|FG004|Overall Study|Study terminated by sponsor|3|||
105676459|NCT04410523|364479350|FG005|Overall Study|Study terminated by sponsor|4|||
105676460|NCT04410523|364479345|FG000|Overall Study|Adverse Event|1|||
105676461|NCT04410523|364479346|FG001|Overall Study|Adverse Event|0|||
105343289|NCT00574249|363258292|FG001|Overall Study|Lost to Follow-up|3|||
105343290|NCT00574249|363258291|FG000|Overall Study|Protocol Violation|5|||
105343291|NCT00574249|363258292|FG001|Overall Study|Protocol Violation|2|||
105343292|NCT00574249|363258291|FG000|Overall Study|History of carcinoma|1|||
105343293|NCT00574249|363258292|FG001|Overall Study|History of carcinoma|0|||
105343294|NCT00574249|363258291|FG000|Overall Study|Withdrawal by Subject|3|||
105343295|NCT00574249|363258292|FG001|Overall Study|Withdrawal by Subject|0|||
105343296|NCT00574249|363258291|FG000|Overall Study|Physician Decision|1|||
105343297|NCT00574249|363258292|FG001|Overall Study|Physician Decision|0|||
105343298|NCT00574249|363258291|FG000|Overall Study|Pregnancy|1|||
105343299|NCT00574249|363258292|FG001|Overall Study|Pregnancy|0|||
105343300|NCT00574249|363258291|FG000|Overall Study|Excluded by company|0|||
105343301|NCT00574249|363258292|FG001|Overall Study|Excluded by company|1|||
105343302|NCT00574249|363258291|FG000|Overall Study|PPD test taken twice|0|||
105343303|NCT00574249|363258292|FG001|Overall Study|PPD test taken twice|1|||
105343304|NCT01866657|363258293|FG000|Overall Study|Surgery canceled|2|||
105343305|NCT01866657|363258294|FG001|Overall Study|Surgery canceled|0|||
105343306|NCT01123941|363258301|FG000|Overall Study|Lost to Follow-up|2|||
105343307|NCT01123941|363258302|FG001|Overall Study|Lost to Follow-up|1|||
105343308|NCT00430352|363258303|FG000|Overall Study|Disease progression|58|||
105343309|NCT00430352|363258303|FG000|Overall Study|Withdrawal by Subject|11|||
105555959|NCT06390839|364031892|FG000|Overall Study|Noncompliance|1|||
105555960|NCT00688636|364031897|FG000|Overall Study|Adverse Event|2|||
105555961|NCT00688636|364031898|FG001|Overall Study|Adverse Event|1|||
105555962|NCT04053764|364031899|FG000|Overall Study|Withdrawal by Subject|6|||
105555963|NCT04053764|364031900|FG001|Overall Study|Withdrawal by Subject|2|||
105555964|NCT04053764|364031899|FG000|Overall Study|Physician Decision|2|||
105555965|NCT04053764|364031900|FG001|Overall Study|Physician Decision|1|||
105555966|NCT04053764|364031899|FG000|Overall Study|Adverse Event|1|||
105555967|NCT04053764|364031900|FG001|Overall Study|Adverse Event|0|||
105555968|NCT04053764|364031899|FG000|Overall Study|Pregnancy|1|||
105555969|NCT04053764|364031900|FG001|Overall Study|Pregnancy|0|||
105555970|NCT04732286|364031901|FG000|Overall Study|Progressive Disease|2|||
105555971|NCT04732286|364031901|FG000|Overall Study|Physician Decision|1|||
105555972|NCT04732286|364031901|FG000|Overall Study|Study Terminated by Sponsor|31|||
105555973|NCT04732286|364031901|FG000|Overall Study|Withdrawal by Subject|10|||
105555974|NCT04732286|364031901|FG000|Overall Study|Non-compliance With Study Drug|1|||
105555975|NCT04732286|364031901|FG000|Overall Study|Lost to Follow-up|4|||
105555976|NCT04732286|364031901|FG000|Overall Study|Death|51|||
105555977|NCT03282227|364031906|FG000|Overall Study|Exposure Goals Achieved|60|||
105555978|NCT03282227|364031906|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
105555979|NCT03282227|364031906|FG000|Overall Study|Adverse Event|15|||
105555980|NCT03282227|364031906|FG000|Overall Study|Lost to Follow-up|21|||
105555981|NCT03282227|364031906|FG000|Overall Study|Withdrawal by Subject|20|||
105555982|NCT03282227|364031906|FG000|Overall Study|Lack of Efficacy|12|||
105555983|NCT03282227|364031906|FG000|Overall Study|Sponsor decision|3|||
105555984|NCT03282227|364031906|FG000|Overall Study|Physician Decision|2|||
105555985|NCT03282227|364031906|FG000|Overall Study|Pregnancy|2|||
105555986|NCT03282227|364031906|FG000|Overall Study|Other|1|||
105555987|NCT00535730|364031907|FG000|Overall Study|Adverse Event|1|||
105555988|NCT00535730|364031908|FG001|Overall Study|Adverse Event|1|||
105555989|NCT00535730|364031907|FG000|Overall Study|Lost to Follow-up|0|||
105555990|NCT00535730|364031908|FG001|Overall Study|Lost to Follow-up|1|||
105555991|NCT00535730|364031907|FG000|Overall Study|Physician Decision|0|||
105555992|NCT00535730|364031908|FG001|Overall Study|Physician Decision|1|||
105555993|NCT00535730|364031907|FG000|Overall Study|Protocol Violation|1|||
105555994|NCT00535730|364031908|FG001|Overall Study|Protocol Violation|0|||
105555995|NCT00535730|364031907|FG000|Overall Study|Withdrawal by Subject|0|||
105555996|NCT00535730|364031908|FG001|Overall Study|Withdrawal by Subject|4|||
105555997|NCT02293538|364031909|FG000|Overall Study|Adverse Event|0|||
105555998|NCT02293538|364031910|FG001|Overall Study|Adverse Event|1|||
105555999|NCT02293538|364031909|FG000|Overall Study|Lost to Follow-up|1|||
105556000|NCT02293538|364031910|FG001|Overall Study|Lost to Follow-up|0|||
105556001|NCT02293538|364031909|FG000|Overall Study|Withdrawal by Subject|0|||
105556002|NCT02293538|364031910|FG001|Overall Study|Withdrawal by Subject|1|||
105556003|NCT02363946|364031911|FG000|Overall Study|Lost to Follow-up|0|||
105556004|NCT02363946|364031912|FG001|Overall Study|Lost to Follow-up|0|||
105556005|NCT02363946|364031913|FG002|Overall Study|Lost to Follow-up|0|||
105676462|NCT04410523|364479347|FG002|Overall Study|Adverse Event|0|||
105343310|NCT00430352|363258303|FG000|Overall Study|Adverse Event|16|||
105343311|NCT00430352|363258303|FG000|Overall Study|Death|5|||
105343312|NCT00430352|363258303|FG000|Overall Study|Other|48|||
105343313|NCT04326439|363258304|FG000|Overall Study|Withdrawal by Subject|1|||
105556006|NCT02363946|364031914|FG003|Overall Study|Lost to Follow-up|0|||
105556007|NCT02363946|364031915|FG004|Overall Study|Lost to Follow-up|0|||
105556008|NCT02363946|364031916|FG005|Overall Study|Lost to Follow-up|0|||
105556009|NCT02363946|364031917|FG006|Overall Study|Lost to Follow-up|0|||
105343314|NCT04326439|363258305|FG001|Overall Study|Withdrawal by Subject|0|||
105343315|NCT04326439|363258304|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
105556010|NCT02363946|364031918|FG007|Overall Study|Lost to Follow-up|1|||
105676463|NCT04410523|364479348|FG003|Overall Study|Adverse Event|0|||
105676464|NCT04410523|364479349|FG004|Overall Study|Adverse Event|0|||
105676465|NCT04410523|364479350|FG005|Overall Study|Adverse Event|2|||
105676466|NCT04410523|364479345|FG000|Overall Study|Lost to Follow-up|0|||
105676467|NCT04410523|364479346|FG001|Overall Study|Lost to Follow-up|1|||
105676468|NCT04410523|364479347|FG002|Overall Study|Lost to Follow-up|0|||
105676469|NCT04410523|364479348|FG003|Overall Study|Lost to Follow-up|0|||
105676470|NCT04410523|364479349|FG004|Overall Study|Lost to Follow-up|0|||
105676471|NCT04410523|364479350|FG005|Overall Study|Lost to Follow-up|0|||
105676472|NCT04410523|364479345|FG000|Overall Study|Physician Decision|0|||
105676473|NCT04410523|364479346|FG001|Overall Study|Physician Decision|1|||
105676474|NCT04410523|364479347|FG002|Overall Study|Physician Decision|0|||
105676475|NCT04410523|364479348|FG003|Overall Study|Physician Decision|0|||
105676476|NCT04410523|364479349|FG004|Overall Study|Physician Decision|0|||
105676477|NCT04410523|364479350|FG005|Overall Study|Physician Decision|0|||
105676478|NCT04410523|364479345|FG000|Overall Study|Pregnancy|0|||
105676479|NCT04410523|364479346|FG001|Overall Study|Pregnancy|0|||
105676480|NCT04410523|364479347|FG002|Overall Study|Pregnancy|0|||
105676481|NCT04410523|364479348|FG003|Overall Study|Pregnancy|0|||
105676482|NCT04410523|364479349|FG004|Overall Study|Pregnancy|0|||
105676483|NCT04410523|364479350|FG005|Overall Study|Pregnancy|1|||
105676484|NCT04410523|364479345|FG000|Overall Study|Protocol deviation|0|||
105676485|NCT04410523|364479346|FG001|Overall Study|Protocol deviation|0|||
105676486|NCT04410523|364479347|FG002|Overall Study|Protocol deviation|0|||
105676487|NCT04410523|364479348|FG003|Overall Study|Protocol deviation|0|||
105676488|NCT04410523|364479349|FG004|Overall Study|Protocol deviation|0|||
105676489|NCT04410523|364479350|FG005|Overall Study|Protocol deviation|2|||
105676490|NCT04410523|364479345|FG000|Overall Study|Subject decision|2|||
105676491|NCT04410523|364479346|FG001|Overall Study|Subject decision|0|||
105676492|NCT04410523|364479347|FG002|Overall Study|Subject decision|0|||
105676493|NCT04410523|364479348|FG003|Overall Study|Subject decision|1|||
105676494|NCT04410523|364479349|FG004|Overall Study|Subject decision|0|||
105676495|NCT04410523|364479350|FG005|Overall Study|Subject decision|1|||
105676496|NCT00657020|364479351|FG000|PERIOD 1|Adverse Event|0|||
105676497|NCT00657020|364479352|FG001|PERIOD 1|Adverse Event|1|||
105676498|NCT00473265|364479353|FG000|Overall Study|Unrelated adverse event|5|||
105676499|NCT00473265|364479353|FG000|Overall Study|Off treatment early|15|||
105676500|NCT02663518|364479358|FG000|Part 1: Phase 1a Escalation|Death|0|||
105676501|NCT02663518|364479359|FG001|Part 1: Phase 1a Escalation|Death|0|||
105676502|NCT02663518|364479360|FG002|Part 1: Phase 1a Escalation|Death|1|||
105676503|NCT02663518|364479361|FG003|Part 1: Phase 1a Escalation|Death|0|||
105676504|NCT02663518|364479362|FG004|Part 1: Phase 1a Escalation|Death|0|||
105676505|NCT02663518|364479363|FG005|Part 1: Phase 1a Escalation|Death|0|||
105676506|NCT02663518|364479364|FG006|Part 1: Phase 1a Escalation|Death|0|||
105676507|NCT02663518|364479365|FG007|Part 1: Phase 1a Escalation|Death|0|||
105676508|NCT02663518|364479366|FG008|Part 1: Phase 1a Escalation|Death|0|||
105676509|NCT02663518|364479367|FG009|Part 1: Phase 1a Escalation|Death|0|||
105676510|NCT02663518|364479368|FG010|Part 1: Phase 1a Escalation|Death|0|||
105676511|NCT02663518|364479369|FG011|Part 1: Phase 1a Escalation|Death|0|||
105676512|NCT02663518|364479370|FG012|Part 1: Phase 1a Escalation|Death|0|||
105676513|NCT02663518|364479371|FG013|Part 1: Phase 1a Escalation|Death|0|||
105676514|NCT02663518|364479358|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676515|NCT02663518|364479359|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676516|NCT02663518|364479360|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
105676517|NCT02663518|364479361|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676518|NCT02663518|364479362|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676519|NCT02663518|364479363|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676520|NCT02663518|364479364|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676521|NCT02663518|364479365|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676522|NCT02663518|364479366|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676523|NCT02663518|364479367|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676524|NCT02663518|364479368|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676525|NCT02663518|364479369|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676526|NCT02663518|364479370|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676527|NCT02663518|364479371|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676528|NCT02663518|364479358|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
105676529|NCT02663518|364479359|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
105676530|NCT02663518|364479360|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
105676531|NCT02663518|364479361|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
105676532|NCT02663518|364479362|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105786425|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Progressive disease|0|||
105786426|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
105786427|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
105676533|NCT02663518|364479363|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105786428|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
105676534|NCT02663518|364479364|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676535|NCT02663518|364479365|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676536|NCT02663518|364479366|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676537|NCT02663518|364479367|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676538|NCT02663518|364479368|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676539|NCT02663518|364479369|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676540|NCT02663518|364479370|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676541|NCT02663518|364479371|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676542|NCT02663518|364479358|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
105676543|NCT02663518|364479359|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676544|NCT02663518|364479360|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
105676545|NCT02663518|364479361|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
105676546|NCT02663518|364479362|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676547|NCT02663518|364479363|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676548|NCT02663518|364479364|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676549|NCT02663518|364479365|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676550|NCT02663518|364479366|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676551|NCT02663518|364479367|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676552|NCT02663518|364479368|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676553|NCT02663518|364479369|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676554|NCT02663518|364479370|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676555|NCT02663518|364479371|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676556|NCT02663518|364479358|FG000|Part 1: Phase 1a Escalation|Other|0|||
105676557|NCT02663518|364479359|FG001|Part 1: Phase 1a Escalation|Other|0|||
105676558|NCT02663518|364479360|FG002|Part 1: Phase 1a Escalation|Other|2|||
105676559|NCT02663518|364479361|FG003|Part 1: Phase 1a Escalation|Other|0|||
105676560|NCT02663518|364479362|FG004|Part 1: Phase 1a Escalation|Other|0|||
105676561|NCT02663518|364479363|FG005|Part 1: Phase 1a Escalation|Other|0|||
105676562|NCT02663518|364479364|FG006|Part 1: Phase 1a Escalation|Other|0|||
105676563|NCT02663518|364479365|FG007|Part 1: Phase 1a Escalation|Other|0|||
105676564|NCT02663518|364479366|FG008|Part 1: Phase 1a Escalation|Other|0|||
105676565|NCT02663518|364479367|FG009|Part 1: Phase 1a Escalation|Other|0|||
105676566|NCT02663518|364479368|FG010|Part 1: Phase 1a Escalation|Other|0|||
105676567|NCT02663518|364479369|FG011|Part 1: Phase 1a Escalation|Other|0|||
105676568|NCT02663518|364479370|FG012|Part 1: Phase 1a Escalation|Other|0|||
105676569|NCT02663518|364479371|FG013|Part 1: Phase 1a Escalation|Other|0|||
105676570|NCT02663518|364479358|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676571|NCT02663518|364479359|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676572|NCT02663518|364479360|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676573|NCT02663518|364479361|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676574|NCT02663518|364479362|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
105676575|NCT02663518|364479363|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676576|NCT02663518|364479364|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
105676577|NCT02663518|364479365|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
105676578|NCT02663518|364479366|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676579|NCT02663518|364479367|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676580|NCT02663518|364479368|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676581|NCT02663518|364479369|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676582|NCT02663518|364479370|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676583|NCT02663518|364479371|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676584|NCT02663518|364479358|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676585|NCT02663518|364479359|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676586|NCT02663518|364479360|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676587|NCT02663518|364479361|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676588|NCT02663518|364479362|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
105676589|NCT02663518|364479363|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676590|NCT02663518|364479364|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
105676591|NCT02663518|364479365|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
105676592|NCT02663518|364479366|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676593|NCT02663518|364479367|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676594|NCT02663518|364479368|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676595|NCT02663518|364479369|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676596|NCT02663518|364479370|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676597|NCT02663518|364479371|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676598|NCT02663518|364479358|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676599|NCT02663518|364479359|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676600|NCT02663518|364479360|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676601|NCT02663518|364479361|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676602|NCT02663518|364479362|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
105676603|NCT02663518|364479363|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676604|NCT02663518|364479364|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676605|NCT02663518|364479365|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676606|NCT02663518|364479366|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676607|NCT02663518|364479367|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676608|NCT02663518|364479368|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676609|NCT02663518|364479369|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676610|NCT02663518|364479370|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676611|NCT02663518|364479371|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676612|NCT02663518|364479358|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676613|NCT02663518|364479359|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676614|NCT02663518|364479360|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676615|NCT02663518|364479361|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676616|NCT02663518|364479362|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
105676617|NCT02663518|364479363|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
105676618|NCT02663518|364479364|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
105676619|NCT02663518|364479365|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
105676620|NCT02663518|364479366|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676621|NCT02663518|364479367|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676622|NCT02663518|364479368|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676623|NCT02663518|364479369|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676624|NCT02663518|364479370|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676625|NCT02663518|364479371|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676626|NCT02663518|364479358|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676627|NCT02663518|364479359|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676628|NCT02663518|364479360|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676629|NCT02663518|364479361|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676630|NCT02663518|364479362|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
105676631|NCT02663518|364479363|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676632|NCT02663518|364479364|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
105676633|NCT02663518|364479365|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676634|NCT02663518|364479366|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676635|NCT02663518|364479367|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676636|NCT02663518|364479368|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676637|NCT02663518|364479369|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676638|NCT02663518|364479370|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676639|NCT02663518|364479371|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676640|NCT02663518|364479358|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676641|NCT02663518|364479359|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676642|NCT02663518|364479360|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676643|NCT02663518|364479361|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676644|NCT02663518|364479362|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676645|NCT02663518|364479363|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676646|NCT02663518|364479364|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
105676647|NCT02663518|364479365|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676648|NCT02663518|364479366|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676649|NCT02663518|364479367|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676650|NCT02663518|364479368|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676651|NCT02663518|364479369|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105556011|NCT02363946|364031919|FG008|Overall Study|Lost to Follow-up|0|||
105676652|NCT02663518|364479370|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676653|NCT02663518|364479371|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676654|NCT02663518|364479358|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
105676655|NCT02663518|364479359|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
105556012|NCT02363946|364031920|FG009|Overall Study|Lost to Follow-up|0|||
105676656|NCT02663518|364479360|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
105676657|NCT02663518|364479361|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
105676658|NCT02663518|364479362|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
105676659|NCT02663518|364479363|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
105676660|NCT02663518|364479364|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
105676661|NCT02663518|364479365|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
105676662|NCT02663518|364479366|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
105676663|NCT02663518|364479367|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
105676664|NCT02663518|364479368|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
105556013|NCT02363946|364031921|FG010|Overall Study|Lost to Follow-up|0|||
105556014|NCT02363946|364031922|FG011|Overall Study|Lost to Follow-up|0|||
105556015|NCT02363946|364031923|FG012|Overall Study|Lost to Follow-up|0|||
105556016|NCT01302119|364031934|FG000|Overall Study|Withdrawal by Subject|30|||
105556017|NCT01302119|364031935|FG001|Overall Study|Withdrawal by Subject|20|||
105556018|NCT01302119|364031934|FG000|Overall Study|Lost to Follow-up|10|||
105556019|NCT01302119|364031935|FG001|Overall Study|Lost to Follow-up|4|||
105556020|NCT01302119|364031934|FG000|Overall Study|Adverse Event|2|||
105556021|NCT01302119|364031935|FG001|Overall Study|Adverse Event|1|||
105556022|NCT01302119|364031934|FG000|Overall Study|Non-compliance|4|||
105556023|NCT01302119|364031935|FG001|Overall Study|Non-compliance|2|||
105556024|NCT01302119|364031934|FG000|Overall Study|Non-specific|4|||
105556025|NCT01302119|364031935|FG001|Overall Study|Non-specific|1|||
105556026|NCT00622167|364031936|FG000|Overall Study|Did not meet angiographic criteria|20|||
105556027|NCT00490646|364031942|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
105556028|NCT00490646|364031943|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
105556029|NCT00490646|364031942|FG000|Overall Study|Never Treated (had an adverse event)|1|||
105556030|NCT00490646|364031943|FG001|Overall Study|Never Treated (had an adverse event)|0|||
105556031|NCT00490646|364031942|FG000|Overall Study|Never Treated (withdrew consent)|0|||
105556032|NCT00490646|364031943|FG001|Overall Study|Never Treated (withdrew consent)|1|||
105556033|NCT02012491|364031944|FG000|Overall Study|Lost to Follow-up|1|||
105556034|NCT02012491|364031945|FG001|Overall Study|Lost to Follow-up|0|||
105556035|NCT02012491|364031944|FG000|Overall Study|Protocol Violation|0|||
105556036|NCT02012491|364031945|FG001|Overall Study|Protocol Violation|1|||
105556037|NCT02012491|364031944|FG000|Overall Study|Withdrawal by Subject|1|||
105556038|NCT02012491|364031945|FG001|Overall Study|Withdrawal by Subject|0|||
105556039|NCT01178086|364031946|FG000|Overall Study|Participant refusal|7|||
105556040|NCT01178086|364031946|FG000|Overall Study|Physician Decision|44|||
105556041|NCT01178086|364031946|FG000|Overall Study|Switch to other CLL therapy|113|||
105556042|NCT01178086|364031946|FG000|Overall Study|Death|59|||
105556043|NCT01178086|364031946|FG000|Overall Study|Other unspecified|89|||
105556044|NCT01178086|364031946|FG000|Overall Study|Excluded from EAS|20|||
105556045|NCT02137369|364031947|FG000|Overall Study|Withdrawal by Subject|3|||
105556046|NCT02137369|364031948|FG001|Overall Study|Withdrawal by Subject|2|||
105556047|NCT02137369|364031947|FG000|Overall Study|Adverse Event|2|||
105556048|NCT02137369|364031948|FG001|Overall Study|Adverse Event|0|||
105556049|NCT02137369|364031947|FG000|Overall Study|Lost to Follow-up|1|||
105556050|NCT02137369|364031948|FG001|Overall Study|Lost to Follow-up|0|||
105556051|NCT02137369|364031947|FG000|Overall Study|Moved away|2|||
105556052|NCT02137369|364031948|FG001|Overall Study|Moved away|0|||
105556053|NCT05608629|364031949|FG000|Overall Study|Lost to Follow-up|2|||
105556054|NCT01453595|364031950|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
105556055|NCT01453595|364031951|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
105556056|NCT01453595|364031952|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
105556057|NCT00234065|364031953|FG000|Overall Study|Adverse Event|268|||
105556058|NCT00234065|364031954|FG001|Overall Study|Adverse Event|166|||
105556059|NCT00234065|364031953|FG000|Overall Study|Withdrawal by Subject|73|||
105556060|NCT00234065|364031954|FG001|Overall Study|Withdrawal by Subject|56|||
105556061|NCT00234065|364031953|FG000|Overall Study|Physician Decision|23|||
105556062|NCT00234065|364031954|FG001|Overall Study|Physician Decision|22|||
105556063|NCT00234065|364031953|FG000|Overall Study|Not Classified|111|||
105556064|NCT00234065|364031954|FG001|Overall Study|Not Classified|112|||
105556065|NCT02313428|364031955|FG000|Overall Study|Lost to Follow-up|1|||
105556066|NCT02313428|364031956|FG001|Overall Study|Lost to Follow-up|1|||
105556067|NCT05374421|364031957|FG000|Overall Study|Withdrawal by Subject|3|||
105556068|NCT05374421|364031958|FG001|Overall Study|Withdrawal by Subject|4|||
105556069|NCT00936390|364031961|FG000|Overall Study|Protocol Violation|21|||
105556070|NCT00936390|364031962|FG001|Overall Study|Protocol Violation|25|||
105556071|NCT01738984|364033645|FG000|Overall Study|Pregnancy|4|||
105556072|NCT01738984|364033646|FG001|Overall Study|Pregnancy|0|||
105676665|NCT02663518|364479369|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
105676666|NCT02663518|364479370|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
105676667|NCT02663518|364479371|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
105676668|NCT02663518|364479358|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676669|NCT02663518|364479359|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676670|NCT02663518|364479360|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676671|NCT02663518|364479361|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676672|NCT02663518|364479362|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676673|NCT02663518|364479363|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676674|NCT02663518|364479364|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676675|NCT02663518|364479365|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676676|NCT02663518|364479366|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676677|NCT02663518|364479367|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676678|NCT02663518|364479368|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676679|NCT02663518|364479369|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676680|NCT02663518|364479370|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
105676681|NCT02663518|364479371|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676682|NCT02663518|364479358|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676683|NCT02663518|364479359|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676684|NCT02663518|364479360|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676685|NCT02663518|364479361|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676686|NCT02663518|364479362|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676687|NCT02663518|364479363|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676688|NCT02663518|364479364|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676689|NCT02663518|364479365|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676690|NCT02663518|364479366|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676691|NCT02663518|364479367|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676692|NCT02663518|364479368|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676693|NCT02663518|364479369|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
105676694|NCT02663518|364479370|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676695|NCT02663518|364479371|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676696|NCT02663518|364479358|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676697|NCT02663518|364479359|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676698|NCT02663518|364479360|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676699|NCT02663518|364479361|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676700|NCT02663518|364479362|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676701|NCT02663518|364479363|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676702|NCT02663518|364479364|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676703|NCT02663518|364479365|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676704|NCT02663518|364479366|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676705|NCT02663518|364479367|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
105676706|NCT02663518|364479368|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676707|NCT02663518|364479369|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
105676708|NCT02663518|364479370|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
105676709|NCT02663518|364479371|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
105676710|NCT02663518|364479358|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
105676711|NCT02663518|364479359|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
105676712|NCT02663518|364479360|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
105676713|NCT02663518|364479361|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
105676714|NCT02663518|364479362|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
105676715|NCT02663518|364479363|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
105676716|NCT02663518|364479364|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
105676717|NCT02663518|364479365|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
105676718|NCT02663518|364479366|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
105676719|NCT02663518|364479367|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
105676720|NCT02663518|364479368|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
105676721|NCT02663518|364479369|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
105676722|NCT02663518|364479370|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
105676723|NCT02663518|364479371|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
105676724|NCT02663518|364479358|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676725|NCT02663518|364479359|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676726|NCT02663518|364479360|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676727|NCT02663518|364479361|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676728|NCT02663518|364479362|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676729|NCT02663518|364479363|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676730|NCT02663518|364479364|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676731|NCT02663518|364479365|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676732|NCT02663518|364479366|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676733|NCT02663518|364479367|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676734|NCT02663518|364479368|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676735|NCT02663518|364479369|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676736|NCT02663518|364479370|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
105676737|NCT02663518|364479371|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676738|NCT01004848|364479377|FG000|Overall Study|Lost to Follow-up|55|||
105676739|NCT01004848|364479378|FG001|Overall Study|Lost to Follow-up|45|||
105676740|NCT00774930|364479379|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
105676741|NCT00774930|364479380|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
105676742|NCT00774930|364479379|FG000|DB Phase|Adverse Event|1|||
105676743|NCT00774930|364479380|FG001|DB Phase|Adverse Event|2|||
105676744|NCT00774930|364479379|FG000|DB Phase|Subject Decision|1|||
105676745|NCT00774930|364479380|FG001|DB Phase|Subject Decision|5|||
105676746|NCT00774930|364479379|FG000|DB Phase|Sponsor Decision|0|||
105676747|NCT00774930|364479380|FG001|DB Phase|Sponsor Decision|1|||
105676748|NCT00774930|364479379|FG000|DB Phase|Disease Progression|1|||
105676749|NCT00774930|364479380|FG001|DB Phase|Disease Progression|1|||
105676750|NCT00774930|364479379|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
105676751|NCT00774930|364479380|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
105676752|NCT00774930|364479379|FG000|IOL Phase|Adverse Event|1|||
105676753|NCT00774930|364479380|FG001|IOL Phase|Adverse Event|1|||
105676754|NCT00774930|364479379|FG000|IOL Phase|Subject Decision|4|||
105676755|NCT00774930|364479380|FG001|IOL Phase|Subject Decision|3|||
105676756|NCT00774930|364479379|FG000|IOL Phase|Physician Decision|3|||
105676757|NCT00774930|364479380|FG001|IOL Phase|Physician Decision|2|||
105676758|NCT00774930|364479379|FG000|IOL Phase|Sponsor Decision|1|||
105676759|NCT00774930|364479380|FG001|IOL Phase|Sponsor Decision|0|||
105676760|NCT00774930|364479379|FG000|IOL Phase|Disease Progression|2|||
105676761|NCT00774930|364479380|FG001|IOL Phase|Disease Progression|1|||
105676762|NCT00774930|364479379|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
105676763|NCT00774930|364479380|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
105676764|NCT00774930|364479379|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
105676765|NCT00774930|364479380|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
105676766|NCT00774930|364479379|FG000|IOL Phase|Other|1|||
105676767|NCT00774930|364479380|FG001|IOL Phase|Other|0|||
105676768|NCT00774930|364479379|FG000|IOL Phase|Brain radiation|0|||
105676769|NCT00774930|364479380|FG001|IOL Phase|Brain radiation|1|||
105676770|NCT00774930|364479379|FG000|LTOLE Phase|Adverse Event|7|||
105676771|NCT00774930|364479380|FG001|LTOLE Phase|Adverse Event|3|||
105676772|NCT00774930|364479379|FG000|LTOLE Phase|Subject decision|0|||
105676773|NCT00774930|364479380|FG001|LTOLE Phase|Subject decision|5|||
105676774|NCT00774930|364479379|FG000|LTOLE Phase|Physician Decision|4|||
105676775|NCT00774930|364479380|FG001|LTOLE Phase|Physician Decision|1|||
105676776|NCT00774930|364479379|FG000|LTOLE Phase|Sponsor decision|2|||
105676777|NCT00774930|364479380|FG001|LTOLE Phase|Sponsor decision|1|||
105676778|NCT00774930|364479379|FG000|LTOLE Phase|Disease Progression|2|||
105676779|NCT00774930|364479380|FG001|LTOLE Phase|Disease Progression|5|||
105676780|NCT00774930|364479379|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
105676781|NCT00774930|364479380|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
105676782|NCT00774930|364479379|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
105676783|NCT00774930|364479380|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
105676784|NCT00766363|364479381|FG000|Overall Study|Withdrawal by Subject|1|||
105676785|NCT00766363|364479382|FG001|Overall Study|Withdrawal by Subject|0|||
105676786|NCT00766363|364479383|FG002|Overall Study|Withdrawal by Subject|0|||
105676787|NCT00766363|364479384|FG003|Overall Study|Withdrawal by Subject|0|||
105676788|NCT00766363|364479381|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
105466627|NCT01217229|363720194|FG000|Overall Study|Protocol Violation|1|||
105466628|NCT01217229|363720194|FG000|Overall Study|Disease progression not confirmed|2|||
105570282|NCT01806584|364086736|FG000|Overall Study|Lost to Follow-up|0|||
105556073|NCT01738984|364033645|FG000|Overall Study|Withdrawal by Subject|1|||
105556074|NCT01738984|364033646|FG001|Overall Study|Withdrawal by Subject|0|||
105556075|NCT01738984|364033645|FG000|Overall Study|Lost to Follow-up|59|||
105556076|NCT01738984|364033646|FG001|Overall Study|Lost to Follow-up|39|||
105556077|NCT03162224|364033656|FG000|Overall Study|Death|4|||
105556078|NCT03162224|364033657|FG001|Overall Study|Death|5|||
105676789|NCT00766363|364479382|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
105676790|NCT00766363|364479383|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
105676791|NCT00766363|364479384|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
105676792|NCT01153321|364479385|FG000|Overall Study|Development of study withdrawal criteria|0|||
105676793|NCT01153321|364479386|FG001|Overall Study|Development of study withdrawal criteria|1|||
105676794|NCT01153321|364479385|FG000|Overall Study|Withdrawal by Subject|0|||
105676795|NCT01153321|364479386|FG001|Overall Study|Withdrawal by Subject|1|||
105676796|NCT01153321|364479385|FG000|Overall Study|Adverse Event|1|||
105676797|NCT01153321|364479386|FG001|Overall Study|Adverse Event|1|||
105676798|NCT03527550|364479387|FG000|Overall Study|Lost to Follow-up|4|||
105676799|NCT03527550|364479388|FG001|Overall Study|Lost to Follow-up|2|||
105676800|NCT03527550|364479387|FG000|Overall Study|Withdrawal by Subject|4|||
105676801|NCT03527550|364479388|FG001|Overall Study|Withdrawal by Subject|1|||
105676802|NCT03527550|364479387|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
105676803|NCT03527550|364479388|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
105676804|NCT03212989|364479389|FG000|Overall Study|Physician Decision|8|||
105676805|NCT00993668|364479390|FG000|Single-Blind Period|Adverse Event|1|||
105676806|NCT00993668|364479391|FG001|Single-Blind Period|Adverse Event|1|||
105676807|NCT00993668|364479390|FG000|Single-Blind Period|Lack of Efficacy|0|||
105676808|NCT00993668|364479391|FG001|Single-Blind Period|Lack of Efficacy|1|||
105676809|NCT00993668|364479390|FG000|Single-Blind Period|Lost to Follow-up|3|||
105676810|NCT00993668|364479391|FG001|Single-Blind Period|Lost to Follow-up|1|||
105676811|NCT00993668|364479390|FG000|Open-Label Period|Adverse Event|9|||
105676812|NCT00993668|364479391|FG001|Open-Label Period|Adverse Event|8|||
105676813|NCT00993668|364479390|FG000|Open-Label Period|Lack of Efficacy|4|||
105676814|NCT00993668|364479391|FG001|Open-Label Period|Lack of Efficacy|3|||
105676815|NCT00993668|364479390|FG000|Open-Label Period|Withdrawal by Subject|4|||
105676816|NCT00993668|364479391|FG001|Open-Label Period|Withdrawal by Subject|3|||
105676817|NCT00993668|364479390|FG000|Open-Label Period|Lost to Follow-up|6|||
105676818|NCT00993668|364479391|FG001|Open-Label Period|Lost to Follow-up|1|||
105676819|NCT01014143|364479400|FG000|Second Intervention|Lost to Follow-up|2|||
105676820|NCT01014143|364479401|FG001|Second Intervention|Lost to Follow-up|0|||
105676821|NCT01014143|364479402|FG002|Second Intervention|Lost to Follow-up|0|||
105676822|NCT00424385|364479405|FG000|Cohort 0|Withdrawal by Subject|5|||
105676823|NCT00424385|364479405|FG000|Cohort 0|Physician Decision|1|||
105676824|NCT00424385|364479405|FG000|Cohort 1|Withdrawal by Subject|1|||
105676825|NCT04638920|364479412|FG000|Overall Study|Withdrawal by Subject|5|||
105676826|NCT00141219|364479417|FG000|Overall Study|Protocol violations|5|||
105676827|NCT00141219|364479418|FG001|Overall Study|Protocol violations|4|||
105676828|NCT00141219|364479417|FG000|Overall Study|Adverse Event|8|||
105676829|NCT00141219|364479418|FG001|Overall Study|Adverse Event|6|||
105676830|NCT00141219|364479417|FG000|Overall Study|Lack of Efficacy|5|||
105676831|NCT00141219|364479418|FG001|Overall Study|Lack of Efficacy|4|||
105676832|NCT00141219|364479417|FG000|Overall Study|Withdrawal by Subject|6|||
105676833|NCT00141219|364479418|FG001|Overall Study|Withdrawal by Subject|2|||
105676834|NCT02224690|364479419|FG000|Overall Study|Adverse Event|8|||
105676835|NCT02224690|364479420|FG001|Overall Study|Adverse Event|1|||
105676836|NCT02224690|364479419|FG000|Overall Study|Met Withdrawal Criteria|4|||
105676837|NCT02224690|364479420|FG001|Overall Study|Met Withdrawal Criteria|0|||
105676838|NCT02224690|364479419|FG000|Overall Study|Use of G-tube|1|||
105676839|NCT02224690|364479420|FG001|Overall Study|Use of G-tube|0|||
105676840|NCT02224690|364479419|FG000|Overall Study|Did not meet eligibility criteria|1|||
105676841|NCT02224690|364479420|FG001|Overall Study|Did not meet eligibility criteria|0|||
105676842|NCT00122460|364479421|FG000|Overall Study|investigational study phase ongoing|7|||
105676843|NCT00122460|364479422|FG001|Overall Study|investigational study phase ongoing|1|||
105676844|NCT02595073|364479425|FG000|Overall Study|Progressive Disease|0|||
105676845|NCT02595073|364479426|FG001|Overall Study|Progressive Disease|1|||
105676846|NCT02595073|364479425|FG000|Overall Study|Protocol Violation|2|||
105466629|NCT01094119|363720211|FG000|Overall Study|Lack of Efficacy|2|||
105676847|NCT02595073|364479426|FG001|Overall Study|Protocol Violation|0|||
105676848|NCT02884908|364479427|FG000|Overall Study|Lost to Follow-up|13|||
105676849|NCT02884908|364479428|FG001|Overall Study|Lost to Follow-up|18|||
105676850|NCT01801735|364479432|FG000|Overall Study|Adverse Event|79|||
105676851|NCT01801735|364479432|FG000|Overall Study|Lack of Efficacy|28|||
105676852|NCT01801735|364479432|FG000|Overall Study|Withdrawal by Subject|27|||
105676853|NCT01801735|364479432|FG000|Overall Study|Protocol Violation|25|||
105676854|NCT01801735|364479432|FG000|Overall Study|Lost to Follow-up|15|||
105676855|NCT01801735|364479432|FG000|Overall Study|Non-compliance with Trial Drug|13|||
105676856|NCT01801735|364479432|FG000|Overall Study|Physician Decision|3|||
105676857|NCT01801735|364479432|FG000|Overall Study|Death|1|||
105676858|NCT01801735|364479432|FG000|Overall Study|Other, including site closure|19|||
105676859|NCT00560066|364479433|FG000|Overall Study|Death|2|||
105676860|NCT00560066|364479434|FG001|Overall Study|Death|1|||
105676861|NCT00560066|364479433|FG000|Overall Study|Withdrawal by Subject|0|||
105676862|NCT00560066|364479434|FG001|Overall Study|Withdrawal by Subject|3|||
105676863|NCT00560066|364479433|FG000|Overall Study|Lost to Follow-up|4|||
105676864|NCT00560066|364479434|FG001|Overall Study|Lost to Follow-up|10|||
105676865|NCT00560066|364479433|FG000|Overall Study|Protocol Violation|0|||
105676866|NCT00560066|364479434|FG001|Overall Study|Protocol Violation|1|||
105676867|NCT00560066|364479433|FG000|Overall Study|Administrative reason|0|||
105676868|NCT00560066|364479434|FG001|Overall Study|Administrative reason|5|||
105676869|NCT00560066|364479433|FG000|Overall Study|Missing primary reason|0|||
105676870|NCT00560066|364479434|FG001|Overall Study|Missing primary reason|2|||
105676871|NCT01605019|364479435|FG000|Overall Study|pt did not meet transplant endpoint|3|||
105676872|NCT01605019|364479436|FG001|Overall Study|pt did not meet transplant endpoint|0|||
105676873|NCT04860297|364479437|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
105676874|NCT04860297|364479438|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
105676875|NCT04860297|364479439|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
105676876|NCT04860297|364479440|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
105676877|NCT04860297|364479441|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
105676878|NCT04860297|364479442|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
105676879|NCT04860297|364479443|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
105676880|NCT04860297|364479444|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
105676881|NCT04860297|364479437|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
105676882|NCT04860297|364479438|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
105676883|NCT04860297|364479439|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
105676884|NCT04860297|364479440|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
105676885|NCT04860297|364479441|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
105676886|NCT04860297|364479442|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
105676887|NCT04860297|364479443|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
105676888|NCT04860297|364479444|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
105676889|NCT04860297|364479437|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
105676890|NCT04860297|364479438|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
105676891|NCT04860297|364479439|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
105676892|NCT04860297|364479440|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
105343316|NCT04326439|363258305|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
105676893|NCT04860297|364479441|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
105676894|NCT04860297|364479442|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
105676895|NCT04860297|364479443|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
105676896|NCT04860297|364479444|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
105676897|NCT04860297|364479437|FG000|Part B (Booster Dose)|Other Than Specified|0|||
105676898|NCT04860297|364479438|FG001|Part B (Booster Dose)|Other Than Specified|0|||
105676899|NCT04860297|364479439|FG002|Part B (Booster Dose)|Other Than Specified|0|||
105676900|NCT04860297|364479440|FG003|Part B (Booster Dose)|Other Than Specified|0|||
105676901|NCT04860297|364479441|FG004|Part B (Booster Dose)|Other Than Specified|0|||
105676902|NCT04860297|364479442|FG005|Part B (Booster Dose)|Other Than Specified|1|||
105676903|NCT04860297|364479443|FG006|Part B (Booster Dose)|Other Than Specified|1|||
105676904|NCT04860297|364479444|FG007|Part B (Booster Dose)|Other Than Specified|0|||
105676905|NCT04860297|364479437|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
105676906|NCT04860297|364479438|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
105676907|NCT04860297|364479439|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
105676908|NCT04860297|364479440|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
105676909|NCT04860297|364479441|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
105676910|NCT04860297|364479442|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
105676911|NCT04860297|364479443|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
105676912|NCT04860297|364479444|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
105676913|NCT04860297|364479437|FG000|Part B (Booster Dose)|Death|0|||
105676914|NCT04860297|364479438|FG001|Part B (Booster Dose)|Death|0|||
105676915|NCT04860297|364479439|FG002|Part B (Booster Dose)|Death|0|||
105676916|NCT04860297|364479440|FG003|Part B (Booster Dose)|Death|0|||
105676917|NCT04860297|364479441|FG004|Part B (Booster Dose)|Death|1|||
105676918|NCT04860297|364479442|FG005|Part B (Booster Dose)|Death|2|||
105676919|NCT04860297|364479443|FG006|Part B (Booster Dose)|Death|1|||
105676920|NCT04860297|364479444|FG007|Part B (Booster Dose)|Death|0|||
105676921|NCT04860297|364479437|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
105676922|NCT04860297|364479438|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
105676923|NCT04860297|364479439|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
105676924|NCT04860297|364479440|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
105676925|NCT04860297|364479441|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
105676926|NCT04860297|364479442|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
105676927|NCT04860297|364479443|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
105676928|NCT04860297|364479444|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
105676929|NCT04811131|364479445|FG000|Overall Study|Adverse Event|0|||
105676930|NCT04811131|364479446|FG001|Overall Study|Adverse Event|0|||
105676931|NCT04811131|364479447|FG002|Overall Study|Adverse Event|1|||
105676932|NCT04811131|364479448|FG003|Overall Study|Adverse Event|0|||
105676933|NCT04811131|364479445|FG000|Overall Study|Lack of Efficacy|0|||
105676934|NCT04811131|364479446|FG001|Overall Study|Lack of Efficacy|0|||
105676935|NCT04811131|364479447|FG002|Overall Study|Lack of Efficacy|0|||
105676936|NCT04811131|364479448|FG003|Overall Study|Lack of Efficacy|1|||
105676937|NCT04811131|364479445|FG000|Overall Study|Lost to Follow-up|0|||
105676938|NCT04811131|364479446|FG001|Overall Study|Lost to Follow-up|1|||
105676939|NCT04811131|364479447|FG002|Overall Study|Lost to Follow-up|0|||
105676940|NCT04811131|364479448|FG003|Overall Study|Lost to Follow-up|0|||
105676941|NCT04811131|364479445|FG000|Overall Study|Sponsor request|31|||
105676942|NCT04811131|364479446|FG001|Overall Study|Sponsor request|35|||
105676943|NCT04811131|364479447|FG002|Overall Study|Sponsor request|27|||
105676944|NCT04811131|364479448|FG003|Overall Study|Sponsor request|10|||
105676945|NCT04811131|364479445|FG000|Overall Study|Withdrawal by Subject|3|||
105676946|NCT04811131|364479446|FG001|Overall Study|Withdrawal by Subject|1|||
105676947|NCT04811131|364479447|FG002|Overall Study|Withdrawal by Subject|3|||
105676948|NCT04811131|364479448|FG003|Overall Study|Withdrawal by Subject|1|||
105676949|NCT00798590|364479449|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
105676950|NCT00798590|364479450|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
105676951|NCT03223662|364479453|FG000|Overall Study|Physician Decision|1|||
105676952|NCT03223662|364479453|FG000|Overall Study|Study closure|1|||
105676953|NCT01258595|364479454|FG000|Overall Study|Lost to Follow-up|1|||
105676954|NCT01258595|364479455|FG001|Overall Study|Lost to Follow-up|0|||
105676955|NCT01258595|364479454|FG000|Overall Study|Withdrawal by Subject|0|||
105676956|NCT01258595|364479455|FG001|Overall Study|Withdrawal by Subject|1|||
105676957|NCT01528345|364479456|FG000|Overall Study|Adverse Event|10|||
105676958|NCT01528345|364479457|FG001|Overall Study|Adverse Event|1|||
105676959|NCT01528345|364479456|FG000|Overall Study|Death|1|||
105676960|NCT01528345|364479457|FG001|Overall Study|Death|1|||
105676961|NCT01528345|364479456|FG000|Overall Study|Non-compliance with study treatment|1|||
105676962|NCT01528345|364479457|FG001|Overall Study|Non-compliance with study treatment|0|||
105676963|NCT01528345|364479456|FG000|Overall Study|Progressive Disease|26|||
105676964|NCT01528345|364479457|FG001|Overall Study|Progressive Disease|40|||
105676965|NCT01528345|364479456|FG000|Overall Study|Study Terminated by Sponsor|4|||
105676966|NCT01528345|364479457|FG001|Overall Study|Study Terminated by Sponsor|8|||
105676967|NCT01528345|364479456|FG000|Overall Study|Subject/Guardian Decision|5|||
105676968|NCT01528345|364479457|FG001|Overall Study|Subject/Guardian Decision|0|||
105676969|NCT00371683|364479458|FG000|DB Treatment Period-Randomized Patients|Death|1|||
105676970|NCT00371683|364479459|FG001|DB Treatment Period-Randomized Patients|Death|1|||
105676971|NCT00371683|364479458|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
105676972|NCT00371683|364479459|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
105676973|NCT00371683|364479458|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
105676974|NCT00371683|364479459|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
105676975|NCT00371683|364479458|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
105676976|NCT00371683|364479459|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
105676977|NCT00371683|364479458|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
105676978|NCT00371683|364479459|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
105676979|NCT00371683|364479458|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
105676980|NCT00371683|364479459|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
105676981|NCT00371683|364479458|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
105676982|NCT00371683|364479459|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
105676983|NCT00371683|364479458|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
105676984|NCT00371683|364479459|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
105676985|NCT00371683|364479458|FG000|Follow-Up Period - Randomized Patients|Death|0|||
105676986|NCT00371683|364479459|FG001|Follow-Up Period - Randomized Patients|Death|2|||
105676987|NCT00371683|364479458|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
105676988|NCT00371683|364479459|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
105676989|NCT00371683|364479458|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
105676990|NCT00371683|364479459|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
105676991|NCT02971761|364479460|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
105676992|NCT03181789|364479461|FG000|Overall Study|Withdrawal by Subject|0|||
105676993|NCT03181789|364479462|FG001|Overall Study|Withdrawal by Subject|1|||
105676994|NCT03181789|364479463|FG002|Overall Study|Withdrawal by Subject|1|||
105676995|NCT03181789|364479464|FG003|Overall Study|Withdrawal by Subject|0|||
105676996|NCT03181789|364479461|FG000|Overall Study|Lost to Follow-up|7|||
105676997|NCT03181789|364479462|FG001|Overall Study|Lost to Follow-up|1|||
105676998|NCT03181789|364479463|FG002|Overall Study|Lost to Follow-up|0|||
105676999|NCT03181789|364479464|FG003|Overall Study|Lost to Follow-up|0|||
105677000|NCT03181789|364479461|FG000|Overall Study|Participant unable to adhere to visit|0|||
105786429|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
105677001|NCT03181789|364479462|FG001|Overall Study|Participant unable to adhere to visit|1|||
105677002|NCT03181789|364479463|FG002|Overall Study|Participant unable to adhere to visit|0|||
105677003|NCT03181789|364479464|FG003|Overall Study|Participant unable to adhere to visit|0|||
105677004|NCT00735475|364479465|FG000|Overall Study|Adverse Event|0|||
105677005|NCT00735475|364479466|FG001|Overall Study|Adverse Event|1|||
105677006|NCT00735475|364479465|FG000|Overall Study|Death|1|||
105677007|NCT00735475|364479466|FG001|Overall Study|Death|1|||
105677008|NCT00735475|364479465|FG000|Overall Study|Lost to Follow-up|3|||
105677009|NCT00735475|364479466|FG001|Overall Study|Lost to Follow-up|3|||
105786430|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
105677010|NCT00735475|364479465|FG000|Overall Study|Physician Decision|0|||
105677011|NCT00735475|364479466|FG001|Overall Study|Physician Decision|1|||
105786431|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
105466630|NCT01094119|363720212|FG001|Overall Study|Lack of Efficacy|4|||
105466631|NCT01523756|363720213|FG000|Baseline Period|Adverse Event|0|||
105556079|NCT03162224|364033658|FG002|Overall Study|Death|8|||
105556080|NCT03162224|364033656|FG000|Overall Study|Withdrawal by Subject|1|||
105343317|NCT04326439|363258304|FG000|Overall Study|Relapse after Induction 2|0|||
105343318|NCT04326439|363258305|FG001|Overall Study|Relapse after Induction 2|1|||
105343319|NCT04326439|363258304|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
105343320|NCT04326439|363258305|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
105343321|NCT01793688|363258317|FG000|Overall Study|Protocol Violation|2|||
105343322|NCT01966068|363258318|FG000|Overall Study|Withdrawal by Subject|57|||
105343323|NCT01966068|363258318|FG000|Overall Study|Lost to Follow-up|81|||
105343324|NCT00102531|363258319|FG000|Overall Study|Adverse Event|0|||
105343325|NCT00102531|363258320|FG001|Overall Study|Adverse Event|1|||
105343326|NCT00102531|363258319|FG000|Overall Study|Disease Progression|5|||
105343327|NCT00102531|363258320|FG001|Overall Study|Disease Progression|9|||
105343328|NCT00102531|363258319|FG000|Overall Study|Physician Decision|0|||
105343329|NCT00102531|363258320|FG001|Overall Study|Physician Decision|1|||
105556081|NCT03162224|364033657|FG001|Overall Study|Withdrawal by Subject|0|||
105556082|NCT03162224|364033658|FG002|Overall Study|Withdrawal by Subject|1|||
105556083|NCT03162224|364033656|FG000|Overall Study|Lost to Follow-up|0|||
105556084|NCT03162224|364033657|FG001|Overall Study|Lost to Follow-up|1|||
105556085|NCT03162224|364033658|FG002|Overall Study|Lost to Follow-up|0|||
105556086|NCT03162224|364033656|FG000|Overall Study|Other|6|||
105556087|NCT03162224|364033657|FG001|Overall Study|Other|2|||
105556088|NCT03162224|364033658|FG002|Overall Study|Other|1|||
105556089|NCT00713648|364033662|FG000|Overall Study|Adverse Event|1|||
105556090|NCT00713648|364033662|FG000|Overall Study|Unclassified|2|||
105556091|NCT00713648|364033662|FG000|Overall Study|According to Protocol|2|||
105556092|NCT00713648|364033662|FG000|Overall Study|Development of antibodies|3|||
105556093|NCT02047045|364033663|FG000|Baseline|Withdrawal by Subject|3|||
105556094|NCT02047045|364033664|FG001|Baseline|Withdrawal by Subject|2|||
105556095|NCT02047045|364033663|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
105556096|NCT02047045|364033664|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
105556097|NCT02047045|364033663|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
105556098|NCT02047045|364033664|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
105556099|NCT02047045|364033663|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
105556100|NCT02047045|364033664|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
105556101|NCT02047045|364033663|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
105556102|NCT02047045|364033664|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
105556103|NCT02047045|364033663|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
105556104|NCT02047045|364033664|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
105556105|NCT02047045|364033663|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
105556106|NCT02047045|364033664|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
105556107|NCT02047045|364033663|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
105556108|NCT02047045|364033664|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
105556109|NCT02047045|364033663|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
105556110|NCT02047045|364033664|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
105556111|NCT03214367|364033665|FG000|Lead-in Period|Withdrawal by Subject|50|||
105556112|NCT03214367|364033666|FG001|Lead-in Period|Withdrawal by Subject|0|||
105556113|NCT03214367|364033667|FG002|Lead-in Period|Withdrawal by Subject|0|||
105556114|NCT03214367|364033668|FG003|Lead-in Period|Withdrawal by Subject|0|||
105556115|NCT03214367|364033669|FG004|Lead-in Period|Withdrawal by Subject|2|||
105556116|NCT03214367|364033670|FG005|Lead-in Period|Withdrawal by Subject|0|||
105556117|NCT03214367|364033671|FG006|Lead-in Period|Withdrawal by Subject|0|||
105556118|NCT03214367|364033672|FG007|Lead-in Period|Withdrawal by Subject|0|||
105556119|NCT03214367|364033665|FG000|Lead-in Period|Adverse Event|3|||
105556120|NCT03214367|364033666|FG001|Lead-in Period|Adverse Event|0|||
105556121|NCT03214367|364033667|FG002|Lead-in Period|Adverse Event|0|||
105556122|NCT03214367|364033668|FG003|Lead-in Period|Adverse Event|0|||
105556123|NCT03214367|364033669|FG004|Lead-in Period|Adverse Event|0|||
105556124|NCT03214367|364033670|FG005|Lead-in Period|Adverse Event|0|||
105556125|NCT03214367|364033671|FG006|Lead-in Period|Adverse Event|0|||
105556126|NCT03214367|364033672|FG007|Lead-in Period|Adverse Event|0|||
105343330|NCT04756154|363258322|FG000|Overall Study|Did not meet treatment day baseline|30|||
105343331|NCT04756154|363258323|FG001|Overall Study|Did not meet treatment day baseline|28|||
105343332|NCT04756154|363258324|FG002|Overall Study|Did not meet treatment day baseline|7|||
105556127|NCT03214367|364033665|FG000|Lead-in Period|Lost to Follow-up|12|||
105556128|NCT03214367|364033666|FG001|Lead-in Period|Lost to Follow-up|0|||
105556129|NCT03214367|364033667|FG002|Lead-in Period|Lost to Follow-up|0|||
105556130|NCT03214367|364033668|FG003|Lead-in Period|Lost to Follow-up|0|||
105556131|NCT03214367|364033669|FG004|Lead-in Period|Lost to Follow-up|0|||
105556132|NCT03214367|364033670|FG005|Lead-in Period|Lost to Follow-up|0|||
105556133|NCT03214367|364033671|FG006|Lead-in Period|Lost to Follow-up|0|||
105677012|NCT00735475|364479465|FG000|Overall Study|Withdrawal by Subject|4|||
105343333|NCT04756154|363258322|FG000|Overall Study|Did not return for final sample collection|1|||
105556134|NCT03214367|364033672|FG007|Lead-in Period|Lost to Follow-up|0|||
105343334|NCT04756154|363258323|FG001|Overall Study|Did not return for final sample collection|1|||
105556135|NCT03214367|364033665|FG000|Lead-in Period|Sponsor Decision|11|||
105677013|NCT00735475|364479466|FG001|Overall Study|Withdrawal by Subject|5|||
105677014|NCT00548262|364479467|FG000|Overall Study|Death|21|||
105677015|NCT00548262|364479467|FG000|Overall Study|Adverse Event|2|||
105677016|NCT00548262|364479467|FG000|Overall Study|Lack of Efficacy|4|||
105677017|NCT00548262|364479467|FG000|Overall Study|Lost to Follow-up|1|||
105677018|NCT00548262|364479467|FG000|Overall Study|Other|3|||
105677019|NCT00548262|364479467|FG000|Overall Study|Withdrawal by Subject|1|||
105677020|NCT02285153|364479468|FG000|Overall Study|Adverse Event|1|||
105677021|NCT02285153|364479469|FG001|Overall Study|Adverse Event|0|||
105677022|NCT02442336|364479476|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
105677023|NCT02442336|364479476|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
105677024|NCT02442336|364479476|FG000|Overall Study|Lost to Follow-up|11|||
105677025|NCT00998790|364479477|FG000|Overall Study|Withdrawal by Subject|21|||
105677026|NCT04602221|364479479|FG000|Overall Study|Discontinuation of trial treatment|0|||
105677027|NCT04602221|364479480|FG001|Overall Study|Discontinuation of trial treatment|0|||
105677028|NCT04602221|364479481|FG002|Overall Study|Discontinuation of trial treatment|1|||
105677029|NCT04602221|364479482|FG003|Overall Study|Discontinuation of trial treatment|0|||
105677030|NCT04602221|364479483|FG004|Overall Study|Discontinuation of trial treatment|0|||
105677031|NCT04602221|364479484|FG005|Overall Study|Discontinuation of trial treatment|0|||
105677032|NCT04602221|364479485|FG006|Overall Study|Discontinuation of trial treatment|0|||
105677033|NCT04602221|364479486|FG007|Overall Study|Discontinuation of trial treatment|0|||
105677034|NCT04602221|364479487|FG008|Overall Study|Discontinuation of trial treatment|0|||
105677035|NCT04602221|364479488|FG009|Overall Study|Discontinuation of trial treatment|0|||
105677036|NCT04602221|364479489|FG010|Overall Study|Discontinuation of trial treatment|0|||
105677037|NCT04602221|364479490|FG011|Overall Study|Discontinuation of trial treatment|0|||
105677038|NCT04602221|364479491|FG012|Overall Study|Discontinuation of trial treatment|0|||
105677039|NCT04602221|364479492|FG013|Overall Study|Discontinuation of trial treatment|0|||
105677040|NCT04602221|364479493|FG014|Overall Study|Discontinuation of trial treatment|0|||
105677041|NCT04602221|364479494|FG015|Overall Study|Discontinuation of trial treatment|0|||
105677042|NCT04602221|364479495|FG016|Overall Study|Discontinuation of trial treatment|0|||
105677043|NCT04602221|364479496|FG017|Overall Study|Discontinuation of trial treatment|0|||
105677044|NCT04602221|364479479|FG000|Overall Study|Other than listed|0|||
105677045|NCT04602221|364479480|FG001|Overall Study|Other than listed|0|||
105677046|NCT04602221|364479481|FG002|Overall Study|Other than listed|0|||
105677047|NCT04602221|364479482|FG003|Overall Study|Other than listed|0|||
105677048|NCT04602221|364479483|FG004|Overall Study|Other than listed|0|||
105677049|NCT04602221|364479484|FG005|Overall Study|Other than listed|0|||
105677050|NCT04602221|364479485|FG006|Overall Study|Other than listed|0|||
105677051|NCT04602221|364479486|FG007|Overall Study|Other than listed|0|||
105677052|NCT04602221|364479487|FG008|Overall Study|Other than listed|0|||
105677053|NCT04602221|364479488|FG009|Overall Study|Other than listed|0|||
105677054|NCT04602221|364479489|FG010|Overall Study|Other than listed|0|||
105677055|NCT04602221|364479490|FG011|Overall Study|Other than listed|0|||
105677056|NCT04602221|364479491|FG012|Overall Study|Other than listed|0|||
105677057|NCT04602221|364479492|FG013|Overall Study|Other than listed|0|||
105677058|NCT04602221|364479493|FG014|Overall Study|Other than listed|0|||
105677059|NCT04602221|364479494|FG015|Overall Study|Other than listed|1|||
105677060|NCT04602221|364479495|FG016|Overall Study|Other than listed|0|||
105677061|NCT04602221|364479496|FG017|Overall Study|Other than listed|1|||
105677062|NCT04602221|364479479|FG000|Overall Study|Withdrawal by Subject|0|||
105677063|NCT04602221|364479480|FG001|Overall Study|Withdrawal by Subject|0|||
105677064|NCT04602221|364479481|FG002|Overall Study|Withdrawal by Subject|0|||
105677065|NCT04602221|364479482|FG003|Overall Study|Withdrawal by Subject|0|||
105677066|NCT04602221|364479483|FG004|Overall Study|Withdrawal by Subject|0|||
105677067|NCT04602221|364479484|FG005|Overall Study|Withdrawal by Subject|0|||
105677068|NCT04602221|364479485|FG006|Overall Study|Withdrawal by Subject|0|||
105677069|NCT04602221|364479486|FG007|Overall Study|Withdrawal by Subject|0|||
105677070|NCT04602221|364479487|FG008|Overall Study|Withdrawal by Subject|0|||
105677071|NCT04602221|364479488|FG009|Overall Study|Withdrawal by Subject|0|||
105677072|NCT04602221|364479489|FG010|Overall Study|Withdrawal by Subject|0|||
105677073|NCT04602221|364479490|FG011|Overall Study|Withdrawal by Subject|0|||
105677074|NCT04602221|364479491|FG012|Overall Study|Withdrawal by Subject|1|||
105677075|NCT04602221|364479492|FG013|Overall Study|Withdrawal by Subject|0|||
105556136|NCT03214367|364033666|FG001|Lead-in Period|Sponsor Decision|0|||
105556137|NCT03214367|364033667|FG002|Lead-in Period|Sponsor Decision|0|||
105556138|NCT03214367|364033668|FG003|Lead-in Period|Sponsor Decision|0|||
105556139|NCT03214367|364033669|FG004|Lead-in Period|Sponsor Decision|0|||
105556140|NCT03214367|364033670|FG005|Lead-in Period|Sponsor Decision|0|||
105556141|NCT03214367|364033671|FG006|Lead-in Period|Sponsor Decision|0|||
105556142|NCT03214367|364033672|FG007|Lead-in Period|Sponsor Decision|0|||
105556143|NCT03214367|364033665|FG000|Lead-in Period|Physician Decision|12|||
105556144|NCT03214367|364033666|FG001|Lead-in Period|Physician Decision|0|||
105556145|NCT03214367|364033667|FG002|Lead-in Period|Physician Decision|0|||
105556146|NCT03214367|364033668|FG003|Lead-in Period|Physician Decision|0|||
105556147|NCT03214367|364033669|FG004|Lead-in Period|Physician Decision|0|||
105556148|NCT03214367|364033670|FG005|Lead-in Period|Physician Decision|0|||
105556149|NCT03214367|364033671|FG006|Lead-in Period|Physician Decision|0|||
105556150|NCT03214367|364033672|FG007|Lead-in Period|Physician Decision|0|||
105556151|NCT03214367|364033665|FG000|Lead-in Period|Protocol Violation|5|||
105556152|NCT03214367|364033666|FG001|Lead-in Period|Protocol Violation|0|||
105556153|NCT03214367|364033667|FG002|Lead-in Period|Protocol Violation|0|||
105556154|NCT03214367|364033668|FG003|Lead-in Period|Protocol Violation|0|||
105556155|NCT03214367|364033669|FG004|Lead-in Period|Protocol Violation|0|||
105556156|NCT03214367|364033670|FG005|Lead-in Period|Protocol Violation|0|||
105556157|NCT03214367|364033671|FG006|Lead-in Period|Protocol Violation|0|||
105556158|NCT03214367|364033672|FG007|Lead-in Period|Protocol Violation|0|||
105556159|NCT03214367|364033665|FG000|Lead-in Period|Treatment Interruption|1|||
105556160|NCT03214367|364033666|FG001|Lead-in Period|Treatment Interruption|0|||
105556161|NCT03214367|364033667|FG002|Lead-in Period|Treatment Interruption|0|||
105556162|NCT03214367|364033668|FG003|Lead-in Period|Treatment Interruption|0|||
105556163|NCT03214367|364033669|FG004|Lead-in Period|Treatment Interruption|0|||
105556164|NCT03214367|364033670|FG005|Lead-in Period|Treatment Interruption|0|||
105556165|NCT03214367|364033671|FG006|Lead-in Period|Treatment Interruption|0|||
105556166|NCT03214367|364033672|FG007|Lead-in Period|Treatment Interruption|0|||
105556167|NCT03214367|364033665|FG000|Treatment Period|Adverse Event|0|||
105556168|NCT03214367|364033666|FG001|Treatment Period|Adverse Event|1|||
105556169|NCT03214367|364033667|FG002|Treatment Period|Adverse Event|4|||
105556170|NCT03214367|364033668|FG003|Treatment Period|Adverse Event|2|||
105556171|NCT03214367|364033669|FG004|Treatment Period|Adverse Event|0|||
105556172|NCT03214367|364033670|FG005|Treatment Period|Adverse Event|0|||
105556173|NCT03214367|364033671|FG006|Treatment Period|Adverse Event|0|||
105556174|NCT03214367|364033672|FG007|Treatment Period|Adverse Event|0|||
105556175|NCT03214367|364033665|FG000|Treatment Period|Death|0|||
105556176|NCT03214367|364033666|FG001|Treatment Period|Death|1|||
105556177|NCT03214367|364033667|FG002|Treatment Period|Death|1|||
105556178|NCT03214367|364033668|FG003|Treatment Period|Death|1|||
105556179|NCT03214367|364033669|FG004|Treatment Period|Death|0|||
105556180|NCT03214367|364033670|FG005|Treatment Period|Death|0|||
105556181|NCT03214367|364033671|FG006|Treatment Period|Death|0|||
105556182|NCT03214367|364033672|FG007|Treatment Period|Death|0|||
105556183|NCT03214367|364033665|FG000|Treatment Period|Lost to Follow-up|0|||
105556184|NCT03214367|364033666|FG001|Treatment Period|Lost to Follow-up|5|||
105556185|NCT03214367|364033667|FG002|Treatment Period|Lost to Follow-up|3|||
105556186|NCT03214367|364033668|FG003|Treatment Period|Lost to Follow-up|2|||
105556187|NCT03214367|364033669|FG004|Treatment Period|Lost to Follow-up|0|||
105556188|NCT03214367|364033670|FG005|Treatment Period|Lost to Follow-up|2|||
105556189|NCT03214367|364033671|FG006|Treatment Period|Lost to Follow-up|1|||
105556190|NCT03214367|364033672|FG007|Treatment Period|Lost to Follow-up|0|||
105556191|NCT03214367|364033665|FG000|Treatment Period|Sponsor Decision|0|||
105556192|NCT03214367|364033666|FG001|Treatment Period|Sponsor Decision|3|||
105556193|NCT03214367|364033667|FG002|Treatment Period|Sponsor Decision|0|||
105556194|NCT03214367|364033668|FG003|Treatment Period|Sponsor Decision|0|||
105556195|NCT03214367|364033669|FG004|Treatment Period|Sponsor Decision|0|||
105556196|NCT03214367|364033670|FG005|Treatment Period|Sponsor Decision|0|||
105556197|NCT03214367|364033671|FG006|Treatment Period|Sponsor Decision|0|||
105556198|NCT03214367|364033672|FG007|Treatment Period|Sponsor Decision|0|||
105556199|NCT03214367|364033665|FG000|Treatment Period|Physician Decision|0|||
105556200|NCT03214367|364033666|FG001|Treatment Period|Physician Decision|1|||
105556201|NCT03214367|364033667|FG002|Treatment Period|Physician Decision|2|||
105556202|NCT03214367|364033668|FG003|Treatment Period|Physician Decision|0|||
105556203|NCT03214367|364033669|FG004|Treatment Period|Physician Decision|0|||
105556204|NCT03214367|364033670|FG005|Treatment Period|Physician Decision|0|||
105556205|NCT03214367|364033671|FG006|Treatment Period|Physician Decision|0|||
105556206|NCT03214367|364033672|FG007|Treatment Period|Physician Decision|0|||
105556207|NCT03214367|364033665|FG000|Treatment Period|Protocol Violation|0|||
105556208|NCT03214367|364033666|FG001|Treatment Period|Protocol Violation|3|||
105556209|NCT03214367|364033667|FG002|Treatment Period|Protocol Violation|0|||
105556210|NCT03214367|364033668|FG003|Treatment Period|Protocol Violation|0|||
105677076|NCT04602221|364479493|FG014|Overall Study|Withdrawal by Subject|0|||
105677077|NCT04602221|364479494|FG015|Overall Study|Withdrawal by Subject|0|||
105677078|NCT04602221|364479495|FG016|Overall Study|Withdrawal by Subject|0|||
105677079|NCT04602221|364479496|FG017|Overall Study|Withdrawal by Subject|0|||
105677080|NCT04602221|364479479|FG000|Overall Study|Lost to Follow-up|0|||
105677081|NCT04602221|364479480|FG001|Overall Study|Lost to Follow-up|0|||
105677082|NCT04602221|364479481|FG002|Overall Study|Lost to Follow-up|0|||
105677083|NCT04602221|364479482|FG003|Overall Study|Lost to Follow-up|0|||
105677084|NCT04602221|364479483|FG004|Overall Study|Lost to Follow-up|0|||
105677085|NCT04602221|364479484|FG005|Overall Study|Lost to Follow-up|1|||
105677086|NCT04602221|364479485|FG006|Overall Study|Lost to Follow-up|0|||
105677087|NCT04602221|364479486|FG007|Overall Study|Lost to Follow-up|0|||
105677088|NCT04602221|364479487|FG008|Overall Study|Lost to Follow-up|0|||
105677089|NCT04602221|364479488|FG009|Overall Study|Lost to Follow-up|0|||
105677090|NCT04602221|364479489|FG010|Overall Study|Lost to Follow-up|0|||
105677091|NCT04602221|364479490|FG011|Overall Study|Lost to Follow-up|0|||
105677092|NCT04602221|364479491|FG012|Overall Study|Lost to Follow-up|0|||
105677093|NCT04602221|364479492|FG013|Overall Study|Lost to Follow-up|0|||
105677094|NCT04602221|364479493|FG014|Overall Study|Lost to Follow-up|0|||
105677095|NCT04602221|364479494|FG015|Overall Study|Lost to Follow-up|0|||
105677096|NCT04602221|364479495|FG016|Overall Study|Lost to Follow-up|0|||
105677097|NCT04602221|364479496|FG017|Overall Study|Lost to Follow-up|0|||
105677098|NCT01942590|364479498|FG000|Overall Study|Withdrawal by Subject|0|||
105677099|NCT01942590|364479499|FG001|Overall Study|Withdrawal by Subject|1|||
105677100|NCT01942590|364479498|FG000|Overall Study|Adverse Event|1|||
105677101|NCT01942590|364479499|FG001|Overall Study|Adverse Event|0|||
105677102|NCT01879553|364479500|FG000|Overall Study|Withdrawal by Subject|1|||
105677103|NCT01879553|364479501|FG001|Overall Study|Withdrawal by Subject|0|||
105677104|NCT04927884|364479508|FG000|Overall Study|Progressive Disease|2|||
105677105|NCT00591370|364481598|FG000|Overall Study|Not Treated|2|||
105677106|NCT01879722|364481599|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
105677107|NCT01879722|364481600|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
105677108|NCT01879722|364481601|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
105677109|NCT01879722|364481602|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
105677110|NCT01879722|364481603|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
105677111|NCT01879722|364481604|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
105677112|NCT01879722|364481605|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
105677113|NCT01879722|364481606|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
105677114|NCT01879722|364481607|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
105677115|NCT01879722|364481608|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
105677116|NCT01879722|364481599|FG000|Overall Study|Voluntary Withdrawal|0|||
105677117|NCT01879722|364481600|FG001|Overall Study|Voluntary Withdrawal|0|||
105677118|NCT01879722|364481601|FG002|Overall Study|Voluntary Withdrawal|0|||
105677119|NCT01879722|364481602|FG003|Overall Study|Voluntary Withdrawal|0|||
105677120|NCT01879722|364481603|FG004|Overall Study|Voluntary Withdrawal|0|||
105677121|NCT01879722|364481604|FG005|Overall Study|Voluntary Withdrawal|0|||
105677122|NCT01879722|364481605|FG006|Overall Study|Voluntary Withdrawal|0|||
105677123|NCT01879722|364481606|FG007|Overall Study|Voluntary Withdrawal|0|||
105677124|NCT01879722|364481607|FG008|Overall Study|Voluntary Withdrawal|1|||
105677125|NCT01879722|364481608|FG009|Overall Study|Voluntary Withdrawal|0|||
105677126|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
105677127|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
105677128|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
105677129|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
105677130|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
105677131|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
105677132|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
105677133|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
105677134|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
105677135|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
105677136|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
105677137|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
105677138|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
105677139|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
105677140|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
105677141|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
105677142|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
105677143|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
105677144|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
105677145|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
105677146|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
105677147|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
105677148|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
105677149|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
105677150|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
105677151|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
105677152|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
105677153|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
105677154|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
105677155|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
105677156|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
105677157|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
105677158|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
105677159|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
105677160|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
105677161|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
105677162|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
105677163|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
105677164|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
105677165|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
105677166|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
105677167|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
105677168|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
105677169|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
105677170|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
105677171|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
105677172|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
105677173|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
105677174|NCT01160289|364481609|FG000|Post-Randomization Period|Adverse Event|0|||
105677175|NCT01160289|364481610|FG001|Post-Randomization Period|Adverse Event|4|||
105677176|NCT01160289|364481611|FG002|Post-Randomization Period|Adverse Event|4|||
105677177|NCT01160289|364481612|FG003|Post-Randomization Period|Adverse Event|2|||
105677178|NCT01160289|364481613|FG004|Post-Randomization Period|Adverse Event|0|||
105677179|NCT01160289|364481614|FG005|Post-Randomization Period|Adverse Event|0|||
105677180|NCT01160289|364481609|FG000|Post-Randomization Period|Death|0|||
105677181|NCT01160289|364481610|FG001|Post-Randomization Period|Death|0|||
105677182|NCT01160289|364481611|FG002|Post-Randomization Period|Death|0|||
105677183|NCT01160289|364481612|FG003|Post-Randomization Period|Death|1|||
105677184|NCT01160289|364481613|FG004|Post-Randomization Period|Death|0|||
105677185|NCT01160289|364481614|FG005|Post-Randomization Period|Death|0|||
105677186|NCT01160289|364481609|FG000|Post-Randomization Period|Lack of Efficacy|0|||
105677187|NCT01160289|364481610|FG001|Post-Randomization Period|Lack of Efficacy|1|||
105677188|NCT01160289|364481611|FG002|Post-Randomization Period|Lack of Efficacy|0|||
105677189|NCT01160289|364481612|FG003|Post-Randomization Period|Lack of Efficacy|3|||
105677190|NCT01160289|364481613|FG004|Post-Randomization Period|Lack of Efficacy|0|||
105677191|NCT01160289|364481614|FG005|Post-Randomization Period|Lack of Efficacy|0|||
105677192|NCT01160289|364481609|FG000|Post-Randomization Period|Lost to Follow-up|0|||
105677193|NCT01160289|364481610|FG001|Post-Randomization Period|Lost to Follow-up|3|||
105677194|NCT01160289|364481611|FG002|Post-Randomization Period|Lost to Follow-up|2|||
105677195|NCT01160289|364481612|FG003|Post-Randomization Period|Lost to Follow-up|5|||
105677196|NCT01160289|364481613|FG004|Post-Randomization Period|Lost to Follow-up|3|||
105677197|NCT01160289|364481614|FG005|Post-Randomization Period|Lost to Follow-up|4|||
105677198|NCT01160289|364481609|FG000|Post-Randomization Period|Physician Decision|0|||
105677199|NCT01160289|364481610|FG001|Post-Randomization Period|Physician Decision|0|||
105677200|NCT01160289|364481611|FG002|Post-Randomization Period|Physician Decision|1|||
105677201|NCT01160289|364481612|FG003|Post-Randomization Period|Physician Decision|0|||
105677202|NCT01160289|364481613|FG004|Post-Randomization Period|Physician Decision|0|||
105677203|NCT01160289|364481614|FG005|Post-Randomization Period|Physician Decision|0|||
105677204|NCT01160289|364481609|FG000|Post-Randomization Period|Protocol Violation|0|||
105677205|NCT01160289|364481610|FG001|Post-Randomization Period|Protocol Violation|4|||
105677206|NCT01160289|364481611|FG002|Post-Randomization Period|Protocol Violation|2|||
105677207|NCT01160289|364481612|FG003|Post-Randomization Period|Protocol Violation|0|||
105677208|NCT01160289|364481613|FG004|Post-Randomization Period|Protocol Violation|1|||
105677209|NCT01160289|364481614|FG005|Post-Randomization Period|Protocol Violation|3|||
105677210|NCT01160289|364481609|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
105677211|NCT01160289|364481610|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
105677212|NCT01160289|364481611|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
105677213|NCT01160289|364481612|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
105677214|NCT01160289|364481613|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
105677215|NCT01160289|364481614|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
105677216|NCT01160289|364481609|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
105677217|NCT01160289|364481610|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
105677218|NCT01160289|364481611|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
105677219|NCT01160289|364481612|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
105677220|NCT01160289|364481613|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
105677221|NCT01160289|364481614|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
105677222|NCT01160289|364481609|FG000|Post-Randomization Period|Sponsor Decision|0|||
105677223|NCT01160289|364481610|FG001|Post-Randomization Period|Sponsor Decision|1|||
105677224|NCT01160289|364481611|FG002|Post-Randomization Period|Sponsor Decision|0|||
105677225|NCT01160289|364481612|FG003|Post-Randomization Period|Sponsor Decision|0|||
105677226|NCT01160289|364481613|FG004|Post-Randomization Period|Sponsor Decision|0|||
105677227|NCT01160289|364481614|FG005|Post-Randomization Period|Sponsor Decision|0|||
105677228|NCT01631227|364481618|FG000|Overall Study|withdrawn consent|27|||
105677229|NCT01631227|364481619|FG001|Overall Study|withdrawn consent|21|||
105677230|NCT01631227|364481618|FG000|Overall Study|Adverse Event|1|||
105677231|NCT01631227|364481619|FG001|Overall Study|Adverse Event|0|||
105677232|NCT01631227|364481618|FG000|Overall Study|administrative|2|||
105677233|NCT01631227|364481619|FG001|Overall Study|administrative|1|||
105677234|NCT01097707|364481620|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
105677235|NCT01097707|364481621|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
105677236|NCT01097707|364481622|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
105677237|NCT01097707|364481623|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
105677238|NCT01097707|364481624|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
105677239|NCT01097707|364481620|FG000|Overall Study|Adverse Event|4|||
105677240|NCT01097707|364481621|FG001|Overall Study|Adverse Event|2|||
105677241|NCT01097707|364481622|FG002|Overall Study|Adverse Event|3|||
105677242|NCT01097707|364481623|FG003|Overall Study|Adverse Event|1|||
105677243|NCT01097707|364481624|FG004|Overall Study|Adverse Event|3|||
105677244|NCT01097707|364481620|FG000|Overall Study|Entry Criteria Not Met|2|||
105677245|NCT01097707|364481621|FG001|Overall Study|Entry Criteria Not Met|1|||
105677246|NCT01097707|364481622|FG002|Overall Study|Entry Criteria Not Met|1|||
105677247|NCT01097707|364481623|FG003|Overall Study|Entry Criteria Not Met|0|||
105677248|NCT01097707|364481624|FG004|Overall Study|Entry Criteria Not Met|1|||
105677249|NCT01097707|364481620|FG000|Overall Study|Lack of Efficacy|1|||
105677250|NCT01097707|364481621|FG001|Overall Study|Lack of Efficacy|0|||
105677251|NCT01097707|364481622|FG002|Overall Study|Lack of Efficacy|0|||
105677252|NCT01097707|364481623|FG003|Overall Study|Lack of Efficacy|1|||
105677253|NCT01097707|364481624|FG004|Overall Study|Lack of Efficacy|0|||
105677254|NCT01097707|364481620|FG000|Overall Study|Lost to Follow-up|1|||
105677255|NCT01097707|364481621|FG001|Overall Study|Lost to Follow-up|1|||
105677256|NCT01097707|364481622|FG002|Overall Study|Lost to Follow-up|2|||
105677257|NCT01097707|364481623|FG003|Overall Study|Lost to Follow-up|0|||
105677258|NCT01097707|364481624|FG004|Overall Study|Lost to Follow-up|3|||
105677259|NCT01097707|364481620|FG000|Overall Study|Protocol Violation|2|||
105677260|NCT01097707|364481621|FG001|Overall Study|Protocol Violation|2|||
105677261|NCT01097707|364481622|FG002|Overall Study|Protocol Violation|3|||
105677262|NCT01097707|364481623|FG003|Overall Study|Protocol Violation|2|||
105677263|NCT01097707|364481624|FG004|Overall Study|Protocol Violation|2|||
105677264|NCT01097707|364481620|FG000|Overall Study|Sponsor Decision|31|||
105677265|NCT01097707|364481621|FG001|Overall Study|Sponsor Decision|31|||
105677266|NCT01097707|364481622|FG002|Overall Study|Sponsor Decision|34|||
105677267|NCT01097707|364481623|FG003|Overall Study|Sponsor Decision|35|||
105343335|NCT04756154|363258324|FG002|Overall Study|Did not return for final sample collection|0|||
105343336|NCT03589976|363258326|FG000|Overall Study|Death|5|||
105343337|NCT03589976|363258327|FG001|Overall Study|Death|1|||
105343338|NCT03589976|363258326|FG000|Overall Study|Adverse Event|5|||
105343339|NCT03589976|363258327|FG001|Overall Study|Adverse Event|1|||
105343340|NCT03589976|363258326|FG000|Overall Study|Withdrawal by Subject|4|||
105343341|NCT03589976|363258327|FG001|Overall Study|Withdrawal by Subject|1|||
105343342|NCT03589976|363258326|FG000|Overall Study|Lost to Follow-up|1|||
105343343|NCT03589976|363258327|FG001|Overall Study|Lost to Follow-up|0|||
105343344|NCT03589976|363258326|FG000|Overall Study|Other|4|||
105556211|NCT03214367|364033669|FG004|Treatment Period|Protocol Violation|0|||
105556212|NCT03214367|364033670|FG005|Treatment Period|Protocol Violation|0|||
105556213|NCT03214367|364033671|FG006|Treatment Period|Protocol Violation|0|||
105556214|NCT03214367|364033672|FG007|Treatment Period|Protocol Violation|0|||
105556215|NCT03214367|364033665|FG000|Treatment Period|Withdrawal by Subject|0|||
105556216|NCT03214367|364033666|FG001|Treatment Period|Withdrawal by Subject|20|||
105556217|NCT03214367|364033667|FG002|Treatment Period|Withdrawal by Subject|23|||
105556218|NCT03214367|364033668|FG003|Treatment Period|Withdrawal by Subject|14|||
105556219|NCT03214367|364033669|FG004|Treatment Period|Withdrawal by Subject|0|||
105556220|NCT03214367|364033670|FG005|Treatment Period|Withdrawal by Subject|1|||
105556221|NCT03214367|364033671|FG006|Treatment Period|Withdrawal by Subject|1|||
105556222|NCT03214367|364033672|FG007|Treatment Period|Withdrawal by Subject|1|||
105556223|NCT02564523|364033673|FG000|Overall Study|Withdrawal by Subject|3|||
105556224|NCT02564523|364033674|FG001|Overall Study|Withdrawal by Subject|0|||
105556225|NCT02564523|364033675|FG002|Overall Study|Withdrawal by Subject|1|||
105556226|NCT02564523|364033676|FG003|Overall Study|Withdrawal by Subject|0|||
105556227|NCT02564523|364033677|FG004|Overall Study|Withdrawal by Subject|1|||
105556228|NCT02564523|364033678|FG005|Overall Study|Withdrawal by Subject|0|||
105556229|NCT02564523|364033679|FG006|Overall Study|Withdrawal by Subject|1|||
105556230|NCT02564523|364033680|FG007|Overall Study|Withdrawal by Subject|0|||
105556231|NCT02564523|364033681|FG008|Overall Study|Withdrawal by Subject|0|||
105556232|NCT02564523|364033682|FG009|Overall Study|Withdrawal by Subject|0|||
105556233|NCT02564523|364033683|FG010|Overall Study|Withdrawal by Subject|1|||
105556234|NCT02564523|364033684|FG011|Overall Study|Withdrawal by Subject|0|||
105677268|NCT01097707|364481624|FG004|Overall Study|Sponsor Decision|36|||
105343345|NCT03589976|363258327|FG001|Overall Study|Other|3|||
105343346|NCT00138073|363258330|FG000|Overall Study|lack of resources|55|||
105343347|NCT04325698|363258337|FG000|Overall Study|Study Terminated By Sponsor|1|||
105343348|NCT04325698|363258338|FG001|Overall Study|Study Terminated By Sponsor|1|||
105343349|NCT04325698|363258337|FG000|Overall Study|Withdrawal by Subject|0|||
105343350|NCT04325698|363258338|FG001|Overall Study|Withdrawal by Subject|2|||
105343351|NCT04216589|363258339|FG000|Overall Study|Withdrawal by Subject|2|||
105343352|NCT04216589|363258339|FG000|Overall Study|Protocol Violation|1|||
105343353|NCT04216589|363258339|FG000|Overall Study|Incarceration|1|||
105343354|NCT03800836|363258343|FG000|Overall Study|Other|2|||
105343355|NCT03800836|363258344|FG001|Overall Study|Other|1|||
105343356|NCT03800836|363258345|FG002|Overall Study|Other|0|||
105343357|NCT03800836|363258346|FG003|Overall Study|Other|2|||
105343358|NCT03800836|363258347|FG004|Overall Study|Other|0|||
105343359|NCT03800836|363258348|FG005|Overall Study|Other|1|||
105343360|NCT03800836|363258343|FG000|Overall Study|Lost to Follow-up|2|||
105343361|NCT03800836|363258344|FG001|Overall Study|Lost to Follow-up|0|||
105343362|NCT03800836|363258345|FG002|Overall Study|Lost to Follow-up|1|||
105343363|NCT03800836|363258346|FG003|Overall Study|Lost to Follow-up|1|||
105343364|NCT03800836|363258347|FG004|Overall Study|Lost to Follow-up|3|||
105343365|NCT03800836|363258348|FG005|Overall Study|Lost to Follow-up|0|||
105343366|NCT03800836|363258343|FG000|Overall Study|Withdrawal by Subject|1|||
105343367|NCT03800836|363258344|FG001|Overall Study|Withdrawal by Subject|0|||
105343368|NCT03800836|363258345|FG002|Overall Study|Withdrawal by Subject|0|||
105343369|NCT03800836|363258346|FG003|Overall Study|Withdrawal by Subject|0|||
105343370|NCT03800836|363258347|FG004|Overall Study|Withdrawal by Subject|0|||
105343371|NCT03800836|363258348|FG005|Overall Study|Withdrawal by Subject|0|||
105343372|NCT03800836|363258343|FG000|Overall Study|Physician Decision|31|||
105343373|NCT03800836|363258344|FG001|Overall Study|Physician Decision|3|||
105343374|NCT03800836|363258345|FG002|Overall Study|Physician Decision|6|||
105556235|NCT02564523|364033685|FG012|Overall Study|Withdrawal by Subject|1|||
105556236|NCT02564523|364033686|FG013|Overall Study|Withdrawal by Subject|0|||
105556237|NCT02564523|364033687|FG014|Overall Study|Withdrawal by Subject|0|||
105556238|NCT02564523|364033688|FG015|Overall Study|Withdrawal by Subject|0|||
105556239|NCT02564523|364033689|FG016|Overall Study|Withdrawal by Subject|0|||
105677269|NCT01097707|364481620|FG000|Overall Study|Withdrawal by Subject|3|||
105343375|NCT03800836|363258346|FG003|Overall Study|Physician Decision|4|||
105343376|NCT03800836|363258347|FG004|Overall Study|Physician Decision|4|||
105343377|NCT03800836|363258348|FG005|Overall Study|Physician Decision|5|||
105343378|NCT03800836|363258343|FG000|Overall Study|Death|34|||
105343379|NCT03800836|363258344|FG001|Overall Study|Death|16|||
105556240|NCT02564523|364033690|FG017|Overall Study|Withdrawal by Subject|0|||
105556241|NCT02564523|364033673|FG000|Overall Study|Adverse Event|0|||
105677270|NCT01097707|364481621|FG001|Overall Study|Withdrawal by Subject|6|||
105677271|NCT01097707|364481622|FG002|Overall Study|Withdrawal by Subject|1|||
105677272|NCT01097707|364481623|FG003|Overall Study|Withdrawal by Subject|4|||
105677273|NCT01097707|364481624|FG004|Overall Study|Withdrawal by Subject|3|||
105677274|NCT01097707|364481620|FG000|Overall Study|Reason unknown|0|||
105677275|NCT01097707|364481621|FG001|Overall Study|Reason unknown|0|||
105677276|NCT01097707|364481622|FG002|Overall Study|Reason unknown|0|||
105677277|NCT01097707|364481623|FG003|Overall Study|Reason unknown|0|||
105677278|NCT01097707|364481624|FG004|Overall Study|Reason unknown|1|||
105677279|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
105677280|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
105786432|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
105786433|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
105786434|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
105786435|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
105343380|NCT03800836|363258345|FG002|Overall Study|Death|5|||
105343381|NCT03800836|363258346|FG003|Overall Study|Death|5|||
105343382|NCT03800836|363258347|FG004|Overall Study|Death|10|||
105343383|NCT03800836|363258348|FG005|Overall Study|Death|0|||
105343384|NCT03800836|363258343|FG000|Overall Study|Symptomatic Deterioration|1|||
105343385|NCT03800836|363258344|FG001|Overall Study|Symptomatic Deterioration|0|||
105343386|NCT03800836|363258345|FG002|Overall Study|Symptomatic Deterioration|1|||
105343387|NCT03800836|363258346|FG003|Overall Study|Symptomatic Deterioration|0|||
105343388|NCT03800836|363258347|FG004|Overall Study|Symptomatic Deterioration|0|||
105343389|NCT03800836|363258348|FG005|Overall Study|Symptomatic Deterioration|0|||
105343390|NCT02203851|363259540|FG000|Overall Study|Lost to Follow-up|4|||
105343391|NCT02203851|363259540|FG000|Overall Study|Withdrawal by Subject|6|||
105343392|NCT02203851|363259540|FG000|Overall Study|Other|1|||
105343393|NCT04161079|363259541|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
105343394|NCT03408444|363259550|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
105343395|NCT03408444|363259551|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
105343396|NCT03408444|363259552|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
105343397|NCT03408444|363259553|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
105343398|NCT03408444|363259550|FG000|Overall Study|Lens Discomfort|0|||
105343399|NCT03408444|363259551|FG001|Overall Study|Lens Discomfort|1|||
105343400|NCT03408444|363259552|FG002|Overall Study|Lens Discomfort|0|||
105343401|NCT03408444|363259553|FG003|Overall Study|Lens Discomfort|0|||
105343402|NCT03408444|363259550|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
105343403|NCT03408444|363259551|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
105343404|NCT03408444|363259552|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
105343405|NCT03408444|363259553|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
105466632|NCT01523756|363720214|FG001|Baseline Period|Adverse Event|1|||
105677281|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
105677282|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
105786436|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
105786437|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
105786438|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Other|2|||
105786439|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Other|0|||
105786440|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Other|0|||
105677283|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
105677284|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
105677285|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
105677286|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
105677287|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
105677288|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
105677289|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
105677290|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
105677291|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
105677292|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
105677293|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
105677294|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
105677295|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
105677296|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
105677297|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
105677298|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
105677299|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
105677300|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
105677301|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
105677302|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
105677303|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
105677304|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
105677305|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
105677306|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
105677307|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
105677308|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
105677309|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
105677310|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
105677311|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
105677312|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
105677313|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
105677314|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
105677315|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
105677316|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
105677317|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
105677318|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
105677319|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
105677320|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
105677321|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
105677322|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
105677323|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
105677324|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
105677325|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
105677326|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
105677327|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
105677328|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
105677329|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
105677330|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
105677331|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
105677332|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
105677333|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
105677334|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
105677335|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
105677336|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
105677337|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
105677338|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
105677339|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
105677340|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
105677341|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
105677342|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
105677343|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
105677344|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
105677345|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
105677346|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
105677347|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
105677348|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
105677349|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
105677350|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
105677351|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
105677352|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
105677353|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
105677354|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
105677355|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
105677356|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
105677357|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
105677358|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
105677359|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
105677360|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
105677361|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
105677362|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
105677363|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
105677364|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
105677365|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
105677366|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
105677367|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
105677368|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
105677369|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
105677370|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
105677371|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
105677372|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
105677373|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
105677374|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
105677375|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
105677376|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
105677377|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
105677378|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
105677379|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
105677380|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
105677381|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
105677382|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
105677383|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
105677384|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
105677385|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
105677386|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
105677387|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
105677388|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
105677389|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
105677390|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
105677391|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
105677392|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
105677393|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
105677394|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
105677395|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
105677396|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
105677397|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
105677398|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
105677399|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
105343406|NCT03408444|363259550|FG000|Overall Study|Withdrawal by Subject|0|||
105343407|NCT03408444|363259551|FG001|Overall Study|Withdrawal by Subject|2|||
105343408|NCT03408444|363259552|FG002|Overall Study|Withdrawal by Subject|3|||
105343409|NCT03408444|363259553|FG003|Overall Study|Withdrawal by Subject|0|||
105677400|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
105677401|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
105677402|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
105677403|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
105677404|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
105677405|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
105677406|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
105677407|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
105677408|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
105677409|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
105677410|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
105677411|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
105677412|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
105677413|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
105677414|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
105677415|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
105677416|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
105677417|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
105677418|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
105677419|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
105677420|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
105677421|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
105677422|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
105677423|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
105677424|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
105677425|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
105677426|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
105677427|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
105677428|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
105677429|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
105677430|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
105677431|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
105677432|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
105677433|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
105343410|NCT03408444|363259550|FG000|Overall Study|Lost to Follow-up|0|||
105343411|NCT03408444|363259551|FG001|Overall Study|Lost to Follow-up|0|||
105343412|NCT03408444|363259552|FG002|Overall Study|Lost to Follow-up|1|||
105343413|NCT03408444|363259553|FG003|Overall Study|Lost to Follow-up|0|||
105343414|NCT03408444|363259550|FG000|Overall Study|Adverse Event|0|||
105343415|NCT03408444|363259551|FG001|Overall Study|Adverse Event|0|||
105677434|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
105677435|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
105556242|NCT02564523|364033674|FG001|Overall Study|Adverse Event|0|||
105556243|NCT02564523|364033675|FG002|Overall Study|Adverse Event|0|||
105556244|NCT02564523|364033676|FG003|Overall Study|Adverse Event|0|||
105556245|NCT02564523|364033677|FG004|Overall Study|Adverse Event|0|||
105556246|NCT02564523|364033678|FG005|Overall Study|Adverse Event|0|||
105556247|NCT02564523|364033679|FG006|Overall Study|Adverse Event|0|||
105556248|NCT02564523|364033680|FG007|Overall Study|Adverse Event|0|||
105556249|NCT02564523|364033681|FG008|Overall Study|Adverse Event|0|||
105556250|NCT02564523|364033682|FG009|Overall Study|Adverse Event|0|||
105556251|NCT02564523|364033683|FG010|Overall Study|Adverse Event|0|||
105556252|NCT02564523|364033684|FG011|Overall Study|Adverse Event|0|||
105556253|NCT02564523|364033685|FG012|Overall Study|Adverse Event|0|||
105556254|NCT02564523|364033686|FG013|Overall Study|Adverse Event|0|||
105556255|NCT02564523|364033687|FG014|Overall Study|Adverse Event|0|||
105556256|NCT02564523|364033688|FG015|Overall Study|Adverse Event|0|||
105556257|NCT02564523|364033689|FG016|Overall Study|Adverse Event|0|||
105556258|NCT02564523|364033690|FG017|Overall Study|Adverse Event|1|||
105556259|NCT02564523|364033673|FG000|Overall Study|Death|0|||
105556260|NCT02564523|364033674|FG001|Overall Study|Death|0|||
105556261|NCT02564523|364033675|FG002|Overall Study|Death|0|||
105556262|NCT02564523|364033676|FG003|Overall Study|Death|0|||
105556263|NCT02564523|364033677|FG004|Overall Study|Death|0|||
105556264|NCT02564523|364033678|FG005|Overall Study|Death|0|||
105556265|NCT02564523|364033679|FG006|Overall Study|Death|1|||
105556266|NCT02564523|364033680|FG007|Overall Study|Death|0|||
105556267|NCT02564523|364033681|FG008|Overall Study|Death|0|||
105556268|NCT02564523|364033682|FG009|Overall Study|Death|0|||
105556269|NCT02564523|364033683|FG010|Overall Study|Death|1|||
105556270|NCT02564523|364033684|FG011|Overall Study|Death|0|||
105556271|NCT02564523|364033685|FG012|Overall Study|Death|0|||
105556272|NCT02564523|364033686|FG013|Overall Study|Death|0|||
105556273|NCT02564523|364033687|FG014|Overall Study|Death|0|||
105556274|NCT02564523|364033688|FG015|Overall Study|Death|0|||
105556275|NCT02564523|364033689|FG016|Overall Study|Death|0|||
105556276|NCT02564523|364033690|FG017|Overall Study|Death|0|||
105556277|NCT02564523|364033673|FG000|Overall Study|Lost to Follow-up|2|||
105556278|NCT02564523|364033674|FG001|Overall Study|Lost to Follow-up|1|||
105556279|NCT02564523|364033675|FG002|Overall Study|Lost to Follow-up|4|||
105786441|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Other|0|||
105556280|NCT02564523|364033676|FG003|Overall Study|Lost to Follow-up|0|||
105556281|NCT02564523|364033677|FG004|Overall Study|Lost to Follow-up|1|||
105556282|NCT02564523|364033678|FG005|Overall Study|Lost to Follow-up|0|||
105556283|NCT02564523|364033679|FG006|Overall Study|Lost to Follow-up|1|||
105556284|NCT02564523|364033680|FG007|Overall Study|Lost to Follow-up|0|||
105556285|NCT02564523|364033681|FG008|Overall Study|Lost to Follow-up|0|||
105556286|NCT02564523|364033682|FG009|Overall Study|Lost to Follow-up|0|||
105556287|NCT02564523|364033683|FG010|Overall Study|Lost to Follow-up|0|||
105556288|NCT02564523|364033684|FG011|Overall Study|Lost to Follow-up|1|||
105556289|NCT02564523|364033685|FG012|Overall Study|Lost to Follow-up|1|||
105556290|NCT02564523|364033686|FG013|Overall Study|Lost to Follow-up|0|||
105556291|NCT02564523|364033687|FG014|Overall Study|Lost to Follow-up|0|||
105556292|NCT02564523|364033688|FG015|Overall Study|Lost to Follow-up|0|||
105556293|NCT02564523|364033689|FG016|Overall Study|Lost to Follow-up|0|||
105556294|NCT02564523|364033690|FG017|Overall Study|Lost to Follow-up|0|||
105556295|NCT02564523|364033673|FG000|Overall Study|Physician Decision|0|||
105556296|NCT02564523|364033674|FG001|Overall Study|Physician Decision|0|||
105556297|NCT02564523|364033675|FG002|Overall Study|Physician Decision|0|||
105556298|NCT02564523|364033676|FG003|Overall Study|Physician Decision|0|||
105556299|NCT02564523|364033677|FG004|Overall Study|Physician Decision|1|||
105556300|NCT02564523|364033678|FG005|Overall Study|Physician Decision|0|||
105556301|NCT02564523|364033679|FG006|Overall Study|Physician Decision|0|||
105556302|NCT02564523|364033680|FG007|Overall Study|Physician Decision|0|||
105677436|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
105677437|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
105677438|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
105677439|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
105677440|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
105677441|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
105677442|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
105677443|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
105677444|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
105677445|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
105677446|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
105677447|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
105677448|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
105677449|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
105677450|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
105677451|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
105677452|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
105677453|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
105677454|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
105677455|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
105677456|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
105677457|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
105677458|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
105677459|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
105677460|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
105677461|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
105677462|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
105677463|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
105677464|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
105677465|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
105677466|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
105677467|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
105677468|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
105677469|NCT05383508|364481633|FG000|Overall Study|Withdrawal by Subject|1|||
105677470|NCT05383508|364481634|FG001|Overall Study|Withdrawal by Subject|0|||
105677471|NCT05383508|364481635|FG002|Overall Study|Withdrawal by Subject|1|||
105677472|NCT05383508|364481636|FG003|Overall Study|Withdrawal by Subject|1|||
105677473|NCT05383508|364481637|FG004|Overall Study|Withdrawal by Subject|2|||
105677474|NCT05383508|364481638|FG005|Overall Study|Withdrawal by Subject|0|||
105677475|NCT03775434|364481639|FG000|Overall Study|Adverse Event|2|||
105677476|NCT03775434|364481639|FG000|Overall Study|Withdrawal by Subject|1|||
105677477|NCT03047395|364481640|FG000|Overall Study|Adverse Event|142|||
105677478|NCT03047395|364481640|FG000|Overall Study|Withdrawal by Subject|155|||
105677479|NCT03047395|364481640|FG000|Overall Study|Lost to Follow-up|144|||
105677480|NCT03047395|364481640|FG000|Overall Study|COVID-19 Infection|2|||
105677481|NCT03047395|364481640|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
105677482|NCT03047395|364481640|FG000|Overall Study|Other, Not Specified|117|||
105677483|NCT01859988|364481641|FG000|Overall Study|Withdrawal by Subject|6|||
105677484|NCT01859988|364481642|FG001|Overall Study|Withdrawal by Subject|3|||
105677485|NCT01859988|364481643|FG002|Overall Study|Withdrawal by Subject|4|||
105677486|NCT01859988|364481644|FG003|Overall Study|Withdrawal by Subject|3|||
105677487|NCT01859988|364481645|FG004|Overall Study|Withdrawal by Subject|2|||
105677488|NCT01859988|364481646|FG005|Overall Study|Withdrawal by Subject|2|||
105677489|NCT01859988|364481641|FG000|Overall Study|Lack of Efficacy|1|||
105677490|NCT01859988|364481642|FG001|Overall Study|Lack of Efficacy|1|||
105677491|NCT01859988|364481643|FG002|Overall Study|Lack of Efficacy|5|||
105677492|NCT01859988|364481644|FG003|Overall Study|Lack of Efficacy|0|||
105677493|NCT01859988|364481645|FG004|Overall Study|Lack of Efficacy|7|||
105677494|NCT01859988|364481646|FG005|Overall Study|Lack of Efficacy|9|||
105677495|NCT01859988|364481641|FG000|Overall Study|Physician Decision|1|||
105677496|NCT01859988|364481642|FG001|Overall Study|Physician Decision|3|||
105677497|NCT01859988|364481643|FG002|Overall Study|Physician Decision|1|||
105677498|NCT01859988|364481644|FG003|Overall Study|Physician Decision|3|||
105677499|NCT01859988|364481645|FG004|Overall Study|Physician Decision|4|||
105677500|NCT01859988|364481646|FG005|Overall Study|Physician Decision|1|||
105677501|NCT01859988|364481641|FG000|Overall Study|Adverse Event|2|||
105677502|NCT01859988|364481642|FG001|Overall Study|Adverse Event|1|||
105343416|NCT03408444|363259552|FG002|Overall Study|Adverse Event|0|||
105677503|NCT01859988|364481643|FG002|Overall Study|Adverse Event|3|||
105677504|NCT01859988|364481644|FG003|Overall Study|Adverse Event|1|||
105677505|NCT01859988|364481645|FG004|Overall Study|Adverse Event|2|||
105677506|NCT01859988|364481646|FG005|Overall Study|Adverse Event|2|||
105677507|NCT01859988|364481641|FG000|Overall Study|Lost to Follow-up|1|||
105677508|NCT01859988|364481642|FG001|Overall Study|Lost to Follow-up|2|||
105677509|NCT01859988|364481643|FG002|Overall Study|Lost to Follow-up|3|||
105677510|NCT01859988|364481644|FG003|Overall Study|Lost to Follow-up|0|||
105677511|NCT01859988|364481645|FG004|Overall Study|Lost to Follow-up|3|||
105677512|NCT01859988|364481646|FG005|Overall Study|Lost to Follow-up|2|||
105677513|NCT01859988|364481641|FG000|Overall Study|Protocol Violation|0|||
105677514|NCT01859988|364481642|FG001|Overall Study|Protocol Violation|0|||
105677515|NCT01859988|364481643|FG002|Overall Study|Protocol Violation|1|||
105677516|NCT01859988|364481644|FG003|Overall Study|Protocol Violation|0|||
105343417|NCT03408444|363259553|FG003|Overall Study|Adverse Event|1|||
105343418|NCT03408444|363259550|FG000|Overall Study|Lens Handling Difficulties|0|||
105343419|NCT03408444|363259551|FG001|Overall Study|Lens Handling Difficulties|0|||
105343420|NCT03408444|363259552|FG002|Overall Study|Lens Handling Difficulties|1|||
105343421|NCT03408444|363259553|FG003|Overall Study|Lens Handling Difficulties|0|||
105343422|NCT03408444|363259550|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
105343423|NCT03408444|363259551|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
105343424|NCT03408444|363259552|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
105343425|NCT03408444|363259553|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
105343426|NCT03535194|363259554|FG000|Induction Period|Adverse Event|2|||
105343427|NCT03535194|363259555|FG001|Induction Period|Adverse Event|2|||
105343428|NCT03535194|363259556|FG002|Induction Period|Adverse Event|1|||
105343429|NCT03535194|363259557|FG003|Induction Period|Adverse Event|3|||
105343430|NCT03535194|363259558|FG004|Induction Period|Adverse Event|0|||
105343431|NCT03535194|363259554|FG000|Induction Period|Death|0|||
105343432|NCT03535194|363259555|FG001|Induction Period|Death|1|||
105343433|NCT03535194|363259556|FG002|Induction Period|Death|0|||
105343434|NCT03535194|363259557|FG003|Induction Period|Death|0|||
105343435|NCT03535194|363259558|FG004|Induction Period|Death|0|||
105343436|NCT03535194|363259554|FG000|Induction Period|Lack of Efficacy|1|||
105343437|NCT03535194|363259555|FG001|Induction Period|Lack of Efficacy|3|||
105343438|NCT03535194|363259556|FG002|Induction Period|Lack of Efficacy|2|||
105343439|NCT03535194|363259557|FG003|Induction Period|Lack of Efficacy|2|||
105343440|NCT03535194|363259558|FG004|Induction Period|Lack of Efficacy|0|||
105343441|NCT03535194|363259554|FG000|Induction Period|Lost to Follow-up|3|||
105343442|NCT03535194|363259555|FG001|Induction Period|Lost to Follow-up|5|||
105343443|NCT03535194|363259556|FG002|Induction Period|Lost to Follow-up|2|||
105343444|NCT03535194|363259557|FG003|Induction Period|Lost to Follow-up|3|||
105677517|NCT01859988|364481645|FG004|Overall Study|Protocol Violation|0|||
105677518|NCT01859988|364481646|FG005|Overall Study|Protocol Violation|0|||
105677519|NCT01859988|364481641|FG000|Overall Study|Other than specified above|0|||
105677520|NCT01859988|364481642|FG001|Overall Study|Other than specified above|2|||
105677521|NCT01859988|364481643|FG002|Overall Study|Other than specified above|11|||
105677522|NCT01859988|364481644|FG003|Overall Study|Other than specified above|3|||
105343445|NCT03535194|363259558|FG004|Induction Period|Lost to Follow-up|0|||
105343446|NCT03535194|363259554|FG000|Induction Period|Physician Decision|1|||
105677523|NCT01859988|364481645|FG004|Overall Study|Other than specified above|5|||
105677524|NCT01859988|364481646|FG005|Overall Study|Other than specified above|3|||
105677525|NCT02334423|364481647|FG000|Overall Study|Protocol Violation|10|||
105677526|NCT02334423|364481648|FG001|Overall Study|Protocol Violation|3|||
105786442|NCT04579666|364871387|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
105677527|NCT00652327|364481649|FG000|Overall Study|Adverse Event|0|||
105677528|NCT00652327|364481650|FG001|Overall Study|Adverse Event|2|||
105677529|NCT00652327|364481649|FG000|Overall Study|Lost to Follow-up|0|||
105786443|NCT04579666|364871388|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
105343447|NCT03535194|363259555|FG001|Induction Period|Physician Decision|1|||
105343448|NCT03535194|363259556|FG002|Induction Period|Physician Decision|0|||
105343449|NCT03535194|363259557|FG003|Induction Period|Physician Decision|0|||
105343450|NCT03535194|363259558|FG004|Induction Period|Physician Decision|0|||
105343451|NCT03535194|363259554|FG000|Induction Period|Protocol Violation|1|||
105343452|NCT03535194|363259555|FG001|Induction Period|Protocol Violation|0|||
105343453|NCT03535194|363259556|FG002|Induction Period|Protocol Violation|0|||
105343454|NCT03535194|363259557|FG003|Induction Period|Protocol Violation|1|||
105677530|NCT00652327|364481650|FG001|Overall Study|Lost to Follow-up|3|||
105677531|NCT01076647|364481651|FG000|Overall Study|Adverse Event|4|||
105466633|NCT01523756|363720213|FG000|Test Period 1|Adverse Event|1|||
105343455|NCT03535194|363259558|FG004|Induction Period|Protocol Violation|0|||
105677532|NCT01076647|364481652|FG001|Overall Study|Adverse Event|1|||
105677533|NCT01076647|364481651|FG000|Overall Study|Lack of Efficacy|0|||
105677534|NCT01076647|364481652|FG001|Overall Study|Lack of Efficacy|1|||
105677535|NCT01076647|364481651|FG000|Overall Study|Protocol Violation|7|||
105343456|NCT03535194|363259554|FG000|Induction Period|Screen Failure|0|||
105343457|NCT03535194|363259555|FG001|Induction Period|Screen Failure|1|||
105343458|NCT03535194|363259556|FG002|Induction Period|Screen Failure|0|||
105343459|NCT03535194|363259557|FG003|Induction Period|Screen Failure|0|||
105343460|NCT03535194|363259558|FG004|Induction Period|Screen Failure|0|||
105343461|NCT03535194|363259554|FG000|Induction Period|Withdrawal by Subject|3|||
105343462|NCT03535194|363259555|FG001|Induction Period|Withdrawal by Subject|4|||
105343463|NCT03535194|363259556|FG002|Induction Period|Withdrawal by Subject|3|||
105343464|NCT03535194|363259557|FG003|Induction Period|Withdrawal by Subject|2|||
105343465|NCT03535194|363259558|FG004|Induction Period|Withdrawal by Subject|0|||
105343466|NCT03535194|363259554|FG000|Maintenance Period|Adverse Event|6|||
105343467|NCT03535194|363259555|FG001|Maintenance Period|Adverse Event|5|||
105343468|NCT03535194|363259556|FG002|Maintenance Period|Adverse Event|1|||
105343469|NCT03535194|363259557|FG003|Maintenance Period|Adverse Event|11|||
105343470|NCT03535194|363259558|FG004|Maintenance Period|Adverse Event|4|||
105556303|NCT02564523|364033681|FG008|Overall Study|Physician Decision|0|||
105556304|NCT02564523|364033682|FG009|Overall Study|Physician Decision|0|||
105556305|NCT02564523|364033683|FG010|Overall Study|Physician Decision|1|||
105556306|NCT02564523|364033684|FG011|Overall Study|Physician Decision|0|||
105556307|NCT02564523|364033685|FG012|Overall Study|Physician Decision|0|||
105677536|NCT01076647|364481652|FG001|Overall Study|Protocol Violation|9|||
105677537|NCT01076647|364481651|FG000|Overall Study|Withdrawal criteria|2|||
105343471|NCT03535194|363259554|FG000|Maintenance Period|Lack of Efficacy|3|||
105343472|NCT03535194|363259555|FG001|Maintenance Period|Lack of Efficacy|2|||
105343473|NCT03535194|363259556|FG002|Maintenance Period|Lack of Efficacy|5|||
105556308|NCT02564523|364033686|FG013|Overall Study|Physician Decision|0|||
105556309|NCT02564523|364033687|FG014|Overall Study|Physician Decision|0|||
105556310|NCT02564523|364033688|FG015|Overall Study|Physician Decision|0|||
105677538|NCT01076647|364481652|FG001|Overall Study|Withdrawal criteria|2|||
105677539|NCT01076647|364481651|FG000|Overall Study|Unclassified|12|||
105677540|NCT01076647|364481652|FG001|Overall Study|Unclassified|12|||
105677541|NCT01871805|364481657|FG000|Phase I|Death|7|||
105677542|NCT01871805|364481658|FG001|Phase I|Death|4|||
105677543|NCT01871805|364481659|FG002|Phase I|Death|6|||
105677544|NCT01871805|364481660|FG003|Phase I|Death|2|||
105677545|NCT01871805|364481661|FG004|Phase I|Death|9|||
105677546|NCT01871805|364481662|FG005|Phase I|Death|0|||
105677547|NCT01871805|364481657|FG000|Phase I|Alive in Survival Follow-up|0|||
105677548|NCT01871805|364481658|FG001|Phase I|Alive in Survival Follow-up|2|||
105677549|NCT01871805|364481659|FG002|Phase I|Alive in Survival Follow-up|4|||
105677550|NCT01871805|364481660|FG003|Phase I|Alive in Survival Follow-up|5|||
105677551|NCT01871805|364481661|FG004|Phase I|Alive in Survival Follow-up|4|||
105677552|NCT01871805|364481662|FG005|Phase I|Alive in Survival Follow-up|0|||
105677553|NCT01871805|364481657|FG000|Phase I|Lost to Follow-up|0|||
105677554|NCT01871805|364481658|FG001|Phase I|Lost to Follow-up|1|||
105677555|NCT01871805|364481659|FG002|Phase I|Lost to Follow-up|3|||
105677556|NCT01871805|364481660|FG003|Phase I|Lost to Follow-up|0|||
105677557|NCT01871805|364481661|FG004|Phase I|Lost to Follow-up|0|||
105677558|NCT01871805|364481662|FG005|Phase I|Lost to Follow-up|0|||
105677559|NCT01871805|364481657|FG000|Phase II|Death|0|||
105677560|NCT01871805|364481658|FG001|Phase II|Death|0|||
105677561|NCT01871805|364481659|FG002|Phase II|Death|0|||
105677562|NCT01871805|364481660|FG003|Phase II|Death|0|||
105677563|NCT01871805|364481661|FG004|Phase II|Death|0|||
105677564|NCT01871805|364481662|FG005|Phase II|Death|45|||
105677565|NCT01871805|364481657|FG000|Phase II|Alive in Survival Follow-up|0|||
105677566|NCT01871805|364481658|FG001|Phase II|Alive in Survival Follow-up|0|||
105677567|NCT01871805|364481659|FG002|Phase II|Alive in Survival Follow-up|0|||
105677568|NCT01871805|364481660|FG003|Phase II|Alive in Survival Follow-up|0|||
105677569|NCT01871805|364481661|FG004|Phase II|Alive in Survival Follow-up|0|||
105677570|NCT01871805|364481662|FG005|Phase II|Alive in Survival Follow-up|29|||
105677571|NCT01871805|364481657|FG000|Phase II|Lost to Follow-up|0|||
105677572|NCT01871805|364481658|FG001|Phase II|Lost to Follow-up|0|||
105677573|NCT01871805|364481659|FG002|Phase II|Lost to Follow-up|0|||
105677574|NCT01871805|364481660|FG003|Phase II|Lost to Follow-up|0|||
105677575|NCT01871805|364481661|FG004|Phase II|Lost to Follow-up|0|||
105677576|NCT01871805|364481662|FG005|Phase II|Lost to Follow-up|13|||
105677577|NCT00635427|364481665|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
105677578|NCT00635427|364481666|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
105677579|NCT00635427|364481667|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
105677580|NCT00635427|364481668|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
105677581|NCT00635427|364481669|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
105677582|NCT00635427|364481665|FG000|Overall Study|Death|0|||
105677583|NCT00635427|364481666|FG001|Overall Study|Death|0|||
105677584|NCT00635427|364481667|FG002|Overall Study|Death|0|||
105677585|NCT00635427|364481668|FG003|Overall Study|Death|1|||
105677586|NCT00635427|364481669|FG004|Overall Study|Death|0|||
105677587|NCT00635427|364481665|FG000|Overall Study|Termination Of Study By Sponsor|12|||
105677588|NCT00635427|364481666|FG001|Overall Study|Termination Of Study By Sponsor|6|||
105677589|NCT00635427|364481667|FG002|Overall Study|Termination Of Study By Sponsor|10|||
105677590|NCT00635427|364481668|FG003|Overall Study|Termination Of Study By Sponsor|6|||
105677591|NCT00635427|364481669|FG004|Overall Study|Termination Of Study By Sponsor|6|||
105677592|NCT00635427|364481665|FG000|Overall Study|Withdrawal Of Consent|0|||
105677593|NCT00635427|364481666|FG001|Overall Study|Withdrawal Of Consent|0|||
105677594|NCT00635427|364481667|FG002|Overall Study|Withdrawal Of Consent|0|||
105677595|NCT00635427|364481668|FG003|Overall Study|Withdrawal Of Consent|2|||
105677596|NCT00635427|364481669|FG004|Overall Study|Withdrawal Of Consent|2|||
105677597|NCT04510090|364481680|FG000|FE-HS|Withdrawal by Subject|0|||
105677598|NCT04510090|364481681|FG001|FE-HS|Withdrawal by Subject|0|||
105677599|NCT04510090|364481682|FG002|FE-HS|Withdrawal by Subject|0|||
105677600|NCT04510090|364481683|FG003|FE-HS|Withdrawal by Subject|0|||
105677601|NCT04510090|364481684|FG004|FE-HS|Withdrawal by Subject|1|||
105677602|NCT04510090|364481685|FG005|FE-HS|Withdrawal by Subject|0|||
105556311|NCT02564523|364033689|FG016|Overall Study|Physician Decision|0|||
105556312|NCT02564523|364033690|FG017|Overall Study|Physician Decision|0|||
105556313|NCT02564523|364033673|FG000|Overall Study|Protocol Violation|2|||
105556314|NCT02564523|364033674|FG001|Overall Study|Protocol Violation|2|||
105556315|NCT02564523|364033675|FG002|Overall Study|Protocol Violation|5|||
105556316|NCT02564523|364033676|FG003|Overall Study|Protocol Violation|0|||
105556317|NCT02564523|364033677|FG004|Overall Study|Protocol Violation|1|||
105556318|NCT02564523|364033678|FG005|Overall Study|Protocol Violation|0|||
105556319|NCT02564523|364033679|FG006|Overall Study|Protocol Violation|0|||
105556320|NCT02564523|364033680|FG007|Overall Study|Protocol Violation|0|||
105556321|NCT02564523|364033681|FG008|Overall Study|Protocol Violation|0|||
105677603|NCT04510090|364481686|FG006|FE-HS|Withdrawal by Subject|0|||
105677604|NCT04510090|364481687|FG007|FE-HS|Withdrawal by Subject|0|||
105556322|NCT02564523|364033682|FG009|Overall Study|Protocol Violation|0|||
105677605|NCT03412747|364481688|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
105556323|NCT02564523|364033683|FG010|Overall Study|Protocol Violation|0|||
105556324|NCT02564523|364033684|FG011|Overall Study|Protocol Violation|0|||
105556325|NCT02564523|364033685|FG012|Overall Study|Protocol Violation|0|||
105677606|NCT03412747|364481689|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
105677607|NCT03412747|364481690|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
105677608|NCT03412747|364481688|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
105677609|NCT03412747|364481689|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
105677610|NCT03412747|364481690|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
105677611|NCT03412747|364481688|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
105677612|NCT03412747|364481689|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
105677613|NCT03412747|364481690|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
105677614|NCT03412747|364481688|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
105677615|NCT03412747|364481689|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
105677616|NCT03412747|364481690|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
105677617|NCT03412747|364481688|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
105677618|NCT03412747|364481689|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
105677619|NCT03412747|364481690|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
105677620|NCT03412747|364481688|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
105677621|NCT03412747|364481689|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
105677622|NCT03412747|364481690|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
105677623|NCT03412747|364481688|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
105677624|NCT03412747|364481689|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
105677625|NCT03412747|364481690|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
105677626|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
105677627|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
105677628|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
105677629|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
105677630|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
105677631|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
105677632|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
105677633|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
105677634|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
105677635|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
105677636|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
105677637|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
105677638|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
105677639|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
105677640|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
105677641|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
105677642|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
105677643|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
105677644|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
105677645|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
105677646|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
105677647|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
105677648|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
105677649|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
105677650|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
105677651|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
105677652|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
105677653|NCT02081417|364481693|FG000|Overall Study|Lost to Follow-up|26|||
105677654|NCT02081417|364481694|FG001|Overall Study|Lost to Follow-up|23|||
105677655|NCT02081417|364481693|FG000|Overall Study|Moved Away|1|||
105677656|NCT02081417|364481694|FG001|Overall Study|Moved Away|2|||
105677657|NCT02081417|364481693|FG000|Overall Study|Incarcerated|2|||
105677658|NCT02081417|364481694|FG001|Overall Study|Incarcerated|2|||
105677659|NCT02081417|364481693|FG000|Overall Study|Death|4|||
105677660|NCT02081417|364481694|FG001|Overall Study|Death|3|||
105677661|NCT02081417|364481693|FG000|Overall Study|Withdrawal by Subject|4|||
105677662|NCT02081417|364481694|FG001|Overall Study|Withdrawal by Subject|0|||
105677663|NCT02081417|364481693|FG000|Overall Study|Admitted to Residential Treatment|2|||
105677664|NCT02081417|364481694|FG001|Overall Study|Admitted to Residential Treatment|0|||
105677665|NCT02081417|364481693|FG000|Overall Study|Did not start treatment|17|||
105677666|NCT02081417|364481694|FG001|Overall Study|Did not start treatment|21|||
105677667|NCT01157676|364481697|FG000|Randomization|Death|1|||
105677668|NCT01157676|364481698|FG001|Randomization|Death|1|||
105677669|NCT01157676|364481697|FG000|Randomization|unresectable|2|||
105677670|NCT01157676|364481698|FG001|Randomization|unresectable|3|||
105677671|NCT01157676|364481697|FG000|Randomization|Withdrawal by Subject|17|||
105677672|NCT01157676|364481698|FG001|Randomization|Withdrawal by Subject|13|||
105556326|NCT02564523|364033686|FG013|Overall Study|Protocol Violation|0|||
105556327|NCT02564523|364033687|FG014|Overall Study|Protocol Violation|0|||
105556328|NCT02564523|364033688|FG015|Overall Study|Protocol Violation|0|||
105556329|NCT02564523|364033689|FG016|Overall Study|Protocol Violation|0|||
105556330|NCT02564523|364033690|FG017|Overall Study|Protocol Violation|0|||
105556331|NCT02564523|364033673|FG000|Overall Study|Other|3|||
105556332|NCT02564523|364033674|FG001|Overall Study|Other|0|||
105556333|NCT02564523|364033675|FG002|Overall Study|Other|0|||
105556334|NCT02564523|364033676|FG003|Overall Study|Other|1|||
105556335|NCT02564523|364033677|FG004|Overall Study|Other|0|||
105556336|NCT02564523|364033678|FG005|Overall Study|Other|0|||
105556337|NCT02564523|364033679|FG006|Overall Study|Other|0|||
105556338|NCT02564523|364033680|FG007|Overall Study|Other|0|||
105556339|NCT02564523|364033681|FG008|Overall Study|Other|0|||
105556340|NCT02564523|364033682|FG009|Overall Study|Other|0|||
105556341|NCT02564523|364033683|FG010|Overall Study|Other|0|||
105556342|NCT02564523|364033684|FG011|Overall Study|Other|0|||
105556343|NCT02564523|364033685|FG012|Overall Study|Other|0|||
105556344|NCT02564523|364033686|FG013|Overall Study|Other|0|||
105556345|NCT02564523|364033687|FG014|Overall Study|Other|0|||
105556346|NCT02564523|364033688|FG015|Overall Study|Other|0|||
105556347|NCT02564523|364033689|FG016|Overall Study|Other|0|||
105556348|NCT02564523|364033690|FG017|Overall Study|Other|0|||
105556349|NCT00448539|364033691|FG000|Overall Study|Medication non-compliance|4|||
105556350|NCT00448539|364033692|FG001|Overall Study|Medication non-compliance|1|||
105556351|NCT00448539|364033691|FG000|Overall Study|Protocol Violation|1|||
105556352|NCT00448539|364033692|FG001|Overall Study|Protocol Violation|0|||
105556353|NCT00448539|364033691|FG000|Overall Study|Request of the investigator or sponsor|67|||
105556354|NCT00448539|364033692|FG001|Overall Study|Request of the investigator or sponsor|54|||
105556355|NCT00448539|364033691|FG000|Overall Study|Withdrawal by Subject|20|||
105556356|NCT00448539|364033692|FG001|Overall Study|Withdrawal by Subject|24|||
105556357|NCT00448539|364033691|FG000|Overall Study|Diary non-compliance|1|||
105556358|NCT00448539|364033692|FG001|Overall Study|Diary non-compliance|0|||
105556359|NCT00448539|364033691|FG000|Overall Study|Adverse Event|9|||
105556360|NCT00448539|364033692|FG001|Overall Study|Adverse Event|26|||
105556361|NCT00448539|364033691|FG000|Overall Study|Lack of Efficacy|27|||
105556362|NCT00448539|364033692|FG001|Overall Study|Lack of Efficacy|40|||
105556363|NCT00448539|364033691|FG000|Overall Study|Miscellaneous|2|||
105556364|NCT00448539|364033692|FG001|Overall Study|Miscellaneous|1|||
105556365|NCT00448539|364033691|FG000|Overall Study|Change of meds|2|||
105556366|NCT00448539|364033692|FG001|Overall Study|Change of meds|3|||
105556367|NCT00448539|364033691|FG000|Overall Study|Lost to Follow-up|1|||
105556368|NCT00448539|364033692|FG001|Overall Study|Lost to Follow-up|3|||
105556369|NCT04862143|364033693|FG000|Overall Study|Adverse Event|1|||
105556370|NCT04862143|364033693|FG000|Overall Study|Study terminated by sponsor|1|||
105556371|NCT04447404|364033698|FG000|Overall Study|Death|2|||
105556372|NCT04447404|364033699|FG001|Overall Study|Death|0|||
105556373|NCT01669629|364033702|FG000|Period 1|protocol deviation|1|||
105556374|NCT01669629|364033703|FG001|Period 1|protocol deviation|2|||
105556375|NCT04420689|364033705|FG000|Overall Study|COVID-19 related hospitalization|0|||
105556376|NCT04420689|364033706|FG001|Overall Study|COVID-19 related hospitalization|0|||
105556377|NCT04420689|364033707|FG002|Overall Study|COVID-19 related hospitalization|0|||
105556378|NCT04420689|364033708|FG003|Overall Study|COVID-19 related hospitalization|0|||
105556379|NCT04420689|364033709|FG004|Overall Study|COVID-19 related hospitalization|1|||
105556380|NCT04420689|364033710|FG005|Overall Study|COVID-19 related hospitalization|0|||
105556381|NCT04420689|364033711|FG006|Overall Study|COVID-19 related hospitalization|0|||
105556382|NCT04420689|364033705|FG000|Overall Study|Physician Decision|0|||
105556383|NCT04420689|364033706|FG001|Overall Study|Physician Decision|0|||
105556384|NCT04420689|364033707|FG002|Overall Study|Physician Decision|0|||
105556385|NCT04420689|364033708|FG003|Overall Study|Physician Decision|0|||
105556386|NCT04420689|364033709|FG004|Overall Study|Physician Decision|0|||
105556387|NCT04420689|364033710|FG005|Overall Study|Physician Decision|1|||
105556388|NCT04420689|364033711|FG006|Overall Study|Physician Decision|0|||
105556389|NCT05224050|364033714|FG000|Overall Study|Withdrawal by Subject|9|||
105556390|NCT05224050|364033714|FG000|Overall Study|Lost to Follow-up|3|||
105677673|NCT01157676|364481697|FG000|Randomization|Physician Decision|1|||
105677674|NCT01157676|364481698|FG001|Randomization|Physician Decision|0|||
105677675|NCT01157676|364481697|FG000|Surgery|underwent open cystectomy|0|||
105677676|NCT01157676|364481698|FG001|Surgery|underwent open cystectomy|4|||
105677677|NCT01157676|364481697|FG000|Surgery|converted to open procedure|0|||
105677678|NCT01157676|364481698|FG001|Surgery|converted to open procedure|5|||
105677679|NCT01157676|364481697|FG000|Surgery|underwent robotic cystectomy|1|||
105677680|NCT01157676|364481698|FG001|Surgery|underwent robotic cystectomy|0|||
105677681|NCT01263665|364481702|FG000|Overall Study|Withdrew Consent|1|||
105677682|NCT01263665|364481702|FG000|Overall Study|Lost to Follow-up|3|||
105677683|NCT01263665|364481702|FG000|Overall Study|Death|2|||
105677684|NCT01263665|364481702|FG000|Overall Study|Amputation above the ankle|1|||
105677685|NCT01263665|364481702|FG000|Overall Study|Surgical Bypass|2|||
105677686|NCT01506609|364481705|FG000|Overall Study|Adverse Event Related to Progression|0|||
105677687|NCT01506609|364481706|FG001|Overall Study|Adverse Event Related to Progression|0|||
105677688|NCT01506609|364481707|FG002|Overall Study|Adverse Event Related to Progression|0|||
105677689|NCT01506609|364481708|FG003|Overall Study|Adverse Event Related to Progression|3|||
105677690|NCT01506609|364481709|FG004|Overall Study|Adverse Event Related to Progression|7|||
105677691|NCT01506609|364481710|FG005|Overall Study|Adverse Event Related to Progression|3|||
105677692|NCT01506609|364481705|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
105677693|NCT01506609|364481706|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
105677694|NCT01506609|364481707|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
105677695|NCT01506609|364481708|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
105677696|NCT01506609|364481709|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
105677697|NCT01506609|364481710|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
105677698|NCT01506609|364481705|FG000|Overall Study|Withdrawal by Subject|0|||
105677699|NCT01506609|364481706|FG001|Overall Study|Withdrawal by Subject|0|||
105677700|NCT01506609|364481707|FG002|Overall Study|Withdrawal by Subject|0|||
105677701|NCT01506609|364481708|FG003|Overall Study|Withdrawal by Subject|9|||
105677702|NCT01506609|364481709|FG004|Overall Study|Withdrawal by Subject|7|||
105677703|NCT01506609|364481710|FG005|Overall Study|Withdrawal by Subject|7|||
105677704|NCT01506609|364481705|FG000|Overall Study|Lost to Follow-up|0|||
105677705|NCT01506609|364481706|FG001|Overall Study|Lost to Follow-up|0|||
105677706|NCT01506609|364481707|FG002|Overall Study|Lost to Follow-up|0|||
105677707|NCT01506609|364481708|FG003|Overall Study|Lost to Follow-up|1|||
105677708|NCT01506609|364481709|FG004|Overall Study|Lost to Follow-up|2|||
105677709|NCT01506609|364481710|FG005|Overall Study|Lost to Follow-up|0|||
105677710|NCT01506609|364481705|FG000|Overall Study|Sponsor Discontinued Study|0|||
105677711|NCT01506609|364481706|FG001|Overall Study|Sponsor Discontinued Study|0|||
105677712|NCT01506609|364481707|FG002|Overall Study|Sponsor Discontinued Study|0|||
105677713|NCT01506609|364481708|FG003|Overall Study|Sponsor Discontinued Study|2|||
105677714|NCT01506609|364481709|FG004|Overall Study|Sponsor Discontinued Study|2|||
105677715|NCT01506609|364481710|FG005|Overall Study|Sponsor Discontinued Study|0|||
105677716|NCT01506609|364481705|FG000|Overall Study|Progressive Disease per Protocol|1|||
105677717|NCT01506609|364481706|FG001|Overall Study|Progressive Disease per Protocol|0|||
105677718|NCT01506609|364481707|FG002|Overall Study|Progressive Disease per Protocol|0|||
105677719|NCT01506609|364481708|FG003|Overall Study|Progressive Disease per Protocol|64|||
105677720|NCT01506609|364481709|FG004|Overall Study|Progressive Disease per Protocol|57|||
105677721|NCT01506609|364481710|FG005|Overall Study|Progressive Disease per Protocol|74|||
105677722|NCT01506609|364481705|FG000|Overall Study|Other, Not Specified|0|||
105677723|NCT01506609|364481706|FG001|Overall Study|Other, Not Specified|0|||
105677724|NCT01506609|364481707|FG002|Overall Study|Other, Not Specified|0|||
105677725|NCT01506609|364481708|FG003|Overall Study|Other, Not Specified|10|||
105677726|NCT01506609|364481709|FG004|Overall Study|Other, Not Specified|7|||
105677727|NCT01506609|364481710|FG005|Overall Study|Other, Not Specified|3|||
105677728|NCT01506609|364481705|FG000|Overall Study|Missing / Unknown Reason|1|||
105677729|NCT01506609|364481706|FG001|Overall Study|Missing / Unknown Reason|0|||
105786444|NCT04579666|364871389|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
105677730|NCT01506609|364481707|FG002|Overall Study|Missing / Unknown Reason|1|||
105677731|NCT01506609|364481708|FG003|Overall Study|Missing / Unknown Reason|4|||
105677732|NCT01506609|364481709|FG004|Overall Study|Missing / Unknown Reason|4|||
105677733|NCT01506609|364481710|FG005|Overall Study|Missing / Unknown Reason|2|||
105677734|NCT00252577|364481711|FG000|Overall Study|Lost to Follow-up|20|||
105677735|NCT02962960|364481714|FG000|Overall Study|Withdrawal by Subject|1|||
105677736|NCT02962960|364481715|FG001|Overall Study|Withdrawal by Subject|1|||
105677737|NCT02962960|364481716|FG002|Overall Study|Withdrawal by Subject|0|||
105786445|NCT04579666|364871390|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
105677738|NCT02962960|364481714|FG000|Overall Study|Adverse Event|1|||
105677739|NCT02962960|364481715|FG001|Overall Study|Adverse Event|1|||
105677740|NCT02962960|364481716|FG002|Overall Study|Adverse Event|0|||
105677741|NCT02962960|364481714|FG000|Overall Study|Protocol Violation|1|||
105677742|NCT02962960|364481715|FG001|Overall Study|Protocol Violation|0|||
105677743|NCT02962960|364481716|FG002|Overall Study|Protocol Violation|0|||
105677744|NCT01744392|364481717|FG000|Overall Study|Physician Decision|1|||
105677745|NCT01435616|364481718|FG000|Overall Study|Adverse Event|39|||
105677746|NCT01435616|364481719|FG001|Overall Study|Adverse Event|21|||
105677747|NCT01435616|364481718|FG000|Overall Study|Death|7|||
105677748|NCT01435616|364481719|FG001|Overall Study|Death|2|||
105677749|NCT01435616|364481718|FG000|Overall Study|Lost to Follow-up|22|||
105677750|NCT01435616|364481719|FG001|Overall Study|Lost to Follow-up|13|||
105677751|NCT01435616|364481718|FG000|Overall Study|Protocol Violation|16|||
105677752|NCT01435616|364481719|FG001|Overall Study|Protocol Violation|13|||
105677753|NCT01435616|364481718|FG000|Overall Study|Withdrawal by Subject|66|||
105677754|NCT01435616|364481719|FG001|Overall Study|Withdrawal by Subject|24|||
105677755|NCT01435616|364481718|FG000|Overall Study|Physician Decision|20|||
105677756|NCT01435616|364481719|FG001|Overall Study|Physician Decision|7|||
105677757|NCT01435616|364481718|FG000|Overall Study|Sponsor Decision|1|||
105677758|NCT01435616|364481719|FG001|Overall Study|Sponsor Decision|0|||
105677759|NCT00468559|364481726|FG000|Open-label Treatment Phase|Adverse Event|5|||
105677760|NCT00468559|364481727|FG001|Open-label Treatment Phase|Adverse Event|0|||
105677761|NCT00468559|364481728|FG002|Open-label Treatment Phase|Adverse Event|0|||
105677762|NCT00468559|364481726|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
105677763|NCT00468559|364481727|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
105677764|NCT00468559|364481728|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
105677765|NCT00468559|364481726|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
105677766|NCT00468559|364481727|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
105677767|NCT00468559|364481728|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
105677768|NCT00468559|364481726|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
105677769|NCT00468559|364481727|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
105677770|NCT00468559|364481728|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
105677771|NCT00468559|364481726|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
105677772|NCT00468559|364481727|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
105677773|NCT00468559|364481728|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
105677774|NCT00862719|364481729|FG000|Overall Study|Disease Progression|5|||
105677775|NCT00862719|364481730|FG001|Overall Study|Disease Progression|0|||
105677776|NCT00862719|364481731|FG002|Overall Study|Disease Progression|1|||
105677777|NCT00862719|364481732|FG003|Overall Study|Disease Progression|0|||
105677778|NCT00862719|364481729|FG000|Overall Study|Death|5|||
105677779|NCT00862719|364481730|FG001|Overall Study|Death|6|||
105677780|NCT00862719|364481731|FG002|Overall Study|Death|1|||
105677781|NCT00862719|364481732|FG003|Overall Study|Death|1|||
105677782|NCT00862719|364481729|FG000|Overall Study|Engraftment failure|0|||
105677783|NCT00862719|364481730|FG001|Overall Study|Engraftment failure|0|||
105677784|NCT00862719|364481731|FG002|Overall Study|Engraftment failure|1|||
105677785|NCT00862719|364481732|FG003|Overall Study|Engraftment failure|0|||
105677786|NCT00862719|364481729|FG000|Overall Study|Veno-Occlusive Disease|0|||
105677787|NCT00862719|364481730|FG001|Overall Study|Veno-Occlusive Disease|0|||
105466634|NCT01523756|363720214|FG001|Test Period 1|Adverse Event|0|||
105677788|NCT00862719|364481731|FG002|Overall Study|Veno-Occlusive Disease|1|||
105677789|NCT00862719|364481732|FG003|Overall Study|Veno-Occlusive Disease|0|||
105677790|NCT00324116|364481733|FG000|Overall Study|Adverse Event|5|||
105677791|NCT00324116|364481733|FG000|Overall Study|Lack of Efficacy|17|||
105677792|NCT00324116|364481733|FG000|Overall Study|Withdrawal by Subject|5|||
105677793|NCT00324116|364481733|FG000|Overall Study|Other|5|||
105677794|NCT01806623|364481736|FG000|Overall Study|Withdrawal by Subject|1|||
105677795|NCT01806623|364481736|FG000|Overall Study|Adverse Event|1|||
105677796|NCT01806623|364481736|FG000|Overall Study|Did not meet the inclusion criteria|56|||
105677797|NCT01451827|364481743|FG000|Overall Study|Adverse Event|2|||
105677798|NCT01451827|364481744|FG001|Overall Study|Adverse Event|0|||
105677799|NCT01451827|364481745|FG002|Overall Study|Adverse Event|1|||
105677800|NCT01451827|364481746|FG003|Overall Study|Adverse Event|1|||
105677801|NCT01451827|364481743|FG000|Overall Study|Protocol deviation|1|||
105677802|NCT01451827|364481744|FG001|Overall Study|Protocol deviation|0|||
105786446|NCT04579666|364871387|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
105786447|NCT04579666|364871388|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
105677803|NCT01451827|364481745|FG002|Overall Study|Protocol deviation|0|||
105677804|NCT01451827|364481746|FG003|Overall Study|Protocol deviation|0|||
105677805|NCT01451827|364481743|FG000|Overall Study|Lost to Follow-up|0|||
105677806|NCT01451827|364481744|FG001|Overall Study|Lost to Follow-up|3|||
105677807|NCT01451827|364481745|FG002|Overall Study|Lost to Follow-up|0|||
105677808|NCT01451827|364481746|FG003|Overall Study|Lost to Follow-up|2|||
105677809|NCT01451827|364481743|FG000|Overall Study|Participant met withdrawal criteria|0|||
105677810|NCT01451827|364481744|FG001|Overall Study|Participant met withdrawal criteria|2|||
105677811|NCT01451827|364481745|FG002|Overall Study|Participant met withdrawal criteria|0|||
105677812|NCT01451827|364481746|FG003|Overall Study|Participant met withdrawal criteria|0|||
105677813|NCT01451827|364481743|FG000|Overall Study|Withdrawal by Subject|0|||
105677814|NCT01451827|364481744|FG001|Overall Study|Withdrawal by Subject|0|||
105677815|NCT01451827|364481745|FG002|Overall Study|Withdrawal by Subject|1|||
105677816|NCT01451827|364481746|FG003|Overall Study|Withdrawal by Subject|1|||
105677817|NCT00620282|364481747|FG000|Overall Study|Adverse Event|0|||
105677818|NCT00620282|364481748|FG001|Overall Study|Adverse Event|1|||
105677819|NCT00620282|364481749|FG002|Overall Study|Adverse Event|0|||
105677820|NCT00620282|364481747|FG000|Overall Study|Arterial line unable to be placed|0|||
105677821|NCT00620282|364481748|FG001|Overall Study|Arterial line unable to be placed|0|||
105677822|NCT00620282|364481749|FG002|Overall Study|Arterial line unable to be placed|1|||
105677823|NCT00620282|364481747|FG000|Overall Study|Withdrawal by Subject|0|||
105677824|NCT00620282|364481748|FG001|Overall Study|Withdrawal by Subject|1|||
105677825|NCT00620282|364481749|FG002|Overall Study|Withdrawal by Subject|0|||
105677826|NCT01964924|364481750|FG000|Trametinib Monotherapy|Progression|19|||
105677827|NCT01964924|364481751|FG001|Trametinib Monotherapy|Progression|0|||
105677828|NCT02217475|364481752|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
105677829|NCT02217475|364481753|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
105677830|NCT02217475|364481754|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
105677831|NCT02217475|364481752|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
105677832|NCT02217475|364481753|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
105677833|NCT02217475|364481754|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
105677834|NCT02217475|364481752|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
105677835|NCT02217475|364481753|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
105677836|NCT02217475|364481754|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
105677837|NCT02217475|364481752|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
105677838|NCT02217475|364481753|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
105677839|NCT02217475|364481754|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
105677840|NCT02217475|364481752|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
105677841|NCT02217475|364481753|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
105677842|NCT02217475|364481754|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
105677843|NCT02217475|364481752|FG000|Discontinued After Period 1|Adverse Event|1|||
105677844|NCT02217475|364481753|FG001|Discontinued After Period 1|Adverse Event|2|||
105677845|NCT02217475|364481754|FG002|Discontinued After Period 1|Adverse Event|0|||
105677846|NCT02217475|364481752|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
105677847|NCT02217475|364481753|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
105677848|NCT02217475|364481754|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
105677849|NCT02217475|364481752|FG000|Discontinued After Period 1|Physician Decision|0|||
105677850|NCT02217475|364481753|FG001|Discontinued After Period 1|Physician Decision|0|||
105677851|NCT02217475|364481754|FG002|Discontinued After Period 1|Physician Decision|1|||
105677852|NCT02217475|364481752|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
105677853|NCT02217475|364481753|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
105677854|NCT02217475|364481754|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
105677855|NCT02217475|364481752|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
105677856|NCT02217475|364481753|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
105677857|NCT02217475|364481754|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
105677858|NCT02217475|364481752|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
105677859|NCT02217475|364481753|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
105677860|NCT02217475|364481754|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
105677861|NCT02217475|364481752|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
105677862|NCT02217475|364481753|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
105677863|NCT02217475|364481754|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
105677864|NCT02217475|364481752|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
105677865|NCT02217475|364481753|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
105677866|NCT02217475|364481754|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
105677867|NCT02544451|364481759|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
105677868|NCT02544451|364481760|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
105677869|NCT02544451|364481761|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
105677870|NCT02544451|364481762|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
105677871|NCT02544451|364481759|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
105677872|NCT02544451|364481760|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
105677873|NCT02544451|364481761|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
105677874|NCT02544451|364481762|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
105677875|NCT02544451|364481759|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
105677876|NCT02544451|364481760|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
105677877|NCT02544451|364481761|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
105677878|NCT02544451|364481762|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
105677879|NCT02544451|364481759|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
105677880|NCT02544451|364481760|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
105677881|NCT02544451|364481761|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
105677882|NCT02544451|364481762|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
105677883|NCT02544451|364481759|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
105677884|NCT02544451|364481760|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
105677885|NCT02544451|364481761|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
105677886|NCT02544451|364481762|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
105677887|NCT02544451|364481759|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
105677888|NCT02544451|364481760|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
105677889|NCT02544451|364481761|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
105677890|NCT02544451|364481762|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
105677891|NCT03001076|364481764|FG000|Overall Study|Withdrawal by patient|2|||
105677892|NCT03001076|364481765|FG001|Overall Study|Withdrawal by patient|0|||
105677893|NCT03001076|364481764|FG000|Overall Study|Other|1|||
105677894|NCT03001076|364481765|FG001|Overall Study|Other|0|||
105677895|NCT03001076|364481764|FG000|Overall Study|Adverse Event|3|||
105677896|NCT03001076|364481765|FG001|Overall Study|Adverse Event|3|||
105677897|NCT03001076|364481764|FG000|Overall Study|Sponsor decision|1|||
105677898|NCT03001076|364481765|FG001|Overall Study|Sponsor decision|0|||
105677899|NCT03001076|364481764|FG000|Overall Study|Lost to Follow-up|0|||
105677900|NCT03001076|364481765|FG001|Overall Study|Lost to Follow-up|2|||
105677901|NCT02842151|364481772|FG000|Overall Study|Adverse Event|1|||
105677902|NCT02842151|364481772|FG000|Overall Study|Subject moved too far away|1|||
105677903|NCT01262027|364481773|FG000|Overall Study|Adverse Event|1|||
105677904|NCT01262027|364481773|FG000|Overall Study|Withdrawal by Subject|3|||
105677905|NCT01262027|364481773|FG000|Overall Study|Protocol Violation|1|||
105677906|NCT03562975|364481783|FG000|Overall Study|Death|1|||
105677907|NCT03562975|364481783|FG000|Overall Study|Lost to Follow-up|1|||
105677908|NCT03562975|364481783|FG000|Overall Study|Withdrawal by Subject|1|||
105677909|NCT03149549|364481784|FG000|Study Discontinuation--Treatment Period|Death|0|||
105677910|NCT03149549|364481785|FG001|Study Discontinuation--Treatment Period|Death|0|||
105677911|NCT03149549|364481786|FG002|Study Discontinuation--Treatment Period|Death|0|||
105677912|NCT03149549|364481787|FG003|Study Discontinuation--Treatment Period|Death|1|||
105677913|NCT03149549|364481788|FG004|Study Discontinuation--Treatment Period|Death|2|||
105677914|NCT03149549|364481789|FG005|Study Discontinuation--Treatment Period|Death|1|||
105677915|NCT03149549|364481790|FG006|Study Discontinuation--Treatment Period|Death|1|||
105677916|NCT03149549|364481791|FG007|Study Discontinuation--Treatment Period|Death|2|||
105677917|NCT03149549|364481792|FG008|Study Discontinuation--Treatment Period|Death|4|||
105677918|NCT03149549|364481793|FG009|Study Discontinuation--Treatment Period|Death|1|||
105677919|NCT03149549|364481794|FG010|Study Discontinuation--Treatment Period|Death|0|||
105677920|NCT03149549|364481795|FG011|Study Discontinuation--Treatment Period|Death|0|||
105677921|NCT03149549|364481796|FG012|Study Discontinuation--Treatment Period|Death|1|||
105677922|NCT03149549|364481784|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677923|NCT03149549|364481785|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677924|NCT03149549|364481786|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677925|NCT03149549|364481787|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677926|NCT03149549|364481788|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677927|NCT03149549|364481789|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677928|NCT03149549|364481790|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677929|NCT03149549|364481791|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
105677930|NCT03149549|364481792|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677931|NCT03149549|364481793|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677932|NCT03149549|364481794|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677933|NCT03149549|364481795|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677934|NCT03149549|364481796|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
105677935|NCT03149549|364481784|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677936|NCT03149549|364481785|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677937|NCT03149549|364481786|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677938|NCT03149549|364481787|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
105677939|NCT03149549|364481788|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
105677940|NCT03149549|364481789|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
105677941|NCT03149549|364481790|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
105677942|NCT03149549|364481791|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677943|NCT03149549|364481792|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
105677944|NCT03149549|364481793|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677945|NCT03149549|364481794|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677946|NCT03149549|364481795|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677947|NCT03149549|364481796|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677948|NCT03149549|364481784|FG000|Study Discontinuation--Treatment Period|Other|0|||
105677949|NCT03149549|364481785|FG001|Study Discontinuation--Treatment Period|Other|0|||
105677950|NCT03149549|364481786|FG002|Study Discontinuation--Treatment Period|Other|0|||
105677951|NCT03149549|364481787|FG003|Study Discontinuation--Treatment Period|Other|0|||
105677952|NCT03149549|364481788|FG004|Study Discontinuation--Treatment Period|Other|0|||
105677953|NCT03149549|364481789|FG005|Study Discontinuation--Treatment Period|Other|0|||
105677954|NCT03149549|364481790|FG006|Study Discontinuation--Treatment Period|Other|0|||
105677955|NCT03149549|364481791|FG007|Study Discontinuation--Treatment Period|Other|1|||
105677956|NCT03149549|364481792|FG008|Study Discontinuation--Treatment Period|Other|0|||
105677957|NCT03149549|364481793|FG009|Study Discontinuation--Treatment Period|Other|1|||
105556391|NCT02278328|364033715|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
105556392|NCT02278328|364033716|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
105677958|NCT03149549|364481794|FG010|Study Discontinuation--Treatment Period|Other|0|||
105677959|NCT03149549|364481795|FG011|Study Discontinuation--Treatment Period|Other|0|||
105677960|NCT03149549|364481796|FG012|Study Discontinuation--Treatment Period|Other|0|||
105677961|NCT03149549|364481784|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677962|NCT03149549|364481785|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677963|NCT03149549|364481786|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677964|NCT03149549|364481787|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677965|NCT03149549|364481788|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677966|NCT03149549|364481789|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
105677967|NCT03149549|364481790|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
105677968|NCT03149549|364481791|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677969|NCT03149549|364481792|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
105677970|NCT03149549|364481793|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677971|NCT03149549|364481794|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677972|NCT03149549|364481795|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677973|NCT03149549|364481796|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677974|NCT03149549|364481784|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677975|NCT03149549|364481785|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677976|NCT03149549|364481786|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677977|NCT03149549|364481787|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677978|NCT03149549|364481788|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
105677979|NCT03149549|364481789|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677980|NCT03149549|364481790|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677981|NCT03149549|364481791|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
105677982|NCT03149549|364481792|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
105677983|NCT03149549|364481793|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677984|NCT03149549|364481794|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677985|NCT03149549|364481795|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
105677986|NCT03149549|364481796|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
105786448|NCT04579666|364871389|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
105786449|NCT04579666|364871390|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
105786450|NCT04579666|364871387|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
105786451|NCT04579666|364871388|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
105786452|NCT04579666|364871389|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
105786453|NCT04579666|364871390|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
105786454|NCT04579666|364871387|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
105786455|NCT04579666|364871388|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
105786456|NCT04579666|364871389|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
105786457|NCT04579666|364871390|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
105786458|NCT04579666|364871387|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
105786459|NCT04579666|364871388|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
105786460|NCT04579666|364871389|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
105786461|NCT04579666|364871390|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
105786462|NCT00643006|364871392|FG000|Overall Study|Lost to Follow-up|5|||
105786463|NCT00643006|364871393|FG001|Overall Study|Lost to Follow-up|4|||
105786464|NCT02506101|364871394|FG000|Overall Study|Transportation issues|1|||
105786465|NCT02506101|364871395|FG001|Overall Study|Transportation issues|0|||
105786466|NCT02506101|364871394|FG000|Overall Study|No enrollment and staff unavailability|1|||
105343474|NCT03535194|363259557|FG003|Maintenance Period|Lack of Efficacy|9|||
105677987|NCT03149549|364481784|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
105786467|NCT02506101|364871395|FG001|Overall Study|No enrollment and staff unavailability|0|||
105786468|NCT03605758|364871396|FG000|Overall Study|Lost to Follow-up|2|||
105677988|NCT03149549|364481785|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
105677989|NCT03149549|364481786|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
105677990|NCT03149549|364481787|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
105570283|NCT01806584|364086737|FG001|Overall Study|Lost to Follow-up|2|||
105570284|NCT01806584|364086736|FG000|Overall Study|Study terminated by sponsor|9|||
105570285|NCT01806584|364086737|FG001|Overall Study|Study terminated by sponsor|14|||
105570286|NCT01806584|364086736|FG000|Overall Study|Withdrawal by Subject|1|||
105570287|NCT01806584|364086737|FG001|Overall Study|Withdrawal by Subject|1|||
105570288|NCT01806584|364086736|FG000|Overall Study|Other unspecified|1|||
105570289|NCT01806584|364086737|FG001|Overall Study|Other unspecified|0|||
105570290|NCT03021668|364086738|FG000|Overall Study|Physician Decision|0|||
105570291|NCT03021668|364086739|FG001|Overall Study|Physician Decision|1|||
105570292|NCT03573908|364086748|FG000|Treatment Period|Adverse Event|4|||
105570293|NCT03573908|364086749|FG001|Treatment Period|Adverse Event|9|||
105570294|NCT03573908|364086750|FG002|Treatment Period|Adverse Event|0|||
105570295|NCT03573908|364086751|FG003|Treatment Period|Adverse Event|0|||
105570296|NCT03573908|364086752|FG004|Treatment Period|Adverse Event|0|||
105570297|NCT03573908|364086748|FG000|Treatment Period|Protocol Violation|1|||
105570298|NCT03573908|364086749|FG001|Treatment Period|Protocol Violation|0|||
105570299|NCT03573908|364086750|FG002|Treatment Period|Protocol Violation|0|||
105570300|NCT03573908|364086751|FG003|Treatment Period|Protocol Violation|0|||
105570301|NCT03573908|364086752|FG004|Treatment Period|Protocol Violation|0|||
105570302|NCT03573908|364086748|FG000|Treatment Period|Withdrawal by Subject|7|||
105570303|NCT03573908|364086749|FG001|Treatment Period|Withdrawal by Subject|5|||
105570304|NCT03573908|364086750|FG002|Treatment Period|Withdrawal by Subject|0|||
105570305|NCT03573908|364086751|FG003|Treatment Period|Withdrawal by Subject|0|||
105570306|NCT03573908|364086752|FG004|Treatment Period|Withdrawal by Subject|0|||
105570307|NCT03573908|364086748|FG000|Treatment Period|Lost to Follow-up|7|||
105570308|NCT03573908|364086749|FG001|Treatment Period|Lost to Follow-up|6|||
105570309|NCT03573908|364086750|FG002|Treatment Period|Lost to Follow-up|0|||
105570310|NCT03573908|364086751|FG003|Treatment Period|Lost to Follow-up|0|||
105570311|NCT03573908|364086752|FG004|Treatment Period|Lost to Follow-up|0|||
105570312|NCT03573908|364086748|FG000|Treatment Period|Pregnancy|1|||
105570313|NCT03573908|364086749|FG001|Treatment Period|Pregnancy|0|||
105570314|NCT03573908|364086750|FG002|Treatment Period|Pregnancy|0|||
105570315|NCT03573908|364086751|FG003|Treatment Period|Pregnancy|0|||
105570316|NCT03573908|364086752|FG004|Treatment Period|Pregnancy|0|||
105677991|NCT03149549|364481788|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
105677992|NCT03149549|364481789|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
105677993|NCT03149549|364481790|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
105677994|NCT03149549|364481791|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
105677995|NCT03149549|364481792|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
105677996|NCT03149549|364481793|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
105677997|NCT03149549|364481794|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
105677998|NCT03149549|364481795|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
105677999|NCT03149549|364481796|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
105678000|NCT03149549|364481784|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
105678001|NCT03149549|364481785|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
105678002|NCT03149549|364481786|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
105678003|NCT03149549|364481787|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
105678004|NCT03149549|364481788|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
105678005|NCT03149549|364481789|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
105678006|NCT03149549|364481790|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
105678007|NCT03149549|364481791|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
105678008|NCT03149549|364481792|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
105678009|NCT03149549|364481793|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
105678010|NCT03149549|364481794|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
105678011|NCT03149549|364481795|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
105678012|NCT03149549|364481796|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
105678013|NCT03149549|364481784|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
105678014|NCT03149549|364481785|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
105678015|NCT03149549|364481786|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
105678016|NCT03149549|364481787|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
105678017|NCT03149549|364481788|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
105678018|NCT03149549|364481789|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
105678019|NCT03149549|364481790|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
105678020|NCT03149549|364481791|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
105678021|NCT03149549|364481792|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
105678022|NCT03149549|364481793|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
105678023|NCT03149549|364481794|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
105678024|NCT03149549|364481795|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
105678025|NCT03149549|364481796|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
105678026|NCT01758900|364481799|FG000|Overall Study|difficulty for further intubation|7|||
105678027|NCT01758900|364481800|FG001|Overall Study|difficulty for further intubation|8|||
105678028|NCT00935818|364481801|FG000|Overall Study|Withdrawal by Subject|45|||
105678029|NCT00935818|364481802|FG001|Overall Study|Withdrawal by Subject|50|||
105678030|NCT00935818|364481801|FG000|Overall Study|Lost to Follow-up|40|||
105678031|NCT00935818|364481802|FG001|Overall Study|Lost to Follow-up|42|||
105678032|NCT00935818|364481801|FG000|Overall Study|Adverse Event|6|||
105678033|NCT00935818|364481802|FG001|Overall Study|Adverse Event|7|||
105678034|NCT00935818|364481801|FG000|Overall Study|Physician Decision|0|||
105678035|NCT00935818|364481802|FG001|Overall Study|Physician Decision|1|||
105678036|NCT01305200|364481804|FG000|Overall Study|Physician Decision|4|||
105678037|NCT01305200|364481805|FG001|Overall Study|Physician Decision|6|||
105678038|NCT01305200|364481806|FG002|Overall Study|Physician Decision|1|||
105343475|NCT03535194|363259558|FG004|Maintenance Period|Lack of Efficacy|0|||
105678039|NCT01305200|364481804|FG000|Overall Study|Withdrawal by Subject|24|||
105678040|NCT01305200|364481805|FG001|Overall Study|Withdrawal by Subject|21|||
105678041|NCT01305200|364481806|FG002|Overall Study|Withdrawal by Subject|1|||
105678042|NCT01305200|364481804|FG000|Overall Study|Ineligible|1|||
105678043|NCT01305200|364481805|FG001|Overall Study|Ineligible|2|||
105678044|NCT01305200|364481806|FG002|Overall Study|Ineligible|1|||
105678045|NCT01305200|364481804|FG000|Overall Study|Death|0|||
105678046|NCT01305200|364481805|FG001|Overall Study|Death|2|||
105678047|NCT01305200|364481806|FG002|Overall Study|Death|0|||
105678048|NCT02317432|364481807|FG000|Overall Study|Death|4|||
105678049|NCT02317432|364481808|FG001|Overall Study|Death|1|||
105343476|NCT03535194|363259554|FG000|Maintenance Period|Lost to Follow-up|4|||
105678050|NCT02317432|364481807|FG000|Overall Study|Lost to Follow-up|0|||
105678051|NCT02317432|364481808|FG001|Overall Study|Lost to Follow-up|5|||
105678052|NCT02317432|364481807|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
105678053|NCT02317432|364481808|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
105678054|NCT00923260|364483399|FG000|Overall Study|Lost to Follow-up|1|||
105678055|NCT00923260|364483400|FG001|Overall Study|Lost to Follow-up|1|||
105678056|NCT02233543|364483402|FG000|Period 1|Withdrawal by Subject|1|||
105678057|NCT02233543|364483403|FG001|Period 1|Withdrawal by Subject|0|||
105678058|NCT02233543|364483402|FG000|Period 1|Participants required other treatment.|2|||
105678059|NCT02233543|364483403|FG001|Period 1|Participants required other treatment.|3|||
105678060|NCT02233543|364483402|FG000|Period 2|Adverse Event|1|||
105678061|NCT02233543|364483403|FG001|Period 2|Adverse Event|0|||
105678062|NCT02233543|364483402|FG000|Period 2|Participant required other treatment.|0|||
105678063|NCT02233543|364483403|FG001|Period 2|Participant required other treatment.|1|||
105678064|NCT02233543|364483402|FG000|Period 2|COPD exacerbation|1|||
105678065|NCT02233543|364483403|FG001|Period 2|COPD exacerbation|0|||
105678066|NCT02349425|364483404|FG000|Period 1|Adverse Event|1|||
105678067|NCT02349425|364483405|FG001|Period 1|Adverse Event|1|||
105678068|NCT02349425|364483406|FG002|Period 1|Adverse Event|0|||
105678069|NCT02349425|364483407|FG003|Period 1|Adverse Event|0|||
105678070|NCT02349425|364483404|FG000|Period 2|Adverse Event|0|||
105678071|NCT02349425|364483405|FG001|Period 2|Adverse Event|1|||
105678072|NCT02349425|364483406|FG002|Period 2|Adverse Event|1|||
105678073|NCT02349425|364483407|FG003|Period 2|Adverse Event|0|||
105678074|NCT03573583|364483408|FG000|Overall Study|Lost to Follow-up|1|||
105678075|NCT03573583|364483409|FG001|Overall Study|Lost to Follow-up|0|||
105678076|NCT03573583|364483408|FG000|Overall Study|Withdrawal by Subject|1|||
105678077|NCT03573583|364483409|FG001|Overall Study|Withdrawal by Subject|1|||
105678078|NCT04343872|364483414|FG000|Overall Study|Lost to Follow-up|6|||
105678079|NCT04343872|364483415|FG001|Overall Study|Lost to Follow-up|3|||
105678080|NCT00591721|364483416|FG000|Overall Study|Withdrawal by Subject|10|||
105678081|NCT00591721|364483417|FG001|Overall Study|Withdrawal by Subject|10|||
105678082|NCT00591721|364483416|FG000|Overall Study|Lost to Follow-up|1|||
105786469|NCT03605758|364871397|FG001|Overall Study|Lost to Follow-up|1|||
105678083|NCT00591721|364483417|FG001|Overall Study|Lost to Follow-up|4|||
105678084|NCT00591721|364483416|FG000|Overall Study|Intervention not received|10|||
105678085|NCT00591721|364483417|FG001|Overall Study|Intervention not received|8|||
105678086|NCT03730480|364483418|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
105678087|NCT01119105|364483423|FG000|Overall Study|Withdrawal by Subject|1|||
105678088|NCT01119105|364483424|FG001|Overall Study|Withdrawal by Subject|1|||
105678089|NCT01119105|364483425|FG002|Overall Study|Withdrawal by Subject|1|||
105678090|NCT01119105|364483423|FG000|Overall Study|Lost to Follow-up|0|||
105678091|NCT01119105|364483424|FG001|Overall Study|Lost to Follow-up|2|||
105678092|NCT01119105|364483425|FG002|Overall Study|Lost to Follow-up|5|||
105678093|NCT01119105|364483423|FG000|Overall Study|Adverse Event|1|||
105678094|NCT01119105|364483424|FG001|Overall Study|Adverse Event|0|||
105678095|NCT01119105|364483425|FG002|Overall Study|Adverse Event|1|||
105678096|NCT01119105|364483423|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
105678097|NCT01119105|364483424|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
105678098|NCT01119105|364483425|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
105678099|NCT01119105|364483423|FG000|Overall Study|Other|1|||
105678100|NCT01119105|364483424|FG001|Overall Study|Other|1|||
105678101|NCT01119105|364483425|FG002|Overall Study|Other|0|||
105678102|NCT02383056|364483426|FG000|Overall Study|Adverse Event|1|||
105678103|NCT02383056|364483427|FG001|Overall Study|Adverse Event|0|||
105678104|NCT02383056|364483426|FG000|Overall Study|Lost to Follow-up|0|||
105678105|NCT02383056|364483427|FG001|Overall Study|Lost to Follow-up|2|||
105678106|NCT00581555|364483428|FG000|Overall Study|Adverse Event|4|||
105678107|NCT00581555|364483429|FG001|Overall Study|Adverse Event|3|||
105678108|NCT00581555|364483428|FG000|Overall Study|Physician Decision|3|||
105678109|NCT00581555|364483429|FG001|Overall Study|Physician Decision|2|||
105678110|NCT00581555|364483428|FG000|Overall Study|Withdrawal by Subject|18|||
105678111|NCT00581555|364483429|FG001|Overall Study|Withdrawal by Subject|9|||
105678112|NCT00581555|364483428|FG000|Overall Study|Lost to Follow-up|2|||
105343477|NCT03535194|363259555|FG001|Maintenance Period|Lost to Follow-up|2|||
105343478|NCT03535194|363259556|FG002|Maintenance Period|Lost to Follow-up|1|||
105678113|NCT00581555|364483429|FG001|Overall Study|Lost to Follow-up|2|||
105678114|NCT00581555|364483428|FG000|Overall Study|Other reasons|16|||
105678115|NCT00581555|364483429|FG001|Overall Study|Other reasons|4|||
105678116|NCT03507777|364483430|FG000|Overall Study|Lost to Follow-up|5|||
105678117|NCT03507777|364483431|FG001|Overall Study|Lost to Follow-up|7|||
105678118|NCT03507777|364483430|FG000|Overall Study|Withdrawal by Subject|6|||
105678119|NCT03507777|364483431|FG001|Overall Study|Withdrawal by Subject|11|||
105678120|NCT03507777|364483430|FG000|Overall Study|Death|30|||
105678121|NCT03507777|364483431|FG001|Overall Study|Death|44|||
105678122|NCT03507777|364483430|FG000|Overall Study|Other Reasons|3|||
105678123|NCT03507777|364483431|FG001|Overall Study|Other Reasons|8|||
105678124|NCT02245737|364483433|FG000|Overall Study|Adverse Event|23|||
105678125|NCT02245737|364483434|FG001|Overall Study|Adverse Event|26|||
105678126|NCT02245737|364483435|FG002|Overall Study|Adverse Event|33|||
105678127|NCT02245737|364483433|FG000|Overall Study|Condition Worsened|9|||
105678128|NCT02245737|364483434|FG001|Overall Study|Condition Worsened|10|||
105678129|NCT02245737|364483435|FG002|Overall Study|Condition Worsened|9|||
105678130|NCT02245737|364483433|FG000|Overall Study|Death|2|||
105678131|NCT02245737|364483434|FG001|Overall Study|Death|4|||
105678132|NCT02245737|364483435|FG002|Overall Study|Death|4|||
105678133|NCT02245737|364483433|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
105678134|NCT02245737|364483434|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
105678135|NCT02245737|364483435|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
105678136|NCT02245737|364483433|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
105678137|NCT02245737|364483434|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
105678138|NCT02245737|364483435|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
105678139|NCT02245737|364483433|FG000|Overall Study|Lost to Follow-up|2|||
105678140|NCT02245737|364483434|FG001|Overall Study|Lost to Follow-up|5|||
105678141|NCT02245737|364483435|FG002|Overall Study|Lost to Follow-up|4|||
105678142|NCT02245737|364483433|FG000|Overall Study|Other-determined by Investigator|9|||
105678143|NCT02245737|364483434|FG001|Overall Study|Other-determined by Investigator|10|||
105678144|NCT02245737|364483435|FG002|Overall Study|Other-determined by Investigator|10|||
105678145|NCT02245737|364483433|FG000|Overall Study|Physician Decision|6|||
105678146|NCT02245737|364483434|FG001|Overall Study|Physician Decision|3|||
105678147|NCT02245737|364483435|FG002|Overall Study|Physician Decision|6|||
105678148|NCT02245737|364483433|FG000|Overall Study|Protocol Violation|3|||
105678149|NCT02245737|364483434|FG001|Overall Study|Protocol Violation|2|||
105678150|NCT02245737|364483435|FG002|Overall Study|Protocol Violation|3|||
105678151|NCT02245737|364483433|FG000|Overall Study|Withdrawal by Subject|40|||
105678152|NCT02245737|364483434|FG001|Overall Study|Withdrawal by Subject|41|||
105678153|NCT02245737|364483435|FG002|Overall Study|Withdrawal by Subject|44|||
105678154|NCT02245737|364483433|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
105678155|NCT02245737|364483434|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
105678156|NCT02245737|364483435|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
105678157|NCT02245737|364483433|FG000|Overall Study|Sponsor Decision|445|||
105678158|NCT02245737|364483434|FG001|Overall Study|Sponsor Decision|430|||
105678159|NCT02245737|364483435|FG002|Overall Study|Sponsor Decision|432|||
105678160|NCT02929329|364483440|FG000|Overall Study|Withdrawal by Subject|24|||
105678161|NCT02929329|364483441|FG001|Overall Study|Withdrawal by Subject|21|||
105678162|NCT02929329|364483440|FG000|Overall Study|Lost to Follow-up|26|||
105678163|NCT02929329|364483441|FG001|Overall Study|Lost to Follow-up|20|||
105678164|NCT02929329|364483440|FG000|Overall Study|Death|1054|||
105678165|NCT02929329|364483441|FG001|Overall Study|Death|1051|||
105678166|NCT04772898|364483442|FG000|Overall Study|Withdrawal by Subject|0|||
105678167|NCT04772898|364483443|FG001|Overall Study|Withdrawal by Subject|1|||
105678168|NCT02947087|364483448|FG000|Overall Study|Withdrawal by Subject|3|||
105678169|NCT02947087|364483449|FG001|Overall Study|Withdrawal by Subject|2|||
105678170|NCT00037830|364483452|FG000|Overall Study|Adverse Event|2|||
105678171|NCT00037830|364483453|FG001|Overall Study|Adverse Event|0|||
105678172|NCT00037830|364483454|FG002|Overall Study|Adverse Event|0|||
105786470|NCT03605758|364871396|FG000|Overall Study|Illness|0|||
105786471|NCT03605758|364871397|FG001|Overall Study|Illness|1|||
105678173|NCT00037830|364483452|FG000|Overall Study|Withdrawal by Subject|4|||
105678174|NCT00037830|364483453|FG001|Overall Study|Withdrawal by Subject|5|||
105678175|NCT00037830|364483454|FG002|Overall Study|Withdrawal by Subject|1|||
105678176|NCT00037830|364483452|FG000|Overall Study|Protocol Violation|2|||
105678177|NCT00037830|364483453|FG001|Overall Study|Protocol Violation|2|||
105678178|NCT00037830|364483454|FG002|Overall Study|Protocol Violation|0|||
105678179|NCT00037830|364483452|FG000|Overall Study|Unrelated Medical Problem|2|||
105678180|NCT00037830|364483453|FG001|Overall Study|Unrelated Medical Problem|0|||
105678181|NCT00037830|364483454|FG002|Overall Study|Unrelated Medical Problem|0|||
105678182|NCT03651622|364483455|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
105678183|NCT03651622|364483456|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
105678184|NCT03651622|364483457|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
105678185|NCT03651622|364483455|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
105678186|NCT03651622|364483456|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
105678187|NCT03651622|364483457|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
105678188|NCT03651622|364483455|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
105678189|NCT03651622|364483456|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
105678190|NCT03651622|364483457|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
105678191|NCT03651622|364483455|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
105678192|NCT03651622|364483456|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
105678193|NCT03651622|364483457|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
105678194|NCT03651622|364483455|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
105678195|NCT03651622|364483456|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
105678196|NCT03651622|364483457|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
105678197|NCT00006011|364483459|FG000|Overall Study|Disease progression|13|||
105678198|NCT00006011|364483460|FG001|Overall Study|Disease progression|6|||
105678199|NCT00006011|364483461|FG002|Overall Study|Disease progression|26|||
105678200|NCT00006011|364483459|FG000|Overall Study|Refused further treatment|15|||
105678201|NCT00006011|364483460|FG001|Overall Study|Refused further treatment|13|||
105678202|NCT00006011|364483461|FG002|Overall Study|Refused further treatment|26|||
105678203|NCT00006011|364483459|FG000|Overall Study|Adverse Event|15|||
105678204|NCT00006011|364483460|FG001|Overall Study|Adverse Event|39|||
105678205|NCT00006011|364483461|FG002|Overall Study|Adverse Event|5|||
105678206|NCT00006011|364483459|FG000|Overall Study|Death|0|||
105678207|NCT00006011|364483460|FG001|Overall Study|Death|1|||
105678208|NCT00006011|364483461|FG002|Overall Study|Death|2|||
105678209|NCT00006011|364483459|FG000|Overall Study|Other|4|||
105678210|NCT00006011|364483460|FG001|Overall Study|Other|2|||
105678211|NCT00006011|364483461|FG002|Overall Study|Other|5|||
105678212|NCT00006011|364483459|FG000|Overall Study|Ineligible|18|||
105678213|NCT00006011|364483460|FG001|Overall Study|Ineligible|16|||
105678214|NCT00006011|364483461|FG002|Overall Study|Ineligible|9|||
105678215|NCT03292432|364483468|FG000|Overall Study|Lost to Follow-up|11|||
105678216|NCT03292432|364483469|FG001|Overall Study|Lost to Follow-up|8|||
105678217|NCT03292432|364483468|FG000|Overall Study|Death|2|||
105678218|NCT03292432|364483469|FG001|Overall Study|Death|1|||
105678219|NCT03292432|364483468|FG000|Overall Study|Withdrawal by Subject|1|||
105678220|NCT03292432|364483469|FG001|Overall Study|Withdrawal by Subject|2|||
105678221|NCT03292432|364483468|FG000|Overall Study|Site closed before any data collected|1|||
105678222|NCT03292432|364483469|FG001|Overall Study|Site closed before any data collected|0|||
105678223|NCT00911937|364483471|FG000|Overall Study|Death|1|||
105678224|NCT00911937|364483472|FG001|Overall Study|Death|0|||
105678225|NCT00911937|364483471|FG000|Overall Study|Lost to Follow-up|8|||
105678226|NCT00911937|364483472|FG001|Overall Study|Lost to Follow-up|5|||
105678227|NCT00911937|364483471|FG000|Overall Study|Withdrawal by Subject|10|||
105678228|NCT00911937|364483472|FG001|Overall Study|Withdrawal by Subject|7|||
105678229|NCT00911937|364483471|FG000|Overall Study|Withdrawn due to pregnancy|1|||
105678230|NCT00911937|364483472|FG001|Overall Study|Withdrawn due to pregnancy|0|||
105678231|NCT00911937|364483471|FG000|Overall Study|Adverse Event|11|||
105678232|NCT00911937|364483472|FG001|Overall Study|Adverse Event|25|||
105678233|NCT00911937|364483471|FG000|Overall Study|Lack of Efficacy|11|||
105678234|NCT00911937|364483472|FG001|Overall Study|Lack of Efficacy|6|||
105678235|NCT00911937|364483471|FG000|Overall Study|Did not meet inclusion criteria|9|||
105678236|NCT00911937|364483472|FG001|Overall Study|Did not meet inclusion criteria|11|||
105678237|NCT00911937|364483471|FG000|Overall Study|Protocol Violation|14|||
105678238|NCT00911937|364483472|FG001|Overall Study|Protocol Violation|23|||
105678239|NCT00911937|364483471|FG000|Overall Study|Randomized but not treated|13|||
105678240|NCT00911937|364483472|FG001|Overall Study|Randomized but not treated|13|||
105678241|NCT00911937|364483471|FG000|Overall Study|Other|9|||
105678242|NCT00911937|364483472|FG001|Overall Study|Other|5|||
105678243|NCT02207569|364483480|FG000|1-Month|Death|6|||
105678244|NCT02207569|364483480|FG000|1-Month|Withdrawal by Subject|2|||
105678245|NCT02207569|364483480|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
105678246|NCT02207569|364483480|FG000|6-Month|Death|8|||
105678247|NCT02207569|364483480|FG000|6-Month|Withdrawal by Subject|2|||
105678248|NCT02207569|364483480|FG000|12-Month|Death|14|||
105678249|NCT02207569|364483480|FG000|12-Month|Withdrawal by Subject|2|||
105678250|NCT02207569|364483480|FG000|24-Month|Death|23|||
105678251|NCT02207569|364483480|FG000|24-Month|Withdrawal by Subject|3|||
105678252|NCT02207569|364483480|FG000|36-Month|Death|23|||
105678253|NCT02207569|364483480|FG000|36-Month|Withdrawal by Subject|4|||
105678254|NCT02207569|364483480|FG000|48-Month|Death|25|||
105678255|NCT02207569|364483480|FG000|48-Month|Withdrawal by Subject|2|||
105678256|NCT02207569|364483480|FG000|48-Month|Lost to Follow-up|4|||
105678257|NCT02207569|364483480|FG000|60-Month|Death|1|||
105678258|NCT02207569|364483480|FG000|60-Month|Lost to Follow-up|1|||
105678259|NCT02207569|364483480|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
105678260|NCT02207569|364483480|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
105678261|NCT02683876|364483481|FG000|Overall Study|samples damaged during shipping|2|||
105678262|NCT02683876|364483482|FG001|Overall Study|samples damaged during shipping|0|||
105678263|NCT02930226|364483483|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
105678264|NCT02930226|364483484|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
105678265|NCT02930226|364483485|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
105678266|NCT02930226|364483486|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
105678267|NCT02930226|364483487|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
105678268|NCT02930226|364483488|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
105678269|NCT04738292|364483491|FG000|Overall Study|Death|1|||
105678270|NCT01151410|364483492|FG000|Overall Study|Withdrawal by Subject|3|||
105678271|NCT01151410|364483493|FG001|Overall Study|Withdrawal by Subject|5|||
105678272|NCT01151410|364483492|FG000|Overall Study|Lost to Follow-up|3|||
105678273|NCT01151410|364483493|FG001|Overall Study|Lost to Follow-up|4|||
105343479|NCT03535194|363259557|FG003|Maintenance Period|Lost to Follow-up|5|||
105343480|NCT03535194|363259558|FG004|Maintenance Period|Lost to Follow-up|2|||
105343481|NCT03535194|363259554|FG000|Maintenance Period|Other|1|||
105343482|NCT03535194|363259555|FG001|Maintenance Period|Other|2|||
105343483|NCT03535194|363259556|FG002|Maintenance Period|Other|0|||
105343484|NCT03535194|363259557|FG003|Maintenance Period|Other|0|||
105343485|NCT03535194|363259558|FG004|Maintenance Period|Other|0|||
105343486|NCT03535194|363259554|FG000|Maintenance Period|Physician Decision|1|||
105343487|NCT03535194|363259555|FG001|Maintenance Period|Physician Decision|2|||
105343488|NCT03535194|363259556|FG002|Maintenance Period|Physician Decision|0|||
105343489|NCT03535194|363259557|FG003|Maintenance Period|Physician Decision|2|||
105343490|NCT03535194|363259558|FG004|Maintenance Period|Physician Decision|0|||
105343491|NCT03535194|363259554|FG000|Maintenance Period|Pregnancy|0|||
105343492|NCT03535194|363259555|FG001|Maintenance Period|Pregnancy|0|||
105343493|NCT03535194|363259556|FG002|Maintenance Period|Pregnancy|0|||
105343494|NCT03535194|363259557|FG003|Maintenance Period|Pregnancy|2|||
105343495|NCT03535194|363259558|FG004|Maintenance Period|Pregnancy|0|||
105343496|NCT03535194|363259554|FG000|Maintenance Period|Protocol Violation|0|||
105343497|NCT03535194|363259555|FG001|Maintenance Period|Protocol Violation|1|||
105343498|NCT03535194|363259556|FG002|Maintenance Period|Protocol Violation|0|||
105678274|NCT01151410|364483492|FG000|Overall Study|Adverse Event|1|||
105678275|NCT01151410|364483493|FG001|Overall Study|Adverse Event|2|||
105678276|NCT01151410|364483492|FG000|Overall Study|Protocol deviation|2|||
105678277|NCT01151410|364483493|FG001|Overall Study|Protocol deviation|1|||
105678278|NCT01151410|364483492|FG000|Overall Study|Administrative problems|1|||
105678279|NCT01151410|364483493|FG001|Overall Study|Administrative problems|1|||
105678280|NCT01151410|364483492|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105678281|NCT01151410|364483493|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105678282|NCT01151410|364483492|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105678283|NCT01151410|364483493|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105678284|NCT01131182|364483494|FG000|Overall Study|Withdrawal by Subject|1|||
105678285|NCT01131182|364483495|FG001|Overall Study|Withdrawal by Subject|1|||
105678286|NCT01131182|364483494|FG000|Overall Study|Lost to Follow-up|14|||
105678287|NCT01131182|364483495|FG001|Overall Study|Lost to Follow-up|15|||
105343499|NCT03535194|363259557|FG003|Maintenance Period|Protocol Violation|0|||
105343500|NCT03535194|363259558|FG004|Maintenance Period|Protocol Violation|0|||
105343501|NCT03535194|363259554|FG000|Maintenance Period|Withdrawal by Subject|7|||
105343502|NCT03535194|363259555|FG001|Maintenance Period|Withdrawal by Subject|2|||
105343503|NCT03535194|363259556|FG002|Maintenance Period|Withdrawal by Subject|1|||
105343504|NCT03535194|363259557|FG003|Maintenance Period|Withdrawal by Subject|8|||
105343505|NCT03535194|363259558|FG004|Maintenance Period|Withdrawal by Subject|0|||
105343506|NCT03535194|363259554|FG000|Post-Treatment Followup Period|Adverse Event|4|||
105343507|NCT03535194|363259555|FG001|Post-Treatment Followup Period|Adverse Event|5|||
105343508|NCT03535194|363259556|FG002|Post-Treatment Followup Period|Adverse Event|1|||
105343509|NCT03535194|363259557|FG003|Post-Treatment Followup Period|Adverse Event|8|||
105343510|NCT03535194|363259558|FG004|Post-Treatment Followup Period|Adverse Event|0|||
105343511|NCT03535194|363259554|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
105343512|NCT03535194|363259555|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
105343513|NCT03535194|363259556|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
105343514|NCT03535194|363259557|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
105343515|NCT03535194|363259558|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
105343516|NCT03535194|363259554|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
105343517|NCT03535194|363259555|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
105343518|NCT03535194|363259556|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
105343519|NCT03535194|363259557|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
105343520|NCT03535194|363259558|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
105343521|NCT03535194|363259554|FG000|Post-Treatment Followup Period|Other|1|||
105343522|NCT03535194|363259555|FG001|Post-Treatment Followup Period|Other|0|||
105343523|NCT03535194|363259556|FG002|Post-Treatment Followup Period|Other|0|||
105343524|NCT03535194|363259557|FG003|Post-Treatment Followup Period|Other|5|||
105343525|NCT03535194|363259558|FG004|Post-Treatment Followup Period|Other|0|||
105343526|NCT03535194|363259554|FG000|Post-Treatment Followup Period|Physician Decision|0|||
105343527|NCT03535194|363259555|FG001|Post-Treatment Followup Period|Physician Decision|2|||
105343528|NCT03535194|363259556|FG002|Post-Treatment Followup Period|Physician Decision|1|||
105678288|NCT01131182|364483494|FG000|Overall Study|Other Reason|1|||
105678289|NCT01131182|364483495|FG001|Overall Study|Other Reason|0|||
105343529|NCT03535194|363259557|FG003|Post-Treatment Followup Period|Physician Decision|1|||
105343530|NCT03535194|363259558|FG004|Post-Treatment Followup Period|Physician Decision|0|||
105343531|NCT03535194|363259554|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
105343532|NCT03535194|363259555|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
105343533|NCT03535194|363259556|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
105343534|NCT03535194|363259557|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
105343535|NCT03535194|363259558|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105343536|NCT05896527|363259559|FG000|Overall Study|Withdrawal by Subject|11|||
105678290|NCT01820585|364483496|FG000|Overall Study|Adverse Event|9|||
105678291|NCT01820585|364483497|FG001|Overall Study|Adverse Event|13|||
105678292|NCT01820585|364483498|FG002|Overall Study|Adverse Event|23|||
105678293|NCT01820585|364483499|FG003|Overall Study|Adverse Event|34|||
105678294|NCT01820585|364483496|FG000|Overall Study|Lack of Efficacy|9|||
105678295|NCT01820585|364483497|FG001|Overall Study|Lack of Efficacy|7|||
105678296|NCT01820585|364483498|FG002|Overall Study|Lack of Efficacy|5|||
105678297|NCT01820585|364483499|FG003|Overall Study|Lack of Efficacy|1|||
105678298|NCT01820585|364483496|FG000|Overall Study|Withdrawal by Subject|3|||
105678299|NCT01820585|364483497|FG001|Overall Study|Withdrawal by Subject|7|||
105678300|NCT01820585|364483498|FG002|Overall Study|Withdrawal by Subject|3|||
105678301|NCT01820585|364483499|FG003|Overall Study|Withdrawal by Subject|8|||
105678302|NCT01820585|364483496|FG000|Overall Study|Lost to Follow-up|3|||
105678303|NCT01820585|364483497|FG001|Overall Study|Lost to Follow-up|3|||
105343537|NCT05896527|363259560|FG001|Overall Study|Withdrawal by Subject|10|||
105343538|NCT05896527|363259561|FG002|Overall Study|Withdrawal by Subject|4|||
105343539|NCT05896527|363259562|FG003|Overall Study|Withdrawal by Subject|3|||
105343540|NCT05896527|363259563|FG004|Overall Study|Withdrawal by Subject|2|||
105343541|NCT05896527|363259559|FG000|Overall Study|Lost to Follow-up|0|||
105343542|NCT05896527|363259560|FG001|Overall Study|Lost to Follow-up|2|||
105343543|NCT05896527|363259561|FG002|Overall Study|Lost to Follow-up|2|||
105678304|NCT01820585|364483498|FG002|Overall Study|Lost to Follow-up|0|||
105678305|NCT01820585|364483499|FG003|Overall Study|Lost to Follow-up|3|||
105678306|NCT01820585|364483496|FG000|Overall Study|Protocol Violation|3|||
105678307|NCT01820585|364483497|FG001|Overall Study|Protocol Violation|1|||
105678308|NCT01820585|364483498|FG002|Overall Study|Protocol Violation|1|||
105678309|NCT01820585|364483499|FG003|Overall Study|Protocol Violation|1|||
105678310|NCT01820585|364483496|FG000|Overall Study|Subject non-compliance|0|||
105343544|NCT05896527|363259562|FG003|Overall Study|Lost to Follow-up|2|||
105678311|NCT01820585|364483497|FG001|Overall Study|Subject non-compliance|0|||
105678312|NCT01820585|364483498|FG002|Overall Study|Subject non-compliance|1|||
105343545|NCT05896527|363259563|FG004|Overall Study|Lost to Follow-up|1|||
105556393|NCT02278328|364033717|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
105556394|NCT02278328|364033715|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
105556395|NCT02278328|364033716|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
105556396|NCT02278328|364033717|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
105556397|NCT02278328|364033715|FG000|Neuropsych Screening|incomplete consent|0|||
105556398|NCT02278328|364033716|FG001|Neuropsych Screening|incomplete consent|0|||
105556399|NCT02278328|364033717|FG002|Neuropsych Screening|incomplete consent|2|||
105556400|NCT03927950|364033718|FG000|Overall Study|Adverse Event|9|||
105556401|NCT02015676|364033719|FG000|Overall Study|Adverse Event|2|||
105556402|NCT02015676|364033720|FG001|Overall Study|Adverse Event|18|||
105556403|NCT02015676|364033721|FG002|Overall Study|Adverse Event|0|||
105556404|NCT02015676|364033719|FG000|Overall Study|Lack of Efficacy|2|||
105556405|NCT02015676|364033720|FG001|Overall Study|Lack of Efficacy|4|||
105556406|NCT02015676|364033721|FG002|Overall Study|Lack of Efficacy|0|||
105556407|NCT02015676|364033719|FG000|Overall Study|Protocol Violation|1|||
105556408|NCT02015676|364033720|FG001|Overall Study|Protocol Violation|0|||
105556409|NCT02015676|364033721|FG002|Overall Study|Protocol Violation|0|||
105556410|NCT02015676|364033719|FG000|Overall Study|Withdrawal by Subject|1|||
105556411|NCT02015676|364033720|FG001|Overall Study|Withdrawal by Subject|7|||
105556412|NCT02015676|364033721|FG002|Overall Study|Withdrawal by Subject|1|||
105556413|NCT02015676|364033719|FG000|Overall Study|Administrative reasons|0|||
105556414|NCT02015676|364033720|FG001|Overall Study|Administrative reasons|3|||
105556415|NCT02015676|364033721|FG002|Overall Study|Administrative reasons|1|||
105556416|NCT02015676|364033719|FG000|Overall Study|Death|0|||
105556417|NCT02015676|364033720|FG001|Overall Study|Death|1|||
105556418|NCT02015676|364033721|FG002|Overall Study|Death|0|||
105556419|NCT02015676|364033719|FG000|Overall Study|Disease progression|3|||
105556420|NCT02015676|364033720|FG001|Overall Study|Disease progression|1|||
105556421|NCT02015676|364033721|FG002|Overall Study|Disease progression|1|||
105556422|NCT01654549|364033727|FG000|Overall Study|H.pylori eradication not successful|0|||
105556423|NCT01654549|364033728|FG001|Overall Study|H.pylori eradication not successful|1|||
105556424|NCT00224874|364033729|FG000|Overall Study|Withdrawal by Subject|0|||
105556425|NCT00224874|364033730|FG001|Overall Study|Withdrawal by Subject|0|||
105556426|NCT00224874|364033731|FG002|Overall Study|Withdrawal by Subject|1|||
105556427|NCT00224874|364033732|FG003|Overall Study|Withdrawal by Subject|0|||
105556428|NCT02807558|364033735|FG000|Overall Study|Consent withdrawn by participant|4|||
105556429|NCT02807558|364033736|FG001|Overall Study|Consent withdrawn by participant|0|||
105556430|NCT02807558|364033737|FG002|Overall Study|Consent withdrawn by participant|4|||
105556431|NCT02807558|364033738|FG003|Overall Study|Consent withdrawn by participant|2|||
105556432|NCT02807558|364033739|FG004|Overall Study|Consent withdrawn by participant|1|||
105556433|NCT02807558|364033740|FG005|Overall Study|Consent withdrawn by participant|0|||
105556434|NCT02807558|364033735|FG000|Overall Study|Non-compliance with Study Drug|0|||
105556435|NCT02807558|364033736|FG001|Overall Study|Non-compliance with Study Drug|0|||
105556436|NCT02807558|364033737|FG002|Overall Study|Non-compliance with Study Drug|1|||
105556437|NCT02807558|364033738|FG003|Overall Study|Non-compliance with Study Drug|0|||
105678313|NCT01820585|364483499|FG003|Overall Study|Subject non-compliance|2|||
105678314|NCT01820585|364483496|FG000|Overall Study|at sponsor request|0|||
105678315|NCT01820585|364483497|FG001|Overall Study|at sponsor request|0|||
105678316|NCT01820585|364483498|FG002|Overall Study|at sponsor request|1|||
105678317|NCT01820585|364483499|FG003|Overall Study|at sponsor request|0|||
105678318|NCT01820585|364483496|FG000|Overall Study|Pregnancy|0|||
105678319|NCT01820585|364483497|FG001|Overall Study|Pregnancy|1|||
105678320|NCT01820585|364483498|FG002|Overall Study|Pregnancy|0|||
105678321|NCT01820585|364483499|FG003|Overall Study|Pregnancy|0|||
105678322|NCT01712659|364483500|FG000|Dose Escalation|Physician Decision|0|||
105678323|NCT01712659|364483501|FG001|Dose Escalation|Physician Decision|1|||
105678324|NCT01712659|364483502|FG002|Dose Escalation|Physician Decision|0|||
105678325|NCT01712659|364483503|FG003|Dose Escalation|Physician Decision|0|||
105678326|NCT01712659|364483504|FG004|Dose Escalation|Physician Decision|0|||
105678327|NCT01712659|364483500|FG000|Dose Escalation|Unable to take study drug|0|||
105678328|NCT01712659|364483501|FG001|Dose Escalation|Unable to take study drug|1|||
105678329|NCT01712659|364483502|FG002|Dose Escalation|Unable to take study drug|0|||
105678330|NCT01712659|364483503|FG003|Dose Escalation|Unable to take study drug|0|||
105678331|NCT01712659|364483504|FG004|Dose Escalation|Unable to take study drug|0|||
105678332|NCT01712659|364483500|FG000|Dose Expansion|Early disease progression|1|||
105556438|NCT02807558|364033739|FG004|Overall Study|Non-compliance with Study Drug|0|||
105556439|NCT02807558|364033740|FG005|Overall Study|Non-compliance with Study Drug|0|||
105556440|NCT02807558|364033735|FG000|Overall Study|Adverse Event|0|||
105556441|NCT02807558|364033736|FG001|Overall Study|Adverse Event|0|||
105556442|NCT02807558|364033737|FG002|Overall Study|Adverse Event|9|||
105556443|NCT02807558|364033738|FG003|Overall Study|Adverse Event|0|||
105556444|NCT02807558|364033739|FG004|Overall Study|Adverse Event|0|||
105556445|NCT02807558|364033740|FG005|Overall Study|Adverse Event|0|||
105556446|NCT02807558|364033735|FG000|Overall Study|Death|23|||
105556447|NCT02807558|364033736|FG001|Overall Study|Death|2|||
105556448|NCT02807558|364033737|FG002|Overall Study|Death|3|||
105556449|NCT02807558|364033738|FG003|Overall Study|Death|43|||
105556450|NCT02807558|364033739|FG004|Overall Study|Death|24|||
105556451|NCT02807558|364033740|FG005|Overall Study|Death|15|||
105556452|NCT02807558|364033735|FG000|Overall Study|Progressive Disease|0|||
105556453|NCT02807558|364033736|FG001|Overall Study|Progressive Disease|0|||
105678333|NCT01712659|364483501|FG001|Dose Expansion|Early disease progression|0|||
105556454|NCT02807558|364033737|FG002|Overall Study|Progressive Disease|1|||
105556455|NCT02807558|364033738|FG003|Overall Study|Progressive Disease|0|||
105556456|NCT02807558|364033739|FG004|Overall Study|Progressive Disease|0|||
105556457|NCT02807558|364033740|FG005|Overall Study|Progressive Disease|0|||
105556458|NCT02807558|364033735|FG000|Overall Study|Other than specified|1|||
105556459|NCT02807558|364033736|FG001|Overall Study|Other than specified|0|||
105786472|NCT03605758|364871396|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
105786473|NCT03605758|364871397|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
105678334|NCT01712659|364483502|FG002|Dose Expansion|Early disease progression|0|||
105678335|NCT01712659|364483503|FG003|Dose Expansion|Early disease progression|0|||
105678336|NCT01712659|364483504|FG004|Dose Expansion|Early disease progression|0|||
105678337|NCT01712659|364483500|FG000|Dose Expansion|Physician Decision|1|||
105678338|NCT01712659|364483501|FG001|Dose Expansion|Physician Decision|0|||
105678339|NCT01712659|364483502|FG002|Dose Expansion|Physician Decision|0|||
105678340|NCT01712659|364483503|FG003|Dose Expansion|Physician Decision|0|||
105678341|NCT01712659|364483504|FG004|Dose Expansion|Physician Decision|0|||
105678342|NCT01489891|364483506|FG000|Overall Study|Endoscopy failure|1|||
105678343|NCT01489891|364483507|FG001|Overall Study|Endoscopy failure|0|||
105678344|NCT02270515|364483508|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
105678345|NCT02270515|364483508|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
105678346|NCT02270515|364483508|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
105678347|NCT02270515|364483508|FG000|Intervention Period 1: 0-6 Months|Death|7|||
105678348|NCT02270515|364483508|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
105678349|NCT02270515|364483508|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
105678350|NCT02270515|364483508|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
105678351|NCT02270515|364483508|FG000|Intervention Period 2: 6-12 Months|Death|5|||
105678352|NCT02270515|364483508|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
105678353|NCT02270515|364483508|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
105678354|NCT02270515|364483508|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
105678355|NCT02270515|364483508|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
105678356|NCT02270515|364483508|FG000|Intervention Period 3: 12-18 Months|Death|3|||
105678357|NCT02270515|364483508|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
105678358|NCT01853644|364483509|FG000|Registration and Treatment Start|Did not start treatment|1|||
105678359|NCT01853644|364483509|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
105678360|NCT01853644|364483509|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
105678361|NCT01853644|364483509|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
105556460|NCT02807558|364033737|FG002|Overall Study|Other than specified|2|||
105556461|NCT02807558|364033738|FG003|Overall Study|Other than specified|0|||
105556462|NCT02807558|364033739|FG004|Overall Study|Other than specified|1|||
105556463|NCT02807558|364033740|FG005|Overall Study|Other than specified|1|||
105556464|NCT02807558|364033735|FG000|Overall Study|Lack of Efficacy|0|||
105556465|NCT02807558|364033736|FG001|Overall Study|Lack of Efficacy|0|||
105556466|NCT02807558|364033737|FG002|Overall Study|Lack of Efficacy|9|||
105556467|NCT02807558|364033738|FG003|Overall Study|Lack of Efficacy|0|||
105678362|NCT01853644|364483509|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
105556468|NCT02807558|364033739|FG004|Overall Study|Lack of Efficacy|0|||
105556469|NCT02807558|364033740|FG005|Overall Study|Lack of Efficacy|0|||
105556470|NCT02701985|364033741|FG000|Overall Study|Withdrawal by Subject|1|||
105556471|NCT02701985|364033742|FG001|Overall Study|Withdrawal by Subject|1|||
105678363|NCT01853644|364483509|FG000|Continued Treatment After First Response|Adverse Event|2|||
105678364|NCT01853644|364483509|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
105678365|NCT01237587|364483510|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
105678366|NCT01237587|364483511|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
105678367|NCT01237587|364483510|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
105678368|NCT01237587|364483511|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
105678369|NCT01237587|364483510|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
105678370|NCT01237587|364483511|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
105678371|NCT01237587|364483510|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
105556472|NCT02701985|364033741|FG000|Overall Study|Lost to Follow-up|1|||
105678372|NCT01237587|364483511|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
105678373|NCT01237587|364483510|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
105678374|NCT01237587|364483511|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
105678375|NCT01237587|364483510|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
105678376|NCT01237587|364483511|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
105678377|NCT01237587|364483510|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
105678378|NCT01237587|364483511|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
105678379|NCT01237587|364483510|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
105678380|NCT01237587|364483511|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
105678381|NCT01237587|364483510|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
105678382|NCT01237587|364483511|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
105678383|NCT01237587|364483510|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
105678384|NCT01237587|364483511|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
105678385|NCT01237587|364483510|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
105678386|NCT01237587|364483511|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
105678387|NCT01237587|364483510|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
105678388|NCT01237587|364483511|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
105678389|NCT01237587|364483510|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
105678390|NCT01237587|364483511|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
105678391|NCT01237587|364483510|FG000|Taper Phase|Adverse Event|0|||
105678392|NCT01237587|364483511|FG001|Taper Phase|Adverse Event|2|||
105678393|NCT01237587|364483510|FG000|Taper Phase|Protocol Violation|2|||
105678394|NCT01237587|364483511|FG001|Taper Phase|Protocol Violation|0|||
105678395|NCT01237587|364483510|FG000|Taper Phase|Lack of Efficacy|2|||
105678396|NCT01237587|364483511|FG001|Taper Phase|Lack of Efficacy|5|||
105678397|NCT01237587|364483510|FG000|Taper Phase|Parent/Guardian Decision|0|||
105466635|NCT01523756|363720213|FG000|Test Period 2|Withdrawal by Subject|0|||
105466636|NCT01523756|363720214|FG001|Test Period 2|Withdrawal by Subject|1|||
105466637|NCT06042855|363720217|FG000|Overall Study|No Receipt of Study Drug|48|||
105466638|NCT06042855|363720218|FG001|Overall Study|No Receipt of Study Drug|57|||
105466639|NCT06042855|363720217|FG000|Overall Study|Administratively Withdrawn|59|||
105466640|NCT06042855|363720218|FG001|Overall Study|Administratively Withdrawn|59|||
105466641|NCT02379091|363720219|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
105466642|NCT02379091|363720220|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
105466643|NCT02379091|363720221|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
105466644|NCT02379091|363720222|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
105466645|NCT02379091|363720219|FG000|Overall Study|Principal Investigator Discretion|0|||
105466646|NCT02379091|363720220|FG001|Overall Study|Principal Investigator Discretion|1|||
105466647|NCT02379091|363720221|FG002|Overall Study|Principal Investigator Discretion|0|||
105466648|NCT02379091|363720222|FG003|Overall Study|Principal Investigator Discretion|0|||
105466649|NCT02379091|363720219|FG000|Overall Study|Lost to Follow-up|0|||
105466650|NCT02379091|363720220|FG001|Overall Study|Lost to Follow-up|0|||
105466651|NCT02379091|363720221|FG002|Overall Study|Lost to Follow-up|0|||
105466652|NCT02379091|363720222|FG003|Overall Study|Lost to Follow-up|1|||
105466653|NCT02379091|363720219|FG000|Overall Study|Voluntary Withdrawal|2|||
105466654|NCT02379091|363720220|FG001|Overall Study|Voluntary Withdrawal|5|||
105466655|NCT02379091|363720221|FG002|Overall Study|Voluntary Withdrawal|2|||
105466656|NCT02379091|363720222|FG003|Overall Study|Voluntary Withdrawal|4|||
105466657|NCT02379091|363720219|FG000|Overall Study|Study Termination|7|||
105466658|NCT02379091|363720220|FG001|Overall Study|Study Termination|2|||
105678398|NCT01237587|364483511|FG001|Taper Phase|Parent/Guardian Decision|2|||
105343546|NCT05896527|363259559|FG000|Overall Study|Significant protocol noncompliance|0|||
105343547|NCT05896527|363259560|FG001|Overall Study|Significant protocol noncompliance|1|||
105343548|NCT05896527|363259561|FG002|Overall Study|Significant protocol noncompliance|0|||
105343549|NCT05896527|363259562|FG003|Overall Study|Significant protocol noncompliance|0|||
105343550|NCT05896527|363259563|FG004|Overall Study|Significant protocol noncompliance|0|||
105343551|NCT05896527|363259559|FG000|Overall Study|Eligibility criteria not met|1|||
105343552|NCT05896527|363259560|FG001|Overall Study|Eligibility criteria not met|0|||
105343553|NCT05896527|363259561|FG002|Overall Study|Eligibility criteria not met|0|||
105343554|NCT05896527|363259562|FG003|Overall Study|Eligibility criteria not met|0|||
105343555|NCT05896527|363259563|FG004|Overall Study|Eligibility criteria not met|0|||
105343556|NCT05896527|363259559|FG000|Overall Study|Sponsor's decision|0|||
105343557|NCT05896527|363259560|FG001|Overall Study|Sponsor's decision|0|||
105343558|NCT05896527|363259561|FG002|Overall Study|Sponsor's decision|0|||
105343559|NCT05896527|363259562|FG003|Overall Study|Sponsor's decision|1|||
105343560|NCT05896527|363259563|FG004|Overall Study|Sponsor's decision|0|||
105343561|NCT05896527|363259559|FG000|Overall Study|Investigator's decision|0|||
105343562|NCT05896527|363259560|FG001|Overall Study|Investigator's decision|1|||
105343563|NCT05896527|363259561|FG002|Overall Study|Investigator's decision|0|||
105343564|NCT05896527|363259562|FG003|Overall Study|Investigator's decision|0|||
105343565|NCT05896527|363259563|FG004|Overall Study|Investigator's decision|0|||
105343566|NCT05896527|363259559|FG000|Overall Study|Pregnancy of his partner|0|||
105343567|NCT05896527|363259560|FG001|Overall Study|Pregnancy of his partner|0|||
105343568|NCT05896527|363259561|FG002|Overall Study|Pregnancy of his partner|0|||
105343569|NCT05896527|363259562|FG003|Overall Study|Pregnancy of his partner|1|||
105343570|NCT05896527|363259563|FG004|Overall Study|Pregnancy of his partner|0|||
105343571|NCT03781583|363259565|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
105343572|NCT03781583|363259566|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
105343573|NCT03781583|363259567|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
105343574|NCT03781583|363259568|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
105343575|NCT03781583|363259565|FG000|Overall Study|Technology did not work for that person in that environment|1|||
105343576|NCT03781583|363259566|FG001|Overall Study|Technology did not work for that person in that environment|0|||
105343577|NCT03781583|363259567|FG002|Overall Study|Technology did not work for that person in that environment|0|||
105343578|NCT03781583|363259568|FG003|Overall Study|Technology did not work for that person in that environment|0|||
105343579|NCT03781583|363259565|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
105343580|NCT03781583|363259566|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
105343581|NCT03781583|363259567|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
105343582|NCT03781583|363259568|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
105343583|NCT03781583|363259565|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
105343584|NCT03781583|363259566|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
105343585|NCT03781583|363259567|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
105343586|NCT03781583|363259568|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
105343587|NCT01968707|363259572|FG000|Overall Study|Did not meet treatment day baseline|49|||
105343588|NCT01968707|363259573|FG001|Overall Study|Did not meet treatment day baseline|12|||
105343589|NCT01968707|363259574|FG002|Overall Study|Did not meet treatment day baseline|41|||
105343590|NCT01968707|363259575|FG003|Overall Study|Did not meet treatment day baseline|44|||
105343591|NCT01968707|363259576|FG004|Overall Study|Did not meet treatment day baseline|36|||
105343592|NCT01968707|363259577|FG005|Overall Study|Did not meet treatment day baseline|11|||
105343593|NCT01968707|363259578|FG006|Overall Study|Did not meet treatment day baseline|34|||
105343594|NCT01968707|363259579|FG007|Overall Study|Did not meet treatment day baseline|35|||
105343595|NCT00916344|363259580|FG000|Overall Study|Death|2|||
105343596|NCT00916344|363259580|FG000|Overall Study|ICD upgrade|1|||
105343597|NCT00916344|363259580|FG000|Overall Study|Drop-out|5|||
105343598|NCT02474589|363259581|FG000|Overall Study|Adverse Event|6|||
105343599|NCT02474589|363259582|FG001|Overall Study|Adverse Event|2|||
105343600|NCT02474589|363259581|FG000|Overall Study|Lost to Follow-up|6|||
105343601|NCT02474589|363259582|FG001|Overall Study|Lost to Follow-up|1|||
105343602|NCT02474589|363259581|FG000|Overall Study|Protocol Violation|4|||
105343603|NCT02474589|363259582|FG001|Overall Study|Protocol Violation|1|||
105343604|NCT02474589|363259581|FG000|Overall Study|Withdrawal by Subject|4|||
105343605|NCT02474589|363259582|FG001|Overall Study|Withdrawal by Subject|0|||
105343606|NCT02474589|363259581|FG000|Overall Study|Inability to complete study procedures|5|||
105343607|NCT02474589|363259582|FG001|Overall Study|Inability to complete study procedures|1|||
105343608|NCT02457832|363259583|FG000|Training|Lost to Follow-up|10|||
105343609|NCT02457832|363259584|FG001|Training|Lost to Follow-up|6|||
105343610|NCT02457832|363259585|FG002|Training|Lost to Follow-up|3|||
105343611|NCT02457832|363259583|FG000|One Month Washout|Lost to Follow-up|0|||
105556473|NCT02701985|364033742|FG001|Overall Study|Lost to Follow-up|0|||
105556474|NCT02701985|364033741|FG000|Overall Study|Death|1|||
105556475|NCT02701985|364033742|FG001|Overall Study|Death|0|||
105466659|NCT02379091|363720221|FG002|Overall Study|Study Termination|5|||
105466660|NCT02379091|363720222|FG003|Overall Study|Study Termination|8|||
105466661|NCT02379091|363720219|FG000|Overall Study|Lack of Efficacy|3|||
105466662|NCT02379091|363720220|FG001|Overall Study|Lack of Efficacy|0|||
105466663|NCT02379091|363720221|FG002|Overall Study|Lack of Efficacy|0|||
105466664|NCT02379091|363720222|FG003|Overall Study|Lack of Efficacy|0|||
105466665|NCT01780974|363720223|FG000|Overall Study|Death|1|||
105466666|NCT01780974|363720224|FG001|Overall Study|Death|0|||
105466667|NCT01780974|363720223|FG000|Overall Study|Adverse Event|1|||
105466668|NCT01780974|363720224|FG001|Overall Study|Adverse Event|3|||
105466669|NCT01724346|363720225|FG000|Overall Study|Death|42|||
105466670|NCT01724346|363720226|FG001|Overall Study|Death|42|||
105466671|NCT01724346|363720225|FG000|Overall Study|Lost to Follow-up|5|||
105466672|NCT01724346|363720226|FG001|Overall Study|Lost to Follow-up|1|||
105466673|NCT01724346|363720225|FG000|Overall Study|Withdrawal by Subject|27|||
105466674|NCT01724346|363720226|FG001|Overall Study|Withdrawal by Subject|19|||
105466675|NCT01724346|363720225|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
105466676|NCT01724346|363720226|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
105466677|NCT00525161|363720229|FG000|Overall Study|Adverse Event|1|||
105466678|NCT01076361|363720230|FG000|Overall Study|22 leads were excluded from analysis|21|||
105466679|NCT03848728|363720231|FG000|Overall Study|Death|16|||
105466680|NCT03848728|363720232|FG001|Overall Study|Death|13|||
105466681|NCT03848728|363720231|FG000|Overall Study|Outmigrated to non-study community|98|||
105466682|NCT03848728|363720232|FG001|Overall Study|Outmigrated to non-study community|106|||
105466683|NCT03848728|363720231|FG000|Overall Study|Transfered to non-study clinic|32|||
105466684|NCT03848728|363720232|FG001|Overall Study|Transfered to non-study clinic|48|||
105466685|NCT03848728|363720231|FG000|Overall Study|Withdrawal by Subject|1|||
105466686|NCT03848728|363720232|FG001|Overall Study|Withdrawal by Subject|0|||
105466687|NCT03728881|363720233|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
105466688|NCT03728881|363720234|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
105466689|NCT03728881|363720233|FG000|Enrolled and Received 1st Vaccination|Death|1|||
105466690|NCT03728881|363720234|FG001|Enrolled and Received 1st Vaccination|Death|1|||
105466691|NCT03728881|363720233|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
105466692|NCT03728881|363720234|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
105466693|NCT03728881|363720233|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
105678399|NCT01237587|364483510|FG000|Taper Phase|Sponsor Decision|1|||
105678400|NCT01237587|364483511|FG001|Taper Phase|Sponsor Decision|0|||
105343612|NCT02457832|363259584|FG001|One Month Washout|Lost to Follow-up|1|||
105343613|NCT02457832|363259585|FG002|One Month Washout|Lost to Follow-up|1|||
105343614|NCT00250458|363259587|FG000|Overall Study|Lost to Follow-up|4|||
105343615|NCT00250458|363259588|FG001|Overall Study|Lost to Follow-up|2|||
105343616|NCT00250458|363259587|FG000|Overall Study|Protocol Violation|0|||
105343617|NCT00250458|363259588|FG001|Overall Study|Protocol Violation|1|||
105343618|NCT00250458|363259587|FG000|Overall Study|Withdrawal by Subject|4|||
105343619|NCT00250458|363259588|FG001|Overall Study|Withdrawal by Subject|2|||
105343620|NCT00250458|363259587|FG000|Overall Study|Lack of Migraine Attack|20|||
105343621|NCT00250458|363259588|FG001|Overall Study|Lack of Migraine Attack|9|||
105343622|NCT00250458|363259587|FG000|Overall Study|Qualifying migraine but did not treat|3|||
105466694|NCT03728881|363720234|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
105466695|NCT03728881|363720233|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
105466696|NCT03728881|363720234|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
105466697|NCT03728881|363720233|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
105466698|NCT03728881|363720234|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
105466699|NCT03728881|363720233|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
105678401|NCT01237587|364483510|FG000|Taper Phase|Withdrawal by Subject|0|||
105678402|NCT01237587|364483511|FG001|Taper Phase|Withdrawal by Subject|1|||
105343623|NCT00250458|363259588|FG001|Overall Study|Qualifying migraine but did not treat|3|||
105343624|NCT00250458|363259587|FG000|Overall Study|Other|1|||
105343625|NCT00250458|363259588|FG001|Overall Study|Other|0|||
105343626|NCT04329091|363259589|FG000|Overall Study|Physician Decision|5|||
105466700|NCT03728881|363720234|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
105678403|NCT02549196|364483512|FG000|Overall Study|Protocol Violation|0|||
105678404|NCT02549196|364483513|FG001|Overall Study|Protocol Violation|0|||
105678405|NCT02549196|364483514|FG002|Overall Study|Protocol Violation|0|||
105678406|NCT02549196|364483515|FG003|Overall Study|Protocol Violation|1|||
105678407|NCT02549196|364483512|FG000|Overall Study|Withdrawal by Subject|1|||
105678408|NCT02549196|364483513|FG001|Overall Study|Withdrawal by Subject|0|||
105678409|NCT02549196|364483514|FG002|Overall Study|Withdrawal by Subject|1|||
105678410|NCT02549196|364483515|FG003|Overall Study|Withdrawal by Subject|0|||
105678411|NCT00196976|364483518|FG000|Primary Study|Migrated from study area|0|||
105678412|NCT00196976|364483519|FG001|Primary Study|Migrated from study area|0|||
105678413|NCT00196976|364483520|FG002|Primary Study|Migrated from study area|0|||
105678414|NCT00196976|364483521|FG003|Primary Study|Migrated from study area|0|||
105678415|NCT00196976|364483522|FG004|Primary Study|Migrated from study area|0|||
105678416|NCT00196976|364483523|FG005|Primary Study|Migrated from study area|0|||
105678417|NCT00196976|364483524|FG006|Primary Study|Migrated from study area|0|||
105678418|NCT00196976|364483525|FG007|Primary Study|Migrated from study area|1|||
105678419|NCT00196976|364483526|FG008|Primary Study|Migrated from study area|0|||
105678420|NCT00196976|364483527|FG009|Primary Study|Migrated from study area|0|||
105678421|NCT00196976|364483528|FG010|Primary Study|Migrated from study area|0|||
105678422|NCT00196976|364483529|FG011|Primary Study|Migrated from study area|0|||
105678423|NCT00196976|364483530|FG012|Primary Study|Migrated from study area|0|||
105678424|NCT00196976|364483531|FG013|Primary Study|Migrated from study area|0|||
105678425|NCT00196976|364483518|FG000|Primary Study|Protocol Violation|0|||
105678426|NCT00196976|364483519|FG001|Primary Study|Protocol Violation|1|||
105678427|NCT00196976|364483520|FG002|Primary Study|Protocol Violation|1|||
105678428|NCT00196976|364483521|FG003|Primary Study|Protocol Violation|0|||
105678429|NCT00196976|364483522|FG004|Primary Study|Protocol Violation|0|||
105343627|NCT01801358|363259590|FG000|Overall Study|Adverse Event|0|||
105678430|NCT00196976|364483523|FG005|Primary Study|Protocol Violation|0|||
105678431|NCT00196976|364483524|FG006|Primary Study|Protocol Violation|0|||
105678432|NCT00196976|364483525|FG007|Primary Study|Protocol Violation|0|||
105678433|NCT00196976|364483526|FG008|Primary Study|Protocol Violation|0|||
105678434|NCT00196976|364483527|FG009|Primary Study|Protocol Violation|0|||
105678435|NCT00196976|364483528|FG010|Primary Study|Protocol Violation|0|||
105678436|NCT00196976|364483529|FG011|Primary Study|Protocol Violation|0|||
105678437|NCT00196976|364483530|FG012|Primary Study|Protocol Violation|0|||
105678438|NCT00196976|364483531|FG013|Primary Study|Protocol Violation|0|||
105678439|NCT00196976|364483518|FG000|Primary Study|Withdrawal by Subject|1|||
105678440|NCT00196976|364483519|FG001|Primary Study|Withdrawal by Subject|0|||
105678441|NCT00196976|364483520|FG002|Primary Study|Withdrawal by Subject|1|||
105678442|NCT00196976|364483521|FG003|Primary Study|Withdrawal by Subject|1|||
105678443|NCT00196976|364483522|FG004|Primary Study|Withdrawal by Subject|2|||
105678444|NCT00196976|364483523|FG005|Primary Study|Withdrawal by Subject|1|||
105678445|NCT00196976|364483524|FG006|Primary Study|Withdrawal by Subject|0|||
105678446|NCT00196976|364483525|FG007|Primary Study|Withdrawal by Subject|0|||
105678447|NCT00196976|364483526|FG008|Primary Study|Withdrawal by Subject|0|||
105678448|NCT00196976|364483527|FG009|Primary Study|Withdrawal by Subject|1|||
105678449|NCT00196976|364483528|FG010|Primary Study|Withdrawal by Subject|0|||
105678450|NCT00196976|364483529|FG011|Primary Study|Withdrawal by Subject|0|||
105678451|NCT00196976|364483530|FG012|Primary Study|Withdrawal by Subject|0|||
105678452|NCT00196976|364483531|FG013|Primary Study|Withdrawal by Subject|0|||
105678453|NCT00196976|364483518|FG000|Primary Study|Lost to Follow-up|0|||
105678454|NCT00196976|364483519|FG001|Primary Study|Lost to Follow-up|0|||
105678455|NCT00196976|364483520|FG002|Primary Study|Lost to Follow-up|0|||
105678456|NCT00196976|364483521|FG003|Primary Study|Lost to Follow-up|0|||
105466701|NCT03728881|363720233|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
105466702|NCT03728881|363720234|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
105466703|NCT03728881|363720233|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
105466704|NCT03728881|363720234|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
105466705|NCT03728881|363720233|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
105466706|NCT03728881|363720234|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
105466707|NCT03728881|363720233|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
105466708|NCT03728881|363720234|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
105466709|NCT00787644|363720237|FG000|Overall Study|Lost to Follow-up|1|||
105466710|NCT00787644|363720238|FG001|Overall Study|Lost to Follow-up|1|||
105466711|NCT00787644|363720237|FG000|Overall Study|Withdrawal by Subject|1|||
105466712|NCT00787644|363720238|FG001|Overall Study|Withdrawal by Subject|1|||
105678457|NCT00196976|364483522|FG004|Primary Study|Lost to Follow-up|1|||
105678458|NCT00196976|364483523|FG005|Primary Study|Lost to Follow-up|1|||
105678459|NCT00196976|364483524|FG006|Primary Study|Lost to Follow-up|0|||
105678460|NCT00196976|364483525|FG007|Primary Study|Lost to Follow-up|2|||
105678461|NCT00196976|364483526|FG008|Primary Study|Lost to Follow-up|0|||
105678462|NCT00196976|364483527|FG009|Primary Study|Lost to Follow-up|0|||
105678463|NCT00196976|364483528|FG010|Primary Study|Lost to Follow-up|0|||
105678464|NCT00196976|364483529|FG011|Primary Study|Lost to Follow-up|0|||
105678465|NCT00196976|364483530|FG012|Primary Study|Lost to Follow-up|0|||
105466713|NCT00536744|363720239|FG000|Overall Study|Adverse Event|13|||
105466714|NCT00536744|363720240|FG001|Overall Study|Adverse Event|10|||
105466715|NCT00536744|363720239|FG000|Overall Study|Death|2|||
105466716|NCT00536744|363720240|FG001|Overall Study|Death|1|||
105466717|NCT00536744|363720239|FG000|Overall Study|Physician Decision|3|||
105466718|NCT00536744|363720240|FG001|Overall Study|Physician Decision|1|||
105466719|NCT00536744|363720239|FG000|Overall Study|Lost to Follow-up|3|||
105466720|NCT00536744|363720240|FG001|Overall Study|Lost to Follow-up|5|||
105466721|NCT00536744|363720239|FG000|Overall Study|Withdrawal by Subject|7|||
105466722|NCT00536744|363720240|FG001|Overall Study|Withdrawal by Subject|8|||
105466723|NCT00536744|363720239|FG000|Overall Study|PI tried alternative treatment|1|||
105466724|NCT00536744|363720240|FG001|Overall Study|PI tried alternative treatment|3|||
105466725|NCT04498832|363720241|FG000|Overall Study|Adverse Event|1|||
105466726|NCT04498832|363720242|FG001|Overall Study|Adverse Event|3|||
105466727|NCT04498832|363720241|FG000|Overall Study|Withdrawal by Subject|0|||
105466728|NCT04498832|363720242|FG001|Overall Study|Withdrawal by Subject|1|||
105466729|NCT04161157|363720243|FG000|Overall Study|Lost to Follow-up|4|||
105466730|NCT04161157|363720243|FG000|Overall Study|Death|3|||
105678466|NCT00196976|364483531|FG013|Primary Study|Lost to Follow-up|0|||
105678467|NCT00196976|364483518|FG000|Primary Study|Other|0|||
105678468|NCT00196976|364483519|FG001|Primary Study|Other|0|||
105678469|NCT00196976|364483520|FG002|Primary Study|Other|2|||
105678470|NCT00196976|364483521|FG003|Primary Study|Other|0|||
105678471|NCT00196976|364483522|FG004|Primary Study|Other|0|||
105678472|NCT00196976|364483523|FG005|Primary Study|Other|0|||
105678473|NCT00196976|364483524|FG006|Primary Study|Other|0|||
105678474|NCT00196976|364483525|FG007|Primary Study|Other|0|||
105678475|NCT00196976|364483526|FG008|Primary Study|Other|0|||
105678476|NCT00196976|364483527|FG009|Primary Study|Other|0|||
105678477|NCT00196976|364483528|FG010|Primary Study|Other|0|||
105678478|NCT00196976|364483529|FG011|Primary Study|Other|0|||
105466731|NCT04161157|363720243|FG000|Overall Study|Ineligible|2|||
105466732|NCT04161157|363720243|FG000|Overall Study|Withdrawal by Subject|4|||
105466733|NCT04108208|363720244|FG000|Overall Study|Withdrawal by Subject|2|||
105466734|NCT04108208|363720245|FG001|Overall Study|Withdrawal by Subject|6|||
105466735|NCT04108208|363720244|FG000|Overall Study|other-ongoing|20|||
105466736|NCT04108208|363720245|FG001|Overall Study|other-ongoing|40|||
105466737|NCT04108208|363720244|FG000|Overall Study|Death|1|||
105466738|NCT04108208|363720245|FG001|Overall Study|Death|4|||
105466739|NCT04108208|363720244|FG000|Overall Study|Lost to Follow-up|2|||
105466740|NCT04108208|363720245|FG001|Overall Study|Lost to Follow-up|0|||
105466741|NCT06078124|363720249|FG000|Overall Study|Lost to Follow-up|14|||
105466742|NCT06078124|363720250|FG001|Overall Study|Lost to Follow-up|14|||
105466743|NCT04579380|363721147|FG000|Overall Study|Death|9|||
105466744|NCT04579380|363721148|FG001|Overall Study|Death|22|||
105466745|NCT04579380|363721149|FG002|Overall Study|Death|22|||
105466746|NCT04579380|363721150|FG003|Overall Study|Death|17|||
105466747|NCT04579380|363721151|FG004|Overall Study|Death|6|||
105466748|NCT04579380|363721152|FG005|Overall Study|Death|21|||
105466749|NCT04579380|363721153|FG006|Overall Study|Death|10|||
105466750|NCT04579380|363721154|FG007|Overall Study|Death|11|||
105466751|NCT04579380|363721155|FG008|Overall Study|Death|25|||
105466752|NCT04579380|363721147|FG000|Overall Study|Withdrawal by Subject|0|||
105466753|NCT04579380|363721148|FG001|Overall Study|Withdrawal by Subject|3|||
105466754|NCT04579380|363721149|FG002|Overall Study|Withdrawal by Subject|4|||
105466755|NCT04579380|363721150|FG003|Overall Study|Withdrawal by Subject|0|||
105343628|NCT01801358|363259591|FG001|Overall Study|Adverse Event|2|||
105466756|NCT04579380|363721151|FG004|Overall Study|Withdrawal by Subject|1|||
105466757|NCT04579380|363721152|FG005|Overall Study|Withdrawal by Subject|2|||
105678479|NCT00196976|364483530|FG012|Primary Study|Other|0|||
105678480|NCT00196976|364483531|FG013|Primary Study|Other|0|||
105343629|NCT01801358|363259592|FG002|Overall Study|Adverse Event|1|||
105466758|NCT04579380|363721153|FG006|Overall Study|Withdrawal by Subject|0|||
105466759|NCT04579380|363721154|FG007|Overall Study|Withdrawal by Subject|1|||
105466760|NCT04579380|363721155|FG008|Overall Study|Withdrawal by Subject|2|||
105466761|NCT04579380|363721147|FG000|Overall Study|Ongoing|2|||
105466762|NCT04579380|363721148|FG001|Overall Study|Ongoing|6|||
105466763|NCT04579380|363721149|FG002|Overall Study|Ongoing|4|||
105466764|NCT04579380|363721150|FG003|Overall Study|Ongoing|8|||
105466765|NCT04579380|363721151|FG004|Overall Study|Ongoing|5|||
105466766|NCT04579380|363721152|FG005|Overall Study|Ongoing|8|||
105466767|NCT04579380|363721153|FG006|Overall Study|Ongoing|3|||
105466768|NCT04579380|363721154|FG007|Overall Study|Ongoing|19|||
105466769|NCT04579380|363721155|FG008|Overall Study|Ongoing|6|||
105466770|NCT04770753|363721156|FG000|Overall Study|Randomized, never treated|1|||
105466771|NCT04770753|363721157|FG001|Overall Study|Randomized, never treated|1|||
105678481|NCT00196976|364483518|FG000|Booster Study|Withdrawal by Subject|0|||
105678482|NCT00196976|364483519|FG001|Booster Study|Withdrawal by Subject|0|||
105678483|NCT00196976|364483520|FG002|Booster Study|Withdrawal by Subject|0|||
105678484|NCT00196976|364483521|FG003|Booster Study|Withdrawal by Subject|0|||
105678485|NCT00196976|364483522|FG004|Booster Study|Withdrawal by Subject|0|||
105678486|NCT00196976|364483523|FG005|Booster Study|Withdrawal by Subject|0|||
105678487|NCT00196976|364483524|FG006|Booster Study|Withdrawal by Subject|0|||
105678488|NCT00196976|364483525|FG007|Booster Study|Withdrawal by Subject|0|||
105678489|NCT00196976|364483526|FG008|Booster Study|Withdrawal by Subject|0|||
105678490|NCT00196976|364483527|FG009|Booster Study|Withdrawal by Subject|0|||
105678491|NCT00196976|364483528|FG010|Booster Study|Withdrawal by Subject|1|||
105678492|NCT00196976|364483529|FG011|Booster Study|Withdrawal by Subject|0|||
105678493|NCT00196976|364483530|FG012|Booster Study|Withdrawal by Subject|0|||
105678494|NCT00196976|364483531|FG013|Booster Study|Withdrawal by Subject|0|||
105678495|NCT00196976|364483518|FG000|Booster Study|Lost to Follow-up|0|||
105678496|NCT00196976|364483519|FG001|Booster Study|Lost to Follow-up|0|||
105678497|NCT00196976|364483520|FG002|Booster Study|Lost to Follow-up|0|||
105678498|NCT00196976|364483521|FG003|Booster Study|Lost to Follow-up|0|||
105678499|NCT00196976|364483522|FG004|Booster Study|Lost to Follow-up|0|||
105678500|NCT00196976|364483523|FG005|Booster Study|Lost to Follow-up|0|||
105678501|NCT00196976|364483524|FG006|Booster Study|Lost to Follow-up|0|||
105678502|NCT00196976|364483525|FG007|Booster Study|Lost to Follow-up|0|||
105678503|NCT00196976|364483526|FG008|Booster Study|Lost to Follow-up|0|||
105678504|NCT00196976|364483527|FG009|Booster Study|Lost to Follow-up|0|||
105678505|NCT00196976|364483528|FG010|Booster Study|Lost to Follow-up|1|||
105678506|NCT00196976|364483529|FG011|Booster Study|Lost to Follow-up|2|||
105678507|NCT00196976|364483530|FG012|Booster Study|Lost to Follow-up|0|||
105678508|NCT00196976|364483531|FG013|Booster Study|Lost to Follow-up|0|||
105678509|NCT03208036|364483532|FG000|Baseline Assessment|Withdrawal by Subject|1|||
105678510|NCT03208036|364483533|FG001|Baseline Assessment|Withdrawal by Subject|1|||
105678511|NCT03208036|364483532|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
105678512|NCT03208036|364483533|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
105678513|NCT03208036|364483532|FG000|Intervention|Withdrawal by Subject|3|||
105678514|NCT03208036|364483533|FG001|Intervention|Withdrawal by Subject|2|||
105678515|NCT03208036|364483532|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
105678516|NCT03208036|364483533|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
105678517|NCT00591851|364483534|FG000|Overall Study|Withdrawal by Subject|3|||
105678518|NCT00591851|364483534|FG000|Overall Study|Adverse Event|2|||
105678519|NCT00591851|364483534|FG000|Overall Study|Progressive Disease|1|||
105678520|NCT02495792|364483538|FG000|Overall Study|Lost to Follow-up|5|||
105678521|NCT02495792|364483539|FG001|Overall Study|Lost to Follow-up|9|||
105678522|NCT02495792|364483538|FG000|Overall Study|Protocol Violation|32|||
105678523|NCT02495792|364483539|FG001|Overall Study|Protocol Violation|31|||
105678524|NCT00867308|364483540|FG000|Overall Study|Death|1|||
105678525|NCT00867308|364483541|FG001|Overall Study|Death|0|||
105678526|NCT00867308|364483540|FG000|Overall Study|Adverse Event|1|||
105678527|NCT00867308|364483541|FG001|Overall Study|Adverse Event|4|||
105678528|NCT00867308|364483540|FG000|Overall Study|Lack of Efficacy|6|||
105678529|NCT00867308|364483541|FG001|Overall Study|Lack of Efficacy|12|||
105678530|NCT00867308|364483540|FG000|Overall Study|Withdrawal by Subject|1|||
105678531|NCT00867308|364483541|FG001|Overall Study|Withdrawal by Subject|2|||
105678532|NCT01775124|364483544|FG000|Core Period|Disease Progression|0|||
105678533|NCT01775124|364483545|FG001|Core Period|Disease Progression|1|||
105678534|NCT01775124|364483544|FG000|Core Period|Physician Decision|1|||
105678535|NCT01775124|364483545|FG001|Core Period|Physician Decision|1|||
105678536|NCT01775124|364483544|FG000|Core Period|Death|0|||
105678537|NCT01775124|364483545|FG001|Core Period|Death|1|||
105678538|NCT01775124|364483544|FG000|Core Period|Administrative problems|1|||
105678539|NCT01775124|364483545|FG001|Core Period|Administrative problems|0|||
105678540|NCT01775124|364483544|FG000|Core Period|Withdrawal by Subject|4|||
105678541|NCT01775124|364483545|FG001|Core Period|Withdrawal by Subject|2|||
105678542|NCT01775124|364483544|FG000|Core Period|Adverse Event|5|||
105678543|NCT01775124|364483545|FG001|Core Period|Adverse Event|5|||
105678544|NCT01775124|364483544|FG000|Extension Period|Adverse Event|3|||
105678545|NCT01775124|364483545|FG001|Extension Period|Adverse Event|2|||
105678546|NCT01775124|364483544|FG000|Extension Period|Physician Decision|0|||
105466772|NCT04770753|363721156|FG000|Overall Study|Withdrawal by Subject|3|||
105466773|NCT04770753|363721157|FG001|Overall Study|Withdrawal by Subject|1|||
105678547|NCT01775124|364483545|FG001|Extension Period|Physician Decision|2|||
105678548|NCT01775124|364483544|FG000|Extension Period|Administrative problems|0|||
105678549|NCT01775124|364483545|FG001|Extension Period|Administrative problems|1|||
105678550|NCT01775124|364483544|FG000|Extension Period|Lost to Follow-up|0|||
105678551|NCT01775124|364483545|FG001|Extension Period|Lost to Follow-up|1|||
105678552|NCT01775124|364483544|FG000|Extension Period|Withdrawal by Subject|9|||
105678553|NCT01775124|364483545|FG001|Extension Period|Withdrawal by Subject|12|||
105678554|NCT05559476|364483546|FG000|Overall Study|Adverse Event|2|||
105678555|NCT05559476|364483547|FG001|Overall Study|Adverse Event|0|||
105678556|NCT05559476|364483546|FG000|Overall Study|Lost to Follow-up|13|||
105678557|NCT05559476|364483547|FG001|Overall Study|Lost to Follow-up|12|||
105678558|NCT05559476|364483546|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
105678559|NCT05559476|364483547|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
105678560|NCT05559476|364483546|FG000|Overall Study|Other|0|||
105678561|NCT05559476|364483547|FG001|Overall Study|Other|2|||
105678562|NCT03647488|364485008|FG000|Overall Study|Progressive disease|10|||
105678563|NCT03647488|364485009|FG001|Overall Study|Progressive disease|0|||
105678564|NCT03647488|364485010|FG002|Overall Study|Progressive disease|0|||
105678565|NCT03647488|364485008|FG000|Overall Study|Adverse Event|5|||
105678566|NCT03647488|364485009|FG001|Overall Study|Adverse Event|0|||
105678567|NCT03647488|364485010|FG002|Overall Study|Adverse Event|0|||
105678568|NCT03647488|364485008|FG000|Overall Study|Clinical progression|2|||
105678569|NCT03647488|364485009|FG001|Overall Study|Clinical progression|0|||
105678570|NCT03647488|364485010|FG002|Overall Study|Clinical progression|0|||
105678571|NCT03647488|364485008|FG000|Overall Study|Participant refused to take investigational product|1|||
105678572|NCT03647488|364485009|FG001|Overall Study|Participant refused to take investigational product|0|||
105678573|NCT03647488|364485010|FG002|Overall Study|Participant refused to take investigational product|0|||
105678574|NCT00565851|364485011|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
105678575|NCT00565851|364485012|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
105678576|NCT00565851|364485013|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
105678577|NCT00565851|364485014|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
105678578|NCT00565851|364485015|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
105678579|NCT00565851|364485016|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
105678580|NCT00565851|364485017|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
105678581|NCT00565851|364485018|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
105678582|NCT00565851|364485011|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
105678583|NCT00565851|364485012|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
105678584|NCT00565851|364485013|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
105678585|NCT00565851|364485014|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
105678586|NCT00565851|364485015|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
105678587|NCT00565851|364485016|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
105678588|NCT00565851|364485017|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
105678589|NCT00565851|364485018|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
105678590|NCT01077271|364485019|FG000|Overall Study|Parental desire|8|||
105678591|NCT01077271|364485019|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
105678592|NCT01077271|364485019|FG000|Overall Study|Noncompliance|2|||
105678593|NCT01077271|364485019|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
105678594|NCT01077271|364485019|FG000|Overall Study|Changed doctors|2|||
105678595|NCT01077271|364485019|FG000|Overall Study|Parents thought too many injections|2|||
105678596|NCT01077271|364485019|FG000|Overall Study|End of RSV season nearly reached|1|||
105678597|NCT01077271|364485019|FG000|Overall Study|Mother unconvinced of the necessity|1|||
105678598|NCT00969709|364485020|FG000|Overall Study|Adverse Event|3|||
105678599|NCT00969709|364485021|FG001|Overall Study|Adverse Event|13|||
105678600|NCT00969709|364485022|FG002|Overall Study|Adverse Event|26|||
105678601|NCT00969709|364485023|FG003|Overall Study|Adverse Event|12|||
105678602|NCT00969709|364485020|FG000|Overall Study|Lack of Efficacy|7|||
105678603|NCT00969709|364485021|FG001|Overall Study|Lack of Efficacy|4|||
105678604|NCT00969709|364485022|FG002|Overall Study|Lack of Efficacy|1|||
105678605|NCT00969709|364485023|FG003|Overall Study|Lack of Efficacy|3|||
105678606|NCT00969709|364485020|FG000|Overall Study|Protocol Violation|9|||
105343630|NCT01801358|363259593|FG003|Overall Study|Adverse Event|0|||
105343631|NCT01801358|363259594|FG004|Overall Study|Adverse Event|0|||
105343632|NCT01801358|363259595|FG005|Overall Study|Adverse Event|1|||
105466774|NCT04770753|363721156|FG000|Overall Study|Adverse Event|2|||
105678607|NCT00969709|364485021|FG001|Overall Study|Protocol Violation|5|||
105678608|NCT00969709|364485022|FG002|Overall Study|Protocol Violation|9|||
105678609|NCT00969709|364485023|FG003|Overall Study|Protocol Violation|10|||
105678610|NCT00969709|364485020|FG000|Overall Study|Withdrawal by Subject|9|||
105678611|NCT00969709|364485021|FG001|Overall Study|Withdrawal by Subject|12|||
105678612|NCT00969709|364485022|FG002|Overall Study|Withdrawal by Subject|11|||
105466775|NCT04770753|363721157|FG001|Overall Study|Adverse Event|0|||
105466776|NCT04770753|363721156|FG000|Overall Study|Pregnancy|1|||
105466777|NCT04770753|363721157|FG001|Overall Study|Pregnancy|0|||
105466778|NCT04770753|363721156|FG000|Overall Study|Other un-specified|1|||
105678613|NCT00969709|364485023|FG003|Overall Study|Withdrawal by Subject|23|||
105678614|NCT00969709|364485020|FG000|Overall Study|Lost to Follow-up|10|||
105678615|NCT00969709|364485021|FG001|Overall Study|Lost to Follow-up|14|||
105678616|NCT00969709|364485022|FG002|Overall Study|Lost to Follow-up|8|||
105678617|NCT00969709|364485023|FG003|Overall Study|Lost to Follow-up|15|||
105678618|NCT00969709|364485020|FG000|Overall Study|Other reasons|0|||
105678619|NCT00969709|364485021|FG001|Overall Study|Other reasons|0|||
105678620|NCT00969709|364485022|FG002|Overall Study|Other reasons|3|||
105678621|NCT00969709|364485023|FG003|Overall Study|Other reasons|0|||
105678622|NCT02980731|364485024|FG000|Overall Study|Death|63|||
105678623|NCT02980731|364485024|FG000|Overall Study|Withdrawal by Subject|6|||
105678624|NCT02980731|364485024|FG000|Overall Study|Lost to Follow-up|5|||
105678625|NCT02980731|364485024|FG000|Overall Study|Study terminated by Sponsor|4|||
105678626|NCT02980731|364485024|FG000|Overall Study|Completed survival follow-up period|65|||
105678627|NCT02980731|364485024|FG000|Overall Study|COVID-19 infection|1|||
105678628|NCT02980731|364485024|FG000|Overall Study|Other, not specified|66|||
105678629|NCT02516332|364485025|FG000|Overall Study|Withdrawal by Subject|2|||
105678630|NCT02516332|364485026|FG001|Overall Study|Withdrawal by Subject|1|||
105678631|NCT02516332|364485027|FG002|Overall Study|Withdrawal by Subject|2|||
105678632|NCT02217332|364485028|FG000|Overall Study|Adverse Event|3|||
105678633|NCT02217332|364485028|FG000|Overall Study|Dose interruption >1 month|1|||
105678634|NCT02217332|364485028|FG000|Overall Study|Protocol Violation (eligibility)|1|||
105678635|NCT02217332|364485028|FG000|Overall Study|Withdrawal by Subject|1|||
105678636|NCT02217332|364485028|FG000|Overall Study|Lost to Follow-up|1|||
105678637|NCT04058366|364485039|FG000|Overall Study|Adverse Event|14|||
105678638|NCT04058366|364485039|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
105678639|NCT04058366|364485039|FG000|Overall Study|Commercial drug is available for participants|6|||
105678640|NCT04058366|364485039|FG000|Overall Study|Death|1|||
105678641|NCT04058366|364485039|FG000|Overall Study|Other non-compliance|2|||
105678642|NCT04058366|364485039|FG000|Overall Study|Other|6|||
105678643|NCT01789567|364485040|FG000|Overall Study|Death|6|||
105678644|NCT02914275|364485041|FG000|Overall Study|Lost to Follow-up|84|||
105678645|NCT02914275|364485042|FG001|Overall Study|Lost to Follow-up|29|||
105678646|NCT02914275|364485041|FG000|Overall Study|Withdrawal by Subject|26|||
105678647|NCT02914275|364485042|FG001|Overall Study|Withdrawal by Subject|10|||
105678648|NCT02914275|364485041|FG000|Overall Study|Protocol Violation|1|||
105678649|NCT02914275|364485042|FG001|Overall Study|Protocol Violation|1|||
105678650|NCT02914275|364485041|FG000|Overall Study|Physician Decision|3|||
105678651|NCT02914275|364485042|FG001|Overall Study|Physician Decision|1|||
105678652|NCT02914275|364485041|FG000|Overall Study|Other|4|||
105678653|NCT02914275|364485042|FG001|Overall Study|Other|1|||
105678654|NCT02914275|364485041|FG000|Overall Study|Excluded due to invalid informed consent|3|||
105678655|NCT02914275|364485042|FG001|Overall Study|Excluded due to invalid informed consent|0|||
105678656|NCT00872989|364485043|FG000|Overall Study|Adverse Event|7|||
105678657|NCT00872989|364485044|FG001|Overall Study|Adverse Event|15|||
105678658|NCT00872989|364485043|FG000|Overall Study|Withdrawal by Subject|8|||
105678659|NCT00872989|364485044|FG001|Overall Study|Withdrawal by Subject|5|||
105678660|NCT00872989|364485043|FG000|Overall Study|Progression/relapse|47|||
105678661|NCT00872989|364485044|FG001|Overall Study|Progression/relapse|35|||
105678662|NCT00872989|364485043|FG000|Overall Study|Not protocol specified|3|||
105678663|NCT00872989|364485044|FG001|Overall Study|Not protocol specified|8|||
105678664|NCT01238900|364485047|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
105678665|NCT01238900|364485047|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
105678666|NCT00603304|364485056|FG000|Overall Study|Lost to Follow-up|5|||
105678667|NCT00603304|364485057|FG001|Overall Study|Lost to Follow-up|7|||
105678668|NCT00603304|364485056|FG000|Overall Study|Withdrawal by Subject|8|||
105678669|NCT00603304|364485057|FG001|Overall Study|Withdrawal by Subject|5|||
105678670|NCT00603304|364485056|FG000|Overall Study|Protocol Violation|1|||
105678671|NCT00603304|364485057|FG001|Overall Study|Protocol Violation|0|||
105678672|NCT00603304|364485056|FG000|Overall Study|Adverse Event|4|||
105678673|NCT00603304|364485057|FG001|Overall Study|Adverse Event|2|||
105678674|NCT00603304|364485056|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
105678675|NCT00603304|364485057|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
105678676|NCT00603304|364485056|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
105678677|NCT00603304|364485057|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
105678678|NCT00603304|364485056|FG000|Overall Study|Exclusionary Medication|2|||
105678679|NCT00603304|364485057|FG001|Overall Study|Exclusionary Medication|3|||
105678680|NCT00603304|364485056|FG000|Overall Study|Non-Compliant|0|||
105678681|NCT00603304|364485057|FG001|Overall Study|Non-Compliant|1|||
105678682|NCT00603304|364485056|FG000|Overall Study|Moved Away|0|||
105678683|NCT00603304|364485057|FG001|Overall Study|Moved Away|2|||
105678684|NCT00603304|364485056|FG000|Overall Study|Other|2|||
105678685|NCT00603304|364485057|FG001|Overall Study|Other|0|||
105678686|NCT00603304|364485056|FG000|Overall Study|Patient Decision|2|||
105678687|NCT00603304|364485057|FG001|Overall Study|Patient Decision|0|||
105678688|NCT01290315|364485060|FG000|Overall Study|Adverse Event|0|||
105678689|NCT01290315|364485061|FG001|Overall Study|Adverse Event|0|||
105678690|NCT01290315|364485062|FG002|Overall Study|Adverse Event|0|||
105678691|NCT01290315|364485063|FG003|Overall Study|Adverse Event|3|||
105678692|NCT01290315|364485060|FG000|Overall Study|Selection criteria/compliance|2|||
105678693|NCT01290315|364485061|FG001|Overall Study|Selection criteria/compliance|1|||
105678694|NCT01290315|364485062|FG002|Overall Study|Selection criteria/compliance|0|||
105678695|NCT01290315|364485063|FG003|Overall Study|Selection criteria/compliance|2|||
105678696|NCT01290315|364485060|FG000|Overall Study|Lost to Follow-up|0|||
105678697|NCT01290315|364485061|FG001|Overall Study|Lost to Follow-up|1|||
105678698|NCT01290315|364485062|FG002|Overall Study|Lost to Follow-up|0|||
105678699|NCT01290315|364485063|FG003|Overall Study|Lost to Follow-up|0|||
105678700|NCT01290315|364485060|FG000|Overall Study|Withdrawal by Subject|1|||
105678701|NCT01290315|364485061|FG001|Overall Study|Withdrawal by Subject|1|||
105678702|NCT01290315|364485062|FG002|Overall Study|Withdrawal by Subject|0|||
105678703|NCT01290315|364485063|FG003|Overall Study|Withdrawal by Subject|0|||
105678704|NCT03725085|364485068|FG000|Overall Study|Lost to Follow-up|2|||
105678705|NCT03809429|364485069|FG000|Overall Study|Withdrawal by Subject|7|||
105678706|NCT03809429|364485070|FG001|Overall Study|Withdrawal by Subject|3|||
105678707|NCT03809429|364485069|FG000|Overall Study|Adverse Event|6|||
105678708|NCT03809429|364485070|FG001|Overall Study|Adverse Event|9|||
105678709|NCT03809429|364485069|FG000|Overall Study|COVID-19|3|||
105678710|NCT03809429|364485070|FG001|Overall Study|COVID-19|1|||
105678711|NCT03809429|364485069|FG000|Overall Study|Participant was discontinued by investigator|12|||
105678712|NCT03809429|364485070|FG001|Overall Study|Participant was discontinued by investigator|7|||
105678713|NCT00901186|364485071|FG000|Overall Study|Lack of Efficacy|0|||
105678714|NCT00901186|364485072|FG001|Overall Study|Lack of Efficacy|1|||
105678715|NCT00901186|364485071|FG000|Overall Study|Abnormal laboratory values|0|||
105678716|NCT00901186|364485072|FG001|Overall Study|Abnormal laboratory values|1|||
105678717|NCT00901186|364485071|FG000|Overall Study|Lost to Follow-up|2|||
105678718|NCT00901186|364485072|FG001|Overall Study|Lost to Follow-up|0|||
105678719|NCT00901186|364485071|FG000|Overall Study|Adverse Event|2|||
105678720|NCT00901186|364485072|FG001|Overall Study|Adverse Event|4|||
105678721|NCT00901186|364485071|FG000|Overall Study|Administration problems|0|||
105678722|NCT00901186|364485072|FG001|Overall Study|Administration problems|1|||
105678723|NCT00901186|364485071|FG000|Overall Study|Protocol deviations|5|||
105678724|NCT00901186|364485072|FG001|Overall Study|Protocol deviations|4|||
105678725|NCT04214600|364485073|FG000|Overall Study|Lost to Follow-up|9|||
105678726|NCT04214600|364485074|FG001|Overall Study|Lost to Follow-up|14|||
105678727|NCT01901341|364485075|FG000|Overall Study|Adverse Event|4|||
105678728|NCT01901341|364485076|FG001|Overall Study|Adverse Event|2|||
105678729|NCT01901341|364485075|FG000|Overall Study|Lack of Efficacy|0|||
105678730|NCT01901341|364485076|FG001|Overall Study|Lack of Efficacy|2|||
105678731|NCT01901341|364485075|FG000|Overall Study|Lost to Follow-up|0|||
105678732|NCT01901341|364485076|FG001|Overall Study|Lost to Follow-up|1|||
105678733|NCT01901341|364485075|FG000|Overall Study|Protocol Violation|2|||
105678734|NCT01901341|364485076|FG001|Overall Study|Protocol Violation|0|||
105678735|NCT01901341|364485075|FG000|Overall Study|Study Terminated by Sponsor|13|||
105678736|NCT01901341|364485076|FG001|Overall Study|Study Terminated by Sponsor|15|||
105678737|NCT01901341|364485075|FG000|Overall Study|Withdrawal by Subject|1|||
105678738|NCT01901341|364485076|FG001|Overall Study|Withdrawal by Subject|1|||
105678739|NCT01183234|364485077|FG000|First Intervention|Adverse Event|1|||
105678740|NCT01183234|364485078|FG001|First Intervention|Adverse Event|0|||
105678741|NCT01983254|364485079|FG000|Overall Study|Death|6|||
105678742|NCT01983254|364485080|FG001|Overall Study|Death|6|||
105678743|NCT01983254|364485079|FG000|Overall Study|Lost to Follow-up|17|||
105678744|NCT01983254|364485080|FG001|Overall Study|Lost to Follow-up|16|||
105678745|NCT01983254|364485079|FG000|Overall Study|too ill|11|||
105678746|NCT01983254|364485080|FG001|Overall Study|too ill|8|||
105678747|NCT00434213|364485083|FG000|Overall Study|Adverse Event|12|||
105678748|NCT00434213|364485083|FG000|Overall Study|Lack of Efficacy|9|||
105678749|NCT00434213|364485083|FG000|Overall Study|Lost to Follow-up|14|||
105678750|NCT00434213|364485083|FG000|Overall Study|Withdrawal by Subject|7|||
105678751|NCT00434213|364485083|FG000|Overall Study|Protocol Violation|3|||
105678752|NCT00434213|364485083|FG000|Overall Study|Unable to comply with study visit window|2|||
105678753|NCT00434213|364485083|FG000|Overall Study|Application site reaction|1|||
105678754|NCT00434213|364485083|FG000|Overall Study|Non-compliant to study schedule|1|||
105678755|NCT05398237|364485084|FG000|Overall Study|Withdrawal by Subject|1|||
105678756|NCT04988867|364485085|FG000|Overall Study|Study terminated by Sponsor|12|||
105678757|NCT04988867|364485085|FG000|Overall Study|Adverse Event|2|||
105678758|NCT04988867|364485085|FG000|Overall Study|Study drug noncompliance|1|||
105678759|NCT01327495|364485086|FG000|Overall Study|Adverse Event|2|||
105678760|NCT01327495|364485087|FG001|Overall Study|Adverse Event|1|||
105678761|NCT01327495|364485088|FG002|Overall Study|Adverse Event|1|||
105678762|NCT01327495|364485089|FG003|Overall Study|Adverse Event|0|||
105678763|NCT01327495|364485090|FG004|Overall Study|Adverse Event|0|||
105678764|NCT01327495|364485091|FG005|Overall Study|Adverse Event|2|||
105678765|NCT01327495|364485086|FG000|Overall Study|Withdrawal by Subject|0|||
105678766|NCT01327495|364485087|FG001|Overall Study|Withdrawal by Subject|1|||
105678767|NCT01327495|364485088|FG002|Overall Study|Withdrawal by Subject|1|||
105678768|NCT01327495|364485089|FG003|Overall Study|Withdrawal by Subject|0|||
105678769|NCT01327495|364485090|FG004|Overall Study|Withdrawal by Subject|1|||
105678770|NCT01327495|364485091|FG005|Overall Study|Withdrawal by Subject|0|||
105678771|NCT01327495|364485086|FG000|Overall Study|Physician Decision|0|||
105678772|NCT01327495|364485087|FG001|Overall Study|Physician Decision|0|||
105678773|NCT01327495|364485088|FG002|Overall Study|Physician Decision|0|||
105678774|NCT01327495|364485089|FG003|Overall Study|Physician Decision|0|||
105678775|NCT01327495|364485090|FG004|Overall Study|Physician Decision|2|||
105678776|NCT01327495|364485091|FG005|Overall Study|Physician Decision|0|||
105678777|NCT01699503|364485094|FG000|Overall Study|Death|31|||
105678778|NCT01699503|364485095|FG001|Overall Study|Death|40|||
105678779|NCT01699503|364485094|FG000|Overall Study|Withdrawal by Subject|65|||
105678780|NCT01699503|364485095|FG001|Overall Study|Withdrawal by Subject|57|||
105678781|NCT01699503|364485094|FG000|Overall Study|Lost to Follow-up|121|||
105678782|NCT01699503|364485095|FG001|Overall Study|Lost to Follow-up|117|||
105678783|NCT01699503|364485094|FG000|Overall Study|Excluded due to quality|783|||
105678784|NCT01699503|364485095|FG001|Overall Study|Excluded due to quality|791|||
105678785|NCT01888900|364485097|FG000|Overall Study|failed treatment|0|||
105678786|NCT01888900|364485098|FG001|Overall Study|failed treatment|2|||
105678787|NCT01639560|364485099|FG000|Overall Study|Withdrawal by Subject|9|||
105678788|NCT01639560|364485100|FG001|Overall Study|Withdrawal by Subject|14|||
105678789|NCT01639560|364485099|FG000|Overall Study|Lack of Efficacy|1|||
105678790|NCT01639560|364485100|FG001|Overall Study|Lack of Efficacy|2|||
105678791|NCT01639560|364485099|FG000|Overall Study|Lost to Follow-up|9|||
105678792|NCT01639560|364485100|FG001|Overall Study|Lost to Follow-up|11|||
105678793|NCT01639560|364485099|FG000|Overall Study|Adverse Event|0|||
105678794|NCT01639560|364485100|FG001|Overall Study|Adverse Event|2|||
105678795|NCT03545503|364485101|FG000|Overall Study|Protocol Violation|14|||
105678796|NCT03545503|364485102|FG001|Overall Study|Protocol Violation|16|||
105678797|NCT00468104|364485103|FG000|First Intervention|Protocol Violation|2|||
105678798|NCT00468104|364485104|FG001|First Intervention|Protocol Violation|1|||
105678799|NCT00468104|364485103|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
105678800|NCT00468104|364485104|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
105678801|NCT00468104|364485103|FG000|First Intervention|died within 3 weeks|1|||
105678802|NCT00468104|364485104|FG001|First Intervention|died within 3 weeks|0|||
105678803|NCT00468104|364485103|FG000|First Intervention|malposition/blocked chest tube tube|2|||
105678804|NCT00468104|364485104|FG001|First Intervention|malposition/blocked chest tube tube|0|||
105678805|NCT00468104|364485103|FG000|First Intervention|large lung mass with minimal effusion|1|||
105678806|NCT00468104|364485104|FG001|First Intervention|large lung mass with minimal effusion|0|||
105678807|NCT00468104|364485103|FG000|First Intervention|associated prolonged pneumothorax|1|||
105678808|NCT00468104|364485104|FG001|First Intervention|associated prolonged pneumothorax|0|||
105678809|NCT00468104|364485103|FG000|First Intervention|trapped lung|1|||
105678810|NCT00468104|364485104|FG001|First Intervention|trapped lung|0|||
105678811|NCT00468104|364485103|FG000|Second Intervention|Withdrawal by Subject|5|||
105678812|NCT00468104|364485104|FG001|Second Intervention|Withdrawal by Subject|2|||
105678813|NCT00468104|364485103|FG000|Second Intervention|discarded for malposition of chest tube|0|||
105678814|NCT00468104|364485104|FG001|Second Intervention|discarded for malposition of chest tube|2|||
105678815|NCT00324675|364485106|FG000|Overall Study|Adverse Event|1|||
105678816|NCT00324675|364485107|FG001|Overall Study|Adverse Event|0|||
105678817|NCT00381615|364485108|FG000|Overall Study|Withdrawal by Subject|1|||
105678818|NCT00381615|364485109|FG001|Overall Study|Withdrawal by Subject|3|||
105678819|NCT00381615|364485110|FG002|Overall Study|Withdrawal by Subject|0|||
105678820|NCT00381615|364485111|FG003|Overall Study|Withdrawal by Subject|1|||
105678821|NCT00381615|364485108|FG000|Overall Study|Lost to Follow-up|3|||
105678822|NCT00381615|364485109|FG001|Overall Study|Lost to Follow-up|2|||
105678823|NCT00381615|364485110|FG002|Overall Study|Lost to Follow-up|0|||
105678824|NCT00381615|364485111|FG003|Overall Study|Lost to Follow-up|1|||
105678825|NCT00381615|364485108|FG000|Overall Study|Protocol Violation|0|||
105678826|NCT00381615|364485109|FG001|Overall Study|Protocol Violation|0|||
105678827|NCT00381615|364485110|FG002|Overall Study|Protocol Violation|1|||
105678828|NCT00381615|364485111|FG003|Overall Study|Protocol Violation|0|||
105678829|NCT02703259|364485112|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
105678830|NCT02703259|364485113|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
105678831|NCT02703259|364485112|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
105678832|NCT02703259|364485113|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
105678833|NCT02703259|364485112|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
105343633|NCT01801358|363259590|FG000|Overall Study|Physician Decision|0|||
105678834|NCT02703259|364485113|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
105678835|NCT02601300|364485114|FG000|Induction Phase|Lack of Efficacy|2|||
105678836|NCT02601300|364485114|FG000|Induction Phase|Protocol Violation|1|||
105678837|NCT02601300|364485114|FG000|Extension Phase|Withdrawal by Subject|3|||
105678838|NCT02601300|364485114|FG000|Extension Phase|Adverse Event|4|||
105678839|NCT02601300|364485114|FG000|Extension Phase|Lack of Efficacy|10|||
105678840|NCT01200589|364485115|FG000|Overall Study|Withdrawal by Subject|13|||
105678841|NCT01200589|364485116|FG001|Overall Study|Withdrawal by Subject|11|||
105678842|NCT01200589|364485115|FG000|Overall Study|Physician Decision|2|||
105678843|NCT01200589|364485116|FG001|Overall Study|Physician Decision|2|||
105678844|NCT01200589|364485115|FG000|Overall Study|Lost to Follow-up|5|||
105678845|NCT01200589|364485116|FG001|Overall Study|Lost to Follow-up|4|||
105678846|NCT01200589|364485115|FG000|Overall Study|Study terminated|170|||
105678847|NCT01200589|364485116|FG001|Overall Study|Study terminated|172|||
105678848|NCT00439231|364485117|FG000|Overall Study|Lack of Efficacy|28|||
105678849|NCT01993927|364485121|FG000|Overall Study|Case Report Forms Uncollected|18|||
105678850|NCT01993927|364485121|FG000|Overall Study|Protocol Violation|11|||
105678851|NCT00598273|364485122|FG000|Overall Study|Adverse Event|4|||
105678852|NCT00598273|364485123|FG001|Overall Study|Adverse Event|5|||
105678853|NCT00598273|364485124|FG002|Overall Study|Adverse Event|2|||
105678854|NCT00598273|364485122|FG000|Overall Study|Death|6|||
105678855|NCT00598273|364485123|FG001|Overall Study|Death|12|||
105678856|NCT00598273|364485124|FG002|Overall Study|Death|8|||
105678857|NCT00598273|364485122|FG000|Overall Study|Lost to Follow-up|8|||
105678858|NCT00598273|364485123|FG001|Overall Study|Lost to Follow-up|3|||
105678859|NCT00598273|364485124|FG002|Overall Study|Lost to Follow-up|5|||
105678860|NCT00598273|364485122|FG000|Overall Study|Physician Decision|0|||
105678861|NCT00598273|364485123|FG001|Overall Study|Physician Decision|0|||
105678862|NCT00598273|364485124|FG002|Overall Study|Physician Decision|1|||
105678863|NCT00598273|364485122|FG000|Overall Study|Withdrawal by Subject|12|||
105678864|NCT00598273|364485123|FG001|Overall Study|Withdrawal by Subject|10|||
105678865|NCT00598273|364485124|FG002|Overall Study|Withdrawal by Subject|10|||
105678866|NCT00598273|364485122|FG000|Overall Study|Noncompliance|3|||
105678867|NCT00598273|364485123|FG001|Overall Study|Noncompliance|2|||
105678868|NCT00598273|364485124|FG002|Overall Study|Noncompliance|3|||
105678869|NCT00598273|364485122|FG000|Overall Study|Relocation|0|||
105678870|NCT00598273|364485123|FG001|Overall Study|Relocation|2|||
105678871|NCT00598273|364485124|FG002|Overall Study|Relocation|4|||
105678872|NCT00598273|364485122|FG000|Overall Study|Renal transplant|1|||
105678873|NCT00598273|364485123|FG001|Overall Study|Renal transplant|0|||
105678874|NCT00598273|364485124|FG002|Overall Study|Renal transplant|1|||
105678875|NCT00598273|364485122|FG000|Overall Study|Site elected to close|1|||
105678876|NCT00598273|364485123|FG001|Overall Study|Site elected to close|0|||
105678877|NCT00598273|364485124|FG002|Overall Study|Site elected to close|0|||
105678878|NCT00598273|364485122|FG000|Overall Study|Started dialysis|6|||
105678879|NCT00598273|364485123|FG001|Overall Study|Started dialysis|4|||
105678880|NCT00598273|364485124|FG002|Overall Study|Started dialysis|5|||
105678881|NCT02729831|364485125|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
105678882|NCT02729831|364485126|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
105678883|NCT02729831|364485127|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
105678884|NCT02729831|364485128|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
105678885|NCT02729831|364485125|FG000|1 Week Post-visit|Lost to Follow-up|43|||
105678886|NCT02729831|364485126|FG001|1 Week Post-visit|Lost to Follow-up|40|||
105678887|NCT02729831|364485127|FG002|1 Week Post-visit|Lost to Follow-up|38|||
105678888|NCT02729831|364485128|FG003|1 Week Post-visit|Lost to Follow-up|36|||
105678889|NCT02729831|364485125|FG000|6 Month Follow-up|Lost to Follow-up|54|||
105678890|NCT02729831|364485126|FG001|6 Month Follow-up|Lost to Follow-up|51|||
105678891|NCT02729831|364485127|FG002|6 Month Follow-up|Lost to Follow-up|48|||
105678892|NCT02729831|364485128|FG003|6 Month Follow-up|Lost to Follow-up|42|||
105678893|NCT02729831|364485125|FG000|6 Month Follow-up|Death|1|||
105678894|NCT02729831|364485126|FG001|6 Month Follow-up|Death|3|||
105678895|NCT02729831|364485127|FG002|6 Month Follow-up|Death|0|||
105466779|NCT04770753|363721157|FG001|Overall Study|Other un-specified|0|||
105678896|NCT02729831|364485128|FG003|6 Month Follow-up|Death|1|||
105678897|NCT02996474|364485129|FG000|Overall Study|Physician Decision|5|||
105678898|NCT04493502|364485130|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
105678899|NCT04493502|364485131|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
105678900|NCT04493502|364485130|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
105678901|NCT04493502|364485131|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
105678902|NCT04493502|364485130|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
105678903|NCT04493502|364485131|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
105678904|NCT04493502|364485130|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
105678905|NCT04493502|364485131|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
105678906|NCT04493502|364485130|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
105466780|NCT00775190|363721158|FG000|Overall Study|Lost to Follow-up|2|||
105466781|NCT00775190|363721159|FG001|Overall Study|Lost to Follow-up|3|||
105466782|NCT00775190|363721158|FG000|Overall Study|Withdrawal by Subject|1|||
105466783|NCT00775190|363721159|FG001|Overall Study|Withdrawal by Subject|2|||
105466784|NCT00775190|363721158|FG000|Overall Study|Protocol Violation|1|||
105466785|NCT00775190|363721159|FG001|Overall Study|Protocol Violation|0|||
105466786|NCT00463567|363721160|FG000|Overall Study|Adverse Event|29|||
105466787|NCT00463567|363721161|FG001|Overall Study|Adverse Event|26|||
105466788|NCT00463567|363721162|FG002|Overall Study|Adverse Event|17|||
105466789|NCT00463567|363721163|FG003|Overall Study|Adverse Event|46|||
105466790|NCT00463567|363721164|FG004|Overall Study|Adverse Event|10|||
105556476|NCT02701985|364033741|FG000|Overall Study|Adverse Event|0|||
105556477|NCT02701985|364033742|FG001|Overall Study|Adverse Event|5|||
105556478|NCT03695172|364033748|FG000|Overall Study|Withdrawal by Subject|1|||
105556479|NCT03695172|364033749|FG001|Overall Study|Withdrawal by Subject|1|||
105556480|NCT03695172|364033750|FG002|Overall Study|Withdrawal by Subject|0|||
105556481|NCT02734212|364033763|FG000|Overall Study|Lost to Follow-up|5|||
105556482|NCT02734212|364033764|FG001|Overall Study|Lost to Follow-up|10|||
105556483|NCT04313881|364033768|FG000|Overall Study|Death|138|||
105556484|NCT04313881|364033769|FG001|Overall Study|Death|126|||
105556485|NCT04313881|364033768|FG000|Overall Study|Study terminated by sponsor|108|||
105556486|NCT04313881|364033769|FG001|Overall Study|Study terminated by sponsor|129|||
105556487|NCT04313881|364033768|FG000|Overall Study|Consent withdrawn|19|||
105556488|NCT04313881|364033769|FG001|Overall Study|Consent withdrawn|15|||
105556489|NCT04313881|364033768|FG000|Overall Study|Reason not Specified|3|||
105556490|NCT04313881|364033769|FG001|Overall Study|Reason not Specified|1|||
105556491|NCT00727272|364033770|FG000|Washout Period A|Adverse Event|0|||
105556492|NCT00727272|364033771|FG001|Washout Period A|Adverse Event|0|||
105556493|NCT00727272|364033772|FG002|Washout Period A|Adverse Event|1|||
105556494|NCT00727272|364033770|FG000|Washout Period B|Withdrawal by Subject|0|||
105556495|NCT00727272|364033771|FG001|Washout Period B|Withdrawal by Subject|0|||
105556496|NCT00727272|364033772|FG002|Washout Period B|Withdrawal by Subject|1|||
105556497|NCT00651664|364033773|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
105556498|NCT00651664|364033774|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
105556499|NCT00651664|364033775|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
105556500|NCT00651664|364033776|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
105556501|NCT00651664|364033777|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
105556502|NCT00651664|364033778|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
105556503|NCT00651664|364033779|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
105556504|NCT00651664|364033780|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
105556505|NCT00651664|364033781|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
105556506|NCT00651664|364033782|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
105556507|NCT00651664|364033773|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
105556508|NCT00651664|364033774|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
105556509|NCT00651664|364033775|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
105556510|NCT00651664|364033776|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
105556511|NCT00651664|364033777|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
105556512|NCT00651664|364033778|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
105556513|NCT00651664|364033779|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
105556514|NCT00651664|364033780|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
105556515|NCT00651664|364033781|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
105556516|NCT00651664|364033782|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
105556517|NCT00651664|364033773|FG000|Overall Study|Progressive Disease|3|||
105556518|NCT00651664|364033774|FG001|Overall Study|Progressive Disease|3|||
105556519|NCT00651664|364033775|FG002|Overall Study|Progressive Disease|3|||
105556520|NCT00651664|364033776|FG003|Overall Study|Progressive Disease|12|||
105556521|NCT00651664|364033777|FG004|Overall Study|Progressive Disease|4|||
105556522|NCT00651664|364033778|FG005|Overall Study|Progressive Disease|1|||
105556523|NCT00651664|364033779|FG006|Overall Study|Progressive Disease|3|||
105556524|NCT00651664|364033780|FG007|Overall Study|Progressive Disease|6|||
105556525|NCT00651664|364033781|FG008|Overall Study|Progressive Disease|5|||
105556526|NCT00651664|364033782|FG009|Overall Study|Progressive Disease|5|||
105556527|NCT00651664|364033773|FG000|Overall Study|Patient Declined Further Treatment|0|||
105556528|NCT00651664|364033774|FG001|Overall Study|Patient Declined Further Treatment|0|||
105556529|NCT00651664|364033775|FG002|Overall Study|Patient Declined Further Treatment|0|||
105556530|NCT00651664|364033776|FG003|Overall Study|Patient Declined Further Treatment|1|||
105343634|NCT01801358|363259591|FG001|Overall Study|Physician Decision|0|||
105343635|NCT01801358|363259592|FG002|Overall Study|Physician Decision|1|||
105466791|NCT00463567|363721165|FG005|Overall Study|Adverse Event|10|||
105466792|NCT00463567|363721166|FG006|Overall Study|Adverse Event|4|||
105556531|NCT00651664|364033777|FG004|Overall Study|Patient Declined Further Treatment|1|||
105556532|NCT00651664|364033778|FG005|Overall Study|Patient Declined Further Treatment|1|||
105556533|NCT00651664|364033779|FG006|Overall Study|Patient Declined Further Treatment|0|||
105556534|NCT00651664|364033780|FG007|Overall Study|Patient Declined Further Treatment|0|||
105556535|NCT00651664|364033781|FG008|Overall Study|Patient Declined Further Treatment|0|||
105556536|NCT00651664|364033782|FG009|Overall Study|Patient Declined Further Treatment|1|||
105678907|NCT04493502|364485131|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
105678908|NCT04493502|364485130|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
105678909|NCT04493502|364485131|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
105678910|NCT04493502|364485130|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
105678911|NCT04493502|364485131|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
105678912|NCT04493502|364485130|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
105678913|NCT04493502|364485131|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
105678914|NCT04493502|364485130|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
105678915|NCT04493502|364485131|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
105678916|NCT04493502|364485130|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
105678917|NCT04493502|364485131|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
105678918|NCT04493502|364485130|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
105678919|NCT04493502|364485131|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
105678920|NCT04493502|364485130|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
105678921|NCT04493502|364485131|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
105678922|NCT04493502|364485130|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
105678923|NCT04493502|364485131|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
105678924|NCT00540046|364485132|FG000|Overall Study|Lost to Follow-up|33|||
105678925|NCT00540046|364485133|FG001|Overall Study|Lost to Follow-up|23|||
105678926|NCT03965351|364485135|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
105678927|NCT03965351|364485136|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
105678928|NCT03965351|364485135|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
105678929|NCT03965351|364485136|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
105678930|NCT02665338|364485137|FG000|Overall Study|Withdrawal by Subject|0|||
105678931|NCT02665338|364485138|FG001|Overall Study|Withdrawal by Subject|1|||
105678932|NCT02412371|364485139|FG000|Overall Study|Withdrawal by Subject|0|||
105678933|NCT02412371|364485140|FG001|Overall Study|Withdrawal by Subject|2|||
105678934|NCT02412371|364485141|FG002|Overall Study|Withdrawal by Subject|0|||
105678935|NCT02412371|364485142|FG003|Overall Study|Withdrawal by Subject|1|||
105678936|NCT02412371|364485143|FG004|Overall Study|Withdrawal by Subject|1|||
105678937|NCT02412371|364485144|FG005|Overall Study|Withdrawal by Subject|0|||
105678938|NCT02412371|364485139|FG000|Overall Study|Sponsor Discontinued Study|1|||
105678939|NCT02412371|364485140|FG001|Overall Study|Sponsor Discontinued Study|4|||
105678940|NCT02412371|364485141|FG002|Overall Study|Sponsor Discontinued Study|6|||
105678941|NCT02412371|364485142|FG003|Overall Study|Sponsor Discontinued Study|4|||
105678942|NCT02412371|364485143|FG004|Overall Study|Sponsor Discontinued Study|5|||
105678943|NCT02412371|364485144|FG005|Overall Study|Sponsor Discontinued Study|0|||
105678944|NCT02412371|364485139|FG000|Overall Study|Death|4|||
105678945|NCT02412371|364485140|FG001|Overall Study|Death|2|||
105678946|NCT02412371|364485141|FG002|Overall Study|Death|1|||
105678947|NCT02412371|364485142|FG003|Overall Study|Death|3|||
105678948|NCT02412371|364485143|FG004|Overall Study|Death|5|||
105678949|NCT02412371|364485144|FG005|Overall Study|Death|2|||
105678950|NCT02412371|364485139|FG000|Overall Study|Other|2|||
105678951|NCT02412371|364485140|FG001|Overall Study|Other|1|||
105678952|NCT02412371|364485141|FG002|Overall Study|Other|0|||
105678953|NCT02412371|364485142|FG003|Overall Study|Other|0|||
105678954|NCT02412371|364485143|FG004|Overall Study|Other|1|||
105678955|NCT02412371|364485144|FG005|Overall Study|Other|3|||
105678956|NCT00903682|364485145|FG000|Overall Study|Adverse Event|6|||
105678957|NCT00903682|364485146|FG001|Overall Study|Adverse Event|13|||
105678958|NCT00903682|364485145|FG000|Overall Study|Lost to Follow-up|1|||
105678959|NCT00903682|364485146|FG001|Overall Study|Lost to Follow-up|0|||
105678960|NCT00903682|364485145|FG000|Overall Study|Withdrawal by Subject|5|||
105678961|NCT00903682|364485146|FG001|Overall Study|Withdrawal by Subject|0|||
105678962|NCT00903682|364485145|FG000|Overall Study|Pregnancy|0|||
105678963|NCT00903682|364485146|FG001|Overall Study|Pregnancy|1|||
105678964|NCT00903682|364485145|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
105678965|NCT00903682|364485146|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
105678966|NCT00903682|364485145|FG000|Overall Study|Subject Non-Compliant|1|||
105786474|NCT01748162|364871401|FG000|Overall Study|no additional croup episodes to evaluate|2|||
105678967|NCT00903682|364485146|FG001|Overall Study|Subject Non-Compliant|0|||
105786475|NCT01748162|364871402|FG001|Overall Study|no additional croup episodes to evaluate|2|||
105678968|NCT00903682|364485145|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
105678969|NCT00903682|364485146|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
105678970|NCT00903682|364485145|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
105678971|NCT00903682|364485146|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
105678972|NCT02053792|364485147|FG000|Overall Study|Physician Decision|0|||
105678973|NCT02053792|364485148|FG001|Overall Study|Physician Decision|1|||
105678974|NCT02053792|364485147|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
105678975|NCT02053792|364485148|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
105678976|NCT02053792|364485147|FG000|Overall Study|Lack of Efficacy|1|||
105678977|NCT02053792|364485148|FG001|Overall Study|Lack of Efficacy|0|||
105678978|NCT02053792|364485147|FG000|Overall Study|Adverse Event|1|||
105678979|NCT02053792|364485148|FG001|Overall Study|Adverse Event|0|||
105678980|NCT02053792|364485147|FG000|Overall Study|Withdrawal by Subject|2|||
105678981|NCT02053792|364485148|FG001|Overall Study|Withdrawal by Subject|2|||
105678982|NCT02053792|364485147|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
105678983|NCT02053792|364485148|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
105678984|NCT02053792|364485147|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
105678985|NCT02053792|364485148|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
105678986|NCT01028027|364485149|FG000|Overall Study|Lost to Follow-up|4|||
105678987|NCT01028027|364485150|FG001|Overall Study|Lost to Follow-up|1|||
105678988|NCT01028027|364485149|FG000|Overall Study|Withdrawal by Subject|5|||
105678989|NCT01028027|364485150|FG001|Overall Study|Withdrawal by Subject|3|||
105678990|NCT01028027|364485149|FG000|Overall Study|Adverse Event|4|||
105678991|NCT01028027|364485150|FG001|Overall Study|Adverse Event|7|||
105678992|NCT01028027|364485149|FG000|Overall Study|Protocol Violation|3|||
105678993|NCT01028027|364485150|FG001|Overall Study|Protocol Violation|1|||
105678994|NCT01028027|364485149|FG000|Overall Study|Lack of Efficacy|0|||
105678995|NCT01028027|364485150|FG001|Overall Study|Lack of Efficacy|1|||
105678996|NCT00529958|364485151|FG000|2-Year Follow-up|Lost to Follow-up|1|||
105678997|NCT00529958|364485152|FG001|2-Year Follow-up|Lost to Follow-up|2|||
105678998|NCT00529958|364485153|FG002|2-Year Follow-up|Lost to Follow-up|2|||
105678999|NCT00529958|364485151|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
105679000|NCT00529958|364485152|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
105679001|NCT00529958|364485153|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
105679002|NCT00529958|364485151|FG000|5-Year Follow-up|Lost to Follow-up|2|||
105679003|NCT00529958|364485152|FG001|5-Year Follow-up|Lost to Follow-up|3|||
105679004|NCT00529958|364485153|FG002|5-Year Follow-up|Lost to Follow-up|1|||
105679005|NCT00529958|364485151|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
105679006|NCT00529958|364485152|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
105679007|NCT00529958|364485153|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
105679008|NCT03141905|364485156|FG000|Overall Study|Death|3|||
105679009|NCT03141905|364485157|FG001|Overall Study|Death|2|||
105679010|NCT03141905|364485156|FG000|Overall Study|Withdrawal by Subject|1|||
105679011|NCT03141905|364485157|FG001|Overall Study|Withdrawal by Subject|0|||
105679012|NCT03141905|364485156|FG000|Overall Study|Lost to Follow-up|3|||
105679013|NCT03141905|364485157|FG001|Overall Study|Lost to Follow-up|7|||
105679014|NCT03141905|364485156|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
105679015|NCT03141905|364485157|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
105679016|NCT05180500|364485158|FG000|Overall Study|Adverse Event|1|||
105679017|NCT05180500|364485159|FG001|Overall Study|Adverse Event|0|||
105679018|NCT05180500|364485158|FG000|Overall Study|Withdrawal by Subject|2|||
105679019|NCT05180500|364485159|FG001|Overall Study|Withdrawal by Subject|0|||
105679020|NCT00432666|364486869|FG000|Main Period|Adverse Event|1|||
105679021|NCT00432666|364486870|FG001|Main Period|Adverse Event|1|||
105679022|NCT00432666|364486869|FG000|Main Period|Consent Withdrawn|1|||
105679023|NCT00432666|364486870|FG001|Main Period|Consent Withdrawn|0|||
105679024|NCT00432666|364486869|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
105679025|NCT00432666|364486870|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
105679026|NCT00432666|364486869|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
105679027|NCT00432666|364486870|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
105679028|NCT00432666|364486869|FG000|Open-Label Extension Period|Adverse Event|5|||
105679029|NCT00432666|364486870|FG001|Open-Label Extension Period|Adverse Event|0|||
105679030|NCT00432666|364486869|FG000|Open-Label Extension Period|Consent withdrawn|10|||
105679031|NCT00432666|364486870|FG001|Open-Label Extension Period|Consent withdrawn|0|||
105679032|NCT00432666|364486869|FG000|Open-Label Extension Period|Physician Decision|3|||
105679033|NCT00432666|364486870|FG001|Open-Label Extension Period|Physician Decision|0|||
105679034|NCT00978627|364486871|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
105679035|NCT00978627|364486872|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
105679036|NCT00978627|364486871|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
105679037|NCT00978627|364486872|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
105679038|NCT00978627|364486871|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
105466793|NCT00463567|363721160|FG000|Overall Study|Withdrawal by Subject|29|||
105679039|NCT00978627|364486872|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
105679040|NCT00978627|364486871|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
105679041|NCT00978627|364486872|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
105679042|NCT00978627|364486871|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
105466794|NCT00463567|363721161|FG001|Overall Study|Withdrawal by Subject|22|||
105466795|NCT00463567|363721162|FG002|Overall Study|Withdrawal by Subject|20|||
105679043|NCT00978627|364486872|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
105679044|NCT00978627|364486871|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
105679045|NCT00978627|364486872|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
105679046|NCT00978627|364486871|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
105679047|NCT00978627|364486872|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
105679048|NCT00978627|364486871|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
105679049|NCT00978627|364486872|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
105679050|NCT00978627|364486871|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
105679051|NCT00978627|364486872|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
105679052|NCT00605215|364486875|FG000|Overall Study|Death|0|||
105679053|NCT00605215|364486876|FG001|Overall Study|Death|0|||
105679054|NCT00605215|364486877|FG002|Overall Study|Death|1|||
105679055|NCT00605215|364486875|FG000|Overall Study|Adverse Event|19|||
105679056|NCT00605215|364486876|FG001|Overall Study|Adverse Event|21|||
105679057|NCT00605215|364486877|FG002|Overall Study|Adverse Event|26|||
105679058|NCT00605215|364486875|FG000|Overall Study|Refusal to sign the re-consent form|8|||
105679059|NCT00605215|364486876|FG001|Overall Study|Refusal to sign the re-consent form|3|||
105679060|NCT00605215|364486877|FG002|Overall Study|Refusal to sign the re-consent form|3|||
105679061|NCT00605215|364486875|FG000|Overall Study|Withdrawal by Subject|39|||
105679062|NCT00605215|364486876|FG001|Overall Study|Withdrawal by Subject|37|||
105679063|NCT00605215|364486877|FG002|Overall Study|Withdrawal by Subject|27|||
105679064|NCT00605215|364486875|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
105679065|NCT00605215|364486876|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
105679066|NCT00605215|364486877|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
105679067|NCT00605215|364486875|FG000|Overall Study|Protocol Violation|3|||
105679068|NCT00605215|364486876|FG001|Overall Study|Protocol Violation|4|||
105679069|NCT00605215|364486877|FG002|Overall Study|Protocol Violation|1|||
105679070|NCT00605215|364486875|FG000|Overall Study|Pregnancy|8|||
105679071|NCT00605215|364486876|FG001|Overall Study|Pregnancy|5|||
105679072|NCT00605215|364486877|FG002|Overall Study|Pregnancy|4|||
105679073|NCT00605215|364486875|FG000|Overall Study|Lost to Follow-up|8|||
105679074|NCT00605215|364486876|FG001|Overall Study|Lost to Follow-up|5|||
105679075|NCT00605215|364486877|FG002|Overall Study|Lost to Follow-up|2|||
105679076|NCT00605215|364486875|FG000|Overall Study|Other than specified|0|||
105679077|NCT00605215|364486876|FG001|Overall Study|Other than specified|2|||
105679078|NCT00605215|364486877|FG002|Overall Study|Other than specified|1|||
105679079|NCT00091169|364486878|FG000|Overall Study|Disease progression|3|||
105679080|NCT00091169|364486879|FG001|Overall Study|Disease progression|1|||
105679081|NCT00091169|364486878|FG000|Overall Study|Adverse Event|11|||
105679082|NCT00091169|364486879|FG001|Overall Study|Adverse Event|17|||
105679083|NCT00091169|364486878|FG000|Overall Study|Death|4|||
105679084|NCT00091169|364486879|FG001|Overall Study|Death|1|||
105679085|NCT00091169|364486878|FG000|Overall Study|Withdrawal by Subject|10|||
105679086|NCT00091169|364486879|FG001|Overall Study|Withdrawal by Subject|13|||
105679087|NCT00091169|364486878|FG000|Overall Study|Other|3|||
105679088|NCT00091169|364486879|FG001|Overall Study|Other|4|||
105679089|NCT00091169|364486878|FG000|Overall Study|Not start protocol therapy|26|||
105679090|NCT00091169|364486879|FG001|Overall Study|Not start protocol therapy|17|||
105679091|NCT02407990|364486880|FG000|Overall Study|Death|2|||
105679092|NCT02407990|364486881|FG001|Overall Study|Death|22|||
105679093|NCT02407990|364486882|FG002|Overall Study|Death|23|||
105679094|NCT02407990|364486883|FG003|Overall Study|Death|7|||
105679095|NCT02407990|364486884|FG004|Overall Study|Death|17|||
105679096|NCT02407990|364486885|FG005|Overall Study|Death|16|||
105679097|NCT02407990|364486886|FG006|Overall Study|Death|10|||
105679098|NCT02407990|364486887|FG007|Overall Study|Death|248|||
105679099|NCT02407990|364486880|FG000|Overall Study|Lost to Follow-up|0|||
105679100|NCT02407990|364486881|FG001|Overall Study|Lost to Follow-up|1|||
105679101|NCT02407990|364486882|FG002|Overall Study|Lost to Follow-up|0|||
105679102|NCT02407990|364486883|FG003|Overall Study|Lost to Follow-up|0|||
105786476|NCT01748162|364871401|FG000|Overall Study|participant consented but did not begin|0|||
105466796|NCT00463567|363721163|FG003|Overall Study|Withdrawal by Subject|37|||
105679103|NCT02407990|364486884|FG004|Overall Study|Lost to Follow-up|0|||
105679104|NCT02407990|364486885|FG005|Overall Study|Lost to Follow-up|0|||
105679105|NCT02407990|364486886|FG006|Overall Study|Lost to Follow-up|0|||
105679106|NCT02407990|364486887|FG007|Overall Study|Lost to Follow-up|17|||
105679107|NCT02407990|364486880|FG000|Overall Study|Progressive Disease|0|||
105679108|NCT02407990|364486881|FG001|Overall Study|Progressive Disease|0|||
105679109|NCT02407990|364486882|FG002|Overall Study|Progressive Disease|0|||
105679110|NCT02407990|364486883|FG003|Overall Study|Progressive Disease|0|||
105679111|NCT02407990|364486884|FG004|Overall Study|Progressive Disease|0|||
105679112|NCT02407990|364486885|FG005|Overall Study|Progressive Disease|0|||
105679113|NCT02407990|364486886|FG006|Overall Study|Progressive Disease|0|||
105679114|NCT02407990|364486887|FG007|Overall Study|Progressive Disease|1|||
105343636|NCT01801358|363259593|FG003|Overall Study|Physician Decision|0|||
105556537|NCT00651664|364033773|FG000|Overall Study|Symptomatic Deterioration|0|||
105556538|NCT00651664|364033774|FG001|Overall Study|Symptomatic Deterioration|0|||
105556539|NCT00651664|364033775|FG002|Overall Study|Symptomatic Deterioration|0|||
105556540|NCT00651664|364033776|FG003|Overall Study|Symptomatic Deterioration|1|||
105556541|NCT00651664|364033777|FG004|Overall Study|Symptomatic Deterioration|0|||
105556542|NCT00651664|364033778|FG005|Overall Study|Symptomatic Deterioration|0|||
105556543|NCT00651664|364033779|FG006|Overall Study|Symptomatic Deterioration|1|||
105556544|NCT00651664|364033780|FG007|Overall Study|Symptomatic Deterioration|0|||
105556545|NCT00651664|364033781|FG008|Overall Study|Symptomatic Deterioration|1|||
105556546|NCT00651664|364033782|FG009|Overall Study|Symptomatic Deterioration|0|||
105556547|NCT00651664|364033773|FG000|Overall Study|Reason not Specified|0|||
105556548|NCT00651664|364033774|FG001|Overall Study|Reason not Specified|0|||
105556549|NCT00651664|364033775|FG002|Overall Study|Reason not Specified|0|||
105556550|NCT00651664|364033776|FG003|Overall Study|Reason not Specified|0|||
105556551|NCT00651664|364033777|FG004|Overall Study|Reason not Specified|0|||
105556552|NCT00651664|364033778|FG005|Overall Study|Reason not Specified|0|||
105556553|NCT00651664|364033779|FG006|Overall Study|Reason not Specified|1|||
105556554|NCT00651664|364033780|FG007|Overall Study|Reason not Specified|0|||
105556555|NCT00651664|364033781|FG008|Overall Study|Reason not Specified|0|||
105556556|NCT00651664|364033782|FG009|Overall Study|Reason not Specified|0|||
105556557|NCT00983073|364033789|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
105556558|NCT00983073|364033789|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
105556559|NCT00983073|364033789|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
105556560|NCT00983073|364033789|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
105556561|NCT00983073|364033789|FG000|Titration and Optimal Dose Period|Other reason|4|||
105556562|NCT00983073|364033789|FG000|Maintenance Period|Adverse Event|5|||
105556563|NCT00983073|364033789|FG000|Maintenance Period|Withdrawal by Subject|2|||
105556564|NCT00983073|364033789|FG000|Maintenance Period|Lack of Efficacy|2|||
105556565|NCT00983073|364033789|FG000|Maintenance Period|Other Reason|7|||
105556566|NCT01261338|364033792|FG000|Overall Study|Withdrawal by Subject|3|||
105556567|NCT01261338|364033793|FG001|Overall Study|Withdrawal by Subject|2|||
105556568|NCT05557942|364033794|FG000|Overall Study|Death|0|||
105556569|NCT05557942|364033795|FG001|Overall Study|Death|0|||
105556570|NCT05557942|364033796|FG002|Overall Study|Death|0|||
105556571|NCT05557942|364033797|FG003|Overall Study|Death|2|||
105556572|NCT05557942|364033798|FG004|Overall Study|Death|1|||
105556573|NCT05557942|364033799|FG005|Overall Study|Death|1|||
105556574|NCT05557942|364033794|FG000|Overall Study|Physician Decision|1|||
105556575|NCT05557942|364033795|FG001|Overall Study|Physician Decision|1|||
105556576|NCT05557942|364033796|FG002|Overall Study|Physician Decision|2|||
105556577|NCT05557942|364033797|FG003|Overall Study|Physician Decision|3|||
105556578|NCT05557942|364033798|FG004|Overall Study|Physician Decision|0|||
105556579|NCT05557942|364033799|FG005|Overall Study|Physician Decision|2|||
105556580|NCT05557942|364033794|FG000|Overall Study|Study terminated by sponsor|17|||
105556581|NCT05557942|364033795|FG001|Overall Study|Study terminated by sponsor|17|||
105556582|NCT05557942|364033796|FG002|Overall Study|Study terminated by sponsor|14|||
105556583|NCT05557942|364033797|FG003|Overall Study|Study terminated by sponsor|40|||
105679115|NCT02407990|364486880|FG000|Overall Study|Withdrawal by Subject|0|||
105556584|NCT05557942|364033798|FG004|Overall Study|Study terminated by sponsor|45|||
105556585|NCT05557942|364033799|FG005|Overall Study|Study terminated by sponsor|37|||
105556586|NCT05557942|364033794|FG000|Overall Study|Protocol Violation|0|||
105556587|NCT05557942|364033795|FG001|Overall Study|Protocol Violation|0|||
105556588|NCT05557942|364033796|FG002|Overall Study|Protocol Violation|0|||
105556589|NCT05557942|364033797|FG003|Overall Study|Protocol Violation|0|||
105556590|NCT05557942|364033798|FG004|Overall Study|Protocol Violation|0|||
105556591|NCT05557942|364033799|FG005|Overall Study|Protocol Violation|1|||
105556592|NCT05557942|364033794|FG000|Overall Study|Withdrawal by Subject|0|||
105556593|NCT05557942|364033795|FG001|Overall Study|Withdrawal by Subject|0|||
105679116|NCT02407990|364486881|FG001|Overall Study|Withdrawal by Subject|0|||
105556594|NCT05557942|364033796|FG002|Overall Study|Withdrawal by Subject|0|||
105556595|NCT05557942|364033797|FG003|Overall Study|Withdrawal by Subject|0|||
105556596|NCT05557942|364033798|FG004|Overall Study|Withdrawal by Subject|2|||
105556597|NCT05557942|364033799|FG005|Overall Study|Withdrawal by Subject|0|||
105556598|NCT01389973|364033800|FG000|Overall Study|Lost to Follow-up|1|||
105556599|NCT01389973|364033800|FG000|Overall Study|Trial Stopped by Sponsor|9|||
105556600|NCT01389973|364033800|FG000|Overall Study|Other|10|||
105556601|NCT02477618|364033801|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
105556602|NCT02477618|364033802|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
105556603|NCT02477618|364033801|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
105556604|NCT02477618|364033802|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
105556605|NCT02477618|364033801|FG000|Overall Study|Adverse Event|1|||
105556606|NCT02477618|364033802|FG001|Overall Study|Adverse Event|1|||
105556607|NCT02477618|364033801|FG000|Overall Study|Transferred Away from Study Site|1|||
105556608|NCT02477618|364033802|FG001|Overall Study|Transferred Away from Study Site|0|||
105556609|NCT02477618|364033801|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
105556610|NCT02477618|364033802|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
105556611|NCT04304833|364033803|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
105556612|NCT04304833|364033804|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
105556613|NCT03456700|364033805|FG000|Overall Study|Withdrawal by Subject|1|||
105556614|NCT05540522|364033810|FG000|Overall Study|Adverse Event|1|||
105556615|NCT05540522|364033811|FG001|Overall Study|Adverse Event|0|||
105556616|NCT05540522|364033812|FG002|Overall Study|Adverse Event|2|||
105556617|NCT05540522|364033813|FG003|Overall Study|Adverse Event|5|||
105556618|NCT05540522|364033810|FG000|Overall Study|Lost to Follow-up|487|||
105556619|NCT05540522|364033811|FG001|Overall Study|Lost to Follow-up|427|||
105556620|NCT05540522|364033812|FG002|Overall Study|Lost to Follow-up|146|||
105556621|NCT05540522|364033813|FG003|Overall Study|Lost to Follow-up|166|||
105556622|NCT05540522|364033810|FG000|Overall Study|Physician Decision|11|||
105556623|NCT05540522|364033811|FG001|Overall Study|Physician Decision|19|||
105556624|NCT05540522|364033812|FG002|Overall Study|Physician Decision|8|||
105556625|NCT05540522|364033813|FG003|Overall Study|Physician Decision|13|||
105556626|NCT05540522|364033810|FG000|Overall Study|Pregnancy|1|||
105556627|NCT05540522|364033811|FG001|Overall Study|Pregnancy|0|||
105556628|NCT05540522|364033812|FG002|Overall Study|Pregnancy|0|||
105556629|NCT05540522|364033813|FG003|Overall Study|Pregnancy|0|||
105556630|NCT05540522|364033810|FG000|Overall Study|Protocol Violation|3|||
105556631|NCT05540522|364033811|FG001|Overall Study|Protocol Violation|1|||
105556632|NCT05540522|364033812|FG002|Overall Study|Protocol Violation|9|||
105556633|NCT05540522|364033813|FG003|Overall Study|Protocol Violation|7|||
105556634|NCT05540522|364033810|FG000|Overall Study|Withdrawal by Subject|168|||
105556635|NCT05540522|364033811|FG001|Overall Study|Withdrawal by Subject|134|||
105556636|NCT05540522|364033812|FG002|Overall Study|Withdrawal by Subject|331|||
105556637|NCT05540522|364033813|FG003|Overall Study|Withdrawal by Subject|322|||
105556638|NCT05540522|364033810|FG000|Overall Study|Death|7|||
105556639|NCT05540522|364033811|FG001|Overall Study|Death|9|||
105556640|NCT05540522|364033812|FG002|Overall Study|Death|49|||
105556641|NCT05540522|364033813|FG003|Overall Study|Death|46|||
105556642|NCT05540522|364033810|FG000|Overall Study|Not vaccinated|34|||
105556643|NCT05540522|364033811|FG001|Overall Study|Not vaccinated|53|||
105556644|NCT05540522|364033812|FG002|Overall Study|Not vaccinated|57|||
105556645|NCT05540522|364033813|FG003|Overall Study|Not vaccinated|50|||
105556646|NCT05540522|364033810|FG000|Overall Study|No longer meets eligibility criteria|0|||
105556647|NCT05540522|364033811|FG001|Overall Study|No longer meets eligibility criteria|0|||
105556648|NCT05540522|364033812|FG002|Overall Study|No longer meets eligibility criteria|3|||
105556649|NCT05540522|364033813|FG003|Overall Study|No longer meets eligibility criteria|2|||
105556650|NCT05540522|364033810|FG000|Overall Study|Other (Unspecified)|8|||
105556651|NCT05540522|364033811|FG001|Overall Study|Other (Unspecified)|10|||
105556652|NCT05540522|364033812|FG002|Overall Study|Other (Unspecified)|4|||
105556653|NCT05540522|364033813|FG003|Overall Study|Other (Unspecified)|2|||
105556654|NCT05239039|364033816|FG000|Overall Study|Withdrawal by Subject|0|||
105556655|NCT05239039|364033817|FG001|Overall Study|Withdrawal by Subject|1|||
105556656|NCT04348604|364033818|FG000|Week 8|Withdrawal by Subject|1|||
105679117|NCT02407990|364486882|FG002|Overall Study|Withdrawal by Subject|0|||
105679118|NCT02407990|364486883|FG003|Overall Study|Withdrawal by Subject|0|||
105556657|NCT04348604|364033819|FG001|Week 8|Withdrawal by Subject|1|||
105556658|NCT04348604|364033818|FG000|Week 8|Lost to Follow-up|1|||
105556659|NCT04348604|364033819|FG001|Week 8|Lost to Follow-up|2|||
105556660|NCT04348604|364033818|FG000|Week 8|Suspended|0|||
105556661|NCT04348604|364033819|FG001|Week 8|Suspended|1|||
105556662|NCT04348604|364033818|FG000|Week 12|Lost to Follow-up|1|||
105556663|NCT04348604|364033819|FG001|Week 12|Lost to Follow-up|2|||
105556664|NCT04348604|364033818|FG000|Week 12|Withdrawal by Subject|1|||
105556665|NCT04348604|364033819|FG001|Week 12|Withdrawal by Subject|0|||
105556666|NCT04348604|364033818|FG000|Week 24|Lost to Follow-up|2|||
105556667|NCT04348604|364033819|FG001|Week 24|Lost to Follow-up|1|||
105556668|NCT02097108|364033820|FG000|Overall Study|Adverse Event|1|||
105556669|NCT02097108|364033820|FG000|Overall Study|patient was abroad for 6 months|1|||
105343637|NCT01801358|363259594|FG004|Overall Study|Physician Decision|0|||
105343638|NCT01801358|363259595|FG005|Overall Study|Physician Decision|0|||
105343639|NCT01801358|363259590|FG000|Overall Study|Progressive Disease|6|||
105343640|NCT01801358|363259591|FG001|Overall Study|Progressive Disease|4|||
105343641|NCT01801358|363259592|FG002|Overall Study|Progressive Disease|4|||
105343642|NCT01801358|363259593|FG003|Overall Study|Progressive Disease|5|||
105343643|NCT01801358|363259594|FG004|Overall Study|Progressive Disease|6|||
105343644|NCT01801358|363259595|FG005|Overall Study|Progressive Disease|5|||
105343645|NCT01801358|363259590|FG000|Overall Study|Withdrawal by Subject|0|||
105343646|NCT01801358|363259591|FG001|Overall Study|Withdrawal by Subject|0|||
105343647|NCT01801358|363259592|FG002|Overall Study|Withdrawal by Subject|0|||
105466797|NCT00463567|363721164|FG004|Overall Study|Withdrawal by Subject|6|||
105466798|NCT00463567|363721165|FG005|Overall Study|Withdrawal by Subject|5|||
105466799|NCT00463567|363721166|FG006|Overall Study|Withdrawal by Subject|1|||
105466800|NCT00463567|363721160|FG000|Overall Study|Protocol Deviation|13|||
105466801|NCT00463567|363721161|FG001|Overall Study|Protocol Deviation|9|||
105466802|NCT00463567|363721162|FG002|Overall Study|Protocol Deviation|14|||
105466803|NCT00463567|363721163|FG003|Overall Study|Protocol Deviation|11|||
105466804|NCT00463567|363721164|FG004|Overall Study|Protocol Deviation|1|||
105466805|NCT00463567|363721165|FG005|Overall Study|Protocol Deviation|1|||
105466806|NCT00463567|363721166|FG006|Overall Study|Protocol Deviation|2|||
105466807|NCT00463567|363721160|FG000|Overall Study|Lost to Follow-up|12|||
105466808|NCT00463567|363721161|FG001|Overall Study|Lost to Follow-up|6|||
105466809|NCT00463567|363721162|FG002|Overall Study|Lost to Follow-up|13|||
105466810|NCT00463567|363721163|FG003|Overall Study|Lost to Follow-up|8|||
105466811|NCT00463567|363721164|FG004|Overall Study|Lost to Follow-up|1|||
105466812|NCT00463567|363721165|FG005|Overall Study|Lost to Follow-up|1|||
105466813|NCT00463567|363721166|FG006|Overall Study|Lost to Follow-up|1|||
105466814|NCT00463567|363721160|FG000|Overall Study|Administrative problems|5|||
105466815|NCT00463567|363721161|FG001|Overall Study|Administrative problems|3|||
105466816|NCT00463567|363721162|FG002|Overall Study|Administrative problems|6|||
105466817|NCT00463567|363721163|FG003|Overall Study|Administrative problems|9|||
105466818|NCT00463567|363721164|FG004|Overall Study|Administrative problems|3|||
105466819|NCT00463567|363721165|FG005|Overall Study|Administrative problems|2|||
105466820|NCT00463567|363721166|FG006|Overall Study|Administrative problems|2|||
105466821|NCT00463567|363721160|FG000|Overall Study|Lack of Efficacy|4|||
105466822|NCT00463567|363721161|FG001|Overall Study|Lack of Efficacy|9|||
105466823|NCT00463567|363721162|FG002|Overall Study|Lack of Efficacy|9|||
105466824|NCT00463567|363721163|FG003|Overall Study|Lack of Efficacy|17|||
105466825|NCT00463567|363721164|FG004|Overall Study|Lack of Efficacy|1|||
105466826|NCT00463567|363721165|FG005|Overall Study|Lack of Efficacy|0|||
105466827|NCT00463567|363721166|FG006|Overall Study|Lack of Efficacy|1|||
105466828|NCT00463567|363721160|FG000|Overall Study|Abnormal lab value(s)|1|||
105466829|NCT00463567|363721161|FG001|Overall Study|Abnormal lab value(s)|1|||
105466830|NCT00463567|363721162|FG002|Overall Study|Abnormal lab value(s)|2|||
105466831|NCT00463567|363721163|FG003|Overall Study|Abnormal lab value(s)|1|||
105466832|NCT00463567|363721164|FG004|Overall Study|Abnormal lab value(s)|1|||
105466833|NCT00463567|363721165|FG005|Overall Study|Abnormal lab value(s)|0|||
105466834|NCT00463567|363721166|FG006|Overall Study|Abnormal lab value(s)|0|||
105466835|NCT00463567|363721160|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105466836|NCT00463567|363721161|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105466837|NCT00463567|363721162|FG002|Overall Study|Abnormal test procedure result(s)|6|||
105466838|NCT00463567|363721163|FG003|Overall Study|Abnormal test procedure result(s)|2|||
105466839|NCT00463567|363721164|FG004|Overall Study|Abnormal test procedure result(s)|0|||
105466840|NCT00463567|363721165|FG005|Overall Study|Abnormal test procedure result(s)|2|||
105466841|NCT00463567|363721166|FG006|Overall Study|Abnormal test procedure result(s)|0|||
105466842|NCT00463567|363721160|FG000|Overall Study|Death|1|||
105466843|NCT00463567|363721161|FG001|Overall Study|Death|0|||
105466844|NCT00463567|363721162|FG002|Overall Study|Death|2|||
105466845|NCT00463567|363721163|FG003|Overall Study|Death|0|||
105466846|NCT00463567|363721164|FG004|Overall Study|Death|0|||
105466847|NCT00463567|363721165|FG005|Overall Study|Death|0|||
105466848|NCT00463567|363721166|FG006|Overall Study|Death|0|||
105466849|NCT01458392|363721169|FG000|Overall Study|Death|2|||
105466850|NCT01458392|363721170|FG001|Overall Study|Death|11|||
105466851|NCT01458392|363721171|FG002|Overall Study|Death|22|||
105466852|NCT01458392|363721169|FG000|Overall Study|At the discretion of the sponsor|0|||
105466853|NCT01458392|363721170|FG001|Overall Study|At the discretion of the sponsor|2|||
105466854|NCT01458392|363721171|FG002|Overall Study|At the discretion of the sponsor|7|||
105466855|NCT01458392|363721169|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
105466856|NCT01458392|363721170|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
105466857|NCT01458392|363721171|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
105466858|NCT03841604|363721174|FG000|Overall Study|Withdrawal by Subject|3|||
105466859|NCT03841604|363721175|FG001|Overall Study|Withdrawal by Subject|1|||
105466860|NCT03841604|363721174|FG000|Overall Study|Adverse Event|4|||
105466861|NCT03841604|363721175|FG001|Overall Study|Adverse Event|2|||
105343648|NCT01801358|363259593|FG003|Overall Study|Withdrawal by Subject|1|||
105556670|NCT00857207|364035518|FG000|Overall Study|Withdrawal by Subject|13|||
105556671|NCT00857207|364035519|FG001|Overall Study|Withdrawal by Subject|0|||
105556672|NCT00857207|364035518|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
105556673|NCT00857207|364035519|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
105556674|NCT00857207|364035518|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
105556675|NCT00857207|364035519|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
105556676|NCT00955357|364035520|FG000|Titration Phase|Adverse Event|9|||
105556677|NCT00955357|364035521|FG001|Titration Phase|Adverse Event|46|||
105556678|NCT00955357|364035520|FG000|Titration Phase|Lack of Efficacy|0|||
105556679|NCT00955357|364035521|FG001|Titration Phase|Lack of Efficacy|2|||
105556680|NCT00955357|364035520|FG000|Titration Phase|Protocol Violation|3|||
105556681|NCT00955357|364035521|FG001|Titration Phase|Protocol Violation|7|||
105556682|NCT00955357|364035520|FG000|Titration Phase|Lost to Follow-up|1|||
105556683|NCT00955357|364035521|FG001|Titration Phase|Lost to Follow-up|3|||
105556684|NCT00955357|364035520|FG000|Titration Phase|Withdrawal by Subject|3|||
105556685|NCT00955357|364035521|FG001|Titration Phase|Withdrawal by Subject|5|||
105556686|NCT00955357|364035520|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
105556687|NCT00955357|364035521|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
105556688|NCT00955357|364035520|FG000|Titration Phase|Study medication not tolerated|0|||
105556689|NCT00955357|364035521|FG001|Titration Phase|Study medication not tolerated|1|||
105556690|NCT00955357|364035520|FG000|Titration Phase|Non compliance to study procedures|0|||
105556691|NCT00955357|364035521|FG001|Titration Phase|Non compliance to study procedures|1|||
105556692|NCT00955357|364035520|FG000|Maintenance Phase|Adverse Event|3|||
105556693|NCT00955357|364035521|FG001|Maintenance Phase|Adverse Event|23|||
105556694|NCT00955357|364035520|FG000|Maintenance Phase|Lack of Efficacy|0|||
105556695|NCT00955357|364035521|FG001|Maintenance Phase|Lack of Efficacy|4|||
105556696|NCT00955357|364035520|FG000|Maintenance Phase|Protocol Violation|2|||
105556697|NCT00955357|364035521|FG001|Maintenance Phase|Protocol Violation|6|||
105556698|NCT00955357|364035520|FG000|Maintenance Phase|Lost to Follow-up|2|||
105556699|NCT00955357|364035521|FG001|Maintenance Phase|Lost to Follow-up|7|||
105556700|NCT00955357|364035520|FG000|Maintenance Phase|Withdrawal by Subject|4|||
105556701|NCT00955357|364035521|FG001|Maintenance Phase|Withdrawal by Subject|4|||
105556702|NCT00955357|364035520|FG000|Maintenance Phase|Patient moving out of area|0|||
105556703|NCT00955357|364035521|FG001|Maintenance Phase|Patient moving out of area|1|||
105556704|NCT00955357|364035520|FG000|Maintenance Phase|Non compliance to study procedures|1|||
105556705|NCT00955357|364035521|FG001|Maintenance Phase|Non compliance to study procedures|0|||
105556706|NCT00765843|364035526|FG000|Overall Study|Lost to Follow-up|1|||
105556707|NCT00765843|364035527|FG001|Overall Study|Lost to Follow-up|3|||
105556708|NCT00765843|364035528|FG002|Overall Study|Lost to Follow-up|2|||
105556709|NCT00765843|364035526|FG000|Overall Study|did not return to receive intervention|0|||
105556710|NCT00765843|364035527|FG001|Overall Study|did not return to receive intervention|1|||
105556711|NCT00765843|364035528|FG002|Overall Study|did not return to receive intervention|0|||
105556712|NCT00765843|364035526|FG000|Overall Study|Adverse Event|0|||
105556713|NCT00765843|364035527|FG001|Overall Study|Adverse Event|0|||
105556714|NCT00765843|364035528|FG002|Overall Study|Adverse Event|1|||
105556715|NCT00454051|364035533|FG000|Overall Study|Adverse Event|1|||
105556716|NCT00454051|364035534|FG001|Overall Study|Adverse Event|2|||
105556717|NCT00454051|364035533|FG000|Overall Study|Withdrawal by Subject|1|||
105556718|NCT00454051|364035534|FG001|Overall Study|Withdrawal by Subject|0|||
105556719|NCT00454051|364035533|FG000|Overall Study|Protocol Violation|1|||
105556720|NCT00454051|364035534|FG001|Overall Study|Protocol Violation|1|||
105556721|NCT01260350|364035537|FG000|Overall Study|Lack of Efficacy|0|||
105556722|NCT01260350|364035538|FG001|Overall Study|Lack of Efficacy|0|||
105556723|NCT01260350|364035539|FG002|Overall Study|Lack of Efficacy|0|||
105556724|NCT01260350|364035540|FG003|Overall Study|Lack of Efficacy|0|||
105556725|NCT01260350|364035541|FG004|Overall Study|Lack of Efficacy|0|||
105556726|NCT01260350|364035542|FG005|Overall Study|Lack of Efficacy|0|||
105556727|NCT01260350|364035543|FG006|Overall Study|Lack of Efficacy|0|||
105556728|NCT01260350|364035544|FG007|Overall Study|Lack of Efficacy|0|||
105556729|NCT01260350|364035545|FG008|Overall Study|Lack of Efficacy|0|||
105556730|NCT01260350|364035546|FG009|Overall Study|Lack of Efficacy|0|||
105556731|NCT01260350|364035547|FG010|Overall Study|Lack of Efficacy|0|||
105556732|NCT01260350|364035548|FG011|Overall Study|Lack of Efficacy|0|||
105556733|NCT01260350|364035549|FG012|Overall Study|Lack of Efficacy|0|||
105556734|NCT01260350|364035550|FG013|Overall Study|Lack of Efficacy|0|||
105556735|NCT01260350|364035551|FG014|Overall Study|Lack of Efficacy|0|||
105556736|NCT01260350|364035552|FG015|Overall Study|Lack of Efficacy|0|||
105556737|NCT01260350|364035553|FG016|Overall Study|Lack of Efficacy|0|||
105556738|NCT01260350|364035554|FG017|Overall Study|Lack of Efficacy|1|||
105556739|NCT01260350|364035555|FG018|Overall Study|Lack of Efficacy|0|||
105556740|NCT01260350|364035556|FG019|Overall Study|Lack of Efficacy|0|||
105556741|NCT01260350|364035557|FG020|Overall Study|Lack of Efficacy|3|||
105556742|NCT01260350|364035558|FG021|Overall Study|Lack of Efficacy|0|||
105556743|NCT01260350|364035537|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556744|NCT01260350|364035538|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556745|NCT01260350|364035539|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105466862|NCT03841604|363721174|FG000|Overall Study|Physician Decision|1|||
105466863|NCT03841604|363721175|FG001|Overall Study|Physician Decision|0|||
105466864|NCT00836693|363721179|FG000|Overall Study|Adverse Event|4|||
105466865|NCT00836693|363721180|FG001|Overall Study|Adverse Event|1|||
105466866|NCT00836693|363721179|FG000|Overall Study|Sponsor Decision|0|||
105466867|NCT00836693|363721180|FG001|Overall Study|Sponsor Decision|1|||
105466868|NCT00836693|363721179|FG000|Overall Study|Physician Decision|2|||
105466869|NCT00836693|363721180|FG001|Overall Study|Physician Decision|0|||
105466870|NCT00836693|363721179|FG000|Overall Study|Withdrawal by Subject|9|||
105466871|NCT00836693|363721180|FG001|Overall Study|Withdrawal by Subject|4|||
105466872|NCT00836693|363721179|FG000|Overall Study|Protocol Violation|1|||
105466873|NCT00836693|363721180|FG001|Overall Study|Protocol Violation|0|||
105466874|NCT00836693|363721179|FG000|Overall Study|Lost to Follow-up|1|||
105466875|NCT00836693|363721180|FG001|Overall Study|Lost to Follow-up|0|||
105466876|NCT02612779|363721181|FG000|Overall Study|Administrative reason by sponsor|4|||
105466877|NCT02612779|363721182|FG001|Overall Study|Administrative reason by sponsor|1|||
105466878|NCT02612779|363721181|FG000|Overall Study|No longer meet study criteria|0|||
105466879|NCT02612779|363721182|FG001|Overall Study|No longer meet study criteria|1|||
105466880|NCT02612779|363721181|FG000|Overall Study|Disease progression|29|||
105466881|NCT02612779|363721182|FG001|Overall Study|Disease progression|2|||
105466882|NCT02612779|363721181|FG000|Overall Study|Study drug toxicity|10|||
105466883|NCT02612779|363721182|FG001|Overall Study|Study drug toxicity|1|||
105466884|NCT02612779|363721181|FG000|Overall Study|Death|1|||
105466885|NCT02612779|363721182|FG001|Overall Study|Death|0|||
105466886|NCT02612779|363721181|FG000|Overall Study|Adverse event unrelated to study drug|5|||
105466887|NCT02612779|363721182|FG001|Overall Study|Adverse event unrelated to study drug|0|||
105466888|NCT02612779|363721181|FG000|Overall Study|Participant withdrew consent|4|||
105466889|NCT02612779|363721182|FG001|Overall Study|Participant withdrew consent|0|||
105466890|NCT02612779|363721181|FG000|Overall Study|Lost to Follow-up|1|||
105466891|NCT02612779|363721182|FG001|Overall Study|Lost to Follow-up|0|||
105466892|NCT02612779|363721181|FG000|Overall Study|Maximum clinical benefit|10|||
105466893|NCT02612779|363721182|FG001|Overall Study|Maximum clinical benefit|1|||
105466894|NCT02612779|363721181|FG000|Overall Study|Other reasons|4|||
105466895|NCT02612779|363721182|FG001|Overall Study|Other reasons|0|||
105466896|NCT03594110|363721186|FG000|Interventional Part|Participant concerned about study treatment|23|||
105466897|NCT03594110|363721187|FG001|Interventional Part|Participant concerned about study treatment|28|||
105466898|NCT03594110|363721186|FG000|Interventional Part|Doctor advice|38|||
105466899|NCT03594110|363721187|FG001|Interventional Part|Doctor advice|40|||
105466900|NCT03594110|363721186|FG000|Interventional Part|Participants' wish|89|||
105466901|NCT03594110|363721187|FG001|Interventional Part|Participants' wish|68|||
105466902|NCT03594110|363721186|FG000|Interventional Part|Adverse event-non-fatal events|119|||
105466903|NCT03594110|363721187|FG001|Interventional Part|Adverse event-non-fatal events|116|||
105466904|NCT03594110|363721186|FG000|Interventional Part|Study drug stopped, reason missing|336|||
105466905|NCT03594110|363721187|FG001|Interventional Part|Study drug stopped, reason missing|294|||
105466906|NCT03594110|363721186|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
105466907|NCT03594110|363721187|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
105466908|NCT03594110|363721186|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
105466909|NCT03594110|363721187|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
105466910|NCT03594110|363721186|FG000|Interventional Part|Contraindicated drug started|32|||
105466911|NCT03594110|363721187|FG001|Interventional Part|Contraindicated drug started|18|||
105466912|NCT03594110|363721186|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
105466913|NCT03594110|363721187|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
105466914|NCT03594110|363721186|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
105466915|NCT03594110|363721187|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
105466916|NCT03594110|363721186|FG000|Non-interventional Part|Withdrawal by Subject|3|||
105466917|NCT03594110|363721187|FG001|Non-interventional Part|Withdrawal by Subject|4|||
105466918|NCT03594110|363721186|FG000|Non-interventional Part|Lost to Follow-up|45|||
105466919|NCT03594110|363721187|FG001|Non-interventional Part|Lost to Follow-up|41|||
105466920|NCT04614974|363721196|FG000|Overall Study|Lost to Follow-up|14|||
105556746|NCT01260350|364035540|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556747|NCT01260350|364035541|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105466921|NCT04614974|363721197|FG001|Overall Study|Lost to Follow-up|11|||
105556748|NCT01260350|364035542|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105466922|NCT03901963|363721198|FG000|Overall Study|Lost to Follow-up|1|||
105466923|NCT03901963|363721199|FG001|Overall Study|Lost to Follow-up|1|||
105466924|NCT03901963|363721198|FG000|Overall Study|Physician Decision|1|||
105466925|NCT03901963|363721199|FG001|Overall Study|Physician Decision|2|||
105466926|NCT03901963|363721198|FG000|Overall Study|Protocol Violation|1|||
105466927|NCT03901963|363721199|FG001|Overall Study|Protocol Violation|1|||
105466928|NCT03901963|363721198|FG000|Overall Study|Withdrawal by Subject|4|||
105466929|NCT03901963|363721199|FG001|Overall Study|Withdrawal by Subject|11|||
105556749|NCT01260350|364035543|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105343649|NCT01801358|363259594|FG004|Overall Study|Withdrawal by Subject|0|||
105343650|NCT01801358|363259595|FG005|Overall Study|Withdrawal by Subject|2|||
105343651|NCT01527487|363259598|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
105343652|NCT01527487|363259599|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
105343653|NCT01527487|363259598|FG000|Overall Study|Disease Progression|4|||
105343654|NCT01527487|363259599|FG001|Overall Study|Disease Progression|1|||
105343655|NCT01527487|363259598|FG000|Overall Study|Adverse Event|1|||
105343656|NCT01527487|363259599|FG001|Overall Study|Adverse Event|1|||
105343657|NCT01527487|363259598|FG000|Overall Study|Death|0|||
105343658|NCT01527487|363259599|FG001|Overall Study|Death|1|||
105343659|NCT01210495|363259600|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
105343660|NCT01210495|363259601|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
105343661|NCT01210495|363259602|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
105343662|NCT01210495|363259603|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
105343663|NCT01210495|363259600|FG000|Overall Study|Death|14|||
105343664|NCT01210495|363259601|FG001|Overall Study|Death|7|||
105343665|NCT01210495|363259602|FG002|Overall Study|Death|112|||
105343666|NCT01210495|363259603|FG003|Overall Study|Death|54|||
105343667|NCT01210495|363259600|FG000|Overall Study|Study Terminated by Sponsor|0|||
105343668|NCT01210495|363259601|FG001|Overall Study|Study Terminated by Sponsor|0|||
105343669|NCT01210495|363259602|FG002|Overall Study|Study Terminated by Sponsor|4|||
105343670|NCT01210495|363259603|FG003|Overall Study|Study Terminated by Sponsor|11|||
105343671|NCT01210495|363259600|FG000|Overall Study|Lost to Follow-up|0|||
105466930|NCT03901963|363721198|FG000|Overall Study|Ongoing|84|||
105466931|NCT03901963|363721199|FG001|Overall Study|Ongoing|73|||
105466932|NCT03901963|363721198|FG000|Overall Study|Randomized but not treated|3|||
105466933|NCT03901963|363721199|FG001|Overall Study|Randomized but not treated|3|||
105466934|NCT04033445|363721205|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
105466935|NCT04033445|363721206|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
105466936|NCT04033445|363721207|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
105466937|NCT04033445|363721208|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
105466938|NCT04033445|363721209|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
105466939|NCT04033445|363721210|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
105466940|NCT04033445|363721211|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
105466941|NCT04033445|363721212|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
105466942|NCT04033445|363721213|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
105466943|NCT04033445|363721214|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
105466944|NCT04033445|363721215|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
105466945|NCT04033445|363721216|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
105466946|NCT04033445|363721217|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
105466947|NCT04033445|363721218|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
105343672|NCT01210495|363259601|FG001|Overall Study|Lost to Follow-up|0|||
105343673|NCT01210495|363259602|FG002|Overall Study|Lost to Follow-up|1|||
105343674|NCT01210495|363259603|FG003|Overall Study|Lost to Follow-up|1|||
105343675|NCT01210495|363259600|FG000|Overall Study|Other unspecified|0|||
105343676|NCT01210495|363259601|FG001|Overall Study|Other unspecified|0|||
105343677|NCT01210495|363259602|FG002|Overall Study|Other unspecified|6|||
105343678|NCT01210495|363259603|FG003|Overall Study|Other unspecified|0|||
105343679|NCT01459718|363259604|FG000|Overall Study|Physician Decision|1|||
105343680|NCT01459718|363259604|FG000|Overall Study|Lost to Follow-up|1|||
105343681|NCT01459718|363259604|FG000|Overall Study|Adverse Event|1|||
105343682|NCT04416737|363259607|FG000|Week 1 (First Injection)|Physician Decision|0|||
105343683|NCT04416737|363259608|FG001|Week 1 (First Injection)|Physician Decision|1|||
105343684|NCT03332628|363259609|FG000|Overall Study|Physician Decision|2|||
105343685|NCT04489381|363259612|FG000|Overall Study|Lost to Follow-up|2|||
105343686|NCT04489381|363259613|FG001|Overall Study|Lost to Follow-up|3|||
105466948|NCT04033445|363721205|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
105466949|NCT04033445|363721206|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
105466950|NCT04033445|363721207|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
105466951|NCT04033445|363721208|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
105466952|NCT04033445|363721209|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
105466953|NCT04033445|363721210|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
105466954|NCT04033445|363721211|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
105466955|NCT04033445|363721212|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
105466956|NCT04033445|363721213|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
105343687|NCT04489381|363259612|FG000|Overall Study|Withdrawal by Subject|1|||
105343688|NCT04489381|363259613|FG001|Overall Study|Withdrawal by Subject|0|||
105343689|NCT02939716|363259616|FG000|Overall Study|scanner failure|0|||
105343690|NCT02939716|363259617|FG001|Overall Study|scanner failure|0|||
105343691|NCT02939716|363259618|FG002|Overall Study|scanner failure|0|||
105343692|NCT02939716|363259619|FG003|Overall Study|scanner failure|1|||
105343693|NCT02939716|363259620|FG004|Overall Study|scanner failure|1|||
105466957|NCT04033445|363721214|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
105466958|NCT04033445|363721215|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
105556750|NCT01260350|364035544|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556751|NCT01260350|364035545|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
105556752|NCT01260350|364035546|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556753|NCT01260350|364035547|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556754|NCT01260350|364035548|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556755|NCT01260350|364035549|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556756|NCT01260350|364035550|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556757|NCT01260350|364035551|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556758|NCT01260350|364035552|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556759|NCT01260350|364035553|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556760|NCT01260350|364035554|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556761|NCT01260350|364035555|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556762|NCT01260350|364035556|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556763|NCT01260350|364035557|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556764|NCT01260350|364035558|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
105556765|NCT00558428|364035561|FG000|Overall Study|Adverse Event|6|||
105556766|NCT00558428|364035562|FG001|Overall Study|Adverse Event|22|||
105556767|NCT00558428|364035563|FG002|Overall Study|Adverse Event|3|||
105556768|NCT00558428|364035564|FG003|Overall Study|Adverse Event|4|||
105556769|NCT00558428|364035561|FG000|Overall Study|Lost to Follow-up|0|||
105556770|NCT00558428|364035562|FG001|Overall Study|Lost to Follow-up|1|||
105556771|NCT00558428|364035563|FG002|Overall Study|Lost to Follow-up|0|||
105556772|NCT00558428|364035564|FG003|Overall Study|Lost to Follow-up|0|||
105556773|NCT00558428|364035561|FG000|Overall Study|Lack of Efficacy|0|||
105556774|NCT00558428|364035562|FG001|Overall Study|Lack of Efficacy|0|||
105556775|NCT00558428|364035563|FG002|Overall Study|Lack of Efficacy|1|||
105556776|NCT00558428|364035564|FG003|Overall Study|Lack of Efficacy|2|||
105556777|NCT00558428|364035561|FG000|Overall Study|Non compliant with protocol|1|||
105556778|NCT00558428|364035562|FG001|Overall Study|Non compliant with protocol|0|||
105556779|NCT00558428|364035563|FG002|Overall Study|Non compliant with protocol|0|||
105556780|NCT00558428|364035564|FG003|Overall Study|Non compliant with protocol|3|||
105556781|NCT00558428|364035561|FG000|Overall Study|Consent withdrawn|2|||
105556782|NCT00558428|364035562|FG001|Overall Study|Consent withdrawn|1|||
105556783|NCT00558428|364035563|FG002|Overall Study|Consent withdrawn|0|||
105556784|NCT00558428|364035564|FG003|Overall Study|Consent withdrawn|1|||
105556785|NCT00558428|364035561|FG000|Overall Study|Other|3|||
105556786|NCT00558428|364035562|FG001|Overall Study|Other|0|||
105556787|NCT00558428|364035563|FG002|Overall Study|Other|0|||
105556788|NCT00558428|364035564|FG003|Overall Study|Other|1|||
105556789|NCT03252587|364035577|FG000|Overall Study|Adverse Event|3|||
105556790|NCT03252587|364035578|FG001|Overall Study|Adverse Event|8|||
105556791|NCT03252587|364035579|FG002|Overall Study|Adverse Event|6|||
105556792|NCT03252587|364035580|FG003|Overall Study|Adverse Event|12|||
105556793|NCT03252587|364035577|FG000|Overall Study|Lack of Efficacy|7|||
105556794|NCT03252587|364035578|FG001|Overall Study|Lack of Efficacy|2|||
105556795|NCT03252587|364035579|FG002|Overall Study|Lack of Efficacy|2|||
105556796|NCT03252587|364035580|FG003|Overall Study|Lack of Efficacy|4|||
105556797|NCT03252587|364035577|FG000|Overall Study|Lost to Follow-up|2|||
105556798|NCT03252587|364035578|FG001|Overall Study|Lost to Follow-up|0|||
105556799|NCT03252587|364035579|FG002|Overall Study|Lost to Follow-up|0|||
105556800|NCT03252587|364035580|FG003|Overall Study|Lost to Follow-up|2|||
105556801|NCT03252587|364035577|FG000|Overall Study|Pregnancy|2|||
105556802|NCT03252587|364035578|FG001|Overall Study|Pregnancy|1|||
105556803|NCT03252587|364035579|FG002|Overall Study|Pregnancy|0|||
105556804|NCT03252587|364035580|FG003|Overall Study|Pregnancy|1|||
105556805|NCT03252587|364035577|FG000|Overall Study|Withdrawal by Subject|8|||
105556806|NCT03252587|364035578|FG001|Overall Study|Withdrawal by Subject|4|||
105556807|NCT03252587|364035579|FG002|Overall Study|Withdrawal by Subject|4|||
105556808|NCT03252587|364035580|FG003|Overall Study|Withdrawal by Subject|4|||
105556809|NCT03252587|364035577|FG000|Overall Study|Other Reasons|2|||
105556810|NCT03252587|364035578|FG001|Overall Study|Other Reasons|5|||
105556811|NCT03252587|364035579|FG002|Overall Study|Other Reasons|5|||
105556812|NCT03252587|364035580|FG003|Overall Study|Other Reasons|4|||
105679119|NCT02407990|364486884|FG004|Overall Study|Withdrawal by Subject|1|||
105556813|NCT04052204|364035581|FG000|Overall Study|Death|1|||
105556814|NCT04052204|364035582|FG001|Overall Study|Death|0|||
105556815|NCT04052204|364035583|FG002|Overall Study|Death|0|||
105556816|NCT04052204|364035581|FG000|Overall Study|Progressive disease|1|||
105556817|NCT04052204|364035582|FG001|Overall Study|Progressive disease|0|||
105556818|NCT04052204|364035583|FG002|Overall Study|Progressive disease|0|||
105556819|NCT04052204|364035581|FG000|Overall Study|Other|1|||
105556820|NCT04052204|364035582|FG001|Overall Study|Other|0|||
105556821|NCT04052204|364035583|FG002|Overall Study|Other|0|||
105556822|NCT03647501|364035585|FG000|Overall Study|Lost to Follow-up|1|||
105556823|NCT03647501|364035586|FG001|Overall Study|Lost to Follow-up|1|||
105556824|NCT03647501|364035585|FG000|Overall Study|Withdrawal by Subject|0|||
105556825|NCT03647501|364035586|FG001|Overall Study|Withdrawal by Subject|1|||
105679120|NCT02407990|364486885|FG005|Overall Study|Withdrawal by Subject|0|||
105466959|NCT04033445|363721216|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
105466960|NCT04033445|363721217|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
105466961|NCT04033445|363721218|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
105466962|NCT04033445|363721205|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
105466963|NCT04033445|363721206|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
105466964|NCT04033445|363721207|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
105466965|NCT04033445|363721208|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
105466966|NCT04033445|363721209|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
105466967|NCT04033445|363721210|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
105466968|NCT04033445|363721211|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
105466969|NCT04033445|363721212|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
105466970|NCT04033445|363721213|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
105466971|NCT04033445|363721214|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
105466972|NCT04033445|363721215|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
105466973|NCT04033445|363721216|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
105466974|NCT04033445|363721217|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
105466975|NCT04033445|363721218|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
105466976|NCT04033445|363721205|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
105466977|NCT04033445|363721206|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
105466978|NCT04033445|363721207|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
105466979|NCT04033445|363721208|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
105466980|NCT04033445|363721209|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
105466981|NCT04033445|363721210|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
105466982|NCT04033445|363721211|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
105679121|NCT02407990|364486886|FG006|Overall Study|Withdrawal by Subject|0|||
105466983|NCT04033445|363721212|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
105466984|NCT04033445|363721213|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
105466985|NCT04033445|363721214|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
105466986|NCT04033445|363721215|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
105679122|NCT02407990|364486887|FG007|Overall Study|Withdrawal by Subject|30|||
105466987|NCT04033445|363721216|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
105466988|NCT04033445|363721217|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
105466989|NCT04033445|363721218|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
105466990|NCT04033445|363721205|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105466991|NCT04033445|363721206|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105466992|NCT04033445|363721207|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105466993|NCT04033445|363721208|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105466994|NCT04033445|363721209|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105556826|NCT03945188|364035587|FG000|Overall Study|Protocol Violation|1|||
105556827|NCT03945188|364035588|FG001|Overall Study|Protocol Violation|0|||
105556828|NCT03945188|364035587|FG000|Overall Study|Disease worsening|79|||
105556829|NCT03945188|364035588|FG001|Overall Study|Disease worsening|73|||
105556830|NCT03945188|364035587|FG000|Overall Study|Physician Decision|2|||
105556831|NCT03945188|364035588|FG001|Overall Study|Physician Decision|2|||
105556832|NCT03945188|364035587|FG000|Overall Study|Lack of Efficacy|7|||
105556833|NCT03945188|364035588|FG001|Overall Study|Lack of Efficacy|4|||
105556834|NCT03945188|364035587|FG000|Overall Study|Pregnancy|2|||
105556835|NCT03945188|364035588|FG001|Overall Study|Pregnancy|0|||
105556836|NCT03945188|364035587|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
105556837|NCT03945188|364035588|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
105343694|NCT02939716|363259621|FG005|Overall Study|scanner failure|1|||
105343695|NCT01259375|363259627|FG000|Overall Study|Adverse Event|1|||
105466995|NCT04033445|363721210|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105466996|NCT04033445|363721211|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
105466997|NCT04033445|363721212|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105466998|NCT04033445|363721213|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105466999|NCT04033445|363721214|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105467000|NCT04033445|363721215|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105467001|NCT04033445|363721216|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105467002|NCT04033445|363721217|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105467003|NCT04033445|363721218|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105556838|NCT03945188|364035587|FG000|Overall Study|Adverse Event|10|||
105556839|NCT03945188|364035588|FG001|Overall Study|Adverse Event|5|||
105679123|NCT02407990|364486880|FG000|Overall Study|Study Terminated by Sponsor|1|||
105679124|NCT02407990|364486881|FG001|Overall Study|Study Terminated by Sponsor|3|||
105343696|NCT01043705|363259630|FG000|Overall Study|Death|28|||
105343697|NCT01043705|363259631|FG001|Overall Study|Death|60|||
105343698|NCT01043705|363259632|FG002|Overall Study|Death|26|||
105343699|NCT01043705|363259630|FG000|Overall Study|Lost to Follow-up|27|||
105343700|NCT01043705|363259631|FG001|Overall Study|Lost to Follow-up|12|||
105343701|NCT01043705|363259632|FG002|Overall Study|Lost to Follow-up|0|||
105343702|NCT01043705|363259630|FG000|Overall Study|Multiple Reasons|4|||
105343703|NCT01043705|363259631|FG001|Overall Study|Multiple Reasons|7|||
105343704|NCT01043705|363259632|FG002|Overall Study|Multiple Reasons|0|||
105343705|NCT01043705|363259630|FG000|Overall Study|Protocol Violation|2|||
105343706|NCT01043705|363259631|FG001|Overall Study|Protocol Violation|1|||
105343707|NCT01043705|363259632|FG002|Overall Study|Protocol Violation|0|||
105679125|NCT02407990|364486882|FG002|Overall Study|Study Terminated by Sponsor|3|||
105679126|NCT02407990|364486883|FG003|Overall Study|Study Terminated by Sponsor|0|||
105679127|NCT02407990|364486884|FG004|Overall Study|Study Terminated by Sponsor|3|||
105679128|NCT02407990|364486885|FG005|Overall Study|Study Terminated by Sponsor|4|||
105343708|NCT01043705|363259630|FG000|Overall Study|Withdrawal by Subject|8|||
105343709|NCT01043705|363259631|FG001|Overall Study|Withdrawal by Subject|6|||
105343710|NCT01043705|363259632|FG002|Overall Study|Withdrawal by Subject|0|||
105343711|NCT01043705|363259630|FG000|Overall Study|Site Closure|8|||
105467004|NCT04033445|363721205|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
105467005|NCT04033445|363721206|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
105467006|NCT04033445|363721207|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
105556840|NCT03945188|364035587|FG000|Overall Study|Other|2|||
105556841|NCT03945188|364035588|FG001|Overall Study|Other|2|||
105343712|NCT01043705|363259631|FG001|Overall Study|Site Closure|0|||
105343713|NCT01043705|363259632|FG002|Overall Study|Site Closure|0|||
105343714|NCT01043705|363259630|FG000|Overall Study|Subsequent Procedure|9|||
105343715|NCT01043705|363259631|FG001|Overall Study|Subsequent Procedure|24|||
105343716|NCT01043705|363259632|FG002|Overall Study|Subsequent Procedure|29|||
105343717|NCT01043705|363259630|FG000|Overall Study|Adverse Event|0|||
105343718|NCT01043705|363259631|FG001|Overall Study|Adverse Event|2|||
105343719|NCT01043705|363259632|FG002|Overall Study|Adverse Event|0|||
105343720|NCT01043705|363259630|FG000|Overall Study|Screen Fail|21|||
105343721|NCT01043705|363259631|FG001|Overall Study|Screen Fail|0|||
105343722|NCT01043705|363259632|FG002|Overall Study|Screen Fail|0|||
105343723|NCT01043705|363259630|FG000|Overall Study|Other|0|||
105343724|NCT01043705|363259631|FG001|Overall Study|Other|19|||
105343725|NCT01043705|363259632|FG002|Overall Study|Other|25|||
105343726|NCT01195844|363259637|FG000|Overall Study|Fecal sample not collected|40|||
105343727|NCT00581542|363259638|FG000|Overall Study|they met an exclusion criteria|2|||
105343728|NCT00581542|363259639|FG001|Overall Study|they met an exclusion criteria|2|||
105343729|NCT00581542|363259638|FG000|Overall Study|Lost to Follow-up|9|||
105343730|NCT00581542|363259639|FG001|Overall Study|Lost to Follow-up|21|||
105343731|NCT00551161|363259640|FG000|Overall Study|Withdrawal by Subject|1|||
105343732|NCT03301844|363259641|FG000|Overall Study|suspected colon cancer|1|||
105343733|NCT03301844|363259642|FG001|Overall Study|suspected colon cancer|1|||
105343734|NCT01537068|363259648|FG000|Overall Study|Lost to Follow-up|2|||
105343735|NCT01537068|363259649|FG001|Overall Study|Lost to Follow-up|1|||
105343736|NCT01537068|363259648|FG000|Overall Study|Adverse Event|0|||
105343737|NCT01537068|363259649|FG001|Overall Study|Adverse Event|1|||
105343738|NCT01537068|363259648|FG000|Overall Study|Withdrawal by Subject|1|||
105343739|NCT01537068|363259649|FG001|Overall Study|Withdrawal by Subject|1|||
105343740|NCT01537068|363259648|FG000|Overall Study|Lack of Efficacy|1|||
105343741|NCT01537068|363259649|FG001|Overall Study|Lack of Efficacy|0|||
105343742|NCT06011161|363259650|FG000|Overall Study|Withdrawal by Subject|2|||
105343743|NCT06011161|363259650|FG000|Overall Study|Lost to Follow-up|5|||
105343744|NCT00721279|363259654|FG000|Overall Study|Lack of Efficacy|6|||
105343745|NCT00721279|363259655|FG001|Overall Study|Lack of Efficacy|3|||
105343746|NCT00721279|363259654|FG000|Overall Study|Tolerability insufficient|5|||
105343747|NCT00721279|363259655|FG001|Overall Study|Tolerability insufficient|2|||
105343748|NCT00721279|363259654|FG000|Overall Study|Withdrawal by Subject|13|||
105343749|NCT00721279|363259655|FG001|Overall Study|Withdrawal by Subject|3|||
105343750|NCT00721279|363259654|FG000|Overall Study|Other|12|||
105343751|NCT00721279|363259655|FG001|Overall Study|Other|16|||
105343752|NCT02089334|363259656|FG000|Overall Study|Withdrawal by Subject|0|||
105343753|NCT02089334|363259657|FG001|Overall Study|Withdrawal by Subject|0|||
105343754|NCT02089334|363259658|FG002|Overall Study|Withdrawal by Subject|0|||
105343755|NCT02089334|363259659|FG003|Overall Study|Withdrawal by Subject|2|||
105343756|NCT02089334|363259656|FG000|Overall Study|Adverse Event|0|||
105343757|NCT02089334|363259657|FG001|Overall Study|Adverse Event|0|||
105343758|NCT02089334|363259658|FG002|Overall Study|Adverse Event|0|||
105343759|NCT02089334|363259659|FG003|Overall Study|Adverse Event|2|||
105343760|NCT02089334|363259656|FG000|Overall Study|Progressive disease|0|||
105343761|NCT02089334|363259657|FG001|Overall Study|Progressive disease|0|||
105343762|NCT02089334|363259658|FG002|Overall Study|Progressive disease|0|||
105343763|NCT02089334|363259659|FG003|Overall Study|Progressive disease|2|||
105343764|NCT02089334|363259656|FG000|Overall Study|Physician Decision|0|||
105343765|NCT02089334|363259657|FG001|Overall Study|Physician Decision|0|||
105343766|NCT02089334|363259658|FG002|Overall Study|Physician Decision|1|||
105343767|NCT02089334|363259659|FG003|Overall Study|Physician Decision|1|||
105343768|NCT01317797|363259662|FG000|Overall Study|Other|0|||
105343769|NCT01317797|363259663|FG001|Overall Study|Other|1|||
105343770|NCT01317797|363259664|FG002|Overall Study|Other|0|||
105343771|NCT01317797|363259662|FG000|Overall Study|Withdrawal of Patient|0|||
105343772|NCT01317797|363259663|FG001|Overall Study|Withdrawal of Patient|0|||
105343773|NCT01317797|363259664|FG002|Overall Study|Withdrawal of Patient|1|||
105343774|NCT02637713|363259674|FG000|Overall Study|Screen Failure|2|||
105343775|NCT02326298|363259677|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105343776|NCT02326298|363259678|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105467007|NCT04033445|363721208|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
105467008|NCT04033445|363721209|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
105467009|NCT04033445|363721210|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
105467010|NCT04033445|363721211|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
105343777|NCT02326298|363259679|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
105343778|NCT02326298|363259680|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105343779|NCT02326298|363259681|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105343780|NCT02326298|363259682|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105343781|NCT02326298|363259683|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105343782|NCT02326298|363259684|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105343783|NCT02326298|363259685|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105343784|NCT02326298|363259686|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105343785|NCT02326298|363259687|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105467011|NCT04033445|363721212|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
105467012|NCT04033445|363721213|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
105467013|NCT04033445|363721214|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
105467014|NCT04033445|363721215|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
105467015|NCT04033445|363721216|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
105467016|NCT04033445|363721217|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
105467017|NCT04033445|363721218|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
105467018|NCT04033445|363721205|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
105467019|NCT04033445|363721206|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
105467020|NCT04033445|363721207|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
105467021|NCT04033445|363721208|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
105467022|NCT04033445|363721209|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
105467023|NCT04033445|363721210|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
105343786|NCT02326298|363259688|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105343787|NCT02326298|363259689|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105343788|NCT02326298|363259690|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105343789|NCT02326298|363259677|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
105343790|NCT02326298|363259678|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105343791|NCT02326298|363259679|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105343792|NCT02326298|363259680|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105467024|NCT04033445|363721211|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
105343793|NCT02326298|363259681|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105467025|NCT04033445|363721212|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
105467026|NCT04033445|363721213|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
105467027|NCT04033445|363721214|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
105467028|NCT04033445|363721215|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
105467029|NCT04033445|363721216|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
105467030|NCT04033445|363721217|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
105467031|NCT04033445|363721218|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
105467032|NCT04033445|363721205|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
105467033|NCT04033445|363721206|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
105467034|NCT04033445|363721207|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
105467035|NCT04033445|363721208|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
105467036|NCT04033445|363721209|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
105467037|NCT04033445|363721210|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
105467038|NCT04033445|363721211|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
105467039|NCT04033445|363721212|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
105467040|NCT04033445|363721213|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
105467041|NCT04033445|363721214|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
105467042|NCT04033445|363721215|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
105467043|NCT04033445|363721216|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
105467044|NCT04033445|363721217|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
105467045|NCT04033445|363721218|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
105467046|NCT04033445|363721205|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
105467047|NCT04033445|363721206|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
105467048|NCT04033445|363721207|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
105467049|NCT04033445|363721208|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
105467050|NCT04033445|363721209|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
105467051|NCT04033445|363721210|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
105467052|NCT04033445|363721211|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
105467053|NCT04033445|363721212|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
105467054|NCT04033445|363721213|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
105467055|NCT04033445|363721214|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
105467056|NCT04033445|363721215|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
105467057|NCT04033445|363721216|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
105467058|NCT04033445|363721217|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
105467059|NCT04033445|363721218|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
105467060|NCT04033445|363721205|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
105467061|NCT04033445|363721206|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
105467062|NCT04033445|363721207|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
105343794|NCT02326298|363259682|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105556842|NCT03945188|364035587|FG000|Overall Study|Lost to Follow-up|1|||
105556843|NCT03945188|364035588|FG001|Overall Study|Lost to Follow-up|2|||
105343795|NCT02326298|363259683|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105467063|NCT04033445|363721208|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
105467064|NCT04033445|363721209|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
105467065|NCT04033445|363721210|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
105467066|NCT04033445|363721211|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
105467067|NCT04033445|363721212|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
105467068|NCT04033445|363721213|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
105467069|NCT04033445|363721214|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
105467070|NCT04033445|363721215|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
105467071|NCT04033445|363721216|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
105467072|NCT04033445|363721217|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
105467073|NCT04033445|363721218|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
105467074|NCT04033445|363721205|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
105467075|NCT04033445|363721206|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
105467076|NCT04033445|363721207|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
105467077|NCT04033445|363721208|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
105467078|NCT04033445|363721209|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
105467079|NCT04033445|363721210|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
105467080|NCT04033445|363721211|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
105467081|NCT04033445|363721212|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
105467082|NCT04033445|363721213|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
105467083|NCT04033445|363721214|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
105467084|NCT04033445|363721215|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
105467085|NCT04033445|363721216|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
105467086|NCT04033445|363721217|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
105343796|NCT02326298|363259684|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105343797|NCT02326298|363259685|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105343798|NCT02326298|363259686|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105343799|NCT02326298|363259687|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105343800|NCT02326298|363259688|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105343801|NCT02326298|363259689|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105343802|NCT02326298|363259690|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105343803|NCT02326298|363259677|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
105343804|NCT02326298|363259678|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
105343805|NCT02326298|363259679|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105343806|NCT02326298|363259680|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105343807|NCT02326298|363259681|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105343808|NCT02326298|363259682|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105343809|NCT02326298|363259683|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105343810|NCT02326298|363259684|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105343811|NCT02326298|363259685|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105343812|NCT02326298|363259686|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105343813|NCT02326298|363259687|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105343814|NCT02326298|363259688|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105343815|NCT02326298|363259689|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105343816|NCT02326298|363259690|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105343817|NCT02326298|363259677|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
105343818|NCT02326298|363259678|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
105343819|NCT02326298|363259679|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105343820|NCT02326298|363259680|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105343821|NCT02326298|363259681|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105343822|NCT02326298|363259682|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105343823|NCT02326298|363259683|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105343824|NCT02326298|363259684|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105343825|NCT02326298|363259685|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105343826|NCT02326298|363259686|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105343827|NCT02326298|363259687|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105343828|NCT02326298|363259688|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105343829|NCT02326298|363259689|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105343830|NCT02326298|363259690|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105467087|NCT04033445|363721218|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
105467088|NCT04033445|363721205|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105467089|NCT04033445|363721206|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105679129|NCT02407990|364486886|FG006|Overall Study|Study Terminated by Sponsor|3|||
105679130|NCT02407990|364486887|FG007|Overall Study|Study Terminated by Sponsor|37|||
105679131|NCT02407990|364486880|FG000|Overall Study|Logistics|0|||
105679132|NCT02407990|364486881|FG001|Overall Study|Logistics|0|||
105467090|NCT04033445|363721207|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105467091|NCT04033445|363721208|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
105467092|NCT04033445|363721209|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105467093|NCT04033445|363721210|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105467094|NCT04033445|363721211|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105467095|NCT04033445|363721212|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105467096|NCT04033445|363721213|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105467097|NCT04033445|363721214|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105467098|NCT04033445|363721215|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105467099|NCT04033445|363721216|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105467100|NCT04033445|363721217|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105467101|NCT04033445|363721218|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105467102|NCT04033445|363721205|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
105467103|NCT04033445|363721206|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
105467104|NCT04033445|363721207|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
105467105|NCT04033445|363721208|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
105467106|NCT04033445|363721209|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
105467107|NCT04033445|363721210|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
105467108|NCT04033445|363721211|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
105467109|NCT04033445|363721212|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
105467110|NCT04033445|363721213|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
105467111|NCT04033445|363721214|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
105467112|NCT04033445|363721215|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
105467113|NCT04033445|363721216|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
105467114|NCT04033445|363721217|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
105467115|NCT04033445|363721218|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
105467116|NCT04033445|363721205|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
105467117|NCT04033445|363721206|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
105467118|NCT04033445|363721207|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
105467119|NCT04033445|363721208|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
105467120|NCT04033445|363721209|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
105467121|NCT04033445|363721210|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
105467122|NCT04033445|363721211|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
105467123|NCT04033445|363721212|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
105467124|NCT04033445|363721213|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
105467125|NCT04033445|363721214|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
105467126|NCT04033445|363721215|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
105467127|NCT04033445|363721216|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
105467128|NCT04033445|363721217|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
105467129|NCT04033445|363721218|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
105467130|NCT04033445|363721205|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105467131|NCT04033445|363721206|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105467132|NCT04033445|363721207|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105467133|NCT04033445|363721208|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105467134|NCT04033445|363721209|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105467135|NCT04033445|363721210|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105467136|NCT04033445|363721211|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105556844|NCT04530448|364035591|FG000|Overall Study|Physician Decision|3|||
105343831|NCT02326298|363259677|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105343832|NCT02326298|363259678|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105343833|NCT02326298|363259679|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
105467137|NCT04033445|363721212|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
105467138|NCT04033445|363721213|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105467139|NCT04033445|363721214|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105467140|NCT04033445|363721215|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105467141|NCT04033445|363721216|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105467142|NCT04033445|363721217|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105467143|NCT04033445|363721218|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105467144|NCT04033445|363721205|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
105467145|NCT04033445|363721206|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
105467146|NCT04033445|363721207|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
105467147|NCT04033445|363721208|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
105467148|NCT04033445|363721209|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
105467149|NCT04033445|363721210|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
105467150|NCT04033445|363721211|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
105467151|NCT04033445|363721212|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
105467152|NCT04033445|363721213|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
105467153|NCT04033445|363721214|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
105467154|NCT04033445|363721215|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
105467155|NCT04033445|363721216|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
105467156|NCT04033445|363721217|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
105467157|NCT04033445|363721218|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
105467158|NCT04033445|363721205|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105467159|NCT04033445|363721206|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105467160|NCT04033445|363721207|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105467161|NCT04033445|363721208|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105467162|NCT04033445|363721209|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105467163|NCT04033445|363721210|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105467164|NCT04033445|363721211|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105467165|NCT04033445|363721212|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105467166|NCT04033445|363721213|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105467167|NCT04033445|363721214|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
105467168|NCT04033445|363721215|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
105467169|NCT04033445|363721216|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
105467170|NCT04033445|363721217|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
105467171|NCT04033445|363721218|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
105467172|NCT04033445|363721205|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
105467173|NCT04033445|363721206|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
105467174|NCT04033445|363721207|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
105467175|NCT04033445|363721208|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
105467176|NCT04033445|363721209|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
105467177|NCT04033445|363721210|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
105467178|NCT04033445|363721211|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
105467179|NCT04033445|363721212|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
105467180|NCT04033445|363721213|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
105467181|NCT04033445|363721214|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
105467182|NCT04033445|363721215|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
105467183|NCT04033445|363721216|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
105556845|NCT04530448|364035592|FG001|Overall Study|Physician Decision|0|||
105343834|NCT02326298|363259680|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105343835|NCT02326298|363259681|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105343836|NCT02326298|363259682|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105343837|NCT02326298|363259683|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105343838|NCT02326298|363259684|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105343839|NCT02326298|363259685|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105343840|NCT02326298|363259686|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105343841|NCT02326298|363259687|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105343842|NCT02326298|363259688|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105343843|NCT02326298|363259689|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105467184|NCT04033445|363721217|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
105467185|NCT04033445|363721218|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
105467186|NCT04033445|363721205|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105467187|NCT04033445|363721206|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105467188|NCT04033445|363721207|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105467189|NCT04033445|363721208|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105467190|NCT04033445|363721209|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105467191|NCT04033445|363721210|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105467192|NCT04033445|363721211|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105467193|NCT04033445|363721212|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105467194|NCT04033445|363721213|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105467195|NCT04033445|363721214|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105467196|NCT04033445|363721215|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
105467197|NCT04033445|363721216|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
105467198|NCT04033445|363721217|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
105467199|NCT04033445|363721218|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
105467200|NCT04033445|363721205|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
105467201|NCT04033445|363721206|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
105467202|NCT04033445|363721207|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
105556846|NCT01540851|364035610|FG000|Overall Study|Lost to Follow-up|14|||
105556847|NCT01540851|364035611|FG001|Overall Study|Lost to Follow-up|15|||
105467203|NCT04033445|363721208|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
105679133|NCT02407990|364486882|FG002|Overall Study|Logistics|0|||
105467204|NCT04033445|363721209|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
105467205|NCT04033445|363721210|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
105467206|NCT04033445|363721211|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
105467207|NCT04033445|363721212|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
105467208|NCT04033445|363721213|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
105467209|NCT04033445|363721214|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
105467210|NCT04033445|363721215|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
105467211|NCT04033445|363721216|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
105467212|NCT04033445|363721217|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
105467213|NCT04033445|363721218|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
105467214|NCT04033445|363721205|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
105467215|NCT04033445|363721206|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
105467216|NCT04033445|363721207|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
105467217|NCT04033445|363721208|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
105467218|NCT04033445|363721209|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
105467219|NCT04033445|363721210|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
105467220|NCT04033445|363721211|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
105467221|NCT04033445|363721212|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
105467222|NCT04033445|363721213|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
105467223|NCT04033445|363721214|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
105467224|NCT04033445|363721215|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
105467225|NCT04033445|363721216|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
105467226|NCT04033445|363721217|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
105467227|NCT04033445|363721218|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
105467228|NCT04033445|363721205|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
105467229|NCT04033445|363721206|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
105467230|NCT04033445|363721207|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
105467231|NCT04033445|363721208|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
105467232|NCT04033445|363721209|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
105467233|NCT04033445|363721210|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
105467234|NCT04033445|363721211|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
105467235|NCT04033445|363721212|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
105467236|NCT04033445|363721213|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
105467237|NCT04033445|363721214|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
105467238|NCT04033445|363721215|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
105467239|NCT04033445|363721216|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
105467240|NCT04033445|363721217|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
105467241|NCT04033445|363721218|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
105467242|NCT04033445|363721205|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
105467243|NCT04033445|363721206|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
105467244|NCT04033445|363721207|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
105467245|NCT04033445|363721208|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
105467246|NCT04033445|363721209|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
105467247|NCT04033445|363721210|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
105467248|NCT04033445|363721211|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
105467249|NCT04033445|363721212|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
105467250|NCT04033445|363721213|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
105556848|NCT01540851|364035610|FG000|Overall Study|Withdrawal by Subject|7|||
105343844|NCT02326298|363259690|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105343845|NCT02326298|363259677|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105343846|NCT02326298|363259678|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105343847|NCT02326298|363259679|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105343848|NCT02326298|363259680|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105343849|NCT02326298|363259681|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105343850|NCT02326298|363259682|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105343851|NCT02326298|363259683|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
105343852|NCT02326298|363259684|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105343853|NCT02326298|363259685|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105343854|NCT02326298|363259686|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105343855|NCT02326298|363259687|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105343856|NCT02326298|363259688|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105679134|NCT02407990|364486883|FG003|Overall Study|Logistics|0|||
105679135|NCT02407990|364486884|FG004|Overall Study|Logistics|0|||
105467251|NCT04033445|363721214|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
105467252|NCT04033445|363721215|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
105467253|NCT04033445|363721216|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
105467254|NCT04033445|363721217|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
105467255|NCT04033445|363721218|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
105467256|NCT03748641|363721219|FG000|Overall Study|Ongoing|155|||
105467257|NCT03748641|363721220|FG001|Overall Study|Ongoing|148|||
105467258|NCT03748641|363721221|FG002|Overall Study|Ongoing|66|||
105467259|NCT03748641|363721222|FG003|Overall Study|Ongoing|79|||
105467260|NCT03748641|363721223|FG004|Overall Study|Ongoing|84|||
105467261|NCT03748641|363721219|FG000|Overall Study|Death|54|||
105467262|NCT03748641|363721220|FG001|Overall Study|Death|59|||
105467263|NCT03748641|363721221|FG002|Overall Study|Death|51|||
105467264|NCT03748641|363721222|FG003|Overall Study|Death|42|||
105467265|NCT03748641|363721223|FG004|Overall Study|Death|9|||
105467266|NCT03748641|363721219|FG000|Overall Study|Lost to Follow-up|0|||
105467267|NCT03748641|363721220|FG001|Overall Study|Lost to Follow-up|2|||
105467268|NCT03748641|363721221|FG002|Overall Study|Lost to Follow-up|1|||
105467269|NCT03748641|363721222|FG003|Overall Study|Lost to Follow-up|0|||
105467270|NCT03748641|363721223|FG004|Overall Study|Lost to Follow-up|0|||
105467271|NCT03748641|363721219|FG000|Overall Study|Withdrawal by Subject|3|||
105467272|NCT03748641|363721220|FG001|Overall Study|Withdrawal by Subject|2|||
105467273|NCT03748641|363721221|FG002|Overall Study|Withdrawal by Subject|5|||
105467274|NCT03748641|363721222|FG003|Overall Study|Withdrawal by Subject|3|||
105467275|NCT03748641|363721223|FG004|Overall Study|Withdrawal by Subject|2|||
105467276|NCT04569032|363721226|FG000|Overall Study|Death|10|||
105467277|NCT04569032|363721227|FG001|Overall Study|Death|13|||
105467278|NCT04569032|363721226|FG000|Overall Study|Withdrawal by Subject|2|||
105467279|NCT04569032|363721227|FG001|Overall Study|Withdrawal by Subject|0|||
105467280|NCT04569032|363721226|FG000|Overall Study|Lost to Follow-up|0|||
105467281|NCT04569032|363721227|FG001|Overall Study|Lost to Follow-up|1|||
105467282|NCT04569032|363721226|FG000|Overall Study|In long term follow up|22|||
105467283|NCT04569032|363721227|FG001|Overall Study|In long term follow up|34|||
105467284|NCT03975647|363721228|FG000|Overall Study|Death|71|||
105343857|NCT02326298|363259689|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105467285|NCT03975647|363721229|FG001|Overall Study|Death|63|||
105467286|NCT03975647|363721228|FG000|Overall Study|Lost to Follow-up|2|||
105467287|NCT03975647|363721229|FG001|Overall Study|Lost to Follow-up|2|||
105467288|NCT03975647|363721228|FG000|Overall Study|Subject withdrawal of consent|7|||
105467289|NCT03975647|363721229|FG001|Overall Study|Subject withdrawal of consent|11|||
105467290|NCT03113487|363721230|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
105467291|NCT01918306|363721236|FG000|Overall Study|progresive disease|4|||
105467292|NCT01918306|363721237|FG001|Overall Study|progresive disease|0|||
105467293|NCT01918306|363721238|FG002|Overall Study|progresive disease|1|||
105467294|NCT01918306|363721239|FG003|Overall Study|progresive disease|1|||
105467295|NCT01918306|363721236|FG000|Overall Study|Withdrawal by Subject|0|||
105467296|NCT01918306|363721237|FG001|Overall Study|Withdrawal by Subject|0|||
105467297|NCT01918306|363721238|FG002|Overall Study|Withdrawal by Subject|0|||
105467298|NCT01918306|363721239|FG003|Overall Study|Withdrawal by Subject|2|||
105467299|NCT01918306|363721236|FG000|Overall Study|neutropenia|1|||
105467300|NCT01918306|363721237|FG001|Overall Study|neutropenia|0|||
105467301|NCT01918306|363721238|FG002|Overall Study|neutropenia|0|||
105467302|NCT01918306|363721239|FG003|Overall Study|neutropenia|0|||
105467303|NCT01918306|363721236|FG000|Overall Study|Lack of Efficacy|1|||
105467304|NCT01918306|363721237|FG001|Overall Study|Lack of Efficacy|0|||
105467305|NCT01918306|363721238|FG002|Overall Study|Lack of Efficacy|0|||
105467306|NCT01918306|363721239|FG003|Overall Study|Lack of Efficacy|0|||
105467307|NCT01918306|363721236|FG000|Overall Study|progress disease, crossover|0|||
105467308|NCT01918306|363721237|FG001|Overall Study|progress disease, crossover|0|||
105467309|NCT01918306|363721238|FG002|Overall Study|progress disease, crossover|1|||
105467310|NCT01918306|363721239|FG003|Overall Study|progress disease, crossover|0|||
105467311|NCT03692052|363721240|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
105467312|NCT03692052|363721240|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
105467313|NCT03692052|363721240|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
105467314|NCT03692052|363721240|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
105467315|NCT02827877|363721241|FG000|Overall Study|Withdrawal by Subject|1|||
105467316|NCT06083506|363721242|FG000|Overall Study|Physician Decision|2|||
105467317|NCT06083506|363721242|FG000|Overall Study|Lack of Efficacy|1|||
105467318|NCT02257736|363721243|FG000|Overall Study|Progressive disease|365|||
105467319|NCT02257736|363721244|FG001|Overall Study|Progressive disease|327|||
105467320|NCT02257736|363721243|FG000|Overall Study|Adverse Event|45|||
105467321|NCT02257736|363721244|FG001|Overall Study|Adverse Event|56|||
105467322|NCT02257736|363721243|FG000|Overall Study|Withdrawal by Subject|21|||
105467323|NCT02257736|363721244|FG001|Overall Study|Withdrawal by Subject|38|||
105467324|NCT02257736|363721243|FG000|Overall Study|Death|11|||
105467325|NCT02257736|363721244|FG001|Overall Study|Death|6|||
105467326|NCT02257736|363721243|FG000|Overall Study|Physician Decision|5|||
105343858|NCT02326298|363259690|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105343859|NCT02326298|363259677|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105343860|NCT02326298|363259678|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105343861|NCT02326298|363259679|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105343862|NCT02326298|363259680|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105343863|NCT02326298|363259681|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105343864|NCT02326298|363259682|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
105343865|NCT02326298|363259683|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
105343866|NCT02326298|363259684|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105343867|NCT02326298|363259685|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
105343868|NCT02326298|363259686|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105343869|NCT02326298|363259687|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105343870|NCT02326298|363259688|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105467327|NCT02257736|363721244|FG001|Overall Study|Physician Decision|9|||
105467328|NCT02257736|363721243|FG000|Overall Study|Non-Compliance with study drug|1|||
105343871|NCT02326298|363259689|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105343872|NCT02326298|363259690|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105343873|NCT02326298|363259677|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105343874|NCT02326298|363259678|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105343875|NCT02326298|363259679|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105343876|NCT02326298|363259680|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105343877|NCT02326298|363259681|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105343878|NCT02326298|363259682|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
105343879|NCT02326298|363259683|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105343880|NCT02326298|363259684|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105343881|NCT02326298|363259685|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105343882|NCT02326298|363259686|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105343883|NCT02326298|363259687|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105343884|NCT02326298|363259688|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105343885|NCT02326298|363259689|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105343886|NCT02326298|363259690|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105343887|NCT02326298|363259677|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105343888|NCT02326298|363259678|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105467329|NCT02257736|363721244|FG001|Overall Study|Non-Compliance with study drug|2|||
105467330|NCT02257736|363721243|FG000|Overall Study|Protocol Violation|1|||
105467331|NCT02257736|363721244|FG001|Overall Study|Protocol Violation|0|||
105467332|NCT02257736|363721243|FG000|Overall Study|Other|1|||
105343889|NCT02326298|363259679|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105343890|NCT02326298|363259680|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105343891|NCT02326298|363259681|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105343892|NCT02326298|363259682|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105343893|NCT02326298|363259683|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
105343894|NCT02326298|363259684|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105343895|NCT02326298|363259685|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105343896|NCT02326298|363259686|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105343897|NCT02326298|363259687|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105343898|NCT02326298|363259688|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105343899|NCT02326298|363259689|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105343900|NCT02326298|363259690|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105343901|NCT02326298|363259677|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105343902|NCT02326298|363259678|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105343903|NCT02326298|363259679|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105343904|NCT02326298|363259680|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105343905|NCT02326298|363259681|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105467333|NCT02257736|363721244|FG001|Overall Study|Other|7|||
105467334|NCT02257736|363721243|FG000|Overall Study|Randomized, not treated|1|||
105467335|NCT02257736|363721244|FG001|Overall Study|Randomized, not treated|2|||
105467336|NCT04325828|363721245|FG000|Overall Study|Ongoing|26|||
105467337|NCT02000115|363721248|FG000|Overall Study|Death|56|||
105467338|NCT02000115|363721249|FG001|Overall Study|Death|45|||
105467339|NCT02000115|363721250|FG002|Overall Study|Death|0|||
105467340|NCT02000115|363721251|FG003|Overall Study|Death|0|||
105467341|NCT02000115|363721248|FG000|Overall Study|Missed Visit|6|||
105467342|NCT02000115|363721249|FG001|Overall Study|Missed Visit|8|||
105467343|NCT02000115|363721250|FG002|Overall Study|Missed Visit|1|||
105467344|NCT02000115|363721251|FG003|Overall Study|Missed Visit|0|||
105467345|NCT02000115|363721248|FG000|Overall Study|Protocol Violation|2|||
105467346|NCT02000115|363721249|FG001|Overall Study|Protocol Violation|1|||
105467347|NCT02000115|363721250|FG002|Overall Study|Protocol Violation|0|||
105467348|NCT02000115|363721251|FG003|Overall Study|Protocol Violation|0|||
105467349|NCT02000115|363721248|FG000|Overall Study|Physician Decision|2|||
105467350|NCT02000115|363721249|FG001|Overall Study|Physician Decision|0|||
105467351|NCT02000115|363721250|FG002|Overall Study|Physician Decision|0|||
105467352|NCT02000115|363721251|FG003|Overall Study|Physician Decision|0|||
105467353|NCT02000115|363721248|FG000|Overall Study|Withdrawal by Subject|11|||
105467354|NCT02000115|363721249|FG001|Overall Study|Withdrawal by Subject|11|||
105467355|NCT02000115|363721250|FG002|Overall Study|Withdrawal by Subject|0|||
105467356|NCT02000115|363721251|FG003|Overall Study|Withdrawal by Subject|0|||
105467357|NCT02000115|363721248|FG000|Overall Study|Lost to Follow-up|0|||
105467358|NCT02000115|363721249|FG001|Overall Study|Lost to Follow-up|1|||
105467359|NCT02000115|363721250|FG002|Overall Study|Lost to Follow-up|0|||
105467360|NCT02000115|363721251|FG003|Overall Study|Lost to Follow-up|0|||
105467361|NCT02000115|363721248|FG000|Overall Study|Non-compliance|2|||
105467362|NCT02000115|363721249|FG001|Overall Study|Non-compliance|1|||
105467363|NCT02000115|363721250|FG002|Overall Study|Non-compliance|0|||
105467364|NCT02000115|363721251|FG003|Overall Study|Non-compliance|0|||
105467365|NCT02000115|363721248|FG000|Overall Study|Withdrawn on day of randomization|0|||
105467366|NCT02000115|363721249|FG001|Overall Study|Withdrawn on day of randomization|1|||
105467367|NCT02000115|363721250|FG002|Overall Study|Withdrawn on day of randomization|0|||
105467368|NCT02000115|363721251|FG003|Overall Study|Withdrawn on day of randomization|0|||
105343906|NCT02326298|363259682|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105343907|NCT02326298|363259683|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105343908|NCT02326298|363259684|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
105343909|NCT02326298|363259685|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105343910|NCT02326298|363259686|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105467369|NCT02000115|363721248|FG000|Overall Study|Still on Study|0|||
105467370|NCT02000115|363721249|FG001|Overall Study|Still on Study|0|||
105467371|NCT02000115|363721250|FG002|Overall Study|Still on Study|0|||
105467372|NCT02000115|363721251|FG003|Overall Study|Still on Study|53|||
105343911|NCT02326298|363259687|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105343912|NCT02326298|363259688|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105343913|NCT02326298|363259689|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105343914|NCT02326298|363259690|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105343915|NCT02326298|363259677|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105343916|NCT02326298|363259678|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105343917|NCT02326298|363259679|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105343918|NCT02326298|363259680|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105343919|NCT02326298|363259681|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105343920|NCT02326298|363259682|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105343921|NCT02326298|363259683|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
105343922|NCT02326298|363259684|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
105343923|NCT02326298|363259685|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105343924|NCT02326298|363259686|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105467373|NCT04801420|363721252|FG000|Overall Study|Other|1|||
105467374|NCT04801420|363721253|FG001|Overall Study|Other|2|||
105467375|NCT04801420|363721254|FG002|Overall Study|Other|1|||
105467376|NCT04801420|363721252|FG000|Overall Study|Lost to Follow-up|7|||
105467377|NCT04801420|363721253|FG001|Overall Study|Lost to Follow-up|9|||
105467378|NCT04801420|363721254|FG002|Overall Study|Lost to Follow-up|10|||
105467379|NCT04801420|363721252|FG000|Overall Study|Moved from study area|0|||
105467380|NCT04801420|363721253|FG001|Overall Study|Moved from study area|1|||
105467381|NCT04801420|363721254|FG002|Overall Study|Moved from study area|1|||
105467382|NCT04801420|363721252|FG000|Overall Study|Withdrawal by Subject|5|||
105467383|NCT04801420|363721253|FG001|Overall Study|Withdrawal by Subject|1|||
105467384|NCT04801420|363721254|FG002|Overall Study|Withdrawal by Subject|4|||
105467385|NCT04801420|363721252|FG000|Overall Study|Individual stopping criteria reached|0|||
105467386|NCT04801420|363721253|FG001|Overall Study|Individual stopping criteria reached|1|||
105467387|NCT04801420|363721254|FG002|Overall Study|Individual stopping criteria reached|0|||
105679136|NCT02407990|364486885|FG005|Overall Study|Logistics|0|||
105467388|NCT04801420|363721252|FG000|Overall Study|Ongoing in the study|195|||
105467389|NCT04801420|363721253|FG001|Overall Study|Ongoing in the study|195|||
105467390|NCT04801420|363721254|FG002|Overall Study|Ongoing in the study|192|||
105467391|NCT03387085|363721255|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
105467392|NCT04487080|363721256|FG000|Overall Study|Withdrawal by Subject|19|||
105467393|NCT04487080|363721257|FG001|Overall Study|Withdrawal by Subject|18|||
105467394|NCT04487080|363721258|FG002|Overall Study|Withdrawal by Subject|13|||
105467395|NCT04487080|363721256|FG000|Overall Study|Lost to Follow-up|3|||
105467396|NCT04487080|363721257|FG001|Overall Study|Lost to Follow-up|1|||
105467397|NCT04487080|363721258|FG002|Overall Study|Lost to Follow-up|0|||
105467398|NCT04487080|363721256|FG000|Overall Study|Ongoing|313|||
105467399|NCT04487080|363721257|FG001|Overall Study|Ongoing|297|||
105467400|NCT04487080|363721258|FG002|Overall Study|Ongoing|149|||
105467401|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
105467402|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
105467403|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
105467404|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
105467405|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
105467406|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
105467407|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
105467408|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
105467409|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
105467410|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
105467411|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
105467412|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
105467413|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
105467414|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
105467415|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
105467416|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
105467417|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
105467418|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
105467419|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
105467420|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
105467421|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
105467422|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
105467423|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
105467424|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
105467425|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
105467426|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
105467427|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
105467428|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
105467429|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
105467430|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
105467431|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
105467432|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
105467433|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
105467434|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
105467435|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
105467436|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
105467437|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
105467438|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
105467439|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
105467440|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
105467441|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
105467442|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
105467443|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
105467444|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
105467445|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
105467446|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
105467447|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
105467448|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
105467449|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
105467450|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
105467451|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
105467452|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
105467453|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
105467454|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
105467455|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
105467456|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
105467457|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
105467458|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
105467459|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
105467460|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
105467461|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
105467462|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
105467463|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
105467464|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
105467465|NCT00217737|363721259|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
105467466|NCT00217737|363721260|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
105467467|NCT00217737|363721261|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
105467468|NCT00217737|363721262|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
105467469|NCT00217737|363721259|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
105467470|NCT00217737|363721260|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
105467471|NCT00217737|363721261|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
105467472|NCT00217737|363721262|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
105467473|NCT00217737|363721259|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
105467474|NCT00217737|363721260|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
105467475|NCT00217737|363721261|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
105467476|NCT00217737|363721262|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
105467477|NCT00217737|363721259|FG000|Step 2 Randomization/Registration|Study suspension|0|||
105556849|NCT01540851|364035611|FG001|Overall Study|Withdrawal by Subject|3|||
105556850|NCT00937924|364035612|FG000|Overall Study|Lost to Follow-up|44|||
105556851|NCT00937924|364035613|FG001|Overall Study|Lost to Follow-up|44|||
105556852|NCT00937924|364035614|FG002|Overall Study|Lost to Follow-up|41|||
105556853|NCT03644186|364035615|FG000|Overall Study|Withdrawal by Subject|1|||
105556854|NCT03644186|364035616|FG001|Overall Study|Withdrawal by Subject|1|||
105556855|NCT01640808|364035618|FG000|Overall Study|Unable to continue dynamic CT|14|||
105467478|NCT00217737|363721260|FG001|Step 2 Randomization/Registration|Study suspension|45|||
105467479|NCT00217737|363721261|FG002|Step 2 Randomization/Registration|Study suspension|0|||
105467480|NCT00217737|363721262|FG003|Step 2 Randomization/Registration|Study suspension|0|||
105556856|NCT01640808|364035619|FG001|Overall Study|Unable to continue dynamic CT|4|||
105556857|NCT01640808|364035618|FG000|Overall Study|Withdrawal by Subject|12|||
105556858|NCT01640808|364035619|FG001|Overall Study|Withdrawal by Subject|4|||
105556859|NCT01640808|364035618|FG000|Overall Study|Lost to Follow-up|4|||
105467481|NCT00217737|363721259|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
105467482|NCT00217737|363721260|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
105467483|NCT00217737|363721261|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
105467484|NCT00217737|363721262|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
105467485|NCT00217737|363721259|FG000|Step 2 Randomization/Registration|Death|2|||
105467486|NCT00217737|363721260|FG001|Step 2 Randomization/Registration|Death|3|||
105467487|NCT00217737|363721261|FG002|Step 2 Randomization/Registration|Death|0|||
105467488|NCT00217737|363721262|FG003|Step 2 Randomization/Registration|Death|0|||
105467489|NCT00217737|363721259|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
105467490|NCT00217737|363721260|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
105467491|NCT00217737|363721261|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
105467492|NCT00217737|363721262|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
105467493|NCT00217737|363721259|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
105467494|NCT00217737|363721260|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
105467495|NCT00217737|363721261|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
105467496|NCT00217737|363721262|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
105467497|NCT00217737|363721259|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
105467498|NCT00217737|363721260|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
105467499|NCT00217737|363721261|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
105467500|NCT00217737|363721262|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
105467501|NCT00217737|363721259|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
105467502|NCT00217737|363721260|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
105467503|NCT00217737|363721261|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
105467504|NCT00217737|363721262|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
105467505|NCT00217737|363721259|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
105467506|NCT00217737|363721260|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
105467507|NCT00217737|363721261|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
105467508|NCT00217737|363721262|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
105467509|NCT00217737|363721259|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
105467510|NCT00217737|363721260|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
105467511|NCT00217737|363721261|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
105467512|NCT00217737|363721262|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
105467513|NCT00217737|363721259|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
105467514|NCT00217737|363721260|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
105467515|NCT00217737|363721261|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
105467516|NCT00217737|363721262|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
105467517|NCT00217737|363721259|FG000|Step 2 Randomization/Registration|Other|1|||
105467518|NCT00217737|363721260|FG001|Step 2 Randomization/Registration|Other|2|||
105467519|NCT00217737|363721261|FG002|Step 2 Randomization/Registration|Other|0|||
105467520|NCT00217737|363721262|FG003|Step 2 Randomization/Registration|Other|0|||
105467521|NCT04145349|363722672|FG000|Overall Study|Withdrawal by Subject|3|||
105467522|NCT04145349|363722673|FG001|Overall Study|Withdrawal by Subject|0|||
105467523|NCT04145349|363722672|FG000|Overall Study|Lost to Follow-up|0|||
105467524|NCT04145349|363722673|FG001|Overall Study|Lost to Follow-up|1|||
105467525|NCT04145349|363722672|FG000|Overall Study|On study treatment (Ongoing)|0|||
105467526|NCT04145349|363722673|FG001|Overall Study|On study treatment (Ongoing)|1|||
105467527|NCT00554216|363722676|FG000|Overall Study|Lost to Follow-up|92|||
105467528|NCT00554216|363722677|FG001|Overall Study|Lost to Follow-up|31|||
105467529|NCT00554216|363722678|FG002|Overall Study|Lost to Follow-up|63|||
105467530|NCT00554216|363722676|FG000|Overall Study|Adverse Event|16|||
105467531|NCT00554216|363722677|FG001|Overall Study|Adverse Event|16|||
105467532|NCT00554216|363722678|FG002|Overall Study|Adverse Event|36|||
105467533|NCT00554216|363722676|FG000|Overall Study|Withdrawal by Subject|92|||
105467534|NCT00554216|363722677|FG001|Overall Study|Withdrawal by Subject|31|||
105467535|NCT00554216|363722678|FG002|Overall Study|Withdrawal by Subject|43|||
105467536|NCT00554216|363722676|FG000|Overall Study|Non compliance|10|||
105467537|NCT00554216|363722677|FG001|Overall Study|Non compliance|4|||
105467538|NCT00554216|363722678|FG002|Overall Study|Non compliance|5|||
105467539|NCT00554216|363722676|FG000|Overall Study|Pregnancy|2|||
105467540|NCT00554216|363722677|FG001|Overall Study|Pregnancy|1|||
105467541|NCT00554216|363722678|FG002|Overall Study|Pregnancy|14|||
105467542|NCT00554216|363722676|FG000|Overall Study|Restricted med|3|||
105467543|NCT00554216|363722677|FG001|Overall Study|Restricted med|1|||
105467544|NCT00554216|363722678|FG002|Overall Study|Restricted med|1|||
105467545|NCT00554216|363722676|FG000|Overall Study|Other|12|||
105467546|NCT00554216|363722677|FG001|Overall Study|Other|7|||
105467547|NCT00554216|363722678|FG002|Overall Study|Other|10|||
105467548|NCT00554216|363722676|FG000|Overall Study|Lack of Efficacy|15|||
105467549|NCT00554216|363722677|FG001|Overall Study|Lack of Efficacy|3|||
105467550|NCT00554216|363722678|FG002|Overall Study|Lack of Efficacy|0|||
105467551|NCT03847896|363722679|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
105467552|NCT03847896|363722680|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
105467553|NCT03847896|363722681|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
105467554|NCT03847896|363722682|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
105467555|NCT03847896|363722683|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
105467556|NCT03847896|363722679|FG000|Overall Study|Withdrawal by Subject|2|||
105467557|NCT03847896|363722680|FG001|Overall Study|Withdrawal by Subject|10|||
105467558|NCT03847896|363722681|FG002|Overall Study|Withdrawal by Subject|5|||
105467559|NCT03847896|363722682|FG003|Overall Study|Withdrawal by Subject|9|||
105467560|NCT03847896|363722683|FG004|Overall Study|Withdrawal by Subject|8|||
105467561|NCT03847896|363722679|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105467562|NCT03847896|363722680|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105467563|NCT03847896|363722681|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105467564|NCT03847896|363722682|FG003|Overall Study|Withdrawal by parent/guardian|0|||
105467565|NCT03847896|363722683|FG004|Overall Study|Withdrawal by parent/guardian|0|||
105467566|NCT03847896|363722679|FG000|Overall Study|Adverse Event|2|||
105467567|NCT03847896|363722680|FG001|Overall Study|Adverse Event|1|||
105467568|NCT03847896|363722681|FG002|Overall Study|Adverse Event|3|||
105467569|NCT03847896|363722682|FG003|Overall Study|Adverse Event|2|||
105467570|NCT03847896|363722683|FG004|Overall Study|Adverse Event|4|||
105467571|NCT03847896|363722679|FG000|Overall Study|A severe exacerbation event|0|||
105467572|NCT03847896|363722680|FG001|Overall Study|A severe exacerbation event|0|||
105467573|NCT03847896|363722681|FG002|Overall Study|A severe exacerbation event|0|||
105467574|NCT03847896|363722682|FG003|Overall Study|A severe exacerbation event|0|||
105467575|NCT03847896|363722683|FG004|Overall Study|A severe exacerbation event|3|||
105467576|NCT03847896|363722679|FG000|Overall Study|Protocol Violation|0|||
105467577|NCT03847896|363722680|FG001|Overall Study|Protocol Violation|2|||
105467578|NCT03847896|363722681|FG002|Overall Study|Protocol Violation|1|||
105467579|NCT03847896|363722682|FG003|Overall Study|Protocol Violation|0|||
105467580|NCT03847896|363722683|FG004|Overall Study|Protocol Violation|2|||
105467581|NCT03847896|363722679|FG000|Overall Study|Lost to Follow-up|0|||
105467582|NCT03847896|363722680|FG001|Overall Study|Lost to Follow-up|0|||
105467583|NCT03847896|363722681|FG002|Overall Study|Lost to Follow-up|0|||
105467584|NCT03847896|363722682|FG003|Overall Study|Lost to Follow-up|1|||
105467585|NCT03847896|363722683|FG004|Overall Study|Lost to Follow-up|0|||
105467586|NCT03847896|363722679|FG000|Overall Study|Condition under investigation worsened|0|||
105467587|NCT03847896|363722680|FG001|Overall Study|Condition under investigation worsened|0|||
105467588|NCT03847896|363722681|FG002|Overall Study|Condition under investigation worsened|0|||
105467589|NCT03847896|363722682|FG003|Overall Study|Condition under investigation worsened|1|||
105467590|NCT03847896|363722683|FG004|Overall Study|Condition under investigation worsened|1|||
105467591|NCT03847896|363722679|FG000|Overall Study|Lack of Efficacy|0|||
105467592|NCT03847896|363722680|FG001|Overall Study|Lack of Efficacy|0|||
105467593|NCT03847896|363722681|FG002|Overall Study|Lack of Efficacy|0|||
105679137|NCT02407990|364486886|FG006|Overall Study|Logistics|0|||
105467594|NCT03847896|363722682|FG003|Overall Study|Lack of Efficacy|2|||
105467595|NCT03847896|363722683|FG004|Overall Study|Lack of Efficacy|2|||
105467596|NCT03847896|363722679|FG000|Overall Study|Other reasons|3|||
105467597|NCT03847896|363722680|FG001|Overall Study|Other reasons|3|||
105467598|NCT03847896|363722681|FG002|Overall Study|Other reasons|1|||
105467599|NCT03847896|363722682|FG003|Overall Study|Other reasons|2|||
105679138|NCT02407990|364486887|FG007|Overall Study|Logistics|1|||
105679139|NCT02407990|364486880|FG000|Overall Study|Rolled into long-term extension study|0|||
105467600|NCT03847896|363722683|FG004|Overall Study|Other reasons|1|||
105467601|NCT02395471|363722684|FG000|Overall Study|Lost to Follow-up|2|||
105679140|NCT02407990|364486881|FG001|Overall Study|Rolled into long-term extension study|0|||
105679141|NCT02407990|364486882|FG002|Overall Study|Rolled into long-term extension study|0|||
105679142|NCT02407990|364486883|FG003|Overall Study|Rolled into long-term extension study|0|||
105467602|NCT02395471|363722685|FG001|Overall Study|Lost to Follow-up|0|||
105467603|NCT02395471|363722684|FG000|Overall Study|Withdrawal by Subject|2|||
105467604|NCT02395471|363722685|FG001|Overall Study|Withdrawal by Subject|1|||
105467605|NCT02395471|363722684|FG000|Overall Study|Physician Decision|1|||
105467606|NCT02395471|363722685|FG001|Overall Study|Physician Decision|0|||
105467607|NCT02395471|363722684|FG000|Overall Study|Protocol Violation|0|||
105467608|NCT02395471|363722685|FG001|Overall Study|Protocol Violation|1|||
105467609|NCT02395471|363722684|FG000|Overall Study|Failure to swollow sponge twice|1|||
105467610|NCT02395471|363722685|FG001|Overall Study|Failure to swollow sponge twice|0|||
105467611|NCT02395471|363722684|FG000|Overall Study|Patient did not return for procedure|0|||
105467612|NCT02395471|363722685|FG001|Overall Study|Patient did not return for procedure|1|||
105467613|NCT02395471|363722684|FG000|Overall Study|Subject not eligible|1|||
105467614|NCT02395471|363722685|FG001|Overall Study|Subject not eligible|0|||
105467615|NCT00118417|363722686|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
105467616|NCT00118417|363722687|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
105467617|NCT00118417|363722686|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
105679143|NCT02407990|364486884|FG004|Overall Study|Rolled into long-term extension study|0|||
105679144|NCT02407990|364486885|FG005|Overall Study|Rolled into long-term extension study|0|||
105679145|NCT02407990|364486886|FG006|Overall Study|Rolled into long-term extension study|0|||
105679146|NCT02407990|364486887|FG007|Overall Study|Rolled into long-term extension study|1|||
105679147|NCT00852540|364486890|FG000|Overall Study|Adverse Event|10|||
105467618|NCT00118417|363722687|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
105467619|NCT00118417|363722686|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
105467620|NCT00118417|363722687|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
105467621|NCT00118417|363722686|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
105467622|NCT00118417|363722687|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
105467623|NCT00118417|363722686|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
105467624|NCT00118417|363722687|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
105467625|NCT00711191|363722690|FG000|Overall Study|Adverse Event|1|||
105467626|NCT00711191|363722691|FG001|Overall Study|Adverse Event|1|||
105467627|NCT00711191|363722692|FG002|Overall Study|Adverse Event|2|||
105467628|NCT00711191|363722690|FG000|Overall Study|Objective progression or relapse|2|||
105467629|NCT00711191|363722691|FG001|Overall Study|Objective progression or relapse|3|||
105467630|NCT00711191|363722692|FG002|Overall Study|Objective progression or relapse|7|||
105467631|NCT00711191|363722690|FG000|Overall Study|Withdrawal by Subject|0|||
105467632|NCT00711191|363722691|FG001|Overall Study|Withdrawal by Subject|1|||
105467633|NCT00711191|363722692|FG002|Overall Study|Withdrawal by Subject|3|||
105467634|NCT03584789|363722693|FG000|Overall Study|refused EHR permission|19|||
105467635|NCT03584789|363722694|FG001|Overall Study|refused EHR permission|28|||
105467636|NCT03584789|363722695|FG002|Overall Study|refused EHR permission|23|||
105467637|NCT03584789|363722693|FG000|Overall Study|patients tied to a provider who retired|0|||
105467638|NCT03584789|363722694|FG001|Overall Study|patients tied to a provider who retired|0|||
105467639|NCT03584789|363722695|FG002|Overall Study|patients tied to a provider who retired|3|||
105467640|NCT02035267|363722696|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
105467641|NCT02035267|363722697|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
105467642|NCT02035267|363722698|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
105467643|NCT02035267|363722699|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
105467644|NCT02035267|363722696|FG000|Overall Study|Adverse Event|0|||
105467645|NCT02035267|363722697|FG001|Overall Study|Adverse Event|0|||
105467646|NCT02035267|363722698|FG002|Overall Study|Adverse Event|1|||
105467647|NCT02035267|363722699|FG003|Overall Study|Adverse Event|0|||
105467648|NCT02035267|363722696|FG000|Overall Study|Lost to Follow-up|0|||
105467649|NCT02035267|363722697|FG001|Overall Study|Lost to Follow-up|0|||
105467650|NCT02035267|363722698|FG002|Overall Study|Lost to Follow-up|0|||
105467651|NCT02035267|363722699|FG003|Overall Study|Lost to Follow-up|1|||
105467652|NCT02035267|363722696|FG000|Overall Study|Other unspecified|0|||
105467653|NCT02035267|363722697|FG001|Overall Study|Other unspecified|1|||
105467654|NCT02035267|363722698|FG002|Overall Study|Other unspecified|0|||
105467655|NCT02035267|363722699|FG003|Overall Study|Other unspecified|0|||
105467656|NCT01750229|363722703|FG000|Randomized Crossover Phase|Adverse Event|1|||
105467657|NCT01750229|363722703|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
105467658|NCT01750229|363722703|FG000|Long-term Follow-up Phase|Adverse Event|2|||
105467659|NCT01750229|363722703|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
105467660|NCT00998296|363722704|FG000|Overall Study|Progressive disease|0|||
105467661|NCT00998296|363722705|FG001|Overall Study|Progressive disease|1|||
105467662|NCT00998296|363722706|FG002|Overall Study|Progressive disease|0|||
105467663|NCT00998296|363722707|FG003|Overall Study|Progressive disease|0|||
105467664|NCT00998296|363722708|FG004|Overall Study|Progressive disease|0|||
105467665|NCT00998296|363722709|FG005|Overall Study|Progressive disease|0|||
105467666|NCT00998296|363722710|FG006|Overall Study|Progressive disease|1|||
105467667|NCT00998296|363722711|FG007|Overall Study|Progressive disease|0|||
105467668|NCT00998296|363722712|FG008|Overall Study|Progressive disease|0|||
105467669|NCT00998296|363722713|FG009|Overall Study|Progressive disease|14|||
105467670|NCT00998296|363722714|FG010|Overall Study|Progressive disease|5|||
105467671|NCT00998296|363722704|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
105556860|NCT01640808|364035619|FG001|Overall Study|Lost to Follow-up|0|||
105467672|NCT00998296|363722705|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
105467673|NCT00998296|363722706|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
105467674|NCT00998296|363722707|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
105467675|NCT00998296|363722708|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
105467676|NCT00998296|363722709|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
105467677|NCT00998296|363722710|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
105467678|NCT00998296|363722711|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
105467679|NCT00998296|363722712|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
105467680|NCT00998296|363722713|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
105467681|NCT00998296|363722714|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
105467682|NCT00998296|363722704|FG000|Overall Study|Other adverse event|0|||
105467683|NCT00998296|363722705|FG001|Overall Study|Other adverse event|0|||
105467684|NCT00998296|363722706|FG002|Overall Study|Other adverse event|0|||
105467685|NCT00998296|363722707|FG003|Overall Study|Other adverse event|0|||
105467686|NCT00998296|363722708|FG004|Overall Study|Other adverse event|1|||
105467687|NCT00998296|363722709|FG005|Overall Study|Other adverse event|0|||
105467688|NCT00998296|363722710|FG006|Overall Study|Other adverse event|0|||
105467689|NCT00998296|363722711|FG007|Overall Study|Other adverse event|0|||
105467690|NCT00998296|363722712|FG008|Overall Study|Other adverse event|0|||
105467691|NCT00998296|363722713|FG009|Overall Study|Other adverse event|1|||
105467692|NCT00998296|363722714|FG010|Overall Study|Other adverse event|2|||
105467693|NCT00998296|363722704|FG000|Overall Study|Refused to continue taking trial med.|0|||
105467694|NCT00998296|363722705|FG001|Overall Study|Refused to continue taking trial med.|0|||
105467695|NCT00998296|363722706|FG002|Overall Study|Refused to continue taking trial med.|0|||
105467696|NCT00998296|363722707|FG003|Overall Study|Refused to continue taking trial med.|0|||
105467697|NCT00998296|363722708|FG004|Overall Study|Refused to continue taking trial med.|0|||
105467698|NCT00998296|363722709|FG005|Overall Study|Refused to continue taking trial med.|0|||
105467699|NCT00998296|363722710|FG006|Overall Study|Refused to continue taking trial med.|0|||
105467700|NCT00998296|363722711|FG007|Overall Study|Refused to continue taking trial med.|0|||
105467701|NCT00998296|363722712|FG008|Overall Study|Refused to continue taking trial med.|0|||
105467702|NCT00998296|363722713|FG009|Overall Study|Refused to continue taking trial med.|2|||
105467703|NCT00998296|363722714|FG010|Overall Study|Refused to continue taking trial med.|0|||
105467704|NCT00998296|363722704|FG000|Overall Study|Reason other than those specified above|0|||
105467705|NCT00998296|363722705|FG001|Overall Study|Reason other than those specified above|0|||
105467706|NCT00998296|363722706|FG002|Overall Study|Reason other than those specified above|0|||
105467707|NCT00998296|363722707|FG003|Overall Study|Reason other than those specified above|0|||
105467708|NCT00998296|363722708|FG004|Overall Study|Reason other than those specified above|0|||
105467709|NCT00998296|363722709|FG005|Overall Study|Reason other than those specified above|0|||
105467710|NCT00998296|363722710|FG006|Overall Study|Reason other than those specified above|0|||
105467711|NCT00998296|363722711|FG007|Overall Study|Reason other than those specified above|0|||
105467712|NCT00998296|363722712|FG008|Overall Study|Reason other than those specified above|0|||
105467713|NCT00998296|363722713|FG009|Overall Study|Reason other than those specified above|1|||
105467714|NCT00998296|363722714|FG010|Overall Study|Reason other than those specified above|0|||
105467715|NCT02346721|363722715|FG000|Overall Study|Withdrew Consent|3|||
105467716|NCT02346721|363722715|FG000|Overall Study|Lack of Efficacy|1|||
105467717|NCT04396639|363722716|FG000|Overall Study|Withdrawal by Subject|1|||
105467718|NCT04396639|363722716|FG000|Overall Study|Other|1|||
105467719|NCT04988295|363722722|FG000|Overall Study|Withdrawal by Subject|9|||
105467720|NCT04988295|363722723|FG001|Overall Study|Withdrawal by Subject|29|||
105467721|NCT04988295|363722724|FG002|Overall Study|Withdrawal by Subject|6|||
105467722|NCT04988295|363722725|FG003|Overall Study|Withdrawal by Subject|0|||
105467723|NCT04988295|363722722|FG000|Overall Study|Lost to Follow-up|1|||
105467724|NCT04988295|363722723|FG001|Overall Study|Lost to Follow-up|0|||
105467725|NCT04988295|363722724|FG002|Overall Study|Lost to Follow-up|0|||
105467726|NCT04988295|363722725|FG003|Overall Study|Lost to Follow-up|0|||
105467727|NCT04988295|363722722|FG000|Overall Study|Study participation ongoing|186|||
105467728|NCT04988295|363722723|FG001|Overall Study|Study participation ongoing|169|||
105467729|NCT04988295|363722724|FG002|Overall Study|Study participation ongoing|99|||
105467730|NCT04988295|363722725|FG003|Overall Study|Study participation ongoing|119|||
105467731|NCT03126591|363722726|FG000|Overall Study|Death|6|||
105467732|NCT03126591|363722727|FG001|Overall Study|Death|3|||
105467733|NCT03126591|363722728|FG002|Overall Study|Death|17|||
105467734|NCT03126591|363722726|FG000|Overall Study|Progressive Disease|0|||
105467735|NCT03126591|363722727|FG001|Overall Study|Progressive Disease|1|||
105467736|NCT03126591|363722728|FG002|Overall Study|Progressive Disease|2|||
105467737|NCT03126591|363722726|FG000|Overall Study|Terminated by Sponsor|0|||
105467738|NCT03126591|363722727|FG001|Overall Study|Terminated by Sponsor|1|||
105467739|NCT03126591|363722728|FG002|Overall Study|Terminated by Sponsor|4|||
105467740|NCT03126591|363722726|FG000|Overall Study|Withdrawal by Subject|1|||
105467741|NCT03126591|363722727|FG001|Overall Study|Withdrawal by Subject|1|||
105467742|NCT03126591|363722728|FG002|Overall Study|Withdrawal by Subject|4|||
105467743|NCT03722238|363722729|FG000|Overall Study|Protocol Violation|1|||
105467744|NCT03722238|363722730|FG001|Overall Study|Protocol Violation|0|||
105467745|NCT03722238|363722729|FG000|Overall Study|Physician Decision|1|||
105467746|NCT03722238|363722730|FG001|Overall Study|Physician Decision|0|||
105467747|NCT03722238|363722729|FG000|Overall Study|Death|1|||
105467748|NCT03722238|363722730|FG001|Overall Study|Death|0|||
105467749|NCT03722238|363722729|FG000|Overall Study|Lost to Follow-up|6|||
105467750|NCT03722238|363722730|FG001|Overall Study|Lost to Follow-up|0|||
105467751|NCT03722238|363722729|FG000|Overall Study|Partial missing data|44|||
105467752|NCT03722238|363722730|FG001|Overall Study|Partial missing data|1|||
105467753|NCT03722238|363722729|FG000|Overall Study|Withdrawal by Subject|2|||
105467754|NCT03722238|363722730|FG001|Overall Study|Withdrawal by Subject|0|||
105467755|NCT03722238|363722729|FG000|Overall Study|Other|4|||
105467756|NCT03722238|363722730|FG001|Overall Study|Other|0|||
105467757|NCT03722238|363722729|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
105467758|NCT03722238|363722730|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
105467759|NCT03722238|363722729|FG000|Overall Study|Did not meet risk classification group criteria|90|||
105467760|NCT03722238|363722730|FG001|Overall Study|Did not meet risk classification group criteria|0|||
105467761|NCT03722238|363722729|FG000|Overall Study|Did not sign consent|17|||
105467762|NCT03722238|363722730|FG001|Overall Study|Did not sign consent|0|||
105467763|NCT03722238|363722729|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
105467764|NCT03722238|363722730|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
105467765|NCT03722238|363722729|FG000|Overall Study|Not willing to purchase study medication|142|||
105467766|NCT03722238|363722730|FG001|Overall Study|Not willing to purchase study medication|0|||
105467767|NCT03722238|363722729|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
105467768|NCT03722238|363722730|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
105467769|NCT00885170|363722731|FG000|Overall Study|Adverse Event|12|||
105467770|NCT00885170|363722732|FG001|Overall Study|Adverse Event|4|||
105467771|NCT00885170|363722731|FG000|Overall Study|Excessive bone loss|6|||
105467772|NCT00885170|363722732|FG001|Overall Study|Excessive bone loss|3|||
105467773|NCT00885170|363722731|FG000|Overall Study|Lost to Follow-up|2|||
105467774|NCT00885170|363722732|FG001|Overall Study|Lost to Follow-up|1|||
105467775|NCT00885170|363722731|FG000|Overall Study|Physician Decision|2|||
105467776|NCT00885170|363722732|FG001|Overall Study|Physician Decision|1|||
105467777|NCT00885170|363722731|FG000|Overall Study|Protocol Violation|3|||
105467778|NCT00885170|363722732|FG001|Overall Study|Protocol Violation|1|||
105467779|NCT00885170|363722731|FG000|Overall Study|Withdrawal by Subject|13|||
105467780|NCT00885170|363722732|FG001|Overall Study|Withdrawal by Subject|13|||
105467781|NCT01635153|363722734|FG000|Overall Study|Lost to Follow-up|40|||
105467782|NCT01635153|363722735|FG001|Overall Study|Lost to Follow-up|43|||
105343925|NCT02326298|363259687|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105343926|NCT02326298|363259688|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105343927|NCT02326298|363259689|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105343928|NCT02326298|363259690|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105343929|NCT02326298|363259677|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105343930|NCT02326298|363259678|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105343931|NCT02326298|363259679|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105343932|NCT02326298|363259680|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105343933|NCT02326298|363259681|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105343934|NCT02326298|363259682|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105343935|NCT02326298|363259683|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105343936|NCT02326298|363259684|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
105343937|NCT02326298|363259685|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105343938|NCT02326298|363259686|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105343939|NCT02326298|363259687|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105343940|NCT02326298|363259688|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105343941|NCT02326298|363259689|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105343942|NCT02326298|363259690|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105343943|NCT02326298|363259677|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105343944|NCT02326298|363259678|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105343945|NCT02326298|363259679|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105343946|NCT02326298|363259680|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105467783|NCT02454517|363722737|FG000|Overall Study|Withdrawal by Subject|3|||
105467784|NCT02454517|363722738|FG001|Overall Study|Withdrawal by Subject|0|||
105467785|NCT02454517|363722737|FG000|Overall Study|Lost to Follow-up|4|||
105467786|NCT02454517|363722738|FG001|Overall Study|Lost to Follow-up|7|||
105484897|NCT02038829|363786997|FG006|Washout Period 2|Withdrawal by Subject|0|||
105484898|NCT02038829|363786998|FG007|Washout Period 2|Withdrawal by Subject|0|||
105484899|NCT02038829|363786999|FG008|Washout Period 2|Withdrawal by Subject|0|||
105484900|NCT02038829|363787000|FG009|Washout Period 2|Withdrawal by Subject|0|||
105484901|NCT02038829|363787001|FG010|Washout Period 2|Withdrawal by Subject|0|||
105484902|NCT02038829|363787002|FG011|Washout Period 2|Withdrawal by Subject|0|||
105343947|NCT02326298|363259681|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105343948|NCT02326298|363259682|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
105343949|NCT02326298|363259683|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105343950|NCT02326298|363259684|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105343951|NCT02326298|363259685|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105343952|NCT02326298|363259686|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105343953|NCT02326298|363259687|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105343954|NCT02326298|363259688|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105343955|NCT02326298|363259689|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105343956|NCT02326298|363259690|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105343957|NCT02326298|363259677|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
105343958|NCT02326298|363259678|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
105343959|NCT02326298|363259679|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
105343960|NCT02326298|363259680|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
105343961|NCT02326298|363259681|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
105343962|NCT02326298|363259682|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
105343963|NCT02326298|363259683|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
105343964|NCT02326298|363259684|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
105343965|NCT02326298|363259685|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
105343966|NCT02326298|363259686|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
105343967|NCT02326298|363259687|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
105343968|NCT02326298|363259688|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
105343969|NCT02326298|363259689|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
105343970|NCT02326298|363259690|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
105343971|NCT02326298|363259677|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105343972|NCT02326298|363259678|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105343973|NCT02326298|363259679|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105343974|NCT02326298|363259680|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105343975|NCT02326298|363259681|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105343976|NCT02326298|363259682|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105343977|NCT02326298|363259683|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105343978|NCT02326298|363259684|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105343979|NCT02326298|363259685|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105343980|NCT02326298|363259686|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105343981|NCT02326298|363259687|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105343982|NCT02326298|363259688|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
105343983|NCT02326298|363259689|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
105343984|NCT02326298|363259690|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105343985|NCT02326298|363259677|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105343986|NCT02326298|363259678|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105343987|NCT02326298|363259679|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105343988|NCT02326298|363259680|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105343989|NCT02326298|363259681|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105343990|NCT02326298|363259682|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105343991|NCT02326298|363259683|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105343992|NCT02326298|363259684|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105343993|NCT02326298|363259685|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105343994|NCT02326298|363259686|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105343995|NCT02326298|363259687|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105343996|NCT02326298|363259688|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
105343997|NCT02326298|363259689|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
105343998|NCT02326298|363259690|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105343999|NCT02326298|363259677|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105344000|NCT02326298|363259678|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105344001|NCT02326298|363259679|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105344002|NCT02326298|363259680|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105344003|NCT02326298|363259681|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105344004|NCT02326298|363259682|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105344005|NCT02326298|363259683|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105679148|NCT00852540|364486891|FG001|Overall Study|Adverse Event|3|||
105679149|NCT00852540|364486890|FG000|Overall Study|Lack of Efficacy|15|||
105679150|NCT00852540|364486891|FG001|Overall Study|Lack of Efficacy|3|||
105679151|NCT00852540|364486890|FG000|Overall Study|Protocol Violation|1|||
105679152|NCT00852540|364486891|FG001|Overall Study|Protocol Violation|2|||
105679153|NCT00852540|364486890|FG000|Overall Study|Lost to Follow-up|2|||
105344006|NCT02326298|363259684|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105344007|NCT02326298|363259685|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105467787|NCT02454517|363722737|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
105467788|NCT02454517|363722738|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
105467789|NCT01470326|363722739|FG000|Overall Study|Protocol Violation|32|||
105467790|NCT01470326|363722739|FG000|Overall Study|No Drug Administration Information|2|||
105467791|NCT01470326|363722739|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
105467792|NCT01166282|363722740|FG000|Open-label Period|Adverse Event|0|||
105467793|NCT01166282|363722741|FG001|Open-label Period|Adverse Event|0|||
105467794|NCT01166282|363722742|FG002|Open-label Period|Adverse Event|6|||
105467795|NCT01166282|363722740|FG000|Open-label Period|Withdrawal by Subject|0|||
105467796|NCT01166282|363722741|FG001|Open-label Period|Withdrawal by Subject|0|||
105467797|NCT01166282|363722742|FG002|Open-label Period|Withdrawal by Subject|4|||
105467798|NCT01166282|363722740|FG000|Open-label Period|Lack of Efficacy|0|||
105467799|NCT01166282|363722741|FG001|Open-label Period|Lack of Efficacy|0|||
105467800|NCT01166282|363722742|FG002|Open-label Period|Lack of Efficacy|2|||
105467801|NCT01166282|363722740|FG000|Open-label Period|Remission|0|||
105467802|NCT01166282|363722741|FG001|Open-label Period|Remission|0|||
105467803|NCT01166282|363722742|FG002|Open-label Period|Remission|4|||
105467804|NCT01166282|363722740|FG000|Open-label Period|Irregular Compliance|0|||
105467805|NCT01166282|363722741|FG001|Open-label Period|Irregular Compliance|0|||
105467806|NCT01166282|363722742|FG002|Open-label Period|Irregular Compliance|1|||
105467807|NCT01995838|363722743|FG000|Overall Study|Lost to Follow-up|0|||
105467808|NCT01995838|363722744|FG001|Overall Study|Lost to Follow-up|1|||
105467809|NCT01995838|363722745|FG002|Overall Study|Lost to Follow-up|0|||
105467810|NCT01995838|363722746|FG003|Overall Study|Lost to Follow-up|0|||
105467811|NCT01995838|363722747|FG004|Overall Study|Lost to Follow-up|0|||
105467812|NCT01995838|363722748|FG005|Overall Study|Lost to Follow-up|0|||
105467813|NCT01995838|363722749|FG006|Overall Study|Lost to Follow-up|1|||
105467814|NCT01995838|363722743|FG000|Overall Study|Participant choice|2|||
105467815|NCT01995838|363722744|FG001|Overall Study|Participant choice|0|||
105467816|NCT01995838|363722745|FG002|Overall Study|Participant choice|0|||
105467817|NCT01995838|363722746|FG003|Overall Study|Participant choice|0|||
105467818|NCT01995838|363722747|FG004|Overall Study|Participant choice|0|||
105467819|NCT01995838|363722748|FG005|Overall Study|Participant choice|1|||
105467820|NCT01995838|363722749|FG006|Overall Study|Participant choice|1|||
105467821|NCT01995838|363722743|FG000|Overall Study|Adverse Event|0|||
105467822|NCT01995838|363722744|FG001|Overall Study|Adverse Event|0|||
105467823|NCT01995838|363722745|FG002|Overall Study|Adverse Event|0|||
105467824|NCT01995838|363722746|FG003|Overall Study|Adverse Event|0|||
105467825|NCT01995838|363722747|FG004|Overall Study|Adverse Event|0|||
105467826|NCT01995838|363722748|FG005|Overall Study|Adverse Event|0|||
105467827|NCT01995838|363722749|FG006|Overall Study|Adverse Event|1|||
105467828|NCT01995838|363722743|FG000|Overall Study|Withdrawal by Subject|0|||
105467829|NCT01995838|363722744|FG001|Overall Study|Withdrawal by Subject|0|||
105467830|NCT01995838|363722745|FG002|Overall Study|Withdrawal by Subject|0|||
105467831|NCT01995838|363722746|FG003|Overall Study|Withdrawal by Subject|0|||
105467832|NCT01995838|363722747|FG004|Overall Study|Withdrawal by Subject|1|||
105467833|NCT01995838|363722748|FG005|Overall Study|Withdrawal by Subject|0|||
105467834|NCT01995838|363722749|FG006|Overall Study|Withdrawal by Subject|0|||
105679154|NCT00852540|364486891|FG001|Overall Study|Lost to Follow-up|3|||
105679155|NCT00852540|364486890|FG000|Overall Study|Investigator Discretion|2|||
105679156|NCT00852540|364486891|FG001|Overall Study|Investigator Discretion|3|||
105679157|NCT00852540|364486890|FG000|Overall Study|Withdrawal by Subject|3|||
105679158|NCT00852540|364486891|FG001|Overall Study|Withdrawal by Subject|1|||
105679159|NCT00852540|364486890|FG000|Overall Study|Did Not Receive Study Drug|3|||
105467835|NCT01995838|363722743|FG000|Overall Study|Other|3|||
105467836|NCT01995838|363722744|FG001|Overall Study|Other|1|||
105467837|NCT01995838|363722745|FG002|Overall Study|Other|0|||
105467838|NCT01995838|363722746|FG003|Overall Study|Other|2|||
105467839|NCT01995838|363722747|FG004|Overall Study|Other|1|||
105467840|NCT01995838|363722748|FG005|Overall Study|Other|1|||
105467841|NCT01995838|363722749|FG006|Overall Study|Other|2|||
105467842|NCT02892448|363722765|FG000|Overall Study|Screening failure|2|||
105467843|NCT02892448|363722766|FG001|Overall Study|Screening failure|2|||
105467844|NCT02892448|363722767|FG002|Overall Study|Screening failure|1|||
105467845|NCT00499083|363722768|FG000|Overall Study|Not evaluable|3|||
105467846|NCT00439517|363722770|FG000|Overall Study|Subject on treatment|1|||
105467847|NCT00439517|363722771|FG001|Overall Study|Subject on treatment|0|||
105467848|NCT00439517|363722770|FG000|Overall Study|Subject in survival follow-up|1|||
105467849|NCT00439517|363722771|FG001|Overall Study|Subject in survival follow-up|0|||
105467850|NCT00686686|363722774|FG000|Overall Study|Non-compliance|1|||
105467851|NCT00686686|363722774|FG000|Overall Study|Adverse Event|2|||
105467852|NCT00686686|363722774|FG000|Overall Study|Lost to Follow-up|3|||
105467853|NCT01012440|363722775|FG000|Overall Study|Withdrawal by Subject|2|||
105467854|NCT00594815|363722776|FG000|Overall Study|Never Treated|3|||
105467855|NCT00594815|363722776|FG000|Overall Study|Withdrawal by Subject|2|||
105467856|NCT00594815|363722776|FG000|Overall Study|Toxicity|4|||
105467857|NCT03214666|363722779|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
105467858|NCT03214666|363722780|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
105467859|NCT03214666|363722781|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
105467860|NCT03214666|363722782|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
105467861|NCT03214666|363722783|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
105467862|NCT03214666|363722784|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
105467863|NCT00477386|363722790|FG000|Overall Study|Adverse Event|4|||
105467864|NCT00477386|363722791|FG001|Overall Study|Adverse Event|8|||
105467865|NCT00477386|363722790|FG000|Overall Study|Disease progression, relapse|3|||
105467866|NCT00477386|363722791|FG001|Overall Study|Disease progression, relapse|4|||
105344008|NCT02326298|363259686|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105344009|NCT02326298|363259687|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105344010|NCT02326298|363259688|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105344011|NCT02326298|363259689|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105344012|NCT02326298|363259690|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
105344013|NCT02326298|363259677|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105344014|NCT02326298|363259678|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105344015|NCT02326298|363259679|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105344016|NCT02326298|363259680|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105344017|NCT02326298|363259681|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105344018|NCT02326298|363259682|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105344019|NCT02326298|363259683|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105344020|NCT02326298|363259684|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105344021|NCT02326298|363259685|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105344022|NCT02326298|363259686|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105344023|NCT02326298|363259687|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105344024|NCT02326298|363259688|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
105344025|NCT02326298|363259689|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
105344026|NCT02326298|363259690|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
105344027|NCT02326298|363259677|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105344028|NCT02326298|363259678|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105344029|NCT02326298|363259679|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105344030|NCT02326298|363259680|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105344031|NCT02326298|363259681|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105344032|NCT02326298|363259682|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105344033|NCT02326298|363259683|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105344034|NCT02326298|363259684|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105344035|NCT02326298|363259685|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105344036|NCT02326298|363259686|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105344037|NCT02326298|363259687|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105344038|NCT02326298|363259688|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
105344039|NCT02326298|363259689|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
105344040|NCT02326298|363259690|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
105344041|NCT02326298|363259677|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105344042|NCT02326298|363259678|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105344043|NCT02326298|363259679|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105344044|NCT02326298|363259680|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105344045|NCT02326298|363259681|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105344046|NCT02326298|363259682|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105344047|NCT02326298|363259683|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105344048|NCT02326298|363259684|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105344049|NCT02326298|363259685|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105344050|NCT02326298|363259686|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105344051|NCT02326298|363259687|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105344052|NCT02326298|363259688|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
105344053|NCT02326298|363259689|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
105344054|NCT02326298|363259690|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
105344055|NCT01668966|363261662|FG000|Overall Study|Withdrawal by Subject|1|||
105344056|NCT01668966|363261662|FG000|Overall Study|Death|1|||
105556861|NCT01640808|364035618|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
105556862|NCT01640808|364035619|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
105344057|NCT01668966|363261662|FG000|Overall Study|Not treated|2|||
105344058|NCT04599933|363261664|FG000|Overall Study|Adverse Event|4|||
105344059|NCT04599933|363261665|FG001|Overall Study|Adverse Event|1|||
105344060|NCT04599933|363261664|FG000|Overall Study|Withdrawal by Subject|4|||
105344061|NCT04599933|363261665|FG001|Overall Study|Withdrawal by Subject|2|||
105344062|NCT04599933|363261664|FG000|Overall Study|Lost to Follow-up|0|||
105344063|NCT04599933|363261665|FG001|Overall Study|Lost to Follow-up|1|||
105344064|NCT04599933|363261664|FG000|Overall Study|Physician Decision|0|||
105344065|NCT04599933|363261665|FG001|Overall Study|Physician Decision|1|||
105344066|NCT04599933|363261664|FG000|Overall Study|Screen Failure|1|||
105344067|NCT04599933|363261665|FG001|Overall Study|Screen Failure|2|||
105556863|NCT01640808|364035618|FG000|Overall Study|Administration of anticancer drugs|2|||
105556864|NCT01640808|364035619|FG001|Overall Study|Administration of anticancer drugs|1|||
105556865|NCT01640808|364035618|FG000|Overall Study|Physician Decision|19|||
105556866|NCT01640808|364035619|FG001|Overall Study|Physician Decision|5|||
105467867|NCT00477386|363722790|FG000|Overall Study|Disease progression, refractory|1|||
105467868|NCT00477386|363722791|FG001|Overall Study|Disease progression, refractory|3|||
105467869|NCT00477386|363722790|FG000|Overall Study|Other|1|||
105467870|NCT00477386|363722791|FG001|Overall Study|Other|2|||
105467871|NCT00477386|363722790|FG000|Overall Study|Physician Decision|1|||
105467872|NCT00477386|363722791|FG001|Overall Study|Physician Decision|0|||
105467873|NCT00477386|363722790|FG000|Overall Study|Withdrawal by Subject|1|||
105467874|NCT00477386|363722791|FG001|Overall Study|Withdrawal by Subject|0|||
105467875|NCT01254422|363722792|FG000|Overall Study|Protocol Violation|1|||
105467876|NCT01254422|363722793|FG001|Overall Study|Protocol Violation|0|||
105467877|NCT01254422|363722792|FG000|Overall Study|Adverse Event|1|||
105467878|NCT01254422|363722793|FG001|Overall Study|Adverse Event|0|||
105467879|NCT01254422|363722792|FG000|Overall Study|Serious adverse event|0|||
105467880|NCT01254422|363722793|FG001|Overall Study|Serious adverse event|1|||
105467881|NCT01254422|363722792|FG000|Overall Study|Lost to Follow-up|1|||
105467882|NCT01254422|363722793|FG001|Overall Study|Lost to Follow-up|0|||
105467883|NCT00643162|363722794|FG000|Overall Study|Withdrawal by Subject|1|||
105467884|NCT00643162|363722795|FG001|Overall Study|Withdrawal by Subject|1|||
105467885|NCT01143246|363722800|FG000|Overall Study|Adverse Event|24|||
105467886|NCT01143246|363722801|FG001|Overall Study|Adverse Event|28|||
105467887|NCT01143246|363722800|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
105467888|NCT01143246|363722801|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
105467889|NCT01143246|363722800|FG000|Overall Study|Lost to Follow-up|0|||
105467890|NCT01143246|363722801|FG001|Overall Study|Lost to Follow-up|1|||
105467891|NCT01143246|363722800|FG000|Overall Study|Death|16|||
105467892|NCT01143246|363722801|FG001|Overall Study|Death|15|||
105467893|NCT01143246|363722800|FG000|Overall Study|Reason not Specified|3|||
105467894|NCT01143246|363722801|FG001|Overall Study|Reason not Specified|5|||
105467895|NCT02365597|363722802|FG000|Overall Study|Lost to Follow-up|0|||
105467896|NCT02365597|363722803|FG001|Overall Study|Lost to Follow-up|1|||
105467897|NCT02365597|363722804|FG002|Overall Study|Lost to Follow-up|0|||
105467898|NCT02365597|363722805|FG003|Overall Study|Lost to Follow-up|1|||
105467899|NCT02365597|363722802|FG000|Overall Study|Withdrawal by Subject|1|||
105467900|NCT02365597|363722803|FG001|Overall Study|Withdrawal by Subject|8|||
105467901|NCT02365597|363722804|FG002|Overall Study|Withdrawal by Subject|5|||
105467902|NCT02365597|363722805|FG003|Overall Study|Withdrawal by Subject|1|||
105467903|NCT02365597|363722802|FG000|Overall Study|Sponsor's decision|1|||
105467904|NCT02365597|363722803|FG001|Overall Study|Sponsor's decision|3|||
105467905|NCT02365597|363722804|FG002|Overall Study|Sponsor's decision|13|||
105467906|NCT02365597|363722805|FG003|Overall Study|Sponsor's decision|0|||
105467907|NCT02365597|363722802|FG000|Overall Study|Other|0|||
105467908|NCT02365597|363722803|FG001|Overall Study|Other|4|||
105467909|NCT02365597|363722804|FG002|Overall Study|Other|0|||
105467910|NCT02365597|363722805|FG003|Overall Study|Other|0|||
105467911|NCT02365597|363722802|FG000|Overall Study|Enrolled but not treated|0|||
105467912|NCT02365597|363722803|FG001|Overall Study|Enrolled but not treated|1|||
105467913|NCT02365597|363722804|FG002|Overall Study|Enrolled but not treated|1|||
105467914|NCT02365597|363722805|FG003|Overall Study|Enrolled but not treated|0|||
105344068|NCT04063657|363261666|FG000|Overall Study|Lost to Follow-up|1|||
105344069|NCT04063657|363261667|FG001|Overall Study|Lost to Follow-up|0|||
105344070|NCT01995175|363261669|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
105344071|NCT01995175|363261669|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
105344072|NCT01995175|363261669|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
105344073|NCT01995175|363261669|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
105344074|NCT01995175|363261669|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
105344075|NCT01995175|363261669|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
105467915|NCT02365597|363722802|FG000|Overall Study|Ongoing|0|||
105467916|NCT02365597|363722803|FG001|Overall Study|Ongoing|0|||
105467917|NCT02365597|363722804|FG002|Overall Study|Ongoing|0|||
105467918|NCT02365597|363722805|FG003|Overall Study|Ongoing|17|||
105467919|NCT04697628|363722808|FG000|Overall Study|Withdrawal by Subject|17|||
105467920|NCT04697628|363722809|FG001|Overall Study|Withdrawal by Subject|23|||
105467921|NCT04697628|363722808|FG000|Overall Study|Lost to Follow-up|0|||
105467922|NCT04697628|363722809|FG001|Overall Study|Lost to Follow-up|4|||
105467923|NCT04697628|363722808|FG000|Overall Study|On-going in study|122|||
105556867|NCT01640808|364035618|FG000|Overall Study|Randomized but not treated|4|||
105556868|NCT01640808|364035619|FG001|Overall Study|Randomized but not treated|2|||
105556869|NCT04391023|364035620|FG000|Overall Study|Withdrawal by Subject|2|||
105467924|NCT04697628|363722809|FG001|Overall Study|On-going in study|91|||
105467925|NCT01946204|363722810|FG000|Overall Study|Death|38|||
105467926|NCT01946204|363722811|FG001|Overall Study|Death|59|||
105467927|NCT01946204|363722810|FG000|Overall Study|Withdrawal by Subject|37|||
105467928|NCT01946204|363722811|FG001|Overall Study|Withdrawal by Subject|50|||
105467929|NCT01946204|363722810|FG000|Overall Study|Lost to Follow-up|3|||
105467930|NCT01946204|363722811|FG001|Overall Study|Lost to Follow-up|7|||
105556870|NCT04391023|364035621|FG001|Overall Study|Withdrawal by Subject|2|||
105556871|NCT01618864|364035622|FG000|Overall Study|Withdrawal by Subject|2|||
105556872|NCT01618864|364035622|FG000|Overall Study|Lost to Follow-up|2|||
105556873|NCT05553808|364035624|FG000|Overall Study|Death|25|||
105556874|NCT05553808|364035625|FG001|Overall Study|Death|62|||
105556875|NCT05553808|364035624|FG000|Overall Study|Site Closed|6|||
105556876|NCT05553808|364035625|FG001|Overall Study|Site Closed|6|||
105556877|NCT05553808|364035624|FG000|Overall Study|Lost to Follow-up|1|||
105556878|NCT05553808|364035625|FG001|Overall Study|Lost to Follow-up|0|||
105556879|NCT05553808|364035624|FG000|Overall Study|Withdrawal by Subject|3|||
105556880|NCT05553808|364035625|FG001|Overall Study|Withdrawal by Subject|2|||
105344076|NCT01995175|363261669|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
105344077|NCT01995175|363261669|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
105344078|NCT01995175|363261669|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
105344079|NCT03602391|363261672|FG000|Overall Study|COVID-19|7|||
105344080|NCT03602391|363261673|FG001|Overall Study|COVID-19|6|||
105344081|NCT04258254|363261682|FG000|Overall Study|Withdrawal by Subject|0|||
105344082|NCT04258254|363261683|FG001|Overall Study|Withdrawal by Subject|1|||
105344083|NCT04258254|363261684|FG002|Overall Study|Withdrawal by Subject|0|||
105344084|NCT03729570|363261685|FG000|Overall Study|Lost to Follow-up|16|||
105344085|NCT03729570|363261686|FG001|Overall Study|Lost to Follow-up|20|||
105344086|NCT03729570|363261685|FG000|Overall Study|Seroconversion|5|||
105344087|NCT03729570|363261686|FG001|Overall Study|Seroconversion|0|||
105344088|NCT03729570|363261685|FG000|Overall Study|Moved out of the city|1|||
105344089|NCT03729570|363261686|FG001|Overall Study|Moved out of the city|0|||
105344090|NCT03729570|363261685|FG000|Overall Study|Time Conflict|1|||
105344091|NCT03729570|363261686|FG001|Overall Study|Time Conflict|0|||
105344092|NCT03729570|363261685|FG000|Overall Study|Time Commitment|2|||
105344093|NCT03729570|363261686|FG001|Overall Study|Time Commitment|0|||
105344094|NCT03729570|363261685|FG000|Overall Study|Bad Experience|0|||
105344095|NCT03729570|363261686|FG001|Overall Study|Bad Experience|1|||
105344096|NCT03729570|363261685|FG000|Overall Study|No reason provided|2|||
105344097|NCT03729570|363261686|FG001|Overall Study|No reason provided|1|||
105344098|NCT03729570|363261685|FG000|Overall Study|Family Conflict|0|||
105467931|NCT01946204|363722810|FG000|Overall Study|Ongoing|316|||
105556881|NCT02270450|364035626|FG000|Overall Study|Refusal unrelated to adverse event|3|||
105556882|NCT02270450|364035627|FG001|Overall Study|Refusal unrelated to adverse event|1|||
105679160|NCT00852540|364486891|FG001|Overall Study|Did Not Receive Study Drug|3|||
105679161|NCT00446043|364486894|FG000|Overall Study|Adverse Event|9|||
105679162|NCT00446043|364486894|FG000|Overall Study|Withdrawal by Subject|70|||
105556883|NCT02270450|364035628|FG002|Overall Study|Refusal unrelated to adverse event|5|||
105679163|NCT00446043|364486894|FG000|Overall Study|Protocol Violation|2|||
105467932|NCT01946204|363722811|FG001|Overall Study|Ongoing|687|||
105467933|NCT01946204|363722810|FG000|Overall Study|Other|7|||
105467934|NCT01946204|363722811|FG001|Overall Study|Other|3|||
105556884|NCT02270450|364035629|FG003|Overall Study|Refusal unrelated to adverse event|14|||
105344099|NCT03729570|363261686|FG001|Overall Study|Family Conflict|1|||
105344100|NCT03729570|363261685|FG000|Overall Study|Did not want to continue taking medications|0|||
105344101|NCT03729570|363261686|FG001|Overall Study|Did not want to continue taking medications|1|||
105467935|NCT02908672|363722812|FG000|Run-in Period|Death|12|||
105679164|NCT00446043|364486894|FG000|Overall Study|Lost to Follow-up|42|||
105679165|NCT00446043|364486894|FG000|Overall Study|Pregnancy|2|||
105679166|NCT01253304|364486902|FG000|Overall Study|Adverse Event|0|||
105679167|NCT01253304|364486903|FG001|Overall Study|Adverse Event|0|||
105467936|NCT02908672|363722813|FG001|Run-in Period|Death|10|||
105467937|NCT02908672|363722814|FG002|Run-in Period|Death|0|||
105467938|NCT02908672|363722815|FG003|Run-in Period|Death|0|||
105467939|NCT02908672|363722812|FG000|Run-in Period|Lost to Follow-up|1|||
105467940|NCT02908672|363722813|FG001|Run-in Period|Lost to Follow-up|1|||
105467941|NCT02908672|363722814|FG002|Run-in Period|Lost to Follow-up|0|||
105467942|NCT02908672|363722815|FG003|Run-in Period|Lost to Follow-up|0|||
105467943|NCT02908672|363722812|FG000|Run-in Period|Reason Not Specified|2|||
105467944|NCT02908672|363722813|FG001|Run-in Period|Reason Not Specified|0|||
105467945|NCT02908672|363722814|FG002|Run-in Period|Reason Not Specified|0|||
105467946|NCT02908672|363722815|FG003|Run-in Period|Reason Not Specified|0|||
105467947|NCT02908672|363722812|FG000|Run-in Period|Protocol Violation|1|||
105467948|NCT02908672|363722813|FG001|Run-in Period|Protocol Violation|1|||
105467949|NCT02908672|363722814|FG002|Run-in Period|Protocol Violation|0|||
105467950|NCT02908672|363722815|FG003|Run-in Period|Protocol Violation|0|||
105467951|NCT02908672|363722812|FG000|Run-in Period|Study Ended by Sponsor|5|||
105467952|NCT02908672|363722813|FG001|Run-in Period|Study Ended by Sponsor|1|||
105484903|NCT02038829|363786991|FG000|Treatment Period 4|Adverse Event|0|||
105484904|NCT02038829|363786992|FG001|Treatment Period 4|Adverse Event|1|||
105484905|NCT02038829|363786993|FG002|Treatment Period 4|Adverse Event|0|||
105484906|NCT02038829|363786994|FG003|Treatment Period 4|Adverse Event|0|||
105484907|NCT02038829|363786995|FG004|Treatment Period 4|Adverse Event|0|||
105484908|NCT02038829|363786996|FG005|Treatment Period 4|Adverse Event|0|||
105484909|NCT02038829|363786997|FG006|Treatment Period 4|Adverse Event|0|||
105484910|NCT02038829|363786998|FG007|Treatment Period 4|Adverse Event|0|||
105484911|NCT02038829|363786999|FG008|Treatment Period 4|Adverse Event|0|||
105484912|NCT02038829|363787000|FG009|Treatment Period 4|Adverse Event|0|||
105484913|NCT02038829|363787001|FG010|Treatment Period 4|Adverse Event|0|||
105484914|NCT02038829|363787002|FG011|Treatment Period 4|Adverse Event|0|||
105484915|NCT02038829|363786991|FG000|Washout Period 4|Adverse Event|0|||
105484916|NCT02038829|363786992|FG001|Washout Period 4|Adverse Event|0|||
105484917|NCT02038829|363786993|FG002|Washout Period 4|Adverse Event|0|||
105484918|NCT02038829|363786994|FG003|Washout Period 4|Adverse Event|0|||
105484919|NCT02038829|363786995|FG004|Washout Period 4|Adverse Event|0|||
105484920|NCT02038829|363786996|FG005|Washout Period 4|Adverse Event|0|||
105484921|NCT02038829|363786997|FG006|Washout Period 4|Adverse Event|1|||
105484922|NCT02038829|363786998|FG007|Washout Period 4|Adverse Event|0|||
105484923|NCT02038829|363786999|FG008|Washout Period 4|Adverse Event|0|||
105484924|NCT02038829|363787000|FG009|Washout Period 4|Adverse Event|0|||
105484925|NCT02038829|363787001|FG010|Washout Period 4|Adverse Event|0|||
105484926|NCT02038829|363787002|FG011|Washout Period 4|Adverse Event|0|||
105484927|NCT02038829|363786991|FG000|Treatment Period 6|Adverse Event|0|||
105484928|NCT02038829|363786992|FG001|Treatment Period 6|Adverse Event|0|||
105484929|NCT02038829|363786993|FG002|Treatment Period 6|Adverse Event|1|||
105484930|NCT02038829|363786994|FG003|Treatment Period 6|Adverse Event|0|||
105484931|NCT02038829|363786995|FG004|Treatment Period 6|Adverse Event|0|||
105484932|NCT02038829|363786996|FG005|Treatment Period 6|Adverse Event|0|||
105484933|NCT02038829|363786997|FG006|Treatment Period 6|Adverse Event|0|||
105484934|NCT02038829|363786998|FG007|Treatment Period 6|Adverse Event|0|||
105484935|NCT02038829|363786999|FG008|Treatment Period 6|Adverse Event|0|||
105484936|NCT02038829|363787000|FG009|Treatment Period 6|Adverse Event|0|||
105484937|NCT02038829|363787001|FG010|Treatment Period 6|Adverse Event|0|||
105484938|NCT02038829|363787002|FG011|Treatment Period 6|Adverse Event|0|||
105484939|NCT00978432|363787003|FG000|Overall Study|Withdrawal by Subject|0|||
105484940|NCT00978432|363787004|FG001|Overall Study|Withdrawal by Subject|0|||
105484941|NCT00978432|363787005|FG002|Overall Study|Withdrawal by Subject|1|||
105484942|NCT00978432|363787003|FG000|Overall Study|Lack of Efficacy|1|||
105484943|NCT00978432|363787004|FG001|Overall Study|Lack of Efficacy|1|||
105484944|NCT00978432|363787005|FG002|Overall Study|Lack of Efficacy|3|||
105484945|NCT00978432|363787003|FG000|Overall Study|Adverse Event|2|||
105484946|NCT00978432|363787004|FG001|Overall Study|Adverse Event|0|||
105484947|NCT00978432|363787005|FG002|Overall Study|Adverse Event|1|||
105484948|NCT04618770|363787006|FG000|Overall Study|Censored from Analysis|12|||
105484949|NCT04618770|363787006|FG000|Overall Study|Early Termination|25|||
105484950|NCT02311582|363787009|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
105484951|NCT02311582|363787010|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
105484952|NCT02311582|363787011|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
105484953|NCT02311582|363787012|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
105484954|NCT02311582|363787013|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
105484955|NCT04972630|363787015|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
105484956|NCT04972630|363787016|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
105556885|NCT02270450|364035626|FG000|Overall Study|Progression/relapse|1|||
105556886|NCT02270450|364035627|FG001|Overall Study|Progression/relapse|2|||
105556887|NCT02270450|364035628|FG002|Overall Study|Progression/relapse|4|||
105556888|NCT02270450|364035629|FG003|Overall Study|Progression/relapse|9|||
105556889|NCT02270450|364035626|FG000|Overall Study|Death|19|||
105556890|NCT02270450|364035627|FG001|Overall Study|Death|19|||
105556891|NCT02270450|364035628|FG002|Overall Study|Death|31|||
105556892|NCT02270450|364035629|FG003|Overall Study|Death|59|||
105556893|NCT02576678|364035630|FG000|Overall Study|Adverse Event|0|||
105556894|NCT02576678|364035631|FG001|Overall Study|Adverse Event|0|||
105556895|NCT02576678|364035632|FG002|Overall Study|Adverse Event|2|||
105556896|NCT02576678|364035630|FG000|Overall Study|Withdrawal by Subject|3|||
105556897|NCT02576678|364035631|FG001|Overall Study|Withdrawal by Subject|1|||
105556898|NCT02576678|364035632|FG002|Overall Study|Withdrawal by Subject|2|||
105556899|NCT02576678|364035630|FG000|Overall Study|Lost to Follow-up|0|||
105556900|NCT02576678|364035631|FG001|Overall Study|Lost to Follow-up|0|||
105556901|NCT02576678|364035632|FG002|Overall Study|Lost to Follow-up|1|||
105556902|NCT02576678|364035630|FG000|Overall Study|Miscellaneous|2|||
105556903|NCT02576678|364035631|FG001|Overall Study|Miscellaneous|0|||
105556904|NCT02576678|364035632|FG002|Overall Study|Miscellaneous|0|||
105556905|NCT02677116|364035637|FG000|Overall Study|Adverse Event|0|||
105556906|NCT02677116|364035638|FG001|Overall Study|Adverse Event|1|||
105556907|NCT02677116|364035639|FG002|Overall Study|Adverse Event|0|||
105556908|NCT02677116|364035640|FG003|Overall Study|Adverse Event|0|||
105556909|NCT02677116|364035641|FG004|Overall Study|Adverse Event|0|||
105556910|NCT02677116|364035642|FG005|Overall Study|Adverse Event|1|||
105556911|NCT02677116|364035643|FG006|Overall Study|Adverse Event|1|||
105556912|NCT02677116|364035644|FG007|Overall Study|Adverse Event|0|||
105556913|NCT02677116|364035645|FG008|Overall Study|Adverse Event|0|||
105556914|NCT02677116|364035637|FG000|Overall Study|Physician Decision|0|||
105556915|NCT02677116|364035638|FG001|Overall Study|Physician Decision|2|||
105556916|NCT02677116|364035639|FG002|Overall Study|Physician Decision|3|||
105556917|NCT02677116|364035640|FG003|Overall Study|Physician Decision|2|||
105556918|NCT02677116|364035641|FG004|Overall Study|Physician Decision|1|||
105556919|NCT02677116|364035642|FG005|Overall Study|Physician Decision|3|||
105556920|NCT02677116|364035643|FG006|Overall Study|Physician Decision|1|||
105556921|NCT02677116|364035644|FG007|Overall Study|Physician Decision|1|||
105556922|NCT02677116|364035645|FG008|Overall Study|Physician Decision|2|||
105556923|NCT02677116|364035637|FG000|Overall Study|Withdrawal by parent or guardian|2|||
105556924|NCT02677116|364035638|FG001|Overall Study|Withdrawal by parent or guardian|1|||
105556925|NCT02677116|364035639|FG002|Overall Study|Withdrawal by parent or guardian|0|||
105556926|NCT02677116|364035640|FG003|Overall Study|Withdrawal by parent or guardian|1|||
105556927|NCT02677116|364035641|FG004|Overall Study|Withdrawal by parent or guardian|0|||
105556928|NCT02677116|364035642|FG005|Overall Study|Withdrawal by parent or guardian|0|||
105556929|NCT02677116|364035643|FG006|Overall Study|Withdrawal by parent or guardian|2|||
105556930|NCT02677116|364035644|FG007|Overall Study|Withdrawal by parent or guardian|1|||
105556931|NCT02677116|364035645|FG008|Overall Study|Withdrawal by parent or guardian|0|||
105556932|NCT02677116|364035637|FG000|Overall Study|Withdrawal by Subject|1|||
105556933|NCT02677116|364035638|FG001|Overall Study|Withdrawal by Subject|0|||
105556934|NCT02677116|364035639|FG002|Overall Study|Withdrawal by Subject|0|||
105556935|NCT02677116|364035640|FG003|Overall Study|Withdrawal by Subject|0|||
105556936|NCT02677116|364035641|FG004|Overall Study|Withdrawal by Subject|0|||
105556937|NCT02677116|364035642|FG005|Overall Study|Withdrawal by Subject|0|||
105556938|NCT02677116|364035643|FG006|Overall Study|Withdrawal by Subject|0|||
105556939|NCT02677116|364035644|FG007|Overall Study|Withdrawal by Subject|0|||
105556940|NCT02677116|364035645|FG008|Overall Study|Withdrawal by Subject|0|||
105556941|NCT03342638|364035646|FG000|Overall Study|Withdrawal by Subject|1|||
105556942|NCT03342638|364035647|FG001|Overall Study|Withdrawal by Subject|0|||
105556943|NCT03342638|364035646|FG000|Overall Study|Physician Decision|0|||
105556944|NCT03342638|364035647|FG001|Overall Study|Physician Decision|1|||
105556945|NCT00113568|364035652|FG000|Overall Study|Adverse Event|97|||
105556946|NCT00113568|364035652|FG000|Overall Study|Death|1|||
105556947|NCT00113568|364035652|FG000|Overall Study|Lack of Efficacy|30|||
105556948|NCT00113568|364035652|FG000|Overall Study|Lost to Follow-up|156|||
105556949|NCT00113568|364035652|FG000|Overall Study|Protocol Violation|32|||
105556950|NCT00113568|364035652|FG000|Overall Study|Withdrawal by Subject|117|||
105556951|NCT00113568|364035652|FG000|Overall Study|Other|112|||
105556952|NCT00262821|364035654|FG000|Overall Study|Ineligible - wrong stage|0|||
105556953|NCT00262821|364035655|FG001|Overall Study|Ineligible - wrong stage|3|||
105556954|NCT00262821|364035654|FG000|Overall Study|Ineligible - wrong cell type|2|||
105556955|NCT00262821|364035655|FG001|Overall Study|Ineligible - wrong cell type|2|||
105556956|NCT00262821|364035654|FG000|Overall Study|Ineligible - wrong primary|0|||
105556957|NCT00262821|364035655|FG001|Overall Study|Ineligible - wrong primary|1|||
105556958|NCT00262821|364035654|FG000|Overall Study|Ineligible - inadequate pathology|1|||
105556959|NCT00262821|364035655|FG001|Overall Study|Ineligible - inadequate pathology|3|||
105556960|NCT00262821|364035654|FG000|Overall Study|Ineligible - elevated creatinine|0|||
105556961|NCT00262821|364035655|FG001|Overall Study|Ineligible - elevated creatinine|2|||
105556962|NCT00262821|364035654|FG000|Overall Study|Ineligible - required test not done|1|||
105556963|NCT00262821|364035655|FG001|Overall Study|Ineligible - required test not done|4|||
105556964|NCT00262821|364035654|FG000|Overall Study|Inevaluable - inadequate data|0|||
105556965|NCT00262821|364035655|FG001|Overall Study|Inevaluable - inadequate data|4|||
105467953|NCT02908672|363722814|FG002|Run-in Period|Study Ended by Sponsor|0|||
105467954|NCT02908672|363722815|FG003|Run-in Period|Study Ended by Sponsor|0|||
105467955|NCT02908672|363722812|FG000|Run-in Period|Withdrawal by Subject|3|||
105467956|NCT02908672|363722813|FG001|Run-in Period|Withdrawal by Subject|9|||
105467957|NCT02908672|363722814|FG002|Run-in Period|Withdrawal by Subject|0|||
105467958|NCT02908672|363722815|FG003|Run-in Period|Withdrawal by Subject|0|||
105467959|NCT02908672|363722812|FG000|Triple Combination Period|Death|0|||
105467960|NCT02908672|363722813|FG001|Triple Combination Period|Death|0|||
105467961|NCT02908672|363722814|FG002|Triple Combination Period|Death|150|||
105467962|NCT02908672|363722815|FG003|Triple Combination Period|Death|127|||
105467963|NCT02908672|363722812|FG000|Triple Combination Period|Lost to Follow-up|0|||
105467964|NCT02908672|363722813|FG001|Triple Combination Period|Lost to Follow-up|0|||
105467965|NCT02908672|363722814|FG002|Triple Combination Period|Lost to Follow-up|6|||
105467966|NCT02908672|363722815|FG003|Triple Combination Period|Lost to Follow-up|8|||
105467967|NCT02908672|363722812|FG000|Triple Combination Period|Reason Not Specified|0|||
105467968|NCT02908672|363722813|FG001|Triple Combination Period|Reason Not Specified|0|||
105467969|NCT02908672|363722814|FG002|Triple Combination Period|Reason Not Specified|0|||
105467970|NCT02908672|363722815|FG003|Triple Combination Period|Reason Not Specified|1|||
105467971|NCT02908672|363722812|FG000|Triple Combination Period|Physician Decision|0|||
105467972|NCT02908672|363722813|FG001|Triple Combination Period|Physician Decision|0|||
105467973|NCT02908672|363722814|FG002|Triple Combination Period|Physician Decision|1|||
105467974|NCT02908672|363722815|FG003|Triple Combination Period|Physician Decision|1|||
105467975|NCT02908672|363722812|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
105467976|NCT02908672|363722813|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
105467977|NCT02908672|363722814|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
105467978|NCT02908672|363722815|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
105467979|NCT02908672|363722812|FG000|Triple Combination Period|Withdrawal by Subject|0|||
105467980|NCT02908672|363722813|FG001|Triple Combination Period|Withdrawal by Subject|0|||
105467981|NCT02908672|363722814|FG002|Triple Combination Period|Withdrawal by Subject|13|||
105467982|NCT02908672|363722815|FG003|Triple Combination Period|Withdrawal by Subject|16|||
105467983|NCT04538664|363722819|FG000|Overall Study|Withdrawal by Subject|5|||
105467984|NCT04538664|363722820|FG001|Overall Study|Withdrawal by Subject|9|||
105467985|NCT04538664|363722819|FG000|Overall Study|Lost to Follow-up|2|||
105467986|NCT04538664|363722820|FG001|Overall Study|Lost to Follow-up|1|||
105467987|NCT04538664|363722819|FG000|Overall Study|Ongoing|106|||
105467988|NCT04538664|363722820|FG001|Overall Study|Ongoing|115|||
105467989|NCT04770779|363722821|FG000|Overall Study|Randomized, never treated|0|||
105467990|NCT04770779|363722822|FG001|Overall Study|Randomized, never treated|1|||
105467991|NCT04770779|363722821|FG000|Overall Study|Adverse Event|9|||
105556966|NCT00695669|364035656|FG000|Overall Study|Adverse Event|0|||
105467992|NCT04770779|363722822|FG001|Overall Study|Adverse Event|1|||
105467993|NCT04770779|363722821|FG000|Overall Study|Withdrawal by Subject|7|||
105467994|NCT04770779|363722822|FG001|Overall Study|Withdrawal by Subject|1|||
105467995|NCT04770779|363722821|FG000|Overall Study|Pregnancy|0|||
105467996|NCT04770779|363722822|FG001|Overall Study|Pregnancy|1|||
105467997|NCT03529422|363722823|FG000|Overall Study|Withdrawal by Subject|1|||
105467998|NCT03529422|363722823|FG000|Overall Study|Protocol Violation|1|||
105467999|NCT03529422|363722823|FG000|Overall Study|Disease progression|2|||
105468000|NCT05006573|363722826|FG000|Double-blind Treatment Period|Physician Decision|2|||
105468001|NCT05006573|363722827|FG001|Double-blind Treatment Period|Physician Decision|0|||
105468002|NCT05006573|363722826|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
105556967|NCT00695669|364035657|FG001|Overall Study|Adverse Event|0|||
105556968|NCT00695669|364035658|FG002|Overall Study|Adverse Event|2|||
105556969|NCT00695669|364035659|FG003|Overall Study|Adverse Event|0|||
105556970|NCT00695669|364035656|FG000|Overall Study|Lost to Follow-up|4|||
105556971|NCT00695669|364035657|FG001|Overall Study|Lost to Follow-up|4|||
105556972|NCT00695669|364035658|FG002|Overall Study|Lost to Follow-up|1|||
105556973|NCT00695669|364035659|FG003|Overall Study|Lost to Follow-up|4|||
105556974|NCT00417079|364035660|FG000|Overall Study|Disease progression|267|||
105556975|NCT00417079|364035661|FG001|Overall Study|Disease progression|180|||
105556976|NCT00417079|364035660|FG000|Overall Study|Adverse Event|32|||
105556977|NCT00417079|364035661|FG001|Overall Study|Adverse Event|67|||
105556978|NCT00417079|364035660|FG000|Overall Study|Non-compliance to protocol|0|||
105556979|NCT00417079|364035661|FG001|Overall Study|Non-compliance to protocol|1|||
105556980|NCT00417079|364035660|FG000|Overall Study|Lost to Follow-up|2|||
105556981|NCT00417079|364035661|FG001|Overall Study|Lost to Follow-up|0|||
105556982|NCT00417079|364035660|FG000|Overall Study|Withdrawal by Subject|17|||
105556983|NCT00417079|364035661|FG001|Overall Study|Withdrawal by Subject|8|||
105556984|NCT00417079|364035660|FG000|Overall Study|Not treated|6|||
105556985|NCT00417079|364035661|FG001|Overall Study|Not treated|7|||
105556986|NCT00417079|364035660|FG000|Overall Study|Screened failure|2|||
105556987|NCT00417079|364035661|FG001|Overall Study|Screened failure|1|||
105556988|NCT00417079|364035660|FG000|Overall Study|Investigator's decision|1|||
105556989|NCT00417079|364035661|FG001|Overall Study|Investigator's decision|4|||
105556990|NCT00417079|364035660|FG000|Overall Study|Non-confirmed Disease progression|1|||
105556991|NCT00417079|364035661|FG001|Overall Study|Non-confirmed Disease progression|1|||
105556992|NCT00417079|364035660|FG000|Overall Study|Clinical deterioration|1|||
105556993|NCT00417079|364035661|FG001|Overall Study|Clinical deterioration|0|||
105556994|NCT00417079|364035660|FG000|Overall Study|Screening error|2|||
105556995|NCT00417079|364035661|FG001|Overall Study|Screening error|1|||
105556996|NCT00417079|364035660|FG000|Overall Study|Withdrawal by subject's family|0|||
105556997|NCT00417079|364035661|FG001|Overall Study|Withdrawal by subject's family|1|||
105556998|NCT00417079|364035660|FG000|Overall Study|Patient unable to come to the clinic|0|||
105556999|NCT00417079|364035661|FG001|Overall Study|Patient unable to come to the clinic|1|||
105557000|NCT00417079|364035660|FG000|Overall Study|abnormal liver function tests|0|||
105557001|NCT00417079|364035661|FG001|Overall Study|abnormal liver function tests|1|||
105557002|NCT01995461|364035673|FG000|Overall Study|Death|1|||
105557003|NCT01995461|364035673|FG000|Overall Study|Lost to Follow-up|2|||
105557004|NCT01995461|364035673|FG000|Overall Study|Withdrawal by Subject|2|||
105557005|NCT02625623|364035677|FG000|Overall Study|Participants randomized but not treated|9|||
105557006|NCT02625623|364035678|FG001|Overall Study|Participants randomized but not treated|1|||
105557007|NCT00808808|364035679|FG000|Overall Study|Vaccinated; survey not completed|131|||
105557008|NCT00808808|364035680|FG001|Overall Study|Vaccinated; survey not completed|169|||
105557009|NCT00808808|364035681|FG002|Overall Study|Vaccinated; survey not completed|302|||
105557010|NCT00808808|364035679|FG000|Overall Study|Employee was not vaccinated.|2686|||
105557011|NCT00808808|364035680|FG001|Overall Study|Employee was not vaccinated.|2268|||
105557012|NCT00808808|364035681|FG002|Overall Study|Employee was not vaccinated.|2255|||
105557013|NCT02962908|364035684|FG000|Overall Study|Lost to Follow-up|0|||
105557014|NCT02962908|364035685|FG001|Overall Study|Lost to Follow-up|3|||
105557015|NCT02962908|364035686|FG002|Overall Study|Lost to Follow-up|0|||
105557016|NCT02962908|364035687|FG003|Overall Study|Lost to Follow-up|1|||
105557017|NCT02962908|364035684|FG000|Overall Study|Withdrawal by Subject|0|||
105557018|NCT02962908|364035685|FG001|Overall Study|Withdrawal by Subject|3|||
105557019|NCT02962908|364035686|FG002|Overall Study|Withdrawal by Subject|0|||
105557020|NCT02962908|364035687|FG003|Overall Study|Withdrawal by Subject|2|||
105557021|NCT02962908|364035684|FG000|Overall Study|Protocol Violation|0|||
105557022|NCT02962908|364035685|FG001|Overall Study|Protocol Violation|1|||
105557023|NCT02962908|364035686|FG002|Overall Study|Protocol Violation|0|||
105557024|NCT02962908|364035687|FG003|Overall Study|Protocol Violation|0|||
105557025|NCT02962908|364035684|FG000|Overall Study|Physician Decision|0|||
105557026|NCT02962908|364035685|FG001|Overall Study|Physician Decision|1|||
105557027|NCT02962908|364035686|FG002|Overall Study|Physician Decision|0|||
105557028|NCT02962908|364035687|FG003|Overall Study|Physician Decision|0|||
105557029|NCT03543254|364035688|FG000|Overall Study|Lost to Follow-up|1|||
105557030|NCT00126438|364035689|FG000|Overall Study|Withdrawal due to adverse event|1|||
105557031|NCT00126438|364035690|FG001|Overall Study|Withdrawal due to adverse event|0|||
105557032|NCT00126438|364035689|FG000|Overall Study|Lost to Follow-up|22|||
105557033|NCT00126438|364035690|FG001|Overall Study|Lost to Follow-up|0|||
105557034|NCT00126438|364035689|FG000|Overall Study|Protocol Violation|8|||
105557035|NCT00126438|364035690|FG001|Overall Study|Protocol Violation|8|||
105557036|NCT00126438|364035689|FG000|Overall Study|Withdrawal by Subject|3|||
105557037|NCT00126438|364035690|FG001|Overall Study|Withdrawal by Subject|2|||
105557038|NCT04154787|364035693|FG000|Overall Study|Adverse Event|0|||
105557039|NCT04154787|364035694|FG001|Overall Study|Adverse Event|1|||
105557040|NCT04154787|364035695|FG002|Overall Study|Adverse Event|0|||
105557041|NCT04154787|364035693|FG000|Overall Study|Patient Requires Other Treatment|0|||
105557042|NCT04154787|364035694|FG001|Overall Study|Patient Requires Other Treatment|1|||
105557043|NCT04154787|364035695|FG002|Overall Study|Patient Requires Other Treatment|0|||
105557044|NCT04154787|364035693|FG000|Overall Study|Study Terminated By Sponsor|0|||
105557045|NCT04154787|364035694|FG001|Overall Study|Study Terminated By Sponsor|6|||
105557046|NCT04154787|364035695|FG002|Overall Study|Study Terminated By Sponsor|1|||
105468003|NCT05006573|363722827|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
105468004|NCT05006573|363722826|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
105468005|NCT05006573|363722827|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
105468006|NCT05006573|363722826|FG000|Double-blind Treatment Period|Protocol Violation|2|||
105468007|NCT05006573|363722827|FG001|Double-blind Treatment Period|Protocol Violation|0|||
105468008|NCT05006573|363722826|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
105468009|NCT05006573|363722827|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
105468010|NCT05006573|363722826|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
105468011|NCT05006573|363722827|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
105468012|NCT04484142|363722828|FG000|Overall Study|Adverse Event|13|||
105468013|NCT04484142|363722828|FG000|Overall Study|Progressive Disease|87|||
105468014|NCT04484142|363722828|FG000|Overall Study|Clinical Progression|10|||
105468015|NCT04484142|363722828|FG000|Overall Study|Withdrawal by Subject|6|||
105468016|NCT04484142|363722828|FG000|Overall Study|Physician Decision|1|||
105468017|NCT04922216|363722829|FG000|Overall Study|Withdrawal by Subject|0|||
105468018|NCT04922216|363722830|FG001|Overall Study|Withdrawal by Subject|1|||
105468019|NCT04922216|363722831|FG002|Overall Study|Withdrawal by Subject|0|||
105468020|NCT04922216|363722832|FG003|Overall Study|Withdrawal by Subject|0|||
105468021|NCT04922216|363722833|FG004|Overall Study|Withdrawal by Subject|0|||
105468022|NCT04922216|363722834|FG005|Overall Study|Withdrawal by Subject|0|||
105468023|NCT04922216|363722835|FG006|Overall Study|Withdrawal by Subject|0|||
105468024|NCT04922216|363722836|FG007|Overall Study|Withdrawal by Subject|2|||
105468025|NCT04922216|363722837|FG008|Overall Study|Withdrawal by Subject|0|||
105468026|NCT04922216|363722838|FG009|Overall Study|Withdrawal by Subject|0|||
105468027|NCT04922216|363722839|FG010|Overall Study|Withdrawal by Subject|0|||
105468028|NCT04922216|363722840|FG011|Overall Study|Withdrawal by Subject|0|||
105468029|NCT04922216|363722841|FG012|Overall Study|Withdrawal by Subject|1|||
105468030|NCT04922216|363722842|FG013|Overall Study|Withdrawal by Subject|1|||
105468031|NCT04922216|363722843|FG014|Overall Study|Withdrawal by Subject|1|||
105468032|NCT04922216|363722844|FG015|Overall Study|Withdrawal by Subject|0|||
105468033|NCT04922216|363722845|FG016|Overall Study|Withdrawal by Subject|0|||
105468034|NCT04922216|363722846|FG017|Overall Study|Withdrawal by Subject|1|||
105468035|NCT04922216|363722847|FG018|Overall Study|Withdrawal by Subject|1|||
105468036|NCT04922216|363722848|FG019|Overall Study|Withdrawal by Subject|1|||
105468037|NCT04922216|363722849|FG020|Overall Study|Withdrawal by Subject|1|||
105468038|NCT04922216|363722850|FG021|Overall Study|Withdrawal by Subject|0|||
105468039|NCT04922216|363722851|FG022|Overall Study|Withdrawal by Subject|0|||
105468040|NCT04922216|363722852|FG023|Overall Study|Withdrawal by Subject|2|||
105468041|NCT04922216|363722853|FG024|Overall Study|Withdrawal by Subject|0|||
105468042|NCT04922216|363722854|FG025|Overall Study|Withdrawal by Subject|0|||
105468043|NCT04922216|363722855|FG026|Overall Study|Withdrawal by Subject|1|||
105468044|NCT04922216|363722856|FG027|Overall Study|Withdrawal by Subject|0|||
105468045|NCT04922216|363722857|FG028|Overall Study|Withdrawal by Subject|0|||
105468046|NCT04922216|363722858|FG029|Overall Study|Withdrawal by Subject|0|||
105468047|NCT04922216|363722859|FG030|Overall Study|Withdrawal by Subject|1|||
105468048|NCT04922216|363722860|FG031|Overall Study|Withdrawal by Subject|0|||
105468049|NCT04922216|363722829|FG000|Overall Study|Lost to Follow-up|1|||
105468050|NCT04922216|363722830|FG001|Overall Study|Lost to Follow-up|0|||
105468051|NCT04922216|363722831|FG002|Overall Study|Lost to Follow-up|2|||
105468052|NCT04922216|363722832|FG003|Overall Study|Lost to Follow-up|0|||
105468053|NCT04922216|363722833|FG004|Overall Study|Lost to Follow-up|0|||
105468054|NCT04922216|363722834|FG005|Overall Study|Lost to Follow-up|2|||
105468055|NCT04922216|363722835|FG006|Overall Study|Lost to Follow-up|0|||
105468056|NCT04922216|363722836|FG007|Overall Study|Lost to Follow-up|1|||
105468057|NCT04922216|363722837|FG008|Overall Study|Lost to Follow-up|1|||
105468058|NCT04922216|363722838|FG009|Overall Study|Lost to Follow-up|2|||
105468059|NCT04922216|363722839|FG010|Overall Study|Lost to Follow-up|2|||
105468060|NCT04922216|363722840|FG011|Overall Study|Lost to Follow-up|1|||
105468061|NCT04922216|363722841|FG012|Overall Study|Lost to Follow-up|1|||
105468062|NCT04922216|363722842|FG013|Overall Study|Lost to Follow-up|0|||
105468063|NCT04922216|363722843|FG014|Overall Study|Lost to Follow-up|1|||
105468064|NCT04922216|363722844|FG015|Overall Study|Lost to Follow-up|0|||
105468065|NCT04922216|363722845|FG016|Overall Study|Lost to Follow-up|0|||
105468066|NCT04922216|363722846|FG017|Overall Study|Lost to Follow-up|2|||
105468067|NCT04922216|363722847|FG018|Overall Study|Lost to Follow-up|1|||
105468068|NCT04922216|363722848|FG019|Overall Study|Lost to Follow-up|0|||
105468069|NCT04922216|363722849|FG020|Overall Study|Lost to Follow-up|1|||
105468070|NCT04922216|363722850|FG021|Overall Study|Lost to Follow-up|0|||
105468071|NCT04922216|363722851|FG022|Overall Study|Lost to Follow-up|2|||
105468072|NCT04922216|363722852|FG023|Overall Study|Lost to Follow-up|1|||
105468073|NCT04922216|363722853|FG024|Overall Study|Lost to Follow-up|0|||
105468074|NCT04922216|363722854|FG025|Overall Study|Lost to Follow-up|2|||
105468075|NCT04922216|363722855|FG026|Overall Study|Lost to Follow-up|0|||
105468076|NCT04922216|363722856|FG027|Overall Study|Lost to Follow-up|0|||
105468077|NCT04922216|363722857|FG028|Overall Study|Lost to Follow-up|1|||
105557047|NCT04154787|364035693|FG000|Overall Study|Subject Decision|0|||
105557048|NCT04154787|364035694|FG001|Overall Study|Subject Decision|1|||
105557049|NCT04154787|364035695|FG002|Overall Study|Subject Decision|0|||
105557050|NCT04154787|364035693|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
105557051|NCT04154787|364035694|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
105557052|NCT04154787|364035695|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
105557053|NCT02858895|364035696|FG000|Overall Study|Disease progression|31|||
105557054|NCT02858895|364035696|FG000|Overall Study|Death|2|||
105557055|NCT02858895|364035696|FG000|Overall Study|Adverse Event|1|||
105557056|NCT02858895|364035696|FG000|Overall Study|Withdrawal by Subject|3|||
105557057|NCT02858895|364035696|FG000|Overall Study|hospice,|1|||
105557058|NCT02858895|364035696|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
105557059|NCT04918784|364037562|FG000|Overall Study|Amputation - no longer eligible|1|||
105557060|NCT04918784|364037563|FG001|Overall Study|Amputation - no longer eligible|2|||
105557061|NCT04918784|364037562|FG000|Overall Study|Death|1|||
105557062|NCT04918784|364037563|FG001|Overall Study|Death|0|||
105557063|NCT04918784|364037562|FG000|Overall Study|patient non-compliance|3|||
105557064|NCT04918784|364037563|FG001|Overall Study|patient non-compliance|1|||
105557065|NCT04918784|364037562|FG000|Overall Study|Adverse Event|1|||
105557066|NCT04918784|364037563|FG001|Overall Study|Adverse Event|0|||
105557067|NCT02119260|364037565|FG000|Overall Study|Adverse Event|1|||
105679168|NCT01253304|364486904|FG002|Overall Study|Adverse Event|0|||
105344102|NCT03729570|363261685|FG000|Overall Study|Found another PrEP provider|1|||
105344103|NCT03729570|363261686|FG001|Overall Study|Found another PrEP provider|0|||
105344104|NCT03729570|363261685|FG000|Overall Study|Did not enjoy being in the control group|0|||
105344105|NCT03729570|363261686|FG001|Overall Study|Did not enjoy being in the control group|1|||
105468078|NCT04922216|363722858|FG029|Overall Study|Lost to Follow-up|0|||
105468079|NCT04922216|363722859|FG030|Overall Study|Lost to Follow-up|2|||
105468080|NCT04922216|363722860|FG031|Overall Study|Lost to Follow-up|1|||
105468081|NCT04610281|363724066|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
105468082|NCT04610281|363724067|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
105468083|NCT02351856|363724068|FG000|Overall Study|Adverse Event|2|||
105468084|NCT02351856|363724068|FG000|Overall Study|Physician Decision|5|||
105468085|NCT02351856|363724068|FG000|Overall Study|Study terminated by sponsor|1|||
105468086|NCT00865566|363724073|FG000|Overall Study|Death|1|||
105468087|NCT00865566|363724074|FG001|Overall Study|Death|11|||
105468088|NCT00865566|363724073|FG000|Overall Study|Lost to Follow-up|314|||
105468089|NCT00865566|363724074|FG001|Overall Study|Lost to Follow-up|315|||
105468090|NCT00865566|363724073|FG000|Overall Study|Withdrawal by Subject|45|||
105468091|NCT00865566|363724074|FG001|Overall Study|Withdrawal by Subject|65|||
105468092|NCT00865566|363724073|FG000|Overall Study|Physician Decision|0|||
105468093|NCT00865566|363724074|FG001|Overall Study|Physician Decision|1|||
105468094|NCT00865566|363724073|FG000|Overall Study|Participant relocated|78|||
105468095|NCT00865566|363724074|FG001|Overall Study|Participant relocated|107|||
105468096|NCT00865566|363724073|FG000|Overall Study|Participant unable to adhere|27|||
105468097|NCT00865566|363724074|FG001|Overall Study|Participant unable to adhere|42|||
105468098|NCT00865566|363724073|FG000|Overall Study|Other; N=245 due to early study closure|154|||
105468099|NCT00865566|363724074|FG001|Overall Study|Other; N=245 due to early study closure|139|||
105468100|NCT00865566|363724073|FG000|Overall Study|HIV infection|5|||
105468101|NCT00865566|363724074|FG001|Overall Study|HIV infection|7|||
105468102|NCT00602472|363724077|FG000|Overall Study|Adverse Event|5|||
105468103|NCT00602472|363724078|FG001|Overall Study|Adverse Event|23|||
105468104|NCT00602472|363724077|FG000|Overall Study|Protocol Violation|4|||
105468105|NCT00602472|363724078|FG001|Overall Study|Protocol Violation|19|||
105468106|NCT00602472|363724077|FG000|Overall Study|Withdrawal by Subject|8|||
105468107|NCT00602472|363724078|FG001|Overall Study|Withdrawal by Subject|14|||
105468108|NCT00602472|363724077|FG000|Overall Study|Other incl. lack of efficacy|4|||
105468109|NCT00602472|363724078|FG001|Overall Study|Other incl. lack of efficacy|2|||
105468110|NCT02803580|363724079|FG000|Overall Study|Death|13|||
105468111|NCT02803580|363724079|FG000|Overall Study|Lost to Follow-up|19|||
105468112|NCT02803580|363724079|FG000|Overall Study|Withdrawal by Subject|3|||
105468113|NCT02803580|363724079|FG000|Overall Study|Inclusion in clinical trial|1|||
105468114|NCT02404025|363724082|FG000|Overall Study|Adverse Event|1|||
105557068|NCT02119260|364037566|FG001|Overall Study|Adverse Event|0|||
105557069|NCT02119260|364037567|FG002|Overall Study|Adverse Event|0|||
105557070|NCT02119260|364037568|FG003|Overall Study|Adverse Event|0|||
105557071|NCT02119260|364037569|FG004|Overall Study|Adverse Event|0|||
105557072|NCT02119260|364037570|FG005|Overall Study|Adverse Event|0|||
105557073|NCT02119260|364037571|FG006|Overall Study|Adverse Event|0|||
105557074|NCT02119260|364037565|FG000|Overall Study|Withdrew consent|0|||
105557075|NCT02119260|364037566|FG001|Overall Study|Withdrew consent|1|||
105557076|NCT02119260|364037567|FG002|Overall Study|Withdrew consent|1|||
105557077|NCT02119260|364037568|FG003|Overall Study|Withdrew consent|0|||
105557078|NCT02119260|364037569|FG004|Overall Study|Withdrew consent|0|||
105557079|NCT02119260|364037570|FG005|Overall Study|Withdrew consent|0|||
105557080|NCT02119260|364037571|FG006|Overall Study|Withdrew consent|0|||
105557081|NCT01258608|364037572|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
105557082|NCT01258608|364037573|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
105557083|NCT01258608|364037572|FG000|Overall Study|Clinical progression|1|||
105557084|NCT01258608|364037573|FG001|Overall Study|Clinical progression|0|||
105557085|NCT01258608|364037572|FG000|Overall Study|Sponsor decision|0|||
105557086|NCT01258608|364037573|FG001|Overall Study|Sponsor decision|1|||
105557087|NCT01258608|364037572|FG000|Overall Study|Physician Decision|6|||
105557088|NCT01258608|364037573|FG001|Overall Study|Physician Decision|1|||
105557089|NCT01258608|364037572|FG000|Overall Study|Lost to Follow-up|0|||
105557090|NCT01258608|364037573|FG001|Overall Study|Lost to Follow-up|1|||
105557091|NCT01258608|364037572|FG000|Overall Study|Lack of compliance|1|||
105557092|NCT01258608|364037573|FG001|Overall Study|Lack of compliance|0|||
105557093|NCT01258608|364037572|FG000|Overall Study|Lack of Efficacy|0|||
105557094|NCT01258608|364037573|FG001|Overall Study|Lack of Efficacy|1|||
105557095|NCT01258608|364037572|FG000|Overall Study|Adverse Event|6|||
105557096|NCT01258608|364037573|FG001|Overall Study|Adverse Event|10|||
105557097|NCT01258608|364037572|FG000|Overall Study|Withdrawal by Subject|6|||
105557098|NCT01258608|364037573|FG001|Overall Study|Withdrawal by Subject|5|||
105557099|NCT04205630|364037577|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
105557100|NCT04205630|364037577|FG000|Overall Study|Disease clinical progression|7|||
105557101|NCT04205630|364037577|FG000|Overall Study|Withdrawal by Subject|2|||
105557102|NCT04205630|364037577|FG000|Overall Study|Adverse Event|17|||
105557103|NCT04205630|364037577|FG000|Overall Study|Other|1|||
105557104|NCT00440531|364037581|FG000|Overall Study|Adverse Event|1|||
105557105|NCT00440531|364037582|FG001|Overall Study|Adverse Event|0|||
105557106|NCT00440531|364037583|FG002|Overall Study|Adverse Event|2|||
105557107|NCT00440531|364037581|FG000|Overall Study|Withdrawal by Subject|2|||
105557108|NCT00440531|364037582|FG001|Overall Study|Withdrawal by Subject|0|||
105557109|NCT00440531|364037583|FG002|Overall Study|Withdrawal by Subject|0|||
105557110|NCT00440531|364037581|FG000|Overall Study|Protocol Violation|1|||
105557111|NCT00440531|364037582|FG001|Overall Study|Protocol Violation|2|||
105557112|NCT00440531|364037583|FG002|Overall Study|Protocol Violation|0|||
105557113|NCT00440531|364037581|FG000|Overall Study|Lost to Follow-up|4|||
105557114|NCT00440531|364037582|FG001|Overall Study|Lost to Follow-up|3|||
105557115|NCT00440531|364037583|FG002|Overall Study|Lost to Follow-up|5|||
105557116|NCT00440531|364037581|FG000|Overall Study|see pre-assignment details|2|||
105557117|NCT00440531|364037582|FG001|Overall Study|see pre-assignment details|0|||
105557118|NCT00440531|364037583|FG002|Overall Study|see pre-assignment details|0|||
105557119|NCT00447057|364037584|FG000|Overall Study|Adverse Event|4|||
105557120|NCT00447057|364037585|FG001|Overall Study|Adverse Event|10|||
105557121|NCT00447057|364037586|FG002|Overall Study|Adverse Event|0|||
105557122|NCT00447057|364037587|FG003|Overall Study|Adverse Event|3|||
105557123|NCT00447057|364037584|FG000|Overall Study|Death due to study disease|6|||
105557124|NCT00447057|364037585|FG001|Overall Study|Death due to study disease|4|||
105557125|NCT00447057|364037586|FG002|Overall Study|Death due to study disease|1|||
105557126|NCT00447057|364037587|FG003|Overall Study|Death due to study disease|1|||
105557127|NCT00447057|364037584|FG000|Overall Study|Lost to Follow-up|0|||
105557128|NCT00447057|364037585|FG001|Overall Study|Lost to Follow-up|1|||
105557129|NCT00447057|364037586|FG002|Overall Study|Lost to Follow-up|0|||
105557130|NCT00447057|364037587|FG003|Overall Study|Lost to Follow-up|0|||
105557131|NCT00447057|364037584|FG000|Overall Study|Entry criteria not met|1|||
105557132|NCT00447057|364037585|FG001|Overall Study|Entry criteria not met|1|||
105557133|NCT00447057|364037586|FG002|Overall Study|Entry criteria not met|0|||
105557134|NCT00447057|364037587|FG003|Overall Study|Entry criteria not met|0|||
105557135|NCT00447057|364037584|FG000|Overall Study|Protocol Violation|0|||
105557136|NCT00447057|364037585|FG001|Overall Study|Protocol Violation|1|||
105557137|NCT00447057|364037586|FG002|Overall Study|Protocol Violation|0|||
105557138|NCT00447057|364037587|FG003|Overall Study|Protocol Violation|0|||
105557139|NCT00447057|364037584|FG000|Overall Study|Withdrawal by Subject|4|||
105557140|NCT00447057|364037585|FG001|Overall Study|Withdrawal by Subject|5|||
105557141|NCT00447057|364037586|FG002|Overall Study|Withdrawal by Subject|1|||
105557142|NCT00447057|364037587|FG003|Overall Study|Withdrawal by Subject|1|||
105557143|NCT00447057|364037584|FG000|Overall Study|Physician Decision|9|||
105557144|NCT00447057|364037585|FG001|Overall Study|Physician Decision|6|||
105557145|NCT00447057|364037586|FG002|Overall Study|Physician Decision|3|||
105557146|NCT00447057|364037587|FG003|Overall Study|Physician Decision|1|||
105557147|NCT00447057|364037584|FG000|Overall Study|Sponsor decision|1|||
105557148|NCT00447057|364037585|FG001|Overall Study|Sponsor decision|1|||
105557149|NCT00447057|364037586|FG002|Overall Study|Sponsor decision|0|||
105557150|NCT00447057|364037587|FG003|Overall Study|Sponsor decision|0|||
105557151|NCT00447057|364037584|FG000|Overall Study|Progressive disease|58|||
105557152|NCT00447057|364037585|FG001|Overall Study|Progressive disease|43|||
105557153|NCT00447057|364037586|FG002|Overall Study|Progressive disease|13|||
105557154|NCT00447057|364037587|FG003|Overall Study|Progressive disease|18|||
105557155|NCT00447057|364037584|FG000|Overall Study|Death due to adverse event|0|||
105557156|NCT00447057|364037585|FG001|Overall Study|Death due to adverse event|0|||
105557157|NCT00447057|364037586|FG002|Overall Study|Death due to adverse event|1|||
105557158|NCT00447057|364037587|FG003|Overall Study|Death due to adverse event|2|||
105557159|NCT00447057|364037584|FG000|Overall Study|Death, study drug related|0|||
105557160|NCT00447057|364037585|FG001|Overall Study|Death, study drug related|1|||
105557161|NCT00447057|364037586|FG002|Overall Study|Death, study drug related|0|||
105557162|NCT00447057|364037587|FG003|Overall Study|Death, study drug related|0|||
105468115|NCT02404025|363724082|FG000|Overall Study|Lack of Efficacy|3|||
105468116|NCT02118961|363724083|FG000|Overall Study|Withdrawal by Subject|1|||
105468117|NCT02118961|363724084|FG001|Overall Study|Withdrawal by Subject|0|||
105468118|NCT00705016|363724087|FG000|Overall Study|Adverse Event|6|||
105468119|NCT00705016|363724088|FG001|Overall Study|Adverse Event|11|||
105468120|NCT00705016|363724089|FG002|Overall Study|Adverse Event|10|||
105468121|NCT00705016|363724087|FG000|Overall Study|Death|5|||
105468122|NCT00705016|363724088|FG001|Overall Study|Death|7|||
105468123|NCT00705016|363724089|FG002|Overall Study|Death|5|||
105468124|NCT00705016|363724087|FG000|Overall Study|Protocol Violation|0|||
105468125|NCT00705016|363724088|FG001|Overall Study|Protocol Violation|1|||
105468126|NCT00705016|363724089|FG002|Overall Study|Protocol Violation|1|||
105468127|NCT00705016|363724087|FG000|Overall Study|Withdrawal by Subject|4|||
105468128|NCT00705016|363724088|FG001|Overall Study|Withdrawal by Subject|3|||
105468129|NCT00705016|363724089|FG002|Overall Study|Withdrawal by Subject|2|||
105468130|NCT00705016|363724087|FG000|Overall Study|Progressive Disease|33|||
105468131|NCT00705016|363724088|FG001|Overall Study|Progressive Disease|29|||
105468132|NCT00705016|363724089|FG002|Overall Study|Progressive Disease|33|||
105468133|NCT00705016|363724087|FG000|Overall Study|Symptomatic Deterioration|3|||
105468134|NCT00705016|363724088|FG001|Overall Study|Symptomatic Deterioration|1|||
105468135|NCT00705016|363724089|FG002|Overall Study|Symptomatic Deterioration|1|||
105468136|NCT00705016|363724087|FG000|Overall Study|Other|9|||
105468137|NCT00705016|363724088|FG001|Overall Study|Other|6|||
105468138|NCT00705016|363724089|FG002|Overall Study|Other|6|||
105468139|NCT02284243|363724090|FG000|Overall Study|Lack of Efficacy|3|||
105468140|NCT02284243|363724091|FG001|Overall Study|Lack of Efficacy|3|||
105468141|NCT02284243|363724090|FG000|Overall Study|Adverse Event|1|||
105468142|NCT02284243|363724091|FG001|Overall Study|Adverse Event|0|||
105468143|NCT01721044|363724097|FG000|Treatment Period|Adverse Event|7|||
105557163|NCT01471054|364037588|FG000|Overall Study|Study terminated prematurely|4|||
105557164|NCT01471054|364037589|FG001|Overall Study|Study terminated prematurely|0|||
105557165|NCT01843192|364037590|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
105557166|NCT01843192|364037591|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
105557167|NCT01843192|364037592|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
105557168|NCT04493216|364037593|FG000|Overall Study|Study terminated by sponsor|30|||
105468144|NCT01721044|363724098|FG001|Treatment Period|Adverse Event|7|||
105468145|NCT01721044|363724099|FG002|Treatment Period|Adverse Event|10|||
105468146|NCT01721044|363724097|FG000|Treatment Period|Death|0|||
105468147|NCT01721044|363724098|FG001|Treatment Period|Death|0|||
105468148|NCT01721044|363724099|FG002|Treatment Period|Death|1|||
105468149|NCT01721044|363724097|FG000|Treatment Period|Lack of Efficacy|16|||
105468150|NCT01721044|363724098|FG001|Treatment Period|Lack of Efficacy|4|||
105468151|NCT01721044|363724099|FG002|Treatment Period|Lack of Efficacy|4|||
105468152|NCT01721044|363724097|FG000|Treatment Period|Lost to Follow-up|0|||
105344106|NCT02083185|363261687|FG000|Overall Study|Lost to Follow-up|0|||
105344107|NCT02083185|363261688|FG001|Overall Study|Lost to Follow-up|3|||
105468153|NCT01721044|363724098|FG001|Treatment Period|Lost to Follow-up|0|||
105468154|NCT01721044|363724099|FG002|Treatment Period|Lost to Follow-up|1|||
105468155|NCT01721044|363724097|FG000|Treatment Period|Physician Decision|1|||
105679169|NCT01253304|364486905|FG003|Overall Study|Adverse Event|1|||
105679170|NCT03932812|364486906|FG000|Overall Study|Lost to Follow-up|12|||
105679171|NCT03932812|364486907|FG001|Overall Study|Lost to Follow-up|14|||
105468156|NCT01721044|363724098|FG001|Treatment Period|Physician Decision|0|||
105468157|NCT01721044|363724099|FG002|Treatment Period|Physician Decision|2|||
105468158|NCT01721044|363724097|FG000|Treatment Period|Protocol Violation|1|||
105468159|NCT01721044|363724098|FG001|Treatment Period|Protocol Violation|0|||
105468160|NCT01721044|363724099|FG002|Treatment Period|Protocol Violation|0|||
105468161|NCT01721044|363724097|FG000|Treatment Period|Withdrawal by Subject|7|||
105468162|NCT01721044|363724098|FG001|Treatment Period|Withdrawal by Subject|6|||
105468163|NCT01721044|363724099|FG002|Treatment Period|Withdrawal by Subject|1|||
105468164|NCT03155841|363724100|FG000|Overall Study|Protocol Violation|3|||
105468165|NCT03155841|363724101|FG001|Overall Study|Protocol Violation|4|||
105468166|NCT01526733|363724102|FG000|Phase 1|Protocol Violation|1|||
105468167|NCT01526733|363724103|FG001|Phase 1|Protocol Violation|0|||
105468168|NCT01526733|363724102|FG000|Phase 1|Withdrawal by Subject|1|||
105468169|NCT01526733|363724103|FG001|Phase 1|Withdrawal by Subject|1|||
105468170|NCT04032093|363724106|FG000|Overall Study|Lost to Follow-up|7|||
105468171|NCT04032093|363724107|FG001|Overall Study|Lost to Follow-up|7|||
105468172|NCT04032093|363724108|FG002|Overall Study|Lost to Follow-up|6|||
105468173|NCT04032093|363724109|FG003|Overall Study|Lost to Follow-up|10|||
105468174|NCT04032093|363724110|FG004|Overall Study|Lost to Follow-up|13|||
105468175|NCT04032093|363724111|FG005|Overall Study|Lost to Follow-up|7|||
105468176|NCT04032093|363724112|FG006|Overall Study|Lost to Follow-up|7|||
105468177|NCT04032093|363724113|FG007|Overall Study|Lost to Follow-up|5|||
105468178|NCT04032093|363724114|FG008|Overall Study|Lost to Follow-up|9|||
105468179|NCT04032093|363724115|FG009|Overall Study|Lost to Follow-up|12|||
105468180|NCT04032093|363724106|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
105468181|NCT04032093|363724107|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
105468182|NCT04032093|363724108|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
105468183|NCT04032093|363724109|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
105344108|NCT02083185|363261689|FG002|Overall Study|Lost to Follow-up|0|||
105344109|NCT02083185|363261687|FG000|Overall Study|Withdrawal by Subject|9|||
105468184|NCT04032093|363724110|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
105468185|NCT04032093|363724111|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
105679172|NCT03932812|364486906|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
105679173|NCT03932812|364486907|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
105468186|NCT04032093|363724112|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
105468187|NCT04032093|363724113|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
105468188|NCT04032093|363724114|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
105468189|NCT04032093|363724115|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
105468190|NCT04032093|363724106|FG000|Overall Study|Other|1|||
105468191|NCT04032093|363724107|FG001|Overall Study|Other|0|||
105468192|NCT04032093|363724108|FG002|Overall Study|Other|0|||
105468193|NCT04032093|363724109|FG003|Overall Study|Other|1|||
105468194|NCT04032093|363724110|FG004|Overall Study|Other|1|||
105468195|NCT04032093|363724111|FG005|Overall Study|Other|0|||
105468196|NCT04032093|363724112|FG006|Overall Study|Other|0|||
105468197|NCT04032093|363724113|FG007|Overall Study|Other|0|||
105468198|NCT04032093|363724114|FG008|Overall Study|Other|0|||
105468199|NCT04032093|363724115|FG009|Overall Study|Other|1|||
105468200|NCT04032093|363724106|FG000|Overall Study|Withdrawal by Subject|1|||
105679174|NCT01156792|364486917|FG000|Overall Study|Adverse Event|1|||
105468201|NCT04032093|363724107|FG001|Overall Study|Withdrawal by Subject|3|||
105557169|NCT04493216|364037594|FG001|Overall Study|Study terminated by sponsor|33|||
105557170|NCT04493216|364037595|FG002|Overall Study|Study terminated by sponsor|28|||
105557171|NCT04493216|364037596|FG003|Overall Study|Study terminated by sponsor|27|||
105557172|NCT04493216|364037593|FG000|Overall Study|Withdrawal by Subject|2|||
105557173|NCT04493216|364037594|FG001|Overall Study|Withdrawal by Subject|1|||
105557174|NCT04493216|364037595|FG002|Overall Study|Withdrawal by Subject|1|||
105557175|NCT04493216|364037596|FG003|Overall Study|Withdrawal by Subject|2|||
105557176|NCT04493216|364037593|FG000|Overall Study|Protocol Violation|1|||
105557177|NCT04493216|364037594|FG001|Overall Study|Protocol Violation|2|||
105557178|NCT04493216|364037595|FG002|Overall Study|Protocol Violation|0|||
105557179|NCT04493216|364037596|FG003|Overall Study|Protocol Violation|2|||
105557180|NCT04493216|364037593|FG000|Overall Study|Physician Decision|0|||
105557181|NCT04493216|364037594|FG001|Overall Study|Physician Decision|0|||
105557182|NCT04493216|364037595|FG002|Overall Study|Physician Decision|1|||
105557183|NCT04493216|364037596|FG003|Overall Study|Physician Decision|0|||
105557184|NCT04493216|364037593|FG000|Overall Study|Lost to Follow-up|2|||
105557185|NCT04493216|364037594|FG001|Overall Study|Lost to Follow-up|1|||
105557186|NCT04493216|364037595|FG002|Overall Study|Lost to Follow-up|0|||
105557187|NCT04493216|364037596|FG003|Overall Study|Lost to Follow-up|1|||
105557188|NCT04493216|364037593|FG000|Overall Study|Adverse Event|1|||
105557189|NCT04493216|364037594|FG001|Overall Study|Adverse Event|4|||
105557190|NCT04493216|364037595|FG002|Overall Study|Adverse Event|5|||
105557191|NCT04493216|364037596|FG003|Overall Study|Adverse Event|2|||
105557192|NCT04493216|364037593|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
105557193|NCT04493216|364037594|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
105557194|NCT04493216|364037595|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
105557195|NCT04493216|364037596|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
105557196|NCT02181803|364037599|FG000|Overall Study|Withdrawal by Subject|0|||
105557197|NCT02181803|364037600|FG001|Overall Study|Withdrawal by Subject|2|||
105557198|NCT02181803|364037601|FG002|Overall Study|Withdrawal by Subject|0|||
105557199|NCT02181803|364037602|FG003|Overall Study|Withdrawal by Subject|0|||
105557200|NCT02181803|364037603|FG004|Overall Study|Withdrawal by Subject|0|||
105557201|NCT02181803|364037604|FG005|Overall Study|Withdrawal by Subject|0|||
105557202|NCT02181803|364037605|FG006|Overall Study|Withdrawal by Subject|0|||
105557203|NCT02181803|364037606|FG007|Overall Study|Withdrawal by Subject|0|||
105557204|NCT02181803|364037607|FG008|Overall Study|Withdrawal by Subject|0|||
105557205|NCT02181803|364037599|FG000|Overall Study|Physician Decision|0|||
105468202|NCT04032093|363724108|FG002|Overall Study|Withdrawal by Subject|2|||
105468203|NCT04032093|363724109|FG003|Overall Study|Withdrawal by Subject|2|||
105468204|NCT04032093|363724110|FG004|Overall Study|Withdrawal by Subject|3|||
105468205|NCT04032093|363724111|FG005|Overall Study|Withdrawal by Subject|0|||
105468206|NCT04032093|363724112|FG006|Overall Study|Withdrawal by Subject|0|||
105468207|NCT04032093|363724113|FG007|Overall Study|Withdrawal by Subject|0|||
105468208|NCT04032093|363724114|FG008|Overall Study|Withdrawal by Subject|0|||
105468209|NCT04032093|363724115|FG009|Overall Study|Withdrawal by Subject|0|||
105468210|NCT04032093|363724106|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105468211|NCT04032093|363724107|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105468212|NCT04032093|363724108|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105468213|NCT04032093|363724109|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
105468214|NCT04032093|363724110|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
105468215|NCT04032093|363724111|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
105468216|NCT04032093|363724112|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
105468217|NCT04032093|363724113|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
105468218|NCT04032093|363724114|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
105468219|NCT04032093|363724115|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
105468220|NCT04032093|363724106|FG000|Overall Study|Adverse Event|0|||
105468221|NCT04032093|363724107|FG001|Overall Study|Adverse Event|0|||
105468222|NCT04032093|363724108|FG002|Overall Study|Adverse Event|0|||
105468223|NCT04032093|363724109|FG003|Overall Study|Adverse Event|0|||
105468224|NCT04032093|363724110|FG004|Overall Study|Adverse Event|0|||
105468225|NCT04032093|363724111|FG005|Overall Study|Adverse Event|0|||
105468226|NCT04032093|363724112|FG006|Overall Study|Adverse Event|0|||
105557206|NCT02181803|364037600|FG001|Overall Study|Physician Decision|0|||
105468227|NCT04032093|363724113|FG007|Overall Study|Adverse Event|0|||
105557207|NCT02181803|364037601|FG002|Overall Study|Physician Decision|0|||
105557208|NCT02181803|364037602|FG003|Overall Study|Physician Decision|1|||
105557209|NCT02181803|364037603|FG004|Overall Study|Physician Decision|0|||
105557210|NCT02181803|364037604|FG005|Overall Study|Physician Decision|0|||
105468228|NCT04032093|363724114|FG008|Overall Study|Adverse Event|0|||
105557211|NCT02181803|364037605|FG006|Overall Study|Physician Decision|0|||
105557212|NCT02181803|364037606|FG007|Overall Study|Physician Decision|1|||
105557213|NCT02181803|364037607|FG008|Overall Study|Physician Decision|0|||
105557214|NCT02181803|364037599|FG000|Overall Study|Adverse Event|0|||
105557215|NCT02181803|364037600|FG001|Overall Study|Adverse Event|2|||
105557216|NCT02181803|364037601|FG002|Overall Study|Adverse Event|0|||
105468229|NCT04032093|363724115|FG009|Overall Study|Adverse Event|1|||
105557217|NCT02181803|364037602|FG003|Overall Study|Adverse Event|1|||
105557218|NCT02181803|364037603|FG004|Overall Study|Adverse Event|0|||
105557219|NCT02181803|364037604|FG005|Overall Study|Adverse Event|0|||
105557220|NCT02181803|364037605|FG006|Overall Study|Adverse Event|1|||
105557221|NCT02181803|364037606|FG007|Overall Study|Adverse Event|0|||
105557222|NCT02181803|364037607|FG008|Overall Study|Adverse Event|0|||
105557223|NCT02525874|364037615|FG000|Overall Study|Other|1|||
105557224|NCT02525874|364037615|FG000|Overall Study|Investigator Decision|1|||
105557225|NCT02525874|364037615|FG000|Overall Study|Consent withdrawn|22|||
105557226|NCT02525874|364037615|FG000|Overall Study|Non-compliance with study drug|3|||
105557227|NCT02525874|364037615|FG000|Overall Study|Adverse Event|17|||
105557228|NCT02525874|364037615|FG000|Overall Study|Lost to Follow-up|7|||
105557229|NCT02525874|364037615|FG000|Overall Study|Disease progression, defined by protocol|2|||
105557230|NCT02525874|364037615|FG000|Overall Study|Disease relapse|4|||
105557231|NCT02525874|364037615|FG000|Overall Study|Alternative Treatment for MS|2|||
105557232|NCT02525874|364037615|FG000|Overall Study|New lesions in Brain|1|||
105557233|NCT01692782|364037617|FG000|Overall Study|Adverse Event|12|||
105557234|NCT01692782|364037618|FG001|Overall Study|Adverse Event|32|||
105557235|NCT01692782|364037619|FG002|Overall Study|Adverse Event|2|||
105557236|NCT01692782|364037617|FG000|Overall Study|Lack of Efficacy|1|||
105557237|NCT01692782|364037618|FG001|Overall Study|Lack of Efficacy|2|||
105557238|NCT01692782|364037619|FG002|Overall Study|Lack of Efficacy|0|||
105557239|NCT01692782|364037617|FG000|Overall Study|Lost to Follow-up|2|||
105557240|NCT01692782|364037618|FG001|Overall Study|Lost to Follow-up|7|||
105557241|NCT01692782|364037619|FG002|Overall Study|Lost to Follow-up|1|||
105557242|NCT01692782|364037617|FG000|Overall Study|Pregnancy|1|||
105557243|NCT01692782|364037618|FG001|Overall Study|Pregnancy|0|||
105557244|NCT01692782|364037619|FG002|Overall Study|Pregnancy|0|||
105557245|NCT01692782|364037617|FG000|Overall Study|Protocol Violation|1|||
105557246|NCT01692782|364037618|FG001|Overall Study|Protocol Violation|0|||
105557247|NCT01692782|364037619|FG002|Overall Study|Protocol Violation|2|||
105557248|NCT01692782|364037617|FG000|Overall Study|Non-complance with study drug|0|||
105557249|NCT01692782|364037618|FG001|Overall Study|Non-complance with study drug|4|||
105557250|NCT01692782|364037619|FG002|Overall Study|Non-complance with study drug|1|||
105557251|NCT01692782|364037617|FG000|Overall Study|Non-compliant with study visits|0|||
105557252|NCT01692782|364037618|FG001|Overall Study|Non-compliant with study visits|0|||
105557253|NCT01692782|364037619|FG002|Overall Study|Non-compliant with study visits|1|||
105557254|NCT01692782|364037617|FG000|Overall Study|SAE not related to study drug|0|||
105557255|NCT01692782|364037618|FG001|Overall Study|SAE not related to study drug|1|||
105557256|NCT01692782|364037619|FG002|Overall Study|SAE not related to study drug|0|||
105557257|NCT01692782|364037617|FG000|Overall Study|Withdrawal by Subject|3|||
105557258|NCT01692782|364037618|FG001|Overall Study|Withdrawal by Subject|10|||
105557259|NCT01692782|364037619|FG002|Overall Study|Withdrawal by Subject|3|||
105557260|NCT02794285|364037620|FG000|Overall Study|Adverse Event|11|||
105557261|NCT02794285|364037621|FG001|Overall Study|Adverse Event|4|||
105557262|NCT02794285|364037622|FG002|Overall Study|Adverse Event|5|||
105557263|NCT02794285|364037623|FG003|Overall Study|Adverse Event|8|||
105557264|NCT02794285|364037620|FG000|Overall Study|Condition Under Investigation Improved|1|||
105679175|NCT01156792|364486917|FG000|Overall Study|Lack of Efficacy|36|||
105468230|NCT04032093|363724106|FG000|Overall Study|Physician Decision|0|||
105468231|NCT04032093|363724107|FG001|Overall Study|Physician Decision|0|||
105468232|NCT04032093|363724108|FG002|Overall Study|Physician Decision|0|||
105468233|NCT04032093|363724109|FG003|Overall Study|Physician Decision|0|||
105468234|NCT04032093|363724110|FG004|Overall Study|Physician Decision|0|||
105468235|NCT04032093|363724111|FG005|Overall Study|Physician Decision|1|||
105468236|NCT04032093|363724112|FG006|Overall Study|Physician Decision|0|||
105468237|NCT04032093|363724113|FG007|Overall Study|Physician Decision|0|||
105468238|NCT04032093|363724114|FG008|Overall Study|Physician Decision|0|||
105557265|NCT02794285|364037621|FG001|Overall Study|Condition Under Investigation Improved|0|||
105557266|NCT02794285|364037622|FG002|Overall Study|Condition Under Investigation Improved|0|||
105557267|NCT02794285|364037623|FG003|Overall Study|Condition Under Investigation Improved|0|||
105557268|NCT02794285|364037620|FG000|Overall Study|Condition Under Investigation Worsened|0|||
105557269|NCT02794285|364037621|FG001|Overall Study|Condition Under Investigation Worsened|2|||
105557270|NCT02794285|364037622|FG002|Overall Study|Condition Under Investigation Worsened|1|||
105557271|NCT02794285|364037623|FG003|Overall Study|Condition Under Investigation Worsened|0|||
105557272|NCT02794285|364037620|FG000|Overall Study|Death|2|||
105557273|NCT02794285|364037621|FG001|Overall Study|Death|1|||
105557274|NCT02794285|364037622|FG002|Overall Study|Death|2|||
105557275|NCT02794285|364037623|FG003|Overall Study|Death|0|||
105679176|NCT01156792|364486917|FG000|Overall Study|Protocol Violation|6|||
105468239|NCT04032093|363724115|FG009|Overall Study|Physician Decision|0|||
105468240|NCT04139018|363724119|FG000|Overall Study|Screen fail|1|||
105468241|NCT04139018|363724120|FG001|Overall Study|Screen fail|0|||
105557276|NCT02794285|364037620|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
105557277|NCT02794285|364037621|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
105557278|NCT02794285|364037622|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
105679177|NCT01156792|364486917|FG000|Overall Study|Lost to Follow-up|3|||
105344110|NCT02083185|363261688|FG001|Overall Study|Withdrawal by Subject|15|||
105344111|NCT02083185|363261689|FG002|Overall Study|Withdrawal by Subject|1|||
105344112|NCT02083185|363261687|FG000|Overall Study|Death|2|||
105344113|NCT02083185|363261688|FG001|Overall Study|Death|2|||
105344114|NCT02083185|363261689|FG002|Overall Study|Death|1|||
105344115|NCT02083185|363261687|FG000|Overall Study|Reason not Specified|9|||
105468242|NCT04139018|363724119|FG000|Overall Study|Withdrawal by Subject|2|||
105468243|NCT04139018|363724120|FG001|Overall Study|Withdrawal by Subject|0|||
105468244|NCT04139018|363724119|FG000|Overall Study|Lost to Follow-up|0|||
105468245|NCT04139018|363724120|FG001|Overall Study|Lost to Follow-up|1|||
105468246|NCT01147874|363724122|FG000|Overall Study|Adverse Event|5|||
105468247|NCT01147874|363724122|FG000|Overall Study|Investigator's Request|1|||
105468248|NCT01147874|363724122|FG000|Overall Study|Lost to Follow-up|25|||
105468249|NCT01147874|363724122|FG000|Overall Study|Other|5|||
105468250|NCT01147874|363724122|FG000|Overall Study|Protocol Violation|5|||
105468251|NCT01147874|363724122|FG000|Overall Study|Sponsor's Decision|2|||
105468252|NCT01147874|363724122|FG000|Overall Study|Withdrawal by Subject|24|||
105468253|NCT02721966|363724125|FG000|Overall Study|Protocol Violation|1|||
105468254|NCT02721966|363724126|FG001|Overall Study|Protocol Violation|0|||
105468255|NCT02721966|363724127|FG002|Overall Study|Protocol Violation|0|||
105468256|NCT02721966|363724128|FG003|Overall Study|Protocol Violation|0|||
105468257|NCT02721966|363724129|FG004|Overall Study|Protocol Violation|0|||
105468258|NCT02721966|363724125|FG000|Overall Study|Withdrawal by Subject|9|||
105468259|NCT02721966|363724126|FG001|Overall Study|Withdrawal by Subject|2|||
105468260|NCT02721966|363724127|FG002|Overall Study|Withdrawal by Subject|3|||
105468261|NCT02721966|363724128|FG003|Overall Study|Withdrawal by Subject|7|||
105468262|NCT02721966|363724129|FG004|Overall Study|Withdrawal by Subject|0|||
105468263|NCT02721966|363724125|FG000|Overall Study|Adverse Event|4|||
105468264|NCT02721966|363724126|FG001|Overall Study|Adverse Event|4|||
105468265|NCT02721966|363724127|FG002|Overall Study|Adverse Event|3|||
105468266|NCT02721966|363724128|FG003|Overall Study|Adverse Event|0|||
105468267|NCT02721966|363724129|FG004|Overall Study|Adverse Event|0|||
105468268|NCT02721966|363724125|FG000|Overall Study|Death|1|||
105468269|NCT02721966|363724126|FG001|Overall Study|Death|0|||
105468270|NCT02721966|363724127|FG002|Overall Study|Death|0|||
105468271|NCT02721966|363724128|FG003|Overall Study|Death|0|||
105468272|NCT02721966|363724129|FG004|Overall Study|Death|0|||
105468273|NCT02721966|363724125|FG000|Overall Study|Lack of Efficacy|7|||
105468274|NCT02721966|363724126|FG001|Overall Study|Lack of Efficacy|4|||
105468275|NCT02721966|363724127|FG002|Overall Study|Lack of Efficacy|0|||
105468276|NCT02721966|363724128|FG003|Overall Study|Lack of Efficacy|0|||
105468277|NCT02721966|363724129|FG004|Overall Study|Lack of Efficacy|0|||
105468278|NCT02721966|363724125|FG000|Overall Study|Lost to Follow-up|0|||
105468279|NCT02721966|363724126|FG001|Overall Study|Lost to Follow-up|0|||
105468280|NCT02721966|363724127|FG002|Overall Study|Lost to Follow-up|3|||
105468281|NCT02721966|363724128|FG003|Overall Study|Lost to Follow-up|0|||
105468282|NCT02721966|363724129|FG004|Overall Study|Lost to Follow-up|0|||
105468283|NCT02721966|363724125|FG000|Overall Study|Physician Decision|1|||
105344116|NCT02083185|363261688|FG001|Overall Study|Reason not Specified|6|||
105344117|NCT02083185|363261689|FG002|Overall Study|Reason not Specified|5|||
105344118|NCT02083185|363261687|FG000|Overall Study|Study Terminated by Sponsor|0|||
105344119|NCT02083185|363261688|FG001|Overall Study|Study Terminated by Sponsor|1|||
105344120|NCT02083185|363261689|FG002|Overall Study|Study Terminated by Sponsor|0|||
105344121|NCT02083185|363261687|FG000|Overall Study|Did not Receive Study Drug|0|||
105344122|NCT02083185|363261688|FG001|Overall Study|Did not Receive Study Drug|2|||
105344123|NCT02083185|363261689|FG002|Overall Study|Did not Receive Study Drug|0|||
105344124|NCT00459706|363261692|FG000|Overall Study|Adverse Event|19|||
105344125|NCT00459706|363261693|FG001|Overall Study|Adverse Event|13|||
105344126|NCT00459706|363261692|FG000|Overall Study|Withdrawal by Subject|1|||
105344127|NCT00459706|363261693|FG001|Overall Study|Withdrawal by Subject|6|||
105344128|NCT00459706|363261692|FG000|Overall Study|Physician Decision|2|||
105344129|NCT00459706|363261693|FG001|Overall Study|Physician Decision|0|||
105344130|NCT00459706|363261692|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
105468284|NCT02721966|363724126|FG001|Overall Study|Physician Decision|1|||
105468285|NCT02721966|363724127|FG002|Overall Study|Physician Decision|0|||
105468286|NCT02721966|363724128|FG003|Overall Study|Physician Decision|0|||
105468287|NCT02721966|363724129|FG004|Overall Study|Physician Decision|0|||
105468288|NCT02721966|363724125|FG000|Overall Study|Pregnancy|1|||
105468289|NCT02721966|363724126|FG001|Overall Study|Pregnancy|0|||
105468290|NCT02721966|363724127|FG002|Overall Study|Pregnancy|0|||
105468291|NCT02721966|363724128|FG003|Overall Study|Pregnancy|0|||
105344131|NCT00459706|363261693|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
105344132|NCT00459706|363261692|FG000|Overall Study|Protocol Violation|2|||
105344133|NCT00459706|363261693|FG001|Overall Study|Protocol Violation|1|||
105344134|NCT00459706|363261692|FG000|Overall Study|Failed to Return|1|||
105344135|NCT00459706|363261693|FG001|Overall Study|Failed to Return|0|||
105344136|NCT00459706|363261692|FG000|Overall Study|Other|0|||
105468292|NCT02721966|363724129|FG004|Overall Study|Pregnancy|0|||
105468293|NCT02721966|363724125|FG000|Overall Study|Did not continue to period 2|5|||
105468294|NCT02721966|363724126|FG001|Overall Study|Did not continue to period 2|12|||
105468295|NCT02721966|363724127|FG002|Overall Study|Did not continue to period 2|0|||
105468296|NCT02721966|363724128|FG003|Overall Study|Did not continue to period 2|0|||
105468297|NCT02721966|363724129|FG004|Overall Study|Did not continue to period 2|5|||
105468298|NCT00467753|363724130|FG000|Overall Study|Lost to Follow-up|1|||
105468299|NCT00467753|363724131|FG001|Overall Study|Lost to Follow-up|2|||
105468300|NCT00467753|363724130|FG000|Overall Study|Adverse Event|2|||
105468301|NCT00467753|363724131|FG001|Overall Study|Adverse Event|0|||
105468302|NCT01869764|363724132|FG000|Overall Study|Withdrawal by Subject|0|||
105468303|NCT01869764|363724133|FG001|Overall Study|Withdrawal by Subject|2|||
105468304|NCT02175030|363724134|FG000|Overall Study|Failed screen after consent|7|||
105468305|NCT02175030|363724135|FG001|Overall Study|Failed screen after consent|6|||
105468306|NCT02175030|363724134|FG000|Overall Study|Failed IUD Insertion|20|||
105468307|NCT02175030|363724135|FG001|Overall Study|Failed IUD Insertion|21|||
105468308|NCT02175030|363724134|FG000|Overall Study|Physician Decision|1|||
105468309|NCT02175030|363724135|FG001|Overall Study|Physician Decision|1|||
105468310|NCT02175030|363724134|FG000|Overall Study|Lost to Follow-up|6|||
105468311|NCT02175030|363724135|FG001|Overall Study|Lost to Follow-up|6|||
105468312|NCT02175030|363724134|FG000|Overall Study|Withdrawal by Subject|1|||
105468313|NCT02175030|363724135|FG001|Overall Study|Withdrawal by Subject|4|||
105468314|NCT01286480|363724138|FG000|Overall Study|Withdrawal by Subject|5|||
105557279|NCT02794285|364037623|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
105557280|NCT02794285|364037620|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
105557281|NCT02794285|364037621|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
105557282|NCT02794285|364037622|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
105557283|NCT02794285|364037623|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
105557284|NCT02794285|364037620|FG000|Overall Study|Lack of Efficacy|10|||
105557285|NCT02794285|364037621|FG001|Overall Study|Lack of Efficacy|6|||
105557286|NCT02794285|364037622|FG002|Overall Study|Lack of Efficacy|3|||
105557287|NCT02794285|364037623|FG003|Overall Study|Lack of Efficacy|3|||
105557288|NCT02794285|364037620|FG000|Overall Study|Lost to Follow-up|5|||
105557289|NCT02794285|364037621|FG001|Overall Study|Lost to Follow-up|6|||
105557290|NCT02794285|364037622|FG002|Overall Study|Lost to Follow-up|3|||
105557291|NCT02794285|364037623|FG003|Overall Study|Lost to Follow-up|1|||
105557292|NCT02794285|364037620|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
105468315|NCT01286480|363724139|FG001|Overall Study|Withdrawal by Subject|3|||
105468316|NCT00834093|363724140|FG000|Overall Study|Progressive Disease|3|||
105468317|NCT00834093|363724140|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
105468318|NCT00960999|363724141|FG000|Overall Study|Withdrawal by Subject|1|||
105468319|NCT00960999|363724142|FG001|Overall Study|Withdrawal by Subject|0|||
105468320|NCT00960999|363724141|FG000|Overall Study|Protocol Violation|5|||
105468321|NCT00960999|363724142|FG001|Overall Study|Protocol Violation|2|||
105468322|NCT00960999|363724141|FG000|Overall Study|RT dose constraints not met|2|||
105468323|NCT00960999|363724142|FG001|Overall Study|RT dose constraints not met|0|||
105468324|NCT00888940|363724143|FG000|Overall Study|Adverse Event|12|||
105468325|NCT00888940|363724144|FG001|Overall Study|Adverse Event|3|||
105468326|NCT00888940|363724143|FG000|Overall Study|Lost to Follow-up|5|||
105468327|NCT00888940|363724144|FG001|Overall Study|Lost to Follow-up|5|||
105468328|NCT00888940|363724143|FG000|Overall Study|Randomized Not Treated|11|||
105468329|NCT00888940|363724144|FG001|Overall Study|Randomized Not Treated|13|||
105468330|NCT01578486|363724145|FG000|Overall Study|Physician Decision|3|||
105468331|NCT01578486|363724145|FG000|Overall Study|Withdrawal by Subject|2|||
105468332|NCT04292899|363724146|FG000|Overall Study|Death|21|||
105468333|NCT04292899|363724147|FG001|Overall Study|Death|28|||
105468334|NCT04292899|363724148|FG002|Overall Study|Death|188|||
105468335|NCT04292899|363724149|FG003|Overall Study|Death|371|||
105468336|NCT04292899|363724146|FG000|Overall Study|Lost to Follow-up|8|||
105468337|NCT04292899|363724147|FG001|Overall Study|Lost to Follow-up|4|||
105468338|NCT04292899|363724148|FG002|Overall Study|Lost to Follow-up|22|||
105468339|NCT04292899|363724149|FG003|Overall Study|Lost to Follow-up|235|||
105468340|NCT04292899|363724146|FG000|Overall Study|Withdrew consent|1|||
105468341|NCT04292899|363724147|FG001|Overall Study|Withdrew consent|0|||
105468342|NCT04292899|363724148|FG002|Overall Study|Withdrew consent|11|||
105468343|NCT04292899|363724149|FG003|Overall Study|Withdrew consent|32|||
105468344|NCT04292899|363724146|FG000|Overall Study|Adverse Event|2|||
105468345|NCT04292899|363724147|FG001|Overall Study|Adverse Event|1|||
105468346|NCT04292899|363724148|FG002|Overall Study|Adverse Event|2|||
105468347|NCT04292899|363724149|FG003|Overall Study|Adverse Event|2|||
105468348|NCT04292899|363724146|FG000|Overall Study|Investigator's Discretion|0|||
105468349|NCT04292899|363724147|FG001|Overall Study|Investigator's Discretion|0|||
105468350|NCT04292899|363724148|FG002|Overall Study|Investigator's Discretion|0|||
105468351|NCT04292899|363724149|FG003|Overall Study|Investigator's Discretion|3|||
105468352|NCT04292899|363724146|FG000|Overall Study|Non-compliance With Study Drug|0|||
105468353|NCT04292899|363724147|FG001|Overall Study|Non-compliance With Study Drug|0|||
105468354|NCT04292899|363724148|FG002|Overall Study|Non-compliance With Study Drug|0|||
105468355|NCT04292899|363724149|FG003|Overall Study|Non-compliance With Study Drug|1|||
105468356|NCT04292899|363724146|FG000|Overall Study|Protocol Violation|0|||
105468357|NCT04292899|363724147|FG001|Overall Study|Protocol Violation|0|||
105468358|NCT04292899|363724148|FG002|Overall Study|Protocol Violation|0|||
105557293|NCT02794285|364037621|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
105468359|NCT04292899|363724149|FG003|Overall Study|Protocol Violation|1|||
105557294|NCT02794285|364037622|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
105557295|NCT02794285|364037623|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
105557296|NCT02794285|364037620|FG000|Overall Study|Withdrawal by Subject|38|||
105557297|NCT02794285|364037621|FG001|Overall Study|Withdrawal by Subject|29|||
105557298|NCT02794285|364037622|FG002|Overall Study|Withdrawal by Subject|20|||
105557299|NCT02794285|364037623|FG003|Overall Study|Withdrawal by Subject|12|||
105557300|NCT02794285|364037620|FG000|Overall Study|Missing|1|||
105557301|NCT02794285|364037621|FG001|Overall Study|Missing|0|||
105557302|NCT02794285|364037622|FG002|Overall Study|Missing|0|||
105557303|NCT02794285|364037623|FG003|Overall Study|Missing|0|||
105557304|NCT02794285|364037620|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
105557305|NCT02794285|364037621|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
105557306|NCT02794285|364037622|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
105557307|NCT02794285|364037623|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
105557308|NCT02794285|364037620|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
105557309|NCT02794285|364037621|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
105557310|NCT02794285|364037622|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
105557311|NCT02794285|364037623|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
105557312|NCT02732938|364037624|FG000|Overall Study|Death|0|||
105557313|NCT02732938|364037625|FG001|Overall Study|Death|11|||
105557314|NCT02732938|364037626|FG002|Overall Study|Death|0|||
105557315|NCT02732938|364037624|FG000|Overall Study|Randomized but did not receive treatment|0|||
105557316|NCT02732938|364037625|FG001|Overall Study|Randomized but did not receive treatment|1|||
105557317|NCT02732938|364037626|FG002|Overall Study|Randomized but did not receive treatment|0|||
105557318|NCT02732938|364037624|FG000|Overall Study|Refused further follow-up|1|||
105557319|NCT02732938|364037625|FG001|Overall Study|Refused further follow-up|0|||
105557320|NCT02732938|364037626|FG002|Overall Study|Refused further follow-up|0|||
105557321|NCT02732938|364037624|FG000|Overall Study|Study terminated by sponsor|3|||
105557322|NCT02732938|364037625|FG001|Overall Study|Study terminated by sponsor|6|||
105557323|NCT02732938|364037626|FG002|Overall Study|Study terminated by sponsor|0|||
105557324|NCT05072080|364037635|FG000|Overall Study|Death|0|||
105557325|NCT05072080|364037636|FG001|Overall Study|Death|0|||
105557326|NCT05072080|364037637|FG002|Overall Study|Death|1|||
105557327|NCT05072080|364037638|FG003|Overall Study|Death|0|||
105557328|NCT05072080|364037635|FG000|Overall Study|Lost to Follow-up|65|||
105557329|NCT05072080|364037636|FG001|Overall Study|Lost to Follow-up|70|||
105557330|NCT05072080|364037637|FG002|Overall Study|Lost to Follow-up|58|||
105557331|NCT05072080|364037638|FG003|Overall Study|Lost to Follow-up|23|||
105557332|NCT05072080|364037635|FG000|Overall Study|Physician Decision|2|||
105557333|NCT05072080|364037636|FG001|Overall Study|Physician Decision|1|||
105557334|NCT05072080|364037637|FG002|Overall Study|Physician Decision|1|||
105557335|NCT05072080|364037638|FG003|Overall Study|Physician Decision|0|||
105557336|NCT05072080|364037635|FG000|Overall Study|Withdrawal by Subject|45|||
105557337|NCT05072080|364037636|FG001|Overall Study|Withdrawal by Subject|30|||
105557338|NCT05072080|364037637|FG002|Overall Study|Withdrawal by Subject|27|||
105557339|NCT05072080|364037638|FG003|Overall Study|Withdrawal by Subject|7|||
105557340|NCT05072080|364037635|FG000|Overall Study|Sponsor Decision|0|||
105557341|NCT05072080|364037636|FG001|Overall Study|Sponsor Decision|1|||
105557342|NCT05072080|364037637|FG002|Overall Study|Sponsor Decision|0|||
105557343|NCT05072080|364037638|FG003|Overall Study|Sponsor Decision|0|||
105557344|NCT05072080|364037635|FG000|Overall Study|Subject moved|1|||
105557345|NCT05072080|364037636|FG001|Overall Study|Subject moved|3|||
105557346|NCT05072080|364037637|FG002|Overall Study|Subject moved|5|||
105557347|NCT05072080|364037638|FG003|Overall Study|Subject moved|2|||
105557348|NCT05072080|364037635|FG000|Overall Study|Withdrawal by parent|0|||
105557349|NCT05072080|364037636|FG001|Overall Study|Withdrawal by parent|0|||
105557350|NCT05072080|364037637|FG002|Overall Study|Withdrawal by parent|1|||
105557351|NCT05072080|364037638|FG003|Overall Study|Withdrawal by parent|0|||
105557352|NCT05072080|364037635|FG000|Overall Study|Subject was deployed|0|||
105557353|NCT05072080|364037636|FG001|Overall Study|Subject was deployed|1|||
105557354|NCT05072080|364037637|FG002|Overall Study|Subject was deployed|0|||
105557355|NCT05072080|364037638|FG003|Overall Study|Subject was deployed|0|||
105557356|NCT05072080|364037635|FG000|Overall Study|Subject left site without receiving dose|0|||
105557357|NCT05072080|364037636|FG001|Overall Study|Subject left site without receiving dose|1|||
105557358|NCT05072080|364037637|FG002|Overall Study|Subject left site without receiving dose|0|||
105557359|NCT05072080|364037638|FG003|Overall Study|Subject left site without receiving dose|0|||
105557360|NCT05072080|364037635|FG000|Overall Study|Subject incarcerated|0|||
105557361|NCT05072080|364037636|FG001|Overall Study|Subject incarcerated|1|||
105557362|NCT05072080|364037637|FG002|Overall Study|Subject incarcerated|0|||
105557363|NCT05072080|364037638|FG003|Overall Study|Subject incarcerated|1|||
105557364|NCT05072080|364037635|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
105679178|NCT01156792|364486917|FG000|Overall Study|Physician Decision|3|||
105679179|NCT01156792|364486917|FG000|Overall Study|Withdrawal by Subject|9|||
105468360|NCT02536963|363724150|FG000|Overall Study|Withdrawal by Subject|18|||
105468361|NCT02425943|363724151|FG000|Overall Study|Adverse Event|3|||
105468362|NCT02425943|363724152|FG001|Overall Study|Adverse Event|1|||
105468363|NCT02425943|363724151|FG000|Overall Study|Lost to Follow-up|59|||
105468364|NCT02425943|363724152|FG001|Overall Study|Lost to Follow-up|37|||
105468365|NCT02425943|363724151|FG000|Overall Study|Protocol Violation|4|||
105468366|NCT02425943|363724152|FG001|Overall Study|Protocol Violation|1|||
105468367|NCT02425943|363724151|FG000|Overall Study|Withdrawal by Subject|64|||
105468368|NCT02425943|363724152|FG001|Overall Study|Withdrawal by Subject|31|||
105468369|NCT02425943|363724151|FG000|Overall Study|Other|6|||
105468370|NCT02425943|363724152|FG001|Overall Study|Other|0|||
105468371|NCT01106248|363724155|FG000|Overall Study|Adverse Event|1|||
105468372|NCT01106248|363724155|FG000|Overall Study|Administrative|2|||
105468373|NCT00357903|363724156|FG000|Overall Study|Adverse Event|87|||
105468374|NCT00357903|363724157|FG001|Overall Study|Adverse Event|4|||
105468375|NCT00357903|363724156|FG000|Overall Study|Death|33|||
105468376|NCT00357903|363724157|FG001|Overall Study|Death|0|||
105468377|NCT00357903|363724156|FG000|Overall Study|Lost to Follow-up|23|||
105468378|NCT00357903|363724157|FG001|Overall Study|Lost to Follow-up|4|||
105468379|NCT00357903|363724156|FG000|Overall Study|Physician Decision|39|||
105468380|NCT00357903|363724157|FG001|Overall Study|Physician Decision|5|||
105468381|NCT00357903|363724156|FG000|Overall Study|Withdrawal by Subject|57|||
105468382|NCT00357903|363724157|FG001|Overall Study|Withdrawal by Subject|7|||
105468383|NCT00357903|363724156|FG000|Overall Study|Completed month 12 only|0|||
105468384|NCT00357903|363724157|FG001|Overall Study|Completed month 12 only|1|||
105468385|NCT00357903|363724156|FG000|Overall Study|Protocol issues|14|||
105468386|NCT00357903|363724157|FG001|Overall Study|Protocol issues|3|||
105468387|NCT00357903|363724156|FG000|Overall Study|Response status|61|||
105468388|NCT00357903|363724157|FG001|Overall Study|Response status|9|||
105468389|NCT00357903|363724156|FG000|Overall Study|Other|49|||
105468390|NCT00357903|363724157|FG001|Overall Study|Other|10|||
105468391|NCT00606593|363724158|FG000|Overall Study|Adverse Event|0|||
105468392|NCT00606593|363724159|FG001|Overall Study|Adverse Event|0|||
105468393|NCT00606593|363724160|FG002|Overall Study|Adverse Event|0|||
105468394|NCT00606593|363724161|FG003|Overall Study|Adverse Event|1|||
105468395|NCT00606593|363724162|FG004|Overall Study|Adverse Event|1|||
105468396|NCT00606593|363724163|FG005|Overall Study|Adverse Event|0|||
105468397|NCT00606593|363724164|FG006|Overall Study|Adverse Event|1|||
105468398|NCT00606593|363724165|FG007|Overall Study|Adverse Event|2|||
105468399|NCT00606593|363724166|FG008|Overall Study|Adverse Event|1|||
105468400|NCT00606593|363724167|FG009|Overall Study|Adverse Event|0|||
105468401|NCT00606593|363724158|FG000|Overall Study|Withdrawal of consent|1|||
105468402|NCT00606593|363724159|FG001|Overall Study|Withdrawal of consent|0|||
105468403|NCT00606593|363724160|FG002|Overall Study|Withdrawal of consent|1|||
105468404|NCT00606593|363724161|FG003|Overall Study|Withdrawal of consent|0|||
105468405|NCT00606593|363724162|FG004|Overall Study|Withdrawal of consent|0|||
105468406|NCT00606593|363724163|FG005|Overall Study|Withdrawal of consent|0|||
105679180|NCT01156792|364486917|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
105468407|NCT00606593|363724164|FG006|Overall Study|Withdrawal of consent|0|||
105468408|NCT00606593|363724165|FG007|Overall Study|Withdrawal of consent|0|||
105468409|NCT00606593|363724166|FG008|Overall Study|Withdrawal of consent|0|||
105468410|NCT00606593|363724167|FG009|Overall Study|Withdrawal of consent|0|||
105468411|NCT00606593|363724158|FG000|Overall Study|Administrative/Other|0|||
105468412|NCT00606593|363724159|FG001|Overall Study|Administrative/Other|0|||
105468413|NCT00606593|363724160|FG002|Overall Study|Administrative/Other|1|||
105468414|NCT00606593|363724161|FG003|Overall Study|Administrative/Other|0|||
105468415|NCT00606593|363724162|FG004|Overall Study|Administrative/Other|0|||
105468416|NCT00606593|363724163|FG005|Overall Study|Administrative/Other|0|||
105468417|NCT00606593|363724164|FG006|Overall Study|Administrative/Other|0|||
105468418|NCT00606593|363724165|FG007|Overall Study|Administrative/Other|0|||
105468419|NCT00606593|363724166|FG008|Overall Study|Administrative/Other|0|||
105468420|NCT00606593|363724167|FG009|Overall Study|Administrative/Other|0|||
105468421|NCT02141204|363724168|FG000|Overall Study|Lost to Follow-up|2|||
105468422|NCT02141204|363724169|FG001|Overall Study|Lost to Follow-up|1|||
105468423|NCT02141204|363724168|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
105468424|NCT02141204|363724169|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
105468425|NCT02141204|363724168|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
105468426|NCT02141204|363724169|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
105468427|NCT02141204|363724168|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
105468428|NCT02141204|363724169|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
105468429|NCT03313037|363724176|FG000|Overall Study|Protocol Violation|4|||
105468430|NCT03313037|363724177|FG001|Overall Study|Protocol Violation|1|||
105468431|NCT03313037|363724176|FG000|Overall Study|Other|1|||
105468432|NCT03313037|363724177|FG001|Overall Study|Other|1|||
105468433|NCT03313037|363724176|FG000|Overall Study|Withdrawal by Subject|4|||
105468434|NCT03313037|363724177|FG001|Overall Study|Withdrawal by Subject|3|||
105468435|NCT03313037|363724176|FG000|Overall Study|No longer meets eligibility criteria|1|||
105468436|NCT03313037|363724177|FG001|Overall Study|No longer meets eligibility criteria|7|||
105468437|NCT03313037|363724176|FG000|Overall Study|Lost to Follow-up|9|||
105468438|NCT03313037|363724177|FG001|Overall Study|Lost to Follow-up|8|||
105468439|NCT03313037|363724176|FG000|Overall Study|Randomized but not treated|1|||
105468440|NCT03313037|363724177|FG001|Overall Study|Randomized but not treated|0|||
105468441|NCT02506244|363724178|FG000|Overall Study|Did not undergo active monitoring|458|||
105468442|NCT02506244|363724179|FG001|Overall Study|Did not undergo active monitoring|459|||
105468443|NCT02506244|363724180|FG002|Overall Study|Did not undergo active monitoring|0|||
105468444|NCT04163016|363724185|FG000|Enrollment|Adverse Event|1|||
105468445|NCT04163016|363724186|FG001|Enrollment|Adverse Event|0|||
105468446|NCT04163016|363724187|FG002|Enrollment|Adverse Event|0|||
105468447|NCT04163016|363724188|FG003|Enrollment|Adverse Event|0|||
105468448|NCT04163016|363724185|FG000|Treatment|Adverse Event|0|||
105468449|NCT04163016|363724186|FG001|Treatment|Adverse Event|1|||
105468450|NCT04163016|363724187|FG002|Treatment|Adverse Event|0|||
105468451|NCT04163016|363724188|FG003|Treatment|Adverse Event|0|||
105468452|NCT04163016|363724185|FG000|Treatment|Withdrawal by Subject|0|||
105468453|NCT04163016|363724186|FG001|Treatment|Withdrawal by Subject|2|||
105468454|NCT04163016|363724187|FG002|Treatment|Withdrawal by Subject|0|||
105468455|NCT04163016|363724188|FG003|Treatment|Withdrawal by Subject|0|||
105468456|NCT04163016|363724185|FG000|Treatment|Indeterminate TB-test|0|||
105468457|NCT04163016|363724186|FG001|Treatment|Indeterminate TB-test|0|||
105468458|NCT04163016|363724187|FG002|Treatment|Indeterminate TB-test|0|||
105468459|NCT04163016|363724188|FG003|Treatment|Indeterminate TB-test|1|||
105468460|NCT04163016|363724185|FG000|Treatment|Participant did not want to continue in study|0|||
105468461|NCT04163016|363724186|FG001|Treatment|Participant did not want to continue in study|0|||
105468462|NCT04163016|363724187|FG002|Treatment|Participant did not want to continue in study|0|||
105468463|NCT04163016|363724188|FG003|Treatment|Participant did not want to continue in study|1|||
105468464|NCT04193189|363724195|FG000|Overall Study|Lost to Follow-up|9|||
105468465|NCT04193189|363724196|FG001|Overall Study|Lost to Follow-up|7|||
105468466|NCT04193189|363724197|FG002|Overall Study|Lost to Follow-up|9|||
105468467|NCT04193189|363724198|FG003|Overall Study|Lost to Follow-up|0|||
105468468|NCT04193189|363724195|FG000|Overall Study|Withdrawal by Subject|1|||
105468469|NCT04193189|363724196|FG001|Overall Study|Withdrawal by Subject|2|||
105468470|NCT04193189|363724197|FG002|Overall Study|Withdrawal by Subject|2|||
105468471|NCT04193189|363724198|FG003|Overall Study|Withdrawal by Subject|0|||
105468472|NCT04193189|363724195|FG000|Overall Study|Death|1|||
105468473|NCT04193189|363724196|FG001|Overall Study|Death|1|||
105468474|NCT04193189|363724197|FG002|Overall Study|Death|0|||
105468475|NCT04193189|363724198|FG003|Overall Study|Death|0|||
105468476|NCT04193189|363724195|FG000|Overall Study|Protocol Violation|0|||
105468477|NCT04193189|363724196|FG001|Overall Study|Protocol Violation|0|||
105468478|NCT04193189|363724197|FG002|Overall Study|Protocol Violation|0|||
105468479|NCT04193189|363724198|FG003|Overall Study|Protocol Violation|1|||
105468480|NCT03474965|363724199|FG000|Overall Study|Pregnancy|1|||
105468481|NCT03474965|363724200|FG001|Overall Study|Pregnancy|0|||
105468482|NCT03474965|363724201|FG002|Overall Study|Pregnancy|0|||
105468483|NCT03474965|363724202|FG003|Overall Study|Pregnancy|0|||
105468484|NCT03474965|363724199|FG000|Overall Study|Lost to Follow-up|0|||
105468485|NCT03474965|363724200|FG001|Overall Study|Lost to Follow-up|0|||
105468486|NCT03474965|363724201|FG002|Overall Study|Lost to Follow-up|1|||
105344137|NCT00459706|363261693|FG001|Overall Study|Other|1|||
105344138|NCT00723190|363261697|FG000|Overall Study|Withdrawal by Subject|45|||
105344139|NCT00723190|363261697|FG000|Overall Study|Lost to Follow-up|37|||
105344140|NCT00723190|363261697|FG000|Overall Study|Adverse Event|18|||
105344141|NCT00723190|363261697|FG000|Overall Study|Lack of Efficacy|16|||
105344142|NCT00723190|363261697|FG000|Overall Study|Protocol Violation|15|||
105344143|NCT00723190|363261697|FG000|Overall Study|Other-Premature Discontinuation|9|||
105344144|NCT00723190|363261697|FG000|Overall Study|Other-Not included in safety population|2|||
105344145|NCT00454818|363261698|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
105344146|NCT00454818|363261699|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
105344147|NCT00454818|363261700|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
105344148|NCT00454818|363261701|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
105344149|NCT00454818|363261702|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
105344150|NCT00454818|363261698|FG000|Phase I: Open-label Dose-escalation|Death|0|||
105344151|NCT00454818|363261699|FG001|Phase I: Open-label Dose-escalation|Death|1|||
105344152|NCT00454818|363261700|FG002|Phase I: Open-label Dose-escalation|Death|0|||
105344153|NCT00454818|363261701|FG003|Phase I: Open-label Dose-escalation|Death|0|||
105344154|NCT00454818|363261702|FG004|Phase I: Open-label Dose-escalation|Death|0|||
105344155|NCT00454818|363261698|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
105344156|NCT00454818|363261699|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
105344157|NCT00454818|363261700|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
105344158|NCT00454818|363261701|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
105344159|NCT00454818|363261702|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
105344160|NCT00454818|363261698|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
105344161|NCT00454818|363261699|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
105344162|NCT00454818|363261700|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
105344163|NCT00454818|363261701|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
105344164|NCT00454818|363261702|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
105344165|NCT00454818|363261698|FG000|Phase 2: Randomized Double-blind|Death|0|||
105344166|NCT00454818|363261699|FG001|Phase 2: Randomized Double-blind|Death|1|||
105344167|NCT00454818|363261700|FG002|Phase 2: Randomized Double-blind|Death|0|||
105344168|NCT00454818|363261701|FG003|Phase 2: Randomized Double-blind|Death|0|||
105344169|NCT00454818|363261702|FG004|Phase 2: Randomized Double-blind|Death|1|||
105344170|NCT00454818|363261698|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
105344171|NCT00454818|363261699|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
105344172|NCT00454818|363261700|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
105344173|NCT00454818|363261701|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
105344174|NCT00454818|363261702|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
105344175|NCT00454818|363261698|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
105344176|NCT00454818|363261699|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
105344177|NCT00454818|363261700|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
105344178|NCT00454818|363261701|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
105344179|NCT00454818|363261702|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
105344180|NCT01384019|363261703|FG000|Overall Study|Withdrawal by Subject|3|||
105344181|NCT01384019|363261704|FG001|Overall Study|Withdrawal by Subject|0|||
105344182|NCT01384019|363261703|FG000|Overall Study|Death|1|||
105344183|NCT01384019|363261704|FG001|Overall Study|Death|0|||
105344184|NCT01384019|363261703|FG000|Overall Study|MRI refusal|6|||
105344185|NCT01384019|363261704|FG001|Overall Study|MRI refusal|6|||
105344186|NCT02505334|363261708|FG000|Main Treatment Period|Adverse Event|3|||
105344187|NCT02505334|363261709|FG001|Main Treatment Period|Adverse Event|3|||
105344188|NCT02505334|363261708|FG000|Main Treatment Period|Lack of Efficacy|7|||
105468487|NCT03474965|363724202|FG003|Overall Study|Lost to Follow-up|0|||
105468488|NCT03474965|363724199|FG000|Overall Study|Death|1|||
105344189|NCT02505334|363261709|FG001|Main Treatment Period|Lack of Efficacy|17|||
105468489|NCT03474965|363724200|FG001|Overall Study|Death|0|||
105468490|NCT03474965|363724201|FG002|Overall Study|Death|0|||
105468491|NCT03474965|363724202|FG003|Overall Study|Death|0|||
105468492|NCT03474965|363724199|FG000|Overall Study|Adverse Event|1|||
105468493|NCT03474965|363724200|FG001|Overall Study|Adverse Event|0|||
105468494|NCT03474965|363724201|FG002|Overall Study|Adverse Event|0|||
105468495|NCT03474965|363724202|FG003|Overall Study|Adverse Event|1|||
105468496|NCT03474965|363724199|FG000|Overall Study|Physician Decision|3|||
105468497|NCT03474965|363724200|FG001|Overall Study|Physician Decision|1|||
105468498|NCT03474965|363724201|FG002|Overall Study|Physician Decision|2|||
105468499|NCT03474965|363724202|FG003|Overall Study|Physician Decision|0|||
105468500|NCT03474965|363724199|FG000|Overall Study|Participant Decision|7|||
105468501|NCT03474965|363724200|FG001|Overall Study|Participant Decision|0|||
105468502|NCT03474965|363724201|FG002|Overall Study|Participant Decision|1|||
105468503|NCT03474965|363724202|FG003|Overall Study|Participant Decision|0|||
105468504|NCT03474965|363724199|FG000|Overall Study|Guardian Decision|4|||
105468505|NCT03474965|363724200|FG001|Overall Study|Guardian Decision|2|||
105468506|NCT03474965|363724201|FG002|Overall Study|Guardian Decision|7|||
105468507|NCT03474965|363724202|FG003|Overall Study|Guardian Decision|2|||
105468508|NCT03349034|363725904|FG000|Overall Study|catheters dislodged during transport|2|||
105468509|NCT03349034|363725905|FG001|Overall Study|catheters dislodged during transport|0|||
105468510|NCT03349034|363725904|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
105468511|NCT03349034|363725905|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
105468512|NCT03349034|363725904|FG000|Overall Study|soft tissue flap used|1|||
105468513|NCT03349034|363725905|FG001|Overall Study|soft tissue flap used|0|||
105468514|NCT03349034|363725904|FG000|Overall Study|Other|0|||
105468515|NCT03349034|363725905|FG001|Overall Study|Other|1|||
105468516|NCT00815659|363725906|FG000|Overall Study|Adverse Event|9|||
105468517|NCT00815659|363725906|FG000|Overall Study|Withdrawal by Subject|9|||
105468518|NCT00815659|363725906|FG000|Overall Study|Lost to Follow-up|4|||
105468519|NCT00815659|363725906|FG000|Overall Study|Protocol Violation|1|||
105468520|NCT01528969|363725907|FG000|Overall Study|absent from the school at baseline|2|||
105468521|NCT01528969|363725908|FG001|Overall Study|absent from the school at baseline|0|||
105468522|NCT01938716|363725914|FG000|Overall Study|Physician Decision|2|||
105468523|NCT01938716|363725914|FG000|Overall Study|Withdrawal by Subject|2|||
105468524|NCT02054104|363725915|FG000|Overall Study|Did not want to continue due to college classes|1|||
105468525|NCT02054104|363725916|FG001|Overall Study|Did not want to continue due to college classes|0|||
105468526|NCT02054104|363725915|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
105468527|NCT02054104|363725916|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
105468528|NCT02054104|363725915|FG000|Overall Study|No evidence of immunologic response|2|||
105468529|NCT02054104|363725916|FG001|Overall Study|No evidence of immunologic response|2|||
105468530|NCT02054104|363725915|FG000|Overall Study|Disease Progression On Study|4|||
105468531|NCT02054104|363725916|FG001|Overall Study|Disease Progression On Study|5|||
105468532|NCT02054104|363725915|FG000|Overall Study|Diagnosis of lymphoma|0|||
105468533|NCT02054104|363725916|FG001|Overall Study|Diagnosis of lymphoma|1|||
105468534|NCT02054104|363725915|FG000|Overall Study|Inconclusive response|0|||
105468535|NCT02054104|363725916|FG001|Overall Study|Inconclusive response|1|||
105468536|NCT01908803|363725917|FG000|Overall Study|Adverse Event|1|||
105468537|NCT01908803|363725918|FG001|Overall Study|Adverse Event|0|||
105468538|NCT01908803|363725917|FG000|Overall Study|Physician Decision|0|||
105468539|NCT01908803|363725918|FG001|Overall Study|Physician Decision|1|||
105468540|NCT01908803|363725917|FG000|Overall Study|Withdrawal by Subject|1|||
105468541|NCT01908803|363725918|FG001|Overall Study|Withdrawal by Subject|0|||
105468542|NCT01908803|363725917|FG000|Overall Study|Randomization Error|1|||
105468543|NCT01908803|363725918|FG001|Overall Study|Randomization Error|0|||
105468544|NCT01908803|363725917|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
105468545|NCT01908803|363725918|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
105468546|NCT01864603|363725923|FG000|Stage 2|DSMB design modification|86056|||
105468547|NCT01864603|363725924|FG001|Stage 2|DSMB design modification|92558|||
105468548|NCT00098813|363725925|FG000|Overall Study|Death|8|||
105468549|NCT00098813|363725925|FG000|Overall Study|Protocol Violation|1|||
105468550|NCT00098813|363725925|FG000|Overall Study|Withdrawal by Subject|7|||
105468551|NCT00098813|363725925|FG000|Overall Study|Progression of Disease|1|||
105468552|NCT00098813|363725925|FG000|Overall Study|Other complicating disease|1|||
105468553|NCT00098813|363725925|FG000|Overall Study|Reversal of RAI resistance|1|||
105468554|NCT02446899|363725927|FG000|Overall Study|Adverse Event|4|||
105468555|NCT02446899|363725928|FG001|Overall Study|Adverse Event|7|||
105468556|NCT02446899|363725927|FG000|Overall Study|Condition Under Investigation Worsened|1|||
105468557|NCT02446899|363725928|FG001|Overall Study|Condition Under Investigation Worsened|4|||
105468558|NCT02446899|363725927|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
105468559|NCT02446899|363725928|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
105468560|NCT02446899|363725927|FG000|Overall Study|Lack of Efficacy|2|||
105468561|NCT02446899|363725928|FG001|Overall Study|Lack of Efficacy|8|||
105468562|NCT02446899|363725927|FG000|Overall Study|Lost to Follow-up|1|||
105468563|NCT02446899|363725928|FG001|Overall Study|Lost to Follow-up|3|||
105557365|NCT05072080|364037636|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
105557366|NCT05072080|364037637|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
105557367|NCT05072080|364037638|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
105557368|NCT05072080|364037635|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
105557369|NCT05072080|364037636|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
105557370|NCT05072080|364037637|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
105557371|NCT05072080|364037638|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
105557372|NCT05554237|364037643|FG000|Part 2 (7 Days)|Adverse Event|0|||
105557373|NCT05554237|364037644|FG001|Part 2 (7 Days)|Adverse Event|0|||
105557374|NCT05554237|364037645|FG002|Part 2 (7 Days)|Adverse Event|0|||
105557375|NCT05554237|364037646|FG003|Part 2 (7 Days)|Adverse Event|0|||
105557376|NCT05554237|364037647|FG004|Part 2 (7 Days)|Adverse Event|2|||
105557377|NCT05554237|364037648|FG005|Part 2 (7 Days)|Adverse Event|0|||
105557378|NCT05554237|364037649|FG006|Part 2 (7 Days)|Adverse Event|0|||
105557379|NCT05554237|364037650|FG007|Part 2 (7 Days)|Adverse Event|0|||
105557380|NCT05554237|364037651|FG008|Part 2 (7 Days)|Adverse Event|0|||
105557381|NCT05554237|364037652|FG009|Part 2 (7 Days)|Adverse Event|1|||
105557382|NCT05554237|364037653|FG010|Part 2 (7 Days)|Adverse Event|0|||
105557383|NCT05554237|364037654|FG011|Part 2 (7 Days)|Adverse Event|0|||
105557384|NCT05554237|364037655|FG012|Part 2 (7 Days)|Adverse Event|1|||
105557385|NCT05554237|364037656|FG013|Part 2 (7 Days)|Adverse Event|0|||
105557386|NCT01324271|364037659|FG000|Overall Study|Lost to Follow-up|3|||
105557387|NCT01324271|364037660|FG001|Overall Study|Lost to Follow-up|0|||
105557388|NCT01324271|364037659|FG000|Overall Study|Physician Decision|1|||
105557389|NCT01324271|364037660|FG001|Overall Study|Physician Decision|0|||
105557390|NCT05130970|364037661|FG000|Overall Study|Adverse Event|1|||
105557391|NCT05130970|364037662|FG001|Overall Study|Adverse Event|1|||
105557392|NCT05130970|364037661|FG000|Overall Study|Death|0|||
105557393|NCT05130970|364037662|FG001|Overall Study|Death|1|||
105557394|NCT05130970|364037661|FG000|Overall Study|Lost to Follow-up|0|||
105557395|NCT05130970|364037662|FG001|Overall Study|Lost to Follow-up|1|||
105557396|NCT05130970|364037661|FG000|Overall Study|Physician Decision|0|||
105557397|NCT05130970|364037662|FG001|Overall Study|Physician Decision|1|||
105557398|NCT05130970|364037661|FG000|Overall Study|Withdrawal by Subject|1|||
105557399|NCT05130970|364037662|FG001|Overall Study|Withdrawal by Subject|1|||
105557400|NCT03996473|364037663|FG000|Treatment Assignment|Withdrawal by Subject|1|||
105557401|NCT03996473|364037663|FG000|Treatment Assignment|Progressive disease|6|||
105557402|NCT03996473|364037663|FG000|Treatment Assignment|Study drug never administered|1|||
105557403|NCT03996473|364037663|FG000|Active Follow-up|Death|1|||
105557404|NCT03996473|364037663|FG000|Long-term Follow-up|Death|5|||
105557405|NCT06116591|364037664|FG000|Overall Study|No longer met eligibility criteria|0|||
105557406|NCT06116591|364037665|FG001|Overall Study|No longer met eligibility criteria|1|||
105557407|NCT06116591|364037664|FG000|Overall Study|Other: Change in life situation|0|||
105557408|NCT06116591|364037665|FG001|Overall Study|Other: Change in life situation|1|||
105557409|NCT01381692|364037666|FG000|Overall Study|Adverse Event|1|||
105557410|NCT01381692|364037667|FG001|Overall Study|Adverse Event|0|||
105557411|NCT01381692|364037668|FG002|Overall Study|Adverse Event|0|||
105557412|NCT01381692|364037669|FG003|Overall Study|Adverse Event|0|||
105557413|NCT01381692|364037670|FG004|Overall Study|Adverse Event|0|||
105557414|NCT01381692|364037671|FG005|Overall Study|Adverse Event|0|||
105557415|NCT04575467|364037672|FG000|Overall Study|Adverse Event|0|||
105557416|NCT04575467|364037673|FG001|Overall Study|Adverse Event|1|||
105557417|NCT04575467|364037674|FG002|Overall Study|Adverse Event|0|||
105557418|NCT04575467|364037675|FG003|Overall Study|Adverse Event|0|||
105557419|NCT02384954|364037676|FG000|Phase 1|Progressive Disease|2|||
105557420|NCT02384954|364037677|FG001|Phase 1|Progressive Disease|0|||
105557421|NCT02384954|364037678|FG002|Phase 1|Progressive Disease|1|||
105557422|NCT02384954|364037679|FG003|Phase 1|Progressive Disease|1|||
105557423|NCT02384954|364037680|FG004|Phase 1|Progressive Disease|0|||
105557424|NCT02384954|364037681|FG005|Phase 1|Progressive Disease|0|||
105557425|NCT02384954|364037682|FG006|Phase 1|Progressive Disease|0|||
105557426|NCT02384954|364037683|FG007|Phase 1|Progressive Disease|0|||
105557427|NCT02384954|364037684|FG008|Phase 1|Progressive Disease|0|||
105557428|NCT02384954|364037676|FG000|Phase 1|Adverse Event|0|||
105557429|NCT02384954|364037677|FG001|Phase 1|Adverse Event|0|||
105557430|NCT02384954|364037678|FG002|Phase 1|Adverse Event|1|||
105679181|NCT00768079|364486918|FG000|Overall Study|Lost to Follow-up|2|||
105679182|NCT00768079|364486919|FG001|Overall Study|Lost to Follow-up|0|||
105557431|NCT02384954|364037679|FG003|Phase 1|Adverse Event|0|||
105557432|NCT02384954|364037680|FG004|Phase 1|Adverse Event|0|||
105557433|NCT02384954|364037681|FG005|Phase 1|Adverse Event|0|||
105557434|NCT02384954|364037682|FG006|Phase 1|Adverse Event|0|||
105557435|NCT02384954|364037683|FG007|Phase 1|Adverse Event|0|||
105557436|NCT02384954|364037684|FG008|Phase 1|Adverse Event|0|||
105679183|NCT00768079|364486920|FG002|Overall Study|Lost to Follow-up|4|||
105557437|NCT02384954|364037676|FG000|Phase 2|Progressive Disease|0|||
105557438|NCT02384954|364037677|FG001|Phase 2|Progressive Disease|0|||
105679184|NCT00768079|364486918|FG000|Overall Study|Participant incarcerated|0|||
105679185|NCT00768079|364486919|FG001|Overall Study|Participant incarcerated|1|||
105679186|NCT00768079|364486920|FG002|Overall Study|Participant incarcerated|0|||
105679187|NCT01177800|364486921|FG000|Overall Study|Adverse Event|9|||
105679188|NCT01177800|364486922|FG001|Overall Study|Adverse Event|3|||
105679189|NCT01177800|364486921|FG000|Overall Study|Protocol Violation|0|||
105679190|NCT01177800|364486922|FG001|Overall Study|Protocol Violation|1|||
105679191|NCT01177800|364486921|FG000|Overall Study|Physician Decision|1|||
105679192|NCT01177800|364486922|FG001|Overall Study|Physician Decision|0|||
105679193|NCT01177800|364486921|FG000|Overall Study|Withdrawal of informed consent|0|||
105679194|NCT01177800|364486922|FG001|Overall Study|Withdrawal of informed consent|1|||
105679195|NCT01844687|364486925|FG000|Visit 1|Protocol Violation|3|||
105679196|NCT01844687|364486925|FG000|Visit 1|Lost to Follow-up|5|||
105679197|NCT01844687|364486925|FG000|Visit 2|Withdrawal by Subject|1|||
105679198|NCT01844687|364486925|FG000|Visit 2|Protocol Violation|1|||
105679199|NCT01844687|364486925|FG000|Visit 3|Lost to Follow-up|1|||
105679200|NCT01844687|364486925|FG000|Visit 3|Withdrawal by Subject|3|||
105679201|NCT01844687|364486925|FG000|Visit 3|child care problems|1|||
105679202|NCT01844687|364486925|FG000|Visit 4|Pregnancy|1|||
105679203|NCT01844687|364486925|FG000|Visit 4|Lost to Follow-up|1|||
105679204|NCT01844687|364486925|FG000|Visit 4|Withdrawal by Subject|2|||
105679205|NCT00986973|364486931|FG000|Overall Study|Withdrawn by study team|1|||
105679206|NCT01146782|364486932|FG000|Screening Cohort|Screen Failure|187|||
105679207|NCT01146782|364486932|FG000|Screening Cohort|Lost to Follow-up|4|||
105679208|NCT01146782|364486932|FG000|Screening Cohort|Physician Decision|1|||
105679209|NCT01146782|364486932|FG000|Screening Cohort|Withdrawal by Subject|29|||
105468564|NCT02446899|363725927|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
105468565|NCT02446899|363725928|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
105468566|NCT02446899|363725927|FG000|Overall Study|Withdrawal by Subject|11|||
105468567|NCT02446899|363725928|FG001|Overall Study|Withdrawal by Subject|19|||
105468568|NCT02446899|363725927|FG000|Overall Study|Miscellaneous|5|||
105679210|NCT01146782|364486932|FG000|Safety Cohort|Screen Failure|61|||
105679211|NCT01146782|364486932|FG000|Safety Cohort|Withdrawal by Subject|4|||
105679212|NCT01146782|364486932|FG000|Safety Cohort|Control AHI <5|4|||
105679213|NCT01146782|364486932|FG000|Safety Cohort|TST <4 hrs|14|||
105679214|NCT01146782|364486932|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
105679215|NCT01146782|364486932|FG000|Primary Endpoint Cohort|Physician Decision|1|||
105679216|NCT01605916|364486933|FG000|Overall Study|Adverse Event|1|||
105679217|NCT01605916|364486934|FG001|Overall Study|Adverse Event|0|||
105679218|NCT01605916|364486935|FG002|Overall Study|Adverse Event|0|||
105679219|NCT01605916|364486936|FG003|Overall Study|Adverse Event|1|||
105679220|NCT01605916|364486937|FG004|Overall Study|Adverse Event|0|||
105679221|NCT01605916|364486933|FG000|Overall Study|Lack of Efficacy|2|||
105679222|NCT01605916|364486934|FG001|Overall Study|Lack of Efficacy|3|||
105679223|NCT01605916|364486935|FG002|Overall Study|Lack of Efficacy|3|||
105679224|NCT01605916|364486936|FG003|Overall Study|Lack of Efficacy|5|||
105679225|NCT01605916|364486937|FG004|Overall Study|Lack of Efficacy|4|||
105679226|NCT01605916|364486933|FG000|Overall Study|Withdrawal by Subject|1|||
105679227|NCT01605916|364486934|FG001|Overall Study|Withdrawal by Subject|1|||
105679228|NCT01605916|364486935|FG002|Overall Study|Withdrawal by Subject|0|||
105679229|NCT01605916|364486936|FG003|Overall Study|Withdrawal by Subject|0|||
105679230|NCT01605916|364486937|FG004|Overall Study|Withdrawal by Subject|2|||
105468569|NCT02446899|363725928|FG001|Overall Study|Miscellaneous|4|||
105679231|NCT00470366|364486938|FG000|Overall Study|Adverse Event|3|||
105679232|NCT00470366|364486938|FG000|Overall Study|Poor compliance|1|||
105679233|NCT02751320|364486940|FG000|Overall Study|Adverse Event|2|||
105679234|NCT02751320|364486940|FG000|Overall Study|Withdrawal by Subject|1|||
105679235|NCT03426605|364486941|FG000|Overall Study|AML relapse or progression|2|||
105679236|NCT03426605|364486942|FG001|Overall Study|AML relapse or progression|1|||
105679237|NCT03426605|364486943|FG002|Overall Study|AML relapse or progression|2|||
105679238|NCT03426605|364486944|FG003|Overall Study|AML relapse or progression|2|||
105679239|NCT03426605|364486941|FG000|Overall Study|Treatment failure|3|||
105679240|NCT03426605|364486942|FG001|Overall Study|Treatment failure|2|||
105679241|NCT03426605|364486943|FG002|Overall Study|Treatment failure|0|||
105679242|NCT03426605|364486944|FG003|Overall Study|Treatment failure|0|||
105679243|NCT03426605|364486941|FG000|Overall Study|Adverse Event|1|||
105679244|NCT03426605|364486942|FG001|Overall Study|Adverse Event|0|||
105679245|NCT03426605|364486943|FG002|Overall Study|Adverse Event|1|||
105679246|NCT03426605|364486944|FG003|Overall Study|Adverse Event|1|||
105679247|NCT03426605|364486941|FG000|Overall Study|Withdrawal by Subject|0|||
105679248|NCT03426605|364486942|FG001|Overall Study|Withdrawal by Subject|0|||
105679249|NCT03426605|364486943|FG002|Overall Study|Withdrawal by Subject|1|||
105679250|NCT03426605|364486944|FG003|Overall Study|Withdrawal by Subject|1|||
105679251|NCT01103362|364486945|FG000|Overall Study|study terminated|596|||
105679252|NCT02047903|364486946|FG000|Overall Study|Adverse Event|14|||
105679253|NCT02047903|364486946|FG000|Overall Study|Serious adverse event|10|||
105679254|NCT02047903|364486946|FG000|Overall Study|Withdrawal by Subject|16|||
105679255|NCT02047903|364486946|FG000|Overall Study|Lost to Follow-up|4|||
105679256|NCT02047903|364486946|FG000|Overall Study|Reason not listed|6|||
105679257|NCT02047903|364486946|FG000|Overall Study|Not Treated|9|||
105679258|NCT01014533|364486947|FG000|Overall Study|Protocol Violation|3|||
105679259|NCT01014533|364486948|FG001|Overall Study|Protocol Violation|2|||
105679260|NCT01014533|364486947|FG000|Overall Study|Withdrawal by Subject|2|||
105679261|NCT01014533|364486948|FG001|Overall Study|Withdrawal by Subject|0|||
105679262|NCT01014533|364486947|FG000|Overall Study|unable to come to appointment|0|||
105679263|NCT01014533|364486948|FG001|Overall Study|unable to come to appointment|3|||
105679264|NCT00296400|364486949|FG000|Overall Study|Adverse Event|7|||
105679265|NCT00296400|364486950|FG001|Overall Study|Adverse Event|7|||
105679266|NCT00296400|364486951|FG002|Overall Study|Adverse Event|7|||
105679267|NCT00296400|364486949|FG000|Overall Study|Withdrawal by Subject|5|||
105679268|NCT00296400|364486950|FG001|Overall Study|Withdrawal by Subject|6|||
105679269|NCT00296400|364486951|FG002|Overall Study|Withdrawal by Subject|2|||
105679270|NCT00296400|364486949|FG000|Overall Study|Incorrect enrollment|2|||
105679271|NCT00296400|364486950|FG001|Overall Study|Incorrect enrollment|0|||
105679272|NCT00296400|364486951|FG002|Overall Study|Incorrect enrollment|0|||
105679273|NCT00296400|364486949|FG000|Overall Study|Protocol Violation|1|||
105679274|NCT00296400|364486950|FG001|Overall Study|Protocol Violation|1|||
105679275|NCT00296400|364486951|FG002|Overall Study|Protocol Violation|1|||
105679276|NCT00296400|364486949|FG000|Overall Study|Lost to Follow-up|1|||
105679277|NCT00296400|364486950|FG001|Overall Study|Lost to Follow-up|1|||
105679278|NCT00296400|364486951|FG002|Overall Study|Lost to Follow-up|2|||
105679279|NCT00296400|364486949|FG000|Overall Study|Study specific discontinuation criteria|0|||
105679280|NCT00296400|364486950|FG001|Overall Study|Study specific discontinuation criteria|0|||
105679281|NCT00296400|364486951|FG002|Overall Study|Study specific discontinuation criteria|1|||
105679282|NCT00296400|364486949|FG000|Overall Study|Visit 10 was performed earlier|0|||
105679283|NCT00296400|364486950|FG001|Overall Study|Visit 10 was performed earlier|1|||
105679284|NCT00296400|364486951|FG002|Overall Study|Visit 10 was performed earlier|0|||
105679285|NCT00296400|364486949|FG000|Overall Study|Pregnancy|1|||
105679286|NCT00296400|364486950|FG001|Overall Study|Pregnancy|2|||
105679287|NCT00296400|364486951|FG002|Overall Study|Pregnancy|0|||
105679288|NCT00412061|364486954|FG000|Double Blind Phase|Disease Progression|101|||
105679289|NCT00412061|364486955|FG001|Double Blind Phase|Disease Progression|154|||
105679290|NCT00412061|364486954|FG000|Double Blind Phase|Adverse Event|61|||
105679291|NCT00412061|364486955|FG001|Double Blind Phase|Adverse Event|16|||
105679292|NCT00412061|364486954|FG000|Double Blind Phase|Final Primary Analysis|26|||
105679293|NCT00412061|364486955|FG001|Double Blind Phase|Final Primary Analysis|14|||
105679294|NCT00412061|364486954|FG000|Double Blind Phase|Withdrawal by Subject|18|||
105679295|NCT00412061|364486955|FG001|Double Blind Phase|Withdrawal by Subject|20|||
105679296|NCT00412061|364486954|FG000|Double Blind Phase|Death|6|||
105679297|NCT00412061|364486955|FG001|Double Blind Phase|Death|3|||
105679298|NCT00412061|364486954|FG000|Double Blind Phase|Protocol Violation|3|||
105679299|NCT00412061|364486955|FG001|Double Blind Phase|Protocol Violation|4|||
105679300|NCT00412061|364486954|FG000|Double Blind Phase|New Cander Therapy|1|||
105679301|NCT00412061|364486955|FG001|Double Blind Phase|New Cander Therapy|1|||
105679302|NCT00412061|364486954|FG000|Double Blind Phase|Lost to Follow-up|0|||
105679303|NCT00412061|364486955|FG001|Double Blind Phase|Lost to Follow-up|1|||
105679304|NCT00412061|364486954|FG000|Open Label Phase|Disease Progression|0|||
105679305|NCT00412061|364486955|FG001|Open Label Phase|Disease Progression|86|||
105679306|NCT00412061|364486954|FG000|Open Label Phase|Adverse Event|0|||
105679307|NCT00412061|364486955|FG001|Open Label Phase|Adverse Event|46|||
105679308|NCT00412061|364486954|FG000|Open Label Phase|Withdrawal by Subject|0|||
105679309|NCT00412061|364486955|FG001|Open Label Phase|Withdrawal by Subject|15|||
105679310|NCT00412061|364486954|FG000|Open Label Phase|Administrative Problems|0|||
105679311|NCT00412061|364486955|FG001|Open Label Phase|Administrative Problems|13|||
105679312|NCT00412061|364486954|FG000|Open Label Phase|Death|0|||
105679313|NCT00412061|364486955|FG001|Open Label Phase|Death|7|||
105679314|NCT00412061|364486954|FG000|Open Label Phase|Lost to Follow-up|0|||
105679315|NCT00412061|364486955|FG001|Open Label Phase|Lost to Follow-up|2|||
105468570|NCT02446899|363725927|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
105468571|NCT02446899|363725928|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
105468572|NCT00084136|363725929|FG000|PI Comparison|Death|10|||
105468573|NCT00084136|363725930|FG001|PI Comparison|Death|9|||
105468574|NCT00084136|363725931|FG002|PI Comparison|Death|0|||
105468575|NCT00084136|363725929|FG000|PI Comparison|Lost to Follow-up|11|||
105679316|NCT00412061|364486954|FG000|Open Label Phase|New Cancer Therapy|0|||
105679317|NCT00412061|364486955|FG001|Open Label Phase|New Cancer Therapy|1|||
105679318|NCT00825825|364486958|FG000|First Medication Period (14 Days)|Adverse Event|1|||
105679319|NCT00825825|364486959|FG001|First Medication Period (14 Days)|Adverse Event|0|||
105679320|NCT00825825|364486960|FG002|First Medication Period (14 Days)|Adverse Event|0|||
105679321|NCT00825825|364486961|FG003|First Medication Period (14 Days)|Adverse Event|0|||
105679322|NCT00825825|364486962|FG004|First Medication Period (14 Days)|Adverse Event|0|||
105679323|NCT00825825|364486963|FG005|First Medication Period (14 Days)|Adverse Event|1|||
105679324|NCT00825825|364486958|FG000|First Medication Period (14 Days)|Physician Decision|2|||
105679325|NCT00825825|364486959|FG001|First Medication Period (14 Days)|Physician Decision|0|||
105468576|NCT00084136|363725930|FG001|PI Comparison|Lost to Follow-up|8|||
105679326|NCT00825825|364486960|FG002|First Medication Period (14 Days)|Physician Decision|1|||
105468577|NCT00084136|363725931|FG002|PI Comparison|Lost to Follow-up|0|||
105679327|NCT00825825|364486961|FG003|First Medication Period (14 Days)|Physician Decision|0|||
105679328|NCT00825825|364486962|FG004|First Medication Period (14 Days)|Physician Decision|0|||
105679329|NCT00825825|364486963|FG005|First Medication Period (14 Days)|Physician Decision|1|||
105679330|NCT00825825|364486958|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
105679331|NCT00825825|364486959|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
105679332|NCT00825825|364486960|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
105679333|NCT00825825|364486961|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
105679334|NCT00825825|364486962|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
105679335|NCT00825825|364486963|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
105679336|NCT00825825|364486958|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
105679337|NCT00825825|364486959|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
105679338|NCT00825825|364486960|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
105679339|NCT00825825|364486961|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
105679340|NCT00825825|364486962|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
105679341|NCT00825825|364486963|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
105679342|NCT00825825|364486958|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
105679343|NCT00825825|364486959|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
105679344|NCT00825825|364486960|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
105679345|NCT00825825|364486961|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
105679346|NCT00825825|364486962|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
105679347|NCT00825825|364486963|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
105679348|NCT00825825|364486958|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
105679349|NCT00825825|364486959|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
105679350|NCT00825825|364486960|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
105679351|NCT00825825|364486961|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
105679352|NCT00825825|364486962|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
105679353|NCT00825825|364486963|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
105679354|NCT00825825|364486958|FG000|Third Medication Period (14 Days)|poor data quality|0|||
105679355|NCT00825825|364486959|FG001|Third Medication Period (14 Days)|poor data quality|1|||
105679356|NCT00825825|364486960|FG002|Third Medication Period (14 Days)|poor data quality|0|||
105679357|NCT00825825|364486961|FG003|Third Medication Period (14 Days)|poor data quality|0|||
105679358|NCT00825825|364486962|FG004|Third Medication Period (14 Days)|poor data quality|0|||
105679359|NCT00825825|364486963|FG005|Third Medication Period (14 Days)|poor data quality|0|||
105679360|NCT01011387|364486966|FG000|Overall Study|Withdrawal by Subject|3|||
105679361|NCT01011387|364486966|FG000|Overall Study|Adverse Event|2|||
105679362|NCT01011387|364486966|FG000|Overall Study|Protocol Violation|1|||
105679363|NCT01178385|364486967|FG000|Overall Study|Withdrawal by Subject|2|||
105679364|NCT01178385|364486968|FG001|Overall Study|Withdrawal by Subject|0|||
105679365|NCT01226095|364486969|FG000|Overall Study|Poor compliance|1|||
105679366|NCT02679508|364486975|FG000|Healing Phase|Protocol Violation|1|||
105679367|NCT02679508|364486976|FG001|Healing Phase|Protocol Violation|1|||
105679368|NCT02679508|364486975|FG000|Healing Phase|Lost to Follow-up|1|||
105679369|NCT02679508|364486976|FG001|Healing Phase|Lost to Follow-up|0|||
105679370|NCT02679508|364486975|FG000|Maintenance Phase|Adverse Event|12|||
105679371|NCT02679508|364486976|FG001|Maintenance Phase|Adverse Event|2|||
105468578|NCT00084136|363725929|FG000|PI Comparison|Withdrawal by Subject|33|||
105468579|NCT00084136|363725930|FG001|PI Comparison|Withdrawal by Subject|30|||
105468580|NCT00084136|363725931|FG002|PI Comparison|Withdrawal by Subject|0|||
105468581|NCT00084136|363725929|FG000|PI Comparison|Clinic site closed|1|||
105468582|NCT00084136|363725930|FG001|PI Comparison|Clinic site closed|0|||
105468583|NCT00084136|363725931|FG002|PI Comparison|Clinic site closed|0|||
105468584|NCT00084136|363725929|FG000|NRTI Comparison|Death|20|||
105679372|NCT02679508|364486975|FG000|Maintenance Phase|Lost to Follow-up|0|||
105679373|NCT02679508|364486976|FG001|Maintenance Phase|Lost to Follow-up|1|||
105679374|NCT02679508|364486975|FG000|Maintenance Phase|Withdrawal by Subject|15|||
105679375|NCT02679508|364486976|FG001|Maintenance Phase|Withdrawal by Subject|8|||
105679376|NCT02679508|364486975|FG000|Maintenance Phase|Other|5|||
105468585|NCT00084136|363725930|FG001|NRTI Comparison|Death|0|||
105679377|NCT02679508|364486976|FG001|Maintenance Phase|Other|4|||
105679378|NCT03538301|364486977|FG000|Overall Study|Adverse Event|1|||
105468586|NCT00084136|363725931|FG002|NRTI Comparison|Death|18|||
105468587|NCT00084136|363725929|FG000|NRTI Comparison|Lost to Follow-up|14|||
105468588|NCT00084136|363725930|FG001|NRTI Comparison|Lost to Follow-up|0|||
105468589|NCT00084136|363725931|FG002|NRTI Comparison|Lost to Follow-up|12|||
105344190|NCT02505334|363261708|FG000|Main Treatment Period|Protocol Violation|0|||
105344191|NCT02505334|363261709|FG001|Main Treatment Period|Protocol Violation|1|||
105344192|NCT02505334|363261708|FG000|Main Treatment Period|Withdrawal by Subject|1|||
105344193|NCT02505334|363261709|FG001|Main Treatment Period|Withdrawal by Subject|8|||
105344194|NCT02505334|363261708|FG000|Main Treatment Period|Unclassified|4|||
105557439|NCT02384954|364037678|FG002|Phase 2|Progressive Disease|0|||
105557440|NCT02384954|364037679|FG003|Phase 2|Progressive Disease|0|||
105557441|NCT02384954|364037680|FG004|Phase 2|Progressive Disease|0|||
105557442|NCT02384954|364037681|FG005|Phase 2|Progressive Disease|0|||
105557443|NCT02384954|364037682|FG006|Phase 2|Progressive Disease|0|||
105557444|NCT02384954|364037683|FG007|Phase 2|Progressive Disease|1|||
105557445|NCT02384954|364037684|FG008|Phase 2|Progressive Disease|2|||
105557446|NCT02384954|364037676|FG000|Phase 2|Adverse Event|0|||
105557447|NCT02384954|364037677|FG001|Phase 2|Adverse Event|0|||
105557448|NCT02384954|364037678|FG002|Phase 2|Adverse Event|0|||
105557449|NCT02384954|364037679|FG003|Phase 2|Adverse Event|0|||
105557450|NCT02384954|364037680|FG004|Phase 2|Adverse Event|0|||
105557451|NCT02384954|364037681|FG005|Phase 2|Adverse Event|0|||
105557452|NCT02384954|364037682|FG006|Phase 2|Adverse Event|0|||
105557453|NCT02384954|364037683|FG007|Phase 2|Adverse Event|1|||
105557454|NCT02384954|364037684|FG008|Phase 2|Adverse Event|1|||
105557455|NCT02384954|364037676|FG000|Phase 2|Failure to meet continuation criteria|0|||
105557456|NCT02384954|364037677|FG001|Phase 2|Failure to meet continuation criteria|0|||
105557457|NCT02384954|364037678|FG002|Phase 2|Failure to meet continuation criteria|0|||
105557458|NCT02384954|364037679|FG003|Phase 2|Failure to meet continuation criteria|0|||
105557459|NCT02384954|364037680|FG004|Phase 2|Failure to meet continuation criteria|0|||
105557460|NCT02384954|364037681|FG005|Phase 2|Failure to meet continuation criteria|0|||
105557461|NCT02384954|364037682|FG006|Phase 2|Failure to meet continuation criteria|0|||
105557462|NCT02384954|364037683|FG007|Phase 2|Failure to meet continuation criteria|1|||
105557463|NCT02384954|364037684|FG008|Phase 2|Failure to meet continuation criteria|0|||
105557464|NCT00003298|364037688|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
105557465|NCT00003298|364037688|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
105557466|NCT00003298|364037688|FG000|Surgery|Unresectable at surgery|3|||
105557467|NCT00003298|364037688|FG000|Surgery|Progression before surgery|2|||
105557468|NCT00003298|364037688|FG000|Surgery|Unevaluable and off study|2|||
105557469|NCT00003298|364037688|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
105557470|NCT00003298|364037688|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
105557471|NCT00003298|364037688|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
105557472|NCT00003298|364037688|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
105557473|NCT00003298|364037688|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
105557474|NCT00003298|364037688|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
105557475|NCT00003298|364037688|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
105557476|NCT00003298|364037688|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
105557477|NCT00003298|364037688|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
105557478|NCT00003298|364037688|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
105557479|NCT02195986|364037689|FG000|Overall Study|Adverse Event|3|||
105557480|NCT02195986|364037690|FG001|Overall Study|Adverse Event|0|||
105557481|NCT02195986|364037691|FG002|Overall Study|Adverse Event|0|||
105557482|NCT02195986|364037689|FG000|Overall Study|Withdrawal by Subject|0|||
105557483|NCT02195986|364037690|FG001|Overall Study|Withdrawal by Subject|3|||
105557484|NCT02195986|364037691|FG002|Overall Study|Withdrawal by Subject|0|||
105557485|NCT02195986|364037689|FG000|Overall Study|Family Emergency|0|||
105557486|NCT02195986|364037690|FG001|Overall Study|Family Emergency|0|||
105557487|NCT02195986|364037691|FG002|Overall Study|Family Emergency|1|||
105557488|NCT02195986|364037689|FG000|Overall Study|Protocol Violation|0|||
105557489|NCT02195986|364037690|FG001|Overall Study|Protocol Violation|1|||
105557490|NCT02195986|364037691|FG002|Overall Study|Protocol Violation|1|||
105557491|NCT02195986|364037689|FG000|Overall Study|Non-compliance|0|||
105557492|NCT02195986|364037690|FG001|Overall Study|Non-compliance|1|||
105557493|NCT02195986|364037691|FG002|Overall Study|Non-compliance|0|||
105557494|NCT02308748|364037692|FG000|Period 1|Withdrawal by Subject|0|||
105557495|NCT02308748|364037693|FG001|Period 1|Withdrawal by Subject|0|||
105557496|NCT02308748|364037694|FG002|Period 1|Withdrawal by Subject|1|||
105557497|NCT02308748|364037695|FG003|Period 1|Withdrawal by Subject|0|||
105557498|NCT02308748|364037696|FG004|Period 1|Withdrawal by Subject|0|||
105557499|NCT02308748|364037697|FG005|Period 1|Withdrawal by Subject|0|||
105557500|NCT02308748|364037698|FG006|Period 1|Withdrawal by Subject|0|||
105557501|NCT02308748|364037699|FG007|Period 1|Withdrawal by Subject|0|||
105557502|NCT02308748|364037700|FG008|Period 1|Withdrawal by Subject|0|||
105557503|NCT02308748|364037701|FG009|Period 1|Withdrawal by Subject|0|||
105557504|NCT02308748|364037692|FG000|Period 2|Adverse Event|0|||
105557505|NCT02308748|364037693|FG001|Period 2|Adverse Event|0|||
105557506|NCT02308748|364037694|FG002|Period 2|Adverse Event|0|||
105557507|NCT02308748|364037695|FG003|Period 2|Adverse Event|0|||
105557508|NCT02308748|364037696|FG004|Period 2|Adverse Event|0|||
105344195|NCT02505334|363261709|FG001|Main Treatment Period|Unclassified|10|||
105557509|NCT02308748|364037697|FG005|Period 2|Adverse Event|0|||
105557510|NCT02308748|364037698|FG006|Period 2|Adverse Event|0|||
105679379|NCT03538301|364486978|FG001|Overall Study|Adverse Event|4|||
105679380|NCT03538301|364486979|FG002|Overall Study|Adverse Event|4|||
105679381|NCT03538301|364486977|FG000|Overall Study|Death|1|||
105679382|NCT03538301|364486978|FG001|Overall Study|Death|1|||
105679383|NCT03538301|364486979|FG002|Overall Study|Death|0|||
105679384|NCT03538301|364486977|FG000|Overall Study|Physician Decision|0|||
105679385|NCT03538301|364486978|FG001|Overall Study|Physician Decision|1|||
105679386|NCT03538301|364486979|FG002|Overall Study|Physician Decision|0|||
105679387|NCT03538301|364486977|FG000|Overall Study|Protocol Violation|0|||
105679388|NCT03538301|364486978|FG001|Overall Study|Protocol Violation|0|||
105679389|NCT03538301|364486979|FG002|Overall Study|Protocol Violation|1|||
105679390|NCT03538301|364486977|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
105679391|NCT03538301|364486978|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
105679392|NCT03538301|364486979|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
105679393|NCT05326815|364486986|FG000|Overall Study|Withdrawal by Subject|3|||
105679394|NCT05326815|364486986|FG000|Overall Study|Did not complete required labs|6|||
105679395|NCT05326815|364486986|FG000|Overall Study|Screen fail- abnormal labs|5|||
105679396|NCT00925132|364486987|FG000|Overall Study|Withdrawal by Subject|2|||
105679397|NCT00925132|364486988|FG001|Overall Study|Withdrawal by Subject|0|||
105679398|NCT00925132|364486989|FG002|Overall Study|Withdrawal by Subject|0|||
105679399|NCT00925132|364486990|FG003|Overall Study|Withdrawal by Subject|0|||
105679400|NCT00925132|364486991|FG004|Overall Study|Withdrawal by Subject|1|||
105679401|NCT00925132|364486987|FG000|Overall Study|Removed due to disease progression|0|||
105679402|NCT00925132|364486988|FG001|Overall Study|Removed due to disease progression|0|||
105679403|NCT00925132|364486989|FG002|Overall Study|Removed due to disease progression|0|||
105679404|NCT00925132|364486990|FG003|Overall Study|Removed due to disease progression|0|||
105679405|NCT00925132|364486991|FG004|Overall Study|Removed due to disease progression|4|||
105679406|NCT02545933|364486992|FG000|Overall Study|Adverse Event|3|||
105679407|NCT02545933|364486993|FG001|Overall Study|Adverse Event|0|||
105679408|NCT02545933|364486994|FG002|Overall Study|Adverse Event|0|||
105679409|NCT02545933|364486992|FG000|Overall Study|Withdrawal by Subject|2|||
105679410|NCT02545933|364486993|FG001|Overall Study|Withdrawal by Subject|3|||
105679411|NCT02545933|364486994|FG002|Overall Study|Withdrawal by Subject|3|||
105679412|NCT02545933|364486992|FG000|Overall Study|Protocol Violation|1|||
105679413|NCT02545933|364486993|FG001|Overall Study|Protocol Violation|0|||
105679414|NCT02545933|364486994|FG002|Overall Study|Protocol Violation|1|||
105679415|NCT00979134|364486995|FG000|Overall Study|Disease progression|18|||
105679416|NCT00979134|364486996|FG001|Overall Study|Disease progression|2|||
105679417|NCT00979134|364486997|FG002|Overall Study|Disease progression|5|||
105679418|NCT00979134|364486995|FG000|Overall Study|Adverse Event|0|||
105679419|NCT00979134|364486996|FG001|Overall Study|Adverse Event|0|||
105679420|NCT00979134|364486997|FG002|Overall Study|Adverse Event|2|||
105679421|NCT00979134|364486995|FG000|Overall Study|Withdrawal by Subject|1|||
105679422|NCT00979134|364486996|FG001|Overall Study|Withdrawal by Subject|1|||
105679423|NCT00979134|364486997|FG002|Overall Study|Withdrawal by Subject|2|||
105679424|NCT00979134|364486995|FG000|Overall Study|Lost to Follow-up|2|||
105679425|NCT00979134|364486996|FG001|Overall Study|Lost to Follow-up|2|||
105679426|NCT00979134|364486997|FG002|Overall Study|Lost to Follow-up|0|||
105679427|NCT00979134|364486995|FG000|Overall Study|Death|4|||
105679428|NCT00979134|364486996|FG001|Overall Study|Death|0|||
105679429|NCT00979134|364486997|FG002|Overall Study|Death|26|||
105679430|NCT00979134|364486995|FG000|Overall Study|Other|8|||
105679431|NCT00979134|364486996|FG001|Overall Study|Other|1|||
105679432|NCT00979134|364486997|FG002|Overall Study|Other|5|||
105679433|NCT03694275|364489645|FG000|Overall Study|Adverse Event|0|||
105679434|NCT03694275|364489646|FG001|Overall Study|Adverse Event|1|||
105679435|NCT03694275|364489645|FG000|Overall Study|Reason not Specified|0|||
105679436|NCT03694275|364489646|FG001|Overall Study|Reason not Specified|1|||
105679437|NCT00266227|364489651|FG000|Initial Treatment|Adverse Event|0|||
105679438|NCT00266227|364489652|FG001|Initial Treatment|Adverse Event|0|||
105679439|NCT00266227|364489653|FG002|Initial Treatment|Adverse Event|13|||
105679440|NCT00266227|364489651|FG000|Initial Treatment|Lost to Follow-up|0|||
105679441|NCT00266227|364489652|FG001|Initial Treatment|Lost to Follow-up|0|||
105344196|NCT02505334|363261708|FG000|Extension Treatment Period|Adverse Event|5|||
105344197|NCT02505334|363261709|FG001|Extension Treatment Period|Adverse Event|0|||
105679442|NCT00266227|364489653|FG002|Initial Treatment|Lost to Follow-up|6|||
105679443|NCT00266227|364489651|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
105679444|NCT00266227|364489652|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
105344198|NCT02505334|363261708|FG000|Extension Treatment Period|Lack of Efficacy|4|||
105344199|NCT02505334|363261709|FG001|Extension Treatment Period|Lack of Efficacy|0|||
105344200|NCT02505334|363261708|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
105344201|NCT02505334|363261709|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
105344202|NCT02505334|363261708|FG000|Extension Treatment Period|Unclassified|3|||
105344203|NCT02505334|363261709|FG001|Extension Treatment Period|Unclassified|0|||
105679445|NCT00266227|364489653|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
105679446|NCT00266227|364489651|FG000|Initial Treatment|Physician decision to withdraw|0|||
105679447|NCT00266227|364489652|FG001|Initial Treatment|Physician decision to withdraw|0|||
105679448|NCT00266227|364489653|FG002|Initial Treatment|Physician decision to withdraw|12|||
105344204|NCT01549041|363261710|FG000|Overall Study|Lack of Efficacy|2|||
105344205|NCT01549041|363261711|FG001|Overall Study|Lack of Efficacy|4|||
105344206|NCT01549041|363261710|FG000|Overall Study|Adverse Event|0|||
105344207|NCT01549041|363261711|FG001|Overall Study|Adverse Event|4|||
105344208|NCT02543892|363261712|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
105344209|NCT02543892|363261713|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
105344210|NCT02543892|363261714|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
105679449|NCT00266227|364489651|FG000|Initial Treatment|Pregnancy|0|||
105679450|NCT00266227|364489652|FG001|Initial Treatment|Pregnancy|0|||
105679451|NCT00266227|364489653|FG002|Initial Treatment|Pregnancy|1|||
105679452|NCT00266227|364489651|FG000|Retreatment: Up to Week 48|Death|1|||
105679453|NCT00266227|364489652|FG001|Retreatment: Up to Week 48|Death|0|||
105679454|NCT00266227|364489653|FG002|Retreatment: Up to Week 48|Death|0|||
105679455|NCT00266227|364489651|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
105679456|NCT00266227|364489652|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
105679457|NCT00266227|364489653|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
105679458|NCT00266227|364489651|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
105679459|NCT00266227|364489652|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
105679460|NCT00266227|364489653|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
105679461|NCT00266227|364489651|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
105679462|NCT00266227|364489652|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
105679463|NCT00266227|364489653|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
105679464|NCT00266227|364489651|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
105679465|NCT00266227|364489652|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
105679466|NCT00266227|364489653|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
105679467|NCT00266227|364489651|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
105679468|NCT00266227|364489652|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
105679469|NCT00266227|364489653|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
105679470|NCT00266227|364489651|FG000|Retreatment: Week 48 to Week 72|Death|1|||
105679471|NCT00266227|364489652|FG001|Retreatment: Week 48 to Week 72|Death|1|||
105679472|NCT00266227|364489653|FG002|Retreatment: Week 48 to Week 72|Death|0|||
105679473|NCT00266227|364489651|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
105679474|NCT00266227|364489652|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
105679475|NCT00266227|364489653|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
105679476|NCT00266227|364489651|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
105679477|NCT00266227|364489652|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
105344211|NCT02543892|363261715|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
105344212|NCT02543892|363261716|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
105344213|NCT02543892|363261717|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
105344214|NCT02543892|363261718|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
105344215|NCT02543892|363261719|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
105344216|NCT02543892|363261712|FG000|Received Vaccination 2|Physician Decision|0|||
105344217|NCT02543892|363261713|FG001|Received Vaccination 2|Physician Decision|0|||
105344218|NCT02543892|363261714|FG002|Received Vaccination 2|Physician Decision|0|||
105344219|NCT02543892|363261715|FG003|Received Vaccination 2|Physician Decision|0|||
105468590|NCT00084136|363725929|FG000|NRTI Comparison|Withdrawal by Subject|54|||
105344220|NCT02543892|363261716|FG004|Received Vaccination 2|Physician Decision|0|||
105679478|NCT00266227|364489653|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
105679479|NCT00266227|364489651|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
105344221|NCT02543892|363261717|FG005|Received Vaccination 2|Physician Decision|1|||
105344222|NCT02543892|363261718|FG006|Received Vaccination 2|Physician Decision|0|||
105344223|NCT02543892|363261719|FG007|Received Vaccination 2|Physician Decision|0|||
105557511|NCT02308748|364037699|FG007|Period 2|Adverse Event|1|||
105679480|NCT00266227|364489652|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
105679481|NCT00266227|364489653|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
105679482|NCT00266227|364489651|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
105679483|NCT00266227|364489652|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
105679484|NCT00266227|364489653|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
105679485|NCT01850446|364489654|FG000|Overall Study|Lack of Efficacy|1|||
105679486|NCT01850446|364489655|FG001|Overall Study|Lack of Efficacy|0|||
105679487|NCT01850446|364489654|FG000|Overall Study|Withdrawal by Subject|4|||
105679488|NCT01850446|364489655|FG001|Overall Study|Withdrawal by Subject|0|||
105679489|NCT01850446|364489654|FG000|Overall Study|Protocol Violation|0|||
105679490|NCT01850446|364489655|FG001|Overall Study|Protocol Violation|2|||
105679491|NCT00705679|364489656|FG000|Overall Study|Adverse Event|1|||
105679492|NCT00705679|364489657|FG001|Overall Study|Adverse Event|1|||
105679493|NCT00705679|364489658|FG002|Overall Study|Adverse Event|0|||
105679494|NCT00705679|364489659|FG003|Overall Study|Adverse Event|0|||
105679495|NCT00705679|364489660|FG004|Overall Study|Adverse Event|0|||
105679496|NCT00705679|364489656|FG000|Overall Study|Death|0|||
105679497|NCT00705679|364489657|FG001|Overall Study|Death|0|||
105679498|NCT00705679|364489658|FG002|Overall Study|Death|3|||
105679499|NCT00705679|364489659|FG003|Overall Study|Death|2|||
105679500|NCT00705679|364489660|FG004|Overall Study|Death|1|||
105679501|NCT00705679|364489656|FG000|Overall Study|Lost to Follow-up|32|||
105679502|NCT00705679|364489657|FG001|Overall Study|Lost to Follow-up|60|||
105679503|NCT00705679|364489658|FG002|Overall Study|Lost to Follow-up|44|||
105679504|NCT00705679|364489659|FG003|Overall Study|Lost to Follow-up|30|||
105679505|NCT00705679|364489660|FG004|Overall Study|Lost to Follow-up|35|||
105679506|NCT00705679|364489656|FG000|Overall Study|Physician Decision|0|||
105679507|NCT00705679|364489657|FG001|Overall Study|Physician Decision|1|||
105679508|NCT00705679|364489658|FG002|Overall Study|Physician Decision|0|||
105679509|NCT00705679|364489659|FG003|Overall Study|Physician Decision|1|||
105679510|NCT00705679|364489660|FG004|Overall Study|Physician Decision|0|||
105679511|NCT00705679|364489656|FG000|Overall Study|Withdrawal by Subject|32|||
105679512|NCT00705679|364489657|FG001|Overall Study|Withdrawal by Subject|77|||
105679513|NCT00705679|364489658|FG002|Overall Study|Withdrawal by Subject|68|||
105679514|NCT00705679|364489659|FG003|Overall Study|Withdrawal by Subject|47|||
105679515|NCT00705679|364489660|FG004|Overall Study|Withdrawal by Subject|33|||
105679516|NCT00759915|364489661|FG000|Overall Study|Withdrawal by Subject|1|||
105679517|NCT00759915|364489662|FG001|Overall Study|Withdrawal by Subject|0|||
105679518|NCT00759915|364489661|FG000|Overall Study|Adverse Event|0|||
105679519|NCT00759915|364489662|FG001|Overall Study|Adverse Event|1|||
105679520|NCT00512317|364489663|FG000|Overall Study|Insufficient clinical response|36|||
105679521|NCT00512317|364489663|FG000|Overall Study|Withdrawal by Subject|23|||
105679522|NCT00512317|364489663|FG000|Overall Study|Sponsor closure of study|21|||
105679523|NCT00512317|364489663|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
105679524|NCT00512317|364489663|FG000|Overall Study|Adverse Event|13|||
105679525|NCT00512317|364489663|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
105679526|NCT00512317|364489663|FG000|Overall Study|Lost to Follow-up|2|||
105679527|NCT00512317|364489663|FG000|Overall Study|Other|2|||
105679528|NCT01639495|364489664|FG000|Overall Study|Lost to Follow-up|6|||
105679529|NCT01639495|364489664|FG000|Overall Study|Consented but didn't have study catheter|4|||
105679530|NCT01639495|364489664|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
105679531|NCT01639495|364489664|FG000|Overall Study|No radiofrequency energy applied|2|||
105679532|NCT00007345|364489669|FG000|Overall Study|Refused further treatment|0|||
105344224|NCT02543892|363261712|FG000|Received Vaccination 2|Adverse Event|0|||
105344225|NCT02543892|363261713|FG001|Received Vaccination 2|Adverse Event|1|||
105679533|NCT00007345|364489670|FG001|Overall Study|Refused further treatment|7|||
105679534|NCT00007345|364489669|FG000|Overall Study|Switched to alternative treatment|0|||
105679535|NCT00007345|364489670|FG001|Overall Study|Switched to alternative treatment|3|||
105679536|NCT00007345|364489669|FG000|Overall Study|Intercurrent illness|1|||
105679537|NCT00007345|364489670|FG001|Overall Study|Intercurrent illness|0|||
105679538|NCT00007345|364489669|FG000|Overall Study|Death on study|1|||
105679539|NCT00007345|364489670|FG001|Overall Study|Death on study|1|||
105679540|NCT00618618|364489671|FG000|Overall Study|Patient Request|0|||
105679541|NCT00618618|364489672|FG001|Overall Study|Patient Request|0|||
105679542|NCT00618618|364489673|FG002|Overall Study|Patient Request|2|||
105679543|NCT00618618|364489674|FG003|Overall Study|Patient Request|0|||
105679544|NCT00618618|364489671|FG000|Overall Study|Inability to Complete Study Procedures|0|||
105679545|NCT00618618|364489672|FG001|Overall Study|Inability to Complete Study Procedures|1|||
105679546|NCT00618618|364489673|FG002|Overall Study|Inability to Complete Study Procedures|0|||
105679547|NCT00618618|364489674|FG003|Overall Study|Inability to Complete Study Procedures|0|||
105679548|NCT00618618|364489671|FG000|Overall Study|Lost to Follow-up|3|||
105679549|NCT00618618|364489672|FG001|Overall Study|Lost to Follow-up|0|||
105679550|NCT00618618|364489673|FG002|Overall Study|Lost to Follow-up|0|||
105679551|NCT00618618|364489674|FG003|Overall Study|Lost to Follow-up|1|||
105679552|NCT00618618|364489671|FG000|Overall Study|Non-compliance|1|||
105679553|NCT00618618|364489672|FG001|Overall Study|Non-compliance|1|||
105468591|NCT00084136|363725930|FG001|NRTI Comparison|Withdrawal by Subject|0|||
105468592|NCT00084136|363725931|FG002|NRTI Comparison|Withdrawal by Subject|38|||
105679554|NCT00618618|364489673|FG002|Overall Study|Non-compliance|0|||
105679555|NCT00618618|364489674|FG003|Overall Study|Non-compliance|0|||
105679556|NCT00618618|364489671|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
105679557|NCT00618618|364489672|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
105679558|NCT00618618|364489673|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
105679559|NCT00618618|364489674|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
105679560|NCT00618618|364489671|FG000|Overall Study|Death|0|||
105468593|NCT00084136|363725929|FG000|NRTI Comparison|Clinic site closed|12|||
105679561|NCT00618618|364489672|FG001|Overall Study|Death|1|||
105679562|NCT00618618|364489673|FG002|Overall Study|Death|0|||
105679563|NCT00618618|364489674|FG003|Overall Study|Death|0|||
105679564|NCT01171807|364489675|FG000|Overall Study|Treatment failure|2|||
105679565|NCT01171807|364489676|FG001|Overall Study|Treatment failure|4|||
105679566|NCT01171807|364489675|FG000|Overall Study|Non compliance|1|||
105679567|NCT01171807|364489676|FG001|Overall Study|Non compliance|0|||
105679568|NCT01171807|364489675|FG000|Overall Study|Lost to Follow-up|3|||
105679569|NCT01171807|364489676|FG001|Overall Study|Lost to Follow-up|0|||
105679570|NCT04101318|364489680|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
105679571|NCT04101318|364489681|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
105679572|NCT04101318|364489680|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
105679573|NCT04101318|364489681|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
105679574|NCT04101318|364489680|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
105679575|NCT04101318|364489681|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
105679576|NCT04289051|364489682|FG000|Overall Study|Lost to Follow-up|0|||
105679577|NCT04289051|364489683|FG001|Overall Study|Lost to Follow-up|0|||
105679578|NCT04289051|364489684|FG002|Overall Study|Lost to Follow-up|2|||
105679579|NCT01052103|364489686|FG000|Overall Study|Adverse Event|10|||
105679580|NCT01052103|364489687|FG001|Overall Study|Adverse Event|6|||
105679581|NCT01052103|364489686|FG000|Overall Study|Entry Criteria Not Met|3|||
105679582|NCT01052103|364489687|FG001|Overall Study|Entry Criteria Not Met|1|||
105679583|NCT01052103|364489686|FG000|Overall Study|Lost to Follow-up|3|||
105679584|NCT01052103|364489687|FG001|Overall Study|Lost to Follow-up|5|||
105679585|NCT01052103|364489686|FG000|Overall Study|Protocol Violation|10|||
105679586|NCT01052103|364489687|FG001|Overall Study|Protocol Violation|4|||
105679587|NCT01052103|364489686|FG000|Overall Study|Scheduling conflict|2|||
105679588|NCT01052103|364489687|FG001|Overall Study|Scheduling conflict|1|||
105679589|NCT01052103|364489686|FG000|Overall Study|Sponsor Decision|2|||
105679590|NCT01052103|364489687|FG001|Overall Study|Sponsor Decision|0|||
105679591|NCT01052103|364489686|FG000|Overall Study|Withdrawal by Subject|3|||
105679592|NCT01052103|364489687|FG001|Overall Study|Withdrawal by Subject|6|||
105679593|NCT01052103|364489686|FG000|Overall Study|Perceived Lack of Efficacy|1|||
105679594|NCT01052103|364489687|FG001|Overall Study|Perceived Lack of Efficacy|0|||
105679595|NCT03836716|364489688|FG000|Overall Study|Adverse Event|3|||
105679596|NCT03836716|364489688|FG000|Overall Study|Death|22|||
105679597|NCT03836716|364489688|FG000|Overall Study|Withdrawal by Subject|8|||
105679598|NCT03836716|364489688|FG000|Overall Study|Study terminated by sponsor|87|||
105679599|NCT03020576|364489691|FG000|Overall Study|Withdrawal by Subject|1|||
105679600|NCT03020576|364489692|FG001|Overall Study|Withdrawal by Subject|2|||
105679601|NCT01474434|364489696|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
105679602|NCT01474434|364489697|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
105679603|NCT01474434|364489698|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
105679604|NCT01474434|364489699|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
105679605|NCT01474434|364489696|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
105679606|NCT01474434|364489697|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
105679607|NCT01474434|364489698|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
105679608|NCT01474434|364489699|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
105679609|NCT01474434|364489696|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
105679610|NCT01474434|364489697|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
105679611|NCT01474434|364489698|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
105679612|NCT01474434|364489699|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
105679613|NCT01236534|364489701|FG000|Overall Study|Adverse Event|3|||
105679614|NCT01236534|364489702|FG001|Overall Study|Adverse Event|0|||
105679615|NCT04275089|364489703|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
105557512|NCT02308748|364037700|FG008|Period 2|Adverse Event|0|||
105557513|NCT02308748|364037701|FG009|Period 2|Adverse Event|0|||
105557514|NCT02308748|364037692|FG000|Period 3|Protocol Violation|0|||
105557515|NCT02308748|364037693|FG001|Period 3|Protocol Violation|0|||
105557516|NCT02308748|364037694|FG002|Period 3|Protocol Violation|0|||
105679616|NCT01153958|364489704|FG000|Overall Study|Study Terminated|36|||
105679617|NCT01153958|364489705|FG001|Overall Study|Study Terminated|32|||
105679618|NCT01034163|364489710|FG000|Overall Study|Treatment completed as per protocol|8|||
105679619|NCT01034163|364489711|FG001|Overall Study|Treatment completed as per protocol|7|||
105679620|NCT01034163|364489710|FG000|Overall Study|Withdrawal by Subject|8|||
105557517|NCT02308748|364037695|FG003|Period 3|Protocol Violation|0|||
105557518|NCT02308748|364037696|FG004|Period 3|Protocol Violation|0|||
105557519|NCT02308748|364037697|FG005|Period 3|Protocol Violation|0|||
105557520|NCT02308748|364037698|FG006|Period 3|Protocol Violation|0|||
105557521|NCT02308748|364037699|FG007|Period 3|Protocol Violation|0|||
105557522|NCT02308748|364037700|FG008|Period 3|Protocol Violation|0|||
105557523|NCT02308748|364037701|FG009|Period 3|Protocol Violation|1|||
105557524|NCT02308748|364037692|FG000|Period 5|Adverse Event|1|||
105557525|NCT02308748|364037693|FG001|Period 5|Adverse Event|0|||
105557526|NCT02308748|364037694|FG002|Period 5|Adverse Event|0|||
105557527|NCT02308748|364037695|FG003|Period 5|Adverse Event|0|||
105557528|NCT02308748|364037696|FG004|Period 5|Adverse Event|0|||
105557529|NCT02308748|364037697|FG005|Period 5|Adverse Event|0|||
105557530|NCT02308748|364037698|FG006|Period 5|Adverse Event|0|||
105557531|NCT02308748|364037699|FG007|Period 5|Adverse Event|0|||
105557532|NCT02308748|364037700|FG008|Period 5|Adverse Event|1|||
105557533|NCT02308748|364037701|FG009|Period 5|Adverse Event|0|||
105557534|NCT02081846|364037703|FG000|Overall Study|Withdrawal by Subject|1|||
105557535|NCT02081846|364037704|FG001|Overall Study|Withdrawal by Subject|0|||
105557536|NCT02081846|364037703|FG000|Overall Study|invalid consent|1|||
105557537|NCT02081846|364037704|FG001|Overall Study|invalid consent|0|||
105557538|NCT02491671|364037707|FG000|Overall Study|Adverse Event|6|||
105557539|NCT02491671|364037708|FG001|Overall Study|Adverse Event|8|||
105557540|NCT02491671|364037707|FG000|Overall Study|Death|0|||
105557541|NCT02491671|364037708|FG001|Overall Study|Death|2|||
105557542|NCT02491671|364037707|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
105557543|NCT02491671|364037708|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
105557544|NCT02199028|364037711|FG000|Week 1|Adverse Event|1|||
105557545|NCT02199028|364037712|FG001|Week 1|Adverse Event|0|||
105557546|NCT02199028|364037711|FG000|Week 3|Adverse Event|1|||
105557547|NCT02199028|364037712|FG001|Week 3|Adverse Event|0|||
105557548|NCT01090453|364037713|FG000|Overall Study|Withdrawal by Subject|1|||
105557549|NCT01090453|364037714|FG001|Overall Study|Withdrawal by Subject|2|||
105557550|NCT01090453|364037713|FG000|Overall Study|Lost to Follow-up|7|||
105557551|NCT01090453|364037714|FG001|Overall Study|Lost to Follow-up|7|||
105557552|NCT01090453|364037713|FG000|Overall Study|Non serious AEs|1|||
105557553|NCT01090453|364037714|FG001|Overall Study|Non serious AEs|0|||
105557554|NCT01090453|364037713|FG000|Overall Study|Protocol Violation|2|||
105557555|NCT01090453|364037714|FG001|Overall Study|Protocol Violation|0|||
105557556|NCT01090453|364037713|FG000|Overall Study|Other|2|||
105557557|NCT01090453|364037714|FG001|Overall Study|Other|4|||
105557558|NCT01090453|364037713|FG000|Overall Study|Eligibility Criteria|0|||
105557559|NCT01090453|364037714|FG001|Overall Study|Eligibility Criteria|1|||
105557560|NCT05045625|364037715|FG000|Overall Study|Lost to Follow-up|3|||
105557561|NCT03570619|364037720|FG000|Overall Study|Adverse Event|2|||
105557562|NCT03570619|364037721|FG001|Overall Study|Adverse Event|0|||
105557563|NCT03570619|364037722|FG002|Overall Study|Adverse Event|1|||
105557564|NCT03570619|364037720|FG000|Overall Study|new diagnosis of new malignancy|1|||
105557565|NCT03570619|364037721|FG001|Overall Study|new diagnosis of new malignancy|0|||
105557566|NCT03570619|364037722|FG002|Overall Study|new diagnosis of new malignancy|0|||
105557567|NCT03570619|364037720|FG000|Overall Study|Physician Decision|1|||
105557568|NCT03570619|364037721|FG001|Overall Study|Physician Decision|1|||
105557569|NCT03570619|364037722|FG002|Overall Study|Physician Decision|0|||
105557570|NCT03570619|364037720|FG000|Overall Study|Withdrawal by Subject|0|||
105557571|NCT03570619|364037721|FG001|Overall Study|Withdrawal by Subject|2|||
105557572|NCT03570619|364037722|FG002|Overall Study|Withdrawal by Subject|0|||
105557573|NCT00802074|364037725|FG000|Overall Study|Adverse Event|1|||
105557574|NCT00802074|364037726|FG001|Overall Study|Adverse Event|1|||
105557575|NCT00802074|364037727|FG002|Overall Study|Adverse Event|1|||
105679621|NCT01034163|364489711|FG001|Overall Study|Withdrawal by Subject|2|||
105679622|NCT01034163|364489710|FG000|Overall Study|Protocol deviation|1|||
105557576|NCT00802074|364037728|FG003|Overall Study|Adverse Event|0|||
105557577|NCT00802074|364037729|FG004|Overall Study|Adverse Event|0|||
105557578|NCT00802074|364037730|FG005|Overall Study|Adverse Event|0|||
105557579|NCT00802074|364037725|FG000|Overall Study|Withdrawal by Subject|1|||
105557580|NCT00802074|364037726|FG001|Overall Study|Withdrawal by Subject|0|||
105679623|NCT01034163|364489711|FG001|Overall Study|Protocol deviation|0|||
105679624|NCT01034163|364489710|FG000|Overall Study|Disease progression|3|||
105679625|NCT01034163|364489711|FG001|Overall Study|Disease progression|4|||
105679626|NCT01034163|364489710|FG000|Overall Study|Adverse Event|6|||
105679627|NCT01034163|364489711|FG001|Overall Study|Adverse Event|0|||
105679628|NCT01034163|364489710|FG000|Overall Study|Administrative problems|0|||
105679629|NCT01034163|364489711|FG001|Overall Study|Administrative problems|1|||
105679630|NCT01034163|364489710|FG000|Overall Study|Abnormal laboratory value|1|||
105679631|NCT01034163|364489711|FG001|Overall Study|Abnormal laboratory value|0|||
105679632|NCT00752557|364489712|FG000|Overall Study|Withdrawal by Subject|4|||
105679633|NCT00752557|364489713|FG001|Overall Study|Withdrawal by Subject|3|||
105679634|NCT00752557|364489714|FG002|Overall Study|Withdrawal by Subject|3|||
105679635|NCT00752557|364489712|FG000|Overall Study|Unspecified resaons|0|||
105679636|NCT00752557|364489713|FG001|Overall Study|Unspecified resaons|2|||
105679637|NCT00752557|364489714|FG002|Overall Study|Unspecified resaons|2|||
105679638|NCT00752557|364489712|FG000|Overall Study|Lost to Follow-up|1|||
105679639|NCT00752557|364489713|FG001|Overall Study|Lost to Follow-up|0|||
105679640|NCT00752557|364489714|FG002|Overall Study|Lost to Follow-up|1|||
105679641|NCT02150343|364489715|FG000|Overall Study|Adverse Event|2|||
105679642|NCT02150343|364489716|FG001|Overall Study|Adverse Event|0|||
105679643|NCT02150343|364489717|FG002|Overall Study|Adverse Event|1|||
105679644|NCT02150343|364489718|FG003|Overall Study|Adverse Event|1|||
105679645|NCT02150343|364489715|FG000|Overall Study|Withdrawal by Subject|13|||
105679646|NCT02150343|364489716|FG001|Overall Study|Withdrawal by Subject|10|||
105679647|NCT02150343|364489717|FG002|Overall Study|Withdrawal by Subject|9|||
105679648|NCT02150343|364489718|FG003|Overall Study|Withdrawal by Subject|4|||
105679649|NCT02150343|364489715|FG000|Overall Study|Lost to Follow-up|4|||
105679650|NCT02150343|364489716|FG001|Overall Study|Lost to Follow-up|4|||
105679651|NCT02150343|364489717|FG002|Overall Study|Lost to Follow-up|2|||
105679652|NCT02150343|364489718|FG003|Overall Study|Lost to Follow-up|3|||
105679653|NCT02150343|364489715|FG000|Overall Study|Other|2|||
105679654|NCT02150343|364489716|FG001|Overall Study|Other|6|||
105679655|NCT02150343|364489717|FG002|Overall Study|Other|0|||
105679656|NCT02150343|364489718|FG003|Overall Study|Other|2|||
105679657|NCT00190749|364489719|FG000|Overall Study|Lost to Follow-up|8|||
105679658|NCT00190749|364489720|FG001|Overall Study|Lost to Follow-up|11|||
105679659|NCT00190749|364489719|FG000|Overall Study|Withdrawal by Subject|10|||
105679660|NCT00190749|364489720|FG001|Overall Study|Withdrawal by Subject|6|||
105679661|NCT00190749|364489719|FG000|Overall Study|Protocol Violation|5|||
105679662|NCT00190749|364489720|FG001|Overall Study|Protocol Violation|4|||
105679663|NCT00190749|364489719|FG000|Overall Study|Adverse Event|0|||
105679664|NCT00190749|364489720|FG001|Overall Study|Adverse Event|5|||
105679665|NCT00190749|364489719|FG000|Overall Study|Lack of Efficacy|2|||
105679666|NCT00190749|364489720|FG001|Overall Study|Lack of Efficacy|3|||
105679667|NCT00190749|364489719|FG000|Overall Study|Reason Not Specified|0|||
105679668|NCT00190749|364489720|FG001|Overall Study|Reason Not Specified|2|||
105679669|NCT00190749|364489719|FG000|Overall Study|Sponsor Decision|1|||
105679670|NCT00190749|364489720|FG001|Overall Study|Sponsor Decision|0|||
105679671|NCT02729753|364489721|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
105679672|NCT02729753|364489722|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
105679673|NCT01154010|364489723|FG000|Overall Study|Lost to Follow-up|0|||
105679674|NCT01154010|364489724|FG001|Overall Study|Lost to Follow-up|1|||
105679675|NCT02413333|364489727|FG000|Period 1|Adverse Event|1|||
105679676|NCT02413333|364489728|FG001|Period 1|Adverse Event|0|||
105679677|NCT02413333|364489727|FG000|Period 1|Reason Not Specified|0|||
105679678|NCT02413333|364489728|FG001|Period 1|Reason Not Specified|1|||
105679679|NCT02413333|364489727|FG000|Period 2|Protocol Deviation|1|||
105679680|NCT02413333|364489728|FG001|Period 2|Protocol Deviation|0|||
105679681|NCT02414932|364489729|FG000|Overall Study|Withdrawal by Subject|2|||
105679682|NCT02414932|364489730|FG001|Overall Study|Withdrawal by Subject|3|||
105679683|NCT02414932|364489729|FG000|Overall Study|Adverse Event|1|||
105679684|NCT02414932|364489730|FG001|Overall Study|Adverse Event|0|||
105679685|NCT01771107|364489731|FG000|Overall Study|Adverse Event|1|||
105679686|NCT01771107|364489732|FG001|Overall Study|Adverse Event|3|||
105679687|NCT01771107|364489731|FG000|Overall Study|Withdrawal by Subject|0|||
105679688|NCT01771107|364489732|FG001|Overall Study|Withdrawal by Subject|2|||
105679689|NCT01771107|364489731|FG000|Overall Study|Lost to Follow-up|0|||
105679690|NCT01771107|364489732|FG001|Overall Study|Lost to Follow-up|1|||
105679691|NCT01771107|364489731|FG000|Overall Study|participant moved|0|||
105679692|NCT01771107|364489732|FG001|Overall Study|participant moved|1|||
105679693|NCT01771107|364489731|FG000|Overall Study|Other|0|||
105679694|NCT01771107|364489732|FG001|Overall Study|Other|1|||
105679695|NCT02891837|364489734|FG000|Overall Study|Lost to Follow-up|2|||
105679696|NCT02891837|364489735|FG001|Overall Study|Lost to Follow-up|0|||
105679697|NCT02891837|364489734|FG000|Overall Study|Withdrawal by Subject|1|||
105679698|NCT02891837|364489735|FG001|Overall Study|Withdrawal by Subject|0|||
105679699|NCT00709852|364489736|FG000|Period 1|Adverse Event|2|||
105679700|NCT00709852|364489737|FG001|Period 1|Adverse Event|0|||
105679701|NCT00709852|364489736|FG000|Period 1|Withdrawal by Subject|4|||
105679702|NCT00709852|364489737|FG001|Period 1|Withdrawal by Subject|2|||
105344226|NCT02543892|363261714|FG002|Received Vaccination 2|Adverse Event|0|||
105344227|NCT02543892|363261715|FG003|Received Vaccination 2|Adverse Event|0|||
105344228|NCT02543892|363261716|FG004|Received Vaccination 2|Adverse Event|0|||
105344229|NCT02543892|363261717|FG005|Received Vaccination 2|Adverse Event|0|||
105344230|NCT02543892|363261718|FG006|Received Vaccination 2|Adverse Event|0|||
105679703|NCT00709852|364489736|FG000|Period 1|Protocol Violation|1|||
105679704|NCT00709852|364489737|FG001|Period 1|Protocol Violation|0|||
105679705|NCT00709852|364489736|FG000|Period 1|Defective scanner|0|||
105679706|NCT00709852|364489737|FG001|Period 1|Defective scanner|1|||
105679707|NCT00709852|364489736|FG000|Period 1|Lost to Follow-up|1|||
105679708|NCT00709852|364489737|FG001|Period 1|Lost to Follow-up|0|||
105679709|NCT00709852|364489736|FG000|Period 2|Protocol Violation|4|||
105679710|NCT00709852|364489737|FG001|Period 2|Protocol Violation|1|||
105679711|NCT00709852|364489736|FG000|Period 2|Adverse Event|1|||
105679712|NCT00709852|364489737|FG001|Period 2|Adverse Event|1|||
105679713|NCT00709852|364489736|FG000|Period 2|Lost to Follow-up|1|||
105679714|NCT00709852|364489737|FG001|Period 2|Lost to Follow-up|0|||
105679715|NCT00709852|364489736|FG000|Period 2|No 72-hour follow-up|3|||
105679716|NCT00709852|364489737|FG001|Period 2|No 72-hour follow-up|0|||
105679717|NCT01021215|364489744|FG000|Overall Study|Lost to Follow-up|3|||
105679718|NCT01021215|364489745|FG001|Overall Study|Lost to Follow-up|0|||
105679719|NCT00185965|364489746|FG000|Overall Study|Adverse Event|0|||
105679720|NCT00185965|364489747|FG001|Overall Study|Adverse Event|1|||
105679721|NCT02533531|364489748|FG000|Overall Study|Device did not turn on|1|||
105679722|NCT02689518|364489749|FG000|Overall Study|Withdrawal by Subject|3|||
105679723|NCT02433340|364489750|FG000|Overall Study|Adverse Event|0|||
105679724|NCT02433340|364489751|FG001|Overall Study|Adverse Event|0|||
105679725|NCT02433340|364489752|FG002|Overall Study|Adverse Event|1|||
105679726|NCT02433340|364489753|FG003|Overall Study|Adverse Event|0|||
105679727|NCT02433340|364489750|FG000|Overall Study|Withdrawal by Subject|1|||
105679728|NCT02433340|364489751|FG001|Overall Study|Withdrawal by Subject|0|||
105679729|NCT02433340|364489752|FG002|Overall Study|Withdrawal by Subject|1|||
105679730|NCT02433340|364489753|FG003|Overall Study|Withdrawal by Subject|2|||
105679731|NCT02433340|364489750|FG000|Overall Study|Lost to Follow-up|0|||
105679732|NCT02433340|364489751|FG001|Overall Study|Lost to Follow-up|1|||
105679733|NCT02433340|364489752|FG002|Overall Study|Lost to Follow-up|0|||
105679734|NCT02433340|364489753|FG003|Overall Study|Lost to Follow-up|0|||
105679735|NCT02433340|364489750|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
105679736|NCT02433340|364489751|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
105679737|NCT02433340|364489752|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
105679738|NCT02433340|364489753|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
105679739|NCT02433340|364489750|FG000|Overall Study|Other|0|||
105679740|NCT02433340|364489751|FG001|Overall Study|Other|1|||
105679741|NCT02433340|364489752|FG002|Overall Study|Other|0|||
105679742|NCT02433340|364489753|FG003|Overall Study|Other|0|||
105679743|NCT01285609|364489754|FG000|Randomized|Progressive Disease|41|||
105679744|NCT01285609|364489755|FG001|Randomized|Progressive Disease|61|||
105679745|NCT01285609|364489754|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
105679746|NCT01285609|364489755|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
105679747|NCT01285609|364489754|FG000|Randomized|Study Drug Toxicity|13|||
105679748|NCT01285609|364489755|FG001|Randomized|Study Drug Toxicity|14|||
105679749|NCT01285609|364489754|FG000|Randomized|Death|5|||
105679750|NCT01285609|364489755|FG001|Randomized|Death|7|||
105679751|NCT01285609|364489754|FG000|Randomized|Withdrawal by Subject|8|||
105679752|NCT01285609|364489755|FG001|Randomized|Withdrawal by Subject|11|||
105679753|NCT01285609|364489754|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
105679754|NCT01285609|364489755|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
105679755|NCT01285609|364489754|FG000|Randomized|Undisclosed Reasons|1|||
105679756|NCT01285609|364489755|FG001|Randomized|Undisclosed Reasons|0|||
105344231|NCT02543892|363261719|FG007|Received Vaccination 2|Adverse Event|0|||
105344232|NCT02543892|363261712|FG000|Had Immunology Data|Withdrawal by Subject|0|||
105468594|NCT00084136|363725930|FG001|NRTI Comparison|Clinic site closed|0|||
105468595|NCT00084136|363725931|FG002|NRTI Comparison|Clinic site closed|14|||
105679757|NCT01285609|364489754|FG000|Randomized|Randomized but not Treated|4|||
105679758|NCT01285609|364489755|FG001|Randomized|Randomized but not Treated|4|||
105679759|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
105679760|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
105679761|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
105679762|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
105679763|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
105679764|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
105679765|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
105679766|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
105679767|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Death|11|||
105344233|NCT02543892|363261713|FG001|Had Immunology Data|Withdrawal by Subject|0|||
105679768|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Death|3|||
105679769|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
105679770|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
105679771|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Not Reported|0|||
105679772|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Not Reported|2|||
105679773|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
105679774|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
105679775|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
105679776|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
105679777|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
105679778|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
105679779|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
105679780|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
105679781|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
105679782|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
105679783|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
105679784|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
105679785|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
105679786|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
105679787|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
105679788|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
105679789|NCT01285609|364489754|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
105679790|NCT01285609|364489755|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
105679791|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
105679792|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
105679793|NCT03616977|364489761|FG000|Period 1|Physician Decision|0|||
105679794|NCT03616977|364489762|FG001|Period 1|Physician Decision|1|||
105679795|NCT03616977|364489761|FG000|Period 3|Adverse Event|1|||
105679796|NCT03616977|364489762|FG001|Period 3|Adverse Event|1|||
105679797|NCT02559895|364489763|FG000|Overall Study|Adverse Event|3|||
105679798|NCT02559895|364489764|FG001|Overall Study|Adverse Event|3|||
105679799|NCT02559895|364489765|FG002|Overall Study|Adverse Event|2|||
105679800|NCT02559895|364489766|FG003|Overall Study|Adverse Event|1|||
105679801|NCT02559895|364489763|FG000|Overall Study|Lack of Efficacy|2|||
105679802|NCT02559895|364489764|FG001|Overall Study|Lack of Efficacy|3|||
105679803|NCT02559895|364489765|FG002|Overall Study|Lack of Efficacy|2|||
105679804|NCT02559895|364489766|FG003|Overall Study|Lack of Efficacy|8|||
105679805|NCT02559895|364489763|FG000|Overall Study|Lost to Follow-up|22|||
105679806|NCT02559895|364489764|FG001|Overall Study|Lost to Follow-up|16|||
105679807|NCT02559895|364489765|FG002|Overall Study|Lost to Follow-up|12|||
105679808|NCT02559895|364489766|FG003|Overall Study|Lost to Follow-up|17|||
105679809|NCT02559895|364489763|FG000|Overall Study|Physician Decision|1|||
105679810|NCT02559895|364489764|FG001|Overall Study|Physician Decision|1|||
105679811|NCT02559895|364489765|FG002|Overall Study|Physician Decision|3|||
105679812|NCT02559895|364489766|FG003|Overall Study|Physician Decision|0|||
105679813|NCT02559895|364489763|FG000|Overall Study|Withdrawal by Subject|16|||
105679814|NCT02559895|364489764|FG001|Overall Study|Withdrawal by Subject|9|||
105679815|NCT02559895|364489765|FG002|Overall Study|Withdrawal by Subject|20|||
105679816|NCT02559895|364489766|FG003|Overall Study|Withdrawal by Subject|9|||
105679817|NCT02559895|364489763|FG000|Overall Study|Study Burden|10|||
105679818|NCT02559895|364489764|FG001|Overall Study|Study Burden|16|||
105679819|NCT02559895|364489765|FG002|Overall Study|Study Burden|12|||
105679820|NCT02559895|364489766|FG003|Overall Study|Study Burden|22|||
105679821|NCT02559895|364489763|FG000|Overall Study|Other|1|||
105679822|NCT02559895|364489764|FG001|Overall Study|Other|5|||
105679823|NCT02559895|364489765|FG002|Overall Study|Other|3|||
105679824|NCT02559895|364489766|FG003|Overall Study|Other|3|||
105679825|NCT03683823|364489772|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
105679826|NCT03683823|364489773|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
105679827|NCT03683823|364489772|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
105679828|NCT03683823|364489773|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
105679829|NCT03683823|364489772|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
105679830|NCT03683823|364489773|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
105679831|NCT01049217|364489782|FG000|Overall Study|Adverse Event|2|||
105679832|NCT01049217|364489783|FG001|Overall Study|Adverse Event|1|||
105679833|NCT01049217|364489782|FG000|Overall Study|Lack of Efficacy|1|||
105679834|NCT01049217|364489783|FG001|Overall Study|Lack of Efficacy|1|||
105679835|NCT01049217|364489782|FG000|Overall Study|Lost to Follow-up|3|||
105468596|NCT00084136|363725929|FG000|NRTI Comparison|Not reason above|1|||
105468597|NCT00084136|363725930|FG001|NRTI Comparison|Not reason above|0|||
105679836|NCT01049217|364489783|FG001|Overall Study|Lost to Follow-up|8|||
105679837|NCT01049217|364489782|FG000|Overall Study|Withdrawal by Subject|4|||
105679838|NCT01049217|364489783|FG001|Overall Study|Withdrawal by Subject|3|||
105679839|NCT01049217|364489782|FG000|Overall Study|Protocol Violation|1|||
105679840|NCT01049217|364489783|FG001|Overall Study|Protocol Violation|3|||
105679841|NCT01049217|364489782|FG000|Overall Study|Pregnancy|1|||
105679842|NCT01049217|364489783|FG001|Overall Study|Pregnancy|0|||
105679843|NCT01049217|364489782|FG000|Overall Study|Study Terminated by Sponsor|43|||
105679844|NCT01049217|364489783|FG001|Overall Study|Study Terminated by Sponsor|43|||
105679845|NCT01049217|364489782|FG000|Overall Study|Other|1|||
105679846|NCT01049217|364489783|FG001|Overall Study|Other|2|||
105679847|NCT01049217|364489782|FG000|Overall Study|Randomized but not Treated|0|||
105679848|NCT01049217|364489783|FG001|Overall Study|Randomized but not Treated|2|||
105679849|NCT00589121|364489784|FG000|Overall Study|Protocol Violation|2|||
105679850|NCT00589121|364489785|FG001|Overall Study|Protocol Violation|6|||
105679851|NCT00589121|364489784|FG000|Overall Study|No protocol treatment received|0|||
105679852|NCT00589121|364489785|FG001|Overall Study|No protocol treatment received|1|||
105679853|NCT00112047|364489790|FG000|Randomized Phase|Lost to Follow-up|26|||
105679854|NCT00112047|364489791|FG001|Randomized Phase|Lost to Follow-up|33|||
105679855|NCT00112047|364489790|FG000|Randomized Phase|Adverse Event|10|||
105679856|NCT00112047|364489791|FG001|Randomized Phase|Adverse Event|10|||
105679857|NCT00112047|364489790|FG000|Randomized Phase|Withrawal of consent|10|||
105679858|NCT00112047|364489791|FG001|Randomized Phase|Withrawal of consent|18|||
105679859|NCT00112047|364489790|FG000|Randomized Phase|Sub-optimal virological response|3|||
105679860|NCT00112047|364489791|FG001|Randomized Phase|Sub-optimal virological response|13|||
105679861|NCT00112047|364489790|FG000|Randomized Phase|Noncompliance|8|||
105679862|NCT00112047|364489791|FG001|Randomized Phase|Noncompliance|4|||
105679863|NCT00112047|364489790|FG000|Randomized Phase|Protocol Violation|2|||
105679864|NCT00112047|364489791|FG001|Randomized Phase|Protocol Violation|0|||
105679865|NCT00112047|364489790|FG000|Randomized Phase|Pregnancy|3|||
105679866|NCT00112047|364489791|FG001|Randomized Phase|Pregnancy|1|||
105679867|NCT00112047|364489790|FG000|Randomized Phase|Death|1|||
105679868|NCT00112047|364489791|FG001|Randomized Phase|Death|3|||
105468598|NCT00084136|363725931|FG002|NRTI Comparison|Not reason above|0|||
105468599|NCT02230670|363725932|FG000|Overall Study|Adverse Event|1|||
105468600|NCT02230670|363725933|FG001|Overall Study|Adverse Event|2|||
105468601|NCT02230670|363725932|FG000|Overall Study|Withdrawal by Subject|2|||
105468602|NCT02230670|363725933|FG001|Overall Study|Withdrawal by Subject|2|||
105468603|NCT02230670|363725932|FG000|Overall Study|Physician Decision|0|||
105468604|NCT02230670|363725933|FG001|Overall Study|Physician Decision|1|||
105468605|NCT02230670|363725932|FG000|Overall Study|Protocol Violation|0|||
105468606|NCT02230670|363725933|FG001|Overall Study|Protocol Violation|1|||
105468607|NCT02230670|363725932|FG000|Overall Study|Progression to Child-Pugh C|1|||
105468608|NCT02230670|363725933|FG001|Overall Study|Progression to Child-Pugh C|2|||
105468609|NCT00892099|363725939|FG000|Overall Study|Death|1|||
105468610|NCT00892099|363725940|FG001|Overall Study|Death|0|||
105468611|NCT00892099|363725941|FG002|Overall Study|Death|1|||
105468612|NCT00892099|363725939|FG000|Overall Study|Adverse Event|1|||
105468613|NCT00892099|363725940|FG001|Overall Study|Adverse Event|0|||
105468614|NCT00892099|363725941|FG002|Overall Study|Adverse Event|0|||
105468615|NCT00892099|363725939|FG000|Overall Study|replocated|1|||
105468616|NCT00892099|363725940|FG001|Overall Study|replocated|0|||
105468617|NCT00892099|363725941|FG002|Overall Study|replocated|2|||
105468618|NCT00892099|363725939|FG000|Overall Study|Prolonged hospitalization|1|||
105468619|NCT00892099|363725940|FG001|Overall Study|Prolonged hospitalization|0|||
105468620|NCT00892099|363725941|FG002|Overall Study|Prolonged hospitalization|1|||
105468621|NCT00892099|363725939|FG000|Overall Study|no further details|1|||
105468622|NCT00892099|363725940|FG001|Overall Study|no further details|0|||
105468623|NCT00892099|363725941|FG002|Overall Study|no further details|1|||
105468624|NCT00892099|363725939|FG000|Overall Study|kidney function recovered|0|||
105468625|NCT00892099|363725940|FG001|Overall Study|kidney function recovered|1|||
105468626|NCT00892099|363725941|FG002|Overall Study|kidney function recovered|0|||
105468627|NCT00892099|363725939|FG000|Overall Study|investigator decision|0|||
105468628|NCT00892099|363725940|FG001|Overall Study|investigator decision|0|||
105468629|NCT00892099|363725941|FG002|Overall Study|investigator decision|1|||
105468630|NCT00892099|363725939|FG000|Overall Study|Lost to Follow-up|0|||
105468631|NCT00892099|363725940|FG001|Overall Study|Lost to Follow-up|0|||
105679869|NCT00112047|364489790|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
105679870|NCT00112047|364489791|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
105557581|NCT00802074|364037727|FG002|Overall Study|Withdrawal by Subject|0|||
105557582|NCT00802074|364037728|FG003|Overall Study|Withdrawal by Subject|0|||
105679871|NCT00112047|364489790|FG000|Randomized Phase|Inability to swallow pills|0|||
105679872|NCT00112047|364489791|FG001|Randomized Phase|Inability to swallow pills|1|||
105679873|NCT00112047|364489790|FG000|Randomized Phase|Incarceration|3|||
105679874|NCT00112047|364489791|FG001|Randomized Phase|Incarceration|2|||
105679875|NCT00112047|364489790|FG000|Randomized Phase|Moved out of State|0|||
105468632|NCT00892099|363725941|FG002|Overall Study|Lost to Follow-up|1|||
105468633|NCT01657019|363725942|FG000|Overall Study|Withdrawal by Subject|65|||
105468634|NCT01657019|363725942|FG000|Overall Study|Adverse Event|55|||
105468635|NCT01657019|363725942|FG000|Overall Study|Lost to Follow-up|48|||
105468636|NCT01657019|363725942|FG000|Overall Study|Protocol Violation|6|||
105557583|NCT00802074|364037729|FG004|Overall Study|Withdrawal by Subject|0|||
105468637|NCT01657019|363725942|FG000|Overall Study|Lack of Efficacy|3|||
105468638|NCT01657019|363725942|FG000|Overall Study|Other|58|||
105679876|NCT00112047|364489791|FG001|Randomized Phase|Moved out of State|1|||
105679877|NCT00112047|364489790|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
105679878|NCT00112047|364489791|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
105679879|NCT00112047|364489790|FG000|Randomized Phase|High Hepatitis B DNA|0|||
105679880|NCT00112047|364489791|FG001|Randomized Phase|High Hepatitis B DNA|1|||
105344234|NCT02543892|363261714|FG002|Had Immunology Data|Withdrawal by Subject|0|||
105344235|NCT02543892|363261715|FG003|Had Immunology Data|Withdrawal by Subject|0|||
105344236|NCT02543892|363261716|FG004|Had Immunology Data|Withdrawal by Subject|0|||
105344237|NCT02543892|363261717|FG005|Had Immunology Data|Withdrawal by Subject|0|||
105344238|NCT02543892|363261718|FG006|Had Immunology Data|Withdrawal by Subject|1|||
105344239|NCT02543892|363261719|FG007|Had Immunology Data|Withdrawal by Subject|0|||
105679881|NCT00112047|364489790|FG000|Atripla Phase|Adverse Event|2|||
105679882|NCT00112047|364489791|FG001|Atripla Phase|Adverse Event|1|||
105679883|NCT00112047|364489790|FG000|Atripla Phase|Lost to Follow-up|5|||
105679884|NCT00112047|364489791|FG001|Atripla Phase|Lost to Follow-up|7|||
105344240|NCT00785213|363261720|FG000|Quinine Sulfate Alone|Adverse Event|4|||
105344241|NCT00785213|363261720|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
105679885|NCT00112047|364489790|FG000|Atripla Phase|Pregnancy|0|||
105679886|NCT00112047|364489791|FG001|Atripla Phase|Pregnancy|1|||
105679887|NCT00112047|364489790|FG000|Atripla Phase|Death|0|||
105679888|NCT00112047|364489791|FG001|Atripla Phase|Death|2|||
105679889|NCT00112047|364489790|FG000|Atripla Phase|Withdrew consent|7|||
105344242|NCT02258542|363261721|FG000|Overall Study|eg. not made to the visit|7|||
105468639|NCT01544335|363725943|FG000|Overall Study|Lost to Follow-up|27|||
105679890|NCT00112047|364489791|FG001|Atripla Phase|Withdrew consent|7|||
105679891|NCT00112047|364489790|FG000|Atripla Phase|Sub-optimal virological response|0|||
105679892|NCT00112047|364489791|FG001|Atripla Phase|Sub-optimal virological response|1|||
105679893|NCT00112047|364489790|FG000|Atripla Phase|Non-compliance|1|||
105679894|NCT00112047|364489791|FG001|Atripla Phase|Non-compliance|0|||
105679895|NCT00112047|364489790|FG000|Atripla Phase|Other|3|||
105679896|NCT00112047|364489791|FG001|Atripla Phase|Other|1|||
105679897|NCT01307579|364489792|FG000|Overall Study|Death|3|||
105679898|NCT01307579|364489793|FG001|Overall Study|Death|6|||
105679899|NCT01307579|364489792|FG000|Overall Study|Physician Decision|26|||
105679900|NCT01307579|364489793|FG001|Overall Study|Physician Decision|29|||
105679901|NCT01307579|364489792|FG000|Overall Study|Withdrawal by Subject|7|||
105679902|NCT01307579|364489793|FG001|Overall Study|Withdrawal by Subject|3|||
105679903|NCT01307579|364489792|FG000|Overall Study|Institutional diagnosis of IFD|21|||
105679904|NCT01307579|364489793|FG001|Overall Study|Institutional diagnosis of IFD|36|||
105679905|NCT01307579|364489792|FG000|Overall Study|Begin conditioning for HSCT|42|||
105679906|NCT01307579|364489793|FG001|Overall Study|Begin conditioning for HSCT|44|||
105679907|NCT01307579|364489792|FG000|Overall Study|Refractory or relapsed AML|38|||
105679908|NCT01307579|364489793|FG001|Overall Study|Refractory or relapsed AML|23|||
105679909|NCT01307579|364489792|FG000|Overall Study|Ineligible|3|||
105679910|NCT01307579|364489793|FG001|Overall Study|Ineligible|4|||
105679911|NCT00812331|364491355|FG000|Overall Study|Adverse Event|1|||
105679912|NCT00812331|364491356|FG001|Overall Study|Adverse Event|0|||
105679913|NCT00812331|364491357|FG002|Overall Study|Adverse Event|0|||
105679914|NCT00812331|364491358|FG003|Overall Study|Adverse Event|0|||
105679915|NCT00812331|364491359|FG004|Overall Study|Adverse Event|0|||
105679916|NCT01034176|364491360|FG000|Overall Study|Physician Decision|2|||
105679917|NCT01034176|364491361|FG001|Overall Study|Physician Decision|0|||
105679918|NCT01034176|364491360|FG000|Overall Study|Withdrawal by Subject|0|||
105679919|NCT01034176|364491361|FG001|Overall Study|Withdrawal by Subject|1|||
105679920|NCT01034176|364491360|FG000|Overall Study|Lost to Follow-up|0|||
105679921|NCT01034176|364491361|FG001|Overall Study|Lost to Follow-up|1|||
105679922|NCT02480153|364491367|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
105679923|NCT02480153|364491368|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
105679924|NCT02480153|364491369|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
105679925|NCT02480153|364491367|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
105679926|NCT02480153|364491368|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
105679927|NCT02480153|364491369|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
105679928|NCT02480153|364491367|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
105679929|NCT02480153|364491368|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
105679930|NCT02480153|364491369|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
105679931|NCT02480153|364491367|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
105679932|NCT02480153|364491368|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
105679933|NCT02480153|364491369|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
105679934|NCT02480153|364491367|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
105468640|NCT01544335|363725943|FG000|Overall Study|Death|4|||
105468641|NCT01544335|363725943|FG000|Overall Study|Disease progression|3|||
105468642|NCT01544335|363725943|FG000|Overall Study|Baseline Measurements not Available|19|||
105468643|NCT00419952|363725944|FG000|Overall Study|Adverse Event|8|||
105468644|NCT00419952|363725945|FG001|Overall Study|Adverse Event|10|||
105679935|NCT02480153|364491368|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
105679936|NCT02480153|364491369|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
105679937|NCT02480153|364491367|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
105679938|NCT02480153|364491368|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
105679939|NCT02480153|364491369|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
105679940|NCT02480153|364491367|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
105679941|NCT02480153|364491368|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
105679942|NCT02480153|364491369|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
105679943|NCT02480153|364491367|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
105344243|NCT02258542|363261722|FG001|Overall Study|eg. not made to the visit|4|||
105344244|NCT02258542|363261723|FG002|Overall Study|eg. not made to the visit|0|||
105344245|NCT02258542|363261724|FG003|Overall Study|eg. not made to the visit|1|||
105344246|NCT02258542|363261721|FG000|Overall Study|study specific discount. criteria|1|||
105344247|NCT02258542|363261722|FG001|Overall Study|study specific discount. criteria|1|||
105344248|NCT02258542|363261723|FG002|Overall Study|study specific discount. criteria|0|||
105344249|NCT02258542|363261724|FG003|Overall Study|study specific discount. criteria|0|||
105344250|NCT02258542|363261721|FG000|Overall Study|Withdrawal by Subject|20|||
105344251|NCT02258542|363261722|FG001|Overall Study|Withdrawal by Subject|20|||
105344252|NCT02258542|363261723|FG002|Overall Study|Withdrawal by Subject|7|||
105344253|NCT02258542|363261724|FG003|Overall Study|Withdrawal by Subject|1|||
105344254|NCT02258542|363261721|FG000|Overall Study|Lost to Follow-up|5|||
105344255|NCT02258542|363261722|FG001|Overall Study|Lost to Follow-up|12|||
105344256|NCT02258542|363261723|FG002|Overall Study|Lost to Follow-up|1|||
105344257|NCT02258542|363261724|FG003|Overall Study|Lost to Follow-up|2|||
105344258|NCT02258542|363261721|FG000|Overall Study|Death|5|||
105344259|NCT02258542|363261722|FG001|Overall Study|Death|4|||
105344260|NCT02258542|363261723|FG002|Overall Study|Death|0|||
105344261|NCT02258542|363261724|FG003|Overall Study|Death|1|||
105344262|NCT02258542|363261721|FG000|Overall Study|Adverse Event|3|||
105344263|NCT02258542|363261722|FG001|Overall Study|Adverse Event|4|||
105344264|NCT02258542|363261723|FG002|Overall Study|Adverse Event|0|||
105344265|NCT02258542|363261724|FG003|Overall Study|Adverse Event|0|||
105344266|NCT02258542|363261721|FG000|Overall Study|Protocol Violation|1|||
105344267|NCT02258542|363261722|FG001|Overall Study|Protocol Violation|2|||
105344268|NCT02258542|363261723|FG002|Overall Study|Protocol Violation|0|||
105344269|NCT02258542|363261724|FG003|Overall Study|Protocol Violation|0|||
105344270|NCT02258542|363261721|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105344271|NCT02258542|363261722|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
105344272|NCT02258542|363261723|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
105344273|NCT02258542|363261724|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
105344274|NCT02858180|363261731|FG000|Overall Study|Lost to Follow-up|0|||
105344275|NCT02858180|363261732|FG001|Overall Study|Lost to Follow-up|2|||
105344276|NCT00844480|363261733|FG000|Overall Study|Withdrawal by Subject|2|||
105344277|NCT00844480|363261734|FG001|Overall Study|Withdrawal by Subject|3|||
105344278|NCT00526331|363261735|FG000|Overall Study|Sponsor Termination|55|||
105344279|NCT00979420|363261736|FG000|Overall Study|Adverse Event|1|||
105344280|NCT00979420|363261737|FG001|Overall Study|Adverse Event|0|||
105344281|NCT00979420|363261738|FG002|Overall Study|Adverse Event|0|||
105344282|NCT00979420|363261739|FG003|Overall Study|Adverse Event|0|||
105344283|NCT00979420|363261736|FG000|Overall Study|Lack of Efficacy|3|||
105344284|NCT00979420|363261737|FG001|Overall Study|Lack of Efficacy|0|||
105344285|NCT00979420|363261738|FG002|Overall Study|Lack of Efficacy|1|||
105344286|NCT00979420|363261739|FG003|Overall Study|Lack of Efficacy|1|||
105344287|NCT00979420|363261736|FG000|Overall Study|Other reasons not related to Viramune|3|||
105344288|NCT00979420|363261737|FG001|Overall Study|Other reasons not related to Viramune|0|||
105344289|NCT00979420|363261738|FG002|Overall Study|Other reasons not related to Viramune|0|||
105344290|NCT00979420|363261739|FG003|Overall Study|Other reasons not related to Viramune|1|||
105344291|NCT05087966|363261742|FG000|Overall Study|Lost to Follow-up|1|||
105344292|NCT05087966|363261742|FG000|Overall Study|Withdrawal by Subject|5|||
105468645|NCT00419952|363725944|FG000|Overall Study|Withdrawal by Subject|44|||
105468646|NCT00419952|363725945|FG001|Overall Study|Withdrawal by Subject|43|||
105468647|NCT00419952|363725944|FG000|Overall Study|Lost to Follow-up|43|||
105468648|NCT00419952|363725945|FG001|Overall Study|Lost to Follow-up|34|||
105468649|NCT00419952|363725944|FG000|Overall Study|Protocol Violation|32|||
105468650|NCT00419952|363725945|FG001|Overall Study|Protocol Violation|24|||
105468651|NCT00419952|363725944|FG000|Overall Study|Pregnancy|4|||
105468652|NCT00419952|363725945|FG001|Overall Study|Pregnancy|2|||
105468653|NCT00419952|363725944|FG000|Overall Study|Physician Decision|1|||
105468654|NCT00419952|363725945|FG001|Overall Study|Physician Decision|3|||
105557584|NCT00802074|364037730|FG005|Overall Study|Withdrawal by Subject|0|||
105557585|NCT00843167|364037733|FG000|Treatment Period|Adverse Event|1|||
105557586|NCT00843167|364037734|FG001|Treatment Period|Adverse Event|5|||
105344293|NCT04050124|363261743|FG000|Overall Study|Death|1|||
105344294|NCT04050124|363261744|FG001|Overall Study|Death|0|||
105344295|NCT03099694|363261746|FG000|Overall Study|Withdrawal by Subject|11|||
105468655|NCT00419952|363725944|FG000|Overall Study|Incorrectly enrolled|10|||
105468656|NCT00419952|363725945|FG001|Overall Study|Incorrectly enrolled|3|||
105557587|NCT00843167|364037733|FG000|Treatment Period|Withdrawal by Subject|2|||
105344296|NCT03099694|363261747|FG001|Overall Study|Withdrawal by Subject|13|||
105344297|NCT03099694|363261746|FG000|Overall Study|Lost to Follow-up|9|||
105344298|NCT03099694|363261747|FG001|Overall Study|Lost to Follow-up|5|||
105344299|NCT00381043|363261748|FG000|Overall Study|Lost to Follow-up|8|||
105344300|NCT00381043|363261749|FG001|Overall Study|Lost to Follow-up|6|||
105344301|NCT00381043|363261748|FG000|Overall Study|Withdrawal by Subject|3|||
105344302|NCT00381043|363261749|FG001|Overall Study|Withdrawal by Subject|1|||
105468657|NCT00419952|363725944|FG000|Overall Study|Intake of prohibited medication|2|||
105557588|NCT00843167|364037734|FG001|Treatment Period|Withdrawal by Subject|3|||
105679944|NCT02480153|364491368|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
105679945|NCT02480153|364491369|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
105679946|NCT02480153|364491367|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
105679947|NCT02480153|364491368|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
105679948|NCT02480153|364491369|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
105679949|NCT02480153|364491367|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
105679950|NCT02480153|364491368|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
105679951|NCT02480153|364491369|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
105679952|NCT02480153|364491367|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
105679953|NCT02480153|364491368|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
105679954|NCT02480153|364491369|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
105679955|NCT02480153|364491367|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
105679956|NCT02480153|364491368|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
105679957|NCT02480153|364491369|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
105679958|NCT02480153|364491367|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
105679959|NCT02480153|364491368|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
105679960|NCT02480153|364491369|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
105679961|NCT02480153|364491367|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
105679962|NCT02480153|364491368|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
105679963|NCT02480153|364491369|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
105679964|NCT02480153|364491367|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
105679965|NCT02480153|364491368|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
105679966|NCT02480153|364491369|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
105679967|NCT02480153|364491367|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
105679968|NCT02480153|364491368|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
105679969|NCT02480153|364491369|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
105679970|NCT02480153|364491367|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
105679971|NCT02480153|364491368|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
105679972|NCT02480153|364491369|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
105679973|NCT02480153|364491367|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
105679974|NCT02480153|364491368|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
105679975|NCT02480153|364491369|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
105679976|NCT00297232|364491374|FG000|Overall Study|Lack of Efficacy|7|||
105679977|NCT00297232|364491374|FG000|Overall Study|Lost to Follow-up|10|||
105679978|NCT00297232|364491374|FG000|Overall Study|Adverse Event|63|||
105679979|NCT00297232|364491374|FG000|Overall Study|Voluntary Withdrawal|120|||
105679980|NCT00297232|364491374|FG000|Overall Study|Subject was Noncompliant|9|||
105679981|NCT00297232|364491374|FG000|Overall Study|Death|9|||
105679982|NCT00297232|364491374|FG000|Overall Study|Anti-natalizumab Positive|8|||
105679983|NCT00297232|364491374|FG000|Overall Study|Switched to Commercial Tysabri|22|||
105679984|NCT00297232|364491374|FG000|Overall Study|Disease Progression|8|||
105679985|NCT00297232|364491374|FG000|Overall Study|Fear of PML|10|||
105679986|NCT00297232|364491374|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
105679987|NCT00297232|364491374|FG000|Overall Study|Miscellaneous|5|||
105679988|NCT00297232|364491374|FG000|Overall Study|Sponsor Decision|34|||
105679989|NCT00297232|364491374|FG000|Overall Study|Subject Relocated|7|||
105679990|NCT00297232|364491374|FG000|Overall Study|Subject Withdrew Consent|37|||
105679991|NCT00297232|364491374|FG000|Overall Study|Persistently Positive Antibodies|11|||
105679992|NCT00297232|364491374|FG000|Overall Study|Investigator Withdrew From Program|19|||
105679993|NCT00297232|364491374|FG000|Overall Study|Did Not Enroll to Week 264|34|||
105679994|NCT00297232|364491374|FG000|Overall Study|Did Not Enroll to Week 480|17|||
105679995|NCT00297232|364491374|FG000|Overall Study|No data available after Week 264|161|||
105679996|NCT00297232|364491374|FG000|Overall Study|Other|1|||
105679997|NCT02257567|364491375|FG000|Overall Study|Adverse Event|0|||
105679998|NCT02257567|364491376|FG001|Overall Study|Adverse Event|0|||
105679999|NCT02257567|364491377|FG002|Overall Study|Adverse Event|0|||
105680000|NCT02257567|364491378|FG003|Overall Study|Adverse Event|1|||
105680001|NCT02257567|364491379|FG004|Overall Study|Adverse Event|1|||
105680002|NCT02257567|364491380|FG005|Overall Study|Adverse Event|0|||
105680003|NCT02257567|364491381|FG006|Overall Study|Adverse Event|0|||
105680004|NCT02257567|364491382|FG007|Overall Study|Adverse Event|0|||
105680005|NCT02257567|364491383|FG008|Overall Study|Adverse Event|1|||
105680006|NCT02257567|364491384|FG009|Overall Study|Adverse Event|0|||
105680007|NCT02257567|364491385|FG010|Overall Study|Adverse Event|0|||
105557589|NCT00127101|364037735|FG000|Base Protocol|Adverse Event|0|||
105680008|NCT02257567|364491375|FG000|Overall Study|Death|2|||
105680009|NCT02257567|364491376|FG001|Overall Study|Death|2|||
105680010|NCT02257567|364491377|FG002|Overall Study|Death|2|||
105680011|NCT02257567|364491378|FG003|Overall Study|Death|4|||
105680012|NCT02257567|364491379|FG004|Overall Study|Death|15|||
105680013|NCT02257567|364491380|FG005|Overall Study|Death|11|||
105680014|NCT02257567|364491381|FG006|Overall Study|Death|26|||
105680015|NCT02257567|364491382|FG007|Overall Study|Death|30|||
105680016|NCT02257567|364491383|FG008|Overall Study|Death|2|||
105680017|NCT02257567|364491384|FG009|Overall Study|Death|18|||
105680018|NCT02257567|364491385|FG010|Overall Study|Death|65|||
105680019|NCT02257567|364491375|FG000|Overall Study|Lost to Follow-up|0|||
105680020|NCT02257567|364491376|FG001|Overall Study|Lost to Follow-up|0|||
105680021|NCT02257567|364491377|FG002|Overall Study|Lost to Follow-up|0|||
105680022|NCT02257567|364491378|FG003|Overall Study|Lost to Follow-up|0|||
105680023|NCT02257567|364491379|FG004|Overall Study|Lost to Follow-up|2|||
105680024|NCT02257567|364491380|FG005|Overall Study|Lost to Follow-up|2|||
105680025|NCT02257567|364491381|FG006|Overall Study|Lost to Follow-up|0|||
105680026|NCT02257567|364491382|FG007|Overall Study|Lost to Follow-up|0|||
105680027|NCT02257567|364491383|FG008|Overall Study|Lost to Follow-up|0|||
105680028|NCT02257567|364491384|FG009|Overall Study|Lost to Follow-up|1|||
105680029|NCT02257567|364491385|FG010|Overall Study|Lost to Follow-up|1|||
105680030|NCT02257567|364491375|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680031|NCT02257567|364491376|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680032|NCT02257567|364491377|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680033|NCT02257567|364491378|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680034|NCT02257567|364491379|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
105680035|NCT02257567|364491380|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680036|NCT02257567|364491381|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
105680037|NCT02257567|364491382|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680038|NCT02257567|364491383|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680039|NCT02257567|364491384|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680040|NCT02257567|364491385|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680041|NCT02257567|364491375|FG000|Overall Study|Physician Decision|0|||
105680042|NCT02257567|364491376|FG001|Overall Study|Physician Decision|0|||
105680043|NCT02257567|364491377|FG002|Overall Study|Physician Decision|0|||
105680044|NCT02257567|364491378|FG003|Overall Study|Physician Decision|0|||
105680045|NCT02257567|364491379|FG004|Overall Study|Physician Decision|0|||
105680046|NCT02257567|364491380|FG005|Overall Study|Physician Decision|0|||
105680047|NCT02257567|364491381|FG006|Overall Study|Physician Decision|0|||
105680048|NCT02257567|364491382|FG007|Overall Study|Physician Decision|2|||
105680049|NCT02257567|364491383|FG008|Overall Study|Physician Decision|0|||
105680050|NCT02257567|364491384|FG009|Overall Study|Physician Decision|1|||
105680051|NCT02257567|364491385|FG010|Overall Study|Physician Decision|0|||
105680052|NCT02257567|364491375|FG000|Overall Study|Withdrawal by Subject|0|||
105680053|NCT02257567|364491376|FG001|Overall Study|Withdrawal by Subject|0|||
105680054|NCT02257567|364491377|FG002|Overall Study|Withdrawal by Subject|2|||
105680055|NCT02257567|364491378|FG003|Overall Study|Withdrawal by Subject|0|||
105680056|NCT02257567|364491379|FG004|Overall Study|Withdrawal by Subject|0|||
105680057|NCT02257567|364491380|FG005|Overall Study|Withdrawal by Subject|6|||
105680058|NCT02257567|364491381|FG006|Overall Study|Withdrawal by Subject|6|||
105680059|NCT02257567|364491382|FG007|Overall Study|Withdrawal by Subject|6|||
105680060|NCT02257567|364491383|FG008|Overall Study|Withdrawal by Subject|1|||
105680061|NCT02257567|364491384|FG009|Overall Study|Withdrawal by Subject|1|||
105680062|NCT02257567|364491385|FG010|Overall Study|Withdrawal by Subject|10|||
105680063|NCT02313233|364491386|FG000|Overall Study|Withdrawal by Subject|1|||
105680064|NCT02313233|364491387|FG001|Overall Study|Withdrawal by Subject|2|||
105680065|NCT02313233|364491386|FG000|Overall Study|Administrative reason|1|||
105680066|NCT02313233|364491387|FG001|Overall Study|Administrative reason|1|||
105680067|NCT00964886|364491388|FG000|Overall Study|Lost to Follow-up|2|||
105680068|NCT00964886|364491389|FG001|Overall Study|Lost to Follow-up|2|||
105680069|NCT00964886|364491390|FG002|Overall Study|Lost to Follow-up|6|||
105680070|NCT00964886|364491391|FG003|Overall Study|Lost to Follow-up|4|||
105680071|NCT00964886|364491388|FG000|Overall Study|Withdrawal by Subject|6|||
105680072|NCT00964886|364491389|FG001|Overall Study|Withdrawal by Subject|2|||
105680073|NCT00964886|364491390|FG002|Overall Study|Withdrawal by Subject|5|||
105680074|NCT00964886|364491391|FG003|Overall Study|Withdrawal by Subject|3|||
105680075|NCT00964886|364491388|FG000|Overall Study|Adverse Event|3|||
105680076|NCT00964886|364491389|FG001|Overall Study|Adverse Event|1|||
105680077|NCT00964886|364491390|FG002|Overall Study|Adverse Event|5|||
105680078|NCT00964886|364491391|FG003|Overall Study|Adverse Event|2|||
105680079|NCT00964886|364491388|FG000|Overall Study|Protocol Violation|0|||
105680080|NCT00964886|364491389|FG001|Overall Study|Protocol Violation|2|||
105680081|NCT00964886|364491390|FG002|Overall Study|Protocol Violation|0|||
105680082|NCT00964886|364491391|FG003|Overall Study|Protocol Violation|0|||
105680083|NCT00523640|364491393|FG000|Overall Study|Death|1|||
105680084|NCT00564889|364491397|FG000|Overall Study|Death|7|||
105680085|NCT00564889|364491397|FG000|Overall Study|Adverse Event|12|||
105680086|NCT00564889|364491397|FG000|Overall Study|Alternative treatment|3|||
105680087|NCT00564889|364491397|FG000|Overall Study|Disease progression|3|||
105680088|NCT00564889|364491397|FG000|Overall Study|Other, not specified|4|||
105680089|NCT03484273|364491402|FG000|Overall Study|Equipment Malfunction|1|||
105680090|NCT03484273|364491402|FG000|Overall Study|Data excluded from analysis|1|||
105680091|NCT00069108|364491403|FG000|Overall Study|Withdrawal by Subject|5|||
105680092|NCT00069108|364491404|FG001|Overall Study|Withdrawal by Subject|9|||
105680093|NCT00069108|364491403|FG000|Overall Study|Adverse Event|64|||
105680094|NCT00069108|364491404|FG001|Overall Study|Adverse Event|42|||
105680095|NCT00069108|364491403|FG000|Overall Study|Death|6|||
105680096|NCT00069108|364491404|FG001|Overall Study|Death|6|||
105680097|NCT00069108|364491403|FG000|Overall Study|Administration|15|||
105680098|NCT00069108|364491404|FG001|Overall Study|Administration|4|||
105680099|NCT00069108|364491403|FG000|Overall Study|Insufficient therapy|117|||
105680100|NCT00069108|364491404|FG001|Overall Study|Insufficient therapy|144|||
105680101|NCT00069108|364491403|FG000|Overall Study|Violation criteria|1|||
105680102|NCT00069108|364491404|FG001|Overall Study|Violation criteria|4|||
105680103|NCT00069108|364491403|FG000|Overall Study|Refused treatment|5|||
105680104|NCT00069108|364491404|FG001|Overall Study|Refused treatment|10|||
105680105|NCT01065844|364491405|FG000|Overall Study|Adverse Event|5|||
105680106|NCT00552240|364491408|FG000|Overall Study|Adverse Event|9|||
105680107|NCT00552240|364491409|FG001|Overall Study|Adverse Event|9|||
105680108|NCT00552240|364491408|FG000|Overall Study|Protocol Violation|1|||
105680109|NCT00552240|364491409|FG001|Overall Study|Protocol Violation|1|||
105680110|NCT00552240|364491408|FG000|Overall Study|Lost to Follow-up|5|||
105680111|NCT00552240|364491409|FG001|Overall Study|Lost to Follow-up|6|||
105680112|NCT00552240|364491408|FG000|Overall Study|Withdrawal by Subject|2|||
105680113|NCT00552240|364491409|FG001|Overall Study|Withdrawal by Subject|2|||
105680114|NCT00552240|364491408|FG000|Overall Study|Lack of Efficacy|6|||
105680115|NCT00552240|364491409|FG001|Overall Study|Lack of Efficacy|0|||
105680116|NCT00552240|364491408|FG000|Overall Study|Other|1|||
105680117|NCT00552240|364491409|FG001|Overall Study|Other|0|||
105680118|NCT02476279|364491413|FG000|Overall Study|Lost to Follow-up|1|||
105680119|NCT02476279|364491414|FG001|Overall Study|Lost to Follow-up|1|||
105680120|NCT01415531|364491419|FG000|Overall Study|Adverse Event|7|||
105680121|NCT01415531|364491420|FG001|Overall Study|Adverse Event|10|||
105680122|NCT01415531|364491419|FG000|Overall Study|Lack of Efficacy|3|||
105680123|NCT01415531|364491420|FG001|Overall Study|Lack of Efficacy|2|||
105680124|NCT01415531|364491419|FG000|Overall Study|Protocol Violation|0|||
105680125|NCT01415531|364491420|FG001|Overall Study|Protocol Violation|1|||
105680126|NCT01415531|364491419|FG000|Overall Study|Withdrawal by Subject|5|||
105680127|NCT01415531|364491420|FG001|Overall Study|Withdrawal by Subject|4|||
105680128|NCT01415531|364491419|FG000|Overall Study|Lost to Follow-up|6|||
105344303|NCT00381043|363261748|FG000|Overall Study|wanted more care|0|||
105344304|NCT00381043|363261749|FG001|Overall Study|wanted more care|1|||
105344305|NCT00381043|363261748|FG000|Overall Study|incarcerated|1|||
105344306|NCT00381043|363261749|FG001|Overall Study|incarcerated|0|||
105468658|NCT00419952|363725945|FG001|Overall Study|Intake of prohibited medication|2|||
105680129|NCT01415531|364491420|FG001|Overall Study|Lost to Follow-up|14|||
105680130|NCT01415531|364491419|FG000|Overall Study|Lack of Compliance|1|||
105680131|NCT01415531|364491420|FG001|Overall Study|Lack of Compliance|4|||
105680132|NCT01415531|364491419|FG000|Overall Study|Other Reasons|3|||
105680133|NCT01415531|364491420|FG001|Overall Study|Other Reasons|2|||
105680134|NCT02706899|364491422|FG000|Overall Study|Withdrawal by Subject|1|||
105680135|NCT02706899|364491423|FG001|Overall Study|Withdrawal by Subject|0|||
105468659|NCT00419952|363725944|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
105680136|NCT02706899|364491422|FG000|Overall Study|Death|8|||
105680137|NCT02706899|364491423|FG001|Overall Study|Death|0|||
105680138|NCT02706899|364491422|FG000|Overall Study|Study Termination by Sponsor|4|||
105680139|NCT02706899|364491423|FG001|Overall Study|Study Termination by Sponsor|6|||
105680140|NCT00577473|364491426|FG000|Overall Study|Protocol Violation|1|||
105680141|NCT00577473|364491427|FG001|Overall Study|Protocol Violation|4|||
105680142|NCT00577473|364491426|FG000|Overall Study|Adverse Event|8|||
105680143|NCT00577473|364491427|FG001|Overall Study|Adverse Event|5|||
105680144|NCT00577473|364491426|FG000|Overall Study|Withdrawal by Subject|2|||
105680145|NCT00577473|364491427|FG001|Overall Study|Withdrawal by Subject|6|||
105680146|NCT00577473|364491426|FG000|Overall Study|Physician Decision|2|||
105680147|NCT00577473|364491427|FG001|Overall Study|Physician Decision|2|||
105680148|NCT00577473|364491426|FG000|Overall Study|Lack of Efficacy|8|||
105680149|NCT00577473|364491427|FG001|Overall Study|Lack of Efficacy|7|||
105680150|NCT01737827|364491436|FG000|Overall Study|Adverse Event|3|||
105680151|NCT01737827|364491437|FG001|Overall Study|Adverse Event|6|||
105680152|NCT01737827|364491438|FG002|Overall Study|Adverse Event|0|||
105680153|NCT01737827|364491436|FG000|Overall Study|Lost to Follow-up|0|||
105680154|NCT01737827|364491437|FG001|Overall Study|Lost to Follow-up|1|||
105680155|NCT01737827|364491438|FG002|Overall Study|Lost to Follow-up|0|||
105680156|NCT01737827|364491436|FG000|Overall Study|Physician Decision|0|||
105680157|NCT01737827|364491437|FG001|Overall Study|Physician Decision|2|||
105680158|NCT01737827|364491438|FG002|Overall Study|Physician Decision|0|||
105680159|NCT01737827|364491436|FG000|Overall Study|Progressive Disease|5|||
105680160|NCT01737827|364491437|FG001|Overall Study|Progressive Disease|16|||
105680161|NCT01737827|364491438|FG002|Overall Study|Progressive Disease|2|||
105680162|NCT01737827|364491436|FG000|Overall Study|Study Terminated by Sponsor|0|||
105680163|NCT01737827|364491437|FG001|Overall Study|Study Terminated by Sponsor|1|||
105680164|NCT01737827|364491438|FG002|Overall Study|Study Terminated by Sponsor|0|||
105680165|NCT01737827|364491436|FG000|Overall Study|Subject/Guardian Decision|0|||
105680166|NCT01737827|364491437|FG001|Overall Study|Subject/Guardian Decision|2|||
105680167|NCT01737827|364491438|FG002|Overall Study|Subject/Guardian Decision|0|||
105680168|NCT00528645|364491441|FG000|Overall Study|Adverse Event|3|||
105680169|NCT01642251|364491442|FG000|Overall Study|Progressive disease|0|||
105680170|NCT01642251|364491443|FG001|Overall Study|Progressive disease|0|||
105680171|NCT01642251|364491444|FG002|Overall Study|Progressive disease|3|||
105680172|NCT01642251|364491445|FG003|Overall Study|Progressive disease|3|||
105680173|NCT01642251|364491442|FG000|Overall Study|Adverse Event|0|||
105680174|NCT01642251|364491443|FG001|Overall Study|Adverse Event|0|||
105680175|NCT01642251|364491444|FG002|Overall Study|Adverse Event|5|||
105680176|NCT01642251|364491445|FG003|Overall Study|Adverse Event|4|||
105680177|NCT01642251|364491442|FG000|Overall Study|Death|0|||
105680178|NCT01642251|364491443|FG001|Overall Study|Death|0|||
105680179|NCT01642251|364491444|FG002|Overall Study|Death|1|||
105680180|NCT01642251|364491445|FG003|Overall Study|Death|3|||
105680181|NCT01642251|364491442|FG000|Overall Study|Withdrawal by Subject|0|||
105680182|NCT01642251|364491443|FG001|Overall Study|Withdrawal by Subject|0|||
105680183|NCT01642251|364491444|FG002|Overall Study|Withdrawal by Subject|1|||
105680184|NCT01642251|364491445|FG003|Overall Study|Withdrawal by Subject|3|||
105680185|NCT01642251|364491442|FG000|Overall Study|Alternative therapy|0|||
105680186|NCT01642251|364491443|FG001|Overall Study|Alternative therapy|0|||
105680187|NCT01642251|364491444|FG002|Overall Study|Alternative therapy|0|||
105680188|NCT01642251|364491445|FG003|Overall Study|Alternative therapy|2|||
105680189|NCT01642251|364491442|FG000|Overall Study|Other complicating disease|0|||
105680190|NCT01642251|364491443|FG001|Overall Study|Other complicating disease|0|||
105680191|NCT01642251|364491444|FG002|Overall Study|Other complicating disease|1|||
105680192|NCT01642251|364491445|FG003|Overall Study|Other complicating disease|0|||
105680193|NCT01642251|364491442|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
105680194|NCT01642251|364491443|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
105680195|NCT01642251|364491444|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
105680196|NCT01642251|364491445|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
105680197|NCT01445301|364491446|FG000|Overall Study|Adverse Event|15|||
105680198|NCT01445301|364491447|FG001|Overall Study|Adverse Event|25|||
105680199|NCT01445301|364491448|FG002|Overall Study|Adverse Event|4|||
105680200|NCT01445301|364491446|FG000|Overall Study|Lack of Efficacy|0|||
105680201|NCT01445301|364491447|FG001|Overall Study|Lack of Efficacy|1|||
105680202|NCT01445301|364491448|FG002|Overall Study|Lack of Efficacy|0|||
105680203|NCT01445301|364491446|FG000|Overall Study|Protocol Violation|1|||
105680204|NCT01445301|364491447|FG001|Overall Study|Protocol Violation|0|||
105680205|NCT01445301|364491448|FG002|Overall Study|Protocol Violation|0|||
105680206|NCT01445301|364491446|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
105680207|NCT01445301|364491447|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
105680208|NCT01445301|364491448|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
105680209|NCT01445301|364491446|FG000|Overall Study|Physician Decision|0|||
105680210|NCT01445301|364491447|FG001|Overall Study|Physician Decision|2|||
105680211|NCT01445301|364491448|FG002|Overall Study|Physician Decision|0|||
105680212|NCT01445301|364491446|FG000|Overall Study|Withdrawal by Subject|5|||
105680213|NCT01445301|364491447|FG001|Overall Study|Withdrawal by Subject|6|||
105680214|NCT01445301|364491448|FG002|Overall Study|Withdrawal by Subject|4|||
105680215|NCT03143166|364491454|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
105680216|NCT02112708|364491455|FG000|Baseline|Physician Decision|16|||
105680217|NCT02112708|364491456|FG001|Baseline|Physician Decision|11|||
105680218|NCT02112708|364491455|FG000|Baseline|Lost to Follow-up|12|||
105680219|NCT02112708|364491456|FG001|Baseline|Lost to Follow-up|0|||
105680220|NCT02112708|364491455|FG000|4 Month|Death|0|||
105680221|NCT02112708|364491456|FG001|4 Month|Death|1|||
105680222|NCT02112708|364491455|FG000|4 Month|Withdrawal by Subject|12|||
105680223|NCT02112708|364491456|FG001|4 Month|Withdrawal by Subject|0|||
105680224|NCT04540887|364491459|FG000|Overall Study|Withdrawal by Subject|2|||
105680225|NCT02232243|364491460|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
105680226|NCT02232243|364491461|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
105680227|NCT02232243|364491462|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
105680228|NCT00490724|364491463|FG000|Period I|Physician Decision|0|||
105680229|NCT00490724|364491464|FG001|Period I|Physician Decision|0|||
105680230|NCT00490724|364491465|FG002|Period I|Physician Decision|1|||
105680231|NCT00490724|364491463|FG000|Period II|Treatment Discontinuation|3|||
105680232|NCT00490724|364491464|FG001|Period II|Treatment Discontinuation|1|||
105680233|NCT00490724|364491465|FG002|Period II|Treatment Discontinuation|3|||
105680234|NCT01323972|364491466|FG000|Overall Study|Withdrawal by Subject|1|||
105680235|NCT01323972|364491467|FG001|Overall Study|Withdrawal by Subject|0|||
105680236|NCT01323972|364491468|FG002|Overall Study|Withdrawal by Subject|1|||
105680237|NCT01323972|364491469|FG003|Overall Study|Withdrawal by Subject|0|||
105680238|NCT01323972|364491466|FG000|Overall Study|Migrated/moved from study area|1|||
105680239|NCT01323972|364491467|FG001|Overall Study|Migrated/moved from study area|2|||
105680240|NCT01323972|364491468|FG002|Overall Study|Migrated/moved from study area|0|||
105680241|NCT01323972|364491469|FG003|Overall Study|Migrated/moved from study area|0|||
105680242|NCT01323972|364491466|FG000|Overall Study|Lost to Follow-up|0|||
105680243|NCT01323972|364491467|FG001|Overall Study|Lost to Follow-up|1|||
105680244|NCT01323972|364491468|FG002|Overall Study|Lost to Follow-up|1|||
105680245|NCT01323972|364491469|FG003|Overall Study|Lost to Follow-up|1|||
105680246|NCT02008877|364491470|FG000|Overall Study|Inevaluable|0|||
105680247|NCT02008877|364491471|FG001|Overall Study|Inevaluable|1|||
105680248|NCT02008877|364491472|FG002|Overall Study|Inevaluable|0|||
105680249|NCT00126503|364491473|FG000|Overall Study|disease progression|23|||
105680250|NCT00126503|364491474|FG001|Overall Study|disease progression|14|||
105680251|NCT00126503|364491473|FG000|Overall Study|Withdrawal by Subject|0|||
105680252|NCT00126503|364491474|FG001|Overall Study|Withdrawal by Subject|1|||
105680253|NCT00126503|364491473|FG000|Overall Study|alternative therapy|1|||
105680254|NCT00126503|364491474|FG001|Overall Study|alternative therapy|1|||
105680255|NCT00126503|364491473|FG000|Overall Study|other complicating disease|4|||
105680256|NCT00126503|364491474|FG001|Overall Study|other complicating disease|1|||
105680257|NCT00126503|364491473|FG000|Overall Study|Death|3|||
105680258|NCT00126503|364491474|FG001|Overall Study|Death|0|||
105680259|NCT00126503|364491473|FG000|Overall Study|Adverse Event|13|||
105680260|NCT00126503|364491474|FG001|Overall Study|Adverse Event|3|||
105680261|NCT00126503|364491473|FG000|Overall Study|non-compliant|1|||
105680262|NCT00126503|364491474|FG001|Overall Study|non-compliant|0|||
105680263|NCT00126503|364491473|FG000|Overall Study|Physician Decision|2|||
105680264|NCT00126503|364491474|FG001|Overall Study|Physician Decision|1|||
105680265|NCT02523599|364491476|FG000|Overall Study|Adverse Event|1|||
105680266|NCT02523599|364491477|FG001|Overall Study|Adverse Event|0|||
105680267|NCT02523599|364491476|FG000|Overall Study|Physician Decision|1|||
105680268|NCT02523599|364491477|FG001|Overall Study|Physician Decision|0|||
105680269|NCT02523599|364491476|FG000|Overall Study|Lost to Follow-up|4|||
105680270|NCT02523599|364491477|FG001|Overall Study|Lost to Follow-up|1|||
105680271|NCT02523599|364491476|FG000|Overall Study|Did not return for Day 30 visit|2|||
105680272|NCT02523599|364491477|FG001|Overall Study|Did not return for Day 30 visit|0|||
105680273|NCT01078454|364491478|FG000|Overall Study|Adverse Event|1|||
105680274|NCT01078454|364491479|FG001|Overall Study|Adverse Event|1|||
105680275|NCT01078454|364491478|FG000|Overall Study|Death|0|||
105680276|NCT01078454|364491479|FG001|Overall Study|Death|1|||
105680277|NCT04227704|364491480|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
105680278|NCT04227704|364491481|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
105680279|NCT04227704|364491482|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
105680280|NCT04227704|364491480|FG000|Overall Study|due to C/S being cancelled|1|||
105680281|NCT04227704|364491481|FG001|Overall Study|due to C/S being cancelled|0|||
105680282|NCT04227704|364491482|FG002|Overall Study|due to C/S being cancelled|0|||
105680283|NCT01880528|364491487|FG000|Overall Study|Other|1|||
105680284|NCT01880528|364491488|FG001|Overall Study|Other|1|||
105680285|NCT00775463|364493857|FG000|Overall Study|Withdrawal by Subject|0|||
105680286|NCT00775463|364493858|FG001|Overall Study|Withdrawal by Subject|1|||
105680287|NCT00775463|364493857|FG000|Overall Study|Adverse Event|7|||
105680288|NCT00775463|364493858|FG001|Overall Study|Adverse Event|9|||
105680289|NCT00775463|364493857|FG000|Overall Study|Protocol Violation|2|||
105680290|NCT00775463|364493858|FG001|Overall Study|Protocol Violation|2|||
105680291|NCT00775463|364493857|FG000|Overall Study|Lost to Follow-up|1|||
105680292|NCT00775463|364493858|FG001|Overall Study|Lost to Follow-up|0|||
105680293|NCT00775463|364493857|FG000|Overall Study|Lack of Efficacy|1|||
105680294|NCT00775463|364493858|FG001|Overall Study|Lack of Efficacy|1|||
105680295|NCT03695237|364493859|FG000|Overall Study|Withdrawal by Subject|1|||
105680296|NCT03695237|364493860|FG001|Overall Study|Withdrawal by Subject|3|||
105680297|NCT03695237|364493859|FG000|Overall Study|Lost to Follow-up|1|||
105680298|NCT03695237|364493860|FG001|Overall Study|Lost to Follow-up|2|||
105680299|NCT03695237|364493859|FG000|Overall Study|Other, Not Specified|8|||
105680300|NCT03695237|364493860|FG001|Overall Study|Other, Not Specified|2|||
105680301|NCT04375761|364493861|FG000|Overall Study|Death|1|||
105680302|NCT04375761|364493862|FG001|Overall Study|Death|2|||
105680303|NCT04375761|364493861|FG000|Overall Study|Lost to Follow-up|203|||
105680304|NCT04375761|364493862|FG001|Overall Study|Lost to Follow-up|380|||
105680305|NCT04375761|364493861|FG000|Overall Study|Withdrawal by Subject|47|||
105680306|NCT04375761|364493862|FG001|Overall Study|Withdrawal by Subject|98|||
105680307|NCT04375761|364493861|FG000|Overall Study|Noncompliance with study procedure|121|||
105680308|NCT04375761|364493862|FG001|Overall Study|Noncompliance with study procedure|251|||
105680309|NCT04375761|364493861|FG000|Overall Study|Reimbursement not enough|1|||
105680310|NCT04375761|364493862|FG001|Overall Study|Reimbursement not enough|2|||
105680311|NCT04375761|364493861|FG000|Overall Study|Unforeseen family circumstances|1|||
105680312|NCT04375761|364493862|FG001|Overall Study|Unforeseen family circumstances|3|||
105680313|NCT04375761|364493861|FG000|Overall Study|Test too painful|1|||
105680314|NCT04375761|364493862|FG001|Overall Study|Test too painful|1|||
105680315|NCT04375761|364493861|FG000|Overall Study|Moved|0|||
105680316|NCT04375761|364493862|FG001|Overall Study|Moved|2|||
105680317|NCT04375761|364493861|FG000|Overall Study|Nonresponsive|0|||
105680318|NCT04375761|364493862|FG001|Overall Study|Nonresponsive|5|||
105680319|NCT03541174|364493863|FG000|Part 1 Double-Blind|Adverse Event|6|||
105680320|NCT03541174|364493864|FG001|Part 1 Double-Blind|Adverse Event|5|||
105680321|NCT03541174|364493865|FG002|Part 1 Double-Blind|Adverse Event|2|||
105680322|NCT03541174|364493866|FG003|Part 1 Double-Blind|Adverse Event|0|||
105680323|NCT03541174|364493867|FG004|Part 1 Double-Blind|Adverse Event|0|||
105680324|NCT03541174|364493868|FG005|Part 1 Double-Blind|Adverse Event|0|||
105680325|NCT03541174|364493863|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
105680326|NCT03541174|364493864|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
105680327|NCT03541174|364493865|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
105680328|NCT03541174|364493866|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
105680329|NCT03541174|364493867|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
105680330|NCT03541174|364493868|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
105680331|NCT03541174|364493863|FG000|Part 1 Double-Blind|Other reasons|3|||
105680332|NCT03541174|364493864|FG001|Part 1 Double-Blind|Other reasons|2|||
105680333|NCT03541174|364493865|FG002|Part 1 Double-Blind|Other reasons|3|||
105680334|NCT03541174|364493866|FG003|Part 1 Double-Blind|Other reasons|0|||
105680335|NCT03541174|364493867|FG004|Part 1 Double-Blind|Other reasons|0|||
105680336|NCT03541174|364493868|FG005|Part 1 Double-Blind|Other reasons|0|||
105680337|NCT03541174|364493863|FG000|Part 2 Single-Blind|Adverse Event|0|||
105680338|NCT03541174|364493864|FG001|Part 2 Single-Blind|Adverse Event|0|||
105680339|NCT03541174|364493865|FG002|Part 2 Single-Blind|Adverse Event|0|||
105680340|NCT03541174|364493866|FG003|Part 2 Single-Blind|Adverse Event|25|||
105680341|NCT03541174|364493867|FG004|Part 2 Single-Blind|Adverse Event|0|||
105680342|NCT03541174|364493868|FG005|Part 2 Single-Blind|Adverse Event|0|||
105680343|NCT03541174|364493863|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
105680344|NCT03541174|364493864|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
105680345|NCT03541174|364493865|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
105680346|NCT03541174|364493866|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
105680347|NCT03541174|364493867|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
105680348|NCT03541174|364493868|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
105680349|NCT03541174|364493863|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
105680350|NCT03541174|364493864|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
105680351|NCT03541174|364493865|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
105680352|NCT03541174|364493866|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
105680353|NCT03541174|364493867|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
105680354|NCT03541174|364493868|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
105680355|NCT03541174|364493863|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
105680356|NCT03541174|364493864|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
105680357|NCT03541174|364493865|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
105680358|NCT03541174|364493866|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
105680359|NCT03541174|364493867|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
105680360|NCT03541174|364493868|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
105680361|NCT03541174|364493863|FG000|Part 2 Single-Blind|Death|0|||
105680362|NCT03541174|364493864|FG001|Part 2 Single-Blind|Death|0|||
105680363|NCT03541174|364493865|FG002|Part 2 Single-Blind|Death|0|||
105680364|NCT03541174|364493866|FG003|Part 2 Single-Blind|Death|5|||
105680365|NCT03541174|364493867|FG004|Part 2 Single-Blind|Death|0|||
105680366|NCT03541174|364493868|FG005|Part 2 Single-Blind|Death|0|||
105680367|NCT03541174|364493863|FG000|Part 2 Single-Blind|Pregnancy|0|||
105680368|NCT03541174|364493864|FG001|Part 2 Single-Blind|Pregnancy|0|||
105680369|NCT03541174|364493865|FG002|Part 2 Single-Blind|Pregnancy|0|||
105680370|NCT03541174|364493866|FG003|Part 2 Single-Blind|Pregnancy|1|||
105680371|NCT03541174|364493867|FG004|Part 2 Single-Blind|Pregnancy|0|||
105680372|NCT03541174|364493868|FG005|Part 2 Single-Blind|Pregnancy|0|||
105680373|NCT03541174|364493863|FG000|Part 2 Single-Blind|Other reasons|0|||
105680374|NCT03541174|364493864|FG001|Part 2 Single-Blind|Other reasons|0|||
105680375|NCT03541174|364493865|FG002|Part 2 Single-Blind|Other reasons|0|||
105680376|NCT03541174|364493866|FG003|Part 2 Single-Blind|Other reasons|32|||
105680377|NCT03541174|364493867|FG004|Part 2 Single-Blind|Other reasons|0|||
105680378|NCT03541174|364493868|FG005|Part 2 Single-Blind|Other reasons|0|||
105680379|NCT03541174|364493863|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
105680380|NCT03541174|364493864|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
105680381|NCT03541174|364493865|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
105680382|NCT03541174|364493866|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
105680383|NCT03541174|364493867|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
105680384|NCT03541174|364493868|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
105680385|NCT03541174|364493863|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
105680386|NCT03541174|364493864|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
105680387|NCT03541174|364493865|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
105680388|NCT03541174|364493866|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
105680389|NCT03541174|364493867|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
105680390|NCT03541174|364493868|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
105680391|NCT03541174|364493863|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
105680392|NCT03541174|364493864|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
105680393|NCT03541174|364493865|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
105680394|NCT03541174|364493866|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
105680395|NCT03541174|364493867|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
105680396|NCT03541174|364493868|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
105680397|NCT03541174|364493863|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
105680398|NCT03541174|364493864|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
105680399|NCT03541174|364493865|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
105680400|NCT03541174|364493866|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
105680401|NCT03541174|364493867|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
105680402|NCT03541174|364493868|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
105680403|NCT03541174|364493863|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
105680404|NCT03541174|364493864|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
105680405|NCT03541174|364493865|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
105680406|NCT03541174|364493866|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
105680407|NCT03541174|364493867|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
105680408|NCT03541174|364493868|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
105680409|NCT00484289|364493870|FG000|Long Term Phase|Adverse Event|1|||
105680410|NCT00484289|364493871|FG001|Long Term Phase|Adverse Event|17|||
105680411|NCT00484289|364493872|FG002|Long Term Phase|Adverse Event|5|||
105680412|NCT00484289|364493870|FG000|Long Term Phase|Withdrawal by Subject|0|||
105680413|NCT00484289|364493871|FG001|Long Term Phase|Withdrawal by Subject|7|||
105680414|NCT00484289|364493872|FG002|Long Term Phase|Withdrawal by Subject|6|||
105680415|NCT00484289|364493870|FG000|Long Term Phase|Inadequate response|2|||
105680416|NCT00484289|364493871|FG001|Long Term Phase|Inadequate response|7|||
105680417|NCT00484289|364493872|FG002|Long Term Phase|Inadequate response|4|||
105680418|NCT00484289|364493870|FG000|Long Term Phase|Other Reason|0|||
105680419|NCT00484289|364493871|FG001|Long Term Phase|Other Reason|5|||
105680420|NCT00484289|364493872|FG002|Long Term Phase|Other Reason|1|||
105680421|NCT00484289|364493870|FG000|Post Marketing Phase|Adverse Event|0|||
105680422|NCT00484289|364493871|FG001|Post Marketing Phase|Adverse Event|1|||
105680423|NCT00484289|364493872|FG002|Post Marketing Phase|Adverse Event|0|||
105680424|NCT00192647|364493873|FG000|Overall Study|Death|1|||
105680425|NCT00192647|364493874|FG001|Overall Study|Death|1|||
105680426|NCT00192647|364493873|FG000|Overall Study|Adverse Event|35|||
105680427|NCT00192647|364493874|FG001|Overall Study|Adverse Event|29|||
105680428|NCT00192647|364493873|FG000|Overall Study|Laboratory Test Abnormality|4|||
105680429|NCT00192647|364493874|FG001|Overall Study|Laboratory Test Abnormality|2|||
105680430|NCT00192647|364493873|FG000|Overall Study|Insufficient Therapeutic Response|53|||
105680431|NCT00192647|364493874|FG001|Overall Study|Insufficient Therapeutic Response|83|||
105680432|NCT00192647|364493873|FG000|Overall Study|Entry Criteria Violation|6|||
105680433|NCT00192647|364493874|FG001|Overall Study|Entry Criteria Violation|6|||
105680434|NCT00192647|364493873|FG000|Overall Study|Protocol Violation|3|||
105680435|NCT00192647|364493874|FG001|Overall Study|Protocol Violation|1|||
105680436|NCT00192647|364493873|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
105680437|NCT00192647|364493874|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
105680438|NCT00192647|364493873|FG000|Overall Study|Failure to Return|11|||
105680439|NCT00192647|364493874|FG001|Overall Study|Failure to Return|13|||
105680440|NCT00192647|364493873|FG000|Overall Study|Other/Administrative|5|||
105680441|NCT00192647|364493874|FG001|Overall Study|Other/Administrative|3|||
105680442|NCT03207009|364493875|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
105680443|NCT01227577|364493876|FG000|Overall Study|Protocol deviation|3|||
105680444|NCT01227577|364493876|FG000|Overall Study|Death|3|||
105680445|NCT01227577|364493876|FG000|Overall Study|Administrative problems|2|||
105680446|NCT01227577|364493876|FG000|Overall Study|Lost to Follow-up|1|||
105680447|NCT01227577|364493876|FG000|Overall Study|Withdrawal by Subject|4|||
105680448|NCT01227577|364493876|FG000|Overall Study|Lack of Efficacy|5|||
105680449|NCT01227577|364493876|FG000|Overall Study|Adverse Event|17|||
105680450|NCT01190514|364493877|FG000|First Intervention (Period 1)|Adverse Event|1|||
105680451|NCT01190514|364493878|FG001|First Intervention (Period 1)|Adverse Event|0|||
105680452|NCT01190514|364493879|FG002|First Intervention (Period 1)|Adverse Event|0|||
105680453|NCT01190514|364493880|FG003|First Intervention (Period 1)|Adverse Event|0|||
105680454|NCT01190514|364493877|FG000|Third Intervention (Period 3)|Adverse Event|1|||
105680455|NCT01190514|364493878|FG001|Third Intervention (Period 3)|Adverse Event|0|||
105680456|NCT01190514|364493879|FG002|Third Intervention (Period 3)|Adverse Event|0|||
105680457|NCT01190514|364493880|FG003|Third Intervention (Period 3)|Adverse Event|0|||
105680458|NCT00194987|364493881|FG000|Overall Study|Withdrawal by Subject|0|||
105680459|NCT00194987|364493882|FG001|Overall Study|Withdrawal by Subject|3|||
105680460|NCT04875676|364493883|FG000|Overall Study|Lost to Follow-up|1|||
105680461|NCT04875676|364493884|FG001|Overall Study|Lost to Follow-up|0|||
105680462|NCT04875676|364493885|FG002|Overall Study|Lost to Follow-up|0|||
105680463|NCT01981473|364493887|FG000|Overall Study|Incorrect diagnosis of RA|0|||
105680464|NCT01981473|364493888|FG001|Overall Study|Incorrect diagnosis of RA|0|||
105680465|NCT01981473|364493889|FG002|Overall Study|Incorrect diagnosis of RA|1|||
105680466|NCT01981473|364493887|FG000|Overall Study|Received treatment for < 6 months|0|||
105680467|NCT01981473|364493888|FG001|Overall Study|Received treatment for < 6 months|0|||
105680468|NCT01981473|364493889|FG002|Overall Study|Received treatment for < 6 months|1|||
105680469|NCT01981473|364493887|FG000|Overall Study|Received treatment for >24 months|2|||
105680470|NCT01981473|364493888|FG001|Overall Study|Received treatment for >24 months|0|||
105680471|NCT01981473|364493889|FG002|Overall Study|Received treatment for >24 months|6|||
105680472|NCT02937454|364493890|FG000|Overall Study|Adverse Event|0|||
105680473|NCT02937454|364493891|FG001|Overall Study|Adverse Event|1|||
105680474|NCT02937454|364493890|FG000|Overall Study|Death|98|||
105680475|NCT02937454|364493891|FG001|Overall Study|Death|95|||
105680476|NCT02937454|364493890|FG000|Overall Study|Lost to Follow-up|1|||
105680477|NCT02937454|364493891|FG001|Overall Study|Lost to Follow-up|1|||
105680478|NCT02937454|364493890|FG000|Overall Study|Physician Decision|0|||
105680479|NCT02937454|364493891|FG001|Overall Study|Physician Decision|1|||
105680480|NCT02937454|364493890|FG000|Overall Study|Protocol Violation|6|||
105680481|NCT02937454|364493891|FG001|Overall Study|Protocol Violation|10|||
105680482|NCT02937454|364493890|FG000|Overall Study|Withdrawal by Subject|27|||
105680483|NCT02937454|364493891|FG001|Overall Study|Withdrawal by Subject|15|||
105680484|NCT02937454|364493890|FG000|Overall Study|Other|8|||
105680485|NCT02937454|364493891|FG001|Overall Study|Other|5|||
105680486|NCT02630693|364493894|FG000|Overall Study|No receive treatment|0|||
105680487|NCT02630693|364493895|FG001|Overall Study|No receive treatment|1|||
105680488|NCT05062759|364493901|FG000|Overall Study|Death|0|||
105680489|NCT05062759|364493902|FG001|Overall Study|Death|1|||
105680490|NCT05062759|364493901|FG000|Overall Study|Lost to Follow-up|1|||
105680491|NCT05062759|364493902|FG001|Overall Study|Lost to Follow-up|0|||
105680492|NCT00903006|364493903|FG000|Overall Study|Withdrawal by Subject|2|||
105680493|NCT00903006|364493904|FG001|Overall Study|Withdrawal by Subject|0|||
105680494|NCT00903006|364493905|FG002|Overall Study|Withdrawal by Subject|0|||
105680495|NCT00903006|364493906|FG003|Overall Study|Withdrawal by Subject|0|||
105468660|NCT00419952|363725945|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
105468661|NCT00419952|363725944|FG000|Overall Study|Diary or medication non-compliance|2|||
105468662|NCT00419952|363725945|FG001|Overall Study|Diary or medication non-compliance|4|||
105468663|NCT00419952|363725944|FG000|Overall Study|Abnormal ECG|1|||
105468664|NCT00419952|363725945|FG001|Overall Study|Abnormal ECG|0|||
105680496|NCT00903006|364493903|FG000|Overall Study|Progressive Disease|0|||
105680497|NCT00903006|364493904|FG001|Overall Study|Progressive Disease|3|||
105680498|NCT00903006|364493905|FG002|Overall Study|Progressive Disease|1|||
105680499|NCT00903006|364493906|FG003|Overall Study|Progressive Disease|0|||
105680500|NCT01383499|364493907|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
105680501|NCT01383499|364493908|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
105680502|NCT01383499|364493909|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
105468665|NCT00196313|363725946|FG000|Overall Study|Protocol Violation|2|||
105680503|NCT01383499|364493910|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
105680504|NCT03606668|364493914|FG000|Overall Study|Screen Failure|1|||
105468666|NCT00196313|363725947|FG001|Overall Study|Protocol Violation|3|||
105468667|NCT00196313|363725946|FG000|Overall Study|Withdrawal by Subject|3|||
105680505|NCT03606668|364493914|FG000|Overall Study|Lost to Follow-up|1|||
105680506|NCT01079663|364493915|FG000|Overall Study|Adverse Event|0|||
105680507|NCT01079663|364493916|FG001|Overall Study|Adverse Event|2|||
105680508|NCT01079663|364493915|FG000|Overall Study|Protocol Violation|0|||
105680509|NCT01079663|364493916|FG001|Overall Study|Protocol Violation|2|||
105680510|NCT01029652|364493920|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
105680511|NCT01029652|364493921|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
105680512|NCT01029652|364493920|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
105680513|NCT01029652|364493921|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
105680514|NCT01029652|364493920|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
105680515|NCT01029652|364493921|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
105680516|NCT01029652|364493920|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
105680517|NCT01029652|364493921|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
105680518|NCT01029652|364493920|FG000|Core Study (0-12 Weeks)|Death|0|||
105680519|NCT01029652|364493921|FG001|Core Study (0-12 Weeks)|Death|1|||
105680520|NCT01029652|364493920|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
105680521|NCT01029652|364493921|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
105680522|NCT01029652|364493920|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
105680523|NCT01029652|364493921|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
105680524|NCT01029652|364493920|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
105680525|NCT01029652|364493921|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
105680526|NCT01029652|364493920|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
105680527|NCT01029652|364493921|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
105680528|NCT01029652|364493920|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
105680529|NCT01029652|364493921|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
105680530|NCT01029652|364493920|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
105680531|NCT01029652|364493921|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
105680532|NCT01029652|364493920|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
105680533|NCT01029652|364493921|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
105680534|NCT02399254|364493925|FG000|Overall Study|Physician Decision|2|||
105680535|NCT02084056|364493928|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
105680536|NCT02084056|364493929|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
105680537|NCT02084056|364493930|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
105680538|NCT02084056|364493931|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
105680539|NCT02084056|364493928|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
105680540|NCT02084056|364493929|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
105680541|NCT02084056|364493930|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
105680542|NCT02084056|364493931|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
105680543|NCT01293487|364493932|FG000|Overall Study|Lost to Follow-up|0|||
105680544|NCT01293487|364493933|FG001|Overall Study|Lost to Follow-up|0|||
105680545|NCT01293487|364493934|FG002|Overall Study|Lost to Follow-up|0|||
105680546|NCT01293487|364493935|FG003|Overall Study|Lost to Follow-up|1|||
105680547|NCT01293487|364493936|FG004|Overall Study|Lost to Follow-up|0|||
105680548|NCT01293487|364493937|FG005|Overall Study|Lost to Follow-up|0|||
105680549|NCT01293487|364493938|FG006|Overall Study|Lost to Follow-up|0|||
105680550|NCT01293487|364493939|FG007|Overall Study|Lost to Follow-up|0|||
105680551|NCT01293487|364493932|FG000|Overall Study|Withdrawal by Subject|0|||
105680552|NCT01293487|364493933|FG001|Overall Study|Withdrawal by Subject|0|||
105680553|NCT01293487|364493934|FG002|Overall Study|Withdrawal by Subject|0|||
105680554|NCT01293487|364493935|FG003|Overall Study|Withdrawal by Subject|0|||
105680555|NCT01293487|364493936|FG004|Overall Study|Withdrawal by Subject|0|||
105680556|NCT01293487|364493937|FG005|Overall Study|Withdrawal by Subject|0|||
105680557|NCT01293487|364493938|FG006|Overall Study|Withdrawal by Subject|0|||
105680558|NCT01293487|364493939|FG007|Overall Study|Withdrawal by Subject|2|||
105680559|NCT00577577|364493941|FG000|Overall Study|Adverse Event|3|||
105680560|NCT00577577|364493942|FG001|Overall Study|Adverse Event|2|||
105680561|NCT00577577|364493941|FG000|Overall Study|Lost to Follow-up|1|||
105680562|NCT00577577|364493942|FG001|Overall Study|Lost to Follow-up|0|||
105680563|NCT00577577|364493941|FG000|Overall Study|Protocol Violation|0|||
105680564|NCT00577577|364493942|FG001|Overall Study|Protocol Violation|3|||
105680565|NCT00577577|364493941|FG000|Overall Study|Transportation|1|||
105680566|NCT00577577|364493942|FG001|Overall Study|Transportation|0|||
105680567|NCT02424734|364493943|FG000|Overall Study|Treatment stopped to be discharged home|2|||
105680568|NCT02424734|364493944|FG001|Overall Study|Treatment stopped to be discharged home|2|||
105680569|NCT02424734|364493945|FG002|Overall Study|Treatment stopped to be discharged home|0|||
105680570|NCT00116753|364493946|FG000|Overall Study|Adverse Event|16|||
105680571|NCT00116753|364493947|FG001|Overall Study|Adverse Event|10|||
105680572|NCT00116753|364493948|FG002|Overall Study|Adverse Event|7|||
105680573|NCT00116753|364493946|FG000|Overall Study|Withdrawal by Subject|11|||
105680574|NCT00116753|364493947|FG001|Overall Study|Withdrawal by Subject|12|||
105680575|NCT00116753|364493948|FG002|Overall Study|Withdrawal by Subject|8|||
105680576|NCT00116753|364493946|FG000|Overall Study|Lost to Follow-up|0|||
105680577|NCT00116753|364493947|FG001|Overall Study|Lost to Follow-up|2|||
105680578|NCT00116753|364493948|FG002|Overall Study|Lost to Follow-up|1|||
105468668|NCT00196313|363725947|FG001|Overall Study|Withdrawal by Subject|1|||
105468669|NCT00196313|363725946|FG000|Overall Study|Adverse Event|3|||
105468670|NCT00196313|363725947|FG001|Overall Study|Adverse Event|1|||
105468671|NCT00196313|363725946|FG000|Overall Study|Subject Pregnant|1|||
105468672|NCT00196313|363725947|FG001|Overall Study|Subject Pregnant|1|||
105468673|NCT00196313|363725946|FG000|Overall Study|Lost to Follow-up|2|||
105468674|NCT00196313|363725947|FG001|Overall Study|Lost to Follow-up|2|||
105468675|NCT01189032|363725948|FG000|Overall Study|Adverse Event|1|||
105468676|NCT01189032|363725949|FG001|Overall Study|Adverse Event|3|||
105468677|NCT01189032|363725950|FG002|Overall Study|Adverse Event|4|||
105468678|NCT01189032|363725948|FG000|Overall Study|Lack of Efficacy|2|||
105468679|NCT01189032|363725949|FG001|Overall Study|Lack of Efficacy|3|||
105680579|NCT00116753|364493946|FG000|Overall Study|Protocol Violation|0|||
105680580|NCT00116753|364493947|FG001|Overall Study|Protocol Violation|0|||
105680581|NCT00116753|364493948|FG002|Overall Study|Protocol Violation|1|||
105680582|NCT00116753|364493946|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
105680583|NCT00116753|364493947|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
105680584|NCT00116753|364493948|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
105680585|NCT00116753|364493946|FG000|Overall Study|Disease Progression|3|||
105680586|NCT00116753|364493947|FG001|Overall Study|Disease Progression|4|||
105680587|NCT00116753|364493948|FG002|Overall Study|Disease Progression|3|||
105680588|NCT00116753|364493946|FG000|Overall Study|Abnormal Echocardiogram|0|||
105680589|NCT00116753|364493947|FG001|Overall Study|Abnormal Echocardiogram|0|||
105680590|NCT00116753|364493948|FG002|Overall Study|Abnormal Echocardiogram|1|||
105680591|NCT00116753|364493946|FG000|Overall Study|Progressive Parkinson's Disease|1|||
105680592|NCT00116753|364493947|FG001|Overall Study|Progressive Parkinson's Disease|0|||
105680593|NCT00116753|364493948|FG002|Overall Study|Progressive Parkinson's Disease|0|||
105680594|NCT00116753|364493946|FG000|Overall Study|Dosing Error|0|||
105680595|NCT00116753|364493947|FG001|Overall Study|Dosing Error|1|||
105680596|NCT00116753|364493948|FG002|Overall Study|Dosing Error|0|||
105680597|NCT01090427|364493949|FG000|After Controlled Period|Death|0|||
105680598|NCT01090427|364493950|FG001|After Controlled Period|Death|0|||
105680599|NCT01090427|364493951|FG002|After Controlled Period|Death|0|||
105680600|NCT01090427|364493952|FG003|After Controlled Period|Death|0|||
105680601|NCT01090427|364493953|FG004|After Controlled Period|Death|0|||
105680602|NCT01090427|364493954|FG005|After Controlled Period|Death|1|||
105680603|NCT01090427|364493955|FG006|After Controlled Period|Death|0|||
105680604|NCT01090427|364493949|FG000|After Controlled Period|Lack of Efficacy|0|||
105680605|NCT01090427|364493950|FG001|After Controlled Period|Lack of Efficacy|0|||
105680606|NCT01090427|364493951|FG002|After Controlled Period|Lack of Efficacy|0|||
105680607|NCT01090427|364493952|FG003|After Controlled Period|Lack of Efficacy|0|||
105680608|NCT01090427|364493953|FG004|After Controlled Period|Lack of Efficacy|0|||
105680609|NCT01090427|364493954|FG005|After Controlled Period|Lack of Efficacy|3|||
105680610|NCT01090427|364493955|FG006|After Controlled Period|Lack of Efficacy|2|||
105680611|NCT01090427|364493949|FG000|After Controlled Period|Adverse Event|0|||
105680612|NCT01090427|364493950|FG001|After Controlled Period|Adverse Event|0|||
105680613|NCT01090427|364493951|FG002|After Controlled Period|Adverse Event|0|||
105680614|NCT01090427|364493952|FG003|After Controlled Period|Adverse Event|2|||
105680615|NCT01090427|364493953|FG004|After Controlled Period|Adverse Event|0|||
105680616|NCT01090427|364493954|FG005|After Controlled Period|Adverse Event|1|||
105680617|NCT01090427|364493955|FG006|After Controlled Period|Adverse Event|0|||
105680618|NCT01465347|364493956|FG000|Overall Study|Withdrawal by Subject|1|||
105680619|NCT01465347|364493957|FG001|Overall Study|Withdrawal by Subject|1|||
105680620|NCT01465347|364493956|FG000|Overall Study|Physician Decision|0|||
105680621|NCT01465347|364493957|FG001|Overall Study|Physician Decision|1|||
105680622|NCT01465347|364493956|FG000|Overall Study|Admitted to hospice|0|||
105680623|NCT01465347|364493957|FG001|Overall Study|Admitted to hospice|1|||
105680624|NCT01210664|364493959|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
105680625|NCT01210664|364493960|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
105680626|NCT01210664|364493961|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
105344307|NCT03045276|363261750|FG000|Intervention Phase|Withdrawal by Subject|7|||
105680627|NCT01210664|364493962|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
105680628|NCT01210664|364493959|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
105680629|NCT01210664|364493960|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
105680630|NCT01210664|364493961|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
105468680|NCT01189032|363725950|FG002|Overall Study|Lack of Efficacy|0|||
105680631|NCT01210664|364493962|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
105468681|NCT01189032|363725948|FG000|Overall Study|Withdrawal by Subject|1|||
105468682|NCT01189032|363725949|FG001|Overall Study|Withdrawal by Subject|0|||
105468683|NCT01189032|363725950|FG002|Overall Study|Withdrawal by Subject|1|||
105680632|NCT01210664|364493959|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
105680633|NCT01210664|364493960|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
105680634|NCT01210664|364493961|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
105680635|NCT01210664|364493962|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
105680636|NCT02649946|364493963|FG000|Overall Study|Withdrawal by Subject|1|||
105680637|NCT02649946|364493964|FG001|Overall Study|Withdrawal by Subject|1|||
105680638|NCT02649946|364493963|FG000|Overall Study|Death|7|||
105680639|NCT02649946|364493964|FG001|Overall Study|Death|9|||
105680640|NCT02649946|364493963|FG000|Overall Study|Physician Decision|1|||
105680641|NCT02649946|364493964|FG001|Overall Study|Physician Decision|0|||
105680642|NCT02649946|364493963|FG000|Overall Study|Lost to Follow-up|2|||
105680643|NCT02649946|364493964|FG001|Overall Study|Lost to Follow-up|1|||
105680644|NCT02649946|364493963|FG000|Overall Study|Erroneously enrolled|1|||
105680645|NCT02649946|364493964|FG001|Overall Study|Erroneously enrolled|0|||
105680646|NCT02649946|364493963|FG000|Overall Study|Missed 6-month follow-up visit|0|||
105680647|NCT02649946|364493964|FG001|Overall Study|Missed 6-month follow-up visit|4|||
105680648|NCT01920854|364493965|FG000|Overall Study|Withdrawal by Subject|1|||
105680649|NCT01920854|364493966|FG001|Overall Study|Withdrawal by Subject|0|||
105680650|NCT01920854|364493967|FG002|Overall Study|Withdrawal by Subject|0|||
105680651|NCT01920854|364493968|FG003|Overall Study|Withdrawal by Subject|0|||
105680652|NCT01920854|364493969|FG004|Overall Study|Withdrawal by Subject|1|||
105680653|NCT01920854|364493970|FG005|Overall Study|Withdrawal by Subject|0|||
105680654|NCT01920854|364493971|FG006|Overall Study|Withdrawal by Subject|1|||
105680655|NCT02372136|364493975|FG000|Overall Study|Death|3|||
105680656|NCT02372136|364493976|FG001|Overall Study|Death|1|||
105680657|NCT01688830|364493977|FG000|Overall Study|Lost to Follow-up|0|||
105680658|NCT01688830|364493978|FG001|Overall Study|Lost to Follow-up|0|||
105680659|NCT01688830|364493979|FG002|Overall Study|Lost to Follow-up|0|||
105680660|NCT01688830|364493980|FG003|Overall Study|Lost to Follow-up|0|||
105680661|NCT01688830|364493981|FG004|Overall Study|Lost to Follow-up|0|||
105680662|NCT01688830|364493982|FG005|Overall Study|Lost to Follow-up|0|||
105680663|NCT01688830|364493983|FG006|Overall Study|Lost to Follow-up|0|||
105680664|NCT01688830|364493984|FG007|Overall Study|Lost to Follow-up|0|||
105680665|NCT01688830|364493985|FG008|Overall Study|Lost to Follow-up|0|||
105680666|NCT01688830|364493986|FG009|Overall Study|Lost to Follow-up|0|||
105680667|NCT01688830|364493987|FG010|Overall Study|Lost to Follow-up|1|||
105680668|NCT01688830|364493988|FG011|Overall Study|Lost to Follow-up|0|||
105680669|NCT01688830|364493989|FG012|Overall Study|Lost to Follow-up|0|||
105680670|NCT01688830|364493990|FG013|Overall Study|Lost to Follow-up|0|||
105680671|NCT01688830|364493991|FG014|Overall Study|Lost to Follow-up|0|||
105680672|NCT01688830|364493992|FG015|Overall Study|Lost to Follow-up|0|||
105680673|NCT01688830|364493993|FG016|Overall Study|Lost to Follow-up|0|||
105680674|NCT01688830|364493994|FG017|Overall Study|Lost to Follow-up|0|||
105680675|NCT01688830|364493995|FG018|Overall Study|Lost to Follow-up|0|||
105680676|NCT01688830|364493996|FG019|Overall Study|Lost to Follow-up|0|||
105680677|NCT01688830|364493997|FG020|Overall Study|Lost to Follow-up|0|||
105680678|NCT02318797|364493998|FG000|Overall Study|Death|3|||
105680679|NCT02318797|364493999|FG001|Overall Study|Death|6|||
105680680|NCT02318797|364493998|FG000|Overall Study|Lost to Follow-up|85|||
105680681|NCT02318797|364493999|FG001|Overall Study|Lost to Follow-up|96|||
105680682|NCT00511472|364494000|FG000|Overall Study|Clinical Adverse Event|1|||
105680683|NCT00511472|364494001|FG001|Overall Study|Clinical Adverse Event|2|||
105680684|NCT00511472|364494000|FG000|Overall Study|Laboratory Adverse Event|0|||
105680685|NCT00511472|364494001|FG001|Overall Study|Laboratory Adverse Event|2|||
105680686|NCT00511472|364494000|FG000|Overall Study|Not reported|2|||
105680687|NCT00511472|364494001|FG001|Overall Study|Not reported|2|||
105680688|NCT02709096|364494002|FG000|Overall Study|non-compliance|1|||
105680689|NCT02709096|364494003|FG001|Overall Study|non-compliance|1|||
105680690|NCT02308020|364494005|FG000|Overall Study|Lost to Follow-up|1|||
105680691|NCT02308020|364494006|FG001|Overall Study|Lost to Follow-up|7|||
105680692|NCT02308020|364494007|FG002|Overall Study|Lost to Follow-up|0|||
105680693|NCT02308020|364494008|FG003|Overall Study|Lost to Follow-up|0|||
105680694|NCT02308020|364494009|FG004|Overall Study|Lost to Follow-up|1|||
105680695|NCT02308020|364494010|FG005|Overall Study|Lost to Follow-up|2|||
105680696|NCT02308020|364494005|FG000|Overall Study|Sponsor Decision|0|||
105680697|NCT02308020|364494006|FG001|Overall Study|Sponsor Decision|8|||
105680698|NCT02308020|364494007|FG002|Overall Study|Sponsor Decision|0|||
105680699|NCT02308020|364494008|FG003|Overall Study|Sponsor Decision|2|||
105680700|NCT02308020|364494009|FG004|Overall Study|Sponsor Decision|2|||
105680701|NCT02308020|364494010|FG005|Overall Study|Sponsor Decision|1|||
105680702|NCT02308020|364494005|FG000|Overall Study|Withdrawal by Subject|3|||
105680703|NCT02308020|364494006|FG001|Overall Study|Withdrawal by Subject|5|||
105680704|NCT02308020|364494007|FG002|Overall Study|Withdrawal by Subject|3|||
105680705|NCT02308020|364494008|FG003|Overall Study|Withdrawal by Subject|2|||
105680706|NCT02308020|364494009|FG004|Overall Study|Withdrawal by Subject|1|||
105680707|NCT02308020|364494010|FG005|Overall Study|Withdrawal by Subject|2|||
105680708|NCT00505284|364494011|FG000|Overall Study|Adverse Event|3|||
105680709|NCT00505284|364494012|FG001|Overall Study|Adverse Event|7|||
105680710|NCT00505284|364494013|FG002|Overall Study|Adverse Event|9|||
105680711|NCT00505284|364494014|FG003|Overall Study|Adverse Event|14|||
105680712|NCT00505284|364494015|FG004|Overall Study|Adverse Event|22|||
105680713|NCT00505284|364494011|FG000|Overall Study|Protocol Violation|0|||
105680714|NCT00505284|364494012|FG001|Overall Study|Protocol Violation|1|||
105680715|NCT00505284|364494013|FG002|Overall Study|Protocol Violation|1|||
105680716|NCT00505284|364494014|FG003|Overall Study|Protocol Violation|0|||
105680717|NCT00505284|364494015|FG004|Overall Study|Protocol Violation|0|||
105680718|NCT00505284|364494011|FG000|Overall Study|Withdrawal by Subject|2|||
105680719|NCT00505284|364494012|FG001|Overall Study|Withdrawal by Subject|6|||
105680720|NCT00505284|364494013|FG002|Overall Study|Withdrawal by Subject|1|||
105680721|NCT00505284|364494014|FG003|Overall Study|Withdrawal by Subject|0|||
105680722|NCT00505284|364494015|FG004|Overall Study|Withdrawal by Subject|6|||
105680723|NCT00505284|364494011|FG000|Overall Study|Lack of Efficacy|0|||
105680724|NCT00505284|364494012|FG001|Overall Study|Lack of Efficacy|1|||
105680725|NCT00505284|364494013|FG002|Overall Study|Lack of Efficacy|1|||
105680726|NCT00505284|364494014|FG003|Overall Study|Lack of Efficacy|1|||
105680727|NCT00505284|364494015|FG004|Overall Study|Lack of Efficacy|1|||
105680728|NCT00505284|364494011|FG000|Overall Study|Physician Decision|0|||
105680729|NCT00505284|364494012|FG001|Overall Study|Physician Decision|1|||
105680730|NCT00505284|364494013|FG002|Overall Study|Physician Decision|0|||
105680731|NCT00505284|364494014|FG003|Overall Study|Physician Decision|0|||
105680732|NCT00505284|364494015|FG004|Overall Study|Physician Decision|0|||
105680733|NCT00505284|364494011|FG000|Overall Study|Other|5|||
105680734|NCT00505284|364494012|FG001|Overall Study|Other|0|||
105680735|NCT00505284|364494013|FG002|Overall Study|Other|0|||
105680736|NCT00505284|364494014|FG003|Overall Study|Other|4|||
105680737|NCT00505284|364494015|FG004|Overall Study|Other|4|||
105680738|NCT03265938|364494016|FG000|Overall Study|Withdrawal by Subject|1|||
105680739|NCT03265938|364494016|FG000|Overall Study|Physician Decision|1|||
105680740|NCT03265938|364494016|FG000|Overall Study|friable mass|6|||
105680741|NCT01211288|364494017|FG000|Overall Study|Lost to Follow-up|1|||
105680742|NCT01211288|364494018|FG001|Overall Study|Lost to Follow-up|1|||
105680743|NCT02471833|364494020|FG000|Overall Study|Lost to Follow-up|1|||
105680744|NCT02471833|364494021|FG001|Overall Study|Lost to Follow-up|0|||
105680745|NCT02471833|364494022|FG002|Overall Study|Lost to Follow-up|0|||
105680746|NCT02471833|364494020|FG000|Overall Study|Withdrawal by Subject|2|||
105680747|NCT02471833|364494021|FG001|Overall Study|Withdrawal by Subject|1|||
105680748|NCT02471833|364494022|FG002|Overall Study|Withdrawal by Subject|5|||
105680749|NCT00953745|364494036|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
105680750|NCT00953745|364494037|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
105680751|NCT00953745|364494036|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
105680752|NCT00953745|364494037|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
105680753|NCT00953745|364494036|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
105680754|NCT00953745|364494037|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
105680755|NCT00953745|364494036|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
105680756|NCT00953745|364494037|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
105680757|NCT00953745|364494036|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
105680758|NCT00953745|364494037|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
105680759|NCT00953745|364494036|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
105680760|NCT00953745|364494037|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
105680761|NCT00994682|364494038|FG000|Double Bilnd|Withdrawal by Subject|5|||
105680762|NCT00994682|364494039|FG001|Double Bilnd|Withdrawal by Subject|6|||
105680763|NCT00994682|364494038|FG000|Double Bilnd|Lost to Follow-up|3|||
105680764|NCT00994682|364494039|FG001|Double Bilnd|Lost to Follow-up|3|||
105680765|NCT00994682|364494038|FG000|Double Bilnd|Adverse Event|1|||
105680766|NCT00994682|364494039|FG001|Double Bilnd|Adverse Event|0|||
105680767|NCT00994682|364494038|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
105680768|NCT00994682|364494039|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
105680769|NCT00994682|364494038|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
105680770|NCT00994682|364494039|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
105680771|NCT00994682|364494038|FG000|Pioglitazone Open Label|Physician Decision|6|||
105680772|NCT00994682|364494039|FG001|Pioglitazone Open Label|Physician Decision|1|||
105680773|NCT00704405|364494042|FG000|Overall Study (NC Population)|Adverse Event|1|||
105680774|NCT00704405|364494043|FG001|Overall Study (NC Population)|Adverse Event|0|||
105680775|NCT00704405|364494044|FG002|Overall Study (NC Population)|Adverse Event|0|||
105680776|NCT00704405|364494045|FG003|Overall Study (NC Population)|Adverse Event|0|||
105680777|NCT00704405|364494046|FG004|Overall Study (NC Population)|Adverse Event|0|||
105680778|NCT00704405|364494042|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
105680779|NCT00704405|364494043|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
105680780|NCT00704405|364494044|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
105680781|NCT00704405|364494045|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
105680782|NCT00704405|364494046|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
105680783|NCT00704405|364494042|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
105680784|NCT00704405|364494043|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
105680785|NCT00704405|364494044|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
105680786|NCT00704405|364494045|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
105680787|NCT00704405|364494046|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
105680788|NCT00704405|364494042|FG000|Overall Study (NC Population)|Other|0|||
105680789|NCT00704405|364494043|FG001|Overall Study (NC Population)|Other|0|||
105680790|NCT00704405|364494044|FG002|Overall Study (NC Population)|Other|0|||
105680791|NCT00704405|364494045|FG003|Overall Study (NC Population)|Other|0|||
105680792|NCT00704405|364494046|FG004|Overall Study (NC Population)|Other|1|||
105680793|NCT00704405|364494042|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
105680794|NCT00704405|364494043|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
105680795|NCT00704405|364494044|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
105680796|NCT00704405|364494045|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
105680797|NCT00704405|364494046|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
105680798|NCT00704405|364494042|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
105680799|NCT00704405|364494043|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
105680800|NCT00704405|364494044|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
105680801|NCT00704405|364494045|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
105680802|NCT00704405|364494046|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
105680803|NCT02859324|364494047|FG000|Overall Study|Death|4|||
105680804|NCT02859324|364494048|FG001|Overall Study|Death|6|||
105680805|NCT02859324|364494049|FG002|Overall Study|Death|5|||
105680806|NCT02859324|364494047|FG000|Overall Study|Other reasons|3|||
105680807|NCT02859324|364494048|FG001|Overall Study|Other reasons|3|||
105680808|NCT02859324|364494049|FG002|Overall Study|Other reasons|0|||
105680809|NCT01946438|364494050|FG000|Overall Study|Adverse Event|0|||
105680810|NCT01946438|364494051|FG001|Overall Study|Adverse Event|0|||
105680811|NCT01946438|364494052|FG002|Overall Study|Adverse Event|0|||
105680812|NCT01946438|364494053|FG003|Overall Study|Adverse Event|1|||
105680813|NCT01946438|364494050|FG000|Overall Study|Serious Adverse event|1|||
105680814|NCT01946438|364494051|FG001|Overall Study|Serious Adverse event|0|||
105680815|NCT01946438|364494052|FG002|Overall Study|Serious Adverse event|0|||
105680816|NCT01946438|364494053|FG003|Overall Study|Serious Adverse event|0|||
105680817|NCT01946438|364494050|FG000|Overall Study|Protocol Violation|0|||
105680818|NCT01946438|364494051|FG001|Overall Study|Protocol Violation|0|||
105680819|NCT01946438|364494052|FG002|Overall Study|Protocol Violation|1|||
105680820|NCT01946438|364494053|FG003|Overall Study|Protocol Violation|0|||
105680821|NCT01946438|364494050|FG000|Overall Study|Withdrawal by Subject|1|||
105680822|NCT01946438|364494051|FG001|Overall Study|Withdrawal by Subject|0|||
105680823|NCT01946438|364494052|FG002|Overall Study|Withdrawal by Subject|0|||
105680824|NCT01946438|364494053|FG003|Overall Study|Withdrawal by Subject|0|||
105680825|NCT01679405|364494054|FG000|Overall Study|Death|2|||
105680826|NCT01679405|364494055|FG001|Overall Study|Death|5|||
105680827|NCT03316300|364494058|FG000|Overall Study|Withdrawal by Subject|3|||
105680828|NCT03316300|364494059|FG001|Overall Study|Withdrawal by Subject|2|||
105680829|NCT03316300|364494058|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
105680830|NCT03316300|364494059|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
105680831|NCT03316300|364494058|FG000|Overall Study|Adverse Event|1|||
105680832|NCT03316300|364494059|FG001|Overall Study|Adverse Event|0|||
105680833|NCT03316300|364494058|FG000|Overall Study|COVID-19|0|||
105680834|NCT03316300|364494059|FG001|Overall Study|COVID-19|1|||
105680835|NCT01439360|364494060|FG000|Overall Study|Adverse Event|4|||
105680836|NCT01439360|364494061|FG001|Overall Study|Adverse Event|16|||
105680837|NCT01439360|364494060|FG000|Overall Study|Lost to Follow-up|43|||
105786477|NCT01748162|364871402|FG001|Overall Study|participant consented but did not begin|1|||
105680838|NCT01439360|364494061|FG001|Overall Study|Lost to Follow-up|58|||
105680839|NCT01439360|364494060|FG000|Overall Study|Others|10|||
105680840|NCT01439360|364494061|FG001|Overall Study|Others|5|||
105680841|NCT01439360|364494060|FG000|Overall Study|Protocol Violation|1|||
105680842|NCT01439360|364494061|FG001|Overall Study|Protocol Violation|0|||
105680843|NCT01439360|364494060|FG000|Overall Study|Withdrawal by Subject|140|||
105680844|NCT01439360|364494061|FG001|Overall Study|Withdrawal by Subject|129|||
105680845|NCT01506453|364495778|FG000|Overall Study|Withdrawal prior to treatment|0|||
105680846|NCT01506453|364495779|FG001|Overall Study|Withdrawal prior to treatment|2|||
105680847|NCT00734097|364495783|FG000|Screening|Protocol Violation|12|||
105680848|NCT00734097|364495783|FG000|Screening|Withdrawal by Subject|5|||
105680849|NCT00734097|364495783|FG000|Screening|Lost to Follow-up|2|||
105680850|NCT00734097|364495783|FG000|Screening|Unconfirmed pregnancy|1|||
105680851|NCT00734097|364495783|FG000|Open Label|Lost to Follow-up|7|||
105680852|NCT00734097|364495783|FG000|Open Label|Withdrawal by Subject|5|||
105680853|NCT00734097|364495783|FG000|Open Label|Protocol Violation|4|||
105680854|NCT01346475|364495791|FG000|First Intervention|Lost to Follow-up|4|||
105344308|NCT03045276|363261751|FG001|Intervention Phase|Withdrawal by Subject|2|||
105344309|NCT03045276|363261752|FG002|Intervention Phase|Withdrawal by Subject|3|||
105344310|NCT03045276|363261753|FG003|Intervention Phase|Withdrawal by Subject|7|||
105344311|NCT03045276|363261750|FG000|Intervention Phase|Developed exclusionary criteria|3|||
105344312|NCT03045276|363261751|FG001|Intervention Phase|Developed exclusionary criteria|3|||
105344313|NCT03045276|363261752|FG002|Intervention Phase|Developed exclusionary criteria|0|||
105344314|NCT03045276|363261753|FG003|Intervention Phase|Developed exclusionary criteria|0|||
105344315|NCT03045276|363261750|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
105344316|NCT03045276|363261751|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
105344317|NCT03045276|363261752|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
105344318|NCT03045276|363261753|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
105344319|NCT03045276|363261750|FG000|Follow-Up Phase|Lost to Follow-up|0|||
105344320|NCT03045276|363261751|FG001|Follow-Up Phase|Lost to Follow-up|1|||
105344321|NCT03045276|363261752|FG002|Follow-Up Phase|Lost to Follow-up|0|||
105344322|NCT03045276|363261753|FG003|Follow-Up Phase|Lost to Follow-up|1|||
105344323|NCT03045276|363261750|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
105344324|NCT03045276|363261751|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
105344325|NCT03045276|363261752|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
105344326|NCT03045276|363261753|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
105344327|NCT03379753|363261754|FG000|Overall Study|Withdrawal by Subject|2|||
105344328|NCT03379753|363261755|FG001|Overall Study|Withdrawal by Subject|1|||
105344329|NCT03379753|363261754|FG000|Overall Study|not having correct procedure|1|||
105344330|NCT03379753|363261755|FG001|Overall Study|not having correct procedure|2|||
105344331|NCT03379753|363261754|FG000|Overall Study|No primary outcome|12|||
105344332|NCT03379753|363261755|FG001|Overall Study|No primary outcome|22|||
105344333|NCT02225366|363261756|FG000|Overall Study|Lack of Efficacy|1|||
105344334|NCT02225366|363261757|FG001|Overall Study|Lack of Efficacy|0|||
105344335|NCT01382225|363261758|FG000|Overall Study|Adverse Event|3|||
105344336|NCT01382225|363261759|FG001|Overall Study|Adverse Event|2|||
105344337|NCT01382225|363261758|FG000|Overall Study|Protocol Violation|2|||
105344338|NCT01382225|363261759|FG001|Overall Study|Protocol Violation|1|||
105344339|NCT01382225|363261758|FG000|Overall Study|Subject Withdrew Consent|5|||
105344340|NCT01382225|363261759|FG001|Overall Study|Subject Withdrew Consent|2|||
105344341|NCT01382225|363261758|FG000|Overall Study|Other|4|||
105344342|NCT01382225|363261759|FG001|Overall Study|Other|2|||
105344343|NCT01797081|363261760|FG000|Overall Study|Adverse Event|1|||
105680855|NCT01346475|364495792|FG001|First Intervention|Lost to Follow-up|3|||
105680856|NCT02366468|364495793|FG000|Overall Study|Adverse Event|2|||
105680857|NCT02366468|364495794|FG001|Overall Study|Adverse Event|0|||
105680858|NCT02366468|364495793|FG000|Overall Study|Withdrawal by Subject|1|||
105680859|NCT02366468|364495794|FG001|Overall Study|Withdrawal by Subject|5|||
105680860|NCT02366468|364495793|FG000|Overall Study|Lost to Follow-up|2|||
105680861|NCT02366468|364495794|FG001|Overall Study|Lost to Follow-up|0|||
105680862|NCT02366468|364495793|FG000|Overall Study|Death|1|||
105680863|NCT02366468|364495794|FG001|Overall Study|Death|2|||
105344344|NCT01797081|363261761|FG001|Overall Study|Adverse Event|0|||
105344345|NCT01797081|363261762|FG002|Overall Study|Adverse Event|1|||
105344346|NCT01797081|363261763|FG003|Overall Study|Adverse Event|0|||
105344347|NCT01797081|363261760|FG000|Overall Study|Pregnancy|1|||
105344348|NCT01797081|363261761|FG001|Overall Study|Pregnancy|0|||
105344349|NCT01797081|363261762|FG002|Overall Study|Pregnancy|0|||
105680864|NCT02366468|364495793|FG000|Overall Study|Other|0|||
105344350|NCT01797081|363261763|FG003|Overall Study|Pregnancy|0|||
105344351|NCT01797081|363261760|FG000|Overall Study|Personal Reasons|12|||
105344352|NCT01797081|363261761|FG001|Overall Study|Personal Reasons|4|||
105680865|NCT02366468|364495794|FG001|Overall Study|Other|2|||
105344353|NCT01797081|363261762|FG002|Overall Study|Personal Reasons|4|||
105344354|NCT01797081|363261763|FG003|Overall Study|Personal Reasons|8|||
105344355|NCT01797081|363261760|FG000|Overall Study|Protocol Violation|0|||
105680866|NCT01776541|364495795|FG000|Overall Study|Administrative Reason|6|||
105680867|NCT01776541|364495796|FG001|Overall Study|Administrative Reason|2|||
105680868|NCT01776541|364495795|FG000|Overall Study|Death|4|||
105680869|NCT01776541|364495796|FG001|Overall Study|Death|0|||
105680870|NCT01776541|364495795|FG000|Overall Study|Lost to Follow-up|27|||
105680871|NCT01776541|364495796|FG001|Overall Study|Lost to Follow-up|48|||
105680872|NCT01776541|364495795|FG000|Overall Study|Unclassified|5|||
105680873|NCT01776541|364495796|FG001|Overall Study|Unclassified|4|||
105680874|NCT01776541|364495795|FG000|Overall Study|Protocol Violation|2|||
105680875|NCT01776541|364495796|FG001|Overall Study|Protocol Violation|1|||
105680876|NCT01776541|364495795|FG000|Overall Study|Withdrawal by Subject|12|||
105680877|NCT01776541|364495796|FG001|Overall Study|Withdrawal by Subject|20|||
105680878|NCT04279392|364495797|FG000|Overall Study|Physician Decision|1|||
105680879|NCT04279392|364495798|FG001|Overall Study|Physician Decision|0|||
105680880|NCT00700258|364495803|FG000|Overall Study|Premature discontinuation of documentation|136|||
105680881|NCT00700258|364495803|FG000|Overall Study|Type of study end not documented|1|||
105680882|NCT00700258|364495803|FG000|Overall Study|Lost to Follow-up|81|||
105680883|NCT00700258|364495803|FG000|Overall Study|Premature discontinuation of therapy|1013|||
105680884|NCT00370331|364495805|FG000|Overall Study|Adverse Event|4|||
105680885|NCT00370331|364495806|FG001|Overall Study|Adverse Event|13|||
105680886|NCT00370331|364495805|FG000|Overall Study|Withdrawal by Subject|2|||
105680887|NCT00370331|364495806|FG001|Overall Study|Withdrawal by Subject|4|||
105680888|NCT00370331|364495805|FG000|Overall Study|Lost to Follow-up|0|||
105680889|NCT00370331|364495806|FG001|Overall Study|Lost to Follow-up|3|||
105680890|NCT00370331|364495805|FG000|Overall Study|Lack of Efficacy|0|||
105680891|NCT00370331|364495806|FG001|Overall Study|Lack of Efficacy|1|||
105680892|NCT00370331|364495805|FG000|Overall Study|Non-compliance|0|||
105680893|NCT00370331|364495806|FG001|Overall Study|Non-compliance|1|||
105680894|NCT00370331|364495805|FG000|Overall Study|Protocol Violation|1|||
105680895|NCT00370331|364495806|FG001|Overall Study|Protocol Violation|1|||
105680896|NCT01874431|364495807|FG000|Overall Study|Physician Decision|0|||
105680897|NCT01874431|364495808|FG001|Overall Study|Physician Decision|0|||
105680898|NCT01874431|364495809|FG002|Overall Study|Physician Decision|1|||
105680899|NCT01874431|364495810|FG003|Overall Study|Physician Decision|0|||
105680900|NCT01874431|364495811|FG004|Overall Study|Physician Decision|0|||
105680901|NCT01874431|364495812|FG005|Overall Study|Physician Decision|0|||
105680902|NCT01874431|364495813|FG006|Overall Study|Physician Decision|0|||
105680903|NCT01874431|364495814|FG007|Overall Study|Physician Decision|0|||
105680904|NCT01874431|364495807|FG000|Overall Study|Adverse Event|5|||
105680905|NCT01874431|364495808|FG001|Overall Study|Adverse Event|4|||
105680906|NCT01874431|364495809|FG002|Overall Study|Adverse Event|6|||
105680907|NCT01874431|364495810|FG003|Overall Study|Adverse Event|5|||
105680908|NCT01874431|364495811|FG004|Overall Study|Adverse Event|2|||
105680909|NCT01874431|364495812|FG005|Overall Study|Adverse Event|8|||
105680910|NCT01874431|364495813|FG006|Overall Study|Adverse Event|2|||
105680911|NCT01874431|364495814|FG007|Overall Study|Adverse Event|3|||
105680912|NCT01874431|364495807|FG000|Overall Study|Protocol Violation|1|||
105680913|NCT01874431|364495808|FG001|Overall Study|Protocol Violation|1|||
105680914|NCT01874431|364495809|FG002|Overall Study|Protocol Violation|1|||
105680915|NCT01874431|364495810|FG003|Overall Study|Protocol Violation|0|||
105680916|NCT01874431|364495811|FG004|Overall Study|Protocol Violation|3|||
105680917|NCT01874431|364495812|FG005|Overall Study|Protocol Violation|2|||
105680918|NCT01874431|364495813|FG006|Overall Study|Protocol Violation|1|||
105680919|NCT01874431|364495814|FG007|Overall Study|Protocol Violation|1|||
105680920|NCT01874431|364495807|FG000|Overall Study|Non-compliance|0|||
105680921|NCT01874431|364495808|FG001|Overall Study|Non-compliance|0|||
105680922|NCT01874431|364495809|FG002|Overall Study|Non-compliance|0|||
105680923|NCT01874431|364495810|FG003|Overall Study|Non-compliance|0|||
105680924|NCT01874431|364495811|FG004|Overall Study|Non-compliance|1|||
105680925|NCT01874431|364495812|FG005|Overall Study|Non-compliance|0|||
105680926|NCT01874431|364495813|FG006|Overall Study|Non-compliance|1|||
105680927|NCT01874431|364495814|FG007|Overall Study|Non-compliance|0|||
105680928|NCT01874431|364495807|FG000|Overall Study|Logistical difficulties|0|||
105680929|NCT01874431|364495808|FG001|Overall Study|Logistical difficulties|0|||
105680930|NCT01874431|364495809|FG002|Overall Study|Logistical difficulties|0|||
105680931|NCT01874431|364495810|FG003|Overall Study|Logistical difficulties|0|||
105680932|NCT01874431|364495811|FG004|Overall Study|Logistical difficulties|0|||
105680933|NCT01874431|364495812|FG005|Overall Study|Logistical difficulties|0|||
105680934|NCT01874431|364495813|FG006|Overall Study|Logistical difficulties|1|||
105680935|NCT01874431|364495814|FG007|Overall Study|Logistical difficulties|0|||
105680936|NCT01874431|364495807|FG000|Overall Study|Withdrawal by Subject|0|||
105680937|NCT01874431|364495808|FG001|Overall Study|Withdrawal by Subject|0|||
105680938|NCT01874431|364495809|FG002|Overall Study|Withdrawal by Subject|1|||
105680939|NCT01874431|364495810|FG003|Overall Study|Withdrawal by Subject|2|||
105680940|NCT01874431|364495811|FG004|Overall Study|Withdrawal by Subject|1|||
105680941|NCT01874431|364495812|FG005|Overall Study|Withdrawal by Subject|1|||
105680942|NCT01874431|364495813|FG006|Overall Study|Withdrawal by Subject|3|||
105680943|NCT01874431|364495814|FG007|Overall Study|Withdrawal by Subject|0|||
105680944|NCT01874431|364495807|FG000|Overall Study|Sponsor decision|0|||
105680945|NCT01874431|364495808|FG001|Overall Study|Sponsor decision|0|||
105680946|NCT01874431|364495809|FG002|Overall Study|Sponsor decision|0|||
105557590|NCT00127101|364037736|FG001|Base Protocol|Adverse Event|2|||
105557591|NCT00127101|364037737|FG002|Base Protocol|Adverse Event|1|||
105557592|NCT00127101|364037738|FG003|Base Protocol|Adverse Event|0|||
105557593|NCT00127101|364037739|FG004|Base Protocol|Adverse Event|0|||
105557594|NCT00127101|364037740|FG005|Base Protocol|Adverse Event|0|||
105557595|NCT00127101|364037735|FG000|Base Protocol|Lack of Efficacy|1|||
105557596|NCT00127101|364037736|FG001|Base Protocol|Lack of Efficacy|0|||
105557597|NCT00127101|364037737|FG002|Base Protocol|Lack of Efficacy|0|||
105557598|NCT00127101|364037738|FG003|Base Protocol|Lack of Efficacy|0|||
105557599|NCT00127101|364037739|FG004|Base Protocol|Lack of Efficacy|2|||
105557600|NCT00127101|364037740|FG005|Base Protocol|Lack of Efficacy|0|||
105557601|NCT00127101|364037735|FG000|Base Protocol|Withdrawal by Subject|1|||
105557602|NCT00127101|364037736|FG001|Base Protocol|Withdrawal by Subject|2|||
105557603|NCT00127101|364037737|FG002|Base Protocol|Withdrawal by Subject|1|||
105557604|NCT00127101|364037738|FG003|Base Protocol|Withdrawal by Subject|0|||
105557605|NCT00127101|364037739|FG004|Base Protocol|Withdrawal by Subject|0|||
105557606|NCT00127101|364037740|FG005|Base Protocol|Withdrawal by Subject|1|||
105557607|NCT00127101|364037735|FG000|Continuation Phase|Adverse Event|0|||
105557608|NCT00127101|364037736|FG001|Continuation Phase|Adverse Event|0|||
105557609|NCT00127101|364037737|FG002|Continuation Phase|Adverse Event|0|||
105557610|NCT00127101|364037738|FG003|Continuation Phase|Adverse Event|0|||
105557611|NCT00127101|364037739|FG004|Continuation Phase|Adverse Event|1|||
105557612|NCT00127101|364037740|FG005|Continuation Phase|Adverse Event|1|||
105557613|NCT00127101|364037735|FG000|Continuation Phase|Lack of Efficacy|0|||
105557614|NCT00127101|364037736|FG001|Continuation Phase|Lack of Efficacy|0|||
105557615|NCT00127101|364037737|FG002|Continuation Phase|Lack of Efficacy|0|||
105557616|NCT00127101|364037738|FG003|Continuation Phase|Lack of Efficacy|0|||
105557617|NCT00127101|364037739|FG004|Continuation Phase|Lack of Efficacy|0|||
105557618|NCT00127101|364037740|FG005|Continuation Phase|Lack of Efficacy|1|||
105557619|NCT00127101|364037735|FG000|Continuation Phase|Withdrawal by Subject|0|||
105557620|NCT00127101|364037736|FG001|Continuation Phase|Withdrawal by Subject|0|||
105557621|NCT00127101|364037737|FG002|Continuation Phase|Withdrawal by Subject|1|||
105557622|NCT00127101|364037738|FG003|Continuation Phase|Withdrawal by Subject|0|||
105557623|NCT00127101|364037739|FG004|Continuation Phase|Withdrawal by Subject|2|||
105557624|NCT00127101|364037740|FG005|Continuation Phase|Withdrawal by Subject|1|||
105557625|NCT03336619|364037741|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
105557626|NCT03336619|364037742|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
105557627|NCT03336619|364037741|FG000|Overall Study|Withdrawal by Subject|17|||
105557628|NCT03336619|364037742|FG001|Overall Study|Withdrawal by Subject|16|||
105557629|NCT03336619|364037741|FG000|Overall Study|Adverse Event|2|||
105557630|NCT03336619|364037742|FG001|Overall Study|Adverse Event|5|||
105557631|NCT03336619|364037741|FG000|Overall Study|Physician Decision|3|||
105557632|NCT03336619|364037742|FG001|Overall Study|Physician Decision|0|||
105557633|NCT02820623|364037743|FG000|Overall Study|Withdrawal by Subject|1|||
105557634|NCT02820623|364037744|FG001|Overall Study|Withdrawal by Subject|3|||
105557635|NCT02820623|364037745|FG002|Overall Study|Withdrawal by Subject|3|||
105557636|NCT02820623|364037743|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
105557637|NCT02820623|364037744|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
105557638|NCT02820623|364037745|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
105557639|NCT02820623|364037743|FG000|Overall Study|Therapist unable to enroll clients|1|||
105557640|NCT02820623|364037744|FG001|Overall Study|Therapist unable to enroll clients|1|||
105557641|NCT02820623|364037745|FG002|Overall Study|Therapist unable to enroll clients|3|||
105557642|NCT02820623|364037743|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
105557643|NCT02820623|364037744|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
105557644|NCT02820623|364037745|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
105557645|NCT01565707|364037746|FG000|Overall Study|Adverse Event|1|||
105557646|NCT01565707|364037747|FG001|Overall Study|Adverse Event|6|||
105557647|NCT01565707|364037748|FG002|Overall Study|Adverse Event|2|||
105557648|NCT01565707|364037749|FG003|Overall Study|Adverse Event|1|||
105557649|NCT01565707|364037746|FG000|Overall Study|Lost to Follow-up|1|||
105557650|NCT01565707|364037747|FG001|Overall Study|Lost to Follow-up|0|||
105557651|NCT01565707|364037748|FG002|Overall Study|Lost to Follow-up|0|||
105557652|NCT01565707|364037749|FG003|Overall Study|Lost to Follow-up|0|||
105557653|NCT01565707|364037746|FG000|Overall Study|Protocol Violation|1|||
105557654|NCT01565707|364037747|FG001|Overall Study|Protocol Violation|0|||
105557655|NCT01565707|364037748|FG002|Overall Study|Protocol Violation|0|||
105557656|NCT01565707|364037749|FG003|Overall Study|Protocol Violation|1|||
105557657|NCT01565707|364037746|FG000|Overall Study|Withdrawal by Subject|3|||
105557658|NCT01565707|364037747|FG001|Overall Study|Withdrawal by Subject|1|||
105557659|NCT01565707|364037748|FG002|Overall Study|Withdrawal by Subject|1|||
105557660|NCT01565707|364037749|FG003|Overall Study|Withdrawal by Subject|1|||
105557661|NCT01565707|364037746|FG000|Overall Study|Randomized but not evaluable|2|||
105557662|NCT01565707|364037747|FG001|Overall Study|Randomized but not evaluable|0|||
105557663|NCT01565707|364037748|FG002|Overall Study|Randomized but not evaluable|0|||
105557664|NCT01565707|364037749|FG003|Overall Study|Randomized but not evaluable|0|||
105557665|NCT01565707|364037746|FG000|Overall Study|Miscellaneous|1|||
105557666|NCT01565707|364037747|FG001|Overall Study|Miscellaneous|1|||
105557667|NCT01565707|364037748|FG002|Overall Study|Miscellaneous|0|||
105557668|NCT01565707|364037749|FG003|Overall Study|Miscellaneous|2|||
105557669|NCT00251745|364037751|FG000|Overall Study|Adverse Event|7|||
105557670|NCT00251745|364037752|FG001|Overall Study|Adverse Event|9|||
105557671|NCT00251745|364037753|FG002|Overall Study|Adverse Event|11|||
105557672|NCT00251745|364037751|FG000|Overall Study|Lost to Follow-up|4|||
105557673|NCT00251745|364037752|FG001|Overall Study|Lost to Follow-up|2|||
105557674|NCT00251745|364037753|FG002|Overall Study|Lost to Follow-up|5|||
105557675|NCT00251745|364037751|FG000|Overall Study|Withdrawal by Subject|13|||
105557676|NCT00251745|364037752|FG001|Overall Study|Withdrawal by Subject|7|||
105557677|NCT00251745|364037753|FG002|Overall Study|Withdrawal by Subject|3|||
105557678|NCT00251745|364037751|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
105557679|NCT00251745|364037752|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
105557680|NCT00251745|364037753|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
105557681|NCT00251745|364037751|FG000|Overall Study|Lack of Efficacy|3|||
105557682|NCT00251745|364037752|FG001|Overall Study|Lack of Efficacy|0|||
105557683|NCT00251745|364037753|FG002|Overall Study|Lack of Efficacy|0|||
105557684|NCT00251745|364037751|FG000|Overall Study|Noncompliant|0|||
105557685|NCT00251745|364037752|FG001|Overall Study|Noncompliant|2|||
105557686|NCT00251745|364037753|FG002|Overall Study|Noncompliant|2|||
105557687|NCT00251745|364037751|FG000|Overall Study|Pregnancy|0|||
105557688|NCT00251745|364037752|FG001|Overall Study|Pregnancy|1|||
105557689|NCT00251745|364037753|FG002|Overall Study|Pregnancy|0|||
105557690|NCT00251745|364037751|FG000|Overall Study|Per Subject Request|0|||
105557691|NCT00251745|364037752|FG001|Overall Study|Per Subject Request|0|||
105557692|NCT00251745|364037753|FG002|Overall Study|Per Subject Request|1|||
105557693|NCT00251745|364037751|FG000|Overall Study|Per Investigator Request|1|||
105557694|NCT00251745|364037752|FG001|Overall Study|Per Investigator Request|0|||
105557695|NCT00251745|364037753|FG002|Overall Study|Per Investigator Request|0|||
105557696|NCT02057874|364039106|FG000|Overall Study|participant did not return for scan|1|||
105557697|NCT01791725|364039113|FG000|Overall Study|Withdrawal by Subject|0|||
105557698|NCT01791725|364039114|FG001|Overall Study|Withdrawal by Subject|1|||
105557699|NCT01791725|364039115|FG002|Overall Study|Withdrawal by Subject|0|||
105557700|NCT03432364|364039118|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
105557701|NCT00160680|364039119|FG000|Overall Study|Adverse Event|0|||
105557702|NCT00160680|364039120|FG001|Overall Study|Adverse Event|1|||
105557703|NCT00160680|364039119|FG000|Overall Study|Lack of Efficacy|2|||
105557704|NCT00160680|364039120|FG001|Overall Study|Lack of Efficacy|1|||
105557705|NCT00160680|364039119|FG000|Overall Study|Lost to Follow-up|3|||
105557706|NCT00160680|364039120|FG001|Overall Study|Lost to Follow-up|2|||
105557707|NCT00160680|364039119|FG000|Overall Study|Withdrawal by Subject|4|||
105557708|NCT00160680|364039120|FG001|Overall Study|Withdrawal by Subject|9|||
105557709|NCT03393000|364039121|FG000|Overall Study|Death|11|||
105557710|NCT03393000|364039121|FG000|Overall Study|Withdrawal by Subject|2|||
105557711|NCT03393000|364039121|FG000|Overall Study|Physician Decision|1|||
105557712|NCT01773070|364039122|FG000|Overall Study|Withdrawal by Subject|24|||
105557713|NCT01773070|364039122|FG000|Overall Study|Lost to Follow-up|39|||
105557714|NCT01773070|364039122|FG000|Overall Study|Other|15|||
105557715|NCT01773070|364039122|FG000|Overall Study|Death (unrelated to study procedures)|3|||
105557716|NCT03151005|364039125|FG000|Overall Study|Lost to Follow-up|5|||
105557717|NCT03151005|364039126|FG001|Overall Study|Lost to Follow-up|5|||
105557718|NCT01786512|364039129|FG000|Overall Study|Lost to Follow-up|0|||
105557719|NCT01786512|364039130|FG001|Overall Study|Lost to Follow-up|0|||
105557720|NCT01786512|364039131|FG002|Overall Study|Lost to Follow-up|0|||
105557721|NCT01786512|364039132|FG003|Overall Study|Lost to Follow-up|0|||
105557722|NCT01786512|364039133|FG004|Overall Study|Lost to Follow-up|0|||
105557723|NCT01786512|364039134|FG005|Overall Study|Lost to Follow-up|0|||
105557724|NCT01786512|364039135|FG006|Overall Study|Lost to Follow-up|0|||
105557725|NCT01786512|364039136|FG007|Overall Study|Lost to Follow-up|0|||
105557726|NCT01786512|364039137|FG008|Overall Study|Lost to Follow-up|0|||
105557727|NCT01786512|364039138|FG009|Overall Study|Lost to Follow-up|1|||
105557728|NCT01786512|364039139|FG010|Overall Study|Lost to Follow-up|0|||
105557729|NCT01786512|364039129|FG000|Overall Study|Decision by sponsor|0|||
105557730|NCT01786512|364039130|FG001|Overall Study|Decision by sponsor|0|||
105680947|NCT01874431|364495810|FG003|Overall Study|Sponsor decision|0|||
105557731|NCT01786512|364039131|FG002|Overall Study|Decision by sponsor|0|||
105557732|NCT01786512|364039132|FG003|Overall Study|Decision by sponsor|0|||
105557733|NCT01786512|364039133|FG004|Overall Study|Decision by sponsor|0|||
105557734|NCT01786512|364039134|FG005|Overall Study|Decision by sponsor|0|||
105680948|NCT01874431|364495811|FG004|Overall Study|Sponsor decision|1|||
105557735|NCT01786512|364039135|FG006|Overall Study|Decision by sponsor|0|||
105680949|NCT01874431|364495812|FG005|Overall Study|Sponsor decision|0|||
105680950|NCT01874431|364495813|FG006|Overall Study|Sponsor decision|0|||
105680951|NCT01874431|364495814|FG007|Overall Study|Sponsor decision|0|||
105680952|NCT01874431|364495807|FG000|Overall Study|Lost to Follow-up|0|||
105680953|NCT01874431|364495808|FG001|Overall Study|Lost to Follow-up|0|||
105680954|NCT01874431|364495809|FG002|Overall Study|Lost to Follow-up|1|||
105680955|NCT01874431|364495810|FG003|Overall Study|Lost to Follow-up|0|||
105680956|NCT01874431|364495811|FG004|Overall Study|Lost to Follow-up|0|||
105680957|NCT01874431|364495812|FG005|Overall Study|Lost to Follow-up|0|||
105680958|NCT01874431|364495813|FG006|Overall Study|Lost to Follow-up|0|||
105680959|NCT01874431|364495814|FG007|Overall Study|Lost to Follow-up|0|||
105680960|NCT00738582|364495816|FG000|Combination Therapy|Completed Combination Therapy|1|||
105680961|NCT00738582|364495817|FG001|Combination Therapy|Completed Combination Therapy|0|||
105680962|NCT00738582|364495816|FG000|Combination Therapy|Physician Decision|1|||
105680963|NCT00738582|364495817|FG001|Combination Therapy|Physician Decision|0|||
105680964|NCT00738582|364495816|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
105680965|NCT00738582|364495817|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
105680966|NCT00738582|364495816|FG000|Combination Therapy|Other|5|||
105680967|NCT00738582|364495817|FG001|Combination Therapy|Other|0|||
105680968|NCT00738582|364495816|FG000|Combination Therapy|Adverse Event|16|||
105680969|NCT00738582|364495817|FG001|Combination Therapy|Adverse Event|0|||
105680970|NCT00738582|364495816|FG000|Combination Therapy|Progressive Disease|9|||
105680971|NCT00738582|364495817|FG001|Combination Therapy|Progressive Disease|0|||
105680972|NCT00738582|364495816|FG000|Maintenance Therapy|Other|0|||
105680973|NCT00738582|364495817|FG001|Maintenance Therapy|Other|2|||
105680974|NCT00738582|364495816|FG000|Maintenance Therapy|Adverse Event|0|||
105680975|NCT00738582|364495817|FG001|Maintenance Therapy|Adverse Event|6|||
105680976|NCT00738582|364495816|FG000|Maintenance Therapy|Progressive Disease|0|||
105680977|NCT00738582|364495817|FG001|Maintenance Therapy|Progressive Disease|47|||
105680978|NCT00738582|364495816|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
105680979|NCT00738582|364495817|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
105680980|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
105680981|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
105680982|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
105680983|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
105680984|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
105680985|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
105680986|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
105680987|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
105680988|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
105680989|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
105680990|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
105680991|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
105680992|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
105680993|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
105680994|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
105680995|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
105680996|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
105680997|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
105680998|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
105680999|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
105681000|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
105681001|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
105681002|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
105681003|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
105681004|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
105681005|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
105681006|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
105681007|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
105681008|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
105681009|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
105681010|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
105681011|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
105681012|NCT01498679|364495821|FG000|Overall Study|Adverse Event|1|||
105681013|NCT01498679|364495822|FG001|Overall Study|Adverse Event|4|||
105681014|NCT01498679|364495821|FG000|Overall Study|Lack of Efficacy|72|||
105681015|NCT01498679|364495822|FG001|Overall Study|Lack of Efficacy|12|||
105681016|NCT01498679|364495821|FG000|Overall Study|Protocol Violation|4|||
105681017|NCT01498679|364495822|FG001|Overall Study|Protocol Violation|0|||
105681018|NCT01498679|364495821|FG000|Overall Study|Physician Decision|0|||
105681019|NCT01498679|364495822|FG001|Overall Study|Physician Decision|2|||
105681020|NCT01498679|364495821|FG000|Overall Study|Withdrawal by Subject|12|||
105681021|NCT01498679|364495822|FG001|Overall Study|Withdrawal by Subject|4|||
105681022|NCT02585232|364495823|FG000|Overall Study|Lost to Follow-up|8|||
105681023|NCT02585232|364495824|FG001|Overall Study|Lost to Follow-up|8|||
105681024|NCT02585232|364495823|FG000|Overall Study|Withdrawal by Subject|4|||
105681025|NCT02585232|364495824|FG001|Overall Study|Withdrawal by Subject|8|||
105681026|NCT01621568|364495830|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
105681027|NCT01621568|364495831|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
105681028|NCT01621568|364495830|FG000|Week 5-6 No Treatment|Death|1|||
105681029|NCT01621568|364495831|FG001|Week 5-6 No Treatment|Death|0|||
105681030|NCT00682890|364495833|FG000|Overall Study|Lost to Follow-up|1|||
105681031|NCT00682890|364495834|FG001|Overall Study|Lost to Follow-up|1|||
105681032|NCT00682890|364495833|FG000|Overall Study|subject moved away|0|||
105681033|NCT00682890|364495834|FG001|Overall Study|subject moved away|1|||
105681034|NCT00682890|364495833|FG000|Overall Study|heavy menstrual bleeding|1|||
105681035|NCT00682890|364495834|FG001|Overall Study|heavy menstrual bleeding|0|||
105681036|NCT01323647|364495835|FG000|Overall Study|Migrated/moved from study area|2|||
105681037|NCT01323647|364495836|FG001|Overall Study|Migrated/moved from study area|0|||
105681038|NCT01323647|364495835|FG000|Overall Study|Withdrawal by Subject|5|||
105681039|NCT01323647|364495836|FG001|Overall Study|Withdrawal by Subject|0|||
105681040|NCT01323647|364495835|FG000|Overall Study|Lost to Follow-up|2|||
105681041|NCT01323647|364495836|FG001|Overall Study|Lost to Follow-up|0|||
105681042|NCT01577745|364495839|FG000|Overall Study|Withdrawal by Subject|0|||
105681043|NCT01577745|364495840|FG001|Overall Study|Withdrawal by Subject|1|||
105681044|NCT01577745|364495841|FG002|Overall Study|Withdrawal by Subject|0|||
105681045|NCT01577745|364495842|FG003|Overall Study|Withdrawal by Subject|3|||
105681046|NCT01577745|364495843|FG004|Overall Study|Withdrawal by Subject|2|||
105681047|NCT01577745|364495844|FG005|Overall Study|Withdrawal by Subject|0|||
105681048|NCT01577745|364495839|FG000|Overall Study|Death|3|||
105681049|NCT01577745|364495840|FG001|Overall Study|Death|2|||
105681050|NCT01577745|364495841|FG002|Overall Study|Death|2|||
105681051|NCT01577745|364495842|FG003|Overall Study|Death|1|||
105681052|NCT01577745|364495843|FG004|Overall Study|Death|1|||
105681053|NCT01577745|364495844|FG005|Overall Study|Death|3|||
105681054|NCT01577745|364495839|FG000|Overall Study|Physician Decision|0|||
105681055|NCT01577745|364495840|FG001|Overall Study|Physician Decision|0|||
105681056|NCT01577745|364495841|FG002|Overall Study|Physician Decision|0|||
105681057|NCT01577745|364495842|FG003|Overall Study|Physician Decision|1|||
105681058|NCT01577745|364495843|FG004|Overall Study|Physician Decision|1|||
105681059|NCT01577745|364495844|FG005|Overall Study|Physician Decision|0|||
105681060|NCT01577745|364495839|FG000|Overall Study|Lost to Follow-up|0|||
105681061|NCT01577745|364495840|FG001|Overall Study|Lost to Follow-up|0|||
105681062|NCT01577745|364495841|FG002|Overall Study|Lost to Follow-up|0|||
105681063|NCT01577745|364495842|FG003|Overall Study|Lost to Follow-up|0|||
105681064|NCT01577745|364495843|FG004|Overall Study|Lost to Follow-up|0|||
105681065|NCT01577745|364495844|FG005|Overall Study|Lost to Follow-up|1|||
105681066|NCT01577745|364495839|FG000|Overall Study|Alternative Therapy|0|||
105681067|NCT01577745|364495840|FG001|Overall Study|Alternative Therapy|0|||
105681068|NCT01577745|364495841|FG002|Overall Study|Alternative Therapy|0|||
105681069|NCT01577745|364495842|FG003|Overall Study|Alternative Therapy|1|||
105681070|NCT01577745|364495843|FG004|Overall Study|Alternative Therapy|1|||
105681071|NCT01577745|364495844|FG005|Overall Study|Alternative Therapy|0|||
105681072|NCT00262951|364495845|FG000|Overall Study|Progressive disease/relapse|3|||
105681073|NCT00262951|364495845|FG000|Overall Study|Adverse Event|7|||
105681074|NCT00262951|364495845|FG000|Overall Study|Death|1|||
105681075|NCT00262951|364495845|FG000|Overall Study|Withdrawal by Subject|1|||
105681076|NCT00262951|364495845|FG000|Overall Study|Alternative treatment|3|||
105681077|NCT00262951|364495845|FG000|Overall Study|Off treatment for other disease|1|||
105681078|NCT01590082|364495846|FG000|Overall Study|Withdrawal by Subject|1|||
105681079|NCT01590082|364495847|FG001|Overall Study|Withdrawal by Subject|0|||
105681080|NCT01590082|364495846|FG000|Overall Study|Ineligible|1|||
105681081|NCT01590082|364495847|FG001|Overall Study|Ineligible|0|||
105681082|NCT02891408|364495848|FG000|Overall Study|Lost to Follow-up|0|||
105681083|NCT02891408|364495849|FG001|Overall Study|Lost to Follow-up|0|||
105681084|NCT02891408|364495850|FG002|Overall Study|Lost to Follow-up|1|||
105681085|NCT02891408|364495851|FG003|Overall Study|Lost to Follow-up|0|||
105681086|NCT02891408|364495852|FG004|Overall Study|Lost to Follow-up|0|||
105681087|NCT02891408|364495853|FG005|Overall Study|Lost to Follow-up|0|||
105681088|NCT02891408|364495854|FG006|Overall Study|Lost to Follow-up|0|||
105681089|NCT03814187|364495855|FG000|Overall Study|Sponsor's Administrative Decision|0|||
105681090|NCT03814187|364495856|FG001|Overall Study|Sponsor's Administrative Decision|0|||
105681091|NCT03814187|364495857|FG002|Overall Study|Sponsor's Administrative Decision|272|||
105681092|NCT03814187|364495855|FG000|Overall Study|Death|80|||
105681093|NCT03814187|364495856|FG001|Overall Study|Death|81|||
105681094|NCT03814187|364495857|FG002|Overall Study|Death|4|||
105681095|NCT03814187|364495855|FG000|Overall Study|Withdrew Consent|77|||
105681096|NCT03814187|364495856|FG001|Overall Study|Withdrew Consent|78|||
105681097|NCT03814187|364495857|FG002|Overall Study|Withdrew Consent|2|||
105681098|NCT03814187|364495855|FG000|Overall Study|Lost to Follow-up|47|||
105681099|NCT03814187|364495856|FG001|Overall Study|Lost to Follow-up|52|||
105681100|NCT03814187|364495857|FG002|Overall Study|Lost to Follow-up|1|||
105681101|NCT03814187|364495855|FG000|Overall Study|Adverse Event|22|||
105681102|NCT03814187|364495856|FG001|Overall Study|Adverse Event|23|||
105681103|NCT03814187|364495857|FG002|Overall Study|Adverse Event|0|||
105681104|NCT03814187|364495855|FG000|Overall Study|Physician Decision|7|||
105681105|NCT03814187|364495856|FG001|Overall Study|Physician Decision|4|||
105681106|NCT03814187|364495857|FG002|Overall Study|Physician Decision|2|||
105681107|NCT03814187|364495855|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
105681108|NCT03814187|364495856|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
105681109|NCT03814187|364495857|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
105681110|NCT03814187|364495855|FG000|Overall Study|Other reasons|34|||
105681111|NCT03814187|364495856|FG001|Overall Study|Other reasons|40|||
105681112|NCT03814187|364495857|FG002|Overall Study|Other reasons|2|||
105681113|NCT01535560|364495858|FG000|Overall Study|Adverse Event|12|||
105681114|NCT01535560|364495859|FG001|Overall Study|Adverse Event|7|||
105681115|NCT01535560|364495858|FG000|Overall Study|Lost to Follow-up|1|||
105681116|NCT01535560|364495859|FG001|Overall Study|Lost to Follow-up|3|||
105681117|NCT01535560|364495858|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
105681118|NCT01535560|364495859|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
105681119|NCT01535560|364495858|FG000|Overall Study|Treatment Failure|21|||
105681120|NCT01535560|364495859|FG001|Overall Study|Treatment Failure|83|||
105681121|NCT01535560|364495858|FG000|Overall Study|Other|0|||
105681122|NCT01535560|364495859|FG001|Overall Study|Other|1|||
105681123|NCT01535560|364495858|FG000|Overall Study|Randomized in Error|0|||
105681124|NCT01535560|364495859|FG001|Overall Study|Randomized in Error|1|||
105681125|NCT00950950|364495865|FG000|Overall Study|Adverse Event|1|||
105681126|NCT00950950|364495866|FG001|Overall Study|Adverse Event|0|||
105681127|NCT00950950|364495865|FG000|Overall Study|Withdrawal by Subject|0|||
105681128|NCT00950950|364495866|FG001|Overall Study|Withdrawal by Subject|1|||
105681129|NCT01047293|364495867|FG000|Overall Study|DLT criteria not fulfilled|1|||
105681130|NCT01047293|364495868|FG001|Overall Study|DLT criteria not fulfilled|1|||
105681131|NCT01047293|364495869|FG002|Overall Study|DLT criteria not fulfilled|0|||
105681132|NCT01047293|364495870|FG003|Overall Study|DLT criteria not fulfilled|0|||
105681133|NCT02054520|364495876|FG000|Overall Study|Adverse Event|1|||
105681134|NCT02054520|364495877|FG001|Overall Study|Adverse Event|4|||
105681135|NCT02054520|364495878|FG002|Overall Study|Adverse Event|2|||
105681136|NCT02054520|364495879|FG003|Overall Study|Adverse Event|1|||
105681137|NCT02054520|364495880|FG004|Overall Study|Adverse Event|1|||
105681138|NCT02054520|364495881|FG005|Overall Study|Adverse Event|0|||
105681139|NCT02054520|364495876|FG000|Overall Study|Lack of Efficacy|7|||
105681140|NCT02054520|364495877|FG001|Overall Study|Lack of Efficacy|0|||
105681141|NCT02054520|364495878|FG002|Overall Study|Lack of Efficacy|2|||
105681142|NCT02054520|364495879|FG003|Overall Study|Lack of Efficacy|1|||
105681143|NCT02054520|364495880|FG004|Overall Study|Lack of Efficacy|3|||
105681144|NCT02054520|364495881|FG005|Overall Study|Lack of Efficacy|2|||
105681145|NCT02054520|364495876|FG000|Overall Study|Withdrawal by Subject|1|||
105681146|NCT02054520|364495877|FG001|Overall Study|Withdrawal by Subject|0|||
105681147|NCT02054520|364495878|FG002|Overall Study|Withdrawal by Subject|0|||
105681148|NCT02054520|364495879|FG003|Overall Study|Withdrawal by Subject|2|||
105681149|NCT02054520|364495880|FG004|Overall Study|Withdrawal by Subject|1|||
105681150|NCT02054520|364495881|FG005|Overall Study|Withdrawal by Subject|0|||
105681151|NCT02054520|364495876|FG000|Overall Study|Physician Decision|0|||
105681152|NCT02054520|364495877|FG001|Overall Study|Physician Decision|1|||
105681153|NCT02054520|364495878|FG002|Overall Study|Physician Decision|0|||
105681154|NCT02054520|364495879|FG003|Overall Study|Physician Decision|1|||
105681155|NCT02054520|364495880|FG004|Overall Study|Physician Decision|0|||
105681156|NCT02054520|364495881|FG005|Overall Study|Physician Decision|1|||
105681157|NCT02054520|364495876|FG000|Overall Study|Study terminated by Sponsor|0|||
105681158|NCT02054520|364495877|FG001|Overall Study|Study terminated by Sponsor|0|||
105681159|NCT02054520|364495878|FG002|Overall Study|Study terminated by Sponsor|2|||
105681160|NCT02054520|364495879|FG003|Overall Study|Study terminated by Sponsor|1|||
105681161|NCT02054520|364495880|FG004|Overall Study|Study terminated by Sponsor|0|||
105681162|NCT02054520|364495881|FG005|Overall Study|Study terminated by Sponsor|0|||
105681163|NCT00985946|364495882|FG000|Overall Study|Lost to Follow-up|6|||
105681164|NCT00985946|364495882|FG000|Overall Study|Withdrawal by Subject|1|||
105468684|NCT01189032|363725948|FG000|Overall Study|Protocol Violation|1|||
105681165|NCT01395888|364495887|FG000|2-week Run-in Period|Adverse Event|2|||
105468685|NCT01189032|363725949|FG001|Overall Study|Protocol Violation|1|||
105681166|NCT01395888|364495888|FG001|2-week Run-in Period|Adverse Event|0|||
105681167|NCT01395888|364495889|FG002|2-week Run-in Period|Adverse Event|0|||
105681168|NCT01395888|364495887|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
105681169|NCT01395888|364495888|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
105681170|NCT01395888|364495889|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
105681171|NCT01395888|364495887|FG000|2-week Run-in Period|Lost to Follow-up|1|||
105468686|NCT01189032|363725950|FG002|Overall Study|Protocol Violation|1|||
105681172|NCT01395888|364495888|FG001|2-week Run-in Period|Lost to Follow-up|0|||
105468687|NCT01134055|363725951|FG000|Overall Study|Adverse Event|5|||
105681173|NCT01395888|364495889|FG002|2-week Run-in Period|Lost to Follow-up|0|||
105681174|NCT01395888|364495887|FG000|2-week Run-in Period|Protocol Violation|2|||
105681175|NCT01395888|364495888|FG001|2-week Run-in Period|Protocol Violation|0|||
105344356|NCT01797081|363261761|FG001|Overall Study|Protocol Violation|0|||
105344357|NCT01797081|363261762|FG002|Overall Study|Protocol Violation|0|||
105344358|NCT01797081|363261763|FG003|Overall Study|Protocol Violation|1|||
105344359|NCT00622336|363261764|FG000|Treatment Phase|Progression of Disease|181|||
105344360|NCT00622336|363261764|FG000|Treatment Phase|Adverse Event|46|||
105344361|NCT00622336|363261764|FG000|Treatment Phase|Other|40|||
105344362|NCT00622336|363261764|FG000|Treatment Phase|Death|14|||
105344363|NCT00622336|363261764|FG000|Treatment Phase|Lack of therapeutic effect|13|||
105344364|NCT00622336|363261764|FG000|Treatment Phase|Withdrawal by Subject|13|||
105344365|NCT00622336|363261764|FG000|Treatment Phase|Lost to Follow-up|2|||
105344366|NCT00622336|363261764|FG000|Extension Phase|Adverse Event|2|||
105344367|NCT00622336|363261764|FG000|Extension Phase|Progressive Disease|6|||
105344368|NCT00622336|363261764|FG000|Extension Phase|Lack of therapeutic effect|2|||
105344369|NCT00622336|363261764|FG000|Extension Phase|Withdrawal by Subject|1|||
105344370|NCT00622336|363261764|FG000|Extension Phase|Lost to Follow-up|1|||
105344371|NCT00622336|363261764|FG000|Extension Phase|Other|9|||
105344372|NCT04450407|363261765|FG000|Overall Study|Withdrawal by Subject|10|||
105344373|NCT04450407|363261766|FG001|Overall Study|Withdrawal by Subject|1|||
105344374|NCT04450407|363261767|FG002|Overall Study|Withdrawal by Subject|4|||
105344375|NCT04450407|363261765|FG000|Overall Study|Adverse Event|0|||
105344376|NCT04450407|363261766|FG001|Overall Study|Adverse Event|0|||
105344377|NCT04450407|363261767|FG002|Overall Study|Adverse Event|1|||
105344378|NCT04450407|363261765|FG000|Overall Study|Lost to Follow-up|1|||
105344379|NCT04450407|363261766|FG001|Overall Study|Lost to Follow-up|0|||
105344380|NCT04450407|363261767|FG002|Overall Study|Lost to Follow-up|0|||
105344381|NCT04450407|363261765|FG000|Overall Study|Physician Decision|0|||
105344382|NCT04450407|363261766|FG001|Overall Study|Physician Decision|0|||
105344383|NCT04450407|363261767|FG002|Overall Study|Physician Decision|1|||
105344384|NCT04450407|363261765|FG000|Overall Study|Pregnancy|1|||
105344385|NCT04450407|363261766|FG001|Overall Study|Pregnancy|0|||
105344386|NCT04450407|363261767|FG002|Overall Study|Pregnancy|0|||
105344387|NCT04450407|363261765|FG000|Overall Study|Protocol Violation|2|||
105344388|NCT04450407|363261766|FG001|Overall Study|Protocol Violation|0|||
105344389|NCT04450407|363261767|FG002|Overall Study|Protocol Violation|0|||
105344390|NCT04450407|363261765|FG000|Overall Study|Investigational site terminated by sponsor|3|||
105344391|NCT04450407|363261766|FG001|Overall Study|Investigational site terminated by sponsor|0|||
105344392|NCT04450407|363261767|FG002|Overall Study|Investigational site terminated by sponsor|2|||
105344393|NCT00824382|363261769|FG000|Overall Study|Adverse Event|4|||
105344394|NCT00824382|363261770|FG001|Overall Study|Adverse Event|1|||
105344395|NCT00824382|363261771|FG002|Overall Study|Adverse Event|1|||
105344396|NCT00824382|363261772|FG003|Overall Study|Adverse Event|4|||
105344397|NCT00824382|363261769|FG000|Overall Study|Protocol Violation|1|||
105344398|NCT00824382|363261770|FG001|Overall Study|Protocol Violation|0|||
105344399|NCT00824382|363261771|FG002|Overall Study|Protocol Violation|0|||
105344400|NCT00824382|363261772|FG003|Overall Study|Protocol Violation|1|||
105344401|NCT00824382|363261769|FG000|Overall Study|Investigator's decision|0|||
105344402|NCT00824382|363261770|FG001|Overall Study|Investigator's decision|1|||
105344403|NCT00824382|363261771|FG002|Overall Study|Investigator's decision|2|||
105344404|NCT00824382|363261772|FG003|Overall Study|Investigator's decision|0|||
105344405|NCT02832375|363261775|FG000|Overall Study|Lost to Follow-up|1|||
105344406|NCT02832375|363261776|FG001|Overall Study|Lost to Follow-up|0|||
105344407|NCT02832375|363261775|FG000|Overall Study|Withdrawal of Consent|1|||
105344408|NCT02832375|363261776|FG001|Overall Study|Withdrawal of Consent|0|||
105344409|NCT00336024|363261777|FG000|Overall Study|Death|2|||
105344410|NCT00336024|363261778|FG001|Overall Study|Death|1|||
105681176|NCT01395888|364495889|FG002|2-week Run-in Period|Protocol Violation|0|||
105681177|NCT01395888|364495887|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
105344411|NCT00336024|363261777|FG000|Overall Study|Physician Decision|4|||
105344412|NCT00336024|363261778|FG001|Overall Study|Physician Decision|1|||
105344413|NCT00336024|363261777|FG000|Overall Study|Protocol Violation|1|||
105344414|NCT00336024|363261778|FG001|Overall Study|Protocol Violation|0|||
105344415|NCT00336024|363261777|FG000|Overall Study|Withdrawal by Subject|1|||
105344416|NCT00336024|363261778|FG001|Overall Study|Withdrawal by Subject|2|||
105344417|NCT00336024|363261777|FG000|Overall Study|Failure to fulfill consolidation|1|||
105344418|NCT00336024|363261778|FG001|Overall Study|Failure to fulfill consolidation|1|||
105344419|NCT00336024|363261777|FG000|Overall Study|Progressive Disease|4|||
105344420|NCT00336024|363261778|FG001|Overall Study|Progressive Disease|7|||
105344421|NCT00336024|363261777|FG000|Overall Study|Ineligible|7|||
105557736|NCT01786512|364039136|FG007|Overall Study|Decision by sponsor|0|||
105557737|NCT01786512|364039137|FG008|Overall Study|Decision by sponsor|0|||
105344422|NCT00336024|363261778|FG001|Overall Study|Ineligible|7|||
105344423|NCT00084318|363261779|FG000|Overall Study|Withdrawal by Subject|5|||
105344424|NCT00084318|363261780|FG001|Overall Study|Withdrawal by Subject|2|||
105344425|NCT00084318|363261779|FG000|Overall Study|Protocol Violation|15|||
105344426|NCT00084318|363261780|FG001|Overall Study|Protocol Violation|11|||
105681178|NCT01395888|364495888|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
105681179|NCT01395888|364495889|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
105681180|NCT01395888|364495887|FG000|Treatment Period (TP)|Adverse Event|0|||
105681181|NCT01395888|364495888|FG001|Treatment Period (TP)|Adverse Event|7|||
105681182|NCT01395888|364495889|FG002|Treatment Period (TP)|Adverse Event|6|||
105681183|NCT01395888|364495887|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
105681184|NCT01395888|364495888|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
105681185|NCT01395888|364495889|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
105681186|NCT01395888|364495887|FG000|Treatment Period (TP)|Protocol Violation|0|||
105681187|NCT01395888|364495888|FG001|Treatment Period (TP)|Protocol Violation|1|||
105681188|NCT01395888|364495889|FG002|Treatment Period (TP)|Protocol Violation|5|||
105681189|NCT01395888|364495887|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
105681190|NCT01395888|364495888|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
105681191|NCT01395888|364495889|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
105681192|NCT01395888|364495887|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
105681193|NCT01395888|364495888|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
105681194|NCT01395888|364495889|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
105681195|NCT00928018|364495890|FG000|Overall Study|Withdrawal by Subject|1|||
105681196|NCT00928018|364495891|FG001|Overall Study|Withdrawal by Subject|0|||
105681197|NCT03218397|364495892|FG000|Overall Study|Prior positive blood culture|8|||
105681198|NCT03218397|364495893|FG001|Overall Study|Prior positive blood culture|13|||
105681199|NCT03218397|364495892|FG000|Overall Study|Comfort care|8|||
105681200|NCT03218397|364495893|FG001|Overall Study|Comfort care|5|||
105681201|NCT03218397|364495892|FG000|Overall Study|Comfort care and positive blood culture|1|||
105681202|NCT03218397|364495893|FG001|Overall Study|Comfort care and positive blood culture|0|||
105681203|NCT03218397|364495892|FG000|Overall Study|Comfort care and mixed culture|0|||
105681204|NCT03218397|364495893|FG001|Overall Study|Comfort care and mixed culture|1|||
105681205|NCT03218397|364495892|FG000|Overall Study|Mixed culture|2|||
105681206|NCT03218397|364495893|FG001|Overall Study|Mixed culture|2|||
105681207|NCT03218397|364495892|FG000|Overall Study|Inaccessible hospital records|2|||
105681208|NCT03218397|364495893|FG001|Overall Study|Inaccessible hospital records|5|||
105681209|NCT03218397|364495892|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
105681210|NCT03218397|364495893|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
105681211|NCT03218397|364495892|FG000|Overall Study|Randomized during laboratory off hours|2|||
105681212|NCT03218397|364495893|FG001|Overall Study|Randomized during laboratory off hours|1|||
105681213|NCT01796548|364495894|FG000|Overall Study|Lost to Follow-up|1|||
105681214|NCT01796548|364495894|FG000|Overall Study|Other|2|||
105681215|NCT02457559|364495895|FG000|Overall Study|Progressive Disease|1|||
105681216|NCT02457559|364495896|FG001|Overall Study|Progressive Disease|2|||
105681217|NCT02457559|364495897|FG002|Overall Study|Progressive Disease|3|||
105681218|NCT02457559|364495898|FG003|Overall Study|Progressive Disease|0|||
105344427|NCT00084318|363261779|FG000|Overall Study|No protocol treatment|2|||
105681219|NCT02457559|364495899|FG004|Overall Study|Progressive Disease|0|||
105681220|NCT02457559|364495900|FG005|Overall Study|Progressive Disease|2|||
105681221|NCT02457559|364495901|FG006|Overall Study|Progressive Disease|1|||
105681222|NCT02457559|364495902|FG007|Overall Study|Progressive Disease|0|||
105681223|NCT02457559|364495903|FG008|Overall Study|Progressive Disease|1|||
105681224|NCT02457559|364495904|FG009|Overall Study|Progressive Disease|1|||
105681225|NCT02457559|364495905|FG010|Overall Study|Progressive Disease|1|||
105681226|NCT02457559|364495895|FG000|Overall Study|Investigator's Discretion|0|||
105681227|NCT02457559|364495896|FG001|Overall Study|Investigator's Discretion|0|||
105681228|NCT02457559|364495897|FG002|Overall Study|Investigator's Discretion|2|||
105681229|NCT02457559|364495898|FG003|Overall Study|Investigator's Discretion|0|||
105681230|NCT02457559|364495899|FG004|Overall Study|Investigator's Discretion|1|||
105681231|NCT02457559|364495900|FG005|Overall Study|Investigator's Discretion|0|||
105344428|NCT00084318|363261780|FG001|Overall Study|No protocol treatment|0|||
105344429|NCT01645891|363261781|FG000|Overall Study|Adverse Event|6|||
105344430|NCT01645891|363261782|FG001|Overall Study|Adverse Event|10|||
105344431|NCT01645891|363261781|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
105344432|NCT01645891|363261782|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
105344433|NCT01645891|363261781|FG000|Overall Study|Withdrawal by Subject|3|||
105344434|NCT01645891|363261782|FG001|Overall Study|Withdrawal by Subject|3|||
105344435|NCT01645891|363261781|FG000|Overall Study|Protocol Violation|4|||
105557738|NCT01786512|364039138|FG009|Overall Study|Decision by sponsor|0|||
105681232|NCT02457559|364495901|FG006|Overall Study|Investigator's Discretion|1|||
105681233|NCT02457559|364495902|FG007|Overall Study|Investigator's Discretion|0|||
105681234|NCT02457559|364495903|FG008|Overall Study|Investigator's Discretion|1|||
105681235|NCT02457559|364495904|FG009|Overall Study|Investigator's Discretion|0|||
105681236|NCT02457559|364495905|FG010|Overall Study|Investigator's Discretion|1|||
105681237|NCT02457559|364495895|FG000|Overall Study|Adverse Event|0|||
105681238|NCT02457559|364495896|FG001|Overall Study|Adverse Event|1|||
105681239|NCT02457559|364495897|FG002|Overall Study|Adverse Event|2|||
105681240|NCT02457559|364495898|FG003|Overall Study|Adverse Event|0|||
105681241|NCT02457559|364495899|FG004|Overall Study|Adverse Event|0|||
105681242|NCT02457559|364495900|FG005|Overall Study|Adverse Event|0|||
105681243|NCT02457559|364495901|FG006|Overall Study|Adverse Event|0|||
105681244|NCT02457559|364495902|FG007|Overall Study|Adverse Event|0|||
105681245|NCT02457559|364495903|FG008|Overall Study|Adverse Event|0|||
105681246|NCT02457559|364495904|FG009|Overall Study|Adverse Event|0|||
105681247|NCT02457559|364495905|FG010|Overall Study|Adverse Event|0|||
105681248|NCT02457559|364495895|FG000|Overall Study|Reason not Specified|1|||
105681249|NCT02457559|364495896|FG001|Overall Study|Reason not Specified|0|||
105681250|NCT02457559|364495897|FG002|Overall Study|Reason not Specified|0|||
105681251|NCT02457559|364495898|FG003|Overall Study|Reason not Specified|0|||
105681252|NCT02457559|364495899|FG004|Overall Study|Reason not Specified|0|||
105681253|NCT02457559|364495900|FG005|Overall Study|Reason not Specified|0|||
105681254|NCT02457559|364495901|FG006|Overall Study|Reason not Specified|0|||
105681255|NCT02457559|364495902|FG007|Overall Study|Reason not Specified|0|||
105681256|NCT02457559|364495903|FG008|Overall Study|Reason not Specified|0|||
105681257|NCT02457559|364495904|FG009|Overall Study|Reason not Specified|2|||
105681258|NCT02457559|364495905|FG010|Overall Study|Reason not Specified|0|||
105681259|NCT02457559|364495895|FG000|Overall Study|Death|0|||
105681260|NCT02457559|364495896|FG001|Overall Study|Death|0|||
105681261|NCT02457559|364495897|FG002|Overall Study|Death|0|||
105681262|NCT02457559|364495898|FG003|Overall Study|Death|0|||
105681263|NCT02457559|364495899|FG004|Overall Study|Death|0|||
105681264|NCT02457559|364495900|FG005|Overall Study|Death|0|||
105681265|NCT02457559|364495901|FG006|Overall Study|Death|0|||
105681266|NCT02457559|364495902|FG007|Overall Study|Death|0|||
105681267|NCT02457559|364495903|FG008|Overall Study|Death|1|||
105681268|NCT02457559|364495904|FG009|Overall Study|Death|1|||
105681269|NCT02457559|364495905|FG010|Overall Study|Death|0|||
105681270|NCT03075410|364495910|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
105681271|NCT03075410|364495911|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
105681272|NCT03075410|364495912|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
105681273|NCT03075410|364495913|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
105681274|NCT03075410|364495914|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
105681275|NCT03075410|364495915|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
105681276|NCT03075410|364495916|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
105681277|NCT03075410|364495917|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
105681278|NCT03075410|364495918|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
105681279|NCT03075410|364495910|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
105681280|NCT03075410|364495911|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681281|NCT03075410|364495912|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681282|NCT03075410|364495913|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681283|NCT03075410|364495914|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681284|NCT03075410|364495915|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681285|NCT03075410|364495916|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681286|NCT03075410|364495917|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681287|NCT03075410|364495918|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681288|NCT01427751|364495919|FG000|Overall Study|Adverse Event|18|||
105681289|NCT01427751|364495920|FG001|Overall Study|Adverse Event|2|||
105681290|NCT01427751|364495919|FG000|Overall Study|No further treatment benefit expected|5|||
105681291|NCT01427751|364495920|FG001|Overall Study|No further treatment benefit expected|1|||
105681292|NCT01427751|364495919|FG000|Overall Study|Lost to Follow-up|3|||
105681293|NCT01427751|364495920|FG001|Overall Study|Lost to Follow-up|1|||
105681294|NCT01427751|364495919|FG000|Overall Study|Withdrawal of consent|2|||
105681295|NCT01427751|364495920|FG001|Overall Study|Withdrawal of consent|2|||
105681296|NCT01427751|364495919|FG000|Overall Study|Protocol Violation|6|||
105681297|NCT01427751|364495920|FG001|Overall Study|Protocol Violation|4|||
105681298|NCT01427751|364495919|FG000|Overall Study|Death|2|||
105681299|NCT01427751|364495920|FG001|Overall Study|Death|0|||
105681300|NCT01427751|364495919|FG000|Overall Study|Other miscellaneous reasons|6|||
105681301|NCT01427751|364495920|FG001|Overall Study|Other miscellaneous reasons|4|||
105681302|NCT00790751|364495929|FG000|Overall Study|Protocol non-compliance|16|||
105681303|NCT00790751|364495930|FG001|Overall Study|Protocol non-compliance|16|||
105681304|NCT00790751|364495931|FG002|Overall Study|Protocol non-compliance|10|||
105681305|NCT00790751|364495932|FG003|Overall Study|Protocol non-compliance|11|||
105681306|NCT00790751|364495929|FG000|Overall Study|Lost to Follow-up|4|||
105681307|NCT00790751|364495930|FG001|Overall Study|Lost to Follow-up|9|||
105681308|NCT00790751|364495931|FG002|Overall Study|Lost to Follow-up|4|||
105681309|NCT00790751|364495932|FG003|Overall Study|Lost to Follow-up|5|||
105681310|NCT00790751|364495929|FG000|Overall Study|Adverse Event|5|||
105681311|NCT00790751|364495930|FG001|Overall Study|Adverse Event|3|||
105681312|NCT00790751|364495931|FG002|Overall Study|Adverse Event|5|||
105681313|NCT00790751|364495932|FG003|Overall Study|Adverse Event|4|||
105681314|NCT00790751|364495929|FG000|Overall Study|Requirement for restricted medication|0|||
105681315|NCT00790751|364495930|FG001|Overall Study|Requirement for restricted medication|2|||
105681316|NCT00790751|364495931|FG002|Overall Study|Requirement for restricted medication|0|||
105681317|NCT00790751|364495932|FG003|Overall Study|Requirement for restricted medication|0|||
105681318|NCT00790751|364495929|FG000|Overall Study|Death|0|||
105681319|NCT00790751|364495930|FG001|Overall Study|Death|0|||
105681320|NCT00790751|364495931|FG002|Overall Study|Death|1|||
105681321|NCT00790751|364495932|FG003|Overall Study|Death|0|||
105681322|NCT00790751|364495929|FG000|Overall Study|Physician Decision|0|||
105557739|NCT01786512|364039139|FG010|Overall Study|Decision by sponsor|2|||
105681323|NCT00790751|364495930|FG001|Overall Study|Physician Decision|0|||
105681324|NCT00790751|364495931|FG002|Overall Study|Physician Decision|0|||
105681325|NCT00790751|364495932|FG003|Overall Study|Physician Decision|1|||
105681326|NCT04002401|364495933|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
105681327|NCT04002401|364495933|FG000|Overall Study|Death|10|||
105681328|NCT04002401|364495933|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
105681329|NCT04002401|364495933|FG000|Overall Study|Enrolled but Never Treated|1|||
105681330|NCT04002401|364495933|FG000|Overall Study|Lost to Follow-up|1|||
105681331|NCT03035201|364495938|FG000|Overall Study|Death|9|||
105681332|NCT03035201|364495939|FG001|Overall Study|Death|12|||
105681333|NCT03035201|364495940|FG002|Overall Study|Death|9|||
105681334|NCT03035201|364495941|FG003|Overall Study|Death|10|||
105681335|NCT03035201|364495938|FG000|Overall Study|Withdrawal by Subject|51|||
105681336|NCT03035201|364495939|FG001|Overall Study|Withdrawal by Subject|49|||
105681337|NCT03035201|364495940|FG002|Overall Study|Withdrawal by Subject|37|||
105681338|NCT03035201|364495941|FG003|Overall Study|Withdrawal by Subject|46|||
105681339|NCT03035201|364495938|FG000|Overall Study|Lost to Follow-up|67|||
105681340|NCT03035201|364495939|FG001|Overall Study|Lost to Follow-up|51|||
105681341|NCT03035201|364495940|FG002|Overall Study|Lost to Follow-up|64|||
105681342|NCT03035201|364495941|FG003|Overall Study|Lost to Follow-up|69|||
105681343|NCT03432260|364495942|FG000|Overall Study|Lost to Follow-up|1|||
105681344|NCT03432260|364495943|FG001|Overall Study|Lost to Follow-up|1|||
105681345|NCT03432260|364495944|FG002|Overall Study|Lost to Follow-up|0|||
105681346|NCT03432260|364495945|FG003|Overall Study|Lost to Follow-up|0|||
105681347|NCT03432260|364495946|FG004|Overall Study|Lost to Follow-up|1|||
105681348|NCT03319849|364495947|FG000|Overall Study|Adverse Event|1|||
105681349|NCT03319849|364495948|FG001|Overall Study|Adverse Event|0|||
105681350|NCT03319849|364495947|FG000|Overall Study|Physician Decision|0|||
105681351|NCT03319849|364495948|FG001|Overall Study|Physician Decision|1|||
105681352|NCT03319849|364495947|FG000|Overall Study|Withdrawal by Subject|0|||
105681353|NCT03319849|364495948|FG001|Overall Study|Withdrawal by Subject|1|||
105681354|NCT03319849|364495947|FG000|Overall Study|COVID-19|0|||
105681355|NCT03319849|364495948|FG001|Overall Study|COVID-19|1|||
105681356|NCT03319849|364495947|FG000|Overall Study|Other|1|||
105681357|NCT03319849|364495948|FG001|Overall Study|Other|2|||
105681358|NCT03319849|364495947|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
105681359|NCT03319849|364495948|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
105681360|NCT03319849|364495947|FG000|Overall Study|Lost to Follow-up|0|||
105681361|NCT03319849|364495948|FG001|Overall Study|Lost to Follow-up|2|||
105681362|NCT02924428|364497842|FG000|Overall Study|Adverse Event|1|||
105681363|NCT02924428|364497843|FG001|Overall Study|Adverse Event|0|||
105681364|NCT02924428|364497842|FG000|Overall Study|Physician Decision|1|||
105681365|NCT02924428|364497843|FG001|Overall Study|Physician Decision|0|||
105681366|NCT02924428|364497842|FG000|Overall Study|Lost to Follow-up|2|||
105681367|NCT02924428|364497843|FG001|Overall Study|Lost to Follow-up|4|||
105681368|NCT02924428|364497842|FG000|Overall Study|Pregnancy|0|||
105681369|NCT02924428|364497843|FG001|Overall Study|Pregnancy|1|||
105681370|NCT02134977|364497844|FG000|Overall Study|Protocol Deviation|102|||
105681371|NCT01773291|364497845|FG000|Overall Study|Protocol Violation|1|||
105681372|NCT01773291|364497846|FG001|Overall Study|Protocol Violation|0|||
105681373|NCT01773291|364497847|FG002|Overall Study|Protocol Violation|0|||
105681374|NCT01773291|364497845|FG000|Overall Study|Withdrawal by Subject|0|||
105681375|NCT01773291|364497846|FG001|Overall Study|Withdrawal by Subject|0|||
105681376|NCT01773291|364497847|FG002|Overall Study|Withdrawal by Subject|1|||
105681377|NCT00203476|364497848|FG000|Overall Study|Lost to Follow-up|1|||
105681378|NCT00203476|364497849|FG001|Overall Study|Lost to Follow-up|0|||
105681379|NCT00203476|364497850|FG002|Overall Study|Lost to Follow-up|0|||
105681380|NCT00203476|364497848|FG000|Overall Study|Withdrawal by Subject|0|||
105681381|NCT00203476|364497849|FG001|Overall Study|Withdrawal by Subject|1|||
105681382|NCT00203476|364497850|FG002|Overall Study|Withdrawal by Subject|0|||
105681383|NCT01635920|364497851|FG000|Overall Study|Adverse Event|1|||
105344436|NCT01645891|363261782|FG001|Overall Study|Protocol Violation|0|||
105681384|NCT01635920|364497852|FG001|Overall Study|Adverse Event|0|||
105681385|NCT01635920|364497851|FG000|Overall Study|Lost to Follow-up|0|||
105681386|NCT01635920|364497852|FG001|Overall Study|Lost to Follow-up|1|||
105344437|NCT01645891|363261781|FG000|Overall Study|Lost to Follow-up|4|||
105344438|NCT01645891|363261782|FG001|Overall Study|Lost to Follow-up|1|||
105681387|NCT01635920|364497851|FG000|Overall Study|Subject decision|2|||
105681388|NCT01635920|364497852|FG001|Overall Study|Subject decision|0|||
105344439|NCT01645891|363261781|FG000|Overall Study|Death|0|||
105681389|NCT04433585|364497853|FG000|Overall Study|Withdrawal by Subject|15|||
105681390|NCT04433585|364497854|FG001|Overall Study|Withdrawal by Subject|3|||
105681391|NCT04433585|364497855|FG002|Overall Study|Withdrawal by Subject|15|||
105681392|NCT04433585|364497856|FG003|Overall Study|Withdrawal by Subject|6|||
105681393|NCT04433585|364497853|FG000|Overall Study|Adverse Event|10|||
105681394|NCT04433585|364497854|FG001|Overall Study|Adverse Event|4|||
105681395|NCT04433585|364497855|FG002|Overall Study|Adverse Event|1|||
105681396|NCT04433585|364497856|FG003|Overall Study|Adverse Event|0|||
105681397|NCT04433585|364497853|FG000|Overall Study|Due to the conflict in Ukraine|2|||
105681398|NCT04433585|364497854|FG001|Overall Study|Due to the conflict in Ukraine|1|||
105681399|NCT04433585|364497855|FG002|Overall Study|Due to the conflict in Ukraine|1|||
105681400|NCT04433585|364497856|FG003|Overall Study|Due to the conflict in Ukraine|2|||
105681401|NCT04433585|364497853|FG000|Overall Study|Physician Decision|1|||
105681402|NCT04433585|364497854|FG001|Overall Study|Physician Decision|2|||
105681403|NCT04433585|364497855|FG002|Overall Study|Physician Decision|0|||
105681404|NCT04433585|364497856|FG003|Overall Study|Physician Decision|0|||
105681405|NCT04433585|364497853|FG000|Overall Study|Lost to Follow-up|1|||
105681406|NCT04433585|364497854|FG001|Overall Study|Lost to Follow-up|1|||
105681407|NCT04433585|364497855|FG002|Overall Study|Lost to Follow-up|1|||
105681408|NCT04433585|364497856|FG003|Overall Study|Lost to Follow-up|0|||
105681409|NCT04433585|364497853|FG000|Overall Study|Lack of Efficacy|0|||
105681410|NCT04433585|364497854|FG001|Overall Study|Lack of Efficacy|1|||
105681411|NCT04433585|364497855|FG002|Overall Study|Lack of Efficacy|1|||
105681412|NCT04433585|364497856|FG003|Overall Study|Lack of Efficacy|1|||
105681413|NCT04433585|364497853|FG000|Overall Study|Death|0|||
105681414|NCT04433585|364497854|FG001|Overall Study|Death|1|||
105681415|NCT04433585|364497855|FG002|Overall Study|Death|0|||
105681416|NCT04433585|364497856|FG003|Overall Study|Death|0|||
105681417|NCT01658150|364497857|FG000|Overall Study|Withdrawal by Subject|1|||
105681418|NCT03602066|364497858|FG000|Overall Study|Withdrawal by Subject|2|||
105681419|NCT03602066|364497859|FG001|Overall Study|Withdrawal by Subject|0|||
105681420|NCT03602066|364497858|FG000|Overall Study|Physician Decision|1|||
105681421|NCT03602066|364497859|FG001|Overall Study|Physician Decision|0|||
105681422|NCT00092495|364497860|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
105681423|NCT00092495|364497861|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
105681424|NCT00092495|364497862|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
105681425|NCT00092495|364497863|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
105681426|NCT00092495|364497864|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
105681427|NCT00092495|364497860|FG000|Base Study Vaccination Period|Extended|0|||
105681428|NCT00092495|364497861|FG001|Base Study Vaccination Period|Extended|0|||
105681429|NCT00092495|364497862|FG002|Base Study Vaccination Period|Extended|0|||
105681430|NCT00092495|364497863|FG003|Base Study Vaccination Period|Extended|1|||
105681431|NCT00092495|364497864|FG004|Base Study Vaccination Period|Extended|0|||
105681432|NCT00092495|364497860|FG000|Base Study Vaccination Period|*Clinical AE|1|||
105681433|NCT00092495|364497861|FG001|Base Study Vaccination Period|*Clinical AE|0|||
105681434|NCT00092495|364497862|FG002|Base Study Vaccination Period|*Clinical AE|1|||
105681435|NCT00092495|364497863|FG003|Base Study Vaccination Period|*Clinical AE|2|||
105681436|NCT00092495|364497864|FG004|Base Study Vaccination Period|*Clinical AE|0|||
105681437|NCT00092495|364497860|FG000|Base Study Vaccination Period|*Other reasons|1|||
105681438|NCT00092495|364497861|FG001|Base Study Vaccination Period|*Other reasons|0|||
105681439|NCT00092495|364497862|FG002|Base Study Vaccination Period|*Other reasons|0|||
105681440|NCT00092495|364497863|FG003|Base Study Vaccination Period|*Other reasons|1|||
105681441|NCT00092495|364497864|FG004|Base Study Vaccination Period|*Other reasons|0|||
105681442|NCT00092495|364497860|FG000|Base Study Vaccination Period|*Pregnancy|0|||
105681443|NCT00092495|364497861|FG001|Base Study Vaccination Period|*Pregnancy|2|||
105681444|NCT00092495|364497862|FG002|Base Study Vaccination Period|*Pregnancy|5|||
105681445|NCT00092495|364497863|FG003|Base Study Vaccination Period|*Pregnancy|7|||
105681446|NCT00092495|364497864|FG004|Base Study Vaccination Period|*Pregnancy|0|||
105681447|NCT00092495|364497860|FG000|Base Study Vaccination Period|Adverse Event|1|||
105681448|NCT00092495|364497861|FG001|Base Study Vaccination Period|Adverse Event|0|||
105344440|NCT01645891|363261782|FG001|Overall Study|Death|2|||
105344441|NCT03026530|363261783|FG000|Overall Study|Lost to Follow-up|19|||
105681449|NCT00092495|364497862|FG002|Base Study Vaccination Period|Adverse Event|0|||
105344442|NCT03026530|363261784|FG001|Overall Study|Lost to Follow-up|24|||
105681450|NCT00092495|364497863|FG003|Base Study Vaccination Period|Adverse Event|3|||
105681451|NCT00092495|364497864|FG004|Base Study Vaccination Period|Adverse Event|0|||
105681452|NCT00092495|364497860|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
105681453|NCT00092495|364497861|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
105681454|NCT00092495|364497862|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
105681455|NCT00092495|364497863|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
105681456|NCT00092495|364497864|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
105681457|NCT00092495|364497860|FG000|Base Study Vaccination Period|Moved|3|||
105344443|NCT03026530|363261783|FG000|Overall Study|Protocol Violation|2|||
105344444|NCT03026530|363261784|FG001|Overall Study|Protocol Violation|5|||
105344445|NCT03301740|363261785|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
105344446|NCT03301740|363261786|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
105557740|NCT01786512|364039129|FG000|Overall Study|Withdrawal by Subject|0|||
105557741|NCT01786512|364039130|FG001|Overall Study|Withdrawal by Subject|1|||
105557742|NCT01786512|364039131|FG002|Overall Study|Withdrawal by Subject|0|||
105557743|NCT01786512|364039132|FG003|Overall Study|Withdrawal by Subject|0|||
105557744|NCT01786512|364039133|FG004|Overall Study|Withdrawal by Subject|0|||
105557745|NCT01786512|364039134|FG005|Overall Study|Withdrawal by Subject|0|||
105557746|NCT01786512|364039135|FG006|Overall Study|Withdrawal by Subject|1|||
105557747|NCT01786512|364039136|FG007|Overall Study|Withdrawal by Subject|0|||
105557748|NCT01786512|364039137|FG008|Overall Study|Withdrawal by Subject|0|||
105557749|NCT01786512|364039138|FG009|Overall Study|Withdrawal by Subject|3|||
105557750|NCT01786512|364039139|FG010|Overall Study|Withdrawal by Subject|7|||
105557751|NCT01786512|364039129|FG000|Overall Study|Death|0|||
105557752|NCT01786512|364039130|FG001|Overall Study|Death|0|||
105557753|NCT01786512|364039131|FG002|Overall Study|Death|0|||
105557754|NCT01786512|364039132|FG003|Overall Study|Death|0|||
105557755|NCT01786512|364039133|FG004|Overall Study|Death|0|||
105557756|NCT01786512|364039134|FG005|Overall Study|Death|0|||
105681458|NCT00092495|364497861|FG001|Base Study Vaccination Period|Moved|1|||
105681459|NCT00092495|364497862|FG002|Base Study Vaccination Period|Moved|2|||
105681460|NCT00092495|364497863|FG003|Base Study Vaccination Period|Moved|2|||
105681461|NCT00092495|364497864|FG004|Base Study Vaccination Period|Moved|0|||
105681462|NCT00092495|364497860|FG000|Base Study Vaccination Period|Other|1|||
105681463|NCT00092495|364497861|FG001|Base Study Vaccination Period|Other|1|||
105681464|NCT00092495|364497862|FG002|Base Study Vaccination Period|Other|0|||
105681465|NCT00092495|364497863|FG003|Base Study Vaccination Period|Other|2|||
105681466|NCT00092495|364497864|FG004|Base Study Vaccination Period|Other|0|||
105557757|NCT01786512|364039135|FG006|Overall Study|Death|0|||
105681467|NCT00092495|364497860|FG000|Base Study Vaccination Period|Pregnancy|2|||
105344447|NCT03301740|363261785|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
105557758|NCT01786512|364039136|FG007|Overall Study|Death|0|||
105557759|NCT01786512|364039137|FG008|Overall Study|Death|4|||
105681468|NCT00092495|364497861|FG001|Base Study Vaccination Period|Pregnancy|0|||
105557760|NCT01786512|364039138|FG009|Overall Study|Death|1|||
105557761|NCT01786512|364039139|FG010|Overall Study|Death|3|||
105681469|NCT00092495|364497862|FG002|Base Study Vaccination Period|Pregnancy|0|||
105681470|NCT00092495|364497863|FG003|Base Study Vaccination Period|Pregnancy|0|||
105681471|NCT00092495|364497864|FG004|Base Study Vaccination Period|Pregnancy|0|||
105681472|NCT00092495|364497860|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
105681473|NCT00092495|364497861|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
105681474|NCT00092495|364497862|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
105681475|NCT00092495|364497863|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
105681476|NCT00092495|364497864|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
105681477|NCT00092495|364497860|FG000|Base Study Vaccination Period|Protocol Violation|1|||
105681478|NCT00092495|364497861|FG001|Base Study Vaccination Period|Protocol Violation|0|||
105681479|NCT00092495|364497862|FG002|Base Study Vaccination Period|Protocol Violation|0|||
105681480|NCT00092495|364497863|FG003|Base Study Vaccination Period|Protocol Violation|0|||
105681481|NCT00092495|364497864|FG004|Base Study Vaccination Period|Protocol Violation|0|||
105681482|NCT00092495|364497860|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
105681483|NCT00092495|364497861|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
105681484|NCT00092495|364497862|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
105681485|NCT00092495|364497863|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
105681486|NCT00092495|364497864|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
105681487|NCT00092495|364497860|FG000|Base Study Follow-up Period|Extended|0|||
105681488|NCT00092495|364497861|FG001|Base Study Follow-up Period|Extended|0|||
105681489|NCT00092495|364497862|FG002|Base Study Follow-up Period|Extended|1|||
105681490|NCT00092495|364497863|FG003|Base Study Follow-up Period|Extended|2|||
105681491|NCT00092495|364497864|FG004|Base Study Follow-up Period|Extended|0|||
105681492|NCT00092495|364497860|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
105681493|NCT00092495|364497861|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
105681494|NCT00092495|364497862|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
105681495|NCT00092495|364497863|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
105681496|NCT00092495|364497864|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
105681497|NCT00092495|364497860|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
105681498|NCT00092495|364497861|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
105681499|NCT00092495|364497862|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
105681500|NCT00092495|364497863|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
105681501|NCT00092495|364497864|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
105681502|NCT00938470|364497865|FG000|Overall Study|Disease Progression|3|||
105681503|NCT00938470|364497866|FG001|Overall Study|Disease Progression|0|||
105681504|NCT00938470|364497865|FG000|Overall Study|Alternate Treatment|1|||
105681505|NCT00938470|364497866|FG001|Overall Study|Alternate Treatment|0|||
105681506|NCT00938470|364497865|FG000|Overall Study|Death|3|||
105681507|NCT00938470|364497866|FG001|Overall Study|Death|2|||
105681508|NCT00938470|364497865|FG000|Overall Study|Other Reason|0|||
105681509|NCT00938470|364497866|FG001|Overall Study|Other Reason|1|||
105681510|NCT01970345|364497867|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
105681511|NCT01970345|364497868|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
105681512|NCT01970345|364497867|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
105681513|NCT01970345|364497868|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
105681514|NCT00558259|364497869|FG000|Overall Study|Adverse Event|50|||
105681515|NCT00558259|364497870|FG001|Overall Study|Adverse Event|81|||
105681516|NCT00558259|364497869|FG000|Overall Study|Protocol Violation|9|||
105681517|NCT00558259|364497870|FG001|Overall Study|Protocol Violation|5|||
105681518|NCT00558259|364497869|FG000|Overall Study|Withdrawal by Subject|12|||
105681519|NCT00558259|364497870|FG001|Overall Study|Withdrawal by Subject|13|||
105681520|NCT02874924|364497871|FG000|Overall Study|Adverse Event|2|||
105681521|NCT02874924|364497872|FG001|Overall Study|Adverse Event|0|||
105681522|NCT02874924|364497873|FG002|Overall Study|Adverse Event|0|||
105681523|NCT02874924|364497871|FG000|Overall Study|Withdrawal by Subject|1|||
105681524|NCT02874924|364497872|FG001|Overall Study|Withdrawal by Subject|0|||
105681525|NCT02874924|364497873|FG002|Overall Study|Withdrawal by Subject|0|||
105681526|NCT00156819|364497874|FG000|Overall Study|Lost to Follow-up|1|||
105786478|NCT01748162|364871401|FG000|Overall Study|reasons not available|3|||
105786479|NCT01748162|364871402|FG001|Overall Study|reasons not available|2|||
105786480|NCT02743117|364871403|FG000|Overall Study|Lost to Follow-up|0|||
105786481|NCT02743117|364871404|FG001|Overall Study|Lost to Follow-up|1|||
105786482|NCT02743117|364871403|FG000|Overall Study|Other|1|||
105681527|NCT00156819|364497875|FG001|Overall Study|Lost to Follow-up|1|||
105681528|NCT00156819|364497876|FG002|Overall Study|Lost to Follow-up|3|||
105786483|NCT02743117|364871404|FG001|Overall Study|Other|0|||
105468688|NCT01134055|363725952|FG001|Overall Study|Adverse Event|2|||
105681529|NCT00717067|364497877|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
105681530|NCT00717067|364497878|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
105681531|NCT00717067|364497879|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
105681532|NCT00717067|364497880|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
105786484|NCT01207219|364871405|FG000|Overall Study|changed diagnosis during study period|5|||
105786485|NCT01207219|364871406|FG001|Overall Study|changed diagnosis during study period|3|||
105681533|NCT00717067|364497881|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
105681534|NCT02090959|364497882|FG000|Overall Study|Withdrawal by Subject|10|||
105681535|NCT02090959|364497882|FG000|Overall Study|Adverse Event|1|||
105681536|NCT02090959|364497882|FG000|Overall Study|Investigator decision|2|||
105681537|NCT02090959|364497882|FG000|Overall Study|Study termination|6|||
105681538|NCT02090959|364497882|FG000|Overall Study|Enrolled but not treated|1|||
105681539|NCT02090959|364497882|FG000|Overall Study|Transfer for compassionate use medicine|4|||
105681540|NCT02090959|364497882|FG000|Overall Study|Move to medical need program|3|||
105681541|NCT02090959|364497882|FG000|Overall Study|Entered in to other study|34|||
105681542|NCT02090959|364497882|FG000|Overall Study|Switched to commercial supply|88|||
105681543|NCT02090959|364497882|FG000|Overall Study|Other than specified|2|||
105681544|NCT00522873|364497883|FG000|Overall Study|Adverse Event|41|||
105681545|NCT00522873|364497884|FG001|Overall Study|Adverse Event|26|||
105681546|NCT00522873|364497883|FG000|Overall Study|Withdrawal by Subject|20|||
105681547|NCT00522873|364497884|FG001|Overall Study|Withdrawal by Subject|9|||
105681548|NCT00522873|364497883|FG000|Overall Study|Protocol Violation|14|||
105681549|NCT00522873|364497884|FG001|Overall Study|Protocol Violation|4|||
105681550|NCT00522873|364497883|FG000|Overall Study|Lost to Follow-up|11|||
105681551|NCT00522873|364497884|FG001|Overall Study|Lost to Follow-up|3|||
105681552|NCT00522873|364497883|FG000|Overall Study|Personal Reasons|8|||
105681553|NCT00522873|364497884|FG001|Overall Study|Personal Reasons|1|||
105681554|NCT00522873|364497883|FG000|Overall Study|Medication Errors|1|||
105681555|NCT00522873|364497884|FG001|Overall Study|Medication Errors|1|||
105681556|NCT00522873|364497883|FG000|Overall Study|Never Received Medication|1|||
105681557|NCT00522873|364497884|FG001|Overall Study|Never Received Medication|0|||
105681558|NCT02029846|364497887|FG000|Overall Study|n=1 each arm|1|||
105681559|NCT02029846|364497888|FG001|Overall Study|n=1 each arm|1|||
105681560|NCT02966301|364497889|FG000|Overall Study|Death|2|||
105681561|NCT02966301|364497889|FG000|Overall Study|Withdrawal by Subject|1|||
105681562|NCT00250679|364497890|FG000|Overall Study|Adverse Event|12|||
105681563|NCT00250679|364497891|FG001|Overall Study|Adverse Event|15|||
105681564|NCT00250679|364497892|FG002|Overall Study|Adverse Event|16|||
105681565|NCT00250679|364497890|FG000|Overall Study|Protocol Violation|2|||
105681566|NCT00250679|364497891|FG001|Overall Study|Protocol Violation|4|||
105681567|NCT00250679|364497892|FG002|Overall Study|Protocol Violation|3|||
105681568|NCT00250679|364497890|FG000|Overall Study|Withdrawal by Subject|15|||
105681569|NCT00250679|364497891|FG001|Overall Study|Withdrawal by Subject|18|||
105681570|NCT00250679|364497892|FG002|Overall Study|Withdrawal by Subject|15|||
105681571|NCT00250679|364497890|FG000|Overall Study|Lost to Follow-up|3|||
105681572|NCT00250679|364497891|FG001|Overall Study|Lost to Follow-up|4|||
105344448|NCT03301740|363261786|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
105681573|NCT00250679|364497892|FG002|Overall Study|Lost to Follow-up|2|||
105344449|NCT02847182|363261788|FG000|Overall Study|Withdrawal by Subject|0|||
105681574|NCT00250679|364497890|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
105681575|NCT00250679|364497891|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
105681576|NCT00250679|364497892|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
105681577|NCT00250679|364497890|FG000|Overall Study|Lack of Efficacy|0|||
105681578|NCT00250679|364497891|FG001|Overall Study|Lack of Efficacy|1|||
105681579|NCT00250679|364497892|FG002|Overall Study|Lack of Efficacy|3|||
105681580|NCT00250679|364497890|FG000|Overall Study|Technical Holter issues|1|||
105681581|NCT00250679|364497891|FG001|Overall Study|Technical Holter issues|0|||
105681582|NCT00250679|364497892|FG002|Overall Study|Technical Holter issues|2|||
105681583|NCT00250679|364497890|FG000|Overall Study|Moved|1|||
105681584|NCT00250679|364497891|FG001|Overall Study|Moved|1|||
105681585|NCT00250679|364497892|FG002|Overall Study|Moved|0|||
105681586|NCT00250679|364497890|FG000|Overall Study|Non-compliance|1|||
105681587|NCT00250679|364497891|FG001|Overall Study|Non-compliance|1|||
105681588|NCT00250679|364497892|FG002|Overall Study|Non-compliance|0|||
105681589|NCT00250679|364497890|FG000|Overall Study|various single events: hip surgery,diary|3|||
105681590|NCT00250679|364497891|FG001|Overall Study|various single events: hip surgery,diary|1|||
105681591|NCT00250679|364497892|FG002|Overall Study|various single events: hip surgery,diary|1|||
105681592|NCT00822172|364497893|FG000|Overall Study|Adverse Event|10|||
105681593|NCT00822172|364497894|FG001|Overall Study|Adverse Event|12|||
105681594|NCT00822172|364497893|FG000|Overall Study|Death|1|||
105681595|NCT00822172|364497894|FG001|Overall Study|Death|0|||
105681596|NCT00822172|364497893|FG000|Overall Study|Lost to Follow-up|3|||
105681597|NCT00822172|364497894|FG001|Overall Study|Lost to Follow-up|1|||
105681598|NCT00822172|364497893|FG000|Overall Study|Withdrawal by Subject|1|||
105681599|NCT00822172|364497894|FG001|Overall Study|Withdrawal by Subject|4|||
105681600|NCT00822172|364497893|FG000|Overall Study|site closed|0|||
105681601|NCT00822172|364497894|FG001|Overall Study|site closed|1|||
105681602|NCT00822172|364497893|FG000|Overall Study|Other|0|||
105681603|NCT00822172|364497894|FG001|Overall Study|Other|1|||
105681604|NCT00448279|364497895|FG000|Overall Study|Lost to Follow-up|2|||
105681605|NCT00448279|364497896|FG001|Overall Study|Lost to Follow-up|2|||
105681606|NCT00448279|364497895|FG000|Overall Study|Adverse Event|1|||
105681607|NCT00448279|364497896|FG001|Overall Study|Adverse Event|1|||
105681608|NCT00448279|364497895|FG000|Overall Study|Disease progression|16|||
105681609|NCT00448279|364497896|FG001|Overall Study|Disease progression|18|||
105681610|NCT00448279|364497895|FG000|Overall Study|Withdrawal by Subject|4|||
105681611|NCT00448279|364497896|FG001|Overall Study|Withdrawal by Subject|3|||
105681612|NCT00448279|364497895|FG000|Overall Study|Other|6|||
105681613|NCT00448279|364497896|FG001|Overall Study|Other|4|||
105681614|NCT00448279|364497895|FG000|Overall Study|Protocol Violation|0|||
105681615|NCT00448279|364497896|FG001|Overall Study|Protocol Violation|1|||
105681616|NCT00642772|364497898|FG000|Overall Study|Lost to Follow-up|3|||
105681617|NCT00642772|364497898|FG000|Overall Study|Withdrawal by Subject|7|||
105681618|NCT00545051|364497901|FG000|Overall Study|Adverse Event|7|||
105681619|NCT00545051|364497902|FG001|Overall Study|Adverse Event|3|||
105681620|NCT00545051|364497901|FG000|Overall Study|Death|1|||
105681621|NCT00545051|364497902|FG001|Overall Study|Death|0|||
105681622|NCT00545051|364497901|FG000|Overall Study|Violation of inclusion/exclusion|0|||
105681623|NCT00545051|364497902|FG001|Overall Study|Violation of inclusion/exclusion|2|||
105681624|NCT00545051|364497901|FG000|Overall Study|Protocol Violation|1|||
105681625|NCT00545051|364497902|FG001|Overall Study|Protocol Violation|0|||
105681626|NCT00545051|364497901|FG000|Overall Study|Withdrawal by Subject|0|||
105681627|NCT00545051|364497902|FG001|Overall Study|Withdrawal by Subject|1|||
105681628|NCT00545051|364497901|FG000|Overall Study|Administrative reasons|0|||
105681629|NCT00545051|364497902|FG001|Overall Study|Administrative reasons|1|||
105681630|NCT02781844|364497905|FG000|Treatment Period 1|Adverse Event|0|||
105681631|NCT02781844|364497906|FG001|Treatment Period 1|Adverse Event|0|||
105681632|NCT02781844|364497907|FG002|Treatment Period 1|Adverse Event|0|||
105681633|NCT02781844|364497908|FG003|Treatment Period 1|Adverse Event|0|||
105681634|NCT02781844|364497909|FG004|Treatment Period 1|Adverse Event|0|||
105681635|NCT02781844|364497910|FG005|Treatment Period 1|Adverse Event|1|||
105681636|NCT02781844|364497911|FG006|Treatment Period 1|Adverse Event|0|||
105681637|NCT02781844|364497912|FG007|Treatment Period 1|Adverse Event|0|||
105681638|NCT04256629|364497915|FG000|Overall Study|Adverse Event|0|||
105681639|NCT04256629|364497916|FG001|Overall Study|Adverse Event|0|||
105681640|NCT04256629|364497917|FG002|Overall Study|Adverse Event|0|||
105681641|NCT04256629|364497918|FG003|Overall Study|Adverse Event|0|||
105681642|NCT04256629|364497919|FG004|Overall Study|Adverse Event|0|||
105681643|NCT04256629|364497920|FG005|Overall Study|Adverse Event|1|||
105681644|NCT04256629|364497915|FG000|Overall Study|Protocol Violation|0|||
105681645|NCT04256629|364497916|FG001|Overall Study|Protocol Violation|1|||
105681646|NCT04256629|364497917|FG002|Overall Study|Protocol Violation|0|||
105681647|NCT04256629|364497918|FG003|Overall Study|Protocol Violation|0|||
105681648|NCT04256629|364497919|FG004|Overall Study|Protocol Violation|0|||
105681649|NCT04256629|364497920|FG005|Overall Study|Protocol Violation|0|||
105681650|NCT00321373|364497921|FG000|Overall Study|Adverse Event|0|||
105681651|NCT00321373|364497922|FG001|Overall Study|Adverse Event|0|||
105681652|NCT00321373|364497923|FG002|Overall Study|Adverse Event|1|||
105681653|NCT00321373|364497921|FG000|Overall Study|Lost to Follow-up|1|||
105681654|NCT00321373|364497922|FG001|Overall Study|Lost to Follow-up|0|||
105681655|NCT00321373|364497923|FG002|Overall Study|Lost to Follow-up|1|||
105681656|NCT00321373|364497921|FG000|Overall Study|Withdrawal by Subject|1|||
105681657|NCT00321373|364497922|FG001|Overall Study|Withdrawal by Subject|0|||
105681658|NCT00321373|364497923|FG002|Overall Study|Withdrawal by Subject|0|||
105681659|NCT00321373|364497921|FG000|Overall Study|Other|0|||
105681660|NCT00321373|364497922|FG001|Overall Study|Other|0|||
105681661|NCT00321373|364497923|FG002|Overall Study|Other|1|||
105344450|NCT02847182|363261789|FG001|Overall Study|Withdrawal by Subject|1|||
105344451|NCT03191864|363261790|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
105344452|NCT03191864|363261791|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
105344453|NCT03191864|363261792|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
105344454|NCT03191864|363261793|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
105344455|NCT03191864|363261794|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
105468689|NCT01134055|363725953|FG002|Overall Study|Adverse Event|2|||
105468690|NCT01134055|363725954|FG003|Overall Study|Adverse Event|2|||
105468691|NCT01134055|363725955|FG004|Overall Study|Adverse Event|5|||
105468692|NCT01134055|363725956|FG005|Overall Study|Adverse Event|7|||
105468693|NCT01134055|363725957|FG006|Overall Study|Adverse Event|2|||
105468694|NCT01134055|363725951|FG000|Overall Study|Lost to Follow-up|0|||
105468695|NCT01134055|363725952|FG001|Overall Study|Lost to Follow-up|1|||
105468696|NCT01134055|363725953|FG002|Overall Study|Lost to Follow-up|0|||
105468697|NCT01134055|363725954|FG003|Overall Study|Lost to Follow-up|1|||
105468698|NCT01134055|363725955|FG004|Overall Study|Lost to Follow-up|0|||
105468699|NCT01134055|363725956|FG005|Overall Study|Lost to Follow-up|0|||
105468700|NCT01134055|363725957|FG006|Overall Study|Lost to Follow-up|0|||
105468701|NCT01134055|363725951|FG000|Overall Study|Withdrawal by Subject|3|||
105468702|NCT01134055|363725952|FG001|Overall Study|Withdrawal by Subject|3|||
105468703|NCT01134055|363725953|FG002|Overall Study|Withdrawal by Subject|1|||
105468704|NCT01134055|363725954|FG003|Overall Study|Withdrawal by Subject|2|||
105468705|NCT01134055|363725955|FG004|Overall Study|Withdrawal by Subject|0|||
105468706|NCT01134055|363725956|FG005|Overall Study|Withdrawal by Subject|0|||
105468707|NCT01134055|363725957|FG006|Overall Study|Withdrawal by Subject|8|||
105468708|NCT01134055|363725951|FG000|Overall Study|Protocol Violation|0|||
105468709|NCT01134055|363725952|FG001|Overall Study|Protocol Violation|0|||
105468710|NCT01134055|363725953|FG002|Overall Study|Protocol Violation|0|||
105468711|NCT01134055|363725954|FG003|Overall Study|Protocol Violation|1|||
105468712|NCT01134055|363725955|FG004|Overall Study|Protocol Violation|1|||
105468713|NCT01134055|363725956|FG005|Overall Study|Protocol Violation|0|||
105468714|NCT01134055|363725957|FG006|Overall Study|Protocol Violation|0|||
105468715|NCT01134055|363725951|FG000|Overall Study|Physician Decision|0|||
105468716|NCT01134055|363725952|FG001|Overall Study|Physician Decision|0|||
105468717|NCT01134055|363725953|FG002|Overall Study|Physician Decision|0|||
105468718|NCT01134055|363725954|FG003|Overall Study|Physician Decision|0|||
105468719|NCT01134055|363725955|FG004|Overall Study|Physician Decision|0|||
105468720|NCT01134055|363725956|FG005|Overall Study|Physician Decision|0|||
105468721|NCT01134055|363725957|FG006|Overall Study|Physician Decision|1|||
105468722|NCT02577718|363725958|FG000|Overall Study|Death|6|||
105468723|NCT02577718|363725958|FG000|Overall Study|Withdrawal by Subject|2|||
105468724|NCT01967576|363725959|FG000|Overall Study|Withdrawal by Subject|3|||
105468725|NCT01967576|363725959|FG000|Overall Study|Progressed/Removed from treatment|1|||
105468726|NCT01967576|363725959|FG000|Overall Study|Study closing at site|1|||
105468727|NCT01967576|363725959|FG000|Overall Study|Adverse Event|1|||
105468728|NCT01967576|363725959|FG000|Overall Study|Refused further treatment|1|||
105468729|NCT01605799|363725966|FG000|Overall Study|Withdrawal by Subject|2|||
105468730|NCT01605799|363725967|FG001|Overall Study|Withdrawal by Subject|1|||
105468731|NCT00392769|363725968|FG000|Overall Study|Clinical Deterioration|9|||
105468732|NCT00392769|363725968|FG000|Overall Study|Adverse Event|1|||
105468733|NCT00345358|363725969|FG000|Primary Vaccination Phase|Other|0|||
105468734|NCT00345358|363725970|FG001|Primary Vaccination Phase|Other|1|||
105468735|NCT00345358|363725971|FG002|Primary Vaccination Phase|Other|1|||
105468736|NCT00345358|363725972|FG003|Primary Vaccination Phase|Other|0|||
105468737|NCT00345358|363725969|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
105468738|NCT00345358|363725970|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
105468739|NCT00345358|363725971|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
105468740|NCT00345358|363725972|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
105468741|NCT00345358|363725969|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
105468742|NCT00345358|363725970|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
105468743|NCT00345358|363725971|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
105468744|NCT00345358|363725972|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
105468745|NCT00345358|363725969|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
105468746|NCT00345358|363725970|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
105468747|NCT00345358|363725971|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
105468748|NCT00345358|363725972|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
105468749|NCT00345358|363725969|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
105468750|NCT00345358|363725970|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
105468751|NCT00345358|363725971|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
105468752|NCT00345358|363725972|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
105468753|NCT00345358|363725969|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
105468754|NCT00345358|363725970|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
105468755|NCT00345358|363725971|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
105681662|NCT01774487|364497924|FG000|Overall Study|Did not tolerate taste|4|||
105681663|NCT01774487|364497925|FG001|Overall Study|Did not tolerate taste|4|||
105681664|NCT00918580|364497926|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
105681665|NCT00918580|364497926|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
105681666|NCT00918580|364497926|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
105681667|NCT00918580|364497926|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
105681668|NCT00918580|364497926|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
105681669|NCT00918580|364497926|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
105681670|NCT00918580|364497926|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
105681671|NCT02572882|364497927|FG000|Overall Study|Withdrawal by Subject|1|||
105681672|NCT02572882|364497927|FG000|Overall Study|Participant received kidney transplant|1|||
105681673|NCT02354508|364497931|FG000|Period 1: Core Phase|Adverse Event|1|||
105681674|NCT02354508|364497932|FG001|Period 1: Core Phase|Adverse Event|1|||
105681675|NCT02354508|364497933|FG002|Period 1: Core Phase|Adverse Event|2|||
105681676|NCT02354508|364497931|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
105681677|NCT02354508|364497932|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
105681678|NCT02354508|364497933|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
105681679|NCT02354508|364497931|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
105681680|NCT02354508|364497932|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
105681681|NCT02354508|364497933|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
105681682|NCT02354508|364497931|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
105681683|NCT02354508|364497932|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
105681684|NCT02354508|364497933|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
105681685|NCT02354508|364497931|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
105681686|NCT02354508|364497932|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
105681687|NCT02354508|364497933|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
105681688|NCT02354508|364497931|FG000|Period 2: Extension Phase|Physician Decision|5|||
105681689|NCT02354508|364497932|FG001|Period 2: Extension Phase|Physician Decision|0|||
105681690|NCT02354508|364497933|FG002|Period 2: Extension Phase|Physician Decision|1|||
105681691|NCT02354508|364497931|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
105681692|NCT02354508|364497932|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
105681693|NCT02354508|364497933|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
105681694|NCT02354508|364497931|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
105681695|NCT02354508|364497932|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
105681696|NCT02354508|364497933|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
105681697|NCT02354508|364497931|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
105681698|NCT02354508|364497932|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
105681699|NCT02354508|364497933|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
105681700|NCT04371198|364497938|FG000|Overall Study|inadequate sample|4|||
105681701|NCT00946101|364497939|FG000|Overall Study|Lost to Follow-up|2|||
105681702|NCT00946101|364497940|FG001|Overall Study|Lost to Follow-up|1|||
105681703|NCT00946101|364497939|FG000|Overall Study|Withdrawal of consent|2|||
105681704|NCT00946101|364497940|FG001|Overall Study|Withdrawal of consent|0|||
105681705|NCT00946101|364497939|FG000|Overall Study|Physician Decision|0|||
105681706|NCT00946101|364497940|FG001|Overall Study|Physician Decision|1|||
105681707|NCT00495586|364497941|FG000|Overall Study|Withdrawal by Subject|4|||
105681708|NCT00495586|364497942|FG001|Overall Study|Withdrawal by Subject|4|||
105681709|NCT03038438|364497943|FG000|Overall Study|Death|3|||
105681710|NCT03038438|364497943|FG000|Overall Study|Lost to Follow-up|8|||
105681711|NCT03038438|364497943|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
105681712|NCT03038438|364497943|FG000|Overall Study|Withdrawal by Subject|5|||
105681713|NCT03038438|364497943|FG000|Overall Study|No 36-Month Follow-Up|18|||
105681714|NCT03215810|364497944|FG000|Overall Study|Still responding to nivolumab|1|||
105681715|NCT03215810|364497944|FG000|Overall Study|Insufficient TIL growth|1|||
105681716|NCT03215810|364497944|FG000|Overall Study|Decline in performance status|1|||
105557762|NCT03561090|364039140|FG000|Overall Study|Adverse Event|11|||
105681717|NCT03215810|364497944|FG000|Overall Study|Withdrawal by Subject|1|||
105557763|NCT03561090|364039141|FG001|Overall Study|Adverse Event|7|||
105681718|NCT00158860|364497947|FG000|Overall Study|Adverse Event|3|||
105681719|NCT00158860|364497948|FG001|Overall Study|Adverse Event|6|||
105681720|NCT00158860|364497947|FG000|Overall Study|Lost to Follow-up|11|||
105681721|NCT00158860|364497948|FG001|Overall Study|Lost to Follow-up|17|||
105681722|NCT00158860|364497947|FG000|Overall Study|Protocol Violation|8|||
105681723|NCT00158860|364497948|FG001|Overall Study|Protocol Violation|23|||
105681724|NCT00158860|364497947|FG000|Overall Study|Withdrawal by Subject|7|||
105681725|NCT00158860|364497948|FG001|Overall Study|Withdrawal by Subject|17|||
105681726|NCT00158860|364497947|FG000|Overall Study|MOVING OUT OF STATE|1|||
105681727|NCT00158860|364497948|FG001|Overall Study|MOVING OUT OF STATE|0|||
105681728|NCT00158860|364497947|FG000|Overall Study|Pregnancy|3|||
105681729|NCT00158860|364497948|FG001|Overall Study|Pregnancy|3|||
105681730|NCT00158860|364497947|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
105681731|NCT00158860|364497948|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
105681732|NCT00158860|364497947|FG000|Overall Study|SPONSOR REQUEST|0|||
105681733|NCT00158860|364497948|FG001|Overall Study|SPONSOR REQUEST|1|||
105681734|NCT00158860|364497947|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
105681735|NCT00158860|364497948|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
105681736|NCT00158860|364497947|FG000|Overall Study|Closed per sponsor|0|||
105681737|NCT00158860|364497948|FG001|Overall Study|Closed per sponsor|1|||
105681738|NCT02095951|364497949|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
105681739|NCT02095951|364497950|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
105681740|NCT03618823|364497951|FG000|Overall Study|Lost to Follow-up|63|||
105681741|NCT03618823|364497952|FG001|Overall Study|Lost to Follow-up|61|||
105681742|NCT00440999|364497953|FG000|Overall Study|Adverse Event|0|||
105681743|NCT00440999|364497954|FG001|Overall Study|Adverse Event|2|||
105681744|NCT00440999|364497953|FG000|Overall Study|Lack of Efficacy|6|||
105681745|NCT00440999|364497954|FG001|Overall Study|Lack of Efficacy|7|||
105681746|NCT00440999|364497953|FG000|Overall Study|Lost to Follow-up|19|||
105681747|NCT00440999|364497954|FG001|Overall Study|Lost to Follow-up|12|||
105681748|NCT00440999|364497953|FG000|Overall Study|Protocol Violation|1|||
105681749|NCT00440999|364497954|FG001|Overall Study|Protocol Violation|0|||
105681750|NCT00440999|364497953|FG000|Overall Study|Withdrawal by Subject|2|||
105681751|NCT00440999|364497954|FG001|Overall Study|Withdrawal by Subject|5|||
105681752|NCT00440999|364497953|FG000|Overall Study|Subjets missed the visit|1|||
105681753|NCT00440999|364497954|FG001|Overall Study|Subjets missed the visit|0|||
105681754|NCT00440999|364497953|FG000|Overall Study|Mixed infection at entry|1|||
105681755|NCT00440999|364497954|FG001|Overall Study|Mixed infection at entry|0|||
105681756|NCT00440999|364497953|FG000|Overall Study|P. falciparum malaria|5|||
105681757|NCT00440999|364497954|FG001|Overall Study|P. falciparum malaria|14|||
105681758|NCT00440999|364497953|FG000|Overall Study|Subj left hosp without inform staff|0|||
105681759|NCT00440999|364497954|FG001|Overall Study|Subj left hosp without inform staff|1|||
105681760|NCT01205152|364497955|FG000|Overall Study|Death|1|||
105681761|NCT03500159|364497956|FG000|Overall Study|Study Terminated|2|||
105681762|NCT03500159|364497957|FG001|Overall Study|Study Terminated|1|||
105681763|NCT01656733|364497961|FG000|Overall Study|No permission to collect birth outcomes|0|||
105681764|NCT01656733|364497962|FG001|Overall Study|No permission to collect birth outcomes|1|||
105681765|NCT01656733|364497961|FG000|Overall Study|Delivery at another hospital|0|||
105681766|NCT01656733|364497962|FG001|Overall Study|Delivery at another hospital|2|||
105681767|NCT01656733|364497961|FG000|Overall Study|Spontaneous abortion|0|||
105681768|NCT01656733|364497962|FG001|Overall Study|Spontaneous abortion|1|||
105681769|NCT00249002|364497963|FG000|Overall Study|Adverse Event|2|||
105681770|NCT00249002|364497963|FG000|Overall Study|Study cancellation|3|||
105681771|NCT00249002|364497963|FG000|Overall Study|Other|2|||
105681772|NCT03625895|364497964|FG000|Overall Study|Protocol Violation|585|||
105681773|NCT01488487|364497970|FG000|Overall Study|Adverse Event|6|||
105681774|NCT01488487|364497970|FG000|Overall Study|Death|1|||
105681775|NCT01488487|364497970|FG000|Overall Study|Withdrawal by Subject|2|||
105681776|NCT00395460|364497971|FG000|Overall Study|Withdrawal by Subject|1|||
105681777|NCT00395460|364497972|FG001|Overall Study|Withdrawal by Subject|0|||
105681778|NCT05208866|364497973|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
105681779|NCT00232544|364497977|FG000|Overall Study|Lost to Follow-up|20|||
105681780|NCT00232544|364497978|FG001|Overall Study|Lost to Follow-up|15|||
105681781|NCT02581631|364497979|FG000|Overall Study|Disease progression|29|||
105681782|NCT02581631|364497980|FG001|Overall Study|Disease progression|19|||
105681783|NCT02581631|364497981|FG002|Overall Study|Disease progression|13|||
105681784|NCT02581631|364497982|FG003|Overall Study|Disease progression|5|||
105681785|NCT02581631|364497983|FG004|Overall Study|Disease progression|8|||
105681786|NCT02581631|364497979|FG000|Overall Study|Study drug toxicity|4|||
105681787|NCT02581631|364497980|FG001|Overall Study|Study drug toxicity|6|||
105681788|NCT02581631|364497981|FG002|Overall Study|Study drug toxicity|7|||
105681789|NCT02581631|364497982|FG003|Overall Study|Study drug toxicity|0|||
105681790|NCT02581631|364497983|FG004|Overall Study|Study drug toxicity|3|||
105681791|NCT02581631|364497979|FG000|Overall Study|AE unrelated to study drug|3|||
105681792|NCT02581631|364497980|FG001|Overall Study|AE unrelated to study drug|1|||
105681793|NCT02581631|364497981|FG002|Overall Study|AE unrelated to study drug|1|||
105681794|NCT02581631|364497982|FG003|Overall Study|AE unrelated to study drug|0|||
105681795|NCT02581631|364497983|FG004|Overall Study|AE unrelated to study drug|2|||
105681796|NCT02581631|364497979|FG000|Overall Study|Request to discontinue|1|||
105681797|NCT02581631|364497980|FG001|Overall Study|Request to discontinue|0|||
105681798|NCT02581631|364497981|FG002|Overall Study|Request to discontinue|3|||
105681799|NCT02581631|364497982|FG003|Overall Study|Request to discontinue|0|||
105681800|NCT02581631|364497983|FG004|Overall Study|Request to discontinue|1|||
105681801|NCT02581631|364497979|FG000|Overall Study|participant withdrew consent|3|||
105681802|NCT02581631|364497980|FG001|Overall Study|participant withdrew consent|0|||
105681803|NCT02581631|364497981|FG002|Overall Study|participant withdrew consent|1|||
105681804|NCT02581631|364497982|FG003|Overall Study|participant withdrew consent|0|||
105681805|NCT02581631|364497983|FG004|Overall Study|participant withdrew consent|0|||
105681806|NCT02581631|364497979|FG000|Overall Study|Maximum clinical benefit|1|||
105681807|NCT02581631|364497980|FG001|Overall Study|Maximum clinical benefit|7|||
105681808|NCT02581631|364497981|FG002|Overall Study|Maximum clinical benefit|1|||
105681809|NCT02581631|364497982|FG003|Overall Study|Maximum clinical benefit|3|||
105681810|NCT02581631|364497983|FG004|Overall Study|Maximum clinical benefit|13|||
105681811|NCT02581631|364497979|FG000|Overall Study|Other Reasons|1|||
105681812|NCT02581631|364497980|FG001|Overall Study|Other Reasons|0|||
105681813|NCT02581631|364497981|FG002|Overall Study|Other Reasons|2|||
105681814|NCT02581631|364497982|FG003|Overall Study|Other Reasons|2|||
105681815|NCT02581631|364497983|FG004|Overall Study|Other Reasons|3|||
105557764|NCT03561090|364039140|FG000|Overall Study|Non-Compliance With Study Drug|2|||
105681816|NCT02581631|364497979|FG000|Overall Study|Poor/Non-Compliance|0|||
105681817|NCT02581631|364497980|FG001|Overall Study|Poor/Non-Compliance|0|||
105681818|NCT02581631|364497981|FG002|Overall Study|Poor/Non-Compliance|1|||
105681819|NCT02581631|364497982|FG003|Overall Study|Poor/Non-Compliance|0|||
105681820|NCT02581631|364497983|FG004|Overall Study|Poor/Non-Compliance|0|||
105681821|NCT01191268|364497984|FG000|Overall Study|Withdrawal by Subject|19|||
105681822|NCT01191268|364497985|FG001|Overall Study|Withdrawal by Subject|25|||
105681823|NCT01191268|364497986|FG002|Overall Study|Withdrawal by Subject|21|||
105681824|NCT01191268|364497984|FG000|Overall Study|Adverse Event|21|||
105681825|NCT01191268|364497985|FG001|Overall Study|Adverse Event|13|||
105681826|NCT01191268|364497986|FG002|Overall Study|Adverse Event|8|||
105681827|NCT01191268|364497984|FG000|Overall Study|Physician Decision|6|||
105681828|NCT01191268|364497985|FG001|Overall Study|Physician Decision|8|||
105681829|NCT01191268|364497986|FG002|Overall Study|Physician Decision|9|||
105681830|NCT01191268|364497984|FG000|Overall Study|Lost to Follow-up|8|||
105681831|NCT01191268|364497985|FG001|Overall Study|Lost to Follow-up|5|||
105681832|NCT01191268|364497986|FG002|Overall Study|Lost to Follow-up|9|||
105681833|NCT01191268|364497984|FG000|Overall Study|Entry Criteria Not Met|3|||
105681834|NCT01191268|364497985|FG001|Overall Study|Entry Criteria Not Met|1|||
105681835|NCT01191268|364497986|FG002|Overall Study|Entry Criteria Not Met|1|||
105681836|NCT01191268|364497984|FG000|Overall Study|Death|0|||
105681837|NCT01191268|364497985|FG001|Overall Study|Death|1|||
105681838|NCT01191268|364497986|FG002|Overall Study|Death|3|||
105681839|NCT01191268|364497984|FG000|Overall Study|Protocol Violation|1|||
105681840|NCT01191268|364497985|FG001|Overall Study|Protocol Violation|0|||
105681841|NCT01191268|364497986|FG002|Overall Study|Protocol Violation|1|||
105681842|NCT01191268|364497984|FG000|Overall Study|Sponsor Decision|0|||
105681843|NCT01191268|364497985|FG001|Overall Study|Sponsor Decision|2|||
105681844|NCT01191268|364497986|FG002|Overall Study|Sponsor Decision|0|||
105681845|NCT02951767|364497987|FG000|Overall Study|Study Terminated By Sponsor|9|||
105681846|NCT02951767|364497987|FG000|Overall Study|Withdrawal by Subject|11|||
105681847|NCT02951767|364497987|FG000|Overall Study|Death|96|||
105681848|NCT02951767|364497987|FG000|Overall Study|Lost to Follow-up|2|||
105681849|NCT02951767|364497987|FG000|Overall Study|Physician Decision|1|||
105681850|NCT00513604|364497988|FG000|Overall Study|Not treated|2|||
105681851|NCT00513604|364497989|FG001|Overall Study|Not treated|0|||
105681852|NCT00513604|364497990|FG002|Overall Study|Not treated|1|||
105681853|NCT00513604|364497991|FG003|Overall Study|Not treated|0|||
105681854|NCT00513604|364497992|FG004|Overall Study|Not treated|0|||
105681855|NCT00513604|364497988|FG000|Overall Study|Death during treatment|0|||
105681856|NCT00513604|364497989|FG001|Overall Study|Death during treatment|3|||
105681857|NCT00513604|364497990|FG002|Overall Study|Death during treatment|2|||
105681858|NCT00513604|364497991|FG003|Overall Study|Death during treatment|0|||
105681859|NCT00513604|364497992|FG004|Overall Study|Death during treatment|0|||
105681860|NCT01242800|364498000|FG000|Overall Study|Patient refusal|0|||
105681861|NCT01242800|364498001|FG001|Overall Study|Patient refusal|10|||
105681862|NCT01242800|364498000|FG000|Overall Study|Physician Decision|0|||
105681863|NCT01242800|364498001|FG001|Overall Study|Physician Decision|1|||
105681864|NCT01242800|364498000|FG000|Overall Study|Disease progression|0|||
105681865|NCT01242800|364498001|FG001|Overall Study|Disease progression|3|||
105681866|NCT01242800|364498000|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
105681867|NCT01242800|364498001|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
105681868|NCT01242800|364498000|FG000|Overall Study|Reasons not reported|0|||
105681869|NCT01242800|364498001|FG001|Overall Study|Reasons not reported|4|||
105681870|NCT00943111|364498003|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
105681871|NCT00943111|364498004|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
105681872|NCT00943111|364498005|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
105681873|NCT00943111|364498003|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
105681874|NCT00943111|364498004|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
105681875|NCT00943111|364498005|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
105681876|NCT00943111|364498003|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
105681877|NCT00943111|364498004|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
105681878|NCT00943111|364498005|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
105681879|NCT00943111|364498003|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
105681880|NCT00943111|364498004|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
105681881|NCT00943111|364498005|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
105681882|NCT00943111|364498003|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
105681883|NCT00943111|364498004|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
105681884|NCT00943111|364498005|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
105681885|NCT00943111|364498003|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
105681886|NCT00943111|364498004|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
105681887|NCT00943111|364498005|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
105681888|NCT00943111|364498003|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
105681889|NCT00943111|364498004|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
105681890|NCT00943111|364498005|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
105681891|NCT00943111|364498003|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
105681892|NCT00943111|364498004|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
105681893|NCT00943111|364498005|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
105681894|NCT00055601|364499444|FG000|Overall Study|Protocol Violation|1|||
105681895|NCT00055601|364499445|FG001|Overall Study|Protocol Violation|1|||
105681896|NCT00055601|364499444|FG000|Overall Study|No protocol treatment received|1|||
105681897|NCT00055601|364499445|FG001|Overall Study|No protocol treatment received|1|||
105681898|NCT02680002|364499446|FG000|Overall Study|Lost to Follow-up|5|||
105681899|NCT02680002|364499447|FG001|Overall Study|Lost to Follow-up|1|||
105681900|NCT02680002|364499448|FG002|Overall Study|Lost to Follow-up|4|||
105681901|NCT02680002|364499449|FG003|Overall Study|Lost to Follow-up|2|||
105681902|NCT02680002|364499450|FG004|Overall Study|Lost to Follow-up|0|||
105681903|NCT02680002|364499451|FG005|Overall Study|Lost to Follow-up|2|||
105681904|NCT02680002|364499446|FG000|Overall Study|Physician Decision|5|||
105681905|NCT02680002|364499447|FG001|Overall Study|Physician Decision|1|||
105681906|NCT02680002|364499448|FG002|Overall Study|Physician Decision|1|||
105681907|NCT02680002|364499449|FG003|Overall Study|Physician Decision|1|||
105681908|NCT02680002|364499450|FG004|Overall Study|Physician Decision|1|||
105681909|NCT02680002|364499451|FG005|Overall Study|Physician Decision|1|||
105681910|NCT02680002|364499446|FG000|Overall Study|Protocol Violation|1|||
105681911|NCT02680002|364499447|FG001|Overall Study|Protocol Violation|0|||
105681912|NCT02680002|364499448|FG002|Overall Study|Protocol Violation|1|||
105681913|NCT02680002|364499449|FG003|Overall Study|Protocol Violation|0|||
105681914|NCT02680002|364499450|FG004|Overall Study|Protocol Violation|1|||
105681915|NCT02680002|364499451|FG005|Overall Study|Protocol Violation|2|||
105681916|NCT02680002|364499446|FG000|Overall Study|Withdrawal by Subject|0|||
105681917|NCT02680002|364499447|FG001|Overall Study|Withdrawal by Subject|0|||
105681918|NCT02680002|364499448|FG002|Overall Study|Withdrawal by Subject|1|||
105681919|NCT02680002|364499449|FG003|Overall Study|Withdrawal by Subject|0|||
105681920|NCT02680002|364499450|FG004|Overall Study|Withdrawal by Subject|2|||
105681921|NCT02680002|364499451|FG005|Overall Study|Withdrawal by Subject|2|||
105681922|NCT02680002|364499446|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
105681923|NCT02680002|364499447|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
105681924|NCT02680002|364499448|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
105681925|NCT02680002|364499449|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
105681926|NCT02680002|364499450|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
105681927|NCT02680002|364499451|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
105681928|NCT02680002|364499446|FG000|Overall Study|Other|0|||
105681929|NCT02680002|364499447|FG001|Overall Study|Other|1|||
105681930|NCT02680002|364499448|FG002|Overall Study|Other|0|||
105681931|NCT02680002|364499449|FG003|Overall Study|Other|0|||
105681932|NCT02680002|364499450|FG004|Overall Study|Other|1|||
105681933|NCT02680002|364499451|FG005|Overall Study|Other|0|||
105681934|NCT02680002|364499446|FG000|Overall Study|Adverse Event|0|||
105681935|NCT02680002|364499447|FG001|Overall Study|Adverse Event|0|||
105681936|NCT02680002|364499448|FG002|Overall Study|Adverse Event|0|||
105681937|NCT02680002|364499449|FG003|Overall Study|Adverse Event|0|||
105681938|NCT02680002|364499450|FG004|Overall Study|Adverse Event|1|||
105681939|NCT02680002|364499451|FG005|Overall Study|Adverse Event|2|||
105681940|NCT01248780|364499452|FG000|Overall Study|Lack of Efficacy|2|||
105681941|NCT01248780|364499453|FG001|Overall Study|Lack of Efficacy|0|||
105681942|NCT01248780|364499452|FG000|Overall Study|Lost to Follow-up|0|||
105681943|NCT01248780|364499453|FG001|Overall Study|Lost to Follow-up|1|||
105681944|NCT01248780|364499452|FG000|Overall Study|Death|0|||
105681945|NCT01248780|364499453|FG001|Overall Study|Death|1|||
105681946|NCT01248780|364499452|FG000|Overall Study|Adverse Event|2|||
105681947|NCT01248780|364499453|FG001|Overall Study|Adverse Event|7|||
105681948|NCT01248780|364499452|FG000|Overall Study|Protocol Violation|1|||
105681949|NCT01248780|364499453|FG001|Overall Study|Protocol Violation|1|||
105681950|NCT01248780|364499452|FG000|Overall Study|Withdrawal by Subject|4|||
105681951|NCT01248780|364499453|FG001|Overall Study|Withdrawal by Subject|4|||
105681952|NCT01248780|364499452|FG000|Overall Study|Not treated|0|||
105681953|NCT01248780|364499453|FG001|Overall Study|Not treated|1|||
105681954|NCT04097301|364499454|FG000|Overall Study|Death|1|||
105681955|NCT04097301|364499454|FG000|Overall Study|Withdrawal by Subject|1|||
105681956|NCT04097301|364499454|FG000|Overall Study|Screening Failure|5|||
105681957|NCT03241225|364499455|FG000|Overall Study|Lost to Follow-up|2|||
105681958|NCT03241225|364499456|FG001|Overall Study|Lost to Follow-up|1|||
105681959|NCT03241225|364499455|FG000|Overall Study|Protocol Violation|4|||
105681960|NCT03241225|364499456|FG001|Overall Study|Protocol Violation|1|||
105681961|NCT03241225|364499455|FG000|Overall Study|Withdrawal by Subject|1|||
105681962|NCT03241225|364499456|FG001|Overall Study|Withdrawal by Subject|0|||
105681963|NCT01813929|364499457|FG000|Overall Study|Withdrawal by Subject|0|||
105681964|NCT01813929|364499458|FG001|Overall Study|Withdrawal by Subject|1|||
105681965|NCT02074553|364499459|FG000|Intervention Period 1|Family Emergency|0|||
105681966|NCT02074553|364499460|FG001|Intervention Period 1|Family Emergency|0|||
105681967|NCT02074553|364499461|FG002|Intervention Period 1|Family Emergency|0|||
105681968|NCT02074553|364499462|FG003|Intervention Period 1|Family Emergency|1|||
105681969|NCT02074553|364499463|FG004|Intervention Period 1|Family Emergency|0|||
105681970|NCT02074553|364499464|FG005|Intervention Period 1|Family Emergency|0|||
105681971|NCT02074553|364499465|FG006|Intervention Period 1|Family Emergency|0|||
105681972|NCT02074553|364499466|FG007|Intervention Period 1|Family Emergency|0|||
105681973|NCT02074553|364499459|FG000|Washout Period 1|Adverse Event|1|||
105681974|NCT02074553|364499460|FG001|Washout Period 1|Adverse Event|0|||
105681975|NCT02074553|364499461|FG002|Washout Period 1|Adverse Event|0|||
105681976|NCT02074553|364499462|FG003|Washout Period 1|Adverse Event|0|||
105681977|NCT02074553|364499463|FG004|Washout Period 1|Adverse Event|0|||
105681978|NCT02074553|364499464|FG005|Washout Period 1|Adverse Event|0|||
105681979|NCT02074553|364499465|FG006|Washout Period 1|Adverse Event|0|||
105681980|NCT02074553|364499466|FG007|Washout Period 1|Adverse Event|0|||
105681981|NCT02074553|364499459|FG000|Washout Period 1|Physician Decision|0|||
105681982|NCT02074553|364499460|FG001|Washout Period 1|Physician Decision|0|||
105681983|NCT02074553|364499461|FG002|Washout Period 1|Physician Decision|0|||
105681984|NCT02074553|364499462|FG003|Washout Period 1|Physician Decision|1|||
105681985|NCT02074553|364499463|FG004|Washout Period 1|Physician Decision|0|||
105681986|NCT02074553|364499464|FG005|Washout Period 1|Physician Decision|0|||
105681987|NCT02074553|364499465|FG006|Washout Period 1|Physician Decision|0|||
105681988|NCT02074553|364499466|FG007|Washout Period 1|Physician Decision|0|||
105681989|NCT02074553|364499459|FG000|Washout Period 1|Other|0|||
105681990|NCT02074553|364499460|FG001|Washout Period 1|Other|0|||
105681991|NCT02074553|364499461|FG002|Washout Period 1|Other|0|||
105681992|NCT02074553|364499462|FG003|Washout Period 1|Other|0|||
105681993|NCT02074553|364499463|FG004|Washout Period 1|Other|0|||
105681994|NCT02074553|364499464|FG005|Washout Period 1|Other|1|||
105681995|NCT02074553|364499465|FG006|Washout Period 1|Other|0|||
105681996|NCT02074553|364499466|FG007|Washout Period 1|Other|0|||
105681997|NCT02074553|364499459|FG000|Washout Period 2|Adverse Event|0|||
105681998|NCT02074553|364499460|FG001|Washout Period 2|Adverse Event|0|||
105681999|NCT02074553|364499461|FG002|Washout Period 2|Adverse Event|0|||
105682000|NCT02074553|364499462|FG003|Washout Period 2|Adverse Event|0|||
105682001|NCT02074553|364499463|FG004|Washout Period 2|Adverse Event|0|||
105682002|NCT02074553|364499464|FG005|Washout Period 2|Adverse Event|0|||
105682003|NCT02074553|364499465|FG006|Washout Period 2|Adverse Event|1|||
105682004|NCT02074553|364499466|FG007|Washout Period 2|Adverse Event|0|||
105682005|NCT02074553|364499459|FG000|Washout Period 2|Physician Decision|0|||
105682006|NCT02074553|364499460|FG001|Washout Period 2|Physician Decision|0|||
105682007|NCT02074553|364499461|FG002|Washout Period 2|Physician Decision|0|||
105682008|NCT02074553|364499462|FG003|Washout Period 2|Physician Decision|0|||
105344456|NCT03191864|363261795|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
105344457|NCT03191864|363261790|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
105557765|NCT03561090|364039141|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105557766|NCT03561090|364039140|FG000|Overall Study|Protocol Violation|2|||
105557767|NCT03561090|364039141|FG001|Overall Study|Protocol Violation|2|||
105557768|NCT03561090|364039140|FG000|Overall Study|Withdrawal by Subject|7|||
105557769|NCT03561090|364039141|FG001|Overall Study|Withdrawal by Subject|7|||
105557770|NCT03561090|364039140|FG000|Overall Study|Lost to Follow-up|7|||
105557771|NCT03561090|364039141|FG001|Overall Study|Lost to Follow-up|2|||
105557772|NCT03561090|364039140|FG000|Overall Study|Study Terminated by Sponsor|10|||
105557773|NCT03561090|364039141|FG001|Overall Study|Study Terminated by Sponsor|15|||
105557774|NCT03561090|364039140|FG000|Overall Study|Randomized by Mistake|1|||
105557775|NCT03561090|364039141|FG001|Overall Study|Randomized by Mistake|1|||
105557776|NCT03561090|364039140|FG000|Overall Study|Other Not Specified|0|||
105557777|NCT03561090|364039141|FG001|Overall Study|Other Not Specified|2|||
105557778|NCT04162769|364039148|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
105557779|NCT04162769|364039149|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
105557780|NCT04162769|364039150|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
105557781|NCT04162769|364039151|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
105557782|NCT04162769|364039148|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
105557783|NCT04162769|364039149|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
105557784|NCT04162769|364039150|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
105557785|NCT04162769|364039151|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
105557786|NCT04162769|364039148|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
105557787|NCT04162769|364039149|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
105557788|NCT04162769|364039150|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
105557789|NCT04162769|364039151|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
105557790|NCT04162769|364039148|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
105557791|NCT04162769|364039149|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
105557792|NCT04162769|364039150|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
105557793|NCT04162769|364039151|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
105557794|NCT04162769|364039148|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
105557795|NCT04162769|364039149|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
105557796|NCT04162769|364039150|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
105557797|NCT04162769|364039151|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
105557798|NCT04162769|364039148|FG000|Double-blind Treatment (12-Week)|Other|0|||
105557799|NCT04162769|364039149|FG001|Double-blind Treatment (12-Week)|Other|1|||
105557800|NCT04162769|364039150|FG002|Double-blind Treatment (12-Week)|Other|1|||
105557801|NCT04162769|364039151|FG003|Double-blind Treatment (12-Week)|Other|0|||
105557802|NCT04162769|364039148|FG000|OLE Period (52-Week)|Adverse Event|0|||
105557803|NCT04162769|364039149|FG001|OLE Period (52-Week)|Adverse Event|0|||
105557804|NCT04162769|364039150|FG002|OLE Period (52-Week)|Adverse Event|0|||
105557805|NCT04162769|364039151|FG003|OLE Period (52-Week)|Adverse Event|5|||
105557806|NCT04162769|364039148|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
105557807|NCT04162769|364039149|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
105557808|NCT04162769|364039150|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
105557809|NCT04162769|364039151|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
105557810|NCT04162769|364039148|FG000|OLE Period (52-Week)|Physician Decision|0|||
105557811|NCT04162769|364039149|FG001|OLE Period (52-Week)|Physician Decision|0|||
105557812|NCT04162769|364039150|FG002|OLE Period (52-Week)|Physician Decision|0|||
105557813|NCT04162769|364039151|FG003|OLE Period (52-Week)|Physician Decision|1|||
105557814|NCT04162769|364039148|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
105557815|NCT04162769|364039149|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
105557816|NCT04162769|364039150|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
105682009|NCT02074553|364499463|FG004|Washout Period 2|Physician Decision|0|||
105682010|NCT02074553|364499464|FG005|Washout Period 2|Physician Decision|1|||
105557817|NCT04162769|364039151|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
105557818|NCT04162769|364039148|FG000|OLE Period (52-Week)|Protocol deviation|0|||
105557819|NCT04162769|364039149|FG001|OLE Period (52-Week)|Protocol deviation|0|||
105557820|NCT04162769|364039150|FG002|OLE Period (52-Week)|Protocol deviation|0|||
105557821|NCT04162769|364039151|FG003|OLE Period (52-Week)|Protocol deviation|2|||
105557822|NCT02163733|364039152|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
105557823|NCT02163733|364039153|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
105682011|NCT02074553|364499465|FG006|Washout Period 2|Physician Decision|0|||
105682012|NCT02074553|364499466|FG007|Washout Period 2|Physician Decision|0|||
105682013|NCT02074553|364499459|FG000|Washout Period 2|Lost to Follow-up|0|||
105682014|NCT02074553|364499460|FG001|Washout Period 2|Lost to Follow-up|0|||
105682015|NCT02074553|364499461|FG002|Washout Period 2|Lost to Follow-up|1|||
105682016|NCT02074553|364499462|FG003|Washout Period 2|Lost to Follow-up|0|||
105682017|NCT02074553|364499463|FG004|Washout Period 2|Lost to Follow-up|0|||
105682018|NCT02074553|364499464|FG005|Washout Period 2|Lost to Follow-up|0|||
105682019|NCT02074553|364499465|FG006|Washout Period 2|Lost to Follow-up|0|||
105682020|NCT02074553|364499466|FG007|Washout Period 2|Lost to Follow-up|0|||
105682021|NCT02074553|364499459|FG000|Washout Period 3|Physician Decision|0|||
105682022|NCT02074553|364499460|FG001|Washout Period 3|Physician Decision|0|||
105682023|NCT02074553|364499461|FG002|Washout Period 3|Physician Decision|0|||
105682024|NCT02074553|364499462|FG003|Washout Period 3|Physician Decision|0|||
105682025|NCT02074553|364499463|FG004|Washout Period 3|Physician Decision|0|||
105682026|NCT02074553|364499464|FG005|Washout Period 3|Physician Decision|0|||
105682027|NCT02074553|364499465|FG006|Washout Period 3|Physician Decision|0|||
105682028|NCT02074553|364499466|FG007|Washout Period 3|Physician Decision|1|||
105682029|NCT01664598|364499467|FG000|Overall Study|Sponsor Decision|1|||
105682030|NCT01664598|364499467|FG000|Overall Study|Withdrawal of Informed Consent|4|||
105682031|NCT01664598|364499467|FG000|Overall Study|Adverse Event|1|||
105682032|NCT04187989|364499468|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
105682033|NCT04187989|364499469|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
105682034|NCT04187989|364499468|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
105682035|NCT04187989|364499469|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
105682036|NCT04882995|364499477|FG000|Overall Study|Withdrawal by Subject|1|||
105682037|NCT04882995|364499478|FG001|Overall Study|Withdrawal by Subject|2|||
105682038|NCT04882995|364499477|FG000|Overall Study|Protocol Violation|4|||
105682039|NCT04882995|364499478|FG001|Overall Study|Protocol Violation|4|||
105682040|NCT04882995|364499477|FG000|Overall Study|Surgery postponed due to COVID|1|||
105682041|NCT04882995|364499478|FG001|Overall Study|Surgery postponed due to COVID|1|||
105682042|NCT00461032|364499479|FG000|Overall Study|Adverse Event|5|||
105682043|NCT00461032|364499480|FG001|Overall Study|Adverse Event|6|||
105682044|NCT00461032|364499479|FG000|Overall Study|Lack of Efficacy|5|||
105682045|NCT00461032|364499480|FG001|Overall Study|Lack of Efficacy|1|||
105682046|NCT00461032|364499479|FG000|Overall Study|Lost to Follow-up|7|||
105682047|NCT00461032|364499480|FG001|Overall Study|Lost to Follow-up|12|||
105682048|NCT00461032|364499479|FG000|Overall Study|Protocol Violation|4|||
105682049|NCT00461032|364499480|FG001|Overall Study|Protocol Violation|4|||
105682050|NCT00461032|364499479|FG000|Overall Study|Withdrawal by Subject|7|||
105682051|NCT00461032|364499480|FG001|Overall Study|Withdrawal by Subject|15|||
105682052|NCT00461032|364499479|FG000|Overall Study|Patient Moved or Relocated|2|||
105682053|NCT00461032|364499480|FG001|Overall Study|Patient Moved or Relocated|1|||
105682054|NCT00461032|364499479|FG000|Overall Study|Other|7|||
105682055|NCT00461032|364499480|FG001|Overall Study|Other|5|||
105682056|NCT04447846|364499481|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
105682057|NCT03536143|364499482|FG000|Overall Study|Early termination, Sponsor decision|1|||
105682058|NCT01878214|364499483|FG000|Overall Study|Withdrawal by Subject|18|||
105682059|NCT01878214|364499484|FG001|Overall Study|Withdrawal by Subject|7|||
105682060|NCT01878214|364499483|FG000|Overall Study|Death|0|||
105682061|NCT01878214|364499484|FG001|Overall Study|Death|1|||
105682062|NCT01878214|364499483|FG000|Overall Study|Lost to Follow-up|35|||
105682063|NCT01878214|364499484|FG001|Overall Study|Lost to Follow-up|36|||
105682064|NCT02057523|364499487|FG000|Overall Study|Withdrawal by Subject|1|||
105682065|NCT02057523|364499487|FG000|Overall Study|Lack of Efficacy|1|||
105682066|NCT02783768|364499491|FG000|Overall Study|Lost to Follow-up|1|||
105682067|NCT02783768|364499492|FG001|Overall Study|Lost to Follow-up|0|||
105682068|NCT02344004|364499493|FG000|Overall Study|Adverse Event|11|||
105682069|NCT02344004|364499494|FG001|Overall Study|Adverse Event|1|||
105682070|NCT02344004|364499493|FG000|Overall Study|Death|9|||
105682071|NCT02344004|364499494|FG001|Overall Study|Death|7|||
105682072|NCT02344004|364499493|FG000|Overall Study|Physician Decision|4|||
105682073|NCT02344004|364499494|FG001|Overall Study|Physician Decision|1|||
105682074|NCT02344004|364499493|FG000|Overall Study|Withdrawal by Subject|22|||
105682075|NCT02344004|364499494|FG001|Overall Study|Withdrawal by Subject|5|||
105682076|NCT02344004|364499493|FG000|Overall Study|Rescue Medication|2|||
105682077|NCT02344004|364499494|FG001|Overall Study|Rescue Medication|0|||
105682078|NCT02344004|364499493|FG000|Overall Study|Other Not Specified|12|||
105682079|NCT02344004|364499494|FG001|Overall Study|Other Not Specified|0|||
105682080|NCT02344004|364499493|FG000|Overall Study|Protocol Violation|1|||
105682081|NCT02344004|364499494|FG001|Overall Study|Protocol Violation|0|||
105682082|NCT02924064|364499495|FG000|Overall Study|Adverse Event|2|||
105682083|NCT02924064|364499496|FG001|Overall Study|Adverse Event|2|||
105682084|NCT02924064|364499495|FG000|Overall Study|Lost to Follow-up|0|||
105682085|NCT02924064|364499496|FG001|Overall Study|Lost to Follow-up|2|||
105682086|NCT02924064|364499495|FG000|Overall Study|Physician Decision|0|||
105682087|NCT02924064|364499496|FG001|Overall Study|Physician Decision|2|||
105682088|NCT02924064|364499495|FG000|Overall Study|Protocol Violation|1|||
105682089|NCT02924064|364499496|FG001|Overall Study|Protocol Violation|3|||
105682090|NCT02924064|364499495|FG000|Overall Study|Withdrawal by Subject|4|||
105682091|NCT02924064|364499496|FG001|Overall Study|Withdrawal by Subject|5|||
105682092|NCT02924064|364499495|FG000|Overall Study|Other|17|||
105682093|NCT02924064|364499496|FG001|Overall Study|Other|29|||
105682094|NCT01502631|364499497|FG000|Overall Study|Adverse Event|5|||
105682095|NCT01502631|364499498|FG001|Overall Study|Adverse Event|8|||
105682096|NCT01502631|364499497|FG000|Overall Study|Lost to Follow-up|2|||
105682097|NCT01502631|364499498|FG001|Overall Study|Lost to Follow-up|2|||
105682098|NCT01502631|364499497|FG000|Overall Study|Participant withdrew consent|2|||
105682099|NCT01502631|364499498|FG001|Overall Study|Participant withdrew consent|4|||
105682100|NCT01502631|364499497|FG000|Overall Study|Participant non-compliant|1|||
105682101|NCT01502631|364499498|FG001|Overall Study|Participant non-compliant|0|||
105682102|NCT01502631|364499497|FG000|Overall Study|Investigator's decision|0|||
105682103|NCT01502631|364499498|FG001|Overall Study|Investigator's decision|1|||
105682104|NCT01502631|364499497|FG000|Overall Study|Other|10|||
105682105|NCT01502631|364499498|FG001|Overall Study|Other|5|||
105682106|NCT01945060|364499499|FG000|Overall Study|Lost to follow up|1|||
105682107|NCT01945060|364499500|FG001|Overall Study|Lost to follow up|0|||
105682108|NCT01945060|364499499|FG000|Overall Study|Distress related to IV access|0|||
105682109|NCT01945060|364499500|FG001|Overall Study|Distress related to IV access|1|||
105682110|NCT00966277|364499501|FG000|Overall Study|Withdrawal by Subject|3|||
105682111|NCT00966277|364499502|FG001|Overall Study|Withdrawal by Subject|0|||
105682112|NCT00966277|364499501|FG000|Overall Study|Ineligible|1|||
105682113|NCT00966277|364499502|FG001|Overall Study|Ineligible|3|||
105682114|NCT00966277|364499501|FG000|Overall Study|Treatment Plan Changed|0|||
105682115|NCT00966277|364499502|FG001|Overall Study|Treatment Plan Changed|1|||
105682116|NCT00819390|364499509|FG000|Overall Study|Lost to Follow-up|1|||
105682117|NCT00819390|364499510|FG001|Overall Study|Lost to Follow-up|1|||
105682118|NCT00819390|364499511|FG002|Overall Study|Lost to Follow-up|0|||
105682119|NCT00819390|364499512|FG003|Overall Study|Lost to Follow-up|0|||
105682120|NCT00819390|364499509|FG000|Overall Study|Withdrawal by Subject|2|||
105682121|NCT00819390|364499510|FG001|Overall Study|Withdrawal by Subject|0|||
105682122|NCT00819390|364499511|FG002|Overall Study|Withdrawal by Subject|0|||
105682123|NCT00819390|364499512|FG003|Overall Study|Withdrawal by Subject|0|||
105682124|NCT00819390|364499509|FG000|Overall Study|Adverse Event|0|||
105682125|NCT00819390|364499510|FG001|Overall Study|Adverse Event|0|||
105682126|NCT00819390|364499511|FG002|Overall Study|Adverse Event|1|||
105682127|NCT00819390|364499512|FG003|Overall Study|Adverse Event|0|||
105682128|NCT00998335|364499515|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
105682129|NCT00998335|364499516|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
105682130|NCT03169101|364499517|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
105682131|NCT03169101|364499518|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
105682132|NCT03169101|364499519|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
105682133|NCT03169101|364499520|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
105682134|NCT02641496|364499521|FG000|Overall Study|Lost to Follow-up|13|||
105682135|NCT02641496|364499522|FG001|Overall Study|Lost to Follow-up|12|||
105682136|NCT02641496|364499521|FG000|Overall Study|Withdrawal by Subject|1|||
105682137|NCT02641496|364499522|FG001|Overall Study|Withdrawal by Subject|0|||
105682138|NCT01204398|364499525|FG000|Overall Study|Adverse Event|1|||
105682139|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
105682140|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
105682141|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
105682142|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
105682143|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
105682144|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
105682145|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
105682146|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
105682147|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
105682148|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
105682149|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
105682150|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
105682151|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
105682152|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
105682153|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
105682154|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
105682155|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
105682156|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
105682157|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
105682158|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
105682159|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
105682160|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
105682161|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
105682162|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
105682163|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
105682164|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
105682165|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
105682166|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
105682167|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Death|1|||
105682168|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Death|1|||
105682169|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
105682170|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
105682171|NCT00600886|364499526|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
105682172|NCT00600886|364499527|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
105682173|NCT00600886|364499526|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
105682174|NCT00600886|364499527|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
105682175|NCT00600886|364499526|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
105682176|NCT00600886|364499527|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
105786486|NCT01207219|364871407|FG002|Overall Study|changed diagnosis during study period|1|||
105786487|NCT01207219|364871405|FG000|Overall Study|Lost to Follow-up|6|||
105786488|NCT01207219|364871406|FG001|Overall Study|Lost to Follow-up|8|||
105786489|NCT01207219|364871407|FG002|Overall Study|Lost to Follow-up|6|||
105786490|NCT04629534|364871414|FG000|Overall Study|Physician Decision|1|||
105786491|NCT04629534|364871415|FG001|Overall Study|Physician Decision|0|||
105682177|NCT00600886|364499526|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
105682178|NCT00600886|364499527|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
105682179|NCT00600886|364499526|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
105682180|NCT00600886|364499527|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
105682181|NCT00600886|364499526|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
105682182|NCT00600886|364499527|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
105682183|NCT00600886|364499526|FG000|Extension - After Crossover (CAS)|Death|1|||
105682184|NCT00600886|364499527|FG001|Extension - After Crossover (CAS)|Death|0|||
105682185|NCT01575028|364499528|FG000|Overall Study|Physician Decision|0|||
105682186|NCT01575028|364499529|FG001|Overall Study|Physician Decision|1|||
105682187|NCT01182194|364499531|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
105682188|NCT01182194|364499532|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
105682189|NCT02533570|364499538|FG000|Overall Study|Adverse Event|0|||
105682190|NCT02533570|364499539|FG001|Overall Study|Adverse Event|1|||
105682191|NCT02533570|364499540|FG002|Overall Study|Adverse Event|1|||
105682192|NCT05330312|364499542|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
105682193|NCT05330312|364499543|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
105682194|NCT05330312|364499544|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
105682195|NCT05330312|364499542|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
105682196|NCT05330312|364499543|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
105682197|NCT05330312|364499544|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
105682198|NCT05330312|364499542|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
105682199|NCT05330312|364499543|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
105682200|NCT05330312|364499544|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
105682201|NCT05330312|364499542|FG000|Pivotal Investigation - Part 2|Death|1|||
105682202|NCT05330312|364499543|FG001|Pivotal Investigation - Part 2|Death|4|||
105682203|NCT05330312|364499544|FG002|Pivotal Investigation - Part 2|Death|0|||
105682204|NCT03534284|364499545|FG000|Overall Study|Death|2|||
105682205|NCT03534284|364499546|FG001|Overall Study|Death|3|||
105682206|NCT03534284|364499547|FG002|Overall Study|Death|3|||
105682207|NCT03534284|364499545|FG000|Overall Study|Withdrawal by Subject|5|||
105682208|NCT03534284|364499546|FG001|Overall Study|Withdrawal by Subject|0|||
105682209|NCT03534284|364499547|FG002|Overall Study|Withdrawal by Subject|0|||
105682210|NCT03705832|364499550|FG000|Overall Study|Physician Decision|0|||
105786492|NCT04629534|364871414|FG000|Overall Study|Protocol Violation|0|||
105786493|NCT04629534|364871415|FG001|Overall Study|Protocol Violation|2|||
105682211|NCT03705832|364499551|FG001|Overall Study|Physician Decision|1|||
105682212|NCT03705832|364499550|FG000|Overall Study|Withdrawal by Subject|1|||
105682213|NCT03705832|364499551|FG001|Overall Study|Withdrawal by Subject|0|||
105786494|NCT04585906|364871422|FG000|Overall Study|Lost to Follow-up|8|||
105786495|NCT04585906|364871423|FG001|Overall Study|Lost to Follow-up|5|||
105682214|NCT01050790|364499552|FG000|Overall Study|Adverse Event|1|||
105682215|NCT02502799|364501263|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
105682216|NCT02502799|364501264|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
105682217|NCT02502799|364501265|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
105682218|NCT02502799|364501266|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
105682219|NCT02502799|364501263|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
105682220|NCT02502799|364501264|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
105682221|NCT02502799|364501265|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
105682222|NCT02502799|364501266|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
105682223|NCT02502799|364501263|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
105682224|NCT02502799|364501264|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
105682225|NCT02502799|364501265|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
105682226|NCT02502799|364501266|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
105682227|NCT02502799|364501263|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
105682228|NCT02502799|364501264|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
105682229|NCT02502799|364501265|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
105682230|NCT02502799|364501266|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
105682231|NCT02502799|364501263|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
105682232|NCT02502799|364501264|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
105682233|NCT02502799|364501265|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
105682234|NCT02502799|364501266|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
105682235|NCT00031551|364501267|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
105682236|NCT00031551|364501268|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
105682237|NCT00189488|364501271|FG000|Overall Study|Ineligibility determined|1|||
105682238|NCT00189488|364501272|FG001|Overall Study|Ineligibility determined|0|||
105344458|NCT03191864|363261791|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
105344459|NCT03191864|363261792|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
105344460|NCT03191864|363261793|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
105344461|NCT03191864|363261794|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
105344462|NCT03191864|363261795|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
105344463|NCT03191864|363261790|FG000|Baseline Symptom Assessment|Adverse Event|0|||
105682239|NCT00189488|364501271|FG000|Overall Study|Protocol deviation|2|||
105682240|NCT00189488|364501272|FG001|Overall Study|Protocol deviation|1|||
105682241|NCT00189488|364501271|FG000|Overall Study|Adverse Event|2|||
105682242|NCT00189488|364501272|FG001|Overall Study|Adverse Event|1|||
105682243|NCT00189488|364501271|FG000|Overall Study|Withdrawal by Subject|2|||
105682244|NCT00189488|364501272|FG001|Overall Study|Withdrawal by Subject|6|||
105682245|NCT00189488|364501271|FG000|Overall Study|Disease progression|2|||
105682246|NCT00189488|364501272|FG001|Overall Study|Disease progression|4|||
105682247|NCT00189488|364501271|FG000|Overall Study|Administrative Decision|0|||
105682248|NCT00189488|364501272|FG001|Overall Study|Administrative Decision|2|||
105682249|NCT00189488|364501271|FG000|Overall Study|Death|5|||
105682250|NCT00189488|364501272|FG001|Overall Study|Death|8|||
105682251|NCT00189488|364501271|FG000|Overall Study|Other|1|||
105682252|NCT00189488|364501272|FG001|Overall Study|Other|0|||
105682253|NCT03527173|364501274|FG000|Overall Study|Lost to Follow-up|4|||
105682254|NCT03527173|364501275|FG001|Overall Study|Lost to Follow-up|2|||
105682255|NCT03527173|364501274|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
105682256|NCT03527173|364501275|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
105682257|NCT03527173|364501274|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
105682258|NCT03527173|364501275|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
105682259|NCT03527173|364501274|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
105682260|NCT03527173|364501275|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105682261|NCT02342743|364501288|FG000|Baseline Period|Withdrawal by Subject|3|||
105682262|NCT02342743|364501288|FG000|Baseline Period|Lost to Follow-up|2|||
105682263|NCT02342743|364501288|FG000|Baseline Period|Change in prophylactic medication|3|||
105682264|NCT02342743|364501288|FG000|Baseline Period|Screening failure regarding baseline|7|||
105682265|NCT02342743|364501288|FG000|Treatment Period|Withdrawal by Subject|2|||
105682266|NCT02342743|364501288|FG000|Treatment Period|Lost to Follow-up|8|||
105682267|NCT02342743|364501288|FG000|Treatment Period|Change in prophylactic medication|1|||
105682268|NCT00686725|364501289|FG000|Overall Study|Adverse Event|1|||
105682269|NCT00686725|364501290|FG001|Overall Study|Adverse Event|1|||
105682270|NCT00686725|364501289|FG000|Overall Study|Progressive Disease|17|||
105682271|NCT00686725|364501290|FG001|Overall Study|Progressive Disease|23|||
105682272|NCT00686725|364501289|FG000|Overall Study|Lost to Follow-up|7|||
105682273|NCT00686725|364501290|FG001|Overall Study|Lost to Follow-up|5|||
105682274|NCT00686725|364501289|FG000|Overall Study|Death|6|||
105682275|NCT00686725|364501290|FG001|Overall Study|Death|3|||
105682276|NCT00686725|364501289|FG000|Overall Study|Withdrawal by Subject|13|||
105682277|NCT00686725|364501290|FG001|Overall Study|Withdrawal by Subject|4|||
105682278|NCT00686725|364501289|FG000|Overall Study|Protocol Violation|1|||
105682279|NCT00686725|364501290|FG001|Overall Study|Protocol Violation|3|||
105682280|NCT00686725|364501289|FG000|Overall Study|Other|1|||
105682281|NCT00686725|364501290|FG001|Overall Study|Other|3|||
105682282|NCT03064035|364501293|FG000|Overall Study|Did not receive allocated intervention|4|||
105682283|NCT03064035|364501294|FG001|Overall Study|Did not receive allocated intervention|2|||
105682284|NCT03064035|364501293|FG000|Overall Study|Lost to Follow-up|1|||
105682285|NCT03064035|364501294|FG001|Overall Study|Lost to Follow-up|1|||
105682286|NCT03646656|364501295|FG000|Overall Study|Lost to Follow-up|1|||
105682287|NCT03646656|364501296|FG001|Overall Study|Lost to Follow-up|0|||
105682288|NCT03646656|364501295|FG000|Overall Study|Withdrawal by Subject|2|||
105682289|NCT03646656|364501296|FG001|Overall Study|Withdrawal by Subject|0|||
105682290|NCT03103763|364501303|FG000|Overall Study|Death|15|||
105682291|NCT03103763|364501304|FG001|Overall Study|Death|5|||
105682292|NCT03103763|364501305|FG002|Overall Study|Death|5|||
105682293|NCT03103763|364501303|FG000|Overall Study|Withdrawal by Subject|0|||
105682294|NCT03103763|364501304|FG001|Overall Study|Withdrawal by Subject|3|||
105682295|NCT03103763|364501305|FG002|Overall Study|Withdrawal by Subject|2|||
105682296|NCT01143038|364501306|FG000|Overall Study|Withdrawal by Subject|4|||
105682297|NCT01143038|364501306|FG000|Overall Study|Requirement for alternative therapy|5|||
105682298|NCT01143038|364501306|FG000|Overall Study|Adverse Event|3|||
105682299|NCT01143038|364501306|FG000|Overall Study|Lost to Follow-up|2|||
105682300|NCT01143038|364501306|FG000|Overall Study|Protocol Deviation|1|||
105682301|NCT01143038|364501306|FG000|Overall Study|Death|1|||
105682302|NCT00618982|364501307|FG000|Overall Study|Adverse Event|23|||
105682303|NCT00618982|364501307|FG000|Overall Study|Withdrawal by Subject|1|||
105682304|NCT00618982|364501307|FG000|Overall Study|Protocol Violation|1|||
105682305|NCT00618982|364501307|FG000|Overall Study|ongoing, still treated with study med.|25|||
105682306|NCT01236365|364501308|FG000|Overall Study|Lost to Follow-up|0|||
105682307|NCT01236365|364501309|FG001|Overall Study|Lost to Follow-up|2|||
105682308|NCT01236365|364501308|FG000|Overall Study|Moved Out of State|1|||
105682309|NCT01236365|364501309|FG001|Overall Study|Moved Out of State|0|||
105682310|NCT01236365|364501308|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
105682311|NCT01236365|364501309|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
105682312|NCT00799513|364501310|FG000|Overall Study|Physician Decision|1|||
105682313|NCT00799513|364501310|FG000|Overall Study|Adverse Event|1|||
105682314|NCT01248065|364501313|FG000|Overall Study|Lost to Follow-up|3|||
105682315|NCT01248065|364501314|FG001|Overall Study|Lost to Follow-up|5|||
105682316|NCT01248065|364501313|FG000|Overall Study|Withdrawal by Subject|14|||
105682317|NCT01248065|364501314|FG001|Overall Study|Withdrawal by Subject|11|||
105682318|NCT01248065|364501313|FG000|Overall Study|Adverse Event|3|||
105682319|NCT01248065|364501314|FG001|Overall Study|Adverse Event|0|||
105468756|NCT00345358|363725972|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
105468757|NCT02304367|363725973|FG000|Overall Study|Lack of Response to Bruosumab|1|||
105468758|NCT02304367|363725973|FG000|Overall Study|Sponsor Decision|3|||
105468759|NCT02304367|363725973|FG000|Overall Study|Death|2|||
105468760|NCT02304367|363725973|FG000|Overall Study|Physician Decision|1|||
105468761|NCT02304367|363725973|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
105468762|NCT03599089|363725974|FG000|Overall Study|Lost to Follow-up|1|||
105468763|NCT03599089|363725975|FG001|Overall Study|Lost to Follow-up|0|||
105682320|NCT01248065|364501313|FG000|Overall Study|Third treatment failure event|3|||
105682321|NCT01248065|364501314|FG001|Overall Study|Third treatment failure event|1|||
105682322|NCT01248065|364501313|FG000|Overall Study|Other|3|||
105682323|NCT01248065|364501314|FG001|Overall Study|Other|5|||
105682324|NCT03271021|364501316|FG000|Overall Study|Adverse Event|3|||
105682325|NCT03271021|364501317|FG001|Overall Study|Adverse Event|2|||
105682326|NCT03271021|364501316|FG000|Overall Study|Withdrawal by Subject|36|||
105682327|NCT03271021|364501317|FG001|Overall Study|Withdrawal by Subject|53|||
105682328|NCT03271021|364501316|FG000|Overall Study|Lost to Follow-up|34|||
105682329|NCT03271021|364501317|FG001|Overall Study|Lost to Follow-up|39|||
105682330|NCT03271021|364501316|FG000|Overall Study|Protocol Violation|6|||
105682331|NCT03271021|364501317|FG001|Overall Study|Protocol Violation|4|||
105682332|NCT03271021|364501316|FG000|Overall Study|Abnormal Lab Results|1|||
105682333|NCT03271021|364501317|FG001|Overall Study|Abnormal Lab Results|0|||
105682334|NCT03271021|364501316|FG000|Overall Study|Miscellaneous|9|||
105468764|NCT03599089|363725976|FG002|Overall Study|Lost to Follow-up|0|||
105468765|NCT03599089|363725977|FG003|Overall Study|Lost to Follow-up|0|||
105682335|NCT03271021|364501317|FG001|Overall Study|Miscellaneous|8|||
105682336|NCT03010176|364501320|FG000|Overall Study|Death|21|||
105682337|NCT03010176|364501321|FG001|Overall Study|Death|35|||
105682338|NCT03010176|364501322|FG002|Overall Study|Death|19|||
105682339|NCT03010176|364501323|FG003|Overall Study|Death|19|||
105682340|NCT03010176|364501324|FG004|Overall Study|Death|14|||
105682341|NCT03010176|364501325|FG005|Overall Study|Death|0|||
105682342|NCT03010176|364501320|FG000|Overall Study|Lost to Follow-up|0|||
105682343|NCT03010176|364501321|FG001|Overall Study|Lost to Follow-up|0|||
105682344|NCT03010176|364501322|FG002|Overall Study|Lost to Follow-up|0|||
105682345|NCT03010176|364501323|FG003|Overall Study|Lost to Follow-up|0|||
105682346|NCT03010176|364501324|FG004|Overall Study|Lost to Follow-up|1|||
105682347|NCT03010176|364501325|FG005|Overall Study|Lost to Follow-up|0|||
105682348|NCT03010176|364501320|FG000|Overall Study|Physician Decision|0|||
105682349|NCT03010176|364501321|FG001|Overall Study|Physician Decision|4|||
105682350|NCT03010176|364501322|FG002|Overall Study|Physician Decision|0|||
105682351|NCT03010176|364501323|FG003|Overall Study|Physician Decision|1|||
105682352|NCT03010176|364501324|FG004|Overall Study|Physician Decision|0|||
105682353|NCT03010176|364501325|FG005|Overall Study|Physician Decision|0|||
105682354|NCT03010176|364501320|FG000|Overall Study|Sponsor Decision|0|||
105682355|NCT03010176|364501321|FG001|Overall Study|Sponsor Decision|4|||
105682356|NCT03010176|364501322|FG002|Overall Study|Sponsor Decision|4|||
105682357|NCT03010176|364501323|FG003|Overall Study|Sponsor Decision|1|||
105682358|NCT03010176|364501324|FG004|Overall Study|Sponsor Decision|6|||
105682359|NCT03010176|364501325|FG005|Overall Study|Sponsor Decision|0|||
105682360|NCT03010176|364501320|FG000|Overall Study|Withdrawal by Subject|11|||
105682361|NCT03010176|364501321|FG001|Overall Study|Withdrawal by Subject|9|||
105682362|NCT03010176|364501322|FG002|Overall Study|Withdrawal by Subject|3|||
105682363|NCT03010176|364501323|FG003|Overall Study|Withdrawal by Subject|0|||
105682364|NCT03010176|364501324|FG004|Overall Study|Withdrawal by Subject|4|||
105682365|NCT03010176|364501325|FG005|Overall Study|Withdrawal by Subject|0|||
105682366|NCT00346632|364501326|FG000|Overall Study|Progressive Disease|2|||
105682367|NCT00346632|364501327|FG001|Overall Study|Progressive Disease|2|||
105682368|NCT00346632|364501328|FG002|Overall Study|Progressive Disease|4|||
105682369|NCT00346632|364501329|FG003|Overall Study|Progressive Disease|3|||
105682370|NCT00346632|364501330|FG004|Overall Study|Progressive Disease|3|||
105682371|NCT00346632|364501331|FG005|Overall Study|Progressive Disease|1|||
105682372|NCT00346632|364501332|FG006|Overall Study|Progressive Disease|2|||
105682373|NCT00346632|364501333|FG007|Overall Study|Progressive Disease|2|||
105682374|NCT00346632|364501334|FG008|Overall Study|Progressive Disease|2|||
105682375|NCT00346632|364501335|FG009|Overall Study|Progressive Disease|2|||
105682376|NCT00346632|364501326|FG000|Overall Study|Adverse Event|0|||
105682377|NCT00346632|364501327|FG001|Overall Study|Adverse Event|0|||
105682378|NCT00346632|364501328|FG002|Overall Study|Adverse Event|0|||
105682379|NCT00346632|364501329|FG003|Overall Study|Adverse Event|0|||
105682380|NCT00346632|364501330|FG004|Overall Study|Adverse Event|1|||
105682381|NCT00346632|364501331|FG005|Overall Study|Adverse Event|1|||
105682382|NCT00346632|364501332|FG006|Overall Study|Adverse Event|1|||
105682383|NCT00346632|364501333|FG007|Overall Study|Adverse Event|0|||
105682384|NCT00346632|364501334|FG008|Overall Study|Adverse Event|0|||
105682385|NCT00346632|364501335|FG009|Overall Study|Adverse Event|0|||
105682386|NCT00346632|364501326|FG000|Overall Study|Death|0|||
105682387|NCT00346632|364501327|FG001|Overall Study|Death|0|||
105682388|NCT00346632|364501328|FG002|Overall Study|Death|1|||
105468766|NCT03599089|363725974|FG000|Overall Study|Withdrawal by Subject|2|||
105468767|NCT03599089|363725975|FG001|Overall Study|Withdrawal by Subject|1|||
105468768|NCT03599089|363725976|FG002|Overall Study|Withdrawal by Subject|0|||
105468769|NCT03599089|363725977|FG003|Overall Study|Withdrawal by Subject|0|||
105468770|NCT03599089|363725974|FG000|Overall Study|Lack of Efficacy|0|||
105468771|NCT03599089|363725975|FG001|Overall Study|Lack of Efficacy|0|||
105468772|NCT03599089|363725976|FG002|Overall Study|Lack of Efficacy|1|||
105468773|NCT03599089|363725977|FG003|Overall Study|Lack of Efficacy|2|||
105468774|NCT00131248|363725978|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
105682389|NCT00346632|364501329|FG003|Overall Study|Death|0|||
105682390|NCT00346632|364501330|FG004|Overall Study|Death|0|||
105682391|NCT00346632|364501331|FG005|Overall Study|Death|0|||
105682392|NCT00346632|364501332|FG006|Overall Study|Death|0|||
105682393|NCT00346632|364501333|FG007|Overall Study|Death|0|||
105682394|NCT00346632|364501334|FG008|Overall Study|Death|0|||
105682395|NCT00346632|364501335|FG009|Overall Study|Death|0|||
105682396|NCT00346632|364501326|FG000|Overall Study|Protocol Violation|0|||
105682397|NCT00346632|364501327|FG001|Overall Study|Protocol Violation|0|||
105682398|NCT00346632|364501328|FG002|Overall Study|Protocol Violation|0|||
105682399|NCT00346632|364501329|FG003|Overall Study|Protocol Violation|0|||
105468775|NCT00131248|363725979|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
105468776|NCT04308291|363725980|FG000|Run-In Phase|Withdrawal by Subject|4|||
105468777|NCT04308291|363725980|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
105468778|NCT04308291|363725980|FG000|Study Phase 6-M|Physician Decision|2|||
105682400|NCT00346632|364501330|FG004|Overall Study|Protocol Violation|0|||
105682401|NCT00346632|364501331|FG005|Overall Study|Protocol Violation|0|||
105682402|NCT00346632|364501332|FG006|Overall Study|Protocol Violation|1|||
105682403|NCT00346632|364501333|FG007|Overall Study|Protocol Violation|0|||
105682404|NCT00346632|364501334|FG008|Overall Study|Protocol Violation|0|||
105682405|NCT00346632|364501335|FG009|Overall Study|Protocol Violation|0|||
105682406|NCT00346632|364501326|FG000|Overall Study|Withdrawal by Subject|0|||
105682407|NCT00346632|364501327|FG001|Overall Study|Withdrawal by Subject|0|||
105682408|NCT00346632|364501328|FG002|Overall Study|Withdrawal by Subject|0|||
105682409|NCT00346632|364501329|FG003|Overall Study|Withdrawal by Subject|0|||
105682410|NCT00346632|364501330|FG004|Overall Study|Withdrawal by Subject|0|||
105682411|NCT00346632|364501331|FG005|Overall Study|Withdrawal by Subject|0|||
105682412|NCT00346632|364501332|FG006|Overall Study|Withdrawal by Subject|1|||
105682413|NCT00346632|364501333|FG007|Overall Study|Withdrawal by Subject|0|||
105682414|NCT00346632|364501334|FG008|Overall Study|Withdrawal by Subject|0|||
105682415|NCT00346632|364501335|FG009|Overall Study|Withdrawal by Subject|0|||
105682416|NCT00346632|364501326|FG000|Overall Study|Switched to alternative treatment|0|||
105682417|NCT00346632|364501327|FG001|Overall Study|Switched to alternative treatment|0|||
105682418|NCT00346632|364501328|FG002|Overall Study|Switched to alternative treatment|1|||
105682419|NCT00346632|364501329|FG003|Overall Study|Switched to alternative treatment|0|||
105682420|NCT00346632|364501330|FG004|Overall Study|Switched to alternative treatment|0|||
105682421|NCT00346632|364501331|FG005|Overall Study|Switched to alternative treatment|0|||
105682422|NCT00346632|364501332|FG006|Overall Study|Switched to alternative treatment|0|||
105682423|NCT00346632|364501333|FG007|Overall Study|Switched to alternative treatment|0|||
105682424|NCT00346632|364501334|FG008|Overall Study|Switched to alternative treatment|0|||
105682425|NCT00346632|364501335|FG009|Overall Study|Switched to alternative treatment|0|||
105682426|NCT00346632|364501326|FG000|Overall Study|Not Stated|1|||
105682427|NCT00346632|364501327|FG001|Overall Study|Not Stated|1|||
105682428|NCT00346632|364501328|FG002|Overall Study|Not Stated|0|||
105682429|NCT00346632|364501329|FG003|Overall Study|Not Stated|0|||
105682430|NCT00346632|364501330|FG004|Overall Study|Not Stated|0|||
105682431|NCT00346632|364501331|FG005|Overall Study|Not Stated|0|||
105682432|NCT00346632|364501332|FG006|Overall Study|Not Stated|0|||
105682433|NCT00346632|364501333|FG007|Overall Study|Not Stated|2|||
105682434|NCT00346632|364501334|FG008|Overall Study|Not Stated|2|||
105682435|NCT00346632|364501335|FG009|Overall Study|Not Stated|1|||
105682436|NCT02038543|364501337|FG000|Overall Study|Screen Failure|0|||
105682437|NCT02038543|364501338|FG001|Overall Study|Screen Failure|0|||
105682438|NCT02038543|364501339|FG002|Overall Study|Screen Failure|0|||
105682439|NCT02038543|364501340|FG003|Overall Study|Screen Failure|1|||
105682440|NCT02038543|364501337|FG000|Overall Study|Withdrawal by Subject|0|||
105682441|NCT02038543|364501338|FG001|Overall Study|Withdrawal by Subject|0|||
105468779|NCT04308291|363725980|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
105468780|NCT04308291|363725980|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
105468781|NCT04308291|363725980|FG000|Study Phase 12-M|Physician Decision|2|||
105468782|NCT04308291|363725980|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
105468783|NCT02699749|363725987|FG000|Overall Study|Other|0|||
105468784|NCT02699749|363725988|FG001|Overall Study|Other|0|||
105468785|NCT02699749|363725989|FG002|Overall Study|Other|2|||
105468786|NCT02699749|363725990|FG003|Overall Study|Other|0|||
105468787|NCT02699749|363725991|FG004|Overall Study|Other|0|||
105468788|NCT02699749|363725992|FG005|Overall Study|Other|1|||
105468789|NCT02699749|363725993|FG006|Overall Study|Other|1|||
105682442|NCT02038543|364501339|FG002|Overall Study|Withdrawal by Subject|0|||
105682443|NCT02038543|364501340|FG003|Overall Study|Withdrawal by Subject|1|||
105682444|NCT02292927|364501343|FG000|Overall Study|Protocol Violation|13|||
105682445|NCT02292927|364501344|FG001|Overall Study|Protocol Violation|7|||
105682446|NCT02679573|364501345|FG000|Overall Study|Adverse Event|13|||
105682447|NCT02679573|364501346|FG001|Overall Study|Adverse Event|6|||
105682448|NCT02679573|364501345|FG000|Overall Study|Lack of Efficacy|12|||
105682449|NCT02679573|364501346|FG001|Overall Study|Lack of Efficacy|15|||
105682450|NCT02679573|364501345|FG000|Overall Study|Could not complete required study visits|6|||
105468790|NCT02699749|363725994|FG007|Overall Study|Other|0|||
105468791|NCT02699749|363725995|FG008|Overall Study|Other|0|||
105468792|NCT02699749|363725996|FG009|Overall Study|Other|0|||
105682451|NCT02679573|364501346|FG001|Overall Study|Could not complete required study visits|2|||
105682452|NCT02679573|364501345|FG000|Overall Study|Withdrawal by Subject|2|||
105682453|NCT02679573|364501346|FG001|Overall Study|Withdrawal by Subject|9|||
105682454|NCT02679573|364501345|FG000|Overall Study|Death|2|||
105682455|NCT02679573|364501346|FG001|Overall Study|Death|0|||
105682456|NCT02679573|364501345|FG000|Overall Study|Physician Decision|2|||
105682457|NCT02679573|364501346|FG001|Overall Study|Physician Decision|4|||
105682458|NCT02679573|364501345|FG000|Overall Study|Lost to Follow-up|0|||
105682459|NCT02679573|364501346|FG001|Overall Study|Lost to Follow-up|3|||
105682460|NCT02128542|364501347|FG000|Overall Study|Lost to Follow-up|3|||
105682461|NCT02128542|364501348|FG001|Overall Study|Lost to Follow-up|0|||
105682462|NCT02128542|364501347|FG000|Overall Study|Withdrew Consent|1|||
105682463|NCT02128542|364501348|FG001|Overall Study|Withdrew Consent|0|||
105682464|NCT00402597|364501354|FG000|Overall Study|Death|15|||
105682465|NCT00402597|364501355|FG001|Overall Study|Death|7|||
105682466|NCT00402597|364501356|FG002|Overall Study|Death|6|||
105682467|NCT00402597|364501357|FG003|Overall Study|Death|4|||
105682468|NCT00402597|364501358|FG004|Overall Study|Death|6|||
105682469|NCT00402597|364501354|FG000|Overall Study|Adverse Event|81|||
105682470|NCT00402597|364501355|FG001|Overall Study|Adverse Event|18|||
105682471|NCT00402597|364501356|FG002|Overall Study|Adverse Event|106|||
105682472|NCT00402597|364501357|FG003|Overall Study|Adverse Event|39|||
105682473|NCT00402597|364501358|FG004|Overall Study|Adverse Event|71|||
105682474|NCT00402597|364501354|FG000|Overall Study|Lost to Follow-up|8|||
105682475|NCT00402597|364501355|FG001|Overall Study|Lost to Follow-up|1|||
105682476|NCT00402597|364501356|FG002|Overall Study|Lost to Follow-up|8|||
105682477|NCT00402597|364501357|FG003|Overall Study|Lost to Follow-up|2|||
105682478|NCT00402597|364501358|FG004|Overall Study|Lost to Follow-up|3|||
105682479|NCT00402597|364501354|FG000|Overall Study|Withdrawal by Subject|57|||
105682480|NCT00402597|364501355|FG001|Overall Study|Withdrawal by Subject|16|||
105682481|NCT00402597|364501356|FG002|Overall Study|Withdrawal by Subject|65|||
105682482|NCT00402597|364501357|FG003|Overall Study|Withdrawal by Subject|15|||
105682483|NCT00402597|364501358|FG004|Overall Study|Withdrawal by Subject|24|||
105682484|NCT00402597|364501354|FG000|Overall Study|reason not specified|30|||
105682485|NCT00402597|364501355|FG001|Overall Study|reason not specified|4|||
105682486|NCT00402597|364501356|FG002|Overall Study|reason not specified|27|||
105682487|NCT00402597|364501357|FG003|Overall Study|reason not specified|14|||
105682488|NCT00402597|364501358|FG004|Overall Study|reason not specified|20|||
105682489|NCT05249829|364501363|FG000|Overall Study|Participant Relocation|0|||
105682490|NCT05249829|364501364|FG001|Overall Study|Participant Relocation|1|||
105682491|NCT05249829|364501365|FG002|Overall Study|Participant Relocation|2|||
105682492|NCT05249829|364501366|FG003|Overall Study|Participant Relocation|2|||
105682493|NCT05249829|364501363|FG000|Overall Study|Withdrawal by Subject|9|||
105682494|NCT05249829|364501364|FG001|Overall Study|Withdrawal by Subject|17|||
105682495|NCT05249829|364501365|FG002|Overall Study|Withdrawal by Subject|40|||
105682496|NCT05249829|364501366|FG003|Overall Study|Withdrawal by Subject|35|||
105682497|NCT05249829|364501363|FG000|Overall Study|Physician Decision|1|||
105682498|NCT05249829|364501364|FG001|Overall Study|Physician Decision|0|||
105682499|NCT05249829|364501365|FG002|Overall Study|Physician Decision|0|||
105682500|NCT05249829|364501366|FG003|Overall Study|Physician Decision|0|||
105682501|NCT05249829|364501363|FG000|Overall Study|Lost to Follow-up|16|||
105682502|NCT05249829|364501364|FG001|Overall Study|Lost to Follow-up|16|||
105682503|NCT05249829|364501365|FG002|Overall Study|Lost to Follow-up|57|||
105682504|NCT05249829|364501366|FG003|Overall Study|Lost to Follow-up|60|||
105682505|NCT05249829|364501363|FG000|Overall Study|Adverse Event|2|||
105682506|NCT05249829|364501364|FG001|Overall Study|Adverse Event|2|||
105682507|NCT05249829|364501365|FG002|Overall Study|Adverse Event|2|||
105682508|NCT05249829|364501366|FG003|Overall Study|Adverse Event|2|||
105682509|NCT05249829|364501363|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
105682510|NCT05249829|364501364|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
105682511|NCT05249829|364501365|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
105682512|NCT05249829|364501366|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
105682513|NCT05249829|364501363|FG000|Overall Study|Protocol Violation|2|||
105682514|NCT05249829|364501364|FG001|Overall Study|Protocol Violation|0|||
105344464|NCT03191864|363261791|FG001|Baseline Symptom Assessment|Adverse Event|0|||
105344465|NCT03191864|363261792|FG002|Baseline Symptom Assessment|Adverse Event|0|||
105682515|NCT05249829|364501365|FG002|Overall Study|Protocol Violation|5|||
105682516|NCT05249829|364501366|FG003|Overall Study|Protocol Violation|3|||
105682517|NCT05249829|364501363|FG000|Overall Study|Death|0|||
105682518|NCT05249829|364501364|FG001|Overall Study|Death|1|||
105682519|NCT05249829|364501365|FG002|Overall Study|Death|2|||
105682520|NCT05249829|364501366|FG003|Overall Study|Death|4|||
105682521|NCT02842827|364501370|FG000|Overall Study|Adverse Event|0|||
105682522|NCT02842827|364501371|FG001|Overall Study|Adverse Event|1|||
105682523|NCT02842827|364501372|FG002|Overall Study|Adverse Event|0|||
105682524|NCT02842827|364501373|FG003|Overall Study|Adverse Event|1|||
105682525|NCT02842827|364501374|FG004|Overall Study|Adverse Event|0|||
105682526|NCT02842827|364501375|FG005|Overall Study|Adverse Event|1|||
105682527|NCT02842827|364501376|FG006|Overall Study|Adverse Event|0|||
105682528|NCT02842827|364501377|FG007|Overall Study|Adverse Event|0|||
105682529|NCT02842827|364501370|FG000|Overall Study|Death|1|||
105682530|NCT02842827|364501371|FG001|Overall Study|Death|0|||
105682531|NCT02842827|364501372|FG002|Overall Study|Death|2|||
105682532|NCT02842827|364501373|FG003|Overall Study|Death|3|||
105682533|NCT02842827|364501374|FG004|Overall Study|Death|2|||
105682534|NCT02842827|364501375|FG005|Overall Study|Death|1|||
105682535|NCT02842827|364501376|FG006|Overall Study|Death|0|||
105682536|NCT02842827|364501377|FG007|Overall Study|Death|4|||
105682537|NCT02842827|364501370|FG000|Overall Study|Physician Decision|1|||
105682538|NCT02842827|364501371|FG001|Overall Study|Physician Decision|3|||
105682539|NCT02842827|364501372|FG002|Overall Study|Physician Decision|0|||
105682540|NCT02842827|364501373|FG003|Overall Study|Physician Decision|0|||
105682541|NCT02842827|364501374|FG004|Overall Study|Physician Decision|1|||
105682542|NCT02842827|364501375|FG005|Overall Study|Physician Decision|4|||
105682543|NCT02842827|364501376|FG006|Overall Study|Physician Decision|2|||
105682544|NCT02842827|364501377|FG007|Overall Study|Physician Decision|1|||
105682545|NCT02842827|364501370|FG000|Overall Study|Protocol Defined Disease Progression|0|||
105682546|NCT02842827|364501371|FG001|Overall Study|Protocol Defined Disease Progression|0|||
105682547|NCT02842827|364501372|FG002|Overall Study|Protocol Defined Disease Progression|0|||
105682548|NCT02842827|364501373|FG003|Overall Study|Protocol Defined Disease Progression|0|||
105682549|NCT02842827|364501374|FG004|Overall Study|Protocol Defined Disease Progression|0|||
105682550|NCT02842827|364501375|FG005|Overall Study|Protocol Defined Disease Progression|1|||
105682551|NCT02842827|364501376|FG006|Overall Study|Protocol Defined Disease Progression|0|||
105682552|NCT02842827|364501377|FG007|Overall Study|Protocol Defined Disease Progression|0|||
105682553|NCT02842827|364501370|FG000|Overall Study|Participant Withdrawal of Consent|1|||
105682554|NCT02842827|364501371|FG001|Overall Study|Participant Withdrawal of Consent|2|||
105682555|NCT02842827|364501372|FG002|Overall Study|Participant Withdrawal of Consent|2|||
105682556|NCT02842827|364501373|FG003|Overall Study|Participant Withdrawal of Consent|2|||
105682557|NCT02842827|364501374|FG004|Overall Study|Participant Withdrawal of Consent|2|||
105682558|NCT02842827|364501375|FG005|Overall Study|Participant Withdrawal of Consent|1|||
105682559|NCT02842827|364501376|FG006|Overall Study|Participant Withdrawal of Consent|2|||
105344466|NCT03191864|363261793|FG003|Baseline Symptom Assessment|Adverse Event|0|||
105682560|NCT02842827|364501377|FG007|Overall Study|Participant Withdrawal of Consent|1|||
105682561|NCT00609765|364501380|FG000|Overall Study|Study ended prior to 12 months|1|||
105682562|NCT01636960|364501386|FG000|Induction Phase|Adverse Event|2|||
105682563|NCT01636960|364501386|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
105682564|NCT01636960|364501386|FG000|Maintenance Phase|Adverse Event|3|||
105682565|NCT01636960|364501386|FG000|Maintenance Phase|Progressive disease|1|||
105682566|NCT01580969|364501389|FG000|Overall Study|Physician Decision|3|||
105682567|NCT01580969|364501390|FG001|Overall Study|Physician Decision|0|||
105682568|NCT01580969|364501391|FG002|Overall Study|Physician Decision|0|||
105344467|NCT03191864|363261794|FG004|Baseline Symptom Assessment|Adverse Event|0|||
105344468|NCT03191864|363261795|FG005|Baseline Symptom Assessment|Adverse Event|2|||
105344469|NCT03191864|363261790|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
105344470|NCT03191864|363261791|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
105344471|NCT03191864|363261792|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
105344472|NCT03191864|363261793|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
105344473|NCT03191864|363261794|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
105682569|NCT00757783|364501392|FG000|Overall Study|Adverse Event|0|||
105682570|NCT00757783|364501393|FG001|Overall Study|Adverse Event|2|||
105682571|NCT00757783|364501392|FG000|Overall Study|Lost to Follow-up|1|||
105682572|NCT00757783|364501393|FG001|Overall Study|Lost to Follow-up|1|||
105682573|NCT00757783|364501392|FG000|Overall Study|Protocol Violation|1|||
105682574|NCT00757783|364501393|FG001|Overall Study|Protocol Violation|0|||
105682575|NCT00757783|364501392|FG000|Overall Study|Withdrawal by Subject|2|||
105682576|NCT00757783|364501393|FG001|Overall Study|Withdrawal by Subject|1|||
105682577|NCT00757783|364501392|FG000|Overall Study|Other|1|||
105682578|NCT00757783|364501393|FG001|Overall Study|Other|2|||
105682579|NCT03801915|364501394|FG000|Overall Study|Screen failure|0|||
105682580|NCT03801915|364501395|FG001|Overall Study|Screen failure|0|||
105682581|NCT03801915|364501396|FG002|Overall Study|Screen failure|1|||
105682582|NCT03801915|364501394|FG000|Overall Study|Ineligible|1|||
105682583|NCT03801915|364501395|FG001|Overall Study|Ineligible|0|||
105682584|NCT03801915|364501396|FG002|Overall Study|Ineligible|0|||
105682585|NCT03801915|364501394|FG000|Overall Study|Physician Decision|2|||
105682586|NCT03801915|364501395|FG001|Overall Study|Physician Decision|1|||
105682587|NCT03801915|364501396|FG002|Overall Study|Physician Decision|0|||
105682588|NCT04822597|364501397|FG000|Overall Study|Withdrawal by Subject|0|||
105682589|NCT04822597|364501398|FG001|Overall Study|Withdrawal by Subject|1|||
105682590|NCT04822597|364501399|FG002|Overall Study|Withdrawal by Subject|1|||
105682591|NCT04822597|364501400|FG003|Overall Study|Withdrawal by Subject|0|||
105682592|NCT04822597|364501397|FG000|Overall Study|Physician Decision|0|||
105682593|NCT04822597|364501398|FG001|Overall Study|Physician Decision|0|||
105682594|NCT04822597|364501399|FG002|Overall Study|Physician Decision|1|||
105682595|NCT04822597|364501400|FG003|Overall Study|Physician Decision|1|||
105682596|NCT04822597|364501397|FG000|Overall Study|Subject withdrawn after enrollment|0|||
105682597|NCT04822597|364501398|FG001|Overall Study|Subject withdrawn after enrollment|1|||
105682598|NCT04822597|364501399|FG002|Overall Study|Subject withdrawn after enrollment|0|||
105682599|NCT04822597|364501400|FG003|Overall Study|Subject withdrawn after enrollment|1|||
105682600|NCT04822597|364501397|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
105682601|NCT04822597|364501398|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
105682602|NCT04822597|364501399|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
105682603|NCT04822597|364501400|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
105682604|NCT00731120|364501405|FG000|Overall Study|Adverse Event|7|||
105682605|NCT00731120|364501406|FG001|Overall Study|Adverse Event|6|||
105682606|NCT00731120|364501407|FG002|Overall Study|Adverse Event|8|||
105682607|NCT00731120|364501405|FG000|Overall Study|Lack of Efficacy|4|||
105682608|NCT00731120|364501406|FG001|Overall Study|Lack of Efficacy|5|||
105682609|NCT00731120|364501407|FG002|Overall Study|Lack of Efficacy|4|||
105682610|NCT00731120|364501405|FG000|Overall Study|Noncompliance with Study Drug|3|||
105682611|NCT00731120|364501406|FG001|Overall Study|Noncompliance with Study Drug|3|||
105682612|NCT00731120|364501407|FG002|Overall Study|Noncompliance with Study Drug|1|||
105468793|NCT02699749|363725997|FG010|Overall Study|Other|1|||
105682613|NCT00731120|364501405|FG000|Overall Study|Protocol Deviations|1|||
105682614|NCT00731120|364501406|FG001|Overall Study|Protocol Deviations|6|||
105682615|NCT00731120|364501407|FG002|Overall Study|Protocol Deviations|1|||
105682616|NCT00731120|364501405|FG000|Overall Study|Withdrawal of Consent|13|||
105682617|NCT00731120|364501406|FG001|Overall Study|Withdrawal of Consent|8|||
105682618|NCT00731120|364501407|FG002|Overall Study|Withdrawal of Consent|4|||
105682619|NCT00731120|364501405|FG000|Overall Study|Lost to Follow-up|10|||
105682620|NCT00731120|364501406|FG001|Overall Study|Lost to Follow-up|15|||
105682621|NCT00731120|364501407|FG002|Overall Study|Lost to Follow-up|17|||
105682622|NCT00731120|364501405|FG000|Overall Study|Other|4|||
105682623|NCT00731120|364501406|FG001|Overall Study|Other|0|||
105682624|NCT00731120|364501407|FG002|Overall Study|Other|1|||
105682625|NCT02673515|364501409|FG000|Overall Study|Lack of motivation|2|||
105682626|NCT02673515|364501410|FG001|Overall Study|Lack of motivation|1|||
105682627|NCT04737187|364501411|FG000|Overall Study|Switched to marketed drug|32|||
105682628|NCT04737187|364501412|FG001|Overall Study|Switched to marketed drug|4|||
105682629|NCT04737187|364501411|FG000|Overall Study|Radiological Progressive Disease|145|||
105682630|NCT04737187|364501412|FG001|Overall Study|Radiological Progressive Disease|146|||
105682631|NCT04737187|364501411|FG000|Overall Study|Clinical Progressive Disease|20|||
105682632|NCT04737187|364501412|FG001|Overall Study|Clinical Progressive Disease|20|||
105682633|NCT04737187|364501411|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
105682634|NCT04737187|364501412|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
105682635|NCT04737187|364501411|FG000|Overall Study|Adverse Event|16|||
105682636|NCT04737187|364501412|FG001|Overall Study|Adverse Event|16|||
105682637|NCT04737187|364501411|FG000|Overall Study|Physician Decision|2|||
105682638|NCT04737187|364501412|FG001|Overall Study|Physician Decision|0|||
105682639|NCT04737187|364501411|FG000|Overall Study|Withdrawal by Subject|5|||
105682640|NCT04737187|364501412|FG001|Overall Study|Withdrawal by Subject|8|||
105682641|NCT00423930|364501413|FG000|Overall Study|Withdrawal by Subject|2|||
105682642|NCT02337751|364501414|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
105682643|NCT02337751|364501415|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
105682644|NCT02337751|364501414|FG000|Overall Study|Voluntary Withdrawal|6|||
105682645|NCT02337751|364501415|FG001|Overall Study|Voluntary Withdrawal|8|||
105682646|NCT02337751|364501414|FG000|Overall Study|Lack of Efficacy|2|||
105682647|NCT02337751|364501415|FG001|Overall Study|Lack of Efficacy|5|||
105682648|NCT02337751|364501414|FG000|Overall Study|Investigator's Judgement|1|||
105682649|NCT02337751|364501415|FG001|Overall Study|Investigator's Judgement|0|||
105682650|NCT01315353|364501421|FG000|Overall Study|Death|2|||
105344474|NCT03191864|363261795|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
105344475|NCT03191864|363261790|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
105557824|NCT02163733|364039154|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
105557825|NCT02163733|364039152|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
105557826|NCT02163733|364039153|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
105557827|NCT02163733|364039154|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
105557828|NCT02633800|364039157|FG000|Overall Study|Death|3|||
105557829|NCT02633800|364039158|FG001|Overall Study|Death|3|||
105557830|NCT02633800|364039157|FG000|Overall Study|Reason not provided|1|||
105557831|NCT02633800|364039158|FG001|Overall Study|Reason not provided|0|||
105557832|NCT02633800|364039157|FG000|Overall Study|Radiologic(al) progression|23|||
105557833|NCT02633800|364039158|FG001|Overall Study|Radiologic(al) progression|23|||
105557834|NCT02633800|364039157|FG000|Overall Study|Clinical progression|3|||
105557835|NCT02633800|364039158|FG001|Overall Study|Clinical progression|6|||
105557836|NCT02633800|364039157|FG000|Overall Study|Study terminated by sponsor|6|||
105557837|NCT02633800|364039158|FG001|Overall Study|Study terminated by sponsor|5|||
105557838|NCT02633800|364039157|FG000|Overall Study|Adverse event, non-fatal|7|||
105557839|NCT02633800|364039158|FG001|Overall Study|Adverse event, non-fatal|2|||
105557840|NCT02633800|364039157|FG000|Overall Study|Withdrawal by Subject|0|||
105557841|NCT02633800|364039158|FG001|Overall Study|Withdrawal by Subject|3|||
105557842|NCT02633800|364039157|FG000|Overall Study|Patient Request|1|||
105557843|NCT02633800|364039158|FG001|Overall Study|Patient Request|1|||
105557844|NCT00082173|364039159|FG000|Overall Study|Withdrawal by Subject|3|||
105557845|NCT00082173|364039160|FG001|Overall Study|Withdrawal by Subject|5|||
105557846|NCT00082173|364039159|FG000|Overall Study|Lost to Follow-up|1|||
105557847|NCT00082173|364039160|FG001|Overall Study|Lost to Follow-up|0|||
105557848|NCT00082173|364039159|FG000|Overall Study|Adverse Event|1|||
105557849|NCT00082173|364039160|FG001|Overall Study|Adverse Event|0|||
105557850|NCT00082173|364039159|FG000|Overall Study|Culture negative or resistant at baselin|5|||
105557851|NCT00082173|364039160|FG001|Overall Study|Culture negative or resistant at baselin|6|||
105557852|NCT00746590|364039161|FG000|Overall Study|Death|1|||
105557853|NCT02261493|364039165|FG000|Overall Study|Noncompliance|0|||
105557854|NCT02261493|364039166|FG001|Overall Study|Noncompliance|0|||
105557855|NCT02261493|364039167|FG002|Overall Study|Noncompliance|2|||
105557856|NCT02261493|364039165|FG000|Overall Study|Physician Decision|0|||
105557857|NCT02261493|364039166|FG001|Overall Study|Physician Decision|1|||
105557858|NCT02261493|364039167|FG002|Overall Study|Physician Decision|0|||
105557859|NCT02261493|364039165|FG000|Overall Study|Undisclosed alcohol abuse|0|||
105557860|NCT02261493|364039166|FG001|Overall Study|Undisclosed alcohol abuse|1|||
105557861|NCT02261493|364039167|FG002|Overall Study|Undisclosed alcohol abuse|0|||
105786496|NCT02686749|364871424|FG000|Overall Study|terminated for poor enrollment|2|||
105557862|NCT02261493|364039165|FG000|Overall Study|Protocol Violation|1|||
105557863|NCT02261493|364039166|FG001|Overall Study|Protocol Violation|0|||
105557864|NCT02261493|364039167|FG002|Overall Study|Protocol Violation|0|||
105557865|NCT02261493|364039165|FG000|Overall Study|Personal Reasons|14|||
105557866|NCT02261493|364039166|FG001|Overall Study|Personal Reasons|14|||
105682651|NCT01315353|364501422|FG001|Overall Study|Death|1|||
105682652|NCT01315353|364501423|FG002|Overall Study|Death|0|||
105682653|NCT01315353|364501421|FG000|Overall Study|Withdrawal by Subject|2|||
105682654|NCT01315353|364501422|FG001|Overall Study|Withdrawal by Subject|6|||
105682655|NCT01315353|364501423|FG002|Overall Study|Withdrawal by Subject|1|||
105682656|NCT01315353|364501421|FG000|Overall Study|Lost to Follow-up|13|||
105682657|NCT01315353|364501422|FG001|Overall Study|Lost to Follow-up|6|||
105682658|NCT01315353|364501423|FG002|Overall Study|Lost to Follow-up|6|||
105682659|NCT01315353|364501421|FG000|Overall Study|Unwilling to adhere to requirements|5|||
105682660|NCT01315353|364501422|FG001|Overall Study|Unwilling to adhere to requirements|5|||
105682661|NCT01315353|364501423|FG002|Overall Study|Unwilling to adhere to requirements|4|||
105682662|NCT01315353|364501421|FG000|Overall Study|Site closing|7|||
105682663|NCT01315353|364501422|FG001|Overall Study|Site closing|4|||
105682664|NCT01315353|364501423|FG002|Overall Study|Site closing|0|||
105682665|NCT01315353|364501421|FG000|Overall Study|Taken off study by site in error|0|||
105682666|NCT01315353|364501422|FG001|Overall Study|Taken off study by site in error|1|||
105682667|NCT01315353|364501423|FG002|Overall Study|Taken off study by site in error|0|||
105682668|NCT01315353|364501421|FG000|Overall Study|Inadvertent randomization/assignment|0|||
105682669|NCT01315353|364501422|FG001|Overall Study|Inadvertent randomization/assignment|0|||
105682670|NCT01315353|364501423|FG002|Overall Study|Inadvertent randomization/assignment|2|||
105682671|NCT02390245|364501428|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
105682672|NCT02390245|364501429|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
105682673|NCT02390245|364501430|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
105682674|NCT02390245|364501428|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
105682675|NCT02390245|364501429|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
105682676|NCT02390245|364501430|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
105682677|NCT00959647|364501432|FG000|Overall Study|Adverse Event|2|||
105682678|NCT00959647|364501432|FG000|Overall Study|Progressive disease|6|||
105682679|NCT00959647|364501432|FG000|Overall Study|Study terminated by sponsor|4|||
105682680|NCT00959647|364501432|FG000|Overall Study|Withdrawal by Subject|7|||
105682681|NCT03727438|364501433|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
105682682|NCT03727438|364501434|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
105682683|NCT03727438|364501433|FG000|Intervention Period|Excluded (health)|1|||
105682684|NCT03727438|364501434|FG001|Intervention Period|Excluded (health)|0|||
105682685|NCT03727438|364501433|FG000|Intervention Period|Withdrawal by Subject|3|||
105682686|NCT03727438|364501434|FG001|Intervention Period|Withdrawal by Subject|1|||
105682687|NCT03727438|364501433|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
105682688|NCT03727438|364501434|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
105682689|NCT03727438|364501433|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
105682690|NCT03727438|364501434|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
105682691|NCT03727438|364501433|FG000|8 Week Assessment|Withdrawal by Subject|6|||
105682692|NCT03727438|364501434|FG001|8 Week Assessment|Withdrawal by Subject|1|||
105682693|NCT03727438|364501433|FG000|6 mo Assessment|did not complete assessment|10|||
105682694|NCT03727438|364501434|FG001|6 mo Assessment|did not complete assessment|11|||
105682695|NCT00924027|364501435|FG000|Overall Study|Lost to Further Follow-Up|4|||
105682696|NCT00924027|364501436|FG001|Overall Study|Lost to Further Follow-Up|0|||
105682697|NCT00924027|364501437|FG002|Overall Study|Lost to Further Follow-Up|0|||
105682698|NCT00924027|364501438|FG003|Overall Study|Lost to Further Follow-Up|0|||
105682699|NCT00924027|364501435|FG000|Overall Study|Physician Decision|1|||
105682700|NCT00924027|364501436|FG001|Overall Study|Physician Decision|0|||
105682701|NCT00924027|364501437|FG002|Overall Study|Physician Decision|0|||
105682702|NCT00924027|364501438|FG003|Overall Study|Physician Decision|1|||
105682703|NCT00924027|364501435|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
105682704|NCT00924027|364501436|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
105682705|NCT00924027|364501437|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
105682706|NCT00924027|364501438|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
105682707|NCT00924027|364501435|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
105682708|NCT00924027|364501436|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
105682709|NCT00924027|364501437|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
105682710|NCT00924027|364501438|FG003|Overall Study|Withdrawal: Refused to start treatment|1|||
105682711|NCT00924027|364501435|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
105682712|NCT00924027|364501436|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
105682713|NCT00924027|364501437|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
105557867|NCT02261493|364039167|FG002|Overall Study|Personal Reasons|16|||
105682714|NCT00924027|364501438|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
105682715|NCT01589237|364503064|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
105682716|NCT01589237|364503065|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
105682717|NCT01589237|364503066|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
105682718|NCT01589237|364503067|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
105682719|NCT01589237|364503064|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
105682720|NCT01589237|364503065|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
105682721|NCT01589237|364503066|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
105682722|NCT01589237|364503067|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
105682723|NCT01589237|364503064|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
105682724|NCT01589237|364503065|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
105682725|NCT01589237|364503066|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
105682726|NCT01589237|364503067|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
105682727|NCT01589237|364503064|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
105682728|NCT01589237|364503065|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
105682729|NCT01589237|364503066|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
105682730|NCT01589237|364503067|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
105682731|NCT01672723|364503068|FG000|First Intervention|Adverse Event|3|||
105682732|NCT01672723|364503069|FG001|First Intervention|Adverse Event|0|||
105682733|NCT01022268|364503070|FG000|Overall Study|Withdrawal by Subject|1|||
105682734|NCT01022268|364503071|FG001|Overall Study|Withdrawal by Subject|0|||
105682735|NCT01022268|364503070|FG000|Overall Study|Withdrawal by Subject|1|||
105682736|NCT01022268|364503071|FG001|Overall Study|Withdrawal by Subject|0|||
105682737|NCT00910689|364503072|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
105682738|NCT00910689|364503073|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
105682739|NCT00910689|364503074|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
105682740|NCT00910689|364503075|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
105682741|NCT00910689|364503072|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
105682742|NCT00910689|364503073|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
105682743|NCT00910689|364503074|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
105468794|NCT02699749|363725998|FG011|Overall Study|Other|0|||
105468795|NCT02699749|363725999|FG012|Overall Study|Other|0|||
105682744|NCT00910689|364503075|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
105682745|NCT00910689|364503072|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
105682746|NCT00910689|364503073|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
105682747|NCT00910689|364503074|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
105682748|NCT00910689|364503075|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
105682749|NCT00910689|364503072|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
105682750|NCT00910689|364503073|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
105682751|NCT00910689|364503074|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
105682752|NCT00910689|364503075|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
105682753|NCT00910689|364503072|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
105682754|NCT00910689|364503073|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
105682755|NCT00910689|364503074|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
105682756|NCT00910689|364503075|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
105682757|NCT00910689|364503072|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
105682758|NCT00910689|364503073|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
105682759|NCT00910689|364503074|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
105682760|NCT00910689|364503075|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
105682761|NCT00910689|364503072|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
105682762|NCT00910689|364503073|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
105682763|NCT00910689|364503074|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
105682764|NCT00910689|364503075|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
105682765|NCT00910689|364503072|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
105682766|NCT00910689|364503073|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
105682767|NCT00910689|364503074|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
105682768|NCT00910689|364503075|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
105682769|NCT00910689|364503072|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
105682770|NCT00910689|364503073|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
105682771|NCT00910689|364503074|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
105682772|NCT00910689|364503075|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
105682773|NCT00910689|364503072|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
105682774|NCT00910689|364503073|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
105682775|NCT00910689|364503074|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
105682776|NCT00910689|364503075|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
105682777|NCT00910689|364503072|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
105682778|NCT00910689|364503073|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
105682779|NCT00910689|364503074|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
105682780|NCT00910689|364503075|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
105682781|NCT00910689|364503072|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
105682782|NCT00910689|364503073|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
105468796|NCT02699749|363726000|FG013|Overall Study|Other|0|||
105468797|NCT02699749|363725987|FG000|Overall Study|Progressive Disease|3|||
105682783|NCT00910689|364503074|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
105682784|NCT00910689|364503075|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
105682785|NCT00910689|364503072|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
105682786|NCT00910689|364503073|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
105682787|NCT00910689|364503074|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
105682788|NCT00910689|364503075|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
105682789|NCT00910689|364503072|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
105682790|NCT00910689|364503073|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
105682791|NCT00910689|364503074|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
105682792|NCT00910689|364503075|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
105682793|NCT00910689|364503072|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
105682794|NCT00910689|364503073|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
105682795|NCT00910689|364503074|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
105682796|NCT00910689|364503075|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
105682797|NCT00910689|364503072|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
105682798|NCT00910689|364503073|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
105682799|NCT00910689|364503074|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
105682800|NCT00910689|364503075|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
105682801|NCT00910689|364503072|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
105682802|NCT00910689|364503073|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
105682803|NCT00910689|364503074|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
105682804|NCT00910689|364503075|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
105682805|NCT00910689|364503072|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
105682806|NCT00910689|364503073|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
105682807|NCT00910689|364503074|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
105682808|NCT00910689|364503075|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
105682809|NCT00910689|364503072|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
105682810|NCT00910689|364503073|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
105682811|NCT00910689|364503074|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
105682812|NCT00910689|364503075|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
105682813|NCT00910689|364503072|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
105682814|NCT00910689|364503073|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
105682815|NCT00910689|364503074|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
105682816|NCT00910689|364503075|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
105682817|NCT00910689|364503072|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
105682818|NCT00910689|364503073|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
105682819|NCT00910689|364503074|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
105682820|NCT00910689|364503075|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
105682821|NCT01290029|364503076|FG000|Overall Study|Other|2|||
105682822|NCT03938545|364503077|FG000|Overall Study|Lost to Follow-up|0|||
105682823|NCT03938545|364503078|FG001|Overall Study|Lost to Follow-up|0|||
105682824|NCT03938545|364503079|FG002|Overall Study|Lost to Follow-up|0|||
105682825|NCT03938545|364503080|FG003|Overall Study|Lost to Follow-up|1|||
105682826|NCT03938545|364503077|FG000|Overall Study|Non-compliance with study drug|0|||
105682827|NCT03938545|364503078|FG001|Overall Study|Non-compliance with study drug|0|||
105682828|NCT03938545|364503079|FG002|Overall Study|Non-compliance with study drug|1|||
105682829|NCT03938545|364503080|FG003|Overall Study|Non-compliance with study drug|0|||
105682830|NCT03938545|364503077|FG000|Overall Study|Pregnancy|1|||
105682831|NCT03938545|364503078|FG001|Overall Study|Pregnancy|0|||
105682832|NCT03938545|364503079|FG002|Overall Study|Pregnancy|0|||
105682833|NCT03938545|364503080|FG003|Overall Study|Pregnancy|0|||
105682834|NCT03938545|364503077|FG000|Overall Study|Study terminated by sponsor|6|||
105682835|NCT03938545|364503078|FG001|Overall Study|Study terminated by sponsor|4|||
105682836|NCT03938545|364503079|FG002|Overall Study|Study terminated by sponsor|2|||
105682837|NCT03938545|364503080|FG003|Overall Study|Study terminated by sponsor|4|||
105682838|NCT03938545|364503077|FG000|Overall Study|Withdrawal by Subject|0|||
105682839|NCT03938545|364503078|FG001|Overall Study|Withdrawal by Subject|1|||
105682840|NCT03938545|364503079|FG002|Overall Study|Withdrawal by Subject|0|||
105682841|NCT03938545|364503080|FG003|Overall Study|Withdrawal by Subject|0|||
105682842|NCT03938545|364503077|FG000|Overall Study|Adverse Event|1|||
105682843|NCT03938545|364503078|FG001|Overall Study|Adverse Event|0|||
105682844|NCT03938545|364503079|FG002|Overall Study|Adverse Event|0|||
105682845|NCT03938545|364503080|FG003|Overall Study|Adverse Event|0|||
105682846|NCT05087979|364503081|FG000|Overall Study|Converted to general anesthesia|1|||
105682847|NCT05087979|364503082|FG001|Overall Study|Converted to general anesthesia|0|||
105682848|NCT00477334|364503083|FG000|Overall Study|Discontinued prior to taking study drug|106|||
105682849|NCT00477334|364503084|FG001|Overall Study|Discontinued prior to taking study drug|53|||
105682850|NCT00477334|364503083|FG000|Overall Study|Adverse Event|1|||
105786497|NCT02686749|364871425|FG001|Overall Study|terminated for poor enrollment|2|||
105682851|NCT00477334|364503084|FG001|Overall Study|Adverse Event|2|||
105682852|NCT00477334|364503083|FG000|Overall Study|Withdrawal by Subject|2|||
105682853|NCT00477334|364503084|FG001|Overall Study|Withdrawal by Subject|1|||
105682854|NCT00477334|364503083|FG000|Overall Study|Lost to Follow-up|15|||
105682855|NCT00477334|364503084|FG001|Overall Study|Lost to Follow-up|4|||
105682856|NCT00477334|364503083|FG000|Overall Study|Administrative Problems|39|||
105682857|NCT00477334|364503084|FG001|Overall Study|Administrative Problems|15|||
105682858|NCT00477334|364503083|FG000|Overall Study|Protocol Violation|7|||
105682859|NCT00477334|364503084|FG001|Overall Study|Protocol Violation|1|||
105682860|NCT00372229|364503085|FG000|Study Phase|Graft loss|0|||
105682861|NCT00372229|364503086|FG001|Study Phase|Graft loss|3|||
105682862|NCT00372229|364503085|FG000|Study Phase|Protocol Violation|3|||
105682863|NCT00372229|364503086|FG001|Study Phase|Protocol Violation|4|||
105682864|NCT00372229|364503085|FG000|Study Phase|Consent withdrawn|16|||
105682865|NCT00372229|364503086|FG001|Study Phase|Consent withdrawn|14|||
105682866|NCT00372229|364503085|FG000|Study Phase|Refused treatment/did not cooperate|3|||
105682867|NCT00372229|364503086|FG001|Study Phase|Refused treatment/did not cooperate|1|||
105682868|NCT00372229|364503085|FG000|Study Phase|Death|3|||
105682869|NCT00372229|364503086|FG001|Study Phase|Death|2|||
105682870|NCT00372229|364503085|FG000|Study Phase|Reason not specified|3|||
105682871|NCT00372229|364503086|FG001|Study Phase|Reason not specified|2|||
105682872|NCT00372229|364503085|FG000|Study Phase|Lost to Follow-up|3|||
105682873|NCT00372229|364503086|FG001|Study Phase|Lost to Follow-up|3|||
105682874|NCT00372229|364503085|FG000|Follow-Up Phase|Graft loss|8|||
105682875|NCT00372229|364503086|FG001|Follow-Up Phase|Graft loss|7|||
105682876|NCT00372229|364503085|FG000|Follow-Up Phase|Consent withdrawn|13|||
105682877|NCT00372229|364503086|FG001|Follow-Up Phase|Consent withdrawn|19|||
105682878|NCT00372229|364503085|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
105682879|NCT00372229|364503086|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
105682880|NCT00372229|364503085|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
105682881|NCT00372229|364503086|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
105682882|NCT00372229|364503085|FG000|Follow-Up Phase|Death|9|||
105682883|NCT00372229|364503086|FG001|Follow-Up Phase|Death|12|||
105682884|NCT00372229|364503085|FG000|Follow-Up Phase|Administrative|1|||
105682885|NCT00372229|364503086|FG001|Follow-Up Phase|Administrative|0|||
105682886|NCT00372229|364503085|FG000|Follow-Up Phase|Reason not specified|2|||
105682887|NCT00372229|364503086|FG001|Follow-Up Phase|Reason not specified|3|||
105682888|NCT00372229|364503085|FG000|Follow-Up Phase|Lost to Follow-up|12|||
105682889|NCT00372229|364503086|FG001|Follow-Up Phase|Lost to Follow-up|10|||
105682890|NCT03235284|364503087|FG000|Overall Study|Adverse Event|1|||
105682891|NCT03235284|364503088|FG001|Overall Study|Adverse Event|2|||
105682892|NCT03235284|364503089|FG002|Overall Study|Adverse Event|1|||
105682893|NCT01236339|364503096|FG000|Overall Study|Termination of study by sponsor|11|||
105682894|NCT01236339|364503097|FG001|Overall Study|Termination of study by sponsor|13|||
105682895|NCT02054741|364503098|FG000|Overall Study|Protocol Violation|13|||
105682896|NCT02054741|364503099|FG001|Overall Study|Protocol Violation|2|||
105682897|NCT02054741|364503098|FG000|Overall Study|Withdrawal by Subject|10|||
105682898|NCT02054741|364503099|FG001|Overall Study|Withdrawal by Subject|5|||
105682899|NCT02054741|364503098|FG000|Overall Study|Death|94|||
105682900|NCT02054741|364503099|FG001|Overall Study|Death|90|||
105682901|NCT02054741|364503098|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
105682902|NCT02054741|364503099|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
105682903|NCT01098097|364503100|FG000|Overall Study|Adverse Event|17|||
105682904|NCT01098097|364503100|FG000|Overall Study|Lost to Follow-up|18|||
105682905|NCT01098097|364503100|FG000|Overall Study|Status unknown|16|||
105682906|NCT01098097|364503100|FG000|Overall Study|No reason reported|31|||
105682907|NCT01411215|364503101|FG000|Overall Study|Adverse Event|1|||
105682908|NCT01411215|364503102|FG001|Overall Study|Adverse Event|2|||
105682909|NCT01411215|364503101|FG000|Overall Study|Lack of Efficacy|2|||
105682910|NCT01411215|364503102|FG001|Overall Study|Lack of Efficacy|4|||
105682911|NCT01411215|364503101|FG000|Overall Study|Lost to Follow-up|12|||
105682912|NCT01411215|364503102|FG001|Overall Study|Lost to Follow-up|18|||
105682913|NCT01411215|364503101|FG000|Overall Study|Did not meet entrance criteria|0|||
105682914|NCT01411215|364503102|FG001|Overall Study|Did not meet entrance criteria|1|||
105682915|NCT01411215|364503101|FG000|Overall Study|Study terminated by sponsor|2|||
105682916|NCT01411215|364503102|FG001|Overall Study|Study terminated by sponsor|15|||
105682917|NCT01411215|364503101|FG000|Overall Study|Protocol Violation|3|||
105682918|NCT01411215|364503102|FG001|Overall Study|Protocol Violation|5|||
105682919|NCT01411215|364503101|FG000|Overall Study|Withdrawal by Subject|34|||
105682920|NCT01411215|364503102|FG001|Overall Study|Withdrawal by Subject|21|||
105682921|NCT01411215|364503101|FG000|Overall Study|Other|12|||
105682922|NCT01411215|364503102|FG001|Overall Study|Other|17|||
105682923|NCT01411215|364503101|FG000|Overall Study|Screen failure|0|||
105682924|NCT01411215|364503102|FG001|Overall Study|Screen failure|1|||
105682925|NCT00848926|364503105|FG000|Treatment Period|Progressive disease|45|||
105682926|NCT00848926|364503105|FG000|Treatment Period|Adverse Event|20|||
105468798|NCT02699749|363725988|FG001|Overall Study|Progressive Disease|3|||
105468799|NCT02699749|363725989|FG002|Overall Study|Progressive Disease|14|||
105682927|NCT00848926|364503105|FG000|Treatment Period|Physician Decision|12|||
105682928|NCT00848926|364503105|FG000|Treatment Period|Withdrawal by Subject|7|||
105682929|NCT00848926|364503105|FG000|Follow-up Period|Lost to Follow-up|7|||
105682930|NCT00848926|364503105|FG000|Follow-up Period|Withdrawal by Subject|3|||
105682931|NCT00848926|364503105|FG000|Follow-up Period|Other|2|||
105682932|NCT00394082|364503106|FG000|Overall Study|Unacceptable toxicity|15|||
105682933|NCT00394082|364503106|FG000|Overall Study|Adverse Event|4|||
105682934|NCT00394082|364503106|FG000|Overall Study|Physician Decision|4|||
105682935|NCT00394082|364503106|FG000|Overall Study|Withdrawal by Subject|2|||
105682936|NCT00394082|364503106|FG000|Overall Study|Other|1|||
105682937|NCT04025580|364503107|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
105682938|NCT04025580|364503108|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
105682939|NCT04025580|364503109|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
105682940|NCT02325557|364503110|FG000|Overall Study|Progressive disease|1|||
105682941|NCT02325557|364503111|FG001|Overall Study|Progressive disease|0|||
105682942|NCT02325557|364503112|FG002|Overall Study|Progressive disease|0|||
105682943|NCT02325557|364503113|FG003|Overall Study|Progressive disease|0|||
105682944|NCT02325557|364503110|FG000|Overall Study|Withdrawal by Subject|4|||
105682945|NCT02325557|364503111|FG001|Overall Study|Withdrawal by Subject|0|||
105682946|NCT02325557|364503112|FG002|Overall Study|Withdrawal by Subject|0|||
105682947|NCT02325557|364503113|FG003|Overall Study|Withdrawal by Subject|15|||
105682948|NCT02325557|364503110|FG000|Overall Study|Death|5|||
105682949|NCT02325557|364503111|FG001|Overall Study|Death|1|||
105682950|NCT02325557|364503112|FG002|Overall Study|Death|1|||
105682951|NCT02325557|364503113|FG003|Overall Study|Death|16|||
105682952|NCT02325557|364503110|FG000|Overall Study|Lost to Follow-up|0|||
105682953|NCT02325557|364503111|FG001|Overall Study|Lost to Follow-up|0|||
105682954|NCT02325557|364503112|FG002|Overall Study|Lost to Follow-up|1|||
105682955|NCT02325557|364503113|FG003|Overall Study|Lost to Follow-up|1|||
105682956|NCT02325557|364503110|FG000|Overall Study|Other|0|||
105682957|NCT02325557|364503111|FG001|Overall Study|Other|0|||
105682958|NCT02325557|364503112|FG002|Overall Study|Other|0|||
105682959|NCT02325557|364503113|FG003|Overall Study|Other|5|||
105682964|NCT01768117|364503116|FG000|Overall Study|Lost to Follow-up|1|||
105682965|NCT01768117|364503116|FG000|Overall Study|Withdrawal by Subject|2|||
105682966|NCT01768117|364503116|FG000|Overall Study|Protocol Violation|3|||
105682967|NCT02752074|364503117|FG000|Overall Study|Lost to Follow-up|1|||
105682968|NCT02752074|364503118|FG001|Overall Study|Lost to Follow-up|4|||
105682969|NCT02752074|364503117|FG000|Overall Study|Death|146|||
105682970|NCT02752074|364503118|FG001|Overall Study|Death|129|||
105682971|NCT02752074|364503117|FG000|Overall Study|Withdrawal by Subject|9|||
105682972|NCT02752074|364503118|FG001|Overall Study|Withdrawal by Subject|10|||
105682973|NCT00938860|364503121|FG000|Overall Study|Adverse Event|2|||
105682974|NCT00938860|364503122|FG001|Overall Study|Adverse Event|1|||
105682975|NCT00938860|364503121|FG000|Overall Study|Abnormal laboratory values|2|||
105682976|NCT00938860|364503122|FG001|Overall Study|Abnormal laboratory values|2|||
105682977|NCT00938860|364503121|FG000|Overall Study|Withdrawal by Subject|11|||
105682978|NCT00938860|364503122|FG001|Overall Study|Withdrawal by Subject|8|||
105682979|NCT00938860|364503121|FG000|Overall Study|Lost to Follow-up|4|||
105682980|NCT00938860|364503122|FG001|Overall Study|Lost to Follow-up|4|||
105682981|NCT00938860|364503121|FG000|Overall Study|Administration problems|2|||
105682982|NCT00938860|364503122|FG001|Overall Study|Administration problems|0|||
105682983|NCT00938860|364503121|FG000|Overall Study|Death|1|||
105682984|NCT00938860|364503122|FG001|Overall Study|Death|1|||
105682985|NCT00938860|364503121|FG000|Overall Study|Protocol Violation|3|||
105682986|NCT00938860|364503122|FG001|Overall Study|Protocol Violation|1|||
105682987|NCT01477333|364503123|FG000|Overall Study|Adverse Event|1|||
105682988|NCT01477333|364503123|FG000|Overall Study|Withdrawal by Subject|1|||
105682989|NCT01477333|364503123|FG000|Overall Study|Clinical Deterioration|1|||
105682990|NCT02004353|364503126|FG000|Overall Study|Voluntary participation|1334|||
105682991|NCT01691768|364503127|FG000|Overall Study|Death|0|||
105682992|NCT01691768|364503128|FG001|Overall Study|Death|2|||
105682993|NCT01691768|364503127|FG000|Overall Study|Lost to Follow-up|4|||
105682994|NCT01691768|364503128|FG001|Overall Study|Lost to Follow-up|3|||
105682995|NCT01691768|364503127|FG000|Overall Study|Withdrawal by Subject|10|||
105682996|NCT01691768|364503128|FG001|Overall Study|Withdrawal by Subject|9|||
105682997|NCT01691768|364503127|FG000|Overall Study|Relocated|0|||
105682998|NCT01691768|364503128|FG001|Overall Study|Relocated|1|||
105682999|NCT01691768|364503127|FG000|Overall Study|Investigator decision|1|||
105683000|NCT01691768|364503128|FG001|Overall Study|Investigator decision|1|||
105468800|NCT02699749|363725990|FG003|Overall Study|Progressive Disease|3|||
105683001|NCT00336895|364503129|FG000|Overall Study|diarrhea|1|||
105683002|NCT00336895|364503129|FG000|Overall Study|nausea and upset stomach|1|||
105683003|NCT00336895|364503129|FG000|Overall Study|Physician Decision|1|||
105683004|NCT00336895|364503129|FG000|Overall Study|screen failed|1|||
105468801|NCT02699749|363725991|FG004|Overall Study|Progressive Disease|3|||
105468802|NCT02699749|363725992|FG005|Overall Study|Progressive Disease|7|||
105468803|NCT02699749|363725993|FG006|Overall Study|Progressive Disease|5|||
105468804|NCT02699749|363725994|FG007|Overall Study|Progressive Disease|5|||
105468805|NCT02699749|363725995|FG008|Overall Study|Progressive Disease|6|||
105468806|NCT02699749|363725996|FG009|Overall Study|Progressive Disease|6|||
105468807|NCT02699749|363725997|FG010|Overall Study|Progressive Disease|5|||
105468808|NCT02699749|363725998|FG011|Overall Study|Progressive Disease|4|||
105468809|NCT02699749|363725999|FG012|Overall Study|Progressive Disease|3|||
105344476|NCT03191864|363261791|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
105344477|NCT03191864|363261792|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
105344478|NCT03191864|363261793|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
105344479|NCT03191864|363261794|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
105344480|NCT03191864|363261795|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
105344481|NCT03191864|363261790|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
105344482|NCT03191864|363261791|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
105344483|NCT03191864|363261792|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
105344484|NCT03191864|363261793|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
105344485|NCT03191864|363261794|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
105344486|NCT03191864|363261795|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
105344487|NCT03191864|363261790|FG000|Part 1 - Induction|Adverse Event|0|||
105344488|NCT03191864|363261791|FG001|Part 1 - Induction|Adverse Event|2|||
105344489|NCT03191864|363261792|FG002|Part 1 - Induction|Adverse Event|0|||
105344490|NCT03191864|363261793|FG003|Part 1 - Induction|Adverse Event|1|||
105344491|NCT03191864|363261794|FG004|Part 1 - Induction|Adverse Event|0|||
105344492|NCT03191864|363261795|FG005|Part 1 - Induction|Adverse Event|2|||
105468810|NCT02699749|363726000|FG013|Overall Study|Progressive Disease|5|||
105468811|NCT02699749|363725987|FG000|Overall Study|Death|0|||
105468812|NCT02699749|363725988|FG001|Overall Study|Death|0|||
105468813|NCT02699749|363725989|FG002|Overall Study|Death|0|||
105468814|NCT02699749|363725990|FG003|Overall Study|Death|0|||
105468815|NCT02699749|363725991|FG004|Overall Study|Death|0|||
105468816|NCT02699749|363725992|FG005|Overall Study|Death|0|||
105468817|NCT02699749|363725993|FG006|Overall Study|Death|0|||
105468818|NCT02699749|363725994|FG007|Overall Study|Death|0|||
105468819|NCT02699749|363725995|FG008|Overall Study|Death|0|||
105468820|NCT02699749|363725996|FG009|Overall Study|Death|0|||
105468821|NCT02699749|363725997|FG010|Overall Study|Death|0|||
105468822|NCT02699749|363725998|FG011|Overall Study|Death|0|||
105468823|NCT02699749|363725999|FG012|Overall Study|Death|0|||
105468824|NCT02699749|363726000|FG013|Overall Study|Death|1|||
105468825|NCT02699749|363725987|FG000|Overall Study|Lost to Follow-up|0|||
105468826|NCT02699749|363725988|FG001|Overall Study|Lost to Follow-up|0|||
105468827|NCT02699749|363725989|FG002|Overall Study|Lost to Follow-up|0|||
105468828|NCT02699749|363725990|FG003|Overall Study|Lost to Follow-up|0|||
105468829|NCT02699749|363725991|FG004|Overall Study|Lost to Follow-up|0|||
105468830|NCT02699749|363725992|FG005|Overall Study|Lost to Follow-up|1|||
105468831|NCT02699749|363725993|FG006|Overall Study|Lost to Follow-up|0|||
105468832|NCT02699749|363725994|FG007|Overall Study|Lost to Follow-up|1|||
105468833|NCT02699749|363725995|FG008|Overall Study|Lost to Follow-up|0|||
105468834|NCT02699749|363725996|FG009|Overall Study|Lost to Follow-up|0|||
105468835|NCT02699749|363725997|FG010|Overall Study|Lost to Follow-up|0|||
105468836|NCT02699749|363725998|FG011|Overall Study|Lost to Follow-up|0|||
105468837|NCT02699749|363725999|FG012|Overall Study|Lost to Follow-up|0|||
105468838|NCT02699749|363726000|FG013|Overall Study|Lost to Follow-up|0|||
105468839|NCT02377817|363726001|FG000|Overall Study|Transportation/childcare barriers.|2|||
105468840|NCT02377817|363726002|FG001|Overall Study|Transportation/childcare barriers.|0|||
105468841|NCT02377817|363726001|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
105468842|NCT02377817|363726002|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
105468843|NCT03895840|363726003|FG000|Overall Study|Withdrawal by Subject|21|||
105468844|NCT02565108|363726004|FG000|Overall Study|Adverse Event|1|||
105468845|NCT02565108|363726005|FG001|Overall Study|Adverse Event|0|||
105468846|NCT02565108|363726004|FG000|Overall Study|Withdrew Consent|1|||
105468847|NCT02565108|363726005|FG001|Overall Study|Withdrew Consent|0|||
105468848|NCT01310075|363726006|FG000|Overall Study|Lost to Follow-up|1|||
105468849|NCT01310075|363726007|FG001|Overall Study|Lost to Follow-up|0|||
105468850|NCT01310075|363726006|FG000|Overall Study|Physician Decision|10|||
105468851|NCT01310075|363726007|FG001|Overall Study|Physician Decision|7|||
105468852|NCT01310075|363726006|FG000|Overall Study|Protocol Violation|2|||
105468853|NCT01310075|363726007|FG001|Overall Study|Protocol Violation|2|||
105468854|NCT01310075|363726006|FG000|Overall Study|Withdrawal by Subject|1|||
105468855|NCT01310075|363726007|FG001|Overall Study|Withdrawal by Subject|1|||
105468856|NCT03614156|363726008|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
105468857|NCT03614156|363726009|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
105468858|NCT03614156|363726010|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
105468859|NCT03614156|363726011|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
105468860|NCT03614156|363726008|FG000|Open-Label Treatment Period|Adverse Event|7|||
105468861|NCT03614156|363726009|FG001|Open-Label Treatment Period|Adverse Event|0|||
105468862|NCT03614156|363726010|FG002|Open-Label Treatment Period|Adverse Event|0|||
105468863|NCT03614156|363726011|FG003|Open-Label Treatment Period|Adverse Event|0|||
105468864|NCT03614156|363726008|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
105468865|NCT03614156|363726009|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
105468866|NCT03614156|363726010|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
105468867|NCT03614156|363726011|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
105683005|NCT00906945|364503130|FG000|Overall Study|Found to be not eligible|0|||
105683006|NCT00906945|364503131|FG001|Overall Study|Found to be not eligible|0|||
105683007|NCT00906945|364503132|FG002|Overall Study|Found to be not eligible|0|||
105683008|NCT00906945|364503133|FG003|Overall Study|Found to be not eligible|1|||
105683009|NCT00906945|364503134|FG004|Overall Study|Found to be not eligible|1|||
105683010|NCT00906945|364503135|FG005|Overall Study|Found to be not eligible|1|||
105683011|NCT00906945|364503130|FG000|Overall Study|Physician Decision|0|||
105683012|NCT00906945|364503131|FG001|Overall Study|Physician Decision|0|||
105683013|NCT00906945|364503132|FG002|Overall Study|Physician Decision|0|||
105683014|NCT00906945|364503133|FG003|Overall Study|Physician Decision|0|||
105683015|NCT00906945|364503134|FG004|Overall Study|Physician Decision|0|||
105683016|NCT00906945|364503135|FG005|Overall Study|Physician Decision|1|||
105683017|NCT01768637|364503136|FG000|Overall Study|Lost to Follow-up|2|||
105683018|NCT01768637|364503137|FG001|Overall Study|Lost to Follow-up|7|||
105683019|NCT01768637|364503136|FG000|Overall Study|Difficult blood draw|1|||
105683020|NCT01768637|364503137|FG001|Overall Study|Difficult blood draw|0|||
105683021|NCT02481947|364503138|FG000|Overall Study|Withdrawal by Subject|24|||
105683022|NCT02481947|364503139|FG001|Overall Study|Withdrawal by Subject|10|||
105683023|NCT02481947|364503138|FG000|Overall Study|Lost to Follow-up|11|||
105683024|NCT02481947|364503139|FG001|Overall Study|Lost to Follow-up|5|||
105683025|NCT02481947|364503138|FG000|Overall Study|Adverse Event|6|||
105683026|NCT02481947|364503139|FG001|Overall Study|Adverse Event|11|||
105683027|NCT02481947|364503138|FG000|Overall Study|Physician Decision|4|||
105683028|NCT02481947|364503139|FG001|Overall Study|Physician Decision|5|||
105683029|NCT02481947|364503138|FG000|Overall Study|Protocol Violation|1|||
105683030|NCT02481947|364503139|FG001|Overall Study|Protocol Violation|5|||
105683031|NCT01054170|364503140|FG000|Overall Study|Protocol Violation|1|||
105683032|NCT01054170|364503141|FG001|Overall Study|Protocol Violation|0|||
105683033|NCT01054170|364503140|FG000|Overall Study|Withdrawal by Subject|3|||
105683034|NCT01054170|364503141|FG001|Overall Study|Withdrawal by Subject|2|||
105683035|NCT01054170|364503140|FG000|Overall Study|Adverse Event|0|||
105683036|NCT01054170|364503141|FG001|Overall Study|Adverse Event|4|||
105683037|NCT01442779|364503142|FG000|Overall Study|Withdrawal by Subject|3|||
105683038|NCT01442779|364503142|FG000|Overall Study|Death|3|||
105683039|NCT01442779|364503142|FG000|Overall Study|Non-compliance|1|||
105683040|NCT01048671|364503143|FG000|Overall Study|Protocol Violation|0|||
105683041|NCT01048671|364503144|FG001|Overall Study|Protocol Violation|1|||
105683042|NCT01048671|364503145|FG002|Overall Study|Protocol Violation|1|||
105683043|NCT02009761|364503146|FG000|Overall Study|Adverse Event|4|||
105683044|NCT01815138|364503147|FG000|Overall Study|Withdrawal by Subject|0|||
105683045|NCT01815138|364503148|FG001|Overall Study|Withdrawal by Subject|1|||
105557868|NCT02261493|364039165|FG000|Overall Study|Lost to Follow-up|14|||
105344493|NCT03191864|363261790|FG000|Part 1 - Induction|Randomized but never dosed|0|||
105344494|NCT03191864|363261791|FG001|Part 1 - Induction|Randomized but never dosed|0|||
105344495|NCT03191864|363261792|FG002|Part 1 - Induction|Randomized but never dosed|1|||
105344496|NCT03191864|363261793|FG003|Part 1 - Induction|Randomized but never dosed|0|||
105344497|NCT03191864|363261794|FG004|Part 1 - Induction|Randomized but never dosed|0|||
105344498|NCT03191864|363261795|FG005|Part 1 - Induction|Randomized but never dosed|0|||
105344499|NCT03191864|363261790|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
105344500|NCT03191864|363261791|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
105344501|NCT03191864|363261792|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
105344502|NCT03191864|363261793|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
105344503|NCT03191864|363261794|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
105344504|NCT03191864|363261795|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
105344505|NCT03191864|363261790|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
105344506|NCT03191864|363261791|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
105344507|NCT03191864|363261792|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
105344508|NCT03191864|363261793|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
105344509|NCT03191864|363261794|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
105344510|NCT03191864|363261795|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
105344511|NCT03191864|363261790|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
105344512|NCT03191864|363261791|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
105344513|NCT03191864|363261792|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
105344514|NCT03191864|363261793|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
105344515|NCT03191864|363261794|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
105344516|NCT03191864|363261795|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
105344517|NCT03191864|363261790|FG000|Part 2 - Maintenance|Physician Decision|1|||
105344518|NCT03191864|363261791|FG001|Part 2 - Maintenance|Physician Decision|0|||
105344519|NCT03191864|363261792|FG002|Part 2 - Maintenance|Physician Decision|0|||
105344520|NCT03191864|363261793|FG003|Part 2 - Maintenance|Physician Decision|0|||
105344521|NCT03191864|363261794|FG004|Part 2 - Maintenance|Physician Decision|0|||
105683046|NCT01815138|364503147|FG000|Overall Study|Physician Decision|8|||
105344522|NCT03191864|363261795|FG005|Part 2 - Maintenance|Physician Decision|0|||
105344523|NCT03191864|363261790|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
105344524|NCT03191864|363261791|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
105344525|NCT03191864|363261792|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
105344526|NCT03191864|363261793|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
105344527|NCT03191864|363261794|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
105344528|NCT03191864|363261795|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
105344529|NCT03191864|363261790|FG000|Part 2 - Maintenance|Adverse Event|0|||
105344530|NCT03191864|363261791|FG001|Part 2 - Maintenance|Adverse Event|0|||
105344531|NCT03191864|363261792|FG002|Part 2 - Maintenance|Adverse Event|0|||
105344532|NCT03191864|363261793|FG003|Part 2 - Maintenance|Adverse Event|0|||
105344533|NCT03191864|363261794|FG004|Part 2 - Maintenance|Adverse Event|1|||
105683047|NCT01815138|364503148|FG001|Overall Study|Physician Decision|5|||
105683048|NCT03426267|364503151|FG000|Overall Study|Physician Decision|1|||
105683049|NCT03426267|364503152|FG001|Overall Study|Physician Decision|4|||
105683050|NCT03426267|364503151|FG000|Overall Study|Lost to Follow-up|1|||
105683051|NCT03426267|364503152|FG001|Overall Study|Lost to Follow-up|0|||
105344534|NCT03191864|363261795|FG005|Part 2 - Maintenance|Adverse Event|0|||
105344535|NCT03191864|363261790|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
105683052|NCT03426267|364503151|FG000|Overall Study|Withdrawal by Subject|4|||
105683053|NCT03426267|364503152|FG001|Overall Study|Withdrawal by Subject|10|||
105683054|NCT03426267|364503151|FG000|Overall Study|Protocol Violation|1|||
105683055|NCT03426267|364503152|FG001|Overall Study|Protocol Violation|3|||
105683056|NCT03426267|364503151|FG000|Overall Study|Adverse Event|9|||
105683057|NCT03426267|364503152|FG001|Overall Study|Adverse Event|27|||
105683058|NCT03426267|364503151|FG000|Overall Study|Prohibited Treatment Intake|2|||
105683059|NCT03426267|364503152|FG001|Overall Study|Prohibited Treatment Intake|3|||
105683060|NCT03426267|364503151|FG000|Overall Study|Lack of Efficacy|0|||
105683061|NCT03426267|364503152|FG001|Overall Study|Lack of Efficacy|25|||
105344536|NCT03191864|363261791|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
105344537|NCT03191864|363261792|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
105344538|NCT03191864|363261793|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
105344539|NCT03191864|363261794|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
105683062|NCT03426267|364503151|FG000|Overall Study|other|3|||
105344540|NCT03191864|363261795|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
105344541|NCT03191864|363261790|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
105468868|NCT03614156|363726008|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
105468869|NCT03614156|363726009|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
105683063|NCT03426267|364503152|FG001|Overall Study|other|0|||
105683064|NCT01209780|364503153|FG000|Overall Study|Adverse Event|0|||
105683065|NCT01209780|364503154|FG001|Overall Study|Adverse Event|1|||
105683066|NCT01209780|364503155|FG002|Overall Study|Adverse Event|0|||
105683067|NCT01209780|364503156|FG003|Overall Study|Adverse Event|0|||
105557869|NCT02261493|364039166|FG001|Overall Study|Lost to Follow-up|27|||
105557870|NCT02261493|364039167|FG002|Overall Study|Lost to Follow-up|8|||
105557871|NCT02261493|364039165|FG000|Overall Study|Pregnancy|1|||
105557872|NCT02261493|364039166|FG001|Overall Study|Pregnancy|2|||
105557873|NCT02261493|364039167|FG002|Overall Study|Pregnancy|0|||
105557874|NCT02261493|364039165|FG000|Overall Study|Lack of Efficacy|0|||
105557875|NCT02261493|364039166|FG001|Overall Study|Lack of Efficacy|1|||
105557876|NCT02261493|364039167|FG002|Overall Study|Lack of Efficacy|0|||
105557877|NCT02261493|364039165|FG000|Overall Study|Adverse Event|0|||
105557878|NCT02261493|364039166|FG001|Overall Study|Adverse Event|1|||
105557879|NCT02261493|364039167|FG002|Overall Study|Adverse Event|0|||
105557880|NCT04402866|364039170|FG000|Overall Study|Discontinued Prior to Treatment|0|||
105557881|NCT04402866|364039171|FG001|Overall Study|Discontinued Prior to Treatment|0|||
105557882|NCT04402866|364039172|FG002|Overall Study|Discontinued Prior to Treatment|0|||
105557883|NCT04402866|364039173|FG003|Overall Study|Discontinued Prior to Treatment|0|||
105557884|NCT04402866|364039174|FG004|Overall Study|Discontinued Prior to Treatment|2|||
105557885|NCT04402866|364039175|FG005|Overall Study|Discontinued Prior to Treatment|3|||
105557886|NCT04402866|364039170|FG000|Overall Study|Adverse Event|2|||
105557887|NCT04402866|364039171|FG001|Overall Study|Adverse Event|1|||
105557888|NCT04402866|364039172|FG002|Overall Study|Adverse Event|0|||
105557889|NCT04402866|364039173|FG003|Overall Study|Adverse Event|0|||
105557890|NCT04402866|364039174|FG004|Overall Study|Adverse Event|13|||
105557891|NCT04402866|364039175|FG005|Overall Study|Adverse Event|8|||
105557892|NCT04402866|364039170|FG000|Overall Study|Miscellaneous|0|||
105557893|NCT04402866|364039171|FG001|Overall Study|Miscellaneous|0|||
105557894|NCT04402866|364039172|FG002|Overall Study|Miscellaneous|1|||
105557895|NCT04402866|364039173|FG003|Overall Study|Miscellaneous|0|||
105557896|NCT04402866|364039174|FG004|Overall Study|Miscellaneous|0|||
105557897|NCT04402866|364039175|FG005|Overall Study|Miscellaneous|0|||
105557898|NCT04402866|364039170|FG000|Overall Study|Lost to Follow-up|0|||
105557899|NCT04402866|364039171|FG001|Overall Study|Lost to Follow-up|0|||
105557900|NCT04402866|364039172|FG002|Overall Study|Lost to Follow-up|0|||
105557901|NCT04402866|364039173|FG003|Overall Study|Lost to Follow-up|0|||
105557902|NCT04402866|364039174|FG004|Overall Study|Lost to Follow-up|0|||
105557903|NCT04402866|364039175|FG005|Overall Study|Lost to Follow-up|1|||
105557904|NCT04402866|364039170|FG000|Overall Study|Withdrawal by Subject|0|||
105557905|NCT04402866|364039171|FG001|Overall Study|Withdrawal by Subject|0|||
105557906|NCT04402866|364039172|FG002|Overall Study|Withdrawal by Subject|0|||
105557907|NCT04402866|364039173|FG003|Overall Study|Withdrawal by Subject|0|||
105557908|NCT04402866|364039174|FG004|Overall Study|Withdrawal by Subject|0|||
105557909|NCT04402866|364039175|FG005|Overall Study|Withdrawal by Subject|2|||
105557910|NCT03643952|364039176|FG000|Overall Study|Lack of Efficacy|1|||
105557911|NCT01358968|364039177|FG000|Period 2|Adverse Event|0|||
105557912|NCT01358968|364039178|FG001|Period 2|Adverse Event|1|||
105557913|NCT01358968|364039179|FG002|Period 2|Adverse Event|0|||
105557914|NCT01358968|364039180|FG003|Period 2|Adverse Event|0|||
105557915|NCT01358968|364039177|FG000|Continued Access Phase|Progression of Disease|0|||
105557916|NCT01358968|364039178|FG001|Continued Access Phase|Progression of Disease|0|||
105557917|NCT01358968|364039179|FG002|Continued Access Phase|Progression of Disease|8|||
105557918|NCT01358968|364039180|FG003|Continued Access Phase|Progression of Disease|4|||
105557919|NCT01358968|364039177|FG000|Continued Access Phase|Protocol Violation|0|||
105557920|NCT01358968|364039178|FG001|Continued Access Phase|Protocol Violation|0|||
105557921|NCT01358968|364039179|FG002|Continued Access Phase|Protocol Violation|0|||
105468870|NCT03614156|363726010|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
105468871|NCT03614156|363726011|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
105468872|NCT03614156|363726008|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
105468873|NCT03614156|363726009|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
105468874|NCT03614156|363726010|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
105468875|NCT03614156|363726011|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
105468876|NCT03614156|363726008|FG000|Open-Label Treatment Period|Protocol Violation|2|||
105468877|NCT03614156|363726009|FG001|Open-Label Treatment Period|Protocol Violation|0|||
105468878|NCT03614156|363726010|FG002|Open-Label Treatment Period|Protocol Violation|0|||
105468879|NCT03614156|363726011|FG003|Open-Label Treatment Period|Protocol Violation|0|||
105468880|NCT03614156|363726008|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
105468881|NCT03614156|363726009|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
105468882|NCT03614156|363726010|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
105468883|NCT03614156|363726011|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
105468884|NCT03614156|363726008|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
105468885|NCT03614156|363726009|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
105468886|NCT03614156|363726010|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
105468887|NCT03614156|363726011|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
105468888|NCT03614156|363726008|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
105468889|NCT03614156|363726009|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
105468890|NCT03614156|363726010|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
105468891|NCT03614156|363726011|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
105468892|NCT03614156|363726008|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
105468893|NCT03614156|363726009|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
105468894|NCT03614156|363726010|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
105683068|NCT01209780|364503157|FG004|Overall Study|Adverse Event|0|||
105683069|NCT01209780|364503153|FG000|Overall Study|Withdrawal by Subject|9|||
105468895|NCT03614156|363726011|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
105468896|NCT03614156|363726008|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
105468897|NCT03614156|363726009|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
105468898|NCT03614156|363726010|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
105468899|NCT03614156|363726011|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
105468900|NCT03614156|363726008|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
105468901|NCT03614156|363726009|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
105468902|NCT03614156|363726010|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
105468903|NCT03614156|363726011|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
105468904|NCT03614156|363726008|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
105468905|NCT03614156|363726009|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
105468906|NCT03614156|363726010|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
105683070|NCT01209780|364503154|FG001|Overall Study|Withdrawal by Subject|2|||
105683071|NCT01209780|364503155|FG002|Overall Study|Withdrawal by Subject|1|||
105683072|NCT01209780|364503156|FG003|Overall Study|Withdrawal by Subject|1|||
105683073|NCT01209780|364503157|FG004|Overall Study|Withdrawal by Subject|0|||
105683074|NCT01209780|364503153|FG000|Overall Study|Lost to Follow-up|17|||
105683075|NCT01209780|364503154|FG001|Overall Study|Lost to Follow-up|12|||
105683076|NCT01209780|364503155|FG002|Overall Study|Lost to Follow-up|3|||
105683077|NCT01209780|364503156|FG003|Overall Study|Lost to Follow-up|9|||
105683078|NCT01209780|364503157|FG004|Overall Study|Lost to Follow-up|4|||
105683079|NCT01209780|364503153|FG000|Overall Study|Protocol Violation|0|||
105683080|NCT01209780|364503154|FG001|Overall Study|Protocol Violation|1|||
105683081|NCT01209780|364503155|FG002|Overall Study|Protocol Violation|0|||
105683082|NCT01209780|364503156|FG003|Overall Study|Protocol Violation|0|||
105683083|NCT01209780|364503157|FG004|Overall Study|Protocol Violation|0|||
105683084|NCT01209780|364503153|FG000|Overall Study|Inappropriate enrollment|0|||
105683085|NCT01209780|364503154|FG001|Overall Study|Inappropriate enrollment|2|||
105683086|NCT01209780|364503155|FG002|Overall Study|Inappropriate enrollment|0|||
105683087|NCT01209780|364503156|FG003|Overall Study|Inappropriate enrollment|0|||
105683088|NCT01209780|364503157|FG004|Overall Study|Inappropriate enrollment|1|||
105683089|NCT01272804|364503162|FG000|Overall Study|Adverse Event|1|||
105683090|NCT01272804|364503163|FG001|Overall Study|Adverse Event|0|||
105683091|NCT01272804|364503164|FG002|Overall Study|Adverse Event|0|||
105683092|NCT01272804|364503165|FG003|Overall Study|Adverse Event|0|||
105683093|NCT01272804|364503166|FG004|Overall Study|Adverse Event|2|||
105683094|NCT01272804|364503167|FG005|Overall Study|Adverse Event|1|||
105683095|NCT02076178|364503168|FG000|Oral Phase|Adverse Event|0|||
105683096|NCT02076178|364503169|FG001|Oral Phase|Adverse Event|7|||
105683097|NCT02076178|364503168|FG000|Oral Phase|Withdrawal by Subject|0|||
105683098|NCT02076178|364503169|FG001|Oral Phase|Withdrawal by Subject|4|||
105683099|NCT02076178|364503168|FG000|Oral Phase|Physician Decision|0|||
105683100|NCT02076178|364503169|FG001|Oral Phase|Physician Decision|1|||
105683101|NCT02076178|364503168|FG000|Injection Phase|Protocol defined stopping criteria|1|||
105683102|NCT02076178|364503169|FG001|Injection Phase|Protocol defined stopping criteria|0|||
105683103|NCT02076178|364503168|FG000|Injection Phase|Withdrawal by Subject|0|||
105683104|NCT02076178|364503169|FG001|Injection Phase|Withdrawal by Subject|3|||
105683105|NCT02076178|364503168|FG000|Injection Phase|Physician Decision|0|||
105683106|NCT02076178|364503169|FG001|Injection Phase|Physician Decision|3|||
105683107|NCT02076178|364503168|FG000|Injection Phase|Lost to Follow-up|0|||
105683108|NCT02076178|364503169|FG001|Injection Phase|Lost to Follow-up|1|||
105683109|NCT00705523|364503170|FG000|Overall Study|Lost to Follow-up|2|||
105683110|NCT00705523|364503171|FG001|Overall Study|Lost to Follow-up|3|||
105683111|NCT02640157|364503172|FG000|Overall Study|Adverse Event|2|||
105683112|NCT02640157|364503173|FG001|Overall Study|Adverse Event|2|||
105683113|NCT02640157|364503174|FG002|Overall Study|Adverse Event|1|||
105683114|NCT02640157|364503172|FG000|Overall Study|Withdrew consent|2|||
105683115|NCT02640157|364503173|FG001|Overall Study|Withdrew consent|0|||
105683116|NCT02640157|364503174|FG002|Overall Study|Withdrew consent|2|||
105683117|NCT02640157|364503172|FG000|Overall Study|Lost to Follow-up|9|||
105683118|NCT02640157|364503173|FG001|Overall Study|Lost to Follow-up|2|||
105683119|NCT02640157|364503174|FG002|Overall Study|Lost to Follow-up|7|||
105683120|NCT02640157|364503172|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
105683121|NCT02640157|364503173|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
105683122|NCT02640157|364503174|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
105683123|NCT00710021|364503175|FG000|Overall Study|Lost to Follow-up|1|||
105683124|NCT00710021|364503176|FG001|Overall Study|Lost to Follow-up|0|||
105683125|NCT00710021|364503177|FG002|Overall Study|Lost to Follow-up|0|||
105683126|NCT00710021|364503175|FG000|Overall Study|Subject's Decision|0|||
105683127|NCT00710021|364503176|FG001|Overall Study|Subject's Decision|1|||
105683128|NCT00710021|364503177|FG002|Overall Study|Subject's Decision|0|||
105683129|NCT00710021|364503175|FG000|Overall Study|Subject misrandomized|0|||
105683130|NCT00710021|364503176|FG001|Overall Study|Subject misrandomized|1|||
105683131|NCT00710021|364503177|FG002|Overall Study|Subject misrandomized|1|||
105683132|NCT00710021|364503175|FG000|Overall Study|Physician Decision|0|||
105683133|NCT00710021|364503176|FG001|Overall Study|Physician Decision|1|||
105683134|NCT00710021|364503177|FG002|Overall Study|Physician Decision|0|||
105683135|NCT04677179|364503179|FG000|Induction Treatment Period|Adverse Event|1|||
105683136|NCT04677179|364503180|FG001|Induction Treatment Period|Adverse Event|0|||
105683137|NCT04677179|364503181|FG002|Induction Treatment Period|Adverse Event|0|||
105683138|NCT04677179|364503182|FG003|Induction Treatment Period|Adverse Event|0|||
105683139|NCT04677179|364503183|FG004|Induction Treatment Period|Adverse Event|0|||
105683140|NCT04677179|364503184|FG005|Induction Treatment Period|Adverse Event|0|||
105683141|NCT04677179|364503185|FG006|Induction Treatment Period|Adverse Event|0|||
105683142|NCT04677179|364503186|FG007|Induction Treatment Period|Adverse Event|0|||
105683143|NCT04677179|364503187|FG008|Induction Treatment Period|Adverse Event|0|||
105683144|NCT04677179|364503188|FG009|Induction Treatment Period|Adverse Event|0|||
105683145|NCT04677179|364503179|FG000|Induction Treatment Period|Physician Decision|1|||
105683146|NCT04677179|364503180|FG001|Induction Treatment Period|Physician Decision|0|||
105683147|NCT04677179|364503181|FG002|Induction Treatment Period|Physician Decision|1|||
105683148|NCT04677179|364503182|FG003|Induction Treatment Period|Physician Decision|0|||
105683149|NCT04677179|364503183|FG004|Induction Treatment Period|Physician Decision|0|||
105683150|NCT04677179|364503184|FG005|Induction Treatment Period|Physician Decision|0|||
105683151|NCT04677179|364503185|FG006|Induction Treatment Period|Physician Decision|0|||
105683152|NCT04677179|364503186|FG007|Induction Treatment Period|Physician Decision|0|||
105683153|NCT04677179|364503187|FG008|Induction Treatment Period|Physician Decision|0|||
105683154|NCT04677179|364503188|FG009|Induction Treatment Period|Physician Decision|0|||
105683155|NCT04677179|364503179|FG000|Induction Treatment Period|Protocol Violation|0|||
105683156|NCT04677179|364503180|FG001|Induction Treatment Period|Protocol Violation|1|||
105683157|NCT04677179|364503181|FG002|Induction Treatment Period|Protocol Violation|0|||
105683158|NCT04677179|364503182|FG003|Induction Treatment Period|Protocol Violation|0|||
105683159|NCT04677179|364503183|FG004|Induction Treatment Period|Protocol Violation|0|||
105683160|NCT04677179|364503184|FG005|Induction Treatment Period|Protocol Violation|0|||
105683161|NCT04677179|364503185|FG006|Induction Treatment Period|Protocol Violation|0|||
105683162|NCT04677179|364503186|FG007|Induction Treatment Period|Protocol Violation|0|||
105683163|NCT04677179|364503187|FG008|Induction Treatment Period|Protocol Violation|0|||
105683164|NCT04677179|364503188|FG009|Induction Treatment Period|Protocol Violation|0|||
105683165|NCT04677179|364503179|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
105683166|NCT04677179|364503180|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
105683167|NCT04677179|364503181|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
105683168|NCT04677179|364503182|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
105683169|NCT04677179|364503183|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
105683170|NCT04677179|364503184|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
105683171|NCT04677179|364503185|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
105683172|NCT04677179|364503186|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
105683173|NCT04677179|364503187|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
105683174|NCT04677179|364503188|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
105683175|NCT04677179|364503179|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
105683176|NCT04677179|364503180|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
105683177|NCT04677179|364503181|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
105683178|NCT04677179|364503182|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
105683179|NCT04677179|364503183|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
105683180|NCT04677179|364503184|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
105683181|NCT04677179|364503185|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
105683182|NCT04677179|364503186|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
105683183|NCT04677179|364503187|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
105683184|NCT04677179|364503188|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
105683185|NCT04677179|364503179|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
105683186|NCT04677179|364503180|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
105683187|NCT04677179|364503181|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
105683188|NCT04677179|364503182|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
105683189|NCT04677179|364503183|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
105683190|NCT04677179|364503184|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
105683191|NCT04677179|364503185|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
105683192|NCT04677179|364503186|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
105683193|NCT04677179|364503187|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
105683194|NCT04677179|364503188|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
105683195|NCT04677179|364503179|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683196|NCT04677179|364503180|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683197|NCT04677179|364503181|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683198|NCT04677179|364503182|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
105683199|NCT04677179|364503183|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683200|NCT04677179|364503184|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683201|NCT04677179|364503185|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683202|NCT04677179|364503186|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683203|NCT04677179|364503187|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683204|NCT04677179|364503188|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683205|NCT04677179|364503179|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
105683206|NCT04677179|364503180|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
105683207|NCT04677179|364503181|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
105683208|NCT04677179|364503182|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
105683209|NCT04677179|364503183|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
105683210|NCT04677179|364503184|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
105683211|NCT04677179|364503185|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
105683212|NCT04677179|364503186|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
105683213|NCT04677179|364503187|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
105683214|NCT04677179|364503188|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
105683215|NCT04677179|364503179|FG000|Extension Treatment Period|Lack of Efficacy|0|||
105683216|NCT04677179|364503180|FG001|Extension Treatment Period|Lack of Efficacy|0|||
105683217|NCT04677179|364503181|FG002|Extension Treatment Period|Lack of Efficacy|0|||
105683218|NCT04677179|364503182|FG003|Extension Treatment Period|Lack of Efficacy|0|||
105683219|NCT04677179|364503183|FG004|Extension Treatment Period|Lack of Efficacy|0|||
105683220|NCT04677179|364503184|FG005|Extension Treatment Period|Lack of Efficacy|0|||
105683221|NCT04677179|364503185|FG006|Extension Treatment Period|Lack of Efficacy|6|||
105683222|NCT04677179|364503186|FG007|Extension Treatment Period|Lack of Efficacy|0|||
105683223|NCT04677179|364503187|FG008|Extension Treatment Period|Lack of Efficacy|0|||
105683224|NCT04677179|364503188|FG009|Extension Treatment Period|Lack of Efficacy|0|||
105683225|NCT04677179|364503179|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
105683226|NCT04677179|364503180|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
105683227|NCT04677179|364503181|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
105683228|NCT04677179|364503182|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
105683229|NCT04677179|364503183|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
105683230|NCT04677179|364503184|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
105683231|NCT04677179|364503185|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
105683232|NCT04677179|364503186|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
105683233|NCT04677179|364503187|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
105683234|NCT04677179|364503188|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
105683235|NCT04677179|364503179|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
105683236|NCT04677179|364503180|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
105683237|NCT04677179|364503181|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
105683238|NCT04677179|364503182|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
105683239|NCT04677179|364503183|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
105683240|NCT04677179|364503184|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
105683241|NCT04677179|364503185|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
105683242|NCT04677179|364503186|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
105683243|NCT04677179|364503187|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
105683244|NCT04677179|364503188|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
105683245|NCT04677179|364503179|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
105683246|NCT04677179|364503180|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
105683247|NCT04677179|364503181|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
105683248|NCT04677179|364503182|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
105683249|NCT04677179|364503183|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
105683250|NCT04677179|364503184|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
105683251|NCT04677179|364503185|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
105683252|NCT04677179|364503186|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
105683253|NCT04677179|364503187|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
105683254|NCT04677179|364503188|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
105683255|NCT04677179|364503179|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
105683256|NCT04677179|364503180|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
105683257|NCT04677179|364503181|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
105683258|NCT04677179|364503182|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
105683259|NCT04677179|364503183|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
105683260|NCT04677179|364503184|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
105683261|NCT04677179|364503185|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
105683262|NCT04677179|364503186|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
105683263|NCT04677179|364503187|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
105683264|NCT04677179|364503188|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
105468907|NCT03614156|363726011|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
105683265|NCT04677179|364503179|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683266|NCT04677179|364503180|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683267|NCT04677179|364503181|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683268|NCT04677179|364503182|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683269|NCT04677179|364503183|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683270|NCT04677179|364503184|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683271|NCT04677179|364503185|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683272|NCT04677179|364503186|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
105683273|NCT04677179|364503187|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683274|NCT04677179|364503188|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683275|NCT04677179|364503179|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683276|NCT04677179|364503180|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683277|NCT04677179|364503181|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683278|NCT04677179|364503182|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683279|NCT04677179|364503183|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683280|NCT04677179|364503184|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683281|NCT04677179|364503185|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683282|NCT04677179|364503186|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
105683283|NCT04677179|364503187|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
105683284|NCT04677179|364503188|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683285|NCT04677179|364503179|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
105683286|NCT04677179|364503180|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
105683287|NCT04677179|364503181|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
105683288|NCT04677179|364503182|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
105683289|NCT04677179|364503183|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
105683290|NCT04677179|364503184|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
105683291|NCT04677179|364503185|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
105683292|NCT04677179|364503186|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
105683293|NCT04677179|364503187|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
105683294|NCT04677179|364503188|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
105683295|NCT01536015|364503189|FG000|Overall Study|Adverse Event|1|||
105683296|NCT01536015|364503190|FG001|Overall Study|Adverse Event|4|||
105683297|NCT01536015|364503189|FG000|Overall Study|Lost to Follow-up|0|||
105683298|NCT01536015|364503190|FG001|Overall Study|Lost to Follow-up|1|||
105683299|NCT01536015|364503189|FG000|Overall Study|Inclusion Criterion not met|2|||
105683300|NCT01536015|364503190|FG001|Overall Study|Inclusion Criterion not met|0|||
105683301|NCT01536015|364503189|FG000|Overall Study|Study closure|5|||
105683302|NCT01536015|364503190|FG001|Overall Study|Study closure|5|||
105683303|NCT02374671|364503191|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
105683304|NCT02374671|364503192|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
105683305|NCT02374671|364503193|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
105683306|NCT02374671|364503191|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
105683307|NCT02374671|364503192|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
105683308|NCT02374671|364503193|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
105683309|NCT02374671|364503191|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
105683310|NCT02374671|364503192|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
105683311|NCT02374671|364503193|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
105557922|NCT01358968|364039180|FG003|Continued Access Phase|Protocol Violation|2|||
105557923|NCT01358968|364039177|FG000|Continued Access Phase|Withdrawal by Subject|0|||
105557924|NCT01358968|364039178|FG001|Continued Access Phase|Withdrawal by Subject|0|||
105557925|NCT01358968|364039179|FG002|Continued Access Phase|Withdrawal by Subject|3|||
105557926|NCT01358968|364039180|FG003|Continued Access Phase|Withdrawal by Subject|0|||
105557927|NCT01358968|364039177|FG000|Continued Access Phase|Death|0|||
105557928|NCT01358968|364039178|FG001|Continued Access Phase|Death|0|||
105557929|NCT01358968|364039179|FG002|Continued Access Phase|Death|1|||
105557930|NCT01358968|364039180|FG003|Continued Access Phase|Death|1|||
105557931|NCT01597050|364039181|FG000|Overall Study|Withdrawal by Subject|1|||
105683312|NCT02374671|364503191|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
105683313|NCT02374671|364503192|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
105683314|NCT02374671|364503193|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
105683315|NCT02374671|364503191|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
105683316|NCT02374671|364503192|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
105683317|NCT02374671|364503193|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
105683318|NCT03110185|364503195|FG000|Overall Study|Death|0|||
105683319|NCT03110185|364503196|FG001|Overall Study|Death|1|||
105683320|NCT03110185|364503195|FG000|Overall Study|Withdrawal by Subject|2|||
105683321|NCT03110185|364503196|FG001|Overall Study|Withdrawal by Subject|7|||
105557932|NCT01597050|364039182|FG001|Overall Study|Withdrawal by Subject|0|||
105557933|NCT00483184|364039183|FG000|Overall Study|Withdrawal by Subject|2|||
105683322|NCT03110185|364503195|FG000|Overall Study|Time Constraints|0|||
105683323|NCT03110185|364503196|FG001|Overall Study|Time Constraints|6|||
105683324|NCT03110185|364503195|FG000|Overall Study|Conflict with care|5|||
105683325|NCT03110185|364503196|FG001|Overall Study|Conflict with care|12|||
105683326|NCT03110185|364503195|FG000|Overall Study|Protocol Violation|1|||
105683327|NCT03110185|364503196|FG001|Overall Study|Protocol Violation|4|||
105683328|NCT03110185|364503195|FG000|Overall Study|MRI Incompatible|2|||
105683329|NCT03110185|364503196|FG001|Overall Study|MRI Incompatible|0|||
105683330|NCT03110185|364503195|FG000|Overall Study|Patient Refusal|0|||
105683331|NCT03110185|364503196|FG001|Overall Study|Patient Refusal|1|||
105683332|NCT00178126|364503197|FG000|Overall Study|Lost to Follow-up|21|||
105683333|NCT00178126|364503198|FG001|Overall Study|Lost to Follow-up|21|||
105683334|NCT00178126|364503197|FG000|Overall Study|did not receive intervention|4|||
105683335|NCT00178126|364503198|FG001|Overall Study|did not receive intervention|6|||
105683336|NCT02796560|364503201|FG000|Overall Study|Adverse Event|2|||
105683337|NCT02796560|364503202|FG001|Overall Study|Adverse Event|0|||
105683338|NCT02796560|364503201|FG000|Overall Study|Withdrawal by Subject|2|||
105683339|NCT02796560|364503202|FG001|Overall Study|Withdrawal by Subject|2|||
105683340|NCT03756129|364503204|FG000|Overall Study|Adverse Event|1|||
105683341|NCT03756129|364503205|FG001|Overall Study|Adverse Event|1|||
105683342|NCT03756129|364503206|FG002|Overall Study|Adverse Event|0|||
105683343|NCT03756129|364503207|FG003|Overall Study|Adverse Event|2|||
105683344|NCT03756129|364503208|FG004|Overall Study|Adverse Event|0|||
105683345|NCT03756129|364503209|FG005|Overall Study|Adverse Event|0|||
105683346|NCT03756129|364503204|FG000|Overall Study|Withdrawal by Subject|2|||
105683347|NCT03756129|364503205|FG001|Overall Study|Withdrawal by Subject|1|||
105683348|NCT03756129|364503206|FG002|Overall Study|Withdrawal by Subject|3|||
105683349|NCT03756129|364503207|FG003|Overall Study|Withdrawal by Subject|1|||
105683350|NCT03756129|364503208|FG004|Overall Study|Withdrawal by Subject|1|||
105683351|NCT03756129|364503209|FG005|Overall Study|Withdrawal by Subject|3|||
105683352|NCT03756129|364503204|FG000|Overall Study|Lost to Follow-up|0|||
105683353|NCT03756129|364503205|FG001|Overall Study|Lost to Follow-up|0|||
105683354|NCT03756129|364503206|FG002|Overall Study|Lost to Follow-up|0|||
105683355|NCT03756129|364503207|FG003|Overall Study|Lost to Follow-up|0|||
105683356|NCT03756129|364503208|FG004|Overall Study|Lost to Follow-up|0|||
105683357|NCT03756129|364503209|FG005|Overall Study|Lost to Follow-up|1|||
105683358|NCT03756129|364503204|FG000|Overall Study|Physician Decision|0|||
105683359|NCT03756129|364503205|FG001|Overall Study|Physician Decision|0|||
105683360|NCT03756129|364503206|FG002|Overall Study|Physician Decision|0|||
105683361|NCT03756129|364503207|FG003|Overall Study|Physician Decision|0|||
105683362|NCT03756129|364503208|FG004|Overall Study|Physician Decision|0|||
105683363|NCT03756129|364503209|FG005|Overall Study|Physician Decision|1|||
105683364|NCT03567434|364503210|FG000|Overall Study|Lost to Follow-up|1|||
105683365|NCT03567434|364503211|FG001|Overall Study|Lost to Follow-up|3|||
105683366|NCT00081497|364503215|FG000|Overall Study|Adverse Event|2|||
105683367|NCT00081497|364503216|FG001|Overall Study|Adverse Event|0|||
105683368|NCT00081497|364503215|FG000|Overall Study|Death|0|||
105683369|NCT00081497|364503216|FG001|Overall Study|Death|1|||
105683370|NCT00081497|364503215|FG000|Overall Study|Withdrawal by Subject|1|||
105683371|NCT00081497|364503216|FG001|Overall Study|Withdrawal by Subject|0|||
105683372|NCT00081497|364503215|FG000|Overall Study|Non-compliance|0|||
105683373|NCT00081497|364503216|FG001|Overall Study|Non-compliance|1|||
105683374|NCT00345293|364503217|FG000|Overall Study|Unable to access line for sample|1|||
105683375|NCT00345293|364503218|FG001|Overall Study|Unable to access line for sample|0|||
105683376|NCT00345293|364503217|FG000|Overall Study|Withdrawal by Subject|1|||
105683377|NCT00345293|364503218|FG001|Overall Study|Withdrawal by Subject|0|||
105683378|NCT01036763|364504886|FG000|Overall Study|Adverse Event|25|||
105683379|NCT01036763|364504886|FG000|Overall Study|Lost to Follow-up|28|||
105683380|NCT01036763|364504886|FG000|Overall Study|Other reason (not specified)|40|||
105683381|NCT00743275|364504887|FG000|Overall Study|Protocol Violation|0|||
105683382|NCT00743275|364504888|FG001|Overall Study|Protocol Violation|1|||
105683383|NCT01076192|364504896|FG000|Overall Study|Other|197|||
105683384|NCT00596427|364504897|FG000|Overall Study|Withdrawal by Subject|2|||
105683385|NCT00596427|364504898|FG001|Overall Study|Withdrawal by Subject|2|||
105683386|NCT00596427|364504897|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
105683387|NCT00596427|364504898|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
105683388|NCT00596427|364504897|FG000|Overall Study|Protocol Violation|1|||
105683389|NCT00596427|364504898|FG001|Overall Study|Protocol Violation|0|||
105683390|NCT02401867|364504899|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
105683391|NCT02401867|364504899|FG000|Analysis|Cervical assay could not be conducted|9|||
105683392|NCT02502097|364504900|FG000|Period 1|Adverse Event|0|||
105683393|NCT02502097|364504901|FG001|Period 1|Adverse Event|0|||
105683394|NCT02502097|364504902|FG002|Period 1|Adverse Event|1|||
105683395|NCT02502097|364504903|FG003|Period 1|Adverse Event|0|||
105683396|NCT02502097|364504900|FG000|Wash Out Period|Adverse Event|0|||
105683397|NCT02502097|364504901|FG001|Wash Out Period|Adverse Event|1|||
105683398|NCT02502097|364504902|FG002|Wash Out Period|Adverse Event|1|||
105683399|NCT02502097|364504903|FG003|Wash Out Period|Adverse Event|1|||
105683400|NCT02502097|364504900|FG000|Period 2|Adverse Event|0|||
105683401|NCT02502097|364504901|FG001|Period 2|Adverse Event|0|||
105683402|NCT02502097|364504902|FG002|Period 2|Adverse Event|1|||
105683403|NCT02502097|364504903|FG003|Period 2|Adverse Event|0|||
105683404|NCT02186223|364504904|FG000|Overall Study|Not eligible for device placement|6|||
105683405|NCT02186223|364504904|FG000|Overall Study|Unable to obtain femoral access|3|||
105683406|NCT02186223|364504904|FG000|Overall Study|Death|3|||
105683407|NCT02186223|364504904|FG000|Overall Study|Device in place less than 48 hours|9|||
105683408|NCT01491672|364504906|FG000|Overall Study|Lost to Follow-up|0|||
105683409|NCT01491672|364504907|FG001|Overall Study|Lost to Follow-up|4|||
105683410|NCT01491672|364504908|FG002|Overall Study|Lost to Follow-up|1|||
105683411|NCT01491672|364504906|FG000|Overall Study|Withdrawal by Subject|6|||
105683412|NCT01491672|364504907|FG001|Overall Study|Withdrawal by Subject|7|||
105683413|NCT01491672|364504908|FG002|Overall Study|Withdrawal by Subject|0|||
105683414|NCT01491672|364504906|FG000|Overall Study|Adverse Event|8|||
105683415|NCT01491672|364504907|FG001|Overall Study|Adverse Event|10|||
105683416|NCT01491672|364504908|FG002|Overall Study|Adverse Event|4|||
105683417|NCT01491672|364504906|FG000|Overall Study|Disease progression|42|||
105683418|NCT01491672|364504907|FG001|Overall Study|Disease progression|34|||
105683419|NCT01491672|364504908|FG002|Overall Study|Disease progression|6|||
105683420|NCT01491672|364504906|FG000|Overall Study|Protocol deviation|0|||
105683421|NCT01491672|364504907|FG001|Overall Study|Protocol deviation|1|||
105683422|NCT01491672|364504908|FG002|Overall Study|Protocol deviation|0|||
105683423|NCT01491672|364504906|FG000|Overall Study|Death|0|||
105683424|NCT01491672|364504907|FG001|Overall Study|Death|4|||
105683425|NCT01491672|364504908|FG002|Overall Study|Death|0|||
105683426|NCT00107120|364504909|FG000|Overall Study|Adverse Event|4|||
105683427|NCT00107120|364504910|FG001|Overall Study|Adverse Event|1|||
105683428|NCT00107120|364504909|FG000|Overall Study|Lack of Efficacy|5|||
105683429|NCT00107120|364504910|FG001|Overall Study|Lack of Efficacy|5|||
105683430|NCT00107120|364504909|FG000|Overall Study|Protocol Violation|3|||
105683431|NCT00107120|364504910|FG001|Overall Study|Protocol Violation|0|||
105683432|NCT00107120|364504909|FG000|Overall Study|Withdrawal by Subject|8|||
105683433|NCT00107120|364504910|FG001|Overall Study|Withdrawal by Subject|9|||
105683434|NCT00107120|364504909|FG000|Overall Study|Lost to Follow-up|8|||
105683435|NCT00107120|364504910|FG001|Overall Study|Lost to Follow-up|6|||
105683436|NCT00107120|364504909|FG000|Overall Study|Pregnancy|0|||
105683437|NCT00107120|364504910|FG001|Overall Study|Pregnancy|1|||
105683438|NCT00107120|364504909|FG000|Overall Study|moving away from site|1|||
105683439|NCT00107120|364504910|FG001|Overall Study|moving away from site|1|||
105683440|NCT00107120|364504909|FG000|Overall Study|death of parent|0|||
105683441|NCT00107120|364504910|FG001|Overall Study|death of parent|1|||
105683442|NCT00896051|364504911|FG000|Overall Study|Adverse Event|2|||
105683443|NCT00896051|364504912|FG001|Overall Study|Adverse Event|1|||
105683444|NCT00896051|364504911|FG000|Overall Study|Lost to Follow-up|3|||
105683445|NCT00896051|364504912|FG001|Overall Study|Lost to Follow-up|2|||
105683446|NCT00896051|364504911|FG000|Overall Study|Withdrawal by Subject|3|||
105683447|NCT00896051|364504912|FG001|Overall Study|Withdrawal by Subject|2|||
105683448|NCT00896051|364504911|FG000|Overall Study|Subject noncompliant|1|||
105683449|NCT00896051|364504912|FG001|Overall Study|Subject noncompliant|3|||
105683450|NCT00896051|364504911|FG000|Overall Study|Other|1|||
105683451|NCT00896051|364504912|FG001|Overall Study|Other|1|||
105683452|NCT02935452|364504913|FG000|Overall Study|work and life commintment|3|||
105683453|NCT02935452|364504914|FG001|Overall Study|work and life commintment|1|||
105683454|NCT00876928|364504915|FG000|Overall Study|Lost to Follow-up|2|||
105683455|NCT00876928|364504916|FG001|Overall Study|Lost to Follow-up|5|||
105683456|NCT00876928|364504915|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
105683457|NCT00876928|364504916|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
105683458|NCT00701779|364504919|FG000|Overall Study|Adverse Event|6|||
105683459|NCT00701779|364504919|FG000|Overall Study|Lost to Follow-up|1|||
105683460|NCT00701779|364504919|FG000|Overall Study|Withdrawal by Subject|2|||
105683461|NCT02079610|364504920|FG000|Overall Study|Withdrawal by Subject|1|||
105683462|NCT02079610|364504921|FG001|Overall Study|Withdrawal by Subject|1|||
105683463|NCT01111474|364504922|FG000|Overall Study|Lost to Follow-up|12|||
105683464|NCT01016977|364504923|FG000|Overall Study|Lost to Follow-up|1|||
105683465|NCT01016977|364504924|FG001|Overall Study|Lost to Follow-up|0|||
105683466|NCT01016977|364504923|FG000|Overall Study|Withdrawal by Subject|2|||
105683467|NCT01016977|364504924|FG001|Overall Study|Withdrawal by Subject|2|||
105683468|NCT02808143|364504928|FG000|Maintenance Phase|Disease recurrence|1|||
105683469|NCT02808143|364504929|FG001|Maintenance Phase|Disease recurrence|3|||
105683470|NCT02808143|364504928|FG000|Maintenance Phase|Disease progression|1|||
105683471|NCT02808143|364504929|FG001|Maintenance Phase|Disease progression|2|||
105683472|NCT02808143|364504928|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
105683473|NCT02808143|364504929|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
105683474|NCT02808143|364504928|FG000|Survival Follow-Up|Disease recurrence|0|||
105683475|NCT02808143|364504929|FG001|Survival Follow-Up|Disease recurrence|2|||
105683476|NCT02808143|364504928|FG000|Survival Follow-Up|Adverse Event|0|||
105683477|NCT02808143|364504929|FG001|Survival Follow-Up|Adverse Event|1|||
105683478|NCT02808143|364504928|FG000|Survival Follow-Up|Death|1|||
105683479|NCT02808143|364504929|FG001|Survival Follow-Up|Death|0|||
105344542|NCT03191864|363261791|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
105344543|NCT03191864|363261792|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
105344544|NCT03191864|363261793|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
105344545|NCT03191864|363261794|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
105344546|NCT03191864|363261795|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
105344547|NCT01047332|363261796|FG000|Overall Study|SEMS Obstruction|11|||
105344548|NCT01047332|363261797|FG001|Overall Study|SEMS Obstruction|20|||
105344549|NCT01047332|363261796|FG000|Overall Study|Died Unobstructed|38|||
105344550|NCT01047332|363261797|FG001|Overall Study|Died Unobstructed|41|||
105344551|NCT01047332|363261796|FG000|Overall Study|Lost to Follow-up|8|||
105344552|NCT01047332|363261797|FG001|Overall Study|Lost to Follow-up|3|||
105344553|NCT03521817|363261798|FG000|Overall Study|Protocol Violation|0|||
105344554|NCT03521817|363261799|FG001|Overall Study|Protocol Violation|1|||
105344555|NCT00778102|363261800|FG000|Overall Study|Adverse Event|8|||
105344556|NCT00778102|363261801|FG001|Overall Study|Adverse Event|5|||
105344557|NCT00778102|363261800|FG000|Overall Study|Death|1|||
105344558|NCT00778102|363261801|FG001|Overall Study|Death|1|||
105344559|NCT00778102|363261800|FG000|Overall Study|Lost to Follow-up|1|||
105344560|NCT00778102|363261801|FG001|Overall Study|Lost to Follow-up|0|||
105344561|NCT00778102|363261800|FG000|Overall Study|Violation of Selection Criteria|1|||
105344562|NCT00778102|363261801|FG001|Overall Study|Violation of Selection Criteria|1|||
105344563|NCT00778102|363261800|FG000|Overall Study|Protocol Violation|0|||
105344564|NCT00778102|363261801|FG001|Overall Study|Protocol Violation|1|||
105344565|NCT00778102|363261800|FG000|Overall Study|Refused Treatment|2|||
105344566|NCT00778102|363261801|FG001|Overall Study|Refused Treatment|3|||
105344567|NCT00778102|363261800|FG000|Overall Study|Withdrawal by Subject|1|||
105344568|NCT00778102|363261801|FG001|Overall Study|Withdrawal by Subject|1|||
105344569|NCT00778102|363261800|FG000|Overall Study|Administrative Reason|7|||
105344570|NCT00778102|363261801|FG001|Overall Study|Administrative Reason|10|||
105344571|NCT03055494|363263450|FG000|Overall Study|Lost to Follow-up|6|||
105344572|NCT03055494|363263451|FG001|Overall Study|Lost to Follow-up|0|||
105344573|NCT03055494|363263450|FG000|Overall Study|Physician Decision|2|||
105344574|NCT03055494|363263451|FG001|Overall Study|Physician Decision|0|||
105557934|NCT00483184|364039184|FG001|Overall Study|Withdrawal by Subject|2|||
105557935|NCT00483184|364039185|FG002|Overall Study|Withdrawal by Subject|0|||
105557936|NCT00483184|364039183|FG000|Overall Study|Lost to Follow-up|1|||
105557937|NCT00483184|364039184|FG001|Overall Study|Lost to Follow-up|0|||
105557938|NCT00483184|364039185|FG002|Overall Study|Lost to Follow-up|0|||
105557939|NCT00483184|364039183|FG000|Overall Study|Adverse Event|1|||
105557940|NCT00483184|364039184|FG001|Overall Study|Adverse Event|2|||
105557941|NCT00483184|364039185|FG002|Overall Study|Adverse Event|2|||
105557942|NCT00483184|364039183|FG000|Overall Study|Protocol Violation|1|||
105557943|NCT00483184|364039184|FG001|Overall Study|Protocol Violation|0|||
105557944|NCT00483184|364039185|FG002|Overall Study|Protocol Violation|1|||
105557945|NCT03321396|364039186|FG000|Overall Study|Physician Decision|1|||
105557946|NCT00423176|364039187|FG000|Overall Study|Adverse Event|4|||
105557947|NCT00423176|364039188|FG001|Overall Study|Adverse Event|6|||
105557948|NCT00423176|364039187|FG000|Overall Study|Treatment Failure|1|||
105557949|NCT00423176|364039188|FG001|Overall Study|Treatment Failure|6|||
105557950|NCT00423176|364039187|FG000|Overall Study|Lost to Follow-up|4|||
105557951|NCT00423176|364039188|FG001|Overall Study|Lost to Follow-up|7|||
105557952|NCT00423176|364039187|FG000|Overall Study|Withdrawal by Subject|4|||
105557953|NCT00423176|364039188|FG001|Overall Study|Withdrawal by Subject|3|||
105557954|NCT00423176|364039187|FG000|Overall Study|Protocol Violation|1|||
105557955|NCT00423176|364039188|FG001|Overall Study|Protocol Violation|3|||
105557956|NCT00423176|364039187|FG000|Overall Study|Did not meet protocol eligibility|2|||
105557957|NCT00423176|364039188|FG001|Overall Study|Did not meet protocol eligibility|4|||
105557958|NCT02013622|364039189|FG000|Overall Study|Lost to Follow-up|10|||
105557959|NCT02013622|364039189|FG000|Overall Study|Adverse Event|3|||
105557960|NCT02013622|364039189|FG000|Overall Study|Met Withdrawal Criteria|3|||
105557961|NCT02013622|364039189|FG000|Overall Study|Withdrawal by Subject|6|||
105557962|NCT02013622|364039189|FG000|Overall Study|Protocol Deviation|1|||
105557963|NCT02013622|364039189|FG000|Overall Study|Lack of Efficacy|1|||
105557964|NCT01984684|364039190|FG000|Overall Study|Lost to Follow-up|25|||
105344575|NCT03055494|363263450|FG000|Overall Study|Withdrawal by Subject|1|||
105344576|NCT03055494|363263451|FG001|Overall Study|Withdrawal by Subject|0|||
105344577|NCT03055494|363263450|FG000|Overall Study|Adverse Event|0|||
105344578|NCT03055494|363263451|FG001|Overall Study|Adverse Event|1|||
105344579|NCT03055494|363263450|FG000|Overall Study|Non-compliance with study treatment|1|||
105344580|NCT03055494|363263451|FG001|Overall Study|Non-compliance with study treatment|0|||
105557965|NCT01984684|364039191|FG001|Overall Study|Lost to Follow-up|24|||
105557966|NCT01984684|364039190|FG000|Overall Study|Adverse Event|8|||
105557967|NCT01984684|364039191|FG001|Overall Study|Adverse Event|12|||
105557968|NCT01984684|364039190|FG000|Overall Study|Withdrawal by Subject|9|||
105557969|NCT01984684|364039191|FG001|Overall Study|Withdrawal by Subject|9|||
105557970|NCT01984684|364039190|FG000|Overall Study|Lack of Efficacy|3|||
105557971|NCT01984684|364039191|FG001|Overall Study|Lack of Efficacy|6|||
105683480|NCT00824161|364504934|FG000|Overall Study|Withdrawal by Subject|1|||
105683481|NCT00824161|364504934|FG000|Overall Study|Screen Failure|1|||
105683482|NCT02518490|364504935|FG000|Overall Study|Withdrawal by Subject|1|||
105683483|NCT02518490|364504936|FG001|Overall Study|Withdrawal by Subject|1|||
105683484|NCT03587974|364504937|FG000|Overall Study|caregiver demented, care recipient died|3|||
105683485|NCT03587974|364504938|FG001|Overall Study|caregiver demented, care recipient died|3|||
105683486|NCT03587974|364504937|FG000|Overall Study|Withdrawal by Subject|2|||
105683487|NCT03587974|364504938|FG001|Overall Study|Withdrawal by Subject|1|||
105683488|NCT01174160|364504939|FG000|Overall Study|Adverse Event|1|||
105683489|NCT01174160|364504940|FG001|Overall Study|Adverse Event|0|||
105683490|NCT01174160|364504939|FG000|Overall Study|Lost to Follow-up|1|||
105683491|NCT01174160|364504940|FG001|Overall Study|Lost to Follow-up|0|||
105683492|NCT01174160|364504939|FG000|Overall Study|Physician Decision|1|||
105683493|NCT01174160|364504940|FG001|Overall Study|Physician Decision|0|||
105683494|NCT01174160|364504939|FG000|Overall Study|Protocol Violation|4|||
105683495|NCT01174160|364504940|FG001|Overall Study|Protocol Violation|6|||
105683496|NCT01174160|364504939|FG000|Overall Study|Withdrawal by Subject|1|||
105683497|NCT01174160|364504940|FG001|Overall Study|Withdrawal by Subject|0|||
105683498|NCT01590017|364504941|FG000|Overall Study|Adverse Event|1|||
105683499|NCT01590017|364504941|FG000|Overall Study|Withdrawal by Subject|1|||
105683500|NCT01590017|364504941|FG000|Overall Study|Lack of Efficacy|1|||
105683501|NCT01590017|364504941|FG000|Overall Study|Physician Decision|1|||
105683502|NCT02647866|364504942|FG000|Overall Study|Adverse Event|0|||
105683503|NCT02647866|364504943|FG001|Overall Study|Adverse Event|0|||
105683504|NCT02647866|364504944|FG002|Overall Study|Adverse Event|2|||
105683505|NCT02647866|364504945|FG003|Overall Study|Adverse Event|2|||
105683506|NCT02647866|364504946|FG004|Overall Study|Adverse Event|1|||
105683507|NCT02647866|364504942|FG000|Overall Study|Disease Worsening|3|||
105683508|NCT02647866|364504943|FG001|Overall Study|Disease Worsening|1|||
105683509|NCT02647866|364504944|FG002|Overall Study|Disease Worsening|0|||
105683510|NCT02647866|364504945|FG003|Overall Study|Disease Worsening|0|||
105683511|NCT02647866|364504946|FG004|Overall Study|Disease Worsening|1|||
105683512|NCT02647866|364504942|FG000|Overall Study|Withdrawal by Subject|1|||
105683513|NCT02647866|364504943|FG001|Overall Study|Withdrawal by Subject|1|||
105683514|NCT02647866|364504944|FG002|Overall Study|Withdrawal by Subject|2|||
105683515|NCT02647866|364504945|FG003|Overall Study|Withdrawal by Subject|4|||
105683516|NCT02647866|364504946|FG004|Overall Study|Withdrawal by Subject|4|||
105683517|NCT02647866|364504942|FG000|Overall Study|Physician Decision|0|||
105683518|NCT02647866|364504943|FG001|Overall Study|Physician Decision|1|||
105683519|NCT02647866|364504944|FG002|Overall Study|Physician Decision|1|||
105683520|NCT02647866|364504945|FG003|Overall Study|Physician Decision|0|||
105683521|NCT02647866|364504946|FG004|Overall Study|Physician Decision|2|||
105683522|NCT02647866|364504942|FG000|Overall Study|Death|0|||
105683523|NCT02647866|364504943|FG001|Overall Study|Death|1|||
105683524|NCT02647866|364504944|FG002|Overall Study|Death|0|||
105683525|NCT02647866|364504945|FG003|Overall Study|Death|0|||
105683526|NCT02647866|364504946|FG004|Overall Study|Death|0|||
105683527|NCT02647866|364504942|FG000|Overall Study|Subject moved to different country|1|||
105683528|NCT02647866|364504943|FG001|Overall Study|Subject moved to different country|0|||
105683529|NCT02647866|364504944|FG002|Overall Study|Subject moved to different country|0|||
105683530|NCT02647866|364504945|FG003|Overall Study|Subject moved to different country|0|||
105683531|NCT02647866|364504946|FG004|Overall Study|Subject moved to different country|0|||
105683532|NCT00701220|364504947|FG000|Overall Study|Withdrawal by Subject|0|||
105683533|NCT00701220|364504948|FG001|Overall Study|Withdrawal by Subject|2|||
105683534|NCT00701220|364504947|FG000|Overall Study|Protocol Violation|2|||
105683535|NCT00701220|364504948|FG001|Overall Study|Protocol Violation|0|||
105683536|NCT00319839|364504949|FG000|Overall Study|Adverse Event|5|||
105683537|NCT00319839|364504949|FG000|Overall Study|Withdrawal by Subject|1|||
105683538|NCT01853137|364504952|FG000|Overall Study|Lost to Follow-up|4|||
105683539|NCT01853137|364504953|FG001|Overall Study|Lost to Follow-up|1|||
105683540|NCT02483585|364504954|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
105683541|NCT02483585|364504955|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
105683542|NCT02483585|364504954|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
105683543|NCT02483585|364504955|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
105683544|NCT02483585|364504954|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
105683545|NCT02483585|364504955|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
105683546|NCT02483585|364504954|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
105683547|NCT02483585|364504955|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
105683548|NCT02483585|364504954|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
105683549|NCT02483585|364504955|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
105683550|NCT02483585|364504954|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
105683551|NCT02483585|364504955|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
105683552|NCT02483585|364504954|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
105683553|NCT02483585|364504955|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
105683554|NCT00842985|364504957|FG000|Screening|Did not meet entrance requirements|27|||
105683555|NCT00842985|364504957|FG000|First Intervention|Withdrawal by Subject|3|||
105683556|NCT00842985|364504957|FG000|First Intervention|Protocol Violation|3|||
105683557|NCT00842985|364504957|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
105683558|NCT00842985|364504957|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
105683559|NCT01037244|364504958|FG000|Overall Study|Adverse Event|3|||
105683560|NCT01037244|364504959|FG001|Overall Study|Adverse Event|2|||
105683561|NCT01037244|364504960|FG002|Overall Study|Adverse Event|6|||
105683562|NCT01037244|364504961|FG003|Overall Study|Adverse Event|3|||
105683563|NCT01037244|364504958|FG000|Overall Study|Lack of Efficacy|1|||
105683564|NCT01037244|364504959|FG001|Overall Study|Lack of Efficacy|1|||
105683565|NCT01037244|364504960|FG002|Overall Study|Lack of Efficacy|0|||
105683566|NCT01037244|364504961|FG003|Overall Study|Lack of Efficacy|1|||
105683567|NCT01037244|364504958|FG000|Overall Study|Lost to Follow-up|3|||
105683568|NCT01037244|364504959|FG001|Overall Study|Lost to Follow-up|3|||
105683569|NCT01037244|364504960|FG002|Overall Study|Lost to Follow-up|4|||
105683570|NCT01037244|364504961|FG003|Overall Study|Lost to Follow-up|4|||
105683571|NCT01037244|364504958|FG000|Overall Study|Withdrawal by Subject|1|||
105683572|NCT01037244|364504959|FG001|Overall Study|Withdrawal by Subject|5|||
105683573|NCT01037244|364504960|FG002|Overall Study|Withdrawal by Subject|3|||
105683574|NCT01037244|364504961|FG003|Overall Study|Withdrawal by Subject|5|||
105683575|NCT01037244|364504958|FG000|Overall Study|Partner Withdrew Consent|2|||
105683576|NCT01037244|364504959|FG001|Overall Study|Partner Withdrew Consent|1|||
105683577|NCT01037244|364504960|FG002|Overall Study|Partner Withdrew Consent|0|||
105683578|NCT01037244|364504961|FG003|Overall Study|Partner Withdrew Consent|0|||
105683579|NCT01037244|364504958|FG000|Overall Study|Various|3|||
105683580|NCT01037244|364504959|FG001|Overall Study|Various|2|||
105683581|NCT01037244|364504960|FG002|Overall Study|Various|1|||
105683582|NCT01037244|364504961|FG003|Overall Study|Various|1|||
105683583|NCT01990560|364504965|FG000|Overall Study|Withdrawal by Subject|1|||
105683584|NCT01778023|364504966|FG000|Overall Study|Withdrawal by Subject|0|||
105683585|NCT01778023|364504967|FG001|Overall Study|Withdrawal by Subject|3|||
105683586|NCT01324440|364504968|FG000|Overall Study|Subject moved|0|||
105683587|NCT01324440|364504969|FG001|Overall Study|Subject moved|1|||
105683588|NCT00903630|364504975|FG000|Phase 2|Adverse Event|0|||
105683589|NCT00903630|364504976|FG001|Phase 2|Adverse Event|0|||
105683590|NCT00903630|364504977|FG002|Phase 2|Adverse Event|1|||
105683591|NCT00138671|364504979|FG000|Overall Study|Death|0|||
105683592|NCT00138671|364504980|FG001|Overall Study|Death|3|||
105683593|NCT00138671|364504979|FG000|Overall Study|Adverse Event|6|||
105683594|NCT00138671|364504980|FG001|Overall Study|Adverse Event|3|||
105683595|NCT00138671|364504979|FG000|Overall Study|Lost to Follow-up|1|||
105683596|NCT00138671|364504980|FG001|Overall Study|Lost to Follow-up|2|||
105683597|NCT00138671|364504979|FG000|Overall Study|Withdrawal by Subject|3|||
105683598|NCT00138671|364504980|FG001|Overall Study|Withdrawal by Subject|5|||
105683599|NCT00138671|364504979|FG000|Overall Study|Other|3|||
105683600|NCT00138671|364504980|FG001|Overall Study|Other|3|||
105683601|NCT03305731|364504981|FG000|Overall Study|Protocol Violation|1|||
105683602|NCT01959516|364504982|FG000|Epoch 1|Adverse Event|4|||
105683603|NCT01959516|364504983|FG001|Epoch 1|Adverse Event|1|||
105683604|NCT01959516|364504982|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
105683605|NCT01959516|364504983|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
105683606|NCT01959516|364504982|FG000|Epoch 1|Subject withdrew consent|3|||
105683607|NCT01959516|364504983|FG001|Epoch 1|Subject withdrew consent|2|||
105683608|NCT01959516|364504982|FG000|Epoch 1|Administrative problems|1|||
105683609|NCT01959516|364504983|FG001|Epoch 1|Administrative problems|0|||
105683610|NCT01959516|364504982|FG000|Epoch 1|Use of prohibited treatment|1|||
105683611|NCT01959516|364504983|FG001|Epoch 1|Use of prohibited treatment|0|||
105683612|NCT01959516|364504982|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
105683613|NCT01959516|364504983|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
105683614|NCT01959516|364504982|FG000|Epoch 1|Protocol deviation|0|||
105683615|NCT01959516|364504983|FG001|Epoch 1|Protocol deviation|1|||
105683616|NCT01959516|364504982|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
105683617|NCT01959516|364504983|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
105683618|NCT01959516|364504982|FG000|Epoch 2|Subject withdrew consent|1|||
105683619|NCT01959516|364504983|FG001|Epoch 2|Subject withdrew consent|0|||
105683620|NCT01959516|364504982|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
105683621|NCT01959516|364504983|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
105683622|NCT05116046|364504988|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105683623|NCT05116046|364504989|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105683624|NCT05116046|364504990|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105683625|NCT05116046|364504988|FG000|Overall Study|Study terminated by sponsor|14|||
105683626|NCT05116046|364504989|FG001|Overall Study|Study terminated by sponsor|16|||
105683627|NCT05116046|364504990|FG002|Overall Study|Study terminated by sponsor|1|||
105683628|NCT04223830|364504992|FG000|Overall Study|Lost to Follow-up|9|||
105683629|NCT04223830|364504992|FG000|Overall Study|Adverse Event|1|||
105683630|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
105683631|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
105683632|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
105683633|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
105683634|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
105683635|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
105683636|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
105683637|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
105683638|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
105683639|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
105683640|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
105683641|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
105683642|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
105683643|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
105683644|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
105683645|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
105683646|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
105683647|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
105683648|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
105683649|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
105683650|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
105683651|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
105683652|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
105683653|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
105683654|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
105683655|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
105683656|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
105683657|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
105683658|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
105683659|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
105683660|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Other|10|||
105683661|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Other|7|||
105683662|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Other|8|||
105683663|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Other|8|||
105683664|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Other|0|||
105683665|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
105683666|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
105683667|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
105683668|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
105683669|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
105683670|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
105683671|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
105683672|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
105683673|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
105683674|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
105683675|NCT01759368|364504999|FG000|Overall Study|Lost to Follow-up|1|||
105683676|NCT01759368|364505000|FG001|Overall Study|Lost to Follow-up|0|||
105683677|NCT01959334|364505007|FG000|Second Dose|Adverse Event|1|||
105683678|NCT01959334|364505008|FG001|Second Dose|Adverse Event|0|||
105683679|NCT01959334|364505007|FG000|Third Dose|Adverse Event|0|||
105683680|NCT01959334|364505008|FG001|Third Dose|Adverse Event|1|||
105683681|NCT01745848|364505011|FG000|Overall Study|Adverse Event|6|||
105683682|NCT00679627|364505012|FG000|Overall Study|Death|41|||
105683683|NCT00679627|364505013|FG001|Overall Study|Death|29|||
105683684|NCT00679627|364505012|FG000|Overall Study|Adverse Event|43|||
105683685|NCT00679627|364505013|FG001|Overall Study|Adverse Event|53|||
105683686|NCT00679627|364505012|FG000|Overall Study|Withdrawal by Subject|168|||
105683687|NCT00679627|364505013|FG001|Overall Study|Withdrawal by Subject|172|||
105683688|NCT00679627|364505012|FG000|Overall Study|Lost to Follow-up|22|||
105683689|NCT00679627|364505013|FG001|Overall Study|Lost to Follow-up|26|||
105683690|NCT00679627|364505012|FG000|Overall Study|Early Study Closure|425|||
105683691|NCT00679627|364505013|FG001|Overall Study|Early Study Closure|405|||
105683692|NCT00448123|364505014|FG000|Overall Study|Lost to Follow-up|9|||
105683693|NCT00448123|364505015|FG001|Overall Study|Lost to Follow-up|6|||
105683694|NCT00448123|364505014|FG000|Overall Study|Physician Decision|6|||
105683695|NCT00448123|364505015|FG001|Overall Study|Physician Decision|6|||
105683696|NCT01588496|364505017|FG000|Overall Study|Withdrawal by Subject|0|||
105683697|NCT01588496|364505018|FG001|Overall Study|Withdrawal by Subject|1|||
105683698|NCT01588496|364505019|FG002|Overall Study|Withdrawal by Subject|0|||
105683699|NCT03581825|364505022|FG000|Period 1|Lens Discomfort|1|||
105683700|NCT03581825|364505023|FG001|Period 1|Lens Discomfort|0|||
105683701|NCT03581825|364505022|FG000|Period 2|Unsatisfactory Vision to Test|0|||
105683702|NCT03581825|364505023|FG001|Period 2|Unsatisfactory Vision to Test|1|||
105683703|NCT00511901|364505024|FG000|Overall Study|Withdrawal by Subject|1|||
105683704|NCT00511901|364505025|FG001|Overall Study|Withdrawal by Subject|3|||
105683705|NCT02447172|364505026|FG000|Overall Study|Adverse Event|11|||
105468908|NCT03614156|363726008|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
105557972|NCT01984684|364039190|FG000|Overall Study|Physician Decision|4|||
105683706|NCT02447172|364505027|FG001|Overall Study|Adverse Event|8|||
105683707|NCT02447172|364505028|FG002|Overall Study|Adverse Event|7|||
105683708|NCT02447172|364505026|FG000|Overall Study|Death|3|||
105683709|NCT02447172|364505027|FG001|Overall Study|Death|1|||
105683710|NCT02447172|364505028|FG002|Overall Study|Death|0|||
105683711|NCT02447172|364505026|FG000|Overall Study|Protocol Violation|2|||
105683712|NCT02447172|364505027|FG001|Overall Study|Protocol Violation|1|||
105683713|NCT02447172|364505028|FG002|Overall Study|Protocol Violation|2|||
105683714|NCT02447172|364505026|FG000|Overall Study|Lost to Follow-up|7|||
105683715|NCT02447172|364505027|FG001|Overall Study|Lost to Follow-up|4|||
105468909|NCT03614156|363726009|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
105468910|NCT03614156|363726010|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
105468911|NCT03614156|363726011|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
105468912|NCT03614156|363726008|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
105468913|NCT03614156|363726009|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
105468914|NCT03614156|363726010|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
105468915|NCT03614156|363726011|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
105468916|NCT03614156|363726008|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
105468917|NCT03614156|363726009|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
105468918|NCT03614156|363726010|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
105468919|NCT03614156|363726011|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
105468920|NCT03614156|363726008|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
105468921|NCT03614156|363726009|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
105468922|NCT03614156|363726010|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
105468923|NCT03614156|363726011|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
105468924|NCT02395081|363726012|FG000|Overall Study|Withdrawal by Subject|1|||
105468925|NCT02395081|363726013|FG001|Overall Study|Withdrawal by Subject|1|||
105468926|NCT02395081|363726014|FG002|Overall Study|Withdrawal by Subject|0|||
105468927|NCT02395081|363726012|FG000|Overall Study|Moved where blood couldn't be collected|4|||
105468928|NCT02395081|363726013|FG001|Overall Study|Moved where blood couldn't be collected|1|||
105468929|NCT02395081|363726014|FG002|Overall Study|Moved where blood couldn't be collected|3|||
105468930|NCT02395081|363726012|FG000|Overall Study|Fetal Loss|2|||
105468931|NCT02395081|363726013|FG001|Overall Study|Fetal Loss|3|||
105468932|NCT02395081|363726014|FG002|Overall Study|Fetal Loss|1|||
105468933|NCT04287517|363726015|FG000|Overall Study|Withdrawal by Subject|1|||
105468934|NCT04287517|363726016|FG001|Overall Study|Withdrawal by Subject|1|||
105468935|NCT03857867|363726017|FG000|Overall Study|Physician Decision|1|||
105468936|NCT03181529|363726018|FG000|Overall Study|Withdrawal by Subject|1|||
105468937|NCT03181529|363726019|FG001|Overall Study|Withdrawal by Subject|1|||
105468938|NCT03181529|363726018|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
105468939|NCT03181529|363726019|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
105468940|NCT00607373|363726020|FG000|Treatment Period|Adverse Event|0|||
105468941|NCT00607373|363726021|FG001|Treatment Period|Adverse Event|4|||
105468942|NCT00607373|363726020|FG000|Treatment Period|Physician Decision|0|||
105468943|NCT00607373|363726021|FG001|Treatment Period|Physician Decision|1|||
105468944|NCT00607373|363726020|FG000|Treatment Period|Withdrawal by Subject|0|||
105468945|NCT00607373|363726021|FG001|Treatment Period|Withdrawal by Subject|1|||
105468946|NCT00607373|363726020|FG000|Follow-up Period|Other|0|||
105468947|NCT00607373|363726021|FG001|Follow-up Period|Other|1|||
105468948|NCT00607373|363726020|FG000|Follow-up Period|Protocol Violation|0|||
105468949|NCT00607373|363726021|FG001|Follow-up Period|Protocol Violation|1|||
105468950|NCT00607373|363726020|FG000|Follow-up Period|Withdrawal by Subject|1|||
105468951|NCT00607373|363726021|FG001|Follow-up Period|Withdrawal by Subject|3|||
105468952|NCT00092443|363726022|FG000|Overall Study|Adverse Event|9|||
105468953|NCT00092443|363726023|FG001|Overall Study|Adverse Event|13|||
105468954|NCT00092443|363726022|FG000|Overall Study|Lost to Follow-up|7|||
105468955|NCT00092443|363726023|FG001|Overall Study|Lost to Follow-up|3|||
105468956|NCT00092443|363726022|FG000|Overall Study|Protocol Violation|11|||
105468957|NCT00092443|363726023|FG001|Overall Study|Protocol Violation|9|||
105468958|NCT00092443|363726022|FG000|Overall Study|Withdrawal by Subject|9|||
105468959|NCT00092443|363726023|FG001|Overall Study|Withdrawal by Subject|11|||
105468960|NCT00092443|363726022|FG000|Overall Study|Moved|5|||
105468961|NCT00092443|363726023|FG001|Overall Study|Moved|5|||
105468962|NCT00092443|363726022|FG000|Overall Study|Other|17|||
105468963|NCT00092443|363726023|FG001|Overall Study|Other|13|||
105468964|NCT00928408|363726026|FG000|Overall Study|Other|2|||
105468965|NCT00928408|363726026|FG000|Overall Study|Withdrawal by Subject|4|||
105468966|NCT00928408|363726026|FG000|Overall Study|Death|5|||
105468967|NCT00928408|363726026|FG000|Overall Study|Lost to Follow-up|12|||
105468968|NCT02876601|363726028|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
105468969|NCT02876601|363726029|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
105468970|NCT02876601|363726030|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
105683716|NCT02447172|364505028|FG002|Overall Study|Lost to Follow-up|4|||
105683717|NCT02447172|364505026|FG000|Overall Study|Withdrawal by Subject|5|||
105683718|NCT02447172|364505027|FG001|Overall Study|Withdrawal by Subject|1|||
105468971|NCT02876601|363726031|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
105468972|NCT00256997|363726034|FG000|Overall Study|Protocol Violation|1|||
105557973|NCT01984684|364039191|FG001|Overall Study|Physician Decision|2|||
105468973|NCT00256997|363726035|FG001|Overall Study|Protocol Violation|4|||
105468974|NCT00256997|363726034|FG000|Overall Study|Lack of Efficacy|1|||
105557974|NCT01984684|364039190|FG000|Overall Study|Protocol Violation|4|||
105468975|NCT00256997|363726035|FG001|Overall Study|Lack of Efficacy|4|||
105468976|NCT00256997|363726034|FG000|Overall Study|Death|2|||
105468977|NCT00256997|363726035|FG001|Overall Study|Death|0|||
105468978|NCT00256997|363726034|FG000|Overall Study|Adverse Event|4|||
105786498|NCT01683565|364871432|FG000|Overall Study|Lost to Follow-up|2|||
105786499|NCT01683565|364871433|FG001|Overall Study|Lost to Follow-up|0|||
105468979|NCT00256997|363726035|FG001|Overall Study|Adverse Event|0|||
105468980|NCT00256997|363726034|FG000|Overall Study|Lost to Follow-up|3|||
105468981|NCT00256997|363726035|FG001|Overall Study|Lost to Follow-up|5|||
105468982|NCT00256997|363726034|FG000|Overall Study|Withdrawal by Subject|13|||
105468983|NCT00256997|363726035|FG001|Overall Study|Withdrawal by Subject|3|||
105468984|NCT00256997|363726034|FG000|Overall Study|Started but not treated|2|||
105468985|NCT00256997|363726035|FG001|Overall Study|Started but not treated|0|||
105468986|NCT00256997|363726034|FG000|Overall Study|Other|5|||
105468987|NCT00256997|363726035|FG001|Overall Study|Other|8|||
105468988|NCT00256997|363726034|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
105468989|NCT00256997|363726035|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
105468990|NCT00256997|363726034|FG000|Overall Study|Participant Non-compliant|3|||
105468991|NCT00256997|363726035|FG001|Overall Study|Participant Non-compliant|6|||
105468992|NCT00256997|363726034|FG000|Overall Study|Investigator Withdrew Participant|2|||
105468993|NCT00256997|363726035|FG001|Overall Study|Investigator Withdrew Participant|1|||
105468994|NCT00354432|363726036|FG000|Overall Study|Adverse Event|3|||
105468995|NCT00354432|363726037|FG001|Overall Study|Adverse Event|1|||
105468996|NCT00354432|363726038|FG002|Overall Study|Adverse Event|5|||
105468997|NCT00354432|363726039|FG003|Overall Study|Adverse Event|5|||
105468998|NCT00354432|363726036|FG000|Overall Study|Off/Toxicity|3|||
105468999|NCT00354432|363726037|FG001|Overall Study|Off/Toxicity|7|||
105469000|NCT00354432|363726038|FG002|Overall Study|Off/Toxicity|5|||
105469001|NCT00354432|363726039|FG003|Overall Study|Off/Toxicity|5|||
105469002|NCT02736578|363726040|FG000|Overall Study|Adverse Event|1|||
105469003|NCT02736578|363726041|FG001|Overall Study|Adverse Event|0|||
105469004|NCT01967238|363726044|FG000|Overall Study|Adverse Event|1|||
105469005|NCT01967238|363726045|FG001|Overall Study|Adverse Event|1|||
105469006|NCT01967238|363726046|FG002|Overall Study|Adverse Event|0|||
105469007|NCT01967238|363726044|FG000|Overall Study|Lost to Follow-up|1|||
105469008|NCT01967238|363726045|FG001|Overall Study|Lost to Follow-up|0|||
105469009|NCT01967238|363726046|FG002|Overall Study|Lost to Follow-up|1|||
105469010|NCT01967238|363726044|FG000|Overall Study|Withdrawal by Subject|0|||
105469011|NCT01967238|363726045|FG001|Overall Study|Withdrawal by Subject|0|||
105469012|NCT01967238|363726046|FG002|Overall Study|Withdrawal by Subject|1|||
105469013|NCT04434937|363726049|FG000|Overall Study|Death|4|||
105469014|NCT04434937|363726049|FG000|Overall Study|Withdrawal by Subject|1|||
105469015|NCT04434937|363726049|FG000|Overall Study|Transitioned to Rollover Study|19|||
105469016|NCT04434937|363726049|FG000|Overall Study|Progressive Disease|18|||
105469017|NCT00777153|363727468|FG000|Overall Study|Lost to Follow-up|1|||
105469018|NCT00777153|363727469|FG001|Overall Study|Lost to Follow-up|1|||
105469019|NCT00777153|363727470|FG002|Overall Study|Lost to Follow-up|0|||
105469020|NCT00777153|363727468|FG000|Overall Study|Death|85|||
105469021|NCT00777153|363727469|FG001|Overall Study|Death|73|||
105469022|NCT00777153|363727470|FG002|Overall Study|Death|33|||
105469023|NCT00777153|363727468|FG000|Overall Study|Withdrawal by Subject|3|||
105469024|NCT00777153|363727469|FG001|Overall Study|Withdrawal by Subject|4|||
105469025|NCT00777153|363727470|FG002|Overall Study|Withdrawal by Subject|3|||
105469026|NCT00777153|363727468|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
105469027|NCT00777153|363727469|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
105469028|NCT00777153|363727470|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
105469029|NCT05097963|363727472|FG000|Overall Study|Protocol Violation|13|||
105469030|NCT05097963|363727472|FG000|Overall Study|Withdrawal by Subject|21|||
105469031|NCT01413204|363727473|FG000|Overall Study|Adverse Event|1|||
105469032|NCT01413204|363727474|FG001|Overall Study|Adverse Event|2|||
105469033|NCT01413204|363727475|FG002|Overall Study|Adverse Event|2|||
105469034|NCT01413204|363727473|FG000|Overall Study|Physician Decision|3|||
105469035|NCT01413204|363727474|FG001|Overall Study|Physician Decision|0|||
105469036|NCT01413204|363727475|FG002|Overall Study|Physician Decision|2|||
105469037|NCT01413204|363727473|FG000|Overall Study|Withdrawal by Subject|1|||
105469038|NCT01413204|363727474|FG001|Overall Study|Withdrawal by Subject|4|||
105469039|NCT01413204|363727475|FG002|Overall Study|Withdrawal by Subject|4|||
105469040|NCT01413204|363727473|FG000|Overall Study|Clearly not eligible for the study|0|||
105469041|NCT01413204|363727474|FG001|Overall Study|Clearly not eligible for the study|0|||
105469042|NCT01413204|363727475|FG002|Overall Study|Clearly not eligible for the study|1|||
105469043|NCT01413204|363727473|FG000|Overall Study|Fasting plasma glucose level increased|1|||
105469044|NCT01413204|363727474|FG001|Overall Study|Fasting plasma glucose level increased|0|||
105469045|NCT01413204|363727475|FG002|Overall Study|Fasting plasma glucose level increased|10|||
105469046|NCT02978781|363727476|FG000|Part A|Adverse Event|1|||
105469047|NCT02978781|363727477|FG001|Part A|Adverse Event|1|||
105469048|NCT02978781|363727478|FG002|Part A|Adverse Event|0|||
105786500|NCT01683565|364871432|FG000|Overall Study|Discontinued Intervention|1|||
105786501|NCT01683565|364871433|FG001|Overall Study|Discontinued Intervention|1|||
105469049|NCT02978781|363727479|FG003|Part A|Adverse Event|0|||
105469050|NCT02978781|363727480|FG004|Part A|Adverse Event|0|||
105469051|NCT02978781|363727476|FG000|Part A|Withdrawal by Subject|0|||
105786502|NCT00859313|364871434|FG000|Overall Study|Lack of Efficacy|2|||
105683719|NCT02447172|364505028|FG002|Overall Study|Withdrawal by Subject|3|||
105683720|NCT02447172|364505026|FG000|Overall Study|protocol specific treatment unrelated|3|||
105683721|NCT02447172|364505027|FG001|Overall Study|protocol specific treatment unrelated|0|||
105683722|NCT02447172|364505028|FG002|Overall Study|protocol specific treatment unrelated|2|||
105683723|NCT00421707|364505029|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
105683724|NCT00421707|364505030|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
105683725|NCT00421707|364505029|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
105683726|NCT00421707|364505030|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
105683727|NCT00421707|364505029|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
105683728|NCT00421707|364505030|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
105683729|NCT00421707|364505029|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
105683730|NCT00421707|364505030|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
105683731|NCT00421707|364505029|FG000|Period 2: Washout|Adverse Event|1|||
105683732|NCT00421707|364505030|FG001|Period 2: Washout|Adverse Event|1|||
105683733|NCT00421707|364505029|FG000|Period 2: Washout|Withdrawal by Subject|0|||
105683734|NCT00421707|364505030|FG001|Period 2: Washout|Withdrawal by Subject|1|||
105683735|NCT00421707|364505029|FG000|Period 2: Washout|Lost to Follow-up|0|||
105683736|NCT00421707|364505030|FG001|Period 2: Washout|Lost to Follow-up|1|||
105683737|NCT00421707|364505029|FG000|Period 2: Washout|Other: Pregnancy|0|||
105683738|NCT00421707|364505030|FG001|Period 2: Washout|Other: Pregnancy|1|||
105683739|NCT00421707|364505029|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
105683740|NCT00421707|364505030|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
105683741|NCT00421707|364505029|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
105683742|NCT00421707|364505030|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
105683743|NCT00421707|364505029|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
105683744|NCT00421707|364505030|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
105683745|NCT01209143|364505031|FG000|Overall Study|Adverse Event|2|||
105683746|NCT01209143|364505032|FG001|Overall Study|Adverse Event|1|||
105683747|NCT01209143|364505031|FG000|Overall Study|Death|0|||
105683748|NCT01209143|364505032|FG001|Overall Study|Death|1|||
105683749|NCT01209143|364505031|FG000|Overall Study|Physician Decision|3|||
105683750|NCT01209143|364505032|FG001|Overall Study|Physician Decision|1|||
105683751|NCT01209143|364505031|FG000|Overall Study|Lost to Follow-up|1|||
105683752|NCT01209143|364505032|FG001|Overall Study|Lost to Follow-up|0|||
105683753|NCT01209143|364505031|FG000|Overall Study|Withdrawal by Subject|2|||
105683754|NCT01209143|364505032|FG001|Overall Study|Withdrawal by Subject|1|||
105683755|NCT01209143|364505031|FG000|Overall Study|Disease progression|11|||
105683756|NCT01209143|364505032|FG001|Overall Study|Disease progression|16|||
105683757|NCT00585195|364505033|FG000|Overall Study|Adverse Event|0|||
105683758|NCT00585195|364505034|FG001|Overall Study|Adverse Event|0|||
105683759|NCT00585195|364505035|FG002|Overall Study|Adverse Event|0|||
105683760|NCT00585195|364505036|FG003|Overall Study|Adverse Event|0|||
105683761|NCT00585195|364505037|FG004|Overall Study|Adverse Event|2|||
105683762|NCT00585195|364505038|FG005|Overall Study|Adverse Event|1|||
105683763|NCT00585195|364505039|FG006|Overall Study|Adverse Event|0|||
105683764|NCT00585195|364505040|FG007|Overall Study|Adverse Event|1|||
105683765|NCT00585195|364505041|FG008|Overall Study|Adverse Event|0|||
105683766|NCT00585195|364505042|FG009|Overall Study|Adverse Event|0|||
105683767|NCT00585195|364505043|FG010|Overall Study|Adverse Event|3|||
105683768|NCT00585195|364505044|FG011|Overall Study|Adverse Event|0|||
105683769|NCT00585195|364505045|FG012|Overall Study|Adverse Event|8|||
105683770|NCT00585195|364505046|FG013|Overall Study|Adverse Event|6|||
105683771|NCT00585195|364505047|FG014|Overall Study|Adverse Event|4|||
105683772|NCT00585195|364505048|FG015|Overall Study|Adverse Event|1|||
105683773|NCT00585195|364505049|FG016|Overall Study|Adverse Event|14|||
105683774|NCT00585195|364505050|FG017|Overall Study|Adverse Event|9|||
105683775|NCT00585195|364505051|FG018|Overall Study|Adverse Event|2|||
105683776|NCT00585195|364505052|FG019|Overall Study|Adverse Event|3|||
105683777|NCT00585195|364505053|FG020|Overall Study|Adverse Event|1|||
105683778|NCT00585195|364505033|FG000|Overall Study|Progressive Disease|2|||
105683779|NCT00585195|364505034|FG001|Overall Study|Progressive Disease|2|||
105683780|NCT00585195|364505035|FG002|Overall Study|Progressive Disease|5|||
105683781|NCT00585195|364505036|FG003|Overall Study|Progressive Disease|4|||
105683782|NCT00585195|364505037|FG004|Overall Study|Progressive Disease|6|||
105683783|NCT00585195|364505038|FG005|Overall Study|Progressive Disease|4|||
105683784|NCT00585195|364505039|FG006|Overall Study|Progressive Disease|6|||
105683785|NCT00585195|364505040|FG007|Overall Study|Progressive Disease|3|||
105683786|NCT00585195|364505041|FG008|Overall Study|Progressive Disease|0|||
105683787|NCT00585195|364505042|FG009|Overall Study|Progressive Disease|5|||
105683788|NCT00585195|364505043|FG010|Overall Study|Progressive Disease|2|||
105683789|NCT00585195|364505044|FG011|Overall Study|Progressive Disease|25|||
105683790|NCT00585195|364505045|FG012|Overall Study|Progressive Disease|29|||
105683791|NCT00585195|364505046|FG013|Overall Study|Progressive Disease|26|||
105683792|NCT00585195|364505047|FG014|Overall Study|Progressive Disease|21|||
105344581|NCT02417961|363263452|FG000|Overall Study|Adverse Event|1|||
105683793|NCT00585195|364505048|FG015|Overall Study|Progressive Disease|12|||
105683794|NCT00585195|364505049|FG016|Overall Study|Progressive Disease|94|||
105683795|NCT00585195|364505050|FG017|Overall Study|Progressive Disease|42|||
105786503|NCT00859313|364871434|FG000|Overall Study|Adverse Event|1|||
105786504|NCT00859313|364871434|FG000|Overall Study|staff error|1|||
105786505|NCT00071006|364871435|FG000|Overall Study|Lack of Efficacy|7|||
105786506|NCT00071006|364871435|FG000|Overall Study|Adverse Event|1|||
105786507|NCT00071006|364871435|FG000|Overall Study|Withdrawal by Subject|1|||
105557975|NCT01984684|364039191|FG001|Overall Study|Protocol Violation|2|||
105557976|NCT01984684|364039190|FG000|Overall Study|Death|0|||
105557977|NCT01984684|364039191|FG001|Overall Study|Death|1|||
105557978|NCT01984684|364039190|FG000|Overall Study|Noncompliance with study drug|2|||
105557979|NCT01984684|364039191|FG001|Overall Study|Noncompliance with study drug|1|||
105557980|NCT01984684|364039190|FG000|Overall Study|Subject incarcerated|1|||
105557981|NCT01984684|364039191|FG001|Overall Study|Subject incarcerated|0|||
105557982|NCT01984684|364039190|FG000|Overall Study|Study drug not available at site|1|||
105557983|NCT01984684|364039191|FG001|Overall Study|Study drug not available at site|1|||
105557984|NCT01984684|364039190|FG000|Overall Study|Subject had inadequate IV access|0|||
105557985|NCT01984684|364039191|FG001|Overall Study|Subject had inadequate IV access|1|||
105557986|NCT02633137|364039192|FG000|Overall Study|Adverse Event|1|||
105557987|NCT02633137|364039192|FG000|Overall Study|Lack of Efficacy|2|||
105557988|NCT02633137|364039192|FG000|Overall Study|Withdrawal by Subject|1|||
105557989|NCT04867369|364039193|FG000|Overall Study|Withdrawal by Subject|1|||
105557990|NCT04867369|364039194|FG001|Overall Study|Withdrawal by Subject|0|||
105557991|NCT03923959|364039195|FG000|Overall Study|Death|16|||
105557992|NCT03923959|364039196|FG001|Overall Study|Death|12|||
105557993|NCT03923959|364039195|FG000|Overall Study|Lost to Follow-up|56|||
105557994|NCT03923959|364039196|FG001|Overall Study|Lost to Follow-up|56|||
105557995|NCT03923959|364039195|FG000|Overall Study|Withdrawal by Subject|1|||
105557996|NCT03923959|364039196|FG001|Overall Study|Withdrawal by Subject|1|||
105557997|NCT03923959|364039195|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
105557998|NCT03923959|364039196|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
105557999|NCT02395042|364039197|FG000|Treatment 1 Period|Adverse Event|1|||
105558000|NCT02395042|364039198|FG001|Treatment 1 Period|Adverse Event|3|||
105558001|NCT02395042|364039199|FG002|Treatment 1 Period|Adverse Event|1|||
105558002|NCT02395042|364039197|FG000|Treatment 1 Period|Lack of Efficacy|1|||
105558003|NCT02395042|364039198|FG001|Treatment 1 Period|Lack of Efficacy|1|||
105558004|NCT02395042|364039199|FG002|Treatment 1 Period|Lack of Efficacy|0|||
105558005|NCT02395042|364039197|FG000|Treatment 1 Period|Lost to Follow-up|1|||
105558006|NCT02395042|364039198|FG001|Treatment 1 Period|Lost to Follow-up|0|||
105558007|NCT02395042|364039199|FG002|Treatment 1 Period|Lost to Follow-up|0|||
105558008|NCT02395042|364039197|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
105558009|NCT02395042|364039198|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
105558010|NCT02395042|364039199|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
105558011|NCT02395042|364039197|FG000|Treatment 2 Period|Lack of Efficacy|1|||
105558012|NCT02395042|364039198|FG001|Treatment 2 Period|Lack of Efficacy|1|||
105558013|NCT02395042|364039199|FG002|Treatment 2 Period|Lack of Efficacy|0|||
105558014|NCT01152580|364039200|FG000|Overall Study|Withdrawal by Subject|0|||
105558015|NCT01152580|364039201|FG001|Overall Study|Withdrawal by Subject|1|||
105558016|NCT02834780|364039202|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
105558017|NCT02834780|364039203|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
105558018|NCT02834780|364039204|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
105558019|NCT02834780|364039205|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
105558020|NCT02834780|364039206|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
105558021|NCT02834780|364039207|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
105558022|NCT02834780|364039208|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
105558023|NCT02834780|364039209|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
105558024|NCT02834780|364039210|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
105558025|NCT02834780|364039211|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
105786508|NCT00071006|364871435|FG000|Overall Study|Other|3|||
105786509|NCT03792633|364871436|FG000|Overall Study|Alternative Treatment|17|||
105786510|NCT03792633|364871437|FG001|Overall Study|Alternative Treatment|19|||
105786511|NCT03792633|364871436|FG000|Overall Study|Death|2|||
105558026|NCT02834780|364039212|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
105558027|NCT02834780|364039213|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
105558028|NCT02834780|364039214|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
105558029|NCT02834780|364039202|FG000|Overall Study|Withdrawal by Subject|0|||
105558030|NCT02834780|364039203|FG001|Overall Study|Withdrawal by Subject|0|||
105558031|NCT02834780|364039204|FG002|Overall Study|Withdrawal by Subject|1|||
105558032|NCT02834780|364039205|FG003|Overall Study|Withdrawal by Subject|0|||
105558033|NCT02834780|364039206|FG004|Overall Study|Withdrawal by Subject|0|||
105558034|NCT02834780|364039207|FG005|Overall Study|Withdrawal by Subject|0|||
105558035|NCT02834780|364039208|FG006|Overall Study|Withdrawal by Subject|0|||
105558036|NCT02834780|364039209|FG007|Overall Study|Withdrawal by Subject|0|||
105786512|NCT03792633|364871437|FG001|Overall Study|Death|0|||
105786513|NCT03792633|364871436|FG000|Overall Study|Disease progression|8|||
105683796|NCT00585195|364505051|FG018|Overall Study|Progressive Disease|4|||
105683797|NCT00585195|364505052|FG019|Overall Study|Progressive Disease|9|||
105683798|NCT00585195|364505053|FG020|Overall Study|Progressive Disease|8|||
105683799|NCT00585195|364505033|FG000|Overall Study|Withdrawal by Subject|1|||
105683800|NCT00585195|364505034|FG001|Overall Study|Withdrawal by Subject|1|||
105683801|NCT00585195|364505035|FG002|Overall Study|Withdrawal by Subject|2|||
105683802|NCT00585195|364505036|FG003|Overall Study|Withdrawal by Subject|2|||
105683803|NCT00585195|364505037|FG004|Overall Study|Withdrawal by Subject|0|||
105683804|NCT00585195|364505038|FG005|Overall Study|Withdrawal by Subject|0|||
105683805|NCT00585195|364505039|FG006|Overall Study|Withdrawal by Subject|0|||
105683806|NCT00585195|364505040|FG007|Overall Study|Withdrawal by Subject|1|||
105683807|NCT00585195|364505041|FG008|Overall Study|Withdrawal by Subject|0|||
105683808|NCT00585195|364505042|FG009|Overall Study|Withdrawal by Subject|0|||
105683809|NCT00585195|364505043|FG010|Overall Study|Withdrawal by Subject|3|||
105683810|NCT00585195|364505044|FG011|Overall Study|Withdrawal by Subject|8|||
105683811|NCT00585195|364505045|FG012|Overall Study|Withdrawal by Subject|15|||
105683812|NCT00585195|364505046|FG013|Overall Study|Withdrawal by Subject|0|||
105683813|NCT00585195|364505047|FG014|Overall Study|Withdrawal by Subject|3|||
105683814|NCT00585195|364505048|FG015|Overall Study|Withdrawal by Subject|0|||
105683815|NCT00585195|364505049|FG016|Overall Study|Withdrawal by Subject|7|||
105683816|NCT00585195|364505050|FG017|Overall Study|Withdrawal by Subject|1|||
105683817|NCT00585195|364505051|FG018|Overall Study|Withdrawal by Subject|2|||
105683818|NCT00585195|364505052|FG019|Overall Study|Withdrawal by Subject|2|||
105683819|NCT00585195|364505053|FG020|Overall Study|Withdrawal by Subject|0|||
105683820|NCT00585195|364505033|FG000|Overall Study|Other|0|||
105683821|NCT00585195|364505034|FG001|Overall Study|Other|1|||
105683822|NCT00585195|364505035|FG002|Overall Study|Other|1|||
105683823|NCT00585195|364505036|FG003|Overall Study|Other|1|||
105683824|NCT00585195|364505037|FG004|Overall Study|Other|0|||
105683825|NCT00585195|364505038|FG005|Overall Study|Other|1|||
105683826|NCT00585195|364505039|FG006|Overall Study|Other|0|||
105683827|NCT00585195|364505040|FG007|Overall Study|Other|0|||
105683828|NCT00585195|364505041|FG008|Overall Study|Other|2|||
105683829|NCT00585195|364505042|FG009|Overall Study|Other|1|||
105683830|NCT00585195|364505043|FG010|Overall Study|Other|0|||
105683831|NCT00585195|364505044|FG011|Overall Study|Other|19|||
105683832|NCT00585195|364505045|FG012|Overall Study|Other|24|||
105683833|NCT00585195|364505046|FG013|Overall Study|Other|7|||
105683834|NCT00585195|364505047|FG014|Overall Study|Other|11|||
105786514|NCT03792633|364871437|FG001|Overall Study|Disease progression|9|||
105786515|NCT03792633|364871436|FG000|Overall Study|Lost to Follow-up|1|||
105786516|NCT03792633|364871437|FG001|Overall Study|Lost to Follow-up|1|||
105786517|NCT03792633|364871436|FG000|Overall Study|Screen fail|1|||
105786518|NCT03792633|364871437|FG001|Overall Study|Screen fail|0|||
105786519|NCT03792633|364871436|FG000|Overall Study|Second malignancy|0|||
105786520|NCT03792633|364871437|FG001|Overall Study|Second malignancy|1|||
105786521|NCT03901274|364871438|FG000|Overall Study|Lost to Follow-up|120|||
105786522|NCT03901274|364871439|FG001|Overall Study|Lost to Follow-up|124|||
105786523|NCT03901274|364871438|FG000|Overall Study|Withdrawal by Subject|0|||
105786524|NCT03901274|364871439|FG001|Overall Study|Withdrawal by Subject|6|||
105786525|NCT04527380|364871442|FG000|Overall Study|Lack of Efficacy|0|||
105786526|NCT04527380|364871443|FG001|Overall Study|Lack of Efficacy|1|||
105344582|NCT02417961|363263452|FG000|Overall Study|Lost to Follow-up|1|||
105344583|NCT02417961|363263452|FG000|Overall Study|Withdrawal by Subject|2|||
105344584|NCT05079750|363263453|FG000|Overall Study|Lost to Follow-up|0|||
105344585|NCT05079750|363263454|FG001|Overall Study|Lost to Follow-up|0|||
105344586|NCT05079750|363263455|FG002|Overall Study|Lost to Follow-up|1|||
105344587|NCT03197467|363263456|FG000|Overall Study|Withdrawal by Subject|1|||
105344588|NCT04488419|363263457|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
105344589|NCT04488419|363263458|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
105344590|NCT04488419|363263459|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
105344591|NCT04488419|363263457|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
105344592|NCT04488419|363263458|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
105344593|NCT04488419|363263459|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
105344594|NCT04488419|363263457|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
105469052|NCT02978781|363727477|FG001|Part A|Withdrawal by Subject|1|||
105683835|NCT00585195|364505048|FG015|Overall Study|Other|3|||
105683836|NCT00585195|364505049|FG016|Overall Study|Other|28|||
105683837|NCT00585195|364505050|FG017|Overall Study|Other|12|||
105683838|NCT00585195|364505051|FG018|Overall Study|Other|10|||
105683839|NCT00585195|364505052|FG019|Overall Study|Other|4|||
105683840|NCT00585195|364505053|FG020|Overall Study|Other|2|||
105786527|NCT04527380|364871442|FG000|Overall Study|Withdrawal by Subject|1|||
105683841|NCT00585195|364505033|FG000|Overall Study|Randomized not treated|0|||
105683842|NCT00585195|364505034|FG001|Overall Study|Randomized not treated|0|||
105683843|NCT00585195|364505035|FG002|Overall Study|Randomized not treated|1|||
105786528|NCT04527380|364871443|FG001|Overall Study|Withdrawal by Subject|0|||
105786529|NCT05048875|364871448|FG000|Overall Study|Withdrawal by Subject|1|||
105683844|NCT00585195|364505036|FG003|Overall Study|Randomized not treated|0|||
105683845|NCT00585195|364505037|FG004|Overall Study|Randomized not treated|1|||
105683846|NCT00585195|364505038|FG005|Overall Study|Randomized not treated|0|||
105683847|NCT00585195|364505039|FG006|Overall Study|Randomized not treated|1|||
105683848|NCT00585195|364505040|FG007|Overall Study|Randomized not treated|0|||
105683849|NCT00585195|364505041|FG008|Overall Study|Randomized not treated|0|||
105683850|NCT00585195|364505042|FG009|Overall Study|Randomized not treated|0|||
105683851|NCT00585195|364505043|FG010|Overall Study|Randomized not treated|2|||
105683852|NCT00585195|364505044|FG011|Overall Study|Randomized not treated|0|||
105683853|NCT00585195|364505045|FG012|Overall Study|Randomized not treated|0|||
105683854|NCT00585195|364505046|FG013|Overall Study|Randomized not treated|0|||
105683855|NCT00585195|364505047|FG014|Overall Study|Randomized not treated|0|||
105683856|NCT00585195|364505048|FG015|Overall Study|Randomized not treated|1|||
105683857|NCT00585195|364505049|FG016|Overall Study|Randomized not treated|0|||
105683858|NCT00585195|364505050|FG017|Overall Study|Randomized not treated|1|||
105683859|NCT00585195|364505051|FG018|Overall Study|Randomized not treated|3|||
105683860|NCT00585195|364505052|FG019|Overall Study|Randomized not treated|0|||
105683861|NCT00585195|364505053|FG020|Overall Study|Randomized not treated|2|||
105683862|NCT00585195|364505033|FG000|Overall Study|Death|0|||
105683863|NCT00585195|364505034|FG001|Overall Study|Death|0|||
105683864|NCT00585195|364505035|FG002|Overall Study|Death|0|||
105683865|NCT00585195|364505036|FG003|Overall Study|Death|0|||
105683866|NCT00585195|364505037|FG004|Overall Study|Death|0|||
105683867|NCT00585195|364505038|FG005|Overall Study|Death|0|||
105683868|NCT00585195|364505039|FG006|Overall Study|Death|0|||
105683869|NCT00585195|364505040|FG007|Overall Study|Death|0|||
105683870|NCT00585195|364505041|FG008|Overall Study|Death|1|||
105344595|NCT04488419|363263458|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
105683871|NCT00585195|364505042|FG009|Overall Study|Death|0|||
105683872|NCT00585195|364505043|FG010|Overall Study|Death|1|||
105683873|NCT00585195|364505044|FG011|Overall Study|Death|1|||
105683874|NCT00585195|364505045|FG012|Overall Study|Death|7|||
105683875|NCT00585195|364505046|FG013|Overall Study|Death|2|||
105683876|NCT00585195|364505047|FG014|Overall Study|Death|8|||
105683877|NCT00585195|364505048|FG015|Overall Study|Death|2|||
105683878|NCT00585195|364505049|FG016|Overall Study|Death|11|||
105683879|NCT00585195|364505050|FG017|Overall Study|Death|0|||
105683880|NCT00585195|364505051|FG018|Overall Study|Death|0|||
105683881|NCT00585195|364505052|FG019|Overall Study|Death|0|||
105683882|NCT00585195|364505053|FG020|Overall Study|Death|1|||
105683883|NCT00585195|364505033|FG000|Overall Study|Lost to Follow-up|0|||
105683884|NCT00585195|364505034|FG001|Overall Study|Lost to Follow-up|0|||
105683885|NCT00585195|364505035|FG002|Overall Study|Lost to Follow-up|0|||
105683886|NCT00585195|364505036|FG003|Overall Study|Lost to Follow-up|0|||
105683887|NCT00585195|364505037|FG004|Overall Study|Lost to Follow-up|0|||
105683888|NCT00585195|364505038|FG005|Overall Study|Lost to Follow-up|0|||
105683889|NCT00585195|364505039|FG006|Overall Study|Lost to Follow-up|0|||
105683890|NCT00585195|364505040|FG007|Overall Study|Lost to Follow-up|0|||
105683891|NCT00585195|364505041|FG008|Overall Study|Lost to Follow-up|0|||
105683892|NCT00585195|364505042|FG009|Overall Study|Lost to Follow-up|0|||
105683893|NCT00585195|364505043|FG010|Overall Study|Lost to Follow-up|0|||
105683894|NCT00585195|364505044|FG011|Overall Study|Lost to Follow-up|0|||
105683895|NCT00585195|364505045|FG012|Overall Study|Lost to Follow-up|1|||
105683896|NCT00585195|364505046|FG013|Overall Study|Lost to Follow-up|0|||
105683897|NCT00585195|364505047|FG014|Overall Study|Lost to Follow-up|0|||
105344596|NCT04488419|363263459|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
105683898|NCT00585195|364505048|FG015|Overall Study|Lost to Follow-up|0|||
105683899|NCT00585195|364505049|FG016|Overall Study|Lost to Follow-up|0|||
105683900|NCT00585195|364505050|FG017|Overall Study|Lost to Follow-up|2|||
105683901|NCT00585195|364505051|FG018|Overall Study|Lost to Follow-up|0|||
105683902|NCT00585195|364505052|FG019|Overall Study|Lost to Follow-up|0|||
105683903|NCT00585195|364505053|FG020|Overall Study|Lost to Follow-up|0|||
105683904|NCT00585195|364505033|FG000|Overall Study|Site Terminated by Sponsor|0|||
105683905|NCT00585195|364505034|FG001|Overall Study|Site Terminated by Sponsor|0|||
105683906|NCT00585195|364505035|FG002|Overall Study|Site Terminated by Sponsor|0|||
105683907|NCT00585195|364505036|FG003|Overall Study|Site Terminated by Sponsor|0|||
105683908|NCT00585195|364505037|FG004|Overall Study|Site Terminated by Sponsor|0|||
105683909|NCT00585195|364505038|FG005|Overall Study|Site Terminated by Sponsor|0|||
105683910|NCT00585195|364505039|FG006|Overall Study|Site Terminated by Sponsor|0|||
105683911|NCT00585195|364505040|FG007|Overall Study|Site Terminated by Sponsor|0|||
105683912|NCT00585195|364505041|FG008|Overall Study|Site Terminated by Sponsor|0|||
105683913|NCT00585195|364505042|FG009|Overall Study|Site Terminated by Sponsor|0|||
105683914|NCT00585195|364505043|FG010|Overall Study|Site Terminated by Sponsor|0|||
105683915|NCT00585195|364505044|FG011|Overall Study|Site Terminated by Sponsor|0|||
105683916|NCT00585195|364505045|FG012|Overall Study|Site Terminated by Sponsor|1|||
105683917|NCT00585195|364505046|FG013|Overall Study|Site Terminated by Sponsor|0|||
105683918|NCT00585195|364505047|FG014|Overall Study|Site Terminated by Sponsor|0|||
105683919|NCT00585195|364505048|FG015|Overall Study|Site Terminated by Sponsor|0|||
105683920|NCT00585195|364505049|FG016|Overall Study|Site Terminated by Sponsor|0|||
105683921|NCT00585195|364505050|FG017|Overall Study|Site Terminated by Sponsor|0|||
105683922|NCT00585195|364505051|FG018|Overall Study|Site Terminated by Sponsor|0|||
105683923|NCT00585195|364505052|FG019|Overall Study|Site Terminated by Sponsor|0|||
105683924|NCT00585195|364505053|FG020|Overall Study|Site Terminated by Sponsor|0|||
105683925|NCT00585195|364505033|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
105683926|NCT00585195|364505034|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
105683927|NCT00585195|364505035|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
105683928|NCT00585195|364505036|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
105683929|NCT00585195|364505037|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
105683930|NCT00585195|364505038|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
105683931|NCT00585195|364505039|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
105683932|NCT00585195|364505040|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
105683933|NCT00585195|364505041|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
105683934|NCT00585195|364505042|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
105683935|NCT00585195|364505043|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
105683936|NCT00585195|364505044|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
105683937|NCT00585195|364505045|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
105683938|NCT00585195|364505046|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
105683939|NCT00585195|364505047|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
105683940|NCT00585195|364505048|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
105683941|NCT00585195|364505049|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
105683942|NCT00585195|364505050|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
105683943|NCT00585195|364505051|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
105683944|NCT00585195|364505052|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
105683945|NCT00585195|364505053|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
105683946|NCT02594163|364506685|FG000|Treatment Period|Progressive disease|2|||
105683947|NCT02594163|364506686|FG001|Treatment Period|Progressive disease|3|||
105683948|NCT02594163|364506685|FG000|Treatment Period|Adverse Event|1|||
105683949|NCT02594163|364506686|FG001|Treatment Period|Adverse Event|5|||
105683950|NCT02594163|364506685|FG000|Treatment Period|Physician Decision|1|||
105683951|NCT02594163|364506686|FG001|Treatment Period|Physician Decision|3|||
105683952|NCT02594163|364506685|FG000|Treatment Period|Study termination by sponsor|2|||
105683953|NCT02594163|364506686|FG001|Treatment Period|Study termination by sponsor|1|||
105683954|NCT02594163|364506685|FG000|Treatment Period|Other, Non-AE|1|||
105683955|NCT02594163|364506686|FG001|Treatment Period|Other, Non-AE|0|||
105683956|NCT02594163|364506685|FG000|Follow-up Period|Withdrawal by Subject|0|||
105683957|NCT02594163|364506686|FG001|Follow-up Period|Withdrawal by Subject|1|||
105683958|NCT02594163|364506685|FG000|Follow-up Period|Study Termination by Sponsor|6|||
105683959|NCT02594163|364506686|FG001|Follow-up Period|Study Termination by Sponsor|4|||
105683960|NCT02594163|364506685|FG000|Follow-up Period|Lost to Follow-up|1|||
105683961|NCT02594163|364506686|FG001|Follow-up Period|Lost to Follow-up|0|||
105683962|NCT02594163|364506685|FG000|Follow-up Period|Death|2|||
105683963|NCT02594163|364506686|FG001|Follow-up Period|Death|5|||
105683964|NCT02594163|364506685|FG000|Follow-up Period|Adverse Event|0|||
105683965|NCT02594163|364506686|FG001|Follow-up Period|Adverse Event|1|||
105683966|NCT02594163|364506685|FG000|Follow-up Period|Progressive Disease|2|||
105683967|NCT02594163|364506686|FG001|Follow-up Period|Progressive Disease|0|||
105683968|NCT02594163|364506685|FG000|Follow-up Period|Physician Decision|0|||
105683969|NCT02594163|364506686|FG001|Follow-up Period|Physician Decision|1|||
105683970|NCT00117845|364506689|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
105683971|NCT01877837|364506694|FG000|Overall Study|Lost to Follow-up|1|||
105683972|NCT01877837|364506694|FG000|Overall Study|Ineligible|4|||
105683973|NCT00320541|364506696|FG000|Overall Study|Adverse Event|21|||
105683974|NCT00320541|364506697|FG001|Overall Study|Adverse Event|19|||
105683975|NCT00320541|364506696|FG000|Overall Study|Protocol Violation|0|||
105683976|NCT00320541|364506697|FG001|Overall Study|Protocol Violation|1|||
105683977|NCT00320541|364506696|FG000|Overall Study|Withdrawal by Subject|12|||
105683978|NCT00320541|364506697|FG001|Overall Study|Withdrawal by Subject|16|||
105683979|NCT00320541|364506696|FG000|Overall Study|Physician Decision|9|||
105683980|NCT00320541|364506697|FG001|Overall Study|Physician Decision|13|||
105683981|NCT00320541|364506696|FG000|Overall Study|Other|3|||
105683982|NCT00320541|364506697|FG001|Overall Study|Other|4|||
105683983|NCT00320541|364506696|FG000|Overall Study|Sponsor Decision|2|||
105683984|NCT00320541|364506697|FG001|Overall Study|Sponsor Decision|1|||
105683985|NCT00320541|364506696|FG000|Overall Study|Death due to Study Disease|1|||
105683986|NCT00320541|364506697|FG001|Overall Study|Death due to Study Disease|3|||
105683987|NCT00320541|364506696|FG000|Overall Study|Death due to Adverse Event(s)|1|||
105683988|NCT00320541|364506697|FG001|Overall Study|Death due to Adverse Event(s)|0|||
105683989|NCT00320541|364506696|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
105683990|NCT00320541|364506697|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
105683991|NCT01403610|364506698|FG000|Overall Study|Withdrawal by Subject|2|||
105683992|NCT01403610|364506699|FG001|Overall Study|Withdrawal by Subject|0|||
105683993|NCT01403610|364506700|FG002|Overall Study|Withdrawal by Subject|0|||
105683994|NCT01403610|364506701|FG003|Overall Study|Withdrawal by Subject|0|||
105683995|NCT01403610|364506698|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
105683996|NCT01403610|364506699|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
105683997|NCT01403610|364506700|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
105683998|NCT01403610|364506701|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
105683999|NCT01350336|364506702|FG000|Overall Study|Lost to Follow-up|31|||
105684000|NCT01350336|364506702|FG000|Overall Study|Withdrawal by Subject|14|||
105684001|NCT01350336|364506702|FG000|Overall Study|Physician Decision|8|||
105684002|NCT01350336|364506702|FG000|Overall Study|Death|4|||
105684003|NCT01689337|364506708|FG000|Overall Study|Study Discontinuation|1|||
105684004|NCT03718533|364506710|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
105684005|NCT03718533|364506710|FG000|Overall Study|Protocol deviation|1|||
105684006|NCT03718533|364506710|FG000|Overall Study|Disease progression|1|||
105684007|NCT03718533|364506710|FG000|Overall Study|Relapse|1|||
105684008|NCT03718533|364506710|FG000|Overall Study|Physician Decision|2|||
105684009|NCT03718533|364506710|FG000|Overall Study|Physician Decision and Adverse Event|1|||
105684010|NCT00666679|364506711|FG000|First Intervention|Lost to Follow-up|1|||
105684011|NCT00666679|364506712|FG001|First Intervention|Lost to Follow-up|0|||
105684012|NCT00666679|364506711|FG000|First Intervention|Protocol Violation|1|||
105684013|NCT00666679|364506712|FG001|First Intervention|Protocol Violation|0|||
105684014|NCT00666679|364506711|FG000|First Intervention|Withdrawal by Subject|1|||
105684015|NCT00666679|364506712|FG001|First Intervention|Withdrawal by Subject|0|||
105684016|NCT00666679|364506711|FG000|First Intervention|Randomized did not start treatment|1|||
105684017|NCT00666679|364506712|FG001|First Intervention|Randomized did not start treatment|1|||
105684018|NCT00666679|364506711|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
105684019|NCT00666679|364506712|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
105684020|NCT00666679|364506711|FG000|Washout Period of 1 Week|Protocol Violation|0|||
105684021|NCT00666679|364506712|FG001|Washout Period of 1 Week|Protocol Violation|1|||
105684022|NCT00666679|364506711|FG000|Second Intervention|Adverse Event|1|||
105684023|NCT00666679|364506712|FG001|Second Intervention|Adverse Event|0|||
105684024|NCT00666679|364506711|FG000|Second Intervention|Death|0|||
105684025|NCT00666679|364506712|FG001|Second Intervention|Death|1|||
105684026|NCT01347762|364506713|FG000|Overall Study|Lost to Follow-up|0|||
105684027|NCT01347762|364506714|FG001|Overall Study|Lost to Follow-up|1|||
105684028|NCT01347762|364506715|FG002|Overall Study|Lost to Follow-up|6|||
105684029|NCT01347762|364506716|FG003|Overall Study|Lost to Follow-up|5|||
105684030|NCT01347762|364506713|FG000|Overall Study|Withdrawal by Subject|4|||
105684031|NCT01347762|364506714|FG001|Overall Study|Withdrawal by Subject|1|||
105684032|NCT01347762|364506715|FG002|Overall Study|Withdrawal by Subject|3|||
105684033|NCT01347762|364506716|FG003|Overall Study|Withdrawal by Subject|3|||
105684034|NCT00093808|364506717|FG000|Overall Study|Cancel participation before receiving tx|1|||
105684035|NCT00093808|364506717|FG000|Overall Study|Protocol Violation|1|||
105684036|NCT00871780|364506718|FG000|Overall Study|Enrolled But Not Treated|6|||
105684037|NCT00871780|364506718|FG000|Overall Study|Withdrawal by Subject|9|||
105684038|NCT00871780|364506718|FG000|Overall Study|Adverse Event|6|||
105684039|NCT00871780|364506718|FG000|Overall Study|Voluntary Discontinuation|4|||
105684040|NCT00871780|364506718|FG000|Overall Study|Death|1|||
105684041|NCT00871780|364506718|FG000|Overall Study|Physician Decision|1|||
105786530|NCT05048875|364871449|FG001|Overall Study|Withdrawal by Subject|0|||
105786531|NCT05048875|364871450|FG002|Overall Study|Withdrawal by Subject|0|||
105786532|NCT05048875|364871451|FG003|Overall Study|Withdrawal by Subject|0|||
105786533|NCT05048875|364871452|FG004|Overall Study|Withdrawal by Subject|0|||
105344597|NCT04488419|363263457|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
105684042|NCT03406260|364506719|FG000|Period 1|Adverse Event|0|||
105684043|NCT03406260|364506720|FG001|Period 1|Adverse Event|0|||
105684044|NCT03406260|364506721|FG002|Period 1|Adverse Event|0|||
105684045|NCT03406260|364506722|FG003|Period 1|Adverse Event|0|||
105684046|NCT03406260|364506723|FG004|Period 1|Adverse Event|1|||
105684047|NCT03406260|364506724|FG005|Period 1|Adverse Event|0|||
105684048|NCT02208999|364506726|FG000|Overall Study|Lost to Follow-up|1|||
105684049|NCT01136772|364506727|FG000|Overall Study|Adverse Event|15|||
105684050|NCT01136772|364506728|FG001|Overall Study|Adverse Event|14|||
105684051|NCT01136772|364506727|FG000|Overall Study|Lack of Efficacy|42|||
105684052|NCT01136772|364506728|FG001|Overall Study|Lack of Efficacy|39|||
105684053|NCT01136772|364506727|FG000|Overall Study|Administrative|14|||
105684054|NCT01136772|364506728|FG001|Overall Study|Administrative|12|||
105684055|NCT01136772|364506727|FG000|Overall Study|Withdrawal by Subject|33|||
105684056|NCT01136772|364506728|FG001|Overall Study|Withdrawal by Subject|36|||
105684057|NCT01136772|364506727|FG000|Overall Study|Did not receive injection|10|||
105684058|NCT01136772|364506728|FG001|Overall Study|Did not receive injection|7|||
105684059|NCT01136772|364506727|FG000|Overall Study|Did not follow up after first injection|2|||
105684060|NCT01136772|364506728|FG001|Overall Study|Did not follow up after first injection|2|||
105684061|NCT01831856|364506729|FG000|Overall Study|Adverse Event|5|||
105684062|NCT01831856|364506730|FG001|Overall Study|Adverse Event|8|||
105684063|NCT01831856|364506729|FG000|Overall Study|Lack of Efficacy|13|||
105684064|NCT01831856|364506730|FG001|Overall Study|Lack of Efficacy|11|||
105684065|NCT01831856|364506729|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
105684066|NCT01831856|364506730|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
105684067|NCT01498653|364506731|FG000|Overall Study|Adverse Event|2|||
105684068|NCT01498653|364506732|FG001|Overall Study|Adverse Event|2|||
105684069|NCT01498653|364506731|FG000|Overall Study|Lack of Efficacy|12|||
105684070|NCT01498653|364506732|FG001|Overall Study|Lack of Efficacy|26|||
105684071|NCT01498653|364506731|FG000|Overall Study|Protocol Violation|0|||
105684072|NCT01498653|364506732|FG001|Overall Study|Protocol Violation|4|||
105684073|NCT01498653|364506731|FG000|Overall Study|Lost to Follow-up|1|||
105684074|NCT01498653|364506732|FG001|Overall Study|Lost to Follow-up|0|||
105684075|NCT01498653|364506731|FG000|Overall Study|Physician Decision|2|||
105684076|NCT01498653|364506732|FG001|Overall Study|Physician Decision|0|||
105684077|NCT01498653|364506731|FG000|Overall Study|Withdrawal by Subject|2|||
105684078|NCT01498653|364506732|FG001|Overall Study|Withdrawal by Subject|3|||
105684079|NCT02070588|364506733|FG000|Overall Study|Withdrawal by Subject|29|||
105684080|NCT02070588|364506734|FG001|Overall Study|Withdrawal by Subject|1|||
105684081|NCT02070588|364506735|FG002|Overall Study|Withdrawal by Subject|0|||
105684082|NCT02070588|364506733|FG000|Overall Study|Writhdrawal due to early termination|9|||
105684083|NCT02070588|364506734|FG001|Overall Study|Writhdrawal due to early termination|0|||
105684084|NCT02070588|364506735|FG002|Overall Study|Writhdrawal due to early termination|0|||
105684085|NCT02070588|364506733|FG000|Overall Study|Adverse Event|1|||
105684086|NCT02070588|364506734|FG001|Overall Study|Adverse Event|0|||
105684087|NCT02070588|364506735|FG002|Overall Study|Adverse Event|0|||
105684088|NCT00836095|364506740|FG000|Overall Study|Physician Decision|0|||
105684089|NCT00836095|364506741|FG001|Overall Study|Physician Decision|3|||
105684090|NCT02319525|364506742|FG000|Overall Study|Withdrawal by Subject|2|||
105684091|NCT02319525|364506743|FG001|Overall Study|Withdrawal by Subject|1|||
105684092|NCT01602562|364506744|FG000|Overall Study|Adverse Event|3|||
105684093|NCT01602562|364506745|FG001|Overall Study|Adverse Event|1|||
105684094|NCT01602562|364506744|FG000|Overall Study|Physician Decision|1|||
105684095|NCT01602562|364506745|FG001|Overall Study|Physician Decision|1|||
105684096|NCT01602562|364506744|FG000|Overall Study|Withdrawal by Subject|1|||
105684097|NCT01602562|364506745|FG001|Overall Study|Withdrawal by Subject|1|||
105684098|NCT03881553|364506746|FG000|Overall Study|Discharged prior to participation|1|||
105684099|NCT03881553|364506747|FG001|Overall Study|Discharged prior to participation|1|||
105684100|NCT03881553|364506748|FG002|Overall Study|Discharged prior to participation|0|||
105684101|NCT03881553|364506746|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
105684102|NCT03881553|364506747|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
105684103|NCT03881553|364506748|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
105684104|NCT01718353|364506749|FG000|Overall Study|Lost to Follow-up|0|||
105684105|NCT01718353|364506750|FG001|Overall Study|Lost to Follow-up|1|||
105684106|NCT01718353|364506749|FG000|Overall Study|Principal Investigator's Decision|10|||
105684107|NCT01718353|364506750|FG001|Overall Study|Principal Investigator's Decision|4|||
105684108|NCT01718353|364506749|FG000|Overall Study|Randomized but not treated|2|||
105684109|NCT01718353|364506750|FG001|Overall Study|Randomized but not treated|0|||
105684110|NCT01078675|364506751|FG000|Overall Study|Withdrawal by Subject|7|||
105344598|NCT04488419|363263458|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
105344599|NCT04488419|363263459|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
105684111|NCT01078675|364506752|FG001|Overall Study|Withdrawal by Subject|3|||
105684112|NCT01078675|364506751|FG000|Overall Study|Protocol Violation|56|||
105684113|NCT01078675|364506752|FG001|Overall Study|Protocol Violation|0|||
105684114|NCT01078675|364506751|FG000|Overall Study|Provided in CRF for specific reasons|2|||
105684115|NCT01078675|364506752|FG001|Overall Study|Provided in CRF for specific reasons|3|||
105684116|NCT01078675|364506751|FG000|Overall Study|Adverse Event|3|||
105684117|NCT01078675|364506752|FG001|Overall Study|Adverse Event|0|||
105684118|NCT00928746|364506753|FG000|Overall Study|Adverse Event|2|||
105684119|NCT00928746|364506753|FG000|Overall Study|Protocol Violation|1|||
105684120|NCT00928746|364506753|FG000|Overall Study|Withdrawal by Subject|1|||
105684121|NCT00928746|364506753|FG000|Overall Study|Other|2|||
105684122|NCT01337115|364506754|FG000|Overall Study|Protocol Violation|2|||
105684123|NCT01337115|364506755|FG001|Overall Study|Protocol Violation|0|||
105684124|NCT01079741|364506757|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
105684125|NCT01079741|364506758|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
105684126|NCT01079741|364506759|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
105684127|NCT01079741|364506760|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
105684128|NCT01079741|364506761|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
105684129|NCT01079741|364506757|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
105684130|NCT01079741|364506758|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
105684131|NCT01079741|364506759|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
105684132|NCT01079741|364506760|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
105684133|NCT01079741|364506761|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
105684134|NCT01275131|364506763|FG000|Period 1|Withdrawal by Subject|1|||
105684135|NCT01275131|364506764|FG001|Period 1|Withdrawal by Subject|0|||
105684136|NCT01275131|364506765|FG002|Period 1|Withdrawal by Subject|3|||
105684137|NCT01275131|364506766|FG003|Period 1|Withdrawal by Subject|2|||
105684138|NCT01275131|364506763|FG000|Period 1|Physician Decision|1|||
105684139|NCT01275131|364506764|FG001|Period 1|Physician Decision|0|||
105684140|NCT01275131|364506765|FG002|Period 1|Physician Decision|0|||
105684141|NCT01275131|364506766|FG003|Period 1|Physician Decision|0|||
105684142|NCT01275131|364506763|FG000|Period 2 (Crossover)|Adverse Event|0|||
105684143|NCT01275131|364506764|FG001|Period 2 (Crossover)|Adverse Event|1|||
105684144|NCT01275131|364506765|FG002|Period 2 (Crossover)|Adverse Event|0|||
105684145|NCT01275131|364506766|FG003|Period 2 (Crossover)|Adverse Event|0|||
105684146|NCT01275131|364506763|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
105684147|NCT01275131|364506764|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
105684148|NCT01275131|364506765|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
105684149|NCT01275131|364506766|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
105684150|NCT01270971|364506767|FG000|Overall Study|Withdrawal by Subject|24|||
105684151|NCT01270971|364506768|FG001|Overall Study|Withdrawal by Subject|11|||
105684152|NCT01270971|364506767|FG000|Overall Study|Lost to Follow-up|18|||
105684153|NCT01270971|364506768|FG001|Overall Study|Lost to Follow-up|5|||
105684154|NCT01270971|364506767|FG000|Overall Study|Adverse Event|1|||
105684155|NCT01270971|364506768|FG001|Overall Study|Adverse Event|2|||
105684156|NCT01270971|364506767|FG000|Overall Study|Non compliance|2|||
105684157|NCT01270971|364506768|FG001|Overall Study|Non compliance|2|||
105684158|NCT01270971|364506767|FG000|Overall Study|Non-specific|7|||
105684159|NCT01270971|364506768|FG001|Overall Study|Non-specific|3|||
105684160|NCT01142596|364506769|FG000|Overall Study|Withdrawal by Subject|9|||
105684161|NCT01142596|364506770|FG001|Overall Study|Withdrawal by Subject|35|||
105684162|NCT01142596|364506769|FG000|Overall Study|Adverse Event|8|||
105684163|NCT01142596|364506770|FG001|Overall Study|Adverse Event|35|||
105684164|NCT01142596|364506769|FG000|Overall Study|Lack of Efficacy|5|||
105684165|NCT01142596|364506770|FG001|Overall Study|Lack of Efficacy|9|||
105684166|NCT01142596|364506769|FG000|Overall Study|Lost to Follow-up|2|||
105684167|NCT01142596|364506770|FG001|Overall Study|Lost to Follow-up|3|||
105684168|NCT01142596|364506769|FG000|Overall Study|Other reason (not specified)|5|||
105684169|NCT01142596|364506770|FG001|Overall Study|Other reason (not specified)|4|||
105684170|NCT03333837|364506774|FG000|Overall Study|Adverse Event|2|||
105684171|NCT03333837|364506775|FG001|Overall Study|Adverse Event|1|||
105684172|NCT03333837|364506776|FG002|Overall Study|Adverse Event|1|||
105684173|NCT03333837|364506777|FG003|Overall Study|Adverse Event|1|||
105684174|NCT03333837|364506778|FG004|Overall Study|Adverse Event|0|||
105684175|NCT03333837|364506774|FG000|Overall Study|Caregiver withdrew|0|||
105684176|NCT03333837|364506775|FG001|Overall Study|Caregiver withdrew|2|||
105684177|NCT03333837|364506776|FG002|Overall Study|Caregiver withdrew|1|||
105684178|NCT03333837|364506777|FG003|Overall Study|Caregiver withdrew|0|||
105684179|NCT03333837|364506778|FG004|Overall Study|Caregiver withdrew|0|||
105684180|NCT03333837|364506774|FG000|Overall Study|Withdrawal by Subject|0|||
105684181|NCT03333837|364506775|FG001|Overall Study|Withdrawal by Subject|0|||
105558037|NCT02834780|364039210|FG008|Overall Study|Withdrawal by Subject|0|||
105684182|NCT03333837|364506776|FG002|Overall Study|Withdrawal by Subject|1|||
105558038|NCT02834780|364039211|FG009|Overall Study|Withdrawal by Subject|0|||
105684183|NCT03333837|364506777|FG003|Overall Study|Withdrawal by Subject|1|||
105684184|NCT03333837|364506778|FG004|Overall Study|Withdrawal by Subject|3|||
105684185|NCT03333837|364506774|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
105684186|NCT03333837|364506775|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
105684187|NCT03333837|364506776|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
105684188|NCT03333837|364506777|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
105684189|NCT03333837|364506778|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
105684190|NCT04217590|364506779|FG000|Overall Study|Other|1|||
105684191|NCT04217590|364506780|FG001|Overall Study|Other|1|||
105684192|NCT04217590|364506779|FG000|Overall Study|Withdrawal by Subject|3|||
105684193|NCT04217590|364506780|FG001|Overall Study|Withdrawal by Subject|1|||
105684194|NCT04217590|364506779|FG000|Overall Study|Death|0|||
105684195|NCT04217590|364506780|FG001|Overall Study|Death|1|||
105684196|NCT03353350|364506781|FG000|30-week Core Treatment Period|Protocol Violation|1|||
105684197|NCT03353350|364506782|FG001|30-week Core Treatment Period|Protocol Violation|1|||
105684198|NCT03353350|364506783|FG002|30-week Core Treatment Period|Protocol Violation|1|||
105684199|NCT03353350|364506784|FG003|30-week Core Treatment Period|Protocol Violation|0|||
105684200|NCT03353350|364506781|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
105684201|NCT03353350|364506782|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
105684202|NCT03353350|364506783|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
105684203|NCT03353350|364506784|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
105684204|NCT03353350|364506781|FG000|30-week Core Treatment Period|Adverse Event|0|||
105684205|NCT03353350|364506782|FG001|30-week Core Treatment Period|Adverse Event|4|||
105684206|NCT03353350|364506783|FG002|30-week Core Treatment Period|Adverse Event|2|||
105684207|NCT03353350|364506784|FG003|30-week Core Treatment Period|Adverse Event|3|||
105684208|NCT03353350|364506781|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
105684209|NCT03353350|364506782|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
105684210|NCT03353350|364506783|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
105684211|NCT03353350|364506784|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
105684212|NCT03353350|364506781|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
105684213|NCT03353350|364506782|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
105684214|NCT03353350|364506783|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
105684215|NCT03353350|364506784|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
105684216|NCT03353350|364506781|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
105684217|NCT03353350|364506782|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
105684218|NCT03353350|364506783|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
105684219|NCT03353350|364506784|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
105684220|NCT03353350|364506781|FG000|26-week Treatment Extension Period|Adverse Event|1|||
105684221|NCT03353350|364506782|FG001|26-week Treatment Extension Period|Adverse Event|0|||
105684222|NCT03353350|364506783|FG002|26-week Treatment Extension Period|Adverse Event|0|||
105684223|NCT03353350|364506784|FG003|26-week Treatment Extension Period|Adverse Event|1|||
105684224|NCT03353350|364506781|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
105684225|NCT03353350|364506782|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
105684226|NCT03353350|364506783|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
105684227|NCT03353350|364506784|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
105684228|NCT02003573|364506785|FG000|Overall Study|Progressive disease|2|||
105684229|NCT02003573|364506786|FG001|Overall Study|Progressive disease|0|||
105684230|NCT02003573|364506787|FG002|Overall Study|Progressive disease|1|||
105684231|NCT02003573|364506785|FG000|Overall Study|Other Adverse event|0|||
105684232|NCT02003573|364506786|FG001|Overall Study|Other Adverse event|1|||
105684233|NCT02003573|364506787|FG002|Overall Study|Other Adverse event|1|||
105684234|NCT02003573|364506785|FG000|Overall Study|Refuse to take trial medication|0|||
105684235|NCT02003573|364506786|FG001|Overall Study|Refuse to take trial medication|1|||
105684236|NCT02003573|364506787|FG002|Overall Study|Refuse to take trial medication|1|||
105684237|NCT02003573|364506785|FG000|Overall Study|Other than specified|1|||
105684238|NCT02003573|364506786|FG001|Overall Study|Other than specified|2|||
105684239|NCT02003573|364506787|FG002|Overall Study|Other than specified|3|||
105684240|NCT02988622|364506788|FG000|Overall Study|Lost to Follow-up|17|||
105684241|NCT03261700|364506789|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
105684242|NCT03261700|364506790|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
105684243|NCT03562247|364506791|FG000|Overall Study|Lost to Follow-up|3|||
105684244|NCT03562247|364506792|FG001|Overall Study|Lost to Follow-up|1|||
105684245|NCT03562247|364506793|FG002|Overall Study|Lost to Follow-up|1|||
105786534|NCT05048875|364871453|FG005|Overall Study|Withdrawal by Subject|0|||
105786535|NCT05048875|364871454|FG006|Overall Study|Withdrawal by Subject|0|||
105786536|NCT05048875|364871455|FG007|Overall Study|Withdrawal by Subject|0|||
105786537|NCT05048875|364871448|FG000|Overall Study|Adverse Event|0|||
105786538|NCT05048875|364871449|FG001|Overall Study|Adverse Event|0|||
105558039|NCT02834780|364039212|FG010|Overall Study|Withdrawal by Subject|1|||
105684246|NCT00983931|364506794|FG000|14 Day Washout Period|Physician Decision|1|||
105684247|NCT02513745|364506802|FG000|Overall Study|Criteria at time of surgery not met.|3|||
105684248|NCT02513745|364506803|FG001|Overall Study|Criteria at time of surgery not met.|3|||
105684249|NCT00427895|364506804|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
105684250|NCT00427895|364506805|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
105684251|NCT00427895|364506806|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
105786539|NCT05048875|364871450|FG002|Overall Study|Adverse Event|0|||
105786540|NCT05048875|364871451|FG003|Overall Study|Adverse Event|1|||
105684252|NCT00427895|364506807|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
105684253|NCT00427895|364506808|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
105684254|NCT00427895|364506809|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
105684255|NCT00427895|364506810|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
105684256|NCT00427895|364506811|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
105684257|NCT00427895|364506804|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
105684258|NCT00427895|364506805|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
105684259|NCT00427895|364506806|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
105684260|NCT00427895|364506807|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
105684261|NCT00427895|364506808|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
105684262|NCT00427895|364506809|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
105684263|NCT00427895|364506810|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
105684264|NCT00427895|364506811|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
105684265|NCT00427895|364506804|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
105684266|NCT00427895|364506805|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
105684267|NCT00427895|364506806|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
105684268|NCT00427895|364506807|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
105684269|NCT00427895|364506808|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
105684270|NCT00427895|364506809|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
105684271|NCT00427895|364506810|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
105684272|NCT00427895|364506811|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
105684273|NCT00427895|364506804|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
105684274|NCT00427895|364506805|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
105684275|NCT00427895|364506806|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
105684276|NCT00427895|364506807|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
105684277|NCT00427895|364506808|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
105684278|NCT00427895|364506809|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
105684279|NCT00427895|364506810|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
105684280|NCT00427895|364506811|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
105684281|NCT00427895|364506804|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
105684282|NCT00427895|364506805|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
105684283|NCT00427895|364506806|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
105684284|NCT00427895|364506807|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
105684285|NCT00427895|364506808|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
105684286|NCT00427895|364506809|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
105684287|NCT00427895|364506810|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
105684288|NCT00427895|364506811|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
105684289|NCT00427895|364506804|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
105684290|NCT00427895|364506805|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
105684291|NCT00427895|364506806|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
105684292|NCT00427895|364506807|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
105684293|NCT00427895|364506808|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
105684294|NCT00427895|364506809|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
105684295|NCT00427895|364506810|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
105684296|NCT00427895|364506811|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
105684297|NCT00427895|364506804|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
105684298|NCT00427895|364506805|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
105684299|NCT00427895|364506806|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
105684300|NCT00427895|364506807|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
105684301|NCT00427895|364506808|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
105684302|NCT00427895|364506809|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
105684303|NCT00427895|364506810|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
105684304|NCT00427895|364506811|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
105684305|NCT00427895|364506804|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
105684306|NCT00427895|364506805|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
105684307|NCT00427895|364506806|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
105684308|NCT00427895|364506807|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
105684309|NCT00427895|364506808|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
105684310|NCT00427895|364506809|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
105684311|NCT00427895|364506810|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
105684312|NCT00427895|364506811|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
105684313|NCT00427895|364506804|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
105558040|NCT02834780|364039213|FG011|Overall Study|Withdrawal by Subject|0|||
105558041|NCT02834780|364039214|FG012|Overall Study|Withdrawal by Subject|0|||
105558042|NCT02834780|364039202|FG000|Overall Study|Adverse Event|0|||
105684314|NCT00427895|364506805|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
105684315|NCT00427895|364506806|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
105558043|NCT02834780|364039203|FG001|Overall Study|Adverse Event|0|||
105684316|NCT00427895|364506807|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
105684317|NCT00427895|364506808|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
105684318|NCT00427895|364506809|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
105684319|NCT00427895|364506810|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
105684320|NCT00427895|364506811|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
105684321|NCT00427895|364506804|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
105684322|NCT00427895|364506805|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
105684323|NCT00427895|364506806|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
105684324|NCT00427895|364506807|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
105684325|NCT00427895|364506808|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
105684326|NCT00427895|364506809|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
105684327|NCT00427895|364506810|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
105684328|NCT00427895|364506811|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
105684329|NCT00427895|364506804|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
105684330|NCT00427895|364506805|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
105684331|NCT00427895|364506806|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
105684332|NCT00427895|364506807|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
105684333|NCT00427895|364506808|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
105684334|NCT00427895|364506809|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
105684335|NCT00427895|364506810|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
105684336|NCT00427895|364506811|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
105684337|NCT00427895|364506804|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
105684338|NCT00427895|364506805|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
105684339|NCT00427895|364506806|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
105684340|NCT00427895|364506807|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
105684341|NCT00427895|364506808|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
105684342|NCT00427895|364506809|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
105684343|NCT00427895|364506810|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
105684344|NCT00427895|364506811|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
105684345|NCT00427895|364506804|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
105684346|NCT00427895|364506805|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
105684347|NCT00427895|364506806|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
105684348|NCT00427895|364506807|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
105684349|NCT00427895|364506808|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
105684350|NCT00427895|364506809|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
105684351|NCT00427895|364506810|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
105684352|NCT00427895|364506811|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
105684353|NCT00427895|364506804|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
105684354|NCT00427895|364506805|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
105684355|NCT00427895|364506806|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
105684356|NCT00427895|364506807|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
105684357|NCT00427895|364506808|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
105684358|NCT00427895|364506809|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
105684359|NCT00427895|364506810|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
105684360|NCT00427895|364506811|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
105684361|NCT00427895|364506804|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
105684362|NCT00427895|364506805|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
105684363|NCT00427895|364506806|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
105684364|NCT00427895|364506807|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
105684365|NCT00427895|364506808|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
105684366|NCT00427895|364506809|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
105684367|NCT00427895|364506810|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
105684368|NCT00427895|364506811|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
105684369|NCT00427895|364506804|FG000|Vax 1/Year 1 Follow-up|Death|1|||
105684370|NCT00427895|364506805|FG001|Vax 1/Year 1 Follow-up|Death|0|||
105684371|NCT00427895|364506806|FG002|Vax 1/Year 1 Follow-up|Death|0|||
105684372|NCT00427895|364506807|FG003|Vax 1/Year 1 Follow-up|Death|0|||
105684373|NCT00427895|364506808|FG004|Vax 1/Year 1 Follow-up|Death|0|||
105684374|NCT00427895|364506809|FG005|Vax 1/Year 1 Follow-up|Death|0|||
105684375|NCT00427895|364506810|FG006|Vax 1/Year 1 Follow-up|Death|0|||
105684376|NCT00427895|364506811|FG007|Vax 1/Year 1 Follow-up|Death|0|||
105684377|NCT00427895|364506804|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
105684378|NCT00427895|364506805|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
105684379|NCT00427895|364506806|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
105684380|NCT00427895|364506807|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
105684381|NCT00427895|364506808|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
105684382|NCT00427895|364506809|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
105684383|NCT00427895|364506810|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
105684384|NCT00427895|364506811|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
105684385|NCT00427895|364506804|FG000|Vax 1/Year 1 Follow-up|Other|0|||
105684386|NCT00427895|364506805|FG001|Vax 1/Year 1 Follow-up|Other|0|||
105684387|NCT00427895|364506806|FG002|Vax 1/Year 1 Follow-up|Other|0|||
105684388|NCT00427895|364506807|FG003|Vax 1/Year 1 Follow-up|Other|2|||
105684389|NCT00427895|364506808|FG004|Vax 1/Year 1 Follow-up|Other|0|||
105684390|NCT00427895|364506809|FG005|Vax 1/Year 1 Follow-up|Other|0|||
105684391|NCT00427895|364506810|FG006|Vax 1/Year 1 Follow-up|Other|0|||
105684392|NCT00427895|364506811|FG007|Vax 1/Year 1 Follow-up|Other|0|||
105684393|NCT00427895|364506804|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
105684394|NCT00427895|364506805|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
105684395|NCT00427895|364506806|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
105684396|NCT00427895|364506807|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
105684397|NCT00427895|364506808|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
105684398|NCT00427895|364506809|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
105684399|NCT00427895|364506810|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
105684400|NCT00427895|364506811|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
105684401|NCT02730598|364506824|FG000|Overall Study|Withdrawal by Subject|3|||
105684402|NCT02730598|364506825|FG001|Overall Study|Withdrawal by Subject|3|||
105684403|NCT02730598|364506824|FG000|Overall Study|Protocol Violation|0|||
105684404|NCT02730598|364506825|FG001|Overall Study|Protocol Violation|1|||
105684405|NCT02730598|364506824|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
105684406|NCT02730598|364506825|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
105684407|NCT03282240|364506826|FG000|Overall Study|Adverse Event|2|||
105684408|NCT03282240|364506827|FG001|Overall Study|Adverse Event|2|||
105684409|NCT03282240|364506828|FG002|Overall Study|Adverse Event|0|||
105684410|NCT03282240|364506826|FG000|Overall Study|Lost to Follow-up|3|||
105684411|NCT03282240|364506827|FG001|Overall Study|Lost to Follow-up|0|||
105684412|NCT03282240|364506828|FG002|Overall Study|Lost to Follow-up|0|||
105684413|NCT03282240|364506826|FG000|Overall Study|Protocol Deviation|4|||
105684414|NCT03282240|364506827|FG001|Overall Study|Protocol Deviation|1|||
105684415|NCT03282240|364506828|FG002|Overall Study|Protocol Deviation|2|||
105684416|NCT03282240|364506826|FG000|Overall Study|Withdrawal by Subject|1|||
105684417|NCT03282240|364506827|FG001|Overall Study|Withdrawal by Subject|0|||
105684418|NCT03282240|364506828|FG002|Overall Study|Withdrawal by Subject|1|||
105684419|NCT01675479|364506829|FG000|Overall Study|Lost to Follow-up|11|||
105684420|NCT02146326|364506830|FG000|Overall Study|Lost to Follow-up|3|||
105684421|NCT02146326|364506831|FG001|Overall Study|Lost to Follow-up|3|||
105684422|NCT02146326|364506832|FG002|Overall Study|Lost to Follow-up|11|||
105684423|NCT02146326|364506833|FG003|Overall Study|Lost to Follow-up|19|||
105684424|NCT02146326|364506830|FG000|Overall Study|Withdrawal by Subject|2|||
105684425|NCT02146326|364506831|FG001|Overall Study|Withdrawal by Subject|1|||
105684426|NCT02146326|364506832|FG002|Overall Study|Withdrawal by Subject|15|||
105684427|NCT02146326|364506833|FG003|Overall Study|Withdrawal by Subject|11|||
105684428|NCT02146326|364506830|FG000|Overall Study|Separated from mental health center|23|||
105684429|NCT02146326|364506831|FG001|Overall Study|Separated from mental health center|33|||
105684430|NCT02146326|364506832|FG002|Overall Study|Separated from mental health center|0|||
105684431|NCT02146326|364506833|FG003|Overall Study|Separated from mental health center|0|||
105684432|NCT02146326|364506830|FG000|Overall Study|Incarcerated|0|||
105684433|NCT02146326|364506831|FG001|Overall Study|Incarcerated|0|||
105684434|NCT02146326|364506832|FG002|Overall Study|Incarcerated|3|||
105684435|NCT02146326|364506833|FG003|Overall Study|Incarcerated|8|||
105684436|NCT02146326|364506830|FG000|Overall Study|Death|0|||
105684437|NCT02146326|364506831|FG001|Overall Study|Death|0|||
105684438|NCT02146326|364506832|FG002|Overall Study|Death|4|||
105684439|NCT02146326|364506833|FG003|Overall Study|Death|4|||
105684440|NCT02146326|364506830|FG000|Overall Study|Unable to complete interview|0|||
105684441|NCT02146326|364506831|FG001|Overall Study|Unable to complete interview|0|||
105684442|NCT02146326|364506832|FG002|Overall Study|Unable to complete interview|10|||
105684443|NCT02146326|364506833|FG003|Overall Study|Unable to complete interview|6|||
105684444|NCT01910181|364506834|FG000|Overall Study|Death|37|||
105684445|NCT01910181|364506834|FG000|Overall Study|Lost to Follow-up|3|||
105684446|NCT01910181|364506834|FG000|Overall Study|Study Terminated by Sponsor|6|||
105684447|NCT01328717|364509251|FG000|Overall Study|Adverse Event|1|||
105684448|NCT00346268|364509252|FG000|Overall Study|Adverse Event|1|||
105684449|NCT00346268|364509253|FG001|Overall Study|Adverse Event|0|||
105684450|NCT00346268|364509252|FG000|Overall Study|Protocol Violation|1|||
105684451|NCT00346268|364509253|FG001|Overall Study|Protocol Violation|0|||
105684452|NCT00346268|364509252|FG000|Overall Study|Participant refused|0|||
105684453|NCT00346268|364509253|FG001|Overall Study|Participant refused|3|||
105684454|NCT01177722|364509256|FG000|Overall Study|Serious Adverse Event|0|||
105684455|NCT01177722|364509257|FG001|Overall Study|Serious Adverse Event|0|||
105684456|NCT01177722|364509258|FG002|Overall Study|Serious Adverse Event|1|||
105684457|NCT01177722|364509259|FG003|Overall Study|Serious Adverse Event|0|||
105684458|NCT01177722|364509256|FG000|Overall Study|Protocol Violation|0|||
105684459|NCT01177722|364509257|FG001|Overall Study|Protocol Violation|0|||
105684460|NCT01177722|364509258|FG002|Overall Study|Protocol Violation|1|||
105684461|NCT01177722|364509259|FG003|Overall Study|Protocol Violation|0|||
105684462|NCT01177722|364509256|FG000|Overall Study|Lost to Follow-up|3|||
105684463|NCT01177722|364509257|FG001|Overall Study|Lost to Follow-up|4|||
105684464|NCT01177722|364509258|FG002|Overall Study|Lost to Follow-up|3|||
105684465|NCT01177722|364509259|FG003|Overall Study|Lost to Follow-up|1|||
105684466|NCT01177722|364509256|FG000|Overall Study|Withdrawal by Subject|10|||
105684467|NCT01177722|364509257|FG001|Overall Study|Withdrawal by Subject|6|||
105684468|NCT01177722|364509258|FG002|Overall Study|Withdrawal by Subject|4|||
105684469|NCT01177722|364509259|FG003|Overall Study|Withdrawal by Subject|6|||
105684470|NCT02831387|364509260|FG000|Overall Study|Withdrawal by Subject|1|||
105684471|NCT02831387|364509261|FG001|Overall Study|Withdrawal by Subject|1|||
105684472|NCT02831387|364509260|FG000|Overall Study|Discontinued due to stock recovery|0|||
105684473|NCT02831387|364509261|FG001|Overall Study|Discontinued due to stock recovery|1|||
105684474|NCT01828073|364509262|FG000|Overall Study|Lost to Follow-up|1|||
105684475|NCT01828073|364509263|FG001|Overall Study|Lost to Follow-up|2|||
105684476|NCT02915302|364509264|FG000|Overall Study|Adverse Event|3|||
105684477|NCT02915302|364509265|FG001|Overall Study|Adverse Event|0|||
105684478|NCT02915302|364509264|FG000|Overall Study|Protocol Violation|20|||
105684479|NCT02915302|364509265|FG001|Overall Study|Protocol Violation|27|||
105684480|NCT02915302|364509264|FG000|Overall Study|Lost to Follow-up|19|||
105684481|NCT02915302|364509265|FG001|Overall Study|Lost to Follow-up|22|||
105684482|NCT02915302|364509264|FG000|Overall Study|Withdrawal by Subject|22|||
105684483|NCT02915302|364509265|FG001|Overall Study|Withdrawal by Subject|29|||
105684484|NCT02915302|364509264|FG000|Overall Study|Other|1|||
105684485|NCT02915302|364509265|FG001|Overall Study|Other|0|||
105684486|NCT00690443|364509270|FG000|Overall Study|Adverse Event|1|||
105684487|NCT00690443|364509271|FG001|Overall Study|Adverse Event|2|||
105684488|NCT00645801|364509272|FG000|Overall Study|unclear if patient took all the medication.|1|||
105684489|NCT00645801|364509273|FG001|Overall Study|unclear if patient took all the medication.|0|||
105684490|NCT00645801|364509272|FG000|Overall Study|Lost to Follow-up|19|||
105684491|NCT00645801|364509273|FG001|Overall Study|Lost to Follow-up|15|||
105684492|NCT00932113|364509274|FG000|Overall Study|Lost to Follow-up|1|||
105684493|NCT00932113|364509275|FG001|Overall Study|Lost to Follow-up|0|||
105684494|NCT01386788|364509280|FG000|Overall Study|Lost to Follow-up|2|||
105684495|NCT00706433|364509283|FG000|Overall Study|Lost to Follow-up|3|||
105684496|NCT00706433|364509284|FG001|Overall Study|Lost to Follow-up|1|||
105684497|NCT00706433|364509285|FG002|Overall Study|Lost to Follow-up|6|||
105684498|NCT00706433|364509286|FG003|Overall Study|Lost to Follow-up|0|||
105684499|NCT00706433|364509283|FG000|Overall Study|Withdrawal by Subject|1|||
105684500|NCT00706433|364509284|FG001|Overall Study|Withdrawal by Subject|2|||
105684501|NCT00706433|364509285|FG002|Overall Study|Withdrawal by Subject|3|||
105684502|NCT00706433|364509286|FG003|Overall Study|Withdrawal by Subject|1|||
105684503|NCT00706433|364509283|FG000|Overall Study|Adverse Event|0|||
105684504|NCT00706433|364509284|FG001|Overall Study|Adverse Event|0|||
105684505|NCT00706433|364509285|FG002|Overall Study|Adverse Event|1|||
105684506|NCT00706433|364509286|FG003|Overall Study|Adverse Event|0|||
105684507|NCT00706433|364509283|FG000|Overall Study|Protocol Violation|1|||
105684508|NCT00706433|364509284|FG001|Overall Study|Protocol Violation|0|||
105684509|NCT00706433|364509285|FG002|Overall Study|Protocol Violation|0|||
105684510|NCT00706433|364509286|FG003|Overall Study|Protocol Violation|0|||
105684511|NCT00706433|364509283|FG000|Overall Study|new job|0|||
105684512|NCT00706433|364509284|FG001|Overall Study|new job|0|||
105684513|NCT00706433|364509285|FG002|Overall Study|new job|0|||
105684514|NCT00706433|364509286|FG003|Overall Study|new job|1|||
105684515|NCT04964388|364509291|FG000|Overall Study|Lost to Follow-up|3|||
105684516|NCT04964388|364509292|FG001|Overall Study|Lost to Follow-up|2|||
105684517|NCT03486457|364509293|FG000|Up to Month 3|Adverse Event|2|||
105684518|NCT03486457|364509294|FG001|Up to Month 3|Adverse Event|5|||
105684519|NCT03486457|364509293|FG000|Up to Month 3|Lack of Efficacy|1|||
105684520|NCT03486457|364509294|FG001|Up to Month 3|Lack of Efficacy|0|||
105684521|NCT03486457|364509293|FG000|Up to Month 3|Withdrawal by Subject|1|||
105684522|NCT03486457|364509294|FG001|Up to Month 3|Withdrawal by Subject|0|||
105684523|NCT03486457|364509293|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
105684524|NCT03486457|364509294|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
105684525|NCT03486457|364509293|FG000|Up to Month 3|Other|1|||
105684526|NCT03486457|364509294|FG001|Up to Month 3|Other|0|||
105684527|NCT03486457|364509293|FG000|Month 3 to Month 6|Adverse Event|2|||
105684528|NCT03486457|364509294|FG001|Month 3 to Month 6|Adverse Event|0|||
105684529|NCT03486457|364509293|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
105684530|NCT03486457|364509294|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
105684531|NCT03486457|364509293|FG000|Month 3 to Month 6|Pregnancy|0|||
105684532|NCT03486457|364509294|FG001|Month 3 to Month 6|Pregnancy|1|||
105684533|NCT03486457|364509293|FG000|Month 3 to Month 6|Other|1|||
105684534|NCT03486457|364509294|FG001|Month 3 to Month 6|Other|0|||
105469053|NCT02978781|363727478|FG002|Part A|Withdrawal by Subject|0|||
105469054|NCT02978781|363727479|FG003|Part A|Withdrawal by Subject|0|||
105469055|NCT02978781|363727480|FG004|Part A|Withdrawal by Subject|0|||
105469056|NCT02978781|363727476|FG000|Part B|Withdrawal by Subject|0|||
105469057|NCT02978781|363727477|FG001|Part B|Withdrawal by Subject|0|||
105469058|NCT02978781|363727478|FG002|Part B|Withdrawal by Subject|0|||
105469059|NCT02978781|363727479|FG003|Part B|Withdrawal by Subject|1|||
105469060|NCT02978781|363727480|FG004|Part B|Withdrawal by Subject|0|||
105469061|NCT02978781|363727476|FG000|Part C|Adverse Event|0|||
105469062|NCT02978781|363727477|FG001|Part C|Adverse Event|0|||
105469063|NCT02978781|363727478|FG002|Part C|Adverse Event|0|||
105469064|NCT02978781|363727479|FG003|Part C|Adverse Event|0|||
105469065|NCT02978781|363727480|FG004|Part C|Adverse Event|2|||
105469066|NCT02978781|363727476|FG000|Part C|Withdrawal by Subject|0|||
105469067|NCT02978781|363727477|FG001|Part C|Withdrawal by Subject|0|||
105469068|NCT02978781|363727478|FG002|Part C|Withdrawal by Subject|0|||
105684535|NCT02527343|364509295|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
105684536|NCT02527343|364509296|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
105469069|NCT02978781|363727479|FG003|Part C|Withdrawal by Subject|0|||
105469070|NCT02978781|363727480|FG004|Part C|Withdrawal by Subject|1|||
105469071|NCT02978781|363727476|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
105469072|NCT02978781|363727477|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
105469073|NCT02978781|363727478|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
105469074|NCT02978781|363727479|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
105469075|NCT02978781|363727480|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
105469076|NCT00785785|363727481|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
105469077|NCT00785785|363727482|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
105469078|NCT00785785|363727481|FG000|Core Phase up to 36 Months|Adverse Event|31|||
105684537|NCT02527343|364509297|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
105684538|NCT02527343|364509298|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
105684539|NCT02527343|364509299|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
105684540|NCT02527343|364509300|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
105684541|NCT02527343|364509295|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
105684542|NCT02527343|364509296|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
105469079|NCT00785785|363727482|FG001|Core Phase up to 36 Months|Adverse Event|21|||
105469080|NCT00785785|363727481|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
105684543|NCT02527343|364509297|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
105684544|NCT02527343|364509298|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
105684545|NCT02527343|364509299|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
105684546|NCT02527343|364509300|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
105684547|NCT02527343|364509295|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
105684548|NCT02527343|364509296|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
105469081|NCT00785785|363727482|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
105684549|NCT02527343|364509297|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
105684550|NCT02527343|364509298|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
105469082|NCT00785785|363727481|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
105469083|NCT00785785|363727482|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
105469084|NCT00785785|363727481|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
105684551|NCT02527343|364509299|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
105684552|NCT02527343|364509300|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
105684553|NCT02527343|364509295|FG000|RT Period: Weeks 1 to 52|Other|4|||
105684554|NCT02527343|364509296|FG001|RT Period: Weeks 1 to 52|Other|3|||
105684555|NCT02527343|364509297|FG002|RT Period: Weeks 1 to 52|Other|0|||
105469085|NCT00785785|363727482|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
105469086|NCT00785785|363727481|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
105469087|NCT00785785|363727482|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
105469088|NCT00785785|363727481|FG000|Core Phase up to 36 Months|Administrative problems|3|||
105469089|NCT00785785|363727482|FG001|Core Phase up to 36 Months|Administrative problems|3|||
105684556|NCT02527343|364509298|FG003|RT Period: Weeks 1 to 52|Other|0|||
105684557|NCT02527343|364509299|FG004|RT Period: Weeks 1 to 52|Other|0|||
105684558|NCT02527343|364509300|FG005|RT Period: Weeks 1 to 52|Other|0|||
105684559|NCT02527343|364509295|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
105684560|NCT02527343|364509296|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
105469090|NCT00785785|363727481|FG000|Core Phase up to 36 Months|Death|5|||
105469091|NCT00785785|363727482|FG001|Core Phase up to 36 Months|Death|8|||
105469092|NCT00785785|363727481|FG000|Core Phase up to 36 Months|Disease progression|139|||
105684561|NCT02527343|364509297|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
105684562|NCT02527343|364509298|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
105684563|NCT02527343|364509299|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
105684564|NCT02527343|364509300|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
105684565|NCT02527343|364509295|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
105684566|NCT02527343|364509296|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
105684567|NCT02527343|364509297|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
105684568|NCT02527343|364509298|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
105684569|NCT02527343|364509299|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
105684570|NCT02527343|364509300|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
105684571|NCT02527343|364509295|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
105684572|NCT02527343|364509296|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
105684573|NCT02527343|364509297|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
105684574|NCT02527343|364509298|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
105684575|NCT02527343|364509299|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
105684576|NCT02527343|364509300|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
105684577|NCT02527343|364509295|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
105684578|NCT02527343|364509296|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
105684579|NCT02527343|364509297|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
105684580|NCT02527343|364509298|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
105684581|NCT02527343|364509299|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
105684582|NCT02527343|364509300|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
105684583|NCT02527343|364509295|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
105684584|NCT02527343|364509296|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
105684585|NCT02527343|364509297|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
105684586|NCT02527343|364509298|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
105684587|NCT02527343|364509299|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
105684588|NCT02527343|364509300|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
105684589|NCT02527343|364509295|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
105684590|NCT02527343|364509296|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
105684591|NCT02527343|364509297|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
105684592|NCT02527343|364509298|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
105684593|NCT02527343|364509299|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
105684594|NCT02527343|364509300|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
105684595|NCT02527343|364509295|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
105684596|NCT02527343|364509296|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
105684597|NCT02527343|364509297|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
105684598|NCT02527343|364509298|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
105684599|NCT02527343|364509299|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
105684600|NCT02527343|364509300|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
105684601|NCT02527343|364509295|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
105684602|NCT02527343|364509296|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
105684603|NCT02527343|364509297|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
105684604|NCT02527343|364509298|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
105684605|NCT02527343|364509299|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
105684606|NCT02527343|364509300|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
105684607|NCT02527343|364509295|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
105684608|NCT02527343|364509296|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
105684609|NCT02527343|364509297|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
105684610|NCT02527343|364509298|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
105684611|NCT02527343|364509299|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
105684612|NCT02527343|364509300|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
105684613|NCT05041101|364509303|FG000|Overall Study|Adverse Event|1|||
105684614|NCT05041101|364509304|FG001|Overall Study|Adverse Event|0|||
105684615|NCT05041101|364509305|FG002|Overall Study|Adverse Event|0|||
105684616|NCT05041101|364509303|FG000|Overall Study|Diease Progression|5|||
105684617|NCT05041101|364509304|FG001|Overall Study|Diease Progression|0|||
105684618|NCT05041101|364509305|FG002|Overall Study|Diease Progression|0|||
105684619|NCT00211185|364509306|FG000|Overall Study|Death|2|||
105684620|NCT00211185|364509306|FG000|Overall Study|Disease progression|7|||
105684621|NCT00211185|364509306|FG000|Overall Study|Withdrawal by Subject|6|||
105684622|NCT00211185|364509306|FG000|Overall Study|Physician Decision|5|||
105684623|NCT03256851|364509307|FG000|Overall Study|Withdrawal by Subject|1|||
105684624|NCT03256851|364509308|FG001|Overall Study|Withdrawal by Subject|0|||
105684625|NCT03451162|364509310|FG000|Overall Study|Lost to Follow-up|1|||
105684626|NCT03451162|364509311|FG001|Overall Study|Lost to Follow-up|0|||
105684627|NCT03451162|364509312|FG002|Overall Study|Lost to Follow-up|0|||
105684628|NCT03451162|364509313|FG003|Overall Study|Lost to Follow-up|0|||
105684629|NCT03451162|364509314|FG004|Overall Study|Lost to Follow-up|0|||
105684630|NCT03451162|364509310|FG000|Overall Study|Physician Decision|0|||
105684631|NCT03451162|364509311|FG001|Overall Study|Physician Decision|1|||
105684632|NCT03451162|364509312|FG002|Overall Study|Physician Decision|0|||
105684633|NCT03451162|364509313|FG003|Overall Study|Physician Decision|0|||
105684634|NCT03451162|364509314|FG004|Overall Study|Physician Decision|0|||
105684635|NCT03451162|364509310|FG000|Overall Study|Withdrawal by Subject|1|||
105684636|NCT03451162|364509311|FG001|Overall Study|Withdrawal by Subject|1|||
105684637|NCT03451162|364509312|FG002|Overall Study|Withdrawal by Subject|0|||
105684638|NCT03451162|364509313|FG003|Overall Study|Withdrawal by Subject|0|||
105684639|NCT03451162|364509314|FG004|Overall Study|Withdrawal by Subject|0|||
105684640|NCT01952054|364509315|FG000|Overall Study|Physician Decision|1|||
105684641|NCT01127139|364509316|FG000|Overall Study|Adverse Event|40|||
105684642|NCT01127139|364509316|FG000|Overall Study|Incompliance|12|||
105684643|NCT01127139|364509316|FG000|Overall Study|Lack of Efficacy|4|||
105684644|NCT01127139|364509316|FG000|Overall Study|Reason not specified|1|||
105684645|NCT02294227|364509322|FG000|Overall Study|Death|0|||
105684646|NCT02294227|364509323|FG001|Overall Study|Death|0|||
105684647|NCT02294227|364509324|FG002|Overall Study|Death|1|||
105684648|NCT02294227|364509322|FG000|Overall Study|Subject/Guardian Decision|6|||
105684649|NCT02294227|364509323|FG001|Overall Study|Subject/Guardian Decision|3|||
105684650|NCT02294227|364509324|FG002|Overall Study|Subject/Guardian Decision|7|||
105684651|NCT02294227|364509322|FG000|Overall Study|Physician Decision|1|||
105684652|NCT02294227|364509323|FG001|Overall Study|Physician Decision|2|||
105684653|NCT02294227|364509324|FG002|Overall Study|Physician Decision|1|||
105684654|NCT02294227|364509322|FG000|Overall Study|Lost to Follow-up|1|||
105684655|NCT02294227|364509323|FG001|Overall Study|Lost to Follow-up|0|||
105684656|NCT02294227|364509324|FG002|Overall Study|Lost to Follow-up|0|||
105684657|NCT02294227|364509322|FG000|Overall Study|Lack of Efficacy|11|||
105684658|NCT02294227|364509323|FG001|Overall Study|Lack of Efficacy|12|||
105684659|NCT02294227|364509324|FG002|Overall Study|Lack of Efficacy|8|||
105684660|NCT02294227|364509322|FG000|Overall Study|Adverse Event|6|||
105684661|NCT02294227|364509323|FG001|Overall Study|Adverse Event|8|||
105684662|NCT02294227|364509324|FG002|Overall Study|Adverse Event|2|||
105684663|NCT00687973|364509325|FG000|Overall Study|Adverse Event|18|||
105684664|NCT00687973|364509326|FG001|Overall Study|Adverse Event|28|||
105684665|NCT00687973|364509325|FG000|Overall Study|Lack of Efficacy|2|||
105684666|NCT00687973|364509326|FG001|Overall Study|Lack of Efficacy|3|||
105684667|NCT00687973|364509325|FG000|Overall Study|Protocol Violation|1|||
105684668|NCT00687973|364509326|FG001|Overall Study|Protocol Violation|2|||
105684669|NCT00687973|364509325|FG000|Overall Study|Administrative Reasons|0|||
105684670|NCT00687973|364509326|FG001|Overall Study|Administrative Reasons|2|||
105684671|NCT00687973|364509325|FG000|Overall Study|Withdrawal by Subject|3|||
105684672|NCT00687973|364509326|FG001|Overall Study|Withdrawal by Subject|3|||
105684673|NCT01007448|364509327|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
105684674|NCT01007448|364509328|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
105684675|NCT01007448|364509327|FG000|Overall Study|Staph Skin Infection Flare|1|||
105684676|NCT01007448|364509328|FG001|Overall Study|Staph Skin Infection Flare|0|||
105684677|NCT01007448|364509327|FG000|Overall Study|Participant Leaving the Country|1|||
105684678|NCT01007448|364509328|FG001|Overall Study|Participant Leaving the Country|0|||
105684679|NCT01007448|364509327|FG000|Overall Study|Participant Given Prohibited Medication|1|||
105684680|NCT01007448|364509328|FG001|Overall Study|Participant Given Prohibited Medication|0|||
105684681|NCT01007448|364509327|FG000|Overall Study|Progressive Disease|1|||
105684682|NCT01007448|364509328|FG001|Overall Study|Progressive Disease|2|||
105684683|NCT01007448|364509327|FG000|Overall Study|Lack of Efficacy|2|||
105684684|NCT01007448|364509328|FG001|Overall Study|Lack of Efficacy|0|||
105684685|NCT01007448|364509327|FG000|Overall Study|Withdrawal by Subject|2|||
105684686|NCT01007448|364509328|FG001|Overall Study|Withdrawal by Subject|3|||
105684687|NCT01007448|364509327|FG000|Overall Study|Adverse Event|1|||
105684688|NCT01007448|364509328|FG001|Overall Study|Adverse Event|4|||
105684689|NCT00887432|364509329|FG000|Overall Study|Start Excluded Therapy|3|||
105684690|NCT00887432|364509330|FG001|Overall Study|Start Excluded Therapy|0|||
105684691|NCT00887432|364509329|FG000|Overall Study|Did not complete treatment|6|||
105684692|NCT00887432|364509330|FG001|Overall Study|Did not complete treatment|8|||
105684693|NCT00887432|364509329|FG000|Overall Study|Protocol Violation|2|||
105684694|NCT00887432|364509330|FG001|Overall Study|Protocol Violation|3|||
105684695|NCT00887432|364509329|FG000|Overall Study|Withdrawal by Subject|3|||
105344600|NCT04488419|363263457|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
105344601|NCT04488419|363263458|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
105344602|NCT04488419|363263459|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
105344603|NCT04488419|363263457|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
105344604|NCT04488419|363263458|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
105344605|NCT04488419|363263459|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
105344606|NCT04488419|363263457|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
105344607|NCT04488419|363263458|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
105684696|NCT00887432|364509330|FG001|Overall Study|Withdrawal by Subject|2|||
105684697|NCT00887432|364509329|FG000|Overall Study|Lost to Follow-up|1|||
105684698|NCT00887432|364509330|FG001|Overall Study|Lost to Follow-up|0|||
105684699|NCT00887432|364509329|FG000|Overall Study|No reason provided|0|||
105684700|NCT00887432|364509330|FG001|Overall Study|No reason provided|1|||
105684701|NCT00899548|364509331|FG000|Overall Study|Physician Decision|3|||
105684702|NCT01886378|364509337|FG000|Overall Study|Adverse Event|1|||
105684703|NCT01886378|364509337|FG000|Overall Study|Withdrawal by Subject|4|||
105684704|NCT00446992|364509346|FG000|Overall Study|Adverse Event|11|||
105684705|NCT00446992|364509346|FG000|Overall Study|Lost to Follow-up|5|||
105684706|NCT00406653|364509347|FG000|Induction Period|Adverse Event|1|||
105684707|NCT00406653|364509348|FG001|Induction Period|Adverse Event|10|||
105684708|NCT00406653|364509349|FG002|Induction Period|Adverse Event|4|||
105684709|NCT00406653|364509350|FG003|Induction Period|Adverse Event|11|||
105684710|NCT00406653|364509351|FG004|Induction Period|Adverse Event|0|||
105684711|NCT00406653|364509352|FG005|Induction Period|Adverse Event|0|||
105684712|NCT00406653|364509353|FG006|Induction Period|Adverse Event|0|||
105684713|NCT00406653|364509347|FG000|Induction Period|Lack of Efficacy|11|||
105684714|NCT00406653|364509348|FG001|Induction Period|Lack of Efficacy|14|||
105684715|NCT00406653|364509349|FG002|Induction Period|Lack of Efficacy|8|||
105684716|NCT00406653|364509350|FG003|Induction Period|Lack of Efficacy|10|||
105684717|NCT00406653|364509351|FG004|Induction Period|Lack of Efficacy|0|||
105684718|NCT00406653|364509352|FG005|Induction Period|Lack of Efficacy|0|||
105684719|NCT00406653|364509353|FG006|Induction Period|Lack of Efficacy|0|||
105684720|NCT00406653|364509347|FG000|Induction Period|Lost to Follow-up|0|||
105684721|NCT00406653|364509348|FG001|Induction Period|Lost to Follow-up|2|||
105684722|NCT00406653|364509349|FG002|Induction Period|Lost to Follow-up|0|||
105684723|NCT00406653|364509350|FG003|Induction Period|Lost to Follow-up|0|||
105684724|NCT00406653|364509351|FG004|Induction Period|Lost to Follow-up|0|||
105684725|NCT00406653|364509352|FG005|Induction Period|Lost to Follow-up|0|||
105684726|NCT00406653|364509353|FG006|Induction Period|Lost to Follow-up|0|||
105684727|NCT00406653|364509347|FG000|Induction Period|Withdrawal of Consent|2|||
105684728|NCT00406653|364509348|FG001|Induction Period|Withdrawal of Consent|5|||
105684729|NCT00406653|364509349|FG002|Induction Period|Withdrawal of Consent|1|||
105684730|NCT00406653|364509350|FG003|Induction Period|Withdrawal of Consent|2|||
105684731|NCT00406653|364509351|FG004|Induction Period|Withdrawal of Consent|0|||
105684732|NCT00406653|364509352|FG005|Induction Period|Withdrawal of Consent|0|||
105684733|NCT00406653|364509353|FG006|Induction Period|Withdrawal of Consent|0|||
105684734|NCT00406653|364509347|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
105684735|NCT00406653|364509348|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
105684736|NCT00406653|364509349|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
105684737|NCT00406653|364509350|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
105684738|NCT00406653|364509351|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
105684739|NCT00406653|364509352|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
105684740|NCT00406653|364509353|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
105684741|NCT00406653|364509347|FG000|Induction Period|Pregnancy|1|||
105684742|NCT00406653|364509348|FG001|Induction Period|Pregnancy|0|||
105684743|NCT00406653|364509349|FG002|Induction Period|Pregnancy|0|||
105684744|NCT00406653|364509350|FG003|Induction Period|Pregnancy|0|||
105684745|NCT00406653|364509351|FG004|Induction Period|Pregnancy|0|||
105684746|NCT00406653|364509352|FG005|Induction Period|Pregnancy|0|||
105684747|NCT00406653|364509353|FG006|Induction Period|Pregnancy|0|||
105684748|NCT00406653|364509347|FG000|Induction Period|Declined participation but followup done|0|||
105684749|NCT00406653|364509348|FG001|Induction Period|Declined participation but followup done|2|||
105684750|NCT00406653|364509349|FG002|Induction Period|Declined participation but followup done|1|||
105684751|NCT00406653|364509350|FG003|Induction Period|Declined participation but followup done|1|||
105684752|NCT00406653|364509351|FG004|Induction Period|Declined participation but followup done|0|||
105684753|NCT00406653|364509352|FG005|Induction Period|Declined participation but followup done|0|||
105684754|NCT00406653|364509353|FG006|Induction Period|Declined participation but followup done|0|||
105684755|NCT00406653|364509347|FG000|Induction Period|Given prohibited drug|0|||
105684756|NCT00406653|364509348|FG001|Induction Period|Given prohibited drug|1|||
105684757|NCT00406653|364509349|FG002|Induction Period|Given prohibited drug|2|||
105684758|NCT00406653|364509350|FG003|Induction Period|Given prohibited drug|0|||
105684759|NCT00406653|364509351|FG004|Induction Period|Given prohibited drug|0|||
105684760|NCT00406653|364509352|FG005|Induction Period|Given prohibited drug|0|||
105684761|NCT00406653|364509353|FG006|Induction Period|Given prohibited drug|0|||
105684762|NCT00406653|364509347|FG000|Induction Period|Incarcerated|0|||
105684763|NCT00406653|364509348|FG001|Induction Period|Incarcerated|0|||
105684764|NCT00406653|364509349|FG002|Induction Period|Incarcerated|1|||
105684765|NCT00406653|364509350|FG003|Induction Period|Incarcerated|0|||
105684766|NCT00406653|364509351|FG004|Induction Period|Incarcerated|0|||
105684767|NCT00406653|364509352|FG005|Induction Period|Incarcerated|0|||
105684768|NCT00406653|364509353|FG006|Induction Period|Incarcerated|0|||
105684769|NCT00406653|364509347|FG000|Induction Period|Patient relocated|0|||
105684770|NCT00406653|364509348|FG001|Induction Period|Patient relocated|0|||
105684771|NCT00406653|364509349|FG002|Induction Period|Patient relocated|1|||
105684772|NCT00406653|364509350|FG003|Induction Period|Patient relocated|0|||
105684773|NCT00406653|364509351|FG004|Induction Period|Patient relocated|0|||
105684774|NCT00406653|364509352|FG005|Induction Period|Patient relocated|0|||
105684775|NCT00406653|364509353|FG006|Induction Period|Patient relocated|0|||
105684776|NCT00406653|364509347|FG000|Maintenance Period|Adverse Event|0|||
105684777|NCT00406653|364509348|FG001|Maintenance Period|Adverse Event|0|||
105684778|NCT00406653|364509349|FG002|Maintenance Period|Adverse Event|0|||
105684779|NCT00406653|364509350|FG003|Maintenance Period|Adverse Event|0|||
105684780|NCT00406653|364509351|FG004|Maintenance Period|Adverse Event|1|||
105684781|NCT00406653|364509352|FG005|Maintenance Period|Adverse Event|1|||
105684782|NCT00406653|364509353|FG006|Maintenance Period|Adverse Event|0|||
105684783|NCT00406653|364509347|FG000|Maintenance Period|Lack of Efficacy|0|||
105684784|NCT00406653|364509348|FG001|Maintenance Period|Lack of Efficacy|0|||
105684785|NCT00406653|364509349|FG002|Maintenance Period|Lack of Efficacy|0|||
105684786|NCT00406653|364509350|FG003|Maintenance Period|Lack of Efficacy|0|||
105684787|NCT00406653|364509351|FG004|Maintenance Period|Lack of Efficacy|20|||
105684788|NCT00406653|364509352|FG005|Maintenance Period|Lack of Efficacy|26|||
105684789|NCT00406653|364509353|FG006|Maintenance Period|Lack of Efficacy|0|||
105684790|NCT00406653|364509347|FG000|Maintenance Period|Lost to Follow-up|0|||
105684791|NCT00406653|364509348|FG001|Maintenance Period|Lost to Follow-up|0|||
105684792|NCT00406653|364509349|FG002|Maintenance Period|Lost to Follow-up|0|||
105684793|NCT00406653|364509350|FG003|Maintenance Period|Lost to Follow-up|0|||
105684794|NCT00406653|364509351|FG004|Maintenance Period|Lost to Follow-up|2|||
105684795|NCT00406653|364509352|FG005|Maintenance Period|Lost to Follow-up|1|||
105684796|NCT00406653|364509353|FG006|Maintenance Period|Lost to Follow-up|0|||
105684797|NCT00406653|364509347|FG000|Maintenance Period|Withdrawal of Consent|0|||
105684798|NCT00406653|364509348|FG001|Maintenance Period|Withdrawal of Consent|0|||
105684799|NCT00406653|364509349|FG002|Maintenance Period|Withdrawal of Consent|0|||
105684800|NCT00406653|364509350|FG003|Maintenance Period|Withdrawal of Consent|0|||
105684801|NCT00406653|364509351|FG004|Maintenance Period|Withdrawal of Consent|2|||
105684802|NCT00406653|364509352|FG005|Maintenance Period|Withdrawal of Consent|0|||
105684803|NCT00406653|364509353|FG006|Maintenance Period|Withdrawal of Consent|0|||
105684804|NCT00406653|364509347|FG000|Maintenance Period|Pregnancy|0|||
105684805|NCT00406653|364509348|FG001|Maintenance Period|Pregnancy|0|||
105684806|NCT00406653|364509349|FG002|Maintenance Period|Pregnancy|0|||
105684807|NCT00406653|364509350|FG003|Maintenance Period|Pregnancy|0|||
105684808|NCT00406653|364509351|FG004|Maintenance Period|Pregnancy|0|||
105684809|NCT00406653|364509352|FG005|Maintenance Period|Pregnancy|1|||
105684810|NCT00406653|364509353|FG006|Maintenance Period|Pregnancy|0|||
105786541|NCT05048875|364871452|FG004|Overall Study|Adverse Event|0|||
105786542|NCT05048875|364871453|FG005|Overall Study|Adverse Event|0|||
105786543|NCT05048875|364871454|FG006|Overall Study|Adverse Event|0|||
105684811|NCT00406653|364509347|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
105684812|NCT00406653|364509348|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
105684813|NCT00406653|364509349|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
105786544|NCT05048875|364871455|FG007|Overall Study|Adverse Event|0|||
105558044|NCT02834780|364039204|FG002|Overall Study|Adverse Event|0|||
105786545|NCT01802281|364871458|FG000|Overall Study|Death|1|||
105684814|NCT00406653|364509350|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
105684815|NCT00406653|364509351|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
105684816|NCT00406653|364509352|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
105684817|NCT00406653|364509353|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
105684818|NCT00406653|364509347|FG000|Maintenance Period|Error in disease score evaluation|0|||
105684819|NCT00406653|364509348|FG001|Maintenance Period|Error in disease score evaluation|0|||
105684820|NCT00406653|364509349|FG002|Maintenance Period|Error in disease score evaluation|0|||
105684821|NCT00406653|364509350|FG003|Maintenance Period|Error in disease score evaluation|0|||
105684822|NCT00406653|364509351|FG004|Maintenance Period|Error in disease score evaluation|1|||
105684823|NCT00406653|364509352|FG005|Maintenance Period|Error in disease score evaluation|0|||
105684824|NCT00406653|364509353|FG006|Maintenance Period|Error in disease score evaluation|0|||
105684825|NCT00406653|364509347|FG000|Open-Label Period|Death|0|||
105684826|NCT00406653|364509348|FG001|Open-Label Period|Death|0|||
105684827|NCT00406653|364509349|FG002|Open-Label Period|Death|0|||
105684828|NCT00406653|364509350|FG003|Open-Label Period|Death|0|||
105684829|NCT00406653|364509351|FG004|Open-Label Period|Death|0|||
105684830|NCT00406653|364509352|FG005|Open-Label Period|Death|0|||
105684831|NCT00406653|364509353|FG006|Open-Label Period|Death|1|||
105684832|NCT00406653|364509347|FG000|Open-Label Period|Adverse Event|0|||
105684833|NCT00406653|364509348|FG001|Open-Label Period|Adverse Event|0|||
105684834|NCT00406653|364509349|FG002|Open-Label Period|Adverse Event|0|||
105684835|NCT00406653|364509350|FG003|Open-Label Period|Adverse Event|0|||
105684836|NCT00406653|364509351|FG004|Open-Label Period|Adverse Event|0|||
105684837|NCT00406653|364509352|FG005|Open-Label Period|Adverse Event|0|||
105684838|NCT00406653|364509353|FG006|Open-Label Period|Adverse Event|18|||
105684839|NCT00406653|364509347|FG000|Open-Label Period|Lack of Efficacy|0|||
105684840|NCT00406653|364509348|FG001|Open-Label Period|Lack of Efficacy|0|||
105684841|NCT00406653|364509349|FG002|Open-Label Period|Lack of Efficacy|0|||
105684842|NCT00406653|364509350|FG003|Open-Label Period|Lack of Efficacy|0|||
105684843|NCT00406653|364509351|FG004|Open-Label Period|Lack of Efficacy|0|||
105684844|NCT00406653|364509352|FG005|Open-Label Period|Lack of Efficacy|0|||
105684845|NCT00406653|364509353|FG006|Open-Label Period|Lack of Efficacy|160|||
105684846|NCT00406653|364509347|FG000|Open-Label Period|Lost to Follow-up|0|||
105684847|NCT00406653|364509348|FG001|Open-Label Period|Lost to Follow-up|0|||
105684848|NCT00406653|364509349|FG002|Open-Label Period|Lost to Follow-up|0|||
105684849|NCT00406653|364509350|FG003|Open-Label Period|Lost to Follow-up|0|||
105684850|NCT00406653|364509351|FG004|Open-Label Period|Lost to Follow-up|0|||
105684851|NCT00406653|364509352|FG005|Open-Label Period|Lost to Follow-up|0|||
105684852|NCT00406653|364509353|FG006|Open-Label Period|Lost to Follow-up|6|||
105684853|NCT00406653|364509347|FG000|Open-Label Period|Withdrawal of Consent|0|||
105684854|NCT00406653|364509348|FG001|Open-Label Period|Withdrawal of Consent|0|||
105684855|NCT00406653|364509349|FG002|Open-Label Period|Withdrawal of Consent|0|||
105684856|NCT00406653|364509350|FG003|Open-Label Period|Withdrawal of Consent|0|||
105684857|NCT00406653|364509351|FG004|Open-Label Period|Withdrawal of Consent|0|||
105684858|NCT00406653|364509352|FG005|Open-Label Period|Withdrawal of Consent|0|||
105684859|NCT00406653|364509353|FG006|Open-Label Period|Withdrawal of Consent|11|||
105684860|NCT00406653|364509347|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
105684861|NCT00406653|364509348|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
105684862|NCT00406653|364509349|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
105684863|NCT00406653|364509350|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
105684864|NCT00406653|364509351|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
105684865|NCT00406653|364509352|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
105684866|NCT00406653|364509353|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
105684867|NCT00406653|364509347|FG000|Open-Label Period|Pregnancy|0|||
105684868|NCT00406653|364509348|FG001|Open-Label Period|Pregnancy|0|||
105684869|NCT00406653|364509349|FG002|Open-Label Period|Pregnancy|0|||
105684870|NCT00406653|364509350|FG003|Open-Label Period|Pregnancy|0|||
105684871|NCT00406653|364509351|FG004|Open-Label Period|Pregnancy|0|||
105684872|NCT00406653|364509352|FG005|Open-Label Period|Pregnancy|0|||
105684873|NCT00406653|364509353|FG006|Open-Label Period|Pregnancy|2|||
105684874|NCT00406653|364509347|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
105684875|NCT00406653|364509348|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
105786546|NCT01802281|364871459|FG001|Overall Study|Death|2|||
105469093|NCT00785785|363727482|FG001|Core Phase up to 36 Months|Disease progression|119|||
105469094|NCT00785785|363727481|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
105684876|NCT00406653|364509349|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
105684877|NCT00406653|364509350|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
105684878|NCT00406653|364509351|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
105786547|NCT01802281|364871458|FG000|Overall Study|Withdrawal by Subject|2|||
105786548|NCT01802281|364871459|FG001|Overall Study|Withdrawal by Subject|1|||
105684879|NCT00406653|364509352|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
105684880|NCT00406653|364509353|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
105684881|NCT00406653|364509347|FG000|Open-Label Period|Declined participation but followup done|0|||
105684882|NCT00406653|364509348|FG001|Open-Label Period|Declined participation but followup done|0|||
105684883|NCT00406653|364509349|FG002|Open-Label Period|Declined participation but followup done|0|||
105684884|NCT00406653|364509350|FG003|Open-Label Period|Declined participation but followup done|0|||
105684885|NCT00406653|364509351|FG004|Open-Label Period|Declined participation but followup done|0|||
105684886|NCT00406653|364509352|FG005|Open-Label Period|Declined participation but followup done|0|||
105684887|NCT00406653|364509353|FG006|Open-Label Period|Declined participation but followup done|8|||
105684888|NCT00406653|364509347|FG000|Open-Label Period|Discontinued by Sponsor|0|||
105684889|NCT00406653|364509348|FG001|Open-Label Period|Discontinued by Sponsor|0|||
105684890|NCT00406653|364509349|FG002|Open-Label Period|Discontinued by Sponsor|0|||
105684891|NCT00406653|364509350|FG003|Open-Label Period|Discontinued by Sponsor|0|||
105684892|NCT00406653|364509351|FG004|Open-Label Period|Discontinued by Sponsor|0|||
105684893|NCT00406653|364509352|FG005|Open-Label Period|Discontinued by Sponsor|0|||
105684894|NCT00406653|364509353|FG006|Open-Label Period|Discontinued by Sponsor|1|||
105684895|NCT00406653|364509347|FG000|Open-Label Period|Refused followup|0|||
105684896|NCT00406653|364509348|FG001|Open-Label Period|Refused followup|0|||
105684897|NCT00406653|364509349|FG002|Open-Label Period|Refused followup|0|||
105684898|NCT00406653|364509350|FG003|Open-Label Period|Refused followup|0|||
105684899|NCT00406653|364509351|FG004|Open-Label Period|Refused followup|0|||
105684900|NCT00406653|364509352|FG005|Open-Label Period|Refused followup|0|||
105684901|NCT00406653|364509353|FG006|Open-Label Period|Refused followup|1|||
105684902|NCT00818649|364509354|FG000|Overall Study|Declining performance status|2|||
105684903|NCT00818649|364509354|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
105684904|NCT00818649|364509354|FG000|Overall Study|Adverse Event|1|||
105684905|NCT03513588|364509355|FG000|Overall Study|Lost to Follow-up|0|||
105684906|NCT03513588|364509356|FG001|Overall Study|Lost to Follow-up|1|||
105684907|NCT03513588|364509357|FG002|Overall Study|Lost to Follow-up|1|||
105684908|NCT03513588|364509355|FG000|Overall Study|Study dosing paused by sponsor|1|||
105684909|NCT03513588|364509356|FG001|Overall Study|Study dosing paused by sponsor|1|||
105684910|NCT03513588|364509357|FG002|Overall Study|Study dosing paused by sponsor|0|||
105684911|NCT03513588|364509355|FG000|Overall Study|Death|0|||
105684912|NCT03513588|364509356|FG001|Overall Study|Death|0|||
105684913|NCT03513588|364509357|FG002|Overall Study|Death|1|||
105684914|NCT00940108|364509358|FG000|Overall Study|Adverse Event|2|||
105684915|NCT00940108|364509359|FG001|Overall Study|Adverse Event|4|||
105684916|NCT00940108|364509360|FG002|Overall Study|Adverse Event|0|||
105684917|NCT00940108|364509361|FG003|Overall Study|Adverse Event|2|||
105684918|NCT00940108|364509358|FG000|Overall Study|Withdrew Consent|2|||
105684919|NCT00940108|364509359|FG001|Overall Study|Withdrew Consent|1|||
105684920|NCT00940108|364509360|FG002|Overall Study|Withdrew Consent|0|||
105684921|NCT00940108|364509361|FG003|Overall Study|Withdrew Consent|1|||
105684922|NCT00940108|364509358|FG000|Overall Study|Dose 2 contraindicated|1|||
105684923|NCT00940108|364509359|FG001|Overall Study|Dose 2 contraindicated|1|||
105684924|NCT00940108|364509360|FG002|Overall Study|Dose 2 contraindicated|0|||
105684925|NCT00940108|364509361|FG003|Overall Study|Dose 2 contraindicated|1|||
105684926|NCT00940108|364509358|FG000|Overall Study|Declined further vaccination|0|||
105684927|NCT00940108|364509359|FG001|Overall Study|Declined further vaccination|1|||
105684928|NCT00940108|364509360|FG002|Overall Study|Declined further vaccination|3|||
105684929|NCT00940108|364509361|FG003|Overall Study|Declined further vaccination|0|||
105684930|NCT00940108|364509358|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
105684931|NCT00940108|364509359|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
105684932|NCT00940108|364509360|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
105684933|NCT00940108|364509361|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
105684934|NCT00940108|364509358|FG000|Overall Study|Viral illness after Dose 1|0|||
105684935|NCT00940108|364509359|FG001|Overall Study|Viral illness after Dose 1|1|||
105684936|NCT00940108|364509360|FG002|Overall Study|Viral illness after Dose 1|0|||
105684937|NCT00940108|364509361|FG003|Overall Study|Viral illness after Dose 1|0|||
105684938|NCT00940108|364509358|FG000|Overall Study|Diagnosed with H1N1|0|||
105684939|NCT00940108|364509359|FG001|Overall Study|Diagnosed with H1N1|0|||
105684940|NCT00940108|364509360|FG002|Overall Study|Diagnosed with H1N1|0|||
105684941|NCT00940108|364509361|FG003|Overall Study|Diagnosed with H1N1|1|||
105684942|NCT02075541|364509362|FG000|Overall Study|Serious Adverse Event|1|||
105684943|NCT02075541|364509363|FG001|Overall Study|Serious Adverse Event|4|||
105684944|NCT02075541|364509362|FG000|Overall Study|Protocol Violation|1|||
105684945|NCT02075541|364509363|FG001|Overall Study|Protocol Violation|0|||
105684946|NCT02075541|364509362|FG000|Overall Study|Withdrawal by Subject|1|||
105684947|NCT02075541|364509363|FG001|Overall Study|Withdrawal by Subject|3|||
105684948|NCT02075541|364509362|FG000|Overall Study|Sponsor study termination|0|||
105684949|NCT02075541|364509363|FG001|Overall Study|Sponsor study termination|1|||
105684950|NCT02075541|364509362|FG000|Overall Study|Other- unable to perform study procedure|1|||
105684951|NCT02075541|364509363|FG001|Overall Study|Other- unable to perform study procedure|0|||
105684952|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
105684953|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
105684954|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Death|0|||
105684955|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Death|2|||
105684956|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
105684957|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
105684958|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
105684959|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
105684960|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
105684961|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
105684962|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
105684963|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
105684964|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
105684965|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
105684966|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
105684967|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
105684968|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
105684969|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
105684970|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
105684971|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
105684972|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Death|3|||
105684973|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Death|3|||
105684974|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
105684975|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
105684976|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
105684977|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
105684978|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
105684979|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
105684980|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
105684981|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
105684982|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
105684983|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
105684984|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
105684985|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
105684986|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
105684987|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
105684988|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
105684989|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
105684990|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Death|4|||
105684991|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Death|5|||
105684992|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
105684993|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
105684994|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
105684995|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
105684996|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
105684997|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
105684998|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
105684999|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
105685000|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
105685001|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
105685002|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
105685003|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
105685004|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
105685005|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
105685006|NCT03945825|364509375|FG000|Overall Study|Enrolled but treatment not administered|0|||
105685007|NCT03945825|364509376|FG001|Overall Study|Enrolled but treatment not administered|0|||
105685008|NCT03945825|364509377|FG002|Overall Study|Enrolled but treatment not administered|0|||
105685009|NCT03945825|364509378|FG003|Overall Study|Enrolled but treatment not administered|0|||
105685010|NCT03945825|364509379|FG004|Overall Study|Enrolled but treatment not administered|1|||
105685011|NCT03945825|364509380|FG005|Overall Study|Enrolled but treatment not administered|0|||
105685012|NCT03945825|364509375|FG000|Overall Study|Lost to Follow-up|1|||
105685013|NCT03945825|364509376|FG001|Overall Study|Lost to Follow-up|5|||
105685014|NCT03945825|364509377|FG002|Overall Study|Lost to Follow-up|0|||
105685015|NCT03945825|364509378|FG003|Overall Study|Lost to Follow-up|1|||
105685016|NCT03945825|364509379|FG004|Overall Study|Lost to Follow-up|2|||
105685017|NCT03945825|364509380|FG005|Overall Study|Lost to Follow-up|2|||
105685018|NCT03945825|364509375|FG000|Overall Study|Withdrawal by Subject|1|||
105685019|NCT03945825|364509376|FG001|Overall Study|Withdrawal by Subject|0|||
105469095|NCT00785785|363727482|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
105469096|NCT00785785|363727481|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
105469097|NCT00785785|363727482|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
105469098|NCT00785785|363727481|FG000|Optional Extension Phase|Adverse Event|4|||
105469099|NCT00785785|363727482|FG001|Optional Extension Phase|Adverse Event|5|||
105469100|NCT00785785|363727481|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
105469101|NCT00785785|363727482|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
105469102|NCT00785785|363727481|FG000|Optional Extension Phase|Lost to Follow-up|1|||
105469103|NCT00785785|363727482|FG001|Optional Extension Phase|Lost to Follow-up|0|||
105469104|NCT00785785|363727481|FG000|Optional Extension Phase|Administrative problems|2|||
105469105|NCT00785785|363727482|FG001|Optional Extension Phase|Administrative problems|0|||
105469106|NCT00785785|363727481|FG000|Optional Extension Phase|Death|1|||
105469107|NCT00785785|363727482|FG001|Optional Extension Phase|Death|5|||
105469108|NCT00785785|363727481|FG000|Optional Extension Phase|Disease progression|22|||
105469109|NCT00785785|363727482|FG001|Optional Extension Phase|Disease progression|70|||
105469110|NCT00785785|363727481|FG000|Optional Extension Phase|Protocol deviation|0|||
105469111|NCT00785785|363727482|FG001|Optional Extension Phase|Protocol deviation|2|||
105469112|NCT00785785|363727481|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
105469113|NCT00785785|363727482|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
105469114|NCT02453321|363727483|FG000|Overall Study|Weakness|1|||
105469115|NCT02453321|363727484|FG001|Overall Study|Weakness|1|||
105469116|NCT02453321|363727485|FG002|Overall Study|Weakness|2|||
105469117|NCT02453321|363727483|FG000|Overall Study|Deep Venous Thrombosis|0|||
105469118|NCT02453321|363727484|FG001|Overall Study|Deep Venous Thrombosis|1|||
105469119|NCT02453321|363727485|FG002|Overall Study|Deep Venous Thrombosis|0|||
105469120|NCT00357552|363727486|FG000|Screening|Did not meet eligibility criteria|84|||
105469121|NCT00357552|363727486|FG000|Weeks 0 to 24|Death|1|||
105469122|NCT00357552|363727486|FG000|Weeks 24 to 104|Death|3|||
105469123|NCT00357552|363727486|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
105469124|NCT00521404|363727489|FG000|Overall Study|Adverse Event|13|||
105469125|NCT00521404|363727489|FG000|Overall Study|Disease Progression|33|||
105469126|NCT00521404|363727489|FG000|Overall Study|Investigator decision|5|||
105469127|NCT00521404|363727489|FG000|Overall Study|Withdrawal of consent|3|||
105469128|NCT00521404|363727489|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
105469129|NCT00521404|363727489|FG000|Overall Study|Other|7|||
105469130|NCT00823615|363727493|FG000|Period 2|Lost to Follow-up|2|||
105469131|NCT00823615|363727494|FG001|Period 2|Lost to Follow-up|0|||
105469132|NCT00823615|363727493|FG000|Period 2|Time/Job Conflict|1|||
105469133|NCT00823615|363727494|FG001|Period 2|Time/Job Conflict|2|||
105469134|NCT00372593|363727495|FG000|Overall Study|Adverse Event|43|||
105469135|NCT00372593|363727496|FG001|Overall Study|Adverse Event|45|||
105469136|NCT00372593|363727497|FG002|Overall Study|Adverse Event|0|||
105469137|NCT00372593|363727495|FG000|Overall Study|Death|16|||
105469138|NCT00372593|363727496|FG001|Overall Study|Death|20|||
105469139|NCT00372593|363727497|FG002|Overall Study|Death|1|||
105469140|NCT00372593|363727495|FG000|Overall Study|Lack of Efficacy|82|||
105469141|NCT00372593|363727496|FG001|Overall Study|Lack of Efficacy|71|||
105469142|NCT00372593|363727497|FG002|Overall Study|Lack of Efficacy|2|||
105469143|NCT00372593|363727495|FG000|Overall Study|Lost to Follow-up|1|||
105469144|NCT00372593|363727496|FG001|Overall Study|Lost to Follow-up|0|||
105469145|NCT00372593|363727497|FG002|Overall Study|Lost to Follow-up|0|||
105469146|NCT00372593|363727495|FG000|Overall Study|Physician Decision|42|||
105469147|NCT00372593|363727496|FG001|Overall Study|Physician Decision|41|||
105469148|NCT00372593|363727497|FG002|Overall Study|Physician Decision|0|||
105469149|NCT00372593|363727495|FG000|Overall Study|Ineligible|20|||
105469150|NCT00372593|363727496|FG001|Overall Study|Ineligible|21|||
105469151|NCT00372593|363727497|FG002|Overall Study|Ineligible|1|||
105469152|NCT00433004|363727498|FG000|Overall Study|Lost to Follow-up|5|||
105469153|NCT00433004|363727499|FG001|Overall Study|Lost to Follow-up|7|||
105469154|NCT02636595|363727504|FG000|Overall Study|Lost to Follow-up|1|||
105469155|NCT02636595|363727504|FG000|Overall Study|Other|1|||
105469156|NCT01106690|363727505|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
105469157|NCT01106690|363727506|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
105469158|NCT01106690|363727507|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
105469159|NCT01106690|363727505|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
105469160|NCT01106690|363727506|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
105469161|NCT01106690|363727507|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
105469162|NCT01106690|363727505|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
105469163|NCT01106690|363727506|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
105469164|NCT01106690|363727507|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
105469165|NCT01106690|363727505|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
105469166|NCT01106690|363727506|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
105469167|NCT01106690|363727507|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
105469168|NCT01106690|363727505|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
105558045|NCT02834780|364039205|FG003|Overall Study|Adverse Event|0|||
105685020|NCT03945825|364509377|FG002|Overall Study|Withdrawal by Subject|1|||
105685021|NCT03945825|364509378|FG003|Overall Study|Withdrawal by Subject|1|||
105685022|NCT03945825|364509379|FG004|Overall Study|Withdrawal by Subject|0|||
105685023|NCT03945825|364509380|FG005|Overall Study|Withdrawal by Subject|1|||
105685024|NCT01551212|364509381|FG000|Overall Study|Graft loss/Retransplantation|0|||
105685025|NCT01551212|364509382|FG001|Overall Study|Graft loss/Retransplantation|1|||
105685026|NCT01551212|364509381|FG000|Overall Study|Administrative problems|1|||
105685027|NCT01551212|364509382|FG001|Overall Study|Administrative problems|2|||
105685028|NCT01551212|364509381|FG000|Overall Study|Lost to Follow-up|0|||
105685029|NCT01551212|364509382|FG001|Overall Study|Lost to Follow-up|1|||
105685030|NCT01551212|364509381|FG000|Overall Study|Protocol Violation|0|||
105685031|NCT01551212|364509382|FG001|Overall Study|Protocol Violation|1|||
105685032|NCT01551212|364509381|FG000|Overall Study|Withdrawal by Subject|0|||
105685033|NCT01551212|364509382|FG001|Overall Study|Withdrawal by Subject|7|||
105685034|NCT01551212|364509381|FG000|Overall Study|Death|2|||
105685035|NCT01551212|364509382|FG001|Overall Study|Death|4|||
105685036|NCT01551212|364509381|FG000|Overall Study|Never Received Study Treatment|2|||
105685037|NCT01551212|364509382|FG001|Overall Study|Never Received Study Treatment|4|||
105685038|NCT01013285|364509384|FG000|Overall Study|Death|48|||
105685039|NCT01013285|364509385|FG001|Overall Study|Death|89|||
105685040|NCT00807235|364509388|FG000|Overall Study|Adverse Event|1|||
105685041|NCT00807235|364509389|FG001|Overall Study|Adverse Event|0|||
105685042|NCT01012713|364509390|FG000|Overall Study|Lack of Efficacy|3|||
105685043|NCT02571049|364509391|FG000|Screening|Did not meet entry criteria|2|||
105685044|NCT02571049|364509392|FG001|Screening|Did not meet entry criteria|2|||
105685045|NCT02571049|364509391|FG000|Randomization|No migraine attack|0|||
105685046|NCT02571049|364509392|FG001|Randomization|No migraine attack|1|||
105685047|NCT02571049|364509391|FG000|Randomization|Adverse Event|0|||
105685048|NCT02571049|364509392|FG001|Randomization|Adverse Event|1|||
105685049|NCT04161495|364509393|FG000|Overall Study|Withdrawal by Subject|3|||
105685050|NCT04161495|364509394|FG001|Overall Study|Withdrawal by Subject|0|||
105685051|NCT04161495|364509393|FG000|Overall Study|Protocol Violation|1|||
105685052|NCT04161495|364509394|FG001|Overall Study|Protocol Violation|0|||
105685053|NCT04161495|364509393|FG000|Overall Study|Prohibited concomitant medication|3|||
105685054|NCT04161495|364509394|FG001|Overall Study|Prohibited concomitant medication|0|||
105685055|NCT04161495|364509393|FG000|Overall Study|Adverse Event|1|||
105685056|NCT04161495|364509394|FG001|Overall Study|Adverse Event|0|||
105685057|NCT04161495|364509393|FG000|Overall Study|Other - Unspecified|1|||
105685058|NCT04161495|364509394|FG001|Overall Study|Other - Unspecified|0|||
105685059|NCT04161495|364509393|FG000|Overall Study|Death|0|||
105685060|NCT04161495|364509394|FG001|Overall Study|Death|1|||
105685061|NCT03866473|364509395|FG000|Phase 1|Death|1|||
105685062|NCT03866473|364509396|FG001|Phase 1|Death|0|||
105685063|NCT03866473|364509395|FG000|Phase 2|Death|0|||
105685064|NCT03866473|364509396|FG001|Phase 2|Death|2|||
105685065|NCT03866473|364509395|FG000|Phase 2|Dropped|1|||
105685066|NCT03866473|364509396|FG001|Phase 2|Dropped|1|||
105685067|NCT03866473|364509395|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
105685068|NCT03866473|364509396|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
105685069|NCT01257425|364509402|FG000|Overall Study|Lack of Efficacy|3|||
105685070|NCT01257425|364509403|FG001|Overall Study|Lack of Efficacy|3|||
105685071|NCT01257425|364509402|FG000|Overall Study|Adverse Event|1|||
105685072|NCT01257425|364509403|FG001|Overall Study|Adverse Event|1|||
105685073|NCT01257425|364509402|FG000|Overall Study|Protocol Violation|1|||
105685074|NCT01257425|364509403|FG001|Overall Study|Protocol Violation|1|||
105685075|NCT01257425|364509402|FG000|Overall Study|Withdrawal by Subject|0|||
105685076|NCT01257425|364509403|FG001|Overall Study|Withdrawal by Subject|1|||
105685077|NCT01257425|364509402|FG000|Overall Study|Death|1|||
105685078|NCT01257425|364509403|FG001|Overall Study|Death|0|||
105685079|NCT00368992|364509404|FG000|Overall Study|Ineligible|5|||
105685080|NCT00368992|364509404|FG000|Overall Study|Refused treatment|3|||
105685081|NCT00368992|364509404|FG000|Overall Study|Lack of Efficacy|63|||
105685082|NCT00368992|364509404|FG000|Overall Study|Adverse Event|26|||
105786549|NCT01802281|364871458|FG000|Overall Study|Ineligible|5|||
105786550|NCT01802281|364871459|FG001|Overall Study|Ineligible|3|||
105685083|NCT00368992|364509404|FG000|Overall Study|Death|4|||
105685084|NCT00368992|364509404|FG000|Overall Study|Other|9|||
105685085|NCT00723021|364509409|FG000|Intervention Period 4|Adverse Event|0|||
105685086|NCT00723021|364509410|FG001|Intervention Period 4|Adverse Event|0|||
105685087|NCT00723021|364509411|FG002|Intervention Period 4|Adverse Event|0|||
105685088|NCT00723021|364509412|FG003|Intervention Period 4|Adverse Event|0|||
105786551|NCT02161380|364871464|FG000|Overall Study|Lost to Follow-up|0|||
105558046|NCT02834780|364039206|FG004|Overall Study|Adverse Event|1|||
105685089|NCT00723021|364509413|FG004|Intervention Period 4|Adverse Event|1|||
105685090|NCT00971243|364509414|FG000|Double Blind Period|Adverse Event|2|||
105685091|NCT00971243|364509415|FG001|Double Blind Period|Adverse Event|3|||
105685092|NCT00971243|364509416|FG002|Double Blind Period|Adverse Event|2|||
105685093|NCT00971243|364509417|FG003|Double Blind Period|Adverse Event|2|||
105685094|NCT00971243|364509418|FG004|Double Blind Period|Adverse Event|3|||
105685095|NCT00971243|364509414|FG000|Double Blind Period|Lost to Follow-up|0|||
105685096|NCT00971243|364509415|FG001|Double Blind Period|Lost to Follow-up|1|||
105685097|NCT00971243|364509416|FG002|Double Blind Period|Lost to Follow-up|1|||
105685098|NCT00971243|364509417|FG003|Double Blind Period|Lost to Follow-up|0|||
105685099|NCT00971243|364509418|FG004|Double Blind Period|Lost to Follow-up|1|||
105685100|NCT00971243|364509414|FG000|Double Blind Period|Physician Decision|10|||
105685101|NCT00971243|364509415|FG001|Double Blind Period|Physician Decision|6|||
105685102|NCT00971243|364509416|FG002|Double Blind Period|Physician Decision|7|||
105685103|NCT00971243|364509417|FG003|Double Blind Period|Physician Decision|6|||
105685104|NCT00971243|364509418|FG004|Double Blind Period|Physician Decision|7|||
105685105|NCT00971243|364509414|FG000|Double Blind Period|Protocol Violation|2|||
105685106|NCT00971243|364509415|FG001|Double Blind Period|Protocol Violation|0|||
105685107|NCT00971243|364509416|FG002|Double Blind Period|Protocol Violation|3|||
105685108|NCT00971243|364509417|FG003|Double Blind Period|Protocol Violation|2|||
105685109|NCT00971243|364509418|FG004|Double Blind Period|Protocol Violation|2|||
105685110|NCT00971243|364509414|FG000|Double Blind Period|Withdrawal by Subject|4|||
105685111|NCT00971243|364509415|FG001|Double Blind Period|Withdrawal by Subject|1|||
105685112|NCT00971243|364509416|FG002|Double Blind Period|Withdrawal by Subject|4|||
105685113|NCT00971243|364509417|FG003|Double Blind Period|Withdrawal by Subject|4|||
105685114|NCT00971243|364509418|FG004|Double Blind Period|Withdrawal by Subject|4|||
105685115|NCT00971243|364509414|FG000|Double Blind Period|Other reasons|1|||
105685116|NCT00971243|364509415|FG001|Double Blind Period|Other reasons|0|||
105685117|NCT00971243|364509416|FG002|Double Blind Period|Other reasons|2|||
105685118|NCT00971243|364509417|FG003|Double Blind Period|Other reasons|0|||
105685119|NCT00971243|364509418|FG004|Double Blind Period|Other reasons|1|||
105685120|NCT00971243|364509414|FG000|Open-label Period|Adverse Event|1|||
105685121|NCT00971243|364509415|FG001|Open-label Period|Adverse Event|0|||
105685122|NCT00971243|364509416|FG002|Open-label Period|Adverse Event|1|||
105685123|NCT00971243|364509417|FG003|Open-label Period|Adverse Event|1|||
105685124|NCT00971243|364509418|FG004|Open-label Period|Adverse Event|0|||
105685125|NCT00971243|364509414|FG000|Open-label Period|Physician Decision|5|||
105685126|NCT00971243|364509415|FG001|Open-label Period|Physician Decision|9|||
105685127|NCT00971243|364509416|FG002|Open-label Period|Physician Decision|3|||
105685128|NCT00971243|364509417|FG003|Open-label Period|Physician Decision|7|||
105685129|NCT00971243|364509418|FG004|Open-label Period|Physician Decision|2|||
105685130|NCT00971243|364509414|FG000|Open-label Period|Protocol Violation|1|||
105685131|NCT00971243|364509415|FG001|Open-label Period|Protocol Violation|1|||
105685132|NCT00971243|364509416|FG002|Open-label Period|Protocol Violation|1|||
105685133|NCT00971243|364509417|FG003|Open-label Period|Protocol Violation|0|||
105685134|NCT00971243|364509418|FG004|Open-label Period|Protocol Violation|1|||
105685135|NCT00971243|364509414|FG000|Open-label Period|Withdrawal by Subject|1|||
105685136|NCT00971243|364509415|FG001|Open-label Period|Withdrawal by Subject|0|||
105685137|NCT00971243|364509416|FG002|Open-label Period|Withdrawal by Subject|0|||
105685138|NCT00971243|364509417|FG003|Open-label Period|Withdrawal by Subject|2|||
105685139|NCT00971243|364509418|FG004|Open-label Period|Withdrawal by Subject|1|||
105685140|NCT00971243|364509414|FG000|Open-label Period|Other reason|0|||
105685141|NCT00971243|364509415|FG001|Open-label Period|Other reason|0|||
105685142|NCT00971243|364509416|FG002|Open-label Period|Other reason|0|||
105685143|NCT00971243|364509417|FG003|Open-label Period|Other reason|0|||
105685144|NCT00971243|364509418|FG004|Open-label Period|Other reason|2|||
105685145|NCT00770341|364509419|FG000|Overall Study|Did not meet eligibility criteria|1|||
105685146|NCT00770341|364509420|FG001|Overall Study|Did not meet eligibility criteria|0|||
105685147|NCT00770341|364509421|FG002|Overall Study|Did not meet eligibility criteria|0|||
105685148|NCT00770341|364509419|FG000|Overall Study|Withdrawal by Subject|0|||
105685149|NCT00770341|364509420|FG001|Overall Study|Withdrawal by Subject|1|||
105685150|NCT00770341|364509421|FG002|Overall Study|Withdrawal by Subject|0|||
105685151|NCT00770341|364509419|FG000|Overall Study|Clinical Adverse Event|3|||
105685152|NCT00770341|364509420|FG001|Overall Study|Clinical Adverse Event|1|||
105685153|NCT00770341|364509421|FG002|Overall Study|Clinical Adverse Event|2|||
105685154|NCT00770341|364509419|FG000|Overall Study|Laboratory adverse event|3|||
105685155|NCT00770341|364509420|FG001|Overall Study|Laboratory adverse event|3|||
105685156|NCT00770341|364509421|FG002|Overall Study|Laboratory adverse event|0|||
105685157|NCT00770341|364509419|FG000|Overall Study|Lack of Efficacy|3|||
105685158|NCT00770341|364509420|FG001|Overall Study|Lack of Efficacy|0|||
105685159|NCT00770341|364509421|FG002|Overall Study|Lack of Efficacy|1|||
105685160|NCT00770341|364509419|FG000|Overall Study|Other|1|||
105685161|NCT00770341|364509420|FG001|Overall Study|Other|0|||
105685162|NCT00770341|364509421|FG002|Overall Study|Other|0|||
105685163|NCT00770341|364509419|FG000|Overall Study|Not treated|1|||
105685164|NCT00770341|364509420|FG001|Overall Study|Not treated|0|||
105685165|NCT00770341|364509421|FG002|Overall Study|Not treated|0|||
105344608|NCT04488419|363263459|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
105558047|NCT02834780|364039207|FG005|Overall Study|Adverse Event|0|||
105558048|NCT02834780|364039208|FG006|Overall Study|Adverse Event|1|||
105558049|NCT02834780|364039209|FG007|Overall Study|Adverse Event|1|||
105558050|NCT02834780|364039210|FG008|Overall Study|Adverse Event|0|||
105558051|NCT02834780|364039211|FG009|Overall Study|Adverse Event|2|||
105558052|NCT02834780|364039212|FG010|Overall Study|Adverse Event|0|||
105558053|NCT02834780|364039213|FG011|Overall Study|Adverse Event|3|||
105558054|NCT02834780|364039214|FG012|Overall Study|Adverse Event|2|||
105558055|NCT02834780|364039202|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
105558056|NCT02834780|364039203|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
105558057|NCT02834780|364039204|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
105558058|NCT02834780|364039205|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
105558059|NCT02834780|364039206|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
105558060|NCT02834780|364039207|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
105558061|NCT02834780|364039208|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
105558062|NCT02834780|364039209|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
105558063|NCT02834780|364039210|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
105558064|NCT02834780|364039211|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
105558065|NCT02834780|364039212|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
105558066|NCT02834780|364039213|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
105558067|NCT02834780|364039214|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
105558068|NCT02834780|364039202|FG000|Overall Study|Other|1|||
105558069|NCT02834780|364039203|FG001|Overall Study|Other|0|||
105558070|NCT02834780|364039204|FG002|Overall Study|Other|1|||
105558071|NCT02834780|364039205|FG003|Overall Study|Other|2|||
105558072|NCT02834780|364039206|FG004|Overall Study|Other|0|||
105558073|NCT02834780|364039207|FG005|Overall Study|Other|0|||
105558074|NCT02834780|364039208|FG006|Overall Study|Other|0|||
105558075|NCT02834780|364039209|FG007|Overall Study|Other|0|||
105558076|NCT02834780|364039210|FG008|Overall Study|Other|0|||
105558077|NCT02834780|364039211|FG009|Overall Study|Other|0|||
105558078|NCT02834780|364039212|FG010|Overall Study|Other|0|||
105558079|NCT02834780|364039213|FG011|Overall Study|Other|0|||
105558080|NCT02834780|364039214|FG012|Overall Study|Other|1|||
105558081|NCT01454583|364039222|FG000|1st Year|Lost to Follow-up|1057|||
105558082|NCT01454583|364039223|FG001|1st Year|Lost to Follow-up|318|||
105558083|NCT01454583|364039224|FG002|1st Year|Lost to Follow-up|180|||
105558084|NCT01454583|364039222|FG000|2nd Year|Lost to Follow-up|3965|||
105558085|NCT01454583|364039223|FG001|2nd Year|Lost to Follow-up|1049|||
105558086|NCT01454583|364039224|FG002|2nd Year|Lost to Follow-up|737|||
105558087|NCT01454583|364039222|FG000|3rd Year|Lost to Follow-up|1959|||
105558088|NCT01454583|364039223|FG001|3rd Year|Lost to Follow-up|512|||
105558089|NCT01454583|364039224|FG002|3rd Year|Lost to Follow-up|297|||
105558090|NCT03265600|364039225|FG000|Overall Study|Lost to Follow-up|17|||
105558091|NCT03265600|364039226|FG001|Overall Study|Lost to Follow-up|5|||
105344609|NCT04488419|363263457|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
105344610|NCT04488419|363263458|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
105558092|NCT03265600|364039225|FG000|Overall Study|Withdrawal by Subject|4|||
105558093|NCT03265600|364039226|FG001|Overall Study|Withdrawal by Subject|2|||
105558094|NCT03265600|364039225|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
105558095|NCT03265600|364039226|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
105558096|NCT01292239|364039238|FG000|Overall Study|Other|1|||
105558097|NCT01292239|364039239|FG001|Overall Study|Other|1|||
105558098|NCT01292239|364039238|FG000|Overall Study|Withdrawal by Subject|3|||
105558099|NCT01292239|364039239|FG001|Overall Study|Withdrawal by Subject|6|||
105558100|NCT01881126|364039245|FG000|Overall Study|Non-compliance|1|||
105558101|NCT01881126|364039246|FG001|Overall Study|Non-compliance|1|||
105685166|NCT00960531|364509422|FG000|Overall Study|Lack of Efficacy|1|||
105685167|NCT00960531|364509423|FG001|Overall Study|Lack of Efficacy|0|||
105685168|NCT00960531|364509424|FG002|Overall Study|Lack of Efficacy|0|||
105685169|NCT00960531|364509425|FG003|Overall Study|Lack of Efficacy|0|||
105685170|NCT00960531|364509426|FG004|Overall Study|Lack of Efficacy|0|||
105685171|NCT00960531|364509427|FG005|Overall Study|Lack of Efficacy|0|||
105685172|NCT00960531|364509428|FG006|Overall Study|Lack of Efficacy|0|||
105685173|NCT00960531|364509429|FG007|Overall Study|Lack of Efficacy|0|||
105685174|NCT00960531|364509430|FG008|Overall Study|Lack of Efficacy|0|||
105685175|NCT00960531|364509431|FG009|Overall Study|Lack of Efficacy|0|||
105685176|NCT00960531|364509422|FG000|Overall Study|Withdrawal by Subject|1|||
105685177|NCT00960531|364509423|FG001|Overall Study|Withdrawal by Subject|0|||
105685178|NCT00960531|364509424|FG002|Overall Study|Withdrawal by Subject|5|||
105685179|NCT00960531|364509425|FG003|Overall Study|Withdrawal by Subject|2|||
105685180|NCT00960531|364509426|FG004|Overall Study|Withdrawal by Subject|0|||
105685181|NCT00960531|364509427|FG005|Overall Study|Withdrawal by Subject|0|||
105685182|NCT00960531|364509428|FG006|Overall Study|Withdrawal by Subject|2|||
105685183|NCT00960531|364509429|FG007|Overall Study|Withdrawal by Subject|0|||
105685184|NCT00960531|364509430|FG008|Overall Study|Withdrawal by Subject|1|||
105685185|NCT00960531|364509431|FG009|Overall Study|Withdrawal by Subject|0|||
105685186|NCT00960531|364509422|FG000|Overall Study|Caregiver Request|2|||
105685187|NCT00960531|364509423|FG001|Overall Study|Caregiver Request|0|||
105685188|NCT00960531|364509424|FG002|Overall Study|Caregiver Request|6|||
105685189|NCT00960531|364509425|FG003|Overall Study|Caregiver Request|5|||
105685190|NCT00960531|364509426|FG004|Overall Study|Caregiver Request|0|||
105685191|NCT00960531|364509427|FG005|Overall Study|Caregiver Request|2|||
105685192|NCT00960531|364509428|FG006|Overall Study|Caregiver Request|3|||
105685193|NCT00960531|364509429|FG007|Overall Study|Caregiver Request|1|||
105685194|NCT00960531|364509430|FG008|Overall Study|Caregiver Request|3|||
105685195|NCT00960531|364509431|FG009|Overall Study|Caregiver Request|0|||
105685196|NCT00960531|364509422|FG000|Overall Study|Investigator Request|0|||
105685197|NCT00960531|364509423|FG001|Overall Study|Investigator Request|0|||
105685198|NCT00960531|364509424|FG002|Overall Study|Investigator Request|1|||
105685199|NCT00960531|364509425|FG003|Overall Study|Investigator Request|0|||
105685200|NCT00960531|364509426|FG004|Overall Study|Investigator Request|0|||
105685201|NCT00960531|364509427|FG005|Overall Study|Investigator Request|0|||
105685202|NCT00960531|364509428|FG006|Overall Study|Investigator Request|0|||
105685203|NCT00960531|364509429|FG007|Overall Study|Investigator Request|0|||
105685204|NCT00960531|364509430|FG008|Overall Study|Investigator Request|0|||
105685205|NCT00960531|364509431|FG009|Overall Study|Investigator Request|0|||
105685206|NCT00960531|364509422|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
105685207|NCT00960531|364509423|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
105685208|NCT00960531|364509424|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
105685209|NCT00960531|364509425|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
105685210|NCT00960531|364509426|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
105685211|NCT00960531|364509427|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
105685212|NCT00960531|364509428|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
105685213|NCT00960531|364509429|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
105685214|NCT00960531|364509430|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
105685215|NCT00960531|364509431|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
105685216|NCT00960531|364509422|FG000|Overall Study|Lost to Follow-up|0|||
105685217|NCT00960531|364509423|FG001|Overall Study|Lost to Follow-up|0|||
105685218|NCT00960531|364509424|FG002|Overall Study|Lost to Follow-up|1|||
105685219|NCT00960531|364509425|FG003|Overall Study|Lost to Follow-up|0|||
105685220|NCT00960531|364509426|FG004|Overall Study|Lost to Follow-up|0|||
105685221|NCT00960531|364509427|FG005|Overall Study|Lost to Follow-up|0|||
105685222|NCT00960531|364509428|FG006|Overall Study|Lost to Follow-up|1|||
105685223|NCT00960531|364509429|FG007|Overall Study|Lost to Follow-up|0|||
105685224|NCT00960531|364509430|FG008|Overall Study|Lost to Follow-up|0|||
105685225|NCT00960531|364509431|FG009|Overall Study|Lost to Follow-up|0|||
105685226|NCT00960531|364509422|FG000|Overall Study|Failed to Return|2|||
105685227|NCT00960531|364509423|FG001|Overall Study|Failed to Return|0|||
105685228|NCT00960531|364509424|FG002|Overall Study|Failed to Return|0|||
105685229|NCT00960531|364509425|FG003|Overall Study|Failed to Return|0|||
105685230|NCT00960531|364509426|FG004|Overall Study|Failed to Return|0|||
105685231|NCT00960531|364509427|FG005|Overall Study|Failed to Return|0|||
105685232|NCT00960531|364509428|FG006|Overall Study|Failed to Return|0|||
105685233|NCT00960531|364509429|FG007|Overall Study|Failed to Return|2|||
105685234|NCT00960531|364509430|FG008|Overall Study|Failed to Return|0|||
105685235|NCT00960531|364509431|FG009|Overall Study|Failed to Return|0|||
105685236|NCT00960531|364509422|FG000|Overall Study|Adverse Event (AE)|2|||
105685237|NCT00960531|364509423|FG001|Overall Study|Adverse Event (AE)|0|||
105685238|NCT00960531|364509424|FG002|Overall Study|Adverse Event (AE)|0|||
105685239|NCT00960531|364509425|FG003|Overall Study|Adverse Event (AE)|0|||
105685240|NCT00960531|364509426|FG004|Overall Study|Adverse Event (AE)|0|||
105685241|NCT00960531|364509427|FG005|Overall Study|Adverse Event (AE)|1|||
105685242|NCT00960531|364509428|FG006|Overall Study|Adverse Event (AE)|2|||
105685243|NCT00960531|364509429|FG007|Overall Study|Adverse Event (AE)|0|||
105685244|NCT00960531|364509430|FG008|Overall Study|Adverse Event (AE)|2|||
105685245|NCT00960531|364509431|FG009|Overall Study|Adverse Event (AE)|0|||
105685246|NCT00960531|364509422|FG000|Overall Study|Reason not Specified|2|||
105685247|NCT00960531|364509423|FG001|Overall Study|Reason not Specified|1|||
105685248|NCT00960531|364509424|FG002|Overall Study|Reason not Specified|13|||
105685249|NCT00960531|364509425|FG003|Overall Study|Reason not Specified|1|||
105685250|NCT00960531|364509426|FG004|Overall Study|Reason not Specified|2|||
105685251|NCT00960531|364509427|FG005|Overall Study|Reason not Specified|0|||
105685252|NCT00960531|364509428|FG006|Overall Study|Reason not Specified|16|||
105685253|NCT00960531|364509429|FG007|Overall Study|Reason not Specified|0|||
105685254|NCT00960531|364509430|FG008|Overall Study|Reason not Specified|8|||
105685255|NCT00960531|364509431|FG009|Overall Study|Reason not Specified|1|||
105685256|NCT00409773|364510857|FG000|Overall Study|Adverse Event|3|||
105685257|NCT00409773|364510858|FG001|Overall Study|Adverse Event|4|||
105685258|NCT00409773|364510859|FG002|Overall Study|Adverse Event|4|||
105685259|NCT00409773|364510860|FG003|Overall Study|Adverse Event|2|||
105685260|NCT00409773|364510861|FG004|Overall Study|Adverse Event|6|||
105685261|NCT00409773|364510857|FG000|Overall Study|Lost to Follow-up|6|||
105685262|NCT00409773|364510858|FG001|Overall Study|Lost to Follow-up|1|||
105685263|NCT00409773|364510859|FG002|Overall Study|Lost to Follow-up|2|||
105685264|NCT00409773|364510860|FG003|Overall Study|Lost to Follow-up|3|||
105685265|NCT00409773|364510861|FG004|Overall Study|Lost to Follow-up|1|||
105685266|NCT00409773|364510857|FG000|Overall Study|Physician Decision|0|||
105685267|NCT00409773|364510858|FG001|Overall Study|Physician Decision|0|||
105685268|NCT00409773|364510859|FG002|Overall Study|Physician Decision|0|||
105685269|NCT00409773|364510860|FG003|Overall Study|Physician Decision|2|||
105685270|NCT00409773|364510861|FG004|Overall Study|Physician Decision|0|||
105685271|NCT00409773|364510857|FG000|Overall Study|Protocol Violation|0|||
105685272|NCT00409773|364510858|FG001|Overall Study|Protocol Violation|2|||
105685273|NCT00409773|364510859|FG002|Overall Study|Protocol Violation|3|||
105685274|NCT00409773|364510860|FG003|Overall Study|Protocol Violation|3|||
105685275|NCT00409773|364510861|FG004|Overall Study|Protocol Violation|1|||
105685276|NCT00409773|364510857|FG000|Overall Study|Withdrawal by Subject|0|||
105685277|NCT00409773|364510858|FG001|Overall Study|Withdrawal by Subject|0|||
105685278|NCT00409773|364510859|FG002|Overall Study|Withdrawal by Subject|0|||
105685279|NCT00409773|364510860|FG003|Overall Study|Withdrawal by Subject|2|||
105685280|NCT00409773|364510861|FG004|Overall Study|Withdrawal by Subject|1|||
105685281|NCT00409773|364510857|FG000|Overall Study|Lack of Eligibility|0|||
105685282|NCT00409773|364510858|FG001|Overall Study|Lack of Eligibility|0|||
105685283|NCT00409773|364510859|FG002|Overall Study|Lack of Eligibility|0|||
105685284|NCT00409773|364510860|FG003|Overall Study|Lack of Eligibility|0|||
105685285|NCT00409773|364510861|FG004|Overall Study|Lack of Eligibility|1|||
105685286|NCT00153062|364510862|FG000|Overall Study|Death|360|||
105685287|NCT00153062|364510863|FG001|Overall Study|Death|352|||
105685288|NCT00153062|364510864|FG002|Overall Study|Death|369|||
105685289|NCT00153062|364510865|FG003|Overall Study|Death|365|||
105685290|NCT00153062|364510862|FG000|Overall Study|Withdrawal by Subject|14|||
105685291|NCT00153062|364510863|FG001|Overall Study|Withdrawal by Subject|30|||
105685292|NCT00153062|364510864|FG002|Overall Study|Withdrawal by Subject|27|||
105685293|NCT00153062|364510865|FG003|Overall Study|Withdrawal by Subject|28|||
105685294|NCT00153062|364510862|FG000|Overall Study|Lost to Follow-up|12|||
105685295|NCT00153062|364510863|FG001|Overall Study|Lost to Follow-up|20|||
105685296|NCT00153062|364510864|FG002|Overall Study|Lost to Follow-up|15|||
105685297|NCT00153062|364510865|FG003|Overall Study|Lost to Follow-up|16|||
105685298|NCT00153062|364510862|FG000|Overall Study|Adverse Event|0|||
105685299|NCT00153062|364510863|FG001|Overall Study|Adverse Event|1|||
105685300|NCT00153062|364510864|FG002|Overall Study|Adverse Event|1|||
105685301|NCT00153062|364510865|FG003|Overall Study|Adverse Event|0|||
105685302|NCT00153062|364510862|FG000|Overall Study|Protocol Violation|0|||
105685303|NCT00153062|364510863|FG001|Overall Study|Protocol Violation|2|||
105685304|NCT00153062|364510864|FG002|Overall Study|Protocol Violation|1|||
105685305|NCT00153062|364510865|FG003|Overall Study|Protocol Violation|1|||
105685306|NCT00153062|364510862|FG000|Overall Study|No disposition data available|1|||
105685307|NCT00153062|364510863|FG001|Overall Study|No disposition data available|1|||
105685308|NCT00153062|364510864|FG002|Overall Study|No disposition data available|1|||
105685309|NCT00153062|364510865|FG003|Overall Study|No disposition data available|1|||
105685310|NCT00153062|364510862|FG000|Overall Study|Other|0|||
105685311|NCT00153062|364510863|FG001|Overall Study|Other|0|||
105685312|NCT00153062|364510864|FG002|Overall Study|Other|1|||
105685313|NCT00153062|364510865|FG003|Overall Study|Other|0|||
105685314|NCT02359877|364510866|FG000|Overall Study|Withdrawal by Subject|1|||
105685315|NCT02359877|364510867|FG001|Overall Study|Withdrawal by Subject|0|||
105685316|NCT02359877|364510868|FG002|Overall Study|Withdrawal by Subject|0|||
105685317|NCT02359877|364510869|FG003|Overall Study|Withdrawal by Subject|2|||
105685318|NCT02359877|364510866|FG000|Overall Study|Adverse Event|0|||
105685319|NCT02359877|364510867|FG001|Overall Study|Adverse Event|0|||
105685320|NCT02359877|364510868|FG002|Overall Study|Adverse Event|0|||
105685321|NCT02359877|364510869|FG003|Overall Study|Adverse Event|1|||
105685322|NCT01919814|364510870|FG000|Overall Study|Adverse Event|1|||
105685323|NCT01919814|364510871|FG001|Overall Study|Adverse Event|0|||
105685324|NCT01919814|364510870|FG000|Overall Study|Protocol Violation|1|||
105685325|NCT01919814|364510871|FG001|Overall Study|Protocol Violation|0|||
105685326|NCT01919814|364510870|FG000|Overall Study|Withdrawal by Subject|1|||
105685327|NCT01919814|364510871|FG001|Overall Study|Withdrawal by Subject|0|||
105685328|NCT00275262|364510872|FG000|Overall Study|Adverse Event|2|||
105685329|NCT00275262|364510873|FG001|Overall Study|Adverse Event|0|||
105685330|NCT00275262|364510872|FG000|Overall Study|Disease progression|2|||
105685331|NCT00275262|364510873|FG001|Overall Study|Disease progression|5|||
105685332|NCT00275262|364510872|FG000|Overall Study|Lost to Follow-up|0|||
105685333|NCT00275262|364510873|FG001|Overall Study|Lost to Follow-up|2|||
105685334|NCT00275262|364510872|FG000|Overall Study|Protocol Violation|0|||
105685335|NCT00275262|364510873|FG001|Overall Study|Protocol Violation|2|||
105685336|NCT00275262|364510872|FG000|Overall Study|Death|1|||
105685337|NCT00275262|364510873|FG001|Overall Study|Death|0|||
105685338|NCT00275262|364510872|FG000|Overall Study|Started Chemotherapy|1|||
105685339|NCT00275262|364510873|FG001|Overall Study|Started Chemotherapy|0|||
105685340|NCT00001962|364510876|FG000|Overall Study|Lack of Efficacy|18|||
105685341|NCT00001962|364510876|FG000|Overall Study|Lack of Accrual|6|||
105685342|NCT00001962|364510876|FG000|Overall Study|Death|1|||
105685343|NCT00001962|364510876|FG000|Overall Study|Lost to Follow-up|2|||
105685344|NCT00001962|364510876|FG000|Overall Study|Adverse Event|1|||
105685345|NCT01201317|364510886|FG000|Overall Study|Withdrawal by Subject|5|||
105685346|NCT01201317|364510887|FG001|Overall Study|Withdrawal by Subject|0|||
105685347|NCT01201317|364510888|FG002|Overall Study|Withdrawal by Subject|3|||
105685348|NCT01201317|364510886|FG000|Overall Study|Adverse Event|2|||
105685349|NCT01201317|364510887|FG001|Overall Study|Adverse Event|2|||
105685350|NCT01201317|364510888|FG002|Overall Study|Adverse Event|2|||
105685351|NCT01201317|364510886|FG000|Overall Study|Screen failure|1|||
105685352|NCT01201317|364510887|FG001|Overall Study|Screen failure|1|||
105685353|NCT01201317|364510888|FG002|Overall Study|Screen failure|0|||
105685354|NCT01201317|364510886|FG000|Overall Study|Protocol Violation|0|||
105685355|NCT01201317|364510887|FG001|Overall Study|Protocol Violation|1|||
105685356|NCT01201317|364510888|FG002|Overall Study|Protocol Violation|1|||
105685357|NCT01201317|364510886|FG000|Overall Study|Death|0|||
105685358|NCT01201317|364510887|FG001|Overall Study|Death|1|||
105685359|NCT01201317|364510888|FG002|Overall Study|Death|0|||
105685360|NCT01201317|364510886|FG000|Overall Study|Study-specific withdrawal criteria|0|||
105685361|NCT01201317|364510887|FG001|Overall Study|Study-specific withdrawal criteria|0|||
105685362|NCT01201317|364510888|FG002|Overall Study|Study-specific withdrawal criteria|1|||
105685363|NCT01201317|364510886|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
105685364|NCT01201317|364510887|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
105685365|NCT01201317|364510888|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
105685366|NCT01201317|364510886|FG000|Overall Study|Decrease in renal function|0|||
105685367|NCT01201317|364510887|FG001|Overall Study|Decrease in renal function|1|||
105685368|NCT01201317|364510888|FG002|Overall Study|Decrease in renal function|0|||
105685369|NCT01201317|364510886|FG000|Overall Study|Lack of Efficacy|1|||
105685370|NCT01201317|364510887|FG001|Overall Study|Lack of Efficacy|0|||
105685371|NCT01201317|364510888|FG002|Overall Study|Lack of Efficacy|0|||
105685372|NCT01201317|364510886|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
105685373|NCT01201317|364510887|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
105685374|NCT01201317|364510888|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
105685375|NCT02795429|364510889|FG000|Overall Study|Adverse Event|1|||
105685376|NCT02795429|364510890|FG001|Overall Study|Adverse Event|2|||
105685377|NCT02795429|364510891|FG002|Overall Study|Adverse Event|1|||
105685378|NCT02795429|364510892|FG003|Overall Study|Adverse Event|2|||
105685379|NCT02795429|364510893|FG004|Overall Study|Adverse Event|1|||
105685380|NCT02795429|364510889|FG000|Overall Study|Death|1|||
105685381|NCT02795429|364510890|FG001|Overall Study|Death|0|||
105685382|NCT02795429|364510891|FG002|Overall Study|Death|1|||
105685383|NCT02795429|364510892|FG003|Overall Study|Death|2|||
105685384|NCT02795429|364510893|FG004|Overall Study|Death|1|||
105685385|NCT02795429|364510889|FG000|Overall Study|Physician Decision|0|||
105685386|NCT02795429|364510890|FG001|Overall Study|Physician Decision|0|||
105685387|NCT02795429|364510891|FG002|Overall Study|Physician Decision|2|||
105685388|NCT02795429|364510892|FG003|Overall Study|Physician Decision|1|||
105685389|NCT02795429|364510893|FG004|Overall Study|Physician Decision|5|||
105685390|NCT02795429|364510889|FG000|Overall Study|Progressive disease|3|||
105685391|NCT02795429|364510890|FG001|Overall Study|Progressive disease|7|||
105685392|NCT02795429|364510891|FG002|Overall Study|Progressive disease|6|||
105685393|NCT02795429|364510892|FG003|Overall Study|Progressive disease|26|||
105685394|NCT02795429|364510893|FG004|Overall Study|Progressive disease|20|||
105685395|NCT02795429|364510889|FG000|Overall Study|Subject/guardian decision|1|||
105685396|NCT02795429|364510890|FG001|Overall Study|Subject/guardian decision|1|||
105685397|NCT02795429|364510891|FG002|Overall Study|Subject/guardian decision|1|||
105685398|NCT02795429|364510892|FG003|Overall Study|Subject/guardian decision|1|||
105685399|NCT02795429|364510893|FG004|Overall Study|Subject/guardian decision|3|||
105685400|NCT03628898|364510894|FG000|Overall Study|Device deficiency|1|||
105685401|NCT03645057|364510899|FG000|Randomization to Baseline|Lost to Follow-up|1|||
105685402|NCT03645057|364510900|FG001|Randomization to Baseline|Lost to Follow-up|0|||
105685403|NCT03645057|364510901|FG002|Randomization to Baseline|Lost to Follow-up|1|||
105685404|NCT03645057|364510902|FG003|Randomization to Baseline|Lost to Follow-up|0|||
105685405|NCT03645057|364510899|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
105685406|NCT03645057|364510900|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
105685407|NCT03645057|364510901|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
105685408|NCT03645057|364510902|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
105685409|NCT03645057|364510899|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
105685410|NCT03645057|364510900|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
105685411|NCT03645057|364510901|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
105685412|NCT03645057|364510902|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
105685413|NCT03645057|364510899|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
105685414|NCT03645057|364510900|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
105685415|NCT03645057|364510901|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
105685416|NCT03645057|364510902|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
105685417|NCT01873495|364510903|FG000|Overall Study|Withdrawal by Subject|1|||
105685418|NCT01873495|364510903|FG000|Overall Study|Physician Decision|3|||
105685419|NCT01873495|364510903|FG000|Overall Study|Adverse Event|1|||
105685420|NCT01873495|364510903|FG000|Overall Study|Removed for Transplantation|1|||
105685421|NCT01873495|364510903|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
105685422|NCT02080221|364510904|FG000|Overall Study|Withdrawal by Subject|1|||
105685423|NCT02080221|364510904|FG000|Overall Study|Clinical Progression of Disease|1|||
105685424|NCT03907410|364510905|FG000|Overall Study|Lost to Follow-up|4|||
105685425|NCT03907410|364510906|FG001|Overall Study|Lost to Follow-up|1|||
105685426|NCT03907410|364510907|FG002|Overall Study|Lost to Follow-up|1|||
105685427|NCT03907410|364510905|FG000|Overall Study|Lost to follow-up and research burden|0|||
105685428|NCT03907410|364510906|FG001|Overall Study|Lost to follow-up and research burden|0|||
105685429|NCT03907410|364510907|FG002|Overall Study|Lost to follow-up and research burden|1|||
105685430|NCT01295034|364510908|FG000|Overall Study|Lost to Follow-up|5|||
105685431|NCT01295034|364510909|FG001|Overall Study|Lost to Follow-up|5|||
105685432|NCT04754477|364510911|FG000|Overall Study|Withdrawal by Subject|1|||
105685433|NCT00986674|364510912|FG000|Overall Study|Lack of Efficacy|28|||
105685434|NCT00986674|364510913|FG001|Overall Study|Lack of Efficacy|25|||
105685435|NCT00986674|364510914|FG002|Overall Study|Lack of Efficacy|23|||
105558102|NCT01881126|364039245|FG000|Overall Study|Adverse Event|0|||
105685436|NCT00986674|364510912|FG000|Overall Study|Adverse Event|4|||
105685437|NCT00986674|364510913|FG001|Overall Study|Adverse Event|8|||
105685438|NCT00986674|364510914|FG002|Overall Study|Adverse Event|9|||
105685439|NCT00986674|364510912|FG000|Overall Study|Death|5|||
105685440|NCT00986674|364510913|FG001|Overall Study|Death|0|||
105685441|NCT00986674|364510914|FG002|Overall Study|Death|4|||
105685442|NCT00986674|364510912|FG000|Overall Study|Withdrawal by Subject|6|||
105685443|NCT00986674|364510913|FG001|Overall Study|Withdrawal by Subject|2|||
105685444|NCT00986674|364510914|FG002|Overall Study|Withdrawal by Subject|1|||
105685445|NCT00986674|364510912|FG000|Overall Study|alternative therapy|0|||
105685446|NCT00986674|364510913|FG001|Overall Study|alternative therapy|0|||
105685447|NCT00986674|364510914|FG002|Overall Study|alternative therapy|1|||
105685448|NCT00986674|364510912|FG000|Overall Study|not start protocol therapy|4|||
105685449|NCT00986674|364510913|FG001|Overall Study|not start protocol therapy|3|||
105685450|NCT00986674|364510914|FG002|Overall Study|not start protocol therapy|1|||
105685451|NCT00986674|364510912|FG000|Overall Study|unknown/not specify|0|||
105685452|NCT00986674|364510913|FG001|Overall Study|unknown/not specify|7|||
105685453|NCT00986674|364510914|FG002|Overall Study|unknown/not specify|9|||
105685454|NCT00825916|364510917|FG000|Overall Study|Lost to Follow-up|4|||
105685455|NCT00825916|364510918|FG001|Overall Study|Lost to Follow-up|2|||
105685456|NCT00825916|364510919|FG002|Overall Study|Lost to Follow-up|1|||
105685457|NCT03421431|364510927|FG000|Overall Study|Adverse Event|2|||
105685458|NCT03421431|364510928|FG001|Overall Study|Adverse Event|1|||
105685459|NCT03421431|364510929|FG002|Overall Study|Adverse Event|12|||
105685460|NCT03421431|364510927|FG000|Overall Study|Lost to Follow-up|1|||
105685461|NCT03421431|364510928|FG001|Overall Study|Lost to Follow-up|1|||
105685462|NCT03421431|364510929|FG002|Overall Study|Lost to Follow-up|1|||
105685463|NCT03421431|364510927|FG000|Overall Study|Withdrawal by Subject|3|||
105685464|NCT03421431|364510928|FG001|Overall Study|Withdrawal by Subject|2|||
105685465|NCT03421431|364510929|FG002|Overall Study|Withdrawal by Subject|1|||
105685466|NCT03421431|364510927|FG000|Overall Study|Protocol Violation|0|||
105685467|NCT03421431|364510928|FG001|Overall Study|Protocol Violation|1|||
105685468|NCT03421431|364510929|FG002|Overall Study|Protocol Violation|0|||
105685469|NCT03421431|364510927|FG000|Overall Study|Participant met Stopping Rules|0|||
105685470|NCT03421431|364510928|FG001|Overall Study|Participant met Stopping Rules|1|||
105685471|NCT03421431|364510929|FG002|Overall Study|Participant met Stopping Rules|0|||
105685472|NCT02216357|364510930|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
105685473|NCT02216357|364510931|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
105685474|NCT04964414|364510932|FG000|Overall Study|Lost to Follow-up|10|||
105685475|NCT04964414|364510933|FG001|Overall Study|Lost to Follow-up|8|||
105685476|NCT04964414|364510932|FG000|Overall Study|Withdrawal by Subject|1|||
105685477|NCT04964414|364510933|FG001|Overall Study|Withdrawal by Subject|1|||
105685478|NCT00051363|364510940|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
105685479|NCT00051363|364510941|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
105685480|NCT00051363|364510940|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
105685481|NCT00051363|364510941|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
105685482|NCT00051363|364510940|FG000|Overall Study|Death|2|||
105685483|NCT00051363|364510941|FG001|Overall Study|Death|2|||
105685484|NCT00051363|364510940|FG000|Overall Study|Excluded Pre-Randomization|2|||
105685485|NCT00051363|364510941|FG001|Overall Study|Excluded Pre-Randomization|5|||
105685486|NCT01596621|364510942|FG000|Overall Study|Death|4|||
105685487|NCT01596621|364510942|FG000|Overall Study|Withdrawal by Subject|9|||
105685488|NCT01596621|364510942|FG000|Overall Study|Disease Progression|49|||
105469169|NCT01106690|363727506|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
105469170|NCT01106690|363727507|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
105469171|NCT01106690|363727505|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
105469172|NCT01106690|363727506|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
105469173|NCT01106690|363727507|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
105469174|NCT01106690|363727505|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
105469175|NCT01106690|363727506|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
105469176|NCT01106690|363727507|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
105469177|NCT01106690|363727505|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
105685489|NCT01596621|364510942|FG000|Overall Study|Lost to Follow-up|3|||
105685490|NCT01596621|364510942|FG000|Overall Study|Other than specified|13|||
105685491|NCT00388154|364510948|FG000|Overall Study|Withdrawal by Subject|1|||
105685492|NCT01201265|364510949|FG000|Overall Study|Death|14|||
105685493|NCT01201265|364510949|FG000|Overall Study|Insufficient Therapeutic Response|3|||
105685494|NCT01201265|364510949|FG000|Overall Study|Lost to Follow-up|10|||
105685495|NCT01201265|364510949|FG000|Overall Study|Withdrawal by Subject|7|||
105685496|NCT01201265|364510949|FG000|Overall Study|Disease Progression|4|||
105685497|NCT03737474|364510950|FG000|Overall Study|Adverse Event|18|||
105685498|NCT03737474|364510951|FG001|Overall Study|Adverse Event|48|||
105685499|NCT03737474|364510950|FG000|Overall Study|Lack of Efficacy|1|||
105469178|NCT01106690|363727506|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
105469179|NCT01106690|363727507|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
105469180|NCT01106690|363727505|FG000|Core Period: Baseline to Week 26|Other|10|||
105469181|NCT01106690|363727506|FG001|Core Period: Baseline to Week 26|Other|2|||
105469182|NCT01106690|363727507|FG002|Core Period: Baseline to Week 26|Other|6|||
105469183|NCT01106690|363727505|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
105469184|NCT01106690|363727506|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
105469185|NCT01106690|363727507|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
105469186|NCT01106690|363727505|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
105469187|NCT01106690|363727506|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
105469188|NCT01106690|363727507|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
105469189|NCT01106690|363727505|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
105469190|NCT01106690|363727506|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
105469191|NCT01106690|363727507|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
105469192|NCT01106690|363727505|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
105685500|NCT03737474|364510951|FG001|Overall Study|Lack of Efficacy|3|||
105685501|NCT03737474|364510950|FG000|Overall Study|Protocol Violation|0|||
105685502|NCT03737474|364510951|FG001|Overall Study|Protocol Violation|8|||
105685503|NCT03737474|364510950|FG000|Overall Study|Withdrawal by Subject|5|||
105685504|NCT03737474|364510951|FG001|Overall Study|Withdrawal by Subject|20|||
105685505|NCT03737474|364510950|FG000|Overall Study|Non-compliance With Study Drug|0|||
105469193|NCT01106690|363727506|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
105469194|NCT01106690|363727507|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
105469195|NCT01106690|363727505|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
105469196|NCT01106690|363727506|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
105469197|NCT01106690|363727507|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
105469198|NCT01106690|363727505|FG000|Extension Period: Week 26 to Week 52|Other|8|||
105469199|NCT01106690|363727506|FG001|Extension Period: Week 26 to Week 52|Other|3|||
105469200|NCT01106690|363727507|FG002|Extension Period: Week 26 to Week 52|Other|4|||
105469201|NCT01106690|363727505|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
105685506|NCT03737474|364510951|FG001|Overall Study|Non-compliance With Study Drug|1|||
105685507|NCT03737474|364510950|FG000|Overall Study|Physician Decision|1|||
105786552|NCT02161380|364871465|FG001|Overall Study|Lost to Follow-up|1|||
105786553|NCT02161380|364871466|FG002|Overall Study|Lost to Follow-up|0|||
105469202|NCT01106690|363727506|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
105469203|NCT01106690|363727507|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
105469204|NCT02578706|363727508|FG000|Overall Study|Withdrawal by Subject|1|||
105469205|NCT02578706|363727509|FG001|Overall Study|Withdrawal by Subject|0|||
105469206|NCT02578706|363727510|FG002|Overall Study|Withdrawal by Subject|0|||
105469207|NCT02578706|363727508|FG000|Overall Study|Lost to Follow-up|0|||
105469208|NCT02578706|363727509|FG001|Overall Study|Lost to Follow-up|4|||
105469209|NCT02578706|363727510|FG002|Overall Study|Lost to Follow-up|0|||
105469210|NCT02578706|363727508|FG000|Overall Study|Physician Decision|0|||
105469211|NCT02578706|363727509|FG001|Overall Study|Physician Decision|1|||
105469212|NCT02578706|363727510|FG002|Overall Study|Physician Decision|0|||
105469213|NCT02015637|363727513|FG000|Overall Study|Lost to Follow-up|3|||
105469214|NCT02015637|363727514|FG001|Overall Study|Lost to Follow-up|5|||
105469215|NCT02015637|363727513|FG000|Overall Study|Adverse Event|3|||
105469216|NCT02015637|363727514|FG001|Overall Study|Adverse Event|0|||
105469217|NCT02015637|363727513|FG000|Overall Study|Did not take study drug|2|||
105469218|NCT02015637|363727514|FG001|Overall Study|Did not take study drug|0|||
105469219|NCT02106390|363727517|FG000|Overall Study|Withdrawal by Subject|15|||
105469220|NCT02106390|363727518|FG001|Overall Study|Withdrawal by Subject|16|||
105469221|NCT02106390|363727519|FG002|Overall Study|Withdrawal by Subject|15|||
105469222|NCT02106390|363727517|FG000|Overall Study|Lost to Follow-up|25|||
105469223|NCT02106390|363727518|FG001|Overall Study|Lost to Follow-up|20|||
105469224|NCT02106390|363727519|FG002|Overall Study|Lost to Follow-up|13|||
105469225|NCT02106390|363727517|FG000|Overall Study|Other: Administrative Reason|8|||
105469226|NCT02106390|363727518|FG001|Overall Study|Other: Administrative Reason|5|||
105469227|NCT02106390|363727519|FG002|Overall Study|Other: Administrative Reason|12|||
105469228|NCT02106390|363727517|FG000|Overall Study|Other: Unspecified|1|||
105469229|NCT02106390|363727518|FG001|Overall Study|Other: Unspecified|4|||
105469230|NCT02106390|363727519|FG002|Overall Study|Other: Unspecified|2|||
105786554|NCT02161380|364871467|FG003|Overall Study|Lost to Follow-up|0|||
105786555|NCT01945034|364872824|FG000|Overall Study|Medication Error|0|||
105469231|NCT02106390|363727517|FG000|Overall Study|Adverse Event|0|||
105469232|NCT02106390|363727518|FG001|Overall Study|Adverse Event|2|||
105469233|NCT02106390|363727519|FG002|Overall Study|Adverse Event|1|||
105685508|NCT03737474|364510951|FG001|Overall Study|Physician Decision|4|||
105685509|NCT01145755|364510952|FG000|Overall Study|Adverse Event|2|||
105685510|NCT01145755|364510953|FG001|Overall Study|Adverse Event|4|||
105786556|NCT01945034|364872825|FG001|Overall Study|Medication Error|1|||
105786557|NCT01945034|364872826|FG002|Overall Study|Medication Error|0|||
105469234|NCT02106390|363727517|FG000|Overall Study|Protocol Violation|0|||
105469235|NCT02106390|363727518|FG001|Overall Study|Protocol Violation|1|||
105469236|NCT02106390|363727519|FG002|Overall Study|Protocol Violation|0|||
105469237|NCT01532986|363727520|FG000|Overall Study|Death|9|||
105469238|NCT01532986|363727521|FG001|Overall Study|Death|9|||
105469239|NCT01532986|363727520|FG000|Overall Study|Withdrawal by Subject|7|||
105469240|NCT01532986|363727521|FG001|Overall Study|Withdrawal by Subject|10|||
105469241|NCT01532986|363727520|FG000|Overall Study|Physician Decision|7|||
105469242|NCT01532986|363727521|FG001|Overall Study|Physician Decision|5|||
105469243|NCT02120898|363727524|FG000|Overall Study|Withdrawal by Subject|4|||
105469244|NCT02120898|363727525|FG001|Overall Study|Withdrawal by Subject|2|||
105469245|NCT02120898|363727526|FG002|Overall Study|Withdrawal by Subject|2|||
105469246|NCT02120898|363727524|FG000|Overall Study|Non-compliance with study drug|3|||
105469247|NCT02120898|363727525|FG001|Overall Study|Non-compliance with study drug|0|||
105469248|NCT02120898|363727526|FG002|Overall Study|Non-compliance with study drug|0|||
105469249|NCT02120898|363727524|FG000|Overall Study|Adverse Event|1|||
105469250|NCT02120898|363727525|FG001|Overall Study|Adverse Event|2|||
105469251|NCT02120898|363727526|FG002|Overall Study|Adverse Event|1|||
105469252|NCT02120898|363727524|FG000|Overall Study|Protocol Violation|1|||
105469253|NCT02120898|363727525|FG001|Overall Study|Protocol Violation|2|||
105469254|NCT02120898|363727526|FG002|Overall Study|Protocol Violation|0|||
105469255|NCT02120898|363727524|FG000|Overall Study|Lost to Follow-up|0|||
105469256|NCT02120898|363727525|FG001|Overall Study|Lost to Follow-up|0|||
105469257|NCT02120898|363727526|FG002|Overall Study|Lost to Follow-up|1|||
105469258|NCT00831181|363727527|FG000|Overall Study|Adverse Event|12|||
105469259|NCT02754440|363727528|FG000|Overall Study|Protocol Violation|3|||
105469260|NCT02754440|363727529|FG001|Overall Study|Protocol Violation|2|||
105469261|NCT02754440|363727530|FG002|Overall Study|Protocol Violation|2|||
105469262|NCT02754440|363727531|FG003|Overall Study|Protocol Violation|6|||
105685511|NCT01145755|364510954|FG002|Overall Study|Adverse Event|2|||
105685512|NCT01145755|364510952|FG000|Overall Study|Withdrawal by Subject|2|||
105685513|NCT01145755|364510953|FG001|Overall Study|Withdrawal by Subject|2|||
105685514|NCT01145755|364510954|FG002|Overall Study|Withdrawal by Subject|2|||
105685515|NCT01145755|364510952|FG000|Overall Study|Lost to Follow-up|2|||
105685516|NCT01145755|364510953|FG001|Overall Study|Lost to Follow-up|3|||
105685517|NCT01145755|364510954|FG002|Overall Study|Lost to Follow-up|1|||
105685518|NCT01145755|364510952|FG000|Overall Study|Protocol Violation|0|||
105685519|NCT01145755|364510953|FG001|Overall Study|Protocol Violation|3|||
105685520|NCT01145755|364510954|FG002|Overall Study|Protocol Violation|1|||
105685521|NCT01145755|364510952|FG000|Overall Study|Study Closure|14|||
105685522|NCT01145755|364510953|FG001|Overall Study|Study Closure|14|||
105685523|NCT01145755|364510954|FG002|Overall Study|Study Closure|17|||
105685524|NCT01145755|364510952|FG000|Overall Study|Lack of Efficacy|0|||
105685525|NCT01145755|364510953|FG001|Overall Study|Lack of Efficacy|1|||
105685526|NCT01145755|364510954|FG002|Overall Study|Lack of Efficacy|0|||
105685527|NCT01145755|364510952|FG000|Overall Study|Patient could not swollow medication|0|||
105685528|NCT01145755|364510953|FG001|Overall Study|Patient could not swollow medication|0|||
105685529|NCT01145755|364510954|FG002|Overall Study|Patient could not swollow medication|1|||
105685530|NCT01145755|364510952|FG000|Overall Study|Withdrawal by Subject|0|||
105685531|NCT01145755|364510953|FG001|Overall Study|Withdrawal by Subject|0|||
105685532|NCT01145755|364510954|FG002|Overall Study|Withdrawal by Subject|1|||
105469263|NCT02754440|363727528|FG000|Overall Study|Adverse Event|3|||
105469264|NCT02754440|363727529|FG001|Overall Study|Adverse Event|1|||
105469265|NCT02754440|363727530|FG002|Overall Study|Adverse Event|0|||
105685533|NCT01145755|364510952|FG000|Overall Study|Positive urine ethanol|0|||
105685534|NCT01145755|364510953|FG001|Overall Study|Positive urine ethanol|1|||
105685535|NCT01145755|364510954|FG002|Overall Study|Positive urine ethanol|0|||
105685536|NCT02739360|364510956|FG000|Overall Study|Adverse Event|1|||
105685537|NCT02739360|364510956|FG000|Overall Study|Study terminated by Sponsor|2|||
105685538|NCT00883051|364510957|FG000|Overall Study|Lost to Follow-up|0|||
105685539|NCT00883051|364510958|FG001|Overall Study|Lost to Follow-up|0|||
105685540|NCT00883051|364510959|FG002|Overall Study|Lost to Follow-up|0|||
105685541|NCT00883051|364510960|FG003|Overall Study|Lost to Follow-up|0|||
105685542|NCT00883051|364510961|FG004|Overall Study|Lost to Follow-up|1|||
105685543|NCT00883051|364510957|FG000|Overall Study|Did not use study medication|24|||
105685544|NCT00883051|364510958|FG001|Overall Study|Did not use study medication|22|||
105685545|NCT00883051|364510959|FG002|Overall Study|Did not use study medication|29|||
105685546|NCT00883051|364510960|FG003|Overall Study|Did not use study medication|29|||
105685547|NCT00883051|364510961|FG004|Overall Study|Did not use study medication|17|||
105685548|NCT03604523|364510962|FG000|Overall Study|Physician Decision|1|||
105685549|NCT03604523|364510963|FG001|Overall Study|Physician Decision|0|||
105685550|NCT02910739|364510968|FG000|Overall Study|Adverse Event|1|||
105685551|NCT02910739|364510969|FG001|Overall Study|Adverse Event|0|||
105685552|NCT02910739|364510970|FG002|Overall Study|Adverse Event|0|||
105685553|NCT02910739|364510971|FG003|Overall Study|Adverse Event|0|||
105685554|NCT02656823|364510972|FG000|Overall Study|Adverse Event|3|||
105344611|NCT04488419|363263459|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
105344612|NCT04488419|363263457|FG000|Primary Analysis Population|Adverse Event|6|||
105344613|NCT04488419|363263458|FG001|Primary Analysis Population|Adverse Event|9|||
105344614|NCT04488419|363263459|FG002|Primary Analysis Population|Adverse Event|0|||
105344615|NCT04488419|363263457|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
105344616|NCT04488419|363263458|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
105344617|NCT04488419|363263459|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
105344618|NCT04488419|363263457|FG000|Primary Analysis Population|Protocol Violation|1|||
105344619|NCT04488419|363263458|FG001|Primary Analysis Population|Protocol Violation|1|||
105344620|NCT04488419|363263459|FG002|Primary Analysis Population|Protocol Violation|0|||
105344621|NCT04488419|363263457|FG000|Primary Analysis Population|Undetermined|7|||
105344622|NCT04488419|363263458|FG001|Primary Analysis Population|Undetermined|3|||
105344623|NCT04488419|363263459|FG002|Primary Analysis Population|Undetermined|0|||
105344624|NCT04488419|363263457|FG000|Primary Analysis Population|>1 Reason|2|||
105344625|NCT04488419|363263458|FG001|Primary Analysis Population|>1 Reason|4|||
105344626|NCT04488419|363263459|FG002|Primary Analysis Population|>1 Reason|0|||
105344627|NCT04743804|363263462|FG000|Overall Study|Other|1|||
105344628|NCT04743804|363263463|FG001|Overall Study|Other|0|||
105344629|NCT04743804|363263462|FG000|Overall Study|Withdrawal by Subject|0|||
105344630|NCT04743804|363263463|FG001|Overall Study|Withdrawal by Subject|1|||
105344631|NCT04743804|363263462|FG000|Overall Study|Study Terminated by Sponsor|1|||
105344632|NCT04743804|363263463|FG001|Overall Study|Study Terminated by Sponsor|4|||
105344633|NCT04743804|363263462|FG000|Overall Study|Physician Decision|0|||
105344634|NCT04743804|363263463|FG001|Overall Study|Physician Decision|1|||
105344635|NCT04743804|363263462|FG000|Overall Study|Death|3|||
105344636|NCT04743804|363263463|FG001|Overall Study|Death|0|||
105344637|NCT01632904|363263464|FG000|Overall Study|Adverse Event|4|||
105344638|NCT01632904|363263465|FG001|Overall Study|Adverse Event|1|||
105344639|NCT01632904|363263464|FG000|Overall Study|Physician Decision|0|||
105344640|NCT01632904|363263465|FG001|Overall Study|Physician Decision|1|||
105344641|NCT01632904|363263464|FG000|Overall Study|Subject decision|3|||
105344642|NCT01632904|363263465|FG001|Overall Study|Subject decision|2|||
105344643|NCT01632904|363263464|FG000|Overall Study|Disease Progression|0|||
105344644|NCT01632904|363263465|FG001|Overall Study|Disease Progression|1|||
105344645|NCT01632904|363263464|FG000|Overall Study|Reason for discontinuation not available|0|||
105344646|NCT01632904|363263465|FG001|Overall Study|Reason for discontinuation not available|1|||
105344647|NCT03201874|363263468|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
105344648|NCT03201874|363263469|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
105344649|NCT03201874|363263468|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
105344650|NCT03201874|363263469|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
105344651|NCT04676412|363263470|FG000|Overall Study|Death|28|||
105344652|NCT04676412|363263471|FG001|Overall Study|Death|31|||
105685555|NCT02656823|364510972|FG000|Overall Study|Lost to Follow-up|2|||
105685556|NCT04675151|364510974|FG000|Overall Study|Protocol Violation|1|||
105685557|NCT04675151|364510975|FG001|Overall Study|Protocol Violation|0|||
105685558|NCT04675151|364510976|FG002|Overall Study|Protocol Violation|0|||
105344653|NCT04676412|363263470|FG000|Overall Study|Lost to Follow-up|1|||
105344654|NCT04676412|363263471|FG001|Overall Study|Lost to Follow-up|2|||
105344655|NCT04676412|363263470|FG000|Overall Study|Sponsor Decision|20|||
105344656|NCT04676412|363263471|FG001|Overall Study|Sponsor Decision|23|||
105685559|NCT04675151|364510977|FG003|Overall Study|Protocol Violation|1|||
105685560|NCT01340651|364510978|FG000|Overall Study|Adverse Event|3|||
105685561|NCT01340651|364510978|FG000|Overall Study|Consent Withdrawn|2|||
105469266|NCT02754440|363727531|FG003|Overall Study|Adverse Event|9|||
105469267|NCT02754440|363727528|FG000|Overall Study|Withdrawal by Subject|0|||
105469268|NCT02754440|363727529|FG001|Overall Study|Withdrawal by Subject|0|||
105469269|NCT02754440|363727530|FG002|Overall Study|Withdrawal by Subject|0|||
105469270|NCT02754440|363727531|FG003|Overall Study|Withdrawal by Subject|1|||
105469271|NCT02754440|363727528|FG000|Overall Study|Equipment failure|0|||
105469272|NCT02754440|363727529|FG001|Overall Study|Equipment failure|5|||
105469273|NCT02754440|363727530|FG002|Overall Study|Equipment failure|5|||
105469274|NCT02754440|363727531|FG003|Overall Study|Equipment failure|7|||
105469275|NCT02754440|363727528|FG000|Overall Study|Subject issues not resulting in AE|0|||
105469276|NCT02754440|363727529|FG001|Overall Study|Subject issues not resulting in AE|0|||
105469277|NCT02754440|363727530|FG002|Overall Study|Subject issues not resulting in AE|0|||
105469278|NCT02754440|363727531|FG003|Overall Study|Subject issues not resulting in AE|12|||
105469279|NCT02560558|363727534|FG000|Overall Study|Adverse Event|1|||
105469280|NCT02560558|363727535|FG001|Overall Study|Adverse Event|0|||
105469281|NCT02560558|363727534|FG000|Overall Study|Death|0|||
105469282|NCT02560558|363727535|FG001|Overall Study|Death|2|||
105469283|NCT02560558|363727534|FG000|Overall Study|Lost to Follow-up|0|||
105685562|NCT01340651|364510978|FG000|Overall Study|Commercial Supply per Sponsor|12|||
105685563|NCT01009580|364510979|FG000|Overall Study|Adverse Event|4|||
105685564|NCT01009580|364510980|FG001|Overall Study|Adverse Event|4|||
105685565|NCT01009580|364510979|FG000|Overall Study|Lack of Efficacy|0|||
105685566|NCT01009580|364510980|FG001|Overall Study|Lack of Efficacy|1|||
105685567|NCT01009580|364510979|FG000|Overall Study|Protocol Violation|2|||
105685568|NCT01009580|364510980|FG001|Overall Study|Protocol Violation|3|||
105685569|NCT01009580|364510979|FG000|Overall Study|Withdrawal Criteria|4|||
105685570|NCT01009580|364510980|FG001|Overall Study|Withdrawal Criteria|6|||
105685571|NCT01009580|364510979|FG000|Overall Study|Unclassified|17|||
105469284|NCT02560558|363727535|FG001|Overall Study|Lost to Follow-up|4|||
105469285|NCT02560558|363727534|FG000|Overall Study|Protocol Violation|3|||
105469286|NCT02560558|363727535|FG001|Overall Study|Protocol Violation|0|||
105469287|NCT02560558|363727534|FG000|Overall Study|Withdrawal by Subject|3|||
105469288|NCT02560558|363727535|FG001|Overall Study|Withdrawal by Subject|0|||
105469289|NCT00473382|363727537|FG000|Core Study|Adverse Event|3|||
105469290|NCT00473382|363727538|FG001|Core Study|Adverse Event|1|||
105469291|NCT00473382|363727539|FG002|Core Study|Adverse Event|1|||
105469292|NCT00473382|363727537|FG000|Core Study|Death|3|||
105469293|NCT00473382|363727538|FG001|Core Study|Death|5|||
105469294|NCT00473382|363727539|FG002|Core Study|Death|10|||
105469295|NCT00473382|363727537|FG000|Core Study|Lost to Follow-up|3|||
105469296|NCT00473382|363727538|FG001|Core Study|Lost to Follow-up|3|||
105469297|NCT00473382|363727539|FG002|Core Study|Lost to Follow-up|3|||
105469298|NCT00473382|363727537|FG000|Core Study|Physician Decision|1|||
105469299|NCT00473382|363727538|FG001|Core Study|Physician Decision|2|||
105469300|NCT00473382|363727539|FG002|Core Study|Physician Decision|2|||
105469301|NCT00473382|363727537|FG000|Core Study|Subject non-compliance|5|||
105469302|NCT00473382|363727538|FG001|Core Study|Subject non-compliance|2|||
105469303|NCT00473382|363727539|FG002|Core Study|Subject non-compliance|1|||
105685572|NCT01009580|364510980|FG001|Overall Study|Unclassified|21|||
105685573|NCT00658684|364510981|FG000|Overall Study|Adverse Event|10|||
105469304|NCT00473382|363727537|FG000|Core Study|Subject needed other treatment|1|||
105685574|NCT00658684|364510982|FG001|Overall Study|Adverse Event|8|||
105685575|NCT00658684|364510983|FG002|Overall Study|Adverse Event|2|||
105469305|NCT00473382|363727538|FG001|Core Study|Subject needed other treatment|3|||
105469306|NCT00473382|363727539|FG002|Core Study|Subject needed other treatment|2|||
105469307|NCT00473382|363727537|FG000|Core Study|Subject's decision|12|||
105685576|NCT00658684|364510984|FG003|Overall Study|Adverse Event|0|||
105685577|NCT00658684|364510981|FG000|Overall Study|Withdrawal by Subject|6|||
105685578|NCT00658684|364510982|FG001|Overall Study|Withdrawal by Subject|4|||
105685579|NCT00658684|364510983|FG002|Overall Study|Withdrawal by Subject|1|||
105469308|NCT00473382|363727538|FG001|Core Study|Subject's decision|11|||
105469309|NCT00473382|363727539|FG002|Core Study|Subject's decision|10|||
105469310|NCT00473382|363727537|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
105469311|NCT00473382|363727538|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
105469312|NCT00473382|363727539|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
105469313|NCT00473382|363727537|FG000|Open-label Extension Through Month 48|Death|1|||
105469314|NCT00473382|363727538|FG001|Open-label Extension Through Month 48|Death|3|||
105685580|NCT00658684|364510984|FG003|Overall Study|Withdrawal by Subject|1|||
105685581|NCT00658684|364510981|FG000|Overall Study|Lack of Efficacy|1|||
105685582|NCT00658684|364510982|FG001|Overall Study|Lack of Efficacy|1|||
105685583|NCT00658684|364510983|FG002|Overall Study|Lack of Efficacy|0|||
105685584|NCT00658684|364510984|FG003|Overall Study|Lack of Efficacy|0|||
105685585|NCT00658684|364510981|FG000|Overall Study|Protocol Violation|1|||
105685586|NCT00658684|364510982|FG001|Overall Study|Protocol Violation|1|||
105685587|NCT00658684|364510983|FG002|Overall Study|Protocol Violation|0|||
105685588|NCT00658684|364510984|FG003|Overall Study|Protocol Violation|0|||
105685589|NCT00658684|364510981|FG000|Overall Study|Pregnancy|1|||
105685590|NCT00658684|364510982|FG001|Overall Study|Pregnancy|1|||
105685591|NCT00658684|364510983|FG002|Overall Study|Pregnancy|0|||
105685592|NCT00658684|364510984|FG003|Overall Study|Pregnancy|0|||
105685593|NCT04646005|364510985|FG000|Overall Study|Adverse Event|1|||
105685594|NCT04646005|364510985|FG000|Overall Study|Progressive Disease|71|||
105685595|NCT04646005|364510985|FG000|Overall Study|Death|20|||
105685596|NCT04646005|364510985|FG000|Overall Study|Withdrawal by Subject|12|||
105685597|NCT04646005|364510985|FG000|Overall Study|Sponsor Request|9|||
105685598|NCT03226275|364510986|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
105685599|NCT03226275|364510987|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
105344657|NCT04676412|363263470|FG000|Overall Study|Withdrawal by Subject|0|||
105344658|NCT04676412|363263471|FG001|Overall Study|Withdrawal by Subject|2|||
105344659|NCT04322539|363263476|FG000|Overall Study|Adverse Event|2|||
105344660|NCT04322539|363263477|FG001|Overall Study|Adverse Event|0|||
105685600|NCT03226275|364510988|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
105685601|NCT03226275|364510989|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
105685602|NCT03226275|364510986|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
105685603|NCT03226275|364510987|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
105685604|NCT03226275|364510988|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
105685605|NCT03226275|364510989|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
105685606|NCT00816400|364512783|FG000|Overall Study|Death|2|||
105685607|NCT00816400|364512784|FG001|Overall Study|Death|3|||
105685608|NCT00816400|364512785|FG002|Overall Study|Death|3|||
105685609|NCT00816400|364512786|FG003|Overall Study|Death|3|||
105685610|NCT00816400|364512787|FG004|Overall Study|Death|2|||
105685611|NCT00816400|364512788|FG005|Overall Study|Death|3|||
105685612|NCT00816400|364512789|FG006|Overall Study|Death|2|||
105344661|NCT04322539|363263476|FG000|Overall Study|Death|411|||
105344662|NCT04322539|363263477|FG001|Overall Study|Death|203|||
105344663|NCT04322539|363263476|FG000|Overall Study|Lost to Follow-up|3|||
105344664|NCT04322539|363263477|FG001|Overall Study|Lost to Follow-up|1|||
105344665|NCT04322539|363263476|FG000|Overall Study|Withdrawal of consent|14|||
105344666|NCT04322539|363263477|FG001|Overall Study|Withdrawal of consent|8|||
105344667|NCT04322539|363263476|FG000|Overall Study|Radiological Disease Progression|6|||
105344668|NCT04322539|363263477|FG001|Overall Study|Radiological Disease Progression|0|||
105344669|NCT04322539|363263476|FG000|Overall Study|Sponsor Decision|19|||
105344670|NCT04322539|363263477|FG001|Overall Study|Sponsor Decision|14|||
105344671|NCT04322539|363263476|FG000|Overall Study|Other|6|||
105344672|NCT04322539|363263477|FG001|Overall Study|Other|4|||
105344673|NCT01846221|363263478|FG000|Overall Study|Catheter Failure|2|||
105344674|NCT01846221|363263479|FG001|Overall Study|Catheter Failure|0|||
105344675|NCT01846221|363263478|FG000|Overall Study|Age Exclusion|1|||
105344676|NCT01846221|363263479|FG001|Overall Study|Age Exclusion|0|||
105344677|NCT02339155|363263480|FG000|Overall Study|Adverse Event|0|||
105344678|NCT02339155|363263481|FG001|Overall Study|Adverse Event|6|||
105344679|NCT02339155|363263480|FG000|Overall Study|Death|1|||
105344680|NCT02339155|363263481|FG001|Overall Study|Death|1|||
105344681|NCT02339155|363263480|FG000|Overall Study|Lost to Follow-up|8|||
105344682|NCT02339155|363263481|FG001|Overall Study|Lost to Follow-up|9|||
105344683|NCT02339155|363263480|FG000|Overall Study|Physician Decision|2|||
105344684|NCT02339155|363263481|FG001|Overall Study|Physician Decision|1|||
105344685|NCT02339155|363263480|FG000|Overall Study|Withdrawal by Subject|4|||
105344686|NCT02339155|363263481|FG001|Overall Study|Withdrawal by Subject|4|||
105344687|NCT04984681|363263482|FG000|Overall Study|Lost to Follow-up|3|||
105344688|NCT04984681|363263483|FG001|Overall Study|Lost to Follow-up|1|||
105344689|NCT03226678|363263486|FG000|Part A (Core Study Phase)|Adverse Event|0|||
105344690|NCT03226678|363263487|FG001|Part A (Core Study Phase)|Adverse Event|1|||
105344691|NCT03226678|363263488|FG002|Part A (Core Study Phase)|Adverse Event|0|||
105344692|NCT03226678|363263489|FG003|Part A (Core Study Phase)|Adverse Event|0|||
105344693|NCT03226678|363263490|FG004|Part A (Core Study Phase)|Adverse Event|0|||
105344694|NCT03226678|363263491|FG005|Part A (Core Study Phase)|Adverse Event|0|||
105344695|NCT03226678|363263486|FG000|Part A (Core Study Phase)|Death|0|||
105344696|NCT03226678|363263487|FG001|Part A (Core Study Phase)|Death|0|||
105344697|NCT03226678|363263488|FG002|Part A (Core Study Phase)|Death|1|||
105344698|NCT03226678|363263489|FG003|Part A (Core Study Phase)|Death|0|||
105344699|NCT03226678|363263490|FG004|Part A (Core Study Phase)|Death|0|||
105344700|NCT03226678|363263491|FG005|Part A (Core Study Phase)|Death|0|||
105344701|NCT03226678|363263486|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
105344702|NCT03226678|363263487|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
105344703|NCT03226678|363263488|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
105344704|NCT03226678|363263489|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
105344705|NCT03226678|363263490|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
105344706|NCT03226678|363263491|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
105344707|NCT03226678|363263486|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
105344708|NCT03226678|363263487|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
105344709|NCT03226678|363263488|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
105344710|NCT03226678|363263489|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
105344711|NCT03226678|363263490|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
105344712|NCT03226678|363263491|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
105344713|NCT03226678|363263486|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
105469315|NCT00473382|363727539|FG002|Open-label Extension Through Month 48|Death|3|||
105469316|NCT00473382|363727537|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
105469317|NCT00473382|363727538|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
105469318|NCT00473382|363727539|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
105469319|NCT00473382|363727537|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
105469320|NCT00473382|363727538|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
105469321|NCT00473382|363727539|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
105469322|NCT00473382|363727537|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
105469323|NCT00473382|363727538|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
105469324|NCT00473382|363727539|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
105685613|NCT00816400|364512790|FG007|Overall Study|Death|5|||
105685614|NCT00816400|364512791|FG008|Overall Study|Death|6|||
105685615|NCT00816400|364512783|FG000|Overall Study|In hospice care at the end of the study|0|||
105685616|NCT00816400|364512784|FG001|Overall Study|In hospice care at the end of the study|0|||
105344714|NCT03226678|363263487|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
105344715|NCT03226678|363263488|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
105558103|NCT01881126|364039246|FG001|Overall Study|Adverse Event|1|||
105558104|NCT01041638|364039251|FG000|Overall Study|Adverse Event|4|||
105558105|NCT01041638|364039251|FG000|Overall Study|Death|1|||
105558106|NCT01041638|364039251|FG000|Overall Study|Lack of Efficacy|7|||
105558107|NCT01041638|364039251|FG000|Overall Study|Physician Decision|4|||
105558108|NCT01041638|364039251|FG000|Overall Study|Withdrawal by Subject|11|||
105558109|NCT01777854|364039252|FG000|Overall Study|Physician Decision|3|||
105558110|NCT01777854|364039253|FG001|Overall Study|Physician Decision|3|||
105558111|NCT01239030|364039254|FG000|Double Blind|Adverse Event|0|||
105558112|NCT01239030|364039255|FG001|Double Blind|Adverse Event|1|||
105558113|NCT01239030|364039256|FG002|Double Blind|Adverse Event|0|||
105558114|NCT01239030|364039257|FG003|Double Blind|Adverse Event|2|||
105558115|NCT01239030|364039258|FG004|Double Blind|Adverse Event|0|||
105558116|NCT01239030|364039254|FG000|Double Blind|Withdrawal by Subject|0|||
105558117|NCT01239030|364039255|FG001|Double Blind|Withdrawal by Subject|1|||
105558118|NCT01239030|364039256|FG002|Double Blind|Withdrawal by Subject|1|||
105558119|NCT01239030|364039257|FG003|Double Blind|Withdrawal by Subject|0|||
105558120|NCT01239030|364039258|FG004|Double Blind|Withdrawal by Subject|1|||
105558121|NCT01239030|364039254|FG000|Double Blind|Lost to Follow-up|1|||
105558122|NCT01239030|364039255|FG001|Double Blind|Lost to Follow-up|1|||
105558123|NCT01239030|364039256|FG002|Double Blind|Lost to Follow-up|0|||
105558124|NCT01239030|364039257|FG003|Double Blind|Lost to Follow-up|0|||
105558125|NCT01239030|364039258|FG004|Double Blind|Lost to Follow-up|0|||
105558126|NCT01239030|364039254|FG000|Double Blind|Physician Decision|0|||
105558127|NCT01239030|364039255|FG001|Double Blind|Physician Decision|1|||
105558128|NCT01239030|364039256|FG002|Double Blind|Physician Decision|0|||
105558129|NCT01239030|364039257|FG003|Double Blind|Physician Decision|0|||
105558130|NCT01239030|364039258|FG004|Double Blind|Physician Decision|0|||
105558131|NCT01239030|364039254|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
105558132|NCT01239030|364039255|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
105558133|NCT01239030|364039256|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
105558134|NCT01239030|364039257|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
105558135|NCT01239030|364039258|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
105558136|NCT01239030|364039254|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
105558137|NCT01239030|364039255|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
105558138|NCT01239030|364039256|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
105558139|NCT01239030|364039257|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
105558140|NCT01239030|364039258|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
105558141|NCT01239030|364039254|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
105558142|NCT01239030|364039255|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
105558143|NCT01239030|364039256|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
105558144|NCT01239030|364039257|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
105558145|NCT01239030|364039258|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
105558146|NCT01239030|364039254|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
105558147|NCT01239030|364039255|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
105558148|NCT01239030|364039256|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
105558149|NCT01239030|364039257|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
105558150|NCT01239030|364039258|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
105558151|NCT04123067|364039260|FG000|Overall Study|Lost to Follow-up|0|||
105558152|NCT04123067|364039261|FG001|Overall Study|Lost to Follow-up|1|||
105558153|NCT03085485|364039263|FG000|Overall Study|Death|1|||
105558154|NCT03085485|364039264|FG001|Overall Study|Death|0|||
105558155|NCT03085485|364039263|FG000|Overall Study|Lost to Follow-up|1|||
105558156|NCT03085485|364039264|FG001|Overall Study|Lost to Follow-up|0|||
105558157|NCT01022762|364039265|FG000|Overall Study|Adverse Event|3|||
105558158|NCT01022762|364039266|FG001|Overall Study|Adverse Event|1|||
105558159|NCT01022762|364039265|FG000|Overall Study|Lack of Efficacy|0|||
105558160|NCT01022762|364039266|FG001|Overall Study|Lack of Efficacy|1|||
105558161|NCT01022762|364039265|FG000|Overall Study|Protocol Violation|7|||
105558162|NCT01022762|364039266|FG001|Overall Study|Protocol Violation|6|||
105685617|NCT00816400|364512785|FG002|Overall Study|In hospice care at the end of the study|2|||
105685618|NCT00816400|364512786|FG003|Overall Study|In hospice care at the end of the study|0|||
105685619|NCT00816400|364512787|FG004|Overall Study|In hospice care at the end of the study|0|||
105685620|NCT00816400|364512788|FG005|Overall Study|In hospice care at the end of the study|0|||
105344716|NCT03226678|363263489|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
105558163|NCT01022762|364039265|FG000|Overall Study|Unclassified|12|||
105558164|NCT01022762|364039266|FG001|Overall Study|Unclassified|20|||
105558165|NCT04302350|364039268|FG000|Overall Study|Physician Decision|1|||
105558166|NCT04302350|364039269|FG001|Overall Study|Physician Decision|1|||
105558167|NCT04302350|364039270|FG002|Overall Study|Physician Decision|2|||
105558168|NCT04302350|364039268|FG000|Overall Study|Lack of Efficacy|1|||
105558169|NCT04302350|364039269|FG001|Overall Study|Lack of Efficacy|1|||
105558170|NCT04302350|364039270|FG002|Overall Study|Lack of Efficacy|4|||
105558171|NCT04302350|364039268|FG000|Overall Study|Adverse Event|0|||
105558172|NCT04302350|364039269|FG001|Overall Study|Adverse Event|1|||
105558173|NCT04302350|364039270|FG002|Overall Study|Adverse Event|2|||
105558174|NCT00374322|364039271|FG000|Overall Study|Lost to Follow-up|92|||
105469325|NCT00473382|363727537|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
105469326|NCT00473382|363727538|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
105469327|NCT00473382|363727539|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
105469328|NCT00473382|363727537|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
105469329|NCT00473382|363727538|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
105469330|NCT00473382|363727539|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
105469331|NCT00473382|363727537|FG000|Open-label Extension Through Month 60|Death|1|||
105469332|NCT00473382|363727538|FG001|Open-label Extension Through Month 60|Death|7|||
105469333|NCT00473382|363727539|FG002|Open-label Extension Through Month 60|Death|4|||
105469334|NCT00473382|363727537|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
105469335|NCT00473382|363727538|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
105469336|NCT00473382|363727539|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
105469337|NCT00473382|363727537|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
105469338|NCT00473382|363727538|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
105469339|NCT00473382|363727539|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
105469340|NCT00473382|363727537|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
105469341|NCT00473382|363727538|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
105469342|NCT00473382|363727539|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
105469343|NCT00473382|363727537|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
105469344|NCT00473382|363727538|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
105469345|NCT00473382|363727539|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
105469346|NCT03048578|363727542|FG000|Overall Study|Withdrawal by Subject|5|||
105469347|NCT03048578|363727543|FG001|Overall Study|Withdrawal by Subject|6|||
105469348|NCT03048578|363727542|FG000|Overall Study|Lost to Follow-up|22|||
105558175|NCT00374322|364039272|FG001|Overall Study|Lost to Follow-up|90|||
105558176|NCT00374322|364039271|FG000|Overall Study|Protocol Violation|8|||
105558177|NCT00374322|364039272|FG001|Overall Study|Protocol Violation|3|||
105558178|NCT00374322|364039271|FG000|Overall Study|Withdrawal by Subject|235|||
105558179|NCT00374322|364039272|FG001|Overall Study|Withdrawal by Subject|167|||
105558180|NCT00374322|364039271|FG000|Overall Study|Sponsor Terminated Study|866|||
105558181|NCT00374322|364039272|FG001|Overall Study|Sponsor Terminated Study|990|||
105558182|NCT00374322|364039271|FG000|Overall Study|Physician Decision|36|||
105558183|NCT00374322|364039272|FG001|Overall Study|Physician Decision|32|||
105558184|NCT00374322|364039271|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
105469349|NCT03048578|363727543|FG001|Overall Study|Lost to Follow-up|10|||
105469350|NCT03048578|363727542|FG000|Overall Study|Adverse Event|1|||
105469351|NCT03048578|363727543|FG001|Overall Study|Adverse Event|2|||
105469352|NCT03048578|363727542|FG000|Overall Study|Terminated|3|||
105469353|NCT03048578|363727543|FG001|Overall Study|Terminated|2|||
105469354|NCT00526071|363727544|FG000|Overall Study|Adverse Event|1|||
105469355|NCT00526071|363727544|FG000|Overall Study|Withdrawal by Subject|1|||
105558185|NCT00374322|364039272|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
105558186|NCT00374322|364039271|FG000|Overall Study|Sponsor Decision|2|||
105558187|NCT00374322|364039272|FG001|Overall Study|Sponsor Decision|3|||
105558188|NCT00374322|364039271|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
105558189|NCT00374322|364039272|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
105558190|NCT00374322|364039271|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
105558191|NCT00374322|364039272|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
105558192|NCT00374322|364039271|FG000|Overall Study|Severe Toxicity|1|||
105558193|NCT00374322|364039272|FG001|Overall Study|Severe Toxicity|0|||
105558194|NCT00374322|364039271|FG000|Overall Study|Site Closed|2|||
105558195|NCT00374322|364039272|FG001|Overall Study|Site Closed|2|||
105558196|NCT00374322|364039271|FG000|Overall Study|Participant Changed Physician|1|||
105558197|NCT00374322|364039272|FG001|Overall Study|Participant Changed Physician|0|||
105558198|NCT00374322|364039271|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
105558199|NCT00374322|364039272|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
105558200|NCT00374322|364039271|FG000|Overall Study|Noncompliance with Study Requirements|0|||
105558201|NCT00374322|364039272|FG001|Overall Study|Noncompliance with Study Requirements|1|||
105558202|NCT00374322|364039271|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
105558203|NCT00374322|364039272|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
105786558|NCT01945034|364872824|FG000|Overall Study|Withdrawal by Subject|0|||
105558204|NCT00374322|364039271|FG000|Overall Study|Did Not Receive Study Medication|8|||
105558205|NCT00374322|364039272|FG001|Overall Study|Did Not Receive Study Medication|6|||
105558206|NCT01400503|364039273|FG000|Overall Study|Withdrawal by Subject|1|||
105558207|NCT01400503|364039273|FG000|Overall Study|Study Terminated by Sponsor|58|||
105558208|NCT01400503|364039273|FG000|Overall Study|Other|1|||
105558209|NCT02626780|364039277|FG000|Overall Study|Withdrawal by Subject|3|||
105786559|NCT01945034|364872825|FG001|Overall Study|Withdrawal by Subject|3|||
105558210|NCT02459574|364039278|FG000|Overall Study|Withdrawal by Subject|6|||
105558211|NCT02459574|364039279|FG001|Overall Study|Withdrawal by Subject|6|||
105558212|NCT02459574|364039280|FG002|Overall Study|Withdrawal by Subject|2|||
105558213|NCT02459574|364039278|FG000|Overall Study|Lost to Follow-up|1|||
105558214|NCT02459574|364039279|FG001|Overall Study|Lost to Follow-up|1|||
105558215|NCT02459574|364039280|FG002|Overall Study|Lost to Follow-up|0|||
105558216|NCT02459574|364039278|FG000|Overall Study|Death|0|||
105558217|NCT02459574|364039279|FG001|Overall Study|Death|1|||
105558218|NCT02459574|364039280|FG002|Overall Study|Death|0|||
105558219|NCT02586025|364041743|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
105558220|NCT02586025|364041744|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
105558221|NCT02586025|364041743|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
105558222|NCT02586025|364041744|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
105558223|NCT02586025|364041743|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
105558224|NCT02586025|364041744|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
105558225|NCT02586025|364041743|FG000|Neoadjuvant Treatment|Death|1|||
105558226|NCT02586025|364041744|FG001|Neoadjuvant Treatment|Death|0|||
105558227|NCT02586025|364041743|FG000|Neoadjuvant Treatment|Adverse Event|1|||
105558228|NCT02586025|364041744|FG001|Neoadjuvant Treatment|Adverse Event|0|||
105558229|NCT02586025|364041743|FG000|Neoadjuvant Treatment|Physician Decision|2|||
105558230|NCT02586025|364041744|FG001|Neoadjuvant Treatment|Physician Decision|1|||
105558231|NCT02586025|364041743|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
105558232|NCT02586025|364041744|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
105558233|NCT02586025|364041743|FG000|Adjuvant Treatment|Recurrent Disease|4|||
105558234|NCT02586025|364041744|FG001|Adjuvant Treatment|Recurrent Disease|5|||
105558235|NCT02586025|364041743|FG000|Adjuvant Treatment|Physician Decision|0|||
105558236|NCT02586025|364041744|FG001|Adjuvant Treatment|Physician Decision|1|||
105558237|NCT02586025|364041743|FG000|Adjuvant Treatment|Pregnancy|1|||
105558238|NCT02586025|364041744|FG001|Adjuvant Treatment|Pregnancy|0|||
105558239|NCT02586025|364041743|FG000|Treatment-Free Follow-Up|Death|11|||
105558240|NCT02586025|364041744|FG001|Treatment-Free Follow-Up|Death|11|||
105558241|NCT02586025|364041743|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
105558242|NCT02586025|364041744|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
105558243|NCT02586025|364041743|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
105558244|NCT02586025|364041744|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
105558245|NCT02586025|364041743|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
105469356|NCT00526071|363727544|FG000|Overall Study|Lack of Response to Study Drug|4|||
105469357|NCT02207088|363727547|FG000|Overall Study|Adverse Event|2|||
105469358|NCT00318643|363727550|FG000|Overall Study|Adverse Event|0|||
105469359|NCT00318643|363727551|FG001|Overall Study|Adverse Event|0|||
105469360|NCT00318643|363727552|FG002|Overall Study|Adverse Event|0|||
105469361|NCT00318643|363727553|FG003|Overall Study|Adverse Event|0|||
105469362|NCT00318643|363727554|FG004|Overall Study|Adverse Event|1|||
105469363|NCT00318643|363727550|FG000|Overall Study|Participant's Decision|0|||
105469364|NCT00318643|363727551|FG001|Overall Study|Participant's Decision|0|||
105469365|NCT00318643|363727552|FG002|Overall Study|Participant's Decision|0|||
105469366|NCT00318643|363727553|FG003|Overall Study|Participant's Decision|0|||
105469367|NCT00318643|363727554|FG004|Overall Study|Participant's Decision|1|||
105558246|NCT02586025|364041744|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
105558247|NCT02586025|364041743|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
105558248|NCT02586025|364041744|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
105558249|NCT00886340|364041749|FG000|Overall Study|Withdrawal by Subject|0|||
105558250|NCT00886340|364041750|FG001|Overall Study|Withdrawal by Subject|7|||
105558251|NCT00951041|364041751|FG000|Overall Study|Withdrawal by Subject|1|||
105558252|NCT00951041|364041752|FG001|Overall Study|Withdrawal by Subject|1|||
105558253|NCT00951041|364041751|FG000|Overall Study|Lost to Follow-up|1|||
105558254|NCT00951041|364041752|FG001|Overall Study|Lost to Follow-up|0|||
105558255|NCT00951041|364041751|FG000|Overall Study|Other|3|||
105558256|NCT00951041|364041752|FG001|Overall Study|Other|0|||
105558257|NCT02314624|364041756|FG000|Overall Study|No participating patient|16|||
105558258|NCT02314624|364041757|FG001|Overall Study|No participating patient|13|||
105558259|NCT02314624|364041756|FG000|Overall Study|Participant withdrew|7|||
105558260|NCT02314624|364041757|FG001|Overall Study|Participant withdrew|2|||
105558261|NCT02314624|364041756|FG000|Overall Study|Lost to Follow-up|2|||
105558262|NCT02314624|364041757|FG001|Overall Study|Lost to Follow-up|5|||
105558263|NCT02314624|364041756|FG000|Overall Study|Dropped/Excluded by PI|6|||
105558264|NCT02314624|364041757|FG001|Overall Study|Dropped/Excluded by PI|6|||
105558265|NCT02723864|364041758|FG000|Overall Study|Refused further treatment|1|||
105558266|NCT02723864|364041759|FG001|Overall Study|Refused further treatment|0|||
105469368|NCT00318643|363727550|FG000|Overall Study|Investigator's Decision|0|||
105469369|NCT00318643|363727551|FG001|Overall Study|Investigator's Decision|0|||
105558267|NCT02723864|364041760|FG002|Overall Study|Refused further treatment|0|||
105558268|NCT02723864|364041761|FG003|Overall Study|Refused further treatment|0|||
105558269|NCT02723864|364041762|FG004|Overall Study|Refused further treatment|1|||
105469370|NCT00318643|363727552|FG002|Overall Study|Investigator's Decision|0|||
105558270|NCT02723864|364041763|FG005|Overall Study|Refused further treatment|2|||
105558271|NCT02723864|364041764|FG006|Overall Study|Refused further treatment|0|||
105558272|NCT02723864|364041758|FG000|Overall Study|Exceed treatment hold time|0|||
105558273|NCT02723864|364041759|FG001|Overall Study|Exceed treatment hold time|1|||
105558274|NCT02723864|364041760|FG002|Overall Study|Exceed treatment hold time|0|||
105558275|NCT02723864|364041761|FG003|Overall Study|Exceed treatment hold time|0|||
105558276|NCT02723864|364041762|FG004|Overall Study|Exceed treatment hold time|0|||
105558277|NCT02723864|364041763|FG005|Overall Study|Exceed treatment hold time|0|||
105469371|NCT00318643|363727553|FG003|Overall Study|Investigator's Decision|0|||
105469372|NCT00318643|363727554|FG004|Overall Study|Investigator's Decision|1|||
105469373|NCT01812252|363727555|FG000|Overall Study|Persistent Disease|1|||
105558278|NCT02723864|364041764|FG006|Overall Study|Exceed treatment hold time|0|||
105558279|NCT02723864|364041758|FG000|Overall Study|Clinical progression|0|||
105558280|NCT02723864|364041759|FG001|Overall Study|Clinical progression|0|||
105558281|NCT02723864|364041760|FG002|Overall Study|Clinical progression|1|||
105558282|NCT02723864|364041761|FG003|Overall Study|Clinical progression|0|||
105558283|NCT02723864|364041762|FG004|Overall Study|Clinical progression|0|||
105558284|NCT02723864|364041763|FG005|Overall Study|Clinical progression|3|||
105558285|NCT02723864|364041764|FG006|Overall Study|Clinical progression|1|||
105469374|NCT01812252|363727556|FG001|Overall Study|Persistent Disease|0|||
105469375|NCT01812252|363727555|FG000|Overall Study|Not transplanted|11|||
105469376|NCT01812252|363727556|FG001|Overall Study|Not transplanted|11|||
105469377|NCT01812252|363727555|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
105469378|NCT01812252|363727556|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
105469379|NCT01812252|363727555|FG000|Overall Study|Withdrawal by Subject|1|||
105469380|NCT01812252|363727556|FG001|Overall Study|Withdrawal by Subject|1|||
105469381|NCT01812252|363727555|FG000|Overall Study|Screen Failure|1|||
105558286|NCT02723864|364041758|FG000|Overall Study|Physician Decision|0|||
105558287|NCT02723864|364041759|FG001|Overall Study|Physician Decision|0|||
105558288|NCT02723864|364041760|FG002|Overall Study|Physician Decision|0|||
105558289|NCT02723864|364041761|FG003|Overall Study|Physician Decision|0|||
105558290|NCT02723864|364041762|FG004|Overall Study|Physician Decision|0|||
105558291|NCT02723864|364041763|FG005|Overall Study|Physician Decision|0|||
105558292|NCT02723864|364041764|FG006|Overall Study|Physician Decision|1|||
105558293|NCT02723864|364041758|FG000|Overall Study|Changes in patient condition|0|||
105558294|NCT02723864|364041759|FG001|Overall Study|Changes in patient condition|0|||
105558295|NCT02723864|364041760|FG002|Overall Study|Changes in patient condition|0|||
105469382|NCT01812252|363727556|FG001|Overall Study|Screen Failure|0|||
105469383|NCT01519921|363727557|FG000|Overall Study|Adverse Event|10|||
105469384|NCT01519921|363727558|FG001|Overall Study|Adverse Event|9|||
105469385|NCT01519921|363727557|FG000|Overall Study|Lack of Efficacy|4|||
105469386|NCT01519921|363727558|FG001|Overall Study|Lack of Efficacy|3|||
105469387|NCT01519921|363727557|FG000|Overall Study|Withdrawal by Subject|3|||
105469388|NCT01519921|363727558|FG001|Overall Study|Withdrawal by Subject|0|||
105469389|NCT01519921|363727557|FG000|Overall Study|Lost to Follow-up|2|||
105469390|NCT01519921|363727558|FG001|Overall Study|Lost to Follow-up|1|||
105469391|NCT01519921|363727557|FG000|Overall Study|Treatment refusal|2|||
105469392|NCT01519921|363727558|FG001|Overall Study|Treatment refusal|1|||
105469393|NCT01519921|363727557|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
105469394|NCT01519921|363727558|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
105469395|NCT02500797|363727559|FG000|Overall Study|Cancel (rapid disease progression)|0|||
105469396|NCT02500797|363727560|FG001|Overall Study|Cancel (rapid disease progression)|0|||
105469397|NCT02500797|363727561|FG002|Overall Study|Cancel (rapid disease progression)|0|||
105469398|NCT02500797|363727562|FG003|Overall Study|Cancel (rapid disease progression)|0|||
105469399|NCT02500797|363727563|FG004|Overall Study|Cancel (rapid disease progression)|1|||
105558296|NCT02723864|364041761|FG003|Overall Study|Changes in patient condition|0|||
105558297|NCT02723864|364041762|FG004|Overall Study|Changes in patient condition|0|||
105558298|NCT02723864|364041763|FG005|Overall Study|Changes in patient condition|1|||
105558299|NCT02723864|364041764|FG006|Overall Study|Changes in patient condition|0|||
105558300|NCT02723864|364041758|FG000|Overall Study|Patient choice|0|||
105558301|NCT02723864|364041759|FG001|Overall Study|Patient choice|0|||
105558302|NCT02723864|364041760|FG002|Overall Study|Patient choice|0|||
105558303|NCT02723864|364041761|FG003|Overall Study|Patient choice|0|||
105558304|NCT02723864|364041762|FG004|Overall Study|Patient choice|0|||
105558305|NCT02723864|364041763|FG005|Overall Study|Patient choice|1|||
105469400|NCT02500797|363727564|FG005|Overall Study|Cancel (rapid disease progression)|1|||
105469401|NCT02500797|363727565|FG006|Overall Study|Cancel (rapid disease progression)|0|||
105558306|NCT02723864|364041764|FG006|Overall Study|Patient choice|0|||
105558307|NCT02723864|364041758|FG000|Overall Study|Adverse Event|0|||
105558308|NCT02723864|364041759|FG001|Overall Study|Adverse Event|0|||
105558309|NCT02723864|364041760|FG002|Overall Study|Adverse Event|0|||
105558310|NCT02723864|364041761|FG003|Overall Study|Adverse Event|0|||
105558311|NCT02723864|364041762|FG004|Overall Study|Adverse Event|0|||
105558312|NCT02723864|364041763|FG005|Overall Study|Adverse Event|1|||
105558313|NCT02723864|364041764|FG006|Overall Study|Adverse Event|0|||
105558314|NCT02723864|364041758|FG000|Overall Study|Started new treatment|0|||
105558315|NCT02723864|364041759|FG001|Overall Study|Started new treatment|0|||
105558316|NCT02723864|364041760|FG002|Overall Study|Started new treatment|0|||
105558317|NCT02723864|364041761|FG003|Overall Study|Started new treatment|0|||
105558318|NCT02723864|364041762|FG004|Overall Study|Started new treatment|0|||
105558319|NCT02723864|364041763|FG005|Overall Study|Started new treatment|1|||
105558320|NCT02723864|364041764|FG006|Overall Study|Started new treatment|0|||
105558321|NCT02723864|364041758|FG000|Overall Study|Switched to alternative treatment|0|||
105558322|NCT02723864|364041759|FG001|Overall Study|Switched to alternative treatment|0|||
105558323|NCT02723864|364041760|FG002|Overall Study|Switched to alternative treatment|0|||
105558324|NCT02723864|364041761|FG003|Overall Study|Switched to alternative treatment|0|||
105558325|NCT02723864|364041762|FG004|Overall Study|Switched to alternative treatment|0|||
105558326|NCT02723864|364041763|FG005|Overall Study|Switched to alternative treatment|1|||
105558327|NCT02723864|364041764|FG006|Overall Study|Switched to alternative treatment|0|||
105558328|NCT02723864|364041758|FG000|Overall Study|Late determination of ineligibility|0|||
105558329|NCT02723864|364041759|FG001|Overall Study|Late determination of ineligibility|0|||
105558330|NCT02723864|364041760|FG002|Overall Study|Late determination of ineligibility|0|||
105558331|NCT02723864|364041761|FG003|Overall Study|Late determination of ineligibility|0|||
105558332|NCT02723864|364041762|FG004|Overall Study|Late determination of ineligibility|0|||
105558333|NCT02723864|364041763|FG005|Overall Study|Late determination of ineligibility|1|||
105558334|NCT02723864|364041764|FG006|Overall Study|Late determination of ineligibility|0|||
105558335|NCT00464815|364041765|FG000|Overall Study|Withdrawal by Subject|6|||
105558336|NCT00464815|364041766|FG001|Overall Study|Withdrawal by Subject|3|||
105558337|NCT01754467|364041771|FG000|Overall Study|Lost to Follow-up|1|||
105558338|NCT02065336|364041772|FG000|Extension Phase|Study Terminated by Sponsor|0|||
105558339|NCT02065336|364041773|FG001|Extension Phase|Study Terminated by Sponsor|0|||
105558340|NCT02065336|364041774|FG002|Extension Phase|Study Terminated by Sponsor|0|||
105558341|NCT02065336|364041775|FG003|Extension Phase|Study Terminated by Sponsor|0|||
105558342|NCT02065336|364041776|FG004|Extension Phase|Study Terminated by Sponsor|0|||
105558343|NCT02065336|364041777|FG005|Extension Phase|Study Terminated by Sponsor|0|||
105558344|NCT02065336|364041778|FG006|Extension Phase|Study Terminated by Sponsor|0|||
105558345|NCT02065336|364041779|FG007|Extension Phase|Study Terminated by Sponsor|0|||
105558346|NCT02065336|364041780|FG008|Extension Phase|Study Terminated by Sponsor|2|||
105558347|NCT02065336|364041781|FG009|Extension Phase|Study Terminated by Sponsor|8|||
105558348|NCT00530855|364041782|FG000|Overall Study|Lack of Efficacy|20|||
105558349|NCT00530855|364041782|FG000|Overall Study|Withdrawal by Subject|30|||
105558350|NCT00530855|364041782|FG000|Overall Study|Fatal Serious AE|3|||
105558351|NCT00530855|364041782|FG000|Overall Study|Non Fatal Serious AE|7|||
105558352|NCT00530855|364041782|FG000|Overall Study|Non Fatal Non Serious AE|12|||
105558353|NCT00530855|364041782|FG000|Overall Study|Protocol Violation|3|||
105558354|NCT00530855|364041782|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
105685621|NCT00816400|364512789|FG006|Overall Study|In hospice care at the end of the study|0|||
105469402|NCT02500797|363727566|FG007|Overall Study|Cancel (rapid disease progression)|0|||
105469403|NCT02500797|363727559|FG000|Overall Study|Withdrawal by Subject|1|||
105469404|NCT02500797|363727560|FG001|Overall Study|Withdrawal by Subject|0|||
105469405|NCT02500797|363727561|FG002|Overall Study|Withdrawal by Subject|0|||
105469406|NCT02500797|363727562|FG003|Overall Study|Withdrawal by Subject|0|||
105469407|NCT02500797|363727563|FG004|Overall Study|Withdrawal by Subject|0|||
105469408|NCT02500797|363727564|FG005|Overall Study|Withdrawal by Subject|0|||
105469409|NCT02500797|363727565|FG006|Overall Study|Withdrawal by Subject|0|||
105469410|NCT02500797|363727566|FG007|Overall Study|Withdrawal by Subject|0|||
105469411|NCT00357006|363727569|FG000|Overall Study|Lost to Follow-up|1|||
105469412|NCT00357006|363727570|FG001|Overall Study|Lost to Follow-up|2|||
105469413|NCT00357006|363727571|FG002|Overall Study|Lost to Follow-up|1|||
105469414|NCT00357006|363727569|FG000|Overall Study|Withdrawal by Subject|1|||
105469415|NCT00357006|363727570|FG001|Overall Study|Withdrawal by Subject|3|||
105469416|NCT00357006|363727571|FG002|Overall Study|Withdrawal by Subject|2|||
105469417|NCT03710161|363727572|FG000|Overall Study|Study halted due to COVID pandemic|3|||
105469418|NCT03710161|363727573|FG001|Overall Study|Study halted due to COVID pandemic|2|||
105685622|NCT00816400|364512790|FG007|Overall Study|In hospice care at the end of the study|0|||
105685623|NCT00816400|364512791|FG008|Overall Study|In hospice care at the end of the study|0|||
105685624|NCT01222507|364512792|FG000|Overall Study|Physician Decision|1|||
105685625|NCT01222507|364512792|FG000|Overall Study|Withdrawal by Subject|1|||
105685626|NCT03057977|364512797|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
105469419|NCT03070964|363727575|FG000|Overall Study|Progressive disease|8|||
105685627|NCT03057977|364512798|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
105469420|NCT03070964|363727575|FG000|Overall Study|Treatment-unrelated adverse event|2|||
105469421|NCT03070964|363727575|FG000|Overall Study|Never treated|1|||
105558355|NCT00530855|364041782|FG000|Overall Study|Lost to Follow-up|9|||
105558356|NCT00530855|364041782|FG000|Overall Study|Other reason for premature termination|17|||
105558357|NCT00626028|364041783|FG000|Overall Study|Adverse Event|1|||
105469422|NCT03070964|363727575|FG000|Overall Study|Physician Decision|1|||
105469423|NCT03070964|363727575|FG000|Overall Study|Withdrawal by Subject|1|||
105469424|NCT03070964|363727575|FG000|Overall Study|Adverse Event|1|||
105469425|NCT02745119|363727577|FG000|Overall Study|Adverse Event|1|||
105469426|NCT02745119|363727578|FG001|Overall Study|Adverse Event|0|||
105469427|NCT02745119|363727579|FG002|Overall Study|Adverse Event|1|||
105469428|NCT02745119|363727580|FG003|Overall Study|Adverse Event|3|||
105469429|NCT02745119|363727577|FG000|Overall Study|Death|3|||
105469430|NCT02745119|363727578|FG001|Overall Study|Death|3|||
105469431|NCT02745119|363727579|FG002|Overall Study|Death|0|||
105469432|NCT02745119|363727580|FG003|Overall Study|Death|4|||
105469433|NCT02745119|363727577|FG000|Overall Study|Lost to Follow-up|0|||
105469434|NCT02745119|363727578|FG001|Overall Study|Lost to Follow-up|0|||
105469435|NCT02745119|363727579|FG002|Overall Study|Lost to Follow-up|0|||
105469436|NCT02745119|363727580|FG003|Overall Study|Lost to Follow-up|1|||
105469437|NCT02745119|363727577|FG000|Overall Study|Protocol Deviation|0|||
105469438|NCT02745119|363727578|FG001|Overall Study|Protocol Deviation|0|||
105469439|NCT02745119|363727579|FG002|Overall Study|Protocol Deviation|0|||
105469440|NCT02745119|363727580|FG003|Overall Study|Protocol Deviation|1|||
105469441|NCT02745119|363727577|FG000|Overall Study|Withdrawal by Subject|7|||
105469442|NCT02745119|363727578|FG001|Overall Study|Withdrawal by Subject|15|||
105469443|NCT02745119|363727579|FG002|Overall Study|Withdrawal by Subject|8|||
105469444|NCT02745119|363727580|FG003|Overall Study|Withdrawal by Subject|14|||
105469445|NCT02745119|363727577|FG000|Overall Study|Study Terminated by Sponsor|134|||
105469446|NCT02745119|363727578|FG001|Overall Study|Study Terminated by Sponsor|252|||
105469447|NCT02745119|363727579|FG002|Overall Study|Study Terminated by Sponsor|135|||
105469448|NCT02745119|363727580|FG003|Overall Study|Study Terminated by Sponsor|251|||
105469449|NCT02745119|363727577|FG000|Overall Study|Physician Decision|0|||
105469450|NCT02745119|363727578|FG001|Overall Study|Physician Decision|2|||
105469451|NCT02745119|363727579|FG002|Overall Study|Physician Decision|2|||
105469452|NCT02745119|363727580|FG003|Overall Study|Physician Decision|2|||
105469453|NCT02745119|363727577|FG000|Overall Study|Reason Not Specified|0|||
105469454|NCT02745119|363727578|FG001|Overall Study|Reason Not Specified|2|||
105469455|NCT02745119|363727579|FG002|Overall Study|Reason Not Specified|0|||
105469456|NCT02745119|363727580|FG003|Overall Study|Reason Not Specified|1|||
105469457|NCT01587924|363727581|FG000|Overall Study|Adverse Event|0|||
105469458|NCT01587924|363727582|FG001|Overall Study|Adverse Event|2|||
105469459|NCT01587924|363727583|FG002|Overall Study|Adverse Event|0|||
105469460|NCT01587924|363727584|FG003|Overall Study|Adverse Event|0|||
105469461|NCT01587924|363727581|FG000|Overall Study|Protocol Violation|2|||
105469462|NCT01587924|363727582|FG001|Overall Study|Protocol Violation|1|||
105469463|NCT01587924|363727583|FG002|Overall Study|Protocol Violation|2|||
105469464|NCT01587924|363727584|FG003|Overall Study|Protocol Violation|1|||
105469465|NCT01587924|363727581|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
105469466|NCT01587924|363727582|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
105469467|NCT01587924|363727583|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
105469468|NCT01587924|363727584|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
105469469|NCT01587924|363727581|FG000|Overall Study|Withdrawal by Subject|0|||
105469470|NCT01587924|363727582|FG001|Overall Study|Withdrawal by Subject|1|||
105469471|NCT01587924|363727583|FG002|Overall Study|Withdrawal by Subject|1|||
105469472|NCT01587924|363727584|FG003|Overall Study|Withdrawal by Subject|0|||
105469473|NCT02157883|363727585|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
105469474|NCT02157883|363727585|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
105469475|NCT02157883|363727585|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
105469476|NCT02157883|363727585|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
105469477|NCT02157883|363727585|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
105469478|NCT01696188|363727587|FG000|Overall Study|Protocol Violation|1|||
105469479|NCT01696188|363727588|FG001|Overall Study|Protocol Violation|1|||
105469480|NCT00432172|363727589|FG000|Overall Study|Physician Decision|0|||
105469481|NCT00432172|363727590|FG001|Overall Study|Physician Decision|0|||
105469482|NCT00432172|363727591|FG002|Overall Study|Physician Decision|2|||
105469483|NCT00432172|363727592|FG003|Overall Study|Physician Decision|0|||
105469484|NCT00432172|363727589|FG000|Overall Study|Adverse Event|4|||
105469485|NCT00432172|363727590|FG001|Overall Study|Adverse Event|2|||
105469486|NCT00432172|363727591|FG002|Overall Study|Adverse Event|4|||
105469487|NCT00432172|363727592|FG003|Overall Study|Adverse Event|3|||
105469488|NCT00432172|363727589|FG000|Overall Study|Disease progression|0|||
105558358|NCT00626028|364041784|FG001|Overall Study|Adverse Event|1|||
105469489|NCT00432172|363727590|FG001|Overall Study|Disease progression|2|||
105469490|NCT00432172|363727591|FG002|Overall Study|Disease progression|5|||
105469491|NCT00432172|363727592|FG003|Overall Study|Disease progression|1|||
105469492|NCT00432172|363727589|FG000|Overall Study|Withdrawal by Subject|0|||
105469493|NCT00432172|363727590|FG001|Overall Study|Withdrawal by Subject|1|||
105469494|NCT00432172|363727591|FG002|Overall Study|Withdrawal by Subject|0|||
105469495|NCT00432172|363727592|FG003|Overall Study|Withdrawal by Subject|2|||
105469496|NCT00432172|363727589|FG000|Overall Study|No treatment received|2|||
105469497|NCT00432172|363727590|FG001|Overall Study|No treatment received|2|||
105558359|NCT00626028|364041783|FG000|Overall Study|Device Failure|0|||
105558360|NCT00626028|364041784|FG001|Overall Study|Device Failure|1|||
105558361|NCT00626028|364041783|FG000|Overall Study|Physician Decision|2|||
105558362|NCT00626028|364041784|FG001|Overall Study|Physician Decision|1|||
105558363|NCT00626028|364041783|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
105558364|NCT00626028|364041784|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
105558365|NCT01970462|364041785|FG000|Overall Study|Lost to Follow-up|0|||
105558366|NCT01970462|364041786|FG001|Overall Study|Lost to Follow-up|2|||
105469498|NCT00432172|363727591|FG002|Overall Study|No treatment received|0|||
105469499|NCT00432172|363727592|FG003|Overall Study|No treatment received|1|||
105469500|NCT02668393|363727593|FG000|Overall Study|Progressive disease|6|||
105469501|NCT02668393|363727594|FG001|Overall Study|Progressive disease|3|||
105469502|NCT02668393|363727593|FG000|Overall Study|Adverse Event|0|||
105469503|NCT02668393|363727594|FG001|Overall Study|Adverse Event|2|||
105469504|NCT02668393|363727593|FG000|Overall Study|Withdrawal from the trial|0|||
105469505|NCT02668393|363727594|FG001|Overall Study|Withdrawal from the trial|1|||
105469506|NCT02668393|363727593|FG000|Overall Study|Lack of benefit and side effects|1|||
105469507|NCT02668393|363727594|FG001|Overall Study|Lack of benefit and side effects|0|||
105469508|NCT03532451|363727603|FG000|Overall Study|Withdrawal by Subject|0|||
105469509|NCT03532451|363727604|FG001|Overall Study|Withdrawal by Subject|1|||
105469510|NCT03532451|363727603|FG000|Overall Study|Did not undergo surgery|1|||
105469511|NCT03532451|363727604|FG001|Overall Study|Did not undergo surgery|1|||
105558367|NCT01292876|364041787|FG000|Overall Study|Physician Decision|4|||
105558368|NCT01627327|364041788|FG000|Overall Study|Adverse Event|6|||
105558369|NCT01627327|364041789|FG001|Overall Study|Adverse Event|12|||
105558370|NCT01627327|364041788|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
105558371|NCT01627327|364041789|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
105469512|NCT02116205|363727605|FG000|Overall Study|Withdrawal by Subject|2|||
105469513|NCT02116205|363727606|FG001|Overall Study|Withdrawal by Subject|4|||
105558372|NCT01627327|364041788|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
105558373|NCT01627327|364041789|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
105558374|NCT01627327|364041788|FG000|Overall Study|Protocol Violation|4|||
105558375|NCT01627327|364041789|FG001|Overall Study|Protocol Violation|10|||
105558376|NCT01627327|364041788|FG000|Overall Study|Lost to Follow-up|1|||
105558377|NCT01627327|364041789|FG001|Overall Study|Lost to Follow-up|3|||
105558378|NCT01627327|364041788|FG000|Overall Study|Physician Decision|1|||
105558379|NCT01627327|364041789|FG001|Overall Study|Physician Decision|0|||
105558380|NCT01627327|364041788|FG000|Overall Study|Withdrawal by Subject|3|||
105558381|NCT01627327|364041789|FG001|Overall Study|Withdrawal by Subject|3|||
105558382|NCT01433354|364041804|FG000|Overall Study|Adverse Event|6|||
105558383|NCT01433354|364041804|FG000|Overall Study|Lost to Follow-up|1|||
105558384|NCT01433354|364041804|FG000|Overall Study|Administrative problems|90|||
105558385|NCT01433354|364041804|FG000|Overall Study|Protocol Violation|2|||
105558386|NCT01433354|364041804|FG000|Overall Study|Lack of Efficacy|17|||
105558387|NCT01433354|364041804|FG000|Overall Study|Subject Withdrew Consent|3|||
105558388|NCT01618162|364041805|FG000|Overall Study|Protocol Violation|13|||
105558389|NCT01618162|364041806|FG001|Overall Study|Protocol Violation|10|||
105558390|NCT01618162|364041805|FG000|Overall Study|Adverse Event|9|||
105558391|NCT01618162|364041806|FG001|Overall Study|Adverse Event|2|||
105558392|NCT01618162|364041805|FG000|Overall Study|Withdrawal Criteria|2|||
105558393|NCT01618162|364041806|FG001|Overall Study|Withdrawal Criteria|10|||
105558394|NCT01618162|364041805|FG000|Overall Study|Unclassified|14|||
105558395|NCT01618162|364041806|FG001|Overall Study|Unclassified|13|||
105558396|NCT01972841|364041811|FG000|Overall Study|Randomized but Never Received Treatment|2|||
105558397|NCT01972841|364041812|FG001|Overall Study|Randomized but Never Received Treatment|5|||
105558398|NCT01972841|364041813|FG002|Overall Study|Randomized but Never Received Treatment|4|||
105558399|NCT01972841|364041814|FG003|Overall Study|Randomized but Never Received Treatment|2|||
105558400|NCT01972841|364041815|FG004|Overall Study|Randomized but Never Received Treatment|6|||
105558401|NCT01972841|364041816|FG005|Overall Study|Randomized but Never Received Treatment|13|||
105558402|NCT01972841|364041811|FG000|Overall Study|Adverse Event|13|||
105558403|NCT01972841|364041812|FG001|Overall Study|Adverse Event|8|||
105469514|NCT02116205|363727607|FG002|Overall Study|Withdrawal by Subject|1|||
105558404|NCT01972841|364041813|FG002|Overall Study|Adverse Event|12|||
105558405|NCT01972841|364041814|FG003|Overall Study|Adverse Event|9|||
105558406|NCT01972841|364041815|FG004|Overall Study|Adverse Event|21|||
105558407|NCT01972841|364041816|FG005|Overall Study|Adverse Event|26|||
105344717|NCT03226678|363263490|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
105469515|NCT02116205|363727608|FG003|Overall Study|Withdrawal by Subject|3|||
105469516|NCT02116205|363727605|FG000|Overall Study|Lost to Follow-up|0|||
105558408|NCT01972841|364041811|FG000|Overall Study|Lack of Efficacy|1|||
105558409|NCT01972841|364041812|FG001|Overall Study|Lack of Efficacy|0|||
105558410|NCT01972841|364041813|FG002|Overall Study|Lack of Efficacy|0|||
105558411|NCT01972841|364041814|FG003|Overall Study|Lack of Efficacy|2|||
105558412|NCT01972841|364041815|FG004|Overall Study|Lack of Efficacy|4|||
105558413|NCT01972841|364041816|FG005|Overall Study|Lack of Efficacy|1|||
105558414|NCT01972841|364041811|FG000|Overall Study|Lost to Follow-up|4|||
105469517|NCT02116205|363727606|FG001|Overall Study|Lost to Follow-up|2|||
105558415|NCT01972841|364041812|FG001|Overall Study|Lost to Follow-up|2|||
105558416|NCT01972841|364041813|FG002|Overall Study|Lost to Follow-up|4|||
105558417|NCT01972841|364041814|FG003|Overall Study|Lost to Follow-up|2|||
105469518|NCT02116205|363727607|FG002|Overall Study|Lost to Follow-up|1|||
105558418|NCT01972841|364041815|FG004|Overall Study|Lost to Follow-up|9|||
105558419|NCT01972841|364041816|FG005|Overall Study|Lost to Follow-up|3|||
105558420|NCT01972841|364041811|FG000|Overall Study|Protocol Violation|2|||
105558421|NCT01972841|364041812|FG001|Overall Study|Protocol Violation|2|||
105558422|NCT01972841|364041813|FG002|Overall Study|Protocol Violation|3|||
105558423|NCT01972841|364041814|FG003|Overall Study|Protocol Violation|5|||
105469519|NCT02116205|363727608|FG003|Overall Study|Lost to Follow-up|2|||
105558424|NCT01972841|364041815|FG004|Overall Study|Protocol Violation|9|||
105558425|NCT01972841|364041816|FG005|Overall Study|Protocol Violation|4|||
105558426|NCT01972841|364041811|FG000|Overall Study|Withdrawal by participants|21|||
105558427|NCT01972841|364041812|FG001|Overall Study|Withdrawal by participants|27|||
105558428|NCT01972841|364041813|FG002|Overall Study|Withdrawal by participants|23|||
105558429|NCT01972841|364041814|FG003|Overall Study|Withdrawal by participants|16|||
105558430|NCT01972841|364041815|FG004|Overall Study|Withdrawal by participants|33|||
105558431|NCT01972841|364041816|FG005|Overall Study|Withdrawal by participants|34|||
105558432|NCT01972841|364041811|FG000|Overall Study|Miscellaneous|0|||
105558433|NCT01972841|364041812|FG001|Overall Study|Miscellaneous|0|||
105558434|NCT01972841|364041813|FG002|Overall Study|Miscellaneous|4|||
105558435|NCT01972841|364041814|FG003|Overall Study|Miscellaneous|1|||
105558436|NCT01972841|364041815|FG004|Overall Study|Miscellaneous|0|||
105558437|NCT01972841|364041816|FG005|Overall Study|Miscellaneous|4|||
105558438|NCT01972841|364041811|FG000|Overall Study|Did not have end of treatment page|0|||
105558439|NCT01972841|364041812|FG001|Overall Study|Did not have end of treatment page|0|||
105558440|NCT01972841|364041813|FG002|Overall Study|Did not have end of treatment page|0|||
105558441|NCT01972841|364041814|FG003|Overall Study|Did not have end of treatment page|0|||
105558442|NCT01972841|364041815|FG004|Overall Study|Did not have end of treatment page|1|||
105558443|NCT01972841|364041816|FG005|Overall Study|Did not have end of treatment page|0|||
105558444|NCT04435366|364041817|FG000|Year 1 (12 Months)|Adverse Event|3|||
105558445|NCT04435366|364041818|FG001|Year 1 (12 Months)|Adverse Event|0|||
105558446|NCT04435366|364041819|FG002|Year 1 (12 Months)|Adverse Event|2|||
105558447|NCT04435366|364041817|FG000|Year 1 (12 Months)|Death|2|||
105558448|NCT04435366|364041818|FG001|Year 1 (12 Months)|Death|0|||
105558449|NCT04435366|364041819|FG002|Year 1 (12 Months)|Death|1|||
105558450|NCT04435366|364041817|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
105558451|NCT04435366|364041818|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
105558452|NCT04435366|364041819|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
105558453|NCT04435366|364041817|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
105558454|NCT04435366|364041818|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
105558455|NCT04435366|364041819|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
105558456|NCT04435366|364041817|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
105558457|NCT04435366|364041818|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
105558458|NCT04435366|364041819|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
105558459|NCT04435366|364041817|FG000|Year 1 (12 Months)|Not treated|0|||
105558460|NCT04435366|364041818|FG001|Year 1 (12 Months)|Not treated|0|||
105558461|NCT04435366|364041819|FG002|Year 1 (12 Months)|Not treated|1|||
105558462|NCT04435366|364041817|FG000|Year 2 (12 Months)|Death|1|||
105558463|NCT04435366|364041818|FG001|Year 2 (12 Months)|Death|4|||
105558464|NCT04435366|364041819|FG002|Year 2 (12 Months)|Death|6|||
105558465|NCT04435366|364041817|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
105558466|NCT04435366|364041818|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
105558467|NCT04435366|364041819|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
105558468|NCT04435366|364041817|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
105558469|NCT04435366|364041818|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
105558470|NCT04435366|364041819|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
105469520|NCT02116205|363727605|FG000|Overall Study|Physician Decision|0|||
105469521|NCT02116205|363727606|FG001|Overall Study|Physician Decision|1|||
105469522|NCT02116205|363727607|FG002|Overall Study|Physician Decision|1|||
105469523|NCT02116205|363727608|FG003|Overall Study|Physician Decision|1|||
105469524|NCT02116205|363727605|FG000|Overall Study|Exclusion criteria|0|||
105558471|NCT04435366|364041817|FG000|Year 2 (12 Months)|Adverse Event|2|||
105558472|NCT04435366|364041818|FG001|Year 2 (12 Months)|Adverse Event|1|||
105558473|NCT04435366|364041819|FG002|Year 2 (12 Months)|Adverse Event|6|||
105558474|NCT02192502|364041824|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
105558475|NCT02192502|364041825|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
105558476|NCT02192502|364041824|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
105558477|NCT02192502|364041825|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
105469525|NCT02116205|363727606|FG001|Overall Study|Exclusion criteria|0|||
105469526|NCT02116205|363727607|FG002|Overall Study|Exclusion criteria|1|||
105558478|NCT02192502|364041824|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
105558479|NCT02192502|364041825|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
105558480|NCT01270347|364041826|FG000|Core Phase|Adverse Event|1|||
105558481|NCT01270347|364041827|FG001|Core Phase|Adverse Event|6|||
105558482|NCT01270347|364041826|FG000|Core Phase|Withdrawal by Subject|1|||
105558483|NCT01270347|364041827|FG001|Core Phase|Withdrawal by Subject|2|||
105558484|NCT01270347|364041826|FG000|Core Phase|Lost to Follow-up|0|||
105558485|NCT01270347|364041827|FG001|Core Phase|Lost to Follow-up|1|||
105558486|NCT01270347|364041826|FG000|Core Phase|Miscellaneous|8|||
105558487|NCT01270347|364041827|FG001|Core Phase|Miscellaneous|14|||
105558488|NCT01270347|364041826|FG000|Extension Phase|Adverse Event|1|||
105558489|NCT01270347|364041827|FG001|Extension Phase|Adverse Event|3|||
105558490|NCT01270347|364041826|FG000|Extension Phase|Withdrawal by Subject|3|||
105558491|NCT01270347|364041827|FG001|Extension Phase|Withdrawal by Subject|4|||
105558492|NCT01270347|364041826|FG000|Extension Phase|Miscellaneous|2|||
105558493|NCT01270347|364041827|FG001|Extension Phase|Miscellaneous|2|||
105558494|NCT03624504|364041831|FG000|Overall Study|Unsuccessful Implant|1|||
105558495|NCT02862457|364041832|FG000|Overall Study|Death|1|||
105558496|NCT02862457|364041833|FG001|Overall Study|Death|3|||
105558497|NCT02862457|364041834|FG002|Overall Study|Death|2|||
105558498|NCT02862457|364041835|FG003|Overall Study|Death|3|||
105558499|NCT02862457|364041836|FG004|Overall Study|Death|0|||
105558500|NCT02862457|364041837|FG005|Overall Study|Death|2|||
105558501|NCT02862457|364041838|FG006|Overall Study|Death|1|||
105558502|NCT02862457|364041832|FG000|Overall Study|Lost to Follow-up|1|||
105558503|NCT02862457|364041833|FG001|Overall Study|Lost to Follow-up|0|||
105558504|NCT02862457|364041834|FG002|Overall Study|Lost to Follow-up|0|||
105558505|NCT02862457|364041835|FG003|Overall Study|Lost to Follow-up|1|||
105558506|NCT02862457|364041836|FG004|Overall Study|Lost to Follow-up|0|||
105558507|NCT02862457|364041837|FG005|Overall Study|Lost to Follow-up|0|||
105558508|NCT02862457|364041838|FG006|Overall Study|Lost to Follow-up|0|||
105558509|NCT02862457|364041832|FG000|Overall Study|Withdrawal by Subject|0|||
105558510|NCT02862457|364041833|FG001|Overall Study|Withdrawal by Subject|0|||
105558511|NCT02862457|364041834|FG002|Overall Study|Withdrawal by Subject|1|||
105558512|NCT02862457|364041835|FG003|Overall Study|Withdrawal by Subject|0|||
105558513|NCT02862457|364041836|FG004|Overall Study|Withdrawal by Subject|0|||
105558514|NCT02862457|364041837|FG005|Overall Study|Withdrawal by Subject|1|||
105558515|NCT02862457|364041838|FG006|Overall Study|Withdrawal by Subject|0|||
105558516|NCT01388816|364041839|FG000|Overall Study|Adverse Event|0|||
105558517|NCT01388816|364041840|FG001|Overall Study|Adverse Event|2|||
105558518|NCT01388816|364041841|FG002|Overall Study|Adverse Event|0|||
105558519|NCT01388816|364041842|FG003|Overall Study|Adverse Event|0|||
105558520|NCT01388816|364041839|FG000|Overall Study|Lost to Follow-up|0|||
105558521|NCT01388816|364041840|FG001|Overall Study|Lost to Follow-up|1|||
105558522|NCT01388816|364041841|FG002|Overall Study|Lost to Follow-up|0|||
105558523|NCT01388816|364041842|FG003|Overall Study|Lost to Follow-up|0|||
105558524|NCT01388816|364041839|FG000|Overall Study|Withdrawal by Subject|2|||
105558525|NCT01388816|364041840|FG001|Overall Study|Withdrawal by Subject|1|||
105558526|NCT01388816|364041841|FG002|Overall Study|Withdrawal by Subject|1|||
105558527|NCT01388816|364041842|FG003|Overall Study|Withdrawal by Subject|0|||
105558528|NCT01388816|364041839|FG000|Overall Study|Protocol Violation|0|||
105558529|NCT01388816|364041840|FG001|Overall Study|Protocol Violation|0|||
105558530|NCT01388816|364041841|FG002|Overall Study|Protocol Violation|2|||
105558531|NCT01388816|364041842|FG003|Overall Study|Protocol Violation|0|||
105558532|NCT03206203|364041843|FG000|Treatment|Death|38|||
105558533|NCT03206203|364041844|FG001|Treatment|Death|26|||
105558534|NCT03206203|364041845|FG002|Treatment|Death|0|||
105558535|NCT03206203|364041843|FG000|Treatment|Withdrawal by Subject|1|||
105558536|NCT03206203|364041844|FG001|Treatment|Withdrawal by Subject|0|||
105786560|NCT01945034|364872826|FG002|Overall Study|Withdrawal by Subject|1|||
105786561|NCT01945034|364872824|FG000|Overall Study|Other|0|||
105558537|NCT03206203|364041845|FG002|Treatment|Withdrawal by Subject|0|||
105558538|NCT03206203|364041843|FG000|Treatment|Lost to Follow-up|4|||
105786562|NCT01945034|364872825|FG001|Overall Study|Other|1|||
105786563|NCT01945034|364872826|FG002|Overall Study|Other|3|||
105786564|NCT01945034|364872824|FG000|Overall Study|Lost to Follow-up|0|||
105786565|NCT01945034|364872825|FG001|Overall Study|Lost to Follow-up|0|||
105786566|NCT01945034|364872826|FG002|Overall Study|Lost to Follow-up|2|||
105786567|NCT01945034|364872824|FG000|Overall Study|Protocol Violation|1|||
105786568|NCT01945034|364872825|FG001|Overall Study|Protocol Violation|0|||
105786569|NCT01945034|364872826|FG002|Overall Study|Protocol Violation|1|||
105558539|NCT03206203|364041844|FG001|Treatment|Lost to Follow-up|0|||
105558540|NCT03206203|364041845|FG002|Treatment|Lost to Follow-up|0|||
105558541|NCT03206203|364041843|FG000|Treatment|N/A in Follow-Up|8|||
105786570|NCT03053102|364872827|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
105786571|NCT03053102|364872827|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
105558542|NCT03206203|364041844|FG001|Treatment|N/A in Follow-Up|1|||
105558543|NCT03206203|364041845|FG002|Treatment|N/A in Follow-Up|0|||
105558544|NCT03206203|364041843|FG000|Treatment|Disease progression|0|||
105558545|NCT03206203|364041844|FG001|Treatment|Disease progression|1|||
105558546|NCT03206203|364041845|FG002|Treatment|Disease progression|0|||
105558547|NCT03206203|364041843|FG000|Treatment|Refused follow-up|0|||
105558548|NCT03206203|364041844|FG001|Treatment|Refused follow-up|1|||
105469527|NCT02116205|363727608|FG003|Overall Study|Exclusion criteria|0|||
105469528|NCT01987453|363729435|FG000|Overall Study|Death|0|||
105469529|NCT01987453|363729436|FG001|Overall Study|Death|0|||
105469530|NCT01987453|363729437|FG002|Overall Study|Death|1|||
105469531|NCT01987453|363729435|FG000|Overall Study|Lack of Efficacy|1|||
105469532|NCT01987453|363729436|FG001|Overall Study|Lack of Efficacy|12|||
105469533|NCT01987453|363729437|FG002|Overall Study|Lack of Efficacy|0|||
105469534|NCT02904954|363729442|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
105469535|NCT02904954|363729443|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
105469536|NCT02904954|363729442|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
105469537|NCT02904954|363729443|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
105469538|NCT02904954|363729442|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
105469539|NCT02904954|363729443|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
105469540|NCT02904954|363729442|FG000|Adjuvant Durvalumab|Recurrence|2|||
105469541|NCT02904954|363729443|FG001|Adjuvant Durvalumab|Recurrence|0|||
105558549|NCT03206203|364041845|FG002|Treatment|Refused follow-up|0|||
105558550|NCT03206203|364041843|FG000|Treatment|Cross over to Arm 1|0|||
105558551|NCT03206203|364041844|FG001|Treatment|Cross over to Arm 1|19|||
105558552|NCT03206203|364041845|FG002|Treatment|Cross over to Arm 1|0|||
105558553|NCT03206203|364041843|FG000|Optional Cross-Over|Death|0|||
105558554|NCT03206203|364041844|FG001|Optional Cross-Over|Death|0|||
105558555|NCT03206203|364041845|FG002|Optional Cross-Over|Death|14|||
105558556|NCT03206203|364041843|FG000|Optional Cross-Over|Refused follow-up|0|||
105558557|NCT03206203|364041844|FG001|Optional Cross-Over|Refused follow-up|0|||
105558558|NCT03206203|364041845|FG002|Optional Cross-Over|Refused follow-up|2|||
105558559|NCT01483924|364041846|FG000|Overall Study|Withdrawal by Subject|2|||
105558560|NCT01483924|364041847|FG001|Overall Study|Withdrawal by Subject|0|||
105558561|NCT01483924|364041848|FG002|Overall Study|Withdrawal by Subject|0|||
105558562|NCT01483924|364041849|FG003|Overall Study|Withdrawal by Subject|1|||
105558563|NCT01483924|364041850|FG004|Overall Study|Withdrawal by Subject|1|||
105558564|NCT01483924|364041846|FG000|Overall Study|Adverse Event|0|||
105558565|NCT01483924|364041847|FG001|Overall Study|Adverse Event|0|||
105558566|NCT01483924|364041848|FG002|Overall Study|Adverse Event|1|||
105558567|NCT01483924|364041849|FG003|Overall Study|Adverse Event|1|||
105558568|NCT01483924|364041850|FG004|Overall Study|Adverse Event|0|||
105469542|NCT02904954|363729442|FG000|Adjuvant Durvalumab|Adverse Event|2|||
105558569|NCT01483924|364041846|FG000|Overall Study|Non-compliance|0|||
105558570|NCT01483924|364041847|FG001|Overall Study|Non-compliance|0|||
105558571|NCT01483924|364041848|FG002|Overall Study|Non-compliance|0|||
105558572|NCT01483924|364041849|FG003|Overall Study|Non-compliance|1|||
105558573|NCT01483924|364041850|FG004|Overall Study|Non-compliance|1|||
105558574|NCT01483924|364041846|FG000|Overall Study|Sponsor concern over ECG result|0|||
105558575|NCT01483924|364041847|FG001|Overall Study|Sponsor concern over ECG result|0|||
105558576|NCT01483924|364041848|FG002|Overall Study|Sponsor concern over ECG result|0|||
105558577|NCT01483924|364041849|FG003|Overall Study|Sponsor concern over ECG result|1|||
105558578|NCT01483924|364041850|FG004|Overall Study|Sponsor concern over ECG result|0|||
105685628|NCT03057977|364512797|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
105685629|NCT03057977|364512798|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
105685630|NCT03057977|364512797|FG000|Discontinuation From Treatment|Protocol Violation|6|||
105685631|NCT03057977|364512798|FG001|Discontinuation From Treatment|Protocol Violation|5|||
105685632|NCT03057977|364512797|FG000|Discontinuation From Treatment|Not treated|4|||
105685633|NCT03057977|364512798|FG001|Discontinuation From Treatment|Not treated|0|||
105685634|NCT03057977|364512797|FG000|Discontinuation From Treatment|Adverse Event|343|||
105685635|NCT03057977|364512798|FG001|Discontinuation From Treatment|Adverse Event|337|||
105685636|NCT03057977|364512797|FG000|Discontinuation From Treatment|Reason Unknown|0|||
105685637|NCT03057977|364512798|FG001|Discontinuation From Treatment|Reason Unknown|1|||
105685638|NCT03057977|364512797|FG000|Discontinuation From Treatment|Personal Reasons|1|||
105685639|NCT03057977|364512798|FG001|Discontinuation From Treatment|Personal Reasons|1|||
105685640|NCT03057977|364512797|FG000|Discontinuation From Treatment|Unblinded medication|1|||
105685641|NCT03057977|364512798|FG001|Discontinuation From Treatment|Unblinded medication|0|||
105685642|NCT03057977|364512797|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
105469543|NCT02904954|363729443|FG001|Adjuvant Durvalumab|Adverse Event|6|||
105558579|NCT03565887|364041854|FG000|Overall Study|Adverse Event|1|||
105558580|NCT03565887|364041855|FG001|Overall Study|Adverse Event|0|||
105558581|NCT03565887|364041854|FG000|Overall Study|Withdrawal by Subject|0|||
105558582|NCT03565887|364041855|FG001|Overall Study|Withdrawal by Subject|2|||
105558583|NCT03182868|364041858|FG000|Overall Study|Protocol Violation|3|||
105558584|NCT03182868|364041859|FG001|Overall Study|Protocol Violation|0|||
105558585|NCT03182868|364041860|FG002|Overall Study|Protocol Violation|4|||
105558586|NCT03182868|364041861|FG003|Overall Study|Protocol Violation|1|||
105685643|NCT03057977|364512798|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
105558587|NCT03182868|364041862|FG004|Overall Study|Protocol Violation|8|||
105469544|NCT02904954|363729442|FG000|Adjuvant Durvalumab|Participant wishes|12|||
105469545|NCT02904954|363729443|FG001|Adjuvant Durvalumab|Participant wishes|7|||
105469546|NCT02904954|363729442|FG000|Adjuvant Durvalumab|Physician Decision|2|||
105469547|NCT02904954|363729443|FG001|Adjuvant Durvalumab|Physician Decision|1|||
105469548|NCT02904954|363729442|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
105469549|NCT02904954|363729443|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
105469550|NCT02904954|363729442|FG000|Adjuvant Durvalumab|Death|0|||
105469551|NCT02904954|363729443|FG001|Adjuvant Durvalumab|Death|1|||
105469552|NCT02904954|363729442|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
105469553|NCT02904954|363729443|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
105469554|NCT03252925|363729448|FG000|Overall Study|Withdrawal by Subject|1|||
105469555|NCT03252925|363729449|FG001|Overall Study|Withdrawal by Subject|0|||
105469556|NCT03252925|363729448|FG000|Overall Study|Protocol Violation|6|||
105469557|NCT03252925|363729449|FG001|Overall Study|Protocol Violation|0|||
105469558|NCT03252925|363729448|FG000|Overall Study|Adverse Event|1|||
105469559|NCT03252925|363729449|FG001|Overall Study|Adverse Event|0|||
105469560|NCT03252925|363729448|FG000|Overall Study|Lost to Follow-up|6|||
105469561|NCT03252925|363729449|FG001|Overall Study|Lost to Follow-up|6|||
105469562|NCT03038880|363729450|FG000|Overall Study|Death|1|||
105469563|NCT03038880|363729451|FG001|Overall Study|Death|2|||
105469564|NCT03038880|363729452|FG002|Overall Study|Death|0|||
105469565|NCT03038880|363729450|FG000|Overall Study|Physician Decision|2|||
105469566|NCT03038880|363729451|FG001|Overall Study|Physician Decision|1|||
105469567|NCT03038880|363729452|FG002|Overall Study|Physician Decision|0|||
105469568|NCT01358721|363729457|FG000|Overall Study|Withdrawal by Subject|0|||
105469569|NCT01358721|363729458|FG001|Overall Study|Withdrawal by Subject|0|||
105469570|NCT01358721|363729459|FG002|Overall Study|Withdrawal by Subject|0|||
105469571|NCT01358721|363729460|FG003|Overall Study|Withdrawal by Subject|1|||
105469572|NCT01358721|363729457|FG000|Overall Study|Death|0|||
105469573|NCT01358721|363729458|FG001|Overall Study|Death|2|||
105469574|NCT01358721|363729459|FG002|Overall Study|Death|0|||
105469575|NCT01358721|363729460|FG003|Overall Study|Death|0|||
105469576|NCT01358721|363729457|FG000|Overall Study|Study Drug Toxicity|1|||
105469577|NCT01358721|363729458|FG001|Overall Study|Study Drug Toxicity|3|||
105469578|NCT01358721|363729459|FG002|Overall Study|Study Drug Toxicity|4|||
105469579|NCT01358721|363729460|FG003|Overall Study|Study Drug Toxicity|5|||
105469580|NCT01358721|363729457|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
105469581|NCT01358721|363729458|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
105469582|NCT01358721|363729459|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
105469583|NCT01358721|363729460|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
105469584|NCT01358721|363729457|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
105469585|NCT01358721|363729458|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
105469586|NCT01358721|363729459|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
105469587|NCT01358721|363729460|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
105469588|NCT01358721|363729457|FG000|Overall Study|Adverse Event related to study drug|1|||
105469589|NCT01358721|363729458|FG001|Overall Study|Adverse Event related to study drug|0|||
105469590|NCT01358721|363729459|FG002|Overall Study|Adverse Event related to study drug|0|||
105469591|NCT01358721|363729460|FG003|Overall Study|Adverse Event related to study drug|1|||
105469592|NCT01358721|363729457|FG000|Overall Study|Disease Progression|19|||
105469593|NCT01358721|363729458|FG001|Overall Study|Disease Progression|15|||
105469594|NCT01358721|363729459|FG002|Overall Study|Disease Progression|17|||
105469595|NCT01358721|363729460|FG003|Overall Study|Disease Progression|15|||
105469596|NCT01358721|363729457|FG000|Overall Study|Out of State/Unmet Criteria|0|||
105469597|NCT01358721|363729458|FG001|Overall Study|Out of State/Unmet Criteria|0|||
105469598|NCT01358721|363729459|FG002|Overall Study|Out of State/Unmet Criteria|1|||
105469599|NCT01358721|363729460|FG003|Overall Study|Out of State/Unmet Criteria|0|||
105469600|NCT00790088|363729461|FG000|Overall Study|Protocol Violation|11|||
105469601|NCT00790088|363729461|FG000|Overall Study|Withdrawal by Subject|17|||
105469602|NCT00790088|363729461|FG000|Overall Study|Lost to Follow-up|7|||
105469603|NCT00790088|363729461|FG000|Overall Study|Physician Decision|4|||
105469604|NCT02863419|363729464|FG000|Overall Study|Lost to Follow-up|0|||
105469605|NCT02863419|363729465|FG001|Overall Study|Lost to Follow-up|1|||
105469606|NCT02863419|363729466|FG002|Overall Study|Lost to Follow-up|4|||
105469607|NCT02863419|363729464|FG000|Overall Study|Withdrawal by Subject|5|||
105469608|NCT02863419|363729465|FG001|Overall Study|Withdrawal by Subject|5|||
105469609|NCT02863419|363729466|FG002|Overall Study|Withdrawal by Subject|3|||
105469610|NCT02863419|363729464|FG000|Overall Study|Died|3|||
105469611|NCT02863419|363729465|FG001|Overall Study|Died|4|||
105469612|NCT02863419|363729466|FG002|Overall Study|Died|1|||
105469613|NCT03682770|363729467|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
105469614|NCT03682770|363729468|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
105469615|NCT03682770|363729469|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
105469616|NCT03682770|363729470|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
105469617|NCT03682770|363729471|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
105469618|NCT03682770|363729472|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
105469619|NCT03682770|363729473|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
105469620|NCT03682770|363729467|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
105469621|NCT03682770|363729468|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
105469622|NCT03682770|363729469|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
105469623|NCT03682770|363729470|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
105469624|NCT03682770|363729471|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
105469625|NCT03682770|363729472|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
105469626|NCT03682770|363729473|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
105469627|NCT03682770|363729467|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
105469628|NCT03682770|363729468|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
105469629|NCT03682770|363729469|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
105469630|NCT03682770|363729470|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
105469631|NCT03682770|363729471|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
105469632|NCT03682770|363729472|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
105469633|NCT03682770|363729473|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
105469634|NCT03682770|363729467|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
105469635|NCT03682770|363729468|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
105469636|NCT03682770|363729469|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
105469637|NCT03682770|363729470|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
105469638|NCT03682770|363729471|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
105469639|NCT03682770|363729472|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
105469640|NCT03682770|363729473|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
105469641|NCT03682770|363729467|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
105469642|NCT03682770|363729468|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
105469643|NCT03682770|363729469|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
105469644|NCT03682770|363729470|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
105558588|NCT01596582|364041864|FG000|Overall Study|Deemed ineligible after study visit|3|||
105558589|NCT01596582|364041865|FG001|Overall Study|Deemed ineligible after study visit|6|||
105685644|NCT03057977|364512797|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
105685645|NCT03057977|364512798|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
105685646|NCT03057977|364512797|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
105685647|NCT03057977|364512798|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
105685648|NCT03057977|364512797|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
105685649|NCT03057977|364512798|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
105685650|NCT03057977|364512797|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
105685651|NCT03057977|364512798|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
105685652|NCT03057977|364512797|FG000|Discontinuation From Treatment|Not attending study visit|3|||
105685653|NCT03057977|364512798|FG001|Discontinuation From Treatment|Not attending study visit|10|||
105685654|NCT03057977|364512797|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
105685655|NCT03057977|364512798|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
105685656|NCT03057977|364512797|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
105685657|NCT03057977|364512798|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
105685658|NCT03057977|364512797|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
105685659|NCT03057977|364512798|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
105685660|NCT03057977|364512797|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
105685661|NCT03057977|364512798|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
105685662|NCT03057977|364512797|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
105685663|NCT03057977|364512798|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
105685664|NCT01650246|364512801|FG000|Overall Study|Adverse Event|23|||
105685665|NCT01650246|364512801|FG000|Overall Study|Protocol Violation|5|||
105685666|NCT01650246|364512801|FG000|Overall Study|Sponsor terminated study|53|||
105685667|NCT01650246|364512801|FG000|Overall Study|Lost to Follow-up|5|||
105685668|NCT01650246|364512801|FG000|Overall Study|Withdrawal by Subject|26|||
105685669|NCT01650246|364512801|FG000|Overall Study|Death|1|||
105685670|NCT01650246|364512801|FG000|Overall Study|Lack of Efficacy|30|||
105685671|NCT00953407|364512802|FG000|Overall Study|Failed inclusion criteria|1|||
105685672|NCT00953407|364512803|FG001|Overall Study|Failed inclusion criteria|1|||
105685673|NCT00953407|364512804|FG002|Overall Study|Failed inclusion criteria|1|||
105685674|NCT00953407|364512805|FG003|Overall Study|Failed inclusion criteria|1|||
105685675|NCT00953407|364512806|FG004|Overall Study|Failed inclusion criteria|1|||
105685676|NCT00953407|364512802|FG000|Overall Study|Lost to Follow-up|0|||
105685677|NCT00953407|364512803|FG001|Overall Study|Lost to Follow-up|0|||
105685678|NCT00953407|364512804|FG002|Overall Study|Lost to Follow-up|0|||
105685679|NCT00953407|364512805|FG003|Overall Study|Lost to Follow-up|1|||
105685680|NCT00953407|364512806|FG004|Overall Study|Lost to Follow-up|0|||
105685681|NCT00288509|364512823|FG000|Treatment Cycle 1|Adverse Event|1|||
105685682|NCT00288509|364512823|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
105685683|NCT00288509|364512823|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
105469645|NCT03682770|363729471|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
105469646|NCT03682770|363729472|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
105469647|NCT03682770|363729473|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
105469648|NCT03682770|363729467|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
105469649|NCT03682770|363729468|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
105469650|NCT03682770|363729469|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
105469651|NCT03682770|363729470|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
105469652|NCT03682770|363729471|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
105469653|NCT03682770|363729472|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
105469654|NCT03682770|363729473|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
105469655|NCT03682770|363729467|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
105469656|NCT03682770|363729468|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
105469657|NCT03682770|363729469|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
105469658|NCT03682770|363729470|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
105469659|NCT03682770|363729471|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
105469660|NCT03682770|363729472|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
105469661|NCT03682770|363729473|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
105469662|NCT03682770|363729467|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
105469663|NCT03682770|363729468|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
105469664|NCT03682770|363729469|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
105469665|NCT03682770|363729470|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
105469666|NCT03682770|363729471|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
105469667|NCT03682770|363729472|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
105469668|NCT03682770|363729473|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
105469669|NCT03682770|363729467|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
105469670|NCT03682770|363729468|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
105469671|NCT03682770|363729469|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
105469672|NCT03682770|363729470|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
105469673|NCT03682770|363729471|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
105469674|NCT03682770|363729472|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
105469675|NCT03682770|363729473|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
105469676|NCT03682770|363729467|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
105469677|NCT03682770|363729468|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
105469678|NCT03682770|363729469|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
105469679|NCT03682770|363729470|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
105469680|NCT03682770|363729471|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
105469681|NCT03682770|363729472|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
105469682|NCT03682770|363729473|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
105469683|NCT03682770|363729467|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
105469684|NCT03682770|363729468|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
105469685|NCT03682770|363729469|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
105469686|NCT03682770|363729470|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
105469687|NCT03682770|363729471|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
105469688|NCT03682770|363729472|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
105469689|NCT03682770|363729473|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
105469690|NCT03682770|363729467|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
105469691|NCT03682770|363729468|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
105469692|NCT03682770|363729469|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
105469693|NCT03682770|363729470|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
105469694|NCT03682770|363729471|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
105469695|NCT03682770|363729472|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
105469696|NCT03682770|363729473|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
105469697|NCT04085289|363729474|FG000|Overall Study|Withdrawal by Subject|0|||
105469698|NCT04085289|363729475|FG001|Overall Study|Withdrawal by Subject|0|||
105469699|NCT04085289|363729476|FG002|Overall Study|Withdrawal by Subject|1|||
105469700|NCT01216189|363729488|FG000|Overall Study|Lost to Follow-up|21|||
105469701|NCT01216189|363729489|FG001|Overall Study|Lost to Follow-up|3|||
105469702|NCT01216189|363729488|FG000|Overall Study|Death|4|||
105469703|NCT01216189|363729489|FG001|Overall Study|Death|2|||
105469704|NCT01301027|363729492|FG000|Overall Study|Physician Decision|2|||
105469705|NCT01301027|363729493|FG001|Overall Study|Physician Decision|0|||
105469706|NCT01301027|363729492|FG000|Overall Study|Withdrawal by Subject|2|||
105469707|NCT01301027|363729493|FG001|Overall Study|Withdrawal by Subject|3|||
105469708|NCT01301027|363729492|FG000|Overall Study|Adverse Event|0|||
105558590|NCT01596582|364041864|FG000|Overall Study|Missing all outcome data|1|||
105558591|NCT01596582|364041865|FG001|Overall Study|Missing all outcome data|1|||
105558592|NCT01967732|364041866|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
105558593|NCT01967732|364041867|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
105469709|NCT01301027|363729493|FG001|Overall Study|Adverse Event|2|||
105469710|NCT01301027|363729492|FG000|Overall Study|Fracture|1|||
105558594|NCT01967732|364041868|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
105685684|NCT00288509|364512823|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
105685685|NCT00288509|364512823|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
105469711|NCT01301027|363729493|FG001|Overall Study|Fracture|3|||
105469712|NCT01301027|363729492|FG000|Overall Study|Transplant|0|||
105469713|NCT01301027|363729493|FG001|Overall Study|Transplant|2|||
105469714|NCT01301027|363729492|FG000|Overall Study|Volume Overload|3|||
105469715|NCT01301027|363729493|FG001|Overall Study|Volume Overload|0|||
105469716|NCT00541385|363729494|FG000|Overall Study|Adverse Event|6|||
105469717|NCT00541385|363729495|FG001|Overall Study|Adverse Event|3|||
105469718|NCT00541385|363729494|FG000|Overall Study|Withdrawal by Subject|2|||
105469719|NCT00541385|363729495|FG001|Overall Study|Withdrawal by Subject|2|||
105469720|NCT00541385|363729494|FG000|Overall Study|Lost to Follow-up|6|||
105469721|NCT00541385|363729495|FG001|Overall Study|Lost to Follow-up|1|||
105469722|NCT00541385|363729494|FG000|Overall Study|Parasite reappearance/malaria|67|||
105469723|NCT00541385|363729495|FG001|Overall Study|Parasite reappearance/malaria|32|||
105469724|NCT01469377|363729496|FG000|Overall Study|Protocol Deviation|7|||
105469725|NCT01469377|363729497|FG001|Overall Study|Protocol Deviation|10|||
105469726|NCT01469377|363729498|FG002|Overall Study|Protocol Deviation|10|||
105469727|NCT01469377|363729496|FG000|Overall Study|Lost to Follow-up|3|||
105469728|NCT01469377|363729497|FG001|Overall Study|Lost to Follow-up|2|||
105469729|NCT01469377|363729498|FG002|Overall Study|Lost to Follow-up|5|||
105469730|NCT01469377|363729496|FG000|Overall Study|Withdrawal of Consent|12|||
105469731|NCT01469377|363729497|FG001|Overall Study|Withdrawal of Consent|14|||
105469732|NCT01469377|363729498|FG002|Overall Study|Withdrawal of Consent|15|||
105469733|NCT01469377|363729496|FG000|Overall Study|Adverse Event|8|||
105469734|NCT01469377|363729497|FG001|Overall Study|Adverse Event|18|||
105469735|NCT01469377|363729498|FG002|Overall Study|Adverse Event|36|||
105469736|NCT01469377|363729496|FG000|Overall Study|Insufficient Therapeutic Response|3|||
105469737|NCT01469377|363729497|FG001|Overall Study|Insufficient Therapeutic Response|4|||
105469738|NCT01469377|363729498|FG002|Overall Study|Insufficient Therapeutic Response|0|||
105469739|NCT01469377|363729496|FG000|Overall Study|Other Miscellaneous Reasons|2|||
105469740|NCT01469377|363729497|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105469741|NCT01469377|363729498|FG002|Overall Study|Other Miscellaneous Reasons|0|||
105469742|NCT03566485|363729499|FG000|Overall Study|Disease progression|5|||
105469743|NCT03566485|363729500|FG001|Overall Study|Disease progression|4|||
105469744|NCT03566485|363729499|FG000|Overall Study|Clinical progression|0|||
105469745|NCT03566485|363729500|FG001|Overall Study|Clinical progression|1|||
105469746|NCT03566485|363729499|FG000|Overall Study|Toxicity|0|||
105469747|NCT03566485|363729500|FG001|Overall Study|Toxicity|2|||
105469748|NCT04269889|363729503|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
105558595|NCT01967732|364041869|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
105685686|NCT00288509|364512823|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
105685687|NCT00288509|364512823|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
105685688|NCT00288509|364512823|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
105685689|NCT00288509|364512823|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
105685690|NCT00288509|364512823|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
105685691|NCT00288509|364512823|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
105685692|NCT00288509|364512823|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
105685693|NCT00288509|364512823|FG000|Treatment Cycle 4|Physician Decision|4|||
105685694|NCT00288509|364512823|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
105685695|NCT02336178|364512830|FG000|Overall Study|Lost to Follow-up|1|||
105685696|NCT02336178|364512830|FG000|Overall Study|Protocol Violation|1|||
105685697|NCT02336178|364512830|FG000|Overall Study|Withdrawal by Subject|1|||
105685698|NCT02336178|364512830|FG000|Overall Study|Other|1|||
105685699|NCT03310268|364512833|FG000|Overall Study|(Not specified)|1|||
105685700|NCT03310268|364512834|FG001|Overall Study|(Not specified)|5|||
105685701|NCT03310268|364512835|FG002|Overall Study|(Not specified)|0|||
105685702|NCT02986334|364512836|FG000|Overall Study|Withdrawal by Subject|0|||
105469749|NCT01354314|363729508|FG000|Overall Study|Lost to Follow-up|1|||
105469750|NCT01354314|363729509|FG001|Overall Study|Lost to Follow-up|0|||
105685703|NCT02986334|364512837|FG001|Overall Study|Withdrawal by Subject|1|||
105685704|NCT02986334|364512838|FG002|Overall Study|Withdrawal by Subject|2|||
105685705|NCT02986334|364512836|FG000|Overall Study|Lost to Follow-up|1|||
105469751|NCT01354314|363729510|FG002|Overall Study|Lost to Follow-up|1|||
105469752|NCT01354314|363729511|FG003|Overall Study|Lost to Follow-up|1|||
105469753|NCT01354314|363729508|FG000|Overall Study|Withdrawal by Subject|0|||
105469754|NCT01354314|363729509|FG001|Overall Study|Withdrawal by Subject|0|||
105469755|NCT01354314|363729510|FG002|Overall Study|Withdrawal by Subject|1|||
105469756|NCT01354314|363729511|FG003|Overall Study|Withdrawal by Subject|0|||
105469757|NCT01354314|363729508|FG000|Overall Study|Adverse Event|0|||
105469758|NCT01354314|363729509|FG001|Overall Study|Adverse Event|0|||
105685706|NCT02986334|364512837|FG001|Overall Study|Lost to Follow-up|2|||
105469759|NCT01354314|363729510|FG002|Overall Study|Adverse Event|0|||
105469760|NCT01354314|363729511|FG003|Overall Study|Adverse Event|1|||
105469761|NCT01354314|363729508|FG000|Overall Study|Protocol Violation|1|||
105469762|NCT01354314|363729509|FG001|Overall Study|Protocol Violation|1|||
105469763|NCT01354314|363729510|FG002|Overall Study|Protocol Violation|0|||
105469764|NCT01354314|363729511|FG003|Overall Study|Protocol Violation|0|||
105469765|NCT01354314|363729508|FG000|Overall Study|Less than 90% Adherence|4|||
105469766|NCT01354314|363729509|FG001|Overall Study|Less than 90% Adherence|2|||
105469767|NCT01354314|363729510|FG002|Overall Study|Less than 90% Adherence|6|||
105469768|NCT01354314|363729511|FG003|Overall Study|Less than 90% Adherence|4|||
105469769|NCT00478023|363729513|FG000|Overall Study|Adverse Event|11|||
105469770|NCT00478023|363729514|FG001|Overall Study|Adverse Event|7|||
105469771|NCT00478023|363729515|FG002|Overall Study|Adverse Event|8|||
105469772|NCT00478023|363729516|FG003|Overall Study|Adverse Event|14|||
105469773|NCT00478023|363729517|FG004|Overall Study|Adverse Event|6|||
105469774|NCT00478023|363729513|FG000|Overall Study|Death|1|||
105469775|NCT00478023|363729514|FG001|Overall Study|Death|0|||
105469776|NCT00478023|363729515|FG002|Overall Study|Death|0|||
105469777|NCT00478023|363729516|FG003|Overall Study|Death|0|||
105469778|NCT00478023|363729517|FG004|Overall Study|Death|0|||
105469779|NCT00478023|363729513|FG000|Overall Study|Lack of Efficacy|11|||
105469780|NCT00478023|363729514|FG001|Overall Study|Lack of Efficacy|10|||
105469781|NCT00478023|363729515|FG002|Overall Study|Lack of Efficacy|4|||
105469782|NCT00478023|363729516|FG003|Overall Study|Lack of Efficacy|5|||
105469783|NCT00478023|363729517|FG004|Overall Study|Lack of Efficacy|41|||
105469784|NCT00478023|363729513|FG000|Overall Study|Lost to Follow-up|3|||
105469785|NCT00478023|363729514|FG001|Overall Study|Lost to Follow-up|1|||
105469786|NCT00478023|363729515|FG002|Overall Study|Lost to Follow-up|1|||
105469787|NCT00478023|363729516|FG003|Overall Study|Lost to Follow-up|1|||
105469788|NCT00478023|363729517|FG004|Overall Study|Lost to Follow-up|0|||
105469789|NCT00478023|363729513|FG000|Overall Study|Withdrawal by Subject|2|||
105685707|NCT02986334|364512838|FG002|Overall Study|Lost to Follow-up|1|||
105685708|NCT02986334|364512836|FG000|Overall Study|Adverse Event|0|||
105685709|NCT02986334|364512837|FG001|Overall Study|Adverse Event|2|||
105685710|NCT02986334|364512838|FG002|Overall Study|Adverse Event|1|||
105685711|NCT02986334|364512836|FG000|Overall Study|non compliance in phone ratings|2|||
105685712|NCT02986334|364512837|FG001|Overall Study|non compliance in phone ratings|1|||
105685713|NCT02986334|364512838|FG002|Overall Study|non compliance in phone ratings|2|||
105685714|NCT02986334|364512836|FG000|Overall Study|undisclosed comorbidities|0|||
105685715|NCT02986334|364512837|FG001|Overall Study|undisclosed comorbidities|1|||
105685716|NCT02986334|364512838|FG002|Overall Study|undisclosed comorbidities|1|||
105685717|NCT00120406|364512839|FG000|Overall Study|Death|9|||
105685718|NCT00120406|364512840|FG001|Overall Study|Death|4|||
105685719|NCT00120406|364512839|FG000|Overall Study|Withdrawal by Subject|5|||
105685720|NCT00120406|364512840|FG001|Overall Study|Withdrawal by Subject|7|||
105685721|NCT00120406|364512839|FG000|Overall Study|Lost to Follow-up|5|||
105685722|NCT00120406|364512840|FG001|Overall Study|Lost to Follow-up|2|||
105685723|NCT00120406|364512839|FG000|Overall Study|received non-study stent|0|||
105685724|NCT00120406|364512840|FG001|Overall Study|received non-study stent|2|||
105685725|NCT00120406|364512839|FG000|Overall Study|patient moved but has not withdrawn|0|||
105685726|NCT00120406|364512840|FG001|Overall Study|patient moved but has not withdrawn|1|||
105685727|NCT03658668|364512843|FG000|Overall Study|Time Commitment|1|||
105685728|NCT03658668|364512844|FG001|Overall Study|Time Commitment|1|||
105685729|NCT04634825|364512845|FG000|Overall Study|Death|10|||
105685730|NCT04634825|364512846|FG001|Overall Study|Death|3|||
105685731|NCT04634825|364512845|FG000|Overall Study|Lost to Follow-up|1|||
105685732|NCT04634825|364512846|FG001|Overall Study|Lost to Follow-up|0|||
105685733|NCT04634825|364512845|FG000|Overall Study|Study terminated by sponsor|35|||
105685734|NCT04634825|364512846|FG001|Overall Study|Study terminated by sponsor|11|||
105685735|NCT04634825|364512845|FG000|Overall Study|Withdrawal by Subject|2|||
105685736|NCT04634825|364512846|FG001|Overall Study|Withdrawal by Subject|0|||
105685737|NCT00235326|364512847|FG000|Overall Study|Lost to Follow-up|746|||
105685738|NCT00235326|364512848|FG001|Overall Study|Lost to Follow-up|1400|||
105685739|NCT01790126|364512849|FG000|Overall Study|PSA Progression|12|||
105469790|NCT00478023|363729514|FG001|Overall Study|Withdrawal by Subject|3|||
105558596|NCT01967732|364041866|FG000|First Intervention (Day 1)|Poor venous access|0|||
105469791|NCT00478023|363729515|FG002|Overall Study|Withdrawal by Subject|2|||
105469792|NCT00478023|363729516|FG003|Overall Study|Withdrawal by Subject|4|||
105469793|NCT00478023|363729517|FG004|Overall Study|Withdrawal by Subject|5|||
105469794|NCT00478023|363729513|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
105469795|NCT00478023|363729514|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
105469796|NCT00478023|363729515|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
105469797|NCT00478023|363729516|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
105558597|NCT01967732|364041867|FG001|First Intervention (Day 1)|Poor venous access|1|||
105685740|NCT01790126|364512850|FG001|Overall Study|PSA Progression|16|||
105685741|NCT01790126|364512851|FG002|Overall Study|PSA Progression|16|||
105685742|NCT01790126|364512849|FG000|Overall Study|Other|5|||
105685743|NCT01790126|364512850|FG001|Overall Study|Other|4|||
105685744|NCT01790126|364512851|FG002|Overall Study|Other|8|||
105685745|NCT01790126|364512849|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
105685746|NCT01790126|364512850|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
105685747|NCT01790126|364512851|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
105685748|NCT01790126|364512849|FG000|Overall Study|Withdrawal by Physician|1|||
105685749|NCT01790126|364512850|FG001|Overall Study|Withdrawal by Physician|1|||
105685750|NCT01790126|364512851|FG002|Overall Study|Withdrawal by Physician|2|||
105685751|NCT01790126|364512849|FG000|Overall Study|Withdrawal by Subject|3|||
105685752|NCT01790126|364512850|FG001|Overall Study|Withdrawal by Subject|1|||
105685753|NCT01790126|364512851|FG002|Overall Study|Withdrawal by Subject|2|||
105685754|NCT01790126|364512849|FG000|Overall Study|Lost to Follow-up|1|||
105469798|NCT00478023|363729517|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
105469799|NCT00369265|363729519|FG000|Overall Study|Study terminated|4|||
105469800|NCT00369265|363729520|FG001|Overall Study|Study terminated|7|||
105469801|NCT00714870|363729521|FG000|Overall Study|Lost to Follow-up|22|||
105469802|NCT00714870|363729522|FG001|Overall Study|Lost to Follow-up|5|||
105469803|NCT00714870|363729521|FG000|Overall Study|patient unable to come b/c back pain|1|||
105469804|NCT00714870|363729522|FG001|Overall Study|patient unable to come b/c back pain|0|||
105469805|NCT00714870|363729521|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
105469806|NCT00714870|363729522|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
105469807|NCT03399552|363729523|FG000|Overall Study|No evidence of disease|1|||
105469808|NCT03399552|363729523|FG000|Overall Study|Unevaluable|1|||
105469809|NCT00611026|363729526|FG000|Randomized to Double-blind Treatment|Not treated|2|||
105469810|NCT00611026|363729527|FG001|Randomized to Double-blind Treatment|Not treated|1|||
105469811|NCT00611026|363729528|FG002|Randomized to Double-blind Treatment|Not treated|3|||
105469812|NCT00611026|363729526|FG000|Double-blind Treatment Period|Death|1|||
105469813|NCT00611026|363729527|FG001|Double-blind Treatment Period|Death|0|||
105469814|NCT00611026|363729528|FG002|Double-blind Treatment Period|Death|0|||
105469815|NCT00611026|363729526|FG000|Double-blind Treatment Period|Adverse Event|9|||
105469816|NCT00611026|363729527|FG001|Double-blind Treatment Period|Adverse Event|28|||
105469817|NCT00611026|363729528|FG002|Double-blind Treatment Period|Adverse Event|46|||
105469818|NCT00611026|363729526|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
105469819|NCT00611026|363729527|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
105469820|NCT00611026|363729528|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
105469821|NCT00611026|363729526|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
105469822|NCT00611026|363729527|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
105469823|NCT00611026|363729528|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
105469824|NCT00611026|363729526|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
105469825|NCT00611026|363729527|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
105469826|NCT00611026|363729528|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
105469827|NCT00611026|363729526|FG000|Double-blind Treatment Period|Other|13|||
105469828|NCT00611026|363729527|FG001|Double-blind Treatment Period|Other|20|||
105469829|NCT00611026|363729528|FG002|Double-blind Treatment Period|Other|18|||
105469830|NCT00760617|363729529|FG000|Overall Study|Adverse Event|5|||
105469831|NCT00760617|363729530|FG001|Overall Study|Adverse Event|2|||
105469832|NCT00760617|363729531|FG002|Overall Study|Adverse Event|0|||
105469833|NCT00760617|363729529|FG000|Overall Study|Lost to Follow-up|0|||
105685755|NCT01790126|364512850|FG001|Overall Study|Lost to Follow-up|0|||
105685756|NCT01790126|364512851|FG002|Overall Study|Lost to Follow-up|1|||
105685757|NCT01790126|364512849|FG000|Overall Study|Adverse Event|0|||
105685758|NCT01790126|364512850|FG001|Overall Study|Adverse Event|2|||
105469834|NCT00760617|363729530|FG001|Overall Study|Lost to Follow-up|0|||
105469835|NCT00760617|363729531|FG002|Overall Study|Lost to Follow-up|5|||
105469836|NCT02991040|363729532|FG000|Overall Study|Withdrawal by Subject|2|||
105469837|NCT02991040|363729532|FG000|Overall Study|Lost to Follow-up|2|||
105469838|NCT00396253|363729541|FG000|Overall Study|Protocol Violation|1|||
105469839|NCT00396253|363729541|FG000|Overall Study|Withdrawal by Subject|7|||
105469840|NCT00396253|363729541|FG000|Overall Study|Death|3|||
105469841|NCT00396253|363729541|FG000|Overall Study|Physician Decision|1|||
105469842|NCT00396253|363729541|FG000|Overall Study|Change in eligibility status|1|||
105469843|NCT04200352|363729549|FG000|Overall Study|Death|1|||
105469844|NCT04200352|363729549|FG000|Overall Study|Adverse Event|6|||
105469845|NCT04200352|363729549|FG000|Overall Study|Withdrawal by parent/guardian|6|||
105469846|NCT04200352|363729549|FG000|Overall Study|Lack of Efficacy|1|||
105469847|NCT04200352|363729549|FG000|Overall Study|Other than specified|6|||
105469848|NCT00828204|363729550|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
105469849|NCT00828204|363729551|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
105469850|NCT00828204|363729550|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
105469851|NCT00828204|363729551|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
105469852|NCT00828204|363729550|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
105469853|NCT00828204|363729551|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
105469854|NCT00828204|363729550|FG000|Main Study: After Study Restart|Adverse Event|0|||
105469855|NCT00828204|363729551|FG001|Main Study: After Study Restart|Adverse Event|2|||
105469856|NCT00828204|363729550|FG000|Main Study: After Study Restart|Noncompliance|0|||
105469857|NCT00828204|363729551|FG001|Main Study: After Study Restart|Noncompliance|1|||
105469858|NCT00828204|363729550|FG000|Extension Study|Lost to Follow-up|0|||
105469859|NCT00828204|363729551|FG001|Extension Study|Lost to Follow-up|1|||
105469860|NCT00828204|363729550|FG000|Extension Study|Physician Decision|0|||
105469861|NCT00828204|363729551|FG001|Extension Study|Physician Decision|2|||
105469862|NCT02447003|363729552|FG000|Overall Study|Other|0|||
105469863|NCT02447003|363729553|FG001|Overall Study|Other|4|||
105469864|NCT02447003|363729552|FG000|Overall Study|Site discontinued|0|||
105469865|NCT02447003|363729553|FG001|Overall Study|Site discontinued|2|||
105469866|NCT02447003|363729552|FG000|Overall Study|Physician Decision|0|||
105469867|NCT02447003|363729553|FG001|Overall Study|Physician Decision|1|||
105469868|NCT02447003|363729552|FG000|Overall Study|Withdrawal by Subject|4|||
105469869|NCT02447003|363729553|FG001|Overall Study|Withdrawal by Subject|3|||
105469870|NCT02447003|363729552|FG000|Overall Study|Sponsor Decision|6|||
105469871|NCT02447003|363729553|FG001|Overall Study|Sponsor Decision|11|||
105469872|NCT02447003|363729552|FG000|Overall Study|Progressive Disease|1|||
105469873|NCT02447003|363729553|FG001|Overall Study|Progressive Disease|0|||
105469874|NCT02447003|363729552|FG000|Overall Study|Lost to Follow-up|5|||
105469875|NCT02447003|363729553|FG001|Overall Study|Lost to Follow-up|0|||
105469876|NCT02447003|363729552|FG000|Overall Study|Death|154|||
105469877|NCT02447003|363729553|FG001|Overall Study|Death|63|||
105469878|NCT00233064|363729556|FG000|Overall Study|Lost to Follow-up|7|||
105469879|NCT00233064|363729557|FG001|Overall Study|Lost to Follow-up|7|||
105469880|NCT00233064|363729556|FG000|Overall Study|Withdrawal by Subject|5|||
105469881|NCT00233064|363729557|FG001|Overall Study|Withdrawal by Subject|3|||
105469882|NCT00233064|363729556|FG000|Overall Study|Death|0|||
105469883|NCT00233064|363729557|FG001|Overall Study|Death|1|||
105469884|NCT00233064|363729556|FG000|Overall Study|Relocation|0|||
105469885|NCT00233064|363729557|FG001|Overall Study|Relocation|1|||
105469886|NCT00233064|363729556|FG000|Overall Study|Protocol Violation|1|||
105469887|NCT00233064|363729557|FG001|Overall Study|Protocol Violation|0|||
105469888|NCT00233064|363729556|FG000|Overall Study|Moved to Dom. Republic|1|||
105469889|NCT00233064|363729557|FG001|Overall Study|Moved to Dom. Republic|0|||
105469890|NCT02302339|363729558|FG000|Overall Study|Lost to Follow-up|1|||
105469891|NCT02302339|363729559|FG001|Overall Study|Lost to Follow-up|0|||
105469892|NCT02302339|363729560|FG002|Overall Study|Lost to Follow-up|0|||
105469893|NCT02302339|363729561|FG003|Overall Study|Lost to Follow-up|0|||
105469894|NCT02302339|363729558|FG000|Overall Study|Withdrawal by Subject|0|||
105469895|NCT02302339|363729559|FG001|Overall Study|Withdrawal by Subject|2|||
105469896|NCT02302339|363729560|FG002|Overall Study|Withdrawal by Subject|1|||
105469897|NCT02302339|363729561|FG003|Overall Study|Withdrawal by Subject|0|||
105469898|NCT01642589|363729569|FG000|Overall Study|Withdrawal by Subject|1|||
105469899|NCT01642589|363729570|FG001|Overall Study|Withdrawal by Subject|1|||
105469900|NCT01120964|363729571|FG000|Overall Study|Did not receive full treatment|1|||
105469901|NCT01120964|363729572|FG001|Overall Study|Did not receive full treatment|0|||
105469902|NCT00472030|363729579|FG000|Overall Study|Physician Decision|1|||
105469903|NCT00472030|363729580|FG001|Overall Study|Physician Decision|0|||
105469904|NCT03212144|363729581|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
105469905|NCT03212144|363729582|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
105469906|NCT03212144|363729581|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
105469907|NCT03212144|363729582|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
105469908|NCT01185080|363729583|FG000|Overall Study|Adverse Event|1|||
105469909|NCT01185080|363729584|FG001|Overall Study|Adverse Event|1|||
105469910|NCT01185080|363729585|FG002|Overall Study|Adverse Event|0|||
105469911|NCT01185080|363729583|FG000|Overall Study|Personal reasons|0|||
105469912|NCT01185080|363729584|FG001|Overall Study|Personal reasons|0|||
105469913|NCT01185080|363729585|FG002|Overall Study|Personal reasons|1|||
105469914|NCT00802945|363729587|FG000|Overall Study|Death|27|||
105469915|NCT00802945|363729588|FG001|Overall Study|Death|23|||
105469916|NCT00802945|363729587|FG000|Overall Study|Terminated by sponsor|8|||
105469917|NCT00802945|363729588|FG001|Overall Study|Terminated by sponsor|12|||
105469918|NCT00494676|363729589|FG000|Allocation|Withdrawal by Subject|2|||
105469919|NCT00494676|363729590|FG001|Allocation|Withdrawal by Subject|4|||
105469920|NCT00494676|363729589|FG000|First Intervention|Withdrawal by Subject|1|||
105469921|NCT00494676|363729590|FG001|First Intervention|Withdrawal by Subject|3|||
105469922|NCT00494676|363729589|FG000|Second Intervention|Withdrawal by Subject|1|||
105469923|NCT00494676|363729590|FG001|Second Intervention|Withdrawal by Subject|1|||
105469924|NCT00560352|363729591|FG000|Overall Study|Adverse event unrelated to study drug|2|||
105469925|NCT00560352|363729592|FG001|Overall Study|Adverse event unrelated to study drug|1|||
105469926|NCT00560352|363729593|FG002|Overall Study|Adverse event unrelated to study drug|1|||
105469927|NCT00560352|363729591|FG000|Overall Study|Study drug toxicity|3|||
105469928|NCT00560352|363729592|FG001|Overall Study|Study drug toxicity|0|||
105469929|NCT00560352|363729593|FG002|Overall Study|Study drug toxicity|1|||
105469930|NCT00560352|363729591|FG000|Overall Study|Disease progression|0|||
105469931|NCT00560352|363729592|FG001|Overall Study|Disease progression|1|||
105469932|NCT00560352|363729593|FG002|Overall Study|Disease progression|1|||
105469933|NCT00560352|363729591|FG000|Overall Study|Withdrawal by Subject|1|||
105469934|NCT00560352|363729592|FG001|Overall Study|Withdrawal by Subject|1|||
105469935|NCT00560352|363729593|FG002|Overall Study|Withdrawal by Subject|1|||
105469936|NCT00560352|363729591|FG000|Overall Study|Maximum clinical benefit|1|||
105469937|NCT00560352|363729592|FG001|Overall Study|Maximum clinical benefit|0|||
105469938|NCT00560352|363729593|FG002|Overall Study|Maximum clinical benefit|0|||
105469939|NCT05767749|363729597|FG000|Overall Study|Withdrawal by Subject|0|||
105469940|NCT05767749|363729598|FG001|Overall Study|Withdrawal by Subject|0|||
105469941|NCT05767749|363729599|FG002|Overall Study|Withdrawal by Subject|2|||
105469942|NCT05767749|363729600|FG003|Overall Study|Withdrawal by Subject|2|||
105469943|NCT05767749|363729601|FG004|Overall Study|Withdrawal by Subject|2|||
105469944|NCT05767749|363729602|FG005|Overall Study|Withdrawal by Subject|2|||
105469945|NCT00114517|363729603|FG000|Overall Study|Adverse Event|6|||
105469946|NCT00114517|363729604|FG001|Overall Study|Adverse Event|1|||
105469947|NCT00114517|363729605|FG002|Overall Study|Adverse Event|6|||
105469948|NCT00114517|363729606|FG003|Overall Study|Adverse Event|3|||
105469949|NCT00114517|363729603|FG000|Overall Study|Lost to Follow-up|2|||
105469950|NCT00114517|363729604|FG001|Overall Study|Lost to Follow-up|2|||
105469951|NCT00114517|363729605|FG002|Overall Study|Lost to Follow-up|2|||
105469952|NCT00114517|363729606|FG003|Overall Study|Lost to Follow-up|1|||
105469953|NCT00114517|363729603|FG000|Overall Study|Too busy|3|||
105469954|NCT00114517|363729604|FG001|Overall Study|Too busy|1|||
105469955|NCT00114517|363729605|FG002|Overall Study|Too busy|1|||
105469956|NCT00114517|363729606|FG003|Overall Study|Too busy|2|||
105469957|NCT00114517|363729603|FG000|Overall Study|Moved from area|0|||
105469958|NCT00114517|363729604|FG001|Overall Study|Moved from area|3|||
105469959|NCT00114517|363729605|FG002|Overall Study|Moved from area|2|||
105469960|NCT00114517|363729606|FG003|Overall Study|Moved from area|1|||
105469961|NCT00114517|363729603|FG000|Overall Study|Did not want estradiol|1|||
105469962|NCT00114517|363729604|FG001|Overall Study|Did not want estradiol|1|||
105469963|NCT00114517|363729605|FG002|Overall Study|Did not want estradiol|0|||
105469964|NCT00114517|363729606|FG003|Overall Study|Did not want estradiol|0|||
105469965|NCT00114517|363729603|FG000|Overall Study|Armed-services duty|0|||
105469966|NCT00114517|363729604|FG001|Overall Study|Armed-services duty|1|||
105469967|NCT00114517|363729605|FG002|Overall Study|Armed-services duty|0|||
105469968|NCT00114517|363729606|FG003|Overall Study|Armed-services duty|1|||
105469969|NCT00114517|363729603|FG000|Overall Study|Competing family issue|0|||
105469970|NCT00114517|363729604|FG001|Overall Study|Competing family issue|1|||
105469971|NCT00114517|363729605|FG002|Overall Study|Competing family issue|0|||
105469972|NCT00114517|363729606|FG003|Overall Study|Competing family issue|1|||
105469973|NCT00114517|363729603|FG000|Overall Study|Physician Decision|0|||
105469974|NCT00114517|363729604|FG001|Overall Study|Physician Decision|1|||
105469975|NCT00114517|363729605|FG002|Overall Study|Physician Decision|0|||
105558598|NCT01967732|364041868|FG002|First Intervention (Day 1)|Poor venous access|0|||
105685759|NCT01790126|364512851|FG002|Overall Study|Adverse Event|0|||
105469976|NCT00114517|363729606|FG003|Overall Study|Physician Decision|0|||
105469977|NCT00114517|363729603|FG000|Overall Study|Lost interest|0|||
105469978|NCT00114517|363729604|FG001|Overall Study|Lost interest|0|||
105469979|NCT00114517|363729605|FG002|Overall Study|Lost interest|1|||
105469980|NCT00114517|363729606|FG003|Overall Study|Lost interest|0|||
105469981|NCT00114517|363729603|FG000|Overall Study|Weight increase|0|||
105469982|NCT00114517|363729604|FG001|Overall Study|Weight increase|0|||
105469983|NCT00114517|363729605|FG002|Overall Study|Weight increase|1|||
105469984|NCT00114517|363729606|FG003|Overall Study|Weight increase|0|||
105469985|NCT00114517|363729603|FG000|Overall Study|Concern about blood clots|0|||
105469986|NCT00114517|363729604|FG001|Overall Study|Concern about blood clots|0|||
105469987|NCT00114517|363729605|FG002|Overall Study|Concern about blood clots|1|||
105469988|NCT00114517|363729606|FG003|Overall Study|Concern about blood clots|0|||
105469989|NCT00114517|363729603|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
105469990|NCT00114517|363729604|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
105469991|NCT00114517|363729605|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
105469992|NCT00114517|363729606|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
105469993|NCT01442103|363731660|FG000|Overall Study|Lost to Follow-up|2|||
105469994|NCT01590888|363731661|FG000|Overall Study|Adverse Event|3|||
105469995|NCT01590888|363731662|FG001|Overall Study|Adverse Event|0|||
105469996|NCT01590888|363731663|FG002|Overall Study|Adverse Event|1|||
105469997|NCT01590888|363731661|FG000|Overall Study|Lost to Follow-up|1|||
105469998|NCT01590888|363731662|FG001|Overall Study|Lost to Follow-up|0|||
105469999|NCT01590888|363731663|FG002|Overall Study|Lost to Follow-up|0|||
105470000|NCT04953728|363731664|FG000|Overall Study|Withdrawal by Subject|3|||
105470001|NCT04953728|363731664|FG000|Overall Study|Physician Decision|1|||
105470002|NCT01148979|363731665|FG000|Overall Study|Lost to Follow-up|0|||
105470003|NCT01148979|363731666|FG001|Overall Study|Lost to Follow-up|1|||
105470004|NCT00990704|363731670|FG000|Overall Study|Adverse Event|1|||
105470005|NCT00990704|363731671|FG001|Overall Study|Adverse Event|1|||
105470006|NCT00990704|363731670|FG000|Overall Study|Physician Decision|0|||
105470007|NCT00990704|363731671|FG001|Overall Study|Physician Decision|1|||
105470008|NCT01376804|363731672|FG000|Treatment Period|Withdrawal by Subject|1|||
105470009|NCT01376804|363731672|FG000|Treatment Period|Adverse Event|6|||
105470010|NCT01376804|363731672|FG000|Treatment Period|Patient did not receive study drug|1|||
105470011|NCT01039376|363731673|FG000|Overall Study|Lost to Follow-up|5|||
105470012|NCT01039376|363731674|FG001|Overall Study|Lost to Follow-up|12|||
105470013|NCT01039376|363731673|FG000|Overall Study|Physician Decision|15|||
105470014|NCT01039376|363731674|FG001|Overall Study|Physician Decision|10|||
105470015|NCT01039376|363731673|FG000|Overall Study|Withdrawal by Subject|20|||
105470016|NCT01039376|363731674|FG001|Overall Study|Withdrawal by Subject|32|||
105470017|NCT01039376|363731673|FG000|Overall Study|Study terminated by Sponsor|90|||
105470018|NCT01039376|363731674|FG001|Overall Study|Study terminated by Sponsor|72|||
105470019|NCT00753649|363731675|FG000|Overall Study|Migrated/moved from study area|1|||
105470020|NCT00753649|363731676|FG001|Overall Study|Migrated/moved from study area|0|||
105470021|NCT00753649|363731675|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
105470022|NCT00753649|363731676|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
105470023|NCT00753649|363731675|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
105470024|NCT00753649|363731676|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
105470025|NCT00753649|363731675|FG000|Overall Study|Protocol Violation|2|||
105470026|NCT00753649|363731676|FG001|Overall Study|Protocol Violation|0|||
105470027|NCT00123422|363731677|FG000|Overall Study|Physician Decision|2|||
105470028|NCT00123422|363731678|FG001|Overall Study|Physician Decision|2|||
105470029|NCT00123422|363731679|FG002|Overall Study|Physician Decision|6|||
105470030|NCT00123422|363731677|FG000|Overall Study|Withdrawal by Subject|1|||
105470031|NCT00123422|363731678|FG001|Overall Study|Withdrawal by Subject|2|||
105470032|NCT00123422|363731679|FG002|Overall Study|Withdrawal by Subject|2|||
105470033|NCT00123422|363731677|FG000|Overall Study|Lost to Follow-up|1|||
105470034|NCT00123422|363731678|FG001|Overall Study|Lost to Follow-up|2|||
105470035|NCT00123422|363731679|FG002|Overall Study|Lost to Follow-up|2|||
105470036|NCT04555616|363731680|FG000|Overall Study|Death|1|||
105470037|NCT04555616|363731681|FG001|Overall Study|Death|0|||
105470038|NCT04555616|363731682|FG002|Overall Study|Death|1|||
105470039|NCT04555616|363731680|FG000|Overall Study|Withdrawal by Subject|2|||
105470040|NCT04555616|363731681|FG001|Overall Study|Withdrawal by Subject|1|||
105470041|NCT04555616|363731682|FG002|Overall Study|Withdrawal by Subject|0|||
105470042|NCT01229267|363731687|FG000|Overall Study|Adverse Event|4|||
105470043|NCT01229267|363731688|FG001|Overall Study|Adverse Event|6|||
105470044|NCT01229267|363731689|FG002|Overall Study|Adverse Event|3|||
105470045|NCT01229267|363731690|FG003|Overall Study|Adverse Event|2|||
105470046|NCT01229267|363731691|FG004|Overall Study|Adverse Event|10|||
105470047|NCT01229267|363731687|FG000|Overall Study|Death|40|||
105470048|NCT01229267|363731688|FG001|Overall Study|Death|37|||
105470049|NCT01229267|363731689|FG002|Overall Study|Death|35|||
105470050|NCT01229267|363731690|FG003|Overall Study|Death|13|||
105470051|NCT01229267|363731691|FG004|Overall Study|Death|103|||
105470052|NCT01229267|363731687|FG000|Overall Study|Withdrawal by Subject|23|||
105470053|NCT01229267|363731688|FG001|Overall Study|Withdrawal by Subject|22|||
105470054|NCT01229267|363731689|FG002|Overall Study|Withdrawal by Subject|32|||
105470055|NCT01229267|363731690|FG003|Overall Study|Withdrawal by Subject|14|||
105470056|NCT01229267|363731691|FG004|Overall Study|Withdrawal by Subject|59|||
105470057|NCT01229267|363731687|FG000|Overall Study|Protocol Violation|0|||
105558599|NCT01967732|364041869|FG003|First Intervention (Day 1)|Poor venous access|0|||
105470058|NCT01229267|363731688|FG001|Overall Study|Protocol Violation|1|||
105470059|NCT01229267|363731689|FG002|Overall Study|Protocol Violation|0|||
105470060|NCT01229267|363731690|FG003|Overall Study|Protocol Violation|0|||
105470061|NCT01229267|363731691|FG004|Overall Study|Protocol Violation|0|||
105470062|NCT01229267|363731687|FG000|Overall Study|Progressive disease|0|||
105470063|NCT01229267|363731688|FG001|Overall Study|Progressive disease|0|||
105470064|NCT01229267|363731689|FG002|Overall Study|Progressive disease|0|||
105470065|NCT01229267|363731690|FG003|Overall Study|Progressive disease|0|||
105470066|NCT01229267|363731691|FG004|Overall Study|Progressive disease|1|||
105470067|NCT01229267|363731687|FG000|Overall Study|Physician Decision|8|||
105470068|NCT01229267|363731688|FG001|Overall Study|Physician Decision|11|||
105344718|NCT03226678|363263491|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
105344719|NCT03226678|363263486|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
105470069|NCT01229267|363731689|FG002|Overall Study|Physician Decision|8|||
105344720|NCT03226678|363263487|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
105344721|NCT03226678|363263488|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
105344722|NCT03226678|363263489|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
105344723|NCT03226678|363263490|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
105344724|NCT03226678|363263491|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
105470070|NCT01229267|363731690|FG003|Overall Study|Physician Decision|3|||
105470071|NCT01229267|363731691|FG004|Overall Study|Physician Decision|25|||
105470072|NCT01229267|363731687|FG000|Overall Study|Lost to Follow-up|6|||
105470073|NCT01229267|363731688|FG001|Overall Study|Lost to Follow-up|5|||
105470074|NCT01229267|363731689|FG002|Overall Study|Lost to Follow-up|8|||
105470075|NCT01229267|363731690|FG003|Overall Study|Lost to Follow-up|3|||
105470076|NCT01229267|363731691|FG004|Overall Study|Lost to Follow-up|22|||
105470077|NCT00808080|363731699|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
105470078|NCT00001213|363731700|FG000|Overall Study|Death|18|||
105470079|NCT01554241|363731702|FG000|Overall Study|Death|3|||
105470080|NCT01554241|363731703|FG001|Overall Study|Death|1|||
105470081|NCT01554241|363731704|FG002|Overall Study|Death|1|||
105470082|NCT01554241|363731705|FG003|Overall Study|Death|0|||
105470083|NCT01554241|363731702|FG000|Overall Study|protocol specified renal stone|0|||
105470084|NCT01554241|363731703|FG001|Overall Study|protocol specified renal stone|0|||
105470085|NCT01554241|363731704|FG002|Overall Study|protocol specified renal stone|0|||
105470086|NCT01554241|363731705|FG003|Overall Study|protocol specified renal stone|1|||
105470087|NCT01554241|363731702|FG000|Overall Study|protocol specified change in eGFR|0|||
105470088|NCT01554241|363731703|FG001|Overall Study|protocol specified change in eGFR|0|||
105470089|NCT01554241|363731704|FG002|Overall Study|protocol specified change in eGFR|1|||
105344725|NCT03226678|363263486|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
105470090|NCT01554241|363731705|FG003|Overall Study|protocol specified change in eGFR|0|||
105470091|NCT01554241|363731702|FG000|Overall Study|Withdrawal by Subject|0|||
105470092|NCT01554241|363731703|FG001|Overall Study|Withdrawal by Subject|0|||
105470093|NCT01554241|363731704|FG002|Overall Study|Withdrawal by Subject|2|||
105470094|NCT01554241|363731705|FG003|Overall Study|Withdrawal by Subject|0|||
105470095|NCT02974543|363731706|FG000|Overall Study|Withdrawal by Subject|1|||
105470096|NCT02974543|363731707|FG001|Overall Study|Withdrawal by Subject|0|||
105470097|NCT03534180|363731708|FG000|Overall Study|Withdrawal by Subject|1|||
105470098|NCT00220636|363731709|FG000|Overall Study|Withdrawal by Subject|4|||
105470099|NCT00330967|363731710|FG000|Overall Study|Withdrawal by Subject|0|||
105470100|NCT00330967|363731711|FG001|Overall Study|Withdrawal by Subject|5|||
105470101|NCT00330967|363731710|FG000|Overall Study|Physician Decision|0|||
105470102|NCT00330967|363731711|FG001|Overall Study|Physician Decision|9|||
105470103|NCT02362282|363731715|FG000|Overall Study|Withdrawal by Subject|1|||
105470104|NCT02362282|363731716|FG001|Overall Study|Withdrawal by Subject|0|||
105470105|NCT02999672|363731717|FG000|Overall Study|Death|0|||
105470106|NCT02999672|363731718|FG001|Overall Study|Death|1|||
105470107|NCT02999672|363731717|FG000|Overall Study|Study Terminated by Sponsor|0|||
105470108|NCT02999672|363731718|FG001|Overall Study|Study Terminated by Sponsor|1|||
105470109|NCT02999672|363731717|FG000|Overall Study|Progressive Disease|9|||
105470110|NCT02999672|363731718|FG001|Overall Study|Progressive Disease|5|||
105470111|NCT02999672|363731717|FG000|Overall Study|Adverse Event|4|||
105344726|NCT03226678|363263487|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
105470112|NCT02999672|363731718|FG001|Overall Study|Adverse Event|0|||
105470113|NCT00275509|363731719|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
105470114|NCT00275509|363731720|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
105470115|NCT01821118|363731726|FG000|Overall Study|Death|0|||
105470116|NCT01821118|363731727|FG001|Overall Study|Death|1|||
105470117|NCT00470275|363731729|FG000|Overall Study|Death|1|||
105470118|NCT00470275|363731729|FG000|Overall Study|Lack of Efficacy|7|||
105470119|NCT00470275|363731729|FG000|Overall Study|Withdrawal by Subject|2|||
105470120|NCT00775593|363731730|FG000|Overall Study|Unmet eligibility criteria|6|||
105470121|NCT00775593|363731730|FG000|Overall Study|Death|1|||
105470122|NCT00996333|363731731|FG000|Overall Study|Screen failure|1|||
105470123|NCT00996333|363731731|FG000|Overall Study|Withdrawal by Subject|1|||
105470124|NCT00996333|363731731|FG000|Overall Study|Death|4|||
105470125|NCT00996333|363731731|FG000|Overall Study|Adverse Event|1|||
105470126|NCT00996333|363731731|FG000|Overall Study|Physician Decision|1|||
105470127|NCT00996333|363731731|FG000|Overall Study|Other|5|||
105470128|NCT01327482|363731732|FG000|Overall Study|Adverse Event|1|||
105470129|NCT02023697|363731733|FG000|Treatment Period|Radiological progression|13|||
105470130|NCT02023697|363731734|FG001|Treatment Period|Radiological progression|17|||
105470131|NCT02023697|363731735|FG002|Treatment Period|Radiological progression|26|||
105470132|NCT02023697|363731733|FG000|Treatment Period|Never Treated|5|||
105470133|NCT02023697|363731734|FG001|Treatment Period|Never Treated|6|||
105470134|NCT02023697|363731735|FG002|Treatment Period|Never Treated|10|||
105470135|NCT02023697|363731733|FG000|Treatment Period|Adverse Event|13|||
105470136|NCT02023697|363731734|FG001|Treatment Period|Adverse Event|25|||
105470137|NCT02023697|363731735|FG002|Treatment Period|Adverse Event|23|||
105470138|NCT02023697|363731733|FG000|Treatment Period|Logistical difficulties|1|||
105470139|NCT02023697|363731734|FG001|Treatment Period|Logistical difficulties|1|||
105470140|NCT02023697|363731735|FG002|Treatment Period|Logistical difficulties|1|||
105470141|NCT02023697|363731733|FG000|Treatment Period|Clinical progression|10|||
105470142|NCT02023697|363731734|FG001|Treatment Period|Clinical progression|8|||
105470143|NCT02023697|363731735|FG002|Treatment Period|Clinical progression|28|||
105470144|NCT02023697|363731733|FG000|Treatment Period|Withdrawal by Subject|4|||
105470145|NCT02023697|363731734|FG001|Treatment Period|Withdrawal by Subject|5|||
105470146|NCT02023697|363731735|FG002|Treatment Period|Withdrawal by Subject|13|||
105470147|NCT02023697|363731733|FG000|Treatment Period|Safety outcome reached|0|||
105470148|NCT02023697|363731734|FG001|Treatment Period|Safety outcome reached|1|||
105470149|NCT02023697|363731735|FG002|Treatment Period|Safety outcome reached|0|||
105470150|NCT02023697|363731733|FG000|Treatment Period|Physician Decision|0|||
105470151|NCT02023697|363731734|FG001|Treatment Period|Physician Decision|0|||
105470152|NCT02023697|363731735|FG002|Treatment Period|Physician Decision|1|||
105470153|NCT02023697|363731733|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
105470154|NCT02023697|363731734|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
105470155|NCT02023697|363731735|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
105470156|NCT02023697|363731733|FG000|Active Follow-up Period|Lost to Follow-up|1|||
105470157|NCT02023697|363731734|FG001|Active Follow-up Period|Lost to Follow-up|1|||
105470158|NCT02023697|363731735|FG002|Active Follow-up Period|Lost to Follow-up|1|||
105470159|NCT02023697|363731733|FG000|Active Follow-up Period|Deterioration of general condition|1|||
105470160|NCT02023697|363731734|FG001|Active Follow-up Period|Deterioration of general condition|1|||
105470161|NCT02023697|363731735|FG002|Active Follow-up Period|Deterioration of general condition|1|||
105470162|NCT02023697|363731733|FG000|Active Follow-up Period|Other unspecified|2|||
105470163|NCT02023697|363731734|FG001|Active Follow-up Period|Other unspecified|0|||
105470164|NCT02023697|363731735|FG002|Active Follow-up Period|Other unspecified|1|||
105470165|NCT02023697|363731733|FG000|Active Follow-up Period|Clinical progression|0|||
105470166|NCT02023697|363731734|FG001|Active Follow-up Period|Clinical progression|2|||
105470167|NCT02023697|363731735|FG002|Active Follow-up Period|Clinical progression|1|||
105470168|NCT02023697|363731733|FG000|Active Follow-up Period|Radiological progression|0|||
105470169|NCT02023697|363731734|FG001|Active Follow-up Period|Radiological progression|0|||
105470170|NCT02023697|363731735|FG002|Active Follow-up Period|Radiological progression|1|||
105470171|NCT02023697|363731733|FG000|Active Follow-up Period|Death|83|||
105470172|NCT02023697|363731734|FG001|Active Follow-up Period|Death|82|||
105470173|NCT02023697|363731735|FG002|Active Follow-up Period|Death|87|||
105470174|NCT02023697|363731733|FG000|Long-term Follow-up Period|Death|9|||
105470175|NCT02023697|363731734|FG001|Long-term Follow-up Period|Death|6|||
105470176|NCT02023697|363731735|FG002|Long-term Follow-up Period|Death|4|||
105470177|NCT02023697|363731733|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
105470178|NCT02023697|363731734|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
105470179|NCT02023697|363731735|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
105470180|NCT02023697|363731733|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
105470181|NCT02023697|363731734|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
105470182|NCT02023697|363731735|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
105470183|NCT02023697|363731733|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
105470184|NCT02023697|363731734|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
105470185|NCT02023697|363731735|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
105470186|NCT02023697|363731733|FG000|Long-term Follow-up Period|Technical problems|0|||
105470187|NCT02023697|363731734|FG001|Long-term Follow-up Period|Technical problems|0|||
105470188|NCT02023697|363731735|FG002|Long-term Follow-up Period|Technical problems|1|||
105470189|NCT02023697|363731733|FG000|Long-term Follow-up Period|Other unspecified|6|||
105470190|NCT02023697|363731734|FG001|Long-term Follow-up Period|Other unspecified|3|||
105470191|NCT02023697|363731735|FG002|Long-term Follow-up Period|Other unspecified|5|||
105470192|NCT01733680|363731736|FG000|Overall Study|Withdrawal by Subject|0|||
105558600|NCT00528775|364041874|FG000|Overall Study|Other not specified|1|||
105470193|NCT01733680|363731737|FG001|Overall Study|Withdrawal by Subject|1|||
105470194|NCT00074490|363731738|FG000|Overall Study|Progressive malignancy|0|||
105470195|NCT00074490|363731739|FG001|Overall Study|Progressive malignancy|7|||
105470196|NCT00074490|363731740|FG002|Overall Study|Progressive malignancy|0|||
105470197|NCT00074490|363731741|FG003|Overall Study|Progressive malignancy|0|||
105470198|NCT00074490|363731742|FG004|Overall Study|Progressive malignancy|3|||
105470199|NCT00074490|363731743|FG005|Overall Study|Progressive malignancy|0|||
105470200|NCT02722499|363731744|FG000|Overall Study|Lost to Follow-up|2|||
105470201|NCT02722499|363731745|FG001|Overall Study|Lost to Follow-up|0|||
105470202|NCT02722499|363731746|FG002|Overall Study|Lost to Follow-up|1|||
105470203|NCT04139798|363731747|FG000|Overall Study|Withdrawal by Subject|6|||
105470204|NCT04139798|363731748|FG001|Overall Study|Withdrawal by Subject|5|||
105470205|NCT04139798|363731747|FG000|Overall Study|Lost to Follow-up|2|||
105470206|NCT04139798|363731748|FG001|Overall Study|Lost to Follow-up|5|||
105470207|NCT04139798|363731747|FG000|Overall Study|Discontinued|4|||
105470208|NCT04139798|363731748|FG001|Overall Study|Discontinued|2|||
105470209|NCT04139798|363731747|FG000|Overall Study|Adverse Event|1|||
105470210|NCT04139798|363731748|FG001|Overall Study|Adverse Event|3|||
105470211|NCT04139798|363731747|FG000|Overall Study|Protocol Violation|1|||
105470212|NCT04139798|363731748|FG001|Overall Study|Protocol Violation|0|||
105470213|NCT04634253|363731749|FG000|Overall Study|Adverse Event|1|||
105470214|NCT04634253|363731750|FG001|Overall Study|Adverse Event|1|||
105470215|NCT04634253|363731751|FG002|Overall Study|Adverse Event|0|||
105470216|NCT04634253|363731749|FG000|Overall Study|Physician Decision|0|||
105470217|NCT04634253|363731750|FG001|Overall Study|Physician Decision|1|||
105470218|NCT04634253|363731751|FG002|Overall Study|Physician Decision|0|||
105470219|NCT04634253|363731749|FG000|Overall Study|Withdrawal by Subject|1|||
105470220|NCT04634253|363731750|FG001|Overall Study|Withdrawal by Subject|0|||
105470221|NCT04634253|363731751|FG002|Overall Study|Withdrawal by Subject|3|||
105470222|NCT01499355|363731752|FG000|Run-In Period|Study Termination|15|||
105470223|NCT01499355|363731753|FG001|Run-In Period|Study Termination|0|||
105470224|NCT01499355|363731754|FG002|Run-In Period|Study Termination|0|||
105470225|NCT01499355|363731755|FG003|Run-In Period|Study Termination|0|||
105470226|NCT01499355|363731752|FG000|Run-In Period|Other|3|||
105470227|NCT01499355|363731753|FG001|Run-In Period|Other|0|||
105470228|NCT01499355|363731754|FG002|Run-In Period|Other|0|||
105470229|NCT01499355|363731755|FG003|Run-In Period|Other|0|||
105470230|NCT01499355|363731752|FG000|Run-In Period|Death|2|||
105470231|NCT01499355|363731753|FG001|Run-In Period|Death|0|||
105470232|NCT01499355|363731754|FG002|Run-In Period|Death|0|||
105470233|NCT01499355|363731755|FG003|Run-In Period|Death|0|||
105470234|NCT01499355|363731752|FG000|Run-In Period|Investigator Decision|2|||
105470235|NCT01499355|363731753|FG001|Run-In Period|Investigator Decision|0|||
105470236|NCT01499355|363731754|FG002|Run-In Period|Investigator Decision|0|||
105470237|NCT01499355|363731755|FG003|Run-In Period|Investigator Decision|0|||
105470238|NCT01499355|363731752|FG000|Run-In Period|Consent Withdrawn|1|||
105558601|NCT03213158|364041875|FG000|Overall Study|Withdrawal by Subject|1|||
105470239|NCT01499355|363731753|FG001|Run-In Period|Consent Withdrawn|0|||
105470240|NCT01499355|363731754|FG002|Run-In Period|Consent Withdrawn|0|||
105470241|NCT01499355|363731755|FG003|Run-In Period|Consent Withdrawn|0|||
105470242|NCT01499355|363731752|FG000|Run-In Period|Adverse Event|8|||
105470243|NCT01499355|363731753|FG001|Run-In Period|Adverse Event|0|||
105470244|NCT01499355|363731754|FG002|Run-In Period|Adverse Event|0|||
105470245|NCT01499355|363731755|FG003|Run-In Period|Adverse Event|0|||
105470246|NCT01499355|363731752|FG000|Double-Blind Period|Adverse Event|0|||
105470247|NCT01499355|363731753|FG001|Double-Blind Period|Adverse Event|2|||
105470248|NCT01499355|363731754|FG002|Double-Blind Period|Adverse Event|3|||
105344727|NCT03226678|363263488|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
105344728|NCT03226678|363263489|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
105344729|NCT03226678|363263490|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
105470249|NCT01499355|363731755|FG003|Double-Blind Period|Adverse Event|2|||
105685760|NCT01790126|364512849|FG000|Overall Study|Death|2|||
105685761|NCT01790126|364512850|FG001|Overall Study|Death|0|||
105685762|NCT01790126|364512851|FG002|Overall Study|Death|0|||
105470250|NCT01499355|363731752|FG000|Double-Blind Period|Study Termination|0|||
105470251|NCT01499355|363731753|FG001|Double-Blind Period|Study Termination|18|||
105470252|NCT01499355|363731754|FG002|Double-Blind Period|Study Termination|16|||
105470253|NCT01499355|363731755|FG003|Double-Blind Period|Study Termination|14|||
105470254|NCT01499355|363731752|FG000|Double-Blind Period|Other|0|||
105470255|NCT01499355|363731753|FG001|Double-Blind Period|Other|1|||
105470256|NCT01499355|363731754|FG002|Double-Blind Period|Other|2|||
105470257|NCT01499355|363731755|FG003|Double-Blind Period|Other|2|||
105470258|NCT01499355|363731752|FG000|Double-Blind Period|Death|0|||
105470259|NCT01499355|363731753|FG001|Double-Blind Period|Death|1|||
105470260|NCT01499355|363731754|FG002|Double-Blind Period|Death|0|||
105685763|NCT01790126|364512849|FG000|Overall Study|Radiographic Progression|3|||
105685764|NCT01790126|364512850|FG001|Overall Study|Radiographic Progression|1|||
105470261|NCT01499355|363731755|FG003|Double-Blind Period|Death|0|||
105470262|NCT01499355|363731752|FG000|Double-Blind Period|Investigator Decision|0|||
105470263|NCT01499355|363731753|FG001|Double-Blind Period|Investigator Decision|0|||
105470264|NCT01499355|363731754|FG002|Double-Blind Period|Investigator Decision|3|||
105470265|NCT01499355|363731755|FG003|Double-Blind Period|Investigator Decision|3|||
105470266|NCT01499355|363731752|FG000|Double-Blind Period|Consent Withdrawn|0|||
105470267|NCT01499355|363731753|FG001|Double-Blind Period|Consent Withdrawn|0|||
105558602|NCT03213158|364041875|FG000|Overall Study|Physician Decision|2|||
105685765|NCT01790126|364512851|FG002|Overall Study|Radiographic Progression|0|||
105470268|NCT01499355|363731754|FG002|Double-Blind Period|Consent Withdrawn|1|||
105470269|NCT01499355|363731755|FG003|Double-Blind Period|Consent Withdrawn|2|||
105470270|NCT01499355|363731752|FG000|Double-Blind Period|Lost to Follow-up|0|||
105470271|NCT01499355|363731753|FG001|Double-Blind Period|Lost to Follow-up|1|||
105470272|NCT01499355|363731754|FG002|Double-Blind Period|Lost to Follow-up|0|||
105470273|NCT01499355|363731755|FG003|Double-Blind Period|Lost to Follow-up|0|||
105470274|NCT03610269|363731757|FG000|Overall Study|Physician Decision|10|||
105470275|NCT03610269|363731757|FG000|Overall Study|Protocol Violation|1|||
105470276|NCT03610269|363731757|FG000|Overall Study|Unable to draw blood|1|||
105470277|NCT03610269|363731757|FG000|Overall Study|Screen fail|4|||
105470278|NCT04411667|363731758|FG000|Overall Study|Physician Decision|1|||
105470279|NCT04411667|363731759|FG001|Overall Study|Physician Decision|0|||
105470280|NCT02817464|363731760|FG000|Overall Study|Lost to Follow-up|1|||
105470281|NCT02817464|363731761|FG001|Overall Study|Lost to Follow-up|0|||
105470282|NCT02817464|363731760|FG000|Overall Study|Discontinued early due to personal decision|1|||
105470283|NCT02817464|363731761|FG001|Overall Study|Discontinued early due to personal decision|1|||
105470284|NCT00885534|363731762|FG000|Overall Study|Patient deemed ineligible|1|||
105470285|NCT01626872|363731763|FG000|Overall Study|Physician Decision|13|||
105470286|NCT01626872|363731764|FG001|Overall Study|Physician Decision|9|||
105470287|NCT01626872|363731765|FG002|Overall Study|Physician Decision|6|||
105470288|NCT01626872|363731763|FG000|Overall Study|Withdrawal by Subject|19|||
105470289|NCT01626872|363731764|FG001|Overall Study|Withdrawal by Subject|27|||
105470290|NCT01626872|363731765|FG002|Overall Study|Withdrawal by Subject|8|||
105470291|NCT01626872|363731763|FG000|Overall Study|Adverse Event (including Death)|20|||
105470292|NCT01626872|363731764|FG001|Overall Study|Adverse Event (including Death)|28|||
105470293|NCT01626872|363731765|FG002|Overall Study|Adverse Event (including Death)|8|||
105470294|NCT01626872|363731763|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
105470295|NCT01626872|363731764|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
105470296|NCT01626872|363731765|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
105470297|NCT02453711|363731766|FG000|Overall Study|Withdrawal by Subject|5|||
105470298|NCT02453711|363731767|FG001|Overall Study|Withdrawal by Subject|4|||
105470299|NCT02453711|363731768|FG002|Overall Study|Withdrawal by Subject|6|||
105470300|NCT02453711|363731769|FG003|Overall Study|Withdrawal by Subject|4|||
105470301|NCT02453711|363731770|FG004|Overall Study|Withdrawal by Subject|1|||
105470302|NCT02453711|363731771|FG005|Overall Study|Withdrawal by Subject|1|||
105470303|NCT02453711|363731772|FG006|Overall Study|Withdrawal by Subject|0|||
105470304|NCT02453711|363731773|FG007|Overall Study|Withdrawal by Subject|1|||
105470305|NCT02453711|363731774|FG008|Overall Study|Withdrawal by Subject|7|||
105470306|NCT02453711|363731766|FG000|Overall Study|Lost to Follow-up|5|||
105470307|NCT02453711|363731767|FG001|Overall Study|Lost to Follow-up|3|||
105470308|NCT02453711|363731768|FG002|Overall Study|Lost to Follow-up|2|||
105470309|NCT02453711|363731769|FG003|Overall Study|Lost to Follow-up|3|||
105470310|NCT02453711|363731770|FG004|Overall Study|Lost to Follow-up|1|||
105470311|NCT02453711|363731771|FG005|Overall Study|Lost to Follow-up|5|||
105470312|NCT02453711|363731772|FG006|Overall Study|Lost to Follow-up|2|||
105470313|NCT02453711|363731773|FG007|Overall Study|Lost to Follow-up|6|||
105470314|NCT02453711|363731774|FG008|Overall Study|Lost to Follow-up|6|||
105470315|NCT02453711|363731766|FG000|Overall Study|Death|0|||
105470316|NCT02453711|363731767|FG001|Overall Study|Death|0|||
105470317|NCT02453711|363731768|FG002|Overall Study|Death|0|||
105470318|NCT02453711|363731769|FG003|Overall Study|Death|0|||
105470319|NCT02453711|363731770|FG004|Overall Study|Death|0|||
105470320|NCT02453711|363731771|FG005|Overall Study|Death|0|||
105470321|NCT02453711|363731772|FG006|Overall Study|Death|1|||
105470322|NCT02453711|363731773|FG007|Overall Study|Death|0|||
105470323|NCT02453711|363731774|FG008|Overall Study|Death|0|||
105470324|NCT02453711|363731766|FG000|Overall Study|Unclassified|1|||
105470325|NCT02453711|363731767|FG001|Overall Study|Unclassified|0|||
105470326|NCT02453711|363731768|FG002|Overall Study|Unclassified|1|||
105786572|NCT02147132|364872828|FG000|Overall Study|Lost to Follow-up|1|||
105470327|NCT02453711|363731769|FG003|Overall Study|Unclassified|0|||
105470328|NCT02453711|363731770|FG004|Overall Study|Unclassified|0|||
105470329|NCT02453711|363731771|FG005|Overall Study|Unclassified|0|||
105470330|NCT02453711|363731772|FG006|Overall Study|Unclassified|0|||
105470331|NCT02453711|363731773|FG007|Overall Study|Unclassified|0|||
105470332|NCT02453711|363731774|FG008|Overall Study|Unclassified|0|||
105470333|NCT01273519|363731776|FG000|Overall Study|Adverse Event|3|||
105470334|NCT01273519|363731777|FG001|Overall Study|Adverse Event|0|||
105470335|NCT01273519|363731778|FG002|Overall Study|Adverse Event|0|||
105470336|NCT01273519|363731776|FG000|Overall Study|Lost to Follow-up|2|||
105470337|NCT01273519|363731777|FG001|Overall Study|Lost to Follow-up|1|||
105470338|NCT01273519|363731778|FG002|Overall Study|Lost to Follow-up|3|||
105470339|NCT01273519|363731776|FG000|Overall Study|Lack of Efficacy|8|||
105470340|NCT01273519|363731777|FG001|Overall Study|Lack of Efficacy|3|||
105470341|NCT01273519|363731778|FG002|Overall Study|Lack of Efficacy|4|||
105470342|NCT01273519|363731776|FG000|Overall Study|Other|6|||
105470343|NCT01273519|363731777|FG001|Overall Study|Other|1|||
105470344|NCT01273519|363731778|FG002|Overall Study|Other|1|||
105470345|NCT03695367|363731779|FG000|Overall Study|Missed the Day 28 visit.|1|||
105470346|NCT03695367|363731780|FG001|Overall Study|Missed the Day 28 visit.|0|||
105470347|NCT03695367|363731779|FG000|Overall Study|Lost to Follow-up|0|||
105470348|NCT03695367|363731780|FG001|Overall Study|Lost to Follow-up|1|||
105685766|NCT01128738|364512852|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
105685767|NCT01128738|364512853|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
105685768|NCT01128738|364512852|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
105685769|NCT01128738|364512853|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
105685770|NCT01128738|364512852|FG000|Second TP|Lost to Follow-up|0|||
105685771|NCT01128738|364512853|FG001|Second TP|Lost to Follow-up|1|||
105685772|NCT01128738|364512852|FG000|Second TP|Withdrawal by Subject|0|||
105685773|NCT01128738|364512853|FG001|Second TP|Withdrawal by Subject|2|||
105685774|NCT00455325|364512854|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
105685775|NCT00455325|364512855|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
105685776|NCT00455325|364512856|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
105685777|NCT00455325|364512857|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
105685778|NCT00455325|364512854|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
105685779|NCT00455325|364512855|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
105685780|NCT00455325|364512856|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
105685781|NCT00455325|364512857|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
105685782|NCT00455325|364512854|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
105685783|NCT00455325|364512855|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
105685784|NCT00455325|364512856|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
105685785|NCT00455325|364512857|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
105685786|NCT00455325|364512854|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
105685787|NCT00455325|364512855|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
105685788|NCT00455325|364512856|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
105685789|NCT00455325|364512857|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
105685790|NCT00455325|364512854|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
105685791|NCT00455325|364512855|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
105470349|NCT03695367|363731779|FG000|Overall Study|Withdrawal by Subject|0|||
105685792|NCT00455325|364512856|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
105685793|NCT00455325|364512857|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
105685794|NCT00455325|364512854|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
105685795|NCT00455325|364512855|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
105685796|NCT00455325|364512856|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
105685797|NCT00455325|364512857|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
105470350|NCT03695367|363731780|FG001|Overall Study|Withdrawal by Subject|1|||
105470351|NCT03695367|363731779|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
105470352|NCT03695367|363731780|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
105470353|NCT05334212|363731793|FG000|Overall Study|Study terminated prematurely|7|||
105470354|NCT01209325|363731794|FG000|Overall Study|Lost to Follow-up|24|||
105470355|NCT01209325|363731794|FG000|Overall Study|Adverse Event|1|||
105470356|NCT01209325|363731794|FG000|Overall Study|Relocated|3|||
105470357|NCT01209325|363731794|FG000|Overall Study|Refusal after starting therapy|8|||
105470358|NCT01209325|363731794|FG000|Overall Study|Protocol Violation|4|||
105470359|NCT01209325|363731794|FG000|Overall Study|Refusal prior to therapy|1|||
105470360|NCT01209325|363731794|FG000|Overall Study|Incarceration|2|||
105470361|NCT02039843|363731797|FG000|Randomization and Observation Period|Adverse Event|2|||
105470362|NCT02039843|363731798|FG001|Randomization and Observation Period|Adverse Event|0|||
105470363|NCT02039843|363731797|FG000|Randomization and Observation Period|Death|1|||
105470364|NCT02039843|363731798|FG001|Randomization and Observation Period|Death|0|||
105470365|NCT02039843|363731797|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
105470366|NCT02039843|363731798|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
105470367|NCT02039843|363731797|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
105470368|NCT02039843|363731798|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
105470369|NCT02039843|363731797|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
105470370|NCT02039843|363731798|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
105470371|NCT02039843|363731797|FG000|Pairing With a Study Dog|Death|1|||
105685798|NCT00455325|364512854|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
105685799|NCT00455325|364512855|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
105685800|NCT00455325|364512856|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
105470372|NCT02039843|363731798|FG001|Pairing With a Study Dog|Death|0|||
105470373|NCT02039843|363731797|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
105685801|NCT00455325|364512857|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
105685802|NCT04620811|364512858|FG000|Overall Study|Withdrawal by Subject|18|||
105685803|NCT04620811|364512859|FG001|Overall Study|Withdrawal by Subject|15|||
105685804|NCT04620811|364512858|FG000|Overall Study|Adverse Event|6|||
105685805|NCT04620811|364512859|FG001|Overall Study|Adverse Event|11|||
105685806|NCT04620811|364512858|FG000|Overall Study|Lost to Follow-up|4|||
105685807|NCT04620811|364512859|FG001|Overall Study|Lost to Follow-up|8|||
105685808|NCT04620811|364512858|FG000|Overall Study|Physician Decision|1|||
105685809|NCT04620811|364512859|FG001|Overall Study|Physician Decision|4|||
105685810|NCT04620811|364512858|FG000|Overall Study|Sponsor Decision|0|||
105685811|NCT04620811|364512859|FG001|Overall Study|Sponsor Decision|1|||
105685812|NCT04620811|364512858|FG000|Overall Study|Elevation of ALT or AST|1|||
105685813|NCT04620811|364512859|FG001|Overall Study|Elevation of ALT or AST|0|||
105685814|NCT04620811|364512858|FG000|Overall Study|Other|3|||
105685815|NCT04620811|364512859|FG001|Overall Study|Other|5|||
105685816|NCT02683941|364512862|FG000|Double-blind Phase|Adverse Event|0|||
105685817|NCT02683941|364512863|FG001|Double-blind Phase|Adverse Event|1|||
105685818|NCT02683941|364512862|FG000|Double-blind Phase|Withdrawal by Subject|4|||
105685819|NCT02683941|364512863|FG001|Double-blind Phase|Withdrawal by Subject|2|||
105685820|NCT02683941|364512862|FG000|Double-blind Phase|Lost to Follow-up|1|||
105685821|NCT02683941|364512863|FG001|Double-blind Phase|Lost to Follow-up|0|||
105685822|NCT02683941|364512862|FG000|Double-blind Phase|Disease Progression|5|||
105685823|NCT02683941|364512863|FG001|Double-blind Phase|Disease Progression|2|||
105685824|NCT02683941|364512862|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
105685825|NCT02683941|364512863|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
105685826|NCT02683941|364512862|FG000|Open-label Treatment Phase|Disease Progression|1|||
105685827|NCT02683941|364512863|FG001|Open-label Treatment Phase|Disease Progression|2|||
105685828|NCT02683941|364512862|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
105685829|NCT02683941|364512863|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
105685830|NCT02683941|364512862|FG000|Open-label Treatment Phase|Other|1|||
105685831|NCT02683941|364512863|FG001|Open-label Treatment Phase|Other|0|||
105685832|NCT02683941|364512862|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
105685833|NCT02683941|364512863|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
105685834|NCT02683941|364512862|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
105685835|NCT02683941|364512863|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
105685836|NCT02683941|364512862|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
105685837|NCT02683941|364512863|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
105685838|NCT02683941|364512862|FG000|Open-label Follow-up Phase|Other|8|||
105685839|NCT02683941|364512863|FG001|Open-label Follow-up Phase|Other|1|||
105685840|NCT02168842|364512865|FG000|Overall Study|Withdrawal by Subject|5|||
105685841|NCT02168842|364512866|FG001|Overall Study|Withdrawal by Subject|3|||
105685842|NCT02168842|364512865|FG000|Overall Study|Lost to Follow-up|0|||
105685843|NCT02168842|364512866|FG001|Overall Study|Lost to Follow-up|2|||
105685844|NCT02168842|364512865|FG000|Overall Study|Death|2|||
105685845|NCT02168842|364512866|FG001|Overall Study|Death|1|||
105685846|NCT02168842|364512865|FG000|Overall Study|Physician Decision|1|||
105685847|NCT02168842|364512866|FG001|Overall Study|Physician Decision|2|||
105685848|NCT02745392|364512867|FG000|Overall Study|Lost to Follow-up|0|||
105470374|NCT02039843|363731798|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
105786573|NCT02147132|364872829|FG001|Overall Study|Lost to Follow-up|0|||
105470375|NCT02039843|363731797|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
105470376|NCT02039843|363731798|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
105685849|NCT02745392|364512868|FG001|Overall Study|Lost to Follow-up|1|||
105685850|NCT02745392|364512869|FG002|Overall Study|Lost to Follow-up|0|||
105786574|NCT02147132|364872830|FG002|Overall Study|Lost to Follow-up|0|||
105786575|NCT02147132|364872831|FG003|Overall Study|Lost to Follow-up|0|||
105470377|NCT02039843|363731797|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
105786576|NCT01013207|364872832|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
105685851|NCT02745392|364512870|FG003|Overall Study|Lost to Follow-up|0|||
105685852|NCT02974088|364512871|FG000|Overall Study|Lost to Follow-up|0|||
105685853|NCT02974088|364512872|FG001|Overall Study|Lost to Follow-up|2|||
105685854|NCT02974088|364512871|FG000|Overall Study|Adverse Event|0|||
105685855|NCT02974088|364512872|FG001|Overall Study|Adverse Event|1|||
105685856|NCT00150969|364512875|FG000|24 Month Main Study|Adverse Event|3|||
105685857|NCT00150969|364512876|FG001|24 Month Main Study|Adverse Event|4|||
105685858|NCT00150969|364512875|FG000|24 Month Main Study|Death|1|||
105685859|NCT00150969|364512876|FG001|24 Month Main Study|Death|1|||
105685860|NCT00150969|364512875|FG000|24 Month Main Study|Lack of Efficacy|1|||
105685861|NCT00150969|364512876|FG001|24 Month Main Study|Lack of Efficacy|8|||
105685862|NCT00150969|364512875|FG000|24 Month Main Study|Lost to Follow-up|3|||
105685863|NCT00150969|364512876|FG001|24 Month Main Study|Lost to Follow-up|2|||
105685864|NCT00150969|364512875|FG000|24 Month Main Study|Protocol Violation|4|||
105685865|NCT00150969|364512876|FG001|24 Month Main Study|Protocol Violation|2|||
105685866|NCT00150969|364512875|FG000|24 Month Main Study|Withdrawal by Subject|7|||
105685867|NCT00150969|364512876|FG001|24 Month Main Study|Withdrawal by Subject|4|||
105685868|NCT00150969|364512875|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
105685869|NCT00150969|364512876|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
105685870|NCT00150969|364512875|FG000|24-48 Month Extension|Lack of Efficacy|0|||
105685871|NCT00150969|364512876|FG001|24-48 Month Extension|Lack of Efficacy|1|||
105685872|NCT00150969|364512875|FG000|24-48 Month Extension|Adverse Event|1|||
105685873|NCT00150969|364512876|FG001|24-48 Month Extension|Adverse Event|3|||
105685874|NCT00150969|364512875|FG000|24-48 Month Extension|Other Reason|81|||
105685875|NCT00150969|364512876|FG001|24-48 Month Extension|Other Reason|91|||
105685876|NCT01313689|364512880|FG000|24-Week Randomization 1|Adverse Event|10|||
105685877|NCT01313689|364512881|FG001|24-Week Randomization 1|Adverse Event|5|||
105685878|NCT01313689|364512882|FG002|24-Week Randomization 1|Adverse Event|0|||
105685879|NCT01313689|364512883|FG003|24-Week Randomization 1|Adverse Event|0|||
105685880|NCT01313689|364512884|FG004|24-Week Randomization 1|Adverse Event|0|||
105685881|NCT01313689|364512880|FG000|24-Week Randomization 1|Physician Decision|4|||
105470378|NCT02039843|363731798|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
105470379|NCT01519167|363731799|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
105470380|NCT01519167|363731800|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
105470381|NCT01519167|363731799|FG000|Overall Study|Adverse Event|0|||
105470382|NCT01519167|363731800|FG001|Overall Study|Adverse Event|1|||
105470383|NCT01519167|363731799|FG000|Overall Study|Lack of Efficacy|0|||
105470384|NCT01519167|363731800|FG001|Overall Study|Lack of Efficacy|1|||
105470385|NCT01519167|363731799|FG000|Overall Study|Medical condition changes&deep sedation|0|||
105470386|NCT01519167|363731800|FG001|Overall Study|Medical condition changes&deep sedation|2|||
105470387|NCT01519167|363731799|FG000|Overall Study|Physician Decision|0|||
105470388|NCT01519167|363731800|FG001|Overall Study|Physician Decision|1|||
105470389|NCT02541604|363731801|FG000|Overall Study|Death|6|||
105470390|NCT02541604|363731802|FG001|Overall Study|Death|5|||
105470391|NCT02541604|363731803|FG002|Overall Study|Death|7|||
105470392|NCT02541604|363731804|FG003|Overall Study|Death|2|||
105470393|NCT02541604|363731805|FG004|Overall Study|Death|9|||
105470394|NCT02541604|363731806|FG005|Overall Study|Death|8|||
105470395|NCT02541604|363731807|FG006|Overall Study|Death|9|||
105470396|NCT02541604|363731808|FG007|Overall Study|Death|9|||
105470397|NCT02541604|363731809|FG008|Overall Study|Death|3|||
105470398|NCT02541604|363731810|FG009|Overall Study|Death|4|||
105470399|NCT02541604|363731811|FG010|Overall Study|Death|2|||
105470400|NCT02541604|363731812|FG011|Overall Study|Death|3|||
105470401|NCT02541604|363731801|FG000|Overall Study|Lost to Follow-up|2|||
105470402|NCT02541604|363731802|FG001|Overall Study|Lost to Follow-up|0|||
105470403|NCT02541604|363731803|FG002|Overall Study|Lost to Follow-up|1|||
105470404|NCT02541604|363731804|FG003|Overall Study|Lost to Follow-up|0|||
105470405|NCT02541604|363731805|FG004|Overall Study|Lost to Follow-up|0|||
105470406|NCT02541604|363731806|FG005|Overall Study|Lost to Follow-up|1|||
105470407|NCT02541604|363731807|FG006|Overall Study|Lost to Follow-up|1|||
105470408|NCT02541604|363731808|FG007|Overall Study|Lost to Follow-up|0|||
105470409|NCT02541604|363731809|FG008|Overall Study|Lost to Follow-up|0|||
105470410|NCT02541604|363731810|FG009|Overall Study|Lost to Follow-up|0|||
105685882|NCT01313689|364512881|FG001|24-Week Randomization 1|Physician Decision|5|||
105685883|NCT01313689|364512882|FG002|24-Week Randomization 1|Physician Decision|0|||
105685884|NCT01313689|364512883|FG003|24-Week Randomization 1|Physician Decision|0|||
105685885|NCT01313689|364512884|FG004|24-Week Randomization 1|Physician Decision|0|||
105685886|NCT01313689|364512880|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
105685887|NCT01313689|364512881|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
105470411|NCT02541604|363731811|FG010|Overall Study|Lost to Follow-up|0|||
105470412|NCT02541604|363731812|FG011|Overall Study|Lost to Follow-up|0|||
105685888|NCT01313689|364512882|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
105685889|NCT01313689|364512883|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
105685890|NCT01313689|364512884|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
105685891|NCT01313689|364512880|FG000|24-Week Randomization 2|Adverse Event|0|||
105685892|NCT01313689|364512881|FG001|24-Week Randomization 2|Adverse Event|0|||
105685893|NCT01313689|364512882|FG002|24-Week Randomization 2|Adverse Event|2|||
105685894|NCT01313689|364512883|FG003|24-Week Randomization 2|Adverse Event|0|||
105685895|NCT01313689|364512884|FG004|24-Week Randomization 2|Adverse Event|8|||
105685896|NCT01313689|364512880|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
105685897|NCT01313689|364512881|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
105685898|NCT01313689|364512882|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
105685899|NCT01313689|364512883|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
105685900|NCT01313689|364512884|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
105685901|NCT01313689|364512880|FG000|24-Week Randomization 2|Physician Decision|0|||
105685902|NCT01313689|364512881|FG001|24-Week Randomization 2|Physician Decision|0|||
105685903|NCT01313689|364512882|FG002|24-Week Randomization 2|Physician Decision|0|||
105685904|NCT01313689|364512883|FG003|24-Week Randomization 2|Physician Decision|0|||
105685905|NCT01313689|364512884|FG004|24-Week Randomization 2|Physician Decision|4|||
105685906|NCT02121834|364512885|FG000|Overall Study|Protocol Violation|0|||
105685907|NCT02121834|364512886|FG001|Overall Study|Protocol Violation|1|||
105685908|NCT02121834|364512887|FG002|Overall Study|Protocol Violation|0|||
105685909|NCT02121834|364512888|FG003|Overall Study|Protocol Violation|0|||
105685910|NCT02121834|364512889|FG004|Overall Study|Protocol Violation|0|||
105685911|NCT02121834|364512890|FG005|Overall Study|Protocol Violation|0|||
105685912|NCT02121834|364512891|FG006|Overall Study|Protocol Violation|0|||
105685913|NCT02121834|364512885|FG000|Overall Study|Withdrawal by Subject|0|||
105685914|NCT02121834|364512886|FG001|Overall Study|Withdrawal by Subject|1|||
105685915|NCT02121834|364512887|FG002|Overall Study|Withdrawal by Subject|1|||
105685916|NCT02121834|364512888|FG003|Overall Study|Withdrawal by Subject|0|||
105685917|NCT02121834|364512889|FG004|Overall Study|Withdrawal by Subject|0|||
105685918|NCT02121834|364512890|FG005|Overall Study|Withdrawal by Subject|0|||
105685919|NCT02121834|364512891|FG006|Overall Study|Withdrawal by Subject|0|||
105685920|NCT02121834|364512885|FG000|Overall Study|Lost to Follow-up|0|||
105685921|NCT02121834|364512886|FG001|Overall Study|Lost to Follow-up|0|||
105685922|NCT02121834|364512887|FG002|Overall Study|Lost to Follow-up|1|||
105685923|NCT02121834|364512888|FG003|Overall Study|Lost to Follow-up|0|||
105685924|NCT02121834|364512889|FG004|Overall Study|Lost to Follow-up|0|||
105685925|NCT02121834|364512890|FG005|Overall Study|Lost to Follow-up|0|||
105685926|NCT02121834|364512891|FG006|Overall Study|Lost to Follow-up|0|||
105685927|NCT00551460|364512892|FG000|Overall Study|Adverse Event|1|||
105685928|NCT00551460|364512892|FG000|Overall Study|Withdrawal by Subject|1|||
105685929|NCT00551460|364512892|FG000|Overall Study|Physician Decision|1|||
105685930|NCT00551460|364512892|FG000|Overall Study|Death|7|||
105685931|NCT00551460|364512892|FG000|Overall Study|Ineligible|4|||
105685932|NCT00551460|364512892|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
105685933|NCT02578862|364512893|FG000|Overall Study|Withdrawal by Subject|0|||
105685934|NCT02578862|364512894|FG001|Overall Study|Withdrawal by Subject|1|||
105685935|NCT02578862|364512893|FG000|Overall Study|Unplanned unilateral procedure|0|||
105685936|NCT02578862|364512894|FG001|Overall Study|Unplanned unilateral procedure|1|||
105685937|NCT02027623|364512895|FG000|Overall Study|Lost to Follow-up|3|||
105685938|NCT02027623|364512896|FG001|Overall Study|Lost to Follow-up|3|||
105685939|NCT02027623|364512895|FG000|Overall Study|Withdrawal by Subject|6|||
105685940|NCT02027623|364512896|FG001|Overall Study|Withdrawal by Subject|9|||
105685941|NCT02019927|364512897|FG000|Overall Study|Lost to Follow-up|2|||
105685942|NCT02019927|364512898|FG001|Overall Study|Lost to Follow-up|4|||
105685943|NCT02019927|364512899|FG002|Overall Study|Lost to Follow-up|1|||
105685944|NCT02019927|364512900|FG003|Overall Study|Lost to Follow-up|2|||
105685945|NCT02019927|364512901|FG004|Overall Study|Lost to Follow-up|3|||
105685946|NCT02019927|364512902|FG005|Overall Study|Lost to Follow-up|1|||
105685947|NCT02434939|364512905|FG000|Overall Study|Lack of Efficacy|34|||
105685948|NCT02434939|364512906|FG001|Overall Study|Lack of Efficacy|48|||
105685949|NCT02434939|364512905|FG000|Overall Study|Withdrawal by Subject|3|||
105685950|NCT02434939|364512906|FG001|Overall Study|Withdrawal by Subject|0|||
105685951|NCT02434939|364512905|FG000|Overall Study|Adverse Event|0|||
105685952|NCT02434939|364512906|FG001|Overall Study|Adverse Event|1|||
105685953|NCT00928447|364512909|FG000|Overall Study|Withdrawal by Subject|1|||
105685954|NCT00928447|364512909|FG000|Overall Study|Investigator's decision|1|||
105685955|NCT03021954|364512912|FG000|Overall Study|Lost to Follow-up|10|||
105685956|NCT03021954|364512913|FG001|Overall Study|Lost to Follow-up|43|||
105685957|NCT03021954|364512912|FG000|Overall Study|Subjects had avulsion trauma|4|||
105685958|NCT03021954|364512913|FG001|Overall Study|Subjects had avulsion trauma|1|||
105685959|NCT00069238|364512914|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
105685960|NCT00069238|364512915|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
105685961|NCT00069238|364512916|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
105685962|NCT00069238|364512914|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
105685963|NCT00069238|364512915|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
105685964|NCT00069238|364512916|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
105685965|NCT00069238|364512914|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
105685966|NCT00069238|364512915|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
105685967|NCT00069238|364512916|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
105685968|NCT01001832|364512917|FG000|Short-term Period|Adverse Event|2|||
105685969|NCT01001832|364512918|FG001|Short-term Period|Adverse Event|3|||
105685970|NCT01001832|364512917|FG000|Long-term Period|Adverse Event|2|||
105685971|NCT01001832|364512918|FG001|Long-term Period|Adverse Event|1|||
105685972|NCT01001832|364512917|FG000|Long-term Period|Withdrawal by Subject|1|||
105685973|NCT01001832|364512918|FG001|Long-term Period|Withdrawal by Subject|0|||
105685974|NCT01001832|364512917|FG000|Long-term Period|Lack of Efficacy|0|||
105685975|NCT01001832|364512918|FG001|Long-term Period|Lack of Efficacy|2|||
105685976|NCT01001832|364512917|FG000|Long-term Period|Other|1|||
105685977|NCT01001832|364512918|FG001|Long-term Period|Other|2|||
105685978|NCT01001832|364512917|FG000|Follow-up Period|Withdrawal by Subject|1|||
105685979|NCT01001832|364512918|FG001|Follow-up Period|Withdrawal by Subject|0|||
105685980|NCT01001832|364512917|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
105685981|NCT01001832|364512918|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
105685982|NCT01001832|364512917|FG000|Follow-up Period|Other|2|||
105685983|NCT01001832|364512918|FG001|Follow-up Period|Other|1|||
105685984|NCT00412971|364512922|FG000|Overall Study|Lost to Follow-up|17|||
105685985|NCT00412971|364512923|FG001|Overall Study|Lost to Follow-up|9|||
105685986|NCT00412971|364512922|FG000|Overall Study|Protocol Violation|13|||
105685987|NCT00412971|364512923|FG001|Overall Study|Protocol Violation|1|||
105685988|NCT00985153|364512924|FG000|Overall Study|Lost to Follow-up|16|||
105685989|NCT00985153|364512925|FG001|Overall Study|Lost to Follow-up|19|||
105685990|NCT00985153|364512926|FG002|Overall Study|Lost to Follow-up|17|||
105685991|NCT00985153|364512927|FG003|Overall Study|Lost to Follow-up|20|||
105685992|NCT00985153|364512924|FG000|Overall Study|Protocol Violation|3|||
105685993|NCT00985153|364512925|FG001|Overall Study|Protocol Violation|2|||
105685994|NCT00985153|364512926|FG002|Overall Study|Protocol Violation|4|||
105685995|NCT00985153|364512927|FG003|Overall Study|Protocol Violation|3|||
105685996|NCT00985153|364512924|FG000|Overall Study|Withdrawal by Subject|6|||
105685997|NCT00985153|364512925|FG001|Overall Study|Withdrawal by Subject|11|||
105685998|NCT00985153|364512926|FG002|Overall Study|Withdrawal by Subject|11|||
105685999|NCT00985153|364512927|FG003|Overall Study|Withdrawal by Subject|10|||
105686000|NCT00985153|364512924|FG000|Overall Study|Missed One or More Bleeds|7|||
105686001|NCT00985153|364512925|FG001|Overall Study|Missed One or More Bleeds|7|||
105686002|NCT00985153|364512926|FG002|Overall Study|Missed One or More Bleeds|8|||
105686003|NCT00985153|364512927|FG003|Overall Study|Missed One or More Bleeds|10|||
105686004|NCT00985153|364512924|FG000|Overall Study|Incomplete Safety Follow-up|3|||
105686005|NCT00985153|364512925|FG001|Overall Study|Incomplete Safety Follow-up|5|||
105686006|NCT00985153|364512926|FG002|Overall Study|Incomplete Safety Follow-up|4|||
105686007|NCT00985153|364512927|FG003|Overall Study|Incomplete Safety Follow-up|4|||
105686008|NCT00561951|364512929|FG000|Overall Study|Adverse Event|11|||
105686009|NCT00561951|364512930|FG001|Overall Study|Adverse Event|14|||
105686010|NCT00561951|364512931|FG002|Overall Study|Adverse Event|14|||
105686011|NCT00561951|364512929|FG000|Overall Study|Lack of Efficacy|5|||
105686012|NCT00561951|364512930|FG001|Overall Study|Lack of Efficacy|3|||
105686013|NCT00561951|364512931|FG002|Overall Study|Lack of Efficacy|2|||
105686014|NCT00561951|364512929|FG000|Overall Study|Lost to Follow-up|1|||
105686015|NCT00561951|364512930|FG001|Overall Study|Lost to Follow-up|1|||
105686016|NCT00561951|364512931|FG002|Overall Study|Lost to Follow-up|0|||
105686017|NCT00561951|364512929|FG000|Overall Study|Withdrawal by Subject|10|||
105686018|NCT00561951|364512930|FG001|Overall Study|Withdrawal by Subject|9|||
105686019|NCT00561951|364512931|FG002|Overall Study|Withdrawal by Subject|10|||
105686020|NCT00561951|364512929|FG000|Overall Study|Protocol Violation|4|||
105686021|NCT00561951|364512930|FG001|Overall Study|Protocol Violation|3|||
105686022|NCT00561951|364512931|FG002|Overall Study|Protocol Violation|4|||
105686023|NCT00561951|364512929|FG000|Overall Study|Physician Decision|1|||
105470413|NCT02541604|363731801|FG000|Overall Study|Withdrawal by Subject|2|||
105470414|NCT02541604|363731802|FG001|Overall Study|Withdrawal by Subject|0|||
105470415|NCT02541604|363731803|FG002|Overall Study|Withdrawal by Subject|1|||
105470416|NCT02541604|363731804|FG003|Overall Study|Withdrawal by Subject|0|||
105686024|NCT00561951|364512930|FG001|Overall Study|Physician Decision|0|||
105686025|NCT00561951|364512931|FG002|Overall Study|Physician Decision|0|||
105686026|NCT00561951|364512929|FG000|Overall Study|Pregnancy|0|||
105686027|NCT00561951|364512930|FG001|Overall Study|Pregnancy|1|||
105686028|NCT00561951|364512931|FG002|Overall Study|Pregnancy|0|||
105470417|NCT02541604|363731805|FG004|Overall Study|Withdrawal by Subject|1|||
105686029|NCT00561951|364512929|FG000|Overall Study|Meet Withdrawal Criterion|0|||
105686030|NCT00561951|364512930|FG001|Overall Study|Meet Withdrawal Criterion|1|||
105686031|NCT00561951|364512931|FG002|Overall Study|Meet Withdrawal Criterion|1|||
105686032|NCT00561951|364512929|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
105686033|NCT00561951|364512930|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
105686034|NCT00561951|364512931|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
105686035|NCT04508023|364512932|FG000|Overall Study|Withdrawal by Subject|1|||
105686036|NCT04508023|364512933|FG001|Overall Study|Withdrawal by Subject|2|||
105686037|NCT02668185|364512936|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
105686038|NCT02668185|364512937|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
105686039|NCT02668185|364512936|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
105686040|NCT02668185|364512937|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
105686041|NCT02668185|364512936|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
105686042|NCT02668185|364512937|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
105686043|NCT02668185|364512936|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
105686044|NCT02668185|364512937|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
105686045|NCT01013597|364512938|FG000|Overall Study|Withdrawal by Subject|1|||
105686046|NCT02678247|364512939|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
105686047|NCT02678247|364512940|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
105686048|NCT02678247|364512939|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
105686049|NCT02678247|364512940|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
105686050|NCT02678247|364512939|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
105686051|NCT02678247|364512940|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
105686052|NCT02678247|364512939|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
105686053|NCT02678247|364512940|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
105686054|NCT02678247|364512939|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
105686055|NCT02678247|364512940|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
105686056|NCT02678247|364512939|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
105686057|NCT02678247|364512940|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
105686058|NCT01313117|364512941|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
105686059|NCT01313117|364512941|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
105686060|NCT03440320|364514571|FG000|Overall Study|Withdrawal by Subject|0|||
105686061|NCT03440320|364514572|FG001|Overall Study|Withdrawal by Subject|1|||
105686062|NCT01912456|364514573|FG000|Period 1|Physician Decision|0|||
105686063|NCT01912456|364514574|FG001|Period 1|Physician Decision|0|||
105686064|NCT01912456|364514575|FG002|Period 1|Physician Decision|1|||
105686065|NCT01912456|364514576|FG003|Period 1|Physician Decision|0|||
105686066|NCT01912456|364514573|FG000|Period 1|non-compliance|1|||
105686067|NCT01912456|364514574|FG001|Period 1|non-compliance|0|||
105686068|NCT01912456|364514575|FG002|Period 1|non-compliance|0|||
105686069|NCT01912456|364514576|FG003|Period 1|non-compliance|1|||
105686070|NCT01912456|364514573|FG000|Period 1|Adverse Event|1|||
105686071|NCT01912456|364514574|FG001|Period 1|Adverse Event|0|||
105686072|NCT01912456|364514575|FG002|Period 1|Adverse Event|0|||
105686073|NCT01912456|364514576|FG003|Period 1|Adverse Event|1|||
105686074|NCT01912456|364514573|FG000|Period 1|Withdrawal by Subject|0|||
105686075|NCT01912456|364514574|FG001|Period 1|Withdrawal by Subject|1|||
105686076|NCT01912456|364514575|FG002|Period 1|Withdrawal by Subject|1|||
105686077|NCT01912456|364514576|FG003|Period 1|Withdrawal by Subject|1|||
105686078|NCT01912456|364514573|FG000|Period 2|Lack of Efficacy|0|||
105686079|NCT01912456|364514574|FG001|Period 2|Lack of Efficacy|2|||
105686080|NCT01912456|364514575|FG002|Period 2|Lack of Efficacy|0|||
105686081|NCT01912456|364514576|FG003|Period 2|Lack of Efficacy|0|||
105686082|NCT01912456|364514573|FG000|Period 2|Adverse Event|0|||
105686083|NCT01912456|364514574|FG001|Period 2|Adverse Event|0|||
105686084|NCT01912456|364514575|FG002|Period 2|Adverse Event|0|||
105686085|NCT01912456|364514576|FG003|Period 2|Adverse Event|1|||
105686086|NCT00252733|364514585|FG000|Overall Study|Withdrawal by Subject|73|||
105686087|NCT00252733|364514586|FG001|Overall Study|Withdrawal by Subject|67|||
105686088|NCT00252733|364514585|FG000|Overall Study|Death|7|||
105470418|NCT02541604|363731806|FG005|Overall Study|Withdrawal by Subject|1|||
105470419|NCT02541604|363731807|FG006|Overall Study|Withdrawal by Subject|0|||
105686089|NCT00252733|364514586|FG001|Overall Study|Death|5|||
105686090|NCT00252733|364514585|FG000|Overall Study|Lost to Follow-up|12|||
105686091|NCT00252733|364514586|FG001|Overall Study|Lost to Follow-up|6|||
105686092|NCT00252733|364514585|FG000|Overall Study|Multiple Reasons|14|||
105686093|NCT00252733|364514586|FG001|Overall Study|Multiple Reasons|14|||
105686094|NCT05220254|364514588|FG000|Overall Study|Withdrawal by Subject|4|||
105686095|NCT05220254|364514588|FG000|Overall Study|Removed due to ineligibility|1|||
105686096|NCT05220254|364514588|FG000|Overall Study|Lost to Follow-up|7|||
105470420|NCT02541604|363731808|FG007|Overall Study|Withdrawal by Subject|0|||
105686097|NCT01211197|364514590|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105686098|NCT01211197|364514591|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105686099|NCT01211197|364514592|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
105686100|NCT01211197|364514593|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105686101|NCT01211197|364514594|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105686102|NCT01211197|364514595|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105686103|NCT01211197|364514590|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
105686104|NCT01211197|364514591|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
105686105|NCT01211197|364514592|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
105686106|NCT01211197|364514593|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
105686107|NCT01211197|364514594|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
105686108|NCT01211197|364514595|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
105686109|NCT00261846|364514596|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
105686110|NCT00261846|364514597|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
105686111|NCT00261846|364514598|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
105686112|NCT00261846|364514599|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686113|NCT00261846|364514600|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686114|NCT00261846|364514601|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686115|NCT00261846|364514602|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686116|NCT00261846|364514603|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686117|NCT00261846|364514604|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686118|NCT00261846|364514605|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686119|NCT00261846|364514606|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686120|NCT00261846|364514607|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686121|NCT00261846|364514596|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686122|NCT00261846|364514597|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686123|NCT00261846|364514598|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686124|NCT00261846|364514599|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
105686125|NCT00261846|364514600|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686126|NCT00261846|364514601|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686127|NCT00261846|364514602|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686128|NCT00261846|364514603|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686129|NCT00261846|364514604|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
105686130|NCT00261846|364514605|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686131|NCT00261846|364514606|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686132|NCT00261846|364514607|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686133|NCT00261846|364514596|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
105686134|NCT00261846|364514597|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
105686135|NCT00261846|364514598|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
105686136|NCT00261846|364514599|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
105686137|NCT00261846|364514600|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
105686138|NCT00261846|364514601|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
105686139|NCT00261846|364514602|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
105686140|NCT00261846|364514603|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
105686141|NCT00261846|364514604|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
105686142|NCT00261846|364514605|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
105686143|NCT00261846|364514606|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
105686144|NCT00261846|364514607|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
105686145|NCT00261846|364514596|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
105686146|NCT00261846|364514597|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
105686147|NCT00261846|364514598|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
105686148|NCT00261846|364514599|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
105686149|NCT00261846|364514600|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
105686150|NCT00261846|364514601|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
105686151|NCT00261846|364514602|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
105686152|NCT00261846|364514603|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
105686153|NCT00261846|364514604|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
105686154|NCT00261846|364514605|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
105686155|NCT00261846|364514606|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
105686156|NCT00261846|364514607|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
105686157|NCT00261846|364514596|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
105686158|NCT00261846|364514597|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
105344730|NCT03226678|363263491|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
105686159|NCT00261846|364514598|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
105686160|NCT00261846|364514599|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
105686161|NCT00261846|364514600|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
105686162|NCT00261846|364514601|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
105686163|NCT00261846|364514602|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
105686164|NCT00261846|364514603|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
105686165|NCT00261846|364514604|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
105686166|NCT00261846|364514605|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
105686167|NCT00261846|364514606|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
105686168|NCT00261846|364514607|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
105686169|NCT00261846|364514596|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
105686170|NCT00261846|364514597|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
105686171|NCT00261846|364514598|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
105686172|NCT00261846|364514599|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
105686173|NCT00261846|364514600|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
105686174|NCT00261846|364514601|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
105686175|NCT00261846|364514602|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
105686176|NCT00261846|364514603|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
105686177|NCT00261846|364514604|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
105686178|NCT00261846|364514605|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
105686179|NCT00261846|364514606|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
105686180|NCT00261846|364514607|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
105786577|NCT01541644|364872838|FG000|Overall Study|Withdrawal by Subject|3|||
105686181|NCT00261846|364514596|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
105686182|NCT00261846|364514597|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
105686183|NCT00261846|364514598|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
105686184|NCT00261846|364514599|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
105686185|NCT00261846|364514600|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
105686186|NCT00261846|364514601|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
105686187|NCT00261846|364514602|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
105686188|NCT00261846|364514603|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
105686189|NCT00261846|364514604|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
105686190|NCT00261846|364514605|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
105686191|NCT00261846|364514606|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
105686192|NCT00261846|364514607|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
105686193|NCT00325039|364514610|FG000|Overall Study|Lost to Follow-up|18|||
105686194|NCT00325039|364514611|FG001|Overall Study|Lost to Follow-up|14|||
105686195|NCT01009203|364514613|FG000|Overall Study|Withdrawal by Subject|1|||
105686196|NCT01009203|364514613|FG000|Overall Study|Adverse Event|5|||
105686197|NCT01009203|364514613|FG000|Overall Study|Treatment-unrelated death|1|||
105686198|NCT00892723|364514614|FG000|Overall Study|Lost to Follow-up|1|||
105686199|NCT00892723|364514615|FG001|Overall Study|Lost to Follow-up|3|||
105686200|NCT00892723|364514616|FG002|Overall Study|Lost to Follow-up|1|||
105686201|NCT00892723|364514614|FG000|Overall Study|Withdrawal by Subject|1|||
105686202|NCT00892723|364514615|FG001|Overall Study|Withdrawal by Subject|1|||
105686203|NCT00892723|364514616|FG002|Overall Study|Withdrawal by Subject|1|||
105686204|NCT01740323|364514624|FG000|Overall Study|Adverse Event|1|||
105686205|NCT01740323|364514625|FG001|Overall Study|Adverse Event|0|||
105686206|NCT01740323|364514624|FG000|Overall Study|Randomized but did not take study drug|1|||
105686207|NCT01740323|364514625|FG001|Overall Study|Randomized but did not take study drug|0|||
105686208|NCT02893930|364514626|FG000|Overall Study|Adverse Event|3|||
105686209|NCT02893930|364514626|FG000|Overall Study|Death|1|||
105686210|NCT02893930|364514626|FG000|Overall Study|Disease progression|5|||
105686211|NCT02893930|364514626|FG000|Overall Study|Withdrawal by Subject|2|||
105686212|NCT02893930|364514626|FG000|Overall Study|Physician Decision|1|||
105686213|NCT02893930|364514626|FG000|Overall Study|Ineligible|1|||
105686214|NCT01054846|364514627|FG000|Overall Study|Lost to Follow-up|76|||
105686215|NCT01054846|364514628|FG001|Overall Study|Lost to Follow-up|17|||
105686216|NCT02446886|364514629|FG000|Overall Study|Adverse Event|1|||
105686217|NCT02446886|364514630|FG001|Overall Study|Adverse Event|3|||
105686218|NCT02446886|364514629|FG000|Overall Study|Withdrawal by Subject|1|||
105686219|NCT02446886|364514630|FG001|Overall Study|Withdrawal by Subject|1|||
105686220|NCT01259284|364514631|FG000|Overall Study|Study Termination|2|||
105686221|NCT01259284|364514632|FG001|Overall Study|Study Termination|0|||
105786578|NCT02389621|364872839|FG000|Treatment Period|Withdrawal by Subject|1|||
105786579|NCT02389621|364872840|FG001|Treatment Period|Withdrawal by Subject|1|||
105786580|NCT02389621|364872839|FG000|Posttreatment Period|Adverse Event|3|||
105786581|NCT02389621|364872840|FG001|Posttreatment Period|Adverse Event|1|||
105470421|NCT02541604|363731809|FG008|Overall Study|Withdrawal by Subject|1|||
105470422|NCT02541604|363731810|FG009|Overall Study|Withdrawal by Subject|0|||
105686222|NCT01259284|364514633|FG002|Overall Study|Study Termination|0|||
105686223|NCT01668667|364514634|FG000|Overall Study|Adverse Event|3|||
105686224|NCT01668667|364514635|FG001|Overall Study|Adverse Event|6|||
105686225|NCT01668667|364514636|FG002|Overall Study|Adverse Event|4|||
105686226|NCT01668667|364514637|FG003|Overall Study|Adverse Event|4|||
105686227|NCT01668667|364514634|FG000|Overall Study|Lack of Efficacy|3|||
105686228|NCT01668667|364514635|FG001|Overall Study|Lack of Efficacy|2|||
105686229|NCT01668667|364514636|FG002|Overall Study|Lack of Efficacy|2|||
105686230|NCT01668667|364514637|FG003|Overall Study|Lack of Efficacy|3|||
105686231|NCT01668667|364514634|FG000|Overall Study|Protocol Violation|6|||
105686232|NCT01668667|364514635|FG001|Overall Study|Protocol Violation|10|||
105470423|NCT02541604|363731811|FG010|Overall Study|Withdrawal by Subject|0|||
105470424|NCT02541604|363731812|FG011|Overall Study|Withdrawal by Subject|0|||
105470425|NCT02541604|363731801|FG000|Overall Study|Study Terminated by Sponsor|1|||
105470426|NCT02541604|363731802|FG001|Overall Study|Study Terminated by Sponsor|4|||
105470427|NCT02541604|363731803|FG002|Overall Study|Study Terminated by Sponsor|2|||
105470428|NCT02541604|363731804|FG003|Overall Study|Study Terminated by Sponsor|1|||
105470429|NCT02541604|363731805|FG004|Overall Study|Study Terminated by Sponsor|0|||
105470430|NCT02541604|363731806|FG005|Overall Study|Study Terminated by Sponsor|0|||
105470431|NCT02541604|363731807|FG006|Overall Study|Study Terminated by Sponsor|0|||
105470432|NCT02541604|363731808|FG007|Overall Study|Study Terminated by Sponsor|0|||
105470433|NCT02541604|363731809|FG008|Overall Study|Study Terminated by Sponsor|0|||
105470434|NCT02541604|363731810|FG009|Overall Study|Study Terminated by Sponsor|0|||
105470435|NCT02541604|363731811|FG010|Overall Study|Study Terminated by Sponsor|0|||
105470436|NCT02541604|363731812|FG011|Overall Study|Study Terminated by Sponsor|0|||
105470437|NCT02541604|363731801|FG000|Overall Study|Medical condition may jeopardize safety|0|||
105470438|NCT02541604|363731802|FG001|Overall Study|Medical condition may jeopardize safety|0|||
105470439|NCT02541604|363731803|FG002|Overall Study|Medical condition may jeopardize safety|0|||
105470440|NCT02541604|363731804|FG003|Overall Study|Medical condition may jeopardize safety|0|||
105470441|NCT02541604|363731805|FG004|Overall Study|Medical condition may jeopardize safety|0|||
105470442|NCT02541604|363731806|FG005|Overall Study|Medical condition may jeopardize safety|0|||
105470443|NCT02541604|363731807|FG006|Overall Study|Medical condition may jeopardize safety|0|||
105470444|NCT02541604|363731808|FG007|Overall Study|Medical condition may jeopardize safety|1|||
105470445|NCT02541604|363731809|FG008|Overall Study|Medical condition may jeopardize safety|0|||
105470446|NCT02541604|363731810|FG009|Overall Study|Medical condition may jeopardize safety|0|||
105470447|NCT02541604|363731811|FG010|Overall Study|Medical condition may jeopardize safety|0|||
105470448|NCT02541604|363731812|FG011|Overall Study|Medical condition may jeopardize safety|0|||
105470449|NCT00993148|363731813|FG000|Overall Study|Lost to Follow-up|2|||
105470450|NCT00993148|363731813|FG000|Overall Study|never initiated treatment|1|||
105470451|NCT00806819|363731816|FG000|Overall Study|progressive disease (modified RECIST )|217|||
105470452|NCT00806819|363731817|FG001|Overall Study|progressive disease (modified RECIST )|216|||
105470453|NCT00806819|363731816|FG000|Overall Study|Worsening or AE of underlying disease|18|||
105470454|NCT00806819|363731817|FG001|Overall Study|Worsening or AE of underlying disease|25|||
105470455|NCT00806819|363731816|FG000|Overall Study|Other AE|38|||
105470456|NCT00806819|363731817|FG001|Overall Study|Other AE|40|||
105470457|NCT00806819|363731816|FG000|Overall Study|Protocol Violation|9|||
105470458|NCT00806819|363731817|FG001|Overall Study|Protocol Violation|4|||
105470459|NCT00806819|363731816|FG000|Overall Study|Lost to Follow-up|1|||
105470460|NCT00806819|363731817|FG001|Overall Study|Lost to Follow-up|0|||
105470461|NCT00806819|363731816|FG000|Overall Study|Withdrawal by Subject|32|||
105470462|NCT00806819|363731817|FG001|Overall Study|Withdrawal by Subject|29|||
105470463|NCT00806819|363731816|FG000|Overall Study|Not treated|6|||
105470464|NCT00806819|363731817|FG001|Overall Study|Not treated|3|||
105470465|NCT00806819|363731816|FG000|Overall Study|Reasons other than stated above|25|||
105470466|NCT00806819|363731817|FG001|Overall Study|Reasons other than stated above|41|||
105470467|NCT04393454|363731820|FG000|Overall Study|Death|1|||
105470468|NCT04393454|363731820|FG000|Overall Study|Lost to Follow-up|1|||
105470469|NCT01704599|363731823|FG000|Overall Study|Adverse Event|1|||
105470470|NCT04237116|363731824|FG000|Overall Study|Adverse Event|0|||
105470471|NCT04237116|363731825|FG001|Overall Study|Adverse Event|1|||
105470472|NCT04237116|363731824|FG000|Overall Study|Study terminated by Sponsor|4|||
105470473|NCT04237116|363731825|FG001|Overall Study|Study terminated by Sponsor|1|||
105470474|NCT00829504|363731826|FG000|First Intervention|Adverse Event|1|||
105470475|NCT00829504|363731827|FG001|First Intervention|Adverse Event|0|||
105470476|NCT00829504|363731826|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
105470477|NCT00829504|363731827|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
105470478|NCT00829504|363731826|FG000|Second Intervention|Physician Decision|1|||
105470479|NCT00829504|363731827|FG001|Second Intervention|Physician Decision|0|||
105470480|NCT02840461|363731828|FG000|Overall Study|Adverse Event|1|||
105470481|NCT02840461|363731829|FG001|Overall Study|Adverse Event|5|||
105470482|NCT02840461|363731830|FG002|Overall Study|Adverse Event|3|||
105470483|NCT02840461|363731828|FG000|Overall Study|Lost to Follow-up|10|||
105470484|NCT02840461|363731829|FG001|Overall Study|Lost to Follow-up|7|||
105470485|NCT02840461|363731830|FG002|Overall Study|Lost to Follow-up|6|||
105470486|NCT02840461|363731828|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
105470487|NCT02840461|363731829|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
105470488|NCT02840461|363731830|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
105470489|NCT02840461|363731828|FG000|Overall Study|Protocol Violation|2|||
105686233|NCT01668667|364514636|FG002|Overall Study|Protocol Violation|12|||
105686234|NCT01668667|364514637|FG003|Overall Study|Protocol Violation|5|||
105686235|NCT01668667|364514634|FG000|Overall Study|Lost to Follow-up|9|||
105686236|NCT01668667|364514635|FG001|Overall Study|Lost to Follow-up|4|||
105686237|NCT01668667|364514636|FG002|Overall Study|Lost to Follow-up|7|||
105686238|NCT01668667|364514637|FG003|Overall Study|Lost to Follow-up|6|||
105686239|NCT01668667|364514634|FG000|Overall Study|Physician Decision|3|||
105686240|NCT01668667|364514635|FG001|Overall Study|Physician Decision|0|||
105686241|NCT01668667|364514636|FG002|Overall Study|Physician Decision|1|||
105686242|NCT01668667|364514637|FG003|Overall Study|Physician Decision|0|||
105686243|NCT01668667|364514634|FG000|Overall Study|Withdrawal by Subject|7|||
105686244|NCT01668667|364514635|FG001|Overall Study|Withdrawal by Subject|4|||
105686245|NCT01668667|364514636|FG002|Overall Study|Withdrawal by Subject|5|||
105686246|NCT01668667|364514637|FG003|Overall Study|Withdrawal by Subject|5|||
105686247|NCT01281969|364514641|FG000|Overall Study|not randomized didn't meet criteria|0|||
105686248|NCT01281969|364514642|FG001|Overall Study|not randomized didn't meet criteria|0|||
105686249|NCT01281969|364514643|FG002|Overall Study|not randomized didn't meet criteria|7|||
105686250|NCT01281969|364514641|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
105686251|NCT01281969|364514642|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
105686252|NCT01281969|364514643|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
105686253|NCT01281969|364514641|FG000|Overall Study|not randomized, child consent not given|0|||
105686254|NCT01281969|364514642|FG001|Overall Study|not randomized, child consent not given|0|||
105686255|NCT01281969|364514643|FG002|Overall Study|not randomized, child consent not given|2|||
105686256|NCT01074216|364514644|FG000|Overall Study|Physician Decision|1|||
105686257|NCT01074216|364514644|FG000|Overall Study|Not Treated|12|||
105686258|NCT01723254|364514645|FG000|Overall Study|Conflict with work schedule|0|||
105686259|NCT01723254|364514646|FG001|Overall Study|Conflict with work schedule|0|||
105686260|NCT01723254|364514647|FG002|Overall Study|Conflict with work schedule|0|||
105686261|NCT01723254|364514648|FG003|Overall Study|Conflict with work schedule|0|||
105686262|NCT01723254|364514649|FG004|Overall Study|Conflict with work schedule|0|||
105686263|NCT01723254|364514650|FG005|Overall Study|Conflict with work schedule|0|||
105686264|NCT01723254|364514651|FG006|Overall Study|Conflict with work schedule|0|||
105686265|NCT01723254|364514652|FG007|Overall Study|Conflict with work schedule|1|||
105686266|NCT01723254|364514645|FG000|Overall Study|Personal issues|0|||
105686267|NCT01723254|364514646|FG001|Overall Study|Personal issues|0|||
105686268|NCT01723254|364514647|FG002|Overall Study|Personal issues|0|||
105686269|NCT01723254|364514648|FG003|Overall Study|Personal issues|0|||
105686270|NCT01723254|364514649|FG004|Overall Study|Personal issues|0|||
105686271|NCT01723254|364514650|FG005|Overall Study|Personal issues|1|||
105686272|NCT01723254|364514651|FG006|Overall Study|Personal issues|0|||
105686273|NCT01723254|364514652|FG007|Overall Study|Personal issues|0|||
105686274|NCT01723254|364514645|FG000|Overall Study|No longer have time to participate|0|||
105686275|NCT01723254|364514646|FG001|Overall Study|No longer have time to participate|0|||
105686276|NCT01723254|364514647|FG002|Overall Study|No longer have time to participate|0|||
105686277|NCT01723254|364514648|FG003|Overall Study|No longer have time to participate|1|||
105686278|NCT01723254|364514649|FG004|Overall Study|No longer have time to participate|0|||
105686279|NCT01723254|364514650|FG005|Overall Study|No longer have time to participate|0|||
105686280|NCT01723254|364514651|FG006|Overall Study|No longer have time to participate|0|||
105686281|NCT01723254|364514652|FG007|Overall Study|No longer have time to participate|0|||
105686282|NCT01723254|364514645|FG000|Overall Study|Move/Left to another country/city|0|||
105686283|NCT01723254|364514646|FG001|Overall Study|Move/Left to another country/city|0|||
105686284|NCT01723254|364514647|FG002|Overall Study|Move/Left to another country/city|2|||
105686285|NCT01723254|364514648|FG003|Overall Study|Move/Left to another country/city|1|||
105686286|NCT01723254|364514649|FG004|Overall Study|Move/Left to another country/city|1|||
105686287|NCT01723254|364514650|FG005|Overall Study|Move/Left to another country/city|0|||
105686288|NCT01723254|364514651|FG006|Overall Study|Move/Left to another country/city|0|||
105686289|NCT01723254|364514652|FG007|Overall Study|Move/Left to another country/city|0|||
105686290|NCT01723254|364514645|FG000|Overall Study|Protocol Violation|0|||
105686291|NCT01723254|364514646|FG001|Overall Study|Protocol Violation|1|||
105686292|NCT01723254|364514647|FG002|Overall Study|Protocol Violation|0|||
105686293|NCT01723254|364514648|FG003|Overall Study|Protocol Violation|0|||
105470490|NCT02840461|363731829|FG001|Overall Study|Protocol Violation|3|||
105686294|NCT01723254|364514649|FG004|Overall Study|Protocol Violation|0|||
105686295|NCT01723254|364514650|FG005|Overall Study|Protocol Violation|0|||
105470491|NCT02840461|363731830|FG002|Overall Study|Protocol Violation|1|||
105686296|NCT01723254|364514651|FG006|Overall Study|Protocol Violation|0|||
105686297|NCT01723254|364514652|FG007|Overall Study|Protocol Violation|0|||
105686298|NCT01723254|364514645|FG000|Overall Study|Withdrawal by Subject|1|||
105686299|NCT01723254|364514646|FG001|Overall Study|Withdrawal by Subject|2|||
105686300|NCT01723254|364514647|FG002|Overall Study|Withdrawal by Subject|1|||
105686301|NCT01723254|364514648|FG003|Overall Study|Withdrawal by Subject|0|||
105686302|NCT01723254|364514649|FG004|Overall Study|Withdrawal by Subject|1|||
105686303|NCT01723254|364514650|FG005|Overall Study|Withdrawal by Subject|1|||
105686304|NCT01723254|364514651|FG006|Overall Study|Withdrawal by Subject|1|||
105686305|NCT01723254|364514652|FG007|Overall Study|Withdrawal by Subject|2|||
105686306|NCT01323634|364514653|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
105686307|NCT01323634|364514654|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
105686308|NCT01323634|364514655|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
105470492|NCT02840461|363731828|FG000|Overall Study|Withdrawal by Subject|10|||
105470493|NCT02840461|363731829|FG001|Overall Study|Withdrawal by Subject|6|||
105470494|NCT02840461|363731830|FG002|Overall Study|Withdrawal by Subject|2|||
105470495|NCT02840461|363731828|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
105470496|NCT02840461|363731829|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
105470497|NCT02840461|363731830|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
105470498|NCT00599339|363731831|FG000|Overall Study|Adverse Event|79|||
105470499|NCT00599339|363731831|FG000|Overall Study|Withdrawal by Subject|137|||
105470500|NCT00599339|363731831|FG000|Overall Study|Other Reason|179|||
105470501|NCT00599339|363731831|FG000|Overall Study|Lost to Follow-up|221|||
105470502|NCT00599339|363731831|FG000|Overall Study|No valid data consent|36|||
105470503|NCT00599339|363731831|FG000|Overall Study|Study Termination Status Unknown|12|||
105470504|NCT00912197|363731834|FG000|Overall Study|Withdrawal by Subject|3|||
105470505|NCT00912197|363731835|FG001|Overall Study|Withdrawal by Subject|3|||
105470506|NCT01104311|363731838|FG000|Overall Study|Withdrawal by Subject|6|||
105470507|NCT01104311|363731839|FG001|Overall Study|Withdrawal by Subject|6|||
105470508|NCT01104311|363731838|FG000|Overall Study|Protocol Violation|0|||
105470509|NCT01104311|363731839|FG001|Overall Study|Protocol Violation|1|||
105470510|NCT01104311|363731838|FG000|Overall Study|Physician Decision|2|||
105470511|NCT01104311|363731839|FG001|Overall Study|Physician Decision|2|||
105470512|NCT01104311|363731838|FG000|Overall Study|low compliance|1|||
105470513|NCT01104311|363731839|FG001|Overall Study|low compliance|1|||
105470514|NCT01104311|363731838|FG000|Overall Study|Adverse Event|1|||
105470515|NCT01104311|363731839|FG001|Overall Study|Adverse Event|2|||
105470516|NCT01077050|363733829|FG000|Overall Study|Subjects signed ICF could not be located|1|||
105470517|NCT01077050|363733829|FG000|Overall Study|Screen failure|8|||
105470518|NCT01646125|363733831|FG000|Overall Study|Untreated|2|||
105470519|NCT01646125|363733832|FG001|Overall Study|Untreated|5|||
105470520|NCT01646125|363733831|FG000|Overall Study|Adverse Event|2|||
105470521|NCT01646125|363733832|FG001|Overall Study|Adverse Event|1|||
105470522|NCT01646125|363733831|FG000|Overall Study|Death|1|||
105470523|NCT01646125|363733832|FG001|Overall Study|Death|1|||
105470524|NCT01646125|363733831|FG000|Overall Study|Physician Decision|1|||
105470525|NCT01646125|363733832|FG001|Overall Study|Physician Decision|3|||
105470526|NCT01646125|363733831|FG000|Overall Study|Progressive disease|22|||
105470527|NCT01646125|363733832|FG001|Overall Study|Progressive disease|16|||
105470528|NCT01646125|363733831|FG000|Overall Study|Study terminated by sponsor|2|||
105470529|NCT01646125|363733832|FG001|Overall Study|Study terminated by sponsor|1|||
105470530|NCT01646125|363733831|FG000|Overall Study|Subject/Guardian decision|1|||
105470531|NCT01646125|363733832|FG001|Overall Study|Subject/Guardian decision|1|||
105470532|NCT02105662|363733833|FG000|Overall Study|Lost to Follow-up|5|||
105470533|NCT02105662|363733833|FG000|Overall Study|Withdrawal by Subject|1|||
105470534|NCT05462756|363733836|FG000|Treatment Period|Adverse Event|3|||
105470535|NCT05462756|363733837|FG001|Treatment Period|Adverse Event|0|||
105470536|NCT05462756|363733836|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
105470537|NCT05462756|363733837|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
105470538|NCT05462756|363733836|FG000|Treatment Period|Death|0|||
105470539|NCT05462756|363733837|FG001|Treatment Period|Death|1|||
105470540|NCT05462756|363733836|FG000|Treatment Period|Lost to Follow-up|2|||
105470541|NCT05462756|363733837|FG001|Treatment Period|Lost to Follow-up|1|||
105470542|NCT05462756|363733836|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
105470543|NCT05462756|363733837|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
105470544|NCT05462756|363733836|FG000|Treatment Period|Physician Decision|2|||
105470545|NCT05462756|363733837|FG001|Treatment Period|Physician Decision|0|||
105470546|NCT05462756|363733836|FG000|Treatment Period|Protocol Violation|0|||
105470547|NCT05462756|363733837|FG001|Treatment Period|Protocol Violation|1|||
105470548|NCT05462756|363733836|FG000|Treatment Period|Withdrawal by Subject|5|||
105470549|NCT05462756|363733837|FG001|Treatment Period|Withdrawal by Subject|12|||
105470550|NCT05462756|363733836|FG000|Follow-Up Period|Adverse Event|1|||
105470551|NCT05462756|363733837|FG001|Follow-Up Period|Adverse Event|0|||
105344731|NCT03226678|363263486|FG000|Part B (Long-Term Extension Phase)|Death|0|||
105344732|NCT03226678|363263487|FG001|Part B (Long-Term Extension Phase)|Death|0|||
105470552|NCT05462756|363733836|FG000|Follow-Up Period|Death|1|||
105470553|NCT05462756|363733837|FG001|Follow-Up Period|Death|0|||
105470554|NCT05462756|363733836|FG000|Follow-Up Period|Lost to Follow-up|3|||
105470555|NCT05462756|363733837|FG001|Follow-Up Period|Lost to Follow-up|1|||
105470556|NCT05462756|363733836|FG000|Follow-Up Period|Withdrawal by Subject|0|||
105470557|NCT05462756|363733837|FG001|Follow-Up Period|Withdrawal by Subject|4|||
105470558|NCT01354899|363733839|FG000|Overall Study|discharge from the hospital|2|||
105470559|NCT01354899|363733839|FG000|Overall Study|Protocol Violation|1|||
105470560|NCT01071798|363733840|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
105470561|NCT01071798|363733840|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
105470562|NCT01071798|363733840|FG000|Participants Who Received One Cycle|Patient requirement|20|||
105686309|NCT01323634|364514653|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
105686310|NCT01323634|364514654|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
105686311|NCT01323634|364514655|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
105686312|NCT01323634|364514653|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
105686313|NCT01323634|364514654|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
105686314|NCT01323634|364514655|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
105686315|NCT01323634|364514653|FG000|2-week Run-in Period|Physician Decision|5|||
105686316|NCT01323634|364514654|FG001|2-week Run-in Period|Physician Decision|0|||
105686317|NCT01323634|364514655|FG002|2-week Run-in Period|Physician Decision|0|||
105686318|NCT01323634|364514653|FG000|2-week Run-in Period|Protocol Violation|1|||
105686319|NCT01323634|364514654|FG001|2-week Run-in Period|Protocol Violation|0|||
105686320|NCT01323634|364514655|FG002|2-week Run-in Period|Protocol Violation|0|||
105686321|NCT01323634|364514653|FG000|2-week Run-in Period|Adverse Event|1|||
105686322|NCT01323634|364514654|FG001|2-week Run-in Period|Adverse Event|0|||
105686323|NCT01323634|364514655|FG002|2-week Run-in Period|Adverse Event|0|||
105686324|NCT01323634|364514653|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105686325|NCT01323634|364514654|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
105686326|NCT01323634|364514655|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
105686327|NCT01323634|364514653|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105686328|NCT01323634|364514654|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105686329|NCT01323634|364514655|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
105686330|NCT01323634|364514653|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105686331|NCT01323634|364514654|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
105686332|NCT01323634|364514655|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
105686333|NCT01323634|364514653|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105686334|NCT01323634|364514654|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
105686335|NCT01323634|364514655|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
105686336|NCT01323634|364514653|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
105686337|NCT01323634|364514654|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
105686338|NCT01323634|364514655|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
105686339|NCT01323634|364514653|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105686340|NCT01323634|364514654|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
105686341|NCT01323634|364514655|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
105686342|NCT01323634|364514653|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
105686343|NCT01323634|364514654|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
105686344|NCT01323634|364514655|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
105686345|NCT04640077|364514656|FG000|Period 1|Withdrawal by Subject|4|||
105686346|NCT04640077|364514657|FG001|Period 1|Withdrawal by Subject|5|||
105686347|NCT04640077|364514658|FG002|Period 1|Withdrawal by Subject|0|||
105686348|NCT04640077|364514656|FG000|Period 1|Adverse Event|1|||
105686349|NCT04640077|364514657|FG001|Period 1|Adverse Event|1|||
105686350|NCT04640077|364514658|FG002|Period 1|Adverse Event|0|||
105686351|NCT04640077|364514656|FG000|Period 1|Screen Failure|2|||
105686352|NCT04640077|364514657|FG001|Period 1|Screen Failure|0|||
105686353|NCT04640077|364514658|FG002|Period 1|Screen Failure|0|||
105686354|NCT04640077|364514656|FG000|Period 2|Withdrawal by Subject|0|||
105686355|NCT04640077|364514657|FG001|Period 2|Withdrawal by Subject|0|||
105686356|NCT04640077|364514658|FG002|Period 2|Withdrawal by Subject|18|||
105686357|NCT04640077|364514656|FG000|Period 2|Adverse Event|0|||
105686358|NCT04640077|364514657|FG001|Period 2|Adverse Event|0|||
105686359|NCT04640077|364514658|FG002|Period 2|Adverse Event|6|||
105686360|NCT04640077|364514656|FG000|Period 2|Lost to Follow-up|0|||
105686361|NCT04640077|364514657|FG001|Period 2|Lost to Follow-up|0|||
105686362|NCT04640077|364514658|FG002|Period 2|Lost to Follow-up|2|||
105686363|NCT04640077|364514656|FG000|Period 2|Death|0|||
105686364|NCT04640077|364514657|FG001|Period 2|Death|0|||
105686365|NCT04640077|364514658|FG002|Period 2|Death|2|||
105686366|NCT04640077|364514656|FG000|Period 2|Progressive Disease|0|||
105686367|NCT04640077|364514657|FG001|Period 2|Progressive Disease|0|||
105686368|NCT04640077|364514658|FG002|Period 2|Progressive Disease|1|||
105686369|NCT04640077|364514656|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
105686370|NCT04640077|364514657|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
105686371|NCT04640077|364514658|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
105686372|NCT05056987|364514659|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
105686373|NCT05056987|364514660|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
105686374|NCT05056987|364514659|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
105686375|NCT05056987|364514660|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
105686376|NCT01759407|364514662|FG000|Overall Study|Protocol Violation|0|||
105686377|NCT01759407|364514663|FG001|Overall Study|Protocol Violation|2|||
105686378|NCT00753272|364514670|FG000|Overall Study|Adverse Event|878|||
105686379|NCT00753272|364514671|FG001|Overall Study|Adverse Event|869|||
105686380|NCT00753272|364514670|FG000|Overall Study|Protocol Violation|28|||
105686381|NCT00753272|364514671|FG001|Overall Study|Protocol Violation|46|||
105686382|NCT00753272|364514670|FG000|Overall Study|Withdrawal by Subject|2481|||
105686383|NCT00753272|364514671|FG001|Overall Study|Withdrawal by Subject|2407|||
105686384|NCT00753272|364514670|FG000|Overall Study|Lost to Follow-up|491|||
105686385|NCT00753272|364514671|FG001|Overall Study|Lost to Follow-up|497|||
105686386|NCT00753272|364514670|FG000|Overall Study|Other|1104|||
105686387|NCT00753272|364514671|FG001|Overall Study|Other|1088|||
105686388|NCT02092220|364514674|FG000|Period 1|Unrelated Illness|0|||
105686389|NCT02092220|364514675|FG001|Period 1|Unrelated Illness|2|||
105686390|NCT02092220|364514674|FG000|Period 2|Severe Hypoglycaemia|1|||
105686391|NCT02092220|364514675|FG001|Period 2|Severe Hypoglycaemia|0|||
105686392|NCT02092220|364514674|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
105686393|NCT02092220|364514675|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
105686394|NCT02225353|364514676|FG000|Overall Study|Lost to Follow-up|0|||
105686395|NCT02225353|364514677|FG001|Overall Study|Lost to Follow-up|1|||
105686396|NCT02225353|364514678|FG002|Overall Study|Lost to Follow-up|3|||
105686397|NCT02225353|364514676|FG000|Overall Study|Protocol Violation|4|||
105686398|NCT02225353|364514677|FG001|Overall Study|Protocol Violation|5|||
105686399|NCT02225353|364514678|FG002|Overall Study|Protocol Violation|12|||
105686400|NCT01117857|364514679|FG000|Overall Study|Lost to Follow-up|4|||
105686401|NCT01117857|364514679|FG000|Overall Study|Withdrawal by Subject|4|||
105686402|NCT01117857|364514679|FG000|Overall Study|Physician Decision|1|||
105686403|NCT01119001|364514680|FG000|Overall Study|Withdrawal by Subject|2|||
105686404|NCT00633061|364514681|FG000|Overall Study|Study closed|86|||
105686405|NCT00633061|364514682|FG001|Overall Study|Study closed|0|||
105686406|NCT05245097|364514683|FG000|Overall Study|Adverse Event|13|||
105686407|NCT05245097|364514684|FG001|Overall Study|Adverse Event|2|||
105686408|NCT05245097|364514683|FG000|Overall Study|Protocol Violation|8|||
105686409|NCT05245097|364514684|FG001|Overall Study|Protocol Violation|6|||
105686410|NCT05245097|364514683|FG000|Overall Study|Withdrawal by Subject|18|||
105686411|NCT05245097|364514684|FG001|Overall Study|Withdrawal by Subject|0|||
105686412|NCT05245097|364514683|FG000|Overall Study|Death|6|||
105686413|NCT05245097|364514684|FG001|Overall Study|Death|7|||
105686414|NCT05245097|364514683|FG000|Overall Study|Physician Decision|6|||
105686415|NCT05245097|364514684|FG001|Overall Study|Physician Decision|0|||
105686416|NCT05245097|364514683|FG000|Overall Study|Relocation|4|||
105686417|NCT05245097|364514684|FG001|Overall Study|Relocation|3|||
105686418|NCT05543187|364514685|FG000|Overall Study|Ongoing|3|||
105686419|NCT05543187|364514686|FG001|Overall Study|Ongoing|2|||
105686420|NCT03254485|364514692|FG000|Overall Study|Adverse Event|3|||
105786582|NCT02389621|364872839|FG000|Posttreatment Period|Withdrawal by Subject|3|||
105470563|NCT01071798|363733840|FG000|Participants Who Received One Cycle|Death|5|||
105470564|NCT01071798|363733840|FG000|Participants Who Received One Cycle|Change of therapy|6|||
105470565|NCT01071798|363733840|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
105470566|NCT01071798|363733840|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
105470567|NCT01071798|363733840|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
105470568|NCT01071798|363733840|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
105470569|NCT01071798|363733840|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
105470570|NCT00641667|363733844|FG000|Overall Study|Withdrawal by Subject|1|||
105470571|NCT00641667|363733844|FG000|Overall Study|Adverse Event|1|||
105470572|NCT00641667|363733844|FG000|Overall Study|Physician Decision|1|||
105470573|NCT00641667|363733844|FG000|Overall Study|Worsening of underlying disease|3|||
105470574|NCT01235741|363733845|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
105470575|NCT01235741|363733846|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
105470576|NCT01235741|363733847|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
105470577|NCT01235741|363733845|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
105470578|NCT01235741|363733846|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
105558603|NCT00587964|364041881|FG000|Overall Study|Withdrawal by Subject|1|||
105686421|NCT03254485|364514693|FG001|Overall Study|Adverse Event|0|||
105686422|NCT03254485|364514694|FG002|Overall Study|Adverse Event|0|||
105686423|NCT03254485|364514695|FG003|Overall Study|Adverse Event|6|||
105686424|NCT03254485|364514692|FG000|Overall Study|Protocol Violation|6|||
105686425|NCT03254485|364514693|FG001|Overall Study|Protocol Violation|0|||
105686426|NCT03254485|364514694|FG002|Overall Study|Protocol Violation|0|||
105686427|NCT03254485|364514695|FG003|Overall Study|Protocol Violation|2|||
105686428|NCT03254485|364514692|FG000|Overall Study|Withdrawal by Subject|1|||
105686429|NCT03254485|364514693|FG001|Overall Study|Withdrawal by Subject|0|||
105344733|NCT03226678|363263488|FG002|Part B (Long-Term Extension Phase)|Death|0|||
105344734|NCT03226678|363263489|FG003|Part B (Long-Term Extension Phase)|Death|0|||
105344735|NCT03226678|363263490|FG004|Part B (Long-Term Extension Phase)|Death|0|||
105344736|NCT03226678|363263491|FG005|Part B (Long-Term Extension Phase)|Death|1|||
105686430|NCT03254485|364514694|FG002|Overall Study|Withdrawal by Subject|0|||
105686431|NCT03254485|364514695|FG003|Overall Study|Withdrawal by Subject|4|||
105686432|NCT03254485|364514692|FG000|Overall Study|Death|0|||
105686433|NCT03254485|364514693|FG001|Overall Study|Death|0|||
105686434|NCT03254485|364514694|FG002|Overall Study|Death|0|||
105686435|NCT03254485|364514695|FG003|Overall Study|Death|1|||
105686436|NCT03254485|364514692|FG000|Overall Study|Lost to Follow-up|1|||
105686437|NCT03254485|364514693|FG001|Overall Study|Lost to Follow-up|0|||
105686438|NCT03254485|364514694|FG002|Overall Study|Lost to Follow-up|0|||
105686439|NCT03254485|364514695|FG003|Overall Study|Lost to Follow-up|0|||
105686440|NCT03254485|364514692|FG000|Overall Study|Other|1|||
105686441|NCT03254485|364514693|FG001|Overall Study|Other|0|||
105686442|NCT03254485|364514694|FG002|Overall Study|Other|0|||
105686443|NCT03254485|364514695|FG003|Overall Study|Other|2|||
105686444|NCT00777946|364514698|FG000|Overall Study|Adverse Event|11|||
105686445|NCT00777946|364514699|FG001|Overall Study|Adverse Event|1|||
105686446|NCT00777946|364514700|FG002|Overall Study|Adverse Event|3|||
105686447|NCT00777946|364514698|FG000|Overall Study|Lack of Efficacy|0|||
105686448|NCT00777946|364514699|FG001|Overall Study|Lack of Efficacy|0|||
105686449|NCT00777946|364514700|FG002|Overall Study|Lack of Efficacy|9|||
105686450|NCT00777946|364514698|FG000|Overall Study|Condition no longer required study drug|1|||
105686451|NCT00777946|364514699|FG001|Overall Study|Condition no longer required study drug|0|||
105686452|NCT00777946|364514700|FG002|Overall Study|Condition no longer required study drug|0|||
105686453|NCT00777946|364514698|FG000|Overall Study|Patient withdrew consent|3|||
105686454|NCT00777946|364514699|FG001|Overall Study|Patient withdrew consent|2|||
105686455|NCT00777946|364514700|FG002|Overall Study|Patient withdrew consent|3|||
105686456|NCT00777946|364514698|FG000|Overall Study|Lost to Follow-up|3|||
105686457|NCT00777946|364514699|FG001|Overall Study|Lost to Follow-up|1|||
105686458|NCT00777946|364514700|FG002|Overall Study|Lost to Follow-up|0|||
105686459|NCT00777946|364514698|FG000|Overall Study|Protocol deviation|2|||
105344737|NCT03226678|363263486|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
105344738|NCT03226678|363263487|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
105344739|NCT03226678|363263488|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
105344740|NCT03226678|363263489|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
105344741|NCT03226678|363263490|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
105344742|NCT03226678|363263491|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
105344743|NCT03226678|363263486|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
105344744|NCT03226678|363263487|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
105344745|NCT03226678|363263488|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
105344746|NCT03226678|363263489|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
105344747|NCT03226678|363263490|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
105344748|NCT03226678|363263491|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
105344749|NCT03226678|363263486|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
105344750|NCT03226678|363263487|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
105344751|NCT03226678|363263488|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
105344752|NCT03226678|363263489|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
105344753|NCT03226678|363263490|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
105344754|NCT03226678|363263491|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
105344755|NCT03427268|363263494|FG000|Overall Study|Progressive disease|25|||
105344756|NCT03427268|363263494|FG000|Overall Study|Never treated|2|||
105344757|NCT03427268|363263494|FG000|Overall Study|Compassionate use|1|||
105344758|NCT03427268|363263494|FG000|Overall Study|Withdrawal by Subject|1|||
105344759|NCT03427268|363263494|FG000|Overall Study|Adverse Event|3|||
105344760|NCT00345878|363263495|FG000|Overall Study|Adverse Event|1|||
105344761|NCT00345878|363263496|FG001|Overall Study|Adverse Event|0|||
105344762|NCT00345878|363263495|FG000|Overall Study|Lost to Follow-up|2|||
105344763|NCT00345878|363263496|FG001|Overall Study|Lost to Follow-up|1|||
105344764|NCT00345878|363263495|FG000|Overall Study|Other|1|||
105344765|NCT00345878|363263496|FG001|Overall Study|Other|0|||
105344766|NCT02659514|363263500|FG000|Overall Study|Adverse Event|3|||
105344767|NCT02659514|363263501|FG001|Overall Study|Adverse Event|12|||
105686460|NCT00777946|364514699|FG001|Overall Study|Protocol deviation|1|||
105686461|NCT00777946|364514700|FG002|Overall Study|Protocol deviation|1|||
105686462|NCT00777946|364514698|FG000|Overall Study|Randomized in error|1|||
105686463|NCT00777946|364514699|FG001|Overall Study|Randomized in error|1|||
105686464|NCT00777946|364514700|FG002|Overall Study|Randomized in error|0|||
105686465|NCT02684357|364514701|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
105686466|NCT02684357|364514702|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
105686467|NCT02684357|364514703|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
105686468|NCT02684357|364514704|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
105686469|NCT02684357|364514705|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
105686470|NCT02684357|364514706|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
105686471|NCT02684357|364514701|FG000|Part A|Lost to Follow-up|0|||
105686472|NCT02684357|364514702|FG001|Part A|Lost to Follow-up|2|||
105686473|NCT02684357|364514703|FG002|Part A|Lost to Follow-up|2|||
105686474|NCT02684357|364514704|FG003|Part A|Lost to Follow-up|0|||
105686475|NCT02684357|364514705|FG004|Part A|Lost to Follow-up|0|||
105686476|NCT02684357|364514706|FG005|Part A|Lost to Follow-up|0|||
105686477|NCT02684357|364514701|FG000|Part A|Withdrawal by Subject|3|||
105686478|NCT02684357|364514702|FG001|Part A|Withdrawal by Subject|0|||
105686479|NCT02684357|364514703|FG002|Part A|Withdrawal by Subject|0|||
105686480|NCT02684357|364514704|FG003|Part A|Withdrawal by Subject|0|||
105686481|NCT02684357|364514705|FG004|Part A|Withdrawal by Subject|0|||
105686482|NCT02684357|364514706|FG005|Part A|Withdrawal by Subject|0|||
105686483|NCT02684357|364514701|FG000|Part A|Other|0|||
105686484|NCT02684357|364514702|FG001|Part A|Other|1|||
105686485|NCT02684357|364514703|FG002|Part A|Other|0|||
105686486|NCT02684357|364514704|FG003|Part A|Other|0|||
105686487|NCT02684357|364514705|FG004|Part A|Other|0|||
105686488|NCT02684357|364514706|FG005|Part A|Other|0|||
105686489|NCT02684357|364514701|FG000|Part B|Adverse Event (Other)|0|||
105686490|NCT02684357|364514702|FG001|Part B|Adverse Event (Other)|0|||
105686491|NCT02684357|364514703|FG002|Part B|Adverse Event (Other)|0|||
105686492|NCT02684357|364514704|FG003|Part B|Adverse Event (Other)|1|||
105686493|NCT02684357|364514705|FG004|Part B|Adverse Event (Other)|1|||
105686494|NCT02684357|364514706|FG005|Part B|Adverse Event (Other)|1|||
105686495|NCT02684357|364514701|FG000|Part B|Lost to Follow-up|0|||
105686496|NCT02684357|364514702|FG001|Part B|Lost to Follow-up|0|||
105686497|NCT02684357|364514703|FG002|Part B|Lost to Follow-up|0|||
105686498|NCT02684357|364514704|FG003|Part B|Lost to Follow-up|1|||
105686499|NCT02684357|364514705|FG004|Part B|Lost to Follow-up|1|||
105686500|NCT02684357|364514706|FG005|Part B|Lost to Follow-up|7|||
105686501|NCT02684357|364514701|FG000|Part B|Withdrawal by Subject|0|||
105686502|NCT02684357|364514702|FG001|Part B|Withdrawal by Subject|0|||
105686503|NCT02684357|364514703|FG002|Part B|Withdrawal by Subject|0|||
105686504|NCT02684357|364514704|FG003|Part B|Withdrawal by Subject|0|||
105686505|NCT02684357|364514705|FG004|Part B|Withdrawal by Subject|2|||
105686506|NCT02684357|364514706|FG005|Part B|Withdrawal by Subject|4|||
105686507|NCT02684357|364514701|FG000|Part B|Other|0|||
105686508|NCT02684357|364514702|FG001|Part B|Other|0|||
105686509|NCT02684357|364514703|FG002|Part B|Other|0|||
105686510|NCT02684357|364514704|FG003|Part B|Other|1|||
105686511|NCT02684357|364514705|FG004|Part B|Other|0|||
105686512|NCT02684357|364514706|FG005|Part B|Other|1|||
105686513|NCT01658826|364514713|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
105686514|NCT01658826|364514714|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
105686515|NCT01658826|364514713|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
105686516|NCT01658826|364514714|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
105686517|NCT01658826|364514713|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
105686518|NCT01658826|364514714|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
105686519|NCT01658826|364514713|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
105686520|NCT01658826|364514714|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
105686521|NCT01658826|364514713|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
105686522|NCT01658826|364514714|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
105686523|NCT01658826|364514713|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
105686524|NCT01658826|364514714|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
105686525|NCT01658826|364514713|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
105686526|NCT01658826|364514714|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
105686527|NCT01658826|364514713|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
105686528|NCT01658826|364514714|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
105786583|NCT02389621|364872840|FG001|Posttreatment Period|Withdrawal by Subject|2|||
105786584|NCT02389621|364872839|FG000|Posttreatment Period|Lost to Follow-up|1|||
105558604|NCT00587964|364041881|FG000|Overall Study|Lost to Follow-up|1|||
105686529|NCT01658826|364514713|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
105686530|NCT01658826|364514714|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
105686531|NCT01696942|364514715|FG000|Overall Study|Withdrawal by Subject|1|||
105686532|NCT01696942|364514716|FG001|Overall Study|Withdrawal by Subject|0|||
105686533|NCT01696942|364514715|FG000|Overall Study|Protocol Violation|1|||
105686534|NCT01696942|364514716|FG001|Overall Study|Protocol Violation|2|||
105686535|NCT01696942|364514715|FG000|Overall Study|screen failure|0|||
105686536|NCT01696942|364514716|FG001|Overall Study|screen failure|1|||
105686537|NCT02881957|364514718|FG000|Overall Study|Comfort care|0|||
105686538|NCT02881957|364514719|FG001|Overall Study|Comfort care|1|||
105686539|NCT02881957|364514718|FG000|Overall Study|Concurrent trial enrollment|0|||
105686540|NCT02881957|364514719|FG001|Overall Study|Concurrent trial enrollment|1|||
105686541|NCT02881957|364514718|FG000|Overall Study|Discharged within 48 hours|0|||
105686542|NCT02881957|364514719|FG001|Overall Study|Discharged within 48 hours|1|||
105686543|NCT02881957|364514718|FG000|Overall Study|Withdrawal by Subject|2|||
105686544|NCT02881957|364514719|FG001|Overall Study|Withdrawal by Subject|1|||
105686545|NCT02881957|364514718|FG000|Overall Study|Protocol Violation|1|||
105686546|NCT02881957|364514719|FG001|Overall Study|Protocol Violation|0|||
105686547|NCT05269355|364514724|FG000|Overall Study|Progressive Disease|104|||
105686548|NCT05269355|364514725|FG001|Overall Study|Progressive Disease|68|||
105686549|NCT05269355|364514724|FG000|Overall Study|Study Terminated by Sponsor|87|||
105686550|NCT05269355|364514725|FG001|Overall Study|Study Terminated by Sponsor|29|||
105686551|NCT05269355|364514724|FG000|Overall Study|Adverse Event|15|||
105686552|NCT05269355|364514725|FG001|Overall Study|Adverse Event|8|||
105686553|NCT05269355|364514724|FG000|Overall Study|Withdrawal by Subject|18|||
105686554|NCT05269355|364514725|FG001|Overall Study|Withdrawal by Subject|5|||
105686555|NCT05269355|364514724|FG000|Overall Study|Physician Decision|6|||
105686556|NCT05269355|364514725|FG001|Overall Study|Physician Decision|4|||
105686557|NCT05269355|364514724|FG000|Overall Study|Death|3|||
105686558|NCT05269355|364514725|FG001|Overall Study|Death|5|||
105686559|NCT05269355|364514724|FG000|Overall Study|Other Than Specified|5|||
105686560|NCT05269355|364514725|FG001|Overall Study|Other Than Specified|1|||
105686561|NCT05269355|364514724|FG000|Overall Study|Randomized But Not Treated|1|||
105686562|NCT05269355|364514725|FG001|Overall Study|Randomized But Not Treated|0|||
105686563|NCT01598311|364514726|FG000|Overall Study|Physician Decision|4|||
105686564|NCT01598311|364514727|FG001|Overall Study|Physician Decision|5|||
105686565|NCT01598311|364514726|FG000|Overall Study|Adverse Event|9|||
105686566|NCT01598311|364514727|FG001|Overall Study|Adverse Event|13|||
105686567|NCT01598311|364514726|FG000|Overall Study|Lost to Follow-up|7|||
105686568|NCT01598311|364514727|FG001|Overall Study|Lost to Follow-up|12|||
105686569|NCT01598311|364514726|FG000|Overall Study|Withdrawal by Subject|9|||
105686570|NCT01598311|364514727|FG001|Overall Study|Withdrawal by Subject|13|||
105686571|NCT01598311|364514726|FG000|Overall Study|No reason provided.|0|||
105686572|NCT01598311|364514727|FG001|Overall Study|No reason provided.|5|||
105686573|NCT01598311|364514726|FG000|Overall Study|Randomized but never treated|8|||
105686574|NCT01598311|364514727|FG001|Overall Study|Randomized but never treated|5|||
105686575|NCT01598311|364514726|FG000|Overall Study|Treated but no confirmed CDAD|9|||
105686576|NCT01598311|364514727|FG001|Overall Study|Treated but no confirmed CDAD|8|||
105686577|NCT01598311|364514726|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
105686578|NCT01598311|364514727|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
105686579|NCT03442114|364514728|FG000|Overall Study|Lost to Follow-up|13|||
105686580|NCT03442114|364514729|FG001|Overall Study|Lost to Follow-up|13|||
105686581|NCT03442114|364514728|FG000|Overall Study|Physician Decision|2|||
105686582|NCT03442114|364514729|FG001|Overall Study|Physician Decision|2|||
105686583|NCT03442114|364514728|FG000|Overall Study|Protocol Violation|0|||
105686584|NCT03442114|364514729|FG001|Overall Study|Protocol Violation|2|||
105686585|NCT03442114|364514728|FG000|Overall Study|Withdrawal by Subject|1|||
105686586|NCT03442114|364514729|FG001|Overall Study|Withdrawal by Subject|3|||
105686587|NCT03442114|364514728|FG000|Overall Study|Guardianship Change|0|||
105686588|NCT03442114|364514729|FG001|Overall Study|Guardianship Change|1|||
105686589|NCT01201343|364516326|FG000|Overall Study|Adverse Event|6|||
105686590|NCT01201343|364516326|FG000|Overall Study|Withdrawal by Subject|5|||
105686591|NCT01201343|364516326|FG000|Overall Study|Lost to Follow-up|2|||
105686592|NCT01201343|364516326|FG000|Overall Study|Lack of Efficacy|2|||
105686593|NCT01201343|364516326|FG000|Overall Study|Participant wrongly included in trial|1|||
105686594|NCT01201343|364516326|FG000|Overall Study|Randomized, not treated|3|||
105686595|NCT02164383|364516327|FG000|Overall Study|Lost to Follow-up|1|||
105686596|NCT02164383|364516328|FG001|Overall Study|Lost to Follow-up|0|||
105686597|NCT01440374|364516333|FG000|Part 1: Open-label Phase|Adverse Event|5|||
105686598|NCT01440374|364516334|FG001|Part 1: Open-label Phase|Adverse Event|0|||
105686599|NCT01440374|364516335|FG002|Part 1: Open-label Phase|Adverse Event|0|||
105558605|NCT00587964|364041881|FG000|Overall Study|Patient found to be ineligible|1|||
105686600|NCT01440374|364516336|FG003|Part 1: Open-label Phase|Adverse Event|0|||
105686601|NCT01440374|364516333|FG000|Part 1: Open-label Phase|Physician Decision|1|||
105686602|NCT01440374|364516334|FG001|Part 1: Open-label Phase|Physician Decision|0|||
105686603|NCT01440374|364516335|FG002|Part 1: Open-label Phase|Physician Decision|0|||
105686604|NCT01440374|364516336|FG003|Part 1: Open-label Phase|Physician Decision|0|||
105686605|NCT01440374|364516333|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
105686606|NCT01440374|364516334|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
105686607|NCT01440374|364516335|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
105686608|NCT01440374|364516336|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
105686609|NCT01440374|364516333|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
105686610|NCT01440374|364516334|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
105686611|NCT01440374|364516335|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
105686612|NCT01440374|364516336|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
105686613|NCT01440374|364516333|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
105686614|NCT01440374|364516334|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
105686615|NCT01440374|364516335|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
105558606|NCT00587964|364041881|FG000|Overall Study|Patient did not receive intervention|5|||
105558607|NCT00587964|364041881|FG000|Overall Study|Progression of Disease|4|||
105558608|NCT00295022|364041885|FG000|Overall Study|Adverse Event|1|||
105558609|NCT00295022|364041886|FG001|Overall Study|Adverse Event|1|||
105558610|NCT00295022|364041887|FG002|Overall Study|Adverse Event|2|||
105558611|NCT00295022|364041885|FG000|Overall Study|Lost to Follow-up|0|||
105558612|NCT00295022|364041886|FG001|Overall Study|Lost to Follow-up|0|||
105558613|NCT00295022|364041887|FG002|Overall Study|Lost to Follow-up|1|||
105558614|NCT00295022|364041885|FG000|Overall Study|Withdrawal by Subject|0|||
105558615|NCT00295022|364041886|FG001|Overall Study|Withdrawal by Subject|0|||
105558616|NCT00295022|364041887|FG002|Overall Study|Withdrawal by Subject|2|||
105558617|NCT00734630|364041889|FG000|Overall Study|Lack of Efficacy|4|||
105558618|NCT00734630|364041890|FG001|Overall Study|Lack of Efficacy|4|||
105558619|NCT00734630|364041889|FG000|Overall Study|Withdrawal by Subject|7|||
105558620|NCT00734630|364041890|FG001|Overall Study|Withdrawal by Subject|9|||
105558621|NCT00734630|364041889|FG000|Overall Study|Lost to Follow-up|13|||
105558622|NCT00734630|364041890|FG001|Overall Study|Lost to Follow-up|7|||
105558623|NCT00734630|364041889|FG000|Overall Study|Protocol Violation|0|||
105558624|NCT00734630|364041890|FG001|Overall Study|Protocol Violation|3|||
105558625|NCT00734630|364041889|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
105558626|NCT00734630|364041890|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
105558627|NCT00734630|364041889|FG000|Overall Study|Adverse Event|3|||
105558628|NCT00734630|364041890|FG001|Overall Study|Adverse Event|6|||
105558629|NCT00734630|364041889|FG000|Overall Study|Randomized in Error|0|||
105558630|NCT00734630|364041890|FG001|Overall Study|Randomized in Error|1|||
105558631|NCT00734630|364041889|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
105558632|NCT00734630|364041890|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
105558633|NCT00734630|364041889|FG000|Overall Study|Poor Compliance|1|||
105686616|NCT01440374|364516336|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
105686617|NCT01440374|364516333|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
105686618|NCT01440374|364516334|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
105686619|NCT01440374|364516335|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
105686620|NCT01440374|364516336|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
105558634|NCT00734630|364041890|FG001|Overall Study|Poor Compliance|1|||
105558635|NCT01922076|364041891|FG000|Overall Study|Adverse Event|0|||
105558636|NCT01922076|364041892|FG001|Overall Study|Adverse Event|0|||
105558637|NCT01922076|364041893|FG002|Overall Study|Adverse Event|0|||
105558638|NCT01922076|364041894|FG003|Overall Study|Adverse Event|0|||
105558639|NCT01922076|364041895|FG004|Overall Study|Adverse Event|1|||
105558640|NCT01922076|364041896|FG005|Overall Study|Adverse Event|0|||
105558641|NCT01922076|364041897|FG006|Overall Study|Adverse Event|0|||
105558642|NCT01922076|364041891|FG000|Overall Study|Physician Decision|0|||
105558643|NCT01922076|364041892|FG001|Overall Study|Physician Decision|0|||
105558644|NCT01922076|364041893|FG002|Overall Study|Physician Decision|1|||
105558645|NCT01922076|364041894|FG003|Overall Study|Physician Decision|0|||
105558646|NCT01922076|364041895|FG004|Overall Study|Physician Decision|0|||
105558647|NCT01922076|364041896|FG005|Overall Study|Physician Decision|0|||
105558648|NCT01922076|364041897|FG006|Overall Study|Physician Decision|0|||
105558649|NCT01922076|364041891|FG000|Overall Study|Withdrawal by Subject|0|||
105558650|NCT01922076|364041892|FG001|Overall Study|Withdrawal by Subject|0|||
105558651|NCT01922076|364041893|FG002|Overall Study|Withdrawal by Subject|0|||
105558652|NCT01922076|364041894|FG003|Overall Study|Withdrawal by Subject|1|||
105558653|NCT01922076|364041895|FG004|Overall Study|Withdrawal by Subject|0|||
105558654|NCT01922076|364041896|FG005|Overall Study|Withdrawal by Subject|1|||
105558655|NCT01922076|364041897|FG006|Overall Study|Withdrawal by Subject|1|||
105558656|NCT01018394|364041902|FG000|Overall Study|Withdrawal by Subject|5|||
105558657|NCT01018394|364041903|FG001|Overall Study|Withdrawal by Subject|5|||
105558658|NCT01018394|364041902|FG000|Overall Study|Lost to Follow-up|4|||
105558659|NCT01018394|364041903|FG001|Overall Study|Lost to Follow-up|3|||
105558660|NCT03792126|364041904|FG000|Overall Study|Adverse Event|1|||
105558661|NCT03792126|364041905|FG001|Overall Study|Adverse Event|2|||
105558662|NCT03792126|364041904|FG000|Overall Study|Death|0|||
105558663|NCT03792126|364041905|FG001|Overall Study|Death|1|||
105558664|NCT03792126|364041904|FG000|Overall Study|Lost to Follow-up|1|||
105558665|NCT03792126|364041905|FG001|Overall Study|Lost to Follow-up|0|||
105558666|NCT03792126|364041904|FG000|Overall Study|Withdrawal by Subject|0|||
105558667|NCT03792126|364041905|FG001|Overall Study|Withdrawal by Subject|1|||
105344768|NCT02659514|363263500|FG000|Overall Study|Disease Progression|23|||
105558668|NCT03792126|364041904|FG000|Overall Study|COVID-19 Restrictions|1|||
105558669|NCT03792126|364041905|FG001|Overall Study|COVID-19 Restrictions|3|||
105558670|NCT03792126|364041904|FG000|Overall Study|Symptoms resolved|0|||
105558671|NCT03792126|364041905|FG001|Overall Study|Symptoms resolved|3|||
105558672|NCT03240692|364041906|FG000|Overall Study|Physician Decision|1|||
105558673|NCT03240692|364041906|FG000|Overall Study|Withdrawal by Subject|1|||
105558674|NCT00683644|364041907|FG000|Overall Study|Withdrawal by Subject|4|||
105558675|NCT00683644|364041908|FG001|Overall Study|Withdrawal by Subject|2|||
105558676|NCT00683644|364041907|FG000|Overall Study|Lost to Follow-up|1|||
105686621|NCT01440374|364516333|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
105470579|NCT01235741|363733847|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
105470580|NCT01235741|363733845|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
105470581|NCT01235741|363733846|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
105470582|NCT01235741|363733847|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
105470583|NCT01235741|363733845|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
105470584|NCT01235741|363733846|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
105470585|NCT01235741|363733847|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
105470586|NCT01235741|363733845|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
105470587|NCT01235741|363733846|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
105470588|NCT01235741|363733847|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
105470589|NCT01235741|363733845|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
105470590|NCT01235741|363733846|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
105470591|NCT01235741|363733847|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
105470592|NCT01235741|363733845|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
105470593|NCT01235741|363733846|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
105470594|NCT01235741|363733847|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
105470595|NCT01235741|363733845|FG000|Randomized to Treatment|Adverse Event|0|||
105470596|NCT01235741|363733846|FG001|Randomized to Treatment|Adverse Event|1|||
105470597|NCT01235741|363733847|FG002|Randomized to Treatment|Adverse Event|1|||
105470598|NCT01235741|363733845|FG000|Randomized to Treatment|Sponsor terminated study|0|||
105470599|NCT01235741|363733846|FG001|Randomized to Treatment|Sponsor terminated study|35|||
105470600|NCT01235741|363733847|FG002|Randomized to Treatment|Sponsor terminated study|34|||
105470601|NCT01235741|363733845|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
105470602|NCT01235741|363733846|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
105470603|NCT01235741|363733847|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
105470604|NCT01235741|363733845|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
105470605|NCT01235741|363733846|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
105470606|NCT01235741|363733847|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
105470607|NCT01235741|363733845|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
105470608|NCT01235741|363733846|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
105470609|NCT01235741|363733847|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
105470610|NCT00854113|363733848|FG000|Overall Study|Adverse Event|0|||
105470611|NCT00854113|363733849|FG001|Overall Study|Adverse Event|0|||
105470612|NCT00854113|363733850|FG002|Overall Study|Adverse Event|0|||
105470613|NCT00854113|363733851|FG003|Overall Study|Adverse Event|0|||
105470614|NCT00854113|363733852|FG004|Overall Study|Adverse Event|0|||
105470615|NCT00854113|363733853|FG005|Overall Study|Adverse Event|0|||
105470616|NCT00854113|363733854|FG006|Overall Study|Adverse Event|0|||
105470617|NCT00854113|363733855|FG007|Overall Study|Adverse Event|2|||
105470618|NCT00854113|363733856|FG008|Overall Study|Adverse Event|0|||
105470619|NCT00854113|363733857|FG009|Overall Study|Adverse Event|0|||
105470620|NCT00854113|363733858|FG010|Overall Study|Adverse Event|0|||
105470621|NCT00854113|363733848|FG000|Overall Study|Withdrawal by Subject|0|||
105470622|NCT00854113|363733849|FG001|Overall Study|Withdrawal by Subject|0|||
105470623|NCT00854113|363733850|FG002|Overall Study|Withdrawal by Subject|0|||
105470624|NCT00854113|363733851|FG003|Overall Study|Withdrawal by Subject|0|||
105470625|NCT00854113|363733852|FG004|Overall Study|Withdrawal by Subject|0|||
105470626|NCT00854113|363733853|FG005|Overall Study|Withdrawal by Subject|0|||
105470627|NCT00854113|363733854|FG006|Overall Study|Withdrawal by Subject|0|||
105470628|NCT00854113|363733855|FG007|Overall Study|Withdrawal by Subject|1|||
105470629|NCT00854113|363733856|FG008|Overall Study|Withdrawal by Subject|1|||
105470630|NCT00854113|363733857|FG009|Overall Study|Withdrawal by Subject|0|||
105470631|NCT00854113|363733858|FG010|Overall Study|Withdrawal by Subject|0|||
105470632|NCT00796419|363733860|FG000|Overall Study|Death|0|||
105470633|NCT00796419|363733861|FG001|Overall Study|Death|1|||
105470634|NCT01596062|363733862|FG000|Overall Study|Adverse Event|1|||
105470635|NCT01596062|363733863|FG001|Overall Study|Adverse Event|0|||
105470636|NCT01596062|363733864|FG002|Overall Study|Adverse Event|2|||
105470637|NCT01596062|363733862|FG000|Overall Study|Lack of Efficacy|0|||
105470638|NCT01596062|363733863|FG001|Overall Study|Lack of Efficacy|0|||
105470639|NCT01596062|363733864|FG002|Overall Study|Lack of Efficacy|1|||
105470640|NCT00145158|363733865|FG000|Overall Study|premature withdrawal|2|||
105470641|NCT00145158|363733866|FG001|Overall Study|premature withdrawal|3|||
105470642|NCT01705509|363733874|FG000|Inclusion CPET|Screen Failure|5|||
105470643|NCT01705509|363733874|FG000|Inclusion CPET|Withdrawal by Subject|2|||
105470644|NCT01705509|363733874|FG000|CPET w/ Ranexa|Screen Failure|2|||
105470645|NCT00904033|363733875|FG000|Overall Study|Withdrawal by Subject|1|||
105470646|NCT00904033|363733876|FG001|Overall Study|Withdrawal by Subject|1|||
105470647|NCT00904033|363733877|FG002|Overall Study|Withdrawal by Subject|0|||
105470648|NCT00904033|363733878|FG003|Overall Study|Withdrawal by Subject|0|||
105470649|NCT00904033|363733875|FG000|Overall Study|Physician Decision|0|||
105470650|NCT00904033|363733876|FG001|Overall Study|Physician Decision|0|||
105686622|NCT01440374|364516334|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
105686623|NCT01440374|364516335|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
105686624|NCT01440374|364516336|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
105686625|NCT01440374|364516333|FG000|Part 2; Double-blind Phase|Not treated|0|||
105686626|NCT01440374|364516334|FG001|Part 2; Double-blind Phase|Not treated|0|||
105686627|NCT01440374|364516335|FG002|Part 2; Double-blind Phase|Not treated|1|||
105686628|NCT01440374|364516336|FG003|Part 2; Double-blind Phase|Not treated|0|||
105686629|NCT01440374|364516333|FG000|Part 3: Extension|Withdrawal by Subject|0|||
105686630|NCT01440374|364516334|FG001|Part 3: Extension|Withdrawal by Subject|0|||
105686631|NCT01440374|364516335|FG002|Part 3: Extension|Withdrawal by Subject|0|||
105686632|NCT01440374|364516336|FG003|Part 3: Extension|Withdrawal by Subject|5|||
105686633|NCT01440374|364516333|FG000|Part 3: Extension|Adverse Event|0|||
105686634|NCT01440374|364516334|FG001|Part 3: Extension|Adverse Event|0|||
105686635|NCT01440374|364516335|FG002|Part 3: Extension|Adverse Event|0|||
105686636|NCT01440374|364516336|FG003|Part 3: Extension|Adverse Event|13|||
105686637|NCT01440374|364516333|FG000|Part 3: Extension|Physician Decision|0|||
105686638|NCT01440374|364516334|FG001|Part 3: Extension|Physician Decision|0|||
105686639|NCT01440374|364516335|FG002|Part 3: Extension|Physician Decision|0|||
105686640|NCT01440374|364516336|FG003|Part 3: Extension|Physician Decision|14|||
105686641|NCT00171704|364516339|FG000|Overall Study|Adverse Event|24|||
105686642|NCT00171704|364516340|FG001|Overall Study|Adverse Event|33|||
105686643|NCT00171704|364516339|FG000|Overall Study|Disease Progression|14|||
105686644|NCT00171704|364516340|FG001|Overall Study|Disease Progression|9|||
105686645|NCT00171704|364516339|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
105686646|NCT00171704|364516340|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
105686647|NCT00171704|364516339|FG000|Overall Study|Administrative Problems|2|||
105686648|NCT00171704|364516340|FG001|Overall Study|Administrative Problems|1|||
105686649|NCT00171704|364516339|FG000|Overall Study|Death|2|||
105686650|NCT00171704|364516340|FG001|Overall Study|Death|2|||
105686651|NCT00171704|364516339|FG000|Overall Study|Withdrawal by Subject|1|||
105686652|NCT00171704|364516340|FG001|Overall Study|Withdrawal by Subject|3|||
105686653|NCT00171704|364516339|FG000|Overall Study|Protocol Violation|0|||
105686654|NCT00171704|364516340|FG001|Overall Study|Protocol Violation|1|||
105686655|NCT03435497|364516343|FG000|Overall Study|Lost to Follow-up|1|||
105686656|NCT03435497|364516344|FG001|Overall Study|Lost to Follow-up|0|||
105686657|NCT03435497|364516343|FG000|Overall Study|Death|1|||
105686658|NCT03435497|364516344|FG001|Overall Study|Death|0|||
105686659|NCT03435497|364516343|FG000|Overall Study|Withdrawal by Subject|0|||
105686660|NCT03435497|364516344|FG001|Overall Study|Withdrawal by Subject|4|||
105686661|NCT03435497|364516343|FG000|Overall Study|Wrong survey administered|0|||
105686662|NCT03435497|364516344|FG001|Overall Study|Wrong survey administered|2|||
105686663|NCT00601419|364516346|FG000|Overall Study|Lost to Follow-up|3|||
105686664|NCT00601419|364516346|FG000|Overall Study|Missed Visits|1|||
105686665|NCT01786174|364516347|FG000|Overall Study|Discontinued Study Drug|2|||
105686666|NCT01786174|364516348|FG001|Overall Study|Discontinued Study Drug|0|||
105686667|NCT03442985|364516349|FG000|Overall Study|Sponsor Request|55|||
105686668|NCT03442985|364516350|FG001|Overall Study|Sponsor Request|60|||
105686669|NCT03442985|364516351|FG002|Overall Study|Sponsor Request|54|||
105686670|NCT03442985|364516349|FG000|Overall Study|Lost to Follow-up|5|||
105686671|NCT03442985|364516350|FG001|Overall Study|Lost to Follow-up|2|||
105686672|NCT03442985|364516351|FG002|Overall Study|Lost to Follow-up|7|||
105686673|NCT03442985|364516349|FG000|Overall Study|Withdrawal by Subject|2|||
105686674|NCT03442985|364516350|FG001|Overall Study|Withdrawal by Subject|3|||
105686675|NCT03442985|364516351|FG002|Overall Study|Withdrawal by Subject|4|||
105686676|NCT03442985|364516349|FG000|Overall Study|Adverse Event|0|||
105686677|NCT03442985|364516350|FG001|Overall Study|Adverse Event|1|||
105686678|NCT03442985|364516351|FG002|Overall Study|Adverse Event|0|||
105686679|NCT01217957|364516352|FG000|Phase 1|Withdrawal by Patient|1|||
105686680|NCT01217957|364516353|FG001|Phase 1|Withdrawal by Patient|0|||
105470651|NCT00904033|363733877|FG002|Overall Study|Physician Decision|1|||
105686681|NCT01217957|364516354|FG002|Phase 1|Withdrawal by Patient|1|||
105686682|NCT01217957|364516355|FG003|Phase 1|Withdrawal by Patient|1|||
105686683|NCT01217957|364516356|FG004|Phase 1|Withdrawal by Patient|0|||
105686684|NCT01217957|364516352|FG000|Phase 2|Withdrawal by Patient|0|||
105686685|NCT01217957|364516353|FG001|Phase 2|Withdrawal by Patient|0|||
105686686|NCT01217957|364516354|FG002|Phase 2|Withdrawal by Patient|0|||
105686687|NCT01217957|364516355|FG003|Phase 2|Withdrawal by Patient|0|||
105686688|NCT01217957|364516356|FG004|Phase 2|Withdrawal by Patient|1|||
105686689|NCT01620255|364516362|FG000|Overall Study|Withdrawal by Subject|4|||
105686690|NCT01620255|364516363|FG001|Overall Study|Withdrawal by Subject|1|||
105686691|NCT01620255|364516364|FG002|Overall Study|Withdrawal by Subject|1|||
105686692|NCT01620255|364516365|FG003|Overall Study|Withdrawal by Subject|2|||
105686693|NCT01620255|364516366|FG004|Overall Study|Withdrawal by Subject|4|||
105686694|NCT01620255|364516362|FG000|Overall Study|Participant underwent fecal transplant|0|||
105686695|NCT01620255|364516363|FG001|Overall Study|Participant underwent fecal transplant|0|||
105686696|NCT01620255|364516364|FG002|Overall Study|Participant underwent fecal transplant|1|||
105686697|NCT01620255|364516365|FG003|Overall Study|Participant underwent fecal transplant|0|||
105686698|NCT01620255|364516366|FG004|Overall Study|Participant underwent fecal transplant|0|||
105686699|NCT01620255|364516362|FG000|Overall Study|Non-compliance|0|||
105686700|NCT01620255|364516363|FG001|Overall Study|Non-compliance|1|||
105686701|NCT01620255|364516364|FG002|Overall Study|Non-compliance|0|||
105686702|NCT01620255|364516365|FG003|Overall Study|Non-compliance|0|||
105686703|NCT01620255|364516366|FG004|Overall Study|Non-compliance|0|||
105686704|NCT01620255|364516362|FG000|Overall Study|Adverse Event|0|||
105686705|NCT01620255|364516363|FG001|Overall Study|Adverse Event|4|||
105686706|NCT01620255|364516364|FG002|Overall Study|Adverse Event|0|||
105686707|NCT01620255|364516365|FG003|Overall Study|Adverse Event|1|||
105686708|NCT01620255|364516366|FG004|Overall Study|Adverse Event|1|||
105686709|NCT01620255|364516362|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
105686710|NCT01620255|364516363|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
105686711|NCT01620255|364516364|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
105686712|NCT01620255|364516365|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
105686713|NCT01620255|364516366|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
105686714|NCT01716117|364516367|FG000|Overall Study|Death|5|||
105686715|NCT01716117|364516368|FG001|Overall Study|Death|2|||
105686716|NCT01716117|364516367|FG000|Overall Study|Withdrawal by Subject|2|||
105686717|NCT01716117|364516368|FG001|Overall Study|Withdrawal by Subject|0|||
105686718|NCT01557283|364516369|FG000|Overall Study|Lost to Follow-up|7|||
105686719|NCT01557283|364516369|FG000|Overall Study|Non-responder|19|||
105686720|NCT01557283|364516369|FG000|Overall Study|Adverse Event|7|||
105686721|NCT01557283|364516369|FG000|Overall Study|Lack of Efficacy|1|||
105686722|NCT01557283|364516369|FG000|Overall Study|Non-compliance|1|||
105686723|NCT01557283|364516369|FG000|Overall Study|Withdrawal by Subject|1|||
105686724|NCT01557283|364516369|FG000|Overall Study|Participant's weight too high for dose|1|||
105686725|NCT01557283|364516369|FG000|Overall Study|Worsening of psoriasis|1|||
105686726|NCT01557283|364516369|FG000|Overall Study|Other|6|||
105686727|NCT01765192|364516370|FG000|Treatment Period 1|Adverse Event|0|||
105686728|NCT01765192|364516371|FG001|Treatment Period 1|Adverse Event|1|||
105686729|NCT01765192|364516370|FG000|Washout Period|Voluntary Withdrawal|1|||
105686730|NCT01765192|364516371|FG001|Washout Period|Voluntary Withdrawal|1|||
105686731|NCT01765192|364516370|FG000|Washout Period|Reason not specified|1|||
105686732|NCT01765192|364516371|FG001|Washout Period|Reason not specified|0|||
105686733|NCT01765192|364516370|FG000|Treatment Period 2|Reason not specified|0|||
105686734|NCT01765192|364516371|FG001|Treatment Period 2|Reason not specified|2|||
105686735|NCT01765192|364516370|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
105686736|NCT01765192|364516371|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
105686737|NCT04335812|364516377|FG000|Overall Study|Withdrawal by Subject|1|||
105686738|NCT04335812|364516378|FG001|Overall Study|Withdrawal by Subject|3|||
105686739|NCT04335812|364516377|FG000|Overall Study|Lost to Follow-up|12|||
105686740|NCT04335812|364516378|FG001|Overall Study|Lost to Follow-up|12|||
105686741|NCT04335812|364516377|FG000|Overall Study|Did not engage in the intervention|22|||
105686742|NCT04335812|364516378|FG001|Overall Study|Did not engage in the intervention|18|||
105686743|NCT01480674|364516379|FG000|Overall Study|Death|23|||
105686744|NCT01480674|364516379|FG000|Overall Study|Lost to Follow-up|2|||
105686745|NCT01480674|364516379|FG000|Overall Study|visit not done|10|||
105686746|NCT00975507|364516380|FG000|Overall Study|Adverse Event|1|||
105686747|NCT00975507|364516381|FG001|Overall Study|Adverse Event|0|||
105686748|NCT00975507|364516380|FG000|Overall Study|Lost to Follow-up|7|||
105686749|NCT00975507|364516381|FG001|Overall Study|Lost to Follow-up|1|||
105686750|NCT00975507|364516380|FG000|Overall Study|Protocol Violation|2|||
105686751|NCT00975507|364516381|FG001|Overall Study|Protocol Violation|0|||
105686752|NCT00975507|364516380|FG000|Overall Study|Withdrawal by Subject|10|||
105686753|NCT00975507|364516381|FG001|Overall Study|Withdrawal by Subject|3|||
105686754|NCT03864146|364516382|FG000|Overall Study|Lost to Follow-up|14|||
105686755|NCT03864146|364516383|FG001|Overall Study|Lost to Follow-up|23|||
105686756|NCT03864146|364516382|FG000|Overall Study|Withdrawal by Subject|3|||
105686757|NCT03864146|364516383|FG001|Overall Study|Withdrawal by Subject|2|||
105686758|NCT00655863|364516390|FG000|Overall Study|Lost to Follow-up|0|||
105686759|NCT00655863|364516391|FG001|Overall Study|Lost to Follow-up|0|||
105686760|NCT00655863|364516392|FG002|Overall Study|Lost to Follow-up|1|||
105686761|NCT04745026|364516393|FG000|Overall Study|Physician Decision|1|||
105686762|NCT04745026|364516394|FG001|Overall Study|Physician Decision|0|||
105686763|NCT04745026|364516393|FG000|Overall Study|Adverse Event|2|||
105686764|NCT04745026|364516394|FG001|Overall Study|Adverse Event|2|||
105686765|NCT04745026|364516393|FG000|Overall Study|Protocol Violation|1|||
105686766|NCT04745026|364516394|FG001|Overall Study|Protocol Violation|3|||
105686767|NCT04745026|364516393|FG000|Overall Study|Lost to Follow-up|4|||
105686768|NCT04745026|364516394|FG001|Overall Study|Lost to Follow-up|3|||
105686769|NCT04745026|364516393|FG000|Overall Study|Withdrawal by Subject|5|||
105686770|NCT04745026|364516394|FG001|Overall Study|Withdrawal by Subject|5|||
105686771|NCT04426851|364516395|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
105686772|NCT04426851|364516396|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
105686773|NCT04426851|364516395|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
105686774|NCT04426851|364516396|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
105686775|NCT05580588|364516397|FG000|Overall Study|Lack of Efficacy|12|||
105686776|NCT00712673|364516400|FG000|Overall Study|Adverse Event|3|||
105686777|NCT00712673|364516401|FG001|Overall Study|Adverse Event|3|||
105686778|NCT00712673|364516402|FG002|Overall Study|Adverse Event|21|||
105686779|NCT00712673|364516403|FG003|Overall Study|Adverse Event|26|||
105686780|NCT00712673|364516400|FG000|Overall Study|Lack of Efficacy|2|||
105686781|NCT00712673|364516401|FG001|Overall Study|Lack of Efficacy|8|||
105686782|NCT00712673|364516402|FG002|Overall Study|Lack of Efficacy|8|||
105686783|NCT00712673|364516403|FG003|Overall Study|Lack of Efficacy|6|||
105686784|NCT00712673|364516400|FG000|Overall Study|Poor Compliance to Protocol|3|||
105686785|NCT00712673|364516401|FG001|Overall Study|Poor Compliance to Protocol|3|||
105686786|NCT00712673|364516402|FG002|Overall Study|Poor Compliance to Protocol|4|||
105686787|NCT00712673|364516403|FG003|Overall Study|Poor Compliance to Protocol|16|||
105686788|NCT00712673|364516400|FG000|Overall Study|Lost to Follow-up|1|||
105686789|NCT00712673|364516401|FG001|Overall Study|Lost to Follow-up|0|||
105686790|NCT00712673|364516402|FG002|Overall Study|Lost to Follow-up|2|||
105686791|NCT00712673|364516403|FG003|Overall Study|Lost to Follow-up|0|||
105686792|NCT00712673|364516400|FG000|Overall Study|Withdrawal by Subject|6|||
105686793|NCT00712673|364516401|FG001|Overall Study|Withdrawal by Subject|7|||
105686794|NCT00712673|364516402|FG002|Overall Study|Withdrawal by Subject|15|||
105686795|NCT00712673|364516403|FG003|Overall Study|Withdrawal by Subject|20|||
105686796|NCT00712673|364516400|FG000|Overall Study|Familial and Personal Reasons|5|||
105686797|NCT00712673|364516401|FG001|Overall Study|Familial and Personal Reasons|0|||
105686798|NCT00712673|364516402|FG002|Overall Study|Familial and Personal Reasons|5|||
105686799|NCT00712673|364516403|FG003|Overall Study|Familial and Personal Reasons|2|||
105686800|NCT00712673|364516400|FG000|Overall Study|Investigator's Decision|1|||
105686801|NCT00712673|364516401|FG001|Overall Study|Investigator's Decision|0|||
105686802|NCT00712673|364516402|FG002|Overall Study|Investigator's Decision|0|||
105686803|NCT00712673|364516403|FG003|Overall Study|Investigator's Decision|0|||
105686804|NCT00712673|364516400|FG000|Overall Study|Protocol Violation|0|||
105686805|NCT00712673|364516401|FG001|Overall Study|Protocol Violation|0|||
105686806|NCT00712673|364516402|FG002|Overall Study|Protocol Violation|2|||
105686807|NCT00712673|364516403|FG003|Overall Study|Protocol Violation|0|||
105686808|NCT03603028|364516404|FG000|Overall Study|Withdrawal by Subject|1|||
105686809|NCT02768870|364516407|FG000|Overall Study|Death|1|||
105686810|NCT02768870|364516407|FG000|Overall Study|Reoperation|6|||
105686811|NCT02768870|364516407|FG000|Overall Study|Lost to Follow-up|1|||
105686812|NCT02768870|364516407|FG000|Overall Study|Exit|4|||
105686813|NCT03401229|364516409|FG000|Overall Study|Lost to Follow-up|2|||
105686814|NCT03401229|364516410|FG001|Overall Study|Lost to Follow-up|1|||
105686815|NCT03401229|364516409|FG000|Overall Study|Other|1|||
105686816|NCT03401229|364516410|FG001|Overall Study|Other|3|||
105686817|NCT03401229|364516409|FG000|Overall Study|Adverse Event|8|||
105686818|NCT03401229|364516410|FG001|Overall Study|Adverse Event|6|||
105686819|NCT03401229|364516409|FG000|Overall Study|Withdrawal by Subject|29|||
105686820|NCT03401229|364516410|FG001|Overall Study|Withdrawal by Subject|26|||
105686821|NCT03401229|364516409|FG000|Overall Study|COVID-19|0|||
105686822|NCT03401229|364516410|FG001|Overall Study|COVID-19|1|||
105686823|NCT02963610|364516411|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
105686824|NCT01122862|364516412|FG000|Period 1|Protocol Violation|0|||
105686825|NCT01122862|364516413|FG001|Period 1|Protocol Violation|1|||
105686826|NCT01122862|364516414|FG002|Period 1|Protocol Violation|0|||
105686827|NCT01122862|364516412|FG000|Period 2|Adverse Event|0|||
105686828|NCT01122862|364516413|FG001|Period 2|Adverse Event|0|||
105470652|NCT00904033|363733878|FG003|Overall Study|Physician Decision|0|||
105686829|NCT01122862|364516414|FG002|Period 2|Adverse Event|1|||
105686830|NCT01249274|364516416|FG000|Overall Study|Lost to Follow-up|3|||
105686831|NCT01249274|364516417|FG001|Overall Study|Lost to Follow-up|4|||
105686832|NCT01249274|364516416|FG000|Overall Study|Received inpatient substance treatment|1|||
105686833|NCT01249274|364516417|FG001|Overall Study|Received inpatient substance treatment|2|||
105686834|NCT01000636|364516418|FG000|Overall Study|Withdrawal by Subject|1|||
105686835|NCT01000636|364516418|FG000|Overall Study|Adverse Event|1|||
105686836|NCT01100034|364516419|FG000|Overall Study|Lost to Follow-up|11|||
105686837|NCT01100034|364516419|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
105686838|NCT01100034|364516419|FG000|Overall Study|Withdrawal by Subject|4|||
105470653|NCT00904033|363733875|FG000|Overall Study|Unable to obtain final blood draw|0|||
105686839|NCT01100034|364516419|FG000|Overall Study|Sponsor decision|21|||
105686840|NCT01100034|364516419|FG000|Overall Study|Participated in another clinical trial|1|||
105686841|NCT01100034|364516419|FG000|Overall Study|Participants moved to another hospital|4|||
105686842|NCT01100034|364516419|FG000|Overall Study|Site closed due to non-responsiveness|1|||
105686843|NCT01259726|364516420|FG000|Overall Study|Death|1|||
105686844|NCT01259726|364516421|FG001|Overall Study|Death|0|||
105686845|NCT01259726|364516422|FG002|Overall Study|Death|0|||
105686846|NCT01259726|364516423|FG003|Overall Study|Death|0|||
105686847|NCT01259726|364516420|FG000|Overall Study|Physician Decision|2|||
105686848|NCT01259726|364516421|FG001|Overall Study|Physician Decision|0|||
105686849|NCT01259726|364516422|FG002|Overall Study|Physician Decision|1|||
105686850|NCT01259726|364516423|FG003|Overall Study|Physician Decision|1|||
105686851|NCT01259726|364516420|FG000|Overall Study|Withdrawal by Subject|1|||
105686852|NCT01259726|364516421|FG001|Overall Study|Withdrawal by Subject|3|||
105686853|NCT01259726|364516422|FG002|Overall Study|Withdrawal by Subject|2|||
105686854|NCT01259726|364516423|FG003|Overall Study|Withdrawal by Subject|1|||
105686855|NCT01259726|364516420|FG000|Overall Study|Lost to Follow-up|1|||
105686856|NCT01259726|364516421|FG001|Overall Study|Lost to Follow-up|1|||
105686857|NCT01259726|364516422|FG002|Overall Study|Lost to Follow-up|1|||
105686858|NCT01259726|364516423|FG003|Overall Study|Lost to Follow-up|3|||
105686859|NCT01978262|364516424|FG000|Overall Study|Withdrawal by Subject|9|||
105686860|NCT01978262|364516424|FG000|Overall Study|Lost to Follow-up|2|||
105686861|NCT00141726|364516427|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
105686862|NCT02435966|364516428|FG000|Overall Study|Withdrawal by Subject|0|||
105686863|NCT02435966|364516429|FG001|Overall Study|Withdrawal by Subject|1|||
105686864|NCT02435966|364516430|FG002|Overall Study|Withdrawal by Subject|0|||
105686865|NCT02147353|364516431|FG000|Overall Study|Lost to Follow-up|2|||
105686866|NCT02147353|364516432|FG001|Overall Study|Lost to Follow-up|0|||
105686867|NCT02147353|364516431|FG000|Overall Study|unable to make visits|4|||
105686868|NCT02147353|364516432|FG001|Overall Study|unable to make visits|0|||
105686869|NCT02147353|364516431|FG000|Overall Study|medication noncompliance|3|||
105686870|NCT02147353|364516432|FG001|Overall Study|medication noncompliance|0|||
105686871|NCT02349360|364516433|FG000|Overall Study|Withdrawal by Subject|0|||
105686872|NCT02349360|364516434|FG001|Overall Study|Withdrawal by Subject|1|||
105686873|NCT02196714|364516439|FG000|Overall Study|Protocol Violation|0|||
105686874|NCT02196714|364516440|FG001|Overall Study|Protocol Violation|0|||
105686875|NCT02196714|364516441|FG002|Overall Study|Protocol Violation|1|||
105686876|NCT02196714|364516442|FG003|Overall Study|Protocol Violation|0|||
105686877|NCT01106404|364516452|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
105686878|NCT01106404|364516453|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
105686879|NCT01106404|364516452|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
105686880|NCT01106404|364516453|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
105686881|NCT01106404|364516452|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
105686882|NCT01106404|364516453|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
105686883|NCT01106404|364516452|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
105686884|NCT01106404|364516453|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
105686885|NCT02409368|364516456|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
105686886|NCT02409368|364516457|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
105686887|NCT02409368|364516458|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
105686888|NCT02409368|364516459|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
105686889|NCT02409368|364516456|FG000|ECOG Reclassification|Death|1|||
105686890|NCT02409368|364516457|FG001|ECOG Reclassification|Death|5|||
105686891|NCT02409368|364516458|FG002|ECOG Reclassification|Death|0|||
105686892|NCT02409368|364516459|FG003|ECOG Reclassification|Death|0|||
105686893|NCT02409368|364516456|FG000|ECOG Reclassification|Disease Progression|113|||
105686894|NCT02409368|364516457|FG001|ECOG Reclassification|Disease Progression|382|||
105686895|NCT02409368|364516458|FG002|ECOG Reclassification|Disease Progression|70|||
105686896|NCT02409368|364516459|FG003|ECOG Reclassification|Disease Progression|1|||
105686897|NCT02409368|364516456|FG000|ECOG Reclassification|Lost to Follow-up|1|||
105686898|NCT02409368|364516457|FG001|ECOG Reclassification|Lost to Follow-up|5|||
105686899|NCT02409368|364516458|FG002|ECOG Reclassification|Lost to Follow-up|0|||
105686900|NCT02409368|364516459|FG003|ECOG Reclassification|Lost to Follow-up|0|||
105686901|NCT02409368|364516456|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
105686902|NCT02409368|364516457|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
105686903|NCT02409368|364516458|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
105686904|NCT02409368|364516459|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
105686905|NCT02409368|364516456|FG000|ECOG Reclassification|Poor/non-compliance|0|||
105686906|NCT02409368|364516457|FG001|ECOG Reclassification|Poor/non-compliance|3|||
105686907|NCT02409368|364516458|FG002|ECOG Reclassification|Poor/non-compliance|2|||
105686908|NCT02409368|364516459|FG003|ECOG Reclassification|Poor/non-compliance|0|||
105686909|NCT02409368|364516456|FG000|ECOG Reclassification|Study drug toxicity|17|||
105686910|NCT02409368|364516457|FG001|ECOG Reclassification|Study drug toxicity|42|||
105686911|NCT02409368|364516458|FG002|ECOG Reclassification|Study drug toxicity|7|||
105686912|NCT02409368|364516459|FG003|ECOG Reclassification|Study drug toxicity|0|||
105686913|NCT02409368|364516456|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
105686914|NCT02409368|364516457|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
105686915|NCT02409368|364516458|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
105686916|NCT02409368|364516459|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
105686917|NCT02409368|364516456|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
105470654|NCT00904033|363733876|FG001|Overall Study|Unable to obtain final blood draw|0|||
105470655|NCT00904033|363733877|FG002|Overall Study|Unable to obtain final blood draw|0|||
105686918|NCT02409368|364516457|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
105686919|NCT02409368|364516458|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
105470656|NCT00904033|363733878|FG003|Overall Study|Unable to obtain final blood draw|2|||
105470657|NCT01227018|363733879|FG000|Overall Study|Disease progression|9|||
105470658|NCT01227018|363733879|FG000|Overall Study|Toxicity|2|||
105470659|NCT01227018|363733879|FG000|Overall Study|Withdrew after beginning treatment|4|||
105470660|NCT01357850|363733880|FG000|Overall Study|Lost to Follow-up|1|||
105470661|NCT01357850|363733881|FG001|Overall Study|Lost to Follow-up|0|||
105470662|NCT01357850|363733882|FG002|Overall Study|Lost to Follow-up|0|||
105470663|NCT01357850|363733883|FG003|Overall Study|Lost to Follow-up|0|||
105470664|NCT02873702|363733886|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
105470665|NCT02873702|363733887|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
105470666|NCT02873702|363733888|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
105470667|NCT02873702|363733889|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
105470668|NCT02873702|363733886|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
105470669|NCT02873702|363733887|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
105470670|NCT02873702|363733888|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
105470671|NCT02873702|363733889|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
105470672|NCT02873702|363733886|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
105470673|NCT02873702|363733887|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
105470674|NCT02873702|363733888|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
105470675|NCT02873702|363733889|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
105470676|NCT02873702|363733886|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
105470677|NCT02873702|363733887|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
105686920|NCT02409368|364516459|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
105686921|NCT02409368|364516456|FG000|ECOG Reclassification|Participant withdrew consent|2|||
105686922|NCT02409368|364516457|FG001|ECOG Reclassification|Participant withdrew consent|3|||
105686923|NCT02409368|364516458|FG002|ECOG Reclassification|Participant withdrew consent|4|||
105686924|NCT02409368|364516459|FG003|ECOG Reclassification|Participant withdrew consent|0|||
105470678|NCT02873702|363733888|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
105470679|NCT02873702|363733889|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
105686925|NCT02409368|364516456|FG000|ECOG Reclassification|Other Reasons|5|||
105686926|NCT02409368|364516457|FG001|ECOG Reclassification|Other Reasons|26|||
105470680|NCT02873702|363733886|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
105470681|NCT02873702|363733887|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
105470682|NCT02873702|363733888|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
105470683|NCT02873702|363733889|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
105470684|NCT03436082|363733891|FG000|Overall Study|Did not undergo procedure|1|||
105470685|NCT03436082|363733892|FG001|Overall Study|Did not undergo procedure|0|||
105470686|NCT00499616|363733893|FG000|Overall Study|Death|1|||
105470687|NCT00499616|363733894|FG001|Overall Study|Death|5|||
105470688|NCT00499616|363733895|FG002|Overall Study|Death|3|||
105686927|NCT02409368|364516458|FG002|ECOG Reclassification|Other Reasons|2|||
105686928|NCT02409368|364516459|FG003|ECOG Reclassification|Other Reasons|0|||
105686929|NCT02409368|364516456|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
105686930|NCT02409368|364516457|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
105686931|NCT02409368|364516458|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
105686932|NCT02409368|364516459|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
105686933|NCT03343301|364516460|FG000|Overall Study|Withdrawal by Subject|1|||
105686934|NCT03343301|364516461|FG001|Overall Study|Withdrawal by Subject|1|||
105686935|NCT03343301|364516460|FG000|Overall Study|Death|0|||
105686936|NCT03343301|364516461|FG001|Overall Study|Death|2|||
105686937|NCT03343301|364516460|FG000|Overall Study|Other|0|||
105686938|NCT03343301|364516461|FG001|Overall Study|Other|6|||
105686939|NCT03343301|364516460|FG000|Overall Study|Missing|2|||
105686940|NCT03343301|364516461|FG001|Overall Study|Missing|0|||
105686941|NCT00494481|364516462|FG000|Overall Study|Condition under investigation worsened|11|||
105686942|NCT00494481|364516463|FG001|Overall Study|Condition under investigation worsened|13|||
105686943|NCT00494481|364516462|FG000|Overall Study|Adverse Event|15|||
105686944|NCT00494481|364516463|FG001|Overall Study|Adverse Event|11|||
105470689|NCT00499616|363733896|FG003|Overall Study|Death|1|||
105470690|NCT00499616|363733893|FG000|Overall Study|Lack of Efficacy|5|||
105470691|NCT00499616|363733894|FG001|Overall Study|Lack of Efficacy|0|||
105470692|NCT00499616|363733895|FG002|Overall Study|Lack of Efficacy|19|||
105470693|NCT00499616|363733896|FG003|Overall Study|Lack of Efficacy|0|||
105558677|NCT00683644|364041908|FG001|Overall Study|Lost to Follow-up|4|||
105558678|NCT00683644|364041907|FG000|Overall Study|Adverse Event|1|||
105558679|NCT00683644|364041908|FG001|Overall Study|Adverse Event|2|||
105558680|NCT00683644|364041907|FG000|Overall Study|Low copper, other health problems,|7|||
105558681|NCT00683644|364041908|FG001|Overall Study|Low copper, other health problems,|6|||
105558682|NCT01857531|364041909|FG000|Overall Study|Withdrawal by Subject|4|||
105686945|NCT00494481|364516462|FG000|Overall Study|Other|1|||
105686946|NCT00494481|364516463|FG001|Overall Study|Other|0|||
105686947|NCT00494481|364516462|FG000|Overall Study|Never received IP|2|||
105470694|NCT00499616|363733893|FG000|Overall Study|Lost to Follow-up|0|||
105470695|NCT00499616|363733894|FG001|Overall Study|Lost to Follow-up|0|||
105470696|NCT00499616|363733895|FG002|Overall Study|Lost to Follow-up|1|||
105470697|NCT00499616|363733896|FG003|Overall Study|Lost to Follow-up|0|||
105470698|NCT00499616|363733893|FG000|Overall Study|Physician Decision|6|||
105470699|NCT00499616|363733894|FG001|Overall Study|Physician Decision|16|||
105470700|NCT00499616|363733895|FG002|Overall Study|Physician Decision|9|||
105686948|NCT00494481|364516463|FG001|Overall Study|Never received IP|0|||
105686949|NCT01193920|364516464|FG000|Overall Study|Withdrawal by Subject|1|||
105686950|NCT01193920|364516465|FG001|Overall Study|Withdrawal by Subject|0|||
105686951|NCT01193920|364516466|FG002|Overall Study|Withdrawal by Subject|5|||
105686952|NCT01193920|364516467|FG003|Overall Study|Withdrawal by Subject|1|||
105686953|NCT01193920|364516468|FG004|Overall Study|Withdrawal by Subject|3|||
105686954|NCT01193920|364516469|FG005|Overall Study|Withdrawal by Subject|1|||
105686955|NCT01193920|364516470|FG006|Overall Study|Withdrawal by Subject|3|||
105686956|NCT01193920|364516471|FG007|Overall Study|Withdrawal by Subject|0|||
105686957|NCT01193920|364516472|FG008|Overall Study|Withdrawal by Subject|1|||
105686958|NCT01193920|364516473|FG009|Overall Study|Withdrawal by Subject|0|||
105686959|NCT01193920|364516464|FG000|Overall Study|Lost to Follow-up|1|||
105686960|NCT01193920|364516465|FG001|Overall Study|Lost to Follow-up|0|||
105686961|NCT01193920|364516466|FG002|Overall Study|Lost to Follow-up|1|||
105686962|NCT01193920|364516467|FG003|Overall Study|Lost to Follow-up|1|||
105686963|NCT01193920|364516468|FG004|Overall Study|Lost to Follow-up|3|||
105686964|NCT01193920|364516469|FG005|Overall Study|Lost to Follow-up|3|||
105686965|NCT01193920|364516470|FG006|Overall Study|Lost to Follow-up|1|||
105686966|NCT01193920|364516471|FG007|Overall Study|Lost to Follow-up|0|||
105686967|NCT01193920|364516472|FG008|Overall Study|Lost to Follow-up|2|||
105686968|NCT01193920|364516473|FG009|Overall Study|Lost to Follow-up|3|||
105686969|NCT01193920|364516464|FG000|Overall Study|Protocol Violation|1|||
105686970|NCT01193920|364516465|FG001|Overall Study|Protocol Violation|0|||
105686971|NCT01193920|364516466|FG002|Overall Study|Protocol Violation|0|||
105686972|NCT01193920|364516467|FG003|Overall Study|Protocol Violation|0|||
105686973|NCT01193920|364516468|FG004|Overall Study|Protocol Violation|0|||
105686974|NCT01193920|364516469|FG005|Overall Study|Protocol Violation|0|||
105686975|NCT01193920|364516470|FG006|Overall Study|Protocol Violation|0|||
105686976|NCT01193920|364516471|FG007|Overall Study|Protocol Violation|0|||
105686977|NCT01193920|364516472|FG008|Overall Study|Protocol Violation|0|||
105686978|NCT01193920|364516473|FG009|Overall Study|Protocol Violation|0|||
105686979|NCT01193920|364516464|FG000|Overall Study|Death|0|||
105686980|NCT01193920|364516465|FG001|Overall Study|Death|0|||
105686981|NCT01193920|364516466|FG002|Overall Study|Death|0|||
105686982|NCT01193920|364516467|FG003|Overall Study|Death|1|||
105686983|NCT01193920|364516468|FG004|Overall Study|Death|0|||
105686984|NCT01193920|364516469|FG005|Overall Study|Death|0|||
105686985|NCT01193920|364516470|FG006|Overall Study|Death|2|||
105686986|NCT01193920|364516471|FG007|Overall Study|Death|3|||
105470701|NCT00499616|363733896|FG003|Overall Study|Physician Decision|0|||
105786585|NCT02389621|364872840|FG001|Posttreatment Period|Lost to Follow-up|1|||
105470702|NCT00499616|363733893|FG000|Overall Study|Withdrawal by Subject|1|||
105470703|NCT00499616|363733894|FG001|Overall Study|Withdrawal by Subject|0|||
105470704|NCT00499616|363733895|FG002|Overall Study|Withdrawal by Subject|1|||
105558683|NCT01775904|364041913|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
105558684|NCT01775904|364041913|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
105686987|NCT01193920|364516472|FG008|Overall Study|Death|2|||
105470705|NCT00499616|363733896|FG003|Overall Study|Withdrawal by Subject|0|||
105470706|NCT00499616|363733893|FG000|Overall Study|Ineligible|1|||
105686988|NCT01193920|364516473|FG009|Overall Study|Death|4|||
105686989|NCT01193920|364516464|FG000|Overall Study|Unable to classify|0|||
105686990|NCT01193920|364516465|FG001|Overall Study|Unable to classify|0|||
105686991|NCT01193920|364516466|FG002|Overall Study|Unable to classify|0|||
105686992|NCT01193920|364516467|FG003|Overall Study|Unable to classify|1|||
105686993|NCT01193920|364516468|FG004|Overall Study|Unable to classify|0|||
105686994|NCT01193920|364516469|FG005|Overall Study|Unable to classify|0|||
105470707|NCT00499616|363733894|FG001|Overall Study|Ineligible|2|||
105686995|NCT01193920|364516470|FG006|Overall Study|Unable to classify|0|||
105686996|NCT01193920|364516471|FG007|Overall Study|Unable to classify|1|||
105686997|NCT01193920|364516472|FG008|Overall Study|Unable to classify|0|||
105686998|NCT01193920|364516473|FG009|Overall Study|Unable to classify|0|||
105686999|NCT00332189|364516474|FG000|Overall Study|Adverse Event|3|||
105687000|NCT00332189|364516474|FG000|Overall Study|Uncooperative/Noncompliant|3|||
105687001|NCT00332189|364516474|FG000|Overall Study|Withdrawal by Subject|9|||
105687002|NCT00332189|364516474|FG000|Overall Study|Lack of Efficacy|4|||
105687003|NCT00332189|364516474|FG000|Overall Study|Moved out of country|2|||
105687004|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
105687005|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
105687006|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
105687007|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
105687008|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
105687009|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
105687010|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
105687011|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
105687012|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
105687013|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
105687014|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
105687015|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
105687016|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
105687017|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
105687018|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
105687019|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
105687020|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
105687021|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
105687022|NCT01231516|364516475|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
105687023|NCT01231516|364516476|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
105687024|NCT01231516|364516475|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
105687025|NCT01231516|364516476|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
105687026|NCT01231516|364516475|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
105687027|NCT01231516|364516476|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
105687028|NCT01231516|364516475|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
105687029|NCT01231516|364516476|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
105687030|NCT01231516|364516475|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
105687031|NCT01231516|364516476|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
105687032|NCT01231516|364516475|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
105687033|NCT01231516|364516476|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
105687034|NCT01231516|364516475|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
105687035|NCT01231516|364516476|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
105687036|NCT01163916|364516477|FG000|Overall Study|Withdrawal by Subject|2|||
105687037|NCT01163916|364516478|FG001|Overall Study|Withdrawal by Subject|0|||
105687038|NCT01163916|364516479|FG002|Overall Study|Withdrawal by Subject|2|||
105687039|NCT01163916|364516477|FG000|Overall Study|Adverse Event|2|||
105687040|NCT01163916|364516478|FG001|Overall Study|Adverse Event|0|||
105687041|NCT01163916|364516479|FG002|Overall Study|Adverse Event|1|||
105687042|NCT01163916|364516477|FG000|Overall Study|Lack of Efficacy|2|||
105687043|NCT01163916|364516478|FG001|Overall Study|Lack of Efficacy|0|||
105687044|NCT01163916|364516479|FG002|Overall Study|Lack of Efficacy|1|||
105687045|NCT01163916|364516477|FG000|Overall Study|Other|24|||
105786586|NCT02389621|364872839|FG000|Posttreatment Period|Other - Miscellaneous|2|||
105786587|NCT02389621|364872840|FG001|Posttreatment Period|Other - Miscellaneous|0|||
105786588|NCT03323034|364872841|FG000|Overall Study|Lack of Efficacy|5|||
105786589|NCT03323034|364872842|FG001|Overall Study|Lack of Efficacy|5|||
105786590|NCT03323034|364872843|FG002|Overall Study|Lack of Efficacy|6|||
105786591|NCT03323034|364872844|FG003|Overall Study|Lack of Efficacy|5|||
105786592|NCT03323034|364872845|FG004|Overall Study|Lack of Efficacy|5|||
105786593|NCT03323034|364872841|FG000|Overall Study|Physician Decision|0|||
105786594|NCT03323034|364872842|FG001|Overall Study|Physician Decision|0|||
105470708|NCT00499616|363733895|FG002|Overall Study|Ineligible|0|||
105470709|NCT00499616|363733896|FG003|Overall Study|Ineligible|15|||
105470710|NCT00499616|363733893|FG000|Overall Study|Not evaluable|0|||
105470711|NCT00499616|363733894|FG001|Overall Study|Not evaluable|0|||
105470712|NCT00499616|363733895|FG002|Overall Study|Not evaluable|0|||
105470713|NCT00499616|363733896|FG003|Overall Study|Not evaluable|41|||
105786595|NCT03323034|364872843|FG002|Overall Study|Physician Decision|0|||
105786596|NCT03323034|364872844|FG003|Overall Study|Physician Decision|0|||
105786597|NCT03323034|364872845|FG004|Overall Study|Physician Decision|1|||
105786598|NCT03323034|364872841|FG000|Overall Study|Withdrawal by Subject|1|||
105470714|NCT00499616|363733893|FG000|Overall Study|Patient/Parent Refusal|1|||
105470715|NCT00499616|363733894|FG001|Overall Study|Patient/Parent Refusal|5|||
105470716|NCT00499616|363733895|FG002|Overall Study|Patient/Parent Refusal|3|||
105687046|NCT01163916|364516478|FG001|Overall Study|Other|4|||
105687047|NCT01163916|364516479|FG002|Overall Study|Other|16|||
105687048|NCT00026208|364516480|FG000|Overall Study|Complications of auto accident|1|||
105687049|NCT00026208|364516481|FG001|Overall Study|Complications of auto accident|0|||
105687050|NCT03170154|364516482|FG000|Overall Study|Lost to Follow-up|4|||
105687051|NCT03170154|364516482|FG000|Overall Study|Death|2|||
105687052|NCT03170154|364516482|FG000|Overall Study|Withdrawal by Subject|2|||
105687053|NCT02279862|364516483|FG000|Overall Study|Study drug toxicity|3|||
105687054|NCT02279862|364516484|FG001|Overall Study|Study drug toxicity|6|||
105687055|NCT02279862|364516483|FG000|Overall Study|No longer meets criteria|0|||
105687056|NCT02279862|364516484|FG001|Overall Study|No longer meets criteria|1|||
105687057|NCT02279862|364516483|FG000|Overall Study|Administrative reason by sponsor|0|||
105687058|NCT02279862|364516484|FG001|Overall Study|Administrative reason by sponsor|1|||
105687059|NCT02279862|364516483|FG000|Overall Study|Disease progression|5|||
105687060|NCT02279862|364516484|FG001|Overall Study|Disease progression|2|||
105687061|NCT02279862|364516483|FG000|Overall Study|Study closed by sponsor|16|||
105687062|NCT02279862|364516484|FG001|Overall Study|Study closed by sponsor|13|||
105687063|NCT02279862|364516483|FG000|Overall Study|Other|1|||
105687064|NCT02279862|364516484|FG001|Overall Study|Other|2|||
105687065|NCT02279862|364516483|FG000|Overall Study|Withdrawal by Subject|1|||
105687066|NCT02279862|364516484|FG001|Overall Study|Withdrawal by Subject|0|||
105687067|NCT05266586|364516485|FG000|Overall Study|Adverse Event|2|||
105687068|NCT05266586|364516486|FG001|Overall Study|Adverse Event|2|||
105687069|NCT05266586|364516487|FG002|Overall Study|Adverse Event|1|||
105687070|NCT05266586|364516485|FG000|Overall Study|Withdrawal by Subject|1|||
105687071|NCT05266586|364516486|FG001|Overall Study|Withdrawal by Subject|0|||
105687072|NCT05266586|364516487|FG002|Overall Study|Withdrawal by Subject|1|||
105687073|NCT05266586|364516485|FG000|Overall Study|Non-compliance with study drug|0|||
105687074|NCT05266586|364516486|FG001|Overall Study|Non-compliance with study drug|1|||
105687075|NCT05266586|364516487|FG002|Overall Study|Non-compliance with study drug|0|||
105687076|NCT05266586|364516485|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
105687077|NCT05266586|364516486|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
105687078|NCT05266586|364516487|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
105687079|NCT03707925|364516488|FG000|Overall Study|Inevaluable|1|||
105687080|NCT00688181|364516489|FG000|Overall Study|Lost to Follow-up|17|||
105687081|NCT00688181|364516489|FG000|Overall Study|Unknown Reason|4|||
105687082|NCT00688181|364516489|FG000|Overall Study|Non-clinical Reason|2|||
105687083|NCT00467285|364516493|FG000|Overall Study|Lost to Follow-up|4|||
105687084|NCT00467285|364516494|FG001|Overall Study|Lost to Follow-up|4|||
105687085|NCT00688103|364516495|FG000|Overall Study|Adverse Event|4|||
105687086|NCT00688103|364516496|FG001|Overall Study|Adverse Event|1|||
105687087|NCT00688103|364516495|FG000|Overall Study|Lack of Efficacy|11|||
105687088|NCT00688103|364516496|FG001|Overall Study|Lack of Efficacy|1|||
105687089|NCT00688103|364516495|FG000|Overall Study|Withdrawal by Subject|4|||
105687090|NCT00688103|364516496|FG001|Overall Study|Withdrawal by Subject|2|||
105687091|NCT00688103|364516495|FG000|Overall Study|complex reasons|11|||
105687092|NCT00688103|364516496|FG001|Overall Study|complex reasons|9|||
105687093|NCT01060540|364518882|FG000|Overall Study|Withdrawal by Subject|10|||
105687094|NCT01060540|364518883|FG001|Overall Study|Withdrawal by Subject|20|||
105687095|NCT01060540|364518882|FG000|Overall Study|Lost to Follow-up|52|||
105687096|NCT01060540|364518883|FG001|Overall Study|Lost to Follow-up|43|||
105687097|NCT01060540|364518882|FG000|Overall Study|Death|2|||
105687098|NCT01060540|364518883|FG001|Overall Study|Death|1|||
105687099|NCT01060540|364518882|FG000|Overall Study|Physician Decision|0|||
105558685|NCT00518115|364041914|FG000|Overall Study|Adverse Event|6|||
105558686|NCT00518115|364041915|FG001|Overall Study|Adverse Event|1|||
105558687|NCT00518115|364041916|FG002|Overall Study|Adverse Event|5|||
105558688|NCT00518115|364041917|FG003|Overall Study|Adverse Event|6|||
105558689|NCT00518115|364041918|FG004|Overall Study|Adverse Event|5|||
105558690|NCT00518115|364041919|FG005|Overall Study|Adverse Event|5|||
105558691|NCT00518115|364041920|FG006|Overall Study|Adverse Event|5|||
105786599|NCT03323034|364872842|FG001|Overall Study|Withdrawal by Subject|1|||
105558692|NCT00518115|364041921|FG007|Overall Study|Adverse Event|10|||
105558693|NCT00518115|364041922|FG008|Overall Study|Adverse Event|2|||
105687100|NCT01060540|364518883|FG001|Overall Study|Physician Decision|1|||
105786600|NCT03323034|364872843|FG002|Overall Study|Withdrawal by Subject|0|||
105558694|NCT00518115|364041923|FG009|Overall Study|Adverse Event|9|||
105687101|NCT02647320|364518884|FG000|Overall Study|Adverse Event|0|||
105687102|NCT02647320|364518885|FG001|Overall Study|Adverse Event|1|||
105687103|NCT02647320|364518886|FG002|Overall Study|Adverse Event|3|||
105687104|NCT02647320|364518887|FG003|Overall Study|Adverse Event|2|||
105687105|NCT02647320|364518888|FG004|Overall Study|Adverse Event|1|||
105687106|NCT02647320|364518884|FG000|Overall Study|Protocol Violation|0|||
105687107|NCT02647320|364518885|FG001|Overall Study|Protocol Violation|0|||
105687108|NCT02647320|364518886|FG002|Overall Study|Protocol Violation|3|||
105687109|NCT02647320|364518887|FG003|Overall Study|Protocol Violation|0|||
105687110|NCT02647320|364518888|FG004|Overall Study|Protocol Violation|0|||
105687111|NCT02647320|364518884|FG000|Overall Study|Withdrawal by Subject|7|||
105687112|NCT02647320|364518885|FG001|Overall Study|Withdrawal by Subject|4|||
105687113|NCT02647320|364518886|FG002|Overall Study|Withdrawal by Subject|2|||
105687114|NCT02647320|364518887|FG003|Overall Study|Withdrawal by Subject|2|||
105687115|NCT02647320|364518888|FG004|Overall Study|Withdrawal by Subject|7|||
105687116|NCT02647320|364518884|FG000|Overall Study|Persistent hyperglycemia|0|||
105687117|NCT02647320|364518885|FG001|Overall Study|Persistent hyperglycemia|1|||
105687118|NCT02647320|364518886|FG002|Overall Study|Persistent hyperglycemia|1|||
105687119|NCT02647320|364518887|FG003|Overall Study|Persistent hyperglycemia|1|||
105687120|NCT02647320|364518888|FG004|Overall Study|Persistent hyperglycemia|1|||
105687121|NCT02647320|364518884|FG000|Overall Study|Study terminated by sponsor|1|||
105687122|NCT02647320|364518885|FG001|Overall Study|Study terminated by sponsor|1|||
105687123|NCT02647320|364518886|FG002|Overall Study|Study terminated by sponsor|1|||
105687124|NCT02647320|364518887|FG003|Overall Study|Study terminated by sponsor|1|||
105687125|NCT02647320|364518888|FG004|Overall Study|Study terminated by sponsor|2|||
105687126|NCT02647320|364518884|FG000|Overall Study|Reason not provided|0|||
105687127|NCT02647320|364518885|FG001|Overall Study|Reason not provided|0|||
105687128|NCT02647320|364518886|FG002|Overall Study|Reason not provided|1|||
105687129|NCT02647320|364518887|FG003|Overall Study|Reason not provided|0|||
105687130|NCT02647320|364518888|FG004|Overall Study|Reason not provided|2|||
105687131|NCT02647320|364518884|FG000|Overall Study|Lost to Follow-up|1|||
105687132|NCT02647320|364518885|FG001|Overall Study|Lost to Follow-up|1|||
105687133|NCT02647320|364518886|FG002|Overall Study|Lost to Follow-up|0|||
105687134|NCT02647320|364518887|FG003|Overall Study|Lost to Follow-up|0|||
105687135|NCT02647320|364518888|FG004|Overall Study|Lost to Follow-up|0|||
105687136|NCT02647320|364518884|FG000|Overall Study|Develop anemia|1|||
105687137|NCT02647320|364518885|FG001|Overall Study|Develop anemia|0|||
105687138|NCT02647320|364518886|FG002|Overall Study|Develop anemia|0|||
105687139|NCT02647320|364518887|FG003|Overall Study|Develop anemia|0|||
105687140|NCT02647320|364518888|FG004|Overall Study|Develop anemia|0|||
105687141|NCT02647320|364518884|FG000|Overall Study|Lack of Efficacy|0|||
105687142|NCT02647320|364518885|FG001|Overall Study|Lack of Efficacy|0|||
105687143|NCT02647320|364518886|FG002|Overall Study|Lack of Efficacy|0|||
105687144|NCT02647320|364518887|FG003|Overall Study|Lack of Efficacy|1|||
105687145|NCT02647320|364518888|FG004|Overall Study|Lack of Efficacy|0|||
105687146|NCT02647320|364518884|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
105687147|NCT02647320|364518885|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
105687148|NCT02647320|364518886|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
105687149|NCT02647320|364518887|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
105687150|NCT02647320|364518888|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
105687151|NCT00081770|364518889|FG000|Overall Study|Adverse Event|130|||
105687152|NCT00081770|364518890|FG001|Overall Study|Adverse Event|98|||
105687153|NCT00081770|364518891|FG002|Overall Study|Adverse Event|136|||
105687154|NCT00081770|364518889|FG000|Overall Study|Lack of Efficacy|262|||
105687155|NCT00081770|364518890|FG001|Overall Study|Lack of Efficacy|357|||
105687156|NCT00081770|364518891|FG002|Overall Study|Lack of Efficacy|211|||
105687157|NCT00081770|364518889|FG000|Overall Study|Lost to Follow-up|45|||
105687158|NCT00081770|364518890|FG001|Overall Study|Lost to Follow-up|34|||
105687159|NCT00081770|364518891|FG002|Overall Study|Lost to Follow-up|45|||
105687160|NCT00081770|364518889|FG000|Overall Study|Protocol Violation|15|||
105687161|NCT00081770|364518890|FG001|Overall Study|Protocol Violation|10|||
105687162|NCT00081770|364518891|FG002|Overall Study|Protocol Violation|10|||
105687163|NCT00081770|364518889|FG000|Overall Study|Withdrawal by Subject|45|||
105687164|NCT00081770|364518890|FG001|Overall Study|Withdrawal by Subject|40|||
105687165|NCT00081770|364518891|FG002|Overall Study|Withdrawal by Subject|42|||
105687166|NCT00081770|364518889|FG000|Overall Study|Did not meet protocol eligibility|2|||
105687167|NCT00081770|364518890|FG001|Overall Study|Did not meet protocol eligibility|0|||
105687168|NCT00081770|364518891|FG002|Overall Study|Did not meet protocol eligibility|3|||
105687169|NCT00081770|364518889|FG000|Overall Study|Administrative|1|||
105687170|NCT00081770|364518890|FG001|Overall Study|Administrative|0|||
105687171|NCT00081770|364518891|FG002|Overall Study|Administrative|1|||
105687172|NCT00081770|364518889|FG000|Overall Study|Other|2|||
105687173|NCT00081770|364518890|FG001|Overall Study|Other|7|||
105687174|NCT00081770|364518891|FG002|Overall Study|Other|8|||
105687175|NCT01614197|364518894|FG000|Overall Study|Withdrawal by Subject|0|||
105687176|NCT01614197|364518895|FG001|Overall Study|Withdrawal by Subject|1|||
105687177|NCT01614197|364518896|FG002|Overall Study|Withdrawal by Subject|0|||
105687178|NCT01614197|364518897|FG003|Overall Study|Withdrawal by Subject|0|||
105687179|NCT04281004|364518898|FG000|Overall Study|Physician Decision|1|||
105687180|NCT04281004|364518899|FG001|Overall Study|Physician Decision|0|||
105687181|NCT00971932|364518900|FG000|Overall Study|Withdrawal by Subject|1|||
105687182|NCT00971932|364518900|FG000|Overall Study|Investigator's decision|2|||
105687183|NCT00971932|364518900|FG000|Overall Study|Ongoing|4|||
105687184|NCT01640054|364518901|FG000|Overall Study|Study-specific disc criteria|1|||
105687185|NCT01640054|364518901|FG000|Overall Study|Lack of Efficacy|3|||
105687186|NCT01640054|364518901|FG000|Overall Study|Adverse Event|2|||
105687187|NCT01206777|364518902|FG000|Overall Study|Death|1|||
105687188|NCT01206777|364518902|FG000|Overall Study|Adverse Event|1|||
105687189|NCT02544217|364518905|FG000|Overall Study|Withdrawal by Subject|1|||
105687190|NCT02544217|364518906|FG001|Overall Study|Withdrawal by Subject|1|||
105687191|NCT02544217|364518907|FG002|Overall Study|Withdrawal by Subject|0|||
105687192|NCT02544217|364518908|FG003|Overall Study|Withdrawal by Subject|0|||
105687193|NCT02544217|364518909|FG004|Overall Study|Withdrawal by Subject|0|||
105687194|NCT02544217|364518910|FG005|Overall Study|Withdrawal by Subject|0|||
105687195|NCT01155375|364518911|FG000|Overall Study|Adverse Event|1|||
105687196|NCT01155375|364518912|FG001|Overall Study|Adverse Event|0|||
105687197|NCT02901041|364518913|FG000|Overall Study|Withdrawal by PI|4|||
105687198|NCT02901041|364518914|FG001|Overall Study|Withdrawal by PI|8|||
105687199|NCT02901041|364518913|FG000|Overall Study|Withdrawal by Subject|7|||
105687200|NCT02901041|364518914|FG001|Overall Study|Withdrawal by Subject|3|||
105687201|NCT00762970|364518915|FG000|Overall Study|Withdrawal by Subject|7|||
105687202|NCT00762970|364518916|FG001|Overall Study|Withdrawal by Subject|4|||
105687203|NCT00762970|364518917|FG002|Overall Study|Withdrawal by Subject|0|||
105687204|NCT00762970|364518915|FG000|Overall Study|Protocol Violation|3|||
105687205|NCT00762970|364518916|FG001|Overall Study|Protocol Violation|1|||
105687206|NCT00762970|364518917|FG002|Overall Study|Protocol Violation|1|||
105687207|NCT00762970|364518915|FG000|Overall Study|Lost to Follow-up|1|||
105687208|NCT00762970|364518916|FG001|Overall Study|Lost to Follow-up|2|||
105687209|NCT00762970|364518917|FG002|Overall Study|Lost to Follow-up|0|||
105687210|NCT00762970|364518915|FG000|Overall Study|Difficulty of handling lens|1|||
105687211|NCT00762970|364518916|FG001|Overall Study|Difficulty of handling lens|2|||
105687212|NCT00762970|364518917|FG002|Overall Study|Difficulty of handling lens|0|||
105687213|NCT03818204|364518918|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687214|NCT03818204|364518919|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687215|NCT03818204|364518920|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687216|NCT03818204|364518921|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687217|NCT03818204|364518922|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
105687218|NCT03818204|364518923|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687219|NCT03818204|364518924|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687220|NCT03818204|364518925|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687221|NCT03818204|364518926|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687222|NCT03818204|364518927|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687223|NCT03818204|364518928|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687224|NCT03818204|364518929|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687225|NCT03818204|364518930|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687226|NCT03818204|364518931|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
105687227|NCT03818204|364518932|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687228|NCT03818204|364518933|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687229|NCT03818204|364518934|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687230|NCT03818204|364518935|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687231|NCT03818204|364518936|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687232|NCT03818204|364518918|FG000|Overall Study|Physician Decision|0|||
105687233|NCT03818204|364518919|FG001|Overall Study|Physician Decision|0|||
105687234|NCT03818204|364518920|FG002|Overall Study|Physician Decision|0|||
105687235|NCT03818204|364518921|FG003|Overall Study|Physician Decision|0|||
105687236|NCT03818204|364518922|FG004|Overall Study|Physician Decision|0|||
105687237|NCT03818204|364518923|FG005|Overall Study|Physician Decision|0|||
105687238|NCT03818204|364518924|FG006|Overall Study|Physician Decision|0|||
105687239|NCT03818204|364518925|FG007|Overall Study|Physician Decision|0|||
105687240|NCT03818204|364518926|FG008|Overall Study|Physician Decision|0|||
105687241|NCT03818204|364518927|FG009|Overall Study|Physician Decision|0|||
105687242|NCT03818204|364518928|FG010|Overall Study|Physician Decision|0|||
105687243|NCT03818204|364518929|FG011|Overall Study|Physician Decision|0|||
105687244|NCT03818204|364518930|FG012|Overall Study|Physician Decision|0|||
105687245|NCT03818204|364518931|FG013|Overall Study|Physician Decision|0|||
105687246|NCT03818204|364518932|FG014|Overall Study|Physician Decision|1|||
105687247|NCT03818204|364518933|FG015|Overall Study|Physician Decision|0|||
105687248|NCT03818204|364518934|FG016|Overall Study|Physician Decision|0|||
105687249|NCT03818204|364518935|FG017|Overall Study|Physician Decision|0|||
105687250|NCT03818204|364518936|FG018|Overall Study|Physician Decision|0|||
105470717|NCT00499616|363733896|FG003|Overall Study|Patient/Parent Refusal|0|||
105470718|NCT01255436|363733906|FG000|Overall Study|Lost to Follow-up|178|||
105470719|NCT01255436|363733907|FG001|Overall Study|Lost to Follow-up|191|||
105470720|NCT01255436|363733906|FG000|Overall Study|Death, stroke, or MI|4|||
105470721|NCT01255436|363733907|FG001|Overall Study|Death, stroke, or MI|3|||
105687251|NCT00887250|364518937|FG000|Overall Study|Adverse Event|3|||
105687252|NCT00887250|364518938|FG001|Overall Study|Adverse Event|0|||
105687253|NCT00887250|364518939|FG002|Overall Study|Adverse Event|7|||
105687254|NCT00887250|364518937|FG000|Overall Study|Lack of Efficacy|9|||
105687255|NCT00887250|364518938|FG001|Overall Study|Lack of Efficacy|6|||
105687256|NCT00887250|364518939|FG002|Overall Study|Lack of Efficacy|1|||
105687257|NCT00887250|364518937|FG000|Overall Study|Lost to Follow-up|2|||
105687258|NCT00887250|364518938|FG001|Overall Study|Lost to Follow-up|3|||
105687259|NCT00887250|364518939|FG002|Overall Study|Lost to Follow-up|1|||
105687260|NCT00887250|364518937|FG000|Overall Study|Protocol Violation|2|||
105687261|NCT00887250|364518938|FG001|Overall Study|Protocol Violation|2|||
105687262|NCT00887250|364518939|FG002|Overall Study|Protocol Violation|1|||
105687263|NCT00887250|364518937|FG000|Overall Study|Withdrawal by Subject|2|||
105687264|NCT00887250|364518938|FG001|Overall Study|Withdrawal by Subject|1|||
105687265|NCT00887250|364518939|FG002|Overall Study|Withdrawal by Subject|2|||
105687266|NCT00887250|364518937|FG000|Overall Study|Patient uncooperative|0|||
105687267|NCT00887250|364518938|FG001|Overall Study|Patient uncooperative|0|||
105687268|NCT00887250|364518939|FG002|Overall Study|Patient uncooperative|1|||
105687269|NCT01933113|364518942|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
105687270|NCT01313637|364518943|FG000|Overall Study|Adverse Event|17|||
105687271|NCT01313637|364518944|FG001|Overall Study|Adverse Event|24|||
105687272|NCT01313637|364518945|FG002|Overall Study|Adverse Event|25|||
105687273|NCT01313637|364518946|FG003|Overall Study|Adverse Event|18|||
105687274|NCT01313637|364518943|FG000|Overall Study|Lack of Efficacy|44|||
105687275|NCT01313637|364518944|FG001|Overall Study|Lack of Efficacy|38|||
105344769|NCT02659514|363263501|FG001|Overall Study|Disease Progression|13|||
105470722|NCT04816669|363733908|FG000|Part 1|Adverse Event|1|||
105687276|NCT01313637|364518945|FG002|Overall Study|Lack of Efficacy|37|||
105687277|NCT01313637|364518946|FG003|Overall Study|Lack of Efficacy|24|||
105687278|NCT01313637|364518943|FG000|Overall Study|Protocol Violation|4|||
105687279|NCT01313637|364518944|FG001|Overall Study|Protocol Violation|3|||
105687280|NCT01313637|364518945|FG002|Overall Study|Protocol Violation|11|||
105470723|NCT04816669|363733909|FG001|Part 1|Adverse Event|1|||
105470724|NCT04816669|363733910|FG002|Part 1|Adverse Event|0|||
105687281|NCT01313637|364518946|FG003|Overall Study|Protocol Violation|5|||
105687282|NCT01313637|364518943|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
105687283|NCT01313637|364518944|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
105687284|NCT01313637|364518945|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
105687285|NCT01313637|364518946|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
105687286|NCT01313637|364518943|FG000|Overall Study|Lost to Follow-up|0|||
105687287|NCT01313637|364518944|FG001|Overall Study|Lost to Follow-up|2|||
105687288|NCT01313637|364518945|FG002|Overall Study|Lost to Follow-up|1|||
105687289|NCT01313637|364518946|FG003|Overall Study|Lost to Follow-up|3|||
105687290|NCT01313637|364518943|FG000|Overall Study|Withdrawal by Subject|11|||
105687291|NCT01313637|364518944|FG001|Overall Study|Withdrawal by Subject|13|||
105687292|NCT01313637|364518945|FG002|Overall Study|Withdrawal by Subject|18|||
105687293|NCT01313637|364518946|FG003|Overall Study|Withdrawal by Subject|15|||
105687294|NCT04218084|364518947|FG000|Overall Study|Adverse Event|7|||
105687295|NCT04218084|364518948|FG001|Overall Study|Adverse Event|2|||
105687296|NCT04218084|364518947|FG000|Overall Study|Withdrawal of Consent|4|||
105687297|NCT04218084|364518948|FG001|Overall Study|Withdrawal of Consent|5|||
105687298|NCT04218084|364518947|FG000|Overall Study|Physician Decision|1|||
105687299|NCT04218084|364518948|FG001|Overall Study|Physician Decision|1|||
105687300|NCT04218084|364518947|FG000|Overall Study|Lost to Follow-up|1|||
105687301|NCT04218084|364518948|FG001|Overall Study|Lost to Follow-up|1|||
105687302|NCT04218084|364518947|FG000|Overall Study|Non-compliance with study drug|1|||
105687303|NCT04218084|364518948|FG001|Overall Study|Non-compliance with study drug|1|||
105687304|NCT04218084|364518947|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
105687305|NCT04218084|364518948|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
105687306|NCT04218084|364518947|FG000|Overall Study|Other|0|||
105687307|NCT04218084|364518948|FG001|Overall Study|Other|1|||
105687308|NCT04218084|364518947|FG000|Overall Study|Ongoing at data cut-off date|62|||
105687309|NCT04218084|364518948|FG001|Overall Study|Ongoing at data cut-off date|58|||
105687310|NCT03840486|364518949|FG000|Overall Study|Withdrawal by Subject|0|||
105687311|NCT03840486|364518950|FG001|Overall Study|Withdrawal by Subject|1|||
105687312|NCT03840486|364518951|FG002|Overall Study|Withdrawal by Subject|0|||
105687313|NCT03840486|364518952|FG003|Overall Study|Withdrawal by Subject|0|||
105687314|NCT03840486|364518953|FG004|Overall Study|Withdrawal by Subject|0|||
105687315|NCT03840486|364518954|FG005|Overall Study|Withdrawal by Subject|0|||
105687316|NCT03840486|364518955|FG006|Overall Study|Withdrawal by Subject|0|||
105687317|NCT03840486|364518956|FG007|Overall Study|Withdrawal by Subject|0|||
105687318|NCT03840486|364518957|FG008|Overall Study|Withdrawal by Subject|0|||
105687319|NCT03840486|364518958|FG009|Overall Study|Withdrawal by Subject|0|||
105687320|NCT03840486|364518959|FG010|Overall Study|Withdrawal by Subject|0|||
105687321|NCT03840486|364518960|FG011|Overall Study|Withdrawal by Subject|0|||
105687322|NCT04661878|364518961|FG000|Overall Study|Lost to Follow-up|6|||
105687323|NCT04661878|364518962|FG001|Overall Study|Lost to Follow-up|5|||
105687324|NCT00690820|364518967|FG000|Period 1|Withdrawal by Subject|0|||
105687325|NCT00690820|364518968|FG001|Period 1|Withdrawal by Subject|1|||
105687326|NCT05333224|364518969|FG000|Overall Study - Infants|Lost to Follow-up|1|||
105687327|NCT05333224|364518970|FG001|Overall Study - Infants|Lost to Follow-up|1|||
105687328|NCT01774110|364518971|FG000|Overall Study|Lost to Follow-up|7|||
105687329|NCT00846391|364518974|FG000|Overall Study|Physician Decision|0|||
105687330|NCT00846391|364518975|FG001|Overall Study|Physician Decision|0|||
105687331|NCT00846391|364518976|FG002|Overall Study|Physician Decision|1|||
105687332|NCT00846391|364518974|FG000|Overall Study|Study Terminated by Sponsor|1|||
105687333|NCT00846391|364518975|FG001|Overall Study|Study Terminated by Sponsor|2|||
105687334|NCT00846391|364518976|FG002|Overall Study|Study Terminated by Sponsor|2|||
105687335|NCT04507126|364518977|FG000|Overall Study|Withdrawal by Subject|1|||
105687336|NCT04507126|364518977|FG000|Overall Study|Protocol Violation|2|||
105687337|NCT04507126|364518977|FG000|Overall Study|Physician Decision|1|||
105687338|NCT02699983|364518978|FG000|Overall Study|Withdrawal by Subject|1|||
105687339|NCT02699983|364518979|FG001|Overall Study|Withdrawal by Subject|0|||
105687340|NCT03575143|364518980|FG000|Overall Study|Lost to Follow-up|0|||
105687341|NCT03575143|364518981|FG001|Overall Study|Lost to Follow-up|0|||
105687342|NCT03575143|364518982|FG002|Overall Study|Lost to Follow-up|4|||
105470725|NCT04816669|363733911|FG003|Part 1|Adverse Event|0|||
105470726|NCT04816669|363733908|FG000|Part 1|Lost to Follow-up|2|||
105470727|NCT04816669|363733909|FG001|Part 1|Lost to Follow-up|2|||
105470728|NCT04816669|363733910|FG002|Part 1|Lost to Follow-up|0|||
105687343|NCT03575143|364518980|FG000|Overall Study|Withdrawal by Subject|0|||
105687344|NCT03575143|364518981|FG001|Overall Study|Withdrawal by Subject|0|||
105687345|NCT03575143|364518982|FG002|Overall Study|Withdrawal by Subject|5|||
105687346|NCT03575143|364518980|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
105687347|NCT03575143|364518981|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
105470729|NCT04816669|363733911|FG003|Part 1|Lost to Follow-up|0|||
105687348|NCT03575143|364518982|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
105786601|NCT03323034|364872844|FG003|Overall Study|Withdrawal by Subject|1|||
105470730|NCT04816669|363733908|FG000|Part 1|Protocol Violation|0|||
105687349|NCT01287065|364518985|FG000|Treatment Period 1|Adverse Event|0|||
105470731|NCT04816669|363733909|FG001|Part 1|Protocol Violation|1|||
105470732|NCT04816669|363733910|FG002|Part 1|Protocol Violation|0|||
105470733|NCT04816669|363733911|FG003|Part 1|Protocol Violation|0|||
105470734|NCT04816669|363733908|FG000|Part 1|Withdrawal by Subject|1|||
105470735|NCT04816669|363733909|FG001|Part 1|Withdrawal by Subject|2|||
105470736|NCT04816669|363733910|FG002|Part 1|Withdrawal by Subject|0|||
105470737|NCT04816669|363733911|FG003|Part 1|Withdrawal by Subject|0|||
105470738|NCT04816669|363733908|FG000|Part 2|Other|0|||
105470739|NCT04816669|363733909|FG001|Part 2|Other|0|||
105470740|NCT04816669|363733910|FG002|Part 2|Other|1|||
105470741|NCT04816669|363733911|FG003|Part 2|Other|0|||
105558695|NCT00518115|364041914|FG000|Overall Study|Lost to Follow-up|0|||
105558696|NCT00518115|364041915|FG001|Overall Study|Lost to Follow-up|0|||
105558697|NCT00518115|364041916|FG002|Overall Study|Lost to Follow-up|2|||
105687350|NCT01287065|364518986|FG001|Treatment Period 1|Adverse Event|0|||
105687351|NCT01287065|364518987|FG002|Treatment Period 1|Adverse Event|0|||
105687352|NCT01287065|364518988|FG003|Treatment Period 1|Adverse Event|0|||
105687353|NCT01287065|364518989|FG004|Treatment Period 1|Adverse Event|1|||
105687354|NCT01287065|364518990|FG005|Treatment Period 1|Adverse Event|0|||
105687355|NCT01287065|364518985|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105687356|NCT01287065|364518986|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105687357|NCT01287065|364518987|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105687358|NCT01287065|364518988|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105687359|NCT01287065|364518989|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105687360|NCT01287065|364518990|FG005|Treatment Period 1|Withdrawal by Subject|1|||
105687361|NCT00973362|364518991|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
105687362|NCT00973362|364518992|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
105687363|NCT00973362|364518991|FG000|Baseline Evaluation|No colposcopy visit|62|||
105687364|NCT00973362|364518992|FG001|Baseline Evaluation|No colposcopy visit|0|||
105687365|NCT00973362|364518991|FG000|Baseline Evaluation|Inevaluable|686|||
105687366|NCT00973362|364518992|FG001|Baseline Evaluation|Inevaluable|223|||
105687367|NCT00973362|364518991|FG000|3-Year Follow-up|Lost to Follow-up|17|||
105687368|NCT00973362|364518992|FG001|3-Year Follow-up|Lost to Follow-up|0|||
105687369|NCT02349451|364518993|FG000|Overall Study|Withdrawal by Subject|0|||
105687370|NCT02349451|364518994|FG001|Overall Study|Withdrawal by Subject|1|||
105687371|NCT02349451|364518995|FG002|Overall Study|Withdrawal by Subject|2|||
105687372|NCT02349451|364518996|FG003|Overall Study|Withdrawal by Subject|1|||
105687373|NCT04781387|364518997|FG000|Overall Study|Withdrawal by Subject|1|||
105687374|NCT04781387|364518998|FG001|Overall Study|Withdrawal by Subject|0|||
105687375|NCT04781387|364518999|FG002|Overall Study|Withdrawal by Subject|1|||
105687376|NCT04781387|364518997|FG000|Overall Study|Lost to Follow-up|1|||
105687377|NCT04781387|364518998|FG001|Overall Study|Lost to Follow-up|0|||
105687378|NCT04781387|364518999|FG002|Overall Study|Lost to Follow-up|0|||
105687379|NCT01423253|364519005|FG000|Overall Study|Adverse Event|2|||
105687380|NCT01423253|364519005|FG000|Overall Study|Lack of Efficacy|2|||
105687381|NCT01423253|364519005|FG000|Overall Study|Lost to Follow-up|1|||
105687382|NCT01423253|364519005|FG000|Overall Study|Protocol Violation|2|||
105687383|NCT01423253|364519005|FG000|Overall Study|Withdrawal by Subject|2|||
105687384|NCT00392327|364519007|FG000|Overall Study|Death|1|||
105687385|NCT00392327|364519008|FG001|Overall Study|Death|0|||
105687386|NCT00392327|364519009|FG002|Overall Study|Death|1|||
105687387|NCT00392327|364519010|FG003|Overall Study|Death|0|||
105687388|NCT00392327|364519011|FG004|Overall Study|Death|0|||
105687389|NCT00392327|364519012|FG005|Overall Study|Death|0|||
105687390|NCT00392327|364519013|FG006|Overall Study|Death|0|||
105687391|NCT00392327|364519014|FG007|Overall Study|Death|0|||
105687392|NCT00392327|364519007|FG000|Overall Study|Lack of Efficacy|8|||
105687393|NCT00392327|364519008|FG001|Overall Study|Lack of Efficacy|8|||
105687394|NCT00392327|364519009|FG002|Overall Study|Lack of Efficacy|9|||
105687395|NCT00392327|364519010|FG003|Overall Study|Lack of Efficacy|6|||
105687396|NCT00392327|364519011|FG004|Overall Study|Lack of Efficacy|3|||
105687397|NCT00392327|364519012|FG005|Overall Study|Lack of Efficacy|3|||
105687398|NCT00392327|364519013|FG006|Overall Study|Lack of Efficacy|3|||
105687399|NCT00392327|364519014|FG007|Overall Study|Lack of Efficacy|3|||
105687400|NCT00392327|364519007|FG000|Overall Study|Physician Decision|3|||
105687401|NCT00392327|364519008|FG001|Overall Study|Physician Decision|5|||
105470742|NCT04816669|363733908|FG000|Part 2|Withdrawal by Subject|0|||
105558698|NCT00518115|364041917|FG003|Overall Study|Lost to Follow-up|3|||
105687402|NCT00392327|364519009|FG002|Overall Study|Physician Decision|2|||
105687403|NCT00392327|364519010|FG003|Overall Study|Physician Decision|2|||
105687404|NCT00392327|364519011|FG004|Overall Study|Physician Decision|0|||
105687405|NCT00392327|364519012|FG005|Overall Study|Physician Decision|1|||
105687406|NCT00392327|364519013|FG006|Overall Study|Physician Decision|5|||
105470743|NCT04816669|363733909|FG001|Part 2|Withdrawal by Subject|0|||
105470744|NCT04816669|363733910|FG002|Part 2|Withdrawal by Subject|0|||
105687407|NCT00392327|364519014|FG007|Overall Study|Physician Decision|3|||
105687408|NCT00392327|364519007|FG000|Overall Study|Protocol Violation|0|||
105687409|NCT00392327|364519008|FG001|Overall Study|Protocol Violation|0|||
105470745|NCT04816669|363733911|FG003|Part 2|Withdrawal by Subject|1|||
105470746|NCT04816669|363733908|FG000|Part 2|Lost to Follow-up|0|||
105687410|NCT00392327|364519009|FG002|Overall Study|Protocol Violation|1|||
105687411|NCT00392327|364519010|FG003|Overall Study|Protocol Violation|0|||
105687412|NCT00392327|364519011|FG004|Overall Study|Protocol Violation|0|||
105687413|NCT00392327|364519012|FG005|Overall Study|Protocol Violation|0|||
105470747|NCT04816669|363733909|FG001|Part 2|Lost to Follow-up|0|||
105470748|NCT04816669|363733910|FG002|Part 2|Lost to Follow-up|1|||
105470749|NCT04816669|363733911|FG003|Part 2|Lost to Follow-up|0|||
105470750|NCT01237899|363733912|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
105470751|NCT01237899|363733913|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
105470752|NCT01237899|363733914|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
105558699|NCT00518115|364041918|FG004|Overall Study|Lost to Follow-up|1|||
105558700|NCT00518115|364041919|FG005|Overall Study|Lost to Follow-up|3|||
105687414|NCT00392327|364519013|FG006|Overall Study|Protocol Violation|0|||
105687415|NCT00392327|364519014|FG007|Overall Study|Protocol Violation|0|||
105687416|NCT00392327|364519007|FG000|Overall Study|Withdrawal by Subject|3|||
105687417|NCT00392327|364519008|FG001|Overall Study|Withdrawal by Subject|2|||
105687418|NCT00392327|364519009|FG002|Overall Study|Withdrawal by Subject|4|||
105687419|NCT00392327|364519010|FG003|Overall Study|Withdrawal by Subject|6|||
105687420|NCT00392327|364519011|FG004|Overall Study|Withdrawal by Subject|0|||
105687421|NCT00392327|364519012|FG005|Overall Study|Withdrawal by Subject|1|||
105687422|NCT00392327|364519013|FG006|Overall Study|Withdrawal by Subject|1|||
105687423|NCT00392327|364519014|FG007|Overall Study|Withdrawal by Subject|5|||
105687424|NCT00392327|364519007|FG000|Overall Study|Ineligible|0|||
105687425|NCT00392327|364519008|FG001|Overall Study|Ineligible|4|||
105687426|NCT00392327|364519009|FG002|Overall Study|Ineligible|3|||
105687427|NCT00392327|364519010|FG003|Overall Study|Ineligible|2|||
105687428|NCT00392327|364519011|FG004|Overall Study|Ineligible|0|||
105687429|NCT00392327|364519012|FG005|Overall Study|Ineligible|0|||
105687430|NCT00392327|364519013|FG006|Overall Study|Ineligible|0|||
105470753|NCT01237899|363733915|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
105470754|NCT01237899|363733916|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
105470755|NCT01237899|363733917|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
105470756|NCT01237899|363733918|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
105470757|NCT01237899|363733919|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
105470758|NCT01237899|363733920|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
105470759|NCT01237899|363733921|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
105470760|NCT01237899|363733922|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
105470761|NCT03219528|363733923|FG000|Overall Study|Lost to Follow-up|5|||
105470762|NCT03219528|363733924|FG001|Overall Study|Lost to Follow-up|4|||
105470763|NCT03219528|363733923|FG000|Overall Study|Withdrawal by Subject|4|||
105470764|NCT03219528|363733924|FG001|Overall Study|Withdrawal by Subject|4|||
105470765|NCT00241839|363733925|FG000|Overall Study|Withdrawal by Subject|18|||
105558701|NCT00518115|364041920|FG006|Overall Study|Lost to Follow-up|0|||
105558702|NCT00518115|364041921|FG007|Overall Study|Lost to Follow-up|1|||
105558703|NCT00518115|364041922|FG008|Overall Study|Lost to Follow-up|1|||
105687431|NCT00392327|364519014|FG007|Overall Study|Ineligible|0|||
105687432|NCT03267940|364519015|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
105687433|NCT03267940|364519016|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
105687434|NCT03267940|364519017|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
105687435|NCT03267940|364519018|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
105687436|NCT03267940|364519019|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
105687437|NCT03267940|364519020|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
105558704|NCT00518115|364041923|FG009|Overall Study|Lost to Follow-up|1|||
105558705|NCT00518115|364041914|FG000|Overall Study|Protocol Violation|1|||
105558706|NCT00518115|364041915|FG001|Overall Study|Protocol Violation|3|||
105558707|NCT00518115|364041916|FG002|Overall Study|Protocol Violation|1|||
105558708|NCT00518115|364041917|FG003|Overall Study|Protocol Violation|0|||
105558709|NCT00518115|364041918|FG004|Overall Study|Protocol Violation|0|||
105558710|NCT00518115|364041919|FG005|Overall Study|Protocol Violation|0|||
105558711|NCT00518115|364041920|FG006|Overall Study|Protocol Violation|0|||
105558712|NCT00518115|364041921|FG007|Overall Study|Protocol Violation|0|||
105687438|NCT03267940|364519015|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
105687439|NCT03267940|364519016|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
105470766|NCT00241839|363733926|FG001|Overall Study|Withdrawal by Subject|17|||
105558713|NCT00518115|364041922|FG008|Overall Study|Protocol Violation|0|||
105558714|NCT00518115|364041923|FG009|Overall Study|Protocol Violation|0|||
105687440|NCT03267940|364519017|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
105687441|NCT03267940|364519018|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
105687442|NCT03267940|364519019|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
105470767|NCT00241839|363733925|FG000|Overall Study|Adverse Event|1|||
105470768|NCT00241839|363733926|FG001|Overall Study|Adverse Event|1|||
105558715|NCT00518115|364041914|FG000|Overall Study|Withdrawal by Subject|1|||
105558716|NCT00518115|364041915|FG001|Overall Study|Withdrawal by Subject|1|||
105558717|NCT00518115|364041916|FG002|Overall Study|Withdrawal by Subject|5|||
105687443|NCT03267940|364519020|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
105687444|NCT03267940|364519015|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
105687445|NCT03267940|364519016|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
105687446|NCT03267940|364519017|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
105687447|NCT03267940|364519018|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
105687448|NCT03267940|364519019|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
105687449|NCT03267940|364519020|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
105687450|NCT03267940|364519015|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
105687451|NCT03267940|364519016|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
105687452|NCT03267940|364519017|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
105687453|NCT03267940|364519018|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
105687454|NCT03267940|364519019|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
105687455|NCT03267940|364519020|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
105687456|NCT03267940|364519015|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
105687457|NCT03267940|364519016|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
105470769|NCT03565497|363733936|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
105470770|NCT03565497|363733937|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
105470771|NCT03565497|363733938|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
105470772|NCT03565497|363733936|FG000|Overall Study|Lost to Follow-up|1|||
105470773|NCT03565497|363733937|FG001|Overall Study|Lost to Follow-up|1|||
105470774|NCT03565497|363733938|FG002|Overall Study|Lost to Follow-up|2|||
105470775|NCT03565497|363733936|FG000|Overall Study|Withdrawal by Subject|1|||
105558718|NCT00518115|364041917|FG003|Overall Study|Withdrawal by Subject|0|||
105558719|NCT00518115|364041918|FG004|Overall Study|Withdrawal by Subject|2|||
105687458|NCT03267940|364519017|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
105687459|NCT03267940|364519018|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
105687460|NCT03267940|364519019|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
105687461|NCT03267940|364519020|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
105687462|NCT03267940|364519015|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
105687463|NCT03267940|364519016|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
105687464|NCT03267940|364519017|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
105687465|NCT03267940|364519018|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
105687466|NCT03267940|364519019|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
105687467|NCT03267940|364519020|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
105687468|NCT03267940|364519015|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
105687469|NCT03267940|364519016|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
105687470|NCT03267940|364519017|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
105687471|NCT03267940|364519018|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
105470776|NCT03565497|363733937|FG001|Overall Study|Withdrawal by Subject|1|||
105470777|NCT03565497|363733938|FG002|Overall Study|Withdrawal by Subject|1|||
105470778|NCT03196349|363733945|FG000|Overall Study|Did not receive study drug|0|||
105470779|NCT03196349|363733946|FG001|Overall Study|Did not receive study drug|1|||
105470780|NCT03196349|363733947|FG002|Overall Study|Did not receive study drug|2|||
105470781|NCT03196349|363733945|FG000|Overall Study|No data entered|2|||
105470782|NCT03196349|363733946|FG001|Overall Study|No data entered|4|||
105470783|NCT03196349|363733947|FG002|Overall Study|No data entered|0|||
105470784|NCT03196349|363733945|FG000|Overall Study|Study Terminated early|15|||
105470785|NCT03196349|363733946|FG001|Overall Study|Study Terminated early|9|||
105470786|NCT03196349|363733947|FG002|Overall Study|Study Terminated early|11|||
105470787|NCT03388164|363733948|FG000|Overall Study|Withdrawal by Subject|3|||
105470788|NCT03388164|363733949|FG001|Overall Study|Withdrawal by Subject|1|||
105470789|NCT00060840|363733952|FG000|Overall Study|Change in surgical plan|2|||
105470790|NCT00060840|363733953|FG001|Overall Study|Change in surgical plan|6|||
105470791|NCT00060840|363733952|FG000|Overall Study|Death|0|||
105470792|NCT00060840|363733953|FG001|Overall Study|Death|1|||
105470793|NCT00060840|363733952|FG000|Overall Study|Withdrawal by Subject|0|||
105470794|NCT00060840|363733953|FG001|Overall Study|Withdrawal by Subject|1|||
105470795|NCT00060840|363733952|FG000|Overall Study|Subinvestigator unavailable|0|||
105470796|NCT00060840|363733953|FG001|Overall Study|Subinvestigator unavailable|1|||
105470797|NCT00060840|363733952|FG000|Overall Study|Physician Decision|1|||
105470798|NCT00060840|363733953|FG001|Overall Study|Physician Decision|0|||
105470799|NCT00060840|363733952|FG000|Overall Study|Other|1|||
105470800|NCT00060840|363733953|FG001|Overall Study|Other|0|||
105470801|NCT00976560|363733958|FG000|Overall Study|Adverse Event|5|||
105470802|NCT00976560|363733959|FG001|Overall Study|Adverse Event|5|||
105470803|NCT00976560|363733958|FG000|Overall Study|Lack of Efficacy|3|||
105470804|NCT00976560|363733959|FG001|Overall Study|Lack of Efficacy|5|||
105470805|NCT00976560|363733958|FG000|Overall Study|Protocol Violation|1|||
105470806|NCT00976560|363733959|FG001|Overall Study|Protocol Violation|0|||
105470807|NCT00976560|363733958|FG000|Overall Study|Lost to Follow-up|1|||
105470808|NCT00976560|363733959|FG001|Overall Study|Lost to Follow-up|0|||
105470809|NCT00976560|363733958|FG000|Overall Study|Physician Decision|2|||
105687472|NCT03267940|364519019|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
105470810|NCT00976560|363733959|FG001|Overall Study|Physician Decision|0|||
105470811|NCT00976560|363733958|FG000|Overall Study|Withdrawal by Subject|2|||
105470812|NCT00976560|363733959|FG001|Overall Study|Withdrawal by Subject|3|||
105470813|NCT00125164|363733962|FG000|Overall Study|Adverse Event|0|||
105470814|NCT00125164|363733963|FG001|Overall Study|Adverse Event|0|||
105470815|NCT00125164|363733964|FG002|Overall Study|Adverse Event|2|||
105470816|NCT00125164|363733965|FG003|Overall Study|Adverse Event|4|||
105470817|NCT00125164|363733962|FG000|Overall Study|Lost to Follow-up|0|||
105470818|NCT00125164|363733963|FG001|Overall Study|Lost to Follow-up|0|||
105470819|NCT00125164|363733964|FG002|Overall Study|Lost to Follow-up|1|||
105470820|NCT00125164|363733965|FG003|Overall Study|Lost to Follow-up|1|||
105470821|NCT00125164|363733962|FG000|Overall Study|Withdrawal by Subject|2|||
105470822|NCT00125164|363733963|FG001|Overall Study|Withdrawal by Subject|0|||
105470823|NCT00125164|363733964|FG002|Overall Study|Withdrawal by Subject|1|||
105470824|NCT00125164|363733965|FG003|Overall Study|Withdrawal by Subject|1|||
105470825|NCT00889720|363733966|FG000|Overall Study|Withdrawal by Subject|4|||
105470826|NCT00889720|363733966|FG000|Overall Study|Other|4|||
105470827|NCT01339052|363733967|FG000|Overall Study|Disease progression|13|||
105470828|NCT01339052|363733968|FG001|Overall Study|Disease progression|46|||
105470829|NCT01339052|363733967|FG000|Overall Study|Adverse Event|1|||
105470830|NCT01339052|363733968|FG001|Overall Study|Adverse Event|1|||
105470831|NCT01339052|363733967|FG000|Overall Study|Withdrawal by Subject|0|||
105470832|NCT01339052|363733968|FG001|Overall Study|Withdrawal by Subject|3|||
105470833|NCT01339052|363733967|FG000|Overall Study|Physician Decision|1|||
105470834|NCT01339052|363733968|FG001|Overall Study|Physician Decision|0|||
105687473|NCT03267940|364519020|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
105687474|NCT03267940|364519015|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
105687475|NCT03267940|364519016|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
105687476|NCT03267940|364519017|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
105687477|NCT03267940|364519018|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
105687478|NCT03267940|364519019|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
105687479|NCT03267940|364519020|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
105687480|NCT03267940|364519015|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
105687481|NCT03267940|364519016|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
105687482|NCT03267940|364519017|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
105470835|NCT03865381|363733971|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
105470836|NCT03865381|363733971|FG000|Overall Study|Withdrawal by Subject|2|||
105470837|NCT00068419|363733974|FG000|Overall Study|Adverse Event|3|||
105470838|NCT00068419|363733974|FG000|Overall Study|Lack of Efficacy|24|||
105470839|NCT00068419|363733974|FG000|Overall Study|Lost to Follow-up|1|||
105470840|NCT00068419|363733974|FG000|Overall Study|Physician Decision|7|||
105470841|NCT00068419|363733974|FG000|Overall Study|Withdrawal by Subject|14|||
105470842|NCT00068419|363733974|FG000|Overall Study|Ineligible|11|||
105470843|NCT01032889|363733975|FG000|Overall Study|Adverse Event|2|||
105470844|NCT01032889|363733976|FG001|Overall Study|Adverse Event|2|||
105470845|NCT01032889|363733977|FG002|Overall Study|Adverse Event|0|||
105470846|NCT01032889|363733975|FG000|Overall Study|Withdrawal of Consent|1|||
105344770|NCT02659514|363263500|FG000|Overall Study|Withdrawal by Subject|0|||
105344771|NCT02659514|363263501|FG001|Overall Study|Withdrawal by Subject|4|||
105344772|NCT02659514|363263500|FG000|Overall Study|Lost to Follow-up|0|||
105344773|NCT02659514|363263501|FG001|Overall Study|Lost to Follow-up|1|||
105344774|NCT02659514|363263500|FG000|Overall Study|Death|6|||
105344775|NCT02659514|363263501|FG001|Overall Study|Death|1|||
105344776|NCT02659514|363263500|FG000|Overall Study|Reason Unspecified|0|||
105344777|NCT02659514|363263501|FG001|Overall Study|Reason Unspecified|3|||
105470847|NCT01032889|363733976|FG001|Overall Study|Withdrawal of Consent|2|||
105470848|NCT01032889|363733977|FG002|Overall Study|Withdrawal of Consent|1|||
105344778|NCT01661933|363263502|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
105344779|NCT01661933|363263502|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
105344780|NCT03385304|363263507|FG000|Overall Study|Death|19|||
105344781|NCT03385304|363263508|FG001|Overall Study|Death|7|||
105344782|NCT03385304|363263507|FG000|Overall Study|Lost to Follow-up|17|||
105344783|NCT03385304|363263508|FG001|Overall Study|Lost to Follow-up|14|||
105344784|NCT03385304|363263507|FG000|Overall Study|Withdrawal by Subject|3|||
105344785|NCT03385304|363263508|FG001|Overall Study|Withdrawal by Subject|2|||
105344786|NCT03385304|363263507|FG000|Overall Study|Incarceration|2|||
105344787|NCT03385304|363263508|FG001|Overall Study|Incarceration|3|||
105470849|NCT01032889|363733975|FG000|Overall Study|Patient Request|0|||
105344788|NCT01565668|363263509|FG000|Overall Study|Death|2|||
105344789|NCT01565668|363263510|FG001|Overall Study|Death|1|||
105344790|NCT01565668|363263509|FG000|Overall Study|Lack of Efficacy|4|||
105344791|NCT01565668|363263510|FG001|Overall Study|Lack of Efficacy|2|||
105344792|NCT01565668|363263509|FG000|Overall Study|Participant went on Hospice Care|1|||
105344793|NCT01565668|363263510|FG001|Overall Study|Participant went on Hospice Care|0|||
105344794|NCT01565668|363263509|FG000|Overall Study|Adverse Event|6|||
105344795|NCT01565668|363263510|FG001|Overall Study|Adverse Event|1|||
105344796|NCT01565668|363263509|FG000|Overall Study|Randomized, but never received drug|0|||
105470850|NCT01032889|363733976|FG001|Overall Study|Patient Request|1|||
105470851|NCT01032889|363733977|FG002|Overall Study|Patient Request|0|||
105687483|NCT03267940|364519018|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
105687484|NCT03267940|364519019|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
105344797|NCT01565668|363263510|FG001|Overall Study|Randomized, but never received drug|2|||
105344798|NCT01565668|363263509|FG000|Overall Study|Progressive disease|13|||
105344799|NCT01565668|363263510|FG001|Overall Study|Progressive disease|14|||
105344800|NCT01565668|363263509|FG000|Overall Study|Withdrawal by Subject|1|||
105470852|NCT01032889|363733975|FG000|Overall Study|Lost to Follow-up|1|||
105344801|NCT01565668|363263510|FG001|Overall Study|Withdrawal by Subject|3|||
105470853|NCT01032889|363733976|FG001|Overall Study|Lost to Follow-up|1|||
105470854|NCT01032889|363733977|FG002|Overall Study|Lost to Follow-up|0|||
105470855|NCT01032889|363733975|FG000|Overall Study|Lack of Submental Fat|2|||
105470856|NCT01032889|363733976|FG001|Overall Study|Lack of Submental Fat|8|||
105470857|NCT01032889|363733977|FG002|Overall Study|Lack of Submental Fat|1|||
105470858|NCT01032889|363733975|FG000|Overall Study|Miscellaneous Reasons|2|||
105470859|NCT01032889|363733976|FG001|Overall Study|Miscellaneous Reasons|1|||
105470860|NCT01032889|363733977|FG002|Overall Study|Miscellaneous Reasons|1|||
105470861|NCT00721968|363733981|FG000|Overall Study|Lost to Follow-up|2|||
105470862|NCT00721968|363733982|FG001|Overall Study|Lost to Follow-up|0|||
105470863|NCT01064947|363733984|FG000|Overall Study|negative culture|41|||
105470864|NCT02970942|363733985|FG000|Overall Study|Death|0|||
105470865|NCT02970942|363733986|FG001|Overall Study|Death|1|||
105470866|NCT02970942|363733987|FG002|Overall Study|Death|0|||
105470867|NCT02970942|363733988|FG003|Overall Study|Death|0|||
105470868|NCT02970942|363733985|FG000|Overall Study|Lost to Follow-up|1|||
105470869|NCT02970942|363733986|FG001|Overall Study|Lost to Follow-up|0|||
105470870|NCT02970942|363733987|FG002|Overall Study|Lost to Follow-up|2|||
105470871|NCT02970942|363733988|FG003|Overall Study|Lost to Follow-up|1|||
105470872|NCT02970942|363733985|FG000|Overall Study|Withdrawal by Subject|3|||
105470873|NCT02970942|363733986|FG001|Overall Study|Withdrawal by Subject|5|||
105470874|NCT02970942|363733987|FG002|Overall Study|Withdrawal by Subject|3|||
105470875|NCT02970942|363733988|FG003|Overall Study|Withdrawal by Subject|2|||
105470876|NCT02930018|363733992|FG000|Overall Study|Lost to Follow-up|1|||
105470877|NCT02930018|363733993|FG001|Overall Study|Lost to Follow-up|1|||
105470878|NCT02930018|363733992|FG000|Overall Study|Withdrawal by Subject|5|||
105470879|NCT02930018|363733993|FG001|Overall Study|Withdrawal by Subject|2|||
105470880|NCT04661579|363735285|FG000|Overall Study|Lost to Follow-up|19|||
105470881|NCT04661579|363735286|FG001|Overall Study|Lost to Follow-up|10|||
105470882|NCT04661579|363735287|FG002|Overall Study|Lost to Follow-up|2|||
105470883|NCT04661579|363735288|FG003|Overall Study|Lost to Follow-up|7|||
105470884|NCT04661579|363735289|FG004|Overall Study|Lost to Follow-up|11|||
105470885|NCT04661579|363735285|FG000|Overall Study|Physician Decision|2|||
105470886|NCT04661579|363735286|FG001|Overall Study|Physician Decision|0|||
105470887|NCT04661579|363735287|FG002|Overall Study|Physician Decision|0|||
105470888|NCT04661579|363735288|FG003|Overall Study|Physician Decision|1|||
105470889|NCT04661579|363735289|FG004|Overall Study|Physician Decision|0|||
105470890|NCT04661579|363735285|FG000|Overall Study|Withdrawal by Subject|1|||
105470891|NCT04661579|363735286|FG001|Overall Study|Withdrawal by Subject|4|||
105470892|NCT04661579|363735287|FG002|Overall Study|Withdrawal by Subject|0|||
105470893|NCT04661579|363735288|FG003|Overall Study|Withdrawal by Subject|2|||
105470894|NCT04661579|363735289|FG004|Overall Study|Withdrawal by Subject|0|||
105470895|NCT04661579|363735285|FG000|Overall Study|Death|1|||
105470896|NCT04661579|363735286|FG001|Overall Study|Death|0|||
105470897|NCT04661579|363735287|FG002|Overall Study|Death|0|||
105470898|NCT04661579|363735288|FG003|Overall Study|Death|0|||
105470899|NCT04661579|363735289|FG004|Overall Study|Death|0|||
105470900|NCT04661579|363735285|FG000|Overall Study|Other|1|||
105470901|NCT04661579|363735286|FG001|Overall Study|Other|2|||
105470902|NCT04661579|363735287|FG002|Overall Study|Other|1|||
105470903|NCT04661579|363735288|FG003|Overall Study|Other|1|||
105470904|NCT04661579|363735289|FG004|Overall Study|Other|1|||
105470905|NCT04661579|363735285|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
105470906|NCT04661579|363735286|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
105470907|NCT04661579|363735287|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
105470908|NCT04661579|363735288|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
105470909|NCT04661579|363735289|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
105687485|NCT03267940|364519020|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
105687486|NCT01296347|364519029|FG000|Allocation|Withdrawal by Subject|1|||
105687487|NCT01296347|364519030|FG001|Allocation|Withdrawal by Subject|2|||
105470910|NCT00742235|363735292|FG000|Overall Study|Lost to Follow-up|0|||
105470911|NCT00742235|363735293|FG001|Overall Study|Lost to Follow-up|31|||
105687488|NCT01296347|364519029|FG000|Allocation|Lack of Efficacy|1|||
105470912|NCT02223858|363735296|FG000|Overall Study|Death|1|||
105470913|NCT02223858|363735297|FG001|Overall Study|Death|1|||
105470914|NCT02223858|363735296|FG000|Overall Study|Lost to Follow-up|6|||
105470915|NCT02223858|363735297|FG001|Overall Study|Lost to Follow-up|11|||
105687489|NCT01296347|364519030|FG001|Allocation|Lack of Efficacy|2|||
105687490|NCT01296347|364519029|FG000|Allocation|not received infusion|1|||
105687491|NCT01296347|364519030|FG001|Allocation|not received infusion|0|||
105687492|NCT01296347|364519029|FG000|6 Week Follow up|Death|0|||
105470916|NCT02223858|363735296|FG000|Overall Study|Withdrawal by Subject|8|||
105470917|NCT02223858|363735297|FG001|Overall Study|Withdrawal by Subject|5|||
105470918|NCT02223858|363735296|FG000|Overall Study|Refused|9|||
105470919|NCT02223858|363735297|FG001|Overall Study|Refused|9|||
105470920|NCT04455815|363735300|FG000|Randomisation Phase|Adverse Event|1|||
105470921|NCT04455815|363735301|FG001|Randomisation Phase|Adverse Event|0|||
105470922|NCT04455815|363735300|FG000|Treatment Phase|Adverse Event|0|||
105687493|NCT01296347|364519030|FG001|6 Week Follow up|Death|1|||
105687494|NCT01296347|364519029|FG000|3 Month Follow up|Death|1|||
105687495|NCT01296347|364519030|FG001|3 Month Follow up|Death|0|||
105687496|NCT01296347|364519029|FG000|3 Month Follow up|Lost to Follow-up|0|||
105687497|NCT01296347|364519030|FG001|3 Month Follow up|Lost to Follow-up|1|||
105687498|NCT01296347|364519029|FG000|6 Month Follow up|Death|2|||
105687499|NCT01296347|364519030|FG001|6 Month Follow up|Death|1|||
105687500|NCT01296347|364519029|FG000|6 Month Follow up|Lost to Follow-up|0|||
105687501|NCT01296347|364519030|FG001|6 Month Follow up|Lost to Follow-up|1|||
105687502|NCT01296347|364519029|FG000|12 Month Follow up|Lost to Follow-up|3|||
105687503|NCT01296347|364519030|FG001|12 Month Follow up|Lost to Follow-up|1|||
105687504|NCT01296347|364519029|FG000|12 Month Follow up|Death|1|||
105687505|NCT01296347|364519030|FG001|12 Month Follow up|Death|1|||
105687506|NCT01296347|364519029|FG000|12 Month Follow up|Withdrawal by Subject|0|||
105687507|NCT01296347|364519030|FG001|12 Month Follow up|Withdrawal by Subject|1|||
105687508|NCT01948908|364519031|FG000|Overall Study|Protocol Violation|1|||
105687509|NCT01948908|364519032|FG001|Overall Study|Protocol Violation|0|||
105687510|NCT01948908|364519033|FG002|Overall Study|Protocol Violation|2|||
105344802|NCT01565668|363263509|FG000|Overall Study|HSCT Transplant|11|||
105344803|NCT01565668|363263510|FG001|Overall Study|HSCT Transplant|15|||
105344804|NCT02499146|363263513|FG000|Overall Study|Lost to Follow-up|1|||
105344805|NCT02499146|363263513|FG000|Overall Study|Withdrawal by Subject|1|||
105344806|NCT02499146|363263513|FG000|Overall Study|Other|2|||
105344807|NCT02499146|363263513|FG000|Overall Study|Ongoing at date of cut-off|9|||
105344808|NCT02499146|363263513|FG000|Overall Study|Began other treatment/therapy|13|||
105344809|NCT04495816|363263531|FG000|Overall Study|Lost to Follow-up|10|||
105344810|NCT04495816|363263532|FG001|Overall Study|Lost to Follow-up|4|||
105344811|NCT04495816|363263531|FG000|Overall Study|Withdrawal by Subject|3|||
105344812|NCT04495816|363263532|FG001|Overall Study|Withdrawal by Subject|5|||
105344813|NCT01149421|363263533|FG000|Overall Study|Adverse Event|22|||
105344814|NCT01149421|363263534|FG001|Overall Study|Adverse Event|6|||
105344815|NCT01149421|363263535|FG002|Overall Study|Adverse Event|11|||
105344816|NCT01149421|363263533|FG000|Overall Study|Withdrawal by Subject|20|||
105344817|NCT01149421|363263534|FG001|Overall Study|Withdrawal by Subject|12|||
105344818|NCT01149421|363263535|FG002|Overall Study|Withdrawal by Subject|13|||
105344819|NCT01149421|363263533|FG000|Overall Study|Sponsor Decision|0|||
105344820|NCT01149421|363263534|FG001|Overall Study|Sponsor Decision|1|||
105344821|NCT01149421|363263535|FG002|Overall Study|Sponsor Decision|1|||
105344822|NCT01149421|363263533|FG000|Overall Study|Lost to Follow-up|2|||
105344823|NCT01149421|363263534|FG001|Overall Study|Lost to Follow-up|4|||
105344824|NCT01149421|363263535|FG002|Overall Study|Lost to Follow-up|5|||
105344825|NCT01149421|363263533|FG000|Overall Study|Physician Decision|5|||
105344826|NCT01149421|363263534|FG001|Overall Study|Physician Decision|3|||
105344827|NCT01149421|363263535|FG002|Overall Study|Physician Decision|6|||
105344828|NCT01149421|363263533|FG000|Overall Study|Entry Criteria Not Met|1|||
105344829|NCT01149421|363263534|FG001|Overall Study|Entry Criteria Not Met|1|||
105344830|NCT01149421|363263535|FG002|Overall Study|Entry Criteria Not Met|2|||
105344831|NCT01149421|363263533|FG000|Overall Study|Protocol Violation|2|||
105344832|NCT01149421|363263534|FG001|Overall Study|Protocol Violation|2|||
105344833|NCT01149421|363263535|FG002|Overall Study|Protocol Violation|6|||
105344834|NCT03181503|363263536|FG000|Overall Study|Adverse Event|2|||
105344835|NCT03181503|363263537|FG001|Overall Study|Adverse Event|2|||
105344836|NCT03181503|363263536|FG000|Overall Study|Protocol Violation|1|||
105344837|NCT03181503|363263537|FG001|Overall Study|Protocol Violation|0|||
105344838|NCT03181503|363263536|FG000|Overall Study|Withdrawal by Subject|3|||
105344839|NCT03181503|363263537|FG001|Overall Study|Withdrawal by Subject|0|||
105344840|NCT03181503|363263536|FG000|Overall Study|Lost to Follow-up|1|||
105344841|NCT03181503|363263537|FG001|Overall Study|Lost to Follow-up|1|||
105344842|NCT01892085|363263538|FG000|Overall Study|Death|4|||
105344843|NCT01892085|363263539|FG001|Overall Study|Death|1|||
105344844|NCT01892085|363263540|FG002|Overall Study|Death|3|||
105344845|NCT01892085|363263538|FG000|Overall Study|Withdrawal by Subject|2|||
105344846|NCT01892085|363263539|FG001|Overall Study|Withdrawal by Subject|0|||
105344847|NCT01892085|363263540|FG002|Overall Study|Withdrawal by Subject|2|||
105344848|NCT00767039|363263543|FG000|Overall Study|Death|5|||
105344849|NCT00767039|363263544|FG001|Overall Study|Death|2|||
105344850|NCT01826370|363263545|FG000|Overall Study|Protocol Violation|6|||
105687511|NCT02240693|364519034|FG000|Overall Study|Adverse Event|0|||
105687512|NCT02240693|364519035|FG001|Overall Study|Adverse Event|0|||
105687513|NCT02240693|364519036|FG002|Overall Study|Adverse Event|0|||
105687514|NCT02240693|364519037|FG003|Overall Study|Adverse Event|0|||
105687515|NCT02240693|364519038|FG004|Overall Study|Adverse Event|1|||
105344851|NCT01826370|363263545|FG000|Overall Study|Lost to Follow-up|12|||
105344852|NCT01826370|363263545|FG000|Overall Study|Other reason not defined above|2|||
105344853|NCT00070018|363263546|FG000|Overall Study|Adverse Event|2|||
105344854|NCT00070018|363263546|FG000|Overall Study|Lack of Efficacy|1|||
105344855|NCT00070018|363263546|FG000|Overall Study|Withdrawal by Subject|1|||
105344856|NCT03199612|363263549|FG000|Overall Study|Adverse Event|1|||
105344857|NCT03199612|363263550|FG001|Overall Study|Adverse Event|0|||
105344858|NCT01629823|363263557|FG000|Trial Period|Missed visit|11|||
105687516|NCT02240693|364519034|FG000|Overall Study|Withdrawal by Subject|0|||
105687517|NCT02240693|364519035|FG001|Overall Study|Withdrawal by Subject|0|||
105470923|NCT04455815|363735301|FG001|Treatment Phase|Adverse Event|1|||
105470924|NCT04455815|363735300|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
105470925|NCT04455815|363735301|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
105470926|NCT04455815|363735300|FG000|Treatment Phase|Withdrawal by Subject|1|||
105470927|NCT04455815|363735301|FG001|Treatment Phase|Withdrawal by Subject|1|||
105470928|NCT03198507|363735302|FG000|Overall Study|Withdrawal by Subject|1|||
105470929|NCT03198507|363735303|FG001|Overall Study|Withdrawal by Subject|0|||
105470930|NCT01349959|363735312|FG000|Overall Study|Adverse Event|7|||
105470931|NCT01491607|363735313|FG000|Overall Study|Lost to Follow-up|7|||
105470932|NCT01491607|363735313|FG000|Overall Study|Withdrawal by Subject|3|||
105470933|NCT01317277|363735314|FG000|Overall Study|Lost to Follow-up|3|||
105470934|NCT01317277|363735315|FG001|Overall Study|Lost to Follow-up|1|||
105470935|NCT01317277|363735314|FG000|Overall Study|Lost MEMS|1|||
105470936|NCT01317277|363735315|FG001|Overall Study|Lost MEMS|1|||
105470937|NCT01317277|363735314|FG000|Overall Study|Unable to comply with intervention|1|||
105470938|NCT01317277|363735315|FG001|Overall Study|Unable to comply with intervention|0|||
105687518|NCT02240693|364519036|FG002|Overall Study|Withdrawal by Subject|2|||
105687519|NCT02240693|364519037|FG003|Overall Study|Withdrawal by Subject|1|||
105687520|NCT02240693|364519038|FG004|Overall Study|Withdrawal by Subject|0|||
105687521|NCT02240693|364519034|FG000|Overall Study|Other than specified|0|||
105470939|NCT01317277|363735314|FG000|Overall Study|Withdrawal by Subject|1|||
105470940|NCT01317277|363735315|FG001|Overall Study|Withdrawal by Subject|0|||
105470941|NCT01317277|363735314|FG000|Overall Study|Adverse Event|1|||
105470942|NCT01317277|363735315|FG001|Overall Study|Adverse Event|0|||
105470943|NCT00774566|363735316|FG000|Overall Study|Protocol Violation|18|||
105470944|NCT00774566|363735317|FG001|Overall Study|Protocol Violation|15|||
105470945|NCT03860259|363735322|FG000|Overall Study|Lost to Follow-up|5|||
105470946|NCT03860259|363735323|FG001|Overall Study|Lost to Follow-up|5|||
105470947|NCT03860259|363735322|FG000|Overall Study|Protocol Violation|1|||
105470948|NCT03860259|363735323|FG001|Overall Study|Protocol Violation|0|||
105470949|NCT01075685|363735324|FG000|Overall Study|Protocol Violation|9|||
105470950|NCT01075685|363735325|FG001|Overall Study|Protocol Violation|1|||
105470951|NCT01075685|363735324|FG000|Overall Study|Withdrawal by Subject|20|||
105470952|NCT01075685|363735325|FG001|Overall Study|Withdrawal by Subject|5|||
105470953|NCT01075685|363735324|FG000|Overall Study|Lost to Follow-up|563|||
105470954|NCT01075685|363735325|FG001|Overall Study|Lost to Follow-up|220|||
105470955|NCT00811018|363735326|FG000|Overall Study|Additional Chronic Treatment|31|||
105470956|NCT00811018|363735326|FG000|Overall Study|Adverse Event|79|||
105470957|NCT00811018|363735326|FG000|Overall Study|Death|147|||
105470958|NCT00811018|363735326|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
105470959|NCT00811018|363735326|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
105470960|NCT00811018|363735326|FG000|Overall Study|Investigator Decision|57|||
105470961|NCT00811018|363735326|FG000|Overall Study|Lost to Follow-up|19|||
105470962|NCT00811018|363735326|FG000|Overall Study|Pregnancy|6|||
105470963|NCT00811018|363735326|FG000|Overall Study|Sponsor Decision|450|||
105470964|NCT00811018|363735326|FG000|Overall Study|Withdrawal by Subject|70|||
105470965|NCT00811018|363735326|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
105470966|NCT00811018|363735326|FG000|Overall Study|Other|26|||
105470967|NCT02858362|363735327|FG000|Overall Study|Protocol Violation|0|||
105470968|NCT02858362|363735328|FG001|Overall Study|Protocol Violation|1|||
105470969|NCT02858362|363735329|FG002|Overall Study|Protocol Violation|0|||
105470970|NCT02858362|363735327|FG000|Overall Study|Withdrawal by Subject|1|||
105470971|NCT02858362|363735328|FG001|Overall Study|Withdrawal by Subject|0|||
105470972|NCT02858362|363735329|FG002|Overall Study|Withdrawal by Subject|0|||
105470973|NCT02858362|363735327|FG000|Overall Study|Early Study Termination|0|||
105470974|NCT02858362|363735328|FG001|Overall Study|Early Study Termination|0|||
105470975|NCT02858362|363735329|FG002|Overall Study|Early Study Termination|3|||
105470976|NCT02858362|363735327|FG000|Overall Study|Lost to Follow-up|1|||
105470977|NCT02858362|363735328|FG001|Overall Study|Lost to Follow-up|0|||
105470978|NCT02858362|363735329|FG002|Overall Study|Lost to Follow-up|0|||
105470979|NCT00934362|363735330|FG000|Overall Study|Adverse Event|1|||
105470980|NCT00934362|363735331|FG001|Overall Study|Adverse Event|0|||
105470981|NCT03527732|363735332|FG000|Overall Study|Lost to Follow-up|21|||
105470982|NCT03527732|363735333|FG001|Overall Study|Lost to Follow-up|23|||
105687522|NCT02240693|364519035|FG001|Overall Study|Other than specified|0|||
105687523|NCT02240693|364519036|FG002|Overall Study|Other than specified|2|||
105470983|NCT03527732|363735334|FG002|Overall Study|Lost to Follow-up|80|||
105470984|NCT03527732|363735335|FG003|Overall Study|Lost to Follow-up|62|||
105470985|NCT03527732|363735336|FG004|Overall Study|Lost to Follow-up|12|||
105470986|NCT03527732|363735337|FG005|Overall Study|Lost to Follow-up|20|||
105470987|NCT04154189|363735338|FG000|Overall Study|Withdrawal by Subject|4|||
105470988|NCT04154189|363735339|FG001|Overall Study|Withdrawal by Subject|6|||
105470989|NCT04154189|363735338|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
105470990|NCT04154189|363735339|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
105470991|NCT04154189|363735338|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
105470992|NCT04154189|363735339|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
105558720|NCT00518115|364041919|FG005|Overall Study|Withdrawal by Subject|1|||
105558721|NCT00518115|364041920|FG006|Overall Study|Withdrawal by Subject|0|||
105558722|NCT00518115|364041921|FG007|Overall Study|Withdrawal by Subject|2|||
105558723|NCT00518115|364041922|FG008|Overall Study|Withdrawal by Subject|1|||
105558724|NCT00518115|364041923|FG009|Overall Study|Withdrawal by Subject|3|||
105558725|NCT00518115|364041914|FG000|Overall Study|Lack of Efficacy|1|||
105558726|NCT00518115|364041915|FG001|Overall Study|Lack of Efficacy|0|||
105558727|NCT00518115|364041916|FG002|Overall Study|Lack of Efficacy|1|||
105558728|NCT00518115|364041917|FG003|Overall Study|Lack of Efficacy|1|||
105558729|NCT00518115|364041918|FG004|Overall Study|Lack of Efficacy|0|||
105558730|NCT00518115|364041919|FG005|Overall Study|Lack of Efficacy|0|||
105558731|NCT00518115|364041920|FG006|Overall Study|Lack of Efficacy|0|||
105558732|NCT00518115|364041921|FG007|Overall Study|Lack of Efficacy|1|||
105558733|NCT00518115|364041922|FG008|Overall Study|Lack of Efficacy|0|||
105558734|NCT00518115|364041923|FG009|Overall Study|Lack of Efficacy|0|||
105558735|NCT00518115|364041914|FG000|Overall Study|Non-Compliance|1|||
105344859|NCT01629823|363263558|FG001|Trial Period|Missed visit|9|||
105344860|NCT01629823|363263559|FG002|Trial Period|Missed visit|8|||
105344861|NCT01629823|363263557|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
105558736|NCT00518115|364041915|FG001|Overall Study|Non-Compliance|0|||
105558737|NCT00518115|364041916|FG002|Overall Study|Non-Compliance|1|||
105558738|NCT00518115|364041917|FG003|Overall Study|Non-Compliance|0|||
105558739|NCT00518115|364041918|FG004|Overall Study|Non-Compliance|1|||
105558740|NCT00518115|364041919|FG005|Overall Study|Non-Compliance|1|||
105558741|NCT00518115|364041920|FG006|Overall Study|Non-Compliance|1|||
105558742|NCT00518115|364041921|FG007|Overall Study|Non-Compliance|1|||
105344862|NCT01629823|363263558|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
105344863|NCT01629823|363263559|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
105558743|NCT00518115|364041922|FG008|Overall Study|Non-Compliance|0|||
105687524|NCT02240693|364519037|FG003|Overall Study|Other than specified|0|||
105687525|NCT02240693|364519038|FG004|Overall Study|Other than specified|0|||
105687526|NCT01585987|364519039|FG000|Randomized|Withdrawal by Subject|0|||
105687527|NCT01585987|364519040|FG001|Randomized|Withdrawal by Subject|4|||
105344864|NCT01629823|363263557|FG000|Trial Period|Pregnancy|1|||
105558744|NCT00518115|364041923|FG009|Overall Study|Non-Compliance|1|||
105558745|NCT00518115|364041914|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
105558746|NCT00518115|364041915|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
105558747|NCT00518115|364041916|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
105558748|NCT00518115|364041917|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
105558749|NCT00518115|364041918|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
105558750|NCT00518115|364041919|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
105687528|NCT01585987|364519039|FG000|Randomized|No longer met criteria|0|||
105344865|NCT01629823|363263558|FG001|Trial Period|Pregnancy|0|||
105344866|NCT01629823|363263559|FG002|Trial Period|Pregnancy|0|||
105344867|NCT01629823|363263557|FG000|Trial Period|Adverse Event|0|||
105344868|NCT01629823|363263558|FG001|Trial Period|Adverse Event|1|||
105344869|NCT01629823|363263559|FG002|Trial Period|Adverse Event|0|||
105344870|NCT01629823|363263557|FG000|Trial Period|Out-of-window visit|0|||
105344871|NCT01629823|363263558|FG001|Trial Period|Out-of-window visit|2|||
105558751|NCT00518115|364041920|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
105558752|NCT00518115|364041921|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
105558753|NCT00518115|364041922|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
105558754|NCT00518115|364041923|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
105687529|NCT01585987|364519040|FG001|Randomized|No longer met criteria|2|||
105687530|NCT01585987|364519039|FG000|Treated|Disease Progression|39|||
105344872|NCT01629823|363263559|FG002|Trial Period|Out-of-window visit|0|||
105687531|NCT01585987|364519040|FG001|Treated|Disease Progression|36|||
105344873|NCT01629823|363263557|FG000|Trial Period|Failed to hold medication|0|||
105344874|NCT01629823|363263558|FG001|Trial Period|Failed to hold medication|0|||
105687532|NCT01585987|364519039|FG000|Treated|Study Drug Toxicity|9|||
105687533|NCT01585987|364519040|FG001|Treated|Study Drug Toxicity|5|||
105687534|NCT01585987|364519039|FG000|Treated|Adverse Event|3|||
105687535|NCT01585987|364519040|FG001|Treated|Adverse Event|0|||
105687536|NCT01585987|364519039|FG000|Treated|Withdrawal by Subject|1|||
105687537|NCT01585987|364519040|FG001|Treated|Withdrawal by Subject|2|||
105687538|NCT01585987|364519039|FG000|Treated|Death|1|||
105558755|NCT00518115|364041914|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
105558756|NCT00518115|364041915|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
105558757|NCT00518115|364041916|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
105558758|NCT00518115|364041917|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
105558759|NCT00518115|364041918|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
105687539|NCT01585987|364519040|FG001|Treated|Death|0|||
105687540|NCT01585987|364519039|FG000|Treated|Lost to Follow-up|0|||
105470993|NCT04154189|363735338|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
105470994|NCT04154189|363735339|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
105470995|NCT04154189|363735338|FG000|Overall Study|Death|25|||
105470996|NCT04154189|363735339|FG001|Overall Study|Death|25|||
105470997|NCT01191762|363735342|FG000|Overall Study|Adverse Event|1|||
105470998|NCT01191762|363735343|FG001|Overall Study|Adverse Event|0|||
105470999|NCT01409811|363735344|FG000|Overall Study|Insurance denial|1|||
105471000|NCT02625909|363735345|FG000|Overall Study|Death|2|||
105471001|NCT02625909|363735346|FG001|Overall Study|Death|0|||
105471002|NCT02625909|363735345|FG000|Overall Study|Lost to Follow-up|3|||
105471003|NCT02625909|363735346|FG001|Overall Study|Lost to Follow-up|5|||
105471004|NCT02625909|363735345|FG000|Overall Study|Lack of Efficacy|9|||
105471005|NCT02625909|363735346|FG001|Overall Study|Lack of Efficacy|2|||
105471006|NCT02625909|363735345|FG000|Overall Study|Reinfection|3|||
105471007|NCT02625909|363735346|FG001|Overall Study|Reinfection|2|||
105471008|NCT00067002|363735358|FG000|Overall Study|Early Death|1|||
105471009|NCT00067002|363735359|FG001|Overall Study|Early Death|2|||
105687541|NCT01585987|364519040|FG001|Treated|Lost to Follow-up|1|||
105687542|NCT01585987|364519039|FG000|Treated|Maximum Clinical Benefit|0|||
105558760|NCT00518115|364041919|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
105687543|NCT01585987|364519040|FG001|Treated|Maximum Clinical Benefit|1|||
105471010|NCT00067002|363735358|FG000|Overall Study|Delayed|1|||
105471011|NCT00067002|363735359|FG001|Overall Study|Delayed|1|||
105471012|NCT00067002|363735358|FG000|Overall Study|Graft Failure|5|||
105471013|NCT00067002|363735359|FG001|Overall Study|Graft Failure|6|||
105471014|NCT03350672|363735360|FG000|Overall Study|Withdrawal by Subject|7|||
105471015|NCT03350672|363735361|FG001|Overall Study|Withdrawal by Subject|0|||
105558761|NCT00518115|364041920|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
105558762|NCT00518115|364041921|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
105558763|NCT00518115|364041922|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
105558764|NCT00518115|364041923|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
105558765|NCT00518115|364041914|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
105558766|NCT00518115|364041915|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
105558767|NCT00518115|364041916|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
105558768|NCT00518115|364041917|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
105687544|NCT01585987|364519039|FG000|Treated|Non-Specified|1|||
105687545|NCT01585987|364519040|FG001|Treated|Non-Specified|2|||
105558769|NCT00518115|364041918|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
105687546|NCT01585987|364519039|FG000|Treated|Subject Request|0|||
105687547|NCT01585987|364519040|FG001|Treated|Subject Request|1|||
105687548|NCT01585987|364519039|FG000|Treated|Poor/Non-Compliance|0|||
105687549|NCT01585987|364519040|FG001|Treated|Poor/Non-Compliance|1|||
105687550|NCT02041520|364519042|FG000|Overall Study|Adverse Event|2|||
105687551|NCT02041520|364519043|FG001|Overall Study|Adverse Event|1|||
105687552|NCT02041520|364519042|FG000|Overall Study|Withdrawal by Subject|3|||
105687553|NCT02041520|364519043|FG001|Overall Study|Withdrawal by Subject|4|||
105687554|NCT02041520|364519042|FG000|Overall Study|Protocol Violation|1|||
105687555|NCT02041520|364519043|FG001|Overall Study|Protocol Violation|0|||
105687556|NCT02041520|364519042|FG000|Overall Study|Lost to Follow-up|0|||
105687557|NCT02041520|364519043|FG001|Overall Study|Lost to Follow-up|1|||
105687558|NCT02041520|364519042|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
105687559|NCT02041520|364519043|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
105687560|NCT01898923|364519047|FG000|Overall Study|Lack of Efficacy|5|||
105687561|NCT01898923|364519048|FG001|Overall Study|Lack of Efficacy|6|||
105687562|NCT01898923|364519047|FG000|Overall Study|Adverse Event|3|||
105687563|NCT01898923|364519048|FG001|Overall Study|Adverse Event|1|||
105687564|NCT01898923|364519047|FG000|Overall Study|Lost to Follow-up|0|||
105687565|NCT01898923|364519048|FG001|Overall Study|Lost to Follow-up|1|||
105687566|NCT01898923|364519047|FG000|Overall Study|Withdrawal by Subject|4|||
105687567|NCT01898923|364519048|FG001|Overall Study|Withdrawal by Subject|7|||
105687568|NCT01898923|364519047|FG000|Overall Study|Physician Decision|3|||
105687569|NCT01898923|364519048|FG001|Overall Study|Physician Decision|4|||
105687570|NCT01898923|364519047|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
105687571|NCT01898923|364519048|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
105687572|NCT04526197|364519049|FG000|Period 1|Adverse Event|0|||
105687573|NCT04526197|364519050|FG001|Period 1|Adverse Event|1|||
105687574|NCT04526197|364519049|FG000|Period 1|Withdrawal by Subject|1|||
105687575|NCT04526197|364519050|FG001|Period 1|Withdrawal by Subject|0|||
105687576|NCT04526197|364519049|FG000|Period 2|Adverse Event|0|||
105687577|NCT04526197|364519050|FG001|Period 2|Adverse Event|1|||
105687578|NCT04526197|364519049|FG000|Period 2|Withdrawal by Subject|0|||
105687579|NCT04526197|364519050|FG001|Period 2|Withdrawal by Subject|1|||
105558770|NCT00518115|364041919|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
105687580|NCT00381303|364519051|FG000|Overall Study|Lost to Follow-up|25|||
105687581|NCT00381303|364519052|FG001|Overall Study|Lost to Follow-up|9|||
105687582|NCT00381303|364519051|FG000|Overall Study|AE/HIV-related event|22|||
105687583|NCT00381303|364519052|FG001|Overall Study|AE/HIV-related event|6|||
105687584|NCT00381303|364519051|FG000|Overall Study|Non-Adherence|13|||
105687585|NCT00381303|364519052|FG001|Overall Study|Non-Adherence|6|||
105687586|NCT00381303|364519051|FG000|Overall Study|Withdrawal by Subject|13|||
105558771|NCT00518115|364041920|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
105558772|NCT00518115|364041921|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
105558773|NCT00518115|364041922|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
105558774|NCT00518115|364041923|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
105558775|NCT00518115|364041914|FG000|Overall Study|Wrong Monotherapy Administered|0|||
105558776|NCT00518115|364041915|FG001|Overall Study|Wrong Monotherapy Administered|0|||
105687587|NCT00381303|364519052|FG001|Overall Study|Withdrawal by Subject|6|||
105687588|NCT00381303|364519051|FG000|Overall Study|Virologic failure|6|||
105687589|NCT00381303|364519052|FG001|Overall Study|Virologic failure|4|||
105471016|NCT03350672|363735362|FG002|Overall Study|Withdrawal by Subject|0|||
105471017|NCT01931566|363735365|FG000|Overall Study|Randomized But Not Treated|6|||
105471018|NCT01931566|363735366|FG001|Overall Study|Randomized But Not Treated|9|||
105471019|NCT01931566|363735367|FG002|Overall Study|Randomized But Not Treated|14|||
105471020|NCT01931566|363735365|FG000|Overall Study|Adverse Event|37|||
105471021|NCT01931566|363735366|FG001|Overall Study|Adverse Event|167|||
105471022|NCT01931566|363735367|FG002|Overall Study|Adverse Event|132|||
105471023|NCT01931566|363735365|FG000|Overall Study|Major Protocol Deviation|5|||
105471024|NCT01931566|363735366|FG001|Overall Study|Major Protocol Deviation|14|||
105471025|NCT01931566|363735367|FG002|Overall Study|Major Protocol Deviation|21|||
105471026|NCT01931566|363735365|FG000|Overall Study|Lost to Follow-up|3|||
105471027|NCT01931566|363735366|FG001|Overall Study|Lost to Follow-up|26|||
105471028|NCT01931566|363735367|FG002|Overall Study|Lost to Follow-up|23|||
105471029|NCT01931566|363735365|FG000|Overall Study|Voluntary Withdrawal|78|||
105471030|NCT01931566|363735366|FG001|Overall Study|Voluntary Withdrawal|245|||
105471031|NCT01931566|363735367|FG002|Overall Study|Voluntary Withdrawal|225|||
105471032|NCT01931566|363735365|FG000|Overall Study|Study Termination|289|||
105471033|NCT01931566|363735366|FG001|Overall Study|Study Termination|968|||
105471034|NCT01931566|363735367|FG002|Overall Study|Study Termination|1037|||
105471035|NCT01931566|363735365|FG000|Overall Study|Reason Not Specified|11|||
105471036|NCT01931566|363735366|FG001|Overall Study|Reason Not Specified|47|||
105471037|NCT01931566|363735367|FG002|Overall Study|Reason Not Specified|53|||
105558777|NCT00518115|364041916|FG002|Overall Study|Wrong Monotherapy Administered|1|||
105344875|NCT01629823|363263559|FG002|Trial Period|Failed to hold medication|1|||
105344876|NCT01629823|363263557|FG000|Washout Period|Safety|2|||
105344877|NCT01629823|363263558|FG001|Washout Period|Safety|5|||
105344878|NCT01629823|363263559|FG002|Washout Period|Safety|0|||
105344879|NCT01629823|363263557|FG000|Washout Period|Pregnancy|1|||
105344880|NCT01629823|363263558|FG001|Washout Period|Pregnancy|0|||
105344881|NCT01629823|363263559|FG002|Washout Period|Pregnancy|0|||
105344882|NCT01629823|363263557|FG000|Washout Period|Protocol Violation|0|||
105344883|NCT01629823|363263558|FG001|Washout Period|Protocol Violation|1|||
105344884|NCT01629823|363263559|FG002|Washout Period|Protocol Violation|0|||
105344885|NCT00525902|363263560|FG000|Overall Study|Lack of Efficacy|1|||
105344886|NCT02386345|363263561|FG000|Overall Study|Not treated|14|||
105344887|NCT02386345|363263561|FG000|Overall Study|Lost to Follow-up|1|||
105344888|NCT02386345|363263561|FG000|Overall Study|Adverse Event|5|||
105344889|NCT02386345|363263561|FG000|Overall Study|Repeat Procedure|10|||
105344890|NCT02386345|363263561|FG000|Overall Study|Did not complete 12-month follow-up|72|||
105344891|NCT02609724|363263562|FG000|Overall Study|Death|2|||
105344892|NCT02609724|363263563|FG001|Overall Study|Death|0|||
105344893|NCT02609724|363263564|FG002|Overall Study|Death|1|||
105344894|NCT02609724|363263562|FG000|Overall Study|Withdrawal by Subject|1|||
105344895|NCT02609724|363263563|FG001|Overall Study|Withdrawal by Subject|2|||
105344896|NCT02609724|363263564|FG002|Overall Study|Withdrawal by Subject|3|||
105344897|NCT02609724|363263562|FG000|Overall Study|Illness|2|||
105344898|NCT02609724|363263563|FG001|Overall Study|Illness|1|||
105344899|NCT02609724|363263564|FG002|Overall Study|Illness|0|||
105344900|NCT02844907|363263565|FG000|With Dexamethasone|No IV access|1|||
105344901|NCT00738062|363263566|FG000|Open Label Treatment|Lack of Efficacy|5|||
105344902|NCT00738062|363263567|FG001|Open Label Treatment|Lack of Efficacy|0|||
105344903|NCT00738062|363263568|FG002|Open Label Treatment|Lack of Efficacy|0|||
105344904|NCT00738062|363263566|FG000|Open Label Treatment|Adverse Event|11|||
105344905|NCT00738062|363263567|FG001|Open Label Treatment|Adverse Event|0|||
105344906|NCT00738062|363263568|FG002|Open Label Treatment|Adverse Event|0|||
105344907|NCT00738062|363263566|FG000|Open Label Treatment|Protocol Violation|2|||
105344908|NCT00738062|363263567|FG001|Open Label Treatment|Protocol Violation|0|||
105344909|NCT00738062|363263568|FG002|Open Label Treatment|Protocol Violation|0|||
105344910|NCT00738062|363263566|FG000|Open Label Treatment|Withdrawal by Subject|9|||
105344911|NCT00738062|363263567|FG001|Open Label Treatment|Withdrawal by Subject|0|||
105344912|NCT00738062|363263568|FG002|Open Label Treatment|Withdrawal by Subject|0|||
105344913|NCT00738062|363263566|FG000|Open Label Treatment|Investigator Decision|1|||
105344914|NCT00738062|363263567|FG001|Open Label Treatment|Investigator Decision|0|||
105344915|NCT00738062|363263568|FG002|Open Label Treatment|Investigator Decision|0|||
105344916|NCT00738062|363263566|FG000|Open-Label Extension|Adverse Event|5|||
105344917|NCT00738062|363263567|FG001|Open-Label Extension|Adverse Event|0|||
105344918|NCT00738062|363263568|FG002|Open-Label Extension|Adverse Event|0|||
105344919|NCT00738062|363263566|FG000|Open-Label Extension|Physician Decision|1|||
105344920|NCT00738062|363263567|FG001|Open-Label Extension|Physician Decision|0|||
105344921|NCT00738062|363263568|FG002|Open-Label Extension|Physician Decision|0|||
105344922|NCT00738062|363263566|FG000|Open-Label Extension|Lack of Efficacy|2|||
105344923|NCT00738062|363263567|FG001|Open-Label Extension|Lack of Efficacy|0|||
105344924|NCT00738062|363263568|FG002|Open-Label Extension|Lack of Efficacy|0|||
105344925|NCT00738062|363263566|FG000|Open-Label Extension|Withdrawal by Subject|6|||
105344926|NCT00738062|363263567|FG001|Open-Label Extension|Withdrawal by Subject|0|||
105344927|NCT00738062|363263568|FG002|Open-Label Extension|Withdrawal by Subject|0|||
105344928|NCT00738062|363263566|FG000|Open-Label Extension|Protocol Violation|1|||
105344929|NCT00738062|363263567|FG001|Open-Label Extension|Protocol Violation|0|||
105344930|NCT00738062|363263568|FG002|Open-Label Extension|Protocol Violation|0|||
105344931|NCT00738062|363263566|FG000|Open-Label Extension|Study Terminated|2|||
105344932|NCT00738062|363263567|FG001|Open-Label Extension|Study Terminated|0|||
105687590|NCT00381303|364519051|FG000|Overall Study|Ineligible to continue the trial|2|||
105687591|NCT00381303|364519052|FG001|Overall Study|Ineligible to continue the trial|1|||
105687592|NCT00381303|364519051|FG000|Overall Study|Pregnancy|2|||
105344933|NCT00738062|363263568|FG002|Open-Label Extension|Study Terminated|0|||
105344934|NCT00550862|363263569|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
105344935|NCT00550862|363263570|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
105344936|NCT00550862|363263571|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
105344937|NCT00550862|363263572|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
105344938|NCT00550862|363263573|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
105344939|NCT00550862|363263569|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
105344940|NCT00550862|363263570|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
105471038|NCT01931566|363735365|FG000|Overall Study|Missing|0|||
105471039|NCT01931566|363735366|FG001|Overall Study|Missing|0|||
105471040|NCT01931566|363735367|FG002|Overall Study|Missing|1|||
105471041|NCT02873377|363735371|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
105471042|NCT02873377|363735372|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
105471043|NCT02873377|363735371|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
105344941|NCT00550862|363263571|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
105344942|NCT00550862|363263572|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
105471044|NCT02873377|363735372|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
105471045|NCT03530124|363735377|FG000|Overall Study|Withdrawal by Subject|0|||
105344943|NCT00550862|363263573|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
105344944|NCT00550862|363263569|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
105344945|NCT00550862|363263570|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
105344946|NCT00550862|363263571|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
105344947|NCT00550862|363263572|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
105344948|NCT00550862|363263573|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
105344949|NCT00550862|363263569|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
105344950|NCT00550862|363263570|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
105471046|NCT03530124|363735378|FG001|Overall Study|Withdrawal by Subject|1|||
105471047|NCT03530124|363735377|FG000|Overall Study|Protocol Violation|1|||
105471048|NCT03530124|363735378|FG001|Overall Study|Protocol Violation|0|||
105471049|NCT03530124|363735377|FG000|Overall Study|Discharged prior to study completion|1|||
105471050|NCT03530124|363735378|FG001|Overall Study|Discharged prior to study completion|0|||
105471051|NCT01583296|363735379|FG000|Overall Study|Withdrawal by Subject|11|||
105471052|NCT01583296|363735380|FG001|Overall Study|Withdrawal by Subject|10|||
105471053|NCT03179319|363735381|FG000|Overall Study|Lost to Follow-up|6|||
105471054|NCT03179319|363735382|FG001|Overall Study|Lost to Follow-up|0|||
105471055|NCT02533453|363735383|FG000|Overall Study|Adverse Event|6|||
105687593|NCT00381303|364519052|FG001|Overall Study|Pregnancy|0|||
105687594|NCT00381303|364519051|FG000|Overall Study|Physician Decision|1|||
105687595|NCT00381303|364519052|FG001|Overall Study|Physician Decision|0|||
105471056|NCT02533453|363735383|FG000|Overall Study|Protocol Violation|1|||
105471057|NCT02533453|363735383|FG000|Overall Study|Withdrawal by Subject|2|||
105471058|NCT01160822|363735394|FG000|Overall Study|Adverse Event|0|||
105471059|NCT01160822|363735395|FG001|Overall Study|Adverse Event|0|||
105471060|NCT01160822|363735396|FG002|Overall Study|Adverse Event|0|||
105471061|NCT01160822|363735397|FG003|Overall Study|Adverse Event|0|||
105471062|NCT01160822|363735398|FG004|Overall Study|Adverse Event|1|||
105471063|NCT01160822|363735399|FG005|Overall Study|Adverse Event|2|||
105471064|NCT01160822|363735400|FG006|Overall Study|Adverse Event|5|||
105471065|NCT01160822|363735394|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105471066|NCT01160822|363735395|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105471067|NCT01160822|363735396|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105471068|NCT01160822|363735397|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
105471069|NCT01160822|363735398|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
105471070|NCT01160822|363735399|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
105471071|NCT01160822|363735400|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
105471072|NCT01160822|363735394|FG000|Overall Study|Withdrawal by Subject|0|||
105471073|NCT01160822|363735395|FG001|Overall Study|Withdrawal by Subject|0|||
105471074|NCT01160822|363735396|FG002|Overall Study|Withdrawal by Subject|0|||
105471075|NCT01160822|363735397|FG003|Overall Study|Withdrawal by Subject|0|||
105471076|NCT01160822|363735398|FG004|Overall Study|Withdrawal by Subject|0|||
105471077|NCT01160822|363735399|FG005|Overall Study|Withdrawal by Subject|0|||
105471078|NCT01160822|363735400|FG006|Overall Study|Withdrawal by Subject|1|||
105471079|NCT01160822|363735394|FG000|Overall Study|Lost to Follow-up|0|||
105471080|NCT01160822|363735395|FG001|Overall Study|Lost to Follow-up|0|||
105471081|NCT01160822|363735396|FG002|Overall Study|Lost to Follow-up|0|||
105471082|NCT01160822|363735397|FG003|Overall Study|Lost to Follow-up|0|||
105471083|NCT01160822|363735398|FG004|Overall Study|Lost to Follow-up|1|||
105471084|NCT01160822|363735399|FG005|Overall Study|Lost to Follow-up|0|||
105471085|NCT01160822|363735400|FG006|Overall Study|Lost to Follow-up|0|||
105471086|NCT01160822|363735394|FG000|Overall Study|Administrative problems|0|||
105471087|NCT01160822|363735395|FG001|Overall Study|Administrative problems|0|||
105471088|NCT01160822|363735396|FG002|Overall Study|Administrative problems|0|||
105471089|NCT01160822|363735397|FG003|Overall Study|Administrative problems|0|||
105471090|NCT01160822|363735398|FG004|Overall Study|Administrative problems|1|||
105471091|NCT01160822|363735399|FG005|Overall Study|Administrative problems|0|||
105471092|NCT01160822|363735400|FG006|Overall Study|Administrative problems|0|||
105471093|NCT01160822|363735394|FG000|Overall Study|Protocol deviation|0|||
105471094|NCT01160822|363735395|FG001|Overall Study|Protocol deviation|0|||
105471095|NCT01160822|363735396|FG002|Overall Study|Protocol deviation|0|||
105471096|NCT01160822|363735397|FG003|Overall Study|Protocol deviation|0|||
105471097|NCT01160822|363735398|FG004|Overall Study|Protocol deviation|2|||
105471098|NCT01160822|363735399|FG005|Overall Study|Protocol deviation|0|||
105471099|NCT01160822|363735400|FG006|Overall Study|Protocol deviation|0|||
105471100|NCT00314795|363735401|FG000|Overall Study|Adverse Event|8|||
105471101|NCT00314795|363735401|FG000|Overall Study|Death|4|||
105471102|NCT00314795|363735401|FG000|Overall Study|Reason not Specified|3|||
105471103|NCT00314795|363735401|FG000|Overall Study|Renal Transplant|3|||
105471104|NCT00314795|363735401|FG000|Overall Study|Participants Withdrew Consent|2|||
105344951|NCT00550862|363263571|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
105471105|NCT04717336|363735402|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
105471106|NCT04717336|363735403|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
105471107|NCT04717336|363735402|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
105471108|NCT04717336|363735403|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
105471109|NCT02087423|363735404|FG000|Overall Study|Withdrawal by Subject|20|||
105471110|NCT02087423|363735405|FG001|Overall Study|Withdrawal by Subject|20|||
105471111|NCT02087423|363735406|FG002|Overall Study|Withdrawal by Subject|3|||
105471112|NCT02087423|363735404|FG000|Overall Study|Death|68|||
105471113|NCT02087423|363735405|FG001|Overall Study|Death|207|||
105471114|NCT02087423|363735406|FG002|Overall Study|Death|40|||
105471115|NCT02087423|363735404|FG000|Overall Study|Lost to Follow-up|0|||
105471116|NCT02087423|363735405|FG001|Overall Study|Lost to Follow-up|2|||
105471117|NCT02087423|363735406|FG002|Overall Study|Lost to Follow-up|0|||
105471118|NCT02087423|363735404|FG000|Overall Study|Terminated from study at final DCO|23|||
105471119|NCT02087423|363735405|FG001|Overall Study|Terminated from study at final DCO|36|||
105471120|NCT02087423|363735406|FG002|Overall Study|Terminated from study at final DCO|25|||
105471121|NCT01010867|363735407|FG000|Overall Study|< 50% adherence to probiotic|1|||
105471122|NCT00884741|363735408|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
105786602|NCT03323034|364872845|FG004|Overall Study|Withdrawal by Subject|0|||
105786603|NCT02815540|364872851|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
105786604|NCT00718809|364872862|FG000|Overall Study|Disease progression|9|||
105786605|NCT00718809|364872863|FG001|Overall Study|Disease progression|7|||
105786606|NCT00718809|364872862|FG000|Overall Study|Adverse Event|1|||
105786607|NCT00718809|364872863|FG001|Overall Study|Adverse Event|1|||
105786608|NCT00718809|364872862|FG000|Overall Study|Withdrawal by Subject|0|||
105786609|NCT00718809|364872863|FG001|Overall Study|Withdrawal by Subject|1|||
105786610|NCT00718809|364872862|FG000|Overall Study|Lost to Follow-up|1|||
105786611|NCT00718809|364872863|FG001|Overall Study|Lost to Follow-up|0|||
105786612|NCT00718809|364872862|FG000|Overall Study|Noncompliance|1|||
105786613|NCT00718809|364872863|FG001|Overall Study|Noncompliance|0|||
105786614|NCT00463385|364872864|FG000|Overall Study|Other|4|||
105344952|NCT00550862|363263572|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
105471123|NCT00884741|363735409|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
105687596|NCT00381303|364519051|FG000|Overall Study|Physician's decision to close the site|3|||
105687597|NCT00381303|364519052|FG001|Overall Study|Physician's decision to close the site|1|||
105687598|NCT00381303|364519051|FG000|Overall Study|Subject moved out of state|2|||
105687599|NCT00381303|364519052|FG001|Overall Study|Subject moved out of state|0|||
105687600|NCT00381303|364519051|FG000|Overall Study|Subject taking too many different meds|1|||
105687601|NCT00381303|364519052|FG001|Overall Study|Subject taking too many different meds|0|||
105687602|NCT00381303|364519051|FG000|Overall Study|No virologic response by week 12|1|||
105786615|NCT00463385|364872865|FG001|Overall Study|Other|3|||
105786616|NCT00463385|364872866|FG002|Overall Study|Other|6|||
105471124|NCT00884741|363735410|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
105471125|NCT00884741|363735411|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
105471126|NCT00884741|363735408|FG000|Step 1 Registration: Tissue Screening|Death|3|||
105471127|NCT00884741|363735409|FG001|Step 1 Registration: Tissue Screening|Death|0|||
105786617|NCT00463385|364872867|FG003|Overall Study|Other|4|||
105786618|NCT00463385|364872864|FG000|Overall Study|Adverse Event|5|||
105558778|NCT00518115|364041917|FG003|Overall Study|Wrong Monotherapy Administered|0|||
105687603|NCT00381303|364519052|FG001|Overall Study|No virologic response by week 12|0|||
105687604|NCT00381303|364519051|FG000|Overall Study|Subject was too busy for appointments|1|||
105687605|NCT00381303|364519052|FG001|Overall Study|Subject was too busy for appointments|0|||
105687606|NCT00381303|364519051|FG000|Overall Study|Subject did not continue visits|1|||
105687607|NCT00381303|364519052|FG001|Overall Study|Subject did not continue visits|0|||
105344953|NCT00550862|363263573|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
105344954|NCT00550862|363263569|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
105344955|NCT00550862|363263570|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
105344956|NCT00550862|363263571|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
105344957|NCT00550862|363263572|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
105344958|NCT00550862|363263573|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
105344959|NCT00550862|363263569|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
105344960|NCT00550862|363263570|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
105344961|NCT00550862|363263571|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
105344962|NCT00550862|363263572|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
105344963|NCT00550862|363263573|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
105344964|NCT00550862|363263569|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
105344965|NCT00550862|363263570|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
105344966|NCT00550862|363263571|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
105344967|NCT00550862|363263572|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
105344968|NCT00550862|363263573|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
105344969|NCT00550862|363263569|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
105344970|NCT00550862|363263570|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
105344971|NCT00550862|363263571|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
105344972|NCT00550862|363263572|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
105344973|NCT00550862|363263573|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
105344974|NCT00550862|363263569|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
105344975|NCT00550862|363263570|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
105344976|NCT00550862|363263571|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
105344977|NCT00550862|363263572|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
105344978|NCT00550862|363263573|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
105344979|NCT00550862|363263569|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
105344980|NCT00550862|363263570|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
105344981|NCT00550862|363263571|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
105344982|NCT00550862|363263572|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
105344983|NCT00550862|363263573|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
105344984|NCT00980174|363263574|FG000|Overall Study|Withdrawal by Subject|1|||
105558779|NCT00518115|364041918|FG004|Overall Study|Wrong Monotherapy Administered|0|||
105558780|NCT00518115|364041919|FG005|Overall Study|Wrong Monotherapy Administered|0|||
105558781|NCT00518115|364041920|FG006|Overall Study|Wrong Monotherapy Administered|1|||
105558782|NCT00518115|364041921|FG007|Overall Study|Wrong Monotherapy Administered|0|||
105558783|NCT00518115|364041922|FG008|Overall Study|Wrong Monotherapy Administered|0|||
105558784|NCT00518115|364041923|FG009|Overall Study|Wrong Monotherapy Administered|0|||
105558785|NCT00518115|364041914|FG000|Overall Study|Violation of Exclusion Criteria|0|||
105558786|NCT00518115|364041915|FG001|Overall Study|Violation of Exclusion Criteria|0|||
105558787|NCT00518115|364041916|FG002|Overall Study|Violation of Exclusion Criteria|0|||
105558788|NCT00518115|364041917|FG003|Overall Study|Violation of Exclusion Criteria|1|||
105558789|NCT00518115|364041918|FG004|Overall Study|Violation of Exclusion Criteria|0|||
105786619|NCT00463385|364872865|FG001|Overall Study|Adverse Event|8|||
105687608|NCT00381303|364519051|FG000|Overall Study|Subject primary physician's decision|1|||
105687609|NCT00381303|364519052|FG001|Overall Study|Subject primary physician's decision|0|||
105687610|NCT01211522|364519054|FG000|Overall Study|Withdrawal by Subject|3|||
105687611|NCT01211522|364519055|FG001|Overall Study|Withdrawal by Subject|7|||
105687612|NCT01211522|364519056|FG002|Overall Study|Withdrawal by Subject|5|||
105687613|NCT00547365|364519057|FG000|Overall Study|Physician Decision|1|||
105687614|NCT00547365|364519057|FG000|Overall Study|Lost to Follow-up|1|||
105687615|NCT00547365|364519057|FG000|Overall Study|Protocol Violation|2|||
105687616|NCT00547365|364519057|FG000|Overall Study|death (not related to study)|4|||
105687617|NCT01777269|364519058|FG000|Overall Study|Adverse Event|24|||
105471128|NCT00884741|363735410|FG002|Step 1 Registration: Tissue Screening|Death|0|||
105471129|NCT00884741|363735411|FG003|Step 1 Registration: Tissue Screening|Death|0|||
105471130|NCT00884741|363735408|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
105471131|NCT00884741|363735409|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
105471132|NCT00884741|363735410|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
105471133|NCT00884741|363735411|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
105471134|NCT00884741|363735408|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
105471135|NCT00884741|363735409|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
105471136|NCT00884741|363735410|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
105471137|NCT00884741|363735411|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
105471138|NCT00884741|363735408|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
105471139|NCT00884741|363735409|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
105471140|NCT00884741|363735410|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
105471141|NCT00884741|363735411|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
105471142|NCT00884741|363735408|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
105471143|NCT00884741|363735409|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
105471144|NCT00884741|363735410|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
105471145|NCT00884741|363735411|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
105471146|NCT00884741|363735408|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
105471147|NCT00884741|363735409|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
105471148|NCT00884741|363735410|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
105471149|NCT00884741|363735411|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
105471150|NCT00884741|363735408|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
105471151|NCT00884741|363735409|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
105558790|NCT00518115|364041919|FG005|Overall Study|Violation of Exclusion Criteria|0|||
105558791|NCT00518115|364041920|FG006|Overall Study|Violation of Exclusion Criteria|1|||
105687618|NCT01777269|364519059|FG001|Overall Study|Adverse Event|33|||
105687619|NCT01777269|364519058|FG000|Overall Study|Lack of Efficacy|8|||
105687620|NCT01777269|364519059|FG001|Overall Study|Lack of Efficacy|10|||
105558792|NCT00518115|364041921|FG007|Overall Study|Violation of Exclusion Criteria|0|||
105558793|NCT00518115|364041922|FG008|Overall Study|Violation of Exclusion Criteria|0|||
105558794|NCT00518115|364041923|FG009|Overall Study|Violation of Exclusion Criteria|0|||
105558795|NCT00518115|364041914|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
105558796|NCT00518115|364041915|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
105558797|NCT00518115|364041916|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
105558798|NCT00518115|364041917|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
105558799|NCT00518115|364041918|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
105558800|NCT00518115|364041919|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
105558801|NCT00518115|364041920|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
105344985|NCT00980174|363263575|FG001|Overall Study|Withdrawal by Subject|4|||
105344986|NCT00980174|363263574|FG000|Overall Study|Adverse Event|0|||
105344987|NCT00980174|363263575|FG001|Overall Study|Adverse Event|3|||
105344988|NCT00980174|363263574|FG000|Overall Study|Ineligibility determined|2|||
105344989|NCT00980174|363263575|FG001|Overall Study|Ineligibility determined|1|||
105558802|NCT00518115|364041921|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
105558803|NCT00518115|364041922|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
105558804|NCT00518115|364041923|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
105558805|NCT00518115|364041914|FG000|Overall Study|Withdrew Consent|0|||
105558806|NCT00518115|364041915|FG001|Overall Study|Withdrew Consent|0|||
105558807|NCT00518115|364041916|FG002|Overall Study|Withdrew Consent|0|||
105344990|NCT00980174|363263574|FG000|Overall Study|Death|1|||
105344991|NCT00980174|363263575|FG001|Overall Study|Death|1|||
105344992|NCT00980174|363263574|FG000|Overall Study|Other|0|||
105344993|NCT00980174|363263575|FG001|Overall Study|Other|1|||
105344994|NCT02248974|363263578|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
105344995|NCT02248974|363263579|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
105344996|NCT02248974|363263578|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
105344997|NCT02248974|363263579|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
105344998|NCT02248974|363263578|FG000|1-Day Follow-Up|Enrolled in another study|1|||
105344999|NCT02248974|363263579|FG001|1-Day Follow-Up|Enrolled in another study|0|||
105345000|NCT02248974|363263578|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
105345001|NCT02248974|363263579|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
105345002|NCT02248974|363263578|FG000|1-Week Follow-Up|Enrolled in another study|1|||
105345003|NCT02248974|363263579|FG001|1-Week Follow-Up|Enrolled in another study|1|||
105345004|NCT02248974|363263578|FG000|1-Week Follow-Up|Transferred to another facility|1|||
105345005|NCT02248974|363263579|FG001|1-Week Follow-Up|Transferred to another facility|0|||
105345006|NCT02248974|363263578|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
105345007|NCT02248974|363263579|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
105345008|NCT02248974|363263578|FG000|1-Week Follow-Up|Death|1|||
105345009|NCT02248974|363263579|FG001|1-Week Follow-Up|Death|1|||
105345010|NCT02248974|363263578|FG000|1-Week Follow-Up|Excluded because of age|0|||
105345011|NCT02248974|363263579|FG001|1-Week Follow-Up|Excluded because of age|1|||
105345012|NCT02248974|363263578|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
105345013|NCT02248974|363263579|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
105345014|NCT02248974|363263578|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
105345015|NCT02248974|363263579|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
105558808|NCT00518115|364041917|FG003|Overall Study|Withdrew Consent|0|||
105345016|NCT02248974|363263578|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
105345017|NCT02248974|363263579|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
105345018|NCT02248974|363263578|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
105345019|NCT02248974|363263579|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
105345020|NCT02248974|363263578|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
105345021|NCT02248974|363263579|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
105345022|NCT03488225|363263581|FG000|Overall Study|Off Protocol Therapy|2|||
105345023|NCT03488225|363263581|FG000|Overall Study|Stem Cell Transplant|2|||
105471152|NCT00884741|363735410|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
105558809|NCT00518115|364041918|FG004|Overall Study|Withdrew Consent|0|||
105345024|NCT00894790|363263584|FG000|Overall Study|Protocol Violation|0|||
105345025|NCT00894790|363263585|FG001|Overall Study|Protocol Violation|1|||
105345026|NCT00894790|363263584|FG000|Overall Study|Lost to Follow-up|0|||
105345027|NCT00894790|363263585|FG001|Overall Study|Lost to Follow-up|1|||
105345028|NCT00894790|363263584|FG000|Overall Study|Did not meet entrance criteria|1|||
105345029|NCT00894790|363263585|FG001|Overall Study|Did not meet entrance criteria|0|||
105345030|NCT04093492|363263586|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
105687621|NCT01777269|364519058|FG000|Overall Study|Protocol Violation|4|||
105687622|NCT01777269|364519059|FG001|Overall Study|Protocol Violation|4|||
105345031|NCT04093492|363263587|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
105345032|NCT04093492|363263588|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
105345033|NCT04093492|363263589|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
105345034|NCT04093492|363263586|FG000|25 Weeks Gestational Age (GA)|No response|5|||
105345035|NCT04093492|363263587|FG001|25 Weeks Gestational Age (GA)|No response|5|||
105345036|NCT04093492|363263588|FG002|25 Weeks Gestational Age (GA)|No response|5|||
105345037|NCT04093492|363263589|FG003|25 Weeks Gestational Age (GA)|No response|2|||
105345038|NCT04093492|363263586|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
105345039|NCT04093492|363263587|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
105345040|NCT04093492|363263588|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
105345041|NCT04093492|363263589|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
105345042|NCT04093492|363263586|FG000|30 Weeks GA|Delivered before assessment|1|||
105345043|NCT04093492|363263587|FG001|30 Weeks GA|Delivered before assessment|2|||
105345044|NCT04093492|363263588|FG002|30 Weeks GA|Delivered before assessment|0|||
105345045|NCT04093492|363263589|FG003|30 Weeks GA|Delivered before assessment|0|||
105345046|NCT04093492|363263586|FG000|30 Weeks GA|No response|7|||
105345047|NCT04093492|363263587|FG001|30 Weeks GA|No response|5|||
105345048|NCT04093492|363263588|FG002|30 Weeks GA|No response|5|||
105345049|NCT04093492|363263589|FG003|30 Weeks GA|No response|2|||
105345050|NCT04093492|363263586|FG000|30 Weeks GA|Lost to Follow-up|0|||
105345051|NCT04093492|363263587|FG001|30 Weeks GA|Lost to Follow-up|1|||
105345052|NCT04093492|363263588|FG002|30 Weeks GA|Lost to Follow-up|0|||
105345053|NCT04093492|363263589|FG003|30 Weeks GA|Lost to Follow-up|0|||
105345054|NCT04093492|363263586|FG000|34 Weeks GA|Delivered before assessment|6|||
105345055|NCT04093492|363263587|FG001|34 Weeks GA|Delivered before assessment|3|||
105345056|NCT04093492|363263588|FG002|34 Weeks GA|Delivered before assessment|0|||
105345057|NCT04093492|363263589|FG003|34 Weeks GA|Delivered before assessment|0|||
105345058|NCT04093492|363263586|FG000|34 Weeks GA|No response|0|||
105345059|NCT04093492|363263587|FG001|34 Weeks GA|No response|7|||
105345060|NCT04093492|363263588|FG002|34 Weeks GA|No response|5|||
105345061|NCT04093492|363263589|FG003|34 Weeks GA|No response|3|||
105345062|NCT04093492|363263586|FG000|34 Weeks GA|Lost to Follow-up|0|||
105345063|NCT04093492|363263587|FG001|34 Weeks GA|Lost to Follow-up|1|||
105345064|NCT04093492|363263588|FG002|34 Weeks GA|Lost to Follow-up|0|||
105345065|NCT04093492|363263589|FG003|34 Weeks GA|Lost to Follow-up|0|||
105345066|NCT05619536|363263591|FG000|Overall Study|Withdrawal by Subject|0|||
105345067|NCT05619536|363263592|FG001|Overall Study|Withdrawal by Subject|1|||
105345068|NCT05619536|363263593|FG002|Overall Study|Withdrawal by Subject|0|||
105345069|NCT05619536|363263594|FG003|Overall Study|Withdrawal by Subject|1|||
105345070|NCT05619536|363263591|FG000|Overall Study|Lost to Follow-up|0|||
105345071|NCT05619536|363263592|FG001|Overall Study|Lost to Follow-up|1|||
105345072|NCT05619536|363263593|FG002|Overall Study|Lost to Follow-up|1|||
105345073|NCT05619536|363263594|FG003|Overall Study|Lost to Follow-up|0|||
105345074|NCT04272606|363263595|FG000|Overall Study|Protocol Violation|1|||
105345075|NCT04272606|363263596|FG001|Overall Study|Protocol Violation|1|||
105345076|NCT04272606|363263595|FG000|Overall Study|Physician Decision|0|||
105345077|NCT04272606|363263596|FG001|Overall Study|Physician Decision|1|||
105345078|NCT05903924|363265391|FG000|Overall Study|Lost to Follow-up|1|||
105345079|NCT05903924|363265392|FG001|Overall Study|Lost to Follow-up|0|||
105345080|NCT05903924|363265393|FG002|Overall Study|Lost to Follow-up|0|||
105345081|NCT04250714|363265394|FG000|Overall Study|Treatment - withdrawal by subject|14|||
105345082|NCT04250714|363265394|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
105687623|NCT01777269|364519058|FG000|Overall Study|Participants reached stopping criteria|1|||
105687624|NCT01777269|364519059|FG001|Overall Study|Participants reached stopping criteria|1|||
105345083|NCT04250714|363265394|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
105345084|NCT04250714|363265394|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
105345085|NCT04250714|363265394|FG000|Overall Study|Treatment - Death|1|||
105345086|NCT04250714|363265394|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
105345087|NCT04250714|363265394|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
105345088|NCT04250714|363265394|FG000|Overall Study|Attempt|2|||
105345089|NCT04250714|363265394|FG000|Overall Study|Intent|7|||
105471153|NCT00884741|363735411|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
105471154|NCT00884741|363735408|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
105345090|NCT01702532|363265399|FG000|Overall Study|Adverse Event|0|||
105471155|NCT00884741|363735409|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
105471156|NCT00884741|363735410|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
105558810|NCT00518115|364041919|FG005|Overall Study|Withdrew Consent|1|||
105345091|NCT01702532|363265400|FG001|Overall Study|Adverse Event|1|||
105345092|NCT00623597|363265401|FG000|Overall Study|Failed to return|1|||
105345093|NCT00623597|363265402|FG001|Overall Study|Failed to return|0|||
105471157|NCT00884741|363735411|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
105471158|NCT00884741|363735408|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
105471159|NCT00884741|363735409|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
105471160|NCT00884741|363735410|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
105471161|NCT00884741|363735411|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
105471162|NCT00884741|363735408|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
105471163|NCT00884741|363735409|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
105471164|NCT00884741|363735410|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
105471165|NCT00884741|363735411|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
105471166|NCT00884741|363735408|FG000|Randomization|Protocol Violation|0|||
105471167|NCT00884741|363735409|FG001|Randomization|Protocol Violation|0|||
105471168|NCT00884741|363735410|FG002|Randomization|Protocol Violation|8|||
105471169|NCT00884741|363735411|FG003|Randomization|Protocol Violation|8|||
105687625|NCT01777269|364519058|FG000|Overall Study|Lost to Follow-up|4|||
105687626|NCT01777269|364519059|FG001|Overall Study|Lost to Follow-up|0|||
105687627|NCT01777269|364519058|FG000|Overall Study|Physician Decision|5|||
105687628|NCT01777269|364519059|FG001|Overall Study|Physician Decision|2|||
105687629|NCT01777269|364519058|FG000|Overall Study|Withdrawal by Subject|9|||
105687630|NCT01777269|364519059|FG001|Overall Study|Withdrawal by Subject|9|||
105687631|NCT01966471|364519061|FG000|Overall Study|Death|44|||
105471170|NCT02281383|363735414|FG000|Overall Study|Progressive Disease|1|||
105687632|NCT01966471|364519062|FG001|Overall Study|Death|56|||
105345094|NCT02515994|363265403|FG000|Overall Study|Protocol Violation|3|||
105345095|NCT02515994|363265404|FG001|Overall Study|Protocol Violation|5|||
105345096|NCT02515994|363265403|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
105345097|NCT02515994|363265404|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
105345098|NCT02515994|363265403|FG000|Overall Study|Adverse Event|3|||
105345099|NCT02515994|363265404|FG001|Overall Study|Adverse Event|1|||
105345100|NCT02515994|363265403|FG000|Overall Study|Withdrawal by Subject|2|||
105345101|NCT02515994|363265404|FG001|Overall Study|Withdrawal by Subject|0|||
105345102|NCT02304380|363265409|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
105345103|NCT02304380|363265410|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
105345104|NCT02304380|363265411|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
105345105|NCT02304380|363265412|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
105345106|NCT02304380|363265413|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
105345107|NCT02304380|363265414|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
105345108|NCT02368210|363265415|FG000|Overall Study|Withdrawal by Subject|1|||
105345109|NCT02368210|363265416|FG001|Overall Study|Withdrawal by Subject|0|||
105345110|NCT02368210|363265415|FG000|Overall Study|Adverse Event|0|||
105345111|NCT02368210|363265416|FG001|Overall Study|Adverse Event|1|||
105345112|NCT04068688|363265417|FG000|Overall Study|Lost to Follow-up|1|||
105345113|NCT04068688|363265418|FG001|Overall Study|Lost to Follow-up|1|||
105345114|NCT04068688|363265419|FG002|Overall Study|Lost to Follow-up|0|||
105345115|NCT04068688|363265420|FG003|Overall Study|Lost to Follow-up|0|||
105345116|NCT04068688|363265421|FG004|Overall Study|Lost to Follow-up|5|||
105345117|NCT04068688|363265422|FG005|Overall Study|Lost to Follow-up|5|||
105345118|NCT04068688|363265423|FG006|Overall Study|Lost to Follow-up|0|||
105345119|NCT04068688|363265424|FG007|Overall Study|Lost to Follow-up|0|||
105345120|NCT04068688|363265425|FG008|Overall Study|Lost to Follow-up|1|||
105345121|NCT04068688|363265426|FG009|Overall Study|Lost to Follow-up|0|||
105345122|NCT04068688|363265417|FG000|Overall Study|Withdrawal by Subject|1|||
105345123|NCT04068688|363265418|FG001|Overall Study|Withdrawal by Subject|1|||
105345124|NCT04068688|363265419|FG002|Overall Study|Withdrawal by Subject|0|||
105345125|NCT04068688|363265420|FG003|Overall Study|Withdrawal by Subject|0|||
105345126|NCT04068688|363265421|FG004|Overall Study|Withdrawal by Subject|0|||
105345127|NCT04068688|363265422|FG005|Overall Study|Withdrawal by Subject|0|||
105345128|NCT04068688|363265423|FG006|Overall Study|Withdrawal by Subject|0|||
105345129|NCT04068688|363265424|FG007|Overall Study|Withdrawal by Subject|0|||
105345130|NCT04068688|363265425|FG008|Overall Study|Withdrawal by Subject|0|||
105345131|NCT04068688|363265426|FG009|Overall Study|Withdrawal by Subject|0|||
105345132|NCT04068688|363265417|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
105345133|NCT04068688|363265418|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
105345134|NCT04068688|363265419|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105345135|NCT04068688|363265420|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105345136|NCT04068688|363265421|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105345137|NCT04068688|363265422|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105345138|NCT04068688|363265423|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105345139|NCT04068688|363265424|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105345140|NCT04068688|363265425|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105345141|NCT04068688|363265426|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105345142|NCT04631107|363265431|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
105345143|NCT04631107|363265431|FG000|Second Intervention (1 Night)|Adverse Event|1|||
105345144|NCT04631107|363265431|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
105345145|NCT04631107|363265431|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
105345146|NCT01717391|363265441|FG000|Overall Study|Withdrawal by Subject|5|||
105345147|NCT01717391|363265441|FG000|Overall Study|Physician Decision|1|||
105345148|NCT01717391|363265441|FG000|Overall Study|FLT technical failure|3|||
105345149|NCT01068626|363265444|FG000|Overall Study|Adverse Event|3|||
105345150|NCT01068626|363265445|FG001|Overall Study|Adverse Event|0|||
105345151|NCT01068626|363265444|FG000|Overall Study|Withdrawal by Subject|0|||
105345152|NCT01068626|363265445|FG001|Overall Study|Withdrawal by Subject|2|||
105345153|NCT03627416|363265447|FG000|Overall Study|Adverse Event|0|||
105471171|NCT02281383|363735414|FG000|Overall Study|Withdrawal by Subject|6|||
105471172|NCT02281383|363735414|FG000|Overall Study|Protocol Violation|2|||
105471173|NCT02281383|363735414|FG000|Overall Study|Death|1|||
105345154|NCT03627416|363265448|FG001|Overall Study|Adverse Event|1|||
105345155|NCT00875433|363265449|FG000|Overall Study|Progressive disease|41|||
105345156|NCT00875433|363265449|FG000|Overall Study|Other Adverse Event|14|||
105345157|NCT00875433|363265449|FG000|Overall Study|Withdrawal by Subject|2|||
105345158|NCT00875433|363265449|FG000|Overall Study|Other|3|||
105345159|NCT03434249|363265450|FG000|Overall Study|Adverse Event|1|||
105345160|NCT03434249|363265451|FG001|Overall Study|Adverse Event|0|||
105345161|NCT03434249|363265450|FG000|Overall Study|Lost to Follow-up|0|||
105345162|NCT03434249|363265451|FG001|Overall Study|Lost to Follow-up|1|||
105345163|NCT03434249|363265450|FG000|Overall Study|Non-compliance of family|2|||
105345164|NCT03434249|363265451|FG001|Overall Study|Non-compliance of family|1|||
105345165|NCT03434249|363265450|FG000|Overall Study|Difficulties in completing daily diary|2|||
105345166|NCT03434249|363265451|FG001|Overall Study|Difficulties in completing daily diary|1|||
105345167|NCT00637806|363265452|FG000|Double-blind Phase|Study Discontinued|2|||
105345168|NCT00637806|363265453|FG001|Double-blind Phase|Study Discontinued|0|||
105345169|NCT00637806|363265454|FG002|Double-blind Phase|Study Discontinued|1|||
105345170|NCT00637806|363265455|FG003|Double-blind Phase|Study Discontinued|0|||
105345171|NCT00637806|363265452|FG000|Extension Phase|Study Discontinued|0|||
105345172|NCT00637806|363265453|FG001|Extension Phase|Study Discontinued|0|||
105345173|NCT00637806|363265454|FG002|Extension Phase|Study Discontinued|0|||
105345174|NCT00637806|363265455|FG003|Extension Phase|Study Discontinued|1|||
105345175|NCT02450552|363265456|FG000|Overall Study|Withdrawal by Subject|4|||
105345176|NCT02450552|363265457|FG001|Overall Study|Withdrawal by Subject|0|||
105345177|NCT02450552|363265458|FG002|Overall Study|Withdrawal by Subject|4|||
105345178|NCT02450552|363265456|FG000|Overall Study|Physician Decision|1|||
105345179|NCT02450552|363265457|FG001|Overall Study|Physician Decision|0|||
105345180|NCT02450552|363265458|FG002|Overall Study|Physician Decision|1|||
105345181|NCT03233204|363265466|FG000|Overall Study|Adverse Event|1|||
105345182|NCT03233204|363265466|FG000|Overall Study|Death|1|||
105345183|NCT03233204|363265466|FG000|Overall Study|Withdrawal by Subject|1|||
105345184|NCT03233204|363265466|FG000|Overall Study|Progressive Disease|3|||
105345185|NCT02680834|363265467|FG000|Overall Study|Physician Decision|5|||
105345186|NCT02680834|363265468|FG001|Overall Study|Physician Decision|2|||
105345187|NCT02680834|363265467|FG000|Overall Study|Withdrawal by Subject|6|||
105345188|NCT02680834|363265468|FG001|Overall Study|Withdrawal by Subject|0|||
105345189|NCT02680834|363265467|FG000|Overall Study|Lost to Follow-up|0|||
105345190|NCT02680834|363265468|FG001|Overall Study|Lost to Follow-up|1|||
105345191|NCT02520427|363265469|FG000|Overall Study|Decision by sponsor|0|||
105345192|NCT02520427|363265470|FG001|Overall Study|Decision by sponsor|0|||
105345193|NCT02520427|363265471|FG002|Overall Study|Decision by sponsor|0|||
105345194|NCT02520427|363265472|FG003|Overall Study|Decision by sponsor|0|||
105345195|NCT02520427|363265473|FG004|Overall Study|Decision by sponsor|0|||
105345196|NCT02520427|363265474|FG005|Overall Study|Decision by sponsor|0|||
105345197|NCT02520427|363265475|FG006|Overall Study|Decision by sponsor|0|||
105345198|NCT02520427|363265476|FG007|Overall Study|Decision by sponsor|0|||
105345199|NCT02520427|363265477|FG008|Overall Study|Decision by sponsor|1|||
105558811|NCT00518115|364041920|FG006|Overall Study|Withdrew Consent|0|||
105558812|NCT00518115|364041921|FG007|Overall Study|Withdrew Consent|0|||
105558813|NCT00518115|364041922|FG008|Overall Study|Withdrew Consent|0|||
105558814|NCT00518115|364041923|FG009|Overall Study|Withdrew Consent|0|||
105558815|NCT00518115|364041914|FG000|Overall Study|Moved Out of State|0|||
105558816|NCT00518115|364041915|FG001|Overall Study|Moved Out of State|0|||
105558817|NCT00518115|364041916|FG002|Overall Study|Moved Out of State|0|||
105558818|NCT00518115|364041917|FG003|Overall Study|Moved Out of State|0|||
105786620|NCT00463385|364872866|FG002|Overall Study|Adverse Event|4|||
105786621|NCT00463385|364872867|FG003|Overall Study|Adverse Event|2|||
105786622|NCT00463385|364872864|FG000|Overall Study|Lack of Efficacy|6|||
105786623|NCT00463385|364872865|FG001|Overall Study|Lack of Efficacy|6|||
105786624|NCT00463385|364872866|FG002|Overall Study|Lack of Efficacy|7|||
105786625|NCT00463385|364872867|FG003|Overall Study|Lack of Efficacy|9|||
105558819|NCT00518115|364041918|FG004|Overall Study|Moved Out of State|0|||
105558820|NCT00518115|364041919|FG005|Overall Study|Moved Out of State|0|||
105558821|NCT00518115|364041920|FG006|Overall Study|Moved Out of State|0|||
105786626|NCT00463385|364872864|FG000|Overall Study|Withdrawal by Subject|3|||
105786627|NCT00463385|364872865|FG001|Overall Study|Withdrawal by Subject|3|||
105786628|NCT00463385|364872866|FG002|Overall Study|Withdrawal by Subject|3|||
105786629|NCT00463385|364872867|FG003|Overall Study|Withdrawal by Subject|4|||
105345200|NCT02520427|363265478|FG009|Overall Study|Decision by sponsor|1|||
105345201|NCT02520427|363265479|FG010|Overall Study|Decision by sponsor|0|||
105345202|NCT02520427|363265480|FG011|Overall Study|Decision by sponsor|0|||
105558822|NCT00518115|364041921|FG007|Overall Study|Moved Out of State|0|||
105558823|NCT00518115|364041922|FG008|Overall Study|Moved Out of State|0|||
105558824|NCT00518115|364041923|FG009|Overall Study|Moved Out of State|1|||
105558825|NCT04891419|364041924|FG000|Overall Study|Withdrawal by Subject|4|||
105558826|NCT04891419|364041925|FG001|Overall Study|Withdrawal by Subject|0|||
105558827|NCT04891419|364041924|FG000|Overall Study|Lost to Follow-up|1|||
105786630|NCT00463385|364872864|FG000|Overall Study|Lost to Follow-up|0|||
105786631|NCT00463385|364872865|FG001|Overall Study|Lost to Follow-up|0|||
105345203|NCT02520427|363265481|FG012|Overall Study|Decision by sponsor|0|||
105345204|NCT02520427|363265482|FG013|Overall Study|Decision by sponsor|0|||
105345205|NCT02520427|363265483|FG014|Overall Study|Decision by sponsor|0|||
105345206|NCT02520427|363265484|FG015|Overall Study|Decision by sponsor|0|||
105345207|NCT02520427|363265485|FG016|Overall Study|Decision by sponsor|0|||
105345208|NCT02520427|363265486|FG017|Overall Study|Decision by sponsor|0|||
105345209|NCT02520427|363265487|FG018|Overall Study|Decision by sponsor|0|||
105345210|NCT02520427|363265488|FG019|Overall Study|Decision by sponsor|0|||
105345211|NCT02520427|363265489|FG020|Overall Study|Decision by sponsor|0|||
105345212|NCT02520427|363265490|FG021|Overall Study|Decision by sponsor|0|||
105345213|NCT02520427|363265491|FG022|Overall Study|Decision by sponsor|0|||
105345214|NCT02520427|363265492|FG023|Overall Study|Decision by sponsor|0|||
105345215|NCT02520427|363265493|FG024|Overall Study|Decision by sponsor|0|||
105345216|NCT02520427|363265494|FG025|Overall Study|Decision by sponsor|0|||
105345217|NCT02520427|363265469|FG000|Overall Study|Withdrawal by Subject|0|||
105345218|NCT02520427|363265470|FG001|Overall Study|Withdrawal by Subject|0|||
105345219|NCT02520427|363265471|FG002|Overall Study|Withdrawal by Subject|1|||
105345220|NCT02520427|363265472|FG003|Overall Study|Withdrawal by Subject|0|||
105345221|NCT02520427|363265473|FG004|Overall Study|Withdrawal by Subject|0|||
105345222|NCT02520427|363265474|FG005|Overall Study|Withdrawal by Subject|0|||
105345223|NCT02520427|363265475|FG006|Overall Study|Withdrawal by Subject|0|||
105345224|NCT02520427|363265476|FG007|Overall Study|Withdrawal by Subject|0|||
105345225|NCT02520427|363265477|FG008|Overall Study|Withdrawal by Subject|0|||
105345226|NCT02520427|363265478|FG009|Overall Study|Withdrawal by Subject|0|||
105345227|NCT02520427|363265479|FG010|Overall Study|Withdrawal by Subject|0|||
105345228|NCT02520427|363265480|FG011|Overall Study|Withdrawal by Subject|0|||
105345229|NCT02520427|363265481|FG012|Overall Study|Withdrawal by Subject|1|||
105345230|NCT02520427|363265482|FG013|Overall Study|Withdrawal by Subject|1|||
105345231|NCT02520427|363265483|FG014|Overall Study|Withdrawal by Subject|1|||
105345232|NCT02520427|363265484|FG015|Overall Study|Withdrawal by Subject|0|||
105345233|NCT02520427|363265485|FG016|Overall Study|Withdrawal by Subject|1|||
105345234|NCT02520427|363265486|FG017|Overall Study|Withdrawal by Subject|0|||
105345235|NCT02520427|363265487|FG018|Overall Study|Withdrawal by Subject|0|||
105345236|NCT02520427|363265488|FG019|Overall Study|Withdrawal by Subject|3|||
105345237|NCT02520427|363265489|FG020|Overall Study|Withdrawal by Subject|2|||
105345238|NCT02520427|363265490|FG021|Overall Study|Withdrawal by Subject|0|||
105345239|NCT02520427|363265491|FG022|Overall Study|Withdrawal by Subject|0|||
105345240|NCT02520427|363265492|FG023|Overall Study|Withdrawal by Subject|0|||
105345241|NCT02520427|363265493|FG024|Overall Study|Withdrawal by Subject|0|||
105345242|NCT02520427|363265494|FG025|Overall Study|Withdrawal by Subject|0|||
105345243|NCT02520427|363265469|FG000|Overall Study|Death|1|||
105345244|NCT02520427|363265470|FG001|Overall Study|Death|0|||
105345245|NCT02520427|363265471|FG002|Overall Study|Death|0|||
105345246|NCT02520427|363265472|FG003|Overall Study|Death|0|||
105345247|NCT02520427|363265473|FG004|Overall Study|Death|0|||
105345248|NCT02520427|363265474|FG005|Overall Study|Death|0|||
105345249|NCT02520427|363265475|FG006|Overall Study|Death|0|||
105345250|NCT02520427|363265476|FG007|Overall Study|Death|0|||
105345251|NCT02520427|363265477|FG008|Overall Study|Death|0|||
105345252|NCT02520427|363265478|FG009|Overall Study|Death|0|||
105345253|NCT02520427|363265479|FG010|Overall Study|Death|0|||
105345254|NCT02520427|363265480|FG011|Overall Study|Death|0|||
105345255|NCT02520427|363265481|FG012|Overall Study|Death|0|||
105345256|NCT02520427|363265482|FG013|Overall Study|Death|0|||
105345257|NCT02520427|363265483|FG014|Overall Study|Death|0|||
105345258|NCT02520427|363265484|FG015|Overall Study|Death|0|||
105345259|NCT02520427|363265485|FG016|Overall Study|Death|2|||
105345260|NCT02520427|363265486|FG017|Overall Study|Death|1|||
105345261|NCT02520427|363265487|FG018|Overall Study|Death|3|||
105345262|NCT02520427|363265488|FG019|Overall Study|Death|2|||
105345263|NCT02520427|363265489|FG020|Overall Study|Death|0|||
105345264|NCT02520427|363265490|FG021|Overall Study|Death|0|||
105345265|NCT02520427|363265491|FG022|Overall Study|Death|1|||
105345266|NCT02520427|363265492|FG023|Overall Study|Death|0|||
105345267|NCT02520427|363265493|FG024|Overall Study|Death|1|||
105345268|NCT02520427|363265494|FG025|Overall Study|Death|0|||
105345269|NCT00793624|363265497|FG000|Overall Study|Adverse Event|18|||
105345270|NCT00793624|363265498|FG001|Overall Study|Adverse Event|16|||
105345271|NCT00793624|363265499|FG002|Overall Study|Adverse Event|15|||
105345272|NCT00793624|363265500|FG003|Overall Study|Adverse Event|20|||
105345273|NCT00793624|363265497|FG000|Overall Study|Lost to Follow-up|2|||
105345274|NCT00793624|363265498|FG001|Overall Study|Lost to Follow-up|2|||
105558828|NCT04891419|364041925|FG001|Overall Study|Lost to Follow-up|3|||
105558829|NCT04084314|364041926|FG000|Overall Study|Subject/guardian decision|91|||
105558830|NCT04084314|364041926|FG000|Overall Study|Adverse Event|24|||
105345275|NCT00793624|363265499|FG002|Overall Study|Lost to Follow-up|4|||
105345276|NCT00793624|363265500|FG003|Overall Study|Lost to Follow-up|0|||
105345277|NCT00793624|363265497|FG000|Overall Study|Withdrawal by Subject|20|||
105345278|NCT00793624|363265498|FG001|Overall Study|Withdrawal by Subject|9|||
105786632|NCT00463385|364872866|FG002|Overall Study|Lost to Follow-up|0|||
105345279|NCT00793624|363265499|FG002|Overall Study|Withdrawal by Subject|11|||
105345280|NCT00793624|363265500|FG003|Overall Study|Withdrawal by Subject|14|||
105345281|NCT00793624|363265497|FG000|Overall Study|Lack of Efficacy|9|||
105345282|NCT00793624|363265498|FG001|Overall Study|Lack of Efficacy|2|||
105345283|NCT00793624|363265499|FG002|Overall Study|Lack of Efficacy|1|||
105345284|NCT00793624|363265500|FG003|Overall Study|Lack of Efficacy|3|||
105345285|NCT00793624|363265497|FG000|Overall Study|Non compliance with protocol|2|||
105345286|NCT00793624|363265498|FG001|Overall Study|Non compliance with protocol|3|||
105345287|NCT00793624|363265499|FG002|Overall Study|Non compliance with protocol|2|||
105345288|NCT00793624|363265500|FG003|Overall Study|Non compliance with protocol|3|||
105345289|NCT00793624|363265497|FG000|Overall Study|Other reason not described above|6|||
105345290|NCT00793624|363265498|FG001|Overall Study|Other reason not described above|4|||
105345291|NCT00793624|363265499|FG002|Overall Study|Other reason not described above|6|||
105345292|NCT00793624|363265500|FG003|Overall Study|Other reason not described above|3|||
105687633|NCT01966471|364519061|FG000|Overall Study|Lost to Follow-up|46|||
105687634|NCT01966471|364519062|FG001|Overall Study|Lost to Follow-up|39|||
105687635|NCT01966471|364519061|FG000|Overall Study|Various reasons|4|||
105345293|NCT00710684|363265501|FG000|Overall Study|Adverse Event|11|||
105687636|NCT01966471|364519062|FG001|Overall Study|Various reasons|4|||
105687637|NCT01966471|364519061|FG000|Overall Study|Physician Decision|7|||
105687638|NCT01966471|364519062|FG001|Overall Study|Physician Decision|5|||
105345294|NCT00710684|363265502|FG001|Overall Study|Adverse Event|19|||
105687639|NCT01966471|364519061|FG000|Overall Study|Study Terminated By Sponsor|758|||
105345295|NCT00710684|363265503|FG002|Overall Study|Adverse Event|16|||
105345296|NCT00710684|363265501|FG000|Overall Study|Lack of Efficacy|4|||
105687640|NCT01966471|364519062|FG001|Overall Study|Study Terminated By Sponsor|773|||
105687641|NCT01966471|364519061|FG000|Overall Study|Withdrawal by Subject|59|||
105471174|NCT02281383|363735414|FG000|Overall Study|Adverse Event|2|||
105471175|NCT00899431|363735415|FG000|Overall Study|Physician Decision|1|||
105471176|NCT00899431|363735416|FG001|Overall Study|Physician Decision|0|||
105471177|NCT00899431|363735417|FG002|Overall Study|Physician Decision|0|||
105471178|NCT01615029|363735419|FG000|Overall Study|Adverse Event|0|||
105471179|NCT01615029|363735420|FG001|Overall Study|Adverse Event|0|||
105558831|NCT04084314|364041926|FG000|Overall Study|Lost to Follow-up|19|||
105558832|NCT04084314|364041926|FG000|Overall Study|New therapy for study indication|9|||
105558833|NCT04084314|364041926|FG000|Overall Study|Pregnancy|9|||
105558834|NCT04084314|364041926|FG000|Overall Study|Withdrawal of informed consent|8|||
105558835|NCT04084314|364041926|FG000|Overall Study|Physician Decision|4|||
105558836|NCT04084314|364041926|FG000|Overall Study|Protocol Deviation|3|||
105558837|NCT01297959|364041927|FG000|Overall Study|Adverse Event|0|||
105558838|NCT01297959|364041928|FG001|Overall Study|Adverse Event|1|||
105558839|NCT01297959|364041927|FG000|Overall Study|Protocol Violation|2|||
105558840|NCT01297959|364041928|FG001|Overall Study|Protocol Violation|1|||
105558841|NCT01297959|364041927|FG000|Overall Study|Withdrawal by Subject|5|||
105558842|NCT01297959|364041928|FG001|Overall Study|Withdrawal by Subject|4|||
105558843|NCT01297959|364041927|FG000|Overall Study|Physician Decision|0|||
105558844|NCT01297959|364041928|FG001|Overall Study|Physician Decision|1|||
105558845|NCT01297959|364041927|FG000|Overall Study|Unrelated medical illness / complication|0|||
105558846|NCT01297959|364041928|FG001|Overall Study|Unrelated medical illness / complication|2|||
105558847|NCT01297959|364041927|FG000|Overall Study|Other|13|||
105471180|NCT01615029|363735421|FG002|Overall Study|Adverse Event|0|||
105471181|NCT01615029|363735422|FG003|Overall Study|Adverse Event|0|||
105471182|NCT01615029|363735423|FG004|Overall Study|Adverse Event|1|||
105558848|NCT01297959|364041928|FG001|Overall Study|Other|7|||
105558849|NCT03519854|364041929|FG000|Overall Study|Technical Error|0|||
105558850|NCT03519854|364041930|FG001|Overall Study|Technical Error|0|||
105687642|NCT01966471|364519062|FG001|Overall Study|Withdrawal by Subject|51|||
105687643|NCT02370043|364519063|FG000|Overall Study|Withdrawal by Subject|0|||
105471183|NCT01615029|363735419|FG000|Overall Study|Death|0|||
105471184|NCT01615029|363735420|FG001|Overall Study|Death|0|||
105471185|NCT01615029|363735421|FG002|Overall Study|Death|0|||
105471186|NCT01615029|363735422|FG003|Overall Study|Death|0|||
105471187|NCT01615029|363735423|FG004|Overall Study|Death|1|||
105471188|NCT01615029|363735419|FG000|Overall Study|Lost to Follow-up|0|||
105471189|NCT01615029|363735420|FG001|Overall Study|Lost to Follow-up|0|||
105471190|NCT01615029|363735421|FG002|Overall Study|Lost to Follow-up|0|||
105471191|NCT01615029|363735422|FG003|Overall Study|Lost to Follow-up|0|||
105471192|NCT01615029|363735423|FG004|Overall Study|Lost to Follow-up|1|||
105471193|NCT01615029|363735419|FG000|Overall Study|Progressive disease|2|||
105471194|NCT01615029|363735420|FG001|Overall Study|Progressive disease|1|||
105471195|NCT01615029|363735421|FG002|Overall Study|Progressive disease|1|||
105471196|NCT01615029|363735422|FG003|Overall Study|Progressive disease|1|||
105471197|NCT01615029|363735423|FG004|Overall Study|Progressive disease|5|||
105471198|NCT01615029|363735419|FG000|Overall Study|Physician Decision|0|||
105471199|NCT01615029|363735420|FG001|Overall Study|Physician Decision|0|||
105471200|NCT01615029|363735421|FG002|Overall Study|Physician Decision|0|||
105558851|NCT03519854|364041931|FG002|Overall Study|Technical Error|1|||
105471201|NCT01615029|363735422|FG003|Overall Study|Physician Decision|0|||
105471202|NCT01615029|363735423|FG004|Overall Study|Physician Decision|1|||
105471203|NCT01615029|363735419|FG000|Overall Study|Ongoing|1|||
105471204|NCT01615029|363735420|FG001|Overall Study|Ongoing|2|||
105471205|NCT01615029|363735421|FG002|Overall Study|Ongoing|3|||
105558852|NCT03519854|364041932|FG003|Overall Study|Technical Error|0|||
105558853|NCT03519854|364041933|FG004|Overall Study|Technical Error|0|||
105558854|NCT03519854|364041934|FG005|Overall Study|Technical Error|0|||
105786633|NCT00463385|364872867|FG003|Overall Study|Lost to Follow-up|1|||
105471206|NCT01615029|363735422|FG003|Overall Study|Ongoing|2|||
105558855|NCT03519854|364041935|FG006|Overall Study|Technical Error|0|||
105558856|NCT03519854|364041936|FG007|Overall Study|Technical Error|0|||
105558857|NCT03519854|364041937|FG008|Overall Study|Technical Error|0|||
105558858|NCT03519854|364041938|FG009|Overall Study|Technical Error|0|||
105558859|NCT03519854|364041939|FG010|Overall Study|Technical Error|0|||
105558860|NCT03519854|364041940|FG011|Overall Study|Technical Error|0|||
105558861|NCT03519854|364041941|FG012|Overall Study|Technical Error|0|||
105558862|NCT03519854|364041942|FG013|Overall Study|Technical Error|0|||
105558863|NCT03519854|364041943|FG014|Overall Study|Technical Error|0|||
105558864|NCT03519854|364041944|FG015|Overall Study|Technical Error|0|||
105558865|NCT03519854|364041945|FG016|Overall Study|Technical Error|0|||
105558866|NCT03519854|364041946|FG017|Overall Study|Technical Error|0|||
105558867|NCT00818753|364041950|FG000|Overall Study|Protocol Violation|1|||
105558868|NCT00818753|364041951|FG001|Overall Study|Protocol Violation|0|||
105558869|NCT00818753|364041952|FG002|Overall Study|Protocol Violation|0|||
105558870|NCT00818753|364041950|FG000|Overall Study|Other reason (not specified)|0|||
105558871|NCT00818753|364041951|FG001|Overall Study|Other reason (not specified)|0|||
105558872|NCT00818753|364041952|FG002|Overall Study|Other reason (not specified)|1|||
105558873|NCT00818753|364041950|FG000|Overall Study|Randomised and not treated|2|||
105558874|NCT00818753|364041951|FG001|Overall Study|Randomised and not treated|0|||
105558875|NCT00818753|364041952|FG002|Overall Study|Randomised and not treated|0|||
105558876|NCT00608582|364044531|FG000|Overall Study|Lost to Follow-up|2|||
105558877|NCT00608582|364044532|FG001|Overall Study|Lost to Follow-up|0|||
105558878|NCT00608582|364044531|FG000|Overall Study|No Best Response in Phase 1 located|1|||
105558879|NCT00608582|364044532|FG001|Overall Study|No Best Response in Phase 1 located|1|||
105558880|NCT00608582|364044531|FG000|Overall Study|Illicit Drug Use|1|||
105558881|NCT00608582|364044532|FG001|Overall Study|Illicit Drug Use|0|||
105558882|NCT00608582|364044531|FG000|Overall Study|Early stage Design Change|0|||
105558883|NCT00608582|364044532|FG001|Overall Study|Early stage Design Change|3|||
105558884|NCT02943408|364044533|FG000|Overall Study|Lost to Follow-up|7|||
105558885|NCT02943408|364044534|FG001|Overall Study|Lost to Follow-up|1|||
105558886|NCT02943408|364044533|FG000|Overall Study|Withdrawal by Subject|0|||
105558887|NCT02943408|364044534|FG001|Overall Study|Withdrawal by Subject|1|||
105558888|NCT02338154|364044535|FG000|Overall Study|Death|46|||
105558889|NCT02338154|364044535|FG000|Overall Study|Valve Implant Failure|17|||
105687644|NCT02370043|364519064|FG001|Overall Study|Withdrawal by Subject|0|||
105687645|NCT02370043|364519065|FG002|Overall Study|Withdrawal by Subject|0|||
105687646|NCT02370043|364519066|FG003|Overall Study|Withdrawal by Subject|0|||
105687647|NCT02370043|364519067|FG004|Overall Study|Withdrawal by Subject|1|||
105687648|NCT02370043|364519068|FG005|Overall Study|Withdrawal by Subject|1|||
105687649|NCT00810394|364519071|FG000|Overall Study|Withdrawal by Subject|3|||
105687650|NCT01079130|364519072|FG000|Overall Study|Adverse Event|1|||
105687651|NCT01079130|364519073|FG001|Overall Study|Adverse Event|1|||
105687652|NCT01079130|364519074|FG002|Overall Study|Adverse Event|0|||
105687653|NCT01079130|364519075|FG003|Overall Study|Adverse Event|1|||
105687654|NCT01079130|364519076|FG004|Overall Study|Adverse Event|5|||
105687655|NCT01079130|364519077|FG005|Overall Study|Adverse Event|1|||
105687656|NCT01079130|364519072|FG000|Overall Study|Administrative problems|1|||
105687657|NCT01079130|364519073|FG001|Overall Study|Administrative problems|3|||
105687658|NCT01079130|364519074|FG002|Overall Study|Administrative problems|0|||
105687659|NCT01079130|364519075|FG003|Overall Study|Administrative problems|0|||
105687660|NCT01079130|364519076|FG004|Overall Study|Administrative problems|0|||
105687661|NCT01079130|364519077|FG005|Overall Study|Administrative problems|1|||
105687662|NCT01079130|364519072|FG000|Overall Study|Withdrawal by Subject|0|||
105687663|NCT01079130|364519073|FG001|Overall Study|Withdrawal by Subject|1|||
105687664|NCT01079130|364519074|FG002|Overall Study|Withdrawal by Subject|0|||
105687665|NCT01079130|364519075|FG003|Overall Study|Withdrawal by Subject|0|||
105687666|NCT01079130|364519076|FG004|Overall Study|Withdrawal by Subject|1|||
105687667|NCT01079130|364519077|FG005|Overall Study|Withdrawal by Subject|3|||
105687668|NCT01079130|364519072|FG000|Overall Study|Protocol deviation|0|||
105786634|NCT00463385|364872864|FG000|Overall Study|Death|2|||
105558890|NCT02338154|364044535|FG000|Overall Study|Valve Explant|11|||
105687669|NCT01079130|364519073|FG001|Overall Study|Protocol deviation|2|||
105687670|NCT01079130|364519074|FG002|Overall Study|Protocol deviation|1|||
105687671|NCT01079130|364519075|FG003|Overall Study|Protocol deviation|2|||
105687672|NCT01079130|364519076|FG004|Overall Study|Protocol deviation|0|||
105687673|NCT01079130|364519077|FG005|Overall Study|Protocol deviation|0|||
105786635|NCT00463385|364872865|FG001|Overall Study|Death|1|||
105558891|NCT02338154|364044535|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
105558892|NCT02338154|364044535|FG000|Overall Study|Lost to Follow-up|8|||
105558893|NCT02338154|364044535|FG000|Overall Study|Other Reason|3|||
105558894|NCT02338154|364044535|FG000|Overall Study|Patients Without Exit Form|47|||
105558895|NCT02338154|364044535|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
105558896|NCT02120027|364044536|FG000|Overall Study|Adverse Event|4|||
105687674|NCT01079130|364519072|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105687675|NCT01079130|364519073|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105687676|NCT01079130|364519074|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105786636|NCT00463385|364872866|FG002|Overall Study|Death|2|||
105687677|NCT01079130|364519075|FG003|Overall Study|Abnormal test procedure result(s)|0|||
105687678|NCT01079130|364519076|FG004|Overall Study|Abnormal test procedure result(s)|1|||
105687679|NCT01079130|364519077|FG005|Overall Study|Abnormal test procedure result(s)|0|||
105687680|NCT01079130|364519072|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105687681|NCT01079130|364519073|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105687682|NCT01079130|364519074|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105471207|NCT01615029|363735423|FG004|Overall Study|Ongoing|23|||
105471208|NCT01326104|363735424|FG000|Overall Study|progressed prior to vaccine|0|||
105471209|NCT01326104|363735425|FG001|Overall Study|progressed prior to vaccine|2|||
105687683|NCT01079130|364519075|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
105687684|NCT01079130|364519076|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
105687685|NCT01079130|364519077|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
105687686|NCT01079130|364519072|FG000|Overall Study|Lost to Follow-up|0|||
105687687|NCT01079130|364519073|FG001|Overall Study|Lost to Follow-up|0|||
105687688|NCT01079130|364519074|FG002|Overall Study|Lost to Follow-up|0|||
105687689|NCT01079130|364519075|FG003|Overall Study|Lost to Follow-up|0|||
105687690|NCT01079130|364519076|FG004|Overall Study|Lost to Follow-up|1|||
105687691|NCT01079130|364519077|FG005|Overall Study|Lost to Follow-up|0|||
105687692|NCT02141984|364520500|FG000|Overall Study|Lack of Efficacy|2|||
105687693|NCT02245672|364520501|FG000|Overall Study|Adverse Event|4|||
105687694|NCT02245672|364520502|FG001|Overall Study|Adverse Event|4|||
105687695|NCT02245672|364520503|FG002|Overall Study|Adverse Event|4|||
105687696|NCT02245672|364520501|FG000|Overall Study|Lost to Follow-up|3|||
105687697|NCT02245672|364520502|FG001|Overall Study|Lost to Follow-up|5|||
105687698|NCT02245672|364520503|FG002|Overall Study|Lost to Follow-up|1|||
105687699|NCT02245672|364520501|FG000|Overall Study|Withdrawal by Subject|6|||
105687700|NCT02245672|364520502|FG001|Overall Study|Withdrawal by Subject|3|||
105687701|NCT02245672|364520503|FG002|Overall Study|Withdrawal by Subject|0|||
105471210|NCT01326104|363735424|FG000|Overall Study|unable to make vaccine|0|||
105471211|NCT01326104|363735425|FG001|Overall Study|unable to make vaccine|2|||
105471212|NCT04421027|363735426|FG000|Treatment Period|Adverse Event|5|||
105471213|NCT04421027|363735427|FG001|Treatment Period|Adverse Event|3|||
105471214|NCT04421027|363735428|FG002|Treatment Period|Adverse Event|0|||
105471215|NCT04421027|363735429|FG003|Treatment Period|Adverse Event|0|||
105471216|NCT04421027|363735426|FG000|Treatment Period|Death|98|||
105471217|NCT04421027|363735427|FG001|Treatment Period|Death|61|||
105471218|NCT04421027|363735428|FG002|Treatment Period|Death|0|||
105471219|NCT04421027|363735429|FG003|Treatment Period|Death|0|||
105471220|NCT04421027|363735426|FG000|Treatment Period|Lost to Follow-up|22|||
105471221|NCT04421027|363735427|FG001|Treatment Period|Lost to Follow-up|20|||
105471222|NCT04421027|363735428|FG002|Treatment Period|Lost to Follow-up|0|||
105471223|NCT04421027|363735429|FG003|Treatment Period|Lost to Follow-up|0|||
105471224|NCT04421027|363735426|FG000|Treatment Period|Other-Unknown|15|||
105471225|NCT04421027|363735427|FG001|Treatment Period|Other-Unknown|9|||
105471226|NCT04421027|363735428|FG002|Treatment Period|Other-Unknown|0|||
105471227|NCT04421027|363735429|FG003|Treatment Period|Other-Unknown|0|||
105471228|NCT04421027|363735426|FG000|Treatment Period|Physician Decision|1|||
105471229|NCT04421027|363735427|FG001|Treatment Period|Physician Decision|1|||
105471230|NCT04421027|363735428|FG002|Treatment Period|Physician Decision|0|||
105471231|NCT04421027|363735429|FG003|Treatment Period|Physician Decision|0|||
105471232|NCT04421027|363735426|FG000|Treatment Period|Withdrawal by Subject|7|||
105471233|NCT04421027|363735427|FG001|Treatment Period|Withdrawal by Subject|12|||
105471234|NCT04421027|363735428|FG002|Treatment Period|Withdrawal by Subject|0|||
105471235|NCT04421027|363735429|FG003|Treatment Period|Withdrawal by Subject|0|||
105471236|NCT04421027|363735426|FG000|Treatment Period|Randomized Not Dosed|9|||
105471237|NCT04421027|363735427|FG001|Treatment Period|Randomized Not Dosed|14|||
105687702|NCT02245672|364520501|FG000|Overall Study|Randomized in error (not treated)|0|||
105687703|NCT02245672|364520502|FG001|Overall Study|Randomized in error (not treated)|1|||
105687704|NCT02245672|364520503|FG002|Overall Study|Randomized in error (not treated)|0|||
105786637|NCT00463385|364872867|FG003|Overall Study|Death|0|||
105471238|NCT04421027|363735428|FG002|Treatment Period|Randomized Not Dosed|0|||
105471239|NCT04421027|363735429|FG003|Treatment Period|Randomized Not Dosed|0|||
105687705|NCT04981366|364520514|FG000|Overall Study|Withdrawal by Subject|5|||
105687706|NCT04981366|364520515|FG001|Overall Study|Withdrawal by Subject|4|||
105687707|NCT04981366|364520516|FG002|Overall Study|Withdrawal by Subject|8|||
105687708|NCT04981366|364520514|FG000|Overall Study|Health issues unrelated to the trial|1|||
105687709|NCT04981366|364520515|FG001|Overall Study|Health issues unrelated to the trial|2|||
105687710|NCT04981366|364520516|FG002|Overall Study|Health issues unrelated to the trial|0|||
105687711|NCT03214094|364520517|FG000|Overall Study|Case Report Forms Uncollected|14|||
105687712|NCT03214094|364520517|FG000|Overall Study|Protocol Deviation|46|||
105687713|NCT00795951|364520524|FG000|Overall Study|Lost to Follow-up|1|||
105687714|NCT00795951|364520524|FG000|Overall Study|Withdrawal by Subject|1|||
105687715|NCT01180998|364520525|FG000|Overall Study|Poor Vision|0|||
105687716|NCT01180998|364520526|FG001|Overall Study|Poor Vision|2|||
105687717|NCT01180998|364520527|FG002|Overall Study|Poor Vision|2|||
105687718|NCT01180998|364520525|FG000|Overall Study|Lost to Follow-up|0|||
105687719|NCT01180998|364520526|FG001|Overall Study|Lost to Follow-up|0|||
105687720|NCT01180998|364520527|FG002|Overall Study|Lost to Follow-up|1|||
105687721|NCT01180998|364520525|FG000|Overall Study|Protocol Violation|1|||
105687722|NCT01180998|364520526|FG001|Overall Study|Protocol Violation|2|||
105687723|NCT01180998|364520527|FG002|Overall Study|Protocol Violation|0|||
105687724|NCT01180998|364520525|FG000|Overall Study|Withdrawal by Subject|0|||
105687725|NCT01180998|364520526|FG001|Overall Study|Withdrawal by Subject|0|||
105687726|NCT01180998|364520527|FG002|Overall Study|Withdrawal by Subject|1|||
105687727|NCT01180998|364520525|FG000|Overall Study|Poor comfort|3|||
105687728|NCT01180998|364520526|FG001|Overall Study|Poor comfort|0|||
105687729|NCT01180998|364520527|FG002|Overall Study|Poor comfort|4|||
105687730|NCT01180998|364520525|FG000|Overall Study|Poor lens handling|0|||
105687731|NCT01180998|364520526|FG001|Overall Study|Poor lens handling|0|||
105558897|NCT02120027|364044537|FG001|Overall Study|Adverse Event|5|||
105687732|NCT01180998|364520527|FG002|Overall Study|Poor lens handling|2|||
105687733|NCT00162032|364520528|FG000|Overall Study|Lost to Follow-up|4|||
105687734|NCT00162032|364520529|FG001|Overall Study|Lost to Follow-up|2|||
105687735|NCT00162032|364520528|FG000|Overall Study|Reason not specified|1|||
105687736|NCT00162032|364520529|FG001|Overall Study|Reason not specified|0|||
105687737|NCT00655486|364520534|FG000|Overall Study|Adverse Event|10|||
105345297|NCT00710684|363265502|FG001|Overall Study|Lack of Efficacy|3|||
105345298|NCT00710684|363265503|FG002|Overall Study|Lack of Efficacy|5|||
105345299|NCT00710684|363265501|FG000|Overall Study|Protocol Violation|5|||
105345300|NCT00710684|363265502|FG001|Overall Study|Protocol Violation|5|||
105345301|NCT00710684|363265503|FG002|Overall Study|Protocol Violation|5|||
105345302|NCT00710684|363265501|FG000|Overall Study|Lost to Follow-up|4|||
105345303|NCT00710684|363265502|FG001|Overall Study|Lost to Follow-up|6|||
105345304|NCT00710684|363265503|FG002|Overall Study|Lost to Follow-up|7|||
105345305|NCT00710684|363265501|FG000|Overall Study|Physician Decision|0|||
105345306|NCT00710684|363265502|FG001|Overall Study|Physician Decision|2|||
105345307|NCT00710684|363265503|FG002|Overall Study|Physician Decision|4|||
105345308|NCT00710684|363265501|FG000|Overall Study|Withdrawal by Subject|24|||
105345309|NCT00710684|363265502|FG001|Overall Study|Withdrawal by Subject|18|||
105345310|NCT00710684|363265503|FG002|Overall Study|Withdrawal by Subject|11|||
105345311|NCT00710684|363265501|FG000|Overall Study|Missing|1|||
105345312|NCT00710684|363265502|FG001|Overall Study|Missing|0|||
105345313|NCT00710684|363265503|FG002|Overall Study|Missing|0|||
105345314|NCT00710684|363265501|FG000|Overall Study|Did not continue after week 24|25|||
105345315|NCT00710684|363265502|FG001|Overall Study|Did not continue after week 24|21|||
105345316|NCT00710684|363265503|FG002|Overall Study|Did not continue after week 24|16|||
105345317|NCT04778059|363265504|FG000|Overall Study|Death|2|||
105345318|NCT04778059|363265505|FG001|Overall Study|Death|2|||
105345319|NCT04778059|363265506|FG002|Overall Study|Death|1|||
105345320|NCT04778059|363265507|FG003|Overall Study|Death|1|||
105345321|NCT04778059|363265508|FG004|Overall Study|Death|1|||
105345322|NCT04778059|363265504|FG000|Overall Study|Lost to Follow-up|0|||
105345323|NCT04778059|363265505|FG001|Overall Study|Lost to Follow-up|0|||
105345324|NCT04778059|363265506|FG002|Overall Study|Lost to Follow-up|0|||
105345325|NCT04778059|363265507|FG003|Overall Study|Lost to Follow-up|0|||
105345326|NCT04778059|363265508|FG004|Overall Study|Lost to Follow-up|1|||
105345327|NCT04778059|363265504|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
105345328|NCT04778059|363265505|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
105345329|NCT04778059|363265506|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
105345330|NCT04778059|363265507|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
105345331|NCT04778059|363265508|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
105345332|NCT05153148|363265509|FG000|Overall Study|Adverse Event|1|||
105345333|NCT05153148|363265510|FG001|Overall Study|Adverse Event|0|||
105345334|NCT05153148|363265511|FG002|Overall Study|Adverse Event|3|||
105345335|NCT05153148|363265512|FG003|Overall Study|Adverse Event|5|||
105345336|NCT05153148|363265509|FG000|Overall Study|Lost to Follow-up|1|||
105345337|NCT05153148|363265510|FG001|Overall Study|Lost to Follow-up|1|||
105345338|NCT05153148|363265511|FG002|Overall Study|Lost to Follow-up|2|||
105345339|NCT05153148|363265512|FG003|Overall Study|Lost to Follow-up|0|||
105345340|NCT05153148|363265509|FG000|Overall Study|Withdrawal by Subject|6|||
105345341|NCT05153148|363265510|FG001|Overall Study|Withdrawal by Subject|8|||
105345342|NCT05153148|363265511|FG002|Overall Study|Withdrawal by Subject|6|||
105345343|NCT05153148|363265512|FG003|Overall Study|Withdrawal by Subject|8|||
105345344|NCT05153148|363265509|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
105345345|NCT05153148|363265510|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
105471240|NCT04421027|363735426|FG000|Follow-Up Period|Adverse Event|0|||
105471241|NCT04421027|363735427|FG001|Follow-Up Period|Adverse Event|0|||
105471242|NCT04421027|363735428|FG002|Follow-Up Period|Adverse Event|0|||
105471243|NCT04421027|363735429|FG003|Follow-Up Period|Adverse Event|3|||
105471244|NCT04421027|363735426|FG000|Follow-Up Period|Death|0|||
105471245|NCT04421027|363735427|FG001|Follow-Up Period|Death|0|||
105345346|NCT05153148|363265511|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
105345347|NCT05153148|363265512|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
105345348|NCT05153148|363265509|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
105345349|NCT05153148|363265510|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
105345350|NCT05153148|363265511|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
105471246|NCT04421027|363735428|FG002|Follow-Up Period|Death|16|||
105471247|NCT04421027|363735429|FG003|Follow-Up Period|Death|17|||
105558898|NCT02120027|364044536|FG000|Overall Study|Lack of Efficacy|3|||
105558899|NCT02120027|364044537|FG001|Overall Study|Lack of Efficacy|5|||
105345351|NCT05153148|363265512|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
105345352|NCT05153148|363265509|FG000|Overall Study|Reason not Specified|1|||
105345353|NCT05153148|363265510|FG001|Overall Study|Reason not Specified|1|||
105345354|NCT05153148|363265511|FG002|Overall Study|Reason not Specified|1|||
105345355|NCT05153148|363265512|FG003|Overall Study|Reason not Specified|1|||
105345356|NCT00232596|363265513|FG000|6-Week Titration Phase|Adverse Event|6|||
105345357|NCT00232596|363265514|FG001|6-Week Titration Phase|Adverse Event|19|||
105345358|NCT00232596|363265513|FG000|6-Week Titration Phase|Failed to Return|2|||
105345359|NCT00232596|363265514|FG001|6-Week Titration Phase|Failed to Return|1|||
105345360|NCT00232596|363265513|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
105345361|NCT00232596|363265514|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
105345362|NCT00232596|363265513|FG000|6-Week Titration Phase|Protocol Violation|1|||
105345363|NCT00232596|363265514|FG001|6-Week Titration Phase|Protocol Violation|3|||
105345364|NCT00232596|363265513|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
105345365|NCT00232596|363265514|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
105345366|NCT00232596|363265513|FG000|6-Week Titration Phase|Other|3|||
105345367|NCT00232596|363265514|FG001|6-Week Titration Phase|Other|3|||
105345368|NCT00232596|363265513|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
105345369|NCT00232596|363265514|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
105345370|NCT00232596|363265513|FG000|12-Week Maintenance Phase|Adverse Event|7|||
105345371|NCT00232596|363265514|FG001|12-Week Maintenance Phase|Adverse Event|22|||
105345372|NCT00232596|363265513|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
105345373|NCT00232596|363265514|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
105345374|NCT00232596|363265513|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
105345375|NCT00232596|363265514|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
105345376|NCT00232596|363265513|FG000|12-Week Maintenance Phase|Other|1|||
105345377|NCT00232596|363265514|FG001|12-Week Maintenance Phase|Other|3|||
105558900|NCT02120027|364044536|FG000|Overall Study|Lost to Follow-up|5|||
105558901|NCT02120027|364044537|FG001|Overall Study|Lost to Follow-up|13|||
105345378|NCT01732471|363265515|FG000|Overall Study|Withdrawal by Subject|1|||
105345379|NCT01253174|363265516|FG000|Period 1|Randomized but not treated|0|||
105345380|NCT01253174|363265517|FG001|Period 1|Randomized but not treated|1|||
105345381|NCT01253174|363265518|FG002|Period 1|Randomized but not treated|1|||
105345382|NCT01253174|363265519|FG003|Period 1|Randomized but not treated|0|||
105345383|NCT01253174|363265520|FG004|Period 1|Randomized but not treated|1|||
105345384|NCT01253174|363265521|FG005|Period 1|Randomized but not treated|0|||
105345385|NCT01253174|363265516|FG000|Period 2|Adverse Event|0|||
105345386|NCT01253174|363265517|FG001|Period 2|Adverse Event|0|||
105345387|NCT01253174|363265518|FG002|Period 2|Adverse Event|1|||
105558902|NCT02120027|364044536|FG000|Overall Study|Other|4|||
105558903|NCT02120027|364044537|FG001|Overall Study|Other|0|||
105687738|NCT00655486|364520534|FG000|Overall Study|Lack of Efficacy|8|||
105687739|NCT00655486|364520534|FG000|Overall Study|Withdrawal by Subject|4|||
105345388|NCT01253174|363265519|FG003|Period 2|Adverse Event|0|||
105345389|NCT01253174|363265520|FG004|Period 2|Adverse Event|0|||
105345390|NCT01253174|363265521|FG005|Period 2|Adverse Event|0|||
105345391|NCT01253174|363265516|FG000|Period 3|Withdrawal by Subject|0|||
105345392|NCT01253174|363265517|FG001|Period 3|Withdrawal by Subject|1|||
105345393|NCT01253174|363265518|FG002|Period 3|Withdrawal by Subject|0|||
105345394|NCT01253174|363265519|FG003|Period 3|Withdrawal by Subject|0|||
105345395|NCT01253174|363265520|FG004|Period 3|Withdrawal by Subject|1|||
105345396|NCT01253174|363265521|FG005|Period 3|Withdrawal by Subject|0|||
105345397|NCT01253174|363265516|FG000|Period 3|Pregnancy|0|||
105345398|NCT01253174|363265517|FG001|Period 3|Pregnancy|0|||
105345399|NCT01253174|363265518|FG002|Period 3|Pregnancy|1|||
105345400|NCT01253174|363265519|FG003|Period 3|Pregnancy|0|||
105345401|NCT01253174|363265520|FG004|Period 3|Pregnancy|0|||
105345402|NCT01253174|363265521|FG005|Period 3|Pregnancy|0|||
105345403|NCT02345889|363265522|FG000|Overall Study|Inadequate Bowel Prep|17|||
105345404|NCT02345889|363265523|FG001|Overall Study|Inadequate Bowel Prep|16|||
105345405|NCT02345889|363265524|FG002|Overall Study|Inadequate Bowel Prep|18|||
105345406|NCT02345889|363265525|FG003|Overall Study|Inadequate Bowel Prep|14|||
105345407|NCT02345889|363265522|FG000|Overall Study|Polyposis identified during procedure|1|||
105345408|NCT02345889|363265523|FG001|Overall Study|Polyposis identified during procedure|1|||
105345409|NCT02345889|363265524|FG002|Overall Study|Polyposis identified during procedure|0|||
105345410|NCT02345889|363265525|FG003|Overall Study|Polyposis identified during procedure|1|||
105345411|NCT02345889|363265522|FG000|Overall Study|Recognized ineligible post-randomization|1|||
105345412|NCT02345889|363265523|FG001|Overall Study|Recognized ineligible post-randomization|0|||
105345413|NCT02345889|363265524|FG002|Overall Study|Recognized ineligible post-randomization|2|||
105345414|NCT02345889|363265525|FG003|Overall Study|Recognized ineligible post-randomization|1|||
105345415|NCT02345889|363265522|FG000|Overall Study|Ulcerative Colitis identified|1|||
105687740|NCT00655486|364520534|FG000|Overall Study|Protocol Violation|1|||
105345416|NCT02345889|363265523|FG001|Overall Study|Ulcerative Colitis identified|0|||
105558904|NCT02120027|364044536|FG000|Overall Study|Physician Decision|4|||
105687741|NCT00655486|364520534|FG000|Overall Study|Unsatisfactory compliance|2|||
105345417|NCT02345889|363265524|FG002|Overall Study|Ulcerative Colitis identified|0|||
105558905|NCT02120027|364044537|FG001|Overall Study|Physician Decision|3|||
105345418|NCT02345889|363265525|FG003|Overall Study|Ulcerative Colitis identified|0|||
105345419|NCT02345889|363265522|FG000|Overall Study|Cecum not intubated|1|||
105345420|NCT02345889|363265523|FG001|Overall Study|Cecum not intubated|0|||
105345421|NCT02345889|363265524|FG002|Overall Study|Cecum not intubated|0|||
105345422|NCT02345889|363265525|FG003|Overall Study|Cecum not intubated|0|||
105345423|NCT03426436|363265526|FG000|Overall Study|Incorrect lead placement|12|||
105345424|NCT03426436|363265526|FG000|Overall Study|Withdrawal by Subject|2|||
105345425|NCT03426436|363265526|FG000|Overall Study|Consent issue|1|||
105345426|NCT03426436|363265526|FG000|Overall Study|ECGs not saved|4|||
105345427|NCT02892513|363265527|FG000|Overall Study|Withdrawal by Subject|0|||
105345428|NCT02892513|363265528|FG001|Overall Study|Withdrawal by Subject|1|||
105345429|NCT03467763|363265529|FG000|Overall Study|Lost to Follow-up|1|||
105345430|NCT03467763|363265529|FG000|Overall Study|Protocol Violation|2|||
105345431|NCT01306045|363265535|FG000|Met General Eligibility Criteria|Screen failures|193|||
105345432|NCT01306045|363265536|FG001|Met General Eligibility Criteria|Screen failures|11|||
105345433|NCT01306045|363265537|FG002|Met General Eligibility Criteria|Screen failures|8|||
105345434|NCT00432276|363265538|FG000|Overall Study|Hyperglycemic Rescue|44|||
105345435|NCT00432276|363265539|FG001|Overall Study|Hyperglycemic Rescue|87|||
105345436|NCT00432276|363265538|FG000|Overall Study|Adverse Event|13|||
105345437|NCT00432276|363265539|FG001|Overall Study|Adverse Event|16|||
105345438|NCT00432276|363265538|FG000|Overall Study|Protocol Violation|25|||
105345439|NCT00432276|363265539|FG001|Overall Study|Protocol Violation|20|||
105345440|NCT00432276|363265538|FG000|Overall Study|Lost to Follow-up|6|||
105345441|NCT00432276|363265539|FG001|Overall Study|Lost to Follow-up|2|||
105345442|NCT00432276|363265538|FG000|Overall Study|Withdrawal by Subject|25|||
105345443|NCT00432276|363265539|FG001|Overall Study|Withdrawal by Subject|20|||
105345444|NCT00432276|363265538|FG000|Overall Study|Physician Decision|6|||
105345445|NCT00432276|363265539|FG001|Overall Study|Physician Decision|8|||
105345446|NCT00432276|363265538|FG000|Overall Study|Other|2|||
105345447|NCT00432276|363265539|FG001|Overall Study|Other|3|||
105345448|NCT02889835|363265544|FG000|Overall Study|Lost to Follow-up|13|||
105345449|NCT02889835|363265545|FG001|Overall Study|Lost to Follow-up|13|||
105345450|NCT02889835|363265546|FG002|Overall Study|Lost to Follow-up|13|||
105345451|NCT02889835|363265544|FG000|Overall Study|Withdrawal by Subject|2|||
105558906|NCT02120027|364044536|FG000|Overall Study|Protocol Violation|18|||
105558907|NCT02120027|364044537|FG001|Overall Study|Protocol Violation|21|||
105687742|NCT00655486|364520534|FG000|Overall Study|Other: Pregnancy|1|||
105687743|NCT00655486|364520534|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
105345452|NCT02889835|363265545|FG001|Overall Study|Withdrawal by Subject|2|||
105345453|NCT02889835|363265546|FG002|Overall Study|Withdrawal by Subject|2|||
105345454|NCT02889835|363265544|FG000|Overall Study|Protocol Violation|1|||
105345455|NCT02889835|363265545|FG001|Overall Study|Protocol Violation|1|||
105345456|NCT02889835|363265546|FG002|Overall Study|Protocol Violation|1|||
105345457|NCT02889835|363265544|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
105345458|NCT02889835|363265545|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
105345459|NCT02889835|363265546|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
105345460|NCT02889835|363265544|FG000|Overall Study|Death|1|||
105345461|NCT02889835|363265545|FG001|Overall Study|Death|1|||
105345462|NCT02889835|363265546|FG002|Overall Study|Death|1|||
105345463|NCT02059434|363267147|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
105345464|NCT02059434|363267148|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
105345465|NCT02059434|363267149|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
105345466|NCT02059434|363267150|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
105345467|NCT02059434|363267151|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
105345468|NCT02059434|363267152|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
105345469|NCT02059434|363267153|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
105345470|NCT02059434|363267154|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
105345471|NCT02059434|363267155|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
105345472|NCT02059434|363267147|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
105345473|NCT02059434|363267148|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
105345474|NCT02059434|363267149|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
105345475|NCT02059434|363267150|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
105345476|NCT02059434|363267151|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
105345477|NCT02059434|363267152|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
105345478|NCT02059434|363267153|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
105345479|NCT02059434|363267154|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
105345480|NCT02059434|363267155|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
105345481|NCT02059434|363267147|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
105345482|NCT02059434|363267148|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
105345483|NCT02059434|363267149|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
105345484|NCT02059434|363267150|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
105345485|NCT02059434|363267151|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
105345486|NCT02059434|363267152|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
105345487|NCT02059434|363267153|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
105345488|NCT02059434|363267154|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
105345489|NCT02059434|363267155|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
105345490|NCT02059434|363267147|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
105345491|NCT02059434|363267148|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
105345492|NCT02059434|363267149|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
105345493|NCT02059434|363267150|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
105345494|NCT02059434|363267151|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
105345495|NCT02059434|363267152|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
105345496|NCT02059434|363267153|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
105345497|NCT02059434|363267154|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
105345498|NCT02059434|363267155|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
105345499|NCT02059434|363267147|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105345500|NCT02059434|363267148|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105345501|NCT02059434|363267149|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105345502|NCT02059434|363267150|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105345503|NCT02059434|363267151|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105345504|NCT02059434|363267152|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105345505|NCT02059434|363267153|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105471248|NCT04421027|363735426|FG000|Follow-Up Period|Lost to Follow-up|0|||
105471249|NCT04421027|363735427|FG001|Follow-Up Period|Lost to Follow-up|0|||
105471250|NCT04421027|363735428|FG002|Follow-Up Period|Lost to Follow-up|7|||
105471251|NCT04421027|363735429|FG003|Follow-Up Period|Lost to Follow-up|7|||
105471252|NCT04421027|363735426|FG000|Follow-Up Period|Protocol Deviation|0|||
105471253|NCT04421027|363735427|FG001|Follow-Up Period|Protocol Deviation|0|||
105687744|NCT00655486|364520534|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
105687745|NCT01138007|364520545|FG000|Overall Study|Adverse Event|4|||
105687746|NCT01138007|364520546|FG001|Overall Study|Adverse Event|12|||
105687747|NCT01138007|364520547|FG002|Overall Study|Adverse Event|9|||
105687748|NCT01138007|364520545|FG000|Overall Study|Lack of Efficacy|2|||
105687749|NCT01138007|364520546|FG001|Overall Study|Lack of Efficacy|0|||
105471254|NCT04421027|363735428|FG002|Follow-Up Period|Protocol Deviation|1|||
105471255|NCT04421027|363735429|FG003|Follow-Up Period|Protocol Deviation|0|||
105687750|NCT01138007|364520547|FG002|Overall Study|Lack of Efficacy|6|||
105687751|NCT01138007|364520545|FG000|Overall Study|Protocol Violation|2|||
105687752|NCT01138007|364520546|FG001|Overall Study|Protocol Violation|3|||
105345506|NCT02059434|363267154|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105345507|NCT02059434|363267155|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
105345508|NCT01004406|363267158|FG000|Overall Study|Withdrawal by Subject|2|||
105345509|NCT01004406|363267159|FG001|Overall Study|Withdrawal by Subject|0|||
105345510|NCT01004406|363267158|FG000|Overall Study|Lost to Follow-up|1|||
105345511|NCT01004406|363267159|FG001|Overall Study|Lost to Follow-up|0|||
105345512|NCT02928770|363267160|FG000|Overall Study|Withdrawal by Subject|2|||
105345513|NCT02907593|363267163|FG000|Overall Study|Withdrawal by Subject|0|||
105345514|NCT02907593|363267164|FG001|Overall Study|Withdrawal by Subject|0|||
105345515|NCT02907593|363267165|FG002|Overall Study|Withdrawal by Subject|1|||
105345516|NCT02907593|363267166|FG003|Overall Study|Withdrawal by Subject|0|||
105345517|NCT04392167|363267170|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
105345518|NCT02963558|363267171|FG000|Overall Study|Withdrawn by investigator|1|||
105345519|NCT02963558|363267172|FG001|Overall Study|Withdrawn by investigator|0|||
105345520|NCT02963558|363267171|FG000|Overall Study|Withdrawal by Subject|0|||
105345521|NCT02963558|363267172|FG001|Overall Study|Withdrawal by Subject|1|||
105345522|NCT03117881|363267173|FG000|Baseline|Withdrawal by Subject|21|||
105345523|NCT03117881|363267174|FG001|Baseline|Withdrawal by Subject|10|||
105345524|NCT03117881|363267175|FG002|Baseline|Withdrawal by Subject|0|||
105345525|NCT03117881|363267173|FG000|Baseline|Lost to Follow-up|22|||
105345526|NCT03117881|363267174|FG001|Baseline|Lost to Follow-up|25|||
105345527|NCT03117881|363267175|FG002|Baseline|Lost to Follow-up|0|||
105345528|NCT03117881|363267173|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
105345529|NCT03117881|363267174|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
105345530|NCT03117881|363267175|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
105345531|NCT03117881|363267173|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
105345532|NCT03117881|363267174|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
105345533|NCT03117881|363267175|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
105345534|NCT03117881|363267173|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
105345535|NCT03117881|363267174|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
105345536|NCT03117881|363267175|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
105345537|NCT03117881|363267173|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
105345538|NCT03117881|363267174|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
105345539|NCT03117881|363267175|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
105345540|NCT03117881|363267173|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
105345541|NCT03117881|363267174|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
105345542|NCT03117881|363267175|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
105345543|NCT03117881|363267173|FG000|6-Month Follow-Up|Did not complete test|53|||
105345544|NCT03117881|363267174|FG001|6-Month Follow-Up|Did not complete test|25|||
105345545|NCT03117881|363267175|FG002|6-Month Follow-Up|Did not complete test|7|||
105345546|NCT03117881|363267173|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
105345547|NCT03117881|363267174|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
105345548|NCT03117881|363267175|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
105345549|NCT03117881|363267173|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
105345550|NCT03117881|363267174|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
105345551|NCT03117881|363267175|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
105345552|NCT03117881|363267173|FG000|12-Month Follow-Up|Did not complete test|40|||
105345553|NCT03117881|363267174|FG001|12-Month Follow-Up|Did not complete test|0|||
105345554|NCT03117881|363267175|FG002|12-Month Follow-Up|Did not complete test|0|||
105345555|NCT00078949|363267176|FG000|Overall Study|No treated|4|||
105345556|NCT00078949|363267177|FG001|Overall Study|No treated|5|||
105345557|NCT00078949|363267178|FG002|Overall Study|No treated|3|||
105345558|NCT00078949|363267179|FG003|Overall Study|No treated|3|||
105345559|NCT02045732|363267180|FG000|Overall Study|At the discretion of the investigator|1|||
105345560|NCT02045732|363267181|FG001|Overall Study|At the discretion of the investigator|1|||
105345561|NCT00741091|363267184|FG000|Overall Study|Death|13|||
105345562|NCT00741091|363267184|FG000|Overall Study|Lost to Follow-up|16|||
105345563|NCT00741091|363267184|FG000|Overall Study|Withdrawal by Subject|6|||
105345564|NCT00741091|363267184|FG000|Overall Study|Missed Visit|22|||
105345565|NCT03435224|363267194|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
105687753|NCT01138007|364520547|FG002|Overall Study|Protocol Violation|2|||
105345566|NCT00081731|363267199|FG000|Overall Study|scientific integrity issue|8|||
105345567|NCT00081731|363267200|FG001|Overall Study|scientific integrity issue|8|||
105345568|NCT01404208|363267202|FG000|Overall Study|Discontinued|3|||
105345569|NCT01404208|363267203|FG001|Overall Study|Discontinued|0|||
105345570|NCT03448939|363267204|FG000|Overall Study|Adverse Event|5|||
105345571|NCT03448939|363267205|FG001|Overall Study|Adverse Event|1|||
105345572|NCT03448939|363267204|FG000|Overall Study|Lost to Follow-up|6|||
105345573|NCT03448939|363267205|FG001|Overall Study|Lost to Follow-up|6|||
105345574|NCT03448939|363267204|FG000|Overall Study|Pregnancy|1|||
105687754|NCT01138007|364520545|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
105345575|NCT03448939|363267205|FG001|Overall Study|Pregnancy|1|||
105345576|NCT03448939|363267204|FG000|Overall Study|Withdrawal by Subject|9|||
105345577|NCT03448939|363267205|FG001|Overall Study|Withdrawal by Subject|3|||
105345578|NCT01472965|363267206|FG000|Overall Study|Withdrawal by Subject|1|||
105345579|NCT01472965|363267207|FG001|Overall Study|Withdrawal by Subject|0|||
105345580|NCT02945254|363267208|FG000|Overall Study|Lost to Follow-up|1|||
105345581|NCT02945254|363267209|FG001|Overall Study|Lost to Follow-up|0|||
105345582|NCT02945254|363267208|FG000|Overall Study|Withdrawal by Subject|1|||
105345583|NCT02945254|363267209|FG001|Overall Study|Withdrawal by Subject|0|||
105345584|NCT02470403|363267210|FG000|Overall Study|Adverse Event|1|||
105345585|NCT02470403|363267211|FG001|Overall Study|Adverse Event|0|||
105345586|NCT02470403|363267212|FG002|Overall Study|Adverse Event|0|||
105345587|NCT02470403|363267213|FG003|Overall Study|Adverse Event|0|||
105345588|NCT02470403|363267214|FG004|Overall Study|Adverse Event|0|||
105345589|NCT02470403|363267210|FG000|Overall Study|Lost to Follow-up|0|||
105345590|NCT02470403|363267211|FG001|Overall Study|Lost to Follow-up|1|||
105345591|NCT02470403|363267212|FG002|Overall Study|Lost to Follow-up|0|||
105345592|NCT02470403|363267213|FG003|Overall Study|Lost to Follow-up|0|||
105345593|NCT02470403|363267214|FG004|Overall Study|Lost to Follow-up|0|||
105345594|NCT02470403|363267210|FG000|Overall Study|Subject/guardian decision|1|||
105345595|NCT02470403|363267211|FG001|Overall Study|Subject/guardian decision|0|||
105345596|NCT02470403|363267212|FG002|Overall Study|Subject/guardian decision|0|||
105345597|NCT02470403|363267213|FG003|Overall Study|Subject/guardian decision|4|||
105345598|NCT02470403|363267214|FG004|Overall Study|Subject/guardian decision|0|||
105345599|NCT00503997|363267216|FG000|Overall Study|disease progression|1|||
105345600|NCT00503997|363267216|FG000|Overall Study|Adverse Event|5|||
105345601|NCT00503997|363267216|FG000|Overall Study|Death|1|||
105345602|NCT00503997|363267216|FG000|Overall Study|Withdrawal by Subject|1|||
105345603|NCT01432275|363267217|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
105345604|NCT01432275|363267218|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
105345605|NCT01432275|363267217|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
105345606|NCT01432275|363267218|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
105345607|NCT01432275|363267217|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
105345608|NCT01432275|363267218|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
105345609|NCT01432275|363267217|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
105345610|NCT01432275|363267218|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
105345611|NCT01432275|363267217|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
105345612|NCT01432275|363267218|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
105345613|NCT01432275|363267217|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
105345614|NCT01432275|363267218|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
105345615|NCT01432275|363267217|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
105345616|NCT01432275|363267218|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
105345617|NCT01432275|363267217|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
105345618|NCT01432275|363267218|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
105345619|NCT01432275|363267217|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
105345620|NCT01432275|363267218|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
105345621|NCT02649426|363267219|FG000|Overall Study|Follow-up on going|1|||
105345622|NCT02649426|363267220|FG001|Overall Study|Follow-up on going|26|||
105345623|NCT02649426|363267221|FG002|Overall Study|Follow-up on going|28|||
105345624|NCT02649426|363267222|FG003|Overall Study|Follow-up on going|31|||
105345625|NCT01440569|363267223|FG000|Main Study|Enrolled but not treated|1|||
105345626|NCT01440569|363267224|FG001|Main Study|Enrolled but not treated|0|||
105345627|NCT01440569|363267223|FG000|Main Study|Adverse Event|9|||
105345628|NCT01440569|363267224|FG001|Main Study|Adverse Event|0|||
105345629|NCT01440569|363267223|FG000|Main Study|Pregnancy|1|||
105345630|NCT01440569|363267224|FG001|Main Study|Pregnancy|0|||
105345631|NCT01440569|363267223|FG000|Main Study|Investigator's Discretion|1|||
105345632|NCT01440569|363267224|FG001|Main Study|Investigator's Discretion|1|||
105345633|NCT01440569|363267223|FG000|Main Study|Withdrew Consent|7|||
105345634|NCT01440569|363267224|FG001|Main Study|Withdrew Consent|1|||
105345635|NCT01440569|363267223|FG000|Main Study|Lost to Follow-up|13|||
105345636|NCT01440569|363267224|FG001|Main Study|Lost to Follow-up|2|||
105345637|NCT01440569|363267223|FG000|Main Study|Subject Non-Compliance|3|||
105345638|NCT01440569|363267224|FG001|Main Study|Subject Non-Compliance|0|||
105345639|NCT01440569|363267223|FG000|Main Study|Protocol Violation|1|||
105345640|NCT01440569|363267224|FG001|Main Study|Protocol Violation|0|||
105345641|NCT01440569|363267223|FG000|Open-Label Rollover Phase|Adverse Event|3|||
105345642|NCT01440569|363267224|FG001|Open-Label Rollover Phase|Adverse Event|0|||
105345643|NCT01440569|363267223|FG000|Open-Label Rollover Phase|Pregnancy|1|||
105558908|NCT02120027|364044536|FG000|Overall Study|Study terminated by Sponsor|45|||
105558909|NCT02120027|364044537|FG001|Overall Study|Study terminated by Sponsor|47|||
105786638|NCT00463385|364872864|FG000|Overall Study|Missing|2|||
105345644|NCT01440569|363267224|FG001|Open-Label Rollover Phase|Pregnancy|0|||
105345645|NCT01440569|363267223|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
105345646|NCT01440569|363267224|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
105345647|NCT01440569|363267223|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
105345648|NCT01440569|363267224|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
105345649|NCT01440569|363267223|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
105345650|NCT01440569|363267224|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
105786639|NCT00463385|364872865|FG001|Overall Study|Missing|0|||
105345651|NCT01440569|363267223|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
105345652|NCT01440569|363267224|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
105345653|NCT01440569|363267223|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
105345654|NCT01440569|363267224|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
105345655|NCT00195494|363267235|FG000|Year 1|Adverse Event|0|||
105345656|NCT00195494|363267236|FG001|Year 1|Adverse Event|0|||
105345657|NCT00195494|363267237|FG002|Year 1|Adverse Event|0|||
105345658|NCT00195494|363267238|FG003|Year 1|Adverse Event|0|||
105345659|NCT00195494|363267239|FG004|Year 1|Adverse Event|34|||
105345660|NCT00195494|363267240|FG005|Year 1|Adverse Event|27|||
105345661|NCT00195494|363267235|FG000|Year 1|System Toxicity|0|||
105345662|NCT00195494|363267236|FG001|Year 1|System Toxicity|0|||
105345663|NCT00195494|363267237|FG002|Year 1|System Toxicity|0|||
105345664|NCT00195494|363267238|FG003|Year 1|System Toxicity|0|||
105345665|NCT00195494|363267239|FG004|Year 1|System Toxicity|0|||
105345666|NCT00195494|363267240|FG005|Year 1|System Toxicity|1|||
105345667|NCT00195494|363267235|FG000|Year 1|Lack of Efficacy|0|||
105345668|NCT00195494|363267236|FG001|Year 1|Lack of Efficacy|0|||
105345669|NCT00195494|363267237|FG002|Year 1|Lack of Efficacy|0|||
105345670|NCT00195494|363267238|FG003|Year 1|Lack of Efficacy|0|||
105345671|NCT00195494|363267239|FG004|Year 1|Lack of Efficacy|24|||
105345672|NCT00195494|363267240|FG005|Year 1|Lack of Efficacy|9|||
105345673|NCT00195494|363267235|FG000|Year 1|Compliance|0|||
105345674|NCT00195494|363267236|FG001|Year 1|Compliance|0|||
105345675|NCT00195494|363267237|FG002|Year 1|Compliance|0|||
105345676|NCT00195494|363267238|FG003|Year 1|Compliance|0|||
105345677|NCT00195494|363267239|FG004|Year 1|Compliance|5|||
105345678|NCT00195494|363267240|FG005|Year 1|Compliance|1|||
105345679|NCT00195494|363267235|FG000|Year 1|Lost to Follow-up|0|||
105345680|NCT00195494|363267236|FG001|Year 1|Lost to Follow-up|0|||
105345681|NCT00195494|363267237|FG002|Year 1|Lost to Follow-up|0|||
105345682|NCT00195494|363267238|FG003|Year 1|Lost to Follow-up|0|||
105345683|NCT00195494|363267239|FG004|Year 1|Lost to Follow-up|1|||
105345684|NCT00195494|363267240|FG005|Year 1|Lost to Follow-up|0|||
105345685|NCT00195494|363267235|FG000|Year 1|Missed >4 consecutive doses|0|||
105345686|NCT00195494|363267236|FG001|Year 1|Missed >4 consecutive doses|0|||
105345687|NCT00195494|363267237|FG002|Year 1|Missed >4 consecutive doses|0|||
105345688|NCT00195494|363267238|FG003|Year 1|Missed >4 consecutive doses|0|||
105345689|NCT00195494|363267239|FG004|Year 1|Missed >4 consecutive doses|3|||
105345690|NCT00195494|363267240|FG005|Year 1|Missed >4 consecutive doses|2|||
105345691|NCT00195494|363267235|FG000|Year 1|Protocol deviation|0|||
105345692|NCT00195494|363267236|FG001|Year 1|Protocol deviation|0|||
105345693|NCT00195494|363267237|FG002|Year 1|Protocol deviation|0|||
105345694|NCT00195494|363267238|FG003|Year 1|Protocol deviation|0|||
105345695|NCT00195494|363267239|FG004|Year 1|Protocol deviation|2|||
105345696|NCT00195494|363267240|FG005|Year 1|Protocol deviation|3|||
105345697|NCT00195494|363267235|FG000|Year 1|Physician Decision|0|||
105345698|NCT00195494|363267236|FG001|Year 1|Physician Decision|0|||
105345699|NCT00195494|363267237|FG002|Year 1|Physician Decision|0|||
105345700|NCT00195494|363267238|FG003|Year 1|Physician Decision|0|||
105345701|NCT00195494|363267239|FG004|Year 1|Physician Decision|1|||
105345702|NCT00195494|363267240|FG005|Year 1|Physician Decision|0|||
105345703|NCT00195494|363267235|FG000|Year 1|Withdrawal by Subject|0|||
105345704|NCT00195494|363267236|FG001|Year 1|Withdrawal by Subject|0|||
105345705|NCT00195494|363267237|FG002|Year 1|Withdrawal by Subject|0|||
105345706|NCT00195494|363267238|FG003|Year 1|Withdrawal by Subject|0|||
105345707|NCT00195494|363267239|FG004|Year 1|Withdrawal by Subject|8|||
105345708|NCT00195494|363267240|FG005|Year 1|Withdrawal by Subject|9|||
105345709|NCT00195494|363267235|FG000|Year 1|Protocol Violation|0|||
105345710|NCT00195494|363267236|FG001|Year 1|Protocol Violation|0|||
105345711|NCT00195494|363267237|FG002|Year 1|Protocol Violation|0|||
105687755|NCT01138007|364520546|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
105345712|NCT00195494|363267238|FG003|Year 1|Protocol Violation|0|||
105345713|NCT00195494|363267239|FG004|Year 1|Protocol Violation|1|||
105345714|NCT00195494|363267240|FG005|Year 1|Protocol Violation|1|||
105345715|NCT00195494|363267235|FG000|Year 2|Adverse Event|3|||
105345716|NCT00195494|363267236|FG001|Year 2|Adverse Event|7|||
105345717|NCT00195494|363267237|FG002|Year 2|Adverse Event|5|||
105345718|NCT00195494|363267238|FG003|Year 2|Adverse Event|9|||
105345719|NCT00195494|363267239|FG004|Year 2|Adverse Event|0|||
105687756|NCT01138007|364520547|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
105687757|NCT01138007|364520545|FG000|Overall Study|Lost to Follow-up|3|||
105345720|NCT00195494|363267240|FG005|Year 2|Adverse Event|0|||
105345721|NCT00195494|363267235|FG000|Year 2|Lack of Efficacy|0|||
105345722|NCT00195494|363267236|FG001|Year 2|Lack of Efficacy|1|||
105345723|NCT00195494|363267237|FG002|Year 2|Lack of Efficacy|7|||
105345724|NCT00195494|363267238|FG003|Year 2|Lack of Efficacy|7|||
105345725|NCT00195494|363267239|FG004|Year 2|Lack of Efficacy|0|||
105345726|NCT00195494|363267240|FG005|Year 2|Lack of Efficacy|0|||
105345727|NCT00195494|363267235|FG000|Year 2|Compliance|1|||
105345728|NCT00195494|363267236|FG001|Year 2|Compliance|0|||
105345729|NCT00195494|363267237|FG002|Year 2|Compliance|0|||
105345730|NCT00195494|363267238|FG003|Year 2|Compliance|2|||
105345731|NCT00195494|363267239|FG004|Year 2|Compliance|0|||
105345732|NCT00195494|363267240|FG005|Year 2|Compliance|0|||
105345733|NCT00195494|363267235|FG000|Year 2|Lost to Follow-up|0|||
105345734|NCT00195494|363267236|FG001|Year 2|Lost to Follow-up|0|||
105345735|NCT00195494|363267237|FG002|Year 2|Lost to Follow-up|1|||
105345736|NCT00195494|363267238|FG003|Year 2|Lost to Follow-up|1|||
105345737|NCT00195494|363267239|FG004|Year 2|Lost to Follow-up|0|||
105345738|NCT00195494|363267240|FG005|Year 2|Lost to Follow-up|0|||
105345739|NCT00195494|363267235|FG000|Year 2|Missed >4 consecutive doses|1|||
105345740|NCT00195494|363267236|FG001|Year 2|Missed >4 consecutive doses|1|||
105345741|NCT00195494|363267237|FG002|Year 2|Missed >4 consecutive doses|1|||
105345742|NCT00195494|363267238|FG003|Year 2|Missed >4 consecutive doses|0|||
105345743|NCT00195494|363267239|FG004|Year 2|Missed >4 consecutive doses|0|||
105345744|NCT00195494|363267240|FG005|Year 2|Missed >4 consecutive doses|0|||
105345745|NCT00195494|363267235|FG000|Year 2|Protocol deviation|0|||
105345746|NCT00195494|363267236|FG001|Year 2|Protocol deviation|1|||
105345747|NCT00195494|363267237|FG002|Year 2|Protocol deviation|0|||
105345748|NCT00195494|363267238|FG003|Year 2|Protocol deviation|0|||
105345749|NCT00195494|363267239|FG004|Year 2|Protocol deviation|0|||
105345750|NCT00195494|363267240|FG005|Year 2|Protocol deviation|0|||
105345751|NCT00195494|363267235|FG000|Year 2|Physician Decision|1|||
105345752|NCT00195494|363267236|FG001|Year 2|Physician Decision|1|||
105345753|NCT00195494|363267237|FG002|Year 2|Physician Decision|0|||
105345754|NCT00195494|363267238|FG003|Year 2|Physician Decision|0|||
105345755|NCT00195494|363267239|FG004|Year 2|Physician Decision|0|||
105345756|NCT00195494|363267240|FG005|Year 2|Physician Decision|0|||
105345757|NCT00195494|363267235|FG000|Year 2|Withdrawal by Subject|1|||
105345758|NCT00195494|363267236|FG001|Year 2|Withdrawal by Subject|5|||
105345759|NCT00195494|363267237|FG002|Year 2|Withdrawal by Subject|4|||
105345760|NCT00195494|363267238|FG003|Year 2|Withdrawal by Subject|3|||
105345761|NCT00195494|363267239|FG004|Year 2|Withdrawal by Subject|0|||
105345762|NCT00195494|363267240|FG005|Year 2|Withdrawal by Subject|0|||
105345763|NCT00195494|363267235|FG000|Year 2|System toxicity|0|||
105345764|NCT00195494|363267236|FG001|Year 2|System toxicity|0|||
105345765|NCT00195494|363267237|FG002|Year 2|System toxicity|0|||
105345766|NCT00195494|363267238|FG003|Year 2|System toxicity|1|||
105345767|NCT00195494|363267239|FG004|Year 2|System toxicity|0|||
105345768|NCT00195494|363267240|FG005|Year 2|System toxicity|0|||
105345769|NCT00835679|363267244|FG000|Overall Study|Withdrawal by Subject|1|||
105345770|NCT00835679|363267245|FG001|Overall Study|Withdrawal by Subject|0|||
105345771|NCT00835679|363267246|FG002|Overall Study|Withdrawal by Subject|0|||
105345772|NCT00835679|363267247|FG003|Overall Study|Withdrawal by Subject|0|||
105345773|NCT00501059|363267248|FG000|Overall Study|Protocol Violation|80|||
105345774|NCT00501059|363267249|FG001|Overall Study|Protocol Violation|69|||
105345775|NCT00501059|363267248|FG000|Overall Study|Death|140|||
105345776|NCT00501059|363267249|FG001|Overall Study|Death|137|||
105345777|NCT00501059|363267248|FG000|Overall Study|Other|236|||
105345778|NCT00501059|363267249|FG001|Overall Study|Other|239|||
105345779|NCT00501059|363267248|FG000|Overall Study|Missing end-of-study page|91|||
105345780|NCT00501059|363267249|FG001|Overall Study|Missing end-of-study page|92|||
105345781|NCT00501059|363267248|FG000|Overall Study|Clinical endpoint reached|110|||
105345782|NCT00501059|363267249|FG001|Overall Study|Clinical endpoint reached|123|||
105345783|NCT00501059|363267248|FG000|Overall Study|Insufficient therapeutic effect|4|||
105345784|NCT00501059|363267249|FG001|Overall Study|Insufficient therapeutic effect|5|||
105345785|NCT00501059|363267248|FG000|Overall Study|Consent withdrawn by subject|817|||
105345786|NCT00501059|363267249|FG001|Overall Study|Consent withdrawn by subject|873|||
105345787|NCT00501059|363267248|FG000|Overall Study|Non-compliant with study treatment|23|||
105345788|NCT00501059|363267249|FG001|Overall Study|Non-compliant with study treatment|16|||
105345789|NCT00501059|363267248|FG000|Overall Study|Reason not given|3|||
105345790|NCT00501059|363267249|FG001|Overall Study|Reason not given|1|||
105345791|NCT00501059|363267248|FG000|Overall Study|Adverse Event|129|||
105345792|NCT00501059|363267249|FG001|Overall Study|Adverse Event|122|||
105345793|NCT00501059|363267248|FG000|Overall Study|Lost to Follow-up|210|||
105345794|NCT00501059|363267249|FG001|Overall Study|Lost to Follow-up|198|||
105345795|NCT00501059|363267248|FG000|Overall Study|Not treated|25|||
105345796|NCT00501059|363267249|FG001|Overall Study|Not treated|17|||
105345797|NCT00955968|363267253|FG000|Overall Study|Death|2|||
105687758|NCT01138007|364520546|FG001|Overall Study|Lost to Follow-up|3|||
105687759|NCT01138007|364520547|FG002|Overall Study|Lost to Follow-up|5|||
105345798|NCT00955968|363267254|FG001|Overall Study|Death|4|||
105345799|NCT00955968|363267253|FG000|Overall Study|Withdrawal by Subject|35|||
105345800|NCT00955968|363267254|FG001|Overall Study|Withdrawal by Subject|31|||
105345801|NCT00955968|363267253|FG000|Overall Study|Lost to Follow-up|45|||
105345802|NCT00955968|363267254|FG001|Overall Study|Lost to Follow-up|39|||
105345803|NCT00955968|363267253|FG000|Overall Study|Site closed|55|||
105345804|NCT00955968|363267254|FG001|Overall Study|Site closed|52|||
105345805|NCT03802565|363267256|FG000|Overall Study|Adverse Event|0|||
105345806|NCT03802565|363267257|FG001|Overall Study|Adverse Event|1|||
105345807|NCT03802565|363267258|FG002|Overall Study|Adverse Event|2|||
105345808|NCT03802565|363267259|FG003|Overall Study|Adverse Event|1|||
105345809|NCT03802565|363267260|FG004|Overall Study|Adverse Event|1|||
105345810|NCT03802565|363267256|FG000|Overall Study|Withdrawal by Subject|2|||
105345811|NCT03802565|363267257|FG001|Overall Study|Withdrawal by Subject|2|||
105345812|NCT03802565|363267258|FG002|Overall Study|Withdrawal by Subject|2|||
105345813|NCT03802565|363267259|FG003|Overall Study|Withdrawal by Subject|0|||
105345814|NCT03802565|363267260|FG004|Overall Study|Withdrawal by Subject|1|||
105345815|NCT03802565|363267256|FG000|Overall Study|Protocol Violation|2|||
105345816|NCT03802565|363267257|FG001|Overall Study|Protocol Violation|1|||
105345817|NCT03802565|363267258|FG002|Overall Study|Protocol Violation|4|||
105345818|NCT03802565|363267259|FG003|Overall Study|Protocol Violation|5|||
105345819|NCT03802565|363267260|FG004|Overall Study|Protocol Violation|1|||
105345820|NCT03802565|363267256|FG000|Overall Study|Lost to Follow-up|0|||
105345821|NCT03802565|363267257|FG001|Overall Study|Lost to Follow-up|0|||
105345822|NCT03802565|363267258|FG002|Overall Study|Lost to Follow-up|1|||
105345823|NCT03802565|363267259|FG003|Overall Study|Lost to Follow-up|0|||
105345824|NCT03802565|363267260|FG004|Overall Study|Lost to Follow-up|0|||
105345825|NCT03802565|363267256|FG000|Overall Study|Subjects Related to Each Other|1|||
105345826|NCT03802565|363267257|FG001|Overall Study|Subjects Related to Each Other|0|||
105345827|NCT03802565|363267258|FG002|Overall Study|Subjects Related to Each Other|0|||
105345828|NCT03802565|363267259|FG003|Overall Study|Subjects Related to Each Other|2|||
105345829|NCT03802565|363267260|FG004|Overall Study|Subjects Related to Each Other|1|||
105345830|NCT03802565|363267256|FG000|Overall Study|Elevated Enzymes|0|||
105345831|NCT03802565|363267257|FG001|Overall Study|Elevated Enzymes|0|||
105345832|NCT03802565|363267258|FG002|Overall Study|Elevated Enzymes|0|||
105345833|NCT03802565|363267259|FG003|Overall Study|Elevated Enzymes|0|||
105345834|NCT03802565|363267260|FG004|Overall Study|Elevated Enzymes|2|||
105345835|NCT05020899|363267261|FG000|8 Week Follow-up|Lost to Follow-up|3|||
105345836|NCT05020899|363267262|FG001|8 Week Follow-up|Lost to Follow-up|6|||
105345837|NCT05020899|363267261|FG000|12 Week Follow-up|Lost to Follow-up|1|||
105345838|NCT05020899|363267262|FG001|12 Week Follow-up|Lost to Follow-up|0|||
105345839|NCT05020899|363267261|FG000|12 Week Follow-up|Death|0|||
105345840|NCT05020899|363267262|FG001|12 Week Follow-up|Death|1|||
105345841|NCT01785849|363267267|FG000|Overall Study|Death|7|||
105345842|NCT01785849|363267268|FG001|Overall Study|Death|9|||
105345843|NCT01785849|363267267|FG000|Overall Study|Protocol Specified Criteria|29|||
105345844|NCT01785849|363267268|FG001|Overall Study|Protocol Specified Criteria|1|||
105345845|NCT01785849|363267267|FG000|Overall Study|Withdrawal by Subject|15|||
105345846|NCT01785849|363267268|FG001|Overall Study|Withdrawal by Subject|12|||
105345847|NCT01785849|363267267|FG000|Overall Study|Sponsor Decision|0|||
105345848|NCT01785849|363267268|FG001|Overall Study|Sponsor Decision|1|||
105345849|NCT01785849|363267267|FG000|Overall Study|Lost to Follow-up|10|||
105345850|NCT01785849|363267268|FG001|Overall Study|Lost to Follow-up|11|||
105345851|NCT00204477|363267269|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
105345852|NCT00204477|363267270|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
105345853|NCT00204477|363267269|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
105345854|NCT00204477|363267270|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
105345855|NCT01294371|363267271|FG000|Overall Study|Adverse Event|1|||
105345856|NCT01294371|363267271|FG000|Overall Study|Withdrawal by Subject|12|||
105345857|NCT01294371|363267271|FG000|Overall Study|Lost to Follow-up|6|||
105345858|NCT01294371|363267271|FG000|Overall Study|Administrative Reason|1|||
105345859|NCT01294371|363267271|FG000|Overall Study|Other|14|||
105345860|NCT02079636|363267272|FG000|Overall Study|Death|2|||
105345861|NCT02079636|363267273|FG001|Overall Study|Death|1|||
105345862|NCT02079636|363267274|FG002|Overall Study|Death|0|||
105345863|NCT02079636|363267275|FG003|Overall Study|Death|5|||
105345864|NCT02079636|363267276|FG004|Overall Study|Death|1|||
105345865|NCT02079636|363267277|FG005|Overall Study|Death|2|||
105345866|NCT02079636|363267278|FG006|Overall Study|Death|1|||
105345867|NCT02079636|363267279|FG007|Overall Study|Death|0|||
105345868|NCT02079636|363267280|FG008|Overall Study|Death|0|||
105345869|NCT02079636|363267281|FG009|Overall Study|Death|0|||
105345870|NCT02079636|363267282|FG010|Overall Study|Death|0|||
105345871|NCT02079636|363267283|FG011|Overall Study|Death|1|||
105345872|NCT02079636|363267284|FG012|Overall Study|Death|1|||
105345873|NCT02079636|363267285|FG013|Overall Study|Death|0|||
105345874|NCT02079636|363267286|FG014|Overall Study|Death|2|||
105345875|NCT02079636|363267272|FG000|Overall Study|Adverse Event|1|||
105345876|NCT02079636|363267273|FG001|Overall Study|Adverse Event|1|||
105345877|NCT02079636|363267274|FG002|Overall Study|Adverse Event|0|||
105558910|NCT02120027|364044536|FG000|Overall Study|Withdrawal by Subject|33|||
105345878|NCT02079636|363267275|FG003|Overall Study|Adverse Event|1|||
105345879|NCT02079636|363267276|FG004|Overall Study|Adverse Event|1|||
105345880|NCT02079636|363267277|FG005|Overall Study|Adverse Event|2|||
105345881|NCT02079636|363267278|FG006|Overall Study|Adverse Event|0|||
105345882|NCT02079636|363267279|FG007|Overall Study|Adverse Event|0|||
105345883|NCT02079636|363267280|FG008|Overall Study|Adverse Event|0|||
105345884|NCT02079636|363267281|FG009|Overall Study|Adverse Event|0|||
105345885|NCT02079636|363267282|FG010|Overall Study|Adverse Event|0|||
105345886|NCT02079636|363267283|FG011|Overall Study|Adverse Event|0|||
105345887|NCT02079636|363267284|FG012|Overall Study|Adverse Event|0|||
105345888|NCT02079636|363267285|FG013|Overall Study|Adverse Event|0|||
105345889|NCT02079636|363267286|FG014|Overall Study|Adverse Event|0|||
105345890|NCT02079636|363267272|FG000|Overall Study|Progressive disease|0|||
105345891|NCT02079636|363267273|FG001|Overall Study|Progressive disease|0|||
105687760|NCT01138007|364520545|FG000|Overall Study|Physician Decision|0|||
105687761|NCT01138007|364520546|FG001|Overall Study|Physician Decision|5|||
105345892|NCT02079636|363267274|FG002|Overall Study|Progressive disease|0|||
105786640|NCT00463385|364872866|FG002|Overall Study|Missing|0|||
105786641|NCT00463385|364872867|FG003|Overall Study|Missing|2|||
105786642|NCT00463385|364872864|FG000|Overall Study|1 participant received commercial drug|0|||
105786643|NCT00463385|364872865|FG001|Overall Study|1 participant received commercial drug|1|||
105786644|NCT00463385|364872866|FG002|Overall Study|1 participant received commercial drug|0|||
105786645|NCT00463385|364872867|FG003|Overall Study|1 participant received commercial drug|0|||
105786646|NCT00449761|364872868|FG000|Overall Study|Disease progression|12|||
105786647|NCT00449761|364872868|FG000|Overall Study|Death|5|||
105786648|NCT00449761|364872868|FG000|Overall Study|New cancer therapy|1|||
105786649|NCT01422876|364872869|FG000|Week 24|Lost to Follow-up|1|||
105786650|NCT01422876|364872870|FG001|Week 24|Lost to Follow-up|1|||
105786651|NCT01422876|364872871|FG002|Week 24|Lost to Follow-up|2|||
105786652|NCT01422876|364872872|FG003|Week 24|Lost to Follow-up|4|||
105786653|NCT01422876|364872873|FG004|Week 24|Lost to Follow-up|2|||
105786654|NCT01422876|364872874|FG005|Week 24|Lost to Follow-up|0|||
105786655|NCT01422876|364872875|FG006|Week 24|Lost to Follow-up|1|||
105786656|NCT01422876|364872876|FG007|Week 24|Lost to Follow-up|3|||
105786657|NCT01422876|364872877|FG008|Week 24|Lost to Follow-up|3|||
105786658|NCT01422876|364872878|FG009|Week 24|Lost to Follow-up|4|||
105786659|NCT01422876|364872869|FG000|Week 24|Consent withdrawn|5|||
105786660|NCT01422876|364872870|FG001|Week 24|Consent withdrawn|1|||
105786661|NCT01422876|364872871|FG002|Week 24|Consent withdrawn|3|||
105786662|NCT01422876|364872872|FG003|Week 24|Consent withdrawn|4|||
105786663|NCT01422876|364872873|FG004|Week 24|Consent withdrawn|5|||
105786664|NCT01422876|364872874|FG005|Week 24|Consent withdrawn|6|||
105786665|NCT01422876|364872875|FG006|Week 24|Consent withdrawn|5|||
105786666|NCT01422876|364872876|FG007|Week 24|Consent withdrawn|4|||
105786667|NCT01422876|364872877|FG008|Week 24|Consent withdrawn|3|||
105786668|NCT01422876|364872878|FG009|Week 24|Consent withdrawn|6|||
105786669|NCT01422876|364872869|FG000|Week 24|Death|0|||
105786670|NCT01422876|364872870|FG001|Week 24|Death|1|||
105786671|NCT01422876|364872871|FG002|Week 24|Death|0|||
105786672|NCT01422876|364872872|FG003|Week 24|Death|0|||
105786673|NCT01422876|364872873|FG004|Week 24|Death|0|||
105786674|NCT01422876|364872874|FG005|Week 24|Death|0|||
105786675|NCT01422876|364872875|FG006|Week 24|Death|0|||
105786676|NCT01422876|364872876|FG007|Week 24|Death|0|||
105786677|NCT01422876|364872877|FG008|Week 24|Death|0|||
105786678|NCT01422876|364872878|FG009|Week 24|Death|0|||
105786679|NCT01422876|364872869|FG000|Week 52|Lost to Follow-up|3|||
105786680|NCT01422876|364872870|FG001|Week 52|Lost to Follow-up|5|||
105786681|NCT01422876|364872871|FG002|Week 52|Lost to Follow-up|7|||
105786682|NCT01422876|364872872|FG003|Week 52|Lost to Follow-up|5|||
105786683|NCT01422876|364872873|FG004|Week 52|Lost to Follow-up|8|||
105786684|NCT01422876|364872874|FG005|Week 52|Lost to Follow-up|5|||
105786685|NCT01422876|364872875|FG006|Week 52|Lost to Follow-up|5|||
105786686|NCT01422876|364872876|FG007|Week 52|Lost to Follow-up|8|||
105786687|NCT01422876|364872877|FG008|Week 52|Lost to Follow-up|7|||
105786688|NCT01422876|364872878|FG009|Week 52|Lost to Follow-up|8|||
105786689|NCT01422876|364872869|FG000|Week 52|Consent withdrawn|9|||
105786690|NCT01422876|364872870|FG001|Week 52|Consent withdrawn|4|||
105786691|NCT01422876|364872871|FG002|Week 52|Consent withdrawn|6|||
105786692|NCT01422876|364872872|FG003|Week 52|Consent withdrawn|12|||
105786693|NCT01422876|364872873|FG004|Week 52|Consent withdrawn|7|||
105786694|NCT01422876|364872874|FG005|Week 52|Consent withdrawn|12|||
105786695|NCT01422876|364872875|FG006|Week 52|Consent withdrawn|10|||
105786696|NCT01422876|364872876|FG007|Week 52|Consent withdrawn|12|||
105786697|NCT01422876|364872877|FG008|Week 52|Consent withdrawn|13|||
105786698|NCT01422876|364872878|FG009|Week 52|Consent withdrawn|9|||
105786699|NCT01422876|364872869|FG000|Week 52|Death|0|||
105786700|NCT01422876|364872870|FG001|Week 52|Death|1|||
105786701|NCT01422876|364872871|FG002|Week 52|Death|0|||
105786702|NCT01422876|364872872|FG003|Week 52|Death|1|||
105786703|NCT01422876|364872873|FG004|Week 52|Death|0|||
105687762|NCT01138007|364520547|FG002|Overall Study|Physician Decision|3|||
105687763|NCT01138007|364520545|FG000|Overall Study|Withdrawal by Subject|5|||
105687764|NCT01138007|364520546|FG001|Overall Study|Withdrawal by Subject|6|||
105687765|NCT01138007|364520547|FG002|Overall Study|Withdrawal by Subject|15|||
105687766|NCT00744523|364520548|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
105687767|NCT00744523|364520549|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
105687768|NCT01139021|364520552|FG000|Overall Study|Adverse Event|0|||
105687769|NCT01139021|364520553|FG001|Overall Study|Adverse Event|0|||
105687770|NCT01139021|364520554|FG002|Overall Study|Adverse Event|0|||
105687771|NCT01139021|364520555|FG003|Overall Study|Adverse Event|0|||
105687772|NCT01139021|364520556|FG004|Overall Study|Adverse Event|1|||
105786704|NCT01422876|364872874|FG005|Week 52|Death|0|||
105786705|NCT01422876|364872875|FG006|Week 52|Death|1|||
105786706|NCT01422876|364872876|FG007|Week 52|Death|3|||
105786707|NCT01422876|364872877|FG008|Week 52|Death|1|||
105786708|NCT01422876|364872878|FG009|Week 52|Death|0|||
105345893|NCT02079636|363267275|FG003|Overall Study|Progressive disease|2|||
105471256|NCT04421027|363735426|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
105687773|NCT01139021|364520557|FG005|Overall Study|Adverse Event|0|||
105687774|NCT01139021|364520552|FG000|Overall Study|Lost to Follow-up|0|||
105687775|NCT01139021|364520553|FG001|Overall Study|Lost to Follow-up|0|||
105687776|NCT01139021|364520554|FG002|Overall Study|Lost to Follow-up|0|||
105786709|NCT00761761|364872879|FG000|Overall Study|Lost to Follow-up|3|||
105786710|NCT00761761|364872880|FG001|Overall Study|Lost to Follow-up|1|||
105345894|NCT02079636|363267276|FG004|Overall Study|Progressive disease|0|||
105345895|NCT02079636|363267277|FG005|Overall Study|Progressive disease|0|||
105345896|NCT02079636|363267278|FG006|Overall Study|Progressive disease|0|||
105345897|NCT02079636|363267279|FG007|Overall Study|Progressive disease|0|||
105345898|NCT02079636|363267280|FG008|Overall Study|Progressive disease|0|||
105345899|NCT02079636|363267281|FG009|Overall Study|Progressive disease|0|||
105345900|NCT02079636|363267282|FG010|Overall Study|Progressive disease|0|||
105345901|NCT02079636|363267283|FG011|Overall Study|Progressive disease|0|||
105345902|NCT02079636|363267284|FG012|Overall Study|Progressive disease|1|||
105345903|NCT02079636|363267285|FG013|Overall Study|Progressive disease|0|||
105345904|NCT02079636|363267286|FG014|Overall Study|Progressive disease|0|||
105345905|NCT02079636|363267272|FG000|Overall Study|Withdrawal by Subject|0|||
105345906|NCT02079636|363267273|FG001|Overall Study|Withdrawal by Subject|0|||
105345907|NCT02079636|363267274|FG002|Overall Study|Withdrawal by Subject|0|||
105345908|NCT02079636|363267275|FG003|Overall Study|Withdrawal by Subject|4|||
105345909|NCT02079636|363267276|FG004|Overall Study|Withdrawal by Subject|0|||
105345910|NCT02079636|363267277|FG005|Overall Study|Withdrawal by Subject|1|||
105345911|NCT02079636|363267278|FG006|Overall Study|Withdrawal by Subject|0|||
105345912|NCT02079636|363267279|FG007|Overall Study|Withdrawal by Subject|0|||
105345913|NCT02079636|363267280|FG008|Overall Study|Withdrawal by Subject|0|||
105345914|NCT02079636|363267281|FG009|Overall Study|Withdrawal by Subject|2|||
105345915|NCT02079636|363267282|FG010|Overall Study|Withdrawal by Subject|1|||
105345916|NCT02079636|363267283|FG011|Overall Study|Withdrawal by Subject|1|||
105345917|NCT02079636|363267284|FG012|Overall Study|Withdrawal by Subject|1|||
105345918|NCT02079636|363267285|FG013|Overall Study|Withdrawal by Subject|0|||
105345919|NCT02079636|363267286|FG014|Overall Study|Withdrawal by Subject|2|||
105345920|NCT02079636|363267272|FG000|Overall Study|Physician Decision|0|||
105471257|NCT04421027|363735427|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
105471258|NCT04421027|363735428|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
105471259|NCT04421027|363735429|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
105345921|NCT02079636|363267273|FG001|Overall Study|Physician Decision|0|||
105345922|NCT02079636|363267274|FG002|Overall Study|Physician Decision|0|||
105345923|NCT02079636|363267275|FG003|Overall Study|Physician Decision|0|||
105345924|NCT02079636|363267276|FG004|Overall Study|Physician Decision|0|||
105345925|NCT02079636|363267277|FG005|Overall Study|Physician Decision|1|||
105471260|NCT04421027|363735426|FG000|Follow-Up Period|Left message, participant did not call back|0|||
105687777|NCT01139021|364520555|FG003|Overall Study|Lost to Follow-up|0|||
105687778|NCT01139021|364520556|FG004|Overall Study|Lost to Follow-up|2|||
105687779|NCT01139021|364520557|FG005|Overall Study|Lost to Follow-up|0|||
105786711|NCT00761761|364872879|FG000|Overall Study|Withdrawal by Subject|3|||
105786712|NCT00761761|364872880|FG001|Overall Study|Withdrawal by Subject|0|||
105786713|NCT00447265|364872884|FG000|Overall Study|Physician Decision|1|||
105687780|NCT01139021|364520552|FG000|Overall Study|Protocol Violation|1|||
105687781|NCT01139021|364520553|FG001|Overall Study|Protocol Violation|0|||
105786714|NCT00447265|364872885|FG001|Overall Study|Physician Decision|0|||
105786715|NCT05064436|364872886|FG000|Overall Study|Other Reasons|1|||
105687782|NCT01139021|364520554|FG002|Overall Study|Protocol Violation|0|||
105786716|NCT05064436|364872887|FG001|Overall Study|Other Reasons|0|||
105345926|NCT02079636|363267278|FG006|Overall Study|Physician Decision|0|||
105345927|NCT02079636|363267279|FG007|Overall Study|Physician Decision|0|||
105345928|NCT02079636|363267280|FG008|Overall Study|Physician Decision|0|||
105345929|NCT02079636|363267281|FG009|Overall Study|Physician Decision|1|||
105345930|NCT02079636|363267282|FG010|Overall Study|Physician Decision|1|||
105345931|NCT02079636|363267283|FG011|Overall Study|Physician Decision|0|||
105471261|NCT04421027|363735427|FG001|Follow-Up Period|Left message, participant did not call back|0|||
105558911|NCT02120027|364044537|FG001|Overall Study|Withdrawal by Subject|25|||
105558912|NCT01559844|364044544|FG000|Overall Study|Consent Withdrawn|7|||
105558913|NCT01559844|364044544|FG000|Overall Study|Death|5|||
105558914|NCT01559844|364044544|FG000|Overall Study|Efficacy Failure|10|||
105558915|NCT01559844|364044544|FG000|Overall Study|No Longer A Transplant Candidate|3|||
105558916|NCT01514448|364044545|FG000|Overall Study|Death|7|||
105558917|NCT01514448|364044546|FG001|Overall Study|Death|8|||
105558918|NCT01514448|364044545|FG000|Overall Study|Withdrawal by Subject|2|||
105558919|NCT01514448|364044546|FG001|Overall Study|Withdrawal by Subject|0|||
105558920|NCT01514448|364044545|FG000|Overall Study|Lost to Follow-up|2|||
105558921|NCT01514448|364044546|FG001|Overall Study|Lost to Follow-up|0|||
105558922|NCT01514448|364044545|FG000|Overall Study|New Cancer Therapy|1|||
105558923|NCT01514448|364044546|FG001|Overall Study|New Cancer Therapy|0|||
105558924|NCT02131272|364044547|FG000|Overall Study|Withdrawal by parent|0|||
105558925|NCT02131272|364044548|FG001|Overall Study|Withdrawal by parent|1|||
105558926|NCT02131272|364044547|FG000|Overall Study|Withdrawal by Subject|0|||
105558927|NCT02131272|364044548|FG001|Overall Study|Withdrawal by Subject|1|||
105558928|NCT02131272|364044547|FG000|Overall Study|Withdrawal Criteria|1|||
105558929|NCT02131272|364044548|FG001|Overall Study|Withdrawal Criteria|0|||
105558930|NCT01925950|364044549|FG000|Part 2|Withdrawal by Subject|1|||
105558931|NCT01925950|364044550|FG001|Part 2|Withdrawal by Subject|0|||
105558932|NCT00381940|364044553|FG000|Overall Study|Lack of Efficacy|3|||
105558933|NCT00381940|364044553|FG000|Overall Study|Protocol Violation|1|||
105558934|NCT00381940|364044553|FG000|Overall Study|Ineligible|1|||
105558935|NCT03137303|364044555|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
105558936|NCT03137303|364044556|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
105558937|NCT03137303|364044555|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
105558938|NCT03137303|364044556|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
105558939|NCT03137303|364044555|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
105558940|NCT03137303|364044556|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
105558941|NCT03137303|364044555|FG000|T3: 9-month Follow-up|Death|1|||
105558942|NCT03137303|364044556|FG001|T3: 9-month Follow-up|Death|0|||
105558943|NCT03137303|364044555|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
105558944|NCT03137303|364044556|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
105558945|NCT03137303|364044555|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
105558946|NCT03137303|364044556|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
105558947|NCT03137303|364044555|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
105558948|NCT03137303|364044556|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
105558949|NCT03318523|364044557|FG000|PC Period: Up to Year 1|Adverse Event|1|||
105558950|NCT03318523|364044558|FG001|PC Period: Up to Year 1|Adverse Event|0|||
105471262|NCT04421027|363735428|FG002|Follow-Up Period|Left message, participant did not call back|0|||
105471263|NCT04421027|363735429|FG003|Follow-Up Period|Left message, participant did not call back|1|||
105471264|NCT04421027|363735426|FG000|Follow-Up Period|Participant died|0|||
105471265|NCT04421027|363735427|FG001|Follow-Up Period|Participant died|0|||
105471266|NCT04421027|363735428|FG002|Follow-Up Period|Participant died|0|||
105471267|NCT04421027|363735429|FG003|Follow-Up Period|Participant died|1|||
105471268|NCT04421027|363735426|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
105471269|NCT04421027|363735427|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
105471270|NCT04421027|363735428|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
105471271|NCT04421027|363735429|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
105471272|NCT02529553|363735432|FG000|Overall Study|Progressive Disease|1|||
105471273|NCT02529553|363735433|FG001|Overall Study|Progressive Disease|0|||
105471274|NCT02529553|363735434|FG002|Overall Study|Progressive Disease|1|||
105471275|NCT02529553|363735435|FG003|Overall Study|Progressive Disease|3|||
105471276|NCT02529553|363735436|FG004|Overall Study|Progressive Disease|2|||
105471277|NCT02529553|363735437|FG005|Overall Study|Progressive Disease|3|||
105471278|NCT02529553|363735438|FG006|Overall Study|Progressive Disease|3|||
105471279|NCT02529553|363735439|FG007|Overall Study|Progressive Disease|5|||
105471280|NCT02529553|363735440|FG008|Overall Study|Progressive Disease|3|||
105471281|NCT02529553|363735432|FG000|Overall Study|Physician Decision|0|||
105471282|NCT02529553|363735433|FG001|Overall Study|Physician Decision|1|||
105471283|NCT02529553|363735434|FG002|Overall Study|Physician Decision|0|||
105558951|NCT03318523|364044559|FG002|PC Period: Up to Year 1|Adverse Event|2|||
105558952|NCT03318523|364044560|FG003|PC Period: Up to Year 1|Adverse Event|0|||
105558953|NCT03318523|364044561|FG004|PC Period: Up to Year 1|Adverse Event|0|||
105558954|NCT03318523|364044562|FG005|PC Period: Up to Year 1|Adverse Event|0|||
105558955|NCT03318523|364044563|FG006|PC Period: Up to Year 1|Adverse Event|0|||
105558956|NCT03318523|364044564|FG007|PC Period: Up to Year 1|Adverse Event|0|||
105558957|NCT03318523|364044565|FG008|PC Period: Up to Year 1|Adverse Event|0|||
105558958|NCT03318523|364044566|FG009|PC Period: Up to Year 1|Adverse Event|0|||
105558959|NCT03318523|364044557|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
105558960|NCT03318523|364044558|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
105558961|NCT03318523|364044559|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
105558962|NCT03318523|364044560|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
105558963|NCT03318523|364044561|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
105687783|NCT01139021|364520555|FG003|Overall Study|Protocol Violation|0|||
105687784|NCT01139021|364520556|FG004|Overall Study|Protocol Violation|2|||
105687785|NCT01139021|364520557|FG005|Overall Study|Protocol Violation|0|||
105687786|NCT01139021|364520552|FG000|Overall Study|Withdrawal by Subject|0|||
105687787|NCT01139021|364520553|FG001|Overall Study|Withdrawal by Subject|0|||
105687788|NCT01139021|364520554|FG002|Overall Study|Withdrawal by Subject|0|||
105687789|NCT01139021|364520555|FG003|Overall Study|Withdrawal by Subject|1|||
105687790|NCT01139021|364520556|FG004|Overall Study|Withdrawal by Subject|4|||
105687791|NCT01139021|364520557|FG005|Overall Study|Withdrawal by Subject|0|||
105687792|NCT04975438|364520558|FG000|Overall Study|Lost to Follow-up|1|||
105687793|NCT04975438|364520559|FG001|Overall Study|Lost to Follow-up|0|||
105687794|NCT04975438|364520560|FG002|Overall Study|Lost to Follow-up|1|||
105687795|NCT04975438|364520561|FG003|Overall Study|Lost to Follow-up|0|||
105687796|NCT04975438|364520558|FG000|Overall Study|Withdrawal by Subject|1|||
105687797|NCT04975438|364520559|FG001|Overall Study|Withdrawal by Subject|0|||
105687798|NCT04975438|364520560|FG002|Overall Study|Withdrawal by Subject|0|||
105687799|NCT04975438|364520561|FG003|Overall Study|Withdrawal by Subject|0|||
105687800|NCT02875977|364520562|FG000|Overall Study|Lost to Follow-up|42|||
105687801|NCT02875977|364520563|FG001|Overall Study|Lost to Follow-up|29|||
105687802|NCT00195507|364520567|FG000|Overall Study|Adverse Event|24|||
105687803|NCT00195507|364520568|FG001|Overall Study|Adverse Event|13|||
105687804|NCT00195507|364520567|FG000|Overall Study|Death|0|||
105345932|NCT02079636|363267284|FG012|Overall Study|Physician Decision|0|||
105345933|NCT02079636|363267285|FG013|Overall Study|Physician Decision|0|||
105345934|NCT02079636|363267286|FG014|Overall Study|Physician Decision|1|||
105345935|NCT02079636|363267272|FG000|Overall Study|Lost to Follow-up|0|||
105345936|NCT02079636|363267273|FG001|Overall Study|Lost to Follow-up|0|||
105345937|NCT02079636|363267274|FG002|Overall Study|Lost to Follow-up|0|||
105345938|NCT02079636|363267275|FG003|Overall Study|Lost to Follow-up|0|||
105345939|NCT02079636|363267276|FG004|Overall Study|Lost to Follow-up|0|||
105345940|NCT02079636|363267277|FG005|Overall Study|Lost to Follow-up|0|||
105345941|NCT02079636|363267278|FG006|Overall Study|Lost to Follow-up|0|||
105345942|NCT02079636|363267279|FG007|Overall Study|Lost to Follow-up|1|||
105345943|NCT02079636|363267280|FG008|Overall Study|Lost to Follow-up|0|||
105345944|NCT02079636|363267281|FG009|Overall Study|Lost to Follow-up|0|||
105345945|NCT02079636|363267282|FG010|Overall Study|Lost to Follow-up|0|||
105345946|NCT02079636|363267283|FG011|Overall Study|Lost to Follow-up|0|||
105345947|NCT02079636|363267284|FG012|Overall Study|Lost to Follow-up|0|||
105345948|NCT02079636|363267285|FG013|Overall Study|Lost to Follow-up|0|||
105345949|NCT02079636|363267286|FG014|Overall Study|Lost to Follow-up|0|||
105345950|NCT00725101|363267290|FG000|Overall Study|Death|3|||
105345951|NCT00725101|363267290|FG000|Overall Study|Lost to Follow-up|353|||
105345952|NCT00725101|363267290|FG000|Overall Study|Protocol Violation|1|||
105345953|NCT00725101|363267290|FG000|Overall Study|Withdrawal by Subject|127|||
105345954|NCT00725101|363267290|FG000|Overall Study|not specified/no reason given|11|||
105345955|NCT01592292|363267291|FG000|Overall Study|Follow-up loss|3|||
105345956|NCT01592292|363267292|FG001|Overall Study|Follow-up loss|3|||
105345957|NCT01592292|363267293|FG002|Overall Study|Follow-up loss|1|||
105345958|NCT01592292|363267294|FG003|Overall Study|Follow-up loss|0|||
105345959|NCT01592292|363267291|FG000|Overall Study|Withdrew consent|2|||
105345960|NCT01592292|363267292|FG001|Overall Study|Withdrew consent|1|||
105345961|NCT01592292|363267293|FG002|Overall Study|Withdrew consent|0|||
105345962|NCT01592292|363267294|FG003|Overall Study|Withdrew consent|0|||
105345963|NCT01592292|363267291|FG000|Overall Study|Other|1|||
105345964|NCT01592292|363267292|FG001|Overall Study|Other|1|||
105345965|NCT01592292|363267293|FG002|Overall Study|Other|2|||
105345966|NCT01592292|363267294|FG003|Overall Study|Other|1|||
105345967|NCT00157248|363267300|FG000|Overall Study|Adverse Event|36|||
105345968|NCT00157248|363267301|FG001|Overall Study|Adverse Event|25|||
105345969|NCT00157248|363267302|FG002|Overall Study|Adverse Event|13|||
105345970|NCT00157248|363267303|FG003|Overall Study|Adverse Event|33|||
105345971|NCT00157248|363267300|FG000|Overall Study|Protocol Violation|4|||
105345972|NCT00157248|363267301|FG001|Overall Study|Protocol Violation|0|||
105345973|NCT00157248|363267302|FG002|Overall Study|Protocol Violation|2|||
105345974|NCT00157248|363267303|FG003|Overall Study|Protocol Violation|2|||
105345975|NCT00157248|363267300|FG000|Overall Study|Lost to Follow-up|0|||
105687805|NCT00195507|364520568|FG001|Overall Study|Death|1|||
105687806|NCT00195507|364520567|FG000|Overall Study|Failed to Return|4|||
105687807|NCT00195507|364520568|FG001|Overall Study|Failed to Return|3|||
105687808|NCT00195507|364520567|FG000|Overall Study|Physician Decision|1|||
105687809|NCT00195507|364520568|FG001|Overall Study|Physician Decision|2|||
105687810|NCT00195507|364520567|FG000|Overall Study|Lost to Follow-up|3|||
105345976|NCT00157248|363267301|FG001|Overall Study|Lost to Follow-up|1|||
105345977|NCT00157248|363267302|FG002|Overall Study|Lost to Follow-up|0|||
105345978|NCT00157248|363267303|FG003|Overall Study|Lost to Follow-up|0|||
105345979|NCT00157248|363267300|FG000|Overall Study|Withdrawal by Subject|1|||
105345980|NCT00157248|363267301|FG001|Overall Study|Withdrawal by Subject|4|||
105345981|NCT00157248|363267302|FG002|Overall Study|Withdrawal by Subject|3|||
105345982|NCT00157248|363267303|FG003|Overall Study|Withdrawal by Subject|3|||
105345983|NCT00157248|363267300|FG000|Overall Study|site closures, subject moving|7|||
105687811|NCT00195507|364520568|FG001|Overall Study|Lost to Follow-up|2|||
105687812|NCT00195507|364520567|FG000|Overall Study|Protocol Violation|5|||
105687813|NCT00195507|364520568|FG001|Overall Study|Protocol Violation|4|||
105687814|NCT00195507|364520567|FG000|Overall Study|Lack of Efficacy|40|||
105687815|NCT00195507|364520568|FG001|Overall Study|Lack of Efficacy|67|||
105471284|NCT02529553|363735435|FG003|Overall Study|Physician Decision|0|||
105471285|NCT02529553|363735436|FG004|Overall Study|Physician Decision|1|||
105687816|NCT00195507|364520567|FG000|Overall Study|Withdrawal by Subject|16|||
105687817|NCT00195507|364520568|FG001|Overall Study|Withdrawal by Subject|23|||
105687818|NCT00195507|364520567|FG000|Overall Study|Protocol Deviation|6|||
105687819|NCT00195507|364520568|FG001|Overall Study|Protocol Deviation|3|||
105687820|NCT01178671|364520569|FG000|Overall Study|Adverse Event|4|||
105687821|NCT01178671|364520570|FG001|Overall Study|Adverse Event|6|||
105687822|NCT01178671|364520569|FG000|Overall Study|Protocol Violation|1|||
105687823|NCT01178671|364520570|FG001|Overall Study|Protocol Violation|1|||
105687824|NCT01178671|364520569|FG000|Overall Study|Lack of Efficacy|0|||
105687825|NCT01178671|364520570|FG001|Overall Study|Lack of Efficacy|1|||
105687826|NCT01178671|364520569|FG000|Overall Study|Lost to Follow-up|3|||
105687827|NCT01178671|364520570|FG001|Overall Study|Lost to Follow-up|1|||
105471286|NCT02529553|363735437|FG005|Overall Study|Physician Decision|0|||
105471287|NCT02529553|363735438|FG006|Overall Study|Physician Decision|0|||
105471288|NCT02529553|363735439|FG007|Overall Study|Physician Decision|0|||
105471289|NCT02529553|363735440|FG008|Overall Study|Physician Decision|0|||
105471290|NCT02529553|363735432|FG000|Overall Study|Withdrawal by Subject|0|||
105471291|NCT02529553|363735433|FG001|Overall Study|Withdrawal by Subject|0|||
105471292|NCT02529553|363735434|FG002|Overall Study|Withdrawal by Subject|0|||
105471293|NCT02529553|363735435|FG003|Overall Study|Withdrawal by Subject|0|||
105471294|NCT02529553|363735436|FG004|Overall Study|Withdrawal by Subject|0|||
105471295|NCT02529553|363735437|FG005|Overall Study|Withdrawal by Subject|1|||
105471296|NCT02529553|363735438|FG006|Overall Study|Withdrawal by Subject|0|||
105471297|NCT02529553|363735439|FG007|Overall Study|Withdrawal by Subject|1|||
105471298|NCT02529553|363735440|FG008|Overall Study|Withdrawal by Subject|0|||
105471299|NCT00702715|363738118|FG000|Overall Study|Lost to Follow-up|1|||
105471300|NCT00702715|363738119|FG001|Overall Study|Lost to Follow-up|0|||
105471301|NCT04040933|363738120|FG000|Overall Study|Protocol Violation|1|||
105471302|NCT04040933|363738120|FG000|Overall Study|Withdrawal by Subject|2|||
105471303|NCT01677377|363738121|FG000|Overall Study|Protocol Violation|1|||
105471304|NCT01677377|363738122|FG001|Overall Study|Protocol Violation|0|||
105471305|NCT01677377|363738123|FG002|Overall Study|Protocol Violation|0|||
105471306|NCT01677377|363738121|FG000|Overall Study|Lost to Follow-up|0|||
105471307|NCT01677377|363738122|FG001|Overall Study|Lost to Follow-up|1|||
105471308|NCT01677377|363738123|FG002|Overall Study|Lost to Follow-up|1|||
105471309|NCT01677377|363738121|FG000|Overall Study|Withdrawal by Subject|0|||
105471310|NCT01677377|363738122|FG001|Overall Study|Withdrawal by Subject|0|||
105471311|NCT01677377|363738123|FG002|Overall Study|Withdrawal by Subject|3|||
105471312|NCT01677377|363738121|FG000|Overall Study|Lack of Efficacy|0|||
105471313|NCT01677377|363738122|FG001|Overall Study|Lack of Efficacy|0|||
105471314|NCT01677377|363738123|FG002|Overall Study|Lack of Efficacy|1|||
105471315|NCT01677377|363738121|FG000|Overall Study|Pregnancy|0|||
105471316|NCT01677377|363738122|FG001|Overall Study|Pregnancy|0|||
105471317|NCT01677377|363738123|FG002|Overall Study|Pregnancy|1|||
105471318|NCT00807001|363738127|FG000|Overall Study|Non-compliance|0|||
105471319|NCT00807001|363738128|FG001|Overall Study|Non-compliance|1|||
105471320|NCT00807001|363738129|FG002|Overall Study|Non-compliance|0|||
105471321|NCT00807001|363738130|FG003|Overall Study|Non-compliance|0|||
105471322|NCT00807001|363738131|FG004|Overall Study|Non-compliance|0|||
105471323|NCT02840799|363738147|FG000|Phase 1|Physician Decision|1|||
105471324|NCT02840799|363738148|FG001|Phase 1|Physician Decision|3|||
105687828|NCT01178671|364520569|FG000|Overall Study|Physician Decision|4|||
105687829|NCT01178671|364520570|FG001|Overall Study|Physician Decision|6|||
105687830|NCT02260882|364520573|FG000|Overall Study|Protocol Violation|0|||
105687831|NCT02260882|364520574|FG001|Overall Study|Protocol Violation|1|||
105687832|NCT01326533|364520575|FG000|Overall Study|Lost to Follow-up|2|||
105687833|NCT01326533|364520576|FG001|Overall Study|Lost to Follow-up|0|||
105687834|NCT01326533|364520575|FG000|Overall Study|Withdrawal by Subject|1|||
105687835|NCT01326533|364520576|FG001|Overall Study|Withdrawal by Subject|0|||
105471325|NCT02840799|363738147|FG000|Phase 1|Withdrawal by Subject|4|||
105687836|NCT01326533|364520575|FG000|Overall Study|Adverse Event|1|||
105687837|NCT01326533|364520576|FG001|Overall Study|Adverse Event|0|||
105687838|NCT04079803|364520577|FG000|Overall Study|Withdrawal by Subject|0|||
105687839|NCT04079803|364520578|FG001|Overall Study|Withdrawal by Subject|0|||
105687840|NCT04079803|364520579|FG002|Overall Study|Withdrawal by Subject|1|||
105471326|NCT02840799|363738148|FG001|Phase 1|Withdrawal by Subject|0|||
105471327|NCT02840799|363738147|FG000|Phase 2 (Crossover)|Adverse Event|0|||
105471328|NCT02840799|363738148|FG001|Phase 2 (Crossover)|Adverse Event|1|||
105471329|NCT02840799|363738147|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
105687841|NCT03370471|364520589|FG000|Overall Study|Withdrawal by Subject|6|||
105687842|NCT03370471|364520590|FG001|Overall Study|Withdrawal by Subject|1|||
105345984|NCT00157248|363267301|FG001|Overall Study|site closures, subject moving|7|||
105345985|NCT00157248|363267302|FG002|Overall Study|site closures, subject moving|3|||
105345986|NCT00157248|363267303|FG003|Overall Study|site closures, subject moving|9|||
105687843|NCT03370471|364520589|FG000|Overall Study|Unable to access veins for blood draw|0|||
105687844|NCT03370471|364520590|FG001|Overall Study|Unable to access veins for blood draw|1|||
105687845|NCT03370471|364520589|FG000|Overall Study|Screen fail|1|||
105687846|NCT03370471|364520590|FG001|Overall Study|Screen fail|0|||
105687847|NCT01030198|364520597|FG000|Overall Study|Could not measure efficacy accurately|0|||
105345987|NCT02342548|363267304|FG000|Overall Study|Adverse Event|12|||
105345988|NCT02342548|363267305|FG001|Overall Study|Adverse Event|17|||
105687848|NCT01030198|364520598|FG001|Overall Study|Could not measure efficacy accurately|7|||
105687849|NCT04908189|364520599|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
105687850|NCT04908189|364520600|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
105687851|NCT04908189|364520601|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
105687852|NCT04908189|364520599|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
105687853|NCT04908189|364520600|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
105687854|NCT04908189|364520601|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
105687855|NCT04908189|364520599|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
105687856|NCT04908189|364520600|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
105687857|NCT04908189|364520601|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
105687858|NCT04908189|364520599|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
105687859|NCT04908189|364520600|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
105345989|NCT02342548|363267306|FG002|Overall Study|Adverse Event|13|||
105345990|NCT02342548|363267304|FG000|Overall Study|Lost to Follow-up|0|||
105345991|NCT02342548|363267305|FG001|Overall Study|Lost to Follow-up|1|||
105345992|NCT02342548|363267306|FG002|Overall Study|Lost to Follow-up|0|||
105345993|NCT02342548|363267304|FG000|Overall Study|Study terminated by sponsor|20|||
105345994|NCT02342548|363267305|FG001|Overall Study|Study terminated by sponsor|39|||
105345995|NCT02342548|363267306|FG002|Overall Study|Study terminated by sponsor|25|||
105345996|NCT02342548|363267304|FG000|Overall Study|Protocol Violation|0|||
105345997|NCT02342548|363267305|FG001|Overall Study|Protocol Violation|1|||
105345998|NCT02342548|363267306|FG002|Overall Study|Protocol Violation|0|||
105345999|NCT02342548|363267304|FG000|Overall Study|Withdrawal by Subject|1|||
105346000|NCT02342548|363267305|FG001|Overall Study|Withdrawal by Subject|3|||
105346001|NCT02342548|363267306|FG002|Overall Study|Withdrawal by Subject|4|||
105687860|NCT04908189|364520601|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
105687861|NCT04908189|364520599|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
105687862|NCT04908189|364520600|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
105687863|NCT04908189|364520601|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
105687864|NCT04908189|364520599|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
105786717|NCT01711736|364872889|FG000|Overall Study|Lost to Follow-up|4|||
105786718|NCT01711736|364872890|FG001|Overall Study|Lost to Follow-up|1|||
105786719|NCT01711736|364872889|FG000|Overall Study|Withdrawal by Subject|6|||
105346002|NCT02342548|363267304|FG000|Overall Study|Other|1|||
105346003|NCT02342548|363267305|FG001|Overall Study|Other|1|||
105346004|NCT02342548|363267306|FG002|Overall Study|Other|1|||
105346005|NCT00787917|363267309|FG000|Blinded Treatment|Adverse Event|1|||
105346006|NCT00787917|363267310|FG001|Blinded Treatment|Adverse Event|0|||
105346007|NCT00787917|363267309|FG000|Blinded Treatment|Lack of Efficacy|1|||
105346008|NCT00787917|363267310|FG001|Blinded Treatment|Lack of Efficacy|0|||
105346009|NCT00787917|363267309|FG000|Blinded Treatment|Administrative problems|3|||
105346010|NCT00787917|363267310|FG001|Blinded Treatment|Administrative problems|2|||
105346011|NCT00787917|363267309|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
105346012|NCT00787917|363267310|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
105471330|NCT02840799|363738148|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
105471331|NCT01621802|363738151|FG000|Overall Study|Protocol Violation|0|||
105471332|NCT01621802|363738152|FG001|Overall Study|Protocol Violation|0|||
105471333|NCT01621802|363738153|FG002|Overall Study|Protocol Violation|0|||
105471334|NCT01621802|363738154|FG003|Overall Study|Protocol Violation|0|||
105471335|NCT01621802|363738155|FG004|Overall Study|Protocol Violation|0|||
105471336|NCT01621802|363738156|FG005|Overall Study|Protocol Violation|1|||
105471337|NCT01621802|363738151|FG000|Overall Study|Withdrawal by Subject|8|||
105471338|NCT01621802|363738152|FG001|Overall Study|Withdrawal by Subject|4|||
105471339|NCT01621802|363738153|FG002|Overall Study|Withdrawal by Subject|4|||
105471340|NCT01621802|363738154|FG003|Overall Study|Withdrawal by Subject|2|||
105471341|NCT01621802|363738155|FG004|Overall Study|Withdrawal by Subject|2|||
105471342|NCT01621802|363738156|FG005|Overall Study|Withdrawal by Subject|0|||
105471343|NCT01621802|363738151|FG000|Overall Study|Migrated/moved from study area|0|||
105471344|NCT01621802|363738152|FG001|Overall Study|Migrated/moved from study area|0|||
105471345|NCT01621802|363738153|FG002|Overall Study|Migrated/moved from study area|2|||
105471346|NCT01621802|363738154|FG003|Overall Study|Migrated/moved from study area|0|||
105346013|NCT00787917|363267309|FG000|Open Label|Administrative problems|3|||
105471347|NCT01621802|363738155|FG004|Overall Study|Migrated/moved from study area|1|||
105471348|NCT01621802|363738156|FG005|Overall Study|Migrated/moved from study area|0|||
105471349|NCT01621802|363738151|FG000|Overall Study|Others|3|||
105471350|NCT01621802|363738152|FG001|Overall Study|Others|3|||
105471351|NCT01621802|363738153|FG002|Overall Study|Others|3|||
105471352|NCT01621802|363738154|FG003|Overall Study|Others|2|||
105471353|NCT01621802|363738155|FG004|Overall Study|Others|1|||
105471354|NCT01621802|363738156|FG005|Overall Study|Others|0|||
105471355|NCT01621802|363738151|FG000|Overall Study|Lost to Follow-up|36|||
105471356|NCT01621802|363738152|FG001|Overall Study|Lost to Follow-up|16|||
105471357|NCT01621802|363738153|FG002|Overall Study|Lost to Follow-up|24|||
105471358|NCT01621802|363738154|FG003|Overall Study|Lost to Follow-up|7|||
105471359|NCT01621802|363738155|FG004|Overall Study|Lost to Follow-up|31|||
105471360|NCT01621802|363738156|FG005|Overall Study|Lost to Follow-up|11|||
105471361|NCT00950859|363738159|FG000|Overall Study|Adverse Event|3|||
105471362|NCT00950859|363738160|FG001|Overall Study|Adverse Event|3|||
105471363|NCT00950859|363738159|FG000|Overall Study|Insufficient Viral Load Response|12|||
105471364|NCT00950859|363738160|FG001|Overall Study|Insufficient Viral Load Response|3|||
105471365|NCT00950859|363738159|FG000|Overall Study|Protocol Violation|1|||
105471366|NCT00950859|363738160|FG001|Overall Study|Protocol Violation|1|||
105471367|NCT00950859|363738159|FG000|Overall Study|Lost to Follow-up|0|||
105471368|NCT00950859|363738160|FG001|Overall Study|Lost to Follow-up|3|||
105471369|NCT04896086|363738161|FG000|Overall Study|Lost to Follow-up|0|||
105471370|NCT04896086|363738162|FG001|Overall Study|Lost to Follow-up|2|||
105471371|NCT04896086|363738163|FG002|Overall Study|Lost to Follow-up|1|||
105471372|NCT04896086|363738164|FG003|Overall Study|Lost to Follow-up|0|||
105471373|NCT04896086|363738165|FG004|Overall Study|Lost to Follow-up|0|||
105471374|NCT04896086|363738161|FG000|Overall Study|Physician Decision|0|||
105471375|NCT04896086|363738162|FG001|Overall Study|Physician Decision|1|||
105471376|NCT04896086|363738163|FG002|Overall Study|Physician Decision|0|||
105471377|NCT04896086|363738164|FG003|Overall Study|Physician Decision|0|||
105471378|NCT04896086|363738165|FG004|Overall Study|Physician Decision|0|||
105471379|NCT04896086|363738161|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
105471380|NCT04896086|363738162|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
105471381|NCT04896086|363738163|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
105471382|NCT04896086|363738164|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
105471383|NCT04896086|363738165|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
105471384|NCT04896086|363738161|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
105471385|NCT04896086|363738162|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
105471386|NCT04896086|363738163|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
105471387|NCT04896086|363738164|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
105471388|NCT04896086|363738165|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
105471389|NCT00867815|363738174|FG000|Overall Study|Lost to Follow-up|1|||
105471390|NCT01499277|363738175|FG000|Overall Study|Adverse Event|3|||
105471391|NCT01499277|363738176|FG001|Overall Study|Adverse Event|6|||
105471392|NCT01499277|363738175|FG000|Overall Study|Death|3|||
105471393|NCT01499277|363738176|FG001|Overall Study|Death|2|||
105471394|NCT01499277|363738175|FG000|Overall Study|Lost to Follow-up|15|||
105471395|NCT01499277|363738176|FG001|Overall Study|Lost to Follow-up|8|||
105471396|NCT01499277|363738175|FG000|Overall Study|Protocol Violation|2|||
105471397|NCT01499277|363738176|FG001|Overall Study|Protocol Violation|3|||
105471398|NCT01499277|363738175|FG000|Overall Study|Withdrawal by Subject|16|||
105471399|NCT01499277|363738176|FG001|Overall Study|Withdrawal by Subject|6|||
105471400|NCT01499277|363738175|FG000|Overall Study|Lack of therapeutic response and other|8|||
105471401|NCT01499277|363738176|FG001|Overall Study|Lack of therapeutic response and other|7|||
105471402|NCT04881942|363738177|FG000|Overall Study|Adverse Event|0|||
105471403|NCT04881942|363738178|FG001|Overall Study|Adverse Event|0|||
105558964|NCT03318523|364044562|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
105558965|NCT03318523|364044563|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
105558966|NCT03318523|364044564|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
105558967|NCT03318523|364044565|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
105558968|NCT03318523|364044566|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
105558969|NCT03318523|364044557|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
105558970|NCT03318523|364044558|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
105471404|NCT04881942|363738179|FG002|Overall Study|Adverse Event|0|||
105471405|NCT04881942|363738180|FG003|Overall Study|Adverse Event|0|||
105471406|NCT04881942|363738181|FG004|Overall Study|Adverse Event|1|||
105471407|NCT04881942|363738177|FG000|Overall Study|Alternates|0|||
105471408|NCT04881942|363738178|FG001|Overall Study|Alternates|0|||
105471409|NCT04881942|363738179|FG002|Overall Study|Alternates|0|||
105471410|NCT04881942|363738180|FG003|Overall Study|Alternates|0|||
105558971|NCT03318523|364044559|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
105558972|NCT03318523|364044560|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
105558973|NCT03318523|364044561|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
105558974|NCT03318523|364044562|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
105558975|NCT03318523|364044563|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
105558976|NCT03318523|364044564|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
105558977|NCT03318523|364044565|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
105558978|NCT03318523|364044566|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
105687865|NCT04908189|364520600|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
105687866|NCT04908189|364520601|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
105687867|NCT04908189|364520599|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
105687868|NCT04908189|364520600|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
105687869|NCT04908189|364520601|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
105687870|NCT04908189|364520599|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
105687871|NCT04908189|364520600|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
105687872|NCT04908189|364520601|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
105687873|NCT04908189|364520599|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
105687874|NCT04908189|364520600|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
105687875|NCT04908189|364520601|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
105687876|NCT04908189|364520599|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
105558979|NCT03318523|364044557|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
105558980|NCT03318523|364044558|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
105558981|NCT03318523|364044559|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
105687877|NCT04908189|364520600|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
105687878|NCT04908189|364520601|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
105687879|NCT04908189|364520599|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
105687880|NCT04908189|364520600|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
105687881|NCT04908189|364520601|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
105687882|NCT04908189|364520599|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
105687883|NCT04908189|364520600|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
105687884|NCT04908189|364520601|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
105687885|NCT00607022|364520602|FG000|Overall Study|Withdrawal by Subject|1|||
105687886|NCT00607022|364520603|FG001|Overall Study|Withdrawal by Subject|0|||
105687887|NCT00607022|364520604|FG002|Overall Study|Withdrawal by Subject|0|||
105687888|NCT01411839|364520607|FG000|Overall Study|Lost to Follow-up|4|||
105687889|NCT01411839|364520608|FG001|Overall Study|Lost to Follow-up|3|||
105471411|NCT04881942|363738181|FG004|Overall Study|Alternates|2|||
105471412|NCT04023396|363738182|FG000|Overall Study|Adverse Event|16|||
105471413|NCT04023396|363738182|FG000|Overall Study|Death|1|||
105471414|NCT04023396|363738182|FG000|Overall Study|Lost to Follow-up|1|||
105471415|NCT04023396|363738182|FG000|Overall Study|Withdrawal by Subject|14|||
105471416|NCT04023396|363738182|FG000|Overall Study|Pregnancy|4|||
105471417|NCT04023396|363738182|FG000|Overall Study|Lack of Efficacy|3|||
105471418|NCT04023396|363738182|FG000|Overall Study|Physician Decision|4|||
105471419|NCT04023396|363738182|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
105471420|NCT04730271|363738183|FG000|Overall Study|Adverse Event|0|||
105471421|NCT04730271|363738184|FG001|Overall Study|Adverse Event|2|||
105471422|NCT04730271|363738183|FG000|Overall Study|Withdrawal by Subject|1|||
105471423|NCT04730271|363738184|FG001|Overall Study|Withdrawal by Subject|1|||
105471424|NCT04730271|363738183|FG000|Overall Study|Protocol Violation|7|||
105471425|NCT04730271|363738184|FG001|Overall Study|Protocol Violation|13|||
105687890|NCT03330847|364520609|FG000|Overall Study|Patients ongoing study|62|||
105687891|NCT03330847|364520610|FG001|Overall Study|Patients ongoing study|65|||
105687892|NCT03330847|364520611|FG002|Overall Study|Patients ongoing study|15|||
105687893|NCT04821869|364520612|FG000|Overall Study|Adverse Event|4|||
105687894|NCT04821869|364520612|FG000|Overall Study|Withdrawal by Subject|2|||
105687895|NCT04821869|364520612|FG000|Overall Study|Did not meet FEV1 criteria|1|||
105687896|NCT03444324|364520614|FG000|Overall Study|Withdrawal by Subject|0|||
105687897|NCT03444324|364520615|FG001|Overall Study|Withdrawal by Subject|1|||
105687898|NCT03444324|364520614|FG000|Overall Study|Lost to Follow-up|4|||
105687899|NCT03444324|364520615|FG001|Overall Study|Lost to Follow-up|2|||
105687900|NCT03444324|364520614|FG000|Overall Study|Protocol Violation|0|||
105687901|NCT03444324|364520615|FG001|Overall Study|Protocol Violation|1|||
105687902|NCT03444324|364520614|FG000|Overall Study|Lack of Trial Compliance|1|||
105687903|NCT03444324|364520615|FG001|Overall Study|Lack of Trial Compliance|1|||
105687904|NCT03444324|364520614|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
105558982|NCT03318523|364044560|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
105558983|NCT03318523|364044561|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
105558984|NCT03318523|364044562|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
105687905|NCT03444324|364520615|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
105687906|NCT02903368|364520616|FG000|Part 1|Adverse Event|3|||
105687907|NCT02903368|364520617|FG001|Part 1|Adverse Event|0|||
105687908|NCT02903368|364520618|FG002|Part 1|Adverse Event|0|||
105687909|NCT02903368|364520619|FG003|Part 1|Adverse Event|0|||
105687910|NCT02903368|364520616|FG000|Part 1|Withdrawal by Subject|1|||
105687911|NCT02903368|364520617|FG001|Part 1|Withdrawal by Subject|0|||
105687912|NCT02903368|364520618|FG002|Part 1|Withdrawal by Subject|0|||
105687913|NCT02903368|364520619|FG003|Part 1|Withdrawal by Subject|0|||
105687914|NCT02903368|364520616|FG000|Part 2|Adverse Event|0|||
105687915|NCT02903368|364520617|FG001|Part 2|Adverse Event|0|||
105687916|NCT02903368|364520618|FG002|Part 2|Adverse Event|5|||
105687917|NCT02903368|364520619|FG003|Part 2|Adverse Event|0|||
105687918|NCT02903368|364520616|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
105687919|NCT02903368|364520617|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
105687920|NCT02903368|364520618|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
105687921|NCT02903368|364520619|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
105687922|NCT02903368|364520616|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
105687923|NCT02903368|364520617|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
105687924|NCT02903368|364520618|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
105687925|NCT02903368|364520619|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
105687926|NCT02903368|364520616|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
105687927|NCT02903368|364520617|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
105687928|NCT02903368|364520618|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
105687929|NCT02903368|364520619|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
105687930|NCT01340196|364522421|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
105687931|NCT00876694|364522422|FG000|Overall Study|Adverse Event|10|||
105687932|NCT00876694|364522423|FG001|Overall Study|Adverse Event|7|||
105687933|NCT00876694|364522422|FG000|Overall Study|Subject withdrew consent|6|||
105687934|NCT00876694|364522423|FG001|Overall Study|Subject withdrew consent|4|||
105687935|NCT00876694|364522422|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105687936|NCT00876694|364522423|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105687937|NCT00876694|364522422|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105687938|NCT00876694|364522423|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105687939|NCT00876694|364522422|FG000|Overall Study|Administrative problems|1|||
105687940|NCT00876694|364522423|FG001|Overall Study|Administrative problems|1|||
105687941|NCT00876694|364522422|FG000|Overall Study|Death|1|||
105687942|NCT00876694|364522423|FG001|Overall Study|Death|0|||
105687943|NCT02382016|364522424|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
105687944|NCT02382016|364522425|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
105687945|NCT02382016|364522424|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
105687946|NCT02382016|364522425|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
105687947|NCT02382016|364522424|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
105687948|NCT02382016|364522425|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
105687949|NCT02382016|364522424|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
105687950|NCT02382016|364522425|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
105687951|NCT02382016|364522424|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
105687952|NCT02382016|364522425|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
105687953|NCT02382016|364522424|FG000|Open-label (OL) Treatment Period|Death|4|||
105687954|NCT02382016|364522425|FG001|Open-label (OL) Treatment Period|Death|0|||
105687955|NCT02382016|364522424|FG000|OL Extension Period|Physician Decision|3|||
105687956|NCT02382016|364522425|FG001|OL Extension Period|Physician Decision|0|||
105687957|NCT02382016|364522424|FG000|OL Extension Period|Death|2|||
105687958|NCT02382016|364522425|FG001|OL Extension Period|Death|0|||
105687959|NCT02382016|364522424|FG000|OL Extension Period|Withdrawal by Subject|1|||
105687960|NCT02382016|364522425|FG001|OL Extension Period|Withdrawal by Subject|0|||
105687961|NCT00730171|364522426|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
105687962|NCT00730171|364522426|FG000|Overall Study|Adverse Event|193|||
105687963|NCT00730171|364522426|FG000|Overall Study|Protocol Violation|48|||
105687964|NCT00730171|364522426|FG000|Overall Study|Withdrawal by Subject|202|||
105687965|NCT00730171|364522426|FG000|Overall Study|Lost to Follow-up|121|||
105687966|NCT00730171|364522426|FG000|Overall Study|Insufficient Therapeutic Response|141|||
105687967|NCT00730171|364522426|FG000|Overall Study|Other|61|||
105687968|NCT01215422|364522427|FG000|Overall Study|Relocation|1|||
105687969|NCT01215422|364522428|FG001|Overall Study|Relocation|0|||
105687970|NCT01215422|364522429|FG002|Overall Study|Relocation|0|||
105687971|NCT01215422|364522430|FG003|Overall Study|Relocation|0|||
105687972|NCT01215422|364522427|FG000|Overall Study|Failed intubations|0|||
105687973|NCT01215422|364522428|FG001|Overall Study|Failed intubations|0|||
105687974|NCT01215422|364522429|FG002|Overall Study|Failed intubations|3|||
105687975|NCT01215422|364522430|FG003|Overall Study|Failed intubations|8|||
105687976|NCT01215422|364522427|FG000|Overall Study|Did not complete all intubations|7|||
105687977|NCT01215422|364522428|FG001|Overall Study|Did not complete all intubations|0|||
105687978|NCT01215422|364522429|FG002|Overall Study|Did not complete all intubations|0|||
105687979|NCT01215422|364522430|FG003|Overall Study|Did not complete all intubations|0|||
105687980|NCT00909792|364522431|FG000|Period 1|Did not meet inclusion criteria|0|||
105687981|NCT00909792|364522432|FG001|Period 1|Did not meet inclusion criteria|1|||
105687982|NCT00909792|364522431|FG000|Period 2|Biomicroscopy|1|||
105687983|NCT00909792|364522432|FG001|Period 2|Biomicroscopy|0|||
105687984|NCT00909792|364522431|FG000|Period 2|Lost to Follow-up|0|||
105687985|NCT00909792|364522432|FG001|Period 2|Lost to Follow-up|1|||
105687986|NCT00294554|364522437|FG000|Overall Study|Lack of Efficacy|0|||
105687987|NCT00294554|364522438|FG001|Overall Study|Lack of Efficacy|1|||
105687988|NCT00294554|364522437|FG000|Overall Study|Physician Decision|0|||
105687989|NCT00294554|364522438|FG001|Overall Study|Physician Decision|1|||
105687990|NCT01717989|364522439|FG000|Overall Study|Ineligibility determined|6|||
105687991|NCT01717989|364522439|FG000|Overall Study|Protocol deviation|6|||
105687992|NCT01717989|364522439|FG000|Overall Study|Withdrawal by Subject|11|||
105687993|NCT01717989|364522439|FG000|Overall Study|Physician Decision|2|||
105687994|NCT01717989|364522439|FG000|Overall Study|Lost to Follow-up|11|||
105687995|NCT01717989|364522439|FG000|Overall Study|Death|439|||
105687996|NCT01717989|364522439|FG000|Overall Study|Protocol-specified criteria|551|||
105687997|NCT01717989|364522439|FG000|Overall Study|Other|40|||
105687998|NCT00462865|364522440|FG000|Overall Study|Adverse Event|1|||
105687999|NCT00792805|364522441|FG000|Overall Study|Adverse Event|12|||
105688000|NCT00792805|364522442|FG001|Overall Study|Adverse Event|10|||
105688001|NCT00792805|364522443|FG002|Overall Study|Adverse Event|10|||
105688002|NCT00792805|364522441|FG000|Overall Study|Subject withdrew consent|5|||
105688003|NCT00792805|364522442|FG001|Overall Study|Subject withdrew consent|6|||
105688004|NCT00792805|364522443|FG002|Overall Study|Subject withdrew consent|5|||
105688005|NCT00792805|364522441|FG000|Overall Study|Administrative problems|2|||
105688006|NCT00792805|364522442|FG001|Overall Study|Administrative problems|0|||
105688007|NCT00792805|364522443|FG002|Overall Study|Administrative problems|4|||
105688008|NCT00792805|364522441|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105688009|NCT00792805|364522442|FG001|Overall Study|Abnormal test procedure result(s)|2|||
105688010|NCT00792805|364522443|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105688011|NCT00792805|364522441|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105688012|NCT00792805|364522442|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
105688013|NCT00792805|364522443|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
105688014|NCT00792805|364522441|FG000|Overall Study|Lost to Follow-up|1|||
105688015|NCT00792805|364522442|FG001|Overall Study|Lost to Follow-up|1|||
105688016|NCT00792805|364522443|FG002|Overall Study|Lost to Follow-up|6|||
105688017|NCT00792805|364522441|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105688018|NCT00792805|364522442|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105688019|NCT00792805|364522443|FG002|Overall Study|Abnormal laboratory value(s)|1|||
105688020|NCT00792805|364522441|FG000|Overall Study|Protocol deviation|0|||
105688021|NCT00792805|364522442|FG001|Overall Study|Protocol deviation|1|||
105688022|NCT00792805|364522443|FG002|Overall Study|Protocol deviation|1|||
105688023|NCT03224325|364522444|FG000|Overall Study|Adverse Event|1|||
105688024|NCT03224325|364522445|FG001|Overall Study|Adverse Event|0|||
105688025|NCT03224325|364522446|FG002|Overall Study|Adverse Event|0|||
105688026|NCT03224325|364522447|FG003|Overall Study|Adverse Event|0|||
105688027|NCT03224325|364522448|FG004|Overall Study|Adverse Event|0|||
105688028|NCT03224325|364522449|FG005|Overall Study|Adverse Event|0|||
105688029|NCT03224325|364522450|FG006|Overall Study|Adverse Event|1|||
105688030|NCT03224325|364522444|FG000|Overall Study|Withdrawal by Subject|0|||
105688031|NCT03224325|364522445|FG001|Overall Study|Withdrawal by Subject|0|||
105688032|NCT03224325|364522446|FG002|Overall Study|Withdrawal by Subject|0|||
105688033|NCT03224325|364522447|FG003|Overall Study|Withdrawal by Subject|1|||
105688034|NCT03224325|364522448|FG004|Overall Study|Withdrawal by Subject|0|||
105688035|NCT03224325|364522449|FG005|Overall Study|Withdrawal by Subject|0|||
105688036|NCT03224325|364522450|FG006|Overall Study|Withdrawal by Subject|0|||
105688037|NCT00888433|364522451|FG000|Overall Study|Withdrawal by Subject|1|||
105688038|NCT00888433|364522452|FG001|Overall Study|Withdrawal by Subject|2|||
105688039|NCT00888433|364522451|FG000|Overall Study|Missed Visit|2|||
105688040|NCT00888433|364522452|FG001|Overall Study|Missed Visit|1|||
105688041|NCT04796896|364522455|FG000|Overall Study|Adverse Event|1|||
105688042|NCT04796896|364522456|FG001|Overall Study|Adverse Event|0|||
105688043|NCT04796896|364522457|FG002|Overall Study|Adverse Event|0|||
105688044|NCT04796896|364522458|FG003|Overall Study|Adverse Event|0|||
105688045|NCT04796896|364522459|FG004|Overall Study|Adverse Event|0|||
105688046|NCT04796896|364522460|FG005|Overall Study|Adverse Event|1|||
105688047|NCT04796896|364522461|FG006|Overall Study|Adverse Event|1|||
105688048|NCT04796896|364522462|FG007|Overall Study|Adverse Event|0|||
105688049|NCT04796896|364522463|FG008|Overall Study|Adverse Event|1|||
105688050|NCT04796896|364522464|FG009|Overall Study|Adverse Event|1|||
105688051|NCT04796896|364522465|FG010|Overall Study|Adverse Event|1|||
105688052|NCT04796896|364522466|FG011|Overall Study|Adverse Event|0|||
105688053|NCT04796896|364522455|FG000|Overall Study|Lost to Follow-up|24|||
105688054|NCT04796896|364522456|FG001|Overall Study|Lost to Follow-up|15|||
105688055|NCT04796896|364522457|FG002|Overall Study|Lost to Follow-up|6|||
105688056|NCT04796896|364522458|FG003|Overall Study|Lost to Follow-up|4|||
105688057|NCT04796896|364522459|FG004|Overall Study|Lost to Follow-up|21|||
105688058|NCT04796896|364522460|FG005|Overall Study|Lost to Follow-up|55|||
105688059|NCT04796896|364522461|FG006|Overall Study|Lost to Follow-up|237|||
105688060|NCT04796896|364522462|FG007|Overall Study|Lost to Follow-up|52|||
105688061|NCT04796896|364522463|FG008|Overall Study|Lost to Follow-up|221|||
105688062|NCT04796896|364522464|FG009|Overall Study|Lost to Follow-up|43|||
105688063|NCT04796896|364522465|FG010|Overall Study|Lost to Follow-up|142|||
105688064|NCT04796896|364522466|FG011|Overall Study|Lost to Follow-up|18|||
105688065|NCT04796896|364522455|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
105688066|NCT04796896|364522456|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
105688067|NCT04796896|364522457|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
105688068|NCT04796896|364522458|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
105688069|NCT04796896|364522459|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
105688070|NCT04796896|364522460|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
105688071|NCT04796896|364522461|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
105688072|NCT04796896|364522462|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
105688073|NCT04796896|364522463|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
105688074|NCT04796896|364522464|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
105688075|NCT04796896|364522465|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
105688076|NCT04796896|364522466|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
105688077|NCT04796896|364522455|FG000|Overall Study|Physician Decision|1|||
105688078|NCT04796896|364522456|FG001|Overall Study|Physician Decision|0|||
105688079|NCT04796896|364522457|FG002|Overall Study|Physician Decision|0|||
105688080|NCT04796896|364522458|FG003|Overall Study|Physician Decision|0|||
105688081|NCT04796896|364522459|FG004|Overall Study|Physician Decision|0|||
105688082|NCT04796896|364522460|FG005|Overall Study|Physician Decision|3|||
105688083|NCT04796896|364522461|FG006|Overall Study|Physician Decision|18|||
105688084|NCT04796896|364522462|FG007|Overall Study|Physician Decision|1|||
105688085|NCT04796896|364522463|FG008|Overall Study|Physician Decision|7|||
105688086|NCT04796896|364522464|FG009|Overall Study|Physician Decision|0|||
105688087|NCT04796896|364522465|FG010|Overall Study|Physician Decision|5|||
105688088|NCT04796896|364522466|FG011|Overall Study|Physician Decision|0|||
105688089|NCT04796896|364522455|FG000|Overall Study|Withdrawal by Subject|36|||
105688090|NCT04796896|364522456|FG001|Overall Study|Withdrawal by Subject|31|||
105688091|NCT04796896|364522457|FG002|Overall Study|Withdrawal by Subject|11|||
105688092|NCT04796896|364522458|FG003|Overall Study|Withdrawal by Subject|8|||
105688093|NCT04796896|364522459|FG004|Overall Study|Withdrawal by Subject|16|||
105688094|NCT04796896|364522460|FG005|Overall Study|Withdrawal by Subject|162|||
105688095|NCT04796896|364522461|FG006|Overall Study|Withdrawal by Subject|299|||
105688096|NCT04796896|364522462|FG007|Overall Study|Withdrawal by Subject|149|||
105688097|NCT04796896|364522463|FG008|Overall Study|Withdrawal by Subject|303|||
105688098|NCT04796896|364522464|FG009|Overall Study|Withdrawal by Subject|94|||
105688099|NCT04796896|364522465|FG010|Overall Study|Withdrawal by Subject|192|||
105688100|NCT04796896|364522466|FG011|Overall Study|Withdrawal by Subject|16|||
105471426|NCT04730271|363738183|FG000|Overall Study|Lost to Follow-up|3|||
105688101|NCT04796896|364522455|FG000|Overall Study|Other Than Specified|6|||
105688102|NCT04796896|364522456|FG001|Overall Study|Other Than Specified|5|||
105688103|NCT04796896|364522457|FG002|Overall Study|Other Than Specified|3|||
105688104|NCT04796896|364522458|FG003|Overall Study|Other Than Specified|2|||
105688105|NCT04796896|364522459|FG004|Overall Study|Other Than Specified|6|||
105688106|NCT04796896|364522460|FG005|Overall Study|Other Than Specified|31|||
105688107|NCT04796896|364522461|FG006|Overall Study|Other Than Specified|86|||
105688108|NCT04796896|364522462|FG007|Overall Study|Other Than Specified|66|||
105688109|NCT04796896|364522463|FG008|Overall Study|Other Than Specified|388|||
105688110|NCT04796896|364522464|FG009|Overall Study|Other Than Specified|48|||
105688111|NCT04796896|364522465|FG010|Overall Study|Other Than Specified|258|||
105688112|NCT04796896|364522466|FG011|Overall Study|Other Than Specified|4|||
105688113|NCT04796896|364522455|FG000|Overall Study|Protocol Deviation|0|||
105688114|NCT04796896|364522456|FG001|Overall Study|Protocol Deviation|0|||
105688115|NCT04796896|364522457|FG002|Overall Study|Protocol Deviation|0|||
105688116|NCT04796896|364522458|FG003|Overall Study|Protocol Deviation|1|||
105688117|NCT04796896|364522459|FG004|Overall Study|Protocol Deviation|1|||
105688118|NCT04796896|364522460|FG005|Overall Study|Protocol Deviation|2|||
105688119|NCT04796896|364522461|FG006|Overall Study|Protocol Deviation|2|||
105688120|NCT04796896|364522462|FG007|Overall Study|Protocol Deviation|2|||
105688121|NCT04796896|364522463|FG008|Overall Study|Protocol Deviation|2|||
105688122|NCT04796896|364522464|FG009|Overall Study|Protocol Deviation|1|||
105688123|NCT04796896|364522465|FG010|Overall Study|Protocol Deviation|0|||
105688124|NCT04796896|364522466|FG011|Overall Study|Protocol Deviation|0|||
105688125|NCT04796896|364522455|FG000|Overall Study|Missing|0|||
105688126|NCT04796896|364522456|FG001|Overall Study|Missing|0|||
105688127|NCT04796896|364522457|FG002|Overall Study|Missing|0|||
105688128|NCT04796896|364522458|FG003|Overall Study|Missing|0|||
105688129|NCT04796896|364522459|FG004|Overall Study|Missing|0|||
105688130|NCT04796896|364522460|FG005|Overall Study|Missing|0|||
105688131|NCT04796896|364522461|FG006|Overall Study|Missing|2|||
105688132|NCT04796896|364522462|FG007|Overall Study|Missing|1|||
105688133|NCT04796896|364522463|FG008|Overall Study|Missing|2|||
105688134|NCT04796896|364522464|FG009|Overall Study|Missing|1|||
105688135|NCT04796896|364522465|FG010|Overall Study|Missing|1|||
105688136|NCT04796896|364522466|FG011|Overall Study|Missing|0|||
105688137|NCT04796896|364522455|FG000|Overall Study|Death|0|||
105688138|NCT04796896|364522456|FG001|Overall Study|Death|0|||
105688139|NCT04796896|364522457|FG002|Overall Study|Death|0|||
105688140|NCT04796896|364522458|FG003|Overall Study|Death|0|||
105688141|NCT04796896|364522459|FG004|Overall Study|Death|0|||
105688142|NCT04796896|364522460|FG005|Overall Study|Death|0|||
105688143|NCT04796896|364522461|FG006|Overall Study|Death|0|||
105688144|NCT04796896|364522462|FG007|Overall Study|Death|0|||
105688145|NCT04796896|364522463|FG008|Overall Study|Death|1|||
105688146|NCT04796896|364522464|FG009|Overall Study|Death|0|||
105688147|NCT04796896|364522465|FG010|Overall Study|Death|0|||
105688148|NCT04796896|364522466|FG011|Overall Study|Death|0|||
105688149|NCT01177787|364522469|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
105688150|NCT01177787|364522469|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
105688151|NCT01177787|364522469|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
105688152|NCT01637623|364522473|FG000|Overall Study|Lost to Follow-up|0|||
105688153|NCT01637623|364522474|FG001|Overall Study|Lost to Follow-up|0|||
105688154|NCT01637623|364522475|FG002|Overall Study|Lost to Follow-up|2|||
105688155|NCT01637623|364522473|FG000|Overall Study|Physician Decision|1|||
105688156|NCT01637623|364522474|FG001|Overall Study|Physician Decision|0|||
105688157|NCT01637623|364522475|FG002|Overall Study|Physician Decision|1|||
105688158|NCT00879762|364522476|FG000|Overall Study|Lost to Follow-up|3|||
105688159|NCT00879762|364522477|FG001|Overall Study|Lost to Follow-up|1|||
105786720|NCT01711736|364872890|FG001|Overall Study|Withdrawal by Subject|6|||
105688160|NCT01676909|364522478|FG000|Overall Study|Withdrawal by Subject|3|||
105786721|NCT01711736|364872889|FG000|Overall Study|Migrated/moved from study area|2|||
105688161|NCT01676909|364522479|FG001|Overall Study|Withdrawal by Subject|5|||
105688162|NCT01676909|364522478|FG000|Overall Study|Lost to Follow-up|15|||
105688163|NCT01676909|364522479|FG001|Overall Study|Lost to Follow-up|9|||
105688164|NCT00881608|364522480|FG000|Overall Study|Study prematurely terminated|11|||
105688165|NCT00887679|364522481|FG000|Overall Study|Withdrawal by Subject|1|||
105688166|NCT00887679|364522481|FG000|Overall Study|Lost to Follow-up|4|||
105688167|NCT00887679|364522481|FG000|Overall Study|Physician Decision|5|||
105688168|NCT03294109|364522486|FG000|Overall Study|Withdrawal by Subject|6|||
105688169|NCT03294109|364522487|FG001|Overall Study|Withdrawal by Subject|5|||
105688170|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
105688171|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
105688172|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
105688173|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
105688174|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
105688175|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
105688176|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
105688177|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
105688178|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
105688179|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
105688180|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
105688181|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
105688182|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
105688183|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
105688184|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
105688185|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
105688186|NCT01294683|364522488|FG000|Post Crossover (Period III)|Adverse Event|6|||
105688187|NCT01294683|364522489|FG001|Post Crossover (Period III)|Adverse Event|6|||
105688188|NCT01294683|364522488|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
105688189|NCT01294683|364522489|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
105688190|NCT01294683|364522488|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
105688191|NCT01294683|364522489|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
105688192|NCT01294683|364522488|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
105688193|NCT01294683|364522489|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
105688194|NCT01881750|364522494|FG000|Overall Study|Changes in concomitant therapies|2|||
105688195|NCT01881750|364522495|FG001|Overall Study|Changes in concomitant therapies|3|||
105688196|NCT01881750|364522494|FG000|Overall Study|Lost to Follow-up|0|||
105688197|NCT01881750|364522495|FG001|Overall Study|Lost to Follow-up|1|||
105688198|NCT00147823|364522501|FG000|Overall Study|Lost to Follow-up|6|||
105688199|NCT00147823|364522502|FG001|Overall Study|Lost to Follow-up|12|||
105688200|NCT00147823|364522501|FG000|Overall Study|Physician Decision|1|||
105688201|NCT00147823|364522502|FG001|Overall Study|Physician Decision|0|||
105688202|NCT00147823|364522501|FG000|Overall Study|Withdrawal by Subject|0|||
105688203|NCT00147823|364522502|FG001|Overall Study|Withdrawal by Subject|1|||
105688204|NCT00147823|364522501|FG000|Overall Study|Did not receive vitoss due to infection|6|||
105688205|NCT00147823|364522502|FG001|Overall Study|Did not receive vitoss due to infection|2|||
105688206|NCT02804178|364522505|FG000|Overall Study|Adverse Event|1|||
105688207|NCT01290601|364522506|FG000|Overall Study|Adverse Event|0|||
105688208|NCT01290601|364522507|FG001|Overall Study|Adverse Event|2|||
105688209|NCT01290601|364522508|FG002|Overall Study|Adverse Event|0|||
105688210|NCT01290601|364522509|FG003|Overall Study|Adverse Event|0|||
105688211|NCT01290601|364522506|FG000|Overall Study|Lack of Efficacy|2|||
105688212|NCT01290601|364522507|FG001|Overall Study|Lack of Efficacy|1|||
105688213|NCT01290601|364522508|FG002|Overall Study|Lack of Efficacy|0|||
105688214|NCT01290601|364522509|FG003|Overall Study|Lack of Efficacy|0|||
105688215|NCT01290601|364522506|FG000|Overall Study|Lost to Follow-up|7|||
105688216|NCT01290601|364522507|FG001|Overall Study|Lost to Follow-up|2|||
105688217|NCT01290601|364522508|FG002|Overall Study|Lost to Follow-up|0|||
105688218|NCT01290601|364522509|FG003|Overall Study|Lost to Follow-up|0|||
105346014|NCT00787917|363267310|FG001|Open Label|Administrative problems|0|||
105346015|NCT04506905|363267311|FG000|Overall Study|Lost to Follow-up|1|||
105346016|NCT04506905|363267312|FG001|Overall Study|Lost to Follow-up|0|||
105688219|NCT01290601|364522506|FG000|Overall Study|Other|1|||
105688220|NCT01290601|364522507|FG001|Overall Study|Other|0|||
105688221|NCT01290601|364522508|FG002|Overall Study|Other|0|||
105346017|NCT04506905|363267313|FG002|Overall Study|Lost to Follow-up|0|||
105471427|NCT04730271|363738184|FG001|Overall Study|Lost to Follow-up|3|||
105346018|NCT04506905|363267314|FG003|Overall Study|Lost to Follow-up|1|||
105688222|NCT01290601|364522509|FG003|Overall Study|Other|0|||
105688223|NCT01290601|364522506|FG000|Overall Study|Protocol Violation|1|||
105688224|NCT01290601|364522507|FG001|Overall Study|Protocol Violation|0|||
105688225|NCT01290601|364522508|FG002|Overall Study|Protocol Violation|0|||
105471428|NCT04730271|363738183|FG000|Overall Study|Death|1|||
105558985|NCT03318523|364044563|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
105558986|NCT03318523|364044564|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
105558987|NCT03318523|364044565|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
105558988|NCT03318523|364044566|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
105558989|NCT03318523|364044557|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
105558990|NCT03318523|364044558|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
105558991|NCT03318523|364044559|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
105558992|NCT03318523|364044560|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
105558993|NCT03318523|364044561|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
105558994|NCT03318523|364044562|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
105688226|NCT01290601|364522509|FG003|Overall Study|Protocol Violation|0|||
105471429|NCT04730271|363738184|FG001|Overall Study|Death|0|||
105471430|NCT02474069|363738187|FG000|Selection Phase (SP)|Adverse Event|8|||
105471431|NCT02474069|363738188|FG001|Selection Phase (SP)|Adverse Event|0|||
105471432|NCT02474069|363738189|FG002|Selection Phase (SP)|Adverse Event|0|||
105471433|NCT02474069|363738187|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
105471434|NCT02474069|363738188|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
105471435|NCT02474069|363738189|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
105471436|NCT02474069|363738187|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
105471437|NCT02474069|363738188|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
105471438|NCT02474069|363738189|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
105471439|NCT02474069|363738187|FG000|Selection Phase (SP)|Physician Decision|1|||
105471440|NCT02474069|363738188|FG001|Selection Phase (SP)|Physician Decision|0|||
105471441|NCT02474069|363738189|FG002|Selection Phase (SP)|Physician Decision|0|||
105471442|NCT02474069|363738187|FG000|Selection Phase (SP)|Protocol Violation|1|||
105471443|NCT02474069|363738188|FG001|Selection Phase (SP)|Protocol Violation|0|||
105471444|NCT02474069|363738189|FG002|Selection Phase (SP)|Protocol Violation|0|||
105471445|NCT02474069|363738187|FG000|Selection Phase (SP)|No longer requires treatment|1|||
105471446|NCT02474069|363738188|FG001|Selection Phase (SP)|No longer requires treatment|0|||
105471447|NCT02474069|363738189|FG002|Selection Phase (SP)|No longer requires treatment|0|||
105471448|NCT02474069|363738187|FG000|Selection Phase (SP)|Technical Problem|1|||
105471449|NCT02474069|363738188|FG001|Selection Phase (SP)|Technical Problem|0|||
105471450|NCT02474069|363738189|FG002|Selection Phase (SP)|Technical Problem|0|||
105471451|NCT02474069|363738187|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
105471452|NCT02474069|363738188|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
105471453|NCT02474069|363738189|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
105471454|NCT02474069|363738187|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
105471455|NCT02474069|363738188|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
105471456|NCT02474069|363738189|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
105471457|NCT02474069|363738187|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
105471458|NCT02474069|363738188|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
105471459|NCT02474069|363738189|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
105471460|NCT02474069|363738187|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
105558995|NCT03318523|364044563|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
105471461|NCT02474069|363738188|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
105471462|NCT02474069|363738189|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
105471463|NCT02474069|363738187|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
105471464|NCT02474069|363738188|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
105688227|NCT00775450|364522510|FG000|Overall Study|Serious Adverse Event|2|||
105688228|NCT00775450|364522511|FG001|Overall Study|Serious Adverse Event|0|||
105688229|NCT00775450|364522512|FG002|Overall Study|Serious Adverse Event|0|||
105688230|NCT00775450|364522513|FG003|Overall Study|Serious Adverse Event|0|||
105688231|NCT00775450|364522514|FG004|Overall Study|Serious Adverse Event|0|||
105688232|NCT00775450|364522510|FG000|Overall Study|Protocol Violation|0|||
105688233|NCT00775450|364522511|FG001|Overall Study|Protocol Violation|0|||
105688234|NCT00775450|364522512|FG002|Overall Study|Protocol Violation|0|||
105688235|NCT00775450|364522513|FG003|Overall Study|Protocol Violation|0|||
105688236|NCT00775450|364522514|FG004|Overall Study|Protocol Violation|1|||
105688237|NCT00775450|364522510|FG000|Overall Study|Withdrawal by Subject|1|||
105688238|NCT00775450|364522511|FG001|Overall Study|Withdrawal by Subject|0|||
105688239|NCT00775450|364522512|FG002|Overall Study|Withdrawal by Subject|0|||
105688240|NCT00775450|364522513|FG003|Overall Study|Withdrawal by Subject|0|||
105688241|NCT00775450|364522514|FG004|Overall Study|Withdrawal by Subject|1|||
105688242|NCT01749540|364522517|FG000|Overall Study|Protocol Violation|0|||
105688243|NCT01749540|364522518|FG001|Overall Study|Protocol Violation|0|||
105688244|NCT01749540|364522519|FG002|Overall Study|Protocol Violation|0|||
105688245|NCT01749540|364522520|FG003|Overall Study|Protocol Violation|0|||
105688246|NCT01749540|364522521|FG004|Overall Study|Protocol Violation|0|||
105688247|NCT01749540|364522522|FG005|Overall Study|Protocol Violation|1|||
105688248|NCT01749540|364522523|FG006|Overall Study|Protocol Violation|1|||
105688249|NCT01749540|364522517|FG000|Overall Study|Withdrawal by Subject|0|||
105688250|NCT01749540|364522518|FG001|Overall Study|Withdrawal by Subject|0|||
105688251|NCT01749540|364522519|FG002|Overall Study|Withdrawal by Subject|0|||
105688252|NCT01749540|364522520|FG003|Overall Study|Withdrawal by Subject|1|||
105688253|NCT01749540|364522521|FG004|Overall Study|Withdrawal by Subject|0|||
105688254|NCT01749540|364522522|FG005|Overall Study|Withdrawal by Subject|0|||
105688255|NCT01749540|364522523|FG006|Overall Study|Withdrawal by Subject|0|||
105688256|NCT01749540|364522517|FG000|Overall Study|Initiated into extension study A536-06|0|||
105688257|NCT01749540|364522518|FG001|Overall Study|Initiated into extension study A536-06|0|||
105688258|NCT01749540|364522519|FG002|Overall Study|Initiated into extension study A536-06|0|||
105688259|NCT01749540|364522520|FG003|Overall Study|Initiated into extension study A536-06|0|||
105688260|NCT01749540|364522521|FG004|Overall Study|Initiated into extension study A536-06|0|||
105688261|NCT01749540|364522522|FG005|Overall Study|Initiated into extension study A536-06|2|||
105688262|NCT01749540|364522523|FG006|Overall Study|Initiated into extension study A536-06|24|||
105688263|NCT01055262|364522524|FG000|Overall Study|Adverse Event|5|||
105688264|NCT01055262|364522524|FG000|Overall Study|Protocol Violation|3|||
105688265|NCT01055262|364522524|FG000|Overall Study|Uncooperativeness|1|||
105688266|NCT01765179|364522525|FG000|Overall Study|Adverse Event|3|||
105688267|NCT01765179|364522525|FG000|Overall Study|Lost to Follow-up|5|||
105688268|NCT01765179|364522525|FG000|Overall Study|Non-compliance with study drug|2|||
105688269|NCT01765179|364522525|FG000|Overall Study|Protocol Violation|1|||
105688270|NCT01765179|364522525|FG000|Overall Study|Withdrawal by Subject|8|||
105688271|NCT01765179|364522525|FG000|Overall Study|Hematocrit >54%|3|||
105688272|NCT01765179|364522525|FG000|Overall Study|prohibited med|1|||
105688273|NCT01765179|364522525|FG000|Overall Study|Out of country unable to finish study|1|||
105688274|NCT01765179|364522525|FG000|Overall Study|lack of venous access|1|||
105688275|NCT01765179|364522525|FG000|Overall Study|work conflict|1|||
105688276|NCT01765179|364522525|FG000|Overall Study|Ca elevated 10.6|1|||
105688277|NCT00894686|364522526|FG000|Overall Study|Withdrawal by Subject|50|||
105688278|NCT00894686|364522526|FG000|Overall Study|Physician Decision|1|||
105688279|NCT00894686|364522526|FG000|Overall Study|Other|5|||
105688280|NCT00564018|364522527|FG000|Overall Study|Withdrawal by Subject|2|||
105688281|NCT00564018|364522528|FG001|Overall Study|Withdrawal by Subject|3|||
105688282|NCT00564018|364522529|FG002|Overall Study|Withdrawal by Subject|1|||
105688283|NCT03291587|364522531|FG000|Overall Study|Lost to Follow-up|62|||
105688284|NCT03291587|364522532|FG001|Overall Study|Lost to Follow-up|43|||
105786722|NCT01711736|364872890|FG001|Overall Study|Migrated/moved from study area|1|||
105786723|NCT00750061|364872895|FG000|Overall Study|Adverse Event|2|||
105786724|NCT00750061|364872896|FG001|Overall Study|Adverse Event|0|||
105786725|NCT00750061|364872895|FG000|Overall Study|Withdrawal by Subject|0|||
105786726|NCT00750061|364872896|FG001|Overall Study|Withdrawal by Subject|1|||
105688285|NCT03291587|364522531|FG000|Overall Study|Refused to Answer|5|||
105786727|NCT00750061|364872895|FG000|Overall Study|Physician Decision|0|||
105786728|NCT00750061|364872896|FG001|Overall Study|Physician Decision|1|||
105786729|NCT04196023|364872898|FG000|Overall Study|Withdrawal by Subject|0|||
105688286|NCT03291587|364522532|FG001|Overall Study|Refused to Answer|2|||
105688287|NCT03291587|364522531|FG000|Overall Study|Death|2|||
105688288|NCT03291587|364522532|FG001|Overall Study|Death|4|||
105688289|NCT03291587|364522531|FG000|Overall Study|Not interested in participating|8|||
105688290|NCT03291587|364522532|FG001|Overall Study|Not interested in participating|6|||
105688291|NCT03291587|364522531|FG000|Overall Study|Too busy to participate|4|||
105688292|NCT03291587|364522532|FG001|Overall Study|Too busy to participate|2|||
105786730|NCT04196023|364872899|FG001|Overall Study|Withdrawal by Subject|1|||
105786731|NCT04196023|364872898|FG000|Overall Study|Adverse Event|3|||
105786732|NCT04196023|364872899|FG001|Overall Study|Adverse Event|1|||
105786733|NCT04196023|364872898|FG000|Overall Study|Lost to Follow-up|0|||
105786734|NCT04196023|364872899|FG001|Overall Study|Lost to Follow-up|1|||
105786735|NCT04359758|364872900|FG000|Overall Study|Protocol Violation|3|||
105786736|NCT04359758|364872901|FG001|Overall Study|Protocol Violation|2|||
105786737|NCT03099096|364872902|FG000|Overall Study|Adverse Event|1|||
105786738|NCT03099096|364872902|FG000|Overall Study|Physician Decision|1|||
105786739|NCT04753606|364872903|FG000|Overall Study|Adverse Event|1|||
105786740|NCT04753606|364872904|FG001|Overall Study|Adverse Event|0|||
105786741|NCT04753606|364872905|FG002|Overall Study|Adverse Event|0|||
105786742|NCT00752206|364872910|FG000|Overall Study|Disease progression|8|||
105786743|NCT00752206|364872911|FG001|Overall Study|Disease progression|11|||
105786744|NCT00752206|364872910|FG000|Overall Study|Pregnancy|1|||
105786745|NCT00752206|364872911|FG001|Overall Study|Pregnancy|0|||
105786746|NCT00678652|364872912|FG000|Overall Study|Protocol Violation|2|||
105786747|NCT00678652|364872913|FG001|Overall Study|Protocol Violation|0|||
105786748|NCT00678652|364872914|FG002|Overall Study|Protocol Violation|0|||
105786749|NCT00678652|364872915|FG003|Overall Study|Protocol Violation|0|||
105786750|NCT00678652|364872912|FG000|Overall Study|Pregnancy|0|||
105786751|NCT00678652|364872913|FG001|Overall Study|Pregnancy|0|||
105786752|NCT00678652|364872914|FG002|Overall Study|Pregnancy|1|||
105786753|NCT00678652|364872915|FG003|Overall Study|Pregnancy|0|||
105786754|NCT00678652|364872912|FG000|Overall Study|Relocation|1|||
105786755|NCT00678652|364872913|FG001|Overall Study|Relocation|0|||
105786756|NCT00678652|364872914|FG002|Overall Study|Relocation|0|||
105786757|NCT00678652|364872915|FG003|Overall Study|Relocation|0|||
105786758|NCT04365387|364872918|FG000|Overall Study|Adverse Event|4|||
105786759|NCT04365387|364872919|FG001|Overall Study|Adverse Event|2|||
105786760|NCT04365387|364872918|FG000|Overall Study|Participants request|14|||
105786761|NCT04365387|364872919|FG001|Overall Study|Participants request|14|||
105786762|NCT04365387|364872918|FG000|Overall Study|Lost to Follow-up|8|||
105786763|NCT04365387|364872919|FG001|Overall Study|Lost to Follow-up|5|||
105786764|NCT04365387|364872918|FG000|Overall Study|Protocol deviation|3|||
105786765|NCT04365387|364872919|FG001|Overall Study|Protocol deviation|4|||
105786766|NCT04365387|364872918|FG000|Overall Study|Participant compliance with visit schedule|1|||
105786767|NCT04365387|364872919|FG001|Overall Study|Participant compliance with visit schedule|0|||
105786768|NCT04365387|364872918|FG000|Overall Study|Participant incarcerated|1|||
105786769|NCT04365387|364872919|FG001|Overall Study|Participant incarcerated|0|||
105786770|NCT04365387|364872918|FG000|Overall Study|Participant moved out of town (relocated)|0|||
105786771|NCT04365387|364872919|FG001|Overall Study|Participant moved out of town (relocated)|1|||
105786772|NCT04365387|364872918|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
105558996|NCT03318523|364044564|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
105558997|NCT03318523|364044565|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
105558998|NCT03318523|364044566|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
105558999|NCT03318523|364044557|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
105559000|NCT03318523|364044558|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
105559001|NCT03318523|364044559|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
105559002|NCT03318523|364044560|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
105559003|NCT03318523|364044561|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
105559004|NCT03318523|364044562|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
105559005|NCT03318523|364044563|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
105559006|NCT03318523|364044564|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
105786773|NCT04365387|364872919|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
105786774|NCT04365387|364872918|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
105786775|NCT04365387|364872919|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
105786776|NCT05770401|364872920|FG000|Overall Study|Lost to Follow-up|5|||
105786777|NCT05770401|364872921|FG001|Overall Study|Lost to Follow-up|4|||
105786778|NCT00402298|364872922|FG000|Overall Study|Withdrawal by Subject|1|||
105786779|NCT00402298|364872923|FG001|Overall Study|Withdrawal by Subject|0|||
105786780|NCT04784455|364872924|FG000|Overall Study|Death|4|||
105559007|NCT03318523|364044565|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
105786781|NCT05570604|364872925|FG000|Overall Study|Lost to Follow-up|1|||
105786782|NCT05570604|364872926|FG001|Overall Study|Lost to Follow-up|5|||
105786783|NCT05570604|364872925|FG000|Overall Study|Illness|2|||
105688293|NCT01116882|364522533|FG000|30-day|Lost to Follow-up|50|||
105688294|NCT01116882|364522534|FG001|30-day|Lost to Follow-up|21|||
105688295|NCT01116882|364522533|FG000|30-day|Withdrawal by Subject|2|||
105688296|NCT01116882|364522534|FG001|30-day|Withdrawal by Subject|4|||
105688297|NCT01116882|364522533|FG000|30-day|Other Reasons|16|||
105688298|NCT01116882|364522534|FG001|30-day|Other Reasons|6|||
105688299|NCT01116882|364522533|FG000|12-month|Lost to Follow-up|111|||
105688300|NCT01116882|364522534|FG001|12-month|Lost to Follow-up|42|||
105688301|NCT01116882|364522533|FG000|12-month|Other Reasons|151|||
105688302|NCT01116882|364522534|FG001|12-month|Other Reasons|49|||
105688303|NCT01116882|364522533|FG000|12-month|Withdrawal by Subject|5|||
105688304|NCT01116882|364522534|FG001|12-month|Withdrawal by Subject|8|||
105688305|NCT00372385|364522535|FG000|Overall Study|Adverse Event|6|||
105688306|NCT00372385|364522536|FG001|Overall Study|Adverse Event|11|||
105688307|NCT00372385|364522537|FG002|Overall Study|Adverse Event|9|||
105688308|NCT00372385|364522538|FG003|Overall Study|Adverse Event|7|||
105688309|NCT00372385|364522535|FG000|Overall Study|Noncompliance|0|||
105688310|NCT00372385|364522536|FG001|Overall Study|Noncompliance|1|||
105688311|NCT00372385|364522537|FG002|Overall Study|Noncompliance|1|||
105688312|NCT00372385|364522538|FG003|Overall Study|Noncompliance|1|||
105688313|NCT00372385|364522535|FG000|Overall Study|Physician Decision|1|||
105688314|NCT00372385|364522536|FG001|Overall Study|Physician Decision|0|||
105688315|NCT00372385|364522537|FG002|Overall Study|Physician Decision|0|||
105688316|NCT00372385|364522538|FG003|Overall Study|Physician Decision|0|||
105688317|NCT00372385|364522535|FG000|Overall Study|Lost to Follow-up|2|||
105688318|NCT00372385|364522536|FG001|Overall Study|Lost to Follow-up|0|||
105688319|NCT00372385|364522537|FG002|Overall Study|Lost to Follow-up|0|||
105688320|NCT00372385|364522538|FG003|Overall Study|Lost to Follow-up|0|||
105688321|NCT00372385|364522535|FG000|Overall Study|Withdrawal by Subject|2|||
105688322|NCT00372385|364522536|FG001|Overall Study|Withdrawal by Subject|1|||
105688323|NCT00372385|364522537|FG002|Overall Study|Withdrawal by Subject|0|||
105688324|NCT00372385|364522538|FG003|Overall Study|Withdrawal by Subject|0|||
105688325|NCT00372385|364522535|FG000|Overall Study|Refusal of Treatment|3|||
105688326|NCT00372385|364522536|FG001|Overall Study|Refusal of Treatment|6|||
105688327|NCT00372385|364522537|FG002|Overall Study|Refusal of Treatment|0|||
105688328|NCT00372385|364522538|FG003|Overall Study|Refusal of Treatment|0|||
105688329|NCT00372385|364522535|FG000|Overall Study|No Response|1|||
105688330|NCT00372385|364522536|FG001|Overall Study|No Response|1|||
105688331|NCT00372385|364522537|FG002|Overall Study|No Response|0|||
105688332|NCT00372385|364522538|FG003|Overall Study|No Response|0|||
105688333|NCT00372385|364522535|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
105688334|NCT00372385|364522536|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
105688335|NCT00372385|364522537|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
105688336|NCT00372385|364522538|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
105688337|NCT00372385|364522535|FG000|Overall Study|Virologic Stopping Rule|17|||
105688338|NCT00372385|364522536|FG001|Overall Study|Virologic Stopping Rule|0|||
105688339|NCT00372385|364522537|FG002|Overall Study|Virologic Stopping Rule|0|||
105688340|NCT00372385|364522538|FG003|Overall Study|Virologic Stopping Rule|0|||
105688341|NCT01139658|364522541|FG000|Overall Study|Adverse Event|10|||
105688342|NCT01139658|364522542|FG001|Overall Study|Adverse Event|27|||
105688343|NCT01139658|364522541|FG000|Overall Study|Lack of Efficacy|15|||
105688344|NCT01139658|364522542|FG001|Overall Study|Lack of Efficacy|7|||
105688345|NCT01139658|364522541|FG000|Overall Study|Withdrawal by Subject|2|||
105688346|NCT01139658|364522542|FG001|Overall Study|Withdrawal by Subject|4|||
105688347|NCT01139658|364522541|FG000|Overall Study|No documentation of treatment|1|||
105688348|NCT01139658|364522542|FG001|Overall Study|No documentation of treatment|0|||
105688349|NCT01139658|364522541|FG000|Overall Study|Other|28|||
105688350|NCT01139658|364522542|FG001|Overall Study|Other|75|||
105688351|NCT00504881|364522543|FG000|Overall Study|Lack of Efficacy|1|||
105688352|NCT00504881|364522544|FG001|Overall Study|Lack of Efficacy|5|||
105688353|NCT00504881|364522543|FG000|Overall Study|Lost to Follow-up|0|||
105688354|NCT00504881|364522544|FG001|Overall Study|Lost to Follow-up|2|||
105688355|NCT00504881|364522543|FG000|Overall Study|Withdrawal by Subject|1|||
105688356|NCT00504881|364522544|FG001|Overall Study|Withdrawal by Subject|4|||
105688357|NCT00504881|364522543|FG000|Overall Study|Non-Compliance|1|||
105688358|NCT00504881|364522544|FG001|Overall Study|Non-Compliance|0|||
105688359|NCT00504881|364522543|FG000|Overall Study|No Birth Control|0|||
105688360|NCT00504881|364522544|FG001|Overall Study|No Birth Control|1|||
105688361|NCT00504881|364522543|FG000|Overall Study|Safety Visit not performed|0|||
105688362|NCT00504881|364522544|FG001|Overall Study|Safety Visit not performed|1|||
105688363|NCT00504881|364522543|FG000|Overall Study|AE, serious fatal|0|||
105688364|NCT00504881|364522544|FG001|Overall Study|AE, serious fatal|1|||
105688365|NCT00504881|364522543|FG000|Overall Study|SAE, non-fatal|2|||
105688366|NCT00504881|364522544|FG001|Overall Study|SAE, non-fatal|6|||
105688367|NCT00504881|364522543|FG000|Overall Study|AE, non-serious non-fatal|4|||
105688368|NCT00504881|364522544|FG001|Overall Study|AE, non-serious non-fatal|14|||
105688369|NCT00504881|364522543|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
105688370|NCT00504881|364522544|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
105786784|NCT05570604|364872926|FG001|Overall Study|Illness|2|||
105688371|NCT00504881|364522543|FG000|Overall Study|AE of unknown type|1|||
105688372|NCT00504881|364522544|FG001|Overall Study|AE of unknown type|0|||
105688373|NCT03240874|364522546|FG000|Overall Study|Lost to Follow-up|0|||
105688374|NCT03240874|364522547|FG001|Overall Study|Lost to Follow-up|2|||
105688375|NCT03240874|364522548|FG002|Overall Study|Lost to Follow-up|4|||
105688376|NCT03240874|364522549|FG003|Overall Study|Lost to Follow-up|1|||
105688377|NCT04223856|364522556|FG000|Overall Study|Progressive disease|153|||
105688378|NCT04223856|364522557|FG001|Overall Study|Progressive disease|73|||
105688379|NCT04223856|364522556|FG000|Overall Study|Adverse Event|97|||
105688380|NCT04223856|364522557|FG001|Overall Study|Adverse Event|62|||
105688381|NCT04223856|364522556|FG000|Overall Study|Physician Decision|9|||
105688382|NCT04223856|364522557|FG001|Overall Study|Physician Decision|28|||
105688383|NCT04223856|364522556|FG000|Overall Study|Withdrawal by Subject|22|||
105688384|NCT04223856|364522557|FG001|Overall Study|Withdrawal by Subject|24|||
105688385|NCT04223856|364522556|FG000|Overall Study|Other|7|||
105688386|NCT04223856|364522557|FG001|Overall Study|Other|2|||
105688387|NCT04223856|364522556|FG000|Overall Study|Randomized but not treated|2|||
105688388|NCT04223856|364522557|FG001|Overall Study|Randomized but not treated|11|||
105688389|NCT04223856|364522556|FG000|Overall Study|On-treatment|144|||
105688390|NCT04223856|364522557|FG001|Overall Study|On-treatment|0|||
105688391|NCT06515483|364522560|FG000|Overall Study|Subject withdraw due to family issues|1|||
105688392|NCT06515483|364522561|FG001|Overall Study|Subject withdraw due to family issues|0|||
105688393|NCT02101034|364524098|FG000|Overall Study|Enrolled but did not start treatment|0|||
105688394|NCT02101034|364524099|FG001|Overall Study|Enrolled but did not start treatment|0|||
105346019|NCT04506905|363267315|FG004|Overall Study|Lost to Follow-up|0|||
105346020|NCT04506905|363267316|FG005|Overall Study|Lost to Follow-up|0|||
105346021|NCT04506905|363267317|FG006|Overall Study|Lost to Follow-up|0|||
105346022|NCT04506905|363267318|FG007|Overall Study|Lost to Follow-up|0|||
105346023|NCT04506905|363267319|FG008|Overall Study|Lost to Follow-up|0|||
105688395|NCT02101034|364524100|FG002|Overall Study|Enrolled but did not start treatment|1|||
105346024|NCT04506905|363267311|FG000|Overall Study|Withdrawal by Subject|0|||
105688396|NCT02101034|364524101|FG003|Overall Study|Enrolled but did not start treatment|0|||
105688397|NCT02101034|364524102|FG004|Overall Study|Enrolled but did not start treatment|0|||
105688398|NCT01101477|364524104|FG000|Overall Study|Protocol Violation|5|||
105688399|NCT01101477|364524105|FG001|Overall Study|Protocol Violation|3|||
105688400|NCT01101477|364524106|FG002|Overall Study|Protocol Violation|1|||
105688401|NCT02952001|364524107|FG000|Overall Study|Adverse Event|3|||
105688402|NCT02952001|364524108|FG001|Overall Study|Adverse Event|0|||
105688403|NCT02952001|364524107|FG000|Overall Study|Prohibited therapy|10|||
105688404|NCT02952001|364524108|FG001|Overall Study|Prohibited therapy|3|||
105688405|NCT02952001|364524107|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
105688406|NCT02952001|364524108|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
105688407|NCT02021292|364524111|FG000|Overall Study|Physician Decision|0|||
105688408|NCT02021292|364524112|FG001|Overall Study|Physician Decision|1|||
105688409|NCT02021292|364524111|FG000|Overall Study|Lost to Follow-up|0|||
105688410|NCT02021292|364524112|FG001|Overall Study|Lost to Follow-up|1|||
105688411|NCT02021292|364524111|FG000|Overall Study|Death|0|||
105688412|NCT02021292|364524112|FG001|Overall Study|Death|1|||
105688413|NCT03249714|364524115|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
105688414|NCT03249714|364524116|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
105688415|NCT03249714|364524115|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
105688416|NCT03249714|364524116|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
105688417|NCT03249714|364524115|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
105688418|NCT03249714|364524116|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
105688419|NCT03249714|364524115|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
105688420|NCT03249714|364524116|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
105688421|NCT02634346|364524119|FG000|Overall Study|Withdrawal by Subject|8|||
105688422|NCT02634346|364524120|FG001|Overall Study|Withdrawal by Subject|9|||
105688423|NCT02634346|364524121|FG002|Overall Study|Withdrawal by Subject|8|||
105688424|NCT02634346|364524119|FG000|Overall Study|Adverse Event|2|||
105688425|NCT02634346|364524120|FG001|Overall Study|Adverse Event|2|||
105688426|NCT02634346|364524121|FG002|Overall Study|Adverse Event|7|||
105688427|NCT02634346|364524119|FG000|Overall Study|Lack of Efficacy|1|||
105688428|NCT02634346|364524120|FG001|Overall Study|Lack of Efficacy|2|||
105688429|NCT02634346|364524121|FG002|Overall Study|Lack of Efficacy|8|||
105688430|NCT02634346|364524119|FG000|Overall Study|Lost to Follow-up|1|||
105688431|NCT02634346|364524120|FG001|Overall Study|Lost to Follow-up|0|||
105688432|NCT02634346|364524121|FG002|Overall Study|Lost to Follow-up|0|||
105688433|NCT02634346|364524119|FG000|Overall Study|Protocol Violation|0|||
105688434|NCT02634346|364524120|FG001|Overall Study|Protocol Violation|1|||
105688435|NCT02634346|364524121|FG002|Overall Study|Protocol Violation|0|||
105688436|NCT02170389|364524126|FG000|Overall Study|Study terminated prior to start of treat|1|||
105688437|NCT02824263|364524127|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
105688438|NCT02824263|364524128|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
105688439|NCT02824263|364524127|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
105688440|NCT02824263|364524128|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
105688441|NCT01112306|364524129|FG000|Overall Study|Death|175|||
105688442|NCT01112306|364524129|FG000|Overall Study|Lost to Follow-up|9|||
105688443|NCT01112306|364524129|FG000|Overall Study|Withdrawal by Subject|31|||
105688444|NCT01112306|364524129|FG000|Overall Study|Other|70|||
105688445|NCT02175004|364524132|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
105688446|NCT02175004|364524133|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
105688447|NCT02175004|364524132|FG000|Overall Study|Investigator Judgment|1|||
105688448|NCT02175004|364524133|FG001|Overall Study|Investigator Judgment|4|||
105688449|NCT02175004|364524132|FG000|Overall Study|Voluntary Withdrawal|6|||
105688450|NCT02175004|364524133|FG001|Overall Study|Voluntary Withdrawal|19|||
105688451|NCT02175004|364524132|FG000|Overall Study|Liver Transplant|1|||
105688452|NCT02175004|364524133|FG001|Overall Study|Liver Transplant|0|||
105688453|NCT02175004|364524132|FG000|Overall Study|Disease Progression|1|||
105688454|NCT02175004|364524133|FG001|Overall Study|Disease Progression|0|||
105688455|NCT02175004|364524132|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
105688456|NCT02175004|364524133|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
105688457|NCT02960854|364524134|FG000|Overall Study|Not Disclosed|2|||
105688458|NCT02960854|364524135|FG001|Overall Study|Not Disclosed|2|||
105688459|NCT02960854|364524134|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
105688460|NCT02960854|364524135|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
105688461|NCT02960854|364524134|FG000|Overall Study|Subject Withdrew Consent|0|||
105688462|NCT02960854|364524135|FG001|Overall Study|Subject Withdrew Consent|1|||
105688463|NCT02960854|364524134|FG000|Overall Study|Death|4|||
105688464|NCT02960854|364524135|FG001|Overall Study|Death|6|||
105688465|NCT00221195|364524136|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
105688466|NCT00221195|364524137|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
105688467|NCT00221195|364524136|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
105688468|NCT00221195|364524137|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
105688469|NCT00221195|364524136|FG000|Washout Period (Months 7-9)|Death|0|||
105688470|NCT00221195|364524137|FG001|Washout Period (Months 7-9)|Death|1|||
105688471|NCT00221195|364524136|FG000|Therapy 2 (Months 10-15)|Death|1|||
105688472|NCT00221195|364524137|FG001|Therapy 2 (Months 10-15)|Death|0|||
105688473|NCT00221195|364524136|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
105688474|NCT00221195|364524137|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
105688475|NCT01607554|364524140|FG000|Overall Study|Disease progression|2|||
105688476|NCT04442737|364524141|FG000|Overall Study|Lost to Follow-up|1|||
105688477|NCT04442737|364524142|FG001|Overall Study|Lost to Follow-up|3|||
105688478|NCT04442737|364524141|FG000|Overall Study|Withdrawal by Subject|3|||
105688479|NCT04442737|364524142|FG001|Overall Study|Withdrawal by Subject|2|||
105688480|NCT04442737|364524141|FG000|Overall Study|Adverse Event|3|||
105688481|NCT04442737|364524142|FG001|Overall Study|Adverse Event|2|||
105688482|NCT04442737|364524141|FG000|Overall Study|Death|0|||
105688483|NCT04442737|364524142|FG001|Overall Study|Death|1|||
105688484|NCT04442737|364524141|FG000|Overall Study|Protocol Violation|0|||
105688485|NCT04442737|364524142|FG001|Overall Study|Protocol Violation|2|||
105688486|NCT04442737|364524141|FG000|Overall Study|Other|1|||
105688487|NCT04442737|364524142|FG001|Overall Study|Other|1|||
105688488|NCT00820027|364524143|FG000|Overall Study|Adverse Event|15|||
105688489|NCT00820027|364524144|FG001|Overall Study|Adverse Event|8|||
105688490|NCT00820027|364524145|FG002|Overall Study|Adverse Event|10|||
105688491|NCT00820027|364524146|FG003|Overall Study|Adverse Event|5|||
105688492|NCT00820027|364524143|FG000|Overall Study|Lack of Efficacy|2|||
105688493|NCT00820027|364524144|FG001|Overall Study|Lack of Efficacy|1|||
105688494|NCT00820027|364524145|FG002|Overall Study|Lack of Efficacy|2|||
105688495|NCT00820027|364524146|FG003|Overall Study|Lack of Efficacy|2|||
105688496|NCT00820027|364524143|FG000|Overall Study|Physician Decision|0|||
105688497|NCT00820027|364524144|FG001|Overall Study|Physician Decision|1|||
105688498|NCT00820027|364524145|FG002|Overall Study|Physician Decision|1|||
105688499|NCT00820027|364524146|FG003|Overall Study|Physician Decision|0|||
105688500|NCT00820027|364524143|FG000|Overall Study|Protocol Violation|3|||
105688501|NCT00820027|364524144|FG001|Overall Study|Protocol Violation|0|||
105688502|NCT00820027|364524145|FG002|Overall Study|Protocol Violation|4|||
105688503|NCT00820027|364524146|FG003|Overall Study|Protocol Violation|0|||
105688504|NCT00820027|364524143|FG000|Overall Study|Withdrawal by Subject|6|||
105688505|NCT00820027|364524144|FG001|Overall Study|Withdrawal by Subject|4|||
105688506|NCT00820027|364524145|FG002|Overall Study|Withdrawal by Subject|4|||
105688507|NCT00820027|364524146|FG003|Overall Study|Withdrawal by Subject|6|||
105688508|NCT02982187|364524147|FG000|Overall Study|Withdrawal by Subject|0|||
105688509|NCT02982187|364524148|FG001|Overall Study|Withdrawal by Subject|0|||
105688510|NCT02982187|364524149|FG002|Overall Study|Withdrawal by Subject|0|||
105688511|NCT02982187|364524150|FG003|Overall Study|Withdrawal by Subject|0|||
105688512|NCT02982187|364524151|FG004|Overall Study|Withdrawal by Subject|0|||
105688513|NCT02982187|364524152|FG005|Overall Study|Withdrawal by Subject|0|||
105688514|NCT02982187|364524153|FG006|Overall Study|Withdrawal by Subject|1|||
105688515|NCT02982187|364524154|FG007|Overall Study|Withdrawal by Subject|0|||
105688516|NCT02604433|364524155|FG000|Overall Study|Withdrawal by Subject|37|||
105688517|NCT02604433|364524156|FG001|Overall Study|Withdrawal by Subject|16|||
105688518|NCT02604433|364524155|FG000|Overall Study|Adverse Event|4|||
105688519|NCT02604433|364524156|FG001|Overall Study|Adverse Event|0|||
105688520|NCT02604433|364524155|FG000|Overall Study|Other reasons|3|||
105688521|NCT02604433|364524156|FG001|Overall Study|Other reasons|5|||
105688522|NCT02604433|364524155|FG000|Overall Study|Death|4|||
105688523|NCT02604433|364524156|FG001|Overall Study|Death|1|||
105688524|NCT02604433|364524155|FG000|Overall Study|Transition to Rollover Protocol|169|||
105688525|NCT02604433|364524156|FG001|Overall Study|Transition to Rollover Protocol|82|||
105688526|NCT02604433|364524155|FG000|Overall Study|Physician Decision|1|||
105688527|NCT02604433|364524156|FG001|Overall Study|Physician Decision|1|||
105688528|NCT02604433|364524155|FG000|Overall Study|Lack of Efficacy|0|||
105688529|NCT02604433|364524156|FG001|Overall Study|Lack of Efficacy|1|||
105688530|NCT03285178|364524164|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
105688531|NCT03285178|364524165|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
105346025|NCT04506905|363267312|FG001|Overall Study|Withdrawal by Subject|0|||
105688532|NCT03285178|364524166|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
105786785|NCT05643573|364872927|FG000|Overall Study|Adverse Event|117|||
105688533|NCT03285178|364524167|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
105688534|NCT03285178|364524168|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
105688535|NCT03285178|364524169|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
105688536|NCT03285178|364524170|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
105688537|NCT03285178|364524164|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
105688538|NCT03285178|364524165|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
105688539|NCT03285178|364524166|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
105688540|NCT03285178|364524167|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
105688541|NCT03285178|364524168|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
105688542|NCT03285178|364524169|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
105688543|NCT03285178|364524170|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
105688544|NCT03285178|364524164|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
105688545|NCT03285178|364524165|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
105688546|NCT03285178|364524166|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
105688547|NCT03285178|364524167|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
105688548|NCT03285178|364524168|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
105688549|NCT03285178|364524169|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
105688550|NCT03285178|364524170|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
105688551|NCT03285178|364524164|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
105688552|NCT03285178|364524165|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
105688553|NCT03285178|364524166|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
105688554|NCT03285178|364524167|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
105688555|NCT03285178|364524168|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
105688556|NCT03285178|364524169|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
105688557|NCT03285178|364524170|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
105688558|NCT03285178|364524164|FG000|Single-Blind Run-In Period|Physician Decision|2|||
105688559|NCT03285178|364524165|FG001|Single-Blind Run-In Period|Physician Decision|0|||
105688560|NCT03285178|364524166|FG002|Single-Blind Run-In Period|Physician Decision|0|||
105688561|NCT03285178|364524167|FG003|Single-Blind Run-In Period|Physician Decision|0|||
105688562|NCT03285178|364524168|FG004|Single-Blind Run-In Period|Physician Decision|0|||
105688563|NCT03285178|364524169|FG005|Single-Blind Run-In Period|Physician Decision|0|||
105688564|NCT03285178|364524170|FG006|Single-Blind Run-In Period|Physician Decision|0|||
105688565|NCT03285178|364524164|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
105688566|NCT03285178|364524165|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
105688567|NCT03285178|364524166|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
105688568|NCT03285178|364524167|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
105688569|NCT03285178|364524168|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
105688570|NCT03285178|364524169|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
105688571|NCT03285178|364524170|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
105688572|NCT03285178|364524164|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105688573|NCT03285178|364524165|FG001|Double-Blind Treatment Period|Adverse Event|0|||
105688574|NCT03285178|364524166|FG002|Double-Blind Treatment Period|Adverse Event|0|||
105688575|NCT03285178|364524167|FG003|Double-Blind Treatment Period|Adverse Event|0|||
105688576|NCT03285178|364524168|FG004|Double-Blind Treatment Period|Adverse Event|0|||
105688577|NCT03285178|364524169|FG005|Double-Blind Treatment Period|Adverse Event|0|||
105688578|NCT03285178|364524170|FG006|Double-Blind Treatment Period|Adverse Event|2|||
105688579|NCT03285178|364524164|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105688580|NCT03285178|364524165|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
105688581|NCT03285178|364524166|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
105688582|NCT03285178|364524167|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
105688583|NCT03285178|364524168|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
105688584|NCT03285178|364524169|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
105688585|NCT03285178|364524170|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
105786786|NCT05643573|364872928|FG001|Overall Study|Adverse Event|90|||
105786787|NCT05643573|364872927|FG000|Overall Study|Death|53|||
105786788|NCT05643573|364872928|FG001|Overall Study|Death|57|||
105786789|NCT05643573|364872927|FG000|Overall Study|Lost to Follow-up|6|||
105346026|NCT04506905|363267313|FG002|Overall Study|Withdrawal by Subject|0|||
105346027|NCT04506905|363267314|FG003|Overall Study|Withdrawal by Subject|2|||
105346028|NCT04506905|363267315|FG004|Overall Study|Withdrawal by Subject|0|||
105346029|NCT04506905|363267316|FG005|Overall Study|Withdrawal by Subject|0|||
105346030|NCT04506905|363267317|FG006|Overall Study|Withdrawal by Subject|0|||
105346031|NCT04506905|363267318|FG007|Overall Study|Withdrawal by Subject|0|||
105346032|NCT04506905|363267319|FG008|Overall Study|Withdrawal by Subject|0|||
105346033|NCT04683939|363267320|FG000|Overall Study|Study termination by the sponsor|0|||
105346034|NCT04683939|363267321|FG001|Overall Study|Study termination by the sponsor|1|||
105346035|NCT04683939|363267322|FG002|Overall Study|Study termination by the sponsor|2|||
105346036|NCT04683939|363267323|FG003|Overall Study|Study termination by the sponsor|2|||
105346037|NCT04683939|363267320|FG000|Overall Study|Death|1|||
105346038|NCT04683939|363267321|FG001|Overall Study|Death|1|||
105346039|NCT04683939|363267322|FG002|Overall Study|Death|2|||
105346040|NCT04683939|363267323|FG003|Overall Study|Death|1|||
105346041|NCT04683939|363267320|FG000|Overall Study|Withdrawal by Subject|1|||
105346042|NCT04683939|363267321|FG001|Overall Study|Withdrawal by Subject|0|||
105471465|NCT02474069|363738189|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
105471466|NCT02474069|363738187|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
105786790|NCT05643573|364872928|FG001|Overall Study|Lost to Follow-up|3|||
105688586|NCT03285178|364524164|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105688587|NCT03285178|364524165|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105688588|NCT03285178|364524166|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105688589|NCT03285178|364524167|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105688590|NCT03285178|364524168|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105688591|NCT03285178|364524169|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
105688592|NCT03285178|364524170|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105688593|NCT03285178|364524164|FG000|Double-Blind Treatment Period|COVID-19|0|||
105688594|NCT03285178|364524165|FG001|Double-Blind Treatment Period|COVID-19|0|||
105688595|NCT03285178|364524166|FG002|Double-Blind Treatment Period|COVID-19|1|||
105688596|NCT03285178|364524167|FG003|Double-Blind Treatment Period|COVID-19|0|||
105688597|NCT03285178|364524168|FG004|Double-Blind Treatment Period|COVID-19|0|||
105786791|NCT05643573|364872927|FG000|Overall Study|Other|18|||
105786792|NCT05643573|364872928|FG001|Overall Study|Other|15|||
105688598|NCT03285178|364524169|FG005|Double-Blind Treatment Period|COVID-19|0|||
105786793|NCT05643573|364872927|FG000|Overall Study|Outcome event|64|||
105688599|NCT03285178|364524170|FG006|Double-Blind Treatment Period|COVID-19|0|||
105688600|NCT01388790|364524171|FG000|Overall Study|Ongoing at data cut-off date|8|||
105688601|NCT01324323|364524172|FG000|Overall Study|Withdrawal by Subject|1|||
105688602|NCT00908232|364524173|FG000|Cycle 1 to 4|Death|5|||
105688603|NCT00908232|364524174|FG001|Cycle 1 to 4|Death|0|||
105688604|NCT00908232|364524175|FG002|Cycle 1 to 4|Death|0|||
105688605|NCT00908232|364524176|FG003|Cycle 1 to 4|Death|0|||
105688606|NCT00908232|364524173|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
105688607|NCT00908232|364524174|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
105688608|NCT00908232|364524175|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
105688609|NCT00908232|364524176|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
105688610|NCT00908232|364524173|FG000|Cycle 1 to 4|Progressive Disease|6|||
105688611|NCT00908232|364524174|FG001|Cycle 1 to 4|Progressive Disease|0|||
105688612|NCT00908232|364524175|FG002|Cycle 1 to 4|Progressive Disease|0|||
105688613|NCT00908232|364524176|FG003|Cycle 1 to 4|Progressive Disease|0|||
105688614|NCT00908232|364524173|FG000|Cycle 1 to 4|Adverse Event|12|||
105688615|NCT00908232|364524174|FG001|Cycle 1 to 4|Adverse Event|0|||
105688616|NCT00908232|364524175|FG002|Cycle 1 to 4|Adverse Event|0|||
105688617|NCT00908232|364524176|FG003|Cycle 1 to 4|Adverse Event|0|||
105688618|NCT00908232|364524173|FG000|Cycle 1 to 4|Other|1|||
105688619|NCT00908232|364524174|FG001|Cycle 1 to 4|Other|0|||
105688620|NCT00908232|364524175|FG002|Cycle 1 to 4|Other|0|||
105688621|NCT00908232|364524176|FG003|Cycle 1 to 4|Other|0|||
105688622|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
105688623|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
105688624|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
105688625|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
105688626|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
105688627|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
105688628|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
105688629|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
105688630|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
105688631|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
105688632|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
105688633|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
105688634|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
105688635|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
105688636|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
105688637|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
105688638|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
105688639|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
105688640|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
105688641|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
105688642|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
105688643|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
105688644|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
105688645|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
105688646|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
105688647|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
105688648|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
105559008|NCT03318523|364044566|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
105559009|NCT03318523|364044557|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
105688649|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
105688650|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
105688651|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
105688652|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
105688653|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
105688654|NCT01128894|364524177|FG000|Overall Study|Adverse Event|31|||
105688655|NCT01128894|364524178|FG001|Overall Study|Adverse Event|41|||
105688656|NCT01128894|364524177|FG000|Overall Study|Protocol Violation|2|||
105559010|NCT03318523|364044558|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
105688657|NCT01128894|364524178|FG001|Overall Study|Protocol Violation|1|||
105688658|NCT01128894|364524177|FG000|Overall Study|Noncompliance|4|||
105688659|NCT01128894|364524178|FG001|Overall Study|Noncompliance|5|||
105688660|NCT01128894|364524177|FG000|Overall Study|Lost to Follow-up|8|||
105688661|NCT01128894|364524178|FG001|Overall Study|Lost to Follow-up|8|||
105688662|NCT01128894|364524177|FG000|Overall Study|Withdrawal by Subject|10|||
105688663|NCT01128894|364524178|FG001|Overall Study|Withdrawal by Subject|12|||
105688664|NCT01128894|364524177|FG000|Overall Study|Physician Decision|2|||
105688665|NCT01128894|364524178|FG001|Overall Study|Physician Decision|1|||
105688666|NCT01128894|364524177|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
105688667|NCT01128894|364524178|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
105688668|NCT03437278|364524179|FG000|Overall Study|Adverse Event|0|||
105688669|NCT03437278|364524180|FG001|Overall Study|Adverse Event|0|||
105688670|NCT03437278|364524181|FG002|Overall Study|Adverse Event|1|||
105688671|NCT03437278|364524179|FG000|Overall Study|Progressive disease|1|||
105688672|NCT03437278|364524180|FG001|Overall Study|Progressive disease|0|||
105688673|NCT03437278|364524181|FG002|Overall Study|Progressive disease|0|||
105688674|NCT03437278|364524179|FG000|Overall Study|Physician Decision|1|||
105688675|NCT03437278|364524180|FG001|Overall Study|Physician Decision|0|||
105688676|NCT03437278|364524181|FG002|Overall Study|Physician Decision|1|||
105688677|NCT03093350|364524183|FG000|Overall Study|Death|1|||
105688678|NCT03093350|364524183|FG000|Overall Study|Signed consent, never began treartment|1|||
105688679|NCT01630434|364524191|FG000|Overall Study|Donor lungs turned down|1|||
105688680|NCT01630434|364524192|FG001|Overall Study|Donor lungs turned down|0|||
105688681|NCT01630434|364524191|FG000|Overall Study|Protocol Violation|9|||
105688682|NCT01630434|364524192|FG001|Overall Study|Protocol Violation|4|||
105688683|NCT01630434|364524191|FG000|Overall Study|Death|20|||
105688684|NCT01630434|364524192|FG001|Overall Study|Death|26|||
105688685|NCT01230788|364524201|FG000|Overall Study|Prescribed exclusion drug|1|||
105688686|NCT01026454|364524202|FG000|Second Intervention|Pregnancy|1|||
105688687|NCT01026454|364524203|FG001|Second Intervention|Pregnancy|1|||
105688688|NCT01176773|364524204|FG000|Overall Study|Screen Failure|2|||
105688689|NCT01176773|364524204|FG000|Overall Study|Withdrew consent|1|||
105688690|NCT03181451|364524219|FG000|Overall Study|Adverse Event|0|||
105688691|NCT03181451|364524220|FG001|Overall Study|Adverse Event|1|||
105688692|NCT03181451|364524221|FG002|Overall Study|Adverse Event|0|||
105688693|NCT03181451|364524219|FG000|Overall Study|Withdrawal by Subject|0|||
105688694|NCT03181451|364524220|FG001|Overall Study|Withdrawal by Subject|1|||
105688695|NCT03181451|364524221|FG002|Overall Study|Withdrawal by Subject|0|||
105688696|NCT01592864|364524228|FG000|Overall Study|Withdrawal by Subject|0|||
105688697|NCT01592864|364524229|FG001|Overall Study|Withdrawal by Subject|1|||
105688698|NCT01019317|364524230|FG000|Overall Study|Not Eligible|4|||
105688699|NCT00926211|364524231|FG000|Overall Study|Lost to Follow-up|1|||
105688700|NCT01032382|364524232|FG000|Overall Study|Disease dissemination|1|||
105688701|NCT01032382|364524233|FG001|Overall Study|Disease dissemination|1|||
105688702|NCT01032382|364524232|FG000|Overall Study|Treatment failure|3|||
105688703|NCT01032382|364524233|FG001|Overall Study|Treatment failure|1|||
105688704|NCT01032382|364524232|FG000|Overall Study|Index lesion relapse|1|||
105688705|NCT01032382|364524233|FG001|Overall Study|Index lesion relapse|3|||
105688706|NCT00413972|364524245|FG000|Overall Study|Adverse Event|2|||
105688707|NCT00413972|364524246|FG001|Overall Study|Adverse Event|1|||
105688708|NCT00413972|364524247|FG002|Overall Study|Adverse Event|0|||
105688709|NCT00413972|364524248|FG003|Overall Study|Adverse Event|0|||
105471467|NCT02474069|363738188|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
105471468|NCT02474069|363738189|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
105688710|NCT00413972|364524245|FG000|Overall Study|Lost to Follow-up|1|||
105688711|NCT00413972|364524246|FG001|Overall Study|Lost to Follow-up|2|||
105688712|NCT00413972|364524247|FG002|Overall Study|Lost to Follow-up|1|||
105471469|NCT01623050|363738192|FG000|Overall Study|Lost to Follow-up|9|||
105688713|NCT00413972|364524248|FG003|Overall Study|Lost to Follow-up|0|||
105688714|NCT00413972|364524245|FG000|Overall Study|Withdrawal by Subject|4|||
105688715|NCT00413972|364524246|FG001|Overall Study|Withdrawal by Subject|5|||
105688716|NCT00413972|364524247|FG002|Overall Study|Withdrawal by Subject|7|||
105688717|NCT00413972|364524248|FG003|Overall Study|Withdrawal by Subject|2|||
105688718|NCT00413972|364524245|FG000|Overall Study|Protocol Violation|0|||
105688719|NCT00413972|364524246|FG001|Overall Study|Protocol Violation|0|||
105688720|NCT00413972|364524247|FG002|Overall Study|Protocol Violation|2|||
105688721|NCT00413972|364524248|FG003|Overall Study|Protocol Violation|0|||
105688722|NCT00413972|364524245|FG000|Overall Study|Other|0|||
105688723|NCT00413972|364524246|FG001|Overall Study|Other|0|||
105688724|NCT00413972|364524247|FG002|Overall Study|Other|0|||
105688725|NCT00413972|364524248|FG003|Overall Study|Other|1|||
105688726|NCT01163721|364524253|FG000|Overall Study|Adverse Event|5|||
105688727|NCT01163721|364524254|FG001|Overall Study|Adverse Event|6|||
105688728|NCT01163721|364524253|FG000|Overall Study|Withdrawal by Subject|3|||
105688729|NCT01163721|364524254|FG001|Overall Study|Withdrawal by Subject|4|||
105688730|NCT01163721|364524253|FG000|Overall Study|Lost to Follow-up|0|||
105688731|NCT01163721|364524254|FG001|Overall Study|Lost to Follow-up|1|||
105688732|NCT01163721|364524253|FG000|Overall Study|Physician Decision|0|||
105688733|NCT01163721|364524254|FG001|Overall Study|Physician Decision|1|||
105688734|NCT01012739|364524255|FG000|Treatment Period 1|Adverse Event|0|||
105688735|NCT01012739|364524256|FG001|Treatment Period 1|Adverse Event|0|||
105688736|NCT01012739|364524257|FG002|Treatment Period 1|Adverse Event|0|||
105688737|NCT01012739|364524258|FG003|Treatment Period 1|Adverse Event|1|||
105688738|NCT01012739|364524255|FG000|Treatment Period 2|Abnormal test procedure results|0|||
105688739|NCT01012739|364524256|FG001|Treatment Period 2|Abnormal test procedure results|0|||
105688740|NCT01012739|364524257|FG002|Treatment Period 2|Abnormal test procedure results|0|||
105688741|NCT01012739|364524258|FG003|Treatment Period 2|Abnormal test procedure results|1|||
105688742|NCT01485354|364525377|FG000|Overall Study|Withdrawal by Subject|5|||
105688743|NCT01096342|364525378|FG000|Overall Study|Protocol Violation|1|||
105688744|NCT00300781|364525379|FG000|Overall Study|Disease Progression|55|||
105688745|NCT00300781|364525380|FG001|Overall Study|Disease Progression|52|||
105688746|NCT00300781|364525379|FG000|Overall Study|Adverse Event|5|||
105688747|NCT00300781|364525380|FG001|Overall Study|Adverse Event|6|||
105688748|NCT00300781|364525379|FG000|Overall Study|Withdrawal by Subject|1|||
105688749|NCT00300781|364525380|FG001|Overall Study|Withdrawal by Subject|2|||
105688750|NCT00300781|364525379|FG000|Overall Study|Physician Decision|1|||
105688751|NCT00300781|364525380|FG001|Overall Study|Physician Decision|0|||
105688752|NCT00300781|364525379|FG000|Overall Study|Not Recorded|0|||
105688753|NCT00300781|364525380|FG001|Overall Study|Not Recorded|1|||
105688754|NCT00300781|364525379|FG000|Overall Study|Symptomatic Deterioration|1|||
105688755|NCT00300781|364525380|FG001|Overall Study|Symptomatic Deterioration|0|||
105688756|NCT00300781|364525379|FG000|Overall Study|Lost to Follow-up|0|||
105688757|NCT00300781|364525380|FG001|Overall Study|Lost to Follow-up|1|||
105688758|NCT02864381|364525381|FG000|Overall Study|Death|58|||
105688759|NCT02864381|364525382|FG001|Overall Study|Death|61|||
105688760|NCT02864381|364525381|FG000|Overall Study|Withdrew Consent|5|||
105688761|NCT02864381|364525382|FG001|Overall Study|Withdrew Consent|6|||
105688762|NCT02864381|364525381|FG000|Overall Study|Reason Unknown|7|||
105688763|NCT02864381|364525382|FG001|Overall Study|Reason Unknown|3|||
105688764|NCT02864381|364525381|FG000|Overall Study|Lost to Follow-up|1|||
105688765|NCT02864381|364525382|FG001|Overall Study|Lost to Follow-up|1|||
105688766|NCT02864381|364525381|FG000|Overall Study|Investigator's Discretion|1|||
105688767|NCT02864381|364525382|FG001|Overall Study|Investigator's Discretion|0|||
105688768|NCT02864381|364525381|FG000|Overall Study|Protocol Violation|0|||
105688769|NCT02864381|364525382|FG001|Overall Study|Protocol Violation|1|||
105688770|NCT02120625|364525387|FG000|Overall Study|Physician Decision|2|||
105688771|NCT04142450|364525390|FG000|Overall Study|Screen Failure|1|||
105688772|NCT04142450|364525390|FG000|Overall Study|Lost to Follow-up|1|||
105688773|NCT03278106|364525401|FG000|Overall Study|No protocol treatment|1|||
105688774|NCT04098068|364525402|FG000|Overall Study|Disease Progression|7|||
105688775|NCT04098068|364525402|FG000|Overall Study|Withdrawal by Subject|2|||
105688776|NCT04098068|364525402|FG000|Overall Study|New Cancer Diagnosis|1|||
105688777|NCT00784693|364525403|FG000|Overall Study|Lost to Follow-up|0|||
105688778|NCT00784693|364525404|FG001|Overall Study|Lost to Follow-up|1|||
105688779|NCT00784693|364525403|FG000|Overall Study|Lack of Efficacy|1|||
105688780|NCT00784693|364525404|FG001|Overall Study|Lack of Efficacy|1|||
105688781|NCT00784693|364525403|FG000|Overall Study|Withdrawal by Subject|0|||
105688782|NCT00784693|364525404|FG001|Overall Study|Withdrawal by Subject|4|||
105688783|NCT00784693|364525403|FG000|Overall Study|Randomized but not Treated|1|||
105688784|NCT00784693|364525404|FG001|Overall Study|Randomized but not Treated|0|||
105688785|NCT00784693|364525403|FG000|Overall Study|Other|1|||
105688786|NCT00784693|364525404|FG001|Overall Study|Other|0|||
105688787|NCT00640016|364525407|FG000|Overall Study|Withdrawal by Subject|0|||
105688788|NCT00640016|364525408|FG001|Overall Study|Withdrawal by Subject|1|||
105688789|NCT00640016|364525409|FG002|Overall Study|Withdrawal by Subject|0|||
105688790|NCT00640016|364525410|FG003|Overall Study|Withdrawal by Subject|0|||
105688791|NCT00640016|364525407|FG000|Overall Study|Study termination|2|||
105688792|NCT00640016|364525408|FG001|Overall Study|Study termination|1|||
105688793|NCT00640016|364525409|FG002|Overall Study|Study termination|3|||
105688794|NCT00640016|364525410|FG003|Overall Study|Study termination|2|||
105688795|NCT00640016|364525407|FG000|Overall Study|Adverse Event|0|||
105688796|NCT00640016|364525408|FG001|Overall Study|Adverse Event|0|||
105688797|NCT00640016|364525409|FG002|Overall Study|Adverse Event|0|||
105688798|NCT00640016|364525410|FG003|Overall Study|Adverse Event|1|||
105688799|NCT03588728|364525411|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
105688800|NCT03588728|364525412|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
105688801|NCT03588728|364525413|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
105688802|NCT03588728|364525414|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
105688803|NCT03588728|364525411|FG000|Overall Study|Lab shut down due to COVID-19|0|||
105688804|NCT03588728|364525412|FG001|Overall Study|Lab shut down due to COVID-19|0|||
105688805|NCT03588728|364525413|FG002|Overall Study|Lab shut down due to COVID-19|0|||
105688806|NCT03588728|364525414|FG003|Overall Study|Lab shut down due to COVID-19|1|||
105688807|NCT03588728|364525411|FG000|Overall Study|multiple technical issues|1|||
105688808|NCT03588728|364525412|FG001|Overall Study|multiple technical issues|0|||
105688809|NCT03588728|364525413|FG002|Overall Study|multiple technical issues|0|||
105688810|NCT03588728|364525414|FG003|Overall Study|multiple technical issues|0|||
105688811|NCT03588728|364525411|FG000|Overall Study|Hospitalized for COVID|1|||
105688812|NCT03588728|364525412|FG001|Overall Study|Hospitalized for COVID|0|||
105688813|NCT03588728|364525413|FG002|Overall Study|Hospitalized for COVID|0|||
105688814|NCT03588728|364525414|FG003|Overall Study|Hospitalized for COVID|0|||
105688815|NCT03588728|364525411|FG000|Overall Study|Schedule change unable to attend sessions|1|||
105688816|NCT03588728|364525412|FG001|Overall Study|Schedule change unable to attend sessions|0|||
105688817|NCT03588728|364525413|FG002|Overall Study|Schedule change unable to attend sessions|0|||
105688818|NCT03588728|364525414|FG003|Overall Study|Schedule change unable to attend sessions|0|||
105688819|NCT02027701|364525416|FG000|Overall Study|Adverse Event|3|||
105688820|NCT02027701|364525416|FG000|Overall Study|Lack of Efficacy|8|||
105688821|NCT02027701|364525416|FG000|Overall Study|Physician Decision|2|||
105688822|NCT02027701|364525416|FG000|Overall Study|Withdrawal by Subject|3|||
105688823|NCT02202551|364525423|FG000|Overall Study|Adverse Event|8|||
105688824|NCT02202551|364525424|FG001|Overall Study|Adverse Event|19|||
105688825|NCT02202551|364525425|FG002|Overall Study|Adverse Event|5|||
105688826|NCT02202551|364525426|FG003|Overall Study|Adverse Event|9|||
105688827|NCT02202551|364525423|FG000|Overall Study|Death|3|||
105688828|NCT02202551|364525424|FG001|Overall Study|Death|2|||
105688829|NCT02202551|364525425|FG002|Overall Study|Death|1|||
105688830|NCT02202551|364525426|FG003|Overall Study|Death|1|||
105688831|NCT02202551|364525423|FG000|Overall Study|Lost to Follow-up|0|||
105688832|NCT02202551|364525424|FG001|Overall Study|Lost to Follow-up|1|||
105688833|NCT02202551|364525425|FG002|Overall Study|Lost to Follow-up|0|||
105688834|NCT02202551|364525426|FG003|Overall Study|Lost to Follow-up|1|||
105688835|NCT02202551|364525423|FG000|Overall Study|Needed to take excluded medication|0|||
105688836|NCT02202551|364525424|FG001|Overall Study|Needed to take excluded medication|2|||
105688837|NCT02202551|364525425|FG002|Overall Study|Needed to take excluded medication|0|||
105688838|NCT02202551|364525426|FG003|Overall Study|Needed to take excluded medication|1|||
105688839|NCT02202551|364525423|FG000|Overall Study|Subject moved away|0|||
105688840|NCT02202551|364525424|FG001|Overall Study|Subject moved away|1|||
105688841|NCT02202551|364525425|FG002|Overall Study|Subject moved away|0|||
105688842|NCT02202551|364525426|FG003|Overall Study|Subject moved away|0|||
105688843|NCT02202551|364525423|FG000|Overall Study|DBS surgery|3|||
105688844|NCT02202551|364525424|FG001|Overall Study|DBS surgery|0|||
105688845|NCT02202551|364525425|FG002|Overall Study|DBS surgery|0|||
105688846|NCT02202551|364525426|FG003|Overall Study|DBS surgery|0|||
105688847|NCT02202551|364525423|FG000|Overall Study|Dyskinesia upon taper|1|||
105688848|NCT02202551|364525424|FG001|Overall Study|Dyskinesia upon taper|0|||
105688849|NCT02202551|364525425|FG002|Overall Study|Dyskinesia upon taper|0|||
105688850|NCT02202551|364525426|FG003|Overall Study|Dyskinesia upon taper|0|||
105688851|NCT02202551|364525423|FG000|Overall Study|Lack of Efficacy|0|||
105688852|NCT02202551|364525424|FG001|Overall Study|Lack of Efficacy|1|||
105688853|NCT02202551|364525425|FG002|Overall Study|Lack of Efficacy|0|||
105688854|NCT02202551|364525426|FG003|Overall Study|Lack of Efficacy|0|||
105688855|NCT02202551|364525423|FG000|Overall Study|Physician Decision|1|||
105688856|NCT02202551|364525424|FG001|Overall Study|Physician Decision|0|||
105688857|NCT02202551|364525425|FG002|Overall Study|Physician Decision|0|||
105688858|NCT02202551|364525426|FG003|Overall Study|Physician Decision|0|||
105688859|NCT02202551|364525423|FG000|Overall Study|Site closure|3|||
105688860|NCT02202551|364525424|FG001|Overall Study|Site closure|0|||
105688861|NCT02202551|364525425|FG002|Overall Study|Site closure|0|||
105688862|NCT02202551|364525426|FG003|Overall Study|Site closure|1|||
105688863|NCT02202551|364525423|FG000|Overall Study|Unable to complete visits per protocol|1|||
105688864|NCT02202551|364525424|FG001|Overall Study|Unable to complete visits per protocol|0|||
105688865|NCT02202551|364525425|FG002|Overall Study|Unable to complete visits per protocol|0|||
105688866|NCT02202551|364525426|FG003|Overall Study|Unable to complete visits per protocol|0|||
105688867|NCT02202551|364525423|FG000|Overall Study|Worsening Dyskinesia|0|||
105688868|NCT02202551|364525424|FG001|Overall Study|Worsening Dyskinesia|0|||
105688869|NCT02202551|364525425|FG002|Overall Study|Worsening Dyskinesia|0|||
105688870|NCT02202551|364525426|FG003|Overall Study|Worsening Dyskinesia|1|||
105688871|NCT02202551|364525423|FG000|Overall Study|Protocol Violation|0|||
105688872|NCT02202551|364525424|FG001|Overall Study|Protocol Violation|1|||
105688873|NCT02202551|364525425|FG002|Overall Study|Protocol Violation|0|||
105688874|NCT02202551|364525426|FG003|Overall Study|Protocol Violation|0|||
105688875|NCT02202551|364525423|FG000|Overall Study|Sponsor's decision|2|||
105688876|NCT02202551|364525424|FG001|Overall Study|Sponsor's decision|0|||
105688877|NCT02202551|364525425|FG002|Overall Study|Sponsor's decision|0|||
105688878|NCT02202551|364525426|FG003|Overall Study|Sponsor's decision|0|||
105688879|NCT02202551|364525423|FG000|Overall Study|Subject unwilling to proceed|1|||
105688880|NCT02202551|364525424|FG001|Overall Study|Subject unwilling to proceed|5|||
105688881|NCT02202551|364525425|FG002|Overall Study|Subject unwilling to proceed|3|||
105688882|NCT02202551|364525426|FG003|Overall Study|Subject unwilling to proceed|5|||
105688883|NCT02202551|364525423|FG000|Overall Study|Subject consent withdrawn|0|||
105688884|NCT02202551|364525424|FG001|Overall Study|Subject consent withdrawn|3|||
105688885|NCT02202551|364525425|FG002|Overall Study|Subject consent withdrawn|1|||
105688886|NCT02202551|364525426|FG003|Overall Study|Subject consent withdrawn|2|||
105688887|NCT02202551|364525423|FG000|Overall Study|eGFR<50mL/min/m2|2|||
105688888|NCT02202551|364525424|FG001|Overall Study|eGFR<50mL/min/m2|2|||
105688889|NCT02202551|364525425|FG002|Overall Study|eGFR<50mL/min/m2|0|||
105688890|NCT02202551|364525426|FG003|Overall Study|eGFR<50mL/min/m2|1|||
105688891|NCT02249767|364525427|FG000|Overall Study|Did not use medication|8|||
105688892|NCT02249767|364525428|FG001|Overall Study|Did not use medication|9|||
105688893|NCT02249767|364525429|FG002|Overall Study|Did not use medication|8|||
105688894|NCT00146757|364525430|FG000|Overall Study|Death|1|||
105688895|NCT00146757|364525431|FG001|Overall Study|Death|0|||
105688896|NCT00146757|364525430|FG000|Overall Study|Adverse Event|1|||
105688897|NCT00146757|364525431|FG001|Overall Study|Adverse Event|0|||
105688898|NCT00867113|364525432|FG000|Treatment Period|Adverse Event|15|||
105688899|NCT00867113|364525432|FG000|Treatment Period|Death|2|||
105346043|NCT04683939|363267322|FG002|Overall Study|Withdrawal by Subject|0|||
105688900|NCT00867113|364525432|FG000|Treatment Period|Withdrawal by Subject|19|||
105688901|NCT00867113|364525432|FG000|Treatment Period|Lost to Follow-up|3|||
105688902|NCT00867113|364525432|FG000|Treatment Period|Administrative problems|1|||
105688903|NCT00867113|364525432|FG000|Treatment Period|Disease progression/relapse|1|||
105688904|NCT00867113|364525432|FG000|Treatment Period|Protocol Violation|4|||
105688905|NCT00867113|364525432|FG000|Post Treatment After Survival Follow-up|Death|1|||
105688906|NCT00867113|364525432|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
105688907|NCT00867113|364525432|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
105688908|NCT00867113|364525432|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
105688909|NCT00394953|364525433|FG000|First Treatment Period|Adverse Event|1|||
105688910|NCT00394953|364525434|FG001|First Treatment Period|Adverse Event|2|||
105688911|NCT00394953|364525433|FG000|First Treatment Period|Death|6|||
105688912|NCT00394953|364525434|FG001|First Treatment Period|Death|7|||
105688913|NCT00394953|364525433|FG000|First Treatment Period|Lack of Efficacy|1|||
105688914|NCT00394953|364525434|FG001|First Treatment Period|Lack of Efficacy|1|||
105688915|NCT00394953|364525433|FG000|First Treatment Period|Withdrawal by Subject|6|||
105688916|NCT00394953|364525434|FG001|First Treatment Period|Withdrawal by Subject|3|||
105688917|NCT00394953|364525433|FG000|First Treatment Period|Lost to Follow-up|0|||
105688918|NCT00394953|364525434|FG001|First Treatment Period|Lost to Follow-up|1|||
105688919|NCT00394953|364525433|FG000|First Treatment Period|Renal transplant|11|||
105688920|NCT00394953|364525434|FG001|First Treatment Period|Renal transplant|7|||
105688921|NCT00394953|364525433|FG000|First Treatment Period|Not defined|4|||
105688922|NCT00394953|364525434|FG001|First Treatment Period|Not defined|1|||
105688923|NCT00394953|364525433|FG000|Second Treatment Period|Adverse Event|2|||
105688924|NCT00394953|364525434|FG001|Second Treatment Period|Adverse Event|5|||
105346044|NCT04683939|363267323|FG003|Overall Study|Withdrawal by Subject|0|||
105346045|NCT04683939|363267320|FG000|Overall Study|Physician Decision|1|||
105346046|NCT04683939|363267321|FG001|Overall Study|Physician Decision|0|||
105346047|NCT04683939|363267322|FG002|Overall Study|Physician Decision|0|||
105346048|NCT04683939|363267323|FG003|Overall Study|Physician Decision|0|||
105688925|NCT00394953|364525433|FG000|Second Treatment Period|Death|8|||
105688926|NCT00394953|364525434|FG001|Second Treatment Period|Death|4|||
105688927|NCT00394953|364525433|FG000|Second Treatment Period|Lack of Efficacy|9|||
105688928|NCT00394953|364525434|FG001|Second Treatment Period|Lack of Efficacy|47|||
105688929|NCT00394953|364525433|FG000|Second Treatment Period|Withdrawal by Subject|3|||
105688930|NCT00394953|364525434|FG001|Second Treatment Period|Withdrawal by Subject|3|||
105346049|NCT04683939|363267320|FG000|Overall Study|Lost to Follow-up|0|||
105346050|NCT04683939|363267321|FG001|Overall Study|Lost to Follow-up|1|||
105346051|NCT04683939|363267322|FG002|Overall Study|Lost to Follow-up|0|||
105688931|NCT00394953|364525433|FG000|Second Treatment Period|Lost to Follow-up|0|||
105688932|NCT00394953|364525434|FG001|Second Treatment Period|Lost to Follow-up|1|||
105688933|NCT00394953|364525433|FG000|Second Treatment Period|Renal transplant|4|||
105688934|NCT00394953|364525434|FG001|Second Treatment Period|Renal transplant|6|||
105688935|NCT00394953|364525433|FG000|Second Treatment Period|Not defined|3|||
105688936|NCT00394953|364525434|FG001|Second Treatment Period|Not defined|8|||
105688937|NCT01971203|364525437|FG000|Overall Study|Protocol Violation|3|||
105688938|NCT01971203|364525438|FG001|Overall Study|Protocol Violation|2|||
105688939|NCT01971203|364525437|FG000|Overall Study|Withdrawal by Subject|5|||
105688940|NCT01971203|364525438|FG001|Overall Study|Withdrawal by Subject|6|||
105688941|NCT01971203|364525437|FG000|Overall Study|Adverse Event|1|||
105688942|NCT01971203|364525438|FG001|Overall Study|Adverse Event|0|||
105688943|NCT01498289|364525439|FG000|Overall Study|Adverse Event|16|||
105688944|NCT01498289|364525440|FG001|Overall Study|Adverse Event|18|||
105688945|NCT01498289|364525439|FG000|Overall Study|Death|6|||
105688946|NCT01498289|364525440|FG001|Overall Study|Death|8|||
105688947|NCT01498289|364525439|FG000|Overall Study|Withdrawal unrelated to AE|16|||
105688948|NCT01498289|364525440|FG001|Overall Study|Withdrawal unrelated to AE|16|||
105688949|NCT01498289|364525439|FG000|Overall Study|Progression/relapse|53|||
105688950|NCT01498289|364525440|FG001|Overall Study|Progression/relapse|59|||
105688951|NCT01498289|364525439|FG000|Overall Study|Not protocol specified|7|||
105688952|NCT01498289|364525440|FG001|Overall Study|Not protocol specified|2|||
105688953|NCT01498289|364525439|FG000|Overall Study|Reason under review|0|||
105688954|NCT01498289|364525440|FG001|Overall Study|Reason under review|1|||
105688955|NCT00307125|364525443|FG000|Screening Phase|Adverse Event|1|||
105688956|NCT00307125|364525444|FG001|Screening Phase|Adverse Event|0|||
105688957|NCT00307125|364525445|FG002|Screening Phase|Adverse Event|0|||
105688958|NCT00307125|364525443|FG000|Screening Phase|Protocol Violation|27|||
105688959|NCT00307125|364525444|FG001|Screening Phase|Protocol Violation|0|||
105688960|NCT00307125|364525445|FG002|Screening Phase|Protocol Violation|0|||
105688961|NCT00307125|364525443|FG000|Screening Phase|Lost to Follow-up|87|||
105688962|NCT00307125|364525444|FG001|Screening Phase|Lost to Follow-up|0|||
105688963|NCT00307125|364525445|FG002|Screening Phase|Lost to Follow-up|0|||
105688964|NCT00307125|364525443|FG000|Screening Phase|Death|10|||
105688965|NCT00307125|364525444|FG001|Screening Phase|Death|0|||
105688966|NCT00307125|364525445|FG002|Screening Phase|Death|0|||
105688967|NCT00307125|364525443|FG000|Screening Phase|Withdrawal by Subject|77|||
105688968|NCT00307125|364525444|FG001|Screening Phase|Withdrawal by Subject|0|||
105688969|NCT00307125|364525445|FG002|Screening Phase|Withdrawal by Subject|0|||
105688970|NCT00307125|364525443|FG000|Screening Phase|Physician Decision|26|||
105688971|NCT00307125|364525444|FG001|Screening Phase|Physician Decision|0|||
105688972|NCT00307125|364525445|FG002|Screening Phase|Physician Decision|0|||
105688973|NCT00307125|364525443|FG000|Screening Phase|Sponsor Decision|4|||
105688974|NCT00307125|364525444|FG001|Screening Phase|Sponsor Decision|0|||
105688975|NCT00307125|364525445|FG002|Screening Phase|Sponsor Decision|0|||
105688976|NCT00307125|364525443|FG000|Screening Phase|Study Terminated|17|||
105688977|NCT00307125|364525444|FG001|Screening Phase|Study Terminated|0|||
105688978|NCT00307125|364525445|FG002|Screening Phase|Study Terminated|0|||
105688979|NCT00307125|364525443|FG000|Screening Phase|Graft Loss|3|||
105688980|NCT00307125|364525444|FG001|Screening Phase|Graft Loss|0|||
105346052|NCT04683939|363267323|FG003|Overall Study|Lost to Follow-up|0|||
105346053|NCT01092637|363269595|FG000|Overall Study|Death|47|||
105346054|NCT01092637|363269596|FG001|Overall Study|Death|49|||
105346055|NCT01752634|363269600|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
105346056|NCT01752634|363269601|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
105346057|NCT01752634|363269602|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
105346058|NCT01752634|363269603|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
105346059|NCT01752634|363269604|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
105346060|NCT01752634|363269605|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
105346061|NCT01752634|363269600|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
105346062|NCT01752634|363269601|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
105346063|NCT01752634|363269602|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
105346064|NCT01752634|363269603|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
105346065|NCT01752634|363269604|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
105346066|NCT01752634|363269605|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
105346067|NCT01752634|363269600|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
105346068|NCT01752634|363269601|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
105559011|NCT03318523|364044559|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
105559012|NCT03318523|364044560|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
105688981|NCT00307125|364525445|FG002|Screening Phase|Graft Loss|0|||
105688982|NCT00307125|364525443|FG000|Screening Phase|Graft Failure|8|||
105688983|NCT00307125|364525444|FG001|Screening Phase|Graft Failure|0|||
105688984|NCT00307125|364525445|FG002|Screening Phase|Graft Failure|0|||
105688985|NCT00307125|364525443|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
105688986|NCT00307125|364525444|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
105688987|NCT00307125|364525445|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
105688988|NCT00307125|364525443|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
105688989|NCT00307125|364525444|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
105688990|NCT00307125|364525445|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
105346069|NCT01752634|363269602|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
105346070|NCT01752634|363269603|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
105346071|NCT01752634|363269604|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
105346072|NCT01752634|363269605|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
105346073|NCT01752634|363269600|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
105346074|NCT01752634|363269601|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
105346075|NCT01752634|363269602|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
105346076|NCT01752634|363269603|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
105346077|NCT01752634|363269604|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
105346078|NCT01752634|363269605|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
105346079|NCT01752634|363269600|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
105346080|NCT01752634|363269601|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
105346081|NCT01752634|363269602|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
105346082|NCT01752634|363269603|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
105688991|NCT00307125|364525443|FG000|Screening Phase|Moved or transferred facilities|34|||
105688992|NCT00307125|364525444|FG001|Screening Phase|Moved or transferred facilities|0|||
105346083|NCT01752634|363269604|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
105346084|NCT01752634|363269605|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
105346085|NCT01752634|363269600|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
105346086|NCT01752634|363269601|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
105346087|NCT01752634|363269602|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
105688993|NCT00307125|364525445|FG002|Screening Phase|Moved or transferred facilities|0|||
105688994|NCT00307125|364525443|FG000|Screening Phase|Received Pancreas Transplant|8|||
105688995|NCT00307125|364525444|FG001|Screening Phase|Received Pancreas Transplant|0|||
105688996|NCT00307125|364525445|FG002|Screening Phase|Received Pancreas Transplant|0|||
105688997|NCT00307125|364525443|FG000|Screening Phase|Ineligible for pilot|4|||
105688998|NCT00307125|364525444|FG001|Screening Phase|Ineligible for pilot|0|||
105688999|NCT00307125|364525445|FG002|Screening Phase|Ineligible for pilot|0|||
105689000|NCT00307125|364525443|FG000|Screening Phase|Try to get pregnant|1|||
105689001|NCT00307125|364525444|FG001|Screening Phase|Try to get pregnant|0|||
105689002|NCT00307125|364525445|FG002|Screening Phase|Try to get pregnant|0|||
105346088|NCT01752634|363269603|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
105346089|NCT01752634|363269604|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
105346090|NCT01752634|363269605|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
105346091|NCT01752634|363269600|FG000|Week 24 to Week 260|Physician Decision|1|||
105346092|NCT01752634|363269601|FG001|Week 24 to Week 260|Physician Decision|2|||
105346093|NCT01752634|363269602|FG002|Week 24 to Week 260|Physician Decision|4|||
105346094|NCT01752634|363269603|FG003|Week 24 to Week 260|Physician Decision|2|||
105689003|NCT00307125|364525443|FG000|Screening Phase|Developed acute leukemia|1|||
105689004|NCT00307125|364525444|FG001|Screening Phase|Developed acute leukemia|0|||
105689005|NCT00307125|364525445|FG002|Screening Phase|Developed acute leukemia|0|||
105346095|NCT01752634|363269604|FG004|Week 24 to Week 260|Physician Decision|1|||
105346096|NCT01752634|363269605|FG005|Week 24 to Week 260|Physician Decision|0|||
105346097|NCT01752634|363269600|FG000|Week 24 to Week 260|Death|0|||
105346098|NCT01752634|363269601|FG001|Week 24 to Week 260|Death|1|||
105346099|NCT01752634|363269602|FG002|Week 24 to Week 260|Death|0|||
105346100|NCT01752634|363269603|FG003|Week 24 to Week 260|Death|0|||
105346101|NCT01752634|363269604|FG004|Week 24 to Week 260|Death|0|||
105346102|NCT01752634|363269605|FG005|Week 24 to Week 260|Death|0|||
105346103|NCT01752634|363269600|FG000|Week 24 to Week 260|Pregnancy|0|||
105346104|NCT01752634|363269601|FG001|Week 24 to Week 260|Pregnancy|0|||
105346105|NCT01752634|363269602|FG002|Week 24 to Week 260|Pregnancy|1|||
105346106|NCT01752634|363269603|FG003|Week 24 to Week 260|Pregnancy|0|||
105689006|NCT00307125|364525443|FG000|Screening Phase|Metastatic colon cancer|1|||
105689007|NCT00307125|364525444|FG001|Screening Phase|Metastatic colon cancer|0|||
105689008|NCT00307125|364525445|FG002|Screening Phase|Metastatic colon cancer|0|||
105689009|NCT00307125|364525443|FG000|Screening Phase|Malignancy|1|||
105689010|NCT00307125|364525444|FG001|Screening Phase|Malignancy|0|||
105689011|NCT00307125|364525445|FG002|Screening Phase|Malignancy|0|||
105689012|NCT00307125|364525443|FG000|Screening Phase|PAK|1|||
105689013|NCT00307125|364525444|FG001|Screening Phase|PAK|0|||
105689014|NCT00307125|364525445|FG002|Screening Phase|PAK|0|||
105689015|NCT00307125|364525443|FG000|Screening Phase|Ineligible|1|||
105346107|NCT01752634|363269604|FG004|Week 24 to Week 260|Pregnancy|0|||
105346108|NCT01752634|363269605|FG005|Week 24 to Week 260|Pregnancy|0|||
105346109|NCT01752634|363269600|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
105346110|NCT01752634|363269601|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
105346111|NCT01752634|363269602|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
105346112|NCT01752634|363269603|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
105346113|NCT01752634|363269604|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
105689016|NCT00307125|364525444|FG001|Screening Phase|Ineligible|0|||
105689017|NCT00307125|364525445|FG002|Screening Phase|Ineligible|0|||
105689018|NCT00307125|364525443|FG000|Screening Phase|Screen Error|1|||
105689019|NCT00307125|364525444|FG001|Screening Phase|Screen Error|0|||
105689020|NCT00307125|364525445|FG002|Screening Phase|Screen Error|0|||
105689021|NCT00307125|364525443|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
105689022|NCT00307125|364525444|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
105689023|NCT00307125|364525445|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
105689024|NCT00307125|364525443|FG000|Screening Phase|AMR and treated with rituximab|1|||
105689025|NCT00307125|364525444|FG001|Screening Phase|AMR and treated with rituximab|0|||
105689026|NCT00307125|364525445|FG002|Screening Phase|AMR and treated with rituximab|0|||
105689027|NCT00307125|364525443|FG000|Screening Phase|Coronary artery bypass|1|||
105689028|NCT00307125|364525444|FG001|Screening Phase|Coronary artery bypass|0|||
105689029|NCT00307125|364525445|FG002|Screening Phase|Coronary artery bypass|0|||
105689030|NCT00307125|364525443|FG000|Pilot Phase|Lost to Follow-up|0|||
105689031|NCT00307125|364525444|FG001|Pilot Phase|Lost to Follow-up|1|||
105689032|NCT00307125|364525445|FG002|Pilot Phase|Lost to Follow-up|0|||
105689033|NCT00307125|364525443|FG000|Pilot Phase|Withdrawal by Subject|0|||
105689034|NCT00307125|364525444|FG001|Pilot Phase|Withdrawal by Subject|1|||
105689035|NCT00307125|364525445|FG002|Pilot Phase|Withdrawal by Subject|1|||
105689036|NCT01699789|364525446|FG000|Overall Study|Withdrawal by Subject|18|||
105689037|NCT01699789|364525447|FG001|Overall Study|Withdrawal by Subject|23|||
105689038|NCT01699789|364525446|FG000|Overall Study|Death|1|||
105689039|NCT01699789|364525447|FG001|Overall Study|Death|2|||
105689040|NCT01699789|364525446|FG000|Overall Study|Lost to Follow-up|83|||
105689041|NCT01699789|364525447|FG001|Overall Study|Lost to Follow-up|101|||
105689042|NCT01050205|364525450|FG000|Overall Study|Lost to Follow-up|7|||
105689043|NCT01050205|364525451|FG001|Overall Study|Lost to Follow-up|1|||
105689044|NCT01050205|364525450|FG000|Overall Study|Withdrawal by Subject|1|||
105689045|NCT01050205|364525451|FG001|Overall Study|Withdrawal by Subject|1|||
105689046|NCT01050205|364525450|FG000|Overall Study|Relocated from area|1|||
105689047|NCT01050205|364525451|FG001|Overall Study|Relocated from area|2|||
105689048|NCT01050205|364525450|FG000|Overall Study|Discontinued Intervention|2|||
105689049|NCT01050205|364525451|FG001|Overall Study|Discontinued Intervention|0|||
105689050|NCT00954421|364525452|FG000|Screening|screen failures|3|||
105689051|NCT00954421|364525452|FG000|6 Months of DBS|Withdrawal by Subject|1|||
105689052|NCT00954421|364525452|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
105689053|NCT01557348|364525453|FG000|Overall Study|Adverse Event|6|||
105689054|NCT01557348|364525454|FG001|Overall Study|Adverse Event|16|||
105689055|NCT01557348|364525453|FG000|Overall Study|Infusion reaction event|5|||
105689056|NCT01557348|364525454|FG001|Overall Study|Infusion reaction event|5|||
105689057|NCT01557348|364525453|FG000|Overall Study|Death|7|||
105689058|NCT01557348|364525454|FG001|Overall Study|Death|4|||
105689059|NCT01557348|364525453|FG000|Overall Study|Insufficient Therapeutic Response|13|||
105689060|NCT01557348|364525454|FG001|Overall Study|Insufficient Therapeutic Response|28|||
105689061|NCT01557348|364525453|FG000|Overall Study|Withdrawal by Subject|5|||
105689062|NCT01557348|364525454|FG001|Overall Study|Withdrawal by Subject|4|||
105689063|NCT01557348|364525453|FG000|Overall Study|Lost to Follow-up|26|||
105689064|NCT01557348|364525454|FG001|Overall Study|Lost to Follow-up|22|||
105689065|NCT01557348|364525453|FG000|Overall Study|Administrative|18|||
105689066|NCT01557348|364525454|FG001|Overall Study|Administrative|11|||
105689067|NCT05125679|364525455|FG000|Overall Study|Study Terminated by Sponsor|2|||
105689068|NCT05125679|364525456|FG001|Overall Study|Study Terminated by Sponsor|5|||
105689069|NCT06132425|364525457|FG000|Overall Study|Withdrawal by Subject|3|||
105689070|NCT06132425|364525458|FG001|Overall Study|Withdrawal by Subject|0|||
105689071|NCT06132425|364525457|FG000|Overall Study|Did not follow study instructions|0|||
105689072|NCT06132425|364525458|FG001|Overall Study|Did not follow study instructions|2|||
105689073|NCT06132425|364525457|FG000|Overall Study|Lost to Follow-up|3|||
105689074|NCT06132425|364525458|FG001|Overall Study|Lost to Follow-up|5|||
105689075|NCT05393037|364525459|FG000|Part A|Death|1|||
105689076|NCT05393037|364525460|FG001|Part A|Death|0|||
105689077|NCT05393037|364525459|FG000|Part A|Lost to Follow-up|1|||
105689078|NCT05393037|364525460|FG001|Part A|Lost to Follow-up|1|||
105689079|NCT05393037|364525459|FG000|Part A|Withdrawal by Subject|2|||
105689080|NCT05393037|364525460|FG001|Part A|Withdrawal by Subject|4|||
105689081|NCT05393037|364525459|FG000|Part B|Lost to Follow-up|1|||
105689082|NCT05393037|364525460|FG001|Part B|Lost to Follow-up|0|||
105689083|NCT05461794|364525463|FG000|Overall Study|Withdrawal by Subject|1|||
105689084|NCT05461794|364525464|FG001|Overall Study|Withdrawal by Subject|1|||
105689085|NCT05461794|364525465|FG002|Overall Study|Withdrawal by Subject|3|||
105689086|NCT05461794|364525463|FG000|Overall Study|Study Terminated By Sponsor|18|||
105689087|NCT05461794|364525464|FG001|Overall Study|Study Terminated By Sponsor|13|||
105689088|NCT05461794|364525465|FG002|Overall Study|Study Terminated By Sponsor|16|||
105689089|NCT05461794|364525463|FG000|Overall Study|Death|20|||
105689090|NCT05461794|364525464|FG001|Overall Study|Death|5|||
105689091|NCT05461794|364525465|FG002|Overall Study|Death|19|||
105689092|NCT01853982|364525466|FG000|Overall Study|Withdrawal by Subject|1|||
105689093|NCT01853982|364525467|FG001|Overall Study|Withdrawal by Subject|0|||
105689094|NCT01853982|364525466|FG000|Overall Study|Death|1|||
105689095|NCT01853982|364525467|FG001|Overall Study|Death|0|||
105689096|NCT01853982|364525466|FG000|Overall Study|Lost to Follow-up|0|||
105689097|NCT01853982|364525467|FG001|Overall Study|Lost to Follow-up|1|||
105689098|NCT05066724|364525470|FG000|Overall Study|Adverse Event|1|||
105786794|NCT05643573|364872928|FG001|Overall Study|Outcome event|36|||
105689099|NCT05066724|364525470|FG000|Overall Study|Non-Compliance With Study Drug|5|||
105689100|NCT05066724|364525470|FG000|Overall Study|Withdrawal by Subject|6|||
105689101|NCT05066724|364525470|FG000|Overall Study|Physician Decision|2|||
105689102|NCT01422850|364525471|FG000|Overall Study|Physician Decision|3|||
105689103|NCT04484831|364525472|FG000|Overall Study|Withdrawal by Subject|1|||
105689104|NCT04484831|364525473|FG001|Overall Study|Withdrawal by Subject|0|||
105689105|NCT02244996|364525474|FG000|Overall Study|Lack of Efficacy|2|||
105689106|NCT02244996|364525475|FG001|Overall Study|Lack of Efficacy|6|||
105689107|NCT00447382|364525476|FG000|Overall Study|Adverse Event|1|||
105689108|NCT00447382|364525477|FG001|Overall Study|Adverse Event|1|||
105689109|NCT00447382|364525476|FG000|Overall Study|Lack of Efficacy|1|||
105689110|NCT00447382|364525477|FG001|Overall Study|Lack of Efficacy|0|||
105689111|NCT00447382|364525476|FG000|Overall Study|Protocol Violation|2|||
105689112|NCT00447382|364525477|FG001|Overall Study|Protocol Violation|0|||
105689113|NCT00447382|364525476|FG000|Overall Study|Unclassified|2|||
105689114|NCT00447382|364525477|FG001|Overall Study|Unclassified|5|||
105689115|NCT04435782|364525478|FG000|Overall Study|Study terminated by sponsor|4|||
105689116|NCT02477696|364525479|FG000|Overall Study|Death|89|||
105689117|NCT02477696|364525480|FG001|Overall Study|Death|106|||
105689118|NCT02477696|364525479|FG000|Overall Study|Lost to Follow-up|7|||
105689119|NCT02477696|364525480|FG001|Overall Study|Lost to Follow-up|5|||
105689120|NCT02477696|364525479|FG000|Overall Study|Withdrawal by Subject|37|||
105689121|NCT02477696|364525480|FG001|Overall Study|Withdrawal by Subject|34|||
105689122|NCT02477696|364525479|FG000|Overall Study|Physician Decision|7|||
105689123|NCT02477696|364525480|FG001|Overall Study|Physician Decision|9|||
105689124|NCT02477696|364525479|FG000|Overall Study|Study terminated by sponsor|103|||
105689125|NCT02477696|364525480|FG001|Overall Study|Study terminated by sponsor|99|||
105689126|NCT02477696|364525479|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
105689127|NCT02477696|364525480|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
105689128|NCT02477696|364525479|FG000|Overall Study|Missing/Unknown|2|||
105689129|NCT02477696|364525480|FG001|Overall Study|Missing/Unknown|0|||
105689130|NCT03602261|364525483|FG000|Overall Study|Adverse Event|5|||
105689131|NCT03602261|364525484|FG001|Overall Study|Adverse Event|1|||
105689132|NCT03602261|364525483|FG000|Overall Study|Physician Decision|1|||
105689133|NCT03602261|364525484|FG001|Overall Study|Physician Decision|0|||
105689134|NCT03602261|364525483|FG000|Overall Study|Withdrawal by Subject|1|||
105689135|NCT03602261|364525484|FG001|Overall Study|Withdrawal by Subject|1|||
105689136|NCT03602261|364525483|FG000|Overall Study|Lack of Efficacy|0|||
105786795|NCT05643573|364872927|FG000|Overall Study|Physician Decision|33|||
105786796|NCT05643573|364872928|FG001|Overall Study|Physician Decision|19|||
105346114|NCT01752634|363269605|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
105346115|NCT01752634|363269600|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
105689137|NCT03602261|364525484|FG001|Overall Study|Lack of Efficacy|1|||
105689138|NCT03602261|364525483|FG000|Overall Study|Subject moving out of state|1|||
105689139|NCT03602261|364525484|FG001|Overall Study|Subject moving out of state|0|||
105689140|NCT04091451|364525485|FG000|Overall Study|Adverse Event|15|||
105689141|NCT04091451|364525486|FG001|Overall Study|Adverse Event|10|||
105689142|NCT04091451|364525485|FG000|Overall Study|Lost to Follow-up|8|||
105346116|NCT01752634|363269601|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
105346117|NCT01752634|363269602|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
105346118|NCT01752634|363269603|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
105689143|NCT04091451|364525486|FG001|Overall Study|Lost to Follow-up|8|||
105689144|NCT04091451|364525485|FG000|Overall Study|Protocol Violation|5|||
105689145|NCT04091451|364525486|FG001|Overall Study|Protocol Violation|4|||
105689146|NCT04091451|364525485|FG000|Overall Study|Withdrawal by Subject|21|||
105689147|NCT04091451|364525486|FG001|Overall Study|Withdrawal by Subject|27|||
105689148|NCT04091451|364525485|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
105689149|NCT04091451|364525486|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
105689150|NCT04091451|364525485|FG000|Overall Study|Migrated/moved from the study area|3|||
105689151|NCT04091451|364525486|FG001|Overall Study|Migrated/moved from the study area|5|||
105689152|NCT04091451|364525485|FG000|Overall Study|Suspected HZ episode|1|||
105689153|NCT04091451|364525486|FG001|Overall Study|Suspected HZ episode|0|||
105689154|NCT04124614|364525488|FG000|Placebo Run-in Period|Not Randomized|34|||
105689155|NCT04124614|364525489|FG001|Placebo Run-in Period|Not Randomized|0|||
105346119|NCT01752634|363269604|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
105689156|NCT04124614|364525490|FG002|Placebo Run-in Period|Not Randomized|0|||
105689157|NCT04124614|364525488|FG000|Double Blind Treatment Period|Adverse Event|0|||
105689158|NCT04124614|364525489|FG001|Double Blind Treatment Period|Adverse Event|7|||
105689159|NCT04124614|364525490|FG002|Double Blind Treatment Period|Adverse Event|22|||
105689160|NCT04124614|364525488|FG000|Double Blind Treatment Period|Death|0|||
105689161|NCT04124614|364525489|FG001|Double Blind Treatment Period|Death|0|||
105689162|NCT04124614|364525490|FG002|Double Blind Treatment Period|Death|1|||
105689163|NCT04124614|364525488|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
105689164|NCT04124614|364525489|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
105689165|NCT04124614|364525490|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
105689166|NCT04124614|364525488|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
105689167|NCT04124614|364525489|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
105689168|NCT04124614|364525490|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
105689169|NCT04124614|364525488|FG000|Double Blind Treatment Period|Physician Decision|0|||
105689170|NCT04124614|364525489|FG001|Double Blind Treatment Period|Physician Decision|0|||
105689171|NCT04124614|364525490|FG002|Double Blind Treatment Period|Physician Decision|3|||
105689172|NCT04124614|364525488|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
105689173|NCT04124614|364525489|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
105346120|NCT01752634|363269605|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
105346121|NCT01752634|363269600|FG000|Week 24 to Week 260|Adverse Event|4|||
105346122|NCT01752634|363269601|FG001|Week 24 to Week 260|Adverse Event|8|||
105346123|NCT01752634|363269602|FG002|Week 24 to Week 260|Adverse Event|8|||
105346124|NCT01752634|363269603|FG003|Week 24 to Week 260|Adverse Event|4|||
105346125|NCT01752634|363269604|FG004|Week 24 to Week 260|Adverse Event|2|||
105346126|NCT01752634|363269605|FG005|Week 24 to Week 260|Adverse Event|0|||
105346127|NCT02879994|363269607|FG000|Overall Study|off treatment early|7|||
105346128|NCT02879994|363269607|FG000|Overall Study|Adverse Event|2|||
105346129|NCT02879994|363269607|FG000|Overall Study|Death|2|||
105346130|NCT00552032|363269614|FG000|Overall Study|Withdrawal by Subject|2|||
105346131|NCT00552032|363269615|FG001|Overall Study|Withdrawal by Subject|2|||
105346132|NCT00552032|363269614|FG000|Overall Study|Protocol Violation|7|||
105346133|NCT00552032|363269615|FG001|Overall Study|Protocol Violation|12|||
105346134|NCT00552032|363269614|FG000|Overall Study|Lost to Follow-up|8|||
105346135|NCT00552032|363269615|FG001|Overall Study|Lost to Follow-up|5|||
105346136|NCT01643798|363269618|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
105346137|NCT01643798|363269619|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
105346138|NCT01027897|363269620|FG000|Overall Study|Protocol Violation|1|||
105346139|NCT01027897|363269620|FG000|Overall Study|Withdrawal by Subject|1|||
105346140|NCT01911780|363269621|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
105346141|NCT01911780|363269622|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
105346142|NCT01911780|363269621|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
105346143|NCT01911780|363269622|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
105689174|NCT04124614|364525490|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
105689175|NCT04124614|364525488|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
105689176|NCT04124614|364525489|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
105689177|NCT04124614|364525490|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
105689178|NCT04124614|364525488|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
105689179|NCT04124614|364525489|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
105346144|NCT01911780|363269621|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
105346145|NCT01911780|363269622|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
105346146|NCT01911780|363269621|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
105346147|NCT01911780|363269622|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
105346148|NCT01911780|363269621|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
105689180|NCT04124614|364525490|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
105689181|NCT00720941|364526619|FG000|Overall Study|Protocol Violation|1|||
105689182|NCT00720941|364526620|FG001|Overall Study|Protocol Violation|2|||
105689183|NCT00720941|364526619|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
105689184|NCT00720941|364526620|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
105689185|NCT00720941|364526619|FG000|Overall Study|Lost to Follow-up|20|||
105689186|NCT00720941|364526620|FG001|Overall Study|Lost to Follow-up|15|||
105689187|NCT00720941|364526619|FG000|Overall Study|Physician Decision|14|||
105689188|NCT00720941|364526620|FG001|Overall Study|Physician Decision|12|||
105689189|NCT00720941|364526619|FG000|Overall Study|Withdrawal by Subject|29|||
105689190|NCT00720941|364526620|FG001|Overall Study|Withdrawal by Subject|36|||
105689191|NCT02425644|364526624|FG000|Overall Study|Lost to Follow-up|2|||
105689192|NCT02425644|364526625|FG001|Overall Study|Lost to Follow-up|3|||
105689193|NCT02425644|364526624|FG000|Overall Study|Withdrawal by Subject|41|||
105689194|NCT02425644|364526625|FG001|Overall Study|Withdrawal by Subject|36|||
105689195|NCT02425644|364526624|FG000|Overall Study|Lack of Efficacy|3|||
105689196|NCT02425644|364526625|FG001|Overall Study|Lack of Efficacy|10|||
105689197|NCT02425644|364526624|FG000|Overall Study|Adverse Event|13|||
105689198|NCT02425644|364526625|FG001|Overall Study|Adverse Event|3|||
105689199|NCT02425644|364526624|FG000|Overall Study|Death|0|||
105689200|NCT02425644|364526625|FG001|Overall Study|Death|2|||
105689201|NCT02425644|364526624|FG000|Overall Study|Other|18|||
105689202|NCT02425644|364526625|FG001|Overall Study|Other|17|||
105689203|NCT01072877|364526626|FG000|Overall Study|Lost to Follow-up|1|||
105689204|NCT01072877|364526627|FG001|Overall Study|Lost to Follow-up|1|||
105689205|NCT01072877|364526628|FG002|Overall Study|Lost to Follow-up|0|||
105689206|NCT01072877|364526629|FG003|Overall Study|Lost to Follow-up|2|||
105689207|NCT01072877|364526630|FG004|Overall Study|Lost to Follow-up|0|||
105689208|NCT01929980|364526631|FG000|Overall Study|Physician Decision|1|||
105689209|NCT00995020|364526632|FG000|Overall Study|margin analysis not performed|2|||
105689210|NCT00995020|364526633|FG001|Overall Study|margin analysis not performed|5|||
105689211|NCT00995020|364526632|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
105689212|NCT00995020|364526633|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
105689213|NCT01940354|364526634|FG000|Overall Study|Withdrawal by Subject|4|||
105689214|NCT01940354|364526635|FG001|Overall Study|Withdrawal by Subject|2|||
105689215|NCT00985166|364526636|FG000|Overall Study|Lost to Follow-up|3|||
105689216|NCT00985166|364526637|FG001|Overall Study|Lost to Follow-up|2|||
105689217|NCT00985166|364526638|FG002|Overall Study|Lost to Follow-up|2|||
105689218|NCT00985166|364526636|FG000|Overall Study|Withdrawal by Subject|3|||
105689219|NCT00985166|364526637|FG001|Overall Study|Withdrawal by Subject|2|||
105689220|NCT00985166|364526638|FG002|Overall Study|Withdrawal by Subject|0|||
105689221|NCT00985166|364526636|FG000|Overall Study|Test not done|2|||
105689222|NCT00985166|364526637|FG001|Overall Study|Test not done|0|||
105689223|NCT00985166|364526638|FG002|Overall Study|Test not done|4|||
105689224|NCT00985166|364526636|FG000|Overall Study|Other|1|||
105689225|NCT00985166|364526637|FG001|Overall Study|Other|0|||
105689226|NCT00985166|364526638|FG002|Overall Study|Other|1|||
105689227|NCT01028222|364526639|FG000|Overall Study|Protocol deviation|1|||
105689228|NCT01028222|364526640|FG001|Overall Study|Protocol deviation|0|||
105689229|NCT01028222|364526639|FG000|Overall Study|Disease progression|33|||
105689230|NCT01028222|364526640|FG001|Overall Study|Disease progression|9|||
105689231|NCT01028222|364526639|FG000|Overall Study|Administrative problems|1|||
105689232|NCT01028222|364526640|FG001|Overall Study|Administrative problems|1|||
105689233|NCT01028222|364526639|FG000|Overall Study|Lost to Follow-up|0|||
105689234|NCT01028222|364526640|FG001|Overall Study|Lost to Follow-up|1|||
105689235|NCT01028222|364526639|FG000|Overall Study|Withdrawal by Subject|1|||
105689236|NCT01028222|364526640|FG001|Overall Study|Withdrawal by Subject|0|||
105689237|NCT01028222|364526639|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
105689238|NCT01028222|364526640|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
105689239|NCT01028222|364526639|FG000|Overall Study|Adverse Event|2|||
105689240|NCT01028222|364526640|FG001|Overall Study|Adverse Event|0|||
105689241|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
105689242|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
105689243|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
105689244|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
105689245|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
105689246|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
105689247|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
105689248|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
105689249|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
105689250|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
105689251|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
105689252|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
105689253|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Death|3|||
105689254|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Death|1|||
105689255|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
105689256|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
105689257|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Adverse Event|7|||
105689258|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Adverse Event|8|||
105689259|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Captured as Other|1|||
105689260|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Captured as Other|2|||
105689261|NCT03236246|364526647|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
105689262|NCT03236246|364526648|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
105689263|NCT03236246|364526647|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
105689264|NCT03236246|364526648|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
105689265|NCT03236246|364526647|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
105689266|NCT03236246|364526648|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
105689267|NCT03236246|364526647|FG000|24-Week Dose Maintenance Period|Death|0|||
105689268|NCT03236246|364526648|FG001|24-Week Dose Maintenance Period|Death|1|||
105689269|NCT03236246|364526647|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
105689270|NCT03236246|364526648|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
105689271|NCT02598557|364526649|FG000|Overall Study|Withdrawal by Subject|1|||
105689272|NCT02598557|364526650|FG001|Overall Study|Withdrawal by Subject|0|||
105689273|NCT02598557|364526651|FG002|Overall Study|Withdrawal by Subject|1|||
105689274|NCT02598557|364526649|FG000|Overall Study|Participant did not start treatment|2|||
105689275|NCT02598557|364526650|FG001|Overall Study|Participant did not start treatment|1|||
105689276|NCT02598557|364526651|FG002|Overall Study|Participant did not start treatment|1|||
105689277|NCT02598557|364526649|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
105689278|NCT02598557|364526650|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
105689279|NCT02598557|364526651|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
105689280|NCT02598557|364526649|FG000|Overall Study|Adverse Event|1|||
105689281|NCT02598557|364526650|FG001|Overall Study|Adverse Event|1|||
105689282|NCT02598557|364526651|FG002|Overall Study|Adverse Event|0|||
105689283|NCT01117454|364526652|FG000|Overall Study|Pregnancy|0|||
105689284|NCT01117454|364526653|FG001|Overall Study|Pregnancy|1|||
105689285|NCT01146054|364526658|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
105689286|NCT01146054|364526658|FG000|Overall Study|Rapid tumor progression|2|||
105689287|NCT01146054|364526658|FG000|Overall Study|Other illness precluded treatment|2|||
105689288|NCT01146054|364526658|FG000|Overall Study|Lost to Follow-up|1|||
105689289|NCT00402363|364526659|FG000|Overall Study|Adverse Event|9|||
105689290|NCT00402363|364526660|FG001|Overall Study|Adverse Event|14|||
105689291|NCT00402363|364526661|FG002|Overall Study|Adverse Event|2|||
105689292|NCT00402363|364526662|FG003|Overall Study|Adverse Event|2|||
105689293|NCT00402363|364526659|FG000|Overall Study|Withdrew Consent|10|||
105689294|NCT00402363|364526660|FG001|Overall Study|Withdrew Consent|5|||
105689295|NCT00402363|364526661|FG002|Overall Study|Withdrew Consent|2|||
105689296|NCT00402363|364526662|FG003|Overall Study|Withdrew Consent|1|||
105689297|NCT00402363|364526659|FG000|Overall Study|Protocol Violation|3|||
105689298|NCT00402363|364526660|FG001|Overall Study|Protocol Violation|5|||
105689299|NCT00402363|364526661|FG002|Overall Study|Protocol Violation|0|||
105689300|NCT00402363|364526662|FG003|Overall Study|Protocol Violation|3|||
105689301|NCT00402363|364526659|FG000|Overall Study|Lost to Follow-up|5|||
105689302|NCT00402363|364526660|FG001|Overall Study|Lost to Follow-up|4|||
105689303|NCT00402363|364526661|FG002|Overall Study|Lost to Follow-up|0|||
105689304|NCT00402363|364526662|FG003|Overall Study|Lost to Follow-up|2|||
105689305|NCT00402363|364526659|FG000|Overall Study|"Captured as Other"|6|||
105689306|NCT00402363|364526660|FG001|Overall Study|"Captured as Other"|2|||
105689307|NCT00402363|364526661|FG002|Overall Study|"Captured as Other"|2|||
105689308|NCT00402363|364526662|FG003|Overall Study|"Captured as Other"|2|||
105689309|NCT00293722|364526663|FG000|Overall Study|Other|427|||
105689310|NCT01008696|364526665|FG000|Overall Study|Participant's evasion of hospital visit|5|||
105689311|NCT01008696|364526666|FG001|Overall Study|Participant's evasion of hospital visit|4|||
105689312|NCT01008696|364526665|FG000|Overall Study|Withdrawal by Subject|2|||
105689313|NCT01008696|364526666|FG001|Overall Study|Withdrawal by Subject|4|||
105689314|NCT01008696|364526665|FG000|Overall Study|Physician Decision|5|||
105689315|NCT01008696|364526666|FG001|Overall Study|Physician Decision|1|||
105689316|NCT01008696|364526665|FG000|Overall Study|Adverse Event|1|||
105346149|NCT01911780|363269622|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
105346150|NCT01911780|363269621|FG000|Extension Period (52 Weeks)|Personal reason|1|||
105346151|NCT01911780|363269622|FG001|Extension Period (52 Weeks)|Personal reason|1|||
105346152|NCT00473824|363269625|FG000|Overall Study|Virologic Breakthrough|1|||
105346153|NCT00473824|363269626|FG001|Overall Study|Virologic Breakthrough|0|||
105689317|NCT01008696|364526666|FG001|Overall Study|Adverse Event|0|||
105346154|NCT00473824|363269625|FG000|Overall Study|Adverse Event|1|||
105346155|NCT00473824|363269626|FG001|Overall Study|Adverse Event|0|||
105346156|NCT00473824|363269625|FG000|Overall Study|Death|1|||
105346157|NCT00473824|363269626|FG001|Overall Study|Death|0|||
105346158|NCT00473824|363269625|FG000|Overall Study|Lost to Follow-up|1|||
105346159|NCT00473824|363269626|FG001|Overall Study|Lost to Follow-up|0|||
105346160|NCT00473824|363269625|FG000|Overall Study|Withdrawal by physician|1|||
105346161|NCT00473824|363269626|FG001|Overall Study|Withdrawal by physician|0|||
105346162|NCT04105010|363269627|FG000|Overall Study|Death|3|||
105346163|NCT04105010|363269628|FG001|Overall Study|Death|1|||
105346164|NCT04105010|363269629|FG002|Overall Study|Death|1|||
105346165|NCT04105010|363269630|FG003|Overall Study|Death|54|||
105346166|NCT04105010|363269627|FG000|Overall Study|Lost to Follow-up|0|||
105346167|NCT04105010|363269628|FG001|Overall Study|Lost to Follow-up|0|||
105346168|NCT04105010|363269629|FG002|Overall Study|Lost to Follow-up|0|||
105689318|NCT01008696|364526665|FG000|Overall Study|Participants' non-cooperation|2|||
105689319|NCT01008696|364526666|FG001|Overall Study|Participants' non-cooperation|3|||
105689320|NCT01008696|364526665|FG000|Overall Study|Other|2|||
105689321|NCT01008696|364526666|FG001|Overall Study|Other|3|||
105689322|NCT01008696|364526665|FG000|Overall Study|Other|0|||
105689323|NCT01008696|364526666|FG001|Overall Study|Other|2|||
105689324|NCT00667355|364526667|FG000|Overall Study|Adverse Event|5|||
105689325|NCT00667355|364526667|FG000|Overall Study|Lost to Follow-up|1|||
105689326|NCT00667355|364526667|FG000|Overall Study|Other reason was not specified|5|||
105689327|NCT01369511|364526669|FG000|Overall Study|Adverse Event|1|||
105689328|NCT01369511|364526670|FG001|Overall Study|Adverse Event|1|||
105689329|NCT01369511|364526671|FG002|Overall Study|Adverse Event|5|||
105689330|NCT01369511|364526672|FG003|Overall Study|Adverse Event|0|||
105689331|NCT01369511|364526669|FG000|Overall Study|Entry criteria not met|2|||
105689332|NCT01369511|364526670|FG001|Overall Study|Entry criteria not met|0|||
105689333|NCT01369511|364526671|FG002|Overall Study|Entry criteria not met|0|||
105689334|NCT01369511|364526672|FG003|Overall Study|Entry criteria not met|1|||
105689335|NCT01369511|364526669|FG000|Overall Study|Lost to Follow-up|0|||
105689336|NCT01369511|364526670|FG001|Overall Study|Lost to Follow-up|1|||
105689337|NCT01369511|364526671|FG002|Overall Study|Lost to Follow-up|1|||
105689338|NCT01369511|364526672|FG003|Overall Study|Lost to Follow-up|2|||
105689339|NCT01369511|364526669|FG000|Overall Study|Protocol Violation|0|||
105689340|NCT01369511|364526670|FG001|Overall Study|Protocol Violation|1|||
105689341|NCT01369511|364526671|FG002|Overall Study|Protocol Violation|0|||
105689342|NCT01369511|364526672|FG003|Overall Study|Protocol Violation|2|||
105689343|NCT01369511|364526669|FG000|Overall Study|Physician Decision|3|||
105689344|NCT01369511|364526670|FG001|Overall Study|Physician Decision|4|||
105689345|NCT01369511|364526671|FG002|Overall Study|Physician Decision|0|||
105689346|NCT01369511|364526672|FG003|Overall Study|Physician Decision|0|||
105689347|NCT01369511|364526669|FG000|Overall Study|Sponsor decision|2|||
105689348|NCT01369511|364526670|FG001|Overall Study|Sponsor decision|0|||
105786797|NCT05643573|364872927|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
105346169|NCT04105010|363269630|FG003|Overall Study|Lost to Follow-up|4|||
105346170|NCT04105010|363269627|FG000|Overall Study|Withdrawal by Subject|8|||
105346171|NCT04105010|363269628|FG001|Overall Study|Withdrawal by Subject|1|||
105346172|NCT04105010|363269629|FG002|Overall Study|Withdrawal by Subject|1|||
105346173|NCT04105010|363269630|FG003|Overall Study|Withdrawal by Subject|4|||
105346174|NCT04105010|363269627|FG000|Overall Study|Other reason|4|||
105346175|NCT04105010|363269628|FG001|Overall Study|Other reason|7|||
105346176|NCT04105010|363269629|FG002|Overall Study|Other reason|0|||
105346177|NCT04105010|363269630|FG003|Overall Study|Other reason|19|||
105346178|NCT02539134|363269634|FG000|Overall Study|Lost to Follow-up|1|||
105346179|NCT02539134|363269635|FG001|Overall Study|Lost to Follow-up|0|||
105346180|NCT02539134|363269636|FG002|Overall Study|Lost to Follow-up|0|||
105346181|NCT02539134|363269637|FG003|Overall Study|Lost to Follow-up|0|||
105346182|NCT02539134|363269638|FG004|Overall Study|Lost to Follow-up|0|||
105689349|NCT01369511|364526671|FG002|Overall Study|Sponsor decision|1|||
105689350|NCT01369511|364526672|FG003|Overall Study|Sponsor decision|0|||
105689351|NCT01369511|364526669|FG000|Overall Study|Withdrawal by Subject|5|||
105689352|NCT01369511|364526670|FG001|Overall Study|Withdrawal by Subject|6|||
105689353|NCT01369511|364526671|FG002|Overall Study|Withdrawal by Subject|4|||
105689354|NCT01369511|364526672|FG003|Overall Study|Withdrawal by Subject|6|||
105689355|NCT00718640|364526673|FG000|Overall Study|Adverse Event|4|||
105689356|NCT00718640|364526673|FG000|Overall Study|Death|1|||
105689357|NCT00718640|364526673|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
105346183|NCT02539134|363269639|FG005|Overall Study|Lost to Follow-up|0|||
105346184|NCT00984061|363269640|FG000|Clarithromycin Alone|Protocol Violation|1|||
105346185|NCT02327013|363269641|FG000|Overall Study|Adverse Event|4|||
105689358|NCT03952806|364526674|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
105689359|NCT03952806|364526675|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
105689360|NCT03952806|364526674|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
105689361|NCT03952806|364526675|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
105689362|NCT03952806|364526674|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
105689363|NCT03952806|364526675|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
105689364|NCT03952806|364526674|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
105689365|NCT03952806|364526675|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
105689366|NCT03952806|364526674|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
105689367|NCT03952806|364526675|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
105689368|NCT03952806|364526674|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
105689369|NCT03952806|364526675|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
105689370|NCT03952806|364526674|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
105689371|NCT03952806|364526675|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
105689372|NCT03952806|364526674|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
105689373|NCT03952806|364526675|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
105689374|NCT03952806|364526674|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
105689375|NCT03952806|364526675|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
105689376|NCT03952806|364526674|FG000|OLE Phase (48 Weeks)|Other|16|||
105689377|NCT03952806|364526675|FG001|OLE Phase (48 Weeks)|Other|13|||
105689378|NCT01137955|364526676|FG000|Overall Study|Withdrawal by Subject|5|||
105689379|NCT01137955|364526677|FG001|Overall Study|Withdrawal by Subject|4|||
105689380|NCT01207596|364526678|FG000|Overall Study|Physician Decision|4|||
105689381|NCT01207596|364526678|FG000|Overall Study|Lack of Efficacy|1|||
105689382|NCT01207596|364526678|FG000|Overall Study|Adverse Event|3|||
105689383|NCT01207596|364526678|FG000|Overall Study|Withdrawal by Subject|1|||
105689384|NCT03871829|364526679|FG000|Overall Study|Lost to Follow-up|0|||
105689385|NCT03871829|364526680|FG001|Overall Study|Lost to Follow-up|1|||
105689386|NCT03871829|364526679|FG000|Overall Study|Withdrawal by Subject|1|||
105689387|NCT03871829|364526680|FG001|Overall Study|Withdrawal by Subject|1|||
105689388|NCT03871829|364526679|FG000|Overall Study|Death|12|||
105689389|NCT03871829|364526680|FG001|Overall Study|Death|8|||
105689390|NCT03871829|364526679|FG000|Overall Study|Study terminated by sponsor|31|||
105689391|NCT03871829|364526680|FG001|Overall Study|Study terminated by sponsor|34|||
105689392|NCT02310672|364526681|FG000|Overall Study|Death|1|||
105689393|NCT02310672|364526681|FG000|Overall Study|Lost to Follow-up|1|||
105689394|NCT02310672|364526681|FG000|Overall Study|Withdrawal by Subject|1|||
105689395|NCT02310672|364526681|FG000|Overall Study|Sponsor's decision|12|||
105689396|NCT04288778|364526682|FG000|Overall Study|Withdrawal by Subject|2|||
105689397|NCT04288778|364526682|FG000|Overall Study|Adverse Event|5|||
105689398|NCT04288778|364526682|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105689399|NCT04288778|364526682|FG000|Overall Study|Other|1|||
105689400|NCT04288778|364526682|FG000|Overall Study|Started but not treated|2|||
105689401|NCT01106014|364526685|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
105689402|NCT01106014|364526686|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
105689403|NCT01106014|364526685|FG000|Overall Study|Adverse Event|78|||
105689404|NCT01106014|364526686|FG001|Overall Study|Adverse Event|42|||
105689405|NCT01106014|364526685|FG000|Overall Study|Withdrawal by Subject|43|||
105689406|NCT01106014|364526686|FG001|Overall Study|Withdrawal by Subject|37|||
105689407|NCT01106014|364526685|FG000|Overall Study|Administrative reason|7|||
105689408|NCT01106014|364526686|FG001|Overall Study|Administrative reason|6|||
105689409|NCT01106014|364526685|FG000|Overall Study|Lost to Follow-up|2|||
105689410|NCT01106014|364526686|FG001|Overall Study|Lost to Follow-up|3|||
105689411|NCT00063154|364526687|FG000|Overall Study|Disease progression|27|||
105689412|NCT00063154|364526687|FG000|Overall Study|Adverse Event|2|||
105689413|NCT00063154|364526687|FG000|Overall Study|Physician Decision|10|||
105689414|NCT00063154|364526687|FG000|Overall Study|Death|3|||
105689415|NCT00063154|364526687|FG000|Overall Study|Reason unspecified|1|||
105689416|NCT00063154|364526687|FG000|Overall Study|Did not receive treatment|8|||
105689417|NCT02554903|364526694|FG000|Overall Study|Death|1|||
105689418|NCT02554903|364526695|FG001|Overall Study|Death|1|||
105689419|NCT02554903|364526694|FG000|Overall Study|Physician Decision|2|||
105689420|NCT02554903|364526695|FG001|Overall Study|Physician Decision|2|||
105689421|NCT02554903|364526694|FG000|Overall Study|Heart Transplant|1|||
105689422|NCT02554903|364526695|FG001|Overall Study|Heart Transplant|2|||
105689423|NCT00364156|364526696|FG000|Overall Study|Withdrawal by Subject|73|||
105786798|NCT05643573|364872928|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
105689424|NCT00364156|364526697|FG001|Overall Study|Withdrawal by Subject|80|||
105689425|NCT00364156|364526696|FG000|Overall Study|Protocol Violation|6|||
105689426|NCT00364156|364526697|FG001|Overall Study|Protocol Violation|1|||
105689427|NCT03049735|364526704|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
105689428|NCT03049735|364526705|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
105786799|NCT05643573|364872927|FG000|Overall Study|Site terminated by sponsor|10|||
105786800|NCT05643573|364872928|FG001|Overall Study|Site terminated by sponsor|10|||
105786801|NCT05643573|364872927|FG000|Overall Study|Study terminated by sponsor|1|||
105786802|NCT05643573|364872928|FG001|Overall Study|Study terminated by sponsor|0|||
105786803|NCT05643573|364872927|FG000|Overall Study|Withdrawal by Subject|178|||
105559013|NCT03318523|364044561|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
105559014|NCT03318523|364044562|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
105559015|NCT03318523|364044563|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
105559016|NCT03318523|364044564|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
105559017|NCT03318523|364044565|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
105559018|NCT03318523|364044566|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
105559019|NCT03318523|364044557|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
105559020|NCT03318523|364044558|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
105559021|NCT03318523|364044559|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
105559022|NCT03318523|364044560|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
105559023|NCT03318523|364044561|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
105559024|NCT03318523|364044562|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
105559025|NCT03318523|364044563|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
105559026|NCT03318523|364044564|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
105559027|NCT03318523|364044565|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
105559028|NCT03318523|364044566|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
105559029|NCT00725452|364044567|FG000|Overall Study|Adverse Event|3|||
105559030|NCT00725452|364044567|FG000|Overall Study|Lack of Efficacy|2|||
105559031|NCT00725452|364044567|FG000|Overall Study|Reason not specified|1|||
105559032|NCT00725452|364044567|FG000|Overall Study|Physician Decision|1|||
105559033|NCT00725452|364044567|FG000|Overall Study|Withdrawal by Subject|3|||
105559034|NCT00725452|364044567|FG000|Overall Study|Lost to Follow-up|1|||
105559035|NCT04465357|364044568|FG000|Overall Study|Adverse Event|2|||
105559036|NCT04465357|364044568|FG000|Overall Study|Lack of Efficacy|1|||
105559037|NCT04465357|364044568|FG000|Overall Study|Lost to Follow-up|2|||
105559038|NCT04465357|364044568|FG000|Overall Study|Withdrawal by Subject|6|||
105559039|NCT04465357|364044568|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
105559040|NCT00831779|364044569|FG000|Overall Study|Lost to Follow-up|1|||
105559041|NCT00831779|364044570|FG001|Overall Study|Lost to Follow-up|0|||
105471470|NCT00953056|363738196|FG000|Overall Study|Withdrew Consent|0|||
105471471|NCT00953056|363738197|FG001|Overall Study|Withdrew Consent|0|||
105471472|NCT00953056|363738198|FG002|Overall Study|Withdrew Consent|0|||
105471473|NCT00953056|363738199|FG003|Overall Study|Withdrew Consent|0|||
105471474|NCT00953056|363738200|FG004|Overall Study|Withdrew Consent|2|||
105471475|NCT00953056|363738201|FG005|Overall Study|Withdrew Consent|3|||
105471476|NCT00953056|363738196|FG000|Overall Study|Serious Adverse Event|0|||
105471477|NCT00953056|363738197|FG001|Overall Study|Serious Adverse Event|0|||
105471478|NCT00953056|363738198|FG002|Overall Study|Serious Adverse Event|0|||
105471479|NCT00953056|363738199|FG003|Overall Study|Serious Adverse Event|0|||
105471480|NCT00953056|363738200|FG004|Overall Study|Serious Adverse Event|0|||
105471481|NCT00953056|363738201|FG005|Overall Study|Serious Adverse Event|1|||
105471482|NCT01598506|363738202|FG000|Overall Study|Withdrawal by Subject|2|||
105471483|NCT00035932|363738207|FG000|Overall Study|Adverse Event|10|||
105471484|NCT00035932|363738208|FG001|Overall Study|Adverse Event|9|||
105471485|NCT00035932|363738209|FG002|Overall Study|Adverse Event|9|||
105471486|NCT00035932|363738207|FG000|Overall Study|Death|0|||
105471487|NCT00035932|363738208|FG001|Overall Study|Death|0|||
105471488|NCT00035932|363738209|FG002|Overall Study|Death|1|||
105471489|NCT00035932|363738207|FG000|Overall Study|Disease Progression / Relapse|1|||
105471490|NCT00035932|363738208|FG001|Overall Study|Disease Progression / Relapse|1|||
105471491|NCT00035932|363738209|FG002|Overall Study|Disease Progression / Relapse|0|||
105471492|NCT00035932|363738207|FG000|Overall Study|Lost to Follow-up|4|||
105471493|NCT00035932|363738208|FG001|Overall Study|Lost to Follow-up|4|||
105471494|NCT00035932|363738209|FG002|Overall Study|Lost to Follow-up|3|||
105471495|NCT00035932|363738207|FG000|Overall Study|Noncompliance|6|||
105471496|NCT00035932|363738208|FG001|Overall Study|Noncompliance|7|||
105471497|NCT00035932|363738209|FG002|Overall Study|Noncompliance|6|||
105471498|NCT00035932|363738207|FG000|Overall Study|Protocol Violation While on Study|0|||
105471499|NCT00035932|363738208|FG001|Overall Study|Protocol Violation While on Study|1|||
105471500|NCT00035932|363738209|FG002|Overall Study|Protocol Violation While on Study|2|||
105471501|NCT00035932|363738207|FG000|Overall Study|Withdrawal by Subject|1|||
105559042|NCT00831779|364044569|FG000|Overall Study|No longer met criteria|0|||
105559043|NCT00831779|364044570|FG001|Overall Study|No longer met criteria|1|||
105559044|NCT02219048|364044579|FG000|Overall Study|Adverse Event|2|||
105559045|NCT02219048|364044580|FG001|Overall Study|Adverse Event|5|||
105559046|NCT02219048|364044579|FG000|Overall Study|No longer meets eligibility criteria|1|||
105471502|NCT00035932|363738208|FG001|Overall Study|Withdrawal by Subject|5|||
105471503|NCT00035932|363738209|FG002|Overall Study|Withdrawal by Subject|0|||
105471504|NCT00035932|363738207|FG000|Overall Study|Study Termination by Sponsor|1|||
105471505|NCT00035932|363738208|FG001|Overall Study|Study Termination by Sponsor|0|||
105346186|NCT02327013|363269642|FG001|Overall Study|Adverse Event|4|||
105346187|NCT02327013|363269643|FG002|Overall Study|Adverse Event|3|||
105346188|NCT02327013|363269644|FG003|Overall Study|Adverse Event|0|||
105346189|NCT02327013|363269645|FG004|Overall Study|Adverse Event|1|||
105346190|NCT02327013|363269641|FG000|Overall Study|Lack of Efficacy|2|||
105346191|NCT02327013|363269642|FG001|Overall Study|Lack of Efficacy|0|||
105346192|NCT02327013|363269643|FG002|Overall Study|Lack of Efficacy|5|||
105346193|NCT02327013|363269644|FG003|Overall Study|Lack of Efficacy|0|||
105346194|NCT02327013|363269645|FG004|Overall Study|Lack of Efficacy|1|||
105346195|NCT02327013|363269641|FG000|Overall Study|Non-compliance with IMP|1|||
105346196|NCT02327013|363269642|FG001|Overall Study|Non-compliance with IMP|2|||
105346197|NCT02327013|363269643|FG002|Overall Study|Non-compliance with IMP|7|||
105346198|NCT02327013|363269644|FG003|Overall Study|Non-compliance with IMP|0|||
105346199|NCT02327013|363269645|FG004|Overall Study|Non-compliance with IMP|0|||
105346200|NCT02327013|363269641|FG000|Overall Study|Withdrawal of Consent|1|||
105346201|NCT02327013|363269642|FG001|Overall Study|Withdrawal of Consent|0|||
105346202|NCT02327013|363269643|FG002|Overall Study|Withdrawal of Consent|3|||
105346203|NCT02327013|363269644|FG003|Overall Study|Withdrawal of Consent|0|||
105346204|NCT02327013|363269645|FG004|Overall Study|Withdrawal of Consent|0|||
105346205|NCT02327013|363269641|FG000|Overall Study|Lost to Follow-up|2|||
105346206|NCT02327013|363269642|FG001|Overall Study|Lost to Follow-up|4|||
105346207|NCT02327013|363269643|FG002|Overall Study|Lost to Follow-up|5|||
105346208|NCT02327013|363269644|FG003|Overall Study|Lost to Follow-up|0|||
105346209|NCT02327013|363269645|FG004|Overall Study|Lost to Follow-up|0|||
105346210|NCT02327013|363269641|FG000|Overall Study|Administrative or other reason(s)|1|||
105346211|NCT02327013|363269642|FG001|Overall Study|Administrative or other reason(s)|5|||
105346212|NCT02327013|363269643|FG002|Overall Study|Administrative or other reason(s)|11|||
105346213|NCT02327013|363269644|FG003|Overall Study|Administrative or other reason(s)|1|||
105346214|NCT02327013|363269645|FG004|Overall Study|Administrative or other reason(s)|1|||
105346215|NCT02327013|363269641|FG000|Overall Study|Protocol Violation|0|||
105346216|NCT02327013|363269642|FG001|Overall Study|Protocol Violation|0|||
105346217|NCT02327013|363269643|FG002|Overall Study|Protocol Violation|3|||
105346218|NCT02327013|363269644|FG003|Overall Study|Protocol Violation|0|||
105471506|NCT00035932|363738209|FG002|Overall Study|Study Termination by Sponsor|0|||
105471507|NCT00035932|363738207|FG000|Overall Study|Lack of Efficacy|33|||
105471508|NCT00035932|363738208|FG001|Overall Study|Lack of Efficacy|33|||
105471509|NCT00035932|363738209|FG002|Overall Study|Lack of Efficacy|28|||
105471510|NCT01976741|363738210|FG000|Overall Study|Withdrawal by Subject|1|||
105471511|NCT01976741|363738211|FG001|Overall Study|Withdrawal by Subject|0|||
105471512|NCT01976741|363738212|FG002|Overall Study|Withdrawal by Subject|1|||
105471513|NCT01976741|363738213|FG003|Overall Study|Withdrawal by Subject|1|||
105471514|NCT01976741|363738214|FG004|Overall Study|Withdrawal by Subject|0|||
105471515|NCT01976741|363738215|FG005|Overall Study|Withdrawal by Subject|0|||
105471516|NCT01976741|363738216|FG006|Overall Study|Withdrawal by Subject|1|||
105471517|NCT01976741|363738217|FG007|Overall Study|Withdrawal by Subject|4|||
105471518|NCT01976741|363738218|FG008|Overall Study|Withdrawal by Subject|0|||
105471519|NCT01976741|363738219|FG009|Overall Study|Withdrawal by Subject|0|||
105471520|NCT01976741|363738210|FG000|Overall Study|Adverse Event|0|||
105471521|NCT01976741|363738211|FG001|Overall Study|Adverse Event|0|||
105471522|NCT01976741|363738212|FG002|Overall Study|Adverse Event|2|||
105471523|NCT01976741|363738213|FG003|Overall Study|Adverse Event|0|||
105786804|NCT05643573|364872928|FG001|Overall Study|Withdrawal by Subject|130|||
105346219|NCT02327013|363269645|FG004|Overall Study|Protocol Violation|1|||
105346220|NCT02327013|363269641|FG000|Overall Study|Withdrawal before treatment|2|||
105346221|NCT02327013|363269642|FG001|Overall Study|Withdrawal before treatment|1|||
105346222|NCT02327013|363269643|FG002|Overall Study|Withdrawal before treatment|5|||
105346223|NCT02327013|363269644|FG003|Overall Study|Withdrawal before treatment|0|||
105346224|NCT02327013|363269645|FG004|Overall Study|Withdrawal before treatment|0|||
105346225|NCT02720744|363269646|FG000|Overall Study|Protocol Violation|0|||
105346226|NCT02720744|363269647|FG001|Overall Study|Protocol Violation|2|||
105346227|NCT02720744|363269646|FG000|Overall Study|Pregnancy|2|||
105346228|NCT02720744|363269647|FG001|Overall Study|Pregnancy|0|||
105346229|NCT02720744|363269646|FG000|Overall Study|Lack of Efficacy|2|||
105346230|NCT02720744|363269647|FG001|Overall Study|Lack of Efficacy|8|||
105346231|NCT02720744|363269646|FG000|Overall Study|Adverse Event|21|||
105346232|NCT02720744|363269647|FG001|Overall Study|Adverse Event|3|||
105346233|NCT02720744|363269646|FG000|Overall Study|Withdrawal by Subject|11|||
105471524|NCT01976741|363738214|FG004|Overall Study|Adverse Event|0|||
105471525|NCT01976741|363738215|FG005|Overall Study|Adverse Event|0|||
105786805|NCT05182840|364872929|FG000|Run-in Period|Not treated|0|||
105786806|NCT05182840|364872930|FG001|Run-in Period|Not treated|1|||
105346234|NCT02720744|363269647|FG001|Overall Study|Withdrawal by Subject|11|||
105346235|NCT02720744|363269646|FG000|Overall Study|Lost to follow up|2|||
105346236|NCT02720744|363269647|FG001|Overall Study|Lost to follow up|0|||
105346237|NCT02720744|363269646|FG000|Overall Study|Non Compliance with Investigational Product|0|||
105346238|NCT02720744|363269647|FG001|Overall Study|Non Compliance with Investigational Product|1|||
105471526|NCT01976741|363738216|FG006|Overall Study|Adverse Event|3|||
105471527|NCT01976741|363738217|FG007|Overall Study|Adverse Event|8|||
105689429|NCT03049735|364526706|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
105689430|NCT03049735|364526704|FG000|Overall Study|Other|5|||
105689431|NCT03049735|364526705|FG001|Overall Study|Other|3|||
105689432|NCT03049735|364526706|FG002|Overall Study|Other|1|||
105689433|NCT03049735|364526704|FG000|Overall Study|Lack of Efficacy|4|||
105689434|NCT03049735|364526705|FG001|Overall Study|Lack of Efficacy|0|||
105689435|NCT03049735|364526706|FG002|Overall Study|Lack of Efficacy|3|||
105689436|NCT03049735|364526704|FG000|Overall Study|Protocol deviation|1|||
105689437|NCT03049735|364526705|FG001|Overall Study|Protocol deviation|0|||
105689438|NCT03049735|364526706|FG002|Overall Study|Protocol deviation|0|||
105689439|NCT03049735|364526704|FG000|Overall Study|Pregnancy|0|||
105689440|NCT03049735|364526705|FG001|Overall Study|Pregnancy|0|||
105689441|NCT03049735|364526706|FG002|Overall Study|Pregnancy|1|||
105689442|NCT03049735|364526704|FG000|Overall Study|Adverse Event|7|||
105689443|NCT03049735|364526705|FG001|Overall Study|Adverse Event|18|||
105689444|NCT03049735|364526706|FG002|Overall Study|Adverse Event|5|||
105689445|NCT03049735|364526704|FG000|Overall Study|Withdrawal by Subject|10|||
105689446|NCT03049735|364526705|FG001|Overall Study|Withdrawal by Subject|3|||
105689447|NCT03049735|364526706|FG002|Overall Study|Withdrawal by Subject|7|||
105689448|NCT03049735|364526704|FG000|Overall Study|Lost to Follow-up|1|||
105689449|NCT03049735|364526705|FG001|Overall Study|Lost to Follow-up|5|||
105689450|NCT03049735|364526706|FG002|Overall Study|Lost to Follow-up|5|||
105689451|NCT03153111|364526708|FG000|Overall Study|Death|2|||
105689452|NCT03153111|364526709|FG001|Overall Study|Death|5|||
105689453|NCT03153111|364526708|FG000|Overall Study|Lost to Follow-up|1|||
105689454|NCT03153111|364526709|FG001|Overall Study|Lost to Follow-up|0|||
105689455|NCT03153111|364526708|FG000|Overall Study|Physician Decision|5|||
105689456|NCT03153111|364526709|FG001|Overall Study|Physician Decision|1|||
105689457|NCT03153111|364526708|FG000|Overall Study|Withdrawal by Subject|3|||
105689458|NCT03153111|364526709|FG001|Overall Study|Withdrawal by Subject|3|||
105689459|NCT01210118|364526710|FG000|Overall Study|Lost to Follow-up|1|||
105689460|NCT01210118|364526711|FG001|Overall Study|Lost to Follow-up|1|||
105689461|NCT01210118|364526710|FG000|Overall Study|Protocol Violation|1|||
105689462|NCT01210118|364526711|FG001|Overall Study|Protocol Violation|1|||
105689463|NCT01210118|364526710|FG000|Overall Study|Spontaneous abortion|1|||
105689464|NCT01210118|364526711|FG001|Overall Study|Spontaneous abortion|3|||
105689465|NCT02958267|364526712|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
105689466|NCT02958267|364526713|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
105689467|NCT02958267|364526712|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
105689468|NCT02958267|364526713|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
105689469|NCT02958267|364526712|FG000|Follow-up Visits|Additional treatment pursued|2|||
105689470|NCT02958267|364526713|FG001|Follow-up Visits|Additional treatment pursued|1|||
105689471|NCT00174265|364526721|FG000|Overall Study|Adverse Event|7|||
105689472|NCT00174265|364526722|FG001|Overall Study|Adverse Event|4|||
105689473|NCT00174265|364526721|FG000|Overall Study|Lack of Efficacy|2|||
105689474|NCT00174265|364526722|FG001|Overall Study|Lack of Efficacy|2|||
105689475|NCT00174265|364526721|FG000|Overall Study|Withdrawal by Subject|3|||
105689476|NCT00174265|364526722|FG001|Overall Study|Withdrawal by Subject|5|||
105689477|NCT00174265|364526721|FG000|Overall Study|Lost to Follow-up|1|||
105689478|NCT00174265|364526722|FG001|Overall Study|Lost to Follow-up|0|||
105786807|NCT05182840|364872931|FG002|Run-in Period|Not treated|0|||
105689479|NCT00174265|364526721|FG000|Overall Study|Other (Not specified)|16|||
105689480|NCT00174265|364526722|FG001|Overall Study|Other (Not specified)|10|||
105689481|NCT03471871|364526727|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
105689482|NCT03471871|364526728|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
105689483|NCT03471871|364526729|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
105689484|NCT03471871|364526730|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
105689485|NCT03471871|364526731|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
105689486|NCT03471871|364526727|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
105689487|NCT03471871|364526728|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
105689488|NCT03471871|364526729|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
105689489|NCT03471871|364526730|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
105689490|NCT03471871|364526731|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
105689491|NCT03471871|364526727|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
105689492|NCT03471871|364526728|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
105689493|NCT03471871|364526729|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
105689494|NCT03471871|364526730|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
105689495|NCT03471871|364526731|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
105689496|NCT03471871|364526727|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
105689497|NCT03471871|364526728|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
105689498|NCT03471871|364526729|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
105689499|NCT03471871|364526730|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
105689500|NCT03471871|364526731|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
105689501|NCT03471871|364526727|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
105689502|NCT03471871|364526728|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
105689503|NCT03471871|364526729|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
105689504|NCT03471871|364526730|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
105689505|NCT03471871|364526731|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
105689506|NCT04600336|364526732|FG000|Initial Treatment|Withdrawal by Subject|1|||
105689507|NCT04600336|364526733|FG001|Initial Treatment|Withdrawal by Subject|2|||
105689508|NCT04600336|364526734|FG002|Initial Treatment|Withdrawal by Subject|0|||
105689509|NCT04600336|364526735|FG003|Initial Treatment|Withdrawal by Subject|0|||
105689510|NCT04600336|364526732|FG000|Initial Treatment|Adverse Event|0|||
105689511|NCT04600336|364526733|FG001|Initial Treatment|Adverse Event|2|||
105689512|NCT04600336|364526734|FG002|Initial Treatment|Adverse Event|0|||
105689513|NCT04600336|364526735|FG003|Initial Treatment|Adverse Event|0|||
105689514|NCT04600336|364526732|FG000|Initial Treatment|Other complicating disease|0|||
105689515|NCT04600336|364526733|FG001|Initial Treatment|Other complicating disease|0|||
105689516|NCT04600336|364526734|FG002|Initial Treatment|Other complicating disease|1|||
105689517|NCT04600336|364526735|FG003|Initial Treatment|Other complicating disease|0|||
105689518|NCT04600336|364526732|FG000|Crossover Treatment|Withdrawal by Subject|0|||
105689519|NCT04600336|364526733|FG001|Crossover Treatment|Withdrawal by Subject|0|||
105689520|NCT04600336|364526734|FG002|Crossover Treatment|Withdrawal by Subject|2|||
105689521|NCT04600336|364526735|FG003|Crossover Treatment|Withdrawal by Subject|1|||
105689522|NCT04600336|364526732|FG000|Crossover Treatment|Adverse Event|0|||
105689523|NCT04600336|364526733|FG001|Crossover Treatment|Adverse Event|0|||
105689524|NCT04600336|364526734|FG002|Crossover Treatment|Adverse Event|1|||
105689525|NCT04600336|364526735|FG003|Crossover Treatment|Adverse Event|1|||
105689526|NCT05460273|364526736|FG000|Overall Study|Death|43|||
105689527|NCT05460273|364526737|FG001|Overall Study|Death|9|||
105689528|NCT05460273|364526736|FG000|Overall Study|Lost to Follow-up|7|||
105689529|NCT05460273|364526737|FG001|Overall Study|Lost to Follow-up|0|||
105689530|NCT05460273|364526736|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
105689531|NCT05460273|364526737|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
105689532|NCT05677893|364528165|FG000|Overall Study|Withdrawal by Subject|0|||
105689533|NCT05677893|364528166|FG001|Overall Study|Withdrawal by Subject|0|||
105689534|NCT05677893|364528167|FG002|Overall Study|Withdrawal by Subject|0|||
105689535|NCT05677893|364528168|FG003|Overall Study|Withdrawal by Subject|0|||
105689536|NCT05677893|364528169|FG004|Overall Study|Withdrawal by Subject|1|||
105689537|NCT05677893|364528170|FG005|Overall Study|Withdrawal by Subject|1|||
105689538|NCT05677893|364528171|FG006|Overall Study|Withdrawal by Subject|0|||
105689539|NCT05677893|364528165|FG000|Overall Study|Others|1|||
105689540|NCT05677893|364528166|FG001|Overall Study|Others|0|||
105689541|NCT05677893|364528167|FG002|Overall Study|Others|0|||
105689542|NCT05677893|364528168|FG003|Overall Study|Others|0|||
105689543|NCT05677893|364528169|FG004|Overall Study|Others|0|||
105559047|NCT02219048|364044580|FG001|Overall Study|No longer meets eligibility criteria|0|||
105689544|NCT05677893|364528170|FG005|Overall Study|Others|0|||
105689545|NCT05677893|364528171|FG006|Overall Study|Others|0|||
105689546|NCT01390181|364528172|FG000|Overall Study|Lost to Follow-up|1|||
105689547|NCT01390181|364528172|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
105689548|NCT00355056|364528173|FG000|Randomization Period|Early Termination|4|||
105689549|NCT00355056|364528174|FG001|Randomization Period|Early Termination|6|||
105689550|NCT02805725|364528175|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
105689551|NCT02805725|364528176|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
105689552|NCT02805725|364528177|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
105689553|NCT02805725|364528178|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
105689554|NCT02805725|364528179|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
105689555|NCT02805725|364528175|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
105689556|NCT02805725|364528176|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
105689557|NCT02805725|364528177|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
105689558|NCT02805725|364528178|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
105689559|NCT02805725|364528179|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
105689560|NCT02805725|364528175|FG000|Phase II|Protocol Violation|0|||
105689561|NCT02805725|364528176|FG001|Phase II|Protocol Violation|0|||
105689562|NCT02805725|364528177|FG002|Phase II|Protocol Violation|0|||
105689563|NCT02805725|364528178|FG003|Phase II|Protocol Violation|0|||
105689564|NCT02805725|364528179|FG004|Phase II|Protocol Violation|6|||
105689565|NCT01195545|364528180|FG000|Overall Study|Protocol Violation|4|||
105689566|NCT00084266|364528181|FG000|Overall Study|Death|42|||
105689567|NCT00084266|364528182|FG001|Overall Study|Death|39|||
105689568|NCT00084266|364528181|FG000|Overall Study|Adverse Event|8|||
105689569|NCT00084266|364528182|FG001|Overall Study|Adverse Event|5|||
105689570|NCT00084266|364528181|FG000|Overall Study|Lack of Efficacy|2|||
105689571|NCT00084266|364528182|FG001|Overall Study|Lack of Efficacy|4|||
105689572|NCT00084266|364528181|FG000|Overall Study|Lost to Follow-up|5|||
105689573|NCT00084266|364528182|FG001|Overall Study|Lost to Follow-up|3|||
105689574|NCT00084266|364528181|FG000|Overall Study|Participant not willing to participate|3|||
105689575|NCT00084266|364528182|FG001|Overall Study|Participant not willing to participate|8|||
105689576|NCT00084266|364528181|FG000|Overall Study|Other|360|||
105689577|NCT00084266|364528182|FG001|Overall Study|Other|344|||
105689578|NCT00084266|364528181|FG000|Overall Study|Randomized not treated|21|||
105689579|NCT00084266|364528182|FG001|Overall Study|Randomized not treated|20|||
105689580|NCT01729156|364528183|FG000|Overall Study|Withdrawal by Subject|1|||
105689581|NCT01729156|364528184|FG001|Overall Study|Withdrawal by Subject|0|||
105689582|NCT01729156|364528185|FG002|Overall Study|Withdrawal by Subject|0|||
105689583|NCT00719563|364528186|FG000|Overall Study|Adverse Event|16|||
105689584|NCT00719563|364528187|FG001|Overall Study|Adverse Event|13|||
105689585|NCT00719563|364528186|FG000|Overall Study|Medical condition changed|3|||
105689586|NCT00719563|364528187|FG001|Overall Study|Medical condition changed|5|||
105689587|NCT00719563|364528186|FG000|Overall Study|Lack of Efficacy|3|||
105689588|NCT00719563|364528187|FG001|Overall Study|Lack of Efficacy|7|||
105689589|NCT00719563|364528186|FG000|Overall Study|Personal reasons|6|||
105689590|NCT00719563|364528187|FG001|Overall Study|Personal reasons|7|||
105689591|NCT00719563|364528186|FG000|Overall Study|Unknown reasons|4|||
105689592|NCT00719563|364528187|FG001|Overall Study|Unknown reasons|6|||
105689593|NCT00719563|364528186|FG000|Overall Study|Noncompliant|1|||
105689594|NCT00719563|364528187|FG001|Overall Study|Noncompliant|1|||
105689595|NCT00719563|364528186|FG000|Overall Study|Lost to Follow-up|5|||
105689596|NCT00719563|364528187|FG001|Overall Study|Lost to Follow-up|3|||
105689597|NCT00567268|364528188|FG000|Overall Study|Protocol Violation|7|||
105689598|NCT00567268|364528188|FG000|Overall Study|Lost to Follow-up|36|||
105689599|NCT00567268|364528188|FG000|Overall Study|No Visit After First Day of Treatment|2|||
105689600|NCT00567268|364528188|FG000|Overall Study|No Drug Administration|4|||
105689601|NCT00567268|364528188|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
105689602|NCT02525861|364528189|FG000|Overall Study|Adverse Event|1|||
105689603|NCT02525861|364528190|FG001|Overall Study|Adverse Event|0|||
105786808|NCT05182840|364872932|FG003|Run-in Period|Not treated|0|||
105689604|NCT02525861|364528189|FG000|Overall Study|Withdrawal by Subject|0|||
105689605|NCT02525861|364528190|FG001|Overall Study|Withdrawal by Subject|1|||
105689606|NCT02525861|364528189|FG000|Overall Study|Physician Decision|0|||
105689607|NCT02525861|364528190|FG001|Overall Study|Physician Decision|1|||
105689608|NCT03942406|364528194|FG000|Overall Study|Lost to Follow-up|4|||
105689609|NCT03942406|364528195|FG001|Overall Study|Lost to Follow-up|5|||
105689610|NCT03942406|364528196|FG002|Overall Study|Lost to Follow-up|3|||
105689611|NCT03942406|364528197|FG003|Overall Study|Lost to Follow-up|7|||
105689612|NCT03942406|364528198|FG004|Overall Study|Lost to Follow-up|1|||
105689613|NCT03942406|364528199|FG005|Overall Study|Lost to Follow-up|0|||
105689614|NCT03942406|364528200|FG006|Overall Study|Lost to Follow-up|0|||
105689615|NCT03942406|364528194|FG000|Overall Study|Withdrawal by Subject|3|||
105689616|NCT03942406|364528195|FG001|Overall Study|Withdrawal by Subject|1|||
105689617|NCT03942406|364528196|FG002|Overall Study|Withdrawal by Subject|1|||
105689618|NCT03942406|364528197|FG003|Overall Study|Withdrawal by Subject|3|||
105689619|NCT03942406|364528198|FG004|Overall Study|Withdrawal by Subject|0|||
105786809|NCT05182840|364872933|FG004|Run-in Period|Not treated|0|||
105786810|NCT05182840|364872934|FG005|Run-in Period|Not treated|0|||
105786811|NCT05182840|364872935|FG006|Run-in Period|Not treated|0|||
105786812|NCT05182840|364872936|FG007|Run-in Period|Not treated|0|||
105786813|NCT05182840|364872937|FG008|Run-in Period|Not treated|0|||
105689620|NCT03942406|364528199|FG005|Overall Study|Withdrawal by Subject|0|||
105689621|NCT03942406|364528200|FG006|Overall Study|Withdrawal by Subject|0|||
105689622|NCT03942406|364528194|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
105689623|NCT03942406|364528195|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
105689624|NCT03942406|364528196|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
105689625|NCT03942406|364528197|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
105689626|NCT03942406|364528198|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
105786814|NCT05182840|364872938|FG009|Run-in Period|Not treated|0|||
105786815|NCT05182840|364872929|FG000|Run-in Period|Other reason but not sponsor termination|14|||
105689627|NCT03942406|364528199|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
105689628|NCT03942406|364528200|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
105689629|NCT00818389|364528201|FG000|Overall Study|Death|1|||
105689630|NCT00818389|364528202|FG001|Overall Study|Death|3|||
105689631|NCT00818389|364528201|FG000|Overall Study|ALS Disease Progression|1|||
105689632|NCT00818389|364528202|FG001|Overall Study|ALS Disease Progression|0|||
105689633|NCT00818389|364528201|FG000|Overall Study|Withdrawal by Subject|2|||
105689634|NCT00818389|364528202|FG001|Overall Study|Withdrawal by Subject|2|||
105689635|NCT00818389|364528201|FG000|Overall Study|Adverse Event|0|||
105689636|NCT00818389|364528202|FG001|Overall Study|Adverse Event|1|||
105689637|NCT04263909|364528203|FG000|Overall Study|Physician Decision|1|||
105689638|NCT04263909|364528204|FG001|Overall Study|Physician Decision|0|||
105689639|NCT04263909|364528205|FG002|Overall Study|Physician Decision|0|||
105689640|NCT04263909|364528203|FG000|Overall Study|Adverse Event|3|||
105786816|NCT05182840|364872930|FG001|Run-in Period|Other reason but not sponsor termination|18|||
105786817|NCT05182840|364872931|FG002|Run-in Period|Other reason but not sponsor termination|0|||
105786818|NCT05182840|364872932|FG003|Run-in Period|Other reason but not sponsor termination|0|||
105786819|NCT05182840|364872933|FG004|Run-in Period|Other reason but not sponsor termination|0|||
105786820|NCT05182840|364872934|FG005|Run-in Period|Other reason but not sponsor termination|0|||
105786821|NCT05182840|364872935|FG006|Run-in Period|Other reason but not sponsor termination|0|||
105786822|NCT05182840|364872936|FG007|Run-in Period|Other reason but not sponsor termination|0|||
105786823|NCT05182840|364872937|FG008|Run-in Period|Other reason but not sponsor termination|0|||
105786824|NCT05182840|364872938|FG009|Run-in Period|Other reason but not sponsor termination|0|||
105786825|NCT05182840|364872929|FG000|Run-in Period|No reason available|2|||
105689641|NCT04263909|364528204|FG001|Overall Study|Adverse Event|0|||
105689642|NCT04263909|364528205|FG002|Overall Study|Adverse Event|0|||
105689643|NCT04263909|364528203|FG000|Overall Study|Protocol Violation|5|||
105689644|NCT04263909|364528204|FG001|Overall Study|Protocol Violation|0|||
105689645|NCT04263909|364528205|FG002|Overall Study|Protocol Violation|0|||
105689646|NCT05193500|364528206|FG000|Overall Study|Withdrawal by Subject|7|||
105689647|NCT05193500|364528207|FG001|Overall Study|Withdrawal by Subject|4|||
105689648|NCT05193500|364528208|FG002|Overall Study|Withdrawal by Subject|3|||
105689649|NCT05193500|364528209|FG003|Overall Study|Withdrawal by Subject|5|||
105689650|NCT05458479|364528210|FG000|Overall Study|Lost to Follow-up|1|||
105689651|NCT00756470|364528211|FG000|Overall Study|Withdrawal by Subject|1|||
105689652|NCT00756470|364528211|FG000|Overall Study|Adverse Event|4|||
105689653|NCT00528866|364528212|FG000|Overall Study|Protocol Violation|6|||
105689654|NCT00954174|364528213|FG000|Overall Study|Adverse Event|28|||
105689655|NCT00954174|364528214|FG001|Overall Study|Adverse Event|23|||
105689656|NCT00954174|364528215|FG002|Overall Study|Adverse Event|4|||
105689657|NCT00954174|364528216|FG003|Overall Study|Adverse Event|9|||
105689658|NCT00954174|364528213|FG000|Overall Study|Death|4|||
105689659|NCT00954174|364528214|FG001|Overall Study|Death|2|||
105689660|NCT00954174|364528215|FG002|Overall Study|Death|0|||
105689661|NCT00954174|364528216|FG003|Overall Study|Death|0|||
105689662|NCT00954174|364528213|FG000|Overall Study|Lack of Efficacy|32|||
105689663|NCT00954174|364528214|FG001|Overall Study|Lack of Efficacy|22|||
105689664|NCT00954174|364528215|FG002|Overall Study|Lack of Efficacy|8|||
105689665|NCT00954174|364528216|FG003|Overall Study|Lack of Efficacy|6|||
105689666|NCT00954174|364528213|FG000|Overall Study|Withdrawal by Subject|14|||
105689667|NCT00954174|364528214|FG001|Overall Study|Withdrawal by Subject|10|||
105689668|NCT00954174|364528215|FG002|Overall Study|Withdrawal by Subject|4|||
105689669|NCT00954174|364528216|FG003|Overall Study|Withdrawal by Subject|3|||
105689670|NCT00954174|364528213|FG000|Overall Study|Medical Reason|4|||
105689671|NCT00954174|364528214|FG001|Overall Study|Medical Reason|2|||
105689672|NCT00954174|364528215|FG002|Overall Study|Medical Reason|1|||
105689673|NCT00954174|364528216|FG003|Overall Study|Medical Reason|0|||
105689674|NCT00954174|364528213|FG000|Overall Study|Ineligible|40|||
105689675|NCT00954174|364528214|FG001|Overall Study|Ineligible|47|||
105689676|NCT00954174|364528215|FG002|Overall Study|Ineligible|7|||
105689677|NCT00954174|364528216|FG003|Overall Study|Ineligible|4|||
105689678|NCT00954174|364528213|FG000|Overall Study|Never Treated|4|||
105689679|NCT00954174|364528214|FG001|Overall Study|Never Treated|17|||
105689680|NCT00954174|364528215|FG002|Overall Study|Never Treated|0|||
105689681|NCT00954174|364528216|FG003|Overall Study|Never Treated|3|||
105689682|NCT01776424|364528217|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
105689683|NCT01776424|364528218|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
105689684|NCT01776424|364528219|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
105689685|NCT01776424|364528217|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
105689686|NCT01776424|364528218|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
105689687|NCT01776424|364528219|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
105689688|NCT01776424|364528217|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
105689689|NCT01776424|364528218|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
105689690|NCT01776424|364528219|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
105689691|NCT01776424|364528217|FG000|LTOLE Part (Open Label)|Refused|5|||
105689692|NCT01776424|364528218|FG001|LTOLE Part (Open Label)|Refused|2|||
105689693|NCT01776424|364528219|FG002|LTOLE Part (Open Label)|Refused|11|||
105689694|NCT01776424|364528217|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
105689695|NCT01776424|364528218|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
105689696|NCT01776424|364528219|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
105689697|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
105786826|NCT05182840|364872930|FG001|Run-in Period|No reason available|2|||
105689698|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
105689699|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
105689700|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
105689701|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
105689702|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
105689703|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
105689704|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
105689705|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Death|1|||
105689706|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Death|1|||
105689707|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
105471528|NCT01976741|363738218|FG008|Overall Study|Adverse Event|1|||
105689708|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
105689709|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
105689710|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
105689711|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
105689712|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
105689713|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
105689714|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
105689715|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
105689716|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
105689717|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
105689718|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
105689719|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
105689720|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
105689721|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
105689722|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
105689723|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
105689724|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
105689725|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
105689726|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
105689727|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
105689728|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
105689729|NCT00559585|364528220|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
105689730|NCT00559585|364528221|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
105689731|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
105689732|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
105689733|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
105689734|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
105689735|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
105689736|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
105689737|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
105689738|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
105689739|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
105689740|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
105689741|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
105689742|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
105689743|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
105471529|NCT01976741|363738219|FG009|Overall Study|Adverse Event|4|||
105471530|NCT00670306|363738224|FG000|Overall Study|Adverse Event|8|||
105471531|NCT00670306|363738224|FG000|Overall Study|Lack of Efficacy|10|||
105471532|NCT00670306|363738224|FG000|Overall Study|Withdrawal by Subject|9|||
105471533|NCT00670306|363738224|FG000|Overall Study|Physician Decision|1|||
105471534|NCT00670306|363738224|FG000|Overall Study|Lost to Follow-up|8|||
105689744|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
105689745|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
105689746|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
105689747|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
105689748|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
105689749|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
105689750|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
105689751|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
105689752|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
105689753|NCT04209621|364528222|FG000|Overall Study|Death|1|||
105689754|NCT04209621|364528222|FG000|Overall Study|Study Terminated Early|2|||
105689755|NCT01372410|364528223|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
105689756|NCT01372410|364528224|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
105689757|NCT01372410|364528225|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
105689758|NCT01372410|364528226|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
105689759|NCT01372410|364528227|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
105689760|NCT01372410|364528228|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
105689761|NCT01372410|364528229|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
105689762|NCT01372410|364528230|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
105689763|NCT01372410|364528223|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
105689764|NCT01372410|364528224|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
105689765|NCT01372410|364528225|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
105689766|NCT01372410|364528226|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
105689767|NCT01372410|364528227|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
105689768|NCT01372410|364528228|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
105689769|NCT01372410|364528229|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
105689770|NCT01372410|364528230|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
105689771|NCT01372410|364528223|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105689772|NCT01372410|364528224|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105689773|NCT01372410|364528225|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105689774|NCT01372410|364528226|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105689775|NCT01372410|364528227|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
105689776|NCT01372410|364528228|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105689777|NCT01372410|364528229|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105689778|NCT01372410|364528230|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105689779|NCT01372410|364528223|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
105689780|NCT01372410|364528224|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
105689781|NCT01372410|364528225|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
105689782|NCT01372410|364528226|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
105689783|NCT01372410|364528227|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
105689784|NCT01372410|364528228|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
105689785|NCT01372410|364528229|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
105689786|NCT01372410|364528230|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
105689787|NCT01372410|364528223|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
105689788|NCT01372410|364528224|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
105689789|NCT01372410|364528225|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
105689790|NCT01372410|364528226|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
105689791|NCT01372410|364528227|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
105689792|NCT01372410|364528228|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
105689793|NCT01372410|364528229|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
105689794|NCT01372410|364528230|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
105689795|NCT01372410|364528223|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
105689796|NCT01372410|364528224|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
105689797|NCT01372410|364528225|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
105689798|NCT01372410|364528226|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
105689799|NCT01372410|364528227|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
105689800|NCT01372410|364528228|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
105689801|NCT01372410|364528229|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
105471535|NCT00670306|363738224|FG000|Overall Study|incl/excl criterias did not meet|19|||
105689802|NCT01372410|364528230|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
105689803|NCT01372410|364528223|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
105689804|NCT01372410|364528224|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
105689805|NCT01372410|364528225|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
105689806|NCT01372410|364528226|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
105689807|NCT01372410|364528227|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
105689808|NCT01372410|364528228|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
105689809|NCT01372410|364528229|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
105689810|NCT01372410|364528230|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
105689811|NCT01372410|364528223|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
105689812|NCT01372410|364528224|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
105689813|NCT01372410|364528225|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
105689814|NCT01372410|364528226|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
105689815|NCT01372410|364528227|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
105689816|NCT01372410|364528228|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
105689817|NCT01372410|364528229|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
105689818|NCT01372410|364528230|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
105689819|NCT01372410|364528223|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
105689820|NCT01372410|364528224|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
105689821|NCT01372410|364528225|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
105689822|NCT01372410|364528226|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
105689823|NCT01372410|364528227|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
105689824|NCT01372410|364528228|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
105689825|NCT01372410|364528229|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
105689826|NCT01372410|364528230|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
105689827|NCT01372410|364528223|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
105689828|NCT01372410|364528224|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
105689829|NCT01372410|364528225|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
105689830|NCT01372410|364528226|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
105689831|NCT01372410|364528227|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
105689832|NCT01372410|364528228|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
105689833|NCT01372410|364528229|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
105689834|NCT01372410|364528230|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
105689835|NCT02644941|364528231|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
105689836|NCT02644941|364528232|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
105689837|NCT04585646|364528233|FG000|First Intervention|Physician Decision|1|||
105689838|NCT04585646|364528234|FG001|First Intervention|Physician Decision|0|||
105689839|NCT04585646|364528233|FG000|First Intervention|Lost to Follow-up|0|||
105689840|NCT04585646|364528234|FG001|First Intervention|Lost to Follow-up|3|||
105689841|NCT04585646|364528233|FG000|First Intervention|Withdrawal by Subject|0|||
105689842|NCT04585646|364528234|FG001|First Intervention|Withdrawal by Subject|1|||
105689843|NCT00769860|364528239|FG000|Overall Study|Withdrawal by Subject|2|||
105689844|NCT00769860|364528240|FG001|Overall Study|Withdrawal by Subject|0|||
105689845|NCT01003990|364528241|FG000|Overall Study|Adverse Event|8|||
105689846|NCT01003990|364528242|FG001|Overall Study|Adverse Event|5|||
105689847|NCT01003990|364528243|FG002|Overall Study|Adverse Event|11|||
105689848|NCT01003990|364528241|FG000|Overall Study|Death|0|||
105689849|NCT01003990|364528242|FG001|Overall Study|Death|8|||
105689850|NCT01003990|364528243|FG002|Overall Study|Death|1|||
105689851|NCT01003990|364528241|FG000|Overall Study|Lack of Efficacy|10|||
105689852|NCT01003990|364528242|FG001|Overall Study|Lack of Efficacy|2|||
105689853|NCT01003990|364528243|FG002|Overall Study|Lack of Efficacy|3|||
105689854|NCT01003990|364528241|FG000|Overall Study|Lost to Follow-up|30|||
105689855|NCT01003990|364528242|FG001|Overall Study|Lost to Follow-up|12|||
105689856|NCT01003990|364528243|FG002|Overall Study|Lost to Follow-up|7|||
105689857|NCT01003990|364528241|FG000|Overall Study|Reasons Not Identified|14|||
105689858|NCT01003990|364528242|FG001|Overall Study|Reasons Not Identified|13|||
105689859|NCT01003990|364528243|FG002|Overall Study|Reasons Not Identified|8|||
105689860|NCT01003990|364528241|FG000|Overall Study|Poor/Non-compliance|4|||
105689861|NCT01003990|364528242|FG001|Overall Study|Poor/Non-compliance|3|||
105689862|NCT01003990|364528243|FG002|Overall Study|Poor/Non-compliance|2|||
105689863|NCT01003990|364528241|FG000|Overall Study|Pregnancy|10|||
105689864|NCT01003990|364528242|FG001|Overall Study|Pregnancy|2|||
105689865|NCT01003990|364528243|FG002|Overall Study|Pregnancy|4|||
105689866|NCT01003990|364528241|FG000|Overall Study|No Longer Met Study Criteria|4|||
105689867|NCT01003990|364528242|FG001|Overall Study|No Longer Met Study Criteria|1|||
105689868|NCT01003990|364528243|FG002|Overall Study|No Longer Met Study Criteria|0|||
105689869|NCT01003990|364528241|FG000|Overall Study|Subject Withdrew Consent|12|||
105689870|NCT01003990|364528242|FG001|Overall Study|Subject Withdrew Consent|5|||
105689871|NCT01003990|364528243|FG002|Overall Study|Subject Withdrew Consent|7|||
105689872|NCT03037619|364528249|FG000|Overall Study|Lost to Follow-up|0|||
105689873|NCT03037619|364528250|FG001|Overall Study|Lost to Follow-up|1|||
105689874|NCT02030405|364528259|FG000|Overall Study|Withdrawal by Subject|1|||
105689875|NCT02030405|364528259|FG000|Overall Study|Lost to Follow-up|1|||
105689876|NCT02520284|364528260|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
105689877|NCT02520284|364528261|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
105689878|NCT02520284|364528262|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
105689879|NCT02520284|364528260|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
105689880|NCT02520284|364528261|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
105689881|NCT02520284|364528262|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
105689882|NCT02520284|364528260|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
105689883|NCT02520284|364528261|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
105689884|NCT02520284|364528262|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
105689885|NCT02520284|364528260|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
105689886|NCT02520284|364528261|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
105689887|NCT02520284|364528262|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
105689888|NCT02520284|364528260|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
105689889|NCT02520284|364528261|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
105689890|NCT02520284|364528262|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
105689891|NCT02520284|364528260|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
105689892|NCT02520284|364528261|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
105689893|NCT02520284|364528262|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
105689894|NCT02520284|364528260|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
105689895|NCT02520284|364528261|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
105689896|NCT02520284|364528262|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
105689897|NCT02520284|364528260|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
105689898|NCT02520284|364528261|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
105689899|NCT02520284|364528262|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
105689900|NCT02520284|364528260|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
105689901|NCT02520284|364528261|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
105689902|NCT02520284|364528262|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
105689903|NCT02520284|364528260|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
105689904|NCT02520284|364528261|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
105689905|NCT02520284|364528262|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
105689906|NCT02520284|364528260|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
105689907|NCT02520284|364528261|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
105689908|NCT02520284|364528262|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
105689909|NCT02411578|364528263|FG000|Crossover Trial Phase|Pregnancy|0|||
105689910|NCT02411578|364528264|FG001|Crossover Trial Phase|Pregnancy|1|||
105689911|NCT02973048|364528265|FG000|Overall Study|Epidural catheter insertion failure|1|||
105689912|NCT02973048|364528266|FG001|Overall Study|Epidural catheter insertion failure|0|||
105689913|NCT02973048|364528265|FG000|Overall Study|Withdrawal by Subject|0|||
105689914|NCT02973048|364528266|FG001|Overall Study|Withdrawal by Subject|3|||
105689915|NCT01472380|364528280|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
105689916|NCT01472380|364528280|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
105689917|NCT02511678|364528281|FG000|Overall Study|Withdrawal by Subject|2|||
105689918|NCT02511678|364528281|FG000|Overall Study|Lost to Follow-up|4|||
105689919|NCT02511678|364528281|FG000|Overall Study|Death|19|||
105689920|NCT02511678|364528281|FG000|Overall Study|Adverse Event|1|||
105689921|NCT02511678|364528281|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
105689922|NCT02511678|364528281|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
105689923|NCT02511678|364528281|FG000|Overall Study|Required Radiofrequency Ablation|1|||
105689924|NCT02511678|364528281|FG000|Overall Study|Biopsy was Negative|1|||
105689925|NCT02511678|364528281|FG000|Overall Study|Protocol Violation|1|||
105689926|NCT02511678|364528281|FG000|Overall Study|Received Radiation Treatment|1|||
105689927|NCT01295281|364528282|FG000|First Intervention (7 Days)|Death|0|||
105689928|NCT01295281|364528283|FG001|First Intervention (7 Days)|Death|1|||
105689929|NCT00292461|364528284|FG000|Overall Study|Adverse Event|4|||
105689930|NCT00292461|364528285|FG001|Overall Study|Adverse Event|2|||
105689931|NCT00292461|364528284|FG000|Overall Study|Lack of Efficacy|1|||
105689932|NCT00292461|364528285|FG001|Overall Study|Lack of Efficacy|0|||
105689933|NCT00292461|364528284|FG000|Overall Study|Withdrawal by Subject|0|||
105689934|NCT00292461|364528285|FG001|Overall Study|Withdrawal by Subject|1|||
105689935|NCT00292461|364528284|FG000|Overall Study|Protocol Violation|4|||
105689936|NCT00292461|364528285|FG001|Overall Study|Protocol Violation|3|||
105689937|NCT00292461|364528284|FG000|Overall Study|Lost to Follow-up|1|||
105689938|NCT00292461|364528285|FG001|Overall Study|Lost to Follow-up|0|||
105689939|NCT01891721|364528286|FG000|Overall Study|Lost to Follow-up|10|||
105689940|NCT01891721|364528287|FG001|Overall Study|Lost to Follow-up|5|||
105689941|NCT01891721|364528288|FG002|Overall Study|Lost to Follow-up|1|||
105689942|NCT02684279|364528289|FG000|Overall Study|Adverse Event|87|||
105689943|NCT02684279|364528289|FG000|Overall Study|Lack of Efficacy|4|||
105689944|NCT02684279|364528289|FG000|Overall Study|Lost to Follow-up|61|||
105689945|NCT02684279|364528289|FG000|Overall Study|Protocol Violation|6|||
105689946|NCT02684279|364528289|FG000|Overall Study|Pregnancy|8|||
105689947|NCT02684279|364528289|FG000|Overall Study|Withdrawal by Subject|92|||
105689948|NCT02684279|364528289|FG000|Overall Study|non-compliance with study drug|9|||
105689949|NCT02684279|364528289|FG000|Overall Study|non compliance with study visits|2|||
105689950|NCT02684279|364528289|FG000|Overall Study|subject to have surgery|1|||
105689951|NCT02684279|364528289|FG000|Overall Study|family emergency|1|||
105689952|NCT02684279|364528289|FG000|Overall Study|Site closures|7|||
105689953|NCT02684279|364528289|FG000|Overall Study|Physician Decision|1|||
105689954|NCT04683731|364528302|FG000|Overall Study|Withdrawal by Subject|1|||
105689955|NCT04683731|364528303|FG001|Overall Study|Withdrawal by Subject|0|||
105689956|NCT04683731|364528304|FG002|Overall Study|Withdrawal by Subject|3|||
105689957|NCT04683731|364528305|FG003|Overall Study|Withdrawal by Subject|2|||
105689958|NCT04683731|364528302|FG000|Overall Study|Determined patient was not eligible|3|||
105689959|NCT04683731|364528303|FG001|Overall Study|Determined patient was not eligible|3|||
105689960|NCT04683731|364528304|FG002|Overall Study|Determined patient was not eligible|12|||
105689961|NCT04683731|364528305|FG003|Overall Study|Determined patient was not eligible|3|||
105689962|NCT01839487|364528306|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
105689963|NCT01839487|364528307|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
105689964|NCT01839487|364528308|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
105689965|NCT01839487|364528309|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
105689966|NCT01839487|364528310|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
105689967|NCT01839487|364528311|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
105689968|NCT01839487|364528306|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
105689969|NCT01839487|364528307|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
105689970|NCT01839487|364528308|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
105689971|NCT01839487|364528309|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
105689972|NCT01839487|364528310|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
105689973|NCT01839487|364528311|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
105689974|NCT01839487|364528306|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
105689975|NCT01839487|364528307|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
105689976|NCT01839487|364528308|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
105689977|NCT01839487|364528309|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
105689978|NCT01839487|364528310|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
105689979|NCT01839487|364528311|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
105689980|NCT01839487|364528306|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
105689981|NCT01839487|364528307|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
105689982|NCT01839487|364528308|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
105689983|NCT01839487|364528309|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
105689984|NCT01839487|364528310|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
105689985|NCT01839487|364528311|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
105689986|NCT01839487|364528306|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
105689987|NCT01839487|364528307|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
105689988|NCT01839487|364528308|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
105689989|NCT01839487|364528309|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
105689990|NCT01839487|364528310|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
105689991|NCT01839487|364528311|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
105689992|NCT01839487|364528306|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
105689993|NCT01839487|364528307|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
105689994|NCT01839487|364528308|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
105689995|NCT01839487|364528309|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
105689996|NCT01839487|364528310|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
105689997|NCT01839487|364528311|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
105689998|NCT01839487|364528306|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
105689999|NCT01839487|364528307|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
105690000|NCT01839487|364528308|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
105690001|NCT01839487|364528309|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
105690002|NCT01839487|364528310|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
105690003|NCT01839487|364528311|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
105690004|NCT01839487|364528306|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
105690005|NCT01839487|364528307|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
105690006|NCT01839487|364528308|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
105690007|NCT01839487|364528309|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
105690008|NCT01839487|364528310|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
105690009|NCT01839487|364528311|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
105690010|NCT01839487|364528306|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
105690011|NCT01839487|364528307|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
105690012|NCT01839487|364528308|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
105690013|NCT01839487|364528309|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
105690014|NCT01839487|364528310|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
105690015|NCT01839487|364528311|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
105690016|NCT00475033|364528312|FG000|Infant Series|Failed to return|3|||
105690017|NCT00475033|364528313|FG001|Infant Series|Failed to return|4|||
105690018|NCT00475033|364528312|FG000|Infant Series|Parent or legal guardian request|1|||
105690019|NCT00475033|364528313|FG001|Infant Series|Parent or legal guardian request|5|||
105690020|NCT00475033|364528312|FG000|Infant Series|Protocol Violation|1|||
105690021|NCT00475033|364528313|FG001|Infant Series|Protocol Violation|2|||
105690022|NCT00475033|364528312|FG000|Infant Series|Lost to Follow-up|2|||
105690023|NCT00475033|364528313|FG001|Infant Series|Lost to Follow-up|0|||
105690024|NCT00475033|364528312|FG000|Infant Series|Adverse Event|0|||
105690025|NCT00475033|364528313|FG001|Infant Series|Adverse Event|2|||
105690026|NCT00475033|364528312|FG000|After the Infant Series|Adverse Event|0|||
105690027|NCT00475033|364528313|FG001|After the Infant Series|Adverse Event|4|||
105690028|NCT00475033|364528312|FG000|After the Infant Series|Parent or legal guardian request|2|||
105690029|NCT00475033|364528313|FG001|After the Infant Series|Parent or legal guardian request|2|||
105690030|NCT00475033|364528312|FG000|After the Infant Series|Failed to return|2|||
105690031|NCT00475033|364528313|FG001|After the Infant Series|Failed to return|1|||
105690032|NCT00475033|364528312|FG000|After the Infant Series|Protocol Violation|1|||
105690033|NCT00475033|364528313|FG001|After the Infant Series|Protocol Violation|0|||
105690034|NCT00475033|364528312|FG000|After the Infant Series|Lost to Follow-up|1|||
105690035|NCT00475033|364528313|FG001|After the Infant Series|Lost to Follow-up|0|||
105690036|NCT00475033|364528312|FG000|After the Infant Series|Other|0|||
105690037|NCT00475033|364528313|FG001|After the Infant Series|Other|1|||
105690038|NCT00475033|364528312|FG000|Toddler Dose|Parent or legal guardian request|2|||
105690039|NCT00475033|364528313|FG001|Toddler Dose|Parent or legal guardian request|0|||
105690040|NCT00475033|364528312|FG000|Toddler Dose|Failed to return|1|||
105690041|NCT00475033|364528313|FG001|Toddler Dose|Failed to return|0|||
105690042|NCT00475033|364528312|FG000|Toddler Dose|Lost to Follow-up|1|||
105690043|NCT00475033|364528313|FG001|Toddler Dose|Lost to Follow-up|0|||
105690044|NCT03566810|364530210|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
105690045|NCT03566810|364530211|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
105690046|NCT03566810|364530212|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
105690047|NCT03566810|364530213|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
105690048|NCT01103245|364530214|FG000|Overall Study|Withdrawal by Subject|1|||
105690049|NCT01103245|364530215|FG001|Overall Study|Withdrawal by Subject|0|||
105690050|NCT01103245|364530216|FG002|Overall Study|Withdrawal by Subject|3|||
105690051|NCT01103245|364530217|FG003|Overall Study|Withdrawal by Subject|0|||
105690052|NCT01103245|364530214|FG000|Overall Study|Inadequate IV access|1|||
105786827|NCT05182840|364872931|FG002|Run-in Period|No reason available|0|||
105786828|NCT05182840|364872932|FG003|Run-in Period|No reason available|0|||
105786829|NCT05182840|364872933|FG004|Run-in Period|No reason available|0|||
105786830|NCT05182840|364872934|FG005|Run-in Period|No reason available|0|||
105786831|NCT05182840|364872935|FG006|Run-in Period|No reason available|0|||
105786832|NCT05182840|364872936|FG007|Run-in Period|No reason available|0|||
105786833|NCT05182840|364872937|FG008|Run-in Period|No reason available|0|||
105786834|NCT05182840|364872938|FG009|Run-in Period|No reason available|0|||
105471536|NCT02637037|363738228|FG000|Overall Study|Positive drug screen at admission|1|||
105471537|NCT02637037|363738229|FG001|Overall Study|Positive drug screen at admission|0|||
105471538|NCT02637037|363738228|FG000|Overall Study|Withdrawal by Subject|2|||
105471539|NCT02637037|363738229|FG001|Overall Study|Withdrawal by Subject|1|||
105690053|NCT01103245|364530215|FG001|Overall Study|Inadequate IV access|0|||
105690054|NCT01103245|364530216|FG002|Overall Study|Inadequate IV access|0|||
105690055|NCT01103245|364530217|FG003|Overall Study|Inadequate IV access|0|||
105690056|NCT01103245|364530214|FG000|Overall Study|Adverse Event|0|||
105690057|NCT01103245|364530215|FG001|Overall Study|Adverse Event|2|||
105690058|NCT01103245|364530216|FG002|Overall Study|Adverse Event|1|||
105690059|NCT01103245|364530217|FG003|Overall Study|Adverse Event|0|||
105786835|NCT05182840|364872929|FG000|Run-in Period|Burden of study procedures|2|||
105690060|NCT01103245|364530214|FG000|Overall Study|Physician Decision|1|||
105690061|NCT01103245|364530215|FG001|Overall Study|Physician Decision|0|||
105690062|NCT01103245|364530216|FG002|Overall Study|Physician Decision|0|||
105690063|NCT01103245|364530217|FG003|Overall Study|Physician Decision|0|||
105690064|NCT03078907|364530220|FG000|Overall Study|Adverse Event|2|||
105690065|NCT03078907|364530221|FG001|Overall Study|Adverse Event|0|||
105690066|NCT03078907|364530220|FG000|Overall Study|Other|1|||
105690067|NCT03078907|364530221|FG001|Overall Study|Other|0|||
105690068|NCT03078907|364530220|FG000|Overall Study|Protocol Violation|0|||
105690069|NCT03078907|364530221|FG001|Overall Study|Protocol Violation|1|||
105690070|NCT00604279|364530222|FG000|Overall Study|Lack of Efficacy|22|||
105690071|NCT00604279|364530223|FG001|Overall Study|Lack of Efficacy|9|||
105690072|NCT00604279|364530222|FG000|Overall Study|Lost to Follow-up|9|||
105690073|NCT00604279|364530223|FG001|Overall Study|Lost to Follow-up|14|||
105690074|NCT00604279|364530222|FG000|Overall Study|Pregnancy|2|||
105690075|NCT00604279|364530223|FG001|Overall Study|Pregnancy|0|||
105690076|NCT00604279|364530222|FG000|Overall Study|Protocol Violation|3|||
105690077|NCT00604279|364530223|FG001|Overall Study|Protocol Violation|1|||
105690078|NCT00604279|364530222|FG000|Overall Study|Withdrawal by Subject|16|||
105690079|NCT00604279|364530223|FG001|Overall Study|Withdrawal by Subject|5|||
105690080|NCT00604279|364530222|FG000|Overall Study|Adverse Event|4|||
105690081|NCT00604279|364530223|FG001|Overall Study|Adverse Event|5|||
105690082|NCT00604279|364530222|FG000|Overall Study|Other|8|||
105690083|NCT00604279|364530223|FG001|Overall Study|Other|4|||
105690084|NCT02720536|364530224|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
105690085|NCT02720536|364530224|FG000|Overall Study|PR - pregnancy|2|||
105690086|NCT02720536|364530224|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
105690087|NCT02720536|364530224|FG000|Overall Study|PR - death|1|||
105690088|NCT02720536|364530224|FG000|Overall Study|PR - adverse event|1|||
105690089|NCT02720536|364530224|FG000|Overall Study|PR - abnormal lab value(s)|1|||
105690090|NCT02720536|364530224|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
105690091|NCT00146328|364530225|FG000|Overall Study|Adverse Event|39|||
105690092|NCT00146328|364530226|FG001|Overall Study|Adverse Event|48|||
105690093|NCT00146328|364530227|FG002|Overall Study|Adverse Event|79|||
105690094|NCT00146328|364530225|FG000|Overall Study|Protocol Violation|11|||
105690095|NCT00146328|364530226|FG001|Overall Study|Protocol Violation|6|||
105690096|NCT00146328|364530227|FG002|Overall Study|Protocol Violation|12|||
105690097|NCT00146328|364530225|FG000|Overall Study|Lost to Follow-up|7|||
105690098|NCT00146328|364530226|FG001|Overall Study|Lost to Follow-up|4|||
105690099|NCT00146328|364530227|FG002|Overall Study|Lost to Follow-up|7|||
105690100|NCT00146328|364530225|FG000|Overall Study|Withdrawal by Subject|16|||
105690101|NCT00146328|364530226|FG001|Overall Study|Withdrawal by Subject|16|||
105690102|NCT00146328|364530227|FG002|Overall Study|Withdrawal by Subject|22|||
105690103|NCT00146328|364530225|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
105690104|NCT00146328|364530226|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
105690105|NCT00146328|364530227|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
105690106|NCT00146328|364530225|FG000|Overall Study|Trial ended/site closed|8|||
105690107|NCT00146328|364530226|FG001|Overall Study|Trial ended/site closed|2|||
105690108|NCT00146328|364530227|FG002|Overall Study|Trial ended/site closed|19|||
105690109|NCT00146328|364530225|FG000|Overall Study|Patient decision to end|0|||
105690110|NCT00146328|364530226|FG001|Overall Study|Patient decision to end|1|||
105690111|NCT00146328|364530227|FG002|Overall Study|Patient decision to end|6|||
105690112|NCT00146328|364530225|FG000|Overall Study|Enroll into other trial|2|||
105690113|NCT00146328|364530226|FG001|Overall Study|Enroll into other trial|4|||
105690114|NCT00146328|364530227|FG002|Overall Study|Enroll into other trial|2|||
105690115|NCT00146328|364530225|FG000|Overall Study|Death|0|||
105690116|NCT00146328|364530226|FG001|Overall Study|Death|1|||
105690117|NCT00146328|364530227|FG002|Overall Study|Death|1|||
105690118|NCT00146328|364530225|FG000|Overall Study|Moved|2|||
105690119|NCT00146328|364530226|FG001|Overall Study|Moved|0|||
105690120|NCT00146328|364530227|FG002|Overall Study|Moved|0|||
105690121|NCT00146328|364530225|FG000|Overall Study|Interaction with other medication|2|||
105690122|NCT00146328|364530226|FG001|Overall Study|Interaction with other medication|0|||
105690123|NCT00146328|364530227|FG002|Overall Study|Interaction with other medication|1|||
105690124|NCT01256658|364530228|FG000|Period 1|Lost to Follow-up|837|||
105471540|NCT02637037|363738228|FG000|Overall Study|Adverse Event|1|||
105690125|NCT01256658|364530229|FG001|Period 1|Lost to Follow-up|661|||
105690126|NCT01256658|364530228|FG000|Period 1|Withdrawal by Subject|35|||
105690127|NCT01256658|364530229|FG001|Period 1|Withdrawal by Subject|43|||
105690128|NCT01256658|364530228|FG000|Period 1|Death|48|||
105690129|NCT01256658|364530229|FG001|Period 1|Death|44|||
105690130|NCT03434353|364530230|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
105690131|NCT03434353|364530231|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
105786836|NCT05182840|364872930|FG001|Run-in Period|Burden of study procedures|2|||
105690132|NCT03434353|364530232|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
105690133|NCT03434353|364530233|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
105690134|NCT03434353|364530234|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
105690135|NCT03434353|364530230|FG000|Overall Study|Withdrew consent|1|||
105690136|NCT03434353|364530231|FG001|Overall Study|Withdrew consent|0|||
105690137|NCT03434353|364530232|FG002|Overall Study|Withdrew consent|3|||
105690138|NCT03434353|364530233|FG003|Overall Study|Withdrew consent|0|||
105690139|NCT03434353|364530234|FG004|Overall Study|Withdrew consent|0|||
105690140|NCT03434353|364530230|FG000|Overall Study|Adverse Event|1|||
105690141|NCT03434353|364530231|FG001|Overall Study|Adverse Event|0|||
105690142|NCT03434353|364530232|FG002|Overall Study|Adverse Event|0|||
105690143|NCT03434353|364530233|FG003|Overall Study|Adverse Event|0|||
105690144|NCT03434353|364530234|FG004|Overall Study|Adverse Event|1|||
105690145|NCT03434353|364530230|FG000|Overall Study|Lost to Follow-up|2|||
105690146|NCT03434353|364530231|FG001|Overall Study|Lost to Follow-up|0|||
105690147|NCT03434353|364530232|FG002|Overall Study|Lost to Follow-up|0|||
105690148|NCT03434353|364530233|FG003|Overall Study|Lost to Follow-up|0|||
105690149|NCT03434353|364530234|FG004|Overall Study|Lost to Follow-up|0|||
105690150|NCT04906616|364530235|FG000|Overall Study|Divorce|3|||
105690151|NCT04906616|364530236|FG001|Overall Study|Divorce|2|||
105690152|NCT02072434|364530237|FG000|Overall Study|Protocol Violation|10|||
105690153|NCT02072434|364530238|FG001|Overall Study|Protocol Violation|9|||
105690154|NCT02072434|364530237|FG000|Overall Study|Physician Decision|5|||
105690155|NCT02072434|364530238|FG001|Overall Study|Physician Decision|10|||
105690156|NCT02072434|364530237|FG000|Overall Study|Adverse event, serious fatal|1|||
105690157|NCT02072434|364530238|FG001|Overall Study|Adverse event, serious fatal|6|||
105690158|NCT02072434|364530237|FG000|Overall Study|Adverse Event|7|||
105690159|NCT02072434|364530238|FG001|Overall Study|Adverse Event|6|||
105690160|NCT02072434|364530237|FG000|Overall Study|Withdrawal by Subject|17|||
105690161|NCT02072434|364530238|FG001|Overall Study|Withdrawal by Subject|29|||
105690162|NCT02072434|364530237|FG000|Overall Study|Other|14|||
105690163|NCT02072434|364530238|FG001|Overall Study|Other|29|||
105690164|NCT02072434|364530237|FG000|Overall Study|Lost to Follow-up|0|||
105690165|NCT02072434|364530238|FG001|Overall Study|Lost to Follow-up|1|||
105690166|NCT00993954|364530239|FG000|Overall Study|Protocol Violation|21|||
105690167|NCT00993954|364530240|FG001|Overall Study|Protocol Violation|2|||
105690168|NCT00234494|364530243|FG000|Overall Study|Protocol Violation|2|||
105690169|NCT03308942|364530249|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
105690170|NCT03308942|364530250|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
105690171|NCT03308942|364530251|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
105690172|NCT03308942|364530252|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
105690173|NCT03308942|364530253|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
105690174|NCT03308942|364530249|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
105690175|NCT03308942|364530250|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
105690176|NCT03308942|364530251|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
105690177|NCT03308942|364530252|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
105690178|NCT03308942|364530253|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
105690179|NCT03308942|364530249|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
105690180|NCT03308942|364530250|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
105690181|NCT03308942|364530251|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
105690182|NCT03308942|364530252|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
105690183|NCT03308942|364530253|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
105690184|NCT03308942|364530249|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
105690185|NCT03308942|364530250|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
105690186|NCT03308942|364530251|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
105690187|NCT03308942|364530252|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
105690188|NCT03308942|364530253|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
105690189|NCT03308942|364530249|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
105690190|NCT03308942|364530250|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
105690191|NCT03308942|364530251|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
105690192|NCT03308942|364530252|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
105690193|NCT03308942|364530253|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
105690194|NCT03308942|364530249|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
105690195|NCT03308942|364530250|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
105690196|NCT03308942|364530251|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
105690197|NCT03308942|364530252|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
105690198|NCT03308942|364530253|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
105690199|NCT03308942|364530249|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
105786837|NCT05182840|364872931|FG002|Run-in Period|Burden of study procedures|0|||
105690200|NCT03308942|364530250|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
105690201|NCT03308942|364530251|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
105690202|NCT03308942|364530252|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
105690203|NCT03308942|364530253|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
105690204|NCT02194062|364530254|FG000|Overall Study|Lost to Follow-up|2|||
105690205|NCT02194062|364530255|FG001|Overall Study|Lost to Follow-up|2|||
105690206|NCT02194062|364530256|FG002|Overall Study|Lost to Follow-up|5|||
105690207|NCT02294682|364530257|FG000|Overall Study|Could not swallow pills|1|||
105690208|NCT02294682|364530258|FG001|Overall Study|Could not swallow pills|0|||
105690209|NCT04175808|364530259|FG000|Part A|Miscellaneous|2|||
105690210|NCT04175808|364530260|FG001|Part A|Miscellaneous|0|||
105690211|NCT04175808|364530261|FG002|Part A|Miscellaneous|0|||
105690212|NCT04175808|364530262|FG003|Part A|Miscellaneous|0|||
105690213|NCT04175808|364530263|FG004|Part A|Miscellaneous|0|||
105690214|NCT04175808|364530264|FG005|Part A|Miscellaneous|0|||
105690215|NCT04175808|364530265|FG006|Part A|Miscellaneous|0|||
105690216|NCT04982588|364530271|FG000|Overall Study|Withdrawal by Subject|2|||
105690217|NCT00568321|364530272|FG000|Overall Study|Adverse Event|1|||
105690218|NCT00568321|364530273|FG001|Overall Study|Adverse Event|0|||
105690219|NCT00568321|364530274|FG002|Overall Study|Adverse Event|0|||
105690220|NCT00568321|364530272|FG000|Overall Study|Lack of Efficacy|8|||
105690221|NCT00568321|364530273|FG001|Overall Study|Lack of Efficacy|5|||
105690222|NCT00568321|364530274|FG002|Overall Study|Lack of Efficacy|6|||
105690223|NCT00568321|364530272|FG000|Overall Study|Lost to Follow-up|0|||
105690224|NCT00568321|364530273|FG001|Overall Study|Lost to Follow-up|0|||
105690225|NCT00568321|364530274|FG002|Overall Study|Lost to Follow-up|1|||
105690226|NCT00568321|364530272|FG000|Overall Study|Withdrawal by Subject|2|||
105690227|NCT00568321|364530273|FG001|Overall Study|Withdrawal by Subject|0|||
105690228|NCT00568321|364530274|FG002|Overall Study|Withdrawal by Subject|0|||
105690229|NCT00568321|364530272|FG000|Overall Study|Protocol Violation|0|||
105690230|NCT00568321|364530273|FG001|Overall Study|Protocol Violation|0|||
105690231|NCT00568321|364530274|FG002|Overall Study|Protocol Violation|1|||
105690232|NCT00568321|364530272|FG000|Overall Study|Randomized, not treated|2|||
105690233|NCT00568321|364530273|FG001|Overall Study|Randomized, not treated|0|||
105690234|NCT00568321|364530274|FG002|Overall Study|Randomized, not treated|1|||
105690235|NCT00992511|364530275|FG000|Overall Study|Migrated/moved from study area|1|||
105690236|NCT00992511|364530276|FG001|Overall Study|Migrated/moved from study area|0|||
105690237|NCT00992511|364530277|FG002|Overall Study|Migrated/moved from study area|1|||
105690238|NCT00992511|364530278|FG003|Overall Study|Migrated/moved from study area|2|||
105690239|NCT00992511|364530275|FG000|Overall Study|Lost to Follow-up|1|||
105690240|NCT00992511|364530276|FG001|Overall Study|Lost to Follow-up|0|||
105690241|NCT00992511|364530277|FG002|Overall Study|Lost to Follow-up|0|||
105690242|NCT00992511|364530278|FG003|Overall Study|Lost to Follow-up|2|||
105690243|NCT00992511|364530275|FG000|Overall Study|Withdrawal by Subject|0|||
105690244|NCT00992511|364530276|FG001|Overall Study|Withdrawal by Subject|0|||
105690245|NCT00992511|364530277|FG002|Overall Study|Withdrawal by Subject|1|||
105690246|NCT00992511|364530278|FG003|Overall Study|Withdrawal by Subject|1|||
105690247|NCT04498169|364530279|FG000|Study Completion|Adverse Event|1|||
105690248|NCT04498169|364530280|FG001|Study Completion|Adverse Event|1|||
105690249|NCT04615247|364530281|FG000|Overall Study|Adverse Event|0|||
105690250|NCT04615247|364530282|FG001|Overall Study|Adverse Event|2|||
105690251|NCT04615247|364530281|FG000|Overall Study|Withdrawal by Subject|1|||
105690252|NCT04615247|364530282|FG001|Overall Study|Withdrawal by Subject|1|||
105690253|NCT01383161|364530288|FG000|Overall Study|Adverse Event|5|||
105690254|NCT01383161|364530289|FG001|Overall Study|Adverse Event|1|||
105690255|NCT01383161|364530288|FG000|Overall Study|Withdrawal by Subject|0|||
105690256|NCT01383161|364530289|FG001|Overall Study|Withdrawal by Subject|2|||
105690257|NCT01383161|364530288|FG000|Overall Study|Lack of Efficacy|0|||
105690258|NCT01383161|364530289|FG001|Overall Study|Lack of Efficacy|1|||
105690259|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
105690260|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
105690261|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
105690262|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
105690263|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
105690264|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
105690265|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
105690266|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
105690267|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
105690268|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
105471541|NCT02637037|363738229|FG001|Overall Study|Adverse Event|0|||
105471542|NCT03339219|363738230|FG000|Overall Study|Death|12|||
105471543|NCT03339219|363738230|FG000|Overall Study|Site Terminated by Sponsor|22|||
105690269|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
105690270|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
105690271|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
105690272|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
105690273|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
105690274|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
105690275|NCT03548987|364530298|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
105690276|NCT03548987|364530299|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
105690277|NCT03548987|364530298|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
105471544|NCT03339219|363738230|FG000|Overall Study|Withdrawal by Subject|1|||
105690278|NCT03548987|364530299|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
105690279|NCT03548987|364530298|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
105690280|NCT03548987|364530299|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
105690281|NCT03548987|364530298|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
105690282|NCT03548987|364530299|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
105690283|NCT03548987|364530298|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
105690284|NCT03548987|364530299|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
105690285|NCT03548987|364530298|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
105690286|NCT03548987|364530299|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
105690287|NCT03153137|364530301|FG000|Overall Study|Lost to Follow-up|1|||
105690288|NCT03153137|364530302|FG001|Overall Study|Lost to Follow-up|0|||
105690289|NCT03153137|364530301|FG000|Overall Study|Withdrawal by Subject|2|||
105690290|NCT03153137|364530302|FG001|Overall Study|Withdrawal by Subject|1|||
105690291|NCT03153137|364530301|FG000|Overall Study|Physician Decision|0|||
105690292|NCT03153137|364530302|FG001|Overall Study|Physician Decision|3|||
105690293|NCT02119325|364530306|FG000|Washout Period 1|Adverse Event|0|||
105690294|NCT02119325|364530307|FG001|Washout Period 1|Adverse Event|1|||
105690295|NCT00578786|364530314|FG000|Overall Study|Adverse Event|27|||
105690296|NCT00578786|364530315|FG001|Overall Study|Adverse Event|37|||
105690297|NCT00578786|364530316|FG002|Overall Study|Adverse Event|17|||
105690298|NCT00578786|364530314|FG000|Overall Study|Lack of Efficacy|2|||
105690299|NCT00578786|364530315|FG001|Overall Study|Lack of Efficacy|5|||
105690300|NCT00578786|364530316|FG002|Overall Study|Lack of Efficacy|2|||
105690301|NCT00578786|364530314|FG000|Overall Study|Early Escape from Prior Study|2|||
105690302|NCT00578786|364530315|FG001|Overall Study|Early Escape from Prior Study|1|||
105690303|NCT00578786|364530316|FG002|Overall Study|Early Escape from Prior Study|2|||
105690304|NCT00578786|364530314|FG000|Overall Study|Withdrawal by Subject|7|||
105690305|NCT00578786|364530315|FG001|Overall Study|Withdrawal by Subject|8|||
105690306|NCT00578786|364530316|FG002|Overall Study|Withdrawal by Subject|5|||
105690307|NCT00578786|364530314|FG000|Overall Study|Protocol Violation|0|||
105690308|NCT00578786|364530315|FG001|Overall Study|Protocol Violation|3|||
105690309|NCT00578786|364530316|FG002|Overall Study|Protocol Violation|1|||
105690310|NCT00578786|364530314|FG000|Overall Study|Physician Decision|1|||
105690311|NCT00578786|364530315|FG001|Overall Study|Physician Decision|0|||
105471545|NCT02067676|363738231|FG000|Overall Study|Withdrawal by Subject|1|||
105471546|NCT02067676|363738232|FG001|Overall Study|Withdrawal by Subject|0|||
105471547|NCT02067676|363738233|FG002|Overall Study|Withdrawal by Subject|0|||
105690312|NCT00578786|364530316|FG002|Overall Study|Physician Decision|1|||
105471548|NCT02067676|363738234|FG003|Overall Study|Withdrawal by Subject|0|||
105690313|NCT00578786|364530314|FG000|Overall Study|Sponsor Decision|0|||
105690314|NCT00578786|364530315|FG001|Overall Study|Sponsor Decision|0|||
105690315|NCT00578786|364530316|FG002|Overall Study|Sponsor Decision|1|||
105690316|NCT00578786|364530314|FG000|Overall Study|Lost to Follow-up|0|||
105690317|NCT00578786|364530315|FG001|Overall Study|Lost to Follow-up|4|||
105690318|NCT00578786|364530316|FG002|Overall Study|Lost to Follow-up|0|||
105690319|NCT00578786|364530314|FG000|Overall Study|Pregnancy|0|||
105690320|NCT00578786|364530315|FG001|Overall Study|Pregnancy|1|||
105690321|NCT00578786|364530316|FG002|Overall Study|Pregnancy|0|||
105690322|NCT00578786|364530314|FG000|Overall Study|Not Otherwise Specified|0|||
105690323|NCT00578786|364530315|FG001|Overall Study|Not Otherwise Specified|4|||
105690324|NCT00578786|364530316|FG002|Overall Study|Not Otherwise Specified|1|||
105690325|NCT00578786|364530314|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
105690326|NCT00578786|364530315|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
105690327|NCT00578786|364530316|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
105690328|NCT00866723|364530317|FG000|Overall Study|Withdrawal by Subject|1|||
105690329|NCT00866723|364530317|FG000|Overall Study|Disease Progression|4|||
105690330|NCT01603082|364530320|FG000|Overall Study|Adverse Event|0|||
105690331|NCT01603082|364530321|FG001|Overall Study|Adverse Event|1|||
105690332|NCT01603082|364530320|FG000|Overall Study|Withdrawal by Subject|1|||
105690333|NCT01603082|364530321|FG001|Overall Study|Withdrawal by Subject|0|||
105690334|NCT01603082|364530320|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
105690335|NCT01603082|364530321|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
105690336|NCT01794923|364530325|FG000|Overall Study|Adverse Event|0|||
105690337|NCT01794923|364530326|FG001|Overall Study|Adverse Event|0|||
105690338|NCT01794923|364530327|FG002|Overall Study|Adverse Event|1|||
105690339|NCT04744285|364530328|FG000|Overall Study|Withdrawal by Subject|1|||
105690340|NCT04744285|364530329|FG001|Overall Study|Withdrawal by Subject|1|||
105690341|NCT04744285|364530330|FG002|Overall Study|Withdrawal by Subject|2|||
105690342|NCT04744285|364530331|FG003|Overall Study|Withdrawal by Subject|1|||
105690343|NCT01717768|364530332|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690344|NCT01717768|364530333|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
105690345|NCT01717768|364530334|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690346|NCT01717768|364530335|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690347|NCT01717768|364530336|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690348|NCT01717768|364530337|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690349|NCT01717768|364530338|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690350|NCT01717768|364530339|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690351|NCT01717768|364530340|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690352|NCT01717768|364530341|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690353|NCT01717768|364530342|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690354|NCT01717768|364530343|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690355|NCT01717768|364530332|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690356|NCT01717768|364530333|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690357|NCT01717768|364530334|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690358|NCT01717768|364530335|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690359|NCT01717768|364530336|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690360|NCT01717768|364530337|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690361|NCT01717768|364530338|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690362|NCT01717768|364530339|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690363|NCT01717768|364530340|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690364|NCT01717768|364530341|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690365|NCT01717768|364530342|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690366|NCT01717768|364530343|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
105690367|NCT01717768|364530332|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690368|NCT01717768|364530333|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690369|NCT01717768|364530334|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690370|NCT01717768|364530335|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690371|NCT01717768|364530336|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690372|NCT01717768|364530337|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690373|NCT01717768|364530338|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690374|NCT01717768|364530339|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
105690375|NCT01717768|364530340|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690376|NCT01717768|364530341|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690377|NCT01717768|364530342|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690378|NCT01717768|364530343|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690379|NCT01717768|364530332|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690380|NCT01717768|364530333|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690381|NCT01717768|364530334|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690382|NCT01717768|364530335|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690383|NCT01717768|364530336|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690384|NCT01717768|364530337|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690385|NCT01717768|364530338|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690386|NCT01717768|364530339|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690387|NCT01717768|364530340|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690388|NCT01717768|364530341|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
105690389|NCT01717768|364530342|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690390|NCT01717768|364530343|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690391|NCT01774084|364530344|FG000|Overall Study|Personal reasons|1|||
105690392|NCT01774084|364530345|FG001|Overall Study|Personal reasons|0|||
105690393|NCT01610687|364530350|FG000|Overall Study|Lack of Efficacy|26|||
105690394|NCT01610687|364530350|FG000|Overall Study|Adverse Event|18|||
105690395|NCT01610687|364530350|FG000|Overall Study|Moved out of area|6|||
105690396|NCT01610687|364530350|FG000|Overall Study|Withdrawal by Subject|7|||
105690397|NCT01610687|364530350|FG000|Overall Study|Lost to Follow-up|4|||
105690398|NCT01610687|364530350|FG000|Overall Study|Symptom control without study medication|2|||
105690399|NCT01610687|364530350|FG000|Overall Study|Unable to make journey|1|||
105690400|NCT01610687|364530350|FG000|Overall Study|Death|1|||
105690401|NCT01610687|364530350|FG000|Overall Study|Cannabis affecting job|1|||
105690402|NCT01610687|364530350|FG000|Overall Study|Felt more alter without study medication|1|||
105690403|NCT01006265|364530351|FG000|Overall Study|Lost to Follow-up|1|||
105690404|NCT01006265|364530352|FG001|Overall Study|Lost to Follow-up|0|||
105690405|NCT01006265|364530353|FG002|Overall Study|Lost to Follow-up|1|||
105690406|NCT01006265|364530354|FG003|Overall Study|Lost to Follow-up|0|||
105690407|NCT01006265|364530351|FG000|Overall Study|Withdrawal by Subject|4|||
105690408|NCT01006265|364530352|FG001|Overall Study|Withdrawal by Subject|7|||
105690409|NCT01006265|364530353|FG002|Overall Study|Withdrawal by Subject|5|||
105690410|NCT01006265|364530354|FG003|Overall Study|Withdrawal by Subject|5|||
105690411|NCT01006265|364530351|FG000|Overall Study|Administrative reason|1|||
105690412|NCT01006265|364530352|FG001|Overall Study|Administrative reason|2|||
105690413|NCT01006265|364530353|FG002|Overall Study|Administrative reason|3|||
105690414|NCT01006265|364530354|FG003|Overall Study|Administrative reason|0|||
105690415|NCT00752622|364530357|FG000|Induction Phase|Adverse Event|3|||
105690416|NCT00752622|364530357|FG000|Induction Phase|Other|3|||
105690417|NCT00752622|364530357|FG000|Induction Phase|Non-responder|14|||
105690418|NCT00752622|364530357|FG000|Induction Phase|Withdrawal by Subject|1|||
105690419|NCT00752622|364530357|FG000|Induction Phase|Premature study termination|14|||
105690420|NCT00752622|364530357|FG000|Observational Phase|Premature Study Termination|36|||
105690421|NCT00752622|364530357|FG000|Observational Phase|Non-responder|2|||
105690422|NCT00752622|364530357|FG000|Observational Phase|Withdrawal by Subject|2|||
105690423|NCT00752622|364530357|FG000|Observational Phase|Adverse Event|1|||
105690424|NCT00752622|364530357|FG000|Observational Phase|Other|2|||
105690425|NCT00752622|364530357|FG000|Interventional Phase|Non-responder|2|||
105690426|NCT00752622|364530357|FG000|Interventional Phase|Physician Decision|1|||
105690427|NCT00752622|364530357|FG000|Interventional Phase|Premature Study Termination|5|||
105690428|NCT00576836|364530358|FG000|Overall Study|Death|0|||
105690429|NCT00576836|364530359|FG001|Overall Study|Death|1|||
105690430|NCT00576836|364530358|FG000|Overall Study|Physician Decision|0|||
105690431|NCT00576836|364530359|FG001|Overall Study|Physician Decision|1|||
105690432|NCT01272947|364530360|FG000|Overall Study|Abnormal Laboratory Value|2|||
105690433|NCT01272947|364530361|FG001|Overall Study|Abnormal Laboratory Value|2|||
105690434|NCT00796120|364530363|FG000|Overall Study|Death|3|||
105690435|NCT00796120|364530364|FG001|Overall Study|Death|0|||
105690436|NCT00796120|364530363|FG000|Overall Study|Adverse Event|11|||
105690437|NCT00796120|364530364|FG001|Overall Study|Adverse Event|6|||
105690438|NCT00796120|364530363|FG000|Overall Study|Progressive disease|22|||
105690439|NCT00796120|364530364|FG001|Overall Study|Progressive disease|13|||
105690440|NCT00796120|364530363|FG000|Overall Study|Participant refusal|3|||
105690441|NCT00796120|364530364|FG001|Overall Study|Participant refusal|4|||
105690442|NCT00796120|364530363|FG000|Overall Study|Other|6|||
105690443|NCT00796120|364530364|FG001|Overall Study|Other|17|||
105690444|NCT00796120|364530363|FG000|Overall Study|Physician Decision|16|||
105690445|NCT00796120|364530364|FG001|Overall Study|Physician Decision|17|||
105690446|NCT00796120|364530363|FG000|Overall Study|Randomized but not treated|0|||
105690447|NCT00796120|364530364|FG001|Overall Study|Randomized but not treated|3|||
105690448|NCT01136811|364530365|FG000|Overall Study|Physician Decision|11|||
105690449|NCT00803270|364530371|FG000|Overall Study|Lost to Follow-up|1|||
105690450|NCT00803270|364530372|FG001|Overall Study|Lost to Follow-up|2|||
105690451|NCT04484259|364530373|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
105690452|NCT04484259|364530374|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
105690453|NCT04484259|364530375|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
105690454|NCT04484259|364530376|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
105690455|NCT04484259|364530377|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
105690456|NCT04484259|364530373|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
105690457|NCT04484259|364530374|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
105690458|NCT04484259|364530375|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
105690459|NCT04484259|364530376|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
105690460|NCT04484259|364530377|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
105690461|NCT04484259|364530373|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
105690462|NCT04484259|364530374|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
105690463|NCT04484259|364530375|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
105690464|NCT04484259|364530376|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
105690465|NCT04484259|364530377|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
105690466|NCT04484259|364530373|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
105690467|NCT04484259|364530374|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
105690468|NCT04484259|364530375|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
105690469|NCT04484259|364530376|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
105690470|NCT04484259|364530377|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
105690471|NCT04484259|364530373|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
105690472|NCT04484259|364530374|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
105690473|NCT04484259|364530375|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
105690474|NCT04484259|364530376|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
105690475|NCT04484259|364530377|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
105690476|NCT04484259|364530373|FG000|Randomized Treatment|Withdrawal by Subject|1|||
105690477|NCT04484259|364530374|FG001|Randomized Treatment|Withdrawal by Subject|0|||
105690478|NCT04484259|364530375|FG002|Randomized Treatment|Withdrawal by Subject|0|||
105690479|NCT04484259|364530376|FG003|Randomized Treatment|Withdrawal by Subject|0|||
105690480|NCT04484259|364530377|FG004|Randomized Treatment|Withdrawal by Subject|0|||
105690481|NCT01681628|364532515|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
105690482|NCT01681628|364532516|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
105690483|NCT01681628|364532515|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
105690484|NCT01681628|364532516|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
105690485|NCT01681628|364532515|FG000|19 Months Follow-up|Death|1|||
105690486|NCT01681628|364532516|FG001|19 Months Follow-up|Death|0|||
105690487|NCT01681628|364532515|FG000|19 Months Follow-up|Lost to Follow-up|61|||
105690488|NCT01681628|364532516|FG001|19 Months Follow-up|Lost to Follow-up|43|||
105690489|NCT01521897|364532517|FG000|Overall Study|Protocol Violation|18|||
105690490|NCT01521897|364532517|FG000|Overall Study|Lost to Follow-up|5|||
105690491|NCT01794520|364532526|FG000|Overall Study|Adverse events- related to progression|0|||
105690492|NCT01794520|364532527|FG001|Overall Study|Adverse events- related to progression|0|||
105690493|NCT01794520|364532528|FG002|Overall Study|Adverse events- related to progression|1|||
105690494|NCT01794520|364532529|FG003|Overall Study|Adverse events- related to progression|2|||
105690495|NCT01794520|364532530|FG004|Overall Study|Adverse events- related to progression|0|||
105690496|NCT01794520|364532531|FG005|Overall Study|Adverse events- related to progression|1|||
105690497|NCT01794520|364532532|FG006|Overall Study|Adverse events- related to progression|0|||
105690498|NCT01794520|364532526|FG000|Overall Study|Adverse event- not related to progression|1|||
105690499|NCT01794520|364532527|FG001|Overall Study|Adverse event- not related to progression|1|||
105690500|NCT01794520|364532528|FG002|Overall Study|Adverse event- not related to progression|0|||
105690501|NCT01794520|364532529|FG003|Overall Study|Adverse event- not related to progression|0|||
105786838|NCT05182840|364872932|FG003|Run-in Period|Burden of study procedures|0|||
105786839|NCT05182840|364872933|FG004|Run-in Period|Burden of study procedures|0|||
105559048|NCT02219048|364044579|FG000|Overall Study|Study terminated by sponsor|16|||
105559049|NCT02219048|364044580|FG001|Overall Study|Study terminated by sponsor|15|||
105559050|NCT02219048|364044579|FG000|Overall Study|Withdrawal by Subject|2|||
105559051|NCT02219048|364044580|FG001|Overall Study|Withdrawal by Subject|0|||
105559052|NCT02219048|364044579|FG000|Overall Study|Other|0|||
105559053|NCT02219048|364044580|FG001|Overall Study|Other|1|||
105559054|NCT04794803|364044581|FG000|Overall Study|Death|1|||
105559055|NCT04794803|364044582|FG001|Overall Study|Death|3|||
105559056|NCT04794803|364044581|FG000|Overall Study|Lost to Follow-up|2|||
105559057|NCT04794803|364044582|FG001|Overall Study|Lost to Follow-up|2|||
105559058|NCT04794803|364044581|FG000|Overall Study|Withdrawal by Subject|1|||
105559059|NCT04794803|364044582|FG001|Overall Study|Withdrawal by Subject|0|||
105559060|NCT04794803|364044581|FG000|Overall Study|Physician Decision|1|||
105559061|NCT04794803|364044582|FG001|Overall Study|Physician Decision|1|||
105559062|NCT04794803|364044581|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
105559063|NCT04794803|364044582|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
105690502|NCT01794520|364532530|FG004|Overall Study|Adverse event- not related to progression|2|||
105690503|NCT01794520|364532531|FG005|Overall Study|Adverse event- not related to progression|0|||
105690504|NCT01794520|364532532|FG006|Overall Study|Adverse event- not related to progression|0|||
105690505|NCT01794520|364532526|FG000|Overall Study|Progressive disease|5|||
105690506|NCT01794520|364532527|FG001|Overall Study|Progressive disease|6|||
105690507|NCT01794520|364532528|FG002|Overall Study|Progressive disease|2|||
105690508|NCT01794520|364532529|FG003|Overall Study|Progressive disease|5|||
105690509|NCT01794520|364532530|FG004|Overall Study|Progressive disease|27|||
105690510|NCT01794520|364532531|FG005|Overall Study|Progressive disease|18|||
105690511|NCT01794520|364532532|FG006|Overall Study|Progressive disease|0|||
105690512|NCT01794520|364532526|FG000|Overall Study|Withdrew consent|0|||
105690513|NCT01794520|364532527|FG001|Overall Study|Withdrew consent|0|||
105690514|NCT01794520|364532528|FG002|Overall Study|Withdrew consent|1|||
105690515|NCT01794520|364532529|FG003|Overall Study|Withdrew consent|1|||
105690516|NCT01794520|364532530|FG004|Overall Study|Withdrew consent|0|||
105690517|NCT01794520|364532531|FG005|Overall Study|Withdrew consent|0|||
105690518|NCT01794520|364532532|FG006|Overall Study|Withdrew consent|0|||
105690519|NCT01794520|364532526|FG000|Overall Study|Lost to Follow-up|0|||
105690520|NCT01794520|364532527|FG001|Overall Study|Lost to Follow-up|0|||
105690521|NCT01794520|364532528|FG002|Overall Study|Lost to Follow-up|0|||
105690522|NCT01794520|364532529|FG003|Overall Study|Lost to Follow-up|0|||
105690523|NCT01794520|364532530|FG004|Overall Study|Lost to Follow-up|1|||
105690524|NCT01794520|364532531|FG005|Overall Study|Lost to Follow-up|0|||
105690525|NCT01794520|364532532|FG006|Overall Study|Lost to Follow-up|0|||
105690526|NCT01794520|364532526|FG000|Overall Study|Toxicity|0|||
105690527|NCT01794520|364532527|FG001|Overall Study|Toxicity|2|||
105690528|NCT01794520|364532528|FG002|Overall Study|Toxicity|0|||
105690529|NCT01794520|364532529|FG003|Overall Study|Toxicity|0|||
105690530|NCT01794520|364532530|FG004|Overall Study|Toxicity|0|||
105690531|NCT01794520|364532531|FG005|Overall Study|Toxicity|0|||
105690532|NCT01794520|364532532|FG006|Overall Study|Toxicity|0|||
105690533|NCT01794520|364532526|FG000|Overall Study|Study terminated by sponsor|0|||
105690534|NCT01794520|364532527|FG001|Overall Study|Study terminated by sponsor|0|||
105690535|NCT01794520|364532528|FG002|Overall Study|Study terminated by sponsor|1|||
105690536|NCT01794520|364532529|FG003|Overall Study|Study terminated by sponsor|0|||
105690537|NCT01794520|364532530|FG004|Overall Study|Study terminated by sponsor|1|||
105690538|NCT01794520|364532531|FG005|Overall Study|Study terminated by sponsor|0|||
105690539|NCT01794520|364532532|FG006|Overall Study|Study terminated by sponsor|7|||
105690540|NCT01794520|364532526|FG000|Overall Study|Death|0|||
105690541|NCT01794520|364532527|FG001|Overall Study|Death|0|||
105690542|NCT01794520|364532528|FG002|Overall Study|Death|0|||
105690543|NCT01794520|364532529|FG003|Overall Study|Death|0|||
105690544|NCT01794520|364532530|FG004|Overall Study|Death|1|||
105690545|NCT01794520|364532531|FG005|Overall Study|Death|0|||
105690546|NCT01794520|364532532|FG006|Overall Study|Death|22|||
105690547|NCT01794520|364532526|FG000|Overall Study|Other, not specified|0|||
105690548|NCT01794520|364532527|FG001|Overall Study|Other, not specified|0|||
105690549|NCT01794520|364532528|FG002|Overall Study|Other, not specified|1|||
105690550|NCT01794520|364532529|FG003|Overall Study|Other, not specified|1|||
105690551|NCT01794520|364532530|FG004|Overall Study|Other, not specified|4|||
105690552|NCT01794520|364532531|FG005|Overall Study|Other, not specified|1|||
105690553|NCT01794520|364532532|FG006|Overall Study|Other, not specified|2|||
105690554|NCT02276872|364532533|FG000|Overall Study|Adverse Event|1|||
105690555|NCT02276872|364532534|FG001|Overall Study|Adverse Event|0|||
105690556|NCT02276872|364532535|FG002|Overall Study|Adverse Event|0|||
105690557|NCT04356183|364532537|FG000|Overall Study|Lost to Follow-up|1|||
105690558|NCT04356183|364532538|FG001|Overall Study|Lost to Follow-up|0|||
105690559|NCT04356183|364532537|FG000|Overall Study|Withdrawal by Subject|1|||
105690560|NCT04356183|364532538|FG001|Overall Study|Withdrawal by Subject|1|||
105690561|NCT00823901|364532541|FG000|Overall Study|Adverse Event|1|||
105690562|NCT00823901|364532542|FG001|Overall Study|Adverse Event|1|||
105690563|NCT00823901|364532541|FG000|Overall Study|Lack of Efficacy|1|||
105690564|NCT00823901|364532542|FG001|Overall Study|Lack of Efficacy|0|||
105690565|NCT00823901|364532541|FG000|Overall Study|Lost to Follow-up|2|||
105690566|NCT00823901|364532542|FG001|Overall Study|Lost to Follow-up|1|||
105690567|NCT01176968|364532543|FG000|Overall Study|Adverse Event|10|||
105690568|NCT01176968|364532544|FG001|Overall Study|Adverse Event|11|||
105690569|NCT01176968|364532543|FG000|Overall Study|Death|2|||
105690570|NCT01176968|364532544|FG001|Overall Study|Death|3|||
105690571|NCT01176968|364532543|FG000|Overall Study|Lack of Efficacy|0|||
105690572|NCT01176968|364532544|FG001|Overall Study|Lack of Efficacy|1|||
105690573|NCT01176968|364532543|FG000|Overall Study|Lost to Follow-up|16|||
105690574|NCT01176968|364532544|FG001|Overall Study|Lost to Follow-up|14|||
105690575|NCT01176968|364532543|FG000|Overall Study|Withdrawal by Subject|48|||
105690576|NCT01176968|364532544|FG001|Overall Study|Withdrawal by Subject|48|||
105690577|NCT01176968|364532543|FG000|Overall Study|Protocol Violation|2|||
105690578|NCT01176968|364532544|FG001|Overall Study|Protocol Violation|1|||
105690579|NCT01176968|364532543|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
105690580|NCT01176968|364532544|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
105690581|NCT01176968|364532543|FG000|Overall Study|Study terminated by sponsor|0|||
105690582|NCT01176968|364532544|FG001|Overall Study|Study terminated by sponsor|1|||
105690583|NCT01176968|364532543|FG000|Overall Study|Reason not defined|5|||
105690584|NCT01176968|364532544|FG001|Overall Study|Reason not defined|3|||
105786840|NCT05182840|364872934|FG005|Run-in Period|Burden of study procedures|0|||
105786841|NCT05182840|364872935|FG006|Run-in Period|Burden of study procedures|0|||
105786842|NCT05182840|364872936|FG007|Run-in Period|Burden of study procedures|0|||
105786843|NCT05182840|364872937|FG008|Run-in Period|Burden of study procedures|0|||
105786844|NCT05182840|364872938|FG009|Run-in Period|Burden of study procedures|0|||
105786845|NCT05182840|364872929|FG000|Run-in Period|Change of residence|1|||
105690585|NCT00833911|364532545|FG000|Titration|Adverse Event|18|||
105690586|NCT00833911|364532545|FG000|Titration|Withdrawal by Subject|3|||
105690587|NCT00833911|364532545|FG000|Maintenance Phase I|Adverse Event|73|||
105690588|NCT00833911|364532545|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
105690589|NCT00833911|364532545|FG000|Maintenance Phase I|Physician Decision|10|||
105690590|NCT00833911|364532545|FG000|Maintenance Phase I|Lack of Efficacy|4|||
105690591|NCT00833911|364532545|FG000|Maintenance Phase II|Adverse Event|6|||
105690592|NCT00833911|364532545|FG000|Maintenance Phase II|Physician Decision|2|||
105690593|NCT00833911|364532545|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
105690594|NCT00833911|364532545|FG000|Maintenance Phase II|Lack of Efficacy|1|||
105690595|NCT00216203|364532548|FG000|Overall Study|Withdrawal by Subject|2|||
105690596|NCT01214187|364532553|FG000|Overall Study|Adverse Event|6|||
105690597|NCT01214187|364532554|FG001|Overall Study|Adverse Event|2|||
105690598|NCT01214187|364532553|FG000|Overall Study|Death|1|||
105690599|NCT01214187|364532554|FG001|Overall Study|Death|1|||
105690600|NCT01214187|364532553|FG000|Overall Study|Withdrawal by Subject|0|||
105690601|NCT01214187|364532554|FG001|Overall Study|Withdrawal by Subject|3|||
105690602|NCT00993915|364532555|FG000|Overall Study|Insufficient clinical response|3|||
105690603|NCT00993915|364532555|FG000|Overall Study|Withdrawal by Subject|2|||
105690604|NCT00993915|364532555|FG000|Overall Study|Other|1|||
105690605|NCT00993915|364532555|FG000|Overall Study|Ongoing|3|||
105690606|NCT01386658|364532556|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
105690607|NCT01386658|364532557|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
105690608|NCT01386658|364532556|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
105690609|NCT01386658|364532557|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
105690610|NCT01601847|364532558|FG000|Overall Study|Death|1|||
105690611|NCT01601847|364532559|FG001|Overall Study|Death|0|||
105690612|NCT01601847|364532558|FG000|Overall Study|Withdrawal by Subject|11|||
105690613|NCT01601847|364532559|FG001|Overall Study|Withdrawal by Subject|7|||
105690614|NCT01601847|364532558|FG000|Overall Study|Lost to Follow-up|1|||
105690615|NCT01601847|364532559|FG001|Overall Study|Lost to Follow-up|3|||
105690616|NCT01284062|364532565|FG000|Overall Study|Adverse Event|4|||
105690617|NCT01284062|364532566|FG001|Overall Study|Adverse Event|5|||
105690618|NCT01284062|364532567|FG002|Overall Study|Adverse Event|0|||
105690619|NCT01284062|364532568|FG003|Overall Study|Adverse Event|5|||
105690620|NCT01284062|364532565|FG000|Overall Study|Lack of Efficacy|3|||
105690621|NCT01284062|364532566|FG001|Overall Study|Lack of Efficacy|2|||
105786846|NCT05182840|364872930|FG001|Run-in Period|Change of residence|0|||
105786847|NCT05182840|364872931|FG002|Run-in Period|Change of residence|0|||
105786848|NCT05182840|364872932|FG003|Run-in Period|Change of residence|0|||
105786849|NCT05182840|364872933|FG004|Run-in Period|Change of residence|0|||
105690622|NCT01284062|364532567|FG002|Overall Study|Lack of Efficacy|2|||
105690623|NCT01284062|364532568|FG003|Overall Study|Lack of Efficacy|1|||
105786850|NCT05182840|364872934|FG005|Run-in Period|Change of residence|0|||
105786851|NCT05182840|364872935|FG006|Run-in Period|Change of residence|0|||
105786852|NCT05182840|364872936|FG007|Run-in Period|Change of residence|0|||
105786853|NCT05182840|364872937|FG008|Run-in Period|Change of residence|0|||
105690624|NCT01284062|364532565|FG000|Overall Study|Medication error without adverse event|0|||
105690625|NCT01284062|364532566|FG001|Overall Study|Medication error without adverse event|0|||
105786854|NCT05182840|364872938|FG009|Run-in Period|Change of residence|0|||
105786855|NCT05182840|364872929|FG000|Run-in Period|Adverse Event|5|||
105786856|NCT05182840|364872930|FG001|Run-in Period|Adverse Event|5|||
105786857|NCT05182840|364872931|FG002|Run-in Period|Adverse Event|0|||
105786858|NCT05182840|364872932|FG003|Run-in Period|Adverse Event|0|||
105786859|NCT05182840|364872933|FG004|Run-in Period|Adverse Event|0|||
105690626|NCT01284062|364532567|FG002|Overall Study|Medication error without adverse event|1|||
105690627|NCT01284062|364532568|FG003|Overall Study|Medication error without adverse event|0|||
105690628|NCT01284062|364532565|FG000|Overall Study|Protocol Violation|1|||
105690629|NCT01284062|364532566|FG001|Overall Study|Protocol Violation|0|||
105690630|NCT01284062|364532567|FG002|Overall Study|Protocol Violation|0|||
105786860|NCT05182840|364872934|FG005|Run-in Period|Adverse Event|0|||
105786861|NCT05182840|364872935|FG006|Run-in Period|Adverse Event|0|||
105786862|NCT05182840|364872936|FG007|Run-in Period|Adverse Event|0|||
105690631|NCT01284062|364532568|FG003|Overall Study|Protocol Violation|2|||
105690632|NCT01284062|364532565|FG000|Overall Study|Withdrawal by Subject|3|||
105690633|NCT01284062|364532566|FG001|Overall Study|Withdrawal by Subject|1|||
105690634|NCT01284062|364532567|FG002|Overall Study|Withdrawal by Subject|2|||
105690635|NCT01284062|364532568|FG003|Overall Study|Withdrawal by Subject|5|||
105690636|NCT01284062|364532565|FG000|Overall Study|Other|0|||
105690637|NCT01284062|364532566|FG001|Overall Study|Other|0|||
105690638|NCT01284062|364532567|FG002|Overall Study|Other|0|||
105690639|NCT01284062|364532568|FG003|Overall Study|Other|1|||
105690640|NCT01284062|364532565|FG000|Overall Study|Site Closed|0|||
105690641|NCT01284062|364532566|FG001|Overall Study|Site Closed|0|||
105690642|NCT01284062|364532567|FG002|Overall Study|Site Closed|1|||
105690643|NCT01284062|364532568|FG003|Overall Study|Site Closed|0|||
105690644|NCT02234323|364532572|FG000|All Enrolled|Not Treated: Completed study in database|2|||
105690645|NCT02234323|364532572|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
105690646|NCT02234323|364532572|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
105690647|NCT02234323|364532572|FG000|All Treated|Death|1|||
105690648|NCT02234323|364532572|FG000|All Treated|Physician Decision|5|||
105690649|NCT02234323|364532572|FG000|All Treated|Lack of Efficacy|3|||
105690650|NCT02234323|364532572|FG000|All Treated|Exceeded lab value limit|2|||
105690651|NCT02234323|364532572|FG000|All Treated|Other|7|||
105690652|NCT02465463|364532573|FG000|Overall Study|Lost to Follow-up|2|||
105690653|NCT02465463|364532574|FG001|Overall Study|Lost to Follow-up|1|||
105690654|NCT02465463|364532573|FG000|Overall Study|Death|1|||
105690655|NCT02465463|364532574|FG001|Overall Study|Death|0|||
105690656|NCT02465463|364532573|FG000|Overall Study|Protocol Violation|1|||
105690657|NCT02465463|364532574|FG001|Overall Study|Protocol Violation|0|||
105690658|NCT05372653|364532575|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
105690659|NCT05372653|364532576|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
105690660|NCT05372653|364532575|FG000|Overall Study|Adverse Event|0|||
105690661|NCT05372653|364532576|FG001|Overall Study|Adverse Event|1|||
105690662|NCT01067326|364532577|FG000|Overall Study|Adverse Event|0|||
105690663|NCT01067326|364532578|FG001|Overall Study|Adverse Event|2|||
105690664|NCT01067326|364532577|FG000|Overall Study|Withdrawal by Subject|1|||
105690665|NCT01067326|364532578|FG001|Overall Study|Withdrawal by Subject|0|||
105690666|NCT01067326|364532577|FG000|Overall Study|Early Study Termination|1|||
105690667|NCT01067326|364532578|FG001|Overall Study|Early Study Termination|1|||
105690668|NCT00323297|364532579|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
105690669|NCT00323297|364532580|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
105690670|NCT00323297|364532579|FG000|Part A (Double Blind Randomized)|Death|0|||
105690671|NCT00323297|364532580|FG001|Part A (Double Blind Randomized)|Death|1|||
105690672|NCT00323297|364532579|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
105690673|NCT00323297|364532580|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
105690674|NCT00323297|364532579|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
105690675|NCT00323297|364532580|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
105690676|NCT00323297|364532579|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
105690677|NCT00323297|364532580|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
105690678|NCT00323297|364532579|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
105690679|NCT00323297|364532580|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
105690680|NCT00323297|364532579|FG000|Part B (Open-label)|Death|0|||
105690681|NCT00323297|364532580|FG001|Part B (Open-label)|Death|1|||
105690682|NCT00323297|364532579|FG000|Part B (Open-label)|Reason unspecified|0|||
105690683|NCT00323297|364532580|FG001|Part B (Open-label)|Reason unspecified|1|||
105690684|NCT00323297|364532579|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
105690685|NCT00323297|364532580|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
105690686|NCT00323297|364532579|FG000|Part B (Open-label)|Lack of Efficacy|3|||
105690687|NCT00323297|364532580|FG001|Part B (Open-label)|Lack of Efficacy|1|||
105690688|NCT00323297|364532579|FG000|Part B (Open-label)|Adverse Event|5|||
105690689|NCT00323297|364532580|FG001|Part B (Open-label)|Adverse Event|5|||
105690690|NCT00323297|364532579|FG000|Part B (Open-label)|Protocol Violation|0|||
105690691|NCT00323297|364532580|FG001|Part B (Open-label)|Protocol Violation|1|||
105690692|NCT02066051|364532583|FG000|Overall Study|Subject developed active GVHD|1|||
105690693|NCT03027557|364532584|FG000|Overall Study|Adverse Event|1|||
105690694|NCT03027557|364532585|FG001|Overall Study|Adverse Event|0|||
105690695|NCT03027557|364532586|FG002|Overall Study|Adverse Event|0|||
105690696|NCT01237340|364532587|FG000|Overall Study|Adverse Event|3|||
105690697|NCT01237340|364532587|FG000|Overall Study|Withdrawal by Subject|1|||
105690698|NCT01237340|364532587|FG000|Overall Study|Early termination of the trial|36|||
105690699|NCT02019420|364532588|FG000|Overall Study|Did not receive study drug|2|||
105690700|NCT02019420|364532589|FG001|Overall Study|Did not receive study drug|2|||
105690701|NCT02019420|364532588|FG000|Overall Study|Withdrawal by Subject|1|||
105690702|NCT02019420|364532589|FG001|Overall Study|Withdrawal by Subject|3|||
105690703|NCT02019420|364532588|FG000|Overall Study|At request of sponsor or investigator|0|||
105690704|NCT02019420|364532589|FG001|Overall Study|At request of sponsor or investigator|1|||
105690705|NCT02019420|364532588|FG000|Overall Study|Death|104|||
105690706|NCT02019420|364532589|FG001|Overall Study|Death|99|||
105690707|NCT02019420|364532588|FG000|Overall Study|Transferred to other care facility|1|||
105690708|NCT02019420|364532589|FG001|Overall Study|Transferred to other care facility|1|||
105690709|NCT00986440|364532590|FG000|Overall Study|Progressive disease|27|||
105690710|NCT00986440|364532591|FG001|Overall Study|Progressive disease|37|||
105690711|NCT00986440|364532590|FG000|Overall Study|Serious adverse event or adverse event|9|||
105690712|NCT00986440|364532591|FG001|Overall Study|Serious adverse event or adverse event|2|||
105690713|NCT00986440|364532590|FG000|Overall Study|Withdrawal by Subject|1|||
105690714|NCT00986440|364532591|FG001|Overall Study|Withdrawal by Subject|2|||
105690715|NCT00986440|364532590|FG000|Overall Study|Screen failure (not dosed)|4|||
105690716|NCT00986440|364532591|FG001|Overall Study|Screen failure (not dosed)|2|||
105690717|NCT00593957|364532592|FG000|Overall Study|Physician Decision|0|||
105690718|NCT00593957|364532593|FG001|Overall Study|Physician Decision|1|||
105690719|NCT00593957|364532594|FG002|Overall Study|Physician Decision|2|||
105690720|NCT01009554|364532595|FG000|Overall Study|Adverse Event|1|||
105690721|NCT01009554|364532596|FG001|Overall Study|Adverse Event|1|||
105690722|NCT01009554|364532595|FG000|Overall Study|Withdrawal by Subject|1|||
105690723|NCT01009554|364532596|FG001|Overall Study|Withdrawal by Subject|3|||
105690724|NCT01009554|364532595|FG000|Overall Study|Noncompliant with Study Product|0|||
105690725|NCT01009554|364532596|FG001|Overall Study|Noncompliant with Study Product|3|||
105690726|NCT01605253|364532597|FG000|Overall Study|Physician Decision|3|||
105690727|NCT01605253|364532598|FG001|Overall Study|Physician Decision|2|||
105690728|NCT01605253|364532597|FG000|Overall Study|Lost to Follow-up|3|||
105690729|NCT01605253|364532598|FG001|Overall Study|Lost to Follow-up|1|||
105690730|NCT02742766|364532599|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690731|NCT02742766|364532600|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690732|NCT02742766|364532601|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690733|NCT02742766|364532602|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690734|NCT02742766|364532603|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690735|NCT02742766|364532604|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690736|NCT02742766|364532605|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690737|NCT02742766|364532606|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690738|NCT02742766|364532607|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690739|NCT02742766|364532608|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690740|NCT02742766|364532609|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690741|NCT02742766|364532610|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690742|NCT02742766|364532611|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690743|NCT02742766|364532612|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
105690744|NCT02742766|364532613|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690745|NCT02742766|364532614|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690746|NCT02742766|364532615|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690747|NCT02742766|364532616|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690748|NCT02742766|364532617|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690749|NCT02742766|364532599|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690750|NCT02742766|364532600|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690751|NCT02742766|364532601|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690752|NCT02742766|364532602|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690753|NCT02742766|364532603|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690754|NCT02742766|364532604|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690755|NCT02742766|364532605|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
105786863|NCT05182840|364872937|FG008|Run-in Period|Adverse Event|0|||
105690756|NCT02742766|364532606|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690757|NCT02742766|364532607|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
105786864|NCT05182840|364872938|FG009|Run-in Period|Adverse Event|0|||
105690758|NCT02742766|364532608|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690759|NCT02742766|364532609|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690760|NCT02742766|364532610|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690761|NCT02742766|364532611|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
105690762|NCT02742766|364532612|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
105690763|NCT02742766|364532613|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690764|NCT02742766|364532614|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
105690765|NCT02742766|364532615|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690766|NCT02742766|364532616|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690767|NCT02742766|364532617|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690768|NCT04427501|364532618|FG000|Overall Study|Death|0|||
105690769|NCT04427501|364532619|FG001|Overall Study|Death|0|||
105690770|NCT04427501|364532620|FG002|Overall Study|Death|0|||
105690771|NCT04427501|364532621|FG003|Overall Study|Death|0|||
105690772|NCT04427501|364532622|FG004|Overall Study|Death|0|||
105690773|NCT04427501|364532623|FG005|Overall Study|Death|15|||
105690774|NCT04427501|364532624|FG006|Overall Study|Death|0|||
105690775|NCT04427501|364532625|FG007|Overall Study|Death|0|||
105690776|NCT04427501|364532626|FG008|Overall Study|Death|0|||
105690777|NCT04427501|364532627|FG009|Overall Study|Death|0|||
105690778|NCT04427501|364532628|FG010|Overall Study|Death|0|||
105690779|NCT04427501|364532629|FG011|Overall Study|Death|0|||
105690780|NCT04427501|364532618|FG000|Overall Study|Lost to Follow-up|5|||
105690781|NCT04427501|364532619|FG001|Overall Study|Lost to Follow-up|1|||
105690782|NCT04427501|364532620|FG002|Overall Study|Lost to Follow-up|2|||
105690783|NCT04427501|364532621|FG003|Overall Study|Lost to Follow-up|0|||
105690784|NCT04427501|364532622|FG004|Overall Study|Lost to Follow-up|2|||
105690785|NCT04427501|364532623|FG005|Overall Study|Lost to Follow-up|11|||
105690786|NCT04427501|364532624|FG006|Overall Study|Lost to Follow-up|10|||
105690787|NCT04427501|364532625|FG007|Overall Study|Lost to Follow-up|10|||
105690788|NCT04427501|364532626|FG008|Overall Study|Lost to Follow-up|2|||
105690789|NCT04427501|364532627|FG009|Overall Study|Lost to Follow-up|5|||
105690790|NCT04427501|364532628|FG010|Overall Study|Lost to Follow-up|2|||
105690791|NCT04427501|364532629|FG011|Overall Study|Lost to Follow-up|0|||
105690792|NCT04427501|364532618|FG000|Overall Study|Physician Decision|0|||
105690793|NCT04427501|364532619|FG001|Overall Study|Physician Decision|3|||
105690794|NCT04427501|364532620|FG002|Overall Study|Physician Decision|0|||
105690795|NCT04427501|364532621|FG003|Overall Study|Physician Decision|0|||
105690796|NCT04427501|364532622|FG004|Overall Study|Physician Decision|0|||
105690797|NCT04427501|364532623|FG005|Overall Study|Physician Decision|0|||
105690798|NCT04427501|364532624|FG006|Overall Study|Physician Decision|2|||
105690799|NCT04427501|364532625|FG007|Overall Study|Physician Decision|0|||
105471549|NCT02067676|363738235|FG004|Overall Study|Withdrawal by Subject|0|||
105471550|NCT02067676|363738236|FG005|Overall Study|Withdrawal by Subject|0|||
105471551|NCT00845897|363738239|FG000|Overall Study|Lost to Follow-up|1|||
105690800|NCT04427501|364532626|FG008|Overall Study|Physician Decision|0|||
105690801|NCT04427501|364532627|FG009|Overall Study|Physician Decision|0|||
105690802|NCT04427501|364532628|FG010|Overall Study|Physician Decision|0|||
105690803|NCT04427501|364532629|FG011|Overall Study|Physician Decision|0|||
105690804|NCT04427501|364532618|FG000|Overall Study|Withdrawal by Subject|9|||
105690805|NCT04427501|364532619|FG001|Overall Study|Withdrawal by Subject|2|||
105690806|NCT04427501|364532620|FG002|Overall Study|Withdrawal by Subject|2|||
105690807|NCT04427501|364532621|FG003|Overall Study|Withdrawal by Subject|3|||
105471552|NCT00845897|363738240|FG001|Overall Study|Lost to Follow-up|1|||
105690808|NCT04427501|364532622|FG004|Overall Study|Withdrawal by Subject|7|||
105690809|NCT04427501|364532623|FG005|Overall Study|Withdrawal by Subject|25|||
105690810|NCT04427501|364532624|FG006|Overall Study|Withdrawal by Subject|15|||
105690811|NCT04427501|364532625|FG007|Overall Study|Withdrawal by Subject|7|||
105690812|NCT04427501|364532626|FG008|Overall Study|Withdrawal by Subject|4|||
105690813|NCT04427501|364532627|FG009|Overall Study|Withdrawal by Subject|1|||
105690814|NCT04427501|364532628|FG010|Overall Study|Withdrawal by Subject|4|||
105690815|NCT04427501|364532629|FG011|Overall Study|Withdrawal by Subject|0|||
105690816|NCT04427501|364532618|FG000|Overall Study|Other - as reported by the investigator|1|||
105690817|NCT04427501|364532619|FG001|Overall Study|Other - as reported by the investigator|0|||
105690818|NCT04427501|364532620|FG002|Overall Study|Other - as reported by the investigator|0|||
105690819|NCT04427501|364532621|FG003|Overall Study|Other - as reported by the investigator|0|||
105690820|NCT04427501|364532622|FG004|Overall Study|Other - as reported by the investigator|0|||
105690821|NCT04427501|364532623|FG005|Overall Study|Other - as reported by the investigator|6|||
105690822|NCT04427501|364532624|FG006|Overall Study|Other - as reported by the investigator|6|||
105690823|NCT04427501|364532625|FG007|Overall Study|Other - as reported by the investigator|0|||
105690824|NCT04427501|364532626|FG008|Overall Study|Other - as reported by the investigator|0|||
105690825|NCT04427501|364532627|FG009|Overall Study|Other - as reported by the investigator|0|||
105690826|NCT04427501|364532628|FG010|Overall Study|Other - as reported by the investigator|0|||
105690827|NCT04427501|364532629|FG011|Overall Study|Other - as reported by the investigator|0|||
105690828|NCT04427501|364532618|FG000|Overall Study|Other|0|||
105690829|NCT04427501|364532619|FG001|Overall Study|Other|0|||
105690830|NCT04427501|364532620|FG002|Overall Study|Other|0|||
105690831|NCT04427501|364532621|FG003|Overall Study|Other|0|||
105690832|NCT04427501|364532622|FG004|Overall Study|Other|0|||
105690833|NCT04427501|364532623|FG005|Overall Study|Other|0|||
105690834|NCT04427501|364532624|FG006|Overall Study|Other|0|||
105786865|NCT05182840|364872929|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
105786866|NCT05182840|364872930|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
105786867|NCT05182840|364872931|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105786868|NCT05182840|364872932|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105786869|NCT05182840|364872933|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105786870|NCT05182840|364872934|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105786871|NCT05182840|364872935|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105786872|NCT05182840|364872936|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105786873|NCT05182840|364872937|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105690835|NCT04427501|364532625|FG007|Overall Study|Other|0|||
105690836|NCT04427501|364532626|FG008|Overall Study|Other|0|||
105690837|NCT04427501|364532627|FG009|Overall Study|Other|0|||
105690838|NCT04427501|364532628|FG010|Overall Study|Other|0|||
105690839|NCT04427501|364532629|FG011|Overall Study|Other|1|||
105690840|NCT00999713|364532630|FG000|Overall Study|Physician Decision|2|||
105690841|NCT00999713|364532631|FG001|Overall Study|Physician Decision|0|||
105690842|NCT01906346|364532634|FG000|Overall Study|AEs|1|||
105690843|NCT03431857|364532638|FG000|Overall Study|Death|6|||
105690844|NCT03431857|364532638|FG000|Overall Study|Lost to Follow-up|41|||
105690845|NCT03431857|364532638|FG000|Overall Study|Adverse Event|6|||
105690846|NCT03431857|364532638|FG000|Overall Study|Withdrawal by Subject|1|||
105690847|NCT01395316|364532639|FG000|Overall Study|Lost to Follow-up|2|||
105690848|NCT01395316|364532639|FG000|Overall Study|poor MRI quality|1|||
105690849|NCT01323621|364532640|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
105690850|NCT01323621|364532641|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
105690851|NCT01323621|364532642|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
105690852|NCT01323621|364532640|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
105690853|NCT01323621|364532641|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
105690854|NCT01323621|364532642|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
105690855|NCT01323621|364532640|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
105690856|NCT01323621|364532641|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
105690857|NCT01323621|364532642|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
105690858|NCT01323621|364532640|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
105690859|NCT01323621|364532641|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
105690860|NCT01323621|364532642|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
105690861|NCT01323621|364532640|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
105690862|NCT01323621|364532641|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
105690863|NCT01323621|364532642|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
105690864|NCT01323621|364532640|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
105690865|NCT01323621|364532641|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
105690866|NCT01323621|364532642|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
105690867|NCT01323621|364532640|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
105690868|NCT01323621|364532641|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
105690869|NCT01323621|364532642|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
105690870|NCT01323621|364532640|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
105690871|NCT01323621|364532641|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
105690872|NCT01323621|364532642|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
105690873|NCT01323621|364532640|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
105690874|NCT01323621|364532641|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
105690875|NCT01323621|364532642|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
105690876|NCT01323621|364532640|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105690877|NCT01323621|364532641|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
105690878|NCT01323621|364532642|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105690879|NCT01323621|364532640|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
105690880|NCT01323621|364532641|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
105690881|NCT01323621|364532642|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
105690882|NCT01323621|364532640|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
105690883|NCT01323621|364532641|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
105690884|NCT01323621|364532642|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
105690885|NCT03359590|364532645|FG000|First Intervention|Withdrawal by Subject|1|||
105690886|NCT03359590|364532646|FG001|First Intervention|Withdrawal by Subject|1|||
105690887|NCT03359590|364532645|FG000|First Intervention|Protocol Violation|0|||
105690888|NCT03359590|364532646|FG001|First Intervention|Protocol Violation|1|||
105690889|NCT04343248|364532652|FG000|Overall Study|Withdrawal by Subject|5|||
105690890|NCT04343248|364532653|FG001|Overall Study|Withdrawal by Subject|6|||
105690891|NCT04343248|364532652|FG000|Overall Study|Death|1|||
105690892|NCT04343248|364532653|FG001|Overall Study|Death|2|||
105690893|NCT04343248|364532652|FG000|Overall Study|Lost to Follow-up|9|||
105690894|NCT04343248|364532653|FG001|Overall Study|Lost to Follow-up|6|||
105690895|NCT04343248|364532652|FG000|Overall Study|Physician Decision|0|||
105690896|NCT04343248|364532653|FG001|Overall Study|Physician Decision|1|||
105690897|NCT04343248|364532652|FG000|Overall Study|Adverse Event|1|||
105690898|NCT04343248|364532653|FG001|Overall Study|Adverse Event|0|||
105690899|NCT02708095|364532654|FG000|Overall Study|Adverse Event|4|||
105690900|NCT02708095|364532655|FG001|Overall Study|Adverse Event|10|||
105690901|NCT02708095|364532656|FG002|Overall Study|Adverse Event|11|||
105690902|NCT02708095|364532654|FG000|Overall Study|Lack of Efficacy|9|||
105690903|NCT02708095|364532655|FG001|Overall Study|Lack of Efficacy|3|||
105690904|NCT02708095|364532656|FG002|Overall Study|Lack of Efficacy|0|||
105690905|NCT02708095|364532654|FG000|Overall Study|Lost to Follow-up|2|||
105690906|NCT02708095|364532655|FG001|Overall Study|Lost to Follow-up|0|||
105690907|NCT02708095|364532656|FG002|Overall Study|Lost to Follow-up|0|||
105690908|NCT02708095|364532654|FG000|Overall Study|Physician Decision|2|||
105690909|NCT02708095|364532655|FG001|Overall Study|Physician Decision|3|||
105690910|NCT02708095|364532656|FG002|Overall Study|Physician Decision|2|||
105690911|NCT02708095|364532654|FG000|Overall Study|Protocol Violation|0|||
105690912|NCT02708095|364532655|FG001|Overall Study|Protocol Violation|0|||
105690913|NCT02708095|364532656|FG002|Overall Study|Protocol Violation|1|||
105690914|NCT02708095|364532654|FG000|Overall Study|Withdrawal by Subject|5|||
105690915|NCT02708095|364532655|FG001|Overall Study|Withdrawal by Subject|3|||
105690916|NCT02708095|364532656|FG002|Overall Study|Withdrawal by Subject|4|||
105690917|NCT04598477|364532657|FG000|Overall Study|Adverse Event|2|||
105690918|NCT04598477|364532658|FG001|Overall Study|Adverse Event|0|||
105690919|NCT04598477|364532657|FG000|Overall Study|Death|0|||
105690920|NCT04598477|364532658|FG001|Overall Study|Death|1|||
105690921|NCT04598477|364532657|FG000|Overall Study|Lost to Follow-up|1|||
105690922|NCT04598477|364532658|FG001|Overall Study|Lost to Follow-up|0|||
105690923|NCT04598477|364532657|FG000|Overall Study|Physician Decision|7|||
105690924|NCT04598477|364532658|FG001|Overall Study|Physician Decision|2|||
105690925|NCT04598477|364532657|FG000|Overall Study|Pregnancy|0|||
105690926|NCT04598477|364532658|FG001|Overall Study|Pregnancy|1|||
105690927|NCT04598477|364532657|FG000|Overall Study|Requires Prohibited Medication|0|||
105690928|NCT04598477|364532658|FG001|Overall Study|Requires Prohibited Medication|1|||
105690929|NCT04598477|364532657|FG000|Overall Study|Study Terminated by Sponsor|18|||
105690930|NCT04598477|364532658|FG001|Overall Study|Study Terminated by Sponsor|12|||
105690931|NCT04598477|364532657|FG000|Overall Study|Withdrawal by Subject|16|||
105690932|NCT04598477|364532658|FG001|Overall Study|Withdrawal by Subject|12|||
105690933|NCT04598477|364532657|FG000|Overall Study|Other|15|||
105690934|NCT04598477|364532658|FG001|Overall Study|Other|8|||
105690935|NCT01313650|364532661|FG000|Overall Study|Adverse Event|9|||
105690936|NCT01313650|364532662|FG001|Overall Study|Adverse Event|34|||
105690937|NCT01313650|364532663|FG002|Overall Study|Adverse Event|24|||
105690938|NCT01313650|364532664|FG003|Overall Study|Adverse Event|23|||
105690939|NCT01313650|364532661|FG000|Overall Study|Lack of Efficacy|37|||
105690940|NCT01313650|364532662|FG001|Overall Study|Lack of Efficacy|20|||
105690941|NCT01313650|364532663|FG002|Overall Study|Lack of Efficacy|32|||
105690942|NCT01313650|364532664|FG003|Overall Study|Lack of Efficacy|20|||
105690943|NCT01313650|364532661|FG000|Overall Study|Lost to Follow-up|1|||
105690944|NCT01313650|364532662|FG001|Overall Study|Lost to Follow-up|0|||
105690945|NCT01313650|364532663|FG002|Overall Study|Lost to Follow-up|3|||
105690946|NCT01313650|364532664|FG003|Overall Study|Lost to Follow-up|2|||
105690947|NCT01313650|364532661|FG000|Overall Study|Withdrawal by Subject|16|||
105690948|NCT01313650|364532662|FG001|Overall Study|Withdrawal by Subject|20|||
105690949|NCT01313650|364532663|FG002|Overall Study|Withdrawal by Subject|15|||
105690950|NCT01313650|364532664|FG003|Overall Study|Withdrawal by Subject|15|||
105690951|NCT01313650|364532661|FG000|Overall Study|Protocol Violation|4|||
105690952|NCT01313650|364532662|FG001|Overall Study|Protocol Violation|7|||
105690953|NCT01313650|364532663|FG002|Overall Study|Protocol Violation|5|||
105690954|NCT01313650|364532664|FG003|Overall Study|Protocol Violation|6|||
105690955|NCT01313650|364532661|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
105690956|NCT01313650|364532662|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
105690957|NCT01313650|364532663|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
105690958|NCT01313650|364532664|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
105690959|NCT00458341|364532665|FG000|Cycle 1|Adverse Event|1|||
105690960|NCT00458341|364532666|FG001|Cycle 1|Adverse Event|0|||
105690961|NCT00390910|364532669|FG000|Overall Study|Adverse Event|1|||
105690962|NCT00390910|364532670|FG001|Overall Study|Adverse Event|0|||
105690963|NCT00390910|364532671|FG002|Overall Study|Adverse Event|0|||
105690964|NCT00390910|364532669|FG000|Overall Study|Lost to Follow-up|0|||
105690965|NCT00390910|364532670|FG001|Overall Study|Lost to Follow-up|1|||
105690966|NCT00390910|364532671|FG002|Overall Study|Lost to Follow-up|5|||
105690967|NCT00390910|364532669|FG000|Overall Study|Withdrawal by Subject|1|||
105690968|NCT00390910|364532670|FG001|Overall Study|Withdrawal by Subject|3|||
105690969|NCT00390910|364532671|FG002|Overall Study|Withdrawal by Subject|2|||
105690970|NCT00390910|364532669|FG000|Overall Study|Migrated/moved from study area|0|||
105690971|NCT00390910|364532670|FG001|Overall Study|Migrated/moved from study area|0|||
105690972|NCT00390910|364532671|FG002|Overall Study|Migrated/moved from study area|3|||
105690973|NCT00835120|364532674|FG000|Overall Study|Lack of Efficacy|1|||
105690974|NCT00835120|364532674|FG000|Overall Study|Lost to Follow-up|3|||
105690975|NCT00835120|364532674|FG000|Overall Study|Adverse Event|2|||
105690976|NCT00835120|364532674|FG000|Overall Study|Withdrawal by Subject|2|||
105690977|NCT02499770|364532677|FG000|Overall Study|Death|17|||
105690978|NCT02499770|364532678|FG001|Overall Study|Death|56|||
105690979|NCT02499770|364532677|FG000|Overall Study|Study completion|1|||
105690980|NCT02499770|364532678|FG001|Overall Study|Study completion|10|||
105690981|NCT02499770|364532677|FG000|Overall Study|Withdrawal by Subject|0|||
105690982|NCT02499770|364532678|FG001|Overall Study|Withdrawal by Subject|7|||
105690983|NCT02499770|364532677|FG000|Overall Study|Lost to Follow-up|0|||
105690984|NCT02499770|364532678|FG001|Overall Study|Lost to Follow-up|2|||
105690985|NCT02499770|364532677|FG000|Overall Study|Subject declined further treatment|1|||
105690986|NCT02499770|364532678|FG001|Overall Study|Subject declined further treatment|0|||
105690987|NCT02499770|364532677|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
105690988|NCT02499770|364532678|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
105690989|NCT02499770|364532677|FG000|Overall Study|Randomized but not enrolled|0|||
105690990|NCT02499770|364532678|FG001|Overall Study|Randomized but not enrolled|1|||
105690991|NCT00232141|364532681|FG000|Overall Study|Adverse Event|9|||
105690992|NCT00232141|364532682|FG001|Overall Study|Adverse Event|4|||
105690993|NCT00232141|364532681|FG000|Overall Study|Lack of Efficacy|0|||
105690994|NCT00232141|364532682|FG001|Overall Study|Lack of Efficacy|3|||
105690995|NCT00232141|364532681|FG000|Overall Study|Lost to Follow-up|9|||
105690996|NCT00232141|364532682|FG001|Overall Study|Lost to Follow-up|6|||
105690997|NCT00232141|364532681|FG000|Overall Study|Other|8|||
105690998|NCT00232141|364532682|FG001|Overall Study|Other|10|||
105690999|NCT00232141|364532681|FG000|Overall Study|Withdrawal by Subject|5|||
105691000|NCT00232141|364532682|FG001|Overall Study|Withdrawal by Subject|3|||
105691001|NCT01298518|364532683|FG000|Overall Study|Withdrawal by Subject|0|||
105691002|NCT01298518|364532684|FG001|Overall Study|Withdrawal by Subject|0|||
105471553|NCT00845897|363738241|FG002|Overall Study|Lost to Follow-up|0|||
105471554|NCT00845897|363738239|FG000|Overall Study|Withdrawal by Subject|0|||
105471555|NCT00845897|363738240|FG001|Overall Study|Withdrawal by Subject|3|||
105691003|NCT01298518|364532685|FG002|Overall Study|Withdrawal by Subject|1|||
105691004|NCT01019980|364532687|FG000|Overall Study|Drug not available.|2|||
105691005|NCT01019980|364532688|FG001|Overall Study|Drug not available.|0|||
105691006|NCT04275297|364532694|FG000|Overall Study|Lost to Follow-up|1|||
105691007|NCT04275297|364532695|FG001|Overall Study|Lost to Follow-up|1|||
105691008|NCT04824521|364532696|FG000|Overall Study|Lost to Follow-up|1|||
105691009|NCT01791803|364532697|FG000|Overall Study|Withdrawal by Subject|0|||
105691010|NCT01791803|364532698|FG001|Overall Study|Withdrawal by Subject|0|||
105691011|NCT01791803|364532699|FG002|Overall Study|Withdrawal by Subject|0|||
105691012|NCT01791803|364532700|FG003|Overall Study|Withdrawal by Subject|2|||
105691013|NCT01791803|364532697|FG000|Overall Study|Physician Decision|0|||
105691014|NCT01791803|364532698|FG001|Overall Study|Physician Decision|2|||
105691015|NCT01791803|364532699|FG002|Overall Study|Physician Decision|0|||
105691016|NCT01791803|364532700|FG003|Overall Study|Physician Decision|1|||
105691017|NCT01791803|364532697|FG000|Overall Study|Death|0|||
105691018|NCT01791803|364532698|FG001|Overall Study|Death|0|||
105691019|NCT01791803|364532699|FG002|Overall Study|Death|2|||
105691020|NCT01791803|364532700|FG003|Overall Study|Death|2|||
105691021|NCT03672461|364532702|FG000|Overall Study|COVID Related|4|||
105691022|NCT03672461|364532703|FG001|Overall Study|COVID Related|2|||
105691023|NCT03672461|364532702|FG000|Overall Study|Adverse Event|2|||
105691024|NCT03672461|364532703|FG001|Overall Study|Adverse Event|0|||
105691025|NCT03672461|364532702|FG000|Overall Study|Serious Adverse Event|0|||
105691026|NCT03672461|364532703|FG001|Overall Study|Serious Adverse Event|1|||
105691027|NCT03672461|364532702|FG000|Overall Study|Too Busy|3|||
105691028|NCT03672461|364532703|FG001|Overall Study|Too Busy|1|||
105691029|NCT03672461|364532702|FG000|Overall Study|Lost to Follow-up|1|||
105691030|NCT03672461|364532703|FG001|Overall Study|Lost to Follow-up|2|||
105691031|NCT03672461|364532702|FG000|Overall Study|Family|2|||
105691032|NCT03672461|364532703|FG001|Overall Study|Family|2|||
105691033|NCT03672461|364532702|FG000|Overall Study|No remote technology access|0|||
105691034|NCT03672461|364532703|FG001|Overall Study|No remote technology access|1|||
105691035|NCT03672461|364532702|FG000|Overall Study|Withdrawal by Subject|1|||
105691036|NCT03672461|364532703|FG001|Overall Study|Withdrawal by Subject|0|||
105691037|NCT03672461|364532702|FG000|Overall Study|Cannot tolerate intervention|1|||
105691038|NCT03672461|364532703|FG001|Overall Study|Cannot tolerate intervention|0|||
105691039|NCT03672461|364532702|FG000|Overall Study|Incomplete outcome data|6|||
105691040|NCT03672461|364532703|FG001|Overall Study|Incomplete outcome data|1|||
105691041|NCT03144804|364532704|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
105691042|NCT05514873|364532705|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
105691043|NCT05514873|364532705|FG000|Main Treatment Period|Adverse Event|2|||
105691044|NCT05514873|364532705|FG000|Extension Treatment Period|Lost to Follow-up|3|||
105691045|NCT04751656|364534724|FG000|Overall Study|Lost to Follow-up|1|||
105691046|NCT01306890|364534725|FG000|Overall Study|Adverse Event|2|||
105691047|NCT01306890|364534725|FG000|Overall Study|Death|1223|||
105691048|NCT01306890|364534725|FG000|Overall Study|Lost to Follow-up|58|||
105691049|NCT01306890|364534725|FG000|Overall Study|Withdrawal by Subject|88|||
105691050|NCT01306890|364534725|FG000|Overall Study|Unspecified reasons|104|||
105691051|NCT01306890|364534725|FG000|Overall Study|Study Termination|3|||
105691052|NCT01306890|364534725|FG000|Overall Study|No discontinuation documentation|41|||
105691053|NCT01955122|364534730|FG000|Overall Study|Physician Decision|5|||
105691054|NCT01955122|364534731|FG001|Overall Study|Physician Decision|5|||
105691055|NCT00826111|364534735|FG000|Overall Study|Lost to Follow-up|0|||
105691056|NCT00826111|364534736|FG001|Overall Study|Lost to Follow-up|1|||
105691057|NCT00826111|364534735|FG000|Overall Study|Protocol Violation|1|||
105691058|NCT00826111|364534736|FG001|Overall Study|Protocol Violation|0|||
105691059|NCT00826111|364534735|FG000|Overall Study|Withdrawal by Subject|5|||
105691060|NCT00826111|364534736|FG001|Overall Study|Withdrawal by Subject|0|||
105691061|NCT00826111|364534735|FG000|Overall Study|Physician Decision|1|||
105691062|NCT00826111|364534736|FG001|Overall Study|Physician Decision|1|||
105691063|NCT00440700|364534739|FG000|Overall Study|Withdrawal by Subject|8|||
105691064|NCT00440700|364534740|FG001|Overall Study|Withdrawal by Subject|8|||
105691065|NCT00440700|364534741|FG002|Overall Study|Withdrawal by Subject|4|||
105691066|NCT01990534|364534742|FG000|Overall Study|Death|22|||
105691067|NCT01990534|364534742|FG000|Overall Study|Progressive disease|3|||
105691068|NCT01990534|364534742|FG000|Overall Study|Protocol Violation|1|||
105691069|NCT01990534|364534742|FG000|Overall Study|Withdrawal of Informed Consent|2|||
105691070|NCT01990534|364534742|FG000|Overall Study|Symptomatic Deterioration|1|||
105691071|NCT01990534|364534742|FG000|Overall Study|Withdrawal by Subject|3|||
105691072|NCT01990534|364534742|FG000|Overall Study|Reason not Specified|2|||
105691073|NCT01990534|364534742|FG000|Overall Study|Lost to Follow-up|1|||
105691074|NCT00907257|364534743|FG000|Overall Study|Adverse Event|0|||
105691075|NCT00907257|364534744|FG001|Overall Study|Adverse Event|4|||
105691076|NCT00907257|364534743|FG000|Overall Study|Protocol Violation|1|||
105691077|NCT00907257|364534744|FG001|Overall Study|Protocol Violation|2|||
105691078|NCT00907257|364534743|FG000|Overall Study|Lost to Follow-up|3|||
105691079|NCT00907257|364534744|FG001|Overall Study|Lost to Follow-up|3|||
105691080|NCT00907257|364534743|FG000|Overall Study|Withdrawal by Subject|1|||
105691081|NCT00907257|364534744|FG001|Overall Study|Withdrawal by Subject|2|||
105691082|NCT00907257|364534743|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
105691083|NCT00907257|364534744|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
105691084|NCT00907257|364534743|FG000|Overall Study|Moved|1|||
105691085|NCT00907257|364534744|FG001|Overall Study|Moved|0|||
105691086|NCT00907257|364534743|FG000|Overall Study|Personal Reasons|6|||
105691087|NCT00907257|364534744|FG001|Overall Study|Personal Reasons|1|||
105691088|NCT00937833|364534748|FG000|Overall Study|Protocol Violation|1|||
105691089|NCT00937833|364534749|FG001|Overall Study|Protocol Violation|2|||
105691090|NCT00937833|364534748|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
105691091|NCT00937833|364534749|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
105691092|NCT00937833|364534748|FG000|Overall Study|Lost to Follow-up|10|||
105691093|NCT00937833|364534749|FG001|Overall Study|Lost to Follow-up|8|||
105691094|NCT00937833|364534748|FG000|Overall Study|Withdrawal by Subject|4|||
105691095|NCT00937833|364534749|FG001|Overall Study|Withdrawal by Subject|6|||
105691096|NCT02366728|364534751|FG000|Overall Study|Death|0|||
105691097|NCT02366728|364534752|FG001|Overall Study|Death|0|||
105691098|NCT02366728|364534753|FG002|Overall Study|Death|1|||
105691099|NCT02366728|364534751|FG000|Overall Study|Adverse Event|1|||
105691100|NCT02366728|364534752|FG001|Overall Study|Adverse Event|0|||
105691101|NCT02366728|364534753|FG002|Overall Study|Adverse Event|0|||
105691102|NCT02366728|364534751|FG000|Overall Study|Screen Failure|2|||
105691103|NCT02366728|364534752|FG001|Overall Study|Screen Failure|1|||
105691104|NCT02366728|364534753|FG002|Overall Study|Screen Failure|0|||
105691105|NCT02366728|364534751|FG000|Overall Study|Only yielded 2 vaccines|1|||
105691106|NCT02366728|364534752|FG001|Overall Study|Only yielded 2 vaccines|0|||
105691107|NCT02366728|364534753|FG002|Overall Study|Only yielded 2 vaccines|0|||
105691108|NCT01376349|364534754|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
105691109|NCT01376349|364534755|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
105691110|NCT01376349|364534756|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
105691111|NCT01376349|364534754|FG000|Raondomized Treatment|Adverse Event|13|||
105691112|NCT01376349|364534755|FG001|Raondomized Treatment|Adverse Event|17|||
105691113|NCT01376349|364534756|FG002|Raondomized Treatment|Adverse Event|14|||
105691114|NCT01376349|364534754|FG000|Raondomized Treatment|Unkown|1|||
105691115|NCT01376349|364534755|FG001|Raondomized Treatment|Unkown|2|||
105691116|NCT01376349|364534756|FG002|Raondomized Treatment|Unkown|1|||
105691117|NCT01376349|364534754|FG000|Raondomized Treatment|Alternative Treatment|0|||
105691118|NCT01376349|364534755|FG001|Raondomized Treatment|Alternative Treatment|0|||
105691119|NCT01376349|364534756|FG002|Raondomized Treatment|Alternative Treatment|1|||
105691120|NCT03155373|364534759|FG000|Overall Study|No longer required surgery|1|||
105691121|NCT03155373|364534759|FG000|Overall Study|Protocol Violation|1|||
105691122|NCT03155373|364534759|FG000|Overall Study|Death|2|||
105691123|NCT03155373|364534759|FG000|Overall Study|Withdrawal by Subject|3|||
105691124|NCT03836807|364534763|FG000|Overall Study|Physician Decision|1|||
105691125|NCT03836807|364534764|FG001|Overall Study|Physician Decision|0|||
105691126|NCT00639223|364534765|FG000|Overall Study|Lost to Follow-up|0|||
105691127|NCT00639223|364534766|FG001|Overall Study|Lost to Follow-up|2|||
105691128|NCT00651157|364534767|FG000|Overall Study|Death|1|||
105691129|NCT00651157|364534767|FG000|Overall Study|Protocol Violation|1|||
105691130|NCT04226833|364534768|FG000|Overall Study|Death|0|||
105691131|NCT04226833|364534769|FG001|Overall Study|Death|0|||
105691132|NCT04226833|364534770|FG002|Overall Study|Death|1|||
105691133|NCT04226833|364534771|FG003|Overall Study|Death|0|||
105691134|NCT02876835|364534774|FG000|Treatment Period (51.1 Month)|Other|1|||
105691135|NCT02876835|364534775|FG001|Treatment Period (51.1 Month)|Other|0|||
105691136|NCT02876835|364534774|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
105691137|NCT02876835|364534775|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
105691138|NCT02876835|364534774|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
105691139|NCT02876835|364534775|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
105691140|NCT02876835|364534774|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
105691141|NCT02876835|364534775|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
105691142|NCT02374021|364534778|FG000|Overall Study|Adverse Event|1|||
105691143|NCT02374021|364534779|FG001|Overall Study|Adverse Event|0|||
105691144|NCT02374021|364534778|FG000|Overall Study|Lost to Follow-up|3|||
105691145|NCT02374021|364534779|FG001|Overall Study|Lost to Follow-up|2|||
105691146|NCT02374021|364534778|FG000|Overall Study|Physician Decision|0|||
105691147|NCT02374021|364534779|FG001|Overall Study|Physician Decision|3|||
105691148|NCT02374021|364534778|FG000|Overall Study|Withdrawal by Subject|6|||
105691149|NCT02374021|364534779|FG001|Overall Study|Withdrawal by Subject|5|||
105691150|NCT02374021|364534778|FG000|Overall Study|Poor Adherence|0|||
105691151|NCT02374021|364534779|FG001|Overall Study|Poor Adherence|1|||
105691152|NCT02374021|364534778|FG000|Overall Study|Scan protocol not followed|0|||
105691153|NCT02374021|364534779|FG001|Overall Study|Scan protocol not followed|1|||
105691154|NCT02374021|364534778|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
105691155|NCT02374021|364534779|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
105691156|NCT04029961|364534783|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
105691157|NCT04029961|364534784|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
105691158|NCT04029961|364534783|FG000|Overall Study|Change in Treatment Course|0|||
105691159|NCT04029961|364534784|FG001|Overall Study|Change in Treatment Course|1|||
105691160|NCT00403754|364534785|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
105691161|NCT00403754|364534786|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
105691162|NCT00403754|364534787|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
105691163|NCT00403754|364534788|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
105691164|NCT00403754|364534785|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
105691165|NCT00403754|364534786|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
105691166|NCT00403754|364534787|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
105691167|NCT00403754|364534788|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
105691168|NCT02000427|364534791|FG000|Overall Study|Death|22|||
105691169|NCT02846532|364534794|FG000|Overall Study|Lost to Follow-up|0|||
105691170|NCT02846532|364534795|FG001|Overall Study|Lost to Follow-up|1|||
105691171|NCT02846532|364534796|FG002|Overall Study|Lost to Follow-up|1|||
105691172|NCT02846532|364534794|FG000|Overall Study|Withdrawal by Subject|1|||
105691173|NCT02846532|364534795|FG001|Overall Study|Withdrawal by Subject|2|||
105691174|NCT02846532|364534796|FG002|Overall Study|Withdrawal by Subject|0|||
105691175|NCT04540133|364534797|FG000|Overall Study|Lost to Follow-up|1|||
105691176|NCT04540133|364534798|FG001|Overall Study|Lost to Follow-up|0|||
105691177|NCT04252287|364534799|FG000|Overall Study|Death|5|||
105691178|NCT04252287|364534800|FG001|Overall Study|Death|3|||
105691179|NCT04252287|364534799|FG000|Overall Study|Lost to Follow-up|4|||
105691180|NCT04252287|364534800|FG001|Overall Study|Lost to Follow-up|6|||
105691181|NCT04252287|364534799|FG000|Overall Study|Withdrawal by Subject|19|||
105691182|NCT04252287|364534800|FG001|Overall Study|Withdrawal by Subject|16|||
105691183|NCT04252287|364534799|FG000|Overall Study|Protocol Violation|3|||
105691184|NCT04252287|364534800|FG001|Overall Study|Protocol Violation|4|||
105691185|NCT03891524|364534801|FG000|Overall Study|Death|0|||
105691186|NCT03891524|364534802|FG001|Overall Study|Death|0|||
105691187|NCT03891524|364534803|FG002|Overall Study|Death|0|||
105691188|NCT03891524|364534804|FG003|Overall Study|Death|0|||
105691189|NCT03891524|364534805|FG004|Overall Study|Death|0|||
105691190|NCT03891524|364534806|FG005|Overall Study|Death|0|||
105691191|NCT03891524|364534807|FG006|Overall Study|Death|0|||
105691192|NCT03891524|364534808|FG007|Overall Study|Death|1|||
105691193|NCT03891524|364534801|FG000|Overall Study|Withdrawal by Subject|0|||
105691194|NCT03891524|364534802|FG001|Overall Study|Withdrawal by Subject|1|||
105691195|NCT03891524|364534803|FG002|Overall Study|Withdrawal by Subject|2|||
105691196|NCT03891524|364534804|FG003|Overall Study|Withdrawal by Subject|1|||
105691197|NCT03891524|364534805|FG004|Overall Study|Withdrawal by Subject|2|||
105691198|NCT03891524|364534806|FG005|Overall Study|Withdrawal by Subject|2|||
105691199|NCT03891524|364534807|FG006|Overall Study|Withdrawal by Subject|2|||
105691200|NCT03891524|364534808|FG007|Overall Study|Withdrawal by Subject|1|||
105691201|NCT02273726|364534809|FG000|Overall Study|Death|70|||
105691202|NCT02273726|364534810|FG001|Overall Study|Death|62|||
105691203|NCT02273726|364534809|FG000|Overall Study|Withdrawal by Subject|41|||
105691204|NCT02273726|364534810|FG001|Overall Study|Withdrawal by Subject|29|||
105691205|NCT02273726|364534809|FG000|Overall Study|Kidney transplant|31|||
105691206|NCT02273726|364534810|FG001|Overall Study|Kidney transplant|39|||
105691207|NCT02273726|364534809|FG000|Overall Study|Physician Decision|30|||
105691208|NCT02273726|364534810|FG001|Overall Study|Physician Decision|15|||
105691209|NCT02273726|364534809|FG000|Overall Study|Adverse Event|27|||
105691210|NCT02273726|364534810|FG001|Overall Study|Adverse Event|9|||
105691211|NCT02273726|364534809|FG000|Overall Study|Lost to Follow-up|6|||
105691212|NCT02273726|364534810|FG001|Overall Study|Lost to Follow-up|3|||
105691213|NCT02273726|364534809|FG000|Overall Study|Lack of Efficacy|6|||
105691214|NCT02273726|364534810|FG001|Overall Study|Lack of Efficacy|1|||
105691215|NCT02273726|364534809|FG000|Overall Study|Protocol Violation|4|||
105691216|NCT02273726|364534810|FG001|Overall Study|Protocol Violation|0|||
105691217|NCT02273726|364534809|FG000|Overall Study|Other than specified|28|||
105691218|NCT02273726|364534810|FG001|Overall Study|Other than specified|30|||
105691219|NCT03610165|364534811|FG000|Overall Study|Device didn't work|0|||
105691220|NCT03610165|364534812|FG001|Overall Study|Device didn't work|1|||
105691221|NCT02129205|364534813|FG000|Overall Study|Withdrawal by Subject|0|||
105691222|NCT02129205|364534814|FG001|Overall Study|Withdrawal by Subject|0|||
105691223|NCT02129205|364534815|FG002|Overall Study|Withdrawal by Subject|0|||
105691224|NCT02129205|364534816|FG003|Overall Study|Withdrawal by Subject|0|||
105691225|NCT02129205|364534817|FG004|Overall Study|Withdrawal by Subject|1|||
105691226|NCT02129205|364534818|FG005|Overall Study|Withdrawal by Subject|1|||
105691227|NCT02129205|364534819|FG006|Overall Study|Withdrawal by Subject|1|||
105691228|NCT02129205|364534820|FG007|Overall Study|Withdrawal by Subject|0|||
105691229|NCT02129205|364534821|FG008|Overall Study|Withdrawal by Subject|1|||
105691230|NCT02129205|364534822|FG009|Overall Study|Withdrawal by Subject|0|||
105691231|NCT02129205|364534813|FG000|Overall Study|Other|1|||
105691232|NCT02129205|364534814|FG001|Overall Study|Other|0|||
105691233|NCT02129205|364534815|FG002|Overall Study|Other|0|||
105691234|NCT02129205|364534816|FG003|Overall Study|Other|0|||
105691235|NCT02129205|364534817|FG004|Overall Study|Other|2|||
105691236|NCT02129205|364534818|FG005|Overall Study|Other|3|||
105691237|NCT02129205|364534819|FG006|Overall Study|Other|3|||
105691238|NCT02129205|364534820|FG007|Overall Study|Other|2|||
105691239|NCT02129205|364534821|FG008|Overall Study|Other|1|||
105691240|NCT02129205|364534822|FG009|Overall Study|Other|0|||
105691241|NCT00671554|364534823|FG000|Overall Study|Disease progression|3|||
105691242|NCT01479829|364534824|FG000|Overall Study|Withdrawal by Subject|8|||
105691243|NCT01479829|364534825|FG001|Overall Study|Withdrawal by Subject|10|||
105691244|NCT02877927|364534826|FG000|Overall Study|Adverse Event|1|||
105691245|NCT02877927|364534827|FG001|Overall Study|Adverse Event|0|||
105691246|NCT02877927|364534826|FG000|Overall Study|Lost to Follow-up|37|||
105691247|NCT02877927|364534827|FG001|Overall Study|Lost to Follow-up|38|||
105691248|NCT02877927|364534826|FG000|Overall Study|Withdrawal by Subject|11|||
105691249|NCT02877927|364534827|FG001|Overall Study|Withdrawal by Subject|12|||
105691250|NCT02877927|364534826|FG000|Overall Study|Physician Decision|0|||
105691251|NCT02877927|364534827|FG001|Overall Study|Physician Decision|1|||
105691252|NCT02877927|364534826|FG000|Overall Study|Missed EOT/PTE Visit|5|||
105691253|NCT02877927|364534827|FG001|Overall Study|Missed EOT/PTE Visit|6|||
105691254|NCT00601250|364534828|FG000|Overall Study|Adverse Event|3|||
105691255|NCT00601250|364534829|FG001|Overall Study|Adverse Event|9|||
105691256|NCT00601250|364534828|FG000|Overall Study|Protocol Violation|3|||
105691257|NCT00601250|364534829|FG001|Overall Study|Protocol Violation|2|||
105691258|NCT00601250|364534828|FG000|Overall Study|Lost to Follow-up|2|||
105691259|NCT00601250|364534829|FG001|Overall Study|Lost to Follow-up|6|||
105691260|NCT00601250|364534828|FG000|Overall Study|Withdrawal by Subject|4|||
105691261|NCT00601250|364534829|FG001|Overall Study|Withdrawal by Subject|13|||
105691262|NCT00601250|364534828|FG000|Overall Study|Other incl. lack of efficacy|2|||
105691263|NCT00601250|364534829|FG001|Overall Study|Other incl. lack of efficacy|9|||
105691264|NCT01810016|364534830|FG000|Overall Study|Progressive disease|1|||
105691265|NCT01810016|364534831|FG001|Overall Study|Progressive disease|1|||
105691266|NCT01810016|364534832|FG002|Overall Study|Progressive disease|0|||
105691267|NCT01810016|364534830|FG000|Overall Study|Death|0|||
105691268|NCT01810016|364534831|FG001|Overall Study|Death|0|||
105691269|NCT01810016|364534832|FG002|Overall Study|Death|1|||
105691270|NCT03231943|364534833|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691271|NCT03231943|364534834|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
105691272|NCT03231943|364534835|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
105691273|NCT03231943|364534836|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691274|NCT03231943|364534837|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691275|NCT03231943|364534838|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691276|NCT03231943|364534839|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691277|NCT03231943|364534840|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691278|NCT03231943|364534841|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691279|NCT03231943|364534842|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691280|NCT03231943|364534843|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691281|NCT03231943|364534844|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691282|NCT03231943|364534845|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691283|NCT03231943|364534833|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691284|NCT03231943|364534834|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
105691285|NCT03231943|364534835|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691286|NCT03231943|364534836|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691287|NCT03231943|364534837|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691288|NCT03231943|364534838|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691289|NCT03231943|364534839|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691290|NCT03231943|364534840|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691291|NCT03231943|364534841|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691292|NCT03231943|364534842|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691293|NCT03231943|364534843|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691294|NCT03231943|364534844|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691295|NCT03231943|364534845|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691296|NCT03231943|364534833|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
105691297|NCT03231943|364534834|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691298|NCT03231943|364534835|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691299|NCT03231943|364534836|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691300|NCT03231943|364534837|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691301|NCT03231943|364534838|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691302|NCT03231943|364534839|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691303|NCT03231943|364534840|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691304|NCT03231943|364534841|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691305|NCT03231943|364534842|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691306|NCT03231943|364534843|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691307|NCT03231943|364534844|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691308|NCT03231943|364534845|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691309|NCT03231943|364534833|FG000|Part 2|Adverse Event|0|||
105691310|NCT03231943|364534834|FG001|Part 2|Adverse Event|0|||
105691311|NCT03231943|364534835|FG002|Part 2|Adverse Event|0|||
105691312|NCT03231943|364534836|FG003|Part 2|Adverse Event|0|||
105691313|NCT03231943|364534837|FG004|Part 2|Adverse Event|0|||
105691314|NCT03231943|364534838|FG005|Part 2|Adverse Event|0|||
105691315|NCT03231943|364534839|FG006|Part 2|Adverse Event|0|||
105691316|NCT03231943|364534840|FG007|Part 2|Adverse Event|0|||
105691317|NCT03231943|364534841|FG008|Part 2|Adverse Event|0|||
105691318|NCT03231943|364534842|FG009|Part 2|Adverse Event|0|||
105691319|NCT03231943|364534843|FG010|Part 2|Adverse Event|1|||
105786874|NCT05182840|364872938|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105786875|NCT05182840|364872929|FG000|Treatment Period|Reason missing|0|||
105786876|NCT05182840|364872930|FG001|Treatment Period|Reason missing|0|||
105786877|NCT05182840|364872931|FG002|Treatment Period|Reason missing|1|||
105786878|NCT05182840|364872932|FG003|Treatment Period|Reason missing|0|||
105691320|NCT03231943|364534844|FG011|Part 2|Adverse Event|0|||
105691321|NCT03231943|364534845|FG012|Part 2|Adverse Event|0|||
105691322|NCT03231943|364534833|FG000|Part 2|Withdrawal by Subject|0|||
105691323|NCT03231943|364534834|FG001|Part 2|Withdrawal by Subject|0|||
105691324|NCT03231943|364534835|FG002|Part 2|Withdrawal by Subject|0|||
105691325|NCT03231943|364534836|FG003|Part 2|Withdrawal by Subject|0|||
105691326|NCT03231943|364534837|FG004|Part 2|Withdrawal by Subject|0|||
105691327|NCT03231943|364534838|FG005|Part 2|Withdrawal by Subject|0|||
105691328|NCT03231943|364534839|FG006|Part 2|Withdrawal by Subject|0|||
105691329|NCT03231943|364534840|FG007|Part 2|Withdrawal by Subject|0|||
105691330|NCT03231943|364534841|FG008|Part 2|Withdrawal by Subject|0|||
105691331|NCT03231943|364534842|FG009|Part 2|Withdrawal by Subject|0|||
105786879|NCT05182840|364872933|FG004|Treatment Period|Reason missing|0|||
105786880|NCT05182840|364872934|FG005|Treatment Period|Reason missing|0|||
105786881|NCT05182840|364872935|FG006|Treatment Period|Reason missing|0|||
105691332|NCT03231943|364534843|FG010|Part 2|Withdrawal by Subject|0|||
105691333|NCT03231943|364534844|FG011|Part 2|Withdrawal by Subject|1|||
105691334|NCT03231943|364534845|FG012|Part 2|Withdrawal by Subject|0|||
105691335|NCT00708175|364534846|FG000|Overall Study|Adverse Event|4|||
105691336|NCT00708175|364534847|FG001|Overall Study|Adverse Event|5|||
105691337|NCT00708175|364534846|FG000|Overall Study|Protocol Violation|2|||
105691338|NCT00708175|364534847|FG001|Overall Study|Protocol Violation|3|||
105691339|NCT00708175|364534846|FG000|Overall Study|Lost to Follow-up|5|||
105691340|NCT00708175|364534847|FG001|Overall Study|Lost to Follow-up|3|||
105691341|NCT00708175|364534846|FG000|Overall Study|Withdrawal by Subject|5|||
105691342|NCT00708175|364534847|FG001|Overall Study|Withdrawal by Subject|7|||
105691343|NCT00708175|364534846|FG000|Overall Study|BMD loss >7%|2|||
105691344|NCT00708175|364534847|FG001|Overall Study|BMD loss >7%|3|||
105691345|NCT02038920|364534855|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
105691346|NCT02038920|364534856|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
105691347|NCT02038920|364534857|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
105691348|NCT02038920|364534858|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
105691349|NCT02038920|364534859|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
105691350|NCT02038920|364534860|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
105691351|NCT02038920|364534855|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
105691352|NCT02038920|364534856|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
105691353|NCT02038920|364534857|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
105691354|NCT02038920|364534858|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
105691355|NCT02038920|364534859|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
105691356|NCT02038920|364534860|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
105691357|NCT02038920|364534855|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
105691358|NCT02038920|364534856|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
105691359|NCT02038920|364534857|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
105691360|NCT02038920|364534858|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
105691361|NCT02038920|364534859|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
105786882|NCT05182840|364872936|FG007|Treatment Period|Reason missing|0|||
105786883|NCT05182840|364872937|FG008|Treatment Period|Reason missing|0|||
105471556|NCT00845897|363738241|FG002|Overall Study|Withdrawal by Subject|2|||
105471557|NCT00845897|363738239|FG000|Overall Study|Ulcer did not heal|1|||
105471558|NCT00845897|363738240|FG001|Overall Study|Ulcer did not heal|0|||
105691362|NCT02038920|364534860|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
105471559|NCT00845897|363738241|FG002|Overall Study|Ulcer did not heal|1|||
105691363|NCT02038920|364534855|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
105691364|NCT02038920|364534856|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
105786884|NCT05182840|364872938|FG009|Treatment Period|Reason missing|0|||
105786885|NCT05182840|364872929|FG000|Treatment Period|Other but not sponsor termination|0|||
105471560|NCT00845897|363738239|FG000|Overall Study|Too ill to participate|0|||
105691365|NCT02038920|364534857|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
105691366|NCT02038920|364534858|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
105691367|NCT02038920|364534859|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
105691368|NCT02038920|364534860|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
105691369|NCT02038920|364534855|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
105691370|NCT02038920|364534856|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
105691371|NCT02038920|364534857|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
105691372|NCT02038920|364534858|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
105691373|NCT02038920|364534859|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
105691374|NCT02038920|364534860|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
105691375|NCT02038920|364534855|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
105691376|NCT02038920|364534856|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
105691377|NCT02038920|364534857|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
105691378|NCT02038920|364534858|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
105691379|NCT02038920|364534859|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
105691380|NCT02038920|364534860|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
105691381|NCT02038920|364534855|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
105691382|NCT02038920|364534856|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
105691383|NCT02038920|364534857|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
105691384|NCT02038920|364534858|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
105691385|NCT02038920|364534859|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
105691386|NCT02038920|364534860|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
105691387|NCT02038920|364534855|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
105691388|NCT02038920|364534856|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
105691389|NCT02038920|364534857|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
105691390|NCT02038920|364534858|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
105691391|NCT02038920|364534859|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
105691392|NCT02038920|364534860|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
105691393|NCT02038920|364534855|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
105691394|NCT02038920|364534856|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
105691395|NCT02038920|364534857|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
105691396|NCT02038920|364534858|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
105691397|NCT02038920|364534859|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
105691398|NCT02038920|364534860|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
105691399|NCT02038920|364534855|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
105691400|NCT02038920|364534856|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
105691401|NCT02038920|364534857|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
105691402|NCT02038920|364534858|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
105691403|NCT02038920|364534859|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
105691404|NCT02038920|364534860|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
105691405|NCT02038920|364534855|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
105691406|NCT02038920|364534856|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
105691407|NCT02038920|364534857|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
105691408|NCT02038920|364534858|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
105691409|NCT02038920|364534859|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
105691410|NCT02038920|364534860|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
105691411|NCT02038920|364534855|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
105691412|NCT02038920|364534856|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
105691413|NCT02038920|364534857|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
105691414|NCT02038920|364534858|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
105691415|NCT02038920|364534859|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
105691416|NCT02038920|364534860|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
105691417|NCT00047320|364534863|FG000|Overall Study|Lack of Efficacy|8|||
105691418|NCT00047320|364534863|FG000|Overall Study|Lost to Follow-up|1|||
105691419|NCT00047320|364534863|FG000|Overall Study|Physician Decision|8|||
105691420|NCT00047320|364534863|FG000|Overall Study|Withdrawal by Subject|9|||
105691421|NCT00047320|364534863|FG000|Overall Study|Ineligible|2|||
105691422|NCT02383589|364534864|FG000|Treatment Period|Adverse Event|1|||
105691423|NCT02383589|364534865|FG001|Treatment Period|Adverse Event|3|||
105691424|NCT02383589|364534864|FG000|Treatment Period|Lost to Follow-up|0|||
105346239|NCT02720744|363269646|FG000|Overall Study|Excluded Concomitant Medication|0|||
105346240|NCT02720744|363269647|FG001|Overall Study|Excluded Concomitant Medication|1|||
105691425|NCT02383589|364534865|FG001|Treatment Period|Lost to Follow-up|1|||
105691426|NCT02383589|364534864|FG000|Treatment Period|Withdrawal by Subject|0|||
105691427|NCT02383589|364534865|FG001|Treatment Period|Withdrawal by Subject|5|||
105691428|NCT02383589|364534864|FG000|Treatment Period|Non-compliance with study drug|0|||
105691429|NCT02383589|364534865|FG001|Treatment Period|Non-compliance with study drug|1|||
105691430|NCT02383589|364534864|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
105691431|NCT02383589|364534865|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
105691432|NCT02383589|364534864|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
105691433|NCT02383589|364534865|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
105691434|NCT02383589|364534864|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
105691435|NCT02383589|364534865|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
105691436|NCT00866697|364534867|FG000|Overall Study|Study closed/terminated|156|||
105691437|NCT00866697|364534868|FG001|Overall Study|Study closed/terminated|138|||
105691438|NCT00866697|364534867|FG000|Overall Study|Lost to Follow-up|22|||
105691439|NCT00866697|364534868|FG001|Overall Study|Lost to Follow-up|28|||
105691440|NCT00866697|364534867|FG000|Overall Study|Physician Decision|3|||
105691441|NCT00866697|364534868|FG001|Overall Study|Physician Decision|5|||
105691442|NCT00866697|364534867|FG000|Overall Study|Withdrawal by Subject|33|||
105691443|NCT00866697|364534868|FG001|Overall Study|Withdrawal by Subject|57|||
105691444|NCT01572922|364534871|FG000|Overall Study|Adverse Event|1|||
105691445|NCT01572922|364534871|FG000|Overall Study|Protocol Violation|1|||
105691446|NCT01572922|364534871|FG000|Overall Study|Death|1|||
105691447|NCT03040622|364534872|FG000|Overall Study|unable to implant device|3|||
105691448|NCT02906787|364534873|FG000|Overall Study|Withdrawal by Subject|12|||
105691449|NCT02906787|364534874|FG001|Overall Study|Withdrawal by Subject|10|||
105691450|NCT02906787|364534873|FG000|Overall Study|Missed|24|||
105691451|NCT02906787|364534874|FG001|Overall Study|Missed|22|||
105691452|NCT04376060|364534875|FG000|Overall Study|Physician Decision|1|||
105691453|NCT01335009|364534876|FG000|Overall Study|Too ill to travel to study sites|1|||
105691454|NCT01335009|364534877|FG001|Overall Study|Too ill to travel to study sites|0|||
105691455|NCT01335009|364534876|FG000|Overall Study|Death|28|||
105691456|NCT01335009|364534877|FG001|Overall Study|Death|32|||
105691457|NCT01335009|364534876|FG000|Overall Study|Withdrawal by Subject|1|||
105691458|NCT01335009|364534877|FG001|Overall Study|Withdrawal by Subject|1|||
105691459|NCT01335009|364534876|FG000|Overall Study|Lost to Follow-up|1|||
105691460|NCT01335009|364534877|FG001|Overall Study|Lost to Follow-up|0|||
105691461|NCT02818920|364534878|FG000|Overall Study|Unresectable|4|||
105691462|NCT02818920|364534878|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
105691463|NCT02818920|364534878|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
105691464|NCT02818920|364534878|FG000|Overall Study|Adverse Event|3|||
105691465|NCT02818920|364534878|FG000|Overall Study|Developed Other Disease|1|||
105691466|NCT02818920|364534878|FG000|Overall Study|Refused Further Treatment|1|||
105691467|NCT00445068|364534879|FG000|Overall Study|Disease progression|26|||
105691468|NCT00445068|364534879|FG000|Overall Study|Adverse Event|5|||
105691469|NCT00445068|364534879|FG000|Overall Study|Abnormal laboratory value|2|||
105691470|NCT00445068|364534879|FG000|Overall Study|Withdrawal by Subject|2|||
105691471|NCT00445068|364534879|FG000|Overall Study|Death|1|||
105691472|NCT02462928|364536280|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
105691473|NCT02462928|364536281|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
105691474|NCT02462928|364536282|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
105691475|NCT02462928|364536280|FG000|Overall Study|Adverse Event|47|||
105691476|NCT02462928|364536281|FG001|Overall Study|Adverse Event|51|||
105691477|NCT02462928|364536282|FG002|Overall Study|Adverse Event|25|||
105691478|NCT02462928|364536280|FG000|Overall Study|Lack of Efficacy|3|||
105691479|NCT02462928|364536281|FG001|Overall Study|Lack of Efficacy|8|||
105691480|NCT02462928|364536282|FG002|Overall Study|Lack of Efficacy|3|||
105691481|NCT02462928|364536280|FG000|Overall Study|Lost to Follow-up|4|||
105691482|NCT02462928|364536281|FG001|Overall Study|Lost to Follow-up|4|||
105691483|NCT02462928|364536282|FG002|Overall Study|Lost to Follow-up|1|||
105691484|NCT02462928|364536280|FG000|Overall Study|Withdrawal by Patient|31|||
105691485|NCT02462928|364536281|FG001|Overall Study|Withdrawal by Patient|21|||
105691486|NCT02462928|364536282|FG002|Overall Study|Withdrawal by Patient|21|||
105691487|NCT02462928|364536280|FG000|Overall Study|Protocol Violation|0|||
105691488|NCT02462928|364536281|FG001|Overall Study|Protocol Violation|1|||
105691489|NCT02462928|364536282|FG002|Overall Study|Protocol Violation|0|||
105691490|NCT02462928|364536280|FG000|Overall Study|Reason not Specified|4|||
105691491|NCT02462928|364536281|FG001|Overall Study|Reason not Specified|6|||
105691492|NCT02462928|364536282|FG002|Overall Study|Reason not Specified|5|||
105691493|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
105691494|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
105691495|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
105691496|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
105691497|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
105691498|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
105691499|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
105786886|NCT05182840|364872930|FG001|Treatment Period|Other but not sponsor termination|0|||
105691500|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
105691501|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
105691502|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
105691503|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
105691504|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
105691505|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
105691506|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
105691507|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
105691508|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
105691509|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
105691510|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
105691511|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Early termination|0|||
105691512|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Early termination|0|||
105691513|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Early termination|34|||
105691514|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
105691515|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
105691516|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
105691517|NCT01493557|364536283|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
105691518|NCT01493557|364536284|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
105691519|NCT01493557|364536285|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
105691520|NCT01493557|364536283|FG000|Randomized to Management Strategies|Other adverse event|8|||
105691521|NCT01493557|364536284|FG001|Randomized to Management Strategies|Other adverse event|5|||
105691522|NCT01493557|364536285|FG002|Randomized to Management Strategies|Other adverse event|0|||
105691523|NCT01493557|364536283|FG000|Randomized to Management Strategies|Protocol Violation|3|||
105691524|NCT01493557|364536284|FG001|Randomized to Management Strategies|Protocol Violation|0|||
105691525|NCT01493557|364536285|FG002|Randomized to Management Strategies|Protocol Violation|0|||
105691526|NCT01493557|364536283|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
105691527|NCT01493557|364536284|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
105691528|NCT01493557|364536285|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
105691529|NCT01493557|364536283|FG000|Randomized to Management Strategies|Other than stated above|1|||
105691530|NCT01493557|364536284|FG001|Randomized to Management Strategies|Other than stated above|3|||
105691531|NCT01493557|364536285|FG002|Randomized to Management Strategies|Other than stated above|0|||
105691532|NCT01493557|364536283|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
105691533|NCT01493557|364536284|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
105691534|NCT01493557|364536285|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
105691535|NCT01493557|364536283|FG000|Adding the Second Strategy|Other adverse event|1|||
105691536|NCT01493557|364536284|FG001|Adding the Second Strategy|Other adverse event|2|||
105691537|NCT01493557|364536285|FG002|Adding the Second Strategy|Other adverse event|0|||
105691538|NCT01493557|364536283|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
105691539|NCT01493557|364536284|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
105691540|NCT01493557|364536285|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
105691541|NCT03338192|364536288|FG000|Year One to Year Two|High Blood Pressure|7|||
105691542|NCT03338192|364536289|FG001|Year One to Year Two|High Blood Pressure|1|||
105691543|NCT03338192|364536288|FG000|Year One to Year Two|HIV +|1|||
105691544|NCT03338192|364536289|FG001|Year One to Year Two|HIV +|0|||
105691545|NCT03338192|364536288|FG000|Year Two to Year Four|High Blood Pressure|1|||
105691546|NCT03338192|364536289|FG001|Year Two to Year Four|High Blood Pressure|0|||
105691547|NCT03338192|364536288|FG000|Year Two to Year Four|HIV +|2|||
105691548|NCT03338192|364536289|FG001|Year Two to Year Four|HIV +|0|||
105691549|NCT03338192|364536288|FG000|Year Four to Year Six|High Blood Pressure|2|||
105691550|NCT03338192|364536289|FG001|Year Four to Year Six|High Blood Pressure|1|||
105691551|NCT03808688|364536290|FG000|Overall Study|Adverse Event|13|||
105691552|NCT03808688|364536291|FG001|Overall Study|Adverse Event|17|||
105691553|NCT03808688|364536290|FG000|Overall Study|Lack of Efficacy|2|||
105691554|NCT03808688|364536291|FG001|Overall Study|Lack of Efficacy|0|||
105691555|NCT03808688|364536290|FG000|Overall Study|Lost to Follow-up|0|||
105691556|NCT03808688|364536291|FG001|Overall Study|Lost to Follow-up|2|||
105691557|NCT03808688|364536290|FG000|Overall Study|Withdrawal by Subject|1|||
105691558|NCT03808688|364536291|FG001|Overall Study|Withdrawal by Subject|0|||
105691559|NCT03808688|364536290|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
105691560|NCT03808688|364536291|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
105691561|NCT03808688|364536290|FG000|Overall Study|IOP Too High|1|||
105346241|NCT01447446|363269648|FG000|Overall Study|Death|6|||
105691562|NCT03808688|364536291|FG001|Overall Study|IOP Too High|1|||
105691563|NCT03808688|364536290|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
105691564|NCT03808688|364536291|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
105691565|NCT03808688|364536290|FG000|Overall Study|Visit Out of Window|0|||
105691566|NCT03808688|364536291|FG001|Overall Study|Visit Out of Window|1|||
105691567|NCT03808688|364536290|FG000|Overall Study|Medication Non-Compliance|0|||
105346242|NCT01447446|363269649|FG001|Overall Study|Death|3|||
105559064|NCT04794803|364044581|FG000|Overall Study|Refused to continue the treatment|1|||
105691568|NCT03808688|364536291|FG001|Overall Study|Medication Non-Compliance|1|||
105691569|NCT03329196|364536294|FG000|Overall Study|Adverse Event|10|||
105691570|NCT03329196|364536295|FG001|Overall Study|Adverse Event|5|||
105691571|NCT03329196|364536294|FG000|Overall Study|Physician Decision|2|||
105691572|NCT03329196|364536295|FG001|Overall Study|Physician Decision|2|||
105691573|NCT03329196|364536294|FG000|Overall Study|Withdrawal by Subject|11|||
105691574|NCT03329196|364536295|FG001|Overall Study|Withdrawal by Subject|3|||
105691575|NCT03329196|364536294|FG000|Overall Study|Hepatic function abnormalities|0|||
105691576|NCT03329196|364536295|FG001|Overall Study|Hepatic function abnormalities|1|||
105691577|NCT03329196|364536294|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
105786887|NCT05182840|364872931|FG002|Treatment Period|Other but not sponsor termination|8|||
105786888|NCT05182840|364872932|FG003|Treatment Period|Other but not sponsor termination|6|||
105786889|NCT05182840|364872933|FG004|Treatment Period|Other but not sponsor termination|6|||
105786890|NCT05182840|364872934|FG005|Treatment Period|Other but not sponsor termination|7|||
105786891|NCT05182840|364872935|FG006|Treatment Period|Other but not sponsor termination|5|||
105786892|NCT05182840|364872936|FG007|Treatment Period|Other but not sponsor termination|8|||
105786893|NCT05182840|364872937|FG008|Treatment Period|Other but not sponsor termination|7|||
105786894|NCT05182840|364872938|FG009|Treatment Period|Other but not sponsor termination|2|||
105786895|NCT05182840|364872929|FG000|Treatment Period|Protocol deviation|0|||
105786896|NCT05182840|364872930|FG001|Treatment Period|Protocol deviation|0|||
105691578|NCT03329196|364536295|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
105691579|NCT03329196|364536294|FG000|Overall Study|Difficult to control Hb|2|||
105691580|NCT03329196|364536295|FG001|Overall Study|Difficult to control Hb|3|||
105786897|NCT05182840|364872931|FG002|Treatment Period|Protocol deviation|0|||
105786898|NCT05182840|364872932|FG003|Treatment Period|Protocol deviation|0|||
105786899|NCT05182840|364872933|FG004|Treatment Period|Protocol deviation|0|||
105786900|NCT05182840|364872934|FG005|Treatment Period|Protocol deviation|0|||
105691581|NCT03329196|364536294|FG000|Overall Study|Dialysis or renal transplant|13|||
105691582|NCT03329196|364536295|FG001|Overall Study|Dialysis or renal transplant|15|||
105691583|NCT03511053|364536306|FG000|Overall Study|Withdrawal by Subject|1|||
105691584|NCT01128361|364536307|FG000|Overall Study|Lost to Follow-up|0|||
105691585|NCT01128361|364536308|FG001|Overall Study|Lost to Follow-up|1|||
105691586|NCT01128361|364536307|FG000|Overall Study|Withdrawal by Subject|5|||
105691587|NCT01128361|364536308|FG001|Overall Study|Withdrawal by Subject|2|||
105691588|NCT00404066|364536309|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
105691589|NCT00404066|364536309|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
105691590|NCT00059839|364536311|FG000|Overall Study|Death|1|||
105691591|NCT00059839|364536312|FG001|Overall Study|Death|1|||
105691592|NCT00059839|364536311|FG000|Overall Study|Lack of Efficacy|6|||
105691593|NCT00059839|364536312|FG001|Overall Study|Lack of Efficacy|5|||
105691594|NCT00059839|364536311|FG000|Overall Study|Lost to Follow-up|2|||
105691595|NCT00059839|364536312|FG001|Overall Study|Lost to Follow-up|0|||
105691596|NCT00059839|364536311|FG000|Overall Study|Physician Decision|1|||
105691597|NCT00059839|364536312|FG001|Overall Study|Physician Decision|2|||
105691598|NCT00059839|364536311|FG000|Overall Study|Withdrawal by Subject|1|||
105691599|NCT00059839|364536312|FG001|Overall Study|Withdrawal by Subject|6|||
105691600|NCT00059839|364536311|FG000|Overall Study|Ineligible|1|||
105691601|NCT00059839|364536312|FG001|Overall Study|Ineligible|3|||
105691602|NCT00436618|364536313|FG000|Overall Study|Withdrawal by Subject|5|||
105786901|NCT05182840|364872935|FG006|Treatment Period|Protocol deviation|0|||
105786902|NCT05182840|364872936|FG007|Treatment Period|Protocol deviation|0|||
105786903|NCT05182840|364872937|FG008|Treatment Period|Protocol deviation|1|||
105786904|NCT05182840|364872938|FG009|Treatment Period|Protocol deviation|0|||
105786905|NCT05182840|364872929|FG000|Treatment Period|No reason available|0|||
105786906|NCT05182840|364872930|FG001|Treatment Period|No reason available|0|||
105786907|NCT05182840|364872931|FG002|Treatment Period|No reason available|0|||
105786908|NCT05182840|364872932|FG003|Treatment Period|No reason available|1|||
105786909|NCT05182840|364872933|FG004|Treatment Period|No reason available|0|||
105786910|NCT05182840|364872934|FG005|Treatment Period|No reason available|2|||
105786911|NCT05182840|364872935|FG006|Treatment Period|No reason available|0|||
105786912|NCT05182840|364872936|FG007|Treatment Period|No reason available|1|||
105346243|NCT01447446|363269650|FG002|Overall Study|Death|2|||
105559065|NCT04794803|364044582|FG001|Overall Study|Refused to continue the treatment|0|||
105559066|NCT04794803|364044581|FG000|Overall Study|Patient admitted to ICU|0|||
105691603|NCT00436618|364536314|FG001|Overall Study|Withdrawal by Subject|8|||
105691604|NCT00436618|364536315|FG002|Overall Study|Withdrawal by Subject|11|||
105691605|NCT00436618|364536313|FG000|Overall Study|Adverse Event|8|||
105786913|NCT05182840|364872937|FG008|Treatment Period|No reason available|0|||
105691606|NCT00436618|364536314|FG001|Overall Study|Adverse Event|8|||
105691607|NCT00436618|364536315|FG002|Overall Study|Adverse Event|9|||
105691608|NCT00436618|364536313|FG000|Overall Study|Alternate Treatment|3|||
105691609|NCT00436618|364536314|FG001|Overall Study|Alternate Treatment|4|||
105691610|NCT00436618|364536315|FG002|Overall Study|Alternate Treatment|12|||
105691611|NCT00436618|364536313|FG000|Overall Study|Other Medical Problems|3|||
105691612|NCT00436618|364536314|FG001|Overall Study|Other Medical Problems|1|||
105691613|NCT00436618|364536315|FG002|Overall Study|Other Medical Problems|7|||
105691614|NCT00436618|364536313|FG000|Overall Study|Death|4|||
105691615|NCT00436618|364536314|FG001|Overall Study|Death|2|||
105691616|NCT00436618|364536315|FG002|Overall Study|Death|3|||
105691617|NCT00436618|364536313|FG000|Overall Study|New Primary or Other Reasons|6|||
105691618|NCT00436618|364536314|FG001|Overall Study|New Primary or Other Reasons|2|||
105691619|NCT00436618|364536315|FG002|Overall Study|New Primary or Other Reasons|12|||
105691620|NCT00436618|364536313|FG000|Overall Study|Still on treatment|1|||
105691621|NCT00436618|364536314|FG001|Overall Study|Still on treatment|2|||
105691622|NCT00436618|364536315|FG002|Overall Study|Still on treatment|7|||
105691623|NCT02596620|364536316|FG000|Overall Study|Lost to Follow-up|1|||
105691624|NCT02596620|364536317|FG001|Overall Study|Lost to Follow-up|1|||
105691625|NCT01054144|364536318|FG000|Overall Study|Death|2|||
105691626|NCT00068588|364536319|FG000|Overall Study|Adverse Event|0|||
105691627|NCT00068588|364536320|FG001|Overall Study|Adverse Event|0|||
105691628|NCT00068588|364536321|FG002|Overall Study|Adverse Event|2|||
105691629|NCT00068588|364536319|FG000|Overall Study|Withdrawal by Subject|0|||
105691630|NCT00068588|364536320|FG001|Overall Study|Withdrawal by Subject|0|||
105691631|NCT00068588|364536321|FG002|Overall Study|Withdrawal by Subject|1|||
105691632|NCT00068588|364536319|FG000|Overall Study|Poor KPS|0|||
105691633|NCT00068588|364536320|FG001|Overall Study|Poor KPS|0|||
105691634|NCT00068588|364536321|FG002|Overall Study|Poor KPS|1|||
105691635|NCT03118674|364536322|FG000|Overall Study|Lost to Follow-up|2|||
105691636|NCT03118674|364536322|FG000|Overall Study|Screen Faliure|8|||
105691637|NCT03118674|364536322|FG000|Overall Study|Withdrawal by Subject|5|||
105691638|NCT01829360|364536323|FG000|Overall Study|Protocol Violation|0|||
105691639|NCT01829360|364536324|FG001|Overall Study|Protocol Violation|0|||
105691640|NCT01829360|364536325|FG002|Overall Study|Protocol Violation|1|||
105691641|NCT01829360|364536326|FG003|Overall Study|Protocol Violation|0|||
105691642|NCT02060721|364536327|FG000|Overall Study|Lost to Follow-up|1|||
105691643|NCT02060721|364536327|FG000|Overall Study|Physician Decision|2|||
105691644|NCT02060721|364536327|FG000|Overall Study|Death|14|||
105691645|NCT02060721|364536327|FG000|Overall Study|Withdrawal by Subject|2|||
105691646|NCT02060721|364536327|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
105691647|NCT00117507|364536328|FG000|Overall Study|Adverse Event|4|||
105691648|NCT00117507|364536328|FG000|Overall Study|Abnormal laboratory values|3|||
105691649|NCT00117507|364536328|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105691650|NCT00117507|364536328|FG000|Overall Study|Patient withdrew consent|4|||
105691651|NCT00117507|364536328|FG000|Overall Study|Death|3|||
105691652|NCT05105789|364536329|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
105691653|NCT00711529|364536336|FG000|Overall Study|Protocol Violation|2|||
105691654|NCT00711529|364536337|FG001|Overall Study|Protocol Violation|0|||
105691655|NCT00711529|364536336|FG000|Overall Study|Withdrawal by Subject|2|||
105691656|NCT00711529|364536337|FG001|Overall Study|Withdrawal by Subject|6|||
105691657|NCT01271803|364536338|FG000|Overall Study|Progressive disease|0|||
105691658|NCT01271803|364536339|FG001|Overall Study|Progressive disease|0|||
105691659|NCT01271803|364536340|FG002|Overall Study|Progressive disease|2|||
105691660|NCT01271803|364536338|FG000|Overall Study|Death|53|||
105691661|NCT01271803|364536339|FG001|Overall Study|Death|34|||
105691662|NCT01271803|364536340|FG002|Overall Study|Death|0|||
105691663|NCT01271803|364536338|FG000|Overall Study|Withdrawal by Subject|1|||
105691664|NCT01271803|364536339|FG001|Overall Study|Withdrawal by Subject|5|||
105691665|NCT01271803|364536340|FG002|Overall Study|Withdrawal by Subject|0|||
105691666|NCT01271803|364536338|FG000|Overall Study|Lost to Follow-up|1|||
105691667|NCT01271803|364536339|FG001|Overall Study|Lost to Follow-up|0|||
105691668|NCT01271803|364536340|FG002|Overall Study|Lost to Follow-up|0|||
105691669|NCT00634010|364536342|FG000|Overall Study|Adverse Event|2|||
105346244|NCT01447446|363269651|FG003|Overall Study|Death|1|||
105691670|NCT00634010|364536343|FG001|Overall Study|Adverse Event|5|||
105691671|NCT00634010|364536342|FG000|Overall Study|Withdrawal by Subject|5|||
105691672|NCT00634010|364536343|FG001|Overall Study|Withdrawal by Subject|6|||
105691673|NCT00634010|364536342|FG000|Overall Study|Physician Decision|1|||
105691674|NCT00634010|364536343|FG001|Overall Study|Physician Decision|1|||
105691675|NCT00634010|364536342|FG000|Overall Study|Disease Progression|1|||
105691676|NCT00634010|364536343|FG001|Overall Study|Disease Progression|1|||
105691677|NCT00634010|364536342|FG000|Overall Study|Non-Compliant|1|||
105691678|NCT00634010|364536343|FG001|Overall Study|Non-Compliant|1|||
105691679|NCT05211739|364536344|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
105691680|NCT05211739|364536345|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
105691681|NCT05211739|364536344|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
105691682|NCT05211739|364536345|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
105691683|NCT05211739|364536344|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
105691684|NCT05211739|364536345|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
105691685|NCT05211739|364536344|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
105691686|NCT05211739|364536345|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
105691687|NCT01975428|364536346|FG000|Overall Study|Lost to Follow-up|17|||
105691688|NCT01975428|364536347|FG001|Overall Study|Lost to Follow-up|4|||
105691689|NCT01975428|364536346|FG000|Overall Study|Withdrawal by Subject|3|||
105691690|NCT01975428|364536347|FG001|Overall Study|Withdrawal by Subject|10|||
105691691|NCT05085665|364536348|FG000|Overall Study|Physician Decision|2|||
105691692|NCT00778622|364536351|FG000|Overall Study|Adverse Event|5|||
105691693|NCT00778622|364536352|FG001|Overall Study|Adverse Event|4|||
105691694|NCT00778622|364536353|FG002|Overall Study|Adverse Event|7|||
105691695|NCT00778622|364536351|FG000|Overall Study|Withdrawal by Subject|4|||
105691696|NCT00778622|364536352|FG001|Overall Study|Withdrawal by Subject|5|||
105691697|NCT00778622|364536353|FG002|Overall Study|Withdrawal by Subject|5|||
105691698|NCT00778622|364536351|FG000|Overall Study|Lost to Follow-up|3|||
105691699|NCT00778622|364536352|FG001|Overall Study|Lost to Follow-up|3|||
105691700|NCT00778622|364536353|FG002|Overall Study|Lost to Follow-up|2|||
105691701|NCT00778622|364536351|FG000|Overall Study|Protocol Violation|0|||
105691702|NCT00778622|364536352|FG001|Overall Study|Protocol Violation|3|||
105691703|NCT00778622|364536353|FG002|Overall Study|Protocol Violation|0|||
105691704|NCT00778622|364536351|FG000|Overall Study|Lack of Efficacy|2|||
105691705|NCT00778622|364536352|FG001|Overall Study|Lack of Efficacy|0|||
105691706|NCT00778622|364536353|FG002|Overall Study|Lack of Efficacy|0|||
105691707|NCT00778622|364536351|FG000|Overall Study|immigration|1|||
105691708|NCT00778622|364536352|FG001|Overall Study|immigration|0|||
105691709|NCT00778622|364536353|FG002|Overall Study|immigration|0|||
105691710|NCT00778622|364536351|FG000|Overall Study|Other|1|||
105691711|NCT00778622|364536352|FG001|Overall Study|Other|0|||
105691712|NCT00778622|364536353|FG002|Overall Study|Other|1|||
105691713|NCT01251120|364536357|FG000|Overall Study|Lack of Efficacy|0|||
105691714|NCT01251120|364536358|FG001|Overall Study|Lack of Efficacy|1|||
105691715|NCT01968070|364536361|FG000|Period 1|Withdrawal by Subject|0|||
105691716|NCT01968070|364536362|FG001|Period 1|Withdrawal by Subject|1|||
105691717|NCT01968070|364536363|FG002|Period 1|Withdrawal by Subject|0|||
105691718|NCT01968070|364536364|FG003|Period 1|Withdrawal by Subject|0|||
105691719|NCT01968070|364536365|FG004|Period 1|Withdrawal by Subject|0|||
105691720|NCT01968070|364536366|FG005|Period 1|Withdrawal by Subject|0|||
105691721|NCT01968070|364536367|FG006|Period 1|Withdrawal by Subject|1|||
105691722|NCT01968070|364536368|FG007|Period 1|Withdrawal by Subject|0|||
105691723|NCT01968070|364536369|FG008|Period 1|Withdrawal by Subject|0|||
105691724|NCT01968070|364536370|FG009|Period 1|Withdrawal by Subject|0|||
105691725|NCT01968070|364536371|FG010|Period 1|Withdrawal by Subject|0|||
105471561|NCT00845897|363738240|FG001|Overall Study|Too ill to participate|1|||
105691726|NCT01968070|364536372|FG011|Period 1|Withdrawal by Subject|0|||
105346245|NCT01447446|363269652|FG004|Overall Study|Death|7|||
105471562|NCT00845897|363738241|FG002|Overall Study|Too ill to participate|0|||
105691727|NCT01968070|364536373|FG012|Period 1|Withdrawal by Subject|0|||
105691728|NCT01968070|364536374|FG013|Period 1|Withdrawal by Subject|0|||
105691729|NCT01968070|364536375|FG014|Period 1|Withdrawal by Subject|0|||
105691730|NCT01968070|364536376|FG015|Period 1|Withdrawal by Subject|1|||
105691731|NCT01968070|364536377|FG016|Period 1|Withdrawal by Subject|0|||
105691732|NCT01968070|364536378|FG017|Period 1|Withdrawal by Subject|0|||
105691733|NCT01968070|364536361|FG000|Period 1|Protocol Violation|0|||
105691734|NCT01968070|364536362|FG001|Period 1|Protocol Violation|0|||
105691735|NCT01968070|364536363|FG002|Period 1|Protocol Violation|0|||
105691736|NCT01968070|364536364|FG003|Period 1|Protocol Violation|1|||
105691737|NCT01968070|364536365|FG004|Period 1|Protocol Violation|1|||
105691738|NCT01968070|364536366|FG005|Period 1|Protocol Violation|0|||
105691739|NCT01968070|364536367|FG006|Period 1|Protocol Violation|0|||
105691740|NCT01968070|364536368|FG007|Period 1|Protocol Violation|0|||
105691741|NCT01968070|364536369|FG008|Period 1|Protocol Violation|0|||
105691742|NCT01968070|364536370|FG009|Period 1|Protocol Violation|0|||
105691743|NCT01968070|364536371|FG010|Period 1|Protocol Violation|0|||
105691744|NCT01968070|364536372|FG011|Period 1|Protocol Violation|0|||
105786914|NCT05182840|364872938|FG009|Treatment Period|No reason available|0|||
105786915|NCT05182840|364872929|FG000|Treatment Period|Burden of study procedures|0|||
105786916|NCT05182840|364872930|FG001|Treatment Period|Burden of study procedures|0|||
105786917|NCT05182840|364872931|FG002|Treatment Period|Burden of study procedures|0|||
105691745|NCT01968070|364536373|FG012|Period 1|Protocol Violation|0|||
105691746|NCT01968070|364536374|FG013|Period 1|Protocol Violation|0|||
105786918|NCT05182840|364872932|FG003|Treatment Period|Burden of study procedures|0|||
105786919|NCT05182840|364872933|FG004|Treatment Period|Burden of study procedures|1|||
105786920|NCT05182840|364872934|FG005|Treatment Period|Burden of study procedures|0|||
105786921|NCT05182840|364872935|FG006|Treatment Period|Burden of study procedures|0|||
105786922|NCT05182840|364872936|FG007|Treatment Period|Burden of study procedures|0|||
105786923|NCT05182840|364872937|FG008|Treatment Period|Burden of study procedures|0|||
105786924|NCT05182840|364872938|FG009|Treatment Period|Burden of study procedures|0|||
105786925|NCT05182840|364872929|FG000|Treatment Period|Change of residence|0|||
105786926|NCT05182840|364872930|FG001|Treatment Period|Change of residence|0|||
105786927|NCT05182840|364872931|FG002|Treatment Period|Change of residence|0|||
105786928|NCT05182840|364872932|FG003|Treatment Period|Change of residence|0|||
105786929|NCT05182840|364872933|FG004|Treatment Period|Change of residence|0|||
105786930|NCT05182840|364872934|FG005|Treatment Period|Change of residence|1|||
105786931|NCT05182840|364872935|FG006|Treatment Period|Change of residence|0|||
105786932|NCT05182840|364872936|FG007|Treatment Period|Change of residence|0|||
105786933|NCT05182840|364872937|FG008|Treatment Period|Change of residence|0|||
105786934|NCT05182840|364872938|FG009|Treatment Period|Change of residence|0|||
105786935|NCT05182840|364872929|FG000|Treatment Period|Adverse Event|0|||
105786936|NCT05182840|364872930|FG001|Treatment Period|Adverse Event|0|||
105786937|NCT05182840|364872931|FG002|Treatment Period|Adverse Event|4|||
105786938|NCT05182840|364872932|FG003|Treatment Period|Adverse Event|16|||
105786939|NCT05182840|364872933|FG004|Treatment Period|Adverse Event|12|||
105786940|NCT05182840|364872934|FG005|Treatment Period|Adverse Event|6|||
105786941|NCT05182840|364872935|FG006|Treatment Period|Adverse Event|4|||
105786942|NCT05182840|364872936|FG007|Treatment Period|Adverse Event|8|||
105786943|NCT05182840|364872937|FG008|Treatment Period|Adverse Event|16|||
105786944|NCT05182840|364872938|FG009|Treatment Period|Adverse Event|5|||
105786945|NCT05182840|364872929|FG000|Treatment Period|Not treated with study drug|0|||
105786946|NCT05182840|364872930|FG001|Treatment Period|Not treated with study drug|0|||
105786947|NCT05182840|364872931|FG002|Treatment Period|Not treated with study drug|0|||
105786948|NCT05182840|364872932|FG003|Treatment Period|Not treated with study drug|1|||
105786949|NCT05182840|364872933|FG004|Treatment Period|Not treated with study drug|0|||
105786950|NCT05182840|364872934|FG005|Treatment Period|Not treated with study drug|0|||
105786951|NCT05182840|364872935|FG006|Treatment Period|Not treated with study drug|1|||
105786952|NCT05182840|364872936|FG007|Treatment Period|Not treated with study drug|1|||
105786953|NCT05182840|364872937|FG008|Treatment Period|Not treated with study drug|0|||
105786954|NCT05182840|364872938|FG009|Treatment Period|Not treated with study drug|0|||
105786955|NCT04342390|364872941|FG000|Overall Study|Lost to Follow-up|3|||
105786956|NCT04342390|364872942|FG001|Overall Study|Lost to Follow-up|0|||
105786957|NCT04768881|364872943|FG000|Overall Study|Completed Study Follow-up|0|||
105691747|NCT01968070|364536375|FG014|Period 1|Protocol Violation|0|||
105786958|NCT04768881|364872944|FG001|Overall Study|Completed Study Follow-up|2|||
105786959|NCT04768881|364872943|FG000|Overall Study|Death|3|||
105786960|NCT04768881|364872944|FG001|Overall Study|Death|2|||
105786961|NCT04768881|364872943|FG000|Overall Study|Study Terminated by Sponsor|2|||
105786962|NCT04768881|364872944|FG001|Overall Study|Study Terminated by Sponsor|2|||
105691748|NCT01968070|364536376|FG015|Period 1|Protocol Violation|0|||
105691749|NCT01968070|364536377|FG016|Period 1|Protocol Violation|0|||
105346246|NCT01447446|363269653|FG005|Overall Study|Death|0|||
105346247|NCT01447446|363269648|FG000|Overall Study|Adverse Event|3|||
105346248|NCT01447446|363269649|FG001|Overall Study|Adverse Event|0|||
105346249|NCT01447446|363269650|FG002|Overall Study|Adverse Event|1|||
105346250|NCT01447446|363269651|FG003|Overall Study|Adverse Event|0|||
105346251|NCT01447446|363269652|FG004|Overall Study|Adverse Event|2|||
105559067|NCT04794803|364044582|FG001|Overall Study|Patient admitted to ICU|1|||
105559068|NCT04124926|364044583|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
105559069|NCT04124926|364044584|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
105559070|NCT04124926|364044585|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
105691750|NCT01968070|364536378|FG017|Period 1|Protocol Violation|0|||
105691751|NCT01968070|364536361|FG000|Period 1|Lost to Follow-up|0|||
105691752|NCT01968070|364536362|FG001|Period 1|Lost to Follow-up|0|||
105691753|NCT01968070|364536363|FG002|Period 1|Lost to Follow-up|0|||
105691754|NCT01968070|364536364|FG003|Period 1|Lost to Follow-up|1|||
105691755|NCT01968070|364536365|FG004|Period 1|Lost to Follow-up|0|||
105691756|NCT01968070|364536366|FG005|Period 1|Lost to Follow-up|0|||
105691757|NCT01968070|364536367|FG006|Period 1|Lost to Follow-up|0|||
105691758|NCT01968070|364536368|FG007|Period 1|Lost to Follow-up|0|||
105691759|NCT01968070|364536369|FG008|Period 1|Lost to Follow-up|0|||
105691760|NCT01968070|364536370|FG009|Period 1|Lost to Follow-up|0|||
105691761|NCT01968070|364536371|FG010|Period 1|Lost to Follow-up|0|||
105691762|NCT01968070|364536372|FG011|Period 1|Lost to Follow-up|0|||
105691763|NCT01968070|364536373|FG012|Period 1|Lost to Follow-up|0|||
105691764|NCT01968070|364536374|FG013|Period 1|Lost to Follow-up|0|||
105691765|NCT01968070|364536375|FG014|Period 1|Lost to Follow-up|0|||
105691766|NCT01968070|364536376|FG015|Period 1|Lost to Follow-up|0|||
105691767|NCT01968070|364536377|FG016|Period 1|Lost to Follow-up|0|||
105691768|NCT01968070|364536378|FG017|Period 1|Lost to Follow-up|0|||
105691769|NCT01968070|364536361|FG000|Period 1|Adverse Event|0|||
105691770|NCT01968070|364536362|FG001|Period 1|Adverse Event|0|||
105691771|NCT01968070|364536363|FG002|Period 1|Adverse Event|0|||
105691772|NCT01968070|364536364|FG003|Period 1|Adverse Event|0|||
105691773|NCT01968070|364536365|FG004|Period 1|Adverse Event|0|||
105691774|NCT01968070|364536366|FG005|Period 1|Adverse Event|0|||
105691775|NCT01968070|364536367|FG006|Period 1|Adverse Event|1|||
105691776|NCT01968070|364536368|FG007|Period 1|Adverse Event|0|||
105691777|NCT01968070|364536369|FG008|Period 1|Adverse Event|0|||
105691778|NCT01968070|364536370|FG009|Period 1|Adverse Event|0|||
105691779|NCT01968070|364536371|FG010|Period 1|Adverse Event|0|||
105691780|NCT01968070|364536372|FG011|Period 1|Adverse Event|0|||
105691781|NCT01968070|364536373|FG012|Period 1|Adverse Event|0|||
105691782|NCT01968070|364536374|FG013|Period 1|Adverse Event|0|||
105691783|NCT01968070|364536375|FG014|Period 1|Adverse Event|0|||
105691784|NCT01968070|364536376|FG015|Period 1|Adverse Event|0|||
105691785|NCT01968070|364536377|FG016|Period 1|Adverse Event|0|||
105691786|NCT01968070|364536378|FG017|Period 1|Adverse Event|0|||
105691787|NCT01968070|364536361|FG000|Period 1|Physician Decision|0|||
105691788|NCT01968070|364536362|FG001|Period 1|Physician Decision|0|||
105691789|NCT01968070|364536363|FG002|Period 1|Physician Decision|0|||
105691790|NCT01968070|364536364|FG003|Period 1|Physician Decision|0|||
105691791|NCT01968070|364536365|FG004|Period 1|Physician Decision|0|||
105691792|NCT01968070|364536366|FG005|Period 1|Physician Decision|0|||
105691793|NCT01968070|364536367|FG006|Period 1|Physician Decision|0|||
105691794|NCT01968070|364536368|FG007|Period 1|Physician Decision|0|||
105691795|NCT01968070|364536369|FG008|Period 1|Physician Decision|0|||
105691796|NCT01968070|364536370|FG009|Period 1|Physician Decision|0|||
105691797|NCT01968070|364536371|FG010|Period 1|Physician Decision|0|||
105691798|NCT01968070|364536372|FG011|Period 1|Physician Decision|1|||
105691799|NCT01968070|364536373|FG012|Period 1|Physician Decision|0|||
105691800|NCT01968070|364536374|FG013|Period 1|Physician Decision|0|||
105691801|NCT01968070|364536375|FG014|Period 1|Physician Decision|0|||
105691802|NCT01968070|364536376|FG015|Period 1|Physician Decision|0|||
105691803|NCT01968070|364536377|FG016|Period 1|Physician Decision|0|||
105691804|NCT01968070|364536378|FG017|Period 1|Physician Decision|0|||
105691805|NCT01968070|364536361|FG000|Period 2|Withdrawal by Subject|0|||
105691806|NCT01968070|364536362|FG001|Period 2|Withdrawal by Subject|0|||
105691807|NCT01968070|364536363|FG002|Period 2|Withdrawal by Subject|0|||
105691808|NCT01968070|364536364|FG003|Period 2|Withdrawal by Subject|0|||
105691809|NCT01968070|364536365|FG004|Period 2|Withdrawal by Subject|1|||
105691810|NCT01968070|364536366|FG005|Period 2|Withdrawal by Subject|0|||
105691811|NCT01968070|364536367|FG006|Period 2|Withdrawal by Subject|0|||
105691812|NCT01968070|364536368|FG007|Period 2|Withdrawal by Subject|0|||
105346252|NCT01447446|363269653|FG005|Overall Study|Adverse Event|0|||
105346253|NCT01447446|363269648|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
105691813|NCT01968070|364536369|FG008|Period 2|Withdrawal by Subject|0|||
105346254|NCT01447446|363269649|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
105691814|NCT01968070|364536370|FG009|Period 2|Withdrawal by Subject|0|||
105691815|NCT01968070|364536371|FG010|Period 2|Withdrawal by Subject|0|||
105691816|NCT01968070|364536372|FG011|Period 2|Withdrawal by Subject|0|||
105691817|NCT01968070|364536373|FG012|Period 2|Withdrawal by Subject|0|||
105691818|NCT01968070|364536374|FG013|Period 2|Withdrawal by Subject|0|||
105691819|NCT01968070|364536375|FG014|Period 2|Withdrawal by Subject|0|||
105691820|NCT01968070|364536376|FG015|Period 2|Withdrawal by Subject|0|||
105691821|NCT01968070|364536377|FG016|Period 2|Withdrawal by Subject|0|||
105691822|NCT01968070|364536378|FG017|Period 2|Withdrawal by Subject|0|||
105691823|NCT00821431|364536383|FG000|Overall Study|Adverse Event|6|||
105691824|NCT00821431|364536384|FG001|Overall Study|Adverse Event|3|||
105691825|NCT00821431|364536383|FG000|Overall Study|Withdrawal by Subject|5|||
105691826|NCT00821431|364536384|FG001|Overall Study|Withdrawal by Subject|0|||
105691827|NCT00821431|364536383|FG000|Overall Study|Lost to Follow-up|1|||
105691828|NCT00821431|364536384|FG001|Overall Study|Lost to Follow-up|0|||
105691829|NCT00821431|364536383|FG000|Overall Study|Protocol Violation|3|||
105691830|NCT00821431|364536384|FG001|Overall Study|Protocol Violation|1|||
105691831|NCT00821431|364536383|FG000|Overall Study|Physician Decision|0|||
105691832|NCT00821431|364536384|FG001|Overall Study|Physician Decision|1|||
105691833|NCT01822522|364536385|FG000|Overall Study|Adverse Event|1|||
105691834|NCT01822522|364536386|FG001|Overall Study|Adverse Event|1|||
105691835|NCT01822522|364536387|FG002|Overall Study|Adverse Event|1|||
105691836|NCT01822522|364536388|FG003|Overall Study|Adverse Event|0|||
105691837|NCT01822522|364536389|FG004|Overall Study|Adverse Event|0|||
105691838|NCT01822522|364536390|FG005|Overall Study|Adverse Event|1|||
105691839|NCT01822522|364536385|FG000|Overall Study|Death|3|||
105691840|NCT01822522|364536386|FG001|Overall Study|Death|0|||
105691841|NCT01822522|364536387|FG002|Overall Study|Death|2|||
105691842|NCT01822522|364536388|FG003|Overall Study|Death|0|||
105691843|NCT01822522|364536389|FG004|Overall Study|Death|0|||
105346255|NCT01447446|363269650|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
105346256|NCT01447446|363269651|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
105346257|NCT01447446|363269652|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
105346258|NCT01447446|363269653|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
105346259|NCT01447446|363269648|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
105346260|NCT01447446|363269649|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
105346261|NCT01447446|363269650|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
105346262|NCT01447446|363269651|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
105346263|NCT01447446|363269652|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
105346264|NCT01447446|363269653|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
105346265|NCT01447446|363269648|FG000|Overall Study|Administrative/Other|34|||
105346266|NCT01447446|363269649|FG001|Overall Study|Administrative/Other|9|||
105346267|NCT01447446|363269650|FG002|Overall Study|Administrative/Other|10|||
105346268|NCT01447446|363269651|FG003|Overall Study|Administrative/Other|2|||
105346269|NCT01447446|363269652|FG004|Overall Study|Administrative/Other|33|||
105346270|NCT01447446|363269653|FG005|Overall Study|Administrative/Other|4|||
105346271|NCT01447446|363269648|FG000|Overall Study|SVR12 Assessment|13|||
105346272|NCT01447446|363269649|FG001|Overall Study|SVR12 Assessment|1|||
105346273|NCT01447446|363269650|FG002|Overall Study|SVR12 Assessment|2|||
105346274|NCT01447446|363269651|FG003|Overall Study|SVR12 Assessment|1|||
105346275|NCT01447446|363269652|FG004|Overall Study|SVR12 Assessment|5|||
105346276|NCT01447446|363269653|FG005|Overall Study|SVR12 Assessment|5|||
105346277|NCT01447446|363269648|FG000|Overall Study|New Treatment Started|8|||
105346278|NCT01447446|363269649|FG001|Overall Study|New Treatment Started|2|||
105346279|NCT01447446|363269650|FG002|Overall Study|New Treatment Started|1|||
105346280|NCT01447446|363269651|FG003|Overall Study|New Treatment Started|0|||
105346281|NCT01447446|363269652|FG004|Overall Study|New Treatment Started|2|||
105346282|NCT01447446|363269653|FG005|Overall Study|New Treatment Started|0|||
105346283|NCT01447446|363269648|FG000|Overall Study|Reason not Specified|1|||
105346284|NCT01447446|363269649|FG001|Overall Study|Reason not Specified|1|||
105346285|NCT01447446|363269650|FG002|Overall Study|Reason not Specified|1|||
105346286|NCT01447446|363269651|FG003|Overall Study|Reason not Specified|1|||
105346287|NCT01447446|363269652|FG004|Overall Study|Reason not Specified|1|||
105346288|NCT01447446|363269653|FG005|Overall Study|Reason not Specified|0|||
105346289|NCT03570554|363269659|FG000|Overall Study|Non-compliance with study drug|0|||
105691844|NCT01822522|364536390|FG005|Overall Study|Death|0|||
105691845|NCT01822522|364536385|FG000|Overall Study|Lost to Follow-up|0|||
105346290|NCT03570554|363269660|FG001|Overall Study|Non-compliance with study drug|0|||
105346291|NCT03570554|363269661|FG002|Overall Study|Non-compliance with study drug|1|||
105346292|NCT03570554|363269662|FG003|Overall Study|Non-compliance with study drug|0|||
105346293|NCT03570554|363269659|FG000|Overall Study|Adverse Event|0|||
105346294|NCT03570554|363269660|FG001|Overall Study|Adverse Event|0|||
105346295|NCT03570554|363269661|FG002|Overall Study|Adverse Event|0|||
105346296|NCT03570554|363269662|FG003|Overall Study|Adverse Event|1|||
105346297|NCT02719353|363269668|FG000|First Intervention|Physician Decision|0|||
105691846|NCT01822522|364536386|FG001|Overall Study|Lost to Follow-up|0|||
105691847|NCT01822522|364536387|FG002|Overall Study|Lost to Follow-up|1|||
105691848|NCT01822522|364536388|FG003|Overall Study|Lost to Follow-up|1|||
105346298|NCT02719353|363269669|FG001|First Intervention|Physician Decision|1|||
105691849|NCT01822522|364536389|FG004|Overall Study|Lost to Follow-up|0|||
105691850|NCT01822522|364536390|FG005|Overall Study|Lost to Follow-up|1|||
105471563|NCT00476229|363738242|FG000|Overall Study|Progressive shortness of breath|1|||
105471564|NCT02164461|363738243|FG000|Overall Study|Adverse Event|0|||
105471565|NCT02164461|363738244|FG001|Overall Study|Adverse Event|0|||
105471566|NCT02164461|363738245|FG002|Overall Study|Adverse Event|1|||
105471567|NCT02164461|363738243|FG000|Overall Study|Disease Progression|1|||
105471568|NCT02164461|363738244|FG001|Overall Study|Disease Progression|3|||
105471569|NCT02164461|363738245|FG002|Overall Study|Disease Progression|4|||
105471570|NCT02164461|363738243|FG000|Overall Study|Withdrawal by Subject|0|||
105471571|NCT02164461|363738244|FG001|Overall Study|Withdrawal by Subject|3|||
105471572|NCT02164461|363738245|FG002|Overall Study|Withdrawal by Subject|0|||
105471573|NCT01932437|363738246|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
105471574|NCT01932437|363738247|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
105471575|NCT01932437|363738248|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
105471576|NCT01932437|363738249|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
105471577|NCT01932437|363738250|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
105471578|NCT01932437|363738251|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
105471579|NCT03904693|363738252|FG000|Overall Study|Death|0|||
105471580|NCT03904693|363738253|FG001|Overall Study|Death|0|||
105471581|NCT03904693|363738254|FG002|Overall Study|Death|3|||
105471582|NCT03904693|363738252|FG000|Overall Study|Physician Decision|0|||
105471583|NCT03904693|363738253|FG001|Overall Study|Physician Decision|0|||
105471584|NCT03904693|363738254|FG002|Overall Study|Physician Decision|2|||
105471585|NCT03904693|363738252|FG000|Overall Study|Withdrawal by Subject|0|||
105471586|NCT03904693|363738253|FG001|Overall Study|Withdrawal by Subject|1|||
105471587|NCT03904693|363738254|FG002|Overall Study|Withdrawal by Subject|4|||
105471588|NCT02100696|363738255|FG000|Induction Phase|Adverse Event|0|||
105471589|NCT02100696|363738256|FG001|Induction Phase|Adverse Event|0|||
105471590|NCT02100696|363738257|FG002|Induction Phase|Adverse Event|1|||
105471591|NCT02100696|363738258|FG003|Induction Phase|Adverse Event|0|||
105471592|NCT02100696|363738259|FG004|Induction Phase|Adverse Event|0|||
105471593|NCT02100696|363738260|FG005|Induction Phase|Adverse Event|0|||
105471594|NCT02100696|363738255|FG000|Induction Phase|Lost to Follow-up|1|||
105471595|NCT02100696|363738256|FG001|Induction Phase|Lost to Follow-up|0|||
105471596|NCT02100696|363738257|FG002|Induction Phase|Lost to Follow-up|1|||
105471597|NCT02100696|363738258|FG003|Induction Phase|Lost to Follow-up|0|||
105471598|NCT02100696|363738259|FG004|Induction Phase|Lost to Follow-up|0|||
105471599|NCT02100696|363738260|FG005|Induction Phase|Lost to Follow-up|0|||
105471600|NCT02100696|363738255|FG000|Induction Phase|Protocol Violation|0|||
105471601|NCT02100696|363738256|FG001|Induction Phase|Protocol Violation|1|||
105471602|NCT02100696|363738257|FG002|Induction Phase|Protocol Violation|1|||
105471603|NCT02100696|363738258|FG003|Induction Phase|Protocol Violation|0|||
105471604|NCT02100696|363738259|FG004|Induction Phase|Protocol Violation|0|||
105471605|NCT02100696|363738260|FG005|Induction Phase|Protocol Violation|0|||
105471606|NCT02100696|363738255|FG000|Induction Phase|Withdrawal by Subject|8|||
105471607|NCT02100696|363738256|FG001|Induction Phase|Withdrawal by Subject|2|||
105471608|NCT02100696|363738257|FG002|Induction Phase|Withdrawal by Subject|13|||
105471609|NCT02100696|363738258|FG003|Induction Phase|Withdrawal by Subject|0|||
105471610|NCT02100696|363738259|FG004|Induction Phase|Withdrawal by Subject|0|||
105471611|NCT02100696|363738260|FG005|Induction Phase|Withdrawal by Subject|0|||
105471612|NCT02100696|363738255|FG000|Induction Phase|Physician Decision|1|||
105471613|NCT02100696|363738256|FG001|Induction Phase|Physician Decision|0|||
105471614|NCT02100696|363738257|FG002|Induction Phase|Physician Decision|2|||
105471615|NCT02100696|363738258|FG003|Induction Phase|Physician Decision|0|||
105559071|NCT04124926|364044586|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
105559072|NCT04124926|364044587|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
105559073|NCT04124926|364044583|FG000|Healing Phase|Protocol Violation|0|||
105559074|NCT04124926|364044584|FG001|Healing Phase|Protocol Violation|1|||
105559075|NCT04124926|364044585|FG002|Healing Phase|Protocol Violation|0|||
105559076|NCT04124926|364044586|FG003|Healing Phase|Protocol Violation|0|||
105559077|NCT04124926|364044587|FG004|Healing Phase|Protocol Violation|0|||
105559078|NCT04124926|364044583|FG000|Healing Phase|Lost to Follow-up|5|||
105559079|NCT04124926|364044584|FG001|Healing Phase|Lost to Follow-up|4|||
105559080|NCT04124926|364044585|FG002|Healing Phase|Lost to Follow-up|0|||
105471616|NCT02100696|363738259|FG004|Induction Phase|Physician Decision|0|||
105471617|NCT02100696|363738260|FG005|Induction Phase|Physician Decision|0|||
105471618|NCT02100696|363738255|FG000|Induction Phase|Multiple Reasons|5|||
105471619|NCT02100696|363738256|FG001|Induction Phase|Multiple Reasons|2|||
105471620|NCT02100696|363738257|FG002|Induction Phase|Multiple Reasons|8|||
105691851|NCT01822522|364536385|FG000|Overall Study|Withdrawal by Subject|0|||
105691852|NCT01822522|364536386|FG001|Overall Study|Withdrawal by Subject|0|||
105471621|NCT02100696|363738258|FG003|Induction Phase|Multiple Reasons|0|||
105471622|NCT02100696|363738259|FG004|Induction Phase|Multiple Reasons|0|||
105559081|NCT04124926|364044586|FG003|Healing Phase|Lost to Follow-up|0|||
105471623|NCT02100696|363738260|FG005|Induction Phase|Multiple Reasons|0|||
105471624|NCT02100696|363738255|FG000|Maintenance Phase|Adverse Event|0|||
105471625|NCT02100696|363738256|FG001|Maintenance Phase|Adverse Event|0|||
105559082|NCT04124926|364044587|FG004|Healing Phase|Lost to Follow-up|0|||
105559083|NCT04124926|364044583|FG000|Healing Phase|Voluntary Withdrawal|10|||
105559084|NCT04124926|364044584|FG001|Healing Phase|Voluntary Withdrawal|7|||
105559085|NCT04124926|364044585|FG002|Healing Phase|Voluntary Withdrawal|0|||
105559086|NCT04124926|364044586|FG003|Healing Phase|Voluntary Withdrawal|0|||
105559087|NCT04124926|364044587|FG004|Healing Phase|Voluntary Withdrawal|0|||
105559088|NCT04124926|364044583|FG000|Healing Phase|Withdrawal of Consent|5|||
105346299|NCT02956057|363269673|FG000|Overall Study|Discontinued intervention|14|||
105346300|NCT02956057|363269674|FG001|Overall Study|Discontinued intervention|10|||
105346301|NCT02956057|363269675|FG002|Overall Study|Discontinued intervention|7|||
105346302|NCT02956057|363269676|FG003|Overall Study|Discontinued intervention|14|||
105346303|NCT02956057|363269677|FG004|Overall Study|Discontinued intervention|4|||
105346304|NCT02956057|363269678|FG005|Overall Study|Discontinued intervention|17|||
105346305|NCT02956057|363269673|FG000|Overall Study|Lost to Follow-up|0|||
105346306|NCT02956057|363269674|FG001|Overall Study|Lost to Follow-up|2|||
105346307|NCT02956057|363269675|FG002|Overall Study|Lost to Follow-up|1|||
105346308|NCT02956057|363269676|FG003|Overall Study|Lost to Follow-up|1|||
105346309|NCT02956057|363269677|FG004|Overall Study|Lost to Follow-up|1|||
105346310|NCT02956057|363269678|FG005|Overall Study|Lost to Follow-up|0|||
105346311|NCT00597506|363269679|FG000|Overall Study|Subject is being followed for survival|1|||
105346312|NCT03077659|363269680|FG000|Overall Study|Withdrawal by Subject|0|||
105346313|NCT03077659|363269681|FG001|Overall Study|Withdrawal by Subject|0|||
105346314|NCT03077659|363269682|FG002|Overall Study|Withdrawal by Subject|1|||
105346315|NCT00480493|363269683|FG000|Overall Study|moved|2|||
105346316|NCT00480493|363269684|FG001|Overall Study|moved|7|||
105346317|NCT01032070|363269687|FG000|Overall Study|Disease progression|13|||
105346318|NCT01032070|363269688|FG001|Overall Study|Disease progression|8|||
105346319|NCT01032070|363269687|FG000|Overall Study|Medical or ethical reasons|0|||
105346320|NCT01032070|363269688|FG001|Overall Study|Medical or ethical reasons|2|||
105346321|NCT01032070|363269687|FG000|Overall Study|Withdrawal by Subject|0|||
105346322|NCT01032070|363269688|FG001|Overall Study|Withdrawal by Subject|2|||
105346323|NCT03769675|363269689|FG000|Overall Study|Lost to Follow-up|1|||
105346324|NCT00426660|363269695|FG000|Overall Study|Death|14|||
105346325|NCT00426660|363269695|FG000|Overall Study|Adverse Event|23|||
105346326|NCT00426660|363269695|FG000|Overall Study|Insufficient Clinical Response|22|||
105346327|NCT00426660|363269695|FG000|Overall Study|Lost to Follow-up|15|||
105346328|NCT00426660|363269695|FG000|Overall Study|Other|23|||
105346329|NCT00426660|363269695|FG000|Overall Study|Withdrawal by Subject|18|||
105346330|NCT00426660|363269695|FG000|Overall Study|Protocol Violation|1|||
105346331|NCT00426660|363269695|FG000|Overall Study|Enrolled Not Treated|15|||
105346332|NCT00455520|363269696|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
105346333|NCT00455520|363269697|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
105346334|NCT00455520|363269696|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
105346335|NCT00455520|363269697|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
105346336|NCT00455520|363269696|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
105346337|NCT00455520|363269697|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
105346338|NCT00455520|363269696|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
105346339|NCT00455520|363269697|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
105346340|NCT00455520|363269696|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
105346341|NCT00455520|363269697|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
105346342|NCT00455520|363269696|FG000|Open Label Tapentadol Extended Release|All other|33|||
105346343|NCT00455520|363269697|FG001|Open Label Tapentadol Extended Release|All other|0|||
105346344|NCT00455520|363269696|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
105346345|NCT00455520|363269697|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
105346346|NCT00455520|363269696|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
105346347|NCT00455520|363269697|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
105346348|NCT00455520|363269696|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
105346349|NCT00455520|363269697|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
105346350|NCT00455520|363269696|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
105691853|NCT01822522|364536387|FG002|Overall Study|Withdrawal by Subject|0|||
105691854|NCT01822522|364536388|FG003|Overall Study|Withdrawal by Subject|1|||
105691855|NCT01822522|364536389|FG004|Overall Study|Withdrawal by Subject|0|||
105691856|NCT01822522|364536390|FG005|Overall Study|Withdrawal by Subject|0|||
105346351|NCT00455520|363269697|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
105691857|NCT01822522|364536385|FG000|Overall Study|Lack of Efficacy|0|||
105346352|NCT00455520|363269696|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
105346353|NCT00455520|363269697|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
105346354|NCT00455520|363269696|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
105346355|NCT00455520|363269697|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
105346356|NCT00115037|363269699|FG000|Phase1|Lost to Follow-up|16|||
105346357|NCT00115037|363269700|FG001|Phase1|Lost to Follow-up|23|||
105346358|NCT00115037|363269701|FG002|Phase1|Lost to Follow-up|0|||
105346359|NCT00115037|363269702|FG003|Phase1|Lost to Follow-up|0|||
105559089|NCT04124926|364044584|FG001|Healing Phase|Withdrawal of Consent|3|||
105471626|NCT02100696|363738257|FG002|Maintenance Phase|Adverse Event|0|||
105471627|NCT02100696|363738258|FG003|Maintenance Phase|Adverse Event|0|||
105471628|NCT02100696|363738259|FG004|Maintenance Phase|Adverse Event|0|||
105471629|NCT02100696|363738260|FG005|Maintenance Phase|Adverse Event|2|||
105471630|NCT02100696|363738255|FG000|Maintenance Phase|Lost to Follow-up|0|||
105471631|NCT02100696|363738256|FG001|Maintenance Phase|Lost to Follow-up|0|||
105471632|NCT02100696|363738257|FG002|Maintenance Phase|Lost to Follow-up|0|||
105471633|NCT02100696|363738258|FG003|Maintenance Phase|Lost to Follow-up|0|||
105471634|NCT02100696|363738259|FG004|Maintenance Phase|Lost to Follow-up|1|||
105471635|NCT02100696|363738260|FG005|Maintenance Phase|Lost to Follow-up|0|||
105471636|NCT02100696|363738255|FG000|Maintenance Phase|Protocol Violation|0|||
105471637|NCT02100696|363738256|FG001|Maintenance Phase|Protocol Violation|0|||
105471638|NCT02100696|363738257|FG002|Maintenance Phase|Protocol Violation|0|||
105471639|NCT02100696|363738258|FG003|Maintenance Phase|Protocol Violation|0|||
105471640|NCT02100696|363738259|FG004|Maintenance Phase|Protocol Violation|1|||
105471641|NCT02100696|363738260|FG005|Maintenance Phase|Protocol Violation|0|||
105471642|NCT02100696|363738255|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105471643|NCT02100696|363738256|FG001|Maintenance Phase|Withdrawal by Subject|0|||
105471644|NCT02100696|363738257|FG002|Maintenance Phase|Withdrawal by Subject|0|||
105471645|NCT02100696|363738258|FG003|Maintenance Phase|Withdrawal by Subject|1|||
105471646|NCT02100696|363738259|FG004|Maintenance Phase|Withdrawal by Subject|4|||
105471647|NCT02100696|363738260|FG005|Maintenance Phase|Withdrawal by Subject|2|||
105471648|NCT02100696|363738255|FG000|Maintenance Phase|Physician Decision|0|||
105471649|NCT02100696|363738256|FG001|Maintenance Phase|Physician Decision|0|||
105471650|NCT02100696|363738257|FG002|Maintenance Phase|Physician Decision|0|||
105471651|NCT02100696|363738258|FG003|Maintenance Phase|Physician Decision|0|||
105471652|NCT02100696|363738259|FG004|Maintenance Phase|Physician Decision|1|||
105471653|NCT02100696|363738260|FG005|Maintenance Phase|Physician Decision|0|||
105471654|NCT02100696|363738255|FG000|Maintenance Phase|Multiple Reasons|0|||
105471655|NCT02100696|363738256|FG001|Maintenance Phase|Multiple Reasons|0|||
105471656|NCT02100696|363738257|FG002|Maintenance Phase|Multiple Reasons|0|||
105471657|NCT02100696|363738258|FG003|Maintenance Phase|Multiple Reasons|0|||
105471658|NCT02100696|363738259|FG004|Maintenance Phase|Multiple Reasons|2|||
105471659|NCT02100696|363738260|FG005|Maintenance Phase|Multiple Reasons|1|||
105471660|NCT02357368|363738263|FG000|Overall Study|Lost to Follow-up|0|||
105471661|NCT02357368|363738264|FG001|Overall Study|Lost to Follow-up|0|||
105471662|NCT02357368|363738265|FG002|Overall Study|Lost to Follow-up|0|||
105471663|NCT02357368|363738266|FG003|Overall Study|Lost to Follow-up|1|||
105471664|NCT02357368|363738263|FG000|Overall Study|Pregnancy|3|||
105471665|NCT02357368|363738264|FG001|Overall Study|Pregnancy|2|||
105471666|NCT02357368|363738265|FG002|Overall Study|Pregnancy|0|||
105471667|NCT02357368|363738266|FG003|Overall Study|Pregnancy|0|||
105471668|NCT02357368|363738263|FG000|Overall Study|Withdrawal by Subject|3|||
105471669|NCT02357368|363738264|FG001|Overall Study|Withdrawal by Subject|1|||
105471670|NCT02357368|363738265|FG002|Overall Study|Withdrawal by Subject|1|||
105471671|NCT02357368|363738266|FG003|Overall Study|Withdrawal by Subject|2|||
105471672|NCT00048074|363738269|FG000|Overall Study|Adverse Event|46|||
105471673|NCT00048074|363738270|FG001|Overall Study|Adverse Event|41|||
105471674|NCT00048074|363738271|FG002|Overall Study|Adverse Event|53|||
105471675|NCT00048074|363738269|FG000|Overall Study|Death|3|||
105471676|NCT00048074|363738270|FG001|Overall Study|Death|3|||
105471677|NCT00048074|363738271|FG002|Overall Study|Death|2|||
105471678|NCT00048074|363738269|FG000|Overall Study|Lost to Follow-up|2|||
105471679|NCT00048074|363738270|FG001|Overall Study|Lost to Follow-up|6|||
105471680|NCT00048074|363738271|FG002|Overall Study|Lost to Follow-up|6|||
105471681|NCT00048074|363738269|FG000|Overall Study|Withdrawal by Subject|28|||
105471682|NCT00048074|363738270|FG001|Overall Study|Withdrawal by Subject|30|||
105471683|NCT00048074|363738271|FG002|Overall Study|Withdrawal by Subject|35|||
105471684|NCT00048074|363738269|FG000|Overall Study|Protocol Violation|1|||
105471685|NCT00048074|363738270|FG001|Overall Study|Protocol Violation|3|||
105471686|NCT00048074|363738271|FG002|Overall Study|Protocol Violation|0|||
105471687|NCT00048074|363738269|FG000|Overall Study|Study participation was terminated|0|||
105471688|NCT00048074|363738270|FG001|Overall Study|Study participation was terminated|1|||
105471689|NCT00048074|363738271|FG002|Overall Study|Study participation was terminated|0|||
105471690|NCT00048074|363738269|FG000|Overall Study|Husband ill|0|||
105471691|NCT00048074|363738270|FG001|Overall Study|Husband ill|1|||
105471692|NCT00048074|363738271|FG002|Overall Study|Husband ill|0|||
105471693|NCT00048074|363738269|FG000|Overall Study|Poor compliance|0|||
105471694|NCT00048074|363738270|FG001|Overall Study|Poor compliance|1|||
105471695|NCT00048074|363738271|FG002|Overall Study|Poor compliance|0|||
105471696|NCT00048074|363738269|FG000|Overall Study|Out of station|0|||
105471697|NCT00048074|363738270|FG001|Overall Study|Out of station|1|||
105471698|NCT00048074|363738271|FG002|Overall Study|Out of station|1|||
105471699|NCT00048074|363738269|FG000|Overall Study|Social reasons|1|||
105471700|NCT00048074|363738270|FG001|Overall Study|Social reasons|0|||
105471701|NCT00048074|363738271|FG002|Overall Study|Social reasons|0|||
105471702|NCT03500224|363738274|FG000|Overall Study|Withdrawal by Subject|2|||
105471703|NCT01324401|363738275|FG000|Overall Study|Withdrawn before any treatment|0|||
105471704|NCT01324401|363738276|FG001|Overall Study|Withdrawn before any treatment|3|||
105471705|NCT01324401|363738275|FG000|Overall Study|Adverse Event|1|||
105471706|NCT01324401|363738276|FG001|Overall Study|Adverse Event|3|||
105471707|NCT01708902|363738277|FG000|Overall Study|Adverse Event|3|||
105471708|NCT01708902|363738278|FG001|Overall Study|Adverse Event|4|||
105471709|NCT01708902|363738279|FG002|Overall Study|Adverse Event|9|||
105471710|NCT01708902|363738280|FG003|Overall Study|Adverse Event|2|||
105471711|NCT01708902|363738281|FG004|Overall Study|Adverse Event|7|||
105471712|NCT01708902|363738282|FG005|Overall Study|Adverse Event|3|||
105471713|NCT01708902|363738283|FG006|Overall Study|Adverse Event|5|||
105471714|NCT01708902|363738277|FG000|Overall Study|Lack of Efficacy|3|||
105471715|NCT01708902|363738278|FG001|Overall Study|Lack of Efficacy|1|||
105471716|NCT01708902|363738279|FG002|Overall Study|Lack of Efficacy|0|||
105471717|NCT01708902|363738280|FG003|Overall Study|Lack of Efficacy|0|||
105471718|NCT01708902|363738281|FG004|Overall Study|Lack of Efficacy|0|||
105471719|NCT01708902|363738282|FG005|Overall Study|Lack of Efficacy|1|||
105471720|NCT01708902|363738283|FG006|Overall Study|Lack of Efficacy|0|||
105471721|NCT01708902|363738277|FG000|Overall Study|Non compliance with protocol|0|||
105471722|NCT01708902|363738278|FG001|Overall Study|Non compliance with protocol|2|||
105471723|NCT01708902|363738279|FG002|Overall Study|Non compliance with protocol|1|||
105471724|NCT01708902|363738280|FG003|Overall Study|Non compliance with protocol|3|||
105471725|NCT01708902|363738281|FG004|Overall Study|Non compliance with protocol|0|||
105471726|NCT01708902|363738282|FG005|Overall Study|Non compliance with protocol|0|||
105471727|NCT01708902|363738283|FG006|Overall Study|Non compliance with protocol|0|||
105471728|NCT01708902|363738277|FG000|Overall Study|Lost to Follow-up|2|||
105471729|NCT01708902|363738278|FG001|Overall Study|Lost to Follow-up|1|||
105471730|NCT01708902|363738279|FG002|Overall Study|Lost to Follow-up|2|||
105471731|NCT01708902|363738280|FG003|Overall Study|Lost to Follow-up|2|||
105471732|NCT01708902|363738281|FG004|Overall Study|Lost to Follow-up|0|||
105471733|NCT01708902|363738282|FG005|Overall Study|Lost to Follow-up|0|||
105471734|NCT01708902|363738283|FG006|Overall Study|Lost to Follow-up|1|||
105471735|NCT01708902|363738277|FG000|Overall Study|Refused to continue trial medication|8|||
105471736|NCT01708902|363738278|FG001|Overall Study|Refused to continue trial medication|0|||
105471737|NCT01708902|363738279|FG002|Overall Study|Refused to continue trial medication|4|||
105471738|NCT01708902|363738280|FG003|Overall Study|Refused to continue trial medication|2|||
105471739|NCT01708902|363738281|FG004|Overall Study|Refused to continue trial medication|8|||
105471740|NCT01708902|363738282|FG005|Overall Study|Refused to continue trial medication|1|||
105471741|NCT01708902|363738283|FG006|Overall Study|Refused to continue trial medication|1|||
105471742|NCT01708902|363738277|FG000|Overall Study|Other Reason|1|||
105471743|NCT01708902|363738278|FG001|Overall Study|Other Reason|0|||
105471744|NCT01708902|363738279|FG002|Overall Study|Other Reason|1|||
105471745|NCT01708902|363738280|FG003|Overall Study|Other Reason|1|||
105471746|NCT01708902|363738281|FG004|Overall Study|Other Reason|1|||
105471747|NCT01708902|363738282|FG005|Overall Study|Other Reason|2|||
105471748|NCT01708902|363738283|FG006|Overall Study|Other Reason|0|||
105471749|NCT01500720|363738284|FG000|Overall Study|Randomized But Not Treated|1|||
105471750|NCT01500720|363738285|FG001|Overall Study|Randomized But Not Treated|1|||
105471751|NCT01500720|363738284|FG000|Overall Study|Other|4|||
105471752|NCT01500720|363738285|FG001|Overall Study|Other|8|||
105471753|NCT00740857|363738286|FG000|Overall Study|Withdrawal by Subject|1|||
105471754|NCT00740857|363738287|FG001|Overall Study|Withdrawal by Subject|0|||
105471755|NCT00740857|363738288|FG002|Overall Study|Withdrawal by Subject|0|||
105471756|NCT02527421|363738289|FG000|Overall Study|Withdrawal by Subject|1|||
105471757|NCT02527421|363738290|FG001|Overall Study|Withdrawal by Subject|0|||
105471758|NCT00334113|363738298|FG000|Overall Study|Lost to Follow-up|2|||
105471759|NCT00334113|363738299|FG001|Overall Study|Lost to Follow-up|2|||
105471760|NCT00334113|363738298|FG000|Overall Study|Withdrawal by Subject|0|||
105471761|NCT00334113|363738299|FG001|Overall Study|Withdrawal by Subject|1|||
105471762|NCT04189224|363738300|FG000|Period 2|Adverse Event|0|||
105471763|NCT04189224|363738301|FG001|Period 2|Adverse Event|1|||
105471764|NCT00488683|363738303|FG000|Overall Study|Withdrawal by Subject|1|||
105471765|NCT00488683|363738304|FG001|Overall Study|Withdrawal by Subject|2|||
105471766|NCT00488683|363738305|FG002|Overall Study|Withdrawal by Subject|2|||
105691858|NCT01822522|364536386|FG001|Overall Study|Lack of Efficacy|0|||
105691859|NCT01822522|364536387|FG002|Overall Study|Lack of Efficacy|0|||
105691860|NCT01822522|364536388|FG003|Overall Study|Lack of Efficacy|0|||
105691861|NCT01822522|364536389|FG004|Overall Study|Lack of Efficacy|0|||
105691862|NCT01822522|364536390|FG005|Overall Study|Lack of Efficacy|2|||
105691863|NCT01807923|364536392|FG000|Overall Study|Adverse Event|2|||
105691864|NCT01807923|364536393|FG001|Overall Study|Adverse Event|1|||
105691865|NCT01807923|364536394|FG002|Overall Study|Adverse Event|2|||
105691866|NCT01807923|364536392|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
105471767|NCT00488683|363738303|FG000|Overall Study|Lost to Follow-up|5|||
105691867|NCT01807923|364536393|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
105471768|NCT00488683|363738304|FG001|Overall Study|Lost to Follow-up|3|||
105471769|NCT00488683|363738305|FG002|Overall Study|Lost to Follow-up|0|||
105471770|NCT00488683|363738303|FG000|Overall Study|Protocol Violation|5|||
105786963|NCT04768881|364872943|FG000|Overall Study|Withdrawal by Subject|2|||
105786964|NCT04768881|364872944|FG001|Overall Study|Withdrawal by Subject|0|||
105786965|NCT04768881|364872943|FG000|Overall Study|Other|2|||
105786966|NCT04768881|364872944|FG001|Overall Study|Other|0|||
105786967|NCT02146365|364872947|FG000|Overall Study|Lost to Follow-up|2|||
105346360|NCT00115037|363269703|FG004|Phase1|Lost to Follow-up|0|||
105346361|NCT00115037|363269704|FG005|Phase1|Lost to Follow-up|0|||
105346362|NCT00115037|363269699|FG000|Phase1|Withdrawal by Subject|9|||
105346363|NCT00115037|363269700|FG001|Phase1|Withdrawal by Subject|4|||
105346364|NCT00115037|363269701|FG002|Phase1|Withdrawal by Subject|0|||
105346365|NCT00115037|363269702|FG003|Phase1|Withdrawal by Subject|0|||
105346366|NCT00115037|363269703|FG004|Phase1|Withdrawal by Subject|0|||
105346367|NCT00115037|363269704|FG005|Phase1|Withdrawal by Subject|0|||
105346368|NCT00115037|363269699|FG000|Phase2|Death|0|||
105346369|NCT00115037|363269700|FG001|Phase2|Death|0|||
105346370|NCT00115037|363269701|FG002|Phase2|Death|1|||
105346371|NCT00115037|363269702|FG003|Phase2|Death|0|||
105346372|NCT00115037|363269703|FG004|Phase2|Death|0|||
105346373|NCT00115037|363269704|FG005|Phase2|Death|1|||
105346374|NCT00115037|363269699|FG000|Phase2|Withdrawal by Subject|0|||
105346375|NCT00115037|363269700|FG001|Phase2|Withdrawal by Subject|0|||
105346376|NCT00115037|363269701|FG002|Phase2|Withdrawal by Subject|2|||
105346377|NCT00115037|363269702|FG003|Phase2|Withdrawal by Subject|1|||
105346378|NCT00115037|363269703|FG004|Phase2|Withdrawal by Subject|2|||
105346379|NCT00115037|363269704|FG005|Phase2|Withdrawal by Subject|1|||
105346380|NCT00115037|363269699|FG000|Phase2|Lost to Follow-up|0|||
105346381|NCT00115037|363269700|FG001|Phase2|Lost to Follow-up|0|||
105346382|NCT00115037|363269701|FG002|Phase2|Lost to Follow-up|12|||
105346383|NCT00115037|363269702|FG003|Phase2|Lost to Follow-up|14|||
105346384|NCT00115037|363269703|FG004|Phase2|Lost to Follow-up|4|||
105346385|NCT00115037|363269704|FG005|Phase2|Lost to Follow-up|10|||
105346386|NCT01711619|363269705|FG000|Overall Study|Early study termination|10|||
105346387|NCT01711619|363269706|FG001|Overall Study|Early study termination|14|||
105346388|NCT01711619|363269705|FG000|Overall Study|Withdrawal by Subject|3|||
105346389|NCT01711619|363269706|FG001|Overall Study|Withdrawal by Subject|7|||
105346390|NCT01711619|363269705|FG000|Overall Study|Protocol Violation|2|||
105346391|NCT01711619|363269706|FG001|Overall Study|Protocol Violation|3|||
105346392|NCT01711619|363269705|FG000|Overall Study|Adverse Event|2|||
105346393|NCT01711619|363269706|FG001|Overall Study|Adverse Event|0|||
105346394|NCT01711619|363269705|FG000|Overall Study|Lost to Follow-up|1|||
105346395|NCT01711619|363269706|FG001|Overall Study|Lost to Follow-up|0|||
105346396|NCT05385224|363269708|FG000|Overall Study|Unable to swallow capsule|2|||
105691868|NCT01807923|364536394|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
105691869|NCT01807923|364536392|FG000|Overall Study|Physician Decision|0|||
105691870|NCT01807923|364536393|FG001|Overall Study|Physician Decision|0|||
105691871|NCT01807923|364536394|FG002|Overall Study|Physician Decision|1|||
105691872|NCT01807923|364536392|FG000|Overall Study|Not Eligible (Genotype)|0|||
105691873|NCT01807923|364536393|FG001|Overall Study|Not Eligible (Genotype)|0|||
105691874|NCT01807923|364536394|FG002|Overall Study|Not Eligible (Genotype)|1|||
105691875|NCT01807923|364536392|FG000|Overall Study|Randomized But Not Treated|3|||
105691876|NCT01807923|364536393|FG001|Overall Study|Randomized But Not Treated|2|||
105691877|NCT01807923|364536394|FG002|Overall Study|Randomized But Not Treated|5|||
105691878|NCT00890929|364536395|FG000|Overall Study|Death before treatment|2|||
105691879|NCT00890929|364536395|FG000|Overall Study|Withdrawal by Subject|3|||
105691880|NCT00890929|364536395|FG000|Overall Study|Physician Decision|1|||
105691881|NCT00995007|364536396|FG000|Overall Study|Withdrew consent|1|||
105691882|NCT00995007|364536397|FG001|Overall Study|Withdrew consent|0|||
105691883|NCT00995007|364536396|FG000|Overall Study|Refused further treatment|8|||
105691884|NCT00995007|364536397|FG001|Overall Study|Refused further treatment|2|||
105691885|NCT00995007|364536396|FG000|Overall Study|Toxicity|8|||
105691886|NCT00995007|364536397|FG001|Overall Study|Toxicity|0|||
105786968|NCT02146365|364872948|FG001|Overall Study|Lost to Follow-up|1|||
105786969|NCT02146365|364872949|FG002|Overall Study|Lost to Follow-up|3|||
105346397|NCT05385224|363269708|FG000|Overall Study|Withdrawal by Subject|2|||
105346398|NCT05385224|363269708|FG000|Overall Study|Did not meet study criteria|1|||
105346399|NCT00087126|363269712|FG000|Overall Study|Ineligible - second primary|1|||
105691887|NCT02469896|364536404|FG000|Overall Study|Withdrawal by Subject|2|||
105346400|NCT00087126|363269712|FG000|Overall Study|Never treated|1|||
105346401|NCT02565706|363269717|FG000|Overall Study|Withdrawal by Subject|5|||
105691888|NCT02469896|364536405|FG001|Overall Study|Withdrawal by Subject|0|||
105691889|NCT01093625|364536410|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
105691890|NCT01093625|364536411|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
105786970|NCT02146365|364872950|FG003|Overall Study|Lost to Follow-up|3|||
105346402|NCT02565706|363269718|FG001|Overall Study|Withdrawal by Subject|7|||
105346403|NCT02565706|363269719|FG002|Overall Study|Withdrawal by Subject|7|||
105346404|NCT02565706|363269720|FG003|Overall Study|Withdrawal by Subject|11|||
105346405|NCT02565706|363269717|FG000|Overall Study|Lost to Follow-up|72|||
105346406|NCT02565706|363269718|FG001|Overall Study|Lost to Follow-up|75|||
105346407|NCT02565706|363269719|FG002|Overall Study|Lost to Follow-up|82|||
105346408|NCT02565706|363269720|FG003|Overall Study|Lost to Follow-up|74|||
105346409|NCT01935700|363269723|FG000|Overall Study|Withdrawal by Subject|1|||
105346410|NCT01935700|363269724|FG001|Overall Study|Withdrawal by Subject|0|||
105346411|NCT01935700|363269723|FG000|Overall Study|Physician Decision|4|||
105346412|NCT01935700|363269724|FG001|Overall Study|Physician Decision|0|||
105346413|NCT00772005|363269726|FG000|Overall Study|Adverse Event|9|||
105346414|NCT00772005|363269727|FG001|Overall Study|Adverse Event|14|||
105346415|NCT00772005|363269728|FG002|Overall Study|Adverse Event|10|||
105346416|NCT00772005|363269729|FG003|Overall Study|Adverse Event|13|||
105346417|NCT00772005|363269726|FG000|Overall Study|Lack of Efficacy|0|||
105346418|NCT00772005|363269727|FG001|Overall Study|Lack of Efficacy|1|||
105346419|NCT00772005|363269728|FG002|Overall Study|Lack of Efficacy|0|||
105346420|NCT00772005|363269729|FG003|Overall Study|Lack of Efficacy|0|||
105346421|NCT00772005|363269726|FG000|Overall Study|Withdrawal by Subject|3|||
105346422|NCT00772005|363269727|FG001|Overall Study|Withdrawal by Subject|7|||
105346423|NCT00772005|363269728|FG002|Overall Study|Withdrawal by Subject|10|||
105346424|NCT00772005|363269729|FG003|Overall Study|Withdrawal by Subject|2|||
105346425|NCT00772005|363269726|FG000|Overall Study|Protocol Violation|2|||
105346426|NCT00772005|363269727|FG001|Overall Study|Protocol Violation|4|||
105346427|NCT00772005|363269728|FG002|Overall Study|Protocol Violation|1|||
105346428|NCT00772005|363269729|FG003|Overall Study|Protocol Violation|6|||
105346429|NCT00772005|363269726|FG000|Overall Study|Lost to Follow-up|7|||
105346430|NCT00772005|363269727|FG001|Overall Study|Lost to Follow-up|3|||
105346431|NCT00772005|363269728|FG002|Overall Study|Lost to Follow-up|6|||
105346432|NCT00772005|363269729|FG003|Overall Study|Lost to Follow-up|3|||
105346433|NCT00772005|363269726|FG000|Overall Study|Non-compliance with study procedures|1|||
105346434|NCT00772005|363269727|FG001|Overall Study|Non-compliance with study procedures|1|||
105346435|NCT00772005|363269728|FG002|Overall Study|Non-compliance with study procedures|0|||
105346436|NCT00772005|363269729|FG003|Overall Study|Non-compliance with study procedures|1|||
105346437|NCT00772005|363269726|FG000|Overall Study|Non-compliance with drug administration|3|||
105346438|NCT00772005|363269727|FG001|Overall Study|Non-compliance with drug administration|0|||
105346439|NCT00772005|363269728|FG002|Overall Study|Non-compliance with drug administration|1|||
105346440|NCT00772005|363269729|FG003|Overall Study|Non-compliance with drug administration|1|||
105346441|NCT01273155|363269731|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
105346442|NCT01273155|363269732|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
105346443|NCT01273155|363269733|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
105346444|NCT01273155|363269734|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
105346445|NCT01273155|363269735|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
105346446|NCT01273155|363269736|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
105346447|NCT01273155|363269737|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
105346448|NCT01273155|363269731|FG000|Overall Study|Change in liver function/no longer eval.|0|||
105346449|NCT01273155|363269732|FG001|Overall Study|Change in liver function/no longer eval.|1|||
105346450|NCT01273155|363269733|FG002|Overall Study|Change in liver function/no longer eval.|0|||
105346451|NCT01273155|363269734|FG003|Overall Study|Change in liver function/no longer eval.|0|||
105346452|NCT01273155|363269735|FG004|Overall Study|Change in liver function/no longer eval.|1|||
105346453|NCT01273155|363269736|FG005|Overall Study|Change in liver function/no longer eval.|0|||
105346454|NCT01273155|363269737|FG006|Overall Study|Change in liver function/no longer eval.|0|||
105346455|NCT01273155|363269731|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
105346456|NCT01273155|363269732|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
105346457|NCT01273155|363269733|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
105346458|NCT01273155|363269734|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
105346459|NCT01273155|363269735|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
105346460|NCT01273155|363269736|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
105346461|NCT01273155|363269737|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
105346462|NCT01273155|363269731|FG000|Overall Study|Died during Cycle 1|0|||
105346463|NCT01273155|363269732|FG001|Overall Study|Died during Cycle 1|0|||
105346464|NCT01273155|363269733|FG002|Overall Study|Died during Cycle 1|1|||
105346465|NCT01273155|363269734|FG003|Overall Study|Died during Cycle 1|1|||
105346466|NCT01273155|363269735|FG004|Overall Study|Died during Cycle 1|0|||
105346467|NCT01273155|363269736|FG005|Overall Study|Died during Cycle 1|2|||
105346468|NCT01273155|363269737|FG006|Overall Study|Died during Cycle 1|2|||
105346469|NCT01273155|363269731|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
105346470|NCT01273155|363269732|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
105346471|NCT01273155|363269733|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
105346472|NCT01273155|363269734|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
105346473|NCT01273155|363269735|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
105346474|NCT01273155|363269736|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
105346475|NCT01273155|363269737|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
105346476|NCT00090987|363269740|FG000|Overall Study|Adverse Event|5|||
105346477|NCT00090987|363269740|FG000|Overall Study|Lack of Efficacy|7|||
105691891|NCT01093625|364536410|FG000|2-Week Visit|Withdrawal by Subject|1|||
105691892|NCT01093625|364536411|FG001|2-Week Visit|Withdrawal by Subject|0|||
105346478|NCT00090987|363269740|FG000|Overall Study|Withdrawal by Subject|3|||
105471771|NCT00488683|363738304|FG001|Overall Study|Protocol Violation|1|||
105471772|NCT00488683|363738305|FG002|Overall Study|Protocol Violation|0|||
105471773|NCT00488683|363738303|FG000|Overall Study|Unable to Classify|1|||
105471774|NCT00488683|363738304|FG001|Overall Study|Unable to Classify|0|||
105471775|NCT00488683|363738305|FG002|Overall Study|Unable to Classify|0|||
105471776|NCT03818035|363738307|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
105471777|NCT03818035|363738308|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
105471778|NCT03818035|363738309|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
105471779|NCT03818035|363738310|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
105471780|NCT03818035|363738307|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
105471781|NCT03818035|363738308|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
105471782|NCT03818035|363738309|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
105471783|NCT03818035|363738310|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
105471784|NCT03818035|363738307|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
105471785|NCT03818035|363738308|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
105471786|NCT03818035|363738309|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
105471787|NCT03818035|363738310|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
105471788|NCT03818035|363738307|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
105471789|NCT03818035|363738308|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
105691893|NCT01093625|364536410|FG000|1-Month Visit|Lost to Follow-up|2|||
105691894|NCT01093625|364536411|FG001|1-Month Visit|Lost to Follow-up|0|||
105691895|NCT01093625|364536410|FG000|3-Month Visit|Lost to Follow-up|2|||
105691896|NCT01093625|364536411|FG001|3-Month Visit|Lost to Follow-up|0|||
105691897|NCT01093625|364536410|FG000|6-Month Visit|Withdrawal by Subject|6|||
105471790|NCT03818035|363738309|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
105471791|NCT03818035|363738310|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
105471792|NCT03818035|363738307|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
105471793|NCT03818035|363738308|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
105471794|NCT03818035|363738309|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
105471795|NCT03818035|363738310|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
105471796|NCT03818035|363738307|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
105471797|NCT03818035|363738308|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
105471798|NCT03818035|363738309|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
105471799|NCT03818035|363738310|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
105471800|NCT03818035|363738307|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
105471801|NCT03818035|363738308|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
105471802|NCT03818035|363738309|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
105471803|NCT03818035|363738310|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
105471804|NCT03818035|363738307|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
105471805|NCT03818035|363738308|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
105471806|NCT03818035|363738309|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
105471807|NCT03818035|363738310|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
105471808|NCT03818035|363738307|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
105471809|NCT03818035|363738308|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
105471810|NCT03818035|363738309|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
105471811|NCT03818035|363738310|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
105471812|NCT03818035|363738307|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
105471813|NCT03818035|363738308|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
105471814|NCT03818035|363738309|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
105471815|NCT03818035|363738310|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
105471816|NCT03818035|363738307|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
105471817|NCT03818035|363738308|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
105471818|NCT03818035|363738309|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
105471819|NCT03818035|363738310|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
105471820|NCT03818035|363738307|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
105471821|NCT03818035|363738308|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
105471822|NCT03818035|363738309|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
105471823|NCT03818035|363738310|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
105471824|NCT03818035|363738307|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
105471825|NCT03818035|363738308|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
105471826|NCT03818035|363738309|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
105471827|NCT03818035|363738310|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
105471828|NCT03818035|363738307|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
105471829|NCT03818035|363738308|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
105471830|NCT03818035|363738309|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
105471831|NCT03818035|363738310|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
105471832|NCT03818035|363738307|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
105691898|NCT01093625|364536411|FG001|6-Month Visit|Withdrawal by Subject|7|||
105691899|NCT01093625|364536410|FG000|6-Month Visit|Lost to Follow-up|2|||
105471833|NCT03818035|363738308|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
105471834|NCT03818035|363738309|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
105691900|NCT01093625|364536411|FG001|6-Month Visit|Lost to Follow-up|2|||
105691901|NCT01093625|364536410|FG000|1-Year Visit|Lost to Follow-up|5|||
105691902|NCT01093625|364536411|FG001|1-Year Visit|Lost to Follow-up|3|||
105691903|NCT03684642|364536415|FG000|Overall Study|Adverse Event|6|||
105691904|NCT03684642|364536416|FG001|Overall Study|Adverse Event|15|||
105691905|NCT03684642|364536417|FG002|Overall Study|Adverse Event|11|||
105786971|NCT02146365|364872951|FG004|Overall Study|Lost to Follow-up|1|||
105346479|NCT00090987|363269740|FG000|Overall Study|alternative therapy|1|||
105346480|NCT00090987|363269740|FG000|Overall Study|Non-compliance|4|||
105346481|NCT00090987|363269740|FG000|Overall Study|Incarcerated|1|||
105346482|NCT02124759|363269744|FG000|Overall Study|Withdrawal by Subject|3|||
105346483|NCT02124759|363269745|FG001|Overall Study|Withdrawal by Subject|1|||
105346484|NCT02124759|363269746|FG002|Overall Study|Withdrawal by Subject|1|||
105346485|NCT02124759|363269744|FG000|Overall Study|Screen Fail|2|||
105346486|NCT02124759|363269745|FG001|Overall Study|Screen Fail|2|||
105346487|NCT02124759|363269746|FG002|Overall Study|Screen Fail|3|||
105346488|NCT04769739|363269747|FG000|Overall Study|Colorectal cancer obstruction|2|||
105346489|NCT04769739|363269748|FG001|Overall Study|Colorectal cancer obstruction|0|||
105346490|NCT04769739|363269749|FG002|Overall Study|Colorectal cancer obstruction|0|||
105346491|NCT04769739|363269750|FG003|Overall Study|Colorectal cancer obstruction|0|||
105346492|NCT04769739|363269747|FG000|Overall Study|Failed cecal intubation|1|||
105346493|NCT04769739|363269748|FG001|Overall Study|Failed cecal intubation|0|||
105346494|NCT04769739|363269749|FG002|Overall Study|Failed cecal intubation|0|||
105346495|NCT04769739|363269750|FG003|Overall Study|Failed cecal intubation|1|||
105346496|NCT04769739|363269747|FG000|Overall Study|Poor bowel preparation|0|||
105346497|NCT04769739|363269748|FG001|Overall Study|Poor bowel preparation|0|||
105346498|NCT04769739|363269749|FG002|Overall Study|Poor bowel preparation|0|||
105346499|NCT04769739|363269750|FG003|Overall Study|Poor bowel preparation|1|||
105346500|NCT01731470|363269751|FG000|Overall Study|Withdrawal by Subject|1|||
105346501|NCT01731470|363269751|FG000|Overall Study|Did not meet study criteria|1|||
105346502|NCT03325894|363269752|FG000|Overall Study|Adverse Event|2|||
105346503|NCT03325894|363269753|FG001|Overall Study|Adverse Event|3|||
105346504|NCT03325894|363269752|FG000|Overall Study|Protocol Violation|1|||
105346505|NCT03325894|363269753|FG001|Overall Study|Protocol Violation|2|||
105346506|NCT03325894|363269752|FG000|Overall Study|Withdrawal by Subject|10|||
105346507|NCT03325894|363269753|FG001|Overall Study|Withdrawal by Subject|6|||
105346508|NCT03325894|363269752|FG000|Overall Study|Lost to Follow-up|4|||
105346509|NCT03325894|363269753|FG001|Overall Study|Lost to Follow-up|9|||
105346510|NCT03325894|363269752|FG000|Overall Study|Lack of Efficacy|8|||
105346511|NCT03325894|363269753|FG001|Overall Study|Lack of Efficacy|14|||
105346512|NCT03325894|363269752|FG000|Overall Study|Study Terminated by Sponsor|38|||
105346513|NCT03325894|363269753|FG001|Overall Study|Study Terminated by Sponsor|43|||
105346514|NCT03325894|363269752|FG000|Overall Study|Other (Not received Treatment)|1|||
105346515|NCT03325894|363269753|FG001|Overall Study|Other (Not received Treatment)|0|||
105346516|NCT01001598|363269756|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
105346517|NCT01001598|363269756|FG000|Overall Study|Adverse Event|1|||
105346518|NCT02923245|363269764|FG000|Overall Study|ultrasound order was cancelled|2|||
105346519|NCT02923245|363269765|FG001|Overall Study|ultrasound order was cancelled|1|||
105346520|NCT01037127|363269767|FG000|Overall Study|Lost to Follow-up|2|||
105346521|NCT01037127|363269768|FG001|Overall Study|Lost to Follow-up|4|||
105346522|NCT01037127|363269767|FG000|Overall Study|Physician Decision|1|||
105346523|NCT01037127|363269768|FG001|Overall Study|Physician Decision|0|||
105346524|NCT01037127|363269767|FG000|Overall Study|Study Closed Terminated|2|||
105346525|NCT01037127|363269768|FG001|Overall Study|Study Closed Terminated|17|||
105346526|NCT02987972|363269769|FG000|Overall Study|Adverse Event|1|||
105346527|NCT02987972|363269770|FG001|Overall Study|Adverse Event|1|||
105346528|NCT02987972|363269771|FG002|Overall Study|Adverse Event|0|||
105346529|NCT02987972|363269769|FG000|Overall Study|Death|1|||
105346530|NCT02987972|363269770|FG001|Overall Study|Death|0|||
105346531|NCT02987972|363269771|FG002|Overall Study|Death|0|||
105346532|NCT02987972|363269769|FG000|Overall Study|Lack of Efficacy|9|||
105346533|NCT02987972|363269770|FG001|Overall Study|Lack of Efficacy|12|||
105346534|NCT02987972|363269771|FG002|Overall Study|Lack of Efficacy|12|||
105346535|NCT02987972|363269769|FG000|Overall Study|Lost to Follow-up|7|||
105346536|NCT02987972|363269770|FG001|Overall Study|Lost to Follow-up|8|||
105346537|NCT02987972|363269771|FG002|Overall Study|Lost to Follow-up|4|||
105346538|NCT02987972|363269769|FG000|Overall Study|Physician Decision|1|||
105346539|NCT02987972|363269770|FG001|Overall Study|Physician Decision|6|||
105346540|NCT02987972|363269771|FG002|Overall Study|Physician Decision|0|||
105346541|NCT02987972|363269769|FG000|Overall Study|Protocol Violation|2|||
105346542|NCT02987972|363269770|FG001|Overall Study|Protocol Violation|1|||
105346543|NCT02987972|363269771|FG002|Overall Study|Protocol Violation|5|||
105346544|NCT02987972|363269769|FG000|Overall Study|Withdrawal by Subject|22|||
105346545|NCT02987972|363269770|FG001|Overall Study|Withdrawal by Subject|17|||
105346546|NCT02987972|363269771|FG002|Overall Study|Withdrawal by Subject|21|||
105346547|NCT04438499|363269772|FG000|Overall Study|Lack of Efficacy|3|||
105346548|NCT04618471|363271352|FG000|Overall Study|Screen Failure|62|||
105691906|NCT03684642|364536415|FG000|Overall Study|Withdrawal by Subject|35|||
105691907|NCT03684642|364536416|FG001|Overall Study|Withdrawal by Subject|53|||
105786972|NCT02146365|364872952|FG005|Overall Study|Lost to Follow-up|1|||
105346549|NCT04618471|363271352|FG000|Overall Study|Withdrawal by Subject|6|||
105346550|NCT04618471|363271352|FG000|Overall Study|Physician Decision|2|||
105346551|NCT04618471|363271352|FG000|Overall Study|Lost to Follow-up|1|||
105346552|NCT04618471|363271352|FG000|Overall Study|Various other reasons|2|||
105346553|NCT04618471|363271352|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
105471835|NCT03818035|363738310|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
105471836|NCT03374202|363738311|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
105471837|NCT03374202|363738312|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
105471838|NCT03374202|363738313|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
105471839|NCT03374202|363738311|FG000|Five Year Long Term Follow Up|Death|0|||
105471840|NCT03374202|363738312|FG001|Five Year Long Term Follow Up|Death|1|||
105471841|NCT03374202|363738313|FG002|Five Year Long Term Follow Up|Death|0|||
105471842|NCT03207763|363739869|FG000|Overall Study|Lost to Follow-up|1|||
105471843|NCT03207763|363739870|FG001|Overall Study|Lost to Follow-up|0|||
105471844|NCT02605122|363739871|FG000|Overall Study|Withdrawal by Subject|4|||
105471845|NCT02605122|363739872|FG001|Overall Study|Withdrawal by Subject|1|||
105471846|NCT02605122|363739871|FG000|Overall Study|Lost to Follow-up|1|||
105471847|NCT02605122|363739872|FG001|Overall Study|Lost to Follow-up|1|||
105471848|NCT00684060|363739873|FG000|Overall Study|Lost to Follow-up|1|||
105471849|NCT00684060|363739874|FG001|Overall Study|Lost to Follow-up|0|||
105471850|NCT00684060|363739873|FG000|Overall Study|New stenosis identified|1|||
105471851|NCT00684060|363739874|FG001|Overall Study|New stenosis identified|0|||
105471852|NCT00684060|363739873|FG000|Overall Study|Unable to collect MRI|1|||
105471853|NCT00684060|363739874|FG001|Overall Study|Unable to collect MRI|2|||
105471854|NCT00684060|363739873|FG000|Overall Study|Death|0|||
105471855|NCT00684060|363739874|FG001|Overall Study|Death|1|||
105471856|NCT02331277|363739875|FG000|Overall Study|Withdrawal by Subject|1|||
105471857|NCT02331277|363739876|FG001|Overall Study|Withdrawal by Subject|0|||
105471858|NCT03894813|363739883|FG000|Overall Study|Adverse Event|1|||
105471859|NCT03894813|363739884|FG001|Overall Study|Adverse Event|1|||
105471860|NCT03894813|363739883|FG000|Overall Study|Lack of Efficacy|3|||
105471861|NCT03894813|363739884|FG001|Overall Study|Lack of Efficacy|3|||
105471862|NCT03894813|363739883|FG000|Overall Study|Lost to Follow-up|1|||
105471863|NCT03894813|363739884|FG001|Overall Study|Lost to Follow-up|0|||
105471864|NCT03894813|363739883|FG000|Overall Study|Pregnancy|2|||
105471865|NCT03894813|363739884|FG001|Overall Study|Pregnancy|1|||
105471866|NCT03894813|363739883|FG000|Overall Study|Protocol Violation|3|||
105471867|NCT03894813|363739884|FG001|Overall Study|Protocol Violation|7|||
105471868|NCT03894813|363739883|FG000|Overall Study|Withdrawal by Subject|1|||
105691908|NCT03684642|364536417|FG002|Overall Study|Withdrawal by Subject|23|||
105691909|NCT03684642|364536415|FG000|Overall Study|Lack of Efficacy|0|||
105691910|NCT03684642|364536416|FG001|Overall Study|Lack of Efficacy|0|||
105691911|NCT03684642|364536417|FG002|Overall Study|Lack of Efficacy|1|||
105691912|NCT03684642|364536415|FG000|Overall Study|Poor compliance to protocol|0|||
105691913|NCT03684642|364536416|FG001|Overall Study|Poor compliance to protocol|4|||
105691914|NCT03684642|364536417|FG002|Overall Study|Poor compliance to protocol|1|||
105691915|NCT03684642|364536415|FG000|Overall Study|Other than specified|62|||
105691916|NCT03684642|364536416|FG001|Overall Study|Other than specified|60|||
105691917|NCT03684642|364536417|FG002|Overall Study|Other than specified|67|||
105691918|NCT03684642|364536415|FG000|Overall Study|Randomized and not treated|0|||
105691919|NCT03684642|364536416|FG001|Overall Study|Randomized and not treated|0|||
105691920|NCT03684642|364536417|FG002|Overall Study|Randomized and not treated|1|||
105691921|NCT03684642|364536415|FG000|Overall Study|Missing completion status but alive at last contact|0|||
105691922|NCT03684642|364536416|FG001|Overall Study|Missing completion status but alive at last contact|1|||
105691923|NCT03684642|364536417|FG002|Overall Study|Missing completion status but alive at last contact|2|||
105691924|NCT01431534|364536418|FG000|Treatment Phase|Adverse Event|0|||
105691925|NCT01431534|364536419|FG001|Treatment Phase|Adverse Event|0|||
105691926|NCT01431534|364536420|FG002|Treatment Phase|Adverse Event|1|||
105691927|NCT01431534|364536418|FG000|Treatment Phase|Progressive Disease|4|||
105691928|NCT01431534|364536419|FG001|Treatment Phase|Progressive Disease|3|||
105691929|NCT01431534|364536420|FG002|Treatment Phase|Progressive Disease|10|||
105691930|NCT01840605|364536421|FG000|Overall Study|Adverse Event|0|||
105691931|NCT01840605|364536422|FG001|Overall Study|Adverse Event|1|||
105691932|NCT01840605|364536421|FG000|Overall Study|Physician Decision|2|||
105691933|NCT01840605|364536422|FG001|Overall Study|Physician Decision|1|||
105691934|NCT03739437|364536423|FG000|Overall Study|Lost to Follow-up|2|||
105691935|NCT03739437|364536424|FG001|Overall Study|Lost to Follow-up|5|||
105691936|NCT04201821|364536426|FG000|Overall Study|Withdrawal by Subject|2|||
105691937|NCT01130974|364536427|FG000|Overall Study|Protocol Violation|10|||
105691938|NCT01130974|364536428|FG001|Overall Study|Protocol Violation|10|||
105691939|NCT01130974|364536427|FG000|Overall Study|Withdrawal by Subject|0|||
105691940|NCT01130974|364536428|FG001|Overall Study|Withdrawal by Subject|1|||
105691941|NCT01130974|364536427|FG000|Overall Study|Ineligibility criteria|5|||
105471869|NCT03894813|363739884|FG001|Overall Study|Withdrawal by Subject|3|||
105471870|NCT03894813|363739883|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
105471871|NCT03894813|363739884|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
105471872|NCT03083873|363739887|FG000|Overall Study|Death|6|||
105471873|NCT03083873|363739888|FG001|Overall Study|Death|15|||
105471874|NCT03083873|363739889|FG002|Overall Study|Death|13|||
105471875|NCT03083873|363739890|FG003|Overall Study|Death|9|||
105471876|NCT03083873|363739891|FG004|Overall Study|Death|0|||
105471877|NCT03083873|363739887|FG000|Overall Study|Sponsor Terminated Study|0|||
105471878|NCT03083873|363739888|FG001|Overall Study|Sponsor Terminated Study|1|||
105471879|NCT03083873|363739889|FG002|Overall Study|Sponsor Terminated Study|2|||
105471880|NCT03083873|363739890|FG003|Overall Study|Sponsor Terminated Study|3|||
105471881|NCT03083873|363739891|FG004|Overall Study|Sponsor Terminated Study|0|||
105471882|NCT03083873|363739887|FG000|Overall Study|Lost to Follow-up|0|||
105471883|NCT03083873|363739888|FG001|Overall Study|Lost to Follow-up|1|||
105471884|NCT03083873|363739889|FG002|Overall Study|Lost to Follow-up|1|||
105471885|NCT03083873|363739890|FG003|Overall Study|Lost to Follow-up|0|||
105471886|NCT03083873|363739891|FG004|Overall Study|Lost to Follow-up|0|||
105471887|NCT03083873|363739887|FG000|Overall Study|Withdrawal by Subject|2|||
105471888|NCT03083873|363739888|FG001|Overall Study|Withdrawal by Subject|0|||
105471889|NCT03083873|363739889|FG002|Overall Study|Withdrawal by Subject|0|||
105471890|NCT03083873|363739890|FG003|Overall Study|Withdrawal by Subject|0|||
105471891|NCT03083873|363739891|FG004|Overall Study|Withdrawal by Subject|0|||
105471892|NCT03083873|363739887|FG000|Overall Study|Did Not Receive TIL|2|||
105471893|NCT03083873|363739888|FG001|Overall Study|Did Not Receive TIL|5|||
105471894|NCT03083873|363739889|FG002|Overall Study|Did Not Receive TIL|3|||
105471895|NCT03083873|363739890|FG003|Overall Study|Did Not Receive TIL|1|||
105471896|NCT03083873|363739891|FG004|Overall Study|Did Not Receive TIL|0|||
105471897|NCT02656693|363739892|FG000|Overall Study|Pregnancy|1|||
105471898|NCT02656693|363739893|FG001|Overall Study|Pregnancy|1|||
105471899|NCT02656693|363739894|FG002|Overall Study|Pregnancy|1|||
105471900|NCT02656693|363739892|FG000|Overall Study|Bariatric surgery|0|||
105471901|NCT02656693|363739893|FG001|Overall Study|Bariatric surgery|1|||
105471902|NCT02656693|363739894|FG002|Overall Study|Bariatric surgery|2|||
105471903|NCT02269267|363739895|FG000|Overall Study|Death|5|||
105471904|NCT03773796|363739896|FG000|Overall Study|Adverse Event|1|||
105471905|NCT03773796|363739896|FG000|Overall Study|Withdrawal by Subject|1|||
105471906|NCT03773796|363739896|FG000|Overall Study|Lack of Efficacy|1|||
105471907|NCT03805659|363739897|FG000|Overall Study|Withdrawal by Subject|0|||
105471908|NCT03805659|363739898|FG001|Overall Study|Withdrawal by Subject|1|||
105471909|NCT00539864|363739900|FG000|Overall Study|Lost to Follow-up|0|||
105471910|NCT00539864|363739901|FG001|Overall Study|Lost to Follow-up|1|||
105471911|NCT00539864|363739900|FG000|Overall Study|Withdrawal by Subject|1|||
105471912|NCT00539864|363739901|FG001|Overall Study|Withdrawal by Subject|1|||
105471913|NCT01250145|363739902|FG000|Overall Study|Adverse Event|2|||
105471914|NCT01250145|363739903|FG001|Overall Study|Adverse Event|1|||
105471915|NCT01250145|363739902|FG000|Overall Study|Withdrawal by Subject|0|||
105471916|NCT01250145|363739903|FG001|Overall Study|Withdrawal by Subject|4|||
105471917|NCT02273596|363739904|FG000|24-Week Treatment Period|Adverse Event|3|||
105471918|NCT02273596|363739904|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
105471919|NCT02273596|363739904|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
105471920|NCT02273596|363739904|FG000|24-Week Treatment Period|Physician Decision|1|||
105471921|NCT02273596|363739904|FG000|24-Week Treatment Period|Protocol Deviation|1|||
105471922|NCT02273596|363739904|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
105471923|NCT02273596|363739904|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
105471924|NCT02273596|363739904|FG000|Extension Period|Lost to Follow-up|1|||
105471925|NCT02273596|363739904|FG000|Extension Period|Protocol Deviation|1|||
105471926|NCT02604160|363739905|FG000|Overall Study|Protocol Violation|0|||
105471927|NCT02604160|363739906|FG001|Overall Study|Protocol Violation|1|||
105471928|NCT02604160|363739905|FG000|Overall Study|Physician Decision|0|||
105471929|NCT02604160|363739906|FG001|Overall Study|Physician Decision|1|||
105471930|NCT02139592|363739909|FG000|Overall Study|Case Report Forms Uncollected|8|||
105471931|NCT01069900|363739911|FG000|Overall Study|Technical problems|0|||
105471932|NCT01069900|363739912|FG001|Overall Study|Technical problems|1|||
105471933|NCT01069900|363739911|FG000|Overall Study|Lost to Follow-up|7|||
105471934|NCT01069900|363739912|FG001|Overall Study|Lost to Follow-up|1|||
105471935|NCT01069900|363739911|FG000|Overall Study|Withdrawal by Subject|6|||
105471936|NCT01069900|363739912|FG001|Overall Study|Withdrawal by Subject|1|||
105471937|NCT01069900|363739911|FG000|Overall Study|Protocol Violation|4|||
105471938|NCT01069900|363739912|FG001|Overall Study|Protocol Violation|1|||
105471939|NCT01069900|363739911|FG000|Overall Study|Insufficient Therapeutic effect|1|||
105471940|NCT01069900|363739912|FG001|Overall Study|Insufficient Therapeutic effect|0|||
105471941|NCT02687191|363739913|FG000|Overall Study|Death|0|||
105471942|NCT02687191|363739914|FG001|Overall Study|Death|1|||
105471943|NCT02687191|363739915|FG002|Overall Study|Death|1|||
105471944|NCT02687191|363739916|FG003|Overall Study|Death|0|||
105471945|NCT02687191|363739917|FG004|Overall Study|Death|1|||
105471946|NCT02687191|363739918|FG005|Overall Study|Death|1|||
105471947|NCT02687191|363739913|FG000|Overall Study|Withdrawal by Subject|0|||
105471948|NCT02687191|363739914|FG001|Overall Study|Withdrawal by Subject|0|||
105471949|NCT02687191|363739915|FG002|Overall Study|Withdrawal by Subject|0|||
105471950|NCT02687191|363739916|FG003|Overall Study|Withdrawal by Subject|1|||
105471951|NCT02687191|363739917|FG004|Overall Study|Withdrawal by Subject|0|||
105471952|NCT02687191|363739918|FG005|Overall Study|Withdrawal by Subject|0|||
105471953|NCT03180840|363739919|FG000|Overall Study|Withdrawal by Subject|1|||
105471954|NCT03887702|363739922|FG000|Overall Study|Study terminated|0|||
105471955|NCT03887702|363739923|FG001|Overall Study|Study terminated|0|||
105471956|NCT03887702|363739924|FG002|Overall Study|Study terminated|2|||
105471957|NCT03887702|363739925|FG003|Overall Study|Study terminated|2|||
105471958|NCT02600819|363739931|FG000|GEN Phase|Adverse Event|2|||
105471959|NCT02600819|363739932|FG001|GEN Phase|Adverse Event|0|||
105471960|NCT02600819|363739931|FG000|GEN Phase|Death|2|||
105471961|NCT02600819|363739932|FG001|GEN Phase|Death|0|||
105471962|NCT02600819|363739931|FG000|GEN Phase|Investigator's Discretion|4|||
105471963|NCT02600819|363739932|FG001|GEN Phase|Investigator's Discretion|0|||
105471964|NCT02600819|363739931|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
105471965|NCT02600819|363739932|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
105471966|NCT02600819|363739931|FG000|GEN Phase|Withdrew Consent|5|||
105471967|NCT02600819|363739932|FG001|GEN Phase|Withdrew Consent|0|||
105471968|NCT02600819|363739931|FG000|GEN Phase|Lost to Follow-up|2|||
105471969|NCT02600819|363739932|FG001|GEN Phase|Lost to Follow-up|0|||
105471970|NCT02563067|363739938|FG000|Overall Study|Subject/guardian decision|14|||
105471971|NCT02563067|363739939|FG001|Overall Study|Subject/guardian decision|20|||
105471972|NCT02563067|363739940|FG002|Overall Study|Subject/guardian decision|16|||
105471973|NCT02563067|363739938|FG000|Overall Study|Physician Decision|0|||
105471974|NCT02563067|363739939|FG001|Overall Study|Physician Decision|1|||
105471975|NCT02563067|363739940|FG002|Overall Study|Physician Decision|3|||
105471976|NCT02563067|363739938|FG000|Overall Study|Lost to Follow-up|1|||
105471977|NCT02563067|363739939|FG001|Overall Study|Lost to Follow-up|2|||
105471978|NCT02563067|363739940|FG002|Overall Study|Lost to Follow-up|0|||
105471979|NCT02563067|363739938|FG000|Overall Study|Technical problems|0|||
105471980|NCT02563067|363739939|FG001|Overall Study|Technical problems|1|||
105471981|NCT02563067|363739940|FG002|Overall Study|Technical problems|0|||
105471982|NCT02563067|363739938|FG000|Overall Study|Lack of Efficacy|1|||
105471983|NCT02563067|363739939|FG001|Overall Study|Lack of Efficacy|0|||
105471984|NCT02563067|363739940|FG002|Overall Study|Lack of Efficacy|0|||
105471985|NCT02563067|363739938|FG000|Overall Study|Death|0|||
105471986|NCT02563067|363739939|FG001|Overall Study|Death|1|||
105471987|NCT02563067|363739940|FG002|Overall Study|Death|1|||
105471988|NCT02563067|363739938|FG000|Overall Study|Adverse Event|2|||
105471989|NCT02563067|363739939|FG001|Overall Study|Adverse Event|1|||
105471990|NCT02563067|363739940|FG002|Overall Study|Adverse Event|0|||
105471991|NCT02563067|363739938|FG000|Overall Study|Death post Treatment/safety period|1|||
105471992|NCT02563067|363739939|FG001|Overall Study|Death post Treatment/safety period|0|||
105471993|NCT02563067|363739940|FG002|Overall Study|Death post Treatment/safety period|0|||
105471994|NCT03544333|363739945|FG000|Overall Study|Withdrawal by Subject|1|||
105471995|NCT03544333|363739946|FG001|Overall Study|Withdrawal by Subject|0|||
105471996|NCT01039519|363739947|FG000|Treatment|Progressive disease|20|||
105471997|NCT01039519|363739947|FG000|Treatment|Treatment failure|2|||
105471998|NCT01039519|363739947|FG000|Treatment|Adverse Event|3|||
105471999|NCT01039519|363739947|FG000|Treatment|Physician Decision|2|||
105472000|NCT01039519|363739947|FG000|Survival Follow-up|Death|23|||
105472001|NCT01039519|363739947|FG000|Survival Follow-up|Sponsor decision|4|||
105472002|NCT00423917|363739956|FG000|Overall Study|Cancel|2|||
105472003|NCT00423917|363739956|FG000|Overall Study|Ineligible|1|||
105472004|NCT00243269|363739957|FG000|Overall Study|Protocol Violation|2|||
105472005|NCT00243269|363739958|FG001|Overall Study|Protocol Violation|1|||
105472006|NCT00243269|363739959|FG002|Overall Study|Protocol Violation|0|||
105472007|NCT00243269|363739960|FG003|Overall Study|Protocol Violation|1|||
105472008|NCT00243269|363739957|FG000|Overall Study|Lost to Follow-up|1|||
105472009|NCT00243269|363739958|FG001|Overall Study|Lost to Follow-up|0|||
105472010|NCT00243269|363739959|FG002|Overall Study|Lost to Follow-up|1|||
105472011|NCT00243269|363739960|FG003|Overall Study|Lost to Follow-up|3|||
105472012|NCT03085797|363739962|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
105472013|NCT03085797|363739963|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
105472014|NCT03085797|363739962|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
105472015|NCT03085797|363739963|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
105472016|NCT03085797|363739962|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
105691942|NCT01130974|364536428|FG001|Overall Study|Ineligibility criteria|2|||
105691943|NCT00387764|364536429|FG000|Overall Study|Adverse Event|12|||
105472017|NCT03085797|363739963|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
105472018|NCT03052400|363739964|FG000|Overall Study|Lost to Follow-up|1|||
105472019|NCT03052400|363739965|FG001|Overall Study|Lost to Follow-up|0|||
105472020|NCT03052400|363739964|FG000|Overall Study|Withdrawal by Subject|0|||
105472021|NCT03052400|363739965|FG001|Overall Study|Withdrawal by Subject|1|||
105691944|NCT00387764|364536429|FG000|Overall Study|Withdrawal by Subject|8|||
105691945|NCT00387764|364536429|FG000|Overall Study|Sponsor Terminated Study|1|||
105691946|NCT00387764|364536429|FG000|Overall Study|Physician Decision|1|||
105691947|NCT00387764|364536429|FG000|Overall Study|Other|2|||
105691948|NCT00387764|364536429|FG000|Overall Study|Death|7|||
105691949|NCT02673619|364536430|FG000|Overall Study|Lost to Follow-up|1|||
105691950|NCT02673619|364536431|FG001|Overall Study|Lost to Follow-up|0|||
105691951|NCT02673619|364536432|FG002|Overall Study|Lost to Follow-up|0|||
105691952|NCT02673619|364536433|FG003|Overall Study|Lost to Follow-up|0|||
105691953|NCT02673619|364536430|FG000|Overall Study|Withdrawal by Subject|1|||
105691954|NCT02673619|364536431|FG001|Overall Study|Withdrawal by Subject|1|||
105691955|NCT02673619|364536432|FG002|Overall Study|Withdrawal by Subject|1|||
105691956|NCT02673619|364536433|FG003|Overall Study|Withdrawal by Subject|0|||
105691957|NCT02673619|364536430|FG000|Overall Study|Adverse Event|0|||
105691958|NCT02673619|364536431|FG001|Overall Study|Adverse Event|0|||
105691959|NCT02673619|364536432|FG002|Overall Study|Adverse Event|1|||
105691960|NCT02673619|364536433|FG003|Overall Study|Adverse Event|0|||
105691961|NCT02673619|364536430|FG000|Overall Study|Lack of Efficacy|0|||
105691962|NCT02673619|364536431|FG001|Overall Study|Lack of Efficacy|0|||
105691963|NCT02673619|364536432|FG002|Overall Study|Lack of Efficacy|1|||
105691964|NCT02673619|364536433|FG003|Overall Study|Lack of Efficacy|0|||
105691965|NCT00972777|364536436|FG000|Overall Study|Adverse Event|3|||
105691966|NCT00972777|364536437|FG001|Overall Study|Adverse Event|2|||
105691967|NCT00972777|364536436|FG000|Overall Study|Lost to Follow-up|0|||
105691968|NCT00972777|364536437|FG001|Overall Study|Lost to Follow-up|4|||
105691969|NCT00972777|364536436|FG000|Overall Study|Withdrawal by Subject|4|||
105691970|NCT00972777|364536437|FG001|Overall Study|Withdrawal by Subject|5|||
105691971|NCT00972777|364536436|FG000|Overall Study|Physician Decision|4|||
105691972|NCT00972777|364536437|FG001|Overall Study|Physician Decision|0|||
105691973|NCT00972777|364536436|FG000|Overall Study|Protocol Violation|0|||
105559090|NCT04124926|364044585|FG002|Healing Phase|Withdrawal of Consent|0|||
105691974|NCT00972777|364536437|FG001|Overall Study|Protocol Violation|2|||
105691975|NCT00972777|364536436|FG000|Overall Study|Screening Failure|2|||
105691976|NCT00972777|364536437|FG001|Overall Study|Screening Failure|1|||
105691977|NCT00972777|364536436|FG000|Overall Study|Missed visit|1|||
105691978|NCT00972777|364536437|FG001|Overall Study|Missed visit|0|||
105691979|NCT00594516|364538305|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
105691980|NCT00594516|364538306|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
105691981|NCT00594516|364538307|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
105346554|NCT01250171|363271353|FG000|Overall Study|Administrative reasons|1|||
105691982|NCT00594516|364538305|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
105691983|NCT00594516|364538306|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
105691984|NCT00594516|364538307|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
105691985|NCT00594516|364538305|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
105691986|NCT00594516|364538306|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
105691987|NCT00594516|364538307|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
105691988|NCT00594516|364538305|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
105691989|NCT00594516|364538306|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
105691990|NCT00594516|364538307|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
105691991|NCT00594516|364538305|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
105691992|NCT00594516|364538306|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
105691993|NCT00594516|364538307|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
105691994|NCT00594516|364538305|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
105691995|NCT00594516|364538306|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
105691996|NCT00594516|364538307|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
105691997|NCT00594516|364538305|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
105691998|NCT00594516|364538306|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
105691999|NCT00594516|364538307|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
105692000|NCT00594516|364538305|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
105692001|NCT00594516|364538306|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
105692002|NCT00594516|364538307|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
105692003|NCT00594516|364538305|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
105692004|NCT00594516|364538306|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
105692005|NCT00594516|364538307|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
105692006|NCT01890148|364538310|FG000|Overall Study|Adverse Event|1|||
105692007|NCT03872453|364538311|FG000|Overall Study|Adverse Event|1|||
105692008|NCT03872453|364538312|FG001|Overall Study|Adverse Event|1|||
105692009|NCT03872453|364538313|FG002|Overall Study|Adverse Event|0|||
105692010|NCT03872453|364538314|FG003|Overall Study|Adverse Event|0|||
105692011|NCT03872453|364538311|FG000|Overall Study|Lost to Follow-up|8|||
105692012|NCT03872453|364538312|FG001|Overall Study|Lost to Follow-up|7|||
105692013|NCT03872453|364538313|FG002|Overall Study|Lost to Follow-up|4|||
105692014|NCT03872453|364538314|FG003|Overall Study|Lost to Follow-up|4|||
105692015|NCT03872453|364538311|FG000|Overall Study|Never Treated Migraine|19|||
105692016|NCT03872453|364538312|FG001|Overall Study|Never Treated Migraine|17|||
105692017|NCT03872453|364538313|FG002|Overall Study|Never Treated Migraine|13|||
105692018|NCT03872453|364538314|FG003|Overall Study|Never Treated Migraine|12|||
105692019|NCT03872453|364538311|FG000|Overall Study|Pregnancy|1|||
105692020|NCT03872453|364538312|FG001|Overall Study|Pregnancy|0|||
105692021|NCT03872453|364538313|FG002|Overall Study|Pregnancy|0|||
105692022|NCT03872453|364538314|FG003|Overall Study|Pregnancy|0|||
105692023|NCT03872453|364538311|FG000|Overall Study|Protocol Deviation|2|||
105692024|NCT03872453|364538312|FG001|Overall Study|Protocol Deviation|0|||
105692025|NCT03872453|364538313|FG002|Overall Study|Protocol Deviation|0|||
105692026|NCT03872453|364538314|FG003|Overall Study|Protocol Deviation|2|||
105692027|NCT03872453|364538311|FG000|Overall Study|Withdrawal by Subject|0|||
105692028|NCT03872453|364538312|FG001|Overall Study|Withdrawal by Subject|1|||
105692029|NCT03872453|364538313|FG002|Overall Study|Withdrawal by Subject|2|||
105692030|NCT03872453|364538314|FG003|Overall Study|Withdrawal by Subject|0|||
105692031|NCT03872453|364538311|FG000|Overall Study|Other Than Specified|1|||
105692032|NCT03872453|364538312|FG001|Overall Study|Other Than Specified|0|||
105692033|NCT03872453|364538313|FG002|Overall Study|Other Than Specified|0|||
105692034|NCT03872453|364538314|FG003|Overall Study|Other Than Specified|0|||
105692035|NCT00352885|364538315|FG000|Overall Study|Withdrawal by Subject|0|||
105692036|NCT00352885|364538316|FG001|Overall Study|Withdrawal by Subject|3|||
105692037|NCT00352885|364538315|FG000|Overall Study|Development of major depression|0|||
105692038|NCT00352885|364538316|FG001|Overall Study|Development of major depression|1|||
105692039|NCT00352885|364538315|FG000|Overall Study|Progression of metastatic melanoma|5|||
105692040|NCT00352885|364538316|FG001|Overall Study|Progression of metastatic melanoma|3|||
105692041|NCT00352885|364538315|FG000|Overall Study|Side effects of IL-2 administration|1|||
105692042|NCT00352885|364538316|FG001|Overall Study|Side effects of IL-2 administration|0|||
105692043|NCT01678209|364538317|FG000|Overall Study|could not scan twice|1|||
105692044|NCT01678209|364538318|FG001|Overall Study|could not scan twice|1|||
105692045|NCT01678209|364538319|FG002|Overall Study|could not scan twice|1|||
105692046|NCT01678209|364538317|FG000|Overall Study|scheduling conflicts|0|||
105692047|NCT01678209|364538318|FG001|Overall Study|scheduling conflicts|0|||
105692048|NCT01678209|364538319|FG002|Overall Study|scheduling conflicts|1|||
105692049|NCT01678209|364538317|FG000|Overall Study|screen fail|16|||
105692050|NCT01678209|364538318|FG001|Overall Study|screen fail|17|||
105692051|NCT01678209|364538319|FG002|Overall Study|screen fail|16|||
105692052|NCT03873493|364538320|FG000|Overall Study|Withdrawal by Subject|1|||
105692053|NCT03873493|364538320|FG000|Overall Study|Death|9|||
105786973|NCT02146365|364872953|FG006|Overall Study|Lost to Follow-up|0|||
105786974|NCT02146365|364872954|FG007|Overall Study|Lost to Follow-up|1|||
105559091|NCT04124926|364044586|FG003|Healing Phase|Withdrawal of Consent|0|||
105692054|NCT03873493|364538320|FG000|Overall Study|Lost to Follow-up|1|||
105786975|NCT02146365|364872947|FG000|Overall Study|Withdrawal by Subject|1|||
105559092|NCT04124926|364044587|FG004|Healing Phase|Withdrawal of Consent|0|||
105692055|NCT03873493|364538320|FG000|Overall Study|Study Terminated by Sponsor|1|||
105692056|NCT03873493|364538320|FG000|Overall Study|Other|2|||
105692057|NCT03756350|364538325|FG000|Overall Study|Lost to Follow-up|1|||
105692058|NCT02464228|364538327|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
105692059|NCT02464228|364538328|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
105692060|NCT02464228|364538329|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
105692061|NCT02464228|364538330|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
105692062|NCT02464228|364538327|FG000|Overall Study|Physician Decision|2|||
105692063|NCT02464228|364538328|FG001|Overall Study|Physician Decision|0|||
105692064|NCT02464228|364538329|FG002|Overall Study|Physician Decision|1|||
105559093|NCT04124926|364044583|FG000|Healing Phase|Miscellaneous|8|||
105559094|NCT04124926|364044584|FG001|Healing Phase|Miscellaneous|7|||
105559095|NCT04124926|364044585|FG002|Healing Phase|Miscellaneous|0|||
105559096|NCT04124926|364044586|FG003|Healing Phase|Miscellaneous|0|||
105692065|NCT02464228|364538330|FG003|Overall Study|Physician Decision|0|||
105692066|NCT02464228|364538327|FG000|Overall Study|Miscellaneous|1|||
105692067|NCT02464228|364538328|FG001|Overall Study|Miscellaneous|0|||
105692068|NCT02464228|364538329|FG002|Overall Study|Miscellaneous|1|||
105559097|NCT04124926|364044587|FG004|Healing Phase|Miscellaneous|0|||
105692069|NCT02464228|364538330|FG003|Overall Study|Miscellaneous|0|||
105472022|NCT00485134|363739967|FG000|Overall Study|Lost to Follow-up|1|||
105472023|NCT00485134|363739968|FG001|Overall Study|Lost to Follow-up|0|||
105472024|NCT00485134|363739969|FG002|Overall Study|Lost to Follow-up|0|||
105472025|NCT00485134|363739970|FG003|Overall Study|Lost to Follow-up|0|||
105472026|NCT00485134|363739971|FG004|Overall Study|Lost to Follow-up|0|||
105472027|NCT00485134|363739972|FG005|Overall Study|Lost to Follow-up|0|||
105472028|NCT00485134|363739973|FG006|Overall Study|Lost to Follow-up|0|||
105472029|NCT00485134|363739974|FG007|Overall Study|Lost to Follow-up|0|||
105472030|NCT00485134|363739967|FG000|Overall Study|Withdrawal by Subject|0|||
105472031|NCT00485134|363739968|FG001|Overall Study|Withdrawal by Subject|1|||
105472032|NCT00485134|363739969|FG002|Overall Study|Withdrawal by Subject|0|||
105472033|NCT00485134|363739970|FG003|Overall Study|Withdrawal by Subject|0|||
105472034|NCT00485134|363739971|FG004|Overall Study|Withdrawal by Subject|0|||
105472035|NCT00485134|363739972|FG005|Overall Study|Withdrawal by Subject|0|||
105472036|NCT00485134|363739973|FG006|Overall Study|Withdrawal by Subject|0|||
105472037|NCT00485134|363739974|FG007|Overall Study|Withdrawal by Subject|0|||
105472038|NCT00485134|363739967|FG000|Overall Study|Change in health status|0|||
105472039|NCT00485134|363739968|FG001|Overall Study|Change in health status|1|||
105472040|NCT00485134|363739969|FG002|Overall Study|Change in health status|2|||
105472041|NCT00485134|363739970|FG003|Overall Study|Change in health status|1|||
105472042|NCT00485134|363739971|FG004|Overall Study|Change in health status|0|||
105472043|NCT00485134|363739972|FG005|Overall Study|Change in health status|1|||
105472044|NCT00485134|363739973|FG006|Overall Study|Change in health status|0|||
105472045|NCT00485134|363739974|FG007|Overall Study|Change in health status|0|||
105472046|NCT00485134|363739967|FG000|Overall Study|Withdrew for adverse event|0|||
105472047|NCT00485134|363739968|FG001|Overall Study|Withdrew for adverse event|0|||
105472048|NCT00485134|363739969|FG002|Overall Study|Withdrew for adverse event|1|||
105472049|NCT00485134|363739970|FG003|Overall Study|Withdrew for adverse event|0|||
105472050|NCT00485134|363739971|FG004|Overall Study|Withdrew for adverse event|0|||
105472051|NCT00485134|363739972|FG005|Overall Study|Withdrew for adverse event|0|||
105472052|NCT00485134|363739973|FG006|Overall Study|Withdrew for adverse event|0|||
105472053|NCT00485134|363739974|FG007|Overall Study|Withdrew for adverse event|0|||
105472054|NCT00485134|363739967|FG000|Overall Study|Positive drug test|0|||
105472055|NCT00485134|363739968|FG001|Overall Study|Positive drug test|0|||
105472056|NCT00485134|363739969|FG002|Overall Study|Positive drug test|0|||
105472057|NCT00485134|363739970|FG003|Overall Study|Positive drug test|0|||
105472058|NCT00485134|363739971|FG004|Overall Study|Positive drug test|2|||
105472059|NCT00485134|363739972|FG005|Overall Study|Positive drug test|1|||
105692070|NCT02464228|364538327|FG000|Overall Study|Adverse Event|9|||
105692071|NCT02464228|364538328|FG001|Overall Study|Adverse Event|0|||
105692072|NCT02464228|364538329|FG002|Overall Study|Adverse Event|3|||
105692073|NCT02464228|364538330|FG003|Overall Study|Adverse Event|0|||
105692074|NCT02464228|364538327|FG000|Overall Study|Withdrawal by Subject|1|||
105692075|NCT02464228|364538328|FG001|Overall Study|Withdrawal by Subject|1|||
105692076|NCT02464228|364538329|FG002|Overall Study|Withdrawal by Subject|1|||
105692077|NCT02464228|364538330|FG003|Overall Study|Withdrawal by Subject|0|||
105692078|NCT02464228|364538327|FG000|Overall Study|Disease Progression|22|||
105472060|NCT00485134|363739973|FG006|Overall Study|Positive drug test|0|||
105472061|NCT00485134|363739974|FG007|Overall Study|Positive drug test|0|||
105472062|NCT00485134|363739967|FG000|Overall Study|Non-compliance|0|||
105472063|NCT00485134|363739968|FG001|Overall Study|Non-compliance|0|||
105472064|NCT00485134|363739969|FG002|Overall Study|Non-compliance|0|||
105472065|NCT00485134|363739970|FG003|Overall Study|Non-compliance|0|||
105472066|NCT00485134|363739971|FG004|Overall Study|Non-compliance|1|||
105472067|NCT00485134|363739972|FG005|Overall Study|Non-compliance|2|||
105472068|NCT00485134|363739973|FG006|Overall Study|Non-compliance|2|||
105472069|NCT00485134|363739974|FG007|Overall Study|Non-compliance|0|||
105472070|NCT00485134|363739967|FG000|Overall Study|Unable to comply with study schedule|0|||
105472071|NCT00485134|363739968|FG001|Overall Study|Unable to comply with study schedule|0|||
105472072|NCT00485134|363739969|FG002|Overall Study|Unable to comply with study schedule|0|||
105472073|NCT00485134|363739970|FG003|Overall Study|Unable to comply with study schedule|0|||
105472074|NCT00485134|363739971|FG004|Overall Study|Unable to comply with study schedule|0|||
105692079|NCT02464228|364538328|FG001|Overall Study|Disease Progression|12|||
105472075|NCT00485134|363739972|FG005|Overall Study|Unable to comply with study schedule|0|||
105472076|NCT00485134|363739973|FG006|Overall Study|Unable to comply with study schedule|0|||
105472077|NCT00485134|363739974|FG007|Overall Study|Unable to comply with study schedule|1|||
105472078|NCT00485134|363739967|FG000|Overall Study|Pregnancy|0|||
105472079|NCT00485134|363739968|FG001|Overall Study|Pregnancy|0|||
105472080|NCT00485134|363739969|FG002|Overall Study|Pregnancy|0|||
105692080|NCT02464228|364538329|FG002|Overall Study|Disease Progression|5|||
105472081|NCT00485134|363739970|FG003|Overall Study|Pregnancy|0|||
105472082|NCT00485134|363739971|FG004|Overall Study|Pregnancy|0|||
105692081|NCT02464228|364538330|FG003|Overall Study|Disease Progression|2|||
105472083|NCT00485134|363739972|FG005|Overall Study|Pregnancy|0|||
105472084|NCT00485134|363739973|FG006|Overall Study|Pregnancy|1|||
105472085|NCT00485134|363739974|FG007|Overall Study|Pregnancy|0|||
105472086|NCT04050202|363739975|FG000|Overall Study|Lost to Follow-up|2|||
105692082|NCT01131351|364538331|FG000|Overall Study|Adverse Event|0|||
105472087|NCT04027608|363739978|FG000|Overall Study|Withdrawal by Subject|13|||
105472088|NCT04027608|363739979|FG001|Overall Study|Withdrawal by Subject|2|||
105472089|NCT04027608|363739978|FG000|Overall Study|Protocol Violation|2|||
105472090|NCT04027608|363739979|FG001|Overall Study|Protocol Violation|1|||
105472091|NCT04027608|363739978|FG000|Overall Study|Physician Decision|1|||
105472092|NCT04027608|363739979|FG001|Overall Study|Physician Decision|0|||
105472093|NCT04027608|363739978|FG000|Overall Study|Lost to Follow-up|20|||
105472094|NCT04027608|363739979|FG001|Overall Study|Lost to Follow-up|4|||
105472095|NCT03275350|363739982|FG000|Overall Study|Lost to Follow-up|4|||
105472096|NCT03275350|363739983|FG001|Overall Study|Lost to Follow-up|6|||
105472097|NCT03275350|363739982|FG000|Overall Study|Death|2|||
105472098|NCT03275350|363739983|FG001|Overall Study|Death|1|||
105472099|NCT03275350|363739982|FG000|Overall Study|Physician Decision|1|||
105472100|NCT03275350|363739983|FG001|Overall Study|Physician Decision|0|||
105472101|NCT03275350|363739982|FG000|Overall Study|Incarcerated|1|||
105472102|NCT03275350|363739983|FG001|Overall Study|Incarcerated|1|||
105472103|NCT00380367|363739987|FG000|Overall Study|Lost to Follow-up|1|||
105472104|NCT00380367|363739987|FG000|Overall Study|Withdrawal by Subject|1|||
105472105|NCT02194985|363739988|FG000|Overall Study|Adverse Event|1|||
105472106|NCT02194985|363739988|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
105692083|NCT01131351|364538332|FG001|Overall Study|Adverse Event|2|||
105692084|NCT01131351|364538331|FG000|Overall Study|Protocol Deviation|0|||
105692085|NCT01131351|364538332|FG001|Overall Study|Protocol Deviation|1|||
105692086|NCT00763971|364538333|FG000|Overall Study|Adverse Event|5|||
105692087|NCT00763971|364538334|FG001|Overall Study|Adverse Event|2|||
105692088|NCT00763971|364538335|FG002|Overall Study|Adverse Event|4|||
105692089|NCT00763971|364538333|FG000|Overall Study|Protocol Violation|3|||
105692090|NCT00763971|364538334|FG001|Overall Study|Protocol Violation|3|||
105692091|NCT00763971|364538335|FG002|Overall Study|Protocol Violation|2|||
105692092|NCT00763971|364538333|FG000|Overall Study|Withdrawal by Subject|4|||
105692093|NCT00763971|364538334|FG001|Overall Study|Withdrawal by Subject|5|||
105692094|NCT00763971|364538335|FG002|Overall Study|Withdrawal by Subject|5|||
105692095|NCT00763971|364538333|FG000|Overall Study|Lost to Follow-up|0|||
105692096|NCT00763971|364538334|FG001|Overall Study|Lost to Follow-up|1|||
105692097|NCT00763971|364538335|FG002|Overall Study|Lost to Follow-up|0|||
105692098|NCT00763971|364538333|FG000|Overall Study|Lack of Efficacy|11|||
105692099|NCT00763971|364538334|FG001|Overall Study|Lack of Efficacy|22|||
105692100|NCT00763971|364538335|FG002|Overall Study|Lack of Efficacy|54|||
105692101|NCT00763971|364538333|FG000|Overall Study|Unable to swallow capsule|2|||
105692102|NCT00763971|364538334|FG001|Overall Study|Unable to swallow capsule|1|||
105692103|NCT00763971|364538335|FG002|Overall Study|Unable to swallow capsule|1|||
105692104|NCT00763971|364538333|FG000|Overall Study|Personal reason|3|||
105692105|NCT00763971|364538334|FG001|Overall Study|Personal reason|0|||
105692106|NCT00763971|364538335|FG002|Overall Study|Personal reason|0|||
105692107|NCT00763971|364538333|FG000|Overall Study|Exclusion criteria met|1|||
105692108|NCT00763971|364538334|FG001|Overall Study|Exclusion criteria met|0|||
105692109|NCT00763971|364538335|FG002|Overall Study|Exclusion criteria met|0|||
105472107|NCT02194985|363739988|FG000|Overall Study|Physician Decision|4|||
105472108|NCT02194985|363739988|FG000|Overall Study|Lost to Follow-up|1|||
105472109|NCT02194985|363739988|FG000|Overall Study|Withdrawal by Subject|2|||
105472110|NCT02561832|363739989|FG000|Overall Study|Withdrawal by Subject|1|||
105472111|NCT02561832|363739990|FG001|Overall Study|Withdrawal by Subject|1|||
105692110|NCT00763971|364538333|FG000|Overall Study|Sponsor decision|1|||
105472112|NCT02561832|363739989|FG000|Overall Study|Adverse Event|3|||
105472113|NCT02561832|363739990|FG001|Overall Study|Adverse Event|0|||
105472114|NCT02561832|363739989|FG000|Overall Study|Disease progression|3|||
105472115|NCT02561832|363739990|FG001|Overall Study|Disease progression|3|||
105472116|NCT02280408|363739991|FG000|Overall Study|Lost to Follow-up|0|||
105346555|NCT01250171|363271354|FG001|Overall Study|Administrative reasons|0|||
105346556|NCT01250171|363271355|FG002|Overall Study|Administrative reasons|0|||
105346557|NCT03292458|363271358|FG000|Period 1|Adverse Event|2|||
105346558|NCT03292458|363271359|FG001|Period 1|Adverse Event|0|||
105346559|NCT04529850|363271360|FG000|Overall Study|Death|2|||
105346560|NCT04529850|363271360|FG000|Overall Study|Physician Decision|1|||
105472117|NCT02280408|363739992|FG001|Overall Study|Lost to Follow-up|2|||
105472118|NCT02280408|363739993|FG002|Overall Study|Lost to Follow-up|0|||
105472119|NCT02280408|363739994|FG003|Overall Study|Lost to Follow-up|0|||
105472120|NCT04380519|363739995|FG000|Overall Study|Withdrawal by Subject|4|||
105472121|NCT04380519|363739996|FG001|Overall Study|Withdrawal by Subject|0|||
105472122|NCT04380519|363739997|FG002|Overall Study|Withdrawal by Subject|1|||
105346561|NCT04529850|363271360|FG000|Overall Study|Withdrawal by Subject|2|||
105346562|NCT03309696|363271361|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
105346563|NCT03309696|363271362|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
105346564|NCT03309696|363271363|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
105346565|NCT03309696|363271364|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
105346566|NCT01573767|363271365|FG000|Overall Study|Adverse Event|0|||
105346567|NCT01573767|363271366|FG001|Overall Study|Adverse Event|1|||
105346568|NCT01573767|363271367|FG002|Overall Study|Adverse Event|0|||
105346569|NCT01573767|363271368|FG003|Overall Study|Adverse Event|1|||
105346570|NCT01573767|363271365|FG000|Overall Study|Lack of Efficacy|18|||
105346571|NCT01573767|363271366|FG001|Overall Study|Lack of Efficacy|15|||
105346572|NCT01573767|363271367|FG002|Overall Study|Lack of Efficacy|12|||
105346573|NCT01573767|363271368|FG003|Overall Study|Lack of Efficacy|17|||
105346574|NCT01573767|363271365|FG000|Overall Study|Protocol Violation|3|||
105346575|NCT01573767|363271366|FG001|Overall Study|Protocol Violation|1|||
105346576|NCT01573767|363271367|FG002|Overall Study|Protocol Violation|1|||
105346577|NCT01573767|363271368|FG003|Overall Study|Protocol Violation|3|||
105346578|NCT01573767|363271365|FG000|Overall Study|Lost to Follow-up|0|||
105472123|NCT04380519|363739995|FG000|Overall Study|Death|14|||
105472124|NCT04380519|363739996|FG001|Overall Study|Death|9|||
105472125|NCT04380519|363739997|FG002|Overall Study|Death|6|||
105559098|NCT04124926|364044583|FG000|Healing Phase|Randomized but not Treated|0|||
105559099|NCT04124926|364044584|FG001|Healing Phase|Randomized but not Treated|3|||
105559100|NCT04124926|364044585|FG002|Healing Phase|Randomized but not Treated|0|||
105559101|NCT04124926|364044586|FG003|Healing Phase|Randomized but not Treated|0|||
105559102|NCT04124926|364044587|FG004|Healing Phase|Randomized but not Treated|0|||
105559103|NCT04124926|364044583|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
105559104|NCT04124926|364044584|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
105559105|NCT04124926|364044585|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
105559106|NCT04124926|364044586|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
105559107|NCT04124926|364044587|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
105559108|NCT04124926|364044583|FG000|Maintenance Phase|Protocol Violation|0|||
105559109|NCT04124926|364044584|FG001|Maintenance Phase|Protocol Violation|0|||
105559110|NCT04124926|364044585|FG002|Maintenance Phase|Protocol Violation|3|||
105559111|NCT04124926|364044586|FG003|Maintenance Phase|Protocol Violation|0|||
105559112|NCT04124926|364044587|FG004|Maintenance Phase|Protocol Violation|0|||
105559113|NCT04124926|364044583|FG000|Maintenance Phase|Lost to Follow-up|0|||
105559114|NCT04124926|364044584|FG001|Maintenance Phase|Lost to Follow-up|0|||
105559115|NCT04124926|364044585|FG002|Maintenance Phase|Lost to Follow-up|7|||
105559116|NCT04124926|364044586|FG003|Maintenance Phase|Lost to Follow-up|8|||
105559117|NCT04124926|364044587|FG004|Maintenance Phase|Lost to Follow-up|9|||
105559118|NCT04124926|364044583|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
105559119|NCT04124926|364044584|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
105559120|NCT04124926|364044585|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
105559121|NCT04124926|364044586|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
105346579|NCT01573767|363271366|FG001|Overall Study|Lost to Follow-up|1|||
105346580|NCT01573767|363271367|FG002|Overall Study|Lost to Follow-up|1|||
105472126|NCT04380519|363739995|FG000|Overall Study|Adverse Event|0|||
105472127|NCT04380519|363739996|FG001|Overall Study|Adverse Event|1|||
105346581|NCT01573767|363271368|FG003|Overall Study|Lost to Follow-up|1|||
105472128|NCT04380519|363739997|FG002|Overall Study|Adverse Event|0|||
105472129|NCT04380519|363739995|FG000|Overall Study|relatives' decision|0|||
105346582|NCT01573767|363271365|FG000|Overall Study|Physician Decision|1|||
105346583|NCT01573767|363271366|FG001|Overall Study|Physician Decision|2|||
105346584|NCT01573767|363271367|FG002|Overall Study|Physician Decision|0|||
105559122|NCT04124926|364044587|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
105559123|NCT04124926|364044583|FG000|Maintenance Phase|Pregnancy|0|||
105559124|NCT04124926|364044584|FG001|Maintenance Phase|Pregnancy|0|||
105692111|NCT00763971|364538334|FG001|Overall Study|Sponsor decision|0|||
105559125|NCT04124926|364044585|FG002|Maintenance Phase|Pregnancy|0|||
105559126|NCT04124926|364044586|FG003|Maintenance Phase|Pregnancy|1|||
105346585|NCT01573767|363271368|FG003|Overall Study|Physician Decision|2|||
105346586|NCT01573767|363271365|FG000|Overall Study|Withdrawal by Subject|0|||
105346587|NCT01573767|363271366|FG001|Overall Study|Withdrawal by Subject|1|||
105346588|NCT01573767|363271367|FG002|Overall Study|Withdrawal by Subject|0|||
105692112|NCT00763971|364538335|FG002|Overall Study|Sponsor decision|0|||
105692113|NCT00763971|364538333|FG000|Overall Study|Due to holiday season|2|||
105692114|NCT00763971|364538334|FG001|Overall Study|Due to holiday season|0|||
105692115|NCT00763971|364538335|FG002|Overall Study|Due to holiday season|1|||
105692116|NCT00763971|364538333|FG000|Overall Study|Randomization error|0|||
105692117|NCT00763971|364538334|FG001|Overall Study|Randomization error|0|||
105692118|NCT00763971|364538335|FG002|Overall Study|Randomization error|1|||
105692119|NCT00763971|364538333|FG000|Overall Study|Medical monitor decision|0|||
105692120|NCT00763971|364538334|FG001|Overall Study|Medical monitor decision|0|||
105692121|NCT00763971|364538335|FG002|Overall Study|Medical monitor decision|1|||
105692122|NCT00763971|364538333|FG000|Overall Study|Moved to another country|0|||
105692123|NCT00763971|364538334|FG001|Overall Study|Moved to another country|1|||
105692124|NCT00763971|364538335|FG002|Overall Study|Moved to another country|0|||
105692125|NCT00763971|364538333|FG000|Overall Study|Subject wanted dose reduction|0|||
105692126|NCT00763971|364538334|FG001|Overall Study|Subject wanted dose reduction|1|||
105692127|NCT00763971|364538335|FG002|Overall Study|Subject wanted dose reduction|0|||
105692128|NCT00763971|364538333|FG000|Overall Study|Lack of availability|0|||
105692129|NCT00763971|364538334|FG001|Overall Study|Lack of availability|1|||
105692130|NCT00763971|364538335|FG002|Overall Study|Lack of availability|0|||
105692131|NCT00763971|364538333|FG000|Overall Study|Performed final visit on phone|0|||
105692132|NCT00763971|364538334|FG001|Overall Study|Performed final visit on phone|1|||
105692133|NCT00763971|364538335|FG002|Overall Study|Performed final visit on phone|0|||
105692134|NCT00763971|364538333|FG000|Overall Study|Participation in 489-326 required|1|||
105692135|NCT00763971|364538334|FG001|Overall Study|Participation in 489-326 required|0|||
105692136|NCT00763971|364538335|FG002|Overall Study|Participation in 489-326 required|0|||
105692137|NCT01524133|364538338|FG000|Treatment Phase|Withdrawal by Subject|13|||
105692138|NCT01524133|364538339|FG001|Treatment Phase|Withdrawal by Subject|28|||
105692139|NCT01524133|364538340|FG002|Treatment Phase|Withdrawal by Subject|31|||
105692140|NCT01524133|364538338|FG000|Treatment Phase|Physician Decision|6|||
105692141|NCT01524133|364538339|FG001|Treatment Phase|Physician Decision|3|||
105692142|NCT01524133|364538340|FG002|Treatment Phase|Physician Decision|3|||
105692143|NCT01524133|364538338|FG000|Treatment Phase|Lost to Follow-up|0|||
105692144|NCT01524133|364538339|FG001|Treatment Phase|Lost to Follow-up|1|||
105692145|NCT01524133|364538340|FG002|Treatment Phase|Lost to Follow-up|2|||
105692146|NCT01524133|364538338|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
105692147|NCT01524133|364538339|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
105692148|NCT01524133|364538340|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
105692149|NCT01524133|364538338|FG000|Overall Study 52 Weeks|Physician Decision|1|||
105692150|NCT01524133|364538339|FG001|Overall Study 52 Weeks|Physician Decision|0|||
105692151|NCT01524133|364538340|FG002|Overall Study 52 Weeks|Physician Decision|2|||
105692152|NCT01524133|364538338|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
105692153|NCT01524133|364538339|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
105692154|NCT01524133|364538340|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
105692155|NCT00733304|364538347|FG000|Overall Study|Adverse Event|3|||
105692156|NCT00733304|364538348|FG001|Overall Study|Adverse Event|0|||
105692157|NCT00733304|364538349|FG002|Overall Study|Adverse Event|0|||
105692158|NCT00733304|364538347|FG000|Overall Study|Lack of Efficacy|0|||
105692159|NCT00733304|364538348|FG001|Overall Study|Lack of Efficacy|0|||
105692160|NCT00733304|364538349|FG002|Overall Study|Lack of Efficacy|2|||
105692161|NCT00733304|364538347|FG000|Overall Study|Lost to Follow-up|0|||
105692162|NCT00733304|364538348|FG001|Overall Study|Lost to Follow-up|1|||
105692163|NCT00733304|364538349|FG002|Overall Study|Lost to Follow-up|0|||
105692164|NCT00733304|364538347|FG000|Overall Study|Physician Decision|3|||
105692165|NCT00733304|364538348|FG001|Overall Study|Physician Decision|1|||
105346589|NCT01573767|363271368|FG003|Overall Study|Withdrawal by Subject|0|||
105472130|NCT04380519|363739996|FG001|Overall Study|relatives' decision|1|||
105692166|NCT00733304|364538349|FG002|Overall Study|Physician Decision|3|||
105692167|NCT00733304|364538347|FG000|Overall Study|Withdrawal by Subject|1|||
105692168|NCT00733304|364538348|FG001|Overall Study|Withdrawal by Subject|1|||
105692169|NCT00733304|364538349|FG002|Overall Study|Withdrawal by Subject|0|||
105692170|NCT00129623|364538350|FG000|Overall Study|Adverse Event|3|||
105692171|NCT00129623|364538351|FG001|Overall Study|Adverse Event|7|||
105692172|NCT00129623|364538350|FG000|Overall Study|Refused Treatment|5|||
105692173|NCT00129623|364538351|FG001|Overall Study|Refused Treatment|3|||
105692174|NCT00129623|364538350|FG000|Overall Study|Failure to Return|1|||
105692175|NCT00129623|364538351|FG001|Overall Study|Failure to Return|1|||
105692176|NCT00129623|364538350|FG000|Overall Study|Relocated job out of state|1|||
105692177|NCT00129623|364538351|FG001|Overall Study|Relocated job out of state|0|||
105692178|NCT00129623|364538350|FG000|Overall Study|Uncertainty to return|0|||
105346590|NCT01371877|363271369|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
105346591|NCT01371877|363271370|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
105472131|NCT04380519|363739997|FG002|Overall Study|relatives' decision|0|||
105692179|NCT00129623|364538351|FG001|Overall Study|Uncertainty to return|1|||
105692180|NCT03239483|364538352|FG000|Overall Study|Lost to Follow-up|1|||
105692181|NCT03239483|364538353|FG001|Overall Study|Lost to Follow-up|0|||
105692182|NCT03239483|364538352|FG000|Overall Study|Withdrawal by Subject|1|||
105692183|NCT03239483|364538353|FG001|Overall Study|Withdrawal by Subject|0|||
105692184|NCT03781323|364538354|FG000|Overall Study|Withdrawal by Subject|1|||
105692185|NCT01338415|364538355|FG000|Core + Extension|Adverse Event|8|||
105692186|NCT01338415|364538356|FG001|Core + Extension|Adverse Event|6|||
105346592|NCT03391232|363271371|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
105692187|NCT01338415|364538357|FG002|Core + Extension|Adverse Event|0|||
105692188|NCT01338415|364538355|FG000|Core + Extension|Withdrawal by Subject|1|||
105692189|NCT01338415|364538356|FG001|Core + Extension|Withdrawal by Subject|1|||
105346593|NCT03391232|363271372|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
105786976|NCT02146365|364872948|FG001|Overall Study|Withdrawal by Subject|2|||
105346594|NCT03391232|363271371|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
105346595|NCT03391232|363271372|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
105346596|NCT02560623|363271377|FG000|Overall Study|Unable to swallow sponge|0|||
105346597|NCT02560623|363271378|FG001|Overall Study|Unable to swallow sponge|1|||
105346598|NCT02560623|363271379|FG002|Overall Study|Unable to swallow sponge|0|||
105346599|NCT02560623|363271380|FG003|Overall Study|Unable to swallow sponge|0|||
105346600|NCT02560623|363271377|FG000|Overall Study|Intervention prior to sponge administration|0|||
105346601|NCT02560623|363271378|FG001|Overall Study|Intervention prior to sponge administration|1|||
105346602|NCT02560623|363271379|FG002|Overall Study|Intervention prior to sponge administration|0|||
105346603|NCT02560623|363271380|FG003|Overall Study|Intervention prior to sponge administration|0|||
105346604|NCT01125813|363271381|FG000|Overall Study|Death|1|||
105692190|NCT01338415|364538357|FG002|Core + Extension|Withdrawal by Subject|0|||
105692191|NCT01338415|364538355|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
105692192|NCT01338415|364538356|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
105692193|NCT01338415|364538357|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
105692194|NCT01338415|364538355|FG000|Core + Extension|Other (administrative reason)|1|||
105692195|NCT01338415|364538356|FG001|Core + Extension|Other (administrative reason)|0|||
105692196|NCT01338415|364538357|FG002|Core + Extension|Other (administrative reason)|0|||
105692197|NCT01338415|364538355|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
105692198|NCT01338415|364538356|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
105692199|NCT01338415|364538357|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
105346605|NCT01125813|363271381|FG000|Overall Study|Withdrawal by Subject|1|||
105346606|NCT01125813|363271381|FG000|Overall Study|Screen Failures|4|||
105346607|NCT01211483|363271382|FG000|Phase 1b|Death|6|||
105346608|NCT01211483|363271383|FG001|Phase 1b|Death|0|||
105346609|NCT01211483|363271384|FG002|Phase 1b|Death|0|||
105346610|NCT01211483|363271385|FG003|Phase 1b|Death|0|||
105346611|NCT01211483|363271382|FG000|Phase 1b|Withdrawal by Subject|1|||
105346612|NCT01211483|363271383|FG001|Phase 1b|Withdrawal by Subject|0|||
105346613|NCT01211483|363271384|FG002|Phase 1b|Withdrawal by Subject|0|||
105346614|NCT01211483|363271385|FG003|Phase 1b|Withdrawal by Subject|0|||
105346615|NCT01211483|363271382|FG000|Phase 2|Lost to Follow-up|0|||
105346616|NCT01211483|363271383|FG001|Phase 2|Lost to Follow-up|1|||
105346617|NCT01211483|363271384|FG002|Phase 2|Lost to Follow-up|1|||
105346618|NCT01211483|363271385|FG003|Phase 2|Lost to Follow-up|2|||
105346619|NCT01211483|363271382|FG000|Phase 2|Death|0|||
105346620|NCT01211483|363271383|FG001|Phase 2|Death|64|||
105346621|NCT01211483|363271384|FG002|Phase 2|Death|53|||
105346622|NCT01211483|363271385|FG003|Phase 2|Death|53|||
105346623|NCT01211483|363271382|FG000|Phase 2|Withdrawal by Subject|0|||
105346624|NCT01211483|363271383|FG001|Phase 2|Withdrawal by Subject|1|||
105346625|NCT01211483|363271384|FG002|Phase 2|Withdrawal by Subject|10|||
105346626|NCT01211483|363271385|FG003|Phase 2|Withdrawal by Subject|5|||
105346627|NCT01211483|363271382|FG000|Phase 2|Study terminated by Sponsor|0|||
105346628|NCT01211483|363271383|FG001|Phase 2|Study terminated by Sponsor|6|||
105346629|NCT01211483|363271384|FG002|Phase 2|Study terminated by Sponsor|8|||
105346630|NCT01211483|363271385|FG003|Phase 2|Study terminated by Sponsor|11|||
105346631|NCT01675154|363271386|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
105346632|NCT01675154|363271387|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
105346633|NCT01675154|363271388|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
105346634|NCT01675154|363271389|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
105346635|NCT01143064|363271390|FG000|Overall Study|Death|109|||
105346636|NCT01143064|363271391|FG001|Overall Study|Death|91|||
105346637|NCT01143064|363271390|FG000|Overall Study|Adverse Event|0|||
105346638|NCT01143064|363271391|FG001|Overall Study|Adverse Event|1|||
105346639|NCT01143064|363271390|FG000|Overall Study|Withdrawal by Subject|7|||
105346640|NCT01143064|363271391|FG001|Overall Study|Withdrawal by Subject|5|||
105346641|NCT01143064|363271390|FG000|Overall Study|Lost to Follow-up|17|||
105346642|NCT01143064|363271391|FG001|Overall Study|Lost to Follow-up|14|||
105346643|NCT01143064|363271390|FG000|Overall Study|Physician Decision|0|||
105346644|NCT01143064|363271391|FG001|Overall Study|Physician Decision|4|||
105346645|NCT00985426|363271392|FG000|Overall Study|Adverse Event|0|||
105346646|NCT00985426|363271393|FG001|Overall Study|Adverse Event|1|||
105346647|NCT00985426|363271392|FG000|Overall Study|Subject Non-Compliance|3|||
105346648|NCT00985426|363271393|FG001|Overall Study|Subject Non-Compliance|3|||
105346649|NCT00985426|363271392|FG000|Overall Study|Withdrawal by Subject|12|||
105346650|NCT00985426|363271393|FG001|Overall Study|Withdrawal by Subject|16|||
105346651|NCT00985426|363271392|FG000|Overall Study|Lost to Follow-up|8|||
105346652|NCT00985426|363271393|FG001|Overall Study|Lost to Follow-up|10|||
105346653|NCT00985426|363271392|FG000|Overall Study|Death|7|||
105346654|NCT00985426|363271393|FG001|Overall Study|Death|3|||
105692200|NCT01338415|364538355|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
105346655|NCT00985426|363271392|FG000|Overall Study|Protocol Violation|2|||
105346656|NCT00985426|363271393|FG001|Overall Study|Protocol Violation|0|||
105346657|NCT00985426|363271392|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
105346658|NCT00985426|363271393|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
105472132|NCT03710083|363739998|FG000|Overall Study|Withdrawal by Subject|2|||
105472133|NCT03710083|363739998|FG000|Overall Study|Unsuccessful Procedure|1|||
105472134|NCT05300763|363739999|FG000|Overall Study|Adverse Event|0|||
105472135|NCT05300763|363740000|FG001|Overall Study|Adverse Event|1|||
105472136|NCT05300763|363739999|FG000|Overall Study|Major Protocol Deviation|1|||
105472137|NCT05300763|363740000|FG001|Overall Study|Major Protocol Deviation|0|||
105472138|NCT05300763|363739999|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
105472139|NCT05300763|363740000|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
105472140|NCT02920242|363740001|FG000|Overall Study|Withdrawal by Subject|1|||
105472141|NCT02920242|363740002|FG001|Overall Study|Withdrawal by Subject|0|||
105472142|NCT02920242|363740003|FG002|Overall Study|Withdrawal by Subject|1|||
105472143|NCT02920242|363740001|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
105472144|NCT02920242|363740002|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
105472145|NCT02920242|363740003|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
105472146|NCT00486291|363740008|FG000|Overall Study|Adverse Event|3|||
105472147|NCT00486291|363740009|FG001|Overall Study|Adverse Event|4|||
105472148|NCT00486291|363740008|FG000|Overall Study|Lost to Follow-up|3|||
105472149|NCT00486291|363740009|FG001|Overall Study|Lost to Follow-up|7|||
105472150|NCT00486291|363740008|FG000|Overall Study|protocol non-compliance|10|||
105472151|NCT00486291|363740009|FG001|Overall Study|protocol non-compliance|15|||
105472152|NCT00486291|363740008|FG000|Overall Study|requirement for restricted medication|0|||
105472153|NCT00486291|363740009|FG001|Overall Study|requirement for restricted medication|3|||
105472154|NCT00126490|363740015|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
105472155|NCT00975780|363740016|FG000|Follow Up|Death|88|||
105472156|NCT00975780|363740017|FG001|Follow Up|Death|122|||
105472157|NCT00975780|363740016|FG000|Follow Up|Facility Withdrawal|7|||
105472158|NCT00975780|363740017|FG001|Follow Up|Facility Withdrawal|23|||
105472159|NCT00975780|363740016|FG000|Follow Up|Discharged from Facility|7|||
105472160|NCT00975780|363740017|FG001|Follow Up|Discharged from Facility|12|||
105472161|NCT01262820|363740027|FG000|Overall Study|Adverse Event|5|||
105472162|NCT01262820|363740027|FG000|Overall Study|Lack of Efficacy|9|||
105472163|NCT01262820|363740027|FG000|Overall Study|Drug held for 21+ days|1|||
105472164|NCT05188053|363740030|FG000|Overall Study|Lost to Follow-up|23|||
105472165|NCT05188053|363740031|FG001|Overall Study|Lost to Follow-up|30|||
105472166|NCT05188053|363740030|FG000|Overall Study|Protocol Violation|16|||
105472167|NCT05188053|363740031|FG001|Overall Study|Protocol Violation|16|||
105472168|NCT05188053|363740030|FG000|Overall Study|Physician Decision|3|||
105472169|NCT05188053|363740031|FG001|Overall Study|Physician Decision|0|||
105472170|NCT05188053|363740030|FG000|Overall Study|Withdrawal by Subject|0|||
105472171|NCT05188053|363740031|FG001|Overall Study|Withdrawal by Subject|1|||
105472172|NCT02447302|363740035|FG000|Overall Study|Physician Decision|1|||
105472173|NCT02447302|363740036|FG001|Overall Study|Physician Decision|0|||
105472174|NCT02447302|363740037|FG002|Overall Study|Physician Decision|0|||
105472175|NCT02447302|363740035|FG000|Overall Study|Adverse Event|4|||
105472176|NCT02447302|363740036|FG001|Overall Study|Adverse Event|3|||
105472177|NCT02447302|363740037|FG002|Overall Study|Adverse Event|0|||
105472178|NCT02447302|363740035|FG000|Overall Study|Withdrawal by Subject|0|||
105472179|NCT02447302|363740036|FG001|Overall Study|Withdrawal by Subject|1|||
105472180|NCT02447302|363740037|FG002|Overall Study|Withdrawal by Subject|5|||
105472181|NCT02447302|363740035|FG000|Overall Study|Sponsor Decision|0|||
105472182|NCT02447302|363740036|FG001|Overall Study|Sponsor Decision|0|||
105472183|NCT02447302|363740037|FG002|Overall Study|Sponsor Decision|1|||
105472184|NCT00943072|363741348|FG000|Overall Study|Adverse Event|0|||
105472185|NCT00943072|363741349|FG001|Overall Study|Adverse Event|3|||
105472186|NCT00943072|363741348|FG000|Overall Study|Death|0|||
105472187|NCT00943072|363741349|FG001|Overall Study|Death|2|||
105472188|NCT00943072|363741348|FG000|Overall Study|Withdrawal by Subject|3|||
105472189|NCT00943072|363741349|FG001|Overall Study|Withdrawal by Subject|1|||
105559127|NCT04124926|364044587|FG004|Maintenance Phase|Pregnancy|0|||
105559128|NCT04124926|364044583|FG000|Maintenance Phase|Lack of Efficacy|0|||
105559129|NCT04124926|364044584|FG001|Maintenance Phase|Lack of Efficacy|0|||
105692201|NCT01338415|364538356|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
105692202|NCT01338415|364538357|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
105472190|NCT00943072|363741348|FG000|Overall Study|Protocol Violation|0|||
105472191|NCT00943072|363741349|FG001|Overall Study|Protocol Violation|1|||
105472192|NCT00943072|363741348|FG000|Overall Study|Lost to Follow-up|1|||
105472193|NCT00943072|363741349|FG001|Overall Study|Lost to Follow-up|2|||
105472194|NCT00943072|363741348|FG000|Overall Study|Lack of Efficacy|0|||
105472195|NCT00943072|363741349|FG001|Overall Study|Lack of Efficacy|4|||
105472196|NCT00943072|363741348|FG000|Overall Study|Other|1|||
105472197|NCT00943072|363741349|FG001|Overall Study|Other|1|||
105472198|NCT00552188|363741351|FG000|Overall Study|Adverse Event|0|||
105472199|NCT00552188|363741352|FG001|Overall Study|Adverse Event|2|||
105472200|NCT00552188|363741351|FG000|Overall Study|Lost to Follow-up|2|||
105472201|NCT00552188|363741352|FG001|Overall Study|Lost to Follow-up|1|||
105559130|NCT04124926|364044585|FG002|Maintenance Phase|Lack of Efficacy|0|||
105692203|NCT01338415|364538355|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
105346659|NCT02284568|363271396|FG000|Overall Study|Adverse Event|2|||
105346660|NCT02284568|363271397|FG001|Overall Study|Adverse Event|9|||
105346661|NCT02284568|363271398|FG002|Overall Study|Adverse Event|4|||
105346662|NCT02284568|363271396|FG000|Overall Study|Withdrawal by Subject|22|||
105346663|NCT02284568|363271397|FG001|Overall Study|Withdrawal by Subject|21|||
105346664|NCT02284568|363271398|FG002|Overall Study|Withdrawal by Subject|1|||
105346665|NCT02284568|363271396|FG000|Overall Study|Noncompliance with study drug admin|1|||
105346666|NCT02284568|363271397|FG001|Overall Study|Noncompliance with study drug admin|2|||
105346667|NCT02284568|363271398|FG002|Overall Study|Noncompliance with study drug admin|0|||
105346668|NCT02284568|363271396|FG000|Overall Study|Noncompliance|1|||
105472202|NCT00552188|363741351|FG000|Overall Study|Withdrawal of consent|0|||
105692204|NCT01338415|364538356|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
105692205|NCT01338415|364538357|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
105692206|NCT01338415|364538355|FG000|Exceptional Use Treatment Period|Death|0|||
105692207|NCT01338415|364538356|FG001|Exceptional Use Treatment Period|Death|0|||
105692208|NCT01338415|364538357|FG002|Exceptional Use Treatment Period|Death|1|||
105692209|NCT02308007|364538358|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
105692210|NCT02308007|364538359|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
105692211|NCT02308007|364538360|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
105692212|NCT02308007|364538358|FG000|Overall Study|Positive for STD at Baseline|7|||
105692213|NCT02308007|364538359|FG001|Overall Study|Positive for STD at Baseline|11|||
105692214|NCT02308007|364538360|FG002|Overall Study|Positive for STD at Baseline|7|||
105692215|NCT02308007|364538358|FG000|Overall Study|Lost to Follow-up|3|||
105692216|NCT02308007|364538359|FG001|Overall Study|Lost to Follow-up|0|||
105692217|NCT02308007|364538360|FG002|Overall Study|Lost to Follow-up|1|||
105692218|NCT01233869|364538361|FG000|Initial Treatment Period (24 Months)|Death|1|||
105692219|NCT01233869|364538362|FG001|Initial Treatment Period (24 Months)|Death|0|||
105692220|NCT01233869|364538363|FG002|Initial Treatment Period (24 Months)|Death|0|||
105692221|NCT01233869|364538364|FG003|Initial Treatment Period (24 Months)|Death|0|||
105692222|NCT01233869|364538361|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
105692223|NCT01233869|364538362|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
105692224|NCT01233869|364538363|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
105786977|NCT02146365|364872949|FG002|Overall Study|Withdrawal by Subject|1|||
105786978|NCT02146365|364872950|FG003|Overall Study|Withdrawal by Subject|5|||
105786979|NCT02146365|364872951|FG004|Overall Study|Withdrawal by Subject|1|||
105786980|NCT02146365|364872952|FG005|Overall Study|Withdrawal by Subject|0|||
105472203|NCT00552188|363741352|FG001|Overall Study|Withdrawal of consent|1|||
105692225|NCT01233869|364538364|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
105786981|NCT02146365|364872953|FG006|Overall Study|Withdrawal by Subject|0|||
105692226|NCT01233869|364538361|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
105692227|NCT01233869|364538362|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
105692228|NCT01233869|364538363|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
105692229|NCT01233869|364538364|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
105692230|NCT01233869|364538361|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
105692231|NCT01233869|364538362|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
105692232|NCT01233869|364538363|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
105692233|NCT01233869|364538364|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
105692234|NCT01233869|364538361|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
105692235|NCT01233869|364538362|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
105692236|NCT01233869|364538363|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
105692237|NCT01233869|364538364|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
105692238|NCT01233869|364538361|FG000|Extended Treatment Period (46 Months)|Other|3|||
105692239|NCT01233869|364538362|FG001|Extended Treatment Period (46 Months)|Other|0|||
105692240|NCT01233869|364538363|FG002|Extended Treatment Period (46 Months)|Other|0|||
105692241|NCT01233869|364538364|FG003|Extended Treatment Period (46 Months)|Other|3|||
105692242|NCT01233869|364538361|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
105692243|NCT01233869|364538362|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
105692244|NCT01233869|364538363|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
105692245|NCT01233869|364538364|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
105692246|NCT03334409|364538365|FG000|Overall Study|Did not meet inclusion criteria|1|||
105692247|NCT03334409|364538366|FG001|Overall Study|Did not meet inclusion criteria|0|||
105692248|NCT03678103|364538367|FG000|Overall Study|Withdrawn prior to completion|4|||
105692249|NCT00537485|364538368|FG000|Overall Study|Adverse Event|10|||
105692250|NCT00537485|364538369|FG001|Overall Study|Adverse Event|5|||
105692251|NCT00537485|364538368|FG000|Overall Study|Withdrawal by Subject|3|||
105692252|NCT00537485|364538369|FG001|Overall Study|Withdrawal by Subject|2|||
105692253|NCT00537485|364538368|FG000|Overall Study|Withdrawal by Subject|1|||
105692254|NCT00537485|364538369|FG001|Overall Study|Withdrawal by Subject|3|||
105692255|NCT00537485|364538368|FG000|Overall Study|Physician Decision|1|||
105692256|NCT00537485|364538369|FG001|Overall Study|Physician Decision|0|||
105692257|NCT01241552|364538379|FG000|Overall Study|Lack of Efficacy|1|||
105692258|NCT01241552|364538380|FG001|Overall Study|Lack of Efficacy|0|||
105692259|NCT01241552|364538381|FG002|Overall Study|Lack of Efficacy|0|||
105692260|NCT01241552|364538382|FG003|Overall Study|Lack of Efficacy|0|||
105692261|NCT01241552|364538379|FG000|Overall Study|Death|26|||
105692262|NCT01241552|364538380|FG001|Overall Study|Death|30|||
105692263|NCT01241552|364538381|FG002|Overall Study|Death|20|||
105692264|NCT01241552|364538382|FG003|Overall Study|Death|25|||
105692265|NCT01241552|364538379|FG000|Overall Study|Adverse Event|1|||
105692266|NCT01241552|364538380|FG001|Overall Study|Adverse Event|1|||
105692267|NCT01241552|364538381|FG002|Overall Study|Adverse Event|0|||
105692268|NCT01241552|364538382|FG003|Overall Study|Adverse Event|0|||
105692269|NCT01241552|364538379|FG000|Overall Study|Technical Problems|2|||
105692270|NCT01241552|364538380|FG001|Overall Study|Technical Problems|0|||
105692271|NCT01241552|364538381|FG002|Overall Study|Technical Problems|2|||
105692272|NCT01241552|364538382|FG003|Overall Study|Technical Problems|2|||
105692273|NCT01241552|364538379|FG000|Overall Study|Progressive Disease|0|||
105692274|NCT01241552|364538380|FG001|Overall Study|Progressive Disease|0|||
105692275|NCT01241552|364538381|FG002|Overall Study|Progressive Disease|1|||
105692276|NCT01241552|364538382|FG003|Overall Study|Progressive Disease|2|||
105692277|NCT01241552|364538379|FG000|Overall Study|Protocol Violation|0|||
105692278|NCT01241552|364538380|FG001|Overall Study|Protocol Violation|2|||
105786982|NCT02146365|364872954|FG007|Overall Study|Withdrawal by Subject|0|||
105692279|NCT01241552|364538381|FG002|Overall Study|Protocol Violation|6|||
105692280|NCT01241552|364538382|FG003|Overall Study|Protocol Violation|1|||
105692281|NCT01241552|364538379|FG000|Overall Study|Withdrawal by Subject|7|||
105692282|NCT01241552|364538380|FG001|Overall Study|Withdrawal by Subject|15|||
105692283|NCT01241552|364538381|FG002|Overall Study|Withdrawal by Subject|14|||
105692284|NCT01241552|364538382|FG003|Overall Study|Withdrawal by Subject|15|||
105786983|NCT02146365|364872947|FG000|Overall Study|Unable to Comply with Protocol|0|||
105692285|NCT01241552|364538379|FG000|Overall Study|Physician Decision|2|||
105692286|NCT01241552|364538380|FG001|Overall Study|Physician Decision|4|||
105692287|NCT01241552|364538381|FG002|Overall Study|Physician Decision|2|||
105472204|NCT00552188|363741351|FG000|Overall Study|Subject returned to home country|0|||
105472205|NCT00552188|363741352|FG001|Overall Study|Subject returned to home country|1|||
105472206|NCT01788358|363741353|FG000|Overall Study|Other|11|||
105472207|NCT01788358|363741353|FG000|Overall Study|Logistical difficulties|1|||
105472208|NCT01788358|363741353|FG000|Overall Study|Lost to Follow-up|5|||
105692288|NCT01241552|364538382|FG003|Overall Study|Physician Decision|3|||
105692289|NCT01241552|364538379|FG000|Overall Study|Lost to Follow-up|2|||
105692290|NCT01241552|364538380|FG001|Overall Study|Lost to Follow-up|11|||
105692291|NCT01241552|364538381|FG002|Overall Study|Lost to Follow-up|15|||
105692292|NCT01241552|364538382|FG003|Overall Study|Lost to Follow-up|16|||
105692293|NCT01296035|364538384|FG000|Overall Study|Withdrawal by Subject|1|||
105692294|NCT00528567|364538385|FG000|Overall Study|Death|4|||
105692295|NCT00528567|364538386|FG001|Overall Study|Death|5|||
105692296|NCT00528567|364538385|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
105692297|NCT00528567|364538386|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
105692298|NCT00528567|364538385|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
105692299|NCT00528567|364538386|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
105692300|NCT00528567|364538385|FG000|Overall Study|Violation Criteria at Entry|3|||
105692301|NCT00528567|364538386|FG001|Overall Study|Violation Criteria at Entry|17|||
105692302|NCT00528567|364538385|FG000|Overall Study|Withdrew Consent|59|||
105692303|NCT00528567|364538386|FG001|Overall Study|Withdrew Consent|55|||
105692304|NCT00528567|364538385|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
105692305|NCT00528567|364538386|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
105692306|NCT00528567|364538385|FG000|Overall Study|Failure to Return|1|||
105692307|NCT00528567|364538386|FG001|Overall Study|Failure to Return|4|||
105692308|NCT00528567|364538385|FG000|Overall Study|Other Protocol Violation|5|||
105692309|NCT00528567|364538386|FG001|Overall Study|Other Protocol Violation|21|||
105692310|NCT00528567|364538385|FG000|Overall Study|Administrative/Other|22|||
105692311|NCT00528567|364538386|FG001|Overall Study|Administrative/Other|75|||
105692312|NCT04004429|364538390|FG000|Overall Study|Protocol Violation|1|||
105692313|NCT04004429|364538391|FG001|Overall Study|Protocol Violation|0|||
105692314|NCT04004429|364538392|FG002|Overall Study|Protocol Violation|0|||
105692315|NCT04004429|364538390|FG000|Overall Study|Physician Decision|0|||
105692316|NCT04004429|364538391|FG001|Overall Study|Physician Decision|1|||
105692317|NCT04004429|364538392|FG002|Overall Study|Physician Decision|1|||
105692318|NCT04004429|364538390|FG000|Overall Study|Withdrawal by Subject|1|||
105692319|NCT04004429|364538391|FG001|Overall Study|Withdrawal by Subject|1|||
105692320|NCT04004429|364538392|FG002|Overall Study|Withdrawal by Subject|1|||
105692321|NCT03085758|364538393|FG000|Overall Study|Death|26|||
105692322|NCT03085758|364538394|FG001|Overall Study|Death|24|||
105692323|NCT03085758|364538395|FG002|Overall Study|Death|53|||
105692324|NCT03085758|364538393|FG000|Overall Study|Lost to Follow-up|1|||
105692325|NCT03085758|364538394|FG001|Overall Study|Lost to Follow-up|1|||
105692326|NCT03085758|364538395|FG002|Overall Study|Lost to Follow-up|1|||
105692327|NCT03085758|364538393|FG000|Overall Study|Withdrawal by Subject|2|||
105692328|NCT03085758|364538394|FG001|Overall Study|Withdrawal by Subject|2|||
105692329|NCT03085758|364538395|FG002|Overall Study|Withdrawal by Subject|1|||
105692330|NCT03085758|364538393|FG000|Overall Study|Refusal to recall it up to day 90|0|||
105692331|NCT03085758|364538394|FG001|Overall Study|Refusal to recall it up to day 90|0|||
105692332|NCT03085758|364538395|FG002|Overall Study|Refusal to recall it up to day 90|1|||
105692333|NCT03085758|364538393|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
105692334|NCT03085758|364538394|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
105692335|NCT03085758|364538395|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
105692336|NCT01287364|364538397|FG000|Overall Study|Adverse Event|0|||
105692337|NCT01287364|364538398|FG001|Overall Study|Adverse Event|3|||
105692338|NCT01287364|364538397|FG000|Overall Study|Protocol Violation|5|||
105692339|NCT01287364|364538398|FG001|Overall Study|Protocol Violation|5|||
105692340|NCT01287364|364538397|FG000|Overall Study|Other Reason|4|||
105692341|NCT01287364|364538398|FG001|Overall Study|Other Reason|2|||
105472209|NCT01788358|363741353|FG000|Overall Study|Protocol Violation|3|||
105692342|NCT02187809|364538404|FG000|Overall Study|The study was terminated|3|||
105692343|NCT01641809|364538405|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
105692344|NCT01641809|364538406|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
105692345|NCT01641809|364538407|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
105692346|NCT01641809|364538408|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
105692347|NCT01641809|364538405|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
105692348|NCT01641809|364538406|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
105692349|NCT01641809|364538407|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
105692350|NCT01641809|364538408|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
105692351|NCT01641809|364538405|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
105692352|NCT01641809|364538406|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
105692353|NCT01641809|364538407|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
105692354|NCT01641809|364538408|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
105692355|NCT01641809|364538405|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
105346669|NCT02284568|363271397|FG001|Overall Study|Noncompliance|0|||
105692356|NCT01641809|364538406|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
105692357|NCT01641809|364538407|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
105692358|NCT01641809|364538408|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
105692359|NCT01641809|364538405|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
105692360|NCT01641809|364538406|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
105692361|NCT01641809|364538407|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
105692362|NCT01641809|364538408|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
105692363|NCT01641809|364538405|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
105346670|NCT02284568|363271398|FG002|Overall Study|Noncompliance|0|||
105346671|NCT02284568|363271396|FG000|Overall Study|Protocol Violation|0|||
105346672|NCT02284568|363271397|FG001|Overall Study|Protocol Violation|1|||
105346673|NCT02284568|363271398|FG002|Overall Study|Protocol Violation|0|||
105346674|NCT02284568|363271396|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
105346675|NCT02284568|363271397|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
105346676|NCT02284568|363271398|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
105346677|NCT02284568|363271396|FG000|Overall Study|Lost to Follow-up|0|||
105346678|NCT02284568|363271397|FG001|Overall Study|Lost to Follow-up|3|||
105346679|NCT02284568|363271398|FG002|Overall Study|Lost to Follow-up|0|||
105346680|NCT02284568|363271396|FG000|Overall Study|Lack of Efficacy|4|||
105346681|NCT02284568|363271397|FG001|Overall Study|Lack of Efficacy|7|||
105346682|NCT02284568|363271398|FG002|Overall Study|Lack of Efficacy|0|||
105692364|NCT01641809|364538406|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
105346683|NCT02284568|363271396|FG000|Overall Study|Other|1|||
105346684|NCT02284568|363271397|FG001|Overall Study|Other|2|||
105346685|NCT02284568|363271398|FG002|Overall Study|Other|0|||
105346686|NCT02284568|363271396|FG000|Overall Study|Withdrew before taking study drug|0|||
105346687|NCT02284568|363271397|FG001|Overall Study|Withdrew before taking study drug|1|||
105692365|NCT01641809|364538407|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
105346688|NCT02284568|363271398|FG002|Overall Study|Withdrew before taking study drug|0|||
105346689|NCT02255552|363271399|FG000|Overall Study|Participants enrolled into another study|0|||
105346690|NCT02255552|363271400|FG001|Overall Study|Participants enrolled into another study|11|||
105346691|NCT02255552|363271399|FG000|Overall Study|Withdrawal by Subject|1|||
105346692|NCT02255552|363271400|FG001|Overall Study|Withdrawal by Subject|4|||
105346693|NCT04829331|363271401|FG000|Overall Study|Lost to Follow-up|1|||
105346694|NCT04829331|363271402|FG001|Overall Study|Lost to Follow-up|0|||
105346695|NCT00460265|363271403|FG000|Overall Study|Lost to Follow-up|14|||
105346696|NCT00460265|363271404|FG001|Overall Study|Lost to Follow-up|15|||
105346697|NCT00460265|363271403|FG000|Overall Study|Physician Decision|1|||
105346698|NCT00460265|363271404|FG001|Overall Study|Physician Decision|2|||
105346699|NCT00460265|363271403|FG000|Overall Study|Withdrawal by Subject|10|||
105346700|NCT00460265|363271404|FG001|Overall Study|Withdrawal by Subject|25|||
105346701|NCT00460265|363271403|FG000|Overall Study|Ongoing|60|||
105346702|NCT00460265|363271404|FG001|Overall Study|Ongoing|47|||
105346703|NCT05323994|363271405|FG000|Overall Study|Protocol Violation|1|||
105346704|NCT00616603|363271408|FG000|Overall Study|Physician Decision|2|||
105346705|NCT00616603|363271409|FG001|Overall Study|Physician Decision|0|||
105346706|NCT00616603|363271410|FG002|Overall Study|Physician Decision|2|||
105346707|NCT01917344|363271418|FG000|Overall Study|Withdrawal by Subject|1|||
105346708|NCT00367484|363271421|FG000|Overall Study|Adverse Event|7|||
105346709|NCT00367484|363271421|FG000|Overall Study|Withdrew informed consent|5|||
105346710|NCT00367484|363271421|FG000|Overall Study|Travel to USA|1|||
105346711|NCT00367484|363271421|FG000|Overall Study|Lost to Follow-up|1|||
105692366|NCT01641809|364538408|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
105692367|NCT01641809|364538405|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
105692368|NCT01641809|364538406|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
105692369|NCT01641809|364538407|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
105346712|NCT00367484|363271421|FG000|Overall Study|Protocol Violation|1|||
105346713|NCT00367484|363271421|FG000|Overall Study|The choice of the patient|1|||
105346714|NCT00367484|363271421|FG000|Overall Study|Lack of Efficacy|1|||
105346715|NCT00943670|363271422|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
105346716|NCT00943670|363271422|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
105346717|NCT00943670|363271422|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
105346718|NCT00943670|363271422|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
105346719|NCT00943670|363271422|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
105346720|NCT00943670|363271422|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
105346721|NCT00943670|363271422|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
105346722|NCT00943670|363271422|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
105346723|NCT00943670|363271422|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
105346724|NCT00943670|363271422|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
105346725|NCT04472026|363271423|FG000|Overall Study|Lost to Follow-up|5|||
105346726|NCT01777295|363271426|FG000|Overall Study|Withdrawal by Subject|2|||
105346727|NCT01777295|363271427|FG001|Overall Study|Withdrawal by Subject|2|||
105346728|NCT01777295|363271426|FG000|Overall Study|Pregnancy|0|||
105346729|NCT01777295|363271427|FG001|Overall Study|Pregnancy|1|||
105346730|NCT01777295|363271426|FG000|Overall Study|Personal problem|1|||
105346731|NCT01777295|363271427|FG001|Overall Study|Personal problem|0|||
105346732|NCT01777295|363271426|FG000|Overall Study|Investigator call for AEs check|1|||
105346733|NCT01777295|363271427|FG001|Overall Study|Investigator call for AEs check|0|||
105346734|NCT02772276|363271428|FG000|Overall Study|Lost to Follow-up|0|||
105346735|NCT02772276|363271429|FG001|Overall Study|Lost to Follow-up|0|||
105346736|NCT02772276|363271430|FG002|Overall Study|Lost to Follow-up|0|||
105346737|NCT02772276|363271431|FG003|Overall Study|Lost to Follow-up|0|||
105346738|NCT02772276|363271432|FG004|Overall Study|Lost to Follow-up|0|||
105346739|NCT02772276|363271433|FG005|Overall Study|Lost to Follow-up|0|||
105346740|NCT02772276|363271434|FG006|Overall Study|Lost to Follow-up|1|||
105692370|NCT01641809|364538408|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
105692371|NCT01641809|364538405|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
105692372|NCT01641809|364538406|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
105346741|NCT02772276|363271435|FG007|Overall Study|Lost to Follow-up|0|||
105346742|NCT02772276|363271436|FG008|Overall Study|Lost to Follow-up|0|||
105346743|NCT02772276|363271437|FG009|Overall Study|Lost to Follow-up|0|||
105346744|NCT02772276|363271438|FG010|Overall Study|Lost to Follow-up|0|||
105692373|NCT01641809|364538407|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
105692374|NCT01641809|364538408|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
105346745|NCT02772276|363271439|FG011|Overall Study|Lost to Follow-up|0|||
105346746|NCT02772276|363271440|FG012|Overall Study|Lost to Follow-up|0|||
105346747|NCT02772276|363271428|FG000|Overall Study|Withdrew consent|0|||
105346748|NCT02772276|363271429|FG001|Overall Study|Withdrew consent|0|||
105346749|NCT02772276|363271430|FG002|Overall Study|Withdrew consent|0|||
105346750|NCT02772276|363271431|FG003|Overall Study|Withdrew consent|0|||
105346751|NCT02772276|363271432|FG004|Overall Study|Withdrew consent|0|||
105346752|NCT02772276|363271433|FG005|Overall Study|Withdrew consent|0|||
105346753|NCT02772276|363271434|FG006|Overall Study|Withdrew consent|0|||
105692375|NCT01641809|364538405|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
105692376|NCT01641809|364538406|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
105692377|NCT01641809|364538407|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
105692378|NCT01641809|364538408|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
105692379|NCT01641809|364538405|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
105692380|NCT01641809|364538406|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
105692381|NCT01641809|364538407|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
105692382|NCT01641809|364538408|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
105692383|NCT01641809|364538405|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
105692384|NCT01641809|364538406|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
105692385|NCT01641809|364538407|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
105692386|NCT01641809|364538408|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
105692387|NCT01641809|364538405|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
105692388|NCT01641809|364538406|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
105692389|NCT01641809|364538407|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
105692390|NCT01641809|364538408|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
105692391|NCT01641809|364538405|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
105692392|NCT01641809|364538406|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
105692393|NCT01641809|364538407|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
105692394|NCT01641809|364538408|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
105692395|NCT01641809|364538405|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
105692396|NCT01641809|364538406|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
105692397|NCT01641809|364538407|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
105692398|NCT01641809|364538408|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
105692399|NCT01641809|364538405|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
105692400|NCT01641809|364538406|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
105692401|NCT01641809|364538407|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
105692402|NCT01641809|364538408|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
105692403|NCT01641809|364538405|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
105692404|NCT01641809|364538406|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
105692405|NCT01641809|364538407|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
105692406|NCT01641809|364538408|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
105692407|NCT01641809|364538405|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
105692408|NCT01641809|364538406|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
105692409|NCT01641809|364538407|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
105692410|NCT01641809|364538408|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
105692411|NCT01641809|364538405|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
105692412|NCT01641809|364538406|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
105692413|NCT01641809|364538407|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
105692414|NCT01641809|364538408|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
105692415|NCT01505010|364538409|FG000|Overall Study|Protocol Violation|0|||
105472210|NCT01788358|363741353|FG000|Overall Study|Withdrawal by Subject|26|||
105472211|NCT01788358|363741353|FG000|Overall Study|Lack of Efficacy|1|||
105692416|NCT01505010|364538410|FG001|Overall Study|Protocol Violation|1|||
105692417|NCT01505010|364538409|FG000|Overall Study|Lost to Follow-up|0|||
105472212|NCT01788358|363741353|FG000|Overall Study|Adverse Event|51|||
105472213|NCT01168219|363741354|FG000|Overall Study|off study before starting treatment|2|||
105472214|NCT01168219|363741354|FG000|Overall Study|withdrew before transplant|1|||
105472215|NCT01168219|363741354|FG000|Overall Study|ineligible due to CML|2|||
105472216|NCT02736890|363741355|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
105692418|NCT01505010|364538410|FG001|Overall Study|Lost to Follow-up|1|||
105692419|NCT04195581|364538413|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
105692420|NCT04195581|364538413|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
105692421|NCT04195581|364538413|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
105692422|NCT04195581|364538413|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
105692423|NCT04195581|364538413|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
105692424|NCT04195581|364538413|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
105692425|NCT01387230|364538414|FG000|Overall Study|Adverse Event|0|||
105692426|NCT01387230|364538415|FG001|Overall Study|Adverse Event|1|||
105692427|NCT01387230|364538416|FG002|Overall Study|Adverse Event|3|||
105472217|NCT02736890|363741356|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
105472218|NCT02736890|363741355|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
105472219|NCT02736890|363741356|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
105472220|NCT01027273|363741357|FG000|Overall Study|Lost to Follow-up|57|||
105472221|NCT01027273|363741358|FG001|Overall Study|Lost to Follow-up|31|||
105472222|NCT01027273|363741357|FG000|Overall Study|Death|2|||
105472223|NCT01027273|363741358|FG001|Overall Study|Death|2|||
105472224|NCT00555061|363741360|FG000|Overall Study|Adverse Event|3|||
105472225|NCT00555061|363741360|FG000|Overall Study|Protocol Violation|1|||
105472226|NCT00555061|363741360|FG000|Overall Study|Lost to Follow-up|2|||
105472227|NCT00555061|363741360|FG000|Overall Study|Withdrawal by Subject|2|||
105472228|NCT00555061|363741360|FG000|Overall Study|Participant enrolled, but never treated|1|||
105472229|NCT03926611|363741361|FG000|Overall Study|Adverse Event|0|||
105472230|NCT03926611|363741362|FG001|Overall Study|Adverse Event|0|||
105472231|NCT03926611|363741363|FG002|Overall Study|Adverse Event|0|||
105472232|NCT03926611|363741364|FG003|Overall Study|Adverse Event|3|||
105472233|NCT03926611|363741365|FG004|Overall Study|Adverse Event|1|||
105472234|NCT03926611|363741366|FG005|Overall Study|Adverse Event|3|||
105472235|NCT03926611|363741367|FG006|Overall Study|Adverse Event|0|||
105472236|NCT03926611|363741361|FG000|Overall Study|Lack of Efficacy|1|||
105472237|NCT03926611|363741362|FG001|Overall Study|Lack of Efficacy|2|||
105472238|NCT03926611|363741363|FG002|Overall Study|Lack of Efficacy|0|||
105472239|NCT03926611|363741364|FG003|Overall Study|Lack of Efficacy|0|||
105472240|NCT03926611|363741365|FG004|Overall Study|Lack of Efficacy|1|||
105472241|NCT03926611|363741366|FG005|Overall Study|Lack of Efficacy|0|||
105472242|NCT03926611|363741367|FG006|Overall Study|Lack of Efficacy|1|||
105472243|NCT03926611|363741361|FG000|Overall Study|Physician Decision|0|||
105472244|NCT03926611|363741362|FG001|Overall Study|Physician Decision|0|||
105472245|NCT03926611|363741363|FG002|Overall Study|Physician Decision|0|||
105472246|NCT03926611|363741364|FG003|Overall Study|Physician Decision|0|||
105472247|NCT03926611|363741365|FG004|Overall Study|Physician Decision|0|||
105472248|NCT03926611|363741366|FG005|Overall Study|Physician Decision|1|||
105472249|NCT03926611|363741367|FG006|Overall Study|Physician Decision|0|||
105472250|NCT03926611|363741361|FG000|Overall Study|Protocol Violation|1|||
105472251|NCT03926611|363741362|FG001|Overall Study|Protocol Violation|0|||
105472252|NCT03926611|363741363|FG002|Overall Study|Protocol Violation|0|||
105472253|NCT03926611|363741364|FG003|Overall Study|Protocol Violation|1|||
105472254|NCT03926611|363741365|FG004|Overall Study|Protocol Violation|1|||
105472255|NCT03926611|363741366|FG005|Overall Study|Protocol Violation|1|||
105472256|NCT03926611|363741367|FG006|Overall Study|Protocol Violation|1|||
105472257|NCT03926611|363741361|FG000|Overall Study|Technical problems|0|||
105472258|NCT03926611|363741362|FG001|Overall Study|Technical problems|0|||
105472259|NCT03926611|363741363|FG002|Overall Study|Technical problems|0|||
105472260|NCT03926611|363741364|FG003|Overall Study|Technical problems|0|||
105472261|NCT03926611|363741365|FG004|Overall Study|Technical problems|0|||
105472262|NCT03926611|363741366|FG005|Overall Study|Technical problems|1|||
105559131|NCT04124926|364044586|FG003|Maintenance Phase|Lack of Efficacy|0|||
105559132|NCT04124926|364044587|FG004|Maintenance Phase|Lack of Efficacy|1|||
105559133|NCT04124926|364044583|FG000|Maintenance Phase|Withdrawal of Consent|0|||
105559134|NCT04124926|364044584|FG001|Maintenance Phase|Withdrawal of Consent|0|||
105692428|NCT01387230|364538414|FG000|Overall Study|Lack of Efficacy|8|||
105692429|NCT01387230|364538415|FG001|Overall Study|Lack of Efficacy|5|||
105692430|NCT01387230|364538416|FG002|Overall Study|Lack of Efficacy|4|||
105692431|NCT01387230|364538414|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
105472263|NCT03926611|363741367|FG006|Overall Study|Technical problems|0|||
105472264|NCT03926611|363741361|FG000|Overall Study|Withdrawal by Subject|1|||
105472265|NCT03926611|363741362|FG001|Overall Study|Withdrawal by Subject|1|||
105472266|NCT03926611|363741363|FG002|Overall Study|Withdrawal by Subject|1|||
105472267|NCT03926611|363741364|FG003|Overall Study|Withdrawal by Subject|0|||
105472268|NCT03926611|363741365|FG004|Overall Study|Withdrawal by Subject|0|||
105472269|NCT03926611|363741366|FG005|Overall Study|Withdrawal by Subject|1|||
105472270|NCT03926611|363741367|FG006|Overall Study|Withdrawal by Subject|3|||
105692432|NCT01387230|364538415|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
105692433|NCT01387230|364538416|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
105692434|NCT01387230|364538414|FG000|Overall Study|Lost to Follow-up|0|||
105692435|NCT01387230|364538415|FG001|Overall Study|Lost to Follow-up|0|||
105692436|NCT01387230|364538416|FG002|Overall Study|Lost to Follow-up|1|||
105692437|NCT01387230|364538414|FG000|Overall Study|Withdrawal by Subject|4|||
105692438|NCT01387230|364538415|FG001|Overall Study|Withdrawal by Subject|1|||
105692439|NCT01387230|364538416|FG002|Overall Study|Withdrawal by Subject|0|||
105692440|NCT02558231|364538420|FG000|Overall Study|Death|4|||
105692441|NCT02558231|364538421|FG001|Overall Study|Death|12|||
105692442|NCT02558231|364538420|FG000|Overall Study|Lost to Follow-up|7|||
105692443|NCT02558231|364538421|FG001|Overall Study|Lost to Follow-up|4|||
105692444|NCT02558231|364538420|FG000|Overall Study|Withdrawal by Subject|7|||
105692445|NCT02558231|364538421|FG001|Overall Study|Withdrawal by Subject|4|||
105692446|NCT02558231|364538420|FG000|Overall Study|Physician Decision|7|||
105692447|NCT02558231|364538421|FG001|Overall Study|Physician Decision|5|||
105692448|NCT02558231|364538420|FG000|Overall Study|Sponsor Decision|0|||
105692449|NCT02558231|364538421|FG001|Overall Study|Sponsor Decision|1|||
105692450|NCT01294150|364538422|FG000|Overall Study|Physician Decision|2|||
105692451|NCT01294150|364538423|FG001|Overall Study|Physician Decision|2|||
105692452|NCT03675776|364538424|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
105692453|NCT03675776|364538425|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
105692454|NCT03675776|364538426|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
105692455|NCT03675776|364538424|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
105692456|NCT03675776|364538425|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
105692457|NCT03675776|364538426|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
105692458|NCT02401412|364538427|FG000|Overall Study|Lost to Follow-up|1|||
105692459|NCT02401412|364538428|FG001|Overall Study|Lost to Follow-up|0|||
105692460|NCT02401412|364538427|FG000|Overall Study|Discontinued Intervention|15|||
105692461|NCT02401412|364538428|FG001|Overall Study|Discontinued Intervention|21|||
105692462|NCT02401412|364538427|FG000|Overall Study|Withdrawal by Subject|4|||
105692463|NCT02401412|364538428|FG001|Overall Study|Withdrawal by Subject|4|||
105692464|NCT02401412|364538427|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
105692465|NCT02401412|364538428|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
105692466|NCT02401412|364538427|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
105472271|NCT03926611|363741361|FG000|Overall Study|Covid-19 pandemic|0|||
105472272|NCT03926611|363741362|FG001|Overall Study|Covid-19 pandemic|0|||
105472273|NCT03926611|363741363|FG002|Overall Study|Covid-19 pandemic|1|||
105692467|NCT02401412|364538428|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
105692468|NCT02608879|364538431|FG000|Overall Study|Lost to Follow-up|1|||
105692469|NCT02608879|364538432|FG001|Overall Study|Lost to Follow-up|0|||
105692470|NCT02608879|364538433|FG002|Overall Study|Lost to Follow-up|0|||
105692471|NCT02608879|364538431|FG000|Overall Study|Did not meet continuation criteria|0|||
105786984|NCT02146365|364872948|FG001|Overall Study|Unable to Comply with Protocol|1|||
105786985|NCT02146365|364872949|FG002|Overall Study|Unable to Comply with Protocol|1|||
105786986|NCT02146365|364872950|FG003|Overall Study|Unable to Comply with Protocol|0|||
105786987|NCT02146365|364872951|FG004|Overall Study|Unable to Comply with Protocol|0|||
105786988|NCT02146365|364872952|FG005|Overall Study|Unable to Comply with Protocol|0|||
105472274|NCT03926611|363741364|FG003|Overall Study|Covid-19 pandemic|0|||
105472275|NCT03926611|363741365|FG004|Overall Study|Covid-19 pandemic|1|||
105786989|NCT02146365|364872953|FG006|Overall Study|Unable to Comply with Protocol|0|||
105786990|NCT02146365|364872954|FG007|Overall Study|Unable to Comply with Protocol|0|||
105786991|NCT02146365|364872947|FG000|Overall Study|Other|1|||
105786992|NCT02146365|364872948|FG001|Overall Study|Other|0|||
105786993|NCT02146365|364872949|FG002|Overall Study|Other|2|||
105786994|NCT02146365|364872950|FG003|Overall Study|Other|1|||
105786995|NCT02146365|364872951|FG004|Overall Study|Other|0|||
105786996|NCT02146365|364872952|FG005|Overall Study|Other|0|||
105786997|NCT02146365|364872953|FG006|Overall Study|Other|0|||
105786998|NCT02146365|364872954|FG007|Overall Study|Other|0|||
105786999|NCT01479777|364874846|FG000|Overall Study|Physician Decision|2|||
105787000|NCT00270205|364874848|FG000|Overall Study|Lost to Follow-up|1|||
105787001|NCT00270205|364874849|FG001|Overall Study|Lost to Follow-up|0|||
105787002|NCT00270205|364874850|FG002|Overall Study|Lost to Follow-up|0|||
105787003|NCT00270205|364874851|FG003|Overall Study|Lost to Follow-up|1|||
105787004|NCT00066573|364874855|FG000|Overall Study|Did not received protocol treatment|28|||
105787005|NCT00066573|364874856|FG001|Overall Study|Did not received protocol treatment|28|||
105787006|NCT01855607|364874859|FG000|Overall Study|Withdrawal by Subject|1|||
105787007|NCT01855607|364874859|FG000|Overall Study|Study was terminated|11|||
105787008|NCT01548573|364874865|FG000|Overall Study|Death|3|||
105787009|NCT01548573|364874865|FG000|Overall Study|Withdrawal by Subject|2|||
105787010|NCT01366846|364874866|FG000|Overall Study|Withdrawal by Subject|2|||
105787011|NCT01366846|364874867|FG001|Overall Study|Withdrawal by Subject|0|||
105787012|NCT01366846|364874868|FG002|Overall Study|Withdrawal by Subject|0|||
105787013|NCT01366846|364874869|FG003|Overall Study|Withdrawal by Subject|0|||
105787014|NCT01366846|364874866|FG000|Overall Study|Communication Difficulties|1|||
105787015|NCT01366846|364874867|FG001|Overall Study|Communication Difficulties|4|||
105346754|NCT02772276|363271435|FG007|Overall Study|Withdrew consent|1|||
105472276|NCT03926611|363741366|FG005|Overall Study|Covid-19 pandemic|2|||
105472277|NCT03926611|363741367|FG006|Overall Study|Covid-19 pandemic|0|||
105692472|NCT02608879|364538432|FG001|Overall Study|Did not meet continuation criteria|0|||
105692473|NCT02608879|364538433|FG002|Overall Study|Did not meet continuation criteria|3|||
105692474|NCT04246801|364538434|FG000|Overall Study|Adverse Event|1|||
105692475|NCT04246801|364538435|FG001|Overall Study|Adverse Event|1|||
105692476|NCT04246801|364538434|FG000|Overall Study|Protocol Violation|1|||
105692477|NCT04246801|364538435|FG001|Overall Study|Protocol Violation|1|||
105692478|NCT04246801|364538434|FG000|Overall Study|Lack of Efficacy|0|||
105692479|NCT04246801|364538435|FG001|Overall Study|Lack of Efficacy|2|||
105692480|NCT04246801|364538434|FG000|Overall Study|Lost to Follow-up|1|||
105692481|NCT04246801|364538435|FG001|Overall Study|Lost to Follow-up|1|||
105692482|NCT04246801|364538434|FG000|Overall Study|Withdrawal by Subject|2|||
105692483|NCT04246801|364538435|FG001|Overall Study|Withdrawal by Subject|1|||
105692484|NCT01184053|364538438|FG000|Overall Study|progression while on treatment|3|||
105692485|NCT01174238|364538440|FG000|Overall Study|Lost to Follow-up|2|||
105692486|NCT02301936|364538441|FG000|Overall Study|Lost to Follow-up|1|||
105692487|NCT02301936|364538442|FG001|Overall Study|Lost to Follow-up|0|||
105692488|NCT03065023|364538443|FG000|Overall Study|Progressive Disease|0|||
105692489|NCT03065023|364538444|FG001|Overall Study|Progressive Disease|1|||
105692490|NCT03065023|364538445|FG002|Overall Study|Progressive Disease|0|||
105692491|NCT03065023|364538446|FG003|Overall Study|Progressive Disease|0|||
105692492|NCT03065023|364538447|FG004|Overall Study|Progressive Disease|0|||
105692493|NCT03065023|364538443|FG000|Overall Study|Death|2|||
105692494|NCT03065023|364538444|FG001|Overall Study|Death|0|||
105692495|NCT03065023|364538445|FG002|Overall Study|Death|1|||
105472278|NCT00859456|363741370|FG000|Overall Study|Adverse Event|3|||
105472279|NCT00859456|363741370|FG000|Overall Study|Progressive disease|2|||
105692496|NCT03065023|364538446|FG003|Overall Study|Death|1|||
105472280|NCT00859456|363741370|FG000|Overall Study|Non-compliance|3|||
105692497|NCT03065023|364538447|FG004|Overall Study|Death|0|||
105692498|NCT03065023|364538443|FG000|Overall Study|Lost to Follow-up|0|||
105692499|NCT03065023|364538444|FG001|Overall Study|Lost to Follow-up|1|||
105692500|NCT03065023|364538445|FG002|Overall Study|Lost to Follow-up|0|||
105692501|NCT03065023|364538446|FG003|Overall Study|Lost to Follow-up|0|||
105787016|NCT01366846|364874868|FG002|Overall Study|Communication Difficulties|0|||
105787017|NCT01366846|364874869|FG003|Overall Study|Communication Difficulties|1|||
105787018|NCT01366846|364874866|FG000|Overall Study|Scheduling Conflicts|0|||
105787019|NCT01366846|364874867|FG001|Overall Study|Scheduling Conflicts|0|||
105787020|NCT01366846|364874868|FG002|Overall Study|Scheduling Conflicts|1|||
105787021|NCT01366846|364874869|FG003|Overall Study|Scheduling Conflicts|0|||
105787022|NCT02204449|364874870|FG000|Overall Study|Lost to Follow-up|7|||
105787023|NCT02204449|364874871|FG001|Overall Study|Lost to Follow-up|9|||
105787024|NCT02204449|364874870|FG000|Overall Study|Death|0|||
105472281|NCT00856518|363741371|FG000|Overall Study|Lost to Follow-up|4|||
105472282|NCT00856518|363741372|FG001|Overall Study|Lost to Follow-up|2|||
105472283|NCT00947193|363741373|FG000|Overall Study|Lost to Follow-up|1|||
105472284|NCT00947193|363741374|FG001|Overall Study|Lost to Follow-up|0|||
105472285|NCT00947193|363741373|FG000|Overall Study|Withdrawal by Subject|1|||
105472286|NCT00947193|363741374|FG001|Overall Study|Withdrawal by Subject|0|||
105472287|NCT00947193|363741373|FG000|Overall Study|Factor VIII >1%|1|||
105472288|NCT00947193|363741374|FG001|Overall Study|Factor VIII >1%|0|||
105472289|NCT04364984|363741375|FG000|Overall Study|Death|2|||
105472290|NCT04364984|363741376|FG001|Overall Study|Death|2|||
105472291|NCT04364984|363741377|FG002|Overall Study|Death|0|||
105472292|NCT00926029|363741378|FG000|Overall Study|Lost to Follow-up|2|||
105472293|NCT00926029|363741379|FG001|Overall Study|Lost to Follow-up|1|||
105472294|NCT00926029|363741380|FG002|Overall Study|Lost to Follow-up|1|||
105472295|NCT01262989|363741381|FG000|Period 1|Lost to Follow-up|1|||
105472296|NCT01262989|363741382|FG001|Period 1|Lost to Follow-up|1|||
105472297|NCT01262989|363741381|FG000|Period 1|Intercurrent disease|0|||
105472298|NCT01262989|363741382|FG001|Period 1|Intercurrent disease|1|||
105472299|NCT01262989|363741381|FG000|Period 1|Positive answer for exclusion criteria|0|||
105472300|NCT01262989|363741382|FG001|Period 1|Positive answer for exclusion criteria|1|||
105472301|NCT01262989|363741381|FG000|Period 2|Intercurrent disease|0|||
105472302|NCT01262989|363741382|FG001|Period 2|Intercurrent disease|1|||
105472303|NCT02147561|363741383|FG000|Overall Study|Lost to Follow-up|3|||
105472304|NCT02147561|363741383|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
105472305|NCT01485172|363741384|FG000|Overall Study|Adverse Event|2|||
105472306|NCT01485172|363741385|FG001|Overall Study|Adverse Event|1|||
105472307|NCT01485172|363741386|FG002|Overall Study|Adverse Event|2|||
105472308|NCT01485172|363741387|FG003|Overall Study|Adverse Event|2|||
105472309|NCT01485172|363741388|FG004|Overall Study|Adverse Event|1|||
105472310|NCT01485172|363741389|FG005|Overall Study|Adverse Event|2|||
105472311|NCT01485172|363741384|FG000|Overall Study|Lack of Efficacy|2|||
105472312|NCT01485172|363741385|FG001|Overall Study|Lack of Efficacy|0|||
105472313|NCT01485172|363741386|FG002|Overall Study|Lack of Efficacy|0|||
105472314|NCT01485172|363741387|FG003|Overall Study|Lack of Efficacy|0|||
105472315|NCT01485172|363741388|FG004|Overall Study|Lack of Efficacy|0|||
105472316|NCT01485172|363741389|FG005|Overall Study|Lack of Efficacy|0|||
105472317|NCT01485172|363741384|FG000|Overall Study|Protocol Violation|0|||
105472318|NCT01485172|363741385|FG001|Overall Study|Protocol Violation|0|||
105472319|NCT01485172|363741386|FG002|Overall Study|Protocol Violation|4|||
105692502|NCT03065023|364538447|FG004|Overall Study|Lost to Follow-up|0|||
105472320|NCT01485172|363741387|FG003|Overall Study|Protocol Violation|5|||
105472321|NCT01485172|363741388|FG004|Overall Study|Protocol Violation|1|||
105472322|NCT01485172|363741389|FG005|Overall Study|Protocol Violation|0|||
105472323|NCT01485172|363741384|FG000|Overall Study|Protocol defined stopping criteria|1|||
105472324|NCT01485172|363741385|FG001|Overall Study|Protocol defined stopping criteria|0|||
105472325|NCT01485172|363741386|FG002|Overall Study|Protocol defined stopping criteria|0|||
105472326|NCT01485172|363741387|FG003|Overall Study|Protocol defined stopping criteria|0|||
105472327|NCT01485172|363741388|FG004|Overall Study|Protocol defined stopping criteria|1|||
105472328|NCT01485172|363741389|FG005|Overall Study|Protocol defined stopping criteria|0|||
105472329|NCT01485172|363741384|FG000|Overall Study|Lost to Follow-up|0|||
105472330|NCT01485172|363741385|FG001|Overall Study|Lost to Follow-up|0|||
105472331|NCT01485172|363741386|FG002|Overall Study|Lost to Follow-up|1|||
105472332|NCT01485172|363741387|FG003|Overall Study|Lost to Follow-up|0|||
105472333|NCT01485172|363741388|FG004|Overall Study|Lost to Follow-up|0|||
105472334|NCT01485172|363741389|FG005|Overall Study|Lost to Follow-up|1|||
105472335|NCT01485172|363741384|FG000|Overall Study|Physician Decision|0|||
105472336|NCT01485172|363741385|FG001|Overall Study|Physician Decision|0|||
105472337|NCT01485172|363741386|FG002|Overall Study|Physician Decision|0|||
105472338|NCT01485172|363741387|FG003|Overall Study|Physician Decision|0|||
105472339|NCT01485172|363741388|FG004|Overall Study|Physician Decision|1|||
105472340|NCT01485172|363741389|FG005|Overall Study|Physician Decision|0|||
105472341|NCT01485172|363741384|FG000|Overall Study|Withdrawal by Subject|2|||
105472342|NCT01485172|363741385|FG001|Overall Study|Withdrawal by Subject|0|||
105472343|NCT01485172|363741386|FG002|Overall Study|Withdrawal by Subject|0|||
105472344|NCT01485172|363741387|FG003|Overall Study|Withdrawal by Subject|1|||
105472345|NCT01485172|363741388|FG004|Overall Study|Withdrawal by Subject|1|||
105472346|NCT01485172|363741389|FG005|Overall Study|Withdrawal by Subject|1|||
105472347|NCT02283762|363741393|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
105472348|NCT02283762|363741394|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
105472349|NCT02283762|363741393|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
105472350|NCT02283762|363741394|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
105472351|NCT02283762|363741393|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
105472352|NCT02283762|363741394|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
105472353|NCT02283762|363741393|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
105472354|NCT02283762|363741394|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
105472355|NCT02283762|363741393|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
105472356|NCT02283762|363741394|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
105472357|NCT02283762|363741393|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
105472358|NCT02283762|363741394|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
105472359|NCT02283762|363741393|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
105472360|NCT02283762|363741394|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
105472361|NCT02283762|363741393|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
105472362|NCT02283762|363741394|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
105472363|NCT02283762|363741393|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
105472364|NCT02283762|363741394|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
105472365|NCT02283762|363741393|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
105472366|NCT02283762|363741394|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
105472367|NCT02283762|363741393|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
105692503|NCT03065023|364538443|FG000|Overall Study|Participant Decision|0|||
105692504|NCT03065023|364538444|FG001|Overall Study|Participant Decision|0|||
105692505|NCT03065023|364538445|FG002|Overall Study|Participant Decision|0|||
105692506|NCT03065023|364538446|FG003|Overall Study|Participant Decision|1|||
105692507|NCT03065023|364538447|FG004|Overall Study|Participant Decision|0|||
105692508|NCT03065023|364538443|FG000|Overall Study|Withdrawal by Subject|0|||
105692509|NCT03065023|364538444|FG001|Overall Study|Withdrawal by Subject|0|||
105692510|NCT03065023|364538445|FG002|Overall Study|Withdrawal by Subject|0|||
105692511|NCT03065023|364538446|FG003|Overall Study|Withdrawal by Subject|1|||
105692512|NCT03065023|364538447|FG004|Overall Study|Withdrawal by Subject|0|||
105692513|NCT03427125|364538448|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
105692514|NCT03427125|364538449|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
105692515|NCT03427125|364538450|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
105692516|NCT04014361|364538451|FG000|Period 2|Physician Decision|0|||
105692517|NCT04014361|364538452|FG001|Period 2|Physician Decision|0|||
105692518|NCT04014361|364538453|FG002|Period 2|Physician Decision|0|||
105692519|NCT04014361|364538454|FG003|Period 2|Physician Decision|1|||
105787025|NCT02204449|364874871|FG001|Overall Study|Death|1|||
105787026|NCT02204449|364874870|FG000|Overall Study|Withdrawal by Subject|0|||
105472368|NCT02283762|363741394|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
105472369|NCT02283762|363741393|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
105472370|NCT02283762|363741394|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
105472371|NCT00202878|363741395|FG000|Overall Study|Death|964|||
105472372|NCT00202878|363741396|FG001|Overall Study|Death|968|||
105472373|NCT00202878|363741395|FG000|Overall Study|Only Vital Status Known|357|||
105472374|NCT00202878|363741396|FG001|Overall Study|Only Vital Status Known|356|||
105472375|NCT00202878|363741395|FG000|Overall Study|Lost to Follow-up|44|||
105472376|NCT00202878|363741396|FG001|Overall Study|Lost to Follow-up|49|||
105472377|NCT00202878|363741395|FG000|Overall Study|Site Closure|39|||
105472378|NCT00202878|363741396|FG001|Overall Study|Site Closure|36|||
105472379|NCT00202878|363741395|FG000|Overall Study|Withdrawal by Subject|795|||
105472380|NCT00202878|363741396|FG001|Overall Study|Withdrawal by Subject|808|||
105472381|NCT01942733|363741400|FG000|Overall Study|Lost to Follow-up|1|||
105472382|NCT01942733|363741400|FG000|Overall Study|Non-compliance with IMP|1|||
105472383|NCT01942733|363741400|FG000|Overall Study|Administrative|1|||
105472384|NCT00838513|363741401|FG000|Screening Period|Screen Failure|3|||
105472385|NCT00838513|363741401|FG000|Extension Treatment Period|Death|1|||
105472386|NCT00838513|363741401|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
105472387|NCT00139477|363741405|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
105472388|NCT00139477|363741406|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
105472389|NCT00139477|363741405|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
105472390|NCT00139477|363741406|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
105472391|NCT00139477|363741405|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
105472392|NCT00139477|363741406|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
105472393|NCT00139477|363741405|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
105472394|NCT00139477|363741406|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
105472395|NCT00139477|363741405|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
105472396|NCT00139477|363741406|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
105472397|NCT00139477|363741405|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
105472398|NCT00139477|363741406|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
105472399|NCT00139477|363741405|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
105472400|NCT00139477|363741406|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
105559135|NCT04124926|364044585|FG002|Maintenance Phase|Withdrawal of Consent|5|||
105559136|NCT04124926|364044586|FG003|Maintenance Phase|Withdrawal of Consent|5|||
105559137|NCT04124926|364044587|FG004|Maintenance Phase|Withdrawal of Consent|5|||
105692520|NCT04014361|364538455|FG004|Period 2|Physician Decision|0|||
105692521|NCT04014361|364538456|FG005|Period 2|Physician Decision|0|||
105692522|NCT04014361|364538457|FG006|Period 2|Physician Decision|0|||
105692523|NCT04014361|364538458|FG007|Period 2|Physician Decision|0|||
105692524|NCT01093326|364538465|FG000|Overall Study|Death|0|||
105692525|NCT01093326|364538466|FG001|Overall Study|Death|1|||
105692526|NCT01093326|364538467|FG002|Overall Study|Death|0|||
105692527|NCT01093326|364538465|FG000|Overall Study|Lack of Efficacy|7|||
105692528|NCT01093326|364538466|FG001|Overall Study|Lack of Efficacy|6|||
105692529|NCT01093326|364538467|FG002|Overall Study|Lack of Efficacy|3|||
105692530|NCT01093326|364538465|FG000|Overall Study|Lost to Follow-up|2|||
105692531|NCT01093326|364538466|FG001|Overall Study|Lost to Follow-up|5|||
105692532|NCT01093326|364538467|FG002|Overall Study|Lost to Follow-up|4|||
105692533|NCT01093326|364538465|FG000|Overall Study|Physician Decision|3|||
105692534|NCT01093326|364538466|FG001|Overall Study|Physician Decision|1|||
105472401|NCT00441064|363741412|FG000|Overall Study|Adverse Event|1|||
105472402|NCT00441064|363741413|FG001|Overall Study|Adverse Event|0|||
105472403|NCT00441064|363741412|FG000|Overall Study|Abnormal laboratory values|0|||
105692535|NCT01093326|364538467|FG002|Overall Study|Physician Decision|3|||
105787027|NCT02204449|364874871|FG001|Overall Study|Withdrawal by Subject|1|||
105787028|NCT00503035|364874872|FG000|Overall Study|Lost to Follow-up|2|||
105787029|NCT00503035|364874872|FG000|Overall Study|Physician Decision|3|||
105787030|NCT00503035|364874872|FG000|Overall Study|Ineligible|15|||
105787031|NCT05604521|364874873|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
105787032|NCT05604521|364874874|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
105787033|NCT05604521|364874873|FG000|Overall Study|Adverse Event|1|||
105787034|NCT05604521|364874874|FG001|Overall Study|Adverse Event|0|||
105787035|NCT05028816|364874883|FG000|Overall Study|Lost to Follow-up|5|||
105787036|NCT05028816|364874884|FG001|Overall Study|Lost to Follow-up|3|||
105787037|NCT05028816|364874883|FG000|Overall Study|Withdrawal by Subject|4|||
105787038|NCT05028816|364874884|FG001|Overall Study|Withdrawal by Subject|1|||
105787039|NCT05028816|364874883|FG000|Overall Study|Physician Decision|1|||
105787040|NCT05028816|364874884|FG001|Overall Study|Physician Decision|0|||
105787041|NCT01342445|364874885|FG000|Overall Study|Experienced side effects|0|||
105787042|NCT01342445|364874886|FG001|Overall Study|Experienced side effects|2|||
105787043|NCT05299359|364874887|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
105787044|NCT05299359|364874888|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
105787045|NCT05299359|364874887|FG000|Main Part: Day 1 up to Day 366|Other|2|||
105787046|NCT05299359|364874888|FG001|Main Part: Day 1 up to Day 366|Other|0|||
105787047|NCT05299359|364874887|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
105787048|NCT05299359|364874888|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
105787049|NCT05299359|364874887|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
105787050|NCT05299359|364874888|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
105346755|NCT02772276|363271436|FG008|Overall Study|Withdrew consent|0|||
105346756|NCT02772276|363271437|FG009|Overall Study|Withdrew consent|0|||
105346757|NCT02772276|363271438|FG010|Overall Study|Withdrew consent|0|||
105346758|NCT02772276|363271439|FG011|Overall Study|Withdrew consent|0|||
105346759|NCT02772276|363271440|FG012|Overall Study|Withdrew consent|0|||
105346760|NCT02332239|363271444|FG000|Overall Study|Lost to Follow-up|4|||
105346761|NCT02332239|363271445|FG001|Overall Study|Lost to Follow-up|6|||
105346762|NCT00628095|363271447|FG000|Overall Study|Adverse Event|5|||
105346763|NCT00628095|363271448|FG001|Overall Study|Adverse Event|3|||
105346764|NCT00628095|363271447|FG000|Overall Study|Lack of Efficacy|0|||
105346765|NCT00628095|363271448|FG001|Overall Study|Lack of Efficacy|3|||
105346766|NCT00628095|363271447|FG000|Overall Study|Withdrawal by Subject|2|||
105346767|NCT00628095|363271448|FG001|Overall Study|Withdrawal by Subject|0|||
105346768|NCT00628095|363271447|FG000|Overall Study|Other|0|||
105346769|NCT00628095|363271448|FG001|Overall Study|Other|1|||
105346770|NCT03235115|363271452|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
105346771|NCT03235115|363271453|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
105346772|NCT03235115|363271454|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
105346773|NCT03235115|363271455|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
105346774|NCT03235115|363271456|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
105346775|NCT03235115|363271457|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
105346776|NCT00006305|363271458|FG000|Overall Study|Withdrawal by Subject|17|||
105346777|NCT00006305|363271459|FG001|Overall Study|Withdrawal by Subject|10|||
105346778|NCT00006305|363271460|FG002|Overall Study|Withdrawal by Subject|15|||
105346779|NCT00006305|363271461|FG003|Overall Study|Withdrawal by Subject|14|||
105346780|NCT00662558|363271462|FG000|Overall Study|Adverse Event|21|||
105346781|NCT00662558|363271463|FG001|Overall Study|Adverse Event|59|||
105346782|NCT00662558|363271462|FG000|Overall Study|Lack of Efficacy|4|||
105346783|NCT00662558|363271463|FG001|Overall Study|Lack of Efficacy|7|||
105346784|NCT00662558|363271462|FG000|Overall Study|Lost to Follow-up|13|||
105346785|NCT00662558|363271463|FG001|Overall Study|Lost to Follow-up|10|||
105346786|NCT00662558|363271462|FG000|Overall Study|Other|9|||
105346787|NCT00662558|363271463|FG001|Overall Study|Other|14|||
105346788|NCT00662558|363271462|FG000|Overall Study|Withdrawal by Subject|7|||
105346789|NCT00662558|363271463|FG001|Overall Study|Withdrawal by Subject|12|||
105346790|NCT00662558|363271462|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
105346791|NCT00662558|363271463|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
105346792|NCT00329641|363271464|FG000|Overall Study|Did not start treatment|1|||
105346793|NCT00329641|363271464|FG000|Overall Study|Not eligible|1|||
105346794|NCT00329641|363271464|FG000|Overall Study|Adverse Event|3|||
105346795|NCT00329641|363271464|FG000|Overall Study|Other reason, not protocol specified|1|||
105346796|NCT00396877|363271465|FG000|Overall Study|Lost to Follow-up|2|||
105346797|NCT00396877|363271466|FG001|Overall Study|Lost to Follow-up|1|||
105346798|NCT00396877|363271465|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
105787051|NCT05299359|364874887|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
105787052|NCT05299359|364874888|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
105787053|NCT05299359|364874887|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
105787054|NCT05299359|364874888|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
105787055|NCT05299359|364874887|FG000|Extension Part: Day 1 to Day 366|Other|0|||
105787056|NCT05299359|364874888|FG001|Extension Part: Day 1 to Day 366|Other|1|||
105472404|NCT00441064|363741413|FG001|Overall Study|Abnormal laboratory values|2|||
105472405|NCT00441064|363741412|FG000|Overall Study|Abnormal test procedure results|0|||
105472406|NCT00441064|363741413|FG001|Overall Study|Abnormal test procedure results|1|||
105472407|NCT00441064|363741412|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105472408|NCT00441064|363741413|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105472409|NCT00441064|363741412|FG000|Overall Study|Protocol Deviation|3|||
105472410|NCT00441064|363741413|FG001|Overall Study|Protocol Deviation|2|||
105472411|NCT00441064|363741412|FG000|Overall Study|Patient withdrew consent|5|||
105559138|NCT04124926|364044583|FG000|Maintenance Phase|Miscellaneous|0|||
105559139|NCT04124926|364044584|FG001|Maintenance Phase|Miscellaneous|0|||
105692536|NCT01093326|364538465|FG000|Overall Study|Withdrawal by Subject|30|||
105692537|NCT01093326|364538466|FG001|Overall Study|Withdrawal by Subject|27|||
105692538|NCT01093326|364538467|FG002|Overall Study|Withdrawal by Subject|26|||
105692539|NCT01093326|364538465|FG000|Overall Study|Adverse Event|2|||
105692540|NCT01093326|364538466|FG001|Overall Study|Adverse Event|1|||
105692541|NCT01093326|364538467|FG002|Overall Study|Adverse Event|4|||
105692542|NCT01093326|364538465|FG000|Overall Study|Other|0|||
105692543|NCT01093326|364538466|FG001|Overall Study|Other|0|||
105692544|NCT01093326|364538467|FG002|Overall Study|Other|1|||
105692545|NCT01444456|364538468|FG000|Overall Study|Withdrawal by Subject|21|||
105692546|NCT01444456|364538468|FG000|Overall Study|Physician Decision|9|||
105692547|NCT01444456|364538468|FG000|Overall Study|Lost to Follow-up|37|||
105692548|NCT01444456|364538468|FG000|Overall Study|Death|73|||
105692549|NCT01444456|364538468|FG000|Overall Study|Ineligibility determined|23|||
105692550|NCT01444456|364538468|FG000|Overall Study|Other|18|||
105692551|NCT01444456|364538468|FG000|Overall Study|Not treated|104|||
105692552|NCT04223791|364538469|FG000|Overall Study|Lost to Follow-up|0|||
105692553|NCT04223791|364538470|FG001|Overall Study|Lost to Follow-up|4|||
105692554|NCT04223791|364538469|FG000|Overall Study|Physician Decision|5|||
105692555|NCT04223791|364538470|FG001|Overall Study|Physician Decision|1|||
105692556|NCT04223791|364538469|FG000|Overall Study|Protocol Violation|1|||
105692557|NCT04223791|364538470|FG001|Overall Study|Protocol Violation|1|||
105692558|NCT04223791|364538469|FG000|Overall Study|Withdrawal by Subject|10|||
105692559|NCT04223791|364538470|FG001|Overall Study|Withdrawal by Subject|12|||
105692560|NCT04223791|364538469|FG000|Overall Study|Pregnancy|1|||
105692561|NCT04223791|364538470|FG001|Overall Study|Pregnancy|1|||
105692562|NCT04223791|364538469|FG000|Overall Study|Ongoing in Study|305|||
105692563|NCT04223791|364538470|FG001|Overall Study|Ongoing in Study|302|||
105760668|NCT00293241|364776123|FG000|Overall Study|Withdrawal by Subject|4|||
105760669|NCT00293241|364776124|FG001|Overall Study|Withdrawal by Subject|8|||
105760670|NCT02661464|364776125|FG000|Overall Study|Lost to Follow-up|28|||
105760671|NCT02661464|364776126|FG001|Overall Study|Lost to Follow-up|0|||
105760672|NCT02661464|364776127|FG002|Overall Study|Lost to Follow-up|0|||
105760673|NCT02661464|364776128|FG003|Overall Study|Lost to Follow-up|0|||
105760674|NCT02661464|364776125|FG000|Overall Study|Withdrawal by Subject|3|||
105760675|NCT02661464|364776126|FG001|Overall Study|Withdrawal by Subject|1|||
105760676|NCT02661464|364776127|FG002|Overall Study|Withdrawal by Subject|0|||
105760677|NCT02661464|364776128|FG003|Overall Study|Withdrawal by Subject|0|||
105760678|NCT02661464|364776125|FG000|Overall Study|Participants terminated prematurely|288|||
105760679|NCT02661464|364776126|FG001|Overall Study|Participants terminated prematurely|52|||
105760680|NCT02661464|364776127|FG002|Overall Study|Participants terminated prematurely|1|||
105760681|NCT02661464|364776128|FG003|Overall Study|Participants terminated prematurely|1|||
105760682|NCT02661464|364776125|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
105760683|NCT02661464|364776126|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
105760684|NCT02661464|364776127|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
105760685|NCT02661464|364776128|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
105760686|NCT05567393|364776131|FG000|Overall Study|Voluntary Withdrawal|0|||
105760687|NCT05567393|364776132|FG001|Overall Study|Voluntary Withdrawal|0|||
105760688|NCT05567393|364776133|FG002|Overall Study|Voluntary Withdrawal|0|||
105760689|NCT05567393|364776134|FG003|Overall Study|Voluntary Withdrawal|0|||
105760690|NCT05567393|364776135|FG004|Overall Study|Voluntary Withdrawal|0|||
105760691|NCT05567393|364776136|FG005|Overall Study|Voluntary Withdrawal|0|||
105760692|NCT05567393|364776137|FG006|Overall Study|Voluntary Withdrawal|0|||
105760693|NCT05567393|364776138|FG007|Overall Study|Voluntary Withdrawal|0|||
105760694|NCT05567393|364776139|FG008|Overall Study|Voluntary Withdrawal|0|||
105760695|NCT05567393|364776140|FG009|Overall Study|Voluntary Withdrawal|0|||
105760696|NCT05567393|364776141|FG010|Overall Study|Voluntary Withdrawal|0|||
105760697|NCT05567393|364776142|FG011|Overall Study|Voluntary Withdrawal|0|||
105760698|NCT05567393|364776143|FG012|Overall Study|Voluntary Withdrawal|0|||
105760699|NCT05567393|364776144|FG013|Overall Study|Voluntary Withdrawal|1|||
105760700|NCT05567393|364776145|FG014|Overall Study|Voluntary Withdrawal|0|||
105760701|NCT05567393|364776146|FG015|Overall Study|Voluntary Withdrawal|0|||
105760702|NCT05567393|364776147|FG016|Overall Study|Voluntary Withdrawal|0|||
105472412|NCT00441064|363741413|FG001|Overall Study|Patient withdrew consent|2|||
105472413|NCT03051178|363741414|FG000|Overall Study|Withdrawal by Subject|5|||
105472414|NCT03962504|363741415|FG000|Overall Study|Other|11|||
105559140|NCT04124926|364044585|FG002|Maintenance Phase|Miscellaneous|1|||
105692564|NCT01310803|364540480|FG000|Overall Study|Subject terminated by Sponsor|1|||
105692565|NCT01310803|364540481|FG001|Overall Study|Subject terminated by Sponsor|0|||
105692566|NCT01444651|364540482|FG000|Overall Study|Adverse Event|3|||
105692567|NCT01444651|364540483|FG001|Overall Study|Adverse Event|2|||
105692568|NCT01444651|364540482|FG000|Overall Study|Lost to Follow-up|5|||
105692569|NCT01444651|364540483|FG001|Overall Study|Lost to Follow-up|5|||
105692570|NCT01444651|364540482|FG000|Overall Study|Non-fasting|2|||
105692571|NCT01444651|364540483|FG001|Overall Study|Non-fasting|1|||
105692572|NCT01444651|364540482|FG000|Overall Study|Missing data|1|||
105692573|NCT01444651|364540483|FG001|Overall Study|Missing data|1|||
105692574|NCT01436071|364540484|FG000|Overall Study|Adverse Event|1|||
105692575|NCT01436071|364540485|FG001|Overall Study|Adverse Event|0|||
105692576|NCT01436071|364540484|FG000|Overall Study|Lack of Efficacy|16|||
105692577|NCT01436071|364540485|FG001|Overall Study|Lack of Efficacy|7|||
105692578|NCT01436071|364540484|FG000|Overall Study|Protocol Violation|0|||
105692579|NCT01436071|364540485|FG001|Overall Study|Protocol Violation|1|||
105692580|NCT01436071|364540484|FG000|Overall Study|Lost to Follow-up|3|||
105692581|NCT01436071|364540485|FG001|Overall Study|Lost to Follow-up|1|||
105692582|NCT01436071|364540484|FG000|Overall Study|Physician Decision|1|||
105692583|NCT01436071|364540485|FG001|Overall Study|Physician Decision|0|||
105692584|NCT01436071|364540484|FG000|Overall Study|Withdrawal by Subject|2|||
105692585|NCT01436071|364540485|FG001|Overall Study|Withdrawal by Subject|2|||
105692586|NCT01436071|364540484|FG000|Overall Study|Did Not Receive Trial Medication|3|||
105692587|NCT01436071|364540485|FG001|Overall Study|Did Not Receive Trial Medication|3|||
105692588|NCT03047551|364540486|FG000|Overall Study|Did not receive TAS|1|||
105692589|NCT03047551|364540487|FG001|Overall Study|Did not receive TAS|0|||
105692590|NCT03047551|364540486|FG000|Overall Study|Physician Decision|1|||
105692591|NCT03047551|364540487|FG001|Overall Study|Physician Decision|0|||
105692592|NCT03047551|364540486|FG000|Overall Study|Withdrawal by Subject|0|||
105692593|NCT03047551|364540487|FG001|Overall Study|Withdrawal by Subject|1|||
105692594|NCT03047551|364540486|FG000|Overall Study|Probe malfunction|0|||
105692595|NCT03047551|364540487|FG001|Overall Study|Probe malfunction|1|||
105692596|NCT03047551|364540486|FG000|Overall Study|Ineligible|0|||
105692597|NCT03047551|364540487|FG001|Overall Study|Ineligible|1|||
105692598|NCT00726622|364540488|FG000|Overall Study|Withdrawal by Subject|16|||
105692599|NCT00726622|364540489|FG001|Overall Study|Withdrawal by Subject|2|||
105692600|NCT00726622|364540488|FG000|Overall Study|Physician Decision|0|||
105692601|NCT00726622|364540489|FG001|Overall Study|Physician Decision|1|||
105692602|NCT00726622|364540488|FG000|Overall Study|Metastasis|2|||
105692603|NCT00726622|364540489|FG001|Overall Study|Metastasis|0|||
105692604|NCT01672788|364540490|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
105692605|NCT01672788|364540491|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
105692606|NCT01672788|364540492|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
105692607|NCT01672788|364540493|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
105692608|NCT01215175|364540495|FG000|Overall Study|Lost to Follow-up|0|||
105692609|NCT01215175|364540496|FG001|Overall Study|Lost to Follow-up|1|||
105692610|NCT01215175|364540497|FG002|Overall Study|Lost to Follow-up|0|||
105692611|NCT01215175|364540498|FG003|Overall Study|Lost to Follow-up|1|||
105692612|NCT01215175|364540499|FG004|Overall Study|Lost to Follow-up|0|||
105692613|NCT00659529|364540500|FG000|Overall Study|Withdrawal by Subject|4|||
105692614|NCT00659529|364540500|FG000|Overall Study|Protocol Violation|3|||
105692615|NCT00659529|364540500|FG000|Overall Study|Screen failure|9|||
105692616|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
105692617|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
105692618|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
105692619|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
105692620|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
105692621|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
105692622|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
105692623|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
105692624|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
105692625|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
105692626|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
105692627|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
105692628|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
105692629|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
105692630|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
105692631|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
105692632|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
105692633|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
105692634|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
105692635|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
105692636|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
105692637|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
105692638|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
105692639|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
105692640|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
105692641|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
105692642|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
105692643|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
105346799|NCT00396877|363271466|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
105346800|NCT00783224|363271467|FG000|Overall Study|Adverse Event|0|||
105346801|NCT00783224|363271468|FG001|Overall Study|Adverse Event|0|||
105346802|NCT00783224|363271469|FG002|Overall Study|Adverse Event|1|||
105346803|NCT00783224|363271470|FG003|Overall Study|Adverse Event|0|||
105346804|NCT00783224|363271467|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
105346805|NCT00783224|363271468|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
105346806|NCT00783224|363271469|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
105346807|NCT00783224|363271470|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
105346808|NCT00783224|363271467|FG000|Overall Study|Inappropriate as a study subject|0|||
105346809|NCT00783224|363271468|FG001|Overall Study|Inappropriate as a study subject|0|||
105346810|NCT00783224|363271469|FG002|Overall Study|Inappropriate as a study subject|0|||
105346811|NCT00783224|363271470|FG003|Overall Study|Inappropriate as a study subject|1|||
105346812|NCT02003963|363271471|FG000|Overall Study|Lost to Follow-up|2|||
105346813|NCT02003963|363271472|FG001|Overall Study|Lost to Follow-up|1|||
105346814|NCT03515629|363271476|FG000|Overall Study|Death|0|||
105346815|NCT03515629|363271477|FG001|Overall Study|Death|1|||
105346816|NCT03515629|363271478|FG002|Overall Study|Death|1|||
105346817|NCT03515629|363271476|FG000|Overall Study|Progressive disease|0|||
105346818|NCT03515629|363271477|FG001|Overall Study|Progressive disease|1|||
105346819|NCT03515629|363271478|FG002|Overall Study|Progressive disease|0|||
105346820|NCT03769194|363271479|FG000|Overall Study|Withdrawal by Subject|0|||
105346821|NCT03769194|363271480|FG001|Overall Study|Withdrawal by Subject|7|||
105346822|NCT03769194|363271481|FG002|Overall Study|Withdrawal by Subject|4|||
105346823|NCT03769194|363271482|FG003|Overall Study|Withdrawal by Subject|1|||
105346824|NCT03769194|363271479|FG000|Overall Study|moved from study area|0|||
105346825|NCT03769194|363271480|FG001|Overall Study|moved from study area|2|||
105346826|NCT03769194|363271481|FG002|Overall Study|moved from study area|1|||
105346827|NCT03769194|363271482|FG003|Overall Study|moved from study area|1|||
105346828|NCT03769194|363271479|FG000|Overall Study|Lost to Follow-up|3|||
105346829|NCT03769194|363271480|FG001|Overall Study|Lost to Follow-up|6|||
105346830|NCT03769194|363271481|FG002|Overall Study|Lost to Follow-up|3|||
105472415|NCT03962504|363741416|FG001|Overall Study|Other|32|||
105472416|NCT02367833|363741417|FG000|Overall Study|Withdrawal by Subject|1|||
105472417|NCT02367833|363741418|FG001|Overall Study|Withdrawal by Subject|1|||
105472418|NCT02367833|363741419|FG002|Overall Study|Withdrawal by Subject|0|||
105472419|NCT04080167|363741422|FG000|Overall Study|Lost to Follow-up-Patients|7|||
105472420|NCT04080167|363741423|FG001|Overall Study|Lost to Follow-up-Patients|14|||
105472421|NCT04080167|363741424|FG002|Overall Study|Lost to Follow-up-Patients|0|||
105472422|NCT04080167|363741422|FG000|Overall Study|Lost to Follow-up-Providers|2|||
105472423|NCT04080167|363741423|FG001|Overall Study|Lost to Follow-up-Providers|2|||
105472424|NCT04080167|363741424|FG002|Overall Study|Lost to Follow-up-Providers|0|||
105472425|NCT04080167|363741422|FG000|Overall Study|Withdrawal by Subject|1|||
105472426|NCT04080167|363741423|FG001|Overall Study|Withdrawal by Subject|2|||
105472427|NCT04080167|363741424|FG002|Overall Study|Withdrawal by Subject|0|||
105472428|NCT04080167|363741422|FG000|Overall Study|Withdrawal by Provider|0|||
105472429|NCT04080167|363741423|FG001|Overall Study|Withdrawal by Provider|0|||
105472430|NCT04080167|363741424|FG002|Overall Study|Withdrawal by Provider|4|||
105472431|NCT04080167|363741422|FG000|Overall Study|Death-Patient|2|||
105472432|NCT04080167|363741423|FG001|Overall Study|Death-Patient|1|||
105346831|NCT03769194|363271482|FG003|Overall Study|Lost to Follow-up|6|||
105346832|NCT03769194|363271479|FG000|Overall Study|other|1|||
105346833|NCT03769194|363271480|FG001|Overall Study|other|3|||
105346834|NCT03769194|363271481|FG002|Overall Study|other|0|||
105346835|NCT03769194|363271482|FG003|Overall Study|other|1|||
105472433|NCT04080167|363741424|FG002|Overall Study|Death-Patient|0|||
105472434|NCT04080167|363741422|FG000|Overall Study|Hydroxyurea New Starts|0|||
105472435|NCT04080167|363741423|FG001|Overall Study|Hydroxyurea New Starts|0|||
105472436|NCT04080167|363741424|FG002|Overall Study|Hydroxyurea New Starts|1|||
105472437|NCT04080167|363741422|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
105472438|NCT04080167|363741423|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
105692644|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
105692645|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
105692646|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
105692647|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
105692648|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
105692649|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
105692650|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
105692651|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
105692652|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
105692653|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
105692654|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
105692655|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
105692656|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
105692657|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
105692658|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
105692659|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
105692660|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
105692661|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
105692662|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
105692663|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
105692664|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
105692665|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
105692666|NCT03627767|364540501|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
105692667|NCT03627767|364540502|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
105692668|NCT03627767|364540503|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
105692669|NCT03627767|364540504|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
105692670|NCT03627767|364540505|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
105692671|NCT03627767|364540501|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
105692672|NCT03627767|364540502|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
105692673|NCT03627767|364540503|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
105692674|NCT03627767|364540504|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
105692675|NCT03627767|364540505|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
105692676|NCT03627767|364540501|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
105692677|NCT03627767|364540502|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
105692678|NCT03627767|364540503|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
105692679|NCT03627767|364540504|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
105692680|NCT03627767|364540505|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
105692681|NCT03627767|364540501|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
105692682|NCT03627767|364540502|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
105692683|NCT03627767|364540503|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
105692684|NCT03627767|364540504|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
105692685|NCT03627767|364540505|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
105692686|NCT03627767|364540501|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
105692687|NCT03627767|364540502|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
105692688|NCT03627767|364540503|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
105692689|NCT03627767|364540504|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
105692690|NCT03627767|364540505|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
105692691|NCT03627767|364540501|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
105692692|NCT03627767|364540502|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
105692693|NCT03627767|364540503|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
105692694|NCT03627767|364540504|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
105692695|NCT03627767|364540505|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
105692696|NCT03627767|364540501|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
105692697|NCT03627767|364540502|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
105692698|NCT03627767|364540503|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
105692699|NCT03627767|364540504|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
105692700|NCT03627767|364540505|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
105692701|NCT03627767|364540501|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
105692702|NCT03627767|364540502|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
105346836|NCT01267201|363271486|FG000|First Intervention Period|Withdrawal by Subject|1|||
105346837|NCT01267201|363271487|FG001|First Intervention Period|Withdrawal by Subject|0|||
105346838|NCT01267201|363271488|FG002|First Intervention Period|Withdrawal by Subject|0|||
105692703|NCT03627767|364540503|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
105692704|NCT03627767|364540504|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
105692705|NCT03627767|364540505|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
105692706|NCT03627767|364540501|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
105692707|NCT03627767|364540502|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
105692708|NCT03627767|364540503|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
105692709|NCT03627767|364540504|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
105692710|NCT03627767|364540505|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
105692711|NCT03627767|364540501|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
105692712|NCT03627767|364540502|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
105692713|NCT03627767|364540503|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
105692714|NCT03627767|364540504|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
105692715|NCT03627767|364540505|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
105692716|NCT03823404|364540506|FG000|Overall Study|Lost to Follow-up|1|||
105692717|NCT03823404|364540507|FG001|Overall Study|Lost to Follow-up|2|||
105692718|NCT03823404|364540508|FG002|Overall Study|Lost to Follow-up|3|||
105692719|NCT03823404|364540506|FG000|Overall Study|Protocol Violation|2|||
105346839|NCT01267201|363271489|FG003|First Intervention Period|Withdrawal by Subject|0|||
105346840|NCT01267201|363271490|FG004|First Intervention Period|Withdrawal by Subject|0|||
105346841|NCT01267201|363271491|FG005|First Intervention Period|Withdrawal by Subject|0|||
105346842|NCT01267201|363271486|FG000|Second Intervention Period|Withdrawal by Subject|0|||
105346843|NCT01267201|363271487|FG001|Second Intervention Period|Withdrawal by Subject|1|||
105346844|NCT01267201|363271488|FG002|Second Intervention Period|Withdrawal by Subject|0|||
105346845|NCT01267201|363271489|FG003|Second Intervention Period|Withdrawal by Subject|0|||
105346846|NCT01267201|363271490|FG004|Second Intervention Period|Withdrawal by Subject|0|||
105346847|NCT01267201|363271491|FG005|Second Intervention Period|Withdrawal by Subject|0|||
105346848|NCT00483704|363271492|FG000|Randomization|Withdrawal by Subject|19|||
105346849|NCT00483704|363271493|FG001|Randomization|Withdrawal by Subject|28|||
105346850|NCT00483704|363271494|FG002|Randomization|Withdrawal by Subject|18|||
105346851|NCT00483704|363271492|FG000|Randomization|Protocol Violation|14|||
105346852|NCT00483704|363271493|FG001|Randomization|Protocol Violation|25|||
105346853|NCT00483704|363271494|FG002|Randomization|Protocol Violation|22|||
105346854|NCT00483704|363271492|FG000|Randomization|Lost to Follow-up|14|||
105346855|NCT00483704|363271493|FG001|Randomization|Lost to Follow-up|14|||
105346856|NCT00483704|363271494|FG002|Randomization|Lost to Follow-up|19|||
105346857|NCT00483704|363271492|FG000|Randomization|Pregnancy|1|||
105346858|NCT00483704|363271493|FG001|Randomization|Pregnancy|0|||
105346859|NCT00483704|363271494|FG002|Randomization|Pregnancy|0|||
105346860|NCT00483704|363271492|FG000|Randomization|Physician Decision|2|||
105346861|NCT00483704|363271493|FG001|Randomization|Physician Decision|4|||
105346862|NCT00483704|363271494|FG002|Randomization|Physician Decision|0|||
105346863|NCT00483704|363271492|FG000|Randomization|Progressive disease|0|||
105346864|NCT00483704|363271493|FG001|Randomization|Progressive disease|0|||
105346865|NCT00483704|363271494|FG002|Randomization|Progressive disease|1|||
105346866|NCT00483704|363271492|FG000|Randomization|Lack of qualifying migraines|21|||
105346867|NCT00483704|363271493|FG001|Randomization|Lack of qualifying migraines|25|||
105346868|NCT00483704|363271494|FG002|Randomization|Lack of qualifying migraines|31|||
105346869|NCT00483704|363271492|FG000|Treatment|Lack of qualifying migraines|101|||
105346870|NCT00483704|363271493|FG001|Treatment|Lack of qualifying migraines|99|||
105346871|NCT00483704|363271494|FG002|Treatment|Lack of qualifying migraines|116|||
105346872|NCT00483704|363271492|FG000|Treatment|Adverse Event|3|||
105346873|NCT00483704|363271493|FG001|Treatment|Adverse Event|5|||
105346874|NCT00483704|363271494|FG002|Treatment|Adverse Event|4|||
105346875|NCT00483704|363271492|FG000|Treatment|Withdrawal by Subject|16|||
105346876|NCT00483704|363271493|FG001|Treatment|Withdrawal by Subject|12|||
105346877|NCT00483704|363271494|FG002|Treatment|Withdrawal by Subject|21|||
105346878|NCT00483704|363271492|FG000|Treatment|Protocol Violation|6|||
105346879|NCT00483704|363271493|FG001|Treatment|Protocol Violation|3|||
105346880|NCT00483704|363271494|FG002|Treatment|Protocol Violation|5|||
105346881|NCT00483704|363271492|FG000|Treatment|Lost to Follow-up|2|||
105346882|NCT00483704|363271493|FG001|Treatment|Lost to Follow-up|7|||
105346883|NCT00483704|363271494|FG002|Treatment|Lost to Follow-up|5|||
105692720|NCT03823404|364540507|FG001|Overall Study|Protocol Violation|0|||
105346884|NCT00483704|363271492|FG000|Treatment|Lack of Efficacy|1|||
105346885|NCT00483704|363271493|FG001|Treatment|Lack of Efficacy|1|||
105346886|NCT00483704|363271494|FG002|Treatment|Lack of Efficacy|1|||
105346887|NCT00483704|363271492|FG000|Treatment|Pregnancy|0|||
105346888|NCT00483704|363271493|FG001|Treatment|Pregnancy|1|||
105346889|NCT00483704|363271494|FG002|Treatment|Pregnancy|0|||
105346890|NCT00483704|363271492|FG000|Treatment|Physician Decision|0|||
105346891|NCT00483704|363271493|FG001|Treatment|Physician Decision|1|||
105346892|NCT00483704|363271494|FG002|Treatment|Physician Decision|4|||
105346893|NCT00672841|363271495|FG000|Overall Study|Comfort care|1|||
105692721|NCT03823404|364540508|FG002|Overall Study|Protocol Violation|2|||
105692722|NCT03823404|364540506|FG000|Overall Study|Adverse Event|35|||
105692723|NCT03823404|364540507|FG001|Overall Study|Adverse Event|38|||
105346894|NCT00672841|363271496|FG001|Overall Study|Comfort care|4|||
105346895|NCT00672841|363271495|FG000|Overall Study|icteric specimens|0|||
105346896|NCT00672841|363271496|FG001|Overall Study|icteric specimens|3|||
105346897|NCT00672841|363271495|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
105346898|NCT00672841|363271496|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
105346899|NCT00672841|363271495|FG000|Overall Study|Adverse Event|0|||
105346900|NCT00672841|363271496|FG001|Overall Study|Adverse Event|3|||
105346901|NCT00672841|363271495|FG000|Overall Study|Pregnancy|0|||
105346902|NCT00672841|363271496|FG001|Overall Study|Pregnancy|1|||
105346903|NCT01298141|363271499|FG000|Overall Study|Adverse Event|3|||
105346904|NCT01298141|363271499|FG000|Overall Study|Refusal of Required Study Procedures|1|||
105346905|NCT01298141|363271499|FG000|Overall Study|Withdrawal by Subject|6|||
105346906|NCT01298141|363271499|FG000|Overall Study|Termination of Study by the Investigator|5|||
105346907|NCT01298141|363271499|FG000|Overall Study|Other|5|||
105346908|NCT01298141|363271499|FG000|Overall Study|Lost to Follow-up|1|||
105346909|NCT01298141|363271499|FG000|Overall Study|Death|6|||
105346910|NCT01298141|363271499|FG000|Overall Study|Not treated|4|||
105692724|NCT03823404|364540508|FG002|Overall Study|Adverse Event|8|||
105692725|NCT03823404|364540506|FG000|Overall Study|Withdrawal by Subject|38|||
105692726|NCT03823404|364540507|FG001|Overall Study|Withdrawal by Subject|40|||
105692727|NCT03823404|364540508|FG002|Overall Study|Withdrawal by Subject|35|||
105692728|NCT03823404|364540506|FG000|Overall Study|Death|4|||
105692729|NCT03823404|364540507|FG001|Overall Study|Death|0|||
105692730|NCT03823404|364540508|FG002|Overall Study|Death|0|||
105692731|NCT03823404|364540506|FG000|Overall Study|Other: Various reasons provided|5|||
105692732|NCT03823404|364540507|FG001|Overall Study|Other: Various reasons provided|5|||
105692733|NCT03823404|364540508|FG002|Overall Study|Other: Various reasons provided|6|||
105692734|NCT03383289|364540511|FG000|Overall Study|Death|83|||
105692735|NCT03383289|364540512|FG001|Overall Study|Death|78|||
105692736|NCT03383289|364540511|FG000|Overall Study|discharge from facility|84|||
105692737|NCT03383289|364540512|FG001|Overall Study|discharge from facility|84|||
105692738|NCT03383289|364540511|FG000|Overall Study|Withdrawal by Subject|4|||
105692739|NCT03383289|364540512|FG001|Overall Study|Withdrawal by Subject|1|||
105692740|NCT00892177|364540513|FG000|Phase II|Ineligible|0|||
105692741|NCT00892177|364540514|FG001|Phase II|Ineligible|0|||
105692742|NCT00892177|364540515|FG002|Phase II|Ineligible|0|||
105692743|NCT00892177|364540516|FG003|Phase II|Ineligible|0|||
105692744|NCT00892177|364540517|FG004|Phase II|Ineligible|1|||
105692745|NCT00892177|364540518|FG005|Phase II|Ineligible|1|||
105692746|NCT00892177|364540513|FG000|Phase II|Withdrawal by Subject|0|||
105692747|NCT00892177|364540514|FG001|Phase II|Withdrawal by Subject|0|||
105692748|NCT00892177|364540515|FG002|Phase II|Withdrawal by Subject|0|||
105692749|NCT00892177|364540516|FG003|Phase II|Withdrawal by Subject|0|||
105692750|NCT00892177|364540517|FG004|Phase II|Withdrawal by Subject|4|||
105692751|NCT00892177|364540518|FG005|Phase II|Withdrawal by Subject|1|||
105692752|NCT02616614|364540519|FG000|Overall Study|Withdrawal by Subject|10|||
105692753|NCT02616614|364540520|FG001|Overall Study|Withdrawal by Subject|5|||
105692754|NCT02616614|364540521|FG002|Overall Study|Withdrawal by Subject|6|||
105692755|NCT02616614|364540519|FG000|Overall Study|Physician Decision|2|||
105692756|NCT02616614|364540520|FG001|Overall Study|Physician Decision|1|||
105692757|NCT02616614|364540521|FG002|Overall Study|Physician Decision|0|||
105692758|NCT02616614|364540519|FG000|Overall Study|Adverse Event|1|||
105692759|NCT02616614|364540520|FG001|Overall Study|Adverse Event|4|||
105692760|NCT02616614|364540521|FG002|Overall Study|Adverse Event|1|||
105692761|NCT02616614|364540519|FG000|Overall Study|Protocol Violation|0|||
105692762|NCT02616614|364540520|FG001|Overall Study|Protocol Violation|3|||
105692763|NCT02616614|364540521|FG002|Overall Study|Protocol Violation|1|||
105692764|NCT02616614|364540519|FG000|Overall Study|Prohibited Medication|12|||
105692765|NCT02616614|364540520|FG001|Overall Study|Prohibited Medication|9|||
105692766|NCT02616614|364540521|FG002|Overall Study|Prohibited Medication|5|||
105692767|NCT02616614|364540519|FG000|Overall Study|More than 3 applications missed|6|||
105692768|NCT02616614|364540520|FG001|Overall Study|More than 3 applications missed|8|||
105692769|NCT02616614|364540521|FG002|Overall Study|More than 3 applications missed|1|||
105692770|NCT02616614|364540519|FG000|Overall Study|Lost to Follow-up|31|||
105692771|NCT02616614|364540520|FG001|Overall Study|Lost to Follow-up|28|||
105692772|NCT02616614|364540521|FG002|Overall Study|Lost to Follow-up|13|||
105692773|NCT02616614|364540519|FG000|Overall Study|Pregnancy|2|||
105692774|NCT02616614|364540520|FG001|Overall Study|Pregnancy|0|||
105692775|NCT02616614|364540521|FG002|Overall Study|Pregnancy|1|||
105692776|NCT02616614|364540519|FG000|Overall Study|Other|1|||
105692777|NCT02616614|364540520|FG001|Overall Study|Other|2|||
105692778|NCT02616614|364540521|FG002|Overall Study|Other|1|||
105692779|NCT01674712|364540524|FG000|Overall Study|Adverse Event|5|||
105692780|NCT01674712|364540525|FG001|Overall Study|Adverse Event|6|||
105692781|NCT01674712|364540526|FG002|Overall Study|Adverse Event|3|||
105692782|NCT01674712|364540527|FG003|Overall Study|Adverse Event|4|||
105692783|NCT01674712|364540528|FG004|Overall Study|Adverse Event|6|||
105346911|NCT01390428|363273231|FG000|Overall Study|Elective Surgery|0|||
105692784|NCT01674712|364540524|FG000|Overall Study|Lost to Follow-up|1|||
105692785|NCT01674712|364540525|FG001|Overall Study|Lost to Follow-up|0|||
105692786|NCT01674712|364540526|FG002|Overall Study|Lost to Follow-up|0|||
105692787|NCT01674712|364540527|FG003|Overall Study|Lost to Follow-up|0|||
105692788|NCT01674712|364540528|FG004|Overall Study|Lost to Follow-up|0|||
105692789|NCT01674712|364540524|FG000|Overall Study|Protocol Violation|2|||
105692790|NCT01674712|364540525|FG001|Overall Study|Protocol Violation|0|||
105692791|NCT01674712|364540526|FG002|Overall Study|Protocol Violation|0|||
105692792|NCT01674712|364540527|FG003|Overall Study|Protocol Violation|0|||
105692793|NCT01674712|364540528|FG004|Overall Study|Protocol Violation|0|||
105692794|NCT01674712|364540524|FG000|Overall Study|Withdrawal by Subject|2|||
105692795|NCT01674712|364540525|FG001|Overall Study|Withdrawal by Subject|2|||
105692796|NCT01674712|364540526|FG002|Overall Study|Withdrawal by Subject|5|||
105692797|NCT01674712|364540527|FG003|Overall Study|Withdrawal by Subject|4|||
105692798|NCT01674712|364540528|FG004|Overall Study|Withdrawal by Subject|3|||
105692799|NCT01674712|364540524|FG000|Overall Study|Administrative|0|||
105692800|NCT01674712|364540525|FG001|Overall Study|Administrative|1|||
105692801|NCT01674712|364540526|FG002|Overall Study|Administrative|0|||
105692802|NCT01674712|364540527|FG003|Overall Study|Administrative|0|||
105346912|NCT01390428|363273232|FG001|Overall Study|Elective Surgery|0|||
105346913|NCT01390428|363273233|FG002|Overall Study|Elective Surgery|0|||
105346914|NCT01390428|363273234|FG003|Overall Study|Elective Surgery|0|||
105346915|NCT01390428|363273235|FG004|Overall Study|Elective Surgery|1|||
105346916|NCT01390428|363273236|FG005|Overall Study|Elective Surgery|0|||
105692803|NCT01674712|364540528|FG004|Overall Study|Administrative|1|||
105692804|NCT01674712|364540524|FG000|Overall Study|Lack of Efficacy|0|||
105692805|NCT01674712|364540525|FG001|Overall Study|Lack of Efficacy|0|||
105692806|NCT01674712|364540526|FG002|Overall Study|Lack of Efficacy|1|||
105692807|NCT01674712|364540527|FG003|Overall Study|Lack of Efficacy|0|||
105692808|NCT01674712|364540528|FG004|Overall Study|Lack of Efficacy|1|||
105692809|NCT00631189|364540529|FG000|Initial Phase|Protocol Violation|347|||
105692810|NCT00631189|364540530|FG001|Initial Phase|Protocol Violation|0|||
105692811|NCT00631189|364540531|FG002|Initial Phase|Protocol Violation|0|||
105692812|NCT00631189|364540532|FG003|Initial Phase|Protocol Violation|0|||
105692813|NCT00631189|364540529|FG000|Initial Phase|Withdrawal by Subject|4|||
105692814|NCT00631189|364540530|FG001|Initial Phase|Withdrawal by Subject|0|||
105692815|NCT00631189|364540531|FG002|Initial Phase|Withdrawal by Subject|0|||
105692816|NCT00631189|364540532|FG003|Initial Phase|Withdrawal by Subject|0|||
105692817|NCT00631189|364540529|FG000|Treatment Phase|Withdrawal by Subject|0|||
105692818|NCT00631189|364540530|FG001|Treatment Phase|Withdrawal by Subject|2|||
105692819|NCT00631189|364540531|FG002|Treatment Phase|Withdrawal by Subject|1|||
105692820|NCT00631189|364540532|FG003|Treatment Phase|Withdrawal by Subject|1|||
105692821|NCT00631189|364540529|FG000|Treatment Phase|Protocol Violation|0|||
105692822|NCT00631189|364540530|FG001|Treatment Phase|Protocol Violation|1|||
105692823|NCT00631189|364540531|FG002|Treatment Phase|Protocol Violation|6|||
105692824|NCT00631189|364540532|FG003|Treatment Phase|Protocol Violation|2|||
105692825|NCT00631189|364540529|FG000|Treatment Phase|Adverse Event|0|||
105692826|NCT00631189|364540530|FG001|Treatment Phase|Adverse Event|3|||
105692827|NCT00631189|364540531|FG002|Treatment Phase|Adverse Event|2|||
105692828|NCT00631189|364540532|FG003|Treatment Phase|Adverse Event|4|||
105692829|NCT00631189|364540529|FG000|Treatment Phase|Lost to Follow-up|0|||
105692830|NCT00631189|364540530|FG001|Treatment Phase|Lost to Follow-up|1|||
105692831|NCT00631189|364540531|FG002|Treatment Phase|Lost to Follow-up|0|||
105692832|NCT00631189|364540532|FG003|Treatment Phase|Lost to Follow-up|0|||
105692833|NCT00631189|364540529|FG000|Treatment Phase|Pregnancy|0|||
105692834|NCT00631189|364540530|FG001|Treatment Phase|Pregnancy|0|||
105692835|NCT00631189|364540531|FG002|Treatment Phase|Pregnancy|1|||
105692836|NCT00631189|364540532|FG003|Treatment Phase|Pregnancy|0|||
105692837|NCT00631189|364540529|FG000|Treatment Phase|patient did not take pravastatin|0|||
105692838|NCT00631189|364540530|FG001|Treatment Phase|patient did not take pravastatin|0|||
105692839|NCT00631189|364540531|FG002|Treatment Phase|patient did not take pravastatin|1|||
105692840|NCT00631189|364540532|FG003|Treatment Phase|patient did not take pravastatin|0|||
105692841|NCT00874770|364540533|FG000|Overall Study|Lack of Efficacy|2|||
105692842|NCT00874770|364540534|FG001|Overall Study|Lack of Efficacy|0|||
105692843|NCT00874770|364540535|FG002|Overall Study|Lack of Efficacy|0|||
105692844|NCT00874770|364540536|FG003|Overall Study|Lack of Efficacy|2|||
105692845|NCT00874770|364540533|FG000|Overall Study|Adverse Event|1|||
105692846|NCT00874770|364540534|FG001|Overall Study|Adverse Event|1|||
105692847|NCT00874770|364540535|FG002|Overall Study|Adverse Event|4|||
105692848|NCT00874770|364540536|FG003|Overall Study|Adverse Event|2|||
105692849|NCT00874770|364540533|FG000|Overall Study|Lost to Follow-up|1|||
105692850|NCT00874770|364540534|FG001|Overall Study|Lost to Follow-up|0|||
105692851|NCT00874770|364540535|FG002|Overall Study|Lost to Follow-up|0|||
105692852|NCT00874770|364540536|FG003|Overall Study|Lost to Follow-up|1|||
105692853|NCT00874770|364540533|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
105692854|NCT00874770|364540534|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
105692855|NCT00874770|364540535|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
105692856|NCT00874770|364540536|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
105692857|NCT04464265|364540537|FG000|Overall Study|Physician Decision|2|||
105692858|NCT03189862|364540542|FG000|Overall Study|Withdrawal by Subject|1|||
105692859|NCT03189862|364540543|FG001|Overall Study|Withdrawal by Subject|0|||
105692860|NCT03189862|364540542|FG000|Overall Study|Lost to Follow-up|54|||
105692861|NCT03189862|364540543|FG001|Overall Study|Lost to Follow-up|62|||
105692862|NCT00056862|364540546|FG000|Overall Study|Protocol Violation|1|||
105692863|NCT00056862|364540547|FG001|Overall Study|Protocol Violation|0|||
105692864|NCT04880447|364540548|FG000|Overall Study|No vaccination information|1|||
105692865|NCT04880447|364540548|FG000|Overall Study|No adverse event information (missing information)|1|||
105692866|NCT04880447|364540548|FG000|Overall Study|Disease not covered in this study|35|||
105692867|NCT01122576|364540549|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
105346917|NCT01390428|363273231|FG000|Overall Study|Withdrawal by Subject|0|||
105346918|NCT01390428|363273232|FG001|Overall Study|Withdrawal by Subject|0|||
105346919|NCT01390428|363273233|FG002|Overall Study|Withdrawal by Subject|1|||
105692868|NCT01122576|364540550|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
105692869|NCT01122576|364540551|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
105692870|NCT01122576|364540549|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
105692871|NCT01122576|364540550|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
105692872|NCT01122576|364540551|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
105692873|NCT01122576|364540549|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
105692874|NCT01122576|364540550|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
105692875|NCT01122576|364540551|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
105692876|NCT05395104|364540553|FG000|Overall Study|Met Liver Stopping Criteria|1|||
105692877|NCT05395104|364540553|FG000|Overall Study|Withdrawal by Subject|1|||
105692878|NCT01145495|364540554|FG000|Overall Study|Adverse Event|6|||
105692879|NCT01145495|364540554|FG000|Overall Study|Withdrawal by Subject|6|||
105692880|NCT01145495|364540554|FG000|Overall Study|Disease progression after respone|2|||
105692881|NCT01886313|364540556|FG000|Overall Study|Adverse Event|1|||
105692882|NCT01886313|364540557|FG001|Overall Study|Adverse Event|1|||
105692883|NCT01379573|364540562|FG000|Overall Study|Lost to Follow-up|1|||
105692884|NCT01379573|364540562|FG000|Overall Study|Screen Failure|10|||
105692885|NCT02378220|364540563|FG000|Overall Study|Death|6|||
105787057|NCT03110107|364874889|FG000|Treatment Period|Disease Progression|3|||
105787058|NCT03110107|364874890|FG001|Treatment Period|Disease Progression|9|||
105346920|NCT01390428|363273234|FG003|Overall Study|Withdrawal by Subject|0|||
105692886|NCT02378220|364540564|FG001|Overall Study|Death|1|||
105692887|NCT00962390|364540565|FG000|Overall Study|Adverse Event|0|||
105787059|NCT03110107|364874891|FG002|Treatment Period|Disease Progression|8|||
105787060|NCT03110107|364874892|FG003|Treatment Period|Disease Progression|11|||
105692888|NCT00962390|364540566|FG001|Overall Study|Adverse Event|0|||
105692889|NCT00962390|364540567|FG002|Overall Study|Adverse Event|3|||
105787061|NCT03110107|364874893|FG004|Treatment Period|Disease Progression|8|||
105346921|NCT01390428|363273235|FG004|Overall Study|Withdrawal by Subject|0|||
105346922|NCT01390428|363273236|FG005|Overall Study|Withdrawal by Subject|0|||
105692890|NCT00962390|364540568|FG003|Overall Study|Adverse Event|1|||
105692891|NCT00962390|364540565|FG000|Overall Study|Lost to Follow-up|2|||
105692892|NCT00962390|364540566|FG001|Overall Study|Lost to Follow-up|2|||
105692893|NCT00962390|364540567|FG002|Overall Study|Lost to Follow-up|0|||
105692894|NCT00962390|364540568|FG003|Overall Study|Lost to Follow-up|0|||
105692895|NCT00962390|364540565|FG000|Overall Study|Protocol Violation|1|||
105692896|NCT00962390|364540566|FG001|Overall Study|Protocol Violation|0|||
105692897|NCT00962390|364540567|FG002|Overall Study|Protocol Violation|0|||
105692898|NCT00962390|364540568|FG003|Overall Study|Protocol Violation|0|||
105692899|NCT00962390|364540565|FG000|Overall Study|Withdrawal by Subject|1|||
105692900|NCT00962390|364540566|FG001|Overall Study|Withdrawal by Subject|1|||
105692901|NCT00962390|364540567|FG002|Overall Study|Withdrawal by Subject|1|||
105692902|NCT00962390|364540568|FG003|Overall Study|Withdrawal by Subject|0|||
105692903|NCT00312221|364540572|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
105692904|NCT00312221|364540573|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
105692905|NCT00312221|364540574|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
105692906|NCT00312221|364540575|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
105692907|NCT00312221|364540572|FG000|Open-label Run-in Period|Adverse Event|74|||
105692908|NCT00312221|364540573|FG001|Open-label Run-in Period|Adverse Event|0|||
105692909|NCT00312221|364540574|FG002|Open-label Run-in Period|Adverse Event|0|||
105346923|NCT01556997|363273237|FG000|Overall Study|Adverse Event|10|||
105346924|NCT01556997|363273238|FG001|Overall Study|Adverse Event|12|||
105346925|NCT01556997|363273239|FG002|Overall Study|Adverse Event|12|||
105692910|NCT00312221|364540575|FG003|Open-label Run-in Period|Adverse Event|0|||
105692911|NCT00312221|364540572|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
105692912|NCT00312221|364540573|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
105692913|NCT00312221|364540574|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
105692914|NCT00312221|364540575|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
105692915|NCT00312221|364540572|FG000|Open-label Run-in Period|Administrative|42|||
105692916|NCT00312221|364540573|FG001|Open-label Run-in Period|Administrative|0|||
105692917|NCT00312221|364540574|FG002|Open-label Run-in Period|Administrative|0|||
105692918|NCT00312221|364540575|FG003|Open-label Run-in Period|Administrative|0|||
105692919|NCT00312221|364540572|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
105692920|NCT00312221|364540573|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
105692921|NCT00312221|364540574|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
105692922|NCT00312221|364540575|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
105692923|NCT00312221|364540572|FG000|Open-label Run-in Period|Did not qualify|5|||
105692924|NCT00312221|364540573|FG001|Open-label Run-in Period|Did not qualify|0|||
105692925|NCT00312221|364540574|FG002|Open-label Run-in Period|Did not qualify|0|||
105692926|NCT00312221|364540575|FG003|Open-label Run-in Period|Did not qualify|0|||
105692927|NCT00312221|364540572|FG000|Double-blind Phase|Withdrawal by Subject|0|||
105692928|NCT00312221|364540573|FG001|Double-blind Phase|Withdrawal by Subject|6|||
105692929|NCT00312221|364540574|FG002|Double-blind Phase|Withdrawal by Subject|8|||
105692930|NCT00312221|364540575|FG003|Double-blind Phase|Withdrawal by Subject|7|||
105692931|NCT00312221|364540572|FG000|Double-blind Phase|Adverse Event|0|||
105692932|NCT00312221|364540573|FG001|Double-blind Phase|Adverse Event|10|||
105692933|NCT00312221|364540574|FG002|Double-blind Phase|Adverse Event|19|||
105692934|NCT00312221|364540575|FG003|Double-blind Phase|Adverse Event|18|||
105692935|NCT00312221|364540572|FG000|Double-blind Phase|Lost to Follow-up|0|||
105692936|NCT00312221|364540573|FG001|Double-blind Phase|Lost to Follow-up|0|||
105692937|NCT00312221|364540574|FG002|Double-blind Phase|Lost to Follow-up|2|||
105692938|NCT00312221|364540575|FG003|Double-blind Phase|Lost to Follow-up|2|||
105692939|NCT00312221|364540572|FG000|Double-blind Phase|Administrative|0|||
105692940|NCT00312221|364540573|FG001|Double-blind Phase|Administrative|26|||
105692941|NCT00312221|364540574|FG002|Double-blind Phase|Administrative|37|||
105692942|NCT00312221|364540575|FG003|Double-blind Phase|Administrative|33|||
105692943|NCT00312221|364540572|FG000|Double-blind Phase|Lack of Efficacy|0|||
105692944|NCT00312221|364540573|FG001|Double-blind Phase|Lack of Efficacy|17|||
105692945|NCT00312221|364540574|FG002|Double-blind Phase|Lack of Efficacy|6|||
105692946|NCT00312221|364540575|FG003|Double-blind Phase|Lack of Efficacy|10|||
105346926|NCT01556997|363273237|FG000|Overall Study|Lost to Follow-up|6|||
105692947|NCT03740997|364540581|FG000|Overall Study|Withdrawal by Subject|1|||
105692948|NCT03740997|364540582|FG001|Overall Study|Withdrawal by Subject|0|||
105692949|NCT03740997|364540581|FG000|Overall Study|Participant was unable to complete study procedures|1|||
105692950|NCT03740997|364540582|FG001|Overall Study|Participant was unable to complete study procedures|0|||
105692951|NCT01829425|364540583|FG000|Overall Study|Withdrawal by Subject|4|||
105692952|NCT01829425|364540584|FG001|Overall Study|Withdrawal by Subject|3|||
105692953|NCT01829425|364540583|FG000|Overall Study|Lost to Follow-up|2|||
105346927|NCT01556997|363273238|FG001|Overall Study|Lost to Follow-up|6|||
105692954|NCT01829425|364540584|FG001|Overall Study|Lost to Follow-up|1|||
105692955|NCT01862640|364540587|FG000|Overall Study|Adverse Event|4|||
105692956|NCT01862640|364540588|FG001|Overall Study|Adverse Event|10|||
105692957|NCT01862640|364540589|FG002|Overall Study|Adverse Event|6|||
105692958|NCT01862640|364540590|FG003|Overall Study|Adverse Event|8|||
105692959|NCT01862640|364540587|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
105692960|NCT01862640|364540588|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
105692961|NCT01862640|364540589|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
105692962|NCT01862640|364540590|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
105692963|NCT01862640|364540587|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
105692964|NCT01862640|364540588|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
105692965|NCT01862640|364540589|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
105692966|NCT01862640|364540590|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
105692967|NCT01862640|364540587|FG000|Overall Study|Withdrawal by Subject|2|||
105692968|NCT01862640|364540588|FG001|Overall Study|Withdrawal by Subject|4|||
105692969|NCT01862640|364540589|FG002|Overall Study|Withdrawal by Subject|8|||
105692970|NCT01862640|364540590|FG003|Overall Study|Withdrawal by Subject|5|||
105692971|NCT01862640|364540587|FG000|Overall Study|Protocol Deviation|0|||
105692972|NCT01862640|364540588|FG001|Overall Study|Protocol Deviation|0|||
105692973|NCT01862640|364540589|FG002|Overall Study|Protocol Deviation|1|||
105692974|NCT01862640|364540590|FG003|Overall Study|Protocol Deviation|0|||
105692975|NCT04178967|364540591|FG000|Induction Period|Adverse Event|4|||
105692976|NCT04178967|364540592|FG001|Induction Period|Adverse Event|6|||
105692977|NCT04178967|364540593|FG002|Induction Period|Adverse Event|0|||
105692978|NCT04178967|364540594|FG003|Induction Period|Adverse Event|0|||
105692979|NCT04178967|364540595|FG004|Induction Period|Adverse Event|0|||
105692980|NCT04178967|364540596|FG005|Induction Period|Adverse Event|0|||
105692981|NCT04178967|364540597|FG006|Induction Period|Adverse Event|0|||
105692982|NCT04178967|364540598|FG007|Induction Period|Adverse Event|0|||
105692983|NCT04178967|364540599|FG008|Induction Period|Adverse Event|0|||
105692984|NCT04178967|364540600|FG009|Induction Period|Adverse Event|0|||
105692985|NCT04178967|364540601|FG010|Induction Period|Adverse Event|0|||
105692986|NCT04178967|364540591|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
105692987|NCT04178967|364540592|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
105692988|NCT04178967|364540593|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
105692989|NCT04178967|364540594|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
105692990|NCT04178967|364540595|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
105692991|NCT04178967|364540596|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
105692992|NCT04178967|364540597|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
105692993|NCT04178967|364540598|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
105692994|NCT04178967|364540599|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
105692995|NCT04178967|364540600|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
105346928|NCT01556997|363273239|FG002|Overall Study|Lost to Follow-up|4|||
105346929|NCT01556997|363273237|FG000|Overall Study|Physician Decision|1|||
105472439|NCT04080167|363741424|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
105692996|NCT04178967|364540601|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
105692997|NCT04178967|364540591|FG000|Induction Period|Lack of Efficacy|4|||
105692998|NCT04178967|364540592|FG001|Induction Period|Lack of Efficacy|1|||
105692999|NCT04178967|364540593|FG002|Induction Period|Lack of Efficacy|0|||
105693000|NCT04178967|364540594|FG003|Induction Period|Lack of Efficacy|0|||
105693001|NCT04178967|364540595|FG004|Induction Period|Lack of Efficacy|0|||
105346930|NCT01556997|363273238|FG001|Overall Study|Physician Decision|1|||
105693002|NCT04178967|364540596|FG005|Induction Period|Lack of Efficacy|0|||
105693003|NCT04178967|364540597|FG006|Induction Period|Lack of Efficacy|0|||
105559141|NCT04124926|364044586|FG003|Maintenance Phase|Miscellaneous|2|||
105346931|NCT01556997|363273239|FG002|Overall Study|Physician Decision|1|||
105346932|NCT01556997|363273237|FG000|Overall Study|Withdrawal by Subject|7|||
105346933|NCT01556997|363273238|FG001|Overall Study|Withdrawal by Subject|6|||
105693004|NCT04178967|364540598|FG007|Induction Period|Lack of Efficacy|0|||
105693005|NCT04178967|364540599|FG008|Induction Period|Lack of Efficacy|0|||
105693006|NCT04178967|364540600|FG009|Induction Period|Lack of Efficacy|0|||
105346934|NCT01556997|363273239|FG002|Overall Study|Withdrawal by Subject|8|||
105346935|NCT01556997|363273237|FG000|Overall Study|Other|2|||
105346936|NCT01556997|363273238|FG001|Overall Study|Other|3|||
105346937|NCT01556997|363273239|FG002|Overall Study|Other|7|||
105346938|NCT01937715|363273245|FG000|Overall Study|Death|0|||
105346939|NCT01937715|363273246|FG001|Overall Study|Death|0|||
105346940|NCT01937715|363273247|FG002|Overall Study|Death|0|||
105346941|NCT01937715|363273248|FG003|Overall Study|Death|1|||
105346942|NCT01937715|363273249|FG004|Overall Study|Death|0|||
105346943|NCT01937715|363273245|FG000|Overall Study|Withdrawal by Subject|0|||
105346944|NCT01937715|363273246|FG001|Overall Study|Withdrawal by Subject|1|||
105346945|NCT01937715|363273247|FG002|Overall Study|Withdrawal by Subject|0|||
105346946|NCT01937715|363273248|FG003|Overall Study|Withdrawal by Subject|0|||
105346947|NCT01937715|363273249|FG004|Overall Study|Withdrawal by Subject|2|||
105346948|NCT01937715|363273245|FG000|Overall Study|Other|0|||
105346949|NCT01937715|363273246|FG001|Overall Study|Other|0|||
105346950|NCT01937715|363273247|FG002|Overall Study|Other|0|||
105346951|NCT01937715|363273248|FG003|Overall Study|Other|3|||
105346952|NCT01937715|363273249|FG004|Overall Study|Other|0|||
105346953|NCT01777139|363273250|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
105346954|NCT01777139|363273251|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
105346955|NCT01777139|363273250|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
105346956|NCT01777139|363273251|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
105346957|NCT01777139|363273250|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
105346958|NCT01777139|363273251|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
105346959|NCT01777139|363273250|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
105346960|NCT01777139|363273251|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
105346961|NCT01777139|363273250|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
105346962|NCT01777139|363273251|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
105346963|NCT01777139|363273250|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
105346964|NCT01777139|363273251|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
105346965|NCT01777139|363273250|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
105346966|NCT01777139|363273251|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
105346967|NCT01777139|363273250|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
105346968|NCT01777139|363273251|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
105346969|NCT02921750|363273252|FG000|Overall Study|Adverse Event|1|||
105346970|NCT02921750|363273253|FG001|Overall Study|Adverse Event|2|||
105346971|NCT02921750|363273252|FG000|Overall Study|Withdrawal by Subject|1|||
105346972|NCT02921750|363273253|FG001|Overall Study|Withdrawal by Subject|1|||
105346973|NCT02921750|363273252|FG000|Overall Study|Lost to Follow-up|3|||
105346974|NCT02921750|363273253|FG001|Overall Study|Lost to Follow-up|3|||
105346975|NCT02921750|363273252|FG000|Overall Study|Wound healed|3|||
105346976|NCT02921750|363273253|FG001|Overall Study|Wound healed|3|||
105346977|NCT02921750|363273252|FG000|Overall Study|Serious Adverse Event|1|||
105346978|NCT02921750|363273253|FG001|Overall Study|Serious Adverse Event|2|||
105346979|NCT01451164|363273258|FG000|Overall Study|Adverse Event|19|||
105346980|NCT01451164|363273259|FG001|Overall Study|Adverse Event|12|||
105346981|NCT01451164|363273260|FG002|Overall Study|Adverse Event|18|||
105346982|NCT01451164|363273261|FG003|Overall Study|Adverse Event|21|||
105346983|NCT01451164|363273258|FG000|Overall Study|Withdrawal Criteria|1|||
105346984|NCT01451164|363273259|FG001|Overall Study|Withdrawal Criteria|1|||
105346985|NCT01451164|363273260|FG002|Overall Study|Withdrawal Criteria|1|||
105346986|NCT01451164|363273261|FG003|Overall Study|Withdrawal Criteria|1|||
105346987|NCT01451164|363273258|FG000|Overall Study|Physician Decision|2|||
105346988|NCT01451164|363273259|FG001|Overall Study|Physician Decision|0|||
105346989|NCT01451164|363273260|FG002|Overall Study|Physician Decision|1|||
105346990|NCT01451164|363273261|FG003|Overall Study|Physician Decision|0|||
105346991|NCT01451164|363273258|FG000|Overall Study|Withdrawal by Subject|14|||
105346992|NCT01451164|363273259|FG001|Overall Study|Withdrawal by Subject|11|||
105346993|NCT01451164|363273260|FG002|Overall Study|Withdrawal by Subject|16|||
105346994|NCT01451164|363273261|FG003|Overall Study|Withdrawal by Subject|17|||
105346995|NCT01451164|363273258|FG000|Overall Study|Protocol Violation|0|||
105346996|NCT01451164|363273259|FG001|Overall Study|Protocol Violation|1|||
105559142|NCT04124926|364044587|FG004|Maintenance Phase|Miscellaneous|4|||
105693007|NCT04178967|364540601|FG010|Induction Period|Lack of Efficacy|0|||
105346997|NCT01451164|363273260|FG002|Overall Study|Protocol Violation|0|||
105559143|NCT04124926|364044583|FG000|Maintenance Phase|Randomized but not Treated|0|||
105693008|NCT04178967|364540591|FG000|Induction Period|Protocol Violation|0|||
105346998|NCT01451164|363273261|FG003|Overall Study|Protocol Violation|0|||
105346999|NCT01451164|363273258|FG000|Overall Study|Lack of Efficacy|7|||
105559144|NCT04124926|364044584|FG001|Maintenance Phase|Randomized but not Treated|0|||
105472440|NCT02167139|363741425|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
105472441|NCT02167139|363741426|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
105472442|NCT02167139|363741427|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
105472443|NCT02167139|363741428|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
105472444|NCT02167139|363741425|FG000|Randomised, Double-blind|Adverse Event|2|||
105472445|NCT02167139|363741426|FG001|Randomised, Double-blind|Adverse Event|9|||
105472446|NCT02167139|363741427|FG002|Randomised, Double-blind|Adverse Event|0|||
105472447|NCT02167139|363741428|FG003|Randomised, Double-blind|Adverse Event|0|||
105472448|NCT02167139|363741425|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
105472449|NCT02167139|363741426|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
105472450|NCT02167139|363741427|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
105472451|NCT02167139|363741428|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
105472452|NCT02167139|363741425|FG000|Randomised, Double-blind|Other|3|||
105472453|NCT02167139|363741426|FG001|Randomised, Double-blind|Other|0|||
105559145|NCT04124926|364044585|FG002|Maintenance Phase|Randomized but not Treated|2|||
105559146|NCT04124926|364044586|FG003|Maintenance Phase|Randomized but not Treated|2|||
105347000|NCT01451164|363273259|FG001|Overall Study|Lack of Efficacy|9|||
105347001|NCT01451164|363273260|FG002|Overall Study|Lack of Efficacy|9|||
105347002|NCT01451164|363273261|FG003|Overall Study|Lack of Efficacy|7|||
105347003|NCT01458951|363273262|FG000|Overall Study|Other|1|||
105347004|NCT01458951|363273263|FG001|Overall Study|Other|0|||
105347005|NCT01458951|363273264|FG002|Overall Study|Other|0|||
105347006|NCT01458951|363273262|FG000|Overall Study|Protocol Violation|5|||
105347007|NCT01458951|363273263|FG001|Overall Study|Protocol Violation|1|||
105347008|NCT01458951|363273264|FG002|Overall Study|Protocol Violation|0|||
105347009|NCT01458951|363273262|FG000|Overall Study|Withdrawal by Subject|2|||
105559147|NCT04124926|364044587|FG004|Maintenance Phase|Randomized but not Treated|0|||
105559148|NCT00338884|364044588|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
105347010|NCT01458951|363273263|FG001|Overall Study|Withdrawal by Subject|0|||
105347011|NCT01458951|363273264|FG002|Overall Study|Withdrawal by Subject|2|||
105472454|NCT02167139|363741427|FG002|Randomised, Double-blind|Other|0|||
105472455|NCT02167139|363741428|FG003|Randomised, Double-blind|Other|0|||
105559149|NCT00338884|364044588|FG000|Overall Study|Adverse Event|14|||
105347012|NCT01458951|363273262|FG000|Overall Study|Adverse Event|7|||
105347013|NCT01458951|363273263|FG001|Overall Study|Adverse Event|0|||
105347014|NCT01458951|363273264|FG002|Overall Study|Adverse Event|2|||
105347015|NCT01458951|363273262|FG000|Overall Study|Insufficient Clinical Response|17|||
105347016|NCT01458951|363273263|FG001|Overall Study|Insufficient Clinical Response|0|||
105347017|NCT01458951|363273264|FG002|Overall Study|Insufficient Clinical Response|11|||
105347018|NCT05932225|363273265|FG000|Overall Study|Lost to Follow-up|0|||
105347019|NCT05932225|363273266|FG001|Overall Study|Lost to Follow-up|1|||
105347020|NCT05932225|363273267|FG002|Overall Study|Lost to Follow-up|0|||
105347021|NCT05932225|363273265|FG000|Overall Study|Withdrawal by Subject|1|||
105347022|NCT05932225|363273266|FG001|Overall Study|Withdrawal by Subject|0|||
105347023|NCT05932225|363273267|FG002|Overall Study|Withdrawal by Subject|0|||
105347024|NCT05932225|363273265|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
105347025|NCT05932225|363273266|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
105347026|NCT05932225|363273267|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
105347027|NCT02638129|363273268|FG000|Overall Study|Study terminated|28|||
105347028|NCT02638129|363273269|FG001|Overall Study|Study terminated|30|||
105347029|NCT00869557|363273270|FG000|Randomized Phase|Lost to Follow-up|2|||
105347030|NCT00869557|363273271|FG001|Randomized Phase|Lost to Follow-up|1|||
105347031|NCT00869557|363273270|FG000|Randomized Phase|Investigator's Discretion|1|||
105347032|NCT00869557|363273271|FG001|Randomized Phase|Investigator's Discretion|0|||
105347033|NCT00869557|363273270|FG000|Randomized Phase|Withdrew Consent|0|||
105347034|NCT00869557|363273271|FG001|Randomized Phase|Withdrew Consent|1|||
105347035|NCT00869557|363273270|FG000|Extension Phase|Adverse Event|2|||
105347036|NCT00869557|363273271|FG001|Extension Phase|Adverse Event|2|||
105347037|NCT00869557|363273270|FG000|Extension Phase|Lack of Efficacy|1|||
105347038|NCT00869557|363273271|FG001|Extension Phase|Lack of Efficacy|0|||
105347039|NCT00869557|363273270|FG000|Extension Phase|Lost to Follow-up|3|||
105347040|NCT00869557|363273271|FG001|Extension Phase|Lost to Follow-up|1|||
105347041|NCT00869557|363273270|FG000|Extension Phase|Investigator's Discretion|2|||
105347042|NCT00869557|363273271|FG001|Extension Phase|Investigator's Discretion|0|||
105347043|NCT00869557|363273270|FG000|Extension Phase|Withdrew Consent|2|||
105347044|NCT00869557|363273271|FG001|Extension Phase|Withdrew Consent|0|||
105347045|NCT01473394|363273272|FG000|Overall Study|Adverse Event|13|||
105347046|NCT01473394|363273273|FG001|Overall Study|Adverse Event|16|||
105347047|NCT01473394|363273272|FG000|Overall Study|Insufficient Therapeutic Response|4|||
105347048|NCT01473394|363273273|FG001|Overall Study|Insufficient Therapeutic Response|1|||
105347049|NCT01473394|363273272|FG000|Overall Study|Protocol Violation|7|||
105347050|NCT01473394|363273273|FG001|Overall Study|Protocol Violation|5|||
105347051|NCT01473394|363273272|FG000|Overall Study|Withdrew Consent|12|||
105347052|NCT01473394|363273273|FG001|Overall Study|Withdrew Consent|10|||
105347053|NCT01473394|363273272|FG000|Overall Study|Lost to Follow-up|9|||
105347054|NCT01473394|363273273|FG001|Overall Study|Lost to Follow-up|11|||
105347055|NCT01358578|363273274|FG000|Induction Period|Adverse Event|2|||
105347056|NCT01358578|363273275|FG001|Induction Period|Adverse Event|4|||
105347057|NCT01358578|363273276|FG002|Induction Period|Adverse Event|2|||
105347058|NCT01358578|363273277|FG003|Induction Period|Adverse Event|6|||
105347059|NCT01358578|363273278|FG004|Induction Period|Adverse Event|0|||
105347060|NCT01358578|363273279|FG005|Induction Period|Adverse Event|0|||
105347061|NCT01358578|363273274|FG000|Induction Period|Lack of Efficacy|0|||
105347062|NCT01358578|363273275|FG001|Induction Period|Lack of Efficacy|0|||
105347063|NCT01358578|363273276|FG002|Induction Period|Lack of Efficacy|9|||
105347064|NCT01358578|363273277|FG003|Induction Period|Lack of Efficacy|1|||
105347065|NCT01358578|363273278|FG004|Induction Period|Lack of Efficacy|0|||
105347066|NCT01358578|363273279|FG005|Induction Period|Lack of Efficacy|0|||
105347067|NCT01358578|363273274|FG000|Induction Period|Lost to Follow-up|0|||
105347068|NCT01358578|363273275|FG001|Induction Period|Lost to Follow-up|0|||
105347069|NCT01358578|363273276|FG002|Induction Period|Lost to Follow-up|1|||
105347070|NCT01358578|363273277|FG003|Induction Period|Lost to Follow-up|4|||
105347071|NCT01358578|363273278|FG004|Induction Period|Lost to Follow-up|0|||
105347072|NCT01358578|363273279|FG005|Induction Period|Lost to Follow-up|0|||
105347073|NCT01358578|363273274|FG000|Induction Period|Physician Decision|2|||
105347074|NCT01358578|363273275|FG001|Induction Period|Physician Decision|1|||
105347075|NCT01358578|363273276|FG002|Induction Period|Physician Decision|2|||
105347076|NCT01358578|363273277|FG003|Induction Period|Physician Decision|0|||
105693009|NCT04178967|364540592|FG001|Induction Period|Protocol Violation|6|||
105693010|NCT04178967|364540593|FG002|Induction Period|Protocol Violation|0|||
105693011|NCT04178967|364540594|FG003|Induction Period|Protocol Violation|0|||
105693012|NCT04178967|364540595|FG004|Induction Period|Protocol Violation|0|||
105347077|NCT01358578|363273278|FG004|Induction Period|Physician Decision|0|||
105347078|NCT01358578|363273279|FG005|Induction Period|Physician Decision|0|||
105347079|NCT01358578|363273274|FG000|Induction Period|Protocol Deviation|3|||
105347080|NCT01358578|363273275|FG001|Induction Period|Protocol Deviation|5|||
105347081|NCT01358578|363273276|FG002|Induction Period|Protocol Deviation|0|||
105347082|NCT01358578|363273277|FG003|Induction Period|Protocol Deviation|3|||
105347083|NCT01358578|363273278|FG004|Induction Period|Protocol Deviation|0|||
105347084|NCT01358578|363273279|FG005|Induction Period|Protocol Deviation|0|||
105347085|NCT01358578|363273274|FG000|Induction Period|technical problems|0|||
105347086|NCT01358578|363273275|FG001|Induction Period|technical problems|0|||
105347087|NCT01358578|363273276|FG002|Induction Period|technical problems|1|||
105347088|NCT01358578|363273277|FG003|Induction Period|technical problems|1|||
105347089|NCT01358578|363273278|FG004|Induction Period|technical problems|0|||
105347090|NCT01358578|363273279|FG005|Induction Period|technical problems|0|||
105347091|NCT01358578|363273274|FG000|Induction Period|Withdrawal by Subject|5|||
105347092|NCT01358578|363273275|FG001|Induction Period|Withdrawal by Subject|5|||
105347093|NCT01358578|363273276|FG002|Induction Period|Withdrawal by Subject|10|||
105347094|NCT01358578|363273277|FG003|Induction Period|Withdrawal by Subject|6|||
105347095|NCT01358578|363273278|FG004|Induction Period|Withdrawal by Subject|0|||
105347096|NCT01358578|363273279|FG005|Induction Period|Withdrawal by Subject|0|||
105347097|NCT01358578|363273274|FG000|Maintenance Period|Adverse Event|2|||
105347098|NCT01358578|363273275|FG001|Maintenance Period|Adverse Event|7|||
105347099|NCT01358578|363273276|FG002|Maintenance Period|Adverse Event|0|||
105347100|NCT01358578|363273277|FG003|Maintenance Period|Adverse Event|6|||
105347101|NCT01358578|363273278|FG004|Maintenance Period|Adverse Event|4|||
105347102|NCT01358578|363273279|FG005|Maintenance Period|Adverse Event|3|||
105347103|NCT01358578|363273274|FG000|Maintenance Period|Lack of Efficacy|10|||
105347104|NCT01358578|363273275|FG001|Maintenance Period|Lack of Efficacy|2|||
105347105|NCT01358578|363273276|FG002|Maintenance Period|Lack of Efficacy|0|||
105347106|NCT01358578|363273277|FG003|Maintenance Period|Lack of Efficacy|11|||
105347107|NCT01358578|363273278|FG004|Maintenance Period|Lack of Efficacy|3|||
105347108|NCT01358578|363273279|FG005|Maintenance Period|Lack of Efficacy|0|||
105347109|NCT01358578|363273274|FG000|Maintenance Period|Lost to Follow-up|4|||
105347110|NCT01358578|363273275|FG001|Maintenance Period|Lost to Follow-up|0|||
105347111|NCT01358578|363273276|FG002|Maintenance Period|Lost to Follow-up|0|||
105347112|NCT01358578|363273277|FG003|Maintenance Period|Lost to Follow-up|5|||
105347113|NCT01358578|363273278|FG004|Maintenance Period|Lost to Follow-up|1|||
105347114|NCT01358578|363273279|FG005|Maintenance Period|Lost to Follow-up|1|||
105347115|NCT01358578|363273274|FG000|Maintenance Period|Non-compliance with study treatment|3|||
105347116|NCT01358578|363273275|FG001|Maintenance Period|Non-compliance with study treatment|1|||
105347117|NCT01358578|363273276|FG002|Maintenance Period|Non-compliance with study treatment|0|||
105347118|NCT01358578|363273277|FG003|Maintenance Period|Non-compliance with study treatment|2|||
105347119|NCT01358578|363273278|FG004|Maintenance Period|Non-compliance with study treatment|1|||
105347120|NCT01358578|363273279|FG005|Maintenance Period|Non-compliance with study treatment|2|||
105347121|NCT01358578|363273274|FG000|Maintenance Period|Physician Decision|0|||
105347122|NCT01358578|363273275|FG001|Maintenance Period|Physician Decision|1|||
105347123|NCT01358578|363273276|FG002|Maintenance Period|Physician Decision|0|||
105347124|NCT01358578|363273277|FG003|Maintenance Period|Physician Decision|1|||
105347125|NCT01358578|363273278|FG004|Maintenance Period|Physician Decision|0|||
105347126|NCT01358578|363273279|FG005|Maintenance Period|Physician Decision|0|||
105347127|NCT01358578|363273274|FG000|Maintenance Period|Pregnancy|1|||
105347128|NCT01358578|363273275|FG001|Maintenance Period|Pregnancy|0|||
105347129|NCT01358578|363273276|FG002|Maintenance Period|Pregnancy|0|||
105347130|NCT01358578|363273277|FG003|Maintenance Period|Pregnancy|0|||
105347131|NCT01358578|363273278|FG004|Maintenance Period|Pregnancy|0|||
105347132|NCT01358578|363273279|FG005|Maintenance Period|Pregnancy|0|||
105347133|NCT01358578|363273274|FG000|Maintenance Period|Protocol deviation|7|||
105347134|NCT01358578|363273275|FG001|Maintenance Period|Protocol deviation|4|||
105347135|NCT01358578|363273276|FG002|Maintenance Period|Protocol deviation|0|||
105347136|NCT01358578|363273277|FG003|Maintenance Period|Protocol deviation|2|||
105347137|NCT01358578|363273278|FG004|Maintenance Period|Protocol deviation|2|||
105347138|NCT01358578|363273279|FG005|Maintenance Period|Protocol deviation|2|||
105347139|NCT01358578|363273274|FG000|Maintenance Period|Withdrawal by Subject|12|||
105347140|NCT01358578|363273275|FG001|Maintenance Period|Withdrawal by Subject|7|||
105347141|NCT01358578|363273276|FG002|Maintenance Period|Withdrawal by Subject|2|||
105347142|NCT01358578|363273277|FG003|Maintenance Period|Withdrawal by Subject|15|||
105347143|NCT01358578|363273278|FG004|Maintenance Period|Withdrawal by Subject|6|||
105347144|NCT01358578|363273279|FG005|Maintenance Period|Withdrawal by Subject|3|||
105347145|NCT01358578|363273274|FG000|Follow-up Period|Adverse Event|1|||
105347146|NCT01358578|363273275|FG001|Follow-up Period|Adverse Event|1|||
105347147|NCT01358578|363273276|FG002|Follow-up Period|Adverse Event|0|||
105787062|NCT03110107|364874894|FG005|Treatment Period|Disease Progression|4|||
105347148|NCT01358578|363273277|FG003|Follow-up Period|Adverse Event|0|||
105347149|NCT01358578|363273278|FG004|Follow-up Period|Adverse Event|0|||
105347150|NCT01358578|363273279|FG005|Follow-up Period|Adverse Event|0|||
105347151|NCT01358578|363273274|FG000|Follow-up Period|Lack of Efficacy|3|||
105347152|NCT01358578|363273275|FG001|Follow-up Period|Lack of Efficacy|0|||
105347153|NCT01358578|363273276|FG002|Follow-up Period|Lack of Efficacy|4|||
105347154|NCT01358578|363273277|FG003|Follow-up Period|Lack of Efficacy|1|||
105347155|NCT01358578|363273278|FG004|Follow-up Period|Lack of Efficacy|0|||
105347156|NCT01358578|363273279|FG005|Follow-up Period|Lack of Efficacy|0|||
105347157|NCT01358578|363273274|FG000|Follow-up Period|Lost to Follow-up|0|||
105347158|NCT01358578|363273275|FG001|Follow-up Period|Lost to Follow-up|1|||
105347159|NCT01358578|363273276|FG002|Follow-up Period|Lost to Follow-up|0|||
105559150|NCT00338884|364044588|FG000|Overall Study|Death|8|||
105559151|NCT00338884|364044588|FG000|Overall Study|Other|4|||
105472456|NCT02167139|363741425|FG000|Transition-extension|Adverse Event|2|||
105347160|NCT01358578|363273277|FG003|Follow-up Period|Lost to Follow-up|4|||
105347161|NCT01358578|363273278|FG004|Follow-up Period|Lost to Follow-up|0|||
105347162|NCT01358578|363273279|FG005|Follow-up Period|Lost to Follow-up|0|||
105347163|NCT01358578|363273274|FG000|Follow-up Period|non- compliance with study treatment|1|||
105347164|NCT01358578|363273275|FG001|Follow-up Period|non- compliance with study treatment|0|||
105347165|NCT01358578|363273276|FG002|Follow-up Period|non- compliance with study treatment|0|||
105347166|NCT01358578|363273277|FG003|Follow-up Period|non- compliance with study treatment|0|||
105347167|NCT01358578|363273278|FG004|Follow-up Period|non- compliance with study treatment|0|||
105347168|NCT01358578|363273279|FG005|Follow-up Period|non- compliance with study treatment|0|||
105347169|NCT01358578|363273274|FG000|Follow-up Period|Pregnancy|1|||
105347170|NCT01358578|363273275|FG001|Follow-up Period|Pregnancy|0|||
105347171|NCT01358578|363273276|FG002|Follow-up Period|Pregnancy|0|||
105347172|NCT01358578|363273277|FG003|Follow-up Period|Pregnancy|0|||
105347173|NCT01358578|363273278|FG004|Follow-up Period|Pregnancy|0|||
105347174|NCT01358578|363273279|FG005|Follow-up Period|Pregnancy|0|||
105347175|NCT01358578|363273274|FG000|Follow-up Period|Withdrawal by Subject|3|||
105347176|NCT01358578|363273275|FG001|Follow-up Period|Withdrawal by Subject|3|||
105347177|NCT01358578|363273276|FG002|Follow-up Period|Withdrawal by Subject|1|||
105347178|NCT01358578|363273277|FG003|Follow-up Period|Withdrawal by Subject|12|||
105347179|NCT01358578|363273278|FG004|Follow-up Period|Withdrawal by Subject|0|||
105347180|NCT01358578|363273279|FG005|Follow-up Period|Withdrawal by Subject|0|||
105347181|NCT01358578|363273274|FG000|Follow-up Period|Physician Decision|1|||
105347182|NCT01358578|363273275|FG001|Follow-up Period|Physician Decision|1|||
105347183|NCT01358578|363273276|FG002|Follow-up Period|Physician Decision|0|||
105347184|NCT01358578|363273277|FG003|Follow-up Period|Physician Decision|2|||
105693013|NCT04178967|364540596|FG005|Induction Period|Protocol Violation|0|||
105693014|NCT04178967|364540597|FG006|Induction Period|Protocol Violation|0|||
105347185|NCT01358578|363273278|FG004|Follow-up Period|Physician Decision|0|||
105347186|NCT01358578|363273279|FG005|Follow-up Period|Physician Decision|0|||
105347187|NCT05940077|363273280|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
105347188|NCT02696434|363273281|FG000|Overall Study|Adverse Event|3|||
105347189|NCT02696434|363273282|FG001|Overall Study|Adverse Event|1|||
105347190|NCT02696434|363273281|FG000|Overall Study|Lost to Follow-up|5|||
105347191|NCT02696434|363273282|FG001|Overall Study|Lost to Follow-up|4|||
105347192|NCT02696434|363273281|FG000|Overall Study|Withdrawal by Subject|14|||
105347193|NCT02696434|363273282|FG001|Overall Study|Withdrawal by Subject|12|||
105347194|NCT02696434|363273281|FG000|Overall Study|Physician Decision|0|||
105347195|NCT02696434|363273282|FG001|Overall Study|Physician Decision|1|||
105347196|NCT00590538|363273283|FG000|Overall Study|Study terminated before completed|2|||
105347197|NCT03738800|363273284|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
105347198|NCT03738800|363273285|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
105347199|NCT03738800|363273286|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105347200|NCT03738800|363273284|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
105347201|NCT03738800|363273285|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
105347202|NCT03738800|363273286|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
105347203|NCT03738800|363273284|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
105347204|NCT03738800|363273285|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
105347205|NCT03738800|363273286|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
105347206|NCT00908076|363273296|FG000|Overall Study|Lack of Efficacy|1|||
105347207|NCT00908076|363273297|FG001|Overall Study|Lack of Efficacy|1|||
105347208|NCT03747302|363273298|FG000|Overall Study|Withdrawal by Subject|1|||
105347209|NCT03747302|363273299|FG001|Overall Study|Withdrawal by Subject|2|||
105347210|NCT04679051|363273300|FG000|Overall Study|felt tired after restricted time in bed|3|||
105347211|NCT04679051|363273301|FG001|Overall Study|felt tired after restricted time in bed|0|||
105347212|NCT04679051|363273300|FG000|Overall Study|discomfort with blood pressure cuff|2|||
105347213|NCT04679051|363273301|FG001|Overall Study|discomfort with blood pressure cuff|0|||
105347214|NCT04679051|363273300|FG000|Overall Study|scheduling conflict|1|||
105347215|NCT04679051|363273301|FG001|Overall Study|scheduling conflict|1|||
105347216|NCT04679051|363273300|FG000|Overall Study|Protocol Violation|0|||
105472457|NCT02167139|363741426|FG001|Transition-extension|Adverse Event|0|||
105693015|NCT04178967|364540598|FG007|Induction Period|Protocol Violation|0|||
105347217|NCT04679051|363273301|FG001|Overall Study|Protocol Violation|4|||
105693016|NCT04178967|364540599|FG008|Induction Period|Protocol Violation|0|||
105347218|NCT02554318|363273302|FG000|Overall Study|Withdrawal by Subject|10|||
105347219|NCT02554318|363273303|FG001|Overall Study|Withdrawal by Subject|8|||
105693017|NCT04178967|364540600|FG009|Induction Period|Protocol Violation|0|||
105693018|NCT04178967|364540601|FG010|Induction Period|Protocol Violation|0|||
105693019|NCT04178967|364540591|FG000|Induction Period|Withdrawal by Subject|6|||
105347220|NCT00033657|363273304|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
105347221|NCT00033657|363273305|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
105347222|NCT00033657|363273304|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
105472458|NCT02167139|363741427|FG002|Transition-extension|Adverse Event|2|||
105472459|NCT02167139|363741428|FG003|Transition-extension|Adverse Event|3|||
105472460|NCT02167139|363741425|FG000|Transition-extension|Withdrawal by Subject|2|||
105472461|NCT02167139|363741426|FG001|Transition-extension|Withdrawal by Subject|0|||
105472462|NCT02167139|363741427|FG002|Transition-extension|Withdrawal by Subject|4|||
105472463|NCT02167139|363741428|FG003|Transition-extension|Withdrawal by Subject|1|||
105472464|NCT02167139|363741425|FG000|Transition-extension|Lack of Efficacy|0|||
105472465|NCT02167139|363741426|FG001|Transition-extension|Lack of Efficacy|0|||
105472466|NCT02167139|363741427|FG002|Transition-extension|Lack of Efficacy|1|||
105472467|NCT02167139|363741428|FG003|Transition-extension|Lack of Efficacy|1|||
105472468|NCT02167139|363741425|FG000|Transition-extension|Other|1|||
105472469|NCT02167139|363741426|FG001|Transition-extension|Other|0|||
105472470|NCT02167139|363741427|FG002|Transition-extension|Other|1|||
105472471|NCT02167139|363741428|FG003|Transition-extension|Other|0|||
105472472|NCT02167139|363741425|FG000|Transition-extension|Lost to Follow-up|1|||
105693020|NCT04178967|364540592|FG001|Induction Period|Withdrawal by Subject|4|||
105693021|NCT04178967|364540593|FG002|Induction Period|Withdrawal by Subject|0|||
105472473|NCT02167139|363741426|FG001|Transition-extension|Lost to Follow-up|0|||
105472474|NCT02167139|363741427|FG002|Transition-extension|Lost to Follow-up|0|||
105472475|NCT02167139|363741428|FG003|Transition-extension|Lost to Follow-up|0|||
105472476|NCT01459497|363741436|FG000|Overall Study|Inability to meet trial constraints.|1|||
105472477|NCT01459497|363741437|FG001|Overall Study|Inability to meet trial constraints.|0|||
105472478|NCT01459497|363741436|FG000|Overall Study|Physician Decision|1|||
105472479|NCT01459497|363741437|FG001|Overall Study|Physician Decision|1|||
105472480|NCT01459497|363741436|FG000|Overall Study|Hospitalization.|0|||
105472481|NCT01459497|363741437|FG001|Overall Study|Hospitalization.|3|||
105693022|NCT04178967|364540594|FG003|Induction Period|Withdrawal by Subject|0|||
105693023|NCT04178967|364540595|FG004|Induction Period|Withdrawal by Subject|0|||
105693024|NCT04178967|364540596|FG005|Induction Period|Withdrawal by Subject|0|||
105693025|NCT04178967|364540597|FG006|Induction Period|Withdrawal by Subject|0|||
105693026|NCT04178967|364540598|FG007|Induction Period|Withdrawal by Subject|0|||
105693027|NCT04178967|364540599|FG008|Induction Period|Withdrawal by Subject|0|||
105693028|NCT04178967|364540600|FG009|Induction Period|Withdrawal by Subject|0|||
105693029|NCT04178967|364540601|FG010|Induction Period|Withdrawal by Subject|0|||
105693030|NCT04178967|364540591|FG000|Induction Period|Lost to Follow-up|2|||
105693031|NCT04178967|364540592|FG001|Induction Period|Lost to Follow-up|0|||
105693032|NCT04178967|364540593|FG002|Induction Period|Lost to Follow-up|0|||
105693033|NCT04178967|364540594|FG003|Induction Period|Lost to Follow-up|0|||
105693034|NCT04178967|364540595|FG004|Induction Period|Lost to Follow-up|0|||
105693035|NCT04178967|364540596|FG005|Induction Period|Lost to Follow-up|0|||
105693036|NCT04178967|364540597|FG006|Induction Period|Lost to Follow-up|0|||
105693037|NCT04178967|364540598|FG007|Induction Period|Lost to Follow-up|0|||
105693038|NCT04178967|364540599|FG008|Induction Period|Lost to Follow-up|0|||
105693039|NCT04178967|364540600|FG009|Induction Period|Lost to Follow-up|0|||
105693040|NCT04178967|364540601|FG010|Induction Period|Lost to Follow-up|0|||
105693041|NCT04178967|364540591|FG000|Induction Period|Participant Missed Study Visits|0|||
105693042|NCT04178967|364540592|FG001|Induction Period|Participant Missed Study Visits|1|||
105693043|NCT04178967|364540593|FG002|Induction Period|Participant Missed Study Visits|0|||
105693044|NCT04178967|364540594|FG003|Induction Period|Participant Missed Study Visits|0|||
105693045|NCT04178967|364540595|FG004|Induction Period|Participant Missed Study Visits|0|||
105693046|NCT04178967|364540596|FG005|Induction Period|Participant Missed Study Visits|0|||
105693047|NCT04178967|364540597|FG006|Induction Period|Participant Missed Study Visits|0|||
105693048|NCT04178967|364540598|FG007|Induction Period|Participant Missed Study Visits|0|||
105693049|NCT04178967|364540599|FG008|Induction Period|Participant Missed Study Visits|0|||
105693050|NCT04178967|364540600|FG009|Induction Period|Participant Missed Study Visits|0|||
105693051|NCT04178967|364540601|FG010|Induction Period|Participant Missed Study Visits|0|||
105693052|NCT04178967|364540591|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693053|NCT04178967|364540592|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693054|NCT04178967|364540593|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693055|NCT04178967|364540594|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693056|NCT04178967|364540595|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693057|NCT04178967|364540596|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
105472482|NCT01459497|363741436|FG000|Overall Study|Disease progression.|0|||
105693058|NCT04178967|364540597|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
105693059|NCT04178967|364540598|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
105693060|NCT04178967|364540599|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693061|NCT04178967|364540600|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693062|NCT04178967|364540601|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693063|NCT04178967|364540591|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693064|NCT04178967|364540592|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105472483|NCT01459497|363741437|FG001|Overall Study|Disease progression.|1|||
105472484|NCT01063283|363741438|FG000|Cycle 1|Adverse Event|2|||
105472485|NCT01063283|363741439|FG001|Cycle 1|Adverse Event|0|||
105472486|NCT01063283|363741440|FG002|Cycle 1|Adverse Event|0|||
105693065|NCT04178967|364540593|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693066|NCT04178967|364540594|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693067|NCT04178967|364540595|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693068|NCT04178967|364540596|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
105693069|NCT04178967|364540597|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693070|NCT04178967|364540598|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693071|NCT04178967|364540599|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693072|NCT04178967|364540600|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693073|NCT04178967|364540601|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105347223|NCT00033657|363273305|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
105347224|NCT00033657|363273304|FG000|Neoadjuvant Chemotherapy|Death|1|||
105347225|NCT00033657|363273305|FG001|Neoadjuvant Chemotherapy|Death|1|||
105347226|NCT00033657|363273304|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
105347227|NCT00033657|363273305|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
105347228|NCT00033657|363273304|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
105347229|NCT00033657|363273305|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
105347230|NCT00033657|363273304|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
105347231|NCT00033657|363273305|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
105347232|NCT00033657|363273304|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
105347233|NCT00033657|363273305|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
105347234|NCT00033657|363273304|FG000|Surgical Resection|not complete resection|0|||
105347235|NCT00033657|363273305|FG001|Surgical Resection|not complete resection|3|||
105347236|NCT00033657|363273304|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
105347237|NCT00033657|363273305|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
105347238|NCT00033657|363273304|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
105347239|NCT00033657|363273305|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
105347240|NCT00033657|363273304|FG000|Adjuvant Chemotherapy|Death|2|||
105347241|NCT00033657|363273305|FG001|Adjuvant Chemotherapy|Death|1|||
105347242|NCT00033657|363273304|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
105347243|NCT00033657|363273305|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
105347244|NCT00033657|363273304|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
105347245|NCT00033657|363273305|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
105347246|NCT00033657|363273304|FG000|Adjuvant Chemotherapy|Other|0|||
105347247|NCT00033657|363273305|FG001|Adjuvant Chemotherapy|Other|2|||
105347248|NCT03114657|363273307|FG000|Overall Study|Adverse Event|9|||
105347249|NCT03114657|363273308|FG001|Overall Study|Adverse Event|6|||
105347250|NCT03114657|363273307|FG000|Overall Study|Death|4|||
105347251|NCT03114657|363273308|FG001|Overall Study|Death|0|||
105347252|NCT03114657|363273307|FG000|Overall Study|Multiple Reasons|1|||
105347253|NCT03114657|363273308|FG001|Overall Study|Multiple Reasons|2|||
105347254|NCT03114657|363273307|FG000|Overall Study|Physician Decision|2|||
105347255|NCT03114657|363273308|FG001|Overall Study|Physician Decision|2|||
105347256|NCT03114657|363273307|FG000|Overall Study|Study Terminated By Sponsor|355|||
105347257|NCT03114657|363273308|FG001|Overall Study|Study Terminated By Sponsor|374|||
105347258|NCT03114657|363273307|FG000|Overall Study|Symptomatic Deterioration|0|||
105347259|NCT03114657|363273308|FG001|Overall Study|Symptomatic Deterioration|1|||
105347260|NCT03114657|363273307|FG000|Overall Study|Withdrawal by Subject|28|||
105347261|NCT03114657|363273308|FG001|Overall Study|Withdrawal by Subject|22|||
105347262|NCT01256385|363273309|FG000|Overall Study|Physician Decision|1|||
105347263|NCT01256385|363273310|FG001|Overall Study|Physician Decision|1|||
105347264|NCT01256385|363273309|FG000|Overall Study|Withdrawal by Subject|2|||
105347265|NCT01256385|363273310|FG001|Overall Study|Withdrawal by Subject|2|||
105347266|NCT01606202|363273311|FG000|Overall Study|Adverse Event|5|||
105472487|NCT01063283|363741438|FG000|Cycle 1|Technical failure in data collection|1|||
105693074|NCT04178967|364540591|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105787063|NCT03110107|364874895|FG006|Treatment Period|Disease Progression|6|||
105787064|NCT03110107|364874896|FG007|Treatment Period|Disease Progression|7|||
105787065|NCT03110107|364874897|FG008|Treatment Period|Disease Progression|2|||
105787066|NCT03110107|364874898|FG009|Treatment Period|Disease Progression|10|||
105347267|NCT01606202|363273312|FG001|Overall Study|Adverse Event|0|||
105472488|NCT01063283|363741439|FG001|Cycle 1|Technical failure in data collection|0|||
105472489|NCT01063283|363741440|FG002|Cycle 1|Technical failure in data collection|0|||
105472490|NCT00104520|363741441|FG000|Overall Study|Unrelated adverse event|34|||
105472491|NCT00104520|363741442|FG001|Overall Study|Unrelated adverse event|47|||
105693075|NCT04178967|364540592|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105693076|NCT04178967|364540593|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105787067|NCT03110107|364874899|FG010|Treatment Period|Disease Progression|5|||
105787068|NCT03110107|364874900|FG011|Treatment Period|Disease Progression|2|||
105347268|NCT01606202|363273311|FG000|Overall Study|Withdrawal by Subject|2|||
105347269|NCT01606202|363273312|FG001|Overall Study|Withdrawal by Subject|1|||
105347270|NCT01606202|363273311|FG000|Overall Study|Personal problems|0|||
105347271|NCT01606202|363273312|FG001|Overall Study|Personal problems|1|||
105472492|NCT00104520|363741441|FG000|Overall Study|Study drug intolerance|0|||
105472493|NCT00104520|363741442|FG001|Overall Study|Study drug intolerance|1|||
105472494|NCT00104520|363741441|FG000|Overall Study|Related adverse event|13|||
105472495|NCT00104520|363741442|FG001|Overall Study|Related adverse event|15|||
105472496|NCT00104520|363741441|FG000|Overall Study|Lost to Follow-up|1|||
105472497|NCT00104520|363741442|FG001|Overall Study|Lost to Follow-up|0|||
105472498|NCT00104520|363741441|FG000|Overall Study|Noncompliance|0|||
105472499|NCT00104520|363741442|FG001|Overall Study|Noncompliance|2|||
105472500|NCT00104520|363741441|FG000|Overall Study|Personal/administrative|1|||
105472501|NCT00104520|363741442|FG001|Overall Study|Personal/administrative|1|||
105472502|NCT00104520|363741441|FG000|Overall Study|Other|1|||
105472503|NCT00104520|363741442|FG001|Overall Study|Other|5|||
105472504|NCT01742286|363741443|FG000|Escalation Phase|Administrative problems|1|||
105472505|NCT01742286|363741444|FG001|Escalation Phase|Administrative problems|1|||
105472506|NCT01742286|363741445|FG002|Escalation Phase|Administrative problems|0|||
105472507|NCT01742286|363741446|FG003|Escalation Phase|Administrative problems|0|||
105472508|NCT01742286|363741447|FG004|Escalation Phase|Administrative problems|0|||
105472509|NCT01742286|363741448|FG005|Escalation Phase|Administrative problems|0|||
105472510|NCT01742286|363741449|FG006|Escalation Phase|Administrative problems|2|||
105472511|NCT01742286|363741443|FG000|Escalation Phase|Adverse Event|0|||
105472512|NCT01742286|363741444|FG001|Escalation Phase|Adverse Event|1|||
105472513|NCT01742286|363741445|FG002|Escalation Phase|Adverse Event|2|||
105472514|NCT01742286|363741446|FG003|Escalation Phase|Adverse Event|0|||
105472515|NCT01742286|363741447|FG004|Escalation Phase|Adverse Event|0|||
105472516|NCT01742286|363741448|FG005|Escalation Phase|Adverse Event|1|||
105472517|NCT01742286|363741449|FG006|Escalation Phase|Adverse Event|0|||
105472518|NCT01742286|363741443|FG000|Escalation Phase|Disease progression|3|||
105472519|NCT01742286|363741444|FG001|Escalation Phase|Disease progression|7|||
105472520|NCT01742286|363741445|FG002|Escalation Phase|Disease progression|4|||
105472521|NCT01742286|363741446|FG003|Escalation Phase|Disease progression|1|||
105472522|NCT01742286|363741447|FG004|Escalation Phase|Disease progression|4|||
105472523|NCT01742286|363741448|FG005|Escalation Phase|Disease progression|3|||
105472524|NCT01742286|363741449|FG006|Escalation Phase|Disease progression|2|||
105472525|NCT01742286|363741443|FG000|Escalation Phase|Death|0|||
105472526|NCT01742286|363741444|FG001|Escalation Phase|Death|0|||
105472527|NCT01742286|363741445|FG002|Escalation Phase|Death|0|||
105472528|NCT01742286|363741446|FG003|Escalation Phase|Death|0|||
105472529|NCT01742286|363741447|FG004|Escalation Phase|Death|0|||
105472530|NCT01742286|363741448|FG005|Escalation Phase|Death|1|||
105472531|NCT01742286|363741449|FG006|Escalation Phase|Death|0|||
105472532|NCT01742286|363741443|FG000|Escalation Phase|Physician Decision|0|||
105472533|NCT01742286|363741444|FG001|Escalation Phase|Physician Decision|3|||
105472534|NCT01742286|363741445|FG002|Escalation Phase|Physician Decision|0|||
105472535|NCT01742286|363741446|FG003|Escalation Phase|Physician Decision|1|||
105472536|NCT01742286|363741447|FG004|Escalation Phase|Physician Decision|0|||
105472537|NCT01742286|363741448|FG005|Escalation Phase|Physician Decision|0|||
105472538|NCT01742286|363741449|FG006|Escalation Phase|Physician Decision|2|||
105472539|NCT01742286|363741443|FG000|Escalation Phase|Subject/guardian decision|1|||
105472540|NCT01742286|363741444|FG001|Escalation Phase|Subject/guardian decision|0|||
105472541|NCT01742286|363741445|FG002|Escalation Phase|Subject/guardian decision|0|||
105472542|NCT01742286|363741446|FG003|Escalation Phase|Subject/guardian decision|0|||
105472543|NCT01742286|363741447|FG004|Escalation Phase|Subject/guardian decision|0|||
105472544|NCT01742286|363741448|FG005|Escalation Phase|Subject/guardian decision|0|||
105472545|NCT01742286|363741449|FG006|Escalation Phase|Subject/guardian decision|0|||
105472546|NCT01742286|363741443|FG000|Expansion Phase|Administrative problems|0|||
105472547|NCT01742286|363741444|FG001|Expansion Phase|Administrative problems|0|||
105472548|NCT01742286|363741445|FG002|Expansion Phase|Administrative problems|0|||
105472549|NCT01742286|363741446|FG003|Expansion Phase|Administrative problems|0|||
105472550|NCT01742286|363741447|FG004|Expansion Phase|Administrative problems|0|||
105472551|NCT01742286|363741448|FG005|Expansion Phase|Administrative problems|0|||
105472552|NCT01742286|363741449|FG006|Expansion Phase|Administrative problems|5|||
105472553|NCT01742286|363741443|FG000|Expansion Phase|Physician Decision|0|||
105472554|NCT01742286|363741444|FG001|Expansion Phase|Physician Decision|0|||
105693077|NCT04178967|364540594|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
105693078|NCT04178967|364540595|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105693079|NCT04178967|364540596|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105472555|NCT01742286|363741445|FG002|Expansion Phase|Physician Decision|4|||
105472556|NCT01742286|363741446|FG003|Expansion Phase|Physician Decision|0|||
105472557|NCT01742286|363741447|FG004|Expansion Phase|Physician Decision|0|||
105472558|NCT01742286|363741448|FG005|Expansion Phase|Physician Decision|0|||
105472559|NCT01742286|363741449|FG006|Expansion Phase|Physician Decision|9|||
105472560|NCT01742286|363741443|FG000|Expansion Phase|Adverse Event|0|||
105472561|NCT01742286|363741444|FG001|Expansion Phase|Adverse Event|0|||
105472562|NCT01742286|363741445|FG002|Expansion Phase|Adverse Event|0|||
105472563|NCT01742286|363741446|FG003|Expansion Phase|Adverse Event|0|||
105472564|NCT01742286|363741447|FG004|Expansion Phase|Adverse Event|0|||
105472565|NCT01742286|363741448|FG005|Expansion Phase|Adverse Event|0|||
105472566|NCT01742286|363741449|FG006|Expansion Phase|Adverse Event|6|||
105472567|NCT01742286|363741443|FG000|Expansion Phase|Disease progression|0|||
105693080|NCT04178967|364540597|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105693081|NCT04178967|364540598|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105693082|NCT04178967|364540599|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105693083|NCT04178967|364540600|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105693084|NCT04178967|364540601|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105347272|NCT01606202|363273311|FG000|Overall Study|Problems with administration|0|||
105347273|NCT01606202|363273312|FG001|Overall Study|Problems with administration|1|||
105347274|NCT05020366|363273313|FG000|Overall Study|Lost to Follow-up|2|||
105347275|NCT05020366|363273314|FG001|Overall Study|Lost to Follow-up|0|||
105347276|NCT05020366|363273313|FG000|Overall Study|Withdrawal by Subject|2|||
105347277|NCT05020366|363273314|FG001|Overall Study|Withdrawal by Subject|0|||
105347278|NCT02584959|363273315|FG000|Period 1|Withdrawn from study|3|||
105347279|NCT02584959|363273316|FG001|Period 1|Withdrawn from study|4|||
105347280|NCT02584959|363273317|FG002|Period 1|Withdrawn from study|0|||
105347281|NCT02584959|363273315|FG000|Period 2|Withdrawn from study|6|||
105347282|NCT02584959|363273316|FG001|Period 2|Withdrawn from study|1|||
105347283|NCT02584959|363273317|FG002|Period 2|Withdrawn from study|2|||
105347284|NCT01162122|363273318|FG000|Overall Study|Withdrawal by Subject|52|||
105347285|NCT01162122|363273319|FG001|Overall Study|Withdrawal by Subject|43|||
105347286|NCT01162122|363273318|FG000|Overall Study|Lost to Follow-up|73|||
105347287|NCT01162122|363273319|FG001|Overall Study|Lost to Follow-up|91|||
105347288|NCT01162122|363273318|FG000|Overall Study|Adverse Event|3|||
105347289|NCT01162122|363273319|FG001|Overall Study|Adverse Event|2|||
105347290|NCT01162122|363273318|FG000|Overall Study|Death|51|||
105347291|NCT01162122|363273319|FG001|Overall Study|Death|46|||
105347292|NCT01162122|363273318|FG000|Overall Study|Protocol Violation|2|||
105347293|NCT01162122|363273319|FG001|Overall Study|Protocol Violation|2|||
105347294|NCT01162122|363273318|FG000|Overall Study|Inappropriate enrollment|5|||
105347295|NCT01162122|363273319|FG001|Overall Study|Inappropriate enrollment|4|||
105347296|NCT01162122|363273318|FG000|Overall Study|Administrative reason|1|||
105347297|NCT01162122|363273319|FG001|Overall Study|Administrative reason|1|||
105347298|NCT01162122|363273318|FG000|Overall Study|Unable to classify|3|||
105347299|NCT01162122|363273319|FG001|Overall Study|Unable to classify|7|||
105347300|NCT01162122|363273318|FG000|Overall Study|Missing primary reason|1|||
105347301|NCT01162122|363273319|FG001|Overall Study|Missing primary reason|0|||
105347302|NCT01074255|363273320|FG000|Overall Study|Did not receive EMEND|2|||
105347303|NCT00926536|363273326|FG000|Overall Study|Physician Decision|1|||
105347304|NCT00926536|363273327|FG001|Overall Study|Physician Decision|2|||
105347305|NCT01217385|363273328|FG000|Overall Study|Withdrawal by Subject|3|||
105347306|NCT01217385|363273328|FG000|Overall Study|DOSI not performed/not eval|12|||
105347307|NCT01217385|363273328|FG000|Overall Study|Central Path not Available|1|||
105347308|NCT01217385|363273328|FG000|Overall Study|Normal Breast TOI not available|10|||
105347309|NCT00990665|363273329|FG000|Overall Study|Unsuccessful Implant|8|||
105347310|NCT00990665|363273329|FG000|Overall Study|Death|29|||
105347311|NCT00990665|363273329|FG000|Overall Study|Heart Transplant|1|||
105347312|NCT00990665|363273329|FG000|Overall Study|Withdrawal by Subject|6|||
105347313|NCT00990665|363273329|FG000|Overall Study|Lost to Follow-up|1|||
105347314|NCT00990665|363273329|FG000|Overall Study|System Explant|3|||
105347315|NCT04442269|363273333|FG000|Overall Study|Adverse Event|1|||
105347316|NCT04442269|363273334|FG001|Overall Study|Adverse Event|0|||
105347317|NCT04442269|363273333|FG000|Overall Study|Death|0|||
105347318|NCT04442269|363273334|FG001|Overall Study|Death|1|||
105347319|NCT04442269|363273333|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
105347320|NCT04442269|363273334|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
105347321|NCT04442269|363273333|FG000|Overall Study|Lost to Follow-up|1|||
105347322|NCT04442269|363273334|FG001|Overall Study|Lost to Follow-up|0|||
105347323|NCT04442269|363273333|FG000|Overall Study|Withdrawal by Subject|3|||
105347324|NCT04442269|363273334|FG001|Overall Study|Withdrawal by Subject|2|||
105347325|NCT04442269|363273333|FG000|Overall Study|Protocol Deviation|0|||
105347326|NCT04442269|363273334|FG001|Overall Study|Protocol Deviation|1|||
105347327|NCT04442269|363273333|FG000|Overall Study|Travel Limitations|1|||
105347328|NCT04442269|363273334|FG001|Overall Study|Travel Limitations|1|||
105347329|NCT02117713|363273338|FG000|Week 48|Adverse Event|4|||
105347330|NCT02117713|363273338|FG000|Week 48|Withdrawal by caregiver|2|||
105347331|NCT02117713|363273338|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
105693085|NCT04178967|364540591|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693086|NCT04178967|364540592|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693087|NCT04178967|364540593|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693088|NCT04178967|364540594|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693089|NCT04178967|364540595|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
105347332|NCT02117713|363273338|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
105347333|NCT02117713|363273338|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
105347334|NCT02117713|363273338|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
105347335|NCT01706575|363273341|FG000|Overall Study|Participant Withdrew Consent|4|||
105347336|NCT01706575|363273341|FG000|Overall Study|Lost to Follow-up|2|||
105347337|NCT01706575|363273341|FG000|Overall Study|Started but not Treated|6|||
105347338|NCT01987232|363273352|FG000|Overall Study|Ongoing in Study|0|||
105693090|NCT04178967|364540596|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693091|NCT04178967|364540597|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
105347339|NCT01987232|363273353|FG001|Overall Study|Ongoing in Study|0|||
105347340|NCT01987232|363273354|FG002|Overall Study|Ongoing in Study|0|||
105347341|NCT01987232|363273355|FG003|Overall Study|Ongoing in Study|1|||
105693092|NCT04178967|364540598|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693093|NCT04178967|364540599|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693094|NCT04178967|364540600|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693095|NCT04178967|364540601|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693096|NCT04178967|364540591|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693097|NCT04178967|364540592|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693098|NCT04178967|364540593|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693099|NCT04178967|364540594|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693100|NCT04178967|364540595|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
105693101|NCT04178967|364540596|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
105693102|NCT04178967|364540597|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693103|NCT04178967|364540598|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
105693104|NCT04178967|364540599|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693105|NCT04178967|364540600|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693106|NCT04178967|364540601|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693107|NCT04178967|364540591|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
105693108|NCT04178967|364540592|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
105693109|NCT04178967|364540593|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
105693110|NCT04178967|364540594|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
105693111|NCT04178967|364540595|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
105693112|NCT04178967|364540596|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
105693113|NCT04178967|364540597|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
105693114|NCT04178967|364540598|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
105693115|NCT04178967|364540599|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
105693116|NCT04178967|364540600|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
105693117|NCT04178967|364540601|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
105693118|NCT04178967|364540591|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105693119|NCT04178967|364540592|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105693120|NCT04178967|364540593|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105693121|NCT04178967|364540594|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
105693122|NCT04178967|364540595|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105693123|NCT04178967|364540596|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
105693124|NCT04178967|364540597|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
105693125|NCT04178967|364540598|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
105693126|NCT04178967|364540599|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105693127|NCT04178967|364540600|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105693128|NCT04178967|364540601|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105693129|NCT04178967|364540591|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693130|NCT04178967|364540592|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693131|NCT04178967|364540593|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693132|NCT04178967|364540594|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693133|NCT04178967|364540595|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693134|NCT04178967|364540596|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693135|NCT04178967|364540597|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693136|NCT04178967|364540598|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693137|NCT04178967|364540599|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
105693138|NCT04178967|364540600|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
105693139|NCT04178967|364540601|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
105472568|NCT01742286|363741444|FG001|Expansion Phase|Disease progression|0|||
105472569|NCT01742286|363741445|FG002|Expansion Phase|Disease progression|3|||
105472570|NCT01742286|363741446|FG003|Expansion Phase|Disease progression|0|||
105472571|NCT01742286|363741447|FG004|Expansion Phase|Disease progression|0|||
105472572|NCT01742286|363741448|FG005|Expansion Phase|Disease progression|0|||
105472573|NCT01742286|363741449|FG006|Expansion Phase|Disease progression|15|||
105472574|NCT01742286|363741443|FG000|Expansion Phase|Withdrawal by Subject|0|||
105472575|NCT01742286|363741444|FG001|Expansion Phase|Withdrawal by Subject|0|||
105472576|NCT01742286|363741445|FG002|Expansion Phase|Withdrawal by Subject|0|||
105472577|NCT01742286|363741446|FG003|Expansion Phase|Withdrawal by Subject|0|||
105472578|NCT01742286|363741447|FG004|Expansion Phase|Withdrawal by Subject|0|||
105472579|NCT01742286|363741448|FG005|Expansion Phase|Withdrawal by Subject|0|||
105472580|NCT01742286|363741449|FG006|Expansion Phase|Withdrawal by Subject|1|||
105472581|NCT01233232|363741450|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
105472582|NCT01233232|363741451|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
105472583|NCT01233232|363741452|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
105472584|NCT02624986|363741453|FG000|Overall Study|Death|0|||
105472585|NCT02624986|363741454|FG001|Overall Study|Death|1|||
105472586|NCT02624986|363741455|FG002|Overall Study|Death|2|||
105472587|NCT02624986|363741456|FG003|Overall Study|Death|2|||
105472588|NCT02624986|363741457|FG004|Overall Study|Death|2|||
105472589|NCT02624986|363741458|FG005|Overall Study|Death|0|||
105472590|NCT02624986|363741459|FG006|Overall Study|Death|0|||
105472591|NCT02624986|363741460|FG007|Overall Study|Death|1|||
105472592|NCT02624986|363741453|FG000|Overall Study|Study Terminated by Sponsor|1|||
105472593|NCT02624986|363741454|FG001|Overall Study|Study Terminated by Sponsor|1|||
105472594|NCT02624986|363741455|FG002|Overall Study|Study Terminated by Sponsor|0|||
105472595|NCT02624986|363741456|FG003|Overall Study|Study Terminated by Sponsor|1|||
105693140|NCT04178967|364540591|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693141|NCT04178967|364540592|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693142|NCT04178967|364540593|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693143|NCT04178967|364540594|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693144|NCT04178967|364540595|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693145|NCT04178967|364540596|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693146|NCT04178967|364540597|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693147|NCT04178967|364540598|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693148|NCT04178967|364540599|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
105347342|NCT01987232|363273356|FG004|Overall Study|Ongoing in Study|0|||
105347343|NCT01634659|363273364|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
105347344|NCT01634659|363273365|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
105347345|NCT01634659|363273364|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
105347346|NCT01634659|363273365|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
105347347|NCT02431806|363273366|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
105472596|NCT02624986|363741457|FG004|Overall Study|Study Terminated by Sponsor|2|||
105472597|NCT02624986|363741458|FG005|Overall Study|Study Terminated by Sponsor|2|||
105472598|NCT02624986|363741459|FG006|Overall Study|Study Terminated by Sponsor|4|||
105693149|NCT04178967|364540600|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
105693150|NCT04178967|364540601|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
105693151|NCT04178967|364540591|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693152|NCT04178967|364540592|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693153|NCT04178967|364540593|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693154|NCT04178967|364540594|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693155|NCT04178967|364540595|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693156|NCT04178967|364540596|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105472599|NCT02624986|363741460|FG007|Overall Study|Study Terminated by Sponsor|3|||
105472600|NCT02624986|363741453|FG000|Overall Study|Progressive Disease|0|||
105472601|NCT02624986|363741454|FG001|Overall Study|Progressive Disease|1|||
105472602|NCT02624986|363741455|FG002|Overall Study|Progressive Disease|0|||
105472603|NCT02624986|363741456|FG003|Overall Study|Progressive Disease|0|||
105472604|NCT02624986|363741457|FG004|Overall Study|Progressive Disease|0|||
105472605|NCT02624986|363741458|FG005|Overall Study|Progressive Disease|0|||
105472606|NCT02624986|363741459|FG006|Overall Study|Progressive Disease|0|||
105472607|NCT02624986|363741460|FG007|Overall Study|Progressive Disease|0|||
105472608|NCT02624986|363741453|FG000|Overall Study|Protocol Violation|1|||
105472609|NCT02624986|363741454|FG001|Overall Study|Protocol Violation|0|||
105693157|NCT04178967|364540597|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693158|NCT04178967|364540598|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693159|NCT04178967|364540599|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693160|NCT04178967|364540600|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
105693161|NCT04178967|364540601|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693162|NCT04178967|364540591|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693163|NCT04178967|364540592|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693164|NCT04178967|364540593|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693165|NCT04178967|364540594|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693166|NCT04178967|364540595|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693167|NCT04178967|364540596|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693168|NCT04178967|364540597|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693169|NCT04178967|364540598|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693170|NCT04178967|364540599|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
105693171|NCT04178967|364540600|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
105693172|NCT04178967|364540601|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
105693173|NCT04178967|364540591|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693174|NCT04178967|364540592|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693175|NCT04178967|364540593|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693176|NCT04178967|364540594|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693177|NCT04178967|364540595|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693178|NCT04178967|364540596|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693179|NCT04178967|364540597|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693180|NCT04178967|364540598|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693181|NCT04178967|364540599|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693182|NCT04178967|364540600|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
105693183|NCT04178967|364540601|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693184|NCT04178967|364540591|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693185|NCT04178967|364540592|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693186|NCT04178967|364540593|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693187|NCT04178967|364540594|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693188|NCT04178967|364540595|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693189|NCT04178967|364540596|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693190|NCT04178967|364540597|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693191|NCT04178967|364540598|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693192|NCT04178967|364540599|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693193|NCT04178967|364540600|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
105693194|NCT04178967|364540601|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693195|NCT03681951|364540602|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
105693196|NCT03681951|364540603|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
105693197|NCT03681951|364540604|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
105693198|NCT03681951|364540605|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
105693199|NCT03681951|364540606|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
105693200|NCT03681951|364540607|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
105693201|NCT03681951|364540608|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
105693202|NCT03681951|364540609|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
105693203|NCT03681951|364540602|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
105693204|NCT03681951|364540603|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
105693205|NCT03681951|364540604|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
105693206|NCT03681951|364540605|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
105693207|NCT03681951|364540606|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
105693208|NCT03681951|364540607|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
105693209|NCT03681951|364540608|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
105693210|NCT03681951|364540609|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
105693211|NCT03681951|364540602|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
105693212|NCT03681951|364540603|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
105693213|NCT03681951|364540604|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
105693214|NCT03681951|364540605|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
105693215|NCT03681951|364540606|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
105693216|NCT03681951|364540607|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
105693217|NCT03681951|364540608|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
105693218|NCT03681951|364540609|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
105693219|NCT02178553|364540610|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
105693220|NCT02178553|364540611|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
105693221|NCT02178553|364540610|FG000|Overall Study|Physician Decision|0|||
105693222|NCT02178553|364540611|FG001|Overall Study|Physician Decision|4|||
105693223|NCT02178553|364540610|FG000|Overall Study|Technical problem with injection|1|||
105693224|NCT02178553|364540611|FG001|Overall Study|Technical problem with injection|3|||
105693225|NCT01020448|364540612|FG000|Pre-assignment|Adverse Event|6|||
105693226|NCT01020448|364540612|FG000|Pre-assignment|Withdrawal by Subject|5|||
105693227|NCT01020448|364540612|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
105693228|NCT01020448|364540612|FG000|Treatment|Adverse Event|11|||
105693229|NCT01020448|364540612|FG000|Treatment|Consent Withdrawn|3|||
105693230|NCT01020448|364540612|FG000|Treatment|Disease Progression|2|||
105693231|NCT01020448|364540612|FG000|Treatment|Lack of Efficacy|8|||
105693232|NCT01020448|364540612|FG000|Treatment|Lost to Follow-up|2|||
105693233|NCT00448435|364540613|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
105693234|NCT00448435|364540614|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
105693235|NCT00108069|364540617|FG000|Overall Study|Never rec'd study drug|0|||
105693236|NCT00108069|364540618|FG001|Overall Study|Never rec'd study drug|1|||
105693237|NCT00108069|364540617|FG000|Overall Study|Adverse Event|1|||
105693238|NCT00108069|364540618|FG001|Overall Study|Adverse Event|1|||
105693239|NCT00108069|364540617|FG000|Overall Study|Withdrawal by Subject|1|||
105693240|NCT00108069|364540618|FG001|Overall Study|Withdrawal by Subject|0|||
105693241|NCT00108069|364540617|FG000|Overall Study|Death|1|||
105693242|NCT00108069|364540618|FG001|Overall Study|Death|0|||
105693243|NCT00108069|364540617|FG000|Overall Study|Progessive disease|27|||
105693244|NCT00108069|364540618|FG001|Overall Study|Progessive disease|11|||
105693245|NCT03933397|364540619|FG000|Overall Study|No emergency department visit|65|||
105693246|NCT03933397|364540620|FG001|Overall Study|No emergency department visit|71|||
105693247|NCT03933397|364540619|FG000|Overall Study|Missed emergency department visit|25|||
105693248|NCT03933397|364540620|FG001|Overall Study|Missed emergency department visit|30|||
105693249|NCT03933397|364540619|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
105693250|NCT03933397|364540620|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
105693251|NCT03933397|364540619|FG000|Overall Study|Withdrawal by Subject|1|||
105693252|NCT03933397|364540620|FG001|Overall Study|Withdrawal by Subject|0|||
105693253|NCT03933397|364540619|FG000|Overall Study|Physician Decision|1|||
105693254|NCT03933397|364540620|FG001|Overall Study|Physician Decision|1|||
105693255|NCT03933397|364540619|FG000|Overall Study|missing pain score|1|||
105693256|NCT03933397|364540620|FG001|Overall Study|missing pain score|1|||
105693257|NCT03933397|364540619|FG000|Overall Study|Confirmed COVID-19|1|||
105693258|NCT03933397|364540620|FG001|Overall Study|Confirmed COVID-19|2|||
105693259|NCT01910116|364540623|FG000|Overall Study|Adverse Event|0|||
105693260|NCT01910116|364540624|FG001|Overall Study|Adverse Event|3|||
105693261|NCT01910116|364540623|FG000|Overall Study|Lack of Efficacy|3|||
105693262|NCT01910116|364540624|FG001|Overall Study|Lack of Efficacy|4|||
105693263|NCT01910116|364540623|FG000|Overall Study|Lost to Follow-up|1|||
105693264|NCT01910116|364540624|FG001|Overall Study|Lost to Follow-up|0|||
105693265|NCT01910116|364540623|FG000|Overall Study|Protocol Violation|1|||
105693266|NCT01910116|364540624|FG001|Overall Study|Protocol Violation|2|||
105693267|NCT01910116|364540623|FG000|Overall Study|Withdrawal by Subject|8|||
105693268|NCT01910116|364540624|FG001|Overall Study|Withdrawal by Subject|3|||
105693269|NCT01910116|364540623|FG000|Overall Study|uncertain allocation|1|||
105693270|NCT01910116|364540624|FG001|Overall Study|uncertain allocation|3|||
105693271|NCT01910116|364540623|FG000|Overall Study|incomplete data|0|||
105693272|NCT01910116|364540624|FG001|Overall Study|incomplete data|1|||
105693273|NCT03606980|364540625|FG000|Overall Study|Lost to Follow-up|3|||
105693274|NCT03606980|364540626|FG001|Overall Study|Lost to Follow-up|2|||
105693275|NCT03606980|364540627|FG002|Overall Study|Lost to Follow-up|3|||
105693276|NCT03606980|364540625|FG000|Overall Study|Withdrawal by Subject|1|||
105693277|NCT03606980|364540626|FG001|Overall Study|Withdrawal by Subject|0|||
105693278|NCT03606980|364540627|FG002|Overall Study|Withdrawal by Subject|4|||
105693279|NCT00132496|364540628|FG000|Overall Study|Withdrawal by Subject|1|||
105693280|NCT00132496|364540629|FG001|Overall Study|Withdrawal by Subject|2|||
105693281|NCT00132496|364540628|FG000|Overall Study|Physician Decision|1|||
105693282|NCT00132496|364540629|FG001|Overall Study|Physician Decision|0|||
105693283|NCT00307333|364540630|FG000|Overall Study|Lost to Follow-up|11|||
105693284|NCT00307333|364540631|FG001|Overall Study|Lost to Follow-up|3|||
105693285|NCT02014740|364540633|FG000|Overall Study|Lost to Follow-up|4|||
105693286|NCT02014740|364540634|FG001|Overall Study|Lost to Follow-up|4|||
105693287|NCT02014740|364540633|FG000|Overall Study|Withdrawal by Subject|2|||
105693288|NCT02014740|364540634|FG001|Overall Study|Withdrawal by Subject|1|||
105693289|NCT04936841|364540640|FG000|Overall Study|Death|1|||
105693290|NCT01351623|364540641|FG000|Overall Study|Protocol Violation|2|||
105693291|NCT01351623|364540641|FG000|Overall Study|Adverse Event|4|||
105693292|NCT01351623|364540641|FG000|Overall Study|Withdrawal by Subject|1|||
105693293|NCT01351623|364540641|FG000|Overall Study|Death|2|||
105693294|NCT01326728|364540642|FG000|Overall Study|Death|13|||
105693295|NCT01326728|364540643|FG001|Overall Study|Death|0|||
105693296|NCT01326728|364540642|FG000|Overall Study|Early closure of study|34|||
105693297|NCT01326728|364540643|FG001|Overall Study|Early closure of study|9|||
105693298|NCT04399122|364540644|FG000|Overall Study|Lost to Follow-up|2|||
105472610|NCT02624986|363741455|FG002|Overall Study|Protocol Violation|0|||
105472611|NCT02624986|363741456|FG003|Overall Study|Protocol Violation|0|||
105472612|NCT02624986|363741457|FG004|Overall Study|Protocol Violation|0|||
105472613|NCT02624986|363741458|FG005|Overall Study|Protocol Violation|0|||
105693299|NCT04399122|364540645|FG001|Overall Study|Lost to Follow-up|0|||
105693300|NCT04399122|364540644|FG000|Overall Study|Withdrawal by Subject|1|||
105693301|NCT04399122|364540645|FG001|Overall Study|Withdrawal by Subject|0|||
105693302|NCT02536755|364540647|FG000|Overall Study|Adverse Event|4|||
105693303|NCT01102803|364540649|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
105693304|NCT01102803|364540650|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
105693305|NCT01102803|364540649|FG000|Post to Follow-Up|Lost to Follow-up|1|||
105693306|NCT01102803|364540650|FG001|Post to Follow-Up|Lost to Follow-up|3|||
105693307|NCT04448756|364540653|FG000|Overall Study|Adverse Event|0|||
105693308|NCT04448756|364540654|FG001|Overall Study|Adverse Event|1|||
105693309|NCT04448756|364540655|FG002|Overall Study|Adverse Event|0|||
105693310|NCT04448756|364540653|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
105693311|NCT04448756|364540654|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
105693312|NCT04448756|364540655|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
105693313|NCT04448756|364540653|FG000|Overall Study|Withdrawal by Subject|0|||
105693314|NCT04448756|364540654|FG001|Overall Study|Withdrawal by Subject|3|||
105693315|NCT04448756|364540655|FG002|Overall Study|Withdrawal by Subject|1|||
105693316|NCT04448756|364540653|FG000|Overall Study|Death|2|||
105693317|NCT04448756|364540654|FG001|Overall Study|Death|1|||
105693318|NCT04448756|364540655|FG002|Overall Study|Death|0|||
105693319|NCT02733185|364540656|FG000|Overall Study|Withdrawal by Subject|12|||
105693320|NCT02733185|364540657|FG001|Overall Study|Withdrawal by Subject|10|||
105693321|NCT02733185|364540658|FG002|Overall Study|Withdrawal by Subject|17|||
105693322|NCT02733185|364540659|FG003|Overall Study|Withdrawal by Subject|21|||
105693323|NCT02733185|364540656|FG000|Overall Study|Death|46|||
105693324|NCT02733185|364540657|FG001|Overall Study|Death|34|||
105693325|NCT02733185|364540658|FG002|Overall Study|Death|35|||
105693326|NCT02733185|364540659|FG003|Overall Study|Death|43|||
105693327|NCT02733185|364540656|FG000|Overall Study|Lost to Follow-up|17|||
105693328|NCT02733185|364540657|FG001|Overall Study|Lost to Follow-up|18|||
105472614|NCT02624986|363741459|FG006|Overall Study|Protocol Violation|0|||
105472615|NCT02624986|363741460|FG007|Overall Study|Protocol Violation|0|||
105472616|NCT02624986|363741453|FG000|Overall Study|Withdrawal by Subject|0|||
105472617|NCT02624986|363741454|FG001|Overall Study|Withdrawal by Subject|0|||
105472618|NCT02624986|363741455|FG002|Overall Study|Withdrawal by Subject|0|||
105472619|NCT02624986|363741456|FG003|Overall Study|Withdrawal by Subject|0|||
105472620|NCT02624986|363741457|FG004|Overall Study|Withdrawal by Subject|0|||
105347348|NCT02431806|363273367|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
105472621|NCT02624986|363741458|FG005|Overall Study|Withdrawal by Subject|0|||
105472622|NCT02624986|363741459|FG006|Overall Study|Withdrawal by Subject|0|||
105693329|NCT02733185|364540658|FG002|Overall Study|Lost to Follow-up|16|||
105693330|NCT02733185|364540659|FG003|Overall Study|Lost to Follow-up|11|||
105693331|NCT02593786|364540660|FG000|Overall Study|Disease progression|12|||
105693332|NCT02593786|364540661|FG001|Overall Study|Disease progression|16|||
105472623|NCT02624986|363741460|FG007|Overall Study|Withdrawal by Subject|1|||
105472624|NCT00530816|363741465|FG000|Overall Study|Progressive Disease|16|||
105472625|NCT00530816|363741466|FG001|Overall Study|Progressive Disease|24|||
105472626|NCT00530816|363741467|FG002|Overall Study|Progressive Disease|24|||
105693333|NCT02593786|364540662|FG002|Overall Study|Disease progression|10|||
105693334|NCT02593786|364540663|FG003|Overall Study|Disease progression|7|||
105693335|NCT02593786|364540660|FG000|Overall Study|Study drug toxicity|1|||
105693336|NCT02593786|364540661|FG001|Overall Study|Study drug toxicity|0|||
105693337|NCT02593786|364540662|FG002|Overall Study|Study drug toxicity|0|||
105693338|NCT02593786|364540663|FG003|Overall Study|Study drug toxicity|0|||
105693339|NCT02593786|364540660|FG000|Overall Study|Adverse event unrelated to study drug|1|||
105693340|NCT02593786|364540661|FG001|Overall Study|Adverse event unrelated to study drug|1|||
105693341|NCT02593786|364540662|FG002|Overall Study|Adverse event unrelated to study drug|1|||
105693342|NCT02593786|364540663|FG003|Overall Study|Adverse event unrelated to study drug|0|||
105347349|NCT02431806|363273368|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
105347350|NCT02431806|363273369|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
105559152|NCT00338884|364044588|FG000|Overall Study|Global Deterioration of Health Status|3|||
105559153|NCT00338884|364044588|FG000|Overall Study|Withdrawal by Subject|3|||
105559154|NCT00338884|364044588|FG000|Overall Study|Lost to Follow-up|1|||
105559155|NCT00338884|364044588|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
105559156|NCT00911534|364044590|FG000|Overall Study|Adverse Event|4|||
105559157|NCT00911534|364044591|FG001|Overall Study|Adverse Event|4|||
105559158|NCT00911534|364044590|FG000|Overall Study|Lost to Follow-up|2|||
105559159|NCT00911534|364044591|FG001|Overall Study|Lost to Follow-up|4|||
105693343|NCT02593786|364540660|FG000|Overall Study|Participant request to discontinue study therapy|0|||
105693344|NCT02593786|364540661|FG001|Overall Study|Participant request to discontinue study therapy|2|||
105693345|NCT02593786|364540662|FG002|Overall Study|Participant request to discontinue study therapy|0|||
105559160|NCT00911534|364044590|FG000|Overall Study|Withdrawal by Subject|2|||
105559161|NCT00911534|364044591|FG001|Overall Study|Withdrawal by Subject|1|||
105693346|NCT02593786|364540663|FG003|Overall Study|Participant request to discontinue study therapy|0|||
105693347|NCT02593786|364540660|FG000|Overall Study|Other reasons|1|||
105693348|NCT02593786|364540661|FG001|Overall Study|Other reasons|1|||
105693349|NCT02593786|364540662|FG002|Overall Study|Other reasons|0|||
105693350|NCT02593786|364540663|FG003|Overall Study|Other reasons|5|||
105693351|NCT01130051|364540664|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
105693352|NCT01130051|364540665|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
105559162|NCT00911534|364044590|FG000|Overall Study|Lack of Efficacy|4|||
105472627|NCT00530816|363741465|FG000|Overall Study|Adverse Event|6|||
105472628|NCT00530816|363741466|FG001|Overall Study|Adverse Event|13|||
105693353|NCT01130051|364540664|FG000|Washout Period of 14 Days|Protocol Violation|1|||
105693354|NCT01130051|364540665|FG001|Washout Period of 14 Days|Protocol Violation|1|||
105693355|NCT04572854|364540666|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
105693356|NCT04572854|364540667|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
105693357|NCT04572854|364540668|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
105693358|NCT04572854|364540669|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
105693359|NCT04572854|364540666|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
105693360|NCT04572854|364540667|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
105693361|NCT04572854|364540668|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
105693362|NCT04572854|364540669|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
105693363|NCT01016964|364541994|FG000|Overall Study|Lost to Follow-up|3|||
105693364|NCT01016964|364541995|FG001|Overall Study|Lost to Follow-up|3|||
105693365|NCT00702845|364541996|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
105693366|NCT00702845|364541997|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
105693367|NCT00702845|364541996|FG000|Overall Study|Too high ovarian response|5|||
105693368|NCT00702845|364541997|FG001|Overall Study|Too high ovarian response|1|||
105693369|NCT00702845|364541996|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
105693370|NCT00702845|364541997|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
105693371|NCT00702845|364541996|FG000|Overall Study|Insufficient ovarian response|1|||
105693372|NCT00702845|364541997|FG001|Overall Study|Insufficient ovarian response|0|||
105693373|NCT00702845|364541996|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
105693374|NCT00702845|364541997|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
105693375|NCT00702845|364541996|FG000|Overall Study|No or abnormal fertilization|4|||
105693376|NCT00702845|364541997|FG001|Overall Study|No or abnormal fertilization|2|||
105693377|NCT00702845|364541996|FG000|Overall Study|Patient's decision|2|||
105693378|NCT00702845|364541997|FG001|Overall Study|Patient's decision|1|||
105693379|NCT00702845|364541996|FG000|Overall Study|Not randomized|0|||
105693380|NCT00702845|364541997|FG001|Overall Study|Not randomized|1|||
105693381|NCT01330914|364542004|FG000|Overall Study|Withdrawal by Subject|4|||
105693382|NCT01330914|364542004|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
105693383|NCT03503513|364542005|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
105693384|NCT03503513|364542005|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
105693385|NCT03503513|364542005|FG000|Overall Study|Physician Decision|3|||
105693386|NCT03503513|364542005|FG000|Overall Study|Withdrawal by Subject|2|||
105693387|NCT03503513|364542005|FG000|Overall Study|Lost to Follow-up|1|||
105693388|NCT00929656|364542010|FG000|Overall Study|Lost to Follow-up|0|||
105693389|NCT00929656|364542011|FG001|Overall Study|Lost to Follow-up|1|||
105693390|NCT00607880|364542012|FG000|Overall Study|Unable to place port due to occlusion|1|||
105693391|NCT00607880|364542013|FG001|Overall Study|Unable to place port due to occlusion|0|||
105693392|NCT01170039|364542014|FG000|Overall Study|Withdrawal by Subject|5|||
105693393|NCT01170039|364542015|FG001|Overall Study|Withdrawal by Subject|3|||
105693394|NCT01170039|364542014|FG000|Overall Study|Lack of funding, drug not available|3|||
105693395|NCT01170039|364542015|FG001|Overall Study|Lack of funding, drug not available|3|||
105693396|NCT00908583|364542016|FG000|Phase 1|Withdrawal by Subject|1|||
105693397|NCT00908583|364542016|FG000|Phase 1|Adverse Event|4|||
105693398|NCT00908583|364542016|FG000|Phase 2|Physician Decision|1|||
105693399|NCT00908583|364542016|FG000|Phase 2|Adverse Event|1|||
105693400|NCT00908583|364542016|FG000|Phase 3|Adverse Event|2|||
105693401|NCT00908583|364542016|FG000|Phase 4|Adverse Event|1|||
105693402|NCT00908583|364542016|FG000|Phase 4|Physician Decision|1|||
105693403|NCT00908583|364542016|FG000|Phase 5|Adverse Event|3|||
105472629|NCT00530816|363741467|FG002|Overall Study|Adverse Event|7|||
105472630|NCT00530816|363741465|FG000|Overall Study|Other|3|||
105472631|NCT00530816|363741466|FG001|Overall Study|Other|3|||
105472632|NCT00530816|363741467|FG002|Overall Study|Other|4|||
105472633|NCT00530816|363741465|FG000|Overall Study|Withdrawal by Subject|1|||
105472634|NCT00530816|363741466|FG001|Overall Study|Withdrawal by Subject|2|||
105472635|NCT00530816|363741467|FG002|Overall Study|Withdrawal by Subject|6|||
105472636|NCT05601544|363741473|FG000|Phase 2 Period 1|Adverse Event|0|||
105472637|NCT05601544|363741474|FG001|Phase 2 Period 1|Adverse Event|1|||
105472638|NCT05601544|363741475|FG002|Phase 2 Period 1|Adverse Event|0|||
105472639|NCT05601544|363741476|FG003|Phase 2 Period 1|Adverse Event|0|||
105472640|NCT05601544|363741477|FG004|Phase 2 Period 1|Adverse Event|0|||
105472641|NCT05601544|363741478|FG005|Phase 2 Period 1|Adverse Event|0|||
105472642|NCT04198714|363741481|FG000|Overall Study|Physician Decision|0|||
105472643|NCT04198714|363741482|FG001|Overall Study|Physician Decision|1|||
105472644|NCT02923921|363743449|FG000|Overall Study|Sponsor Decision|39|||
105472645|NCT02923921|363743450|FG001|Overall Study|Sponsor Decision|38|||
105472646|NCT02923921|363743449|FG000|Overall Study|Lost to Follow-up|1|||
105472647|NCT02923921|363743450|FG001|Overall Study|Lost to Follow-up|0|||
105472648|NCT02923921|363743449|FG000|Overall Study|Withdrawal by Subject|6|||
105472649|NCT02923921|363743450|FG001|Overall Study|Withdrawal by Subject|13|||
105472650|NCT02923921|363743449|FG000|Overall Study|Unknown, Not Collected|7|||
105472651|NCT02923921|363743450|FG001|Overall Study|Unknown, Not Collected|6|||
105472652|NCT02565784|363743459|FG000|First Treatment|Adverse Event|1|||
105472653|NCT02565784|363743459|FG000|First Treatment|Withdrawal by Subject|1|||
105472654|NCT02565784|363743459|FG000|Second Treatment|Withdrawal by Subject|2|||
105693404|NCT02615470|364542017|FG000|Overall Study|Lost to Follow-up|21|||
105693405|NCT02615470|364542018|FG001|Overall Study|Lost to Follow-up|32|||
105693406|NCT00860951|364542019|FG000|Overall Study|Withdrawal by Subject|2|||
105693407|NCT00860951|364542019|FG000|Overall Study|Lost to Follow-up|5|||
105693408|NCT00727649|364542020|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
105693409|NCT00727649|364542021|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
105693410|NCT00727649|364542020|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
105693411|NCT00727649|364542021|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
105693412|NCT00727649|364542020|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
105693413|NCT00727649|364542021|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
105693414|NCT00727649|364542020|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
105472655|NCT03983317|363743460|FG000|Overall Study|Physician Decision|5|||
105472656|NCT02741518|363743463|FG000|Overall Study|Withdrawal by Subject|1|||
105472657|NCT02741518|363743464|FG001|Overall Study|Withdrawal by Subject|1|||
105693415|NCT00727649|364542021|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
105693416|NCT00727649|364542020|FG000|Second Intervention (4-weeks)|Death|1|||
105693417|NCT00727649|364542021|FG001|Second Intervention (4-weeks)|Death|0|||
105472658|NCT02948634|363743469|FG000|Overall Study|Lack of efficacy and study suspended|10|||
105472659|NCT02948634|363743470|FG001|Overall Study|Lack of efficacy and study suspended|2|||
105472660|NCT02249832|363743471|FG000|Overall Study|Withdrawal by Subject|3|||
105472661|NCT02249832|363743471|FG000|Overall Study|Lost to Follow-up|10|||
105472662|NCT00970684|363743472|FG000|Overall Study|Lack of Efficacy|5|||
105472663|NCT00970684|363743472|FG000|Overall Study|Adverse Event|4|||
105472664|NCT00970684|363743472|FG000|Overall Study|Withdrawal by Subject|1|||
105472665|NCT00436345|363743473|FG000|Overall Study|ICU resident beyond follow-up period|3|||
105472666|NCT00436345|363743474|FG001|Overall Study|ICU resident beyond follow-up period|0|||
105472667|NCT00481091|363743475|FG000|Overall Study|Withdrawal by Subject|0|||
105472668|NCT00481091|363743476|FG001|Overall Study|Withdrawal by Subject|1|||
105472669|NCT00481091|363743477|FG002|Overall Study|Withdrawal by Subject|1|||
105472670|NCT00481091|363743478|FG003|Overall Study|Withdrawal by Subject|0|||
105472671|NCT00481091|363743479|FG004|Overall Study|Withdrawal by Subject|0|||
105472672|NCT00481091|363743480|FG005|Overall Study|Withdrawal by Subject|0|||
105472673|NCT00481091|363743481|FG006|Overall Study|Withdrawal by Subject|0|||
105472674|NCT00481091|363743482|FG007|Overall Study|Withdrawal by Subject|0|||
105472675|NCT00481091|363743483|FG008|Overall Study|Withdrawal by Subject|1|||
105472676|NCT00481091|363743484|FG009|Overall Study|Withdrawal by Subject|6|||
105472677|NCT00481091|363743475|FG000|Overall Study|Other, Not Specified|0|||
105472678|NCT00481091|363743476|FG001|Overall Study|Other, Not Specified|1|||
105472679|NCT00481091|363743477|FG002|Overall Study|Other, Not Specified|1|||
105472680|NCT00481091|363743478|FG003|Overall Study|Other, Not Specified|0|||
105472681|NCT00481091|363743479|FG004|Overall Study|Other, Not Specified|0|||
105472682|NCT00481091|363743480|FG005|Overall Study|Other, Not Specified|1|||
105472683|NCT00481091|363743481|FG006|Overall Study|Other, Not Specified|0|||
105472684|NCT00481091|363743482|FG007|Overall Study|Other, Not Specified|0|||
105472685|NCT00481091|363743483|FG008|Overall Study|Other, Not Specified|0|||
105472686|NCT00481091|363743484|FG009|Overall Study|Other, Not Specified|4|||
105472687|NCT00481091|363743475|FG000|Overall Study|Adverse Event|1|||
105472688|NCT00481091|363743476|FG001|Overall Study|Adverse Event|2|||
105472689|NCT00481091|363743477|FG002|Overall Study|Adverse Event|0|||
105472690|NCT00481091|363743478|FG003|Overall Study|Adverse Event|1|||
105472691|NCT00481091|363743479|FG004|Overall Study|Adverse Event|1|||
105472692|NCT00481091|363743480|FG005|Overall Study|Adverse Event|1|||
105472693|NCT00481091|363743481|FG006|Overall Study|Adverse Event|2|||
105472694|NCT00481091|363743482|FG007|Overall Study|Adverse Event|1|||
105472695|NCT00481091|363743483|FG008|Overall Study|Adverse Event|1|||
105472696|NCT00481091|363743484|FG009|Overall Study|Adverse Event|6|||
105472697|NCT00481091|363743475|FG000|Overall Study|Progressive disease clinical|0|||
105472698|NCT00481091|363743476|FG001|Overall Study|Progressive disease clinical|0|||
105472699|NCT00481091|363743477|FG002|Overall Study|Progressive disease clinical|0|||
105472700|NCT00481091|363743478|FG003|Overall Study|Progressive disease clinical|0|||
105472701|NCT00481091|363743479|FG004|Overall Study|Progressive disease clinical|0|||
105472702|NCT00481091|363743480|FG005|Overall Study|Progressive disease clinical|0|||
105472703|NCT00481091|363743481|FG006|Overall Study|Progressive disease clinical|0|||
105472704|NCT00481091|363743482|FG007|Overall Study|Progressive disease clinical|0|||
105472705|NCT00481091|363743483|FG008|Overall Study|Progressive disease clinical|1|||
105472706|NCT00481091|363743484|FG009|Overall Study|Progressive disease clinical|7|||
105472707|NCT00481091|363743475|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
105472708|NCT00481091|363743476|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
105472709|NCT00481091|363743477|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
105472710|NCT00481091|363743478|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
105472711|NCT00481091|363743479|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
105472712|NCT00481091|363743480|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
105472713|NCT00481091|363743481|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
105472714|NCT00481091|363743482|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
105472715|NCT00481091|363743483|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
105472716|NCT00481091|363743484|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
105472717|NCT00481091|363743475|FG000|Overall Study|Progressive disease other|1|||
105472718|NCT00481091|363743476|FG001|Overall Study|Progressive disease other|1|||
105472719|NCT00481091|363743477|FG002|Overall Study|Progressive disease other|0|||
105472720|NCT00481091|363743478|FG003|Overall Study|Progressive disease other|1|||
105559163|NCT00911534|364044591|FG001|Overall Study|Lack of Efficacy|1|||
105559164|NCT00911534|364044590|FG000|Overall Study|Withdrawal of consent|1|||
105559165|NCT00911534|364044591|FG001|Overall Study|Withdrawal of consent|4|||
105559166|NCT00911534|364044590|FG000|Overall Study|Other|2|||
105787069|NCT03110107|364874901|FG012|Treatment Period|Disease Progression|0|||
105472721|NCT00481091|363743479|FG004|Overall Study|Progressive disease other|1|||
105472722|NCT00481091|363743480|FG005|Overall Study|Progressive disease other|1|||
105472723|NCT00481091|363743481|FG006|Overall Study|Progressive disease other|0|||
105472724|NCT00481091|363743482|FG007|Overall Study|Progressive disease other|2|||
105472725|NCT00481091|363743483|FG008|Overall Study|Progressive disease other|0|||
105472726|NCT00481091|363743484|FG009|Overall Study|Progressive disease other|0|||
105472727|NCT00481091|363743475|FG000|Overall Study|No reason given|0|||
105472728|NCT00481091|363743476|FG001|Overall Study|No reason given|0|||
105559167|NCT00911534|364044591|FG001|Overall Study|Other|2|||
105472729|NCT00481091|363743477|FG002|Overall Study|No reason given|1|||
105472730|NCT00481091|363743478|FG003|Overall Study|No reason given|1|||
105472731|NCT00481091|363743479|FG004|Overall Study|No reason given|1|||
105472732|NCT00481091|363743480|FG005|Overall Study|No reason given|0|||
105472733|NCT00481091|363743481|FG006|Overall Study|No reason given|1|||
105472734|NCT00481091|363743482|FG007|Overall Study|No reason given|1|||
105472735|NCT00481091|363743483|FG008|Overall Study|No reason given|1|||
105472736|NCT00481091|363743484|FG009|Overall Study|No reason given|4|||
105472737|NCT04294680|363743485|FG000|Overall Study|Withdrawal by Subject|2|||
105472738|NCT04294680|363743486|FG001|Overall Study|Withdrawal by Subject|1|||
105472739|NCT04294680|363743485|FG000|Overall Study|Follow-up visits completed outside of window|1|||
105472740|NCT04294680|363743486|FG001|Overall Study|Follow-up visits completed outside of window|0|||
105472741|NCT01296672|363743487|FG000|Overall Study|Lost to Follow-up|73|||
105472742|NCT01296672|363743488|FG001|Overall Study|Lost to Follow-up|18|||
105472743|NCT01716052|363743489|FG000|Overall Study|Withdrawal of funding|1|||
105472744|NCT01716052|363743490|FG001|Overall Study|Withdrawal of funding|1|||
105472745|NCT03830892|363743494|FG000|Overall Study|Physician Decision|2|||
105472746|NCT03830892|363743495|FG001|Overall Study|Physician Decision|3|||
105472747|NCT03830892|363743494|FG000|Overall Study|Study terminated due to COVID|4|||
105472748|NCT03830892|363743495|FG001|Overall Study|Study terminated due to COVID|0|||
105472749|NCT03830892|363743494|FG000|Overall Study|Protocol Violation|0|||
105472750|NCT03830892|363743495|FG001|Overall Study|Protocol Violation|1|||
105472751|NCT03830892|363743494|FG000|Overall Study|Withdrawal by Subject|0|||
105472752|NCT03830892|363743495|FG001|Overall Study|Withdrawal by Subject|2|||
105472753|NCT00337675|363743496|FG000|Overall Study|Adverse Event|10|||
105472754|NCT00337675|363743497|FG001|Overall Study|Adverse Event|9|||
105472755|NCT00337675|363743498|FG002|Overall Study|Adverse Event|19|||
105472756|NCT00337675|363743496|FG000|Overall Study|Lack of Efficacy|10|||
105472757|NCT00337675|363743497|FG001|Overall Study|Lack of Efficacy|7|||
105472758|NCT00337675|363743498|FG002|Overall Study|Lack of Efficacy|9|||
105693418|NCT00727649|364542020|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
105693419|NCT00727649|364542021|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
105559168|NCT01970982|364044592|FG000|Overall Study|Withdrawal by Subject|0|||
105559169|NCT01970982|364044593|FG001|Overall Study|Withdrawal by Subject|0|||
105559170|NCT01970982|364044594|FG002|Overall Study|Withdrawal by Subject|2|||
105559171|NCT03896035|364044595|FG000|Overall Study|Lost to Follow-up|2|||
105559172|NCT03896035|364044596|FG001|Overall Study|Lost to Follow-up|6|||
105693420|NCT00727649|364542020|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
105693421|NCT00727649|364542021|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
105347351|NCT02431806|363273366|FG000|Double-blind Treatment Period|Adverse Event|4|||
105347352|NCT02431806|363273367|FG001|Double-blind Treatment Period|Adverse Event|7|||
105347353|NCT02431806|363273368|FG002|Double-blind Treatment Period|Adverse Event|11|||
105347354|NCT02431806|363273369|FG003|Double-blind Treatment Period|Adverse Event|7|||
105347355|NCT02431806|363273366|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
105347356|NCT02431806|363273367|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
105347357|NCT02431806|363273368|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
105347358|NCT02431806|363273369|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
105347359|NCT02431806|363273366|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
105347360|NCT02431806|363273367|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
105347361|NCT02431806|363273368|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
105347362|NCT02431806|363273369|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
105347363|NCT02431806|363273366|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
105347364|NCT02431806|363273367|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
105347365|NCT02431806|363273368|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
105347366|NCT02431806|363273369|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
105347367|NCT02431806|363273366|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
105347368|NCT02431806|363273367|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
105347369|NCT02431806|363273368|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
105347370|NCT02431806|363273369|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
105347371|NCT02431806|363273366|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
105347372|NCT02431806|363273367|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
105347373|NCT02431806|363273368|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
105347374|NCT02431806|363273369|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
105472759|NCT00337675|363743496|FG000|Overall Study|Lost to Follow-up|22|||
105472760|NCT00337675|363743497|FG001|Overall Study|Lost to Follow-up|19|||
105693422|NCT01650285|364542022|FG000|Overall Study|Adverse Event|1|||
105472761|NCT00337675|363743498|FG002|Overall Study|Lost to Follow-up|17|||
105472762|NCT00337675|363743496|FG000|Overall Study|Physician Decision|9|||
105472763|NCT00337675|363743497|FG001|Overall Study|Physician Decision|17|||
105472764|NCT00337675|363743498|FG002|Overall Study|Physician Decision|14|||
105472765|NCT00337675|363743496|FG000|Overall Study|Protocol Violation|21|||
105472766|NCT00337675|363743497|FG001|Overall Study|Protocol Violation|24|||
105559173|NCT03896035|364044595|FG000|Overall Study|Withdrawal by Subject|0|||
105693423|NCT00385203|364542028|FG000|Overall Study|Adverse Event|5|||
105693424|NCT00385203|364542029|FG001|Overall Study|Adverse Event|4|||
105693425|NCT00385203|364542028|FG000|Overall Study|Death|1|||
105693426|NCT00385203|364542029|FG001|Overall Study|Death|0|||
105693427|NCT00385203|364542028|FG000|Overall Study|Condition under investigation worsened|18|||
105693428|NCT00385203|364542029|FG001|Overall Study|Condition under investigation worsened|3|||
105693429|NCT00385203|364542028|FG000|Overall Study|Incorrect enrollment|2|||
105693430|NCT00385203|364542029|FG001|Overall Study|Incorrect enrollment|0|||
105693431|NCT01186939|364542030|FG000|Overall Study|Death|7|||
105693432|NCT01186939|364542030|FG000|Overall Study|Withdrawal by Subject|2|||
105693433|NCT01186939|364542030|FG000|Overall Study|No longer receiving clinical benefit|17|||
105693434|NCT01186939|364542030|FG000|Overall Study|Program closed|5|||
105693435|NCT01186939|364542030|FG000|Overall Study|Sponsor decision|4|||
105693436|NCT01186939|364542030|FG000|Overall Study|Started additional treatment|1|||
105693437|NCT01186939|364542030|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
105693438|NCT01186939|364542030|FG000|Overall Study|Myocardial infarction|1|||
105693439|NCT01186939|364542030|FG000|Overall Study|Bone marrow transplant|1|||
105693440|NCT01186939|364542030|FG000|Overall Study|Transformation to AML|1|||
105693441|NCT03842163|364542031|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
105693442|NCT03842163|364542031|FG000|Overall Study|Scintigraphy was not performed|44|||
105693443|NCT03829241|364542035|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
105693444|NCT03829241|364542036|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
105693445|NCT03829241|364542035|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
105693446|NCT03829241|364542036|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
105693447|NCT03829241|364542035|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
105693448|NCT03829241|364542036|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
105693449|NCT03829241|364542035|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
105693450|NCT03829241|364542036|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
105693451|NCT03829241|364542035|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
105693452|NCT03829241|364542036|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
105693453|NCT03829241|364542035|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
105693454|NCT03829241|364542036|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
105693455|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
105693456|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
105693457|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
105693458|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
105693459|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
105693460|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
105693461|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
105693462|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
105693463|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
105693464|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
105472767|NCT00337675|363743498|FG002|Overall Study|Protocol Violation|19|||
105472768|NCT00337675|363743496|FG000|Overall Study|Withdrawal by Subject|25|||
105472769|NCT00337675|363743497|FG001|Overall Study|Withdrawal by Subject|25|||
105693465|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
105693466|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
105693467|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
105693468|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
105693469|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
105472770|NCT00337675|363743498|FG002|Overall Study|Withdrawal by Subject|19|||
105693470|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
105347375|NCT02968433|363273370|FG000|Overall Study|Withdrawal by Subject|1|||
105347376|NCT02918552|363273371|FG000|Overall Study|Failed Pharmacokinetics|1|||
105347377|NCT02918552|363273372|FG001|Overall Study|Failed Pharmacokinetics|0|||
105347378|NCT02918552|363273371|FG000|Overall Study|Withdrawal by Subject|0|||
105347379|NCT02918552|363273372|FG001|Overall Study|Withdrawal by Subject|1|||
105347380|NCT02918552|363273371|FG000|Overall Study|Lost to Follow-up|0|||
105347381|NCT02918552|363273372|FG001|Overall Study|Lost to Follow-up|1|||
105347382|NCT04395274|363273373|FG000|Overall Study|Lost to Follow-up|20|||
105347383|NCT04395274|363273374|FG001|Overall Study|Lost to Follow-up|11|||
105347384|NCT04395274|363273373|FG000|Overall Study|Withdrawal by Subject|13|||
105347385|NCT04395274|363273374|FG001|Overall Study|Withdrawal by Subject|10|||
105347386|NCT04395274|363273373|FG000|Overall Study|Moved Abroad|0|||
105347387|NCT04395274|363273374|FG001|Overall Study|Moved Abroad|1|||
105347388|NCT03482167|363273375|FG000|Allocated to Intervention|Physician Decision|1|||
105347389|NCT03482167|363273376|FG001|Allocated to Intervention|Physician Decision|2|||
105347390|NCT03482167|363273375|FG000|Received Intervention|Adverse Event|3|||
105347391|NCT03482167|363273376|FG001|Received Intervention|Adverse Event|1|||
105347392|NCT03482167|363273375|FG000|Received Intervention|Physician Decision|1|||
105347393|NCT03482167|363273376|FG001|Received Intervention|Physician Decision|1|||
105347394|NCT03482167|363273375|FG000|Received Intervention|Withdrawal by Subject|1|||
105347395|NCT03482167|363273376|FG001|Received Intervention|Withdrawal by Subject|0|||
105347396|NCT01524783|363273380|FG000|Blinded Period|Adverse Event|64|||
105347397|NCT01524783|363273381|FG001|Blinded Period|Adverse Event|7|||
105347398|NCT01524783|363273382|FG002|Blinded Period|Adverse Event|0|||
105347399|NCT01524783|363273380|FG000|Blinded Period|Disease Progression|89|||
105347400|NCT01524783|363273381|FG001|Blinded Period|Disease Progression|75|||
105347401|NCT01524783|363273382|FG002|Blinded Period|Disease Progression|0|||
105347402|NCT01524783|363273380|FG000|Blinded Period|Withdrawal by Subject|19|||
105347403|NCT01524783|363273381|FG001|Blinded Period|Withdrawal by Subject|6|||
105347404|NCT01524783|363273382|FG002|Blinded Period|Withdrawal by Subject|0|||
105347405|NCT01524783|363273380|FG000|Blinded Period|Protocol deviation|2|||
105347406|NCT01524783|363273381|FG001|Blinded Period|Protocol deviation|1|||
105347407|NCT01524783|363273382|FG002|Blinded Period|Protocol deviation|0|||
105347408|NCT01524783|363273380|FG000|Blinded Period|Death|5|||
105347409|NCT01524783|363273381|FG001|Blinded Period|Death|2|||
105347410|NCT01524783|363273382|FG002|Blinded Period|Death|0|||
105347411|NCT01524783|363273380|FG000|Open-label Period|Disease progression|13|||
105347412|NCT01524783|363273381|FG001|Open-label Period|Disease progression|0|||
105347413|NCT01524783|363273382|FG002|Open-label Period|Disease progression|2|||
105347414|NCT01524783|363273380|FG000|Open-label Period|Administrative problems|5|||
105347415|NCT01524783|363273381|FG001|Open-label Period|Administrative problems|0|||
105347416|NCT01524783|363273382|FG002|Open-label Period|Administrative problems|2|||
105347417|NCT01524783|363273380|FG000|Open-label Period|Adverse Event|5|||
105347418|NCT01524783|363273381|FG001|Open-label Period|Adverse Event|0|||
105347419|NCT01524783|363273382|FG002|Open-label Period|Adverse Event|1|||
105347420|NCT01524783|363273380|FG000|Open-label Period|Withdrawal by Subject|2|||
105347421|NCT01524783|363273381|FG001|Open-label Period|Withdrawal by Subject|0|||
105347422|NCT01524783|363273382|FG002|Open-label Period|Withdrawal by Subject|1|||
105347423|NCT01524783|363273380|FG000|Open-label Period|Protocol deviation|1|||
105347424|NCT01524783|363273381|FG001|Open-label Period|Protocol deviation|0|||
105347425|NCT01524783|363273382|FG002|Open-label Period|Protocol deviation|0|||
105347426|NCT02920177|363273383|FG000|Overall Study|Withdrawal by Subject|1|||
105347427|NCT02920177|363273384|FG001|Overall Study|Withdrawal by Subject|1|||
105347428|NCT02920177|363273383|FG000|Overall Study|Physician Decision|1|||
105347429|NCT02920177|363273384|FG001|Overall Study|Physician Decision|0|||
105347430|NCT02920177|363273383|FG000|Overall Study|Lost to Follow-up|0|||
105347431|NCT02920177|363273384|FG001|Overall Study|Lost to Follow-up|1|||
105347432|NCT01876979|363273385|FG000|Overall Study|Physician Decision|2|||
105347433|NCT01876979|363273386|FG001|Overall Study|Physician Decision|3|||
105347434|NCT01096589|363273387|FG000|Overall Study|Adverse Event|2|||
105347435|NCT01096589|363273388|FG001|Overall Study|Adverse Event|1|||
105347436|NCT01096589|363273389|FG002|Overall Study|Adverse Event|2|||
105347437|NCT01096589|363273390|FG003|Overall Study|Adverse Event|1|||
105347438|NCT01096589|363273387|FG000|Overall Study|Withdrawal by Subject|2|||
105347439|NCT01096589|363273388|FG001|Overall Study|Withdrawal by Subject|1|||
105347440|NCT01096589|363273389|FG002|Overall Study|Withdrawal by Subject|1|||
105347441|NCT01096589|363273390|FG003|Overall Study|Withdrawal by Subject|1|||
105347442|NCT01096589|363273387|FG000|Overall Study|Compliance with protocol|0|||
105693471|NCT00698204|364542037|FG000|Overall Study|Withdrawal by Subject|1|||
105347443|NCT01096589|363273388|FG001|Overall Study|Compliance with protocol|0|||
105347444|NCT01096589|363273389|FG002|Overall Study|Compliance with protocol|1|||
105559174|NCT03896035|364044596|FG001|Overall Study|Withdrawal by Subject|1|||
105693472|NCT00698204|364542038|FG001|Overall Study|Withdrawal by Subject|0|||
105347445|NCT01096589|363273390|FG003|Overall Study|Compliance with protocol|0|||
105347446|NCT01096589|363273387|FG000|Overall Study|found treatment exhausting|0|||
105347447|NCT01096589|363273388|FG001|Overall Study|found treatment exhausting|0|||
105347448|NCT01096589|363273389|FG002|Overall Study|found treatment exhausting|0|||
105347449|NCT01096589|363273390|FG003|Overall Study|found treatment exhausting|1|||
105347450|NCT03806231|363273391|FG000|Overall Study|Physician Decision|1|||
105347451|NCT03806231|363273392|FG001|Overall Study|Physician Decision|0|||
105347452|NCT03806231|363273391|FG000|Overall Study|Withdrawal by Subject|1|||
105347453|NCT03806231|363273392|FG001|Overall Study|Withdrawal by Subject|0|||
105347454|NCT00900731|363273393|FG000|Overall Study|Adverse Event|31|||
105347455|NCT00900731|363273394|FG001|Overall Study|Adverse Event|27|||
105347456|NCT00900731|363273393|FG000|Overall Study|Withdrawal by Subject|8|||
105347457|NCT00900731|363273394|FG001|Overall Study|Withdrawal by Subject|7|||
105347458|NCT00900731|363273393|FG000|Overall Study|Protocol Deviation|8|||
105347459|NCT00900731|363273394|FG001|Overall Study|Protocol Deviation|11|||
105347460|NCT00900731|363273393|FG000|Overall Study|Administrative Problems|5|||
105347461|NCT00900731|363273394|FG001|Overall Study|Administrative Problems|4|||
105347462|NCT00900731|363273393|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
105347463|NCT00900731|363273394|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
105347464|NCT00900731|363273393|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
105347465|NCT00900731|363273394|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
105347466|NCT00900731|363273393|FG000|Overall Study|Lost to Follow-up|2|||
105347467|NCT00900731|363273394|FG001|Overall Study|Lost to Follow-up|3|||
105347468|NCT00900731|363273393|FG000|Overall Study|Lack of Efficacy|1|||
105347469|NCT00900731|363273394|FG001|Overall Study|Lack of Efficacy|3|||
105347470|NCT00900731|363273393|FG000|Overall Study|Death|0|||
105347471|NCT00900731|363273394|FG001|Overall Study|Death|2|||
105347472|NCT02919267|363273395|FG000|Overall Study|Protocol Violation|0|||
105347473|NCT02919267|363273396|FG001|Overall Study|Protocol Violation|3|||
105347474|NCT02919267|363273397|FG002|Overall Study|Protocol Violation|3|||
105347475|NCT02919267|363273398|FG003|Overall Study|Protocol Violation|4|||
105347476|NCT02407054|363273399|FG000|Overall Study|Adverse Event|1|||
105347477|NCT02407054|363273400|FG001|Overall Study|Adverse Event|4|||
105347478|NCT02407054|363273401|FG002|Overall Study|Adverse Event|1|||
105347479|NCT02407054|363273399|FG000|Overall Study|Non-compliance with Study|0|||
105347480|NCT02407054|363273400|FG001|Overall Study|Non-compliance with Study|2|||
105347481|NCT02407054|363273401|FG002|Overall Study|Non-compliance with Study|1|||
105347482|NCT02407054|363273399|FG000|Overall Study|Physician Decision|1|||
105347483|NCT02407054|363273400|FG001|Overall Study|Physician Decision|3|||
105347484|NCT02407054|363273401|FG002|Overall Study|Physician Decision|3|||
105347485|NCT02407054|363273399|FG000|Overall Study|Withdrawal by Subject|5|||
105347486|NCT02407054|363273400|FG001|Overall Study|Withdrawal by Subject|9|||
105347487|NCT02407054|363273401|FG002|Overall Study|Withdrawal by Subject|2|||
105347488|NCT00932698|363273402|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
105347489|NCT00932698|363273403|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
105347490|NCT00932698|363273404|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
105347491|NCT00932698|363273405|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
105347492|NCT00932698|363273406|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
105347493|NCT00932698|363273407|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
105347494|NCT00932698|363273408|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
105347495|NCT00932698|363273409|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
105347496|NCT00932698|363273410|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
105347497|NCT00932698|363273411|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
105347498|NCT00932698|363273412|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
105347499|NCT00932698|363273402|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
105347500|NCT00932698|363273403|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
105347501|NCT00932698|363273404|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
105347502|NCT00932698|363273405|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
105347503|NCT00932698|363273406|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
105347504|NCT00932698|363273407|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
105347505|NCT00932698|363273408|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
105347506|NCT00932698|363273409|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
105347507|NCT00932698|363273410|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
105347508|NCT00932698|363273411|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
105347509|NCT00932698|363273412|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
105347510|NCT00932698|363273402|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
105347511|NCT00932698|363273403|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
105347512|NCT00932698|363273404|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
105347513|NCT00932698|363273405|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
105347514|NCT00932698|363273406|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
105347515|NCT00932698|363273407|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
105347516|NCT00932698|363273408|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
105347517|NCT00932698|363273409|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
105347518|NCT00932698|363273410|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
105347519|NCT00932698|363273411|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
105347520|NCT00932698|363273412|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
105472771|NCT00337675|363743496|FG000|Overall Study|Progressive Disease|0|||
105472772|NCT00337675|363743497|FG001|Overall Study|Progressive Disease|2|||
105472773|NCT00337675|363743498|FG002|Overall Study|Progressive Disease|0|||
105472774|NCT00337675|363743496|FG000|Overall Study|Trial Terminated|0|||
105472775|NCT00337675|363743497|FG001|Overall Study|Trial Terminated|0|||
105472776|NCT00337675|363743498|FG002|Overall Study|Trial Terminated|2|||
105472777|NCT04693234|363743499|FG000|Overall Study|Death|79|||
105472778|NCT04693234|363743500|FG001|Overall Study|Death|19|||
105472779|NCT04693234|363743499|FG000|Overall Study|Sponsor Ended Study|47|||
105472780|NCT04693234|363743500|FG001|Overall Study|Sponsor Ended Study|18|||
105472781|NCT04693234|363743499|FG000|Overall Study|Withdrawal by Subject|10|||
105472782|NCT04693234|363743500|FG001|Overall Study|Withdrawal by Subject|2|||
105472783|NCT04693234|363743499|FG000|Overall Study|Lost to Follow-up|2|||
105472784|NCT04693234|363743500|FG001|Overall Study|Lost to Follow-up|1|||
105472785|NCT00459186|363743501|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
105472786|NCT00459186|363743501|FG000|PET Imaging and Assessment|Adverse Event|3|||
105472787|NCT01587014|363743502|FG000|Overall Study|Death|2|||
105472788|NCT03801031|363743503|FG000|Overall Study|Lost to Follow-up|1|||
105472789|NCT03801031|363743504|FG001|Overall Study|Lost to Follow-up|0|||
105472790|NCT03801031|363743503|FG000|Overall Study|Unable to comply|1|||
105472791|NCT03801031|363743504|FG001|Overall Study|Unable to comply|0|||
105472792|NCT03801031|363743503|FG000|Overall Study|Withdrawal by Subject|0|||
105472793|NCT03801031|363743504|FG001|Overall Study|Withdrawal by Subject|1|||
105472794|NCT02948088|363743505|FG000|Overall Study|Lost to Follow-up|8|||
105472795|NCT02948088|363743505|FG000|Overall Study|Death|1|||
105472796|NCT02948088|363743505|FG000|Overall Study|Withdrawal by Subject|4|||
105472797|NCT02948088|363743505|FG000|Overall Study|Other|2|||
105472798|NCT00634101|363743506|FG000|Overall Study|Study Terminated|3|||
105472799|NCT00634101|363743507|FG001|Overall Study|Study Terminated|3|||
105472800|NCT00634101|363743506|FG000|Overall Study|Lost to Follow-up|2|||
105472801|NCT00634101|363743507|FG001|Overall Study|Lost to Follow-up|0|||
105472802|NCT01077076|363743510|FG000|First Intervention|Withdrawal by Subject|1|||
105472803|NCT01077076|363743511|FG001|First Intervention|Withdrawal by Subject|0|||
105472804|NCT01077076|363743512|FG002|First Intervention|Withdrawal by Subject|0|||
105472805|NCT01077076|363743513|FG003|First Intervention|Withdrawal by Subject|0|||
105472806|NCT01077076|363743514|FG004|First Intervention|Withdrawal by Subject|0|||
105472807|NCT01077076|363743515|FG005|First Intervention|Withdrawal by Subject|0|||
105472808|NCT01077076|363743510|FG000|Third Intervention|Death in the participant's family|0|||
105472809|NCT01077076|363743511|FG001|Third Intervention|Death in the participant's family|0|||
105472810|NCT01077076|363743512|FG002|Third Intervention|Death in the participant's family|0|||
105472811|NCT01077076|363743513|FG003|Third Intervention|Death in the participant's family|0|||
105472812|NCT01077076|363743514|FG004|Third Intervention|Death in the participant's family|0|||
105472813|NCT01077076|363743515|FG005|Third Intervention|Death in the participant's family|1|||
105472814|NCT01388335|363743516|FG000|Period 1|Progressive Disease|1|||
105472815|NCT01388335|363743516|FG000|Period 2|Progressive Disease|2|||
105693473|NCT00698451|364542039|FG000|Overall Study|Adverse Event|22|||
105693474|NCT00698451|364542039|FG000|Overall Study|Physician Decision|2|||
105472816|NCT01388335|363743516|FG000|Period 2|Sponsor Decision|1|||
105472817|NCT01388335|363743516|FG000|Safety Extension|Progressive Disease|7|||
105472818|NCT01297491|363743517|FG000|Overall Study|Adverse Event|11|||
105472819|NCT01297491|363743518|FG001|Overall Study|Adverse Event|6|||
105472820|NCT01297491|363743517|FG000|Overall Study|Physician Decision|3|||
105472821|NCT01297491|363743518|FG001|Overall Study|Physician Decision|2|||
105472822|NCT01297491|363743517|FG000|Overall Study|Progressive disease|11|||
105693475|NCT00698451|364542039|FG000|Overall Study|Protocol Violation|6|||
105472823|NCT01297491|363743518|FG001|Overall Study|Progressive disease|20|||
105472824|NCT01297491|363743517|FG000|Overall Study|Patient/Guardian decision|3|||
105472825|NCT01297491|363743518|FG001|Overall Study|Patient/Guardian decision|4|||
105472826|NCT01297491|363743517|FG000|Overall Study|Death|2|||
105472827|NCT01297491|363743518|FG001|Overall Study|Death|1|||
105472828|NCT04973436|363743519|FG000|Overall Study|Lost to Follow-up|3|||
105472829|NCT04973436|363743519|FG000|Overall Study|Withdrawal by Subject|1|||
105472830|NCT04973436|363743519|FG000|Overall Study|Death|2|||
105472831|NCT01192191|363743522|FG000|Overall Study|Adverse Event|7|||
105472832|NCT01192191|363743523|FG001|Overall Study|Adverse Event|12|||
105472833|NCT01192191|363743522|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
105472834|NCT01192191|363743523|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
105472835|NCT01192191|363743522|FG000|Overall Study|Lost to Follow-up|0|||
105472836|NCT01192191|363743523|FG001|Overall Study|Lost to Follow-up|1|||
105472837|NCT01192191|363743522|FG000|Overall Study|Withdrawal by Subject|1|||
105472838|NCT01192191|363743523|FG001|Overall Study|Withdrawal by Subject|6|||
105472839|NCT01047553|363743525|FG000|Overall Study|Adverse Event|10|||
105472840|NCT01047553|363743526|FG001|Overall Study|Adverse Event|5|||
105472841|NCT01047553|363743525|FG000|Overall Study|Withdrawal by Subject|4|||
105472842|NCT01047553|363743526|FG001|Overall Study|Withdrawal by Subject|2|||
105472843|NCT01047553|363743525|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
105472844|NCT01047553|363743526|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
105472845|NCT01047553|363743525|FG000|Overall Study|Lost to Follow-up|1|||
105472846|NCT01047553|363743526|FG001|Overall Study|Lost to Follow-up|0|||
105472847|NCT01047553|363743525|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
105472848|NCT01047553|363743526|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
105472849|NCT01047553|363743525|FG000|Overall Study|PI's decision|0|||
105472850|NCT01047553|363743526|FG001|Overall Study|PI's decision|1|||
105472851|NCT05343624|363743527|FG000|Overall Study|Chart review not completed|1|||
105472852|NCT00223080|363743534|FG000|Overall Study|Withdrawal by Subject|253|||
105472853|NCT00223080|363743535|FG001|Overall Study|Withdrawal by Subject|232|||
105472854|NCT00223080|363743534|FG000|Overall Study|Required contraindicated med|0|||
105472855|NCT00223080|363743535|FG001|Overall Study|Required contraindicated med|1|||
105472856|NCT00223080|363743534|FG000|Overall Study|Non-compliant|7|||
105472857|NCT00223080|363743535|FG001|Overall Study|Non-compliant|7|||
105472858|NCT00223080|363743534|FG000|Overall Study|Moved from study area|37|||
105472859|NCT00223080|363743535|FG001|Overall Study|Moved from study area|47|||
105472860|NCT00223080|363743534|FG000|Overall Study|Lost to Follow-up|259|||
105472861|NCT00223080|363743535|FG001|Overall Study|Lost to Follow-up|284|||
105472862|NCT00223080|363743534|FG000|Overall Study|Death|85|||
105472863|NCT00223080|363743535|FG001|Overall Study|Death|74|||
105472864|NCT00223080|363743534|FG000|Overall Study|Other|14|||
105472865|NCT00223080|363743535|FG001|Overall Study|Other|11|||
105472866|NCT00223080|363743534|FG000|Overall Study|Reason not provided|141|||
105472867|NCT00223080|363743535|FG001|Overall Study|Reason not provided|140|||
105472868|NCT00223080|363743534|FG000|Overall Study|Adverse Event|0|||
105472869|NCT00223080|363743535|FG001|Overall Study|Adverse Event|1|||
105472870|NCT02598583|363743536|FG000|Extension Period|Withdrawal by Subject|1|||
105472871|NCT02598583|363743537|FG001|Extension Period|Withdrawal by Subject|0|||
105472872|NCT03237286|363743538|FG000|Overall Study|Withdrawal by Subject|1|||
105472873|NCT03237286|363743539|FG001|Overall Study|Withdrawal by Subject|0|||
105472874|NCT03237286|363743540|FG002|Overall Study|Withdrawal by Subject|2|||
105472875|NCT03237286|363743538|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
105472876|NCT03237286|363743539|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
105472877|NCT03237286|363743540|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
105472878|NCT00948441|363743541|FG000|Overall Study|no longer meet inclusion criteria|1|||
105472879|NCT00948441|363743542|FG001|Overall Study|no longer meet inclusion criteria|4|||
105472880|NCT02792829|363743543|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
105472881|NCT02792829|363743544|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
105472882|NCT02792829|363743545|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
105472883|NCT02792829|363743546|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
105472884|NCT02792829|363743547|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
105472885|NCT02792829|363743548|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
105472886|NCT02792829|363743549|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
105472887|NCT02792829|363743550|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
105472888|NCT02792829|363743543|FG000|Treatment Period 2|Adverse Event|0|||
105347521|NCT00932698|363273402|FG000|Part 1 (Dose Escalation)|Other|0|||
105472889|NCT02792829|363743544|FG001|Treatment Period 2|Adverse Event|0|||
105472890|NCT02792829|363743545|FG002|Treatment Period 2|Adverse Event|0|||
105472891|NCT02792829|363743546|FG003|Treatment Period 2|Adverse Event|0|||
105472892|NCT02792829|363743547|FG004|Treatment Period 2|Adverse Event|1|||
105472893|NCT02792829|363743548|FG005|Treatment Period 2|Adverse Event|0|||
105472894|NCT02792829|363743549|FG006|Treatment Period 2|Adverse Event|1|||
105472895|NCT02792829|363743550|FG007|Treatment Period 2|Adverse Event|1|||
105693476|NCT00698451|364542039|FG000|Overall Study|Withdrawal by Subject|6|||
105693477|NCT00698451|364542039|FG000|Overall Study|Disease progression|3|||
105693478|NCT01179672|364542040|FG000|Overall Study|Adverse Event|17|||
105693479|NCT01179672|364542041|FG001|Overall Study|Adverse Event|8|||
105693480|NCT01179672|364542040|FG000|Overall Study|Withdrawal by Subject|10|||
105693481|NCT01179672|364542041|FG001|Overall Study|Withdrawal by Subject|12|||
105693482|NCT01179672|364542040|FG000|Overall Study|Entry Criteria Not Met|0|||
105693483|NCT01179672|364542041|FG001|Overall Study|Entry Criteria Not Met|2|||
105693484|NCT01179672|364542040|FG000|Overall Study|Lost to Follow-up|0|||
105693485|NCT01179672|364542041|FG001|Overall Study|Lost to Follow-up|1|||
105693486|NCT01179672|364542040|FG000|Overall Study|Protocol Violation|2|||
105693487|NCT01179672|364542041|FG001|Overall Study|Protocol Violation|2|||
105693488|NCT01179672|364542040|FG000|Overall Study|Physician Decision|1|||
105693489|NCT01179672|364542041|FG001|Overall Study|Physician Decision|1|||
105693490|NCT02224599|364542044|FG000|Overall Study|Physician Decision|1|||
105693491|NCT02224599|364542044|FG000|Overall Study|Progression of Disease|1|||
105693492|NCT01949155|364542046|FG000|Overall Study|Lost to Follow-up|1|||
105693493|NCT01949155|364542047|FG001|Overall Study|Lost to Follow-up|0|||
105693494|NCT01949155|364542046|FG000|Overall Study|Protocol Violation|1|||
105693495|NCT01949155|364542047|FG001|Overall Study|Protocol Violation|0|||
105693496|NCT00314249|364542048|FG000|Overall Study|Adverse Event|73|||
105693497|NCT00314249|364542049|FG001|Overall Study|Adverse Event|94|||
105693498|NCT00314249|364542048|FG000|Overall Study|Lack of Efficacy|33|||
105693499|NCT00314249|364542049|FG001|Overall Study|Lack of Efficacy|24|||
105693500|NCT00314249|364542048|FG000|Overall Study|Withdrawal by Subject|21|||
105693501|NCT00314249|364542049|FG001|Overall Study|Withdrawal by Subject|28|||
105693502|NCT00314249|364542048|FG000|Overall Study|Lost to Follow-up|15|||
105693503|NCT00314249|364542049|FG001|Overall Study|Lost to Follow-up|9|||
105693504|NCT00314249|364542048|FG000|Overall Study|Physician Decision|1|||
105693505|NCT00314249|364542049|FG001|Overall Study|Physician Decision|1|||
105693506|NCT00314249|364542048|FG000|Overall Study|Withdrawn for other reasons|4|||
105693507|NCT00314249|364542049|FG001|Overall Study|Withdrawn for other reasons|1|||
105693508|NCT00314249|364542048|FG000|Overall Study|Non-Compliant|5|||
105693509|NCT00314249|364542049|FG001|Overall Study|Non-Compliant|6|||
105693510|NCT01187550|364542050|FG000|Overall Study|Protocol Violation|3|||
105693511|NCT01187550|364542051|FG001|Overall Study|Protocol Violation|1|||
105693512|NCT01187550|364542050|FG000|Overall Study|Other|3|||
105693513|NCT01187550|364542051|FG001|Overall Study|Other|0|||
105693514|NCT01187550|364542050|FG000|Overall Study|Randomized but not treated|8|||
105693515|NCT01187550|364542051|FG001|Overall Study|Randomized but not treated|0|||
105693516|NCT00596934|364542052|FG000|Overall Study|Protocol Violation|1|||
105693517|NCT00596934|364542052|FG000|Overall Study|Withdrawal by Subject|1|||
105693518|NCT00975715|364542058|FG000|Titration Period|Adverse Event|6|||
105693519|NCT00975715|364542059|FG001|Titration Period|Adverse Event|0|||
105693520|NCT00975715|364542058|FG000|Titration Period|Protocol Violation|1|||
105693521|NCT00975715|364542059|FG001|Titration Period|Protocol Violation|0|||
105693522|NCT00975715|364542058|FG000|Maintenance Period|Adverse Event|2|||
105693523|NCT00975715|364542059|FG001|Maintenance Period|Adverse Event|1|||
105693524|NCT00974090|364542066|FG000|Period 1: Double Blind Period|Adverse Event|2|||
105693525|NCT00974090|364542067|FG001|Period 1: Double Blind Period|Adverse Event|1|||
105693526|NCT00974090|364542066|FG000|Period 1: Double Blind Period|Physician Decision|1|||
105693527|NCT00974090|364542067|FG001|Period 1: Double Blind Period|Physician Decision|0|||
105693528|NCT00974090|364542066|FG000|Period 2: Open-label Period|Adverse Event|4|||
105347522|NCT00932698|363273403|FG001|Part 1 (Dose Escalation)|Other|0|||
105693529|NCT00974090|364542067|FG001|Period 2: Open-label Period|Adverse Event|6|||
105693530|NCT00974090|364542066|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
105693531|NCT00974090|364542067|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
105693532|NCT00974090|364542066|FG000|Period 2: Open-label Period|Physician Decision|0|||
105693533|NCT00974090|364542067|FG001|Period 2: Open-label Period|Physician Decision|3|||
105693534|NCT00974090|364542066|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
105693535|NCT00974090|364542067|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
105693536|NCT02606461|364542071|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
105693537|NCT02606461|364542072|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
105347523|NCT00932698|363273404|FG002|Part 1 (Dose Escalation)|Other|1|||
105347524|NCT00932698|363273405|FG003|Part 1 (Dose Escalation)|Other|0|||
105347525|NCT00932698|363273406|FG004|Part 1 (Dose Escalation)|Other|0|||
105347526|NCT00932698|363273407|FG005|Part 1 (Dose Escalation)|Other|0|||
105347527|NCT00932698|363273408|FG006|Part 1 (Dose Escalation)|Other|1|||
105347528|NCT00932698|363273409|FG007|Part 1 (Dose Escalation)|Other|0|||
105347529|NCT00932698|363273410|FG008|Part 1 (Dose Escalation)|Other|0|||
105347530|NCT00932698|363273411|FG009|Part 1 (Dose Escalation)|Other|0|||
105347531|NCT00932698|363273412|FG010|Part 1 (Dose Escalation)|Other|0|||
105347532|NCT00932698|363273402|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
105347533|NCT00932698|363273403|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
105347534|NCT00932698|363273404|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
105347535|NCT00932698|363273405|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
105347536|NCT00932698|363273406|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
105347537|NCT00932698|363273407|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
105347538|NCT00932698|363273408|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
105347539|NCT00932698|363273409|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
105347540|NCT00932698|363273410|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
105347541|NCT00932698|363273411|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
105347542|NCT00932698|363273412|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
105347543|NCT00932698|363273402|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105347544|NCT00932698|363273403|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105347545|NCT00932698|363273404|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105347546|NCT00932698|363273405|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105347547|NCT00932698|363273406|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105347548|NCT00932698|363273407|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105347549|NCT00932698|363273408|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105347550|NCT00932698|363273409|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
105347551|NCT00932698|363273410|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
105559175|NCT03896035|364044595|FG000|Overall Study|Health/family health issues during COVID|0|||
105559176|NCT03896035|364044596|FG001|Overall Study|Health/family health issues during COVID|4|||
105559177|NCT00743366|364044597|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
105559178|NCT00743366|364044598|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
105559179|NCT00335322|364044599|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
105559180|NCT00335322|364044600|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
105559181|NCT00335322|364044601|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
105559182|NCT00951483|364044602|FG000|Overall Study|Physician Decision|4|||
105559183|NCT00951483|364044603|FG001|Overall Study|Physician Decision|0|||
105559184|NCT00951483|364044602|FG000|Overall Study|Withdrawal by Subject|15|||
105347552|NCT00932698|363273411|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
105693538|NCT02606461|364542073|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
105693539|NCT02606461|364542074|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
105693540|NCT02606461|364542075|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
105693541|NCT02606461|364542076|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
105693542|NCT02092350|364542077|FG000|Overall Study|Adverse Event|0|||
105693543|NCT02092350|364542078|FG001|Overall Study|Adverse Event|3|||
105693544|NCT02092350|364542077|FG000|Overall Study|Death|2|||
105693545|NCT02092350|364542078|FG001|Overall Study|Death|5|||
105693546|NCT02092350|364542077|FG000|Overall Study|Lost to Follow-up|3|||
105693547|NCT02092350|364542078|FG001|Overall Study|Lost to Follow-up|1|||
105693548|NCT02092350|364542077|FG000|Overall Study|Protocol Violation|1|||
105347553|NCT00932698|363273412|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105693549|NCT02092350|364542078|FG001|Overall Study|Protocol Violation|0|||
105693550|NCT02092350|364542077|FG000|Overall Study|Physician Decision|1|||
105693551|NCT02092350|364542078|FG001|Overall Study|Physician Decision|1|||
105347554|NCT00932698|363273402|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
105347555|NCT00932698|363273403|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
105347556|NCT00932698|363273404|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
105347557|NCT00932698|363273405|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
105347558|NCT00932698|363273406|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
105347559|NCT00932698|363273407|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
105559185|NCT00951483|364044603|FG001|Overall Study|Withdrawal by Subject|0|||
105559186|NCT04393441|364044604|FG000|Overall Study|Adverse Event|0|||
105472896|NCT02792829|363743543|FG000|Treatment Period 2|Use of proscribed medications|0|||
105472897|NCT02792829|363743544|FG001|Treatment Period 2|Use of proscribed medications|0|||
105472898|NCT02792829|363743545|FG002|Treatment Period 2|Use of proscribed medications|0|||
105472899|NCT02792829|363743546|FG003|Treatment Period 2|Use of proscribed medications|0|||
105472900|NCT02792829|363743547|FG004|Treatment Period 2|Use of proscribed medications|0|||
105472901|NCT02792829|363743548|FG005|Treatment Period 2|Use of proscribed medications|0|||
105472902|NCT02792829|363743549|FG006|Treatment Period 2|Use of proscribed medications|0|||
105472903|NCT02792829|363743550|FG007|Treatment Period 2|Use of proscribed medications|1|||
105472904|NCT00947882|363743554|FG000|Overall Study|Adverse Event|0|||
105472905|NCT00947882|363743555|FG001|Overall Study|Adverse Event|1|||
105472906|NCT00947882|363743556|FG002|Overall Study|Adverse Event|4|||
105472907|NCT00947882|363743557|FG003|Overall Study|Adverse Event|4|||
105472908|NCT00947882|363743554|FG000|Overall Study|Withdrawal by Subject|2|||
105472909|NCT00947882|363743555|FG001|Overall Study|Withdrawal by Subject|0|||
105472910|NCT00947882|363743556|FG002|Overall Study|Withdrawal by Subject|8|||
105472911|NCT00947882|363743557|FG003|Overall Study|Withdrawal by Subject|2|||
105472912|NCT00947882|363743554|FG000|Overall Study|Protocol Violation|0|||
105472913|NCT00947882|363743555|FG001|Overall Study|Protocol Violation|0|||
105472914|NCT00947882|363743556|FG002|Overall Study|Protocol Violation|1|||
105472915|NCT00947882|363743557|FG003|Overall Study|Protocol Violation|0|||
105472916|NCT00947882|363743554|FG000|Overall Study|Lost to Follow-up|0|||
105472917|NCT00947882|363743555|FG001|Overall Study|Lost to Follow-up|2|||
105472918|NCT00947882|363743556|FG002|Overall Study|Lost to Follow-up|1|||
105472919|NCT00947882|363743557|FG003|Overall Study|Lost to Follow-up|0|||
105472920|NCT00947882|363743554|FG000|Overall Study|Other/Unknown|10|||
105472921|NCT00947882|363743555|FG001|Overall Study|Other/Unknown|13|||
105472922|NCT00947882|363743556|FG002|Overall Study|Other/Unknown|3|||
105472923|NCT00947882|363743557|FG003|Overall Study|Other/Unknown|6|||
105472924|NCT00947882|363743554|FG000|Overall Study|Trial Terminated by Sponsor|62|||
105472925|NCT00947882|363743555|FG001|Overall Study|Trial Terminated by Sponsor|61|||
105559187|NCT04393441|364044605|FG001|Overall Study|Adverse Event|3|||
105559188|NCT04393441|364044604|FG000|Overall Study|Withdrawal by Subject|5|||
105693552|NCT02092350|364542077|FG000|Overall Study|Screen Failure|1|||
105347560|NCT00932698|363273408|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
105347561|NCT00932698|363273409|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
105472926|NCT00947882|363743556|FG002|Overall Study|Trial Terminated by Sponsor|62|||
105472927|NCT00947882|363743557|FG003|Overall Study|Trial Terminated by Sponsor|70|||
105472928|NCT00329797|363743558|FG000|Overall Study|Protocol Violation|1|||
105472929|NCT00329797|363743559|FG001|Overall Study|Protocol Violation|0|||
105472930|NCT00329797|363743558|FG000|Overall Study|Withdrawal by Subject|6|||
105472931|NCT00329797|363743559|FG001|Overall Study|Withdrawal by Subject|6|||
105472932|NCT01026324|363743560|FG000|Follow up/Survival|Withdrawal by Subject|1|||
105472933|NCT01026324|363743561|FG001|Follow up/Survival|Withdrawal by Subject|0|||
105347562|NCT00932698|363273410|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
105347563|NCT00932698|363273411|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
105347564|NCT00932698|363273412|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
105347565|NCT00131365|363273413|FG000|Overall Study|Withdrawal by Subject|1|||
105347566|NCT00131365|363273413|FG000|Overall Study|Alternative treatment|3|||
105347567|NCT00655681|363273414|FG000|Overall Study|Lost to Follow-up|1|||
105347568|NCT00655681|363273415|FG001|Overall Study|Lost to Follow-up|1|||
105347569|NCT01085136|363273416|FG000|Part A|Other Adverse event|223|||
105347570|NCT01085136|363273417|FG001|Part A|Other Adverse event|0|||
105347571|NCT01085136|363273418|FG002|Part A|Other Adverse event|0|||
105347572|NCT01085136|363273416|FG000|Part A|Protocol Violation|3|||
105347573|NCT01085136|363273417|FG001|Part A|Protocol Violation|0|||
105347574|NCT01085136|363273418|FG002|Part A|Protocol Violation|0|||
105347575|NCT01085136|363273416|FG000|Part A|Lost to Follow-up|3|||
105347576|NCT01085136|363273417|FG001|Part A|Lost to Follow-up|0|||
105347577|NCT01085136|363273418|FG002|Part A|Lost to Follow-up|0|||
105347578|NCT01085136|363273416|FG000|Part A|Refusal to continue trial medication|64|||
105347579|NCT01085136|363273417|FG001|Part A|Refusal to continue trial medication|0|||
105347580|NCT01085136|363273418|FG002|Part A|Refusal to continue trial medication|0|||
105347581|NCT01085136|363273416|FG000|Part A|Other reason not defined above|30|||
105347582|NCT01085136|363273417|FG001|Part A|Other reason not defined above|0|||
105347583|NCT01085136|363273418|FG002|Part A|Other reason not defined above|0|||
105347584|NCT01085136|363273416|FG000|Part B|Other AE|0|||
105347585|NCT01085136|363273417|FG001|Part B|Other AE|29|||
105347586|NCT01085136|363273418|FG002|Part B|Other AE|8|||
105347587|NCT01085136|363273416|FG000|Part B|Refusal to continue trial medication|0|||
105347588|NCT01085136|363273417|FG001|Part B|Refusal to continue trial medication|12|||
105347589|NCT01085136|363273418|FG002|Part B|Refusal to continue trial medication|7|||
105347590|NCT01085136|363273416|FG000|Part B|Not treated|0|||
105347591|NCT01085136|363273417|FG001|Part B|Not treated|4|||
105347592|NCT01085136|363273418|FG002|Part B|Not treated|8|||
105347593|NCT01085136|363273416|FG000|Part B|Other reason not defined above|0|||
105347594|NCT01085136|363273417|FG001|Part B|Other reason not defined above|6|||
105347595|NCT01085136|363273418|FG002|Part B|Other reason not defined above|3|||
105347596|NCT00593606|363275277|FG000|Overall Study|Adverse Event|13|||
105347597|NCT00593606|363275277|FG000|Overall Study|Withdrawal by Subject|1|||
105347598|NCT00593606|363275277|FG000|Overall Study|Protocol Violation|3|||
105347599|NCT00593606|363275277|FG000|Overall Study|Lost to Follow-up|2|||
105347600|NCT00593606|363275277|FG000|Overall Study|Run-In Failure|5|||
105347601|NCT00593606|363275277|FG000|Overall Study|Screen Failure|3|||
105347602|NCT02278367|363275278|FG000|Overall Study|Physician Decision|5|||
105347603|NCT02278367|363275279|FG001|Overall Study|Physician Decision|0|||
105347604|NCT02278367|363275278|FG000|Overall Study|Withdrawal by Subject|5|||
105347605|NCT02278367|363275279|FG001|Overall Study|Withdrawal by Subject|0|||
105347606|NCT04643964|363275281|FG000|Overall Study|Lost to Follow-up|55|||
105347607|NCT04643964|363275282|FG001|Overall Study|Lost to Follow-up|59|||
105347608|NCT04643964|363275283|FG002|Overall Study|Lost to Follow-up|54|||
105347609|NCT04643964|363275284|FG003|Overall Study|Lost to Follow-up|129|||
105347610|NCT04643964|363275285|FG004|Overall Study|Lost to Follow-up|48|||
105347611|NCT04643964|363275281|FG000|Overall Study|Failed attention check|1|||
105347612|NCT04643964|363275282|FG001|Overall Study|Failed attention check|8|||
105347613|NCT04643964|363275283|FG002|Overall Study|Failed attention check|2|||
105347614|NCT04643964|363275284|FG003|Overall Study|Failed attention check|14|||
105347615|NCT04643964|363275285|FG004|Overall Study|Failed attention check|11|||
105347616|NCT02949908|363275286|FG000|Overall Study|Study termination|2|||
105347617|NCT01472939|363275287|FG000|Overall Study|Adverse Event|3|||
105472934|NCT01026324|363743562|FG002|Follow up/Survival|Withdrawal by Subject|0|||
105472935|NCT00711477|363743565|FG000|Overall Study|Adverse Event|3|||
105472936|NCT00711477|363743566|FG001|Overall Study|Adverse Event|1|||
105693553|NCT02092350|364542078|FG001|Overall Study|Screen Failure|0|||
105693554|NCT02092350|364542077|FG000|Overall Study|Withdrawal by Subject|2|||
105347618|NCT01472939|363275288|FG001|Overall Study|Adverse Event|7|||
105347619|NCT01472939|363275289|FG002|Overall Study|Adverse Event|7|||
105347620|NCT01472939|363275290|FG003|Overall Study|Adverse Event|14|||
105347621|NCT01472939|363275287|FG000|Overall Study|Lack of Efficacy|1|||
105347622|NCT01472939|363275288|FG001|Overall Study|Lack of Efficacy|0|||
105347623|NCT01472939|363275289|FG002|Overall Study|Lack of Efficacy|0|||
105347624|NCT01472939|363275290|FG003|Overall Study|Lack of Efficacy|1|||
105347625|NCT01472939|363275287|FG000|Overall Study|Lost to Follow-up|3|||
105347626|NCT01472939|363275288|FG001|Overall Study|Lost to Follow-up|0|||
105347627|NCT01472939|363275289|FG002|Overall Study|Lost to Follow-up|2|||
105347628|NCT01472939|363275290|FG003|Overall Study|Lost to Follow-up|0|||
105347629|NCT01472939|363275287|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
105347630|NCT01472939|363275288|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
105693555|NCT02092350|364542078|FG001|Overall Study|Withdrawal by Subject|2|||
105347631|NCT01472939|363275289|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
105347632|NCT01472939|363275290|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
105347633|NCT01472939|363275287|FG000|Overall Study|Prohibited Medication|0|||
105472937|NCT00711477|363743565|FG000|Overall Study|Lost to Follow-up|0|||
105693556|NCT00024167|364542079|FG000|Overall Study|Death|53|||
105693557|NCT00024167|364542080|FG001|Overall Study|Death|47|||
105693558|NCT00931944|364542081|FG000|Overall Study|Adverse Event|4|||
105693559|NCT00931944|364542081|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
105693560|NCT00931944|364542081|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
105693561|NCT00931944|364542081|FG000|Overall Study|Death|28|||
105693562|NCT00931944|364542081|FG000|Overall Study|Other|2|||
105693563|NCT00006392|364542087|FG000|Overall Study|Ineligible|11|||
105693564|NCT00006392|364542088|FG001|Overall Study|Ineligible|3|||
105693565|NCT00006392|364542089|FG002|Overall Study|Ineligible|5|||
105693566|NCT00006392|364542090|FG003|Overall Study|Ineligible|5|||
105693567|NCT00006392|364542087|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
105693568|NCT00006392|364542088|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
105693569|NCT00006392|364542089|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
105693570|NCT00006392|364542090|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
105693571|NCT03838198|364542095|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
105693572|NCT03838198|364542096|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
105693573|NCT03838198|364542097|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
105693574|NCT03838198|364542098|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
105693575|NCT03838198|364542095|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
105693576|NCT03838198|364542096|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
105693577|NCT03838198|364542097|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
105693578|NCT03838198|364542098|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
105693579|NCT00770770|364542104|FG000|Overall Study|Lost to Follow-up|1|||
105693580|NCT00770770|364542105|FG001|Overall Study|Lost to Follow-up|0|||
105693581|NCT00770770|364542104|FG000|Overall Study|Withdrawal by Subject|1|||
105693582|NCT00770770|364542105|FG001|Overall Study|Withdrawal by Subject|0|||
105472938|NCT00711477|363743566|FG001|Overall Study|Lost to Follow-up|1|||
105693583|NCT00770770|364542104|FG000|Overall Study|Death|0|||
105693584|NCT00770770|364542105|FG001|Overall Study|Death|1|||
105693585|NCT00770770|364542104|FG000|Overall Study|Study Terminated|8|||
105693586|NCT00770770|364542105|FG001|Overall Study|Study Terminated|0|||
105693587|NCT01026142|364542106|FG000|Overall Study|Death|136|||
105693588|NCT01026142|364542107|FG001|Overall Study|Death|134|||
105693589|NCT01026142|364542106|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
105693590|NCT01026142|364542107|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
105693591|NCT00628251|364542111|FG000|Randomised Part|Withdrawal by Subject|0|||
105693592|NCT00628251|364542112|FG001|Randomised Part|Withdrawal by Subject|0|||
105693593|NCT00628251|364542113|FG002|Randomised Part|Withdrawal by Subject|1|||
105693594|NCT00628251|364542111|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
105693595|NCT00628251|364542112|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
105693596|NCT00628251|364542113|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
105693597|NCT00628251|364542111|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
105693598|NCT00628251|364542112|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
105472939|NCT00711477|363743565|FG000|Overall Study|Noncompliance|0|||
105472940|NCT00711477|363743566|FG001|Overall Study|Noncompliance|1|||
105472941|NCT03037580|363743568|FG000|Overall Study|Withdrawal by Subject|3|||
105693599|NCT00628251|364542113|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
105693600|NCT00628251|364542111|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
105693601|NCT00628251|364542112|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
105693602|NCT00628251|364542113|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
105693603|NCT00628251|364542111|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
105693604|NCT00628251|364542112|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
105693605|NCT00628251|364542113|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
105693606|NCT00628251|364542111|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
105693607|NCT00628251|364542112|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
105693608|NCT00628251|364542113|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
105693609|NCT00728481|364542114|FG000|Overall Study|Withdrawal by Subject|0|||
105693610|NCT00728481|364542115|FG001|Overall Study|Withdrawal by Subject|1|||
105693611|NCT00728481|364542114|FG000|Overall Study|Adverse Event|0|||
105693612|NCT00728481|364542115|FG001|Overall Study|Adverse Event|1|||
105693613|NCT00728481|364542114|FG000|Overall Study|Study medication non-compliance|0|||
105693614|NCT00728481|364542115|FG001|Overall Study|Study medication non-compliance|2|||
105693615|NCT00728481|364542114|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
105693616|NCT00728481|364542115|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
105693617|NCT03690141|364542116|FG000|Overall Study|Adverse Event|5|||
105693618|NCT03690141|364542116|FG000|Overall Study|Withdrawal by Subject|3|||
105693619|NCT03690141|364542116|FG000|Overall Study|Physician Decision|4|||
105693620|NCT03690141|364542116|FG000|Overall Study|Disease progression|4|||
105693621|NCT02540538|364542119|FG000|Overall Study|Pregnancy|0|||
105693622|NCT02540538|364542120|FG001|Overall Study|Pregnancy|1|||
105693623|NCT02540538|364542121|FG002|Overall Study|Pregnancy|0|||
105693624|NCT00375219|364542123|FG000|Overall Study|Failure to achieve a response|16|||
105693625|NCT00375219|364542124|FG001|Overall Study|Failure to achieve a response|2|||
105693626|NCT00375219|364542125|FG002|Overall Study|Failure to achieve a response|0|||
105693627|NCT00375219|364542123|FG000|Overall Study|Adverse Event|8|||
105693628|NCT00375219|364542124|FG001|Overall Study|Adverse Event|2|||
105693629|NCT00375219|364542125|FG002|Overall Study|Adverse Event|1|||
105693630|NCT00375219|364542123|FG000|Overall Study|Protocol Violation|1|||
105693631|NCT00375219|364542124|FG001|Overall Study|Protocol Violation|0|||
105693632|NCT00375219|364542125|FG002|Overall Study|Protocol Violation|1|||
105693633|NCT00375219|364542123|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
105693634|NCT00375219|364542124|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
105693635|NCT00375219|364542125|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
105693636|NCT00375219|364542123|FG000|Overall Study|Lost to Follow-up|1|||
105693637|NCT00375219|364542124|FG001|Overall Study|Lost to Follow-up|1|||
105693638|NCT00375219|364542125|FG002|Overall Study|Lost to Follow-up|0|||
105693639|NCT00375219|364542123|FG000|Overall Study|Disease progression|18|||
105693640|NCT00375219|364542124|FG001|Overall Study|Disease progression|9|||
105693641|NCT00375219|364542125|FG002|Overall Study|Disease progression|12|||
105693642|NCT00375219|364542123|FG000|Overall Study|Death|4|||
105693643|NCT00375219|364542124|FG001|Overall Study|Death|3|||
105693644|NCT00375219|364542125|FG002|Overall Study|Death|7|||
105693645|NCT00375219|364542123|FG000|Overall Study|Hematologic resistance|1|||
105693646|NCT00375219|364542124|FG001|Overall Study|Hematologic resistance|0|||
105693647|NCT00375219|364542125|FG002|Overall Study|Hematologic resistance|0|||
105693648|NCT00375219|364542123|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
105693649|NCT00375219|364542124|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
105693650|NCT00375219|364542125|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
105693651|NCT00375219|364542123|FG000|Overall Study|Allograft|2|||
105693652|NCT00375219|364542124|FG001|Overall Study|Allograft|0|||
105693653|NCT00375219|364542125|FG002|Overall Study|Allograft|0|||
105693654|NCT00375219|364542123|FG000|Overall Study|Cord blood transplantation|1|||
105693655|NCT00375219|364542124|FG001|Overall Study|Cord blood transplantation|0|||
105693656|NCT00375219|364542125|FG002|Overall Study|Cord blood transplantation|0|||
105693657|NCT00375219|364542123|FG000|Overall Study|Withdrawal by Subject|1|||
105693658|NCT00375219|364542124|FG001|Overall Study|Withdrawal by Subject|0|||
105693659|NCT00375219|364542125|FG002|Overall Study|Withdrawal by Subject|0|||
105693660|NCT01252810|364542128|FG000|Overall Study|Withdrawal by Subject|4|||
105693661|NCT01252810|364542129|FG001|Overall Study|Withdrawal by Subject|1|||
105693662|NCT01252810|364542128|FG000|Overall Study|Lost to Follow-up|0|||
105693663|NCT01252810|364542129|FG001|Overall Study|Lost to Follow-up|1|||
105693664|NCT01252810|364542128|FG000|Overall Study|Physician Decision|2|||
105693665|NCT01252810|364542129|FG001|Overall Study|Physician Decision|1|||
105693666|NCT01252810|364542128|FG000|Overall Study|Various reasons|8|||
105693667|NCT01252810|364542129|FG001|Overall Study|Various reasons|0|||
105693668|NCT01162239|364542133|FG000|Treatment Phase|Withdrawal by Subject|1|||
105693669|NCT01162239|364542134|FG001|Treatment Phase|Withdrawal by Subject|3|||
105693670|NCT01162239|364542135|FG002|Treatment Phase|Withdrawal by Subject|2|||
105693671|NCT01162239|364542136|FG003|Treatment Phase|Withdrawal by Subject|3|||
105693672|NCT01162239|364542133|FG000|Treatment Phase|Death|0|||
105693673|NCT01162239|364542134|FG001|Treatment Phase|Death|0|||
105472942|NCT03037580|363743569|FG001|Overall Study|Withdrawal by Subject|0|||
105472943|NCT03037580|363743568|FG000|Overall Study|Adverse Event|1|||
105472944|NCT03037580|363743569|FG001|Overall Study|Adverse Event|0|||
105472945|NCT03037580|363743568|FG000|Overall Study|Study Terminated by Sponsor|12|||
105472946|NCT03037580|363743569|FG001|Overall Study|Study Terminated by Sponsor|15|||
105472947|NCT03037580|363743568|FG000|Overall Study|Death|0|||
105472948|NCT03037580|363743569|FG001|Overall Study|Death|1|||
105472949|NCT02442804|363743570|FG000|Overall Study|Withdrawal by Subject|0|||
105472950|NCT02442804|363743571|FG001|Overall Study|Withdrawal by Subject|1|||
105472951|NCT02442804|363743570|FG000|Overall Study|Adverse Event|1|||
105472952|NCT02442804|363743571|FG001|Overall Study|Adverse Event|0|||
105472953|NCT02036853|363743572|FG000|Overall Study|Adverse Event|0|||
105472954|NCT02036853|363743573|FG001|Overall Study|Adverse Event|2|||
105472955|NCT02036853|363743572|FG000|Overall Study|Lack of Efficacy|0|||
105472956|NCT02036853|363743573|FG001|Overall Study|Lack of Efficacy|2|||
105472957|NCT02036853|363743572|FG000|Overall Study|Physician Decision|0|||
105472958|NCT02036853|363743573|FG001|Overall Study|Physician Decision|1|||
105472959|NCT02036853|363743572|FG000|Overall Study|Withdrawal by Subject|0|||
105472960|NCT02036853|363743573|FG001|Overall Study|Withdrawal by Subject|1|||
105693674|NCT01162239|364542135|FG002|Treatment Phase|Death|0|||
105472961|NCT00101452|363743578|FG000|Overall Study|Adverse Event|2|||
105472962|NCT00101452|363743579|FG001|Overall Study|Adverse Event|0|||
105472963|NCT00101452|363743580|FG002|Overall Study|Adverse Event|1|||
105472964|NCT00101452|363743578|FG000|Overall Study|Lost to Follow-up|13|||
105472965|NCT00101452|363743579|FG001|Overall Study|Lost to Follow-up|8|||
105472966|NCT00101452|363743580|FG002|Overall Study|Lost to Follow-up|14|||
105472967|NCT00101452|363743578|FG000|Overall Study|Withdrawal by Subject|10|||
105472968|NCT00101452|363743579|FG001|Overall Study|Withdrawal by Subject|14|||
105472969|NCT00101452|363743580|FG002|Overall Study|Withdrawal by Subject|9|||
105472970|NCT00101452|363743578|FG000|Overall Study|Baseline Fail|2|||
105472971|NCT00101452|363743579|FG001|Overall Study|Baseline Fail|1|||
105472972|NCT00101452|363743580|FG002|Overall Study|Baseline Fail|2|||
105472973|NCT00101452|363743578|FG000|Overall Study|Physician Decision|0|||
105472974|NCT00101452|363743579|FG001|Overall Study|Physician Decision|3|||
105472975|NCT00101452|363743580|FG002|Overall Study|Physician Decision|2|||
105472976|NCT00101452|363743578|FG000|Overall Study|Protocol Violation|2|||
105472977|NCT00101452|363743579|FG001|Overall Study|Protocol Violation|1|||
105472978|NCT00101452|363743580|FG002|Overall Study|Protocol Violation|3|||
105472979|NCT00101452|363743578|FG000|Overall Study|Other|15|||
105472980|NCT00101452|363743579|FG001|Overall Study|Other|16|||
105472981|NCT00101452|363743580|FG002|Overall Study|Other|12|||
105472982|NCT02633020|363743581|FG000|Overall Study|Adverse Event|1|||
105472983|NCT02633020|363743582|FG001|Overall Study|Adverse Event|0|||
105472984|NCT01057589|363743583|FG000|Overall Study|Disease Progression|35|||
105472985|NCT01057589|363743583|FG000|Overall Study|Adverse Event|10|||
105693675|NCT01162239|364542136|FG003|Treatment Phase|Death|1|||
105693676|NCT01162239|364542133|FG000|Treatment Phase|Lost to Follow-up|5|||
105693677|NCT01162239|364542134|FG001|Treatment Phase|Lost to Follow-up|4|||
105693678|NCT01162239|364542135|FG002|Treatment Phase|Lost to Follow-up|2|||
105693679|NCT01162239|364542136|FG003|Treatment Phase|Lost to Follow-up|1|||
105693680|NCT01162239|364542133|FG000|Extended Follow-up|Lost to Follow-up|8|||
105693681|NCT01162239|364542134|FG001|Extended Follow-up|Lost to Follow-up|13|||
105693682|NCT01162239|364542135|FG002|Extended Follow-up|Lost to Follow-up|8|||
105693683|NCT01162239|364542136|FG003|Extended Follow-up|Lost to Follow-up|6|||
105693684|NCT00228566|364542137|FG000|Overall Study|Adverse Event|31|||
105693685|NCT00228566|364542137|FG000|Overall Study|Lack of Efficacy|14|||
105693686|NCT00228566|364542137|FG000|Overall Study|Lost to Follow-up|16|||
105693687|NCT00228566|364542137|FG000|Overall Study|Physician Decision|5|||
105693688|NCT00228566|364542137|FG000|Overall Study|Withdrawal by Subject|4|||
105693689|NCT00228566|364542137|FG000|Overall Study|Miscellaneous|1|||
105693690|NCT03431350|364542140|FG000|Overall Study|ONGOING|0|||
105693691|NCT03431350|364542141|FG001|Overall Study|ONGOING|0|||
105693692|NCT03431350|364542142|FG002|Overall Study|ONGOING|2|||
105693693|NCT03431350|364542143|FG003|Overall Study|ONGOING|0|||
105693694|NCT03431350|364542144|FG004|Overall Study|ONGOING|1|||
105693695|NCT03431350|364542145|FG005|Overall Study|ONGOING|3|||
105693696|NCT03431350|364542146|FG006|Overall Study|ONGOING|0|||
105693697|NCT03431350|364542147|FG007|Overall Study|ONGOING|1|||
105472986|NCT01057589|363743583|FG000|Overall Study|Physician Decision|8|||
105472987|NCT01057589|363743583|FG000|Overall Study|Withdrawal by Subject|3|||
105472988|NCT01057589|363743583|FG000|Overall Study|Sponsor Decision|1|||
105472989|NCT01057589|363743583|FG000|Overall Study|Death|8|||
105472990|NCT01057589|363743583|FG000|Overall Study|Lost to Follow-up|1|||
105472991|NCT02252939|363743584|FG000|Overall Study|Lost to Follow-up|3|||
105472992|NCT00661427|363743592|FG000|Overall Study|Adverse Event|5|||
105472993|NCT00661427|363743593|FG001|Overall Study|Adverse Event|5|||
105472994|NCT00661427|363743592|FG000|Overall Study|Patient not treated|0|||
105472995|NCT00661427|363743593|FG001|Overall Study|Patient not treated|2|||
105472996|NCT01821560|363743594|FG000|Overall Study|Lost to Follow-up|5|||
105693698|NCT03431350|364542148|FG008|Overall Study|ONGOING|3|||
105693699|NCT03431350|364542149|FG009|Overall Study|ONGOING|4|||
105693700|NCT03431350|364542150|FG010|Overall Study|ONGOING|2|||
105693701|NCT03431350|364542151|FG011|Overall Study|ONGOING|1|||
105693702|NCT03431350|364542140|FG000|Overall Study|Death|6|||
105693703|NCT03431350|364542141|FG001|Overall Study|Death|5|||
105693704|NCT03431350|364542142|FG002|Overall Study|Death|18|||
105693705|NCT03431350|364542143|FG003|Overall Study|Death|7|||
105693706|NCT03431350|364542144|FG004|Overall Study|Death|4|||
105693707|NCT03431350|364542145|FG005|Overall Study|Death|3|||
105693708|NCT03431350|364542146|FG006|Overall Study|Death|2|||
105693709|NCT03431350|364542147|FG007|Overall Study|Death|0|||
105693710|NCT03431350|364542148|FG008|Overall Study|Death|0|||
105693711|NCT03431350|364542149|FG009|Overall Study|Death|0|||
105693712|NCT03431350|364542150|FG010|Overall Study|Death|4|||
105693713|NCT03431350|364542151|FG011|Overall Study|Death|0|||
105693714|NCT03431350|364542140|FG000|Overall Study|Lost to Follow-up|0|||
105693715|NCT03431350|364542141|FG001|Overall Study|Lost to Follow-up|1|||
105693716|NCT03431350|364542142|FG002|Overall Study|Lost to Follow-up|0|||
105693717|NCT03431350|364542143|FG003|Overall Study|Lost to Follow-up|0|||
105693718|NCT03431350|364542144|FG004|Overall Study|Lost to Follow-up|0|||
105693719|NCT03431350|364542145|FG005|Overall Study|Lost to Follow-up|0|||
105693720|NCT03431350|364542146|FG006|Overall Study|Lost to Follow-up|0|||
105693721|NCT03431350|364542147|FG007|Overall Study|Lost to Follow-up|0|||
105693722|NCT03431350|364542148|FG008|Overall Study|Lost to Follow-up|0|||
105693723|NCT03431350|364542149|FG009|Overall Study|Lost to Follow-up|0|||
105693724|NCT03431350|364542150|FG010|Overall Study|Lost to Follow-up|0|||
105693725|NCT03431350|364542151|FG011|Overall Study|Lost to Follow-up|0|||
105693726|NCT03431350|364542140|FG000|Overall Study|Withdrawal by Subject|0|||
105693727|NCT03431350|364542141|FG001|Overall Study|Withdrawal by Subject|0|||
105693728|NCT03431350|364542142|FG002|Overall Study|Withdrawal by Subject|0|||
105693729|NCT03431350|364542143|FG003|Overall Study|Withdrawal by Subject|1|||
105693730|NCT03431350|364542144|FG004|Overall Study|Withdrawal by Subject|1|||
105693731|NCT03431350|364542145|FG005|Overall Study|Withdrawal by Subject|1|||
105693732|NCT03431350|364542146|FG006|Overall Study|Withdrawal by Subject|0|||
105693733|NCT03431350|364542147|FG007|Overall Study|Withdrawal by Subject|0|||
105693734|NCT03431350|364542148|FG008|Overall Study|Withdrawal by Subject|0|||
105693735|NCT03431350|364542149|FG009|Overall Study|Withdrawal by Subject|2|||
105693736|NCT03431350|364542150|FG010|Overall Study|Withdrawal by Subject|0|||
105693737|NCT03431350|364542151|FG011|Overall Study|Withdrawal by Subject|1|||
105693738|NCT03431350|364542140|FG000|Overall Study|Other|0|||
105693739|NCT03431350|364542141|FG001|Overall Study|Other|0|||
105693740|NCT03431350|364542142|FG002|Overall Study|Other|1|||
105693741|NCT03431350|364542143|FG003|Overall Study|Other|3|||
105693742|NCT03431350|364542144|FG004|Overall Study|Other|2|||
105693743|NCT03431350|364542145|FG005|Overall Study|Other|2|||
105693744|NCT03431350|364542146|FG006|Overall Study|Other|4|||
105693745|NCT03431350|364542147|FG007|Overall Study|Other|0|||
105693746|NCT03431350|364542148|FG008|Overall Study|Other|14|||
105693747|NCT03431350|364542149|FG009|Overall Study|Other|11|||
105693748|NCT03431350|364542150|FG010|Overall Study|Other|11|||
105693749|NCT03431350|364542151|FG011|Overall Study|Other|15|||
105693750|NCT00583024|364542152|FG000|Overall Study|Lost to Follow-up|4|||
105693751|NCT00088907|364543445|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
105693752|NCT00088907|364543446|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
105693753|NCT00088907|364543445|FG000|Randomized Study (Step 1)|Adverse Event|14|||
105693754|NCT00088907|364543446|FG001|Randomized Study (Step 1)|Adverse Event|19|||
105693755|NCT00088907|364543445|FG000|Randomized Study (Step 1)|Death|11|||
105693756|NCT00088907|364543446|FG001|Randomized Study (Step 1)|Death|12|||
105693757|NCT00088907|364543445|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
105693758|NCT00088907|364543446|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
105693759|NCT00088907|364543445|FG000|Randomized Study (Step 1)|complicating disease|3|||
105693760|NCT00088907|364543446|FG001|Randomized Study (Step 1)|complicating disease|1|||
105693761|NCT00088907|364543445|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
105693762|NCT00088907|364543446|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
105693763|NCT00088907|364543445|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
105693764|NCT00088907|364543446|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
105693765|NCT00088907|364543445|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
105693766|NCT00088907|364543446|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
105693767|NCT00088907|364543445|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
105693768|NCT00088907|364543446|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
105693769|NCT00088907|364543445|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
105693770|NCT00088907|364543446|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
105693771|NCT00088907|364543445|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
105693772|NCT00088907|364543446|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
105693773|NCT03426787|364543447|FG000|Overall Study|Withdrawal by Subject|6|||
105693774|NCT03426787|364543447|FG000|Overall Study|Lost to Follow-up|7|||
105693775|NCT03426787|364543447|FG000|Overall Study|Unrelated to intervention death|1|||
105693776|NCT00928564|364543453|FG000|Overall Study|Lost to Follow-up|6|||
105693777|NCT00928564|364543454|FG001|Overall Study|Lost to Follow-up|0|||
105693778|NCT02973425|364543455|FG000|Overall Study|Lost to Follow-up|49|||
105693779|NCT02973425|364543456|FG001|Overall Study|Lost to Follow-up|53|||
105693780|NCT02460497|364543459|FG000|Overall Study|Participant Requested Withdrawal|4|||
105693781|NCT02460497|364543459|FG000|Overall Study|Non-Compliance|1|||
105693782|NCT02460497|364543459|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
105693783|NCT02460497|364543459|FG000|Overall Study|Lost to Follow-up|2|||
105693784|NCT02460497|364543459|FG000|Overall Study|Investigator Decision|1|||
105693785|NCT01448213|364543462|FG000|Overall Study|Lost to Follow-up|12|||
105693786|NCT01448213|364543463|FG001|Overall Study|Lost to Follow-up|10|||
105693787|NCT01448213|364543462|FG000|Overall Study|Adverse Event|4|||
105693788|NCT01448213|364543463|FG001|Overall Study|Adverse Event|10|||
105693789|NCT01448213|364543462|FG000|Overall Study|Protocol Violation|1|||
105693790|NCT01448213|364543463|FG001|Overall Study|Protocol Violation|2|||
105693791|NCT03876171|364543464|FG000|Overall Study|Withdrawal by Subject|3|||
105693792|NCT03876171|364543465|FG001|Overall Study|Withdrawal by Subject|3|||
105693793|NCT03876171|364543464|FG000|Overall Study|Re-arrest|0|||
105693794|NCT03876171|364543465|FG001|Overall Study|Re-arrest|4|||
105693795|NCT02012296|364543466|FG000|Overall Study|Lack of Efficacy|0|||
105693796|NCT02012296|364543467|FG001|Overall Study|Lack of Efficacy|0|||
105693797|NCT02012296|364543468|FG002|Overall Study|Lack of Efficacy|15|||
105693798|NCT02012296|364543466|FG000|Overall Study|Adverse Event|0|||
105693799|NCT02012296|364543467|FG001|Overall Study|Adverse Event|0|||
105693800|NCT02012296|364543468|FG002|Overall Study|Adverse Event|2|||
105693801|NCT02012296|364543466|FG000|Overall Study|Early study closure|0|||
105693802|NCT02012296|364543467|FG001|Overall Study|Early study closure|0|||
105693803|NCT02012296|364543468|FG002|Overall Study|Early study closure|5|||
105693804|NCT02012296|364543466|FG000|Overall Study|Protocol Violation|0|||
105693805|NCT02012296|364543467|FG001|Overall Study|Protocol Violation|1|||
105693806|NCT02012296|364543468|FG002|Overall Study|Protocol Violation|0|||
105693807|NCT03739762|364543469|FG000|Overall Study|Lost to Follow-up|1|||
105693808|NCT03739762|364543470|FG001|Overall Study|Lost to Follow-up|1|||
105693809|NCT03739762|364543469|FG000|Overall Study|Withdrawal by Subject|2|||
105693810|NCT03739762|364543470|FG001|Overall Study|Withdrawal by Subject|6|||
105693811|NCT04163900|364543477|FG000|Overall Study|Radiological disease progression|112|||
105693812|NCT04163900|364543478|FG001|Overall Study|Radiological disease progression|127|||
105693813|NCT04163900|364543477|FG000|Overall Study|Study closure|98|||
105693814|NCT04163900|364543478|FG001|Overall Study|Study closure|133|||
105693815|NCT04163900|364543477|FG000|Overall Study|Adverse Event|78|||
105693816|NCT04163900|364543478|FG001|Overall Study|Adverse Event|32|||
105693817|NCT04163900|364543477|FG000|Overall Study|Withdrawal by Subject|37|||
105693818|NCT04163900|364543478|FG001|Overall Study|Withdrawal by Subject|34|||
105693819|NCT04163900|364543477|FG000|Overall Study|Death|29|||
105693820|NCT04163900|364543478|FG001|Overall Study|Death|16|||
105693821|NCT04163900|364543477|FG000|Overall Study|Physician Decision|17|||
105693822|NCT04163900|364543478|FG001|Overall Study|Physician Decision|25|||
105693823|NCT04163900|364543477|FG000|Overall Study|Clinical disease progression|14|||
105693824|NCT04163900|364543478|FG001|Overall Study|Clinical disease progression|13|||
105693825|NCT04163900|364543477|FG000|Overall Study|Protocol Violation|3|||
105693826|NCT04163900|364543478|FG001|Overall Study|Protocol Violation|4|||
105693827|NCT04163900|364543477|FG000|Overall Study|Lost to Follow-up|0|||
105693828|NCT04163900|364543478|FG001|Overall Study|Lost to Follow-up|1|||
105693829|NCT00283049|364543479|FG000|Overall Study|Adverse Event|6|||
105693830|NCT00283049|364543480|FG001|Overall Study|Adverse Event|1|||
105693831|NCT00283049|364543481|FG002|Overall Study|Adverse Event|4|||
105693832|NCT00283049|364543479|FG000|Overall Study|Protocol Violation|3|||
105693833|NCT00283049|364543480|FG001|Overall Study|Protocol Violation|0|||
105693834|NCT00283049|364543481|FG002|Overall Study|Protocol Violation|3|||
105693835|NCT00283049|364543479|FG000|Overall Study|Death|1|||
105693836|NCT00283049|364543480|FG001|Overall Study|Death|1|||
105693837|NCT00283049|364543481|FG002|Overall Study|Death|1|||
105693838|NCT00283049|364543479|FG000|Overall Study|Lack of Efficacy|0|||
105693839|NCT00283049|364543480|FG001|Overall Study|Lack of Efficacy|1|||
105693840|NCT00283049|364543481|FG002|Overall Study|Lack of Efficacy|1|||
105693841|NCT00283049|364543479|FG000|Overall Study|Lost to Follow-up|4|||
105693842|NCT00283049|364543480|FG001|Overall Study|Lost to Follow-up|2|||
105693843|NCT00283049|364543481|FG002|Overall Study|Lost to Follow-up|5|||
105693844|NCT00283049|364543479|FG000|Overall Study|Withdrawal by Subject|26|||
105693845|NCT00283049|364543480|FG001|Overall Study|Withdrawal by Subject|24|||
105693846|NCT00283049|364543481|FG002|Overall Study|Withdrawal by Subject|19|||
105693847|NCT00283049|364543479|FG000|Overall Study|Discontinuation of Study|18|||
105693848|NCT00283049|364543480|FG001|Overall Study|Discontinuation of Study|16|||
105693849|NCT00283049|364543481|FG002|Overall Study|Discontinuation of Study|20|||
105693850|NCT00283049|364543479|FG000|Overall Study|No longer requires study treatment|0|||
105693851|NCT00283049|364543480|FG001|Overall Study|No longer requires study treatment|0|||
105693852|NCT00283049|364543481|FG002|Overall Study|No longer requires study treatment|1|||
105693853|NCT01873417|364543482|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
105693854|NCT01873417|364543482|FG000|Overall Study|Adverse Event|24|||
105693855|NCT01873417|364543482|FG000|Overall Study|Lost to Follow-up|2|||
105693856|NCT01873417|364543482|FG000|Overall Study|Withdrawal by Subject|2|||
105472997|NCT01821560|363743595|FG001|Overall Study|Lost to Follow-up|5|||
105472998|NCT01821560|363743594|FG000|Overall Study|Withdrawal by Subject|1|||
105472999|NCT01821560|363743595|FG001|Overall Study|Withdrawal by Subject|1|||
105473000|NCT01821560|363743594|FG000|Overall Study|Protocol Violation|0|||
105473001|NCT01821560|363743595|FG001|Overall Study|Protocol Violation|1|||
105473002|NCT00531427|363743598|FG000|Overall Study|Withdrawal by Subject|7|||
105473003|NCT00531427|363743599|FG001|Overall Study|Withdrawal by Subject|13|||
105473004|NCT00531427|363743598|FG000|Overall Study|Adverse Event|44|||
105473005|NCT00531427|363743599|FG001|Overall Study|Adverse Event|30|||
105473006|NCT00531427|363743598|FG000|Overall Study|Lost to Follow-up|4|||
105473007|NCT00531427|363743599|FG001|Overall Study|Lost to Follow-up|3|||
105473008|NCT00531427|363743598|FG000|Overall Study|Lack of Efficacy|14|||
105473009|NCT00531427|363743599|FG001|Overall Study|Lack of Efficacy|39|||
105473010|NCT00531427|363743598|FG000|Overall Study|Administrative|4|||
105473011|NCT00531427|363743599|FG001|Overall Study|Administrative|9|||
105473012|NCT01287741|363743603|FG000|Overall Study|Withdrawal by Subject|35|||
105473013|NCT01287741|363743604|FG001|Overall Study|Withdrawal by Subject|38|||
105473014|NCT01287741|363743603|FG000|Overall Study|Protocol Violation|2|||
105473015|NCT01287741|363743604|FG001|Overall Study|Protocol Violation|0|||
105473016|NCT01287741|363743603|FG000|Overall Study|Physician Decision|15|||
105693857|NCT01873417|364543482|FG000|Overall Study|Physician Decision|3|||
105693858|NCT00785044|364543483|FG000|Overall Study|Dosed at non-participating sites|152|||
105693859|NCT00785044|364543483|FG000|Overall Study|Death|77|||
105693860|NCT00785044|364543483|FG000|Overall Study|Lost to Follow-up|266|||
105693861|NCT00785044|364543483|FG000|Overall Study|Withdrawal by Subject|1|||
105693862|NCT01798992|364543485|FG000|Overall Study|Administrative withdrawal|0|||
105693863|NCT01798992|364543486|FG001|Overall Study|Administrative withdrawal|1|||
105693864|NCT01798992|364543487|FG002|Overall Study|Administrative withdrawal|0|||
105693865|NCT01798992|364543488|FG003|Overall Study|Administrative withdrawal|1|||
105693866|NCT01798992|364543485|FG000|Overall Study|Lost to Follow-up|0|||
105693867|NCT01798992|364543486|FG001|Overall Study|Lost to Follow-up|1|||
105693868|NCT01798992|364543487|FG002|Overall Study|Lost to Follow-up|1|||
105693869|NCT01798992|364543488|FG003|Overall Study|Lost to Follow-up|0|||
105693870|NCT01798992|364543485|FG000|Overall Study|Insufficient biopsy tissue|0|||
105693871|NCT01798992|364543486|FG001|Overall Study|Insufficient biopsy tissue|0|||
105693872|NCT01798992|364543487|FG002|Overall Study|Insufficient biopsy tissue|1|||
105693873|NCT01798992|364543488|FG003|Overall Study|Insufficient biopsy tissue|0|||
105693874|NCT03422172|364543489|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
105693875|NCT03422172|364543489|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
105693876|NCT03422172|364543489|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
105693877|NCT01446016|364543498|FG000|Overall Study|Lost to Follow-up|3|||
105693878|NCT01446016|364543498|FG000|Overall Study|Withdrawal by Subject|1|||
105693879|NCT01446016|364543498|FG000|Overall Study|Toxicity|3|||
105693880|NCT01087957|364543499|FG000|Overall Study|Death|2|||
105693881|NCT01087957|364543500|FG001|Overall Study|Death|2|||
105473017|NCT01287741|363743604|FG001|Overall Study|Physician Decision|23|||
105473018|NCT01287741|363743603|FG000|Overall Study|Non-compliance|8|||
105473019|NCT01287741|363743604|FG001|Overall Study|Non-compliance|6|||
105693882|NCT01087957|364543499|FG000|Overall Study|Lost to Follow-up|3|||
105693883|NCT01087957|364543500|FG001|Overall Study|Lost to Follow-up|4|||
105693884|NCT01087957|364543499|FG000|Overall Study|Protocol Violation|13|||
105693885|NCT01087957|364543500|FG001|Overall Study|Protocol Violation|25|||
105473020|NCT01287741|363743603|FG000|Overall Study|Lost to Follow-up|10|||
105473021|NCT01287741|363743604|FG001|Overall Study|Lost to Follow-up|8|||
105473022|NCT01287741|363743603|FG000|Overall Study|Death|32|||
105693886|NCT01087957|364543499|FG000|Overall Study|Withdrawal by Subject|18|||
105693887|NCT01087957|364543500|FG001|Overall Study|Withdrawal by Subject|15|||
105693888|NCT01087957|364543499|FG000|Overall Study|Physician Decision|5|||
105473023|NCT01287741|363743604|FG001|Overall Study|Death|44|||
105473024|NCT01287741|363743603|FG000|Overall Study|Adverse Event|4|||
105473025|NCT01287741|363743604|FG001|Overall Study|Adverse Event|6|||
105559189|NCT04393441|364044605|FG001|Overall Study|Withdrawal by Subject|7|||
105559190|NCT04393441|364044604|FG000|Overall Study|Lost to Follow-up|0|||
105559191|NCT04393441|364044605|FG001|Overall Study|Lost to Follow-up|2|||
105693889|NCT01087957|364543500|FG001|Overall Study|Physician Decision|9|||
105693890|NCT01509079|364543501|FG000|Overall Study|Lack of Efficacy|0|||
105473026|NCT01287741|363743603|FG000|Overall Study|Study terminated by Sponsor|307|||
105473027|NCT01287741|363743604|FG001|Overall Study|Study terminated by Sponsor|315|||
105473028|NCT01287741|363743603|FG000|Overall Study|Progressive disease|190|||
105473029|NCT01287741|363743604|FG001|Overall Study|Progressive disease|166|||
105559192|NCT04393441|364044604|FG000|Overall Study|Protocol Deviation|2|||
105473030|NCT01287741|363743603|FG000|Overall Study|Reason not specified|23|||
105693891|NCT01509079|364543502|FG001|Overall Study|Lack of Efficacy|2|||
105693892|NCT01509079|364543501|FG000|Overall Study|started an excluded medication|0|||
105693893|NCT01509079|364543502|FG001|Overall Study|started an excluded medication|1|||
105693894|NCT01423812|364543505|FG000|Overall Study|Lost to Follow-up|2|||
105693895|NCT01423812|364543506|FG001|Overall Study|Lost to Follow-up|2|||
105693896|NCT01423812|364543505|FG000|Overall Study|Withdrawal by Subject|1|||
105693897|NCT01423812|364543506|FG001|Overall Study|Withdrawal by Subject|2|||
105693898|NCT01970488|364543507|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
105693899|NCT01970488|364543508|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
105693900|NCT01970488|364543509|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
105693901|NCT01970488|364543510|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
105693902|NCT01970488|364543511|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
105693903|NCT01970488|364543507|FG000|Part 1: Through Week 16|Protocol Violation|1|||
105693904|NCT01970488|364543508|FG001|Part 1: Through Week 16|Protocol Violation|2|||
105693905|NCT01970488|364543509|FG002|Part 1: Through Week 16|Protocol Violation|0|||
105693906|NCT01970488|364543510|FG003|Part 1: Through Week 16|Protocol Violation|0|||
105693907|NCT01970488|364543511|FG004|Part 1: Through Week 16|Protocol Violation|0|||
105693908|NCT01970488|364543507|FG000|Part 1: Through Week 16|Adverse Event|6|||
105693909|NCT01970488|364543508|FG001|Part 1: Through Week 16|Adverse Event|5|||
105693910|NCT01970488|364543509|FG002|Part 1: Through Week 16|Adverse Event|0|||
105693911|NCT01970488|364543510|FG003|Part 1: Through Week 16|Adverse Event|0|||
105693912|NCT01970488|364543511|FG004|Part 1: Through Week 16|Adverse Event|0|||
105693913|NCT01970488|364543507|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
105693914|NCT01970488|364543508|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
105693915|NCT01970488|364543509|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
105693916|NCT01970488|364543510|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
105693917|NCT01970488|364543511|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
105693918|NCT01970488|364543507|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
105693919|NCT01970488|364543508|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
105693920|NCT01970488|364543509|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
105693921|NCT01970488|364543510|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
105693922|NCT01970488|364543511|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
105693923|NCT01970488|364543507|FG000|Part 2: Post Week 16|Physician Decision|0|||
105693924|NCT01970488|364543508|FG001|Part 2: Post Week 16|Physician Decision|0|||
105693925|NCT01970488|364543509|FG002|Part 2: Post Week 16|Physician Decision|0|||
105693926|NCT01970488|364543510|FG003|Part 2: Post Week 16|Physician Decision|0|||
105693927|NCT01970488|364543511|FG004|Part 2: Post Week 16|Physician Decision|1|||
105693928|NCT01970488|364543507|FG000|Part 2: Post Week 16|Non-compliance|0|||
105693929|NCT01970488|364543508|FG001|Part 2: Post Week 16|Non-compliance|0|||
105693930|NCT01970488|364543509|FG002|Part 2: Post Week 16|Non-compliance|1|||
105693931|NCT01970488|364543510|FG003|Part 2: Post Week 16|Non-compliance|0|||
105693932|NCT01970488|364543511|FG004|Part 2: Post Week 16|Non-compliance|0|||
105693933|NCT01970488|364543507|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
105693934|NCT01970488|364543508|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
105693935|NCT01970488|364543509|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
105693936|NCT01970488|364543510|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
105693937|NCT01970488|364543511|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
105693938|NCT01970488|364543507|FG000|Part 2: Post Week 16|Adverse Event|0|||
105693939|NCT01970488|364543508|FG001|Part 2: Post Week 16|Adverse Event|0|||
105473031|NCT01287741|363743604|FG001|Overall Study|Reason not specified|9|||
105347634|NCT01472939|363275288|FG001|Overall Study|Prohibited Medication|1|||
105347635|NCT01472939|363275289|FG002|Overall Study|Prohibited Medication|0|||
105347636|NCT01472939|363275290|FG003|Overall Study|Prohibited Medication|0|||
105347637|NCT01472939|363275287|FG000|Overall Study|Withdrawal By PI|1|||
105347638|NCT01472939|363275288|FG001|Overall Study|Withdrawal By PI|0|||
105347639|NCT01472939|363275289|FG002|Overall Study|Withdrawal By PI|0|||
105347640|NCT01472939|363275290|FG003|Overall Study|Withdrawal By PI|0|||
105347641|NCT01472939|363275287|FG000|Overall Study|Protocol Violation|3|||
105559193|NCT04393441|364044605|FG001|Overall Study|Protocol Deviation|1|||
105559194|NCT04393441|364044604|FG000|Overall Study|Reason not Specified|1|||
105559195|NCT04393441|364044605|FG001|Overall Study|Reason not Specified|1|||
105693940|NCT01970488|364543509|FG002|Part 2: Post Week 16|Adverse Event|5|||
105693941|NCT01970488|364543510|FG003|Part 2: Post Week 16|Adverse Event|1|||
105693942|NCT01970488|364543511|FG004|Part 2: Post Week 16|Adverse Event|1|||
105693943|NCT01970488|364543507|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
105693944|NCT01970488|364543508|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
105693945|NCT01970488|364543509|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
105693946|NCT01970488|364543510|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
105693947|NCT01970488|364543511|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
105693948|NCT01970488|364543507|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
105693949|NCT01970488|364543508|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
105693950|NCT01970488|364543509|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
105693951|NCT01970488|364543510|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
105693952|NCT01970488|364543511|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
105693953|NCT03974334|364543512|FG000|Overall Study|Lost to Follow-up|1|||
105693954|NCT00239226|364543513|FG000|Overall Study|permAF during stabilization period|0|||
105347642|NCT01472939|363275288|FG001|Overall Study|Protocol Violation|3|||
105347643|NCT01472939|363275289|FG002|Overall Study|Protocol Violation|0|||
105347644|NCT01472939|363275290|FG003|Overall Study|Protocol Violation|1|||
105693955|NCT00239226|364543514|FG001|Overall Study|permAF during stabilization period|0|||
105693956|NCT00239226|364543515|FG002|Overall Study|permAF during stabilization period|0|||
105693957|NCT00239226|364543516|FG003|Overall Study|permAF during stabilization period|3|||
105693958|NCT00239226|364543513|FG000|Overall Study|Lost to Follow-up|1|||
105693959|NCT00239226|364543514|FG001|Overall Study|Lost to Follow-up|0|||
105693960|NCT00239226|364543515|FG002|Overall Study|Lost to Follow-up|1|||
105693961|NCT00239226|364543516|FG003|Overall Study|Lost to Follow-up|0|||
105693962|NCT01109173|364543518|FG000|Overall Study|Adverse Event|15|||
105693963|NCT01109173|364543519|FG001|Overall Study|Adverse Event|17|||
105693964|NCT01109173|364543520|FG002|Overall Study|Adverse Event|9|||
105693965|NCT01109173|364543521|FG003|Overall Study|Adverse Event|6|||
105347645|NCT01472939|363275287|FG000|Overall Study|Withdrawal by Subject|9|||
105693966|NCT01109173|364543518|FG000|Overall Study|Lost to Follow-up|0|||
105693967|NCT01109173|364543519|FG001|Overall Study|Lost to Follow-up|1|||
105693968|NCT01109173|364543520|FG002|Overall Study|Lost to Follow-up|0|||
105693969|NCT01109173|364543521|FG003|Overall Study|Lost to Follow-up|0|||
105693970|NCT01109173|364543518|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
105693971|NCT01109173|364543519|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
105347646|NCT01472939|363275288|FG001|Overall Study|Withdrawal by Subject|3|||
105347647|NCT01472939|363275289|FG002|Overall Study|Withdrawal by Subject|1|||
105347648|NCT01472939|363275290|FG003|Overall Study|Withdrawal by Subject|4|||
105347649|NCT00114738|363275291|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
105693972|NCT01109173|364543520|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
105693973|NCT01109173|364543521|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
105693974|NCT01109173|364543518|FG000|Overall Study|Noncompliance|0|||
105693975|NCT01109173|364543519|FG001|Overall Study|Noncompliance|1|||
105693976|NCT01109173|364543520|FG002|Overall Study|Noncompliance|0|||
105693977|NCT01109173|364543521|FG003|Overall Study|Noncompliance|0|||
105347650|NCT00114738|363275292|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
105347651|NCT00114738|363275293|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
105347652|NCT00114738|363275291|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
105347653|NCT00114738|363275292|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
105347654|NCT00114738|363275293|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
105347655|NCT00114738|363275291|FG000|Screening for Randomization|Neuropathy|17|||
105347656|NCT00114738|363275292|FG001|Screening for Randomization|Neuropathy|0|||
105347657|NCT00114738|363275293|FG002|Screening for Randomization|Neuropathy|0|||
105347658|NCT00114738|363275291|FG000|Screening for Randomization|Progressive disease|2|||
105347659|NCT00114738|363275292|FG001|Screening for Randomization|Progressive disease|0|||
105347660|NCT00114738|363275293|FG002|Screening for Randomization|Progressive disease|0|||
105347661|NCT00114738|363275291|FG000|Screening for Randomization|CNS Hemorrhage|1|||
105347662|NCT00114738|363275292|FG001|Screening for Randomization|CNS Hemorrhage|0|||
105347663|NCT00114738|363275293|FG002|Screening for Randomization|CNS Hemorrhage|0|||
105347664|NCT00114738|363275291|FG000|Screening for Randomization|Other|1|||
105347665|NCT00114738|363275292|FG001|Screening for Randomization|Other|0|||
105347666|NCT00114738|363275293|FG002|Screening for Randomization|Other|0|||
105347667|NCT00308750|363275294|FG000|Overall Study|Adverse Event|9|||
105347668|NCT00308750|363275295|FG001|Overall Study|Adverse Event|9|||
105347669|NCT00308750|363275296|FG002|Overall Study|Adverse Event|13|||
105347670|NCT00308750|363275294|FG000|Overall Study|Withdrawal by Subject|6|||
105347671|NCT00308750|363275295|FG001|Overall Study|Withdrawal by Subject|2|||
105347672|NCT00308750|363275296|FG002|Overall Study|Withdrawal by Subject|3|||
105347673|NCT00308750|363275294|FG000|Overall Study|Physician Decision|3|||
105347674|NCT00308750|363275295|FG001|Overall Study|Physician Decision|4|||
105347675|NCT00308750|363275296|FG002|Overall Study|Physician Decision|3|||
105347676|NCT00308750|363275294|FG000|Overall Study|Sponsor Decision|1|||
105347677|NCT00308750|363275295|FG001|Overall Study|Sponsor Decision|0|||
105347678|NCT00308750|363275296|FG002|Overall Study|Sponsor Decision|0|||
105347679|NCT00308750|363275294|FG000|Overall Study|Disease Progression|47|||
105347680|NCT00308750|363275295|FG001|Overall Study|Disease Progression|24|||
105347681|NCT00308750|363275296|FG002|Overall Study|Disease Progression|28|||
105347682|NCT00308750|363275294|FG000|Overall Study|Unrelated Complication|3|||
105347683|NCT00308750|363275295|FG001|Overall Study|Unrelated Complication|0|||
105347684|NCT00308750|363275296|FG002|Overall Study|Unrelated Complication|1|||
105347685|NCT00308750|363275294|FG000|Overall Study|Death|1|||
105347686|NCT00308750|363275295|FG001|Overall Study|Death|0|||
105347687|NCT00308750|363275296|FG002|Overall Study|Death|1|||
105347688|NCT00308750|363275294|FG000|Overall Study|Protocol Violation|1|||
105347689|NCT00308750|363275295|FG001|Overall Study|Protocol Violation|0|||
105347690|NCT00308750|363275296|FG002|Overall Study|Protocol Violation|0|||
105347691|NCT00308750|363275294|FG000|Overall Study|New Primary Disease Identified|1|||
105347692|NCT00308750|363275295|FG001|Overall Study|New Primary Disease Identified|1|||
105347693|NCT00308750|363275296|FG002|Overall Study|New Primary Disease Identified|0|||
105347694|NCT00388297|363275297|FG000|Overall Study|Lost to Follow-up|16|||
105347695|NCT00388297|363275298|FG001|Overall Study|Lost to Follow-up|12|||
105347696|NCT00388297|363275299|FG002|Overall Study|Lost to Follow-up|11|||
105347697|NCT00388297|363275300|FG003|Overall Study|Lost to Follow-up|8|||
105347698|NCT03605849|363275301|FG000|Overall Study|Adverse Event|20|||
105347699|NCT03605849|363275302|FG001|Overall Study|Adverse Event|21|||
105347700|NCT03605849|363275303|FG002|Overall Study|Adverse Event|29|||
105347701|NCT03605849|363275304|FG003|Overall Study|Adverse Event|11|||
105347702|NCT03605849|363275301|FG000|Overall Study|Lack of Efficacy|4|||
105347703|NCT03605849|363275302|FG001|Overall Study|Lack of Efficacy|7|||
105347704|NCT03605849|363275303|FG002|Overall Study|Lack of Efficacy|9|||
105347705|NCT03605849|363275304|FG003|Overall Study|Lack of Efficacy|2|||
105347706|NCT03605849|363275301|FG000|Overall Study|Lost to Follow-up|8|||
105693978|NCT01109173|364543518|FG000|Overall Study|Treatment Failure|25|||
105693979|NCT01109173|364543519|FG001|Overall Study|Treatment Failure|32|||
105347707|NCT03605849|363275302|FG001|Overall Study|Lost to Follow-up|8|||
105347708|NCT03605849|363275303|FG002|Overall Study|Lost to Follow-up|14|||
105347709|NCT03605849|363275304|FG003|Overall Study|Lost to Follow-up|11|||
105347710|NCT03605849|363275301|FG000|Overall Study|Non-compliance With IMP|6|||
105347711|NCT03605849|363275302|FG001|Overall Study|Non-compliance With IMP|5|||
105347712|NCT03605849|363275303|FG002|Overall Study|Non-compliance With IMP|2|||
105347713|NCT03605849|363275304|FG003|Overall Study|Non-compliance With IMP|1|||
105347714|NCT03605849|363275301|FG000|Overall Study|Protocol Deviation|1|||
105347715|NCT03605849|363275302|FG001|Overall Study|Protocol Deviation|2|||
105347716|NCT03605849|363275303|FG002|Overall Study|Protocol Deviation|1|||
105347717|NCT03605849|363275304|FG003|Overall Study|Protocol Deviation|3|||
105347718|NCT03605849|363275301|FG000|Overall Study|Withdrawal by Subject|33|||
105347719|NCT03605849|363275302|FG001|Overall Study|Withdrawal by Subject|28|||
105347720|NCT03605849|363275303|FG002|Overall Study|Withdrawal by Subject|30|||
105347721|NCT03605849|363275304|FG003|Overall Study|Withdrawal by Subject|28|||
105347722|NCT03605849|363275301|FG000|Overall Study|Site Terminated by Sponsor|0|||
105347723|NCT03605849|363275302|FG001|Overall Study|Site Terminated by Sponsor|0|||
105347724|NCT03605849|363275303|FG002|Overall Study|Site Terminated by Sponsor|0|||
105347725|NCT03605849|363275304|FG003|Overall Study|Site Terminated by Sponsor|1|||
105347726|NCT03605849|363275301|FG000|Overall Study|Physician Decision|2|||
105347727|NCT03605849|363275302|FG001|Overall Study|Physician Decision|1|||
105347728|NCT03605849|363275303|FG002|Overall Study|Physician Decision|2|||
105347729|NCT03605849|363275304|FG003|Overall Study|Physician Decision|1|||
105347730|NCT03605849|363275301|FG000|Overall Study|Enrolled, but not Treated|2|||
105347731|NCT03605849|363275302|FG001|Overall Study|Enrolled, but not Treated|2|||
105347732|NCT03605849|363275303|FG002|Overall Study|Enrolled, but not Treated|3|||
105347733|NCT03605849|363275304|FG003|Overall Study|Enrolled, but not Treated|2|||
105473032|NCT05307692|363743605|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
105473033|NCT05307692|363743606|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
105473034|NCT05307692|363743607|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
105693980|NCT01109173|364543520|FG002|Overall Study|Treatment Failure|69|||
105693981|NCT01109173|364543521|FG003|Overall Study|Treatment Failure|64|||
105693982|NCT01109173|364543518|FG000|Overall Study|Protocol Violation|4|||
105693983|NCT01109173|364543519|FG001|Overall Study|Protocol Violation|5|||
105693984|NCT01109173|364543520|FG002|Overall Study|Protocol Violation|1|||
105693985|NCT01109173|364543521|FG003|Overall Study|Protocol Violation|2|||
105693986|NCT01109173|364543518|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
105693987|NCT01109173|364543519|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
105693988|NCT01109173|364543520|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
105693989|NCT01109173|364543521|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
105693990|NCT01109173|364543518|FG000|Overall Study|Not Specifiied|5|||
105473035|NCT05307692|363743608|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
105473036|NCT05307692|363743605|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
105473037|NCT05307692|363743606|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
105473038|NCT05307692|363743607|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
105473039|NCT05307692|363743608|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
105473040|NCT05307692|363743605|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
105473041|NCT05307692|363743606|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
105473042|NCT05307692|363743607|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
105473043|NCT05307692|363743608|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
105473044|NCT05307692|363743605|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
105473045|NCT05307692|363743606|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
105473046|NCT05307692|363743607|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
105473047|NCT05307692|363743608|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
105473048|NCT05307692|363743605|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
105473049|NCT05307692|363743606|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
105473050|NCT05307692|363743607|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
105473051|NCT05307692|363743608|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
105693991|NCT01109173|364543519|FG001|Overall Study|Not Specifiied|4|||
105693992|NCT01109173|364543520|FG002|Overall Study|Not Specifiied|9|||
105347734|NCT03605849|363275301|FG000|Overall Study|Other (COVID-19 Related)|0|||
105347735|NCT03605849|363275302|FG001|Overall Study|Other (COVID-19 Related)|1|||
105347736|NCT03605849|363275303|FG002|Overall Study|Other (COVID-19 Related)|1|||
105473052|NCT05307692|363743605|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
105473053|NCT05307692|363743606|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
105473054|NCT05307692|363743607|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
105473055|NCT05307692|363743608|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
105473056|NCT05307692|363743605|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
105473057|NCT05307692|363743606|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
105473058|NCT05307692|363743607|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
105473059|NCT05307692|363743608|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
105473060|NCT05307692|363743605|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
105473061|NCT05307692|363743606|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
105473062|NCT05307692|363743607|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
105473063|NCT05307692|363743608|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
105473064|NCT05148234|363743609|FG000|Phase I|Ineligible|0|||
105473065|NCT05148234|363743610|FG001|Phase I|Ineligible|0|||
105473066|NCT05148234|363743611|FG002|Phase I|Ineligible|0|||
105473067|NCT05148234|363743612|FG003|Phase I|Ineligible|0|||
105473068|NCT05148234|363743613|FG004|Phase I|Ineligible|0|||
105473069|NCT05148234|363743614|FG005|Phase I|Ineligible|0|||
105473070|NCT05148234|363743615|FG006|Phase I|Ineligible|0|||
105473071|NCT05148234|363743616|FG007|Phase I|Ineligible|1|||
105473072|NCT05148234|363743609|FG000|Phase I|Company closed the trial.|0|||
105473073|NCT05148234|363743610|FG001|Phase I|Company closed the trial.|1|||
105473074|NCT05148234|363743611|FG002|Phase I|Company closed the trial.|0|||
105473075|NCT05148234|363743612|FG003|Phase I|Company closed the trial.|0|||
105473076|NCT05148234|363743613|FG004|Phase I|Company closed the trial.|0|||
105473077|NCT05148234|363743614|FG005|Phase I|Company closed the trial.|0|||
105473078|NCT05148234|363743615|FG006|Phase I|Company closed the trial.|0|||
105473079|NCT05148234|363743616|FG007|Phase I|Company closed the trial.|0|||
105473080|NCT02499328|363743619|FG000|Overall Study|Withdrawal by Subject|1|||
105473081|NCT02499328|363743620|FG001|Overall Study|Withdrawal by Subject|1|||
105347737|NCT03605849|363275304|FG003|Overall Study|Other (COVID-19 Related)|0|||
105347738|NCT03605849|363275301|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
105347739|NCT03605849|363275302|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
105347740|NCT03605849|363275303|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
105347741|NCT03605849|363275304|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
105347742|NCT02607280|363275305|FG000|Overall Study|Adverse Event|4|||
105347743|NCT02607280|363275306|FG001|Overall Study|Adverse Event|0|||
105347744|NCT02607280|363275305|FG000|Overall Study|Decrease in CrCl <15|0|||
105347745|NCT02607280|363275306|FG001|Overall Study|Decrease in CrCl <15|1|||
105347746|NCT00328094|363275307|FG000|Overall Study|Physician Decision|3|||
105347747|NCT00328094|363275308|FG001|Overall Study|Physician Decision|3|||
105347748|NCT02667626|363275309|FG000|Overall Study|Withdrawal by Subject|0|||
105347749|NCT02667626|363275310|FG001|Overall Study|Withdrawal by Subject|1|||
105347750|NCT00766467|363275314|FG000|Overall Study|Withdrawal by Subject|7|||
105347751|NCT00766467|363275315|FG001|Overall Study|Withdrawal by Subject|2|||
105347752|NCT00766467|363275314|FG000|Overall Study|Adverse Event|1|||
105347753|NCT00766467|363275315|FG001|Overall Study|Adverse Event|1|||
105347754|NCT00766467|363275314|FG000|Overall Study|Protocol Violation|2|||
105347755|NCT00766467|363275315|FG001|Overall Study|Protocol Violation|4|||
105347756|NCT00766467|363275314|FG000|Overall Study|Tumor Progression on Study|0|||
105347757|NCT00766467|363275315|FG001|Overall Study|Tumor Progression on Study|1|||
105347758|NCT00766467|363275314|FG000|Overall Study|Physician Decision|1|||
105347759|NCT00766467|363275315|FG001|Overall Study|Physician Decision|0|||
105347760|NCT01420679|363275317|FG000|Overall Study|Disease Progression|3|||
105473082|NCT02499328|363743621|FG002|Overall Study|Withdrawal by Subject|5|||
105473083|NCT02499328|363743622|FG003|Overall Study|Withdrawal by Subject|3|||
105473084|NCT02499328|363743623|FG004|Overall Study|Withdrawal by Subject|5|||
105473085|NCT02499328|363743624|FG005|Overall Study|Withdrawal by Subject|0|||
105473086|NCT02499328|363743625|FG006|Overall Study|Withdrawal by Subject|0|||
105473087|NCT02499328|363743626|FG007|Overall Study|Withdrawal by Subject|0|||
105473088|NCT02499328|363743627|FG008|Overall Study|Withdrawal by Subject|2|||
105473089|NCT02499328|363743628|FG009|Overall Study|Withdrawal by Subject|2|||
105473090|NCT02499328|363743629|FG010|Overall Study|Withdrawal by Subject|0|||
105693993|NCT01109173|364543521|FG003|Overall Study|Not Specifiied|14|||
105693994|NCT01132612|364543522|FG000|Overall Study|Death|0|||
105347761|NCT01420679|363275318|FG001|Overall Study|Disease Progression|2|||
105347762|NCT01420679|363275317|FG000|Overall Study|Adverse Event|4|||
105347763|NCT01420679|363275318|FG001|Overall Study|Adverse Event|0|||
105347764|NCT01420679|363275317|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
105347765|NCT01420679|363275318|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
105473091|NCT02499328|363743630|FG011|Overall Study|Withdrawal by Subject|3|||
105473092|NCT02499328|363743631|FG012|Overall Study|Withdrawal by Subject|7|||
105473093|NCT02499328|363743632|FG013|Overall Study|Withdrawal by Subject|3|||
105473094|NCT02499328|363743633|FG014|Overall Study|Withdrawal by Subject|1|||
105473095|NCT02499328|363743634|FG015|Overall Study|Withdrawal by Subject|0|||
105693995|NCT01132612|364543523|FG001|Overall Study|Death|0|||
105693996|NCT01132612|364543524|FG002|Overall Study|Death|1|||
105693997|NCT01132612|364543522|FG000|Overall Study|Protocol deviation|0|||
105693998|NCT01132612|364543523|FG001|Overall Study|Protocol deviation|0|||
105693999|NCT01132612|364543524|FG002|Overall Study|Protocol deviation|3|||
105694000|NCT01132612|364543522|FG000|Overall Study|Lost to Follow-up|2|||
105694001|NCT01132612|364543523|FG001|Overall Study|Lost to Follow-up|2|||
105694002|NCT01132612|364543524|FG002|Overall Study|Lost to Follow-up|7|||
105694003|NCT01132612|364543522|FG000|Overall Study|Adverse Event|5|||
105694004|NCT01132612|364543523|FG001|Overall Study|Adverse Event|2|||
105694005|NCT01132612|364543524|FG002|Overall Study|Adverse Event|15|||
105694006|NCT01132612|364543522|FG000|Overall Study|Withdrawal by Subject|5|||
105473096|NCT02499328|363743635|FG016|Overall Study|Withdrawal by Subject|0|||
105694007|NCT01132612|364543523|FG001|Overall Study|Withdrawal by Subject|8|||
105694008|NCT01132612|364543524|FG002|Overall Study|Withdrawal by Subject|19|||
105347766|NCT01420679|363275317|FG000|Overall Study|Patient Decision|1|||
105473097|NCT02499328|363743636|FG017|Overall Study|Withdrawal by Subject|3|||
105473098|NCT02499328|363743637|FG018|Overall Study|Withdrawal by Subject|0|||
105694009|NCT01132612|364543522|FG000|Overall Study|Administrative problems|5|||
105694010|NCT01132612|364543523|FG001|Overall Study|Administrative problems|1|||
105694011|NCT01132612|364543524|FG002|Overall Study|Administrative problems|52|||
105694012|NCT01132612|364543522|FG000|Overall Study|Lack of Efficacy|23|||
105347767|NCT01420679|363275318|FG001|Overall Study|Patient Decision|0|||
105694013|NCT01132612|364543523|FG001|Overall Study|Lack of Efficacy|22|||
105694014|NCT01132612|364543524|FG002|Overall Study|Lack of Efficacy|73|||
105694015|NCT02252536|364543528|FG000|Overall Study|Lost to Follow-up|5|||
105694016|NCT02252536|364543529|FG001|Overall Study|Lost to Follow-up|3|||
105694017|NCT02459769|364543532|FG000|Overall Study|Withdrawal by Subject|7|||
105694018|NCT02459769|364543533|FG001|Overall Study|Withdrawal by Subject|4|||
105694019|NCT02459769|364543534|FG002|Overall Study|Withdrawal by Subject|8|||
105694020|NCT02459769|364543535|FG003|Overall Study|Withdrawal by Subject|5|||
105694021|NCT02459769|364543532|FG000|Overall Study|Lost to Follow-up|1|||
105694022|NCT02459769|364543533|FG001|Overall Study|Lost to Follow-up|0|||
105694023|NCT02459769|364543534|FG002|Overall Study|Lost to Follow-up|1|||
105694024|NCT02459769|364543535|FG003|Overall Study|Lost to Follow-up|0|||
105694025|NCT00041067|364543541|FG000|Overall Study|Adverse Event|20|||
105694026|NCT00041067|364543541|FG000|Overall Study|Progression|19|||
105694027|NCT00041067|364543541|FG000|Overall Study|Patient refusal|12|||
105694028|NCT00041067|364543541|FG000|Overall Study|Other reasons|23|||
105694029|NCT00041067|364543541|FG000|Overall Study|Ineligible|2|||
105694030|NCT01289821|364543546|FG000|Treatment Period|Withdrawal by Subject|1|||
105694031|NCT01289821|364543546|FG000|Treatment Period|Physician Decision|3|||
105694032|NCT01289821|364543546|FG000|Treatment Period|Adverse Event|4|||
105694033|NCT01289821|364543546|FG000|Treatment Period|Radiological Progression|43|||
105694034|NCT01289821|364543546|FG000|Treatment Period|Clinical Progression|2|||
105694035|NCT01289821|364543546|FG000|Treatment Period|Therapeutic procedure required|1|||
105694036|NCT01289821|364543546|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
105694037|NCT01289821|364543546|FG000|Safety Follow-up Period|Protocol Violation|3|||
105694038|NCT01289821|364543546|FG000|Safety Follow-up Period|Unspecified reason|1|||
105694039|NCT01289821|364543546|FG000|Survival Follow-up Period|Protocol Violation|1|||
105694040|NCT01289821|364543546|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
105694041|NCT01289821|364543546|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
105694042|NCT00773136|364543549|FG000|Overall Study|Physician Decision|2|||
105694043|NCT01514136|364543553|FG000|Test Period 1; Test A|Protocol Violation|1|||
105694044|NCT01514136|364543554|FG001|Test Period 1; Test A|Protocol Violation|0|||
105694045|NCT01514136|364543555|FG002|Test Period 1; Test A|Protocol Violation|0|||
105473099|NCT02499328|363743619|FG000|Overall Study|Lost to Follow-up|0|||
105694046|NCT01514136|364543556|FG003|Test Period 1; Test A|Protocol Violation|0|||
105694047|NCT01514136|364543557|FG004|Test Period 1; Test A|Protocol Violation|0|||
105694048|NCT01514136|364543558|FG005|Test Period 1; Test A|Protocol Violation|0|||
105694049|NCT01514136|364543559|FG006|Test Period 1; Test A|Protocol Violation|0|||
105694050|NCT01514136|364543560|FG007|Test Period 1; Test A|Protocol Violation|0|||
105694051|NCT01514136|364543553|FG000|Test Period 1; Test A|Break from study holiday|2|||
105694052|NCT01514136|364543554|FG001|Test Period 1; Test A|Break from study holiday|0|||
105694053|NCT01514136|364543555|FG002|Test Period 1; Test A|Break from study holiday|0|||
105694054|NCT01514136|364543556|FG003|Test Period 1; Test A|Break from study holiday|0|||
105694055|NCT01514136|364543557|FG004|Test Period 1; Test A|Break from study holiday|0|||
105694056|NCT01514136|364543558|FG005|Test Period 1; Test A|Break from study holiday|0|||
105694057|NCT01514136|364543559|FG006|Test Period 1; Test A|Break from study holiday|0|||
105694058|NCT01514136|364543560|FG007|Test Period 1; Test A|Break from study holiday|0|||
105694059|NCT01514136|364543553|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
105694060|NCT01514136|364543554|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
105694061|NCT01514136|364543555|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
105694062|NCT01514136|364543556|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
105694063|NCT01514136|364543557|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
105694064|NCT01514136|364543558|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
105694065|NCT01514136|364543559|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
105694066|NCT01514136|364543560|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
105694067|NCT01514136|364543553|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
105694068|NCT01514136|364543554|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
105694069|NCT01514136|364543555|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
105694070|NCT01514136|364543556|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
105694071|NCT01514136|364543557|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
105694072|NCT01514136|364543558|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
105694073|NCT01514136|364543559|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
105694074|NCT01514136|364543560|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
105694075|NCT01514136|364543553|FG000|Test Period 2; Test A*|Adverse Event|0|||
105694076|NCT01514136|364543554|FG001|Test Period 2; Test A*|Adverse Event|0|||
105694077|NCT01514136|364543555|FG002|Test Period 2; Test A*|Adverse Event|0|||
105694078|NCT01514136|364543556|FG003|Test Period 2; Test A*|Adverse Event|0|||
105694079|NCT01514136|364543557|FG004|Test Period 2; Test A*|Adverse Event|1|||
105694080|NCT01514136|364543558|FG005|Test Period 2; Test A*|Adverse Event|0|||
105694081|NCT01514136|364543559|FG006|Test Period 2; Test A*|Adverse Event|0|||
105694082|NCT01514136|364543560|FG007|Test Period 2; Test A*|Adverse Event|0|||
105694083|NCT01514136|364543553|FG000|Test Period 2; Test A*|Holiday|0|||
105694084|NCT01514136|364543554|FG001|Test Period 2; Test A*|Holiday|0|||
105694085|NCT01514136|364543555|FG002|Test Period 2; Test A*|Holiday|0|||
105694086|NCT01514136|364543556|FG003|Test Period 2; Test A*|Holiday|0|||
105694087|NCT01514136|364543557|FG004|Test Period 2; Test A*|Holiday|1|||
105694088|NCT01514136|364543558|FG005|Test Period 2; Test A*|Holiday|0|||
105694089|NCT01514136|364543559|FG006|Test Period 2; Test A*|Holiday|0|||
105694090|NCT01514136|364543560|FG007|Test Period 2; Test A*|Holiday|0|||
105694091|NCT01514136|364543553|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
105694092|NCT01514136|364543554|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
105694093|NCT01514136|364543555|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
105694094|NCT01514136|364543556|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
105694095|NCT01514136|364543557|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
105694096|NCT01514136|364543558|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
105694097|NCT01514136|364543559|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
105694098|NCT01514136|364543560|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
105694099|NCT01514136|364543553|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
105694100|NCT01514136|364543554|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
105694101|NCT01514136|364543555|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
105694102|NCT01514136|364543556|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
105694103|NCT01514136|364543557|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
105694104|NCT01514136|364543558|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
105694105|NCT01514136|364543559|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
105694106|NCT01514136|364543560|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
105694107|NCT01514136|364543553|FG000|Test Period 2; Test C*|holiday|0|||
105694108|NCT01514136|364543554|FG001|Test Period 2; Test C*|holiday|0|||
105347768|NCT01420679|363275317|FG000|Overall Study|Investigator Decision|1|||
105694109|NCT01514136|364543555|FG002|Test Period 2; Test C*|holiday|0|||
105694110|NCT01514136|364543556|FG003|Test Period 2; Test C*|holiday|0|||
105694111|NCT01514136|364543557|FG004|Test Period 2; Test C*|holiday|0|||
105694112|NCT01514136|364543558|FG005|Test Period 2; Test C*|holiday|0|||
105694113|NCT01514136|364543559|FG006|Test Period 2; Test C*|holiday|1|||
105694114|NCT01514136|364543560|FG007|Test Period 2; Test C*|holiday|0|||
105694115|NCT01514136|364543553|FG000|Test Period 2; Test C*|Protocol Violation|0|||
105694116|NCT01514136|364543554|FG001|Test Period 2; Test C*|Protocol Violation|0|||
105694117|NCT01514136|364543555|FG002|Test Period 2; Test C*|Protocol Violation|0|||
105694118|NCT01514136|364543556|FG003|Test Period 2; Test C*|Protocol Violation|0|||
105694119|NCT01514136|364543557|FG004|Test Period 2; Test C*|Protocol Violation|0|||
105694120|NCT01514136|364543558|FG005|Test Period 2; Test C*|Protocol Violation|0|||
105694121|NCT01514136|364543559|FG006|Test Period 2; Test C*|Protocol Violation|1|||
105694122|NCT01514136|364543560|FG007|Test Period 2; Test C*|Protocol Violation|0|||
105694123|NCT01010633|364543561|FG000|Overall Study|Adverse Event|1|||
105347769|NCT01420679|363275318|FG001|Overall Study|Investigator Decision|2|||
105347770|NCT01420679|363275317|FG000|Overall Study|Sponsor Decision|3|||
105347771|NCT01420679|363275318|FG001|Overall Study|Sponsor Decision|3|||
105347772|NCT01420679|363275317|FG000|Overall Study|Other|1|||
105347773|NCT01420679|363275318|FG001|Overall Study|Other|0|||
105347774|NCT03956615|363275321|FG000|Overall Study|No multiple myeloma confirmed|2|||
105347775|NCT03956615|363275321|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
105347776|NCT03956615|363275321|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
105347777|NCT03956615|363275321|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
105347778|NCT02604550|363275322|FG000|Overall Study|Lost to Follow-up|7|||
105347779|NCT02604550|363275323|FG001|Overall Study|Lost to Follow-up|6|||
105347780|NCT02604550|363275322|FG000|Overall Study|Withdrawal by Subject|0|||
105347781|NCT02604550|363275323|FG001|Overall Study|Withdrawal by Subject|1|||
105473100|NCT02499328|363743620|FG001|Overall Study|Lost to Follow-up|1|||
105347782|NCT02604550|363275322|FG000|Overall Study|Incomplete data using paper journal|18|||
105473101|NCT02499328|363743621|FG002|Overall Study|Lost to Follow-up|1|||
105473102|NCT02499328|363743622|FG003|Overall Study|Lost to Follow-up|2|||
105473103|NCT02499328|363743623|FG004|Overall Study|Lost to Follow-up|0|||
105694124|NCT01010633|364543562|FG001|Overall Study|Adverse Event|1|||
105347783|NCT02604550|363275323|FG001|Overall Study|Incomplete data using paper journal|19|||
105694125|NCT01010633|364543561|FG000|Overall Study|Protocol Violation|1|||
105694126|NCT01010633|364543562|FG001|Overall Study|Protocol Violation|2|||
105694127|NCT01010633|364543561|FG000|Overall Study|Withdrawal by Subject|2|||
105473104|NCT02499328|363743624|FG005|Overall Study|Lost to Follow-up|0|||
105694128|NCT01010633|364543562|FG001|Overall Study|Withdrawal by Subject|1|||
105473105|NCT02499328|363743625|FG006|Overall Study|Lost to Follow-up|0|||
105694129|NCT01010633|364543561|FG000|Overall Study|Investigator decision|0|||
105694130|NCT01010633|364543562|FG001|Overall Study|Investigator decision|1|||
105694131|NCT02941926|364543563|FG000|Core Phase|Progressive disease|1109|||
105694132|NCT02941926|364543563|FG000|Core Phase|Adverse Event|504|||
105694133|NCT02941926|364543563|FG000|Core Phase|Subject/guardian decision|127|||
105694134|NCT02941926|364543563|FG000|Core Phase|Physician Decision|112|||
105694135|NCT02941926|364543563|FG000|Core Phase|Death|46|||
105694136|NCT02941926|364543563|FG000|Core Phase|Protocol deviation|34|||
105694137|NCT02941926|364543563|FG000|Core Phase|Lost to Follow-up|8|||
105694138|NCT02941926|364543563|FG000|Core Phase|Technical problems|5|||
105694139|NCT02941926|364543563|FG000|Extension Phase|Physician Decision|155|||
105694140|NCT02941926|364543563|FG000|Extension Phase|Progressive disease|115|||
105694141|NCT02941926|364543563|FG000|Extension Phase|Adverse Event|13|||
105694142|NCT02941926|364543563|FG000|Extension Phase|Subject/Guardian decision|12|||
105694143|NCT02941926|364543563|FG000|Extension Phase|Death|6|||
105694144|NCT02729740|364543564|FG000|Overall Study|Early Termination|130|||
105694145|NCT02729740|364543564|FG000|Overall Study|Other|1|||
105694146|NCT00882310|364543565|FG000|Overall Study|Screen Failure|10|||
105694147|NCT00882310|364543565|FG000|Overall Study|Never received treatment|1|||
105694148|NCT00882310|364543565|FG000|Overall Study|Death|6|||
105694149|NCT00882310|364543565|FG000|Overall Study|Progression of disease|4|||
105694150|NCT00882310|364543565|FG000|Overall Study|Adverse Event|1|||
105694151|NCT01494350|364543566|FG000|Overall Study|Worsening of lesion|1|||
105694152|NCT00698932|364543567|FG000|Overall Study|Adverse Event|0|||
105694153|NCT00698932|364543568|FG001|Overall Study|Adverse Event|2|||
105694154|NCT00698932|364543567|FG000|Overall Study|Incorrect enrollment|0|||
105694155|NCT00698932|364543568|FG001|Overall Study|Incorrect enrollment|2|||
105694156|NCT00698932|364543567|FG000|Overall Study|Study specific discontinuation criteria|3|||
105694157|NCT00698932|364543568|FG001|Overall Study|Study specific discontinuation criteria|4|||
105694158|NCT00698932|364543567|FG000|Overall Study|Withdrawal by Subject|11|||
105694159|NCT00698932|364543568|FG001|Overall Study|Withdrawal by Subject|23|||
105694160|NCT00698932|364543567|FG000|Overall Study|Lost to Follow-up|6|||
105694161|NCT00698932|364543568|FG001|Overall Study|Lost to Follow-up|1|||
105694162|NCT00698932|364543567|FG000|Overall Study|Severe non-compliance to protocol|1|||
105694163|NCT00698932|364543568|FG001|Overall Study|Severe non-compliance to protocol|2|||
105694164|NCT00698932|364543567|FG000|Overall Study|Safety reasons|0|||
105694165|NCT00698932|364543568|FG001|Overall Study|Safety reasons|2|||
105694166|NCT00698932|364543567|FG000|Overall Study|Death|1|||
105694167|NCT00698932|364543568|FG001|Overall Study|Death|0|||
105694168|NCT00601705|364543571|FG000|Overall Study|Withdrawal by Subject|1|||
105694169|NCT04233164|364543572|FG000|Overall Study|Unable to obtain specimen|0|||
105694170|NCT04233164|364543573|FG001|Overall Study|Unable to obtain specimen|1|||
105694171|NCT03250832|364543591|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
105694172|NCT03250832|364543592|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
105694173|NCT03250832|364543593|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
105694174|NCT03250832|364543594|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
105694175|NCT03250832|364543595|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
105694176|NCT03250832|364543596|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
105694177|NCT03250832|364543597|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
105694178|NCT03250832|364543598|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
105694179|NCT03250832|364543599|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
105694180|NCT03250832|364543600|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
105694181|NCT03250832|364543601|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
105694182|NCT03250832|364543602|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
105694183|NCT03250832|364543591|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
105694184|NCT03250832|364543592|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
105694185|NCT03250832|364543593|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
105694186|NCT03250832|364543594|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
105694187|NCT03250832|364543595|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
105694188|NCT03250832|364543596|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
105694189|NCT03250832|364543597|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
105694190|NCT03250832|364543598|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
105694191|NCT03250832|364543599|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
105694192|NCT03250832|364543600|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
105694193|NCT03250832|364543601|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
105694194|NCT03250832|364543602|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
105694195|NCT03250832|364543591|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694196|NCT03250832|364543592|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694197|NCT03250832|364543593|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
105347784|NCT01199822|363275324|FG000|Overall Study|Investigator discontinued therapy|0|||
105347785|NCT01199822|363275325|FG001|Overall Study|Investigator discontinued therapy|1|||
105347786|NCT01199822|363275326|FG002|Overall Study|Investigator discontinued therapy|0|||
105347787|NCT02382796|363275327|FG000|Overall Study|Global deterioration of health status|1|||
105347788|NCT02382796|363275327|FG000|Overall Study|Objective progression or relapse|3|||
105347789|NCT02382796|363275327|FG000|Overall Study|Commercial dacomitinib became available|3|||
105347790|NCT01179737|363275333|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
105347791|NCT01179737|363275334|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
105347792|NCT01179737|363275335|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
105347793|NCT01179737|363275336|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
105347794|NCT01179737|363275333|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
105347795|NCT01179737|363275334|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
105347796|NCT01179737|363275335|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
105347797|NCT01179737|363275336|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
105347798|NCT01179737|363275333|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
105347799|NCT01179737|363275334|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
105559196|NCT03364751|364044606|FG000|Overall Study|Withdrawal by Subject|1|||
105559197|NCT03364751|364044607|FG001|Overall Study|Withdrawal by Subject|0|||
105694198|NCT03250832|364543594|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694199|NCT03250832|364543595|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694200|NCT03250832|364543596|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694201|NCT03250832|364543597|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694202|NCT03250832|364543598|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694203|NCT03250832|364543599|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694204|NCT03250832|364543600|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694205|NCT03250832|364543601|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694206|NCT03250832|364543602|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694207|NCT03250832|364543591|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694208|NCT03250832|364543592|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694209|NCT03250832|364543593|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694210|NCT03250832|364543594|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694211|NCT03250832|364543595|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694212|NCT03250832|364543596|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694213|NCT03250832|364543597|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694214|NCT03250832|364543598|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
105694215|NCT03250832|364543599|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694216|NCT03250832|364543600|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694217|NCT03250832|364543601|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694218|NCT03250832|364543602|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694219|NCT03250832|364543591|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694220|NCT03250832|364543592|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694221|NCT03250832|364543593|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694222|NCT03250832|364543594|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694223|NCT03250832|364543595|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694224|NCT03250832|364543596|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694225|NCT03250832|364543597|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694226|NCT03250832|364543598|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
105347800|NCT01179737|363275335|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
105347801|NCT01179737|363275336|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
105694227|NCT03250832|364543599|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694228|NCT03250832|364543600|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694229|NCT03250832|364543601|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694230|NCT03250832|364543602|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694231|NCT03250832|364543591|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694232|NCT03250832|364543592|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694233|NCT03250832|364543593|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694234|NCT03250832|364543594|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694235|NCT03250832|364543595|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694236|NCT03250832|364543596|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694237|NCT03250832|364543597|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694238|NCT03250832|364543598|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
105694239|NCT03250832|364543599|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694240|NCT03250832|364543600|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694241|NCT03250832|364543601|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694242|NCT03250832|364543602|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694243|NCT03250832|364543591|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694244|NCT03250832|364543592|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694245|NCT03250832|364543593|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694246|NCT03250832|364543594|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694247|NCT03250832|364543595|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694248|NCT03250832|364543596|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694249|NCT03250832|364543597|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694250|NCT03250832|364543598|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
105694251|NCT03250832|364543599|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694252|NCT03250832|364543600|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694253|NCT03250832|364543601|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694254|NCT03250832|364543602|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694255|NCT03250832|364543591|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694256|NCT03250832|364543592|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694257|NCT03250832|364543593|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694258|NCT03250832|364543594|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694259|NCT03250832|364543595|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694260|NCT03250832|364543596|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694261|NCT03250832|364543597|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694262|NCT03250832|364543598|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
105694263|NCT03250832|364543599|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694264|NCT03250832|364543600|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694265|NCT03250832|364543601|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694266|NCT03250832|364543602|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694267|NCT03250832|364543591|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694268|NCT03250832|364543592|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694269|NCT03250832|364543593|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694270|NCT03250832|364543594|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694271|NCT03250832|364543595|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694272|NCT03250832|364543596|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694273|NCT03250832|364543597|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694274|NCT03250832|364543598|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694275|NCT03250832|364543599|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
105694276|NCT03250832|364543600|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
105694277|NCT03250832|364543601|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694278|NCT03250832|364543602|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694279|NCT03250832|364543591|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105347802|NCT01179737|363275333|FG000|Cohort 1 & Cohort 2|Death|0|||
105347803|NCT01179737|363275334|FG001|Cohort 1 & Cohort 2|Death|0|||
105347804|NCT01179737|363275335|FG002|Cohort 1 & Cohort 2|Death|1|||
105694280|NCT03250832|364543592|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694281|NCT03250832|364543593|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694282|NCT03250832|364543594|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694283|NCT03250832|364543595|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694284|NCT03250832|364543596|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694285|NCT03250832|364543597|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694286|NCT03250832|364543598|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694287|NCT03250832|364543599|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
105694288|NCT03250832|364543600|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
105694289|NCT03250832|364543601|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694290|NCT03250832|364543602|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694291|NCT03250832|364543591|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694292|NCT03250832|364543592|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694293|NCT03250832|364543593|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694294|NCT03250832|364543594|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694295|NCT03250832|364543595|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105347805|NCT01179737|363275336|FG003|Cohort 1 & Cohort 2|Death|0|||
105347806|NCT01179737|363275333|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
105694296|NCT03250832|364543596|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694297|NCT03250832|364543597|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694298|NCT03250832|364543598|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694299|NCT03250832|364543599|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
105694300|NCT03250832|364543600|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
105694301|NCT03250832|364543601|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694302|NCT03250832|364543602|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694303|NCT03250832|364543591|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694304|NCT03250832|364543592|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694305|NCT03250832|364543593|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694306|NCT03250832|364543594|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694307|NCT03250832|364543595|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694308|NCT03250832|364543596|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694309|NCT03250832|364543597|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105347807|NCT01179737|363275334|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
105347808|NCT01179737|363275335|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
105347809|NCT01179737|363275336|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
105347810|NCT01179737|363275333|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
105347811|NCT01179737|363275334|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
105347812|NCT01179737|363275335|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
105694310|NCT03250832|364543598|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694311|NCT03250832|364543599|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694312|NCT03250832|364543600|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694313|NCT03250832|364543601|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694314|NCT03250832|364543602|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
105694315|NCT02303704|364543603|FG000|Overall Study|Protocol Violation|5|||
105694316|NCT02303704|364543604|FG001|Overall Study|Protocol Violation|9|||
105694317|NCT00705432|364543605|FG000|Treatment Period|Adverse Event|45|||
105347813|NCT01179737|363275336|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
105347814|NCT01179737|363275333|FG000|Extension|The study was terminated|3|||
105694318|NCT00705432|364543606|FG001|Treatment Period|Adverse Event|37|||
105694319|NCT00705432|364543607|FG002|Treatment Period|Adverse Event|51|||
105694320|NCT00705432|364543608|FG003|Treatment Period|Adverse Event|12|||
105694321|NCT00705432|364543609|FG004|Treatment Period|Adverse Event|8|||
105694322|NCT00705432|364543610|FG005|Treatment Period|Adverse Event|9|||
105694323|NCT00705432|364543605|FG000|Treatment Period|Treatment failure|92|||
105694324|NCT00705432|364543606|FG001|Treatment Period|Treatment failure|42|||
105694325|NCT00705432|364543607|FG002|Treatment Period|Treatment failure|33|||
105694326|NCT00705432|364543608|FG003|Treatment Period|Treatment failure|25|||
105473106|NCT02499328|363743626|FG007|Overall Study|Lost to Follow-up|2|||
105347815|NCT01179737|363275334|FG001|Extension|The study was terminated|0|||
105694327|NCT00705432|364543609|FG004|Treatment Period|Treatment failure|13|||
105694328|NCT00705432|364543610|FG005|Treatment Period|Treatment failure|14|||
105694329|NCT00705432|364543605|FG000|Treatment Period|Non medical reason|26|||
105694330|NCT00705432|364543606|FG001|Treatment Period|Non medical reason|32|||
105694331|NCT00705432|364543607|FG002|Treatment Period|Non medical reason|37|||
105694332|NCT00705432|364543608|FG003|Treatment Period|Non medical reason|4|||
105694333|NCT00705432|364543609|FG004|Treatment Period|Non medical reason|7|||
105694334|NCT00705432|364543610|FG005|Treatment Period|Non medical reason|7|||
105694335|NCT00705432|364543605|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
105694336|NCT00705432|364543606|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
105694337|NCT00705432|364543607|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
105694338|NCT00705432|364543608|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
105694339|NCT00705432|364543609|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
105694340|NCT00705432|364543610|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
105694341|NCT00705432|364543605|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
105694342|NCT00705432|364543606|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
105694343|NCT00705432|364543607|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
105694344|NCT00705432|364543608|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
105694345|NCT00705432|364543609|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
105694346|NCT00705432|364543610|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
105694347|NCT00805025|364543611|FG000|Overall Study|Screened but not enrolled/treated|42|||
105694348|NCT00805025|364543611|FG000|Overall Study|Adverse Event|4|||
105694349|NCT00805025|364543611|FG000|Overall Study|Withdrawal by Subject|2|||
105694350|NCT00805025|364543611|FG000|Overall Study|Physician Decision|1|||
105694351|NCT03631667|364545029|FG000|Overall Study|Withdrawal by Subject|3|||
105694352|NCT01383096|364545036|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
105694353|NCT01383096|364545037|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
105694354|NCT01383096|364545038|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
105473107|NCT02499328|363743627|FG008|Overall Study|Lost to Follow-up|3|||
105694355|NCT01383096|364545036|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
105694356|NCT01383096|364545037|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
105694357|NCT01383096|364545038|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
105694358|NCT01383096|364545036|FG000|Third Intervention (8 Days)|Elevated AST|0|||
105694359|NCT01383096|364545037|FG001|Third Intervention (8 Days)|Elevated AST|1|||
105694360|NCT01383096|364545038|FG002|Third Intervention (8 Days)|Elevated AST|0|||
105694361|NCT01383096|364545036|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
105694362|NCT01383096|364545037|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
105694363|NCT01383096|364545038|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
105694364|NCT01383096|364545036|FG000|Third Intervention (8 Days)|Adverse Event|1|||
105694365|NCT01383096|364545037|FG001|Third Intervention (8 Days)|Adverse Event|0|||
105694366|NCT01383096|364545038|FG002|Third Intervention (8 Days)|Adverse Event|0|||
105694367|NCT01383096|364545036|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
105694368|NCT01383096|364545037|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
105694369|NCT01383096|364545038|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
105694370|NCT01383096|364545036|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
105694371|NCT01383096|364545037|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
105694372|NCT01383096|364545038|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
105694373|NCT01383096|364545036|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
105787070|NCT03110107|364874902|FG013|Treatment Period|Disease Progression|5|||
105787071|NCT03110107|364874903|FG014|Treatment Period|Disease Progression|14|||
105694374|NCT01383096|364545037|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
105694375|NCT01383096|364545038|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
105694376|NCT01383096|364545036|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
105787072|NCT03110107|364874904|FG015|Treatment Period|Disease Progression|14|||
105347816|NCT01179737|363275335|FG002|Extension|The study was terminated|0|||
105787073|NCT03110107|364874905|FG016|Treatment Period|Disease Progression|4|||
105347817|NCT01179737|363275336|FG003|Extension|The study was terminated|0|||
105347818|NCT01546038|363275339|FG000|Overall Study|Death|15|||
105347819|NCT01546038|363275340|FG001|Overall Study|Death|6|||
105347820|NCT01546038|363275341|FG002|Overall Study|Death|4|||
105347821|NCT01546038|363275342|FG003|Overall Study|Death|2|||
105347822|NCT01546038|363275343|FG004|Overall Study|Death|9|||
105347823|NCT01546038|363275344|FG005|Overall Study|Death|3|||
105347824|NCT01546038|363275345|FG006|Overall Study|Death|46|||
105347825|NCT01546038|363275346|FG007|Overall Study|Death|76|||
105347826|NCT01546038|363275347|FG008|Overall Study|Death|39|||
105347827|NCT01546038|363275339|FG000|Overall Study|Lost to Follow-up|0|||
105347828|NCT01546038|363275340|FG001|Overall Study|Lost to Follow-up|0|||
105347829|NCT01546038|363275341|FG002|Overall Study|Lost to Follow-up|0|||
105347830|NCT01546038|363275342|FG003|Overall Study|Lost to Follow-up|0|||
105347831|NCT01546038|363275343|FG004|Overall Study|Lost to Follow-up|1|||
105347832|NCT01546038|363275344|FG005|Overall Study|Lost to Follow-up|0|||
105347833|NCT01546038|363275345|FG006|Overall Study|Lost to Follow-up|2|||
105347834|NCT01546038|363275346|FG007|Overall Study|Lost to Follow-up|1|||
105347835|NCT01546038|363275347|FG008|Overall Study|Lost to Follow-up|0|||
105347836|NCT01546038|363275339|FG000|Overall Study|Withdrawal by Subject|1|||
105347837|NCT01546038|363275340|FG001|Overall Study|Withdrawal by Subject|0|||
105347838|NCT01546038|363275341|FG002|Overall Study|Withdrawal by Subject|0|||
105347839|NCT01546038|363275342|FG003|Overall Study|Withdrawal by Subject|1|||
105347840|NCT01546038|363275343|FG004|Overall Study|Withdrawal by Subject|0|||
105347841|NCT01546038|363275344|FG005|Overall Study|Withdrawal by Subject|1|||
105347842|NCT01546038|363275345|FG006|Overall Study|Withdrawal by Subject|3|||
105347843|NCT01546038|363275346|FG007|Overall Study|Withdrawal by Subject|3|||
105347844|NCT01546038|363275347|FG008|Overall Study|Withdrawal by Subject|1|||
105347845|NCT01546038|363275339|FG000|Overall Study|: Randomized, not treated|0|||
105347846|NCT01546038|363275340|FG001|Overall Study|: Randomized, not treated|0|||
105347847|NCT01546038|363275341|FG002|Overall Study|: Randomized, not treated|0|||
105347848|NCT01546038|363275342|FG003|Overall Study|: Randomized, not treated|0|||
105347849|NCT01546038|363275343|FG004|Overall Study|: Randomized, not treated|0|||
105347850|NCT01546038|363275344|FG005|Overall Study|: Randomized, not treated|0|||
105347851|NCT01546038|363275345|FG006|Overall Study|: Randomized, not treated|2|||
105347852|NCT01546038|363275346|FG007|Overall Study|: Randomized, not treated|4|||
105347853|NCT01546038|363275347|FG008|Overall Study|: Randomized, not treated|3|||
105347854|NCT04245202|363275348|FG000|Overall Study|Lack of Efficacy|10|||
105347855|NCT04245202|363275349|FG001|Overall Study|Lack of Efficacy|1|||
105347856|NCT00334802|363275350|FG000|Overall Study|Progressive Disease|2|||
105347857|NCT00334802|363275351|FG001|Overall Study|Progressive Disease|24|||
105347858|NCT00334802|363275350|FG000|Overall Study|Toxicity|1|||
105347859|NCT00334802|363275351|FG001|Overall Study|Toxicity|5|||
105347860|NCT00334802|363275350|FG000|Overall Study|Lack of Efficacy|1|||
105347861|NCT00334802|363275351|FG001|Overall Study|Lack of Efficacy|3|||
105347862|NCT00334802|363275350|FG000|Overall Study|Patient Condition Aggrevated|1|||
105347863|NCT00334802|363275351|FG001|Overall Study|Patient Condition Aggrevated|0|||
105347864|NCT00334802|363275350|FG000|Overall Study|Physician Decision|1|||
105347865|NCT00334802|363275351|FG001|Overall Study|Physician Decision|0|||
105347866|NCT00334802|363275350|FG000|Overall Study|Withdrawal by Subject|0|||
105347867|NCT00334802|363275351|FG001|Overall Study|Withdrawal by Subject|4|||
105347868|NCT00334802|363275350|FG000|Overall Study|Adverse Event|0|||
105347869|NCT00334802|363275351|FG001|Overall Study|Adverse Event|3|||
105347870|NCT00334802|363275350|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
105347871|NCT00334802|363275351|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
105347872|NCT03422159|363275352|FG000|Overall Study|Exclusion due to terminal disease|2|||
105347873|NCT03422159|363275353|FG001|Overall Study|Exclusion due to terminal disease|1|||
105347874|NCT00717275|363275358|FG000|Overall Study|Premature study termination.|3|||
105347875|NCT01285492|363275363|FG000|Overall Study|Adverse Event|11|||
105347876|NCT01285492|363275364|FG001|Overall Study|Adverse Event|0|||
105347877|NCT01285492|363275363|FG000|Overall Study|Protocol Violation|3|||
105347878|NCT01285492|363275364|FG001|Overall Study|Protocol Violation|0|||
105347879|NCT01285492|363275363|FG000|Overall Study|Withdrawal by Subject|2|||
105347880|NCT01285492|363275364|FG001|Overall Study|Withdrawal by Subject|1|||
105347881|NCT01285492|363275363|FG000|Overall Study|Death|1|||
105347882|NCT01285492|363275364|FG001|Overall Study|Death|0|||
105347883|NCT01935128|363275365|FG000|Overall Study|Death|1|||
105347884|NCT01935128|363275365|FG000|Overall Study|Adverse Event|6|||
105347885|NCT00096993|363275366|FG000|Overall Study|Death|1|||
105347886|NCT00096993|363275367|FG001|Overall Study|Death|0|||
105347887|NCT00096993|363275366|FG000|Overall Study|Disease progression|56|||
105347888|NCT00096993|363275367|FG001|Overall Study|Disease progression|53|||
105347889|NCT00096993|363275366|FG000|Overall Study|Adverse Event|2|||
105347890|NCT00096993|363275367|FG001|Overall Study|Adverse Event|8|||
105347891|NCT00096993|363275366|FG000|Overall Study|Subject's decision|3|||
105347892|NCT00096993|363275367|FG001|Overall Study|Subject's decision|1|||
105347893|NCT00096993|363275366|FG000|Overall Study|Physician Decision|2|||
105694377|NCT01383096|364545037|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
105473108|NCT02499328|363743628|FG009|Overall Study|Lost to Follow-up|0|||
105473109|NCT02499328|363743629|FG010|Overall Study|Lost to Follow-up|0|||
105694378|NCT01383096|364545038|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
105694379|NCT01383096|364545036|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
105694380|NCT01383096|364545037|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
105694381|NCT01383096|364545038|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
105694382|NCT01383096|364545036|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
105694383|NCT01383096|364545037|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
105694384|NCT01383096|364545038|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
105694385|NCT00616434|364545043|FG000|Overall Study|Adverse Event|5|||
105694386|NCT00616434|364545044|FG001|Overall Study|Adverse Event|2|||
105694387|NCT00616434|364545043|FG000|Overall Study|Physician Decision|0|||
105694388|NCT00616434|364545044|FG001|Overall Study|Physician Decision|4|||
105694389|NCT00616434|364545043|FG000|Overall Study|Withdrawal by Subject|1|||
105694390|NCT00616434|364545044|FG001|Overall Study|Withdrawal by Subject|1|||
105694391|NCT00616434|364545043|FG000|Overall Study|Protocol deviation|0|||
105694392|NCT00616434|364545044|FG001|Overall Study|Protocol deviation|1|||
105694393|NCT01754857|364545045|FG000|Overall Study|Adverse Event|7|||
105694394|NCT01754857|364545045|FG000|Overall Study|Disease progression|3|||
105694395|NCT01754857|364545045|FG000|Overall Study|Physician Decision|2|||
105694396|NCT01754857|364545045|FG000|Overall Study|Withdrawal by Subject|3|||
105694397|NCT01754857|364545045|FG000|Overall Study|other complicating disease|1|||
105694398|NCT01754857|364545045|FG000|Overall Study|ineligible to continue onto maintenance|1|||
105694399|NCT01754857|364545045|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
105694400|NCT01754857|364545045|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
105694401|NCT03945591|364545046|FG000|Overall Study|Participant not transplanted|1|||
105694402|NCT03945591|364545046|FG000|Overall Study|Change in treatment plan|3|||
105694403|NCT03945591|364545046|FG000|Overall Study|Adverse Event|1|||
105694404|NCT01399190|364545047|FG000|Overall Study|Not Eligible for Final Analysis|5|||
105694405|NCT01399190|364545047|FG000|Overall Study|Adverse Event|8|||
105694406|NCT01399190|364545047|FG000|Overall Study|Participant's Request|5|||
105694407|NCT01399190|364545047|FG000|Overall Study|Physician Decision|2|||
105694408|NCT00791258|364545048|FG000|Overall Study|Adverse Event|87|||
105694409|NCT00791258|364545048|FG000|Overall Study|Lost to Follow-up|18|||
105694410|NCT00791258|364545048|FG000|Overall Study|Protocol Violation|109|||
105694411|NCT00791258|364545048|FG000|Overall Study|Withdrawal by Subject|40|||
105694412|NCT00791258|364545048|FG000|Overall Study|Did not take medication for >3 days|1|||
105694413|NCT00791258|364545048|FG000|Overall Study|subject left area|2|||
105694414|NCT00791258|364545048|FG000|Overall Study|non-compliance|3|||
105694415|NCT00791258|364545048|FG000|Overall Study|Subject incarcerated|1|||
105694416|NCT00791258|364545048|FG000|Overall Study|Subject required restricted medication|1|||
105694417|NCT00791258|364545048|FG000|Overall Study|Lack of Efficacy|1|||
105694418|NCT00210184|364545058|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
105694419|NCT02445755|364545061|FG000|Overall Study|Withdrawal by Subject|2|||
105694420|NCT02445755|364545061|FG000|Overall Study|Protocol Violation|6|||
105694421|NCT02445755|364545061|FG000|Overall Study|Screen Failure|5|||
105694422|NCT01118325|364545063|FG000|Overall Study|Adverse Event|1|||
105694423|NCT01118325|364545064|FG001|Overall Study|Adverse Event|0|||
105694424|NCT01118325|364545065|FG002|Overall Study|Adverse Event|1|||
105694425|NCT00381563|364545070|FG000|Overall Study|Withdrawal by Subject|5|||
105694426|NCT00381563|364545071|FG001|Overall Study|Withdrawal by Subject|5|||
105694427|NCT00381563|364545070|FG000|Overall Study|Lost to Follow-up|2|||
105694428|NCT00381563|364545071|FG001|Overall Study|Lost to Follow-up|0|||
105694429|NCT00381563|364545070|FG000|Overall Study|Protocol Violation|0|||
105473110|NCT02499328|363743630|FG011|Overall Study|Lost to Follow-up|0|||
105347894|NCT00096993|363275367|FG001|Overall Study|Physician Decision|1|||
105694430|NCT00381563|364545071|FG001|Overall Study|Protocol Violation|1|||
105694431|NCT01438151|364545072|FG000|Overall Study|study terminated|8|||
105694432|NCT01303965|364545075|FG000|Overall Study|Adverse Event|1|||
105694433|NCT01303965|364545076|FG001|Overall Study|Adverse Event|1|||
105694434|NCT01303965|364545075|FG000|Overall Study|Death|0|||
105694435|NCT01303965|364545076|FG001|Overall Study|Death|3|||
105694436|NCT01303965|364545075|FG000|Overall Study|Withdrawal by Subject|1|||
105694437|NCT01303965|364545076|FG001|Overall Study|Withdrawal by Subject|0|||
105694438|NCT01303965|364545075|FG000|Overall Study|Disease Progression|1|||
105694439|NCT01303965|364545076|FG001|Overall Study|Disease Progression|6|||
105694440|NCT02448225|364545077|FG000|Overall Study|Withdrawal by Subject|1|||
105694441|NCT02448225|364545077|FG000|Overall Study|Did not get FSPG scan|18|||
105694442|NCT02448225|364545077|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
105694443|NCT00851682|364545078|FG000|Overall Study|screen failure|5|||
105694444|NCT00851682|364545079|FG001|Overall Study|screen failure|0|||
105694445|NCT04060563|364545080|FG000|Overall Study|Lost to Follow-up|1|||
105694446|NCT04060563|364545081|FG001|Overall Study|Lost to Follow-up|1|||
105694447|NCT04060563|364545080|FG000|Overall Study|Physician Decision|0|||
105694448|NCT04060563|364545081|FG001|Overall Study|Physician Decision|1|||
105694449|NCT01106027|364545088|FG000|Overall Study|Lost graft early, discontinued|1|||
105694450|NCT02545322|364545089|FG000|Overall Study|Withdrawal by Subject|3|||
105694451|NCT01230554|364545091|FG000|Overall Study|Lost to Follow-up|2|||
105694452|NCT01230554|364545091|FG000|Overall Study|Inability to maintain visit schedule|1|||
105694453|NCT02653300|364545092|FG000|Overall Study|Withdrawal by Subject|2|||
105694454|NCT02678416|364545095|FG000|Part 1|Withdrawal by Subject|1|||
105694455|NCT02678416|364545095|FG000|Part 2|Adverse Event|2|||
105694456|NCT02678416|364545095|FG000|Part 2|Withdrawal by Subject|1|||
105694457|NCT04556136|364545096|FG000|Overall Study|Lost to Follow-up|6|||
105694458|NCT04556136|364545097|FG001|Overall Study|Lost to Follow-up|6|||
105694459|NCT04556136|364545096|FG000|Overall Study|Physician Decision|2|||
105694460|NCT04556136|364545097|FG001|Overall Study|Physician Decision|1|||
105694461|NCT04556136|364545096|FG000|Overall Study|Withdrawal by Subject|2|||
105694462|NCT04556136|364545097|FG001|Overall Study|Withdrawal by Subject|1|||
105694463|NCT01848353|364545098|FG000|Phase 1|Withdrawal by Subject|3|||
105694464|NCT01848353|364545099|FG001|Phase 1|Withdrawal by Subject|1|||
105694465|NCT01848353|364545100|FG002|Phase 1|Withdrawal by Subject|0|||
105694466|NCT01848353|364545101|FG003|Phase 1|Withdrawal by Subject|0|||
105694467|NCT01848353|364545098|FG000|Phase 2|Withdrawal by Subject|3|||
105347895|NCT00096993|363275366|FG000|Overall Study|Non-compliance|0|||
105347896|NCT00096993|363275367|FG001|Overall Study|Non-compliance|1|||
105347897|NCT00096993|363275366|FG000|Overall Study|Other unspecified|1|||
105347898|NCT00096993|363275367|FG001|Overall Study|Other unspecified|1|||
105347899|NCT00090584|363275370|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
105347900|NCT00090584|363275371|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
105347901|NCT00090584|363275370|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
105347902|NCT00090584|363275371|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
105347903|NCT01904903|363275380|FG000|Overall Study|Withdrawal by Subject|1|||
105347904|NCT00574795|363275383|FG000|Infant Series|Withdrawal by Subject|2|||
105347905|NCT00574795|363275383|FG000|Infant Series|Protocol Violation|2|||
105347906|NCT00574795|363275383|FG000|Infant Series|Adverse Event|1|||
105347907|NCT00574795|363275383|FG000|After Infant Series|Withdrawal by Subject|1|||
105347908|NCT00574795|363275383|FG000|After Infant Series|Adverse Event|2|||
105347909|NCT00574795|363275383|FG000|Toddler Dose|Withdrawal by Subject|1|||
105347910|NCT04299048|363275384|FG000|Overall Study|Death|1|||
105347911|NCT04299048|363275384|FG000|Overall Study|Global deterioration of health status|2|||
105347912|NCT04299048|363275384|FG000|Overall Study|Enrolled and not treated|1|||
105347913|NCT03578146|363275385|FG000|Overall Study|Did Not Receive Treatment|1|||
105347914|NCT03578146|363275386|FG001|Overall Study|Did Not Receive Treatment|0|||
105473111|NCT02499328|363743631|FG012|Overall Study|Lost to Follow-up|0|||
105473112|NCT02499328|363743632|FG013|Overall Study|Lost to Follow-up|0|||
105473113|NCT02499328|363743633|FG014|Overall Study|Lost to Follow-up|0|||
105473114|NCT02499328|363743634|FG015|Overall Study|Lost to Follow-up|0|||
105694468|NCT01848353|364545099|FG001|Phase 2|Withdrawal by Subject|2|||
105694469|NCT01848353|364545100|FG002|Phase 2|Withdrawal by Subject|0|||
105347915|NCT03578146|363275387|FG002|Overall Study|Did Not Receive Treatment|0|||
105347916|NCT03578146|363275388|FG003|Overall Study|Did Not Receive Treatment|0|||
105347917|NCT03578146|363275389|FG004|Overall Study|Did Not Receive Treatment|0|||
105347918|NCT03578146|363275390|FG005|Overall Study|Did Not Receive Treatment|2|||
105347919|NCT03578146|363275385|FG000|Overall Study|Lost to Follow-up|0|||
105473115|NCT02499328|363743635|FG016|Overall Study|Lost to Follow-up|0|||
105473116|NCT02499328|363743636|FG017|Overall Study|Lost to Follow-up|0|||
105694470|NCT01848353|364545101|FG003|Phase 2|Withdrawal by Subject|0|||
105694471|NCT01848353|364545098|FG000|Phase 3|Withdrawal by Subject|1|||
105694472|NCT01848353|364545099|FG001|Phase 3|Withdrawal by Subject|1|||
105694473|NCT01848353|364545100|FG002|Phase 3|Withdrawal by Subject|0|||
105694474|NCT01848353|364545101|FG003|Phase 3|Withdrawal by Subject|0|||
105694475|NCT03492554|364545108|FG000|Overall Study|Protocol Violation|0|||
105694476|NCT03492554|364545109|FG001|Overall Study|Protocol Violation|14|||
105694477|NCT02289352|364545110|FG000|Overall Study|Withdrawal by Subject|1|||
105694478|NCT02289352|364545111|FG001|Overall Study|Withdrawal by Subject|1|||
105694479|NCT02289352|364545112|FG002|Overall Study|Withdrawal by Subject|0|||
105694480|NCT04340557|364545113|FG000|Overall Study|Transferred to ICU and/or death|1|||
105694481|NCT04340557|364545114|FG001|Overall Study|Transferred to ICU and/or death|2|||
105694482|NCT00685685|364545115|FG000|Washout Period of 7 Days|Adverse Event|2|||
105694483|NCT00685685|364545116|FG001|Washout Period of 7 Days|Adverse Event|0|||
105694484|NCT00685685|364545115|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
105694485|NCT00685685|364545116|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105694486|NCT04029116|364545117|FG000|Overall Study|Adverse Event|0|||
105694487|NCT04029116|364545118|FG001|Overall Study|Adverse Event|2|||
105694488|NCT04029116|364545117|FG000|Overall Study|Lost to Follow-up|3|||
105694489|NCT04029116|364545118|FG001|Overall Study|Lost to Follow-up|5|||
105694490|NCT04029116|364545117|FG000|Overall Study|Physician Decision|2|||
105694491|NCT04029116|364545118|FG001|Overall Study|Physician Decision|0|||
105694492|NCT04029116|364545117|FG000|Overall Study|Pregnancy|1|||
105694493|NCT04029116|364545118|FG001|Overall Study|Pregnancy|2|||
105694494|NCT04029116|364545117|FG000|Overall Study|Withdrawal by Subject|4|||
105694495|NCT04029116|364545118|FG001|Overall Study|Withdrawal by Subject|6|||
105694496|NCT04029116|364545117|FG000|Overall Study|Other|2|||
105694497|NCT04029116|364545118|FG001|Overall Study|Other|1|||
105694498|NCT01177384|364545119|FG000|Overall Study|Adverse Event|6|||
105694499|NCT01177384|364545120|FG001|Overall Study|Adverse Event|4|||
105694500|NCT01177384|364545119|FG000|Overall Study|Lack of Efficacy|0|||
105694501|NCT01177384|364545120|FG001|Overall Study|Lack of Efficacy|1|||
105694502|NCT01177384|364545119|FG000|Overall Study|Lost to Follow-up|3|||
105694503|NCT01177384|364545120|FG001|Overall Study|Lost to Follow-up|4|||
105694504|NCT01177384|364545119|FG000|Overall Study|Physician Decision|0|||
105694505|NCT01177384|364545120|FG001|Overall Study|Physician Decision|3|||
105347920|NCT03578146|363275386|FG001|Overall Study|Lost to Follow-up|1|||
105347921|NCT03578146|363275387|FG002|Overall Study|Lost to Follow-up|1|||
105347922|NCT03578146|363275388|FG003|Overall Study|Lost to Follow-up|0|||
105347923|NCT03578146|363275389|FG004|Overall Study|Lost to Follow-up|0|||
105347924|NCT03578146|363275390|FG005|Overall Study|Lost to Follow-up|1|||
105347925|NCT00634049|363275391|FG000|Overall Study|Never received study drug|1|||
105347926|NCT00634049|363275391|FG000|Overall Study|Died prior to receiving study drug|1|||
105347927|NCT00634049|363275391|FG000|Overall Study|Screening failure|1|||
105347928|NCT00314132|363275395|FG000|Overall Study|Lost to Follow-up|3|||
105347929|NCT00314132|363275396|FG001|Overall Study|Lost to Follow-up|13|||
105347930|NCT00314132|363275395|FG000|Overall Study|Withdrawal by Subject|3|||
105347931|NCT00314132|363275396|FG001|Overall Study|Withdrawal by Subject|5|||
105347932|NCT00314132|363275395|FG000|Overall Study|Adverse Event|1|||
105347933|NCT00314132|363275396|FG001|Overall Study|Adverse Event|0|||
105347934|NCT00314132|363275395|FG000|Overall Study|Physician Decision|1|||
105473117|NCT02499328|363743637|FG018|Overall Study|Lost to Follow-up|1|||
105473118|NCT02499328|363743619|FG000|Overall Study|Death|0|||
105473119|NCT02499328|363743620|FG001|Overall Study|Death|3|||
105473120|NCT02499328|363743621|FG002|Overall Study|Death|3|||
105347935|NCT00314132|363275396|FG001|Overall Study|Physician Decision|0|||
105347936|NCT03677934|363275397|FG000|Overall Study|Adverse Event|1|||
105473121|NCT02499328|363743622|FG003|Overall Study|Death|2|||
105347937|NCT03677934|363275398|FG001|Overall Study|Adverse Event|1|||
105473122|NCT02499328|363743623|FG004|Overall Study|Death|4|||
105473123|NCT02499328|363743624|FG005|Overall Study|Death|7|||
105473124|NCT02499328|363743625|FG006|Overall Study|Death|3|||
105694506|NCT01177384|364545119|FG000|Overall Study|Protocol Violation|0|||
105694507|NCT01177384|364545120|FG001|Overall Study|Protocol Violation|2|||
105473125|NCT02499328|363743626|FG007|Overall Study|Death|0|||
105473126|NCT02499328|363743627|FG008|Overall Study|Death|2|||
105473127|NCT02499328|363743628|FG009|Overall Study|Death|6|||
105473128|NCT02499328|363743629|FG010|Overall Study|Death|6|||
105347938|NCT03677934|363275397|FG000|Overall Study|Death|8|||
105347939|NCT03677934|363275398|FG001|Overall Study|Death|4|||
105347940|NCT03677934|363275397|FG000|Overall Study|Lost to Follow-up|3|||
105347941|NCT03677934|363275398|FG001|Overall Study|Lost to Follow-up|0|||
105347942|NCT03677934|363275397|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105347943|NCT03677934|363275398|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105347944|NCT03677934|363275397|FG000|Overall Study|Physician Decision|0|||
105473129|NCT02499328|363743630|FG011|Overall Study|Death|20|||
105473130|NCT02499328|363743631|FG012|Overall Study|Death|9|||
105473131|NCT02499328|363743632|FG013|Overall Study|Death|7|||
105694508|NCT01177384|364545119|FG000|Overall Study|Withdrawal by Subject|5|||
105694509|NCT01177384|364545120|FG001|Overall Study|Withdrawal by Subject|12|||
105694510|NCT01009034|364545129|FG000|Overall Study|Lost to Follow-up|2|||
105694511|NCT01009034|364545129|FG000|Overall Study|Withdrawal by Subject|2|||
105694512|NCT03061175|364545133|FG000|Baseline|Participant was deemed ineligible|1|||
105347945|NCT03677934|363275398|FG001|Overall Study|Physician Decision|1|||
105473132|NCT02499328|363743633|FG014|Overall Study|Death|3|||
105473133|NCT02499328|363743634|FG015|Overall Study|Death|1|||
105473134|NCT02499328|363743635|FG016|Overall Study|Death|1|||
105694513|NCT03061175|364545134|FG001|Baseline|Participant was deemed ineligible|0|||
105347946|NCT03677934|363275397|FG000|Overall Study|Withdrawal by Subject|1|||
105347947|NCT03677934|363275398|FG001|Overall Study|Withdrawal by Subject|7|||
105347948|NCT00932451|363275402|FG000|Overall Study|Withdrawal by Subject|69|||
105347949|NCT00932451|363275402|FG000|Overall Study|Lost to Follow-up|22|||
105347950|NCT00932451|363275402|FG000|Overall Study|Death|726|||
105347951|NCT00932451|363275402|FG000|Overall Study|Other reasons|5|||
105347952|NCT00335959|363275403|FG000|Overall Study|Adverse Event|2|||
105347953|NCT00335959|363275403|FG000|Overall Study|Ineligible|1|||
105347954|NCT03564795|363275404|FG000|Overall Study|Withdrawal by Subject|3|||
105347955|NCT03564795|363275404|FG000|Overall Study|Lost to Follow-up|6|||
105347956|NCT03564795|363275404|FG000|Overall Study|Physician Decision|2|||
105347957|NCT05079230|363275405|FG000|Overall Study|Study Terminated by Sponsor|101|||
105347958|NCT05079230|363275406|FG001|Overall Study|Study Terminated by Sponsor|102|||
105347959|NCT05079230|363275405|FG000|Overall Study|Death|72|||
105347960|NCT05079230|363275406|FG001|Overall Study|Death|66|||
105347961|NCT05079230|363275405|FG000|Overall Study|Withdrew Consent|16|||
105347962|NCT05079230|363275406|FG001|Overall Study|Withdrew Consent|18|||
105347963|NCT05079230|363275405|FG000|Overall Study|Lost to Follow-up|0|||
105347964|NCT05079230|363275406|FG001|Overall Study|Lost to Follow-up|3|||
105347965|NCT01333956|363275407|FG000|Overall Study|Lost to Follow-up|1|||
105347966|NCT01333956|363275408|FG001|Overall Study|Lost to Follow-up|2|||
105347967|NCT01333956|363275409|FG002|Overall Study|Lost to Follow-up|0|||
105347968|NCT01333956|363275410|FG003|Overall Study|Lost to Follow-up|1|||
105347969|NCT01333956|363275407|FG000|Overall Study|Unable to complete study procedure|1|||
105347970|NCT01333956|363275408|FG001|Overall Study|Unable to complete study procedure|0|||
105347971|NCT01333956|363275409|FG002|Overall Study|Unable to complete study procedure|0|||
105347972|NCT01333956|363275410|FG003|Overall Study|Unable to complete study procedure|1|||
105347973|NCT01333956|363275407|FG000|Overall Study|Withdrawal by Subject|0|||
105473135|NCT02499328|363743636|FG017|Overall Study|Death|16|||
105473136|NCT02499328|363743637|FG018|Overall Study|Death|5|||
105473137|NCT02499328|363743619|FG000|Overall Study|"Other"|2|||
105473138|NCT02499328|363743620|FG001|Overall Study|"Other"|2|||
105473139|NCT02499328|363743621|FG002|Overall Study|"Other"|1|||
105694514|NCT03061175|364545133|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
105694515|NCT03061175|364545134|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
105347974|NCT01333956|363275408|FG001|Overall Study|Withdrawal by Subject|2|||
105347975|NCT01333956|363275409|FG002|Overall Study|Withdrawal by Subject|1|||
105347976|NCT01333956|363275410|FG003|Overall Study|Withdrawal by Subject|0|||
105347977|NCT03673345|363275411|FG000|Overall Study|Lost to Follow-up|1|||
105347978|NCT03673345|363275412|FG001|Overall Study|Lost to Follow-up|0|||
105347979|NCT03673345|363275413|FG002|Overall Study|Lost to Follow-up|3|||
105347980|NCT03673345|363275414|FG003|Overall Study|Lost to Follow-up|3|||
105347981|NCT03673345|363275415|FG004|Overall Study|Lost to Follow-up|2|||
105473140|NCT02499328|363743622|FG003|Overall Study|"Other"|3|||
105473141|NCT02499328|363743623|FG004|Overall Study|"Other"|6|||
105347982|NCT03673345|363275416|FG005|Overall Study|Lost to Follow-up|1|||
105347983|NCT03673345|363275417|FG006|Overall Study|Lost to Follow-up|0|||
105347984|NCT03673345|363275418|FG007|Overall Study|Lost to Follow-up|0|||
105347985|NCT03673345|363275411|FG000|Overall Study|Withdrawal by Subject|1|||
105347986|NCT03673345|363275412|FG001|Overall Study|Withdrawal by Subject|0|||
105347987|NCT03673345|363275413|FG002|Overall Study|Withdrawal by Subject|4|||
105347988|NCT03673345|363275414|FG003|Overall Study|Withdrawal by Subject|2|||
105347989|NCT03673345|363275415|FG004|Overall Study|Withdrawal by Subject|0|||
105347990|NCT03673345|363275416|FG005|Overall Study|Withdrawal by Subject|0|||
105347991|NCT03673345|363275417|FG006|Overall Study|Withdrawal by Subject|0|||
105347992|NCT03673345|363275418|FG007|Overall Study|Withdrawal by Subject|0|||
105347993|NCT03673345|363275411|FG000|Overall Study|Physician Decision|0|||
105347994|NCT03673345|363275412|FG001|Overall Study|Physician Decision|0|||
105347995|NCT03673345|363275413|FG002|Overall Study|Physician Decision|2|||
105347996|NCT03673345|363275414|FG003|Overall Study|Physician Decision|0|||
105347997|NCT03673345|363275415|FG004|Overall Study|Physician Decision|0|||
105347998|NCT03673345|363275416|FG005|Overall Study|Physician Decision|0|||
105347999|NCT03673345|363275417|FG006|Overall Study|Physician Decision|0|||
105348000|NCT03673345|363275418|FG007|Overall Study|Physician Decision|0|||
105348001|NCT01712334|363275419|FG000|Treatment Period 1|Randomized in Error|0|||
105348002|NCT01712334|363275420|FG001|Treatment Period 1|Randomized in Error|2|||
105348003|NCT00474786|363275421|FG000|Overall Study|Not Meeting Study Criteria|0|||
105348004|NCT00474786|363275422|FG001|Overall Study|Not Meeting Study Criteria|1|||
105348005|NCT00474786|363275421|FG000|Overall Study|Investigator Request|2|||
105348006|NCT00474786|363275422|FG001|Overall Study|Investigator Request|1|||
105348007|NCT00474786|363275421|FG000|Overall Study|Death|189|||
105348008|NCT00474786|363275422|FG001|Overall Study|Death|170|||
105348009|NCT00474786|363275421|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
105348010|NCT00474786|363275422|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
105348011|NCT00474786|363275421|FG000|Overall Study|Lost to Follow-up|4|||
105348012|NCT00474786|363275422|FG001|Overall Study|Lost to Follow-up|7|||
105348013|NCT00474786|363275421|FG000|Overall Study|Protocol Violation|2|||
105348014|NCT00474786|363275422|FG001|Overall Study|Protocol Violation|0|||
105348015|NCT00474786|363275421|FG000|Overall Study|Withdrawal by Subject|15|||
105348016|NCT00474786|363275422|FG001|Overall Study|Withdrawal by Subject|15|||
105348017|NCT00474786|363275421|FG000|Overall Study|Other|5|||
105348018|NCT00474786|363275422|FG001|Overall Study|Other|0|||
105348019|NCT04608344|363275423|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
105348020|NCT04608344|363275424|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
105348021|NCT04608344|363275423|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
105348022|NCT04608344|363275424|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
105348023|NCT01900431|363275430|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
105348024|NCT01900431|363275431|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
105348025|NCT01900431|363275432|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
105348026|NCT01900431|363275430|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
105348027|NCT01900431|363275431|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
105473142|NCT02499328|363743624|FG005|Overall Study|"Other"|2|||
105473143|NCT02499328|363743625|FG006|Overall Study|"Other"|3|||
105473144|NCT02499328|363743626|FG007|Overall Study|"Other"|4|||
105473145|NCT02499328|363743627|FG008|Overall Study|"Other"|6|||
105348028|NCT01900431|363275432|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
105348029|NCT01900431|363275430|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
105348030|NCT01900431|363275431|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
105787074|NCT03110107|364874906|FG017|Treatment Period|Disease Progression|3|||
105787075|NCT03110107|364874907|FG018|Treatment Period|Disease Progression|16|||
105348031|NCT01900431|363275432|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
105348032|NCT01900431|363275430|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
105348033|NCT01900431|363275431|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
105348034|NCT01900431|363275432|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
105473146|NCT02499328|363743628|FG009|Overall Study|"Other"|16|||
105473147|NCT02499328|363743629|FG010|Overall Study|"Other"|13|||
105348035|NCT01900431|363275430|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
105348036|NCT01900431|363275431|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
105348037|NCT01900431|363275432|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
105348038|NCT01900431|363275430|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
105348039|NCT01900431|363275431|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
105348040|NCT01900431|363275432|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
105348041|NCT01900431|363275430|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
105348042|NCT01900431|363275431|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
105348043|NCT01900431|363275432|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
105348044|NCT01900431|363275430|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
105348045|NCT01900431|363275431|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
105348046|NCT01900431|363275432|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
105348047|NCT01900431|363275430|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
105348048|NCT01900431|363275431|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
105348049|NCT01900431|363275432|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
105348050|NCT04226495|363275433|FG000|Overall Study|Withdrawal by Subject|3|||
105348051|NCT04226495|363275434|FG001|Overall Study|Withdrawal by Subject|3|||
105348052|NCT04226495|363275433|FG000|Overall Study|PI discretion|3|||
105348053|NCT04226495|363275434|FG001|Overall Study|PI discretion|4|||
105348054|NCT02093390|363275435|FG000|Overall Study|Withdrawal by Subject|0|||
105348055|NCT02093390|363275436|FG001|Overall Study|Withdrawal by Subject|1|||
105348056|NCT01854879|363275437|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
105348057|NCT01854879|363275437|FG000|Overall Study|screen fail|3|||
105348058|NCT01854879|363275437|FG000|Overall Study|incomplete data set|1|||
105348059|NCT00908596|363276962|FG000|Overall Study|Other reasons|46|||
105348060|NCT00908596|363276963|FG001|Overall Study|Other reasons|6|||
105348061|NCT00908596|363276964|FG002|Overall Study|Other reasons|2|||
105348062|NCT00908596|363276965|FG003|Overall Study|Other reasons|0|||
105348063|NCT00908596|363276962|FG000|Overall Study|Lost to Follow-up|0|||
105348064|NCT00908596|363276963|FG001|Overall Study|Lost to Follow-up|1|||
105348065|NCT00908596|363276964|FG002|Overall Study|Lost to Follow-up|12|||
105348066|NCT00908596|363276965|FG003|Overall Study|Lost to Follow-up|4|||
105348067|NCT00908596|363276962|FG000|Overall Study|Death|0|||
105348068|NCT00908596|363276963|FG001|Overall Study|Death|5|||
105348069|NCT00908596|363276964|FG002|Overall Study|Death|57|||
105348070|NCT00908596|363276965|FG003|Overall Study|Death|32|||
105348071|NCT00908596|363276962|FG000|Overall Study|Protocol Violation|1|||
105348072|NCT00908596|363276963|FG001|Overall Study|Protocol Violation|0|||
105348073|NCT00908596|363276964|FG002|Overall Study|Protocol Violation|0|||
105348074|NCT00908596|363276965|FG003|Overall Study|Protocol Violation|0|||
105348075|NCT00908596|363276962|FG000|Overall Study|Withdrawal by Subject|0|||
105348076|NCT00908596|363276963|FG001|Overall Study|Withdrawal by Subject|1|||
105348077|NCT00908596|363276964|FG002|Overall Study|Withdrawal by Subject|3|||
105348078|NCT00908596|363276965|FG003|Overall Study|Withdrawal by Subject|1|||
105348079|NCT01937884|363276970|FG000|Overall Study|Withdrawal by Subject|1|||
105348080|NCT01937884|363276971|FG001|Overall Study|Withdrawal by Subject|0|||
105348081|NCT02305446|363276972|FG000|Overall Study|Adverse Event|1|||
105348082|NCT00577005|363276976|FG000|Overall Study|Lost to Follow-up|3|||
105348083|NCT00577005|363276977|FG001|Overall Study|Lost to Follow-up|2|||
105348084|NCT00577005|363276976|FG000|Overall Study|Withdrawal by Subject|2|||
105348085|NCT00577005|363276977|FG001|Overall Study|Withdrawal by Subject|1|||
105473148|NCT02499328|363743630|FG011|Overall Study|"Other"|31|||
105473149|NCT02499328|363743631|FG012|Overall Study|"Other"|8|||
105473150|NCT02499328|363743632|FG013|Overall Study|"Other"|7|||
105473151|NCT02499328|363743633|FG014|Overall Study|"Other"|6|||
105473152|NCT02499328|363743634|FG015|Overall Study|"Other"|0|||
105473153|NCT02499328|363743635|FG016|Overall Study|"Other"|0|||
105473154|NCT02499328|363743636|FG017|Overall Study|"Other"|34|||
105473155|NCT02499328|363743637|FG018|Overall Study|"Other"|43|||
105473156|NCT02499328|363743619|FG000|Overall Study|Disease Progression|0|||
105473157|NCT02499328|363743620|FG001|Overall Study|Disease Progression|0|||
105473158|NCT02499328|363743621|FG002|Overall Study|Disease Progression|0|||
105473159|NCT02499328|363743622|FG003|Overall Study|Disease Progression|0|||
105473160|NCT02499328|363743623|FG004|Overall Study|Disease Progression|0|||
105473161|NCT02499328|363743624|FG005|Overall Study|Disease Progression|0|||
105473162|NCT02499328|363743625|FG006|Overall Study|Disease Progression|1|||
105473163|NCT02499328|363743626|FG007|Overall Study|Disease Progression|0|||
105473164|NCT02499328|363743627|FG008|Overall Study|Disease Progression|1|||
105473165|NCT02499328|363743628|FG009|Overall Study|Disease Progression|0|||
105473166|NCT02499328|363743629|FG010|Overall Study|Disease Progression|1|||
105348086|NCT01004432|363276978|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
105348087|NCT01004432|363276979|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
105348088|NCT01004432|363276980|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
105348089|NCT01004432|363276981|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
105473167|NCT02499328|363743630|FG011|Overall Study|Disease Progression|0|||
105473168|NCT02499328|363743631|FG012|Overall Study|Disease Progression|0|||
105694516|NCT03061175|364545133|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
105694517|NCT03061175|364545134|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
105694518|NCT03061175|364545133|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
105694519|NCT03061175|364545134|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
105694520|NCT02243865|364545135|FG000|Overall Study|Protocol Violation|1|||
105694521|NCT02243865|364545136|FG001|Overall Study|Protocol Violation|3|||
105694522|NCT02243865|364545135|FG000|Overall Study|Lost to Follow-up|1|||
105694523|NCT02243865|364545136|FG001|Overall Study|Lost to Follow-up|1|||
105694524|NCT02243865|364545135|FG000|Overall Study|Withdrawal by Subject|1|||
105694525|NCT02243865|364545136|FG001|Overall Study|Withdrawal by Subject|0|||
105694526|NCT02243865|364545135|FG000|Overall Study|Adverse Event|1|||
105694527|NCT02243865|364545136|FG001|Overall Study|Adverse Event|1|||
105694528|NCT03044249|364545137|FG000|Overall Study|Adverse Event|4|||
105348090|NCT01004432|363276982|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
105694529|NCT03044249|364545138|FG001|Overall Study|Adverse Event|9|||
105694530|NCT03044249|364545137|FG000|Overall Study|Lost to Follow-up|1|||
105694531|NCT03044249|364545138|FG001|Overall Study|Lost to Follow-up|0|||
105348091|NCT01004432|363276978|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
105348092|NCT01004432|363276979|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
105348093|NCT01004432|363276980|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
105348094|NCT01004432|363276981|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
105348095|NCT01004432|363276982|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
105348096|NCT01004432|363276978|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
105348097|NCT01004432|363276979|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
105348098|NCT01004432|363276980|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
105348099|NCT01004432|363276981|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
105348100|NCT01004432|363276982|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
105348101|NCT01004432|363276978|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
105348102|NCT01004432|363276979|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
105348103|NCT01004432|363276980|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
105348104|NCT01004432|363276981|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
105348105|NCT01004432|363276982|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
105348106|NCT01004432|363276978|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
105348107|NCT01004432|363276979|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
105348108|NCT01004432|363276980|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
105348109|NCT01004432|363276981|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
105348110|NCT01004432|363276982|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
105348111|NCT01004432|363276978|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
105348112|NCT01004432|363276979|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
105348113|NCT01004432|363276980|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
105348114|NCT01004432|363276981|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
105348115|NCT01004432|363276982|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
105348116|NCT01004432|363276978|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
105348117|NCT01004432|363276979|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
105348118|NCT01004432|363276980|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
105348119|NCT01004432|363276981|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
105348120|NCT01004432|363276982|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
105348121|NCT01004432|363276978|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
105348122|NCT01004432|363276979|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
105348123|NCT01004432|363276980|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
105348124|NCT01004432|363276981|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
105348125|NCT01004432|363276982|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
105348126|NCT01004432|363276978|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
105348127|NCT01004432|363276979|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
105348128|NCT01004432|363276980|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
105348129|NCT01004432|363276981|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
105348130|NCT01004432|363276982|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
105348131|NCT01004432|363276978|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
105348132|NCT01004432|363276979|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
105348133|NCT01004432|363276980|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
105348134|NCT01004432|363276981|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
105348135|NCT01004432|363276982|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
105348136|NCT01004432|363276978|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
105348137|NCT01004432|363276979|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
105348138|NCT01004432|363276980|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
105348139|NCT01004432|363276981|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
105348140|NCT01004432|363276982|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
105348141|NCT01004432|363276978|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
105348142|NCT01004432|363276979|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
105348143|NCT01004432|363276980|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
105348144|NCT01004432|363276981|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
105348145|NCT01004432|363276982|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
105348146|NCT01004432|363276978|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
105348147|NCT01004432|363276979|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
105348148|NCT01004432|363276980|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
105348149|NCT01004432|363276981|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
105348150|NCT01004432|363276982|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
105694532|NCT03044249|364545137|FG000|Overall Study|Non-compliance with Study Drug|1|||
105694533|NCT03044249|364545138|FG001|Overall Study|Non-compliance with Study Drug|0|||
105694534|NCT03044249|364545137|FG000|Overall Study|Study Terminated by Sponsor|2|||
105694535|NCT03044249|364545138|FG001|Overall Study|Study Terminated by Sponsor|0|||
105787076|NCT03110107|364874908|FG019|Treatment Period|Disease Progression|14|||
105787077|NCT03110107|364874909|FG020|Treatment Period|Disease Progression|12|||
105787078|NCT03110107|364874910|FG021|Treatment Period|Disease Progression|16|||
105473169|NCT02499328|363743632|FG013|Overall Study|Disease Progression|0|||
105473170|NCT02499328|363743633|FG014|Overall Study|Disease Progression|0|||
105473171|NCT02499328|363743634|FG015|Overall Study|Disease Progression|0|||
105473172|NCT02499328|363743635|FG016|Overall Study|Disease Progression|0|||
105473173|NCT02499328|363743636|FG017|Overall Study|Disease Progression|2|||
105473174|NCT02499328|363743637|FG018|Overall Study|Disease Progression|0|||
105473175|NCT02499328|363743619|FG000|Overall Study|Adverse Event|1|||
105473176|NCT02499328|363743620|FG001|Overall Study|Adverse Event|0|||
105473177|NCT02499328|363743621|FG002|Overall Study|Adverse Event|0|||
105473178|NCT02499328|363743622|FG003|Overall Study|Adverse Event|1|||
105473179|NCT02499328|363743623|FG004|Overall Study|Adverse Event|0|||
105473180|NCT02499328|363743624|FG005|Overall Study|Adverse Event|0|||
105473181|NCT02499328|363743625|FG006|Overall Study|Adverse Event|0|||
105473182|NCT02499328|363743626|FG007|Overall Study|Adverse Event|0|||
105473183|NCT02499328|363743627|FG008|Overall Study|Adverse Event|0|||
105473184|NCT02499328|363743628|FG009|Overall Study|Adverse Event|0|||
105473185|NCT02499328|363743629|FG010|Overall Study|Adverse Event|0|||
105473186|NCT02499328|363743630|FG011|Overall Study|Adverse Event|0|||
105473187|NCT02499328|363743631|FG012|Overall Study|Adverse Event|1|||
105473188|NCT02499328|363743632|FG013|Overall Study|Adverse Event|0|||
105473189|NCT02499328|363743633|FG014|Overall Study|Adverse Event|0|||
105473190|NCT02499328|363743634|FG015|Overall Study|Adverse Event|0|||
105473191|NCT02499328|363743635|FG016|Overall Study|Adverse Event|0|||
105473192|NCT02499328|363743636|FG017|Overall Study|Adverse Event|0|||
105473193|NCT02499328|363743637|FG018|Overall Study|Adverse Event|0|||
105484957|NCT04972630|363787017|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
105484958|NCT04656275|363787018|FG000|Overall Study|Study terminated by sponsor|2|||
105484959|NCT04656275|363787019|FG001|Overall Study|Study terminated by sponsor|4|||
105484960|NCT00159822|363787023|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
105484961|NCT00159822|363787023|FG000|Voriconazole Treatment Period|Adverse Event|9|||
105484962|NCT00159822|363787023|FG000|Voriconazole Treatment Period|Death|4|||
105484963|NCT00159822|363787023|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
105484964|NCT00159822|363787023|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
105484965|NCT00159822|363787023|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
105694536|NCT03044249|364545137|FG000|Overall Study|Withdrawal by Subject|2|||
105484966|NCT00159822|363787023|FG000|Post-treatment Follow-up Period|Death|1|||
105484967|NCT00159822|363787023|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
105484968|NCT00159822|363787023|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
105484969|NCT01895361|363787031|FG000|Overall Study|Adverse Event|1|||
105484970|NCT01895361|363787032|FG001|Overall Study|Adverse Event|1|||
105484971|NCT01895361|363787033|FG002|Overall Study|Adverse Event|3|||
105484972|NCT01895361|363787031|FG000|Overall Study|Death|2|||
105694537|NCT03044249|364545138|FG001|Overall Study|Withdrawal by Subject|5|||
105694538|NCT02966223|364545145|FG000|Overall Study|Physician Decision|3|||
105694539|NCT02966223|364545145|FG000|Overall Study|Withdrawal by Subject|11|||
105694540|NCT02966223|364545145|FG000|Overall Study|Lost to Follow-up|1|||
105694541|NCT02003014|364545148|FG000|Overall Study|Case report forms uncollected|9|||
105694542|NCT02003014|364545148|FG000|Overall Study|Treatment started after contract period|1|||
105694543|NCT02003014|364545148|FG000|Overall Study|Patient did not visit the study site|5|||
105484973|NCT01895361|363787032|FG001|Overall Study|Death|1|||
105484974|NCT01895361|363787033|FG002|Overall Study|Death|2|||
105484975|NCT01895361|363787031|FG000|Overall Study|Lost to Follow-up|4|||
105484976|NCT01895361|363787032|FG001|Overall Study|Lost to Follow-up|4|||
105484977|NCT01895361|363787033|FG002|Overall Study|Lost to Follow-up|6|||
105484978|NCT01895361|363787031|FG000|Overall Study|Non-compliance with study|1|||
105484979|NCT01895361|363787032|FG001|Overall Study|Non-compliance with study|3|||
105484980|NCT01895361|363787033|FG002|Overall Study|Non-compliance with study|1|||
105484981|NCT01895361|363787031|FG000|Overall Study|Physician Decision|2|||
105694544|NCT02003014|364545148|FG000|Overall Study|Investigator's transfer|4|||
105484982|NCT01895361|363787032|FG001|Overall Study|Physician Decision|2|||
105694545|NCT01660451|364545149|FG000|Overall Study|Protocol Violation|0|||
105473194|NCT02175199|363745268|FG000|Overall Study|Withdrawal by Subject|1|||
105473195|NCT02175199|363745269|FG001|Overall Study|Withdrawal by Subject|5|||
105473196|NCT02175199|363745268|FG000|Overall Study|Randomized in Error|1|||
105473197|NCT02175199|363745269|FG001|Overall Study|Randomized in Error|0|||
105473198|NCT02175199|363745268|FG000|Overall Study|Sponsor Decision|1|||
105473199|NCT02175199|363745269|FG001|Overall Study|Sponsor Decision|0|||
105473200|NCT01193257|363745274|FG000|Overall Study|Death|202|||
105473201|NCT01193257|363745275|FG001|Overall Study|Death|391|||
105473202|NCT01193257|363745274|FG000|Overall Study|Study termination by sponsor|0|||
105473203|NCT01193257|363745275|FG001|Overall Study|Study termination by sponsor|3|||
105473204|NCT01193257|363745274|FG000|Overall Study|Withdrawal by Subject|26|||
105473205|NCT01193257|363745275|FG001|Overall Study|Withdrawal by Subject|86|||
105473206|NCT01193257|363745274|FG000|Overall Study|Lost to Follow-up|2|||
105473207|NCT01193257|363745275|FG001|Overall Study|Lost to Follow-up|3|||
105473208|NCT01193257|363745274|FG000|Overall Study|Unblinded due to futility|135|||
105473209|NCT01193257|363745275|FG001|Overall Study|Unblinded due to futility|251|||
105473210|NCT00375609|363745276|FG000|Overall Study|Did not receive treatment|1|||
105473211|NCT00375609|363745277|FG001|Overall Study|Did not receive treatment|0|||
105473212|NCT00375609|363745278|FG002|Overall Study|Did not receive treatment|0|||
105473213|NCT00375609|363745276|FG000|Overall Study|Adverse Event|0|||
105473214|NCT00375609|363745277|FG001|Overall Study|Adverse Event|3|||
105473215|NCT00375609|363745278|FG002|Overall Study|Adverse Event|0|||
105473216|NCT00375609|363745276|FG000|Overall Study|Lost to Follow-up|1|||
105473217|NCT00375609|363745277|FG001|Overall Study|Lost to Follow-up|0|||
105473218|NCT00375609|363745278|FG002|Overall Study|Lost to Follow-up|0|||
105473219|NCT00375609|363745276|FG000|Overall Study|Physician Decision|0|||
105473220|NCT00375609|363745277|FG001|Overall Study|Physician Decision|0|||
105473221|NCT00375609|363745278|FG002|Overall Study|Physician Decision|1|||
105473222|NCT00375609|363745276|FG000|Overall Study|Withdrawal by Subject|1|||
105473223|NCT00375609|363745277|FG001|Overall Study|Withdrawal by Subject|4|||
105473224|NCT00375609|363745278|FG002|Overall Study|Withdrawal by Subject|0|||
105473225|NCT00375609|363745276|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
105473226|NCT00375609|363745277|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
105473227|NCT00375609|363745278|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
105473228|NCT00792571|363745279|FG000|Overall Study|Death|1|||
105473229|NCT00792571|363745279|FG000|Overall Study|Adverse Event|4|||
105473230|NCT00792571|363745279|FG000|Overall Study|Withdrawal by Subject|1|||
105473231|NCT00792571|363745279|FG000|Overall Study|Other|4|||
105473232|NCT01754727|363745280|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
105473233|NCT01715857|363745281|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
105473234|NCT00505778|363745282|FG000|Overall Study|Adverse Event|2|||
105473235|NCT00505778|363745283|FG001|Overall Study|Adverse Event|7|||
105473236|NCT00505778|363745282|FG000|Overall Study|Physician Decision|8|||
105473237|NCT00505778|363745283|FG001|Overall Study|Physician Decision|14|||
105473238|NCT00505778|363745282|FG000|Overall Study|Lost to Follow-up|17|||
105473239|NCT00505778|363745283|FG001|Overall Study|Lost to Follow-up|23|||
105473240|NCT00505778|363745282|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
105473241|NCT00505778|363745283|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
105473242|NCT00505778|363745282|FG000|Overall Study|Protocol Violation|7|||
105473243|NCT00505778|363745283|FG001|Overall Study|Protocol Violation|9|||
105559198|NCT03364751|364044608|FG002|Overall Study|Withdrawal by Subject|0|||
105559199|NCT03364751|364044609|FG003|Overall Study|Withdrawal by Subject|0|||
105559200|NCT03364751|364044606|FG000|Overall Study|Lost to Follow-up|0|||
105473244|NCT00505778|363745282|FG000|Overall Study|Withdrawal by Subject|29|||
105473245|NCT00505778|363745283|FG001|Overall Study|Withdrawal by Subject|14|||
105473246|NCT00505778|363745282|FG000|Overall Study|Relapse|65|||
105473247|NCT00505778|363745283|FG001|Overall Study|Relapse|65|||
105473248|NCT00505778|363745282|FG000|Overall Study|Took No Study Drug|2|||
105473249|NCT00505778|363745283|FG001|Overall Study|Took No Study Drug|2|||
105473250|NCT03790696|363745284|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
105473251|NCT03790696|363745285|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
105473252|NCT01149148|363745286|FG000|Overall Study|Lost to Follow-up|1|||
105473253|NCT01149148|363745287|FG001|Overall Study|Lost to Follow-up|2|||
105473254|NCT01149148|363745286|FG000|Overall Study|Death|1|||
105473255|NCT01149148|363745287|FG001|Overall Study|Death|0|||
105473256|NCT01330108|363745288|FG000|Overall Study|Withdrawal by Subject|4|||
105473257|NCT01175083|363745289|FG000|Primary Epoch|Withdrawal by Subject|0|||
105694546|NCT01660451|364545150|FG001|Overall Study|Protocol Violation|1|||
105694547|NCT01660451|364545151|FG002|Overall Study|Protocol Violation|1|||
105694548|NCT01660451|364545149|FG000|Overall Study|AE not associated with clinical disease progression|13|||
105694549|NCT01660451|364545150|FG001|Overall Study|AE not associated with clinical disease progression|10|||
105694550|NCT01660451|364545151|FG002|Overall Study|AE not associated with clinical disease progression|40|||
105694551|NCT01660451|364545149|FG000|Overall Study|AE associated with clinical disease progression|1|||
105694552|NCT01660451|364545150|FG001|Overall Study|AE associated with clinical disease progression|3|||
105694553|NCT01660451|364545151|FG002|Overall Study|AE associated with clinical disease progression|11|||
105694554|NCT01660451|364545149|FG000|Overall Study|Sponsor Decision|0|||
105694555|NCT01660451|364545150|FG001|Overall Study|Sponsor Decision|0|||
105694556|NCT01660451|364545151|FG002|Overall Study|Sponsor Decision|1|||
105694557|NCT01660451|364545149|FG000|Overall Study|Protocol Deviation|0|||
105694558|NCT01660451|364545150|FG001|Overall Study|Protocol Deviation|0|||
105694559|NCT01660451|364545151|FG002|Overall Study|Protocol Deviation|1|||
105694560|NCT01660451|364545149|FG000|Overall Study|Physician Decision|1|||
105694561|NCT01660451|364545150|FG001|Overall Study|Physician Decision|2|||
105694562|NCT01660451|364545151|FG002|Overall Study|Physician Decision|5|||
105694563|NCT01660451|364545149|FG000|Overall Study|Withdrawal by Subject|1|||
105694564|NCT01660451|364545150|FG001|Overall Study|Withdrawal by Subject|1|||
105694565|NCT01660451|364545151|FG002|Overall Study|Withdrawal by Subject|20|||
105694566|NCT01660451|364545149|FG000|Overall Study|Trial closure.|0|||
105694567|NCT01660451|364545150|FG001|Overall Study|Trial closure.|0|||
105694568|NCT01660451|364545151|FG002|Overall Study|Trial closure.|1|||
105694569|NCT01660451|364545149|FG000|Overall Study|Switching to other therapy|0|||
105694570|NCT01660451|364545150|FG001|Overall Study|Switching to other therapy|1|||
105694571|NCT01660451|364545151|FG002|Overall Study|Switching to other therapy|1|||
105694572|NCT01660451|364545149|FG000|Overall Study|Progressive disease - clinical progression|4|||
105694573|NCT01660451|364545150|FG001|Overall Study|Progressive disease - clinical progression|10|||
105694574|NCT01660451|364545151|FG002|Overall Study|Progressive disease - clinical progression|9|||
105694575|NCT01660451|364545149|FG000|Overall Study|Progressive disease - radiological progression|12|||
105694576|NCT01660451|364545150|FG001|Overall Study|Progressive disease - radiological progression|23|||
105694577|NCT01660451|364545151|FG002|Overall Study|Progressive disease - radiological progression|50|||
105694578|NCT01660451|364545149|FG000|Overall Study|Death|1|||
105694579|NCT01660451|364545150|FG001|Overall Study|Death|0|||
105694580|NCT01660451|364545151|FG002|Overall Study|Death|1|||
105694581|NCT01660451|364545149|FG000|Overall Study|Other|0|||
105694582|NCT01660451|364545150|FG001|Overall Study|Other|0|||
105694583|NCT01660451|364545151|FG002|Overall Study|Other|1|||
105694584|NCT03785678|364545152|FG000|Overall Study|Death|44|||
105694585|NCT03785678|364545153|FG001|Overall Study|Death|42|||
105694586|NCT03785678|364545152|FG000|Overall Study|Lost to Follow-up|4|||
105694587|NCT03785678|364545153|FG001|Overall Study|Lost to Follow-up|2|||
105694588|NCT03785678|364545152|FG000|Overall Study|Physician Decision|0|||
105694589|NCT03785678|364545153|FG001|Overall Study|Physician Decision|2|||
105694590|NCT03785678|364545152|FG000|Overall Study|Withdrawal by Subject|5|||
105694591|NCT03785678|364545153|FG001|Overall Study|Withdrawal by Subject|3|||
105694592|NCT01159912|364545154|FG000|Overall Study|Adverse Event|2|||
105694593|NCT01159912|364545155|FG001|Overall Study|Adverse Event|2|||
105694594|NCT01159912|364545156|FG002|Overall Study|Adverse Event|3|||
105348151|NCT01004432|363276978|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
105694595|NCT01159912|364545154|FG000|Overall Study|Lack of Efficacy|23|||
105694596|NCT01159912|364545155|FG001|Overall Study|Lack of Efficacy|15|||
105694597|NCT01159912|364545156|FG002|Overall Study|Lack of Efficacy|14|||
105694598|NCT01159912|364545154|FG000|Overall Study|Protocol Violation|1|||
105694599|NCT01159912|364545155|FG001|Overall Study|Protocol Violation|2|||
105694600|NCT01159912|364545156|FG002|Overall Study|Protocol Violation|3|||
105694601|NCT01159912|364545154|FG000|Overall Study|Lost to Follow-up|4|||
105694602|NCT01159912|364545155|FG001|Overall Study|Lost to Follow-up|0|||
105694603|NCT01159912|364545156|FG002|Overall Study|Lost to Follow-up|0|||
105694604|NCT01159912|364545154|FG000|Overall Study|Physician Decision|0|||
105694605|NCT01159912|364545155|FG001|Overall Study|Physician Decision|0|||
105694606|NCT01159912|364545156|FG002|Overall Study|Physician Decision|3|||
105348152|NCT01004432|363276979|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
105348153|NCT01004432|363276980|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
105348154|NCT01004432|363276981|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
105348155|NCT01004432|363276982|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
105694607|NCT01159912|364545154|FG000|Overall Study|Withdrawal by Subject|10|||
105694608|NCT01159912|364545155|FG001|Overall Study|Withdrawal by Subject|3|||
105694609|NCT01159912|364545156|FG002|Overall Study|Withdrawal by Subject|3|||
105694610|NCT02456662|364545157|FG000|Overall Study|Lost to Follow-up|2|||
105694611|NCT02456662|364545158|FG001|Overall Study|Lost to Follow-up|1|||
105694612|NCT02322229|364545159|FG000|Overall Study|Physician Decision|2|||
105694613|NCT01667107|364545160|FG000|Overall Study|Adverse Event|4|||
105694614|NCT01667107|364545161|FG001|Overall Study|Adverse Event|3|||
105787079|NCT03110107|364874911|FG022|Treatment Period|Disease Progression|18|||
105787080|NCT03110107|364874912|FG023|Treatment Period|Disease Progression|13|||
105787081|NCT03110107|364874913|FG024|Treatment Period|Disease Progression|16|||
105787082|NCT03110107|364874914|FG025|Treatment Period|Disease Progression|31|||
105787083|NCT03110107|364874889|FG000|Treatment Period|Study drug toxicity|1|||
105787084|NCT03110107|364874890|FG001|Treatment Period|Study drug toxicity|0|||
105787085|NCT03110107|364874891|FG002|Treatment Period|Study drug toxicity|1|||
105787086|NCT03110107|364874892|FG003|Treatment Period|Study drug toxicity|2|||
105787087|NCT03110107|364874893|FG004|Treatment Period|Study drug toxicity|0|||
105787088|NCT03110107|364874894|FG005|Treatment Period|Study drug toxicity|3|||
105787089|NCT03110107|364874895|FG006|Treatment Period|Study drug toxicity|1|||
105787090|NCT03110107|364874896|FG007|Treatment Period|Study drug toxicity|1|||
105787091|NCT03110107|364874897|FG008|Treatment Period|Study drug toxicity|3|||
105787092|NCT03110107|364874898|FG009|Treatment Period|Study drug toxicity|2|||
105787093|NCT03110107|364874899|FG010|Treatment Period|Study drug toxicity|0|||
105787094|NCT03110107|364874900|FG011|Treatment Period|Study drug toxicity|2|||
105787095|NCT03110107|364874901|FG012|Treatment Period|Study drug toxicity|0|||
105348156|NCT01004432|363276978|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
105348157|NCT01004432|363276979|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
105348158|NCT01004432|363276980|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
105348159|NCT01004432|363276981|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
105348160|NCT01004432|363276982|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
105348161|NCT00427999|363276984|FG000|Overall Study|Adverse Event|6|||
105694615|NCT01667107|364545160|FG000|Overall Study|Tolerability issues|0|||
105694616|NCT01667107|364545161|FG001|Overall Study|Tolerability issues|2|||
105787096|NCT03110107|364874902|FG013|Treatment Period|Study drug toxicity|0|||
105787097|NCT03110107|364874903|FG014|Treatment Period|Study drug toxicity|2|||
105787098|NCT03110107|364874904|FG015|Treatment Period|Study drug toxicity|3|||
105694617|NCT01667107|364545160|FG000|Overall Study|Protocol Violation|0|||
105348162|NCT00427999|363276984|FG000|Overall Study|Abnormal laboratory values|1|||
105694618|NCT01667107|364545161|FG001|Overall Study|Protocol Violation|1|||
105787099|NCT03110107|364874905|FG016|Treatment Period|Study drug toxicity|3|||
105694619|NCT01667107|364545160|FG000|Overall Study|Lack of Efficacy|0|||
105694620|NCT01667107|364545161|FG001|Overall Study|Lack of Efficacy|1|||
105694621|NCT02281357|364545162|FG000|Overall Study|Adverse Event|2|||
105694622|NCT02281357|364545163|FG001|Overall Study|Adverse Event|1|||
105694623|NCT02281357|364545162|FG000|Overall Study|Lost to Follow-up|1|||
105694624|NCT02281357|364545163|FG001|Overall Study|Lost to Follow-up|0|||
105694625|NCT02281357|364545162|FG000|Overall Study|Withdrawal by Subject|4|||
105694626|NCT02281357|364545163|FG001|Overall Study|Withdrawal by Subject|3|||
105694627|NCT00493220|364545164|FG000|Third Intervention|Withdrawal by Subject|1|||
105694628|NCT00493220|364545165|FG001|Third Intervention|Withdrawal by Subject|0|||
105694629|NCT00493220|364545166|FG002|Third Intervention|Withdrawal by Subject|0|||
105694630|NCT00493220|364545167|FG003|Third Intervention|Withdrawal by Subject|0|||
105694631|NCT00493220|364545168|FG004|Third Intervention|Withdrawal by Subject|0|||
105694632|NCT00493220|364545169|FG005|Third Intervention|Withdrawal by Subject|0|||
105694633|NCT04376827|364545171|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
105694634|NCT04376827|364545172|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
105694635|NCT04376827|364545171|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
105694636|NCT04376827|364545172|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
105694637|NCT04376827|364545171|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
105694638|NCT04376827|364545172|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
105694639|NCT04376827|364545171|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
105694640|NCT04376827|364545172|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
105694641|NCT04376827|364545171|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
105694642|NCT04376827|364545172|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
105694643|NCT04042740|364546252|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
105694644|NCT04042740|364546252|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
105694645|NCT01809132|364546255|FG000|Overall Study|Withdrawal by Subject|0|||
105694646|NCT01809132|364546256|FG001|Overall Study|Withdrawal by Subject|0|||
105694647|NCT01809132|364546257|FG002|Overall Study|Withdrawal by Subject|1|||
105694648|NCT01480284|364546258|FG000|Overall Study|Withdrawal by Subject|2|||
105694649|NCT01480284|364546259|FG001|Overall Study|Withdrawal by Subject|0|||
105694650|NCT01480284|364546258|FG000|Overall Study|Adverse Event|1|||
105694651|NCT01480284|364546259|FG001|Overall Study|Adverse Event|0|||
105694652|NCT01480284|364546258|FG000|Overall Study|Study closed/terminated|3|||
105694653|NCT01480284|364546259|FG001|Overall Study|Study closed/terminated|0|||
105694654|NCT01480284|364546258|FG000|Overall Study|Lost to Follow-up|1|||
105694655|NCT01480284|364546259|FG001|Overall Study|Lost to Follow-up|0|||
105694656|NCT01480284|364546258|FG000|Overall Study|Physician Decision|1|||
105694657|NCT01480284|364546259|FG001|Overall Study|Physician Decision|0|||
105694658|NCT00832117|364546260|FG000|Overall Study|Death|1|||
105694659|NCT00832117|364546260|FG000|Overall Study|Disease Progression|11|||
105694660|NCT04439071|364546261|FG000|Overall Study|Lost to Follow-up|0|||
105694661|NCT04439071|364546262|FG001|Overall Study|Lost to Follow-up|3|||
105694662|NCT04439071|364546261|FG000|Overall Study|Withdrawal by Subject|3|||
105694663|NCT04439071|364546262|FG001|Overall Study|Withdrawal by Subject|8|||
105694664|NCT04439071|364546261|FG000|Overall Study|Death|6|||
105694665|NCT04439071|364546262|FG001|Overall Study|Death|4|||
105694666|NCT04439071|364546261|FG000|Overall Study|Other than specified|3|||
105694667|NCT04439071|364546262|FG001|Overall Study|Other than specified|3|||
105694668|NCT04439071|364546261|FG000|Overall Study|Randomized but not treated|2|||
105694669|NCT04439071|364546262|FG001|Overall Study|Randomized but not treated|0|||
105694670|NCT00529451|364546275|FG000|Overall Study|Subject withdrew consent|16|||
105694671|NCT00529451|364546276|FG001|Overall Study|Subject withdrew consent|21|||
105694672|NCT00529451|364546277|FG002|Overall Study|Subject withdrew consent|13|||
105694673|NCT00529451|364546278|FG003|Overall Study|Subject withdrew consent|12|||
105694674|NCT00529451|364546275|FG000|Overall Study|Adverse Event|9|||
105694675|NCT00529451|364546276|FG001|Overall Study|Adverse Event|16|||
105694676|NCT00529451|364546277|FG002|Overall Study|Adverse Event|14|||
105694677|NCT00529451|364546278|FG003|Overall Study|Adverse Event|8|||
105694678|NCT00529451|364546275|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
105694679|NCT00529451|364546276|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
105694680|NCT00529451|364546277|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
105694681|NCT00529451|364546278|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
105694682|NCT00529451|364546275|FG000|Overall Study|Lost to Follow-up|4|||
105348163|NCT00427999|363276984|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
105348164|NCT00427999|363276984|FG000|Overall Study|Protocol Violation|2|||
105348165|NCT00427999|363276984|FG000|Overall Study|Withdrawal by Subject|9|||
105348166|NCT00427999|363276984|FG000|Overall Study|Death|1|||
105348167|NCT02380859|363276985|FG000|Overall Study|Withdrawal by Subject|2|||
105348168|NCT02380859|363276986|FG001|Overall Study|Withdrawal by Subject|0|||
105348169|NCT02971800|363276987|FG000|Overall Study|Protocol Violation|1|||
105348170|NCT02971800|363276987|FG000|Overall Study|Withdrawal by Subject|1|||
105348171|NCT02971800|363276987|FG000|Overall Study|Exclusion criteria prior intervention|1|||
105348172|NCT02971800|363276987|FG000|Overall Study|Number evaluable participant already reached|4|||
105348173|NCT02223819|363276990|FG000|Overall Study|Lost to Follow-up|2|||
105348174|NCT01069419|363276993|FG000|Overall Study|Adverse Event|233|||
105348175|NCT01069419|363276993|FG000|Overall Study|Lack of Efficacy|332|||
105694683|NCT00529451|364546276|FG001|Overall Study|Lost to Follow-up|7|||
105694684|NCT00529451|364546277|FG002|Overall Study|Lost to Follow-up|4|||
105694685|NCT00529451|364546278|FG003|Overall Study|Lost to Follow-up|4|||
105348176|NCT01069419|363276993|FG000|Overall Study|Lost to Follow-up|49|||
105348177|NCT01069419|363276993|FG000|Overall Study|Remission of disease|11|||
105348178|NCT01069419|363276993|FG000|Overall Study|Withdrawal by Subject|34|||
105348179|NCT01069419|363276993|FG000|Overall Study|Other Reason|43|||
105694686|NCT00529451|364546275|FG000|Overall Study|Protocol deviation|1|||
105694687|NCT00529451|364546276|FG001|Overall Study|Protocol deviation|1|||
105694688|NCT00529451|364546277|FG002|Overall Study|Protocol deviation|4|||
105694689|NCT00529451|364546278|FG003|Overall Study|Protocol deviation|1|||
105348180|NCT01069419|363276993|FG000|Overall Study|Missing termination information|13|||
105348181|NCT04007107|363276994|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
105348182|NCT04007107|363276995|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
105348183|NCT04007107|363276996|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
105348184|NCT04007107|363276997|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
105348185|NCT04027075|363276998|FG000|Overall Study|Lost to Follow-up|41|||
105348186|NCT04027075|363276999|FG001|Overall Study|Lost to Follow-up|22|||
105348187|NCT02631070|363277002|FG000|Overall Study|Withdrawal by Subject|35|||
105348188|NCT02631070|363277003|FG001|Overall Study|Withdrawal by Subject|13|||
105348189|NCT02631070|363277002|FG000|Overall Study|Death|45|||
105348190|NCT02631070|363277003|FG001|Overall Study|Death|24|||
105348191|NCT02631070|363277002|FG000|Overall Study|Lost to Follow-up|5|||
105348192|NCT02631070|363277003|FG001|Overall Study|Lost to Follow-up|1|||
105348193|NCT02631070|363277002|FG000|Overall Study|Transition to rollover protocol|52|||
105348194|NCT02631070|363277003|FG001|Overall Study|Transition to rollover protocol|21|||
105348195|NCT02631070|363277002|FG000|Overall Study|Other reasons|12|||
105348196|NCT02631070|363277003|FG001|Overall Study|Other reasons|5|||
105348197|NCT01886781|363277012|FG000|Overall Study|Protocol Violation|5|||
105559201|NCT03364751|364044607|FG001|Overall Study|Lost to Follow-up|1|||
105559202|NCT03364751|364044608|FG002|Overall Study|Lost to Follow-up|0|||
105559203|NCT03364751|364044609|FG003|Overall Study|Lost to Follow-up|0|||
105559204|NCT01994954|364044610|FG000|Overall Study|Death|1|||
105559205|NCT01994954|364044611|FG001|Overall Study|Death|0|||
105559206|NCT01994954|364044610|FG000|Overall Study|Withdrawal by Subject|9|||
105559207|NCT01994954|364044611|FG001|Overall Study|Withdrawal by Subject|14|||
105559208|NCT01994954|364044610|FG000|Overall Study|Physician Decision|2|||
105559209|NCT01994954|364044611|FG001|Overall Study|Physician Decision|2|||
105559210|NCT01994954|364044610|FG000|Overall Study|Lost to Follow-up|8|||
105559211|NCT01994954|364044611|FG001|Overall Study|Lost to Follow-up|10|||
105559212|NCT01994954|364044610|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
105559213|NCT01994954|364044611|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
105559214|NCT00449176|364044612|FG000|Overall Study|Withdrawal by Subject|39|||
105559215|NCT00449176|364044613|FG001|Overall Study|Withdrawal by Subject|43|||
105559216|NCT00449176|364044614|FG002|Overall Study|Withdrawal by Subject|59|||
105559217|NCT00449176|364044612|FG000|Overall Study|Lost to Follow-up|13|||
105559218|NCT00449176|364044613|FG001|Overall Study|Lost to Follow-up|8|||
105559219|NCT00449176|364044614|FG002|Overall Study|Lost to Follow-up|12|||
105559220|NCT00449176|364044612|FG000|Overall Study|Adverse Event|51|||
105559221|NCT00449176|364044613|FG001|Overall Study|Adverse Event|107|||
105559222|NCT00449176|364044614|FG002|Overall Study|Adverse Event|15|||
105559223|NCT00449176|364044612|FG000|Overall Study|Lack of Efficacy|13|||
105559224|NCT00449176|364044613|FG001|Overall Study|Lack of Efficacy|7|||
105559225|NCT00449176|364044614|FG002|Overall Study|Lack of Efficacy|50|||
105559226|NCT00449176|364044612|FG000|Overall Study|Study drug non-compliant|14|||
105559227|NCT00449176|364044613|FG001|Overall Study|Study drug non-compliant|11|||
105559228|NCT00449176|364044614|FG002|Overall Study|Study drug non-compliant|11|||
105559229|NCT00449176|364044612|FG000|Overall Study|all other|22|||
105559230|NCT00449176|364044613|FG001|Overall Study|all other|19|||
105559231|NCT00449176|364044614|FG002|Overall Study|all other|20|||
105559232|NCT04435665|364044617|FG000|Overall Study|Lost to Follow-up|0|||
105559233|NCT04435665|364044618|FG001|Overall Study|Lost to Follow-up|0|||
105559234|NCT04435665|364044619|FG002|Overall Study|Lost to Follow-up|0|||
105559235|NCT04435665|364044620|FG003|Overall Study|Lost to Follow-up|1|||
105559236|NCT01988779|364044621|FG000|Overall Study|Withdrawal by Subject|2|||
105559237|NCT01988779|364044622|FG001|Overall Study|Withdrawal by Subject|2|||
105559238|NCT01988779|364044621|FG000|Overall Study|Protocol Violation|1|||
105559239|NCT01988779|364044622|FG001|Overall Study|Protocol Violation|0|||
105559240|NCT04072159|364044623|FG000|Overall Study|Lost to Follow-up|6|||
105559241|NCT04072159|364044624|FG001|Overall Study|Lost to Follow-up|6|||
105559242|NCT04072159|364044623|FG000|Overall Study|Withdrawal by Subject|2|||
105559243|NCT04072159|364044624|FG001|Overall Study|Withdrawal by Subject|0|||
105559244|NCT00377403|364044629|FG000|Overall Study|Unable to contact for telephone intervie|4|||
105694690|NCT00529451|364546275|FG000|Overall Study|Administrative problems|1|||
105694691|NCT00529451|364546276|FG001|Overall Study|Administrative problems|1|||
105694692|NCT00529451|364546277|FG002|Overall Study|Administrative problems|0|||
105348198|NCT01886781|363277013|FG001|Overall Study|Protocol Violation|0|||
105348199|NCT01886781|363277012|FG000|Overall Study|Adverse Event|1|||
105348200|NCT01886781|363277013|FG001|Overall Study|Adverse Event|0|||
105348201|NCT01886781|363277012|FG000|Overall Study|Lost to Follow-up|5|||
105559245|NCT00377403|364044630|FG001|Overall Study|Unable to contact for telephone intervie|7|||
105559246|NCT02275065|364044631|FG000|Overall Study|Randomized but not treated|1|||
105559247|NCT02275065|364044632|FG001|Overall Study|Randomized but not treated|0|||
105559248|NCT02275065|364044633|FG002|Overall Study|Randomized but not treated|1|||
105559249|NCT02275065|364044634|FG003|Overall Study|Randomized but not treated|1|||
105559250|NCT02275065|364044635|FG004|Overall Study|Randomized but not treated|0|||
105559251|NCT00989287|364044636|FG000|Overall Study|Adverse Event|1|||
105559252|NCT00989287|364044637|FG001|Overall Study|Adverse Event|0|||
105559253|NCT00989287|364044636|FG000|Overall Study|Lost to Follow-up|0|||
105348202|NCT01886781|363277013|FG001|Overall Study|Lost to Follow-up|0|||
105348203|NCT01886781|363277012|FG000|Overall Study|Withdrawal by Subject|2|||
105348204|NCT01886781|363277013|FG001|Overall Study|Withdrawal by Subject|1|||
105348205|NCT01886781|363277012|FG000|Overall Study|Worsening of symptoms|1|||
105348206|NCT01886781|363277013|FG001|Overall Study|Worsening of symptoms|1|||
105348207|NCT00980018|363277014|FG000|Overall Study|Adverse Event|8|||
105348208|NCT00980018|363277014|FG000|Overall Study|Patient withdrew consent|3|||
105348209|NCT00980018|363277014|FG000|Overall Study|Lost to Follow-up|1|||
105348210|NCT01522235|363277015|FG000|Overall Study|Physician Decision|1|||
105348211|NCT01522235|363277016|FG001|Overall Study|Physician Decision|1|||
105348212|NCT00987402|363277017|FG000|Overall Study|Insufficient data entry|86|||
105348213|NCT00987402|363277018|FG001|Overall Study|Insufficient data entry|98|||
105348214|NCT00424021|363277019|FG000|NCT00046319 Study Period|Adverse Event|1|||
105348215|NCT00424021|363277020|FG001|NCT00046319 Study Period|Adverse Event|0|||
105348216|NCT00424021|363277021|FG002|NCT00046319 Study Period|Adverse Event|1|||
105348217|NCT00424021|363277022|FG003|NCT00046319 Study Period|Adverse Event|1|||
105348218|NCT00424021|363277019|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
105348219|NCT00424021|363277020|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
105348220|NCT00424021|363277021|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
105348221|NCT00424021|363277022|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
105348222|NCT00424021|363277019|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
105348223|NCT00424021|363277020|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
105348224|NCT00424021|363277021|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
105348225|NCT00424021|363277022|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
105348226|NCT00424021|363277019|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
105348227|NCT00424021|363277020|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
105348228|NCT00424021|363277021|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
105348229|NCT00424021|363277022|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
105348230|NCT00424021|363277019|FG000|AMB-220-E Study Period|Adverse Event|1|||
105348231|NCT00424021|363277020|FG001|AMB-220-E Study Period|Adverse Event|1|||
105348232|NCT00424021|363277021|FG002|AMB-220-E Study Period|Adverse Event|3|||
105348233|NCT00424021|363277022|FG003|AMB-220-E Study Period|Adverse Event|7|||
105348234|NCT00424021|363277019|FG000|AMB-220-E Study Period|Death|0|||
105694693|NCT00529451|364546278|FG003|Overall Study|Administrative problems|2|||
105694694|NCT01245387|364546279|FG000|Overall Study|Lost to Follow-up|106|||
105694695|NCT01245387|364546279|FG000|Overall Study|Lack of Efficacy|195|||
105694696|NCT01245387|364546279|FG000|Overall Study|Adverse Event|9|||
105694697|NCT01245387|364546279|FG000|Overall Study|Death|3|||
105694698|NCT01245387|364546279|FG000|Overall Study|Other|131|||
105694699|NCT01245387|364546279|FG000|Overall Study|Missing discontinuation status|369|||
105694700|NCT04513665|364546280|FG000|Overall Study|Adverse Event|2|||
105694701|NCT04513665|364546281|FG001|Overall Study|Adverse Event|0|||
105694702|NCT04513665|364546280|FG000|Overall Study|Lack of Efficacy|14|||
105694703|NCT04513665|364546281|FG001|Overall Study|Lack of Efficacy|0|||
105694704|NCT02790138|364546282|FG000|Overall Study|Adverse Event|5|||
105694705|NCT02790138|364546283|FG001|Overall Study|Adverse Event|2|||
105694706|NCT02790138|364546282|FG000|Overall Study|Significant Protocol Deviation|0|||
105694707|NCT02790138|364546283|FG001|Overall Study|Significant Protocol Deviation|1|||
105694708|NCT02790138|364546282|FG000|Overall Study|Lost to Follow-up|1|||
105694709|NCT02790138|364546283|FG001|Overall Study|Lost to Follow-up|0|||
105694710|NCT02790138|364546282|FG000|Overall Study|Voluntary Withdrawal|8|||
105694711|NCT02790138|364546283|FG001|Overall Study|Voluntary Withdrawal|9|||
105694712|NCT02790138|364546282|FG000|Overall Study|Lack of Efficacy|6|||
105694713|NCT02790138|364546283|FG001|Overall Study|Lack of Efficacy|7|||
105694714|NCT02790138|364546282|FG000|Overall Study|Reason not Specified|1|||
105787100|NCT03110107|364874906|FG017|Treatment Period|Study drug toxicity|3|||
105348235|NCT00424021|363277020|FG001|AMB-220-E Study Period|Death|0|||
105348236|NCT00424021|363277021|FG002|AMB-220-E Study Period|Death|1|||
105348237|NCT00424021|363277022|FG003|AMB-220-E Study Period|Death|1|||
105348238|NCT00424021|363277019|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
105348239|NCT00424021|363277020|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
105348240|NCT00424021|363277021|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
105348241|NCT00424021|363277022|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
105348242|NCT00424021|363277019|FG000|AMB-220-E Study Period|Physician Decision|0|||
105694715|NCT02790138|364546283|FG001|Overall Study|Reason not Specified|0|||
105694716|NCT02146599|364546286|FG000|Overall Study|Failed to meet inclusion criteria|5|||
105787101|NCT03110107|364874907|FG018|Treatment Period|Study drug toxicity|1|||
105473258|NCT01175083|363745290|FG001|Primary Epoch|Withdrawal by Subject|0|||
105473259|NCT01175083|363745291|FG002|Primary Epoch|Withdrawal by Subject|0|||
105473260|NCT01175083|363745292|FG003|Primary Epoch|Withdrawal by Subject|0|||
105473261|NCT01175083|363745293|FG004|Primary Epoch|Withdrawal by Subject|0|||
105473262|NCT01175083|363745294|FG005|Primary Epoch|Withdrawal by Subject|2|||
105473263|NCT01175083|363745289|FG000|Primary Epoch|Lost to Follow-up|0|||
105473264|NCT01175083|363745290|FG001|Primary Epoch|Lost to Follow-up|0|||
105473265|NCT01175083|363745291|FG002|Primary Epoch|Lost to Follow-up|0|||
105473266|NCT01175083|363745292|FG003|Primary Epoch|Lost to Follow-up|0|||
105473267|NCT01175083|363745293|FG004|Primary Epoch|Lost to Follow-up|0|||
105473268|NCT01175083|363745294|FG005|Primary Epoch|Lost to Follow-up|1|||
105473269|NCT01175083|363745289|FG000|Booster Epoch|Death|0|||
105473270|NCT01175083|363745290|FG001|Booster Epoch|Death|0|||
105473271|NCT01175083|363745291|FG002|Booster Epoch|Death|1|||
105473272|NCT01175083|363745292|FG003|Booster Epoch|Death|0|||
105473273|NCT01175083|363745293|FG004|Booster Epoch|Death|0|||
105473274|NCT01175083|363745294|FG005|Booster Epoch|Death|0|||
105473275|NCT01175083|363745289|FG000|Booster Epoch|Withdrawal by Subject|0|||
105473276|NCT01175083|363745290|FG001|Booster Epoch|Withdrawal by Subject|0|||
105473277|NCT01175083|363745291|FG002|Booster Epoch|Withdrawal by Subject|0|||
105473278|NCT01175083|363745292|FG003|Booster Epoch|Withdrawal by Subject|1|||
105473279|NCT01175083|363745293|FG004|Booster Epoch|Withdrawal by Subject|0|||
105473280|NCT01175083|363745294|FG005|Booster Epoch|Withdrawal by Subject|0|||
105473281|NCT01652469|363745295|FG000|Overall Study|Withdrawal by Subject|1|||
105473282|NCT01652469|363745296|FG001|Overall Study|Withdrawal by Subject|4|||
105473283|NCT01652469|363745295|FG000|Overall Study|Lost to Follow-up|0|||
105473284|NCT01652469|363745296|FG001|Overall Study|Lost to Follow-up|2|||
105473285|NCT01049009|363745297|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
105473286|NCT01049009|363745298|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
105473287|NCT01049009|363745297|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105473288|NCT01049009|363745298|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
105473289|NCT01049009|363745297|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
105473290|NCT01049009|363745298|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
105473291|NCT01049009|363745297|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
105473292|NCT01049009|363745298|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
105473293|NCT02350478|363745299|FG000|Overall Study|Lost to Follow-up|5|||
105473294|NCT02350478|363745300|FG001|Overall Study|Lost to Follow-up|1|||
105473295|NCT00578292|363745313|FG000|Overall Study|Death|1|||
105473296|NCT00578292|363745313|FG000|Overall Study|Graft failure|2|||
105473297|NCT02888119|363745318|FG000|Overall Study|Lost to Follow-up|5|||
105473298|NCT02888119|363745319|FG001|Overall Study|Lost to Follow-up|4|||
105473299|NCT02888119|363745320|FG002|Overall Study|Lost to Follow-up|0|||
105473300|NCT04849559|363745324|FG000|Overall Study|Withdrawal by Subject|2|||
105473301|NCT04849559|363745325|FG001|Overall Study|Withdrawal by Subject|1|||
105473302|NCT02675634|363745327|FG000|Test Period 1|Adverse Event|0|||
105473303|NCT02675634|363745328|FG001|Test Period 1|Adverse Event|1|||
105473304|NCT02675634|363745329|FG002|Test Period 1|Adverse Event|0|||
105473305|NCT02675634|363745330|FG003|Test Period 1|Adverse Event|1|||
105473306|NCT02675634|363745331|FG004|Test Period 1|Adverse Event|0|||
105473307|NCT02675634|363745332|FG005|Test Period 1|Adverse Event|0|||
105473308|NCT02675634|363745327|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
105473309|NCT02675634|363745328|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
105473310|NCT02675634|363745329|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
105473311|NCT02675634|363745330|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
105473312|NCT02675634|363745331|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
105473313|NCT02675634|363745332|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
105473314|NCT02675634|363745327|FG000|Test Period 2|Lack of Efficacy|1|||
105473315|NCT02675634|363745328|FG001|Test Period 2|Lack of Efficacy|0|||
105473316|NCT02675634|363745329|FG002|Test Period 2|Lack of Efficacy|0|||
105473317|NCT02675634|363745330|FG003|Test Period 2|Lack of Efficacy|0|||
105473318|NCT02675634|363745331|FG004|Test Period 2|Lack of Efficacy|0|||
105473319|NCT02675634|363745332|FG005|Test Period 2|Lack of Efficacy|0|||
105473320|NCT02675634|363745327|FG000|Test Period 2|Adverse Event|0|||
105473321|NCT02675634|363745328|FG001|Test Period 2|Adverse Event|0|||
105473322|NCT02675634|363745329|FG002|Test Period 2|Adverse Event|0|||
105473323|NCT02675634|363745330|FG003|Test Period 2|Adverse Event|0|||
105473324|NCT02675634|363745331|FG004|Test Period 2|Adverse Event|0|||
105473325|NCT02675634|363745332|FG005|Test Period 2|Adverse Event|1|||
105473326|NCT01652534|363745333|FG000|Overall Study|Lack of Efficacy|1|||
105473327|NCT01652534|363745334|FG001|Overall Study|Lack of Efficacy|0|||
105473328|NCT02105961|363745335|FG000|Overall Study|Adverse Event|18|||
105473329|NCT02105961|363745336|FG001|Overall Study|Adverse Event|7|||
105473330|NCT02105961|363745337|FG002|Overall Study|Adverse Event|13|||
105473331|NCT02105961|363745335|FG000|Overall Study|Lack of Efficacy|3|||
105473332|NCT02105961|363745336|FG001|Overall Study|Lack of Efficacy|0|||
105473333|NCT02105961|363745337|FG002|Overall Study|Lack of Efficacy|3|||
105473334|NCT02105961|363745335|FG000|Overall Study|Lost to Follow-up|2|||
105473335|NCT02105961|363745336|FG001|Overall Study|Lost to Follow-up|0|||
105348243|NCT00424021|363277020|FG001|AMB-220-E Study Period|Physician Decision|0|||
105473336|NCT02105961|363745337|FG002|Overall Study|Lost to Follow-up|1|||
105473337|NCT02105961|363745335|FG000|Overall Study|Physician Decision|3|||
105473338|NCT02105961|363745336|FG001|Overall Study|Physician Decision|3|||
105473339|NCT02105961|363745337|FG002|Overall Study|Physician Decision|2|||
105473340|NCT02105961|363745335|FG000|Overall Study|Withdrawal by Subject|15|||
105473341|NCT02105961|363745336|FG001|Overall Study|Withdrawal by Subject|7|||
105473342|NCT02105961|363745337|FG002|Overall Study|Withdrawal by Subject|11|||
105473343|NCT02813577|363745338|FG000|Overall Study|Study terminated|4|||
105473344|NCT04413617|363745339|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
105473345|NCT04413617|363745340|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
105473346|NCT04413617|363745341|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
105473347|NCT04413617|363745342|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
105473348|NCT04413617|363745343|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
105473349|NCT04413617|363745339|FG000|Overall Study|Protocol Violation|0|||
105559254|NCT00989287|364044637|FG001|Overall Study|Lost to Follow-up|1|||
105559255|NCT00729833|364044638|FG000|Overall Study|Death|5|||
105559256|NCT00729833|364044639|FG001|Overall Study|Death|1|||
105559257|NCT00729833|364044640|FG002|Overall Study|Death|3|||
105559258|NCT00729833|364044641|FG003|Overall Study|Death|5|||
105559259|NCT00729833|364044638|FG000|Overall Study|Study Terminated by Sponsor|0|||
105559260|NCT00729833|364044639|FG001|Overall Study|Study Terminated by Sponsor|0|||
105559261|NCT00729833|364044640|FG002|Overall Study|Study Terminated by Sponsor|1|||
105559262|NCT00729833|364044641|FG003|Overall Study|Study Terminated by Sponsor|0|||
105559263|NCT00729833|364044638|FG000|Overall Study|Lost to Follow-up|1|||
105559264|NCT00729833|364044639|FG001|Overall Study|Lost to Follow-up|0|||
105559265|NCT00729833|364044640|FG002|Overall Study|Lost to Follow-up|0|||
105559266|NCT00729833|364044641|FG003|Overall Study|Lost to Follow-up|0|||
105559267|NCT00729833|364044638|FG000|Overall Study|Withdrawal by Subject|3|||
105559268|NCT00729833|364044639|FG001|Overall Study|Withdrawal by Subject|1|||
105559269|NCT00729833|364044640|FG002|Overall Study|Withdrawal by Subject|3|||
105559270|NCT00729833|364044641|FG003|Overall Study|Withdrawal by Subject|0|||
105559271|NCT00729833|364044638|FG000|Overall Study|Unspecified Reasons|11|||
105559272|NCT00729833|364044639|FG001|Overall Study|Unspecified Reasons|5|||
105559273|NCT00729833|364044640|FG002|Overall Study|Unspecified Reasons|5|||
105559274|NCT00729833|364044641|FG003|Overall Study|Unspecified Reasons|1|||
105559275|NCT03015402|364044643|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
105559276|NCT03015402|364044644|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
105559277|NCT03015402|364044643|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
105473350|NCT04413617|363745340|FG001|Overall Study|Protocol Violation|1|||
105473351|NCT04413617|363745341|FG002|Overall Study|Protocol Violation|0|||
105473352|NCT04413617|363745342|FG003|Overall Study|Protocol Violation|0|||
105473353|NCT04413617|363745343|FG004|Overall Study|Protocol Violation|1|||
105559278|NCT03015402|364044644|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
105559279|NCT00540124|364044645|FG000|Overall Study|Adverse Event|0|||
105559280|NCT00540124|364044646|FG001|Overall Study|Adverse Event|2|||
105559281|NCT00540124|364044647|FG002|Overall Study|Adverse Event|1|||
105694717|NCT00175877|364546287|FG000|Overall Study|Adverse Event|136|||
105694718|NCT00175877|364546287|FG000|Overall Study|Withdrawal by Subject|141|||
105694719|NCT00175877|364546287|FG000|Overall Study|Lost to Follow-up|9|||
105694720|NCT00175877|364546287|FG000|Overall Study|Lack of Efficacy|26|||
105694721|NCT00175877|364546287|FG000|Overall Study|Protocol Violation|15|||
105694722|NCT00175877|364546287|FG000|Overall Study|Other Reason|20|||
105694723|NCT00175877|364546287|FG000|Overall Study|AE & Other|1|||
105694724|NCT00175877|364546287|FG000|Overall Study|Withdrawal by subject & Other|1|||
105694725|NCT01368042|364546289|FG000|Overall Study|Death|14|||
105694726|NCT01368042|364546289|FG000|Overall Study|Protocol Violation|11|||
105694727|NCT01368042|364546289|FG000|Overall Study|Lost to Follow-up|4|||
105694728|NCT01368042|364546289|FG000|Overall Study|Transplanted|1|||
105694729|NCT00760669|364546290|FG000|Overall Study|Not assessed for overall improvement|18|||
105694730|NCT00760669|364546290|FG000|Overall Study|Participants missing efficacy assessment|6|||
105694731|NCT00760669|364546290|FG000|Overall Study|Participants with overlapping cases|1|||
105694732|NCT00760669|364546290|FG000|Overall Study|Took drug before entering in contract|5|||
105694733|NCT02632721|364546291|FG000|Overall Study|Adverse Event|0|||
105694734|NCT02632721|364546292|FG001|Overall Study|Adverse Event|0|||
105694735|NCT02632721|364546293|FG002|Overall Study|Adverse Event|2|||
105694736|NCT02632721|364546294|FG003|Overall Study|Adverse Event|5|||
105694737|NCT02632721|364546295|FG004|Overall Study|Adverse Event|3|||
105694738|NCT02632721|364546291|FG000|Overall Study|Dose limiting toxicity|0|||
105694739|NCT02632721|364546292|FG001|Overall Study|Dose limiting toxicity|0|||
105694740|NCT02632721|364546293|FG002|Overall Study|Dose limiting toxicity|0|||
105694741|NCT02632721|364546294|FG003|Overall Study|Dose limiting toxicity|1|||
105694742|NCT02632721|364546295|FG004|Overall Study|Dose limiting toxicity|0|||
105694743|NCT02632721|364546291|FG000|Overall Study|Progressive disease|3|||
105694744|NCT02632721|364546292|FG001|Overall Study|Progressive disease|0|||
105694745|NCT02632721|364546293|FG002|Overall Study|Progressive disease|4|||
105694746|NCT02632721|364546294|FG003|Overall Study|Progressive disease|6|||
105694747|NCT02632721|364546295|FG004|Overall Study|Progressive disease|5|||
105694748|NCT02632721|364546291|FG000|Overall Study|Refused to continue taking trial medication|0|||
105694749|NCT02632721|364546292|FG001|Overall Study|Refused to continue taking trial medication|1|||
105694750|NCT02632721|364546293|FG002|Overall Study|Refused to continue taking trial medication|1|||
105694751|NCT02632721|364546294|FG003|Overall Study|Refused to continue taking trial medication|1|||
105694752|NCT02632721|364546295|FG004|Overall Study|Refused to continue taking trial medication|2|||
105694753|NCT02632721|364546291|FG000|Overall Study|Inadequate clinical condition|0|||
105694754|NCT02632721|364546292|FG001|Overall Study|Inadequate clinical condition|0|||
105694755|NCT02632721|364546293|FG002|Overall Study|Inadequate clinical condition|0|||
105694756|NCT02632721|364546294|FG003|Overall Study|Inadequate clinical condition|0|||
105694757|NCT02632721|364546295|FG004|Overall Study|Inadequate clinical condition|1|||
105473354|NCT04413617|363745339|FG000|Overall Study|Lack of Efficacy|2|||
105694758|NCT02632721|364546291|FG000|Overall Study|No meet eligibility|0|||
105694759|NCT02632721|364546292|FG001|Overall Study|No meet eligibility|0|||
105694760|NCT02632721|364546293|FG002|Overall Study|No meet eligibility|0|||
105694761|NCT02632721|364546294|FG003|Overall Study|No meet eligibility|0|||
105694762|NCT02632721|364546295|FG004|Overall Study|No meet eligibility|1|||
105694763|NCT02632721|364546291|FG000|Overall Study|Allergic reaction|0|||
105694764|NCT02632721|364546292|FG001|Overall Study|Allergic reaction|0|||
105694765|NCT02632721|364546293|FG002|Overall Study|Allergic reaction|0|||
105694766|NCT02632721|364546294|FG003|Overall Study|Allergic reaction|1|||
105694767|NCT02632721|364546295|FG004|Overall Study|Allergic reaction|0|||
105694768|NCT02632721|364546291|FG000|Overall Study|Receiving Decitabine locally|0|||
105694769|NCT02632721|364546292|FG001|Overall Study|Receiving Decitabine locally|0|||
105694770|NCT02632721|364546293|FG002|Overall Study|Receiving Decitabine locally|1|||
105694771|NCT02632721|364546294|FG003|Overall Study|Receiving Decitabine locally|0|||
105694772|NCT02632721|364546295|FG004|Overall Study|Receiving Decitabine locally|0|||
105694773|NCT02632721|364546291|FG000|Overall Study|No benefit from study treatment|1|||
105694774|NCT02632721|364546292|FG001|Overall Study|No benefit from study treatment|1|||
105694775|NCT02632721|364546293|FG002|Overall Study|No benefit from study treatment|0|||
105694776|NCT02632721|364546294|FG003|Overall Study|No benefit from study treatment|0|||
105694777|NCT02632721|364546295|FG004|Overall Study|No benefit from study treatment|1|||
105694778|NCT02632721|364546291|FG000|Overall Study|Patient wish for other treatment|0|||
105694779|NCT02632721|364546292|FG001|Overall Study|Patient wish for other treatment|1|||
105694780|NCT02632721|364546293|FG002|Overall Study|Patient wish for other treatment|0|||
105694781|NCT02632721|364546294|FG003|Overall Study|Patient wish for other treatment|0|||
105694782|NCT02632721|364546295|FG004|Overall Study|Patient wish for other treatment|0|||
105694783|NCT02632721|364546291|FG000|Overall Study|Relapsed Pneumonia|0|||
105694784|NCT02632721|364546292|FG001|Overall Study|Relapsed Pneumonia|0|||
105694785|NCT02632721|364546293|FG002|Overall Study|Relapsed Pneumonia|0|||
105694786|NCT02632721|364546294|FG003|Overall Study|Relapsed Pneumonia|0|||
105694787|NCT02632721|364546295|FG004|Overall Study|Relapsed Pneumonia|1|||
105694788|NCT02632721|364546291|FG000|Overall Study|Therapy refractory AML|0|||
105348244|NCT00424021|363277021|FG002|AMB-220-E Study Period|Physician Decision|0|||
105348245|NCT00424021|363277022|FG003|AMB-220-E Study Period|Physician Decision|1|||
105348246|NCT01955109|363277023|FG000|Overall Study|Adverse Event|2|||
105348247|NCT01955109|363277024|FG001|Overall Study|Adverse Event|0|||
105348248|NCT01955109|363277023|FG000|Overall Study|Participant unwilling to continue|35|||
105348249|NCT01955109|363277024|FG001|Overall Study|Participant unwilling to continue|7|||
105348250|NCT01955109|363277023|FG000|Overall Study|Physician Decision|2|||
105348251|NCT01955109|363277024|FG001|Overall Study|Physician Decision|0|||
105348252|NCT01955109|363277023|FG000|Overall Study|Lost to Follow-up|3|||
105348253|NCT01955109|363277024|FG001|Overall Study|Lost to Follow-up|1|||
105348254|NCT01955109|363277023|FG000|Overall Study|Non-compliance|3|||
105348255|NCT01955109|363277024|FG001|Overall Study|Non-compliance|1|||
105694789|NCT02632721|364546292|FG001|Overall Study|Therapy refractory AML|0|||
105348256|NCT03597022|363277026|FG000|Overall Study|Premature termination of the study|7|||
105694790|NCT02632721|364546293|FG002|Overall Study|Therapy refractory AML|0|||
105694791|NCT02632721|364546294|FG003|Overall Study|Therapy refractory AML|0|||
105694792|NCT02632721|364546295|FG004|Overall Study|Therapy refractory AML|1|||
105694793|NCT02632721|364546291|FG000|Overall Study|Increase of white blood cell count|0|||
105348257|NCT03597022|363277027|FG001|Overall Study|Premature termination of the study|7|||
105348258|NCT03597022|363277028|FG002|Overall Study|Premature termination of the study|8|||
105694794|NCT02632721|364546292|FG001|Overall Study|Increase of white blood cell count|0|||
105348259|NCT03597022|363277026|FG000|Overall Study|Serious adverse event|1|||
105694795|NCT02632721|364546293|FG002|Overall Study|Increase of white blood cell count|0|||
105694796|NCT02632721|364546294|FG003|Overall Study|Increase of white blood cell count|0|||
105694797|NCT02632721|364546295|FG004|Overall Study|Increase of white blood cell count|1|||
105694798|NCT02632721|364546291|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
105694799|NCT02632721|364546292|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
105694800|NCT02632721|364546293|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
105694801|NCT02632721|364546294|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
105694802|NCT02632721|364546295|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
105694803|NCT02663271|364546296|FG000|Overall Study|Withdrawal by Subject|5|||
105694804|NCT02663271|364546296|FG000|Overall Study|Lack of Efficacy|1|||
105694805|NCT01572675|364546297|FG000|Overall Study|End of prescribed treatment|140|||
105694806|NCT01572675|364546298|FG001|Overall Study|End of prescribed treatment|118|||
105694807|NCT01572675|364546297|FG000|Overall Study|Recovery|16|||
105694808|NCT01572675|364546298|FG001|Overall Study|Recovery|23|||
105694809|NCT01572675|364546297|FG000|Overall Study|Lack of Efficacy|31|||
105694810|NCT01572675|364546298|FG001|Overall Study|Lack of Efficacy|31|||
105694811|NCT01572675|364546297|FG000|Overall Study|Intolerance|6|||
105694812|NCT01572675|364546298|FG001|Overall Study|Intolerance|5|||
105694813|NCT01572675|364546297|FG000|Overall Study|Improved symptoms|8|||
105694814|NCT01572675|364546298|FG001|Overall Study|Improved symptoms|2|||
105694815|NCT01572675|364546297|FG000|Overall Study|Surgical intervention|3|||
105694816|NCT01572675|364546298|FG001|Overall Study|Surgical intervention|6|||
105694817|NCT01572675|364546297|FG000|Overall Study|Withdrawal by Subject|5|||
105694818|NCT01572675|364546298|FG001|Overall Study|Withdrawal by Subject|1|||
105694819|NCT01572675|364546297|FG000|Overall Study|Physician Decision|2|||
105694820|NCT01572675|364546298|FG001|Overall Study|Physician Decision|2|||
105694821|NCT01572675|364546297|FG000|Overall Study|Death unrelated to coxibs|1|||
105694822|NCT01572675|364546298|FG001|Overall Study|Death unrelated to coxibs|1|||
105694823|NCT01572675|364546297|FG000|Overall Study|Other disease detected|1|||
105694824|NCT01572675|364546298|FG001|Overall Study|Other disease detected|1|||
105694825|NCT01572675|364546297|FG000|Overall Study|Unknown reason|1|||
105694826|NCT01572675|364546298|FG001|Overall Study|Unknown reason|1|||
105694827|NCT01572675|364546297|FG000|Overall Study|Rheumatologist new evaluation|0|||
105694828|NCT01572675|364546298|FG001|Overall Study|Rheumatologist new evaluation|1|||
105694829|NCT01572675|364546297|FG000|Overall Study|Missing data|1|||
105694830|NCT01572675|364546298|FG001|Overall Study|Missing data|4|||
105694831|NCT01572675|364546297|FG000|Overall Study|Lost to Follow-up|22|||
105694832|NCT01572675|364546298|FG001|Overall Study|Lost to Follow-up|27|||
105694833|NCT03986866|364546307|FG000|Overall Study|Withdrawal by Subject|0|||
105694834|NCT03986866|364546308|FG001|Overall Study|Withdrawal by Subject|3|||
105694835|NCT03986866|364546307|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
105694836|NCT03986866|364546308|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
105694837|NCT04166383|364546309|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
105694838|NCT04166383|364546309|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
105694839|NCT04166383|364546309|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
105694840|NCT03346057|364546310|FG000|Overall Study|Death|1|||
105694841|NCT03346057|364546311|FG001|Overall Study|Death|2|||
105694842|NCT03346057|364546312|FG002|Overall Study|Death|0|||
105694843|NCT03346057|364546313|FG003|Overall Study|Death|0|||
105694844|NCT03346057|364546310|FG000|Overall Study|Lost to Follow-up|0|||
105694845|NCT03346057|364546311|FG001|Overall Study|Lost to Follow-up|2|||
105694846|NCT03346057|364546312|FG002|Overall Study|Lost to Follow-up|1|||
105694847|NCT03346057|364546313|FG003|Overall Study|Lost to Follow-up|0|||
105694848|NCT03346057|364546310|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
105694849|NCT03346057|364546311|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
105694850|NCT03346057|364546312|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
105694851|NCT03346057|364546313|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
105694852|NCT03346057|364546310|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
105694853|NCT03346057|364546311|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
105694854|NCT03346057|364546312|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
105694855|NCT03346057|364546313|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
105694856|NCT03346057|364546310|FG000|Overall Study|Physician Decision|3|||
105694857|NCT03346057|364546311|FG001|Overall Study|Physician Decision|2|||
105694858|NCT03346057|364546312|FG002|Overall Study|Physician Decision|0|||
105694859|NCT03346057|364546313|FG003|Overall Study|Physician Decision|2|||
105694860|NCT03346057|364546310|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
105694861|NCT03346057|364546311|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
105694862|NCT03346057|364546312|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
105694863|NCT03346057|364546313|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
105694864|NCT03346057|364546310|FG000|Overall Study|Withdrawal by Subject|1|||
105694865|NCT03346057|364546311|FG001|Overall Study|Withdrawal by Subject|0|||
105694866|NCT03346057|364546312|FG002|Overall Study|Withdrawal by Subject|0|||
105694867|NCT03346057|364546313|FG003|Overall Study|Withdrawal by Subject|0|||
105694868|NCT03044886|364546314|FG000|Overall Study|Lost to Follow-up|15|||
105694869|NCT03044886|364546315|FG001|Overall Study|Lost to Follow-up|10|||
105694870|NCT03044886|364546316|FG002|Overall Study|Lost to Follow-up|12|||
105694871|NCT02921269|364546317|FG000|Overall Study|Did not complete DLT period|1|||
105694872|NCT02054325|364546320|FG000|Overall Study|Lost to Follow-up|8|||
105694873|NCT02054325|364546321|FG001|Overall Study|Lost to Follow-up|5|||
105694874|NCT00521053|364546324|FG000|Observation Phase|Disease Progression|55|||
105694875|NCT00521053|364546324|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
105694876|NCT00521053|364546324|FG000|Observation Phase|Death|2|||
105694877|NCT00521053|364546324|FG000|Observation Phase|Adverse Event|1|||
105694878|NCT00521053|364546324|FG000|Observation Phase|Other non-study melanoma treatment|1|||
105694879|NCT00521053|364546324|FG000|Observation Phase|Physician Decision|1|||
105694880|NCT01034540|364546325|FG000|Overall Study|Adverse Event|0|||
105694881|NCT01034540|364546326|FG001|Overall Study|Adverse Event|1|||
105694882|NCT05293743|364546330|FG000|Overall Study|Withdrawal by Subject|1|||
105694883|NCT05293743|364546331|FG001|Overall Study|Withdrawal by Subject|0|||
105694884|NCT00667823|364546337|FG000|Overall Study|Lost to Follow-up|5|||
105694885|NCT00667823|364546337|FG000|Overall Study|Adverse Event|7|||
105694886|NCT00667823|364546337|FG000|Overall Study|Death|182|||
105694887|NCT00667823|364546337|FG000|Overall Study|Withdrawal by Subject|12|||
105694888|NCT00667823|364546337|FG000|Overall Study|Other|8|||
105694889|NCT00667823|364546337|FG000|Overall Study|Missing (completion page missing)|2|||
105694890|NCT03734016|364546338|FG000|Overall Study|Sponsor Ended Study|225|||
105694891|NCT03734016|364546339|FG001|Overall Study|Sponsor Ended Study|200|||
105694892|NCT03734016|364546338|FG000|Overall Study|Death|69|||
105694893|NCT03734016|364546339|FG001|Overall Study|Death|83|||
105694894|NCT03734016|364546338|FG000|Overall Study|Withdrawal by Subject|21|||
105694895|NCT03734016|364546339|FG001|Overall Study|Withdrawal by Subject|27|||
105694896|NCT03734016|364546338|FG000|Overall Study|Physician Decision|1|||
105694897|NCT03734016|364546339|FG001|Overall Study|Physician Decision|12|||
105694898|NCT03734016|364546338|FG000|Overall Study|Lost to Follow-up|6|||
105694899|NCT03734016|364546339|FG001|Overall Study|Lost to Follow-up|2|||
105694900|NCT03734016|364546338|FG000|Overall Study|Miscellaneous|5|||
105694901|NCT03734016|364546339|FG001|Overall Study|Miscellaneous|1|||
105694902|NCT01624259|364546342|FG000|Overall Study|Adverse Event|18|||
105694903|NCT01624259|364546343|FG001|Overall Study|Adverse Event|18|||
105694904|NCT01624259|364546342|FG000|Overall Study|Protocol Violation|1|||
105694905|NCT01624259|364546343|FG001|Overall Study|Protocol Violation|2|||
105694906|NCT01624259|364546342|FG000|Overall Study|Withdrawal by Subject|5|||
105694907|NCT01624259|364546343|FG001|Overall Study|Withdrawal by Subject|7|||
105694908|NCT01624259|364546342|FG000|Overall Study|Physician Decision|1|||
105694909|NCT01624259|364546343|FG001|Overall Study|Physician Decision|1|||
105694910|NCT01624259|364546342|FG000|Overall Study|Lost to Follow-up|2|||
105694911|NCT01624259|364546343|FG001|Overall Study|Lost to Follow-up|3|||
105694912|NCT01624259|364546342|FG000|Overall Study|Abnormal laboratory measure|3|||
105694913|NCT01624259|364546343|FG001|Overall Study|Abnormal laboratory measure|0|||
105694914|NCT01979835|364546346|FG000|Primary Outcome SA Measurment|failed insertion|18|||
105694915|NCT01979835|364546346|FG000|Follow-up|Lost to Follow-up|32|||
105694916|NCT01428661|364546352|FG000|Double-Masked Phase|Protocol Violation|9|||
105694917|NCT01428661|364546353|FG001|Double-Masked Phase|Protocol Violation|4|||
105694918|NCT01428661|364546354|FG002|Double-Masked Phase|Protocol Violation|0|||
105694919|NCT01428661|364546352|FG000|Double-Masked Phase|Adverse Event|13|||
105694920|NCT01428661|364546353|FG001|Double-Masked Phase|Adverse Event|4|||
105694921|NCT01428661|364546354|FG002|Double-Masked Phase|Adverse Event|0|||
105694922|NCT01428661|364546352|FG000|Double-Masked Phase|Lost to Follow-up|14|||
105694923|NCT01428661|364546353|FG001|Double-Masked Phase|Lost to Follow-up|14|||
105694924|NCT01428661|364546354|FG002|Double-Masked Phase|Lost to Follow-up|0|||
105694925|NCT01428661|364546352|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
105694926|NCT01428661|364546353|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
105694927|NCT01428661|364546354|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
105694928|NCT01428661|364546352|FG000|Double-Masked Phase|Lack of Efficacy|2|||
105694929|NCT01428661|364546353|FG001|Double-Masked Phase|Lack of Efficacy|1|||
105694930|NCT01428661|364546354|FG002|Double-Masked Phase|Lack of Efficacy|0|||
105694931|NCT01428661|364546352|FG000|Double-Masked Phase|*Various|1|||
105694932|NCT01428661|364546353|FG001|Double-Masked Phase|*Various|6|||
105694933|NCT01428661|364546354|FG002|Double-Masked Phase|*Various|0|||
105694934|NCT01428661|364546352|FG000|Open Label Extension|Protocol Violation|0|||
105694935|NCT01428661|364546353|FG001|Open Label Extension|Protocol Violation|0|||
105694936|NCT01428661|364546354|FG002|Open Label Extension|Protocol Violation|9|||
105694937|NCT01428661|364546352|FG000|Open Label Extension|Adverse Event|0|||
105694938|NCT01428661|364546353|FG001|Open Label Extension|Adverse Event|0|||
105694939|NCT01428661|364546354|FG002|Open Label Extension|Adverse Event|15|||
105694940|NCT01428661|364546352|FG000|Open Label Extension|Lost to Follow-up|0|||
105694941|NCT01428661|364546353|FG001|Open Label Extension|Lost to Follow-up|0|||
105694942|NCT01428661|364546354|FG002|Open Label Extension|Lost to Follow-up|38|||
105694943|NCT01428661|364546352|FG000|Open Label Extension|Withdrawal by Subject|0|||
105694944|NCT01428661|364546353|FG001|Open Label Extension|Withdrawal by Subject|0|||
105694945|NCT01428661|364546354|FG002|Open Label Extension|Withdrawal by Subject|49|||
105694946|NCT01428661|364546352|FG000|Open Label Extension|Lack of Efficacy|0|||
105694947|NCT01428661|364546353|FG001|Open Label Extension|Lack of Efficacy|0|||
105694948|NCT01428661|364546354|FG002|Open Label Extension|Lack of Efficacy|24|||
105694949|NCT01428661|364546352|FG000|Open Label Extension|**Various|0|||
105694950|NCT01428661|364546353|FG001|Open Label Extension|**Various|0|||
105694951|NCT01428661|364546354|FG002|Open Label Extension|**Various|185|||
105694952|NCT01129921|364546357|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
105694953|NCT01129921|364546358|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
105694954|NCT01129921|364546357|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
105694955|NCT01129921|364546358|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
105694956|NCT01129921|364546357|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
105694957|NCT01129921|364546358|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
105694958|NCT01129921|364546357|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
105694959|NCT01129921|364546358|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
105694960|NCT01357577|364546359|FG000|Overall Study|Lost to Follow-up|20|||
105348260|NCT03597022|363277027|FG001|Overall Study|Serious adverse event|1|||
105348261|NCT03597022|363277028|FG002|Overall Study|Serious adverse event|0|||
105348262|NCT00904839|363277029|FG000|Overall Study|Adverse Event|0|||
105348263|NCT00904839|363277030|FG001|Overall Study|Adverse Event|5|||
105348264|NCT00904839|363277031|FG002|Overall Study|Adverse Event|4|||
105348265|NCT00904839|363277029|FG000|Overall Study|Protocol Violation|0|||
105348266|NCT00904839|363277030|FG001|Overall Study|Protocol Violation|1|||
105348267|NCT00904839|363277031|FG002|Overall Study|Protocol Violation|1|||
105348268|NCT00904839|363277029|FG000|Overall Study|Lost to Follow-up|0|||
105348269|NCT00904839|363277030|FG001|Overall Study|Lost to Follow-up|1|||
105348270|NCT00904839|363277031|FG002|Overall Study|Lost to Follow-up|2|||
105348271|NCT00904839|363277029|FG000|Overall Study|Withdrawal by Subject|0|||
105348272|NCT00904839|363277030|FG001|Overall Study|Withdrawal by Subject|2|||
105348273|NCT00904839|363277031|FG002|Overall Study|Withdrawal by Subject|0|||
105348274|NCT00904839|363277029|FG000|Overall Study|Not treated|1|||
105348275|NCT00904839|363277030|FG001|Overall Study|Not treated|0|||
105348276|NCT00904839|363277031|FG002|Overall Study|Not treated|1|||
105348277|NCT00904839|363277029|FG000|Overall Study|Other than above|0|||
105348278|NCT00904839|363277030|FG001|Overall Study|Other than above|9|||
105348279|NCT00904839|363277031|FG002|Overall Study|Other than above|7|||
105348280|NCT01167634|363277034|FG000|Overall Study|Lost to Follow-up|1|||
105348281|NCT01167634|363277035|FG001|Overall Study|Lost to Follow-up|3|||
105348282|NCT01167634|363277036|FG002|Overall Study|Lost to Follow-up|3|||
105348283|NCT01167634|363277037|FG003|Overall Study|Lost to Follow-up|4|||
105348284|NCT01167634|363277034|FG000|Overall Study|Withdrawal by Subject|1|||
105348285|NCT01167634|363277035|FG001|Overall Study|Withdrawal by Subject|1|||
105348286|NCT01167634|363277036|FG002|Overall Study|Withdrawal by Subject|0|||
105694961|NCT01357577|364546360|FG001|Overall Study|Lost to Follow-up|16|||
105348287|NCT01167634|363277037|FG003|Overall Study|Withdrawal by Subject|0|||
105473355|NCT04413617|363745340|FG001|Overall Study|Lack of Efficacy|0|||
105473356|NCT04413617|363745341|FG002|Overall Study|Lack of Efficacy|2|||
105348288|NCT01832818|363277040|FG000|Overall Study|Lost to Follow-up|6|||
105348289|NCT00236899|363277041|FG000|Overall Study|Adverse Event (Study Related)|1|||
105473357|NCT04413617|363745342|FG003|Overall Study|Lack of Efficacy|1|||
105348290|NCT00236899|363277042|FG001|Overall Study|Adverse Event (Study Related)|1|||
105348291|NCT00236899|363277043|FG002|Overall Study|Adverse Event (Study Related)|2|||
105348292|NCT00236899|363277044|FG003|Overall Study|Adverse Event (Study Related)|1|||
105348293|NCT00236899|363277041|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
105348294|NCT00236899|363277042|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
105348295|NCT00236899|363277043|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
105694962|NCT01357577|364546359|FG000|Overall Study|Withdrawal by Subject|16|||
105694963|NCT01357577|364546360|FG001|Overall Study|Withdrawal by Subject|8|||
105694964|NCT01357577|364546359|FG000|Overall Study|look at data in database?|1|||
105694965|NCT01357577|364546360|FG001|Overall Study|look at data in database?|2|||
105694966|NCT04313153|364548159|FG000|Overall Study|Adverse Event (includes Death)|14|||
105694967|NCT04313153|364548160|FG001|Overall Study|Adverse Event (includes Death)|19|||
105694968|NCT04313153|364548161|FG002|Overall Study|Adverse Event (includes Death)|10|||
105694969|NCT04313153|364548159|FG000|Overall Study|Physician Decision|4|||
105694970|NCT04313153|364548160|FG001|Overall Study|Physician Decision|2|||
105694971|NCT04313153|364548161|FG002|Overall Study|Physician Decision|1|||
105694972|NCT04313153|364548159|FG000|Overall Study|Withdrawal by Subject|7|||
105694973|NCT04313153|364548160|FG001|Overall Study|Withdrawal by Subject|6|||
105694974|NCT04313153|364548161|FG002|Overall Study|Withdrawal by Subject|2|||
105694975|NCT04313153|364548159|FG000|Overall Study|Lack of Efficacy|3|||
105694976|NCT04313153|364548160|FG001|Overall Study|Lack of Efficacy|3|||
105694977|NCT04313153|364548161|FG002|Overall Study|Lack of Efficacy|0|||
105694978|NCT04313153|364548159|FG000|Overall Study|Lost to Follow-up|1|||
105694979|NCT04313153|364548160|FG001|Overall Study|Lost to Follow-up|0|||
105694980|NCT04313153|364548161|FG002|Overall Study|Lost to Follow-up|2|||
105694981|NCT04313153|364548159|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
105694982|NCT04313153|364548160|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
105694983|NCT04313153|364548161|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
105694984|NCT04313153|364548159|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
105694985|NCT04313153|364548160|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
105694986|NCT04313153|364548161|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
105694987|NCT04313153|364548159|FG000|Overall Study|Change in Dialysis Modality|0|||
105694988|NCT04313153|364548160|FG001|Overall Study|Change in Dialysis Modality|1|||
105694989|NCT04313153|364548161|FG002|Overall Study|Change in Dialysis Modality|2|||
105694990|NCT04313153|364548159|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
105694991|NCT04313153|364548160|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
105694992|NCT04313153|364548161|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
105694993|NCT04313153|364548159|FG000|Overall Study|Other|5|||
105694994|NCT04313153|364548160|FG001|Overall Study|Other|3|||
105694995|NCT04313153|364548161|FG002|Overall Study|Other|2|||
105694996|NCT05586269|364548164|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
105694997|NCT05586269|364548165|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
105694998|NCT05586269|364548166|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
105694999|NCT05586269|364548167|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
105695000|NCT05586269|364548164|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
105695001|NCT05586269|364548165|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
105695002|NCT05586269|364548166|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
105695003|NCT05586269|364548167|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
105695004|NCT04752475|364548168|FG000|Overall Study|Withdrawal by Subject|1|||
105695005|NCT04752475|364548169|FG001|Overall Study|Withdrawal by Subject|1|||
105695006|NCT00523718|364548175|FG000|Overall Study|Withdrawal by Subject|1|||
105695007|NCT00523718|364548176|FG001|Overall Study|Withdrawal by Subject|0|||
105695008|NCT00523718|364548175|FG000|Overall Study|Protocol Violation|2|||
105695009|NCT00523718|364548176|FG001|Overall Study|Protocol Violation|0|||
105695010|NCT02113579|364548179|FG000|Overall Study|Adverse Event|1|||
105473358|NCT04413617|363745343|FG004|Overall Study|Lack of Efficacy|0|||
105473359|NCT04413617|363745339|FG000|Overall Study|Withdrawal by Subject|3|||
105695011|NCT02113579|364548180|FG001|Overall Study|Adverse Event|0|||
105695012|NCT02113579|364548179|FG000|Overall Study|Withdrawal by Subject|3|||
105695013|NCT02113579|364548180|FG001|Overall Study|Withdrawal by Subject|2|||
105695014|NCT02113579|364548179|FG000|Overall Study|Lost to Follow-up|6|||
105695015|NCT02113579|364548180|FG001|Overall Study|Lost to Follow-up|2|||
105695016|NCT02060383|364548181|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
105695017|NCT02060383|364548182|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
105695018|NCT02060383|364548183|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
105695019|NCT02060383|364548184|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
105695020|NCT02060383|364548185|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
105695021|NCT02060383|364548181|FG000|Core Phase|Adverse Event|2|||
105695022|NCT02060383|364548182|FG001|Core Phase|Adverse Event|0|||
105695023|NCT02060383|364548183|FG002|Core Phase|Adverse Event|0|||
105695024|NCT02060383|364548184|FG003|Core Phase|Adverse Event|2|||
105695025|NCT02060383|364548185|FG004|Core Phase|Adverse Event|6|||
105695026|NCT02060383|364548181|FG000|Core Phase|Administrative problems|0|||
105695027|NCT02060383|364548182|FG001|Core Phase|Administrative problems|1|||
105695028|NCT02060383|364548183|FG002|Core Phase|Administrative problems|0|||
105695029|NCT02060383|364548184|FG003|Core Phase|Administrative problems|0|||
105695030|NCT02060383|364548185|FG004|Core Phase|Administrative problems|0|||
105348296|NCT00236899|363277044|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
105695031|NCT02060383|364548181|FG000|Core Phase|Protocol Violation|0|||
105695032|NCT02060383|364548182|FG001|Core Phase|Protocol Violation|0|||
105695033|NCT02060383|364548183|FG002|Core Phase|Protocol Violation|0|||
105695034|NCT02060383|364548184|FG003|Core Phase|Protocol Violation|1|||
105695035|NCT02060383|364548185|FG004|Core Phase|Protocol Violation|0|||
105695036|NCT02060383|364548181|FG000|Core Phase|Withdrawal by Subject|0|||
105695037|NCT02060383|364548182|FG001|Core Phase|Withdrawal by Subject|0|||
105695038|NCT02060383|364548183|FG002|Core Phase|Withdrawal by Subject|0|||
105695039|NCT02060383|364548184|FG003|Core Phase|Withdrawal by Subject|4|||
105695040|NCT02060383|364548185|FG004|Core Phase|Withdrawal by Subject|2|||
105695041|NCT02060383|364548181|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
105695042|NCT02060383|364548182|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
105695043|NCT02060383|364548183|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
105695044|NCT02060383|364548184|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
105695045|NCT02060383|364548185|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
105695046|NCT02060383|364548181|FG000|Extension Phase|Adverse Event|1|||
105695047|NCT02060383|364548182|FG001|Extension Phase|Adverse Event|1|||
105473360|NCT04413617|363745340|FG001|Overall Study|Withdrawal by Subject|4|||
105695048|NCT02060383|364548183|FG002|Extension Phase|Adverse Event|2|||
105695049|NCT02060383|364548184|FG003|Extension Phase|Adverse Event|0|||
105695050|NCT02060383|364548185|FG004|Extension Phase|Adverse Event|1|||
105695051|NCT02060383|364548181|FG000|Extension Phase|Withdrawal by Subject|0|||
105695052|NCT02060383|364548182|FG001|Extension Phase|Withdrawal by Subject|1|||
105695053|NCT02060383|364548183|FG002|Extension Phase|Withdrawal by Subject|0|||
105695054|NCT02060383|364548184|FG003|Extension Phase|Withdrawal by Subject|0|||
105695055|NCT02060383|364548185|FG004|Extension Phase|Withdrawal by Subject|2|||
105695056|NCT02060383|364548181|FG000|Extension Phase|Administrative problems|1|||
105695057|NCT02060383|364548182|FG001|Extension Phase|Administrative problems|0|||
105695058|NCT02060383|364548183|FG002|Extension Phase|Administrative problems|0|||
105695059|NCT02060383|364548184|FG003|Extension Phase|Administrative problems|0|||
105695060|NCT02060383|364548185|FG004|Extension Phase|Administrative problems|0|||
105695061|NCT02060383|364548181|FG000|Extension Phase|Death|0|||
105695062|NCT02060383|364548182|FG001|Extension Phase|Death|0|||
105695063|NCT02060383|364548183|FG002|Extension Phase|Death|1|||
105695064|NCT02060383|364548184|FG003|Extension Phase|Death|0|||
105695065|NCT02060383|364548185|FG004|Extension Phase|Death|1|||
105695066|NCT02060383|364548181|FG000|Extension Phase|Protocol Violation|0|||
105695067|NCT02060383|364548182|FG001|Extension Phase|Protocol Violation|0|||
105695068|NCT02060383|364548183|FG002|Extension Phase|Protocol Violation|0|||
105695069|NCT02060383|364548184|FG003|Extension Phase|Protocol Violation|0|||
105695070|NCT02060383|364548185|FG004|Extension Phase|Protocol Violation|1|||
105695071|NCT00332839|364548186|FG000|Core (Months 0 - 12)|Administrative problems|1|||
105695072|NCT00332839|364548187|FG001|Core (Months 0 - 12)|Administrative problems|1|||
105695073|NCT00332839|364548186|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
105695074|NCT00332839|364548187|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
105695075|NCT00332839|364548186|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
105695076|NCT00332839|364548187|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
105695077|NCT00332839|364548186|FG000|Core (Months 0 - 12)|Adverse Event|5|||
105695078|NCT00332839|364548187|FG001|Core (Months 0 - 12)|Adverse Event|15|||
105695079|NCT00332839|364548186|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
105695080|NCT00332839|364548187|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
105695081|NCT00332839|364548186|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
105695082|NCT00332839|364548187|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
105695083|NCT00332839|364548186|FG000|Follow-up (Months 12 - 60)|Death|1|||
105695084|NCT00332839|364548187|FG001|Follow-up (Months 12 - 60)|Death|1|||
105695085|NCT02217436|364548195|FG000|Overall Study|Protocol Violation|1|||
105695086|NCT02217436|364548196|FG001|Overall Study|Protocol Violation|1|||
105695087|NCT02217436|364548195|FG000|Overall Study|Incomplete data|0|||
105695088|NCT02217436|364548196|FG001|Overall Study|Incomplete data|1|||
105695089|NCT04641299|364548204|FG000|Overall Study|Adverse Event|0|||
105695090|NCT04641299|364548205|FG001|Overall Study|Adverse Event|0|||
105695091|NCT04641299|364548206|FG002|Overall Study|Adverse Event|2|||
105695092|NCT04641299|364548207|FG003|Overall Study|Adverse Event|0|||
105695093|NCT04641299|364548204|FG000|Overall Study|Lost to Follow-up|0|||
105695094|NCT04641299|364548205|FG001|Overall Study|Lost to Follow-up|1|||
105695095|NCT04641299|364548206|FG002|Overall Study|Lost to Follow-up|0|||
105695096|NCT04641299|364548207|FG003|Overall Study|Lost to Follow-up|0|||
105695097|NCT04641299|364548204|FG000|Overall Study|Withdrawal by Subject|1|||
105695098|NCT04641299|364548205|FG001|Overall Study|Withdrawal by Subject|0|||
105695099|NCT04641299|364548206|FG002|Overall Study|Withdrawal by Subject|0|||
105695100|NCT04641299|364548207|FG003|Overall Study|Withdrawal by Subject|0|||
105348297|NCT00236899|363277041|FG000|Overall Study|Death (Study Disease)|1|||
105348298|NCT00236899|363277042|FG001|Overall Study|Death (Study Disease)|4|||
105348299|NCT00236899|363277043|FG002|Overall Study|Death (Study Disease)|0|||
105348300|NCT00236899|363277044|FG003|Overall Study|Death (Study Disease)|0|||
105695101|NCT04641299|364548204|FG000|Overall Study|Reason not given|1|||
105695102|NCT04641299|364548205|FG001|Overall Study|Reason not given|0|||
105695103|NCT04641299|364548206|FG002|Overall Study|Reason not given|0|||
105695104|NCT04641299|364548207|FG003|Overall Study|Reason not given|0|||
105695105|NCT02020863|364548208|FG000|Overall Study|Discovery of Metastatic disease|4|||
105695106|NCT02020863|364548208|FG000|Overall Study|Team chose not to place an a line|1|||
105695107|NCT01920594|364548209|FG000|Overall Study|Adverse Event|4|||
105695108|NCT01920594|364548210|FG001|Overall Study|Adverse Event|2|||
105473361|NCT04413617|363745341|FG002|Overall Study|Withdrawal by Subject|2|||
105695109|NCT01920594|364548209|FG000|Overall Study|Lost to Follow-up|1|||
105695110|NCT01920594|364548210|FG001|Overall Study|Lost to Follow-up|0|||
105695111|NCT01920594|364548209|FG000|Overall Study|Recovery|2|||
105695112|NCT01920594|364548210|FG001|Overall Study|Recovery|0|||
105695113|NCT01920594|364548209|FG000|Overall Study|Investigator discretion|0|||
105695114|NCT01920594|364548210|FG001|Overall Study|Investigator discretion|1|||
105695115|NCT00880555|364548213|FG000|Overall Study|Physician Decision|0|||
105695116|NCT00880555|364548214|FG001|Overall Study|Physician Decision|8|||
105695117|NCT00880555|364548215|FG002|Overall Study|Physician Decision|0|||
105695118|NCT00880555|364548216|FG003|Overall Study|Physician Decision|2|||
105695119|NCT00880555|364548217|FG004|Overall Study|Physician Decision|1|||
105695120|NCT00880555|364548218|FG005|Overall Study|Physician Decision|0|||
105695121|NCT00880555|364548213|FG000|Overall Study|Withdrawal by Subject|1|||
105695122|NCT00880555|364548214|FG001|Overall Study|Withdrawal by Subject|1|||
105695123|NCT00880555|364548215|FG002|Overall Study|Withdrawal by Subject|0|||
105695124|NCT00880555|364548216|FG003|Overall Study|Withdrawal by Subject|0|||
105695125|NCT00880555|364548217|FG004|Overall Study|Withdrawal by Subject|0|||
105695126|NCT00880555|364548218|FG005|Overall Study|Withdrawal by Subject|0|||
105695127|NCT00880555|364548213|FG000|Overall Study|Lack of resources (hired rater)|9|||
105695128|NCT00880555|364548214|FG001|Overall Study|Lack of resources (hired rater)|7|||
105695129|NCT00880555|364548215|FG002|Overall Study|Lack of resources (hired rater)|5|||
105695130|NCT00880555|364548216|FG003|Overall Study|Lack of resources (hired rater)|0|||
105695131|NCT00880555|364548217|FG004|Overall Study|Lack of resources (hired rater)|0|||
105695132|NCT00880555|364548218|FG005|Overall Study|Lack of resources (hired rater)|0|||
105695133|NCT00880555|364548213|FG000|Overall Study|Death|0|||
105695134|NCT00880555|364548214|FG001|Overall Study|Death|0|||
105695135|NCT00880555|364548215|FG002|Overall Study|Death|0|||
105695136|NCT00880555|364548216|FG003|Overall Study|Death|0|||
105695137|NCT00880555|364548217|FG004|Overall Study|Death|0|||
105695138|NCT00880555|364548218|FG005|Overall Study|Death|1|||
105695139|NCT00880555|364548213|FG000|Overall Study|Lost to Follow-up|0|||
105695140|NCT00880555|364548214|FG001|Overall Study|Lost to Follow-up|1|||
105695141|NCT00880555|364548215|FG002|Overall Study|Lost to Follow-up|0|||
105695142|NCT00880555|364548216|FG003|Overall Study|Lost to Follow-up|0|||
105695143|NCT00880555|364548217|FG004|Overall Study|Lost to Follow-up|0|||
105695144|NCT00880555|364548218|FG005|Overall Study|Lost to Follow-up|0|||
105695145|NCT01628107|364548219|FG000|Overall Study|Withdrawal by Subject|17|||
105695146|NCT01628107|364548219|FG000|Overall Study|Lost to Follow-up|4|||
105695147|NCT01628107|364548219|FG000|Overall Study|Adverse Event|33|||
105695148|NCT01628107|364548219|FG000|Overall Study|Physician Decision|2|||
105695149|NCT01628107|364548219|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
105695150|NCT01628107|364548219|FG000|Overall Study|Non-compliant with Study Procedures|10|||
105695151|NCT01628107|364548219|FG000|Overall Study|Not Treated|8|||
105695152|NCT01628107|364548219|FG000|Overall Study|Sponsor Decision|11|||
105695153|NCT01628107|364548219|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
105695154|NCT01628107|364548219|FG000|Overall Study|Relocated|8|||
105695155|NCT01628107|364548219|FG000|Overall Study|Kidney Transplant|9|||
105695156|NCT01628107|364548219|FG000|Overall Study|Use of Standard of Care|9|||
105695157|NCT01205438|364548220|FG000|Overall Study|Adverse Event|19|||
105695158|NCT01205438|364548221|FG001|Overall Study|Adverse Event|17|||
105695159|NCT01205438|364548222|FG002|Overall Study|Adverse Event|24|||
105695160|NCT01205438|364548220|FG000|Overall Study|Death|1|||
105695161|NCT01205438|364548221|FG001|Overall Study|Death|1|||
105695162|NCT01205438|364548222|FG002|Overall Study|Death|3|||
105695163|NCT01205438|364548220|FG000|Overall Study|Entry Criteria Not Met|16|||
105695164|NCT01205438|364548221|FG001|Overall Study|Entry Criteria Not Met|15|||
105695165|NCT01205438|364548222|FG002|Overall Study|Entry Criteria Not Met|13|||
105695166|NCT01205438|364548220|FG000|Overall Study|Lack of Efficacy|14|||
105695167|NCT01205438|364548221|FG001|Overall Study|Lack of Efficacy|11|||
105695168|NCT01205438|364548222|FG002|Overall Study|Lack of Efficacy|14|||
105695169|NCT01205438|364548220|FG000|Overall Study|Lost to Follow-up|6|||
105695170|NCT01205438|364548221|FG001|Overall Study|Lost to Follow-up|7|||
105695171|NCT01205438|364548222|FG002|Overall Study|Lost to Follow-up|8|||
105695172|NCT01205438|364548220|FG000|Overall Study|Withdrawal by Subject|19|||
105695173|NCT01205438|364548221|FG001|Overall Study|Withdrawal by Subject|25|||
105695174|NCT01205438|364548222|FG002|Overall Study|Withdrawal by Subject|19|||
105695175|NCT01205438|364548220|FG000|Overall Study|Physician Decision|0|||
105695176|NCT01205438|364548221|FG001|Overall Study|Physician Decision|3|||
105484983|NCT01895361|363787033|FG002|Overall Study|Physician Decision|2|||
105695177|NCT01205438|364548222|FG002|Overall Study|Physician Decision|2|||
105695178|NCT01205438|364548220|FG000|Overall Study|Protocol Violation|2|||
105695179|NCT01205438|364548221|FG001|Overall Study|Protocol Violation|7|||
105695180|NCT01205438|364548222|FG002|Overall Study|Protocol Violation|4|||
105695181|NCT01205438|364548220|FG000|Overall Study|Sponsor Decision|0|||
105695182|NCT01205438|364548221|FG001|Overall Study|Sponsor Decision|1|||
105695183|NCT01205438|364548222|FG002|Overall Study|Sponsor Decision|1|||
105695184|NCT00884325|364548223|FG000|Overall Study|Lost to Follow-up|1|||
105695185|NCT00884325|364548224|FG001|Overall Study|Lost to Follow-up|2|||
105559282|NCT00540124|364044645|FG000|Overall Study|Entry Criteria Not Met|2|||
105559283|NCT00540124|364044646|FG001|Overall Study|Entry Criteria Not Met|0|||
105559284|NCT00540124|364044647|FG002|Overall Study|Entry Criteria Not Met|0|||
105559285|NCT00540124|364044645|FG000|Overall Study|Lack of Efficacy|1|||
105559286|NCT00540124|364044646|FG001|Overall Study|Lack of Efficacy|0|||
105559287|NCT00540124|364044647|FG002|Overall Study|Lack of Efficacy|0|||
105559288|NCT00540124|364044645|FG000|Overall Study|Withdrawal by Subject|1|||
105559289|NCT00540124|364044646|FG001|Overall Study|Withdrawal by Subject|1|||
105559290|NCT00540124|364044647|FG002|Overall Study|Withdrawal by Subject|0|||
105559291|NCT01569438|364044651|FG000|Overall Study|Lack of Efficacy|1|||
105559292|NCT01569438|364044652|FG001|Overall Study|Lack of Efficacy|2|||
105559293|NCT01569438|364044651|FG000|Overall Study|Withdrawal by Subject|0|||
105559294|NCT01569438|364044652|FG001|Overall Study|Withdrawal by Subject|3|||
105559295|NCT01569438|364044651|FG000|Overall Study|Adverse Event|2|||
105559296|NCT01569438|364044652|FG001|Overall Study|Adverse Event|15|||
105559297|NCT01569438|364044651|FG000|Overall Study|Protocol Violation|2|||
105559298|NCT01569438|364044652|FG001|Overall Study|Protocol Violation|0|||
105559299|NCT01569438|364044651|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
105559300|NCT01569438|364044652|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
105559301|NCT01569438|364044651|FG000|Overall Study|Sponsor/Physician decision|1|||
105559302|NCT01569438|364044652|FG001|Overall Study|Sponsor/Physician decision|1|||
105559303|NCT01569438|364044651|FG000|Overall Study|Unable to adhere to study schedule|0|||
105559304|NCT01569438|364044652|FG001|Overall Study|Unable to adhere to study schedule|1|||
105559305|NCT01936857|364044653|FG000|Overall Study|Sent to prison or 06 center|11|||
105559306|NCT01936857|364044654|FG001|Overall Study|Sent to prison or 06 center|12|||
105559307|NCT01936857|364044653|FG000|Overall Study|Lost to Follow-up|10|||
105559308|NCT01936857|364044654|FG001|Overall Study|Lost to Follow-up|7|||
105559309|NCT01936857|364044653|FG000|Overall Study|Death|7|||
105559310|NCT01936857|364044654|FG001|Overall Study|Death|3|||
105559311|NCT01936857|364044653|FG000|Overall Study|Moved|2|||
105559312|NCT01936857|364044654|FG001|Overall Study|Moved|1|||
105559313|NCT01936857|364044653|FG000|Overall Study|Withdrawal by Subject|1|||
105559314|NCT01936857|364044654|FG001|Overall Study|Withdrawal by Subject|0|||
105559315|NCT01936857|364044653|FG000|Overall Study|Side effect of medication|1|||
105559316|NCT01936857|364044654|FG001|Overall Study|Side effect of medication|0|||
105559317|NCT01936857|364044653|FG000|Overall Study|Other|2|||
105559318|NCT01936857|364044654|FG001|Overall Study|Other|2|||
105559319|NCT01207102|364044657|FG000|Overall Study|Withdrawal by Subject|5|||
105559320|NCT01207102|364044657|FG000|Overall Study|Adverse Event|2|||
105559321|NCT01207102|364044657|FG000|Overall Study|progression|2|||
105559322|NCT01207102|364044657|FG000|Overall Study|Withdrawal by Treating Physician|1|||
105559323|NCT00736645|364044658|FG000|Overall Study|Adverse Event|0|||
105559324|NCT00736645|364044659|FG001|Overall Study|Adverse Event|2|||
105559325|NCT00736645|364044660|FG002|Overall Study|Adverse Event|0|||
105559326|NCT00736645|364044661|FG003|Overall Study|Adverse Event|0|||
105559327|NCT02300220|364044666|FG000|Overall Study|Lost to Follow-up|1|||
105559328|NCT02300220|364044667|FG001|Overall Study|Lost to Follow-up|2|||
105559329|NCT02300220|364044666|FG000|Overall Study|Death|1|||
105559330|NCT02300220|364044667|FG001|Overall Study|Death|1|||
105559331|NCT02300220|364044666|FG000|Overall Study|Adverse Event|1|||
105559332|NCT02300220|364044667|FG001|Overall Study|Adverse Event|1|||
105559333|NCT02300220|364044666|FG000|Overall Study|Protocol Violation|1|||
105559334|NCT02300220|364044667|FG001|Overall Study|Protocol Violation|0|||
105559335|NCT02300220|364044666|FG000|Overall Study|Withdrawal by Subject|0|||
105559336|NCT02300220|364044667|FG001|Overall Study|Withdrawal by Subject|2|||
105559337|NCT02300220|364044666|FG000|Overall Study|Did not tolerate IMP|0|||
105559338|NCT02300220|364044667|FG001|Overall Study|Did not tolerate IMP|1|||
105559339|NCT04322682|364044668|FG000|Overall Study|Withdrawal by Subject|33|||
105559340|NCT04322682|364044669|FG001|Overall Study|Withdrawal by Subject|47|||
105559341|NCT04322682|364044668|FG000|Overall Study|Death|5|||
105559342|NCT04322682|364044669|FG001|Overall Study|Death|9|||
105559343|NCT04322682|364044668|FG000|Overall Study|Lost to Follow-up|4|||
105559344|NCT04322682|364044669|FG001|Overall Study|Lost to Follow-up|8|||
105559345|NCT04322682|364044668|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
105695186|NCT00884325|364548223|FG000|Overall Study|Lack of Efficacy|0|||
105695187|NCT00884325|364548224|FG001|Overall Study|Lack of Efficacy|1|||
105695188|NCT00884325|364548223|FG000|Overall Study|Withdrawal by Subject|1|||
105695189|NCT00884325|364548224|FG001|Overall Study|Withdrawal by Subject|1|||
105695190|NCT00884325|364548223|FG000|Overall Study|Not provided|1|||
105695191|NCT00884325|364548224|FG001|Overall Study|Not provided|0|||
105695192|NCT01186796|364548235|FG000|Overall Study|Adverse Event|3|||
105695193|NCT01186796|364548236|FG001|Overall Study|Adverse Event|0|||
105695194|NCT01186796|364548235|FG000|Overall Study|Withdrawal by Subject|1|||
105695195|NCT01186796|364548236|FG001|Overall Study|Withdrawal by Subject|1|||
105695196|NCT01186796|364548235|FG000|Overall Study|Protocol Violation|0|||
105695197|NCT01186796|364548236|FG001|Overall Study|Protocol Violation|1|||
105695198|NCT00433914|364548240|FG000|Overall Study|Withdrawal by Subject|0|||
105695199|NCT00433914|364548241|FG001|Overall Study|Withdrawal by Subject|2|||
105695200|NCT00433914|364548240|FG000|Overall Study|Lost to Follow-up|0|||
105695201|NCT00433914|364548241|FG001|Overall Study|Lost to Follow-up|1|||
105695202|NCT01490814|364548242|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
105695203|NCT01490814|364548243|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
105695204|NCT01490814|364548242|FG000|Overall Study|Physician Decision|1|||
105695205|NCT01490814|364548243|FG001|Overall Study|Physician Decision|0|||
105695206|NCT01490814|364548242|FG000|Overall Study|Withdrawal by Subject|0|||
105695207|NCT01490814|364548243|FG001|Overall Study|Withdrawal by Subject|5|||
105695208|NCT00935272|364548257|FG000|Overall Study|Lost to Follow-up|10|||
105695209|NCT00935272|364548258|FG001|Overall Study|Lost to Follow-up|3|||
105695210|NCT00935272|364548257|FG000|Overall Study|Withdrawal by Subject|8|||
105559346|NCT04322682|364044669|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
105695211|NCT00935272|364548258|FG001|Overall Study|Withdrawal by Subject|2|||
105695212|NCT00935272|364548257|FG000|Overall Study|Physician Decision|1|||
105695213|NCT00935272|364548258|FG001|Overall Study|Physician Decision|0|||
105695214|NCT00935272|364548257|FG000|Overall Study|Protocol Violation|0|||
105695215|NCT00935272|364548258|FG001|Overall Study|Protocol Violation|1|||
105695216|NCT01478360|364548261|FG000|Overall Study|Lost to Follow-up|1|||
105695217|NCT01478360|364548262|FG001|Overall Study|Lost to Follow-up|0|||
105695218|NCT01478360|364548261|FG000|Overall Study|Adverse Event|0|||
105695219|NCT01478360|364548262|FG001|Overall Study|Adverse Event|1|||
105695220|NCT01478360|364548261|FG000|Overall Study|Administrative problems|1|||
105695221|NCT01478360|364548262|FG001|Overall Study|Administrative problems|2|||
105695222|NCT01849497|364548264|FG000|Overall Study|Withdrawal by Subject|1|||
105695223|NCT01849497|364548265|FG001|Overall Study|Withdrawal by Subject|2|||
105695224|NCT01849497|364548264|FG000|Overall Study|Sponsor Decision|0|||
105695225|NCT01849497|364548265|FG001|Overall Study|Sponsor Decision|1|||
105695226|NCT01849497|364548264|FG000|Overall Study|Lost to Follow-up|0|||
105695227|NCT01849497|364548265|FG001|Overall Study|Lost to Follow-up|1|||
105695228|NCT00911625|364548289|FG000|Overall Study|Lost to Follow-up|7|||
105695229|NCT00911625|364548290|FG001|Overall Study|Lost to Follow-up|0|||
105695230|NCT00888381|364548296|FG000|Overall Study|Lost to Follow-up|0|||
105695231|NCT00888381|364548297|FG001|Overall Study|Lost to Follow-up|1|||
105695232|NCT00097773|364548298|FG000|Overall Study|Lost to Follow-up|2|||
105695233|NCT00097773|364548299|FG001|Overall Study|Lost to Follow-up|2|||
105695234|NCT00097773|364548300|FG002|Overall Study|Lost to Follow-up|0|||
105695235|NCT00097773|364548301|FG003|Overall Study|Lost to Follow-up|1|||
105695236|NCT00097773|364548298|FG000|Overall Study|Physician Decision|2|||
105695237|NCT00097773|364548299|FG001|Overall Study|Physician Decision|2|||
105695238|NCT00097773|364548300|FG002|Overall Study|Physician Decision|3|||
105695239|NCT00097773|364548301|FG003|Overall Study|Physician Decision|1|||
105695240|NCT00097773|364548298|FG000|Overall Study|Withdrawal by Subject|3|||
105695241|NCT00097773|364548299|FG001|Overall Study|Withdrawal by Subject|3|||
105695242|NCT00097773|364548300|FG002|Overall Study|Withdrawal by Subject|3|||
105695243|NCT00097773|364548301|FG003|Overall Study|Withdrawal by Subject|1|||
105695244|NCT00097773|364548298|FG000|Overall Study|Adverse Event|0|||
105695245|NCT00097773|364548299|FG001|Overall Study|Adverse Event|1|||
105695246|NCT00097773|364548300|FG002|Overall Study|Adverse Event|0|||
105695247|NCT00097773|364548301|FG003|Overall Study|Adverse Event|0|||
105695248|NCT00097773|364548298|FG000|Overall Study|Other|1|||
105695249|NCT00097773|364548299|FG001|Overall Study|Other|0|||
105695250|NCT00097773|364548300|FG002|Overall Study|Other|2|||
105695251|NCT00097773|364548301|FG003|Overall Study|Other|0|||
105695252|NCT00003702|364548302|FG000|Overall Study|Ineligible cell types|2|||
105695253|NCT00003702|364548303|FG001|Overall Study|Ineligible cell types|2|||
105695254|NCT00003702|364548302|FG000|Overall Study|Did not meet criteria for persistence|8|||
105695255|NCT00003702|364548303|FG001|Overall Study|Did not meet criteria for persistence|5|||
105695256|NCT00003702|364548302|FG000|Overall Study|WHO score > 6|2|||
105695257|NCT00003702|364548303|FG001|Overall Study|WHO score > 6|1|||
105695258|NCT00003702|364548302|FG000|Overall Study|Inadequate documentation of disease|1|||
105695259|NCT00003702|364548303|FG001|Overall Study|Inadequate documentation of disease|3|||
105695260|NCT00757003|364548304|FG000|Overall Study|Death|33|||
105695261|NCT00757003|364548304|FG000|Overall Study|Lost to Follow-up|9|||
105695262|NCT00757003|364548304|FG000|Overall Study|Withdrawal by Subject|4|||
105695263|NCT00757003|364548304|FG000|Overall Study|Surgically explanted|2|||
105695264|NCT00757003|364548304|FG000|Overall Study|Not implanted|1|||
105695265|NCT00544648|364548307|FG000|Overall Study|Withdrawal by Subject|1|||
105695266|NCT00544648|364548308|FG001|Overall Study|Withdrawal by Subject|0|||
105695267|NCT00544648|364548307|FG000|Overall Study|Adverse Event|1|||
105695268|NCT00544648|364548308|FG001|Overall Study|Adverse Event|1|||
105695269|NCT00544648|364548307|FG000|Overall Study|progression of disease|1|||
105695270|NCT00544648|364548308|FG001|Overall Study|progression of disease|0|||
105695271|NCT00504153|364548315|FG000|Overall Study|Withdrawal by Subject|1|||
105695272|NCT00504153|364548315|FG000|Overall Study|Adverse Event|4|||
105695273|NCT00504153|364548315|FG000|Overall Study|Death|1|||
105695274|NCT00074581|364548317|FG000|Overall Study|Death|15|||
105695275|NCT00074581|364548318|FG001|Overall Study|Death|16|||
105695276|NCT00074581|364548317|FG000|Overall Study|Withdrawal by Subject|50|||
105695277|NCT00074581|364548318|FG001|Overall Study|Withdrawal by Subject|49|||
105695278|NCT00074581|364548317|FG000|Overall Study|Unable to adhere to visit schedule|13|||
105695279|NCT00074581|364548318|FG001|Overall Study|Unable to adhere to visit schedule|14|||
105695280|NCT00074581|364548317|FG000|Overall Study|Relocated|14|||
105695281|NCT00074581|364548318|FG001|Overall Study|Relocated|9|||
105695282|NCT00074581|364548317|FG000|Overall Study|Were withdrawn by investigator|5|||
105695283|NCT00074581|364548318|FG001|Overall Study|Were withdrawn by investigator|2|||
105695284|NCT00074581|364548317|FG000|Overall Study|Lost to Follow-up|16|||
105695285|NCT00074581|364548318|FG001|Overall Study|Lost to Follow-up|11|||
105787102|NCT03110107|364874908|FG019|Treatment Period|Study drug toxicity|2|||
105787103|NCT03110107|364874909|FG020|Treatment Period|Study drug toxicity|2|||
105695286|NCT00074581|364548317|FG000|Overall Study|Ended relationship w. index participant|117|||
105695287|NCT00074581|364548318|FG001|Overall Study|Ended relationship w. index participant|106|||
105695288|NCT00074581|364548317|FG000|Overall Study|Other|14|||
105695289|NCT00074581|364548318|FG001|Overall Study|Other|19|||
105695290|NCT00617604|364548322|FG000|Overall Study|Death|2|||
105695291|NCT00617604|364548323|FG001|Overall Study|Death|1|||
105695292|NCT00617604|364548322|FG000|Overall Study|Lost to Follow-up|1|||
105695293|NCT00617604|364548323|FG001|Overall Study|Lost to Follow-up|0|||
105695294|NCT00617604|364548322|FG000|Overall Study|Miscellaneous Reasons|8|||
105695295|NCT00617604|364548323|FG001|Overall Study|Miscellaneous Reasons|10|||
105695296|NCT00617604|364548322|FG000|Overall Study|Withdrawal by Subject|4|||
105695297|NCT00617604|364548323|FG001|Overall Study|Withdrawal by Subject|6|||
105695298|NCT00617604|364548322|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
105695299|NCT00617604|364548323|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
105695300|NCT01708291|364548324|FG000|Overall Study|fighting|2|||
105695301|NCT01708291|364548325|FG001|Overall Study|fighting|1|||
105695302|NCT04411628|364548328|FG000|Overall Study|Withdrawal by Subject|1|||
105695303|NCT04411628|364548329|FG001|Overall Study|Withdrawal by Subject|1|||
105695304|NCT04411628|364548330|FG002|Overall Study|Withdrawal by Subject|2|||
105695305|NCT04411628|364548331|FG003|Overall Study|Withdrawal by Subject|0|||
105695306|NCT04411628|364548328|FG000|Overall Study|Lost to Follow-up|0|||
105695307|NCT04411628|364548329|FG001|Overall Study|Lost to Follow-up|1|||
105695308|NCT04411628|364548330|FG002|Overall Study|Lost to Follow-up|0|||
105695309|NCT04411628|364548331|FG003|Overall Study|Lost to Follow-up|0|||
105695310|NCT00732251|364548332|FG000|Overall Study|Lost to Follow-up|3|||
105695311|NCT00732251|364548332|FG000|Overall Study|Withdrawal by Subject|3|||
105695312|NCT00732251|364548332|FG000|Overall Study|Early Term due to Site Closure|1|||
105695313|NCT00932425|364548338|FG000|Overall Study|Lost to Follow-up|0|||
105695314|NCT00932425|364548339|FG001|Overall Study|Lost to Follow-up|1|||
105695315|NCT00932425|364548338|FG000|Overall Study|Withdrawal by Subject|0|||
105695316|NCT00932425|364548339|FG001|Overall Study|Withdrawal by Subject|1|||
105695317|NCT01854645|364548342|FG000|Overall Study|Protocol-Specified Criteria|13|||
105695318|NCT01854645|364548343|FG001|Overall Study|Protocol-Specified Criteria|10|||
105695319|NCT01854645|364548344|FG002|Overall Study|Protocol-Specified Criteria|8|||
105695320|NCT01854645|364548345|FG003|Overall Study|Protocol-Specified Criteria|5|||
105695321|NCT01854645|364548346|FG004|Overall Study|Protocol-Specified Criteria|7|||
105695322|NCT01854645|364548342|FG000|Overall Study|Administrative Reasons / Missing|0|||
105695323|NCT01854645|364548343|FG001|Overall Study|Administrative Reasons / Missing|0|||
105695324|NCT01854645|364548344|FG002|Overall Study|Administrative Reasons / Missing|0|||
105695325|NCT01854645|364548345|FG003|Overall Study|Administrative Reasons / Missing|1|||
105695326|NCT01854645|364548346|FG004|Overall Study|Administrative Reasons / Missing|1|||
105695327|NCT01854645|364548342|FG000|Overall Study|Protocol Violation|3|||
105695328|NCT01854645|364548343|FG001|Overall Study|Protocol Violation|0|||
105559347|NCT00827918|364044670|FG000|Overall Study|Adverse Event|4|||
105695329|NCT01854645|364548344|FG002|Overall Study|Protocol Violation|5|||
105695330|NCT01854645|364548345|FG003|Overall Study|Protocol Violation|4|||
105695331|NCT01854645|364548346|FG004|Overall Study|Protocol Violation|1|||
105695332|NCT01854645|364548342|FG000|Overall Study|Lost to Follow-up|10|||
105695333|NCT01854645|364548343|FG001|Overall Study|Lost to Follow-up|7|||
105559348|NCT00827918|364044671|FG001|Overall Study|Adverse Event|0|||
105559349|NCT00827918|364044672|FG002|Overall Study|Adverse Event|0|||
105559350|NCT00827918|364044670|FG000|Overall Study|Lack of Efficacy|16|||
105559351|NCT00827918|364044671|FG001|Overall Study|Lack of Efficacy|4|||
105559352|NCT00827918|364044672|FG002|Overall Study|Lack of Efficacy|15|||
105695334|NCT01854645|364548344|FG002|Overall Study|Lost to Follow-up|8|||
105695335|NCT01854645|364548345|FG003|Overall Study|Lost to Follow-up|5|||
105695336|NCT01854645|364548346|FG004|Overall Study|Lost to Follow-up|0|||
105695337|NCT01854645|364548342|FG000|Overall Study|Physician Decision|1|||
105695338|NCT01854645|364548343|FG001|Overall Study|Physician Decision|5|||
105695339|NCT01854645|364548344|FG002|Overall Study|Physician Decision|3|||
105695340|NCT01854645|364548345|FG003|Overall Study|Physician Decision|3|||
105695341|NCT01854645|364548346|FG004|Overall Study|Physician Decision|7|||
105695342|NCT01854645|364548342|FG000|Overall Study|Withdrawal by Subject|31|||
105695343|NCT01854645|364548343|FG001|Overall Study|Withdrawal by Subject|41|||
105695344|NCT01854645|364548344|FG002|Overall Study|Withdrawal by Subject|30|||
105695345|NCT01854645|364548345|FG003|Overall Study|Withdrawal by Subject|21|||
105695346|NCT01854645|364548346|FG004|Overall Study|Withdrawal by Subject|24|||
105695347|NCT01854645|364548342|FG000|Overall Study|Lack of Efficacy|7|||
105695348|NCT01854645|364548343|FG001|Overall Study|Lack of Efficacy|12|||
105695349|NCT01854645|364548344|FG002|Overall Study|Lack of Efficacy|9|||
105695350|NCT01854645|364548345|FG003|Overall Study|Lack of Efficacy|3|||
105695351|NCT01854645|364548346|FG004|Overall Study|Lack of Efficacy|9|||
105695352|NCT01854645|364548342|FG000|Overall Study|Adverse Event|33|||
105695353|NCT01854645|364548343|FG001|Overall Study|Adverse Event|31|||
105695354|NCT01854645|364548344|FG002|Overall Study|Adverse Event|19|||
105695355|NCT01854645|364548345|FG003|Overall Study|Adverse Event|20|||
105695356|NCT01854645|364548346|FG004|Overall Study|Adverse Event|11|||
105695357|NCT01721876|364548347|FG000|Overall Study|Not treated|1|||
105695358|NCT01721876|364548348|FG001|Overall Study|Not treated|4|||
105695359|NCT01721876|364548347|FG000|Overall Study|Disease progression / relapse|123|||
105695360|NCT01721876|364548348|FG001|Overall Study|Disease progression / relapse|156|||
105695361|NCT01721876|364548347|FG000|Overall Study|Death|6|||
105695362|NCT01721876|364548348|FG001|Overall Study|Death|13|||
105695363|NCT01721876|364548347|FG000|Overall Study|Adverse Event|41|||
105695364|NCT01721876|364548348|FG001|Overall Study|Adverse Event|165|||
105695365|NCT01721876|364548347|FG000|Overall Study|Protocol Violation|2|||
105695366|NCT01721876|364548348|FG001|Overall Study|Protocol Violation|1|||
105695367|NCT01721876|364548347|FG000|Overall Study|Withdrawal by Subject|15|||
105695368|NCT01721876|364548348|FG001|Overall Study|Withdrawal by Subject|38|||
105695369|NCT01721876|364548347|FG000|Overall Study|Reason not listed|34|||
105695370|NCT01721876|364548348|FG001|Overall Study|Reason not listed|63|||
105695371|NCT01721876|364548347|FG000|Overall Study|Sponsor terminated trial|0|||
105695372|NCT01721876|364548348|FG001|Overall Study|Sponsor terminated trial|4|||
105695373|NCT01202279|364548351|FG000|Overall Study|Adverse Event|8|||
105695374|NCT01202279|364548352|FG001|Overall Study|Adverse Event|6|||
105695375|NCT01202279|364548351|FG000|Overall Study|Withdrawal by Subject|13|||
105695376|NCT01202279|364548352|FG001|Overall Study|Withdrawal by Subject|10|||
105695377|NCT01202279|364548351|FG000|Overall Study|Physician Decision|0|||
105695378|NCT01202279|364548352|FG001|Overall Study|Physician Decision|1|||
105695379|NCT01202279|364548351|FG000|Overall Study|Lost to Follow-up|10|||
105695380|NCT01202279|364548352|FG001|Overall Study|Lost to Follow-up|7|||
105695381|NCT01202279|364548351|FG000|Overall Study|Protocol Violation|1|||
105695382|NCT01202279|364548352|FG001|Overall Study|Protocol Violation|1|||
105695383|NCT01202279|364548351|FG000|Overall Study|study compliance|5|||
105695384|NCT01202279|364548352|FG001|Overall Study|study compliance|2|||
105695385|NCT03805750|364548353|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
105695386|NCT03805750|364548354|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
105695387|NCT01984164|364548355|FG000|Overall Study|Withdrawal by Subject|4|||
105695388|NCT01984164|364548356|FG001|Overall Study|Withdrawal by Subject|3|||
105695389|NCT01984164|364548355|FG000|Overall Study|Adverse Event|5|||
105695390|NCT01984164|364548356|FG001|Overall Study|Adverse Event|19|||
105695391|NCT01984164|364548355|FG000|Overall Study|Lost to Follow-up|1|||
105695392|NCT01984164|364548356|FG001|Overall Study|Lost to Follow-up|3|||
105695393|NCT02546765|364548359|FG000|Overall Study|Withdrawal by Subject|0|||
105695394|NCT02546765|364548360|FG001|Overall Study|Withdrawal by Subject|1|||
105695395|NCT02546765|364548361|FG002|Overall Study|Withdrawal by Subject|0|||
105695396|NCT02546765|364548362|FG003|Overall Study|Withdrawal by Subject|0|||
105695397|NCT00475722|364548363|FG000|Overall Study|Withdrawal by Subject|12|||
105695398|NCT00475722|364548364|FG001|Overall Study|Withdrawal by Subject|12|||
105695399|NCT00475722|364548363|FG000|Overall Study|Protocol Violation|3|||
105695400|NCT00475722|364548364|FG001|Overall Study|Protocol Violation|0|||
105695401|NCT02568475|364548365|FG000|Overall Study|Lost to Follow-up|40|||
105695402|NCT02568475|364548366|FG001|Overall Study|Lost to Follow-up|39|||
105695403|NCT02568475|364548365|FG000|Overall Study|Withdrawal by Subject|2|||
105695404|NCT02568475|364548366|FG001|Overall Study|Withdrawal by Subject|0|||
105695405|NCT02568475|364548365|FG000|Overall Study|Discharged home|4|||
105695406|NCT02568475|364548366|FG001|Overall Study|Discharged home|4|||
105695407|NCT02568475|364548365|FG000|Overall Study|Short-term: Discharge location unknown|4|||
105695408|NCT02568475|364548366|FG001|Overall Study|Short-term: Discharge location unknown|0|||
105695409|NCT02568475|364548365|FG000|Overall Study|Transferred to another facility|1|||
105695410|NCT02568475|364548366|FG001|Overall Study|Transferred to another facility|0|||
105695411|NCT00290186|364548367|FG000|Overall Study|Adverse Event|1|||
105695412|NCT00290186|364548368|FG001|Overall Study|Adverse Event|1|||
105695413|NCT00290186|364548367|FG000|Overall Study|Lost to Follow-up|3|||
105695414|NCT00290186|364548368|FG001|Overall Study|Lost to Follow-up|2|||
105695415|NCT00290186|364548367|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
105695416|NCT00290186|364548368|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
105695417|NCT00290186|364548367|FG000|Overall Study|Withdrawal by Subject|0|||
105695418|NCT00290186|364548368|FG001|Overall Study|Withdrawal by Subject|1|||
105695419|NCT01200238|364548372|FG000|Overall Study|Adverse Event|2|||
105695420|NCT01200238|364548373|FG001|Overall Study|Adverse Event|1|||
105695421|NCT01200238|364548372|FG000|Overall Study|Progressive Disease|5|||
105695422|NCT01200238|364548373|FG001|Overall Study|Progressive Disease|8|||
105695423|NCT01200238|364548372|FG000|Overall Study|Withdrawal by Subject|0|||
105695424|NCT01200238|364548373|FG001|Overall Study|Withdrawal by Subject|1|||
105695425|NCT03441334|364549814|FG000|Overall Study|Withdrawal by Subject|1|||
105695426|NCT03441334|364549815|FG001|Overall Study|Withdrawal by Subject|0|||
105695427|NCT00395863|364549818|FG000|Overall Study|Patients did not complete both exams|2|||
105695428|NCT00395863|364549819|FG001|Overall Study|Patients did not complete both exams|3|||
105695429|NCT03034460|364549823|FG000|Overall Study|Adverse Event|0|||
105695430|NCT03034460|364549824|FG001|Overall Study|Adverse Event|1|||
105695431|NCT03034460|364549823|FG000|Overall Study|Withdrawal by Subject|2|||
105695432|NCT03034460|364549824|FG001|Overall Study|Withdrawal by Subject|2|||
105695433|NCT03034460|364549823|FG000|Overall Study|Personal Reasons|1|||
105695434|NCT03034460|364549824|FG001|Overall Study|Personal Reasons|0|||
105695435|NCT00295633|364549825|FG000|Overall Study|Lack of Efficacy|19|||
105695436|NCT00295633|364549826|FG001|Overall Study|Lack of Efficacy|7|||
105695437|NCT00295633|364549827|FG002|Overall Study|Lack of Efficacy|16|||
105695438|NCT00295633|364549825|FG000|Overall Study|Withdrawal of consent by subject|16|||
105695439|NCT00295633|364549826|FG001|Overall Study|Withdrawal of consent by subject|16|||
105695440|NCT00295633|364549827|FG002|Overall Study|Withdrawal of consent by subject|26|||
105695441|NCT00295633|364549825|FG000|Overall Study|Adverse Event|9|||
105695442|NCT00295633|364549826|FG001|Overall Study|Adverse Event|17|||
105695443|NCT00295633|364549827|FG002|Overall Study|Adverse Event|9|||
105695444|NCT00295633|364549825|FG000|Overall Study|Lost to Follow-up|6|||
105559353|NCT00827918|364044670|FG000|Overall Study|Physician Decision|1|||
105559354|NCT00827918|364044671|FG001|Overall Study|Physician Decision|0|||
105695445|NCT00295633|364549826|FG001|Overall Study|Lost to Follow-up|11|||
105695446|NCT00295633|364549827|FG002|Overall Study|Lost to Follow-up|7|||
105348301|NCT00236899|363277041|FG000|Overall Study|Death (Not Study Related)|2|||
105348302|NCT00236899|363277042|FG001|Overall Study|Death (Not Study Related)|0|||
105348303|NCT00236899|363277043|FG002|Overall Study|Death (Not Study Related)|0|||
105348304|NCT00236899|363277044|FG003|Overall Study|Death (Not Study Related)|0|||
105348305|NCT00236899|363277041|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
105348306|NCT00236899|363277042|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
105473362|NCT04413617|363745342|FG003|Overall Study|Withdrawal by Subject|5|||
105695447|NCT00295633|364549825|FG000|Overall Study|Physician Decision|9|||
105695448|NCT00295633|364549826|FG001|Overall Study|Physician Decision|10|||
105695449|NCT00295633|364549827|FG002|Overall Study|Physician Decision|8|||
105695450|NCT00295633|364549825|FG000|Overall Study|Poor/Noncompliance|2|||
105695451|NCT00295633|364549826|FG001|Overall Study|Poor/Noncompliance|2|||
105695452|NCT00295633|364549827|FG002|Overall Study|Poor/Noncompliance|6|||
105695453|NCT00295633|364549825|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
105695454|NCT00295633|364549826|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
105695455|NCT00295633|364549827|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
105695456|NCT00295633|364549825|FG000|Overall Study|Death|1|||
105695457|NCT00295633|364549826|FG001|Overall Study|Death|1|||
105695458|NCT00295633|364549827|FG002|Overall Study|Death|0|||
105695459|NCT00295633|364549825|FG000|Overall Study|Administrative reason by sponsor|0|||
105695460|NCT00295633|364549826|FG001|Overall Study|Administrative reason by sponsor|0|||
105695461|NCT00295633|364549827|FG002|Overall Study|Administrative reason by sponsor|1|||
105695462|NCT00419120|364549829|FG000|Long Term Follow up Period|study ongoing|10|||
105695463|NCT01069120|364549830|FG000|Overall Study|Study prematurely terminated|27|||
105695464|NCT00710879|364549832|FG000|Overall Study|Lost to Follow-up|2|||
105695465|NCT00710879|364549833|FG001|Overall Study|Lost to Follow-up|1|||
105695466|NCT00710879|364549832|FG000|Overall Study|Protocol Violation|0|||
105695467|NCT00710879|364549833|FG001|Overall Study|Protocol Violation|3|||
105695468|NCT01688466|364549834|FG000|Overall Study|Withdrawal by Subject|2|||
105695469|NCT01688466|364549835|FG001|Overall Study|Withdrawal by Subject|1|||
105695470|NCT01688466|364549834|FG000|Overall Study|Death|0|||
105695471|NCT01688466|364549835|FG001|Overall Study|Death|1|||
105695472|NCT01688466|364549834|FG000|Overall Study|Adverse Event|0|||
105695473|NCT01688466|364549835|FG001|Overall Study|Adverse Event|4|||
105695474|NCT01688466|364549834|FG000|Overall Study|Not evaluable|0|||
105695475|NCT01688466|364549835|FG001|Overall Study|Not evaluable|1|||
105695476|NCT01641237|364549837|FG000|Period II|Withdrawal by Subject|1|||
105695477|NCT01641237|364549838|FG001|Period II|Withdrawal by Subject|0|||
105695478|NCT01641237|364549839|FG002|Period II|Withdrawal by Subject|0|||
105695479|NCT01641237|364549840|FG003|Period II|Withdrawal by Subject|0|||
105473363|NCT04413617|363745343|FG004|Overall Study|Withdrawal by Subject|3|||
105473364|NCT04413617|363745339|FG000|Overall Study|Death|1|||
105695480|NCT01641237|364549837|FG000|Period III|Lost to Follow-up|1|||
105695481|NCT01641237|364549838|FG001|Period III|Lost to Follow-up|0|||
105695482|NCT01641237|364549839|FG002|Period III|Lost to Follow-up|0|||
105695483|NCT01641237|364549840|FG003|Period III|Lost to Follow-up|0|||
105695484|NCT00709111|364549841|FG000|Overall Study|Withdrawal by Subject|1|||
105695485|NCT00709111|364549841|FG000|Overall Study|Unable to attend clinic visits|1|||
105695486|NCT00915772|364549842|FG000|Overall Study|Adverse Event|12|||
105787104|NCT03110107|364874910|FG021|Treatment Period|Study drug toxicity|0|||
105348307|NCT00236899|363277043|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
105695487|NCT00915772|364549843|FG001|Overall Study|Adverse Event|13|||
105695488|NCT00915772|364549844|FG002|Overall Study|Adverse Event|11|||
105695489|NCT00915772|364549842|FG000|Overall Study|Protocol Violation|4|||
105695490|NCT00915772|364549843|FG001|Overall Study|Protocol Violation|1|||
105695491|NCT00915772|364549844|FG002|Overall Study|Protocol Violation|2|||
105695492|NCT00915772|364549842|FG000|Overall Study|Lost to Follow-up|1|||
105695493|NCT00915772|364549843|FG001|Overall Study|Lost to Follow-up|2|||
105695494|NCT00915772|364549844|FG002|Overall Study|Lost to Follow-up|2|||
105695495|NCT00915772|364549842|FG000|Overall Study|Lack of Efficacy|9|||
105695496|NCT00915772|364549843|FG001|Overall Study|Lack of Efficacy|15|||
105695497|NCT00915772|364549844|FG002|Overall Study|Lack of Efficacy|3|||
105695498|NCT00915772|364549842|FG000|Overall Study|Refused to continue trial medication|6|||
105695499|NCT00915772|364549843|FG001|Overall Study|Refused to continue trial medication|8|||
105695500|NCT00915772|364549844|FG002|Overall Study|Refused to continue trial medication|4|||
105695501|NCT00915772|364549842|FG000|Overall Study|Any other reason|4|||
105695502|NCT00915772|364549843|FG001|Overall Study|Any other reason|7|||
105695503|NCT00915772|364549844|FG002|Overall Study|Any other reason|7|||
105695504|NCT00041080|364549853|FG000|Overall Study|Adverse Event|21|||
105695505|NCT00041080|364549854|FG001|Overall Study|Adverse Event|1|||
105695506|NCT00041080|364549853|FG000|Overall Study|Withdrawal by Subject|6|||
105695507|NCT00041080|364549854|FG001|Overall Study|Withdrawal by Subject|6|||
105695508|NCT00041080|364549853|FG000|Overall Study|Concommitant Illness/Other|1|||
105695509|NCT00041080|364549854|FG001|Overall Study|Concommitant Illness/Other|2|||
105695510|NCT00041080|364549853|FG000|Overall Study|Did not start therapy|1|||
105695511|NCT00041080|364549854|FG001|Overall Study|Did not start therapy|1|||
105695512|NCT00041080|364549853|FG000|Overall Study|Ineligible|1|||
105695513|NCT00041080|364549854|FG001|Overall Study|Ineligible|0|||
105695514|NCT01670539|364549855|FG000|Overall Study|Death|3|||
105695515|NCT01670539|364549856|FG001|Overall Study|Death|5|||
105695516|NCT01670539|364549855|FG000|Overall Study|Withdrawal by Subject|3|||
105695517|NCT01670539|364549856|FG001|Overall Study|Withdrawal by Subject|0|||
105695518|NCT00536809|364549859|FG000|Phase II|Adverse Event|1|||
105695519|NCT00536809|364549859|FG000|Phase II|Referred for surgical resection|1|||
105695520|NCT01526551|364549862|FG000|Overall Study|Lack of returned parental consent form|424|||
105695521|NCT05215262|364549863|FG000|Overall Study|Lost to Follow-up|12|||
105695522|NCT05215262|364549864|FG001|Overall Study|Lost to Follow-up|0|||
105695523|NCT00873366|364549866|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
105695524|NCT00873366|364549866|FG000|Overall Study|Off tamoxifen due to side effects|2|||
105695525|NCT00873366|364549866|FG000|Overall Study|Refused to continue DM-BT testing|3|||
105695526|NCT00646906|364549867|FG000|Crossover Period 1|Withdrawal by Subject|1|||
105695527|NCT00646906|364549868|FG001|Crossover Period 1|Withdrawal by Subject|0|||
105695528|NCT00646906|364549869|FG002|Crossover Period 1|Withdrawal by Subject|0|||
105695529|NCT00646906|364549870|FG003|Crossover Period 1|Withdrawal by Subject|0|||
105695530|NCT00646906|364549871|FG004|Crossover Period 1|Withdrawal by Subject|0|||
105695531|NCT00646906|364549872|FG005|Crossover Period 1|Withdrawal by Subject|1|||
105559355|NCT00827918|364044672|FG002|Overall Study|Physician Decision|0|||
105559356|NCT00827918|364044670|FG000|Overall Study|Pregnancy|0|||
105559357|NCT00827918|364044671|FG001|Overall Study|Pregnancy|1|||
105695532|NCT00646906|364549873|FG006|Crossover Period 1|Withdrawal by Subject|0|||
105695533|NCT00646906|364549867|FG000|Crossover Period 2|Withdrawal by Subject|0|||
105559358|NCT00827918|364044672|FG002|Overall Study|Pregnancy|0|||
105559359|NCT00827918|364044670|FG000|Overall Study|Progressive Disease|1|||
105559360|NCT00827918|364044671|FG001|Overall Study|Progressive Disease|1|||
105559361|NCT00827918|364044672|FG002|Overall Study|Progressive Disease|0|||
105695534|NCT00646906|364549868|FG001|Crossover Period 2|Withdrawal by Subject|1|||
105695535|NCT00646906|364549869|FG002|Crossover Period 2|Withdrawal by Subject|2|||
105695536|NCT00646906|364549870|FG003|Crossover Period 2|Withdrawal by Subject|1|||
105695537|NCT00646906|364549871|FG004|Crossover Period 2|Withdrawal by Subject|0|||
105695538|NCT00646906|364549872|FG005|Crossover Period 2|Withdrawal by Subject|0|||
105695539|NCT00646906|364549873|FG006|Crossover Period 2|Withdrawal by Subject|0|||
105695540|NCT00646906|364549867|FG000|Crossover Period 2|Physician Decision|0|||
105559362|NCT00827918|364044670|FG000|Overall Study|Protocol Violation|0|||
105695541|NCT00646906|364549868|FG001|Crossover Period 2|Physician Decision|0|||
105695542|NCT00646906|364549869|FG002|Crossover Period 2|Physician Decision|0|||
105695543|NCT00646906|364549870|FG003|Crossover Period 2|Physician Decision|0|||
105695544|NCT00646906|364549871|FG004|Crossover Period 2|Physician Decision|0|||
105695545|NCT00646906|364549872|FG005|Crossover Period 2|Physician Decision|0|||
105695546|NCT00646906|364549873|FG006|Crossover Period 2|Physician Decision|1|||
105695547|NCT02613884|364549882|FG000|Overall Study|Death|1|||
105695548|NCT02613884|364549882|FG000|Overall Study|Lost to Follow-up|1|||
105695549|NCT04422990|364549883|FG000|Overall Study|Withdrawal by Subject|0|||
105695550|NCT04422990|364549884|FG001|Overall Study|Withdrawal by Subject|1|||
105695551|NCT04422990|364549883|FG000|Overall Study|Travel|3|||
105695552|NCT04422990|364549884|FG001|Overall Study|Travel|0|||
105695553|NCT02486653|364549887|FG000|Overall Study|Withdrawal by Subject|1|||
105695554|NCT02486653|364549888|FG001|Overall Study|Withdrawal by Subject|3|||
105695555|NCT02486653|364549887|FG000|Overall Study|Protocol Violation|1|||
105695556|NCT02486653|364549888|FG001|Overall Study|Protocol Violation|0|||
105695557|NCT02486653|364549887|FG000|Overall Study|surgery cancelled|4|||
105695558|NCT02486653|364549888|FG001|Overall Study|surgery cancelled|1|||
105695559|NCT01092143|364549889|FG000|Overall Study|Adverse Event|10|||
105695560|NCT01092143|364549890|FG001|Overall Study|Adverse Event|5|||
105695561|NCT01092143|364549891|FG002|Overall Study|Adverse Event|1|||
105695562|NCT01092143|364549892|FG003|Overall Study|Adverse Event|4|||
105695563|NCT01092143|364549893|FG004|Overall Study|Adverse Event|3|||
105695564|NCT01092143|364549889|FG000|Overall Study|Lost to Follow-up|1|||
105695565|NCT01092143|364549890|FG001|Overall Study|Lost to Follow-up|0|||
105695566|NCT01092143|364549891|FG002|Overall Study|Lost to Follow-up|1|||
105695567|NCT01092143|364549892|FG003|Overall Study|Lost to Follow-up|0|||
105695568|NCT01092143|364549893|FG004|Overall Study|Lost to Follow-up|0|||
105695569|NCT01092143|364549889|FG000|Overall Study|Consent withdrawn|2|||
105695570|NCT01092143|364549890|FG001|Overall Study|Consent withdrawn|1|||
105695571|NCT01092143|364549891|FG002|Overall Study|Consent withdrawn|0|||
105695572|NCT01092143|364549892|FG003|Overall Study|Consent withdrawn|1|||
105695573|NCT01092143|364549893|FG004|Overall Study|Consent withdrawn|3|||
105695574|NCT01092143|364549889|FG000|Overall Study|Not treated|0|||
105695575|NCT01092143|364549890|FG001|Overall Study|Not treated|0|||
105695576|NCT01092143|364549891|FG002|Overall Study|Not treated|1|||
105695577|NCT01092143|364549892|FG003|Overall Study|Not treated|0|||
105695578|NCT01092143|364549893|FG004|Overall Study|Not treated|0|||
105695579|NCT01092143|364549889|FG000|Overall Study|did not reversibility criteria|0|||
105695580|NCT01092143|364549890|FG001|Overall Study|did not reversibility criteria|0|||
105695581|NCT01092143|364549891|FG002|Overall Study|did not reversibility criteria|1|||
105695582|NCT01092143|364549892|FG003|Overall Study|did not reversibility criteria|0|||
105695583|NCT01092143|364549893|FG004|Overall Study|did not reversibility criteria|0|||
105695584|NCT01092143|364549889|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
105695585|NCT01092143|364549890|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
105695586|NCT01092143|364549891|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
105695587|NCT01092143|364549892|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
105695588|NCT01092143|364549893|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
105695589|NCT01092143|364549889|FG000|Overall Study|Ineligible patient|1|||
105695590|NCT01092143|364549890|FG001|Overall Study|Ineligible patient|0|||
105695591|NCT01092143|364549891|FG002|Overall Study|Ineligible patient|0|||
105695592|NCT01092143|364549892|FG003|Overall Study|Ineligible patient|0|||
105695593|NCT01092143|364549893|FG004|Overall Study|Ineligible patient|0|||
105695594|NCT01092143|364549889|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
105695595|NCT01092143|364549890|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
105695596|NCT01092143|364549891|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
105695597|NCT01092143|364549892|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
105695598|NCT01092143|364549893|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
105695599|NCT01092143|364549889|FG000|Overall Study|Patient travel|0|||
105695600|NCT01092143|364549890|FG001|Overall Study|Patient travel|0|||
105695601|NCT01092143|364549891|FG002|Overall Study|Patient travel|0|||
105695602|NCT01092143|364549892|FG003|Overall Study|Patient travel|0|||
105695603|NCT01092143|364549893|FG004|Overall Study|Patient travel|1|||
105695604|NCT01092143|364549889|FG000|Overall Study|Non compliance with study medication|0|||
105695605|NCT01092143|364549890|FG001|Overall Study|Non compliance with study medication|0|||
105695606|NCT01092143|364549891|FG002|Overall Study|Non compliance with study medication|0|||
105695607|NCT01092143|364549892|FG003|Overall Study|Non compliance with study medication|0|||
105695608|NCT01092143|364549893|FG004|Overall Study|Non compliance with study medication|1|||
105695609|NCT01092143|364549889|FG000|Overall Study|Randomized by mistake|0|||
105695610|NCT01092143|364549890|FG001|Overall Study|Randomized by mistake|0|||
105473365|NCT04413617|363745340|FG001|Overall Study|Death|0|||
105473366|NCT04413617|363745341|FG002|Overall Study|Death|0|||
105473367|NCT04413617|363745342|FG003|Overall Study|Death|0|||
105473368|NCT04413617|363745343|FG004|Overall Study|Death|0|||
105473369|NCT04413617|363745339|FG000|Overall Study|Adverse Event|1|||
105473370|NCT04413617|363745340|FG001|Overall Study|Adverse Event|0|||
105473371|NCT04413617|363745341|FG002|Overall Study|Adverse Event|0|||
105473372|NCT04413617|363745342|FG003|Overall Study|Adverse Event|1|||
105473373|NCT04413617|363745343|FG004|Overall Study|Adverse Event|1|||
105473374|NCT04413617|363745339|FG000|Overall Study|COVID-19|0|||
105473375|NCT04413617|363745340|FG001|Overall Study|COVID-19|1|||
105473376|NCT04413617|363745341|FG002|Overall Study|COVID-19|0|||
105473377|NCT04413617|363745342|FG003|Overall Study|COVID-19|0|||
105473378|NCT04413617|363745343|FG004|Overall Study|COVID-19|0|||
105473379|NCT00312195|363745344|FG000|Overall Study|Adverse Event|4|||
105473380|NCT00312195|363745345|FG001|Overall Study|Adverse Event|6|||
105473381|NCT00312195|363745344|FG000|Overall Study|Lost to Follow-up|1|||
105473382|NCT00312195|363745345|FG001|Overall Study|Lost to Follow-up|0|||
105473383|NCT00312195|363745344|FG000|Overall Study|Protocol Violation|1|||
105473384|NCT00312195|363745345|FG001|Overall Study|Protocol Violation|0|||
105473385|NCT02657408|363745346|FG000|Overall Study|Adverse Event|3|||
105473386|NCT02657408|363745347|FG001|Overall Study|Adverse Event|7|||
105473387|NCT00344487|363745349|FG000|Overall Study|immunologic failure|1|||
105473388|NCT02504216|363745351|FG000|Overall Study|Lost to Follow-up|3|||
105473389|NCT02504216|363745352|FG001|Overall Study|Lost to Follow-up|3|||
105473390|NCT02504216|363745351|FG000|Overall Study|Withdrawal by Subject|8|||
105473391|NCT02504216|363745352|FG001|Overall Study|Withdrawal by Subject|12|||
105473392|NCT00862082|363745353|FG000|Overall Study|Sponsor decision to terminate the study|5|||
105473393|NCT00862082|363745354|FG001|Overall Study|Sponsor decision to terminate the study|0|||
105473394|NCT00862082|363745353|FG000|Overall Study|Withdrawal by Subject|0|||
105473395|NCT00862082|363745354|FG001|Overall Study|Withdrawal by Subject|1|||
105473396|NCT00452361|363745355|FG000|Overall Study|Adverse Event|8|||
105473397|NCT00452361|363745356|FG001|Overall Study|Adverse Event|0|||
105473398|NCT00452361|363745355|FG000|Overall Study|Withdrawal by Subject|0|||
105473399|NCT00452361|363745356|FG001|Overall Study|Withdrawal by Subject|1|||
105473400|NCT00452361|363745355|FG000|Overall Study|Premature termination|13|||
105473401|NCT00452361|363745356|FG001|Overall Study|Premature termination|9|||
105473402|NCT00776919|363745357|FG000|Overall Study|Withdrawal by Subject|16|||
105473403|NCT00776919|363745358|FG001|Overall Study|Withdrawal by Subject|14|||
105473404|NCT00776919|363745359|FG002|Overall Study|Withdrawal by Subject|15|||
105473405|NCT00776919|363745360|FG003|Overall Study|Withdrawal by Subject|26|||
105473406|NCT00776919|363745357|FG000|Overall Study|Lost to Follow-up|8|||
105473407|NCT00776919|363745358|FG001|Overall Study|Lost to Follow-up|12|||
105473408|NCT00776919|363745359|FG002|Overall Study|Lost to Follow-up|11|||
105473409|NCT00776919|363745360|FG003|Overall Study|Lost to Follow-up|8|||
105473410|NCT00776919|363745357|FG000|Overall Study|Adverse Event|1|||
105473411|NCT00776919|363745358|FG001|Overall Study|Adverse Event|0|||
105473412|NCT00776919|363745359|FG002|Overall Study|Adverse Event|2|||
105473413|NCT00776919|363745360|FG003|Overall Study|Adverse Event|2|||
105473414|NCT00776919|363745357|FG000|Overall Study|Protocol Violation|1|||
105473415|NCT00776919|363745358|FG001|Overall Study|Protocol Violation|2|||
105473416|NCT00776919|363745359|FG002|Overall Study|Protocol Violation|0|||
105473417|NCT00776919|363745360|FG003|Overall Study|Protocol Violation|1|||
105473418|NCT00776919|363745357|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
105473419|NCT00776919|363745358|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
105473420|NCT00776919|363745359|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
105473421|NCT00776919|363745360|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
105473422|NCT01396070|363745363|FG000|Overall Study|Withdrawal by Subject|2|||
105473423|NCT01396070|363745363|FG000|Overall Study|Death|2|||
105473424|NCT01396070|363745363|FG000|Overall Study|Adverse Event|8|||
105473425|NCT01396070|363745363|FG000|Overall Study|Physician Decision|3|||
105473426|NCT01396070|363745363|FG000|Overall Study|Lack of Efficacy|4|||
105473427|NCT01561313|363745364|FG000|Overall Study|Withdrawal by Subject|1|||
105473428|NCT01561313|363745365|FG001|Overall Study|Withdrawal by Subject|0|||
105787105|NCT03110107|364874911|FG022|Treatment Period|Study drug toxicity|2|||
105473429|NCT01561313|363745364|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
105473430|NCT01561313|363745365|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
105473431|NCT00916929|363745366|FG000|Overall Study|Lost to Follow-up|1|||
105473432|NCT00916929|363745367|FG001|Overall Study|Lost to Follow-up|3|||
105473433|NCT00916929|363745366|FG000|Overall Study|Death|5|||
105473434|NCT00916929|363745367|FG001|Overall Study|Death|10|||
105473435|NCT00916929|363745366|FG000|Overall Study|Withdrawal by Subject|1|||
105695611|NCT01092143|364549891|FG002|Overall Study|Randomized by mistake|0|||
105695612|NCT01092143|364549892|FG003|Overall Study|Randomized by mistake|1|||
105695613|NCT01092143|364549893|FG004|Overall Study|Randomized by mistake|0|||
105695614|NCT01092143|364549889|FG000|Overall Study|Pregnancy|0|||
105695615|NCT01092143|364549890|FG001|Overall Study|Pregnancy|0|||
105695616|NCT01092143|364549891|FG002|Overall Study|Pregnancy|0|||
105695617|NCT01092143|364549892|FG003|Overall Study|Pregnancy|1|||
105695618|NCT01092143|364549893|FG004|Overall Study|Pregnancy|0|||
105695619|NCT01621542|364549898|FG000|Overall Study|Adverse Event|0|||
105695620|NCT01621542|364549899|FG001|Overall Study|Adverse Event|0|||
105695621|NCT01621542|364549900|FG002|Overall Study|Adverse Event|1|||
105695622|NCT01621542|364549901|FG003|Overall Study|Adverse Event|3|||
105695623|NCT01621542|364549902|FG004|Overall Study|Adverse Event|0|||
105695624|NCT01621542|364549903|FG005|Overall Study|Adverse Event|0|||
105695625|NCT01621542|364549898|FG000|Overall Study|Death|0|||
105695626|NCT01621542|364549899|FG001|Overall Study|Death|1|||
105695627|NCT01621542|364549900|FG002|Overall Study|Death|0|||
105695628|NCT01621542|364549901|FG003|Overall Study|Death|0|||
105695629|NCT01621542|364549902|FG004|Overall Study|Death|0|||
105695630|NCT01621542|364549903|FG005|Overall Study|Death|0|||
105695631|NCT01621542|364549898|FG000|Overall Study|Physician Decision|1|||
105695632|NCT01621542|364549899|FG001|Overall Study|Physician Decision|0|||
105695633|NCT01621542|364549900|FG002|Overall Study|Physician Decision|1|||
105695634|NCT01621542|364549901|FG003|Overall Study|Physician Decision|13|||
105695635|NCT01621542|364549902|FG004|Overall Study|Physician Decision|3|||
105695636|NCT01621542|364549903|FG005|Overall Study|Physician Decision|1|||
105695637|NCT01621542|364549898|FG000|Overall Study|Withdrawal by Subject|2|||
105695638|NCT01621542|364549899|FG001|Overall Study|Withdrawal by Subject|0|||
105695639|NCT01621542|364549900|FG002|Overall Study|Withdrawal by Subject|1|||
105695640|NCT01621542|364549901|FG003|Overall Study|Withdrawal by Subject|3|||
105695641|NCT01621542|364549902|FG004|Overall Study|Withdrawal by Subject|3|||
105695642|NCT01621542|364549903|FG005|Overall Study|Withdrawal by Subject|3|||
105695643|NCT01621542|364549898|FG000|Overall Study|progression/treatment failure|2|||
105695644|NCT01621542|364549899|FG001|Overall Study|progression/treatment failure|4|||
105695645|NCT01621542|364549900|FG002|Overall Study|progression/treatment failure|3|||
105559363|NCT00827918|364044671|FG001|Overall Study|Protocol Violation|1|||
105695646|NCT01621542|364549901|FG003|Overall Study|progression/treatment failure|7|||
105695647|NCT01621542|364549902|FG004|Overall Study|progression/treatment failure|3|||
105695648|NCT01621542|364549903|FG005|Overall Study|progression/treatment failure|5|||
105695649|NCT01621542|364549898|FG000|Overall Study|Protocol Violation|0|||
105695650|NCT01621542|364549899|FG001|Overall Study|Protocol Violation|0|||
105695651|NCT01621542|364549900|FG002|Overall Study|Protocol Violation|0|||
105695652|NCT01621542|364549901|FG003|Overall Study|Protocol Violation|1|||
105695653|NCT01621542|364549902|FG004|Overall Study|Protocol Violation|0|||
105695654|NCT01621542|364549903|FG005|Overall Study|Protocol Violation|0|||
105695655|NCT01621542|364549898|FG000|Overall Study|study stopped by sponsor|0|||
105695656|NCT01621542|364549899|FG001|Overall Study|study stopped by sponsor|0|||
105695657|NCT01621542|364549900|FG002|Overall Study|study stopped by sponsor|0|||
105695658|NCT01621542|364549901|FG003|Overall Study|study stopped by sponsor|1|||
105695659|NCT01621542|364549902|FG004|Overall Study|study stopped by sponsor|0|||
105473436|NCT00916929|363745367|FG001|Overall Study|Withdrawal by Subject|5|||
105473437|NCT00916929|363745366|FG000|Overall Study|Left ventricular epicardial lead|1|||
105473438|NCT00916929|363745367|FG001|Overall Study|Left ventricular epicardial lead|2|||
105473439|NCT00916929|363745366|FG000|Overall Study|Transferred to hospice care|1|||
105473440|NCT00916929|363745367|FG001|Overall Study|Transferred to hospice care|1|||
105473441|NCT00916929|363745366|FG000|Overall Study|System explant|1|||
105473442|NCT00916929|363745367|FG001|Overall Study|System explant|0|||
105473443|NCT00916929|363745366|FG000|Overall Study|Moved to another state|0|||
105473444|NCT00916929|363745367|FG001|Overall Study|Moved to another state|1|||
105473445|NCT00916929|363745366|FG000|Overall Study|Device unable to process impedance data|0|||
105473446|NCT00916929|363745367|FG001|Overall Study|Device unable to process impedance data|7|||
105473447|NCT04530136|363745370|FG000|Overall Study|Lost to Follow-up|2|||
105695660|NCT01621542|364549903|FG005|Overall Study|study stopped by sponsor|0|||
105695661|NCT00955279|364549904|FG000|Overall Study|Other|0|||
105695662|NCT00955279|364549905|FG001|Overall Study|Other|0|||
105695663|NCT00955279|364549906|FG002|Overall Study|Other|3|||
105695664|NCT00955279|364549904|FG000|Overall Study|Death|1|||
105695665|NCT00955279|364549905|FG001|Overall Study|Death|1|||
105695666|NCT00955279|364549906|FG002|Overall Study|Death|1|||
105695667|NCT00955279|364549904|FG000|Overall Study|Lost to Follow-up|0|||
105695668|NCT00955279|364549905|FG001|Overall Study|Lost to Follow-up|3|||
105695669|NCT00955279|364549906|FG002|Overall Study|Lost to Follow-up|1|||
105695670|NCT00955279|364549904|FG000|Overall Study|Withdrawal by Subject|2|||
105695671|NCT00955279|364549905|FG001|Overall Study|Withdrawal by Subject|0|||
105695672|NCT00955279|364549906|FG002|Overall Study|Withdrawal by Subject|3|||
105695673|NCT00430482|364549921|FG000|Completed Treatment|Insufficient Treatment|7|||
105695674|NCT00430482|364549922|FG001|Completed Treatment|Insufficient Treatment|11|||
105695675|NCT00397033|364549923|FG000|Overall Study|Adverse Event|7|||
105695676|NCT00397033|364549924|FG001|Overall Study|Adverse Event|10|||
105695677|NCT00397033|364549925|FG002|Overall Study|Adverse Event|4|||
105695678|NCT00397033|364549923|FG000|Overall Study|Lack of Efficacy|22|||
105695679|NCT00397033|364549924|FG001|Overall Study|Lack of Efficacy|12|||
105695680|NCT00397033|364549925|FG002|Overall Study|Lack of Efficacy|9|||
105695681|NCT00397033|364549923|FG000|Overall Study|Lost to Follow-up|3|||
105695682|NCT00397033|364549924|FG001|Overall Study|Lost to Follow-up|3|||
105473448|NCT04530136|363745371|FG001|Overall Study|Lost to Follow-up|3|||
105473449|NCT04530136|363745370|FG000|Overall Study|Withdrawal by Subject|1|||
105473450|NCT04530136|363745371|FG001|Overall Study|Withdrawal by Subject|0|||
105473451|NCT04530136|363745370|FG000|Overall Study|Death|0|||
105473452|NCT04530136|363745371|FG001|Overall Study|Death|1|||
105473453|NCT01309282|363745372|FG000|Overall Study|Lost to Follow-up|1|||
105473454|NCT00499590|363745375|FG000|Overall Study|Study Terminated|112|||
105473455|NCT00499590|363745376|FG001|Overall Study|Study Terminated|112|||
105473456|NCT00499590|363745377|FG002|Overall Study|Study Terminated|112|||
105473457|NCT00499590|363745375|FG000|Overall Study|Not treated|1|||
105695683|NCT00397033|364549925|FG002|Overall Study|Lost to Follow-up|3|||
105695684|NCT00397033|364549923|FG000|Overall Study|Withdrawal by Subject|12|||
105695685|NCT00397033|364549924|FG001|Overall Study|Withdrawal by Subject|7|||
105695686|NCT00397033|364549925|FG002|Overall Study|Withdrawal by Subject|5|||
105473458|NCT00499590|363745376|FG001|Overall Study|Not treated|0|||
105348308|NCT00236899|363277044|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
105559364|NCT00827918|364044672|FG002|Overall Study|Protocol Violation|0|||
105559365|NCT00827918|364044670|FG000|Overall Study|Withdrawal by Subject|6|||
105559366|NCT00827918|364044671|FG001|Overall Study|Withdrawal by Subject|2|||
105787106|NCT03110107|364874912|FG023|Treatment Period|Study drug toxicity|6|||
105559367|NCT00827918|364044672|FG002|Overall Study|Withdrawal by Subject|6|||
105473459|NCT00499590|363745377|FG002|Overall Study|Not treated|1|||
105473460|NCT01668589|363745378|FG000|Overall Study|Lost to Follow-up|29|||
105473461|NCT01668589|363745379|FG001|Overall Study|Lost to Follow-up|37|||
105473462|NCT01668589|363745380|FG002|Overall Study|Lost to Follow-up|15|||
105473463|NCT01668589|363745381|FG003|Overall Study|Lost to Follow-up|5|||
105473464|NCT01668589|363745378|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
105473465|NCT01668589|363745379|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
105473466|NCT01668589|363745380|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
105473467|NCT01668589|363745381|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
105473468|NCT01668589|363745378|FG000|Overall Study|Death|12|||
105787107|NCT03110107|364874913|FG024|Treatment Period|Study drug toxicity|7|||
105473469|NCT01668589|363745379|FG001|Overall Study|Death|3|||
105473470|NCT01668589|363745380|FG002|Overall Study|Death|2|||
105473471|NCT01668589|363745381|FG003|Overall Study|Death|11|||
105473472|NCT01668589|363745378|FG000|Overall Study|Other|44|||
105473473|NCT01668589|363745379|FG001|Overall Study|Other|10|||
105473474|NCT01668589|363745380|FG002|Overall Study|Other|7|||
105695687|NCT00397033|364549923|FG000|Overall Study|Other|0|||
105695688|NCT00397033|364549924|FG001|Overall Study|Other|5|||
105695689|NCT00397033|364549925|FG002|Overall Study|Other|2|||
105695690|NCT03519867|364549926|FG000|Overall Study|Adverse Event|1|||
105695691|NCT03519867|364549927|FG001|Overall Study|Adverse Event|1|||
105695692|NCT03519867|364549928|FG002|Overall Study|Adverse Event|0|||
105695693|NCT03519867|364549929|FG003|Overall Study|Adverse Event|0|||
105695694|NCT03519867|364549930|FG004|Overall Study|Adverse Event|0|||
105695695|NCT03519867|364549931|FG005|Overall Study|Adverse Event|0|||
105695696|NCT03519867|364549932|FG006|Overall Study|Adverse Event|0|||
105695697|NCT03519867|364549933|FG007|Overall Study|Adverse Event|0|||
105695698|NCT03519867|364549934|FG008|Overall Study|Adverse Event|0|||
105695699|NCT03519867|364549935|FG009|Overall Study|Adverse Event|0|||
105695700|NCT03519867|364549926|FG000|Overall Study|Protocol Violation|0|||
105695701|NCT03519867|364549927|FG001|Overall Study|Protocol Violation|0|||
105695702|NCT03519867|364549928|FG002|Overall Study|Protocol Violation|0|||
105695703|NCT03519867|364549929|FG003|Overall Study|Protocol Violation|0|||
105695704|NCT03519867|364549930|FG004|Overall Study|Protocol Violation|0|||
105695705|NCT03519867|364549931|FG005|Overall Study|Protocol Violation|1|||
105695706|NCT03519867|364549932|FG006|Overall Study|Protocol Violation|0|||
105695707|NCT03519867|364549933|FG007|Overall Study|Protocol Violation|0|||
105695708|NCT03519867|364549934|FG008|Overall Study|Protocol Violation|0|||
105695709|NCT03519867|364549935|FG009|Overall Study|Protocol Violation|0|||
105695710|NCT03519867|364549926|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695711|NCT03519867|364549927|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695712|NCT03519867|364549928|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695713|NCT03519867|364549929|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695714|NCT03519867|364549930|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695715|NCT03519867|364549931|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695716|NCT03519867|364549932|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
105695717|NCT03519867|364549933|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695718|NCT03519867|364549934|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695719|NCT03519867|364549935|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695720|NCT03519867|364549926|FG000|Overall Study|Admin. of other reversal agent|1|||
105348309|NCT00236899|363277041|FG000|Overall Study|Lost to Follow-up|0|||
105348310|NCT00236899|363277042|FG001|Overall Study|Lost to Follow-up|1|||
105348311|NCT00236899|363277043|FG002|Overall Study|Lost to Follow-up|0|||
105348312|NCT00236899|363277044|FG003|Overall Study|Lost to Follow-up|0|||
105348313|NCT00236899|363277041|FG000|Overall Study|Entry Criteria Exclusion|0|||
105348314|NCT00236899|363277042|FG001|Overall Study|Entry Criteria Exclusion|1|||
105348315|NCT00236899|363277043|FG002|Overall Study|Entry Criteria Exclusion|1|||
105348316|NCT00236899|363277044|FG003|Overall Study|Entry Criteria Exclusion|0|||
105348317|NCT00236899|363277041|FG000|Overall Study|Protocol Violation|1|||
105348318|NCT00236899|363277042|FG001|Overall Study|Protocol Violation|0|||
105348319|NCT00236899|363277043|FG002|Overall Study|Protocol Violation|0|||
105348320|NCT00236899|363277044|FG003|Overall Study|Protocol Violation|0|||
105348321|NCT00236899|363277041|FG000|Overall Study|Withdrawal by Subject|6|||
105348322|NCT00236899|363277042|FG001|Overall Study|Withdrawal by Subject|4|||
105348323|NCT00236899|363277043|FG002|Overall Study|Withdrawal by Subject|5|||
105348324|NCT00236899|363277044|FG003|Overall Study|Withdrawal by Subject|2|||
105348325|NCT00236899|363277041|FG000|Overall Study|Physician Decision|7|||
105695721|NCT03519867|364549927|FG001|Overall Study|Admin. of other reversal agent|1|||
105695722|NCT03519867|364549928|FG002|Overall Study|Admin. of other reversal agent|0|||
105348326|NCT00236899|363277042|FG001|Overall Study|Physician Decision|8|||
105348327|NCT00236899|363277043|FG002|Overall Study|Physician Decision|7|||
105473475|NCT01668589|363745381|FG003|Overall Study|Other|15|||
105695723|NCT03519867|364549929|FG003|Overall Study|Admin. of other reversal agent|0|||
105348328|NCT00236899|363277044|FG003|Overall Study|Physician Decision|6|||
105348329|NCT00236899|363277041|FG000|Overall Study|Satisfactory Response|2|||
105348330|NCT00236899|363277042|FG001|Overall Study|Satisfactory Response|0|||
105348331|NCT00236899|363277043|FG002|Overall Study|Satisfactory Response|0|||
105348332|NCT00236899|363277044|FG003|Overall Study|Satisfactory Response|1|||
105348333|NCT00236899|363277041|FG000|Overall Study|Lack of Efficacy|18|||
105348334|NCT00236899|363277042|FG001|Overall Study|Lack of Efficacy|18|||
105348335|NCT00236899|363277043|FG002|Overall Study|Lack of Efficacy|25|||
105348336|NCT00236899|363277044|FG003|Overall Study|Lack of Efficacy|23|||
105348337|NCT00934856|363277045|FG000|Feasibility Part|Progressive disease|4|||
105348338|NCT00934856|363277046|FG001|Feasibility Part|Progressive disease|4|||
105348339|NCT00934856|363277047|FG002|Feasibility Part|Progressive disease|2|||
105348340|NCT00934856|363277048|FG003|Feasibility Part|Progressive disease|3|||
105348341|NCT00934856|363277049|FG004|Feasibility Part|Progressive disease|0|||
105348342|NCT00934856|363277050|FG005|Feasibility Part|Progressive disease|0|||
105348343|NCT00934856|363277045|FG000|Feasibility Part|Physician Decision|0|||
105559368|NCT02291614|364044675|FG000|Overall Study|Lost to Follow-up|0|||
105559369|NCT02291614|364044676|FG001|Overall Study|Lost to Follow-up|0|||
105559370|NCT02291614|364044677|FG002|Overall Study|Lost to Follow-up|0|||
105559371|NCT02291614|364044678|FG003|Overall Study|Lost to Follow-up|0|||
105559372|NCT02291614|364044679|FG004|Overall Study|Lost to Follow-up|0|||
105559373|NCT02291614|364044680|FG005|Overall Study|Lost to Follow-up|0|||
105559374|NCT02291614|364044681|FG006|Overall Study|Lost to Follow-up|0|||
105559375|NCT02291614|364044682|FG007|Overall Study|Lost to Follow-up|1|||
105348344|NCT00934856|363277046|FG001|Feasibility Part|Physician Decision|0|||
105348345|NCT00934856|363277047|FG002|Feasibility Part|Physician Decision|1|||
105348346|NCT00934856|363277048|FG003|Feasibility Part|Physician Decision|0|||
105559376|NCT02291614|364044683|FG008|Overall Study|Lost to Follow-up|0|||
105559377|NCT02291614|364044684|FG009|Overall Study|Lost to Follow-up|0|||
105348347|NCT00934856|363277049|FG004|Feasibility Part|Physician Decision|0|||
105559378|NCT02291614|364044685|FG010|Overall Study|Lost to Follow-up|0|||
105559379|NCT02291614|364044675|FG000|Overall Study|Withdrawal by Subject|0|||
105348348|NCT00934856|363277050|FG005|Feasibility Part|Physician Decision|0|||
105348349|NCT00934856|363277045|FG000|Feasibility Part|Adverse Event|1|||
105348350|NCT00934856|363277046|FG001|Feasibility Part|Adverse Event|1|||
105348351|NCT00934856|363277047|FG002|Feasibility Part|Adverse Event|0|||
105348352|NCT00934856|363277048|FG003|Feasibility Part|Adverse Event|1|||
105348353|NCT00934856|363277049|FG004|Feasibility Part|Adverse Event|0|||
105348354|NCT00934856|363277050|FG005|Feasibility Part|Adverse Event|2|||
105348355|NCT00934856|363277045|FG000|Feasibility Part|Withdrawal by Subject|0|||
105473476|NCT00853567|363745382|FG000|Overall Study|Study prematurely terminated|71|||
105473477|NCT02055118|363745383|FG000|Overall Study|Withdrawal by Subject|0|||
105695724|NCT03519867|364549930|FG004|Overall Study|Admin. of other reversal agent|0|||
105695725|NCT03519867|364549931|FG005|Overall Study|Admin. of other reversal agent|1|||
105695726|NCT03519867|364549932|FG006|Overall Study|Admin. of other reversal agent|0|||
105695727|NCT03519867|364549933|FG007|Overall Study|Admin. of other reversal agent|0|||
105695728|NCT03519867|364549934|FG008|Overall Study|Admin. of other reversal agent|0|||
105695729|NCT03519867|364549935|FG009|Overall Study|Admin. of other reversal agent|0|||
105695730|NCT03519867|364549926|FG000|Overall Study|Reason not provided|1|||
105695731|NCT03519867|364549927|FG001|Overall Study|Reason not provided|1|||
105695732|NCT03519867|364549928|FG002|Overall Study|Reason not provided|1|||
105695733|NCT03519867|364549929|FG003|Overall Study|Reason not provided|1|||
105695734|NCT03519867|364549930|FG004|Overall Study|Reason not provided|0|||
105695735|NCT03519867|364549931|FG005|Overall Study|Reason not provided|1|||
105695736|NCT03519867|364549932|FG006|Overall Study|Reason not provided|0|||
105695737|NCT03519867|364549933|FG007|Overall Study|Reason not provided|1|||
105695738|NCT03519867|364549934|FG008|Overall Study|Reason not provided|1|||
105695739|NCT03519867|364549935|FG009|Overall Study|Reason not provided|0|||
105695740|NCT02064920|364549939|FG000|Overall Study|Adverse Event|0|||
105695741|NCT02064920|364549940|FG001|Overall Study|Adverse Event|4|||
105695742|NCT02064920|364549939|FG000|Overall Study|Physician Decision|0|||
105695743|NCT02064920|364549940|FG001|Overall Study|Physician Decision|1|||
105695744|NCT02064920|364549939|FG000|Overall Study|Technical Problems|0|||
105695745|NCT02064920|364549940|FG001|Overall Study|Technical Problems|1|||
105695746|NCT02064920|364549939|FG000|Overall Study|Withdrawal by Subject|1|||
105695747|NCT02064920|364549940|FG001|Overall Study|Withdrawal by Subject|3|||
105695748|NCT00916279|364549941|FG000|Overall Study|Death|2|||
105695749|NCT00916279|364549941|FG000|Overall Study|Lost to Follow-up|2|||
105695750|NCT02109562|364549942|FG000|Overall Study|Insufficient clinical response|2|||
105695751|NCT02109562|364549943|FG001|Overall Study|Insufficient clinical response|0|||
105695752|NCT02109562|364549944|FG002|Overall Study|Insufficient clinical response|4|||
105695753|NCT02109562|364549942|FG000|Overall Study|Adverse Event|0|||
105695754|NCT02109562|364549943|FG001|Overall Study|Adverse Event|2|||
105695755|NCT02109562|364549944|FG002|Overall Study|Adverse Event|3|||
105695756|NCT02109562|364549942|FG000|Overall Study|Lost to Follow-up|1|||
105695757|NCT02109562|364549943|FG001|Overall Study|Lost to Follow-up|0|||
105695758|NCT02109562|364549944|FG002|Overall Study|Lost to Follow-up|1|||
105695759|NCT02109562|364549942|FG000|Overall Study|Protocol Violation|0|||
105695760|NCT02109562|364549943|FG001|Overall Study|Protocol Violation|3|||
105695761|NCT02109562|364549944|FG002|Overall Study|Protocol Violation|1|||
105695762|NCT02109562|364549942|FG000|Overall Study|Withdrawal by Subject|20|||
105695763|NCT02109562|364549943|FG001|Overall Study|Withdrawal by Subject|25|||
105695764|NCT02109562|364549944|FG002|Overall Study|Withdrawal by Subject|21|||
105695765|NCT02109562|364549942|FG000|Overall Study|Physician Decision|3|||
105695766|NCT02109562|364549943|FG001|Overall Study|Physician Decision|4|||
105695767|NCT02109562|364549944|FG002|Overall Study|Physician Decision|5|||
105695768|NCT00688155|364549945|FG000|Overall Study|Withdrawal by Subject|2|||
105695769|NCT00688155|364549946|FG001|Overall Study|Withdrawal by Subject|2|||
105695770|NCT00688155|364549947|FG002|Overall Study|Withdrawal by Subject|1|||
105695771|NCT00688155|364549948|FG003|Overall Study|Withdrawal by Subject|1|||
105695772|NCT03318978|364549949|FG000|Overall Study|Withdrawal by Subject|1|||
105695773|NCT02844816|364549950|FG000|Overall Study|No protocol treatment received|5|||
105695774|NCT02844816|364549951|FG001|Overall Study|No protocol treatment received|1|||
105695775|NCT02844816|364549950|FG000|Overall Study|Ineligible|22|||
105695776|NCT02844816|364549951|FG001|Overall Study|Ineligible|15|||
105695777|NCT02844816|364549950|FG000|Overall Study|Participant refusal|5|||
105695778|NCT02844816|364549951|FG001|Overall Study|Participant refusal|5|||
105695779|NCT02844816|364549950|FG000|Overall Study|Adverse Event|5|||
105695780|NCT02844816|364549951|FG001|Overall Study|Adverse Event|4|||
105695781|NCT02844816|364549950|FG000|Overall Study|Death|0|||
105695782|NCT02844816|364549951|FG001|Overall Study|Death|1|||
105695783|NCT02844816|364549950|FG000|Overall Study|Disease progression/recurrence|50|||
105695784|NCT02844816|364549951|FG001|Overall Study|Disease progression/recurrence|24|||
105695785|NCT02844816|364549950|FG000|Overall Study|Physician Decision|1|||
105695786|NCT02844816|364549951|FG001|Overall Study|Physician Decision|1|||
105695787|NCT04085523|364549952|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
105695788|NCT04085523|364549953|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
105695789|NCT04085523|364549954|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
105695790|NCT04085523|364549955|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
105695791|NCT04085523|364549956|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
105695792|NCT04085523|364549957|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
105695793|NCT01877915|364549961|FG000|Overall Study|Lost to Follow-up|10|||
105695794|NCT01877915|364549962|FG001|Overall Study|Lost to Follow-up|9|||
105695795|NCT01877915|364549961|FG000|Overall Study|Withdrawal by Subject|42|||
105695796|NCT01877915|364549962|FG001|Overall Study|Withdrawal by Subject|55|||
105695797|NCT01877915|364549961|FG000|Overall Study|Other|2|||
105695798|NCT01877915|364549962|FG001|Overall Study|Other|4|||
105559380|NCT02291614|364044676|FG001|Overall Study|Withdrawal by Subject|1|||
105695799|NCT03007979|364549963|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
105695800|NCT01005745|364549964|FG000|Overall Study|No TIL growth|1|||
105695801|NCT01005745|364549964|FG000|Overall Study|Disease progressed during TIL growth|3|||
105695802|NCT01005745|364549964|FG000|Overall Study|Death prior to treatment|1|||
105695803|NCT01005745|364549964|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
105695804|NCT03520959|364549965|FG000|Overall Study|Study terminated by Sponsor|0|||
105695805|NCT03520959|364549966|FG001|Overall Study|Study terminated by Sponsor|1|||
105695806|NCT01659151|364549969|FG000|Overall Study|Inadequate TIL growth|1|||
105695807|NCT00597753|364549970|FG000|Overall Study|Adverse Event|6|||
105695808|NCT00597753|364549971|FG001|Overall Study|Adverse Event|2|||
105695809|NCT00597753|364549970|FG000|Overall Study|Death|55|||
105695810|NCT00597753|364549971|FG001|Overall Study|Death|29|||
105695811|NCT00597753|364549970|FG000|Overall Study|Lack of Efficacy|2|||
105695812|NCT00597753|364549971|FG001|Overall Study|Lack of Efficacy|0|||
105695813|NCT00597753|364549970|FG000|Overall Study|Lost to Follow-up|10|||
105695814|NCT00597753|364549971|FG001|Overall Study|Lost to Follow-up|3|||
105695815|NCT00597753|364549970|FG000|Overall Study|Physician Decision|5|||
105695816|NCT00597753|364549971|FG001|Overall Study|Physician Decision|1|||
105695817|NCT00597753|364549970|FG000|Overall Study|Pregnancy|1|||
105695818|NCT00597753|364549971|FG001|Overall Study|Pregnancy|0|||
105695819|NCT00597753|364549970|FG000|Overall Study|Withdrawal by Subject|35|||
105695820|NCT00597753|364549971|FG001|Overall Study|Withdrawal by Subject|12|||
105695821|NCT00597753|364549970|FG000|Overall Study|Discontinued Dialysis|0|||
105695822|NCT00597753|364549971|FG001|Overall Study|Discontinued Dialysis|1|||
105695823|NCT00597753|364549970|FG000|Overall Study|Never dosed|2|||
105695824|NCT00597753|364549971|FG001|Overall Study|Never dosed|0|||
105695825|NCT00597753|364549970|FG000|Overall Study|Noncompliance|2|||
105695826|NCT00597753|364549971|FG001|Overall Study|Noncompliance|1|||
105695827|NCT00597753|364549970|FG000|Overall Study|Relocation|17|||
105695828|NCT00597753|364549971|FG001|Overall Study|Relocation|6|||
105695829|NCT00597753|364549970|FG000|Overall Study|Renal transplant|10|||
105695830|NCT00597753|364549971|FG001|Overall Study|Renal transplant|3|||
105559381|NCT02291614|364044677|FG002|Overall Study|Withdrawal by Subject|0|||
105695831|NCT00597753|364549970|FG000|Overall Study|Site closed by sponsor|19|||
105695832|NCT00597753|364549971|FG001|Overall Study|Site closed by sponsor|7|||
105695833|NCT00597753|364549970|FG000|Overall Study|Site elected to close|2|||
105695834|NCT00597753|364549971|FG001|Overall Study|Site elected to close|4|||
105695835|NCT03713034|364552401|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
105695836|NCT03713034|364552402|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
105695837|NCT02982590|364552408|FG000|Overall Study|Lost to Follow-up|0|||
105695838|NCT02982590|364552409|FG001|Overall Study|Lost to Follow-up|1|||
105695839|NCT02982590|364552408|FG000|Overall Study|Death|4|||
105695840|NCT02982590|364552409|FG001|Overall Study|Death|0|||
105695841|NCT01086410|364552410|FG000|Overall Study|Adverse Event|1|||
105695842|NCT01086410|364552411|FG001|Overall Study|Adverse Event|0|||
105695843|NCT01086410|364552412|FG002|Overall Study|Adverse Event|0|||
105695844|NCT01086410|364552413|FG003|Overall Study|Adverse Event|2|||
105695845|NCT01086410|364552410|FG000|Overall Study|Lack of Efficacy|1|||
105695846|NCT01086410|364552411|FG001|Overall Study|Lack of Efficacy|1|||
105695847|NCT01086410|364552412|FG002|Overall Study|Lack of Efficacy|0|||
105695848|NCT01086410|364552413|FG003|Overall Study|Lack of Efficacy|0|||
105695849|NCT01086410|364552410|FG000|Overall Study|Protocol Violation|1|||
105695850|NCT01086410|364552411|FG001|Overall Study|Protocol Violation|1|||
105695851|NCT01086410|364552412|FG002|Overall Study|Protocol Violation|0|||
105695852|NCT01086410|364552413|FG003|Overall Study|Protocol Violation|0|||
105695853|NCT01086410|364552410|FG000|Overall Study|Lost to Follow-up|0|||
105695854|NCT01086410|364552411|FG001|Overall Study|Lost to Follow-up|0|||
105695855|NCT01086410|364552412|FG002|Overall Study|Lost to Follow-up|1|||
105695856|NCT01086410|364552413|FG003|Overall Study|Lost to Follow-up|0|||
105695857|NCT02953639|364552414|FG000|Overall Study|Adverse Event|2|||
105695858|NCT02953639|364552415|FG001|Overall Study|Adverse Event|0|||
105559382|NCT02291614|364044678|FG003|Overall Study|Withdrawal by Subject|0|||
105559383|NCT02291614|364044679|FG004|Overall Study|Withdrawal by Subject|0|||
105559384|NCT02291614|364044680|FG005|Overall Study|Withdrawal by Subject|0|||
105559385|NCT02291614|364044681|FG006|Overall Study|Withdrawal by Subject|0|||
105695859|NCT02953639|364552416|FG002|Overall Study|Adverse Event|1|||
105695860|NCT02953639|364552414|FG000|Overall Study|Lost to Follow-up|8|||
105695861|NCT02953639|364552415|FG001|Overall Study|Lost to Follow-up|4|||
105695862|NCT02953639|364552416|FG002|Overall Study|Lost to Follow-up|3|||
105695863|NCT02953639|364552414|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105695864|NCT02953639|364552415|FG001|Overall Study|Non-Compliance With Study Drug|2|||
105695865|NCT02953639|364552416|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105695866|NCT02953639|364552414|FG000|Overall Study|Multiple Reasons|1|||
105695867|NCT02953639|364552415|FG001|Overall Study|Multiple Reasons|0|||
105695868|NCT02953639|364552416|FG002|Overall Study|Multiple Reasons|1|||
105695869|NCT02953639|364552414|FG000|Overall Study|Physician Decision|1|||
105695870|NCT02953639|364552415|FG001|Overall Study|Physician Decision|0|||
105695871|NCT02953639|364552416|FG002|Overall Study|Physician Decision|0|||
105695872|NCT02953639|364552414|FG000|Overall Study|Withdrawal by Subject|7|||
105695873|NCT02953639|364552415|FG001|Overall Study|Withdrawal by Subject|8|||
105695874|NCT02953639|364552416|FG002|Overall Study|Withdrawal by Subject|10|||
105695875|NCT02953639|364552414|FG000|Overall Study|Completed or Discontinued information is missing|1|||
105695876|NCT02953639|364552415|FG001|Overall Study|Completed or Discontinued information is missing|0|||
105559386|NCT02291614|364044682|FG007|Overall Study|Withdrawal by Subject|0|||
105695877|NCT02953639|364552416|FG002|Overall Study|Completed or Discontinued information is missing|0|||
105695878|NCT01022996|364552417|FG000|Overall Study|Adverse Event|14|||
105695879|NCT01022996|364552417|FG000|Overall Study|Withdrawal by Subject|3|||
105695880|NCT01022996|364552417|FG000|Overall Study|Lost to Follow-up|1|||
105695881|NCT01022996|364552417|FG000|Overall Study|Administrative problems|6|||
105695882|NCT01022996|364552417|FG000|Overall Study|Disease Progression|32|||
105695883|NCT01022996|364552417|FG000|Overall Study|Protocol Violation|1|||
105695884|NCT01830855|364552418|FG000|Overall Study|Other|7|||
105695885|NCT01830855|364552419|FG001|Overall Study|Other|1|||
105695886|NCT01830855|364552420|FG002|Overall Study|Other|4|||
105695887|NCT01830855|364552421|FG003|Overall Study|Other|4|||
105695888|NCT01830855|364552418|FG000|Overall Study|Medication error without associated AE|1|||
105695889|NCT01830855|364552419|FG001|Overall Study|Medication error without associated AE|0|||
105695890|NCT01830855|364552420|FG002|Overall Study|Medication error without associated AE|0|||
105695891|NCT01830855|364552421|FG003|Overall Study|Medication error without associated AE|1|||
105695892|NCT01830855|364552418|FG000|Overall Study|Pregnancy|3|||
105695893|NCT01830855|364552419|FG001|Overall Study|Pregnancy|1|||
105695894|NCT01830855|364552420|FG002|Overall Study|Pregnancy|2|||
105473478|NCT02055118|363745384|FG001|Overall Study|Withdrawal by Subject|2|||
105473479|NCT02055118|363745385|FG002|Overall Study|Withdrawal by Subject|0|||
105473480|NCT01001325|363745386|FG000|Overall Study|Lost to Follow-up|16|||
105473481|NCT01001325|363745387|FG001|Overall Study|Lost to Follow-up|10|||
105473482|NCT01001325|363745386|FG000|Overall Study|Protocol Violation|2|||
105473483|NCT01001325|363745387|FG001|Overall Study|Protocol Violation|0|||
105473484|NCT01584440|363745388|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
105473485|NCT01584440|363745389|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
105473486|NCT01584440|363745390|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
105473487|NCT01584440|363745391|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
105473488|NCT01584440|363745392|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
105473489|NCT01584440|363745388|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
105473490|NCT01584440|363745389|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
105473491|NCT01584440|363745390|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
105473492|NCT01584440|363745391|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
105473493|NCT01584440|363745392|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
105473494|NCT01584440|363745388|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
105473495|NCT01584440|363745389|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
105473496|NCT01584440|363745390|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
105473497|NCT01584440|363745391|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
105473498|NCT01584440|363745392|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
105473499|NCT01584440|363745388|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
105473500|NCT01584440|363745389|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
105473501|NCT01584440|363745390|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
105473502|NCT01584440|363745391|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
105473503|NCT01584440|363745392|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
105473504|NCT01584440|363745388|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
105473505|NCT01584440|363745389|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
105473506|NCT01584440|363745390|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
105473507|NCT01584440|363745391|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
105473508|NCT01584440|363745392|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
105473509|NCT01584440|363745388|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
105473510|NCT01584440|363745389|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
105473511|NCT01584440|363745390|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
105473512|NCT01584440|363745391|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
105473513|NCT01584440|363745392|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
105473514|NCT01584440|363745388|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
105473515|NCT01584440|363745389|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
105473516|NCT01584440|363745390|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
105473517|NCT01584440|363745391|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
105473518|NCT01584440|363745392|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
105473519|NCT01584440|363745388|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
105473520|NCT01584440|363745389|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
105473521|NCT01584440|363745390|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
105473522|NCT01584440|363745391|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
105473523|NCT01584440|363745392|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
105473524|NCT01584440|363745388|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
105473525|NCT01584440|363745389|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
105473526|NCT01584440|363745390|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
105473527|NCT01584440|363745391|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
105473528|NCT01584440|363745392|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
105473529|NCT03304249|363745396|FG000|Overall Study|Lost to Follow-up|8|||
105473530|NCT03304249|363745397|FG001|Overall Study|Lost to Follow-up|10|||
105559387|NCT02291614|364044683|FG008|Overall Study|Withdrawal by Subject|0|||
105559388|NCT02291614|364044684|FG009|Overall Study|Withdrawal by Subject|2|||
105695895|NCT01830855|364552421|FG003|Overall Study|Pregnancy|1|||
105695896|NCT01830855|364552418|FG000|Overall Study|No longer meets eligibility criteria|11|||
105695897|NCT01830855|364552419|FG001|Overall Study|No longer meets eligibility criteria|2|||
105695898|NCT01830855|364552420|FG002|Overall Study|No longer meets eligibility criteria|3|||
105695899|NCT01830855|364552421|FG003|Overall Study|No longer meets eligibility criteria|5|||
105695900|NCT01830855|364552418|FG000|Overall Study|Adverse Event|11|||
105695901|NCT01830855|364552419|FG001|Overall Study|Adverse Event|5|||
105695902|NCT01830855|364552420|FG002|Overall Study|Adverse Event|6|||
105695903|NCT01830855|364552421|FG003|Overall Study|Adverse Event|3|||
105695904|NCT01830855|364552418|FG000|Overall Study|Protocol deviation|10|||
105695905|NCT01830855|364552419|FG001|Overall Study|Protocol deviation|5|||
105695906|NCT01830855|364552420|FG002|Overall Study|Protocol deviation|6|||
105695907|NCT01830855|364552421|FG003|Overall Study|Protocol deviation|6|||
105695908|NCT01830855|364552418|FG000|Overall Study|Withdrawal by Subject|33|||
105695909|NCT01830855|364552419|FG001|Overall Study|Withdrawal by Subject|14|||
105695910|NCT01830855|364552420|FG002|Overall Study|Withdrawal by Subject|10|||
105695911|NCT01830855|364552421|FG003|Overall Study|Withdrawal by Subject|12|||
105695912|NCT01830855|364552418|FG000|Overall Study|No longer willing to participate|32|||
105695913|NCT01830855|364552419|FG001|Overall Study|No longer willing to participate|13|||
105695914|NCT01830855|364552420|FG002|Overall Study|No longer willing to participate|12|||
105695915|NCT01830855|364552421|FG003|Overall Study|No longer willing to participate|17|||
105695916|NCT01830855|364552418|FG000|Overall Study|Lost to Follow-up|47|||
105695917|NCT01830855|364552419|FG001|Overall Study|Lost to Follow-up|20|||
105695918|NCT01830855|364552420|FG002|Overall Study|Lost to Follow-up|23|||
105695919|NCT01830855|364552421|FG003|Overall Study|Lost to Follow-up|33|||
105695920|NCT02767323|364552422|FG000|Overall Study|Withdrawal by Subject|17|||
105695921|NCT02767323|364552423|FG001|Overall Study|Withdrawal by Subject|5|||
105695922|NCT02767323|364552424|FG002|Overall Study|Withdrawal by Subject|13|||
105695923|NCT02767323|364552425|FG003|Overall Study|Withdrawal by Subject|0|||
105695924|NCT02767323|364552422|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
105695925|NCT02767323|364552423|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
105695926|NCT02767323|364552424|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
105695927|NCT02767323|364552425|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
105695928|NCT01667081|364552426|FG000|Overall Study|Death|43|||
105695929|NCT01667081|364552427|FG001|Overall Study|Death|3|||
105695930|NCT01667081|364552426|FG000|Overall Study|Lost to Follow-up|99|||
105695931|NCT01667081|364552427|FG001|Overall Study|Lost to Follow-up|48|||
105695932|NCT01667081|364552426|FG000|Overall Study|Physician Decision|16|||
105695933|NCT01667081|364552427|FG001|Overall Study|Physician Decision|2|||
105695934|NCT01667081|364552426|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
105695935|NCT01667081|364552427|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
105695936|NCT01667081|364552426|FG000|Overall Study|Withdrawal by Subject|90|||
105695937|NCT01667081|364552427|FG001|Overall Study|Withdrawal by Subject|35|||
105695938|NCT00930722|364552428|FG000|Overall Study|Lost to Follow-up|16|||
105695939|NCT00930722|364552428|FG000|Overall Study|No longer willing to participate|9|||
105695940|NCT00930722|364552428|FG000|Overall Study|Study terminated by sponsor|2|||
105695941|NCT03523728|364552429|FG000|Stage 1 (24 Months)|Adverse Event|2|||
105695942|NCT03523728|364552430|FG001|Stage 1 (24 Months)|Adverse Event|2|||
105695943|NCT03523728|364552431|FG002|Stage 1 (24 Months)|Adverse Event|4|||
105695944|NCT03523728|364552432|FG003|Stage 1 (24 Months)|Adverse Event|0|||
105695945|NCT03523728|364552433|FG004|Stage 1 (24 Months)|Adverse Event|0|||
105695946|NCT03523728|364552429|FG000|Stage 1 (24 Months)|Progressive disease|0|||
105695947|NCT03523728|364552430|FG001|Stage 1 (24 Months)|Progressive disease|0|||
105695948|NCT03523728|364552431|FG002|Stage 1 (24 Months)|Progressive disease|1|||
105695949|NCT03523728|364552432|FG003|Stage 1 (24 Months)|Progressive disease|0|||
105695950|NCT03523728|364552433|FG004|Stage 1 (24 Months)|Progressive disease|0|||
105695951|NCT03523728|364552429|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
105695952|NCT03523728|364552430|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
105695953|NCT03523728|364552431|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
105695954|NCT03523728|364552432|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
105695955|NCT03523728|364552433|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
105695956|NCT03523728|364552429|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
105695957|NCT03523728|364552430|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
105695958|NCT03523728|364552431|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
105695959|NCT03523728|364552432|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
105695960|NCT03523728|364552433|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
105695961|NCT03523728|364552429|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
105695962|NCT03523728|364552430|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
105695963|NCT03523728|364552431|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
105787108|NCT03110107|364874914|FG025|Treatment Period|Study drug toxicity|6|||
105695964|NCT03523728|364552432|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
105695965|NCT03523728|364552433|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
105695966|NCT03523728|364552429|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
105787109|NCT03110107|364874889|FG000|Treatment Period|Death|0|||
105787110|NCT03110107|364874890|FG001|Treatment Period|Death|0|||
105695967|NCT03523728|364552430|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
105695968|NCT03523728|364552431|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
105695969|NCT03523728|364552432|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
105787111|NCT03110107|364874891|FG002|Treatment Period|Death|0|||
105695970|NCT03523728|364552433|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
105695971|NCT03523728|364552429|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
105695972|NCT03523728|364552430|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
105695973|NCT03523728|364552431|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
105695974|NCT03523728|364552432|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
105695975|NCT03523728|364552433|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
105695976|NCT03523728|364552429|FG000|Stage 2 (24 Months)|Adverse Event|0|||
105695977|NCT03523728|364552430|FG001|Stage 2 (24 Months)|Adverse Event|0|||
105695978|NCT03523728|364552431|FG002|Stage 2 (24 Months)|Adverse Event|0|||
105695979|NCT03523728|364552432|FG003|Stage 2 (24 Months)|Adverse Event|1|||
105695980|NCT03523728|364552433|FG004|Stage 2 (24 Months)|Adverse Event|2|||
105695981|NCT03523728|364552429|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
105695982|NCT03523728|364552430|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
105695983|NCT03523728|364552431|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
105695984|NCT03523728|364552432|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
105695985|NCT03523728|364552433|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
105695986|NCT03523728|364552429|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
105695987|NCT03523728|364552430|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
105695988|NCT03523728|364552431|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
105695989|NCT03523728|364552432|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
105695990|NCT03523728|364552433|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
105695991|NCT03523728|364552429|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
105695992|NCT03523728|364552430|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
105695993|NCT03523728|364552431|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
105695994|NCT03523728|364552432|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
105695995|NCT03523728|364552433|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
105695996|NCT03523728|364552429|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
105695997|NCT03523728|364552430|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
105695998|NCT03523728|364552431|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
105695999|NCT03523728|364552432|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
105696000|NCT03523728|364552433|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
105696001|NCT00621751|364552437|FG000|Overall Study|Adverse Event|0|||
105696002|NCT00621751|364552438|FG001|Overall Study|Adverse Event|1|||
105696003|NCT01950247|364552439|FG000|Overall Study|Withdrawal by Subject|28|||
105696004|NCT01950247|364552440|FG001|Overall Study|Withdrawal by Subject|13|||
105696005|NCT01950247|364552439|FG000|Overall Study|Lost to Follow-up|18|||
105696006|NCT01950247|364552440|FG001|Overall Study|Lost to Follow-up|16|||
105696007|NCT01950247|364552439|FG000|Overall Study|Physician Decision|3|||
105696008|NCT01950247|364552440|FG001|Overall Study|Physician Decision|4|||
105696009|NCT01950247|364552439|FG000|Overall Study|Adverse Event|3|||
105696010|NCT01950247|364552440|FG001|Overall Study|Adverse Event|2|||
105696011|NCT01950247|364552439|FG000|Overall Study|Death|1|||
105696012|NCT01950247|364552440|FG001|Overall Study|Death|1|||
105696013|NCT01950247|364552439|FG000|Overall Study|Not Defined|4|||
105696014|NCT01950247|364552440|FG001|Overall Study|Not Defined|10|||
105696015|NCT00066742|364552447|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
105696016|NCT00066742|364552447|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
105696017|NCT00066742|364552447|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
105696018|NCT00066742|364552447|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
105696019|NCT00066742|364552447|FG000|Induction Chemoradiotherapy|Ineligible|3|||
105696020|NCT00066742|364552447|FG000|Consolidation Chemotherapy|not protocol specified|1|||
105696021|NCT00066742|364552447|FG000|Consolidation Chemotherapy|Ineligible|2|||
105696022|NCT02357134|364552448|FG000|Overall Study|Lost to Follow-up|1|||
105696023|NCT02357134|364552449|FG001|Overall Study|Lost to Follow-up|0|||
105696024|NCT02357134|364552450|FG002|Overall Study|Lost to Follow-up|0|||
105696025|NCT02357134|364552451|FG003|Overall Study|Lost to Follow-up|0|||
105696026|NCT03583450|364552463|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
105696027|NCT03583450|364552464|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
105696028|NCT03374995|364552465|FG000|Overall Study|Withdrawal by Subject|0|||
105696029|NCT03374995|364552466|FG001|Overall Study|Withdrawal by Subject|1|||
105696030|NCT03593850|364552468|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
105696031|NCT03593850|364552469|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
105696032|NCT05097716|364552470|FG000|Period 1|Adverse Event|1|||
105696033|NCT05097716|364552470|FG000|Period 1|Close contact with highly-transmissible infection|1|||
105696034|NCT00467779|364552475|FG000|Stage 1|Adverse Event|1|||
105696035|NCT00467779|364552476|FG001|Stage 1|Adverse Event|0|||
105696036|NCT00467779|364552477|FG002|Stage 1|Adverse Event|0|||
105696037|NCT00467779|364552478|FG003|Stage 1|Adverse Event|0|||
105696038|NCT00467779|364552479|FG004|Stage 1|Adverse Event|0|||
105696039|NCT00467779|364552480|FG005|Stage 1|Adverse Event|1|||
105696040|NCT00467779|364552481|FG006|Stage 1|Adverse Event|2|||
105696041|NCT00467779|364552482|FG007|Stage 1|Adverse Event|1|||
105696042|NCT00467779|364552483|FG008|Stage 1|Adverse Event|0|||
105696043|NCT00467779|364552484|FG009|Stage 1|Adverse Event|0|||
105787112|NCT03110107|364874892|FG003|Treatment Period|Death|0|||
105696044|NCT00467779|364552485|FG010|Stage 1|Adverse Event|0|||
105696045|NCT00467779|364552486|FG011|Stage 1|Adverse Event|0|||
105696046|NCT00467779|364552487|FG012|Stage 1|Adverse Event|0|||
105696047|NCT00467779|364552488|FG013|Stage 1|Adverse Event|0|||
105696048|NCT00467779|364552489|FG014|Stage 1|Adverse Event|0|||
105696049|NCT00467779|364552475|FG000|Stage 1|Disease Progression|2|||
105696050|NCT00467779|364552476|FG001|Stage 1|Disease Progression|2|||
105696051|NCT00467779|364552477|FG002|Stage 1|Disease Progression|2|||
105696052|NCT00467779|364552478|FG003|Stage 1|Disease Progression|3|||
105696053|NCT00467779|364552479|FG004|Stage 1|Disease Progression|2|||
105696054|NCT00467779|364552480|FG005|Stage 1|Disease Progression|2|||
105696055|NCT00467779|364552481|FG006|Stage 1|Disease Progression|4|||
105696056|NCT00467779|364552482|FG007|Stage 1|Disease Progression|5|||
105696057|NCT00467779|364552483|FG008|Stage 1|Disease Progression|0|||
105696058|NCT00467779|364552484|FG009|Stage 1|Disease Progression|0|||
105696059|NCT00467779|364552485|FG010|Stage 1|Disease Progression|0|||
105696060|NCT00467779|364552486|FG011|Stage 1|Disease Progression|0|||
105696061|NCT00467779|364552487|FG012|Stage 1|Disease Progression|0|||
105696062|NCT00467779|364552488|FG013|Stage 1|Disease Progression|0|||
105696063|NCT00467779|364552489|FG014|Stage 1|Disease Progression|0|||
105696064|NCT00467779|364552475|FG000|Stage 1|Unspecified Reason|1|||
105696065|NCT00467779|364552476|FG001|Stage 1|Unspecified Reason|0|||
105696066|NCT00467779|364552477|FG002|Stage 1|Unspecified Reason|1|||
105696067|NCT00467779|364552478|FG003|Stage 1|Unspecified Reason|0|||
105696068|NCT00467779|364552479|FG004|Stage 1|Unspecified Reason|1|||
105696069|NCT00467779|364552480|FG005|Stage 1|Unspecified Reason|2|||
105696070|NCT00467779|364552481|FG006|Stage 1|Unspecified Reason|0|||
105696071|NCT00467779|364552482|FG007|Stage 1|Unspecified Reason|0|||
105696072|NCT00467779|364552483|FG008|Stage 1|Unspecified Reason|0|||
105696073|NCT00467779|364552484|FG009|Stage 1|Unspecified Reason|0|||
105696074|NCT00467779|364552485|FG010|Stage 1|Unspecified Reason|0|||
105696075|NCT00467779|364552486|FG011|Stage 1|Unspecified Reason|0|||
105696076|NCT00467779|364552487|FG012|Stage 1|Unspecified Reason|0|||
105696077|NCT00467779|364552488|FG013|Stage 1|Unspecified Reason|0|||
105696078|NCT00467779|364552489|FG014|Stage 1|Unspecified Reason|0|||
105696079|NCT00467779|364552475|FG000|Stage 1|Physician Decision|0|||
105696080|NCT00467779|364552476|FG001|Stage 1|Physician Decision|1|||
105696081|NCT00467779|364552477|FG002|Stage 1|Physician Decision|0|||
105696082|NCT00467779|364552478|FG003|Stage 1|Physician Decision|0|||
105696083|NCT00467779|364552479|FG004|Stage 1|Physician Decision|0|||
105696084|NCT00467779|364552480|FG005|Stage 1|Physician Decision|0|||
105696085|NCT00467779|364552481|FG006|Stage 1|Physician Decision|0|||
105696086|NCT00467779|364552482|FG007|Stage 1|Physician Decision|0|||
105696087|NCT00467779|364552483|FG008|Stage 1|Physician Decision|0|||
105696088|NCT00467779|364552484|FG009|Stage 1|Physician Decision|0|||
105696089|NCT00467779|364552485|FG010|Stage 1|Physician Decision|0|||
105696090|NCT00467779|364552486|FG011|Stage 1|Physician Decision|0|||
105696091|NCT00467779|364552487|FG012|Stage 1|Physician Decision|0|||
105696092|NCT00467779|364552488|FG013|Stage 1|Physician Decision|0|||
105696093|NCT00467779|364552489|FG014|Stage 1|Physician Decision|0|||
105696094|NCT00467779|364552475|FG000|Stage 1|Withdrawal by Subject|0|||
105696095|NCT00467779|364552476|FG001|Stage 1|Withdrawal by Subject|0|||
105696096|NCT00467779|364552477|FG002|Stage 1|Withdrawal by Subject|0|||
105696097|NCT00467779|364552478|FG003|Stage 1|Withdrawal by Subject|0|||
105696098|NCT00467779|364552479|FG004|Stage 1|Withdrawal by Subject|0|||
105696099|NCT00467779|364552480|FG005|Stage 1|Withdrawal by Subject|0|||
105696100|NCT00467779|364552481|FG006|Stage 1|Withdrawal by Subject|1|||
105696101|NCT00467779|364552482|FG007|Stage 1|Withdrawal by Subject|1|||
105696102|NCT00467779|364552483|FG008|Stage 1|Withdrawal by Subject|0|||
105696103|NCT00467779|364552484|FG009|Stage 1|Withdrawal by Subject|0|||
105696104|NCT00467779|364552485|FG010|Stage 1|Withdrawal by Subject|0|||
105696105|NCT00467779|364552486|FG011|Stage 1|Withdrawal by Subject|0|||
105696106|NCT00467779|364552487|FG012|Stage 1|Withdrawal by Subject|0|||
105696107|NCT00467779|364552488|FG013|Stage 1|Withdrawal by Subject|0|||
105696108|NCT00467779|364552489|FG014|Stage 1|Withdrawal by Subject|0|||
105696109|NCT00467779|364552475|FG000|Stage 1A|Adverse Event|0|||
105696110|NCT00467779|364552476|FG001|Stage 1A|Adverse Event|0|||
105696111|NCT00467779|364552477|FG002|Stage 1A|Adverse Event|0|||
105696112|NCT00467779|364552478|FG003|Stage 1A|Adverse Event|0|||
105696113|NCT00467779|364552479|FG004|Stage 1A|Adverse Event|0|||
105696114|NCT00467779|364552480|FG005|Stage 1A|Adverse Event|0|||
105696115|NCT00467779|364552481|FG006|Stage 1A|Adverse Event|0|||
105696116|NCT00467779|364552482|FG007|Stage 1A|Adverse Event|0|||
105696117|NCT00467779|364552483|FG008|Stage 1A|Adverse Event|0|||
105696118|NCT00467779|364552484|FG009|Stage 1A|Adverse Event|0|||
105696119|NCT00467779|364552485|FG010|Stage 1A|Adverse Event|0|||
105696120|NCT00467779|364552486|FG011|Stage 1A|Adverse Event|0|||
105696121|NCT00467779|364552487|FG012|Stage 1A|Adverse Event|1|||
105696122|NCT00467779|364552488|FG013|Stage 1A|Adverse Event|0|||
105696123|NCT00467779|364552489|FG014|Stage 1A|Adverse Event|0|||
105696124|NCT00467779|364552475|FG000|Stage 1A|Death|0|||
105696125|NCT00467779|364552476|FG001|Stage 1A|Death|0|||
105696126|NCT00467779|364552477|FG002|Stage 1A|Death|0|||
105696127|NCT00467779|364552478|FG003|Stage 1A|Death|0|||
105696128|NCT00467779|364552479|FG004|Stage 1A|Death|0|||
105696129|NCT00467779|364552480|FG005|Stage 1A|Death|0|||
105696130|NCT00467779|364552481|FG006|Stage 1A|Death|0|||
105696131|NCT00467779|364552482|FG007|Stage 1A|Death|0|||
105696132|NCT00467779|364552483|FG008|Stage 1A|Death|0|||
105696133|NCT00467779|364552484|FG009|Stage 1A|Death|0|||
105696134|NCT00467779|364552485|FG010|Stage 1A|Death|0|||
105696135|NCT00467779|364552486|FG011|Stage 1A|Death|1|||
105696136|NCT00467779|364552487|FG012|Stage 1A|Death|1|||
105696137|NCT00467779|364552488|FG013|Stage 1A|Death|0|||
105696138|NCT00467779|364552489|FG014|Stage 1A|Death|0|||
105696139|NCT00467779|364552475|FG000|Stage 1A|Disease Progression|0|||
105696140|NCT00467779|364552476|FG001|Stage 1A|Disease Progression|0|||
105696141|NCT00467779|364552477|FG002|Stage 1A|Disease Progression|0|||
105696142|NCT00467779|364552478|FG003|Stage 1A|Disease Progression|0|||
105696143|NCT00467779|364552479|FG004|Stage 1A|Disease Progression|0|||
105696144|NCT00467779|364552480|FG005|Stage 1A|Disease Progression|0|||
105696145|NCT00467779|364552481|FG006|Stage 1A|Disease Progression|0|||
105696146|NCT00467779|364552482|FG007|Stage 1A|Disease Progression|0|||
105696147|NCT00467779|364552483|FG008|Stage 1A|Disease Progression|0|||
105696148|NCT00467779|364552484|FG009|Stage 1A|Disease Progression|2|||
105696149|NCT00467779|364552485|FG010|Stage 1A|Disease Progression|2|||
105696150|NCT00467779|364552486|FG011|Stage 1A|Disease Progression|5|||
105696151|NCT00467779|364552487|FG012|Stage 1A|Disease Progression|2|||
105696152|NCT00467779|364552488|FG013|Stage 1A|Disease Progression|0|||
105696153|NCT00467779|364552489|FG014|Stage 1A|Disease Progression|0|||
105696154|NCT00467779|364552475|FG000|Stage 1A|Physician Decision|0|||
105696155|NCT00467779|364552476|FG001|Stage 1A|Physician Decision|0|||
105696156|NCT00467779|364552477|FG002|Stage 1A|Physician Decision|0|||
105696157|NCT00467779|364552478|FG003|Stage 1A|Physician Decision|0|||
105696158|NCT00467779|364552479|FG004|Stage 1A|Physician Decision|0|||
105696159|NCT00467779|364552480|FG005|Stage 1A|Physician Decision|0|||
105696160|NCT00467779|364552481|FG006|Stage 1A|Physician Decision|0|||
105696161|NCT00467779|364552482|FG007|Stage 1A|Physician Decision|0|||
105696162|NCT00467779|364552483|FG008|Stage 1A|Physician Decision|0|||
105696163|NCT00467779|364552484|FG009|Stage 1A|Physician Decision|1|||
105696164|NCT00467779|364552485|FG010|Stage 1A|Physician Decision|0|||
105696165|NCT00467779|364552486|FG011|Stage 1A|Physician Decision|0|||
105696166|NCT00467779|364552487|FG012|Stage 1A|Physician Decision|0|||
105696167|NCT00467779|364552488|FG013|Stage 1A|Physician Decision|0|||
105696168|NCT00467779|364552489|FG014|Stage 1A|Physician Decision|0|||
105696169|NCT00467779|364552475|FG000|Stage 1A|Withdrawal by Subject|0|||
105696170|NCT00467779|364552476|FG001|Stage 1A|Withdrawal by Subject|0|||
105696171|NCT00467779|364552477|FG002|Stage 1A|Withdrawal by Subject|0|||
105696172|NCT00467779|364552478|FG003|Stage 1A|Withdrawal by Subject|0|||
105696173|NCT00467779|364552479|FG004|Stage 1A|Withdrawal by Subject|0|||
105696174|NCT00467779|364552480|FG005|Stage 1A|Withdrawal by Subject|0|||
105696175|NCT00467779|364552481|FG006|Stage 1A|Withdrawal by Subject|0|||
105696176|NCT00467779|364552482|FG007|Stage 1A|Withdrawal by Subject|0|||
105696177|NCT00467779|364552483|FG008|Stage 1A|Withdrawal by Subject|0|||
105696178|NCT00467779|364552484|FG009|Stage 1A|Withdrawal by Subject|0|||
105696179|NCT00467779|364552485|FG010|Stage 1A|Withdrawal by Subject|1|||
105696180|NCT00467779|364552486|FG011|Stage 1A|Withdrawal by Subject|1|||
105696181|NCT00467779|364552487|FG012|Stage 1A|Withdrawal by Subject|1|||
105696182|NCT00467779|364552488|FG013|Stage 1A|Withdrawal by Subject|0|||
105696183|NCT00467779|364552489|FG014|Stage 1A|Withdrawal by Subject|0|||
105696184|NCT00467779|364552475|FG000|Stage 1A|Unspecified Reason|0|||
105696185|NCT00467779|364552476|FG001|Stage 1A|Unspecified Reason|0|||
105696186|NCT00467779|364552477|FG002|Stage 1A|Unspecified Reason|0|||
105696187|NCT00467779|364552478|FG003|Stage 1A|Unspecified Reason|0|||
105696188|NCT00467779|364552479|FG004|Stage 1A|Unspecified Reason|0|||
105696189|NCT00467779|364552480|FG005|Stage 1A|Unspecified Reason|0|||
105696190|NCT00467779|364552481|FG006|Stage 1A|Unspecified Reason|0|||
105696191|NCT00467779|364552482|FG007|Stage 1A|Unspecified Reason|0|||
105696192|NCT00467779|364552483|FG008|Stage 1A|Unspecified Reason|0|||
105696193|NCT00467779|364552484|FG009|Stage 1A|Unspecified Reason|0|||
105696194|NCT00467779|364552485|FG010|Stage 1A|Unspecified Reason|0|||
105696195|NCT00467779|364552486|FG011|Stage 1A|Unspecified Reason|1|||
105696196|NCT00467779|364552487|FG012|Stage 1A|Unspecified Reason|1|||
105696197|NCT00467779|364552488|FG013|Stage 1A|Unspecified Reason|0|||
105696198|NCT00467779|364552489|FG014|Stage 1A|Unspecified Reason|0|||
105696199|NCT00467779|364552475|FG000|Stage 2|Adverse Event|0|||
105696200|NCT00467779|364552476|FG001|Stage 2|Adverse Event|0|||
105696201|NCT00467779|364552477|FG002|Stage 2|Adverse Event|0|||
105696202|NCT00467779|364552478|FG003|Stage 2|Adverse Event|0|||
105696203|NCT00467779|364552479|FG004|Stage 2|Adverse Event|0|||
105696204|NCT00467779|364552480|FG005|Stage 2|Adverse Event|0|||
105696205|NCT00467779|364552481|FG006|Stage 2|Adverse Event|0|||
105696206|NCT00467779|364552482|FG007|Stage 2|Adverse Event|0|||
105696207|NCT00467779|364552483|FG008|Stage 2|Adverse Event|1|||
105696208|NCT00467779|364552484|FG009|Stage 2|Adverse Event|0|||
105696209|NCT00467779|364552485|FG010|Stage 2|Adverse Event|0|||
105696210|NCT00467779|364552486|FG011|Stage 2|Adverse Event|0|||
105696211|NCT00467779|364552487|FG012|Stage 2|Adverse Event|0|||
105696212|NCT00467779|364552488|FG013|Stage 2|Adverse Event|0|||
105696213|NCT00467779|364552489|FG014|Stage 2|Adverse Event|0|||
105696214|NCT00467779|364552475|FG000|Stage 2|Death|0|||
105696215|NCT00467779|364552476|FG001|Stage 2|Death|0|||
105696216|NCT00467779|364552477|FG002|Stage 2|Death|0|||
105696217|NCT00467779|364552478|FG003|Stage 2|Death|0|||
105696218|NCT00467779|364552479|FG004|Stage 2|Death|0|||
105696219|NCT00467779|364552480|FG005|Stage 2|Death|0|||
105696220|NCT00467779|364552481|FG006|Stage 2|Death|0|||
105696221|NCT00467779|364552482|FG007|Stage 2|Death|0|||
105696222|NCT00467779|364552483|FG008|Stage 2|Death|1|||
105696223|NCT00467779|364552484|FG009|Stage 2|Death|0|||
105696224|NCT00467779|364552485|FG010|Stage 2|Death|0|||
105696225|NCT00467779|364552486|FG011|Stage 2|Death|0|||
105696226|NCT00467779|364552487|FG012|Stage 2|Death|0|||
105696227|NCT00467779|364552488|FG013|Stage 2|Death|0|||
105696228|NCT00467779|364552489|FG014|Stage 2|Death|0|||
105696229|NCT00467779|364552475|FG000|Stage 2|Disease Progression|0|||
105696230|NCT00467779|364552476|FG001|Stage 2|Disease Progression|0|||
105696231|NCT00467779|364552477|FG002|Stage 2|Disease Progression|0|||
105696232|NCT00467779|364552478|FG003|Stage 2|Disease Progression|0|||
105696233|NCT00467779|364552479|FG004|Stage 2|Disease Progression|0|||
105696234|NCT00467779|364552480|FG005|Stage 2|Disease Progression|0|||
105696235|NCT00467779|364552481|FG006|Stage 2|Disease Progression|0|||
105696236|NCT00467779|364552482|FG007|Stage 2|Disease Progression|0|||
105696237|NCT00467779|364552483|FG008|Stage 2|Disease Progression|16|||
105696238|NCT00467779|364552484|FG009|Stage 2|Disease Progression|0|||
105696239|NCT00467779|364552485|FG010|Stage 2|Disease Progression|0|||
105696240|NCT00467779|364552486|FG011|Stage 2|Disease Progression|0|||
105696241|NCT00467779|364552487|FG012|Stage 2|Disease Progression|0|||
105696242|NCT00467779|364552488|FG013|Stage 2|Disease Progression|0|||
105696243|NCT00467779|364552489|FG014|Stage 2|Disease Progression|0|||
105696244|NCT00467779|364552475|FG000|Stage 2|Unspecified Reason|0|||
105696245|NCT00467779|364552476|FG001|Stage 2|Unspecified Reason|0|||
105696246|NCT00467779|364552477|FG002|Stage 2|Unspecified Reason|0|||
105696247|NCT00467779|364552478|FG003|Stage 2|Unspecified Reason|0|||
105696248|NCT00467779|364552479|FG004|Stage 2|Unspecified Reason|0|||
105696249|NCT00467779|364552480|FG005|Stage 2|Unspecified Reason|0|||
105696250|NCT00467779|364552481|FG006|Stage 2|Unspecified Reason|0|||
105696251|NCT00467779|364552482|FG007|Stage 2|Unspecified Reason|0|||
105696252|NCT00467779|364552483|FG008|Stage 2|Unspecified Reason|3|||
105696253|NCT00467779|364552484|FG009|Stage 2|Unspecified Reason|0|||
105696254|NCT00467779|364552485|FG010|Stage 2|Unspecified Reason|0|||
105696255|NCT00467779|364552486|FG011|Stage 2|Unspecified Reason|0|||
105696256|NCT00467779|364552487|FG012|Stage 2|Unspecified Reason|0|||
105696257|NCT00467779|364552488|FG013|Stage 2|Unspecified Reason|0|||
105696258|NCT00467779|364552489|FG014|Stage 2|Unspecified Reason|0|||
105696259|NCT00467779|364552475|FG000|Stage 2A|Adverse Event|0|||
105696260|NCT00467779|364552476|FG001|Stage 2A|Adverse Event|0|||
105696261|NCT00467779|364552477|FG002|Stage 2A|Adverse Event|0|||
105696262|NCT00467779|364552478|FG003|Stage 2A|Adverse Event|0|||
105696263|NCT00467779|364552479|FG004|Stage 2A|Adverse Event|0|||
105696264|NCT00467779|364552480|FG005|Stage 2A|Adverse Event|0|||
105696265|NCT00467779|364552481|FG006|Stage 2A|Adverse Event|0|||
105696266|NCT00467779|364552482|FG007|Stage 2A|Adverse Event|0|||
105696267|NCT00467779|364552483|FG008|Stage 2A|Adverse Event|0|||
105696268|NCT00467779|364552484|FG009|Stage 2A|Adverse Event|0|||
105696269|NCT00467779|364552485|FG010|Stage 2A|Adverse Event|0|||
105696270|NCT00467779|364552486|FG011|Stage 2A|Adverse Event|0|||
105696271|NCT00467779|364552487|FG012|Stage 2A|Adverse Event|0|||
105696272|NCT00467779|364552488|FG013|Stage 2A|Adverse Event|2|||
105696273|NCT00467779|364552489|FG014|Stage 2A|Adverse Event|0|||
105696274|NCT00467779|364552475|FG000|Stage 2A|Death|0|||
105696275|NCT00467779|364552476|FG001|Stage 2A|Death|0|||
105696276|NCT00467779|364552477|FG002|Stage 2A|Death|0|||
105696277|NCT00467779|364552478|FG003|Stage 2A|Death|0|||
105696278|NCT00467779|364552479|FG004|Stage 2A|Death|0|||
105696279|NCT00467779|364552480|FG005|Stage 2A|Death|0|||
105696280|NCT00467779|364552481|FG006|Stage 2A|Death|0|||
105696281|NCT00467779|364552482|FG007|Stage 2A|Death|0|||
105696282|NCT00467779|364552483|FG008|Stage 2A|Death|0|||
105696283|NCT00467779|364552484|FG009|Stage 2A|Death|0|||
105696284|NCT00467779|364552485|FG010|Stage 2A|Death|0|||
105696285|NCT00467779|364552486|FG011|Stage 2A|Death|0|||
105696286|NCT00467779|364552487|FG012|Stage 2A|Death|0|||
105696287|NCT00467779|364552488|FG013|Stage 2A|Death|1|||
105696288|NCT00467779|364552489|FG014|Stage 2A|Death|0|||
105696289|NCT00467779|364552475|FG000|Stage 2A|Disease Progression|0|||
105696290|NCT00467779|364552476|FG001|Stage 2A|Disease Progression|0|||
105696291|NCT00467779|364552477|FG002|Stage 2A|Disease Progression|0|||
105696292|NCT00467779|364552478|FG003|Stage 2A|Disease Progression|0|||
105696293|NCT00467779|364552479|FG004|Stage 2A|Disease Progression|0|||
105696294|NCT00467779|364552480|FG005|Stage 2A|Disease Progression|0|||
105696295|NCT00467779|364552481|FG006|Stage 2A|Disease Progression|0|||
105696296|NCT00467779|364552482|FG007|Stage 2A|Disease Progression|0|||
105696297|NCT00467779|364552483|FG008|Stage 2A|Disease Progression|0|||
105696298|NCT00467779|364552484|FG009|Stage 2A|Disease Progression|0|||
105696299|NCT00467779|364552485|FG010|Stage 2A|Disease Progression|0|||
105696300|NCT00467779|364552486|FG011|Stage 2A|Disease Progression|0|||
105696301|NCT00467779|364552487|FG012|Stage 2A|Disease Progression|0|||
105696302|NCT00467779|364552488|FG013|Stage 2A|Disease Progression|10|||
105696303|NCT00467779|364552489|FG014|Stage 2A|Disease Progression|0|||
105696304|NCT00467779|364552475|FG000|Stage 2A|Unspecified Reason|0|||
105696305|NCT00467779|364552476|FG001|Stage 2A|Unspecified Reason|0|||
105696306|NCT00467779|364552477|FG002|Stage 2A|Unspecified Reason|0|||
105696307|NCT00467779|364552478|FG003|Stage 2A|Unspecified Reason|0|||
105696308|NCT00467779|364552479|FG004|Stage 2A|Unspecified Reason|0|||
105696309|NCT00467779|364552480|FG005|Stage 2A|Unspecified Reason|0|||
105696310|NCT00467779|364552481|FG006|Stage 2A|Unspecified Reason|0|||
105696311|NCT00467779|364552482|FG007|Stage 2A|Unspecified Reason|0|||
105696312|NCT00467779|364552483|FG008|Stage 2A|Unspecified Reason|0|||
105696313|NCT00467779|364552484|FG009|Stage 2A|Unspecified Reason|0|||
105696314|NCT00467779|364552485|FG010|Stage 2A|Unspecified Reason|0|||
105696315|NCT00467779|364552486|FG011|Stage 2A|Unspecified Reason|0|||
105696316|NCT00467779|364552487|FG012|Stage 2A|Unspecified Reason|0|||
105696317|NCT00467779|364552488|FG013|Stage 2A|Unspecified Reason|7|||
105696318|NCT00467779|364552489|FG014|Stage 2A|Unspecified Reason|0|||
105696319|NCT00467779|364552475|FG000|Stage 2A|Withdrawal by Subject|0|||
105696320|NCT00467779|364552476|FG001|Stage 2A|Withdrawal by Subject|0|||
105696321|NCT00467779|364552477|FG002|Stage 2A|Withdrawal by Subject|0|||
105696322|NCT00467779|364552478|FG003|Stage 2A|Withdrawal by Subject|0|||
105696323|NCT00467779|364552479|FG004|Stage 2A|Withdrawal by Subject|0|||
105696324|NCT00467779|364552480|FG005|Stage 2A|Withdrawal by Subject|0|||
105696325|NCT00467779|364552481|FG006|Stage 2A|Withdrawal by Subject|0|||
105696326|NCT00467779|364552482|FG007|Stage 2A|Withdrawal by Subject|0|||
105696327|NCT00467779|364552483|FG008|Stage 2A|Withdrawal by Subject|0|||
105696328|NCT00467779|364552484|FG009|Stage 2A|Withdrawal by Subject|0|||
105696329|NCT00467779|364552485|FG010|Stage 2A|Withdrawal by Subject|0|||
105696330|NCT00467779|364552486|FG011|Stage 2A|Withdrawal by Subject|0|||
105696331|NCT00467779|364552487|FG012|Stage 2A|Withdrawal by Subject|0|||
105696332|NCT00467779|364552488|FG013|Stage 2A|Withdrawal by Subject|1|||
105696333|NCT00467779|364552489|FG014|Stage 2A|Withdrawal by Subject|0|||
105696334|NCT00467779|364552475|FG000|Stage 3|Adverse Event|0|||
105696335|NCT00467779|364552476|FG001|Stage 3|Adverse Event|0|||
105696336|NCT00467779|364552477|FG002|Stage 3|Adverse Event|0|||
105696337|NCT00467779|364552478|FG003|Stage 3|Adverse Event|0|||
105696338|NCT00467779|364552479|FG004|Stage 3|Adverse Event|0|||
105696339|NCT00467779|364552480|FG005|Stage 3|Adverse Event|0|||
105696340|NCT00467779|364552481|FG006|Stage 3|Adverse Event|0|||
105696341|NCT00467779|364552482|FG007|Stage 3|Adverse Event|0|||
105696342|NCT00467779|364552483|FG008|Stage 3|Adverse Event|0|||
105696343|NCT00467779|364552484|FG009|Stage 3|Adverse Event|0|||
105696344|NCT00467779|364552485|FG010|Stage 3|Adverse Event|0|||
105696345|NCT00467779|364552486|FG011|Stage 3|Adverse Event|0|||
105696346|NCT00467779|364552487|FG012|Stage 3|Adverse Event|0|||
105696347|NCT00467779|364552488|FG013|Stage 3|Adverse Event|0|||
105696348|NCT00467779|364552489|FG014|Stage 3|Adverse Event|2|||
105696349|NCT00467779|364552475|FG000|Stage 3|Death|0|||
105696350|NCT00467779|364552476|FG001|Stage 3|Death|0|||
105696351|NCT00467779|364552477|FG002|Stage 3|Death|0|||
105696352|NCT00467779|364552478|FG003|Stage 3|Death|0|||
105696353|NCT00467779|364552479|FG004|Stage 3|Death|0|||
105696354|NCT00467779|364552480|FG005|Stage 3|Death|0|||
105696355|NCT00467779|364552481|FG006|Stage 3|Death|0|||
105696356|NCT00467779|364552482|FG007|Stage 3|Death|0|||
105696357|NCT00467779|364552483|FG008|Stage 3|Death|0|||
105696358|NCT00467779|364552484|FG009|Stage 3|Death|0|||
105696359|NCT00467779|364552485|FG010|Stage 3|Death|0|||
105696360|NCT00467779|364552486|FG011|Stage 3|Death|0|||
105696361|NCT00467779|364552487|FG012|Stage 3|Death|0|||
105696362|NCT00467779|364552488|FG013|Stage 3|Death|0|||
105696363|NCT00467779|364552489|FG014|Stage 3|Death|1|||
105696364|NCT00467779|364552475|FG000|Stage 3|Disease Progression|0|||
105696365|NCT00467779|364552476|FG001|Stage 3|Disease Progression|0|||
105696366|NCT00467779|364552477|FG002|Stage 3|Disease Progression|0|||
105696367|NCT00467779|364552478|FG003|Stage 3|Disease Progression|0|||
105696368|NCT00467779|364552479|FG004|Stage 3|Disease Progression|0|||
105696369|NCT00467779|364552480|FG005|Stage 3|Disease Progression|0|||
105696370|NCT00467779|364552481|FG006|Stage 3|Disease Progression|0|||
105696371|NCT00467779|364552482|FG007|Stage 3|Disease Progression|0|||
105696372|NCT00467779|364552483|FG008|Stage 3|Disease Progression|0|||
105696373|NCT00467779|364552484|FG009|Stage 3|Disease Progression|0|||
105696374|NCT00467779|364552485|FG010|Stage 3|Disease Progression|0|||
105696375|NCT00467779|364552486|FG011|Stage 3|Disease Progression|0|||
105696376|NCT00467779|364552487|FG012|Stage 3|Disease Progression|0|||
105696377|NCT00467779|364552488|FG013|Stage 3|Disease Progression|0|||
105696378|NCT00467779|364552489|FG014|Stage 3|Disease Progression|9|||
105696379|NCT00467779|364552475|FG000|Stage 3|Unspecified Reason|0|||
105696380|NCT00467779|364552476|FG001|Stage 3|Unspecified Reason|0|||
105696381|NCT00467779|364552477|FG002|Stage 3|Unspecified Reason|0|||
105696382|NCT00467779|364552478|FG003|Stage 3|Unspecified Reason|0|||
105696383|NCT00467779|364552479|FG004|Stage 3|Unspecified Reason|0|||
105696384|NCT00467779|364552480|FG005|Stage 3|Unspecified Reason|0|||
105696385|NCT00467779|364552481|FG006|Stage 3|Unspecified Reason|0|||
105696386|NCT00467779|364552482|FG007|Stage 3|Unspecified Reason|0|||
105696387|NCT00467779|364552483|FG008|Stage 3|Unspecified Reason|0|||
105696388|NCT00467779|364552484|FG009|Stage 3|Unspecified Reason|0|||
105696389|NCT00467779|364552485|FG010|Stage 3|Unspecified Reason|0|||
105696390|NCT00467779|364552486|FG011|Stage 3|Unspecified Reason|0|||
105696391|NCT00467779|364552487|FG012|Stage 3|Unspecified Reason|0|||
105696392|NCT00467779|364552488|FG013|Stage 3|Unspecified Reason|0|||
105696393|NCT00467779|364552489|FG014|Stage 3|Unspecified Reason|5|||
105696394|NCT01195090|364552492|FG000|Overall Study|Adverse Event|1|||
105696395|NCT01195090|364552493|FG001|Overall Study|Adverse Event|2|||
105696396|NCT01195090|364552492|FG000|Overall Study|Lost to Follow-up|2|||
105696397|NCT01195090|364552493|FG001|Overall Study|Lost to Follow-up|2|||
105696398|NCT01195090|364552492|FG000|Overall Study|Protocol Violation|3|||
105696399|NCT01195090|364552493|FG001|Overall Study|Protocol Violation|4|||
105696400|NCT01701674|364552494|FG000|Overall Study|Unable to safely complete treatment|1|||
105696401|NCT00922480|364552499|FG000|Main Study|Protocol Violation|3|||
105696402|NCT00922480|364552500|FG001|Main Study|Protocol Violation|6|||
105696403|NCT00922480|364552499|FG000|Main Study|Adverse Event|6|||
105696404|NCT00922480|364552500|FG001|Main Study|Adverse Event|7|||
105696405|NCT00922480|364552499|FG000|Main Study|Lack of Efficacy|3|||
105696406|NCT00922480|364552500|FG001|Main Study|Lack of Efficacy|0|||
105696407|NCT00922480|364552499|FG000|Main Study|Withdrawal by Subject|20|||
105696408|NCT00922480|364552500|FG001|Main Study|Withdrawal by Subject|15|||
105696409|NCT00922480|364552499|FG000|Main Study|Lost to Follow-up|5|||
105696410|NCT00922480|364552500|FG001|Main Study|Lost to Follow-up|0|||
105696411|NCT00922480|364552499|FG000|Main Study|Physician Decision|0|||
105696412|NCT00922480|364552500|FG001|Main Study|Physician Decision|1|||
105696413|NCT00922480|364552499|FG000|Extension Study|Protocol Violation|3|||
105696414|NCT00922480|364552500|FG001|Extension Study|Protocol Violation|0|||
105696415|NCT00922480|364552499|FG000|Extension Study|Adverse Event|1|||
105696416|NCT00922480|364552500|FG001|Extension Study|Adverse Event|1|||
105696417|NCT00922480|364552499|FG000|Extension Study|Withdrawal by Subject|1|||
105696418|NCT00922480|364552500|FG001|Extension Study|Withdrawal by Subject|1|||
105696419|NCT00922480|364552499|FG000|Extension Study|Others|0|||
105696420|NCT00922480|364552500|FG001|Extension Study|Others|1|||
105696421|NCT04784897|364552501|FG000|Overall Study|Death|4|||
105696422|NCT04784897|364552502|FG001|Overall Study|Death|2|||
105696423|NCT04784897|364552503|FG002|Overall Study|Death|1|||
105696424|NCT04784897|364552501|FG000|Overall Study|Withdrawal by Subject|0|||
105696425|NCT04784897|364552502|FG001|Overall Study|Withdrawal by Subject|0|||
105696426|NCT04784897|364552503|FG002|Overall Study|Withdrawal by Subject|1|||
105696427|NCT03083847|364552504|FG000|Main|Physician Decision|0|||
105696428|NCT03083847|364552505|FG001|Main|Physician Decision|0|||
105696429|NCT03083847|364552506|FG002|Main|Physician Decision|0|||
105696430|NCT03083847|364552507|FG003|Main|Physician Decision|0|||
105696431|NCT03083847|364552508|FG004|Main|Physician Decision|0|||
105696432|NCT03083847|364552509|FG005|Main|Physician Decision|1|||
105696433|NCT03083847|364552510|FG006|Main|Physician Decision|0|||
105696434|NCT03083847|364552511|FG007|Main|Physician Decision|0|||
105696435|NCT03083847|364552512|FG008|Main|Physician Decision|0|||
105696436|NCT03083847|364552513|FG009|Main|Physician Decision|0|||
105696437|NCT03083847|364552504|FG000|Main|Pregnancy|0|||
105696438|NCT03083847|364552505|FG001|Main|Pregnancy|0|||
105696439|NCT03083847|364552506|FG002|Main|Pregnancy|0|||
105696440|NCT03083847|364552507|FG003|Main|Pregnancy|0|||
105696441|NCT03083847|364552508|FG004|Main|Pregnancy|0|||
105696442|NCT03083847|364552509|FG005|Main|Pregnancy|0|||
105696443|NCT03083847|364552510|FG006|Main|Pregnancy|0|||
105696444|NCT03083847|364552511|FG007|Main|Pregnancy|1|||
105696445|NCT03083847|364552512|FG008|Main|Pregnancy|0|||
105696446|NCT03083847|364552513|FG009|Main|Pregnancy|0|||
105696447|NCT03083847|364552504|FG000|Main|Adverse Event|0|||
105696448|NCT03083847|364552505|FG001|Main|Adverse Event|0|||
105696449|NCT03083847|364552506|FG002|Main|Adverse Event|0|||
105696450|NCT03083847|364552507|FG003|Main|Adverse Event|0|||
105696451|NCT03083847|364552508|FG004|Main|Adverse Event|0|||
105696452|NCT03083847|364552509|FG005|Main|Adverse Event|0|||
105696453|NCT03083847|364552510|FG006|Main|Adverse Event|0|||
105696454|NCT03083847|364552511|FG007|Main|Adverse Event|2|||
105696455|NCT03083847|364552512|FG008|Main|Adverse Event|0|||
105696456|NCT03083847|364552513|FG009|Main|Adverse Event|0|||
105696457|NCT03083847|364552504|FG000|Main|Withdrawal by Subject|0|||
105696458|NCT03083847|364552505|FG001|Main|Withdrawal by Subject|0|||
105696459|NCT03083847|364552506|FG002|Main|Withdrawal by Subject|0|||
105696460|NCT03083847|364552507|FG003|Main|Withdrawal by Subject|0|||
105696461|NCT03083847|364552508|FG004|Main|Withdrawal by Subject|0|||
105696462|NCT03083847|364552509|FG005|Main|Withdrawal by Subject|0|||
105696463|NCT03083847|364552510|FG006|Main|Withdrawal by Subject|1|||
105696464|NCT03083847|364552511|FG007|Main|Withdrawal by Subject|1|||
105696465|NCT03083847|364552512|FG008|Main|Withdrawal by Subject|0|||
105696466|NCT03083847|364552513|FG009|Main|Withdrawal by Subject|0|||
105696467|NCT00058552|364552514|FG000|Overall Study|Died prior to receiving treatment|4|||
105696468|NCT00058552|364552515|FG001|Overall Study|Died prior to receiving treatment|2|||
105696469|NCT00058552|364552514|FG000|Overall Study|Disease progression|52|||
105696470|NCT00058552|364552515|FG001|Overall Study|Disease progression|44|||
105696471|NCT00058552|364552514|FG000|Overall Study|Adverse Event|4|||
105696472|NCT00058552|364552515|FG001|Overall Study|Adverse Event|2|||
105696473|NCT00058552|364552514|FG000|Overall Study|Withdrawal by Subject|3|||
105696474|NCT00058552|364552515|FG001|Overall Study|Withdrawal by Subject|5|||
105696475|NCT00058552|364552514|FG000|Overall Study|Physician Decision|2|||
105696476|NCT00058552|364552515|FG001|Overall Study|Physician Decision|5|||
105696477|NCT00058552|364552514|FG000|Overall Study|Clinical disease progression|0|||
105696478|NCT00058552|364552515|FG001|Overall Study|Clinical disease progression|4|||
105696479|NCT02428855|364552516|FG000|Overall Study|Withdrawal by Subject|2|||
105696480|NCT02066311|364552517|FG000|Overall Study|Adverse Event|4|||
105696481|NCT02066311|364552517|FG000|Overall Study|Withdrawal by Subject|1|||
105696482|NCT02319668|364552520|FG000|Overall Study|Other (Not specified)|0|||
105696483|NCT02319668|364552521|FG001|Overall Study|Other (Not specified)|2|||
105696484|NCT01372150|364552524|FG000|Overall Study|Lack of Efficacy|3|||
105696485|NCT01372150|364552525|FG001|Overall Study|Lack of Efficacy|0|||
105696486|NCT01372150|364552526|FG002|Overall Study|Lack of Efficacy|1|||
105696487|NCT01372150|364552524|FG000|Overall Study|Lost to Follow-up|4|||
105696488|NCT01372150|364552525|FG001|Overall Study|Lost to Follow-up|5|||
105696489|NCT01372150|364552526|FG002|Overall Study|Lost to Follow-up|6|||
105696490|NCT01372150|364552524|FG000|Overall Study|Protocol Violation|1|||
105696491|NCT01372150|364552525|FG001|Overall Study|Protocol Violation|0|||
105696492|NCT01372150|364552526|FG002|Overall Study|Protocol Violation|3|||
105696493|NCT01372150|364552524|FG000|Overall Study|Withdrawal by Subject|2|||
105696494|NCT01372150|364552525|FG001|Overall Study|Withdrawal by Subject|7|||
105696495|NCT01372150|364552526|FG002|Overall Study|Withdrawal by Subject|2|||
105696496|NCT01372150|364552524|FG000|Overall Study|Other|1|||
105696497|NCT01372150|364552525|FG001|Overall Study|Other|0|||
105696498|NCT01372150|364552526|FG002|Overall Study|Other|2|||
105696499|NCT01372150|364552524|FG000|Overall Study|Adverse Event|2|||
105696500|NCT01372150|364552525|FG001|Overall Study|Adverse Event|1|||
105696501|NCT01372150|364552526|FG002|Overall Study|Adverse Event|2|||
105696502|NCT01372150|364552524|FG000|Overall Study|Randomized but not treated|0|||
105696503|NCT01372150|364552525|FG001|Overall Study|Randomized but not treated|1|||
105696504|NCT01372150|364552526|FG002|Overall Study|Randomized but not treated|0|||
105696505|NCT03198520|364552527|FG000|Overall Study|Physician Decision|2|||
105696506|NCT03198520|364552527|FG000|Overall Study|Protocol Violation|2|||
105696507|NCT03198520|364552527|FG000|Overall Study|Withdrawal by Subject|1|||
105696508|NCT03198520|364552527|FG000|Overall Study|Study Ended|1|||
105696509|NCT04353596|364552528|FG000|Overall Study|Protocol Violation|4|||
105348356|NCT00934856|363277046|FG001|Feasibility Part|Withdrawal by Subject|0|||
105348357|NCT00934856|363277047|FG002|Feasibility Part|Withdrawal by Subject|0|||
105348358|NCT00934856|363277048|FG003|Feasibility Part|Withdrawal by Subject|1|||
105348359|NCT00934856|363277049|FG004|Feasibility Part|Withdrawal by Subject|0|||
105348360|NCT00934856|363277050|FG005|Feasibility Part|Withdrawal by Subject|1|||
105348361|NCT00934856|363277045|FG000|Extension Part|Adverse Event|0|||
105696510|NCT04353596|364552529|FG001|Overall Study|Protocol Violation|4|||
105696511|NCT04353596|364552528|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
105696512|NCT04353596|364552529|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
105696513|NCT02316340|364552532|FG000|First Progression|Clinical progression|2|||
105696514|NCT02316340|364552533|FG001|First Progression|Clinical progression|1|||
105696515|NCT02316340|364552532|FG000|First Progression|Withdrawal by Subject|1|||
105696516|NCT02316340|364552533|FG001|First Progression|Withdrawal by Subject|0|||
105696517|NCT02665052|364552534|FG000|Overall Study|Lost to Follow-up|1|||
105696518|NCT02665052|364552535|FG001|Overall Study|Lost to Follow-up|0|||
105696519|NCT02665052|364552536|FG002|Overall Study|Lost to Follow-up|0|||
105696520|NCT02665052|364552537|FG003|Overall Study|Lost to Follow-up|0|||
105696521|NCT02665052|364552534|FG000|Overall Study|Withdrawal by Subject|1|||
105696522|NCT02665052|364552535|FG001|Overall Study|Withdrawal by Subject|1|||
105696523|NCT02665052|364552536|FG002|Overall Study|Withdrawal by Subject|0|||
105696524|NCT02665052|364552537|FG003|Overall Study|Withdrawal by Subject|5|||
105696525|NCT02665052|364552534|FG000|Overall Study|Adverse Event|1|||
105696526|NCT02665052|364552535|FG001|Overall Study|Adverse Event|1|||
105696527|NCT02665052|364552536|FG002|Overall Study|Adverse Event|0|||
105696528|NCT02665052|364552537|FG003|Overall Study|Adverse Event|0|||
105696529|NCT00823823|364552538|FG000|Overall Study|Lost to Follow-up|3|||
105696530|NCT00823823|364552539|FG001|Overall Study|Lost to Follow-up|1|||
105348362|NCT00934856|363277046|FG001|Extension Part|Adverse Event|0|||
105348363|NCT00934856|363277047|FG002|Extension Part|Adverse Event|0|||
105348364|NCT00934856|363277048|FG003|Extension Part|Adverse Event|1|||
105348365|NCT00934856|363277049|FG004|Extension Part|Adverse Event|4|||
105696531|NCT00823823|364552538|FG000|Overall Study|Protocol Violation|5|||
105787113|NCT03110107|364874893|FG004|Treatment Period|Death|0|||
105787114|NCT03110107|364874894|FG005|Treatment Period|Death|0|||
105787115|NCT03110107|364874895|FG006|Treatment Period|Death|0|||
105787116|NCT03110107|364874896|FG007|Treatment Period|Death|0|||
105787117|NCT03110107|364874897|FG008|Treatment Period|Death|0|||
105787118|NCT03110107|364874898|FG009|Treatment Period|Death|0|||
105787119|NCT03110107|364874899|FG010|Treatment Period|Death|0|||
105787120|NCT03110107|364874900|FG011|Treatment Period|Death|0|||
105787121|NCT03110107|364874901|FG012|Treatment Period|Death|1|||
105787122|NCT03110107|364874902|FG013|Treatment Period|Death|0|||
105787123|NCT03110107|364874903|FG014|Treatment Period|Death|0|||
105787124|NCT03110107|364874904|FG015|Treatment Period|Death|0|||
105787125|NCT03110107|364874905|FG016|Treatment Period|Death|0|||
105787126|NCT03110107|364874906|FG017|Treatment Period|Death|0|||
105787127|NCT03110107|364874907|FG018|Treatment Period|Death|0|||
105787128|NCT03110107|364874908|FG019|Treatment Period|Death|0|||
105787129|NCT03110107|364874909|FG020|Treatment Period|Death|0|||
105787130|NCT03110107|364874910|FG021|Treatment Period|Death|0|||
105787131|NCT03110107|364874911|FG022|Treatment Period|Death|0|||
105787132|NCT03110107|364874912|FG023|Treatment Period|Death|0|||
105787133|NCT03110107|364874913|FG024|Treatment Period|Death|0|||
105787134|NCT03110107|364874914|FG025|Treatment Period|Death|0|||
105787135|NCT03110107|364874889|FG000|Treatment Period|Adverse Event|0|||
105696532|NCT00823823|364552539|FG001|Overall Study|Protocol Violation|5|||
105696533|NCT01986920|364552540|FG000|A- 101 25%|Withdrawal by Subject|1|||
105787136|NCT03110107|364874890|FG001|Treatment Period|Adverse Event|0|||
105787137|NCT03110107|364874891|FG002|Treatment Period|Adverse Event|1|||
105787138|NCT03110107|364874892|FG003|Treatment Period|Adverse Event|0|||
105787139|NCT03110107|364874893|FG004|Treatment Period|Adverse Event|0|||
105787140|NCT03110107|364874894|FG005|Treatment Period|Adverse Event|2|||
105787141|NCT03110107|364874895|FG006|Treatment Period|Adverse Event|0|||
105787142|NCT03110107|364874896|FG007|Treatment Period|Adverse Event|2|||
105787143|NCT03110107|364874897|FG008|Treatment Period|Adverse Event|0|||
105696534|NCT01986920|364552541|FG001|A- 101 25%|Withdrawal by Subject|0|||
105696535|NCT01986920|364552542|FG002|A- 101 25%|Withdrawal by Subject|0|||
105696536|NCT01986920|364552543|FG003|A- 101 25%|Withdrawal by Subject|0|||
105696537|NCT01986920|364552540|FG000|A-101 32.5%|Withdrawal by Subject|0|||
105696538|NCT01986920|364552541|FG001|A-101 32.5%|Withdrawal by Subject|1|||
105696539|NCT01986920|364552542|FG002|A-101 32.5%|Withdrawal by Subject|0|||
105696540|NCT01986920|364552543|FG003|A-101 32.5%|Withdrawal by Subject|0|||
105696541|NCT01986920|364552540|FG000|A-101 40%|Withdrawal by Subject|0|||
105696542|NCT01986920|364552541|FG001|A-101 40%|Withdrawal by Subject|0|||
105696543|NCT01986920|364552542|FG002|A-101 40%|Withdrawal by Subject|1|||
105696544|NCT01986920|364552543|FG003|A-101 40%|Withdrawal by Subject|0|||
105696545|NCT01986920|364552540|FG000|Placebo|Withdrawal by Subject|0|||
105696546|NCT01986920|364552541|FG001|Placebo|Withdrawal by Subject|0|||
105696547|NCT01986920|364552542|FG002|Placebo|Withdrawal by Subject|0|||
105696548|NCT01986920|364552543|FG003|Placebo|Withdrawal by Subject|1|||
105696549|NCT00233363|364552545|FG000|Overall Study|Adverse Event|1|||
105696550|NCT00233363|364552546|FG001|Overall Study|Adverse Event|2|||
105696551|NCT00233363|364552545|FG000|Overall Study|Lack of Efficacy|0|||
105696552|NCT00233363|364552546|FG001|Overall Study|Lack of Efficacy|2|||
105696553|NCT00233363|364552545|FG000|Overall Study|Withdrawal by Subject|1|||
105473531|NCT03304249|363745396|FG000|Overall Study|Withdrawal by Subject|12|||
105473532|NCT03304249|363745397|FG001|Overall Study|Withdrawal by Subject|2|||
105473533|NCT03304249|363745396|FG000|Overall Study|Moved Out of District|4|||
105473534|NCT03304249|363745397|FG001|Overall Study|Moved Out of District|2|||
105473535|NCT01253577|363745398|FG000|Overall Study|Lost to Follow-up|3|||
105473536|NCT02509026|363745399|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
105473537|NCT02509026|363745399|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
105473538|NCT02509026|363745399|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
105473539|NCT02509026|363745399|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
105473540|NCT02509026|363745399|FG000|Induction Period (24 Weeks)|Other|2|||
105473541|NCT02509026|363745399|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
105473542|NCT02509026|363745399|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
105473543|NCT02509026|363745399|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
105696554|NCT00233363|364552546|FG001|Overall Study|Withdrawal by Subject|1|||
105696555|NCT00233363|364552545|FG000|Overall Study|Aggravation of complication|1|||
105787144|NCT03110107|364874898|FG009|Treatment Period|Adverse Event|1|||
105787145|NCT03110107|364874899|FG010|Treatment Period|Adverse Event|0|||
105787146|NCT03110107|364874900|FG011|Treatment Period|Adverse Event|0|||
105787147|NCT03110107|364874901|FG012|Treatment Period|Adverse Event|0|||
105787148|NCT03110107|364874902|FG013|Treatment Period|Adverse Event|0|||
105696556|NCT00233363|364552546|FG001|Overall Study|Aggravation of complication|0|||
105696557|NCT00718549|364552547|FG000|Induction Phase|Disease Progression|1|||
105787149|NCT03110107|364874903|FG014|Treatment Period|Adverse Event|0|||
105787150|NCT03110107|364874904|FG015|Treatment Period|Adverse Event|2|||
105787151|NCT03110107|364874905|FG016|Treatment Period|Adverse Event|0|||
105787152|NCT03110107|364874906|FG017|Treatment Period|Adverse Event|1|||
105787153|NCT03110107|364874907|FG018|Treatment Period|Adverse Event|2|||
105696558|NCT00718549|364552548|FG001|Induction Phase|Disease Progression|0|||
105696559|NCT00718549|364552549|FG002|Induction Phase|Disease Progression|0|||
105696560|NCT00718549|364552547|FG000|Induction Phase|Eligibility Criteria Violation|2|||
105696561|NCT00718549|364552548|FG001|Induction Phase|Eligibility Criteria Violation|0|||
105696562|NCT00718549|364552549|FG002|Induction Phase|Eligibility Criteria Violation|0|||
105696563|NCT00718549|364552547|FG000|Induction Phase|Early Termination - No Additional Info|59|||
105696564|NCT00718549|364552548|FG001|Induction Phase|Early Termination - No Additional Info|0|||
105696565|NCT00718549|364552549|FG002|Induction Phase|Early Termination - No Additional Info|0|||
105696566|NCT00718549|364552547|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
105696567|NCT00718549|364552548|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
105696568|NCT00718549|364552549|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
105348366|NCT00934856|363277050|FG005|Extension Part|Adverse Event|4|||
105348367|NCT00934856|363277045|FG000|Extension Part|Progressive disease|0|||
105348368|NCT00934856|363277046|FG001|Extension Part|Progressive disease|0|||
105348369|NCT00934856|363277047|FG002|Extension Part|Progressive disease|0|||
105348370|NCT00934856|363277048|FG003|Extension Part|Progressive disease|1|||
105348371|NCT00934856|363277049|FG004|Extension Part|Progressive disease|0|||
105348372|NCT00934856|363277050|FG005|Extension Part|Progressive disease|0|||
105348373|NCT00934856|363277045|FG000|Extension Part|Non-compliance with drug|0|||
105696569|NCT00718549|364552547|FG000|Maintenance/ Observation Phase|Death|0|||
105696570|NCT00718549|364552548|FG001|Maintenance/ Observation Phase|Death|1|||
105348374|NCT00934856|363277046|FG001|Extension Part|Non-compliance with drug|0|||
105473544|NCT02509026|363745399|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
105473545|NCT02509026|363745399|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
105473546|NCT02509026|363745399|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
105473547|NCT02509026|363745399|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
105473548|NCT02509026|363745399|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
105473549|NCT01165216|363745400|FG000|Overall Study|Adverse Event|6|||
105473550|NCT01165216|363745401|FG001|Overall Study|Adverse Event|3|||
105473551|NCT01165216|363745400|FG000|Overall Study|Withdrawal by Subject|1|||
105473552|NCT01165216|363745401|FG001|Overall Study|Withdrawal by Subject|1|||
105473553|NCT01165216|363745400|FG000|Overall Study|Disease progression|1|||
105473554|NCT01165216|363745401|FG001|Overall Study|Disease progression|3|||
105473555|NCT02626624|363745409|FG000|Overall Study|Adverse Event|1|||
105473556|NCT02626624|363745409|FG000|Overall Study|Lost to Follow-up|3|||
105473557|NCT02626624|363745409|FG000|Overall Study|Protocol Violation|4|||
105473558|NCT02626624|363745409|FG000|Overall Study|Death|2|||
105473559|NCT05141448|363745410|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
105473560|NCT05141448|363745411|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
105473561|NCT05141448|363745412|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
105473562|NCT05141448|363745413|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
105473563|NCT05141448|363745414|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
105473564|NCT05141448|363745415|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
105473565|NCT05141448|363745410|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
105473566|NCT05141448|363745411|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
105473567|NCT05141448|363745412|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
105473568|NCT05141448|363745413|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
105473569|NCT05141448|363745414|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
105473570|NCT05141448|363745415|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
105473571|NCT05141448|363745410|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
105473572|NCT05141448|363745411|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
105473573|NCT05141448|363745412|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
105473574|NCT05141448|363745413|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
105473575|NCT05141448|363745414|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
105473576|NCT05141448|363745415|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
105473577|NCT05141448|363745410|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
105473578|NCT05141448|363745411|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
105473579|NCT05141448|363745412|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
105473580|NCT05141448|363745413|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
105473581|NCT05141448|363745414|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
105473582|NCT05141448|363745415|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
105473583|NCT05141448|363745410|FG000|Period 2|COVID-19 Related|0|||
105473584|NCT05141448|363745411|FG001|Period 2|COVID-19 Related|0|||
105473585|NCT05141448|363745412|FG002|Period 2|COVID-19 Related|0|||
105473586|NCT05141448|363745413|FG003|Period 2|COVID-19 Related|1|||
105473587|NCT05141448|363745414|FG004|Period 2|COVID-19 Related|0|||
105473588|NCT05141448|363745415|FG005|Period 2|COVID-19 Related|1|||
105473589|NCT05141448|363745410|FG000|3|Covid-19 related|2|||
105473590|NCT05141448|363745411|FG001|3|Covid-19 related|0|||
105473591|NCT05141448|363745412|FG002|3|Covid-19 related|0|||
105696571|NCT00718549|364552549|FG002|Maintenance/ Observation Phase|Death|2|||
105696572|NCT00718549|364552547|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
105696573|NCT00718549|364552548|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
105696574|NCT00718549|364552549|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
105696575|NCT00718549|364552547|FG000|Maintenance/ Observation Phase|Progression|0|||
105696576|NCT00718549|364552548|FG001|Maintenance/ Observation Phase|Progression|5|||
105696577|NCT00718549|364552549|FG002|Maintenance/ Observation Phase|Progression|14|||
105696578|NCT00718549|364552547|FG000|Maintenance/ Observation Phase|Relapse|0|||
105696579|NCT00718549|364552548|FG001|Maintenance/ Observation Phase|Relapse|3|||
105696580|NCT00718549|364552549|FG002|Maintenance/ Observation Phase|Relapse|2|||
105696581|NCT01353508|364552550|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
105696582|NCT01353508|364552551|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
105696583|NCT01353508|364552552|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
105348375|NCT00934856|363277047|FG002|Extension Part|Non-compliance with drug|0|||
105696584|NCT01353508|364552553|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
105696585|NCT01353508|364552550|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
105696586|NCT01353508|364552551|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
105696587|NCT01353508|364552552|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
105696588|NCT01353508|364552553|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
105696589|NCT00701090|364552554|FG000|Overall Study|Adverse Event|11|||
105696590|NCT00701090|364552555|FG001|Overall Study|Adverse Event|2|||
105696591|NCT00701090|364552554|FG000|Overall Study|Death|0|||
105696592|NCT00701090|364552555|FG001|Overall Study|Death|1|||
105696593|NCT00701090|364552554|FG000|Overall Study|Lack of Efficacy|5|||
105696594|NCT00701090|364552555|FG001|Overall Study|Lack of Efficacy|4|||
105696595|NCT00701090|364552554|FG000|Overall Study|Lost to Follow-up|9|||
105348376|NCT00934856|363277048|FG003|Extension Part|Non-compliance with drug|0|||
105348377|NCT00934856|363277049|FG004|Extension Part|Non-compliance with drug|0|||
105696596|NCT00701090|364552555|FG001|Overall Study|Lost to Follow-up|9|||
105696597|NCT00701090|364552554|FG000|Overall Study|Physician Decision|3|||
105696598|NCT00701090|364552555|FG001|Overall Study|Physician Decision|4|||
105696599|NCT00701090|364552554|FG000|Overall Study|Protocol Violation|2|||
105696600|NCT00701090|364552555|FG001|Overall Study|Protocol Violation|3|||
105696601|NCT00701090|364552554|FG000|Overall Study|Withdrawal by Subject|11|||
105696602|NCT00701090|364552555|FG001|Overall Study|Withdrawal by Subject|16|||
105696603|NCT00701090|364552554|FG000|Overall Study|Other|7|||
105696604|NCT00701090|364552555|FG001|Overall Study|Other|12|||
105696605|NCT02844920|364552558|FG000|Overall Study|Lost to Follow-up|2|||
105696606|NCT02871778|364552565|FG000|Part A: Treatment Period 1|Adverse Event|1|||
105696607|NCT02871778|364552566|FG001|Part A: Treatment Period 1|Adverse Event|1|||
105696608|NCT02871778|364552567|FG002|Part A: Treatment Period 1|Adverse Event|1|||
105696609|NCT02871778|364552568|FG003|Part A: Treatment Period 1|Adverse Event|0|||
105696610|NCT02871778|364552569|FG004|Part A: Treatment Period 1|Adverse Event|0|||
105696611|NCT02871778|364552570|FG005|Part A: Treatment Period 1|Adverse Event|0|||
105696612|NCT02871778|364552571|FG006|Part A: Treatment Period 1|Adverse Event|0|||
105696613|NCT02871778|364552572|FG007|Part A: Treatment Period 1|Adverse Event|0|||
105696614|NCT02871778|364552565|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
105696615|NCT02871778|364552566|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
105696616|NCT02871778|364552567|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
105696617|NCT02871778|364552568|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
105696618|NCT02871778|364552569|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
105696619|NCT02871778|364552570|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
105696620|NCT02871778|364552571|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
105696621|NCT02871778|364552572|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
105696622|NCT02871778|364552565|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
105787154|NCT03110107|364874908|FG019|Treatment Period|Adverse Event|1|||
105787155|NCT03110107|364874909|FG020|Treatment Period|Adverse Event|4|||
105787156|NCT03110107|364874910|FG021|Treatment Period|Adverse Event|2|||
105348378|NCT00934856|363277050|FG005|Extension Part|Non-compliance with drug|1|||
105348379|NCT01672294|363277056|FG000|Overall Study|Withdrawal by Subject|4|||
105348380|NCT01672294|363277057|FG001|Overall Study|Withdrawal by Subject|4|||
105348381|NCT01672294|363277058|FG002|Overall Study|Withdrawal by Subject|4|||
105696623|NCT02871778|364552566|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
105696624|NCT02871778|364552567|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
105696625|NCT02871778|364552568|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
105696626|NCT02871778|364552569|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
105696627|NCT02871778|364552570|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
105696628|NCT02871778|364552571|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
105696629|NCT02871778|364552572|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
105787157|NCT03110107|364874911|FG022|Treatment Period|Adverse Event|2|||
105473592|NCT05141448|363745413|FG003|3|Covid-19 related|0|||
105696630|NCT02871778|364552565|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
105696631|NCT02871778|364552566|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
105696632|NCT02871778|364552567|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
105696633|NCT02871778|364552568|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
105696634|NCT02871778|364552569|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
105696635|NCT02871778|364552570|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
105696636|NCT02871778|364552571|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
105696637|NCT02871778|364552572|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
105696638|NCT02871778|364552565|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
105696639|NCT02871778|364552566|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
105473593|NCT05141448|363745414|FG004|3|Covid-19 related|0|||
105473594|NCT05141448|363745415|FG005|3|Covid-19 related|1|||
105696640|NCT02871778|364552567|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
105696641|NCT02871778|364552568|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
105696642|NCT02871778|364552569|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
105696643|NCT02871778|364552570|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
105696644|NCT02871778|364552571|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
105696645|NCT02871778|364552572|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
105696646|NCT02871778|364552565|FG000|Part A: Treatment Period 2|Adverse Event|2|||
105696647|NCT02871778|364552566|FG001|Part A: Treatment Period 2|Adverse Event|2|||
105696648|NCT02871778|364552567|FG002|Part A: Treatment Period 2|Adverse Event|0|||
105696649|NCT02871778|364552568|FG003|Part A: Treatment Period 2|Adverse Event|0|||
105696650|NCT02871778|364552569|FG004|Part A: Treatment Period 2|Adverse Event|0|||
105696651|NCT02871778|364552570|FG005|Part A: Treatment Period 2|Adverse Event|0|||
105696652|NCT02871778|364552571|FG006|Part A: Treatment Period 2|Adverse Event|0|||
105696653|NCT02871778|364552572|FG007|Part A: Treatment Period 2|Adverse Event|0|||
105696654|NCT02871778|364552565|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
105696655|NCT02871778|364552566|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
105696656|NCT02871778|364552567|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
105696657|NCT02871778|364552568|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
105696658|NCT02871778|364552569|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
105696659|NCT02871778|364552570|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
105696660|NCT02871778|364552571|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
105696661|NCT02871778|364552572|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
105696662|NCT02871778|364552565|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
105696663|NCT02871778|364552566|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
105696664|NCT02871778|364552567|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
105696665|NCT02871778|364552568|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
105696666|NCT02871778|364552569|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
105696667|NCT02871778|364552570|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
105696668|NCT02871778|364552571|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
105696669|NCT02871778|364552572|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
105696670|NCT02871778|364552565|FG000|Part B: Treatment Period 3|Adverse Event|0|||
105696671|NCT02871778|364552566|FG001|Part B: Treatment Period 3|Adverse Event|0|||
105696672|NCT02871778|364552567|FG002|Part B: Treatment Period 3|Adverse Event|0|||
105696673|NCT02871778|364552568|FG003|Part B: Treatment Period 3|Adverse Event|0|||
105696674|NCT02871778|364552569|FG004|Part B: Treatment Period 3|Adverse Event|1|||
105696675|NCT02871778|364552570|FG005|Part B: Treatment Period 3|Adverse Event|1|||
105696676|NCT02871778|364552571|FG006|Part B: Treatment Period 3|Adverse Event|1|||
105696677|NCT02871778|364552572|FG007|Part B: Treatment Period 3|Adverse Event|0|||
105696678|NCT02170779|364552581|FG000|Overall Study|Withdrawal by Subject|1|||
105696679|NCT02170779|364552582|FG001|Overall Study|Withdrawal by Subject|0|||
105696680|NCT02170779|364552581|FG000|Overall Study|Lost to Follow-up|0|||
105473595|NCT05141448|363745410|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
105473596|NCT05141448|363745411|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
105473597|NCT05141448|363745412|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
105473598|NCT05141448|363745413|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
105696681|NCT02170779|364552582|FG001|Overall Study|Lost to Follow-up|1|||
105696682|NCT00369785|364552583|FG000|Overall Study|Physician Decision|3|||
105696683|NCT00369785|364552584|FG001|Overall Study|Physician Decision|2|||
105696684|NCT00369785|364552583|FG000|Overall Study|Death|1|||
105696685|NCT00369785|364552584|FG001|Overall Study|Death|2|||
105696686|NCT00369785|364552583|FG000|Overall Study|Withdrawal by Subject|7|||
105696687|NCT00369785|364552584|FG001|Overall Study|Withdrawal by Subject|6|||
105696688|NCT00369785|364552583|FG000|Overall Study|Toxicity|6|||
105696689|NCT00369785|364552584|FG001|Overall Study|Toxicity|4|||
105696690|NCT00369785|364552583|FG000|Overall Study|Never started|0|||
105696691|NCT00369785|364552584|FG001|Overall Study|Never started|2|||
105696692|NCT00369785|364552583|FG000|Overall Study|Progression|4|||
105696693|NCT00369785|364552584|FG001|Overall Study|Progression|4|||
105696694|NCT00369785|364552583|FG000|Overall Study|Multiple reasons|6|||
105696695|NCT00369785|364552584|FG001|Overall Study|Multiple reasons|5|||
105696696|NCT00800683|364552585|FG000|Overall Study|Adverse Event|11|||
105696697|NCT00800683|364552586|FG001|Overall Study|Adverse Event|8|||
105696698|NCT00800683|364552585|FG000|Overall Study|Lost to Follow-up|3|||
105696699|NCT00800683|364552586|FG001|Overall Study|Lost to Follow-up|1|||
105696700|NCT00800683|364552585|FG000|Overall Study|Withdrawal by Subject|1|||
105696701|NCT00800683|364552586|FG001|Overall Study|Withdrawal by Subject|7|||
105696702|NCT00800683|364552585|FG000|Overall Study|Lack of Efficacy|1|||
105696703|NCT00800683|364552586|FG001|Overall Study|Lack of Efficacy|1|||
105696704|NCT00800683|364552585|FG000|Overall Study|Other|1|||
105696705|NCT00800683|364552586|FG001|Overall Study|Other|2|||
105696706|NCT00545402|364552587|FG000|Overall Study|Discontinuation of treatment|17|||
105696707|NCT00545402|364552588|FG001|Overall Study|Discontinuation of treatment|9|||
105696708|NCT00545402|364552587|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
105696709|NCT00545402|364552588|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
105696710|NCT00545402|364552587|FG000|Overall Study|Death|5|||
105696711|NCT00545402|364552588|FG001|Overall Study|Death|7|||
105696712|NCT00545402|364552587|FG000|Overall Study|Graft loss|2|||
105696713|NCT00545402|364552588|FG001|Overall Study|Graft loss|4|||
105696714|NCT00545402|364552587|FG000|Overall Study|Withdrawal by Subject|0|||
105696715|NCT00545402|364552588|FG001|Overall Study|Withdrawal by Subject|1|||
105696716|NCT00545402|364552587|FG000|Overall Study|Protocol Violation|1|||
105696717|NCT00545402|364552588|FG001|Overall Study|Protocol Violation|0|||
105696718|NCT00545402|364552587|FG000|Overall Study|Reason not specified|1|||
105696719|NCT00545402|364552588|FG001|Overall Study|Reason not specified|1|||
105696720|NCT00310804|364552589|FG000|Overall Study|Lost to Follow-up|2|||
105696721|NCT00310804|364552590|FG001|Overall Study|Lost to Follow-up|0|||
105696722|NCT00310804|364552589|FG000|Overall Study|Withdrawal by Subject|3|||
105696723|NCT00310804|364552590|FG001|Overall Study|Withdrawal by Subject|0|||
105696724|NCT04136184|364552591|FG000|Overall Study|Lost to Follow-up|0|||
105696725|NCT04136184|364552592|FG001|Overall Study|Lost to Follow-up|3|||
105696726|NCT04136184|364552591|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
105696727|NCT04136184|364552592|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
105696728|NCT02783274|364552593|FG000|Overall Study|Withdrawal by Subject|16|||
105696729|NCT02783274|364552593|FG000|Overall Study|Physician Decision|6|||
105696730|NCT02783274|364552593|FG000|Overall Study|Death|9|||
105696731|NCT02783274|364552593|FG000|Overall Study|Lost to Follow-up|22|||
105696732|NCT02783274|364552593|FG000|Overall Study|Other|22|||
105696733|NCT03509467|364552594|FG000|Overall Study|Withdrawal by Subject|5|||
105696734|NCT03509467|364552595|FG001|Overall Study|Withdrawal by Subject|1|||
105696735|NCT03509467|364552596|FG002|Overall Study|Withdrawal by Subject|6|||
105696736|NCT03509467|364552597|FG003|Overall Study|Withdrawal by Subject|7|||
105696737|NCT03509467|364552598|FG004|Overall Study|Withdrawal by Subject|10|||
105696738|NCT03509467|364552599|FG005|Overall Study|Withdrawal by Subject|10|||
105696739|NCT03509467|364552600|FG006|Overall Study|Withdrawal by Subject|10|||
105696740|NCT03509467|364552601|FG007|Overall Study|Withdrawal by Subject|10|||
105696741|NCT03509467|364552594|FG000|Overall Study|Death|0|||
105696742|NCT03509467|364552595|FG001|Overall Study|Death|0|||
105696743|NCT03509467|364552596|FG002|Overall Study|Death|2|||
105696744|NCT03509467|364552597|FG003|Overall Study|Death|2|||
105696745|NCT03509467|364552598|FG004|Overall Study|Death|1|||
105696746|NCT03509467|364552599|FG005|Overall Study|Death|0|||
105696747|NCT03509467|364552600|FG006|Overall Study|Death|1|||
105696748|NCT03509467|364552601|FG007|Overall Study|Death|0|||
105696749|NCT03509467|364552594|FG000|Overall Study|Proxy Withdrawal|0|||
105696750|NCT03509467|364552595|FG001|Overall Study|Proxy Withdrawal|0|||
105696751|NCT03509467|364552596|FG002|Overall Study|Proxy Withdrawal|0|||
105696752|NCT03509467|364552597|FG003|Overall Study|Proxy Withdrawal|0|||
105696753|NCT03509467|364552598|FG004|Overall Study|Proxy Withdrawal|0|||
105787158|NCT03110107|364874912|FG023|Treatment Period|Adverse Event|2|||
105787159|NCT03110107|364874913|FG024|Treatment Period|Adverse Event|2|||
105787160|NCT03110107|364874914|FG025|Treatment Period|Adverse Event|4|||
105696754|NCT03509467|364552599|FG005|Overall Study|Proxy Withdrawal|0|||
105696755|NCT03509467|364552600|FG006|Overall Study|Proxy Withdrawal|0|||
105696756|NCT03509467|364552601|FG007|Overall Study|Proxy Withdrawal|1|||
105696757|NCT00482703|364552602|FG000|Overall Study|Poor compliance|1|||
105696758|NCT00482703|364552603|FG001|Overall Study|Poor compliance|0|||
105696759|NCT02982239|364554404|FG000|Overall Study|Lost to Follow-up|3|||
105696760|NCT02982239|364554405|FG001|Overall Study|Lost to Follow-up|2|||
105696761|NCT00388505|364554409|FG000|Overall Study|Adverse Event or Death|43|||
105696762|NCT00388505|364554410|FG001|Overall Study|Adverse Event or Death|17|||
105696763|NCT00388505|364554409|FG000|Overall Study|Withdrawal by Subject|24|||
105696764|NCT00388505|364554410|FG001|Overall Study|Withdrawal by Subject|9|||
105787161|NCT03110107|364874889|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
105696765|NCT00388505|364554409|FG000|Overall Study|Lost to Follow-up|5|||
105696766|NCT00388505|364554410|FG001|Overall Study|Lost to Follow-up|3|||
105696767|NCT00388505|364554409|FG000|Overall Study|Inappropriate Enrollment|0|||
105787162|NCT03110107|364874890|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
105696768|NCT00388505|364554410|FG001|Overall Study|Inappropriate Enrollment|1|||
105696769|NCT00388505|364554409|FG000|Overall Study|Administrative Reason|1|||
105696770|NCT00388505|364554410|FG001|Overall Study|Administrative Reason|0|||
105696771|NCT00388505|364554409|FG000|Overall Study|Protocol Violation|6|||
105696772|NCT00388505|364554410|FG001|Overall Study|Protocol Violation|5|||
105696773|NCT00388505|364554409|FG000|Overall Study|Unable to classify|4|||
105696774|NCT00388505|364554410|FG001|Overall Study|Unable to classify|3|||
105696775|NCT01942148|364554416|FG000|Overall Study|Adverse Event|4|||
105696776|NCT01942148|364554416|FG000|Overall Study|Lack of Efficacy|2|||
105696777|NCT01942148|364554416|FG000|Overall Study|Physician Decision|11|||
105696778|NCT01942148|364554416|FG000|Overall Study|Protocol Violation|1|||
105696779|NCT01942148|364554416|FG000|Overall Study|Withdrawal by Subject|8|||
105696780|NCT01942148|364554416|FG000|Overall Study|Use of the prohibition medicine|1|||
105696781|NCT02248259|364554417|FG000|Treatment Period 1|Adverse Event|0|||
105696782|NCT02248259|364554418|FG001|Treatment Period 1|Adverse Event|0|||
105696783|NCT02248259|364554419|FG002|Treatment Period 1|Adverse Event|1|||
105696784|NCT02248259|364554420|FG003|Treatment Period 1|Adverse Event|0|||
105696785|NCT02573870|364554421|FG000|Overall Study|Adverse Event|0|||
105696786|NCT02573870|364554422|FG001|Overall Study|Adverse Event|2|||
105696787|NCT02573870|364554421|FG000|Overall Study|Lack of Efficacy|0|||
105696788|NCT02573870|364554422|FG001|Overall Study|Lack of Efficacy|1|||
105696789|NCT02573870|364554421|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
105696790|NCT02573870|364554422|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
105696791|NCT02573870|364554421|FG000|Overall Study|Lost to Follow-up|0|||
105696792|NCT02573870|364554422|FG001|Overall Study|Lost to Follow-up|1|||
105696793|NCT02573870|364554421|FG000|Overall Study|Other: Fail to Meet Visit|0|||
105696794|NCT02573870|364554422|FG001|Overall Study|Other: Fail to Meet Visit|2|||
105696795|NCT01858532|364554423|FG000|Overall Study|Adverse Event|58|||
105696796|NCT01858532|364554424|FG001|Overall Study|Adverse Event|50|||
105696797|NCT01858532|364554425|FG002|Overall Study|Adverse Event|23|||
105696798|NCT01858532|364554426|FG003|Overall Study|Adverse Event|28|||
105696799|NCT01858532|364554423|FG000|Overall Study|Withdrew consent|71|||
105696800|NCT01858532|364554424|FG001|Overall Study|Withdrew consent|93|||
105696801|NCT01858532|364554425|FG002|Overall Study|Withdrew consent|46|||
105696802|NCT01858532|364554426|FG003|Overall Study|Withdrew consent|27|||
105696803|NCT01858532|364554423|FG000|Overall Study|Lost to Follow-up|17|||
105696804|NCT01858532|364554424|FG001|Overall Study|Lost to Follow-up|26|||
105696805|NCT01858532|364554425|FG002|Overall Study|Lost to Follow-up|11|||
105696806|NCT01858532|364554426|FG003|Overall Study|Lost to Follow-up|14|||
105696807|NCT01858532|364554423|FG000|Overall Study|Deterioration of medical status|3|||
105696808|NCT01858532|364554424|FG001|Overall Study|Deterioration of medical status|4|||
105696809|NCT01858532|364554425|FG002|Overall Study|Deterioration of medical status|3|||
105696810|NCT01858532|364554426|FG003|Overall Study|Deterioration of medical status|7|||
105696811|NCT01858532|364554423|FG000|Overall Study|Investigator request|3|||
105696812|NCT01858532|364554424|FG001|Overall Study|Investigator request|4|||
105696813|NCT01858532|364554425|FG002|Overall Study|Investigator request|2|||
105696814|NCT01858532|364554426|FG003|Overall Study|Investigator request|6|||
105696815|NCT01858532|364554423|FG000|Overall Study|Other, not specified|29|||
105696816|NCT01858532|364554424|FG001|Overall Study|Other, not specified|15|||
105696817|NCT01858532|364554425|FG002|Overall Study|Other, not specified|13|||
105696818|NCT01858532|364554426|FG003|Overall Study|Other, not specified|11|||
105696819|NCT00434421|364554427|FG000|Overall Study|Withdrawal by Subject|1|||
105696820|NCT00434421|364554427|FG000|Overall Study|Non-compliance with study treatment|1|||
105696821|NCT02667275|364554430|FG000|Overall Study|Protocol Violation|11|||
105696822|NCT02667275|364554431|FG001|Overall Study|Protocol Violation|7|||
105696823|NCT02667275|364554430|FG000|Overall Study|Lost to Follow-up|0|||
105696824|NCT02667275|364554431|FG001|Overall Study|Lost to Follow-up|2|||
105696825|NCT02667275|364554430|FG000|Overall Study|Withdrawal by Subject|0|||
105696826|NCT02667275|364554431|FG001|Overall Study|Withdrawal by Subject|5|||
105696827|NCT02667275|364554430|FG000|Overall Study|Discontinued early without completing|0|||
105696828|NCT02667275|364554431|FG001|Overall Study|Discontinued early without completing|1|||
105696829|NCT01301456|364554432|FG000|Stage 1|Withdrawal by Subject|0|||
105696830|NCT01301456|364554433|FG001|Stage 1|Withdrawal by Subject|0|||
105696831|NCT01301456|364554434|FG002|Stage 1|Withdrawal by Subject|1|||
105696832|NCT01301456|364554435|FG003|Stage 1|Withdrawal by Subject|0|||
105696833|NCT01301456|364554436|FG004|Stage 1|Withdrawal by Subject|1|||
105696834|NCT01301456|364554437|FG005|Stage 1|Withdrawal by Subject|0|||
105696835|NCT01301456|364554438|FG006|Stage 1|Withdrawal by Subject|0|||
105696836|NCT01301456|364554439|FG007|Stage 1|Withdrawal by Subject|0|||
105696837|NCT01301456|364554440|FG008|Stage 1|Withdrawal by Subject|0|||
105696838|NCT01301456|364554441|FG009|Stage 1|Withdrawal by Subject|0|||
105696839|NCT01301456|364554442|FG010|Stage 1|Withdrawal by Subject|0|||
105696840|NCT01301456|364554443|FG011|Stage 1|Withdrawal by Subject|0|||
105696841|NCT01301456|364554432|FG000|Stage 1|Randomized but not treated|0|||
105696842|NCT01301456|364554433|FG001|Stage 1|Randomized but not treated|0|||
105696843|NCT01301456|364554434|FG002|Stage 1|Randomized but not treated|0|||
105696844|NCT01301456|364554435|FG003|Stage 1|Randomized but not treated|0|||
105696845|NCT01301456|364554436|FG004|Stage 1|Randomized but not treated|0|||
105696846|NCT01301456|364554437|FG005|Stage 1|Randomized but not treated|0|||
105696847|NCT01301456|364554438|FG006|Stage 1|Randomized but not treated|1|||
105696848|NCT01301456|364554439|FG007|Stage 1|Randomized but not treated|0|||
105696849|NCT01301456|364554440|FG008|Stage 1|Randomized but not treated|0|||
105696850|NCT01301456|364554441|FG009|Stage 1|Randomized but not treated|0|||
105696851|NCT01301456|364554442|FG010|Stage 1|Randomized but not treated|0|||
105696852|NCT01301456|364554443|FG011|Stage 1|Randomized but not treated|0|||
105696853|NCT01301456|364554432|FG000|Stage 2|Adverse Event|0|||
105696854|NCT01301456|364554433|FG001|Stage 2|Adverse Event|0|||
105348382|NCT01672294|363277059|FG003|Overall Study|Withdrawal by Subject|4|||
105348383|NCT01672294|363277056|FG000|Overall Study|Excluded by study|1|||
105348384|NCT01672294|363277057|FG001|Overall Study|Excluded by study|1|||
105348385|NCT01672294|363277058|FG002|Overall Study|Excluded by study|0|||
105348386|NCT01672294|363277059|FG003|Overall Study|Excluded by study|0|||
105696855|NCT01301456|364554434|FG002|Stage 2|Adverse Event|0|||
105696856|NCT01301456|364554435|FG003|Stage 2|Adverse Event|0|||
105696857|NCT01301456|364554436|FG004|Stage 2|Adverse Event|0|||
105696858|NCT01301456|364554437|FG005|Stage 2|Adverse Event|0|||
105696859|NCT01301456|364554438|FG006|Stage 2|Adverse Event|0|||
105696860|NCT01301456|364554439|FG007|Stage 2|Adverse Event|0|||
105348387|NCT01672294|363277056|FG000|Overall Study|Lost to Follow-up|1|||
105348388|NCT01672294|363277057|FG001|Overall Study|Lost to Follow-up|16|||
105348389|NCT01672294|363277058|FG002|Overall Study|Lost to Follow-up|7|||
105696861|NCT01301456|364554440|FG008|Stage 2|Adverse Event|0|||
105696862|NCT01301456|364554441|FG009|Stage 2|Adverse Event|0|||
105696863|NCT01301456|364554442|FG010|Stage 2|Adverse Event|1|||
105696864|NCT01301456|364554443|FG011|Stage 2|Adverse Event|0|||
105696865|NCT03794583|364554444|FG000|Overall Study|Death|8|||
105696866|NCT03794583|364554444|FG000|Overall Study|Study Terminated by Sponsor|24|||
105348390|NCT01672294|363277059|FG003|Overall Study|Lost to Follow-up|9|||
105696867|NCT03794583|364554444|FG000|Overall Study|Withdrawal by Subject|9|||
105696868|NCT01735279|364554447|FG000|Overall Study|Lost to Follow-up|11|||
105696869|NCT01735279|364554448|FG001|Overall Study|Lost to Follow-up|8|||
105696870|NCT01368536|364554449|FG000|Overall Study|Adverse Event|5|||
105696871|NCT01368536|364554450|FG001|Overall Study|Adverse Event|6|||
105696872|NCT01368536|364554451|FG002|Overall Study|Adverse Event|8|||
105696873|NCT01368536|364554449|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105696874|NCT01368536|364554450|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105696875|NCT01368536|364554451|FG002|Overall Study|Abnormal laboratory value(s)|2|||
105696876|NCT01368536|364554449|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105696877|NCT01368536|364554450|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105696878|NCT01368536|364554451|FG002|Overall Study|Abnormal test procedure result(s)|1|||
105696879|NCT01368536|364554449|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
105696880|NCT01368536|364554450|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105696881|NCT01368536|364554451|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
105696882|NCT01368536|364554449|FG000|Overall Study|No longer required study medication|0|||
105696883|NCT01368536|364554450|FG001|Overall Study|No longer required study medication|0|||
105696884|NCT01368536|364554451|FG002|Overall Study|No longer required study medication|1|||
105696885|NCT01368536|364554449|FG000|Overall Study|Withdrawal by Subject|2|||
105696886|NCT01368536|364554450|FG001|Overall Study|Withdrawal by Subject|5|||
105696887|NCT01368536|364554451|FG002|Overall Study|Withdrawal by Subject|4|||
105696888|NCT01368536|364554449|FG000|Overall Study|Lost to Follow-up|3|||
105696889|NCT01368536|364554450|FG001|Overall Study|Lost to Follow-up|3|||
105696890|NCT01368536|364554451|FG002|Overall Study|Lost to Follow-up|5|||
105696891|NCT01368536|364554449|FG000|Overall Study|Administrative problems|34|||
105696892|NCT01368536|364554450|FG001|Overall Study|Administrative problems|39|||
105696893|NCT01368536|364554451|FG002|Overall Study|Administrative problems|35|||
105696894|NCT01368536|364554449|FG000|Overall Study|Protocol deviation|0|||
105696895|NCT01368536|364554450|FG001|Overall Study|Protocol deviation|3|||
105696896|NCT01368536|364554451|FG002|Overall Study|Protocol deviation|1|||
105696897|NCT00496730|364554452|FG000|Overall Study|Lost to Follow-up|4|||
105696898|NCT00496730|364554453|FG001|Overall Study|Lost to Follow-up|3|||
105696899|NCT00496730|364554452|FG000|Overall Study|Withdrawal by Subject|2|||
105696900|NCT00496730|364554453|FG001|Overall Study|Withdrawal by Subject|2|||
105696901|NCT03962738|364554458|FG000|Overall Study|Protocol Deviation|3|||
105696902|NCT03962738|364554459|FG001|Overall Study|Protocol Deviation|0|||
105696903|NCT03962738|364554460|FG002|Overall Study|Protocol Deviation|1|||
105696904|NCT03962738|364554461|FG003|Overall Study|Protocol Deviation|1|||
105696905|NCT03962738|364554458|FG000|Overall Study|Withdrawal by Subject|4|||
105696906|NCT03962738|364554459|FG001|Overall Study|Withdrawal by Subject|0|||
105696907|NCT03962738|364554460|FG002|Overall Study|Withdrawal by Subject|0|||
105696908|NCT03962738|364554461|FG003|Overall Study|Withdrawal by Subject|0|||
105696909|NCT03962738|364554458|FG000|Overall Study|Lost to Follow-up|0|||
105696910|NCT03962738|364554459|FG001|Overall Study|Lost to Follow-up|0|||
105696911|NCT03962738|364554460|FG002|Overall Study|Lost to Follow-up|1|||
105696912|NCT03962738|364554461|FG003|Overall Study|Lost to Follow-up|0|||
105696913|NCT00509067|364554462|FG000|Overall Study|Lost to Follow-up|1|||
105696914|NCT00509067|364554463|FG001|Overall Study|Lost to Follow-up|1|||
105696915|NCT00509067|364554462|FG000|Overall Study|Adverse Event|3|||
105696916|NCT00509067|364554463|FG001|Overall Study|Adverse Event|1|||
105696917|NCT00509067|364554462|FG000|Overall Study|Protocol Violation|0|||
105696918|NCT00509067|364554463|FG001|Overall Study|Protocol Violation|3|||
105696919|NCT00131469|364554464|FG000|Overall Study|Withdrawal by Subject|3|||
105696920|NCT00131469|364554465|FG001|Overall Study|Withdrawal by Subject|4|||
105696921|NCT00131469|364554464|FG000|Overall Study|Protocol Violation|3|||
105696922|NCT00131469|364554465|FG001|Overall Study|Protocol Violation|1|||
105696923|NCT00131469|364554464|FG000|Overall Study|Death|0|||
105696924|NCT00131469|364554465|FG001|Overall Study|Death|1|||
105696925|NCT00131469|364554464|FG000|Overall Study|Lost to Follow-up|0|||
105696926|NCT00131469|364554465|FG001|Overall Study|Lost to Follow-up|1|||
105696927|NCT00131469|364554464|FG000|Overall Study|scan not analyzable|3|||
105696928|NCT00131469|364554465|FG001|Overall Study|scan not analyzable|6|||
105696929|NCT02247960|364554467|FG000|Patient Consent and Randomization|Physician Decision|2|||
105696930|NCT02247960|364554468|FG001|Patient Consent and Randomization|Physician Decision|2|||
105696931|NCT02247960|364554467|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
105696932|NCT02247960|364554468|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
105696933|NCT02247960|364554467|FG000|Catheter Removed|Lost to Follow-up|7|||
105696934|NCT02247960|364554468|FG001|Catheter Removed|Lost to Follow-up|10|||
105696935|NCT00702325|364554469|FG000|Overall Study|Adverse Event|1|||
105696936|NCT00702325|364554470|FG001|Overall Study|Adverse Event|0|||
105696937|NCT00702325|364554469|FG000|Overall Study|Withdrawal by Subject|7|||
105696938|NCT00702325|364554470|FG001|Overall Study|Withdrawal by Subject|7|||
105696939|NCT00702325|364554469|FG000|Overall Study|Lost to Follow-up|3|||
105696940|NCT00702325|364554470|FG001|Overall Study|Lost to Follow-up|4|||
105696941|NCT00702325|364554469|FG000|Overall Study|Incorrect enrollment|5|||
105696942|NCT00702325|364554470|FG001|Overall Study|Incorrect enrollment|7|||
105696943|NCT00702325|364554469|FG000|Overall Study|Developed study discontinuation criteria|18|||
105696944|NCT00702325|364554470|FG001|Overall Study|Developed study discontinuation criteria|28|||
105696945|NCT00702325|364554469|FG000|Overall Study|Severe noncompliance to protocol|3|||
105696946|NCT00702325|364554470|FG001|Overall Study|Severe noncompliance to protocol|3|||
105696947|NCT00702325|364554469|FG000|Overall Study|Termination due to lab results|1|||
105696948|NCT00702325|364554470|FG001|Overall Study|Termination due to lab results|0|||
105696949|NCT00702325|364554469|FG000|Overall Study|Didn't follow study medication dosage|0|||
105696950|NCT00702325|364554470|FG001|Overall Study|Didn't follow study medication dosage|2|||
105696951|NCT00702325|364554469|FG000|Overall Study|Withdrew consent|0|||
105696952|NCT00702325|364554470|FG001|Overall Study|Withdrew consent|1|||
105696953|NCT00702325|364554469|FG000|Overall Study|Incorrectly Discontinued|0|||
105696954|NCT00702325|364554470|FG001|Overall Study|Incorrectly Discontinued|1|||
105696955|NCT00736034|364554476|FG000|Overall Study|Adverse Event|2|||
105696956|NCT01022502|364554480|FG000|Overall Study|Adverse Event|1|||
105696957|NCT01022502|364554480|FG000|Overall Study|employment related reasons|1|||
105696958|NCT01022502|364554480|FG000|Overall Study|Withdrawal by Subject|1|||
105696959|NCT03716050|364554481|FG000|Overall Study|Lost to Follow-up|0|||
105696960|NCT03716050|364554482|FG001|Overall Study|Lost to Follow-up|0|||
105696961|NCT03716050|364554483|FG002|Overall Study|Lost to Follow-up|1|||
105696962|NCT03716050|364554484|FG003|Overall Study|Lost to Follow-up|0|||
105696963|NCT03716050|364554485|FG004|Overall Study|Lost to Follow-up|0|||
105696964|NCT03716050|364554486|FG005|Overall Study|Lost to Follow-up|0|||
105696965|NCT03716050|364554487|FG006|Overall Study|Lost to Follow-up|0|||
105696966|NCT03716050|364554488|FG007|Overall Study|Lost to Follow-up|0|||
105696967|NCT03716050|364554481|FG000|Overall Study|Physician Decision|0|||
105696968|NCT03716050|364554482|FG001|Overall Study|Physician Decision|0|||
105696969|NCT03716050|364554483|FG002|Overall Study|Physician Decision|0|||
105696970|NCT03716050|364554484|FG003|Overall Study|Physician Decision|1|||
105696971|NCT03716050|364554485|FG004|Overall Study|Physician Decision|0|||
105696972|NCT03716050|364554486|FG005|Overall Study|Physician Decision|0|||
105696973|NCT03716050|364554487|FG006|Overall Study|Physician Decision|0|||
105696974|NCT03716050|364554488|FG007|Overall Study|Physician Decision|0|||
105696975|NCT03716050|364554481|FG000|Overall Study|Protocol Violation|0|||
105696976|NCT03716050|364554482|FG001|Overall Study|Protocol Violation|0|||
105696977|NCT03716050|364554483|FG002|Overall Study|Protocol Violation|0|||
105696978|NCT03716050|364554484|FG003|Overall Study|Protocol Violation|1|||
105696979|NCT03716050|364554485|FG004|Overall Study|Protocol Violation|0|||
105696980|NCT03716050|364554486|FG005|Overall Study|Protocol Violation|0|||
105696981|NCT03716050|364554487|FG006|Overall Study|Protocol Violation|0|||
105696982|NCT03716050|364554488|FG007|Overall Study|Protocol Violation|2|||
105696983|NCT02361944|364554489|FG000|Overall Study|surgery cancellation|0|||
105696984|NCT02361944|364554490|FG001|Overall Study|surgery cancellation|1|||
105696985|NCT02463071|364554491|FG000|Overall Study|Adverse Event|3|||
105696986|NCT02463071|364554492|FG001|Overall Study|Adverse Event|5|||
105696987|NCT02463071|364554493|FG002|Overall Study|Adverse Event|1|||
105696988|NCT02463071|364554491|FG000|Overall Study|Death|1|||
105696989|NCT02463071|364554492|FG001|Overall Study|Death|0|||
105696990|NCT02463071|364554493|FG002|Overall Study|Death|0|||
105696991|NCT02463071|364554491|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
105696992|NCT02463071|364554492|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105696993|NCT02463071|364554493|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
105696994|NCT02463071|364554491|FG000|Overall Study|Reason not specified|7|||
105696995|NCT02463071|364554492|FG001|Overall Study|Reason not specified|9|||
105696996|NCT02463071|364554493|FG002|Overall Study|Reason not specified|4|||
105696997|NCT02463071|364554491|FG000|Overall Study|Protocol Violation|0|||
105696998|NCT02463071|364554492|FG001|Overall Study|Protocol Violation|2|||
105696999|NCT02463071|364554493|FG002|Overall Study|Protocol Violation|0|||
105697000|NCT02463071|364554491|FG000|Overall Study|Lost to Follow-up|0|||
105697001|NCT02463071|364554492|FG001|Overall Study|Lost to Follow-up|0|||
105697002|NCT02463071|364554493|FG002|Overall Study|Lost to Follow-up|1|||
105697003|NCT00073528|364554494|FG000|Overall Study|Death|488|||
105348391|NCT02854605|363277068|FG000|Overall Study|Adverse Event|1|||
105348392|NCT02854605|363277069|FG001|Overall Study|Adverse Event|5|||
105697004|NCT00073528|364554495|FG001|Overall Study|Death|473|||
105697005|NCT00073528|364554494|FG000|Overall Study|Lost to Follow-up|52|||
105697006|NCT00073528|364554495|FG001|Overall Study|Lost to Follow-up|45|||
105697007|NCT00073528|364554494|FG000|Overall Study|Withdrawal by Subject|50|||
105697008|NCT00073528|364554495|FG001|Overall Study|Withdrawal by Subject|45|||
105697009|NCT00073528|364554494|FG000|Overall Study|Study terminated by Sponsor|10|||
105697010|NCT00073528|364554495|FG001|Overall Study|Study terminated by Sponsor|29|||
105697011|NCT00073528|364554494|FG000|Overall Study|Other|18|||
105697012|NCT00073528|364554495|FG001|Overall Study|Other|19|||
105697013|NCT00073528|364554494|FG000|Overall Study|Other|9|||
105697014|NCT00073528|364554495|FG001|Overall Study|Other|12|||
105697015|NCT00073528|364554494|FG000|Overall Study|Protocol Violation|3|||
105697016|NCT00073528|364554495|FG001|Overall Study|Protocol Violation|5|||
105697017|NCT03086057|364554496|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
105697018|NCT03086057|364554497|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
105697019|NCT03086057|364554498|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
105348393|NCT02854605|363277070|FG002|Overall Study|Adverse Event|2|||
105697020|NCT03086057|364554499|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
105697021|NCT03086057|364554496|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
105697022|NCT03086057|364554497|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
105697023|NCT03086057|364554498|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
105697024|NCT03086057|364554499|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
105697025|NCT03086057|364554496|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
105697026|NCT03086057|364554497|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
105697027|NCT03086057|364554498|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
105697028|NCT03086057|364554499|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
105697029|NCT03086057|364554496|FG000|Stage 1: PrEP Uptake|Death|1|||
105697030|NCT03086057|364554497|FG001|Stage 1: PrEP Uptake|Death|0|||
105697031|NCT03086057|364554498|FG002|Stage 1: PrEP Uptake|Death|0|||
105697032|NCT03086057|364554499|FG003|Stage 1: PrEP Uptake|Death|0|||
105697033|NCT03086057|364554496|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
105697034|NCT03086057|364554497|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
105697035|NCT03086057|364554498|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
105697036|NCT03086057|364554499|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
105697037|NCT03086057|364554496|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
105697038|NCT03086057|364554497|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
105697039|NCT03086057|364554498|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
105697040|NCT03086057|364554499|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
105697041|NCT03086057|364554496|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
105697042|NCT03086057|364554497|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
105697043|NCT03086057|364554498|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
105697044|NCT03086057|364554499|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
105697045|NCT00199836|364554504|FG000|Overall Study|Progressive Disease|5|||
105697046|NCT00199836|364554504|FG000|Overall Study|Death|1|||
105697047|NCT02101021|364554507|FG000|Overall Study|Death|4|||
105697048|NCT02101021|364554508|FG001|Overall Study|Death|3|||
105697049|NCT02101021|364554509|FG002|Overall Study|Death|6|||
105697050|NCT02101021|364554510|FG003|Overall Study|Death|0|||
105697051|NCT02101021|364554511|FG004|Overall Study|Death|3|||
105697052|NCT02101021|364554507|FG000|Overall Study|Withdrew Consent from study|1|||
105697053|NCT02101021|364554508|FG001|Overall Study|Withdrew Consent from study|1|||
105697054|NCT02101021|364554509|FG002|Overall Study|Withdrew Consent from study|0|||
105697055|NCT02101021|364554510|FG003|Overall Study|Withdrew Consent from study|2|||
105697056|NCT02101021|364554511|FG004|Overall Study|Withdrew Consent from study|0|||
105697057|NCT02101021|364554507|FG000|Overall Study|Lost to Follow-up|1|||
105697058|NCT02101021|364554508|FG001|Overall Study|Lost to Follow-up|0|||
105697059|NCT02101021|364554509|FG002|Overall Study|Lost to Follow-up|0|||
105697060|NCT02101021|364554510|FG003|Overall Study|Lost to Follow-up|0|||
105697061|NCT02101021|364554511|FG004|Overall Study|Lost to Follow-up|0|||
105697062|NCT02101021|364554507|FG000|Overall Study|Study Terminated by Sponsor|1|||
105697063|NCT02101021|364554508|FG001|Overall Study|Study Terminated by Sponsor|0|||
105697064|NCT02101021|364554509|FG002|Overall Study|Study Terminated by Sponsor|1|||
105697065|NCT02101021|364554510|FG003|Overall Study|Study Terminated by Sponsor|1|||
105697066|NCT02101021|364554511|FG004|Overall Study|Study Terminated by Sponsor|1|||
105697067|NCT01235793|364554512|FG000|Overall Study|Death|6|||
105697068|NCT01770912|364554513|FG000|Overall Study|Lost to Follow-up|2|||
105697069|NCT01770912|364554514|FG001|Overall Study|Lost to Follow-up|0|||
105697070|NCT04695392|364554515|FG000|Overall Study|Withdrawn by parent/guardian|0|||
105697071|NCT04695392|364554516|FG001|Overall Study|Withdrawn by parent/guardian|1|||
105697072|NCT04695392|364554515|FG000|Overall Study|Withdrawn by physician|0|||
105697073|NCT04695392|364554516|FG001|Overall Study|Withdrawn by physician|1|||
105697074|NCT01536951|364554517|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697075|NCT01536951|364554518|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697076|NCT01536951|364554519|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
105697077|NCT01536951|364554520|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697078|NCT01536951|364554521|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697079|NCT01536951|364554522|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697080|NCT01536951|364554523|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697081|NCT01536951|364554524|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697082|NCT01536951|364554525|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697083|NCT01536951|364554517|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
105697084|NCT01536951|364554518|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
105697085|NCT01536951|364554519|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
105697086|NCT01536951|364554520|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
105697087|NCT01536951|364554521|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
105697088|NCT01536951|364554522|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
105697089|NCT01536951|364554523|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
105697090|NCT01536951|364554524|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
105697091|NCT01536951|364554525|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
105697092|NCT01843972|364554526|FG000|Overall Study|Withdrawal by Subject|0|||
105697093|NCT01843972|364554527|FG001|Overall Study|Withdrawal by Subject|0|||
105697094|NCT01843972|364554528|FG002|Overall Study|Withdrawal by Subject|0|||
105697095|NCT01843972|364554529|FG003|Overall Study|Withdrawal by Subject|0|||
105697096|NCT01843972|364554530|FG004|Overall Study|Withdrawal by Subject|1|||
105697097|NCT01843972|364554531|FG005|Overall Study|Withdrawal by Subject|0|||
105697098|NCT01843972|364554532|FG006|Overall Study|Withdrawal by Subject|0|||
105697099|NCT01843972|364554533|FG007|Overall Study|Withdrawal by Subject|0|||
105697100|NCT01843972|364554534|FG008|Overall Study|Withdrawal by Subject|0|||
105697101|NCT01843972|364554535|FG009|Overall Study|Withdrawal by Subject|0|||
105697102|NCT00555477|364554538|FG000|Overall Study|Adverse Event|0|||
105697103|NCT00555477|364554539|FG001|Overall Study|Adverse Event|9|||
105697104|NCT00555477|364554538|FG000|Overall Study|Withdrawal by Subject|1|||
105697105|NCT00555477|364554539|FG001|Overall Study|Withdrawal by Subject|2|||
105697106|NCT00555477|364554538|FG000|Overall Study|Physician Decision|1|||
105697107|NCT00555477|364554539|FG001|Overall Study|Physician Decision|2|||
105697108|NCT01817751|364554540|FG000|Overall Study|Physician Decision|1|||
105697109|NCT00382018|364554541|FG000|Overall Study|Progression|0|||
105697110|NCT00382018|364554542|FG001|Overall Study|Progression|136|||
105697111|NCT00382018|364554543|FG002|Overall Study|Progression|51|||
105697112|NCT00382018|364554544|FG003|Overall Study|Progression|43|||
105697113|NCT00382018|364554541|FG000|Overall Study|Death|0|||
105697114|NCT00382018|364554542|FG001|Overall Study|Death|9|||
105697115|NCT00382018|364554543|FG002|Overall Study|Death|7|||
105697116|NCT00382018|364554544|FG003|Overall Study|Death|11|||
105697117|NCT00382018|364554541|FG000|Overall Study|Withdrawal by Subject|0|||
105697118|NCT00382018|364554542|FG001|Overall Study|Withdrawal by Subject|4|||
105697119|NCT00382018|364554543|FG002|Overall Study|Withdrawal by Subject|3|||
105697120|NCT00382018|364554544|FG003|Overall Study|Withdrawal by Subject|4|||
105697121|NCT00382018|364554541|FG000|Overall Study|Other, not protocol specified|0|||
105697122|NCT00382018|364554542|FG001|Overall Study|Other, not protocol specified|16|||
105697123|NCT00382018|364554543|FG002|Overall Study|Other, not protocol specified|3|||
105697124|NCT00382018|364554544|FG003|Overall Study|Other, not protocol specified|1|||
105697125|NCT01846624|364554545|FG000|Overall Study|Died during induction, no midostaurin|1|||
105697126|NCT01721057|364554548|FG000|Treatment Period|Withdrawal by Subject|11|||
105697127|NCT01721057|364554549|FG001|Treatment Period|Withdrawal by Subject|5|||
105697128|NCT01721057|364554550|FG002|Treatment Period|Withdrawal by Subject|8|||
105697129|NCT01721057|364554551|FG003|Treatment Period|Withdrawal by Subject|0|||
105697130|NCT01721057|364554552|FG004|Treatment Period|Withdrawal by Subject|0|||
105697131|NCT01721057|364554553|FG005|Treatment Period|Withdrawal by Subject|0|||
105697132|NCT01721057|364554554|FG006|Treatment Period|Withdrawal by Subject|0|||
105697133|NCT01721057|364554548|FG000|Treatment Period|Adverse Event|7|||
105697134|NCT01721057|364554549|FG001|Treatment Period|Adverse Event|10|||
105697135|NCT01721057|364554550|FG002|Treatment Period|Adverse Event|12|||
105697136|NCT01721057|364554551|FG003|Treatment Period|Adverse Event|0|||
105697137|NCT01721057|364554552|FG004|Treatment Period|Adverse Event|0|||
105697138|NCT01721057|364554553|FG005|Treatment Period|Adverse Event|0|||
105697139|NCT01721057|364554554|FG006|Treatment Period|Adverse Event|0|||
105697140|NCT01721057|364554548|FG000|Treatment Period|Lack of Efficacy|7|||
105697141|NCT01721057|364554549|FG001|Treatment Period|Lack of Efficacy|3|||
105697142|NCT01721057|364554550|FG002|Treatment Period|Lack of Efficacy|0|||
105697143|NCT01721057|364554551|FG003|Treatment Period|Lack of Efficacy|0|||
105697144|NCT01721057|364554552|FG004|Treatment Period|Lack of Efficacy|0|||
105697145|NCT01721057|364554553|FG005|Treatment Period|Lack of Efficacy|0|||
105697146|NCT01721057|364554554|FG006|Treatment Period|Lack of Efficacy|0|||
105697147|NCT01721057|364554548|FG000|Treatment Period|Lost to Follow-up|1|||
105473599|NCT05141448|363745414|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
105697148|NCT01721057|364554549|FG001|Treatment Period|Lost to Follow-up|0|||
105697149|NCT01721057|364554550|FG002|Treatment Period|Lost to Follow-up|0|||
105697150|NCT01721057|364554551|FG003|Treatment Period|Lost to Follow-up|0|||
105697151|NCT01721057|364554552|FG004|Treatment Period|Lost to Follow-up|0|||
105697152|NCT01721057|364554553|FG005|Treatment Period|Lost to Follow-up|0|||
105697153|NCT01721057|364554554|FG006|Treatment Period|Lost to Follow-up|0|||
105473600|NCT05141448|363745415|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
105473601|NCT01006291|363746987|FG000|Overall Study|Adverse Event|2|||
105473602|NCT01006291|363746988|FG001|Overall Study|Adverse Event|1|||
105697154|NCT01721057|364554548|FG000|Treatment Period|Physician Decision|0|||
105697155|NCT01721057|364554549|FG001|Treatment Period|Physician Decision|1|||
105697156|NCT01721057|364554550|FG002|Treatment Period|Physician Decision|3|||
105806510|NCT03038113|364949004|FG004|Overall Study|Withdrawal by Subject|0|||
105473603|NCT01006291|363746989|FG002|Overall Study|Adverse Event|2|||
105697157|NCT01721057|364554551|FG003|Treatment Period|Physician Decision|0|||
105697158|NCT01721057|364554552|FG004|Treatment Period|Physician Decision|0|||
105697159|NCT01721057|364554553|FG005|Treatment Period|Physician Decision|0|||
105697160|NCT01721057|364554554|FG006|Treatment Period|Physician Decision|0|||
105697161|NCT01721057|364554548|FG000|Treatment Period|Death|2|||
105697162|NCT01721057|364554549|FG001|Treatment Period|Death|0|||
105697163|NCT01721057|364554550|FG002|Treatment Period|Death|0|||
105697164|NCT01721057|364554551|FG003|Treatment Period|Death|0|||
105697165|NCT01721057|364554552|FG004|Treatment Period|Death|0|||
105697166|NCT01721057|364554553|FG005|Treatment Period|Death|0|||
105697167|NCT01721057|364554554|FG006|Treatment Period|Death|0|||
105697168|NCT01721057|364554548|FG000|Rescue Period|Adverse Event|0|||
105697169|NCT01721057|364554549|FG001|Rescue Period|Adverse Event|0|||
105697170|NCT01721057|364554550|FG002|Rescue Period|Adverse Event|0|||
105697171|NCT01721057|364554551|FG003|Rescue Period|Adverse Event|1|||
105697172|NCT01721057|364554552|FG004|Rescue Period|Adverse Event|0|||
105697173|NCT01721057|364554553|FG005|Rescue Period|Adverse Event|0|||
105697174|NCT01721057|364554554|FG006|Rescue Period|Adverse Event|0|||
105697175|NCT01721057|364554548|FG000|Rescue Period|Lack of Efficacy|0|||
105697176|NCT01721057|364554549|FG001|Rescue Period|Lack of Efficacy|0|||
105697177|NCT01721057|364554550|FG002|Rescue Period|Lack of Efficacy|0|||
105697178|NCT01721057|364554551|FG003|Rescue Period|Lack of Efficacy|2|||
105697179|NCT01721057|364554552|FG004|Rescue Period|Lack of Efficacy|0|||
105697180|NCT01721057|364554553|FG005|Rescue Period|Lack of Efficacy|0|||
105697181|NCT01721057|364554554|FG006|Rescue Period|Lack of Efficacy|0|||
105697182|NCT01889238|364554560|FG000|Overall Study|Death|1|||
105697183|NCT01889238|364554560|FG000|Overall Study|Withdrawal by Subject|1|||
105697184|NCT01889238|364554560|FG000|Overall Study|Adverse Event|6|||
105697185|NCT01889238|364554560|FG000|Overall Study|Disease Progression|104|||
105697186|NCT01889238|364554560|FG000|Overall Study|Other|6|||
105697187|NCT02717754|364554563|FG000|Overall Study|Incorrect Infusion Duration|0|||
105697188|NCT02717754|364554564|FG001|Overall Study|Incorrect Infusion Duration|0|||
105697189|NCT02717754|364554565|FG002|Overall Study|Incorrect Infusion Duration|0|||
105697190|NCT02717754|364554566|FG003|Overall Study|Incorrect Infusion Duration|10|||
105697191|NCT02717754|364554567|FG004|Overall Study|Incorrect Infusion Duration|20|||
105697192|NCT02717754|364554568|FG005|Overall Study|Incorrect Infusion Duration|20|||
105697193|NCT02592018|364554571|FG000|Overall Study|Adverse Event|1|||
105697194|NCT02592018|364554571|FG000|Overall Study|Lost to Follow-up|1|||
105697195|NCT02710136|364554572|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
105697196|NCT02710136|364554573|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
105697197|NCT00418665|364554574|FG000|Treatment Period|Ineligibility determined|1|||
105697198|NCT00418665|364554575|FG001|Treatment Period|Ineligibility determined|1|||
105697199|NCT00418665|364554576|FG002|Treatment Period|Ineligibility determined|0|||
105697200|NCT00418665|364554574|FG000|Treatment Period|Adverse Event|2|||
105697201|NCT00418665|364554575|FG001|Treatment Period|Adverse Event|2|||
105697202|NCT00418665|364554576|FG002|Treatment Period|Adverse Event|0|||
105697203|NCT00418665|364554574|FG000|Treatment Period|Withdrawal by Subject|0|||
105348394|NCT02854605|363277068|FG000|Overall Study|Lost to Follow-up|0|||
105348395|NCT02854605|363277069|FG001|Overall Study|Lost to Follow-up|2|||
105348396|NCT02854605|363277070|FG002|Overall Study|Lost to Follow-up|0|||
105348397|NCT02854605|363277068|FG000|Overall Study|Withdrew Consent|1|||
105348398|NCT02854605|363277069|FG001|Overall Study|Withdrew Consent|0|||
105348399|NCT02854605|363277070|FG002|Overall Study|Withdrew Consent|1|||
105348400|NCT02854605|363277068|FG000|Overall Study|Investigator's Discretion|1|||
105348401|NCT02854605|363277069|FG001|Overall Study|Investigator's Discretion|0|||
105348402|NCT02854605|363277070|FG002|Overall Study|Investigator's Discretion|0|||
105348403|NCT02854605|363277068|FG000|Overall Study|Protocol Violation|0|||
105348404|NCT02854605|363277069|FG001|Overall Study|Protocol Violation|0|||
105348405|NCT02854605|363277070|FG002|Overall Study|Protocol Violation|1|||
105348406|NCT00568334|363277075|FG000|Overall Study|Withdrawal by Subject|0|||
105348407|NCT00568334|363277076|FG001|Overall Study|Withdrawal by Subject|1|||
105348408|NCT00568334|363277075|FG000|Overall Study|Lost to Follow-up|1|||
105348409|NCT00568334|363277076|FG001|Overall Study|Lost to Follow-up|0|||
105348410|NCT01897571|363277077|FG000|Overall Study|Lost to Follow-up|3|||
105348411|NCT01897571|363277078|FG001|Overall Study|Lost to Follow-up|0|||
105348412|NCT01897571|363277079|FG002|Overall Study|Lost to Follow-up|0|||
105348413|NCT01897571|363277080|FG003|Overall Study|Lost to Follow-up|0|||
105348414|NCT01897571|363277081|FG004|Overall Study|Lost to Follow-up|2|||
105348415|NCT01897571|363277082|FG005|Overall Study|Lost to Follow-up|0|||
105348416|NCT01897571|363277083|FG006|Overall Study|Lost to Follow-up|0|||
105348417|NCT01897571|363277084|FG007|Overall Study|Lost to Follow-up|0|||
105348418|NCT01897571|363277085|FG008|Overall Study|Lost to Follow-up|1|||
105697204|NCT00418665|364554575|FG001|Treatment Period|Withdrawal by Subject|3|||
105697205|NCT00418665|364554576|FG002|Treatment Period|Withdrawal by Subject|1|||
105697206|NCT00418665|364554574|FG000|Treatment Period|Requirement for alternative therapy|1|||
105697207|NCT00418665|364554575|FG001|Treatment Period|Requirement for alternative therapy|0|||
105697208|NCT00418665|364554576|FG002|Treatment Period|Requirement for alternative therapy|0|||
105697209|NCT00418665|364554574|FG000|Treatment Period|Physician Decision|1|||
105697210|NCT00418665|364554575|FG001|Treatment Period|Physician Decision|0|||
105697211|NCT00418665|364554576|FG002|Treatment Period|Physician Decision|3|||
105697212|NCT00418665|364554574|FG000|Treatment Extension|Adverse Event|1|||
105348419|NCT01897571|363277086|FG009|Overall Study|Lost to Follow-up|2|||
105348420|NCT01897571|363277087|FG010|Overall Study|Lost to Follow-up|4|||
105348421|NCT01897571|363277077|FG000|Overall Study|Withdrawal by Subject|0|||
105348422|NCT01897571|363277078|FG001|Overall Study|Withdrawal by Subject|0|||
105697213|NCT00418665|364554575|FG001|Treatment Extension|Adverse Event|0|||
105697214|NCT00418665|364554576|FG002|Treatment Extension|Adverse Event|0|||
105697215|NCT00418665|364554574|FG000|Treatment Extension|Withdrawal by Subject|1|||
105697216|NCT00418665|364554575|FG001|Treatment Extension|Withdrawal by Subject|0|||
105697217|NCT00418665|364554576|FG002|Treatment Extension|Withdrawal by Subject|0|||
105697218|NCT00418665|364554574|FG000|Treatment Extension|Requirement for alternative therapy|2|||
105697219|NCT00418665|364554575|FG001|Treatment Extension|Requirement for alternative therapy|2|||
105697220|NCT00418665|364554576|FG002|Treatment Extension|Requirement for alternative therapy|0|||
105697221|NCT00418665|364554574|FG000|Treatment Extension|Physician Decision|2|||
105697222|NCT00418665|364554575|FG001|Treatment Extension|Physician Decision|2|||
105697223|NCT00418665|364554576|FG002|Treatment Extension|Physician Decision|1|||
105697224|NCT00418665|364554574|FG000|Treatment Extension|Death|0|||
105697225|NCT00418665|364554575|FG001|Treatment Extension|Death|0|||
105697226|NCT00418665|364554576|FG002|Treatment Extension|Death|1|||
105697227|NCT01133379|364554577|FG000|Overall Study|Withdrawal by Subject|0|||
105697228|NCT01133379|364554578|FG001|Overall Study|Withdrawal by Subject|1|||
105697229|NCT01133379|364554579|FG002|Overall Study|Withdrawal by Subject|1|||
105697230|NCT01133379|364554577|FG000|Overall Study|Lost to Follow-up|1|||
105697231|NCT01133379|364554578|FG001|Overall Study|Lost to Follow-up|1|||
105697232|NCT01133379|364554579|FG002|Overall Study|Lost to Follow-up|1|||
105697233|NCT00591214|364554580|FG000|Overall Study|Physician Decision|7|||
105697234|NCT00591214|364554580|FG000|Overall Study|Withdrawal by Subject|1|||
105697235|NCT00729378|364556082|FG000|Baseline|Did not complete study measurements|72|||
105697236|NCT00729378|364556083|FG001|Baseline|Did not complete study measurements|33|||
105697237|NCT00729378|364556082|FG000|Baseline|Withdrawal by Subject|66|||
105697238|NCT00729378|364556083|FG001|Baseline|Withdrawal by Subject|59|||
105697239|NCT00729378|364556082|FG000|12-months|Lost to Follow-up|100|||
105697240|NCT00729378|364556083|FG001|12-months|Lost to Follow-up|65|||
105697241|NCT00729378|364556082|FG000|24-months|Lost to Follow-up|72|||
105697242|NCT00729378|364556083|FG001|24-months|Lost to Follow-up|51|||
105697243|NCT00729378|364556082|FG000|36-months|Lost to Follow-up|15|||
105697244|NCT00729378|364556083|FG001|36-months|Lost to Follow-up|6|||
105697245|NCT02246582|364556086|FG000|Overall Study|Withdrawal by Subject|3|||
105697246|NCT02246582|364556087|FG001|Overall Study|Withdrawal by Subject|4|||
105697247|NCT00574145|364556088|FG000|Overall Study|Withdrawal by Subject|2|||
105697248|NCT00574145|364556089|FG001|Overall Study|Withdrawal by Subject|1|||
105697249|NCT00382720|364556091|FG000|Overall Study|Adverse Event|21|||
105697250|NCT00382720|364556092|FG001|Overall Study|Adverse Event|23|||
105697251|NCT00382720|364556093|FG002|Overall Study|Adverse Event|15|||
105697252|NCT00382720|364556091|FG000|Overall Study|Protocol Violation|2|||
105697253|NCT00382720|364556092|FG001|Overall Study|Protocol Violation|5|||
105697254|NCT00382720|364556093|FG002|Overall Study|Protocol Violation|1|||
105697255|NCT00382720|364556091|FG000|Overall Study|Death|0|||
105697256|NCT00382720|364556092|FG001|Overall Study|Death|1|||
105697257|NCT00382720|364556093|FG002|Overall Study|Death|2|||
105697258|NCT00382720|364556091|FG000|Overall Study|Progressive disease|37|||
105697259|NCT00382720|364556092|FG001|Overall Study|Progressive disease|28|||
105697260|NCT00382720|364556093|FG002|Overall Study|Progressive disease|38|||
105697261|NCT00382720|364556091|FG000|Overall Study|Withdrew consent|1|||
105697262|NCT00382720|364556092|FG001|Overall Study|Withdrew consent|1|||
105697263|NCT00382720|364556093|FG002|Overall Study|Withdrew consent|2|||
105697264|NCT00382720|364556091|FG000|Overall Study|Withdrawal by Subject|11|||
105697265|NCT00382720|364556092|FG001|Overall Study|Withdrawal by Subject|20|||
105697266|NCT00382720|364556093|FG002|Overall Study|Withdrawal by Subject|12|||
105697267|NCT00382720|364556091|FG000|Overall Study|Surgery|1|||
105697268|NCT00382720|364556092|FG001|Overall Study|Surgery|1|||
105697269|NCT00382720|364556093|FG002|Overall Study|Surgery|4|||
105697270|NCT00382720|364556091|FG000|Overall Study|Patient did not receive study medication|1|||
105697271|NCT00382720|364556092|FG001|Overall Study|Patient did not receive study medication|1|||
105697272|NCT00382720|364556093|FG002|Overall Study|Patient did not receive study medication|4|||
105697273|NCT00382720|364556091|FG000|Overall Study|Clinically progressive disease|0|||
105697274|NCT00382720|364556092|FG001|Overall Study|Clinically progressive disease|1|||
105697275|NCT00382720|364556093|FG002|Overall Study|Clinically progressive disease|0|||
105697276|NCT00382720|364556091|FG000|Overall Study|Good prognosis|0|||
105697277|NCT00382720|364556092|FG001|Overall Study|Good prognosis|1|||
105697278|NCT00382720|364556093|FG002|Overall Study|Good prognosis|0|||
105697279|NCT00382720|364556091|FG000|Overall Study|Investigator/Clinical decision|5|||
105697280|NCT00382720|364556092|FG001|Overall Study|Investigator/Clinical decision|6|||
105697281|NCT00382720|364556093|FG002|Overall Study|Investigator/Clinical decision|6|||
105697282|NCT00382720|364556091|FG000|Overall Study|Discontinued at end of study|0|||
105697283|NCT00382720|364556092|FG001|Overall Study|Discontinued at end of study|1|||
105697284|NCT00382720|364556093|FG002|Overall Study|Discontinued at end of study|2|||
105697285|NCT00682448|364556094|FG000|Overall Study|Adverse Event|1|||
105697286|NCT00682448|364556095|FG001|Overall Study|Adverse Event|2|||
105697287|NCT00682448|364556094|FG000|Overall Study|Lack of Efficacy|1|||
105697288|NCT00682448|364556095|FG001|Overall Study|Lack of Efficacy|0|||
105697289|NCT00682448|364556094|FG000|Overall Study|Lost to Follow-up|1|||
105697290|NCT00682448|364556095|FG001|Overall Study|Lost to Follow-up|3|||
105697291|NCT00682448|364556094|FG000|Overall Study|Pregnancy|0|||
105697292|NCT00682448|364556095|FG001|Overall Study|Pregnancy|1|||
105697293|NCT00682448|364556094|FG000|Overall Study|Withdrawal by Subject|2|||
105697294|NCT00682448|364556095|FG001|Overall Study|Withdrawal by Subject|0|||
105697295|NCT02737852|364556096|FG000|Overall Study|Withdrawal by Subject|2|||
105697296|NCT02592551|364556097|FG000|Overall Study|Not evaluable|1|||
105697297|NCT02592551|364556098|FG001|Overall Study|Not evaluable|3|||
105697298|NCT02592551|364556099|FG002|Overall Study|Not evaluable|0|||
105697299|NCT01876251|364556102|FG000|Overall Study|Clinical progression|1|||
105697300|NCT01876251|364556103|FG001|Overall Study|Clinical progression|0|||
105697301|NCT01876251|364556104|FG002|Overall Study|Clinical progression|0|||
105697302|NCT01876251|364556102|FG000|Overall Study|Death|2|||
105697303|NCT01876251|364556103|FG001|Overall Study|Death|0|||
105697304|NCT01876251|364556104|FG002|Overall Study|Death|1|||
105697305|NCT01876251|364556102|FG000|Overall Study|Participant started new treatment|1|||
105697306|NCT01876251|364556103|FG001|Overall Study|Participant started new treatment|0|||
105697307|NCT01876251|364556104|FG002|Overall Study|Participant started new treatment|1|||
105697308|NCT01876251|364556102|FG000|Overall Study|Participant refused further follow-up|0|||
105697309|NCT01876251|364556103|FG001|Overall Study|Participant refused further follow-up|0|||
105697310|NCT01876251|364556104|FG002|Overall Study|Participant refused further follow-up|1|||
105697311|NCT01876251|364556102|FG000|Overall Study|Study terminated|1|||
105697312|NCT01876251|364556103|FG001|Overall Study|Study terminated|0|||
105348423|NCT01897571|363277079|FG002|Overall Study|Withdrawal by Subject|0|||
105348424|NCT01897571|363277080|FG003|Overall Study|Withdrawal by Subject|0|||
105348425|NCT01897571|363277081|FG004|Overall Study|Withdrawal by Subject|0|||
105348426|NCT01897571|363277082|FG005|Overall Study|Withdrawal by Subject|0|||
105348427|NCT01897571|363277083|FG006|Overall Study|Withdrawal by Subject|0|||
105348428|NCT01897571|363277084|FG007|Overall Study|Withdrawal by Subject|1|||
105697313|NCT01876251|364556104|FG002|Overall Study|Study terminated|0|||
105697314|NCT01876251|364556102|FG000|Overall Study|Objective progression or relapse|10|||
105697315|NCT01876251|364556103|FG001|Overall Study|Objective progression or relapse|3|||
105697316|NCT01876251|364556104|FG002|Overall Study|Objective progression or relapse|8|||
105697317|NCT00761306|364556105|FG000|Overall Study|Adverse Event|5|||
105697318|NCT00761306|364556105|FG000|Overall Study|Lack of Efficacy|4|||
105697319|NCT00761306|364556105|FG000|Overall Study|Protocol Violation|2|||
105697320|NCT00761306|364556105|FG000|Overall Study|Withdrawal of Consent|3|||
105697321|NCT00761306|364556105|FG000|Overall Study|Lost to Follow-up|1|||
105697322|NCT00761306|364556105|FG000|Overall Study|Administrative or Other Reasons|5|||
105697323|NCT00268437|364556106|FG000|Overall Study|Ineligible|1|||
105697324|NCT05162027|364556109|FG000|Overall Study|Adverse Event|1|||
105697325|NCT05162027|364556110|FG001|Overall Study|Adverse Event|0|||
105697326|NCT03335163|364556111|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
105697327|NCT03335163|364556111|FG000|Overall Study|Withdrawal by Subject|18|||
105697328|NCT01704287|364556114|FG000|Initial Treatment Period|Death|139|||
105697329|NCT01704287|364556115|FG001|Initial Treatment Period|Death|129|||
105697330|NCT01704287|364556116|FG002|Initial Treatment Period|Death|71|||
105697331|NCT01704287|364556117|FG003|Initial Treatment Period|Death|0|||
105697332|NCT01704287|364556118|FG004|Initial Treatment Period|Death|0|||
105348429|NCT01897571|363277085|FG008|Overall Study|Withdrawal by Subject|4|||
105473604|NCT01006291|363746987|FG000|Overall Study|Lack of Efficacy|2|||
105697333|NCT01704287|364556114|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
105697334|NCT01704287|364556115|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
105697335|NCT01704287|364556116|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
105697336|NCT01704287|364556117|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
105697337|NCT01704287|364556118|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
105697338|NCT01704287|364556114|FG000|Initial Treatment Period|Lost to Follow-up|5|||
105697339|NCT01704287|364556115|FG001|Initial Treatment Period|Lost to Follow-up|3|||
105697340|NCT01704287|364556116|FG002|Initial Treatment Period|Lost to Follow-up|0|||
105697341|NCT01704287|364556117|FG003|Initial Treatment Period|Lost to Follow-up|0|||
105697342|NCT01704287|364556118|FG004|Initial Treatment Period|Lost to Follow-up|0|||
105697343|NCT01704287|364556114|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
105348430|NCT01897571|363277086|FG009|Overall Study|Withdrawal by Subject|3|||
105697344|NCT01704287|364556115|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
105697345|NCT01704287|364556116|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
105697346|NCT01704287|364556117|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
105697347|NCT01704287|364556118|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
105697348|NCT01704287|364556114|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
105697349|NCT01704287|364556115|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
105697350|NCT01704287|364556116|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
105697351|NCT01704287|364556117|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
105697352|NCT01704287|364556118|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
105697353|NCT01704287|364556114|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
105697354|NCT01704287|364556115|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
105697355|NCT01704287|364556116|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
105697356|NCT01704287|364556117|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
105697357|NCT01704287|364556118|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
105697358|NCT01704287|364556114|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
105697359|NCT01704287|364556115|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
105697360|NCT01704287|364556116|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
105697361|NCT01704287|364556117|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
105697362|NCT01704287|364556118|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
105348431|NCT01897571|363277087|FG010|Overall Study|Withdrawal by Subject|1|||
105697363|NCT04196803|364556119|FG000|Overall Study|Withdrawal by Subject|1|||
105697364|NCT04196803|364556120|FG001|Overall Study|Withdrawal by Subject|3|||
105697365|NCT04196803|364556119|FG000|Overall Study|Adverse Event|4|||
105697366|NCT04196803|364556120|FG001|Overall Study|Adverse Event|2|||
105348432|NCT01897571|363277077|FG000|Overall Study|Other|1|||
105348433|NCT01897571|363277078|FG001|Overall Study|Other|0|||
105348434|NCT01897571|363277079|FG002|Overall Study|Other|0|||
105348435|NCT01897571|363277080|FG003|Overall Study|Other|3|||
105348436|NCT01897571|363277081|FG004|Overall Study|Other|3|||
105348437|NCT01897571|363277082|FG005|Overall Study|Other|4|||
105348438|NCT01897571|363277083|FG006|Overall Study|Other|7|||
105348439|NCT01897571|363277084|FG007|Overall Study|Other|0|||
105348440|NCT01897571|363277085|FG008|Overall Study|Other|0|||
105697367|NCT04196803|364556119|FG000|Overall Study|Lost to Follow-up|0|||
105697368|NCT04196803|364556120|FG001|Overall Study|Lost to Follow-up|1|||
105697369|NCT04490395|364556121|FG000|Overall Study|Lost to Follow-up|0|||
105697370|NCT04490395|364556122|FG001|Overall Study|Lost to Follow-up|1|||
105697371|NCT01462435|364556126|FG000|Overall Study|Lack of Efficacy|1|||
105697372|NCT01462435|364556127|FG001|Overall Study|Lack of Efficacy|0|||
105697373|NCT01462435|364556128|FG002|Overall Study|Lack of Efficacy|0|||
105697374|NCT01462435|364556129|FG003|Overall Study|Lack of Efficacy|3|||
105697375|NCT01462435|364556126|FG000|Overall Study|Physician Decision|0|||
105697376|NCT01462435|364556127|FG001|Overall Study|Physician Decision|0|||
105697377|NCT01462435|364556128|FG002|Overall Study|Physician Decision|1|||
105697378|NCT01462435|364556129|FG003|Overall Study|Physician Decision|0|||
105697379|NCT01462435|364556126|FG000|Overall Study|Withdrawal by Subject|0|||
105697380|NCT01462435|364556127|FG001|Overall Study|Withdrawal by Subject|0|||
105697381|NCT01462435|364556128|FG002|Overall Study|Withdrawal by Subject|0|||
105697382|NCT01462435|364556129|FG003|Overall Study|Withdrawal by Subject|1|||
105697383|NCT01462435|364556126|FG000|Overall Study|Lost to Follow-up|0|||
105697384|NCT01462435|364556127|FG001|Overall Study|Lost to Follow-up|0|||
105697385|NCT01462435|364556128|FG002|Overall Study|Lost to Follow-up|0|||
105697386|NCT01462435|364556129|FG003|Overall Study|Lost to Follow-up|1|||
105697387|NCT03104075|364556131|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
105697388|NCT03104075|364556132|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
105697389|NCT03349775|364556133|FG000|Overall Study|Side Effects|1|||
105697390|NCT03349775|364556134|FG001|Overall Study|Side Effects|2|||
105697391|NCT03349775|364556133|FG000|Overall Study|Withdrawal by Subject|1|||
105697392|NCT03349775|364556134|FG001|Overall Study|Withdrawal by Subject|1|||
105697393|NCT03349775|364556133|FG000|Overall Study|No primary outcome measurements|0|||
105697394|NCT03349775|364556134|FG001|Overall Study|No primary outcome measurements|1|||
105697395|NCT01516970|364556135|FG000|Overall Study|Lost to Follow-up|7|||
105697396|NCT01516970|364556136|FG001|Overall Study|Lost to Follow-up|8|||
105697397|NCT01516970|364556135|FG000|Overall Study|Adverse Event|1|||
105697398|NCT01516970|364556136|FG001|Overall Study|Adverse Event|5|||
105697399|NCT01516970|364556135|FG000|Overall Study|Withdrawal by Subject|1|||
105697400|NCT01516970|364556136|FG001|Overall Study|Withdrawal by Subject|1|||
105697401|NCT01516970|364556135|FG000|Overall Study|Other|9|||
105697402|NCT01516970|364556136|FG001|Overall Study|Other|7|||
105697403|NCT02716675|364556138|FG000|Overall Study|Death|2|||
105697404|NCT02716675|364556139|FG001|Overall Study|Death|3|||
105697405|NCT02716675|364556140|FG002|Overall Study|Death|0|||
105348441|NCT01897571|363277086|FG009|Overall Study|Other|0|||
105348442|NCT01897571|363277087|FG010|Overall Study|Other|0|||
105348443|NCT01897571|363277077|FG000|Overall Study|Enrolled in rollover study|0|||
105473605|NCT01006291|363746988|FG001|Overall Study|Lack of Efficacy|2|||
105697406|NCT02716675|364556138|FG000|Overall Study|Physician Decision|2|||
105697407|NCT02716675|364556139|FG001|Overall Study|Physician Decision|1|||
105697408|NCT02716675|364556140|FG002|Overall Study|Physician Decision|1|||
105697409|NCT02716675|364556138|FG000|Overall Study|Lost to Follow-up|100|||
105697410|NCT02716675|364556139|FG001|Overall Study|Lost to Follow-up|87|||
105697411|NCT02716675|364556140|FG002|Overall Study|Lost to Follow-up|99|||
105697412|NCT02716675|364556138|FG000|Overall Study|Withdrawal by Subject|22|||
105697413|NCT02716675|364556139|FG001|Overall Study|Withdrawal by Subject|25|||
105697414|NCT02716675|364556140|FG002|Overall Study|Withdrawal by Subject|20|||
105697415|NCT02716675|364556138|FG000|Overall Study|Protocol Violation|0|||
105697416|NCT02716675|364556139|FG001|Overall Study|Protocol Violation|3|||
105697417|NCT02716675|364556140|FG002|Overall Study|Protocol Violation|1|||
105697418|NCT02716675|364556138|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
105697419|NCT02716675|364556139|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
105697420|NCT02716675|364556140|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
105697421|NCT02716675|364556138|FG000|Overall Study|Other|38|||
105697422|NCT02716675|364556139|FG001|Overall Study|Other|47|||
105697423|NCT02716675|364556140|FG002|Overall Study|Other|48|||
105697424|NCT01211535|364556143|FG000|Overall Study|Adverse Event|0|||
105697425|NCT01211535|364556144|FG001|Overall Study|Adverse Event|1|||
105697426|NCT01380730|364556150|FG000|Overall Study|Death|0|||
105697427|NCT01380730|364556151|FG001|Overall Study|Death|0|||
105697428|NCT01380730|364556152|FG002|Overall Study|Death|0|||
105697429|NCT01380730|364556153|FG003|Overall Study|Death|0|||
105697430|NCT01380730|364556154|FG004|Overall Study|Death|1|||
105697431|NCT01380730|364556155|FG005|Overall Study|Death|0|||
105697432|NCT01380730|364556156|FG006|Overall Study|Death|0|||
105697433|NCT01380730|364556157|FG007|Overall Study|Death|0|||
105697434|NCT05111041|364556159|FG000|Overall Study|Lost to Follow-up|6|||
105697435|NCT05111041|364556160|FG001|Overall Study|Lost to Follow-up|7|||
105697436|NCT05111041|364556159|FG000|Overall Study|Withdrawal by Subject|1|||
105697437|NCT05111041|364556160|FG001|Overall Study|Withdrawal by Subject|0|||
105697438|NCT01205230|364556161|FG000|Overall Study|Adverse Event|4|||
105697439|NCT01205230|364556162|FG001|Overall Study|Adverse Event|0|||
105697440|NCT01205230|364556161|FG000|Overall Study|Physician Decision|1|||
105697441|NCT01205230|364556162|FG001|Overall Study|Physician Decision|0|||
105697442|NCT00359021|364556163|FG000|Overall Study|Adverse Event|26|||
105697443|NCT00359021|364556164|FG001|Overall Study|Adverse Event|8|||
105697444|NCT00359021|364556163|FG000|Overall Study|Subject Non-Compliant|1|||
105697445|NCT00359021|364556164|FG001|Overall Study|Subject Non-Compliant|2|||
105697446|NCT00359021|364556163|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
105697447|NCT00359021|364556164|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
105697448|NCT00359021|364556163|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
105697449|NCT00359021|364556164|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
105697450|NCT00359021|364556163|FG000|Overall Study|Withdrawal by Subject|2|||
105697451|NCT00359021|364556164|FG001|Overall Study|Withdrawal by Subject|9|||
105697452|NCT00359021|364556163|FG000|Overall Study|Lost to Follow-up|1|||
105697453|NCT00359021|364556164|FG001|Overall Study|Lost to Follow-up|0|||
105697454|NCT00359021|364556163|FG000|Overall Study|Other|4|||
105697455|NCT00359021|364556164|FG001|Overall Study|Other|1|||
105697456|NCT00359021|364556163|FG000|Overall Study|Pregnancy|1|||
105697457|NCT00359021|364556164|FG001|Overall Study|Pregnancy|0|||
105697458|NCT01537198|364556172|FG000|Overall Study|RSV infection|2|||
105697459|NCT01537198|364556172|FG000|Overall Study|Adverse Event|4|||
105697460|NCT01537198|364556172|FG000|Overall Study|No Further Visits to the Clinic|37|||
105697461|NCT01537198|364556172|FG000|Overall Study|Other|111|||
105697462|NCT00766090|364556173|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697463|NCT00766090|364556174|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697464|NCT00766090|364556175|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697465|NCT00766090|364556176|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697466|NCT00766090|364556177|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105473606|NCT01006291|363746989|FG002|Overall Study|Lack of Efficacy|1|||
105697467|NCT00766090|364556178|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697468|NCT00766090|364556179|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697469|NCT00766090|364556180|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697470|NCT00766090|364556181|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
105697471|NCT00766090|364556182|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697472|NCT00766090|364556183|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697473|NCT00766090|364556184|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697474|NCT00766090|364556173|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
105697475|NCT00766090|364556174|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697476|NCT00766090|364556175|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697477|NCT00766090|364556176|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697478|NCT00766090|364556177|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697479|NCT00766090|364556178|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697480|NCT00766090|364556179|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697481|NCT00766090|364556180|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697482|NCT00766090|364556181|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697483|NCT00766090|364556182|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697484|NCT00766090|364556183|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697485|NCT00766090|364556184|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697486|NCT00766090|364556173|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
105697487|NCT00766090|364556174|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697488|NCT00766090|364556175|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697489|NCT00766090|364556176|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
105697490|NCT00766090|364556177|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697491|NCT00766090|364556178|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697492|NCT00766090|364556179|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697493|NCT00766090|364556180|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697494|NCT00766090|364556181|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697495|NCT00766090|364556182|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697496|NCT00766090|364556183|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697497|NCT00766090|364556184|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697498|NCT00766090|364556173|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697499|NCT00766090|364556174|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697500|NCT00766090|364556175|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
105697501|NCT00766090|364556176|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697502|NCT00766090|364556177|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697503|NCT00766090|364556178|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697504|NCT00766090|364556179|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697505|NCT00766090|364556180|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697506|NCT00766090|364556181|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697507|NCT00766090|364556182|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697508|NCT00766090|364556183|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697509|NCT00766090|364556184|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697510|NCT00766090|364556173|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697511|NCT00766090|364556174|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697512|NCT00766090|364556175|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697513|NCT00766090|364556176|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697514|NCT00766090|364556177|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
105697515|NCT00766090|364556178|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697516|NCT00766090|364556179|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697517|NCT00766090|364556180|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697518|NCT00766090|364556181|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697519|NCT00766090|364556182|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697520|NCT00766090|364556183|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697521|NCT00766090|364556184|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697522|NCT00766090|364556173|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697523|NCT00766090|364556174|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697524|NCT00766090|364556175|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
105697525|NCT00766090|364556176|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697526|NCT00766090|364556177|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697527|NCT00766090|364556178|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697528|NCT00766090|364556179|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697529|NCT00766090|364556180|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697530|NCT00766090|364556181|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697531|NCT00766090|364556182|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697532|NCT00766090|364556183|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697533|NCT00766090|364556184|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697534|NCT00766090|364556173|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
105697535|NCT00766090|364556174|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
105697536|NCT00766090|364556175|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
105697537|NCT00766090|364556176|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
105697538|NCT00766090|364556177|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
105697539|NCT00766090|364556178|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
105697540|NCT00766090|364556179|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
105697541|NCT00766090|364556180|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
105697542|NCT00766090|364556181|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
105697543|NCT00766090|364556182|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
105697544|NCT00766090|364556183|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
105697545|NCT00766090|364556184|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
105697546|NCT00766090|364556173|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697547|NCT00766090|364556174|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697548|NCT00766090|364556175|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697549|NCT00766090|364556176|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697550|NCT00766090|364556177|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697551|NCT00766090|364556178|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
105697552|NCT00766090|364556179|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697553|NCT00766090|364556180|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697554|NCT00766090|364556181|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697555|NCT00766090|364556182|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105559389|NCT02291614|364044685|FG010|Overall Study|Withdrawal by Subject|2|||
105559390|NCT02291614|364044675|FG000|Overall Study|Decision by sponsor|0|||
105559391|NCT02291614|364044676|FG001|Overall Study|Decision by sponsor|0|||
105559392|NCT02291614|364044677|FG002|Overall Study|Decision by sponsor|0|||
105559393|NCT02291614|364044678|FG003|Overall Study|Decision by sponsor|1|||
105559394|NCT02291614|364044679|FG004|Overall Study|Decision by sponsor|0|||
105559395|NCT02291614|364044680|FG005|Overall Study|Decision by sponsor|0|||
105697556|NCT00766090|364556183|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697557|NCT00766090|364556184|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697558|NCT00766090|364556173|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697559|NCT00766090|364556174|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
105697560|NCT00766090|364556175|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697561|NCT00766090|364556176|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
105697562|NCT00766090|364556177|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697563|NCT00766090|364556178|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697564|NCT00766090|364556179|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697565|NCT00766090|364556180|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697566|NCT00766090|364556181|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697567|NCT00766090|364556182|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697568|NCT00766090|364556183|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697569|NCT00766090|364556184|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
105697570|NCT00766090|364556173|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697571|NCT00766090|364556174|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697572|NCT00766090|364556175|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697573|NCT00766090|364556176|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697574|NCT00766090|364556177|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
105697575|NCT00766090|364556178|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697576|NCT00766090|364556179|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697577|NCT00766090|364556180|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697578|NCT00766090|364556181|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697579|NCT00766090|364556182|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697580|NCT00766090|364556183|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697581|NCT00766090|364556184|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697582|NCT01221727|364556185|FG000|Overall Study|Physician Decision|2|||
105697583|NCT01221727|364556186|FG001|Overall Study|Physician Decision|0|||
105697584|NCT01221727|364556185|FG000|Overall Study|Withdrawal by Subject|1|||
105697585|NCT01221727|364556186|FG001|Overall Study|Withdrawal by Subject|1|||
105697586|NCT02566577|364556188|FG000|Overall Study|Withdrawal by Subject|1|||
105697587|NCT02566577|364556189|FG001|Overall Study|Withdrawal by Subject|1|||
105697588|NCT02566577|364556188|FG000|Overall Study|Equipment failure|1|||
105559396|NCT02291614|364044681|FG006|Overall Study|Decision by sponsor|0|||
105697589|NCT02566577|364556189|FG001|Overall Study|Equipment failure|1|||
105697590|NCT02566577|364556188|FG000|Overall Study|Physical limitation|1|||
105348444|NCT01897571|363277078|FG001|Overall Study|Enrolled in rollover study|0|||
105348445|NCT01897571|363277079|FG002|Overall Study|Enrolled in rollover study|0|||
105348446|NCT01897571|363277080|FG003|Overall Study|Enrolled in rollover study|0|||
105697591|NCT02566577|364556189|FG001|Overall Study|Physical limitation|0|||
105697592|NCT03654976|364556198|FG000|Overall Study|Withdrawal by Subject|12|||
105697593|NCT03654976|364556199|FG001|Overall Study|Withdrawal by Subject|11|||
105697594|NCT03654976|364556198|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
105697595|NCT03654976|364556199|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
105348447|NCT01897571|363277081|FG004|Overall Study|Enrolled in rollover study|0|||
105697596|NCT03654976|364556198|FG000|Overall Study|Adverse Event|5|||
105697597|NCT03654976|364556199|FG001|Overall Study|Adverse Event|0|||
105697598|NCT03654976|364556198|FG000|Overall Study|Lost to Follow-up|2|||
105697599|NCT03654976|364556199|FG001|Overall Study|Lost to Follow-up|0|||
105697600|NCT03654976|364556198|FG000|Overall Study|Lack of Efficacy|0|||
105697601|NCT03654976|364556199|FG001|Overall Study|Lack of Efficacy|1|||
105697602|NCT00898443|364556200|FG000|Overall Study|Withdrawal by Subject|1|||
105697603|NCT00898443|364556201|FG001|Overall Study|Withdrawal by Subject|0|||
105697604|NCT00078325|364556204|FG000|Overall Study|Adverse Event|15|||
105697605|NCT00078325|364556205|FG001|Overall Study|Adverse Event|10|||
105697606|NCT00078325|364556206|FG002|Overall Study|Adverse Event|5|||
105697607|NCT00078325|364556204|FG000|Overall Study|Protocol Violation|2|||
105697608|NCT00078325|364556205|FG001|Overall Study|Protocol Violation|2|||
105348448|NCT01897571|363277082|FG005|Overall Study|Enrolled in rollover study|0|||
105348449|NCT01897571|363277083|FG006|Overall Study|Enrolled in rollover study|0|||
105348450|NCT01897571|363277084|FG007|Overall Study|Enrolled in rollover study|9|||
105348451|NCT01897571|363277085|FG008|Overall Study|Enrolled in rollover study|7|||
105348452|NCT01897571|363277086|FG009|Overall Study|Enrolled in rollover study|9|||
105348453|NCT01897571|363277087|FG010|Overall Study|Enrolled in rollover study|1|||
105348454|NCT01897571|363277077|FG000|Overall Study|Death|2|||
105348455|NCT01897571|363277078|FG001|Overall Study|Death|2|||
105348456|NCT01897571|363277079|FG002|Overall Study|Death|3|||
105348457|NCT01897571|363277080|FG003|Overall Study|Death|6|||
105348458|NCT01897571|363277081|FG004|Overall Study|Death|7|||
105348459|NCT01897571|363277082|FG005|Overall Study|Death|9|||
105348460|NCT01897571|363277083|FG006|Overall Study|Death|5|||
105348461|NCT01897571|363277084|FG007|Overall Study|Death|22|||
105348462|NCT01897571|363277085|FG008|Overall Study|Death|23|||
105348463|NCT01897571|363277086|FG009|Overall Study|Death|129|||
105348464|NCT01897571|363277087|FG010|Overall Study|Death|59|||
105348465|NCT01797094|363277089|FG000|Overall Study|Adverse Event|1|||
105348466|NCT01797094|363277090|FG001|Overall Study|Adverse Event|1|||
105348467|NCT01797094|363277089|FG000|Overall Study|Personal Reasons|4|||
105348468|NCT01797094|363277090|FG001|Overall Study|Personal Reasons|0|||
105348469|NCT01797094|363277089|FG000|Overall Study|Protocol Violation|0|||
105697609|NCT00078325|364556206|FG002|Overall Study|Protocol Violation|0|||
105697610|NCT00078325|364556204|FG000|Overall Study|Withdrawal by Subject|1|||
105697611|NCT00078325|364556205|FG001|Overall Study|Withdrawal by Subject|5|||
105697612|NCT00078325|364556206|FG002|Overall Study|Withdrawal by Subject|3|||
105697613|NCT00078325|364556204|FG000|Overall Study|Lost to Follow-up|0|||
105697614|NCT00078325|364556205|FG001|Overall Study|Lost to Follow-up|1|||
105348470|NCT01797094|363277090|FG001|Overall Study|Protocol Violation|1|||
105348471|NCT01797094|363277089|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105348472|NCT01797094|363277090|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105697615|NCT00078325|364556206|FG002|Overall Study|Lost to Follow-up|1|||
105697616|NCT00078325|364556204|FG000|Overall Study|Physician Decision|2|||
105697617|NCT00078325|364556205|FG001|Overall Study|Physician Decision|0|||
105697618|NCT00078325|364556206|FG002|Overall Study|Physician Decision|1|||
105348473|NCT00401960|363277091|FG000|Overall Study|Lost to Follow-up|3|||
105348474|NCT00401960|363277092|FG001|Overall Study|Lost to Follow-up|0|||
105348475|NCT00401960|363277091|FG000|Overall Study|Death|2|||
105473607|NCT01006291|363746987|FG000|Overall Study|Protocol Violation|3|||
105697619|NCT00078325|364556204|FG000|Overall Study|Miscellaneous|1|||
105697620|NCT00078325|364556205|FG001|Overall Study|Miscellaneous|1|||
105697621|NCT00078325|364556206|FG002|Overall Study|Miscellaneous|1|||
105697622|NCT02625233|364556207|FG000|Overall Study|Adverse Event|2|||
105697623|NCT02625233|364556208|FG001|Overall Study|Adverse Event|0|||
105697624|NCT01436084|364556209|FG000|Overall Study|Disease Progression|2|||
105697625|NCT01436084|364556209|FG000|Overall Study|Withdrawal by Subject|1|||
105697626|NCT01436084|364556209|FG000|Overall Study|Early Closure of Study|1|||
105348476|NCT00401960|363277092|FG001|Overall Study|Death|0|||
105348477|NCT03217968|363277093|FG000|Overall Study|Withdrawal by Subject|4|||
105348478|NCT03217968|363277093|FG000|Overall Study|Lost to Follow-up|1|||
105348479|NCT03217968|363277093|FG000|Overall Study|Protocol Violation|6|||
105348480|NCT01870297|363277096|FG000|Overall Study|Adverse Event|0|||
105348481|NCT01870297|363277097|FG001|Overall Study|Adverse Event|0|||
105348482|NCT01870297|363277098|FG002|Overall Study|Adverse Event|0|||
105348483|NCT01870297|363277099|FG003|Overall Study|Adverse Event|0|||
105348484|NCT01870297|363277100|FG004|Overall Study|Adverse Event|2|||
105697627|NCT00445224|364556215|FG000|Specific Exercises|Withdrawal by Subject|3|||
105697628|NCT00445224|364556216|FG001|Specific Exercises|Withdrawal by Subject|3|||
105697629|NCT00445224|364556215|FG000|Specific Exercises|Withdrawal by Subject|1|||
105697630|NCT00445224|364556216|FG001|Specific Exercises|Withdrawal by Subject|0|||
105697631|NCT02046096|364556217|FG000|Overall Study|Death|28|||
105697632|NCT02046096|364556218|FG001|Overall Study|Death|45|||
105697633|NCT02046096|364556217|FG000|Overall Study|Lost to Follow-up|9|||
105697634|NCT02046096|364556218|FG001|Overall Study|Lost to Follow-up|20|||
105697635|NCT02046096|364556217|FG000|Overall Study|Withdrawal by Subject|5|||
105697636|NCT02046096|364556218|FG001|Overall Study|Withdrawal by Subject|17|||
105697637|NCT02046096|364556217|FG000|Overall Study|Other endpoint|2|||
105697638|NCT02046096|364556218|FG001|Overall Study|Other endpoint|19|||
105697639|NCT00943579|364556219|FG000|Overall Study|Adverse Event|4|||
105697640|NCT00943579|364556220|FG001|Overall Study|Adverse Event|3|||
105697641|NCT00943579|364556219|FG000|Overall Study|Lack of Efficacy|2|||
105697642|NCT00943579|364556220|FG001|Overall Study|Lack of Efficacy|2|||
105697643|NCT03337542|364556225|FG000|Overall Study|Withdrew Consent|17|||
105697644|NCT03337542|364556225|FG000|Overall Study|Allergic Adverse Event|1|||
105697645|NCT03337542|364556225|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
105697646|NCT03337542|364556225|FG000|Overall Study|Lost to Follow-up|1|||
105697647|NCT03337542|364556225|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
105697648|NCT00121108|364556226|FG000|Overall Study|Lost to Follow-up|10|||
105697649|NCT00121108|364556227|FG001|Overall Study|Lost to Follow-up|22|||
105697650|NCT00121108|364556226|FG000|Overall Study|Withdrawal by Subject|106|||
105697651|NCT00121108|364556227|FG001|Overall Study|Withdrawal by Subject|195|||
105697652|NCT00121108|364556226|FG000|Overall Study|Death|5|||
105697653|NCT00121108|364556227|FG001|Overall Study|Death|8|||
105697654|NCT01380379|364556228|FG000|Overall Study|Pregnancy|1|||
105697655|NCT02779855|364556235|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
105697656|NCT02779855|364556236|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
105697657|NCT02779855|364556237|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
105697658|NCT02229539|364557339|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
105697659|NCT02229539|364557340|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
105697660|NCT02229539|364557341|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
105697661|NCT02229539|364557339|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
105697662|NCT02229539|364557340|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
105697663|NCT02229539|364557341|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
105697664|NCT02229539|364557339|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
105697665|NCT02229539|364557340|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
105697666|NCT02229539|364557341|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
105697667|NCT02229539|364557339|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
105697668|NCT02229539|364557340|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
105697669|NCT02229539|364557341|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
105697670|NCT02229539|364557339|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
105697671|NCT02229539|364557340|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
105697672|NCT02229539|364557341|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
105697673|NCT02229539|364557339|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
105697674|NCT02229539|364557340|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
105697675|NCT02229539|364557341|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
105697676|NCT00938717|364557343|FG000|Overall Study|Adverse Event|10|||
105697677|NCT00938717|364557344|FG001|Overall Study|Adverse Event|41|||
105697678|NCT00938717|364557343|FG000|Overall Study|Protocol Violation|11|||
105697679|NCT00938717|364557344|FG001|Overall Study|Protocol Violation|8|||
105697680|NCT00938717|364557343|FG000|Overall Study|Withdrawal by Subject|26|||
105697681|NCT00938717|364557344|FG001|Overall Study|Withdrawal by Subject|24|||
105697682|NCT00938717|364557343|FG000|Overall Study|Lost to Follow-up|13|||
105697683|NCT00938717|364557344|FG001|Overall Study|Lost to Follow-up|18|||
105697684|NCT00938717|364557343|FG000|Overall Study|Lack of Efficacy|33|||
105697685|NCT00938717|364557344|FG001|Overall Study|Lack of Efficacy|15|||
105697686|NCT00938717|364557343|FG000|Overall Study|Other reason|5|||
105697687|NCT00938717|364557344|FG001|Overall Study|Other reason|2|||
105697688|NCT02230254|364557347|FG000|Overall Study|Lost to Follow-up|3|||
105697689|NCT02023242|364557349|FG000|Overall Study|Lost to Follow-up|3|||
105697690|NCT02023242|364557350|FG001|Overall Study|Lost to Follow-up|1|||
105697691|NCT02023242|364557349|FG000|Overall Study|Death|0|||
105697692|NCT02023242|364557350|FG001|Overall Study|Death|1|||
105697777|NCT02713542|364557361|FG000|Overall Study|Use of prohibited medication|14|||
105697778|NCT02713542|364557362|FG001|Overall Study|Use of prohibited medication|5|||
105697779|NCT02713542|364557361|FG000|Overall Study|Withdrawal by Subject|4|||
105697780|NCT02713542|364557362|FG001|Overall Study|Withdrawal by Subject|1|||
105697781|NCT01555151|364557365|FG000|Overall Study|Withdrawal by Subject|6|||
105697782|NCT01555151|364557366|FG001|Overall Study|Withdrawal by Subject|2|||
105697783|NCT01555151|364557367|FG002|Overall Study|Withdrawal by Subject|0|||
105697784|NCT01555151|364557368|FG003|Overall Study|Withdrawal by Subject|2|||
105697785|NCT01555151|364557365|FG000|Overall Study|Administrative|3|||
105697786|NCT01555151|364557366|FG001|Overall Study|Administrative|1|||
105697787|NCT01555151|364557367|FG002|Overall Study|Administrative|2|||
105697788|NCT01555151|364557368|FG003|Overall Study|Administrative|0|||
105697789|NCT01555151|364557365|FG000|Overall Study|Protocol Violation|3|||
105697790|NCT01555151|364557366|FG001|Overall Study|Protocol Violation|3|||
105697791|NCT01555151|364557367|FG002|Overall Study|Protocol Violation|3|||
105697792|NCT01555151|364557368|FG003|Overall Study|Protocol Violation|5|||
105697793|NCT01555151|364557365|FG000|Overall Study|Adverse Event|1|||
105697794|NCT01555151|364557366|FG001|Overall Study|Adverse Event|2|||
105697795|NCT01555151|364557367|FG002|Overall Study|Adverse Event|1|||
105697796|NCT01555151|364557368|FG003|Overall Study|Adverse Event|2|||
105697797|NCT01555151|364557365|FG000|Overall Study|Lost to Follow-up|0|||
105697798|NCT01555151|364557366|FG001|Overall Study|Lost to Follow-up|0|||
105697799|NCT01555151|364557367|FG002|Overall Study|Lost to Follow-up|0|||
105697800|NCT01555151|364557368|FG003|Overall Study|Lost to Follow-up|1|||
105697801|NCT01576172|364557369|FG000|Overall Study|Ineligible|2|||
105697802|NCT01576172|364557370|FG001|Overall Study|Ineligible|1|||
105697803|NCT01576172|364557369|FG000|Overall Study|Withdrawal by Subject|2|||
105697804|NCT01576172|364557370|FG001|Overall Study|Withdrawal by Subject|0|||
105697805|NCT01576172|364557369|FG000|Overall Study|Insurance issue|1|||
105697806|NCT01576172|364557370|FG001|Overall Study|Insurance issue|0|||
105697807|NCT00800436|364557373|FG000|Overall Study|Withdrawal by Subject|0|||
105697808|NCT00800436|364557374|FG001|Overall Study|Withdrawal by Subject|0|||
105697809|NCT00800436|364557375|FG002|Overall Study|Withdrawal by Subject|1|||
105697810|NCT00800436|364557376|FG003|Overall Study|Withdrawal by Subject|1|||
105697811|NCT00800436|364557377|FG004|Overall Study|Withdrawal by Subject|0|||
105697812|NCT00800436|364557378|FG005|Overall Study|Withdrawal by Subject|0|||
105697813|NCT00800436|364557379|FG006|Overall Study|Withdrawal by Subject|0|||
105697814|NCT03680911|364557385|FG000|At Home Treatment|Study Termination|3|||
105697815|NCT03680911|364557386|FG001|At Home Treatment|Study Termination|0|||
105697816|NCT03680911|364557385|FG000|At Home Treatment|Lost to Follow-up|0|||
105697817|NCT03680911|364557386|FG001|At Home Treatment|Lost to Follow-up|1|||
105697818|NCT03680911|364557385|FG000|At Home Treatment|Withdrawal by Subject|0|||
105697819|NCT03680911|364557386|FG001|At Home Treatment|Withdrawal by Subject|2|||
105697820|NCT03680911|364557385|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
105697821|NCT03680911|364557386|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
105697822|NCT03024970|364557389|FG000|First Intervention|Adverse Event|1|||
105697823|NCT03024970|364557390|FG001|First Intervention|Adverse Event|0|||
105697824|NCT03024970|364557389|FG000|Second Intervention|Lost to Follow-up|1|||
105697825|NCT03024970|364557390|FG001|Second Intervention|Lost to Follow-up|0|||
105697826|NCT00356889|364557392|FG000|Overall Study|Protocol Violation|2|||
105697827|NCT00356889|364557392|FG000|Overall Study|Adverse Event|1|||
105697828|NCT03123250|364557393|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
105697829|NCT03199040|364557394|FG000|Overall Study|Lack of Efficacy|2|||
105697830|NCT03199040|364557395|FG001|Overall Study|Lack of Efficacy|0|||
105697831|NCT03199040|364557394|FG000|Overall Study|Withdrawal by Subject|2|||
105697832|NCT03199040|364557395|FG001|Overall Study|Withdrawal by Subject|0|||
105697833|NCT03199040|364557394|FG000|Overall Study|Adverse Event|0|||
105697834|NCT03199040|364557395|FG001|Overall Study|Adverse Event|1|||
105697835|NCT03199040|364557394|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
105697836|NCT03199040|364557395|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
105697837|NCT01226459|364557396|FG000|Overall Study|Adverse Event|2|||
105697838|NCT01226459|364557397|FG001|Overall Study|Adverse Event|8|||
105697839|NCT01226459|364557396|FG000|Overall Study|Protocol Violation|4|||
105697840|NCT01226459|364557397|FG001|Overall Study|Protocol Violation|3|||
105787163|NCT03110107|364874891|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
105697841|NCT01226459|364557396|FG000|Overall Study|Withdrawal by Subject|10|||
105697842|NCT01226459|364557397|FG001|Overall Study|Withdrawal by Subject|13|||
105697843|NCT01226459|364557396|FG000|Overall Study|Lost to Follow-up|4|||
105697844|NCT01226459|364557397|FG001|Overall Study|Lost to Follow-up|8|||
105697845|NCT01226459|364557396|FG000|Overall Study|Pregnancy|1|||
105697846|NCT01226459|364557397|FG001|Overall Study|Pregnancy|0|||
105697847|NCT03700320|364557401|FG000|Overall Study|Adverse Event|5|||
105697848|NCT03700320|364557402|FG001|Overall Study|Adverse Event|31|||
105697849|NCT03700320|364557401|FG000|Overall Study|Lack of Efficacy|2|||
105697850|NCT03700320|364557402|FG001|Overall Study|Lack of Efficacy|5|||
105697851|NCT03700320|364557401|FG000|Overall Study|Withdrawal by Subject|29|||
105697852|NCT03700320|364557402|FG001|Overall Study|Withdrawal by Subject|75|||
105697853|NCT03700320|364557401|FG000|Overall Study|Lost to Follow-up|16|||
105697854|NCT03700320|364557402|FG001|Overall Study|Lost to Follow-up|23|||
105697855|NCT03700320|364557401|FG000|Overall Study|Pregnancy|2|||
105697856|NCT03700320|364557402|FG001|Overall Study|Pregnancy|4|||
105697857|NCT03700320|364557401|FG000|Overall Study|Protocol Deviation|7|||
105697858|NCT03700320|364557402|FG001|Overall Study|Protocol Deviation|31|||
105697859|NCT03700320|364557401|FG000|Overall Study|Non-compliance with Study Drug|1|||
105697860|NCT03700320|364557402|FG001|Overall Study|Non-compliance with Study Drug|3|||
105697861|NCT03700320|364557401|FG000|Overall Study|Reason not Specified|0|||
105697862|NCT03700320|364557402|FG001|Overall Study|Reason not Specified|1|||
105697863|NCT04688775|364557405|FG000|Placebo-controlled Period|Randomized, not treated|1|||
105697864|NCT04688775|364557406|FG001|Placebo-controlled Period|Randomized, not treated|1|||
105697865|NCT04688775|364557407|FG002|Placebo-controlled Period|Randomized, not treated|0|||
105697866|NCT04688775|364557408|FG003|Placebo-controlled Period|Randomized, not treated|0|||
105697867|NCT04688775|364557405|FG000|Placebo-controlled Period|Adverse Event|2|||
105697868|NCT04688775|364557406|FG001|Placebo-controlled Period|Adverse Event|0|||
105697869|NCT04688775|364557407|FG002|Placebo-controlled Period|Adverse Event|0|||
105697870|NCT04688775|364557408|FG003|Placebo-controlled Period|Adverse Event|0|||
105697871|NCT04688775|364557405|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
105697872|NCT04688775|364557406|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
105697873|NCT04688775|364557407|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
105697874|NCT04688775|364557408|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
105697875|NCT04688775|364557405|FG000|Placebo-controlled Period|Protocol Violation|0|||
105697876|NCT04688775|364557406|FG001|Placebo-controlled Period|Protocol Violation|1|||
105697877|NCT04688775|364557407|FG002|Placebo-controlled Period|Protocol Violation|0|||
105697878|NCT04688775|364557408|FG003|Placebo-controlled Period|Protocol Violation|0|||
105697879|NCT04688775|364557405|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
105348485|NCT01870297|363277101|FG005|Overall Study|Adverse Event|0|||
105348486|NCT01870297|363277102|FG006|Overall Study|Adverse Event|0|||
105348487|NCT01870297|363277096|FG000|Overall Study|Lost to Follow-up|0|||
105348488|NCT01870297|363277097|FG001|Overall Study|Lost to Follow-up|1|||
105348489|NCT01870297|363277098|FG002|Overall Study|Lost to Follow-up|1|||
105348490|NCT01870297|363277099|FG003|Overall Study|Lost to Follow-up|0|||
105348491|NCT01870297|363277100|FG004|Overall Study|Lost to Follow-up|0|||
105348492|NCT01870297|363277101|FG005|Overall Study|Lost to Follow-up|0|||
105348493|NCT01870297|363277102|FG006|Overall Study|Lost to Follow-up|0|||
105348494|NCT01870297|363277096|FG000|Overall Study|Withdrawal by Subject|0|||
105348495|NCT01870297|363277097|FG001|Overall Study|Withdrawal by Subject|0|||
105348496|NCT01870297|363277098|FG002|Overall Study|Withdrawal by Subject|0|||
105348497|NCT01870297|363277099|FG003|Overall Study|Withdrawal by Subject|0|||
105348498|NCT01870297|363277100|FG004|Overall Study|Withdrawal by Subject|1|||
105348499|NCT01870297|363277101|FG005|Overall Study|Withdrawal by Subject|1|||
105348500|NCT01870297|363277102|FG006|Overall Study|Withdrawal by Subject|1|||
105348501|NCT01870297|363277096|FG000|Overall Study|Sponsor Decision|0|||
105348502|NCT01870297|363277097|FG001|Overall Study|Sponsor Decision|6|||
105348503|NCT01870297|363277098|FG002|Overall Study|Sponsor Decision|0|||
105348504|NCT01870297|363277099|FG003|Overall Study|Sponsor Decision|0|||
105348505|NCT01870297|363277100|FG004|Overall Study|Sponsor Decision|0|||
105348506|NCT01870297|363277101|FG005|Overall Study|Sponsor Decision|0|||
105348507|NCT01870297|363277102|FG006|Overall Study|Sponsor Decision|1|||
105697880|NCT04688775|364557406|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
105348508|NCT00513357|363277103|FG000|Overall Study|did not receive allocated placebo|2|||
105348509|NCT00513357|363277104|FG001|Overall Study|did not receive allocated placebo|3|||
105697881|NCT04688775|364557407|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
105697882|NCT04688775|364557408|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
105697883|NCT04688775|364557405|FG000|Placebo-controlled Period|Other reasons|0|||
105348510|NCT00513357|363277103|FG000|Overall Study|Adverse Event|4|||
105697884|NCT04688775|364557406|FG001|Placebo-controlled Period|Other reasons|1|||
105697885|NCT04688775|364557407|FG002|Placebo-controlled Period|Other reasons|0|||
105697886|NCT04688775|364557408|FG003|Placebo-controlled Period|Other reasons|0|||
105697887|NCT04688775|364557405|FG000|Delayed Start Period|Adverse Event|0|||
105697888|NCT04688775|364557406|FG001|Delayed Start Period|Adverse Event|0|||
105697889|NCT04688775|364557407|FG002|Delayed Start Period|Adverse Event|1|||
105697890|NCT04688775|364557408|FG003|Delayed Start Period|Adverse Event|0|||
105348511|NCT00513357|363277104|FG001|Overall Study|Adverse Event|2|||
105348512|NCT00513357|363277103|FG000|Overall Study|Death|2|||
105348513|NCT00513357|363277104|FG001|Overall Study|Death|0|||
105348514|NCT00513357|363277103|FG000|Overall Study|Withdrawal by Subject|5|||
105348515|NCT00513357|363277104|FG001|Overall Study|Withdrawal by Subject|4|||
105348516|NCT00513357|363277103|FG000|Overall Study|Disease Progression|2|||
105697891|NCT04688775|364557405|FG000|Delayed Start Period|Lack of Efficacy|0|||
105697892|NCT04688775|364557406|FG001|Delayed Start Period|Lack of Efficacy|0|||
105559397|NCT02291614|364044682|FG007|Overall Study|Decision by sponsor|0|||
105559398|NCT02291614|364044683|FG008|Overall Study|Decision by sponsor|0|||
105559399|NCT02291614|364044684|FG009|Overall Study|Decision by sponsor|0|||
105697893|NCT04688775|364557407|FG002|Delayed Start Period|Lack of Efficacy|0|||
105697894|NCT04688775|364557408|FG003|Delayed Start Period|Lack of Efficacy|3|||
105697895|NCT04688775|364557405|FG000|Delayed Start Period|Withdrawal by Subject|0|||
105697896|NCT04688775|364557406|FG001|Delayed Start Period|Withdrawal by Subject|0|||
105697897|NCT04688775|364557407|FG002|Delayed Start Period|Withdrawal by Subject|2|||
105697898|NCT04688775|364557408|FG003|Delayed Start Period|Withdrawal by Subject|4|||
105697899|NCT04688775|364557405|FG000|Delayed Start Period|Lost to Follow-up|0|||
105697900|NCT04688775|364557406|FG001|Delayed Start Period|Lost to Follow-up|0|||
105697901|NCT04688775|364557407|FG002|Delayed Start Period|Lost to Follow-up|2|||
105697902|NCT04688775|364557408|FG003|Delayed Start Period|Lost to Follow-up|1|||
105697903|NCT04688775|364557405|FG000|Delayed Start Period|other reasons|0|||
105697904|NCT04688775|364557406|FG001|Delayed Start Period|other reasons|0|||
105697905|NCT04688775|364557407|FG002|Delayed Start Period|other reasons|1|||
105697906|NCT04688775|364557408|FG003|Delayed Start Period|other reasons|0|||
105697907|NCT05093322|364557409|FG000|Overall Study|Death|6|||
105697908|NCT05093322|364557410|FG001|Overall Study|Death|2|||
105697909|NCT05093322|364557409|FG000|Overall Study|Other|4|||
105697910|NCT05093322|364557410|FG001|Overall Study|Other|1|||
105697911|NCT03574753|364557413|FG000|Overall Study|Adverse Event|3|||
105697912|NCT03574753|364557413|FG000|Overall Study|Progression/relapse|19|||
105697913|NCT03574753|364557413|FG000|Overall Study|Death|1|||
105697914|NCT02811549|364557414|FG000|Overall Study|Lost to Follow-up|1|||
105697915|NCT02811549|364557414|FG000|Overall Study|Withdrawal by Subject|3|||
105697916|NCT02811549|364557414|FG000|Overall Study|Subject screen failed|4|||
105697917|NCT02811549|364557414|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
105697918|NCT00789880|364557416|FG000|Overall Study|Adverse Event|0|||
105697919|NCT00789880|364557417|FG001|Overall Study|Adverse Event|0|||
105697920|NCT00789880|364557418|FG002|Overall Study|Adverse Event|0|||
105697921|NCT00789880|364557419|FG003|Overall Study|Adverse Event|0|||
105697922|NCT00789880|364557420|FG004|Overall Study|Adverse Event|1|||
105697923|NCT00789880|364557421|FG005|Overall Study|Adverse Event|0|||
105697924|NCT00789880|364557416|FG000|Overall Study|Protocol Violation|0|||
105697925|NCT00789880|364557417|FG001|Overall Study|Protocol Violation|1|||
105697926|NCT00789880|364557418|FG002|Overall Study|Protocol Violation|0|||
105697927|NCT00789880|364557419|FG003|Overall Study|Protocol Violation|1|||
105697928|NCT00789880|364557420|FG004|Overall Study|Protocol Violation|0|||
105697929|NCT00789880|364557421|FG005|Overall Study|Protocol Violation|0|||
105697930|NCT00789880|364557416|FG000|Overall Study|Withdrawal by Subject|1|||
105697931|NCT00789880|364557417|FG001|Overall Study|Withdrawal by Subject|0|||
105697932|NCT00789880|364557418|FG002|Overall Study|Withdrawal by Subject|0|||
105697933|NCT00789880|364557419|FG003|Overall Study|Withdrawal by Subject|0|||
105697934|NCT00789880|364557420|FG004|Overall Study|Withdrawal by Subject|2|||
105697935|NCT00789880|364557421|FG005|Overall Study|Withdrawal by Subject|0|||
105697936|NCT01177683|364557422|FG000|Study Treatment|Disease Progressions during treatment|2|||
105697937|NCT01177683|364557423|FG001|Study Treatment|Disease Progressions during treatment|0|||
105697938|NCT01177683|364557424|FG002|Study Treatment|Disease Progressions during treatment|3|||
105697939|NCT01177683|364557422|FG000|Study Treatment|Adverse Event|0|||
105697940|NCT01177683|364557423|FG001|Study Treatment|Adverse Event|1|||
105697941|NCT01177683|364557424|FG002|Study Treatment|Adverse Event|12|||
105697942|NCT01177683|364557422|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
105697943|NCT01177683|364557423|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
105697944|NCT01177683|364557424|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
105697945|NCT01177683|364557422|FG000|Study Treatment|Alternative therapy|0|||
105697946|NCT01177683|364557423|FG001|Study Treatment|Alternative therapy|0|||
105697947|NCT01177683|364557424|FG002|Study Treatment|Alternative therapy|4|||
105697948|NCT01177683|364557422|FG000|Study Treatment|Physician Decision|1|||
105697949|NCT01177683|364557423|FG001|Study Treatment|Physician Decision|0|||
105697950|NCT01177683|364557424|FG002|Study Treatment|Physician Decision|1|||
105697951|NCT01177683|364557422|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
105559400|NCT02291614|364044685|FG010|Overall Study|Decision by sponsor|0|||
105697952|NCT01177683|364557423|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
105697953|NCT01177683|364557424|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
105697954|NCT01177683|364557422|FG000|Study Treatment|Symptomatic Deterioration|0|||
105697955|NCT01177683|364557423|FG001|Study Treatment|Symptomatic Deterioration|0|||
105348517|NCT00513357|363277104|FG001|Overall Study|Disease Progression|1|||
105559401|NCT02291614|364044675|FG000|Overall Study|Death|0|||
105697956|NCT01177683|364557424|FG002|Study Treatment|Symptomatic Deterioration|1|||
105697957|NCT01177683|364557422|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
105697958|NCT01177683|364557423|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
105697959|NCT01177683|364557424|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
105348518|NCT02020512|363277105|FG000|Overall Study|Adverse Event|1|||
105348519|NCT02020512|363277105|FG000|Overall Study|Lost to Follow-up|3|||
105348520|NCT02020512|363277105|FG000|Overall Study|Protocol Violation|4|||
105348521|NCT00422422|363277106|FG000|Overall Study|Lack of Efficacy|1|||
105348522|NCT00422422|363277106|FG000|Overall Study|Protocol Violation|1|||
105348523|NCT00422422|363277106|FG000|Overall Study|Withdrawal by Subject|2|||
105348524|NCT00422422|363277106|FG000|Overall Study|SAE, non-fatal|1|||
105348525|NCT00422422|363277106|FG000|Overall Study|AE, non-serious non-fatal|5|||
105348526|NCT01534208|363277114|FG000|Overall Study|Lost to Follow-up|19|||
105348527|NCT01534208|363277115|FG001|Overall Study|Lost to Follow-up|14|||
105348528|NCT01534208|363277114|FG000|Overall Study|Withdrawal by Subject|6|||
105473608|NCT01006291|363746988|FG001|Overall Study|Protocol Violation|3|||
105473609|NCT01006291|363746989|FG002|Overall Study|Protocol Violation|3|||
105473610|NCT01006291|363746987|FG000|Overall Study|Withdrawal criteria|5|||
105473611|NCT01006291|363746988|FG001|Overall Study|Withdrawal criteria|4|||
105697960|NCT01177683|364557422|FG000|Follow up|Patient lost to follow up|0|||
105697961|NCT01177683|364557423|FG001|Follow up|Patient lost to follow up|0|||
105697962|NCT01177683|364557424|FG002|Follow up|Patient lost to follow up|2|||
105697963|NCT01177683|364557422|FG000|Follow up|Death|2|||
105697964|NCT01177683|364557423|FG001|Follow up|Death|1|||
105697965|NCT01177683|364557424|FG002|Follow up|Death|7|||
105697966|NCT01177683|364557422|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
105697967|NCT01177683|364557423|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
105697968|NCT01177683|364557424|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
105697969|NCT03472924|364557430|FG000|Overall Study|Adverse Event|1|||
105697970|NCT03472924|364557431|FG001|Overall Study|Adverse Event|0|||
105697971|NCT00427349|364557434|FG000|Overall Study|Lack of Efficacy|23|||
105697972|NCT00427349|364557434|FG000|Overall Study|Adverse Event|14|||
105697973|NCT00427349|364557434|FG000|Overall Study|Death|1|||
105697974|NCT00427349|364557434|FG000|Overall Study|Withdrawal by Subject|3|||
105697975|NCT00427349|364557434|FG000|Overall Study|Alternative therapy|1|||
105697976|NCT00427349|364557434|FG000|Overall Study|Other|2|||
105697977|NCT00427349|364557434|FG000|Overall Study|Ineligible|1|||
105697978|NCT00427349|364557434|FG000|Overall Study|Never started therapy|1|||
105697979|NCT01977820|364557435|FG000|Overall Study|Sponsor terminated the study|1|||
105697980|NCT01977820|364557436|FG001|Overall Study|Sponsor terminated the study|1|||
105473612|NCT01006291|363746989|FG002|Overall Study|Withdrawal criteria|4|||
105473613|NCT01006291|363746987|FG000|Overall Study|Other|14|||
105473614|NCT01006291|363746988|FG001|Overall Study|Other|14|||
105473615|NCT01006291|363746989|FG002|Overall Study|Other|17|||
105473616|NCT03751657|363746990|FG000|Overall Study|Physician Decision|0|||
105473617|NCT03751657|363746991|FG001|Overall Study|Physician Decision|1|||
105473618|NCT03751657|363746990|FG000|Overall Study|Withdrawal by Subject|1|||
105473619|NCT03751657|363746991|FG001|Overall Study|Withdrawal by Subject|1|||
105473620|NCT03751657|363746990|FG000|Overall Study|Lost to Follow-up|2|||
105473621|NCT03751657|363746991|FG001|Overall Study|Lost to Follow-up|1|||
105473622|NCT03079102|363746992|FG000|Overall Study|Physician Decision|0|||
105473623|NCT03079102|363746993|FG001|Overall Study|Physician Decision|1|||
105473624|NCT00479687|363746996|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
105473625|NCT00479687|363746997|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
105473626|NCT00479687|363746998|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
105473627|NCT00479687|363746996|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
105473628|NCT00479687|363746997|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
105697981|NCT00698997|364557438|FG000|Overall Study|Lost to Follow-up|3|||
105697982|NCT00698997|364557439|FG001|Overall Study|Lost to Follow-up|0|||
105697983|NCT00698997|364557438|FG000|Overall Study|Withdrawal by Subject|7|||
105697984|NCT00698997|364557439|FG001|Overall Study|Withdrawal by Subject|27|||
105697985|NCT05082376|364557442|FG000|Overall Study|Lost to Follow-up|2|||
105348529|NCT01534208|363277115|FG001|Overall Study|Withdrawal by Subject|20|||
105348530|NCT01534208|363277114|FG000|Overall Study|Adverse Event|15|||
105348531|NCT01534208|363277115|FG001|Overall Study|Adverse Event|8|||
105348532|NCT01534208|363277114|FG000|Overall Study|Physician Decision|2|||
105473629|NCT00479687|363746998|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
105473630|NCT00479687|363746996|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
105473631|NCT00479687|363746997|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
105697986|NCT01045798|364557450|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
105697987|NCT01045798|364557451|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
105697988|NCT01045798|364557450|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
105473632|NCT00479687|363746998|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
105473633|NCT00479687|363746996|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
105697989|NCT01045798|364557451|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
105697990|NCT01045798|364557450|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
105697991|NCT01045798|364557451|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
105348533|NCT01534208|363277115|FG001|Overall Study|Physician Decision|0|||
105348534|NCT01534208|363277114|FG000|Overall Study|Lack of Efficacy|0|||
105348535|NCT01534208|363277115|FG001|Overall Study|Lack of Efficacy|3|||
105348536|NCT01534208|363277114|FG000|Overall Study|Protocol Violation|2|||
105348537|NCT01534208|363277115|FG001|Overall Study|Protocol Violation|2|||
105348538|NCT01534208|363277114|FG000|Overall Study|Sponsor decision|4|||
105348539|NCT01534208|363277115|FG001|Overall Study|Sponsor decision|1|||
105348540|NCT01534208|363277114|FG000|Overall Study|Subject relocation|2|||
105348541|NCT01534208|363277115|FG001|Overall Study|Subject relocation|0|||
105348542|NCT01534208|363277114|FG000|Overall Study|Lab assessment|2|||
105348543|NCT01534208|363277115|FG001|Overall Study|Lab assessment|1|||
105348544|NCT01534208|363277114|FG000|Overall Study|Eligibility error|3|||
105348545|NCT01534208|363277115|FG001|Overall Study|Eligibility error|0|||
105348546|NCT01534208|363277114|FG000|Overall Study|PCP decision|1|||
105348547|NCT01534208|363277115|FG001|Overall Study|PCP decision|0|||
105348548|NCT01534208|363277114|FG000|Overall Study|Needed prohibited meds|1|||
105697992|NCT01045798|364557450|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
105697993|NCT01045798|364557451|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
105697994|NCT04669535|364557453|FG000|Overall Study|Death|1|||
105697995|NCT04669535|364557454|FG001|Overall Study|Death|1|||
105697996|NCT04669535|364557455|FG002|Overall Study|Death|0|||
105697997|NCT04669535|364557456|FG003|Overall Study|Death|0|||
105697998|NCT01401842|364557457|FG000|Overall Study|Withdrawal by Subject|3|||
105697999|NCT01401842|364557458|FG001|Overall Study|Withdrawal by Subject|2|||
105698000|NCT01401842|364557457|FG000|Overall Study|academic reason|4|||
105698001|NCT01401842|364557458|FG001|Overall Study|academic reason|1|||
105698002|NCT01401842|364557457|FG000|Overall Study|changed companies|20|||
105698003|NCT01401842|364557458|FG001|Overall Study|changed companies|34|||
105698004|NCT01401842|364557457|FG000|Overall Study|discharged from US Army|3|||
105698005|NCT01401842|364557458|FG001|Overall Study|discharged from US Army|4|||
105698006|NCT01401842|364557457|FG000|Overall Study|invalid follow-up strength data|1|||
105698007|NCT01401842|364557458|FG001|Overall Study|invalid follow-up strength data|4|||
105698008|NCT01401842|364557457|FG000|Overall Study|on profile|9|||
105698009|NCT01401842|364557458|FG001|Overall Study|on profile|5|||
105698010|NCT01401842|364557457|FG000|Overall Study|other/unknown|28|||
105698011|NCT01401842|364557458|FG001|Overall Study|other/unknown|17|||
105698012|NCT00282295|364557459|FG000|Overall Study|Adverse Event|0|||
105698013|NCT00282295|364557460|FG001|Overall Study|Adverse Event|1|||
105348549|NCT01534208|363277115|FG001|Overall Study|Needed prohibited meds|0|||
105348550|NCT02912455|363277117|FG000|Overall Study|Withdrawal by Subject|0|||
105348551|NCT02912455|363277118|FG001|Overall Study|Withdrawal by Subject|1|||
105348552|NCT02912455|363277117|FG000|Overall Study|Lack of Efficacy|0|||
105348553|NCT02912455|363277118|FG001|Overall Study|Lack of Efficacy|1|||
105348554|NCT02912455|363277117|FG000|Overall Study|Lost to Follow-up|2|||
105348555|NCT02912455|363277118|FG001|Overall Study|Lost to Follow-up|1|||
105348556|NCT02267135|363277121|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
105348557|NCT02267135|363277122|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
105348558|NCT02267135|363277121|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
105348559|NCT02267135|363277122|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
105348560|NCT02267135|363277121|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
105348561|NCT02267135|363277122|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
105348562|NCT02267135|363277121|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
105348563|NCT02267135|363277122|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
105348564|NCT02267135|363277121|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
105348565|NCT02267135|363277122|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
105348566|NCT04776018|363277123|FG000|Overall Study|Death|0|||
105348567|NCT04776018|363277124|FG001|Overall Study|Death|1|||
105348568|NCT04776018|363277125|FG002|Overall Study|Death|4|||
105348569|NCT04776018|363277126|FG003|Overall Study|Death|1|||
105348570|NCT04776018|363277127|FG004|Overall Study|Death|4|||
105348571|NCT04776018|363277128|FG005|Overall Study|Death|0|||
105348572|NCT04776018|363277129|FG006|Overall Study|Death|0|||
105348573|NCT04776018|363277123|FG000|Overall Study|Study terminated by sponsor|2|||
105348574|NCT04776018|363277124|FG001|Overall Study|Study terminated by sponsor|1|||
105348575|NCT04776018|363277125|FG002|Overall Study|Study terminated by sponsor|4|||
105348576|NCT04776018|363277126|FG003|Overall Study|Study terminated by sponsor|0|||
105698014|NCT00282295|364557461|FG002|Overall Study|Adverse Event|0|||
105698015|NCT00282295|364557459|FG000|Overall Study|Serious Adverse Events|0|||
105698016|NCT00282295|364557460|FG001|Overall Study|Serious Adverse Events|0|||
105698017|NCT00282295|364557461|FG002|Overall Study|Serious Adverse Events|1|||
105698018|NCT00282295|364557459|FG000|Overall Study|Protocol Violation|0|||
105348577|NCT04776018|363277127|FG004|Overall Study|Study terminated by sponsor|3|||
105348578|NCT04776018|363277128|FG005|Overall Study|Study terminated by sponsor|0|||
105348579|NCT04776018|363277129|FG006|Overall Study|Study terminated by sponsor|0|||
105348580|NCT04776018|363277123|FG000|Overall Study|Withdrawal by Subject|1|||
105348581|NCT04776018|363277124|FG001|Overall Study|Withdrawal by Subject|0|||
105348582|NCT04776018|363277125|FG002|Overall Study|Withdrawal by Subject|0|||
105348583|NCT04776018|363277126|FG003|Overall Study|Withdrawal by Subject|2|||
105698019|NCT00282295|364557460|FG001|Overall Study|Protocol Violation|2|||
105348584|NCT04776018|363277127|FG004|Overall Study|Withdrawal by Subject|1|||
105348585|NCT04776018|363277128|FG005|Overall Study|Withdrawal by Subject|0|||
105698020|NCT00282295|364557461|FG002|Overall Study|Protocol Violation|1|||
105698021|NCT00282295|364557459|FG000|Overall Study|Withdrawal by Subject|2|||
105698022|NCT00282295|364557460|FG001|Overall Study|Withdrawal by Subject|6|||
105698023|NCT00282295|364557461|FG002|Overall Study|Withdrawal by Subject|4|||
105698024|NCT00282295|364557459|FG000|Overall Study|Lost to Follow-up|1|||
105698025|NCT00282295|364557460|FG001|Overall Study|Lost to Follow-up|7|||
105698026|NCT00282295|364557461|FG002|Overall Study|Lost to Follow-up|2|||
105698027|NCT00282295|364557459|FG000|Overall Study|Other|0|||
105698028|NCT00282295|364557460|FG001|Overall Study|Other|1|||
105698029|NCT00282295|364557461|FG002|Overall Study|Other|0|||
105698030|NCT03416153|364557464|FG000|Overall Study|Physician Decision|1|||
105698031|NCT03416153|364557465|FG001|Overall Study|Physician Decision|1|||
105698032|NCT03416153|364557464|FG000|Overall Study|Withdrawal by Subject|1|||
105698033|NCT03416153|364557465|FG001|Overall Study|Withdrawal by Subject|0|||
105698034|NCT03227471|364559132|FG000|Overall Study|Withdrawal by Subject|0|||
105698035|NCT03227471|364559133|FG001|Overall Study|Withdrawal by Subject|0|||
105559402|NCT02291614|364044676|FG001|Overall Study|Death|0|||
105559403|NCT02291614|364044677|FG002|Overall Study|Death|1|||
105559404|NCT02291614|364044678|FG003|Overall Study|Death|0|||
105559405|NCT02291614|364044679|FG004|Overall Study|Death|1|||
105559406|NCT02291614|364044680|FG005|Overall Study|Death|1|||
105559407|NCT02291614|364044681|FG006|Overall Study|Death|1|||
105559408|NCT02291614|364044682|FG007|Overall Study|Death|0|||
105559409|NCT02291614|364044683|FG008|Overall Study|Death|0|||
105698036|NCT03227471|364559134|FG002|Overall Study|Withdrawal by Subject|0|||
105698037|NCT03227471|364559135|FG003|Overall Study|Withdrawal by Subject|0|||
105698038|NCT03227471|364559136|FG004|Overall Study|Withdrawal by Subject|1|||
105698039|NCT03227471|364559137|FG005|Overall Study|Withdrawal by Subject|0|||
105698040|NCT03227471|364559138|FG006|Overall Study|Withdrawal by Subject|0|||
105559410|NCT02291614|364044684|FG009|Overall Study|Death|0|||
105559411|NCT02291614|364044685|FG010|Overall Study|Death|0|||
105559412|NCT01662310|364044688|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
105559413|NCT01662310|364044689|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
105559414|NCT01662310|364044690|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
105559415|NCT01662310|364044691|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
105559416|NCT01662310|364044692|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
105559417|NCT01662310|364044688|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
105559418|NCT01662310|364044689|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
105559419|NCT01662310|364044690|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
105559420|NCT01662310|364044691|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
105559421|NCT01662310|364044692|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
105559422|NCT01662310|364044688|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
105559423|NCT01662310|364044689|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
105559424|NCT01662310|364044690|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
105348586|NCT04776018|363277129|FG006|Overall Study|Withdrawal by Subject|0|||
105559425|NCT01662310|364044691|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
105559426|NCT01662310|364044692|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
105559427|NCT01662310|364044688|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
105787164|NCT03110107|364874892|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
105787165|NCT03110107|364874893|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
105787166|NCT03110107|364874894|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
105787167|NCT03110107|364874895|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
105787168|NCT03110107|364874896|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
105787169|NCT03110107|364874897|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
105787170|NCT03110107|364874898|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
105787171|NCT03110107|364874899|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
105787172|NCT03110107|364874900|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
105787173|NCT03110107|364874901|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
105787174|NCT03110107|364874902|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
105787175|NCT03110107|364874903|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
105787176|NCT03110107|364874904|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
105787177|NCT03110107|364874905|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
105787178|NCT03110107|364874906|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
105787179|NCT03110107|364874907|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
105787180|NCT03110107|364874908|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
105787181|NCT03110107|364874909|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
105787182|NCT03110107|364874910|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
105787183|NCT03110107|364874911|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
105787184|NCT03110107|364874912|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
105787185|NCT03110107|364874913|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
105787186|NCT03110107|364874914|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
105787187|NCT03110107|364874889|FG000|Treatment Period|Participant withdrew consent|0|||
105787188|NCT03110107|364874890|FG001|Treatment Period|Participant withdrew consent|0|||
105787189|NCT03110107|364874891|FG002|Treatment Period|Participant withdrew consent|1|||
105787190|NCT03110107|364874892|FG003|Treatment Period|Participant withdrew consent|0|||
105787191|NCT03110107|364874893|FG004|Treatment Period|Participant withdrew consent|4|||
105559428|NCT01662310|364044689|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
105559429|NCT01662310|364044690|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
105559430|NCT01662310|364044691|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
105559431|NCT01662310|364044692|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
105559432|NCT01662310|364044688|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
105559433|NCT01662310|364044689|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
105559434|NCT01662310|364044690|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
105559435|NCT01662310|364044691|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
105559436|NCT01662310|364044692|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
105559437|NCT01662310|364044688|FG000|Run-In or Stabilization Phase|Other|1|||
105559438|NCT01662310|364044689|FG001|Run-In or Stabilization Phase|Other|0|||
105559439|NCT01662310|364044690|FG002|Run-In or Stabilization Phase|Other|0|||
105559440|NCT01662310|364044691|FG003|Run-In or Stabilization Phase|Other|0|||
105559441|NCT01662310|364044692|FG004|Run-In or Stabilization Phase|Other|0|||
105559442|NCT01662310|364044688|FG000|Double-Blind Phase|Adverse Event|0|||
105559443|NCT01662310|364044689|FG001|Double-Blind Phase|Adverse Event|0|||
105559444|NCT01662310|364044690|FG002|Double-Blind Phase|Adverse Event|1|||
105559445|NCT01662310|364044691|FG003|Double-Blind Phase|Adverse Event|0|||
105559446|NCT01662310|364044692|FG004|Double-Blind Phase|Adverse Event|0|||
105559447|NCT01662310|364044688|FG000|Double-Blind Phase|Lost to Follow-up|0|||
105559448|NCT01662310|364044689|FG001|Double-Blind Phase|Lost to Follow-up|3|||
105559449|NCT01662310|364044690|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105559450|NCT01662310|364044691|FG003|Double-Blind Phase|Lost to Follow-up|0|||
105559451|NCT01662310|364044692|FG004|Double-Blind Phase|Lost to Follow-up|0|||
105559452|NCT01662310|364044688|FG000|Double-Blind Phase|Pregnancy|0|||
105559453|NCT01662310|364044689|FG001|Double-Blind Phase|Pregnancy|2|||
105559454|NCT01662310|364044690|FG002|Double-Blind Phase|Pregnancy|0|||
105559455|NCT01662310|364044691|FG003|Double-Blind Phase|Pregnancy|0|||
105559456|NCT01662310|364044692|FG004|Double-Blind Phase|Pregnancy|0|||
105559457|NCT01662310|364044688|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
105559458|NCT01662310|364044689|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
105559459|NCT01662310|364044690|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
105559460|NCT01662310|364044691|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
105559461|NCT01662310|364044692|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
105787192|NCT03110107|364874894|FG005|Treatment Period|Participant withdrew consent|3|||
105559462|NCT01662310|364044688|FG000|Double-Blind Phase|Other|0|||
105559463|NCT01662310|364044689|FG001|Double-Blind Phase|Other|0|||
105559464|NCT01662310|364044690|FG002|Double-Blind Phase|Other|1|||
105559465|NCT01662310|364044691|FG003|Double-Blind Phase|Other|0|||
105559466|NCT01662310|364044692|FG004|Double-Blind Phase|Other|0|||
105559467|NCT01662310|364044688|FG000|Double-Blind Phase|Randomized but not treated|0|||
105559468|NCT01662310|364044689|FG001|Double-Blind Phase|Randomized but not treated|1|||
105559469|NCT01662310|364044690|FG002|Double-Blind Phase|Randomized but not treated|0|||
105559470|NCT01662310|364044691|FG003|Double-Blind Phase|Randomized but not treated|0|||
105559471|NCT01662310|364044692|FG004|Double-Blind Phase|Randomized but not treated|0|||
105559472|NCT01662310|364044688|FG000|Open-Label Extension Phase|Adverse Event|0|||
105559473|NCT01662310|364044689|FG001|Open-Label Extension Phase|Adverse Event|0|||
105559474|NCT01662310|364044690|FG002|Open-Label Extension Phase|Adverse Event|0|||
105559475|NCT01662310|364044691|FG003|Open-Label Extension Phase|Adverse Event|3|||
105559476|NCT01662310|364044692|FG004|Open-Label Extension Phase|Adverse Event|0|||
105559477|NCT01662310|364044688|FG000|Open-Label Extension Phase|Death|0|||
105559478|NCT01662310|364044689|FG001|Open-Label Extension Phase|Death|0|||
105559479|NCT01662310|364044690|FG002|Open-Label Extension Phase|Death|0|||
105559480|NCT01662310|364044691|FG003|Open-Label Extension Phase|Death|1|||
105559481|NCT01662310|364044692|FG004|Open-Label Extension Phase|Death|0|||
105559482|NCT01662310|364044688|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
105559483|NCT01662310|364044689|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
105559484|NCT01662310|364044690|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
105559485|NCT01662310|364044691|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
105559486|NCT01662310|364044692|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
105559487|NCT01662310|364044688|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
105559488|NCT01662310|364044689|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
105559489|NCT01662310|364044690|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
105559490|NCT01662310|364044691|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
105559491|NCT01662310|364044692|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
105559492|NCT01662310|364044688|FG000|Open-Label Extension Phase|Pregnancy|0|||
105559493|NCT01662310|364044689|FG001|Open-Label Extension Phase|Pregnancy|0|||
105559494|NCT01662310|364044690|FG002|Open-Label Extension Phase|Pregnancy|0|||
105559495|NCT01662310|364044691|FG003|Open-Label Extension Phase|Pregnancy|1|||
105559496|NCT01662310|364044692|FG004|Open-Label Extension Phase|Pregnancy|0|||
105559497|NCT01662310|364044688|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
105559498|NCT01662310|364044689|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
105559499|NCT01662310|364044690|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
105559500|NCT01662310|364044691|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
105559501|NCT01662310|364044692|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
105559502|NCT02432105|364044699|FG000|Overall Study|Lost to Follow-up|1|||
105559503|NCT02432105|364044700|FG001|Overall Study|Lost to Follow-up|1|||
105559504|NCT02432105|364044701|FG002|Overall Study|Lost to Follow-up|0|||
105559505|NCT02432105|364044699|FG000|Overall Study|Withdrawal by Subject|1|||
105559506|NCT02432105|364044700|FG001|Overall Study|Withdrawal by Subject|0|||
105559507|NCT02432105|364044701|FG002|Overall Study|Withdrawal by Subject|1|||
105559508|NCT02432105|364044699|FG000|Overall Study|Culture positive for yeast|0|||
105559509|NCT02432105|364044700|FG001|Overall Study|Culture positive for yeast|1|||
105559510|NCT02432105|364044701|FG002|Overall Study|Culture positive for yeast|0|||
105559511|NCT02432105|364044699|FG000|Overall Study|Randomized in error|0|||
105559512|NCT02432105|364044700|FG001|Overall Study|Randomized in error|0|||
105559513|NCT02432105|364044701|FG002|Overall Study|Randomized in error|2|||
105559514|NCT01302847|364044702|FG000|Overall Study|Death|0|||
105559515|NCT01302847|364044703|FG001|Overall Study|Death|1|||
105559516|NCT01302847|364044704|FG002|Overall Study|Death|0|||
105559517|NCT01302847|364044705|FG003|Overall Study|Death|0|||
105559518|NCT01302847|364044706|FG004|Overall Study|Death|0|||
105559519|NCT01302847|364044707|FG005|Overall Study|Death|1|||
105559520|NCT01302847|364044708|FG006|Overall Study|Death|1|||
105348587|NCT04776018|363277123|FG000|Overall Study|Other|0|||
105348588|NCT04776018|363277124|FG001|Overall Study|Other|1|||
105348589|NCT04776018|363277125|FG002|Overall Study|Other|1|||
105348590|NCT04776018|363277126|FG003|Overall Study|Other|0|||
105348591|NCT04776018|363277127|FG004|Overall Study|Other|0|||
105348592|NCT04776018|363277128|FG005|Overall Study|Other|0|||
105348593|NCT04776018|363277129|FG006|Overall Study|Other|0|||
105348594|NCT04776018|363277123|FG000|Overall Study|Lost to Follow-up|0|||
105348595|NCT04776018|363277124|FG001|Overall Study|Lost to Follow-up|0|||
105348596|NCT04776018|363277125|FG002|Overall Study|Lost to Follow-up|1|||
105348597|NCT04776018|363277126|FG003|Overall Study|Lost to Follow-up|0|||
105348598|NCT04776018|363277127|FG004|Overall Study|Lost to Follow-up|0|||
105348599|NCT04776018|363277128|FG005|Overall Study|Lost to Follow-up|0|||
105348600|NCT04776018|363277129|FG006|Overall Study|Lost to Follow-up|0|||
105348601|NCT05249127|363277130|FG000|Overall Study|Protocol Violation|13|||
105348602|NCT05249127|363277130|FG000|Overall Study|Physician Decision|4|||
105473634|NCT00479687|363746997|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
105473635|NCT00479687|363746998|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
105473636|NCT00479687|363746996|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
105348603|NCT05249127|363277130|FG000|Overall Study|Withdrawal by Subject|2|||
105348604|NCT05249127|363277130|FG000|Overall Study|Participant Non-compliance|1|||
105348605|NCT00415597|363277131|FG000|Enrollment|Withdrawal by Subject|1|||
105698041|NCT03227471|364559139|FG007|Overall Study|Withdrawal by Subject|0|||
105698042|NCT03227471|364559140|FG008|Overall Study|Withdrawal by Subject|0|||
105698043|NCT03227471|364559141|FG009|Overall Study|Withdrawal by Subject|0|||
105698044|NCT03227471|364559142|FG010|Overall Study|Withdrawal by Subject|0|||
105473637|NCT00479687|363746997|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
105473638|NCT00479687|363746998|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
105473639|NCT00479687|363746996|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
105559521|NCT01302847|364044709|FG007|Overall Study|Death|0|||
105559522|NCT01302847|364044702|FG000|Overall Study|Pregnancy|2|||
105698045|NCT03227471|364559143|FG011|Overall Study|Withdrawal by Subject|0|||
105698046|NCT03227471|364559144|FG012|Overall Study|Withdrawal by Subject|1|||
105698047|NCT03227471|364559145|FG013|Overall Study|Withdrawal by Subject|0|||
105559523|NCT01302847|364044703|FG001|Overall Study|Pregnancy|0|||
105559524|NCT01302847|364044704|FG002|Overall Study|Pregnancy|0|||
105559525|NCT01302847|364044705|FG003|Overall Study|Pregnancy|0|||
105787193|NCT03110107|364874895|FG006|Treatment Period|Participant withdrew consent|0|||
105559526|NCT01302847|364044706|FG004|Overall Study|Pregnancy|0|||
105348606|NCT00415597|363277131|FG000|Enrollment|Protocol Violation|1|||
105348607|NCT00415597|363277131|FG000|Treatment|Adverse Event|110|||
105348608|NCT00415597|363277131|FG000|Treatment|Lack of Efficacy|39|||
105348609|NCT00415597|363277131|FG000|Treatment|Protocol Violation|67|||
105348610|NCT00415597|363277131|FG000|Treatment|Physician Decision|3|||
105348611|NCT00415597|363277131|FG000|Treatment|Withdrawal by Subject|51|||
105348612|NCT00415597|363277131|FG000|Treatment|Lost to Follow-up|28|||
105348613|NCT00415597|363277131|FG000|Treatment|Drug Screen|2|||
105348614|NCT00415597|363277131|FG000|Treatment|Administrative|3|||
105348615|NCT00415597|363277131|FG000|Treatment|Sponsor Decision|1|||
105348616|NCT00415597|363277131|FG000|Treatment|Multiple Reasons|1|||
105348617|NCT00435019|363277132|FG000|Overall Study|Adverse Event|1|||
105348618|NCT00435019|363277133|FG001|Overall Study|Adverse Event|0|||
105348619|NCT00435019|363277132|FG000|Overall Study|Lack of Efficacy|1|||
105348620|NCT00435019|363277133|FG001|Overall Study|Lack of Efficacy|2|||
105348621|NCT00435019|363277132|FG000|Overall Study|Protocol Violation|3|||
105348622|NCT00435019|363277133|FG001|Overall Study|Protocol Violation|1|||
105348623|NCT00435019|363277132|FG000|Overall Study|Personal reasons for withdrawal|8|||
105348624|NCT00435019|363277133|FG001|Overall Study|Personal reasons for withdrawal|7|||
105348625|NCT02172040|363277136|FG000|Overall Study|Adverse Event|0|||
105348626|NCT02172040|363277137|FG001|Overall Study|Adverse Event|2|||
105348627|NCT02172040|363277138|FG002|Overall Study|Adverse Event|0|||
105348628|NCT02172040|363277139|FG003|Overall Study|Adverse Event|0|||
105348629|NCT02172040|363277136|FG000|Overall Study|Protocol Violation|0|||
105348630|NCT02172040|363277137|FG001|Overall Study|Protocol Violation|1|||
105348631|NCT02172040|363277138|FG002|Overall Study|Protocol Violation|0|||
105348632|NCT02172040|363277139|FG003|Overall Study|Protocol Violation|0|||
105348633|NCT02172040|363277136|FG000|Overall Study|Withdrawal by Subject|0|||
105348634|NCT02172040|363277137|FG001|Overall Study|Withdrawal by Subject|0|||
105348635|NCT02172040|363277138|FG002|Overall Study|Withdrawal by Subject|1|||
105348636|NCT02172040|363277139|FG003|Overall Study|Withdrawal by Subject|0|||
105348637|NCT02172040|363277136|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
105348638|NCT02172040|363277137|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
105348639|NCT02172040|363277138|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
105348640|NCT02172040|363277139|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
105348641|NCT02172040|363277136|FG000|Overall Study|Family emergency abroad|0|||
105348642|NCT02172040|363277137|FG001|Overall Study|Family emergency abroad|0|||
105348643|NCT02172040|363277138|FG002|Overall Study|Family emergency abroad|0|||
105348644|NCT02172040|363277139|FG003|Overall Study|Family emergency abroad|1|||
105348645|NCT03887117|363279128|FG000|Overall Study|Discontinued prematurely|0|||
105348646|NCT03887117|363279129|FG001|Overall Study|Discontinued prematurely|1|||
105348647|NCT03887117|363279130|FG002|Overall Study|Discontinued prematurely|1|||
105348648|NCT03887117|363279131|FG003|Overall Study|Discontinued prematurely|2|||
105348649|NCT04908475|363279132|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
105348650|NCT04908475|363279133|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105348651|NCT04908475|363279134|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105348652|NCT04908475|363279135|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105348653|NCT04908475|363279136|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105787194|NCT03110107|364874896|FG007|Treatment Period|Participant withdrew consent|0|||
105348654|NCT04908475|363279137|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105348655|NCT04908475|363279132|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
105348656|NCT04908475|363279133|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
105348657|NCT04908475|363279134|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
105348658|NCT04908475|363279135|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
105348659|NCT04908475|363279136|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
105348660|NCT04908475|363279137|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
105348661|NCT04908475|363279132|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
105473640|NCT00479687|363746997|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
105473641|NCT00479687|363746998|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
105473642|NCT00479687|363746996|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
105473643|NCT00479687|363746997|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
105473644|NCT00479687|363746998|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
105348662|NCT04908475|363279133|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
105348663|NCT04908475|363279134|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
105348664|NCT04908475|363279135|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
105348665|NCT04908475|363279136|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
105348666|NCT04908475|363279137|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
105348667|NCT04908475|363279132|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105348668|NCT04908475|363279133|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
105348669|NCT04908475|363279134|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
105348670|NCT04908475|363279135|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
105348671|NCT04908475|363279136|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105348672|NCT04908475|363279137|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105348673|NCT04908475|363279132|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
105348674|NCT04908475|363279133|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
105348675|NCT04908475|363279134|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
105473645|NCT00479687|363746996|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
105348676|NCT04908475|363279135|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
105348677|NCT04908475|363279136|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
105348678|NCT04908475|363279137|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
105473646|NCT00479687|363746997|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
105473647|NCT00479687|363746998|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
105473648|NCT00479687|363746996|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
105559527|NCT01302847|364044707|FG005|Overall Study|Pregnancy|0|||
105348679|NCT04908475|363279132|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
105698048|NCT03227471|364559146|FG014|Overall Study|Withdrawal by Subject|0|||
105698049|NCT03227471|364559132|FG000|Overall Study|Randomized, Never Dosed|0|||
105698050|NCT03227471|364559133|FG001|Overall Study|Randomized, Never Dosed|0|||
105698051|NCT03227471|364559134|FG002|Overall Study|Randomized, Never Dosed|0|||
105698052|NCT03227471|364559135|FG003|Overall Study|Randomized, Never Dosed|0|||
105698053|NCT03227471|364559136|FG004|Overall Study|Randomized, Never Dosed|0|||
105698054|NCT03227471|364559137|FG005|Overall Study|Randomized, Never Dosed|0|||
105698055|NCT03227471|364559138|FG006|Overall Study|Randomized, Never Dosed|0|||
105698056|NCT03227471|364559139|FG007|Overall Study|Randomized, Never Dosed|0|||
105698057|NCT03227471|364559140|FG008|Overall Study|Randomized, Never Dosed|0|||
105698058|NCT03227471|364559141|FG009|Overall Study|Randomized, Never Dosed|0|||
105698059|NCT03227471|364559142|FG010|Overall Study|Randomized, Never Dosed|0|||
105698060|NCT03227471|364559143|FG011|Overall Study|Randomized, Never Dosed|0|||
105698061|NCT03227471|364559144|FG012|Overall Study|Randomized, Never Dosed|0|||
105698062|NCT03227471|364559145|FG013|Overall Study|Randomized, Never Dosed|0|||
105698063|NCT03227471|364559146|FG014|Overall Study|Randomized, Never Dosed|1|||
105698064|NCT00257166|364559150|FG000|Overall Study|Adverse Event|18|||
105698065|NCT00257166|364559151|FG001|Overall Study|Adverse Event|13|||
105698066|NCT00257166|364559150|FG000|Overall Study|Laboratory abnormality|1|||
105698067|NCT00257166|364559151|FG001|Overall Study|Laboratory abnormality|0|||
105698068|NCT00257166|364559150|FG000|Overall Study|Lost to Follow-up|8|||
105698069|NCT00257166|364559151|FG001|Overall Study|Lost to Follow-up|1|||
105698070|NCT00257166|364559150|FG000|Overall Study|Withdrawal by Subject|9|||
105698071|NCT00257166|364559151|FG001|Overall Study|Withdrawal by Subject|2|||
105698072|NCT00257166|364559150|FG000|Overall Study|Other|16|||
105698073|NCT00257166|364559151|FG001|Overall Study|Other|21|||
105698074|NCT00257166|364559150|FG000|Overall Study|Randomized, but not treated|1|||
105698075|NCT00257166|364559151|FG001|Overall Study|Randomized, but not treated|0|||
105698076|NCT00525044|364559158|FG000|Overall Study|Lost to Follow-up|0|||
105698077|NCT00525044|364559159|FG001|Overall Study|Lost to Follow-up|1|||
105698078|NCT02142738|364559165|FG000|Overall Study|Adverse Event|13|||
105698079|NCT02142738|364559166|FG001|Overall Study|Adverse Event|9|||
105698080|NCT02142738|364559165|FG000|Overall Study|Death|92|||
105698081|NCT02142738|364559166|FG001|Overall Study|Death|112|||
105698082|NCT02142738|364559165|FG000|Overall Study|Lost to Follow-up|0|||
105698083|NCT02142738|364559166|FG001|Overall Study|Lost to Follow-up|3|||
105698084|NCT02142738|364559165|FG000|Overall Study|Withdrawal by Subject|6|||
105698085|NCT02142738|364559166|FG001|Overall Study|Withdrawal by Subject|7|||
105698086|NCT02142738|364559165|FG000|Overall Study|Follow up ended by sponsor|43|||
105698087|NCT02142738|364559166|FG001|Overall Study|Follow up ended by sponsor|20|||
105698088|NCT03688880|364559167|FG000|Overall Study|Withdrawal by Subject|0|||
105698089|NCT03688880|364559168|FG001|Overall Study|Withdrawal by Subject|2|||
105698090|NCT03688880|364559167|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
105698091|NCT03688880|364559168|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
105698092|NCT03688880|364559167|FG000|Overall Study|Lost to Follow-up|4|||
105698093|NCT03688880|364559168|FG001|Overall Study|Lost to Follow-up|7|||
105698094|NCT03688880|364559167|FG000|Overall Study|Adverse Event|0|||
105698095|NCT03688880|364559168|FG001|Overall Study|Adverse Event|2|||
105698096|NCT03688880|364559167|FG000|Overall Study|Device deficiencies|0|||
105698097|NCT03688880|364559168|FG001|Overall Study|Device deficiencies|2|||
105698098|NCT03688880|364559167|FG000|Overall Study|Other|10|||
105698099|NCT03688880|364559168|FG001|Overall Study|Other|16|||
105698100|NCT02553265|364559169|FG000|Enrollment|Death|0|||
105698101|NCT02553265|364559170|FG001|Enrollment|Death|0|||
105698102|NCT02553265|364559171|FG002|Enrollment|Death|1|||
105698103|NCT02553265|364559169|FG000|First Intervention (28 Days)|Adverse Event|1|||
105698104|NCT02553265|364559170|FG001|First Intervention (28 Days)|Adverse Event|0|||
105698105|NCT02553265|364559171|FG002|First Intervention (28 Days)|Adverse Event|0|||
105698106|NCT02553265|364559169|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
105698107|NCT02553265|364559170|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
105698108|NCT02553265|364559171|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
105698109|NCT02553265|364559169|FG000|Second Intervention (28 Days)|Adverse Event|1|||
105698110|NCT02553265|364559170|FG001|Second Intervention (28 Days)|Adverse Event|0|||
105698111|NCT02553265|364559171|FG002|Second Intervention (28 Days)|Adverse Event|0|||
105698112|NCT02553265|364559169|FG000|Third Intervention (28 Days)|Adverse Event|1|||
105698113|NCT02553265|364559170|FG001|Third Intervention (28 Days)|Adverse Event|0|||
105698114|NCT02553265|364559171|FG002|Third Intervention (28 Days)|Adverse Event|0|||
105698115|NCT02553265|364559169|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
105698116|NCT02553265|364559170|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
105698117|NCT02553265|364559171|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
105698118|NCT02163187|364559173|FG000|Overall Study|Device removed|1|||
105698119|NCT02163187|364559174|FG001|Overall Study|Device removed|0|||
105698120|NCT02163187|364559173|FG000|Overall Study|Progressive disease|1|||
105698121|NCT02163187|364559174|FG001|Overall Study|Progressive disease|0|||
105698122|NCT04854434|364559175|FG000|Overall Study|Death|1|||
105698123|NCT04854434|364559176|FG001|Overall Study|Death|3|||
105698124|NCT04854434|364559177|FG002|Overall Study|Death|4|||
105698125|NCT04854434|364559175|FG000|Overall Study|Study Terminated by Sponsor|2|||
105698126|NCT04854434|364559176|FG001|Overall Study|Study Terminated by Sponsor|0|||
105698127|NCT04854434|364559177|FG002|Overall Study|Study Terminated by Sponsor|0|||
105698128|NCT04854434|364559175|FG000|Overall Study|Other|1|||
105698129|NCT04854434|364559176|FG001|Overall Study|Other|1|||
105698130|NCT04854434|364559177|FG002|Overall Study|Other|0|||
105698131|NCT01469182|364559179|FG000|Overall Study|Adverse Event|21|||
105698132|NCT01469182|364559180|FG001|Overall Study|Adverse Event|3|||
105698133|NCT01469182|364559179|FG000|Overall Study|Lost to Follow-up|3|||
105698134|NCT01469182|364559180|FG001|Overall Study|Lost to Follow-up|0|||
105698135|NCT01469182|364559179|FG000|Overall Study|Withdrawal by Subject|4|||
105698136|NCT01469182|364559180|FG001|Overall Study|Withdrawal by Subject|1|||
105698137|NCT01469182|364559179|FG000|Overall Study|Protocol Violation|4|||
105698138|NCT01469182|364559180|FG001|Overall Study|Protocol Violation|2|||
105698139|NCT01469182|364559179|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
105698140|NCT01469182|364559180|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
105698141|NCT00514514|364559181|FG000|Pre-phase|Death|10|||
105698142|NCT00514514|364559182|FG001|Pre-phase|Death|0|||
105698143|NCT00514514|364559183|FG002|Pre-phase|Death|0|||
105698144|NCT00514514|364559181|FG000|Pre-phase|administrative problems|2|||
105698145|NCT00514514|364559182|FG001|Pre-phase|administrative problems|0|||
105698146|NCT00514514|364559183|FG002|Pre-phase|administrative problems|0|||
105698147|NCT00514514|364559181|FG000|Pre-phase|Protocol Violation|6|||
105698148|NCT00514514|364559182|FG001|Pre-phase|Protocol Violation|0|||
105698149|NCT00514514|364559183|FG002|Pre-phase|Protocol Violation|0|||
105698150|NCT00514514|364559181|FG000|Pre-phase|condition no longer requires study drug|7|||
105698151|NCT00514514|364559182|FG001|Pre-phase|condition no longer requires study drug|0|||
105698152|NCT00514514|364559183|FG002|Pre-phase|condition no longer requires study drug|0|||
105698153|NCT00514514|364559181|FG000|Pre-phase|abnormal test procedure results|15|||
105698154|NCT00514514|364559182|FG001|Pre-phase|abnormal test procedure results|0|||
105698155|NCT00514514|364559183|FG002|Pre-phase|abnormal test procedure results|0|||
105698156|NCT00514514|364559181|FG000|Pre-phase|Lost to Follow-up|2|||
105787195|NCT03110107|364874897|FG008|Treatment Period|Participant withdrew consent|0|||
105787196|NCT03110107|364874898|FG009|Treatment Period|Participant withdrew consent|1|||
105787197|NCT03110107|364874899|FG010|Treatment Period|Participant withdrew consent|0|||
105698157|NCT00514514|364559182|FG001|Pre-phase|Lost to Follow-up|0|||
105698158|NCT00514514|364559183|FG002|Pre-phase|Lost to Follow-up|0|||
105698159|NCT00514514|364559181|FG000|Pre-phase|abnormal lab values|23|||
105698160|NCT00514514|364559182|FG001|Pre-phase|abnormal lab values|0|||
105698161|NCT00514514|364559183|FG002|Pre-phase|abnormal lab values|0|||
105698162|NCT00514514|364559181|FG000|Pre-phase|Lack of Efficacy|35|||
105787198|NCT03110107|364874900|FG011|Treatment Period|Participant withdrew consent|0|||
105698163|NCT00514514|364559182|FG001|Pre-phase|Lack of Efficacy|0|||
105698164|NCT00514514|364559183|FG002|Pre-phase|Lack of Efficacy|0|||
105698165|NCT00514514|364559181|FG000|Pre-phase|Adverse Event|137|||
105698166|NCT00514514|364559182|FG001|Pre-phase|Adverse Event|0|||
105698167|NCT00514514|364559183|FG002|Pre-phase|Adverse Event|0|||
105698168|NCT00514514|364559181|FG000|Pre-phase|Withdrawal by Subject|66|||
105698169|NCT00514514|364559182|FG001|Pre-phase|Withdrawal by Subject|0|||
105698170|NCT00514514|364559183|FG002|Pre-phase|Withdrawal by Subject|0|||
105698171|NCT00514514|364559181|FG000|Randomized - 9 Month|Death|3|||
105698172|NCT00514514|364559182|FG001|Randomized - 9 Month|Death|2|||
105698173|NCT00514514|364559183|FG002|Randomized - 9 Month|Death|2|||
105698174|NCT00514514|364559181|FG000|Randomized - 9 Month|Administrative problems|1|||
105698175|NCT00514514|364559182|FG001|Randomized - 9 Month|Administrative problems|1|||
105698176|NCT00514514|364559183|FG002|Randomized - 9 Month|Administrative problems|2|||
105698177|NCT00514514|364559181|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
105698178|NCT00514514|364559182|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
105698179|NCT00514514|364559183|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
105698180|NCT00514514|364559181|FG000|Randomized - 9 Month|Protocol Violation|1|||
105698181|NCT00514514|364559182|FG001|Randomized - 9 Month|Protocol Violation|1|||
105698182|NCT00514514|364559183|FG002|Randomized - 9 Month|Protocol Violation|0|||
105698183|NCT00514514|364559181|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
105698184|NCT00514514|364559182|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
105698185|NCT00514514|364559183|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
105698186|NCT00514514|364559181|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
105698187|NCT00514514|364559182|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
105698188|NCT00514514|364559183|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
105348680|NCT04908475|363279133|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
105348681|NCT04908475|363279134|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
105348682|NCT04908475|363279135|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
105348683|NCT04908475|363279136|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
105348684|NCT04908475|363279137|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
105348685|NCT01739764|363279138|FG000|Overall Study|Adverse Event|0|||
105348686|NCT01739764|363279139|FG001|Overall Study|Adverse Event|3|||
105348687|NCT01739764|363279140|FG002|Overall Study|Adverse Event|4|||
105348688|NCT01739764|363279138|FG000|Overall Study|Death|4|||
105348689|NCT01739764|363279139|FG001|Overall Study|Death|6|||
105348690|NCT01739764|363279140|FG002|Overall Study|Death|38|||
105348691|NCT01739764|363279138|FG000|Overall Study|Lost to Follow-up|0|||
105348692|NCT01739764|363279139|FG001|Overall Study|Lost to Follow-up|0|||
105348693|NCT01739764|363279140|FG002|Overall Study|Lost to Follow-up|5|||
105348694|NCT01739764|363279138|FG000|Overall Study|Non-Compliance|0|||
105348695|NCT01739764|363279139|FG001|Overall Study|Non-Compliance|0|||
105348696|NCT01739764|363279140|FG002|Overall Study|Non-Compliance|1|||
105348697|NCT01739764|363279138|FG000|Overall Study|Multiple Reasons|3|||
105348698|NCT01739764|363279139|FG001|Overall Study|Multiple Reasons|2|||
105348699|NCT01739764|363279140|FG002|Overall Study|Multiple Reasons|3|||
105348700|NCT01739764|363279138|FG000|Overall Study|Physician Decision|2|||
105348701|NCT01739764|363279139|FG001|Overall Study|Physician Decision|2|||
105348702|NCT01739764|363279140|FG002|Overall Study|Physician Decision|4|||
105348703|NCT01739764|363279138|FG000|Overall Study|Progressive Disease|3|||
105348704|NCT01739764|363279139|FG001|Overall Study|Progressive Disease|5|||
105348705|NCT01739764|363279140|FG002|Overall Study|Progressive Disease|16|||
105348706|NCT01739764|363279138|FG000|Overall Study|Protocol Violation|0|||
105348707|NCT01739764|363279139|FG001|Overall Study|Protocol Violation|0|||
105348708|NCT01739764|363279140|FG002|Overall Study|Protocol Violation|2|||
105348709|NCT01739764|363279138|FG000|Overall Study|Study Terminated by Sponsor|8|||
105348710|NCT01739764|363279139|FG001|Overall Study|Study Terminated by Sponsor|13|||
105348711|NCT01739764|363279140|FG002|Overall Study|Study Terminated by Sponsor|26|||
105348712|NCT01739764|363279138|FG000|Overall Study|Withdrawal by Subject|6|||
105348713|NCT01739764|363279139|FG001|Overall Study|Withdrawal by Subject|5|||
105348714|NCT01739764|363279140|FG002|Overall Study|Withdrawal by Subject|27|||
105348715|NCT00337779|363279141|FG000|Overall Study|Withdrawal by Subject|10|||
105348716|NCT00337779|363279142|FG001|Overall Study|Withdrawal by Subject|12|||
105348717|NCT00337779|363279141|FG000|Overall Study|Sponsor decision|1|||
105348718|NCT00337779|363279142|FG001|Overall Study|Sponsor decision|1|||
105698189|NCT00514514|364559181|FG000|Randomized - 9 Month|Adverse Event|25|||
105698190|NCT00514514|364559182|FG001|Randomized - 9 Month|Adverse Event|44|||
105698191|NCT00514514|364559183|FG002|Randomized - 9 Month|Adverse Event|27|||
105698192|NCT00514514|364559181|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
105698193|NCT00514514|364559182|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
105698194|NCT00514514|364559183|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
105698195|NCT00514514|364559181|FG000|Extension - 4 Years|Lost to Follow-up|12|||
105698196|NCT00514514|364559182|FG001|Extension - 4 Years|Lost to Follow-up|10|||
105698197|NCT00514514|364559183|FG002|Extension - 4 Years|Lost to Follow-up|9|||
105348719|NCT00337779|363279141|FG000|Overall Study|Physician Decision|3|||
105348720|NCT00337779|363279142|FG001|Overall Study|Physician Decision|6|||
105348721|NCT00337779|363279141|FG000|Overall Study|Protocol Violation|1|||
105348722|NCT00337779|363279142|FG001|Overall Study|Protocol Violation|1|||
105348723|NCT00337779|363279141|FG000|Overall Study|Lost to Follow-up|6|||
105348724|NCT00337779|363279142|FG001|Overall Study|Lost to Follow-up|5|||
105348725|NCT00337779|363279141|FG000|Overall Study|Adverse Event|28|||
105348726|NCT00337779|363279142|FG001|Overall Study|Adverse Event|51|||
105348727|NCT00337779|363279141|FG000|Overall Study|Pregnancy|3|||
105348728|NCT00337779|363279142|FG001|Overall Study|Pregnancy|2|||
105348729|NCT00337779|363279141|FG000|Overall Study|Death|0|||
105348730|NCT00337779|363279142|FG001|Overall Study|Death|1|||
105348731|NCT00404924|363279145|FG000|Overall Study|Adverse Event|75|||
105348732|NCT00404924|363279146|FG001|Overall Study|Adverse Event|16|||
105348733|NCT00404924|363279145|FG000|Overall Study|Condition under investigation worsened|475|||
105348734|NCT00404924|363279146|FG001|Overall Study|Condition under investigation worsened|264|||
105698198|NCT00514514|364559181|FG000|Extension - 4 Years|Administrative problems|3|||
105698199|NCT00514514|364559182|FG001|Extension - 4 Years|Administrative problems|1|||
105698200|NCT00514514|364559183|FG002|Extension - 4 Years|Administrative problems|1|||
105698201|NCT00514514|364559181|FG000|Extension - 4 Years|Death|8|||
105698202|NCT00514514|364559182|FG001|Extension - 4 Years|Death|3|||
105698203|NCT00514514|364559183|FG002|Extension - 4 Years|Death|6|||
105698204|NCT00514514|364559181|FG000|Extension - 4 Years|Adverse Event|9|||
105698205|NCT00514514|364559182|FG001|Extension - 4 Years|Adverse Event|6|||
105698206|NCT00514514|364559183|FG002|Extension - 4 Years|Adverse Event|3|||
105698207|NCT03785925|364559185|FG000|Overall Study|Withdrawal by Subject|15|||
105698208|NCT03785925|364559185|FG000|Overall Study|Lost to Follow-up|1|||
105698209|NCT01756040|364559186|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
105698210|NCT01756040|364559186|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
105698211|NCT01756040|364559186|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
105698212|NCT01274715|364559187|FG000|Overall Study|Lost to Follow-up|1|||
105698213|NCT01274715|364559187|FG000|Overall Study|After consent, met exclusion criteria.|1|||
105698214|NCT01274715|364559187|FG000|Overall Study|After consent, met exclusion criteria.|1|||
105698215|NCT01274715|364559187|FG000|Overall Study|After consent, met exclusion criteria.|1|||
105698216|NCT04479436|364559189|FG000|Overall Study|Progressive disease|26|||
105698217|NCT04479436|364559190|FG001|Overall Study|Progressive disease|1|||
105698218|NCT04479436|364559189|FG000|Overall Study|Adverse Event|6|||
105698219|NCT04479436|364559190|FG001|Overall Study|Adverse Event|0|||
105698220|NCT04479436|364559189|FG000|Overall Study|Withdrawal by Subject|5|||
105698221|NCT04479436|364559190|FG001|Overall Study|Withdrawal by Subject|0|||
105698222|NCT04479436|364559189|FG000|Overall Study|Clinical progression|1|||
105698223|NCT04479436|364559190|FG001|Overall Study|Clinical progression|0|||
105698224|NCT04479436|364559189|FG000|Overall Study|Physician Decision|1|||
105698225|NCT04479436|364559190|FG001|Overall Study|Physician Decision|0|||
105698226|NCT01848288|364559191|FG000|Overall Study|Death|1|||
105698227|NCT01848288|364559191|FG000|Overall Study|Protocol Violation|1|||
105698228|NCT01848288|364559191|FG000|Overall Study|Withdrawal by Subject|1|||
105698229|NCT02865018|364559196|FG000|Overall Study|Withdrawal by Subject|1|||
105698230|NCT00290290|364559197|FG000|Overall Study|Death|3|||
105698231|NCT00290290|364559198|FG001|Overall Study|Death|4|||
105698232|NCT00290290|364559197|FG000|Overall Study|Withdrawal by Subject|2|||
105698233|NCT00290290|364559198|FG001|Overall Study|Withdrawal by Subject|2|||
105698234|NCT00290290|364559197|FG000|Overall Study|Underwent clean surgical procedure|13|||
105698235|NCT00290290|364559198|FG001|Overall Study|Underwent clean surgical procedure|12|||
105698236|NCT00549939|364559203|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
105698237|NCT00549939|364559204|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
105698238|NCT00549939|364559205|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
105698239|NCT00549939|364559203|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
105698240|NCT00549939|364559204|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
105698241|NCT00549939|364559205|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
105698242|NCT00549939|364559203|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
105698243|NCT00549939|364559204|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
105698244|NCT00549939|364559205|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
105698245|NCT00549939|364559203|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
105698246|NCT00549939|364559204|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
105698247|NCT00549939|364559205|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
105698248|NCT00549939|364559203|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
105698249|NCT00549939|364559204|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
105698250|NCT00549939|364559205|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
105698251|NCT00549939|364559203|FG000|40-week Open Label Treatment Period|Other|0|||
105698252|NCT00549939|364559204|FG001|40-week Open Label Treatment Period|Other|1|||
105698253|NCT00549939|364559205|FG002|40-week Open Label Treatment Period|Other|4|||
105698254|NCT01519934|364559208|FG000|Overall Study|Lost to Follow-up|3|||
105698255|NCT01994382|364559209|FG000|Overall Study|Informed consent withdrawn|0|||
105698256|NCT01994382|364559210|FG001|Overall Study|Informed consent withdrawn|0|||
105698257|NCT01994382|364559211|FG002|Overall Study|Informed consent withdrawn|0|||
105698258|NCT01994382|364559212|FG003|Overall Study|Informed consent withdrawn|0|||
105698259|NCT01994382|364559213|FG004|Overall Study|Informed consent withdrawn|0|||
105698260|NCT01994382|364559214|FG005|Overall Study|Informed consent withdrawn|0|||
105698261|NCT01994382|364559215|FG006|Overall Study|Informed consent withdrawn|1|||
105559528|NCT01302847|364044708|FG006|Overall Study|Pregnancy|0|||
105698262|NCT01994382|364559216|FG007|Overall Study|Informed consent withdrawn|0|||
105698263|NCT01994382|364559217|FG008|Overall Study|Informed consent withdrawn|0|||
105698264|NCT01994382|364559218|FG009|Overall Study|Informed consent withdrawn|0|||
105698265|NCT01994382|364559219|FG010|Overall Study|Informed consent withdrawn|0|||
105698266|NCT01994382|364559220|FG011|Overall Study|Informed consent withdrawn|0|||
105698267|NCT01994382|364559221|FG012|Overall Study|Informed consent withdrawn|0|||
105559529|NCT01302847|364044709|FG007|Overall Study|Pregnancy|0|||
105348735|NCT00404924|363279145|FG000|Overall Study|Lost to Follow-up|1|||
105348736|NCT00404924|363279146|FG001|Overall Study|Lost to Follow-up|1|||
105698268|NCT01994382|364559222|FG013|Overall Study|Informed consent withdrawn|0|||
105698269|NCT01994382|364559223|FG014|Overall Study|Informed consent withdrawn|0|||
105698270|NCT01994382|364559224|FG015|Overall Study|Informed consent withdrawn|0|||
105698271|NCT01994382|364559225|FG016|Overall Study|Informed consent withdrawn|0|||
105698272|NCT01994382|364559209|FG000|Overall Study|Progressive disease|3|||
105698273|NCT01994382|364559210|FG001|Overall Study|Progressive disease|4|||
105698274|NCT01994382|364559211|FG002|Overall Study|Progressive disease|4|||
105698275|NCT01994382|364559212|FG003|Overall Study|Progressive disease|3|||
105698276|NCT01994382|364559213|FG004|Overall Study|Progressive disease|2|||
105698277|NCT01994382|364559214|FG005|Overall Study|Progressive disease|3|||
105698278|NCT01994382|364559215|FG006|Overall Study|Progressive disease|3|||
105698279|NCT01994382|364559216|FG007|Overall Study|Progressive disease|6|||
105698280|NCT01994382|364559217|FG008|Overall Study|Progressive disease|2|||
105698281|NCT01994382|364559218|FG009|Overall Study|Progressive disease|2|||
105698282|NCT01994382|364559219|FG010|Overall Study|Progressive disease|13|||
105698283|NCT01994382|364559220|FG011|Overall Study|Progressive disease|8|||
105698284|NCT01994382|364559221|FG012|Overall Study|Progressive disease|7|||
105698285|NCT01994382|364559222|FG013|Overall Study|Progressive disease|3|||
105698286|NCT01994382|364559223|FG014|Overall Study|Progressive disease|6|||
105698287|NCT01994382|364559224|FG015|Overall Study|Progressive disease|44|||
105698288|NCT01994382|364559225|FG016|Overall Study|Progressive disease|28|||
105698289|NCT01994382|364559209|FG000|Overall Study|Physician Decision|0|||
105698290|NCT01994382|364559210|FG001|Overall Study|Physician Decision|1|||
105698291|NCT01994382|364559211|FG002|Overall Study|Physician Decision|0|||
105698292|NCT01994382|364559212|FG003|Overall Study|Physician Decision|0|||
105698293|NCT01994382|364559213|FG004|Overall Study|Physician Decision|0|||
105348737|NCT00404924|363279145|FG000|Overall Study|Withdrawal by Subject|26|||
105348738|NCT00404924|363279146|FG001|Overall Study|Withdrawal by Subject|13|||
105348739|NCT00404924|363279145|FG000|Overall Study|Other|25|||
105348740|NCT00404924|363279146|FG001|Overall Study|Other|11|||
105348741|NCT00404924|363279145|FG000|Overall Study|Randomised but not received treatment|1|||
105348742|NCT00404924|363279146|FG001|Overall Study|Randomised but not received treatment|1|||
105348743|NCT03913104|363279153|FG000|Overall Study|Lost to Follow-up|20|||
105348744|NCT03913104|363279153|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
105348745|NCT03913104|363279153|FG000|Overall Study|Withdrawal by Subject|2|||
105348746|NCT04490018|363279154|FG000|Overall Study|Protocol Violation|0|||
105348747|NCT04490018|363279155|FG001|Overall Study|Protocol Violation|2|||
105348748|NCT04490018|363279156|FG002|Overall Study|Protocol Violation|1|||
105348749|NCT04490018|363279154|FG000|Overall Study|Lost to Follow-up|2|||
105348750|NCT04490018|363279155|FG001|Overall Study|Lost to Follow-up|2|||
105348751|NCT04490018|363279156|FG002|Overall Study|Lost to Follow-up|0|||
105348752|NCT04490018|363279154|FG000|Overall Study|Withdrawal by Subject|2|||
105348753|NCT04490018|363279155|FG001|Overall Study|Withdrawal by Subject|1|||
105348754|NCT04490018|363279156|FG002|Overall Study|Withdrawal by Subject|0|||
105348755|NCT04490018|363279154|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105348756|NCT04490018|363279155|FG001|Overall Study|Withdrawal by parent/guardian|3|||
105348757|NCT04490018|363279156|FG002|Overall Study|Withdrawal by parent/guardian|0|||
105348758|NCT00089635|363279157|FG000|Overall Study|Adverse Event|2|||
105348759|NCT00089635|363279157|FG000|Overall Study|Death|17|||
105348760|NCT00089635|363279157|FG000|Overall Study|Disease Progression|12|||
105348761|NCT00089635|363279157|FG000|Overall Study|Lost to Follow-up|3|||
105348762|NCT00089635|363279157|FG000|Overall Study|Withdrawal by Subject|6|||
105348763|NCT00089635|363279157|FG000|Overall Study|Ineligibility determined|1|||
105348764|NCT00089635|363279157|FG000|Overall Study|Other|2|||
105348765|NCT01389258|363279158|FG000|Overall Study|Lost to Follow-up|5|||
105698294|NCT01994382|364559214|FG005|Overall Study|Physician Decision|0|||
105698295|NCT01994382|364559215|FG006|Overall Study|Physician Decision|0|||
105698296|NCT01994382|364559216|FG007|Overall Study|Physician Decision|0|||
105698297|NCT01994382|364559217|FG008|Overall Study|Physician Decision|0|||
105698298|NCT01994382|364559218|FG009|Overall Study|Physician Decision|0|||
105698299|NCT01994382|364559219|FG010|Overall Study|Physician Decision|3|||
105698300|NCT01994382|364559220|FG011|Overall Study|Physician Decision|1|||
105698301|NCT01994382|364559221|FG012|Overall Study|Physician Decision|1|||
105698302|NCT01994382|364559222|FG013|Overall Study|Physician Decision|0|||
105698303|NCT01994382|364559223|FG014|Overall Study|Physician Decision|1|||
105698304|NCT01994382|364559224|FG015|Overall Study|Physician Decision|4|||
105698305|NCT01994382|364559225|FG016|Overall Study|Physician Decision|2|||
105698306|NCT01994382|364559209|FG000|Overall Study|Death|0|||
105698307|NCT01994382|364559210|FG001|Overall Study|Death|0|||
105698308|NCT01994382|364559211|FG002|Overall Study|Death|0|||
105698309|NCT01994382|364559212|FG003|Overall Study|Death|0|||
105698310|NCT01994382|364559213|FG004|Overall Study|Death|1|||
105698311|NCT01994382|364559214|FG005|Overall Study|Death|0|||
105698312|NCT01994382|364559215|FG006|Overall Study|Death|0|||
105698313|NCT01994382|364559216|FG007|Overall Study|Death|0|||
105698314|NCT01994382|364559217|FG008|Overall Study|Death|1|||
105698315|NCT01994382|364559218|FG009|Overall Study|Death|1|||
105698316|NCT01994382|364559219|FG010|Overall Study|Death|0|||
105698317|NCT01994382|364559220|FG011|Overall Study|Death|0|||
105698318|NCT01994382|364559221|FG012|Overall Study|Death|0|||
105698319|NCT01994382|364559222|FG013|Overall Study|Death|0|||
105698320|NCT01994382|364559223|FG014|Overall Study|Death|0|||
105698321|NCT01994382|364559224|FG015|Overall Study|Death|1|||
105698322|NCT01994382|364559225|FG016|Overall Study|Death|0|||
105698323|NCT01994382|364559209|FG000|Overall Study|Adverse Event|0|||
105698324|NCT01994382|364559210|FG001|Overall Study|Adverse Event|1|||
105698325|NCT01994382|364559211|FG002|Overall Study|Adverse Event|2|||
105698326|NCT01994382|364559212|FG003|Overall Study|Adverse Event|0|||
105698327|NCT01994382|364559213|FG004|Overall Study|Adverse Event|0|||
105698328|NCT01994382|364559214|FG005|Overall Study|Adverse Event|0|||
105698329|NCT01994382|364559215|FG006|Overall Study|Adverse Event|0|||
105698330|NCT01994382|364559216|FG007|Overall Study|Adverse Event|0|||
105698331|NCT01994382|364559217|FG008|Overall Study|Adverse Event|0|||
105698332|NCT01994382|364559218|FG009|Overall Study|Adverse Event|0|||
105698333|NCT01994382|364559219|FG010|Overall Study|Adverse Event|15|||
105698334|NCT01994382|364559220|FG011|Overall Study|Adverse Event|2|||
105698335|NCT01994382|364559221|FG012|Overall Study|Adverse Event|7|||
105698336|NCT01994382|364559222|FG013|Overall Study|Adverse Event|3|||
105698337|NCT01994382|364559223|FG014|Overall Study|Adverse Event|17|||
105698338|NCT01994382|364559224|FG015|Overall Study|Adverse Event|6|||
105698339|NCT01994382|364559225|FG016|Overall Study|Adverse Event|3|||
105698340|NCT01994382|364559209|FG000|Overall Study|Other than specified|0|||
105698341|NCT01994382|364559210|FG001|Overall Study|Other than specified|0|||
105698342|NCT01994382|364559211|FG002|Overall Study|Other than specified|0|||
105698343|NCT01994382|364559212|FG003|Overall Study|Other than specified|0|||
105698344|NCT01994382|364559213|FG004|Overall Study|Other than specified|0|||
105698345|NCT01994382|364559214|FG005|Overall Study|Other than specified|0|||
105698346|NCT01994382|364559215|FG006|Overall Study|Other than specified|0|||
105698347|NCT01994382|364559216|FG007|Overall Study|Other than specified|0|||
105698348|NCT01994382|364559217|FG008|Overall Study|Other than specified|0|||
105698349|NCT01994382|364559218|FG009|Overall Study|Other than specified|0|||
105698350|NCT01994382|364559219|FG010|Overall Study|Other than specified|2|||
105698351|NCT01994382|364559220|FG011|Overall Study|Other than specified|0|||
105698352|NCT01994382|364559221|FG012|Overall Study|Other than specified|2|||
105698353|NCT01994382|364559222|FG013|Overall Study|Other than specified|0|||
105698354|NCT01994382|364559223|FG014|Overall Study|Other than specified|0|||
105698355|NCT01994382|364559224|FG015|Overall Study|Other than specified|4|||
105698356|NCT01994382|364559225|FG016|Overall Study|Other than specified|4|||
105698357|NCT01994382|364559209|FG000|Overall Study|Withdrawal by Subject|0|||
105698358|NCT01994382|364559210|FG001|Overall Study|Withdrawal by Subject|0|||
105698359|NCT01994382|364559211|FG002|Overall Study|Withdrawal by Subject|0|||
105698360|NCT01994382|364559212|FG003|Overall Study|Withdrawal by Subject|0|||
105698361|NCT01994382|364559213|FG004|Overall Study|Withdrawal by Subject|0|||
105698362|NCT01994382|364559214|FG005|Overall Study|Withdrawal by Subject|0|||
105698363|NCT01994382|364559215|FG006|Overall Study|Withdrawal by Subject|0|||
105698364|NCT01994382|364559216|FG007|Overall Study|Withdrawal by Subject|0|||
105698365|NCT01994382|364559217|FG008|Overall Study|Withdrawal by Subject|0|||
105698366|NCT01994382|364559218|FG009|Overall Study|Withdrawal by Subject|0|||
105698367|NCT01994382|364559219|FG010|Overall Study|Withdrawal by Subject|6|||
105698368|NCT01994382|364559220|FG011|Overall Study|Withdrawal by Subject|0|||
105698369|NCT01994382|364559221|FG012|Overall Study|Withdrawal by Subject|2|||
105698370|NCT01994382|364559222|FG013|Overall Study|Withdrawal by Subject|0|||
105698371|NCT01994382|364559223|FG014|Overall Study|Withdrawal by Subject|4|||
105698372|NCT01994382|364559224|FG015|Overall Study|Withdrawal by Subject|3|||
105698373|NCT01994382|364559225|FG016|Overall Study|Withdrawal by Subject|0|||
105698374|NCT01994382|364559209|FG000|Overall Study|Lost to Follow-up|0|||
105698375|NCT01994382|364559210|FG001|Overall Study|Lost to Follow-up|0|||
105698376|NCT01994382|364559211|FG002|Overall Study|Lost to Follow-up|0|||
105698377|NCT01994382|364559212|FG003|Overall Study|Lost to Follow-up|0|||
105698378|NCT01994382|364559213|FG004|Overall Study|Lost to Follow-up|0|||
105698379|NCT01994382|364559214|FG005|Overall Study|Lost to Follow-up|0|||
105698380|NCT01994382|364559215|FG006|Overall Study|Lost to Follow-up|0|||
105698381|NCT01994382|364559216|FG007|Overall Study|Lost to Follow-up|0|||
105698382|NCT01994382|364559217|FG008|Overall Study|Lost to Follow-up|0|||
105698383|NCT01994382|364559218|FG009|Overall Study|Lost to Follow-up|0|||
105348766|NCT03313310|363279159|FG000|Phase 2|Lost to Follow-up|4|||
105348767|NCT03313310|363279160|FG001|Phase 2|Lost to Follow-up|0|||
105348768|NCT03313310|363279159|FG000|Phase 3|Lost to Follow-up|0|||
105348769|NCT03313310|363279160|FG001|Phase 3|Lost to Follow-up|1|||
105698384|NCT01994382|364559219|FG010|Overall Study|Lost to Follow-up|1|||
105698385|NCT01994382|364559220|FG011|Overall Study|Lost to Follow-up|0|||
105698386|NCT01994382|364559221|FG012|Overall Study|Lost to Follow-up|0|||
105698387|NCT01994382|364559222|FG013|Overall Study|Lost to Follow-up|0|||
105698388|NCT01994382|364559223|FG014|Overall Study|Lost to Follow-up|0|||
105698389|NCT01994382|364559224|FG015|Overall Study|Lost to Follow-up|0|||
105698390|NCT01994382|364559225|FG016|Overall Study|Lost to Follow-up|0|||
105698391|NCT01994382|364559209|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698392|NCT01994382|364559210|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698393|NCT01994382|364559211|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698394|NCT01994382|364559212|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698395|NCT01994382|364559213|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698396|NCT01994382|364559214|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698397|NCT01994382|364559215|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698398|NCT01994382|364559216|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698399|NCT01994382|364559217|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698400|NCT01994382|364559218|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698401|NCT01994382|364559219|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
105698402|NCT01994382|364559220|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698403|NCT01994382|364559221|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
105698404|NCT01994382|364559222|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698405|NCT01994382|364559223|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698406|NCT01994382|364559224|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
105698407|NCT01994382|364559225|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
105698408|NCT01994382|364559209|FG000|Overall Study|Protocol violation/noncompliance|0|||
105698409|NCT01994382|364559210|FG001|Overall Study|Protocol violation/noncompliance|0|||
105698410|NCT01994382|364559211|FG002|Overall Study|Protocol violation/noncompliance|0|||
105698411|NCT01994382|364559212|FG003|Overall Study|Protocol violation/noncompliance|0|||
105698412|NCT01994382|364559213|FG004|Overall Study|Protocol violation/noncompliance|0|||
105698413|NCT01994382|364559214|FG005|Overall Study|Protocol violation/noncompliance|0|||
105698414|NCT01994382|364559215|FG006|Overall Study|Protocol violation/noncompliance|0|||
105698415|NCT01994382|364559216|FG007|Overall Study|Protocol violation/noncompliance|0|||
105698416|NCT01994382|364559217|FG008|Overall Study|Protocol violation/noncompliance|0|||
105698417|NCT01994382|364559218|FG009|Overall Study|Protocol violation/noncompliance|0|||
105698418|NCT01994382|364559219|FG010|Overall Study|Protocol violation/noncompliance|0|||
105698419|NCT01994382|364559220|FG011|Overall Study|Protocol violation/noncompliance|1|||
105698420|NCT01994382|364559221|FG012|Overall Study|Protocol violation/noncompliance|0|||
105698421|NCT01994382|364559222|FG013|Overall Study|Protocol violation/noncompliance|0|||
105698422|NCT01994382|364559223|FG014|Overall Study|Protocol violation/noncompliance|0|||
105698423|NCT01994382|364559224|FG015|Overall Study|Protocol violation/noncompliance|0|||
105698424|NCT01994382|364559225|FG016|Overall Study|Protocol violation/noncompliance|2|||
105698425|NCT01994382|364559209|FG000|Overall Study|Rolled over to Phase 2a|0|||
105698426|NCT01994382|364559210|FG001|Overall Study|Rolled over to Phase 2a|0|||
105698427|NCT01994382|364559211|FG002|Overall Study|Rolled over to Phase 2a|1|||
105698428|NCT01994382|364559212|FG003|Overall Study|Rolled over to Phase 2a|0|||
105698429|NCT01994382|364559213|FG004|Overall Study|Rolled over to Phase 2a|0|||
105348770|NCT01593254|363279161|FG000|Overall Study|Disease progression|2|||
105348771|NCT01593254|363279162|FG001|Overall Study|Disease progression|7|||
105348772|NCT01593254|363279161|FG000|Overall Study|Study drug toxicity|6|||
105348773|NCT01593254|363279162|FG001|Overall Study|Study drug toxicity|20|||
105348774|NCT01593254|363279161|FG000|Overall Study|Death|3|||
105348775|NCT01593254|363279162|FG001|Overall Study|Death|3|||
105348776|NCT01593254|363279161|FG000|Overall Study|AE unrelated to study drug|0|||
105348777|NCT01593254|363279162|FG001|Overall Study|AE unrelated to study drug|1|||
105348778|NCT01593254|363279161|FG000|Overall Study|participant request to discontinue study treatment|1|||
105348779|NCT01593254|363279162|FG001|Overall Study|participant request to discontinue study treatment|3|||
105698430|NCT01994382|364559214|FG005|Overall Study|Rolled over to Phase 2a|0|||
105698431|NCT01994382|364559215|FG006|Overall Study|Rolled over to Phase 2a|0|||
105698432|NCT01994382|364559216|FG007|Overall Study|Rolled over to Phase 2a|0|||
105698433|NCT01994382|364559217|FG008|Overall Study|Rolled over to Phase 2a|0|||
105698434|NCT01994382|364559218|FG009|Overall Study|Rolled over to Phase 2a|2|||
105348780|NCT01593254|363279161|FG000|Overall Study|participant withdrew consent|0|||
105348781|NCT01593254|363279162|FG001|Overall Study|participant withdrew consent|9|||
105348782|NCT01593254|363279161|FG000|Overall Study|lost to follow up|1|||
105473649|NCT00479687|363746997|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
105698435|NCT01994382|364559219|FG010|Overall Study|Rolled over to Phase 2a|0|||
105698436|NCT01994382|364559220|FG011|Overall Study|Rolled over to Phase 2a|0|||
105698437|NCT01994382|364559221|FG012|Overall Study|Rolled over to Phase 2a|0|||
105698438|NCT01994382|364559222|FG013|Overall Study|Rolled over to Phase 2a|0|||
105698439|NCT01994382|364559223|FG014|Overall Study|Rolled over to Phase 2a|0|||
105698440|NCT01994382|364559224|FG015|Overall Study|Rolled over to Phase 2a|0|||
105698441|NCT01994382|364559225|FG016|Overall Study|Rolled over to Phase 2a|0|||
105698442|NCT01236573|364559228|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698443|NCT01236573|364559229|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698444|NCT01236573|364559230|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698445|NCT01236573|364559231|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698446|NCT01236573|364559232|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698447|NCT01236573|364559233|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698448|NCT01236573|364559234|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
105698449|NCT01236573|364559235|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698450|NCT01236573|364559236|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
105698451|NCT01236573|364559237|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
105698452|NCT01236573|364559238|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698453|NCT01236573|364559228|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698454|NCT01236573|364559229|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698455|NCT01236573|364559230|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698456|NCT01236573|364559231|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698457|NCT01236573|364559232|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698458|NCT01236573|364559233|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698459|NCT01236573|364559234|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698460|NCT01236573|364559235|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698461|NCT01236573|364559236|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
105698462|NCT01236573|364559237|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698463|NCT01236573|364559238|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698464|NCT01236573|364559228|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698465|NCT01236573|364559229|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698466|NCT01236573|364559230|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698467|NCT01236573|364559231|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698468|NCT01236573|364559232|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698469|NCT01236573|364559233|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698470|NCT01236573|364559234|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698471|NCT01236573|364559235|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105348783|NCT01593254|363279162|FG001|Overall Study|lost to follow up|6|||
105348784|NCT01593254|363279161|FG000|Overall Study|maximum clinical benefit|1|||
105348785|NCT01593254|363279162|FG001|Overall Study|maximum clinical benefit|2|||
105698472|NCT01236573|364559236|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698473|NCT01236573|364559237|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698474|NCT01236573|364559238|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
105698475|NCT00424749|364559240|FG000|Overall Study|Withdrawal by Subject|1|||
105698476|NCT04534491|364559241|FG000|Overall Study|Not completed end-of-study interview|24|||
105698477|NCT04534491|364559241|FG000|Overall Study|Non-users|70|||
105698478|NCT04534491|364559241|FG000|Overall Study|Non-verifiable users|58|||
105698479|NCT01231659|364559242|FG000|Overall Study|Adverse Event|9|||
105698480|NCT01231659|364559242|FG000|Overall Study|Disease Progression|48|||
105698481|NCT01231659|364559242|FG000|Overall Study|Death|2|||
105698482|NCT01231659|364559242|FG000|Overall Study|Patient refused to complete study visit|1|||
105698483|NCT01231659|364559242|FG000|Overall Study|Other protocol defined criteria|12|||
105698484|NCT03000179|364559243|FG000|Overall Study|Lost to Follow-up|2|||
105698485|NCT01299376|364559249|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
105698486|NCT01299376|364559250|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
105698487|NCT01299376|364559249|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
105698488|NCT01299376|364559250|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
105698489|NCT01299376|364559249|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
105698490|NCT01299376|364559250|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
105698491|NCT01299376|364559249|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
105698492|NCT01299376|364559250|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
105698493|NCT01299376|364559249|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
105698494|NCT01299376|364559250|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
105698495|NCT01299376|364559249|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
105698496|NCT01299376|364559250|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
105698497|NCT01299376|364559249|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
105698498|NCT01299376|364559250|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
105698499|NCT01299376|364559249|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
105698500|NCT01299376|364559250|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
105698501|NCT01299376|364559249|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
105698502|NCT01299376|364559250|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
105698503|NCT01299376|364559249|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
105698504|NCT01299376|364559250|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
105698505|NCT01299376|364559249|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
105698506|NCT01299376|364559250|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
105787199|NCT03110107|364874901|FG012|Treatment Period|Participant withdrew consent|0|||
105787200|NCT03110107|364874902|FG013|Treatment Period|Participant withdrew consent|0|||
105787201|NCT03110107|364874903|FG014|Treatment Period|Participant withdrew consent|0|||
105787202|NCT03110107|364874904|FG015|Treatment Period|Participant withdrew consent|0|||
105787203|NCT03110107|364874905|FG016|Treatment Period|Participant withdrew consent|0|||
105787204|NCT03110107|364874906|FG017|Treatment Period|Participant withdrew consent|0|||
105787205|NCT03110107|364874907|FG018|Treatment Period|Participant withdrew consent|0|||
105473650|NCT00479687|363746998|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
105473651|NCT01243242|363746999|FG000|Overall Study|Adverse Event|1|||
105473652|NCT01243242|363747000|FG001|Overall Study|Adverse Event|1|||
105698507|NCT00113074|364559252|FG000|Overall Study|Lost to Follow-up|10|||
105698508|NCT00113074|364559253|FG001|Overall Study|Lost to Follow-up|10|||
105698509|NCT00113074|364559254|FG002|Overall Study|Lost to Follow-up|14|||
105698510|NCT02375724|364559255|FG000|Overall Study|Lack of Efficacy|1|||
105698511|NCT02375724|364559256|FG001|Overall Study|Lack of Efficacy|1|||
105473653|NCT01243242|363746999|FG000|Overall Study|Withdrawal by Subject|1|||
105698512|NCT02375724|364559255|FG000|Overall Study|Withdrawal by Subject|1|||
105698513|NCT02375724|364559256|FG001|Overall Study|Withdrawal by Subject|1|||
105698514|NCT02375724|364559255|FG000|Overall Study|Lost to Follow-up|1|||
105698515|NCT02375724|364559256|FG001|Overall Study|Lost to Follow-up|0|||
105698516|NCT02375724|364559255|FG000|Overall Study|Protocol Violation|1|||
105698517|NCT02375724|364559256|FG001|Overall Study|Protocol Violation|0|||
105698518|NCT02375724|364559255|FG000|Overall Study|Adverse Event|2|||
105698519|NCT02375724|364559256|FG001|Overall Study|Adverse Event|4|||
105698520|NCT02114268|364559257|FG000|Overall Study|Lost to Follow-up|4|||
105698521|NCT02114268|364559258|FG001|Overall Study|Lost to Follow-up|1|||
105698522|NCT02114268|364559259|FG002|Overall Study|Lost to Follow-up|1|||
105698523|NCT02114268|364559260|FG003|Overall Study|Lost to Follow-up|0|||
105698524|NCT02114268|364559261|FG004|Overall Study|Lost to Follow-up|0|||
105698525|NCT02114268|364559262|FG005|Overall Study|Lost to Follow-up|2|||
105698526|NCT02114268|364559257|FG000|Overall Study|Withdrawal by Subject|1|||
105698527|NCT02114268|364559258|FG001|Overall Study|Withdrawal by Subject|0|||
105698528|NCT02114268|364559259|FG002|Overall Study|Withdrawal by Subject|0|||
105698529|NCT02114268|364559260|FG003|Overall Study|Withdrawal by Subject|0|||
105698530|NCT02114268|364559261|FG004|Overall Study|Withdrawal by Subject|0|||
105698531|NCT02114268|364559262|FG005|Overall Study|Withdrawal by Subject|1|||
105698532|NCT02114268|364559257|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
105698533|NCT02114268|364559258|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
105698534|NCT02114268|364559259|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
105698535|NCT02114268|364559260|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
105698536|NCT02114268|364559261|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
105698537|NCT02114268|364559262|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
105698538|NCT02285777|364559263|FG000|Overall Study|Withdrawal by Subject|1|||
105698539|NCT02285777|364559264|FG001|Overall Study|Withdrawal by Subject|1|||
105698540|NCT02285777|364559263|FG000|Overall Study|Lost to Follow-up|4|||
105698541|NCT02285777|364559264|FG001|Overall Study|Lost to Follow-up|2|||
105698542|NCT00590044|364559265|FG000|Overall Study|Withdrawal by Subject|2|||
105698543|NCT00590044|364559266|FG001|Overall Study|Withdrawal by Subject|2|||
105698544|NCT00590044|364559265|FG000|Overall Study|wrong insulin arm assigned|1|||
105698545|NCT00590044|364559266|FG001|Overall Study|wrong insulin arm assigned|0|||
105698546|NCT00590044|364559265|FG000|Overall Study|Protocol Violation|1|||
105698547|NCT00590044|364559266|FG001|Overall Study|Protocol Violation|0|||
105698548|NCT01924182|364559267|FG000|Overall Study|Withdrawal by Subject|1|||
105698549|NCT01924182|364559268|FG001|Overall Study|Withdrawal by Subject|0|||
105698550|NCT04425720|364559272|FG000|Overall Study|Withdrawal by Subject|0|||
105698551|NCT04425720|364559273|FG001|Overall Study|Withdrawal by Subject|20|||
105698552|NCT00609986|364559274|FG000|Overall Study|Did not receive transplant or treatment|8|||
105698553|NCT00609986|364559275|FG001|Overall Study|Did not receive transplant or treatment|3|||
105698554|NCT02090413|364559280|FG000|Overall Study|Adverse Event|11|||
105698555|NCT02090413|364559281|FG001|Overall Study|Adverse Event|15|||
105698556|NCT02090413|364559282|FG002|Overall Study|Adverse Event|20|||
105698557|NCT02090413|364559280|FG000|Overall Study|Flushing event|2|||
105698558|NCT02090413|364559281|FG001|Overall Study|Flushing event|0|||
105698559|NCT02090413|364559282|FG002|Overall Study|Flushing event|1|||
105698560|NCT02090413|364559280|FG000|Overall Study|Withdrawal by Subject|2|||
105698561|NCT02090413|364559281|FG001|Overall Study|Withdrawal by Subject|2|||
105698562|NCT02090413|364559282|FG002|Overall Study|Withdrawal by Subject|2|||
105698563|NCT02090413|364559280|FG000|Overall Study|Investigator Decision|1|||
105698564|NCT02090413|364559281|FG001|Overall Study|Investigator Decision|1|||
105698565|NCT02090413|364559282|FG002|Overall Study|Investigator Decision|0|||
105698566|NCT02090413|364559280|FG000|Overall Study|Other|2|||
105698567|NCT02090413|364559281|FG001|Overall Study|Other|1|||
105698568|NCT02090413|364559282|FG002|Overall Study|Other|0|||
105698569|NCT02090413|364559280|FG000|Overall Study|Lost to Follow-up|1|||
105698570|NCT02090413|364559281|FG001|Overall Study|Lost to Follow-up|1|||
105698571|NCT02090413|364559282|FG002|Overall Study|Lost to Follow-up|0|||
105698572|NCT04998812|364559283|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
105348786|NCT01593254|363279161|FG000|Overall Study|Poor/non compliance|1|||
105787206|NCT03110107|364874908|FG019|Treatment Period|Participant withdrew consent|1|||
105698573|NCT04998812|364559284|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
105698574|NCT04998812|364559283|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
105698575|NCT04998812|364559284|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
105698576|NCT04998812|364559283|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
105698577|NCT04998812|364559284|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
105698578|NCT04998812|364559283|FG000|Vaccination Period|Ongoing in study|23|||
105698579|NCT04998812|364559284|FG001|Vaccination Period|Ongoing in study|23|||
105698580|NCT03496012|364561271|FG000|Overall Study|Withdrawal by Subject|2|||
105698581|NCT03496012|364561272|FG001|Overall Study|Withdrawal by Subject|0|||
105698582|NCT03496012|364561273|FG002|Overall Study|Withdrawal by Subject|2|||
105698583|NCT03496012|364561271|FG000|Overall Study|Adverse Event|0|||
105698584|NCT03496012|364561272|FG001|Overall Study|Adverse Event|0|||
105698585|NCT03496012|364561273|FG002|Overall Study|Adverse Event|1|||
105698586|NCT03496012|364561271|FG000|Overall Study|Reason Not Specified|2|||
105698587|NCT03496012|364561272|FG001|Overall Study|Reason Not Specified|0|||
105698588|NCT03496012|364561273|FG002|Overall Study|Reason Not Specified|1|||
105698589|NCT04050670|364561276|FG000|Period 3|Physician Decision|0|||
105698590|NCT04050670|364561277|FG001|Period 3|Physician Decision|1|||
105698591|NCT04050670|364561278|FG002|Period 3|Physician Decision|0|||
105698592|NCT00449670|364561280|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
105698593|NCT00449670|364561281|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
105698594|NCT00449670|364561280|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
105698595|NCT00449670|364561281|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
105698596|NCT00449670|364561280|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
105698597|NCT00449670|364561281|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
105698598|NCT00449670|364561280|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
105698599|NCT00449670|364561281|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
105698600|NCT00449670|364561280|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
105698601|NCT00449670|364561281|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
105698602|NCT00449670|364561280|FG000|Booster Phase (Study no.109873)|Other|0|||
105698603|NCT00449670|364561281|FG001|Booster Phase (Study no.109873)|Other|2|||
105698604|NCT04183790|364561285|FG000|Overall Study|Participants did not rollover to Part B|12|||
105698605|NCT04183790|364561286|FG001|Overall Study|Participants did not rollover to Part B|0|||
105698606|NCT04183790|364561285|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
105698607|NCT04183790|364561286|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
105698608|NCT04183790|364561285|FG000|Overall Study|Commercial drug is available for participant|6|||
105698609|NCT04183790|364561286|FG001|Overall Study|Commercial drug is available for participant|0|||
105698610|NCT04183790|364561285|FG000|Overall Study|Adverse Event|1|||
105698611|NCT04183790|364561286|FG001|Overall Study|Adverse Event|0|||
105698612|NCT04183790|364561285|FG000|Overall Study|Not enrolled in 107 study|0|||
105698613|NCT04183790|364561286|FG001|Overall Study|Not enrolled in 107 study|2|||
105698614|NCT01251653|364561287|FG000|Overall Study|Progressive Disease|1|||
105698615|NCT01251653|364561288|FG001|Overall Study|Progressive Disease|7|||
105698616|NCT01251653|364561289|FG002|Overall Study|Progressive Disease|16|||
105698617|NCT01251653|364561290|FG003|Overall Study|Progressive Disease|4|||
105698618|NCT01251653|364561291|FG004|Overall Study|Progressive Disease|0|||
105698619|NCT01251653|364561292|FG005|Overall Study|Progressive Disease|17|||
105698620|NCT01251653|364561293|FG006|Overall Study|Progressive Disease|14|||
105698621|NCT01251653|364561294|FG007|Overall Study|Progressive Disease|7|||
105698622|NCT01251653|364561295|FG008|Overall Study|Progressive Disease|5|||
105473654|NCT01243242|363747000|FG001|Overall Study|Withdrawal by Subject|1|||
105698623|NCT01251653|364561287|FG000|Overall Study|Dose-limiting toxicity|0|||
105698624|NCT01251653|364561288|FG001|Overall Study|Dose-limiting toxicity|1|||
105698625|NCT01251653|364561289|FG002|Overall Study|Dose-limiting toxicity|1|||
105698626|NCT01251653|364561290|FG003|Overall Study|Dose-limiting toxicity|1|||
105698627|NCT01251653|364561291|FG004|Overall Study|Dose-limiting toxicity|0|||
105698628|NCT01251653|364561292|FG005|Overall Study|Dose-limiting toxicity|0|||
105698629|NCT01251653|364561293|FG006|Overall Study|Dose-limiting toxicity|2|||
105698630|NCT01251653|364561294|FG007|Overall Study|Dose-limiting toxicity|0|||
105698631|NCT01251653|364561295|FG008|Overall Study|Dose-limiting toxicity|0|||
105698632|NCT01251653|364561287|FG000|Overall Study|Adverse Event|1|||
105698633|NCT01251653|364561288|FG001|Overall Study|Adverse Event|0|||
105698634|NCT01251653|364561289|FG002|Overall Study|Adverse Event|2|||
105559530|NCT01302847|364044702|FG000|Overall Study|Virologic failure|0|||
105698635|NCT01251653|364561290|FG003|Overall Study|Adverse Event|1|||
105698636|NCT01251653|364561291|FG004|Overall Study|Adverse Event|1|||
105698637|NCT01251653|364561292|FG005|Overall Study|Adverse Event|0|||
105698638|NCT01251653|364561293|FG006|Overall Study|Adverse Event|2|||
105698639|NCT01251653|364561294|FG007|Overall Study|Adverse Event|2|||
105698640|NCT01251653|364561295|FG008|Overall Study|Adverse Event|1|||
105698641|NCT01251653|364561287|FG000|Overall Study|Withdrawal by Subject|1|||
105698642|NCT01251653|364561288|FG001|Overall Study|Withdrawal by Subject|0|||
105698643|NCT01251653|364561289|FG002|Overall Study|Withdrawal by Subject|1|||
105698644|NCT01251653|364561290|FG003|Overall Study|Withdrawal by Subject|0|||
105698645|NCT01251653|364561291|FG004|Overall Study|Withdrawal by Subject|1|||
105698646|NCT01251653|364561292|FG005|Overall Study|Withdrawal by Subject|1|||
105559531|NCT01302847|364044703|FG001|Overall Study|Virologic failure|2|||
105559532|NCT01302847|364044704|FG002|Overall Study|Virologic failure|0|||
105698647|NCT01251653|364561293|FG006|Overall Study|Withdrawal by Subject|0|||
105698648|NCT01251653|364561294|FG007|Overall Study|Withdrawal by Subject|1|||
105698649|NCT01251653|364561295|FG008|Overall Study|Withdrawal by Subject|0|||
105698650|NCT01251653|364561287|FG000|Overall Study|Other reason not mentioned above|0|||
105698651|NCT01251653|364561288|FG001|Overall Study|Other reason not mentioned above|0|||
105698652|NCT01251653|364561289|FG002|Overall Study|Other reason not mentioned above|0|||
105698653|NCT01251653|364561290|FG003|Overall Study|Other reason not mentioned above|0|||
105698654|NCT01251653|364561291|FG004|Overall Study|Other reason not mentioned above|0|||
105698655|NCT01251653|364561292|FG005|Overall Study|Other reason not mentioned above|0|||
105698656|NCT01251653|364561293|FG006|Overall Study|Other reason not mentioned above|0|||
105698657|NCT01251653|364561294|FG007|Overall Study|Other reason not mentioned above|2|||
105698658|NCT01251653|364561295|FG008|Overall Study|Other reason not mentioned above|0|||
105698659|NCT00847145|364561296|FG000|Overall Study|AE or Death|0|||
105698660|NCT00847145|364561297|FG001|Overall Study|AE or Death|1|||
105698661|NCT00847145|364561298|FG002|Overall Study|AE or Death|1|||
105698662|NCT00847145|364561299|FG003|Overall Study|AE or Death|0|||
105698663|NCT00847145|364561300|FG004|Overall Study|AE or Death|0|||
105698664|NCT00847145|364561301|FG005|Overall Study|AE or Death|0|||
105698665|NCT00847145|364561302|FG006|Overall Study|AE or Death|0|||
105698666|NCT00847145|364561303|FG007|Overall Study|AE or Death|0|||
105698667|NCT00847145|364561296|FG000|Overall Study|Withdrawal by Subject|3|||
105698668|NCT00847145|364561297|FG001|Overall Study|Withdrawal by Subject|4|||
105698669|NCT00847145|364561298|FG002|Overall Study|Withdrawal by Subject|6|||
105698670|NCT00847145|364561299|FG003|Overall Study|Withdrawal by Subject|1|||
105698671|NCT00847145|364561300|FG004|Overall Study|Withdrawal by Subject|0|||
105559533|NCT01302847|364044705|FG003|Overall Study|Virologic failure|2|||
105559534|NCT01302847|364044706|FG004|Overall Study|Virologic failure|1|||
105559535|NCT01302847|364044707|FG005|Overall Study|Virologic failure|3|||
105559536|NCT01302847|364044708|FG006|Overall Study|Virologic failure|1|||
105559537|NCT01302847|364044709|FG007|Overall Study|Virologic failure|2|||
105559538|NCT01302847|364044702|FG000|Overall Study|Severe debilitation, unable to continue|0|||
105559539|NCT01302847|364044703|FG001|Overall Study|Severe debilitation, unable to continue|0|||
105559540|NCT01302847|364044704|FG002|Overall Study|Severe debilitation, unable to continue|0|||
105559541|NCT01302847|364044705|FG003|Overall Study|Severe debilitation, unable to continue|0|||
105559542|NCT01302847|364044706|FG004|Overall Study|Severe debilitation, unable to continue|0|||
105559543|NCT01302847|364044707|FG005|Overall Study|Severe debilitation, unable to continue|1|||
105698672|NCT00847145|364561301|FG005|Overall Study|Withdrawal by Subject|0|||
105698673|NCT00847145|364561302|FG006|Overall Study|Withdrawal by Subject|1|||
105698674|NCT00847145|364561303|FG007|Overall Study|Withdrawal by Subject|1|||
105698675|NCT00847145|364561296|FG000|Overall Study|Lost to Follow-up|3|||
105698676|NCT00847145|364561297|FG001|Overall Study|Lost to Follow-up|1|||
105698677|NCT00847145|364561298|FG002|Overall Study|Lost to Follow-up|1|||
105698678|NCT00847145|364561299|FG003|Overall Study|Lost to Follow-up|0|||
105698679|NCT00847145|364561300|FG004|Overall Study|Lost to Follow-up|4|||
105698680|NCT00847145|364561301|FG005|Overall Study|Lost to Follow-up|4|||
105698681|NCT00847145|364561302|FG006|Overall Study|Lost to Follow-up|8|||
105698682|NCT00847145|364561303|FG007|Overall Study|Lost to Follow-up|2|||
105698683|NCT00847145|364561296|FG000|Overall Study|Inappropriate enrollment|0|||
105698684|NCT00847145|364561297|FG001|Overall Study|Inappropriate enrollment|0|||
105698685|NCT00847145|364561298|FG002|Overall Study|Inappropriate enrollment|0|||
105698686|NCT00847145|364561299|FG003|Overall Study|Inappropriate enrollment|0|||
105698687|NCT00847145|364561300|FG004|Overall Study|Inappropriate enrollment|1|||
105698688|NCT00847145|364561301|FG005|Overall Study|Inappropriate enrollment|0|||
105698689|NCT00847145|364561302|FG006|Overall Study|Inappropriate enrollment|0|||
105698690|NCT00847145|364561303|FG007|Overall Study|Inappropriate enrollment|0|||
105698691|NCT00847145|364561296|FG000|Overall Study|Protocol Violation|0|||
105698692|NCT00847145|364561297|FG001|Overall Study|Protocol Violation|0|||
105698693|NCT00847145|364561298|FG002|Overall Study|Protocol Violation|3|||
105698694|NCT00847145|364561299|FG003|Overall Study|Protocol Violation|0|||
105698695|NCT00847145|364561300|FG004|Overall Study|Protocol Violation|1|||
105698696|NCT00847145|364561301|FG005|Overall Study|Protocol Violation|0|||
105348787|NCT01593254|363279162|FG001|Overall Study|Poor/non compliance|1|||
105348788|NCT01593254|363279161|FG000|Overall Study|Pregnancy|0|||
105698697|NCT00847145|364561302|FG006|Overall Study|Protocol Violation|0|||
105698698|NCT00847145|364561303|FG007|Overall Study|Protocol Violation|1|||
105348789|NCT01593254|363279162|FG001|Overall Study|Pregnancy|3|||
105348790|NCT01593254|363279161|FG000|Overall Study|participant no longer meets study criteria|1|||
105698699|NCT04419610|364561304|FG000|Overall Study|Withdrawal by Subject|3|||
105698700|NCT04419610|364561305|FG001|Overall Study|Withdrawal by Subject|1|||
105698701|NCT04419610|364561304|FG000|Overall Study|Adverse Event|1|||
105698702|NCT04419610|364561305|FG001|Overall Study|Adverse Event|0|||
105698703|NCT04419610|364561304|FG000|Overall Study|discharged early|1|||
105698704|NCT04419610|364561305|FG001|Overall Study|discharged early|1|||
105698705|NCT00885703|364561306|FG000|Overall Study|Death|9|||
105698706|NCT00885703|364561307|FG001|Overall Study|Death|7|||
105698707|NCT00885703|364561308|FG002|Overall Study|Death|8|||
105698708|NCT00885703|364561309|FG003|Overall Study|Death|7|||
105698709|NCT00885703|364561310|FG004|Overall Study|Death|7|||
105698710|NCT00885703|364561311|FG005|Overall Study|Death|8|||
105698711|NCT00885703|364561312|FG006|Overall Study|Death|4|||
105698712|NCT00885703|364561306|FG000|Overall Study|Lost to Follow-up|0|||
105698713|NCT00885703|364561307|FG001|Overall Study|Lost to Follow-up|0|||
105698714|NCT00885703|364561308|FG002|Overall Study|Lost to Follow-up|1|||
105698715|NCT00885703|364561309|FG003|Overall Study|Lost to Follow-up|0|||
105698716|NCT00885703|364561310|FG004|Overall Study|Lost to Follow-up|0|||
105698717|NCT00885703|364561311|FG005|Overall Study|Lost to Follow-up|1|||
105698718|NCT00885703|364561312|FG006|Overall Study|Lost to Follow-up|0|||
105698719|NCT00885703|364561306|FG000|Overall Study|Withdrawal by Subject|0|||
105698720|NCT00885703|364561307|FG001|Overall Study|Withdrawal by Subject|0|||
105698721|NCT00885703|364561308|FG002|Overall Study|Withdrawal by Subject|0|||
105698722|NCT00885703|364561309|FG003|Overall Study|Withdrawal by Subject|1|||
105698723|NCT00885703|364561310|FG004|Overall Study|Withdrawal by Subject|3|||
105698724|NCT00885703|364561311|FG005|Overall Study|Withdrawal by Subject|1|||
105698725|NCT00885703|364561312|FG006|Overall Study|Withdrawal by Subject|1|||
105698726|NCT00885703|364561306|FG000|Overall Study|Ineligible (no CM)|1|||
105698727|NCT00885703|364561307|FG001|Overall Study|Ineligible (no CM)|3|||
105698728|NCT00885703|364561308|FG002|Overall Study|Ineligible (no CM)|2|||
105698729|NCT00885703|364561309|FG003|Overall Study|Ineligible (no CM)|1|||
105698730|NCT00885703|364561310|FG004|Overall Study|Ineligible (no CM)|2|||
105698731|NCT00885703|364561311|FG005|Overall Study|Ineligible (no CM)|3|||
105698732|NCT00885703|364561312|FG006|Overall Study|Ineligible (no CM)|1|||
105698733|NCT01717287|364561316|FG000|Overall Study|Lost to Follow-up|0|||
105698734|NCT01717287|364561317|FG001|Overall Study|Lost to Follow-up|2|||
105698735|NCT01717287|364561316|FG000|Overall Study|Protocol Violation|0|||
105698736|NCT01717287|364561317|FG001|Overall Study|Protocol Violation|1|||
105698737|NCT00404820|364561318|FG000|Overall Study|Adverse Event|4|||
105698738|NCT00404820|364561319|FG001|Overall Study|Adverse Event|16|||
105698739|NCT00404820|364561318|FG000|Overall Study|Withdrawal by Subject|5|||
105698740|NCT00404820|364561319|FG001|Overall Study|Withdrawal by Subject|3|||
105698741|NCT00404820|364561318|FG000|Overall Study|Lost to Follow-up|7|||
105698742|NCT00404820|364561319|FG001|Overall Study|Lost to Follow-up|3|||
105698743|NCT00404820|364561318|FG000|Overall Study|Administrative problems|2|||
105698744|NCT00404820|364561319|FG001|Overall Study|Administrative problems|0|||
105348791|NCT01593254|363279162|FG001|Overall Study|participant no longer meets study criteria|1|||
105348792|NCT01593254|363279161|FG000|Overall Study|Admin reason by sponsor|7|||
105348793|NCT01593254|363279162|FG001|Overall Study|Admin reason by sponsor|3|||
105348794|NCT01593254|363279161|FG000|Overall Study|Imatinib treatment failure|2|||
105348795|NCT01593254|363279162|FG001|Overall Study|Imatinib treatment failure|0|||
105348796|NCT01593254|363279161|FG000|Overall Study|Other Reasons|61|||
105348797|NCT01593254|363279162|FG001|Overall Study|Other Reasons|115|||
105473655|NCT01243242|363746999|FG000|Overall Study|Physician Decision|0|||
105698745|NCT00404820|364561318|FG000|Overall Study|Death|1|||
105698746|NCT00404820|364561319|FG001|Overall Study|Death|0|||
105698747|NCT00404820|364561318|FG000|Overall Study|Other|0|||
105698748|NCT00404820|364561319|FG001|Overall Study|Other|2|||
105698749|NCT01168973|364561320|FG000|Overall Study|Progressive Disease|341|||
105698750|NCT01168973|364561321|FG001|Overall Study|Progressive Disease|429|||
105698751|NCT01168973|364561320|FG000|Overall Study|Adverse Event|94|||
105698752|NCT01168973|364561321|FG001|Overall Study|Adverse Event|55|||
105698753|NCT01168973|364561320|FG000|Overall Study|Withdrawal by Subject|90|||
105698754|NCT01168973|364561321|FG001|Overall Study|Withdrawal by Subject|53|||
105698755|NCT01168973|364561320|FG000|Overall Study|Death|42|||
105698756|NCT01168973|364561321|FG001|Overall Study|Death|45|||
105698757|NCT01168973|364561320|FG000|Overall Study|Physician Decision|37|||
105698758|NCT01168973|364561321|FG001|Overall Study|Physician Decision|19|||
105698759|NCT01168973|364561320|FG000|Overall Study|Sponsor Decision|2|||
105698760|NCT01168973|364561321|FG001|Overall Study|Sponsor Decision|1|||
105698761|NCT01168973|364561320|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
105698762|NCT01168973|364561321|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
105698763|NCT05092919|364561322|FG000|Overall Study|Lost to Follow-up|7|||
105698764|NCT05092919|364561322|FG000|Overall Study|Withdrawal by Subject|2|||
105473656|NCT01243242|363747000|FG001|Overall Study|Physician Decision|1|||
105473657|NCT01243242|363746999|FG000|Overall Study|sponsor decision|0|||
105698765|NCT02807480|364561323|FG000|Overall Study|Withdrawal by Subject|14|||
105698766|NCT02807480|364561324|FG001|Overall Study|Withdrawal by Subject|10|||
105698767|NCT01007032|364561326|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
105698768|NCT01007032|364561327|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
105698769|NCT01007032|364561328|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
105698770|NCT01007032|364561329|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
105698771|NCT01007032|364561326|FG000|Overall Study|Withdrawal by Subject|0|||
105698772|NCT01007032|364561327|FG001|Overall Study|Withdrawal by Subject|0|||
105698773|NCT01007032|364561328|FG002|Overall Study|Withdrawal by Subject|0|||
105348798|NCT03013985|363279163|FG000|Overall Study|Protocol Violation|2|||
105348799|NCT03013985|363279164|FG001|Overall Study|Protocol Violation|2|||
105348800|NCT03013985|363279163|FG000|Overall Study|Withdrawal by Subject|14|||
105348801|NCT03013985|363279164|FG001|Overall Study|Withdrawal by Subject|17|||
105348802|NCT01080391|363279172|FG000|Overall Study|Randomized but not treated|7|||
105348803|NCT01080391|363279173|FG001|Overall Study|Randomized but not treated|4|||
105348804|NCT01380691|363279174|FG000|Washout (7 Days)|Protocol Violation|0|||
105348805|NCT01380691|363279175|FG001|Washout (7 Days)|Protocol Violation|0|||
105348806|NCT01380691|363279176|FG002|Washout (7 Days)|Protocol Violation|0|||
105348807|NCT01380691|363279177|FG003|Washout (7 Days)|Protocol Violation|1|||
105348808|NCT01380691|363279174|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
105348809|NCT01380691|363279175|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
105348810|NCT01380691|363279176|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
105348811|NCT01380691|363279177|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
105348812|NCT01260584|363279178|FG000|Period 1|Protocol Violation|0|||
105348813|NCT01260584|363279179|FG001|Period 1|Protocol Violation|0|||
105348814|NCT01260584|363279180|FG002|Period 1|Protocol Violation|1|||
105348815|NCT01260584|363279181|FG003|Period 1|Protocol Violation|1|||
105348816|NCT01260584|363279178|FG000|Period 1|Adverse Event|0|||
105348817|NCT01260584|363279179|FG001|Period 1|Adverse Event|0|||
105348818|NCT01260584|363279180|FG002|Period 1|Adverse Event|1|||
105348819|NCT01260584|363279181|FG003|Period 1|Adverse Event|0|||
105348820|NCT01260584|363279178|FG000|Period 2|Protocol Violation|0|||
105348821|NCT01260584|363279179|FG001|Period 2|Protocol Violation|2|||
105348822|NCT01260584|363279180|FG002|Period 2|Protocol Violation|3|||
105348823|NCT01260584|363279181|FG003|Period 2|Protocol Violation|1|||
105348824|NCT01260584|363279178|FG000|Period 2|Adverse Event|1|||
105348825|NCT01260584|363279179|FG001|Period 2|Adverse Event|0|||
105348826|NCT01260584|363279180|FG002|Period 2|Adverse Event|2|||
105348827|NCT01260584|363279181|FG003|Period 2|Adverse Event|0|||
105348828|NCT01260584|363279178|FG000|Period 2|Withdrawal by Subject|0|||
105348829|NCT01260584|363279179|FG001|Period 2|Withdrawal by Subject|1|||
105348830|NCT01260584|363279180|FG002|Period 2|Withdrawal by Subject|0|||
105348831|NCT01260584|363279181|FG003|Period 2|Withdrawal by Subject|0|||
105348832|NCT02536781|363279182|FG000|Overall Study|Lost to Follow-up|2|||
105348833|NCT02536781|363279183|FG001|Overall Study|Lost to Follow-up|0|||
105348834|NCT00045734|363279184|FG000|Overall Study|Protocol Violation|1|||
105348835|NCT00561470|363279185|FG000|Overall Study|Adverse Event|74|||
105473658|NCT01243242|363747000|FG001|Overall Study|sponsor decision|1|||
105473659|NCT01243242|363746999|FG000|Overall Study|non compliance|1|||
105473660|NCT01243242|363747000|FG001|Overall Study|non compliance|0|||
105473661|NCT02260180|363747001|FG000|Overall Study|Adverse Event|2|||
105473662|NCT02260180|363747002|FG001|Overall Study|Adverse Event|0|||
105473663|NCT02260180|363747003|FG002|Overall Study|Adverse Event|1|||
105473664|NCT02891070|363747008|FG000|Overall Study|Adverse Event|1|||
105473665|NCT02891070|363747009|FG001|Overall Study|Adverse Event|0|||
105473666|NCT02891070|363747008|FG000|Overall Study|Physician Decision|0|||
105473667|NCT02891070|363747009|FG001|Overall Study|Physician Decision|1|||
105698774|NCT01007032|364561329|FG003|Overall Study|Withdrawal by Subject|1|||
105698775|NCT02285920|364561331|FG000|Overall Study|Kidney transplantation|2|||
105473668|NCT02891070|363747008|FG000|Overall Study|Lost to Follow-up|4|||
105698776|NCT02285920|364561332|FG001|Overall Study|Kidney transplantation|2|||
105698777|NCT02285920|364561333|FG002|Overall Study|Kidney transplantation|2|||
105348836|NCT00561470|363279186|FG001|Overall Study|Adverse Event|163|||
105348837|NCT00561470|363279185|FG000|Overall Study|Disease progression|437|||
105348838|NCT00561470|363279186|FG001|Overall Study|Disease progression|305|||
105348839|NCT00561470|363279185|FG000|Overall Study|poor compliance to protocol|4|||
105348840|NCT00561470|363279186|FG001|Overall Study|poor compliance to protocol|4|||
105348841|NCT00561470|363279185|FG000|Overall Study|Lost to Follow-up|2|||
105348842|NCT00561470|363279186|FG001|Overall Study|Lost to Follow-up|0|||
105348843|NCT00561470|363279185|FG000|Overall Study|Physician Decision|21|||
105348844|NCT00561470|363279186|FG001|Overall Study|Physician Decision|20|||
105348845|NCT00561470|363279185|FG000|Overall Study|Consent Withdrawn|2|||
105348846|NCT00561470|363279186|FG001|Overall Study|Consent Withdrawn|6|||
105348847|NCT00561470|363279185|FG000|Overall Study|Subject request|43|||
105348848|NCT00561470|363279186|FG001|Overall Study|Subject request|77|||
105473669|NCT02891070|363747009|FG001|Overall Study|Lost to Follow-up|4|||
105698778|NCT02285920|364561334|FG003|Overall Study|Kidney transplantation|0|||
105348849|NCT00561470|363279185|FG000|Overall Study|Metastatic surgery|10|||
105348850|NCT00561470|363279186|FG001|Overall Study|Metastatic surgery|12|||
105473670|NCT02891070|363747008|FG000|Overall Study|Other|1|||
105473671|NCT02891070|363747009|FG001|Overall Study|Other|0|||
105473672|NCT02891070|363747008|FG000|Overall Study|Protocol Violation|0|||
105473673|NCT02891070|363747009|FG001|Overall Study|Protocol Violation|1|||
105473674|NCT02891070|363747008|FG000|Overall Study|Withdrawal by Subject|1|||
105473675|NCT02891070|363747009|FG001|Overall Study|Withdrawal by Subject|2|||
105473676|NCT02891070|363747008|FG000|Overall Study|Death|3|||
105473677|NCT02891070|363747009|FG001|Overall Study|Death|0|||
105473678|NCT03539549|363747014|FG000|Overall Study|Adverse Event|12|||
105473679|NCT03539549|363747014|FG000|Overall Study|Lost to Follow-up|1|||
105473680|NCT03539549|363747014|FG000|Overall Study|Death|2|||
105473681|NCT03539549|363747014|FG000|Overall Study|Progressive Disease|1|||
105473682|NCT03539549|363747014|FG000|Overall Study|Reason not Specified|1|||
105473683|NCT02405442|363747015|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
105473684|NCT02405442|363747016|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
105698779|NCT02285920|364561331|FG000|Overall Study|Change to peritoneal dialysis|0|||
105698780|NCT02285920|364561332|FG001|Overall Study|Change to peritoneal dialysis|0|||
105698781|NCT02285920|364561333|FG002|Overall Study|Change to peritoneal dialysis|1|||
105698782|NCT02285920|364561334|FG003|Overall Study|Change to peritoneal dialysis|0|||
105698783|NCT02285920|364561331|FG000|Overall Study|Transfer to non-participating unit|0|||
105698784|NCT02285920|364561332|FG001|Overall Study|Transfer to non-participating unit|1|||
105698785|NCT02285920|364561333|FG002|Overall Study|Transfer to non-participating unit|0|||
105698786|NCT02285920|364561334|FG003|Overall Study|Transfer to non-participating unit|0|||
105348851|NCT00561470|363279185|FG000|Overall Study|Unauthorized procedure|3|||
105348852|NCT00561470|363279186|FG001|Overall Study|Unauthorized procedure|1|||
105348853|NCT00561470|363279185|FG000|Overall Study|Randomized but not treated|5|||
105348854|NCT00561470|363279186|FG001|Overall Study|Randomized but not treated|5|||
105348855|NCT00561470|363279185|FG000|Overall Study|Missed visit window|1|||
105348856|NCT00561470|363279186|FG001|Overall Study|Missed visit window|4|||
105348857|NCT00561470|363279185|FG000|Overall Study|Planning surgery|1|||
105348858|NCT00561470|363279186|FG001|Overall Study|Planning surgery|1|||
105348859|NCT00561470|363279185|FG000|Overall Study|Ongoing Treatment|11|||
105348860|NCT00561470|363279186|FG001|Overall Study|Ongoing Treatment|14|||
105348861|NCT02258334|363279191|FG000|Overall Study|Adverse Event|1|||
105348862|NCT02258334|363279192|FG001|Overall Study|Adverse Event|0|||
105348863|NCT02258334|363279193|FG002|Overall Study|Adverse Event|0|||
105348864|NCT02258334|363279194|FG003|Overall Study|Adverse Event|0|||
105348865|NCT02054910|363279199|FG000|Overall Study|Lost to Follow-up|4|||
105348866|NCT02054910|363279200|FG001|Overall Study|Lost to Follow-up|1|||
105348867|NCT01625689|363279204|FG000|Overall Study|Migration|2|||
105348868|NCT01625689|363279205|FG001|Overall Study|Migration|1|||
105348869|NCT00106639|363279210|FG000|Overall Study|Adverse Event|3|||
105348870|NCT00106639|363279211|FG001|Overall Study|Adverse Event|4|||
105348871|NCT00106639|363279212|FG002|Overall Study|Adverse Event|1|||
105348872|NCT00106639|363279210|FG000|Overall Study|Protocol Violation|0|||
105348873|NCT00106639|363279211|FG001|Overall Study|Protocol Violation|1|||
105348874|NCT00106639|363279212|FG002|Overall Study|Protocol Violation|0|||
105348875|NCT00106639|363279210|FG000|Overall Study|Withdrawal by Subject|0|||
105348876|NCT00106639|363279211|FG001|Overall Study|Withdrawal by Subject|1|||
105348877|NCT00106639|363279212|FG002|Overall Study|Withdrawal by Subject|0|||
105348878|NCT00106639|363279210|FG000|Overall Study|Participant defaulted|0|||
105348879|NCT00106639|363279211|FG001|Overall Study|Participant defaulted|1|||
105473685|NCT02405442|363747017|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
105473686|NCT02405442|363747018|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
105698787|NCT02285920|364561331|FG000|Overall Study|Dialysis discontinuation|0|||
105348880|NCT00106639|363279212|FG002|Overall Study|Participant defaulted|1|||
105348881|NCT04907227|363279213|FG000|Overall Study|Death|12|||
105348882|NCT04907227|363279214|FG001|Overall Study|Death|8|||
105473687|NCT02405442|363747015|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
105348883|NCT04907227|363279213|FG000|Overall Study|Withdrawal by Subject|2|||
105698788|NCT02285920|364561332|FG001|Overall Study|Dialysis discontinuation|1|||
105698789|NCT02285920|364561333|FG002|Overall Study|Dialysis discontinuation|0|||
105698790|NCT02285920|364561334|FG003|Overall Study|Dialysis discontinuation|0|||
105698791|NCT02285920|364561331|FG000|Overall Study|Death|2|||
105698792|NCT02285920|364561332|FG001|Overall Study|Death|0|||
105698793|NCT02285920|364561333|FG002|Overall Study|Death|2|||
105698794|NCT02285920|364561334|FG003|Overall Study|Death|1|||
105698795|NCT00677820|364561335|FG000|Overall Study|Lost to Follow-up|1|||
105698796|NCT00677820|364561336|FG001|Overall Study|Lost to Follow-up|0|||
105698797|NCT01101438|364561338|FG000|Overall Study|Withdrawal by Subject|8|||
105698798|NCT01101438|364561339|FG001|Overall Study|Withdrawal by Subject|9|||
105698799|NCT01444742|364561340|FG000|Overall Study|Death|1|||
105698800|NCT01365039|364561344|FG000|Overall Study|Study related symptoms and complaints|1|||
105698801|NCT01365039|364561345|FG001|Overall Study|Study related symptoms and complaints|0|||
105698802|NCT00909181|364561346|FG000|Overall Study|Lost to Follow-up|39|||
105698803|NCT00909181|364561347|FG001|Overall Study|Lost to Follow-up|18|||
105698804|NCT00909181|364561348|FG002|Overall Study|Lost to Follow-up|33|||
105698805|NCT03677596|364561349|FG000|Overall Study|Adverse Event|0|||
105698806|NCT03677596|364561350|FG001|Overall Study|Adverse Event|1|||
105698807|NCT03677596|364561349|FG000|Overall Study|Death|10|||
105698808|NCT03677596|364561350|FG001|Overall Study|Death|6|||
105698809|NCT03677596|364561349|FG000|Overall Study|Lost to Follow-up|0|||
105698810|NCT03677596|364561350|FG001|Overall Study|Lost to Follow-up|1|||
105698811|NCT03677596|364561349|FG000|Overall Study|Progressive Disease|8|||
105698812|NCT03677596|364561350|FG001|Overall Study|Progressive Disease|8|||
105698813|NCT03677596|364561349|FG000|Overall Study|Withdrawal by Subject|3|||
105698814|NCT03677596|364561350|FG001|Overall Study|Withdrawal by Subject|0|||
105698815|NCT03677596|364561349|FG000|Overall Study|Disease Relapse|2|||
105698816|NCT03677596|364561350|FG001|Overall Study|Disease Relapse|2|||
105698817|NCT03677596|364561349|FG000|Overall Study|Other|0|||
105698818|NCT03677596|364561350|FG001|Overall Study|Other|1|||
105698819|NCT00003895|364561351|FG000|Overall Study|Adverse Event|4|||
105698820|NCT00003895|364561352|FG001|Overall Study|Adverse Event|0|||
105698821|NCT00003895|364561351|FG000|Overall Study|Lack of Efficacy|1|||
105698822|NCT00003895|364561352|FG001|Overall Study|Lack of Efficacy|1|||
105698823|NCT00003895|364561351|FG000|Overall Study|Patient Vacation|2|||
105698824|NCT00003895|364561352|FG001|Overall Study|Patient Vacation|0|||
105698825|NCT00003895|364561351|FG000|Overall Study|Withdrawal by Subject|0|||
105698826|NCT00003895|364561352|FG001|Overall Study|Withdrawal by Subject|3|||
105698827|NCT00806195|364561353|FG000|Overall Study|Death|6|||
105698828|NCT00806195|364561354|FG001|Overall Study|Death|0|||
105698829|NCT00806195|364561355|FG002|Overall Study|Death|1|||
105698830|NCT00806195|364561356|FG003|Overall Study|Death|0|||
105698831|NCT00806195|364561353|FG000|Overall Study|Adverse Event|25|||
105698832|NCT00806195|364561354|FG001|Overall Study|Adverse Event|5|||
105698833|NCT00806195|364561355|FG002|Overall Study|Adverse Event|11|||
105698834|NCT00806195|364561356|FG003|Overall Study|Adverse Event|2|||
105698835|NCT00806195|364561353|FG000|Overall Study|Withdrawal by Subject|119|||
105698836|NCT00806195|364561354|FG001|Overall Study|Withdrawal by Subject|31|||
105698837|NCT00806195|364561355|FG002|Overall Study|Withdrawal by Subject|76|||
105698838|NCT00806195|364561356|FG003|Overall Study|Withdrawal by Subject|35|||
105698839|NCT00806195|364561353|FG000|Overall Study|Lost to Follow-up|217|||
105698840|NCT00806195|364561354|FG001|Overall Study|Lost to Follow-up|66|||
105698841|NCT00806195|364561355|FG002|Overall Study|Lost to Follow-up|90|||
105698842|NCT00806195|364561356|FG003|Overall Study|Lost to Follow-up|34|||
105698843|NCT00806195|364561353|FG000|Overall Study|Inappropriate Enrollment|0|||
105698844|NCT00806195|364561354|FG001|Overall Study|Inappropriate Enrollment|1|||
105698845|NCT00806195|364561355|FG002|Overall Study|Inappropriate Enrollment|0|||
105698846|NCT00806195|364561356|FG003|Overall Study|Inappropriate Enrollment|0|||
105698847|NCT00806195|364561353|FG000|Overall Study|Administrative Reason|113|||
105698848|NCT00806195|364561354|FG001|Overall Study|Administrative Reason|35|||
105698849|NCT00806195|364561355|FG002|Overall Study|Administrative Reason|66|||
105698850|NCT00806195|364561356|FG003|Overall Study|Administrative Reason|26|||
105698851|NCT00806195|364561353|FG000|Overall Study|Protocol Violation|34|||
105698852|NCT00806195|364561354|FG001|Overall Study|Protocol Violation|24|||
105698853|NCT00806195|364561355|FG002|Overall Study|Protocol Violation|26|||
105698854|NCT00806195|364561356|FG003|Overall Study|Protocol Violation|9|||
105698855|NCT02490475|364561357|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
105698856|NCT02490475|364561358|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
105698857|NCT02490475|364561359|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
105698858|NCT02490475|364561360|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
105698859|NCT02490475|364561357|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
105698860|NCT02490475|364561358|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
105698861|NCT02490475|364561359|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
105698862|NCT02490475|364561360|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
105698863|NCT02490475|364561357|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
105698864|NCT02490475|364561358|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
105698865|NCT02490475|364561359|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
105698866|NCT02490475|364561360|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
105698867|NCT02490475|364561357|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
105698868|NCT02490475|364561358|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
105698869|NCT02490475|364561359|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
105698870|NCT02490475|364561360|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
105698871|NCT02490475|364561357|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
105698872|NCT02490475|364561358|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
105698873|NCT02490475|364561359|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
105698874|NCT02490475|364561360|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
105698875|NCT02490475|364561357|FG000|Period 2: Extension Phase|Refused Treatment|0|||
105698876|NCT02490475|364561358|FG001|Period 2: Extension Phase|Refused Treatment|0|||
105698877|NCT02490475|364561359|FG002|Period 2: Extension Phase|Refused Treatment|0|||
105698878|NCT02490475|364561360|FG003|Period 2: Extension Phase|Refused Treatment|1|||
105698879|NCT02490475|364561357|FG000|Period 2: Extension Phase|Adverse Event|0|||
105698880|NCT02490475|364561358|FG001|Period 2: Extension Phase|Adverse Event|0|||
105698881|NCT02490475|364561359|FG002|Period 2: Extension Phase|Adverse Event|1|||
105698882|NCT02490475|364561360|FG003|Period 2: Extension Phase|Adverse Event|0|||
105698883|NCT00139776|364561361|FG000|Period I|Did not enter Period II|575|||
105348884|NCT04907227|363279214|FG001|Overall Study|Withdrawal by Subject|2|||
105348885|NCT04907227|363279213|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
105698884|NCT00139776|364561362|FG001|Period I|Did not enter Period II|0|||
105698885|NCT00139776|364561363|FG002|Period I|Did not enter Period II|0|||
105698886|NCT00139776|364561364|FG003|Period I|Did not enter Period II|0|||
105698887|NCT00139776|364561361|FG000|Period II|Not Randomized into Period III|0|||
105698888|NCT00139776|364561362|FG001|Period II|Not Randomized into Period III|322|||
105698889|NCT00139776|364561363|FG002|Period II|Not Randomized into Period III|0|||
105698890|NCT00139776|364561364|FG003|Period II|Not Randomized into Period III|0|||
105698891|NCT00139776|364561361|FG000|Period III|Adverse Event|0|||
105698892|NCT00139776|364561362|FG001|Period III|Adverse Event|0|||
105698893|NCT00139776|364561363|FG002|Period III|Adverse Event|22|||
105698894|NCT00139776|364561364|FG003|Period III|Adverse Event|23|||
105698895|NCT00139776|364561361|FG000|Period III|Other|0|||
105698896|NCT00139776|364561362|FG001|Period III|Other|0|||
105698897|NCT00139776|364561363|FG002|Period III|Other|23|||
105698898|NCT00139776|364561364|FG003|Period III|Other|34|||
105698899|NCT00139776|364561361|FG000|Period III|Lack of Efficacy|0|||
105698900|NCT00139776|364561362|FG001|Period III|Lack of Efficacy|0|||
105698901|NCT00139776|364561363|FG002|Period III|Lack of Efficacy|10|||
105348886|NCT04907227|363279214|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
105348887|NCT04907227|363279213|FG000|Overall Study|Sponsor Decision|25|||
105348888|NCT04907227|363279214|FG001|Overall Study|Sponsor Decision|30|||
105348889|NCT04907227|363279213|FG000|Overall Study|Physician Decision|1|||
105348890|NCT04907227|363279214|FG001|Overall Study|Physician Decision|0|||
105348891|NCT03723070|363279215|FG000|Overall Study|Lost to Follow-up|2|||
105348892|NCT03723070|363279215|FG000|Overall Study|Physician Decision|1|||
105348893|NCT03723070|363279215|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
105348894|NCT00477607|363279216|FG000|Overall Study|Lost to Follow-up|7|||
105348895|NCT00477607|363279217|FG001|Overall Study|Lost to Follow-up|7|||
105348896|NCT01362244|363279218|FG000|Overall Study|Adverse Event|3|||
105348897|NCT01362244|363279219|FG001|Overall Study|Adverse Event|5|||
105698902|NCT00139776|364561364|FG003|Period III|Lack of Efficacy|24|||
105348898|NCT01362244|363279218|FG000|Overall Study|Lack of Efficacy|5|||
105348899|NCT01362244|363279219|FG001|Overall Study|Lack of Efficacy|11|||
105348900|NCT01362244|363279218|FG000|Overall Study|Lost to Follow-up|0|||
105473688|NCT02405442|363747016|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
105473689|NCT02405442|363747017|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
105698903|NCT00139776|364561361|FG000|Period III|Lost to Follow-up|0|||
105698904|NCT00139776|364561362|FG001|Period III|Lost to Follow-up|0|||
105698905|NCT00139776|364561363|FG002|Period III|Lost to Follow-up|5|||
105698906|NCT00139776|364561364|FG003|Period III|Lost to Follow-up|4|||
105698907|NCT00139776|364561361|FG000|Period III|Withdrawal by Subject|0|||
105348901|NCT01362244|363279219|FG001|Overall Study|Lost to Follow-up|2|||
105348902|NCT01362244|363279218|FG000|Overall Study|Protocol Violation|5|||
105698908|NCT00139776|364561362|FG001|Period III|Withdrawal by Subject|0|||
105698909|NCT00139776|364561363|FG002|Period III|Withdrawal by Subject|16|||
105698910|NCT00139776|364561364|FG003|Period III|Withdrawal by Subject|21|||
105698911|NCT01360554|364561365|FG000|Overall Study|Death|359|||
105698912|NCT01360554|364561366|FG001|Overall Study|Death|371|||
105698913|NCT01360554|364561365|FG000|Overall Study|Lost to Follow-up|4|||
105698914|NCT01360554|364561366|FG001|Overall Study|Lost to Follow-up|4|||
105698915|NCT01360554|364561365|FG000|Overall Study|Withdrawal by Subject|23|||
105698916|NCT01360554|364561366|FG001|Overall Study|Withdrawal by Subject|24|||
105698917|NCT01360554|364561365|FG000|Overall Study|Study terminated by sponsor|49|||
105698918|NCT01360554|364561366|FG001|Overall Study|Study terminated by sponsor|37|||
105698919|NCT01360554|364561365|FG000|Overall Study|Other, not specified|1|||
105698920|NCT01360554|364561366|FG001|Overall Study|Other, not specified|0|||
105698921|NCT01360554|364561365|FG000|Overall Study|Randomized but not treated.|3|||
105698922|NCT01360554|364561366|FG001|Overall Study|Randomized but not treated.|3|||
105698923|NCT00187096|364561367|FG000|Overall Study|unacceptable toxicity|0|||
105698924|NCT00187096|364561368|FG001|Overall Study|unacceptable toxicity|0|||
105698925|NCT00187096|364561369|FG002|Overall Study|unacceptable toxicity|1|||
105698926|NCT04912245|364561374|FG000|Overall Study|Withdrawal by Subject|21|||
105698927|NCT04912245|364561375|FG001|Overall Study|Withdrawal by Subject|4|||
105698928|NCT04912245|364561374|FG000|Overall Study|Lost to Follow-up|5|||
105698929|NCT04912245|364561375|FG001|Overall Study|Lost to Follow-up|11|||
105698930|NCT04667377|364561380|FG000|Dose Escalation Period|Other not specified below|3|||
105698931|NCT04667377|364561381|FG001|Dose Escalation Period|Other not specified below|3|||
105698932|NCT04667377|364561382|FG002|Dose Escalation Period|Other not specified below|2|||
105698933|NCT04667377|364561383|FG003|Dose Escalation Period|Other not specified below|1|||
105698934|NCT04667377|364561384|FG004|Dose Escalation Period|Other not specified below|3|||
105698935|NCT04667377|364561380|FG000|Dose Escalation Period|Protocol Violation|2|||
105698936|NCT04667377|364561381|FG001|Dose Escalation Period|Protocol Violation|2|||
105698937|NCT04667377|364561382|FG002|Dose Escalation Period|Protocol Violation|0|||
105698938|NCT04667377|364561383|FG003|Dose Escalation Period|Protocol Violation|2|||
105698939|NCT04667377|364561384|FG004|Dose Escalation Period|Protocol Violation|1|||
105698940|NCT04667377|364561380|FG000|Dose Escalation Period|Burden of study procedures|2|||
105698941|NCT04667377|364561381|FG001|Dose Escalation Period|Burden of study procedures|1|||
105698942|NCT04667377|364561382|FG002|Dose Escalation Period|Burden of study procedures|1|||
105698943|NCT04667377|364561383|FG003|Dose Escalation Period|Burden of study procedures|1|||
105698944|NCT04667377|364561384|FG004|Dose Escalation Period|Burden of study procedures|5|||
105698945|NCT04667377|364561380|FG000|Dose Escalation Period|Change of residence|0|||
105698946|NCT04667377|364561381|FG001|Dose Escalation Period|Change of residence|0|||
105698947|NCT04667377|364561382|FG002|Dose Escalation Period|Change of residence|1|||
105698948|NCT04667377|364561383|FG003|Dose Escalation Period|Change of residence|0|||
105698949|NCT04667377|364561384|FG004|Dose Escalation Period|Change of residence|0|||
105698950|NCT04667377|364561380|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
105698951|NCT04667377|364561381|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
105698952|NCT04667377|364561382|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
105698953|NCT04667377|364561383|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
105698954|NCT04667377|364561384|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
105698955|NCT04667377|364561380|FG000|Dose Escalation Period|Adverse Event|9|||
105698956|NCT04667377|364561381|FG001|Dose Escalation Period|Adverse Event|10|||
105698957|NCT04667377|364561382|FG002|Dose Escalation Period|Adverse Event|12|||
105698958|NCT04667377|364561383|FG003|Dose Escalation Period|Adverse Event|17|||
105698959|NCT04667377|364561384|FG004|Dose Escalation Period|Adverse Event|3|||
105698960|NCT04667377|364561380|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
105698961|NCT04667377|364561381|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
105698962|NCT04667377|364561382|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
105698963|NCT04667377|364561383|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
105698964|NCT04667377|364561384|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
105698965|NCT04667377|364561380|FG000|Dose Escalation Period|Not treated|1|||
105698966|NCT04667377|364561381|FG001|Dose Escalation Period|Not treated|0|||
105698967|NCT04667377|364561382|FG002|Dose Escalation Period|Not treated|0|||
105698968|NCT04667377|364561383|FG003|Dose Escalation Period|Not treated|0|||
105698969|NCT04667377|364561384|FG004|Dose Escalation Period|Not treated|0|||
105698970|NCT04667377|364561380|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
105698971|NCT04667377|364561381|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
105698972|NCT04667377|364561382|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
105698973|NCT04667377|364561383|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
105698974|NCT04667377|364561384|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
105698975|NCT04667377|364561380|FG000|Dose Escalation Period|Lost to Follow-up|0|||
105348903|NCT01362244|363279219|FG001|Overall Study|Protocol Violation|1|||
105348904|NCT01362244|363279218|FG000|Overall Study|Withdrawal by Subject|2|||
105348905|NCT01362244|363279219|FG001|Overall Study|Withdrawal by Subject|1|||
105348906|NCT01362244|363279218|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
105698976|NCT04667377|364561381|FG001|Dose Escalation Period|Lost to Follow-up|1|||
105698977|NCT04667377|364561382|FG002|Dose Escalation Period|Lost to Follow-up|0|||
105698978|NCT04667377|364561383|FG003|Dose Escalation Period|Lost to Follow-up|0|||
105698979|NCT04667377|364561384|FG004|Dose Escalation Period|Lost to Follow-up|0|||
105348907|NCT01362244|363279219|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
105348908|NCT01362244|363279218|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
105348909|NCT01362244|363279219|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
105348910|NCT00467961|363279225|FG000|Overall Study|Technical Failures|5|||
105348911|NCT00467961|363279225|FG000|Overall Study|Disease Progression|2|||
105348912|NCT01447927|363279226|FG000|Overall Study|Adverse Event|4|||
105348913|NCT01447927|363279227|FG001|Overall Study|Adverse Event|3|||
105348914|NCT01447927|363279226|FG000|Overall Study|Withdrawal by Subject|1|||
105348915|NCT01447927|363279227|FG001|Overall Study|Withdrawal by Subject|0|||
105348916|NCT02908074|363279228|FG000|Overall Study|sponsor/ICON decision|0|||
105348917|NCT02908074|363279229|FG001|Overall Study|sponsor/ICON decision|0|||
105348918|NCT02908074|363279230|FG002|Overall Study|sponsor/ICON decision|1|||
105348919|NCT02908074|363279231|FG003|Overall Study|sponsor/ICON decision|0|||
105348920|NCT02908074|363279232|FG004|Overall Study|sponsor/ICON decision|0|||
105348921|NCT02908074|363279233|FG005|Overall Study|sponsor/ICON decision|0|||
105348922|NCT02908074|363279228|FG000|Overall Study|Protocol Violation|0|||
105348923|NCT02908074|363279229|FG001|Overall Study|Protocol Violation|1|||
105348924|NCT02908074|363279230|FG002|Overall Study|Protocol Violation|0|||
105348925|NCT02908074|363279231|FG003|Overall Study|Protocol Violation|0|||
105348926|NCT02908074|363279232|FG004|Overall Study|Protocol Violation|0|||
105348927|NCT02908074|363279233|FG005|Overall Study|Protocol Violation|0|||
105348928|NCT02908074|363279228|FG000|Overall Study|Adverse Event|5|||
105348929|NCT02908074|363279229|FG001|Overall Study|Adverse Event|2|||
105348930|NCT02908074|363279230|FG002|Overall Study|Adverse Event|0|||
105348931|NCT02908074|363279231|FG003|Overall Study|Adverse Event|0|||
105348932|NCT02908074|363279232|FG004|Overall Study|Adverse Event|1|||
105348933|NCT02908074|363279233|FG005|Overall Study|Adverse Event|0|||
105348934|NCT02908074|363279228|FG000|Overall Study|AESI|1|||
105348935|NCT02908074|363279229|FG001|Overall Study|AESI|0|||
105348936|NCT02908074|363279230|FG002|Overall Study|AESI|1|||
105348937|NCT02908074|363279231|FG003|Overall Study|AESI|0|||
105348938|NCT02908074|363279232|FG004|Overall Study|AESI|1|||
105348939|NCT02908074|363279233|FG005|Overall Study|AESI|0|||
105348940|NCT02908074|363279228|FG000|Overall Study|Discontinuation criteria per protocol|0|||
105348941|NCT02908074|363279229|FG001|Overall Study|Discontinuation criteria per protocol|0|||
105348942|NCT02908074|363279230|FG002|Overall Study|Discontinuation criteria per protocol|1|||
105698980|NCT04667377|364561380|FG000|Maintenance Period|Perceived lack of efficacy|0|||
105348943|NCT02908074|363279231|FG003|Overall Study|Discontinuation criteria per protocol|0|||
105348944|NCT02908074|363279232|FG004|Overall Study|Discontinuation criteria per protocol|0|||
105348945|NCT02908074|363279233|FG005|Overall Study|Discontinuation criteria per protocol|1|||
105348946|NCT02908074|363279228|FG000|Overall Study|Withdrawal by Subject|3|||
105348947|NCT02908074|363279229|FG001|Overall Study|Withdrawal by Subject|2|||
105348948|NCT02908074|363279230|FG002|Overall Study|Withdrawal by Subject|2|||
105348949|NCT02908074|363279231|FG003|Overall Study|Withdrawal by Subject|2|||
105348950|NCT02908074|363279232|FG004|Overall Study|Withdrawal by Subject|2|||
105348951|NCT02908074|363279233|FG005|Overall Study|Withdrawal by Subject|2|||
105348952|NCT02908074|363279228|FG000|Overall Study|Lost to Follow-up|0|||
105348953|NCT02908074|363279229|FG001|Overall Study|Lost to Follow-up|1|||
105348954|NCT02908074|363279230|FG002|Overall Study|Lost to Follow-up|1|||
105698981|NCT04667377|364561381|FG001|Maintenance Period|Perceived lack of efficacy|2|||
105698982|NCT04667377|364561382|FG002|Maintenance Period|Perceived lack of efficacy|1|||
105348955|NCT02908074|363279231|FG003|Overall Study|Lost to Follow-up|1|||
105348956|NCT02908074|363279232|FG004|Overall Study|Lost to Follow-up|0|||
105348957|NCT02908074|363279233|FG005|Overall Study|Lost to Follow-up|1|||
105348958|NCT02073565|363279234|FG000|Cohort A|Withdrawal by Subject|1|||
105473690|NCT02405442|363747018|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
105473691|NCT02405442|363747015|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
105698983|NCT04667377|364561383|FG003|Maintenance Period|Perceived lack of efficacy|0|||
105698984|NCT04667377|364561384|FG004|Maintenance Period|Perceived lack of efficacy|1|||
105348959|NCT02073565|363279235|FG001|Cohort A|Withdrawal by Subject|0|||
105348960|NCT02073565|363279234|FG000|Cohort B|Withdrawal by Subject|1|||
105348961|NCT02073565|363279235|FG001|Cohort B|Withdrawal by Subject|2|||
105698985|NCT04667377|364561380|FG000|Maintenance Period|Adverse Event|2|||
105348962|NCT02073565|363279234|FG000|Cohort C|Withdrawal by Subject|0|||
105348963|NCT02073565|363279235|FG001|Cohort C|Withdrawal by Subject|2|||
105348964|NCT02073565|363279234|FG000|Cohort C|Lost to Follow-up|0|||
105348965|NCT02073565|363279235|FG001|Cohort C|Lost to Follow-up|2|||
105348966|NCT04102865|363279236|FG000|Overall Study|Adverse Event|4|||
105348967|NCT04102865|363279237|FG001|Overall Study|Adverse Event|0|||
105348968|NCT04102865|363279236|FG000|Overall Study|Lost to Follow-up|1|||
105348969|NCT04102865|363279237|FG001|Overall Study|Lost to Follow-up|0|||
105348970|NCT04102865|363279236|FG000|Overall Study|Withdrawal by Subject|2|||
105348971|NCT04102865|363279237|FG001|Overall Study|Withdrawal by Subject|0|||
105348972|NCT01764997|363279238|FG000|Run-in Period|Adverse Event|15|||
105348973|NCT01764997|363279239|FG001|Run-in Period|Adverse Event|0|||
105348974|NCT01764997|363279240|FG002|Run-in Period|Adverse Event|0|||
105348975|NCT01764997|363279241|FG003|Run-in Period|Adverse Event|0|||
105348976|NCT01764997|363279242|FG004|Run-in Period|Adverse Event|0|||
105348977|NCT01764997|363279238|FG000|Run-in Period|Lack of Efficacy|5|||
105348978|NCT01764997|363279239|FG001|Run-in Period|Lack of Efficacy|0|||
105348979|NCT01764997|363279240|FG002|Run-in Period|Lack of Efficacy|0|||
105348980|NCT01764997|363279241|FG003|Run-in Period|Lack of Efficacy|0|||
105348981|NCT01764997|363279242|FG004|Run-in Period|Lack of Efficacy|0|||
105348982|NCT01764997|363279238|FG000|Run-in Period|Poor compliance to protocol|1|||
105348983|NCT01764997|363279239|FG001|Run-in Period|Poor compliance to protocol|0|||
105348984|NCT01764997|363279240|FG002|Run-in Period|Poor compliance to protocol|0|||
105698986|NCT04667377|364561381|FG001|Maintenance Period|Adverse Event|8|||
105698987|NCT04667377|364561382|FG002|Maintenance Period|Adverse Event|5|||
105698988|NCT04667377|364561383|FG003|Maintenance Period|Adverse Event|4|||
105698989|NCT04667377|364561384|FG004|Maintenance Period|Adverse Event|1|||
105698990|NCT04667377|364561380|FG000|Maintenance Period|Adverse event: COVID infection|0|||
105698991|NCT04667377|364561381|FG001|Maintenance Period|Adverse event: COVID infection|1|||
105698992|NCT04667377|364561382|FG002|Maintenance Period|Adverse event: COVID infection|0|||
105698993|NCT04667377|364561383|FG003|Maintenance Period|Adverse event: COVID infection|0|||
105698994|NCT04667377|364561384|FG004|Maintenance Period|Adverse event: COVID infection|0|||
105698995|NCT04667377|364561380|FG000|Maintenance Period|COVID-related|0|||
105698996|NCT04667377|364561381|FG001|Maintenance Period|COVID-related|0|||
105698997|NCT04667377|364561382|FG002|Maintenance Period|COVID-related|1|||
105698998|NCT04667377|364561383|FG003|Maintenance Period|COVID-related|1|||
105348985|NCT01764997|363279241|FG003|Run-in Period|Poor compliance to protocol|0|||
105348986|NCT01764997|363279242|FG004|Run-in Period|Poor compliance to protocol|0|||
105348987|NCT01764997|363279238|FG000|Run-in Period|Other than specified above|17|||
105348988|NCT01764997|363279239|FG001|Run-in Period|Other than specified above|0|||
105348989|NCT01764997|363279240|FG002|Run-in Period|Other than specified above|0|||
105348990|NCT01764997|363279241|FG003|Run-in Period|Other than specified above|0|||
105348991|NCT01764997|363279242|FG004|Run-in Period|Other than specified above|0|||
105348992|NCT01764997|363279238|FG000|Study Drug Treatment Period|Adverse Event|0|||
105698999|NCT04667377|364561384|FG004|Maintenance Period|COVID-related|0|||
105699000|NCT04667377|364561380|FG000|Maintenance Period|Protocol Violation|1|||
105699001|NCT04667377|364561381|FG001|Maintenance Period|Protocol Violation|0|||
105699002|NCT04667377|364561382|FG002|Maintenance Period|Protocol Violation|0|||
105699003|NCT04667377|364561383|FG003|Maintenance Period|Protocol Violation|0|||
105699004|NCT04667377|364561384|FG004|Maintenance Period|Protocol Violation|1|||
105348993|NCT01764997|363279239|FG001|Study Drug Treatment Period|Adverse Event|1|||
105348994|NCT01764997|363279240|FG002|Study Drug Treatment Period|Adverse Event|0|||
105348995|NCT01764997|363279241|FG003|Study Drug Treatment Period|Adverse Event|0|||
105348996|NCT01764997|363279242|FG004|Study Drug Treatment Period|Adverse Event|24|||
105348997|NCT01764997|363279238|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
105699005|NCT04667377|364561380|FG000|Maintenance Period|Burden of study procedures|1|||
105699006|NCT04667377|364561381|FG001|Maintenance Period|Burden of study procedures|2|||
105699007|NCT04667377|364561382|FG002|Maintenance Period|Burden of study procedures|0|||
105699008|NCT04667377|364561383|FG003|Maintenance Period|Burden of study procedures|1|||
105699009|NCT04667377|364561384|FG004|Maintenance Period|Burden of study procedures|0|||
105699010|NCT04667377|364561380|FG000|Maintenance Period|Change of residence|0|||
105699011|NCT04667377|364561381|FG001|Maintenance Period|Change of residence|1|||
105699012|NCT04667377|364561382|FG002|Maintenance Period|Change of residence|0|||
105699013|NCT04667377|364561383|FG003|Maintenance Period|Change of residence|0|||
105699014|NCT04667377|364561384|FG004|Maintenance Period|Change of residence|1|||
105699015|NCT04667377|364561380|FG000|Maintenance Period|Missing|1|||
105699016|NCT04667377|364561381|FG001|Maintenance Period|Missing|0|||
105699017|NCT04667377|364561382|FG002|Maintenance Period|Missing|0|||
105699018|NCT04667377|364561383|FG003|Maintenance Period|Missing|0|||
105699019|NCT04667377|364561384|FG004|Maintenance Period|Missing|0|||
105699020|NCT04667377|364561380|FG000|Maintenance Period|Other than listed above|2|||
105699021|NCT04667377|364561381|FG001|Maintenance Period|Other than listed above|0|||
105699022|NCT04667377|364561382|FG002|Maintenance Period|Other than listed above|3|||
105699023|NCT04667377|364561383|FG003|Maintenance Period|Other than listed above|2|||
105699024|NCT04667377|364561384|FG004|Maintenance Period|Other than listed above|6|||
105699025|NCT04667377|364561380|FG000|Maintenance Period|Withdrawal by Subject|0|||
105699026|NCT04667377|364561381|FG001|Maintenance Period|Withdrawal by Subject|1|||
105699027|NCT04667377|364561382|FG002|Maintenance Period|Withdrawal by Subject|0|||
105699028|NCT04667377|364561383|FG003|Maintenance Period|Withdrawal by Subject|0|||
105699029|NCT04667377|364561384|FG004|Maintenance Period|Withdrawal by Subject|0|||
105699030|NCT04667377|364561380|FG000|Maintenance Period|Lost to Follow-up|1|||
105699031|NCT04667377|364561381|FG001|Maintenance Period|Lost to Follow-up|0|||
105699032|NCT04667377|364561382|FG002|Maintenance Period|Lost to Follow-up|1|||
105699033|NCT04667377|364561383|FG003|Maintenance Period|Lost to Follow-up|0|||
105699034|NCT04667377|364561384|FG004|Maintenance Period|Lost to Follow-up|1|||
105699035|NCT01011439|364561385|FG000|Overall Study|Death|37|||
105699036|NCT01011439|364561385|FG000|Overall Study|Lost to Follow-up|4|||
105699037|NCT01011439|364561385|FG000|Overall Study|Withdrawal by Subject|1|||
105699038|NCT01011439|364561385|FG000|Overall Study|Sponsor's decision|15|||
105699039|NCT03861936|364561386|FG000|Overall Study|Withdrawal by Subject|4|||
105699040|NCT03861936|364561387|FG001|Overall Study|Withdrawal by Subject|1|||
105699041|NCT03861936|364561388|FG002|Overall Study|Withdrawal by Subject|3|||
105699042|NCT03861936|364561386|FG000|Overall Study|Lost to Follow-up|5|||
105699043|NCT03861936|364561387|FG001|Overall Study|Lost to Follow-up|3|||
105699044|NCT03861936|364561388|FG002|Overall Study|Lost to Follow-up|3|||
105699045|NCT03861936|364561386|FG000|Overall Study|Physician Decision|0|||
105699046|NCT03861936|364561387|FG001|Overall Study|Physician Decision|1|||
105699047|NCT03861936|364561388|FG002|Overall Study|Physician Decision|0|||
105699048|NCT03861936|364561386|FG000|Overall Study|Protocol Deviation|0|||
105699049|NCT03861936|364561387|FG001|Overall Study|Protocol Deviation|0|||
105699050|NCT03861936|364561388|FG002|Overall Study|Protocol Deviation|1|||
105699051|NCT03861936|364561386|FG000|Overall Study|Reason not Specified|5|||
105699052|NCT03861936|364561387|FG001|Overall Study|Reason not Specified|5|||
105699053|NCT03861936|364561388|FG002|Overall Study|Reason not Specified|3|||
105699054|NCT01161043|364561389|FG000|Overall Study|Withdrawal by Subject|3|||
105699055|NCT00383084|364561396|FG000|Overall Study|Withdrawal by Subject|12|||
105699056|NCT00383084|364561397|FG001|Overall Study|Withdrawal by Subject|10|||
105699057|NCT05418673|364561398|FG000|Overall Study|Study Terminated by Sponsor|2|||
105699058|NCT05418673|364561399|FG001|Overall Study|Study Terminated by Sponsor|4|||
105699059|NCT05418673|364561398|FG000|Overall Study|Lost to Follow-up|1|||
105699060|NCT05418673|364561399|FG001|Overall Study|Lost to Follow-up|0|||
105699061|NCT02161575|364561402|FG000|Overall Study|Protocol Violation|8|||
105699062|NCT02161575|364561402|FG000|Overall Study|Lack of Efficacy|1|||
105699063|NCT02161575|364561402|FG000|Overall Study|Adverse Event|2|||
105699064|NCT01835015|364561403|FG000|Overall Study|Adverse Event|0|||
105699065|NCT01835015|364561404|FG001|Overall Study|Adverse Event|0|||
105699066|NCT01835015|364561405|FG002|Overall Study|Adverse Event|1|||
105699067|NCT01835015|364561406|FG003|Overall Study|Adverse Event|0|||
105699068|NCT01835015|364561407|FG004|Overall Study|Adverse Event|0|||
105473692|NCT02405442|363747016|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
105699069|NCT02138617|364561412|FG000|Overall Study|Death|1|||
105699070|NCT02138617|364561413|FG001|Overall Study|Death|2|||
105699071|NCT02138617|364561414|FG002|Overall Study|Death|2|||
105699072|NCT02138617|364561412|FG000|Overall Study|Adverse Event|8|||
105699073|NCT02138617|364561413|FG001|Overall Study|Adverse Event|5|||
105699074|NCT02138617|364561414|FG002|Overall Study|Adverse Event|2|||
105699075|NCT02138617|364561412|FG000|Overall Study|Disease Progression|20|||
105699076|NCT02138617|364561413|FG001|Overall Study|Disease Progression|13|||
105699077|NCT02138617|364561414|FG002|Overall Study|Disease Progression|4|||
105699078|NCT02138617|364561412|FG000|Overall Study|Withdrawal by Subject|7|||
105699079|NCT02138617|364561413|FG001|Overall Study|Withdrawal by Subject|10|||
105699080|NCT02138617|364561414|FG002|Overall Study|Withdrawal by Subject|2|||
105699081|NCT02138617|364561412|FG000|Overall Study|other complicating disease|0|||
105699082|NCT02138617|364561413|FG001|Overall Study|other complicating disease|2|||
105699083|NCT02138617|364561414|FG002|Overall Study|other complicating disease|0|||
105699084|NCT02138617|364561412|FG000|Overall Study|Protocol Violation|1|||
105699085|NCT02138617|364561413|FG001|Overall Study|Protocol Violation|0|||
105699086|NCT02138617|364561414|FG002|Overall Study|Protocol Violation|0|||
105699087|NCT02138617|364561412|FG000|Overall Study|Physician Decision|7|||
105699088|NCT02138617|364561413|FG001|Overall Study|Physician Decision|6|||
105699089|NCT02138617|364561414|FG002|Overall Study|Physician Decision|0|||
105699090|NCT02138617|364561412|FG000|Overall Study|financial reason|0|||
105699091|NCT02138617|364561413|FG001|Overall Study|financial reason|1|||
105699092|NCT02138617|364561414|FG002|Overall Study|financial reason|0|||
105699093|NCT02138617|364561412|FG000|Overall Study|other therapy|3|||
105699094|NCT02138617|364561413|FG001|Overall Study|other therapy|4|||
105699095|NCT02138617|364561414|FG002|Overall Study|other therapy|0|||
105699096|NCT01961349|364561415|FG000|Overall Study|Withdrawal by Subject|1|||
105699097|NCT01961349|364561416|FG001|Overall Study|Withdrawal by Subject|4|||
105699098|NCT01961349|364561417|FG002|Overall Study|Withdrawal by Subject|0|||
105699099|NCT01961349|364561415|FG000|Overall Study|Adverse Event|0|||
105699100|NCT01961349|364561416|FG001|Overall Study|Adverse Event|0|||
105699101|NCT01961349|364561417|FG002|Overall Study|Adverse Event|1|||
105699102|NCT01961349|364561415|FG000|Overall Study|registration error, personal reason etc|2|||
105699103|NCT01961349|364561416|FG001|Overall Study|registration error, personal reason etc|2|||
105699104|NCT01961349|364561417|FG002|Overall Study|registration error, personal reason etc|1|||
105699105|NCT00574288|364561428|FG000|Overall Study|Adverse Event|2|||
105699106|NCT00574288|364561429|FG001|Overall Study|Adverse Event|0|||
105699107|NCT00574288|364561430|FG002|Overall Study|Adverse Event|0|||
105699108|NCT00574288|364561431|FG003|Overall Study|Adverse Event|0|||
105699109|NCT00574288|364561432|FG004|Overall Study|Adverse Event|1|||
105699110|NCT00574288|364561433|FG005|Overall Study|Adverse Event|0|||
105699111|NCT00574288|364561434|FG006|Overall Study|Adverse Event|0|||
105699112|NCT00574288|364561428|FG000|Overall Study|Death|0|||
105699113|NCT00574288|364561429|FG001|Overall Study|Death|0|||
105699114|NCT00574288|364561430|FG002|Overall Study|Death|0|||
105699115|NCT00574288|364561431|FG003|Overall Study|Death|0|||
105699116|NCT00574288|364561432|FG004|Overall Study|Death|0|||
105699117|NCT00574288|364561433|FG005|Overall Study|Death|25|||
105699118|NCT00574288|364561434|FG006|Overall Study|Death|21|||
105699119|NCT00574288|364561428|FG000|Overall Study|Lost to Follow-up|0|||
105699120|NCT00574288|364561429|FG001|Overall Study|Lost to Follow-up|0|||
105699121|NCT00574288|364561430|FG002|Overall Study|Lost to Follow-up|0|||
105699122|NCT00574288|364561431|FG003|Overall Study|Lost to Follow-up|0|||
105699123|NCT00574288|364561432|FG004|Overall Study|Lost to Follow-up|0|||
105699124|NCT00574288|364561433|FG005|Overall Study|Lost to Follow-up|1|||
105699125|NCT00574288|364561434|FG006|Overall Study|Lost to Follow-up|2|||
105699126|NCT00574288|364561428|FG000|Overall Study|Study Terminated By Sponsor|0|||
105699127|NCT00574288|364561429|FG001|Overall Study|Study Terminated By Sponsor|0|||
105699128|NCT00574288|364561430|FG002|Overall Study|Study Terminated By Sponsor|0|||
105699129|NCT00574288|364561431|FG003|Overall Study|Study Terminated By Sponsor|0|||
105699130|NCT00574288|364561432|FG004|Overall Study|Study Terminated By Sponsor|0|||
105699131|NCT00574288|364561433|FG005|Overall Study|Study Terminated By Sponsor|0|||
105699132|NCT00574288|364561434|FG006|Overall Study|Study Terminated By Sponsor|5|||
105699133|NCT00574288|364561428|FG000|Overall Study|Progressive Disease|17|||
105699134|NCT00574288|364561429|FG001|Overall Study|Progressive Disease|2|||
105699135|NCT00574288|364561430|FG002|Overall Study|Progressive Disease|3|||
105699136|NCT00574288|364561431|FG003|Overall Study|Progressive Disease|2|||
105699137|NCT00574288|364561432|FG004|Overall Study|Progressive Disease|1|||
105699138|NCT00574288|364561433|FG005|Overall Study|Progressive Disease|0|||
105699139|NCT00574288|364561434|FG006|Overall Study|Progressive Disease|0|||
105699140|NCT00574288|364561428|FG000|Overall Study|Other|1|||
105699141|NCT00574288|364561429|FG001|Overall Study|Other|1|||
105699142|NCT00574288|364561430|FG002|Overall Study|Other|0|||
105699143|NCT00574288|364561431|FG003|Overall Study|Other|0|||
105699144|NCT00574288|364561432|FG004|Overall Study|Other|0|||
105699145|NCT00574288|364561433|FG005|Overall Study|Other|0|||
105699146|NCT00574288|364561434|FG006|Overall Study|Other|0|||
105699147|NCT03625687|364561435|FG000|Overall Study|Death|1|||
105699148|NCT01431274|364561436|FG000|Overall Study|Adverse Event|51|||
105699149|NCT01431274|364561437|FG001|Overall Study|Adverse Event|37|||
105699150|NCT01431274|364561438|FG002|Overall Study|Adverse Event|43|||
105699151|NCT01431274|364561439|FG003|Overall Study|Adverse Event|30|||
105699152|NCT01431274|364561440|FG004|Overall Study|Adverse Event|37|||
105699153|NCT01431274|364561436|FG000|Overall Study|Consent withdrawn not due to AE|29|||
105699154|NCT01431274|364561437|FG001|Overall Study|Consent withdrawn not due to AE|20|||
105699155|NCT01431274|364561438|FG002|Overall Study|Consent withdrawn not due to AE|17|||
105699156|NCT01431274|364561439|FG003|Overall Study|Consent withdrawn not due to AE|20|||
105699157|NCT01431274|364561440|FG004|Overall Study|Consent withdrawn not due to AE|11|||
105699158|NCT01431274|364561436|FG000|Overall Study|Non compliant with protocol|5|||
105699159|NCT01431274|364561437|FG001|Overall Study|Non compliant with protocol|8|||
105699160|NCT01431274|364561438|FG002|Overall Study|Non compliant with protocol|4|||
105699161|NCT01431274|364561439|FG003|Overall Study|Non compliant with protocol|4|||
105699162|NCT01431274|364561440|FG004|Overall Study|Non compliant with protocol|4|||
105699163|NCT01431274|364561436|FG000|Overall Study|Lost to Follow-up|6|||
105699164|NCT01431274|364561437|FG001|Overall Study|Lost to Follow-up|7|||
105699165|NCT01431274|364561438|FG002|Overall Study|Lost to Follow-up|1|||
105699166|NCT01431274|364561439|FG003|Overall Study|Lost to Follow-up|4|||
105699167|NCT01431274|364561440|FG004|Overall Study|Lost to Follow-up|0|||
105699168|NCT01431274|364561436|FG000|Overall Study|Other reason not stated above|6|||
105699169|NCT01431274|364561437|FG001|Overall Study|Other reason not stated above|5|||
105699170|NCT01431274|364561438|FG002|Overall Study|Other reason not stated above|7|||
105699171|NCT01431274|364561439|FG003|Overall Study|Other reason not stated above|2|||
105699172|NCT01431274|364561440|FG004|Overall Study|Other reason not stated above|4|||
105699173|NCT01543828|364561441|FG000|Treatment 2|Lost to Follow-up|1|||
105699174|NCT01543828|364561442|FG001|Treatment 2|Lost to Follow-up|0|||
105699175|NCT00474708|364561443|FG000|Overall Study|Lack of Efficacy|11|||
105699176|NCT00474708|364561444|FG001|Overall Study|Lack of Efficacy|5|||
105699177|NCT00474708|364561443|FG000|Overall Study|Suicide ideation/behavior|0|||
105699178|NCT00474708|364561444|FG001|Overall Study|Suicide ideation/behavior|1|||
105699179|NCT00474708|364561443|FG000|Overall Study|Withdrawal by Subject|7|||
105699180|NCT00474708|364561444|FG001|Overall Study|Withdrawal by Subject|0|||
105699181|NCT00474708|364561443|FG000|Overall Study|Lack of compliance|12|||
105699182|NCT00474708|364561444|FG001|Overall Study|Lack of compliance|4|||
105699183|NCT00474708|364561443|FG000|Overall Study|Lost to Follow-up|18|||
105699184|NCT00474708|364561444|FG001|Overall Study|Lost to Follow-up|9|||
105699185|NCT00474708|364561443|FG000|Overall Study|Physician Decision|9|||
105699186|NCT00474708|364561444|FG001|Overall Study|Physician Decision|6|||
105699187|NCT04607148|364561449|FG000|Overall Study|Withdrawal by Subject|0|||
105699188|NCT04607148|364561450|FG001|Overall Study|Withdrawal by Subject|4|||
105699189|NCT04607148|364561451|FG002|Overall Study|Withdrawal by Subject|2|||
105699190|NCT04607148|364561452|FG003|Overall Study|Withdrawal by Subject|8|||
105699191|NCT04607148|364561449|FG000|Overall Study|Study Terminated by Sponsor|14|||
105699192|NCT04607148|364561450|FG001|Overall Study|Study Terminated by Sponsor|59|||
105699193|NCT04607148|364561451|FG002|Overall Study|Study Terminated by Sponsor|9|||
105699194|NCT04607148|364561452|FG003|Overall Study|Study Terminated by Sponsor|39|||
105699195|NCT04607148|364561449|FG000|Overall Study|Sponsor Decision|0|||
105348998|NCT01764997|363279239|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
105348999|NCT01764997|363279240|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
105349000|NCT01764997|363279241|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
105349001|NCT01764997|363279242|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
105349002|NCT01764997|363279238|FG000|Study Drug Treatment Period|Other than specified above|0|||
105349003|NCT01764997|363279239|FG001|Study Drug Treatment Period|Other than specified above|0|||
105699196|NCT04607148|364561450|FG001|Overall Study|Sponsor Decision|0|||
105699197|NCT04607148|364561451|FG002|Overall Study|Sponsor Decision|1|||
105699198|NCT04607148|364561452|FG003|Overall Study|Sponsor Decision|0|||
105699199|NCT04607148|364561449|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105699200|NCT04607148|364561450|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105699201|NCT04607148|364561451|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105787207|NCT03110107|364874909|FG020|Treatment Period|Participant withdrew consent|0|||
105699202|NCT04607148|364561452|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105699203|NCT04607148|364561449|FG000|Overall Study|Lost to Follow-up|0|||
105699204|NCT04607148|364561450|FG001|Overall Study|Lost to Follow-up|2|||
105699205|NCT04607148|364561451|FG002|Overall Study|Lost to Follow-up|0|||
105787208|NCT03110107|364874910|FG021|Treatment Period|Participant withdrew consent|2|||
105787209|NCT03110107|364874911|FG022|Treatment Period|Participant withdrew consent|0|||
105787210|NCT03110107|364874912|FG023|Treatment Period|Participant withdrew consent|0|||
105787211|NCT03110107|364874913|FG024|Treatment Period|Participant withdrew consent|0|||
105787212|NCT03110107|364874914|FG025|Treatment Period|Participant withdrew consent|2|||
105787213|NCT03110107|364874889|FG000|Treatment Period|Participants no longer meets study criteria|0|||
105787214|NCT03110107|364874890|FG001|Treatment Period|Participants no longer meets study criteria|0|||
105787215|NCT03110107|364874891|FG002|Treatment Period|Participants no longer meets study criteria|0|||
105699206|NCT04607148|364561452|FG003|Overall Study|Lost to Follow-up|0|||
105699207|NCT04607148|364561449|FG000|Overall Study|Death|0|||
105699208|NCT04607148|364561450|FG001|Overall Study|Death|3|||
105699209|NCT04607148|364561451|FG002|Overall Study|Death|0|||
105787216|NCT03110107|364874892|FG003|Treatment Period|Participants no longer meets study criteria|0|||
105699210|NCT04607148|364561452|FG003|Overall Study|Death|1|||
105699211|NCT04607148|364561449|FG000|Overall Study|Adverse Event|0|||
105699212|NCT04607148|364561450|FG001|Overall Study|Adverse Event|1|||
105699213|NCT04607148|364561451|FG002|Overall Study|Adverse Event|0|||
105349004|NCT01764997|363279240|FG002|Study Drug Treatment Period|Other than specified above|0|||
105699214|NCT04607148|364561452|FG003|Overall Study|Adverse Event|0|||
105699215|NCT00916149|364561453|FG000|Overall Study|Lost to Follow-up|3|||
105699216|NCT00916149|364561454|FG001|Overall Study|Lost to Follow-up|2|||
105699217|NCT00916149|364561455|FG002|Overall Study|Lost to Follow-up|0|||
105699218|NCT00916149|364561453|FG000|Overall Study|Unable to place scalp EEG leads|1|||
105699219|NCT00916149|364561454|FG001|Overall Study|Unable to place scalp EEG leads|0|||
105699220|NCT00916149|364561455|FG002|Overall Study|Unable to place scalp EEG leads|0|||
105699221|NCT04305275|364561456|FG000|Overall Study|Adverse Event|4|||
105699222|NCT04305275|364561457|FG001|Overall Study|Adverse Event|0|||
105699223|NCT04305275|364561456|FG000|Overall Study|Lost to Follow-up|1|||
105699224|NCT04305275|364561457|FG001|Overall Study|Lost to Follow-up|1|||
105699225|NCT04305275|364561456|FG000|Overall Study|Withdrawal by Participant|8|||
105699226|NCT04305275|364561457|FG001|Overall Study|Withdrawal by Participant|1|||
105699227|NCT00589420|364561458|FG000|Overall Study|screen failure|1|||
105699228|NCT00243386|364561459|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
105699229|NCT00243386|364561460|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
105699230|NCT00243386|364561461|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
105699231|NCT00243386|364561459|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
105699232|NCT00243386|364561460|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
105699233|NCT00243386|364561461|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
105699234|NCT00243386|364561459|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
105699235|NCT00243386|364561460|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
105699236|NCT00243386|364561461|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
105699237|NCT00243386|364561459|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
105699238|NCT00243386|364561460|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
105699239|NCT00243386|364561461|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
105699240|NCT00243386|364561459|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
105699241|NCT00243386|364561460|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
105699242|NCT00243386|364561461|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
105699243|NCT00243386|364561459|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
105699244|NCT00243386|364561460|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
105699245|NCT00243386|364561461|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
105699246|NCT00243386|364561459|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
105699247|NCT00243386|364561460|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
105699248|NCT00243386|364561461|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
105699249|NCT00243386|364561459|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
105699250|NCT00243386|364561460|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
105699251|NCT00243386|364561461|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
105699252|NCT00912028|364561462|FG000|Overall Study|Lost to Follow-up|2|||
105699253|NCT00912028|364561463|FG001|Overall Study|Lost to Follow-up|3|||
105699254|NCT00912028|364561464|FG002|Overall Study|Lost to Follow-up|0|||
105699255|NCT00912028|364561465|FG003|Overall Study|Lost to Follow-up|1|||
105699256|NCT00912028|364561466|FG004|Overall Study|Lost to Follow-up|3|||
105699257|NCT00912028|364561462|FG000|Overall Study|Withdrawal by Subject|3|||
105699258|NCT00912028|364561463|FG001|Overall Study|Withdrawal by Subject|0|||
105699259|NCT00912028|364561464|FG002|Overall Study|Withdrawal by Subject|0|||
105699260|NCT00912028|364561465|FG003|Overall Study|Withdrawal by Subject|0|||
105699261|NCT00912028|364561466|FG004|Overall Study|Withdrawal by Subject|0|||
105699262|NCT00766038|364562941|FG000|Overall Study|Lost to Follow-up|15|||
105699263|NCT00766038|364562942|FG001|Overall Study|Lost to Follow-up|14|||
105699264|NCT01524198|364562943|FG000|Overall Study|Protocol Violation|8|||
105699265|NCT01524198|364562944|FG001|Overall Study|Protocol Violation|6|||
105699266|NCT01524198|364562943|FG000|Overall Study|Withdrawal by Subject|15|||
105699267|NCT01524198|364562944|FG001|Overall Study|Withdrawal by Subject|10|||
105699268|NCT01502709|364562945|FG000|Overall Study|Lost to Follow-up|4|||
105699269|NCT01502709|364562946|FG001|Overall Study|Lost to Follow-up|0|||
105699270|NCT00307151|364562947|FG000|Overall Study|Death|4|||
105699271|NCT00307151|364562948|FG001|Overall Study|Death|3|||
105699272|NCT00307151|364562949|FG002|Overall Study|Death|10|||
105699273|NCT00307151|364562950|FG003|Overall Study|Death|3|||
105699274|NCT00307151|364562947|FG000|Overall Study|Severe debilitation, unable to continue|1|||
105699275|NCT00307151|364562948|FG001|Overall Study|Severe debilitation, unable to continue|0|||
105699276|NCT00307151|364562949|FG002|Overall Study|Severe debilitation, unable to continue|0|||
105699277|NCT00307151|364562950|FG003|Overall Study|Severe debilitation, unable to continue|0|||
105699278|NCT00307151|364562947|FG000|Overall Study|Subject unable to get to clinic|1|||
105699279|NCT00307151|364562948|FG001|Overall Study|Subject unable to get to clinic|0|||
105699280|NCT00307151|364562949|FG002|Overall Study|Subject unable to get to clinic|6|||
105699281|NCT00307151|364562950|FG003|Overall Study|Subject unable to get to clinic|2|||
105699282|NCT00307151|364562947|FG000|Overall Study|Withdrew consent|0|||
105699283|NCT00307151|364562948|FG001|Overall Study|Withdrew consent|1|||
105699284|NCT00307151|364562949|FG002|Overall Study|Withdrew consent|1|||
105699285|NCT00307151|364562950|FG003|Overall Study|Withdrew consent|3|||
105699286|NCT00307151|364562947|FG000|Overall Study|Not willing to adhere to study reqs|2|||
105699287|NCT00307151|364562948|FG001|Overall Study|Not willing to adhere to study reqs|0|||
105699288|NCT00307151|364562949|FG002|Overall Study|Not willing to adhere to study reqs|2|||
105699289|NCT00307151|364562950|FG003|Overall Study|Not willing to adhere to study reqs|2|||
105699290|NCT00307151|364562947|FG000|Overall Study|Clinic unable to contact subject|3|||
105699291|NCT00307151|364562948|FG001|Overall Study|Clinic unable to contact subject|3|||
105699292|NCT00307151|364562949|FG002|Overall Study|Clinic unable to contact subject|1|||
105699293|NCT00307151|364562950|FG003|Overall Study|Clinic unable to contact subject|1|||
105699294|NCT01490450|364562951|FG000|Period 1|Lack of Efficacy|2|||
105699295|NCT01490450|364562952|FG001|Period 1|Lack of Efficacy|0|||
105699296|NCT01490450|364562953|FG002|Period 1|Lack of Efficacy|3|||
105349005|NCT01764997|363279241|FG003|Study Drug Treatment Period|Other than specified above|0|||
105349006|NCT01764997|363279242|FG004|Study Drug Treatment Period|Other than specified above|10|||
105349007|NCT01554176|363279243|FG000|Treatment Phase|Protocol Violation|1|||
105699297|NCT01490450|364562954|FG003|Period 1|Lack of Efficacy|0|||
105699298|NCT01490450|364562951|FG000|Period 1|Adverse Event|0|||
105699299|NCT01490450|364562952|FG001|Period 1|Adverse Event|0|||
105699300|NCT01490450|364562953|FG002|Period 1|Adverse Event|0|||
105699301|NCT01490450|364562954|FG003|Period 1|Adverse Event|5|||
105699302|NCT01490450|364562951|FG000|Period 1|Request to discontinue treatment|1|||
105699303|NCT01490450|364562952|FG001|Period 1|Request to discontinue treatment|0|||
105699304|NCT01490450|364562953|FG002|Period 1|Request to discontinue treatment|0|||
105699305|NCT01490450|364562954|FG003|Period 1|Request to discontinue treatment|0|||
105699306|NCT01490450|364562951|FG000|Period 1|Withdrawal by Subject|0|||
105699307|NCT01490450|364562952|FG001|Period 1|Withdrawal by Subject|0|||
105349008|NCT01554176|363279244|FG001|Treatment Phase|Protocol Violation|2|||
105349009|NCT01554176|363279245|FG002|Treatment Phase|Protocol Violation|0|||
105699308|NCT01490450|364562953|FG002|Period 1|Withdrawal by Subject|0|||
105699309|NCT01490450|364562954|FG003|Period 1|Withdrawal by Subject|3|||
105699310|NCT01490450|364562951|FG000|Period 1|No longer met study criteria|0|||
105699311|NCT01490450|364562952|FG001|Period 1|No longer met study criteria|1|||
105699312|NCT01490450|364562953|FG002|Period 1|No longer met study criteria|1|||
105699313|NCT01490450|364562954|FG003|Period 1|No longer met study criteria|0|||
105699314|NCT01490450|364562951|FG000|Period 2|Lack of Efficacy|0|||
105699315|NCT01490450|364562952|FG001|Period 2|Lack of Efficacy|0|||
105699316|NCT01490450|364562953|FG002|Period 2|Lack of Efficacy|0|||
105699317|NCT01490450|364562954|FG003|Period 2|Lack of Efficacy|1|||
105699318|NCT01490450|364562951|FG000|Period 2|Adverse Event|1|||
105699319|NCT01490450|364562952|FG001|Period 2|Adverse Event|1|||
105699320|NCT01490450|364562953|FG002|Period 2|Adverse Event|0|||
105699321|NCT01490450|364562954|FG003|Period 2|Adverse Event|1|||
105699322|NCT01490450|364562951|FG000|Period 2|Withdrawal by Subject|1|||
105699323|NCT01490450|364562952|FG001|Period 2|Withdrawal by Subject|0|||
105699324|NCT01490450|364562953|FG002|Period 2|Withdrawal by Subject|0|||
105699325|NCT01490450|364562954|FG003|Period 2|Withdrawal by Subject|0|||
105699326|NCT01490450|364562951|FG000|Period 2|Lost to Follow-up|0|||
105699327|NCT01490450|364562952|FG001|Period 2|Lost to Follow-up|0|||
105699328|NCT01490450|364562953|FG002|Period 2|Lost to Follow-up|0|||
105699329|NCT01490450|364562954|FG003|Period 2|Lost to Follow-up|2|||
105699330|NCT00516048|364562957|FG000|Overall Study|Death|0|||
105699331|NCT00516048|364562958|FG001|Overall Study|Death|0|||
105699332|NCT00516048|364562959|FG002|Overall Study|Death|1|||
105699333|NCT00516048|364562957|FG000|Overall Study|Subject Decision|0|||
105699334|NCT00516048|364562958|FG001|Overall Study|Subject Decision|2|||
105699335|NCT00516048|364562959|FG002|Overall Study|Subject Decision|0|||
105699336|NCT00054704|364562964|FG000|Overall Study|Lack of Efficacy|2|||
105699337|NCT00054704|364562965|FG001|Overall Study|Lack of Efficacy|3|||
105699338|NCT00054704|364562964|FG000|Overall Study|Adverse Event|3|||
105699339|NCT00054704|364562965|FG001|Overall Study|Adverse Event|1|||
105699340|NCT00054704|364562964|FG000|Overall Study|Lost to Follow-up|0|||
105699341|NCT00054704|364562965|FG001|Overall Study|Lost to Follow-up|1|||
105699342|NCT02289742|364562968|FG000|First Wear Period|Adverse event prior to treatment|0|||
105699343|NCT02289742|364562969|FG001|First Wear Period|Adverse event prior to treatment|1|||
105699344|NCT02289742|364562970|FG002|First Wear Period|Adverse event prior to treatment|0|||
105699345|NCT02289742|364562971|FG003|First Wear Period|Adverse event prior to treatment|0|||
105699346|NCT02289742|364562968|FG000|First Wear Period|Adverse Event|0|||
105699347|NCT02289742|364562969|FG001|First Wear Period|Adverse Event|0|||
105699348|NCT02289742|364562970|FG002|First Wear Period|Adverse Event|1|||
105699349|NCT02289742|364562971|FG003|First Wear Period|Adverse Event|0|||
105699350|NCT02289742|364562968|FG000|First Wear Period|Other prior to treatment|0|||
105699351|NCT02289742|364562969|FG001|First Wear Period|Other prior to treatment|0|||
105699352|NCT02289742|364562970|FG002|First Wear Period|Other prior to treatment|0|||
105699353|NCT02289742|364562971|FG003|First Wear Period|Other prior to treatment|1|||
105699354|NCT02289742|364562968|FG000|Third Wear Period|Adverse Event|0|||
105699355|NCT02289742|364562969|FG001|Third Wear Period|Adverse Event|1|||
105699356|NCT02289742|364562970|FG002|Third Wear Period|Adverse Event|0|||
105699357|NCT02289742|364562971|FG003|Third Wear Period|Adverse Event|0|||
105473693|NCT02405442|363747017|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
105473694|NCT02405442|363747018|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
105699358|NCT02289742|364562968|FG000|Third Wear Period|Reason not given|0|||
105699359|NCT02289742|364562969|FG001|Third Wear Period|Reason not given|0|||
105699360|NCT02289742|364562970|FG002|Third Wear Period|Reason not given|0|||
105699361|NCT02289742|364562971|FG003|Third Wear Period|Reason not given|1|||
105699362|NCT02535715|364562975|FG000|Overall Study|Withdrawal by Subject|0|||
105699363|NCT02535715|364562976|FG001|Overall Study|Withdrawal by Subject|0|||
105699364|NCT02535715|364562977|FG002|Overall Study|Withdrawal by Subject|1|||
105699365|NCT00971178|364562981|FG000|Overall Study|Lost to Follow-up|2|||
105699366|NCT00971178|364562982|FG001|Overall Study|Lost to Follow-up|2|||
105699367|NCT00971178|364562983|FG002|Overall Study|Lost to Follow-up|2|||
105699368|NCT01376778|364562987|FG000|Overall Study|Lost to Follow-up|3|||
105699369|NCT01376778|364562988|FG001|Overall Study|Lost to Follow-up|2|||
105699370|NCT00596947|364562990|FG000|Overall Study|study halted due to low enrollment|5|||
105699371|NCT00596947|364562991|FG001|Overall Study|study halted due to low enrollment|3|||
105699372|NCT00596947|364562990|FG000|Overall Study|Lost to Follow-up|1|||
105699373|NCT00596947|364562991|FG001|Overall Study|Lost to Follow-up|0|||
105699374|NCT01075412|364562992|FG000|Overall Study|Withdrawal by Subject|0|||
105699375|NCT01075412|364562993|FG001|Overall Study|Withdrawal by Subject|1|||
105699376|NCT01390272|364562994|FG000|Overall Study|Death|3|||
105699377|NCT01390272|364562995|FG001|Overall Study|Death|2|||
105699378|NCT01390272|364562994|FG000|Overall Study|Withdrawal by Subject|9|||
105699379|NCT01390272|364562995|FG001|Overall Study|Withdrawal by Subject|5|||
105699380|NCT01390272|364562994|FG000|Overall Study|Patient moved, no longer eligible|5|||
105699381|NCT01390272|364562995|FG001|Overall Study|Patient moved, no longer eligible|8|||
105699382|NCT01069172|364562998|FG000|Overall Study|Withdrawal by Subject|1|||
105699383|NCT01069172|364562999|FG001|Overall Study|Withdrawal by Subject|0|||
105699384|NCT00843518|364563002|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
105699385|NCT00843518|364563003|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
105699386|NCT00843518|364563002|FG000|Period 2 (Double-blind Treatment)|Death|0|||
105699387|NCT00843518|364563003|FG001|Period 2 (Double-blind Treatment)|Death|1|||
105699388|NCT00843518|364563002|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
105699389|NCT00843518|364563003|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
105699390|NCT00843518|364563002|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
105699391|NCT00843518|364563003|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
105699392|NCT00843518|364563002|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
105699393|NCT00843518|364563003|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
105699394|NCT00843518|364563002|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
105699395|NCT00843518|364563003|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
105699396|NCT00843518|364563002|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
105699397|NCT00843518|364563003|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
105699398|NCT01786603|364563004|FG000|Overall Study|Death|5|||
105699399|NCT01786603|364563005|FG001|Overall Study|Death|1|||
105699400|NCT01786603|364563004|FG000|Overall Study|Adverse Event|6|||
105699401|NCT01786603|364563005|FG001|Overall Study|Adverse Event|2|||
105699402|NCT01786603|364563004|FG000|Overall Study|Physician decision to withdraw|6|||
105699403|NCT01786603|364563005|FG001|Overall Study|Physician decision to withdraw|7|||
105699404|NCT01786603|364563004|FG000|Overall Study|Lost to Follow-up|1|||
105699405|NCT01786603|364563005|FG001|Overall Study|Lost to Follow-up|2|||
105699406|NCT01066585|364563010|FG000|Overall Study|Protocol Violation|1|||
105699407|NCT01066585|364563011|FG001|Overall Study|Protocol Violation|0|||
105699408|NCT01066585|364563010|FG000|Overall Study|Withdrawal by Subject|0|||
105699409|NCT01066585|364563011|FG001|Overall Study|Withdrawal by Subject|3|||
105699410|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
105699411|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
105699412|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
105699413|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
105699414|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
105699415|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
105699416|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
105699417|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
105699418|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
105699419|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
105699420|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
105699421|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
105699422|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
105699423|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
105699424|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
105699425|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
105699426|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
105699427|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
105473695|NCT02405442|363747015|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
105473696|NCT02405442|363747016|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
105473697|NCT02405442|363747017|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
105473698|NCT02405442|363747018|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
105699428|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
105699429|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
105699430|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
105699431|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
105699432|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
105699433|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
105699434|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Death|2|||
105699435|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Death|1|||
105699436|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Death|0|||
105699437|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Death|0|||
105699438|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
105699439|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
105699440|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
105699441|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
105699442|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
105699443|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
105699444|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
105699445|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
105699446|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
105699447|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
105699448|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
105699449|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
105699450|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
105473699|NCT02405442|363747015|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
105699451|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
105699452|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
105699453|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
105699454|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
105699455|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
105699456|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
105699457|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
105699458|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
105699459|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
105699460|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
105699461|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
105699462|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
105699463|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
105699464|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
105699465|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
105699466|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
105699467|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
105699468|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
105699469|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
105699470|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
105699471|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
105699472|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
105699473|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
105699474|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
105699475|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
105699476|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
105699477|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
105699478|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
105699479|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
105699480|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
105699481|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
105699482|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
105699483|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
105699484|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
105699485|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
105699486|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
105699487|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
105699488|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
105699489|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
105699490|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
105699491|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
105699492|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
105699493|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
105699494|NCT01136655|364563018|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
105699495|NCT01136655|364563018|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
105699496|NCT01136655|364563018|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
105699497|NCT01136655|364563018|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
105699498|NCT01358760|364563023|FG000|Overall Study|Adverse Event|3|||
105699499|NCT01358760|364563024|FG001|Overall Study|Adverse Event|4|||
105699500|NCT01358760|364563025|FG002|Overall Study|Adverse Event|3|||
105699501|NCT01358760|364563023|FG000|Overall Study|Lost to Follow-up|1|||
105699502|NCT01358760|364563024|FG001|Overall Study|Lost to Follow-up|1|||
105699503|NCT01358760|364563025|FG002|Overall Study|Lost to Follow-up|3|||
105699504|NCT01358760|364563023|FG000|Overall Study|Withdrawal by Subject|5|||
105699505|NCT01358760|364563024|FG001|Overall Study|Withdrawal by Subject|3|||
105699506|NCT01358760|364563025|FG002|Overall Study|Withdrawal by Subject|2|||
105699507|NCT01358760|364563023|FG000|Overall Study|Physician Decision|1|||
105699508|NCT01358760|364563024|FG001|Overall Study|Physician Decision|0|||
105699509|NCT01358760|364563025|FG002|Overall Study|Physician Decision|1|||
105699510|NCT01358760|364563023|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
105699511|NCT01358760|364563024|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
105699512|NCT01358760|364563025|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
105699513|NCT03710486|364563026|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
105699514|NCT03710486|364563027|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
105699515|NCT03710486|364563026|FG000|Overall Study|Missing|0|||
105699516|NCT03710486|364563027|FG001|Overall Study|Missing|2|||
105699517|NCT01987960|364563028|FG000|Period 1|Adverse Event|24|||
105699518|NCT01987960|364563029|FG001|Period 1|Adverse Event|0|||
105699519|NCT01987960|364563030|FG002|Period 1|Adverse Event|0|||
105699520|NCT01987960|364563031|FG003|Period 1|Adverse Event|0|||
105699521|NCT01987960|364563028|FG000|Period 1|Lack of Efficacy|4|||
105699522|NCT01987960|364563029|FG001|Period 1|Lack of Efficacy|0|||
105699523|NCT01987960|364563030|FG002|Period 1|Lack of Efficacy|0|||
105699524|NCT01987960|364563031|FG003|Period 1|Lack of Efficacy|0|||
105699525|NCT01987960|364563028|FG000|Period 1|Non-compliance with IMP|6|||
105699526|NCT01987960|364563029|FG001|Period 1|Non-compliance with IMP|0|||
105699527|NCT01987960|364563030|FG002|Period 1|Non-compliance with IMP|0|||
105349010|NCT01554176|363279246|FG003|Treatment Phase|Protocol Violation|0|||
105349011|NCT01554176|363279247|FG004|Treatment Phase|Protocol Violation|0|||
105349012|NCT01554176|363279243|FG000|Treatment Phase|Physician Decision|1|||
105699528|NCT01987960|364563031|FG003|Period 1|Non-compliance with IMP|0|||
105699529|NCT01987960|364563028|FG000|Period 1|Protocol Violation|12|||
105699530|NCT01987960|364563029|FG001|Period 1|Protocol Violation|0|||
105699531|NCT01987960|364563030|FG002|Period 1|Protocol Violation|0|||
105699532|NCT01987960|364563031|FG003|Period 1|Protocol Violation|0|||
105699533|NCT01987960|364563028|FG000|Period 1|Withdrawal by Subject|21|||
105699534|NCT01987960|364563029|FG001|Period 1|Withdrawal by Subject|0|||
105699535|NCT01987960|364563030|FG002|Period 1|Withdrawal by Subject|0|||
105699536|NCT01987960|364563031|FG003|Period 1|Withdrawal by Subject|0|||
105699537|NCT01987960|364563028|FG000|Period 1|Lost to Follow-up|40|||
105699538|NCT01987960|364563029|FG001|Period 1|Lost to Follow-up|0|||
105699539|NCT01987960|364563030|FG002|Period 1|Lost to Follow-up|0|||
105699540|NCT01987960|364563031|FG003|Period 1|Lost to Follow-up|0|||
105699541|NCT01987960|364563028|FG000|Period 1|administrative or other reason|75|||
105699542|NCT01987960|364563029|FG001|Period 1|administrative or other reason|0|||
105699543|NCT01987960|364563030|FG002|Period 1|administrative or other reason|0|||
105699544|NCT01987960|364563031|FG003|Period 1|administrative or other reason|0|||
105699545|NCT01987960|364563028|FG000|Period 1|Withdrawal of consent before treatment|4|||
105699546|NCT01987960|364563029|FG001|Period 1|Withdrawal of consent before treatment|0|||
105699547|NCT01987960|364563030|FG002|Period 1|Withdrawal of consent before treatment|0|||
105699548|NCT01987960|364563031|FG003|Period 1|Withdrawal of consent before treatment|0|||
105699549|NCT01987960|364563028|FG000|Period 2|Adverse Event|0|||
105699550|NCT01987960|364563029|FG001|Period 2|Adverse Event|0|||
105699551|NCT01987960|364563030|FG002|Period 2|Adverse Event|1|||
105349013|NCT01554176|363279244|FG001|Treatment Phase|Physician Decision|1|||
105349014|NCT01554176|363279245|FG002|Treatment Phase|Physician Decision|0|||
105699552|NCT01987960|364563031|FG003|Period 2|Adverse Event|0|||
105699553|NCT01987960|364563028|FG000|Period 2|Withdrawal by Subject|0|||
105699554|NCT01987960|364563029|FG001|Period 2|Withdrawal by Subject|0|||
105699555|NCT01987960|364563030|FG002|Period 2|Withdrawal by Subject|1|||
105699556|NCT01987960|364563031|FG003|Period 2|Withdrawal by Subject|0|||
105699557|NCT01987960|364563028|FG000|Period 2|Administrative or other reason|0|||
105699558|NCT01987960|364563029|FG001|Period 2|Administrative or other reason|5|||
105699559|NCT01987960|364563030|FG002|Period 2|Administrative or other reason|7|||
105699560|NCT01987960|364563031|FG003|Period 2|Administrative or other reason|0|||
105699561|NCT01987960|364563028|FG000|Period 3|Adverse Event|0|||
105699562|NCT01987960|364563029|FG001|Period 3|Adverse Event|0|||
105699563|NCT01987960|364563030|FG002|Period 3|Adverse Event|0|||
105699564|NCT01987960|364563031|FG003|Period 3|Adverse Event|7|||
105699565|NCT01987960|364563028|FG000|Period 3|Non-compliance with IMP|0|||
105349015|NCT01554176|363279246|FG003|Treatment Phase|Physician Decision|0|||
105349016|NCT01554176|363279247|FG004|Treatment Phase|Physician Decision|0|||
105349017|NCT01554176|363279243|FG000|Treatment Phase|Lack of Efficacy|0|||
105699566|NCT01987960|364563029|FG001|Period 3|Non-compliance with IMP|0|||
105699567|NCT01987960|364563030|FG002|Period 3|Non-compliance with IMP|0|||
105699568|NCT01987960|364563031|FG003|Period 3|Non-compliance with IMP|1|||
105699569|NCT01987960|364563028|FG000|Period 3|Protocol Violation|0|||
105699570|NCT01987960|364563029|FG001|Period 3|Protocol Violation|0|||
105699571|NCT01987960|364563030|FG002|Period 3|Protocol Violation|0|||
105349018|NCT01554176|363279244|FG001|Treatment Phase|Lack of Efficacy|1|||
105349019|NCT01554176|363279245|FG002|Treatment Phase|Lack of Efficacy|0|||
105699572|NCT01987960|364563031|FG003|Period 3|Protocol Violation|6|||
105699573|NCT01987960|364563028|FG000|Period 3|Withdrawal by Subject|0|||
105699574|NCT01987960|364563029|FG001|Period 3|Withdrawal by Subject|0|||
105699575|NCT01987960|364563030|FG002|Period 3|Withdrawal by Subject|0|||
105699576|NCT01987960|364563031|FG003|Period 3|Withdrawal by Subject|9|||
105699577|NCT01987960|364563028|FG000|Period 3|Lost to Follow-up|0|||
105349020|NCT01554176|363279246|FG003|Treatment Phase|Lack of Efficacy|0|||
105349021|NCT01554176|363279247|FG004|Treatment Phase|Lack of Efficacy|0|||
105473700|NCT02405442|363747016|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
105699578|NCT01987960|364563029|FG001|Period 3|Lost to Follow-up|0|||
105699579|NCT01987960|364563030|FG002|Period 3|Lost to Follow-up|0|||
105699580|NCT01987960|364563031|FG003|Period 3|Lost to Follow-up|5|||
105699581|NCT01987960|364563028|FG000|Period 3|Administrative or other reason|0|||
105699582|NCT01987960|364563029|FG001|Period 3|Administrative or other reason|0|||
105699583|NCT01987960|364563030|FG002|Period 3|Administrative or other reason|0|||
105699584|NCT01987960|364563031|FG003|Period 3|Administrative or other reason|43|||
105699585|NCT00932360|364563032|FG000|Washout (One Week)|Withdrawal by Subject|0|||
105699586|NCT00932360|364563033|FG001|Washout (One Week)|Withdrawal by Subject|0|||
105699587|NCT00932360|364563034|FG002|Washout (One Week)|Withdrawal by Subject|0|||
105699588|NCT00932360|364563035|FG003|Washout (One Week)|Withdrawal by Subject|0|||
105699589|NCT00932360|364563036|FG004|Washout (One Week)|Withdrawal by Subject|2|||
105699590|NCT00932360|364563037|FG005|Washout (One Week)|Withdrawal by Subject|0|||
105699591|NCT01147744|364563038|FG000|Overall Study|Protocol Violation|1|||
105699592|NCT01147744|364563039|FG001|Overall Study|Protocol Violation|0|||
105699593|NCT01147744|364563040|FG002|Overall Study|Protocol Violation|1|||
105699594|NCT01147744|364563041|FG003|Overall Study|Protocol Violation|0|||
105699595|NCT01147744|364563042|FG004|Overall Study|Protocol Violation|1|||
105699596|NCT01147744|364563043|FG005|Overall Study|Protocol Violation|3|||
105699597|NCT01147744|364563044|FG006|Overall Study|Protocol Violation|1|||
105699598|NCT01147744|364563038|FG000|Overall Study|Physician Decision|0|||
105699599|NCT01147744|364563039|FG001|Overall Study|Physician Decision|1|||
105699600|NCT01147744|364563040|FG002|Overall Study|Physician Decision|1|||
105699601|NCT01147744|364563041|FG003|Overall Study|Physician Decision|0|||
105699602|NCT01147744|364563042|FG004|Overall Study|Physician Decision|0|||
105699603|NCT01147744|364563043|FG005|Overall Study|Physician Decision|0|||
105699604|NCT01147744|364563044|FG006|Overall Study|Physician Decision|1|||
105699605|NCT01147744|364563038|FG000|Overall Study|Lack of Efficacy|11|||
105699606|NCT01147744|364563039|FG001|Overall Study|Lack of Efficacy|11|||
105699607|NCT01147744|364563040|FG002|Overall Study|Lack of Efficacy|9|||
105699608|NCT01147744|364563041|FG003|Overall Study|Lack of Efficacy|11|||
105699609|NCT01147744|364563042|FG004|Overall Study|Lack of Efficacy|13|||
105699610|NCT01147744|364563043|FG005|Overall Study|Lack of Efficacy|8|||
105699611|NCT01147744|364563044|FG006|Overall Study|Lack of Efficacy|7|||
105699612|NCT01147744|364563038|FG000|Overall Study|Adverse Event|1|||
105699613|NCT01147744|364563039|FG001|Overall Study|Adverse Event|2|||
105699614|NCT01147744|364563040|FG002|Overall Study|Adverse Event|3|||
105699615|NCT01147744|364563041|FG003|Overall Study|Adverse Event|0|||
105699616|NCT01147744|364563042|FG004|Overall Study|Adverse Event|2|||
105699617|NCT01147744|364563043|FG005|Overall Study|Adverse Event|1|||
105699618|NCT01147744|364563044|FG006|Overall Study|Adverse Event|2|||
105699619|NCT01147744|364563038|FG000|Overall Study|Withdrawal by Subject|8|||
105699620|NCT01147744|364563039|FG001|Overall Study|Withdrawal by Subject|4|||
105699621|NCT01147744|364563040|FG002|Overall Study|Withdrawal by Subject|2|||
105699622|NCT01147744|364563041|FG003|Overall Study|Withdrawal by Subject|2|||
105699623|NCT01147744|364563042|FG004|Overall Study|Withdrawal by Subject|2|||
105699624|NCT01147744|364563043|FG005|Overall Study|Withdrawal by Subject|5|||
105699625|NCT01147744|364563044|FG006|Overall Study|Withdrawal by Subject|2|||
105699626|NCT01147744|364563038|FG000|Overall Study|Lost to Follow-up|0|||
105699627|NCT01147744|364563039|FG001|Overall Study|Lost to Follow-up|1|||
105699628|NCT01147744|364563040|FG002|Overall Study|Lost to Follow-up|0|||
105699629|NCT01147744|364563041|FG003|Overall Study|Lost to Follow-up|0|||
105699630|NCT01147744|364563042|FG004|Overall Study|Lost to Follow-up|0|||
105699631|NCT01147744|364563043|FG005|Overall Study|Lost to Follow-up|0|||
105699632|NCT01147744|364563044|FG006|Overall Study|Lost to Follow-up|0|||
105699633|NCT01147744|364563038|FG000|Overall Study|Sponsor decision to amend protocol|7|||
105699634|NCT01147744|364563039|FG001|Overall Study|Sponsor decision to amend protocol|4|||
105699635|NCT01147744|364563040|FG002|Overall Study|Sponsor decision to amend protocol|2|||
105699636|NCT01147744|364563041|FG003|Overall Study|Sponsor decision to amend protocol|5|||
105699637|NCT01147744|364563042|FG004|Overall Study|Sponsor decision to amend protocol|7|||
105699638|NCT01147744|364563043|FG005|Overall Study|Sponsor decision to amend protocol|2|||
105699639|NCT01147744|364563044|FG006|Overall Study|Sponsor decision to amend protocol|6|||
105699640|NCT01147744|364563038|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105699641|NCT01147744|364563039|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
105699642|NCT01147744|364563040|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
105699643|NCT01147744|364563041|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
105699644|NCT01147744|364563042|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
105787217|NCT03110107|364874893|FG004|Treatment Period|Participants no longer meets study criteria|0|||
105787218|NCT03110107|364874894|FG005|Treatment Period|Participants no longer meets study criteria|0|||
105787219|NCT03110107|364874895|FG006|Treatment Period|Participants no longer meets study criteria|0|||
105787220|NCT03110107|364874896|FG007|Treatment Period|Participants no longer meets study criteria|0|||
105699645|NCT01147744|364563043|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105699646|NCT01147744|364563044|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
105699647|NCT02437864|364563049|FG000|Overall Study|Protocol Violation|4|||
105699648|NCT02437864|364563050|FG001|Overall Study|Protocol Violation|0|||
105699649|NCT00219284|364563052|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
105699650|NCT00219284|364563053|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
105699651|NCT00219284|364563052|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
105699652|NCT00219284|364563053|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
105699653|NCT00219284|364563052|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
105699654|NCT00219284|364563053|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
105559544|NCT01302847|364044708|FG006|Overall Study|Severe debilitation, unable to continue|1|||
105559545|NCT01302847|364044709|FG007|Overall Study|Severe debilitation, unable to continue|0|||
105559546|NCT01302847|364044702|FG000|Overall Study|Not able to get to clinic|1|||
105559547|NCT01302847|364044703|FG001|Overall Study|Not able to get to clinic|1|||
105559548|NCT01302847|364044704|FG002|Overall Study|Not able to get to clinic|0|||
105559549|NCT01302847|364044705|FG003|Overall Study|Not able to get to clinic|0|||
105559550|NCT01302847|364044706|FG004|Overall Study|Not able to get to clinic|0|||
105559551|NCT01302847|364044707|FG005|Overall Study|Not able to get to clinic|0|||
105559552|NCT01302847|364044708|FG006|Overall Study|Not able to get to clinic|0|||
105559553|NCT01302847|364044709|FG007|Overall Study|Not able to get to clinic|0|||
105559554|NCT01302847|364044702|FG000|Overall Study|Site closing|2|||
105559555|NCT01302847|364044703|FG001|Overall Study|Site closing|2|||
105559556|NCT01302847|364044704|FG002|Overall Study|Site closing|0|||
105559557|NCT01302847|364044705|FG003|Overall Study|Site closing|0|||
105559558|NCT01302847|364044706|FG004|Overall Study|Site closing|0|||
105559559|NCT01302847|364044707|FG005|Overall Study|Site closing|0|||
105559560|NCT01302847|364044708|FG006|Overall Study|Site closing|0|||
105559561|NCT01302847|364044709|FG007|Overall Study|Site closing|0|||
105559562|NCT01302847|364044702|FG000|Overall Study|Withdrawal by Subject|1|||
105559563|NCT01302847|364044703|FG001|Overall Study|Withdrawal by Subject|0|||
105559564|NCT01302847|364044704|FG002|Overall Study|Withdrawal by Subject|0|||
105559565|NCT01302847|364044705|FG003|Overall Study|Withdrawal by Subject|0|||
105559566|NCT01302847|364044706|FG004|Overall Study|Withdrawal by Subject|1|||
105559567|NCT01302847|364044707|FG005|Overall Study|Withdrawal by Subject|0|||
105559568|NCT01302847|364044708|FG006|Overall Study|Withdrawal by Subject|0|||
105559569|NCT01302847|364044709|FG007|Overall Study|Withdrawal by Subject|1|||
105559570|NCT01302847|364044702|FG000|Overall Study|Not willing to adhere to requirements|5|||
105559571|NCT01302847|364044703|FG001|Overall Study|Not willing to adhere to requirements|0|||
105559572|NCT01302847|364044704|FG002|Overall Study|Not willing to adhere to requirements|1|||
105559573|NCT01302847|364044705|FG003|Overall Study|Not willing to adhere to requirements|0|||
105559574|NCT01302847|364044706|FG004|Overall Study|Not willing to adhere to requirements|0|||
105559575|NCT01302847|364044707|FG005|Overall Study|Not willing to adhere to requirements|0|||
105559576|NCT01302847|364044708|FG006|Overall Study|Not willing to adhere to requirements|0|||
105559577|NCT01302847|364044709|FG007|Overall Study|Not willing to adhere to requirements|2|||
105559578|NCT01302847|364044702|FG000|Overall Study|Site unable to contact participant|2|||
105559579|NCT01302847|364044703|FG001|Overall Study|Site unable to contact participant|1|||
105559580|NCT01302847|364044704|FG002|Overall Study|Site unable to contact participant|0|||
105559581|NCT01302847|364044705|FG003|Overall Study|Site unable to contact participant|0|||
105559582|NCT01302847|364044706|FG004|Overall Study|Site unable to contact participant|0|||
105559583|NCT01302847|364044707|FG005|Overall Study|Site unable to contact participant|0|||
105559584|NCT01302847|364044708|FG006|Overall Study|Site unable to contact participant|2|||
105559585|NCT01302847|364044709|FG007|Overall Study|Site unable to contact participant|0|||
105559586|NCT03969719|364044722|FG000|Overall Study|Other reasons not specified|1|||
105559587|NCT03969719|364044723|FG001|Overall Study|Other reasons not specified|1|||
105559588|NCT03969719|364044724|FG002|Overall Study|Other reasons not specified|3|||
105559589|NCT03969719|364044722|FG000|Overall Study|Withdrawal by Subject|2|||
105559590|NCT03969719|364044723|FG001|Overall Study|Withdrawal by Subject|3|||
105559591|NCT03969719|364044724|FG002|Overall Study|Withdrawal by Subject|2|||
105559592|NCT03969719|364044722|FG000|Overall Study|Protocol Violation|1|||
105559593|NCT03969719|364044723|FG001|Overall Study|Protocol Violation|2|||
105559594|NCT03969719|364044724|FG002|Overall Study|Protocol Violation|0|||
105559595|NCT03969719|364044722|FG000|Overall Study|Adverse Event|0|||
105559596|NCT03969719|364044723|FG001|Overall Study|Adverse Event|2|||
105559597|NCT03969719|364044724|FG002|Overall Study|Adverse Event|0|||
105559598|NCT03969719|364044722|FG000|Overall Study|Lost to Follow-up|0|||
105559599|NCT03969719|364044723|FG001|Overall Study|Lost to Follow-up|1|||
105559600|NCT03969719|364044724|FG002|Overall Study|Lost to Follow-up|0|||
105559601|NCT00058123|364044728|FG000|Overall Study|Wrong histology|9|||
105559602|NCT00058123|364044728|FG000|Overall Study|Received >3 prior treatments|1|||
105559603|NCT02130193|364044729|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
105559604|NCT02130193|364044730|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
105559605|NCT02130193|364044731|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
105559606|NCT02130193|364044729|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
105559607|NCT02130193|364044730|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
105559608|NCT02130193|364044731|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
105559609|NCT02130193|364044729|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
105559610|NCT02130193|364044730|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
105559611|NCT02130193|364044731|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
105559612|NCT02130193|364044729|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
105559613|NCT02130193|364044730|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
105559614|NCT02130193|364044731|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
105559615|NCT01212770|364044732|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
105699655|NCT00219284|364563052|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
105699656|NCT00219284|364563053|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
105699657|NCT00219284|364563052|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
105699658|NCT00219284|364563053|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
105699659|NCT00219284|364563052|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
105699660|NCT00219284|364563053|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
105473701|NCT02405442|363747017|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
105473702|NCT02405442|363747018|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
105473703|NCT02405442|363747015|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
105473704|NCT02405442|363747016|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
105473705|NCT02405442|363747017|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
105473706|NCT02405442|363747018|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
105473707|NCT02405442|363747015|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
105473708|NCT02405442|363747016|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
105473709|NCT02405442|363747017|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
105473710|NCT02405442|363747018|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
105473711|NCT02405442|363747015|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
105473712|NCT02405442|363747016|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
105473713|NCT02405442|363747017|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
105473714|NCT02405442|363747018|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
105473715|NCT02405442|363747015|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
105473716|NCT02405442|363747016|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
105473717|NCT02405442|363747017|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
105473718|NCT02405442|363747018|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
105473719|NCT02405442|363747015|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
105473720|NCT02405442|363747016|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
105473721|NCT02405442|363747017|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
105473722|NCT02405442|363747018|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
105473723|NCT02405442|363747015|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
105699661|NCT00219284|364563052|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
105699662|NCT00219284|364563053|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
105473724|NCT02405442|363747016|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
105787221|NCT03110107|364874897|FG008|Treatment Period|Participants no longer meets study criteria|0|||
105473725|NCT02405442|363747017|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
105473726|NCT02405442|363747018|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
105473727|NCT02405442|363747015|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
105473728|NCT02405442|363747016|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
105473729|NCT02405442|363747017|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
105473730|NCT02405442|363747018|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
105473731|NCT02405442|363747015|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
105473732|NCT02405442|363747016|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
105473733|NCT02405442|363747017|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
105473734|NCT02405442|363747018|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
105473735|NCT02405442|363747015|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
105473736|NCT02405442|363747016|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
105473737|NCT02405442|363747017|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
105473738|NCT02405442|363747018|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
105699663|NCT00219284|364563052|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
105473739|NCT02078960|363747020|FG000|Treatment Period|Other|0|||
105699664|NCT00219284|364563053|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
105473740|NCT02078960|363747021|FG001|Treatment Period|Other|0|||
105473741|NCT02078960|363747022|FG002|Treatment Period|Other|1|||
105473742|NCT02078960|363747020|FG000|Treatment Period|Lack of Efficacy|0|||
105473743|NCT02078960|363747021|FG001|Treatment Period|Lack of Efficacy|1|||
105473744|NCT02078960|363747022|FG002|Treatment Period|Lack of Efficacy|0|||
105473745|NCT02078960|363747020|FG000|Treatment Period|Disease progression - accelerated phase|0|||
105473746|NCT02078960|363747021|FG001|Treatment Period|Disease progression - accelerated phase|1|||
105473747|NCT02078960|363747022|FG002|Treatment Period|Disease progression - accelerated phase|0|||
105699665|NCT00219284|364563052|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
105349022|NCT01554176|363279243|FG000|Treatment Phase|Adverse event, non-fatal|1|||
105349023|NCT01554176|363279244|FG001|Treatment Phase|Adverse event, non-fatal|1|||
105349024|NCT01554176|363279245|FG002|Treatment Phase|Adverse event, non-fatal|0|||
105349025|NCT01554176|363279246|FG003|Treatment Phase|Adverse event, non-fatal|0|||
105349026|NCT01554176|363279247|FG004|Treatment Phase|Adverse event, non-fatal|0|||
105349027|NCT01554176|363279243|FG000|Treatment Phase|Non-compliance with study drug|1|||
105349028|NCT01554176|363279244|FG001|Treatment Phase|Non-compliance with study drug|0|||
105349029|NCT01554176|363279245|FG002|Treatment Phase|Non-compliance with study drug|0|||
105349030|NCT01554176|363279246|FG003|Treatment Phase|Non-compliance with study drug|0|||
105349031|NCT01554176|363279247|FG004|Treatment Phase|Non-compliance with study drug|0|||
105699666|NCT00219284|364563053|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
105699667|NCT03184077|364563056|FG000|Overall Study|Lost to Follow-up|21|||
105699668|NCT03184077|364563057|FG001|Overall Study|Lost to Follow-up|21|||
105699669|NCT04013529|364563058|FG000|Overall Study|Withdrawal by Subject|1|||
105699670|NCT04013529|364563059|FG001|Overall Study|Withdrawal by Subject|1|||
105699671|NCT00262522|364563060|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
105699672|NCT00262522|364563061|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
105699673|NCT00262522|364563062|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
105699674|NCT00262522|364563063|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
105699675|NCT00262522|364563060|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
105699676|NCT00262522|364563061|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
105699677|NCT00262522|364563062|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
105699678|NCT00262522|364563063|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
105699679|NCT00262522|364563060|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
105699680|NCT00262522|364563061|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
105699681|NCT00262522|364563062|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
105699682|NCT00262522|364563063|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
105699683|NCT00262522|364563060|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
105699684|NCT00262522|364563061|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
105699685|NCT00262522|364563062|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
105699686|NCT00262522|364563063|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
105699687|NCT00262522|364563060|FG000|Study Start Through 8 Weeks|Death|1|||
105699688|NCT00262522|364563061|FG001|Study Start Through 8 Weeks|Death|0|||
105699689|NCT00262522|364563062|FG002|Study Start Through 8 Weeks|Death|0|||
105699690|NCT00262522|364563063|FG003|Study Start Through 8 Weeks|Death|0|||
105699691|NCT00262522|364563060|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
105699692|NCT00262522|364563061|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
105699693|NCT00262522|364563062|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
105699694|NCT00262522|364563063|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
105699695|NCT00262522|364563060|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
105699696|NCT00262522|364563061|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
105699697|NCT00262522|364563062|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
105699698|NCT00262522|364563063|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
105699699|NCT00262522|364563060|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
105699700|NCT00262522|364563061|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
105699701|NCT00262522|364563062|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
105699702|NCT00262522|364563063|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
105699703|NCT00262522|364563060|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
105699704|NCT00262522|364563061|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
105699705|NCT00262522|364563062|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
105699706|NCT00262522|364563063|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
105699707|NCT00262522|364563060|FG000|Study Start Through 48 Weeks|Death|2|||
105699708|NCT00262522|364563061|FG001|Study Start Through 48 Weeks|Death|0|||
105699709|NCT00262522|364563062|FG002|Study Start Through 48 Weeks|Death|1|||
105349032|NCT01554176|363279243|FG000|Treatment Phase|Withdrawal by Subject|1|||
105349033|NCT01554176|363279244|FG001|Treatment Phase|Withdrawal by Subject|0|||
105349034|NCT01554176|363279245|FG002|Treatment Phase|Withdrawal by Subject|0|||
105349035|NCT01554176|363279246|FG003|Treatment Phase|Withdrawal by Subject|0|||
105349036|NCT01554176|363279247|FG004|Treatment Phase|Withdrawal by Subject|0|||
105349037|NCT01554176|363279243|FG000|Treatment Phase|Lost to Follow-up|3|||
105349038|NCT01554176|363279244|FG001|Treatment Phase|Lost to Follow-up|0|||
105349039|NCT01554176|363279245|FG002|Treatment Phase|Lost to Follow-up|0|||
105349040|NCT01554176|363279246|FG003|Treatment Phase|Lost to Follow-up|0|||
105349041|NCT01554176|363279247|FG004|Treatment Phase|Lost to Follow-up|0|||
105349042|NCT01554176|363279243|FG000|Run-out Phase|Protocol Violation|0|||
105349043|NCT01554176|363279244|FG001|Run-out Phase|Protocol Violation|0|||
105349044|NCT01554176|363279245|FG002|Run-out Phase|Protocol Violation|0|||
105349045|NCT01554176|363279246|FG003|Run-out Phase|Protocol Violation|1|||
105349046|NCT01554176|363279247|FG004|Run-out Phase|Protocol Violation|0|||
105349047|NCT03168919|363279248|FG000|Overall Study|Withdrawal by Subject|2|||
105349048|NCT04015518|363279249|FG000|Overall Study|Adverse Event|6|||
105473748|NCT02078960|363747020|FG000|Treatment Period|Disease progression - blast phase|1|||
105473749|NCT02078960|363747021|FG001|Treatment Period|Disease progression - blast phase|0|||
105473750|NCT02078960|363747022|FG002|Treatment Period|Disease progression - blast phase|0|||
105473751|NCT02078960|363747020|FG000|Treatment Period|Withdrawal by Subject|0|||
105473752|NCT02078960|363747021|FG001|Treatment Period|Withdrawal by Subject|1|||
105349049|NCT04015518|363279250|FG001|Overall Study|Adverse Event|1|||
105349050|NCT04015518|363279251|FG002|Overall Study|Adverse Event|1|||
105349051|NCT04015518|363279252|FG003|Overall Study|Adverse Event|3|||
105349052|NCT04015518|363279253|FG004|Overall Study|Adverse Event|3|||
105349053|NCT04015518|363279249|FG000|Overall Study|Lack of Efficacy|1|||
105349054|NCT04015518|363279250|FG001|Overall Study|Lack of Efficacy|0|||
105349055|NCT04015518|363279251|FG002|Overall Study|Lack of Efficacy|1|||
105349056|NCT04015518|363279252|FG003|Overall Study|Lack of Efficacy|0|||
105349057|NCT04015518|363279253|FG004|Overall Study|Lack of Efficacy|4|||
105349058|NCT04015518|363279249|FG000|Overall Study|Lost to Follow-up|0|||
105349059|NCT04015518|363279250|FG001|Overall Study|Lost to Follow-up|0|||
105349060|NCT04015518|363279251|FG002|Overall Study|Lost to Follow-up|0|||
105349061|NCT04015518|363279252|FG003|Overall Study|Lost to Follow-up|0|||
105349062|NCT04015518|363279253|FG004|Overall Study|Lost to Follow-up|1|||
105349063|NCT04015518|363279249|FG000|Overall Study|Withdrawal by Subject|0|||
105349064|NCT04015518|363279250|FG001|Overall Study|Withdrawal by Subject|1|||
105349065|NCT04015518|363279251|FG002|Overall Study|Withdrawal by Subject|0|||
105349066|NCT04015518|363279252|FG003|Overall Study|Withdrawal by Subject|1|||
105349067|NCT04015518|363279253|FG004|Overall Study|Withdrawal by Subject|1|||
105349068|NCT04015518|363279249|FG000|Overall Study|Patient did not come for consecutive visits|0|||
105349069|NCT04015518|363279250|FG001|Overall Study|Patient did not come for consecutive visits|1|||
105349070|NCT04015518|363279251|FG002|Overall Study|Patient did not come for consecutive visits|0|||
105349071|NCT04015518|363279252|FG003|Overall Study|Patient did not come for consecutive visits|0|||
105349072|NCT04015518|363279253|FG004|Overall Study|Patient did not come for consecutive visits|0|||
105349073|NCT04015518|363279249|FG000|Overall Study|not willing to travel due to Covid-19|0|||
105349074|NCT04015518|363279250|FG001|Overall Study|not willing to travel due to Covid-19|0|||
105349075|NCT04015518|363279251|FG002|Overall Study|not willing to travel due to Covid-19|1|||
105349076|NCT04015518|363279252|FG003|Overall Study|not willing to travel due to Covid-19|0|||
105349077|NCT04015518|363279253|FG004|Overall Study|not willing to travel due to Covid-19|0|||
105349078|NCT04015518|363279249|FG000|Overall Study|Patient wants to discontinue treatment|0|||
105349079|NCT04015518|363279250|FG001|Overall Study|Patient wants to discontinue treatment|0|||
105349080|NCT04015518|363279251|FG002|Overall Study|Patient wants to discontinue treatment|0|||
105349081|NCT04015518|363279252|FG003|Overall Study|Patient wants to discontinue treatment|1|||
105349082|NCT04015518|363279253|FG004|Overall Study|Patient wants to discontinue treatment|0|||
105349083|NCT04015518|363279249|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
105349084|NCT04015518|363279250|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
105349085|NCT04015518|363279251|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
105349086|NCT04015518|363279252|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
105349087|NCT04015518|363279253|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
105349088|NCT04015518|363279249|FG000|Overall Study|Pregnancy|0|||
105349089|NCT04015518|363279250|FG001|Overall Study|Pregnancy|0|||
105349090|NCT04015518|363279251|FG002|Overall Study|Pregnancy|0|||
105349091|NCT04015518|363279252|FG003|Overall Study|Pregnancy|0|||
105349092|NCT04015518|363279253|FG004|Overall Study|Pregnancy|1|||
105349093|NCT04015518|363279249|FG000|Overall Study|Personal reasons|1|||
105349094|NCT04015518|363279250|FG001|Overall Study|Personal reasons|0|||
105349095|NCT04015518|363279251|FG002|Overall Study|Personal reasons|0|||
105349096|NCT04015518|363279252|FG003|Overall Study|Personal reasons|0|||
105349097|NCT04015518|363279253|FG004|Overall Study|Personal reasons|1|||
105349098|NCT04015518|363279249|FG000|Overall Study|Withdrew consent|1|||
105473753|NCT02078960|363747022|FG002|Treatment Period|Withdrawal by Subject|1|||
105349099|NCT04015518|363279250|FG001|Overall Study|Withdrew consent|0|||
105349100|NCT04015518|363279251|FG002|Overall Study|Withdrew consent|0|||
105349101|NCT04015518|363279252|FG003|Overall Study|Withdrew consent|0|||
105559616|NCT01212770|364044733|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
105559617|NCT01212770|364044734|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
105559618|NCT01212770|364044735|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105559619|NCT01212770|364044736|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105559620|NCT01212770|364044737|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105559621|NCT01212770|364044738|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105559622|NCT01212770|364044739|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105559623|NCT01212770|364044740|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105559624|NCT01212770|364044732|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
105559625|NCT01212770|364044733|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
105559626|NCT01212770|364044734|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
105559627|NCT01212770|364044735|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105559628|NCT01212770|364044736|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105559629|NCT01212770|364044737|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105559630|NCT01212770|364044738|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105559631|NCT01212770|364044739|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105559632|NCT01212770|364044740|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105559633|NCT01212770|364044732|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
105559634|NCT01212770|364044733|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
105559635|NCT01212770|364044734|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
105559636|NCT01212770|364044735|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105559637|NCT01212770|364044736|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105559638|NCT01212770|364044737|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105559639|NCT01212770|364044738|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105559640|NCT01212770|364044739|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105559641|NCT01212770|364044740|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105349102|NCT04015518|363279253|FG004|Overall Study|Withdrew consent|0|||
105349103|NCT04015518|363279249|FG000|Overall Study|Prostate carcinoma|1|||
105349104|NCT04015518|363279250|FG001|Overall Study|Prostate carcinoma|0|||
105349105|NCT04015518|363279251|FG002|Overall Study|Prostate carcinoma|0|||
105349106|NCT04015518|363279252|FG003|Overall Study|Prostate carcinoma|0|||
105349107|NCT04015518|363279253|FG004|Overall Study|Prostate carcinoma|0|||
105349108|NCT04015518|363279249|FG000|Overall Study|Could not keep appointments due to work|1|||
105349109|NCT04015518|363279250|FG001|Overall Study|Could not keep appointments due to work|0|||
105349110|NCT04015518|363279251|FG002|Overall Study|Could not keep appointments due to work|0|||
105349111|NCT04015518|363279252|FG003|Overall Study|Could not keep appointments due to work|0|||
105349112|NCT04015518|363279253|FG004|Overall Study|Could not keep appointments due to work|0|||
105349113|NCT02195427|363279254|FG000|Overall Study|Did not consent to study extension|13|||
105349114|NCT02195427|363279255|FG001|Overall Study|Did not consent to study extension|9|||
105349115|NCT02195427|363279254|FG000|Overall Study|Withdrawal by Subject|4|||
105349116|NCT02195427|363279255|FG001|Overall Study|Withdrawal by Subject|2|||
105349117|NCT02195427|363279254|FG000|Overall Study|Lost to Follow-up|0|||
105349118|NCT02195427|363279255|FG001|Overall Study|Lost to Follow-up|1|||
105349119|NCT02195427|363279254|FG000|Overall Study|Protocol Violation|7|||
105349120|NCT02195427|363279255|FG001|Overall Study|Protocol Violation|14|||
105349121|NCT02195427|363279254|FG000|Overall Study|Conditional re-treatment at W52|2|||
105349122|NCT02195427|363279255|FG001|Overall Study|Conditional re-treatment at W52|1|||
105349123|NCT02678000|363279258|FG000|PART 2|Adverse Event|0|||
105349124|NCT02678000|363279259|FG001|PART 2|Adverse Event|0|||
105349125|NCT02678000|363279260|FG002|PART 2|Adverse Event|2|||
105349126|NCT02678000|363279261|FG003|PART 2|Adverse Event|1|||
105349127|NCT02678000|363279262|FG004|PART 2|Adverse Event|0|||
105349128|NCT02678000|363279258|FG000|PART 2|Withdrawal by Subject|0|||
105349129|NCT02678000|363279259|FG001|PART 2|Withdrawal by Subject|0|||
105349130|NCT02678000|363279260|FG002|PART 2|Withdrawal by Subject|1|||
105349131|NCT02678000|363279261|FG003|PART 2|Withdrawal by Subject|0|||
105349132|NCT02678000|363279262|FG004|PART 2|Withdrawal by Subject|0|||
105349133|NCT01324570|363279269|FG000|Overall Study|Adverse Event|4|||
105349134|NCT01324570|363279270|FG001|Overall Study|Adverse Event|7|||
105349135|NCT01324570|363279269|FG000|Overall Study|Withdrawal by Subject|0|||
105349136|NCT01324570|363279270|FG001|Overall Study|Withdrawal by Subject|3|||
105349137|NCT01324570|363279269|FG000|Overall Study|Lack of Efficacy|0|||
105349138|NCT01324570|363279270|FG001|Overall Study|Lack of Efficacy|1|||
105349139|NCT01324570|363279269|FG000|Overall Study|Confirmed or suspected diversion|0|||
105349140|NCT01324570|363279270|FG001|Overall Study|Confirmed or suspected diversion|1|||
105349141|NCT01324570|363279269|FG000|Overall Study|Administrative|0|||
105349142|NCT01324570|363279270|FG001|Overall Study|Administrative|2|||
105699710|NCT00262522|364563063|FG003|Study Start Through 48 Weeks|Death|0|||
105349143|NCT02360475|363279275|FG000|Overall Study|Lost to Follow-up|4|||
105349144|NCT02360475|363279276|FG001|Overall Study|Lost to Follow-up|12|||
105349145|NCT02360475|363279277|FG002|Overall Study|Lost to Follow-up|6|||
105349146|NCT02360475|363279278|FG003|Overall Study|Lost to Follow-up|4|||
105699711|NCT00262522|364563060|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
105699712|NCT00262522|364563061|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
105699713|NCT00262522|364563062|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
105699714|NCT00262522|364563063|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
105699715|NCT00262522|364563060|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
105699716|NCT00262522|364563061|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
105699717|NCT00262522|364563062|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
105699718|NCT00262522|364563063|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
105699719|NCT00262522|364563060|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
105699720|NCT00262522|364563061|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
105699721|NCT00262522|364563062|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
105699722|NCT00262522|364563063|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
105699723|NCT00262522|364563060|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
105699724|NCT00262522|364563061|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
105699725|NCT00262522|364563062|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
105699726|NCT00262522|364563063|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
105699727|NCT00262522|364563060|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
105699728|NCT00262522|364563061|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
105699729|NCT00262522|364563062|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
105699730|NCT00262522|364563063|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
105699731|NCT00262522|364563060|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
105699732|NCT00262522|364563061|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
105699733|NCT00262522|364563062|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
105699734|NCT00262522|364563063|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
105699735|NCT00262522|364563060|FG000|Study Start Through 96 Weeks|Death|2|||
105699736|NCT00262522|364563061|FG001|Study Start Through 96 Weeks|Death|0|||
105699737|NCT00262522|364563062|FG002|Study Start Through 96 Weeks|Death|2|||
105699738|NCT00262522|364563063|FG003|Study Start Through 96 Weeks|Death|0|||
105699739|NCT00262522|364563060|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
105699740|NCT00262522|364563061|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
105699741|NCT00262522|364563062|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
105699742|NCT00262522|364563063|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
105699743|NCT00262522|364563060|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
105699744|NCT00262522|364563061|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
105699745|NCT00262522|364563062|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
105699746|NCT00262522|364563063|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
105699747|NCT05419128|364563065|FG000|Overall Study|Withdrawal by Subject|1|||
105699748|NCT05419128|364563066|FG001|Overall Study|Withdrawal by Subject|1|||
105699749|NCT05419128|364563067|FG002|Overall Study|Withdrawal by Subject|0|||
105699750|NCT05419128|364563068|FG003|Overall Study|Withdrawal by Subject|1|||
105699751|NCT05419128|364563069|FG004|Overall Study|Withdrawal by Subject|1|||
105699752|NCT05419128|364563070|FG005|Overall Study|Withdrawal by Subject|0|||
105699753|NCT05419128|364563065|FG000|Overall Study|Lost to Follow-up|0|||
105699754|NCT05419128|364563066|FG001|Overall Study|Lost to Follow-up|0|||
105699755|NCT05419128|364563067|FG002|Overall Study|Lost to Follow-up|1|||
105699756|NCT05419128|364563068|FG003|Overall Study|Lost to Follow-up|0|||
105699757|NCT05419128|364563069|FG004|Overall Study|Lost to Follow-up|0|||
105699758|NCT05419128|364563070|FG005|Overall Study|Lost to Follow-up|1|||
105699759|NCT00517751|364563071|FG000|Overall Study|Death|3|||
105699760|NCT00517751|364563071|FG000|Overall Study|Withdrawal by Subject|37|||
105699761|NCT00517751|364563071|FG000|Overall Study|Lost to Follow-up|4|||
105699762|NCT00517751|364563071|FG000|Overall Study|patient not over due|6|||
105699763|NCT00517751|364563071|FG000|Overall Study|Patient not due for visit|76|||
105699764|NCT00517751|364563071|FG000|Overall Study|Missing|3|||
105699765|NCT02321930|364563076|FG000|Overall Study|Lost to Follow-up|1|||
105699766|NCT01293968|364563077|FG000|Overall Study|non-cooperation|3|||
105349147|NCT02360475|363279275|FG000|Overall Study|Withdrawal by Subject|0|||
105349148|NCT02360475|363279276|FG001|Overall Study|Withdrawal by Subject|1|||
105473754|NCT02078960|363747020|FG000|Treatment Period|Adverse Event|1|||
105473755|NCT02078960|363747021|FG001|Treatment Period|Adverse Event|0|||
105559642|NCT01212770|364044732|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
105559643|NCT01212770|364044733|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105559644|NCT01212770|364044734|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
105559645|NCT01212770|364044735|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105559646|NCT01212770|364044736|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105559647|NCT01212770|364044737|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105559648|NCT01212770|364044738|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105559649|NCT01212770|364044739|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105559650|NCT01212770|364044740|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105559651|NCT01212770|364044732|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105559652|NCT01212770|364044733|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105559653|NCT01212770|364044734|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
105559654|NCT01212770|364044735|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105559655|NCT01212770|364044736|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105559656|NCT01212770|364044737|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105559657|NCT01212770|364044738|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105559658|NCT01212770|364044739|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105559659|NCT01212770|364044740|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105559660|NCT01212770|364044732|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
105559661|NCT01212770|364044733|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
105559662|NCT01212770|364044734|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
105559663|NCT01212770|364044735|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
105559664|NCT01212770|364044736|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
105559665|NCT01212770|364044737|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
105559666|NCT01212770|364044738|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
105559667|NCT01212770|364044739|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
105559668|NCT01212770|364044740|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
105559669|NCT01212770|364044732|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
105559670|NCT01212770|364044733|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
105559671|NCT01212770|364044734|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
105559672|NCT01212770|364044735|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
105559673|NCT01212770|364044736|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
105559674|NCT01212770|364044737|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
105699767|NCT01293968|364563078|FG001|Overall Study|non-cooperation|3|||
105699768|NCT02228720|364563079|FG000|Open Label - Day 30|Lost to Follow-up|1|||
105699769|NCT01423851|364563080|FG000|Whole Study|Disease progression|2|||
105699770|NCT01423851|364563081|FG001|Whole Study|Disease progression|1|||
105699771|NCT01423851|364563082|FG002|Whole Study|Disease progression|1|||
105699772|NCT01423851|364563083|FG003|Whole Study|Disease progression|4|||
105699773|NCT01423851|364563084|FG004|Whole Study|Disease progression|1|||
105699774|NCT01423851|364563085|FG005|Whole Study|Disease progression|3|||
105699775|NCT01423851|364563086|FG006|Whole Study|Disease progression|1|||
105699776|NCT01423851|364563087|FG007|Whole Study|Disease progression|4|||
105699777|NCT01423851|364563088|FG008|Whole Study|Disease progression|0|||
105699778|NCT01423851|364563089|FG009|Whole Study|Disease progression|2|||
105699779|NCT01423851|364563090|FG010|Whole Study|Disease progression|10|||
105699780|NCT01423851|364563080|FG000|Whole Study|Physician Decision|0|||
105473756|NCT02078960|363747022|FG002|Treatment Period|Adverse Event|0|||
105473757|NCT02078960|363747020|FG000|Treatment Period|Death|0|||
105473758|NCT02078960|363747021|FG001|Treatment Period|Death|0|||
105473759|NCT02078960|363747022|FG002|Treatment Period|Death|1|||
105473760|NCT02078960|363747020|FG000|Follow-up Period|Death|2|||
105473761|NCT02078960|363747021|FG001|Follow-up Period|Death|0|||
105473762|NCT02078960|363747022|FG002|Follow-up Period|Death|0|||
105473763|NCT02078960|363747020|FG000|Follow-up Period|Lost to Follow-up|0|||
105473764|NCT02078960|363747021|FG001|Follow-up Period|Lost to Follow-up|1|||
105473765|NCT02078960|363747022|FG002|Follow-up Period|Lost to Follow-up|0|||
105473766|NCT04335136|363747031|FG000|Overall Study|Death|8|||
105699781|NCT01423851|364563081|FG001|Whole Study|Physician Decision|1|||
105699782|NCT01423851|364563082|FG002|Whole Study|Physician Decision|2|||
105473767|NCT04335136|363747032|FG001|Overall Study|Death|4|||
105473768|NCT04335136|363747031|FG000|Overall Study|Lost to Follow-up|2|||
105473769|NCT04335136|363747032|FG001|Overall Study|Lost to Follow-up|0|||
105473770|NCT04335136|363747031|FG000|Overall Study|Protocol Violation|1|||
105349149|NCT02360475|363279277|FG002|Overall Study|Withdrawal by Subject|2|||
105349150|NCT02360475|363279278|FG003|Overall Study|Withdrawal by Subject|0|||
105349151|NCT02360475|363279275|FG000|Overall Study|Migrated/moved from study area|0|||
105349152|NCT02360475|363279276|FG001|Overall Study|Migrated/moved from study area|0|||
105349153|NCT02360475|363279277|FG002|Overall Study|Migrated/moved from study area|0|||
105349154|NCT02360475|363279278|FG003|Overall Study|Migrated/moved from study area|1|||
105349155|NCT00207727|363279280|FG000|Overall Study|Withdrawal by Subject|0|||
105349156|NCT00207727|363279281|FG001|Overall Study|Withdrawal by Subject|0|||
105349157|NCT00207727|363279282|FG002|Overall Study|Withdrawal by Subject|0|||
105349158|NCT00207727|363279283|FG003|Overall Study|Withdrawal by Subject|0|||
105349159|NCT00207727|363279284|FG004|Overall Study|Withdrawal by Subject|1|||
105349160|NCT00207727|363279280|FG000|Overall Study|Lost to Follow-up|0|||
105349161|NCT00207727|363279281|FG001|Overall Study|Lost to Follow-up|1|||
105349162|NCT00207727|363279282|FG002|Overall Study|Lost to Follow-up|0|||
105349163|NCT00207727|363279283|FG003|Overall Study|Lost to Follow-up|0|||
105349164|NCT00207727|363279284|FG004|Overall Study|Lost to Follow-up|0|||
105349165|NCT00207727|363279280|FG000|Overall Study|Other|38|||
105349166|NCT00207727|363279281|FG001|Overall Study|Other|41|||
105349167|NCT00207727|363279282|FG002|Overall Study|Other|41|||
105349168|NCT00207727|363279283|FG003|Overall Study|Other|37|||
105349169|NCT00207727|363279284|FG004|Overall Study|Other|33|||
105349170|NCT03759366|363279285|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
105349171|NCT03759366|363279285|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
105349172|NCT03759366|363279285|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
105349173|NCT03759366|363279285|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
105349174|NCT03759366|363279285|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
105349175|NCT03759366|363279285|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
105349176|NCT03759366|363279285|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
105349177|NCT00597012|363279286|FG000|Overall Study|Death|1|||
105349178|NCT00597012|363279287|FG001|Overall Study|Death|1|||
105559675|NCT01212770|364044738|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
105559676|NCT01212770|364044739|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
105559677|NCT01212770|364044740|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
105559678|NCT01212770|364044732|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
105559679|NCT01212770|364044733|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
105559680|NCT01212770|364044734|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
105559681|NCT01212770|364044735|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
105559682|NCT01212770|364044736|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
105559683|NCT01212770|364044737|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
105559684|NCT01212770|364044738|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
105559685|NCT01212770|364044739|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
105559686|NCT01212770|364044740|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
105559687|NCT01212770|364044732|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
105559688|NCT01212770|364044733|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
105559689|NCT01212770|364044734|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
105559690|NCT01212770|364044735|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
105559691|NCT01212770|364044736|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
105559692|NCT01212770|364044737|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
105559693|NCT01212770|364044738|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
105559694|NCT01212770|364044739|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
105559695|NCT01212770|364044740|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
105559696|NCT01212770|364044732|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
105559697|NCT01212770|364044733|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
105559698|NCT01212770|364044734|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
105559699|NCT01212770|364044735|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
105559700|NCT01212770|364044736|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
105559701|NCT01212770|364044737|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
105559702|NCT01212770|364044738|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
105559703|NCT01212770|364044739|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
105559704|NCT01212770|364044740|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
105699783|NCT01423851|364563083|FG003|Whole Study|Physician Decision|0|||
105349179|NCT00597012|363279286|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
105349180|NCT00597012|363279287|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
105349181|NCT00597012|363279286|FG000|Overall Study|Withdrawal by Subject|7|||
105349182|NCT00597012|363279287|FG001|Overall Study|Withdrawal by Subject|4|||
105699784|NCT01423851|364563084|FG004|Whole Study|Physician Decision|2|||
105349183|NCT00597012|363279286|FG000|Overall Study|Ineligible|2|||
105349184|NCT00597012|363279287|FG001|Overall Study|Ineligible|0|||
105349185|NCT00597012|363279286|FG000|Overall Study|Lost to Follow-up|0|||
105349186|NCT00597012|363279287|FG001|Overall Study|Lost to Follow-up|2|||
105349187|NCT03755518|363279288|FG000|Overall Study|Lack of Efficacy|10|||
105349188|NCT03755518|363279288|FG000|Overall Study|Adverse Event|7|||
105349189|NCT03755518|363279288|FG000|Overall Study|Study Terminated by Sponsor|5|||
105349190|NCT03755518|363279288|FG000|Overall Study|Death|1|||
105349191|NCT03755518|363279288|FG000|Overall Study|Withdrawal by Subject|3|||
105559705|NCT01212770|364044732|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
105559706|NCT01212770|364044733|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
105559707|NCT01212770|364044734|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
105559708|NCT01212770|364044735|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
105559709|NCT01212770|364044736|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
105559710|NCT01212770|364044737|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
105559711|NCT01212770|364044738|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
105559712|NCT01212770|364044739|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
105559713|NCT01212770|364044740|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
105559714|NCT01212770|364044732|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
105559715|NCT01212770|364044733|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
105559716|NCT01212770|364044734|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
105559717|NCT01212770|364044735|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
105559718|NCT01212770|364044736|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
105559719|NCT01212770|364044737|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
105559720|NCT01212770|364044738|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
105559721|NCT01212770|364044739|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
105559722|NCT01212770|364044740|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
105559723|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105559724|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
105559725|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
105559726|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105559727|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105559728|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105559729|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105559730|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105559731|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
105559732|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
105559733|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
105559734|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
105559735|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
105559736|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
105559737|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
105559738|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
105559739|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
105559740|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
105559741|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
105559742|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
105559743|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
105559744|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
105559745|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
105559746|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
105559747|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
105559748|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
105559749|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
105559750|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105559751|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
105559752|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
105559753|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105559754|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105559755|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105559756|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105559757|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
105559758|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
105559759|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
105559760|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
105559761|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
105559762|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
105559763|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
105699785|NCT01423851|364563085|FG005|Whole Study|Physician Decision|0|||
105699786|NCT01423851|364563086|FG006|Whole Study|Physician Decision|2|||
105349192|NCT03755518|363279288|FG000|Overall Study|Progressive Disease|4|||
105349193|NCT03755518|363279288|FG000|Overall Study|Bone Marrow Transplant|4|||
105473771|NCT04335136|363747032|FG001|Overall Study|Protocol Violation|0|||
105473772|NCT04335136|363747031|FG000|Overall Study|Withdrawal by Subject|1|||
105473773|NCT04335136|363747032|FG001|Overall Study|Withdrawal by Subject|1|||
105473774|NCT04335136|363747031|FG000|Overall Study|Health-threatening condition|0|||
105473775|NCT04335136|363747032|FG001|Overall Study|Health-threatening condition|1|||
105473776|NCT04335136|363747031|FG000|Overall Study|Adverse Event|0|||
105473777|NCT04335136|363747032|FG001|Overall Study|Adverse Event|1|||
105473778|NCT04335136|363747031|FG000|Overall Study|Erroneously randomized|2|||
105473779|NCT04335136|363747032|FG001|Overall Study|Erroneously randomized|0|||
105473780|NCT01396447|363747033|FG000|Overall Study|Did Not Receive Treatment|3|||
105473781|NCT01396447|363747034|FG001|Overall Study|Did Not Receive Treatment|2|||
105473782|NCT01396447|363747035|FG002|Overall Study|Did Not Receive Treatment|1|||
105473783|NCT01396447|363747036|FG003|Overall Study|Did Not Receive Treatment|0|||
105473784|NCT01396447|363747033|FG000|Overall Study|Adverse Event|15|||
105473785|NCT01396447|363747034|FG001|Overall Study|Adverse Event|12|||
105473786|NCT01396447|363747035|FG002|Overall Study|Adverse Event|12|||
105473787|NCT01396447|363747036|FG003|Overall Study|Adverse Event|17|||
105473788|NCT01396447|363747033|FG000|Overall Study|Insufficient Therapeutic Response|5|||
105473789|NCT01396447|363747034|FG001|Overall Study|Insufficient Therapeutic Response|5|||
105473790|NCT01396447|363747035|FG002|Overall Study|Insufficient Therapeutic Response|2|||
105473791|NCT01396447|363747036|FG003|Overall Study|Insufficient Therapeutic Response|4|||
105473792|NCT01396447|363747033|FG000|Overall Study|Protocol Violation|5|||
105473793|NCT01396447|363747034|FG001|Overall Study|Protocol Violation|2|||
105473794|NCT01396447|363747035|FG002|Overall Study|Protocol Violation|3|||
105473795|NCT01396447|363747036|FG003|Overall Study|Protocol Violation|7|||
105473796|NCT01396447|363747033|FG000|Overall Study|Withdrawal of Consent|11|||
105473797|NCT01396447|363747034|FG001|Overall Study|Withdrawal of Consent|9|||
105473798|NCT01396447|363747035|FG002|Overall Study|Withdrawal of Consent|4|||
105473799|NCT01396447|363747036|FG003|Overall Study|Withdrawal of Consent|15|||
105473800|NCT01396447|363747033|FG000|Overall Study|Lost to Follow-up|4|||
105473801|NCT01396447|363747034|FG001|Overall Study|Lost to Follow-up|8|||
105473802|NCT01396447|363747035|FG002|Overall Study|Lost to Follow-up|7|||
105473803|NCT01396447|363747036|FG003|Overall Study|Lost to Follow-up|9|||
105473804|NCT01396447|363747033|FG000|Overall Study|Other Miscellaneous Reasons|0|||
105473805|NCT01396447|363747034|FG001|Overall Study|Other Miscellaneous Reasons|2|||
105473806|NCT01396447|363747035|FG002|Overall Study|Other Miscellaneous Reasons|1|||
105473807|NCT01396447|363747036|FG003|Overall Study|Other Miscellaneous Reasons|0|||
105473808|NCT02597478|363747043|FG000|Overall Study|Withdrawal by Subject|2|||
105473809|NCT02597478|363747044|FG001|Overall Study|Withdrawal by Subject|0|||
105473810|NCT02597478|363747043|FG000|Overall Study|Change of opioid dose|1|||
105473811|NCT02597478|363747044|FG001|Overall Study|Change of opioid dose|0|||
105473812|NCT02597478|363747043|FG000|Overall Study|Insufficient exertional dyspnea|0|||
105473813|NCT02597478|363747044|FG001|Overall Study|Insufficient exertional dyspnea|1|||
105473814|NCT00796978|363747045|FG000|Overall Study|Cardiac adverse event|5|||
105473815|NCT00796978|363747045|FG000|Overall Study|Adverse Event|4|||
105473816|NCT00796978|363747045|FG000|Overall Study|Withdrawal by Subject|3|||
105473817|NCT01386970|363747046|FG000|Overall Study|Withdrawal by Subject|0|||
105473818|NCT01386970|363747047|FG001|Overall Study|Withdrawal by Subject|1|||
105473819|NCT01386970|363747046|FG000|Overall Study|Adverse Event|4|||
105473820|NCT01386970|363747047|FG001|Overall Study|Adverse Event|1|||
105473821|NCT02364336|363747048|FG000|Overall Study|Adverse Event|0|||
105473822|NCT02364336|363747049|FG001|Overall Study|Adverse Event|1|||
105473823|NCT01731938|363747050|FG000|Preliminary Part I|Withdrawal by Subject|2|||
105473824|NCT01731938|363747051|FG001|Preliminary Part I|Withdrawal by Subject|2|||
105473825|NCT01731938|363747050|FG000|Preliminary Part I|Physician Decision|1|||
105473826|NCT01731938|363747051|FG001|Preliminary Part I|Physician Decision|0|||
105473827|NCT01731938|363747050|FG000|Preliminary Part I|Lost to Follow-up|0|||
105473828|NCT01731938|363747051|FG001|Preliminary Part I|Lost to Follow-up|3|||
105473829|NCT01731938|363747050|FG000|Preliminary Part I|Missed Week 6 visit|0|||
105473830|NCT01731938|363747051|FG001|Preliminary Part I|Missed Week 6 visit|3|||
105473831|NCT01731938|363747050|FG000|Primary Part II|Withdrawal by Subject|5|||
105473832|NCT01731938|363747051|FG001|Primary Part II|Withdrawal by Subject|4|||
105473833|NCT01731938|363747050|FG000|Primary Part II|Lost to Follow-up|4|||
105473834|NCT01731938|363747051|FG001|Primary Part II|Lost to Follow-up|5|||
105787222|NCT03110107|364874898|FG009|Treatment Period|Participants no longer meets study criteria|0|||
105473835|NCT01731938|363747050|FG000|Primary Part II|Death|2|||
105473836|NCT01731938|363747051|FG001|Primary Part II|Death|1|||
105473837|NCT01731938|363747050|FG000|Primary Part II|Missed Week 6 visit|2|||
105473838|NCT01731938|363747051|FG001|Primary Part II|Missed Week 6 visit|3|||
105473839|NCT01092546|363747053|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
105473840|NCT00771953|363747054|FG000|Overall Study|Adverse Event|5|||
105473841|NCT00771953|363747055|FG001|Overall Study|Adverse Event|3|||
105473842|NCT00771953|363747054|FG000|Overall Study|Death|2|||
105473843|NCT00771953|363747055|FG001|Overall Study|Death|2|||
105473844|NCT00771953|363747054|FG000|Overall Study|Progression before active Tx|1|||
105473845|NCT00771953|363747055|FG001|Overall Study|Progression before active Tx|2|||
105473846|NCT00771953|363747054|FG000|Overall Study|Sponsor decision|1|||
105559764|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
105559765|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
105559766|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
105559767|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
105559768|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105559769|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
105559770|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
105559771|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105559772|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105559773|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105559774|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105559775|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105559776|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
105559777|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
105559778|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
105559779|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
105559780|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
105559781|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
105559782|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
105559783|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
105559784|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
105559785|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
105559786|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
105559787|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
105559788|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
105559789|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
105699787|NCT01423851|364563087|FG007|Whole Study|Physician Decision|1|||
105699788|NCT01423851|364563088|FG008|Whole Study|Physician Decision|3|||
105699789|NCT01423851|364563089|FG009|Whole Study|Physician Decision|4|||
105699790|NCT01423851|364563090|FG010|Whole Study|Physician Decision|12|||
105349194|NCT03755518|363279288|FG000|Overall Study|Physicians Decision|1|||
105349195|NCT03755518|363279288|FG000|Overall Study|Relapse|1|||
105349196|NCT03755518|363279288|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
105349197|NCT03755518|363279288|FG000|Overall Study|Withdrawal by PI|1|||
105349198|NCT01653327|363279295|FG000|Overall Study|Withdrawal by Subject|1|||
105349199|NCT00422292|363279296|FG000|Overall Study|Serious adverse events|1|||
105349200|NCT00422292|363279297|FG001|Overall Study|Serious adverse events|4|||
105349201|NCT00422292|363279298|FG002|Overall Study|Serious adverse events|0|||
105349202|NCT00422292|363279299|FG003|Overall Study|Serious adverse events|0|||
105349203|NCT00422292|363279296|FG000|Overall Study|Adverse Event|1|||
105349204|NCT00422292|363279297|FG001|Overall Study|Adverse Event|0|||
105349205|NCT00422292|363279298|FG002|Overall Study|Adverse Event|1|||
105349206|NCT00422292|363279299|FG003|Overall Study|Adverse Event|0|||
105349207|NCT00422292|363279296|FG000|Overall Study|Protocol Violation|4|||
105349208|NCT00422292|363279297|FG001|Overall Study|Protocol Violation|25|||
105349209|NCT00422292|363279298|FG002|Overall Study|Protocol Violation|8|||
105349210|NCT00422292|363279299|FG003|Overall Study|Protocol Violation|5|||
105349211|NCT00422292|363279296|FG000|Overall Study|Lost to Follow-up|6|||
105349212|NCT00422292|363279297|FG001|Overall Study|Lost to Follow-up|12|||
105349213|NCT00422292|363279298|FG002|Overall Study|Lost to Follow-up|6|||
105349214|NCT00422292|363279299|FG003|Overall Study|Lost to Follow-up|6|||
105349215|NCT00422292|363279296|FG000|Overall Study|Withdrawal by Subject|6|||
105349216|NCT00422292|363279297|FG001|Overall Study|Withdrawal by Subject|25|||
105349217|NCT00422292|363279298|FG002|Overall Study|Withdrawal by Subject|7|||
105349218|NCT00422292|363279299|FG003|Overall Study|Withdrawal by Subject|13|||
105473847|NCT00771953|363747055|FG001|Overall Study|Sponsor decision|0|||
105473848|NCT00771953|363747054|FG000|Overall Study|Other complicating disease|1|||
105473849|NCT00771953|363747055|FG001|Overall Study|Other complicating disease|0|||
105473850|NCT00771953|363747054|FG000|Overall Study|Withdrawal by Subject|0|||
105473851|NCT00771953|363747055|FG001|Overall Study|Withdrawal by Subject|3|||
105473852|NCT01086358|363747056|FG000|First Intervention|Lost to Follow-up|9|||
105473853|NCT01086358|363747057|FG001|First Intervention|Lost to Follow-up|4|||
105473854|NCT01086358|363747056|FG000|First Intervention|Withdrawal by Subject|0|||
105473855|NCT01086358|363747057|FG001|First Intervention|Withdrawal by Subject|1|||
105473856|NCT01086358|363747056|FG000|Second Intervention|Lost to Follow-up|4|||
105473857|NCT01086358|363747057|FG001|Second Intervention|Lost to Follow-up|4|||
105473858|NCT01667419|363747058|FG000|Overall Study|Reason Not Specified|1|||
105473859|NCT01667419|363747059|FG001|Overall Study|Reason Not Specified|0|||
105473860|NCT01667419|363747060|FG002|Overall Study|Reason Not Specified|0|||
105473861|NCT01667419|363747061|FG003|Overall Study|Reason Not Specified|0|||
105473862|NCT01667419|363747058|FG000|Overall Study|Withdrawal by Subject|16|||
105473863|NCT01667419|363747059|FG001|Overall Study|Withdrawal by Subject|8|||
105473864|NCT01667419|363747060|FG002|Overall Study|Withdrawal by Subject|9|||
105473865|NCT01667419|363747061|FG003|Overall Study|Withdrawal by Subject|8|||
105473866|NCT01667419|363747058|FG000|Overall Study|Non-compliance|0|||
105473867|NCT01667419|363747059|FG001|Overall Study|Non-compliance|0|||
105473868|NCT01667419|363747060|FG002|Overall Study|Non-compliance|0|||
105473869|NCT01667419|363747061|FG003|Overall Study|Non-compliance|1|||
105473870|NCT01667419|363747058|FG000|Overall Study|Protocol Violation|1|||
105473871|NCT01667419|363747059|FG001|Overall Study|Protocol Violation|0|||
105473872|NCT01667419|363747060|FG002|Overall Study|Protocol Violation|0|||
105473873|NCT01667419|363747061|FG003|Overall Study|Protocol Violation|0|||
105473874|NCT01667419|363747058|FG000|Overall Study|Lost to Follow-up|7|||
105473875|NCT01667419|363747059|FG001|Overall Study|Lost to Follow-up|6|||
105473876|NCT01667419|363747060|FG002|Overall Study|Lost to Follow-up|2|||
105473877|NCT01667419|363747061|FG003|Overall Study|Lost to Follow-up|4|||
105473878|NCT01667419|363747058|FG000|Overall Study|Death|18|||
105473879|NCT01667419|363747059|FG001|Overall Study|Death|33|||
105559790|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
105699791|NCT01423851|364563080|FG000|Whole Study|Withdrawal by Subject|1|||
105699792|NCT01423851|364563081|FG001|Whole Study|Withdrawal by Subject|1|||
105699793|NCT01423851|364563082|FG002|Whole Study|Withdrawal by Subject|0|||
105349219|NCT04852276|363279300|FG000|Overall Study|Death|2|||
105699794|NCT01423851|364563083|FG003|Whole Study|Withdrawal by Subject|0|||
105349220|NCT04852276|363279301|FG001|Overall Study|Death|0|||
105349221|NCT04852276|363279300|FG000|Overall Study|Lost to Follow-up|15|||
105473880|NCT01667419|363747060|FG002|Overall Study|Death|25|||
105559791|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
105349222|NCT04852276|363279301|FG001|Overall Study|Lost to Follow-up|9|||
105473881|NCT01667419|363747061|FG003|Overall Study|Death|26|||
105473882|NCT01941186|363747062|FG000|Follow-up|Lost to Follow-up|1|||
105473883|NCT01941186|363747063|FG001|Follow-up|Lost to Follow-up|0|||
105473884|NCT01092117|363747064|FG000|Index Procedure to 1 Month|Death|1|||
105699795|NCT01423851|364563084|FG004|Whole Study|Withdrawal by Subject|0|||
105349223|NCT04852276|363279300|FG000|Overall Study|Withdrawal by Subject|26|||
105349224|NCT04852276|363279301|FG001|Overall Study|Withdrawal by Subject|6|||
105473885|NCT01092117|363747064|FG000|1 Month|Death|1|||
105473886|NCT01092117|363747064|FG000|1 Month|Withdrawal by Subject|1|||
105473887|NCT01092117|363747064|FG000|1 Month|Lost to Follow-up|1|||
105559792|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
105559793|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
105559794|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
105559795|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105559796|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
105559797|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
105559798|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105559799|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105559800|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105559801|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105559802|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
105559803|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
105559804|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105559805|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
105559806|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105559807|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105559808|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105787223|NCT03110107|364874899|FG010|Treatment Period|Participants no longer meets study criteria|0|||
105787224|NCT03110107|364874900|FG011|Treatment Period|Participants no longer meets study criteria|0|||
105559809|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105559810|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105559811|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105559812|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105559813|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
105559814|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
105559815|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
105787225|NCT03110107|364874901|FG012|Treatment Period|Participants no longer meets study criteria|0|||
105559816|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
105559817|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
105559818|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
105559819|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
105559820|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
105559821|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
105559822|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105559823|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
105559824|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
105559825|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105559826|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105559827|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105559828|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105559829|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
105559830|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
105559831|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105559832|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
105559833|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
105559834|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105559835|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105559836|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105559837|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105559838|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105559839|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
105559840|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105559841|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
105559842|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
105559843|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105559844|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105559845|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105559846|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105559847|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
105559848|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105559849|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
105559850|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
105559851|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
105559852|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
105559853|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
105559854|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
105559855|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
105699796|NCT01423851|364563085|FG005|Whole Study|Withdrawal by Subject|0|||
105699797|NCT01423851|364563086|FG006|Whole Study|Withdrawal by Subject|0|||
105699798|NCT01423851|364563087|FG007|Whole Study|Withdrawal by Subject|0|||
105699799|NCT01423851|364563088|FG008|Whole Study|Withdrawal by Subject|2|||
105699800|NCT01423851|364563089|FG009|Whole Study|Withdrawal by Subject|0|||
105699801|NCT01423851|364563090|FG010|Whole Study|Withdrawal by Subject|4|||
105699802|NCT01423851|364563080|FG000|Whole Study|Adverse Event|0|||
105699803|NCT01423851|364563081|FG001|Whole Study|Adverse Event|0|||
105699804|NCT01423851|364563082|FG002|Whole Study|Adverse Event|0|||
105699805|NCT01423851|364563083|FG003|Whole Study|Adverse Event|2|||
105699806|NCT01423851|364563084|FG004|Whole Study|Adverse Event|0|||
105699807|NCT01423851|364563085|FG005|Whole Study|Adverse Event|0|||
105699808|NCT01423851|364563086|FG006|Whole Study|Adverse Event|0|||
105699809|NCT01423851|364563087|FG007|Whole Study|Adverse Event|3|||
105699810|NCT01423851|364563088|FG008|Whole Study|Adverse Event|3|||
105699811|NCT01423851|364563089|FG009|Whole Study|Adverse Event|2|||
105699812|NCT01423851|364563090|FG010|Whole Study|Adverse Event|3|||
105699813|NCT00362414|364565016|FG000|Overall Study|Death|2|||
105699814|NCT00362414|364565016|FG000|Overall Study|Adverse Event|1|||
105699815|NCT02369848|364565017|FG000|Overall Study|Death|1|||
105699816|NCT02369848|364565017|FG000|Overall Study|Withdrawal by Subject|2|||
105699817|NCT02369848|364565017|FG000|Overall Study|Lost to Follow-up|1|||
105699818|NCT03281668|364565019|FG000|Overall Study|Physician Decision|1|||
105699819|NCT03281668|364565019|FG000|Overall Study|scheduling conflict, family circumstance|2|||
105699820|NCT03281668|364565019|FG000|Overall Study|Withdrawal by Subject|4|||
105699821|NCT03281668|364565019|FG000|Overall Study|Lost to Follow-up|1|||
105699822|NCT02053168|364565020|FG000|Overall Study|Withdrawal by Subject|1|||
105699823|NCT02053168|364565020|FG000|Overall Study|Physician Decision|1|||
105699824|NCT02053168|364565020|FG000|Overall Study|Lost to Follow-up|1|||
105699825|NCT02687542|364565021|FG000|Overall Study|Medication error without associated AEs|0|||
105699826|NCT02687542|364565022|FG001|Overall Study|Medication error without associated AEs|0|||
105699827|NCT02687542|364565023|FG002|Overall Study|Medication error without associated AEs|0|||
105473888|NCT01092117|363747064|FG000|6 Months|Death|2|||
105473889|NCT01092117|363747064|FG000|6 Months|Withdrawal by Subject|3|||
105473890|NCT01092117|363747064|FG000|12 Month|Death|11|||
105473891|NCT01092117|363747064|FG000|12 Month|Withdrawal by Subject|2|||
105699828|NCT02687542|364565024|FG003|Overall Study|Medication error without associated AEs|0|||
105473892|NCT01092117|363747064|FG000|12 Month|Lost to Follow-up|1|||
105473893|NCT01092117|363747064|FG000|Year 2|Death|5|||
105473894|NCT01092117|363747064|FG000|Year 2|Withdrawal by Subject|4|||
105473895|NCT01092117|363747064|FG000|Year 2|Lost to Follow-up|1|||
105473896|NCT01092117|363747064|FG000|Year 3|Death|7|||
105473897|NCT01092117|363747064|FG000|Year 3|Withdrawal by Subject|9|||
105473898|NCT01092117|363747064|FG000|Year 3|Lost to Follow-up|3|||
105473899|NCT01092117|363747064|FG000|Year 4|Death|8|||
105473900|NCT01092117|363747064|FG000|Year 4|Withdrawal by Subject|4|||
105473901|NCT01092117|363747064|FG000|Year 4|Lost to Follow-up|4|||
105473902|NCT01068600|363747065|FG000|Overall Study|Withdrawal by Subject|5|||
105473903|NCT01068600|363747066|FG001|Overall Study|Withdrawal by Subject|6|||
105473904|NCT01068600|363747065|FG000|Overall Study|Adverse Event|3|||
105473905|NCT01068600|363747066|FG001|Overall Study|Adverse Event|3|||
105473906|NCT01068600|363747065|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105473907|NCT01068600|363747066|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105473908|NCT01068600|363747065|FG000|Overall Study|Lost to Follow-up|1|||
105473909|NCT01068600|363747066|FG001|Overall Study|Lost to Follow-up|2|||
105473910|NCT01068600|363747065|FG000|Overall Study|Protocol deviation|1|||
105473911|NCT01068600|363747066|FG001|Overall Study|Protocol deviation|1|||
105473912|NCT01068600|363747065|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105473913|NCT01068600|363747066|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
105473914|NCT01068600|363747065|FG000|Overall Study|Administrative problems|0|||
105473915|NCT01068600|363747066|FG001|Overall Study|Administrative problems|1|||
105473916|NCT02644109|363747067|FG000|Overall Study|Adverse Event|0|||
105473917|NCT02644109|363747068|FG001|Overall Study|Adverse Event|4|||
105473918|NCT04173494|363747069|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
105473919|NCT04173494|363747070|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
105473920|NCT04173494|363747069|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
105473921|NCT04173494|363747070|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
105473922|NCT04173494|363747069|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
105473923|NCT04173494|363747070|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
105473924|NCT04173494|363747069|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
105473925|NCT04173494|363747070|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
105473926|NCT04173494|363747069|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
105473927|NCT04173494|363747070|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
105473928|NCT04173494|363747069|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
105473929|NCT04173494|363747070|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
105473930|NCT04173494|363747069|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
105473931|NCT04173494|363747070|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
105473932|NCT04173494|363747069|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
105473933|NCT04173494|363747070|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
105473934|NCT04173494|363747069|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
105473935|NCT04173494|363747070|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
105473936|NCT04173494|363747069|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
105473937|NCT04173494|363747070|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
105473938|NCT04173494|363747069|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
105473939|NCT04173494|363747070|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
105473940|NCT04173494|363747069|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
105473941|NCT04173494|363747070|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
105473942|NCT04173494|363747069|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
105473943|NCT04173494|363747070|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
105473944|NCT04173494|363747069|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
105473945|NCT04173494|363747070|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
105473946|NCT04173494|363747069|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
105473947|NCT04173494|363747070|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
105473948|NCT04173494|363747069|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
105473949|NCT04173494|363747070|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
105473950|NCT04195893|363747071|FG000|Second Intervention|Withdrawal by Subject|1|||
105473951|NCT04195893|363747072|FG001|Second Intervention|Withdrawal by Subject|0|||
105473952|NCT01519869|363747073|FG000|Overall Study|Lost to Follow-up|1|||
105473953|NCT03023813|363747074|FG000|Overall Study|Lost to Follow-up|1|||
105473954|NCT03023813|363747075|FG001|Overall Study|Lost to Follow-up|2|||
105473955|NCT03023813|363747076|FG002|Overall Study|Lost to Follow-up|0|||
105473956|NCT04075734|363747079|FG000|Overall Study|Lost to Follow-up|1|||
105473957|NCT04075734|363747080|FG001|Overall Study|Lost to Follow-up|1|||
105473958|NCT04075734|363747081|FG002|Overall Study|Lost to Follow-up|0|||
105473959|NCT04075734|363747079|FG000|Overall Study|Withdrawal by Subject|3|||
105473960|NCT04075734|363747080|FG001|Overall Study|Withdrawal by Subject|0|||
105473961|NCT04075734|363747081|FG002|Overall Study|Withdrawal by Subject|0|||
105473962|NCT01802073|363747082|FG000|Overall Study|Lost to Follow-up|0|||
105473963|NCT01802073|363747083|FG001|Overall Study|Lost to Follow-up|1|||
105473964|NCT01802073|363747082|FG000|Overall Study|Non-compliant|4|||
105473965|NCT01802073|363747083|FG001|Overall Study|Non-compliant|2|||
105473966|NCT01802073|363747082|FG000|Overall Study|Withdrawal by Subject|1|||
105473967|NCT01802073|363747083|FG001|Overall Study|Withdrawal by Subject|1|||
105473968|NCT01802073|363747082|FG000|Overall Study|Physician Decision|0|||
105473969|NCT01802073|363747083|FG001|Overall Study|Physician Decision|7|||
105473970|NCT00393861|363747084|FG000|Overall Study|Adverse Event|2|||
105473971|NCT00393861|363747084|FG000|Overall Study|Disease Progression|24|||
105473972|NCT00918736|363747088|FG000|Overall Study|Withdrawal by Subject|4|||
105473973|NCT01474018|363747089|FG000|Overall Study|Lost to Follow-up|0|||
105473974|NCT01474018|363747090|FG001|Overall Study|Lost to Follow-up|1|||
105473975|NCT01474018|363747089|FG000|Overall Study|Withdrawal by Subject|0|||
105473976|NCT01474018|363747090|FG001|Overall Study|Withdrawal by Subject|2|||
105473977|NCT01137604|363747091|FG000|Overall Study|Adverse Event|3|||
105473978|NCT01137604|363747092|FG001|Overall Study|Adverse Event|6|||
105473979|NCT01137604|363747093|FG002|Overall Study|Adverse Event|9|||
105473980|NCT01137604|363747094|FG003|Overall Study|Adverse Event|9|||
105473981|NCT01137604|363747091|FG000|Overall Study|Participant Choice|0|||
105473982|NCT01137604|363747092|FG001|Overall Study|Participant Choice|2|||
105473983|NCT01137604|363747093|FG002|Overall Study|Participant Choice|2|||
105473984|NCT01137604|363747094|FG003|Overall Study|Participant Choice|0|||
105473985|NCT01137604|363747091|FG000|Overall Study|Withdrawal of consent|0|||
105473986|NCT01137604|363747092|FG001|Overall Study|Withdrawal of consent|0|||
105473987|NCT01137604|363747093|FG002|Overall Study|Withdrawal of consent|0|||
105473988|NCT01137604|363747094|FG003|Overall Study|Withdrawal of consent|2|||
105473989|NCT01137604|363747091|FG000|Overall Study|Clinical progression/deterioration|1|||
105473990|NCT01137604|363747092|FG001|Overall Study|Clinical progression/deterioration|2|||
105473991|NCT01137604|363747093|FG002|Overall Study|Clinical progression/deterioration|2|||
105473992|NCT01137604|363747094|FG003|Overall Study|Clinical progression/deterioration|0|||
105473993|NCT00573144|363747095|FG000|Overall Study|Withdrawal by Subject|2|||
105473994|NCT00573144|363747096|FG001|Overall Study|Withdrawal by Subject|3|||
105473995|NCT03735667|363747103|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
105473996|NCT03735667|363747104|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
105473997|NCT03735667|363747105|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
105473998|NCT03735667|363747103|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
105473999|NCT03735667|363747104|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
105474000|NCT03735667|363747105|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
105474001|NCT03735667|363747103|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
105474002|NCT03735667|363747104|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
105474003|NCT03735667|363747105|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
105474004|NCT03735667|363747103|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
105474005|NCT03735667|363747104|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
105474006|NCT03735667|363747105|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
105474007|NCT03735667|363747103|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
105474008|NCT03735667|363747104|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
105474009|NCT03735667|363747105|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
105474010|NCT03735667|363747103|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
105474011|NCT03735667|363747104|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
105474012|NCT03735667|363747105|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
105474013|NCT03735667|363747103|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
105474014|NCT03735667|363747104|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
105474015|NCT03735667|363747105|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
105474016|NCT03735667|363747103|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
105474017|NCT03735667|363747104|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
105474018|NCT03735667|363747105|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
105474019|NCT03735667|363747103|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
105474020|NCT03735667|363747104|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
105474021|NCT03735667|363747105|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
105474022|NCT03735667|363747103|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
105474023|NCT03735667|363747104|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
105474024|NCT03735667|363747105|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
105474025|NCT03735667|363747103|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
105474026|NCT03735667|363747104|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
105474027|NCT03735667|363747105|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
105474028|NCT03735667|363747103|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
105474029|NCT03735667|363747104|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
105474030|NCT03735667|363747105|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
105699829|NCT02687542|364565025|FG004|Overall Study|Medication error without associated AEs|1|||
105699830|NCT02687542|364565021|FG000|Overall Study|Lost to Follow-up|0|||
105699831|NCT02687542|364565022|FG001|Overall Study|Lost to Follow-up|0|||
105699832|NCT02687542|364565023|FG002|Overall Study|Lost to Follow-up|0|||
105699833|NCT02687542|364565024|FG003|Overall Study|Lost to Follow-up|0|||
105699834|NCT02687542|364565025|FG004|Overall Study|Lost to Follow-up|1|||
105699835|NCT02687542|364565021|FG000|Overall Study|Protocol Violation|0|||
105699836|NCT02687542|364565022|FG001|Overall Study|Protocol Violation|1|||
105699837|NCT02687542|364565023|FG002|Overall Study|Protocol Violation|0|||
105699838|NCT02687542|364565024|FG003|Overall Study|Protocol Violation|0|||
105699839|NCT02687542|364565025|FG004|Overall Study|Protocol Violation|0|||
105699840|NCT02687542|364565021|FG000|Overall Study|Other|5|||
105699841|NCT02687542|364565022|FG001|Overall Study|Other|9|||
105699842|NCT02687542|364565023|FG002|Overall Study|Other|10|||
105699843|NCT02687542|364565024|FG003|Overall Study|Other|6|||
105699844|NCT02687542|364565025|FG004|Overall Study|Other|5|||
105699845|NCT02687542|364565021|FG000|Overall Study|Adverse Event|3|||
105699846|NCT02687542|364565022|FG001|Overall Study|Adverse Event|1|||
105699847|NCT02687542|364565023|FG002|Overall Study|Adverse Event|3|||
105699848|NCT02687542|364565024|FG003|Overall Study|Adverse Event|2|||
105699849|NCT02687542|364565025|FG004|Overall Study|Adverse Event|9|||
105699850|NCT02687542|364565021|FG000|Overall Study|Withdrawal by Subject|0|||
105699851|NCT02687542|364565022|FG001|Overall Study|Withdrawal by Subject|1|||
105699852|NCT02687542|364565023|FG002|Overall Study|Withdrawal by Subject|1|||
105699853|NCT02687542|364565024|FG003|Overall Study|Withdrawal by Subject|2|||
105699854|NCT02687542|364565025|FG004|Overall Study|Withdrawal by Subject|4|||
105699855|NCT01838616|364565026|FG000|Titration Period|Adverse Event|18|||
105699856|NCT01838616|364565027|FG001|Titration Period|Adverse Event|48|||
105699857|NCT01838616|364565026|FG000|Titration Period|Lack of Efficacy|5|||
105699858|NCT01838616|364565027|FG001|Titration Period|Lack of Efficacy|12|||
105699859|NCT01838616|364565026|FG000|Titration Period|Withdrawal by Subject|5|||
105699860|NCT01838616|364565027|FG001|Titration Period|Withdrawal by Subject|5|||
105699861|NCT01838616|364565026|FG000|Titration Period|Technical problems|1|||
105699862|NCT01838616|364565027|FG001|Titration Period|Technical problems|0|||
105699863|NCT01838616|364565026|FG000|Titration Period|Other|1|||
105699864|NCT01838616|364565027|FG001|Titration Period|Other|0|||
105699865|NCT01838616|364565026|FG000|Titration Period|Protocol Violation|0|||
105699866|NCT01838616|364565027|FG001|Titration Period|Protocol Violation|1|||
105699867|NCT01838616|364565026|FG000|Continuation Period|Lack of Efficacy|3|||
105699868|NCT01838616|364565027|FG001|Continuation Period|Lack of Efficacy|5|||
105699869|NCT01838616|364565026|FG000|Continuation Period|Adverse Event|8|||
105699870|NCT01838616|364565027|FG001|Continuation Period|Adverse Event|4|||
105699871|NCT01838616|364565026|FG000|Continuation Period|Protocol Violation|2|||
105699872|NCT01838616|364565027|FG001|Continuation Period|Protocol Violation|0|||
105699873|NCT01838616|364565026|FG000|Continuation Period|Lost to Follow-up|1|||
105699874|NCT01838616|364565027|FG001|Continuation Period|Lost to Follow-up|0|||
105699875|NCT01838616|364565026|FG000|Continuation Period|Withdrawal by Subject|0|||
105699876|NCT01838616|364565027|FG001|Continuation Period|Withdrawal by Subject|4|||
105699877|NCT01838616|364565026|FG000|Continuation Period|Technical problems|0|||
105699878|NCT01838616|364565027|FG001|Continuation Period|Technical problems|1|||
105699879|NCT01838616|364565026|FG000|Pick-up Arm|Lack of Efficacy|4|||
105699880|NCT01838616|364565027|FG001|Pick-up Arm|Lack of Efficacy|0|||
105699881|NCT01838616|364565026|FG000|Pick-up Arm|Adverse Event|9|||
105699882|NCT01838616|364565027|FG001|Pick-up Arm|Adverse Event|0|||
105699883|NCT01838616|364565026|FG000|Pick-up Arm|Withdrawal by Subject|1|||
105699884|NCT01838616|364565027|FG001|Pick-up Arm|Withdrawal by Subject|0|||
105699885|NCT01838616|364565026|FG000|Pick-up Arm|Technical problems|1|||
105474031|NCT01120717|363747106|FG000|Overall Study|Withdrawal by Subject|11|||
105474032|NCT01120717|363747107|FG001|Overall Study|Withdrawal by Subject|6|||
105474033|NCT01120717|363747106|FG000|Overall Study|Adverse Event|10|||
105699886|NCT01838616|364565027|FG001|Pick-up Arm|Technical problems|0|||
105699887|NCT00257725|364565028|FG000|Overall Study|Adverse Event|3|||
105699888|NCT00833053|364565035|FG000|Overall Study|Adverse Event|4|||
105699889|NCT00833053|364565036|FG001|Overall Study|Adverse Event|0|||
105699890|NCT00833053|364565035|FG000|Overall Study|Treatment Failure|3|||
105699891|NCT00833053|364565036|FG001|Overall Study|Treatment Failure|1|||
105699892|NCT00833053|364565035|FG000|Overall Study|Withdrawal by Subject|0|||
105699893|NCT00833053|364565036|FG001|Overall Study|Withdrawal by Subject|1|||
105699894|NCT00833053|364565035|FG000|Overall Study|Protocol Violation|2|||
105699895|NCT00833053|364565036|FG001|Overall Study|Protocol Violation|1|||
105699896|NCT02318667|364565043|FG000|Overall Study|Adverse Event|1|||
105699897|NCT02318667|364565043|FG000|Overall Study|Lack of Efficacy|6|||
105699898|NCT02318667|364565043|FG000|Overall Study|Protocol Violation|2|||
105699899|NCT00003535|364565044|FG000|Overall Study|Not evaluable|5|||
105699900|NCT04353284|364565049|FG000|Overall Study|Adverse Event|1|||
105699901|NCT04353284|364565050|FG001|Overall Study|Adverse Event|1|||
105699902|NCT04353284|364565049|FG000|Overall Study|Lost to Follow-up|1|||
105699903|NCT04353284|364565050|FG001|Overall Study|Lost to Follow-up|0|||
105699904|NCT03807349|364565051|FG000|Overall Study|Early Study Termination|9|||
105349225|NCT00224406|363281088|FG000|Overall Study|Re-transplant|0|||
105474034|NCT01120717|363747107|FG001|Overall Study|Adverse Event|6|||
105474035|NCT01120717|363747106|FG000|Overall Study|Protocol Deviation|2|||
105474036|NCT01120717|363747107|FG001|Overall Study|Protocol Deviation|5|||
105474037|NCT01120717|363747106|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
105474038|NCT01120717|363747107|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
105474039|NCT01120717|363747106|FG000|Overall Study|Lost to Follow-up|2|||
105474040|NCT01120717|363747107|FG001|Overall Study|Lost to Follow-up|3|||
105474041|NCT01120717|363747106|FG000|Overall Study|Death|3|||
105474042|NCT01120717|363747107|FG001|Overall Study|Death|1|||
105474043|NCT01120717|363747106|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
105474044|NCT01120717|363747107|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
105474045|NCT04535453|363747108|FG000|Overall Study|Death|0|||
105474046|NCT04535453|363747109|FG001|Overall Study|Death|1|||
105474047|NCT04535453|363747110|FG002|Overall Study|Death|0|||
105474048|NCT04535453|363747111|FG003|Overall Study|Death|0|||
105474049|NCT04535453|363747112|FG004|Overall Study|Death|0|||
105474050|NCT04535453|363747113|FG005|Overall Study|Death|0|||
105474051|NCT04535453|363747114|FG006|Overall Study|Death|0|||
105474052|NCT04535453|363747115|FG007|Overall Study|Death|0|||
105474053|NCT04535453|363747116|FG008|Overall Study|Death|0|||
105474054|NCT04535453|363747117|FG009|Overall Study|Death|0|||
105474055|NCT04535453|363747118|FG010|Overall Study|Death|0|||
105474056|NCT04535453|363747119|FG011|Overall Study|Death|0|||
105474057|NCT04535453|363747108|FG000|Overall Study|Lost to Follow-up|1|||
105474058|NCT04535453|363747109|FG001|Overall Study|Lost to Follow-up|1|||
105474059|NCT04535453|363747110|FG002|Overall Study|Lost to Follow-up|1|||
105474060|NCT04535453|363747111|FG003|Overall Study|Lost to Follow-up|0|||
105474061|NCT04535453|363747112|FG004|Overall Study|Lost to Follow-up|3|||
105474062|NCT04535453|363747113|FG005|Overall Study|Lost to Follow-up|1|||
105474063|NCT04535453|363747114|FG006|Overall Study|Lost to Follow-up|0|||
105474064|NCT04535453|363747115|FG007|Overall Study|Lost to Follow-up|0|||
105474065|NCT04535453|363747116|FG008|Overall Study|Lost to Follow-up|1|||
105474066|NCT04535453|363747117|FG009|Overall Study|Lost to Follow-up|1|||
105474067|NCT04535453|363747118|FG010|Overall Study|Lost to Follow-up|0|||
105474068|NCT04535453|363747119|FG011|Overall Study|Lost to Follow-up|0|||
105474069|NCT04535453|363747108|FG000|Overall Study|Physician Decision|0|||
105474070|NCT04535453|363747109|FG001|Overall Study|Physician Decision|0|||
105474071|NCT04535453|363747110|FG002|Overall Study|Physician Decision|0|||
105474072|NCT04535453|363747111|FG003|Overall Study|Physician Decision|1|||
105474073|NCT04535453|363747112|FG004|Overall Study|Physician Decision|0|||
105474074|NCT04535453|363747113|FG005|Overall Study|Physician Decision|0|||
105474075|NCT04535453|363747114|FG006|Overall Study|Physician Decision|0|||
105474076|NCT04535453|363747115|FG007|Overall Study|Physician Decision|0|||
105474077|NCT04535453|363747116|FG008|Overall Study|Physician Decision|0|||
105474078|NCT04535453|363747117|FG009|Overall Study|Physician Decision|0|||
105474079|NCT04535453|363747118|FG010|Overall Study|Physician Decision|0|||
105474080|NCT04535453|363747119|FG011|Overall Study|Physician Decision|0|||
105474081|NCT04535453|363747108|FG000|Overall Study|Withdrawal by Subject|3|||
105474082|NCT04535453|363747109|FG001|Overall Study|Withdrawal by Subject|6|||
105474083|NCT04535453|363747110|FG002|Overall Study|Withdrawal by Subject|3|||
105474084|NCT04535453|363747111|FG003|Overall Study|Withdrawal by Subject|3|||
105474085|NCT04535453|363747112|FG004|Overall Study|Withdrawal by Subject|2|||
105474086|NCT04535453|363747113|FG005|Overall Study|Withdrawal by Subject|1|||
105474087|NCT04535453|363747114|FG006|Overall Study|Withdrawal by Subject|1|||
105474088|NCT04535453|363747115|FG007|Overall Study|Withdrawal by Subject|1|||
105474089|NCT04535453|363747116|FG008|Overall Study|Withdrawal by Subject|1|||
105474090|NCT04535453|363747117|FG009|Overall Study|Withdrawal by Subject|1|||
105474091|NCT04535453|363747118|FG010|Overall Study|Withdrawal by Subject|0|||
105474092|NCT04535453|363747119|FG011|Overall Study|Withdrawal by Subject|1|||
105474093|NCT04535453|363747108|FG000|Overall Study|Other|0|||
105474094|NCT04535453|363747109|FG001|Overall Study|Other|0|||
105474095|NCT04535453|363747110|FG002|Overall Study|Other|1|||
105474096|NCT04535453|363747111|FG003|Overall Study|Other|0|||
105474097|NCT04535453|363747112|FG004|Overall Study|Other|1|||
105474098|NCT04535453|363747113|FG005|Overall Study|Other|0|||
105474099|NCT04535453|363747114|FG006|Overall Study|Other|1|||
105474100|NCT04535453|363747115|FG007|Overall Study|Other|1|||
105474101|NCT04535453|363747116|FG008|Overall Study|Other|1|||
105474102|NCT04535453|363747117|FG009|Overall Study|Other|0|||
105474103|NCT04535453|363747118|FG010|Overall Study|Other|0|||
105474104|NCT04535453|363747119|FG011|Overall Study|Other|0|||
105474105|NCT01387542|363747120|FG000|Overall Study|Adverse Event|3|||
105474106|NCT01387542|363747120|FG000|Overall Study|Withdrawal by Subject|1|||
105474107|NCT01387542|363747120|FG000|Overall Study|Changed diagnosis|1|||
105474108|NCT01387542|363747120|FG000|Overall Study|Insufficient response|1|||
105474109|NCT01387542|363747120|FG000|Overall Study|Non-compliant|1|||
105474110|NCT01387542|363747120|FG000|Overall Study|Lost to Follow-up|1|||
105474111|NCT00335764|363747122|FG000|Overall Study|wrong histology|1|||
105474112|NCT00335764|363747123|FG001|Overall Study|wrong histology|0|||
105474113|NCT00335764|363747124|FG002|Overall Study|wrong histology|0|||
105474114|NCT00335764|363747125|FG003|Overall Study|wrong histology|0|||
105474115|NCT00335764|363747126|FG004|Overall Study|wrong histology|1|||
105474116|NCT05661851|363747128|FG000|Overall Study|Protocol Violation|1|||
105474117|NCT05661851|363747129|FG001|Overall Study|Protocol Violation|1|||
105474118|NCT05661851|363747128|FG000|Overall Study|Covid-19 Related|3|||
105474119|NCT05661851|363747129|FG001|Overall Study|Covid-19 Related|4|||
105474120|NCT05661851|363747128|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
105474121|NCT05661851|363747129|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
105474122|NCT05661851|363747128|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
105474123|NCT05661851|363747129|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
105474124|NCT02873429|363747130|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
105474125|NCT02873429|363747131|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
105474126|NCT02873429|363747130|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
105474127|NCT02873429|363747131|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
105474128|NCT02873429|363747130|FG000|16 Weeks|Lost to Follow-up|3|||
105474129|NCT02873429|363747131|FG001|16 Weeks|Lost to Follow-up|0|||
105474130|NCT01388985|363747132|FG000|Overall Study|Death|0|||
105474131|NCT01388985|363747133|FG001|Overall Study|Death|1|||
105474132|NCT01388985|363747132|FG000|Overall Study|Lost to Follow-up|30|||
105474133|NCT01388985|363747133|FG001|Overall Study|Lost to Follow-up|30|||
105474134|NCT01388985|363747132|FG000|Overall Study|Withdrawal by Subject|13|||
105474135|NCT01388985|363747133|FG001|Overall Study|Withdrawal by Subject|4|||
105474136|NCT01388985|363747132|FG000|Overall Study|Subject unavailable|1|||
105474137|NCT01388985|363747133|FG001|Overall Study|Subject unavailable|1|||
105474138|NCT01388985|363747132|FG000|Overall Study|Other (no reason)|0|||
105474139|NCT01388985|363747133|FG001|Overall Study|Other (no reason)|1|||
105474140|NCT01388985|363747132|FG000|Overall Study|Error of nurse|5|||
105474141|NCT01388985|363747133|FG001|Overall Study|Error of nurse|1|||
105474142|NCT00782834|363747136|FG000|Treatment Phase|fibrous tumor not GIST|1|||
105474143|NCT04629066|363747137|FG000|Overall Study|Lost to Follow-up|3|||
105474144|NCT04629066|363747138|FG001|Overall Study|Lost to Follow-up|2|||
105349226|NCT00224406|363281089|FG001|Overall Study|Re-transplant|2|||
105349227|NCT00224406|363281088|FG000|Overall Study|Death|0|||
105349228|NCT00224406|363281089|FG001|Overall Study|Death|1|||
105349229|NCT00224406|363281088|FG000|Overall Study|Transplant cancelled|0|||
105349230|NCT00224406|363281089|FG001|Overall Study|Transplant cancelled|4|||
105349231|NCT00224406|363281088|FG000|Overall Study|Drug not delivered|2|||
105349232|NCT00224406|363281089|FG001|Overall Study|Drug not delivered|0|||
105349233|NCT00224406|363281088|FG000|Overall Study|Other|4|||
105349234|NCT00224406|363281089|FG001|Overall Study|Other|0|||
105349235|NCT00224406|363281088|FG000|Overall Study|Transplant cancelled|3|||
105349236|NCT00224406|363281089|FG001|Overall Study|Transplant cancelled|0|||
105349237|NCT02437188|363281092|FG000|Overall Study|Randomized but did not receive surgery|4|||
105349238|NCT02437188|363281093|FG001|Overall Study|Randomized but did not receive surgery|8|||
105349239|NCT02437188|363281092|FG000|Overall Study|Adverse Event|0|||
105349240|NCT02437188|363281093|FG001|Overall Study|Adverse Event|1|||
105349241|NCT03774394|363281094|FG000|Overall Study|Withdrawal by Subject|2|||
105349242|NCT03774394|363281095|FG001|Overall Study|Withdrawal by Subject|0|||
105349243|NCT00153816|363281096|FG000|Overall Study|Death|6|||
105349244|NCT00153816|363281097|FG001|Overall Study|Death|5|||
105349245|NCT00153816|363281098|FG002|Overall Study|Death|4|||
105349246|NCT00153816|363281099|FG003|Overall Study|Death|6|||
105349247|NCT00153816|363281100|FG004|Overall Study|Death|0|||
105349248|NCT00153816|363281101|FG005|Overall Study|Death|2|||
105349249|NCT00153816|363281096|FG000|Overall Study|Lost to Follow-up|7|||
105349250|NCT00153816|363281097|FG001|Overall Study|Lost to Follow-up|8|||
105349251|NCT00153816|363281098|FG002|Overall Study|Lost to Follow-up|5|||
105349252|NCT00153816|363281099|FG003|Overall Study|Lost to Follow-up|8|||
105349253|NCT00153816|363281100|FG004|Overall Study|Lost to Follow-up|7|||
105349254|NCT00153816|363281101|FG005|Overall Study|Lost to Follow-up|9|||
105349255|NCT00153816|363281096|FG000|Overall Study|Withdrawal by Subject|9|||
105349256|NCT00153816|363281097|FG001|Overall Study|Withdrawal by Subject|9|||
105349257|NCT00153816|363281098|FG002|Overall Study|Withdrawal by Subject|9|||
105349258|NCT00153816|363281099|FG003|Overall Study|Withdrawal by Subject|4|||
105349259|NCT00153816|363281100|FG004|Overall Study|Withdrawal by Subject|1|||
105349260|NCT00153816|363281101|FG005|Overall Study|Withdrawal by Subject|5|||
105349261|NCT00153816|363281096|FG000|Overall Study|Follow-up exam not done|8|||
105349262|NCT00153816|363281097|FG001|Overall Study|Follow-up exam not done|7|||
105349263|NCT00153816|363281098|FG002|Overall Study|Follow-up exam not done|11|||
105349264|NCT00153816|363281099|FG003|Overall Study|Follow-up exam not done|10|||
105349265|NCT00153816|363281100|FG004|Overall Study|Follow-up exam not done|8|||
105559856|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
105559857|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
105559858|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105559859|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
105559860|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
105559861|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105559862|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105559863|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105559864|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105559865|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105559866|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105559867|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105559868|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105559869|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
105349266|NCT00153816|363281101|FG005|Overall Study|Follow-up exam not done|9|||
105349267|NCT00153816|363281096|FG000|Overall Study|Follow-up exam done, histology missing|2|||
105349268|NCT00153816|363281097|FG001|Overall Study|Follow-up exam done, histology missing|3|||
105349269|NCT00153816|363281098|FG002|Overall Study|Follow-up exam done, histology missing|3|||
105349270|NCT00153816|363281099|FG003|Overall Study|Follow-up exam done, histology missing|3|||
105349271|NCT00153816|363281100|FG004|Overall Study|Follow-up exam done, histology missing|1|||
105349272|NCT00153816|363281101|FG005|Overall Study|Follow-up exam done, histology missing|2|||
105349273|NCT02907619|363281102|FG000|Overall Study|Study terminated by sponsor|18|||
105349274|NCT02907619|363281103|FG001|Overall Study|Study terminated by sponsor|18|||
105349275|NCT02907619|363281104|FG002|Overall Study|Study terminated by sponsor|19|||
105787226|NCT03110107|364874902|FG013|Treatment Period|Participants no longer meets study criteria|0|||
105787227|NCT03110107|364874903|FG014|Treatment Period|Participants no longer meets study criteria|0|||
105787228|NCT03110107|364874904|FG015|Treatment Period|Participants no longer meets study criteria|0|||
105787229|NCT03110107|364874905|FG016|Treatment Period|Participants no longer meets study criteria|0|||
105787230|NCT03110107|364874906|FG017|Treatment Period|Participants no longer meets study criteria|0|||
105787231|NCT03110107|364874907|FG018|Treatment Period|Participants no longer meets study criteria|0|||
105787232|NCT03110107|364874908|FG019|Treatment Period|Participants no longer meets study criteria|0|||
105787233|NCT03110107|364874909|FG020|Treatment Period|Participants no longer meets study criteria|0|||
105474145|NCT01497366|363747139|FG000|Overall Study|Virologic failure|2|||
105474146|NCT01497366|363747140|FG001|Overall Study|Virologic failure|50|||
105474147|NCT01497366|363747139|FG000|Overall Study|Lost to Follow-up|11|||
105474148|NCT01497366|363747140|FG001|Overall Study|Lost to Follow-up|10|||
105474149|NCT01497366|363747139|FG000|Overall Study|Withdrawal by Subject|6|||
105474150|NCT01497366|363747140|FG001|Overall Study|Withdrawal by Subject|6|||
105474151|NCT01497366|363747139|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
105474152|NCT01497366|363747140|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
105474153|NCT01497366|363747139|FG000|Overall Study|Other|5|||
105474154|NCT01497366|363747140|FG001|Overall Study|Other|0|||
105474155|NCT01497366|363747139|FG000|Overall Study|Death|1|||
105474156|NCT01497366|363747140|FG001|Overall Study|Death|1|||
105474157|NCT01497366|363747139|FG000|Overall Study|Randomized but not treated|7|||
105474158|NCT01497366|363747140|FG001|Overall Study|Randomized but not treated|21|||
105474159|NCT00282308|363747141|FG000|Treatment Period|Lost to Follow-up|1|||
105474160|NCT00282308|363747142|FG001|Treatment Period|Lost to Follow-up|0|||
105474161|NCT00282308|363747143|FG002|Treatment Period|Lost to Follow-up|0|||
105474162|NCT00282308|363747141|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
105474163|NCT00282308|363747142|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
105474164|NCT00282308|363747143|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
105474165|NCT00282308|363747141|FG000|Treatment Period|Adverse Event|0|||
105474166|NCT00282308|363747142|FG001|Treatment Period|Adverse Event|2|||
105474167|NCT00282308|363747143|FG002|Treatment Period|Adverse Event|0|||
105474168|NCT00282308|363747141|FG000|Treatment Period|Not Treated with Study Drug|1|||
105474169|NCT00282308|363747142|FG001|Treatment Period|Not Treated with Study Drug|0|||
105474170|NCT00282308|363747143|FG002|Treatment Period|Not Treated with Study Drug|0|||
105474171|NCT00282308|363747141|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
105474172|NCT00282308|363747142|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
105474173|NCT00282308|363747143|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
105474174|NCT00282308|363747141|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
105474175|NCT00282308|363747142|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
105474176|NCT00282308|363747143|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
105474177|NCT00282308|363747141|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
105474178|NCT00282308|363747142|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
105474179|NCT00282308|363747143|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
105474180|NCT00282308|363747141|FG000|Safety Follow-up Period|Adverse Event|0|||
105474181|NCT00282308|363747142|FG001|Safety Follow-up Period|Adverse Event|0|||
105474182|NCT00282308|363747143|FG002|Safety Follow-up Period|Adverse Event|1|||
105474183|NCT00282308|363747141|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
105474184|NCT00282308|363747142|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
105474185|NCT00282308|363747143|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
105474186|NCT00282308|363747141|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
105474187|NCT00282308|363747142|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
105474188|NCT00282308|363747143|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
105474189|NCT00282308|363747141|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
105474190|NCT00282308|363747142|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
105474191|NCT00282308|363747143|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
105474192|NCT00530504|363747145|FG000|Overall Study|Death|54|||
105474193|NCT00530504|363747145|FG000|Overall Study|Lost to Follow-up|26|||
105474194|NCT00530504|363747145|FG000|Overall Study|Withdrawal by Subject|39|||
105474195|NCT00530504|363747145|FG000|Overall Study|Exited study due to other reasons|33|||
105474196|NCT00006289|363747146|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
105474197|NCT00006289|363747147|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
105559870|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105559871|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105559872|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105559873|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105559874|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105559875|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105559876|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105559877|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
105559878|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105559879|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105559880|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105559881|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105559882|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105559883|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105559884|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
105559885|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
105559886|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
105559887|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
105559888|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
105559889|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
105559890|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
105559891|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
105559892|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
105559893|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
105559894|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105559895|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105559896|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
105559897|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105559898|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105559899|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105559900|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105559901|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105559902|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105559903|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105559904|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105559905|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
105559906|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105559907|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105559908|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105559909|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105559910|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105559911|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
105559912|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105787234|NCT03110107|364874910|FG021|Treatment Period|Participants no longer meets study criteria|0|||
105559913|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105559914|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
105559915|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105559916|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105559917|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105349276|NCT02907619|363281102|FG000|Overall Study|Death|0|||
105349277|NCT02907619|363281103|FG001|Overall Study|Death|0|||
105349278|NCT02907619|363281104|FG002|Overall Study|Death|1|||
105349279|NCT02907619|363281102|FG000|Overall Study|Withdrawal by Subject|1|||
105349280|NCT02907619|363281103|FG001|Overall Study|Withdrawal by Subject|1|||
105349281|NCT02907619|363281104|FG002|Overall Study|Withdrawal by Subject|0|||
105349282|NCT02907619|363281102|FG000|Overall Study|Other|0|||
105349283|NCT02907619|363281103|FG001|Overall Study|Other|1|||
105349284|NCT02907619|363281104|FG002|Overall Study|Other|0|||
105349285|NCT05916131|363281109|FG000|Overall Study|Lost to Follow-up|0|||
105349286|NCT05916131|363281110|FG001|Overall Study|Lost to Follow-up|0|||
105349287|NCT05916131|363281111|FG002|Overall Study|Lost to Follow-up|1|||
105349288|NCT05916131|363281112|FG003|Overall Study|Lost to Follow-up|0|||
105349289|NCT05619692|363281113|FG000|Overall Study|Adverse Event|2|||
105349290|NCT05619692|363281114|FG001|Overall Study|Adverse Event|2|||
105349291|NCT05619692|363281113|FG000|Overall Study|Withdrawal by Participant|3|||
105349292|NCT05619692|363281114|FG001|Overall Study|Withdrawal by Participant|4|||
105349293|NCT05619692|363281113|FG000|Overall Study|Lost to Follow-up|2|||
105349294|NCT05619692|363281114|FG001|Overall Study|Lost to Follow-up|1|||
105349295|NCT05619692|363281113|FG000|Overall Study|Randomized but not treated|1|||
105349296|NCT05619692|363281114|FG001|Overall Study|Randomized but not treated|3|||
105349297|NCT01492101|363281115|FG000|Overall Study|Death|323|||
105349298|NCT01492101|363281116|FG001|Overall Study|Death|322|||
105349299|NCT01492101|363281115|FG000|Overall Study|Withdrawal by Subject|14|||
105349300|NCT01492101|363281116|FG001|Overall Study|Withdrawal by Subject|18|||
105349301|NCT01492101|363281115|FG000|Overall Study|Lost to Follow-up|0|||
105349302|NCT01492101|363281116|FG001|Overall Study|Lost to Follow-up|2|||
105787235|NCT03110107|364874911|FG022|Treatment Period|Participants no longer meets study criteria|0|||
105349303|NCT01038752|363281117|FG000|Overall Study|Tumor Progression|2|||
105349304|NCT01038752|363281118|FG001|Overall Study|Tumor Progression|2|||
105349305|NCT01038752|363281117|FG000|Overall Study|Lost to Follow-up|3|||
105349306|NCT01038752|363281118|FG001|Overall Study|Lost to Follow-up|3|||
105349307|NCT02309723|363281121|FG000|Overall Study|Withdrawal by Subject|24|||
105349308|NCT02309723|363281122|FG001|Overall Study|Withdrawal by Subject|23|||
105349309|NCT02309723|363281123|FG002|Overall Study|Withdrawal by Subject|24|||
105474198|NCT00006289|363747146|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
105474199|NCT00006289|363747147|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
105474200|NCT04359901|363747148|FG000|Overall Study|Withdrawal by Subject|0|||
105474201|NCT04359901|363747149|FG001|Overall Study|Withdrawal by Subject|1|||
105474202|NCT04359901|363747148|FG000|Overall Study|Death|6|||
105474203|NCT04359901|363747149|FG001|Overall Study|Death|2|||
105474204|NCT02872285|363747150|FG000|Overall Study|Withdrawal by Subject|2|||
105474205|NCT02872285|363747151|FG001|Overall Study|Withdrawal by Subject|0|||
105474206|NCT02872285|363747150|FG000|Overall Study|Lost to Follow-up|2|||
105474207|NCT02872285|363747151|FG001|Overall Study|Lost to Follow-up|2|||
105474208|NCT02872285|363747150|FG000|Overall Study|Discontinued due to back surgery|1|||
105474209|NCT02872285|363747151|FG001|Overall Study|Discontinued due to back surgery|0|||
105474210|NCT02660983|363747152|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
105474211|NCT02660983|363747153|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
105474212|NCT02660983|363747152|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
105474213|NCT02660983|363747153|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
105474214|NCT02660983|363747152|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
105474215|NCT02660983|363747153|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
105474216|NCT02660983|363747152|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
105474217|NCT02660983|363747153|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
105474218|NCT02660983|363747152|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
105474219|NCT02660983|363747153|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
105474220|NCT02660983|363747152|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
105474221|NCT02660983|363747153|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
105474222|NCT02660983|363747152|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
105474223|NCT02660983|363747153|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
105474224|NCT01675167|363747154|FG000|Open-label Titration Phase|Adverse Event|81|||
105474225|NCT01675167|363747155|FG001|Open-label Titration Phase|Adverse Event|0|||
105474226|NCT01675167|363747156|FG002|Open-label Titration Phase|Adverse Event|0|||
105474227|NCT01675167|363747154|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
105474228|NCT01675167|363747155|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
105474229|NCT01675167|363747156|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
105474230|NCT01675167|363747154|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
105474231|NCT01675167|363747155|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
105474232|NCT01675167|363747156|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
105474233|NCT01675167|363747154|FG000|Open-label Titration Phase|Protocol Violation|43|||
105474234|NCT01675167|363747155|FG001|Open-label Titration Phase|Protocol Violation|0|||
105349310|NCT03379792|363281129|FG000|Overall Study|Physician Decision|0|||
105349311|NCT03379792|363281130|FG001|Overall Study|Physician Decision|0|||
105349312|NCT03379792|363281131|FG002|Overall Study|Physician Decision|0|||
105474235|NCT01675167|363747156|FG002|Open-label Titration Phase|Protocol Violation|0|||
105474236|NCT01675167|363747154|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
105474237|NCT01675167|363747155|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
105474238|NCT01675167|363747156|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
105474239|NCT01675167|363747154|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
105474240|NCT01675167|363747155|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
105474241|NCT01675167|363747156|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
105474242|NCT01675167|363747154|FG000|Open-label Titration Phase|Other|55|||
105474243|NCT01675167|363747155|FG001|Open-label Titration Phase|Other|0|||
105474244|NCT01675167|363747156|FG002|Open-label Titration Phase|Other|0|||
105474245|NCT01675167|363747154|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
105474246|NCT01675167|363747155|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
105474247|NCT01675167|363747156|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
105474248|NCT01675167|363747154|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105474249|NCT01675167|363747155|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
105474250|NCT01675167|363747156|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
105474251|NCT01675167|363747154|FG000|Double-blind Treatment Phase|Adverse Event|0|||
105474252|NCT01675167|363747155|FG001|Double-blind Treatment Phase|Adverse Event|5|||
105474253|NCT01675167|363747156|FG002|Double-blind Treatment Phase|Adverse Event|13|||
105474254|NCT01675167|363747154|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
105474255|NCT01675167|363747155|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
105474256|NCT01675167|363747156|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
105474257|NCT01675167|363747154|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
105474258|NCT01675167|363747155|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
105474259|NCT01675167|363747156|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
105474260|NCT01675167|363747154|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
105474261|NCT01675167|363747155|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
105474262|NCT01675167|363747156|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
105474263|NCT01675167|363747154|FG000|Double-blind Treatment Phase|Other|0|||
105474264|NCT01675167|363747155|FG001|Double-blind Treatment Phase|Other|7|||
105474265|NCT01675167|363747156|FG002|Double-blind Treatment Phase|Other|5|||
105474266|NCT01525225|363747162|FG000|Enrollment|No longer met study criteria|1|||
105474267|NCT01525225|363747162|FG000|Enrollment|Other|1|||
105474268|NCT02102204|363748510|FG000|Overall Study|Withdrawal by Subject|137|||
105474269|NCT02102204|363748510|FG000|Overall Study|Death|92|||
105474270|NCT02102204|363748510|FG000|Overall Study|Lost to Follow-up|65|||
105474271|NCT02102204|363748510|FG000|Overall Study|Sponsor Decision|5|||
105474272|NCT02102204|363748510|FG000|Overall Study|Ongoing|5|||
105474273|NCT00295880|363748511|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
105474274|NCT00295880|363748511|FG000|Overall Study|Unit randomization did not occur|1|||
105474275|NCT00122980|363748512|FG000|Overall Study|Death|0|||
105474276|NCT00122980|363748513|FG001|Overall Study|Death|1|||
105474277|NCT00122980|363748512|FG000|Overall Study|Physician Decision|2|||
105474278|NCT00122980|363748513|FG001|Overall Study|Physician Decision|0|||
105474279|NCT00122980|363748512|FG000|Overall Study|Protocol Violation|5|||
105474280|NCT00122980|363748513|FG001|Overall Study|Protocol Violation|1|||
105474281|NCT00122980|363748512|FG000|Overall Study|Withdrawal by Subject|2|||
105474282|NCT00122980|363748513|FG001|Overall Study|Withdrawal by Subject|3|||
105474283|NCT00122980|363748512|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
105474284|NCT00122980|363748513|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
105474285|NCT00122980|363748512|FG000|Overall Study|Study termination|27|||
105474286|NCT00122980|363748513|FG001|Overall Study|Study termination|35|||
105474287|NCT01675544|363748521|FG000|Overall Study|Withdrawal by Subject|2|||
105474288|NCT00476008|363748525|FG000|Overall Study|Adverse Event|4|||
105474289|NCT00476008|363748526|FG001|Overall Study|Adverse Event|4|||
105474290|NCT00476008|363748525|FG000|Overall Study|Placebo concerns|2|||
105474291|NCT00476008|363748526|FG001|Overall Study|Placebo concerns|2|||
105474292|NCT00476008|363748525|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
105474293|NCT00476008|363748526|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
105474294|NCT00476008|363748525|FG000|Overall Study|Withdrawal by Subject|0|||
105474295|NCT00476008|363748526|FG001|Overall Study|Withdrawal by Subject|1|||
105474296|NCT00476008|363748525|FG000|Overall Study|Death|1|||
105474297|NCT00476008|363748526|FG001|Overall Study|Death|0|||
105474298|NCT00724711|363748532|FG000|Overall Study|Adverse Event|7|||
105474299|NCT00724711|363748533|FG001|Overall Study|Adverse Event|3|||
105474300|NCT00724711|363748532|FG000|Overall Study|Pregnancy|0|||
105474301|NCT00724711|363748533|FG001|Overall Study|Pregnancy|1|||
105474302|NCT00724711|363748532|FG000|Overall Study|Lack of Efficacy|0|||
105474303|NCT00724711|363748533|FG001|Overall Study|Lack of Efficacy|1|||
105474304|NCT00724711|363748532|FG000|Overall Study|Physician Decision|0|||
105474305|NCT00724711|363748533|FG001|Overall Study|Physician Decision|3|||
105474306|NCT00724711|363748532|FG000|Overall Study|Withdrawal by Subject|5|||
105474307|NCT00724711|363748533|FG001|Overall Study|Withdrawal by Subject|4|||
105474308|NCT00724711|363748532|FG000|Overall Study|Lost to Follow-up|4|||
105474309|NCT00724711|363748533|FG001|Overall Study|Lost to Follow-up|5|||
105474310|NCT00724711|363748532|FG000|Overall Study|Protocol Violation|1|||
105474311|NCT00724711|363748533|FG001|Overall Study|Protocol Violation|0|||
105474312|NCT05367492|363748535|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
105474313|NCT05367492|363748536|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
105474314|NCT05367492|363748537|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
105474315|NCT05367492|363748535|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
105474316|NCT05367492|363748536|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
105474317|NCT05367492|363748537|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
105474318|NCT05367492|363748535|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
105474319|NCT05367492|363748536|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
105474320|NCT05367492|363748537|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
105474321|NCT05367492|363748535|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
105474322|NCT05367492|363748536|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
105474323|NCT05367492|363748537|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
105474324|NCT01088048|363748538|FG000|Overall Study|Adverse Event|7|||
105474325|NCT01088048|363748539|FG001|Overall Study|Adverse Event|9|||
105474326|NCT01088048|363748540|FG002|Overall Study|Adverse Event|7|||
105474327|NCT01088048|363748541|FG003|Overall Study|Adverse Event|5|||
105474328|NCT01088048|363748542|FG004|Overall Study|Adverse Event|6|||
105474329|NCT01088048|363748543|FG005|Overall Study|Adverse Event|3|||
105474330|NCT01088048|363748544|FG006|Overall Study|Adverse Event|3|||
105474331|NCT01088048|363748545|FG007|Overall Study|Adverse Event|0|||
105474332|NCT01088048|363748546|FG008|Overall Study|Adverse Event|2|||
105474333|NCT01088048|363748547|FG009|Overall Study|Adverse Event|2|||
105474334|NCT01088048|363748538|FG000|Overall Study|Withdrew Consent|1|||
105474335|NCT01088048|363748539|FG001|Overall Study|Withdrew Consent|1|||
105474336|NCT01088048|363748540|FG002|Overall Study|Withdrew Consent|1|||
105474337|NCT01088048|363748541|FG003|Overall Study|Withdrew Consent|1|||
105559918|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105559919|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105559920|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105559921|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105559922|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
105559923|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
105559924|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105559925|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105559926|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105559927|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105559928|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
105559929|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105559930|NCT01212770|364044732|FG000|Long-term Safety Phase (Year 5)|Death|0|||
105559931|NCT01212770|364044733|FG001|Long-term Safety Phase (Year 5)|Death|0|||
105559932|NCT01212770|364044734|FG002|Long-term Safety Phase (Year 5)|Death|0|||
105559933|NCT01212770|364044735|FG003|Long-term Safety Phase (Year 5)|Death|0|||
105559934|NCT01212770|364044736|FG004|Long-term Safety Phase (Year 5)|Death|0|||
105559935|NCT01212770|364044737|FG005|Long-term Safety Phase (Year 5)|Death|0|||
105559936|NCT01212770|364044738|FG006|Long-term Safety Phase (Year 5)|Death|0|||
105559937|NCT01212770|364044739|FG007|Long-term Safety Phase (Year 5)|Death|1|||
105559938|NCT01212770|364044740|FG008|Long-term Safety Phase (Year 5)|Death|0|||
105559939|NCT01667432|364044743|FG000|Overall Study|Premature Study Termination|26|||
105559940|NCT01667432|364044743|FG000|Overall Study|Failure to Return|10|||
105559941|NCT01667432|364044743|FG000|Overall Study|Moved to Another Center|3|||
105559942|NCT01667432|364044743|FG000|Overall Study|Lost to Follow-up|3|||
105559943|NCT01667432|364044743|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
105559944|NCT01667432|364044743|FG000|Overall Study|Insufficient Therapeutic Response|4|||
105559945|NCT01667432|364044743|FG000|Overall Study|Adverse Event|1|||
105559946|NCT01667432|364044743|FG000|Overall Study|Protocol Deviation|2|||
105559947|NCT01667432|364044743|FG000|Overall Study|Principal Investigator Decision|1|||
105699941|NCT04773106|364565056|FG000|Overall Study|Withdrawal by Subject|3|||
105699942|NCT04773106|364565056|FG000|Overall Study|Death|1|||
105699943|NCT02819635|364565057|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
105699944|NCT02819635|364565058|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
105699945|NCT02819635|364565059|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
105699946|NCT02819635|364565060|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
105699947|NCT02819635|364565061|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
105699948|NCT02819635|364565062|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
105559948|NCT01667432|364044743|FG000|Overall Study|Reason Not Specified|2|||
105559949|NCT01667432|364044743|FG000|Overall Study|Missing Information|4|||
105559950|NCT03762473|364044744|FG000|Overall Study|Death|1|||
105699949|NCT02819635|364565063|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
105699950|NCT02819635|364565064|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
105699951|NCT02819635|364565065|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
105699952|NCT02819635|364565066|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
105699953|NCT02819635|364565067|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
105699954|NCT02819635|364565068|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
105699955|NCT02819635|364565057|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699956|NCT02819635|364565058|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699957|NCT02819635|364565059|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699958|NCT02819635|364565060|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699959|NCT02819635|364565061|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
105699960|NCT02819635|364565062|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
105699961|NCT02819635|364565063|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
105699962|NCT02819635|364565064|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699963|NCT02819635|364565065|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699964|NCT02819635|364565066|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699965|NCT02819635|364565067|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699966|NCT02819635|364565068|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699967|NCT02819635|364565057|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699968|NCT02819635|364565058|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699969|NCT02819635|364565059|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699970|NCT02819635|364565060|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699971|NCT02819635|364565061|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699972|NCT02819635|364565062|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
105699973|NCT02819635|364565063|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
105699974|NCT02819635|364565064|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699975|NCT02819635|364565065|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699976|NCT02819635|364565066|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699977|NCT02819635|364565067|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699978|NCT02819635|364565068|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699979|NCT02819635|364565057|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699980|NCT02819635|364565058|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699981|NCT02819635|364565059|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699982|NCT02819635|364565060|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699983|NCT02819635|364565061|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699984|NCT02819635|364565062|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699985|NCT02819635|364565063|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
105349313|NCT03379792|363281132|FG003|Overall Study|Physician Decision|1|||
105474338|NCT01088048|363748542|FG004|Overall Study|Withdrew Consent|2|||
105559951|NCT03762473|364044745|FG001|Overall Study|Death|0|||
105559952|NCT00829387|364044746|FG000|Overall Study|Withdrawal by Subject|2|||
105349314|NCT03379792|363281133|FG004|Overall Study|Physician Decision|0|||
105559953|NCT00829387|364044747|FG001|Overall Study|Withdrawal by Subject|3|||
105559954|NCT00829387|364044746|FG000|Overall Study|Disqualified by PI|1|||
105559955|NCT00829387|364044747|FG001|Overall Study|Disqualified by PI|0|||
105559956|NCT02077166|364044757|FG000|Overall Study|Death|6|||
105559957|NCT02077166|364044758|FG001|Overall Study|Death|7|||
105559958|NCT02077166|364044759|FG002|Overall Study|Death|5|||
105559959|NCT02077166|364044760|FG003|Overall Study|Death|6|||
105559960|NCT02077166|364044761|FG004|Overall Study|Death|4|||
105559961|NCT02077166|364044762|FG005|Overall Study|Death|32|||
105559962|NCT02077166|364044763|FG006|Overall Study|Death|22|||
105559963|NCT02077166|364044757|FG000|Overall Study|Study Closure by Sponsor|3|||
105559964|NCT02077166|364044758|FG001|Overall Study|Study Closure by Sponsor|0|||
105559965|NCT02077166|364044759|FG002|Overall Study|Study Closure by Sponsor|2|||
105559966|NCT02077166|364044760|FG003|Overall Study|Study Closure by Sponsor|2|||
105559967|NCT02077166|364044761|FG004|Overall Study|Study Closure by Sponsor|2|||
105559968|NCT02077166|364044762|FG005|Overall Study|Study Closure by Sponsor|12|||
105559969|NCT02077166|364044763|FG006|Overall Study|Study Closure by Sponsor|4|||
105559970|NCT02077166|364044757|FG000|Overall Study|Lost to Follow-up|0|||
105559971|NCT02077166|364044758|FG001|Overall Study|Lost to Follow-up|0|||
105559972|NCT02077166|364044759|FG002|Overall Study|Lost to Follow-up|0|||
105559973|NCT02077166|364044760|FG003|Overall Study|Lost to Follow-up|0|||
105559974|NCT02077166|364044761|FG004|Overall Study|Lost to Follow-up|0|||
105559975|NCT02077166|364044762|FG005|Overall Study|Lost to Follow-up|1|||
105559976|NCT02077166|364044763|FG006|Overall Study|Lost to Follow-up|0|||
105559977|NCT02077166|364044757|FG000|Overall Study|Withdrawal by Subject|3|||
105559978|NCT02077166|364044758|FG001|Overall Study|Withdrawal by Subject|0|||
105559979|NCT02077166|364044759|FG002|Overall Study|Withdrawal by Subject|1|||
105559980|NCT02077166|364044760|FG003|Overall Study|Withdrawal by Subject|1|||
105559981|NCT02077166|364044761|FG004|Overall Study|Withdrawal by Subject|1|||
105559982|NCT02077166|364044762|FG005|Overall Study|Withdrawal by Subject|3|||
105559983|NCT02077166|364044763|FG006|Overall Study|Withdrawal by Subject|0|||
105559984|NCT02077166|364044757|FG000|Overall Study|Other, Not Specified|0|||
105559985|NCT02077166|364044758|FG001|Overall Study|Other, Not Specified|0|||
105559986|NCT02077166|364044759|FG002|Overall Study|Other, Not Specified|1|||
105559987|NCT02077166|364044760|FG003|Overall Study|Other, Not Specified|0|||
105559988|NCT02077166|364044761|FG004|Overall Study|Other, Not Specified|1|||
105559989|NCT02077166|364044762|FG005|Overall Study|Other, Not Specified|7|||
105559990|NCT02077166|364044763|FG006|Overall Study|Other, Not Specified|8|||
105559991|NCT00707031|364044764|FG000|Overall Study|Adverse Event|45|||
105559992|NCT00707031|364044765|FG001|Overall Study|Adverse Event|45|||
105559993|NCT00707031|364044764|FG000|Overall Study|Lack of Efficacy|19|||
105559994|NCT00707031|364044765|FG001|Overall Study|Lack of Efficacy|6|||
105559995|NCT00707031|364044764|FG000|Overall Study|Lost to Follow-up|2|||
105559996|NCT00707031|364044765|FG001|Overall Study|Lost to Follow-up|1|||
105559997|NCT00707031|364044764|FG000|Overall Study|Protocol Violation|1|||
105559998|NCT00707031|364044765|FG001|Overall Study|Protocol Violation|0|||
105559999|NCT00707031|364044764|FG000|Overall Study|Withdrawal by Subject|7|||
105560000|NCT00707031|364044765|FG001|Overall Study|Withdrawal by Subject|8|||
105349315|NCT03379792|363281134|FG005|Overall Study|Physician Decision|0|||
105349316|NCT03379792|363281129|FG000|Overall Study|Withdrawal by Subject|0|||
105349317|NCT03379792|363281130|FG001|Overall Study|Withdrawal by Subject|0|||
105349318|NCT03379792|363281131|FG002|Overall Study|Withdrawal by Subject|0|||
105349319|NCT03379792|363281132|FG003|Overall Study|Withdrawal by Subject|0|||
105349320|NCT03379792|363281133|FG004|Overall Study|Withdrawal by Subject|1|||
105349321|NCT03379792|363281134|FG005|Overall Study|Withdrawal by Subject|1|||
105349322|NCT01121536|363281135|FG000|Overall Study|Adverse Event|63|||
105349323|NCT01121536|363281135|FG000|Overall Study|Lack of Efficacy|35|||
105349324|NCT01121536|363281135|FG000|Overall Study|Withdrawal by Subject|65|||
105349325|NCT01121536|363281135|FG000|Overall Study|Protocol Violation|20|||
105560001|NCT00707031|364044764|FG000|Overall Study|Poor Compliance to Protocol|7|||
105560002|NCT00707031|364044765|FG001|Overall Study|Poor Compliance to Protocol|13|||
105560003|NCT00707031|364044764|FG000|Overall Study|Familial or Personal Reasons|12|||
105560004|NCT00707031|364044765|FG001|Overall Study|Familial or Personal Reasons|15|||
105560005|NCT00707031|364044764|FG000|Overall Study|Serious Noncompliance|2|||
105787236|NCT03110107|364874912|FG023|Treatment Period|Participants no longer meets study criteria|1|||
105349326|NCT01121536|363281135|FG000|Overall Study|Noncompliance with study medication|12|||
105560006|NCT00707031|364044765|FG001|Overall Study|Serious Noncompliance|3|||
105560007|NCT00707031|364044764|FG000|Overall Study|Sponsor Decision|9|||
105560008|NCT00707031|364044765|FG001|Overall Study|Sponsor Decision|8|||
105560009|NCT00003508|364046503|FG000|Overall Study|Not evaluable|5|||
105560010|NCT01712009|364046504|FG000|Overall Study|Withdrawal by Subject|24|||
105349327|NCT01121536|363281135|FG000|Overall Study|Noncompliance with study procedures|9|||
105560011|NCT01712009|364046505|FG001|Overall Study|Withdrawal by Subject|15|||
105349328|NCT01121536|363281135|FG000|Overall Study|Lost to Follow-up|39|||
105560012|NCT01712009|364046506|FG002|Overall Study|Withdrawal by Subject|8|||
105699986|NCT02819635|364565064|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699987|NCT02819635|364565065|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699988|NCT02819635|364565066|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699989|NCT02819635|364565067|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699990|NCT02819635|364565068|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699991|NCT02819635|364565057|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
105699992|NCT02819635|364565058|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
105699993|NCT02819635|364565059|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
105699994|NCT02819635|364565060|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
105699995|NCT02819635|364565061|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
105699996|NCT02819635|364565062|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
105699997|NCT02819635|364565063|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
105699998|NCT02819635|364565064|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
105699999|NCT02819635|364565065|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
105700000|NCT02819635|364565066|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
105700001|NCT02819635|364565067|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
105700002|NCT02819635|364565068|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
105700003|NCT02819635|364565057|FG000|Substudy 2, Part 2|Adverse Event|0|||
105700004|NCT02819635|364565058|FG001|Substudy 2, Part 2|Adverse Event|0|||
105700005|NCT02819635|364565059|FG002|Substudy 2, Part 2|Adverse Event|0|||
105700006|NCT02819635|364565060|FG003|Substudy 2, Part 2|Adverse Event|0|||
105700007|NCT02819635|364565061|FG004|Substudy 2, Part 2|Adverse Event|0|||
105700008|NCT02819635|364565062|FG005|Substudy 2, Part 2|Adverse Event|4|||
105700009|NCT02819635|364565063|FG006|Substudy 2, Part 2|Adverse Event|0|||
105700010|NCT02819635|364565064|FG007|Substudy 2, Part 2|Adverse Event|0|||
105700011|NCT02819635|364565065|FG008|Substudy 2, Part 2|Adverse Event|0|||
105700012|NCT02819635|364565066|FG009|Substudy 2, Part 2|Adverse Event|0|||
105700013|NCT02819635|364565067|FG010|Substudy 2, Part 2|Adverse Event|0|||
105700014|NCT02819635|364565068|FG011|Substudy 2, Part 2|Adverse Event|0|||
105700015|NCT02819635|364565057|FG000|Substudy 2, Part 2|Withdrew consent|0|||
105700016|NCT02819635|364565058|FG001|Substudy 2, Part 2|Withdrew consent|0|||
105700017|NCT02819635|364565059|FG002|Substudy 2, Part 2|Withdrew consent|0|||
105700018|NCT02819635|364565060|FG003|Substudy 2, Part 2|Withdrew consent|0|||
105700019|NCT02819635|364565061|FG004|Substudy 2, Part 2|Withdrew consent|0|||
105700020|NCT02819635|364565062|FG005|Substudy 2, Part 2|Withdrew consent|3|||
105700021|NCT02819635|364565063|FG006|Substudy 2, Part 2|Withdrew consent|1|||
105700022|NCT02819635|364565064|FG007|Substudy 2, Part 2|Withdrew consent|0|||
105700023|NCT02819635|364565065|FG008|Substudy 2, Part 2|Withdrew consent|0|||
105700024|NCT02819635|364565066|FG009|Substudy 2, Part 2|Withdrew consent|0|||
105700025|NCT02819635|364565067|FG010|Substudy 2, Part 2|Withdrew consent|0|||
105700026|NCT02819635|364565068|FG011|Substudy 2, Part 2|Withdrew consent|0|||
105700027|NCT02819635|364565057|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
105700028|NCT02819635|364565058|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
105700029|NCT02819635|364565059|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
105700030|NCT02819635|364565060|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
105700031|NCT02819635|364565061|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
105700032|NCT02819635|364565062|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
105700033|NCT02819635|364565063|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
105700034|NCT02819635|364565064|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
105700035|NCT02819635|364565065|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
105700036|NCT02819635|364565066|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
105700037|NCT02819635|364565067|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
105700038|NCT02819635|364565068|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
105700039|NCT02819635|364565057|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700040|NCT02819635|364565058|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700041|NCT02819635|364565059|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700042|NCT02819635|364565060|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700043|NCT02819635|364565061|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700044|NCT02819635|364565062|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700045|NCT02819635|364565063|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
105700046|NCT02819635|364565064|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700047|NCT02819635|364565065|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700048|NCT02819635|364565066|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700049|NCT02819635|364565067|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700050|NCT02819635|364565068|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700051|NCT02819635|364565057|FG000|Substudy 2, Part 2|Other, not specified|0|||
105700052|NCT02819635|364565058|FG001|Substudy 2, Part 2|Other, not specified|0|||
105700053|NCT02819635|364565059|FG002|Substudy 2, Part 2|Other, not specified|0|||
105700054|NCT02819635|364565060|FG003|Substudy 2, Part 2|Other, not specified|0|||
105700055|NCT02819635|364565061|FG004|Substudy 2, Part 2|Other, not specified|0|||
105700056|NCT02819635|364565062|FG005|Substudy 2, Part 2|Other, not specified|4|||
105700057|NCT02819635|364565063|FG006|Substudy 2, Part 2|Other, not specified|8|||
105700058|NCT02819635|364565064|FG007|Substudy 2, Part 2|Other, not specified|0|||
105700059|NCT02819635|364565065|FG008|Substudy 2, Part 2|Other, not specified|0|||
105700060|NCT02819635|364565066|FG009|Substudy 2, Part 2|Other, not specified|0|||
105700061|NCT02819635|364565067|FG010|Substudy 2, Part 2|Other, not specified|0|||
105700062|NCT02819635|364565068|FG011|Substudy 2, Part 2|Other, not specified|0|||
105700063|NCT02819635|364565057|FG000|Substudy 3|Adverse Event|0|||
105700064|NCT02819635|364565058|FG001|Substudy 3|Adverse Event|0|||
105700065|NCT02819635|364565059|FG002|Substudy 3|Adverse Event|0|||
105700066|NCT02819635|364565060|FG003|Substudy 3|Adverse Event|0|||
105700067|NCT02819635|364565061|FG004|Substudy 3|Adverse Event|0|||
105700068|NCT02819635|364565062|FG005|Substudy 3|Adverse Event|0|||
105700069|NCT02819635|364565063|FG006|Substudy 3|Adverse Event|0|||
105700070|NCT02819635|364565064|FG007|Substudy 3|Adverse Event|0|||
105700071|NCT02819635|364565065|FG008|Substudy 3|Adverse Event|32|||
105700072|NCT02819635|364565066|FG009|Substudy 3|Adverse Event|3|||
105700073|NCT02819635|364565067|FG010|Substudy 3|Adverse Event|12|||
105700074|NCT02819635|364565068|FG011|Substudy 3|Adverse Event|18|||
105700075|NCT02819635|364565057|FG000|Substudy 3|Withdrew consent|0|||
105700076|NCT02819635|364565058|FG001|Substudy 3|Withdrew consent|0|||
105700077|NCT02819635|364565059|FG002|Substudy 3|Withdrew consent|0|||
105700078|NCT02819635|364565060|FG003|Substudy 3|Withdrew consent|0|||
105700079|NCT02819635|364565061|FG004|Substudy 3|Withdrew consent|0|||
105700080|NCT02819635|364565062|FG005|Substudy 3|Withdrew consent|0|||
105700081|NCT02819635|364565063|FG006|Substudy 3|Withdrew consent|0|||
105700082|NCT02819635|364565064|FG007|Substudy 3|Withdrew consent|0|||
105700083|NCT02819635|364565065|FG008|Substudy 3|Withdrew consent|11|||
105700084|NCT02819635|364565066|FG009|Substudy 3|Withdrew consent|1|||
105700085|NCT02819635|364565067|FG010|Substudy 3|Withdrew consent|4|||
105700086|NCT02819635|364565068|FG011|Substudy 3|Withdrew consent|9|||
105700087|NCT02819635|364565057|FG000|Substudy 3|Lost to Follow-up|0|||
105700088|NCT02819635|364565058|FG001|Substudy 3|Lost to Follow-up|0|||
105700089|NCT02819635|364565059|FG002|Substudy 3|Lost to Follow-up|0|||
105700090|NCT02819635|364565060|FG003|Substudy 3|Lost to Follow-up|0|||
105700091|NCT02819635|364565061|FG004|Substudy 3|Lost to Follow-up|0|||
105474339|NCT01088048|363748543|FG005|Overall Study|Withdrew Consent|1|||
105700092|NCT02819635|364565062|FG005|Substudy 3|Lost to Follow-up|0|||
105700093|NCT02819635|364565063|FG006|Substudy 3|Lost to Follow-up|0|||
105700094|NCT02819635|364565064|FG007|Substudy 3|Lost to Follow-up|0|||
105474340|NCT01088048|363748544|FG006|Overall Study|Withdrew Consent|0|||
105474341|NCT01088048|363748545|FG007|Overall Study|Withdrew Consent|2|||
105700095|NCT02819635|364565065|FG008|Substudy 3|Lost to Follow-up|1|||
105700096|NCT02819635|364565066|FG009|Substudy 3|Lost to Follow-up|0|||
105700097|NCT02819635|364565067|FG010|Substudy 3|Lost to Follow-up|1|||
105700098|NCT02819635|364565068|FG011|Substudy 3|Lost to Follow-up|1|||
105700099|NCT02819635|364565057|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700100|NCT02819635|364565058|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700101|NCT02819635|364565059|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700102|NCT02819635|364565060|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
105474342|NCT01088048|363748546|FG008|Overall Study|Withdrew Consent|2|||
105349329|NCT01121536|363281135|FG000|Overall Study|Other|118|||
105349330|NCT00306787|363281139|FG000|Overall Study|Discontinued without taking study drug|208|||
105349331|NCT00306787|363281140|FG001|Overall Study|Discontinued without taking study drug|215|||
105474343|NCT01088048|363748547|FG009|Overall Study|Withdrew Consent|1|||
105474344|NCT01088048|363748538|FG000|Overall Study|Concomitant Medication Prohibited|1|||
105474345|NCT01088048|363748539|FG001|Overall Study|Concomitant Medication Prohibited|0|||
105474346|NCT01088048|363748540|FG002|Overall Study|Concomitant Medication Prohibited|0|||
105474347|NCT01088048|363748541|FG003|Overall Study|Concomitant Medication Prohibited|0|||
105474348|NCT01088048|363748542|FG004|Overall Study|Concomitant Medication Prohibited|0|||
105474349|NCT01088048|363748543|FG005|Overall Study|Concomitant Medication Prohibited|0|||
105474350|NCT01088048|363748544|FG006|Overall Study|Concomitant Medication Prohibited|0|||
105474351|NCT01088048|363748545|FG007|Overall Study|Concomitant Medication Prohibited|0|||
105474352|NCT01088048|363748546|FG008|Overall Study|Concomitant Medication Prohibited|0|||
105474353|NCT01088048|363748547|FG009|Overall Study|Concomitant Medication Prohibited|0|||
105474354|NCT01088048|363748538|FG000|Overall Study|Investigator Request|2|||
105474355|NCT01088048|363748539|FG001|Overall Study|Investigator Request|2|||
105474356|NCT01088048|363748540|FG002|Overall Study|Investigator Request|0|||
105474357|NCT01088048|363748541|FG003|Overall Study|Investigator Request|0|||
105474358|NCT01088048|363748542|FG004|Overall Study|Investigator Request|3|||
105474359|NCT01088048|363748543|FG005|Overall Study|Investigator Request|1|||
105474360|NCT01088048|363748544|FG006|Overall Study|Investigator Request|1|||
105474361|NCT01088048|363748545|FG007|Overall Study|Investigator Request|0|||
105474362|NCT01088048|363748546|FG008|Overall Study|Investigator Request|0|||
105474363|NCT01088048|363748547|FG009|Overall Study|Investigator Request|0|||
105474364|NCT01088048|363748538|FG000|Overall Study|Patient Non-compliance|0|||
105474365|NCT01088048|363748539|FG001|Overall Study|Patient Non-compliance|1|||
105474366|NCT01088048|363748540|FG002|Overall Study|Patient Non-compliance|0|||
105474367|NCT01088048|363748541|FG003|Overall Study|Patient Non-compliance|0|||
105474368|NCT01088048|363748542|FG004|Overall Study|Patient Non-compliance|0|||
105474369|NCT01088048|363748543|FG005|Overall Study|Patient Non-compliance|0|||
105474370|NCT01088048|363748544|FG006|Overall Study|Patient Non-compliance|0|||
105474371|NCT01088048|363748545|FG007|Overall Study|Patient Non-compliance|0|||
105474372|NCT01088048|363748546|FG008|Overall Study|Patient Non-compliance|0|||
105474373|NCT01088048|363748547|FG009|Overall Study|Patient Non-compliance|0|||
105474374|NCT01088048|363748538|FG000|Overall Study|Disease Progression|7|||
105474375|NCT01088048|363748539|FG001|Overall Study|Disease Progression|4|||
105474376|NCT01088048|363748540|FG002|Overall Study|Disease Progression|3|||
105474377|NCT01088048|363748541|FG003|Overall Study|Disease Progression|5|||
105474378|NCT01088048|363748542|FG004|Overall Study|Disease Progression|3|||
105474379|NCT01088048|363748543|FG005|Overall Study|Disease Progression|3|||
105474380|NCT01088048|363748544|FG006|Overall Study|Disease Progression|2|||
105474381|NCT01088048|363748545|FG007|Overall Study|Disease Progression|1|||
105474382|NCT01088048|363748546|FG008|Overall Study|Disease Progression|0|||
105474383|NCT01088048|363748547|FG009|Overall Study|Disease Progression|0|||
105474384|NCT01088048|363748538|FG000|Overall Study|Death|1|||
105474385|NCT01088048|363748539|FG001|Overall Study|Death|5|||
105474386|NCT01088048|363748540|FG002|Overall Study|Death|3|||
105474387|NCT01088048|363748541|FG003|Overall Study|Death|3|||
105474388|NCT01088048|363748542|FG004|Overall Study|Death|1|||
105474389|NCT01088048|363748543|FG005|Overall Study|Death|3|||
105474390|NCT01088048|363748544|FG006|Overall Study|Death|0|||
105474391|NCT01088048|363748545|FG007|Overall Study|Death|0|||
105474392|NCT01088048|363748546|FG008|Overall Study|Death|3|||
105474393|NCT01088048|363748547|FG009|Overall Study|Death|1|||
105474394|NCT01088048|363748538|FG000|Overall Study|Other|3|||
105474395|NCT01088048|363748539|FG001|Overall Study|Other|5|||
105474396|NCT01088048|363748540|FG002|Overall Study|Other|0|||
105474397|NCT01088048|363748541|FG003|Overall Study|Other|0|||
105474398|NCT01088048|363748542|FG004|Overall Study|Other|2|||
105474399|NCT01088048|363748543|FG005|Overall Study|Other|0|||
105474400|NCT01088048|363748544|FG006|Overall Study|Other|0|||
105474401|NCT01088048|363748545|FG007|Overall Study|Other|2|||
105474402|NCT01088048|363748546|FG008|Overall Study|Other|0|||
105474403|NCT01088048|363748547|FG009|Overall Study|Other|0|||
105474404|NCT01837823|363748550|FG000|Overall Study|Lost to Follow-up|6|||
105474405|NCT01874340|363748551|FG000|Overall Study|Study terminated by Sponsor|6|||
105474406|NCT01874340|363748552|FG001|Overall Study|Study terminated by Sponsor|8|||
105474407|NCT01874340|363748553|FG002|Overall Study|Study terminated by Sponsor|8|||
105474408|NCT01874340|363748554|FG003|Overall Study|Study terminated by Sponsor|4|||
105474409|NCT01874340|363748551|FG000|Overall Study|Withdrawal by Subject|0|||
105474410|NCT01874340|363748552|FG001|Overall Study|Withdrawal by Subject|0|||
105474411|NCT01874340|363748553|FG002|Overall Study|Withdrawal by Subject|0|||
105474412|NCT01874340|363748554|FG003|Overall Study|Withdrawal by Subject|1|||
105474413|NCT00724867|363748557|FG000|Overall Study|Adverse Event|25|||
105474414|NCT00724867|363748557|FG000|Overall Study|Lack of Efficacy|14|||
105474415|NCT00724867|363748557|FG000|Overall Study|Lost to Follow-up|12|||
105474416|NCT00724867|363748557|FG000|Overall Study|Non-compliance with study drug|6|||
105700103|NCT02819635|364565061|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700104|NCT02819635|364565062|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700105|NCT02819635|364565063|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700106|NCT02819635|364565064|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700107|NCT02819635|364565065|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700108|NCT02819635|364565066|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700109|NCT02819635|364565067|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700110|NCT02819635|364565068|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
105700111|NCT02819635|364565057|FG000|Substudy 3|Other, not specified|0|||
105700112|NCT02819635|364565058|FG001|Substudy 3|Other, not specified|0|||
105700113|NCT02819635|364565059|FG002|Substudy 3|Other, not specified|0|||
105700114|NCT02819635|364565060|FG003|Substudy 3|Other, not specified|0|||
105700115|NCT02819635|364565061|FG004|Substudy 3|Other, not specified|0|||
105700116|NCT02819635|364565062|FG005|Substudy 3|Other, not specified|0|||
105700117|NCT02819635|364565063|FG006|Substudy 3|Other, not specified|0|||
105700118|NCT02819635|364565064|FG007|Substudy 3|Other, not specified|0|||
105700119|NCT02819635|364565065|FG008|Substudy 3|Other, not specified|202|||
105700120|NCT02819635|364565066|FG009|Substudy 3|Other, not specified|5|||
105700121|NCT02819635|364565067|FG010|Substudy 3|Other, not specified|89|||
105700122|NCT02819635|364565068|FG011|Substudy 3|Other, not specified|39|||
105700123|NCT02164929|364565073|FG000|Overall Study|Converted to open procedure|1|||
105700124|NCT02164929|364565074|FG001|Overall Study|Converted to open procedure|0|||
105700125|NCT02164929|364565075|FG002|Overall Study|Converted to open procedure|0|||
105700126|NCT02164929|364565076|FG003|Overall Study|Converted to open procedure|2|||
105700127|NCT02164929|364565073|FG000|Overall Study|Failed regional block|0|||
105700128|NCT02164929|364565074|FG001|Overall Study|Failed regional block|0|||
105700129|NCT02164929|364565075|FG002|Overall Study|Failed regional block|1|||
105700130|NCT02164929|364565076|FG003|Overall Study|Failed regional block|0|||
105700131|NCT02969187|364565077|FG000|Overall Study|Physician Decision|12|||
105700132|NCT02969187|364565078|FG001|Overall Study|Physician Decision|13|||
105700133|NCT01486927|364565079|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
105700134|NCT01486927|364565079|FG000|Overall Study|Physician Decision|1|||
105700135|NCT01486927|364565079|FG000|Overall Study|50 Exposure days not reached|2|||
105700136|NCT01486927|364565079|FG000|Overall Study|Withdrawal by Subject|8|||
105700137|NCT01486927|364565079|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
105700138|NCT00365456|364565080|FG000|Trial Period I (12 Months)|Adverse Event|84|||
105700139|NCT00365456|364565081|FG001|Trial Period I (12 Months)|Adverse Event|0|||
105700140|NCT00365456|364565080|FG000|Trial Period I (12 Months)|Non-compliance|3|||
105700141|NCT00365456|364565081|FG001|Trial Period I (12 Months)|Non-compliance|0|||
105700142|NCT00365456|364565080|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
105700143|NCT00365456|364565081|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
105700144|NCT00365456|364565080|FG000|Trial Period I (12 Months)|Other|11|||
105700145|NCT00365456|364565081|FG001|Trial Period I (12 Months)|Other|0|||
105700146|NCT00365456|364565080|FG000|Trial Period II (12 Months)|Adverse Event|0|||
105700147|NCT00365456|364565081|FG001|Trial Period II (12 Months)|Adverse Event|6|||
105700148|NCT00365456|364565080|FG000|Trial Period II (12 Months)|Non-compliance|0|||
105700149|NCT00365456|364565081|FG001|Trial Period II (12 Months)|Non-compliance|2|||
105700150|NCT00365456|364565080|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
105700151|NCT00365456|364565081|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
105700152|NCT00365456|364565080|FG000|Trial Period II (12 Months)|Other|0|||
105700153|NCT00365456|364565081|FG001|Trial Period II (12 Months)|Other|1|||
105700154|NCT00365456|364565080|FG000|Trial Period III (12 Months)|Adverse Event|13|||
105700155|NCT00365456|364565081|FG001|Trial Period III (12 Months)|Adverse Event|3|||
105700156|NCT00365456|364565080|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
105700157|NCT00365456|364565081|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
105700158|NCT00365456|364565080|FG000|Trial Period III (12 Months)|Other|1|||
105700159|NCT00365456|364565081|FG001|Trial Period III (12 Months)|Other|1|||
105700160|NCT03668600|364565082|FG000|Overall Study|Study Terminated by the Sponsor|157|||
105700161|NCT03668600|364565082|FG000|Overall Study|Protocol Violation|1|||
105700162|NCT03668600|364565082|FG000|Overall Study|Pregnancy|1|||
105700163|NCT03668600|364565082|FG000|Overall Study|Lost to Follow-up|7|||
105700164|NCT03668600|364565082|FG000|Overall Study|Withdrawal by Subject|56|||
105700165|NCT03668600|364565082|FG000|Overall Study|Lack of Efficacy|7|||
105700166|NCT03668600|364565082|FG000|Overall Study|Adverse Event|1|||
105700167|NCT02234284|364565084|FG000|Overall Study|Death|4|||
105700168|NCT02234284|364565085|FG001|Overall Study|Death|2|||
105700169|NCT02234284|364565084|FG000|Overall Study|Withdrawal by Subject|1|||
105700170|NCT02234284|364565085|FG001|Overall Study|Withdrawal by Subject|0|||
105700171|NCT02234284|364565084|FG000|Overall Study|Lost to Follow-up|20|||
105700172|NCT02234284|364565085|FG001|Overall Study|Lost to Follow-up|7|||
105700173|NCT01476475|364565086|FG000|Overall Study|Adverse Event|6|||
105700174|NCT01476475|364565087|FG001|Overall Study|Adverse Event|0|||
105700175|NCT01476475|364565086|FG000|Overall Study|Poor compliance to protocol|1|||
105700176|NCT01476475|364565087|FG001|Overall Study|Poor compliance to protocol|1|||
105700177|NCT01476475|364565086|FG000|Overall Study|Other reasons|4|||
105700178|NCT01476475|364565087|FG001|Overall Study|Other reasons|2|||
105474417|NCT00724867|363748557|FG000|Overall Study|Physician Decision|17|||
105700179|NCT02577406|364565088|FG000|Randomized Period|Death|1|||
105700180|NCT02577406|364565089|FG001|Randomized Period|Death|0|||
105700181|NCT02577406|364565088|FG000|Randomized Period|Other reasons|0|||
105700182|NCT02577406|364565089|FG001|Randomized Period|Other reasons|20|||
105700183|NCT02577406|364565088|FG000|Treatment Period|Death|38|||
105700184|NCT02577406|364565089|FG001|Treatment Period|Death|23|||
105700185|NCT02577406|364565088|FG000|Treatment Period|Adverse Event|17|||
105700186|NCT02577406|364565089|FG001|Treatment Period|Adverse Event|12|||
105700187|NCT02577406|364565088|FG000|Treatment Period|Progressive Disease|53|||
105700188|NCT02577406|364565089|FG001|Treatment Period|Progressive Disease|37|||
105700189|NCT02577406|364565088|FG000|Treatment Period|Withdrawal by Subject|10|||
105700190|NCT02577406|364565089|FG001|Treatment Period|Withdrawal by Subject|24|||
105700191|NCT02577406|364565088|FG000|Treatment Period|Lost to Follow-up|0|||
105700192|NCT02577406|364565089|FG001|Treatment Period|Lost to Follow-up|1|||
105700193|NCT02577406|364565088|FG000|Treatment Period|Transition to commercially available treatment|1|||
105700194|NCT02577406|364565089|FG001|Treatment Period|Transition to commercially available treatment|1|||
105700195|NCT02577406|364565088|FG000|Treatment Period|Physician Decision|1|||
105700196|NCT02577406|364565089|FG001|Treatment Period|Physician Decision|0|||
105700197|NCT02577406|364565088|FG000|Treatment Period|Disease Relapse|28|||
105700198|NCT02577406|364565089|FG001|Treatment Period|Disease Relapse|1|||
105700199|NCT02577406|364565088|FG000|Treatment Period|Protocol Violation|0|||
105700200|NCT02577406|364565089|FG001|Treatment Period|Protocol Violation|1|||
105700201|NCT02577406|364565088|FG000|Treatment Period|Other Reasons|3|||
105700202|NCT02577406|364565089|FG001|Treatment Period|Other Reasons|39|||
105700203|NCT02577406|364565088|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
105700204|NCT02577406|364565089|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
105700205|NCT05291689|364565092|FG000|Overall Study|Adverse Event|3|||
105700206|NCT05291689|364565092|FG000|Overall Study|Lack of Efficacy|10|||
105700207|NCT05291689|364565092|FG000|Overall Study|Withdrawal by Subject|4|||
105700208|NCT05500274|364565093|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
105700209|NCT05500274|364565094|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
105700210|NCT05500274|364565093|FG000|Overall Study|Lost to Follow-up|76|||
105700211|NCT05500274|364565094|FG001|Overall Study|Lost to Follow-up|51|||
105700212|NCT01816061|364565097|FG000|Overall Study|Lost to Follow-up|13|||
105700213|NCT01816061|364565098|FG001|Overall Study|Lost to Follow-up|24|||
105700214|NCT01265615|364565099|FG000|Overall Study|Protocol Violation|2|||
105700215|NCT01265615|364565100|FG001|Overall Study|Protocol Violation|2|||
105700216|NCT01265615|364565101|FG002|Overall Study|Protocol Violation|4|||
105700217|NCT01265615|364565102|FG003|Overall Study|Protocol Violation|3|||
105700218|NCT02576444|364565105|FG000|Overall Study|Death|1|||
105700219|NCT02576444|364565106|FG001|Overall Study|Death|1|||
105700220|NCT02576444|364565107|FG002|Overall Study|Death|0|||
105700221|NCT02576444|364565108|FG003|Overall Study|Death|0|||
105700222|NCT02576444|364565105|FG000|Overall Study|Withdrawal by Subject|0|||
105700223|NCT02576444|364565106|FG001|Overall Study|Withdrawal by Subject|0|||
105700224|NCT02576444|364565107|FG002|Overall Study|Withdrawal by Subject|2|||
105700225|NCT02576444|364565108|FG003|Overall Study|Withdrawal by Subject|0|||
105474418|NCT00724867|363748557|FG000|Overall Study|Protocol Violation|1|||
105700226|NCT02576444|364565105|FG000|Overall Study|Adverse Event|0|||
105700227|NCT02576444|364565106|FG001|Overall Study|Adverse Event|0|||
105700228|NCT02576444|364565107|FG002|Overall Study|Adverse Event|1|||
105700229|NCT02576444|364565108|FG003|Overall Study|Adverse Event|0|||
105700230|NCT02576444|364565105|FG000|Overall Study|Physician Decision|0|||
105700231|NCT02576444|364565106|FG001|Overall Study|Physician Decision|0|||
105700232|NCT02576444|364565107|FG002|Overall Study|Physician Decision|1|||
105700233|NCT02576444|364565108|FG003|Overall Study|Physician Decision|0|||
105700234|NCT02953340|364565109|FG000|Overall Study|Death|0|||
105700235|NCT02953340|364565110|FG001|Overall Study|Death|1|||
105700236|NCT02953340|364565109|FG000|Overall Study|Investigator Decision|3|||
105700237|NCT02953340|364565110|FG001|Overall Study|Investigator Decision|3|||
105700238|NCT02953340|364565109|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
105787237|NCT03110107|364874913|FG024|Treatment Period|Participants no longer meets study criteria|0|||
105787238|NCT03110107|364874914|FG025|Treatment Period|Participants no longer meets study criteria|0|||
105787239|NCT03110107|364874889|FG000|Treatment Period|Other Reasons|0|||
105787240|NCT03110107|364874890|FG001|Treatment Period|Other Reasons|0|||
105787241|NCT03110107|364874891|FG002|Treatment Period|Other Reasons|1|||
105787242|NCT03110107|364874892|FG003|Treatment Period|Other Reasons|1|||
105700239|NCT02953340|364565110|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
105700240|NCT02953340|364565109|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
105700241|NCT02953340|364565110|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
105787243|NCT03110107|364874893|FG004|Treatment Period|Other Reasons|0|||
105700242|NCT02953340|364565109|FG000|Overall Study|Withdrawal by Subject|9|||
105787244|NCT03110107|364874894|FG005|Treatment Period|Other Reasons|1|||
105700243|NCT02953340|364565110|FG001|Overall Study|Withdrawal by Subject|9|||
105700244|NCT02953340|364565109|FG000|Overall Study|Sponsor decision|0|||
105700245|NCT02953340|364565110|FG001|Overall Study|Sponsor decision|2|||
105700246|NCT02953340|364565109|FG000|Overall Study|Lost to Follow-up|3|||
105700247|NCT02953340|364565110|FG001|Overall Study|Lost to Follow-up|2|||
105700248|NCT02953340|364565109|FG000|Overall Study|Reason not specified|2|||
105700249|NCT02953340|364565110|FG001|Overall Study|Reason not specified|2|||
105700250|NCT03370120|364565111|FG000|Overall Study|Adverse event, non-fatal|24|||
105700251|NCT03370120|364565111|FG000|Overall Study|Withdrawal by Subject|6|||
105700252|NCT03370120|364565111|FG000|Overall Study|Lost to Follow-up|1|||
105700253|NCT03370120|364565111|FG000|Overall Study|Lack of Efficacy|37|||
105700254|NCT03370120|364565111|FG000|Overall Study|Per sponsor's instructions|1|||
105700255|NCT03370120|364565111|FG000|Overall Study|Study was terminated by parent company UCB|2|||
105700256|NCT03370120|364565111|FG000|Overall Study|The study was ended by the promoter|3|||
105700257|NCT03370120|364565111|FG000|Overall Study|Discontinuation of drug development|3|||
105700258|NCT03370120|364565111|FG000|Overall Study|End of project|2|||
105700259|NCT03370120|364565111|FG000|Overall Study|Premature study closure|2|||
105700260|NCT03370120|364565111|FG000|Overall Study|Premature program termination|1|||
105700261|NCT03370120|364565111|FG000|Overall Study|Premature study termination|7|||
105700262|NCT03370120|364565111|FG000|Overall Study|Trial terminated by sponsor|2|||
105700263|NCT03370120|364565111|FG000|Overall Study|Trial discontinued by sponsor|2|||
105700264|NCT03370120|364565111|FG000|Overall Study|Study ended|15|||
105700265|NCT03370120|364565111|FG000|Overall Study|Clinical trial has been cancelled|1|||
105700266|NCT03370120|364565111|FG000|Overall Study|End of study per sponsor decision|2|||
105700267|NCT03370120|364565111|FG000|Overall Study|Promoter's decision|2|||
105700268|NCT03370120|364565111|FG000|Overall Study|The trial has been suspended|3|||
105700269|NCT03370120|364565111|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
105700270|NCT03370120|364565111|FG000|Overall Study|Early termination by order of sponsor|2|||
105700271|NCT03370120|364565111|FG000|Overall Study|Discontinuation of the study|5|||
105700272|NCT03370120|364565111|FG000|Overall Study|End of clinical trial discontinuation|1|||
105700273|NCT03370120|364565111|FG000|Overall Study|Because the clinical trial ended halfway|4|||
105700274|NCT03370120|364565111|FG000|Overall Study|Development discontinued|5|||
105700275|NCT03370120|364565111|FG000|Overall Study|Padsenovil program closed|3|||
105700276|NCT03370120|364565111|FG000|Overall Study|End of project|2|||
105700277|NCT03370120|364565111|FG000|Overall Study|Termination of project|1|||
105700278|NCT03370120|364565111|FG000|Overall Study|The study was interrupted by sponsor|4|||
105700279|NCT03370120|364565111|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
105700280|NCT03370120|364565111|FG000|Overall Study|End of sponsor decision|1|||
105700281|NCT03370120|364565111|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
105700282|NCT03370120|364565111|FG000|Overall Study|Early termination of studies|5|||
105700283|NCT03370120|364565111|FG000|Overall Study|This study is ended early|1|||
105700284|NCT03370120|364565111|FG000|Overall Study|End of padsevonil program|2|||
105700285|NCT03370120|364565111|FG000|Overall Study|Decision of sponsor|6|||
105700286|NCT03370120|364565111|FG000|Overall Study|Asked by the sponsor|3|||
105700287|NCT03370120|364565111|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
105700288|NCT03370120|364565111|FG000|Overall Study|PI decision poor compliance from participant|1|||
105700289|NCT03370120|364565111|FG000|Overall Study|Promoter ended the study|3|||
105700290|NCT03370120|364565111|FG000|Overall Study|Premature study close by sponsor's decision|4|||
105474419|NCT00724867|363748557|FG000|Overall Study|Withdrawal by Subject|31|||
105474420|NCT00724867|363748557|FG000|Overall Study|Sponsor decision to end study|14|||
105560013|NCT01712009|364046504|FG000|Overall Study|Lost to Follow-up|2|||
105700291|NCT03370120|364565111|FG000|Overall Study|Study terminated by sponsor|33|||
105700292|NCT03370120|364565111|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
105700293|NCT03370120|364565111|FG000|Overall Study|Sponsor decision to terminate study|63|||
105700294|NCT03370120|364565111|FG000|Overall Study|Program closure|3|||
105700295|NCT03370120|364565111|FG000|Overall Study|Study ended prematurely|1|||
105700296|NCT03370120|364565111|FG000|Overall Study|Study stopped by sponsor|2|||
105700297|NCT03370120|364565111|FG000|Overall Study|Program termination|55|||
105700298|NCT03370120|364565111|FG000|Overall Study|Sponsor decision|62|||
105700299|NCT03370120|364565111|FG000|Overall Study|Sponsor study closure|10|||
105700300|NCT00454857|364565112|FG000|Overall Study|Withdrawal by Subject|15|||
105700301|NCT00454857|364565112|FG000|Overall Study|Lost to Follow-up|16|||
105700302|NCT00454857|364565112|FG000|Overall Study|Noncompliance|6|||
105700303|NCT00454857|364565112|FG000|Overall Study|Death|5|||
105700304|NCT00454857|364565112|FG000|Overall Study|Other|11|||
105700305|NCT00454857|364565112|FG000|Overall Study|Reason unknown|1|||
105700306|NCT04206020|364565114|FG000|Overall Study|Adverse Event|1|||
105700307|NCT04206020|364565115|FG001|Overall Study|Adverse Event|4|||
105700308|NCT04206020|364565114|FG000|Overall Study|Protocol Violation|2|||
105700309|NCT04206020|364565115|FG001|Overall Study|Protocol Violation|0|||
105700310|NCT04206020|364565114|FG000|Overall Study|Withdrawal by Subject|2|||
105700311|NCT04206020|364565115|FG001|Overall Study|Withdrawal by Subject|0|||
105700312|NCT04206020|364565114|FG000|Overall Study|Lost to Follow-up|2|||
105700313|NCT04206020|364565115|FG001|Overall Study|Lost to Follow-up|0|||
105700314|NCT04206020|364565114|FG000|Overall Study|Pregnancy|0|||
105700315|NCT04206020|364565115|FG001|Overall Study|Pregnancy|1|||
105700316|NCT04206020|364565114|FG000|Overall Study|Unable to attend visits|1|||
105700317|NCT04206020|364565115|FG001|Overall Study|Unable to attend visits|2|||
105700318|NCT00829179|364565116|FG000|Overall Study|Withdrawal by Subject|1|||
105700319|NCT00928889|364565117|FG000|Overall Study|Lost to Follow-up|3|||
105700320|NCT00928889|364565118|FG001|Overall Study|Lost to Follow-up|1|||
105700321|NCT00928889|364565117|FG000|Overall Study|Protocol Violation|0|||
105700322|NCT00928889|364565118|FG001|Overall Study|Protocol Violation|1|||
105700323|NCT00928889|364565117|FG000|Overall Study|Adverse Event|1|||
105700324|NCT00928889|364565118|FG001|Overall Study|Adverse Event|0|||
105700325|NCT00928889|364565117|FG000|Overall Study|Other|1|||
105700326|NCT00928889|364565118|FG001|Overall Study|Other|0|||
105700327|NCT02700412|364565119|FG000|Overall Study|Adverse Event|6|||
105700328|NCT02700412|364565119|FG000|Overall Study|Death|1|||
105700329|NCT02700412|364565119|FG000|Overall Study|Lack of Efficacy|19|||
105700330|NCT02700412|364565119|FG000|Overall Study|Protocol Violation|5|||
105700331|NCT02700412|364565119|FG000|Overall Study|Withdrawal by Subject|2|||
105700332|NCT04416555|364565120|FG000|Overall Study|Withdrawal by Subject|0|||
105700333|NCT04416555|364565121|FG001|Overall Study|Withdrawal by Subject|3|||
105700334|NCT01517893|364565128|FG000|Overall Study|Withdrawal by Subject|3|||
105700335|NCT01517893|364565129|FG001|Overall Study|Withdrawal by Subject|0|||
105700336|NCT00865904|364565133|FG000|Overall Study|Randomized but not Treated|2|||
105700337|NCT00865904|364565134|FG001|Overall Study|Randomized but not Treated|0|||
105700338|NCT00865904|364565135|FG002|Overall Study|Randomized but not Treated|0|||
105700339|NCT00865904|364565136|FG003|Overall Study|Randomized but not Treated|1|||
105700340|NCT00865904|364565137|FG004|Overall Study|Randomized but not Treated|1|||
105700341|NCT04206605|364565138|FG000|Overall Study|Adverse Event|0|||
105700342|NCT04206605|364565139|FG001|Overall Study|Adverse Event|1|||
105700343|NCT04206605|364565138|FG000|Overall Study|Withdrawal by Subject|1|||
105700344|NCT04206605|364565139|FG001|Overall Study|Withdrawal by Subject|0|||
105700345|NCT00942175|364565141|FG000|Overall Study|Adverse Event|2|||
105700346|NCT00942175|364565142|FG001|Overall Study|Adverse Event|1|||
105700347|NCT00942175|364565143|FG002|Overall Study|Adverse Event|0|||
105700348|NCT00942175|364565144|FG003|Overall Study|Adverse Event|0|||
105700349|NCT00942175|364565141|FG000|Overall Study|Protocol Violation|0|||
105700350|NCT00942175|364565142|FG001|Overall Study|Protocol Violation|1|||
105700351|NCT00942175|364565143|FG002|Overall Study|Protocol Violation|2|||
105700352|NCT00942175|364565144|FG003|Overall Study|Protocol Violation|0|||
105700353|NCT00942175|364565141|FG000|Overall Study|Pregnancy|0|||
105700354|NCT00942175|364565142|FG001|Overall Study|Pregnancy|0|||
105700355|NCT00942175|364565143|FG002|Overall Study|Pregnancy|0|||
105700356|NCT00942175|364565144|FG003|Overall Study|Pregnancy|1|||
105700357|NCT00942175|364565141|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
105700358|NCT00942175|364565142|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
105700359|NCT00942175|364565143|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
105700360|NCT00942175|364565144|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
105700361|NCT00942175|364565141|FG000|Overall Study|Low Platelet Count|0|||
105700362|NCT00942175|364565142|FG001|Overall Study|Low Platelet Count|2|||
105700363|NCT00942175|364565143|FG002|Overall Study|Low Platelet Count|0|||
105700364|NCT00942175|364565144|FG003|Overall Study|Low Platelet Count|0|||
105349332|NCT00306787|363281139|FG000|Overall Study|Adverse Event|1|||
105349333|NCT00306787|363281140|FG001|Overall Study|Adverse Event|1|||
105349334|NCT00306787|363281139|FG000|Overall Study|Lack of Efficacy|1|||
105349335|NCT00306787|363281140|FG001|Overall Study|Lack of Efficacy|0|||
105349336|NCT00306787|363281139|FG000|Overall Study|Protocol Violation|8|||
105349337|NCT00306787|363281140|FG001|Overall Study|Protocol Violation|10|||
105349338|NCT00306787|363281139|FG000|Overall Study|Withdrawal by Subject|2|||
105349339|NCT00306787|363281140|FG001|Overall Study|Withdrawal by Subject|9|||
105349340|NCT00306787|363281139|FG000|Overall Study|Lost to Follow-up|9|||
105349341|NCT00306787|363281140|FG001|Overall Study|Lost to Follow-up|6|||
105349342|NCT00306787|363281139|FG000|Overall Study|Administrative problems|4|||
105349343|NCT00306787|363281140|FG001|Overall Study|Administrative problems|0|||
105349344|NCT00306787|363281139|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105349345|NCT00306787|363281140|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105349346|NCT01438814|363281143|FG000|Overall Study|Adverse Event|3|||
105349347|NCT01438814|363281144|FG001|Overall Study|Adverse Event|3|||
105349348|NCT01438814|363281143|FG000|Overall Study|Protocol Violation|1|||
105349349|NCT01438814|363281144|FG001|Overall Study|Protocol Violation|2|||
105349350|NCT01438814|363281143|FG000|Overall Study|Lost to Follow-up|4|||
105349351|NCT01438814|363281144|FG001|Overall Study|Lost to Follow-up|3|||
105349352|NCT01438814|363281143|FG000|Overall Study|Withdrawal by Subject|4|||
105349353|NCT01438814|363281144|FG001|Overall Study|Withdrawal by Subject|2|||
105349354|NCT01438814|363281143|FG000|Overall Study|Other|2|||
105349355|NCT01438814|363281144|FG001|Overall Study|Other|4|||
105349356|NCT02603107|363281150|FG000|Randomized Phase|Withdrew consent|8|||
105349357|NCT02603107|363281151|FG001|Randomized Phase|Withdrew consent|15|||
105349358|NCT02603107|363281150|FG000|Randomized Phase|Lost to Follow-up|1|||
105349359|NCT02603107|363281151|FG001|Randomized Phase|Lost to Follow-up|3|||
105349360|NCT02603107|363281150|FG000|Randomized Phase|Adverse Event|2|||
105349361|NCT02603107|363281151|FG001|Randomized Phase|Adverse Event|0|||
105349362|NCT02603107|363281150|FG000|Randomized Phase|Death|1|||
105349363|NCT02603107|363281151|FG001|Randomized Phase|Death|1|||
105349364|NCT02603107|363281150|FG000|Randomized Phase|Non-compliance with study drug|1|||
105349365|NCT02603107|363281151|FG001|Randomized Phase|Non-compliance with study drug|1|||
105349366|NCT02603107|363281150|FG000|Randomized Phase|Investigator's discretion|0|||
105349367|NCT02603107|363281151|FG001|Randomized Phase|Investigator's discretion|1|||
105349368|NCT02603107|363281150|FG000|Randomized Phase|Lack of Efficacy|1|||
105349369|NCT02603107|363281151|FG001|Randomized Phase|Lack of Efficacy|0|||
105349370|NCT02603107|363281150|FG000|Randomized Phase|Protocol Violation|1|||
105349371|NCT02603107|363281151|FG001|Randomized Phase|Protocol Violation|0|||
105349372|NCT02603107|363281150|FG000|Optional Extension Phase|Lost to Follow-up|3|||
105349373|NCT02603107|363281151|FG001|Optional Extension Phase|Lost to Follow-up|3|||
105349374|NCT02603107|363281150|FG000|Optional Extension Phase|Withdrew consent|3|||
105349375|NCT02603107|363281151|FG001|Optional Extension Phase|Withdrew consent|2|||
105349376|NCT02603107|363281150|FG000|Optional Extension Phase|Investigator's discretion|2|||
105349377|NCT02603107|363281151|FG001|Optional Extension Phase|Investigator's discretion|2|||
105349378|NCT02603107|363281150|FG000|Optional Extension Phase|Pregnancy|0|||
105349379|NCT02603107|363281151|FG001|Optional Extension Phase|Pregnancy|3|||
105349380|NCT02603107|363281150|FG000|Optional Extension Phase|Adverse Event|0|||
105349381|NCT02603107|363281151|FG001|Optional Extension Phase|Adverse Event|2|||
105349382|NCT02603107|363281150|FG000|Optional Extension Phase|Not treated in extension phase|0|||
105349383|NCT02603107|363281151|FG001|Optional Extension Phase|Not treated in extension phase|1|||
105349384|NCT02603107|363281150|FG000|Optional Extension Phase|Protocol Violation|1|||
105349385|NCT02603107|363281151|FG001|Optional Extension Phase|Protocol Violation|0|||
105349386|NCT00821015|363281152|FG000|Overall Study|Lost to Follow-up|12|||
105349387|NCT01281956|363281153|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
105349388|NCT01281956|363281154|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
105349389|NCT01887678|363281155|FG000|Overall Study|Adverse Event|4|||
105349390|NCT01887678|363281156|FG001|Overall Study|Adverse Event|6|||
105349391|NCT01887678|363281155|FG000|Overall Study|Exceeded rescue medication dosage|4|||
105474421|NCT00724867|363748557|FG000|Overall Study|Subject incarcerated|1|||
105474422|NCT00724867|363748557|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
105349392|NCT01887678|363281156|FG001|Overall Study|Exceeded rescue medication dosage|5|||
105700365|NCT02973087|364565149|FG000|Overall Study|Withdrawal by Subject|2|||
105700366|NCT02973087|364565150|FG001|Overall Study|Withdrawal by Subject|1|||
105700367|NCT02973087|364565149|FG000|Overall Study|Adverse Event|1|||
105700368|NCT02973087|364565150|FG001|Overall Study|Adverse Event|0|||
105700369|NCT02973087|364565149|FG000|Overall Study|other|1|||
105700370|NCT02973087|364565150|FG001|Overall Study|other|1|||
105700371|NCT00450723|364565152|FG000|Overall Study|Physician Decision|5|||
105700372|NCT01473563|364565153|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
105700373|NCT02536313|364565154|FG000|Overall Study|Lack of Efficacy|0|||
105700374|NCT02536313|364565155|FG001|Overall Study|Lack of Efficacy|1|||
105700375|NCT04143009|364565159|FG000|Pilot Trial|Lost to Follow-up|0|||
105700376|NCT04143009|364565160|FG001|Pilot Trial|Lost to Follow-up|1|||
105700377|NCT04143009|364565161|FG002|Pilot Trial|Lost to Follow-up|1|||
105700378|NCT01357655|364565162|FG000|Overall Study|Administrative Reason by Sponsor|45|||
105700379|NCT01357655|364565163|FG001|Overall Study|Administrative Reason by Sponsor|0|||
105700380|NCT01357655|364565162|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
105700381|NCT01357655|364565163|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
105700382|NCT01357655|364565162|FG000|Overall Study|Disease Progression|1|||
105700383|NCT01357655|364565163|FG001|Overall Study|Disease Progression|0|||
105700384|NCT01357655|364565162|FG000|Overall Study|Lost to Follow-up|2|||
105700385|NCT01357655|364565163|FG001|Overall Study|Lost to Follow-up|0|||
105700386|NCT01357655|364565162|FG000|Overall Study|Maximum Clinical Benefit|2|||
105700387|NCT01357655|364565163|FG001|Overall Study|Maximum Clinical Benefit|0|||
105700388|NCT01357655|364565162|FG000|Overall Study|Reason Unspecified|1|||
105700389|NCT01357655|364565163|FG001|Overall Study|Reason Unspecified|0|||
105700390|NCT01357655|364565162|FG000|Overall Study|Study Drug Toxicity|11|||
105700391|NCT01357655|364565163|FG001|Overall Study|Study Drug Toxicity|0|||
105700392|NCT01357655|364565162|FG000|Overall Study|Subject Withdrew Consent|1|||
105700393|NCT01357655|364565163|FG001|Overall Study|Subject Withdrew Consent|0|||
105700394|NCT05003622|364565164|FG000|Overall Study|Progressive disease|2|||
105700395|NCT05003622|364565164|FG000|Overall Study|Withdrawal by Subject|1|||
105700396|NCT04722042|364565169|FG000|Overall Study|Withdrawal by Subject|2|||
105700397|NCT04722042|364565170|FG001|Overall Study|Withdrawal by Subject|1|||
105700398|NCT04722042|364565171|FG002|Overall Study|Withdrawal by Subject|0|||
105700399|NCT01449461|364565174|FG000|Overall Study|Adverse Event|0|||
105700400|NCT01449461|364565175|FG001|Overall Study|Adverse Event|3|||
105700401|NCT01449461|364565176|FG002|Overall Study|Adverse Event|2|||
105700402|NCT01449461|364565177|FG003|Overall Study|Adverse Event|3|||
105700403|NCT01449461|364565178|FG004|Overall Study|Adverse Event|4|||
105700404|NCT01449461|364565179|FG005|Overall Study|Adverse Event|4|||
105700405|NCT01449461|364565174|FG000|Overall Study|Death|0|||
105700406|NCT01449461|364565175|FG001|Overall Study|Death|2|||
105700407|NCT01449461|364565176|FG002|Overall Study|Death|0|||
105700408|NCT01449461|364565177|FG003|Overall Study|Death|0|||
105700409|NCT01449461|364565178|FG004|Overall Study|Death|7|||
105700410|NCT01449461|364565179|FG005|Overall Study|Death|1|||
105700411|NCT01449461|364565174|FG000|Overall Study|Physician Decision|0|||
105700412|NCT01449461|364565175|FG001|Overall Study|Physician Decision|1|||
105700413|NCT01449461|364565176|FG002|Overall Study|Physician Decision|0|||
105560014|NCT01712009|364046505|FG001|Overall Study|Lost to Follow-up|0|||
105700414|NCT01449461|364565177|FG003|Overall Study|Physician Decision|4|||
105700415|NCT01449461|364565178|FG004|Overall Study|Physician Decision|1|||
105700416|NCT01449461|364565179|FG005|Overall Study|Physician Decision|0|||
105700417|NCT01449461|364565174|FG000|Overall Study|Documented Progressive Disease|4|||
105700418|NCT01449461|364565175|FG001|Overall Study|Documented Progressive Disease|7|||
105700419|NCT01449461|364565176|FG002|Overall Study|Documented Progressive Disease|14|||
105700420|NCT01449461|364565177|FG003|Overall Study|Documented Progressive Disease|15|||
105700421|NCT01449461|364565178|FG004|Overall Study|Documented Progressive Disease|24|||
105700422|NCT01449461|364565179|FG005|Overall Study|Documented Progressive Disease|5|||
105700423|NCT01449461|364565174|FG000|Overall Study|Clinical Progressive Disease|2|||
105700424|NCT01449461|364565175|FG001|Overall Study|Clinical Progressive Disease|2|||
105700425|NCT01449461|364565176|FG002|Overall Study|Clinical Progressive Disease|0|||
105700426|NCT01449461|364565177|FG003|Overall Study|Clinical Progressive Disease|3|||
105700427|NCT01449461|364565178|FG004|Overall Study|Clinical Progressive Disease|4|||
105700428|NCT01449461|364565179|FG005|Overall Study|Clinical Progressive Disease|2|||
105700429|NCT01449461|364565174|FG000|Overall Study|Protocol Violation|0|||
105700430|NCT01449461|364565175|FG001|Overall Study|Protocol Violation|0|||
105700431|NCT01449461|364565176|FG002|Overall Study|Protocol Violation|0|||
105700432|NCT01449461|364565177|FG003|Overall Study|Protocol Violation|1|||
105700433|NCT01449461|364565178|FG004|Overall Study|Protocol Violation|0|||
105700434|NCT01449461|364565179|FG005|Overall Study|Protocol Violation|0|||
105700435|NCT01449461|364565174|FG000|Overall Study|Site Terminated by Sponsor|0|||
105700436|NCT01449461|364565175|FG001|Overall Study|Site Terminated by Sponsor|1|||
105700437|NCT01449461|364565176|FG002|Overall Study|Site Terminated by Sponsor|2|||
105700438|NCT01449461|364565177|FG003|Overall Study|Site Terminated by Sponsor|3|||
105700439|NCT01449461|364565178|FG004|Overall Study|Site Terminated by Sponsor|4|||
105700440|NCT01449461|364565179|FG005|Overall Study|Site Terminated by Sponsor|1|||
105700441|NCT01449461|364565174|FG000|Overall Study|Withdrawal by Subject|0|||
105700442|NCT01449461|364565175|FG001|Overall Study|Withdrawal by Subject|1|||
105700443|NCT01449461|364565176|FG002|Overall Study|Withdrawal by Subject|0|||
105700444|NCT01449461|364565177|FG003|Overall Study|Withdrawal by Subject|0|||
105700445|NCT01449461|364565178|FG004|Overall Study|Withdrawal by Subject|2|||
105700446|NCT01449461|364565179|FG005|Overall Study|Withdrawal by Subject|1|||
105700447|NCT01449461|364565174|FG000|Overall Study|Reason not Specified|0|||
105700448|NCT01449461|364565175|FG001|Overall Study|Reason not Specified|1|||
105700449|NCT01449461|364565176|FG002|Overall Study|Reason not Specified|0|||
105700450|NCT01449461|364565177|FG003|Overall Study|Reason not Specified|3|||
105700451|NCT01449461|364565178|FG004|Overall Study|Reason not Specified|2|||
105700452|NCT01449461|364565179|FG005|Overall Study|Reason not Specified|1|||
105700453|NCT00853749|364565184|FG000|Overall Study|Lost to Follow-up|0|||
105700454|NCT00853749|364565185|FG001|Overall Study|Lost to Follow-up|1|||
105700455|NCT04857996|364565186|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
105700456|NCT04857996|364565187|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
105700457|NCT04857996|364565186|FG000|Overall Study|Lost to Follow-up|1|||
105700458|NCT04857996|364565187|FG001|Overall Study|Lost to Follow-up|3|||
105787245|NCT03110107|364874895|FG006|Treatment Period|Other Reasons|0|||
105787246|NCT03110107|364874896|FG007|Treatment Period|Other Reasons|0|||
105787247|NCT03110107|364874897|FG008|Treatment Period|Other Reasons|0|||
105787248|NCT03110107|364874898|FG009|Treatment Period|Other Reasons|0|||
105787249|NCT03110107|364874899|FG010|Treatment Period|Other Reasons|0|||
105787250|NCT03110107|364874900|FG011|Treatment Period|Other Reasons|0|||
105349393|NCT01887678|363281155|FG000|Overall Study|Withdrawal of consent|3|||
105474423|NCT00724867|363748557|FG000|Overall Study|Subject moved out of state|1|||
105700459|NCT04857996|364565186|FG000|Overall Study|Site Closure|1|||
105700460|NCT04857996|364565187|FG001|Overall Study|Site Closure|0|||
105700461|NCT04857996|364565186|FG000|Overall Study|Withdrawal by Subject|1|||
105700462|NCT04857996|364565187|FG001|Overall Study|Withdrawal by Subject|0|||
105787251|NCT03110107|364874901|FG012|Treatment Period|Other Reasons|0|||
105560015|NCT01712009|364046506|FG002|Overall Study|Lost to Follow-up|1|||
105560016|NCT01712009|364046504|FG000|Overall Study|Decision by Sponsor|12|||
105560017|NCT01712009|364046505|FG001|Overall Study|Decision by Sponsor|14|||
105560018|NCT01712009|364046506|FG002|Overall Study|Decision by Sponsor|12|||
105560019|NCT02160314|364046507|FG000|Overall Study|Adverse Event|0|||
105560020|NCT02160314|364046508|FG001|Overall Study|Adverse Event|6|||
105560021|NCT02160314|364046507|FG000|Overall Study|Protocol Violation|0|||
105560022|NCT02160314|364046508|FG001|Overall Study|Protocol Violation|4|||
105560023|NCT02160314|364046507|FG000|Overall Study|Withdrawal by Subject|1|||
105560024|NCT02160314|364046508|FG001|Overall Study|Withdrawal by Subject|2|||
105560025|NCT02160314|364046507|FG000|Overall Study|Lost to Follow-up|0|||
105560026|NCT02160314|364046508|FG001|Overall Study|Lost to Follow-up|1|||
105560027|NCT01986881|364046509|FG000|Overall Study|Death|228|||
105560028|NCT01986881|364046510|FG001|Overall Study|Death|233|||
105560029|NCT01986881|364046511|FG002|Overall Study|Death|247|||
105560030|NCT01986881|364046509|FG000|Overall Study|Lost to Follow-up|51|||
105560031|NCT01986881|364046510|FG001|Overall Study|Lost to Follow-up|44|||
105560032|NCT01986881|364046511|FG002|Overall Study|Lost to Follow-up|55|||
105560033|NCT01986881|364046509|FG000|Overall Study|Physician Decision|7|||
105560034|NCT01986881|364046510|FG001|Overall Study|Physician Decision|4|||
105560035|NCT01986881|364046511|FG002|Overall Study|Physician Decision|6|||
105560036|NCT01986881|364046509|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
105560037|NCT01986881|364046510|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
105560038|NCT01986881|364046511|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
105560039|NCT01986881|364046509|FG000|Overall Study|Withdrawal by Subject|41|||
105700463|NCT02269787|364565188|FG000|Overall Study|Lost to Follow-up|20|||
105700464|NCT02269787|364565189|FG001|Overall Study|Lost to Follow-up|6|||
105700465|NCT02269787|364565188|FG000|Overall Study|Death|2|||
105700466|NCT02269787|364565189|FG001|Overall Study|Death|3|||
105700467|NCT02269787|364565188|FG000|Overall Study|Incapacitated|0|||
105700468|NCT02269787|364565189|FG001|Overall Study|Incapacitated|1|||
105560040|NCT01986881|364046510|FG001|Overall Study|Withdrawal by Subject|60|||
105560041|NCT01986881|364046511|FG002|Overall Study|Withdrawal by Subject|45|||
105560042|NCT01986881|364046509|FG000|Overall Study|Subject Moved|0|||
105560043|NCT01986881|364046510|FG001|Overall Study|Subject Moved|1|||
105560044|NCT01986881|364046511|FG002|Overall Study|Subject Moved|0|||
105560045|NCT01986881|364046509|FG000|Overall Study|Other|1|||
105560046|NCT01986881|364046510|FG001|Overall Study|Other|2|||
105560047|NCT01986881|364046511|FG002|Overall Study|Other|2|||
105560048|NCT00844857|364046512|FG000|Overall Study|Adverse Event|24|||
105560049|NCT00844857|364046513|FG001|Overall Study|Adverse Event|5|||
105700469|NCT00470054|364565190|FG000|Overall Study|Ineligible|1|||
105700470|NCT00840086|364566664|FG000|Overall Study|Adverse Event|1|||
105700471|NCT00840086|364566664|FG000|Overall Study|Protocol Violation|2|||
105700472|NCT00840086|364566664|FG000|Overall Study|Lost to Follow-up|1|||
105700473|NCT02236520|364566666|FG000|Overall Study|Physician Decision|0|||
105700474|NCT02236520|364566667|FG001|Overall Study|Physician Decision|5|||
105700475|NCT02236520|364566668|FG002|Overall Study|Physician Decision|0|||
105700476|NCT02236520|364566669|FG003|Overall Study|Physician Decision|0|||
105700477|NCT02236520|364566666|FG000|Overall Study|Withdrawal by Subject|1|||
105700478|NCT02236520|364566667|FG001|Overall Study|Withdrawal by Subject|0|||
105700479|NCT02236520|364566668|FG002|Overall Study|Withdrawal by Subject|0|||
105700480|NCT02236520|364566669|FG003|Overall Study|Withdrawal by Subject|1|||
105700481|NCT02236520|364566666|FG000|Overall Study|Pregnancy|1|||
105700482|NCT02236520|364566667|FG001|Overall Study|Pregnancy|0|||
105700483|NCT02236520|364566668|FG002|Overall Study|Pregnancy|0|||
105700484|NCT02236520|364566669|FG003|Overall Study|Pregnancy|0|||
105700485|NCT01785160|364566670|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
105700486|NCT01785160|364566670|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
105700487|NCT02081534|364566671|FG000|Overall Study|Adverse Event|5|||
105700488|NCT02081534|364566672|FG001|Overall Study|Adverse Event|4|||
105700489|NCT02081534|364566673|FG002|Overall Study|Adverse Event|3|||
105700490|NCT02081534|364566674|FG003|Overall Study|Adverse Event|10|||
105700491|NCT02081534|364566675|FG004|Overall Study|Adverse Event|2|||
105700492|NCT02081534|364566676|FG005|Overall Study|Adverse Event|8|||
105700493|NCT02081534|364566677|FG006|Overall Study|Adverse Event|2|||
105700494|NCT02081534|364566671|FG000|Overall Study|Withdrawal by Subject|0|||
105700495|NCT02081534|364566672|FG001|Overall Study|Withdrawal by Subject|1|||
105700496|NCT02081534|364566673|FG002|Overall Study|Withdrawal by Subject|1|||
105700497|NCT02081534|364566674|FG003|Overall Study|Withdrawal by Subject|1|||
105700498|NCT02081534|364566675|FG004|Overall Study|Withdrawal by Subject|1|||
105700499|NCT02081534|364566676|FG005|Overall Study|Withdrawal by Subject|0|||
105700500|NCT02081534|364566677|FG006|Overall Study|Withdrawal by Subject|1|||
105700501|NCT02081534|364566671|FG000|Overall Study|Protocol Violation|0|||
105700502|NCT02081534|364566672|FG001|Overall Study|Protocol Violation|3|||
105700503|NCT02081534|364566673|FG002|Overall Study|Protocol Violation|0|||
105700504|NCT02081534|364566674|FG003|Overall Study|Protocol Violation|0|||
105700505|NCT02081534|364566675|FG004|Overall Study|Protocol Violation|0|||
105700506|NCT02081534|364566676|FG005|Overall Study|Protocol Violation|0|||
105700507|NCT02081534|364566677|FG006|Overall Study|Protocol Violation|1|||
105700508|NCT02081534|364566671|FG000|Overall Study|Lost to Follow-up|0|||
105700509|NCT02081534|364566672|FG001|Overall Study|Lost to Follow-up|0|||
105700510|NCT02081534|364566673|FG002|Overall Study|Lost to Follow-up|0|||
105700511|NCT02081534|364566674|FG003|Overall Study|Lost to Follow-up|2|||
105700512|NCT02081534|364566675|FG004|Overall Study|Lost to Follow-up|1|||
105700513|NCT02081534|364566676|FG005|Overall Study|Lost to Follow-up|1|||
105349394|NCT01887678|363281156|FG001|Overall Study|Withdrawal of consent|4|||
105349395|NCT01887678|363281155|FG000|Overall Study|Lost to Follow-up|4|||
105349396|NCT01887678|363281156|FG001|Overall Study|Lost to Follow-up|2|||
105349397|NCT01887678|363281155|FG000|Overall Study|Deterioration of clinical condition|0|||
105349398|NCT01887678|363281156|FG001|Overall Study|Deterioration of clinical condition|4|||
105349399|NCT01887678|363281155|FG000|Overall Study|Lack of Efficacy|1|||
105349400|NCT01887678|363281156|FG001|Overall Study|Lack of Efficacy|2|||
105349401|NCT01887678|363281155|FG000|Overall Study|Non-compliance|0|||
105349402|NCT01887678|363281156|FG001|Overall Study|Non-compliance|3|||
105349403|NCT01887678|363281155|FG000|Overall Study|Specified|1|||
105349404|NCT01887678|363281156|FG001|Overall Study|Specified|2|||
105349405|NCT01490697|363281160|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
105349406|NCT01490697|363281161|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
105349407|NCT00270231|363281164|FG000|First Intervention|Lost to Follow-up|1|||
105349408|NCT00270231|363281165|FG001|First Intervention|Lost to Follow-up|1|||
105349409|NCT00270231|363281164|FG000|Washout Period|Lost to Follow-up|1|||
105349410|NCT00270231|363281165|FG001|Washout Period|Lost to Follow-up|0|||
105349411|NCT00270231|363281164|FG000|Second Intervention|Lost to Follow-up|0|||
105349412|NCT00270231|363281165|FG001|Second Intervention|Lost to Follow-up|1|||
105700514|NCT02081534|364566677|FG006|Overall Study|Lost to Follow-up|0|||
105349413|NCT02638259|363281173|FG000|Treatment Period 1|Adverse Event|1|||
105349414|NCT02638259|363281174|FG001|Treatment Period 1|Adverse Event|5|||
105349415|NCT02638259|363281173|FG000|Treatment Period 1|Death|0|||
105349416|NCT02638259|363281174|FG001|Treatment Period 1|Death|1|||
105349417|NCT02638259|363281173|FG000|Treatment Period 1|Lack of Efficacy|0|||
105349418|NCT02638259|363281174|FG001|Treatment Period 1|Lack of Efficacy|1|||
105700515|NCT00762892|364566678|FG000|Overall Study|Lost to Follow-up|2|||
105700516|NCT00762892|364566679|FG001|Overall Study|Lost to Follow-up|5|||
105700517|NCT00762892|364566678|FG000|Overall Study|Withdrawal by Subject|0|||
105700518|NCT00762892|364566679|FG001|Overall Study|Withdrawal by Subject|1|||
105700519|NCT00762892|364566678|FG000|Overall Study|Death|1|||
105700520|NCT00762892|364566679|FG001|Overall Study|Death|0|||
105700521|NCT00762892|364566678|FG000|Overall Study|Pregnancy|1|||
105700522|NCT00762892|364566679|FG001|Overall Study|Pregnancy|0|||
105700523|NCT00762892|364566678|FG000|Overall Study|Incarceration|1|||
105700524|NCT00762892|364566679|FG001|Overall Study|Incarceration|0|||
105700525|NCT04640272|364566680|FG000|Overall Study|Subject moved out of area|1|||
105700526|NCT00880399|364566681|FG000|Overall Study|Adverse Event|4|||
105700527|NCT00880399|364566682|FG001|Overall Study|Adverse Event|6|||
105700528|NCT00880399|364566683|FG002|Overall Study|Adverse Event|5|||
105700529|NCT00880399|364566681|FG000|Overall Study|Lack of Efficacy|1|||
105700530|NCT00880399|364566682|FG001|Overall Study|Lack of Efficacy|4|||
105700531|NCT00880399|364566683|FG002|Overall Study|Lack of Efficacy|2|||
105700532|NCT00880399|364566681|FG000|Overall Study|Protocol Violation|4|||
105700533|NCT00880399|364566682|FG001|Overall Study|Protocol Violation|4|||
105700534|NCT00880399|364566683|FG002|Overall Study|Protocol Violation|6|||
105700535|NCT00880399|364566681|FG000|Overall Study|Study closed/terminated|3|||
105700536|NCT00880399|364566682|FG001|Overall Study|Study closed/terminated|7|||
105700537|NCT00880399|364566683|FG002|Overall Study|Study closed/terminated|4|||
105700538|NCT00880399|364566681|FG000|Overall Study|Lost to Follow-up|8|||
105700539|NCT00880399|364566682|FG001|Overall Study|Lost to Follow-up|5|||
105700540|NCT00880399|364566683|FG002|Overall Study|Lost to Follow-up|3|||
105700541|NCT00880399|364566681|FG000|Overall Study|Physician Decision|5|||
105700542|NCT00880399|364566682|FG001|Overall Study|Physician Decision|0|||
105700543|NCT00880399|364566683|FG002|Overall Study|Physician Decision|3|||
105700544|NCT00880399|364566681|FG000|Overall Study|Withdrawal by Subject|6|||
105700545|NCT00880399|364566682|FG001|Overall Study|Withdrawal by Subject|3|||
105700546|NCT00880399|364566683|FG002|Overall Study|Withdrawal by Subject|3|||
105700547|NCT02181816|364566684|FG000|Overall Study|Case Report Forms Uncollected|38|||
105700548|NCT02181816|364566684|FG000|Overall Study|Protocol Deviation|21|||
105700549|NCT00294060|364566687|FG000|Overall Study|Death|225|||
105700550|NCT00294060|364566687|FG000|Overall Study|Other|59|||
105700551|NCT00294060|364566687|FG000|Overall Study|Lost to Follow-up|55|||
105700552|NCT00294060|364566687|FG000|Overall Study|Withdrawal by Subject|11|||
105700553|NCT00294060|364566687|FG000|Overall Study|Physician Decision|797|||
105700554|NCT00294060|364566687|FG000|Overall Study|Medical condition|3|||
105700555|NCT00294060|364566687|FG000|Overall Study|Device explanted/not replaced|23|||
105700556|NCT02349048|364566689|FG000|Overall Study|Withdrawal by Subject|4|||
105700557|NCT02349048|364566690|FG001|Overall Study|Withdrawal by Subject|0|||
105700558|NCT02349048|364566689|FG000|Overall Study|Lost to Follow-up|1|||
105700559|NCT02349048|364566690|FG001|Overall Study|Lost to Follow-up|0|||
105700560|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
105700561|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
105700562|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
105700563|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
105700564|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
105700565|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
105700566|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
105700567|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
105700568|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
105700569|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
105700570|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
105700571|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
105700572|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
105700573|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
105700574|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
105700575|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
105700576|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
105700577|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
105349419|NCT02638259|363281173|FG000|Treatment Period 1|Protocol Violation|0|||
105349420|NCT02638259|363281174|FG001|Treatment Period 1|Protocol Violation|3|||
105349421|NCT02638259|363281173|FG000|Treatment Period 1|Withdrawal by Subject|4|||
105349422|NCT02638259|363281174|FG001|Treatment Period 1|Withdrawal by Subject|6|||
105349423|NCT02638259|363281173|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
105474424|NCT00724867|363748557|FG000|Overall Study|Elected to exit due to site closure|2|||
105474425|NCT02881567|363748560|FG000|Overall Study|Adverse Event|1|||
105700578|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
105700579|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
105700580|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
105700581|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
105700582|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
105474426|NCT02881567|363748560|FG000|Overall Study|Lost to Follow-up|3|||
105700583|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
105700584|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
105700585|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
105700586|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
105700587|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
105700588|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
105700589|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
105700590|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
105700591|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
105700592|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
105700593|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
105700594|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
105700595|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
105700596|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
105700597|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
105700598|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
105700599|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
105700600|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
105700601|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
105700602|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
105700603|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
105560050|NCT00844857|364046512|FG000|Overall Study|Sponsor Decision|1|||
105700604|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
105700605|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
105700606|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
105700607|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
105700608|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
105700609|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
105700610|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
105700611|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
105700612|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
105700613|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
105700614|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
105700615|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
105349424|NCT02638259|363281174|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
105349425|NCT02638259|363281173|FG000|Treatment Period 2|Adverse Event|5|||
105349426|NCT02638259|363281174|FG001|Treatment Period 2|Adverse Event|4|||
105349427|NCT02638259|363281173|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105349428|NCT02638259|363281174|FG001|Treatment Period 2|Withdrawal by Subject|7|||
105349429|NCT02069093|363281179|FG000|Overall Study|Disease progression|14|||
105349430|NCT02069093|363281179|FG000|Overall Study|New cancer therapy|1|||
105349431|NCT02069093|363281179|FG000|Overall Study|Death|1|||
105349432|NCT02069093|363281179|FG000|Overall Study|Administrative problems|1|||
105349433|NCT02069093|363281179|FG000|Overall Study|Withdrawal by Subject|2|||
105349434|NCT02069093|363281179|FG000|Overall Study|Abnormal laboratory values|1|||
105700616|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
105700617|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
105700618|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
105700619|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
105700620|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
105700621|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
105700622|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
105700623|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
105700624|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
105700625|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
105700626|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
105700627|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
105700628|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
105700629|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
105560051|NCT00844857|364046513|FG001|Overall Study|Sponsor Decision|1|||
105700630|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
105700631|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
105700632|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
105700633|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
105700634|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
105700635|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
105700636|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
105700637|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
105700638|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
105700639|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
105700640|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
105700641|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
105700642|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
105700643|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
105700644|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
105700645|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
105700646|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
105700647|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
105700648|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
105700649|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
105700650|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
105700651|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
105560052|NCT00844857|364046512|FG000|Overall Study|Physician Decision|2|||
105560053|NCT00844857|364046513|FG001|Overall Study|Physician Decision|0|||
105700652|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
105700653|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
105700654|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
105349435|NCT02069093|363281179|FG000|Overall Study|Adverse Event|10|||
105349436|NCT00862459|363281180|FG000|Overall Study|Lost to Follow-up|1|||
105349437|NCT00862459|363281181|FG001|Overall Study|Lost to Follow-up|2|||
105349438|NCT00862459|363281182|FG002|Overall Study|Lost to Follow-up|2|||
105349439|NCT00862459|363281180|FG000|Overall Study|Protocol Violation|1|||
105700655|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
105700656|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
105700657|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
105700658|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
105700659|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
105700660|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
105700661|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
105700662|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
105700663|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
105700664|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
105700665|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
105700666|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
105700667|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
105700668|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
105700669|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
105700670|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
105700671|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
105700672|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
105700673|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
105700674|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
105700675|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
105700676|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
105700677|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
105700678|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
105700679|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
105700680|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
105349440|NCT00862459|363281181|FG001|Overall Study|Protocol Violation|0|||
105349441|NCT00862459|363281182|FG002|Overall Study|Protocol Violation|0|||
105349442|NCT00862459|363281180|FG000|Overall Study|Withdrawal by Subject|1|||
105349443|NCT00862459|363281181|FG001|Overall Study|Withdrawal by Subject|1|||
105349444|NCT00862459|363281182|FG002|Overall Study|Withdrawal by Subject|3|||
105349445|NCT00862459|363281180|FG000|Overall Study|Adverse Event|0|||
105349446|NCT00862459|363281181|FG001|Overall Study|Adverse Event|1|||
105349447|NCT00862459|363281182|FG002|Overall Study|Adverse Event|0|||
105349448|NCT00862459|363281180|FG000|Overall Study|Personal reasons|1|||
105349449|NCT00862459|363281181|FG001|Overall Study|Personal reasons|0|||
105349450|NCT00862459|363281182|FG002|Overall Study|Personal reasons|0|||
105349451|NCT00862459|363281180|FG000|Overall Study|Operation|1|||
105700681|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
105700682|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
105700683|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
105700684|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
105700685|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
105700686|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
105700687|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
105700688|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
105700689|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
105787252|NCT03110107|364874902|FG013|Treatment Period|Other Reasons|0|||
105787253|NCT03110107|364874903|FG014|Treatment Period|Other Reasons|0|||
105349452|NCT00862459|363281181|FG001|Overall Study|Operation|1|||
105349453|NCT00862459|363281182|FG002|Overall Study|Operation|0|||
105349454|NCT00862459|363281180|FG000|Overall Study|Intravenous (IV) site problems|1|||
105349455|NCT00862459|363281181|FG001|Overall Study|Intravenous (IV) site problems|0|||
105349456|NCT00862459|363281182|FG002|Overall Study|Intravenous (IV) site problems|1|||
105349457|NCT00862459|363281180|FG000|Overall Study|Unable to hold still for imaging|0|||
105349458|NCT00862459|363281181|FG001|Overall Study|Unable to hold still for imaging|1|||
105349459|NCT00862459|363281182|FG002|Overall Study|Unable to hold still for imaging|0|||
105349460|NCT00862459|363281180|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
105349461|NCT00862459|363281181|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
105474427|NCT02881567|363748560|FG000|Overall Study|Consent withdrawn|1|||
105700690|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
105700691|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
105700692|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
105700693|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
105700694|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
105700695|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
105787254|NCT03110107|364874904|FG015|Treatment Period|Other Reasons|0|||
105787255|NCT03110107|364874905|FG016|Treatment Period|Other Reasons|0|||
105787256|NCT03110107|364874906|FG017|Treatment Period|Other Reasons|0|||
105787257|NCT03110107|364874907|FG018|Treatment Period|Other Reasons|0|||
105787258|NCT03110107|364874908|FG019|Treatment Period|Other Reasons|0|||
105787259|NCT03110107|364874909|FG020|Treatment Period|Other Reasons|0|||
105787260|NCT03110107|364874910|FG021|Treatment Period|Other Reasons|0|||
105787261|NCT03110107|364874911|FG022|Treatment Period|Other Reasons|0|||
105787262|NCT03110107|364874912|FG023|Treatment Period|Other Reasons|0|||
105787263|NCT03110107|364874913|FG024|Treatment Period|Other Reasons|1|||
105787264|NCT03110107|364874914|FG025|Treatment Period|Other Reasons|0|||
105787265|NCT02652793|364874915|FG000|Overall Study|Adverse Event|1|||
105787266|NCT02652793|364874915|FG000|Overall Study|Lost to Follow-up|2|||
105349462|NCT00862459|363281182|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
105787267|NCT02652793|364874915|FG000|Overall Study|Withdrawal by Subject|1|||
105349463|NCT00862459|363281180|FG000|Overall Study|Administrative problems|0|||
105787268|NCT03985982|364874916|FG000|Double-Blind Phase|Lost to Follow-up|4|||
105787269|NCT03985982|364874917|FG001|Double-Blind Phase|Lost to Follow-up|3|||
105474428|NCT02881567|363748560|FG000|Overall Study|Investigator decision|1|||
105349464|NCT00862459|363281181|FG001|Overall Study|Administrative problems|1|||
105474429|NCT02881567|363748560|FG000|Overall Study|Study terminated by sponsor|9|||
105474430|NCT02881567|363748560|FG000|Overall Study|Reason not Specified|3|||
105474431|NCT02864862|363748561|FG000|Overall Study|Lost to Follow-up|1|||
105349465|NCT00862459|363281182|FG002|Overall Study|Administrative problems|0|||
105349466|NCT02906033|363281183|FG000|Baseline|Protocol Violation|37|||
105349467|NCT02906033|363281184|FG001|Baseline|Protocol Violation|33|||
105349468|NCT02906033|363281183|FG000|Follow-up|Lost to Follow-up|46|||
105349469|NCT02906033|363281184|FG001|Follow-up|Lost to Follow-up|62|||
105349470|NCT02240069|363281193|FG000|Overall Study|Withdrawal by Subject|5|||
105349471|NCT02240069|363281194|FG001|Overall Study|Withdrawal by Subject|5|||
105349472|NCT02240069|363281195|FG002|Overall Study|Withdrawal by Subject|2|||
105349473|NCT02134353|363281199|FG000|Overall Study|Adverse Event|10|||
105349474|NCT02134353|363281200|FG001|Overall Study|Adverse Event|6|||
105349475|NCT02134353|363281199|FG000|Overall Study|Lost to Follow-up|1|||
105349476|NCT02134353|363281200|FG001|Overall Study|Lost to Follow-up|1|||
105349477|NCT02134353|363281199|FG000|Overall Study|Lack of Efficacy|2|||
105349478|NCT02134353|363281200|FG001|Overall Study|Lack of Efficacy|1|||
105349479|NCT02134353|363281199|FG000|Overall Study|Withdrawal by Subject|12|||
105349480|NCT02134353|363281200|FG001|Overall Study|Withdrawal by Subject|13|||
105349481|NCT02134353|363281199|FG000|Overall Study|Death|0|||
105349482|NCT02134353|363281200|FG001|Overall Study|Death|1|||
105349483|NCT02134353|363281199|FG000|Overall Study|Pregnancy|0|||
105349484|NCT02134353|363281200|FG001|Overall Study|Pregnancy|1|||
105700696|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
105700697|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
105700698|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
105700699|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
105700700|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
105700701|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
105700702|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
105700703|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
105700704|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
105700705|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
105700706|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
105700707|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
105700708|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
105700709|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
105700710|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
105700711|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
105349485|NCT02134353|363281199|FG000|Overall Study|Relocation|1|||
105349486|NCT02134353|363281200|FG001|Overall Study|Relocation|0|||
105349487|NCT02134353|363281199|FG000|Overall Study|Other - Patient's Choice|0|||
105700712|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
105700713|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
105700714|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
105349488|NCT02134353|363281200|FG001|Overall Study|Other - Patient's Choice|1|||
105349489|NCT02429310|363281201|FG000|Overall Study|Lost to Follow-up|1|||
105349490|NCT02429310|363281202|FG001|Overall Study|Lost to Follow-up|2|||
105349491|NCT02429310|363281201|FG000|Overall Study|Protocol Violation|1|||
105700715|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
105700716|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
105700717|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
105700718|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
105700719|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
105700720|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
105700721|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
105700722|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
105700723|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
105700724|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
105700725|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
105700726|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
105700727|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
105700728|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
105700729|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
105700730|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
105700731|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
105700732|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
105700733|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
105700734|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
105700735|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
105700736|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
105700737|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
105700738|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
105700739|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
105700740|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
105700741|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
105700742|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
105700743|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
105700744|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
105700745|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
105700746|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
105700747|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
105700748|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
105700749|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
105700750|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
105700751|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
105700752|NCT00253643|364566699|FG000|Overall Study|Withdrawal by Subject|0|||
105700753|NCT00253643|364566700|FG001|Overall Study|Withdrawal by Subject|0|||
105700754|NCT00253643|364566701|FG002|Overall Study|Withdrawal by Subject|1|||
105700755|NCT00253643|364566702|FG003|Overall Study|Withdrawal by Subject|1|||
105700756|NCT00253643|364566699|FG000|Overall Study|Non-Compliance|0|||
105700757|NCT00253643|364566700|FG001|Overall Study|Non-Compliance|0|||
105700758|NCT00253643|364566701|FG002|Overall Study|Non-Compliance|0|||
105700759|NCT00253643|364566702|FG003|Overall Study|Non-Compliance|2|||
105700760|NCT01549275|364566703|FG000|Overall Study|Lost to Follow-up|1|||
105700761|NCT01549275|364566704|FG001|Overall Study|Lost to Follow-up|0|||
105700762|NCT01843842|364566707|FG000|Overall Study|Do not meet inclusion criteria|1|||
105700763|NCT01843842|364566708|FG001|Overall Study|Do not meet inclusion criteria|1|||
105700764|NCT01671111|364566709|FG000|Overall Study|Adverse Event|2|||
105700765|NCT01671111|364566709|FG000|Overall Study|Lack of Efficacy|1|||
105700766|NCT01671111|364566709|FG000|Overall Study|Withdrawal by Subject|2|||
105700767|NCT01671111|364566709|FG000|Overall Study|Physician Decision|1|||
105700768|NCT01671111|364566709|FG000|Overall Study|Other|24|||
105700769|NCT02343159|364566712|FG000|Overall Study|Early Study Termination|16|||
105700770|NCT02343159|364566713|FG001|Overall Study|Early Study Termination|19|||
105700771|NCT02343159|364566714|FG002|Overall Study|Early Study Termination|23|||
105700772|NCT02343159|364566712|FG000|Overall Study|Physician Decision|2|||
105700773|NCT02343159|364566713|FG001|Overall Study|Physician Decision|0|||
105700774|NCT02343159|364566714|FG002|Overall Study|Physician Decision|1|||
105700775|NCT02343159|364566712|FG000|Overall Study|Withdrawal by Subject|3|||
105700776|NCT02343159|364566713|FG001|Overall Study|Withdrawal by Subject|0|||
105700777|NCT02343159|364566714|FG002|Overall Study|Withdrawal by Subject|2|||
105700778|NCT02343159|364566712|FG000|Overall Study|Lost to Follow-up|0|||
105700779|NCT02343159|364566713|FG001|Overall Study|Lost to Follow-up|2|||
105700780|NCT02343159|364566714|FG002|Overall Study|Lost to Follow-up|2|||
105700781|NCT02343159|364566712|FG000|Overall Study|Adverse Event|4|||
105700782|NCT02343159|364566713|FG001|Overall Study|Adverse Event|4|||
105700783|NCT02343159|364566714|FG002|Overall Study|Adverse Event|2|||
105700784|NCT02343159|364566712|FG000|Overall Study|Sponsor Decision|0|||
105700785|NCT02343159|364566713|FG001|Overall Study|Sponsor Decision|1|||
105700786|NCT02343159|364566714|FG002|Overall Study|Sponsor Decision|0|||
105700787|NCT02343159|364566712|FG000|Overall Study|Enrollment Error|1|||
105700788|NCT02343159|364566713|FG001|Overall Study|Enrollment Error|0|||
105787270|NCT03985982|364874918|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105787271|NCT03985982|364874916|FG000|Double-Blind Phase|Physician Decision|1|||
105787272|NCT03985982|364874917|FG001|Double-Blind Phase|Physician Decision|0|||
105787273|NCT03985982|364874918|FG002|Double-Blind Phase|Physician Decision|0|||
105787274|NCT03985982|364874916|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
105787275|NCT03985982|364874917|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
105787276|NCT03985982|364874918|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
105787277|NCT03985982|364874916|FG000|Double-Blind Phase|COVID-19|1|||
105787278|NCT03985982|364874917|FG001|Double-Blind Phase|COVID-19|0|||
105787279|NCT03985982|364874918|FG002|Double-Blind Phase|COVID-19|0|||
105787280|NCT03985982|364874916|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
105474432|NCT02864862|363748562|FG001|Overall Study|Lost to Follow-up|0|||
105474433|NCT02864862|363748563|FG002|Overall Study|Lost to Follow-up|1|||
105474434|NCT02864862|363748561|FG000|Overall Study|Protocol Violation|0|||
105474435|NCT02864862|363748562|FG001|Overall Study|Protocol Violation|0|||
105474436|NCT02864862|363748563|FG002|Overall Study|Protocol Violation|1|||
105474437|NCT00975689|363748564|FG000|Overall Study|Adverse Event|0|||
105474438|NCT00975689|363748565|FG001|Overall Study|Adverse Event|3|||
105474439|NCT00975689|363748564|FG000|Overall Study|Withdrawal by Subject|1|||
105474440|NCT00975689|363748565|FG001|Overall Study|Withdrawal by Subject|0|||
105474441|NCT00975689|363748564|FG000|Overall Study|Physician Decision|1|||
105474442|NCT00975689|363748565|FG001|Overall Study|Physician Decision|0|||
105474443|NCT01402102|363748566|FG000|Overall Study|Protocol Violation|1|||
105474444|NCT01402102|363748567|FG001|Overall Study|Protocol Violation|0|||
105474445|NCT01402102|363748566|FG000|Overall Study|Insufficiency of compliance|1|||
105474446|NCT01402102|363748567|FG001|Overall Study|Insufficiency of compliance|1|||
105474447|NCT01402102|363748566|FG000|Overall Study|Withdrawal by Subject|0|||
105700789|NCT02343159|364566714|FG002|Overall Study|Enrollment Error|0|||
105700790|NCT02004262|364566715|FG000|Overall Study|Death|67|||
105700791|NCT02004262|364566716|FG001|Overall Study|Death|64|||
105700792|NCT02004262|364566717|FG002|Overall Study|Death|66|||
105700793|NCT02004262|364566718|FG003|Overall Study|Death|28|||
105700794|NCT02004262|364566719|FG004|Overall Study|Death|29|||
105474448|NCT01402102|363748567|FG001|Overall Study|Withdrawal by Subject|2|||
105474449|NCT01256190|363748569|FG000|Overall Study|Lost to Follow-up|2|||
105700795|NCT02004262|364566720|FG005|Overall Study|Death|22|||
105700796|NCT02004262|364566715|FG000|Overall Study|Withdrawal by Subject|1|||
105474450|NCT01256190|363748570|FG001|Overall Study|Lost to Follow-up|0|||
105700797|NCT02004262|364566716|FG001|Overall Study|Withdrawal by Subject|0|||
105700798|NCT02004262|364566717|FG002|Overall Study|Withdrawal by Subject|4|||
105700799|NCT02004262|364566718|FG003|Overall Study|Withdrawal by Subject|0|||
105700800|NCT02004262|364566719|FG004|Overall Study|Withdrawal by Subject|1|||
105700801|NCT02004262|364566720|FG005|Overall Study|Withdrawal by Subject|3|||
105700802|NCT02004262|364566715|FG000|Overall Study|Lost to Follow-up|1|||
105700803|NCT02004262|364566716|FG001|Overall Study|Lost to Follow-up|1|||
105700804|NCT02004262|364566717|FG002|Overall Study|Lost to Follow-up|0|||
105700805|NCT02004262|364566718|FG003|Overall Study|Lost to Follow-up|0|||
105700806|NCT02004262|364566719|FG004|Overall Study|Lost to Follow-up|0|||
105700807|NCT02004262|364566720|FG005|Overall Study|Lost to Follow-up|0|||
105700808|NCT02004262|364566715|FG000|Overall Study|Study Terminated by Sponsor|4|||
105700809|NCT02004262|364566716|FG001|Overall Study|Study Terminated by Sponsor|3|||
105700810|NCT02004262|364566717|FG002|Overall Study|Study Terminated by Sponsor|2|||
105700811|NCT02004262|364566718|FG003|Overall Study|Study Terminated by Sponsor|1|||
105700812|NCT02004262|364566719|FG004|Overall Study|Study Terminated by Sponsor|1|||
105700813|NCT02004262|364566720|FG005|Overall Study|Study Terminated by Sponsor|5|||
105700814|NCT01923285|364566721|FG000|Overall Study|Withdrawal by Subject|7|||
105700815|NCT01923285|364566722|FG001|Overall Study|Withdrawal by Subject|6|||
105700816|NCT03200366|364566723|FG000|Patient Navigation Intervention Given|Death|0|||
105700817|NCT03200366|364566724|FG001|Patient Navigation Intervention Given|Death|2|||
105700818|NCT03200366|364566725|FG002|Patient Navigation Intervention Given|Death|0|||
105700819|NCT03200366|364566723|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
105700820|NCT03200366|364566724|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
105700821|NCT03200366|364566725|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
105700822|NCT03200366|364566723|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
105700823|NCT03200366|364566724|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
105700824|NCT03200366|364566725|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
105700825|NCT03200366|364566723|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
105700826|NCT03200366|364566724|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
105700827|NCT03200366|364566725|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
105700828|NCT03200366|364566723|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
105474451|NCT04931888|363748571|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
105700829|NCT03200366|364566724|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
105787281|NCT03985982|364874917|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
105700830|NCT03200366|364566725|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
105700831|NCT03200366|364566723|FG000|6 Month Post-Baseline Interview|Death|1|||
105700832|NCT03200366|364566724|FG001|6 Month Post-Baseline Interview|Death|1|||
105700833|NCT03200366|364566725|FG002|6 Month Post-Baseline Interview|Death|1|||
105700834|NCT03200366|364566723|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
105700835|NCT03200366|364566724|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
105700836|NCT03200366|364566725|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
105700837|NCT03200366|364566723|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
105700838|NCT03200366|364566724|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
105700839|NCT03200366|364566725|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
105700840|NCT03200366|364566723|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
105700841|NCT03200366|364566724|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
105700842|NCT03200366|364566725|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
105700843|NCT03200366|364566723|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
105700844|NCT03200366|364566724|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
105700845|NCT03200366|364566725|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
105700846|NCT03200366|364566723|FG000|9 Month Post-Baseline Interview|Death|1|||
105700847|NCT03200366|364566724|FG001|9 Month Post-Baseline Interview|Death|1|||
105700848|NCT03200366|364566725|FG002|9 Month Post-Baseline Interview|Death|1|||
105700849|NCT03200366|364566723|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
105700850|NCT03200366|364566724|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
105700851|NCT03200366|364566725|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
105700852|NCT03200366|364566723|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
105700853|NCT03200366|364566724|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
105700854|NCT03200366|364566725|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
105700855|NCT03200366|364566723|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
105700856|NCT03200366|364566724|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
105700857|NCT03200366|364566725|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
105700858|NCT04315181|364566728|FG000|Overall Study|Non-responsive to drug conditions.|1|||
105700859|NCT00711425|364566729|FG000|Overall Study|Protocol Violation|1|||
105700860|NCT00711425|364566729|FG000|Overall Study|Death|2|||
105700861|NCT00711425|364566729|FG000|Overall Study|Lost to Follow-up|1|||
105700862|NCT05879107|364566730|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
105700863|NCT05879107|364566731|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
105700864|NCT05879107|364566730|FG000|Overall Study|Migrated / moved from the study area|1|||
105700865|NCT05879107|364566731|FG001|Overall Study|Migrated / moved from the study area|1|||
105700866|NCT05879107|364566730|FG000|Overall Study|Lost to Follow-up|8|||
105700867|NCT05879107|364566731|FG001|Overall Study|Lost to Follow-up|13|||
105700868|NCT05879107|364566730|FG000|Overall Study|Death|0|||
105700869|NCT05879107|364566731|FG001|Overall Study|Death|2|||
105700870|NCT05879107|364566730|FG000|Overall Study|Other|0|||
105700871|NCT05879107|364566731|FG001|Overall Study|Other|3|||
105700872|NCT01056510|364566732|FG000|Overall Study|Dropout Before Start of Treatment|1|||
105700873|NCT01056510|364566733|FG001|Overall Study|Dropout Before Start of Treatment|1|||
105700874|NCT01056510|364566732|FG000|Overall Study|Withdrawal by Subject|4|||
105700875|NCT01056510|364566733|FG001|Overall Study|Withdrawal by Subject|2|||
105700876|NCT01056510|364566732|FG000|Overall Study|Death|29|||
105700877|NCT01056510|364566733|FG001|Overall Study|Death|34|||
105700878|NCT01056510|364566732|FG000|Overall Study|Noncompliance|1|||
105700879|NCT01056510|364566733|FG001|Overall Study|Noncompliance|3|||
105700880|NCT01056510|364566732|FG000|Overall Study|Physician Decision|4|||
105700881|NCT01056510|364566733|FG001|Overall Study|Physician Decision|5|||
105700882|NCT01056510|364566732|FG000|Overall Study|Lost to Follow-up|5|||
105700883|NCT01056510|364566733|FG001|Overall Study|Lost to Follow-up|6|||
105700884|NCT01056510|364566732|FG000|Overall Study|Other|10|||
105700885|NCT01056510|364566733|FG001|Overall Study|Other|12|||
105700886|NCT01056510|364566732|FG000|Overall Study|Missing|0|||
105700887|NCT01056510|364566733|FG001|Overall Study|Missing|1|||
105700888|NCT01793142|364566736|FG000|Overall Study|Randomized not treated|7|||
105700889|NCT01087775|364566737|FG000|Overall Study|failed inclusion criteria|2|||
105700890|NCT01553188|364566738|FG000|Overall Study|Patient choice|1|||
105700891|NCT01553188|364566739|FG001|Overall Study|Patient choice|0|||
105700892|NCT01553188|364566740|FG002|Overall Study|Patient choice|0|||
105700893|NCT01553188|364566741|FG003|Overall Study|Patient choice|0|||
105700894|NCT01553188|364566738|FG000|Overall Study|Intercurrent illness and adverse event|0|||
105700895|NCT01553188|364566739|FG001|Overall Study|Intercurrent illness and adverse event|1|||
105700896|NCT01553188|364566740|FG002|Overall Study|Intercurrent illness and adverse event|2|||
105700897|NCT01553188|364566741|FG003|Overall Study|Intercurrent illness and adverse event|0|||
105700898|NCT01617070|364566743|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
105700899|NCT00117598|364566744|FG000|Prior to Treatment Cross Over|Death|40|||
105700900|NCT00117598|364566745|FG001|Prior to Treatment Cross Over|Death|41|||
105700901|NCT00117598|364566746|FG002|Prior to Treatment Cross Over|Death|37|||
105700902|NCT00117598|364566747|FG003|Prior to Treatment Cross Over|Death|0|||
105700903|NCT00117598|364566748|FG004|Prior to Treatment Cross Over|Death|0|||
105700904|NCT00117598|364566744|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
105700905|NCT00117598|364566745|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
105700906|NCT00117598|364566746|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
105700907|NCT00117598|364566747|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
105700908|NCT00117598|364566748|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
105700909|NCT00117598|364566744|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
105700910|NCT00117598|364566745|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
105700911|NCT00117598|364566746|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
105700912|NCT00117598|364566747|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
105700913|NCT00117598|364566748|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
105700914|NCT00117598|364566744|FG000|Prior to Treatment Cross Over|Other|15|||
105700915|NCT00117598|364566745|FG001|Prior to Treatment Cross Over|Other|9|||
105700916|NCT00117598|364566746|FG002|Prior to Treatment Cross Over|Other|9|||
105700917|NCT00117598|364566747|FG003|Prior to Treatment Cross Over|Other|0|||
105700918|NCT00117598|364566748|FG004|Prior to Treatment Cross Over|Other|0|||
105700919|NCT00117598|364566744|FG000|After Treament Cross Over|Death|0|||
105700920|NCT00117598|364566745|FG001|After Treament Cross Over|Death|0|||
105700921|NCT00117598|364566746|FG002|After Treament Cross Over|Death|0|||
105700922|NCT00117598|364566747|FG003|After Treament Cross Over|Death|1|||
105700923|NCT00117598|364566748|FG004|After Treament Cross Over|Death|2|||
105700924|NCT00117598|364566744|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
105700925|NCT00117598|364566745|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
105700926|NCT00117598|364566746|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
105700927|NCT00117598|364566747|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
105700928|NCT00117598|364566748|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
105700929|NCT00117598|364566744|FG000|After Treament Cross Over|Other|0|||
105700930|NCT00117598|364566745|FG001|After Treament Cross Over|Other|0|||
105700931|NCT00117598|364566746|FG002|After Treament Cross Over|Other|0|||
105700932|NCT00117598|364566747|FG003|After Treament Cross Over|Other|1|||
105700933|NCT00117598|364566748|FG004|After Treament Cross Over|Other|2|||
105700934|NCT04544475|364566749|FG000|Overall Study|Withdrawal by Subject|1|||
105700935|NCT04544475|364566750|FG001|Overall Study|Withdrawal by Subject|3|||
105349492|NCT02429310|363281202|FG001|Overall Study|Protocol Violation|1|||
105349493|NCT00394433|363281203|FG000|Overall Study|Adverse Event|2|||
105349494|NCT00394433|363281203|FG000|Overall Study|Alternative Therapy|1|||
105349495|NCT04459598|363281204|FG000|Overall Study|Adverse Event|1|||
105349496|NCT04459598|363281205|FG001|Overall Study|Adverse Event|1|||
105700936|NCT00808236|364566751|FG000|Overall Study|Was not resuscitated|50|||
105700937|NCT00808236|364566752|FG001|Overall Study|Was not resuscitated|56|||
105700938|NCT00808236|364566751|FG000|Overall Study|Pre-defined exclusion|13|||
105700939|NCT00808236|364566752|FG001|Overall Study|Pre-defined exclusion|3|||
105700940|NCT00808236|364566751|FG000|Overall Study|Lost to Follow-up|1|||
105700941|NCT00808236|364566752|FG001|Overall Study|Lost to Follow-up|1|||
105700942|NCT00808236|364566751|FG000|Overall Study|Physician Decision|0|||
105700943|NCT00808236|364566752|FG001|Overall Study|Physician Decision|1|||
105700944|NCT00808236|364566751|FG000|Overall Study|Death|18|||
105700945|NCT00808236|364566752|FG001|Overall Study|Death|30|||
105700946|NCT02230384|364566753|FG000|Phase 1|Lost to Follow-up|1|||
105700947|NCT02230384|364566754|FG001|Phase 1|Lost to Follow-up|0|||
105700948|NCT02230384|364566753|FG000|Phase 1|Physician Decision|0|||
105700949|NCT02230384|364566754|FG001|Phase 1|Physician Decision|1|||
105700950|NCT02230384|364566753|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
105700951|NCT02230384|364566754|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
105700952|NCT02230384|364566753|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
105700953|NCT02230384|364566754|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
105700954|NCT02230384|364566753|FG000|Phase 2 - Switch|Adverse Event|2|||
105700955|NCT02230384|364566754|FG001|Phase 2 - Switch|Adverse Event|0|||
105700956|NCT05376215|364566755|FG000|Overall Study|Withdrawal by Subject|2|||
105700957|NCT05376215|364566756|FG001|Overall Study|Withdrawal by Subject|1|||
105700958|NCT05376215|364566755|FG000|Overall Study|Lost to Follow-up|0|||
105700959|NCT05376215|364566756|FG001|Overall Study|Lost to Follow-up|1|||
105700960|NCT01301950|364566761|FG000|Overall Study|Surgery was cancelled by patient|0|||
105349497|NCT01078298|363281206|FG000|Overall Study|Lost to Follow-up|12|||
105349498|NCT01078298|363281207|FG001|Overall Study|Lost to Follow-up|13|||
105349499|NCT01078298|363281206|FG000|Overall Study|Withdrawal by Subject|31|||
105349500|NCT01078298|363281207|FG001|Overall Study|Withdrawal by Subject|33|||
105349501|NCT01078298|363281206|FG000|Overall Study|Protocol Violation|6|||
105349502|NCT01078298|363281207|FG001|Overall Study|Protocol Violation|6|||
105349503|NCT01078298|363281206|FG000|Overall Study|Adverse Event|6|||
105349504|NCT01078298|363281207|FG001|Overall Study|Adverse Event|5|||
105349505|NCT01078298|363281206|FG000|Overall Study|Death|2|||
105349506|NCT01078298|363281207|FG001|Overall Study|Death|0|||
105349507|NCT01078298|363281206|FG000|Overall Study|Did not meet entrance criteria|0|||
105349508|NCT01078298|363281207|FG001|Overall Study|Did not meet entrance criteria|1|||
105349509|NCT01078298|363281206|FG000|Overall Study|Other|24|||
105349510|NCT01078298|363281207|FG001|Overall Study|Other|32|||
105700961|NCT01301950|364566762|FG001|Overall Study|Surgery was cancelled by patient|1|||
105700962|NCT01378858|364566763|FG000|Overall Study|Withdrawal by Subject|4|||
105700963|NCT01378858|364566764|FG001|Overall Study|Withdrawal by Subject|4|||
105700964|NCT03715153|364566765|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
105700965|NCT03715153|364566766|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
105700966|NCT03715153|364566765|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
105700967|NCT03715153|364566766|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
105700968|NCT03715153|364566765|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
105700969|NCT03715153|364566766|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
105700970|NCT03715153|364566765|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
105700971|NCT03715153|364566766|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
105700972|NCT03715153|364566765|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
105700973|NCT03715153|364566766|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
105700974|NCT03715153|364566765|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
105349511|NCT01764659|363281208|FG000|Overall Study|Death|1|||
105349512|NCT01764659|363281208|FG000|Overall Study|Physician Decision|1|||
105349513|NCT01210352|363281209|FG000|Overall Study|Adverse Event|0|||
105349514|NCT01210352|363281210|FG001|Overall Study|Adverse Event|0|||
105700975|NCT03715153|364566766|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
105700976|NCT01378104|364566767|FG000|Overall Study|Adverse Event|8|||
105700977|NCT01378104|364566768|FG001|Overall Study|Adverse Event|8|||
105700978|NCT01378104|364566767|FG000|Overall Study|Lack of Efficacy|7|||
105700979|NCT01378104|364566768|FG001|Overall Study|Lack of Efficacy|5|||
105700980|NCT01378104|364566767|FG000|Overall Study|Withdrawal by Subject|12|||
105700981|NCT01378104|364566768|FG001|Overall Study|Withdrawal by Subject|13|||
105700982|NCT01506960|364566773|FG000|Overall Study|Did not meet angiographic criteria|47|||
105700983|NCT03610724|364566774|FG000|Overall Study|Death|17|||
105700984|NCT03610724|364566774|FG000|Overall Study|Lost to Follow-up|1|||
105700985|NCT03610724|364566774|FG000|Overall Study|Physician Decision|1|||
105700986|NCT03610724|364566774|FG000|Overall Study|Died prior to infusion|1|||
105700987|NCT01519765|364566775|FG000|Overall Study|Adverse Event|0|||
105700988|NCT01519765|364566776|FG001|Overall Study|Adverse Event|1|||
105700989|NCT01519765|364566775|FG000|Overall Study|Lack of Efficacy|2|||
105700990|NCT01519765|364566776|FG001|Overall Study|Lack of Efficacy|0|||
105700991|NCT01519765|364566775|FG000|Overall Study|Protocol Violation|1|||
105700992|NCT01519765|364566776|FG001|Overall Study|Protocol Violation|0|||
105700993|NCT01519765|364566775|FG000|Overall Study|Withdrawal by Subject|0|||
105700994|NCT01519765|364566776|FG001|Overall Study|Withdrawal by Subject|1|||
105700995|NCT00786565|364566780|FG000|Enrollment Prior to Surgery|Site Closed|3|||
105700996|NCT00786565|364566780|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
105700997|NCT00786565|364566780|FG000|Post Surgery|Abnormal macular pucker|1|||
105700998|NCT00786565|364566780|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
105700999|NCT00578136|364566781|FG000|Overall Study|Not given intervention|1|||
105701000|NCT00578136|364566782|FG001|Overall Study|Not given intervention|1|||
105701001|NCT02047253|364566783|FG000|Overall Study|Lost to Follow-up|8|||
105701002|NCT01892163|364566788|FG000|Overall Study|Death|1|||
105701003|NCT01892163|364566789|FG001|Overall Study|Death|1|||
105701004|NCT01892163|364566788|FG000|Overall Study|Lost to Follow-up|1|||
105701005|NCT01892163|364566789|FG001|Overall Study|Lost to Follow-up|0|||
105701006|NCT03302975|364566790|FG000|Overall Study|Lost to Follow-up|4|||
105701007|NCT00432042|364566792|FG000|Overall Study|Protocol Violation|2|||
105701008|NCT00432042|364566793|FG001|Overall Study|Protocol Violation|0|||
105701009|NCT00432042|364566794|FG002|Overall Study|Protocol Violation|0|||
105701010|NCT00432042|364566792|FG000|Overall Study|Withdrawal by Subject|0|||
105701011|NCT00432042|364566793|FG001|Overall Study|Withdrawal by Subject|0|||
105701012|NCT00432042|364566794|FG002|Overall Study|Withdrawal by Subject|2|||
105701013|NCT00432042|364566792|FG000|Overall Study|Lost to Follow-up|5|||
105701014|NCT00432042|364566793|FG001|Overall Study|Lost to Follow-up|1|||
105701015|NCT00432042|364566794|FG002|Overall Study|Lost to Follow-up|0|||
105701016|NCT00993265|364566795|FG000|Overall Study|Adverse Event|1|||
105701017|NCT00993265|364566796|FG001|Overall Study|Adverse Event|0|||
105701018|NCT00993265|364566795|FG000|Overall Study|Changed dose of concomitant drug|2|||
105701019|NCT00993265|364566796|FG001|Overall Study|Changed dose of concomitant drug|0|||
105701020|NCT00993265|364566795|FG000|Overall Study|Non-compliant with study medication|1|||
105701021|NCT00993265|364566796|FG001|Overall Study|Non-compliant with study medication|0|||
105701022|NCT01484977|364566797|FG000|Overall Study|Adverse Event|8|||
105701023|NCT01484977|364566797|FG000|Overall Study|Lack of Efficacy|4|||
105701024|NCT01484977|364566797|FG000|Overall Study|Protocol Violation|6|||
105701025|NCT01484977|364566797|FG000|Overall Study|Lost to Follow-up|1|||
105701026|NCT01484977|364566797|FG000|Overall Study|Withdrawal by Subject|4|||
105701027|NCT01484977|364566797|FG000|Overall Study|Subject Protocol Non-compliant|1|||
105701028|NCT01484977|364566797|FG000|Overall Study|Moving Overseas|1|||
105701029|NCT01484977|364566797|FG000|Overall Study|Low White Blood Cell Count|1|||
105701030|NCT01484977|364566797|FG000|Overall Study|Lack of Compliance|1|||
105701031|NCT00798135|364566800|FG000|Overall Study|Disease progression, relapse|11|||
105701032|NCT00798135|364566800|FG000|Overall Study|Disease progression, refractory|1|||
105701033|NCT00798135|364566800|FG000|Overall Study|Physician Decision|1|||
105701034|NCT01392677|364566809|FG000|Overall Study|Adverse Event|3|||
105701035|NCT01392677|364566810|FG001|Overall Study|Adverse Event|1|||
105701036|NCT01392677|364566809|FG000|Overall Study|Withdrawal by Subject|0|||
105701037|NCT01392677|364566810|FG001|Overall Study|Withdrawal by Subject|2|||
105701038|NCT01392677|364566809|FG000|Overall Study|Incorrect enrollment|2|||
105701039|NCT01392677|364566810|FG001|Overall Study|Incorrect enrollment|3|||
105701040|NCT01392677|364566809|FG000|Overall Study|Other reason|3|||
105701041|NCT01392677|364566810|FG001|Overall Study|Other reason|2|||
105701042|NCT00528021|364566813|FG000|Overall Study|Lack of Efficacy|17|||
105701043|NCT00528021|364566814|FG001|Overall Study|Lack of Efficacy|13|||
105701044|NCT00528021|364566815|FG002|Overall Study|Lack of Efficacy|7|||
105701045|NCT00528021|364566816|FG003|Overall Study|Lack of Efficacy|9|||
105701046|NCT00388973|364568489|FG000|Overall Study|Adverse Event|16|||
105701047|NCT00388973|364568490|FG001|Overall Study|Adverse Event|6|||
105701048|NCT00388973|364568489|FG000|Overall Study|Lack of Efficacy|1|||
105701049|NCT00388973|364568490|FG001|Overall Study|Lack of Efficacy|12|||
105701050|NCT00388973|364568489|FG000|Overall Study|Protocol Violation|3|||
105701051|NCT00388973|364568490|FG001|Overall Study|Protocol Violation|0|||
105701052|NCT00388973|364568489|FG000|Overall Study|Withdrawal by Subject|14|||
105701053|NCT00388973|364568490|FG001|Overall Study|Withdrawal by Subject|17|||
105701054|NCT00388973|364568489|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
105701055|NCT00388973|364568490|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
105701056|NCT00388973|364568489|FG000|Overall Study|Did not complete 61 days of treatment|5|||
105474452|NCT04931888|363748572|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
105474453|NCT04931888|363748573|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
105474454|NCT04931888|363748574|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
105349515|NCT01210352|363281211|FG002|Overall Study|Adverse Event|0|||
105349516|NCT01210352|363281212|FG003|Overall Study|Adverse Event|0|||
105701057|NCT00388973|364568490|FG001|Overall Study|Did not complete 61 days of treatment|4|||
105701058|NCT00388973|364568489|FG000|Overall Study|Left region|0|||
105701059|NCT00388973|364568490|FG001|Overall Study|Left region|1|||
105701060|NCT00388973|364568489|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
105701061|NCT00388973|364568490|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
105701062|NCT02833974|364568497|FG000|Overall Study|Lost to Follow-up|1|||
105701063|NCT02833974|364568498|FG001|Overall Study|Lost to Follow-up|0|||
105701064|NCT02833974|364568497|FG000|Overall Study|Adverse Event|0|||
105701065|NCT02833974|364568498|FG001|Overall Study|Adverse Event|3|||
105701066|NCT00636675|364568499|FG000|Overall Study|Lost to Follow-up|121|||
105701067|NCT00636675|364568500|FG001|Overall Study|Lost to Follow-up|31|||
105701068|NCT00636675|364568499|FG000|Overall Study|Withdrawal by Subject|19|||
105701069|NCT00636675|364568500|FG001|Overall Study|Withdrawal by Subject|10|||
105701070|NCT00096785|364568501|FG000|Overall Study|Lost to Follow-up|1|||
105701071|NCT00096785|364568502|FG001|Overall Study|Lost to Follow-up|0|||
105701072|NCT00096785|364568501|FG000|Overall Study|Withdrawal by Subject|0|||
105701073|NCT00096785|364568502|FG001|Overall Study|Withdrawal by Subject|1|||
105701074|NCT00096785|364568501|FG000|Overall Study|Relocated|1|||
105701075|NCT00096785|364568502|FG001|Overall Study|Relocated|0|||
105701076|NCT04053868|364568503|FG000|Overall Study|Withdrawal by Subject|1|||
105701077|NCT04053868|364568504|FG001|Overall Study|Withdrawal by Subject|0|||
105701078|NCT01761292|364568505|FG000|Part 1|Adverse Event|1|||
105701079|NCT01761292|364568505|FG000|Part 1|not receiving treatment in Part 1|1|||
105701080|NCT01761292|364568505|FG000|Extension 1|Withdrawal by Subject|1|||
105701081|NCT03332498|364568506|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
105701082|NCT03332498|364568507|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
105701083|NCT03332498|364568508|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
105701084|NCT01566773|364568509|FG000|Overall Study|Protocol specified criteria|4|||
105701085|NCT01566773|364568509|FG000|Overall Study|Protocol Violation|4|||
105701086|NCT01566773|364568509|FG000|Overall Study|Withdrawal by Subject|9|||
105701087|NCT01566773|364568509|FG000|Overall Study|Administrative reason|1|||
105701088|NCT01566773|364568509|FG000|Overall Study|Adverse Event|10|||
105701089|NCT01566773|364568509|FG000|Overall Study|Physician Decision|2|||
105701090|NCT02187471|364568511|FG000|Overall Study|Protocol Violation|4|||
105701091|NCT02187471|364568512|FG001|Overall Study|Protocol Violation|5|||
105701092|NCT02187471|364568513|FG002|Overall Study|Protocol Violation|4|||
105701093|NCT02187471|364568514|FG003|Overall Study|Protocol Violation|4|||
105701094|NCT02187471|364568511|FG000|Overall Study|Missing|0|||
105701095|NCT02187471|364568512|FG001|Overall Study|Missing|0|||
105701096|NCT02187471|364568513|FG002|Overall Study|Missing|0|||
105701097|NCT02187471|364568514|FG003|Overall Study|Missing|1|||
105701098|NCT02187471|364568511|FG000|Overall Study|Lack of Efficacy|18|||
105701099|NCT02187471|364568512|FG001|Overall Study|Lack of Efficacy|9|||
105701100|NCT02187471|364568513|FG002|Overall Study|Lack of Efficacy|13|||
105701101|NCT02187471|364568514|FG003|Overall Study|Lack of Efficacy|11|||
105701102|NCT02187471|364568511|FG000|Overall Study|Adverse Event|24|||
105701103|NCT02187471|364568512|FG001|Overall Study|Adverse Event|34|||
105701104|NCT02187471|364568513|FG002|Overall Study|Adverse Event|44|||
105701105|NCT02187471|364568514|FG003|Overall Study|Adverse Event|36|||
105349517|NCT01210352|363281213|FG004|Overall Study|Adverse Event|0|||
105349518|NCT01210352|363281214|FG005|Overall Study|Adverse Event|0|||
105349519|NCT01210352|363281215|FG006|Overall Study|Adverse Event|0|||
105349520|NCT01210352|363281216|FG007|Overall Study|Adverse Event|2|||
105349521|NCT01210352|363281217|FG008|Overall Study|Adverse Event|1|||
105349522|NCT01210352|363281209|FG000|Overall Study|Lack of Efficacy|0|||
105349523|NCT01210352|363281210|FG001|Overall Study|Lack of Efficacy|0|||
105349524|NCT01210352|363281211|FG002|Overall Study|Lack of Efficacy|0|||
105349525|NCT01210352|363281212|FG003|Overall Study|Lack of Efficacy|0|||
105474455|NCT02779556|363748575|FG000|Baseline|Partial baseline interview completed|1|||
105474456|NCT02779556|363748576|FG001|Baseline|Partial baseline interview completed|0|||
105474457|NCT02779556|363748575|FG000|3 Months|Lost to Follow-up|40|||
105474458|NCT02779556|363748576|FG001|3 Months|Lost to Follow-up|29|||
105474459|NCT02779556|363748575|FG000|3 Months|Missed 3 month clinic visit|27|||
105474460|NCT02779556|363748576|FG001|3 Months|Missed 3 month clinic visit|19|||
105474461|NCT02779556|363748575|FG000|6 Month|Lost to Follow-up|33|||
105701106|NCT02187471|364568511|FG000|Overall Study|Withdrawal by Subject|23|||
105349526|NCT01210352|363281213|FG004|Overall Study|Lack of Efficacy|0|||
105349527|NCT01210352|363281214|FG005|Overall Study|Lack of Efficacy|0|||
105701107|NCT02187471|364568512|FG001|Overall Study|Withdrawal by Subject|29|||
105701108|NCT02187471|364568513|FG002|Overall Study|Withdrawal by Subject|22|||
105701109|NCT02187471|364568514|FG003|Overall Study|Withdrawal by Subject|24|||
105701110|NCT02187471|364568511|FG000|Overall Study|Other|7|||
105701111|NCT02187471|364568512|FG001|Overall Study|Other|5|||
105701112|NCT02187471|364568513|FG002|Overall Study|Other|3|||
105701113|NCT02187471|364568514|FG003|Overall Study|Other|4|||
105701114|NCT00957528|364568516|FG000|Overall Study|Protocol Violation|0|||
105701115|NCT00957528|364568517|FG001|Overall Study|Protocol Violation|1|||
105701116|NCT00957528|364568518|FG002|Overall Study|Protocol Violation|0|||
105701117|NCT00957528|364568516|FG000|Overall Study|Withdrawal by Subject|0|||
105701118|NCT00957528|364568517|FG001|Overall Study|Withdrawal by Subject|0|||
105701119|NCT00957528|364568518|FG002|Overall Study|Withdrawal by Subject|1|||
105701120|NCT01033734|364568519|FG000|Overall Study|Withdrawal by Subject|1|||
105701121|NCT00914927|364568520|FG000|Overall Study|Adverse Event|0|||
105701122|NCT00914927|364568521|FG001|Overall Study|Adverse Event|0|||
105701123|NCT00914927|364568522|FG002|Overall Study|Adverse Event|0|||
105701124|NCT00914927|364568523|FG003|Overall Study|Adverse Event|0|||
105701125|NCT00914927|364568524|FG004|Overall Study|Adverse Event|1|||
105701126|NCT00914927|364568525|FG005|Overall Study|Adverse Event|0|||
105701127|NCT00914927|364568526|FG006|Overall Study|Adverse Event|0|||
105701128|NCT00914927|364568520|FG000|Overall Study|Withdrawal by Subject|0|||
105701129|NCT00914927|364568521|FG001|Overall Study|Withdrawal by Subject|1|||
105701130|NCT00914927|364568522|FG002|Overall Study|Withdrawal by Subject|0|||
105701131|NCT00914927|364568523|FG003|Overall Study|Withdrawal by Subject|1|||
105701132|NCT00914927|364568524|FG004|Overall Study|Withdrawal by Subject|0|||
105701133|NCT00914927|364568525|FG005|Overall Study|Withdrawal by Subject|0|||
105701134|NCT00914927|364568526|FG006|Overall Study|Withdrawal by Subject|0|||
105701135|NCT00914927|364568520|FG000|Overall Study|Lost to Follow-up|0|||
105701136|NCT00914927|364568521|FG001|Overall Study|Lost to Follow-up|0|||
105701137|NCT00914927|364568522|FG002|Overall Study|Lost to Follow-up|0|||
105701138|NCT00914927|364568523|FG003|Overall Study|Lost to Follow-up|1|||
105701139|NCT00914927|364568524|FG004|Overall Study|Lost to Follow-up|0|||
105701140|NCT00914927|364568525|FG005|Overall Study|Lost to Follow-up|0|||
105701141|NCT00914927|364568526|FG006|Overall Study|Lost to Follow-up|0|||
105701142|NCT00914927|364568520|FG000|Overall Study|Administrative/Other|2|||
105701143|NCT00914927|364568521|FG001|Overall Study|Administrative/Other|1|||
105701144|NCT00914927|364568522|FG002|Overall Study|Administrative/Other|0|||
105701145|NCT00914927|364568523|FG003|Overall Study|Administrative/Other|0|||
105701146|NCT00914927|364568524|FG004|Overall Study|Administrative/Other|1|||
105701147|NCT00914927|364568525|FG005|Overall Study|Administrative/Other|0|||
105701148|NCT00914927|364568526|FG006|Overall Study|Administrative/Other|0|||
105701149|NCT01040351|364568529|FG000|Overall Study|poor ovarian response|1|||
105701150|NCT01040351|364568530|FG001|Overall Study|poor ovarian response|2|||
105701151|NCT00122681|364568534|FG000|Overall Study|Adverse Event|20|||
105701152|NCT00122681|364568535|FG001|Overall Study|Adverse Event|16|||
105701153|NCT00122681|364568534|FG000|Overall Study|Lost to Follow-up|1080|||
105701154|NCT00122681|364568535|FG001|Overall Study|Lost to Follow-up|1097|||
105701155|NCT00122681|364568534|FG000|Overall Study|Protocol Violation|7|||
105701156|NCT00122681|364568535|FG001|Overall Study|Protocol Violation|10|||
105701157|NCT00122681|364568534|FG000|Overall Study|Withdrawal by Subject|257|||
105701158|NCT00122681|364568535|FG001|Overall Study|Withdrawal by Subject|251|||
105701159|NCT00122681|364568534|FG000|Overall Study|Personal reasons|150|||
105701160|NCT00122681|364568535|FG001|Overall Study|Personal reasons|147|||
105701161|NCT02016820|364568537|FG000|Overall Study|Lost to Follow-up|2|||
105701162|NCT02016820|364568538|FG001|Overall Study|Lost to Follow-up|4|||
105701163|NCT00258674|364568539|FG000|Overall Study|Death|32|||
105701164|NCT00258674|364568540|FG001|Overall Study|Death|53|||
105701165|NCT00258674|364568541|FG002|Overall Study|Death|34|||
105701166|NCT04247061|364568542|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
105701167|NCT04247061|364568542|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
105349528|NCT01210352|363281215|FG006|Overall Study|Lack of Efficacy|1|||
105701168|NCT04247061|364568542|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
105349529|NCT01210352|363281216|FG007|Overall Study|Lack of Efficacy|0|||
105349530|NCT01210352|363281217|FG008|Overall Study|Lack of Efficacy|0|||
105349531|NCT01210352|363281209|FG000|Overall Study|Physician Decision|0|||
105349532|NCT01210352|363281210|FG001|Overall Study|Physician Decision|0|||
105349533|NCT01210352|363281211|FG002|Overall Study|Physician Decision|0|||
105349534|NCT01210352|363281212|FG003|Overall Study|Physician Decision|0|||
105349535|NCT01210352|363281213|FG004|Overall Study|Physician Decision|0|||
105349536|NCT01210352|363281214|FG005|Overall Study|Physician Decision|0|||
105349537|NCT01210352|363281215|FG006|Overall Study|Physician Decision|0|||
105349538|NCT01210352|363281216|FG007|Overall Study|Physician Decision|1|||
105474462|NCT02779556|363748576|FG001|6 Month|Lost to Follow-up|39|||
105701169|NCT01744665|364568556|FG000|Monitoring Phase|Adverse Event|4|||
105474463|NCT02779556|363748575|FG000|6 Month HbA1c|No value collected during window|69|||
105701170|NCT01744665|364568556|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
105701171|NCT01744665|364568556|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
105701172|NCT01744665|364568556|FG000|Monitoring Phase|Withdrawal by Subject|5|||
105349539|NCT01210352|363281217|FG008|Overall Study|Physician Decision|2|||
105349540|NCT01210352|363281209|FG000|Overall Study|Withdrawal by Subject|0|||
105349541|NCT01210352|363281210|FG001|Overall Study|Withdrawal by Subject|0|||
105701173|NCT01744665|364568556|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
105701174|NCT01744665|364568556|FG000|Consolidation Phase|Adverse Event|2|||
105701175|NCT01744665|364568556|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
105701176|NCT01744665|364568556|FG000|Consolidation Phase|Withdrawal by Subject|4|||
105701177|NCT01744665|364568556|FG000|Consolidation Phase|Administrative problems|9|||
105701178|NCT01744665|364568556|FG000|Re-initiation Phase|Administrative problems|10|||
105701179|NCT01744665|364568556|FG000|Re-initiation Phase|Adverse Event|1|||
105701180|NCT01744665|364568556|FG000|Re-initiation Phase|No longer required treatment|1|||
105701181|NCT01744665|364568556|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
105701182|NCT00807742|364568557|FG000|Overall Study|Death|9|||
105701183|NCT00807742|364568558|FG001|Overall Study|Death|2|||
105701184|NCT00807742|364568557|FG000|Overall Study|Withdrawal by Subject|2|||
105701185|NCT00807742|364568558|FG001|Overall Study|Withdrawal by Subject|1|||
105701186|NCT00807742|364568557|FG000|Overall Study|Lost to Follow-up|35|||
105701187|NCT00807742|364568558|FG001|Overall Study|Lost to Follow-up|51|||
105701188|NCT00492752|364568559|FG000|Double Blind Treatment|Death|13|||
105701189|NCT00492752|364568560|FG001|Double Blind Treatment|Death|0|||
105701190|NCT00492752|364568561|FG002|Double Blind Treatment|Death|2|||
105701191|NCT00492752|364568562|FG003|Double Blind Treatment|Death|0|||
105701192|NCT00492752|364568559|FG000|Double Blind Treatment|Adverse Event|1|||
105701193|NCT00492752|364568560|FG001|Double Blind Treatment|Adverse Event|0|||
105701194|NCT00492752|364568561|FG002|Double Blind Treatment|Adverse Event|0|||
105701195|NCT00492752|364568562|FG003|Double Blind Treatment|Adverse Event|0|||
105701196|NCT00492752|364568559|FG000|Double Blind Treatment|Protocol Violation|0|||
105701197|NCT00492752|364568560|FG001|Double Blind Treatment|Protocol Violation|0|||
105701198|NCT00492752|364568561|FG002|Double Blind Treatment|Protocol Violation|1|||
105701199|NCT00492752|364568562|FG003|Double Blind Treatment|Protocol Violation|0|||
105701200|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
105701201|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
105701202|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
105701203|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
105701204|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
105701205|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
105701206|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
105701207|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
105349542|NCT01210352|363281211|FG002|Overall Study|Withdrawal by Subject|1|||
105349543|NCT01210352|363281212|FG003|Overall Study|Withdrawal by Subject|0|||
105349544|NCT01210352|363281213|FG004|Overall Study|Withdrawal by Subject|0|||
105349545|NCT01210352|363281214|FG005|Overall Study|Withdrawal by Subject|0|||
105349546|NCT01210352|363281215|FG006|Overall Study|Withdrawal by Subject|1|||
105349547|NCT01210352|363281216|FG007|Overall Study|Withdrawal by Subject|0|||
105701208|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
105701209|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
105701210|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
105701211|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
105701212|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
105701213|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
105701214|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
105701215|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
105701216|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
105701217|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
105349548|NCT01210352|363281217|FG008|Overall Study|Withdrawal by Subject|1|||
105349549|NCT01210352|363281209|FG000|Overall Study|Patient Discharged Early|0|||
105349550|NCT01210352|363281210|FG001|Overall Study|Patient Discharged Early|0|||
105349551|NCT01210352|363281211|FG002|Overall Study|Patient Discharged Early|1|||
105349552|NCT01210352|363281212|FG003|Overall Study|Patient Discharged Early|0|||
105349553|NCT01210352|363281213|FG004|Overall Study|Patient Discharged Early|0|||
105349554|NCT01210352|363281214|FG005|Overall Study|Patient Discharged Early|0|||
105349555|NCT01210352|363281215|FG006|Overall Study|Patient Discharged Early|0|||
105349556|NCT01210352|363281216|FG007|Overall Study|Patient Discharged Early|0|||
105349557|NCT01210352|363281217|FG008|Overall Study|Patient Discharged Early|0|||
105349558|NCT00628927|363281218|FG000|Overall Study|Problems performing blood draw|6|||
105349559|NCT00628927|363281219|FG001|Overall Study|Problems performing blood draw|0|||
105349560|NCT00628927|363281218|FG000|Overall Study|Lost to Follow-up|1|||
105349561|NCT00628927|363281219|FG001|Overall Study|Lost to Follow-up|0|||
105701218|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
105701219|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
105349562|NCT00628927|363281218|FG000|Overall Study|Equipment failure|1|||
105349563|NCT00628927|363281219|FG001|Overall Study|Equipment failure|0|||
105349564|NCT01738191|363281220|FG000|Overall Study|Withdrawal by Subject|4|||
105349565|NCT01738191|363281221|FG001|Overall Study|Withdrawal by Subject|1|||
105349566|NCT02440854|363281222|FG000|Overall Study|Relocation of patient|1|||
105701220|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
105701221|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
105701222|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
105701223|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
105701224|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
105701225|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
105701226|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
105701227|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
105701228|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
105701229|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
105701230|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
105701231|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
105701232|NCT03803059|364568563|FG000|Overall Study|Protocol Violation|2|||
105701233|NCT03803059|364568563|FG000|Overall Study|Lost to Follow-up|1|||
105701234|NCT03159091|364568564|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
105701235|NCT03159091|364568565|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
105701236|NCT03159091|364568564|FG000|Overall Study|Patient has taken no dose of study drug|0|||
105701237|NCT03159091|364568565|FG001|Overall Study|Patient has taken no dose of study drug|1|||
105701238|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
105701239|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
105701240|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
105701241|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
105701242|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
105701243|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
105701244|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
105701245|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
105701246|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to death|4|||
105701247|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to death|3|||
105701248|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
105701249|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
105701250|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
105701251|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
105701252|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
105701253|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
105701254|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
105701255|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
105701256|NCT02258451|364568566|FG000|Overall Study|Other reason|1|||
105701257|NCT02258451|364568567|FG001|Overall Study|Other reason|1|||
105701258|NCT02258451|364568566|FG000|Overall Study|Never treated|2|||
105701259|NCT02258451|364568567|FG001|Overall Study|Never treated|3|||
105701260|NCT05248295|364568579|FG000|Overall Study|found ineligible|4|||
105701261|NCT05248295|364568580|FG001|Overall Study|found ineligible|1|||
105701262|NCT05248295|364568579|FG000|Overall Study|Withdrawal by Subject|0|||
105701263|NCT05248295|364568580|FG001|Overall Study|Withdrawal by Subject|1|||
105701264|NCT05248295|364568579|FG000|Overall Study|Data loss: audio recording error|1|||
105701265|NCT05248295|364568580|FG001|Overall Study|Data loss: audio recording error|1|||
105701266|NCT04066491|364568581|FG000|Overall Study|Randomized, not treated|0|||
105701267|NCT04066491|364568582|FG001|Overall Study|Randomized, not treated|0|||
105701268|NCT04066491|364568583|FG002|Overall Study|Randomized, not treated|2|||
105701269|NCT04506086|364568584|FG000|Overall Study|Withdrawal by Subject|2|||
105701270|NCT03021499|364568585|FG000|Overall Study|Adverse Event|1|||
105701271|NCT03021499|364568586|FG001|Overall Study|Adverse Event|0|||
105701272|NCT03021499|364568585|FG000|Overall Study|Death|1|||
105701273|NCT03021499|364568586|FG001|Overall Study|Death|5|||
105701274|NCT03021499|364568585|FG000|Overall Study|Lack of Efficacy|0|||
105701275|NCT03021499|364568586|FG001|Overall Study|Lack of Efficacy|1|||
105701276|NCT03021499|364568585|FG000|Overall Study|Lost to Follow-up|1|||
105701277|NCT03021499|364568586|FG001|Overall Study|Lost to Follow-up|3|||
105701278|NCT03021499|364568585|FG000|Overall Study|Physician Decision|2|||
105701279|NCT03021499|364568586|FG001|Overall Study|Physician Decision|3|||
105701280|NCT03021499|364568585|FG000|Overall Study|Pregnancy|1|||
105701281|NCT03021499|364568586|FG001|Overall Study|Pregnancy|0|||
105701282|NCT03021499|364568585|FG000|Overall Study|Withdrawal by Subject|7|||
105701283|NCT03021499|364568586|FG001|Overall Study|Withdrawal by Subject|14|||
105701284|NCT03021499|364568585|FG000|Overall Study|Prohibited medication required|1|||
105701285|NCT03021499|364568586|FG001|Overall Study|Prohibited medication required|0|||
105701286|NCT03021499|364568585|FG000|Overall Study|Protocol non-compliance|1|||
105701287|NCT03021499|364568586|FG001|Overall Study|Protocol non-compliance|1|||
105701288|NCT03021499|364568585|FG000|Overall Study|None of the above|0|||
105701289|NCT03021499|364568586|FG001|Overall Study|None of the above|4|||
105701290|NCT03021499|364568585|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
105701291|NCT03021499|364568586|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
105701292|NCT01210690|364568587|FG000|Overall Study|Adverse Event|7|||
105701293|NCT01210690|364568587|FG000|Overall Study|Lack of Efficacy|12|||
105701294|NCT01210690|364568587|FG000|Overall Study|Lost to Follow-up|3|||
105701295|NCT01210690|364568587|FG000|Overall Study|Disease Remission|1|||
105701296|NCT01210690|364568587|FG000|Overall Study|Withdrawal by Subject|1|||
105701297|NCT01210690|364568587|FG000|Overall Study|Patient refused to swallow|1|||
105701298|NCT01210690|364568587|FG000|Overall Study|Patient could not take glucose|1|||
105701299|NCT00495820|364568588|FG000|Overall Study|Adverse Event|1|||
105701300|NCT00495820|364568589|FG001|Overall Study|Adverse Event|1|||
105701301|NCT00820950|364568590|FG000|Overall Study|Scheduling Conflict|0|||
105701302|NCT00820950|364568591|FG001|Overall Study|Scheduling Conflict|0|||
105701303|NCT00820950|364568592|FG002|Overall Study|Scheduling Conflict|0|||
105701304|NCT00820950|364568593|FG003|Overall Study|Scheduling Conflict|0|||
105701305|NCT00820950|364568594|FG004|Overall Study|Scheduling Conflict|0|||
105701306|NCT00820950|364568595|FG005|Overall Study|Scheduling Conflict|0|||
105701307|NCT00820950|364568596|FG006|Overall Study|Scheduling Conflict|1|||
105701308|NCT00820950|364568597|FG007|Overall Study|Scheduling Conflict|1|||
105701309|NCT00820950|364568598|FG008|Overall Study|Scheduling Conflict|0|||
105701310|NCT00820950|364568599|FG009|Overall Study|Scheduling Conflict|0|||
105701311|NCT00820950|364568590|FG000|Overall Study|Protocol Violation|1|||
105701312|NCT00820950|364568591|FG001|Overall Study|Protocol Violation|1|||
105701313|NCT00820950|364568592|FG002|Overall Study|Protocol Violation|0|||
105701314|NCT00820950|364568593|FG003|Overall Study|Protocol Violation|0|||
105701315|NCT00820950|364568594|FG004|Overall Study|Protocol Violation|0|||
105701316|NCT00820950|364568595|FG005|Overall Study|Protocol Violation|0|||
105701317|NCT00820950|364568596|FG006|Overall Study|Protocol Violation|0|||
105701318|NCT00820950|364568597|FG007|Overall Study|Protocol Violation|0|||
105701319|NCT00820950|364568598|FG008|Overall Study|Protocol Violation|0|||
105701320|NCT00820950|364568599|FG009|Overall Study|Protocol Violation|0|||
105701321|NCT04202679|364568600|FG000|Overall Study|Adverse Event|2|||
105701322|NCT04202679|364568601|FG001|Overall Study|Adverse Event|0|||
105701323|NCT04202679|364568600|FG000|Overall Study|Poor compliance to protocol|1|||
105701324|NCT04202679|364568601|FG001|Overall Study|Poor compliance to protocol|0|||
105701325|NCT04202679|364568600|FG000|Overall Study|Withdrawal by Subject|23|||
105701326|NCT04202679|364568601|FG001|Overall Study|Withdrawal by Subject|6|||
105701327|NCT00687440|364568602|FG000|Overall Study|Adverse Event|3|||
105701328|NCT00687440|364568602|FG000|Overall Study|Lost to Follow-up|3|||
105701329|NCT00687440|364568602|FG000|Overall Study|Lack of Efficacy|2|||
105701330|NCT00687440|364568602|FG000|Overall Study|Death|2|||
105701331|NCT00687440|364568602|FG000|Overall Study|Other|1|||
105701332|NCT00687440|364568602|FG000|Overall Study|Missing|1|||
105701333|NCT04869345|364568606|FG000|Overall Study|Lost to Follow-up|8|||
105701334|NCT04869345|364568607|FG001|Overall Study|Lost to Follow-up|3|||
105701335|NCT03996876|364568610|FG000|Overall Study|Incomplete Data|2|||
105701336|NCT03996876|364568611|FG001|Overall Study|Incomplete Data|4|||
105701337|NCT05054114|364568614|FG000|Overall Study|Protocol Violation|13|||
105701338|NCT05054114|364568615|FG001|Overall Study|Protocol Violation|1|||
105701339|NCT05054114|364568614|FG000|Overall Study|Pregnancy|0|||
105701340|NCT05054114|364568615|FG001|Overall Study|Pregnancy|1|||
105701341|NCT02186847|364568618|FG000|Overall Study|Protocol Violation|3|||
105701342|NCT02186847|364568619|FG001|Overall Study|Protocol Violation|0|||
105701343|NCT05264740|364568620|FG000|Baseline|Withdrawal by Subject|0|||
105701344|NCT05264740|364568621|FG001|Baseline|Withdrawal by Subject|1|||
105701345|NCT05264740|364568620|FG000|Follow Up 1|Lost to Follow-up|1|||
105701346|NCT05264740|364568621|FG001|Follow Up 1|Lost to Follow-up|1|||
105701347|NCT05264740|364568620|FG000|Follow Up 1|Withdrawal by Subject|0|||
105701348|NCT05264740|364568621|FG001|Follow Up 1|Withdrawal by Subject|1|||
105701349|NCT05264740|364568620|FG000|Follow Up 2|Lost to Follow-up|1|||
105701350|NCT05264740|364568621|FG001|Follow Up 2|Lost to Follow-up|4|||
105701351|NCT05264740|364568620|FG000|Follow Up 3|Lost to Follow-up|7|||
105701352|NCT05264740|364568621|FG001|Follow Up 3|Lost to Follow-up|4|||
105701353|NCT03080883|364568623|FG000|Overall Study|Withdrawal by Subject|11|||
105701354|NCT03080883|364568624|FG001|Overall Study|Withdrawal by Subject|15|||
105701355|NCT03080883|364568623|FG000|Overall Study|Adverse Event|22|||
105701356|NCT03080883|364568624|FG001|Overall Study|Adverse Event|22|||
105701357|NCT03080883|364568623|FG000|Overall Study|Alternative Therapy|0|||
105701358|NCT03080883|364568624|FG001|Overall Study|Alternative Therapy|3|||
105701359|NCT03080883|364568623|FG000|Overall Study|Other Complicating Disease|9|||
105701360|NCT03080883|364568624|FG001|Overall Study|Other Complicating Disease|5|||
105701361|NCT03080883|364568623|FG000|Overall Study|Death|21|||
105701362|NCT03080883|364568624|FG001|Overall Study|Death|16|||
105701363|NCT03080883|364568623|FG000|Overall Study|Physician Decision|2|||
105701364|NCT03080883|364568624|FG001|Overall Study|Physician Decision|2|||
105701365|NCT03080883|364568623|FG000|Overall Study|Disease Progression|2|||
105701366|NCT03080883|364568624|FG001|Overall Study|Disease Progression|8|||
105701367|NCT03080883|364568623|FG000|Overall Study|Lost to Follow-up|1|||
105701368|NCT03080883|364568624|FG001|Overall Study|Lost to Follow-up|1|||
105701369|NCT02663453|364568628|FG000|Overall Study|Death|4|||
105701370|NCT02663453|364568629|FG001|Overall Study|Death|4|||
105701371|NCT02663453|364568628|FG000|Overall Study|Withdrawal by Subject|1|||
105701372|NCT02663453|364568629|FG001|Overall Study|Withdrawal by Subject|0|||
105560054|NCT00844857|364046512|FG000|Overall Study|Parent/Caregiver Decision|6|||
105560055|NCT00844857|364046513|FG001|Overall Study|Parent/Caregiver Decision|2|||
105701373|NCT03697720|364569894|FG000|Overall Study|Lost to Follow-up|7|||
105701374|NCT01439282|364569901|FG000|Overall Study|Adverse Event|5|||
105701375|NCT01439282|364569902|FG001|Overall Study|Adverse Event|0|||
105701376|NCT01439282|364569901|FG000|Overall Study|Withdrawal by Subject|2|||
105701377|NCT01439282|364569902|FG001|Overall Study|Withdrawal by Subject|0|||
105701378|NCT01439282|364569901|FG000|Overall Study|Other|1|||
105701379|NCT01439282|364569902|FG001|Overall Study|Other|1|||
105701380|NCT02966509|364569905|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
105701381|NCT02966509|364569906|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
105701382|NCT02966509|364569905|FG000|Baseline Satisfaction Survey|Death|0|||
105701383|NCT02966509|364569906|FG001|Baseline Satisfaction Survey|Death|1|||
105701384|NCT02966509|364569905|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
105701385|NCT02966509|364569906|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
105701386|NCT02966509|364569905|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
105701387|NCT02966509|364569906|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
105701388|NCT02966509|364569905|FG000|6 Month Satisfaction Decision Survey|Death|22|||
105701389|NCT02966509|364569906|FG001|6 Month Satisfaction Decision Survey|Death|25|||
105701390|NCT02966509|364569905|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
105701391|NCT02966509|364569906|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
105701392|NCT02966509|364569905|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
105701393|NCT02966509|364569906|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
105701394|NCT02966509|364569905|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
105701395|NCT02966509|364569906|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
105701396|NCT02966509|364569905|FG000|6 Month Satisfaction Survey|Death|36|||
105701397|NCT02966509|364569906|FG001|6 Month Satisfaction Survey|Death|33|||
105701398|NCT02966509|364569905|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
105701399|NCT02966509|364569906|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
105701400|NCT02966509|364569905|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
105701401|NCT02966509|364569906|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
105701402|NCT02966509|364569905|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
105701403|NCT02966509|364569906|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
105701404|NCT02966509|364569905|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
105701405|NCT02966509|364569906|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
105701406|NCT02966509|364569905|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
105701407|NCT02966509|364569906|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
105701408|NCT01543152|364569909|FG000|Overall Study|Withdrawal by Subject|0|||
105701409|NCT01543152|364569910|FG001|Overall Study|Withdrawal by Subject|2|||
105474464|NCT02779556|363748576|FG001|6 Month HbA1c|No value collected during window|50|||
105701410|NCT01543152|364569911|FG002|Overall Study|Withdrawal by Subject|0|||
105701411|NCT01543152|364569912|FG003|Overall Study|Withdrawal by Subject|0|||
105474465|NCT02779556|363748575|FG000|12 Month HbA1c|No value collected during window|138|||
105474466|NCT02779556|363748576|FG001|12 Month HbA1c|No value collected during window|102|||
105474467|NCT00622440|363748577|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
105474468|NCT00622440|363748578|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
105474469|NCT00622440|363748577|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
105474470|NCT00622440|363748578|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
105474471|NCT00622440|363748577|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
105560056|NCT00844857|364046512|FG000|Overall Study|Withdrawal by Subject|8|||
105560057|NCT00844857|364046513|FG001|Overall Study|Withdrawal by Subject|7|||
105701412|NCT01543152|364569913|FG004|Overall Study|Withdrawal by Subject|0|||
105560058|NCT00844857|364046512|FG000|Overall Study|Protocol Violation|6|||
105701413|NCT00916357|364569914|FG000|Period 1|Withdrawal by Subject|1|||
105701414|NCT00916357|364569915|FG001|Period 1|Withdrawal by Subject|0|||
105560059|NCT00844857|364046513|FG001|Overall Study|Protocol Violation|0|||
105560060|NCT00844857|364046512|FG000|Overall Study|Lack of Efficacy|5|||
105701415|NCT00916357|364569916|FG002|Period 1|Withdrawal by Subject|0|||
105701416|NCT00916357|364569917|FG003|Period 1|Withdrawal by Subject|0|||
105701417|NCT00916357|364569918|FG004|Period 1|Withdrawal by Subject|0|||
105701418|NCT00916357|364569919|FG005|Period 1|Withdrawal by Subject|0|||
105701419|NCT00916357|364569914|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
105701420|NCT00916357|364569915|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
105701421|NCT00916357|364569916|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
105701422|NCT00916357|364569917|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
105701423|NCT00916357|364569918|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
105701424|NCT00916357|364569919|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
105701425|NCT02234479|364569920|FG000|Overall Study|Withdrawal by Subject|1|||
105701426|NCT02234479|364569921|FG001|Overall Study|Withdrawal by Subject|3|||
105560061|NCT00844857|364046513|FG001|Overall Study|Lack of Efficacy|5|||
105560062|NCT00844857|364046512|FG000|Overall Study|Clinical Relapse|0|||
105560063|NCT00844857|364046513|FG001|Overall Study|Clinical Relapse|1|||
105560064|NCT00844857|364046512|FG000|Overall Study|Entry Criteria Not Met|0|||
105560065|NCT00844857|364046513|FG001|Overall Study|Entry Criteria Not Met|1|||
105560066|NCT00844857|364046512|FG000|Overall Study|Lost to Follow-up|2|||
105560067|NCT00844857|364046513|FG001|Overall Study|Lost to Follow-up|3|||
105560068|NCT00844857|364046512|FG000|Overall Study|Did Not Take Study Drug|3|||
105560069|NCT00844857|364046513|FG001|Overall Study|Did Not Take Study Drug|1|||
105560070|NCT00844857|364046512|FG000|Overall Study|Good Clinical Practice Violations|21|||
105560071|NCT00844857|364046513|FG001|Overall Study|Good Clinical Practice Violations|11|||
105560072|NCT00570674|364046514|FG000|Overall Study|Withdrawal by Subject|0|||
105560073|NCT00570674|364046515|FG001|Overall Study|Withdrawal by Subject|0|||
105560074|NCT00570674|364046516|FG002|Overall Study|Withdrawal by Subject|1|||
105560075|NCT00570674|364046517|FG003|Overall Study|Withdrawal by Subject|0|||
105560076|NCT00570674|364046518|FG004|Overall Study|Withdrawal by Subject|0|||
105560077|NCT00570674|364046519|FG005|Overall Study|Withdrawal by Subject|0|||
105560078|NCT00570674|364046520|FG006|Overall Study|Withdrawal by Subject|0|||
105560079|NCT02822222|364046530|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
105560080|NCT02822222|364046531|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
105560081|NCT00643916|364046532|FG000|Overall Study|Protocol Violation|0|||
105560082|NCT00643916|364046533|FG001|Overall Study|Protocol Violation|1|||
105560083|NCT00643916|364046534|FG002|Overall Study|Protocol Violation|1|||
105560084|NCT00643916|364046535|FG003|Overall Study|Protocol Violation|1|||
105560085|NCT00643916|364046536|FG004|Overall Study|Protocol Violation|0|||
105560086|NCT00643916|364046537|FG005|Overall Study|Protocol Violation|0|||
105560087|NCT00643916|364046532|FG000|Overall Study|Lost to Follow-up|0|||
105560088|NCT00643916|364046533|FG001|Overall Study|Lost to Follow-up|1|||
105560089|NCT00643916|364046534|FG002|Overall Study|Lost to Follow-up|0|||
105560090|NCT00643916|364046535|FG003|Overall Study|Lost to Follow-up|0|||
105560091|NCT00643916|364046536|FG004|Overall Study|Lost to Follow-up|0|||
105560092|NCT00643916|364046537|FG005|Overall Study|Lost to Follow-up|0|||
105560093|NCT00643916|364046532|FG000|Overall Study|Withdrawal by Subject|2|||
105560094|NCT00643916|364046533|FG001|Overall Study|Withdrawal by Subject|2|||
105560095|NCT00643916|364046534|FG002|Overall Study|Withdrawal by Subject|2|||
105560096|NCT00643916|364046535|FG003|Overall Study|Withdrawal by Subject|1|||
105560097|NCT00643916|364046536|FG004|Overall Study|Withdrawal by Subject|0|||
105560098|NCT00643916|364046537|FG005|Overall Study|Withdrawal by Subject|1|||
105560099|NCT00643916|364046532|FG000|Overall Study|Not Vaccinated|2|||
105560100|NCT00643916|364046533|FG001|Overall Study|Not Vaccinated|2|||
105560101|NCT00643916|364046534|FG002|Overall Study|Not Vaccinated|3|||
105560102|NCT00643916|364046535|FG003|Overall Study|Not Vaccinated|0|||
105560103|NCT00643916|364046536|FG004|Overall Study|Not Vaccinated|2|||
105560104|NCT00643916|364046537|FG005|Overall Study|Not Vaccinated|0|||
105560105|NCT02450331|364046544|FG000|Overall Study|Death|162|||
105560106|NCT02450331|364046545|FG001|Overall Study|Death|171|||
105560107|NCT02450331|364046544|FG000|Overall Study|Lost to Follow-up|14|||
105560108|NCT02450331|364046545|FG001|Overall Study|Lost to Follow-up|12|||
105560109|NCT02450331|364046544|FG000|Overall Study|Withdrawal by Subject|55|||
105560110|NCT02450331|364046545|FG001|Overall Study|Withdrawal by Subject|44|||
105560111|NCT02450331|364046544|FG000|Overall Study|Non-specified other|1|||
105560112|NCT02450331|364046545|FG001|Overall Study|Non-specified other|1|||
105560113|NCT00828984|364046546|FG000|Overall Study|Adverse Event|2|||
105560114|NCT00828984|364046547|FG001|Overall Study|Adverse Event|3|||
105560115|NCT00828984|364046548|FG002|Overall Study|Adverse Event|0|||
105560116|NCT00828984|364046546|FG000|Overall Study|Lost to Follow-up|5|||
105560117|NCT00828984|364046547|FG001|Overall Study|Lost to Follow-up|3|||
105560118|NCT00828984|364046548|FG002|Overall Study|Lost to Follow-up|1|||
105560119|NCT00828984|364046546|FG000|Overall Study|Withdrawal by Subject|4|||
105560120|NCT00828984|364046547|FG001|Overall Study|Withdrawal by Subject|4|||
105560121|NCT00828984|364046548|FG002|Overall Study|Withdrawal by Subject|4|||
105701427|NCT01911442|364569922|FG000|Overall Study|Adverse Event|2|||
105701428|NCT01911442|364569923|FG001|Overall Study|Adverse Event|2|||
105560122|NCT00828984|364046546|FG000|Overall Study|Ineligable|1|||
105560123|NCT00828984|364046547|FG001|Overall Study|Ineligable|2|||
105560124|NCT00828984|364046548|FG002|Overall Study|Ineligable|0|||
105560125|NCT00828984|364046546|FG000|Overall Study|Medical Contraindication|0|||
105560126|NCT00828984|364046547|FG001|Overall Study|Medical Contraindication|1|||
105560127|NCT00828984|364046548|FG002|Overall Study|Medical Contraindication|0|||
105560128|NCT00828984|364046546|FG000|Overall Study|Noncompliant|1|||
105701429|NCT01911442|364569924|FG002|Overall Study|Adverse Event|4|||
105701430|NCT01911442|364569922|FG000|Overall Study|Lack of Efficacy|1|||
105701431|NCT01911442|364569923|FG001|Overall Study|Lack of Efficacy|1|||
105701432|NCT01911442|364569924|FG002|Overall Study|Lack of Efficacy|1|||
105701433|NCT01911442|364569922|FG000|Overall Study|Lost to Follow-up|2|||
105701434|NCT01911442|364569923|FG001|Overall Study|Lost to Follow-up|0|||
105701435|NCT01911442|364569924|FG002|Overall Study|Lost to Follow-up|1|||
105701436|NCT01911442|364569922|FG000|Overall Study|Withdrawal by Subject|1|||
105701437|NCT01911442|364569923|FG001|Overall Study|Withdrawal by Subject|0|||
105701438|NCT01911442|364569924|FG002|Overall Study|Withdrawal by Subject|6|||
105701439|NCT01911442|364569922|FG000|Overall Study|Mother's Work Schedule|0|||
105701440|NCT01911442|364569923|FG001|Overall Study|Mother's Work Schedule|1|||
105701441|NCT01911442|364569924|FG002|Overall Study|Mother's Work Schedule|0|||
105701442|NCT01648790|364569925|FG000|Treatment 3|Withdrawal by Subject|0|||
105701443|NCT01648790|364569926|FG001|Treatment 3|Withdrawal by Subject|0|||
105701444|NCT01648790|364569927|FG002|Treatment 3|Withdrawal by Subject|0|||
105701445|NCT01648790|364569928|FG003|Treatment 3|Withdrawal by Subject|1|||
105701446|NCT01648790|364569929|FG004|Treatment 3|Withdrawal by Subject|0|||
105701447|NCT02159729|364569931|FG000|Overall Study|Adverse Event|0|||
105701448|NCT02159729|364569932|FG001|Overall Study|Adverse Event|1|||
105701449|NCT02159729|364569931|FG000|Overall Study|Subject's Request|13|||
105701450|NCT02159729|364569932|FG001|Overall Study|Subject's Request|10|||
105701451|NCT02159729|364569931|FG000|Overall Study|Lost to Follow-up|24|||
105701452|NCT02159729|364569932|FG001|Overall Study|Lost to Follow-up|9|||
105701453|NCT02159729|364569931|FG000|Overall Study|Non compliance|2|||
105701454|NCT02159729|364569932|FG001|Overall Study|Non compliance|0|||
105701455|NCT02159729|364569931|FG000|Overall Study|Other Unspecified|3|||
105701456|NCT02159729|364569932|FG001|Overall Study|Other Unspecified|1|||
105701457|NCT02636582|364569933|FG000|Overall Study|Surgical Pathology|1|||
105701458|NCT02636582|364569934|FG001|Overall Study|Surgical Pathology|0|||
105701459|NCT01263483|364569935|FG000|Overall Study|Adverse Event|4|||
105701460|NCT01263483|364569936|FG001|Overall Study|Adverse Event|0|||
105701461|NCT01263483|364569937|FG002|Overall Study|Adverse Event|3|||
105701462|NCT01263483|364569935|FG000|Overall Study|Withdrawal by Subject|1|||
105701463|NCT01263483|364569936|FG001|Overall Study|Withdrawal by Subject|0|||
105701464|NCT01263483|364569937|FG002|Overall Study|Withdrawal by Subject|0|||
105701465|NCT01263483|364569935|FG000|Overall Study|Lack of Efficacy|2|||
105701466|NCT01263483|364569936|FG001|Overall Study|Lack of Efficacy|0|||
105701467|NCT01263483|364569937|FG002|Overall Study|Lack of Efficacy|0|||
105701468|NCT01263483|364569935|FG000|Overall Study|Protocol Violation|0|||
105701469|NCT01263483|364569936|FG001|Overall Study|Protocol Violation|1|||
105701470|NCT01263483|364569937|FG002|Overall Study|Protocol Violation|1|||
105701471|NCT01263483|364569935|FG000|Overall Study|Participant Unavailability|0|||
105701472|NCT01263483|364569936|FG001|Overall Study|Participant Unavailability|1|||
105701473|NCT01263483|364569937|FG002|Overall Study|Participant Unavailability|1|||
105701474|NCT00326209|364569938|FG000|Overall Study|Adverse Event|28|||
105701475|NCT00326209|364569938|FG000|Overall Study|Withdrawal by Subject|22|||
105701476|NCT00326209|364569938|FG000|Overall Study|Lack of Efficacy|31|||
105701477|NCT00326209|364569938|FG000|Overall Study|Lost to Follow-up|18|||
105701478|NCT00326209|364569938|FG000|Overall Study|Participant non-compliant|6|||
105701479|NCT00326209|364569938|FG000|Overall Study|Sponsor closed study|173|||
105701480|NCT00326209|364569938|FG000|Overall Study|Prohibited medication use|1|||
105701481|NCT00326209|364569938|FG000|Overall Study|Violation of entry criteria|1|||
105474472|NCT00622440|363748578|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
105474473|NCT00622440|363748577|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
105701482|NCT00326209|364569938|FG000|Overall Study|Withdrawn in error|1|||
105701483|NCT00326209|364569938|FG000|Overall Study|Pregnancy|1|||
105701484|NCT00714285|364569939|FG000|Overall Study|Lost to Follow-up|0|||
105701485|NCT00714285|364569940|FG001|Overall Study|Lost to Follow-up|2|||
105701486|NCT00714285|364569941|FG002|Overall Study|Lost to Follow-up|0|||
105701487|NCT00714285|364569942|FG003|Overall Study|Lost to Follow-up|1|||
105701488|NCT00714285|364569939|FG000|Overall Study|Migrated/moved from study area|0|||
105701489|NCT00714285|364569940|FG001|Overall Study|Migrated/moved from study area|1|||
105701490|NCT00714285|364569941|FG002|Overall Study|Migrated/moved from study area|0|||
105701491|NCT00714285|364569942|FG003|Overall Study|Migrated/moved from study area|0|||
105701492|NCT01372384|364569943|FG000|Overall Study|Progression of disease|3|||
105701493|NCT01131676|364569948|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
105701494|NCT01131676|364569949|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
105701495|NCT01131676|364569950|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
105701496|NCT01131676|364569948|FG000|Discontinuation From Treatment|Not treated|4|||
105701497|NCT01131676|364569949|FG001|Discontinuation From Treatment|Not treated|2|||
105701498|NCT01131676|364569950|FG002|Discontinuation From Treatment|Not treated|2|||
105701499|NCT01131676|364569948|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
105701500|NCT01131676|364569949|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
105701501|NCT01131676|364569950|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
105701502|NCT01131676|364569948|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
105474474|NCT00622440|363748578|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
105474475|NCT03110770|363748582|FG000|Overall Study|Death|1|||
105474476|NCT03110770|363748583|FG001|Overall Study|Death|0|||
105474477|NCT03110770|363748584|FG002|Overall Study|Death|0|||
105474478|NCT03110770|363748585|FG003|Overall Study|Death|1|||
105701503|NCT01131676|364569949|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
105701504|NCT01131676|364569950|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
105701505|NCT01131676|364569948|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
105701506|NCT01131676|364569949|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
105701507|NCT01131676|364569950|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
105701508|NCT01131676|364569948|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
105701509|NCT01131676|364569949|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
105701510|NCT01131676|364569950|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
105701511|NCT01131676|364569948|FG000|Discontinuation From Treatment|Other than those specified|162|||
105701512|NCT01131676|364569949|FG001|Discontinuation From Treatment|Other than those specified|142|||
105701513|NCT01131676|364569950|FG002|Discontinuation From Treatment|Other than those specified|125|||
105701514|NCT01131676|364569948|FG000|Discontinuation From Treatment|Adverse Event|303|||
105701515|NCT01131676|364569949|FG001|Discontinuation From Treatment|Adverse Event|267|||
105701516|NCT01131676|364569950|FG002|Discontinuation From Treatment|Adverse Event|273|||
105701517|NCT01131676|364569948|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
105701518|NCT01131676|364569949|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
105701519|NCT01131676|364569950|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
105701520|NCT01131676|364569948|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
105701521|NCT01131676|364569949|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
105701522|NCT01131676|364569950|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
105701523|NCT01131676|364569948|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
105701524|NCT01131676|364569949|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
105701525|NCT01131676|364569950|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
105701526|NCT01131676|364569948|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
105701527|NCT01131676|364569949|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
105474479|NCT03110770|363748586|FG004|Overall Study|Death|0|||
105474480|NCT03110770|363748582|FG000|Overall Study|Enrolled but did not receive product|0|||
105474481|NCT03110770|363748583|FG001|Overall Study|Enrolled but did not receive product|0|||
105474482|NCT03110770|363748584|FG002|Overall Study|Enrolled but did not receive product|0|||
105787282|NCT03985982|364874918|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
105787283|NCT03985982|364874916|FG000|Open-Label Phase|Lost to Follow-up|0|||
105787284|NCT03985982|364874917|FG001|Open-Label Phase|Lost to Follow-up|0|||
105701528|NCT01131676|364569950|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
105701529|NCT01131676|364569948|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
105701530|NCT01131676|364569949|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
105701531|NCT01131676|364569950|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
105701532|NCT01131676|364569948|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
105701533|NCT01131676|364569949|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
105701534|NCT01131676|364569950|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
105787285|NCT03985982|364874918|FG002|Open-Label Phase|Lost to Follow-up|13|||
105787286|NCT03985982|364874916|FG000|Open-Label Phase|Physician Decision|0|||
105701535|NCT01278745|364569951|FG000|Overall Study|Death|2|||
105701536|NCT01278745|364569952|FG001|Overall Study|Death|5|||
105701537|NCT01278745|364569953|FG002|Overall Study|Death|7|||
105701538|NCT01278745|364569954|FG003|Overall Study|Death|0|||
105701539|NCT01278745|364569951|FG000|Overall Study|Physician Decision|1|||
105701540|NCT01278745|364569952|FG001|Overall Study|Physician Decision|0|||
105701541|NCT01278745|364569953|FG002|Overall Study|Physician Decision|0|||
105701542|NCT01278745|364569954|FG003|Overall Study|Physician Decision|9|||
105701543|NCT01278745|364569951|FG000|Overall Study|Withdrawal by Subject|1|||
105701544|NCT01278745|364569952|FG001|Overall Study|Withdrawal by Subject|1|||
105701545|NCT01278745|364569953|FG002|Overall Study|Withdrawal by Subject|5|||
105701546|NCT01278745|364569954|FG003|Overall Study|Withdrawal by Subject|1|||
105701547|NCT01278745|364569951|FG000|Overall Study|Sponsor Decision|1|||
105701548|NCT01278745|364569952|FG001|Overall Study|Sponsor Decision|0|||
105701549|NCT01278745|364569953|FG002|Overall Study|Sponsor Decision|62|||
105701550|NCT01278745|364569954|FG003|Overall Study|Sponsor Decision|6|||
105701551|NCT01278745|364569951|FG000|Overall Study|Ineligible|0|||
105701552|NCT01278745|364569952|FG001|Overall Study|Ineligible|0|||
105701553|NCT01278745|364569953|FG002|Overall Study|Ineligible|42|||
105474483|NCT03110770|363748585|FG003|Overall Study|Enrolled but did not receive product|8|||
105474484|NCT03110770|363748586|FG004|Overall Study|Enrolled but did not receive product|7|||
105349567|NCT02440854|363281222|FG000|Overall Study|Death|6|||
105701554|NCT01278745|364569954|FG003|Overall Study|Ineligible|61|||
105701555|NCT01278745|364569951|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
105701556|NCT01278745|364569952|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
105701557|NCT01278745|364569953|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
105701558|NCT01278745|364569954|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
105701559|NCT00441974|364569955|FG000|Overall Study|Adverse Event|6|||
105701560|NCT00441974|364569955|FG000|Overall Study|Consent Withdrawn|35|||
105701561|NCT00441974|364569955|FG000|Overall Study|Lost to Follow-up|80|||
105701562|NCT00441974|364569955|FG000|Overall Study|Protocol Violation|7|||
105701563|NCT01111851|364569956|FG000|Overall Study|All planned PET scans were not obtained.|2|||
105701564|NCT01111851|364569957|FG001|Overall Study|All planned PET scans were not obtained.|0|||
105701565|NCT01471015|364569958|FG000|Overall Study|Death|0|||
105701566|NCT01471015|364569959|FG001|Overall Study|Death|1|||
105349568|NCT02440854|363281222|FG000|Overall Study|Lost to Follow-up|10|||
105349569|NCT02440854|363281222|FG000|Overall Study|Afatinib discontinuation|46|||
105349570|NCT02440854|363281222|FG000|Overall Study|stopped study at earlier timepoint|14|||
105349571|NCT02440854|363281222|FG000|Overall Study|Study medication not received|1|||
105349572|NCT02440854|363281222|FG000|Overall Study|Violation of inclusion criteria|2|||
105349573|NCT04607980|363281223|FG000|Overall Study|Adverse Event|3|||
105349574|NCT04607980|363281224|FG001|Overall Study|Adverse Event|4|||
105349575|NCT04607980|363281223|FG000|Overall Study|Death|0|||
105349576|NCT04607980|363281224|FG001|Overall Study|Death|1|||
105701567|NCT01471015|364569960|FG002|Overall Study|Death|1|||
105349577|NCT04607980|363281223|FG000|Overall Study|Withdrawal by Subject|2|||
105349578|NCT04607980|363281224|FG001|Overall Study|Withdrawal by Subject|5|||
105349579|NCT04607980|363281223|FG000|Overall Study|Lost to Follow-up|4|||
105349580|NCT04607980|363281224|FG001|Overall Study|Lost to Follow-up|8|||
105349581|NCT04607980|363281223|FG000|Overall Study|Protocol Violation|0|||
105349582|NCT04607980|363281224|FG001|Overall Study|Protocol Violation|3|||
105349583|NCT04607980|363281223|FG000|Overall Study|Other|3|||
105701568|NCT03374189|364569965|FG000|Overall Study|Lost to Follow-up|1|||
105701569|NCT03374189|364569966|FG001|Overall Study|Lost to Follow-up|0|||
105701570|NCT04712110|364569967|FG000|Overall Study|Lost to Follow-up|0|||
105701571|NCT04712110|364569968|FG001|Overall Study|Lost to Follow-up|1|||
105701572|NCT04712110|364569967|FG000|Overall Study|Withdrawal by Subject|0|||
105701573|NCT04712110|364569968|FG001|Overall Study|Withdrawal by Subject|4|||
105701574|NCT04712110|364569967|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
105349584|NCT04607980|363281224|FG001|Overall Study|Other|0|||
105349585|NCT02669082|363281225|FG000|Overall Study|Adverse Event|1|||
105349586|NCT01172808|363283282|FG000|Overall Study|Adverse Event|8|||
105349587|NCT01172808|363283283|FG001|Overall Study|Adverse Event|4|||
105349588|NCT01172808|363283284|FG002|Overall Study|Adverse Event|8|||
105349589|NCT01172808|363283285|FG003|Overall Study|Adverse Event|3|||
105349590|NCT01172808|363283282|FG000|Overall Study|Lack of Efficacy|1|||
105349591|NCT01172808|363283283|FG001|Overall Study|Lack of Efficacy|0|||
105349592|NCT01172808|363283284|FG002|Overall Study|Lack of Efficacy|0|||
105349593|NCT01172808|363283285|FG003|Overall Study|Lack of Efficacy|0|||
105349594|NCT01172808|363283282|FG000|Overall Study|Protocol Violation|2|||
105349595|NCT01172808|363283283|FG001|Overall Study|Protocol Violation|2|||
105349596|NCT01172808|363283284|FG002|Overall Study|Protocol Violation|2|||
105349597|NCT01172808|363283285|FG003|Overall Study|Protocol Violation|0|||
105474485|NCT03110770|363748582|FG000|Overall Study|Lost to Follow-up|0|||
105474486|NCT03110770|363748583|FG001|Overall Study|Lost to Follow-up|0|||
105474487|NCT03110770|363748584|FG002|Overall Study|Lost to Follow-up|0|||
105474488|NCT03110770|363748585|FG003|Overall Study|Lost to Follow-up|53|||
105474489|NCT03110770|363748586|FG004|Overall Study|Lost to Follow-up|45|||
105701575|NCT04712110|364569968|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
105701576|NCT01309659|364569969|FG000|Overall Study|Protocol Violation|0|||
105701577|NCT01309659|364569970|FG001|Overall Study|Protocol Violation|1|||
105701578|NCT00804570|364569971|FG000|Overall Study|Adverse Event|14|||
105474490|NCT03110770|363748582|FG000|Overall Study|Investigator Decision|0|||
105701579|NCT00804570|364569972|FG001|Overall Study|Adverse Event|7|||
105701580|NCT00804570|364569971|FG000|Overall Study|Lack of Efficacy|0|||
105701581|NCT00804570|364569972|FG001|Overall Study|Lack of Efficacy|1|||
105701582|NCT00804570|364569971|FG000|Overall Study|Lost to Follow-up|18|||
105701583|NCT00804570|364569972|FG001|Overall Study|Lost to Follow-up|21|||
105701584|NCT00804570|364569971|FG000|Overall Study|Entry criteria not met|5|||
105349598|NCT01172808|363283282|FG000|Overall Study|Lost to Follow-up|0|||
105349599|NCT01172808|363283283|FG001|Overall Study|Lost to Follow-up|1|||
105349600|NCT01172808|363283284|FG002|Overall Study|Lost to Follow-up|1|||
105349601|NCT01172808|363283285|FG003|Overall Study|Lost to Follow-up|3|||
105701585|NCT00804570|364569972|FG001|Overall Study|Entry criteria not met|5|||
105701586|NCT00804570|364569971|FG000|Overall Study|Protocol Violation|12|||
105349602|NCT01172808|363283282|FG000|Overall Study|Withdrawal by Subject|4|||
105349603|NCT01172808|363283283|FG001|Overall Study|Withdrawal by Subject|1|||
105349604|NCT01172808|363283284|FG002|Overall Study|Withdrawal by Subject|3|||
105474491|NCT03110770|363748583|FG001|Overall Study|Investigator Decision|0|||
105349605|NCT01172808|363283285|FG003|Overall Study|Withdrawal by Subject|2|||
105349606|NCT01172808|363283282|FG000|Overall Study|Other|6|||
105349607|NCT01172808|363283283|FG001|Overall Study|Other|5|||
105349608|NCT01172808|363283284|FG002|Overall Study|Other|9|||
105349609|NCT01172808|363283285|FG003|Overall Study|Other|7|||
105349610|NCT04942210|363283291|FG000|Overall Study|Adverse Event|0|||
105349611|NCT04942210|363283292|FG001|Overall Study|Adverse Event|1|||
105349612|NCT04942210|363283291|FG000|Overall Study|Protocol Deviation|4|||
105349613|NCT04942210|363283292|FG001|Overall Study|Protocol Deviation|1|||
105349614|NCT04942210|363283291|FG000|Overall Study|Withdrawal by Subject|5|||
105349615|NCT04942210|363283292|FG001|Overall Study|Withdrawal by Subject|2|||
105349616|NCT04942210|363283291|FG000|Overall Study|Lost to Follow-up|16|||
105349617|NCT04942210|363283292|FG001|Overall Study|Lost to Follow-up|7|||
105349618|NCT04942210|363283291|FG000|Overall Study|Ongoing at the time of DBL date|60|||
105349619|NCT04942210|363283292|FG001|Overall Study|Ongoing at the time of DBL date|25|||
105701587|NCT00804570|364569972|FG001|Overall Study|Protocol Violation|16|||
105701588|NCT00804570|364569971|FG000|Overall Study|Physician Decision|1|||
105349620|NCT04942210|363283291|FG000|Overall Study|Randomized but did not receive vaccination|3|||
105349621|NCT04942210|363283292|FG001|Overall Study|Randomized but did not receive vaccination|0|||
105349622|NCT05697627|363283293|FG000|Overall Study|Adverse Event|1|||
105349623|NCT02570750|363283294|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
105349624|NCT02570750|363283295|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
105349625|NCT02570750|363283294|FG000|Overall Study|Protocol deviation|4|||
105349626|NCT02570750|363283295|FG001|Overall Study|Protocol deviation|2|||
105349627|NCT02570750|363283294|FG000|Overall Study|Withdrawal by Subject|5|||
105349628|NCT02570750|363283295|FG001|Overall Study|Withdrawal by Subject|0|||
105349629|NCT02570750|363283294|FG000|Overall Study|Lost to Follow-up|2|||
105349630|NCT02570750|363283295|FG001|Overall Study|Lost to Follow-up|2|||
105349631|NCT02570750|363283294|FG000|Overall Study|Adverse Event|2|||
105349632|NCT02570750|363283295|FG001|Overall Study|Adverse Event|1|||
105349633|NCT04122625|363283296|FG000|Part A (up to 2.92 Years)|Death|2|||
105349634|NCT04122625|363283297|FG001|Part A (up to 2.92 Years)|Death|4|||
105349635|NCT04122625|363283298|FG002|Part A (up to 2.92 Years)|Death|0|||
105349636|NCT04122625|363283299|FG003|Part A (up to 2.92 Years)|Death|0|||
105349637|NCT04122625|363283300|FG004|Part A (up to 2.92 Years)|Death|0|||
105349638|NCT04122625|363283301|FG005|Part A (up to 2.92 Years)|Death|0|||
105349639|NCT04122625|363283296|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
105349640|NCT04122625|363283297|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
105349641|NCT04122625|363283298|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
105701589|NCT00804570|364569972|FG001|Overall Study|Physician Decision|2|||
105701590|NCT00804570|364569971|FG000|Overall Study|Sponsor decision|1|||
105701591|NCT00804570|364569972|FG001|Overall Study|Sponsor decision|4|||
105701592|NCT00804570|364569971|FG000|Overall Study|Withdrawal by Subject|21|||
105701593|NCT00804570|364569972|FG001|Overall Study|Withdrawal by Subject|38|||
105701594|NCT02285998|364569975|FG000|Overall Study|Adverse Event|9|||
105701595|NCT02285998|364569976|FG001|Overall Study|Adverse Event|8|||
105701596|NCT02285998|364569975|FG000|Overall Study|Physician Decision|1|||
105701597|NCT02285998|364569976|FG001|Overall Study|Physician Decision|2|||
105701598|NCT02285998|364569975|FG000|Overall Study|Lost to Follow-up|176|||
105701599|NCT02285998|364569976|FG001|Overall Study|Lost to Follow-up|172|||
105701600|NCT02285998|364569975|FG000|Overall Study|Withdrawal by Subject|53|||
105701601|NCT02285998|364569976|FG001|Overall Study|Withdrawal by Subject|61|||
105701602|NCT02285998|364569975|FG000|Overall Study|Other Reasons|7|||
105701603|NCT02285998|364569976|FG001|Overall Study|Other Reasons|10|||
105701604|NCT04037748|364569977|FG000|Treatment Period 1|Withdrawal by Subject|3|||
105701605|NCT04037748|364569978|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105701606|NCT04037748|364569977|FG000|Treatment Period 1|Adverse Event|1|||
105701607|NCT04037748|364569978|FG001|Treatment Period 1|Adverse Event|1|||
105701608|NCT04037748|364569977|FG000|Treatment Period 1|Protocol Violation|4|||
105701609|NCT04037748|364569978|FG001|Treatment Period 1|Protocol Violation|5|||
105701610|NCT04037748|364569977|FG000|Treatment Period 2|Adverse Event|0|||
105701611|NCT04037748|364569978|FG001|Treatment Period 2|Adverse Event|1|||
105701612|NCT04037748|364569977|FG000|Treatment Period 2|Protocol Violation|2|||
105701613|NCT04037748|364569978|FG001|Treatment Period 2|Protocol Violation|0|||
105701614|NCT00545298|364569979|FG000|Overall Study|Issues with Standard of Care|2|||
105701615|NCT00545298|364569980|FG001|Overall Study|Issues with Standard of Care|0|||
105701616|NCT00545298|364569981|FG002|Overall Study|Issues with Standard of Care|1|||
105474492|NCT03110770|363748584|FG002|Overall Study|Investigator Decision|0|||
105349642|NCT04122625|363283299|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
105474493|NCT03110770|363748585|FG003|Overall Study|Investigator Decision|5|||
105701617|NCT01820364|364569982|FG000|Part I: LGX818|Death|1|||
105349643|NCT04122625|363283300|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
105349644|NCT04122625|363283301|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
105349645|NCT04122625|363283296|FG000|Part B (up to 2.33 Years)|Death|0|||
105349646|NCT04122625|363283297|FG001|Part B (up to 2.33 Years)|Death|0|||
105349647|NCT04122625|363283298|FG002|Part B (up to 2.33 Years)|Death|5|||
105349648|NCT04122625|363283299|FG003|Part B (up to 2.33 Years)|Death|7|||
105349649|NCT04122625|363283300|FG004|Part B (up to 2.33 Years)|Death|6|||
105349650|NCT04122625|363283301|FG005|Part B (up to 2.33 Years)|Death|7|||
105349651|NCT02636699|363283302|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
105349652|NCT02636699|363283303|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
105349653|NCT02636699|363283304|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
105349654|NCT02636699|363283302|FG000|Screening Period|Withdrawal by Subject|0|||
105349655|NCT02636699|363283303|FG001|Screening Period|Withdrawal by Subject|0|||
105349656|NCT02636699|363283304|FG002|Screening Period|Withdrawal by Subject|23|||
105349657|NCT02636699|363283302|FG000|Screening Period|Adverse Event|0|||
105349658|NCT02636699|363283303|FG001|Screening Period|Adverse Event|0|||
105349659|NCT02636699|363283304|FG002|Screening Period|Adverse Event|1|||
105349660|NCT02636699|363283302|FG000|Screening Period|Other not specified|0|||
105349661|NCT02636699|363283303|FG001|Screening Period|Other not specified|0|||
105349662|NCT02636699|363283304|FG002|Screening Period|Other not specified|3|||
105349663|NCT02636699|363283302|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
105349664|NCT02636699|363283303|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
105349665|NCT02636699|363283304|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
105349666|NCT02636699|363283302|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
105349667|NCT02636699|363283303|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
105349668|NCT02636699|363283304|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
105349669|NCT02636699|363283302|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
105349670|NCT02636699|363283303|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
105349671|NCT02636699|363283304|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
105349672|NCT02636699|363283302|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
105349673|NCT02636699|363283303|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
105349674|NCT02636699|363283304|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
105349675|NCT02636699|363283302|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
105349676|NCT02636699|363283303|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
105349677|NCT02636699|363283304|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
105349678|NCT02636699|363283302|FG000|Treatment and Follow-up Periods|Other|3|||
105349679|NCT02636699|363283303|FG001|Treatment and Follow-up Periods|Other|1|||
105349680|NCT02636699|363283304|FG002|Treatment and Follow-up Periods|Other|0|||
105349681|NCT04379700|363283305|FG000|Overall Study|Withdrawal by Subject|10|||
105349682|NCT04379700|363283305|FG000|Overall Study|Screen Fail|4|||
105349683|NCT04379700|363283305|FG000|Overall Study|Lost to Follow-up|3|||
105349684|NCT00316914|363283330|FG000|Overall Study|Withdrawal by Subject|5|||
105349685|NCT00316914|363283331|FG001|Overall Study|Withdrawal by Subject|3|||
105349686|NCT00316914|363283330|FG000|Overall Study|Adverse Event|8|||
105349687|NCT00316914|363283331|FG001|Overall Study|Adverse Event|7|||
105349688|NCT00316914|363283330|FG000|Overall Study|Other Problems|6|||
105349689|NCT00316914|363283331|FG001|Overall Study|Other Problems|11|||
105349690|NCT00316914|363283330|FG000|Overall Study|Missing end of treatment documentation|14|||
105349691|NCT00316914|363283331|FG001|Overall Study|Missing end of treatment documentation|15|||
105349692|NCT03810235|363283332|FG000|Overall Study|Withdrawal by Subject|2|||
105349693|NCT03810235|363283333|FG001|Overall Study|Withdrawal by Subject|0|||
105349694|NCT00412217|363283334|FG000|Overall Study|Insufficient Data Available|8|||
105349695|NCT00412217|363283335|FG001|Overall Study|Insufficient Data Available|3|||
105349696|NCT00412217|363283334|FG000|Overall Study|Death|5|||
105349697|NCT00412217|363283335|FG001|Overall Study|Death|4|||
105349698|NCT00412217|363283334|FG000|Overall Study|Disease Progression|2|||
105349699|NCT00412217|363283335|FG001|Overall Study|Disease Progression|3|||
105349700|NCT00412217|363283334|FG000|Overall Study|Investigator Decision|1|||
105349701|NCT00412217|363283335|FG001|Overall Study|Investigator Decision|0|||
105349702|NCT00412217|363283334|FG000|Overall Study|Withdrawal by Subject|2|||
105349703|NCT00412217|363283335|FG001|Overall Study|Withdrawal by Subject|0|||
105349704|NCT00412217|363283334|FG000|Overall Study|Lost to Follow-up|1|||
105474494|NCT03110770|363748586|FG004|Overall Study|Investigator Decision|3|||
105474495|NCT03110770|363748582|FG000|Overall Study|Withdrawal by Subject|0|||
105474496|NCT03110770|363748583|FG001|Overall Study|Withdrawal by Subject|0|||
105349705|NCT00412217|363283335|FG001|Overall Study|Lost to Follow-up|4|||
105349706|NCT00412217|363283334|FG000|Overall Study|Study Terminated by Sponsor|26|||
105349707|NCT00412217|363283335|FG001|Overall Study|Study Terminated by Sponsor|33|||
105349708|NCT00412217|363283334|FG000|Overall Study|Other|1|||
105349709|NCT00412217|363283335|FG001|Overall Study|Other|1|||
105349710|NCT04526574|363283342|FG000|Overall Study|Protocol Violation|3|||
105349711|NCT04526574|363283343|FG001|Overall Study|Protocol Violation|1|||
105349712|NCT04526574|363283342|FG000|Overall Study|Withdrawal by Subject|12|||
105349713|NCT04526574|363283343|FG001|Overall Study|Withdrawal by Subject|9|||
105349714|NCT04526574|363283342|FG000|Overall Study|Other|1|||
105474497|NCT03110770|363748584|FG002|Overall Study|Withdrawal by Subject|0|||
105349715|NCT04526574|363283343|FG001|Overall Study|Other|2|||
105349716|NCT04526574|363283342|FG000|Overall Study|Adverse Event|1|||
105349717|NCT04526574|363283343|FG001|Overall Study|Adverse Event|1|||
105349718|NCT04526574|363283342|FG000|Overall Study|Death|2|||
105560129|NCT00828984|364046547|FG001|Overall Study|Noncompliant|2|||
105560130|NCT00828984|364046548|FG002|Overall Study|Noncompliant|3|||
105560131|NCT00828984|364046546|FG000|Overall Study|ConMed|1|||
105560132|NCT00828984|364046547|FG001|Overall Study|ConMed|1|||
105560133|NCT00828984|364046548|FG002|Overall Study|ConMed|1|||
105560134|NCT01733732|364046549|FG000|Overall Study|Adverse Event|1|||
105560135|NCT01733732|364046550|FG001|Overall Study|Adverse Event|0|||
105560136|NCT01733732|364046549|FG000|Overall Study|Did not attend all study visits|1|||
105560137|NCT01733732|364046550|FG001|Overall Study|Did not attend all study visits|0|||
105560138|NCT00754338|364046552|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
105560139|NCT00754338|364046553|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
105560140|NCT00754338|364046554|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
105560141|NCT00754338|364046555|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
105560142|NCT00754338|364046552|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
105560143|NCT00754338|364046553|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
105560144|NCT00754338|364046554|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
105560145|NCT00754338|364046555|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
105560146|NCT04528069|364046556|FG000|Overall Study|Adverse Event|1|||
105560147|NCT04528069|364046556|FG000|Overall Study|Lost to Follow-up|1|||
105560148|NCT04528069|364046556|FG000|Overall Study|Patient Unable to Come|1|||
105560149|NCT04528069|364046556|FG000|Overall Study|Patient Unable to Attend|1|||
105701618|NCT01820364|364569983|FG001|Part I: LGX818|Death|0|||
105701619|NCT01820364|364569982|FG000|Part I: LGX818|Administrative Problems|3|||
105701620|NCT01820364|364569983|FG001|Part I: LGX818|Administrative Problems|0|||
105701621|NCT01820364|364569982|FG000|Part I: LGX818|Adverse Event|6|||
105560150|NCT03152526|364046557|FG000|Overall Study|Withdrawal by Subject|0|||
105560151|NCT03152526|364046558|FG001|Overall Study|Withdrawal by Subject|1|||
105560152|NCT04040751|364046559|FG000|Overall Study|Withdrawal by Subject|2|||
105560153|NCT04040751|364046560|FG001|Overall Study|Withdrawal by Subject|0|||
105560154|NCT04040751|364046561|FG002|Overall Study|Withdrawal by Subject|2|||
105560155|NCT04040751|364046562|FG003|Overall Study|Withdrawal by Subject|0|||
105560156|NCT03492281|364046563|FG000|Overall Study|Withdrawal by Subject|21|||
105560157|NCT03492281|364046564|FG001|Overall Study|Withdrawal by Subject|14|||
105560158|NCT03492281|364046565|FG002|Overall Study|Withdrawal by Subject|13|||
105560159|NCT03492281|364046563|FG000|Overall Study|Lost to Follow-up|14|||
105701622|NCT01820364|364569983|FG001|Part I: LGX818|Adverse Event|0|||
105701623|NCT01820364|364569982|FG000|Part I: LGX818|Disease Progression|4|||
105701624|NCT01820364|364569983|FG001|Part I: LGX818|Disease Progression|0|||
105701625|NCT01820364|364569982|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
105701626|NCT01820364|364569983|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
105701627|NCT03451084|364569986|FG000|Overall Study|Withdrawal by Subject|2|||
105701628|NCT03451084|364569987|FG001|Overall Study|Withdrawal by Subject|1|||
105701629|NCT03451084|364569988|FG002|Overall Study|Withdrawal by Subject|2|||
105701630|NCT03451084|364569989|FG003|Overall Study|Withdrawal by Subject|1|||
105701631|NCT03451084|364569986|FG000|Overall Study|Disease recurrence|0|||
105701632|NCT03451084|364569987|FG001|Overall Study|Disease recurrence|2|||
105701633|NCT03451084|364569988|FG002|Overall Study|Disease recurrence|0|||
105701634|NCT03451084|364569989|FG003|Overall Study|Disease recurrence|0|||
105701635|NCT03451084|364569986|FG000|Overall Study|Lack of Efficacy|0|||
105701636|NCT03451084|364569987|FG001|Overall Study|Lack of Efficacy|3|||
105701637|NCT03451084|364569988|FG002|Overall Study|Lack of Efficacy|0|||
105701638|NCT03451084|364569989|FG003|Overall Study|Lack of Efficacy|1|||
105701639|NCT03451084|364569986|FG000|Overall Study|Death|1|||
105701640|NCT03451084|364569987|FG001|Overall Study|Death|0|||
105701641|NCT03451084|364569988|FG002|Overall Study|Death|2|||
105701642|NCT03451084|364569989|FG003|Overall Study|Death|0|||
105701643|NCT03451084|364569986|FG000|Overall Study|Physician Decision|0|||
105701644|NCT03451084|364569987|FG001|Overall Study|Physician Decision|0|||
105701645|NCT03451084|364569988|FG002|Overall Study|Physician Decision|2|||
105701646|NCT03451084|364569989|FG003|Overall Study|Physician Decision|2|||
105474498|NCT03110770|363748585|FG003|Overall Study|Withdrawal by Subject|24|||
105474499|NCT03110770|363748586|FG004|Overall Study|Withdrawal by Subject|24|||
105474500|NCT03110770|363748582|FG000|Overall Study|Moved from area|5|||
105474501|NCT03110770|363748583|FG001|Overall Study|Moved from area|0|||
105474502|NCT03110770|363748584|FG002|Overall Study|Moved from area|2|||
105474503|NCT03110770|363748585|FG003|Overall Study|Moved from area|42|||
105474504|NCT03110770|363748586|FG004|Overall Study|Moved from area|43|||
105560160|NCT03492281|364046564|FG001|Overall Study|Lost to Follow-up|15|||
105560161|NCT03492281|364046565|FG002|Overall Study|Lost to Follow-up|10|||
105560162|NCT03492281|364046563|FG000|Overall Study|Adverse Event|6|||
105560163|NCT03492281|364046564|FG001|Overall Study|Adverse Event|8|||
105474505|NCT03110770|363748582|FG000|Overall Study|Illness/Injury unrelated to product|0|||
105560164|NCT03492281|364046565|FG002|Overall Study|Adverse Event|13|||
105701647|NCT03451084|364569986|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
105701648|NCT03451084|364569987|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
105474506|NCT03110770|363748583|FG001|Overall Study|Illness/Injury unrelated to product|0|||
105701649|NCT03451084|364569988|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
105701650|NCT03451084|364569989|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
105701651|NCT03418129|364569992|FG000|Overall Study|Lost to Follow-up|11|||
105701652|NCT03418129|364569993|FG001|Overall Study|Lost to Follow-up|20|||
105701653|NCT03418129|364569994|FG002|Overall Study|Lost to Follow-up|15|||
105701654|NCT03418129|364569992|FG000|Overall Study|Withdrawal by Subject|3|||
105701655|NCT03418129|364569993|FG001|Overall Study|Withdrawal by Subject|6|||
105701656|NCT03418129|364569994|FG002|Overall Study|Withdrawal by Subject|4|||
105701657|NCT05289570|364570008|FG000|Overall Study|Physician Decision|1|||
105701658|NCT02664272|364570013|FG000|Overall Study|Fluoroscopic images not made available|2|||
105701659|NCT00964743|364570018|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
105701660|NCT00781911|364570020|FG000|Overall Study|Adverse Event|4|||
105701661|NCT00781911|364570021|FG001|Overall Study|Adverse Event|4|||
105701662|NCT00781911|364570020|FG000|Overall Study|Withdrawal by Subject|1|||
105701663|NCT00781911|364570021|FG001|Overall Study|Withdrawal by Subject|2|||
105701664|NCT00781911|364570020|FG000|Overall Study|Physician Decision|0|||
105701665|NCT00781911|364570021|FG001|Overall Study|Physician Decision|2|||
105701666|NCT00781911|364570020|FG000|Overall Study|Sponsor Decision|1|||
105701667|NCT00781911|364570021|FG001|Overall Study|Sponsor Decision|0|||
105701668|NCT00501007|364570028|FG000|Overall Study|Inclusion criteria not met.|29|||
105701669|NCT00501007|364570029|FG001|Overall Study|Inclusion criteria not met.|25|||
105701670|NCT02255409|364570032|FG000|Overall Study|Administrative Reason|3|||
105701671|NCT02255409|364570033|FG001|Overall Study|Administrative Reason|7|||
105701672|NCT02255409|364570032|FG000|Overall Study|Withdrawal by Subject|1|||
105701673|NCT02255409|364570033|FG001|Overall Study|Withdrawal by Subject|5|||
105701674|NCT02255409|364570032|FG000|Overall Study|Lost to Follow-up|10|||
105701675|NCT02255409|364570033|FG001|Overall Study|Lost to Follow-up|19|||
105701676|NCT03765138|364570034|FG000|Overall Study|Lost to Follow-up|1|||
105701677|NCT04050982|364570035|FG000|Overall Study|Did not meet eligibility criteria|0|||
105701678|NCT04050982|364570036|FG001|Overall Study|Did not meet eligibility criteria|1|||
105701679|NCT04050982|364570037|FG002|Overall Study|Did not meet eligibility criteria|0|||
105701680|NCT04050982|364570035|FG000|Overall Study|Withdrawal by Subject|1|||
105701681|NCT04050982|364570036|FG001|Overall Study|Withdrawal by Subject|0|||
105701682|NCT04050982|364570037|FG002|Overall Study|Withdrawal by Subject|0|||
105701683|NCT04050982|364570035|FG000|Overall Study|Unable to enroll on platform|1|||
105701684|NCT04050982|364570036|FG001|Overall Study|Unable to enroll on platform|0|||
105701685|NCT04050982|364570037|FG002|Overall Study|Unable to enroll on platform|0|||
105701686|NCT01538628|364570041|FG000|Overall Study|Withdrawal by Subject|1|||
105701687|NCT01538628|364570042|FG001|Overall Study|Withdrawal by Subject|1|||
105701688|NCT01538628|364570041|FG000|Overall Study|Lost to Follow-up|0|||
105701689|NCT01538628|364570042|FG001|Overall Study|Lost to Follow-up|1|||
105701690|NCT00102960|364570044|FG000|Overall Study|Death|23|||
105701691|NCT00102960|364570045|FG001|Overall Study|Death|11|||
105701692|NCT00102960|364570046|FG002|Overall Study|Death|11|||
105701693|NCT00102960|364570044|FG000|Overall Study|Lost to Follow-up|6|||
105701694|NCT00102960|364570045|FG001|Overall Study|Lost to Follow-up|12|||
105701695|NCT00102960|364570046|FG002|Overall Study|Lost to Follow-up|16|||
105701696|NCT00102960|364570044|FG000|Overall Study|Withdrawal by Subject|1|||
105701697|NCT00102960|364570045|FG001|Overall Study|Withdrawal by Subject|0|||
105701698|NCT00102960|364570046|FG002|Overall Study|Withdrawal by Subject|1|||
105701699|NCT00736255|364571799|FG000|Overall Study|Adverse Event|1|||
105701700|NCT00736255|364571800|FG001|Overall Study|Adverse Event|0|||
105701701|NCT00736255|364571799|FG000|Overall Study|Physician Decision|1|||
105701702|NCT00736255|364571800|FG001|Overall Study|Physician Decision|0|||
105701703|NCT00736255|364571799|FG000|Overall Study|Non-compliance|1|||
105701704|NCT00736255|364571800|FG001|Overall Study|Non-compliance|1|||
105701705|NCT02232802|364571804|FG000|Period 1|Sponsor request|1|||
105701706|NCT02232802|364571805|FG001|Period 1|Sponsor request|0|||
105701707|NCT02232802|364571804|FG000|Period 1|Adverse Event|1|||
105701708|NCT02232802|364571805|FG001|Period 1|Adverse Event|1|||
105701709|NCT01183143|364571809|FG000|Overall Study|Protocol Violation|115|||
105701710|NCT01183143|364571809|FG000|Overall Study|Withdrawal by Subject|19|||
105701711|NCT01183143|364571809|FG000|Overall Study|Subject Questionnaires not returned|5|||
105701712|NCT01183143|364571809|FG000|Overall Study|Subjects enrolled, but not treated|11|||
105701713|NCT04096274|364571811|FG000|Phase I|Lost to Follow-up|5|||
105701714|NCT04096274|364571812|FG001|Phase I|Lost to Follow-up|5|||
105701715|NCT04096274|364571811|FG000|Phase II|Lost to Follow-up|11|||
105701716|NCT04096274|364571812|FG001|Phase II|Lost to Follow-up|11|||
105701717|NCT00346073|364571821|FG000|Overall Study|Serious Adverse Event|2|||
105701718|NCT00346073|364571822|FG001|Overall Study|Serious Adverse Event|0|||
105701719|NCT00346073|364571821|FG000|Overall Study|Lost to Follow-up|39|||
105701720|NCT00346073|364571822|FG001|Overall Study|Lost to Follow-up|24|||
105701721|NCT00457015|364571823|FG000|Overall Study|Left study site against medical advice|0|||
105701722|NCT00457015|364571824|FG001|Overall Study|Left study site against medical advice|1|||
105701723|NCT04342871|364571825|FG000|Overall Study|Death|4|||
105701724|NCT04342871|364571825|FG000|Overall Study|Clinical deterioration/illness progression|2|||
105701725|NCT04342871|364571825|FG000|Overall Study|Did not complete baseline assessments|5|||
105701726|NCT04342871|364571825|FG000|Overall Study|Lost to Follow-up|13|||
105701727|NCT00747643|364571827|FG000|Overall Study|Withdrawal by Subject|36|||
105701728|NCT00747643|364571828|FG001|Overall Study|Withdrawal by Subject|27|||
105701729|NCT02263079|364571831|FG000|Overall Study|Physician Decision|1|||
105701730|NCT02263079|364571832|FG001|Overall Study|Physician Decision|0|||
105701731|NCT02263079|364571833|FG002|Overall Study|Physician Decision|0|||
105701732|NCT02263079|364571831|FG000|Overall Study|Withdrawal by Subject|2|||
105701733|NCT02263079|364571832|FG001|Overall Study|Withdrawal by Subject|8|||
105701734|NCT02263079|364571833|FG002|Overall Study|Withdrawal by Subject|0|||
105701735|NCT01199042|364571834|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
105701736|NCT01199042|364571834|FG000|At Home (3 Months)|Lost to Follow-up|1|||
105701737|NCT01227187|364571839|FG000|Overall Study|Physician Decision|0|||
105701738|NCT01227187|364571840|FG001|Overall Study|Physician Decision|0|||
105701739|NCT01227187|364571841|FG002|Overall Study|Physician Decision|0|||
105701740|NCT01227187|364571842|FG003|Overall Study|Physician Decision|1|||
105701741|NCT02554019|364571843|FG000|Overall Study|Withdrawal by Subject|1|||
105701742|NCT02554019|364571844|FG001|Overall Study|Withdrawal by Subject|0|||
105701743|NCT02554019|364571845|FG002|Overall Study|Withdrawal by Subject|2|||
105701744|NCT02554019|364571843|FG000|Overall Study|Adverse Event|1|||
105701745|NCT02554019|364571844|FG001|Overall Study|Adverse Event|0|||
105701746|NCT02554019|364571845|FG002|Overall Study|Adverse Event|0|||
105701747|NCT03179891|364571849|FG000|First Intervention|Withdrawal by Subject|1|||
105701748|NCT03179891|364571850|FG001|First Intervention|Withdrawal by Subject|1|||
105701749|NCT03179891|364571849|FG000|First Intervention|Unspecified reason|1|||
105701750|NCT03179891|364571850|FG001|First Intervention|Unspecified reason|0|||
105701751|NCT03179891|364571849|FG000|First Intervention|Protocol Violation|0|||
105701752|NCT03179891|364571850|FG001|First Intervention|Protocol Violation|1|||
105701753|NCT02113436|364571851|FG000|Period 1: 8 Weeks|Adverse Event|1|||
105701754|NCT02113436|364571852|FG001|Period 1: 8 Weeks|Adverse Event|0|||
105701755|NCT02113436|364571853|FG002|Period 1: 8 Weeks|Adverse Event|0|||
105701756|NCT02113436|364571854|FG003|Period 1: 8 Weeks|Adverse Event|0|||
105701757|NCT02113436|364571851|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
105701758|NCT02113436|364571852|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
105701759|NCT02113436|364571853|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
105701760|NCT02113436|364571854|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
105701761|NCT02113436|364571851|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
105701762|NCT02113436|364571852|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
105701763|NCT02113436|364571853|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
105701764|NCT02113436|364571854|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
105701765|NCT02113436|364571851|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
105701766|NCT02113436|364571852|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
105701767|NCT02113436|364571853|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
105701768|NCT02113436|364571854|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
105701769|NCT02113436|364571851|FG000|Period 2: 16 Weeks|Adverse Event|0|||
105701770|NCT02113436|364571852|FG001|Period 2: 16 Weeks|Adverse Event|0|||
105701771|NCT02113436|364571853|FG002|Period 2: 16 Weeks|Adverse Event|4|||
105701772|NCT02113436|364571854|FG003|Period 2: 16 Weeks|Adverse Event|5|||
105701773|NCT02113436|364571851|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
105701774|NCT02113436|364571852|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
105701775|NCT02113436|364571853|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
105701776|NCT02113436|364571854|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
105701777|NCT02113436|364571851|FG000|Period 2: 16 Weeks|Physician Decision|0|||
105701778|NCT02113436|364571852|FG001|Period 2: 16 Weeks|Physician Decision|0|||
105701779|NCT02113436|364571853|FG002|Period 2: 16 Weeks|Physician Decision|2|||
105701780|NCT02113436|364571854|FG003|Period 2: 16 Weeks|Physician Decision|0|||
105701781|NCT02113436|364571851|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
105701782|NCT02113436|364571852|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
105701783|NCT02113436|364571853|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
105701784|NCT02113436|364571854|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
105701785|NCT01732796|364571855|FG000|Overall Study|Adverse Event|16|||
105701786|NCT01732796|364571856|FG001|Overall Study|Adverse Event|16|||
105701787|NCT01732796|364571857|FG002|Overall Study|Adverse Event|4|||
105701788|NCT01732796|364571855|FG000|Overall Study|Lack of Efficacy|21|||
105701789|NCT01732796|364571856|FG001|Overall Study|Lack of Efficacy|18|||
105701790|NCT01732796|364571857|FG002|Overall Study|Lack of Efficacy|5|||
105701791|NCT01732796|364571855|FG000|Overall Study|Lost to Follow-up|2|||
105701792|NCT01732796|364571856|FG001|Overall Study|Lost to Follow-up|0|||
105701793|NCT01732796|364571857|FG002|Overall Study|Lost to Follow-up|0|||
105701794|NCT01732796|364571855|FG000|Overall Study|Withdrawal by Subject|6|||
105701795|NCT01732796|364571856|FG001|Overall Study|Withdrawal by Subject|8|||
105701796|NCT01732796|364571857|FG002|Overall Study|Withdrawal by Subject|2|||
105701797|NCT01732796|364571855|FG000|Overall Study|Other reason not defined above|1|||
105701798|NCT01732796|364571856|FG001|Overall Study|Other reason not defined above|0|||
105701799|NCT01732796|364571857|FG002|Overall Study|Other reason not defined above|2|||
105701800|NCT01967628|364571861|FG000|Overall Study|Withdrawal by Subject|2|||
105701801|NCT01967628|364571862|FG001|Overall Study|Withdrawal by Subject|0|||
105701802|NCT01967628|364571861|FG000|Overall Study|Unable to complete bronchoscopy|4|||
105701803|NCT01967628|364571862|FG001|Overall Study|Unable to complete bronchoscopy|6|||
105701804|NCT01967628|364571861|FG000|Overall Study|Lost to Follow-up|1|||
105701805|NCT01967628|364571862|FG001|Overall Study|Lost to Follow-up|0|||
105701806|NCT01967628|364571861|FG000|Overall Study|Low protein concentration in sample|20|||
105701807|NCT01967628|364571862|FG001|Overall Study|Low protein concentration in sample|25|||
105701808|NCT01197521|364571863|FG000|Overall Study|Not reported|24|||
105701809|NCT01197521|364571864|FG001|Overall Study|Not reported|25|||
105701810|NCT01197521|364571865|FG002|Overall Study|Not reported|21|||
105701811|NCT01197521|364571863|FG000|Overall Study|Enrolment in long term extension|42|||
105349719|NCT04526574|363283343|FG001|Overall Study|Death|3|||
105349720|NCT04526574|363283342|FG000|Overall Study|Lost to Follow-up|9|||
105349721|NCT04526574|363283343|FG001|Overall Study|Lost to Follow-up|9|||
105701812|NCT01197521|364571864|FG001|Overall Study|Enrolment in long term extension|36|||
105701813|NCT01197521|364571865|FG002|Overall Study|Enrolment in long term extension|87|||
105701814|NCT01197521|364571863|FG000|Overall Study|Severe non-compliance to protocol|1|||
105701815|NCT01197521|364571864|FG001|Overall Study|Severe non-compliance to protocol|3|||
105701816|NCT01197521|364571865|FG002|Overall Study|Severe non-compliance to protocol|3|||
105701817|NCT01197521|364571863|FG000|Overall Study|Lack of therapeutic response|2|||
105701818|NCT01197521|364571864|FG001|Overall Study|Lack of therapeutic response|3|||
105701819|NCT01197521|364571865|FG002|Overall Study|Lack of therapeutic response|4|||
105701820|NCT01197521|364571863|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
105701821|NCT01197521|364571864|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
105701822|NCT01197521|364571865|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
105701823|NCT01197521|364571863|FG000|Overall Study|Lost to Follow-up|3|||
105701824|NCT01197521|364571864|FG001|Overall Study|Lost to Follow-up|2|||
105701825|NCT01197521|364571865|FG002|Overall Study|Lost to Follow-up|2|||
105349722|NCT04526574|363283342|FG000|Overall Study|No longer meets eligibility criteria|8|||
105349723|NCT04526574|363283343|FG001|Overall Study|No longer meets eligibility criteria|8|||
105349724|NCT01398410|363283344|FG000|Overall Study|Adverse Event|12|||
105349725|NCT01398410|363283345|FG001|Overall Study|Adverse Event|16|||
105349726|NCT01398410|363283344|FG000|Overall Study|Participants Choice|8|||
105349727|NCT01398410|363283345|FG001|Overall Study|Participants Choice|11|||
105349728|NCT01398410|363283344|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
105349729|NCT01398410|363283345|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
105349730|NCT01398410|363283344|FG000|Overall Study|Other|36|||
105349731|NCT01398410|363283345|FG001|Overall Study|Other|29|||
105349732|NCT03436199|363283349|FG000|Overall Study|Adverse Event|15|||
105349733|NCT03436199|363283350|FG001|Overall Study|Adverse Event|40|||
105349734|NCT03436199|363283351|FG002|Overall Study|Adverse Event|7|||
105349735|NCT03436199|363283349|FG000|Overall Study|Withdrawal by Subject|4|||
105349736|NCT03436199|363283350|FG001|Overall Study|Withdrawal by Subject|10|||
105349737|NCT03436199|363283351|FG002|Overall Study|Withdrawal by Subject|3|||
105349738|NCT03436199|363283349|FG000|Overall Study|Lost to Follow-up|1|||
105349739|NCT03436199|363283350|FG001|Overall Study|Lost to Follow-up|0|||
105349740|NCT03436199|363283351|FG002|Overall Study|Lost to Follow-up|2|||
105349741|NCT03436199|363283349|FG000|Overall Study|Protocol Violation|1|||
105349742|NCT03436199|363283350|FG001|Overall Study|Protocol Violation|1|||
105349743|NCT03436199|363283351|FG002|Overall Study|Protocol Violation|0|||
105349744|NCT03436199|363283349|FG000|Overall Study|Physician Decision|0|||
105349745|NCT03436199|363283350|FG001|Overall Study|Physician Decision|1|||
105349746|NCT03436199|363283351|FG002|Overall Study|Physician Decision|0|||
105349747|NCT03436199|363283349|FG000|Overall Study|Could not return to clinic|1|||
105349748|NCT03436199|363283350|FG001|Overall Study|Could not return to clinic|0|||
105349749|NCT03436199|363283351|FG002|Overall Study|Could not return to clinic|0|||
105349750|NCT03436199|363283349|FG000|Overall Study|Withdrawn per physician|0|||
105349751|NCT03436199|363283350|FG001|Overall Study|Withdrawn per physician|1|||
105349752|NCT03436199|363283351|FG002|Overall Study|Withdrawn per physician|0|||
105349753|NCT00085098|363283352|FG000|Overall Study|Withdrawal by Subject|0|||
105349754|NCT00085098|363283353|FG001|Overall Study|Withdrawal by Subject|1|||
105349755|NCT00085098|363283352|FG000|Overall Study|Ineligible|1|||
105349756|NCT00085098|363283353|FG001|Overall Study|Ineligible|1|||
105701826|NCT01197521|364571863|FG000|Overall Study|Adverse Event|25|||
105349757|NCT03329248|363283354|FG000|Overall Study|Progressive Disease|6|||
105349758|NCT01254721|363283355|FG000|Overall Study|Lost to Follow-up|0|||
105349759|NCT01254721|363283356|FG001|Overall Study|Lost to Follow-up|4|||
105349760|NCT01254721|363283355|FG000|Overall Study|Lack of Efficacy|4|||
105349761|NCT01254721|363283356|FG001|Overall Study|Lack of Efficacy|2|||
105349762|NCT01254721|363283355|FG000|Overall Study|Death|0|||
105349763|NCT01254721|363283356|FG001|Overall Study|Death|1|||
105349764|NCT01254721|363283355|FG000|Overall Study|technical problum|1|||
105349765|NCT01254721|363283356|FG001|Overall Study|technical problum|0|||
105349766|NCT01254721|363283355|FG000|Overall Study|Adverse Event|2|||
105349767|NCT01254721|363283356|FG001|Overall Study|Adverse Event|3|||
105701827|NCT01197521|364571864|FG001|Overall Study|Adverse Event|28|||
105701828|NCT01197521|364571865|FG002|Overall Study|Adverse Event|24|||
105701829|NCT03259074|364571866|FG000|Overall Study|Adverse Event|9|||
105701830|NCT03259074|364571867|FG001|Overall Study|Adverse Event|12|||
105701831|NCT03259074|364571868|FG002|Overall Study|Adverse Event|8|||
105701832|NCT03259074|364571866|FG000|Overall Study|Death|1|||
105701833|NCT03259074|364571867|FG001|Overall Study|Death|1|||
105701834|NCT03259074|364571868|FG002|Overall Study|Death|3|||
105701835|NCT03259074|364571866|FG000|Overall Study|Lost to Follow-up|2|||
105701836|NCT03259074|364571867|FG001|Overall Study|Lost to Follow-up|4|||
105701837|NCT03259074|364571868|FG002|Overall Study|Lost to Follow-up|3|||
105701838|NCT03259074|364571866|FG000|Overall Study|New Therapy For Study Indication|1|||
105701839|NCT03259074|364571867|FG001|Overall Study|New Therapy For Study Indication|2|||
105701840|NCT03259074|364571868|FG002|Overall Study|New Therapy For Study Indication|2|||
105701841|NCT03259074|364571866|FG000|Overall Study|Physician Decision|4|||
105701842|NCT03259074|364571867|FG001|Overall Study|Physician Decision|12|||
105701843|NCT03259074|364571868|FG002|Overall Study|Physician Decision|10|||
105701844|NCT03259074|364571866|FG000|Overall Study|Pregnancy|1|||
105701845|NCT03259074|364571867|FG001|Overall Study|Pregnancy|1|||
105701846|NCT03259074|364571868|FG002|Overall Study|Pregnancy|0|||
105701847|NCT03259074|364571866|FG000|Overall Study|Progressive Disease|1|||
105701848|NCT03259074|364571867|FG001|Overall Study|Progressive Disease|0|||
105701849|NCT03259074|364571868|FG002|Overall Study|Progressive Disease|0|||
105701850|NCT03259074|364571866|FG000|Overall Study|Protocol Deviation|1|||
105701851|NCT03259074|364571867|FG001|Overall Study|Protocol Deviation|1|||
105701852|NCT03259074|364571868|FG002|Overall Study|Protocol Deviation|3|||
105701853|NCT03259074|364571866|FG000|Overall Study|Subject/Guardian Decision|13|||
105701854|NCT03259074|364571867|FG001|Overall Study|Subject/Guardian Decision|16|||
105701855|NCT03259074|364571868|FG002|Overall Study|Subject/Guardian Decision|14|||
105701856|NCT00618410|364571871|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
105701857|NCT00618410|364571872|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
105701858|NCT03901079|364571875|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
105701859|NCT03975920|364571876|FG000|Overall Study|Lost to Follow-up|1|||
105701860|NCT03975920|364571877|FG001|Overall Study|Lost to Follow-up|2|||
105701861|NCT03975920|364571876|FG000|Overall Study|Protocol Violation|1|||
105701862|NCT03975920|364571877|FG001|Overall Study|Protocol Violation|1|||
105701863|NCT03975920|364571876|FG000|Overall Study|Did not complete survey|2|||
105701864|NCT03975920|364571877|FG001|Overall Study|Did not complete survey|1|||
105701865|NCT00827606|364571878|FG000|Overall Study|Protocol Violation|4|||
105701866|NCT00827606|364571879|FG001|Overall Study|Protocol Violation|3|||
105701867|NCT00827606|364571878|FG000|Overall Study|Lost to Follow-up|3|||
105701868|NCT00827606|364571879|FG001|Overall Study|Lost to Follow-up|1|||
105701869|NCT00827606|364571878|FG000|Overall Study|Withdrawal by Subject|7|||
105701870|NCT00827606|364571879|FG001|Overall Study|Withdrawal by Subject|6|||
105701871|NCT00827606|364571878|FG000|Overall Study|Pregnancy|0|||
105701872|NCT00827606|364571879|FG001|Overall Study|Pregnancy|1|||
105701873|NCT00827606|364571878|FG000|Overall Study|Other|5|||
105701874|NCT00827606|364571879|FG001|Overall Study|Other|13|||
105701875|NCT00827606|364571878|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
105701876|NCT00827606|364571879|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
105701877|NCT00827606|364571878|FG000|Overall Study|Adverse Event|4|||
105701878|NCT00827606|364571879|FG001|Overall Study|Adverse Event|2|||
105701879|NCT00841568|364571880|FG000|Overall Study|Adverse Event|1|||
105701880|NCT00841568|364571880|FG000|Overall Study|Death|1|||
105701881|NCT00841568|364571880|FG000|Overall Study|Withdrawal by Subject|2|||
105701882|NCT00841568|364571880|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
105701883|NCT04995055|364571887|FG000|Period 1|COVID-19 Related|1|||
105701884|NCT04995055|364571888|FG001|Period 1|COVID-19 Related|0|||
105701885|NCT04995055|364571887|FG000|Period 1|Withdrawal by Subject|0|||
105701886|NCT04995055|364571888|FG001|Period 1|Withdrawal by Subject|1|||
105701887|NCT04995055|364571887|FG000|Period 1|Subject discontinued due to timing|4|||
105701888|NCT04995055|364571888|FG001|Period 1|Subject discontinued due to timing|4|||
105701889|NCT00825162|364571891|FG000|Overall Study|Withdrawal by Subject|11|||
105701890|NCT00825162|364571892|FG001|Overall Study|Withdrawal by Subject|13|||
105701891|NCT00825162|364571893|FG002|Overall Study|Withdrawal by Subject|3|||
105701892|NCT00825162|364571891|FG000|Overall Study|Lost to Follow-up|9|||
105701893|NCT00825162|364571892|FG001|Overall Study|Lost to Follow-up|6|||
105701894|NCT00825162|364571893|FG002|Overall Study|Lost to Follow-up|3|||
105701895|NCT00825162|364571891|FG000|Overall Study|Physician Decision|2|||
105701896|NCT00825162|364571892|FG001|Overall Study|Physician Decision|0|||
105701897|NCT00825162|364571893|FG002|Overall Study|Physician Decision|0|||
105701898|NCT00825162|364571891|FG000|Overall Study|Move away from the study area|1|||
105701899|NCT00825162|364571892|FG001|Overall Study|Move away from the study area|0|||
105701900|NCT00825162|364571893|FG002|Overall Study|Move away from the study area|0|||
105701901|NCT00825162|364571891|FG000|Overall Study|Unable to attend the study visit|5|||
105701902|NCT00825162|364571892|FG001|Overall Study|Unable to attend the study visit|2|||
105701903|NCT00825162|364571893|FG002|Overall Study|Unable to attend the study visit|0|||
105701904|NCT00939783|364571894|FG000|Overall Study|Death|6|||
105701905|NCT00939783|364571894|FG000|Overall Study|Adverse Event|39|||
105701906|NCT00939783|364571894|FG000|Overall Study|Study Terminated by Sponsor|498|||
105701907|NCT00939783|364571894|FG000|Overall Study|Withdrawal by Subject|78|||
105701908|NCT00939783|364571894|FG000|Overall Study|Other|16|||
105701909|NCT00939783|364571894|FG000|Overall Study|Lost to Follow-up|8|||
105701910|NCT00939783|364571894|FG000|Overall Study|Protocol Violation|3|||
105701911|NCT00939783|364571894|FG000|Overall Study|Enrolled but not treated|1|||
105701912|NCT03073980|364571895|FG000|Overall Study|Lost to Follow-up|10|||
105701913|NCT03073980|364571896|FG001|Overall Study|Lost to Follow-up|2|||
105701914|NCT03073980|364571897|FG002|Overall Study|Lost to Follow-up|9|||
105701915|NCT03073980|364571895|FG000|Overall Study|No post-procedure data|0|||
105701916|NCT03073980|364571896|FG001|Overall Study|No post-procedure data|0|||
105701917|NCT03073980|364571897|FG002|Overall Study|No post-procedure data|2|||
105701918|NCT00545064|364571900|FG000|Overall Study|Lost to Follow-up|3|||
105701919|NCT00545064|364571900|FG000|Overall Study|Withdrawal by Subject|2|||
105701920|NCT00545064|364571900|FG000|Overall Study|did not complete course of treatment|1|||
105701921|NCT00545064|364571900|FG000|Overall Study|cancel all appointments, no rebooking|1|||
105701922|NCT00545064|364571900|FG000|Overall Study|inclement weather|1|||
105701923|NCT00884273|364571903|FG000|Overall Study|Adverse Event|0|||
105701924|NCT00884273|364571904|FG001|Overall Study|Adverse Event|2|||
105701925|NCT00884273|364571903|FG000|Overall Study|Protocol Violation|1|||
105701926|NCT00884273|364571904|FG001|Overall Study|Protocol Violation|3|||
105701927|NCT00884273|364571903|FG000|Overall Study|Practical reasons|1|||
105701928|NCT00884273|364571904|FG001|Overall Study|Practical reasons|0|||
105701929|NCT00583362|364571905|FG000|Overall Study|Adverse Event|44|||
105701930|NCT00583362|364571905|FG000|Overall Study|Lack of Efficacy|22|||
105701931|NCT00583362|364571905|FG000|Overall Study|Lost to Follow-up|4|||
105701932|NCT00583362|364571905|FG000|Overall Study|Non-compliance with study drug|28|||
105701933|NCT00583362|364571905|FG000|Overall Study|Pregnancy|7|||
105701934|NCT00583362|364571905|FG000|Overall Study|Miscommunication of visit window|5|||
105701935|NCT00583362|364571905|FG000|Overall Study|Current site closed|7|||
105701936|NCT00583362|364571905|FG000|Overall Study|Subject not dosed in LBSL99|1|||
105701937|NCT00583362|364571905|FG000|Overall Study|Subject moved out of the country/state|2|||
105701938|NCT00583362|364571905|FG000|Overall Study|Missed visits due to staff changes|1|||
105701939|NCT00583362|364571905|FG000|Overall Study|Misunderstanding of protocol|1|||
105701940|NCT00583362|364571905|FG000|Overall Study|Behavioral problems and non-compliance|1|||
105701941|NCT00583362|364571905|FG000|Overall Study|Sponsor request due to missed doses|1|||
105701942|NCT00583362|364571905|FG000|Overall Study|Physician Decision|19|||
105701943|NCT00583362|364571905|FG000|Overall Study|Protocol Violation|2|||
105701944|NCT00583362|364571905|FG000|Overall Study|Withdrawal by Subject|57|||
105701945|NCT02937818|364571906|FG000|Overall Study|Participants decision|2|||
105701946|NCT02937818|364571907|FG001|Overall Study|Participants decision|1|||
105701947|NCT02937818|364571908|FG002|Overall Study|Participants decision|1|||
105701948|NCT02937818|364571909|FG003|Overall Study|Participants decision|1|||
105701949|NCT02937818|364571906|FG000|Overall Study|Adverse Event|2|||
105701950|NCT02937818|364571907|FG001|Overall Study|Adverse Event|4|||
105701951|NCT02937818|364571908|FG002|Overall Study|Adverse Event|1|||
105701952|NCT02937818|364571909|FG003|Overall Study|Adverse Event|1|||
105701953|NCT02937818|364571906|FG000|Overall Study|Disease progression|17|||
105701954|NCT02937818|364571907|FG001|Overall Study|Disease progression|15|||
105701955|NCT02937818|364571908|FG002|Overall Study|Disease progression|7|||
105701956|NCT02937818|364571909|FG003|Overall Study|Disease progression|19|||
105701957|NCT02937818|364571906|FG000|Overall Study|Condition under investigation worsened|0|||
105701958|NCT02937818|364571907|FG001|Overall Study|Condition under investigation worsened|0|||
105701959|NCT02937818|364571908|FG002|Overall Study|Condition under investigation worsened|1|||
105701960|NCT02937818|364571909|FG003|Overall Study|Condition under investigation worsened|0|||
105701961|NCT02700997|364571910|FG000|Overall Study|Did not undergo CT imaging|1|||
105701962|NCT02700997|364571910|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
105701963|NCT02739620|364571913|FG000|Overall Study|Lost to Follow-up|3|||
105701964|NCT02739620|364571914|FG001|Overall Study|Lost to Follow-up|1|||
105701965|NCT02739620|364571913|FG000|Overall Study|Adverse Event|0|||
105701966|NCT02739620|364571914|FG001|Overall Study|Adverse Event|1|||
105701967|NCT04126083|364571915|FG000|Overall Study|Withdrawal by Subject|1|||
105701968|NCT02873936|364571916|FG000|Overall Study|Withdrew Consent|4|||
105349768|NCT01254721|363283355|FG000|Overall Study|Withdrawal by Subject|8|||
105701969|NCT02873936|364571917|FG001|Overall Study|Withdrew Consent|11|||
105701970|NCT02873936|364571918|FG002|Overall Study|Withdrew Consent|20|||
105701971|NCT02873936|364571916|FG000|Overall Study|Investigator's Discretion|3|||
105701972|NCT02873936|364571917|FG001|Overall Study|Investigator's Discretion|5|||
105701973|NCT02873936|364571918|FG002|Overall Study|Investigator's Discretion|4|||
105701974|NCT02873936|364571916|FG000|Overall Study|Adverse Event|3|||
105701975|NCT02873936|364571917|FG001|Overall Study|Adverse Event|5|||
105349769|NCT01254721|363283356|FG001|Overall Study|Withdrawal by Subject|11|||
105701976|NCT02873936|364571918|FG002|Overall Study|Adverse Event|3|||
105701977|NCT02873936|364571916|FG000|Overall Study|Protocol Violation|0|||
105349770|NCT01254721|363283355|FG000|Overall Study|Wrongly randomization|0|||
105701978|NCT02873936|364571917|FG001|Overall Study|Protocol Violation|1|||
105349771|NCT01254721|363283356|FG001|Overall Study|Wrongly randomization|1|||
105701979|NCT02873936|364571918|FG002|Overall Study|Protocol Violation|3|||
105701980|NCT02873936|364571916|FG000|Overall Study|Lost to Follow-up|1|||
105701981|NCT02873936|364571917|FG001|Overall Study|Lost to Follow-up|1|||
105701982|NCT02873936|364571918|FG002|Overall Study|Lost to Follow-up|1|||
105349772|NCT03000530|363283357|FG000|Overall Study|Adverse Event|0|||
105349773|NCT03000530|363283358|FG001|Overall Study|Adverse Event|0|||
105701983|NCT02873936|364571916|FG000|Overall Study|Non-compliance With Study Drug|1|||
105701984|NCT02873936|364571917|FG001|Overall Study|Non-compliance With Study Drug|0|||
105701985|NCT02873936|364571918|FG002|Overall Study|Non-compliance With Study Drug|1|||
105349774|NCT03000530|363283359|FG002|Overall Study|Adverse Event|2|||
105349775|NCT03000530|363283357|FG000|Overall Study|Lost to Follow-up|0|||
105349776|NCT03000530|363283358|FG001|Overall Study|Lost to Follow-up|3|||
105349777|NCT03000530|363283359|FG002|Overall Study|Lost to Follow-up|1|||
105349778|NCT03000530|363283357|FG000|Overall Study|Withdrawal by Subject|0|||
105349779|NCT03000530|363283358|FG001|Overall Study|Withdrawal by Subject|2|||
105349780|NCT03000530|363283359|FG002|Overall Study|Withdrawal by Subject|1|||
105349781|NCT01430624|363283365|FG000|Overall Study|Lost to Follow-up|23|||
105349782|NCT01430624|363283366|FG001|Overall Study|Lost to Follow-up|29|||
105349783|NCT01430624|363283367|FG002|Overall Study|Lost to Follow-up|27|||
105349784|NCT01430624|363283365|FG000|Overall Study|technical or eligibility|5|||
105349785|NCT01430624|363283366|FG001|Overall Study|technical or eligibility|5|||
105701986|NCT02873936|364571916|FG000|Overall Study|Randomized but not Dosed|1|||
105701987|NCT02873936|364571917|FG001|Overall Study|Randomized but not Dosed|0|||
105701988|NCT02873936|364571918|FG002|Overall Study|Randomized but not Dosed|0|||
105701989|NCT05513625|364571919|FG000|Overall Study|Withdrawal by Subject|1|||
105701990|NCT01279850|364571920|FG000|Overall Study|Protocol Violation|50|||
105701991|NCT01279850|364571920|FG000|Overall Study|No Drug Administration Information|7|||
105701992|NCT01279850|364571920|FG000|Overall Study|No Visit After Treatment|34|||
105701993|NCT01131520|364571921|FG000|Overall Study|Computer problem|1|||
105701994|NCT01131520|364571922|FG001|Overall Study|Computer problem|0|||
105701995|NCT01131520|364571921|FG000|Overall Study|Counselor not available|0|||
105701996|NCT01131520|364571922|FG001|Overall Study|Counselor not available|3|||
105701997|NCT01131520|364571921|FG000|Overall Study|Subject changed history after enrollment|0|||
105701998|NCT01131520|364571922|FG001|Overall Study|Subject changed history after enrollment|1|||
105701999|NCT01073267|364571926|FG000|Overall Study|Disease Progression|3|||
105702000|NCT01225731|364571927|FG000|Part 1|Did not meet eligibility criteria|1|||
105349786|NCT01430624|363283367|FG002|Overall Study|technical or eligibility|2|||
105349787|NCT01362517|363283368|FG000|Overall Study|Protocol Violation|1|||
105349788|NCT01362517|363283368|FG000|Overall Study|Lost to Follow-up|1|||
105349789|NCT02614131|363283369|FG000|Overall Study|Withdrawal by Subject|1|||
105349790|NCT02614131|363283370|FG001|Overall Study|Withdrawal by Subject|0|||
105349791|NCT02614131|363283371|FG002|Overall Study|Withdrawal by Subject|0|||
105349792|NCT02614131|363283372|FG003|Overall Study|Withdrawal by Subject|0|||
105349793|NCT02614131|363283373|FG004|Overall Study|Withdrawal by Subject|0|||
105349794|NCT02614131|363283374|FG005|Overall Study|Withdrawal by Subject|0|||
105349795|NCT02614131|363283375|FG006|Overall Study|Withdrawal by Subject|0|||
105349796|NCT02614131|363283369|FG000|Overall Study|Adverse Event|0|||
105702001|NCT01225731|364571928|FG001|Part 1|Did not meet eligibility criteria|0|||
105702002|NCT01225731|364571929|FG002|Part 1|Did not meet eligibility criteria|0|||
105702003|NCT01225731|364571930|FG003|Part 1|Did not meet eligibility criteria|0|||
105702004|NCT01225731|364571931|FG004|Part 1|Did not meet eligibility criteria|1|||
105702005|NCT01225731|364571932|FG005|Part 1|Did not meet eligibility criteria|0|||
105702006|NCT01225731|364571933|FG006|Part 1|Did not meet eligibility criteria|0|||
105702007|NCT01225731|364571934|FG007|Part 1|Did not meet eligibility criteria|0|||
105702008|NCT01225731|364571935|FG008|Part 1|Did not meet eligibility criteria|0|||
105702009|NCT01225731|364571936|FG009|Part 1|Did not meet eligibility criteria|0|||
105702010|NCT01225731|364571937|FG010|Part 1|Did not meet eligibility criteria|0|||
105702011|NCT01225731|364571938|FG011|Part 1|Did not meet eligibility criteria|0|||
105702012|NCT01225731|364571939|FG012|Part 1|Did not meet eligibility criteria|0|||
105702013|NCT01225731|364571927|FG000|Part 1|Adverse Event|1|||
105702014|NCT01225731|364571928|FG001|Part 1|Adverse Event|2|||
105702015|NCT01225731|364571929|FG002|Part 1|Adverse Event|1|||
105702016|NCT01225731|364571930|FG003|Part 1|Adverse Event|1|||
105702017|NCT01225731|364571931|FG004|Part 1|Adverse Event|1|||
105702018|NCT01225731|364571932|FG005|Part 1|Adverse Event|0|||
105702019|NCT01225731|364571933|FG006|Part 1|Adverse Event|0|||
105702020|NCT01225731|364571934|FG007|Part 1|Adverse Event|0|||
105702021|NCT01225731|364571935|FG008|Part 1|Adverse Event|0|||
105702022|NCT01225731|364571936|FG009|Part 1|Adverse Event|0|||
105702023|NCT01225731|364571937|FG010|Part 1|Adverse Event|0|||
105702024|NCT01225731|364571938|FG011|Part 1|Adverse Event|0|||
105702025|NCT01225731|364571939|FG012|Part 1|Adverse Event|0|||
105702026|NCT01225731|364571927|FG000|Part 1|Withdrawal by Subject|0|||
105349797|NCT02614131|363283370|FG001|Overall Study|Adverse Event|0|||
105349798|NCT02614131|363283371|FG002|Overall Study|Adverse Event|0|||
105349799|NCT02614131|363283372|FG003|Overall Study|Adverse Event|0|||
105702027|NCT01225731|364571928|FG001|Part 1|Withdrawal by Subject|3|||
105349800|NCT02614131|363283373|FG004|Overall Study|Adverse Event|0|||
105349801|NCT02614131|363283374|FG005|Overall Study|Adverse Event|0|||
105349802|NCT02614131|363283375|FG006|Overall Study|Adverse Event|1|||
105702028|NCT01225731|364571929|FG002|Part 1|Withdrawal by Subject|0|||
105702029|NCT01225731|364571930|FG003|Part 1|Withdrawal by Subject|0|||
105702030|NCT01225731|364571931|FG004|Part 1|Withdrawal by Subject|4|||
105702031|NCT01225731|364571932|FG005|Part 1|Withdrawal by Subject|0|||
105702032|NCT01225731|364571933|FG006|Part 1|Withdrawal by Subject|0|||
105702033|NCT01225731|364571934|FG007|Part 1|Withdrawal by Subject|0|||
105702034|NCT01225731|364571935|FG008|Part 1|Withdrawal by Subject|0|||
105702035|NCT01225731|364571936|FG009|Part 1|Withdrawal by Subject|0|||
105702036|NCT01225731|364571937|FG010|Part 1|Withdrawal by Subject|0|||
105702037|NCT01225731|364571938|FG011|Part 1|Withdrawal by Subject|0|||
105702038|NCT01225731|364571939|FG012|Part 1|Withdrawal by Subject|0|||
105702039|NCT01225731|364571927|FG000|Part 1|Protocol Violation|0|||
105702040|NCT01225731|364571928|FG001|Part 1|Protocol Violation|0|||
105702041|NCT01225731|364571929|FG002|Part 1|Protocol Violation|0|||
105702042|NCT01225731|364571930|FG003|Part 1|Protocol Violation|1|||
105702043|NCT01225731|364571931|FG004|Part 1|Protocol Violation|0|||
105702044|NCT01225731|364571932|FG005|Part 1|Protocol Violation|0|||
105702045|NCT01225731|364571933|FG006|Part 1|Protocol Violation|0|||
105702046|NCT01225731|364571934|FG007|Part 1|Protocol Violation|0|||
105702047|NCT01225731|364571935|FG008|Part 1|Protocol Violation|0|||
105702048|NCT01225731|364571936|FG009|Part 1|Protocol Violation|0|||
105702049|NCT01225731|364571937|FG010|Part 1|Protocol Violation|0|||
105702050|NCT01225731|364571938|FG011|Part 1|Protocol Violation|0|||
105702051|NCT01225731|364571939|FG012|Part 1|Protocol Violation|0|||
105702052|NCT01225731|364571927|FG000|Part 2|Protocol Violation|0|||
105702053|NCT01225731|364571928|FG001|Part 2|Protocol Violation|0|||
105702054|NCT01225731|364571929|FG002|Part 2|Protocol Violation|0|||
105702055|NCT01225731|364571930|FG003|Part 2|Protocol Violation|0|||
105702056|NCT01225731|364571931|FG004|Part 2|Protocol Violation|0|||
105702057|NCT01225731|364571932|FG005|Part 2|Protocol Violation|1|||
105702058|NCT01225731|364571933|FG006|Part 2|Protocol Violation|0|||
105702059|NCT01225731|364571934|FG007|Part 2|Protocol Violation|0|||
105702060|NCT01225731|364571935|FG008|Part 2|Protocol Violation|1|||
105702061|NCT01225731|364571936|FG009|Part 2|Protocol Violation|0|||
105702062|NCT01225731|364571937|FG010|Part 2|Protocol Violation|0|||
105702063|NCT01225731|364571938|FG011|Part 2|Protocol Violation|0|||
105702064|NCT01225731|364571939|FG012|Part 2|Protocol Violation|0|||
105702065|NCT01225731|364571927|FG000|Part 2|Adverse Event|0|||
105702066|NCT01225731|364571928|FG001|Part 2|Adverse Event|0|||
105702067|NCT01225731|364571929|FG002|Part 2|Adverse Event|0|||
105702068|NCT01225731|364571930|FG003|Part 2|Adverse Event|0|||
105702069|NCT01225731|364571931|FG004|Part 2|Adverse Event|0|||
105702070|NCT01225731|364571932|FG005|Part 2|Adverse Event|0|||
105702071|NCT01225731|364571933|FG006|Part 2|Adverse Event|4|||
105702072|NCT01225731|364571934|FG007|Part 2|Adverse Event|4|||
105702073|NCT01225731|364571935|FG008|Part 2|Adverse Event|2|||
105702074|NCT01225731|364571936|FG009|Part 2|Adverse Event|0|||
105702075|NCT01225731|364571937|FG010|Part 2|Adverse Event|0|||
105702076|NCT01225731|364571938|FG011|Part 2|Adverse Event|0|||
105702077|NCT01225731|364571939|FG012|Part 2|Adverse Event|0|||
105702078|NCT01225731|364571927|FG000|Part 2|Lack of Efficacy|0|||
105702079|NCT01225731|364571928|FG001|Part 2|Lack of Efficacy|0|||
105702080|NCT01225731|364571929|FG002|Part 2|Lack of Efficacy|0|||
105702081|NCT01225731|364571930|FG003|Part 2|Lack of Efficacy|0|||
105702082|NCT01225731|364571931|FG004|Part 2|Lack of Efficacy|0|||
105349803|NCT03209518|363283376|FG000|Overall Study|Case Report Forms Uncollected|1|||
105349804|NCT03209518|363283376|FG000|Overall Study|Protocol Deviation|1|||
105349805|NCT02273908|363283377|FG000|Overall Study|Adverse Event|16|||
105702083|NCT01225731|364571932|FG005|Part 2|Lack of Efficacy|1|||
105702084|NCT01225731|364571933|FG006|Part 2|Lack of Efficacy|0|||
105702085|NCT01225731|364571934|FG007|Part 2|Lack of Efficacy|12|||
105702086|NCT01225731|364571935|FG008|Part 2|Lack of Efficacy|3|||
105702087|NCT01225731|364571936|FG009|Part 2|Lack of Efficacy|0|||
105702088|NCT01225731|364571937|FG010|Part 2|Lack of Efficacy|0|||
105702089|NCT01225731|364571938|FG011|Part 2|Lack of Efficacy|0|||
105702090|NCT01225731|364571939|FG012|Part 2|Lack of Efficacy|0|||
105702091|NCT01225731|364571927|FG000|Part 2|Pregnancy|0|||
105702092|NCT01225731|364571928|FG001|Part 2|Pregnancy|0|||
105702093|NCT01225731|364571929|FG002|Part 2|Pregnancy|0|||
105787287|NCT03985982|364874917|FG001|Open-Label Phase|Physician Decision|0|||
105702094|NCT01225731|364571930|FG003|Part 2|Pregnancy|0|||
105787288|NCT03985982|364874918|FG002|Open-Label Phase|Physician Decision|2|||
105702095|NCT01225731|364571931|FG004|Part 2|Pregnancy|0|||
105702096|NCT01225731|364571932|FG005|Part 2|Pregnancy|0|||
105702097|NCT01225731|364571933|FG006|Part 2|Pregnancy|1|||
105702098|NCT01225731|364571934|FG007|Part 2|Pregnancy|0|||
105702099|NCT01225731|364571935|FG008|Part 2|Pregnancy|1|||
105702100|NCT01225731|364571936|FG009|Part 2|Pregnancy|0|||
105702101|NCT01225731|364571937|FG010|Part 2|Pregnancy|0|||
105702102|NCT01225731|364571938|FG011|Part 2|Pregnancy|0|||
105702103|NCT01225731|364571939|FG012|Part 2|Pregnancy|0|||
105702104|NCT01225731|364571927|FG000|Part 2|Lost to Follow-up|0|||
105702105|NCT01225731|364571928|FG001|Part 2|Lost to Follow-up|0|||
105702106|NCT01225731|364571929|FG002|Part 2|Lost to Follow-up|0|||
105702107|NCT01225731|364571930|FG003|Part 2|Lost to Follow-up|0|||
105702108|NCT01225731|364571931|FG004|Part 2|Lost to Follow-up|0|||
105702109|NCT01225731|364571932|FG005|Part 2|Lost to Follow-up|0|||
105702110|NCT01225731|364571933|FG006|Part 2|Lost to Follow-up|0|||
105702111|NCT01225731|364571934|FG007|Part 2|Lost to Follow-up|3|||
105702112|NCT01225731|364571935|FG008|Part 2|Lost to Follow-up|1|||
105702113|NCT01225731|364571936|FG009|Part 2|Lost to Follow-up|0|||
105702114|NCT01225731|364571937|FG010|Part 2|Lost to Follow-up|0|||
105702115|NCT01225731|364571938|FG011|Part 2|Lost to Follow-up|0|||
105702116|NCT01225731|364571939|FG012|Part 2|Lost to Follow-up|0|||
105702117|NCT01225731|364571927|FG000|Part 2|Physician Decision|0|||
105702118|NCT01225731|364571928|FG001|Part 2|Physician Decision|0|||
105702119|NCT01225731|364571929|FG002|Part 2|Physician Decision|0|||
105702120|NCT01225731|364571930|FG003|Part 2|Physician Decision|0|||
105702121|NCT01225731|364571931|FG004|Part 2|Physician Decision|0|||
105702122|NCT01225731|364571932|FG005|Part 2|Physician Decision|0|||
105702123|NCT01225731|364571933|FG006|Part 2|Physician Decision|0|||
105702124|NCT01225731|364571934|FG007|Part 2|Physician Decision|2|||
105702125|NCT01225731|364571935|FG008|Part 2|Physician Decision|2|||
105702126|NCT01225731|364571936|FG009|Part 2|Physician Decision|0|||
105702127|NCT01225731|364571937|FG010|Part 2|Physician Decision|0|||
105702128|NCT01225731|364571938|FG011|Part 2|Physician Decision|0|||
105702129|NCT01225731|364571939|FG012|Part 2|Physician Decision|0|||
105702130|NCT01225731|364571927|FG000|Part 2|Withdrawal by Subject|0|||
105702131|NCT01225731|364571928|FG001|Part 2|Withdrawal by Subject|0|||
105787289|NCT03985982|364874916|FG000|Open-Label Phase|Withdrawal by Subject|0|||
105787290|NCT03985982|364874917|FG001|Open-Label Phase|Withdrawal by Subject|0|||
105787291|NCT03985982|364874918|FG002|Open-Label Phase|Withdrawal by Subject|11|||
105787292|NCT02356159|364874925|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
105787293|NCT02356159|364874926|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
105787294|NCT02356159|364874927|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
105787295|NCT02356159|364874928|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
105787296|NCT02356159|364874929|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
105787297|NCT02356159|364874930|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
105787298|NCT04963231|364874931|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
105702132|NCT01225731|364571929|FG002|Part 2|Withdrawal by Subject|0|||
105702133|NCT01225731|364571930|FG003|Part 2|Withdrawal by Subject|0|||
105702134|NCT01225731|364571931|FG004|Part 2|Withdrawal by Subject|0|||
105702135|NCT01225731|364571932|FG005|Part 2|Withdrawal by Subject|1|||
105702136|NCT01225731|364571933|FG006|Part 2|Withdrawal by Subject|3|||
105702137|NCT01225731|364571934|FG007|Part 2|Withdrawal by Subject|4|||
105702138|NCT01225731|364571935|FG008|Part 2|Withdrawal by Subject|1|||
105702139|NCT01225731|364571936|FG009|Part 2|Withdrawal by Subject|0|||
105702140|NCT01225731|364571937|FG010|Part 2|Withdrawal by Subject|0|||
105702141|NCT01225731|364571938|FG011|Part 2|Withdrawal by Subject|0|||
105702142|NCT01225731|364571939|FG012|Part 2|Withdrawal by Subject|0|||
105702143|NCT01225731|364571927|FG000|Part 3|Adverse Event|0|||
105702144|NCT01225731|364571928|FG001|Part 3|Adverse Event|0|||
105702145|NCT01225731|364571929|FG002|Part 3|Adverse Event|0|||
105787299|NCT04963231|364874932|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
105787300|NCT04963231|364874933|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
105787301|NCT04963231|364874931|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
105787302|NCT04963231|364874932|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
105702146|NCT01225731|364571930|FG003|Part 3|Adverse Event|0|||
105702147|NCT01225731|364571931|FG004|Part 3|Adverse Event|0|||
105702148|NCT01225731|364571932|FG005|Part 3|Adverse Event|0|||
105702149|NCT01225731|364571933|FG006|Part 3|Adverse Event|0|||
105702150|NCT01225731|364571934|FG007|Part 3|Adverse Event|0|||
105787303|NCT04963231|364874933|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
105787304|NCT04963231|364874931|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
105787305|NCT04963231|364874932|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
105702151|NCT01225731|364571935|FG008|Part 3|Adverse Event|0|||
105702152|NCT01225731|364571936|FG009|Part 3|Adverse Event|0|||
105702153|NCT01225731|364571937|FG010|Part 3|Adverse Event|1|||
105702154|NCT01225731|364571938|FG011|Part 3|Adverse Event|1|||
105702155|NCT01225731|364571939|FG012|Part 3|Adverse Event|0|||
105702156|NCT01225731|364571927|FG000|Part 3|Lost to Follow-up|0|||
105702157|NCT01225731|364571928|FG001|Part 3|Lost to Follow-up|0|||
105702158|NCT01225731|364571929|FG002|Part 3|Lost to Follow-up|0|||
105702159|NCT01225731|364571930|FG003|Part 3|Lost to Follow-up|0|||
105702160|NCT01225731|364571931|FG004|Part 3|Lost to Follow-up|0|||
105702161|NCT01225731|364571932|FG005|Part 3|Lost to Follow-up|0|||
105702162|NCT01225731|364571933|FG006|Part 3|Lost to Follow-up|0|||
105702163|NCT01225731|364571934|FG007|Part 3|Lost to Follow-up|0|||
105702164|NCT01225731|364571935|FG008|Part 3|Lost to Follow-up|0|||
105702165|NCT01225731|364571936|FG009|Part 3|Lost to Follow-up|0|||
105702166|NCT01225731|364571937|FG010|Part 3|Lost to Follow-up|1|||
105702167|NCT01225731|364571938|FG011|Part 3|Lost to Follow-up|2|||
105702168|NCT01225731|364571939|FG012|Part 3|Lost to Follow-up|1|||
105702169|NCT01225731|364571927|FG000|Part 3|Physician Decision|0|||
105702170|NCT01225731|364571928|FG001|Part 3|Physician Decision|0|||
105702171|NCT01225731|364571929|FG002|Part 3|Physician Decision|0|||
105702172|NCT01225731|364571930|FG003|Part 3|Physician Decision|0|||
105702173|NCT01225731|364571931|FG004|Part 3|Physician Decision|0|||
105702174|NCT01225731|364571932|FG005|Part 3|Physician Decision|0|||
105702175|NCT01225731|364571933|FG006|Part 3|Physician Decision|0|||
105702176|NCT01225731|364571934|FG007|Part 3|Physician Decision|0|||
105702177|NCT01225731|364571935|FG008|Part 3|Physician Decision|0|||
105702178|NCT01225731|364571936|FG009|Part 3|Physician Decision|0|||
105702179|NCT01225731|364571937|FG010|Part 3|Physician Decision|0|||
105702180|NCT01225731|364571938|FG011|Part 3|Physician Decision|1|||
105702181|NCT01225731|364571939|FG012|Part 3|Physician Decision|2|||
105702182|NCT01225731|364571927|FG000|Part 3|Withdrawal by Subject|0|||
105702183|NCT01225731|364571928|FG001|Part 3|Withdrawal by Subject|0|||
105702184|NCT01225731|364571929|FG002|Part 3|Withdrawal by Subject|0|||
105702185|NCT01225731|364571930|FG003|Part 3|Withdrawal by Subject|0|||
105702186|NCT01225731|364571931|FG004|Part 3|Withdrawal by Subject|0|||
105702187|NCT01225731|364571932|FG005|Part 3|Withdrawal by Subject|0|||
105702188|NCT01225731|364571933|FG006|Part 3|Withdrawal by Subject|0|||
105702189|NCT01225731|364571934|FG007|Part 3|Withdrawal by Subject|0|||
105702190|NCT01225731|364571935|FG008|Part 3|Withdrawal by Subject|0|||
105702191|NCT01225731|364571936|FG009|Part 3|Withdrawal by Subject|0|||
105702192|NCT01225731|364571937|FG010|Part 3|Withdrawal by Subject|4|||
105702193|NCT01225731|364571938|FG011|Part 3|Withdrawal by Subject|6|||
105702194|NCT01225731|364571939|FG012|Part 3|Withdrawal by Subject|4|||
105702195|NCT01342484|364571942|FG000|Overall Study|Other Reasons|1|||
105702196|NCT01342484|364571943|FG001|Overall Study|Other Reasons|0|||
105702197|NCT01342484|364571944|FG002|Overall Study|Other Reasons|0|||
105702198|NCT01342484|364571942|FG000|Overall Study|Protocol Violation|0|||
105702199|NCT01342484|364571943|FG001|Overall Study|Protocol Violation|0|||
105702200|NCT01342484|364571944|FG002|Overall Study|Protocol Violation|1|||
105702201|NCT01342484|364571942|FG000|Overall Study|Withdrawal by Subject|1|||
105702202|NCT01342484|364571943|FG001|Overall Study|Withdrawal by Subject|0|||
105702203|NCT01342484|364571944|FG002|Overall Study|Withdrawal by Subject|0|||
105702204|NCT01840579|364571947|FG000|Overall Study|Status not recorded|0|||
105702205|NCT01840579|364571948|FG001|Overall Study|Status not recorded|0|||
105702206|NCT01840579|364571949|FG002|Overall Study|Status not recorded|2|||
105702207|NCT01840579|364571950|FG003|Overall Study|Status not recorded|3|||
105702208|NCT01840579|364571951|FG004|Overall Study|Status not recorded|4|||
105702209|NCT01840579|364571952|FG005|Overall Study|Status not recorded|3|||
105702210|NCT01840579|364571953|FG006|Overall Study|Status not recorded|0|||
105702211|NCT01840579|364571954|FG007|Overall Study|Status not recorded|3|||
105702212|NCT01840579|364571955|FG008|Overall Study|Status not recorded|3|||
105702213|NCT01840579|364571956|FG009|Overall Study|Status not recorded|3|||
105702214|NCT01840579|364571947|FG000|Overall Study|Progressive disease|3|||
105702215|NCT01840579|364571948|FG001|Overall Study|Progressive disease|5|||
105702216|NCT01840579|364571949|FG002|Overall Study|Progressive disease|0|||
105702217|NCT01840579|364571950|FG003|Overall Study|Progressive disease|0|||
105702218|NCT01840579|364571951|FG004|Overall Study|Progressive disease|0|||
105702219|NCT01840579|364571952|FG005|Overall Study|Progressive disease|0|||
105702220|NCT01840579|364571953|FG006|Overall Study|Progressive disease|0|||
105702221|NCT01840579|364571954|FG007|Overall Study|Progressive disease|0|||
105702222|NCT01840579|364571955|FG008|Overall Study|Progressive disease|0|||
105702223|NCT01840579|364571956|FG009|Overall Study|Progressive disease|0|||
105702224|NCT01840579|364571947|FG000|Overall Study|Ongoing in study|0|||
105702225|NCT01840579|364571948|FG001|Overall Study|Ongoing in study|1|||
105702226|NCT01840579|364571949|FG002|Overall Study|Ongoing in study|0|||
105702227|NCT01840579|364571950|FG003|Overall Study|Ongoing in study|0|||
105702228|NCT01840579|364571951|FG004|Overall Study|Ongoing in study|0|||
105702229|NCT01840579|364571952|FG005|Overall Study|Ongoing in study|0|||
105702230|NCT01840579|364571953|FG006|Overall Study|Ongoing in study|0|||
105702231|NCT01840579|364571954|FG007|Overall Study|Ongoing in study|0|||
105702232|NCT01840579|364571955|FG008|Overall Study|Ongoing in study|0|||
105702233|NCT01840579|364571956|FG009|Overall Study|Ongoing in study|0|||
105702234|NCT01840579|364571947|FG000|Overall Study|Death|0|||
105702235|NCT01840579|364571948|FG001|Overall Study|Death|0|||
105702236|NCT01840579|364571949|FG002|Overall Study|Death|0|||
105702237|NCT01840579|364571950|FG003|Overall Study|Death|0|||
105702238|NCT01840579|364571951|FG004|Overall Study|Death|0|||
105702239|NCT01840579|364571952|FG005|Overall Study|Death|1|||
105702240|NCT01840579|364571953|FG006|Overall Study|Death|0|||
105702241|NCT01840579|364571954|FG007|Overall Study|Death|0|||
105702242|NCT01840579|364571955|FG008|Overall Study|Death|0|||
105702243|NCT01840579|364571956|FG009|Overall Study|Death|0|||
105702244|NCT01840579|364571947|FG000|Overall Study|Adverse Event|0|||
105702245|NCT01840579|364571948|FG001|Overall Study|Adverse Event|1|||
105702246|NCT01840579|364571949|FG002|Overall Study|Adverse Event|0|||
105702247|NCT01840579|364571950|FG003|Overall Study|Adverse Event|0|||
105702248|NCT01840579|364571951|FG004|Overall Study|Adverse Event|0|||
105702249|NCT01840579|364571952|FG005|Overall Study|Adverse Event|0|||
105702250|NCT01840579|364571953|FG006|Overall Study|Adverse Event|0|||
105702251|NCT01840579|364571954|FG007|Overall Study|Adverse Event|0|||
105702252|NCT01840579|364571955|FG008|Overall Study|Adverse Event|0|||
105702253|NCT01840579|364571956|FG009|Overall Study|Adverse Event|0|||
105702254|NCT01840579|364571947|FG000|Overall Study|Follow-up ended by Sponsor|0|||
105702255|NCT01840579|364571948|FG001|Overall Study|Follow-up ended by Sponsor|0|||
105702256|NCT01840579|364571949|FG002|Overall Study|Follow-up ended by Sponsor|0|||
105560165|NCT03492281|364046563|FG000|Overall Study|Lack of Efficacy|3|||
105560166|NCT03492281|364046564|FG001|Overall Study|Lack of Efficacy|0|||
105560167|NCT03492281|364046565|FG002|Overall Study|Lack of Efficacy|1|||
105560168|NCT03492281|364046563|FG000|Overall Study|Physician Decision|1|||
105560169|NCT03492281|364046564|FG001|Overall Study|Physician Decision|0|||
105560170|NCT03492281|364046565|FG002|Overall Study|Physician Decision|3|||
105560171|NCT03492281|364046563|FG000|Overall Study|Protocol Violation|0|||
105560172|NCT03492281|364046564|FG001|Overall Study|Protocol Violation|2|||
105560173|NCT03492281|364046565|FG002|Overall Study|Protocol Violation|1|||
105560174|NCT03492281|364046563|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
105560175|NCT03492281|364046564|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
105560176|NCT03492281|364046565|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
105560177|NCT03492281|364046563|FG000|Overall Study|Death|0|||
105560178|NCT03492281|364046564|FG001|Overall Study|Death|0|||
105560179|NCT03492281|364046565|FG002|Overall Study|Death|1|||
105560180|NCT03492281|364046563|FG000|Overall Study|Captured as Other in Database|8|||
105560181|NCT03492281|364046564|FG001|Overall Study|Captured as Other in Database|6|||
105560182|NCT03492281|364046565|FG002|Overall Study|Captured as Other in Database|3|||
105560183|NCT01506193|364046566|FG000|Overall Study|Protocol Violation|1|||
105560184|NCT01506193|364046567|FG001|Overall Study|Protocol Violation|0|||
105560185|NCT01506193|364046568|FG002|Overall Study|Protocol Violation|1|||
105560186|NCT01506193|364046566|FG000|Overall Study|Migrated/moved from study area|0|||
105560187|NCT01506193|364046567|FG001|Overall Study|Migrated/moved from study area|0|||
105702257|NCT01840579|364571950|FG003|Overall Study|Follow-up ended by Sponsor|0|||
105702258|NCT01840579|364571951|FG004|Overall Study|Follow-up ended by Sponsor|0|||
105702259|NCT01840579|364571952|FG005|Overall Study|Follow-up ended by Sponsor|0|||
105702260|NCT01840579|364571953|FG006|Overall Study|Follow-up ended by Sponsor|2|||
105702261|NCT01840579|364571954|FG007|Overall Study|Follow-up ended by Sponsor|0|||
105702262|NCT01840579|364571955|FG008|Overall Study|Follow-up ended by Sponsor|0|||
105702263|NCT01840579|364571956|FG009|Overall Study|Follow-up ended by Sponsor|0|||
105702264|NCT02577146|364571958|FG000|Overall Study|Lost to Follow-up|8|||
105702265|NCT02577146|364571958|FG000|Overall Study|Physician Decision|3|||
105702266|NCT02577146|364571958|FG000|Overall Study|Screen Failure|17|||
105702267|NCT01624662|364571959|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
105702268|NCT01624662|364571960|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
105702269|NCT01624662|364571961|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
105702270|NCT01624662|364571962|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
105702271|NCT01624662|364571959|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
105702272|NCT01624662|364571960|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
105702273|NCT01624662|364571961|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
105702274|NCT01624662|364571962|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
105702275|NCT01624662|364571959|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
105702276|NCT01624662|364571960|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
105702277|NCT01624662|364571961|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
105702278|NCT01624662|364571962|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
105702279|NCT01624662|364571959|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
105702280|NCT01624662|364571960|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
105702281|NCT01624662|364571961|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
105702282|NCT01624662|364571962|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
105702283|NCT01624662|364571959|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
105702284|NCT01624662|364571960|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
105702285|NCT01624662|364571961|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
105702286|NCT01624662|364571962|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
105702287|NCT01624662|364571959|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
105702288|NCT01624662|364571960|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
105702289|NCT01624662|364571961|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
105702290|NCT01624662|364571962|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
105702291|NCT01624662|364571959|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
105702292|NCT01624662|364571960|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
105702293|NCT01624662|364571961|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
105702294|NCT01624662|364571962|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
105702295|NCT03116698|364571965|FG000|Overall Study|Adverse Event|1|||
105702296|NCT03116698|364571966|FG001|Overall Study|Adverse Event|1|||
105702297|NCT03116698|364571967|FG002|Overall Study|Adverse Event|1|||
105702298|NCT03116698|364571968|FG003|Overall Study|Adverse Event|0|||
105702299|NCT03116698|364571965|FG000|Overall Study|Withdrawal by Subject|1|||
105702300|NCT03116698|364571966|FG001|Overall Study|Withdrawal by Subject|4|||
105349806|NCT02273908|363283378|FG001|Overall Study|Adverse Event|0|||
105560188|NCT01506193|364046568|FG002|Overall Study|Migrated/moved from study area|1|||
105560189|NCT01506193|364046566|FG000|Overall Study|Adverse event, non-fatal|0|||
105702301|NCT03116698|364571967|FG002|Overall Study|Withdrawal by Subject|5|||
105702302|NCT03116698|364571968|FG003|Overall Study|Withdrawal by Subject|2|||
105702303|NCT03116698|364571965|FG000|Overall Study|Lost to Follow-up|2|||
105702304|NCT03116698|364571966|FG001|Overall Study|Lost to Follow-up|0|||
105702305|NCT03116698|364571967|FG002|Overall Study|Lost to Follow-up|0|||
105702306|NCT03116698|364571968|FG003|Overall Study|Lost to Follow-up|0|||
105702307|NCT03116698|364571965|FG000|Overall Study|Physician Decision|1|||
105702308|NCT03116698|364571966|FG001|Overall Study|Physician Decision|1|||
105702309|NCT03116698|364571967|FG002|Overall Study|Physician Decision|0|||
105702310|NCT03116698|364571968|FG003|Overall Study|Physician Decision|0|||
105702311|NCT03116698|364571965|FG000|Overall Study|Protocol Violation|1|||
105702312|NCT03116698|364571966|FG001|Overall Study|Protocol Violation|0|||
105702313|NCT03116698|364571967|FG002|Overall Study|Protocol Violation|0|||
105702314|NCT03116698|364571968|FG003|Overall Study|Protocol Violation|0|||
105702315|NCT03116698|364571965|FG000|Overall Study|Death|0|||
105702316|NCT03116698|364571966|FG001|Overall Study|Death|0|||
105702317|NCT03116698|364571967|FG002|Overall Study|Death|2|||
105702318|NCT03116698|364571968|FG003|Overall Study|Death|0|||
105702319|NCT03834519|364571969|FG000|Overall Study|Lost to Follow-up|2|||
105702320|NCT03834519|364571970|FG001|Overall Study|Lost to Follow-up|1|||
105702321|NCT03834519|364571969|FG000|Overall Study|Withdrawal by Subject|5|||
105702322|NCT03834519|364571970|FG001|Overall Study|Withdrawal by Subject|8|||
105702323|NCT03834519|364571969|FG000|Overall Study|Death|368|||
105702324|NCT03834519|364571970|FG001|Overall Study|Death|174|||
105702325|NCT03834519|364571969|FG000|Overall Study|Physician Decision|5|||
105702326|NCT03834519|364571970|FG001|Overall Study|Physician Decision|1|||
105702327|NCT03834519|364571969|FG000|Overall Study|Sponsor decision|149|||
105702328|NCT03834519|364571970|FG001|Overall Study|Sponsor decision|80|||
105702329|NCT04294901|364571971|FG000|Overall Study|Death|86|||
105702330|NCT04294901|364571972|FG001|Overall Study|Death|110|||
105702331|NCT04294901|364571971|FG000|Overall Study|Provider did not have historical control patients|581|||
105702332|NCT04294901|364571972|FG001|Overall Study|Provider did not have historical control patients|0|||
105702333|NCT04294901|364571971|FG000|Overall Study|Provider did not have intervention patients|0|||
105702334|NCT04294901|364571972|FG001|Overall Study|Provider did not have intervention patients|98|||
105702335|NCT03581786|364572917|FG000|Overall Study|Death|17|||
105702336|NCT03581786|364572918|FG001|Overall Study|Death|12|||
105702337|NCT03581786|364572917|FG000|Overall Study|Withdrawal by Subject|2|||
105702338|NCT03581786|364572918|FG001|Overall Study|Withdrawal by Subject|4|||
105702339|NCT03581786|364572917|FG000|Overall Study|Lost to Follow-up|1|||
105702340|NCT03581786|364572918|FG001|Overall Study|Lost to Follow-up|0|||
105702341|NCT03581786|364572917|FG000|Overall Study|reason other than specified above|0|||
105702342|NCT03581786|364572918|FG001|Overall Study|reason other than specified above|1|||
105702343|NCT03581786|364572917|FG000|Overall Study|Ongoing in the study|123|||
105702344|NCT03581786|364572918|FG001|Overall Study|Ongoing in the study|129|||
105702345|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
105702346|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
105702347|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
105702348|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
105702349|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
105702350|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
105702351|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Death|2|||
105702352|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Death|0|||
105702353|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
105702354|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
105702355|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
105702356|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
105702357|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
105702358|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
105349807|NCT02273908|363283377|FG000|Overall Study|Lost to Follow-up|10|||
105702359|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
105702360|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
105702361|NCT02603120|364572919|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
105702362|NCT02603120|364572920|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
105702363|NCT02603120|364572919|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
105702364|NCT02603120|364572920|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
105702365|NCT02603120|364572919|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
105702366|NCT02603120|364572920|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
105702367|NCT02603120|364572919|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
105702368|NCT02603120|364572920|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
105349808|NCT02273908|363283378|FG001|Overall Study|Lost to Follow-up|1|||
105349809|NCT02273908|363283377|FG000|Overall Study|Did not meet entrance criteria|3|||
105702369|NCT02603120|364572919|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
105702370|NCT02603120|364572920|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
105702371|NCT02603120|364572919|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
105349810|NCT02273908|363283378|FG001|Overall Study|Did not meet entrance criteria|2|||
105349811|NCT02273908|363283377|FG000|Overall Study|Withdrawal by Subject|4|||
105349812|NCT02273908|363283378|FG001|Overall Study|Withdrawal by Subject|2|||
105349813|NCT00791492|363283384|FG000|Overall Study|Withdrawal by Subject|1|||
105349814|NCT00791492|363283385|FG001|Overall Study|Withdrawal by Subject|2|||
105349815|NCT00791492|363283384|FG000|Overall Study|Liver transplantation|5|||
105349816|NCT00791492|363283385|FG001|Overall Study|Liver transplantation|1|||
105702372|NCT02603120|364572920|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
105702373|NCT00176605|364572924|FG000|Overall Study|Withdrawal by Subject|2|||
105702374|NCT01321710|364572925|FG000|Overall Study|Lost to Follow-up|4|||
105702375|NCT01321710|364572926|FG001|Overall Study|Lost to Follow-up|5|||
105702376|NCT01321710|364572927|FG002|Overall Study|Lost to Follow-up|0|||
105702377|NCT02463409|364572928|FG000|Overall Study|Withdrawal by Subject|1|||
105702378|NCT02463409|364572928|FG000|Overall Study|Screen failure|1|||
105702379|NCT00772954|364572929|FG000|Overall Study|Adverse Event|0|||
105702380|NCT00772954|364572930|FG001|Overall Study|Adverse Event|0|||
105702381|NCT00772954|364572931|FG002|Overall Study|Adverse Event|1|||
105702382|NCT01349465|364572933|FG000|Overall Study|Adverse Event|1|||
105702383|NCT01349465|364572934|FG001|Overall Study|Adverse Event|0|||
105702384|NCT01349465|364572933|FG000|Overall Study|Death|3|||
105702385|NCT01349465|364572934|FG001|Overall Study|Death|0|||
105702386|NCT01349465|364572933|FG000|Overall Study|Lost to Follow-up|10|||
105702387|NCT01349465|364572934|FG001|Overall Study|Lost to Follow-up|1|||
105702388|NCT01349465|364572933|FG000|Overall Study|Withdrawal by Subject|4|||
105702389|NCT01349465|364572934|FG001|Overall Study|Withdrawal by Subject|2|||
105702390|NCT01349465|364572933|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
105702391|NCT01349465|364572934|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
105702392|NCT01438489|364572935|FG000|Overall Study|Lost to Follow-up|4|||
105702393|NCT01438489|364572936|FG001|Overall Study|Lost to Follow-up|2|||
105702394|NCT01438489|364572937|FG002|Overall Study|Lost to Follow-up|2|||
105702395|NCT01438489|364572935|FG000|Overall Study|Withdrawal by Subject|11|||
105702396|NCT01438489|364572936|FG001|Overall Study|Withdrawal by Subject|3|||
105702397|NCT01438489|364572937|FG002|Overall Study|Withdrawal by Subject|8|||
105702398|NCT01438489|364572935|FG000|Overall Study|Death|0|||
105702399|NCT01438489|364572936|FG001|Overall Study|Death|0|||
105702400|NCT01438489|364572937|FG002|Overall Study|Death|1|||
105702401|NCT01438489|364572935|FG000|Overall Study|Sponsor decision|4|||
105702402|NCT01438489|364572936|FG001|Overall Study|Sponsor decision|1|||
105702403|NCT01438489|364572937|FG002|Overall Study|Sponsor decision|4|||
105702404|NCT01438489|364572935|FG000|Overall Study|Subject choice/Subject moved|2|||
105702405|NCT01438489|364572936|FG001|Overall Study|Subject choice/Subject moved|1|||
105702406|NCT01438489|364572937|FG002|Overall Study|Subject choice/Subject moved|1|||
105702407|NCT01438489|364572935|FG000|Overall Study|Investigator decision|0|||
105702408|NCT01438489|364572936|FG001|Overall Study|Investigator decision|1|||
105702409|NCT01438489|364572937|FG002|Overall Study|Investigator decision|0|||
105702410|NCT01438489|364572935|FG000|Overall Study|AE/SAEs|2|||
105702411|NCT01438489|364572936|FG001|Overall Study|AE/SAEs|1|||
105702412|NCT01438489|364572937|FG002|Overall Study|AE/SAEs|1|||
105702413|NCT01438489|364572935|FG000|Overall Study|Received prohibited medication|1|||
105702414|NCT01438489|364572936|FG001|Overall Study|Received prohibited medication|0|||
105702415|NCT01438489|364572937|FG002|Overall Study|Received prohibited medication|0|||
105702416|NCT01438489|364572935|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
105702417|NCT01438489|364572936|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
105702418|NCT01438489|364572937|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
105702419|NCT01438489|364572935|FG000|Overall Study|Inadequate venous access|0|||
105702420|NCT01438489|364572936|FG001|Overall Study|Inadequate venous access|2|||
105702421|NCT01438489|364572937|FG002|Overall Study|Inadequate venous access|0|||
105702422|NCT02037295|364572938|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
105702423|NCT02037295|364572939|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
105474507|NCT03110770|363748584|FG002|Overall Study|Illness/Injury unrelated to product|0|||
105474508|NCT03110770|363748585|FG003|Overall Study|Illness/Injury unrelated to product|0|||
105474509|NCT03110770|363748586|FG004|Overall Study|Illness/Injury unrelated to product|1|||
105702424|NCT02037295|364572940|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
105702425|NCT02037295|364572941|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
105702426|NCT01140451|364572945|FG000|Overall Study|Withdrawal by Subject|26|||
105702427|NCT01140451|364572946|FG001|Overall Study|Withdrawal by Subject|33|||
105702428|NCT01140451|364572945|FG000|Overall Study|Adverse Event|2|||
105702429|NCT01140451|364572946|FG001|Overall Study|Adverse Event|6|||
105702430|NCT01140451|364572945|FG000|Overall Study|Physician Decision|5|||
105702431|NCT01140451|364572946|FG001|Overall Study|Physician Decision|3|||
105702432|NCT01140451|364572945|FG000|Overall Study|Lost to Follow-up|2|||
105702433|NCT01140451|364572946|FG001|Overall Study|Lost to Follow-up|0|||
105474510|NCT01776307|363748589|FG000|Overall Study|Not dosed|0|||
105349817|NCT00803205|363283391|FG000|Overall Study|Adverse Event|7|||
105349818|NCT00803205|363283392|FG001|Overall Study|Adverse Event|2|||
105702434|NCT01140451|364572945|FG000|Overall Study|Participants Planning Pregnancy|3|||
105702435|NCT01140451|364572946|FG001|Overall Study|Participants Planning Pregnancy|0|||
105702436|NCT00960661|364572950|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
105702437|NCT00960661|364572951|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
105702438|NCT00960661|364572952|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
105702439|NCT00960661|364572950|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
105702440|NCT00960661|364572951|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
105702441|NCT00960661|364572952|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
105702442|NCT00960661|364572950|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
105702443|NCT00960661|364572951|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
105702444|NCT00960661|364572952|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
105702445|NCT00960661|364572950|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
105702446|NCT00960661|364572951|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
105702447|NCT00960661|364572952|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
105702448|NCT00960661|364572950|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
105702449|NCT00960661|364572951|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
105702450|NCT00960661|364572952|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
105702451|NCT00960661|364572950|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
105702452|NCT00960661|364572951|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
105702453|NCT00960661|364572952|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
105702454|NCT00960661|364572950|FG000|Interventional Phase|Adverse Event|0|||
105702455|NCT00960661|364572951|FG001|Interventional Phase|Adverse Event|17|||
105702456|NCT00960661|364572952|FG002|Interventional Phase|Adverse Event|8|||
105702457|NCT00960661|364572950|FG000|Interventional Phase|Death|0|||
105702458|NCT00960661|364572951|FG001|Interventional Phase|Death|1|||
105702459|NCT00960661|364572952|FG002|Interventional Phase|Death|0|||
105702460|NCT00960661|364572950|FG000|Interventional Phase|Lost to Follow-up|0|||
105702461|NCT00960661|364572951|FG001|Interventional Phase|Lost to Follow-up|0|||
105702462|NCT00960661|364572952|FG002|Interventional Phase|Lost to Follow-up|2|||
105702463|NCT00960661|364572950|FG000|Interventional Phase|entry criteria not met|0|||
105702464|NCT00960661|364572951|FG001|Interventional Phase|entry criteria not met|3|||
105702465|NCT00960661|364572952|FG002|Interventional Phase|entry criteria not met|0|||
105702466|NCT00960661|364572950|FG000|Interventional Phase|Protocol Violation|0|||
105702467|NCT00960661|364572951|FG001|Interventional Phase|Protocol Violation|7|||
105702468|NCT00960661|364572952|FG002|Interventional Phase|Protocol Violation|2|||
105702469|NCT00960661|364572950|FG000|Interventional Phase|Withdrawal by Subject|0|||
105702470|NCT00960661|364572951|FG001|Interventional Phase|Withdrawal by Subject|18|||
105702471|NCT00960661|364572952|FG002|Interventional Phase|Withdrawal by Subject|29|||
105702472|NCT00960661|364572950|FG000|Interventional Phase|Physician Decision|0|||
105702473|NCT00960661|364572951|FG001|Interventional Phase|Physician Decision|3|||
105702474|NCT00960661|364572952|FG002|Interventional Phase|Physician Decision|5|||
105702475|NCT00960661|364572950|FG000|Interventional Phase|sponsor decision|0|||
105702476|NCT00960661|364572951|FG001|Interventional Phase|sponsor decision|1|||
105702477|NCT00960661|364572952|FG002|Interventional Phase|sponsor decision|0|||
105702478|NCT00960661|364572950|FG000|Interventional Phase|Lack of Efficacy|0|||
105702479|NCT00960661|364572951|FG001|Interventional Phase|Lack of Efficacy|2|||
105702480|NCT00960661|364572952|FG002|Interventional Phase|Lack of Efficacy|0|||
105702481|NCT02699892|364572953|FG000|Overall Study|Other|36|||
105702482|NCT01148537|364572959|FG000|Overall Study|Withdrawal by Subject|1|||
105702483|NCT01148537|364572960|FG001|Overall Study|Withdrawal by Subject|0|||
105702484|NCT01148537|364572961|FG002|Overall Study|Withdrawal by Subject|2|||
105702485|NCT01148537|364572959|FG000|Overall Study|Adverse Event|2|||
105702486|NCT01148537|364572960|FG001|Overall Study|Adverse Event|0|||
105702487|NCT01148537|364572961|FG002|Overall Study|Adverse Event|1|||
105702488|NCT02770547|364572962|FG000|Overall Study|Patient non-compliant|1|||
105702489|NCT02770547|364572963|FG001|Overall Study|Patient non-compliant|0|||
105702490|NCT02770547|364572962|FG000|Overall Study|Adverse Event|0|||
105702491|NCT02770547|364572963|FG001|Overall Study|Adverse Event|1|||
105702492|NCT03134599|364572965|FG000|Week 1|Lost to Follow-up|0|||
105702493|NCT03134599|364572966|FG001|Week 1|Lost to Follow-up|0|||
105702494|NCT03134599|364572967|FG002|Week 1|Lost to Follow-up|0|||
105702495|NCT03134599|364572968|FG003|Week 1|Lost to Follow-up|0|||
105702496|NCT03134599|364572969|FG004|Week 1|Lost to Follow-up|1|||
105702497|NCT03134599|364572970|FG005|Week 1|Lost to Follow-up|0|||
105702498|NCT03134599|364572965|FG000|Week 2|Lost to Follow-up|1|||
105702499|NCT03134599|364572966|FG001|Week 2|Lost to Follow-up|0|||
105702500|NCT03134599|364572967|FG002|Week 2|Lost to Follow-up|0|||
105702501|NCT03134599|364572968|FG003|Week 2|Lost to Follow-up|1|||
105702502|NCT03134599|364572969|FG004|Week 2|Lost to Follow-up|1|||
105702503|NCT03134599|364572970|FG005|Week 2|Lost to Follow-up|0|||
105702504|NCT03134599|364572965|FG000|Week 3|Lost to Follow-up|0|||
105702505|NCT03134599|364572966|FG001|Week 3|Lost to Follow-up|0|||
105702506|NCT03134599|364572967|FG002|Week 3|Lost to Follow-up|0|||
105702507|NCT03134599|364572968|FG003|Week 3|Lost to Follow-up|1|||
105702508|NCT03134599|364572969|FG004|Week 3|Lost to Follow-up|0|||
105702509|NCT03134599|364572970|FG005|Week 3|Lost to Follow-up|1|||
105349819|NCT00803205|363283391|FG000|Overall Study|Lost to Follow-up|1|||
105349820|NCT00803205|363283392|FG001|Overall Study|Lost to Follow-up|0|||
105349821|NCT00803205|363283391|FG000|Overall Study|Withdrawal by Subject|9|||
105349822|NCT00803205|363283392|FG001|Overall Study|Withdrawal by Subject|9|||
105349823|NCT00803205|363283391|FG000|Overall Study|Physician Decision|1|||
105349824|NCT00803205|363283392|FG001|Overall Study|Physician Decision|0|||
105349825|NCT00803205|363283391|FG000|Overall Study|Protocol Violation|1|||
105349826|NCT00803205|363283392|FG001|Overall Study|Protocol Violation|1|||
105349827|NCT00803205|363283391|FG000|Overall Study|Medical Monitor Decision|1|||
105349828|NCT00803205|363283392|FG001|Overall Study|Medical Monitor Decision|0|||
105349829|NCT00803205|363283391|FG000|Overall Study|Acquired a Lung Infection|0|||
105349830|NCT00803205|363283392|FG001|Overall Study|Acquired a Lung Infection|1|||
105349831|NCT00803205|363283391|FG000|Overall Study|Sponsor Decision|0|||
105349832|NCT00803205|363283392|FG001|Overall Study|Sponsor Decision|1|||
105349833|NCT01857102|363283393|FG000|Period 1|No longer meets Eligibility Criteria|0|||
105349834|NCT01857102|363283394|FG001|Period 1|No longer meets Eligibility Criteria|2|||
105349835|NCT01857102|363283393|FG000|Period 1|Lost to Follow-up|0|||
105349836|NCT01857102|363283394|FG001|Period 1|Lost to Follow-up|3|||
105349837|NCT01857102|363283393|FG000|Period 1|Unsatisfactory Lens Fit|1|||
105349838|NCT01857102|363283394|FG001|Period 1|Unsatisfactory Lens Fit|0|||
105349839|NCT01857102|363283393|FG000|Period 1|Unsatisfactory Visual Response|1|||
105349840|NCT01857102|363283394|FG001|Period 1|Unsatisfactory Visual Response|0|||
105349841|NCT01857102|363283393|FG000|Period 1|Physician Decision|1|||
105349842|NCT01857102|363283394|FG001|Period 1|Physician Decision|0|||
105349843|NCT01857102|363283393|FG000|Period 2|Lens Discomfort|1|||
105349844|NCT01857102|363283394|FG001|Period 2|Lens Discomfort|0|||
105349845|NCT01857102|363283393|FG000|Period 2|Unsatisfactory Lens Fit|1|||
105349846|NCT01857102|363283394|FG001|Period 2|Unsatisfactory Lens Fit|0|||
105349847|NCT02603562|363283395|FG000|Overall Study|Lost to Follow-up|1|||
105349848|NCT00379808|363283396|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
105349849|NCT00379808|363283397|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
105349850|NCT03742258|363283399|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
105349851|NCT03742258|363283400|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
105349852|NCT03742258|363283401|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
105349853|NCT03742258|363283399|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
105349854|NCT03742258|363283400|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
105349855|NCT03742258|363283401|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
105349856|NCT03742258|363283399|FG000|Survival Follow-Up|Still in Follow-up|0|||
105702510|NCT00393887|364572971|FG000|Overall Study|Physician Decision|5|||
105349857|NCT03742258|363283400|FG001|Survival Follow-Up|Still in Follow-up|0|||
105349858|NCT03742258|363283401|FG002|Survival Follow-Up|Still in Follow-up|2|||
105349859|NCT00957905|363283402|FG000|Part B|Not Treated|0|||
105349860|NCT00957905|363283403|FG001|Part B|Not Treated|1|||
105349861|NCT00957905|363283402|FG000|Part B|Physician Decision|0|||
105349862|NCT00957905|363283403|FG001|Part B|Physician Decision|1|||
105349863|NCT00957905|363283402|FG000|Part B|Death|0|||
105349864|NCT00957905|363283403|FG001|Part B|Death|1|||
105349865|NCT00957905|363283402|FG000|Part B|Protocol Violation|0|||
105349866|NCT00957905|363283403|FG001|Part B|Protocol Violation|1|||
105349867|NCT02073656|363283420|FG000|Primary Study|Lost to Follow-up|6|||
105349868|NCT02073656|363283420|FG000|Primary Study|Death|1|||
105349869|NCT02073656|363283420|FG000|Primary Study|Withdrew Consent|1|||
105349870|NCT03423147|363283421|FG000|Overall Study|Lost to Follow-up|5|||
105349871|NCT03423147|363283422|FG001|Overall Study|Lost to Follow-up|8|||
105349872|NCT03423147|363283421|FG000|Overall Study|Withdrawal by Subject|1|||
105349873|NCT03423147|363283422|FG001|Overall Study|Withdrawal by Subject|0|||
105349874|NCT03423147|363283421|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
105349875|NCT03423147|363283422|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
105349876|NCT03423147|363283421|FG000|Overall Study|Age < 18|1|||
105474511|NCT01776307|363748590|FG001|Overall Study|Not dosed|0|||
105474512|NCT01776307|363748591|FG002|Overall Study|Not dosed|1|||
105474513|NCT03615040|363748592|FG000|Overall Study|Withdrawal by Subject|2|||
105474514|NCT03615040|363748593|FG001|Overall Study|Withdrawal by Subject|1|||
105474515|NCT03615040|363748592|FG000|Overall Study|Physician Decision|2|||
105349877|NCT03423147|363283422|FG001|Overall Study|Age < 18|0|||
105349878|NCT03423147|363283421|FG000|Overall Study|No Trial of Labor|0|||
105349879|NCT03423147|363283422|FG001|Overall Study|No Trial of Labor|1|||
105349880|NCT01969084|363283423|FG000|Overall Study|Adverse Event|0|||
105349881|NCT01969084|363283424|FG001|Overall Study|Adverse Event|1|||
105349882|NCT01926197|363283425|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
105349883|NCT01926197|363283426|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
105349884|NCT01926197|363283425|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
105349885|NCT01926197|363283426|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
105349886|NCT01810783|363283427|FG000|Overall Study|Adverse Event|32|||
105349887|NCT01810783|363283427|FG000|Overall Study|Withdrawal by Subject|22|||
105349888|NCT01810783|363283427|FG000|Overall Study|Lack of Efficacy|12|||
105349889|NCT01810783|363283427|FG000|Overall Study|Lost to Follow-up|10|||
105349890|NCT01810783|363283427|FG000|Overall Study|Protocol Violation|5|||
105702511|NCT00393887|364572972|FG001|Overall Study|Physician Decision|0|||
105702512|NCT00393887|364572971|FG000|Overall Study|Lost to Follow-up|11|||
105702513|NCT00393887|364572972|FG001|Overall Study|Lost to Follow-up|9|||
105702514|NCT00632099|364572981|FG000|Overall Study|Lost to Follow-up|3|||
105702515|NCT00632099|364572982|FG001|Overall Study|Lost to Follow-up|3|||
105702516|NCT03462576|364572990|FG000|Overall Study|Protocol Violation|5|||
105702517|NCT03462576|364572991|FG001|Overall Study|Protocol Violation|11|||
105702518|NCT03462576|364572992|FG002|Overall Study|Protocol Violation|7|||
105702519|NCT03462576|364572990|FG000|Overall Study|Device Malfunction|0|||
105702520|NCT03462576|364572991|FG001|Overall Study|Device Malfunction|0|||
105702521|NCT03462576|364572992|FG002|Overall Study|Device Malfunction|1|||
105702522|NCT03201458|364572996|FG000|Overall Study|No longer eligible|2|||
105702523|NCT03201458|364572997|FG001|Overall Study|No longer eligible|5|||
105702524|NCT03201458|364572996|FG000|Overall Study|Health event before starting|1|||
105702525|NCT03201458|364572997|FG001|Overall Study|Health event before starting|0|||
105702526|NCT03201458|364572996|FG000|Overall Study|Physician Decision|1|||
105702527|NCT03201458|364572997|FG001|Overall Study|Physician Decision|0|||
105702528|NCT00715026|364573002|FG000|Overall Study|Withdrawal by Subject|5|||
105702529|NCT00715026|364573002|FG000|Overall Study|Lost to Follow-up|3|||
105702530|NCT00715026|364573002|FG000|Overall Study|Protocol Violation|1|||
105702531|NCT00715026|364573002|FG000|Overall Study|Surgery done on non-study consented hip|1|||
105702532|NCT03962101|364573004|FG000|Overall Study|Adverse Event|1|||
105702533|NCT03962101|364573004|FG000|Overall Study|Physician Decision|2|||
105702534|NCT03962101|364573004|FG000|Overall Study|Not related to medical events|1|||
105702535|NCT00750737|364573005|FG000|Overall Study|Withdrawal by Subject|3|||
105702536|NCT00750737|364573006|FG001|Overall Study|Withdrawal by Subject|3|||
105702537|NCT00271596|364573007|FG000|Overall Study|Protocol Violation|1|||
105702538|NCT00271596|364573008|FG001|Overall Study|Protocol Violation|0|||
105702539|NCT00271596|364573007|FG000|Overall Study|Withdrawal by Subject|0|||
105702540|NCT00271596|364573008|FG001|Overall Study|Withdrawal by Subject|1|||
105702541|NCT04707157|364573009|FG000|Overall Study|Adverse Event|12|||
105702542|NCT04707157|364573010|FG001|Overall Study|Adverse Event|3|||
105702543|NCT04707157|364573009|FG000|Overall Study|Lost to Follow-up|2|||
105702544|NCT04707157|364573010|FG001|Overall Study|Lost to Follow-up|0|||
105702545|NCT04707157|364573009|FG000|Overall Study|Sponsor's decision|1|||
105702546|NCT04707157|364573010|FG001|Overall Study|Sponsor's decision|0|||
105702547|NCT04707157|364573009|FG000|Overall Study|Physician Decision|8|||
105702548|NCT04707157|364573010|FG001|Overall Study|Physician Decision|5|||
105702549|NCT04707157|364573009|FG000|Overall Study|Protocol Deviation|1|||
105702550|NCT04707157|364573010|FG001|Overall Study|Protocol Deviation|0|||
105702551|NCT04707157|364573009|FG000|Overall Study|Withdrawal by Subject|1|||
105702552|NCT04707157|364573010|FG001|Overall Study|Withdrawal by Subject|1|||
105702553|NCT02409290|364573013|FG000|Overall Study|Protocol Violation|3|||
105702554|NCT02409290|364573014|FG001|Overall Study|Protocol Violation|6|||
105702555|NCT02409290|364573015|FG002|Overall Study|Protocol Violation|9|||
105702556|NCT02409290|364573016|FG003|Overall Study|Protocol Violation|4|||
105702557|NCT02409290|364573013|FG000|Overall Study|No positive culture/no baseline sample|3|||
105702558|NCT02409290|364573014|FG001|Overall Study|No positive culture/no baseline sample|9|||
105702559|NCT02409290|364573015|FG002|Overall Study|No positive culture/no baseline sample|6|||
105702560|NCT02409290|364573016|FG003|Overall Study|No positive culture/no baseline sample|5|||
105702561|NCT02409290|364573013|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
105702562|NCT02409290|364573014|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
105702563|NCT02409290|364573015|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
105702564|NCT02409290|364573016|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
105702565|NCT02025907|364573021|FG000|Overall Study|Lack of Efficacy|1|||
105702566|NCT02025907|364573022|FG001|Overall Study|Lack of Efficacy|0|||
105702567|NCT02025907|364573021|FG000|Overall Study|Withdrawal by Subject|15|||
105702568|NCT02025907|364573022|FG001|Overall Study|Withdrawal by Subject|8|||
105702569|NCT02025907|364573021|FG000|Overall Study|Protocol Violation|2|||
105702570|NCT02025907|364573022|FG001|Overall Study|Protocol Violation|0|||
105702571|NCT02025907|364573021|FG000|Overall Study|Physician Decision|2|||
105702572|NCT02025907|364573022|FG001|Overall Study|Physician Decision|0|||
105702573|NCT02025907|364573021|FG000|Overall Study|Lost to Follow-up|2|||
105702574|NCT02025907|364573022|FG001|Overall Study|Lost to Follow-up|2|||
105349891|NCT01810783|363283427|FG000|Overall Study|Non-compliance with IMP|4|||
105349892|NCT01810783|363283427|FG000|Overall Study|Adminstrative or other reason(s)|23|||
105349893|NCT01810783|363283427|FG000|Overall Study|Enrolled, not treated|1|||
105702575|NCT02025907|364573021|FG000|Overall Study|Adverse Event|3|||
105702576|NCT02025907|364573022|FG001|Overall Study|Adverse Event|1|||
105702577|NCT02025907|364573021|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
105702578|NCT02025907|364573022|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
105702579|NCT03317795|364573023|FG000|Overall Study|IUD Expulsion|1|||
105702580|NCT03317795|364573024|FG001|Overall Study|IUD Expulsion|0|||
105702581|NCT03317795|364573023|FG000|Overall Study|Lost to Follow-up|1|||
105702582|NCT03317795|364573024|FG001|Overall Study|Lost to Follow-up|3|||
105349894|NCT00358956|363283428|FG000|Overall Study|Adverse Event|3|||
105702583|NCT03317795|364573023|FG000|Overall Study|Treatment change|0|||
105702584|NCT03317795|364573024|FG001|Overall Study|Treatment change|3|||
105702585|NCT03317795|364573023|FG000|Overall Study|Intolerance of medication|0|||
105702586|NCT03317795|364573024|FG001|Overall Study|Intolerance of medication|1|||
105702587|NCT03077685|364573025|FG000|Overall Study|Lost to Follow-up|0|||
105702588|NCT03077685|364573026|FG001|Overall Study|Lost to Follow-up|0|||
105702589|NCT03077685|364573027|FG002|Overall Study|Lost to Follow-up|0|||
105702590|NCT03077685|364573028|FG003|Overall Study|Lost to Follow-up|0|||
105702591|NCT03077685|364573029|FG004|Overall Study|Lost to Follow-up|1|||
105702592|NCT03077685|364573025|FG000|Overall Study|Death|0|||
105702593|NCT03077685|364573026|FG001|Overall Study|Death|0|||
105702594|NCT03077685|364573027|FG002|Overall Study|Death|1|||
105702595|NCT03077685|364573028|FG003|Overall Study|Death|1|||
105702596|NCT03077685|364573029|FG004|Overall Study|Death|3|||
105702597|NCT03077685|364573025|FG000|Overall Study|Withdrawal by Subject|0|||
105702598|NCT03077685|364573026|FG001|Overall Study|Withdrawal by Subject|0|||
105702599|NCT03077685|364573027|FG002|Overall Study|Withdrawal by Subject|0|||
105702600|NCT03077685|364573028|FG003|Overall Study|Withdrawal by Subject|2|||
105702601|NCT03077685|364573029|FG004|Overall Study|Withdrawal by Subject|1|||
105702602|NCT03077685|364573025|FG000|Overall Study|Physician Decision|0|||
105702603|NCT03077685|364573026|FG001|Overall Study|Physician Decision|0|||
105702604|NCT03077685|364573027|FG002|Overall Study|Physician Decision|1|||
105702605|NCT03077685|364573028|FG003|Overall Study|Physician Decision|0|||
105702606|NCT03077685|364573029|FG004|Overall Study|Physician Decision|3|||
105702607|NCT03077685|364573025|FG000|Overall Study|Disease Progression|1|||
105702608|NCT03077685|364573026|FG001|Overall Study|Disease Progression|0|||
105702609|NCT03077685|364573027|FG002|Overall Study|Disease Progression|0|||
105702610|NCT03077685|364573028|FG003|Overall Study|Disease Progression|2|||
105702611|NCT03077685|364573029|FG004|Overall Study|Disease Progression|1|||
105702612|NCT03077685|364573025|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
105702613|NCT03077685|364573026|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
105702614|NCT03077685|364573027|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
105702615|NCT03077685|364573028|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
105702616|NCT03077685|364573029|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
105702617|NCT03077685|364573025|FG000|Overall Study|Subject entered hospice care|0|||
105702618|NCT03077685|364573026|FG001|Overall Study|Subject entered hospice care|0|||
105702619|NCT03077685|364573027|FG002|Overall Study|Subject entered hospice care|0|||
105702620|NCT03077685|364573028|FG003|Overall Study|Subject entered hospice care|0|||
105702621|NCT03077685|364573029|FG004|Overall Study|Subject entered hospice care|1|||
105702622|NCT02116777|364573040|FG000|Overall Study|Adverse Event|0|||
105702623|NCT02116777|364573041|FG001|Overall Study|Adverse Event|0|||
105702624|NCT02116777|364573042|FG002|Overall Study|Adverse Event|0|||
105702625|NCT02116777|364573043|FG003|Overall Study|Adverse Event|0|||
105702626|NCT02116777|364573044|FG004|Overall Study|Adverse Event|2|||
105702627|NCT02116777|364573045|FG005|Overall Study|Adverse Event|2|||
105702628|NCT02116777|364573046|FG006|Overall Study|Adverse Event|0|||
105702629|NCT02116777|364573040|FG000|Overall Study|Death|0|||
105702630|NCT02116777|364573041|FG001|Overall Study|Death|0|||
105702631|NCT02116777|364573042|FG002|Overall Study|Death|0|||
105702632|NCT02116777|364573043|FG003|Overall Study|Death|1|||
105702633|NCT02116777|364573044|FG004|Overall Study|Death|0|||
105702634|NCT02116777|364573045|FG005|Overall Study|Death|0|||
105702635|NCT02116777|364573046|FG006|Overall Study|Death|0|||
105702636|NCT02116777|364573040|FG000|Overall Study|Lack of Efficacy|3|||
105702637|NCT02116777|364573041|FG001|Overall Study|Lack of Efficacy|3|||
105702638|NCT02116777|364573042|FG002|Overall Study|Lack of Efficacy|3|||
105702639|NCT02116777|364573043|FG003|Overall Study|Lack of Efficacy|8|||
105702640|NCT02116777|364573044|FG004|Overall Study|Lack of Efficacy|4|||
105702641|NCT02116777|364573045|FG005|Overall Study|Lack of Efficacy|1|||
105702642|NCT02116777|364573046|FG006|Overall Study|Lack of Efficacy|9|||
105474516|NCT03615040|363748593|FG001|Overall Study|Physician Decision|2|||
105474517|NCT03615040|363748592|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
105474518|NCT03615040|363748593|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
105702643|NCT02116777|364573040|FG000|Overall Study|Physician Decision|0|||
105702644|NCT02116777|364573041|FG001|Overall Study|Physician Decision|0|||
105702645|NCT02116777|364573042|FG002|Overall Study|Physician Decision|0|||
105702646|NCT02116777|364573043|FG003|Overall Study|Physician Decision|2|||
105702647|NCT02116777|364573044|FG004|Overall Study|Physician Decision|0|||
105702648|NCT02116777|364573045|FG005|Overall Study|Physician Decision|0|||
105702649|NCT02116777|364573046|FG006|Overall Study|Physician Decision|0|||
105702650|NCT02116777|364573040|FG000|Overall Study|Protocol Violation|0|||
105702651|NCT02116777|364573041|FG001|Overall Study|Protocol Violation|0|||
105702652|NCT02116777|364573042|FG002|Overall Study|Protocol Violation|0|||
105702653|NCT02116777|364573043|FG003|Overall Study|Protocol Violation|1|||
105702654|NCT02116777|364573044|FG004|Overall Study|Protocol Violation|0|||
105702655|NCT02116777|364573045|FG005|Overall Study|Protocol Violation|0|||
105702656|NCT02116777|364573046|FG006|Overall Study|Protocol Violation|0|||
105702657|NCT02116777|364573040|FG000|Overall Study|Withdrawal by Subject|0|||
105702658|NCT02116777|364573041|FG001|Overall Study|Withdrawal by Subject|0|||
105349895|NCT00358956|363283428|FG000|Overall Study|condition under investigation worsened|4|||
105349896|NCT00358956|363283428|FG000|Overall Study|Withdrawal by Subject|1|||
105349897|NCT03646305|363283431|FG000|Overall Study|Lost to Follow-up|4|||
105349898|NCT03646305|363283432|FG001|Overall Study|Lost to Follow-up|2|||
105349899|NCT03646305|363283433|FG002|Overall Study|Lost to Follow-up|2|||
105349900|NCT03646305|363283434|FG003|Overall Study|Lost to Follow-up|1|||
105349901|NCT03646305|363283431|FG000|Overall Study|Withdrawal by Subject|1|||
105349902|NCT03646305|363283432|FG001|Overall Study|Withdrawal by Subject|0|||
105349903|NCT03646305|363283433|FG002|Overall Study|Withdrawal by Subject|0|||
105349904|NCT03646305|363283434|FG003|Overall Study|Withdrawal by Subject|1|||
105349905|NCT03417024|363283437|FG000|Overall Study|Study Termination prior to follow-up|11|||
105349906|NCT03417024|363283437|FG000|Overall Study|Physician Decision|2|||
105349907|NCT00386425|363283438|FG000|Overall Study|Physician Decision|3|||
105349908|NCT00386425|363283439|FG001|Overall Study|Physician Decision|0|||
105349909|NCT00386425|363283440|FG002|Overall Study|Physician Decision|0|||
105349910|NCT00386425|363283438|FG000|Overall Study|Withdrawal by Subject|0|||
105349911|NCT00386425|363283439|FG001|Overall Study|Withdrawal by Subject|1|||
105349912|NCT00386425|363283440|FG002|Overall Study|Withdrawal by Subject|0|||
105349913|NCT02655419|363283441|FG000|Overall Study|Enrolled but not treated|1|||
105349914|NCT02655419|363283442|FG001|Overall Study|Enrolled but not treated|5|||
105349915|NCT02655419|363283441|FG000|Overall Study|Withdrawal by Subject|4|||
105349916|NCT02655419|363283442|FG001|Overall Study|Withdrawal by Subject|1|||
105349917|NCT02655419|363283441|FG000|Overall Study|Other|0|||
105349918|NCT02655419|363283442|FG001|Overall Study|Other|1|||
105349919|NCT02607306|363283445|FG000|Overall Study|Adverse Event|8|||
105349920|NCT02607306|363283446|FG001|Overall Study|Adverse Event|6|||
105349921|NCT02607306|363283447|FG002|Overall Study|Adverse Event|6|||
105349922|NCT02607306|363283445|FG000|Overall Study|Unclassified|1|||
105349923|NCT02607306|363283446|FG001|Overall Study|Unclassified|4|||
105349924|NCT02607306|363283447|FG002|Overall Study|Unclassified|0|||
105349925|NCT02607306|363283445|FG000|Overall Study|Withdrawal by Subject|8|||
105349926|NCT02607306|363283446|FG001|Overall Study|Withdrawal by Subject|10|||
105349927|NCT02607306|363283447|FG002|Overall Study|Withdrawal by Subject|2|||
105349928|NCT02607306|363283445|FG000|Overall Study|Lack of Efficacy|0|||
105349929|NCT02607306|363283446|FG001|Overall Study|Lack of Efficacy|1|||
105349930|NCT02607306|363283447|FG002|Overall Study|Lack of Efficacy|1|||
105349931|NCT02607306|363283445|FG000|Overall Study|Protocol Violation|4|||
105349932|NCT02607306|363283446|FG001|Overall Study|Protocol Violation|2|||
105349933|NCT02607306|363283447|FG002|Overall Study|Protocol Violation|1|||
105349934|NCT00539032|363283451|FG000|Overall Study|Withdrawal by Subject|2|||
105349935|NCT00539032|363283452|FG001|Overall Study|Withdrawal by Subject|1|||
105349936|NCT02306694|363283453|FG000|Overall Study|Withdrawal by Subject|3|||
105349937|NCT02306694|363283453|FG000|Overall Study|Lost to Follow-up|1|||
105349938|NCT03403621|363283454|FG000|Overall Study|Withdrawal by Subject|2|||
105560190|NCT01506193|364046567|FG001|Overall Study|Adverse event, non-fatal|0|||
105702659|NCT02116777|364573042|FG002|Overall Study|Withdrawal by Subject|0|||
105702660|NCT02116777|364573043|FG003|Overall Study|Withdrawal by Subject|1|||
105702661|NCT02116777|364573044|FG004|Overall Study|Withdrawal by Subject|0|||
105702662|NCT02116777|364573045|FG005|Overall Study|Withdrawal by Subject|0|||
105702663|NCT02116777|364573046|FG006|Overall Study|Withdrawal by Subject|0|||
105702664|NCT02322125|364574460|FG000|Overall Study|Withdrawal by Subject|2|||
105702665|NCT00750698|364574466|FG000|Overall Study|Withdrawal by Subject|1|||
105349939|NCT03403621|363283455|FG001|Overall Study|Withdrawal by Subject|2|||
105349940|NCT00583102|363283456|FG000|Overall Study|Adverse Event|3|||
105702666|NCT00750698|364574467|FG001|Overall Study|Withdrawal by Subject|0|||
105702667|NCT00750698|364574466|FG000|Overall Study|Progressive disease|5|||
105702668|NCT00750698|364574467|FG001|Overall Study|Progressive disease|2|||
105702669|NCT03557281|364574468|FG000|Overall Study|Investigator discretion|0|||
105702670|NCT03557281|364574469|FG001|Overall Study|Investigator discretion|0|||
105702671|NCT03557281|364574470|FG002|Overall Study|Investigator discretion|1|||
105349941|NCT00395642|363283461|FG000|Overall Study|Death|4|||
105702672|NCT03557281|364574471|FG003|Overall Study|Investigator discretion|0|||
105349942|NCT00395642|363283461|FG000|Overall Study|Lost to Follow-up|1|||
105349943|NCT00395642|363283461|FG000|Overall Study|Physician Decision|7|||
105349944|NCT00395642|363283461|FG000|Overall Study|Withdrawal by Subject|1|||
105702673|NCT03557281|364574472|FG004|Overall Study|Investigator discretion|0|||
105702674|NCT03557281|364574468|FG000|Overall Study|Withdrawal by Subject|0|||
105702675|NCT03557281|364574469|FG001|Overall Study|Withdrawal by Subject|1|||
105702676|NCT03557281|364574470|FG002|Overall Study|Withdrawal by Subject|1|||
105702677|NCT03557281|364574471|FG003|Overall Study|Withdrawal by Subject|1|||
105702678|NCT03557281|364574472|FG004|Overall Study|Withdrawal by Subject|2|||
105787306|NCT04963231|364874933|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
105787307|NCT04963231|364874931|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
105787308|NCT04963231|364874932|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
105787309|NCT04963231|364874933|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
105787310|NCT04963231|364874931|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
105787311|NCT04963231|364874932|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
105787312|NCT04963231|364874933|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
105787313|NCT04963231|364874931|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
105787314|NCT04963231|364874932|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
105702679|NCT03557281|364574468|FG000|Overall Study|Randomized, but did not receive treatment|0|||
105702680|NCT03557281|364574469|FG001|Overall Study|Randomized, but did not receive treatment|0|||
105702681|NCT03557281|364574470|FG002|Overall Study|Randomized, but did not receive treatment|0|||
105702682|NCT03557281|364574471|FG003|Overall Study|Randomized, but did not receive treatment|0|||
105702683|NCT03557281|364574472|FG004|Overall Study|Randomized, but did not receive treatment|1|||
105702684|NCT02325219|364574473|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
105702685|NCT02325219|364574474|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
105702686|NCT02325219|364574475|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
105702687|NCT02325219|364574476|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
105702688|NCT02325219|364574477|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
105787315|NCT04963231|364874933|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
105702689|NCT02325219|364574473|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
105702690|NCT02325219|364574474|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
105702691|NCT02325219|364574475|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
105702692|NCT02325219|364574476|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
105702693|NCT02325219|364574477|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
105702694|NCT02325219|364574473|FG000|Controlled Period (Week 0 - 16)|Other|0|||
105702695|NCT02325219|364574474|FG001|Controlled Period (Week 0 - 16)|Other|0|||
105702696|NCT02325219|364574475|FG002|Controlled Period (Week 0 - 16)|Other|1|||
105560191|NCT01506193|364046568|FG002|Overall Study|Adverse event, non-fatal|1|||
105560192|NCT01506193|364046566|FG000|Overall Study|Withdrawal by Subject|5|||
105560193|NCT01506193|364046567|FG001|Overall Study|Withdrawal by Subject|1|||
105560194|NCT01506193|364046568|FG002|Overall Study|Withdrawal by Subject|8|||
105560195|NCT01506193|364046566|FG000|Overall Study|Lost to Follow-up|8|||
105560196|NCT01506193|364046567|FG001|Overall Study|Lost to Follow-up|3|||
105560197|NCT01506193|364046568|FG002|Overall Study|Lost to Follow-up|3|||
105787316|NCT04963231|364874931|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
105787317|NCT04963231|364874932|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
105787318|NCT04963231|364874933|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
105787319|NCT05450198|364874934|FG000|Overall Study|Withdrawal by Subject|1|||
105560198|NCT00675766|364046570|FG000|Overall Study|Lost to Follow-up|6|||
105702697|NCT02325219|364574476|FG003|Controlled Period (Week 0 - 16)|Other|0|||
105702698|NCT02325219|364574477|FG004|Controlled Period (Week 0 - 16)|Other|0|||
105702699|NCT02325219|364574473|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
105702700|NCT02325219|364574474|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
105702701|NCT02325219|364574475|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
105702702|NCT02325219|364574476|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
105702703|NCT02325219|364574477|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
105702704|NCT02325219|364574473|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
105702705|NCT02325219|364574474|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
105702706|NCT02325219|364574475|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
105702707|NCT02325219|364574476|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
105702708|NCT02325219|364574477|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
105787320|NCT05450198|364874935|FG001|Overall Study|Withdrawal by Subject|1|||
105787321|NCT05450198|364874936|FG002|Overall Study|Withdrawal by Subject|2|||
105787322|NCT05450198|364874937|FG003|Overall Study|Withdrawal by Subject|0|||
105787323|NCT05450198|364874934|FG000|Overall Study|Lost to Follow-up|1|||
105702709|NCT02325219|364574473|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
105702710|NCT02325219|364574474|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
105702711|NCT02325219|364574475|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
105702712|NCT02325219|364574476|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
105702713|NCT02325219|364574477|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
105702714|NCT04036708|364574478|FG000|Overall Study|Lost to Follow-up|14|||
105787324|NCT05450198|364874935|FG001|Overall Study|Lost to Follow-up|0|||
105702715|NCT04036708|364574479|FG001|Overall Study|Lost to Follow-up|4|||
105702716|NCT04036708|364574480|FG002|Overall Study|Lost to Follow-up|14|||
105702717|NCT04036708|364574481|FG003|Overall Study|Lost to Follow-up|4|||
105702718|NCT02918864|364574482|FG000|Overall Study|Withdrawal by Subject|1|||
105702719|NCT02918864|364574483|FG001|Overall Study|Withdrawal by Subject|1|||
105702720|NCT02918864|364574482|FG000|Overall Study|Lost to Follow-up|3|||
105702721|NCT02918864|364574483|FG001|Overall Study|Lost to Follow-up|2|||
105702722|NCT02257372|364574486|FG000|Overall Study|Adverse Event|3|||
105702723|NCT02257372|364574487|FG001|Overall Study|Adverse Event|7|||
105702724|NCT02257372|364574486|FG000|Overall Study|Lack of Efficacy|2|||
105702725|NCT02257372|364574487|FG001|Overall Study|Lack of Efficacy|1|||
105702726|NCT02257372|364574486|FG000|Overall Study|Protocol Violation|1|||
105702727|NCT02257372|364574487|FG001|Overall Study|Protocol Violation|1|||
105702728|NCT02257372|364574486|FG000|Overall Study|Lost to Follow-up|0|||
105702729|NCT02257372|364574487|FG001|Overall Study|Lost to Follow-up|1|||
105702730|NCT02257372|364574486|FG000|Overall Study|Withdrew consent|1|||
105702731|NCT02257372|364574487|FG001|Overall Study|Withdrew consent|0|||
105702732|NCT00552175|364574498|FG000|Overall Study|Lack of Efficacy|2|||
105702733|NCT00552175|364574499|FG001|Overall Study|Lack of Efficacy|0|||
105702734|NCT00552175|364574500|FG002|Overall Study|Lack of Efficacy|1|||
105702735|NCT00552175|364574498|FG000|Overall Study|Adverse Event|9|||
105702736|NCT00552175|364574499|FG001|Overall Study|Adverse Event|9|||
105702737|NCT00552175|364574500|FG002|Overall Study|Adverse Event|10|||
105702738|NCT00552175|364574498|FG000|Overall Study|Withdrawal by Subject|2|||
105702739|NCT00552175|364574499|FG001|Overall Study|Withdrawal by Subject|2|||
105702740|NCT00552175|364574500|FG002|Overall Study|Withdrawal by Subject|1|||
105702741|NCT00552175|364574498|FG000|Overall Study|Lost to Follow-up|0|||
105702742|NCT00552175|364574499|FG001|Overall Study|Lost to Follow-up|0|||
105702743|NCT00552175|364574500|FG002|Overall Study|Lost to Follow-up|1|||
105702744|NCT00552175|364574498|FG000|Overall Study|Entry Criteria Not Met|1|||
105702745|NCT00552175|364574499|FG001|Overall Study|Entry Criteria Not Met|1|||
105702746|NCT00552175|364574500|FG002|Overall Study|Entry Criteria Not Met|0|||
105702747|NCT00552175|364574498|FG000|Overall Study|Reason Not Specified|3|||
105702748|NCT00552175|364574499|FG001|Overall Study|Reason Not Specified|1|||
105702749|NCT00552175|364574500|FG002|Overall Study|Reason Not Specified|1|||
105702750|NCT00631020|364574507|FG000|Overall Study|Lost to Follow-up|7|||
105702751|NCT00631020|364574507|FG000|Overall Study|Incarcerated|1|||
105702752|NCT02614859|364574512|FG000|Overall Study|Physician Decision|0|||
105702753|NCT02614859|364574513|FG001|Overall Study|Physician Decision|1|||
105702754|NCT03972969|364574515|FG000|3-month Follow-up|Death|1|||
105702755|NCT03972969|364574516|FG001|3-month Follow-up|Death|1|||
105702756|NCT03972969|364574517|FG002|3-month Follow-up|Death|0|||
105702757|NCT03972969|364574515|FG000|6-month Follow-up|Death|1|||
105702758|NCT03972969|364574516|FG001|6-month Follow-up|Death|1|||
105702759|NCT03972969|364574517|FG002|6-month Follow-up|Death|1|||
105702760|NCT03972969|364574515|FG000|6-month Follow-up|Lost to Follow-up|2|||
105702761|NCT03972969|364574516|FG001|6-month Follow-up|Lost to Follow-up|2|||
105702762|NCT03972969|364574517|FG002|6-month Follow-up|Lost to Follow-up|2|||
105702763|NCT00732303|364574518|FG000|Overall Study|Study Terminated|2|||
105702764|NCT02919436|364574519|FG000|Overall Study|Did not undergo surgery|16|||
105702765|NCT02919436|364574520|FG001|Overall Study|Did not undergo surgery|20|||
105702766|NCT02919436|364574519|FG000|Overall Study|Enrolled before trial registration|44|||
105702767|NCT02919436|364574520|FG001|Overall Study|Enrolled before trial registration|33|||
105702768|NCT04718974|364574522|FG000|Overall Study|Death|0|||
105702769|NCT04718974|364574523|FG001|Overall Study|Death|2|||
105702770|NCT04718974|364574522|FG000|Overall Study|Lost to Follow-up|10|||
105702771|NCT04718974|364574523|FG001|Overall Study|Lost to Follow-up|20|||
105702772|NCT04718974|364574522|FG000|Overall Study|Transferred out|2|||
105702773|NCT04718974|364574523|FG001|Overall Study|Transferred out|4|||
105702774|NCT01389752|364574524|FG000|Study Period 1|Sponsor decision|0|||
105702775|NCT01389752|364574525|FG001|Study Period 1|Sponsor decision|2|||
105702776|NCT01389752|364574524|FG000|Study Period 2|Sponsor decision|1|||
105702777|NCT01389752|364574525|FG001|Study Period 2|Sponsor decision|0|||
105702778|NCT01157364|364574530|FG000|Overall Study|Other Reasons|1|||
105702779|NCT01157364|364574531|FG001|Overall Study|Other Reasons|1|||
105702780|NCT01157364|364574532|FG002|Overall Study|Other Reasons|2|||
105702781|NCT01157364|364574533|FG003|Overall Study|Other Reasons|1|||
105702782|NCT01157364|364574534|FG004|Overall Study|Other Reasons|0|||
105702783|NCT01157364|364574535|FG005|Overall Study|Other Reasons|0|||
105702784|NCT01157364|364574530|FG000|Overall Study|Personal Reasons|0|||
105702785|NCT01157364|364574531|FG001|Overall Study|Personal Reasons|2|||
105702786|NCT01157364|364574532|FG002|Overall Study|Personal Reasons|0|||
105702787|NCT01157364|364574533|FG003|Overall Study|Personal Reasons|0|||
105702788|NCT01157364|364574534|FG004|Overall Study|Personal Reasons|1|||
105702789|NCT01157364|364574535|FG005|Overall Study|Personal Reasons|1|||
105702790|NCT01157364|364574530|FG000|Overall Study|Lost to Follow-up|1|||
105702791|NCT01157364|364574531|FG001|Overall Study|Lost to Follow-up|0|||
105702792|NCT01157364|364574532|FG002|Overall Study|Lost to Follow-up|1|||
105702793|NCT01157364|364574533|FG003|Overall Study|Lost to Follow-up|0|||
105702794|NCT01157364|364574534|FG004|Overall Study|Lost to Follow-up|0|||
105702795|NCT01157364|364574535|FG005|Overall Study|Lost to Follow-up|0|||
105702796|NCT01157364|364574530|FG000|Overall Study|Lack of Efficacy|0|||
105702797|NCT01157364|364574531|FG001|Overall Study|Lack of Efficacy|0|||
105702798|NCT01157364|364574532|FG002|Overall Study|Lack of Efficacy|0|||
105702799|NCT01157364|364574533|FG003|Overall Study|Lack of Efficacy|1|||
105702800|NCT01157364|364574534|FG004|Overall Study|Lack of Efficacy|0|||
105702801|NCT01157364|364574535|FG005|Overall Study|Lack of Efficacy|0|||
105702802|NCT01157364|364574530|FG000|Overall Study|Adverse Event|0|||
105702803|NCT01157364|364574531|FG001|Overall Study|Adverse Event|1|||
105702804|NCT01157364|364574532|FG002|Overall Study|Adverse Event|1|||
105702805|NCT01157364|364574533|FG003|Overall Study|Adverse Event|0|||
105702806|NCT01157364|364574534|FG004|Overall Study|Adverse Event|1|||
105702807|NCT01157364|364574535|FG005|Overall Study|Adverse Event|0|||
105702808|NCT01576549|364574546|FG000|Overall Study|Sponsor Decision|2|||
105702809|NCT04191382|364574547|FG000|Overall Study|Withdrawal by Subject|1|||
105702810|NCT04191382|364574548|FG001|Overall Study|Withdrawal by Subject|0|||
105702811|NCT04191382|364574549|FG002|Overall Study|Withdrawal by Subject|0|||
105702812|NCT03882970|364574556|FG000|Overall Study|Adverse Event|5|||
105702813|NCT03882970|364574557|FG001|Overall Study|Adverse Event|7|||
105702814|NCT03882970|364574558|FG002|Overall Study|Adverse Event|3|||
105702815|NCT03882970|364574559|FG003|Overall Study|Adverse Event|1|||
105702816|NCT03882970|364574556|FG000|Overall Study|Death|1|||
105702817|NCT03882970|364574557|FG001|Overall Study|Death|2|||
105702818|NCT03882970|364574558|FG002|Overall Study|Death|1|||
105702819|NCT03882970|364574559|FG003|Overall Study|Death|1|||
105702820|NCT03882970|364574556|FG000|Overall Study|Lost to Follow-up|8|||
105702821|NCT03882970|364574557|FG001|Overall Study|Lost to Follow-up|9|||
105702822|NCT03882970|364574558|FG002|Overall Study|Lost to Follow-up|5|||
105702823|NCT03882970|364574559|FG003|Overall Study|Lost to Follow-up|5|||
105702824|NCT03882970|364574556|FG000|Overall Study|Physician Decision|0|||
105702825|NCT03882970|364574557|FG001|Overall Study|Physician Decision|2|||
105702826|NCT03882970|364574558|FG002|Overall Study|Physician Decision|2|||
105702827|NCT03882970|364574559|FG003|Overall Study|Physician Decision|2|||
105702828|NCT03882970|364574556|FG000|Overall Study|Protocol Violation|2|||
105702829|NCT03882970|364574557|FG001|Overall Study|Protocol Violation|0|||
105702830|NCT03882970|364574558|FG002|Overall Study|Protocol Violation|0|||
105702831|NCT03882970|364574559|FG003|Overall Study|Protocol Violation|0|||
105702832|NCT03882970|364574556|FG000|Overall Study|Withdrawal by Subject|8|||
105702833|NCT03882970|364574557|FG001|Overall Study|Withdrawal by Subject|17|||
105702834|NCT03882970|364574558|FG002|Overall Study|Withdrawal by Subject|7|||
105702835|NCT03882970|364574559|FG003|Overall Study|Withdrawal by Subject|22|||
105702836|NCT03882970|364574556|FG000|Overall Study|Personal Reason|2|||
105702837|NCT03882970|364574557|FG001|Overall Study|Personal Reason|3|||
105702838|NCT03882970|364574558|FG002|Overall Study|Personal Reason|1|||
105702839|NCT03882970|364574559|FG003|Overall Study|Personal Reason|3|||
105702840|NCT04744207|364574560|FG000|Treatment|Withdrawal by Subject|2|||
105702841|NCT04744207|364574561|FG001|Treatment|Withdrawal by Subject|0|||
105702842|NCT04744207|364574560|FG000|Treatment|Adverse Event|1|||
105702843|NCT04744207|364574561|FG001|Treatment|Adverse Event|2|||
105702844|NCT00282334|364574564|FG000|Overall Study|Withdrawal by Subject|8|||
105702845|NCT00282334|364574565|FG001|Overall Study|Withdrawal by Subject|5|||
105702846|NCT03681119|364574568|FG000|Overall Study|No specific reason|4|||
105702847|NCT03681119|364574569|FG001|Overall Study|No specific reason|0|||
105702848|NCT03681119|364574568|FG000|Overall Study|Sickness|2|||
105702849|NCT03681119|364574569|FG001|Overall Study|Sickness|0|||
105702850|NCT02813694|364574573|FG000|Overall Study|Physician Decision|0|||
105702851|NCT02813694|364574574|FG001|Overall Study|Physician Decision|1|||
105702852|NCT02813694|364574573|FG000|Overall Study|Withdrawal by Subject|10|||
105702853|NCT02813694|364574574|FG001|Overall Study|Withdrawal by Subject|9|||
105702854|NCT02813694|364574573|FG000|Overall Study|Lost to Follow-up|1|||
105702855|NCT02813694|364574574|FG001|Overall Study|Lost to Follow-up|1|||
105702856|NCT02813694|364574573|FG000|Overall Study|Death|3|||
105702857|NCT02813694|364574574|FG001|Overall Study|Death|3|||
105702858|NCT02813694|364574573|FG000|Overall Study|Randomized- did not receive study drug|2|||
105702859|NCT02813694|364574574|FG001|Overall Study|Randomized- did not receive study drug|0|||
105702860|NCT02813694|364574573|FG000|Overall Study|Patient hospitalized|1|||
105702861|NCT02813694|364574574|FG001|Overall Study|Patient hospitalized|0|||
105702862|NCT00879645|364574581|FG000|Overall Study|Adverse Event|1|||
105702863|NCT00879645|364574582|FG001|Overall Study|Adverse Event|0|||
105702864|NCT00879645|364574583|FG002|Overall Study|Adverse Event|0|||
105702865|NCT00879645|364574584|FG003|Overall Study|Adverse Event|0|||
105702866|NCT01549002|364574587|FG000|Overall Study|Excessive pain|0|||
105702867|NCT01549002|364574588|FG001|Overall Study|Excessive pain|2|||
105702868|NCT01549002|364574587|FG000|Overall Study|Moderate sedation required|0|||
105702869|NCT01549002|364574588|FG001|Overall Study|Moderate sedation required|2|||
105702870|NCT03631732|364574591|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
105702871|NCT03631732|364574592|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
105702872|NCT03631732|364574591|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
105702873|NCT03631732|364574592|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
105702874|NCT03631732|364574591|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
105702875|NCT03631732|364574592|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
105702876|NCT03631732|364574591|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
105702877|NCT03631732|364574592|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
105560199|NCT00675766|364046571|FG001|Overall Study|Lost to Follow-up|5|||
105560200|NCT00675766|364046572|FG002|Overall Study|Lost to Follow-up|21|||
105560201|NCT00675766|364046573|FG003|Overall Study|Lost to Follow-up|26|||
105560202|NCT02251990|364046579|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
105560203|NCT02251990|364046580|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
105560204|NCT02251990|364046579|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
105560205|NCT02251990|364046580|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
105560206|NCT02251990|364046579|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
105560207|NCT02251990|364046580|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
105560208|NCT02251990|364046579|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
105560209|NCT02251990|364046580|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
105560210|NCT02251990|364046579|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
105560211|NCT02251990|364046580|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
105560212|NCT02251990|364046579|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
105560213|NCT02251990|364046580|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
105560214|NCT01749982|364046581|FG000|Overall Study|Physician Decision|0|||
105560215|NCT01749982|364046582|FG001|Overall Study|Physician Decision|0|||
105560216|NCT01749982|364046583|FG002|Overall Study|Physician Decision|0|||
105560217|NCT01749982|364046584|FG003|Overall Study|Physician Decision|1|||
105560218|NCT01749982|364046581|FG000|Overall Study|Lost to Follow-up|0|||
105560219|NCT01749982|364046582|FG001|Overall Study|Lost to Follow-up|0|||
105560220|NCT01749982|364046583|FG002|Overall Study|Lost to Follow-up|0|||
105560221|NCT01749982|364046584|FG003|Overall Study|Lost to Follow-up|1|||
105560222|NCT01749982|364046581|FG000|Overall Study|Withdrawal by Subject|0|||
105560223|NCT01749982|364046582|FG001|Overall Study|Withdrawal by Subject|0|||
105560224|NCT01749982|364046583|FG002|Overall Study|Withdrawal by Subject|0|||
105560225|NCT01749982|364046584|FG003|Overall Study|Withdrawal by Subject|1|||
105560226|NCT04672941|364046586|FG000|Overall Study|Investigator decision|1|||
105560227|NCT04672941|364046586|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
105560228|NCT04672941|364046586|FG000|Overall Study|COVID-19 related but no adverse event|1|||
105560229|NCT04672941|364046586|FG000|Overall Study|Adverse Event|2|||
105560230|NCT04672941|364046586|FG000|Overall Study|Lost to Follow-up|2|||
105560231|NCT00765388|364046589|FG000|Period 1|Lack of Efficacy|1|||
105560232|NCT00765388|364046590|FG001|Period 1|Lack of Efficacy|2|||
105560233|NCT00765388|364046589|FG000|Period 1|Lost to Follow-up|0|||
105560234|NCT00765388|364046590|FG001|Period 1|Lost to Follow-up|1|||
105560235|NCT00765388|364046589|FG000|Period 1|Herpes Zoster|0|||
105560236|NCT00765388|364046590|FG001|Period 1|Herpes Zoster|1|||
105560237|NCT00765388|364046589|FG000|Period 1|Hip operation|0|||
105560238|NCT00765388|364046590|FG001|Period 1|Hip operation|1|||
105560239|NCT00765674|364046594|FG000|Overall Study|Adverse Event|7|||
105560240|NCT00765674|364046595|FG001|Overall Study|Adverse Event|2|||
105560241|NCT00765674|364046596|FG002|Overall Study|Adverse Event|8|||
105560242|NCT00765674|364046597|FG003|Overall Study|Adverse Event|11|||
105560243|NCT00765674|364046594|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
105560244|NCT00765674|364046595|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
105560245|NCT00765674|364046596|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
105560246|NCT00765674|364046597|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
105560247|NCT00765674|364046594|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
105560248|NCT00765674|364046595|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
105560249|NCT00765674|364046596|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
105560250|NCT00765674|364046597|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
105560251|NCT00765674|364046594|FG000|Overall Study|Lack of Efficacy|2|||
105560252|NCT00765674|364046595|FG001|Overall Study|Lack of Efficacy|3|||
105560253|NCT00765674|364046596|FG002|Overall Study|Lack of Efficacy|1|||
105560254|NCT00765674|364046597|FG003|Overall Study|Lack of Efficacy|2|||
105560255|NCT00765674|364046594|FG000|Overall Study|Protocol Violation|2|||
105560256|NCT00765674|364046595|FG001|Overall Study|Protocol Violation|0|||
105560257|NCT00765674|364046596|FG002|Overall Study|Protocol Violation|1|||
105560258|NCT00765674|364046597|FG003|Overall Study|Protocol Violation|0|||
105560259|NCT00765674|364046594|FG000|Overall Study|Withdrawal by Subject|5|||
105702878|NCT03631732|364574591|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
105702879|NCT03631732|364574592|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
105560260|NCT00765674|364046595|FG001|Overall Study|Withdrawal by Subject|7|||
105560261|NCT00765674|364046596|FG002|Overall Study|Withdrawal by Subject|3|||
105560262|NCT00765674|364046597|FG003|Overall Study|Withdrawal by Subject|8|||
105560263|NCT00765674|364046594|FG000|Overall Study|Lost to Follow-up|4|||
105560264|NCT00765674|364046595|FG001|Overall Study|Lost to Follow-up|6|||
105560265|NCT00765674|364046596|FG002|Overall Study|Lost to Follow-up|2|||
105560266|NCT00765674|364046597|FG003|Overall Study|Lost to Follow-up|1|||
105560267|NCT00765674|364046594|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
105702880|NCT03631732|364574591|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
105702881|NCT03631732|364574592|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
105702882|NCT03631732|364574591|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
105702883|NCT03631732|364574592|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
105702884|NCT03631732|364574591|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
105702885|NCT03631732|364574592|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
105702886|NCT03631732|364574591|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
105702887|NCT03631732|364574592|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
105702888|NCT03631732|364574591|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
105702889|NCT03631732|364574592|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
105702890|NCT02354222|364574597|FG000|Overall Study|Adverse Event|0|||
105702891|NCT02354222|364574598|FG001|Overall Study|Adverse Event|3|||
105702892|NCT02354222|364574597|FG000|Overall Study|Physician Decision|1|||
105702893|NCT02354222|364574598|FG001|Overall Study|Physician Decision|1|||
105702894|NCT02354222|364574597|FG000|Overall Study|Pregnancy|1|||
105702895|NCT02354222|364574598|FG001|Overall Study|Pregnancy|0|||
105702896|NCT02354222|364574597|FG000|Overall Study|Withdrawal by Subject|2|||
105702897|NCT02354222|364574598|FG001|Overall Study|Withdrawal by Subject|3|||
105702898|NCT02354222|364574597|FG000|Overall Study|Conflict with the stopping criteria|0|||
105702899|NCT02354222|364574598|FG001|Overall Study|Conflict with the stopping criteria|4|||
105702900|NCT01585272|364574599|FG000|Overall Study|Adverse Event|22|||
105702901|NCT01585272|364574599|FG000|Overall Study|Protocol Violation|7|||
105702902|NCT01585272|364574599|FG000|Overall Study|Withdrawal by Subject|10|||
105702903|NCT00645593|364574600|FG000|Overall Study|Later found to be ineligible|1|||
105702904|NCT00645593|364574601|FG001|Overall Study|Later found to be ineligible|0|||
105702905|NCT00788372|364574603|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
105702906|NCT00788372|364574603|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
105702907|NCT00788372|364574603|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
105702908|NCT00788372|364574603|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
105702909|NCT00788372|364574603|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
105702910|NCT00788372|364574603|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
105702911|NCT00788372|364574603|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
105702912|NCT01508702|364574604|FG000|Overall Study|Adverse Event|7|||
105702913|NCT01508702|364574605|FG001|Overall Study|Adverse Event|3|||
105702914|NCT01508702|364574604|FG000|Overall Study|Gout flare|2|||
105702915|NCT01508702|364574605|FG001|Overall Study|Gout flare|0|||
105702916|NCT01508702|364574604|FG000|Overall Study|Protocol Violation|2|||
105702917|NCT01508702|364574605|FG001|Overall Study|Protocol Violation|1|||
105702918|NCT01508702|364574604|FG000|Overall Study|Lost to Follow-up|1|||
105702919|NCT01508702|364574605|FG001|Overall Study|Lost to Follow-up|2|||
105702920|NCT01508702|364574604|FG000|Overall Study|Withdrawal by Subject|11|||
105702921|NCT01508702|364574605|FG001|Overall Study|Withdrawal by Subject|7|||
105702922|NCT01553136|364574606|FG000|Overall Study|Adverse Event|3|||
105702923|NCT01553136|364574607|FG001|Overall Study|Adverse Event|2|||
105702924|NCT01553136|364574606|FG000|Overall Study|Withdrawal by Subject|2|||
105702925|NCT01553136|364574607|FG001|Overall Study|Withdrawal by Subject|3|||
105702926|NCT01553136|364574606|FG000|Overall Study|Lost to Follow-up|4|||
105702927|NCT01553136|364574607|FG001|Overall Study|Lost to Follow-up|10|||
105702928|NCT01553136|364574606|FG000|Overall Study|Physician Decision|2|||
105702929|NCT01553136|364574607|FG001|Overall Study|Physician Decision|3|||
105702930|NCT01553136|364574606|FG000|Overall Study|Scheduling Difficulties|5|||
105702931|NCT01553136|364574607|FG001|Overall Study|Scheduling Difficulties|4|||
105702932|NCT01979536|364574608|FG000|Overall Study|Physician Decision|2|||
105702933|NCT01979536|364574609|FG001|Overall Study|Physician Decision|3|||
105702934|NCT01979536|364574608|FG000|Overall Study|Withdrawal by Subject|0|||
105702935|NCT01979536|364574609|FG001|Overall Study|Withdrawal by Subject|1|||
105702936|NCT01979536|364574608|FG000|Overall Study|Refusal|0|||
105702937|NCT01979536|364574609|FG001|Overall Study|Refusal|1|||
105702938|NCT01979536|364574608|FG000|Overall Study|Relapse|0|||
105702939|NCT01979536|364574609|FG001|Overall Study|Relapse|1|||
105702940|NCT01979536|364574608|FG000|Overall Study|Study terminated by Sponsor|0|||
105702941|NCT01979536|364574609|FG001|Overall Study|Study terminated by Sponsor|1|||
105702942|NCT01979536|364574608|FG000|Overall Study|Did not start treatment|0|||
105787325|NCT05450198|364874936|FG002|Overall Study|Lost to Follow-up|2|||
105787326|NCT05450198|364874937|FG003|Overall Study|Lost to Follow-up|1|||
105702943|NCT01979536|364574609|FG001|Overall Study|Did not start treatment|1|||
105787327|NCT01243762|364874938|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
105787328|NCT01243762|364874939|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
105787329|NCT01243762|364874940|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
105702944|NCT01014689|364574610|FG000|Overall Study|Lack of Efficacy|0|||
105702945|NCT01014689|364574611|FG001|Overall Study|Lack of Efficacy|1|||
105702946|NCT01014689|364574610|FG000|Overall Study|Adverse Event|3|||
105702947|NCT01014689|364574611|FG001|Overall Study|Adverse Event|0|||
105702948|NCT01014689|364574610|FG000|Overall Study|Withdrawal by Subject|5|||
105702949|NCT01014689|364574611|FG001|Overall Study|Withdrawal by Subject|4|||
105702950|NCT01014689|364574610|FG000|Overall Study|Protocol Violation|1|||
105702951|NCT01014689|364574611|FG001|Overall Study|Protocol Violation|1|||
105702952|NCT01014689|364574610|FG000|Overall Study|Lost to Follow-up|3|||
105702953|NCT01014689|364574611|FG001|Overall Study|Lost to Follow-up|7|||
105702954|NCT01014689|364574610|FG000|Overall Study|Pregnancy|1|||
105702955|NCT01014689|364574611|FG001|Overall Study|Pregnancy|0|||
105702956|NCT00733954|364574612|FG000|Overall Study|Lost to Follow-up|5|||
105702957|NCT00733954|364574613|FG001|Overall Study|Lost to Follow-up|2|||
105702958|NCT00733954|364574612|FG000|Overall Study|Protocol Violation|1|||
105702959|NCT00733954|364574613|FG001|Overall Study|Protocol Violation|0|||
105702960|NCT00733954|364574612|FG000|Overall Study|Withdrawal by Subject|2|||
105702961|NCT00733954|364574613|FG001|Overall Study|Withdrawal by Subject|0|||
105702962|NCT04360551|364576421|FG000|Overall Study|Withdrawal by Subject|1|||
105702963|NCT04360551|364576422|FG001|Overall Study|Withdrawal by Subject|0|||
105702964|NCT00075023|364576424|FG000|Pilot Study|Physician Decision|1|||
105702965|NCT00075023|364576425|FG001|Pilot Study|Physician Decision|2|||
105702966|NCT00075023|364576424|FG000|Pilot Study|Withdrawal by Subject|1|||
105702967|NCT00075023|364576425|FG001|Pilot Study|Withdrawal by Subject|0|||
105702968|NCT04179734|364576426|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
105702969|NCT04179734|364576427|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
105702970|NCT04179734|364576426|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
105702971|NCT04179734|364576427|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
105702972|NCT02982954|364576428|FG000|Overall Study|Death|55|||
105702973|NCT02982954|364576429|FG001|Overall Study|Death|29|||
105702974|NCT02982954|364576430|FG002|Overall Study|Death|15|||
105702975|NCT02982954|364576431|FG003|Overall Study|Death|20|||
105702976|NCT02982954|364576428|FG000|Overall Study|Lost to Follow-up|2|||
105702977|NCT02982954|364576429|FG001|Overall Study|Lost to Follow-up|1|||
105702978|NCT02982954|364576430|FG002|Overall Study|Lost to Follow-up|0|||
105702979|NCT02982954|364576431|FG003|Overall Study|Lost to Follow-up|0|||
105702980|NCT02982954|364576428|FG000|Overall Study|Participant withdrew consent|7|||
105702981|NCT02982954|364576429|FG001|Overall Study|Participant withdrew consent|5|||
105702982|NCT02982954|364576430|FG002|Overall Study|Participant withdrew consent|1|||
105702983|NCT02982954|364576431|FG003|Overall Study|Participant withdrew consent|1|||
105702984|NCT02982954|364576428|FG000|Overall Study|Other reasons|42|||
105702985|NCT02982954|364576429|FG001|Overall Study|Other reasons|17|||
105702986|NCT02982954|364576430|FG002|Overall Study|Other reasons|12|||
105702987|NCT02982954|364576431|FG003|Overall Study|Other reasons|3|||
105702988|NCT02982954|364576428|FG000|Overall Study|Premature site closure|0|||
105702989|NCT02982954|364576429|FG001|Overall Study|Premature site closure|0|||
105702990|NCT02982954|364576430|FG002|Overall Study|Premature site closure|0|||
105702991|NCT02982954|364576431|FG003|Overall Study|Premature site closure|1|||
105702992|NCT01429584|364576432|FG000|Overall Study|Withdrawal by Subject|1|||
105702993|NCT01429584|364576433|FG001|Overall Study|Withdrawal by Subject|0|||
105702994|NCT01429584|364576432|FG000|Overall Study|Protocol Violation|0|||
105702995|NCT01429584|364576433|FG001|Overall Study|Protocol Violation|1|||
105702996|NCT00402649|364576434|FG000|Overall Study|Lost to Follow-up|1|||
105702997|NCT00402649|364576434|FG000|Overall Study|Withdrawal by Subject|1|||
105702998|NCT01999465|364576435|FG000|Overall Study|Lost to Follow-up|0|||
105702999|NCT01999465|364576436|FG001|Overall Study|Lost to Follow-up|2|||
105703000|NCT01999465|364576435|FG000|Overall Study|Protocol Violation|0|||
105703001|NCT01999465|364576436|FG001|Overall Study|Protocol Violation|1|||
105703002|NCT01611974|364576440|FG000|Overall Study|Death|10|||
105703003|NCT01611974|364576441|FG001|Overall Study|Death|12|||
105703004|NCT01611974|364576442|FG002|Overall Study|Death|10|||
105703005|NCT01611974|364576440|FG000|Overall Study|Lost to Follow-up|0|||
105703006|NCT01611974|364576441|FG001|Overall Study|Lost to Follow-up|1|||
105703007|NCT01611974|364576442|FG002|Overall Study|Lost to Follow-up|0|||
105703008|NCT01611974|364576440|FG000|Overall Study|Physician Decision|5|||
105703009|NCT01611974|364576441|FG001|Overall Study|Physician Decision|1|||
105703010|NCT01611974|364576442|FG002|Overall Study|Physician Decision|2|||
105349945|NCT00505661|363283462|FG000|Overall Study|Not Eligible|4|||
105349946|NCT03611582|363283465|FG000|Overall Study|Adverse Event|26|||
105703011|NCT01611974|364576440|FG000|Overall Study|Withdrawal by Subject|0|||
105349947|NCT03611582|363283466|FG001|Overall Study|Adverse Event|6|||
105703012|NCT01611974|364576441|FG001|Overall Study|Withdrawal by Subject|1|||
105703013|NCT01611974|364576442|FG002|Overall Study|Withdrawal by Subject|4|||
105349948|NCT03611582|363283465|FG000|Overall Study|Protocol Violation|0|||
105703014|NCT01308008|364576443|FG000|4 Weeks|Illness, disinterest, time|9|||
105349949|NCT03611582|363283466|FG001|Overall Study|Protocol Violation|1|||
105703015|NCT01308008|364576444|FG001|4 Weeks|Illness, disinterest, time|2|||
105703016|NCT01417195|364576445|FG000|Overall Study|Stimulation failure|1|||
105703017|NCT01417195|364576446|FG001|Overall Study|Stimulation failure|0|||
105703018|NCT01417195|364576445|FG000|Overall Study|No embryos for transfer|0|||
105703019|NCT01417195|364576446|FG001|Overall Study|No embryos for transfer|1|||
105703020|NCT01417195|364576445|FG000|Overall Study|No transfer due to risk of OHSS|1|||
105703021|NCT01417195|364576446|FG001|Overall Study|No transfer due to risk of OHSS|0|||
105349950|NCT03611582|363283465|FG000|Overall Study|Pregnancy|1|||
105703022|NCT01417195|364576445|FG000|Overall Study|No transfer due to elevated progesterone|1|||
105703023|NCT01417195|364576446|FG001|Overall Study|No transfer due to elevated progesterone|0|||
105703024|NCT01773109|364576447|FG000|Overall Study|Symptomatic Progression|2|||
105703025|NCT01773109|364576447|FG000|Overall Study|Death|1|||
105703026|NCT01239342|364576448|FG000|Overall Study|Adverse Event|1|||
105703027|NCT01239342|364576449|FG001|Overall Study|Adverse Event|0|||
105703028|NCT01239342|364576448|FG000|Overall Study|Withdrawal by Subject|1|||
105703029|NCT01239342|364576449|FG001|Overall Study|Withdrawal by Subject|5|||
105703030|NCT01239342|364576448|FG000|Overall Study|Reason Unknown|1|||
105703031|NCT01239342|364576449|FG001|Overall Study|Reason Unknown|1|||
105474519|NCT03615040|363748592|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
105474520|NCT03615040|363748593|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
105474521|NCT03615040|363748592|FG000|Overall Study|Death|0|||
105474522|NCT03615040|363748593|FG001|Overall Study|Death|2|||
105474523|NCT01015638|363748601|FG000|Overall Study|Withdrawal by Subject|1|||
105474524|NCT01015638|363748602|FG001|Overall Study|Withdrawal by Subject|0|||
105474525|NCT04450381|363748605|FG000|Overall Study|Protocol Violation|4|||
105474526|NCT04450381|363748605|FG000|Overall Study|Wrong device setting|2|||
105474527|NCT00324961|363748606|FG000|Overall Study|Adverse Event|5|||
105474528|NCT00324961|363748606|FG000|Overall Study|Consent Withdrawn|11|||
105474529|NCT00324961|363748606|FG000|Overall Study|Lost to Follow-up|22|||
105474530|NCT00324961|363748606|FG000|Overall Study|Protocol Violation|3|||
105474531|NCT00324961|363748606|FG000|Overall Study|Other|2|||
105474532|NCT01276054|363748612|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
105474533|NCT01276054|363748613|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
105474534|NCT01456897|363748614|FG000|Overall Study|Adverse Event|19|||
105474535|NCT01456897|363748615|FG001|Overall Study|Adverse Event|22|||
105703032|NCT02495844|364576450|FG000|Overall Study|Lack of Efficacy|1|||
105703033|NCT02495844|364576451|FG001|Overall Study|Lack of Efficacy|2|||
105474536|NCT01456897|363748614|FG000|Overall Study|Protocol Violation|3|||
105474537|NCT01456897|363748615|FG001|Overall Study|Protocol Violation|4|||
105560268|NCT00765674|364046595|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
105560269|NCT00765674|364046596|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
105560270|NCT00765674|364046597|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
105560271|NCT01813474|364046598|FG000|Overall Study|Withdrawal by Subject|0|||
105560272|NCT01813474|364046599|FG001|Overall Study|Withdrawal by Subject|0|||
105560273|NCT01813474|364046600|FG002|Overall Study|Withdrawal by Subject|1|||
105560274|NCT01813474|364046598|FG000|Overall Study|Adverse Event|1|||
105560275|NCT01813474|364046599|FG001|Overall Study|Adverse Event|1|||
105560276|NCT01813474|364046600|FG002|Overall Study|Adverse Event|0|||
105560277|NCT01813474|364046598|FG000|Overall Study|Lack of Efficacy|2|||
105560278|NCT01813474|364046599|FG001|Overall Study|Lack of Efficacy|6|||
105560279|NCT01813474|364046600|FG002|Overall Study|Lack of Efficacy|9|||
105560280|NCT01813474|364046598|FG000|Overall Study|Death|0|||
105560281|NCT01813474|364046599|FG001|Overall Study|Death|0|||
105560282|NCT01813474|364046600|FG002|Overall Study|Death|1|||
105560283|NCT01441102|364046601|FG000|Overall Study|Adverse Event|1|||
105560284|NCT01441102|364046601|FG000|Overall Study|Withdrawal by Subject|2|||
105560285|NCT02747238|364046607|FG000|Overall Study|Lack of Efficacy|0|||
105560286|NCT02747238|364046608|FG001|Overall Study|Lack of Efficacy|1|||
105560287|NCT02747238|364046607|FG000|Overall Study|Data lost|3|||
105560288|NCT02747238|364046608|FG001|Overall Study|Data lost|5|||
105560289|NCT02085252|364046609|FG000|Overall Study|Withdrawal of Consent|1|||
105560290|NCT02085252|364046610|FG001|Overall Study|Withdrawal of Consent|0|||
105560291|NCT02085252|364046609|FG000|Overall Study|Adverse Event|0|||
105560292|NCT02085252|364046610|FG001|Overall Study|Adverse Event|1|||
105560293|NCT02085252|364046609|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
105560294|NCT02085252|364046610|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
105560295|NCT02085252|364046609|FG000|Overall Study|Reason Not Specified|0|||
105560296|NCT02085252|364046610|FG001|Overall Study|Reason Not Specified|1|||
105560297|NCT02085252|364046609|FG000|Overall Study|Reason Unknown|0|||
105560298|NCT02085252|364046610|FG001|Overall Study|Reason Unknown|1|||
105703034|NCT02495844|364576450|FG000|Overall Study|AE, non-fatal|0|||
105703035|NCT02495844|364576451|FG001|Overall Study|AE, non-fatal|1|||
105703036|NCT02495844|364576450|FG000|Overall Study|Hepatitis Positivity|0|||
105703037|NCT02495844|364576451|FG001|Overall Study|Hepatitis Positivity|1|||
105474538|NCT01456897|363748614|FG000|Overall Study|Physician Decision|5|||
105703038|NCT04766021|364576454|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
105787330|NCT01243762|364874941|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
105787331|NCT01243762|364874942|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
105787332|NCT01243762|364874943|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
105787333|NCT01243762|364874944|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
105787334|NCT01243762|364874938|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
105787335|NCT01243762|364874939|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
105787336|NCT01243762|364874940|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
105787337|NCT01243762|364874941|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
105787338|NCT01243762|364874942|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
105787339|NCT01243762|364874943|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
105787340|NCT01243762|364874944|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
105787341|NCT01243762|364874938|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
105787342|NCT01243762|364874939|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
105787343|NCT01243762|364874940|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
105787344|NCT01243762|364874941|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
105787345|NCT01243762|364874942|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
105787346|NCT01243762|364874943|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
105787347|NCT01243762|364874944|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
105787348|NCT01243762|364874938|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
105787349|NCT01243762|364874939|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
105787350|NCT01243762|364874940|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
105787351|NCT01243762|364874941|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
105787352|NCT01243762|364874942|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
105787353|NCT01243762|364874943|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
105787354|NCT01243762|364874944|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
105703039|NCT04766021|364576454|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
105703040|NCT03577730|364576456|FG000|Overall Study|Physician Decision|3|||
105703041|NCT03577730|364576457|FG001|Overall Study|Physician Decision|1|||
105703042|NCT03577730|364576456|FG000|Overall Study|Did not receive allocated intervention|1|||
105703043|NCT03577730|364576457|FG001|Overall Study|Did not receive allocated intervention|0|||
105703044|NCT02187172|364576458|FG000|Overall Study|Lost to Follow-up|1|||
105703045|NCT02187172|364576459|FG001|Overall Study|Lost to Follow-up|2|||
105703046|NCT02187172|364576458|FG000|Overall Study|Lack of Efficacy|1|||
105703047|NCT02187172|364576459|FG001|Overall Study|Lack of Efficacy|2|||
105703048|NCT02187172|364576458|FG000|Overall Study|Adverse Event|0|||
105703049|NCT02187172|364576459|FG001|Overall Study|Adverse Event|1|||
105703050|NCT02187172|364576458|FG000|Overall Study|Physician Decision|1|||
105703051|NCT02187172|364576459|FG001|Overall Study|Physician Decision|1|||
105703052|NCT04091087|364576466|FG000|Overall Study|Not treated|1|||
105703053|NCT04091087|364576467|FG001|Overall Study|Not treated|0|||
105703054|NCT04091087|364576466|FG000|Overall Study|Adverse Event|4|||
105703055|NCT04091087|364576467|FG001|Overall Study|Adverse Event|4|||
105703056|NCT04091087|364576466|FG000|Overall Study|Protocol Violation|0|||
105703057|NCT04091087|364576467|FG001|Overall Study|Protocol Violation|1|||
105703058|NCT04091087|364576466|FG000|Overall Study|Withdrawal by Subject|5|||
105703059|NCT04091087|364576467|FG001|Overall Study|Withdrawal by Subject|2|||
105703060|NCT04962022|364576468|FG000|Period 1|Withdrawal by Subject|1|||
105703061|NCT04962022|364576469|FG001|Period 1|Withdrawal by Subject|0|||
105703062|NCT01356407|364576472|FG000|Overall Study|Lost to Follow-up|2|||
105703063|NCT01356407|364576473|FG001|Overall Study|Lost to Follow-up|0|||
105703064|NCT01356407|364576472|FG000|Overall Study|Patient Withdrew Consent|2|||
105703065|NCT01356407|364576473|FG001|Overall Study|Patient Withdrew Consent|1|||
105703066|NCT01356407|364576472|FG000|Overall Study|Could not afford IMP administration|0|||
105703067|NCT01356407|364576473|FG001|Overall Study|Could not afford IMP administration|1|||
105703068|NCT01356407|364576472|FG000|Overall Study|Not complete Endoscopy|2|||
105703069|NCT01356407|364576473|FG001|Overall Study|Not complete Endoscopy|2|||
105703070|NCT02055820|364576474|FG000|Phase I: Dose-Finding|Death|1|||
105703071|NCT02055820|364576475|FG001|Phase I: Dose-Finding|Death|0|||
105703072|NCT02055820|364576476|FG002|Phase I: Dose-Finding|Death|1|||
105703073|NCT02055820|364576477|FG003|Phase I: Dose-Finding|Death|2|||
105703074|NCT02055820|364576478|FG004|Phase I: Dose-Finding|Death|0|||
105703075|NCT02055820|364576479|FG005|Phase I: Dose-Finding|Death|1|||
105703076|NCT02055820|364576480|FG006|Phase I: Dose-Finding|Death|1|||
105474539|NCT01456897|363748615|FG001|Overall Study|Physician Decision|3|||
105474540|NCT01456897|363748614|FG000|Overall Study|Withdrawal by Subject|44|||
105474541|NCT01456897|363748615|FG001|Overall Study|Withdrawal by Subject|17|||
105474542|NCT01456897|363748614|FG000|Overall Study|Lack of Efficacy|4|||
105474543|NCT01456897|363748615|FG001|Overall Study|Lack of Efficacy|11|||
105474544|NCT04254913|363748621|FG000|Overall Study|Adverse Event|1|||
105474545|NCT01396057|363748622|FG000|Overall Study|Adverse Event|2|||
105703077|NCT02055820|364576481|FG007|Phase I: Dose-Finding|Death|0|||
105703078|NCT02055820|364576482|FG008|Phase I: Dose-Finding|Death|0|||
105703079|NCT02055820|364576483|FG009|Phase I: Dose-Finding|Death|0|||
105703080|NCT02055820|364576474|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105787355|NCT01243762|364874938|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
105703081|NCT02055820|364576475|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703082|NCT02055820|364576476|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703083|NCT02055820|364576477|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703084|NCT02055820|364576478|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703085|NCT02055820|364576479|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
105703086|NCT02055820|364576480|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703087|NCT02055820|364576481|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703088|NCT02055820|364576482|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703089|NCT02055820|364576483|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703090|NCT02055820|364576474|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703091|NCT02055820|364576475|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703092|NCT02055820|364576476|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703093|NCT02055820|364576477|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
105703094|NCT02055820|364576478|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703095|NCT02055820|364576479|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703096|NCT02055820|364576480|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
105703097|NCT02055820|364576481|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703098|NCT02055820|364576482|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703099|NCT02055820|364576483|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703100|NCT02055820|364576474|FG000|Phase II: Expansion|Death|0|||
105703101|NCT02055820|364576475|FG001|Phase II: Expansion|Death|0|||
105703102|NCT02055820|364576476|FG002|Phase II: Expansion|Death|0|||
105703103|NCT02055820|364576477|FG003|Phase II: Expansion|Death|0|||
105703104|NCT02055820|364576478|FG004|Phase II: Expansion|Death|33|||
105703105|NCT02055820|364576479|FG005|Phase II: Expansion|Death|0|||
105703106|NCT02055820|364576480|FG006|Phase II: Expansion|Death|0|||
105560299|NCT03832595|364046611|FG000|Overall Study|Death|142|||
105560300|NCT03832595|364046612|FG001|Overall Study|Death|130|||
105560301|NCT03832595|364046611|FG000|Overall Study|Medical management without dialysis|37|||
105560302|NCT03832595|364046612|FG001|Overall Study|Medical management without dialysis|1|||
105560303|NCT00951275|364046614|FG000|Overall Study|Administrative Reason|1|||
105560304|NCT00951275|364046614|FG000|Overall Study|Adverse Event|7|||
105560305|NCT00951275|364046614|FG000|Overall Study|Withdrawal by Subject|4|||
105560306|NCT00951275|364046614|FG000|Overall Study|Protocol Violation|1|||
105560307|NCT01112579|364046615|FG000|Overall Study|Missed Visit|1|||
105560308|NCT01112579|364046616|FG001|Overall Study|Missed Visit|1|||
105560309|NCT01112579|364046615|FG000|Overall Study|Death|0|||
105560310|NCT01112579|364046616|FG001|Overall Study|Death|2|||
105560311|NCT01971723|364046617|FG000|Overall Study|Withdrawal by Subject|1|||
105560312|NCT01971723|364046618|FG001|Overall Study|Withdrawal by Subject|1|||
105560313|NCT01971723|364046617|FG000|Overall Study|Protocol Violation|1|||
105560314|NCT01971723|364046618|FG001|Overall Study|Protocol Violation|2|||
105560315|NCT00725296|364046619|FG000|Overall Study|Adverse Event|11|||
105560316|NCT00725296|364046619|FG000|Overall Study|Lack of Efficacy|7|||
105560317|NCT00725296|364046619|FG000|Overall Study|Withdrawal by Subject|3|||
105560318|NCT00725296|364046619|FG000|Overall Study|Non-Compliance|2|||
105560319|NCT00725296|364046619|FG000|Overall Study|Lost to Follow-up|1|||
105560320|NCT00725296|364046619|FG000|Overall Study|Other|38|||
105560321|NCT02693743|364046620|FG000|Overall Study|Physician Decision|1|||
105560322|NCT02693743|364046621|FG001|Overall Study|Physician Decision|0|||
105703107|NCT02055820|364576481|FG007|Phase II: Expansion|Death|0|||
105703108|NCT02055820|364576482|FG008|Phase II: Expansion|Death|0|||
105703109|NCT02055820|364576483|FG009|Phase II: Expansion|Death|0|||
105703110|NCT02055820|364576474|FG000|Phase II: Expansion|Lost to Follow-up|0|||
105703111|NCT02055820|364576475|FG001|Phase II: Expansion|Lost to Follow-up|0|||
105703112|NCT02055820|364576476|FG002|Phase II: Expansion|Lost to Follow-up|0|||
105703113|NCT02055820|364576477|FG003|Phase II: Expansion|Lost to Follow-up|0|||
105703114|NCT02055820|364576478|FG004|Phase II: Expansion|Lost to Follow-up|4|||
105703115|NCT02055820|364576479|FG005|Phase II: Expansion|Lost to Follow-up|0|||
105349951|NCT03611582|363283466|FG001|Overall Study|Pregnancy|2|||
105703116|NCT02055820|364576480|FG006|Phase II: Expansion|Lost to Follow-up|0|||
105349952|NCT03611582|363283465|FG000|Overall Study|Lack of Efficacy|0|||
105349953|NCT03611582|363283466|FG001|Overall Study|Lack of Efficacy|1|||
105349954|NCT03611582|363283465|FG000|Overall Study|At the discretion of the investigator|1|||
105349955|NCT03611582|363283466|FG001|Overall Study|At the discretion of the investigator|0|||
105349956|NCT03611582|363283465|FG000|Overall Study|Safety concern as judged by the investigator|1|||
105703117|NCT02055820|364576481|FG007|Phase II: Expansion|Lost to Follow-up|0|||
105560323|NCT03053050|364046623|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
105703118|NCT02055820|364576482|FG008|Phase II: Expansion|Lost to Follow-up|0|||
105703119|NCT02055820|364576483|FG009|Phase II: Expansion|Lost to Follow-up|0|||
105703120|NCT02055820|364576474|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
105349957|NCT03611582|363283466|FG001|Overall Study|Safety concern as judged by the investigator|2|||
105560324|NCT03053050|364046624|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
105560325|NCT03053050|364046625|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
105560326|NCT03053050|364046626|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
105703121|NCT02055820|364576475|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
105703122|NCT02055820|364576476|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
105703123|NCT02055820|364576477|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
105703124|NCT02055820|364576478|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
105703125|NCT02055820|364576479|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
105703126|NCT02055820|364576480|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
105703127|NCT02055820|364576481|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
105703128|NCT02055820|364576482|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
105703129|NCT02055820|364576483|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
105703130|NCT00133991|364576486|FG000|Overall Study|Death|4|||
105703131|NCT03002155|364576487|FG000|Overall Study|Lost to Follow-up|1|||
105703132|NCT03002155|364576488|FG001|Overall Study|Lost to Follow-up|2|||
105703133|NCT03002155|364576487|FG000|Overall Study|Withdrawal by Subject|1|||
105703134|NCT03002155|364576488|FG001|Overall Study|Withdrawal by Subject|0|||
105703135|NCT03002155|364576487|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
105703136|NCT03002155|364576488|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
105349958|NCT03611582|363283465|FG000|Overall Study|Withdrawal by Subject|4|||
105349959|NCT03611582|363283466|FG001|Overall Study|Withdrawal by Subject|3|||
105349960|NCT03611582|363283465|FG000|Overall Study|Lost to Follow-up|18|||
105349961|NCT03611582|363283466|FG001|Overall Study|Lost to Follow-up|7|||
105349962|NCT03611582|363283465|FG000|Overall Study|other|17|||
105703137|NCT02830776|364576489|FG000|Overall Study|Lost to Follow-up|1|||
105703138|NCT03029143|364576490|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
105703139|NCT03029143|364576491|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
105703140|NCT03029143|364576492|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
105703141|NCT03029143|364576490|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
105703142|NCT03029143|364576491|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
105703143|NCT03029143|364576492|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
105703144|NCT03029143|364576490|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
105703145|NCT03029143|364576491|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
105703146|NCT03029143|364576492|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
105703147|NCT03029143|364576490|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
105703148|NCT03029143|364576491|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
105703149|NCT03029143|364576492|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
105703150|NCT03029143|364576490|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
105703151|NCT03029143|364576491|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
105703152|NCT03029143|364576492|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
105703153|NCT03029143|364576490|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
105703154|NCT03029143|364576491|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
105703155|NCT03029143|364576492|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
105703156|NCT03029143|364576490|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
105703157|NCT03029143|364576491|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
105703158|NCT03029143|364576492|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
105703159|NCT03029143|364576490|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105703160|NCT03029143|364576491|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105703161|NCT03029143|364576492|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
105703162|NCT03029143|364576490|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
105703163|NCT03029143|364576491|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
105703164|NCT03029143|364576492|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
105703165|NCT03029143|364576490|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
105703166|NCT03029143|364576491|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
105703167|NCT03029143|364576492|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
105703168|NCT03029143|364576490|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
105703169|NCT03029143|364576491|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
105349963|NCT03611582|363283466|FG001|Overall Study|other|16|||
105703170|NCT03029143|364576492|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
105703171|NCT01765920|364576495|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
105703172|NCT01765920|364576496|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
105703173|NCT01765920|364576495|FG000|Overall Study|Patient code disclosure|0|||
105703174|NCT01765920|364576496|FG001|Overall Study|Patient code disclosure|1|||
105703175|NCT00961220|364576497|FG000|Overall Study|Adverse Event|3|||
105349964|NCT00463840|363283468|FG000|Overall Study|Disease progression|7|||
105349965|NCT00463840|363283468|FG000|Overall Study|Withdrawal by Subject|2|||
105349966|NCT00463840|363283468|FG000|Overall Study|Adverse Event|3|||
105474546|NCT01396057|363748623|FG001|Overall Study|Adverse Event|6|||
105474547|NCT01396057|363748622|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105349967|NCT00866333|363283469|FG000|Overall Study|Withdrawal of consent|0|||
105349968|NCT00866333|363283470|FG001|Overall Study|Withdrawal of consent|1|||
105349969|NCT00866333|363283471|FG002|Overall Study|Withdrawal of consent|2|||
105349970|NCT00866333|363283469|FG000|Overall Study|Reason not Specified|3|||
105349971|NCT00866333|363283470|FG001|Overall Study|Reason not Specified|1|||
105703176|NCT00961220|364576497|FG000|Overall Study|Lack of Efficacy|1|||
105703177|NCT00961220|364576497|FG000|Overall Study|No IV access for O6BG|1|||
105703178|NCT00961220|364576497|FG000|Overall Study|O6BG no longer supplied|1|||
105703179|NCT00961220|364576497|FG000|Overall Study|Complete Response prior to 12 courses|1|||
105703180|NCT01265797|364576498|FG000|Run-in Month|Withdrawal by Subject|0|||
105703181|NCT01265797|364576499|FG001|Run-in Month|Withdrawal by Subject|4|||
105703182|NCT01265797|364576498|FG000|Run-in Month|1st seizure during run-in month|0|||
105703183|NCT01265797|364576499|FG001|Run-in Month|1st seizure during run-in month|1|||
105703184|NCT01265797|364576498|FG000|Blinded Month|Lack of Efficacy|5|||
105703185|NCT01265797|364576499|FG001|Blinded Month|Lack of Efficacy|0|||
105703186|NCT01265797|364576498|FG000|Blinded Month|Lost to Follow-up|1|||
105703187|NCT01265797|364576499|FG001|Blinded Month|Lost to Follow-up|0|||
105703188|NCT01265797|364576498|FG000|Blinded Month|Protocol Violation|2|||
105703189|NCT01265797|364576499|FG001|Blinded Month|Protocol Violation|1|||
105703190|NCT01265797|364576498|FG000|Blinded Month|Adverse Event|2|||
105703191|NCT01265797|364576499|FG001|Blinded Month|Adverse Event|0|||
105703192|NCT01265797|364576498|FG000|Blinded Month|Diary data incomplete|0|||
105703193|NCT01265797|364576499|FG001|Blinded Month|Diary data incomplete|1|||
105703194|NCT01265797|364576498|FG000|Open Label Month|Lost to Follow-up|0|||
105703195|NCT01265797|364576499|FG001|Open Label Month|Lost to Follow-up|1|||
105703196|NCT01439204|364576500|FG000|Overall Study|Withdrawal by Subject|0|||
105703197|NCT01439204|364576501|FG001|Overall Study|Withdrawal by Subject|1|||
105703198|NCT01439204|364576500|FG000|Overall Study|Lost to Follow-up|0|||
105703199|NCT01439204|364576501|FG001|Overall Study|Lost to Follow-up|2|||
105703200|NCT01439204|364576500|FG000|Overall Study|No longer meets study criteria|1|||
105703201|NCT01439204|364576501|FG001|Overall Study|No longer meets study criteria|0|||
105703202|NCT01439204|364576500|FG000|Overall Study|poor/non-compliance|3|||
105703203|NCT01439204|364576501|FG001|Overall Study|poor/non-compliance|0|||
105703204|NCT03917823|364576503|FG000|Overall Study|Lost to Follow-up|1|||
105703205|NCT03917823|364576504|FG001|Overall Study|Lost to Follow-up|1|||
105703206|NCT03917823|364576503|FG000|Overall Study|Withdrawal by Subject|0|||
105703207|NCT03917823|364576504|FG001|Overall Study|Withdrawal by Subject|1|||
105703208|NCT02370615|364576505|FG000|Overall Study|Adverse Event|1|||
105703209|NCT02370615|364576506|FG001|Overall Study|Adverse Event|0|||
105703210|NCT00455013|364576507|FG000|Short Term Period|Adverse Event|2|||
105703211|NCT00455013|364576508|FG001|Short Term Period|Adverse Event|5|||
105703212|NCT00455013|364576509|FG002|Short Term Period|Adverse Event|0|||
105703213|NCT00455013|364576507|FG000|Short Term Period|Withdrawal by Subject|0|||
105703214|NCT00455013|364576508|FG001|Short Term Period|Withdrawal by Subject|0|||
105703215|NCT00455013|364576509|FG002|Short Term Period|Withdrawal by Subject|1|||
105703216|NCT00455013|364576507|FG000|Short Term Period|Lack of Efficacy|4|||
105703217|NCT00455013|364576508|FG001|Short Term Period|Lack of Efficacy|0|||
105703218|NCT00455013|364576509|FG002|Short Term Period|Lack of Efficacy|0|||
105703219|NCT00455013|364576507|FG000|Short Term Period|Other|0|||
105703220|NCT00455013|364576508|FG001|Short Term Period|Other|0|||
105703221|NCT00455013|364576509|FG002|Short Term Period|Other|1|||
105703222|NCT00455013|364576507|FG000|Long Term Extension (LTE)|Adverse Event|0|||
105703223|NCT00455013|364576508|FG001|Long Term Extension (LTE)|Adverse Event|1|||
105703224|NCT00455013|364576509|FG002|Long Term Extension (LTE)|Adverse Event|1|||
105703225|NCT00455013|364576507|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
105703226|NCT00455013|364576508|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
105349972|NCT00866333|363283471|FG002|Overall Study|Reason not Specified|1|||
105349973|NCT00866333|363283469|FG000|Overall Study|Study Terminated by Sponsor|2|||
105703227|NCT00455013|364576509|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
105703228|NCT00455013|364576507|FG000|Long Term Extension (LTE)|Death|1|||
105703229|NCT00455013|364576508|FG001|Long Term Extension (LTE)|Death|1|||
105703230|NCT00455013|364576509|FG002|Long Term Extension (LTE)|Death|0|||
105703231|NCT00455013|364576507|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
105703232|NCT00455013|364576508|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
105703233|NCT00455013|364576509|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
105703234|NCT00455013|364576507|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
105703235|NCT00455013|364576508|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
105703236|NCT00455013|364576509|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
105703237|NCT00455013|364576507|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
105703238|NCT00455013|364576508|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
105703239|NCT00455013|364576509|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
105703240|NCT00455013|364576507|FG000|Long Term Extension (LTE)|non-specified|0|||
105703241|NCT00455013|364576508|FG001|Long Term Extension (LTE)|non-specified|0|||
105703242|NCT00455013|364576509|FG002|Long Term Extension (LTE)|non-specified|1|||
105703243|NCT01015768|364576511|FG000|Overall Study|Some subject data unuseable|4|||
105703244|NCT01015768|364576512|FG001|Overall Study|Some subject data unuseable|4|||
105349974|NCT00866333|363283470|FG001|Overall Study|Study Terminated by Sponsor|5|||
105703245|NCT00754793|364576513|FG000|Overall Study|voluntary withdrawn from study|0|||
105703246|NCT00754793|364576514|FG001|Overall Study|voluntary withdrawn from study|1|||
105703247|NCT00577642|364576515|FG000|Overall Study|Clinical Disease Progression|1|||
105703248|NCT00917150|364576520|FG000|Overall Study|Adverse Event|12|||
105560327|NCT03053050|364046623|FG000|Randomized Phase|Withdrew Consent|16|||
105560328|NCT03053050|364046624|FG001|Randomized Phase|Withdrew Consent|8|||
105560329|NCT03053050|364046625|FG002|Randomized Phase|Withdrew Consent|9|||
105560330|NCT03053050|364046626|FG003|Randomized Phase|Withdrew Consent|0|||
105560331|NCT03053050|364046623|FG000|Randomized Phase|Investigator's Discretion|6|||
105560332|NCT03053050|364046624|FG001|Randomized Phase|Investigator's Discretion|6|||
105560333|NCT03053050|364046625|FG002|Randomized Phase|Investigator's Discretion|3|||
105560334|NCT03053050|364046626|FG003|Randomized Phase|Investigator's Discretion|0|||
105560335|NCT03053050|364046623|FG000|Randomized Phase|Lost to Follow-up|5|||
105560336|NCT03053050|364046624|FG001|Randomized Phase|Lost to Follow-up|1|||
105560337|NCT03053050|364046625|FG002|Randomized Phase|Lost to Follow-up|1|||
105560338|NCT03053050|364046626|FG003|Randomized Phase|Lost to Follow-up|0|||
105560339|NCT03053050|364046623|FG000|Randomized Phase|Adverse Event|0|||
105560340|NCT03053050|364046624|FG001|Randomized Phase|Adverse Event|1|||
105560341|NCT03053050|364046625|FG002|Randomized Phase|Adverse Event|0|||
105560342|NCT03053050|364046626|FG003|Randomized Phase|Adverse Event|0|||
105560343|NCT03053050|364046623|FG000|Randomized Phase|Randomized but Never Treated|2|||
105560344|NCT03053050|364046624|FG001|Randomized Phase|Randomized but Never Treated|2|||
105560345|NCT03053050|364046625|FG002|Randomized Phase|Randomized but Never Treated|2|||
105560346|NCT03053050|364046626|FG003|Randomized Phase|Randomized but Never Treated|0|||
105560347|NCT03053050|364046623|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
105560348|NCT03053050|364046624|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
105560349|NCT03053050|364046625|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
105560350|NCT03053050|364046626|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
105560351|NCT03053050|364046623|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
105560352|NCT03053050|364046624|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
105560353|NCT03053050|364046625|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
105560354|NCT03053050|364046626|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
105560355|NCT03053050|364046623|FG000|Open-label Phase|Withdrew Consent|0|||
105560356|NCT03053050|364046624|FG001|Open-label Phase|Withdrew Consent|0|||
105560357|NCT03053050|364046625|FG002|Open-label Phase|Withdrew Consent|0|||
105560358|NCT03053050|364046626|FG003|Open-label Phase|Withdrew Consent|6|||
105560359|NCT03053050|364046623|FG000|Open-label Phase|Investigator's Discretion|0|||
105560360|NCT03053050|364046624|FG001|Open-label Phase|Investigator's Discretion|0|||
105560361|NCT03053050|364046625|FG002|Open-label Phase|Investigator's Discretion|0|||
105560362|NCT03053050|364046626|FG003|Open-label Phase|Investigator's Discretion|4|||
105560363|NCT03703466|364046629|FG000|Overall Study|Death|2|||
105560364|NCT03703466|364046630|FG001|Overall Study|Death|1|||
105560365|NCT03703466|364046631|FG002|Overall Study|Death|0|||
105560366|NCT03703466|364046629|FG000|Overall Study|Withdrawal by Subject|0|||
105560367|NCT03703466|364046630|FG001|Overall Study|Withdrawal by Subject|3|||
105560368|NCT03703466|364046631|FG002|Overall Study|Withdrawal by Subject|0|||
105560369|NCT03703466|364046629|FG000|Overall Study|Completed < 3 Cycles|2|||
105560370|NCT03703466|364046630|FG001|Overall Study|Completed < 3 Cycles|2|||
105560371|NCT03703466|364046631|FG002|Overall Study|Completed < 3 Cycles|2|||
105560372|NCT05338333|364046632|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
105560373|NCT05338333|364046633|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
105560374|NCT04508699|364046642|FG000|Overall Study|Lack of Efficacy|2|||
105560375|NCT04508699|364046643|FG001|Overall Study|Lack of Efficacy|15|||
105560376|NCT04508699|364046642|FG000|Overall Study|Withdrawal by Subject|0|||
105560377|NCT04508699|364046643|FG001|Overall Study|Withdrawal by Subject|2|||
105560378|NCT04866017|364046644|FG000|Overall Study|Study Terminated by Sponsor|13|||
105560379|NCT04866017|364046645|FG001|Overall Study|Study Terminated by Sponsor|14|||
105703249|NCT00917150|364576521|FG001|Overall Study|Adverse Event|7|||
105703250|NCT00917150|364576522|FG002|Overall Study|Adverse Event|12|||
105703251|NCT00917150|364576523|FG003|Overall Study|Adverse Event|11|||
105703252|NCT00917150|364576520|FG000|Overall Study|Death|1|||
105703253|NCT00917150|364576521|FG001|Overall Study|Death|4|||
105703254|NCT00917150|364576522|FG002|Overall Study|Death|3|||
105703255|NCT00917150|364576523|FG003|Overall Study|Death|2|||
105703256|NCT00917150|364576520|FG000|Overall Study|Lost to Follow-up|1|||
105703257|NCT00917150|364576521|FG001|Overall Study|Lost to Follow-up|0|||
105703258|NCT00917150|364576522|FG002|Overall Study|Lost to Follow-up|4|||
105703259|NCT00917150|364576523|FG003|Overall Study|Lost to Follow-up|2|||
105703260|NCT00917150|364576520|FG000|Overall Study|Physician Decision|0|||
105560380|NCT04866017|364046646|FG002|Overall Study|Study Terminated by Sponsor|13|||
105560381|NCT04866017|364046644|FG000|Overall Study|Death|8|||
105703261|NCT00917150|364576521|FG001|Overall Study|Physician Decision|2|||
105703262|NCT00917150|364576522|FG002|Overall Study|Physician Decision|0|||
105703263|NCT00917150|364576523|FG003|Overall Study|Physician Decision|1|||
105560382|NCT04866017|364046645|FG001|Overall Study|Death|4|||
105560383|NCT04866017|364046646|FG002|Overall Study|Death|8|||
105560384|NCT04866017|364046644|FG000|Overall Study|Withdrawal by Subject|1|||
105560385|NCT04866017|364046645|FG001|Overall Study|Withdrawal by Subject|0|||
105703264|NCT00917150|364576520|FG000|Overall Study|Protocol Violation|5|||
105703265|NCT00917150|364576521|FG001|Overall Study|Protocol Violation|5|||
105703266|NCT00917150|364576522|FG002|Overall Study|Protocol Violation|3|||
105703267|NCT00917150|364576523|FG003|Overall Study|Protocol Violation|5|||
105703268|NCT00917150|364576520|FG000|Overall Study|Withdrawal by Subject|15|||
105703269|NCT00917150|364576521|FG001|Overall Study|Withdrawal by Subject|16|||
105703270|NCT00917150|364576522|FG002|Overall Study|Withdrawal by Subject|18|||
105703271|NCT00917150|364576523|FG003|Overall Study|Withdrawal by Subject|11|||
105703272|NCT00917150|364576520|FG000|Overall Study|Other than specified|3|||
105703273|NCT00917150|364576521|FG001|Overall Study|Other than specified|3|||
105703274|NCT00917150|364576522|FG002|Overall Study|Other than specified|2|||
105703275|NCT00917150|364576523|FG003|Overall Study|Other than specified|2|||
105703276|NCT02054897|364576528|FG000|Overall Study|Withdrawal by Subject|2|||
105703277|NCT02054897|364576529|FG001|Overall Study|Withdrawal by Subject|0|||
105703278|NCT02054897|364576530|FG002|Overall Study|Withdrawal by Subject|2|||
105703279|NCT02054897|364576528|FG000|Overall Study|Missing follow-up information|3|||
105703280|NCT02054897|364576529|FG001|Overall Study|Missing follow-up information|5|||
105703281|NCT02054897|364576530|FG002|Overall Study|Missing follow-up information|3|||
105703282|NCT02054897|364576528|FG000|Overall Study|Lost to Follow-up|4|||
105703283|NCT02054897|364576529|FG001|Overall Study|Lost to Follow-up|2|||
105703284|NCT02054897|364576530|FG002|Overall Study|Lost to Follow-up|7|||
105703285|NCT02054897|364576528|FG000|Overall Study|Randomized but not exposed|1|||
105703286|NCT02054897|364576529|FG001|Overall Study|Randomized but not exposed|0|||
105703287|NCT02054897|364576530|FG002|Overall Study|Randomized but not exposed|0|||
105703288|NCT00950664|364576534|FG000|First Intervention|Lost to Follow-up|1|||
105703289|NCT00950664|364576535|FG001|First Intervention|Lost to Follow-up|3|||
105703290|NCT00950664|364576534|FG000|First Intervention|Withdrawal by Subject|2|||
105703291|NCT00950664|364576535|FG001|First Intervention|Withdrawal by Subject|2|||
105703292|NCT00640328|364576536|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
105703293|NCT00640328|364576537|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
105703294|NCT00640328|364576538|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
105703295|NCT00640328|364576539|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
105703296|NCT00640328|364576540|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
105703297|NCT00640328|364576541|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
105703298|NCT00640328|364576536|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
105703299|NCT00640328|364576537|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
105703300|NCT00640328|364576538|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
105703301|NCT00640328|364576539|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
105703302|NCT00640328|364576540|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
105703303|NCT00640328|364576541|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
105703304|NCT00640328|364576536|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
105703305|NCT00640328|364576537|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
105703306|NCT00640328|364576538|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
105703307|NCT00640328|364576539|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
105703308|NCT00640328|364576540|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
105703309|NCT00640328|364576541|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
105703310|NCT00640328|364576536|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
105703311|NCT00640328|364576537|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
105703312|NCT00640328|364576538|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
105703313|NCT00640328|364576539|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
105703314|NCT00640328|364576540|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
105703315|NCT00640328|364576541|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
105703316|NCT02374099|364576542|FG000|Overall Study|Adverse Event|1|||
105703317|NCT02374099|364576543|FG001|Overall Study|Adverse Event|0|||
105703318|NCT02374099|364576542|FG000|Overall Study|Progressive Disease|35|||
105703319|NCT02374099|364576543|FG001|Overall Study|Progressive Disease|40|||
105703320|NCT02374099|364576542|FG000|Overall Study|Withdrawal by Subject|5|||
105703321|NCT02374099|364576543|FG001|Overall Study|Withdrawal by Subject|1|||
105703322|NCT02374099|364576542|FG000|Overall Study|Miscellaneous|2|||
105703323|NCT02374099|364576543|FG001|Overall Study|Miscellaneous|3|||
105703324|NCT02374099|364576542|FG000|Overall Study|Randomized, but not treated|2|||
105703325|NCT02374099|364576543|FG001|Overall Study|Randomized, but not treated|1|||
105703326|NCT02374099|364576542|FG000|Overall Study|Study Terminated by Sponsor|3|||
105703327|NCT02374099|364576543|FG001|Overall Study|Study Terminated by Sponsor|4|||
105703328|NCT01033825|364576544|FG000|Overall Study|Withdrawal by Subject|2|||
105703329|NCT01033825|364576545|FG001|Overall Study|Withdrawal by Subject|3|||
105703330|NCT01033825|364576546|FG002|Overall Study|Withdrawal by Subject|2|||
105703331|NCT01033825|364576547|FG003|Overall Study|Withdrawal by Subject|1|||
105703332|NCT01033825|364576548|FG004|Overall Study|Withdrawal by Subject|1|||
105703333|NCT01033825|364576549|FG005|Overall Study|Withdrawal by Subject|0|||
105703334|NCT01033825|364576550|FG006|Overall Study|Withdrawal by Subject|0|||
105703335|NCT01033825|364576544|FG000|Overall Study|Adverse Event|0|||
105703336|NCT01033825|364576545|FG001|Overall Study|Adverse Event|0|||
105703337|NCT01033825|364576546|FG002|Overall Study|Adverse Event|0|||
105703338|NCT01033825|364576547|FG003|Overall Study|Adverse Event|1|||
105703339|NCT01033825|364576548|FG004|Overall Study|Adverse Event|0|||
105703340|NCT01033825|364576549|FG005|Overall Study|Adverse Event|0|||
105703341|NCT01033825|364576550|FG006|Overall Study|Adverse Event|0|||
105703342|NCT01033825|364576544|FG000|Overall Study|Protocol Violation|1|||
105703343|NCT01033825|364576545|FG001|Overall Study|Protocol Violation|0|||
105703344|NCT01033825|364576546|FG002|Overall Study|Protocol Violation|0|||
105703345|NCT01033825|364576547|FG003|Overall Study|Protocol Violation|0|||
105703346|NCT01033825|364576548|FG004|Overall Study|Protocol Violation|0|||
105703347|NCT01033825|364576549|FG005|Overall Study|Protocol Violation|0|||
105703348|NCT01033825|364576550|FG006|Overall Study|Protocol Violation|0|||
105703349|NCT01033825|364576544|FG000|Overall Study|Other|0|||
105703350|NCT01033825|364576545|FG001|Overall Study|Other|0|||
105703351|NCT01033825|364576546|FG002|Overall Study|Other|0|||
105703352|NCT01033825|364576547|FG003|Overall Study|Other|0|||
105703353|NCT01033825|364576548|FG004|Overall Study|Other|1|||
105703354|NCT01033825|364576549|FG005|Overall Study|Other|0|||
105703355|NCT01033825|364576550|FG006|Overall Study|Other|0|||
105703356|NCT00081159|364576551|FG000|Overall Study|Withdrawal by Subject|0|||
105703357|NCT00081159|364576552|FG001|Overall Study|Withdrawal by Subject|3|||
105703358|NCT00081159|364576551|FG000|Overall Study|Myelosuppression prior to treatment|0|||
105703359|NCT00081159|364576552|FG001|Overall Study|Myelosuppression prior to treatment|1|||
105703360|NCT00081159|364576551|FG000|Overall Study|Lost to Follow-up|2|||
105703361|NCT00081159|364576552|FG001|Overall Study|Lost to Follow-up|1|||
105703362|NCT01714687|364576555|FG000|Overall Study|Withdrawal by Subject|1|||
105703363|NCT01714687|364576556|FG001|Overall Study|Withdrawal by Subject|0|||
105703364|NCT01714687|364576555|FG000|Overall Study|Lost to Follow-up|2|||
105703365|NCT01714687|364576556|FG001|Overall Study|Lost to Follow-up|4|||
105703366|NCT01439555|364576558|FG000|Overall Study|Protocol Violation|1|||
105474548|NCT01396057|363748623|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
105474549|NCT01396057|363748622|FG000|Overall Study|Protocol deviation|4|||
105474550|NCT01396057|363748623|FG001|Overall Study|Protocol deviation|4|||
105474551|NCT01396057|363748622|FG000|Overall Study|Consent withdrawn|3|||
105474552|NCT01396057|363748623|FG001|Overall Study|Consent withdrawn|2|||
105474553|NCT02695420|363748624|FG000|Overall Study|Death|0|||
105474554|NCT02695420|363748625|FG001|Overall Study|Death|1|||
105703367|NCT02581202|364576563|FG000|Overall Study|Lack of Efficacy|2|||
105703368|NCT02581202|364576563|FG000|Overall Study|Withdrawal by Subject|4|||
105703369|NCT02581202|364576563|FG000|Overall Study|Lost to Follow-up|5|||
105703370|NCT02581202|364576563|FG000|Overall Study|Pregnancy|3|||
105703371|NCT05038020|364576567|FG000|Overall Study|Early Termination|3|||
105703372|NCT05038020|364576568|FG001|Overall Study|Early Termination|0|||
105703373|NCT03703882|364578375|FG000|Overall Study|Adverse Event|1|||
105703374|NCT03703882|364578376|FG001|Overall Study|Adverse Event|0|||
105703375|NCT03703882|364578375|FG000|Overall Study|Lost to Follow-up|0|||
105703376|NCT03703882|364578376|FG001|Overall Study|Lost to Follow-up|2|||
105703377|NCT03703882|364578375|FG000|Overall Study|Non-compliance with study drug|0|||
105703378|NCT03703882|364578376|FG001|Overall Study|Non-compliance with study drug|1|||
105703379|NCT03703882|364578375|FG000|Overall Study|Physician Decision|0|||
105703380|NCT03703882|364578376|FG001|Overall Study|Physician Decision|1|||
105703381|NCT03703882|364578375|FG000|Overall Study|Progressive disease|1|||
105703382|NCT03703882|364578376|FG001|Overall Study|Progressive disease|0|||
105703383|NCT03703882|364578375|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105703384|NCT03703882|364578376|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105703385|NCT03703882|364578375|FG000|Overall Study|Starting another treatment|0|||
105703386|NCT03703882|364578376|FG001|Overall Study|Starting another treatment|1|||
105703387|NCT03703882|364578375|FG000|Overall Study|noncompliance with study procedures|0|||
105703388|NCT03703882|364578376|FG001|Overall Study|noncompliance with study procedures|1|||
105703389|NCT03357731|364578377|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
105349975|NCT00866333|363283471|FG002|Overall Study|Study Terminated by Sponsor|9|||
105349976|NCT01180049|363283472|FG000|Overall Study|Other|9|||
105349977|NCT01180049|363283473|FG001|Overall Study|Other|7|||
105349978|NCT01180049|363283472|FG000|Overall Study|Lost to Follow-up|8|||
105349979|NCT01180049|363283473|FG001|Overall Study|Lost to Follow-up|6|||
105349980|NCT01180049|363283472|FG000|Overall Study|Death|36|||
105349981|NCT01180049|363283473|FG001|Overall Study|Death|35|||
105349982|NCT03338569|363283474|FG000|Overall Study|Physician Decision|8|||
105349983|NCT03338569|363283475|FG001|Overall Study|Physician Decision|3|||
105349984|NCT03338569|363283474|FG000|Overall Study|Withdrawal by Subject|0|||
105349985|NCT03338569|363283475|FG001|Overall Study|Withdrawal by Subject|1|||
105349986|NCT03338569|363283474|FG000|Overall Study|Lost to Follow-up|0|||
105349987|NCT03338569|363283475|FG001|Overall Study|Lost to Follow-up|1|||
105349988|NCT00958412|363283476|FG000|Overall Study|Study prematurely terminated|18|||
105349989|NCT02661061|363284784|FG000|Overall Study|Lack of Efficacy|1|||
105349990|NCT02661061|363284785|FG001|Overall Study|Lack of Efficacy|1|||
105349991|NCT02661061|363284784|FG000|Overall Study|Withdrawal by Subject|1|||
105349992|NCT02661061|363284785|FG001|Overall Study|Withdrawal by Subject|1|||
105349993|NCT06439095|363284788|FG000|Overall Study|Lost to Follow-up|2|||
105349994|NCT04348500|363284791|FG000|Overall Study|Death|2|||
105349995|NCT04348500|363284792|FG001|Overall Study|Death|2|||
105349996|NCT04348500|363284791|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
105349997|NCT04348500|363284792|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
105349998|NCT01410240|363284793|FG000|Overall Study|Physician Decision|0|||
105349999|NCT01410240|363284794|FG001|Overall Study|Physician Decision|0|||
105350000|NCT01410240|363284795|FG002|Overall Study|Physician Decision|1|||
105350001|NCT01410240|363284793|FG000|Overall Study|Missed week 6 assessments|1|||
105350002|NCT01410240|363284794|FG001|Overall Study|Missed week 6 assessments|1|||
105350003|NCT01410240|363284795|FG002|Overall Study|Missed week 6 assessments|1|||
105350004|NCT02722746|363284797|FG000|Overall Study|Withdrawal by Subject|0|||
105350005|NCT02722746|363284798|FG001|Overall Study|Withdrawal by Subject|1|||
105350006|NCT02722746|363284799|FG002|Overall Study|Withdrawal by Subject|0|||
105350007|NCT02722746|363284797|FG000|Overall Study|Protocol Violation|8|||
105350008|NCT02722746|363284798|FG001|Overall Study|Protocol Violation|4|||
105350009|NCT02722746|363284799|FG002|Overall Study|Protocol Violation|6|||
105350010|NCT02700698|363284809|FG000|Overall Study|Withdrawal by Subject|1|||
105350011|NCT02700698|363284810|FG001|Overall Study|Withdrawal by Subject|0|||
105350012|NCT00530790|363284813|FG000|Overall Study|Adverse Event|2|||
105350013|NCT00530790|363284813|FG000|Overall Study|Withdrawal by Subject|2|||
105350014|NCT00530790|363284813|FG000|Overall Study|Physician Decision|1|||
105350015|NCT00312572|363284814|FG000|Overall Study|Adverse Event|10|||
105350016|NCT00312572|363284815|FG001|Overall Study|Adverse Event|16|||
105350017|NCT00312572|363284814|FG000|Overall Study|Lost to Follow-up|1|||
105350018|NCT00312572|363284815|FG001|Overall Study|Lost to Follow-up|1|||
105350019|NCT00312572|363284814|FG000|Overall Study|Administrative|4|||
105350020|NCT00312572|363284815|FG001|Overall Study|Administrative|2|||
105350021|NCT00312572|363284814|FG000|Overall Study|Lack of Efficacy|1|||
105350022|NCT00312572|363284815|FG001|Overall Study|Lack of Efficacy|2|||
105350023|NCT04150068|363284820|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
105350024|NCT04150068|363284821|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
105350025|NCT04150068|363284822|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
105350026|NCT04150068|363284820|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
105350027|NCT04150068|363284821|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
105350028|NCT04150068|363284822|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
105350029|NCT04933617|363284832|FG000|Dose Escalation|Early closure of study|0|||
105350030|NCT04933617|363284833|FG001|Dose Escalation|Early closure of study|3|||
105350031|NCT04933617|363284834|FG002|Dose Escalation|Early closure of study|0|||
105350032|NCT04933617|363284835|FG003|Dose Escalation|Early closure of study|0|||
105350033|NCT04933617|363284836|FG004|Dose Escalation|Early closure of study|0|||
105350034|NCT05268016|363284837|FG000|Overall Study|Unacceptable toxicity or AE|2|||
105350035|NCT05268016|363284838|FG001|Overall Study|Unacceptable toxicity or AE|2|||
105350036|NCT05268016|363284839|FG002|Overall Study|Unacceptable toxicity or AE|4|||
105350037|NCT05268016|363284840|FG003|Overall Study|Unacceptable toxicity or AE|3|||
105350038|NCT05268016|363284841|FG004|Overall Study|Unacceptable toxicity or AE|1|||
105474555|NCT02695420|363748626|FG002|Overall Study|Death|0|||
105703390|NCT03357731|364578378|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
105350039|NCT05268016|363284837|FG000|Overall Study|Withdrawal by Subject|1|||
105350040|NCT05268016|363284838|FG001|Overall Study|Withdrawal by Subject|3|||
105350041|NCT05268016|363284839|FG002|Overall Study|Withdrawal by Subject|2|||
105350042|NCT05268016|363284840|FG003|Overall Study|Withdrawal by Subject|2|||
105350043|NCT05268016|363284841|FG004|Overall Study|Withdrawal by Subject|1|||
105350044|NCT05268016|363284837|FG000|Overall Study|Lost to Follow-up|4|||
105350045|NCT05268016|363284838|FG001|Overall Study|Lost to Follow-up|7|||
105350046|NCT05268016|363284839|FG002|Overall Study|Lost to Follow-up|1|||
105350047|NCT05268016|363284840|FG003|Overall Study|Lost to Follow-up|3|||
105350048|NCT05268016|363284841|FG004|Overall Study|Lost to Follow-up|5|||
105350049|NCT05268016|363284837|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
105350050|NCT05268016|363284838|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
105350051|NCT05268016|363284839|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
105350052|NCT05268016|363284840|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
105350053|NCT05268016|363284841|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
105350054|NCT05268016|363284837|FG000|Overall Study|Lack of Efficacy|0|||
105350055|NCT05268016|363284838|FG001|Overall Study|Lack of Efficacy|0|||
105350056|NCT05268016|363284839|FG002|Overall Study|Lack of Efficacy|0|||
105350057|NCT05268016|363284840|FG003|Overall Study|Lack of Efficacy|0|||
105350058|NCT05268016|363284841|FG004|Overall Study|Lack of Efficacy|4|||
105350059|NCT05268016|363284837|FG000|Overall Study|Physician Decision|0|||
105350060|NCT05268016|363284838|FG001|Overall Study|Physician Decision|0|||
105350061|NCT05268016|363284839|FG002|Overall Study|Physician Decision|0|||
105350062|NCT05268016|363284840|FG003|Overall Study|Physician Decision|1|||
105350063|NCT05268016|363284841|FG004|Overall Study|Physician Decision|0|||
105350064|NCT05268016|363284837|FG000|Overall Study|Other|1|||
105350065|NCT05268016|363284838|FG001|Overall Study|Other|0|||
105350066|NCT05268016|363284839|FG002|Overall Study|Other|1|||
105350067|NCT05268016|363284840|FG003|Overall Study|Other|2|||
105350068|NCT05268016|363284841|FG004|Overall Study|Other|0|||
105350069|NCT00369161|363284842|FG000|Overall Study|Adverse Event|15|||
105350070|NCT00369161|363284843|FG001|Overall Study|Adverse Event|13|||
105350071|NCT00369161|363284842|FG000|Overall Study|Abnormal laboratory value|0|||
105350072|NCT00369161|363284843|FG001|Overall Study|Abnormal laboratory value|1|||
105350073|NCT00369161|363284842|FG000|Overall Study|Lack of Efficacy|3|||
105350074|NCT00369161|363284843|FG001|Overall Study|Lack of Efficacy|1|||
105350075|NCT00369161|363284842|FG000|Overall Study|Protocol Violation|0|||
105350076|NCT00369161|363284843|FG001|Overall Study|Protocol Violation|2|||
105350077|NCT00369161|363284842|FG000|Overall Study|Withdrawal by Subject|2|||
105350078|NCT00369161|363284843|FG001|Overall Study|Withdrawal by Subject|3|||
105703391|NCT03357731|364578379|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
105703392|NCT03357731|364578380|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
105703393|NCT03357731|364578381|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
105703394|NCT03357731|364578382|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
105703395|NCT03357731|364578377|FG000|Overall Study|Acute bradycardia and hypotension|0|||
105703396|NCT03357731|364578378|FG001|Overall Study|Acute bradycardia and hypotension|0|||
105703397|NCT03357731|364578379|FG002|Overall Study|Acute bradycardia and hypotension|0|||
105703398|NCT03357731|364578380|FG003|Overall Study|Acute bradycardia and hypotension|1|||
105703399|NCT03357731|364578381|FG004|Overall Study|Acute bradycardia and hypotension|0|||
105703400|NCT03357731|364578382|FG005|Overall Study|Acute bradycardia and hypotension|0|||
105703401|NCT03357731|364578377|FG000|Overall Study|Adverse Event|0|||
105703402|NCT03357731|364578378|FG001|Overall Study|Adverse Event|0|||
105703403|NCT03357731|364578379|FG002|Overall Study|Adverse Event|0|||
105703404|NCT03357731|364578380|FG003|Overall Study|Adverse Event|0|||
105703405|NCT03357731|364578381|FG004|Overall Study|Adverse Event|0|||
105703406|NCT03357731|364578382|FG005|Overall Study|Adverse Event|1|||
105703407|NCT03357731|364578377|FG000|Overall Study|Hypotension|0|||
105703408|NCT03357731|364578378|FG001|Overall Study|Hypotension|0|||
105703409|NCT03357731|364578379|FG002|Overall Study|Hypotension|1|||
105703410|NCT03357731|364578380|FG003|Overall Study|Hypotension|1|||
105703411|NCT03357731|364578381|FG004|Overall Study|Hypotension|0|||
105703412|NCT03357731|364578382|FG005|Overall Study|Hypotension|0|||
105703413|NCT03357731|364578377|FG000|Overall Study|Lost to Follow-up|0|||
105703414|NCT03357731|364578378|FG001|Overall Study|Lost to Follow-up|0|||
105703415|NCT03357731|364578379|FG002|Overall Study|Lost to Follow-up|0|||
105703416|NCT03357731|364578380|FG003|Overall Study|Lost to Follow-up|1|||
105703417|NCT03357731|364578381|FG004|Overall Study|Lost to Follow-up|0|||
105703418|NCT03357731|364578382|FG005|Overall Study|Lost to Follow-up|0|||
105703419|NCT02104583|364578383|FG000|Overall Study|New ICD or CRT-D implanted|2|||
105703420|NCT02104583|364578384|FG001|Overall Study|New ICD or CRT-D implanted|0|||
105703421|NCT02104583|364578385|FG002|Overall Study|New ICD or CRT-D implanted|1|||
105703422|NCT02104583|364578386|FG003|Overall Study|New ICD or CRT-D implanted|0|||
105350079|NCT00369161|363284842|FG000|Overall Study|Death|1|||
105350080|NCT00369161|363284843|FG001|Overall Study|Death|2|||
105350081|NCT00369161|363284842|FG000|Overall Study|Graft loss|4|||
105350082|NCT00369161|363284843|FG001|Overall Study|Graft loss|0|||
105350083|NCT00369161|363284842|FG000|Overall Study|Administrative Problem|2|||
105703423|NCT02104583|364578387|FG004|Overall Study|New ICD or CRT-D implanted|0|||
105703424|NCT02104583|364578383|FG000|Overall Study|Death|2|||
105703425|NCT02104583|364578384|FG001|Overall Study|Death|1|||
105703426|NCT02104583|364578385|FG002|Overall Study|Death|3|||
105703427|NCT02104583|364578386|FG003|Overall Study|Death|3|||
105703428|NCT02104583|364578387|FG004|Overall Study|Death|5|||
105350084|NCT00369161|363284843|FG001|Overall Study|Administrative Problem|2|||
105350085|NCT03760458|363284844|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
105350086|NCT03760458|363284845|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
105350087|NCT03760458|363284846|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
105350088|NCT03760458|363284847|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
105703429|NCT02104583|364578383|FG000|Overall Study|Subject required cardiac ablation|6|||
105703430|NCT02104583|364578384|FG001|Overall Study|Subject required cardiac ablation|4|||
105703431|NCT02104583|364578385|FG002|Overall Study|Subject required cardiac ablation|4|||
105703432|NCT02104583|364578386|FG003|Overall Study|Subject required cardiac ablation|5|||
105703433|NCT02104583|364578387|FG004|Overall Study|Subject required cardiac ablation|4|||
105703434|NCT02104583|364578383|FG000|Overall Study|Subject required prohibited medication|0|||
105703435|NCT02104583|364578384|FG001|Overall Study|Subject required prohibited medication|1|||
105703436|NCT02104583|364578385|FG002|Overall Study|Subject required prohibited medication|1|||
105703437|NCT02104583|364578386|FG003|Overall Study|Subject required prohibited medication|0|||
105703438|NCT02104583|364578387|FG004|Overall Study|Subject required prohibited medication|1|||
105703439|NCT02104583|364578383|FG000|Overall Study|Withdrew Consent|3|||
105703440|NCT02104583|364578384|FG001|Overall Study|Withdrew Consent|2|||
105703441|NCT02104583|364578385|FG002|Overall Study|Withdrew Consent|0|||
105703442|NCT02104583|364578386|FG003|Overall Study|Withdrew Consent|2|||
105703443|NCT02104583|364578387|FG004|Overall Study|Withdrew Consent|1|||
105703444|NCT02104583|364578383|FG000|Overall Study|Investigator's Discretion|1|||
105703445|NCT02104583|364578384|FG001|Overall Study|Investigator's Discretion|0|||
105703446|NCT02104583|364578385|FG002|Overall Study|Investigator's Discretion|0|||
105703447|NCT02104583|364578386|FG003|Overall Study|Investigator's Discretion|0|||
105703448|NCT02104583|364578387|FG004|Overall Study|Investigator's Discretion|0|||
105703449|NCT02104583|364578383|FG000|Overall Study|Protocol Violation|0|||
105703450|NCT02104583|364578384|FG001|Overall Study|Protocol Violation|0|||
105703451|NCT02104583|364578385|FG002|Overall Study|Protocol Violation|1|||
105703452|NCT02104583|364578386|FG003|Overall Study|Protocol Violation|0|||
105703453|NCT02104583|364578387|FG004|Overall Study|Protocol Violation|0|||
105703454|NCT02104583|364578383|FG000|Overall Study|Adverse Event|3|||
105703455|NCT02104583|364578384|FG001|Overall Study|Adverse Event|3|||
105703456|NCT02104583|364578385|FG002|Overall Study|Adverse Event|6|||
105703457|NCT02104583|364578386|FG003|Overall Study|Adverse Event|6|||
105703458|NCT02104583|364578387|FG004|Overall Study|Adverse Event|1|||
105703459|NCT02104583|364578383|FG000|Overall Study|Lost to Follow-up|1|||
105703460|NCT02104583|364578384|FG001|Overall Study|Lost to Follow-up|0|||
105703461|NCT02104583|364578385|FG002|Overall Study|Lost to Follow-up|0|||
105703462|NCT02104583|364578386|FG003|Overall Study|Lost to Follow-up|0|||
105703463|NCT02104583|364578387|FG004|Overall Study|Lost to Follow-up|0|||
105703464|NCT02104583|364578383|FG000|Overall Study|Randomized but Never Treated|0|||
105703465|NCT02104583|364578384|FG001|Overall Study|Randomized but Never Treated|0|||
105703466|NCT02104583|364578385|FG002|Overall Study|Randomized but Never Treated|0|||
105703467|NCT02104583|364578386|FG003|Overall Study|Randomized but Never Treated|1|||
105703468|NCT02104583|364578387|FG004|Overall Study|Randomized but Never Treated|0|||
105703469|NCT02347098|364578388|FG000|Overall Study|Death|1|||
105703470|NCT02347098|364578389|FG001|Overall Study|Death|0|||
105703471|NCT02347098|364578388|FG000|Overall Study|Withdrawal by Subject|1|||
105703472|NCT02347098|364578389|FG001|Overall Study|Withdrawal by Subject|0|||
105703473|NCT02347098|364578388|FG000|Overall Study|Lost to Follow-up|2|||
105703474|NCT02347098|364578389|FG001|Overall Study|Lost to Follow-up|2|||
105703475|NCT02347098|364578388|FG000|Overall Study|Refuse Follow-up Visit|1|||
105703476|NCT02347098|364578389|FG001|Overall Study|Refuse Follow-up Visit|5|||
105703477|NCT02347098|364578388|FG000|Overall Study|no visit due to illness|2|||
105703478|NCT02347098|364578389|FG001|Overall Study|no visit due to illness|1|||
105703479|NCT03923426|364578391|FG000|Overall Study|Other|19|||
105703480|NCT03923426|364578391|FG000|Overall Study|Lost to Follow-up|16|||
105703481|NCT03923426|364578391|FG000|Overall Study|Death|107|||
105703482|NCT03923426|364578391|FG000|Overall Study|Incomplete response to question|13|||
105350089|NCT03760458|363284848|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
105350090|NCT00750919|363284849|FG000|Overall Study|Adverse Event|9|||
105350091|NCT00750919|363284849|FG000|Overall Study|Withdrawal by Subject|1|||
105560386|NCT04866017|364046646|FG002|Overall Study|Withdrawal by Subject|1|||
105703483|NCT00751400|364578394|FG000|Overall Study|Lost to Follow-up|10|||
105703484|NCT00847912|364578396|FG000|Overall Study|Protocol Violation|6|||
105703485|NCT00847912|364578397|FG001|Overall Study|Protocol Violation|7|||
105703486|NCT00847912|364578396|FG000|Overall Study|Withdrawal by Subject|3|||
105703487|NCT00847912|364578397|FG001|Overall Study|Withdrawal by Subject|6|||
105703488|NCT01324232|364578398|FG000|Overall Study|Protocol Violation|0|||
105703489|NCT01324232|364578399|FG001|Overall Study|Protocol Violation|0|||
105703490|NCT01324232|364578400|FG002|Overall Study|Protocol Violation|0|||
105703491|NCT01324232|364578401|FG003|Overall Study|Protocol Violation|2|||
105703492|NCT01324232|364578398|FG000|Overall Study|Missing|0|||
105703493|NCT01324232|364578399|FG001|Overall Study|Missing|0|||
105703494|NCT01324232|364578400|FG002|Overall Study|Missing|1|||
105703495|NCT01324232|364578401|FG003|Overall Study|Missing|0|||
105703496|NCT01324232|364578398|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
105703497|NCT01324232|364578399|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
105703498|NCT01324232|364578400|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
105703499|NCT01324232|364578401|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
105350092|NCT00750919|363284849|FG000|Overall Study|Lack of Efficacy|8|||
105703500|NCT01324232|364578398|FG000|Overall Study|Lack of Efficacy|2|||
105703501|NCT01324232|364578399|FG001|Overall Study|Lack of Efficacy|1|||
105703502|NCT01324232|364578400|FG002|Overall Study|Lack of Efficacy|2|||
105703503|NCT01324232|364578401|FG003|Overall Study|Lack of Efficacy|2|||
105703504|NCT01324232|364578398|FG000|Overall Study|Participant Refused Medication|0|||
105703505|NCT01324232|364578399|FG001|Overall Study|Participant Refused Medication|1|||
105703506|NCT01324232|364578400|FG002|Overall Study|Participant Refused Medication|0|||
105703507|NCT01324232|364578401|FG003|Overall Study|Participant Refused Medication|0|||
105703508|NCT01324232|364578398|FG000|Overall Study|Intercurrent illness|0|||
105703509|NCT01324232|364578399|FG001|Overall Study|Intercurrent illness|0|||
105703510|NCT01324232|364578400|FG002|Overall Study|Intercurrent illness|0|||
105703511|NCT01324232|364578401|FG003|Overall Study|Intercurrent illness|1|||
105703512|NCT01324232|364578398|FG000|Overall Study|Adverse Event|2|||
105703513|NCT01324232|364578399|FG001|Overall Study|Adverse Event|5|||
105703514|NCT01324232|364578400|FG002|Overall Study|Adverse Event|6|||
105703515|NCT01324232|364578401|FG003|Overall Study|Adverse Event|6|||
105560387|NCT04866017|364046644|FG000|Overall Study|Physician Decision|0|||
105703516|NCT01324232|364578398|FG000|Overall Study|Withdrawal by Subject|0|||
105703517|NCT01324232|364578399|FG001|Overall Study|Withdrawal by Subject|3|||
105703518|NCT01324232|364578400|FG002|Overall Study|Withdrawal by Subject|4|||
105703519|NCT01324232|364578401|FG003|Overall Study|Withdrawal by Subject|0|||
105703520|NCT01324232|364578398|FG000|Overall Study|Lost to Follow-up|1|||
105703521|NCT01324232|364578399|FG001|Overall Study|Lost to Follow-up|0|||
105703522|NCT01324232|364578400|FG002|Overall Study|Lost to Follow-up|0|||
105703523|NCT01324232|364578401|FG003|Overall Study|Lost to Follow-up|0|||
105703524|NCT00661531|364578402|FG000|Overall Study|Withdrawal by Subject|3|||
105703525|NCT00530270|364578405|FG000|Overall Study|Protocol Violation|1|||
105703526|NCT00530270|364578406|FG001|Overall Study|Protocol Violation|0|||
105703527|NCT03703102|364578414|FG000|Overall Study|Adverse Event|4|||
105703528|NCT03703102|364578415|FG001|Overall Study|Adverse Event|3|||
105703529|NCT03703102|364578416|FG002|Overall Study|Adverse Event|7|||
105703530|NCT03703102|364578417|FG003|Overall Study|Adverse Event|3|||
105703531|NCT03703102|364578418|FG004|Overall Study|Adverse Event|13|||
105703532|NCT03703102|364578414|FG000|Overall Study|Lack of Efficacy|4|||
105703533|NCT03703102|364578415|FG001|Overall Study|Lack of Efficacy|0|||
105703534|NCT03703102|364578416|FG002|Overall Study|Lack of Efficacy|1|||
105703535|NCT03703102|364578417|FG003|Overall Study|Lack of Efficacy|4|||
105703536|NCT03703102|364578418|FG004|Overall Study|Lack of Efficacy|1|||
105703537|NCT03703102|364578414|FG000|Overall Study|Lost to Follow-up|0|||
105703538|NCT03703102|364578415|FG001|Overall Study|Lost to Follow-up|0|||
105703539|NCT03703102|364578416|FG002|Overall Study|Lost to Follow-up|1|||
105703540|NCT03703102|364578417|FG003|Overall Study|Lost to Follow-up|2|||
105703541|NCT03703102|364578418|FG004|Overall Study|Lost to Follow-up|2|||
105703542|NCT03703102|364578414|FG000|Overall Study|Physician Decision|2|||
105703543|NCT03703102|364578415|FG001|Overall Study|Physician Decision|2|||
105703544|NCT03703102|364578416|FG002|Overall Study|Physician Decision|2|||
105703545|NCT03703102|364578417|FG003|Overall Study|Physician Decision|2|||
105703546|NCT03703102|364578418|FG004|Overall Study|Physician Decision|4|||
105703547|NCT03703102|364578414|FG000|Overall Study|Withdrawal by Subject|7|||
105703548|NCT03703102|364578415|FG001|Overall Study|Withdrawal by Subject|5|||
105703549|NCT03703102|364578416|FG002|Overall Study|Withdrawal by Subject|5|||
105703550|NCT03703102|364578417|FG003|Overall Study|Withdrawal by Subject|5|||
105703551|NCT03703102|364578418|FG004|Overall Study|Withdrawal by Subject|9|||
105703552|NCT03703102|364578414|FG000|Overall Study|Ineligibility|0|||
105703553|NCT03703102|364578415|FG001|Overall Study|Ineligibility|0|||
105703554|NCT03703102|364578416|FG002|Overall Study|Ineligibility|1|||
105703555|NCT03703102|364578417|FG003|Overall Study|Ineligibility|0|||
105703556|NCT03703102|364578418|FG004|Overall Study|Ineligibility|0|||
105703557|NCT03703102|364578414|FG000|Overall Study|Protocol Deviation|4|||
105703558|NCT03703102|364578415|FG001|Overall Study|Protocol Deviation|4|||
105703559|NCT03703102|364578416|FG002|Overall Study|Protocol Deviation|3|||
105560388|NCT04866017|364046645|FG001|Overall Study|Physician Decision|1|||
105703560|NCT03703102|364578417|FG003|Overall Study|Protocol Deviation|0|||
105703561|NCT03703102|364578418|FG004|Overall Study|Protocol Deviation|0|||
105703562|NCT03703102|364578414|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105703563|NCT03703102|364578415|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105703564|NCT03703102|364578416|FG002|Overall Study|Non-Compliance with Study Drug|2|||
105703565|NCT03703102|364578417|FG003|Overall Study|Non-Compliance with Study Drug|1|||
105703566|NCT03703102|364578418|FG004|Overall Study|Non-Compliance with Study Drug|4|||
105703567|NCT02311153|364578419|FG000|Overall Study|Lost to Follow-up|5|||
105703568|NCT02311153|364578420|FG001|Overall Study|Lost to Follow-up|7|||
105703569|NCT00838331|364578421|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
105703570|NCT00405067|364578426|FG000|Overall Study|Adverse Event|4|||
105703571|NCT00405067|364578427|FG001|Overall Study|Adverse Event|9|||
105703572|NCT00405067|364578428|FG002|Overall Study|Adverse Event|4|||
105703573|NCT00405067|364578426|FG000|Overall Study|Lost to Follow-up|0|||
105703574|NCT00405067|364578427|FG001|Overall Study|Lost to Follow-up|0|||
105703575|NCT00405067|364578428|FG002|Overall Study|Lost to Follow-up|1|||
105350093|NCT00750919|363284849|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
105350094|NCT00750919|363284849|FG000|Overall Study|Other|36|||
105350095|NCT02147067|363284850|FG000|Overall Study|Withdrawal by Subject|2|||
105350096|NCT02147067|363284851|FG001|Overall Study|Withdrawal by Subject|2|||
105350097|NCT02943785|363284855|FG000|Overall Study|Adverse Event|112|||
105350098|NCT02943785|363284856|FG001|Overall Study|Adverse Event|97|||
105350099|NCT02943785|363284855|FG000|Overall Study|Withdrawal by Subject|63|||
105350100|NCT02943785|363284856|FG001|Overall Study|Withdrawal by Subject|126|||
105350101|NCT02943785|363284855|FG000|Overall Study|Physician Decision|23|||
105350102|NCT02943785|363284856|FG001|Overall Study|Physician Decision|47|||
105350103|NCT02943785|363284855|FG000|Overall Study|Death|46|||
105350104|NCT02943785|363284856|FG001|Overall Study|Death|46|||
105350105|NCT02943785|363284855|FG000|Overall Study|Lost to Follow-up|1|||
105350106|NCT02943785|363284856|FG001|Overall Study|Lost to Follow-up|0|||
105350107|NCT02943785|363284855|FG000|Overall Study|Other|16|||
105350108|NCT02943785|363284856|FG001|Overall Study|Other|19|||
105350109|NCT02943785|363284855|FG000|Overall Study|Did not receive any study medication|21|||
105350110|NCT02943785|363284856|FG001|Overall Study|Did not receive any study medication|28|||
105350111|NCT03170609|363284859|FG000|Overall Study|Death|0|||
105350112|NCT03170609|363284860|FG001|Overall Study|Death|0|||
105350113|NCT03170609|363284861|FG002|Overall Study|Death|1|||
105350114|NCT03170609|363284862|FG003|Overall Study|Death|0|||
105350115|NCT03170609|363284863|FG004|Overall Study|Death|0|||
105350116|NCT03170609|363284864|FG005|Overall Study|Death|0|||
105350117|NCT03170609|363284865|FG006|Overall Study|Death|0|||
105350118|NCT03170609|363284859|FG000|Overall Study|Withdrawal by Subject|1|||
105474556|NCT02695420|363748627|FG003|Overall Study|Death|0|||
105474557|NCT02762370|363748628|FG000|Overall Study|Protocol Violation|1|||
105474558|NCT02762370|363748629|FG001|Overall Study|Protocol Violation|0|||
105474559|NCT01536392|363748632|FG000|Overall Study|Adverse Event|2|||
105474560|NCT01536392|363748633|FG001|Overall Study|Adverse Event|2|||
105474561|NCT01536392|363748632|FG000|Overall Study|Physician Decision|2|||
105350119|NCT03170609|363284860|FG001|Overall Study|Withdrawal by Subject|2|||
105350120|NCT03170609|363284861|FG002|Overall Study|Withdrawal by Subject|0|||
105350121|NCT03170609|363284862|FG003|Overall Study|Withdrawal by Subject|0|||
105350122|NCT03170609|363284863|FG004|Overall Study|Withdrawal by Subject|0|||
105350123|NCT03170609|363284864|FG005|Overall Study|Withdrawal by Subject|0|||
105350124|NCT03170609|363284865|FG006|Overall Study|Withdrawal by Subject|1|||
105474562|NCT01536392|363748633|FG001|Overall Study|Physician Decision|3|||
105474563|NCT01536392|363748632|FG000|Overall Study|Withdrawal by Subject|3|||
105474564|NCT01536392|363748633|FG001|Overall Study|Withdrawal by Subject|6|||
105474565|NCT01536392|363748632|FG000|Overall Study|Non Compliance|3|||
105703576|NCT01650636|364578429|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
105703577|NCT01650636|364578430|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
105703578|NCT01650636|364578429|FG000|Washout up to 5 Months|Physician Decision|2|||
105350125|NCT03170609|363284859|FG000|Overall Study|Lost to Follow-up|1|||
105350126|NCT03170609|363284860|FG001|Overall Study|Lost to Follow-up|0|||
105703579|NCT01650636|364578430|FG001|Washout up to 5 Months|Physician Decision|2|||
105350127|NCT03170609|363284861|FG002|Overall Study|Lost to Follow-up|5|||
105350128|NCT03170609|363284862|FG003|Overall Study|Lost to Follow-up|2|||
105350129|NCT03170609|363284863|FG004|Overall Study|Lost to Follow-up|1|||
105350130|NCT03170609|363284864|FG005|Overall Study|Lost to Follow-up|1|||
105350131|NCT03170609|363284865|FG006|Overall Study|Lost to Follow-up|0|||
105350132|NCT03170609|363284859|FG000|Overall Study|Other|1|||
105350133|NCT03170609|363284860|FG001|Overall Study|Other|0|||
105350134|NCT03170609|363284861|FG002|Overall Study|Other|0|||
105350135|NCT03170609|363284862|FG003|Overall Study|Other|0|||
105350136|NCT03170609|363284863|FG004|Overall Study|Other|0|||
105474566|NCT01536392|363748633|FG001|Overall Study|Non Compliance|4|||
105703580|NCT01650636|364578429|FG000|Washout up to 5 Months|Death|1|||
105703581|NCT01650636|364578430|FG001|Washout up to 5 Months|Death|0|||
105703582|NCT01650636|364578429|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
105703583|NCT01650636|364578430|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
105703584|NCT01650636|364578429|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
105703585|NCT01650636|364578430|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
105703586|NCT01650636|364578429|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
105703587|NCT01650636|364578430|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
105703588|NCT02018822|364578431|FG000|Overall Study|filling replaced by crown|0|||
105350137|NCT03170609|363284864|FG005|Overall Study|Other|1|||
105350138|NCT03170609|363284865|FG006|Overall Study|Other|0|||
105474567|NCT01536392|363748632|FG000|Overall Study|Completed therapy early|3|||
105350139|NCT00575510|363284868|FG000|Overall Study|Lost to Follow-up|4|||
105474568|NCT01536392|363748633|FG001|Overall Study|Completed therapy early|0|||
105474569|NCT00145977|363748634|FG000|Overall Study|Lack of Efficacy|0|||
105474570|NCT00145977|363748635|FG001|Overall Study|Lack of Efficacy|4|||
105474571|NCT00145977|363748634|FG000|Overall Study|Lost to Follow-up|1|||
105474572|NCT00145977|363748635|FG001|Overall Study|Lost to Follow-up|0|||
105474573|NCT00145977|363748634|FG000|Overall Study|Withdrawal by Subject|1|||
105474574|NCT00145977|363748635|FG001|Overall Study|Withdrawal by Subject|0|||
105474575|NCT02954172|363748638|FG000|Overall Study|Protocol Violation|3|||
105474576|NCT02954172|363748639|FG001|Overall Study|Protocol Violation|0|||
105474577|NCT02954172|363748638|FG000|Overall Study|allergic reaction|2|||
105474578|NCT02954172|363748639|FG001|Overall Study|allergic reaction|1|||
105474579|NCT02954172|363748638|FG000|Overall Study|non-measurable lesions at baseline|1|||
105474580|NCT02954172|363748639|FG001|Overall Study|non-measurable lesions at baseline|2|||
105474581|NCT02745080|363748642|FG000|Overall Study|Adverse Event|13|||
105474582|NCT02745080|363748643|FG001|Overall Study|Adverse Event|21|||
105474583|NCT02745080|363748642|FG000|Overall Study|Lack of Efficacy|11|||
105474584|NCT02745080|363748643|FG001|Overall Study|Lack of Efficacy|23|||
105474585|NCT02745080|363748642|FG000|Overall Study|Lost to Follow-up|3|||
105474586|NCT02745080|363748643|FG001|Overall Study|Lost to Follow-up|3|||
105474587|NCT02745080|363748642|FG000|Overall Study|Physician Decision|3|||
105474588|NCT02745080|363748643|FG001|Overall Study|Physician Decision|0|||
105474589|NCT02745080|363748642|FG000|Overall Study|Protocol Violation|3|||
105474590|NCT02745080|363748643|FG001|Overall Study|Protocol Violation|1|||
105474591|NCT02745080|363748642|FG000|Overall Study|Withdrawal by Subject|22|||
105474592|NCT02745080|363748643|FG001|Overall Study|Withdrawal by Subject|41|||
105703589|NCT02018822|364578432|FG001|Overall Study|filling replaced by crown|1|||
105703590|NCT02018822|364578433|FG002|Overall Study|filling replaced by crown|0|||
105703591|NCT02018822|364578431|FG000|Overall Study|Physician Decision|0|||
105703592|NCT02018822|364578432|FG001|Overall Study|Physician Decision|1|||
105703593|NCT02018822|364578433|FG002|Overall Study|Physician Decision|1|||
105703594|NCT02018822|364578431|FG000|Overall Study|Lost to Follow-up|6|||
105703595|NCT02018822|364578432|FG001|Overall Study|Lost to Follow-up|6|||
105703596|NCT02018822|364578433|FG002|Overall Study|Lost to Follow-up|5|||
105703597|NCT03699007|364578444|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
105703598|NCT03699007|364578445|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
105703599|NCT03699007|364578444|FG000|6-month Follow Up|Lost to Follow-up|2|||
105703600|NCT03699007|364578445|FG001|6-month Follow Up|Lost to Follow-up|3|||
105703601|NCT04081363|364578446|FG000|Overall Study|Withdrawal by Subject|1|||
105703602|NCT04081363|364578447|FG001|Overall Study|Withdrawal by Subject|0|||
105703603|NCT04251910|364578449|FG000|Overall Study|Covid 19 lockdown|0|||
105703604|NCT04251910|364578450|FG001|Overall Study|Covid 19 lockdown|5|||
105703605|NCT04251910|364578451|FG002|Overall Study|Covid 19 lockdown|0|||
105703606|NCT04251910|364578452|FG003|Overall Study|Covid 19 lockdown|4|||
105703607|NCT04251910|364578453|FG004|Overall Study|Covid 19 lockdown|0|||
105703608|NCT04251910|364578454|FG005|Overall Study|Covid 19 lockdown|0|||
105703609|NCT04251910|364578449|FG000|Overall Study|Assisted living facility was closed|0|||
105703610|NCT04251910|364578450|FG001|Overall Study|Assisted living facility was closed|0|||
105703611|NCT04251910|364578451|FG002|Overall Study|Assisted living facility was closed|0|||
105350140|NCT00575510|363284869|FG001|Overall Study|Lost to Follow-up|6|||
105350141|NCT00575510|363284870|FG002|Overall Study|Lost to Follow-up|9|||
105350142|NCT00575510|363284868|FG000|Overall Study|Withdrawal by Subject|1|||
105350143|NCT00575510|363284869|FG001|Overall Study|Withdrawal by Subject|0|||
105350144|NCT00575510|363284870|FG002|Overall Study|Withdrawal by Subject|0|||
105350145|NCT00575510|363284868|FG000|Overall Study|Clinic Called Patient|7|||
105350146|NCT00575510|363284869|FG001|Overall Study|Clinic Called Patient|7|||
105350147|NCT00575510|363284870|FG002|Overall Study|Clinic Called Patient|7|||
105350148|NCT00575510|363284868|FG000|Overall Study|Pregnancy|0|||
105350149|NCT00575510|363284869|FG001|Overall Study|Pregnancy|0|||
105350150|NCT00575510|363284870|FG002|Overall Study|Pregnancy|1|||
105350151|NCT01606748|363284877|FG000|Overall Study|Adverse Event|1|||
105350152|NCT01606748|363284878|FG001|Overall Study|Adverse Event|0|||
105350153|NCT01606748|363284877|FG000|Overall Study|Progressive Disease|1|||
105350154|NCT01606748|363284878|FG001|Overall Study|Progressive Disease|0|||
105350155|NCT01606748|363284877|FG000|Overall Study|Withdrawal by Subject|1|||
105350156|NCT01606748|363284878|FG001|Overall Study|Withdrawal by Subject|0|||
105350157|NCT00549601|363286116|FG000|Randomized|Protocol Violation|0|||
105703612|NCT04251910|364578452|FG003|Overall Study|Assisted living facility was closed|0|||
105703613|NCT04251910|364578453|FG004|Overall Study|Assisted living facility was closed|1|||
105703614|NCT04251910|364578454|FG005|Overall Study|Assisted living facility was closed|0|||
105703615|NCT02184195|364578457|FG000|Overall Study|Patient decision|5|||
105703616|NCT02184195|364578458|FG001|Overall Study|Patient decision|2|||
105350158|NCT00549601|363286117|FG001|Randomized|Protocol Violation|0|||
105350159|NCT00549601|363286118|FG002|Randomized|Protocol Violation|1|||
105350160|NCT00549601|363286116|FG000|Randomized|Withdrawal by Subject|0|||
105350161|NCT00549601|363286117|FG001|Randomized|Withdrawal by Subject|1|||
105474593|NCT04002908|363748644|FG000|Overall Study|Death|41|||
105474594|NCT04002908|363748645|FG001|Overall Study|Death|0|||
105474595|NCT04002908|363748646|FG002|Overall Study|Death|0|||
105350162|NCT00549601|363286118|FG002|Randomized|Withdrawal by Subject|1|||
105350163|NCT00549601|363286116|FG000|Received Study Drug|Adverse Event|2|||
105350164|NCT00549601|363286117|FG001|Received Study Drug|Adverse Event|5|||
105350165|NCT00549601|363286118|FG002|Received Study Drug|Adverse Event|1|||
105350166|NCT00549601|363286116|FG000|Received Study Drug|Death|0|||
105350167|NCT00549601|363286117|FG001|Received Study Drug|Death|1|||
105350168|NCT00549601|363286118|FG002|Received Study Drug|Death|0|||
105350169|NCT00549601|363286116|FG000|Received Study Drug|Lost to Follow-up|0|||
105350170|NCT00549601|363286117|FG001|Received Study Drug|Lost to Follow-up|1|||
105350171|NCT00549601|363286118|FG002|Received Study Drug|Lost to Follow-up|1|||
105350172|NCT00549601|363286116|FG000|Received Study Drug|Protocol Violation|3|||
105350173|NCT00549601|363286117|FG001|Received Study Drug|Protocol Violation|4|||
105350174|NCT00549601|363286118|FG002|Received Study Drug|Protocol Violation|1|||
105350175|NCT00549601|363286116|FG000|Received Study Drug|Withdrawal by Subject|2|||
105350176|NCT00549601|363286117|FG001|Received Study Drug|Withdrawal by Subject|0|||
105350177|NCT00549601|363286118|FG002|Received Study Drug|Withdrawal by Subject|1|||
105350178|NCT04114656|363286119|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
105350179|NCT04114656|363286120|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
105350180|NCT04114656|363286119|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
105350181|NCT04114656|363286120|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
105350182|NCT04114656|363286119|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
105350183|NCT04114656|363286120|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
105350184|NCT04114656|363286119|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
105350185|NCT04114656|363286120|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
105350186|NCT04114656|363286119|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
105350187|NCT04114656|363286120|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
105350188|NCT02732015|363286121|FG000|Overall Study|Lost to Follow-up|0|||
105350189|NCT02732015|363286122|FG001|Overall Study|Lost to Follow-up|1|||
105350190|NCT03052920|363286123|FG000|Overall Study|Withdrawal by Subject|1|||
105350191|NCT01313221|363286126|FG000|Overall Study|Protocol Violation|0|||
105350192|NCT01313221|363286127|FG001|Overall Study|Protocol Violation|1|||
105350193|NCT01313221|363286128|FG002|Overall Study|Protocol Violation|1|||
105350194|NCT01313221|363286126|FG000|Overall Study|Non-compliance|3|||
105350195|NCT01313221|363286127|FG001|Overall Study|Non-compliance|0|||
105350196|NCT01313221|363286128|FG002|Overall Study|Non-compliance|2|||
105350197|NCT01313221|363286126|FG000|Overall Study|Withdrawal by Subject|2|||
105350198|NCT01313221|363286127|FG001|Overall Study|Withdrawal by Subject|3|||
105350199|NCT01313221|363286128|FG002|Overall Study|Withdrawal by Subject|5|||
105350200|NCT01313221|363286126|FG000|Overall Study|Requirement for alternative therapy|0|||
105350201|NCT01313221|363286127|FG001|Overall Study|Requirement for alternative therapy|1|||
105350202|NCT01313221|363286128|FG002|Overall Study|Requirement for alternative therapy|1|||
105350203|NCT01313221|363286126|FG000|Overall Study|Lost to Follow-up|6|||
105350204|NCT01313221|363286127|FG001|Overall Study|Lost to Follow-up|3|||
105350205|NCT01313221|363286128|FG002|Overall Study|Lost to Follow-up|1|||
105350206|NCT01313221|363286126|FG000|Overall Study|Other|1|||
105350207|NCT01313221|363286127|FG001|Overall Study|Other|0|||
105350208|NCT01313221|363286128|FG002|Overall Study|Other|0|||
105350209|NCT01313221|363286126|FG000|Overall Study|Adverse Event|0|||
105350210|NCT01313221|363286127|FG001|Overall Study|Adverse Event|0|||
105350211|NCT01313221|363286128|FG002|Overall Study|Adverse Event|7|||
105350212|NCT01313221|363286126|FG000|Overall Study|Disease progression|0|||
105350213|NCT01313221|363286127|FG001|Overall Study|Disease progression|0|||
105350214|NCT01313221|363286128|FG002|Overall Study|Disease progression|2|||
105350215|NCT01313221|363286126|FG000|Overall Study|Physician Decision|0|||
105350216|NCT01313221|363286127|FG001|Overall Study|Physician Decision|0|||
105350217|NCT01313221|363286128|FG002|Overall Study|Physician Decision|2|||
105350218|NCT01313221|363286126|FG000|Overall Study|Pregnancy|0|||
105350219|NCT01313221|363286127|FG001|Overall Study|Pregnancy|0|||
105350220|NCT01313221|363286128|FG002|Overall Study|Pregnancy|2|||
105474596|NCT04002908|363748647|FG003|Overall Study|Death|0|||
105474597|NCT04002908|363748644|FG000|Overall Study|Withdrawal by Subject|112|||
105474598|NCT04002908|363748645|FG001|Overall Study|Withdrawal by Subject|0|||
105703617|NCT02184195|364578457|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105703618|NCT02184195|364578458|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
105703619|NCT02184195|364578457|FG000|Overall Study|Death|67|||
105703620|NCT02184195|364578458|FG001|Overall Study|Death|44|||
105703621|NCT02184195|364578457|FG000|Overall Study|Lost to Follow-up|1|||
105703622|NCT02184195|364578458|FG001|Overall Study|Lost to Follow-up|5|||
105703623|NCT02184195|364578457|FG000|Overall Study|Other|0|||
105703624|NCT02184195|364578458|FG001|Overall Study|Other|3|||
105703625|NCT00290342|364578459|FG000|Overall Study|Other|0|||
105703626|NCT00290342|364578460|FG001|Overall Study|Other|1|||
105703627|NCT00290342|364578459|FG000|Overall Study|Withdrawal by Subject|6|||
105703628|NCT00290342|364578460|FG001|Overall Study|Withdrawal by Subject|4|||
105703629|NCT00290342|364578459|FG000|Overall Study|Lost to Follow-up|1|||
105703630|NCT00290342|364578460|FG001|Overall Study|Lost to Follow-up|0|||
105703631|NCT00978029|364578466|FG000|Overall Study|Adverse Event|1|||
105703632|NCT00978029|364578467|FG001|Overall Study|Adverse Event|2|||
105703633|NCT00978029|364578468|FG002|Overall Study|Adverse Event|5|||
105703634|NCT00978029|364578466|FG000|Overall Study|Withdrawal by Subject|0|||
105703635|NCT00978029|364578467|FG001|Overall Study|Withdrawal by Subject|0|||
105703636|NCT00978029|364578468|FG002|Overall Study|Withdrawal by Subject|1|||
105703637|NCT00978029|364578466|FG000|Overall Study|Protocol Violation|0|||
105703638|NCT00978029|364578467|FG001|Overall Study|Protocol Violation|1|||
105703639|NCT00978029|364578468|FG002|Overall Study|Protocol Violation|0|||
105703640|NCT02121262|364578469|FG000|Overall Study|Adverse Event|6|||
105703641|NCT02121262|364578470|FG001|Overall Study|Adverse Event|3|||
105703642|NCT02121262|364578469|FG000|Overall Study|Lack of Efficacy|3|||
105703643|NCT02121262|364578470|FG001|Overall Study|Lack of Efficacy|0|||
105703644|NCT02121262|364578469|FG000|Overall Study|Personal Reasons|19|||
105703645|NCT02121262|364578470|FG001|Overall Study|Personal Reasons|5|||
105703646|NCT02121262|364578469|FG000|Overall Study|Protocol Violation|1|||
105703647|NCT02121262|364578470|FG001|Overall Study|Protocol Violation|1|||
105703648|NCT02121262|364578469|FG000|Overall Study|Participant Dropped-out|0|||
105703649|NCT02121262|364578470|FG001|Overall Study|Participant Dropped-out|1|||
105703650|NCT02121262|364578469|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
105703651|NCT02121262|364578470|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
105703652|NCT02121262|364578469|FG000|Overall Study|Consent Withdrawn|1|||
105703653|NCT02121262|364578470|FG001|Overall Study|Consent Withdrawn|0|||
105703654|NCT02829138|364578471|FG000|Overall Study|Withdrawal by Subject|1|||
105703655|NCT02829138|364578472|FG001|Overall Study|Withdrawal by Subject|0|||
105703656|NCT01394627|364578473|FG000|First Intervention (1 Day)|poor intravenous access|0|||
105703657|NCT01394627|364578474|FG001|First Intervention (1 Day)|poor intravenous access|1|||
105703658|NCT01394627|364578473|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
105703659|NCT01394627|364578474|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
105787356|NCT01243762|364874939|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
105787357|NCT01243762|364874940|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
105703660|NCT00777101|364578478|FG000|Overall Study|Death|48|||
105703661|NCT00777101|364578479|FG001|Overall Study|Death|43|||
105703662|NCT00777101|364578478|FG000|Overall Study|Withdrawal by Subject|11|||
105703663|NCT00777101|364578479|FG001|Overall Study|Withdrawal by Subject|6|||
105703664|NCT00777101|364578478|FG000|Overall Study|Lost to Follow-up|2|||
105703665|NCT00777101|364578479|FG001|Overall Study|Lost to Follow-up|1|||
105703666|NCT00777101|364578478|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
105703667|NCT00777101|364578479|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
105703668|NCT00777101|364578478|FG000|Overall Study|Failed to Return|0|||
105703669|NCT00777101|364578479|FG001|Overall Study|Failed to Return|1|||
105703670|NCT02411539|364578482|FG000|Overall Study|Lost to Follow-up|2|||
105703671|NCT02411539|364578483|FG001|Overall Study|Lost to Follow-up|0|||
105703672|NCT02411539|364578482|FG000|Overall Study|Confounding medical condition|0|||
105703673|NCT02411539|364578483|FG001|Overall Study|Confounding medical condition|1|||
105703674|NCT01347554|364578484|FG000|Overall Study|Lack of Efficacy|7|||
105703675|NCT01347554|364578485|FG001|Overall Study|Lack of Efficacy|11|||
105703676|NCT00886600|364578486|FG000|Double-blind Monotherapy|Adverse Event|1|||
105703677|NCT00886600|364578487|FG001|Double-blind Monotherapy|Adverse Event|1|||
105703678|NCT00886600|364578488|FG002|Double-blind Monotherapy|Adverse Event|1|||
105703679|NCT00886600|364578489|FG003|Double-blind Monotherapy|Adverse Event|1|||
105703680|NCT00886600|364578486|FG000|Double-blind Monotherapy|Protocol Violation|0|||
105703681|NCT00886600|364578487|FG001|Double-blind Monotherapy|Protocol Violation|0|||
105703682|NCT00886600|364578488|FG002|Double-blind Monotherapy|Protocol Violation|0|||
105703683|NCT00886600|364578489|FG003|Double-blind Monotherapy|Protocol Violation|1|||
105703684|NCT00886600|364578486|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
105703685|NCT00886600|364578487|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
105703686|NCT00886600|364578488|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
105703687|NCT00886600|364578489|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
105703688|NCT00886600|364578486|FG000|Combination Therapy Period|Adverse Event|0|||
105703689|NCT00886600|364578487|FG001|Combination Therapy Period|Adverse Event|0|||
105703690|NCT00886600|364578488|FG002|Combination Therapy Period|Adverse Event|1|||
105350221|NCT00994214|363286129|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
105350222|NCT00994214|363286130|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
105350223|NCT00994214|363286131|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
105350224|NCT00994214|363286132|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
105350225|NCT00994214|363286129|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
105703691|NCT00886600|364578489|FG003|Combination Therapy Period|Adverse Event|0|||
105703692|NCT00886600|364578486|FG000|Combination Therapy Period|Protocol Violation|0|||
105703693|NCT00886600|364578487|FG001|Combination Therapy Period|Protocol Violation|0|||
105703694|NCT00886600|364578488|FG002|Combination Therapy Period|Protocol Violation|1|||
105703695|NCT00886600|364578489|FG003|Combination Therapy Period|Protocol Violation|0|||
105703696|NCT04288154|364578490|FG000|Overall Study|Withdrawal by Subject|9|||
105703697|NCT04288154|364578491|FG001|Overall Study|Withdrawal by Subject|9|||
105703698|NCT01251367|364578492|FG000|Overall Study|Protocol Violation|1|||
105703699|NCT01251367|364578492|FG000|Overall Study|Lack of Efficacy|2|||
105703700|NCT01251367|364578492|FG000|Overall Study|Adverse Event|19|||
105703701|NCT01251367|364578492|FG000|Overall Study|Withdrawal by Subject|36|||
105350226|NCT00994214|363286130|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
105703702|NCT01251367|364578492|FG000|Overall Study|Lost to Follow-up|5|||
105703703|NCT01251367|364578492|FG000|Overall Study|Subject Required Alternative Treatment|7|||
105703704|NCT01251367|364578492|FG000|Overall Study|No Study Drug Available|1|||
105703705|NCT01251367|364578492|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
105703706|NCT01251367|364578492|FG000|Overall Study|End of Study Visit Performed in Error|1|||
105703707|NCT00004259|364578494|FG000|Overall Study|Protocol Violation|1|||
105703708|NCT00004259|364578495|FG001|Overall Study|Protocol Violation|2|||
105703709|NCT00004259|364578496|FG002|Overall Study|Protocol Violation|0|||
105703710|NCT00004259|364578497|FG003|Overall Study|Protocol Violation|0|||
105703711|NCT00004259|364578494|FG000|Overall Study|Withdrawal by Subject|0|||
105703712|NCT00004259|364578495|FG001|Overall Study|Withdrawal by Subject|2|||
105703713|NCT00004259|364578496|FG002|Overall Study|Withdrawal by Subject|0|||
105703714|NCT00004259|364578497|FG003|Overall Study|Withdrawal by Subject|0|||
105703715|NCT00135668|364578498|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
105703716|NCT00135668|364578499|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
105703717|NCT00135668|364578500|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
105703718|NCT00135668|364578501|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
105703719|NCT01227044|364578504|FG000|Overall Study|Lost to Follow-up|5|||
105703720|NCT01227044|364578505|FG001|Overall Study|Lost to Follow-up|7|||
105703721|NCT01227044|364578504|FG000|Overall Study|Discontinued Intervention|1|||
105703722|NCT01227044|364578505|FG001|Overall Study|Discontinued Intervention|2|||
105703723|NCT01277549|364578508|FG000|Overall Study|Failed to meet eligibility criteria|13|||
105703724|NCT01277549|364578509|FG001|Overall Study|Failed to meet eligibility criteria|9|||
105703725|NCT01277549|364578508|FG000|Overall Study|Withdrawal by Subject|1|||
105703726|NCT01277549|364578509|FG001|Overall Study|Withdrawal by Subject|3|||
105703727|NCT01277549|364578508|FG000|Overall Study|Protocol Violation|10|||
105703728|NCT01277549|364578509|FG001|Overall Study|Protocol Violation|1|||
105703729|NCT01277549|364578508|FG000|Overall Study|Physician Decision|2|||
105703730|NCT01277549|364578509|FG001|Overall Study|Physician Decision|1|||
105703731|NCT02424253|364578510|FG000|Overall Study|Other, unspecified|1|||
105703732|NCT02424253|364578511|FG001|Overall Study|Other, unspecified|0|||
105703733|NCT02424253|364578510|FG000|Overall Study|Compliance problems|1|||
105703734|NCT02424253|364578511|FG001|Overall Study|Compliance problems|0|||
105703735|NCT02424253|364578510|FG000|Overall Study|Physician Decision|2|||
105703736|NCT02424253|364578511|FG001|Overall Study|Physician Decision|0|||
105703737|NCT02424253|364578510|FG000|Overall Study|Lack of Efficacy|0|||
105703738|NCT02424253|364578511|FG001|Overall Study|Lack of Efficacy|7|||
105703739|NCT02424253|364578510|FG000|Overall Study|Adverse Event|2|||
105703740|NCT02424253|364578511|FG001|Overall Study|Adverse Event|0|||
105703741|NCT02424253|364578510|FG000|Overall Study|Consent withdrawn by subject|4|||
105703742|NCT02424253|364578511|FG001|Overall Study|Consent withdrawn by subject|1|||
105703743|NCT02424253|364578510|FG000|Overall Study|Lost to Follow-up|1|||
105703744|NCT02424253|364578511|FG001|Overall Study|Lost to Follow-up|1|||
105703745|NCT00473343|364578512|FG000|Overall Study|Adverse Event|9|||
105703746|NCT00473343|364578512|FG000|Overall Study|Lost to Follow-up|8|||
105703747|NCT00473343|364578512|FG000|Overall Study|Treatment failure|27|||
105703748|NCT00473343|364578512|FG000|Overall Study|Withdrew consent|3|||
105703749|NCT00473343|364578512|FG000|Overall Study|Other un-specified reason|3|||
105703750|NCT02290873|364578523|FG000|Overall Study|Withdrawal by Subject|0|||
105703751|NCT02290873|364578524|FG001|Overall Study|Withdrawal by Subject|1|||
105703752|NCT02290873|364578525|FG002|Overall Study|Withdrawal by Subject|1|||
105703753|NCT02290873|364578523|FG000|Overall Study|Nellcor device error|1|||
105703754|NCT02290873|364578524|FG001|Overall Study|Nellcor device error|0|||
105703755|NCT02290873|364578525|FG002|Overall Study|Nellcor device error|0|||
105703756|NCT02290873|364578523|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
105703757|NCT02290873|364578524|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
105703758|NCT02290873|364578525|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
105703759|NCT02290873|364578523|FG000|Overall Study|Protocol Violation|0|||
105703760|NCT02290873|364578524|FG001|Overall Study|Protocol Violation|0|||
105703761|NCT02290873|364578525|FG002|Overall Study|Protocol Violation|1|||
105703762|NCT02287623|364578529|FG000|Overall Study|Protocol Violation|0|||
105703763|NCT02287623|364578530|FG001|Overall Study|Protocol Violation|1|||
105703764|NCT03891264|364578531|FG000|Overall Study|Adverse Event|1|||
105703765|NCT03891264|364578531|FG000|Overall Study|Withdrawal by Subject|2|||
105703766|NCT03891264|364578531|FG000|Overall Study|Physician Decision|2|||
105703767|NCT01970501|364578532|FG000|Overall Study|Discontinuation of study by sponsor|16|||
105703768|NCT01970501|364578533|FG001|Overall Study|Discontinuation of study by sponsor|14|||
105703769|NCT01970501|364578532|FG000|Overall Study|Withdrawal by Subject|6|||
105703770|NCT01970501|364578533|FG001|Overall Study|Withdrawal by Subject|7|||
105703771|NCT01970501|364578532|FG000|Overall Study|Adverse Event|2|||
105703772|NCT01970501|364578533|FG001|Overall Study|Adverse Event|4|||
105703773|NCT01970501|364578532|FG000|Overall Study|Death|1|||
105703774|NCT01970501|364578533|FG001|Overall Study|Death|3|||
105703775|NCT01970501|364578532|FG000|Overall Study|Physician Decision|2|||
105703776|NCT01970501|364578533|FG001|Overall Study|Physician Decision|0|||
105703777|NCT00794157|364578534|FG000|Overall Study|Adverse Event|4|||
105703778|NCT00794157|364578535|FG001|Overall Study|Adverse Event|1|||
105350227|NCT00994214|363286131|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
105350228|NCT00994214|363286132|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
105350229|NCT00994214|363286129|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
105350230|NCT00994214|363286130|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
105350231|NCT00994214|363286131|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
105350232|NCT00994214|363286132|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
105350233|NCT00994214|363286129|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
105350234|NCT00994214|363286130|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
105350235|NCT00994214|363286131|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
105350236|NCT00994214|363286132|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
105350237|NCT00994214|363286129|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
105350238|NCT00994214|363286130|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
105350239|NCT00994214|363286131|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
105350240|NCT00994214|363286132|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
105350241|NCT00994214|363286129|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
105350242|NCT00994214|363286130|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
105350243|NCT00994214|363286131|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
105350244|NCT00994214|363286132|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
105350245|NCT02864316|363286135|FG000|Overall Study|Progressive Disease|2|||
105350246|NCT02864316|363286136|FG001|Overall Study|Progressive Disease|1|||
105350247|NCT02864316|363286135|FG000|Overall Study|Adverse Event|0|||
105350248|NCT02864316|363286136|FG001|Overall Study|Adverse Event|1|||
105350249|NCT00298363|363286138|FG000|Overall Study|Lost to Follow-up|0|||
105350250|NCT00298363|363286139|FG001|Overall Study|Lost to Follow-up|0|||
105350251|NCT00298363|363286140|FG002|Overall Study|Lost to Follow-up|1|||
105350252|NCT00298363|363286138|FG000|Overall Study|Physician Decision|4|||
105350253|NCT00298363|363286139|FG001|Overall Study|Physician Decision|1|||
105350254|NCT00298363|363286140|FG002|Overall Study|Physician Decision|0|||
105350255|NCT00298363|363286138|FG000|Overall Study|Protocol Violation|1|||
105350256|NCT00298363|363286139|FG001|Overall Study|Protocol Violation|1|||
105350257|NCT00298363|363286140|FG002|Overall Study|Protocol Violation|0|||
105350258|NCT00298363|363286138|FG000|Overall Study|Withdrawal by Subject|5|||
105350259|NCT00298363|363286139|FG001|Overall Study|Withdrawal by Subject|1|||
105350260|NCT00298363|363286140|FG002|Overall Study|Withdrawal by Subject|3|||
105350261|NCT00298363|363286138|FG000|Overall Study|Adverse Event|5|||
105350262|NCT00298363|363286139|FG001|Overall Study|Adverse Event|2|||
105350263|NCT00298363|363286140|FG002|Overall Study|Adverse Event|2|||
105703779|NCT00794157|364578536|FG002|Overall Study|Adverse Event|8|||
105703780|NCT00794157|364578534|FG000|Overall Study|Subject withdrew consent|2|||
105703781|NCT00794157|364578535|FG001|Overall Study|Subject withdrew consent|0|||
105703782|NCT00794157|364578536|FG002|Overall Study|Subject withdrew consent|3|||
105703783|NCT00794157|364578534|FG000|Overall Study|Lost to Follow-up|2|||
105703784|NCT00794157|364578535|FG001|Overall Study|Lost to Follow-up|0|||
105703785|NCT00794157|364578536|FG002|Overall Study|Lost to Follow-up|1|||
105703786|NCT00794157|364578534|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105703787|NCT00794157|364578535|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105703788|NCT00794157|364578536|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
105703789|NCT00794157|364578534|FG000|Overall Study|Administrative problems|1|||
105703790|NCT00794157|364578535|FG001|Overall Study|Administrative problems|7|||
105703791|NCT00794157|364578536|FG002|Overall Study|Administrative problems|4|||
105703792|NCT00794157|364578534|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105703793|NCT00794157|364578535|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105703794|NCT00794157|364578536|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105703795|NCT00794157|364578534|FG000|Overall Study|Protocol deviation|0|||
105703796|NCT00794157|364578535|FG001|Overall Study|Protocol deviation|1|||
105703797|NCT00794157|364578536|FG002|Overall Study|Protocol deviation|1|||
105703798|NCT01692275|364578537|FG000|Overall Study|Lost to Follow-up|57|||
105703799|NCT01692275|364578538|FG001|Overall Study|Lost to Follow-up|48|||
105703800|NCT01692275|364578537|FG000|Overall Study|Withdrawal by Subject|9|||
105703801|NCT01692275|364578538|FG001|Overall Study|Withdrawal by Subject|11|||
105703802|NCT00708123|364578540|FG000|Period 1|Protocol Violation|0|||
105703803|NCT00708123|364578541|FG001|Period 1|Protocol Violation|1|||
105350264|NCT00298363|363286138|FG000|Overall Study|Lack of Efficacy|2|||
105350265|NCT00298363|363286139|FG001|Overall Study|Lack of Efficacy|3|||
105350266|NCT00298363|363286140|FG002|Overall Study|Lack of Efficacy|0|||
105350267|NCT00433017|363286141|FG000|Overall Study|Adverse Event|5|||
105350268|NCT00433017|363286142|FG001|Overall Study|Adverse Event|3|||
105350269|NCT00433017|363286141|FG000|Overall Study|Withdrawal by Subject|4|||
105703804|NCT00708123|364578542|FG002|Period 1|Protocol Violation|0|||
105703805|NCT00708123|364578543|FG003|Period 1|Protocol Violation|1|||
105703806|NCT00708123|364578544|FG004|Period 1|Protocol Violation|0|||
105703807|NCT00708123|364578540|FG000|Period 1|Adverse Event|0|||
105703808|NCT00708123|364578541|FG001|Period 1|Adverse Event|0|||
105474599|NCT04002908|363748646|FG002|Overall Study|Withdrawal by Subject|0|||
105474600|NCT04002908|363748647|FG003|Overall Study|Withdrawal by Subject|0|||
105474601|NCT04002908|363748644|FG000|Overall Study|Lost to Follow-up|72|||
105474602|NCT04002908|363748645|FG001|Overall Study|Lost to Follow-up|0|||
105474603|NCT04002908|363748646|FG002|Overall Study|Lost to Follow-up|0|||
105703809|NCT00708123|364578542|FG002|Period 1|Adverse Event|1|||
105703810|NCT00708123|364578543|FG003|Period 1|Adverse Event|0|||
105703811|NCT00708123|364578544|FG004|Period 1|Adverse Event|0|||
105703812|NCT00708123|364578540|FG000|Period 2|Protocol Violation|0|||
105703813|NCT00708123|364578541|FG001|Period 2|Protocol Violation|0|||
105703814|NCT00708123|364578542|FG002|Period 2|Protocol Violation|0|||
105703815|NCT00708123|364578543|FG003|Period 2|Protocol Violation|1|||
105703816|NCT00708123|364578544|FG004|Period 2|Protocol Violation|0|||
105703817|NCT00708123|364578540|FG000|Period 2|Other Reason|1|||
105703818|NCT00708123|364578541|FG001|Period 2|Other Reason|0|||
105703819|NCT00708123|364578542|FG002|Period 2|Other Reason|0|||
105703820|NCT00708123|364578543|FG003|Period 2|Other Reason|0|||
105703821|NCT00708123|364578544|FG004|Period 2|Other Reason|0|||
105703822|NCT00708123|364578540|FG000|Period 3|Lost to Follow-up|0|||
105703823|NCT00708123|364578541|FG001|Period 3|Lost to Follow-up|0|||
105703824|NCT00708123|364578542|FG002|Period 3|Lost to Follow-up|1|||
105703825|NCT00708123|364578543|FG003|Period 3|Lost to Follow-up|1|||
105703826|NCT00708123|364578544|FG004|Period 3|Lost to Follow-up|0|||
105703827|NCT00708123|364578540|FG000|Period 4|Protocol Violation|0|||
105703828|NCT00708123|364578541|FG001|Period 4|Protocol Violation|1|||
105703829|NCT00708123|364578542|FG002|Period 4|Protocol Violation|0|||
105703830|NCT00708123|364578543|FG003|Period 4|Protocol Violation|0|||
105703831|NCT00708123|364578544|FG004|Period 4|Protocol Violation|0|||
105703832|NCT00531752|364578545|FG000|First Double-blind Intervention Period|Adverse Event|2|||
105703833|NCT00531752|364578546|FG001|First Double-blind Intervention Period|Adverse Event|0|||
105703834|NCT00531752|364578547|FG002|First Double-blind Intervention Period|Adverse Event|1|||
105703835|NCT00531752|364578548|FG003|First Double-blind Intervention Period|Adverse Event|1|||
105703836|NCT00531752|364578545|FG000|First Double-blind Intervention Period|Other|1|||
105703837|NCT00531752|364578546|FG001|First Double-blind Intervention Period|Other|4|||
105703838|NCT00531752|364578547|FG002|First Double-blind Intervention Period|Other|4|||
105703839|NCT00531752|364578548|FG003|First Double-blind Intervention Period|Other|0|||
105703840|NCT00531752|364578545|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
105703841|NCT00531752|364578546|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
105703842|NCT00531752|364578547|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
105703843|NCT00531752|364578548|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
105703844|NCT00531752|364578545|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
105703845|NCT00531752|364578546|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
105703846|NCT00531752|364578547|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
105703847|NCT00531752|364578548|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
105703848|NCT00531752|364578545|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
105703849|NCT00531752|364578546|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
105703850|NCT00531752|364578547|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
105703851|NCT00531752|364578548|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
105703852|NCT00531752|364578545|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
105703853|NCT00531752|364578546|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
105703854|NCT00531752|364578547|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
105703855|NCT00531752|364578548|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
105703856|NCT00531752|364578545|FG000|Second Double-blind Intervention Period|Other|1|||
105703857|NCT00531752|364578546|FG001|Second Double-blind Intervention Period|Other|1|||
105703858|NCT00531752|364578547|FG002|Second Double-blind Intervention Period|Other|0|||
105703859|NCT00531752|364578548|FG003|Second Double-blind Intervention Period|Other|0|||
105703860|NCT00531752|364578545|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
105703861|NCT00531752|364578546|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
105703862|NCT00531752|364578547|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
105703863|NCT00531752|364578548|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
105703864|NCT00531752|364578545|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
105474604|NCT04002908|363748647|FG003|Overall Study|Lost to Follow-up|0|||
105474605|NCT04002908|363748644|FG000|Overall Study|Infant died, so mother withdrawn|34|||
105703865|NCT00531752|364578546|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
105703866|NCT00531752|364578547|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
105703867|NCT00531752|364578548|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
105703868|NCT03099187|364578551|FG000|Double-blind Treatment|Adverse Event|19|||
105703869|NCT03099187|364578552|FG001|Double-blind Treatment|Adverse Event|1|||
105703870|NCT03099187|364578553|FG002|Double-blind Treatment|Adverse Event|0|||
105703871|NCT03099187|364578554|FG003|Double-blind Treatment|Adverse Event|0|||
105703872|NCT03099187|364578551|FG000|Double-blind Treatment|Death|1|||
105474606|NCT04002908|363748645|FG001|Overall Study|Infant died, so mother withdrawn|0|||
105703873|NCT03099187|364578552|FG001|Double-blind Treatment|Death|3|||
105703874|NCT03099187|364578553|FG002|Double-blind Treatment|Death|0|||
105703875|NCT03099187|364578554|FG003|Double-blind Treatment|Death|0|||
105703876|NCT03099187|364578551|FG000|Double-blind Treatment|Lack of Efficacy|1|||
105703877|NCT03099187|364578552|FG001|Double-blind Treatment|Lack of Efficacy|0|||
105703878|NCT03099187|364578553|FG002|Double-blind Treatment|Lack of Efficacy|0|||
105703879|NCT03099187|364578554|FG003|Double-blind Treatment|Lack of Efficacy|0|||
105703880|NCT03099187|364578551|FG000|Double-blind Treatment|Physician Decision|2|||
105703881|NCT03099187|364578552|FG001|Double-blind Treatment|Physician Decision|1|||
105703882|NCT03099187|364578553|FG002|Double-blind Treatment|Physician Decision|0|||
105703883|NCT03099187|364578554|FG003|Double-blind Treatment|Physician Decision|0|||
105703884|NCT03099187|364578551|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
105703885|NCT03099187|364578552|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
105703886|NCT03099187|364578553|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
105703887|NCT03099187|364578554|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
105703888|NCT03099187|364578551|FG000|Double-blind Treatment|Lung transplantation|0|||
105350270|NCT00433017|363286142|FG001|Overall Study|Withdrawal by Subject|5|||
105350271|NCT00433017|363286141|FG000|Overall Study|Lost to Follow-up|3|||
105703889|NCT03099187|364578552|FG001|Double-blind Treatment|Lung transplantation|1|||
105703890|NCT03099187|364578553|FG002|Double-blind Treatment|Lung transplantation|0|||
105703891|NCT03099187|364578554|FG003|Double-blind Treatment|Lung transplantation|0|||
105703892|NCT03099187|364578551|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
105703893|NCT03099187|364578552|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
105703894|NCT03099187|364578553|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
105703895|NCT03099187|364578554|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
105703896|NCT03099187|364578551|FG000|Double-blind Treatment|Disease progression|0|||
105703897|NCT03099187|364578552|FG001|Double-blind Treatment|Disease progression|1|||
105703898|NCT03099187|364578553|FG002|Double-blind Treatment|Disease progression|0|||
105703899|NCT03099187|364578554|FG003|Double-blind Treatment|Disease progression|0|||
105703900|NCT03099187|364578551|FG000|Double-blind Treatment|Randomization error|0|||
105703901|NCT03099187|364578552|FG001|Double-blind Treatment|Randomization error|2|||
105703902|NCT03099187|364578553|FG002|Double-blind Treatment|Randomization error|0|||
105703903|NCT03099187|364578554|FG003|Double-blind Treatment|Randomization error|0|||
105703904|NCT03099187|364578551|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
105703905|NCT03099187|364578552|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
105703906|NCT03099187|364578553|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
105703907|NCT03099187|364578554|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
105703908|NCT03099187|364578551|FG000|12-month Safety Follow-up|Adverse Event|0|||
105703909|NCT03099187|364578552|FG001|12-month Safety Follow-up|Adverse Event|0|||
105703910|NCT03099187|364578553|FG002|12-month Safety Follow-up|Adverse Event|5|||
105703911|NCT03099187|364578554|FG003|12-month Safety Follow-up|Adverse Event|12|||
105703912|NCT03099187|364578551|FG000|12-month Safety Follow-up|Death|0|||
105703913|NCT03099187|364578552|FG001|12-month Safety Follow-up|Death|0|||
105703914|NCT03099187|364578553|FG002|12-month Safety Follow-up|Death|7|||
105703915|NCT03099187|364578554|FG003|12-month Safety Follow-up|Death|9|||
105703916|NCT03099187|364578551|FG000|12-month Safety Follow-up|Lung transplantation|0|||
105703917|NCT03099187|364578552|FG001|12-month Safety Follow-up|Lung transplantation|0|||
105703918|NCT03099187|364578553|FG002|12-month Safety Follow-up|Lung transplantation|2|||
105703919|NCT03099187|364578554|FG003|12-month Safety Follow-up|Lung transplantation|1|||
105703920|NCT03099187|364578551|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
105703921|NCT03099187|364578552|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
105703922|NCT03099187|364578553|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
105703923|NCT03099187|364578554|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
105703924|NCT03099187|364578551|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
105703925|NCT03099187|364578552|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
105703926|NCT03099187|364578553|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
105703927|NCT03099187|364578554|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
105703928|NCT03099187|364578551|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
105703929|NCT03099187|364578552|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
105703930|NCT03099187|364578553|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
105703931|NCT03099187|364578554|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
105703932|NCT03099187|364578551|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
105703933|NCT03099187|364578552|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
105703934|NCT03099187|364578553|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
105703935|NCT03099187|364578554|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
105703936|NCT01100437|364578555|FG000|Titration/Stabilization|Adverse Event|0|||
105703937|NCT01100437|364578556|FG001|Titration/Stabilization|Adverse Event|0|||
105703938|NCT01100437|364578557|FG002|Titration/Stabilization|Adverse Event|4|||
105703939|NCT01100437|364578555|FG000|Titration/Stabilization|Non-compliance|0|||
105703940|NCT01100437|364578556|FG001|Titration/Stabilization|Non-compliance|0|||
105703941|NCT01100437|364578557|FG002|Titration/Stabilization|Non-compliance|1|||
105703942|NCT01100437|364578555|FG000|Titration/Stabilization|Sponsor canceled study|0|||
105703943|NCT01100437|364578556|FG001|Titration/Stabilization|Sponsor canceled study|0|||
105703944|NCT01100437|364578557|FG002|Titration/Stabilization|Sponsor canceled study|1|||
105703945|NCT01100437|364578555|FG000|Maintenance|Withdrawal by Subject|0|||
105703946|NCT01100437|364578556|FG001|Maintenance|Withdrawal by Subject|0|||
105703947|NCT01100437|364578557|FG002|Maintenance|Withdrawal by Subject|1|||
105350272|NCT00433017|363286142|FG001|Overall Study|Lost to Follow-up|4|||
105350273|NCT00433017|363286141|FG000|Overall Study|Administrative problems|80|||
105350274|NCT00433017|363286142|FG001|Overall Study|Administrative problems|86|||
105703948|NCT01100437|364578555|FG000|Maintenance|Sponsor termination of study|0|||
105703949|NCT01100437|364578556|FG001|Maintenance|Sponsor termination of study|0|||
105703950|NCT01100437|364578557|FG002|Maintenance|Sponsor termination of study|1|||
105703951|NCT00894556|364578563|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
105703952|NCT00894556|364578564|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
105703953|NCT00894556|364578565|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
105350275|NCT00433017|363286141|FG000|Overall Study|Protocol Violation|1|||
105703954|NCT00894556|364578566|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
105474607|NCT04002908|363748646|FG002|Overall Study|Infant died, so mother withdrawn|0|||
105474608|NCT04002908|363748647|FG003|Overall Study|Infant died, so mother withdrawn|0|||
105474609|NCT01865552|363751141|FG000|Period 1|Adverse Event|1|||
105703955|NCT00894556|364578563|FG000|Treatment Phase|Lost to Follow-up|2|||
105703956|NCT00894556|364578564|FG001|Treatment Phase|Lost to Follow-up|3|||
105703957|NCT00894556|364578565|FG002|Treatment Phase|Lost to Follow-up|1|||
105703958|NCT00894556|364578566|FG003|Treatment Phase|Lost to Follow-up|0|||
105703959|NCT00894556|364578563|FG000|Treatment Phase|Lack of Qualifying Event|2|||
105703960|NCT00894556|364578564|FG001|Treatment Phase|Lack of Qualifying Event|1|||
105703961|NCT00894556|364578565|FG002|Treatment Phase|Lack of Qualifying Event|0|||
105703962|NCT00894556|364578566|FG003|Treatment Phase|Lack of Qualifying Event|0|||
105703963|NCT01430455|364578569|FG000|Overall Study|Withdrawal by Subject|1|||
105703964|NCT01430455|364578569|FG000|Overall Study|Switched to follow-up phase|1|||
105703965|NCT01617460|364580148|FG000|Overall Study|Adverse Event|10|||
105703966|NCT01617460|364580148|FG000|Overall Study|Physician Decision|16|||
105703967|NCT01617460|364580148|FG000|Overall Study|Protocol Violation|5|||
105703968|NCT01617460|364580148|FG000|Overall Study|Withdrawal by Subject|9|||
105703969|NCT02634151|364580149|FG000|Overall Study|Withdrawal by Subject|1|||
105703970|NCT02634151|364580150|FG001|Overall Study|Withdrawal by Subject|0|||
105703971|NCT02634151|364580149|FG000|Overall Study|Non-Compliance|0|||
105703972|NCT02634151|364580150|FG001|Overall Study|Non-Compliance|1|||
105703973|NCT02634151|364580149|FG000|Overall Study|Other|0|||
105703974|NCT02634151|364580150|FG001|Overall Study|Other|1|||
105703975|NCT01146873|364580157|FG000|Overall Study|Transfer out|0|||
105703976|NCT01146873|364580158|FG001|Overall Study|Transfer out|6|||
105703977|NCT01379274|364580159|FG000|Overall Study|funding withdrawn|1|||
105703978|NCT01560780|364580160|FG000|Overall Study|Death|2|||
105703979|NCT01560780|364580161|FG001|Overall Study|Death|1|||
105703980|NCT01560780|364580160|FG000|Overall Study|Patient Preference|11|||
105703981|NCT01560780|364580161|FG001|Overall Study|Patient Preference|11|||
105703982|NCT01032915|364580162|FG000|Overall Study|Adverse Event|2|||
105703983|NCT01032915|364580163|FG001|Overall Study|Adverse Event|2|||
105703984|NCT01032915|364580164|FG002|Overall Study|Adverse Event|1|||
105703985|NCT01032915|364580165|FG003|Overall Study|Adverse Event|1|||
105703986|NCT01032915|364580162|FG000|Overall Study|Abnormal test procedure result|0|||
105703987|NCT01032915|364580163|FG001|Overall Study|Abnormal test procedure result|0|||
105703988|NCT01032915|364580164|FG002|Overall Study|Abnormal test procedure result|1|||
105703989|NCT01032915|364580165|FG003|Overall Study|Abnormal test procedure result|0|||
105703990|NCT01032915|364580162|FG000|Overall Study|Withdrawal by Subject|0|||
105703991|NCT01032915|364580163|FG001|Overall Study|Withdrawal by Subject|3|||
105703992|NCT01032915|364580164|FG002|Overall Study|Withdrawal by Subject|1|||
105703993|NCT01032915|364580165|FG003|Overall Study|Withdrawal by Subject|1|||
105703994|NCT01032915|364580162|FG000|Overall Study|Administrative reasons|5|||
105703995|NCT01032915|364580163|FG001|Overall Study|Administrative reasons|6|||
105703996|NCT01032915|364580164|FG002|Overall Study|Administrative reasons|4|||
105703997|NCT01032915|364580165|FG003|Overall Study|Administrative reasons|4|||
105703998|NCT01032915|364580162|FG000|Overall Study|Protocol Violation|1|||
105703999|NCT01032915|364580163|FG001|Overall Study|Protocol Violation|0|||
105704000|NCT01032915|364580164|FG002|Overall Study|Protocol Violation|0|||
105704001|NCT01032915|364580165|FG003|Overall Study|Protocol Violation|1|||
105704002|NCT02915523|364580166|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
105704003|NCT02915523|364580167|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
105704004|NCT02915523|364580168|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
105704005|NCT02915523|364580169|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
105704006|NCT02915523|364580166|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
105704007|NCT02915523|364580167|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
105704008|NCT02915523|364580168|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
105704009|NCT02915523|364580169|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
105704010|NCT02915523|364580166|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
105704011|NCT02915523|364580167|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
105704012|NCT02915523|364580168|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
105704013|NCT02915523|364580169|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
105704014|NCT02915523|364580166|FG000|Expansion Phase (Phase 2)|Death|0|||
105704015|NCT02915523|364580167|FG001|Expansion Phase (Phase 2)|Death|0|||
105704016|NCT02915523|364580168|FG002|Expansion Phase (Phase 2)|Death|26|||
105704017|NCT02915523|364580169|FG003|Expansion Phase (Phase 2)|Death|53|||
105474610|NCT01865552|363751142|FG001|Period 1|Adverse Event|0|||
105704018|NCT02915523|364580166|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
105704019|NCT02915523|364580167|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
105704020|NCT02915523|364580168|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
105704021|NCT02915523|364580169|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
105704022|NCT02915523|364580166|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
105474611|NCT01865552|363751143|FG002|Period 1|Adverse Event|0|||
105704023|NCT02915523|364580167|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
105704024|NCT02915523|364580168|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
105704025|NCT02915523|364580169|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
105704026|NCT02915523|364580166|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
105704027|NCT02915523|364580167|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
105704028|NCT02915523|364580168|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
105704029|NCT02915523|364580169|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
105704030|NCT03548935|364580170|FG000|Overall Study|Withdrawal by Subject|26|||
105704031|NCT03548935|364580171|FG001|Overall Study|Withdrawal by Subject|17|||
105704032|NCT03548935|364580170|FG000|Overall Study|Lost to Follow-up|39|||
105704033|NCT03548935|364580171|FG001|Overall Study|Lost to Follow-up|28|||
105704034|NCT03548935|364580170|FG000|Overall Study|Death|1|||
105704035|NCT03548935|364580171|FG001|Overall Study|Death|1|||
105704036|NCT01074190|364580173|FG000|Overall Study|Emergency Cesarean Delivery|1|||
105704037|NCT01074190|364580174|FG001|Overall Study|Emergency Cesarean Delivery|2|||
105704038|NCT01074190|364580175|FG002|Overall Study|Emergency Cesarean Delivery|1|||
105704039|NCT01074190|364580173|FG000|Overall Study|Protocol Violation|2|||
105704040|NCT01074190|364580174|FG001|Overall Study|Protocol Violation|1|||
105704041|NCT01074190|364580175|FG002|Overall Study|Protocol Violation|0|||
105704042|NCT01074190|364580173|FG000|Overall Study|Delivered in under 90 minutes|0|||
105704043|NCT01074190|364580174|FG001|Overall Study|Delivered in under 90 minutes|2|||
105704044|NCT01074190|364580175|FG002|Overall Study|Delivered in under 90 minutes|1|||
105704045|NCT01074190|364580173|FG000|Overall Study|Subject withdrew consent|1|||
105704046|NCT01074190|364580174|FG001|Overall Study|Subject withdrew consent|1|||
105704047|NCT01074190|364580175|FG002|Overall Study|Subject withdrew consent|1|||
105704048|NCT01399788|364580178|FG000|First Intervention Period|Adverse Event|1|||
105704049|NCT01399788|364580179|FG001|First Intervention Period|Adverse Event|0|||
105704050|NCT01709435|364580183|FG000|Overall Study|Adverse Event|1|||
105704051|NCT01709435|364580184|FG001|Overall Study|Adverse Event|1|||
105704052|NCT01709435|364580185|FG002|Overall Study|Adverse Event|1|||
105704053|NCT01709435|364580186|FG003|Overall Study|Adverse Event|0|||
105704054|NCT01709435|364580187|FG004|Overall Study|Adverse Event|0|||
105704055|NCT01709435|364580188|FG005|Overall Study|Adverse Event|1|||
105704056|NCT01709435|364580183|FG000|Overall Study|Lack of Efficacy|5|||
105704057|NCT01709435|364580184|FG001|Overall Study|Lack of Efficacy|7|||
105704058|NCT01709435|364580185|FG002|Overall Study|Lack of Efficacy|2|||
105704059|NCT01709435|364580186|FG003|Overall Study|Lack of Efficacy|2|||
105704060|NCT01709435|364580187|FG004|Overall Study|Lack of Efficacy|6|||
105704061|NCT01709435|364580188|FG005|Overall Study|Lack of Efficacy|3|||
105704062|NCT01709435|364580183|FG000|Overall Study|Physician Decision|0|||
105704063|NCT01709435|364580184|FG001|Overall Study|Physician Decision|1|||
105704064|NCT01709435|364580185|FG002|Overall Study|Physician Decision|0|||
105704065|NCT01709435|364580186|FG003|Overall Study|Physician Decision|1|||
105704066|NCT01709435|364580187|FG004|Overall Study|Physician Decision|2|||
105704067|NCT01709435|364580188|FG005|Overall Study|Physician Decision|0|||
105704068|NCT01709435|364580183|FG000|Overall Study|Withdrawal by Subject|0|||
105704069|NCT01709435|364580184|FG001|Overall Study|Withdrawal by Subject|0|||
105704070|NCT01709435|364580185|FG002|Overall Study|Withdrawal by Subject|3|||
105704071|NCT01709435|364580186|FG003|Overall Study|Withdrawal by Subject|0|||
105704072|NCT01709435|364580187|FG004|Overall Study|Withdrawal by Subject|2|||
105704073|NCT01709435|364580188|FG005|Overall Study|Withdrawal by Subject|2|||
105704074|NCT01780662|364580189|FG000|Overall Study|Adverse Event|1|||
105704075|NCT01780662|364580190|FG001|Overall Study|Adverse Event|0|||
105704076|NCT01780662|364580191|FG002|Overall Study|Adverse Event|2|||
105704077|NCT01780662|364580189|FG000|Overall Study|Physician Decision|0|||
105704078|NCT01780662|364580190|FG001|Overall Study|Physician Decision|5|||
105704079|NCT01780662|364580191|FG002|Overall Study|Physician Decision|7|||
105704080|NCT01780662|364580189|FG000|Overall Study|Protocol Violation|0|||
105704081|NCT01780662|364580190|FG001|Overall Study|Protocol Violation|1|||
105704082|NCT01780662|364580191|FG002|Overall Study|Protocol Violation|0|||
105704083|NCT01780662|364580189|FG000|Overall Study|Ineligible|0|||
105704084|NCT01780662|364580190|FG001|Overall Study|Ineligible|0|||
105704085|NCT01780662|364580191|FG002|Overall Study|Ineligible|1|||
105704086|NCT01604265|364580192|FG000|Overall Study|Adverse Event|1|||
105704087|NCT01604265|364580193|FG001|Overall Study|Adverse Event|0|||
105704088|NCT01604265|364580192|FG000|Overall Study|Withdrawal by Subject|1|||
105704089|NCT01604265|364580193|FG001|Overall Study|Withdrawal by Subject|0|||
105704090|NCT00708500|364580194|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
105704091|NCT00708500|364580195|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
105704092|NCT00708500|364580196|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
105704093|NCT00708500|364580194|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
105704094|NCT00708500|364580195|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
105704095|NCT00708500|364580196|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
105704096|NCT00708500|364580194|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
105704097|NCT00708500|364580195|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
105704098|NCT00708500|364580196|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
105704099|NCT00708500|364580194|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
105704100|NCT00708500|364580195|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
105704101|NCT00708500|364580196|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
105704102|NCT00708500|364580194|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
105704103|NCT00708500|364580195|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
105704104|NCT00708500|364580196|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
105704105|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
105704106|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
105704107|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
105704108|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
105704109|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
105704110|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
105704111|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
105704112|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
105704113|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
105704114|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
105704115|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
105704116|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
105704117|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
105704118|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
105704119|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
105704120|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
105704121|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
105704122|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
105704123|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
105704124|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
105704125|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
105704126|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
105704127|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
105704128|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
105704129|NCT00708500|364580194|FG000|FOLLOWUP|Adverse Event|0|||
105704130|NCT00708500|364580195|FG001|FOLLOWUP|Adverse Event|1|||
105704131|NCT00708500|364580196|FG002|FOLLOWUP|Adverse Event|0|||
105704132|NCT00708500|364580194|FG000|FOLLOWUP|Lost to Follow-up|1|||
105704133|NCT00708500|364580195|FG001|FOLLOWUP|Lost to Follow-up|6|||
105704134|NCT00708500|364580196|FG002|FOLLOWUP|Lost to Follow-up|4|||
105704135|NCT00708500|364580194|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
105704136|NCT00708500|364580195|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
105704137|NCT00708500|364580196|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
105704138|NCT00708500|364580194|FG000|FOLLOWUP|Subject withdrew consent|31|||
105704139|NCT00708500|364580195|FG001|FOLLOWUP|Subject withdrew consent|4|||
105704140|NCT00708500|364580196|FG002|FOLLOWUP|Subject withdrew consent|5|||
105704141|NCT00708500|364580194|FG000|FOLLOWUP|Non-compliance with protocol|5|||
105704142|NCT00708500|364580195|FG001|FOLLOWUP|Non-compliance with protocol|0|||
105704143|NCT00708500|364580196|FG002|FOLLOWUP|Non-compliance with protocol|1|||
105704144|NCT00705783|364580201|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
105704145|NCT00705783|364580202|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
105704146|NCT00705783|364580203|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
105704147|NCT00705783|364580201|FG000|Conversion Phase|Lost to Follow-up|13|||
105704148|NCT00705783|364580202|FG001|Conversion Phase|Lost to Follow-up|0|||
105704149|NCT00705783|364580203|FG002|Conversion Phase|Lost to Follow-up|0|||
105704150|NCT00705783|364580201|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
105704151|NCT00705783|364580202|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
105560389|NCT04866017|364046646|FG002|Overall Study|Physician Decision|0|||
105704152|NCT00705783|364580203|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
105704153|NCT00705783|364580201|FG000|Conversion Phase|Withdrawn by Investigator|4|||
105704154|NCT00705783|364580202|FG001|Conversion Phase|Withdrawn by Investigator|0|||
105704155|NCT00705783|364580203|FG002|Conversion Phase|Withdrawn by Investigator|0|||
105704156|NCT00705783|364580201|FG000|Conversion Phase|Withdrew Consent|24|||
105704157|NCT00705783|364580202|FG001|Conversion Phase|Withdrew Consent|0|||
105704158|NCT00705783|364580203|FG002|Conversion Phase|Withdrew Consent|0|||
105560390|NCT01475136|364046647|FG000|Overall Study|Sponsor Decision|0|||
105704159|NCT00705783|364580201|FG000|Conversion Phase|Protocol Deviation|2|||
105704160|NCT00705783|364580202|FG001|Conversion Phase|Protocol Deviation|0|||
105704161|NCT00705783|364580203|FG002|Conversion Phase|Protocol Deviation|0|||
105704162|NCT00705783|364580201|FG000|Conversion Phase|Adverse Event|11|||
105704163|NCT00705783|364580202|FG001|Conversion Phase|Adverse Event|0|||
105704164|NCT00705783|364580203|FG002|Conversion Phase|Adverse Event|0|||
105704165|NCT00705783|364580201|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
105704166|NCT00705783|364580202|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
105704167|NCT00705783|364580203|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
105704168|NCT00705783|364580201|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
105704169|NCT00705783|364580202|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
105704170|NCT00705783|364580203|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
105704171|NCT00705783|364580201|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
105704172|NCT00705783|364580202|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
105704173|NCT00705783|364580203|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
105704174|NCT00705783|364580201|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
105704175|NCT00705783|364580202|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
105704176|NCT00705783|364580203|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
105704177|NCT00705783|364580201|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
105704178|NCT00705783|364580202|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
105704179|NCT00705783|364580203|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
105704180|NCT00705783|364580201|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
105704181|NCT00705783|364580202|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
105704182|NCT00705783|364580203|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
105704183|NCT00705783|364580201|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
105704184|NCT00705783|364580202|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
105704185|NCT00705783|364580203|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
105704186|NCT00705783|364580201|FG000|Oral Stabilization Phase|Adverse Event|14|||
105704187|NCT00705783|364580202|FG001|Oral Stabilization Phase|Adverse Event|0|||
105704188|NCT00705783|364580203|FG002|Oral Stabilization Phase|Adverse Event|0|||
105704189|NCT00705783|364580201|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
105704190|NCT00705783|364580202|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
105704191|NCT00705783|364580203|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
105704192|NCT00705783|364580201|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
105704193|NCT00705783|364580202|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
105704194|NCT00705783|364580203|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
105704195|NCT00705783|364580201|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
105704196|NCT00705783|364580202|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
105704197|NCT00705783|364580203|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
105704198|NCT00705783|364580201|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
105704199|NCT00705783|364580202|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
105704200|NCT00705783|364580203|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
105704201|NCT00705783|364580201|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
105704202|NCT00705783|364580202|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
105704203|NCT00705783|364580203|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
105704204|NCT00705783|364580201|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
105704205|NCT00705783|364580202|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
105704206|NCT00705783|364580203|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
105704207|NCT00705783|364580201|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
105704208|NCT00705783|364580202|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
105704209|NCT00705783|364580203|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
105704210|NCT00705783|364580201|FG000|Depot Stabilization Phase|Adverse Event|17|||
105704211|NCT00705783|364580202|FG001|Depot Stabilization Phase|Adverse Event|0|||
105704212|NCT00705783|364580203|FG002|Depot Stabilization Phase|Adverse Event|0|||
105704213|NCT00705783|364580201|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
105704214|NCT00705783|364580202|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
105704215|NCT00705783|364580203|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
105704216|NCT00705783|364580201|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
105704217|NCT00705783|364580202|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
105704218|NCT00705783|364580203|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
105704219|NCT00705783|364580201|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
105704220|NCT00705783|364580202|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
105704221|NCT00705783|364580203|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
105704222|NCT00705783|364580201|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
105704223|NCT00705783|364580202|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
105704224|NCT00705783|364580203|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
105704225|NCT00705783|364580201|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
105704226|NCT00705783|364580202|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
105704227|NCT00705783|364580203|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
105704228|NCT00705783|364580201|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
105704229|NCT00705783|364580202|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
105704230|NCT00705783|364580203|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
105704231|NCT00705783|364580201|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
105704232|NCT00705783|364580202|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
105704233|NCT00705783|364580203|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
105704234|NCT00705783|364580201|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
105704235|NCT00705783|364580202|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
105704236|NCT00705783|364580203|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
105704237|NCT00705783|364580201|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
105704238|NCT00705783|364580202|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
105704239|NCT00705783|364580203|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
105704240|NCT00705783|364580201|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
105704241|NCT00705783|364580202|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
105704242|NCT00705783|364580203|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
105704243|NCT00705783|364580201|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
105704244|NCT00705783|364580202|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
105704245|NCT00705783|364580203|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
105704246|NCT01029366|364580216|FG000|Overall Study|Withdrawal by Subject|1|||
105704247|NCT01029366|364580217|FG001|Overall Study|Withdrawal by Subject|0|||
105704248|NCT01029366|364580216|FG000|Overall Study|Death|1|||
105704249|NCT01029366|364580217|FG001|Overall Study|Death|1|||
105704250|NCT01029366|364580216|FG000|Overall Study|disease progression|2|||
105704251|NCT01029366|364580217|FG001|Overall Study|disease progression|0|||
105704252|NCT01029366|364580216|FG000|Overall Study|manufacturing failure|0|||
105704253|NCT01029366|364580217|FG001|Overall Study|manufacturing failure|1|||
105704254|NCT00607386|364580223|FG000|Overall Study|Physician Decision|1|||
105704255|NCT01422915|364580229|FG000|Overall Study|Adverse Event|1|||
105704256|NCT01152021|364580231|FG000|Overall Study|Adverse Event|4|||
105704257|NCT01152021|364580232|FG001|Overall Study|Adverse Event|4|||
105704258|NCT01152021|364580231|FG000|Overall Study|Study drug had expired|1|||
105704259|NCT01152021|364580232|FG001|Overall Study|Study drug had expired|0|||
105704260|NCT01152021|364580231|FG000|Overall Study|Physician Decision|1|||
105704261|NCT01152021|364580232|FG001|Overall Study|Physician Decision|1|||
105704262|NCT01152021|364580231|FG000|Overall Study|No access to study drug in Pharmacy|0|||
105704263|NCT01152021|364580232|FG001|Overall Study|No access to study drug in Pharmacy|1|||
105704264|NCT03775421|364580234|FG000|Overall Study|Lost to Follow-up|2|||
105704265|NCT03775421|364580234|FG000|Overall Study|Withdrawal by Subject|10|||
105704266|NCT03775421|364580234|FG000|Overall Study|Physician Decision|3|||
105704267|NCT03775421|364580234|FG000|Overall Study|Death|1|||
105704268|NCT03775421|364580234|FG000|Overall Study|Study Terminated by Sponsor|94|||
105704269|NCT00623428|364580235|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
105704270|NCT00623428|364580236|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
105704271|NCT00623428|364580235|FG000|Treatment Period|Death|0|||
105704272|NCT00623428|364580236|FG001|Treatment Period|Death|1|||
105704273|NCT00623428|364580235|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
105704274|NCT00623428|364580236|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
105704275|NCT00623428|364580235|FG000|Treatment Period|Insufficient therapeutic response|0|||
105704276|NCT00623428|364580236|FG001|Treatment Period|Insufficient therapeutic response|2|||
105704277|NCT00623428|364580235|FG000|Treatment Period|Other|0|||
105704278|NCT00623428|364580236|FG001|Treatment Period|Other|1|||
105704279|NCT00623428|364580235|FG000|Treatment Period|Withdrawal by Subject|0|||
105704280|NCT00623428|364580236|FG001|Treatment Period|Withdrawal by Subject|1|||
105704281|NCT00623428|364580235|FG000|Follow-up Period|Relapse post-treatment|11|||
105704282|NCT00623428|364580236|FG001|Follow-up Period|Relapse post-treatment|3|||
105704283|NCT00623428|364580235|FG000|Follow-up Period|Failure to return|10|||
105704284|NCT00623428|364580236|FG001|Follow-up Period|Failure to return|2|||
105704285|NCT00623428|364580235|FG000|Follow-up Period|Patient withdrew consent|5|||
105704286|NCT00623428|364580236|FG001|Follow-up Period|Patient withdrew consent|4|||
105704287|NCT00623428|364580235|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
105704288|NCT00623428|364580236|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
105704289|NCT00623428|364580235|FG000|Follow-up Period|Did not cooperate|0|||
105704290|NCT00623428|364580236|FG001|Follow-up Period|Did not cooperate|3|||
105474612|NCT01865552|363751144|FG003|Period 1|Adverse Event|1|||
105704291|NCT00623428|364580235|FG000|Follow-up Period|Reason not specified|1|||
105704292|NCT00623428|364580236|FG001|Follow-up Period|Reason not specified|1|||
105704293|NCT00623428|364580235|FG000|Follow-up Period|Death|0|||
105474613|NCT01865552|363751145|FG004|Period 1|Adverse Event|1|||
105474614|NCT01865552|363751146|FG005|Period 1|Adverse Event|1|||
105704294|NCT00623428|364580236|FG001|Follow-up Period|Death|1|||
105704295|NCT00205855|364580245|FG000|Overall Study|Only received temporary implants|16|||
105704296|NCT00205855|364580245|FG000|Overall Study|Withdrawal by Subject|5|||
105704297|NCT01445951|364580247|FG000|Overall Study|Adverse Event|16|||
105704298|NCT01445951|364580248|FG001|Overall Study|Adverse Event|9|||
105704299|NCT01445951|364580249|FG002|Overall Study|Adverse Event|0|||
105704300|NCT01445951|364580247|FG000|Overall Study|Protocol Violation|2|||
105704301|NCT01445951|364580248|FG001|Overall Study|Protocol Violation|2|||
105704302|NCT01445951|364580249|FG002|Overall Study|Protocol Violation|2|||
105704303|NCT01445951|364580247|FG000|Overall Study|Withdrawal by Subject|21|||
105704304|NCT01445951|364580248|FG001|Overall Study|Withdrawal by Subject|16|||
105704305|NCT01445951|364580249|FG002|Overall Study|Withdrawal by Subject|8|||
105704306|NCT01445951|364580247|FG000|Overall Study|Physician Decision|3|||
105704307|NCT01445951|364580248|FG001|Overall Study|Physician Decision|1|||
105704308|NCT01445951|364580249|FG002|Overall Study|Physician Decision|0|||
105704309|NCT01445951|364580247|FG000|Overall Study|Lost to Follow-up|1|||
105704310|NCT01445951|364580248|FG001|Overall Study|Lost to Follow-up|2|||
105704311|NCT01445951|364580249|FG002|Overall Study|Lost to Follow-up|4|||
105704312|NCT01445951|364580247|FG000|Overall Study|Pregnancy|0|||
105704313|NCT01445951|364580248|FG001|Overall Study|Pregnancy|1|||
105704314|NCT01445951|364580249|FG002|Overall Study|Pregnancy|4|||
105704315|NCT01445951|364580247|FG000|Overall Study|Death|0|||
105704316|NCT01445951|364580248|FG001|Overall Study|Death|0|||
105704317|NCT01445951|364580249|FG002|Overall Study|Death|1|||
105704318|NCT01445951|364580247|FG000|Overall Study|Non-compliance with study drug|1|||
105704319|NCT01445951|364580248|FG001|Overall Study|Non-compliance with study drug|2|||
105704320|NCT01445951|364580249|FG002|Overall Study|Non-compliance with study drug|0|||
105704321|NCT01445951|364580247|FG000|Overall Study|Non-compliance with protocol|0|||
105704322|NCT01445951|364580248|FG001|Overall Study|Non-compliance with protocol|1|||
105704323|NCT01445951|364580249|FG002|Overall Study|Non-compliance with protocol|0|||
105704324|NCT01445951|364580247|FG000|Overall Study|Sponsor decision - subject travel|0|||
105704325|NCT01445951|364580248|FG001|Overall Study|Sponsor decision - subject travel|1|||
105704326|NCT01445951|364580249|FG002|Overall Study|Sponsor decision - subject travel|0|||
105704327|NCT01445951|364580247|FG000|Overall Study|Cough|0|||
105704328|NCT01445951|364580248|FG001|Overall Study|Cough|1|||
105704329|NCT01445951|364580249|FG002|Overall Study|Cough|0|||
105704330|NCT02943564|364580250|FG000|Overall Study|Miscellaneous Reasons|0|||
105704331|NCT02943564|364580251|FG001|Overall Study|Miscellaneous Reasons|0|||
105704332|NCT02943564|364580252|FG002|Overall Study|Miscellaneous Reasons|3|||
105704333|NCT02943564|364580250|FG000|Overall Study|Site terminated by sponsor|0|||
105704334|NCT02943564|364580251|FG001|Overall Study|Site terminated by sponsor|1|||
105704335|NCT02943564|364580252|FG002|Overall Study|Site terminated by sponsor|0|||
105704336|NCT02943564|364580250|FG000|Overall Study|Non-compliance with study drug|0|||
105704337|NCT02943564|364580251|FG001|Overall Study|Non-compliance with study drug|1|||
105704338|NCT02943564|364580252|FG002|Overall Study|Non-compliance with study drug|0|||
105704339|NCT02943564|364580250|FG000|Overall Study|Pregnancy|0|||
105704340|NCT02943564|364580251|FG001|Overall Study|Pregnancy|1|||
105704341|NCT02943564|364580252|FG002|Overall Study|Pregnancy|1|||
105704342|NCT02943564|364580250|FG000|Overall Study|Protocol Violation|2|||
105704343|NCT02943564|364580251|FG001|Overall Study|Protocol Violation|2|||
105704344|NCT02943564|364580252|FG002|Overall Study|Protocol Violation|2|||
105704345|NCT02943564|364580250|FG000|Overall Study|Lost to Follow-up|1|||
105704346|NCT02943564|364580251|FG001|Overall Study|Lost to Follow-up|0|||
105704347|NCT02943564|364580252|FG002|Overall Study|Lost to Follow-up|0|||
105704348|NCT02943564|364580250|FG000|Overall Study|Withdrawal by Subject|6|||
105704349|NCT02943564|364580251|FG001|Overall Study|Withdrawal by Subject|5|||
105704350|NCT02943564|364580252|FG002|Overall Study|Withdrawal by Subject|2|||
105704351|NCT02943564|364580250|FG000|Overall Study|Adverse Event|1|||
105704352|NCT02943564|364580251|FG001|Overall Study|Adverse Event|2|||
105704353|NCT02943564|364580252|FG002|Overall Study|Adverse Event|1|||
105704354|NCT02943564|364580250|FG000|Overall Study|Lack of Efficacy|0|||
105704355|NCT02943564|364580251|FG001|Overall Study|Lack of Efficacy|1|||
105704356|NCT02943564|364580252|FG002|Overall Study|Lack of Efficacy|0|||
105704357|NCT03028870|364580253|FG000|Overall Study|Adverse Event|7|||
105704358|NCT03028870|364580254|FG001|Overall Study|Adverse Event|4|||
105704359|NCT03028870|364580255|FG002|Overall Study|Adverse Event|3|||
105704360|NCT03028870|364580256|FG003|Overall Study|Adverse Event|3|||
105704361|NCT03028870|364580253|FG000|Overall Study|Withdrawal by Subject|1|||
105704362|NCT03028870|364580254|FG001|Overall Study|Withdrawal by Subject|1|||
105704363|NCT03028870|364580255|FG002|Overall Study|Withdrawal by Subject|1|||
105704364|NCT03028870|364580256|FG003|Overall Study|Withdrawal by Subject|2|||
105704365|NCT03028870|364580253|FG000|Overall Study|Lost to Follow-up|1|||
105704366|NCT03028870|364580254|FG001|Overall Study|Lost to Follow-up|0|||
105704367|NCT03028870|364580255|FG002|Overall Study|Lost to Follow-up|0|||
105704368|NCT03028870|364580256|FG003|Overall Study|Lost to Follow-up|0|||
105704369|NCT03028870|364580253|FG000|Overall Study|Lack of Efficacy|3|||
105704370|NCT03028870|364580254|FG001|Overall Study|Lack of Efficacy|0|||
105704371|NCT03028870|364580255|FG002|Overall Study|Lack of Efficacy|0|||
105704372|NCT03028870|364580256|FG003|Overall Study|Lack of Efficacy|0|||
105704373|NCT03028870|364580253|FG000|Overall Study|Administrative|5|||
105704374|NCT03028870|364580254|FG001|Overall Study|Administrative|5|||
105704375|NCT03028870|364580255|FG002|Overall Study|Administrative|12|||
105704376|NCT03028870|364580256|FG003|Overall Study|Administrative|4|||
105704377|NCT00490451|364580259|FG000|Overall Study|Adverse Event|3|||
105474615|NCT01865552|363751141|FG000|Period 1|Pathological lab|0|||
105474616|NCT01865552|363751142|FG001|Period 1|Pathological lab|0|||
105704378|NCT00490451|364580260|FG001|Overall Study|Adverse Event|3|||
105704379|NCT00490451|364580259|FG000|Overall Study|Death|3|||
105704380|NCT00490451|364580260|FG001|Overall Study|Death|1|||
105704381|NCT00490451|364580259|FG000|Overall Study|Withdrawal by Subject|2|||
105704382|NCT00490451|364580260|FG001|Overall Study|Withdrawal by Subject|0|||
105704383|NCT00490451|364580259|FG000|Overall Study|Investigator Decision|1|||
105704384|NCT00490451|364580260|FG001|Overall Study|Investigator Decision|0|||
105704385|NCT00490451|364580259|FG000|Overall Study|Protocol Violation|1|||
105704386|NCT00490451|364580260|FG001|Overall Study|Protocol Violation|0|||
105704387|NCT00490451|364580259|FG000|Overall Study|Progressive Disease|53|||
105704388|NCT00490451|364580260|FG001|Overall Study|Progressive Disease|34|||
105704389|NCT04486950|364580261|FG000|Overall Study|Lost to Follow-up|0|||
105704390|NCT04486950|364580262|FG001|Overall Study|Lost to Follow-up|0|||
105704391|NCT04486950|364580263|FG002|Overall Study|Lost to Follow-up|0|||
105704392|NCT04486950|364580264|FG003|Overall Study|Lost to Follow-up|0|||
105704393|NCT04486950|364580265|FG004|Overall Study|Lost to Follow-up|0|||
105704394|NCT04486950|364580266|FG005|Overall Study|Lost to Follow-up|1|||
105704395|NCT04486950|364580267|FG006|Overall Study|Lost to Follow-up|0|||
105704396|NCT01181011|364580268|FG000|Overall Study|Adverse Event|2|||
105704397|NCT01181011|364580268|FG000|Overall Study|Lost to Follow-up|1|||
105704398|NCT00550680|364580269|FG000|Overall Study|Administrative Reasons|1|||
105474617|NCT01865552|363751143|FG002|Period 1|Pathological lab|0|||
105474618|NCT01865552|363751144|FG003|Period 1|Pathological lab|0|||
105704399|NCT00550680|364580269|FG000|Overall Study|Adverse Event|5|||
105704400|NCT00550680|364580269|FG000|Overall Study|Death|3|||
105704401|NCT00550680|364580269|FG000|Overall Study|Early Improvement|1|||
105704402|NCT00550680|364580269|FG000|Overall Study|Lost to Follow-up|3|||
105704403|NCT00550680|364580269|FG000|Overall Study|Lack of Efficacy|1|||
105704404|NCT00550680|364580269|FG000|Overall Study|Other|10|||
105704405|NCT00550680|364580269|FG000|Overall Study|Protocol Violation|7|||
105704406|NCT00550680|364580269|FG000|Overall Study|Refused Treatment|19|||
105704407|NCT00550680|364580269|FG000|Overall Study|Screen Failure|6|||
105704408|NCT00923130|364580270|FG000|Overall Study|Stopped treatment due to progression|17|||
105704409|NCT00923130|364580270|FG000|Overall Study|Death|1|||
105474619|NCT01865552|363751145|FG004|Period 1|Pathological lab|1|||
105474620|NCT01865552|363751146|FG005|Period 1|Pathological lab|0|||
105704410|NCT00923130|364580270|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
105704411|NCT00923130|364580270|FG000|Overall Study|Switched to alternative treatment|2|||
105704412|NCT00923130|364580270|FG000|Overall Study|Refused further treatment|2|||
105704413|NCT00562354|364580271|FG000|Overall Study|Physician Decision|0|||
105704414|NCT00562354|364580272|FG001|Overall Study|Physician Decision|1|||
105704415|NCT00562354|364580271|FG000|Overall Study|Lost to Follow-up|0|||
105704416|NCT00562354|364580272|FG001|Overall Study|Lost to Follow-up|1|||
105704417|NCT03693625|364580273|FG000|Overall Study|Adverse Event|2|||
105704418|NCT03693625|364580274|FG001|Overall Study|Adverse Event|0|||
105704419|NCT03693625|364580273|FG000|Overall Study|Study Terminated By Sponsor|20|||
105704420|NCT03693625|364580274|FG001|Overall Study|Study Terminated By Sponsor|7|||
105704421|NCT03693625|364580273|FG000|Overall Study|Withdrawal by Subject|1|||
105704422|NCT03693625|364580274|FG001|Overall Study|Withdrawal by Subject|1|||
105704423|NCT00250835|364580276|FG000|Overall Study|Withdrawal by Subject|1|||
105474621|NCT01865552|363751141|FG000|Period 1|Other|0|||
105704424|NCT01187953|364580277|FG000|Overall Study|Death|11|||
105704425|NCT01187953|364580278|FG001|Overall Study|Death|13|||
105704426|NCT01187953|364580277|FG000|Overall Study|Adverse Event|1|||
105704427|NCT01187953|364580278|FG001|Overall Study|Adverse Event|2|||
105704428|NCT01187953|364580277|FG000|Overall Study|Lost to Follow-up|0|||
105704429|NCT01187953|364580278|FG001|Overall Study|Lost to Follow-up|3|||
105704430|NCT01187953|364580277|FG000|Overall Study|Withdrawal by Subject|3|||
105704431|NCT01187953|364580278|FG001|Overall Study|Withdrawal by Subject|3|||
105704432|NCT03921424|364580279|FG000|Overall Study|Lost to Follow-up|0|||
105704433|NCT03921424|364580280|FG001|Overall Study|Lost to Follow-up|1|||
105704434|NCT03921424|364580279|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
105704435|NCT03921424|364580280|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
105704436|NCT01246583|364580287|FG000|Overall Study|Lost to Follow-up|0|||
105704437|NCT01246583|364580288|FG001|Overall Study|Lost to Follow-up|0|||
105474622|NCT01865552|363751142|FG001|Period 1|Other|0|||
105474623|NCT01865552|363751143|FG002|Period 1|Other|0|||
105474624|NCT01865552|363751144|FG003|Period 1|Other|0|||
105704438|NCT01246583|364580289|FG002|Overall Study|Lost to Follow-up|0|||
105704439|NCT01246583|364580290|FG003|Overall Study|Lost to Follow-up|1|||
105704440|NCT01246583|364580287|FG000|Overall Study|Protocol Violation|0|||
105704441|NCT01246583|364580288|FG001|Overall Study|Protocol Violation|0|||
105704442|NCT01246583|364580289|FG002|Overall Study|Protocol Violation|1|||
105704443|NCT01246583|364580290|FG003|Overall Study|Protocol Violation|0|||
105704444|NCT01246583|364580287|FG000|Overall Study|Withdrawal by Subject|1|||
105704445|NCT01246583|364580288|FG001|Overall Study|Withdrawal by Subject|0|||
105704446|NCT01246583|364580289|FG002|Overall Study|Withdrawal by Subject|0|||
105704447|NCT01246583|364580290|FG003|Overall Study|Withdrawal by Subject|0|||
105704448|NCT01806779|364580291|FG000|Overall Study|Physician Decision|2|||
105704449|NCT01806779|364580292|FG001|Overall Study|Physician Decision|0|||
105704450|NCT01806779|364580293|FG002|Overall Study|Physician Decision|1|||
105704451|NCT01806779|364580291|FG000|Overall Study|Lack of Efficacy|1|||
105704452|NCT01806779|364580292|FG001|Overall Study|Lack of Efficacy|1|||
105704453|NCT01806779|364580293|FG002|Overall Study|Lack of Efficacy|0|||
105704454|NCT01806779|364580291|FG000|Overall Study|Lost to Follow-up|19|||
105704455|NCT01806779|364580292|FG001|Overall Study|Lost to Follow-up|20|||
105704456|NCT01806779|364580293|FG002|Overall Study|Lost to Follow-up|0|||
105704457|NCT01806779|364580291|FG000|Overall Study|Withdrawal by Subject|20|||
105560391|NCT01475136|364046648|FG001|Overall Study|Sponsor Decision|1|||
105560392|NCT01475136|364046649|FG002|Overall Study|Sponsor Decision|0|||
105560393|NCT01475136|364046650|FG003|Overall Study|Sponsor Decision|0|||
105560394|NCT01475136|364046647|FG000|Overall Study|Entry Criteria Not Met|0|||
105560395|NCT01475136|364046648|FG001|Overall Study|Entry Criteria Not Met|2|||
105560396|NCT01475136|364046649|FG002|Overall Study|Entry Criteria Not Met|3|||
105560397|NCT01475136|364046650|FG003|Overall Study|Entry Criteria Not Met|1|||
105560398|NCT01475136|364046647|FG000|Overall Study|Withdrawal by Subject|0|||
105560399|NCT01475136|364046648|FG001|Overall Study|Withdrawal by Subject|0|||
105560400|NCT01475136|364046649|FG002|Overall Study|Withdrawal by Subject|0|||
105560401|NCT01475136|364046650|FG003|Overall Study|Withdrawal by Subject|2|||
105560402|NCT01475136|364046647|FG000|Overall Study|Adverse Event|1|||
105560403|NCT01475136|364046648|FG001|Overall Study|Adverse Event|0|||
105560404|NCT01475136|364046649|FG002|Overall Study|Adverse Event|0|||
105560405|NCT01475136|364046650|FG003|Overall Study|Adverse Event|1|||
105560406|NCT01475136|364046647|FG000|Overall Study|Death|0|||
105560407|NCT01475136|364046648|FG001|Overall Study|Death|0|||
105560408|NCT01475136|364046649|FG002|Overall Study|Death|0|||
105560409|NCT01475136|364046650|FG003|Overall Study|Death|1|||
105560410|NCT02979639|364048377|FG000|Overall Study|Withdrawal based on medical judgement|1|||
105560411|NCT02979639|364048377|FG000|Overall Study|Lost to Follow-up|8|||
105560412|NCT02979639|364048377|FG000|Overall Study|Withdrawal by Subject|3|||
105560413|NCT02979639|364048377|FG000|Overall Study|Adverse Event|2|||
105560414|NCT00175825|364048384|FG000|Overall Study|Adverse Event|3|||
105560415|NCT00175825|364048385|FG001|Overall Study|Adverse Event|2|||
105560416|NCT00175825|364048386|FG002|Overall Study|Adverse Event|1|||
105560417|NCT00175825|364048387|FG003|Overall Study|Adverse Event|1|||
105560418|NCT00175825|364048384|FG000|Overall Study|Lost to Follow-up|1|||
105560419|NCT00175825|364048385|FG001|Overall Study|Lost to Follow-up|2|||
105560420|NCT00175825|364048386|FG002|Overall Study|Lost to Follow-up|0|||
105560421|NCT00175825|364048387|FG003|Overall Study|Lost to Follow-up|0|||
105560422|NCT00175825|364048384|FG000|Overall Study|Withdrawal by Subject|1|||
105560423|NCT00175825|364048385|FG001|Overall Study|Withdrawal by Subject|0|||
105560424|NCT00175825|364048386|FG002|Overall Study|Withdrawal by Subject|0|||
105560425|NCT00175825|364048387|FG003|Overall Study|Withdrawal by Subject|0|||
105560426|NCT02030015|364048388|FG000|Overall Study|Withdrawal by Subject|3|||
105560427|NCT02030015|364048388|FG000|Overall Study|Death|13|||
105560428|NCT03014674|364048389|FG000|Overall Study|Withdrawal by Subject|1|||
105560429|NCT03014674|364048390|FG001|Overall Study|Withdrawal by Subject|0|||
105560430|NCT03014674|364048391|FG002|Overall Study|Withdrawal by Subject|0|||
105560431|NCT01332227|364048392|FG000|Overall Study|Adverse Event|4|||
105560432|NCT01332227|364048393|FG001|Overall Study|Adverse Event|1|||
105560433|NCT01332227|364048392|FG000|Overall Study|Withdrawal by Subject|5|||
105560434|NCT01332227|364048393|FG001|Overall Study|Withdrawal by Subject|1|||
105560435|NCT01332227|364048392|FG000|Overall Study|Lost to Follow-up|2|||
105560436|NCT01332227|364048393|FG001|Overall Study|Lost to Follow-up|0|||
105560437|NCT01332227|364048392|FG000|Overall Study|Lack of Efficacy|3|||
105560438|NCT01332227|364048393|FG001|Overall Study|Lack of Efficacy|1|||
105560439|NCT01332227|364048392|FG000|Overall Study|Poor compliance/noncompliance|1|||
105560440|NCT01332227|364048393|FG001|Overall Study|Poor compliance/noncompliance|1|||
105560441|NCT01332227|364048392|FG000|Overall Study|Patient moved from area|1|||
105560442|NCT01332227|364048393|FG001|Overall Study|Patient moved from area|0|||
105560443|NCT01332227|364048392|FG000|Overall Study|Patient began prohibited medication|0|||
105560444|NCT01332227|364048393|FG001|Overall Study|Patient began prohibited medication|1|||
105560445|NCT02173548|364048399|FG000|Overall Study|Lost to Follow-up|0|||
105704458|NCT01806779|364580292|FG001|Overall Study|Withdrawal by Subject|23|||
105704459|NCT01806779|364580293|FG002|Overall Study|Withdrawal by Subject|22|||
105560446|NCT02173548|364048400|FG001|Overall Study|Lost to Follow-up|2|||
105560447|NCT02173548|364048399|FG000|Overall Study|Withdrawal by Subject|1|||
105560448|NCT02173548|364048400|FG001|Overall Study|Withdrawal by Subject|0|||
105560449|NCT03597568|364048404|FG000|Overall Study|Withdrawal by Subject|1|||
105560450|NCT03597568|364048405|FG001|Overall Study|Withdrawal by Subject|1|||
105560451|NCT03597568|364048404|FG000|Overall Study|Unable to analyze vascular data|1|||
105704460|NCT02595450|364580296|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
105704461|NCT02595450|364580296|FG000|Overall Study|Enrolled, but not treated|8|||
105704462|NCT01934556|364580297|FG000|Overall Study|Withdrawal by Subject|0|||
105704463|NCT01934556|364580298|FG001|Overall Study|Withdrawal by Subject|1|||
105704464|NCT01934556|364580299|FG002|Overall Study|Withdrawal by Subject|1|||
105704465|NCT01934556|364580297|FG000|Overall Study|Lost to Follow-up|4|||
105704466|NCT01934556|364580298|FG001|Overall Study|Lost to Follow-up|10|||
105704467|NCT01934556|364580299|FG002|Overall Study|Lost to Follow-up|7|||
105704468|NCT01934556|364580297|FG000|Overall Study|Death|1|||
105704469|NCT01934556|364580298|FG001|Overall Study|Death|5|||
105704470|NCT01934556|364580299|FG002|Overall Study|Death|2|||
105704471|NCT03723707|364582298|FG000|Overall Study|Death|32|||
105704472|NCT03723707|364582299|FG001|Overall Study|Death|32|||
105704473|NCT03723707|364582298|FG000|Overall Study|Admitted to long term care|12|||
105704474|NCT03723707|364582299|FG001|Overall Study|Admitted to long term care|12|||
105704475|NCT03723707|364582298|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
105704476|NCT03723707|364582299|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
105704477|NCT03723707|364582298|FG000|Overall Study|Lost to Follow-up|40|||
105704478|NCT03723707|364582299|FG001|Overall Study|Lost to Follow-up|22|||
105704479|NCT03723707|364582298|FG000|Overall Study|Discontinued after study closure|24|||
105704480|NCT03723707|364582299|FG001|Overall Study|Discontinued after study closure|12|||
105704481|NCT05121480|364582300|FG000|Overall Study|Lack of Efficacy|2|||
105704482|NCT05121480|364582301|FG001|Overall Study|Lack of Efficacy|2|||
105704483|NCT05121480|364582302|FG002|Overall Study|Lack of Efficacy|1|||
105704484|NCT05121480|364582303|FG003|Overall Study|Lack of Efficacy|4|||
105704485|NCT05121480|364582304|FG004|Overall Study|Lack of Efficacy|0|||
105704486|NCT05121480|364582305|FG005|Overall Study|Lack of Efficacy|1|||
105704487|NCT05121480|364582306|FG006|Overall Study|Lack of Efficacy|0|||
105704488|NCT05121480|364582307|FG007|Overall Study|Lack of Efficacy|2|||
105704489|NCT05121480|364582300|FG000|Overall Study|Treatment Failure|0|||
105704490|NCT05121480|364582301|FG001|Overall Study|Treatment Failure|2|||
105704491|NCT05121480|364582302|FG002|Overall Study|Treatment Failure|0|||
105704492|NCT05121480|364582303|FG003|Overall Study|Treatment Failure|1|||
105704493|NCT05121480|364582304|FG004|Overall Study|Treatment Failure|0|||
105704494|NCT05121480|364582305|FG005|Overall Study|Treatment Failure|0|||
105704495|NCT05121480|364582306|FG006|Overall Study|Treatment Failure|0|||
105704496|NCT05121480|364582307|FG007|Overall Study|Treatment Failure|0|||
105704497|NCT05121480|364582300|FG000|Overall Study|Adverse Event|0|||
105704498|NCT05121480|364582301|FG001|Overall Study|Adverse Event|1|||
105704499|NCT05121480|364582302|FG002|Overall Study|Adverse Event|0|||
105704500|NCT05121480|364582303|FG003|Overall Study|Adverse Event|5|||
105704501|NCT05121480|364582304|FG004|Overall Study|Adverse Event|3|||
105704502|NCT05121480|364582305|FG005|Overall Study|Adverse Event|2|||
105704503|NCT05121480|364582306|FG006|Overall Study|Adverse Event|0|||
105704504|NCT05121480|364582307|FG007|Overall Study|Adverse Event|4|||
105704505|NCT05121480|364582300|FG000|Overall Study|Withdrawal by Subject|4|||
105704506|NCT05121480|364582301|FG001|Overall Study|Withdrawal by Subject|9|||
105704507|NCT05121480|364582302|FG002|Overall Study|Withdrawal by Subject|1|||
105704508|NCT05121480|364582303|FG003|Overall Study|Withdrawal by Subject|8|||
105704509|NCT05121480|364582304|FG004|Overall Study|Withdrawal by Subject|0|||
105704510|NCT05121480|364582305|FG005|Overall Study|Withdrawal by Subject|9|||
105704511|NCT05121480|364582306|FG006|Overall Study|Withdrawal by Subject|0|||
105704512|NCT05121480|364582307|FG007|Overall Study|Withdrawal by Subject|4|||
105704513|NCT05121480|364582300|FG000|Overall Study|Non-compliance with the protocol|0|||
105704514|NCT05121480|364582301|FG001|Overall Study|Non-compliance with the protocol|0|||
105704515|NCT05121480|364582302|FG002|Overall Study|Non-compliance with the protocol|0|||
105704516|NCT05121480|364582303|FG003|Overall Study|Non-compliance with the protocol|0|||
105704517|NCT05121480|364582304|FG004|Overall Study|Non-compliance with the protocol|1|||
105704518|NCT05121480|364582305|FG005|Overall Study|Non-compliance with the protocol|6|||
105350276|NCT00433017|363286142|FG001|Overall Study|Protocol Violation|0|||
105704519|NCT05121480|364582306|FG006|Overall Study|Non-compliance with the protocol|0|||
105704520|NCT05121480|364582307|FG007|Overall Study|Non-compliance with the protocol|1|||
105704521|NCT05121480|364582300|FG000|Overall Study|Lost to Follow-up|0|||
105704522|NCT05121480|364582301|FG001|Overall Study|Lost to Follow-up|4|||
105704523|NCT05121480|364582302|FG002|Overall Study|Lost to Follow-up|1|||
105704524|NCT05121480|364582303|FG003|Overall Study|Lost to Follow-up|3|||
105704525|NCT05121480|364582304|FG004|Overall Study|Lost to Follow-up|1|||
105704526|NCT05121480|364582305|FG005|Overall Study|Lost to Follow-up|1|||
105704527|NCT05121480|364582306|FG006|Overall Study|Lost to Follow-up|1|||
105704528|NCT05121480|364582307|FG007|Overall Study|Lost to Follow-up|4|||
105704529|NCT05121480|364582300|FG000|Overall Study|Physician Decision|0|||
105704530|NCT05121480|364582301|FG001|Overall Study|Physician Decision|0|||
105704531|NCT05121480|364582302|FG002|Overall Study|Physician Decision|0|||
105704532|NCT05121480|364582303|FG003|Overall Study|Physician Decision|0|||
105704533|NCT05121480|364582304|FG004|Overall Study|Physician Decision|0|||
105704534|NCT05121480|364582305|FG005|Overall Study|Physician Decision|1|||
105704535|NCT05121480|364582306|FG006|Overall Study|Physician Decision|0|||
105704536|NCT05121480|364582307|FG007|Overall Study|Physician Decision|1|||
105704537|NCT05121480|364582300|FG000|Overall Study|Other Reason|0|||
105704538|NCT05121480|364582301|FG001|Overall Study|Other Reason|0|||
105704539|NCT05121480|364582302|FG002|Overall Study|Other Reason|0|||
105704540|NCT05121480|364582303|FG003|Overall Study|Other Reason|0|||
105704541|NCT05121480|364582304|FG004|Overall Study|Other Reason|0|||
105704542|NCT05121480|364582305|FG005|Overall Study|Other Reason|1|||
105704543|NCT05121480|364582306|FG006|Overall Study|Other Reason|1|||
105704544|NCT05121480|364582307|FG007|Overall Study|Other Reason|1|||
105704545|NCT00666458|364582308|FG000|Overall Study|Adverse Event|8|||
105704546|NCT00666458|364582309|FG001|Overall Study|Adverse Event|7|||
105704547|NCT00666458|364582308|FG000|Overall Study|Withdrawal by Subject|5|||
105704548|NCT00666458|364582309|FG001|Overall Study|Withdrawal by Subject|4|||
105704549|NCT00666458|364582308|FG000|Overall Study|Lost to Follow-up|0|||
105704550|NCT00666458|364582309|FG001|Overall Study|Lost to Follow-up|3|||
105704551|NCT00666458|364582308|FG000|Overall Study|Administrative reason by sponsor|1|||
105350277|NCT00433017|363286141|FG000|Overall Study|Death|2|||
105350278|NCT00433017|363286142|FG001|Overall Study|Death|2|||
105350279|NCT00433017|363286141|FG000|Overall Study|Subject no longer requires study drug|1|||
105350280|NCT00433017|363286142|FG001|Overall Study|Subject no longer requires study drug|1|||
105350281|NCT04710368|363286143|FG000|Overall Study|Withdrawal by Subject|9|||
105350282|NCT04710368|363286143|FG000|Overall Study|Lost to Follow-up|4|||
105350283|NCT04710368|363286143|FG000|Overall Study|Death|2|||
105350284|NCT04710368|363286143|FG000|Overall Study|Patient preference|11|||
105350285|NCT04710368|363286143|FG000|Overall Study|Treatment discontinuation|1|||
105350286|NCT00135356|363286144|FG000|Overall Study|Adverse Event|6|||
105350287|NCT00135356|363286145|FG001|Overall Study|Adverse Event|2|||
105350288|NCT00135356|363286144|FG000|Overall Study|Lack of Efficacy|2|||
105350289|NCT00135356|363286145|FG001|Overall Study|Lack of Efficacy|0|||
105350290|NCT00135356|363286144|FG000|Overall Study|Lost to Follow-up|3|||
105350291|NCT00135356|363286145|FG001|Overall Study|Lost to Follow-up|1|||
105350292|NCT00135356|363286144|FG000|Overall Study|Surgery for abdominal fat|1|||
105350293|NCT00135356|363286145|FG001|Overall Study|Surgery for abdominal fat|0|||
105350294|NCT00135356|363286144|FG000|Overall Study|Change in antiviral regimen|0|||
105350295|NCT00135356|363286145|FG001|Overall Study|Change in antiviral regimen|1|||
105350296|NCT00135356|363286144|FG000|Overall Study|Poor/noncompliance|1|||
105350297|NCT00135356|363286145|FG001|Overall Study|Poor/noncompliance|1|||
105704552|NCT00666458|364582309|FG001|Overall Study|Administrative reason by sponsor|1|||
105704553|NCT00666458|364582308|FG000|Overall Study|Incorrect enrollment|7|||
105704554|NCT00666458|364582309|FG001|Overall Study|Incorrect enrollment|1|||
105704555|NCT00666458|364582308|FG000|Overall Study|Study specific discontinuation criteria|14|||
105704556|NCT00666458|364582309|FG001|Overall Study|Study specific discontinuation criteria|7|||
105704557|NCT00666458|364582308|FG000|Overall Study|Severe non-compliance to the protocol|1|||
105704558|NCT00666458|364582309|FG001|Overall Study|Severe non-compliance to the protocol|1|||
105704559|NCT00666458|364582308|FG000|Overall Study|Safety reasons|1|||
105704560|NCT00666458|364582309|FG001|Overall Study|Safety reasons|0|||
105704561|NCT00666458|364582308|FG000|Overall Study|Medical history of anemia|1|||
105704562|NCT00666458|364582309|FG001|Overall Study|Medical history of anemia|0|||
105704563|NCT02222207|364582310|FG000|Overall Study|Death|1|||
105704564|NCT02222207|364582310|FG000|Overall Study|Other reasons|2|||
105704565|NCT02222207|364582310|FG000|Overall Study|Adverse Event|1|||
105704566|NCT01230307|364582316|FG000|Overall Study|LVAD Placement|0|||
105704567|NCT01230307|364582317|FG001|Overall Study|LVAD Placement|2|||
105704568|NCT00530894|364582322|FG000|Overall Study|Death|84|||
105704569|NCT00530894|364582323|FG001|Overall Study|Death|89|||
105704570|NCT00530894|364582324|FG002|Overall Study|Death|55|||
105704571|NCT00530894|364582325|FG003|Overall Study|Death|89|||
105704572|NCT00530894|364582322|FG000|Overall Study|Lost to Follow-up|1|||
105704573|NCT00530894|364582323|FG001|Overall Study|Lost to Follow-up|3|||
105704574|NCT00530894|364582324|FG002|Overall Study|Lost to Follow-up|0|||
105704575|NCT00530894|364582325|FG003|Overall Study|Lost to Follow-up|0|||
105704576|NCT00530894|364582322|FG000|Overall Study|Withdrawal by Subject|1|||
105704577|NCT00530894|364582323|FG001|Overall Study|Withdrawal by Subject|23|||
105704578|NCT00530894|364582324|FG002|Overall Study|Withdrawal by Subject|0|||
105704579|NCT00530894|364582325|FG003|Overall Study|Withdrawal by Subject|5|||
105704580|NCT00530894|364582322|FG000|Overall Study|Alive and censored prior to 1 year|2|||
105704581|NCT00530894|364582323|FG001|Overall Study|Alive and censored prior to 1 year|0|||
105704582|NCT00530894|364582324|FG002|Overall Study|Alive and censored prior to 1 year|0|||
105704583|NCT00530894|364582325|FG003|Overall Study|Alive and censored prior to 1 year|0|||
105704584|NCT02256540|364582326|FG000|Overall Study|Withdrawal by Subject|0|||
105704585|NCT02256540|364582327|FG001|Overall Study|Withdrawal by Subject|1|||
105704586|NCT02256540|364582328|FG002|Overall Study|Withdrawal by Subject|1|||
105704587|NCT02256540|364582326|FG000|Overall Study|Back pain preventing exercise|0|||
105704588|NCT02256540|364582327|FG001|Overall Study|Back pain preventing exercise|0|||
105704589|NCT02256540|364582328|FG002|Overall Study|Back pain preventing exercise|1|||
105704590|NCT01230242|364582329|FG000|Overall Study|Physician Decision|2|||
105704591|NCT01230242|364582329|FG000|Overall Study|Withdrawal by Subject|1|||
105350298|NCT00135356|363286144|FG000|Overall Study|No longer meets study criteria|2|||
105350299|NCT00135356|363286145|FG001|Overall Study|No longer meets study criteria|0|||
105350300|NCT00135356|363286144|FG000|Overall Study|Withdrawal by Subject|2|||
105350301|NCT00135356|363286145|FG001|Overall Study|Withdrawal by Subject|4|||
105350302|NCT01533688|363286146|FG000|Overall Study|Withdrawal by Subject|5|||
105350303|NCT01533688|363286147|FG001|Overall Study|Withdrawal by Subject|4|||
105350304|NCT01533688|363286148|FG002|Overall Study|Withdrawal by Subject|3|||
105350305|NCT01533688|363286146|FG000|Overall Study|Medically unstable|1|||
105350306|NCT01533688|363286147|FG001|Overall Study|Medically unstable|3|||
105350307|NCT01533688|363286148|FG002|Overall Study|Medically unstable|3|||
105704592|NCT04329702|364582336|FG000|Overall Study|illness|3|||
105704593|NCT04329702|364582337|FG001|Overall Study|illness|4|||
105350308|NCT01533688|363286146|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
105350309|NCT01533688|363286147|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
105474625|NCT01865552|363751145|FG004|Period 1|Other|1|||
105704594|NCT04329702|364582338|FG002|Overall Study|illness|0|||
105350310|NCT01533688|363286148|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
105560452|NCT03597568|364048405|FG001|Overall Study|Unable to analyze vascular data|1|||
105560453|NCT01621126|364048406|FG000|Overall Study|Physician Decision|6|||
105560454|NCT01949311|364048407|FG000|Overall Study|Lost to Follow-up|73|||
105560455|NCT01949311|364048407|FG000|Overall Study|Terminated by Sponsor|708|||
105560456|NCT01949311|364048407|FG000|Overall Study|Withdrawal by Subject|375|||
105560457|NCT01949311|364048407|FG000|Overall Study|Lack of Efficacy|50|||
105560458|NCT01949311|364048407|FG000|Overall Study|Protocol Deviation|34|||
105560459|NCT01949311|364048407|FG000|Overall Study|Pregnancy|20|||
105560460|NCT01949311|364048407|FG000|Overall Study|Physician Decision|9|||
105560461|NCT01949311|364048407|FG000|Overall Study|Other|4|||
105560462|NCT01949311|364048407|FG000|Overall Study|Adverse Event|107|||
105560463|NCT03751631|364048408|FG000|Overall Study|Withdrawal by Subject|0|||
105560464|NCT03751631|364048409|FG001|Overall Study|Withdrawal by Subject|0|||
105560465|NCT03751631|364048410|FG002|Overall Study|Withdrawal by Subject|1|||
105560466|NCT03751631|364048411|FG003|Overall Study|Withdrawal by Subject|1|||
105560467|NCT03751631|364048412|FG004|Overall Study|Withdrawal by Subject|0|||
105560468|NCT03751631|364048413|FG005|Overall Study|Withdrawal by Subject|0|||
105560469|NCT03224182|364048414|FG000|Overall Study|Study Drug Not Instilled|6|||
105560470|NCT03224182|364048415|FG001|Overall Study|Study Drug Not Instilled|1|||
105560471|NCT03224182|364048414|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
105350331|NCT01134263|363286160|FG000|Overall Study|Serious adverse event|2|||
105350332|NCT01134263|363286161|FG001|Overall Study|Serious adverse event|1|||
105350333|NCT01134263|363286162|FG002|Overall Study|Serious adverse event|1|||
105350334|NCT01134263|363286163|FG003|Overall Study|Serious adverse event|1|||
105350335|NCT01134263|363286164|FG004|Overall Study|Serious adverse event|1|||
105350336|NCT01134263|363286160|FG000|Overall Study|Other adverse event|1|||
105350337|NCT01134263|363286161|FG001|Overall Study|Other adverse event|2|||
105350338|NCT01134263|363286162|FG002|Overall Study|Other adverse event|5|||
105350339|NCT01134263|363286163|FG003|Overall Study|Other adverse event|3|||
105350340|NCT01134263|363286164|FG004|Overall Study|Other adverse event|0|||
105350341|NCT01134263|363286160|FG000|Overall Study|Protocol Violation|8|||
105350342|NCT01134263|363286161|FG001|Overall Study|Protocol Violation|7|||
105350343|NCT01134263|363286162|FG002|Overall Study|Protocol Violation|2|||
105350344|NCT01134263|363286163|FG003|Overall Study|Protocol Violation|4|||
105350345|NCT01134263|363286164|FG004|Overall Study|Protocol Violation|2|||
105350346|NCT01134263|363286160|FG000|Overall Study|Lost to Follow-up|4|||
105350347|NCT01134263|363286161|FG001|Overall Study|Lost to Follow-up|3|||
105350348|NCT01134263|363286162|FG002|Overall Study|Lost to Follow-up|5|||
105704595|NCT04329702|364582336|FG000|Overall Study|Lost to Follow-up|0|||
105704596|NCT04329702|364582337|FG001|Overall Study|Lost to Follow-up|0|||
105704597|NCT04329702|364582338|FG002|Overall Study|Lost to Follow-up|2|||
105704598|NCT04329702|364582336|FG000|Overall Study|Death|0|||
105704599|NCT04329702|364582337|FG001|Overall Study|Death|2|||
105704600|NCT04329702|364582338|FG002|Overall Study|Death|0|||
105704601|NCT00766532|364582339|FG000|Overall Study|Protocol Violation|2|||
105704602|NCT03719690|364582342|FG000|Overall Study|Withdrawal by Subject|5|||
105704603|NCT03719690|364582343|FG001|Overall Study|Withdrawal by Subject|10|||
105704604|NCT03719690|364582342|FG000|Overall Study|Death|40|||
105704605|NCT03719690|364582343|FG001|Overall Study|Death|149|||
105704606|NCT03719690|364582342|FG000|Overall Study|Miscellaneous|12|||
105704607|NCT03719690|364582343|FG001|Overall Study|Miscellaneous|56|||
105704608|NCT03719690|364582342|FG000|Overall Study|Lost to Follow-up|2|||
105704609|NCT03719690|364582343|FG001|Overall Study|Lost to Follow-up|18|||
105704610|NCT03719690|364582342|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
105704611|NCT03719690|364582343|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
105704612|NCT00573430|364582346|FG000|Overall Study|Incorrect enrollment of randomization|0|||
105350349|NCT01134263|363286163|FG003|Overall Study|Lost to Follow-up|3|||
105704613|NCT00573430|364582347|FG001|Overall Study|Incorrect enrollment of randomization|4|||
105704614|NCT00573430|364582348|FG002|Overall Study|Incorrect enrollment of randomization|3|||
105704615|NCT00573430|364582346|FG000|Overall Study|Adverse Event|0|||
105350350|NCT01134263|363286164|FG004|Overall Study|Lost to Follow-up|1|||
105350351|NCT01134263|363286160|FG000|Overall Study|Withdrawal by Subject|8|||
105350352|NCT01134263|363286161|FG001|Overall Study|Withdrawal by Subject|6|||
105350353|NCT01134263|363286162|FG002|Overall Study|Withdrawal by Subject|16|||
105350354|NCT01134263|363286163|FG003|Overall Study|Withdrawal by Subject|7|||
105350355|NCT01134263|363286164|FG004|Overall Study|Withdrawal by Subject|5|||
105350356|NCT01134263|363286160|FG000|Overall Study|Enrolled, but not treated|1|||
105350357|NCT01134263|363286161|FG001|Overall Study|Enrolled, but not treated|1|||
105704616|NCT00573430|364582347|FG001|Overall Study|Adverse Event|0|||
105704617|NCT00573430|364582348|FG002|Overall Study|Adverse Event|2|||
105704618|NCT00573430|364582346|FG000|Overall Study|Withdrawal by Subject|1|||
105560472|NCT03224182|364048415|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
105704619|NCT00573430|364582347|FG001|Overall Study|Withdrawal by Subject|0|||
105704620|NCT00573430|364582348|FG002|Overall Study|Withdrawal by Subject|1|||
105560473|NCT03224182|364048414|FG000|Overall Study|Withdrew of Consent|4|||
105704621|NCT00573430|364582346|FG000|Overall Study|Protocol Violation|0|||
105474626|NCT01865552|363751146|FG005|Period 1|Other|0|||
105474627|NCT00843284|363751147|FG000|Overall Study|Adverse Event|39|||
105474628|NCT00843284|363751147|FG000|Overall Study|Lack of Efficacy|5|||
105474629|NCT00843284|363751147|FG000|Overall Study|Lost to Follow-up|11|||
105474630|NCT00843284|363751147|FG000|Overall Study|Other|10|||
105474631|NCT00843284|363751147|FG000|Overall Study|Withdrawal by Subject|4|||
105474632|NCT00843284|363751147|FG000|Overall Study|Death|3|||
105704622|NCT00573430|364582347|FG001|Overall Study|Protocol Violation|1|||
105704623|NCT00573430|364582348|FG002|Overall Study|Protocol Violation|1|||
105704624|NCT00573430|364582346|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105704625|NCT00573430|364582347|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105704626|NCT00573430|364582348|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
105704627|NCT00769002|364582350|FG000|Overall Study|Study was not completed, no data|9|||
105704628|NCT00769002|364582351|FG001|Overall Study|Study was not completed, no data|9|||
105704629|NCT01918007|364582352|FG000|Overall Study|Baseline oximetry not acceptable|11|||
105704630|NCT01918007|364582353|FG001|Overall Study|Baseline oximetry not acceptable|7|||
105704631|NCT01918007|364582352|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
105704632|NCT01918007|364582353|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
105704633|NCT01918007|364582352|FG000|Overall Study|Lost to Follow-up|4|||
105704634|NCT01918007|364582353|FG001|Overall Study|Lost to Follow-up|7|||
105704635|NCT03363321|364582354|FG000|Overall Study|Withdrawal by Subject|0|||
105704636|NCT03363321|364582355|FG001|Overall Study|Withdrawal by Subject|1|||
105704637|NCT03363321|364582356|FG002|Overall Study|Withdrawal by Subject|0|||
105704638|NCT03363321|364582357|FG003|Overall Study|Withdrawal by Subject|1|||
105704639|NCT03363321|364582358|FG004|Overall Study|Withdrawal by Subject|0|||
105704640|NCT00930761|364582360|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
105474633|NCT01474239|363751148|FG000|Overall Study|Disease Progression|37|||
105474634|NCT01474239|363751149|FG001|Overall Study|Disease Progression|25|||
105474635|NCT01474239|363751148|FG000|Overall Study|Adverse Event|12|||
105474636|NCT01474239|363751149|FG001|Overall Study|Adverse Event|3|||
105704641|NCT00930761|364582361|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
105704642|NCT00930761|364582360|FG000|Overall Study|less than 3 music therapy sessions|0|||
105350358|NCT01134263|363286162|FG002|Overall Study|Enrolled, but not treated|0|||
105350359|NCT01134263|363286163|FG003|Overall Study|Enrolled, but not treated|1|||
105350360|NCT01134263|363286164|FG004|Overall Study|Enrolled, but not treated|0|||
105350361|NCT01636947|363286172|FG000|Overall Study|Not Treated|2|||
105350362|NCT01636947|363286173|FG001|Overall Study|Not Treated|2|||
105350363|NCT01636947|363286172|FG000|Overall Study|Lost to Follow-up|4|||
105350364|NCT01636947|363286173|FG001|Overall Study|Lost to Follow-up|0|||
105350365|NCT01636947|363286172|FG000|Overall Study|Protocol Violation|1|||
105704643|NCT00930761|364582361|FG001|Overall Study|less than 3 music therapy sessions|3|||
105704644|NCT01118351|364582362|FG000|Overall Study|Adverse Event|3|||
105350366|NCT01636947|363286173|FG001|Overall Study|Protocol Violation|1|||
105350367|NCT01636947|363286172|FG000|Overall Study|Withdrawal by Subject|3|||
105350368|NCT01636947|363286173|FG001|Overall Study|Withdrawal by Subject|3|||
105350369|NCT01636947|363286172|FG000|Overall Study|Adverse Event|1|||
105350370|NCT01636947|363286173|FG001|Overall Study|Adverse Event|1|||
105350371|NCT01636947|363286172|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
105350372|NCT01636947|363286173|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
105350373|NCT00957424|363286174|FG000|Overall Study|Lost to Follow-up|19|||
105350374|NCT00957424|363286174|FG000|Overall Study|Protocol Violation|3|||
105350375|NCT00957424|363286174|FG000|Overall Study|Withdrawal by Subject|1|||
105474637|NCT01474239|363751148|FG000|Overall Study|Withdrawal by Subject|1|||
105474638|NCT01474239|363751149|FG001|Overall Study|Withdrawal by Subject|2|||
105474639|NCT01474239|363751148|FG000|Overall Study|Death|1|||
105474640|NCT01474239|363751149|FG001|Overall Study|Death|1|||
105474641|NCT01474239|363751148|FG000|Overall Study|Clinical Disease Progression|7|||
105704645|NCT01118351|364582362|FG000|Overall Study|Withdrawal by Subject|1|||
105704646|NCT03221751|364582363|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
105704647|NCT03221751|364582364|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
105704648|NCT01263639|364582365|FG000|Overall Study|Lost to Follow-up|66|||
105704649|NCT01263639|364582366|FG001|Overall Study|Lost to Follow-up|70|||
105704650|NCT01263639|364582365|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
105704651|NCT01263639|364582366|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
105704652|NCT00053417|364582367|FG000|Overall Study|Adverse Event|1|||
105704653|NCT00053417|364582368|FG001|Overall Study|Adverse Event|0|||
105704654|NCT00053417|364582369|FG002|Overall Study|Adverse Event|1|||
105704655|NCT00053417|364582370|FG003|Overall Study|Adverse Event|5|||
105704656|NCT00053417|364582367|FG000|Overall Study|Non-Compliance|0|||
105704657|NCT00053417|364582368|FG001|Overall Study|Non-Compliance|0|||
105704658|NCT00053417|364582369|FG002|Overall Study|Non-Compliance|0|||
105704659|NCT00053417|364582370|FG003|Overall Study|Non-Compliance|1|||
105704660|NCT00053417|364582367|FG000|Overall Study|Withdrawal by Subject|0|||
105704661|NCT00053417|364582368|FG001|Overall Study|Withdrawal by Subject|1|||
105704662|NCT00053417|364582369|FG002|Overall Study|Withdrawal by Subject|0|||
105704663|NCT00053417|364582370|FG003|Overall Study|Withdrawal by Subject|0|||
105704664|NCT00053417|364582367|FG000|Overall Study|Lost to Follow-up|1|||
105704665|NCT00053417|364582368|FG001|Overall Study|Lost to Follow-up|1|||
105704666|NCT00053417|364582369|FG002|Overall Study|Lost to Follow-up|0|||
105704667|NCT00053417|364582370|FG003|Overall Study|Lost to Follow-up|0|||
105704668|NCT04951037|364582371|FG000|Overall Study|Lost to Follow-up|16|||
105704669|NCT04951037|364582371|FG000|Overall Study|Withdrawal by Subject|5|||
105704670|NCT04951037|364582371|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
105704671|NCT00183274|364582372|FG000|Phase 1: Open-Label|Adverse Event|31|||
105704672|NCT00183274|364582373|FG001|Phase 1: Open-Label|Adverse Event|0|||
105704673|NCT00183274|364582374|FG002|Phase 1: Open-Label|Adverse Event|0|||
105704674|NCT00183274|364582375|FG003|Phase 1: Open-Label|Adverse Event|0|||
105704675|NCT00183274|364582376|FG004|Phase 1: Open-Label|Adverse Event|0|||
105704676|NCT00183274|364582377|FG005|Phase 1: Open-Label|Adverse Event|0|||
105704677|NCT00183274|364582372|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
105704678|NCT00183274|364582373|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
105704679|NCT00183274|364582374|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
105704680|NCT00183274|364582375|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
105704681|NCT00183274|364582376|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
105350376|NCT00553358|363286177|FG000|Overall Study|Randomized but did not receive treatment|3|||
105350377|NCT00553358|363286178|FG001|Overall Study|Randomized but did not receive treatment|3|||
105474642|NCT01474239|363751149|FG001|Overall Study|Clinical Disease Progression|1|||
105350378|NCT00553358|363286179|FG002|Overall Study|Randomized but did not receive treatment|1|||
105350379|NCT00553358|363286177|FG000|Overall Study|Lost to Follow-up|22|||
105350380|NCT00553358|363286178|FG001|Overall Study|Lost to Follow-up|26|||
105350381|NCT00553358|363286179|FG002|Overall Study|Lost to Follow-up|18|||
105350382|NCT00553358|363286177|FG000|Overall Study|Withdrew completely|23|||
105350383|NCT00553358|363286178|FG001|Overall Study|Withdrew completely|33|||
105350384|NCT00553358|363286179|FG002|Overall Study|Withdrew completely|34|||
105350385|NCT00553358|363286177|FG000|Overall Study|Died during clinical follow-up|25|||
105350386|NCT00553358|363286178|FG001|Overall Study|Died during clinical follow-up|29|||
105704682|NCT00183274|364582377|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
105704683|NCT00183274|364582372|FG000|Phase 1: Open-Label|Protocol Violation|11|||
105704684|NCT00183274|364582373|FG001|Phase 1: Open-Label|Protocol Violation|0|||
105704685|NCT00183274|364582374|FG002|Phase 1: Open-Label|Protocol Violation|0|||
105704686|NCT00183274|364582375|FG003|Phase 1: Open-Label|Protocol Violation|0|||
105704687|NCT00183274|364582376|FG004|Phase 1: Open-Label|Protocol Violation|0|||
105704688|NCT00183274|364582377|FG005|Phase 1: Open-Label|Protocol Violation|0|||
105704689|NCT00183274|364582372|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
105704690|NCT00183274|364582373|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
105704691|NCT00183274|364582374|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
105704692|NCT00183274|364582375|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
105704693|NCT00183274|364582376|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
105704694|NCT00183274|364582377|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
105704695|NCT00183274|364582372|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
105704696|NCT00183274|364582373|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
105704697|NCT00183274|364582374|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
105704698|NCT00183274|364582375|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
105704699|NCT00183274|364582376|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
105704700|NCT00183274|364582377|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
105704701|NCT00183274|364582372|FG000|Phase 1: Open-Label|Other|9|||
105704702|NCT00183274|364582373|FG001|Phase 1: Open-Label|Other|0|||
105704703|NCT00183274|364582374|FG002|Phase 1: Open-Label|Other|0|||
105704704|NCT00183274|364582375|FG003|Phase 1: Open-Label|Other|0|||
105704705|NCT00183274|364582376|FG004|Phase 1: Open-Label|Other|0|||
105704706|NCT00183274|364582377|FG005|Phase 1: Open-Label|Other|0|||
105704707|NCT00183274|364582372|FG000|Phase 2: Double-Blind|Relapsed|0|||
105704708|NCT00183274|364582373|FG001|Phase 2: Double-Blind|Relapsed|8|||
105704709|NCT00183274|364582374|FG002|Phase 2: Double-Blind|Relapsed|29|||
105350387|NCT00553358|363286179|FG002|Overall Study|Died during clinical follow-up|32|||
105350388|NCT00553358|363286177|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
105350389|NCT00553358|363286178|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
105704710|NCT00183274|364582375|FG003|Phase 2: Double-Blind|Relapsed|0|||
105704711|NCT00183274|364582376|FG004|Phase 2: Double-Blind|Relapsed|0|||
105704712|NCT00183274|364582377|FG005|Phase 2: Double-Blind|Relapsed|0|||
105704713|NCT00183274|364582372|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
105560474|NCT03224182|364048415|FG001|Overall Study|Withdrew of Consent|2|||
105704714|NCT00183274|364582373|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
105704715|NCT00183274|364582374|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
105704716|NCT00183274|364582375|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
105704717|NCT00183274|364582376|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
105704718|NCT00183274|364582377|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
105704719|NCT00183274|364582372|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
105704720|NCT00183274|364582373|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
105704721|NCT00183274|364582374|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
105704722|NCT00183274|364582375|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
105704723|NCT00183274|364582376|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
105704724|NCT00183274|364582377|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
105704725|NCT00183274|364582372|FG000|Phase 3: Double-Blind|Relapsed|0|||
105704726|NCT00183274|364582373|FG001|Phase 3: Double-Blind|Relapsed|0|||
105704727|NCT00183274|364582374|FG002|Phase 3: Double-Blind|Relapsed|0|||
105704728|NCT00183274|364582375|FG003|Phase 3: Double-Blind|Relapsed|1|||
105704729|NCT00183274|364582376|FG004|Phase 3: Double-Blind|Relapsed|11|||
105704730|NCT00183274|364582377|FG005|Phase 3: Double-Blind|Relapsed|2|||
105704731|NCT02706873|364582380|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
105704732|NCT02706873|364582381|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
105704733|NCT02706873|364582382|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
105704734|NCT02706873|364582383|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
105704735|NCT02706873|364582380|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
105704736|NCT02706873|364582381|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
105704737|NCT02706873|364582382|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
105704738|NCT02706873|364582383|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
105704739|NCT02706873|364582380|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
105704740|NCT02706873|364582381|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
105704741|NCT02706873|364582382|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
105704742|NCT02706873|364582383|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
105704743|NCT02706873|364582380|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
105704744|NCT02706873|364582381|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
105704745|NCT02706873|364582382|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
105704746|NCT02706873|364582383|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
105704747|NCT02706873|364582380|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
105350390|NCT00553358|363286179|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
105350391|NCT00553358|363286177|FG000|Overall Study|Died after clinical follow-up ended|1|||
105350392|NCT00553358|363286178|FG001|Overall Study|Died after clinical follow-up ended|2|||
105350393|NCT00553358|363286179|FG002|Overall Study|Died after clinical follow-up ended|0|||
105350394|NCT00553358|363286177|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
105350395|NCT00553358|363286178|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
105350396|NCT00553358|363286179|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
105350397|NCT01133288|363286182|FG000|Eligibility Assessment|met exclusion criteria|5|||
105350398|NCT01133288|363286182|FG000|Intervention Allocation|study terminated|2|||
105704748|NCT02706873|364582381|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
105704749|NCT02706873|364582382|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
105704750|NCT02706873|364582383|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
105704751|NCT02706873|364582380|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
105704752|NCT02706873|364582381|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
105704753|NCT02706873|364582382|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
105704754|NCT02706873|364582383|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
105704755|NCT02706873|364582380|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
105704756|NCT02706873|364582381|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
105704757|NCT02706873|364582382|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
105704758|NCT02706873|364582383|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
105704759|NCT02706873|364582380|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
105704760|NCT02706873|364582381|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
105704761|NCT02706873|364582382|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
105704762|NCT02706873|364582383|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
105704763|NCT02706873|364582380|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
105704764|NCT02706873|364582381|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
105704765|NCT02706873|364582382|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
105704766|NCT02706873|364582383|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
105704767|NCT02706873|364582380|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
105704768|NCT02706873|364582381|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
105704769|NCT02706873|364582382|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
105704770|NCT02706873|364582383|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
105704771|NCT02706873|364582380|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
105704772|NCT02706873|364582381|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
105704773|NCT02706873|364582382|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
105704774|NCT02706873|364582383|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
105704775|NCT02706873|364582380|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
105704776|NCT02706873|364582381|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
105704777|NCT02706873|364582382|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
105704778|NCT02706873|364582383|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
105704779|NCT02706873|364582380|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
105704780|NCT02706873|364582381|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
105704781|NCT02706873|364582382|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
105704782|NCT02706873|364582383|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
105704783|NCT00143312|364582398|FG000|Overall Study|Death|11|||
105704784|NCT00143312|364582398|FG000|Overall Study|Adverse Event|2|||
105704785|NCT00143312|364582398|FG000|Overall Study|Lost to Follow-up|1|||
105704786|NCT00143312|364582398|FG000|Overall Study|Other|1|||
105704787|NCT00143312|364582398|FG000|Overall Study|Withdrawal by Subject|1|||
105704788|NCT02863809|364582399|FG000|Overall Study|Adverse Event|8|||
105704789|NCT02863809|364582400|FG001|Overall Study|Adverse Event|8|||
105704790|NCT02863809|364582399|FG000|Overall Study|Withdrawal by Subject|0|||
105704791|NCT02863809|364582400|FG001|Overall Study|Withdrawal by Subject|1|||
105704792|NCT02863809|364582399|FG000|Overall Study|Lost to Follow-up|1|||
105704793|NCT02863809|364582400|FG001|Overall Study|Lost to Follow-up|1|||
105704794|NCT02863809|364582399|FG000|Overall Study|Death|1|||
105704795|NCT02863809|364582400|FG001|Overall Study|Death|0|||
105350399|NCT03008278|363286183|FG000|Overall Study|Progressive Disease|0|||
105350400|NCT03008278|363286184|FG001|Overall Study|Progressive Disease|0|||
105350401|NCT03008278|363286185|FG002|Overall Study|Progressive Disease|32|||
105350402|NCT03008278|363286183|FG000|Overall Study|Adverse Event|0|||
105350403|NCT03008278|363286184|FG001|Overall Study|Adverse Event|0|||
105350404|NCT03008278|363286185|FG002|Overall Study|Adverse Event|4|||
105787358|NCT01243762|364874941|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
105350405|NCT03008278|363286183|FG000|Overall Study|Withdrawal by Subject|0|||
105474643|NCT01474239|363751148|FG000|Overall Study|Withdrawal for Economic Reason|1|||
105474644|NCT01474239|363751149|FG001|Overall Study|Withdrawal for Economic Reason|0|||
105704796|NCT00440947|364582401|FG000|36-Week Induction Phase|Adverse Event|16|||
105704797|NCT00440947|364582402|FG001|36-Week Induction Phase|Adverse Event|0|||
105350406|NCT03008278|363286184|FG001|Overall Study|Withdrawal by Subject|0|||
105474645|NCT01761162|363751152|FG000|Overall Study|Withdrawal by Subject|3|||
105704798|NCT00440947|364582403|FG002|36-Week Induction Phase|Adverse Event|0|||
105350407|NCT03008278|363286185|FG002|Overall Study|Withdrawal by Subject|3|||
105350408|NCT03008278|363286183|FG000|Overall Study|Physician Decision|0|||
105350409|NCT03008278|363286184|FG001|Overall Study|Physician Decision|2|||
105350410|NCT03008278|363286185|FG002|Overall Study|Physician Decision|0|||
105350411|NCT03411902|363286189|FG000|Overall Study|Lost to Follow-up|3|||
105350412|NCT03411902|363286190|FG001|Overall Study|Lost to Follow-up|0|||
105350413|NCT00419159|363286191|FG000|Overall Study|Adverse Event|7|||
105350414|NCT00419159|363286192|FG001|Overall Study|Adverse Event|15|||
105350415|NCT00419159|363286191|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105350416|NCT00419159|363286192|FG001|Overall Study|Abnormal laboratory value(s)|2|||
105350417|NCT00419159|363286191|FG000|Overall Study|Subject's no longer requires study drug|0|||
105350418|NCT00419159|363286192|FG001|Overall Study|Subject's no longer requires study drug|1|||
105350419|NCT00419159|363286191|FG000|Overall Study|Protocol Violation|1|||
105350420|NCT00419159|363286192|FG001|Overall Study|Protocol Violation|0|||
105350421|NCT00419159|363286191|FG000|Overall Study|Withdrawal by Subject|10|||
105350422|NCT00419159|363286192|FG001|Overall Study|Withdrawal by Subject|3|||
105350423|NCT00419159|363286191|FG000|Overall Study|Lost to Follow-up|0|||
105350424|NCT00419159|363286192|FG001|Overall Study|Lost to Follow-up|1|||
105350425|NCT00419159|363286191|FG000|Overall Study|Death|2|||
105350426|NCT00419159|363286192|FG001|Overall Study|Death|2|||
105350427|NCT00419159|363286191|FG000|Overall Study|Disease progression|79|||
105350428|NCT00419159|363286192|FG001|Overall Study|Disease progression|76|||
105350429|NCT01017601|363286193|FG000|Overall Study|Disease Progression|12|||
105350430|NCT01017601|363286194|FG001|Overall Study|Disease Progression|12|||
105350431|NCT01017601|363286193|FG000|Overall Study|Withdrawal by Subject|0|||
105350432|NCT01017601|363286194|FG001|Overall Study|Withdrawal by Subject|1|||
105350433|NCT02279745|363286195|FG000|Overall Study|Adverse Event|7|||
105350434|NCT02279745|363286195|FG000|Overall Study|Death|6|||
105350435|NCT02279745|363286195|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
105350436|NCT02279745|363286195|FG000|Overall Study|Withdrawal by Subject|2|||
105350437|NCT02279745|363286195|FG000|Overall Study|Pregnancy|1|||
105350438|NCT02279745|363286195|FG000|Overall Study|Study Non-compliance|1|||
105350439|NCT02279745|363286195|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
105350440|NCT01094782|363286197|FG000|Overall Study|Withdrawal by Subject|5|||
105350441|NCT01094782|363286198|FG001|Overall Study|Withdrawal by Subject|5|||
105350442|NCT01094782|363286199|FG002|Overall Study|Withdrawal by Subject|1|||
105350443|NCT01094782|363286200|FG003|Overall Study|Withdrawal by Subject|5|||
105350444|NCT01094782|363286201|FG004|Overall Study|Withdrawal by Subject|5|||
105350445|NCT01094782|363286202|FG005|Overall Study|Withdrawal by Subject|0|||
105350446|NCT01094782|363286197|FG000|Overall Study|Lost to Follow-up|1|||
105350447|NCT01094782|363286198|FG001|Overall Study|Lost to Follow-up|0|||
105350448|NCT01094782|363286199|FG002|Overall Study|Lost to Follow-up|0|||
105350449|NCT01094782|363286200|FG003|Overall Study|Lost to Follow-up|2|||
105350450|NCT01094782|363286201|FG004|Overall Study|Lost to Follow-up|1|||
105350451|NCT01094782|363286202|FG005|Overall Study|Lost to Follow-up|4|||
105350452|NCT01094782|363286197|FG000|Overall Study|Positive Drug Screen|2|||
105350453|NCT01094782|363286198|FG001|Overall Study|Positive Drug Screen|2|||
105350454|NCT01094782|363286199|FG002|Overall Study|Positive Drug Screen|1|||
105350455|NCT01094782|363286200|FG003|Overall Study|Positive Drug Screen|1|||
105350456|NCT01094782|363286201|FG004|Overall Study|Positive Drug Screen|3|||
105350457|NCT01094782|363286202|FG005|Overall Study|Positive Drug Screen|2|||
105350458|NCT01094782|363286197|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
105350459|NCT01094782|363286198|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
105350460|NCT01094782|363286199|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
105350461|NCT01094782|363286200|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
105350462|NCT01094782|363286201|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
105350463|NCT01094782|363286202|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
105350464|NCT01094782|363286197|FG000|Overall Study|Unable to Complete Questionnaires|0|||
105350465|NCT01094782|363286198|FG001|Overall Study|Unable to Complete Questionnaires|1|||
105350466|NCT01094782|363286199|FG002|Overall Study|Unable to Complete Questionnaires|0|||
105350467|NCT01094782|363286200|FG003|Overall Study|Unable to Complete Questionnaires|0|||
105350468|NCT01094782|363286201|FG004|Overall Study|Unable to Complete Questionnaires|0|||
105350469|NCT01094782|363286202|FG005|Overall Study|Unable to Complete Questionnaires|0|||
105350470|NCT01094782|363286197|FG000|Overall Study|Healthy Subject Had Pain|0|||
105350471|NCT01094782|363286198|FG001|Overall Study|Healthy Subject Had Pain|1|||
105350472|NCT01094782|363286199|FG002|Overall Study|Healthy Subject Had Pain|0|||
105350473|NCT01094782|363286200|FG003|Overall Study|Healthy Subject Had Pain|0|||
105350474|NCT01094782|363286201|FG004|Overall Study|Healthy Subject Had Pain|0|||
105350475|NCT01094782|363286202|FG005|Overall Study|Healthy Subject Had Pain|0|||
105350476|NCT01094782|363286197|FG000|Overall Study|Hypertension|0|||
105350477|NCT01094782|363286198|FG001|Overall Study|Hypertension|0|||
105350478|NCT01094782|363286199|FG002|Overall Study|Hypertension|1|||
105350479|NCT01094782|363286200|FG003|Overall Study|Hypertension|0|||
105350480|NCT01094782|363286201|FG004|Overall Study|Hypertension|0|||
105350481|NCT01094782|363286202|FG005|Overall Study|Hypertension|0|||
105350482|NCT01094782|363286197|FG000|Overall Study|Wrong Pain Condition|0|||
105350483|NCT01094782|363286198|FG001|Overall Study|Wrong Pain Condition|0|||
105350484|NCT01094782|363286199|FG002|Overall Study|Wrong Pain Condition|0|||
105350485|NCT01094782|363286200|FG003|Overall Study|Wrong Pain Condition|2|||
105350486|NCT01094782|363286201|FG004|Overall Study|Wrong Pain Condition|1|||
105350487|NCT01094782|363286202|FG005|Overall Study|Wrong Pain Condition|1|||
105350488|NCT01094782|363286197|FG000|Overall Study|Recent Interventional Injection|0|||
105350489|NCT01094782|363286198|FG001|Overall Study|Recent Interventional Injection|0|||
105350490|NCT01094782|363286199|FG002|Overall Study|Recent Interventional Injection|0|||
105350491|NCT01094782|363286200|FG003|Overall Study|Recent Interventional Injection|0|||
105350492|NCT01094782|363286201|FG004|Overall Study|Recent Interventional Injection|0|||
105350493|NCT01094782|363286202|FG005|Overall Study|Recent Interventional Injection|1|||
105350494|NCT01094782|363286197|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
105350495|NCT01094782|363286198|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
105350496|NCT01094782|363286199|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
105350497|NCT01094782|363286200|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
105350498|NCT01094782|363286201|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
105350499|NCT01094782|363286202|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
105350500|NCT01094782|363286197|FG000|Overall Study|Noncompliance With Study Schedule|0|||
105350501|NCT01094782|363286198|FG001|Overall Study|Noncompliance With Study Schedule|0|||
105350502|NCT01094782|363286199|FG002|Overall Study|Noncompliance With Study Schedule|0|||
105350503|NCT01094782|363286200|FG003|Overall Study|Noncompliance With Study Schedule|1|||
105350504|NCT01094782|363286201|FG004|Overall Study|Noncompliance With Study Schedule|0|||
105350505|NCT01094782|363286202|FG005|Overall Study|Noncompliance With Study Schedule|0|||
105350506|NCT03084315|363286203|FG000|Overall Study|Lost to Follow-up|8|||
105350507|NCT03084315|363286204|FG001|Overall Study|Lost to Follow-up|7|||
105350508|NCT03084315|363286203|FG000|Overall Study|Withdrawal by Subject|2|||
105350509|NCT03084315|363286204|FG001|Overall Study|Withdrawal by Subject|2|||
105350510|NCT02839876|363286206|FG000|Overall Study|Protocol Violation|10|||
105350511|NCT02839876|363286207|FG001|Overall Study|Protocol Violation|11|||
105350512|NCT00586898|363286208|FG000|Overall Study|Adverse Event|1|||
105350513|NCT00586898|363286208|FG000|Overall Study|Patiemt Non-compliance|1|||
105704799|NCT00440947|364582404|FG003|36-Week Induction Phase|Adverse Event|0|||
105704800|NCT00440947|364582405|FG004|36-Week Induction Phase|Adverse Event|0|||
105704801|NCT00440947|364582401|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
105704802|NCT00440947|364582402|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
105704803|NCT00440947|364582403|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
105704804|NCT00440947|364582404|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
105704805|NCT00440947|364582405|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
105704806|NCT00440947|364582401|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
105704807|NCT00440947|364582402|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
105704808|NCT00440947|364582403|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
105704809|NCT00440947|364582404|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
105704810|NCT00440947|364582405|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
105704811|NCT00440947|364582401|FG000|36-Week Induction Phase|Non-compliance|10|||
105704812|NCT00440947|364582402|FG001|36-Week Induction Phase|Non-compliance|0|||
105704813|NCT00440947|364582403|FG002|36-Week Induction Phase|Non-compliance|0|||
105704814|NCT00440947|364582404|FG003|36-Week Induction Phase|Non-compliance|0|||
105704815|NCT00440947|364582405|FG004|36-Week Induction Phase|Non-compliance|0|||
105704816|NCT00440947|364582401|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
105704817|NCT00440947|364582402|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
105704818|NCT00440947|364582403|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
105704819|NCT00440947|364582404|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
105704820|NCT00440947|364582405|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
105704821|NCT00440947|364582401|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
105350514|NCT00586898|363286208|FG000|Overall Study|Evaluable for Toxicity Only|5|||
105350515|NCT02208050|363286213|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
105350516|NCT02208050|363286214|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
105787359|NCT01243762|364874942|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
105787360|NCT01243762|364874943|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
105787361|NCT01243762|364874944|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
105787362|NCT01243762|364874938|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
105787363|NCT01243762|364874939|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
105787364|NCT01243762|364874940|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
105787365|NCT01243762|364874941|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
105787366|NCT01243762|364874942|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
105787367|NCT01243762|364874943|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
105787368|NCT01243762|364874944|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
105787369|NCT01243762|364874938|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
105787370|NCT01243762|364874939|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
105787371|NCT01243762|364874940|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
105787372|NCT01243762|364874941|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
105787373|NCT01243762|364874942|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
105787374|NCT01243762|364874943|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
105787375|NCT01243762|364874944|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
105787376|NCT01243762|364874938|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
105787377|NCT01243762|364874939|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
105474646|NCT01349049|363751159|FG000|Overall Study|Disease progression|3|||
105787378|NCT01243762|364874940|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
105704822|NCT00440947|364582402|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
105704823|NCT00440947|364582403|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
105704824|NCT00440947|364582404|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
105704825|NCT00440947|364582405|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
105704826|NCT00440947|364582401|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
105704827|NCT00440947|364582402|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
105704828|NCT00440947|364582403|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
105704829|NCT00440947|364582404|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
105704830|NCT00440947|364582405|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
105704831|NCT00440947|364582401|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
105704832|NCT00440947|364582402|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
105704833|NCT00440947|364582403|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
105704834|NCT00440947|364582404|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
105704835|NCT00440947|364582405|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
105704836|NCT00440947|364582401|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
105704837|NCT00440947|364582402|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
105704838|NCT00440947|364582403|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
105704839|NCT00440947|364582404|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
105704840|NCT00440947|364582405|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
105704841|NCT00440947|364582401|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
105350517|NCT01210144|363286217|FG000|Overall Study|Lack of ovarian response|1|||
105350518|NCT01210144|363286218|FG001|Overall Study|Lack of ovarian response|0|||
105350519|NCT01210144|363286217|FG000|Overall Study|No fertilization|1|||
105350520|NCT01210144|363286218|FG001|Overall Study|No fertilization|0|||
105704842|NCT00440947|364582402|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
105350521|NCT01210144|363286217|FG000|Overall Study|No transfer|1|||
105350522|NCT01210144|363286218|FG001|Overall Study|No transfer|0|||
105704843|NCT00440947|364582403|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
105704844|NCT00440947|364582404|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
105704845|NCT00440947|364582405|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
105704846|NCT00440947|364582401|FG000|36-Week Induction Phase|Incarceration|3|||
105704847|NCT00440947|364582402|FG001|36-Week Induction Phase|Incarceration|0|||
105704848|NCT00440947|364582403|FG002|36-Week Induction Phase|Incarceration|0|||
105704849|NCT00440947|364582404|FG003|36-Week Induction Phase|Incarceration|0|||
105704850|NCT00440947|364582405|FG004|36-Week Induction Phase|Incarceration|0|||
105704851|NCT00440947|364582401|FG000|36-Week Induction Phase|Pregnancy|1|||
105704852|NCT00440947|364582402|FG001|36-Week Induction Phase|Pregnancy|0|||
105704853|NCT00440947|364582403|FG002|36-Week Induction Phase|Pregnancy|0|||
105704854|NCT00440947|364582404|FG003|36-Week Induction Phase|Pregnancy|0|||
105704855|NCT00440947|364582405|FG004|36-Week Induction Phase|Pregnancy|0|||
105704856|NCT00440947|364582401|FG000|48-Week Randomization Phase|Adverse Event|0|||
105704857|NCT00440947|364582402|FG001|48-Week Randomization Phase|Adverse Event|2|||
105704858|NCT00440947|364582403|FG002|48-Week Randomization Phase|Adverse Event|5|||
105704859|NCT00440947|364582404|FG003|48-Week Randomization Phase|Adverse Event|0|||
105704860|NCT00440947|364582405|FG004|48-Week Randomization Phase|Adverse Event|0|||
105704861|NCT00440947|364582401|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
105704862|NCT00440947|364582402|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
105704863|NCT00440947|364582403|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
105704864|NCT00440947|364582404|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
105704865|NCT00440947|364582405|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
105704866|NCT00440947|364582401|FG000|48-Week Randomization Phase|Non-compliance|0|||
105704867|NCT00440947|364582402|FG001|48-Week Randomization Phase|Non-compliance|3|||
105704868|NCT00440947|364582403|FG002|48-Week Randomization Phase|Non-compliance|4|||
105704869|NCT00440947|364582404|FG003|48-Week Randomization Phase|Non-compliance|0|||
105704870|NCT00440947|364582405|FG004|48-Week Randomization Phase|Non-compliance|0|||
105704871|NCT00440947|364582401|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
105704872|NCT00440947|364582402|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
105474647|NCT01349049|363751160|FG001|Overall Study|Disease progression|5|||
105704873|NCT00440947|364582403|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
105704874|NCT00440947|364582404|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
105704875|NCT00440947|364582405|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
105704876|NCT00440947|364582401|FG000|48-Week Randomization Phase|Protocol Violation|0|||
105704877|NCT00440947|364582402|FG001|48-Week Randomization Phase|Protocol Violation|0|||
105704878|NCT00440947|364582403|FG002|48-Week Randomization Phase|Protocol Violation|1|||
105350523|NCT02620384|363286219|FG000|Overall Study|Adverse Event|2|||
105350524|NCT02620384|363286220|FG001|Overall Study|Adverse Event|1|||
105704879|NCT00440947|364582404|FG003|48-Week Randomization Phase|Protocol Violation|0|||
105350525|NCT02620384|363286219|FG000|Overall Study|Discharged prior to 2nd dose|2|||
105350526|NCT02620384|363286220|FG001|Overall Study|Discharged prior to 2nd dose|5|||
105704880|NCT00440947|364582405|FG004|48-Week Randomization Phase|Protocol Violation|0|||
105704881|NCT00440947|364582401|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
105704882|NCT00440947|364582402|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
105704883|NCT00440947|364582403|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
105704884|NCT00440947|364582404|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
105704885|NCT00440947|364582405|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
105704886|NCT00440947|364582401|FG000|48-Week Randomization Phase|Pregnancy|0|||
105704887|NCT00440947|364582402|FG001|48-Week Randomization Phase|Pregnancy|0|||
105704888|NCT00440947|364582403|FG002|48-Week Randomization Phase|Pregnancy|1|||
105704889|NCT00440947|364582404|FG003|48-Week Randomization Phase|Pregnancy|0|||
105704890|NCT00440947|364582405|FG004|48-Week Randomization Phase|Pregnancy|0|||
105704891|NCT00440947|364582401|FG000|48-Week Randomization Phase|Incarceration|0|||
105704892|NCT00440947|364582402|FG001|48-Week Randomization Phase|Incarceration|3|||
105704893|NCT00440947|364582403|FG002|48-Week Randomization Phase|Incarceration|0|||
105704894|NCT00440947|364582404|FG003|48-Week Randomization Phase|Incarceration|0|||
105704895|NCT00440947|364582405|FG004|48-Week Randomization Phase|Incarceration|0|||
105704896|NCT00440947|364582401|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
105704897|NCT00440947|364582402|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
105704898|NCT00440947|364582403|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
105704899|NCT00440947|364582404|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
105704900|NCT00440947|364582405|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
105704901|NCT00440947|364582401|FG000|48-Week Randomization Phase|Physician Decision|0|||
105704902|NCT00440947|364582402|FG001|48-Week Randomization Phase|Physician Decision|2|||
105704903|NCT00440947|364582403|FG002|48-Week Randomization Phase|Physician Decision|0|||
105704904|NCT00440947|364582404|FG003|48-Week Randomization Phase|Physician Decision|0|||
105704905|NCT00440947|364582405|FG004|48-Week Randomization Phase|Physician Decision|0|||
105704906|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
105704907|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
105704908|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
105704909|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
105704910|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
105704911|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
105704912|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
105704913|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
105704914|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
105704915|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
105704916|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
105704917|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
105704918|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
105704919|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
105704920|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
105704921|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
105704922|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
105704923|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
105704924|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
105704925|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
105704926|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
105704927|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
105704928|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
105704929|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
105704930|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
105704931|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
105704932|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
105704933|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
105704934|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
105704935|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
105704936|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
105704937|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
105704938|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
105704939|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
105704940|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
105704941|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
105704942|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
105704943|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
105704944|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
105704945|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
105704946|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
105704947|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
105704948|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
105704949|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
105704950|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
105704951|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
105704952|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
105350527|NCT02620384|363286219|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
105474648|NCT01349049|363751161|FG002|Overall Study|Disease progression|3|||
105474649|NCT01349049|363751162|FG003|Overall Study|Disease progression|2|||
105704953|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
105704954|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
105704955|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
105704956|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
105704957|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
105704958|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
105704959|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
105704960|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
105704961|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Other|0|||
105704962|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Other|0|||
105704963|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Other|0|||
105704964|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Other|1|||
105704965|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Other|0|||
105704966|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
105704967|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
105704968|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
105704969|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
105704970|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
105704971|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
105704972|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
105704973|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
105704974|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
105704975|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
105704976|NCT00974675|364582406|FG000|Overall Study|Adverse Event|2|||
105704977|NCT00974675|364582407|FG001|Overall Study|Adverse Event|1|||
105704978|NCT00974675|364582408|FG002|Overall Study|Adverse Event|1|||
105704979|NCT00974675|364582409|FG003|Overall Study|Adverse Event|1|||
105704980|NCT00974675|364582406|FG000|Overall Study|Physician Decision|0|||
105704981|NCT00974675|364582407|FG001|Overall Study|Physician Decision|0|||
105704982|NCT00974675|364582408|FG002|Overall Study|Physician Decision|1|||
105704983|NCT00974675|364582409|FG003|Overall Study|Physician Decision|0|||
105704984|NCT00974675|364582406|FG000|Overall Study|Participant on holiday; unable to attend|0|||
105350528|NCT02620384|363286220|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
105704985|NCT00974675|364582407|FG001|Overall Study|Participant on holiday; unable to attend|0|||
105704986|NCT00974675|364582408|FG002|Overall Study|Participant on holiday; unable to attend|0|||
105704987|NCT00974675|364582409|FG003|Overall Study|Participant on holiday; unable to attend|1|||
105704988|NCT04041284|364582413|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
105704989|NCT04041284|364582414|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
105704990|NCT04041284|364582413|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
105704991|NCT04041284|364582414|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
105704992|NCT04041284|364582413|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
105350529|NCT00094536|363286221|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
105704993|NCT04041284|364582414|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
105704994|NCT04041284|364582413|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
105704995|NCT04041284|364582414|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
105704996|NCT04041284|364582413|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
105704997|NCT04041284|364582414|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
105704998|NCT04041284|364582413|FG000|DB Phase (12 Weeks)|Other than specified|1|||
105704999|NCT04041284|364582414|FG001|DB Phase (12 Weeks)|Other than specified|0|||
105705000|NCT04041284|364582413|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
105705001|NCT04041284|364582414|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
105705002|NCT04041284|364582413|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
105705003|NCT04041284|364582414|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
105705004|NCT04041284|364582413|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
105705005|NCT04041284|364582414|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
105705006|NCT04041284|364582413|FG000|OL Phase (12 Weeks)|Other than specified|6|||
105705007|NCT04041284|364582414|FG001|OL Phase (12 Weeks)|Other than specified|2|||
105705008|NCT00606320|364582415|FG000|Overall Study|Adverse Event|3|||
105705009|NCT00606320|364582415|FG000|Overall Study|Lack of Efficacy|5|||
105705010|NCT00606320|364582415|FG000|Overall Study|Physician Decision|7|||
105705011|NCT00606320|364582415|FG000|Overall Study|Protocol Violation|8|||
105705012|NCT00606320|364582415|FG000|Overall Study|Withdrawal by Subject|10|||
105705013|NCT00606320|364582415|FG000|Overall Study|Progression to depressive phase|4|||
105705014|NCT00563186|364582416|FG000|Overall Study|LOS<48 hours|97|||
105705015|NCT00563186|364582417|FG001|Overall Study|LOS<48 hours|74|||
105705016|NCT00563186|364582416|FG000|Overall Study|Incomplete data|1|||
105705017|NCT00563186|364582417|FG001|Overall Study|Incomplete data|1|||
105705018|NCT04839380|364582418|FG000|Overall Study|Withdrawal by Subject|2|||
105705019|NCT04839380|364582418|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
105705020|NCT00513500|364582419|FG000|Overall Study|Lost to Follow-up|35|||
105705021|NCT00513500|364582420|FG001|Overall Study|Lost to Follow-up|39|||
105705022|NCT00513500|364582419|FG000|Overall Study|Death|2|||
105705023|NCT00513500|364582420|FG001|Overall Study|Death|1|||
105705024|NCT00513500|364582419|FG000|Overall Study|Hospitalized|4|||
105705025|NCT00513500|364582420|FG001|Overall Study|Hospitalized|14|||
105705026|NCT00996944|364582422|FG000|Double-blind Treatment Period|Adverse Event|2|||
105705027|NCT00996944|364582423|FG001|Double-blind Treatment Period|Adverse Event|1|||
105705028|NCT00996944|364582422|FG000|Double-blind Treatment Period|Protocol Violation|1|||
105705029|NCT00996944|364582423|FG001|Double-blind Treatment Period|Protocol Violation|0|||
105705030|NCT00996944|364582422|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
105705031|NCT00996944|364582423|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
105705032|NCT00996944|364582422|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
105705033|NCT00996944|364582423|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
105705034|NCT00996944|364582422|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
105705035|NCT00996944|364582423|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
105705036|NCT00769184|364582424|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
105705037|NCT00769184|364582425|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
105705038|NCT00769184|364582424|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
105705039|NCT00769184|364582425|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
105705040|NCT00769184|364582424|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
105705041|NCT00769184|364582425|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
105705042|NCT00889265|364582433|FG000|Overall Study|Adverse Event|1|||
105705043|NCT00889265|364582433|FG000|Overall Study|Lost to Follow-up|5|||
105705044|NCT00889265|364582433|FG000|Overall Study|Protocol Violation|1|||
105705045|NCT00401375|364582437|FG000|Overall Study|Protocol Violation|2|||
105705046|NCT00401375|364582438|FG001|Overall Study|Protocol Violation|2|||
105705047|NCT00401375|364582439|FG002|Overall Study|Protocol Violation|1|||
105705048|NCT00401375|364582437|FG000|Overall Study|Adverse Event|6|||
105705049|NCT00401375|364582438|FG001|Overall Study|Adverse Event|11|||
105350530|NCT00094536|363286221|FG000|Treatment and Follow-up|Adverse Event|4|||
105350531|NCT00094536|363286221|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
105705050|NCT00401375|364582439|FG002|Overall Study|Adverse Event|10|||
105705051|NCT00401375|364582437|FG000|Overall Study|Withdrawal by Subject|9|||
105705052|NCT00401375|364582438|FG001|Overall Study|Withdrawal by Subject|7|||
105705053|NCT00401375|364582439|FG002|Overall Study|Withdrawal by Subject|7|||
105705054|NCT00401375|364582437|FG000|Overall Study|Lost to Follow-up|0|||
105350532|NCT00094536|363286221|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
105705055|NCT00401375|364582438|FG001|Overall Study|Lost to Follow-up|1|||
105705056|NCT00401375|364582439|FG002|Overall Study|Lost to Follow-up|1|||
105350533|NCT00094536|363286221|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
105705057|NCT00401375|364582437|FG000|Overall Study|Other than specified|2|||
105705058|NCT00401375|364582438|FG001|Overall Study|Other than specified|1|||
105705059|NCT00401375|364582439|FG002|Overall Study|Other than specified|3|||
105705060|NCT00401375|364582437|FG000|Overall Study|Randomized but not treated|3|||
105705061|NCT00401375|364582438|FG001|Overall Study|Randomized but not treated|3|||
105705062|NCT00401375|364582439|FG002|Overall Study|Randomized but not treated|3|||
105350534|NCT00094536|363286221|FG000|Treatment and Follow-up|Subject non-compliance|9|||
105705063|NCT00361270|364582440|FG000|Overall Study|Death|0|||
105705064|NCT00361270|364582441|FG001|Overall Study|Death|0|||
105705065|NCT00361270|364582442|FG002|Overall Study|Death|0|||
105705066|NCT00361270|364582443|FG003|Overall Study|Death|2|||
105705067|NCT00361270|364582440|FG000|Overall Study|Lost to Follow-up|4|||
105705068|NCT00361270|364582441|FG001|Overall Study|Lost to Follow-up|1|||
105705069|NCT00361270|364582442|FG002|Overall Study|Lost to Follow-up|0|||
105705070|NCT00361270|364582443|FG003|Overall Study|Lost to Follow-up|0|||
105705071|NCT00361270|364582440|FG000|Overall Study|Physician Decision|0|||
105705072|NCT00361270|364582441|FG001|Overall Study|Physician Decision|0|||
105705073|NCT00361270|364582442|FG002|Overall Study|Physician Decision|1|||
105705074|NCT00361270|364582443|FG003|Overall Study|Physician Decision|0|||
105705075|NCT00361270|364582440|FG000|Overall Study|Protocol Violation|9|||
105705076|NCT00361270|364582441|FG001|Overall Study|Protocol Violation|4|||
105705077|NCT00361270|364582442|FG002|Overall Study|Protocol Violation|5|||
105705078|NCT00361270|364582443|FG003|Overall Study|Protocol Violation|4|||
105705079|NCT00361270|364582440|FG000|Overall Study|Withdrawal by Subject|6|||
105705080|NCT00361270|364582441|FG001|Overall Study|Withdrawal by Subject|6|||
105705081|NCT00361270|364582442|FG002|Overall Study|Withdrawal by Subject|3|||
105705082|NCT00361270|364582443|FG003|Overall Study|Withdrawal by Subject|7|||
105705083|NCT00361270|364582440|FG000|Overall Study|Afraid of Hypnosis|1|||
105705084|NCT00361270|364582441|FG001|Overall Study|Afraid of Hypnosis|2|||
105705085|NCT00361270|364582442|FG002|Overall Study|Afraid of Hypnosis|0|||
105705086|NCT00361270|364582443|FG003|Overall Study|Afraid of Hypnosis|0|||
105705087|NCT00361270|364582440|FG000|Overall Study|Problems with Transportation|4|||
105705088|NCT00361270|364582441|FG001|Overall Study|Problems with Transportation|0|||
105705089|NCT00361270|364582442|FG002|Overall Study|Problems with Transportation|0|||
105705090|NCT00361270|364582443|FG003|Overall Study|Problems with Transportation|0|||
105705091|NCT00361270|364582440|FG000|Overall Study|Adverse Event|0|||
105705092|NCT00361270|364582441|FG001|Overall Study|Adverse Event|1|||
105705093|NCT00361270|364582442|FG002|Overall Study|Adverse Event|1|||
105705094|NCT00361270|364582443|FG003|Overall Study|Adverse Event|0|||
105705095|NCT02821715|364582445|FG000|Overall Study|Protocol Violation|1|||
105705096|NCT02821715|364582446|FG001|Overall Study|Protocol Violation|0|||
105705097|NCT02821715|364582447|FG002|Overall Study|Protocol Violation|0|||
105705098|NCT02821715|364582448|FG003|Overall Study|Protocol Violation|0|||
105705099|NCT02821715|364582449|FG004|Overall Study|Protocol Violation|0|||
105705100|NCT02821715|364582450|FG005|Overall Study|Protocol Violation|0|||
105705101|NCT00677014|364582451|FG000|Overall Study|Lost to Follow-up|20|||
105705102|NCT00677014|364582452|FG001|Overall Study|Lost to Follow-up|12|||
105705103|NCT00677014|364582453|FG002|Overall Study|Lost to Follow-up|24|||
105705104|NCT00677014|364582451|FG000|Overall Study|Death|6|||
105705105|NCT00677014|364582452|FG001|Overall Study|Death|15|||
105705106|NCT00677014|364582453|FG002|Overall Study|Death|7|||
105705107|NCT00677014|364582451|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
105705108|NCT00677014|364582452|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
105705109|NCT00677014|364582453|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
105705110|NCT01326546|364582454|FG000|Overall Study|Lost to Follow-up|8|||
105705111|NCT01326546|364582455|FG001|Overall Study|Lost to Follow-up|7|||
105705112|NCT01326546|364582454|FG000|Overall Study|Protocol Violation|3|||
105705113|NCT01326546|364582455|FG001|Overall Study|Protocol Violation|4|||
105705114|NCT01326546|364582454|FG000|Overall Study|Pregnancy|0|||
105705115|NCT01326546|364582455|FG001|Overall Study|Pregnancy|1|||
105705116|NCT01326546|364582454|FG000|Overall Study|Adverse Event|1|||
105705117|NCT01326546|364582455|FG001|Overall Study|Adverse Event|0|||
105705118|NCT01326546|364582454|FG000|Overall Study|Withdrawal by Subject|5|||
105705119|NCT01326546|364582455|FG001|Overall Study|Withdrawal by Subject|1|||
105705120|NCT03152019|364582456|FG000|Overall Study|Adverse Event|0|||
105705121|NCT03152019|364582457|FG001|Overall Study|Adverse Event|1|||
105705122|NCT04294719|364582458|FG000|Overall Study|Withdrawal by Subject|1|||
105705123|NCT00254501|364582462|FG000|Overall Study|Lost to Follow-up|1|||
105705124|NCT00254501|364582463|FG001|Overall Study|Lost to Follow-up|1|||
105705125|NCT04194528|364582471|FG000|Overall Study|Adverse Event|1|||
105705126|NCT03770260|364583693|FG000|Overall Study|Disease progression|0|||
105705127|NCT03770260|364583694|FG001|Overall Study|Disease progression|1|||
105705128|NCT03770260|364583695|FG002|Overall Study|Disease progression|0|||
105705129|NCT03770260|364583696|FG003|Overall Study|Disease progression|0|||
105705130|NCT00609791|364583697|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
105705131|NCT00075400|364583698|FG000|Overall Study|Ineligible: wrong primary|1|||
105705132|NCT00075400|364583698|FG000|Overall Study|Never treated|2|||
105705133|NCT00980200|364583702|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
105705134|NCT00980200|364583703|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
105705135|NCT00980200|364583704|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
105705136|NCT00980200|364583705|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
105705137|NCT00980200|364583706|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
105705138|NCT00980200|364583702|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
105705139|NCT00980200|364583703|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
105705140|NCT00980200|364583704|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
105705141|NCT00980200|364583705|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
105705142|NCT00980200|364583706|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
105705143|NCT03670953|364583712|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
105705144|NCT03670953|364583713|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
105705145|NCT03670953|364583714|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
105705146|NCT03670953|364583715|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
105705147|NCT03670953|364583712|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
105705148|NCT03670953|364583713|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
105705149|NCT03670953|364583714|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
105705150|NCT03670953|364583715|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
105705151|NCT03670953|364583712|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
105705152|NCT03670953|364583713|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
105705153|NCT03670953|364583714|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
105705154|NCT03670953|364583715|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
105705155|NCT03670953|364583712|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
105705156|NCT03670953|364583713|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
105705157|NCT03670953|364583714|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
105705158|NCT03670953|364583715|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
105705159|NCT03670953|364583712|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
105705160|NCT03670953|364583713|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
105705161|NCT03670953|364583714|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
105705162|NCT03670953|364583715|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
105705163|NCT03670953|364583712|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
105705164|NCT03670953|364583713|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
105705165|NCT03670953|364583714|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
105705166|NCT03670953|364583715|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
105705167|NCT03670953|364583712|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
105705168|NCT03670953|364583713|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
105705169|NCT03670953|364583714|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
105705170|NCT03670953|364583715|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
105705171|NCT03670953|364583712|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
105705172|NCT03670953|364583713|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
105705173|NCT03670953|364583714|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
105705174|NCT03670953|364583715|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
105705175|NCT03670953|364583712|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
105705176|NCT03670953|364583713|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
105474650|NCT01349049|363751163|FG004|Overall Study|Disease progression|2|||
105350535|NCT00094536|363286221|FG000|Treatment and Follow-up|Unable to attend visits|1|||
105350536|NCT03053427|363286222|FG000|Overall Study|Adverse Event|4|||
105350537|NCT03053427|363286223|FG001|Overall Study|Adverse Event|4|||
105350538|NCT03053427|363286222|FG000|Overall Study|Lack of Efficacy|1|||
105350539|NCT03053427|363286223|FG001|Overall Study|Lack of Efficacy|3|||
105350540|NCT03053427|363286222|FG000|Overall Study|Lost to Follow-up|2|||
105350541|NCT03053427|363286223|FG001|Overall Study|Lost to Follow-up|2|||
105350542|NCT03053427|363286222|FG000|Overall Study|Worsening of the target disease|0|||
105350543|NCT03053427|363286223|FG001|Overall Study|Worsening of the target disease|1|||
105350544|NCT03053427|363286222|FG000|Overall Study|Protocol Deviation|3|||
105350545|NCT03053427|363286223|FG001|Overall Study|Protocol Deviation|3|||
105350546|NCT03053427|363286222|FG000|Overall Study|Withdrawal by Subject|3|||
105350547|NCT03053427|363286223|FG001|Overall Study|Withdrawal by Subject|2|||
105350548|NCT03053427|363286222|FG000|Overall Study|Miscellaneous|0|||
105350549|NCT03053427|363286223|FG001|Overall Study|Miscellaneous|1|||
105350550|NCT01416155|363286224|FG000|Overall Study|Adverse Event|8|||
105350551|NCT01416155|363286224|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
105350552|NCT01416155|363286224|FG000|Overall Study|Withdrawal by Subject|33|||
105350553|NCT01416155|363286224|FG000|Overall Study|Investigator decision|8|||
105350554|NCT01416155|363286224|FG000|Overall Study|Other|7|||
105350555|NCT01714609|363286225|FG000|Overall Study|Protocol Violation|1|||
105350556|NCT01714609|363286226|FG001|Overall Study|Protocol Violation|0|||
105350557|NCT02012959|363286227|FG000|Treatment Phase A|Adverse Event|2|||
105350558|NCT02012959|363286228|FG001|Treatment Phase A|Adverse Event|0|||
105350559|NCT02012959|363286229|FG002|Treatment Phase A|Adverse Event|0|||
105350560|NCT02012959|363286230|FG003|Treatment Phase A|Adverse Event|0|||
105350561|NCT02012959|363286231|FG004|Treatment Phase A|Adverse Event|0|||
105350562|NCT01900899|363286240|FG000|Overall Study|Withdrawal by Subject|7|||
105350563|NCT01900899|363286241|FG001|Overall Study|Withdrawal by Subject|1|||
105350564|NCT01900899|363286240|FG000|Overall Study|Migrated from study area|2|||
105350565|NCT01900899|363286241|FG001|Overall Study|Migrated from study area|0|||
105350566|NCT02427802|363286242|FG000|Overall Study|Adverse Event|11|||
105350567|NCT02427802|363286243|FG001|Overall Study|Adverse Event|3|||
105350568|NCT02427802|363286244|FG002|Overall Study|Adverse Event|7|||
105350569|NCT02427802|363286242|FG000|Overall Study|Death|0|||
105350570|NCT02427802|363286243|FG001|Overall Study|Death|4|||
105350571|NCT02427802|363286244|FG002|Overall Study|Death|1|||
105350572|NCT02427802|363286242|FG000|Overall Study|Lost to Follow-up|13|||
105350573|NCT02427802|363286243|FG001|Overall Study|Lost to Follow-up|8|||
105350574|NCT02427802|363286244|FG002|Overall Study|Lost to Follow-up|8|||
105350575|NCT02427802|363286242|FG000|Overall Study|Physician Decision|4|||
105350576|NCT02427802|363286243|FG001|Overall Study|Physician Decision|2|||
105350577|NCT02427802|363286244|FG002|Overall Study|Physician Decision|4|||
105350578|NCT02427802|363286242|FG000|Overall Study|Withdrawal by Subject|10|||
105350579|NCT02427802|363286243|FG001|Overall Study|Withdrawal by Subject|5|||
105350580|NCT02427802|363286244|FG002|Overall Study|Withdrawal by Subject|11|||
105350581|NCT02427802|363286242|FG000|Overall Study|Protocol Violation|3|||
105350582|NCT02427802|363286243|FG001|Overall Study|Protocol Violation|1|||
105350583|NCT02427802|363286244|FG002|Overall Study|Protocol Violation|1|||
105350584|NCT02427802|363286242|FG000|Overall Study|protocol specific treatment unrelated|18|||
105350585|NCT02427802|363286243|FG001|Overall Study|protocol specific treatment unrelated|11|||
105350586|NCT02427802|363286244|FG002|Overall Study|protocol specific treatment unrelated|11|||
105350587|NCT02109445|363286245|FG000|Overall Study|Symptomatic deterioration|2|||
105705177|NCT03670953|364583714|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
105705178|NCT03670953|364583715|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
105705179|NCT03670953|364583712|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
105705180|NCT03670953|364583713|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
105705181|NCT03670953|364583714|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
105705182|NCT03670953|364583715|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
105705183|NCT03670953|364583712|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
105350588|NCT02109445|363286245|FG000|Overall Study|Adverse Event|1|||
105350589|NCT02000882|363288119|FG000|Overall Study|Adverse Event|3|||
105350590|NCT02000882|363288119|FG000|Overall Study|Physician Decision|2|||
105350591|NCT02000882|363288119|FG000|Overall Study|Withdrawal by Subject|1|||
105350592|NCT05243563|363288120|FG000|Overall Study|Withdrawal by Subject|1|||
105350593|NCT05243563|363288121|FG001|Overall Study|Withdrawal by Subject|0|||
105350594|NCT05243563|363288120|FG000|Overall Study|Physician Decision|1|||
105350595|NCT05243563|363288121|FG001|Overall Study|Physician Decision|0|||
105350596|NCT00441363|363288122|FG000|Overall Study|Adverse Event|4|||
105350597|NCT00441363|363288123|FG001|Overall Study|Adverse Event|2|||
105350598|NCT00441363|363288122|FG000|Overall Study|Withdrawal by Subject|3|||
105350599|NCT00441363|363288123|FG001|Overall Study|Withdrawal by Subject|4|||
105350600|NCT00441363|363288122|FG000|Overall Study|Physician Decision|6|||
105350601|NCT00441363|363288123|FG001|Overall Study|Physician Decision|7|||
105350602|NCT00441363|363288122|FG000|Overall Study|Lost to Follow-up|2|||
105350603|NCT00441363|363288123|FG001|Overall Study|Lost to Follow-up|2|||
105350604|NCT00441363|363288122|FG000|Overall Study|Other|2|||
105350605|NCT00441363|363288123|FG001|Overall Study|Other|0|||
105350606|NCT02578940|363288124|FG000|Overall Study|Screening failure|5|||
105350607|NCT02578940|363288124|FG000|Overall Study|Lost to Follow-up|1|||
105705184|NCT03670953|364583713|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
105705185|NCT03670953|364583714|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
105705186|NCT03670953|364583715|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
105705187|NCT03670953|364583712|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
105705188|NCT03670953|364583713|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
105705189|NCT03670953|364583714|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
105350608|NCT03334422|363288125|FG000|Overall Study|Adverse Event|1|||
105705190|NCT03670953|364583715|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
105705191|NCT03670953|364583712|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
105705192|NCT03670953|364583713|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
105705193|NCT03670953|364583714|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
105705194|NCT03670953|364583715|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
105705195|NCT03670953|364583712|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
105705196|NCT03670953|364583713|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
105705197|NCT03670953|364583714|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
105350609|NCT03334422|363288126|FG001|Overall Study|Adverse Event|3|||
105705198|NCT03670953|364583715|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
105705199|NCT03670953|364583712|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
105705200|NCT03670953|364583713|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
105705201|NCT03670953|364583714|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
105705202|NCT03670953|364583715|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
105705203|NCT03670953|364583712|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
105705204|NCT03670953|364583713|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
105705205|NCT03670953|364583714|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
105705206|NCT03670953|364583715|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
105705207|NCT03670953|364583712|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
105705208|NCT03670953|364583713|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
105705209|NCT03670953|364583714|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
105705210|NCT03670953|364583715|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
105705211|NCT03670953|364583712|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
105705212|NCT03670953|364583713|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
105705213|NCT03670953|364583714|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
105705214|NCT03670953|364583715|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
105705215|NCT00412750|364583716|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105705216|NCT00412750|364583717|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105705217|NCT00412750|364583718|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105705218|NCT00412750|364583716|FG000|Overall Study|Administrative problems|21|||
105705219|NCT00412750|364583717|FG001|Overall Study|Administrative problems|17|||
105705220|NCT00412750|364583718|FG002|Overall Study|Administrative problems|14|||
105705221|NCT00412750|364583716|FG000|Overall Study|Adverse Event|8|||
105705222|NCT00412750|364583717|FG001|Overall Study|Adverse Event|3|||
105705223|NCT00412750|364583718|FG002|Overall Study|Adverse Event|3|||
105705224|NCT00412750|364583716|FG000|Overall Study|Lost to Follow-up|1|||
105787379|NCT01243762|364874941|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
105350610|NCT03334422|363288127|FG002|Overall Study|Adverse Event|2|||
105350611|NCT03334422|363288128|FG003|Overall Study|Adverse Event|2|||
105705225|NCT00412750|364583717|FG001|Overall Study|Lost to Follow-up|0|||
105705226|NCT00412750|364583718|FG002|Overall Study|Lost to Follow-up|1|||
105705227|NCT00412750|364583716|FG000|Overall Study|Withdrawal by Subject|0|||
105705228|NCT00412750|364583717|FG001|Overall Study|Withdrawal by Subject|1|||
105705229|NCT00412750|364583718|FG002|Overall Study|Withdrawal by Subject|2|||
105705230|NCT00412750|364583716|FG000|Overall Study|Lack of Efficacy|0|||
105705231|NCT00412750|364583717|FG001|Overall Study|Lack of Efficacy|0|||
105705232|NCT00412750|364583718|FG002|Overall Study|Lack of Efficacy|3|||
105705233|NCT01097746|364583724|FG000|Overall Study|Adverse Event|4|||
105705234|NCT01097746|364583724|FG000|Overall Study|taken off study before any treatment given|1|||
105705235|NCT00390546|364583725|FG000|Overall Study|Renal impairment|1|||
105705236|NCT00390546|364583726|FG001|Overall Study|Renal impairment|0|||
105705237|NCT00390546|364583725|FG000|Overall Study|Physician Decision|5|||
105705238|NCT00390546|364583726|FG001|Overall Study|Physician Decision|5|||
105705239|NCT00631371|364583727|FG000|Overall Study|Lost to Follow-up|24|||
105705240|NCT00631371|364583728|FG001|Overall Study|Lost to Follow-up|19|||
105705241|NCT00631371|364583727|FG000|Overall Study|Other reason|5|||
105705242|NCT00631371|364583728|FG001|Overall Study|Other reason|12|||
105705243|NCT00631371|364583727|FG000|Overall Study|subject request|38|||
105705244|NCT00631371|364583728|FG001|Overall Study|subject request|45|||
105705245|NCT00631371|364583727|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
105350612|NCT03334422|363288125|FG000|Overall Study|Lack of Efficacy|10|||
105350613|NCT03334422|363288126|FG001|Overall Study|Lack of Efficacy|2|||
105350614|NCT03334422|363288127|FG002|Overall Study|Lack of Efficacy|7|||
105350615|NCT03334422|363288128|FG003|Overall Study|Lack of Efficacy|3|||
105705246|NCT00631371|364583728|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
105705247|NCT00631371|364583727|FG000|Overall Study|Death|263|||
105705248|NCT00631371|364583728|FG001|Overall Study|Death|239|||
105705249|NCT01135498|364583736|FG000|Overall Study|Adverse Event|20|||
105705250|NCT01135498|364583736|FG000|Overall Study|Progressive disease|38|||
105705251|NCT01135498|364583736|FG000|Overall Study|Investigator judgement|25|||
105350616|NCT03334422|363288125|FG000|Overall Study|Withdrawal by Subject|8|||
105350617|NCT03334422|363288126|FG001|Overall Study|Withdrawal by Subject|3|||
105350618|NCT03334422|363288127|FG002|Overall Study|Withdrawal by Subject|1|||
105350619|NCT03334422|363288128|FG003|Overall Study|Withdrawal by Subject|0|||
105350620|NCT03334422|363288125|FG000|Overall Study|Lost to Follow-up|0|||
105350621|NCT03334422|363288126|FG001|Overall Study|Lost to Follow-up|0|||
105350622|NCT03334422|363288127|FG002|Overall Study|Lost to Follow-up|0|||
105350623|NCT03334422|363288128|FG003|Overall Study|Lost to Follow-up|1|||
105350624|NCT03334422|363288125|FG000|Overall Study|Inability to obtain laboratory samples|0|||
105350625|NCT03334422|363288126|FG001|Overall Study|Inability to obtain laboratory samples|1|||
105350626|NCT03334422|363288127|FG002|Overall Study|Inability to obtain laboratory samples|0|||
105350627|NCT03334422|363288128|FG003|Overall Study|Inability to obtain laboratory samples|0|||
105350628|NCT03334422|363288125|FG000|Overall Study|Pregnancy|0|||
105350629|NCT03334422|363288126|FG001|Overall Study|Pregnancy|1|||
105350630|NCT03334422|363288127|FG002|Overall Study|Pregnancy|0|||
105350631|NCT03334422|363288128|FG003|Overall Study|Pregnancy|0|||
105350632|NCT05459558|363288129|FG000|Overall Study|Adverse Event|1|||
105350633|NCT05459558|363288130|FG001|Overall Study|Adverse Event|0|||
105350634|NCT05459558|363288131|FG002|Overall Study|Adverse Event|0|||
105350635|NCT05459558|363288129|FG000|Overall Study|Scheduling issue|0|||
105350636|NCT05459558|363288130|FG001|Overall Study|Scheduling issue|1|||
105350637|NCT05459558|363288131|FG002|Overall Study|Scheduling issue|3|||
105350638|NCT05459558|363288129|FG000|Overall Study|Withdrawal by Subject|0|||
105350639|NCT05459558|363288130|FG001|Overall Study|Withdrawal by Subject|0|||
105350640|NCT05459558|363288131|FG002|Overall Study|Withdrawal by Subject|2|||
105350641|NCT04571385|363288132|FG000|Overall Study|Participant non-compliance|1|||
105350642|NCT04571385|363288133|FG001|Overall Study|Participant non-compliance|0|||
105350643|NCT04571385|363288134|FG002|Overall Study|Participant non-compliance|0|||
105350644|NCT04571385|363288132|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
105350645|NCT04571385|363288133|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
105350646|NCT04571385|363288134|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
105350647|NCT04571385|363288132|FG000|Overall Study|Screen failure|0|||
105350648|NCT04571385|363288133|FG001|Overall Study|Screen failure|0|||
105350649|NCT04571385|363288134|FG002|Overall Study|Screen failure|1|||
105350650|NCT04591015|363288136|FG000|Overall Study|Death|6|||
105350651|NCT04591015|363288137|FG001|Overall Study|Death|4|||
105350652|NCT04591015|363288136|FG000|Overall Study|Withdrawal by Subject|6|||
105350653|NCT04591015|363288137|FG001|Overall Study|Withdrawal by Subject|3|||
105350654|NCT04591015|363288136|FG000|Overall Study|Lost to Follow-up|16|||
105350655|NCT04591015|363288137|FG001|Overall Study|Lost to Follow-up|11|||
105705252|NCT01135498|364583736|FG000|Overall Study|Withdrawal by Subject|4|||
105705253|NCT01135498|364583736|FG000|Overall Study|Death|1|||
105705254|NCT01135498|364583736|FG000|Overall Study|Ongoing at time of analysis|2|||
105705255|NCT00129766|364583741|FG000|Overall Study|Death|3|||
105705256|NCT00129766|364583742|FG001|Overall Study|Death|8|||
105705257|NCT00129766|364583741|FG000|Overall Study|Withdrawal of consent|31|||
105350656|NCT02509078|363288138|FG000|Overall Study|Protocol Violation|1|||
105350657|NCT02509078|363288139|FG001|Overall Study|Protocol Violation|1|||
105350658|NCT02686814|363288140|FG000|Overall Study|Physician Decision|14|||
105350659|NCT02686814|363288140|FG000|Overall Study|Withdrawal by Subject|4|||
105350660|NCT02686814|363288140|FG000|Overall Study|Death|1|||
105705258|NCT00129766|364583742|FG001|Overall Study|Withdrawal of consent|30|||
105705259|NCT00129766|364583741|FG000|Overall Study|Lost to Follow-up|26|||
105705260|NCT00129766|364583742|FG001|Overall Study|Lost to Follow-up|21|||
105350661|NCT03341936|363288141|FG000|Overall Study|Ineligible|1|||
105350662|NCT03341936|363288141|FG000|Overall Study|Disease Progression|2|||
105350663|NCT03341936|363288141|FG000|Overall Study|Withdrew Consent|4|||
105705261|NCT05440539|364583744|FG000|Overall Study|Lost to Follow-up|4|||
105350664|NCT03341936|363288141|FG000|Overall Study|Non-Compliance|1|||
105350665|NCT03341936|363288141|FG000|Overall Study|Physician Decision|1|||
105350666|NCT03341936|363288141|FG000|Overall Study|Withdrawal by Subject|1|||
105350667|NCT03341936|363288141|FG000|Overall Study|Other|1|||
105350668|NCT02368886|363288142|FG000|Overall Study|Cancel|1|||
105350669|NCT02368886|363288143|FG001|Overall Study|Cancel|1|||
105350670|NCT02368886|363288144|FG002|Overall Study|Cancel|1|||
105350671|NCT02368886|363288145|FG003|Overall Study|Cancel|3|||
105350672|NCT02368886|363288142|FG000|Overall Study|Ineligible|0|||
105350673|NCT02368886|363288143|FG001|Overall Study|Ineligible|0|||
105350674|NCT02368886|363288144|FG002|Overall Study|Ineligible|0|||
105705262|NCT05440539|364583745|FG001|Overall Study|Lost to Follow-up|4|||
105705263|NCT05440539|364583744|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
105705264|NCT05440539|364583745|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
105705265|NCT01577186|364583746|FG000|Overall Study|Adverse Event|23|||
105705266|NCT01577186|364583746|FG000|Overall Study|Death|1|||
105705267|NCT01577186|364583746|FG000|Overall Study|Lost to Follow-up|28|||
105705268|NCT01577186|364583746|FG000|Overall Study|Withdrawal by Subject|35|||
105705269|NCT01577186|364583746|FG000|Overall Study|Insufficient Response|18|||
105705270|NCT01577186|364583746|FG000|Overall Study|Ineligible to Continue|15|||
105705271|NCT01577186|364583746|FG000|Overall Study|Non-Compliant|8|||
105705272|NCT01577186|364583746|FG000|Overall Study|Other|2|||
105705273|NCT03287219|364583747|FG000|Overall Study|Protocol Violation|0|||
105705274|NCT03287219|364583748|FG001|Overall Study|Protocol Violation|2|||
105705275|NCT02797808|364583753|FG000|Overall Study|Withdrawal by Subject|1|||
105705276|NCT02797808|364583754|FG001|Overall Study|Withdrawal by Subject|1|||
105705277|NCT02797808|364583753|FG000|Overall Study|Physician Decision|6|||
105705278|NCT02797808|364583754|FG001|Overall Study|Physician Decision|2|||
105705279|NCT03571646|364583756|FG000|Overall Study|Adverse Event|1|||
105705280|NCT03571646|364583757|FG001|Overall Study|Adverse Event|0|||
105705281|NCT03571646|364583756|FG000|Overall Study|Withdrawal by Subject|1|||
105705282|NCT03571646|364583757|FG001|Overall Study|Withdrawal by Subject|1|||
105705283|NCT04677959|364583758|FG000|Overall Study|Adverse Event|1|||
105705284|NCT04677959|364583759|FG001|Overall Study|Adverse Event|9|||
105705285|NCT04677959|364583758|FG000|Overall Study|Withdrawal by Subject|2|||
105705286|NCT04677959|364583759|FG001|Overall Study|Withdrawal by Subject|15|||
105705287|NCT04677959|364583758|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105705288|NCT04677959|364583759|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105705289|NCT04677959|364583758|FG000|Overall Study|Non-compliance with study drug|0|||
105705290|NCT04677959|364583759|FG001|Overall Study|Non-compliance with study drug|2|||
105705291|NCT04677959|364583758|FG000|Overall Study|Protocol deviation|0|||
105705292|NCT04677959|364583759|FG001|Overall Study|Protocol deviation|11|||
105705293|NCT04677959|364583758|FG000|Overall Study|Lost to Follow-up|9|||
105705294|NCT04677959|364583759|FG001|Overall Study|Lost to Follow-up|13|||
105705295|NCT04677959|364583758|FG000|Overall Study|Other than specified|0|||
105705296|NCT04677959|364583759|FG001|Overall Study|Other than specified|8|||
105705297|NCT00535132|364583760|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
105705298|NCT00535132|364583761|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
105705299|NCT00535132|364583760|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
105705300|NCT00535132|364583761|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
105705301|NCT00264875|364583762|FG000|Overall Study|Adverse Event|6|||
105705302|NCT00264875|364583762|FG000|Overall Study|Lost to Follow-up|6|||
105705303|NCT00264875|364583762|FG000|Overall Study|Protocol Violation|11|||
105705304|NCT00264875|364583762|FG000|Overall Study|Withdrawal by Subject|7|||
105705305|NCT02590588|364583763|FG000|Overall Study|Adverse Event|1|||
105705306|NCT05630937|364583765|FG000|Overall Study|Study terminated by sponsor|1|||
105705307|NCT05630937|364583766|FG001|Overall Study|Study terminated by sponsor|1|||
105705308|NCT05630937|364583767|FG002|Overall Study|Study terminated by sponsor|8|||
105705309|NCT05630937|364583768|FG003|Overall Study|Study terminated by sponsor|0|||
105705310|NCT05630937|364583765|FG000|Overall Study|Lost to Follow-up|0|||
105705311|NCT05630937|364583766|FG001|Overall Study|Lost to Follow-up|0|||
105705312|NCT05630937|364583767|FG002|Overall Study|Lost to Follow-up|1|||
105705313|NCT05630937|364583768|FG003|Overall Study|Lost to Follow-up|0|||
105705314|NCT05630937|364583765|FG000|Overall Study|Enrolled but not treated|0|||
105705315|NCT05630937|364583766|FG001|Overall Study|Enrolled but not treated|0|||
105705316|NCT05630937|364583767|FG002|Overall Study|Enrolled but not treated|0|||
105705317|NCT05630937|364583768|FG003|Overall Study|Enrolled but not treated|1|||
105705318|NCT03031301|364583769|FG000|Overall Study|Protocol Violation|4|||
105705319|NCT03031301|364583770|FG001|Overall Study|Protocol Violation|8|||
105705320|NCT03031301|364583769|FG000|Overall Study|Withdrawal by Subject|7|||
105705321|NCT03031301|364583770|FG001|Overall Study|Withdrawal by Subject|4|||
105705322|NCT03031301|364583769|FG000|Overall Study|Lost to Follow-up|4|||
105705323|NCT03031301|364583770|FG001|Overall Study|Lost to Follow-up|12|||
105705324|NCT03031301|364583769|FG000|Overall Study|Noncompliance|1|||
105705325|NCT03031301|364583770|FG001|Overall Study|Noncompliance|3|||
105705326|NCT03031301|364583769|FG000|Overall Study|Technical issue|1|||
105705327|NCT03031301|364583770|FG001|Overall Study|Technical issue|1|||
105705328|NCT03031301|364583769|FG000|Overall Study|Adverse Event|1|||
105705329|NCT03031301|364583770|FG001|Overall Study|Adverse Event|0|||
105705330|NCT02182687|364583782|FG000|Overall Study|Withdrawal by Subject|4|||
105705331|NCT02182687|364583783|FG001|Overall Study|Withdrawal by Subject|0|||
105705332|NCT02182687|364583782|FG000|Overall Study|Adverse Event|1|||
105705333|NCT02182687|364583783|FG001|Overall Study|Adverse Event|0|||
105705334|NCT02182687|364583782|FG000|Overall Study|Lost to Follow-up|0|||
105705335|NCT02182687|364583783|FG001|Overall Study|Lost to Follow-up|1|||
105705336|NCT01297270|364583784|FG000|Overall Study|Adverse Event|19|||
105705337|NCT01297270|364583785|FG001|Overall Study|Adverse Event|32|||
105705338|NCT01297270|364583786|FG002|Overall Study|Adverse Event|5|||
105705339|NCT01297270|364583784|FG000|Overall Study|Lack of Efficacy|15|||
105705340|NCT01297270|364583785|FG001|Overall Study|Lack of Efficacy|17|||
105705341|NCT01297270|364583786|FG002|Overall Study|Lack of Efficacy|15|||
105705342|NCT01297270|364583784|FG000|Overall Study|Lost to Follow-up|1|||
105705343|NCT01297270|364583785|FG001|Overall Study|Lost to Follow-up|2|||
105705344|NCT01297270|364583786|FG002|Overall Study|Lost to Follow-up|1|||
105705345|NCT01297270|364583784|FG000|Overall Study|Protocol Violation|0|||
105705346|NCT01297270|364583785|FG001|Overall Study|Protocol Violation|2|||
105705347|NCT01297270|364583786|FG002|Overall Study|Protocol Violation|0|||
105705348|NCT01297270|364583784|FG000|Overall Study|Withdrawal by Subject|7|||
105705349|NCT01297270|364583785|FG001|Overall Study|Withdrawal by Subject|15|||
105705350|NCT01297270|364583786|FG002|Overall Study|Withdrawal by Subject|7|||
105705351|NCT01297270|364583784|FG000|Overall Study|Other reason not defined above|3|||
105705352|NCT01297270|364583785|FG001|Overall Study|Other reason not defined above|3|||
105705353|NCT01297270|364583786|FG002|Overall Study|Other reason not defined above|1|||
105705354|NCT01297270|364583784|FG000|Overall Study|Not treated|0|||
105705355|NCT01297270|364583785|FG001|Overall Study|Not treated|1|||
105705356|NCT01297270|364583786|FG002|Overall Study|Not treated|0|||
105705357|NCT03965689|364583787|FG000|Overall Study|Too sick to get study intervention|2|||
105705358|NCT00794677|364583793|FG000|First Intervention|Withdrawal by Subject|2|||
105705359|NCT00794677|364583794|FG001|First Intervention|Withdrawal by Subject|0|||
105705360|NCT02716987|364583795|FG000|Overall Study|Ligand synthesis failure|0|||
105705361|NCT02716987|364583796|FG001|Overall Study|Ligand synthesis failure|0|||
105705362|NCT02716987|364583797|FG002|Overall Study|Ligand synthesis failure|1|||
105705363|NCT02716987|364583798|FG003|Overall Study|Ligand synthesis failure|0|||
105705364|NCT02716987|364583799|FG004|Overall Study|Ligand synthesis failure|0|||
105705365|NCT02716987|364583800|FG005|Overall Study|Ligand synthesis failure|0|||
105705366|NCT02716987|364583795|FG000|Overall Study|Withdrawal by Subject|0|||
105705367|NCT02716987|364583796|FG001|Overall Study|Withdrawal by Subject|0|||
105705368|NCT02716987|364583797|FG002|Overall Study|Withdrawal by Subject|0|||
105705369|NCT02716987|364583798|FG003|Overall Study|Withdrawal by Subject|0|||
105705370|NCT02716987|364583799|FG004|Overall Study|Withdrawal by Subject|1|||
105705371|NCT02716987|364583800|FG005|Overall Study|Withdrawal by Subject|1|||
105705372|NCT03223428|364583802|FG000|Overall Study|No longer taking Xermelo|27|||
105705373|NCT03223428|364583802|FG000|Overall Study|Declined Consent|1|||
105705374|NCT03223428|364583802|FG000|Overall Study|Non-responders|56|||
105705375|NCT03223428|364583802|FG000|Overall Study|Withdrawal by Subject|14|||
105705376|NCT01834274|364583803|FG000|Overall Study|Study Termination|41|||
105705377|NCT01834274|364583804|FG001|Overall Study|Study Termination|38|||
105705378|NCT01834274|364583803|FG000|Overall Study|Withdrawal by Subject|1|||
105705379|NCT01834274|364583804|FG001|Overall Study|Withdrawal by Subject|1|||
105705380|NCT01834274|364583803|FG000|Overall Study|Lost to Follow-up|3|||
105705381|NCT01834274|364583804|FG001|Overall Study|Lost to Follow-up|1|||
105705382|NCT01834274|364583803|FG000|Overall Study|Other|2|||
105705383|NCT01834274|364583804|FG001|Overall Study|Other|1|||
105787380|NCT01243762|364874942|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
105705384|NCT02728830|364583805|FG000|Overall Study|Exclusionary Surgery|9|||
105705385|NCT02728830|364583805|FG000|Overall Study|Exclusionary Pathology|6|||
105705386|NCT02728830|364583805|FG000|Overall Study|Physician Decision|3|||
105705387|NCT02728830|364583805|FG000|Overall Study|Withdrawal by Subject|2|||
105705388|NCT02728830|364583805|FG000|Overall Study|Lost to Follow-up|1|||
105705389|NCT02728830|364583805|FG000|Overall Study|Exclusionary Lab Values|1|||
105705390|NCT02728830|364583805|FG000|Overall Study|Contraindicated Illness|1|||
105705391|NCT02728830|364583805|FG000|Overall Study|Language Barrier|1|||
105705392|NCT02039375|364583810|FG000|Overall Study|Lost to Follow-up|2|||
105705393|NCT04770389|364583811|FG000|Overall Study|Adverse Event|1|||
105705394|NCT04770389|364583812|FG001|Overall Study|Adverse Event|2|||
105705395|NCT04770389|364583813|FG002|Overall Study|Adverse Event|0|||
105705396|NCT04770389|364583814|FG003|Overall Study|Adverse Event|1|||
105705397|NCT04770389|364583811|FG000|Overall Study|Withdrawal by Subject|0|||
105705398|NCT04770389|364583812|FG001|Overall Study|Withdrawal by Subject|2|||
105705399|NCT04770389|364583813|FG002|Overall Study|Withdrawal by Subject|1|||
105705400|NCT04770389|364583814|FG003|Overall Study|Withdrawal by Subject|0|||
105705401|NCT04770389|364583811|FG000|Overall Study|Failed attempt to draw blood|1|||
105705402|NCT04770389|364583812|FG001|Overall Study|Failed attempt to draw blood|0|||
105705403|NCT04770389|364583813|FG002|Overall Study|Failed attempt to draw blood|0|||
105705404|NCT04770389|364583814|FG003|Overall Study|Failed attempt to draw blood|0|||
105705405|NCT04770389|364583811|FG000|Overall Study|Left the country|0|||
105705406|NCT04770389|364583812|FG001|Overall Study|Left the country|0|||
105705407|NCT04770389|364583813|FG002|Overall Study|Left the country|1|||
105705408|NCT04770389|364583814|FG003|Overall Study|Left the country|2|||
105705409|NCT04770389|364583811|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
105705410|NCT04770389|364583812|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
105705411|NCT04770389|364583813|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
105705412|NCT04770389|364583814|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
105705413|NCT04770389|364583811|FG000|Overall Study|Lost to Follow-up|0|||
105705414|NCT04770389|364583812|FG001|Overall Study|Lost to Follow-up|0|||
105705415|NCT04770389|364583813|FG002|Overall Study|Lost to Follow-up|0|||
105705416|NCT04770389|364583814|FG003|Overall Study|Lost to Follow-up|1|||
105705417|NCT04770389|364583811|FG000|Overall Study|Moved away from study site|0|||
105705418|NCT04770389|364583812|FG001|Overall Study|Moved away from study site|1|||
105705419|NCT04770389|364583813|FG002|Overall Study|Moved away from study site|0|||
105705420|NCT04770389|364583814|FG003|Overall Study|Moved away from study site|0|||
105705421|NCT00137111|364583818|FG000|Total Therapy|Death|35|||
105705422|NCT00137111|364583819|FG001|Total Therapy|Death|0|||
105705423|NCT00137111|364583820|FG002|Total Therapy|Death|0|||
105705424|NCT00137111|364583821|FG003|Total Therapy|Death|0|||
105705425|NCT00137111|364583818|FG000|Total Therapy|Non Compliance|5|||
105705426|NCT00137111|364583819|FG001|Total Therapy|Non Compliance|0|||
105705427|NCT00137111|364583820|FG002|Total Therapy|Non Compliance|0|||
105705428|NCT00137111|364583821|FG003|Total Therapy|Non Compliance|0|||
105705429|NCT00317109|364583826|FG000|Overall Study|Withdrawal by Subject|2|||
105705430|NCT00317109|364583827|FG001|Overall Study|Withdrawal by Subject|0|||
105705431|NCT00317109|364583826|FG000|Overall Study|Migated/moved from study area|1|||
105705432|NCT00317109|364583827|FG001|Overall Study|Migated/moved from study area|0|||
105705433|NCT01026831|364583828|FG000|Overall Study|Adverse Event|4|||
105705434|NCT01026831|364583829|FG001|Overall Study|Adverse Event|3|||
105705435|NCT01026831|364583828|FG000|Overall Study|Lost to Follow-up|2|||
105705436|NCT01026831|364583829|FG001|Overall Study|Lost to Follow-up|0|||
105705437|NCT01026831|364583828|FG000|Overall Study|Physician Decision|1|||
105705438|NCT01026831|364583829|FG001|Overall Study|Physician Decision|1|||
105705439|NCT01026831|364583828|FG000|Overall Study|Protocol Violation|0|||
105705440|NCT01026831|364583829|FG001|Overall Study|Protocol Violation|2|||
105705441|NCT01026831|364583828|FG000|Overall Study|Withdrawal by Subject|7|||
105705442|NCT01026831|364583829|FG001|Overall Study|Withdrawal by Subject|5|||
105705443|NCT00761514|364583832|FG000|Overall Study|Adverse Event|1|||
105705444|NCT00761514|364583832|FG000|Overall Study|Withdrawal by Subject|2|||
105705445|NCT00761514|364583832|FG000|Overall Study|Lost to Follow-up|1|||
105350675|NCT02368886|363288145|FG003|Overall Study|Ineligible|1|||
105474651|NCT01349049|363751164|FG005|Overall Study|Disease progression|2|||
105474652|NCT01349049|363751165|FG006|Overall Study|Disease progression|3|||
105705446|NCT00761514|364583832|FG000|Overall Study|Health insurance didn't cover study drug|1|||
105705447|NCT00761514|364583832|FG000|Overall Study|Problem complying with study visit|1|||
105705448|NCT00761514|364583832|FG000|Overall Study|Unable to pay for medications|1|||
105705449|NCT00852995|364583835|FG000|Overall Study|Adverse Event|1|||
105705450|NCT00852995|364583836|FG001|Overall Study|Adverse Event|0|||
105705451|NCT00852995|364583837|FG002|Overall Study|Adverse Event|4|||
105705452|NCT00852995|364583838|FG003|Overall Study|Adverse Event|0|||
105705453|NCT00852995|364583839|FG004|Overall Study|Adverse Event|0|||
105705454|NCT00852995|364583835|FG000|Overall Study|Lost to Follow-up|0|||
105705455|NCT00852995|364583836|FG001|Overall Study|Lost to Follow-up|1|||
105705456|NCT00852995|364583837|FG002|Overall Study|Lost to Follow-up|1|||
105705457|NCT00852995|364583838|FG003|Overall Study|Lost to Follow-up|0|||
105705458|NCT00852995|364583839|FG004|Overall Study|Lost to Follow-up|0|||
105705459|NCT00852995|364583835|FG000|Overall Study|Withdrawal by Subject|4|||
105705460|NCT00852995|364583836|FG001|Overall Study|Withdrawal by Subject|0|||
105705461|NCT00852995|364583837|FG002|Overall Study|Withdrawal by Subject|0|||
105705462|NCT00852995|364583838|FG003|Overall Study|Withdrawal by Subject|1|||
105705463|NCT00852995|364583839|FG004|Overall Study|Withdrawal by Subject|2|||
105705464|NCT00852995|364583835|FG000|Overall Study|Non-Compliance|0|||
105705465|NCT00852995|364583836|FG001|Overall Study|Non-Compliance|0|||
105705466|NCT00852995|364583837|FG002|Overall Study|Non-Compliance|0|||
105705467|NCT00852995|364583838|FG003|Overall Study|Non-Compliance|2|||
105705468|NCT00852995|364583839|FG004|Overall Study|Non-Compliance|0|||
105705469|NCT00852995|364583835|FG000|Overall Study|Progressive Disease|1|||
105705470|NCT00852995|364583836|FG001|Overall Study|Progressive Disease|0|||
105705471|NCT00852995|364583837|FG002|Overall Study|Progressive Disease|0|||
105705472|NCT00852995|364583838|FG003|Overall Study|Progressive Disease|2|||
105705473|NCT00852995|364583839|FG004|Overall Study|Progressive Disease|1|||
105705474|NCT00852995|364583835|FG000|Overall Study|Physician Decision|1|||
105705475|NCT00852995|364583836|FG001|Overall Study|Physician Decision|0|||
105705476|NCT00852995|364583837|FG002|Overall Study|Physician Decision|0|||
105705477|NCT00852995|364583838|FG003|Overall Study|Physician Decision|0|||
105705478|NCT00852995|364583839|FG004|Overall Study|Physician Decision|0|||
105705479|NCT00852995|364583835|FG000|Overall Study|Protocol Violation|0|||
105705480|NCT00852995|364583836|FG001|Overall Study|Protocol Violation|0|||
105705481|NCT00852995|364583837|FG002|Overall Study|Protocol Violation|0|||
105705482|NCT00852995|364583838|FG003|Overall Study|Protocol Violation|0|||
105705483|NCT00852995|364583839|FG004|Overall Study|Protocol Violation|1|||
105705484|NCT00852995|364583835|FG000|Overall Study|Moved Out of Area|1|||
105705485|NCT00852995|364583836|FG001|Overall Study|Moved Out of Area|0|||
105705486|NCT00852995|364583837|FG002|Overall Study|Moved Out of Area|0|||
105705487|NCT00852995|364583838|FG003|Overall Study|Moved Out of Area|0|||
105705488|NCT00852995|364583839|FG004|Overall Study|Moved Out of Area|0|||
105705489|NCT02457637|364583840|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
105705490|NCT01836783|364583841|FG000|Overall Study|Withdrawal by Subject|0|||
105705491|NCT01836783|364583842|FG001|Overall Study|Withdrawal by Subject|2|||
105705492|NCT04942925|364583844|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
105705493|NCT04942925|364583845|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
105705494|NCT04942925|364583844|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
105705495|NCT04942925|364583845|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
105705496|NCT01273883|364583846|FG000|First Intervention|Adverse Event|2|||
105705497|NCT01273883|364583847|FG001|First Intervention|Adverse Event|1|||
105474653|NCT01349049|363751166|FG007|Overall Study|Disease progression|2|||
105705498|NCT01273883|364583846|FG000|Second Intervention|Lost to Follow-up|1|||
105705499|NCT01273883|364583847|FG001|Second Intervention|Lost to Follow-up|1|||
105705500|NCT01273883|364583846|FG000|Second Intervention|Lack of Efficacy|1|||
105705501|NCT01273883|364583847|FG001|Second Intervention|Lack of Efficacy|0|||
105705502|NCT00371865|364583849|FG000|Overall Study|Lack of Efficacy|0|||
105705503|NCT00371865|364583850|FG001|Overall Study|Lack of Efficacy|2|||
105705504|NCT00371865|364583849|FG000|Overall Study|Protocol Violation|3|||
105705505|NCT00371865|364583850|FG001|Overall Study|Protocol Violation|2|||
105705506|NCT00371865|364583849|FG000|Overall Study|Withdrawal by Subject|12|||
105705507|NCT00371865|364583850|FG001|Overall Study|Withdrawal by Subject|10|||
105474654|NCT01349049|363751167|FG008|Overall Study|Disease progression|33|||
105705508|NCT03217266|364585136|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
105705509|NCT03217266|364585137|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
105705510|NCT03217266|364585138|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
105705511|NCT03217266|364585139|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
105705512|NCT03217266|364585136|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
105705513|NCT03217266|364585137|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
105705514|NCT03217266|364585138|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
105705515|NCT03217266|364585139|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
105705516|NCT03217266|364585136|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
105705517|NCT03217266|364585137|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
105705518|NCT03217266|364585138|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
105705519|NCT03217266|364585139|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
105705520|NCT04218201|364585140|FG000|Overall Study|Death|0|||
105705521|NCT04218201|364585141|FG001|Overall Study|Death|0|||
105705522|NCT04218201|364585142|FG002|Overall Study|Death|2|||
105705523|NCT04218201|364585143|FG003|Overall Study|Death|0|||
105705524|NCT04218201|364585140|FG000|Overall Study|Unable to contact participant|4|||
105705525|NCT04218201|364585141|FG001|Overall Study|Unable to contact participant|0|||
105705526|NCT04218201|364585142|FG002|Overall Study|Unable to contact participant|3|||
105705527|NCT04218201|364585143|FG003|Overall Study|Unable to contact participant|0|||
105705528|NCT04218201|364585140|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
105705529|NCT04218201|364585141|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
105705530|NCT04218201|364585142|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
105705531|NCT04218201|364585143|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
105705532|NCT04218201|364585140|FG000|Overall Study|Withdrawal by Subject|2|||
105705533|NCT04218201|364585141|FG001|Overall Study|Withdrawal by Subject|0|||
105705534|NCT04218201|364585142|FG002|Overall Study|Withdrawal by Subject|0|||
105705535|NCT04218201|364585143|FG003|Overall Study|Withdrawal by Subject|0|||
105705536|NCT04218201|364585140|FG000|Overall Study|PCP plans to leave practice|0|||
105705537|NCT04218201|364585141|FG001|Overall Study|PCP plans to leave practice|8|||
105705538|NCT04218201|364585142|FG002|Overall Study|PCP plans to leave practice|0|||
105705539|NCT04218201|364585143|FG003|Overall Study|PCP plans to leave practice|5|||
105705540|NCT04218201|364585140|FG000|Overall Study|Reduced panel|0|||
105705541|NCT04218201|364585141|FG001|Overall Study|Reduced panel|0|||
105705542|NCT04218201|364585142|FG002|Overall Study|Reduced panel|0|||
105705543|NCT04218201|364585143|FG003|Overall Study|Reduced panel|1|||
105705544|NCT04218201|364585140|FG000|Overall Study|No longer interested in participating|0|||
105705545|NCT04218201|364585141|FG001|Overall Study|No longer interested in participating|1|||
105705546|NCT04218201|364585142|FG002|Overall Study|No longer interested in participating|0|||
105705547|NCT04218201|364585143|FG003|Overall Study|No longer interested in participating|0|||
105705548|NCT04649255|364585146|FG000|Overall Study|Death|9|||
105705549|NCT04649255|364585146|FG000|Overall Study|Withdrawal by Subject|1|||
105705550|NCT01395394|364585159|FG000|Baseline Study Visit|Protocol Violation|1|||
105705551|NCT01395394|364585160|FG001|Baseline Study Visit|Protocol Violation|0|||
105705552|NCT01395394|364585161|FG002|Baseline Study Visit|Protocol Violation|0|||
105705553|NCT01157078|364585164|FG000|Overall Study|Withdrawal by Subject|12|||
105705554|NCT01157078|364585165|FG001|Overall Study|Withdrawal by Subject|14|||
105705555|NCT01157078|364585164|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
105705556|NCT01157078|364585165|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105705557|NCT01157078|364585164|FG000|Overall Study|Adverse Event|6|||
105705558|NCT01157078|364585165|FG001|Overall Study|Adverse Event|6|||
105705559|NCT01157078|364585164|FG000|Overall Study|Severe non-compliance to protocol|2|||
105705560|NCT01157078|364585165|FG001|Overall Study|Severe non-compliance to protocol|4|||
105705561|NCT01157078|364585164|FG000|Overall Study|Condition under investigation worsened|0|||
105705562|NCT01157078|364585165|FG001|Overall Study|Condition under investigation worsened|1|||
105705563|NCT01157078|364585164|FG000|Overall Study|Lack of Efficacy|2|||
105705564|NCT01157078|364585165|FG001|Overall Study|Lack of Efficacy|0|||
105705565|NCT01157078|364585164|FG000|Overall Study|Study-specific withdrawal criteria|2|||
105705566|NCT01157078|364585165|FG001|Overall Study|Study-specific withdrawal criteria|2|||
105705567|NCT01157078|364585164|FG000|Overall Study|Lost to Follow-up|7|||
105705568|NCT01157078|364585165|FG001|Overall Study|Lost to Follow-up|5|||
105705569|NCT01157078|364585164|FG000|Overall Study|Other|2|||
105705570|NCT01157078|364585165|FG001|Overall Study|Other|4|||
105705571|NCT04329806|364585168|FG000|Overall Study|Physician Decision|3|||
105705572|NCT04329806|364585169|FG001|Overall Study|Physician Decision|4|||
105705573|NCT00513409|364585170|FG000|Overall Study|Adverse Event|0|||
105705574|NCT00513409|364585171|FG001|Overall Study|Adverse Event|1|||
105787381|NCT01243762|364874943|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
105787382|NCT01243762|364874944|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
105787383|NCT00003526|364874945|FG000|Overall Study|Not evaluable|6|||
105787384|NCT00489411|364874946|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
105787385|NCT00489411|364874947|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
105787386|NCT00489411|364874946|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
105787387|NCT00489411|364874947|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
105787388|NCT00489411|364874946|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
105787389|NCT00489411|364874947|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
105787390|NCT00489411|364874946|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
105787391|NCT00489411|364874947|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
105787392|NCT00489411|364874946|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
105787393|NCT00489411|364874947|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
105787394|NCT00308555|364874948|FG000|Overall Study|Withdrawal by Subject|1|||
105787395|NCT00308555|364874949|FG001|Overall Study|Withdrawal by Subject|0|||
105787396|NCT00308555|364874948|FG000|Overall Study|Physician Decision|2|||
105787397|NCT00308555|364874949|FG001|Overall Study|Physician Decision|0|||
105787398|NCT00276458|364874950|FG000|Overall Study|Adverse Event|0|||
105787399|NCT00276458|364874951|FG001|Overall Study|Adverse Event|2|||
105787400|NCT00276458|364874950|FG000|Overall Study|Lost to Follow-up|2|||
105787401|NCT00276458|364874951|FG001|Overall Study|Lost to Follow-up|2|||
105705575|NCT00513409|364585170|FG000|Overall Study|Withdrawal by Subject|0|||
105705576|NCT00513409|364585171|FG001|Overall Study|Withdrawal by Subject|2|||
105787402|NCT00276458|364874950|FG000|Overall Study|Protocol Violation|4|||
105705577|NCT00513409|364585170|FG000|Overall Study|Lost to Follow-up|0|||
105705578|NCT00513409|364585171|FG001|Overall Study|Lost to Follow-up|1|||
105705579|NCT00513409|364585170|FG000|Overall Study|Physician Decision|1|||
105705580|NCT00513409|364585171|FG001|Overall Study|Physician Decision|0|||
105705581|NCT00513409|364585170|FG000|Overall Study|Visit 3 not done|1|||
105705582|NCT00513409|364585171|FG001|Overall Study|Visit 3 not done|2|||
105705583|NCT02145741|364585172|FG000|Overall Study|Progressive disease|3|||
105705584|NCT02145741|364585173|FG001|Overall Study|Progressive disease|6|||
105705585|NCT02145741|364585174|FG002|Overall Study|Progressive disease|6|||
105705586|NCT02145741|364585172|FG000|Overall Study|quality issue with the administered drug|3|||
105705587|NCT02145741|364585173|FG001|Overall Study|quality issue with the administered drug|0|||
105705588|NCT02145741|364585174|FG002|Overall Study|quality issue with the administered drug|0|||
105705589|NCT01192022|364585175|FG000|Overall Study|Withdrawal of Consent|3|||
105705590|NCT01192022|364585176|FG001|Overall Study|Withdrawal of Consent|1|||
105705591|NCT01192022|364585177|FG002|Overall Study|Withdrawal of Consent|0|||
105705592|NCT01192022|364585178|FG003|Overall Study|Withdrawal of Consent|0|||
105705593|NCT01192022|364585179|FG004|Overall Study|Withdrawal of Consent|0|||
105705594|NCT01192022|364585175|FG000|Overall Study|Lost to Follow-up|4|||
105705595|NCT01192022|364585176|FG001|Overall Study|Lost to Follow-up|2|||
105705596|NCT01192022|364585177|FG002|Overall Study|Lost to Follow-up|1|||
105705597|NCT01192022|364585178|FG003|Overall Study|Lost to Follow-up|1|||
105787403|NCT00276458|364874951|FG001|Overall Study|Protocol Violation|3|||
105787404|NCT04668066|364874954|FG000|Part 1: Treatment Phase|Adverse Event|0|||
105787405|NCT04668066|364874955|FG001|Part 1: Treatment Phase|Adverse Event|0|||
105787406|NCT04668066|364874956|FG002|Part 1: Treatment Phase|Adverse Event|0|||
105787407|NCT04668066|364874957|FG003|Part 1: Treatment Phase|Adverse Event|0|||
105705598|NCT01192022|364585179|FG004|Overall Study|Lost to Follow-up|0|||
105787408|NCT04668066|364874958|FG004|Part 1: Treatment Phase|Adverse Event|0|||
105787409|NCT04668066|364874959|FG005|Part 1: Treatment Phase|Adverse Event|0|||
105787410|NCT04668066|364874960|FG006|Part 1: Treatment Phase|Adverse Event|0|||
105705599|NCT01192022|364585175|FG000|Overall Study|Adverse Event|1|||
105705600|NCT01192022|364585176|FG001|Overall Study|Adverse Event|0|||
105705601|NCT01192022|364585177|FG002|Overall Study|Adverse Event|0|||
105705602|NCT01192022|364585178|FG003|Overall Study|Adverse Event|0|||
105705603|NCT01192022|364585179|FG004|Overall Study|Adverse Event|0|||
105787411|NCT04668066|364874961|FG007|Part 1: Treatment Phase|Adverse Event|0|||
105787412|NCT04668066|364874962|FG008|Part 1: Treatment Phase|Adverse Event|0|||
105787413|NCT04668066|364874963|FG009|Part 1: Treatment Phase|Adverse Event|0|||
105787414|NCT04668066|364874964|FG010|Part 1: Treatment Phase|Adverse Event|0|||
105787415|NCT04668066|364874965|FG011|Part 1: Treatment Phase|Adverse Event|1|||
105787416|NCT04668066|364874966|FG012|Part 1: Treatment Phase|Adverse Event|1|||
105787417|NCT04668066|364874967|FG013|Part 1: Treatment Phase|Adverse Event|0|||
105787418|NCT04668066|364874968|FG014|Part 1: Treatment Phase|Adverse Event|0|||
105787419|NCT04668066|364874969|FG015|Part 1: Treatment Phase|Adverse Event|0|||
105787420|NCT04668066|364874970|FG016|Part 1: Treatment Phase|Adverse Event|0|||
105787421|NCT04668066|364874971|FG017|Part 1: Treatment Phase|Adverse Event|0|||
105787422|NCT04668066|364874972|FG018|Part 1: Treatment Phase|Adverse Event|0|||
105787423|NCT04668066|364874954|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787424|NCT04668066|364874955|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787425|NCT04668066|364874956|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
105787426|NCT04668066|364874957|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787427|NCT04668066|364874958|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787428|NCT04668066|364874959|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787429|NCT04668066|364874960|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787430|NCT04668066|364874961|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787431|NCT04668066|364874962|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787432|NCT04668066|364874963|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787433|NCT04668066|364874964|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787434|NCT04668066|364874965|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787435|NCT04668066|364874966|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787436|NCT04668066|364874967|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787437|NCT04668066|364874968|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787438|NCT04668066|364874969|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787439|NCT04668066|364874970|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787440|NCT04668066|364874971|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787441|NCT04668066|364874972|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787442|NCT04668066|364874954|FG000|Part 1: Treatment Phase|Other|0|||
105787443|NCT04668066|364874955|FG001|Part 1: Treatment Phase|Other|0|||
105787444|NCT04668066|364874956|FG002|Part 1: Treatment Phase|Other|0|||
105787445|NCT04668066|364874957|FG003|Part 1: Treatment Phase|Other|0|||
105787446|NCT04668066|364874958|FG004|Part 1: Treatment Phase|Other|0|||
105787447|NCT04668066|364874959|FG005|Part 1: Treatment Phase|Other|0|||
105787448|NCT04668066|364874960|FG006|Part 1: Treatment Phase|Other|0|||
105787449|NCT04668066|364874961|FG007|Part 1: Treatment Phase|Other|0|||
105787450|NCT04668066|364874962|FG008|Part 1: Treatment Phase|Other|0|||
105787451|NCT04668066|364874963|FG009|Part 1: Treatment Phase|Other|0|||
105787452|NCT04668066|364874964|FG010|Part 1: Treatment Phase|Other|0|||
105787453|NCT04668066|364874965|FG011|Part 1: Treatment Phase|Other|1|||
105787454|NCT04668066|364874966|FG012|Part 1: Treatment Phase|Other|0|||
105787455|NCT04668066|364874967|FG013|Part 1: Treatment Phase|Other|0|||
105787456|NCT04668066|364874968|FG014|Part 1: Treatment Phase|Other|0|||
105787457|NCT04668066|364874969|FG015|Part 1: Treatment Phase|Other|0|||
105787458|NCT04668066|364874970|FG016|Part 1: Treatment Phase|Other|0|||
105787459|NCT04668066|364874971|FG017|Part 1: Treatment Phase|Other|0|||
105787460|NCT04668066|364874972|FG018|Part 1: Treatment Phase|Other|0|||
105787461|NCT04668066|364874954|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787462|NCT04668066|364874955|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105350676|NCT04849416|363288147|FG000|Overall Study|Ongoing Treatment|12|||
105787463|NCT04668066|364874956|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787464|NCT04668066|364874957|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787465|NCT04668066|364874958|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787466|NCT04668066|364874959|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787467|NCT04668066|364874960|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787468|NCT04668066|364874961|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787469|NCT04668066|364874962|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787470|NCT04668066|364874963|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787471|NCT04668066|364874964|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787472|NCT04668066|364874965|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105705604|NCT01192022|364585175|FG000|Overall Study|Fatal Adverse Event|4|||
105705605|NCT01192022|364585176|FG001|Overall Study|Fatal Adverse Event|6|||
105705606|NCT01192022|364585177|FG002|Overall Study|Fatal Adverse Event|0|||
105705607|NCT01192022|364585178|FG003|Overall Study|Fatal Adverse Event|0|||
105705608|NCT01192022|364585179|FG004|Overall Study|Fatal Adverse Event|1|||
105705609|NCT01192022|364585175|FG000|Overall Study|Physician withdrew-patient hardship|1|||
105705610|NCT01192022|364585176|FG001|Overall Study|Physician withdrew-patient hardship|0|||
105705611|NCT01192022|364585177|FG002|Overall Study|Physician withdrew-patient hardship|0|||
105705612|NCT01192022|364585178|FG003|Overall Study|Physician withdrew-patient hardship|0|||
105705613|NCT01192022|364585179|FG004|Overall Study|Physician withdrew-patient hardship|0|||
105705614|NCT01192022|364585175|FG000|Overall Study|Patient too sick from chemotherapy|0|||
105705615|NCT01192022|364585176|FG001|Overall Study|Patient too sick from chemotherapy|1|||
105705616|NCT01192022|364585177|FG002|Overall Study|Patient too sick from chemotherapy|0|||
105705617|NCT01192022|364585178|FG003|Overall Study|Patient too sick from chemotherapy|0|||
105705618|NCT01192022|364585179|FG004|Overall Study|Patient too sick from chemotherapy|0|||
105705619|NCT01192022|364585175|FG000|Overall Study|Patient needed surgery|0|||
105705620|NCT01192022|364585176|FG001|Overall Study|Patient needed surgery|1|||
105705621|NCT01192022|364585177|FG002|Overall Study|Patient needed surgery|0|||
105705622|NCT01192022|364585178|FG003|Overall Study|Patient needed surgery|0|||
105705623|NCT01192022|364585179|FG004|Overall Study|Patient needed surgery|0|||
105705624|NCT01192022|364585175|FG000|Overall Study|Parents did not allow all follow up|0|||
105705625|NCT01192022|364585176|FG001|Overall Study|Parents did not allow all follow up|0|||
105705626|NCT01192022|364585177|FG002|Overall Study|Parents did not allow all follow up|0|||
105705627|NCT01192022|364585178|FG003|Overall Study|Parents did not allow all follow up|1|||
105705628|NCT01192022|364585179|FG004|Overall Study|Parents did not allow all follow up|0|||
105705629|NCT02646982|364585180|FG000|Overall Study|Adverse Event|1|||
105705630|NCT02646982|364585181|FG001|Overall Study|Adverse Event|1|||
105705631|NCT02646982|364585180|FG000|Overall Study|Withdrawal by Subject|2|||
105705632|NCT02646982|364585181|FG001|Overall Study|Withdrawal by Subject|1|||
105705633|NCT01594853|364585182|FG000|Overall Study|Withdrawal by Subject|1|||
105705634|NCT01594853|364585183|FG001|Overall Study|Withdrawal by Subject|1|||
105705635|NCT01594853|364585182|FG000|Overall Study|Lost to Follow-up|1|||
105705636|NCT01594853|364585183|FG001|Overall Study|Lost to Follow-up|1|||
105705637|NCT01594853|364585182|FG000|Overall Study|noncompliance with exercise|0|||
105705638|NCT01594853|364585183|FG001|Overall Study|noncompliance with exercise|1|||
105705639|NCT01902966|364585184|FG000|Overall Study|Death|1|||
105705640|NCT01902966|364585184|FG000|Overall Study|Physician Decision|1|||
105705641|NCT01902966|364585184|FG000|Overall Study|Withdrawal by Subject|1|||
105705642|NCT01081912|364585190|FG000|Conversion/Titration|Adverse Event|47|||
105705643|NCT01081912|364585191|FG001|Conversion/Titration|Adverse Event|0|||
105705644|NCT01081912|364585192|FG002|Conversion/Titration|Adverse Event|0|||
105705645|NCT01081912|364585190|FG000|Conversion/Titration|Lack of Efficacy|17|||
105705646|NCT01081912|364585191|FG001|Conversion/Titration|Lack of Efficacy|0|||
105705647|NCT01081912|364585192|FG002|Conversion/Titration|Lack of Efficacy|0|||
105705648|NCT01081912|364585190|FG000|Conversion/Titration|Lost to Follow-up|5|||
105705649|NCT01081912|364585191|FG001|Conversion/Titration|Lost to Follow-up|0|||
105705650|NCT01081912|364585192|FG002|Conversion/Titration|Lost to Follow-up|0|||
105705651|NCT01081912|364585190|FG000|Conversion/Titration|Physician Decision|2|||
105705652|NCT01081912|364585191|FG001|Conversion/Titration|Physician Decision|0|||
105705653|NCT01081912|364585192|FG002|Conversion/Titration|Physician Decision|0|||
105705654|NCT01081912|364585190|FG000|Conversion/Titration|Protocol Violation|67|||
105705655|NCT01081912|364585191|FG001|Conversion/Titration|Protocol Violation|0|||
105705656|NCT01081912|364585192|FG002|Conversion/Titration|Protocol Violation|0|||
105705657|NCT01081912|364585190|FG000|Conversion/Titration|Withdrawal by Subject|23|||
105705658|NCT01081912|364585191|FG001|Conversion/Titration|Withdrawal by Subject|0|||
105705659|NCT01081912|364585192|FG002|Conversion/Titration|Withdrawal by Subject|0|||
105705660|NCT01081912|364585190|FG000|Conversion/Titration|Non-Compliance|47|||
105705661|NCT01081912|364585191|FG001|Conversion/Titration|Non-Compliance|0|||
105705662|NCT01081912|364585192|FG002|Conversion/Titration|Non-Compliance|0|||
105705663|NCT01081912|364585190|FG000|Maintenance Treatment|Adverse Event|0|||
105705664|NCT01081912|364585191|FG001|Maintenance Treatment|Adverse Event|2|||
105705665|NCT01081912|364585192|FG002|Maintenance Treatment|Adverse Event|12|||
105705666|NCT01081912|364585190|FG000|Maintenance Treatment|Lack of Efficacy|0|||
105705667|NCT01081912|364585191|FG001|Maintenance Treatment|Lack of Efficacy|14|||
105705668|NCT01081912|364585192|FG002|Maintenance Treatment|Lack of Efficacy|64|||
105705669|NCT01081912|364585190|FG000|Maintenance Treatment|Lost to Follow-up|0|||
105705670|NCT01081912|364585191|FG001|Maintenance Treatment|Lost to Follow-up|1|||
105705671|NCT01081912|364585192|FG002|Maintenance Treatment|Lost to Follow-up|0|||
105705672|NCT01081912|364585190|FG000|Maintenance Treatment|Physician Decision|0|||
105705673|NCT01081912|364585191|FG001|Maintenance Treatment|Physician Decision|0|||
105787473|NCT04668066|364874966|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
105787474|NCT04668066|364874967|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787475|NCT04668066|364874968|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787476|NCT04668066|364874969|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
105787477|NCT04668066|364874970|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787478|NCT04668066|364874971|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787479|NCT04668066|364874972|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787480|NCT04668066|364874954|FG000|Part 1: Follow-Up|Adverse Event|0|||
105787481|NCT04668066|364874955|FG001|Part 1: Follow-Up|Adverse Event|0|||
105787482|NCT04668066|364874956|FG002|Part 1: Follow-Up|Adverse Event|0|||
105787483|NCT04668066|364874957|FG003|Part 1: Follow-Up|Adverse Event|0|||
105787484|NCT04668066|364874958|FG004|Part 1: Follow-Up|Adverse Event|0|||
105787485|NCT04668066|364874959|FG005|Part 1: Follow-Up|Adverse Event|0|||
105787486|NCT04668066|364874960|FG006|Part 1: Follow-Up|Adverse Event|0|||
105787487|NCT04668066|364874961|FG007|Part 1: Follow-Up|Adverse Event|0|||
105787488|NCT04668066|364874962|FG008|Part 1: Follow-Up|Adverse Event|0|||
105787489|NCT04668066|364874963|FG009|Part 1: Follow-Up|Adverse Event|0|||
105787490|NCT04668066|364874964|FG010|Part 1: Follow-Up|Adverse Event|0|||
105787491|NCT04668066|364874965|FG011|Part 1: Follow-Up|Adverse Event|1|||
105787492|NCT04668066|364874966|FG012|Part 1: Follow-Up|Adverse Event|0|||
105787493|NCT04668066|364874967|FG013|Part 1: Follow-Up|Adverse Event|0|||
105787494|NCT04668066|364874968|FG014|Part 1: Follow-Up|Adverse Event|0|||
105787495|NCT04668066|364874969|FG015|Part 1: Follow-Up|Adverse Event|0|||
105787496|NCT04668066|364874970|FG016|Part 1: Follow-Up|Adverse Event|0|||
105787497|NCT04668066|364874971|FG017|Part 1: Follow-Up|Adverse Event|0|||
105787498|NCT04668066|364874972|FG018|Part 1: Follow-Up|Adverse Event|0|||
105787499|NCT04668066|364874954|FG000|Part 1: Follow-Up|Other|0|||
105787500|NCT04668066|364874955|FG001|Part 1: Follow-Up|Other|0|||
105787501|NCT04668066|364874956|FG002|Part 1: Follow-Up|Other|0|||
105787502|NCT04668066|364874957|FG003|Part 1: Follow-Up|Other|0|||
105787503|NCT04668066|364874958|FG004|Part 1: Follow-Up|Other|0|||
105787504|NCT04668066|364874959|FG005|Part 1: Follow-Up|Other|0|||
105787505|NCT04668066|364874960|FG006|Part 1: Follow-Up|Other|0|||
105787506|NCT04668066|364874961|FG007|Part 1: Follow-Up|Other|0|||
105787507|NCT04668066|364874962|FG008|Part 1: Follow-Up|Other|0|||
105787508|NCT04668066|364874963|FG009|Part 1: Follow-Up|Other|0|||
105787509|NCT04668066|364874964|FG010|Part 1: Follow-Up|Other|0|||
105787510|NCT04668066|364874965|FG011|Part 1: Follow-Up|Other|1|||
105787511|NCT04668066|364874966|FG012|Part 1: Follow-Up|Other|1|||
105787512|NCT04668066|364874967|FG013|Part 1: Follow-Up|Other|0|||
105787513|NCT04668066|364874968|FG014|Part 1: Follow-Up|Other|0|||
105787514|NCT04668066|364874969|FG015|Part 1: Follow-Up|Other|0|||
105787515|NCT04668066|364874970|FG016|Part 1: Follow-Up|Other|0|||
105787516|NCT04668066|364874971|FG017|Part 1: Follow-Up|Other|0|||
105787517|NCT04668066|364874972|FG018|Part 1: Follow-Up|Other|0|||
105787518|NCT04668066|364874954|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787519|NCT04668066|364874955|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787520|NCT04668066|364874956|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787521|NCT04668066|364874957|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787522|NCT04668066|364874958|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787523|NCT04668066|364874959|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787524|NCT04668066|364874960|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787525|NCT04668066|364874961|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787526|NCT04668066|364874962|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787527|NCT04668066|364874963|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787528|NCT04668066|364874964|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787529|NCT04668066|364874965|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787530|NCT04668066|364874966|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
105787531|NCT04668066|364874967|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
105474655|NCT01349049|363751159|FG000|Overall Study|Adverse Event|0|||
105474656|NCT01349049|363751160|FG001|Overall Study|Adverse Event|1|||
105787532|NCT04668066|364874968|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787533|NCT04668066|364874969|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
105787534|NCT04668066|364874970|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787535|NCT04668066|364874971|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787536|NCT04668066|364874972|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787537|NCT04668066|364874954|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105474657|NCT01349049|363751161|FG002|Overall Study|Adverse Event|0|||
105787538|NCT04668066|364874955|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787539|NCT04668066|364874956|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787540|NCT04668066|364874957|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787541|NCT04668066|364874958|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787542|NCT04668066|364874959|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787543|NCT04668066|364874960|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787544|NCT04668066|364874961|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787545|NCT04668066|364874962|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105705674|NCT01081912|364585192|FG002|Maintenance Treatment|Physician Decision|1|||
105705675|NCT01081912|364585190|FG000|Maintenance Treatment|Protocol Violation|0|||
105705676|NCT01081912|364585191|FG001|Maintenance Treatment|Protocol Violation|1|||
105705677|NCT01081912|364585192|FG002|Maintenance Treatment|Protocol Violation|2|||
105705678|NCT01081912|364585190|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
105705679|NCT01081912|364585191|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
105705680|NCT01081912|364585192|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
105705681|NCT01081912|364585190|FG000|Maintenance Treatment|Non-Compliance|0|||
105474658|NCT01349049|363751162|FG003|Overall Study|Adverse Event|0|||
105474659|NCT01349049|363751163|FG004|Overall Study|Adverse Event|0|||
105474660|NCT01349049|363751164|FG005|Overall Study|Adverse Event|3|||
105705682|NCT01081912|364585191|FG001|Maintenance Treatment|Non-Compliance|4|||
105705683|NCT01081912|364585192|FG002|Maintenance Treatment|Non-Compliance|7|||
105705684|NCT01081912|364585190|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
105705685|NCT01081912|364585191|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
105705686|NCT01081912|364585192|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
105705687|NCT00001379|364585193|FG000|Initial Treatment|Disease progression|21|||
105705688|NCT00001379|364585194|FG001|Initial Treatment|Disease progression|3|||
105705689|NCT00001379|364585195|FG002|Initial Treatment|Disease progression|0|||
105705690|NCT00001379|364585196|FG003|Initial Treatment|Disease progression|0|||
105705691|NCT00001379|364585193|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
105705692|NCT00001379|364585194|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
105705693|NCT00001379|364585195|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
105705694|NCT00001379|364585196|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
105705695|NCT00001379|364585193|FG000|Initial Treatment|Received alternative treatment|2|||
105705696|NCT00001379|364585194|FG001|Initial Treatment|Received alternative treatment|1|||
105705697|NCT00001379|364585195|FG002|Initial Treatment|Received alternative treatment|0|||
105474661|NCT01349049|363751165|FG006|Overall Study|Adverse Event|1|||
105705698|NCT00001379|364585196|FG003|Initial Treatment|Received alternative treatment|0|||
105705699|NCT00001379|364585193|FG000|Initial Treatment|Refused further treatment|2|||
105474662|NCT01349049|363751166|FG007|Overall Study|Adverse Event|0|||
105474663|NCT01349049|363751167|FG008|Overall Study|Adverse Event|4|||
105474664|NCT01349049|363751159|FG000|Overall Study|Physician Decision|0|||
105474665|NCT01349049|363751160|FG001|Overall Study|Physician Decision|1|||
105474666|NCT01349049|363751161|FG002|Overall Study|Physician Decision|0|||
105474667|NCT01349049|363751162|FG003|Overall Study|Physician Decision|0|||
105474668|NCT01349049|363751163|FG004|Overall Study|Physician Decision|0|||
105474669|NCT01349049|363751164|FG005|Overall Study|Physician Decision|0|||
105474670|NCT01349049|363751165|FG006|Overall Study|Physician Decision|0|||
105474671|NCT01349049|363751166|FG007|Overall Study|Physician Decision|0|||
105705700|NCT00001379|364585194|FG001|Initial Treatment|Refused further treatment|0|||
105705701|NCT00001379|364585195|FG002|Initial Treatment|Refused further treatment|0|||
105705702|NCT00001379|364585196|FG003|Initial Treatment|Refused further treatment|0|||
105705703|NCT00001379|364585193|FG000|Initial Treatment|Did not receive protocol treatment|0|||
105705704|NCT00001379|364585194|FG001|Initial Treatment|Did not receive protocol treatment|0|||
105705705|NCT00001379|364585195|FG002|Initial Treatment|Did not receive protocol treatment|5|||
105705706|NCT00001379|364585196|FG003|Initial Treatment|Did not receive protocol treatment|0|||
105705707|NCT00001379|364585193|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
105705708|NCT00001379|364585194|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
105705709|NCT00001379|364585195|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
105705710|NCT00001379|364585196|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
105705711|NCT00001379|364585193|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
105705712|NCT00001379|364585194|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
105705713|NCT00001379|364585195|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
105705714|NCT00001379|364585196|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
105705715|NCT00001379|364585193|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
105705716|NCT00001379|364585194|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
105474672|NCT01349049|363751167|FG008|Overall Study|Physician Decision|2|||
105474673|NCT01349049|363751159|FG000|Overall Study|Protocol Violation|0|||
105474674|NCT01349049|363751160|FG001|Overall Study|Protocol Violation|0|||
105474675|NCT01349049|363751161|FG002|Overall Study|Protocol Violation|0|||
105474676|NCT01349049|363751162|FG003|Overall Study|Protocol Violation|0|||
105474677|NCT01349049|363751163|FG004|Overall Study|Protocol Violation|0|||
105474678|NCT01349049|363751164|FG005|Overall Study|Protocol Violation|0|||
105705717|NCT00001379|364585195|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
105705718|NCT00001379|364585196|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
105705719|NCT00001379|364585193|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
105705720|NCT00001379|364585194|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
105474679|NCT01349049|363751165|FG006|Overall Study|Protocol Violation|0|||
105705721|NCT00001379|364585195|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
105705722|NCT00001379|364585196|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
105705723|NCT00001379|364585193|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
105705724|NCT00001379|364585194|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
105705725|NCT00001379|364585195|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
105705726|NCT00001379|364585196|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
105705727|NCT04458922|364585197|FG000|Overall Study|Withdrawal by Subject|1|||
105705728|NCT04458922|364585198|FG001|Overall Study|Withdrawal by Subject|0|||
105705729|NCT04458922|364585199|FG002|Overall Study|Withdrawal by Subject|2|||
105705730|NCT04458922|364585197|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
105705731|NCT04458922|364585198|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
105705732|NCT04458922|364585199|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
105705733|NCT04458922|364585197|FG000|Overall Study|Adverse Event|1|||
105705734|NCT04458922|364585198|FG001|Overall Study|Adverse Event|0|||
105705735|NCT04458922|364585199|FG002|Overall Study|Adverse Event|0|||
105705736|NCT04458922|364585197|FG000|Overall Study|Started new study|0|||
105705737|NCT04458922|364585198|FG001|Overall Study|Started new study|0|||
105705738|NCT04458922|364585199|FG002|Overall Study|Started new study|1|||
105705739|NCT04458922|364585197|FG000|Overall Study|Progressive disease|6|||
105705740|NCT04458922|364585198|FG001|Overall Study|Progressive disease|8|||
105705741|NCT04458922|364585199|FG002|Overall Study|Progressive disease|2|||
105705742|NCT04458922|364585197|FG000|Overall Study|Death|1|||
105705743|NCT04458922|364585198|FG001|Overall Study|Death|0|||
105705744|NCT04458922|364585199|FG002|Overall Study|Death|2|||
105705745|NCT04458922|364585197|FG000|Overall Study|Participant started chemotherapy|0|||
105705746|NCT04458922|364585198|FG001|Overall Study|Participant started chemotherapy|1|||
105705747|NCT04458922|364585199|FG002|Overall Study|Participant started chemotherapy|0|||
105705748|NCT00960843|364585200|FG000|Overall Study|Lost to Follow-up|2|||
105705749|NCT00960843|364585201|FG001|Overall Study|Lost to Follow-up|0|||
105705750|NCT00960843|364585200|FG000|Overall Study|Protocol Violation|0|||
105705751|NCT00960843|364585201|FG001|Overall Study|Protocol Violation|4|||
105705752|NCT00960843|364585200|FG000|Overall Study|Repeated needle dislodgment|0|||
105705753|NCT00960843|364585201|FG001|Overall Study|Repeated needle dislodgment|1|||
105705754|NCT00542269|364585202|FG000|Overall Study|Adverse Event|10|||
105705755|NCT00542269|364585203|FG001|Overall Study|Adverse Event|4|||
105705756|NCT00542269|364585204|FG002|Overall Study|Adverse Event|5|||
105705757|NCT00542269|364585202|FG000|Overall Study|Protocol Violation|1|||
105705758|NCT00542269|364585203|FG001|Overall Study|Protocol Violation|1|||
105705759|NCT00542269|364585204|FG002|Overall Study|Protocol Violation|0|||
105705760|NCT00542269|364585202|FG000|Overall Study|Withdrawal by Subject|1|||
105705761|NCT00542269|364585203|FG001|Overall Study|Withdrawal by Subject|0|||
105705762|NCT00542269|364585204|FG002|Overall Study|Withdrawal by Subject|0|||
105705763|NCT00542269|364585202|FG000|Overall Study|Administrative problems|1|||
105705764|NCT00542269|364585203|FG001|Overall Study|Administrative problems|1|||
105705765|NCT00542269|364585204|FG002|Overall Study|Administrative problems|1|||
105705766|NCT00652366|364585205|FG000|Overall Study|Adverse Event|8|||
105705767|NCT00652366|364585206|FG001|Overall Study|Adverse Event|4|||
105705768|NCT00652366|364585207|FG002|Overall Study|Adverse Event|7|||
105705769|NCT00652366|364585208|FG003|Overall Study|Adverse Event|17|||
105705770|NCT00652366|364585209|FG004|Overall Study|Adverse Event|13|||
105705771|NCT00652366|364585205|FG000|Overall Study|Death|5|||
105705772|NCT00652366|364585206|FG001|Overall Study|Death|4|||
105705773|NCT00652366|364585207|FG002|Overall Study|Death|1|||
105705774|NCT00652366|364585208|FG003|Overall Study|Death|8|||
105705775|NCT00652366|364585209|FG004|Overall Study|Death|5|||
105705776|NCT00652366|364585205|FG000|Overall Study|Lack of Efficacy|84|||
105705777|NCT00652366|364585206|FG001|Overall Study|Lack of Efficacy|58|||
105705778|NCT00652366|364585207|FG002|Overall Study|Lack of Efficacy|53|||
105787546|NCT04668066|364874963|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787547|NCT04668066|364874964|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787548|NCT04668066|364874965|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787549|NCT04668066|364874966|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787550|NCT04668066|364874967|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787551|NCT04668066|364874968|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787552|NCT04668066|364874969|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787553|NCT04668066|364874970|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787554|NCT04668066|364874971|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787555|NCT04668066|364874972|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
105787556|NCT04668066|364874954|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787557|NCT04668066|364874955|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787558|NCT04668066|364874956|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787559|NCT04668066|364874957|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787560|NCT04668066|364874958|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787561|NCT04668066|364874959|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787562|NCT04668066|364874960|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787563|NCT04668066|364874961|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787564|NCT04668066|364874962|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787565|NCT04668066|364874963|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787566|NCT04668066|364874964|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787567|NCT04668066|364874965|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787568|NCT04668066|364874966|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787569|NCT04668066|364874967|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787570|NCT04668066|364874968|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787571|NCT04668066|364874969|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787572|NCT04668066|364874970|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787573|NCT04668066|364874971|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787574|NCT04668066|364874972|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
105787575|NCT04668066|364874954|FG000|Part 2: Treatment Phase|Other|0|||
105787576|NCT04668066|364874955|FG001|Part 2: Treatment Phase|Other|0|||
105787577|NCT04668066|364874956|FG002|Part 2: Treatment Phase|Other|0|||
105787578|NCT04668066|364874957|FG003|Part 2: Treatment Phase|Other|0|||
105787579|NCT04668066|364874958|FG004|Part 2: Treatment Phase|Other|0|||
105787580|NCT04668066|364874959|FG005|Part 2: Treatment Phase|Other|0|||
105705779|NCT00652366|364585208|FG003|Overall Study|Lack of Efficacy|133|||
105705780|NCT00652366|364585209|FG004|Overall Study|Lack of Efficacy|13|||
105705781|NCT00652366|364585205|FG000|Overall Study|Violation of Selection Criteria|0|||
105705782|NCT00652366|364585206|FG001|Overall Study|Violation of Selection Criteria|0|||
105705783|NCT00652366|364585207|FG002|Overall Study|Violation of Selection Criteria|1|||
105705784|NCT00652366|364585208|FG003|Overall Study|Violation of Selection Criteria|0|||
105705785|NCT00652366|364585209|FG004|Overall Study|Violation of Selection Criteria|0|||
105705786|NCT00652366|364585205|FG000|Overall Study|Protocol Violation|1|||
105705787|NCT00652366|364585206|FG001|Overall Study|Protocol Violation|0|||
105705788|NCT00652366|364585207|FG002|Overall Study|Protocol Violation|0|||
105705789|NCT00652366|364585208|FG003|Overall Study|Protocol Violation|0|||
105705790|NCT00652366|364585209|FG004|Overall Study|Protocol Violation|0|||
105705791|NCT00652366|364585205|FG000|Overall Study|Refused treatment|3|||
105705792|NCT00652366|364585206|FG001|Overall Study|Refused treatment|7|||
105705793|NCT00652366|364585207|FG002|Overall Study|Refused treatment|6|||
105705794|NCT00652366|364585208|FG003|Overall Study|Refused treatment|17|||
105705795|NCT00652366|364585209|FG004|Overall Study|Refused treatment|5|||
105705796|NCT00652366|364585205|FG000|Overall Study|Other|5|||
105705797|NCT00652366|364585206|FG001|Overall Study|Other|2|||
105705798|NCT00652366|364585207|FG002|Overall Study|Other|3|||
105705799|NCT00652366|364585208|FG003|Overall Study|Other|4|||
105705800|NCT00652366|364585209|FG004|Overall Study|Other|0|||
105705801|NCT00845650|364585214|FG000|Overall Study|Withdrawal by Subject|0|||
105705802|NCT00845650|364585215|FG001|Overall Study|Withdrawal by Subject|0|||
105705803|NCT00845650|364585216|FG002|Overall Study|Withdrawal by Subject|0|||
105705804|NCT00845650|364585217|FG003|Overall Study|Withdrawal by Subject|0|||
105705805|NCT00845650|364585218|FG004|Overall Study|Withdrawal by Subject|2|||
105705806|NCT00845650|364585219|FG005|Overall Study|Withdrawal by Subject|0|||
105705807|NCT00845650|364585214|FG000|Overall Study|Lost to Follow-up|0|||
105705808|NCT00845650|364585215|FG001|Overall Study|Lost to Follow-up|0|||
105787581|NCT04668066|364874960|FG006|Part 2: Treatment Phase|Other|0|||
105787582|NCT04668066|364874961|FG007|Part 2: Treatment Phase|Other|0|||
105787583|NCT04668066|364874962|FG008|Part 2: Treatment Phase|Other|0|||
105787584|NCT04668066|364874963|FG009|Part 2: Treatment Phase|Other|0|||
105787585|NCT04668066|364874964|FG010|Part 2: Treatment Phase|Other|0|||
105787586|NCT04668066|364874965|FG011|Part 2: Treatment Phase|Other|0|||
105787587|NCT04668066|364874966|FG012|Part 2: Treatment Phase|Other|0|||
105787588|NCT04668066|364874967|FG013|Part 2: Treatment Phase|Other|0|||
105787589|NCT04668066|364874968|FG014|Part 2: Treatment Phase|Other|0|||
105705809|NCT00845650|364585216|FG002|Overall Study|Lost to Follow-up|3|||
105705810|NCT00845650|364585217|FG003|Overall Study|Lost to Follow-up|1|||
105705811|NCT00845650|364585218|FG004|Overall Study|Lost to Follow-up|0|||
105787590|NCT04668066|364874969|FG015|Part 2: Treatment Phase|Other|0|||
105787591|NCT04668066|364874970|FG016|Part 2: Treatment Phase|Other|0|||
105787592|NCT04668066|364874971|FG017|Part 2: Treatment Phase|Other|0|||
105787593|NCT04668066|364874972|FG018|Part 2: Treatment Phase|Other|1|||
105787594|NCT04668066|364874954|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787595|NCT04668066|364874955|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787596|NCT04668066|364874956|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787597|NCT04668066|364874957|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787598|NCT04668066|364874958|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787599|NCT04668066|364874959|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787600|NCT04668066|364874960|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787601|NCT04668066|364874961|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787602|NCT04668066|364874962|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787603|NCT04668066|364874963|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787604|NCT04668066|364874964|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787605|NCT04668066|364874965|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787606|NCT04668066|364874966|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787607|NCT04668066|364874967|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787608|NCT04668066|364874968|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787609|NCT04668066|364874969|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787610|NCT04668066|364874970|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787611|NCT04668066|364874971|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787612|NCT04668066|364874972|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
105787613|NCT01015118|364874974|FG000|Overall Study|Protocol Violation|5|||
105787614|NCT01015118|364874975|FG001|Overall Study|Protocol Violation|6|||
105787615|NCT01015118|364874974|FG000|Overall Study|Withdrawal by Subject|103|||
105787616|NCT01015118|364874975|FG001|Overall Study|Withdrawal by Subject|27|||
105787617|NCT01015118|364874974|FG000|Overall Study|Other Adverse Event (AE)|141|||
105787618|NCT01015118|364874975|FG001|Overall Study|Other Adverse Event (AE)|33|||
105787619|NCT01015118|364874974|FG000|Overall Study|Worsening or AE of underlying disease|5|||
105787620|NCT01015118|364874975|FG001|Overall Study|Worsening or AE of underlying disease|4|||
105787621|NCT01015118|364874974|FG000|Overall Study|Progressive disease|364|||
105787622|NCT01015118|364874975|FG001|Overall Study|Progressive disease|229|||
105787623|NCT01015118|364874974|FG000|Overall Study|Not treated|9|||
105787624|NCT01015118|364874975|FG001|Overall Study|Not treated|5|||
105787625|NCT01015118|364874974|FG000|Overall Study|Other than stated above|42|||
105787626|NCT01015118|364874975|FG001|Overall Study|Other than stated above|23|||
105787627|NCT02388906|364874976|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
105787628|NCT02388906|364874977|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
105787629|NCT02388906|364874976|FG000|Treatment Period|Disease progression|121|||
105787630|NCT02388906|364874977|FG001|Treatment Period|Disease progression|100|||
105787631|NCT02388906|364874976|FG000|Treatment Period|Study drug toxicity|41|||
105787632|NCT02388906|364874977|FG001|Treatment Period|Study drug toxicity|208|||
105787633|NCT02388906|364874976|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
105787634|NCT02388906|364874977|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
105787635|NCT02388906|364874976|FG000|Treatment Period|Participant request to stop treatment|5|||
105787636|NCT02388906|364874977|FG001|Treatment Period|Participant request to stop treatment|9|||
105787637|NCT02388906|364874976|FG000|Treatment Period|Participant withdrew consent|2|||
105787638|NCT02388906|364874977|FG001|Treatment Period|Participant withdrew consent|3|||
105787639|NCT02388906|364874976|FG000|Treatment Period|Poor/non-compliance|0|||
105787640|NCT02388906|364874977|FG001|Treatment Period|Poor/non-compliance|1|||
105787641|NCT02388906|364874976|FG000|Treatment Period|Participant no longer meets study criteria|0|||
105787642|NCT02388906|364874977|FG001|Treatment Period|Participant no longer meets study criteria|1|||
105787643|NCT02388906|364874976|FG000|Treatment Period|Other reasons|3|||
105787644|NCT02388906|364874977|FG001|Treatment Period|Other reasons|3|||
105787645|NCT00480077|364874978|FG000|Overall Study|Death|19|||
105787646|NCT00480077|364874979|FG001|Overall Study|Death|15|||
105787647|NCT00480077|364874978|FG000|Overall Study|early exit|12|||
105787648|NCT00480077|364874979|FG001|Overall Study|early exit|11|||
105787649|NCT02255422|364874980|FG000|Overall Study|Withdrawal by Subject|0|||
105787650|NCT02255422|364874981|FG001|Overall Study|Withdrawal by Subject|0|||
105787651|NCT02255422|364874982|FG002|Overall Study|Withdrawal by Subject|0|||
105787652|NCT02255422|364874983|FG003|Overall Study|Withdrawal by Subject|0|||
105787653|NCT02255422|364874984|FG004|Overall Study|Withdrawal by Subject|0|||
105787654|NCT02255422|364874985|FG005|Overall Study|Withdrawal by Subject|0|||
105787655|NCT02255422|364874986|FG006|Overall Study|Withdrawal by Subject|2|||
105787656|NCT02255422|364874980|FG000|Overall Study|Lost to Follow-up|0|||
105787657|NCT02255422|364874981|FG001|Overall Study|Lost to Follow-up|0|||
105787658|NCT02255422|364874982|FG002|Overall Study|Lost to Follow-up|1|||
105787659|NCT02255422|364874983|FG003|Overall Study|Lost to Follow-up|0|||
105787660|NCT02255422|364874984|FG004|Overall Study|Lost to Follow-up|0|||
105787661|NCT02255422|364874985|FG005|Overall Study|Lost to Follow-up|0|||
105787662|NCT02255422|364874986|FG006|Overall Study|Lost to Follow-up|0|||
105787663|NCT03282123|364874987|FG000|Overall Study|Withdrawal by Subject|5|||
105787664|NCT05153629|364874989|FG000|Overall Study|Withdrawal by Subject|0|||
105787665|NCT05153629|364874990|FG001|Overall Study|Withdrawal by Subject|2|||
105705812|NCT00845650|364585219|FG005|Overall Study|Lost to Follow-up|1|||
105705813|NCT00845650|364585214|FG000|Overall Study|Sponsor hold on dosing|0|||
105705814|NCT00845650|364585215|FG001|Overall Study|Sponsor hold on dosing|0|||
105705815|NCT00845650|364585216|FG002|Overall Study|Sponsor hold on dosing|0|||
105705816|NCT00845650|364585217|FG003|Overall Study|Sponsor hold on dosing|0|||
105705817|NCT00845650|364585218|FG004|Overall Study|Sponsor hold on dosing|1|||
105705818|NCT00845650|364585219|FG005|Overall Study|Sponsor hold on dosing|1|||
105705819|NCT00845650|364585214|FG000|Overall Study|Unable to access IV line|1|||
105705820|NCT00845650|364585215|FG001|Overall Study|Unable to access IV line|0|||
105705821|NCT00845650|364585216|FG002|Overall Study|Unable to access IV line|0|||
105705822|NCT00845650|364585217|FG003|Overall Study|Unable to access IV line|0|||
105705823|NCT00845650|364585218|FG004|Overall Study|Unable to access IV line|0|||
105705824|NCT00845650|364585219|FG005|Overall Study|Unable to access IV line|0|||
105705825|NCT00814892|364585220|FG000|Overall Study|Disease Progression|1|||
105705826|NCT00814892|364585220|FG000|Overall Study|Study Termination|1|||
105705827|NCT03861559|364585223|FG000|Overall Study|Adverse Event|0|||
105705828|NCT03861559|364585224|FG001|Overall Study|Adverse Event|2|||
105705829|NCT03861559|364585223|FG000|Overall Study|Treatment failure|0|||
105705830|NCT03861559|364585224|FG001|Overall Study|Treatment failure|2|||
105705831|NCT03861559|364585223|FG000|Overall Study|Noncompliance|1|||
105705832|NCT03861559|364585224|FG001|Overall Study|Noncompliance|1|||
105705833|NCT03861559|364585223|FG000|Overall Study|Did not meet eligibility requirements|1|||
105705834|NCT03861559|364585224|FG001|Overall Study|Did not meet eligibility requirements|0|||
105705835|NCT03440814|364585229|FG000|Overall Study|Adverse Event|2|||
105705836|NCT03440814|364585230|FG001|Overall Study|Adverse Event|1|||
105705837|NCT03440814|364585229|FG000|Overall Study|Lost to Follow-up|2|||
105705838|NCT03440814|364585230|FG001|Overall Study|Lost to Follow-up|0|||
105705839|NCT03440814|364585229|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
105705840|NCT03440814|364585230|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
105705841|NCT02500121|364585231|FG000|Overall Study|Lost to Follow-up|0|||
105705842|NCT02500121|364585232|FG001|Overall Study|Lost to Follow-up|1|||
105705843|NCT02500121|364585231|FG000|Overall Study|Withdrawal by Subject|1|||
105705844|NCT02500121|364585232|FG001|Overall Study|Withdrawal by Subject|1|||
105705845|NCT02500121|364585231|FG000|Overall Study|Death|26|||
105705846|NCT02500121|364585232|FG001|Overall Study|Death|24|||
105705847|NCT00088374|364585233|FG000|Overall Study|patient did not receive any 17AAG|1|||
105705848|NCT00088374|364585233|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
105705849|NCT01437397|364585234|FG000|Overall Study|Lost to Follow-up|9|||
105705850|NCT01437397|364585235|FG001|Overall Study|Lost to Follow-up|4|||
105705851|NCT01437397|364585236|FG002|Overall Study|Lost to Follow-up|2|||
105705852|NCT01437397|364585237|FG003|Overall Study|Lost to Follow-up|4|||
105705853|NCT01437397|364585238|FG004|Overall Study|Lost to Follow-up|5|||
105705854|NCT01437397|364585234|FG000|Overall Study|Withdrawal by Subject|11|||
105705855|NCT01437397|364585235|FG001|Overall Study|Withdrawal by Subject|12|||
105705856|NCT01437397|364585236|FG002|Overall Study|Withdrawal by Subject|24|||
105705857|NCT01437397|364585237|FG003|Overall Study|Withdrawal by Subject|11|||
105705858|NCT01437397|364585238|FG004|Overall Study|Withdrawal by Subject|22|||
105705859|NCT01437397|364585234|FG000|Overall Study|Protocol Violation|10|||
105705860|NCT01437397|364585235|FG001|Overall Study|Protocol Violation|12|||
105705861|NCT01437397|364585236|FG002|Overall Study|Protocol Violation|13|||
105705862|NCT01437397|364585237|FG003|Overall Study|Protocol Violation|21|||
105705863|NCT01437397|364585238|FG004|Overall Study|Protocol Violation|19|||
105705864|NCT01437397|364585234|FG000|Overall Study|Lack of Efficacy|5|||
105705865|NCT01437397|364585235|FG001|Overall Study|Lack of Efficacy|4|||
105705866|NCT01437397|364585236|FG002|Overall Study|Lack of Efficacy|8|||
105350677|NCT04849416|363288148|FG001|Overall Study|Ongoing Treatment|5|||
105350678|NCT04849416|363288149|FG002|Overall Study|Ongoing Treatment|3|||
105350679|NCT04849416|363288147|FG000|Overall Study|On Post-Treatment Follow-up|8|||
105350680|NCT04849416|363288148|FG001|Overall Study|On Post-Treatment Follow-up|9|||
105350681|NCT04849416|363288149|FG002|Overall Study|On Post-Treatment Follow-up|10|||
105350682|NCT04849416|363288147|FG000|Overall Study|Withdrawal by Subject|0|||
105350683|NCT04849416|363288148|FG001|Overall Study|Withdrawal by Subject|0|||
105705867|NCT01437397|364585237|FG003|Overall Study|Lack of Efficacy|10|||
105705868|NCT01437397|364585238|FG004|Overall Study|Lack of Efficacy|20|||
105705869|NCT01437397|364585234|FG000|Overall Study|Adverse Event|21|||
105705870|NCT01437397|364585235|FG001|Overall Study|Adverse Event|22|||
105350684|NCT04849416|363288149|FG002|Overall Study|Withdrawal by Subject|1|||
105350685|NCT04849416|363288147|FG000|Overall Study|Lost to Follow-up|1|||
105705871|NCT01437397|364585236|FG002|Overall Study|Adverse Event|16|||
105705872|NCT01437397|364585237|FG003|Overall Study|Adverse Event|14|||
105705873|NCT01437397|364585238|FG004|Overall Study|Adverse Event|21|||
105705874|NCT01437397|364585234|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
105705875|NCT01437397|364585235|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
105705876|NCT01437397|364585236|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
105705877|NCT01437397|364585237|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
105705878|NCT01437397|364585238|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
105705879|NCT00159861|364585239|FG000|Core Study - 16 Weeks|Death|3|||
105705880|NCT00159861|364585240|FG001|Core Study - 16 Weeks|Death|0|||
105705881|NCT00159861|364585239|FG000|Core Study - 16 Weeks|Adverse Event|12|||
105705882|NCT00159861|364585240|FG001|Core Study - 16 Weeks|Adverse Event|6|||
105705883|NCT00159861|364585239|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
105705884|NCT00159861|364585240|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
105705885|NCT00159861|364585239|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
105705886|NCT00159861|364585240|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
105705887|NCT00159861|364585239|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
105705888|NCT00159861|364585240|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
105705889|NCT00159861|364585239|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
105705890|NCT00159861|364585240|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
105705891|NCT00159861|364585239|FG000|Extension Study - up to 3 Years|Death|24|||
105705892|NCT00159861|364585240|FG001|Extension Study - up to 3 Years|Death|28|||
105705893|NCT00159861|364585239|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
105705894|NCT00159861|364585240|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
105705895|NCT00159861|364585239|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
105705896|NCT00159861|364585240|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
105705897|NCT00159861|364585239|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
105705898|NCT00159861|364585240|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
105705899|NCT00159861|364585239|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
105705900|NCT00159861|364585240|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
105705901|NCT01632566|364585241|FG000|Overall Study|Withdrawal by Subject|0|||
105705902|NCT01632566|364585242|FG001|Overall Study|Withdrawal by Subject|1|||
105705903|NCT01632566|364585243|FG002|Overall Study|Withdrawal by Subject|0|||
105705904|NCT01632566|364585244|FG003|Overall Study|Withdrawal by Subject|0|||
105705905|NCT01632566|364585245|FG004|Overall Study|Withdrawal by Subject|0|||
105705906|NCT01632566|364585241|FG000|Overall Study|Sponsor Decision|0|||
105705907|NCT01632566|364585242|FG001|Overall Study|Sponsor Decision|2|||
105705908|NCT01632566|364585243|FG002|Overall Study|Sponsor Decision|9|||
105705909|NCT01632566|364585244|FG003|Overall Study|Sponsor Decision|2|||
105705910|NCT01632566|364585245|FG004|Overall Study|Sponsor Decision|2|||
105705911|NCT01318109|364585246|FG000|Overall Study|Adverse Event|0|||
105705912|NCT01318109|364585247|FG001|Overall Study|Adverse Event|2|||
105705913|NCT01318109|364585248|FG002|Overall Study|Adverse Event|0|||
105705914|NCT01318109|364585246|FG000|Overall Study|Withdrawal by Subject|1|||
105705915|NCT01318109|364585247|FG001|Overall Study|Withdrawal by Subject|0|||
105705916|NCT01318109|364585248|FG002|Overall Study|Withdrawal by Subject|0|||
105705917|NCT01318109|364585246|FG000|Overall Study|Schedule Conflict|0|||
105705918|NCT01318109|364585247|FG001|Overall Study|Schedule Conflict|1|||
105705919|NCT01318109|364585248|FG002|Overall Study|Schedule Conflict|0|||
105705920|NCT02124564|364585251|FG000|Treatment Period|Adverse Event|2|||
105705921|NCT02124564|364585251|FG000|Treatment Period|Lack of Efficacy|3|||
105705922|NCT02124564|364585251|FG000|Treatment Period|Withdrawal by Subject|2|||
105705923|NCT03885089|364585253|FG000|Overall Study|No informed consent for publication of study results|2|||
105705924|NCT03349099|364585256|FG000|Overall Study|Physician Decision|3|||
105705925|NCT03349099|364585257|FG001|Overall Study|Physician Decision|4|||
105705926|NCT03349099|364585256|FG000|Overall Study|Stone migrated from the kidney|1|||
105705927|NCT03349099|364585257|FG001|Overall Study|Stone migrated from the kidney|0|||
105705928|NCT00278993|364585260|FG000|Overall Study|Adverse Event|24|||
105705929|NCT00278993|364585260|FG000|Overall Study|Withdrawal by Subject|5|||
105705930|NCT00278993|364585260|FG000|Overall Study|Progressive Disease|65|||
105705931|NCT00278993|364585260|FG000|Overall Study|Physician Decision|9|||
105705932|NCT00278993|364585260|FG000|Overall Study|Not Otherwise Specified|4|||
105705933|NCT02043548|364585263|FG000|Overall Study|Lack of Efficacy|1|||
105705934|NCT02043548|364585264|FG001|Overall Study|Lack of Efficacy|0|||
105705935|NCT02043548|364585263|FG000|Overall Study|Adverse Event|0|||
105705936|NCT02043548|364585264|FG001|Overall Study|Adverse Event|1|||
105705937|NCT04518462|364585266|FG000|Overall Study|Withdrawal by Subject|0|||
105705938|NCT04518462|364585267|FG001|Overall Study|Withdrawal by Subject|0|||
105705939|NCT04518462|364585268|FG002|Overall Study|Withdrawal by Subject|1|||
105705940|NCT04518462|364585266|FG000|Overall Study|Physician Decision|1|||
105705941|NCT04518462|364585267|FG001|Overall Study|Physician Decision|1|||
105705942|NCT04518462|364585268|FG002|Overall Study|Physician Decision|0|||
105705943|NCT01003210|364585269|FG000|Overall Study|Lost to Follow-up|1|||
105474680|NCT01349049|363751166|FG007|Overall Study|Protocol Violation|0|||
105705944|NCT01003210|364585270|FG001|Overall Study|Lost to Follow-up|3|||
105705945|NCT03829657|364585273|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
105705946|NCT03829657|364585274|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
105705947|NCT03829657|364585275|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
105705948|NCT03829657|364585276|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
105705949|NCT03829657|364585277|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
105705950|NCT03829657|364585273|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
105705951|NCT03829657|364585274|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
105705952|NCT03829657|364585275|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
105705953|NCT03829657|364585276|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
105705954|NCT03829657|364585277|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
105705955|NCT03829657|364585273|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
105705956|NCT03829657|364585274|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
105705957|NCT03829657|364585275|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
105705958|NCT03829657|364585276|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
105705959|NCT03829657|364585277|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
105705960|NCT03829657|364585273|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
105705961|NCT03829657|364585274|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
105705962|NCT03829657|364585275|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
105705963|NCT03829657|364585276|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
105705964|NCT03829657|364585277|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
105705965|NCT03829657|364585273|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
105705966|NCT03829657|364585274|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
105705967|NCT03829657|364585275|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
105705968|NCT03829657|364585276|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
105705969|NCT03829657|364585277|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
105705970|NCT03829657|364585273|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
105705971|NCT03829657|364585274|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
105705972|NCT03829657|364585275|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
105705973|NCT03829657|364585276|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
105705974|NCT03829657|364585277|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
105705975|NCT03829657|364585273|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
105705976|NCT03829657|364585274|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
105705977|NCT03829657|364585275|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
105705978|NCT03829657|364585276|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
105705979|NCT03829657|364585277|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
105705980|NCT03829657|364585273|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
105705981|NCT03829657|364585274|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
105705982|NCT03829657|364585275|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
105705983|NCT03829657|364585276|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
105705984|NCT03829657|364585277|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
105705985|NCT03829657|364585273|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
105705986|NCT03829657|364585274|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
105705987|NCT03829657|364585275|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
105705988|NCT03829657|364585276|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
105705989|NCT03829657|364585277|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
105705990|NCT03829657|364585273|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
105705991|NCT03829657|364585274|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
105705992|NCT03829657|364585275|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
105705993|NCT03829657|364585276|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
105705994|NCT03829657|364585277|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
105705995|NCT00333359|364585280|FG000|Overall Study|Adverse Event|29|||
105705996|NCT00333359|364585281|FG001|Overall Study|Adverse Event|35|||
105705997|NCT00333359|364585280|FG000|Overall Study|Withdrawal by Subject|19|||
105705998|NCT00333359|364585281|FG001|Overall Study|Withdrawal by Subject|37|||
105705999|NCT00333359|364585280|FG000|Overall Study|Physician Decision|2|||
105706000|NCT00333359|364585281|FG001|Overall Study|Physician Decision|2|||
105706001|NCT00333359|364585280|FG000|Overall Study|Protocol Non-compliance|2|||
105706002|NCT00333359|364585281|FG001|Overall Study|Protocol Non-compliance|8|||
105706003|NCT00333359|364585280|FG000|Overall Study|Lost to Follow-up|15|||
105706004|NCT00333359|364585281|FG001|Overall Study|Lost to Follow-up|25|||
105706005|NCT00333359|364585280|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
105706006|NCT00333359|364585281|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
105706007|NCT00333359|364585280|FG000|Overall Study|Treatment Failure|3|||
105706008|NCT00333359|364585281|FG001|Overall Study|Treatment Failure|8|||
105706009|NCT00333359|364585280|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
105706010|NCT00333359|364585281|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
105706011|NCT01452152|364585282|FG000|Overall Study|Study termination by sponsor|5|||
105706012|NCT01452152|364585283|FG001|Overall Study|Study termination by sponsor|0|||
105706013|NCT01452152|364585284|FG002|Overall Study|Study termination by sponsor|4|||
105350686|NCT04849416|363288148|FG001|Overall Study|Lost to Follow-up|0|||
105350687|NCT04849416|363288149|FG002|Overall Study|Lost to Follow-up|0|||
105350688|NCT02173379|363288153|FG000|Overall Study|Lost to Follow-up|89|||
105350689|NCT02173379|363288154|FG001|Overall Study|Lost to Follow-up|81|||
105787666|NCT03743571|364874991|FG000|Overall Study|Withdrawal by Subject|1|||
105787667|NCT03743571|364874992|FG001|Overall Study|Withdrawal by Subject|1|||
105787668|NCT03743571|364874991|FG000|Overall Study|Lost to Follow-up|1|||
105787669|NCT03743571|364874992|FG001|Overall Study|Lost to Follow-up|2|||
105787670|NCT04115488|364874993|FG000|Overall Study|Adverse Event|8|||
105787671|NCT04115488|364874994|FG001|Overall Study|Adverse Event|4|||
105787672|NCT04115488|364874993|FG000|Overall Study|Withdrawal by Subject|3|||
105787673|NCT04115488|364874994|FG001|Overall Study|Withdrawal by Subject|6|||
105787674|NCT04115488|364874993|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
105706014|NCT02867995|364585285|FG000|Overall Study|Withdrawal by Subject|0|||
105706015|NCT02867995|364585286|FG001|Overall Study|Withdrawal by Subject|1|||
105706016|NCT02867995|364585285|FG000|Overall Study|Lost to Follow-up|0|||
105706017|NCT02867995|364585286|FG001|Overall Study|Lost to Follow-up|2|||
105706018|NCT03315871|364585289|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
105706019|NCT03315871|364585290|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
105706020|NCT03315871|364585291|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
105706021|NCT03315871|364585289|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
105706022|NCT03315871|364585290|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
105706023|NCT03315871|364585291|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
105706024|NCT03315871|364585289|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
105706025|NCT03315871|364585290|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
105706026|NCT03315871|364585291|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
105787675|NCT04115488|364874994|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
105787676|NCT04115488|364874993|FG000|Overall Study|Patient 's location change|1|||
105706027|NCT03315871|364585289|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
105706028|NCT03315871|364585290|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
105706029|NCT03315871|364585291|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
105706030|NCT03315871|364585289|FG000|PROSTVAC + CV301|Progressive disease|0|||
105706031|NCT03315871|364585290|FG001|PROSTVAC + CV301|Progressive disease|0|||
105706032|NCT03315871|364585291|FG002|PROSTVAC + CV301|Progressive disease|1|||
105787677|NCT04115488|364874994|FG001|Overall Study|Patient 's location change|0|||
105787678|NCT04115488|364874993|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
105787679|NCT04115488|364874994|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
105706033|NCT03315871|364585289|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
105787680|NCT02756182|364875005|FG000|Overall Study|StudyTechnical Difficulties|4|||
105787681|NCT01458535|364876749|FG000|Overall Study|Other|0|||
105787682|NCT01458535|364876750|FG001|Overall Study|Other|0|||
105787683|NCT01458535|364876751|FG002|Overall Study|Other|0|||
105706034|NCT03315871|364585290|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
105706035|NCT03315871|364585291|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
105706036|NCT03578367|364585292|FG000|Overall Study|Adverse Event|0|||
105706037|NCT03578367|364585293|FG001|Overall Study|Adverse Event|3|||
105706038|NCT03578367|364585294|FG002|Overall Study|Adverse Event|0|||
105706039|NCT03578367|364585295|FG003|Overall Study|Adverse Event|5|||
105706040|NCT03578367|364585292|FG000|Overall Study|Withdrawal by Subject|2|||
105706041|NCT03578367|364585293|FG001|Overall Study|Withdrawal by Subject|2|||
105706042|NCT03578367|364585294|FG002|Overall Study|Withdrawal by Subject|1|||
105787684|NCT01458535|364876752|FG003|Overall Study|Other|0|||
105787685|NCT01458535|364876753|FG004|Overall Study|Other|1|||
105787686|NCT01458535|364876754|FG005|Overall Study|Other|1|||
105787687|NCT01458535|364876749|FG000|Overall Study|Withdrawal by Subject|0|||
105787688|NCT01458535|364876750|FG001|Overall Study|Withdrawal by Subject|0|||
105787689|NCT01458535|364876751|FG002|Overall Study|Withdrawal by Subject|2|||
105787690|NCT01458535|364876752|FG003|Overall Study|Withdrawal by Subject|0|||
105787691|NCT01458535|364876753|FG004|Overall Study|Withdrawal by Subject|1|||
105787692|NCT01458535|364876754|FG005|Overall Study|Withdrawal by Subject|1|||
105787693|NCT01458535|364876749|FG000|Overall Study|Lost to Follow-up|0|||
105787694|NCT01458535|364876750|FG001|Overall Study|Lost to Follow-up|2|||
105787695|NCT01458535|364876751|FG002|Overall Study|Lost to Follow-up|0|||
105560475|NCT03224182|364048414|FG000|Overall Study|Investigator Decision|3|||
105560476|NCT03224182|364048415|FG001|Overall Study|Investigator Decision|1|||
105787696|NCT01458535|364876752|FG003|Overall Study|Lost to Follow-up|3|||
105560477|NCT03224182|364048414|FG000|Overall Study|Sponsor Decision|26|||
105787697|NCT01458535|364876753|FG004|Overall Study|Lost to Follow-up|2|||
105787698|NCT01458535|364876754|FG005|Overall Study|Lost to Follow-up|2|||
105787699|NCT01458535|364876749|FG000|Overall Study|Adverse Event|0|||
105787700|NCT01458535|364876750|FG001|Overall Study|Adverse Event|0|||
105560478|NCT03224182|364048415|FG001|Overall Study|Sponsor Decision|12|||
105706043|NCT03578367|364585295|FG003|Overall Study|Withdrawal by Subject|3|||
105706044|NCT03578367|364585292|FG000|Overall Study|Physician Decision|0|||
105706045|NCT03578367|364585293|FG001|Overall Study|Physician Decision|0|||
105787701|NCT01458535|364876751|FG002|Overall Study|Adverse Event|0|||
105787702|NCT01458535|364876752|FG003|Overall Study|Adverse Event|1|||
105787703|NCT01458535|364876753|FG004|Overall Study|Adverse Event|0|||
105706046|NCT03578367|364585294|FG002|Overall Study|Physician Decision|14|||
105706047|NCT03578367|364585295|FG003|Overall Study|Physician Decision|0|||
105706048|NCT03578367|364585292|FG000|Overall Study|Death|1|||
105706049|NCT03578367|364585293|FG001|Overall Study|Death|0|||
105706050|NCT03578367|364585294|FG002|Overall Study|Death|0|||
105706051|NCT03578367|364585295|FG003|Overall Study|Death|0|||
105706052|NCT03578367|364585292|FG000|Overall Study|Not treated|0|||
105706053|NCT03578367|364585293|FG001|Overall Study|Not treated|0|||
105706054|NCT03578367|364585294|FG002|Overall Study|Not treated|1|||
105350690|NCT02173379|363288153|FG000|Overall Study|Withdrawal by Subject|24|||
105350691|NCT02173379|363288154|FG001|Overall Study|Withdrawal by Subject|29|||
105706055|NCT03578367|364585295|FG003|Overall Study|Not treated|0|||
105706056|NCT02484911|364587202|FG000|Overall Study|Withdrawal by Subject|2|||
105706057|NCT02484911|364587203|FG001|Overall Study|Withdrawal by Subject|1|||
105706058|NCT02484911|364587202|FG000|Overall Study|Protocol Violation|2|||
105706059|NCT02484911|364587203|FG001|Overall Study|Protocol Violation|1|||
105706060|NCT01652885|364587204|FG000|Overall Study|Adverse Event|1|||
105706061|NCT00490568|364587205|FG000|Overall Study|Adverse Event|116|||
105706062|NCT00490568|364587205|FG000|Overall Study|Lost to Follow-up|13|||
105706063|NCT00490568|364587205|FG000|Overall Study|Protocol Violation|45|||
105706064|NCT00490568|364587205|FG000|Overall Study|Withdrawal by Subject|135|||
105706065|NCT00490568|364587205|FG000|Overall Study|Still in the study at termination|974|||
105706066|NCT00490568|364587205|FG000|Overall Study|Other|1|||
105706067|NCT00490568|364587205|FG000|Overall Study|Exclusion criteria met|1|||
105706068|NCT00490568|364587205|FG000|Overall Study|Caregiver related|20|||
105706069|NCT00490568|364587205|FG000|Overall Study|Abnormal ECG|25|||
105706070|NCT00490568|364587205|FG000|Overall Study|Participant refused follow-up|9|||
105706071|NCT00490568|364587205|FG000|Overall Study|Legal representative withdrew consent|1|||
105706072|NCT00490568|364587205|FG000|Overall Study|Disease progression|4|||
105706073|NCT00490568|364587205|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
105706074|NCT00490568|364587205|FG000|Overall Study|Investigator decision|3|||
105706075|NCT00490568|364587205|FG000|Overall Study|Non-Compliance|7|||
105706076|NCT00490568|364587205|FG000|Overall Study|Efficacy related|3|||
105706077|NCT00490568|364587205|FG000|Overall Study|Participant died|1|||
105706078|NCT00490568|364587205|FG000|Overall Study|Participant withdrawal due to surgery|1|||
105350692|NCT02173379|363288153|FG000|Overall Study|Physician Decision|8|||
105350693|NCT02173379|363288154|FG001|Overall Study|Physician Decision|8|||
105350694|NCT02173379|363288153|FG000|Overall Study|Death|75|||
105350695|NCT02173379|363288154|FG001|Overall Study|Death|72|||
105350696|NCT02173379|363288153|FG000|Overall Study|Other Reason|1|||
105350697|NCT02173379|363288154|FG001|Overall Study|Other Reason|0|||
105350698|NCT04767529|363288161|FG000|Overall Study|Adverse Event|0|||
105350699|NCT04767529|363288162|FG001|Overall Study|Adverse Event|4|||
105350700|NCT04767529|363288163|FG002|Overall Study|Adverse Event|3|||
105350701|NCT04767529|363288161|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
105350702|NCT04767529|363288162|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
105350703|NCT04767529|363288163|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
105350704|NCT04767529|363288161|FG000|Overall Study|Required use of a prohibited medication|0|||
105350705|NCT04767529|363288162|FG001|Overall Study|Required use of a prohibited medication|1|||
105706079|NCT03468855|364587206|FG000|Overall Study|Adverse Event|2|||
105706080|NCT03468855|364587206|FG000|Overall Study|Lost to Follow-up|5|||
105706081|NCT03468855|364587206|FG000|Overall Study|Withdrawal by Subject|3|||
105706082|NCT03468855|364587206|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
105350706|NCT04767529|363288163|FG002|Overall Study|Required use of a prohibited medication|0|||
105706083|NCT02135692|364587207|FG000|Overall Study|Adverse Event|3|||
105706084|NCT02135692|364587207|FG000|Overall Study|Lack of Efficacy|2|||
105350707|NCT04767529|363288161|FG000|Overall Study|Withdrawal by Subject|7|||
105706085|NCT02135692|364587207|FG000|Overall Study|Protocol Violation|2|||
105706086|NCT02135692|364587207|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
105706087|NCT02135692|364587207|FG000|Overall Study|Product commercially available|159|||
105706088|NCT02135692|364587207|FG000|Overall Study|Study closed/terminated|153|||
105706089|NCT02135692|364587207|FG000|Overall Study|Lost to Follow-up|4|||
105706090|NCT02135692|364587207|FG000|Overall Study|Withdrawal by Subject|15|||
105706091|NCT01042600|364587208|FG000|Overall Study|Ineligible|1|||
105706092|NCT01042600|364587209|FG001|Overall Study|Ineligible|0|||
105706093|NCT01137773|364587213|FG000|Overall Study|Death|3|||
105706094|NCT01137773|364587214|FG001|Overall Study|Death|3|||
105706095|NCT01137773|364587213|FG000|Overall Study|Lost to Follow-up|6|||
105706096|NCT01137773|364587214|FG001|Overall Study|Lost to Follow-up|0|||
105706097|NCT00812214|364587215|FG000|Overall Study|Lost to Follow-up|3|||
105706098|NCT00812214|364587216|FG001|Overall Study|Lost to Follow-up|1|||
105706099|NCT00789529|364587220|FG000|Overall Study|Withdrawal by Subject|0|||
105706100|NCT00789529|364587221|FG001|Overall Study|Withdrawal by Subject|1|||
105706101|NCT00789529|364587220|FG000|Overall Study|Other Reason|1|||
105706102|NCT00789529|364587221|FG001|Overall Study|Other Reason|0|||
105706103|NCT01849874|364587223|FG000|Overall Study|Death|89|||
105706104|NCT01849874|364587224|FG001|Overall Study|Death|42|||
105706105|NCT01849874|364587223|FG000|Overall Study|Withdrawal by Subject|17|||
105706106|NCT01849874|364587224|FG001|Overall Study|Withdrawal by Subject|16|||
105706107|NCT01849874|364587223|FG000|Overall Study|Lost to Follow-up|3|||
105706108|NCT01849874|364587224|FG001|Overall Study|Lost to Follow-up|2|||
105706109|NCT01849874|364587223|FG000|Overall Study|Study Termination By Sponsor|93|||
105706110|NCT01849874|364587224|FG001|Overall Study|Study Termination By Sponsor|48|||
105706111|NCT01849874|364587223|FG000|Overall Study|Completed as per protocol amendment 6|3|||
105706112|NCT01849874|364587224|FG001|Overall Study|Completed as per protocol amendment 6|0|||
105706113|NCT01849874|364587223|FG000|Overall Study|Physician Decision|7|||
105706114|NCT01849874|364587224|FG001|Overall Study|Physician Decision|1|||
105706115|NCT01849874|364587223|FG000|Overall Study|Other|16|||
105706116|NCT01849874|364587224|FG001|Overall Study|Other|4|||
105706117|NCT03189446|364587225|FG000|Overall Study|Adverse Event|2|||
105706118|NCT03189446|364587225|FG000|Overall Study|Withdrawal by Subject|2|||
105706119|NCT03189446|364587225|FG000|Overall Study|Physician Decision|1|||
105706120|NCT05634577|364587226|FG000|Overall Study|Lost to Follow-up|1|||
105706121|NCT05634577|364587226|FG000|Overall Study|Withdrawal by Subject|1|||
105706122|NCT01351389|364587227|FG000|Overall Study|Withdrawal by Subject|7|||
105706123|NCT01351389|364587228|FG001|Overall Study|Withdrawal by Subject|0|||
105706124|NCT01351389|364587227|FG000|Overall Study|did not complete intervention|23|||
105706125|NCT01351389|364587228|FG001|Overall Study|did not complete intervention|15|||
105706126|NCT02830880|364587229|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
105706127|NCT02830880|364587229|FG000|Overall Study|Death|1|||
105706128|NCT02830880|364587229|FG000|Overall Study|Physician Decision|1|||
105706129|NCT00713700|364587230|FG000|Overall Study|Lost to Follow-up|3|||
105706130|NCT00713700|364587230|FG000|Overall Study|Withdrawal by Subject|1|||
105706131|NCT03551509|364587235|FG000|Overall Study|Lost to Follow-up|0|||
105706132|NCT03551509|364587236|FG001|Overall Study|Lost to Follow-up|1|||
105706133|NCT03551509|364587237|FG002|Overall Study|Lost to Follow-up|0|||
105706134|NCT03709654|364587238|FG000|Overall Study|Lost to Follow-up|1|||
105706135|NCT03709654|364587239|FG001|Overall Study|Lost to Follow-up|1|||
105706136|NCT03709654|364587238|FG000|Overall Study|Withdrawal by Subject|1|||
105706137|NCT03709654|364587239|FG001|Overall Study|Withdrawal by Subject|1|||
105706138|NCT03709654|364587238|FG000|Overall Study|Adverse Event|1|||
105706139|NCT03709654|364587239|FG001|Overall Study|Adverse Event|0|||
105706140|NCT02631200|364587242|FG000|First Period|Death|1|||
105706141|NCT02631200|364587243|FG001|First Period|Death|2|||
105706142|NCT02631200|364587242|FG000|First Period|Patient ill-health|2|||
105706143|NCT02631200|364587243|FG001|First Period|Patient ill-health|4|||
105706144|NCT02631200|364587242|FG000|First Period|Withdrawal by Subject|4|||
105706145|NCT02631200|364587243|FG001|First Period|Withdrawal by Subject|1|||
105787704|NCT01458535|364876754|FG005|Overall Study|Adverse Event|0|||
105706146|NCT02631200|364587242|FG000|Deferred Period|Death|0|||
105706147|NCT02631200|364587243|FG001|Deferred Period|Death|1|||
105706148|NCT02631200|364587242|FG000|Deferred Period|Received kidney transplant|0|||
105706149|NCT02631200|364587243|FG001|Deferred Period|Received kidney transplant|1|||
105706150|NCT02631200|364587242|FG000|Deferred Period|Withdrawal by Subject|0|||
105706151|NCT02631200|364587243|FG001|Deferred Period|Withdrawal by Subject|2|||
105706152|NCT02631200|364587242|FG000|Deferred Period|Lost to Follow-up|0|||
105706153|NCT02631200|364587243|FG001|Deferred Period|Lost to Follow-up|1|||
105706154|NCT00711100|364587246|FG000|Overall Study|Lack of Efficacy|5|||
105706155|NCT00711100|364587246|FG000|Overall Study|Withdrawal by Subject|8|||
105706156|NCT03548558|364587247|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
105706157|NCT03548558|364587248|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
105706158|NCT03548558|364587249|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
105706159|NCT03548558|364587250|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
105706160|NCT03548558|364587251|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
105706161|NCT03548558|364587252|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
105706162|NCT03548558|364587253|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
105706163|NCT03548558|364587247|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
105706164|NCT03548558|364587248|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
105706165|NCT03548558|364587249|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
105706166|NCT03548558|364587250|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
105706167|NCT03548558|364587251|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
105706168|NCT03548558|364587252|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
105706169|NCT03548558|364587253|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
105706170|NCT03548558|364587247|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
105706171|NCT03548558|364587248|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
105706172|NCT03548558|364587249|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
105706173|NCT03548558|364587250|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
105706174|NCT03548558|364587251|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
105706175|NCT03548558|364587252|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
105706176|NCT03548558|364587253|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
105706177|NCT03548558|364587247|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
105706178|NCT03548558|364587248|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
105706179|NCT03548558|364587249|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
105706180|NCT03548558|364587250|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
105706181|NCT03548558|364587251|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
105706182|NCT03548558|364587252|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
105706183|NCT03548558|364587253|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
105706184|NCT03548558|364587247|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
105706185|NCT03548558|364587248|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
105706186|NCT03548558|364587249|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
105706187|NCT03548558|364587250|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
105706188|NCT03548558|364587251|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
105706189|NCT03548558|364587252|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
105706190|NCT03548558|364587253|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
105706191|NCT03548558|364587247|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
105706192|NCT03548558|364587248|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
105706193|NCT03548558|364587249|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
105706194|NCT03548558|364587250|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
105706195|NCT03548558|364587251|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
105706196|NCT03548558|364587252|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
105706197|NCT03548558|364587253|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
105706198|NCT00783094|364587254|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
105706199|NCT00783094|364587255|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
105706200|NCT00783094|364587256|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
105706201|NCT00783094|364587254|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
105706202|NCT00783094|364587255|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
105706203|NCT00783094|364587256|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
105706204|NCT00783094|364587254|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
105706205|NCT00783094|364587255|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
105706206|NCT00783094|364587256|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
105706207|NCT00783094|364587254|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
105706208|NCT00783094|364587255|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
105706209|NCT00783094|364587256|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
105706210|NCT00783094|364587254|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
105706211|NCT00783094|364587255|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
105787705|NCT02546986|364876755|FG000|Treatment Period|Progressive Disease|20|||
105787706|NCT02546986|364876756|FG001|Treatment Period|Progressive Disease|22|||
105787707|NCT02546986|364876755|FG000|Treatment Period|Adverse Event|14|||
105787708|NCT02546986|364876756|FG001|Treatment Period|Adverse Event|6|||
105787709|NCT02546986|364876755|FG000|Treatment Period|Symptomatic Deterioration|4|||
105787710|NCT02546986|364876756|FG001|Treatment Period|Symptomatic Deterioration|3|||
105787711|NCT02546986|364876755|FG000|Treatment Period|Death|3|||
105787712|NCT02546986|364876756|FG001|Treatment Period|Death|4|||
105787713|NCT02546986|364876755|FG000|Treatment Period|Physician Decision|1|||
105787714|NCT02546986|364876756|FG001|Treatment Period|Physician Decision|2|||
105787715|NCT02546986|364876755|FG000|Treatment Period|Protocol Violation|1|||
105787716|NCT02546986|364876756|FG001|Treatment Period|Protocol Violation|0|||
105787717|NCT02546986|364876755|FG000|Treatment Period|Withdrawal by Subject|1|||
105787718|NCT02546986|364876756|FG001|Treatment Period|Withdrawal by Subject|1|||
105787719|NCT02546986|364876755|FG000|Treatment Period|Non-compliance with Study Drug|0|||
105787720|NCT02546986|364876756|FG001|Treatment Period|Non-compliance with Study Drug|1|||
105787721|NCT02546986|364876755|FG000|Treatment Period|Study Terminated by Sponsor|0|||
105787722|NCT02546986|364876756|FG001|Treatment Period|Study Terminated by Sponsor|1|||
105787723|NCT02546986|364876755|FG000|Treatment Period|Miscellaneous|7|||
105787724|NCT02546986|364876756|FG001|Treatment Period|Miscellaneous|9|||
105787725|NCT02546986|364876755|FG000|Survival Follow-Up Phase|Missing Status|3|||
105787726|NCT02546986|364876756|FG001|Survival Follow-Up Phase|Missing Status|5|||
105787727|NCT02546986|364876755|FG000|Survival Follow-Up Phase|Death|18|||
105787728|NCT02546986|364876756|FG001|Survival Follow-Up Phase|Death|12|||
105787729|NCT02546986|364876755|FG000|Survival Follow-Up Phase|Alive|13|||
105787730|NCT02546986|364876756|FG001|Survival Follow-Up Phase|Alive|16|||
105706212|NCT00783094|364587256|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
105706213|NCT00783094|364587254|FG000|Open-Label Extension Period|Adverse Event|12|||
105706214|NCT00783094|364587255|FG001|Open-Label Extension Period|Adverse Event|7|||
105706215|NCT00783094|364587256|FG002|Open-Label Extension Period|Adverse Event|16|||
105706216|NCT00783094|364587254|FG000|Open-Label Extension Period|Death|0|||
105706217|NCT00783094|364587255|FG001|Open-Label Extension Period|Death|0|||
105706218|NCT00783094|364587256|FG002|Open-Label Extension Period|Death|1|||
105706219|NCT00783094|364587254|FG000|Open-Label Extension Period|Protocol Violation|4|||
105706220|NCT00783094|364587255|FG001|Open-Label Extension Period|Protocol Violation|5|||
105706221|NCT00783094|364587256|FG002|Open-Label Extension Period|Protocol Violation|7|||
105706222|NCT00783094|364587254|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
105706223|NCT00783094|364587255|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
105706224|NCT00783094|364587256|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
105706225|NCT00783094|364587254|FG000|Open-Label Extension Period|Physician Decision|4|||
105706226|NCT00783094|364587255|FG001|Open-Label Extension Period|Physician Decision|2|||
105706227|NCT00783094|364587256|FG002|Open-Label Extension Period|Physician Decision|3|||
105706228|NCT00783094|364587254|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
105706229|NCT00783094|364587255|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
105706230|NCT00783094|364587256|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
105706231|NCT02513329|364587262|FG000|Overall Study|Lost to Follow-up|5|||
105706232|NCT02513329|364587263|FG001|Overall Study|Lost to Follow-up|2|||
105706233|NCT01496885|364587264|FG000|Overall Study|Lost to Follow-up|13|||
105706234|NCT01496885|364587264|FG000|Overall Study|Withdrawal by Subject|7|||
105706235|NCT01496885|364587264|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
105787731|NCT02546986|364876755|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
105706236|NCT01496885|364587264|FG000|Overall Study|Death|1|||
105706237|NCT03273166|364587265|FG000|Overall Study|Withdrawn prior to Completion|31|||
105706238|NCT01294670|364587266|FG000|Overall Study|Not treated|1|||
105706239|NCT01294670|364587267|FG001|Overall Study|Not treated|0|||
105706240|NCT01294670|364587268|FG002|Overall Study|Not treated|0|||
105706241|NCT01294670|364587269|FG003|Overall Study|Not treated|0|||
105706242|NCT01294670|364587270|FG004|Overall Study|Not treated|0|||
105787732|NCT02546986|364876756|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
105474681|NCT01349049|363751167|FG008|Overall Study|Protocol Violation|1|||
105474682|NCT01349049|363751159|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
105474683|NCT01349049|363751160|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
105474684|NCT01349049|363751161|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
105474685|NCT01349049|363751162|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
105706243|NCT02083380|364587272|FG000|Overall Study|Lack of Efficacy|68|||
105706244|NCT02083380|364587273|FG001|Overall Study|Lack of Efficacy|79|||
105706245|NCT02083380|364587274|FG002|Overall Study|Lack of Efficacy|64|||
105706246|NCT02083380|364587272|FG000|Overall Study|Withdrawal by Subject|9|||
105706247|NCT02083380|364587273|FG001|Overall Study|Withdrawal by Subject|3|||
105706248|NCT02083380|364587274|FG002|Overall Study|Withdrawal by Subject|7|||
105706249|NCT02083380|364587272|FG000|Overall Study|Physician Decision|1|||
105706250|NCT02083380|364587273|FG001|Overall Study|Physician Decision|6|||
105706251|NCT02083380|364587274|FG002|Overall Study|Physician Decision|3|||
105706252|NCT02083380|364587272|FG000|Overall Study|Adverse Event|0|||
105706253|NCT02083380|364587273|FG001|Overall Study|Adverse Event|0|||
105706254|NCT02083380|364587274|FG002|Overall Study|Adverse Event|1|||
105706255|NCT02083380|364587272|FG000|Overall Study|Lost to Follow-up|5|||
105706256|NCT02083380|364587273|FG001|Overall Study|Lost to Follow-up|3|||
105706257|NCT02083380|364587274|FG002|Overall Study|Lost to Follow-up|3|||
105706258|NCT02083380|364587272|FG000|Overall Study|Other|8|||
105706259|NCT02083380|364587273|FG001|Overall Study|Other|4|||
105706260|NCT02083380|364587274|FG002|Overall Study|Other|6|||
105706261|NCT02669017|364587275|FG000|Overall Study|Death|1|||
105706262|NCT02669017|364587276|FG001|Overall Study|Death|2|||
105706263|NCT02669017|364587277|FG002|Overall Study|Death|2|||
105706264|NCT02669017|364587278|FG003|Overall Study|Death|3|||
105706265|NCT02669017|364587279|FG004|Overall Study|Death|8|||
105706266|NCT02669017|364587280|FG005|Overall Study|Death|18|||
105706267|NCT02669017|364587281|FG006|Overall Study|Death|10|||
105706268|NCT02669017|364587282|FG007|Overall Study|Death|47|||
105706269|NCT02669017|364587283|FG008|Overall Study|Death|20|||
105706270|NCT02669017|364587275|FG000|Overall Study|Withdrawal by Subject|0|||
105706271|NCT02669017|364587276|FG001|Overall Study|Withdrawal by Subject|0|||
105706272|NCT02669017|364587277|FG002|Overall Study|Withdrawal by Subject|0|||
105706273|NCT02669017|364587278|FG003|Overall Study|Withdrawal by Subject|1|||
105706274|NCT02669017|364587279|FG004|Overall Study|Withdrawal by Subject|2|||
105706275|NCT02669017|364587280|FG005|Overall Study|Withdrawal by Subject|0|||
105560479|NCT03224182|364048414|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
105560480|NCT03224182|364048415|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
105560481|NCT03224182|364048414|FG000|Overall Study|Lost to Follow-up|1|||
105560482|NCT03224182|364048415|FG001|Overall Study|Lost to Follow-up|0|||
105560483|NCT03224182|364048414|FG000|Overall Study|Participant Had Recurrence|11|||
105560484|NCT03224182|364048415|FG001|Overall Study|Participant Had Recurrence|5|||
105560485|NCT03224182|364048414|FG000|Overall Study|Death|0|||
105560486|NCT03224182|364048415|FG001|Overall Study|Death|1|||
105560487|NCT03224182|364048414|FG000|Overall Study|Reason not Specified|3|||
105560488|NCT03224182|364048415|FG001|Overall Study|Reason not Specified|3|||
105560489|NCT03224182|364048414|FG000|Overall Study|Other|1|||
105560490|NCT03224182|364048415|FG001|Overall Study|Other|0|||
105560491|NCT02481310|364048416|FG000|Follow up|Still in follow up|0|||
105560492|NCT02481310|364048417|FG001|Follow up|Still in follow up|3|||
105560493|NCT02481310|364048418|FG002|Follow up|Still in follow up|0|||
105560494|NCT00833560|364048419|FG000|Overall Study|Toxicity|13|||
105560495|NCT00833560|364048419|FG000|Overall Study|Adverse Event|11|||
105560496|NCT00833560|364048419|FG000|Overall Study|Protocol Violation|6|||
105560497|NCT00833560|364048419|FG000|Overall Study|Lack of Efficacy|4|||
105560498|NCT00833560|364048419|FG000|Overall Study|Death|2|||
105560499|NCT00833560|364048419|FG000|Overall Study|Pregression of other disease|1|||
105560500|NCT00833560|364048419|FG000|Overall Study|Other|5|||
105560501|NCT02184611|364048422|FG000|Overall Study|Lack of Efficacy|11|||
105560502|NCT02184611|364048423|FG001|Overall Study|Lack of Efficacy|15|||
105560503|NCT02184611|364048422|FG000|Overall Study|Withdrawal by Subject|5|||
105560504|NCT02184611|364048423|FG001|Overall Study|Withdrawal by Subject|6|||
105560505|NCT02184611|364048422|FG000|Overall Study|Adverse Event|4|||
105560506|NCT02184611|364048423|FG001|Overall Study|Adverse Event|5|||
105560507|NCT02184611|364048422|FG000|Overall Study|Protocol Violation|1|||
105560508|NCT02184611|364048423|FG001|Overall Study|Protocol Violation|1|||
105560509|NCT02184611|364048422|FG000|Overall Study|Protocol defined stopping criteria|0|||
105560510|NCT02184611|364048423|FG001|Overall Study|Protocol defined stopping criteria|1|||
105560511|NCT02366910|364048430|FG000|Overall Study|Withdrawal by Subject|2|||
105560512|NCT02366910|364048430|FG000|Overall Study|Screen Failure|3|||
105560513|NCT00985725|364048431|FG000|Overall Study|Adverse Event|4|||
105560514|NCT00985725|364048432|FG001|Overall Study|Adverse Event|1|||
105560515|NCT00985725|364048431|FG000|Overall Study|Protocol Violation|1|||
105560516|NCT00985725|364048432|FG001|Overall Study|Protocol Violation|3|||
105560517|NCT00985725|364048431|FG000|Overall Study|Withdrawal by Subject|4|||
105560518|NCT00985725|364048432|FG001|Overall Study|Withdrawal by Subject|4|||
105560519|NCT00985725|364048431|FG000|Overall Study|Lost to Follow-up|1|||
105560520|NCT00985725|364048432|FG001|Overall Study|Lost to Follow-up|1|||
105560521|NCT00985725|364048431|FG000|Overall Study|Lack of Efficacy|0|||
105560522|NCT00985725|364048432|FG001|Overall Study|Lack of Efficacy|1|||
105560523|NCT00985725|364048431|FG000|Overall Study|Non-compliance|1|||
105560524|NCT00985725|364048432|FG001|Overall Study|Non-compliance|2|||
105560525|NCT00985725|364048431|FG000|Overall Study|Out-of-window visits|0|||
105560526|NCT00985725|364048432|FG001|Overall Study|Out-of-window visits|1|||
105560527|NCT02623322|364048433|FG000|Overall Study|Lost to Follow-up|2|||
105560528|NCT02623322|364048434|FG001|Overall Study|Lost to Follow-up|1|||
105560529|NCT02623322|364048435|FG002|Overall Study|Lost to Follow-up|0|||
105560530|NCT03813238|364048439|FG000|Overall Study|Adverse Event|0|||
105560531|NCT03813238|364048440|FG001|Overall Study|Adverse Event|6|||
105560532|NCT03813238|364048439|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105560533|NCT03813238|364048440|FG001|Overall Study|Withdrawal by parent/guardian|2|||
105560534|NCT03813238|364048439|FG000|Overall Study|Lost to Follow-up|0|||
105560535|NCT03813238|364048440|FG001|Overall Study|Lost to Follow-up|1|||
105560536|NCT03813238|364048439|FG000|Overall Study|Other than specified|1|||
105560537|NCT03813238|364048440|FG001|Overall Study|Other than specified|2|||
105560538|NCT03581981|364048441|FG000|Overall Study|Withdrawal by Subject|12|||
105560539|NCT03581981|364048442|FG001|Overall Study|Withdrawal by Subject|13|||
105560540|NCT03581981|364048441|FG000|Overall Study|Physician Decision|1|||
105560541|NCT03581981|364048442|FG001|Overall Study|Physician Decision|2|||
105560542|NCT03581981|364048441|FG000|Overall Study|Lost to Follow-up|0|||
105560543|NCT03581981|364048442|FG001|Overall Study|Lost to Follow-up|4|||
105560544|NCT02080871|364048443|FG000|Overall Study|Death|1|||
105560545|NCT02080871|364048443|FG000|Overall Study|Lost to Follow-up|1|||
105560546|NCT00234052|364048444|FG000|Treatment|Withdrawal by Subject|3|||
105560547|NCT00234052|364048444|FG000|Treatment|Adverse Event|5|||
105560548|NCT00234052|364048444|FG000|Treatment|Death|2|||
105560549|NCT00234052|364048444|FG000|Treatment|Progressive Disease|11|||
105560550|NCT00234052|364048444|FG000|Follow-up for 5 Years|Death|41|||
105560551|NCT00234052|364048444|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
105560552|NCT00234052|364048444|FG000|Follow-up for 5 Years|Other|7|||
105706276|NCT02669017|364587281|FG006|Overall Study|Withdrawal by Subject|0|||
105706277|NCT02669017|364587282|FG007|Overall Study|Withdrawal by Subject|2|||
105706278|NCT02669017|364587283|FG008|Overall Study|Withdrawal by Subject|2|||
105706279|NCT02669017|364587275|FG000|Overall Study|Lost to Follow-up|0|||
105706280|NCT02669017|364587276|FG001|Overall Study|Lost to Follow-up|0|||
105706281|NCT02669017|364587277|FG002|Overall Study|Lost to Follow-up|0|||
105706282|NCT02669017|364587278|FG003|Overall Study|Lost to Follow-up|0|||
105706283|NCT02669017|364587279|FG004|Overall Study|Lost to Follow-up|0|||
105706284|NCT02669017|364587280|FG005|Overall Study|Lost to Follow-up|0|||
105706285|NCT02669017|364587281|FG006|Overall Study|Lost to Follow-up|0|||
105706286|NCT02669017|364587282|FG007|Overall Study|Lost to Follow-up|0|||
105706287|NCT02669017|364587283|FG008|Overall Study|Lost to Follow-up|1|||
105706288|NCT02669017|364587275|FG000|Overall Study|Miscellaneous|0|||
105706289|NCT02669017|364587276|FG001|Overall Study|Miscellaneous|0|||
105706290|NCT02669017|364587277|FG002|Overall Study|Miscellaneous|0|||
105706291|NCT02669017|364587278|FG003|Overall Study|Miscellaneous|0|||
105706292|NCT02669017|364587279|FG004|Overall Study|Miscellaneous|2|||
105706293|NCT02669017|364587280|FG005|Overall Study|Miscellaneous|1|||
105706294|NCT02669017|364587281|FG006|Overall Study|Miscellaneous|1|||
105706295|NCT02669017|364587282|FG007|Overall Study|Miscellaneous|13|||
105706296|NCT02669017|364587283|FG008|Overall Study|Miscellaneous|2|||
105706297|NCT03808077|364587284|FG000|Overall Study|Physician Decision|2|||
105706298|NCT03808077|364587285|FG001|Overall Study|Physician Decision|3|||
105706299|NCT03808077|364587284|FG000|Overall Study|Withdrawal by Subject|1|||
105706300|NCT03808077|364587285|FG001|Overall Study|Withdrawal by Subject|0|||
105706301|NCT03808077|364587284|FG000|Overall Study|Equipment Issues|2|||
105706302|NCT03808077|364587285|FG001|Overall Study|Equipment Issues|1|||
105706303|NCT04152161|364587286|FG000|Overall Study|Death|0|||
105706304|NCT04152161|364587287|FG001|Overall Study|Death|1|||
105706305|NCT04152161|364587286|FG000|Overall Study|Physician Decision|0|||
105706306|NCT04152161|364587287|FG001|Overall Study|Physician Decision|1|||
105706307|NCT04152161|364587286|FG000|Overall Study|Lost to Follow-up|9|||
105706308|NCT04152161|364587287|FG001|Overall Study|Lost to Follow-up|3|||
105706309|NCT04152161|364587286|FG000|Overall Study|Protocol Violation|1|||
105706310|NCT04152161|364587287|FG001|Overall Study|Protocol Violation|0|||
105706311|NCT04152161|364587286|FG000|Overall Study|Withdrawal by Subject|29|||
105706312|NCT04152161|364587287|FG001|Overall Study|Withdrawal by Subject|28|||
105706313|NCT04152161|364587286|FG000|Overall Study|Sponsor termination of study|750|||
105706314|NCT04152161|364587287|FG001|Overall Study|Sponsor termination of study|755|||
105706315|NCT04152161|364587286|FG000|Overall Study|Other|20|||
105706316|NCT04152161|364587287|FG001|Overall Study|Other|18|||
105706318|NCT03246958|364587289|FG000|Overall Study|Withdrawal by Subject|0|||
105706319|NCT03246958|364587290|FG001|Overall Study|Withdrawal by Subject|1|||
105706320|NCT03246958|364587291|FG002|Overall Study|Withdrawal by Subject|0|||
105706321|NCT03246958|364587292|FG003|Overall Study|Withdrawal by Subject|0|||
105706322|NCT03246958|364587293|FG004|Overall Study|Withdrawal by Subject|0|||
105706323|NCT03246958|364587294|FG005|Overall Study|Withdrawal by Subject|1|||
105706324|NCT03246958|364587295|FG006|Overall Study|Withdrawal by Subject|0|||
105706325|NCT03246958|364587289|FG000|Overall Study|Progression|13|||
105706326|NCT03246958|364587290|FG001|Overall Study|Progression|9|||
105706327|NCT03246958|364587291|FG002|Overall Study|Progression|3|||
105706328|NCT03246958|364587292|FG003|Overall Study|Progression|2|||
105706329|NCT03246958|364587293|FG004|Overall Study|Progression|1|||
105706330|NCT03246958|364587294|FG005|Overall Study|Progression|2|||
105706331|NCT03246958|364587295|FG006|Overall Study|Progression|1|||
105706332|NCT03246958|364587289|FG000|Overall Study|Adverse Event|2|||
105706333|NCT03246958|364587290|FG001|Overall Study|Adverse Event|2|||
105706334|NCT03246958|364587291|FG002|Overall Study|Adverse Event|0|||
105706335|NCT03246958|364587292|FG003|Overall Study|Adverse Event|1|||
105706336|NCT03246958|364587293|FG004|Overall Study|Adverse Event|1|||
105706337|NCT03246958|364587294|FG005|Overall Study|Adverse Event|0|||
105706338|NCT03246958|364587295|FG006|Overall Study|Adverse Event|2|||
105706339|NCT03246958|364587289|FG000|Overall Study|Death|0|||
105706340|NCT03246958|364587290|FG001|Overall Study|Death|1|||
105706341|NCT03246958|364587291|FG002|Overall Study|Death|0|||
105706342|NCT03246958|364587292|FG003|Overall Study|Death|0|||
105706343|NCT03246958|364587293|FG004|Overall Study|Death|0|||
105706344|NCT03246958|364587294|FG005|Overall Study|Death|0|||
105706345|NCT03246958|364587295|FG006|Overall Study|Death|0|||
105706346|NCT03246958|364587289|FG000|Overall Study|Physician Decision|0|||
105706347|NCT03246958|364587290|FG001|Overall Study|Physician Decision|0|||
105706348|NCT03246958|364587291|FG002|Overall Study|Physician Decision|0|||
105706349|NCT03246958|364587292|FG003|Overall Study|Physician Decision|1|||
105706350|NCT03246958|364587293|FG004|Overall Study|Physician Decision|0|||
105706351|NCT03246958|364587294|FG005|Overall Study|Physician Decision|0|||
105706352|NCT03246958|364587295|FG006|Overall Study|Physician Decision|0|||
105706353|NCT03246958|364587289|FG000|Overall Study|Never start treatment|1|||
105706354|NCT03246958|364587290|FG001|Overall Study|Never start treatment|0|||
105706355|NCT03246958|364587291|FG002|Overall Study|Never start treatment|0|||
105706356|NCT03246958|364587292|FG003|Overall Study|Never start treatment|0|||
105706357|NCT03246958|364587293|FG004|Overall Study|Never start treatment|0|||
105706358|NCT03246958|364587294|FG005|Overall Study|Never start treatment|0|||
105706359|NCT03246958|364587295|FG006|Overall Study|Never start treatment|0|||
105706360|NCT03246958|364587289|FG000|Overall Study|Over enrollment|0|||
105706361|NCT03246958|364587290|FG001|Overall Study|Over enrollment|2|||
105706362|NCT03246958|364587291|FG002|Overall Study|Over enrollment|0|||
105706363|NCT03246958|364587292|FG003|Overall Study|Over enrollment|0|||
105706364|NCT03246958|364587293|FG004|Overall Study|Over enrollment|0|||
105706365|NCT03246958|364587294|FG005|Overall Study|Over enrollment|0|||
105706366|NCT03246958|364587295|FG006|Overall Study|Over enrollment|0|||
105706367|NCT00876187|364587302|FG000|Overall Study|Adverse Event|14|||
105706368|NCT00876187|364587303|FG001|Overall Study|Adverse Event|12|||
105706369|NCT00876187|364587304|FG002|Overall Study|Adverse Event|19|||
105706370|NCT00876187|364587305|FG003|Overall Study|Adverse Event|29|||
105706371|NCT00876187|364587306|FG004|Overall Study|Adverse Event|10|||
105706372|NCT00876187|364587302|FG000|Overall Study|Lack of Efficacy|59|||
105706373|NCT00876187|364587303|FG001|Overall Study|Lack of Efficacy|34|||
105706374|NCT00876187|364587304|FG002|Overall Study|Lack of Efficacy|45|||
105706375|NCT00876187|364587305|FG003|Overall Study|Lack of Efficacy|34|||
105706376|NCT00876187|364587306|FG004|Overall Study|Lack of Efficacy|59|||
105706377|NCT00876187|364587302|FG000|Overall Study|Lost to Follow-up|9|||
105706378|NCT00876187|364587303|FG001|Overall Study|Lost to Follow-up|10|||
105706379|NCT00876187|364587304|FG002|Overall Study|Lost to Follow-up|8|||
105706380|NCT00876187|364587305|FG003|Overall Study|Lost to Follow-up|8|||
105706381|NCT00876187|364587306|FG004|Overall Study|Lost to Follow-up|11|||
105706382|NCT00876187|364587302|FG000|Overall Study|Protocol Violation|6|||
105706383|NCT00876187|364587303|FG001|Overall Study|Protocol Violation|7|||
105706384|NCT00876187|364587304|FG002|Overall Study|Protocol Violation|7|||
105706385|NCT00876187|364587305|FG003|Overall Study|Protocol Violation|6|||
105706386|NCT00876187|364587306|FG004|Overall Study|Protocol Violation|3|||
105706387|NCT00876187|364587302|FG000|Overall Study|Withdrawal by Subject|16|||
105706388|NCT00876187|364587303|FG001|Overall Study|Withdrawal by Subject|26|||
105706389|NCT00876187|364587304|FG002|Overall Study|Withdrawal by Subject|32|||
105706390|NCT00876187|364587305|FG003|Overall Study|Withdrawal by Subject|38|||
105706391|NCT00876187|364587306|FG004|Overall Study|Withdrawal by Subject|37|||
105706392|NCT00876187|364587302|FG000|Overall Study|Entered extension study|101|||
105706393|NCT00876187|364587303|FG001|Overall Study|Entered extension study|120|||
105706394|NCT00876187|364587304|FG002|Overall Study|Entered extension study|156|||
105706395|NCT00876187|364587305|FG003|Overall Study|Entered extension study|151|||
105706396|NCT00876187|364587306|FG004|Overall Study|Entered extension study|144|||
105706397|NCT00876187|364587302|FG000|Overall Study|Randomized but not treated|3|||
105706398|NCT00876187|364587303|FG001|Overall Study|Randomized but not treated|1|||
105706399|NCT00876187|364587304|FG002|Overall Study|Randomized but not treated|3|||
105706400|NCT00876187|364587305|FG003|Overall Study|Randomized but not treated|2|||
105706401|NCT00876187|364587306|FG004|Overall Study|Randomized but not treated|3|||
105706402|NCT00876187|364587302|FG000|Overall Study|Other|2|||
105706403|NCT00876187|364587303|FG001|Overall Study|Other|5|||
105706404|NCT00876187|364587304|FG002|Overall Study|Other|9|||
105706405|NCT00876187|364587305|FG003|Overall Study|Other|7|||
105706406|NCT00876187|364587306|FG004|Overall Study|Other|4|||
105706407|NCT01500278|364587307|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
105706408|NCT01500278|364587308|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
105706409|NCT01500278|364587307|FG000|Week 0 - Week 12|Protocol Violation|10|||
105706410|NCT01500278|364587308|FG001|Week 0 - Week 12|Protocol Violation|16|||
105706411|NCT01500278|364587307|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
105706412|NCT01500278|364587308|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
105706413|NCT01500278|364587307|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
105706414|NCT01500278|364587308|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
105706415|NCT01500278|364587307|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
105706416|NCT01500278|364587308|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
105706417|NCT01500278|364587307|FG000|Week 0 - Week 12|Patient decision|1|||
105706418|NCT01500278|364587308|FG001|Week 0 - Week 12|Patient decision|0|||
105706419|NCT01500278|364587307|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
105706420|NCT01500278|364587308|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
105706421|NCT01500278|364587307|FG000|Week 0 - Week 12|Investigator decision|1|||
105560553|NCT05763628|364048445|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
105560554|NCT05763628|364048446|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
105560555|NCT05763628|364048445|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
105706422|NCT01500278|364587308|FG001|Week 0 - Week 12|Investigator decision|0|||
105560556|NCT05763628|364048446|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
105560557|NCT05763628|364048445|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
105706423|NCT01500278|364587307|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
105787733|NCT05993299|364876757|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
105706424|NCT01500278|364587308|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
105706425|NCT01500278|364587307|FG000|Week 0 - Week 12|Sponsor decision|1|||
105706426|NCT01500278|364587308|FG001|Week 0 - Week 12|Sponsor decision|0|||
105706427|NCT01500278|364587307|FG000|Week 0 - Week 12|Personal reason|0|||
105706428|NCT01500278|364587308|FG001|Week 0 - Week 12|Personal reason|1|||
105706429|NCT01500278|364587307|FG000|Week 0 - Week 12|Other serious disease|0|||
105706430|NCT01500278|364587308|FG001|Week 0 - Week 12|Other serious disease|1|||
105706431|NCT01500278|364587307|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
105706432|NCT01500278|364587308|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
105706433|NCT01500278|364587307|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
105706434|NCT01500278|364587308|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
105706435|NCT01500278|364587307|FG000|Week 13 - Week 104|Protocol Violation|6|||
105706436|NCT01500278|364587308|FG001|Week 13 - Week 104|Protocol Violation|6|||
105706437|NCT01500278|364587307|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
105706438|NCT01500278|364587308|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
105706439|NCT01500278|364587307|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
105706440|NCT01500278|364587308|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
105706441|NCT01500278|364587307|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
105706442|NCT01500278|364587308|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
105706443|NCT01500278|364587307|FG000|Week 13 - Week 104|Non/bad compliance|7|||
105706444|NCT01500278|364587308|FG001|Week 13 - Week 104|Non/bad compliance|5|||
105706445|NCT01500278|364587307|FG000|Week 13 - Week 104|Recurrent infections|1|||
105706446|NCT01500278|364587308|FG001|Week 13 - Week 104|Recurrent infections|0|||
105706447|NCT01500278|364587307|FG000|Week 13 - Week 104|False positive test|1|||
105706448|NCT01500278|364587308|FG001|Week 13 - Week 104|False positive test|2|||
105706449|NCT01500278|364587307|FG000|Week 13 - Week 104|Sponsor request|4|||
105706450|NCT01500278|364587308|FG001|Week 13 - Week 104|Sponsor request|0|||
105706451|NCT01500278|364587307|FG000|Week 13 - Week 104|Withdrawn in error|1|||
105706452|NCT01500278|364587308|FG001|Week 13 - Week 104|Withdrawn in error|0|||
105706453|NCT01500278|364587307|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
105706454|NCT01500278|364587308|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
105706455|NCT01500278|364587307|FG000|Week 13 - Week 104|Protocol deviation|1|||
105706456|NCT01500278|364587308|FG001|Week 13 - Week 104|Protocol deviation|0|||
105706457|NCT01500278|364587307|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
105706458|NCT01500278|364587308|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
105706459|NCT01500278|364587307|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
105706460|NCT01500278|364587308|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
105706461|NCT01500278|364587307|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
105706462|NCT01500278|364587308|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
105706463|NCT01500278|364587307|FG000|Week 13 - Week 104|Relocation|0|||
105706464|NCT01500278|364587308|FG001|Week 13 - Week 104|Relocation|1|||
105706465|NCT01500278|364587307|FG000|Week 13 - Week 104|Sponsor decision|0|||
105706466|NCT01500278|364587308|FG001|Week 13 - Week 104|Sponsor decision|2|||
105706467|NCT01500278|364587307|FG000|Week 13 - Week 104|Medical monitor decision|0|||
105706468|NCT01500278|364587308|FG001|Week 13 - Week 104|Medical monitor decision|2|||
105706469|NCT01500278|364587307|FG000|Week 13 - Week 104|Personal reason|0|||
105706470|NCT01500278|364587308|FG001|Week 13 - Week 104|Personal reason|1|||
105706471|NCT01500278|364587307|FG000|Week 13 - Week 104|Not completed|0|||
105706472|NCT01500278|364587308|FG001|Week 13 - Week 104|Not completed|1|||
105706473|NCT01500278|364587307|FG000|Week 13 - Week 104|Death|2|||
105706474|NCT01500278|364587308|FG001|Week 13 - Week 104|Death|4|||
105706475|NCT01500278|364587307|FG000|Week 13 - Week 104|Adverse Event|54|||
105706476|NCT01500278|364587308|FG001|Week 13 - Week 104|Adverse Event|54|||
105706477|NCT00763815|364587309|FG000|Overall Study|Adverse Event|14|||
105706478|NCT00763815|364587310|FG001|Overall Study|Adverse Event|29|||
105706479|NCT00763815|364587309|FG000|Overall Study|Lack of Efficacy|10|||
105706480|NCT00763815|364587310|FG001|Overall Study|Lack of Efficacy|11|||
105706481|NCT00763815|364587309|FG000|Overall Study|Poor Compliance to Protocol|6|||
105706482|NCT00763815|364587310|FG001|Overall Study|Poor Compliance to Protocol|6|||
105706483|NCT00763815|364587309|FG000|Overall Study|Lost to Follow-up|2|||
105706484|NCT00763815|364587310|FG001|Overall Study|Lost to Follow-up|4|||
105706485|NCT00763815|364587309|FG000|Overall Study|Early Termination|1|||
105706486|NCT00763815|364587310|FG001|Overall Study|Early Termination|0|||
105787734|NCT05993299|364876757|FG000|Overall Study|Ongoing|4|||
105787735|NCT05644756|364876758|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
105787736|NCT05644756|364876758|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
105787737|NCT02968810|364876759|FG000|Overall Study|Lost to Follow-up|1|||
105787738|NCT02968810|364876760|FG001|Overall Study|Lost to Follow-up|0|||
105787739|NCT02968810|364876759|FG000|Overall Study|Physician Decision|1|||
105787740|NCT02968810|364876760|FG001|Overall Study|Physician Decision|0|||
105787741|NCT02968810|364876759|FG000|Overall Study|Withdrawal by Subject|1|||
105787742|NCT02968810|364876760|FG001|Overall Study|Withdrawal by Subject|3|||
105787743|NCT02968810|364876759|FG000|Overall Study|Disease Progression|0|||
105787744|NCT02968810|364876760|FG001|Overall Study|Disease Progression|1|||
105787745|NCT03113760|364876761|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
105787746|NCT03113760|364876762|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
105787747|NCT03113760|364876763|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
105787748|NCT03113760|364876764|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
105787749|NCT03113760|364876761|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
105787750|NCT03113760|364876762|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
105787751|NCT03113760|364876763|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
105787752|NCT03113760|364876764|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
105787753|NCT03113760|364876761|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
105787754|NCT03113760|364876762|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
105787755|NCT03113760|364876763|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
105706487|NCT00763815|364587309|FG000|Overall Study|Familial and Personal Reasons|9|||
105706488|NCT00763815|364587310|FG001|Overall Study|Familial and Personal Reasons|16|||
105706489|NCT00763815|364587309|FG000|Overall Study|Physician Decision|1|||
105706490|NCT00763815|364587310|FG001|Overall Study|Physician Decision|0|||
105706491|NCT00763815|364587309|FG000|Overall Study|Withdrawal by Subject|7|||
105706492|NCT00763815|364587310|FG001|Overall Study|Withdrawal by Subject|12|||
105706493|NCT00763815|364587309|FG000|Overall Study|Protocol Violation|2|||
105706494|NCT00763815|364587310|FG001|Overall Study|Protocol Violation|5|||
105706495|NCT00763815|364587309|FG000|Overall Study|Sponsor's Decision|0|||
105706496|NCT00763815|364587310|FG001|Overall Study|Sponsor's Decision|1|||
105706497|NCT00283595|364587311|FG000|Overall Study|Withdrawal by Subject|1|||
105787756|NCT03113760|364876764|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
105787757|NCT01059175|364876766|FG000|Overall Study|Death|17|||
105787758|NCT01059175|364876767|FG001|Overall Study|Death|17|||
105787759|NCT01059175|364876766|FG000|Overall Study|Adverse Event|4|||
105787760|NCT01059175|364876767|FG001|Overall Study|Adverse Event|2|||
105787761|NCT01059175|364876766|FG000|Overall Study|Lost to Follow-up|0|||
105787762|NCT01059175|364876767|FG001|Overall Study|Lost to Follow-up|1|||
105787763|NCT01283009|364876768|FG000|Overall Study|Death|83|||
105787764|NCT01283009|364876769|FG001|Overall Study|Death|78|||
105787765|NCT01283009|364876768|FG000|Overall Study|Study ended early|23|||
105787766|NCT01283009|364876769|FG001|Overall Study|Study ended early|26|||
105787767|NCT01283009|364876768|FG000|Overall Study|Withdrawal by Subject|10|||
105787768|NCT01283009|364876769|FG001|Overall Study|Withdrawal by Subject|8|||
105787769|NCT01283009|364876768|FG000|Overall Study|Physician Decision|1|||
105787770|NCT01283009|364876769|FG001|Overall Study|Physician Decision|1|||
105787771|NCT01283009|364876768|FG000|Overall Study|Lost to Follow-up|1|||
105787772|NCT01283009|364876769|FG001|Overall Study|Lost to Follow-up|0|||
105787773|NCT01283009|364876768|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
105787774|NCT01283009|364876769|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
105787775|NCT03557775|364876770|FG000|Overall Study|Withdrawal by Subject|1|||
105787776|NCT03557775|364876771|FG001|Overall Study|Withdrawal by Subject|2|||
105787777|NCT03557775|364876772|FG002|Overall Study|Withdrawal by Subject|4|||
105787778|NCT03557775|364876770|FG000|Overall Study|Physician Decision|0|||
105787779|NCT03557775|364876771|FG001|Overall Study|Physician Decision|1|||
105787780|NCT03557775|364876772|FG002|Overall Study|Physician Decision|0|||
105787781|NCT01725217|364876775|FG000|Overall Study|Withdrawal by Subject|1|||
105787782|NCT01725217|364876776|FG001|Overall Study|Withdrawal by Subject|0|||
105787783|NCT01725217|364876777|FG002|Overall Study|Withdrawal by Subject|0|||
105787784|NCT01353586|364876778|FG000|Overall Study|Procedure terminated prior to ablation|3|||
105787785|NCT01353586|364876779|FG001|Overall Study|Procedure terminated prior to ablation|0|||
105706498|NCT00283595|364587312|FG001|Overall Study|Withdrawal by Subject|2|||
105706499|NCT00906087|364587315|FG000|Initial Washout|Withdrawal by Subject|1|||
105706500|NCT00906087|364587315|FG000|Initial Washout|Physician Decision|1|||
105787786|NCT01353586|364876778|FG000|Overall Study|Never had insertion of study catheter|4|||
105787787|NCT01353586|364876779|FG001|Overall Study|Never had insertion of study catheter|1|||
105787788|NCT01353586|364876778|FG000|Overall Study|Neurological exam not done|0|||
105787789|NCT01353586|364876779|FG001|Overall Study|Neurological exam not done|1|||
105787790|NCT01023815|364876780|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
105787791|NCT01023815|364876781|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
105787792|NCT01023815|364876782|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
105706501|NCT01081249|364587320|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
105706502|NCT01081249|364587321|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
105706503|NCT03016325|364587324|FG000|Treatment Period|Participant withdrew consent|0|||
105706504|NCT03016325|364587325|FG001|Treatment Period|Participant withdrew consent|1|||
105706505|NCT03016325|364587326|FG002|Treatment Period|Participant withdrew consent|0|||
105706506|NCT03016325|364587327|FG003|Treatment Period|Participant withdrew consent|0|||
105706507|NCT03016325|364587328|FG004|Treatment Period|Participant withdrew consent|0|||
105706508|NCT03016325|364587329|FG005|Treatment Period|Participant withdrew consent|0|||
105706509|NCT03016325|364587330|FG006|Treatment Period|Participant withdrew consent|0|||
105706510|NCT03016325|364587331|FG007|Treatment Period|Participant withdrew consent|0|||
105706511|NCT03016325|364587324|FG000|Treatment Period|Death|0|||
105706512|NCT03016325|364587325|FG001|Treatment Period|Death|0|||
105706513|NCT03016325|364587326|FG002|Treatment Period|Death|0|||
105706514|NCT03016325|364587327|FG003|Treatment Period|Death|0|||
105706515|NCT03016325|364587328|FG004|Treatment Period|Death|2|||
105706516|NCT03016325|364587329|FG005|Treatment Period|Death|0|||
105706517|NCT03016325|364587330|FG006|Treatment Period|Death|0|||
105706518|NCT03016325|364587331|FG007|Treatment Period|Death|0|||
105706519|NCT03016325|364587324|FG000|Treatment Period|Participant refuses assessments|0|||
105706520|NCT03016325|364587325|FG001|Treatment Period|Participant refuses assessments|0|||
105706521|NCT03016325|364587326|FG002|Treatment Period|Participant refuses assessments|1|||
105706522|NCT03016325|364587327|FG003|Treatment Period|Participant refuses assessments|0|||
105706523|NCT03016325|364587328|FG004|Treatment Period|Participant refuses assessments|0|||
105706524|NCT03016325|364587329|FG005|Treatment Period|Participant refuses assessments|0|||
105706525|NCT03016325|364587330|FG006|Treatment Period|Participant refuses assessments|0|||
105706526|NCT03016325|364587331|FG007|Treatment Period|Participant refuses assessments|0|||
105706527|NCT03016325|364587324|FG000|32-Day Follow-Up Period|Death|2|||
105706528|NCT03016325|364587325|FG001|32-Day Follow-Up Period|Death|0|||
105706529|NCT03016325|364587326|FG002|32-Day Follow-Up Period|Death|5|||
105706530|NCT03016325|364587327|FG003|32-Day Follow-Up Period|Death|6|||
105706531|NCT03016325|364587328|FG004|32-Day Follow-Up Period|Death|3|||
105706532|NCT03016325|364587329|FG005|32-Day Follow-Up Period|Death|0|||
105706533|NCT03016325|364587330|FG006|32-Day Follow-Up Period|Death|0|||
105706534|NCT03016325|364587331|FG007|32-Day Follow-Up Period|Death|0|||
105706535|NCT03016325|364587324|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
105706536|NCT03016325|364587325|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
105706537|NCT03016325|364587326|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
105706538|NCT03016325|364587327|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
105706539|NCT03016325|364587328|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
105706540|NCT03016325|364587329|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
105706541|NCT03016325|364587330|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
105706542|NCT03016325|364587331|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
105706543|NCT03016325|364587324|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
105706544|NCT03016325|364587325|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
105706545|NCT03016325|364587326|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
105706546|NCT03016325|364587327|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
105706547|NCT03016325|364587328|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
105706548|NCT03016325|364587329|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
105706549|NCT03016325|364587330|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
105706550|NCT03016325|364587331|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
105706551|NCT03016325|364587324|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
105706552|NCT03016325|364587325|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
105706553|NCT03016325|364587326|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
105706554|NCT03016325|364587327|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
105706555|NCT03016325|364587328|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
105706556|NCT03016325|364587329|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
105706557|NCT03016325|364587330|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
105706558|NCT03016325|364587331|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
105706559|NCT03016325|364587324|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
105706560|NCT03016325|364587325|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
105706561|NCT03016325|364587326|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
105706562|NCT03016325|364587327|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
105706563|NCT03016325|364587328|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
105706564|NCT03016325|364587329|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
105706565|NCT03016325|364587330|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
105706566|NCT03016325|364587331|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
105706567|NCT03016325|364587324|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
105706568|NCT03016325|364587325|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
105474686|NCT01349049|363751163|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
105706569|NCT03016325|364587326|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
105706570|NCT03016325|364587327|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
105474687|NCT01349049|363751164|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
105706571|NCT03016325|364587328|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
105706572|NCT03016325|364587329|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
105706573|NCT03016325|364587330|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
105706574|NCT03016325|364587331|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
105706575|NCT03016325|364587324|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
105706576|NCT03016325|364587325|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
105706577|NCT03016325|364587326|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
105706578|NCT03016325|364587327|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
105706579|NCT03016325|364587328|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
105706580|NCT03016325|364587329|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
105706581|NCT03016325|364587330|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
105706582|NCT03016325|364587331|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
105706583|NCT03016325|364587324|FG000|182-Day Follow-Up Period|Death|3|||
105706584|NCT03016325|364587325|FG001|182-Day Follow-Up Period|Death|3|||
105706585|NCT03016325|364587326|FG002|182-Day Follow-Up Period|Death|11|||
105706586|NCT03016325|364587327|FG003|182-Day Follow-Up Period|Death|12|||
105706587|NCT03016325|364587328|FG004|182-Day Follow-Up Period|Death|9|||
105706588|NCT03016325|364587329|FG005|182-Day Follow-Up Period|Death|0|||
105706589|NCT03016325|364587330|FG006|182-Day Follow-Up Period|Death|0|||
105706590|NCT03016325|364587331|FG007|182-Day Follow-Up Period|Death|1|||
105706591|NCT03016325|364587324|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
105706592|NCT03016325|364587325|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
105706593|NCT03016325|364587326|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
105706594|NCT03016325|364587327|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
105706595|NCT03016325|364587328|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
105706596|NCT03016325|364587329|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
105706597|NCT03016325|364587330|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
105706598|NCT03016325|364587331|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
105706599|NCT03016325|364587324|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
105706600|NCT03016325|364587325|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
105706601|NCT03016325|364587326|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
105706602|NCT03016325|364587327|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
105706603|NCT03016325|364587328|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
105706604|NCT03016325|364587329|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
105706605|NCT03016325|364587330|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
105706606|NCT03016325|364587331|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
105706607|NCT03016325|364587324|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
105706608|NCT03016325|364587325|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
105706609|NCT03016325|364587326|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
105706610|NCT03016325|364587327|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
105706611|NCT03016325|364587328|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
105706612|NCT03016325|364587329|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
105706613|NCT03016325|364587330|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
105706614|NCT03016325|364587331|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
105706615|NCT03016325|364587324|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
105706616|NCT03016325|364587325|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
105706617|NCT03016325|364587326|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
105706618|NCT03016325|364587327|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
105706619|NCT03016325|364587328|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
105706620|NCT03016325|364587329|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
105706621|NCT03016325|364587330|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
105706622|NCT03016325|364587331|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
105706623|NCT03016325|364587324|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
105787793|NCT01023815|364876783|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
105474688|NCT01349049|363751165|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
105474689|NCT01349049|363751166|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
105474690|NCT01349049|363751167|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
105474691|NCT01349049|363751159|FG000|Overall Study|Other|0|||
105787794|NCT01023815|364876780|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
105474692|NCT01349049|363751160|FG001|Overall Study|Other|0|||
105706624|NCT03016325|364587325|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
105706625|NCT03016325|364587326|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
105706626|NCT03016325|364587327|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
105706627|NCT03016325|364587328|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
105706628|NCT03016325|364587329|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
105706629|NCT03016325|364587330|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
105706630|NCT03016325|364587331|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
105706631|NCT03016325|364587324|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
105706632|NCT03016325|364587325|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
105706633|NCT03016325|364587326|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
105706634|NCT03016325|364587327|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
105706635|NCT03016325|364587328|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
105706636|NCT03016325|364587329|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
105706637|NCT03016325|364587330|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
105706638|NCT03016325|364587331|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
105706639|NCT03016325|364587324|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
105706640|NCT03016325|364587325|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
105706641|NCT03016325|364587326|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
105706642|NCT03016325|364587327|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
105706643|NCT03016325|364587328|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
105706644|NCT03016325|364587329|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
105706645|NCT03016325|364587330|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
105706646|NCT03016325|364587331|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
105706647|NCT02595723|364587332|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
105706648|NCT02595723|364587333|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
105706649|NCT02595723|364587334|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
105706650|NCT02595723|364587332|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
105706651|NCT02595723|364587333|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
105706652|NCT02595723|364587334|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
105706653|NCT01087905|364587335|FG000|Overall Study|Lost to Follow-up|24|||
105706654|NCT01087905|364587336|FG001|Overall Study|Lost to Follow-up|28|||
105706655|NCT01087905|364587337|FG002|Overall Study|Lost to Follow-up|18|||
105706656|NCT01087905|364587338|FG003|Overall Study|Lost to Follow-up|31|||
105706657|NCT01087905|364587339|FG004|Overall Study|Lost to Follow-up|27|||
105706658|NCT01087905|364587340|FG005|Overall Study|Lost to Follow-up|25|||
105706659|NCT01087905|364587341|FG006|Overall Study|Lost to Follow-up|20|||
105706660|NCT01087905|364587342|FG007|Overall Study|Lost to Follow-up|24|||
105706661|NCT01087905|364587335|FG000|Overall Study|Withdrawal by Subject|5|||
105706662|NCT01087905|364587336|FG001|Overall Study|Withdrawal by Subject|4|||
105706663|NCT01087905|364587337|FG002|Overall Study|Withdrawal by Subject|4|||
105706664|NCT01087905|364587338|FG003|Overall Study|Withdrawal by Subject|5|||
105706665|NCT01087905|364587339|FG004|Overall Study|Withdrawal by Subject|4|||
105706666|NCT01087905|364587340|FG005|Overall Study|Withdrawal by Subject|3|||
105706667|NCT01087905|364587341|FG006|Overall Study|Withdrawal by Subject|3|||
105706668|NCT01087905|364587342|FG007|Overall Study|Withdrawal by Subject|5|||
105706669|NCT00749996|364587344|FG000|Overall Study|Lost to Follow-up|7|||
105706670|NCT00749996|364587345|FG001|Overall Study|Lost to Follow-up|4|||
105706671|NCT00749996|364587344|FG000|Overall Study|Withdrawal by Subject|5|||
105706672|NCT00749996|364587345|FG001|Overall Study|Withdrawal by Subject|4|||
105706673|NCT00749996|364587344|FG000|Overall Study|Protocol Violation|2|||
105706674|NCT00749996|364587345|FG001|Overall Study|Protocol Violation|3|||
105706675|NCT00749996|364587344|FG000|Overall Study|Physician Decision|2|||
105706676|NCT00749996|364587345|FG001|Overall Study|Physician Decision|0|||
105706677|NCT00749996|364587344|FG000|Overall Study|Pregnancy|0|||
105706678|NCT00749996|364587345|FG001|Overall Study|Pregnancy|2|||
105706679|NCT00749996|364587344|FG000|Overall Study|Adverse Event|1|||
105706680|NCT00749996|364587345|FG001|Overall Study|Adverse Event|0|||
105706681|NCT00749996|364587344|FG000|Overall Study|Death|1|||
105706682|NCT00749996|364587345|FG001|Overall Study|Death|0|||
105706683|NCT01902290|364587346|FG000|Overall Study|Withdrawal by Subject|19|||
105706684|NCT01902290|364587347|FG001|Overall Study|Withdrawal by Subject|27|||
105706685|NCT01902290|364587346|FG000|Overall Study|Lost to Follow-up|2|||
105474693|NCT01349049|363751161|FG002|Overall Study|Other|0|||
105474694|NCT01349049|363751162|FG003|Overall Study|Other|0|||
105706686|NCT01902290|364587347|FG001|Overall Study|Lost to Follow-up|2|||
105706687|NCT01902290|364587346|FG000|Overall Study|Death|1|||
105706688|NCT01902290|364587347|FG001|Overall Study|Death|0|||
105706689|NCT01902290|364587346|FG000|Overall Study|Sponsor Decision|26|||
105706690|NCT01902290|364587347|FG001|Overall Study|Sponsor Decision|24|||
105706691|NCT00517829|364587348|FG000|Overall Study|Adverse Event|22|||
105706692|NCT00517829|364587349|FG001|Overall Study|Adverse Event|34|||
105706693|NCT00517829|364587348|FG000|Overall Study|Disease Progression|39|||
105706694|NCT00517829|364587349|FG001|Overall Study|Disease Progression|32|||
105706695|NCT00517829|364587348|FG000|Overall Study|Patient Request|6|||
105706696|NCT00517829|364587349|FG001|Overall Study|Patient Request|5|||
105706697|NCT00517829|364587348|FG000|Overall Study|Investigator Request|5|||
105706698|NCT00517829|364587349|FG001|Overall Study|Investigator Request|3|||
105706699|NCT00517829|364587348|FG000|Overall Study|Other|3|||
105706700|NCT00517829|364587349|FG001|Overall Study|Other|1|||
105706701|NCT01568593|364587352|FG000|Overall Study|Lack of Efficacy|4|||
105706702|NCT01568593|364587353|FG001|Overall Study|Lack of Efficacy|1|||
105706703|NCT01568593|364587352|FG000|Overall Study|Adverse Event|3|||
105706704|NCT01568593|364587353|FG001|Overall Study|Adverse Event|2|||
105706705|NCT00419380|364587358|FG000|Overall Study|Lack of Efficacy|1|||
105706706|NCT00419380|364587359|FG001|Overall Study|Lack of Efficacy|7|||
105706707|NCT00419380|364587358|FG000|Overall Study|Physician Decision|0|||
105706708|NCT00419380|364587359|FG001|Overall Study|Physician Decision|1|||
105706709|NCT00419380|364587358|FG000|Overall Study|Lost to Follow-up|0|||
105706710|NCT00419380|364587359|FG001|Overall Study|Lost to Follow-up|1|||
105706711|NCT00419380|364587358|FG000|Overall Study|Withdrawal by Subject|0|||
105706712|NCT00419380|364587359|FG001|Overall Study|Withdrawal by Subject|1|||
105706713|NCT03127384|364587362|FG000|Overall Study|Lost to Follow-up|4|||
105706714|NCT03127384|364587362|FG000|Overall Study|Subject request|2|||
105706715|NCT01505634|364587364|FG000|Overall Study|Withdrawal by Subject|2|||
105706716|NCT01505634|364587365|FG001|Overall Study|Withdrawal by Subject|5|||
105706717|NCT01505634|364587366|FG002|Overall Study|Withdrawal by Subject|1|||
105706718|NCT01505634|364587364|FG000|Overall Study|Physician Decision|1|||
105706719|NCT01505634|364587365|FG001|Overall Study|Physician Decision|1|||
105706720|NCT01505634|364587366|FG002|Overall Study|Physician Decision|0|||
105706721|NCT01505634|364587364|FG000|Overall Study|Adverse Event|1|||
105706722|NCT01505634|364587365|FG001|Overall Study|Adverse Event|0|||
105706723|NCT01505634|364587366|FG002|Overall Study|Adverse Event|0|||
105706724|NCT01505634|364587364|FG000|Overall Study|Insufficient supply of drug at site|1|||
105706725|NCT01505634|364587365|FG001|Overall Study|Insufficient supply of drug at site|0|||
105706726|NCT01505634|364587366|FG002|Overall Study|Insufficient supply of drug at site|0|||
105706727|NCT01505634|364587364|FG000|Overall Study|Protocol Violation|2|||
105706728|NCT01505634|364587365|FG001|Overall Study|Protocol Violation|0|||
105706729|NCT01505634|364587366|FG002|Overall Study|Protocol Violation|0|||
105706730|NCT01505634|364587364|FG000|Overall Study|Lost to Follow-up|1|||
105706731|NCT01505634|364587365|FG001|Overall Study|Lost to Follow-up|4|||
105706732|NCT01505634|364587366|FG002|Overall Study|Lost to Follow-up|4|||
105706733|NCT01505634|364587364|FG000|Overall Study|Death|1|||
105706734|NCT01505634|364587365|FG001|Overall Study|Death|0|||
105706735|NCT01505634|364587366|FG002|Overall Study|Death|0|||
105706736|NCT01505634|364587364|FG000|Overall Study|In a conflict zone|0|||
105706737|NCT01505634|364587365|FG001|Overall Study|In a conflict zone|0|||
105706738|NCT01505634|364587366|FG002|Overall Study|In a conflict zone|1|||
105706739|NCT03873714|364587367|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
105706740|NCT01883635|364587368|FG000|Overall Study|Withdrawal by Subject|4|||
105706741|NCT01883635|364587369|FG001|Overall Study|Withdrawal by Subject|0|||
105706742|NCT00844753|364587370|FG000|Overall Study|Lack of Efficacy|1|||
105706743|NCT00844753|364587371|FG001|Overall Study|Lack of Efficacy|0|||
105706744|NCT00844753|364587372|FG002|Overall Study|Lack of Efficacy|2|||
105706745|NCT00844753|364587373|FG003|Overall Study|Lack of Efficacy|2|||
105706746|NCT00844753|364587370|FG000|Overall Study|Adverse Event|3|||
105706747|NCT00844753|364587371|FG001|Overall Study|Adverse Event|2|||
105706748|NCT00844753|364587372|FG002|Overall Study|Adverse Event|5|||
105706749|NCT00844753|364587373|FG003|Overall Study|Adverse Event|5|||
105706750|NCT00844753|364587370|FG000|Overall Study|Lost to Follow-up|1|||
105706751|NCT00844753|364587371|FG001|Overall Study|Lost to Follow-up|1|||
105706752|NCT00844753|364587372|FG002|Overall Study|Lost to Follow-up|0|||
105706753|NCT00844753|364587373|FG003|Overall Study|Lost to Follow-up|1|||
105706754|NCT00844753|364587370|FG000|Overall Study|could not swallow medication|2|||
105706755|NCT00844753|364587371|FG001|Overall Study|could not swallow medication|0|||
105706756|NCT00844753|364587372|FG002|Overall Study|could not swallow medication|0|||
105706757|NCT00844753|364587373|FG003|Overall Study|could not swallow medication|0|||
105706758|NCT00844753|364587370|FG000|Overall Study|Withdrawal by Subject|1|||
105706759|NCT00844753|364587371|FG001|Overall Study|Withdrawal by Subject|0|||
105706760|NCT00844753|364587372|FG002|Overall Study|Withdrawal by Subject|0|||
105706761|NCT00844753|364587373|FG003|Overall Study|Withdrawal by Subject|3|||
105706762|NCT03499028|364587379|FG000|Overall Study|Lost to Follow-up|12|||
105706763|NCT03499028|364587380|FG001|Overall Study|Lost to Follow-up|9|||
105706764|NCT03499028|364587379|FG000|Overall Study|Withdrawal by Subject|5|||
105706765|NCT03499028|364587380|FG001|Overall Study|Withdrawal by Subject|8|||
105706766|NCT03499028|364587379|FG000|Overall Study|Unplanned SNF discharge|5|||
105706767|NCT03499028|364587380|FG001|Overall Study|Unplanned SNF discharge|8|||
105706768|NCT03451773|364589091|FG000|Overall Study|Death on study|1|||
105706769|NCT03451773|364589092|FG001|Overall Study|Death on study|5|||
105706770|NCT03451773|364589091|FG000|Overall Study|Death during follow-up period|0|||
105787795|NCT01023815|364876781|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
105787796|NCT01023815|364876782|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
105787797|NCT01023815|364876783|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
105787798|NCT01023815|364876780|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
105706771|NCT03451773|364589092|FG001|Overall Study|Death during follow-up period|1|||
105706772|NCT01908101|364589097|FG000|Overall Study|Physician Decision|1|||
105706773|NCT01908101|364589097|FG000|Overall Study|Withdrawal by Subject|1|||
105706774|NCT01908101|364589097|FG000|Overall Study|Incorrect Diagnosis|2|||
105706775|NCT01908101|364589097|FG000|Overall Study|Incorrect Starting Dose|1|||
105706776|NCT01908101|364589097|FG000|Overall Study|Did not complete the first cycle|4|||
105706777|NCT02356562|364589098|FG000|Overall Study|Withdrawal by Subject|0|||
105787799|NCT01023815|364876781|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
105787800|NCT01023815|364876782|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
105787801|NCT01023815|364876783|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
105787802|NCT01023815|364876780|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
105787803|NCT01023815|364876781|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
105787804|NCT01023815|364876782|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
105787805|NCT01023815|364876783|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
105787806|NCT01023815|364876780|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
105787807|NCT01023815|364876781|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
105706778|NCT02356562|364589099|FG001|Overall Study|Withdrawal by Subject|1|||
105706779|NCT02356562|364589098|FG000|Overall Study|Re-entered treatment in a previous study|1|||
105787808|NCT01023815|364876782|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
105787809|NCT01023815|364876783|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
105787810|NCT01901393|364876784|FG000|Overall Study|Adverse Event|1|||
105787811|NCT01901393|364876785|FG001|Overall Study|Adverse Event|0|||
105787812|NCT00910000|364876786|FG000|Overall Study|Adverse Event|0|||
105787813|NCT00910000|364876787|FG001|Overall Study|Adverse Event|3|||
105787814|NCT00910000|364876788|FG002|Overall Study|Adverse Event|2|||
105787815|NCT00910000|364876789|FG003|Overall Study|Adverse Event|2|||
105787816|NCT00910000|364876790|FG004|Overall Study|Adverse Event|0|||
105787817|NCT00910000|364876791|FG005|Overall Study|Adverse Event|1|||
105787818|NCT00910000|364876786|FG000|Overall Study|Withdrawal by Subject|0|||
105787819|NCT00910000|364876787|FG001|Overall Study|Withdrawal by Subject|0|||
105787820|NCT00910000|364876788|FG002|Overall Study|Withdrawal by Subject|1|||
105787821|NCT00910000|364876789|FG003|Overall Study|Withdrawal by Subject|0|||
105787822|NCT00910000|364876790|FG004|Overall Study|Withdrawal by Subject|1|||
105787823|NCT00910000|364876791|FG005|Overall Study|Withdrawal by Subject|0|||
105787824|NCT03125382|364876794|FG000|Randomization|screening failure|1|||
105787825|NCT03125382|364876795|FG001|Randomization|screening failure|4|||
105787826|NCT03125382|364876796|FG002|Randomization|screening failure|2|||
105787827|NCT03125382|364876797|FG003|Randomization|screening failure|0|||
105787828|NCT03125382|364876794|FG000|Follow-up|Death|1|||
105787829|NCT03125382|364876795|FG001|Follow-up|Death|2|||
105787830|NCT03125382|364876796|FG002|Follow-up|Death|1|||
105787831|NCT03125382|364876797|FG003|Follow-up|Death|2|||
105787832|NCT03125382|364876794|FG000|Follow-up|Lost to Follow-up|1|||
105787833|NCT03125382|364876795|FG001|Follow-up|Lost to Follow-up|4|||
105787834|NCT03125382|364876796|FG002|Follow-up|Lost to Follow-up|3|||
105787835|NCT03125382|364876797|FG003|Follow-up|Lost to Follow-up|1|||
105787836|NCT00483119|364876798|FG000|Overall Study|Adverse Event|0|||
105787837|NCT00483119|364876799|FG001|Overall Study|Adverse Event|1|||
105787838|NCT00483119|364876798|FG000|Overall Study|Physician Decision|1|||
105787839|NCT00483119|364876799|FG001|Overall Study|Physician Decision|0|||
105787840|NCT03522506|364876801|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105787841|NCT03522506|364876802|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105787842|NCT03522506|364876803|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105787843|NCT03522506|364876804|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
105787844|NCT03522506|364876801|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
105350708|NCT04767529|363288162|FG001|Overall Study|Withdrawal by Subject|5|||
105706780|NCT02356562|364589099|FG001|Overall Study|Re-entered treatment in a previous study|0|||
105706781|NCT02356562|364589098|FG000|Overall Study|site closure|1|||
105350709|NCT04767529|363288163|FG002|Overall Study|Withdrawal by Subject|4|||
105787845|NCT03522506|364876802|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
105787846|NCT03522506|364876803|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
105706782|NCT02356562|364589099|FG001|Overall Study|site closure|0|||
105706783|NCT03311711|364589102|FG000|Overall Study|Death|1|||
105787847|NCT03522506|364876804|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
105787848|NCT03480243|364876805|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
105787849|NCT03480243|364876805|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
105360882|NCT00873730|363328099|FG000|Overall Study|Withdrawal by Subject|0|||
105787850|NCT04035499|364876810|FG000|Overall Study|Death|2|||
105706784|NCT03311711|364589103|FG001|Overall Study|Death|0|||
105706785|NCT03311711|364589104|FG002|Overall Study|Death|0|||
105706786|NCT03311711|364589105|FG003|Overall Study|Death|0|||
105706787|NCT03311711|364589106|FG004|Overall Study|Death|0|||
105706788|NCT03311711|364589107|FG005|Overall Study|Death|0|||
105706789|NCT03311711|364589108|FG006|Overall Study|Death|1|||
105706790|NCT03311711|364589109|FG007|Overall Study|Death|0|||
105706791|NCT03311711|364589110|FG008|Overall Study|Death|1|||
105706792|NCT03311711|364589111|FG009|Overall Study|Death|0|||
105706793|NCT03311711|364589102|FG000|Overall Study|Death of dyad partner|0|||
105706794|NCT03311711|364589103|FG001|Overall Study|Death of dyad partner|1|||
105706795|NCT03311711|364589104|FG002|Overall Study|Death of dyad partner|0|||
105706796|NCT03311711|364589105|FG003|Overall Study|Death of dyad partner|0|||
105706797|NCT03311711|364589106|FG004|Overall Study|Death of dyad partner|0|||
105706798|NCT03311711|364589107|FG005|Overall Study|Death of dyad partner|0|||
105706799|NCT03311711|364589108|FG006|Overall Study|Death of dyad partner|0|||
105706800|NCT03311711|364589109|FG007|Overall Study|Death of dyad partner|1|||
105706801|NCT03311711|364589110|FG008|Overall Study|Death of dyad partner|0|||
105706802|NCT03311711|364589111|FG009|Overall Study|Death of dyad partner|1|||
105706803|NCT03311711|364589102|FG000|Overall Study|Lost to Follow-up|2|||
105706804|NCT03311711|364589103|FG001|Overall Study|Lost to Follow-up|2|||
105706805|NCT03311711|364589104|FG002|Overall Study|Lost to Follow-up|0|||
105706806|NCT03311711|364589105|FG003|Overall Study|Lost to Follow-up|0|||
105706807|NCT03311711|364589106|FG004|Overall Study|Lost to Follow-up|0|||
105706808|NCT03311711|364589107|FG005|Overall Study|Lost to Follow-up|0|||
105706809|NCT03311711|364589108|FG006|Overall Study|Lost to Follow-up|1|||
105706810|NCT03311711|364589109|FG007|Overall Study|Lost to Follow-up|1|||
105706811|NCT03311711|364589110|FG008|Overall Study|Lost to Follow-up|0|||
105706812|NCT03311711|364589111|FG009|Overall Study|Lost to Follow-up|0|||
105706813|NCT03311711|364589102|FG000|Overall Study|Withdrawal by Subject|1|||
105706814|NCT03311711|364589103|FG001|Overall Study|Withdrawal by Subject|1|||
105706815|NCT03311711|364589104|FG002|Overall Study|Withdrawal by Subject|0|||
105706816|NCT03311711|364589105|FG003|Overall Study|Withdrawal by Subject|0|||
105706817|NCT03311711|364589106|FG004|Overall Study|Withdrawal by Subject|0|||
105706818|NCT03311711|364589107|FG005|Overall Study|Withdrawal by Subject|0|||
105706819|NCT03311711|364589108|FG006|Overall Study|Withdrawal by Subject|3|||
105706820|NCT03311711|364589109|FG007|Overall Study|Withdrawal by Subject|3|||
105706821|NCT03311711|364589110|FG008|Overall Study|Withdrawal by Subject|0|||
105706822|NCT03311711|364589111|FG009|Overall Study|Withdrawal by Subject|0|||
105706823|NCT01982292|364589112|FG000|Overall Study|Adverse Event|2|||
105706824|NCT01982292|364589113|FG001|Overall Study|Adverse Event|0|||
105706825|NCT01982292|364589112|FG000|Overall Study|Death|1|||
105706826|NCT01982292|364589113|FG001|Overall Study|Death|0|||
105706827|NCT01982292|364589112|FG000|Overall Study|Lost to Follow-up|2|||
105706828|NCT01982292|364589113|FG001|Overall Study|Lost to Follow-up|0|||
105706829|NCT01982292|364589112|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
105706830|NCT01982292|364589113|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
105706831|NCT01982292|364589112|FG000|Overall Study|Protocol Deviation|1|||
105706832|NCT01982292|364589113|FG001|Overall Study|Protocol Deviation|0|||
105706833|NCT01982292|364589112|FG000|Overall Study|Patient/Guardian Decision|3|||
105706834|NCT01982292|364589113|FG001|Overall Study|Patient/Guardian Decision|1|||
105706835|NCT01982292|364589112|FG000|Overall Study|Technical Problems|2|||
105706836|NCT01982292|364589113|FG001|Overall Study|Technical Problems|0|||
105706837|NCT04839978|364589114|FG000|Overall Study|Lost to Follow-up|135|||
105706838|NCT04839978|364589115|FG001|Overall Study|Lost to Follow-up|147|||
105706839|NCT03865706|364589117|FG000|Overall Study|Death|0|||
105706840|NCT03865706|364589118|FG001|Overall Study|Death|3|||
105706841|NCT03865706|364589119|FG002|Overall Study|Death|1|||
105706842|NCT02095535|364589120|FG000|Recruitment|Protocol Violation|2|||
105706843|NCT01877187|364589121|FG000|Overall Study|Death|2|||
105706844|NCT01877187|364589121|FG000|Overall Study|Withdrawal by Subject|4|||
105706845|NCT01877187|364589121|FG000|Overall Study|Lost to Follow-up|3|||
105706846|NCT01877187|364589121|FG000|Overall Study|Declining clinical status|11|||
105706847|NCT01877187|364589121|FG000|Overall Study|Liver transplant|2|||
105706848|NCT03776175|364589122|FG000|Treatment Period (42 Days)|Adverse Event|0|||
105474695|NCT01349049|363751163|FG004|Overall Study|Other|0|||
105706849|NCT03776175|364589123|FG001|Treatment Period (42 Days)|Adverse Event|1|||
105706850|NCT03776175|364589124|FG002|Treatment Period (42 Days)|Adverse Event|1|||
105706851|NCT03776175|364589125|FG003|Treatment Period (42 Days)|Adverse Event|0|||
105706852|NCT03776175|364589122|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
105706853|NCT03776175|364589123|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
105706854|NCT03776175|364589124|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
105706855|NCT03776175|364589125|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
105706856|NCT03776175|364589122|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
105706857|NCT03776175|364589123|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
105706858|NCT03776175|364589124|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
105706859|NCT03776175|364589125|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
105706860|NCT03776175|364589122|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
105706861|NCT03776175|364589123|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
105706862|NCT03776175|364589124|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
105706863|NCT03776175|364589125|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
105706864|NCT03776175|364589122|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
105706865|NCT03776175|364589123|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
105706866|NCT03776175|364589124|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
105706867|NCT03776175|364589125|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
105706868|NCT03776175|364589122|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
105706869|NCT03776175|364589123|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
105706870|NCT03776175|364589124|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
105706871|NCT03776175|364589125|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
105706872|NCT00811135|364589128|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
105706873|NCT00811135|364589128|FG000|Overall Study|Death|3|||
105706874|NCT00811135|364589128|FG000|Overall Study|Protocol Violation|2|||
105706875|NCT00811135|364589128|FG000|Overall Study|Violation of Selection Criteria|1|||
105706876|NCT00811135|364589128|FG000|Overall Study|Refused Treatment|1|||
105706877|NCT00811135|364589128|FG000|Overall Study|Withdrawal by Subject|3|||
105706878|NCT00811135|364589128|FG000|Overall Study|Administrative/Other Unspecified|11|||
105706879|NCT00811135|364589128|FG000|Overall Study|Ongoing|59|||
105706880|NCT05098041|364589134|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
105706881|NCT02599961|364589135|FG000|Overall Study|Withdrawal by Subject|1|||
105706882|NCT02599961|364589135|FG000|Overall Study|Subject Non-Compliance|2|||
105706883|NCT02599961|364589135|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
105706884|NCT02599961|364589135|FG000|Overall Study|Other, Not Specified|3|||
105706885|NCT00464334|364589138|FG000|Overall Study|Adverse Event|0|||
105706886|NCT00464334|364589139|FG001|Overall Study|Adverse Event|0|||
105706887|NCT00464334|364589140|FG002|Overall Study|Adverse Event|0|||
105706888|NCT00464334|364589141|FG003|Overall Study|Adverse Event|1|||
105706889|NCT00464334|364589142|FG004|Overall Study|Adverse Event|1|||
105706890|NCT00464334|364589143|FG005|Overall Study|Adverse Event|1|||
105706891|NCT00464334|364589144|FG006|Overall Study|Adverse Event|0|||
105706892|NCT00464334|364589145|FG007|Overall Study|Adverse Event|0|||
105706893|NCT00464334|364589146|FG008|Overall Study|Adverse Event|2|||
105706894|NCT00464334|364589147|FG009|Overall Study|Adverse Event|1|||
105706895|NCT00464334|364589148|FG010|Overall Study|Adverse Event|2|||
105706896|NCT00464334|364589138|FG000|Overall Study|Lack of Efficacy|0|||
105706897|NCT00464334|364589139|FG001|Overall Study|Lack of Efficacy|1|||
105706898|NCT00464334|364589140|FG002|Overall Study|Lack of Efficacy|0|||
105706899|NCT00464334|364589141|FG003|Overall Study|Lack of Efficacy|0|||
105706900|NCT00464334|364589142|FG004|Overall Study|Lack of Efficacy|0|||
105706901|NCT00464334|364589143|FG005|Overall Study|Lack of Efficacy|0|||
105706902|NCT00464334|364589144|FG006|Overall Study|Lack of Efficacy|0|||
105706903|NCT00464334|364589145|FG007|Overall Study|Lack of Efficacy|0|||
105706904|NCT00464334|364589146|FG008|Overall Study|Lack of Efficacy|0|||
105706905|NCT00464334|364589147|FG009|Overall Study|Lack of Efficacy|0|||
105706906|NCT00464334|364589148|FG010|Overall Study|Lack of Efficacy|0|||
105706907|NCT00464334|364589138|FG000|Overall Study|Lost to Follow-up|0|||
105706908|NCT00464334|364589139|FG001|Overall Study|Lost to Follow-up|0|||
105706909|NCT00464334|364589140|FG002|Overall Study|Lost to Follow-up|1|||
105706910|NCT00464334|364589141|FG003|Overall Study|Lost to Follow-up|0|||
105706911|NCT00464334|364589142|FG004|Overall Study|Lost to Follow-up|1|||
105706912|NCT00464334|364589143|FG005|Overall Study|Lost to Follow-up|0|||
105706913|NCT00464334|364589144|FG006|Overall Study|Lost to Follow-up|1|||
105706914|NCT00464334|364589145|FG007|Overall Study|Lost to Follow-up|0|||
105706915|NCT00464334|364589146|FG008|Overall Study|Lost to Follow-up|0|||
105706916|NCT00464334|364589147|FG009|Overall Study|Lost to Follow-up|0|||
105706917|NCT00464334|364589148|FG010|Overall Study|Lost to Follow-up|2|||
105706918|NCT00464334|364589138|FG000|Overall Study|Progressive Disease|0|||
105706919|NCT00464334|364589139|FG001|Overall Study|Progressive Disease|0|||
105706920|NCT00464334|364589140|FG002|Overall Study|Progressive Disease|0|||
105706921|NCT00464334|364589141|FG003|Overall Study|Progressive Disease|0|||
105706922|NCT00464334|364589142|FG004|Overall Study|Progressive Disease|0|||
105706923|NCT00464334|364589143|FG005|Overall Study|Progressive Disease|1|||
105706924|NCT00464334|364589144|FG006|Overall Study|Progressive Disease|0|||
105706925|NCT00464334|364589145|FG007|Overall Study|Progressive Disease|0|||
105706926|NCT00464334|364589146|FG008|Overall Study|Progressive Disease|1|||
105706927|NCT00464334|364589147|FG009|Overall Study|Progressive Disease|0|||
105706928|NCT00464334|364589148|FG010|Overall Study|Progressive Disease|0|||
105706929|NCT00464334|364589138|FG000|Overall Study|Study Terminated by Sponsor|0|||
105706930|NCT00464334|364589139|FG001|Overall Study|Study Terminated by Sponsor|0|||
105706931|NCT00464334|364589140|FG002|Overall Study|Study Terminated by Sponsor|0|||
105706932|NCT00464334|364589141|FG003|Overall Study|Study Terminated by Sponsor|1|||
105706933|NCT00464334|364589142|FG004|Overall Study|Study Terminated by Sponsor|0|||
105706934|NCT00464334|364589143|FG005|Overall Study|Study Terminated by Sponsor|0|||
105706935|NCT00464334|364589144|FG006|Overall Study|Study Terminated by Sponsor|0|||
105706936|NCT00464334|364589145|FG007|Overall Study|Study Terminated by Sponsor|0|||
105706937|NCT00464334|364589146|FG008|Overall Study|Study Terminated by Sponsor|0|||
105706938|NCT00464334|364589147|FG009|Overall Study|Study Terminated by Sponsor|0|||
105706939|NCT00464334|364589148|FG010|Overall Study|Study Terminated by Sponsor|0|||
105706940|NCT00464334|364589138|FG000|Overall Study|Withdrawal by Subject|1|||
105706941|NCT00464334|364589139|FG001|Overall Study|Withdrawal by Subject|7|||
105706942|NCT00464334|364589140|FG002|Overall Study|Withdrawal by Subject|4|||
105706943|NCT00464334|364589141|FG003|Overall Study|Withdrawal by Subject|2|||
105706944|NCT00464334|364589142|FG004|Overall Study|Withdrawal by Subject|2|||
105706945|NCT00464334|364589143|FG005|Overall Study|Withdrawal by Subject|2|||
105706946|NCT00464334|364589144|FG006|Overall Study|Withdrawal by Subject|2|||
105706947|NCT00464334|364589145|FG007|Overall Study|Withdrawal by Subject|1|||
105706948|NCT00464334|364589146|FG008|Overall Study|Withdrawal by Subject|3|||
105706949|NCT00464334|364589147|FG009|Overall Study|Withdrawal by Subject|0|||
105706950|NCT00464334|364589148|FG010|Overall Study|Withdrawal by Subject|0|||
105706951|NCT00586495|364589151|FG000|Treatment Period|Adverse Event|11|||
105706952|NCT00586495|364589151|FG000|Treatment Period|Death|1|||
105706953|NCT00586495|364589151|FG000|Treatment Period|Protocol Violation|1|||
105706954|NCT00586495|364589151|FG000|Treatment Period|Withdrawal by Subject|1|||
105706955|NCT00586495|364589151|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
105706956|NCT00586495|364589151|FG000|Treatment Period|Switch to commercial drug|10|||
105706957|NCT00586495|364589151|FG000|Follow-up|Death|40|||
105706958|NCT00586495|364589151|FG000|Follow-up|Lost to Follow-up|1|||
105706959|NCT00586495|364589151|FG000|Follow-up|Withdrawal by Subject|4|||
105706960|NCT00586495|364589151|FG000|Follow-up|Protocol driven decision point|37|||
105706961|NCT00586495|364589151|FG000|Follow-up|Switch to commercial drug|10|||
105706962|NCT00401752|364589152|FG000|Overall Study|Adverse Event|2|||
105706963|NCT00401752|364589153|FG001|Overall Study|Adverse Event|5|||
105706964|NCT00401752|364589152|FG000|Overall Study|Withdrawal by Subject|2|||
105706965|NCT00401752|364589153|FG001|Overall Study|Withdrawal by Subject|6|||
105706966|NCT00401752|364589152|FG000|Overall Study|Lost to Follow-up|1|||
105706967|NCT00401752|364589153|FG001|Overall Study|Lost to Follow-up|4|||
105706968|NCT00401752|364589152|FG000|Overall Study|Development of any exclusion criteria|4|||
105474696|NCT01349049|363751164|FG005|Overall Study|Other|1|||
105706969|NCT00401752|364589153|FG001|Overall Study|Development of any exclusion criteria|2|||
105706970|NCT00401752|364589152|FG000|Overall Study|Physician Decision|1|||
105706971|NCT00401752|364589153|FG001|Overall Study|Physician Decision|1|||
105706972|NCT02432235|364589154|FG000|Overall Study|Death|1|||
105706973|NCT02432235|364589155|FG001|Overall Study|Death|1|||
105706974|NCT02432235|364589156|FG002|Overall Study|Death|2|||
105706975|NCT02432235|364589157|FG003|Overall Study|Death|2|||
105706976|NCT02432235|364589158|FG004|Overall Study|Death|1|||
105706977|NCT02432235|364589159|FG005|Overall Study|Death|3|||
105706978|NCT02432235|364589160|FG006|Overall Study|Death|11|||
105706979|NCT02432235|364589161|FG007|Overall Study|Death|15|||
105706980|NCT02432235|364589162|FG008|Overall Study|Death|15|||
105706981|NCT02432235|364589163|FG009|Overall Study|Death|3|||
105706982|NCT02432235|364589164|FG010|Overall Study|Death|1|||
105706983|NCT02432235|364589165|FG011|Overall Study|Death|0|||
105706984|NCT02432235|364589154|FG000|Overall Study|Withdrawal by Subject|0|||
105706985|NCT02432235|364589155|FG001|Overall Study|Withdrawal by Subject|1|||
105706986|NCT02432235|364589156|FG002|Overall Study|Withdrawal by Subject|0|||
105706987|NCT02432235|364589157|FG003|Overall Study|Withdrawal by Subject|0|||
105706988|NCT02432235|364589158|FG004|Overall Study|Withdrawal by Subject|0|||
105706989|NCT02432235|364589159|FG005|Overall Study|Withdrawal by Subject|2|||
105706990|NCT02432235|364589160|FG006|Overall Study|Withdrawal by Subject|5|||
105706991|NCT02432235|364589161|FG007|Overall Study|Withdrawal by Subject|3|||
105706992|NCT02432235|364589162|FG008|Overall Study|Withdrawal by Subject|1|||
105706993|NCT02432235|364589163|FG009|Overall Study|Withdrawal by Subject|0|||
105706994|NCT02432235|364589164|FG010|Overall Study|Withdrawal by Subject|0|||
105706995|NCT02432235|364589165|FG011|Overall Study|Withdrawal by Subject|0|||
105706996|NCT02432235|364589154|FG000|Overall Study|Lost to Follow-up|0|||
105706997|NCT02432235|364589155|FG001|Overall Study|Lost to Follow-up|0|||
105706998|NCT02432235|364589156|FG002|Overall Study|Lost to Follow-up|0|||
105706999|NCT02432235|364589157|FG003|Overall Study|Lost to Follow-up|0|||
105707000|NCT02432235|364589158|FG004|Overall Study|Lost to Follow-up|0|||
105707001|NCT02432235|364589159|FG005|Overall Study|Lost to Follow-up|1|||
105707002|NCT02432235|364589160|FG006|Overall Study|Lost to Follow-up|0|||
105707003|NCT02432235|364589161|FG007|Overall Study|Lost to Follow-up|0|||
105707004|NCT02432235|364589162|FG008|Overall Study|Lost to Follow-up|1|||
105707005|NCT02432235|364589163|FG009|Overall Study|Lost to Follow-up|0|||
105707006|NCT02432235|364589164|FG010|Overall Study|Lost to Follow-up|0|||
105707007|NCT02432235|364589165|FG011|Overall Study|Lost to Follow-up|0|||
105707008|NCT02432235|364589154|FG000|Overall Study|Miscellaneous|0|||
105707009|NCT02432235|364589155|FG001|Overall Study|Miscellaneous|0|||
105707010|NCT02432235|364589156|FG002|Overall Study|Miscellaneous|0|||
105707011|NCT02432235|364589157|FG003|Overall Study|Miscellaneous|0|||
105707012|NCT02432235|364589158|FG004|Overall Study|Miscellaneous|1|||
105707013|NCT02432235|364589159|FG005|Overall Study|Miscellaneous|6|||
105707014|NCT02432235|364589160|FG006|Overall Study|Miscellaneous|2|||
105707015|NCT02432235|364589161|FG007|Overall Study|Miscellaneous|2|||
105707016|NCT02432235|364589162|FG008|Overall Study|Miscellaneous|4|||
105707017|NCT02432235|364589163|FG009|Overall Study|Miscellaneous|0|||
105707018|NCT02432235|364589164|FG010|Overall Study|Miscellaneous|0|||
105707019|NCT02432235|364589165|FG011|Overall Study|Miscellaneous|1|||
105707020|NCT01965262|364589168|FG000|Second Intervention (7 Days)|Discontinued|0|||
105707021|NCT01965262|364589169|FG001|Second Intervention (7 Days)|Discontinued|1|||
105707022|NCT01965262|364589168|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
105707023|NCT01965262|364589169|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
105707024|NCT01965262|364589168|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
105707025|NCT01965262|364589169|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
105707026|NCT02898259|364589170|FG000|Overall Study|Adverse Event|0|||
105707027|NCT02898259|364589171|FG001|Overall Study|Adverse Event|0|||
105707028|NCT02898259|364589172|FG002|Overall Study|Adverse Event|1|||
105707029|NCT02898259|364589173|FG003|Overall Study|Adverse Event|0|||
105707030|NCT02898259|364589174|FG004|Overall Study|Adverse Event|0|||
105707031|NCT02898259|364589170|FG000|Overall Study|Lack of Efficacy|1|||
105707032|NCT02898259|364589171|FG001|Overall Study|Lack of Efficacy|1|||
105707033|NCT02898259|364589172|FG002|Overall Study|Lack of Efficacy|3|||
105707034|NCT02898259|364589173|FG003|Overall Study|Lack of Efficacy|0|||
105707035|NCT02898259|364589174|FG004|Overall Study|Lack of Efficacy|0|||
105707036|NCT02898259|364589170|FG000|Overall Study|Lost to Follow-up|0|||
105707037|NCT02898259|364589171|FG001|Overall Study|Lost to Follow-up|0|||
105707038|NCT02898259|364589172|FG002|Overall Study|Lost to Follow-up|1|||
105707039|NCT02898259|364589173|FG003|Overall Study|Lost to Follow-up|0|||
105707040|NCT02898259|364589174|FG004|Overall Study|Lost to Follow-up|0|||
105707041|NCT02898259|364589170|FG000|Overall Study|Transformation before study began|0|||
105707042|NCT02898259|364589171|FG001|Overall Study|Transformation before study began|0|||
105707043|NCT02898259|364589172|FG002|Overall Study|Transformation before study began|0|||
105707044|NCT02898259|364589173|FG003|Overall Study|Transformation before study began|1|||
105707045|NCT02898259|364589174|FG004|Overall Study|Transformation before study began|0|||
105707046|NCT01046877|364589175|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
105707047|NCT01046877|364589175|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
105707048|NCT01888640|364589179|FG000|Overall Study|Lost to Follow-up|1|||
105707049|NCT01888640|364589180|FG001|Overall Study|Lost to Follow-up|2|||
105707050|NCT01888640|364589181|FG002|Overall Study|Lost to Follow-up|0|||
105707051|NCT01888640|364589179|FG000|Overall Study|Withdrawal by Subject|15|||
105707052|NCT01888640|364589180|FG001|Overall Study|Withdrawal by Subject|11|||
105707053|NCT01888640|364589181|FG002|Overall Study|Withdrawal by Subject|4|||
105707054|NCT01888640|364589179|FG000|Overall Study|Minimum dose not met|10|||
105707055|NCT01888640|364589180|FG001|Overall Study|Minimum dose not met|16|||
105707056|NCT01888640|364589181|FG002|Overall Study|Minimum dose not met|0|||
105787851|NCT04035499|364876810|FG000|Overall Study|Withdrawal by Subject|1|||
105787852|NCT00262119|364876814|FG000|Overall Study|Lost to Follow-up|38|||
105787853|NCT00262119|364876815|FG001|Overall Study|Lost to Follow-up|51|||
105787854|NCT00262119|364876816|FG002|Overall Study|Lost to Follow-up|42|||
105787855|NCT00262119|364876814|FG000|Overall Study|Death|20|||
105707057|NCT01888640|364589179|FG000|Overall Study|Given wrong unit (placebo)|1|||
105787856|NCT00262119|364876815|FG001|Overall Study|Death|19|||
105787857|NCT00262119|364876816|FG002|Overall Study|Death|16|||
105707058|NCT01888640|364589180|FG001|Overall Study|Given wrong unit (placebo)|0|||
105707059|NCT01888640|364589181|FG002|Overall Study|Given wrong unit (placebo)|0|||
105787858|NCT00400985|364876817|FG000|Overall Study|Withdrawal by Subject|5|||
105787859|NCT00400985|364876817|FG000|Overall Study|system modification|8|||
105787860|NCT00400985|364876817|FG000|Overall Study|Death|30|||
105787861|NCT00400985|364876817|FG000|Overall Study|Lost to Follow-up|9|||
105787862|NCT00965562|364876818|FG000|Overall Study|Lost to Follow-up|1|||
105787863|NCT00965562|364876819|FG001|Overall Study|Lost to Follow-up|2|||
105787864|NCT00965562|364876820|FG002|Overall Study|Lost to Follow-up|3|||
105787865|NCT00965562|364876818|FG000|Overall Study|Withdrawal by Subject|2|||
105787866|NCT00965562|364876819|FG001|Overall Study|Withdrawal by Subject|2|||
105787867|NCT00965562|364876820|FG002|Overall Study|Withdrawal by Subject|0|||
105787868|NCT04411641|364876829|FG000|DB Period|Other|7|||
105787869|NCT04411641|364876830|FG001|DB Period|Other|27|||
105787870|NCT04411641|364876831|FG002|DB Period|Other|0|||
105787871|NCT04411641|364876832|FG003|DB Period|Other|0|||
105787872|NCT04411641|364876829|FG000|DB Period|Withdrawal by Subject|67|||
105787873|NCT04411641|364876830|FG001|DB Period|Withdrawal by Subject|122|||
105787874|NCT04411641|364876831|FG002|DB Period|Withdrawal by Subject|0|||
105787875|NCT04411641|364876832|FG003|DB Period|Withdrawal by Subject|0|||
105787876|NCT04411641|364876829|FG000|DB Period|Progressive disease|76|||
105787877|NCT04411641|364876830|FG001|DB Period|Progressive disease|116|||
105787878|NCT04411641|364876831|FG002|DB Period|Progressive disease|0|||
105787879|NCT04411641|364876832|FG003|DB Period|Progressive disease|0|||
105787880|NCT04411641|364876829|FG000|DB Period|Poor compliance to protocol|1|||
105787881|NCT04411641|364876830|FG001|DB Period|Poor compliance to protocol|5|||
105787882|NCT04411641|364876831|FG002|DB Period|Poor compliance to protocol|0|||
105787883|NCT04411641|364876832|FG003|DB Period|Poor compliance to protocol|0|||
105787884|NCT04411641|364876829|FG000|DB Period|Lack of Efficacy|19|||
105787885|NCT04411641|364876830|FG001|DB Period|Lack of Efficacy|19|||
105787886|NCT04411641|364876831|FG002|DB Period|Lack of Efficacy|0|||
105787887|NCT04411641|364876832|FG003|DB Period|Lack of Efficacy|0|||
105787888|NCT04411641|364876829|FG000|DB Period|Adverse Event|13|||
105787889|NCT04411641|364876830|FG001|DB Period|Adverse Event|29|||
105787890|NCT04411641|364876831|FG002|DB Period|Adverse Event|0|||
105787891|NCT04411641|364876832|FG003|DB Period|Adverse Event|0|||
105787892|NCT04411641|364876829|FG000|DB Period|Randomized and not treated|2|||
105787893|NCT04411641|364876830|FG001|DB Period|Randomized and not treated|2|||
105707060|NCT01888640|364589179|FG000|Overall Study|Excluded for prior TENS|0|||
105707061|NCT01888640|364589180|FG001|Overall Study|Excluded for prior TENS|1|||
105707062|NCT01888640|364589181|FG002|Overall Study|Excluded for prior TENS|0|||
105707063|NCT01888640|364589179|FG000|Overall Study|Researcher Termination of Participant|0|||
105707064|NCT01888640|364589180|FG001|Overall Study|Researcher Termination of Participant|1|||
105707065|NCT01888640|364589181|FG002|Overall Study|Researcher Termination of Participant|1|||
105707066|NCT00385255|364589190|FG000|Overall Study|Serious Adverse Event|1|||
105787894|NCT04411641|364876831|FG002|DB Period|Randomized and not treated|0|||
105787895|NCT04411641|364876832|FG003|DB Period|Randomized and not treated|0|||
105787896|NCT04411641|364876829|FG000|OL|Withdrawal by Subject|0|||
105787897|NCT04411641|364876830|FG001|OL|Withdrawal by Subject|0|||
105787898|NCT04411641|364876831|FG002|OL|Withdrawal by Subject|6|||
105787899|NCT04411641|364876832|FG003|OL|Withdrawal by Subject|17|||
105350710|NCT04767529|363288161|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
105360883|NCT00873730|363328100|FG001|Overall Study|Withdrawal by Subject|1|||
105474697|NCT01349049|363751165|FG006|Overall Study|Other|0|||
105474698|NCT01349049|363751166|FG007|Overall Study|Other|0|||
105707067|NCT00385255|364589191|FG001|Overall Study|Serious Adverse Event|2|||
105707068|NCT00385255|364589190|FG000|Overall Study|Protocol Violation|0|||
105787900|NCT04411641|364876829|FG000|OL|Progressive disease|0|||
105787901|NCT04411641|364876830|FG001|OL|Progressive disease|0|||
105787902|NCT04411641|364876831|FG002|OL|Progressive disease|1|||
105787903|NCT04411641|364876832|FG003|OL|Progressive disease|2|||
105787904|NCT04411641|364876829|FG000|OL|Poor compliance to protocol|0|||
105787905|NCT04411641|364876830|FG001|OL|Poor compliance to protocol|0|||
105787906|NCT04411641|364876831|FG002|OL|Poor compliance to protocol|1|||
105787907|NCT04411641|364876832|FG003|OL|Poor compliance to protocol|0|||
105787908|NCT04411641|364876829|FG000|OL|Adverse Event|0|||
105787909|NCT04411641|364876830|FG001|OL|Adverse Event|0|||
105787910|NCT04411641|364876831|FG002|OL|Adverse Event|1|||
105787911|NCT04411641|364876832|FG003|OL|Adverse Event|0|||
105787912|NCT04411641|364876829|FG000|OL|Other|0|||
105787913|NCT04411641|364876830|FG001|OL|Other|0|||
105787914|NCT04411641|364876831|FG002|OL|Other|0|||
105787915|NCT04411641|364876832|FG003|OL|Other|6|||
105787916|NCT00602667|364876833|FG000|Overall Study|Still on Therapy|0|||
105707069|NCT00385255|364589191|FG001|Overall Study|Protocol Violation|4|||
105707070|NCT00385255|364589190|FG000|Overall Study|Withdrawal by Subject|0|||
105707071|NCT00385255|364589191|FG001|Overall Study|Withdrawal by Subject|8|||
105707072|NCT00385255|364589190|FG000|Overall Study|Migrated/moved from study area|0|||
105707073|NCT00385255|364589191|FG001|Overall Study|Migrated/moved from study area|1|||
105707074|NCT00385255|364589190|FG000|Overall Study|Lost to Follow-up|20|||
105707075|NCT00385255|364589191|FG001|Overall Study|Lost to Follow-up|58|||
105707076|NCT02199080|364589192|FG000|Overall Study|Protocol Violation|12|||
105707077|NCT01929408|364589195|FG000|Overall Study|received HCT as initial treatment|8|||
105707078|NCT02228590|364589197|FG000|Overall Study|Withdrawal by Subject|1|||
105707079|NCT00506883|364589200|FG000|Overall Study|Lost to Follow-up|1|||
105707080|NCT00506883|364589201|FG001|Overall Study|Lost to Follow-up|1|||
105707081|NCT00506883|364589202|FG002|Overall Study|Lost to Follow-up|1|||
105707082|NCT00506883|364589200|FG000|Overall Study|Withdrawal by Subject|1|||
105707083|NCT00506883|364589201|FG001|Overall Study|Withdrawal by Subject|0|||
105707084|NCT00506883|364589202|FG002|Overall Study|Withdrawal by Subject|1|||
105707085|NCT00506883|364589200|FG000|Overall Study|Lack of Efficacy|0|||
105707086|NCT00506883|364589201|FG001|Overall Study|Lack of Efficacy|1|||
105707087|NCT00506883|364589202|FG002|Overall Study|Lack of Efficacy|1|||
105707088|NCT00506883|364589200|FG000|Overall Study|Other|5|||
105707089|NCT00506883|364589201|FG001|Overall Study|Other|1|||
105707090|NCT00506883|364589202|FG002|Overall Study|Other|1|||
105707091|NCT00391222|364589203|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
105707092|NCT00391222|364589204|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
105707093|NCT00391222|364589205|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
105707094|NCT00391222|364589206|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
105707095|NCT00391222|364589203|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
105707096|NCT00391222|364589204|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
105707097|NCT00391222|364589205|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
105707098|NCT00391222|364589206|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
105707099|NCT00391222|364589203|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
105707100|NCT00391222|364589204|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
105707101|NCT00391222|364589205|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
105707102|NCT00391222|364589206|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
105707103|NCT00391222|364589203|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
105707104|NCT00391222|364589204|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
105707105|NCT00391222|364589205|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
105707106|NCT00391222|364589206|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
105707107|NCT00391222|364589203|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
105707108|NCT00391222|364589204|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
105707109|NCT00391222|364589205|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
105707110|NCT00391222|364589206|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
105707111|NCT00391222|364589203|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
105707112|NCT00391222|364589204|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
105707113|NCT00391222|364589205|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
105707114|NCT00391222|364589206|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
105707115|NCT00391222|364589203|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
105707116|NCT00391222|364589204|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
105707117|NCT00391222|364589205|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
105707118|NCT00391222|364589206|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
105707119|NCT00391222|364589203|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
105707120|NCT00391222|364589204|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
105707121|NCT00391222|364589205|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
105707122|NCT00391222|364589206|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
105707123|NCT00391222|364589203|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
105707124|NCT00391222|364589204|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
105707125|NCT00391222|364589205|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
105707126|NCT00391222|364589206|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
105707127|NCT00391222|364589203|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
105707128|NCT00391222|364589204|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
105707129|NCT00391222|364589205|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
105707130|NCT00391222|364589206|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
105707131|NCT00391222|364589203|FG000|Period III (Double-Blind Treatment)|Other|6|||
105707132|NCT00391222|364589204|FG001|Period III (Double-Blind Treatment)|Other|1|||
105707133|NCT00391222|364589205|FG002|Period III (Double-Blind Treatment)|Other|6|||
105707134|NCT00391222|364589206|FG003|Period III (Double-Blind Treatment)|Other|0|||
105707135|NCT02109484|364589207|FG000|Overall Study|Lost to Follow-up|0|||
105707136|NCT02109484|364589208|FG001|Overall Study|Lost to Follow-up|0|||
105707137|NCT02109484|364589209|FG002|Overall Study|Lost to Follow-up|0|||
105707138|NCT02109484|364589210|FG003|Overall Study|Lost to Follow-up|1|||
105707139|NCT02109484|364589211|FG004|Overall Study|Lost to Follow-up|1|||
105707140|NCT02109484|364589212|FG005|Overall Study|Lost to Follow-up|0|||
105707141|NCT02109484|364589213|FG006|Overall Study|Lost to Follow-up|1|||
105707142|NCT02109484|364589214|FG007|Overall Study|Lost to Follow-up|0|||
105707143|NCT02109484|364589207|FG000|Overall Study|Withdrawal by Subject|0|||
105707144|NCT02109484|364589208|FG001|Overall Study|Withdrawal by Subject|0|||
105707145|NCT02109484|364589209|FG002|Overall Study|Withdrawal by Subject|0|||
105707146|NCT02109484|364589210|FG003|Overall Study|Withdrawal by Subject|0|||
105707147|NCT02109484|364589211|FG004|Overall Study|Withdrawal by Subject|1|||
105707148|NCT02109484|364589212|FG005|Overall Study|Withdrawal by Subject|1|||
105707149|NCT02109484|364589213|FG006|Overall Study|Withdrawal by Subject|1|||
105707150|NCT02109484|364589214|FG007|Overall Study|Withdrawal by Subject|0|||
105707151|NCT02109484|364589207|FG000|Overall Study|Physician Decision|0|||
105707152|NCT02109484|364589208|FG001|Overall Study|Physician Decision|0|||
105707153|NCT02109484|364589209|FG002|Overall Study|Physician Decision|0|||
105707154|NCT02109484|364589210|FG003|Overall Study|Physician Decision|0|||
105707155|NCT02109484|364589211|FG004|Overall Study|Physician Decision|2|||
105707156|NCT02109484|364589212|FG005|Overall Study|Physician Decision|0|||
105707157|NCT02109484|364589213|FG006|Overall Study|Physician Decision|0|||
105707158|NCT02109484|364589214|FG007|Overall Study|Physician Decision|0|||
105707159|NCT02109484|364589207|FG000|Overall Study|Death|0|||
105707160|NCT02109484|364589208|FG001|Overall Study|Death|0|||
105707161|NCT02109484|364589209|FG002|Overall Study|Death|0|||
105707162|NCT02109484|364589210|FG003|Overall Study|Death|0|||
105707163|NCT02109484|364589211|FG004|Overall Study|Death|0|||
105707164|NCT02109484|364589212|FG005|Overall Study|Death|0|||
105707165|NCT02109484|364589213|FG006|Overall Study|Death|0|||
105707166|NCT02109484|364589214|FG007|Overall Study|Death|2|||
105707167|NCT02109484|364589207|FG000|Overall Study|Moved away from study area|0|||
105707168|NCT02109484|364589208|FG001|Overall Study|Moved away from study area|0|||
105707169|NCT02109484|364589209|FG002|Overall Study|Moved away from study area|0|||
105707170|NCT02109484|364589210|FG003|Overall Study|Moved away from study area|0|||
105707171|NCT02109484|364589211|FG004|Overall Study|Moved away from study area|0|||
105707172|NCT02109484|364589212|FG005|Overall Study|Moved away from study area|0|||
105707173|NCT02109484|364589213|FG006|Overall Study|Moved away from study area|1|||
105707174|NCT02109484|364589214|FG007|Overall Study|Moved away from study area|1|||
105707175|NCT00143455|364589215|FG000|Cohort 1|Adverse Event|8|||
105707176|NCT00143455|364589216|FG001|Cohort 1|Adverse Event|4|||
105707177|NCT00143455|364589217|FG002|Cohort 1|Adverse Event|0|||
105707178|NCT00143455|364589218|FG003|Cohort 1|Adverse Event|0|||
105707179|NCT00143455|364589215|FG000|Cohort 1|Death|5|||
105707180|NCT00143455|364589216|FG001|Cohort 1|Death|2|||
105707181|NCT00143455|364589217|FG002|Cohort 1|Death|0|||
105707182|NCT00143455|364589218|FG003|Cohort 1|Death|0|||
105707183|NCT00143455|364589215|FG000|Cohort 1|Progressive Disease|0|||
105707184|NCT00143455|364589216|FG001|Cohort 1|Progressive Disease|6|||
105707185|NCT00143455|364589217|FG002|Cohort 1|Progressive Disease|0|||
105707186|NCT00143455|364589218|FG003|Cohort 1|Progressive Disease|0|||
105707187|NCT00143455|364589215|FG000|Cohort 1|Withdrawal by Subject|1|||
105707188|NCT00143455|364589216|FG001|Cohort 1|Withdrawal by Subject|4|||
105707189|NCT00143455|364589217|FG002|Cohort 1|Withdrawal by Subject|0|||
105707190|NCT00143455|364589218|FG003|Cohort 1|Withdrawal by Subject|0|||
105707191|NCT00143455|364589215|FG000|Cohort 1|Randomized But Not Treated|0|||
105707192|NCT00143455|364589216|FG001|Cohort 1|Randomized But Not Treated|1|||
105474699|NCT01349049|363751167|FG008|Overall Study|Other|4|||
105474700|NCT01349049|363751159|FG000|Overall Study|Death|0|||
105707193|NCT00143455|364589217|FG002|Cohort 1|Randomized But Not Treated|0|||
105707194|NCT00143455|364589218|FG003|Cohort 1|Randomized But Not Treated|0|||
105707195|NCT00143455|364589215|FG000|Cohort 2|Adverse Event|0|||
105707196|NCT00143455|364589216|FG001|Cohort 2|Adverse Event|0|||
105707197|NCT00143455|364589217|FG002|Cohort 2|Adverse Event|42|||
105474701|NCT01349049|363751160|FG001|Overall Study|Death|0|||
105474702|NCT01349049|363751161|FG002|Overall Study|Death|0|||
105707198|NCT00143455|364589218|FG003|Cohort 2|Adverse Event|30|||
105707199|NCT00143455|364589215|FG000|Cohort 2|No Longer Required Study Treatment|0|||
105707200|NCT00143455|364589216|FG001|Cohort 2|No Longer Required Study Treatment|0|||
105707201|NCT00143455|364589217|FG002|Cohort 2|No Longer Required Study Treatment|1|||
105350711|NCT04767529|363288162|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
105350712|NCT04767529|363288163|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
105350713|NCT04767529|363288161|FG000|Overall Study|Lost to Follow-up|0|||
105707202|NCT00143455|364589218|FG003|Cohort 2|No Longer Required Study Treatment|0|||
105707203|NCT00143455|364589215|FG000|Cohort 2|Protocol Violation|0|||
105707204|NCT00143455|364589216|FG001|Cohort 2|Protocol Violation|0|||
105707205|NCT00143455|364589217|FG002|Cohort 2|Protocol Violation|1|||
105707206|NCT00143455|364589218|FG003|Cohort 2|Protocol Violation|1|||
105707207|NCT00143455|364589215|FG000|Cohort 2|Lost to Follow-up|0|||
105707208|NCT00143455|364589216|FG001|Cohort 2|Lost to Follow-up|0|||
105707209|NCT00143455|364589217|FG002|Cohort 2|Lost to Follow-up|1|||
105707210|NCT00143455|364589218|FG003|Cohort 2|Lost to Follow-up|4|||
105707211|NCT00143455|364589215|FG000|Cohort 2|Death|0|||
105707212|NCT00143455|364589216|FG001|Cohort 2|Death|0|||
105707213|NCT00143455|364589217|FG002|Cohort 2|Death|20|||
105707214|NCT00143455|364589218|FG003|Cohort 2|Death|12|||
105707215|NCT00143455|364589215|FG000|Cohort 2|Progressive Disease|0|||
105707216|NCT00143455|364589216|FG001|Cohort 2|Progressive Disease|0|||
105707217|NCT00143455|364589217|FG002|Cohort 2|Progressive Disease|20|||
105707218|NCT00143455|364589218|FG003|Cohort 2|Progressive Disease|27|||
105707219|NCT00143455|364589215|FG000|Cohort 2|Withdrawal by Subject|0|||
105707220|NCT00143455|364589216|FG001|Cohort 2|Withdrawal by Subject|0|||
105707221|NCT00143455|364589217|FG002|Cohort 2|Withdrawal by Subject|13|||
105707222|NCT00143455|364589218|FG003|Cohort 2|Withdrawal by Subject|12|||
105707223|NCT00143455|364589215|FG000|Cohort 2|Other|0|||
105707224|NCT00143455|364589216|FG001|Cohort 2|Other|0|||
105707225|NCT00143455|364589217|FG002|Cohort 2|Other|7|||
105707226|NCT00143455|364589218|FG003|Cohort 2|Other|6|||
105707227|NCT00143455|364589215|FG000|Cohort 2|Randomized But Not Treated|0|||
105707228|NCT00143455|364589216|FG001|Cohort 2|Randomized But Not Treated|0|||
105707229|NCT00143455|364589217|FG002|Cohort 2|Randomized But Not Treated|1|||
105707230|NCT00143455|364589218|FG003|Cohort 2|Randomized But Not Treated|1|||
105707231|NCT01325428|364589219|FG000|Part A|Progressive disease according to RECIST|9|||
105707232|NCT01325428|364589219|FG000|Part A|Clinical signs, symptoms of progression|2|||
105707233|NCT01325428|364589219|FG000|Part A|Other adverse event|1|||
105707234|NCT01325428|364589219|FG000|Part A|Refused continue taking trial medication|2|||
105707235|NCT01325428|364589219|FG000|Part A|Other reason not defined above|2|||
105707236|NCT01325428|364589219|FG000|Part B|Refused continue taking trial medication|2|||
105707237|NCT01325428|364589219|FG000|Part B|Other reason not defined above|1|||
105707238|NCT03215771|364589224|FG000|Overall Study|Withdrawal by Subject|2|||
105707239|NCT03215771|364589224|FG000|Overall Study|Physician Decision|1|||
105707240|NCT00574275|364589225|FG000|Overall Study|Randomized but not treated|2|||
105707241|NCT00574275|364589226|FG001|Overall Study|Randomized but not treated|3|||
105707242|NCT00574275|364589225|FG000|Overall Study|Adverse Event|32|||
105707243|NCT00574275|364589226|FG001|Overall Study|Adverse Event|76|||
105707244|NCT00574275|364589225|FG000|Overall Study|Disease progression|160|||
105707245|NCT00574275|364589226|FG001|Overall Study|Disease progression|146|||
105707246|NCT00574275|364589225|FG000|Overall Study|Lost to Follow-up|2|||
105707247|NCT00574275|364589226|FG001|Overall Study|Lost to Follow-up|1|||
105707248|NCT00574275|364589225|FG000|Overall Study|Study stopped based on DMC decision|62|||
105707249|NCT00574275|364589226|FG001|Overall Study|Study stopped based on DMC decision|23|||
105707250|NCT00574275|364589225|FG000|Overall Study|Withdrawal by Subject|15|||
105707251|NCT00574275|364589226|FG001|Overall Study|Withdrawal by Subject|17|||
105707252|NCT00574275|364589225|FG000|Overall Study|Error calculating tumor measurement|1|||
105707253|NCT00574275|364589226|FG001|Overall Study|Error calculating tumor measurement|0|||
105707254|NCT00574275|364589225|FG000|Overall Study|Physician Decision|1|||
105707255|NCT00574275|364589226|FG001|Overall Study|Physician Decision|1|||
105707256|NCT00574275|364589225|FG000|Overall Study|Protocol Violation|0|||
105350714|NCT04767529|363288162|FG001|Overall Study|Lost to Follow-up|2|||
105350715|NCT04767529|363288163|FG002|Overall Study|Lost to Follow-up|3|||
105350716|NCT04847232|363288164|FG000|Overall Study|Death|123|||
105350717|NCT04847232|363288165|FG001|Overall Study|Death|115|||
105707257|NCT00574275|364589226|FG001|Overall Study|Protocol Violation|1|||
105707258|NCT00574275|364589225|FG000|Overall Study|Patient and Investigator decision|0|||
105707259|NCT00574275|364589226|FG001|Overall Study|Patient and Investigator decision|1|||
105707260|NCT00574275|364589225|FG000|Overall Study|Insurance change|0|||
105707261|NCT00574275|364589226|FG001|Overall Study|Insurance change|1|||
105707262|NCT00574275|364589225|FG000|Overall Study|Operation for curative intent|0|||
105707263|NCT00574275|364589226|FG001|Overall Study|Operation for curative intent|1|||
105707264|NCT00689871|364589227|FG000|Overall Study|Lost to Follow-up|123|||
105707265|NCT00689871|364589228|FG001|Overall Study|Lost to Follow-up|13|||
105707266|NCT00689871|364589229|FG002|Overall Study|Lost to Follow-up|37|||
105707267|NCT00689871|364589230|FG003|Overall Study|Lost to Follow-up|1|||
105350718|NCT04847232|363288164|FG000|Overall Study|Lost to Follow-up|3|||
105474703|NCT01349049|363751162|FG003|Overall Study|Death|0|||
105707268|NCT00689871|364589227|FG000|Overall Study|Explanted of All Study Devices|36|||
105474704|NCT01349049|363751163|FG004|Overall Study|Death|0|||
105707269|NCT00689871|364589228|FG001|Overall Study|Explanted of All Study Devices|25|||
105787917|NCT00602667|364876834|FG001|Overall Study|Still on Therapy|2|||
105787918|NCT00602667|364876835|FG002|Overall Study|Still on Therapy|2|||
105787919|NCT00602667|364876833|FG000|Overall Study|Death|0|||
105787920|NCT00602667|364876834|FG001|Overall Study|Death|1|||
105787921|NCT00602667|364876835|FG002|Overall Study|Death|1|||
105787922|NCT00602667|364876833|FG000|Overall Study|Family request|3|||
105787923|NCT00602667|364876834|FG001|Overall Study|Family request|25|||
105787924|NCT00602667|364876835|FG002|Overall Study|Family request|6|||
105787925|NCT00602667|364876833|FG000|Overall Study|Excessive toxicity|1|||
105787926|NCT00602667|364876834|FG001|Overall Study|Excessive toxicity|1|||
105787927|NCT00602667|364876835|FG002|Overall Study|Excessive toxicity|0|||
105350719|NCT04847232|363288165|FG001|Overall Study|Lost to Follow-up|10|||
105787928|NCT00602667|364876833|FG000|Overall Study|Second malignancy|0|||
105787929|NCT00602667|364876834|FG001|Overall Study|Second malignancy|1|||
105787930|NCT00602667|364876835|FG002|Overall Study|Second malignancy|0|||
105787931|NCT00602667|364876833|FG000|Overall Study|Physician Decision|2|||
105707270|NCT00689871|364589229|FG002|Overall Study|Explanted of All Study Devices|29|||
105707271|NCT00689871|364589230|FG003|Overall Study|Explanted of All Study Devices|3|||
105707272|NCT00689871|364589227|FG000|Overall Study|Withdrawal by Subject|13|||
105707273|NCT00689871|364589228|FG001|Overall Study|Withdrawal by Subject|3|||
105707274|NCT00689871|364589229|FG002|Overall Study|Withdrawal by Subject|4|||
105787932|NCT00602667|364876834|FG001|Overall Study|Physician Decision|3|||
105787933|NCT00602667|364876835|FG002|Overall Study|Physician Decision|8|||
105787934|NCT00602667|364876833|FG000|Overall Study|Progressive disease|13|||
105787935|NCT00602667|364876834|FG001|Overall Study|Progressive disease|48|||
105787936|NCT00602667|364876835|FG002|Overall Study|Progressive disease|45|||
105787937|NCT00602667|364876833|FG000|Overall Study|Progressive disease prior to therapy|0|||
105787938|NCT00602667|364876834|FG001|Overall Study|Progressive disease prior to therapy|0|||
105787939|NCT00602667|364876835|FG002|Overall Study|Progressive disease prior to therapy|1|||
105787940|NCT04410991|364876836|FG000|Overall Study|Poor compliance to protocol|5|||
105787941|NCT04410991|364876837|FG001|Overall Study|Poor compliance to protocol|4|||
105787942|NCT04410991|364876836|FG000|Overall Study|Withdrawal by Subject|59|||
105787943|NCT04410991|364876837|FG001|Overall Study|Withdrawal by Subject|55|||
105787944|NCT04410991|364876836|FG000|Overall Study|Other|10|||
105787945|NCT04410991|364876837|FG001|Overall Study|Other|4|||
105787946|NCT02003209|364876838|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
105787947|NCT02003209|364876839|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
105787948|NCT01195662|364876840|FG000|Double Blind Treatment Period|Adverse Event|4|||
105707275|NCT00689871|364589230|FG003|Overall Study|Withdrawal by Subject|1|||
105707276|NCT00689871|364589227|FG000|Overall Study|Death|1|||
105707277|NCT00689871|364589228|FG001|Overall Study|Death|10|||
105707278|NCT00689871|364589229|FG002|Overall Study|Death|2|||
105707279|NCT00689871|364589230|FG003|Overall Study|Death|2|||
105707280|NCT00689871|364589227|FG000|Overall Study|Physician Decision|2|||
105707281|NCT00689871|364589228|FG001|Overall Study|Physician Decision|1|||
105707282|NCT00689871|364589229|FG002|Overall Study|Physician Decision|1|||
105787949|NCT01195662|364876841|FG001|Double Blind Treatment Period|Adverse Event|1|||
105787950|NCT01195662|364876842|FG002|Double Blind Treatment Period|Adverse Event|2|||
105787951|NCT01195662|364876840|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
105787952|NCT01195662|364876841|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
105787953|NCT01195662|364876842|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
105787954|NCT01195662|364876840|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
105787955|NCT01195662|364876841|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
105474705|NCT01349049|363751164|FG005|Overall Study|Death|0|||
105707283|NCT00689871|364589230|FG003|Overall Study|Physician Decision|0|||
105707284|NCT02703311|364589231|FG000|Overall Study|Death|5|||
105707285|NCT02703311|364589231|FG000|Overall Study|Withdrawal by Subject|3|||
105707286|NCT04703075|364589235|FG000|Overall Study|Adverse Event|11|||
105787956|NCT01195662|364876842|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
105787957|NCT01195662|364876840|FG000|Double Blind Treatment Period|Administrative reason|2|||
105787958|NCT01195662|364876841|FG001|Double Blind Treatment Period|Administrative reason|1|||
105787959|NCT01195662|364876842|FG002|Double Blind Treatment Period|Administrative reason|1|||
105787960|NCT01195662|364876840|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
105787961|NCT01195662|364876841|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
105787962|NCT01195662|364876842|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
105707287|NCT04703075|364589236|FG001|Overall Study|Adverse Event|7|||
105707288|NCT04703075|364589235|FG000|Overall Study|Lost to Follow-up|6|||
105707289|NCT04703075|364589236|FG001|Overall Study|Lost to Follow-up|12|||
105707290|NCT04703075|364589235|FG000|Overall Study|Physician Decision|3|||
105707291|NCT04703075|364589236|FG001|Overall Study|Physician Decision|0|||
105707292|NCT04703075|364589235|FG000|Overall Study|Moved|0|||
105707293|NCT04703075|364589236|FG001|Overall Study|Moved|2|||
105707294|NCT04703075|364589235|FG000|Overall Study|Index INH Resistant|0|||
105707295|NCT04703075|364589236|FG001|Overall Study|Index INH Resistant|1|||
105707296|NCT04703075|364589235|FG000|Overall Study|Lack of Efficacy|6|||
105707297|NCT04703075|364589236|FG001|Overall Study|Lack of Efficacy|18|||
105707298|NCT02788747|364589237|FG000|Overall Study|Adverse Event|1|||
105707299|NCT02788747|364589238|FG001|Overall Study|Adverse Event|0|||
105707300|NCT02788747|364589239|FG002|Overall Study|Adverse Event|0|||
105707301|NCT01119248|364589240|FG000|Overall Study|Physician Decision|5|||
105707302|NCT01967550|364589241|FG000|Overall Study|Withdrawal by Subject|1|||
105707303|NCT01967550|364589242|FG001|Overall Study|Withdrawal by Subject|0|||
105707304|NCT01967550|364589241|FG000|Overall Study|Adverse Event|2|||
105707305|NCT01967550|364589242|FG001|Overall Study|Adverse Event|0|||
105707306|NCT01967550|364589241|FG000|Overall Study|Protocol Violation|2|||
105707307|NCT01967550|364589242|FG001|Overall Study|Protocol Violation|1|||
105707308|NCT01967550|364589241|FG000|Overall Study|Non Compliance|0|||
105707309|NCT01967550|364589242|FG001|Overall Study|Non Compliance|1|||
105707310|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
105707311|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
105707312|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
105707313|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
105707314|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
105707315|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
105707316|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
105707317|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
105707318|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
105707319|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
105707320|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
105707321|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
105707322|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
105707323|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
105707324|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
105707325|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
105707326|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
105707327|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
105707328|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
105707329|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
105707330|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
105707331|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
105787963|NCT01195662|364876840|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
105787964|NCT01195662|364876841|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
105787965|NCT01195662|364876842|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
105787966|NCT01195662|364876840|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
105707332|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
105707333|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
105707334|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
105787967|NCT01195662|364876841|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
105787968|NCT01195662|364876842|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
105707335|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
105707336|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
105707337|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
105707338|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
105707339|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
105707340|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
105707341|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
105707342|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
105707343|NCT00784654|364589243|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
105707344|NCT00784654|364589244|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
105707345|NCT00784654|364589245|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
105707346|NCT00784654|364589243|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
105707347|NCT00784654|364589244|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
105707348|NCT00784654|364589245|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
105707349|NCT00784654|364589243|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105707350|NCT00784654|364589244|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
105707351|NCT00784654|364589245|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
105787969|NCT01195662|364876840|FG000|Double Blind Treatment Period|Non-specified|3|||
105787970|NCT01195662|364876841|FG001|Double Blind Treatment Period|Non-specified|0|||
105787971|NCT01195662|364876842|FG002|Double Blind Treatment Period|Non-specified|0|||
105787972|NCT01195662|364876840|FG000|Double Blind Treatment Period|Missing disposition information|0|||
105787973|NCT01195662|364876841|FG001|Double Blind Treatment Period|Missing disposition information|1|||
105787974|NCT01195662|364876842|FG002|Double Blind Treatment Period|Missing disposition information|1|||
105787975|NCT01195662|364876840|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
105707352|NCT00784654|364589243|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
105707353|NCT00784654|364589244|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
105707354|NCT00784654|364589245|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
105707355|NCT00784654|364589243|FG000|Randomized Withdrawal Period|Adverse Event|0|||
105707356|NCT00784654|364589244|FG001|Randomized Withdrawal Period|Adverse Event|1|||
105707357|NCT00784654|364589245|FG002|Randomized Withdrawal Period|Adverse Event|1|||
105707358|NCT00784654|364589243|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
105707359|NCT00784654|364589244|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
105707360|NCT00784654|364589245|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
105707361|NCT00784654|364589243|FG000|Randomized Withdrawal Period|Family reasons|0|||
105707362|NCT00784654|364589244|FG001|Randomized Withdrawal Period|Family reasons|0|||
105707363|NCT00784654|364589245|FG002|Randomized Withdrawal Period|Family reasons|1|||
105707364|NCT01180660|364589246|FG000|Overall Study|Changed to open surgery|1|||
105707365|NCT01180660|364589247|FG001|Overall Study|Changed to open surgery|0|||
105707366|NCT02425826|364589251|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
105707367|NCT02425826|364589252|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
105707368|NCT02425826|364589253|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
105787976|NCT01195662|364876841|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
105787977|NCT01195662|364876842|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
105787978|NCT01195662|364876840|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
105787979|NCT01195662|364876841|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
105787980|NCT01195662|364876842|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
105787981|NCT01215968|364876843|FG000|Overall Study|Adverse Event|0|||
105474706|NCT01349049|363751165|FG006|Overall Study|Death|0|||
105474707|NCT01349049|363751166|FG007|Overall Study|Death|1|||
105787982|NCT01215968|364876844|FG001|Overall Study|Adverse Event|2|||
105787983|NCT01215968|364876843|FG000|Overall Study|Protocol Violation|2|||
105474708|NCT01349049|363751167|FG008|Overall Study|Death|5|||
105707369|NCT02425826|364589251|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
105707370|NCT02425826|364589252|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
105707371|NCT02425826|364589253|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
105707372|NCT02425826|364589251|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
105707373|NCT02425826|364589252|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
105707374|NCT02425826|364589253|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
105707375|NCT02425826|364589251|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
105707376|NCT02425826|364589252|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
105707377|NCT02425826|364589253|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
105707378|NCT02425826|364589251|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
105707379|NCT02425826|364589252|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
105707380|NCT02425826|364589253|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
105707381|NCT02425826|364589251|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
105707382|NCT02425826|364589252|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
105707383|NCT02425826|364589253|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
105707384|NCT02425826|364589251|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
105707385|NCT02425826|364589252|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
105707386|NCT02425826|364589253|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
105707387|NCT02425826|364589251|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
105707388|NCT02425826|364589252|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
105707389|NCT02425826|364589253|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
105707390|NCT02425826|364589251|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
105707391|NCT02425826|364589252|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
105707392|NCT02425826|364589253|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
105707393|NCT02425826|364589251|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
105707394|NCT02425826|364589252|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
105707395|NCT02425826|364589253|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
105707396|NCT01328951|364589262|FG000|Overall Study|Disease Progression|17|||
105707397|NCT01328951|364589263|FG001|Overall Study|Disease Progression|14|||
105707398|NCT01328951|364589262|FG000|Overall Study|Adverse Event|2|||
105707399|NCT01328951|364589263|FG001|Overall Study|Adverse Event|0|||
105707400|NCT01328951|364589262|FG000|Overall Study|Death|243|||
105707401|NCT01328951|364589263|FG001|Overall Study|Death|258|||
105707402|NCT01328951|364589262|FG000|Overall Study|Lost to Follow-up|6|||
105707403|NCT01328951|364589263|FG001|Overall Study|Lost to Follow-up|7|||
105707404|NCT01328951|364589262|FG000|Overall Study|Withdrawal by Subject|6|||
105707405|NCT01328951|364589263|FG001|Overall Study|Withdrawal by Subject|6|||
105707406|NCT01328951|364589262|FG000|Overall Study|Study Closed by the Sponsor|36|||
105707407|NCT01328951|364589263|FG001|Overall Study|Study Closed by the Sponsor|31|||
105707408|NCT01328951|364589262|FG000|Overall Study|Other|11|||
105707409|NCT01328951|364589263|FG001|Overall Study|Other|6|||
105707410|NCT04489888|364589264|FG000|Overall Study|Death|75|||
105707411|NCT04489888|364589264|FG000|Overall Study|Sponsor Decision|26|||
105707412|NCT04042103|364589265|FG000|Overall Study|Lost to Follow-up|1|||
105707413|NCT04042103|364589265|FG000|Overall Study|Withdrawal by Subject|1|||
105707414|NCT04153188|364589266|FG000|Overall Study|Lost to Follow-up|1|||
105707415|NCT04153188|364589267|FG001|Overall Study|Lost to Follow-up|1|||
105707416|NCT04153188|364589266|FG000|Overall Study|Withdrawal by Subject|2|||
105707417|NCT04153188|364589267|FG001|Overall Study|Withdrawal by Subject|0|||
105707418|NCT04153188|364589266|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
105707419|NCT04153188|364589267|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
105707420|NCT04418076|364589268|FG000|Overall Study|Death|1|||
105707421|NCT04418076|364589269|FG001|Overall Study|Death|0|||
105707422|NCT04418076|364589270|FG002|Overall Study|Death|0|||
105707423|NCT04418076|364589271|FG003|Overall Study|Death|0|||
105707424|NCT04418076|364589268|FG000|Overall Study|Lost to Follow-up|2|||
105707425|NCT04418076|364589269|FG001|Overall Study|Lost to Follow-up|5|||
105707426|NCT04418076|364589270|FG002|Overall Study|Lost to Follow-up|1|||
105707427|NCT04418076|364589271|FG003|Overall Study|Lost to Follow-up|2|||
105787984|NCT01215968|364876844|FG001|Overall Study|Protocol Violation|4|||
105787985|NCT01215968|364876843|FG000|Overall Study|Not received study drug|0|||
105707428|NCT04418076|364589268|FG000|Overall Study|Withdrawal by Subject|1|||
105707429|NCT04418076|364589269|FG001|Overall Study|Withdrawal by Subject|0|||
105707430|NCT04418076|364589270|FG002|Overall Study|Withdrawal by Subject|1|||
105707431|NCT04418076|364589271|FG003|Overall Study|Withdrawal by Subject|1|||
105707432|NCT04418076|364589268|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
105707433|NCT04418076|364589269|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
105707434|NCT04418076|364589270|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
105707435|NCT04418076|364589271|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
105707436|NCT00805480|364589272|FG000|Overall Study|Withdrawal by Subject|13|||
105707437|NCT00805480|364589273|FG001|Overall Study|Withdrawal by Subject|5|||
105707438|NCT00805480|364589274|FG002|Overall Study|Withdrawal by Subject|11|||
105707439|NCT00805480|364589275|FG003|Overall Study|Withdrawal by Subject|5|||
105707440|NCT00805480|364589272|FG000|Overall Study|Lost to Follow-up|1|||
105707441|NCT00805480|364589273|FG001|Overall Study|Lost to Follow-up|2|||
105787986|NCT01215968|364876844|FG001|Overall Study|Not received study drug|1|||
105707442|NCT00805480|364589274|FG002|Overall Study|Lost to Follow-up|0|||
105707443|NCT00805480|364589275|FG003|Overall Study|Lost to Follow-up|0|||
105707444|NCT00805480|364589272|FG000|Overall Study|Adverse Event|0|||
105707445|NCT00805480|364589273|FG001|Overall Study|Adverse Event|0|||
105707446|NCT00805480|364589274|FG002|Overall Study|Adverse Event|1|||
105707447|NCT00805480|364589275|FG003|Overall Study|Adverse Event|0|||
105707448|NCT04129528|364590813|FG000|Overall Study|Adverse Event|1|||
105707449|NCT04129528|364590814|FG001|Overall Study|Adverse Event|0|||
105707450|NCT04129528|364590813|FG000|Overall Study|Physician Decision|1|||
105707451|NCT04129528|364590814|FG001|Overall Study|Physician Decision|1|||
105707452|NCT04129528|364590813|FG000|Overall Study|Withdrawal by Subject|1|||
105707453|NCT04129528|364590814|FG001|Overall Study|Withdrawal by Subject|1|||
105787987|NCT01250418|364876848|FG000|Overall Study|monitor data failure|1|||
105787988|NCT01250418|364876849|FG001|Overall Study|monitor data failure|1|||
105707454|NCT01964352|364590815|FG000|Overall Study|Adverse Event|13|||
105787989|NCT01761565|364876850|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
105787990|NCT00816166|364876851|FG000|Overall Study|Lost to Follow-up|6|||
105787991|NCT00816166|364876852|FG001|Overall Study|Lost to Follow-up|10|||
105787992|NCT00816166|364876851|FG000|Overall Study|Death|4|||
105787993|NCT00816166|364876852|FG001|Overall Study|Death|2|||
105787994|NCT02851069|364876854|FG000|Overall Study|Failure to Return|3|||
105787995|NCT02851069|364876854|FG000|Overall Study|Other|3|||
105787996|NCT04745676|364876857|FG000|Overall Study|Death|1|||
105787997|NCT04745676|364876858|FG001|Overall Study|Death|0|||
105787998|NCT04745676|364876859|FG002|Overall Study|Death|0|||
105787999|NCT00885677|364876860|FG000|Overall Study|Death|40|||
105788000|NCT00885677|364876861|FG001|Overall Study|Death|34|||
105788001|NCT00885677|364876860|FG000|Overall Study|Lost to Follow-up|15|||
105788002|NCT00885677|364876861|FG001|Overall Study|Lost to Follow-up|13|||
105788003|NCT00885677|364876860|FG000|Overall Study|Protocol Violation|54|||
105788004|NCT00885677|364876861|FG001|Overall Study|Protocol Violation|54|||
105788005|NCT00885677|364876860|FG000|Overall Study|premature study closure|41|||
105788006|NCT00885677|364876861|FG001|Overall Study|premature study closure|44|||
105788007|NCT00885677|364876860|FG000|Overall Study|device/lead revision or replacement|7|||
105788008|NCT00885677|364876861|FG001|Overall Study|device/lead revision or replacement|6|||
105788009|NCT00885677|364876860|FG000|Overall Study|Heart transplantation|1|||
105788010|NCT00885677|364876861|FG001|Overall Study|Heart transplantation|0|||
105788011|NCT00885677|364876860|FG000|Overall Study|Inclusion/exclusion not met|25|||
105788012|NCT00885677|364876861|FG001|Overall Study|Inclusion/exclusion not met|27|||
105788013|NCT01821391|364876862|FG000|Overall Study|Adverse Event|1|||
105788014|NCT01821391|364876863|FG001|Overall Study|Adverse Event|0|||
105788015|NCT00975000|364876865|FG000|Overall Study|Other|1|||
105788016|NCT00975000|364876866|FG001|Overall Study|Other|0|||
105788017|NCT00975000|364876865|FG000|Overall Study|Adverse Event|1|||
105788018|NCT00975000|364876866|FG001|Overall Study|Adverse Event|1|||
105788019|NCT00975000|364876865|FG000|Overall Study|Withdrawal by Subject|2|||
105788020|NCT00975000|364876866|FG001|Overall Study|Withdrawal by Subject|2|||
105788021|NCT00975000|364876865|FG000|Overall Study|Lost to Follow-up|0|||
105788022|NCT00975000|364876866|FG001|Overall Study|Lost to Follow-up|1|||
105788023|NCT00975000|364876865|FG000|Overall Study|Protocol-specified Criteria|1|||
105788024|NCT00975000|364876866|FG001|Overall Study|Protocol-specified Criteria|0|||
105788025|NCT00975000|364876865|FG000|Overall Study|Non-compliance|0|||
105788026|NCT00975000|364876866|FG001|Overall Study|Non-compliance|1|||
105788027|NCT04880850|364876872|FG000|Overall Study|Death|2|||
105788028|NCT04880850|364876873|FG001|Overall Study|Death|1|||
105788029|NCT04880850|364876872|FG000|Overall Study|Lost to Follow-up|3|||
105788030|NCT04880850|364876873|FG001|Overall Study|Lost to Follow-up|6|||
105788031|NCT04880850|364876872|FG000|Overall Study|Physician Decision|2|||
105788032|NCT04880850|364876873|FG001|Overall Study|Physician Decision|1|||
105788033|NCT04880850|364876872|FG000|Overall Study|Withdrawal by Subject|9|||
105788034|NCT04880850|364876873|FG001|Overall Study|Withdrawal by Subject|10|||
105788035|NCT00437294|364878169|FG000|Overall Study|Adverse Event|5|||
105788036|NCT00437294|364878170|FG001|Overall Study|Adverse Event|4|||
105788037|NCT00437294|364878169|FG000|Overall Study|Death|5|||
105707455|NCT01964352|364590816|FG001|Overall Study|Adverse Event|3|||
105707456|NCT01964352|364590817|FG002|Overall Study|Adverse Event|4|||
105707457|NCT01964352|364590818|FG003|Overall Study|Adverse Event|3|||
105707458|NCT01964352|364590815|FG000|Overall Study|Lack of Efficacy|6|||
105707459|NCT01964352|364590816|FG001|Overall Study|Lack of Efficacy|0|||
105707460|NCT01964352|364590817|FG002|Overall Study|Lack of Efficacy|0|||
105788038|NCT00437294|364878170|FG001|Overall Study|Death|2|||
105788039|NCT00437294|364878169|FG000|Overall Study|Physician Decision|0|||
105707461|NCT01964352|364590818|FG003|Overall Study|Lack of Efficacy|0|||
105707462|NCT01964352|364590815|FG000|Overall Study|Protocol Violation|2|||
105707463|NCT01964352|364590816|FG001|Overall Study|Protocol Violation|4|||
105707464|NCT01964352|364590817|FG002|Overall Study|Protocol Violation|0|||
105707465|NCT01964352|364590818|FG003|Overall Study|Protocol Violation|2|||
105707466|NCT01964352|364590815|FG000|Overall Study|Lost to Follow-up|1|||
105707467|NCT01964352|364590816|FG001|Overall Study|Lost to Follow-up|0|||
105707468|NCT01964352|364590817|FG002|Overall Study|Lost to Follow-up|0|||
105707469|NCT01964352|364590818|FG003|Overall Study|Lost to Follow-up|1|||
105707470|NCT01964352|364590815|FG000|Overall Study|Withdrawal by Subject|4|||
105707471|NCT01964352|364590816|FG001|Overall Study|Withdrawal by Subject|2|||
105707472|NCT01964352|364590817|FG002|Overall Study|Withdrawal by Subject|1|||
105707473|NCT01964352|364590818|FG003|Overall Study|Withdrawal by Subject|0|||
105707474|NCT01964352|364590815|FG000|Overall Study|Other than stated above|0|||
105707475|NCT01964352|364590816|FG001|Overall Study|Other than stated above|2|||
105707476|NCT01964352|364590817|FG002|Overall Study|Other than stated above|1|||
105707477|NCT01964352|364590818|FG003|Overall Study|Other than stated above|2|||
105707478|NCT00105443|364590830|FG000|Double-Blind Treatment|Adverse Event|1|||
105707479|NCT00105443|364590831|FG001|Double-Blind Treatment|Adverse Event|0|||
105707480|NCT00105443|364590832|FG002|Double-Blind Treatment|Adverse Event|0|||
105707481|NCT00105443|364590833|FG003|Double-Blind Treatment|Adverse Event|0|||
105707482|NCT00105443|364590830|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
105707483|NCT00105443|364590831|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
105707484|NCT00105443|364590832|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
105707485|NCT00105443|364590833|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
105707486|NCT00105443|364590830|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
105707487|NCT00105443|364590831|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
105707488|NCT00105443|364590832|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
105707489|NCT00105443|364590833|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
105707490|NCT00105443|364590830|FG000|Double-Blind Treatment|Physician Decision|1|||
105707491|NCT00105443|364590831|FG001|Double-Blind Treatment|Physician Decision|0|||
105707492|NCT00105443|364590832|FG002|Double-Blind Treatment|Physician Decision|2|||
105707493|NCT00105443|364590833|FG003|Double-Blind Treatment|Physician Decision|0|||
105707494|NCT00105443|364590830|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
105707495|NCT00105443|364590831|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
105707496|NCT00105443|364590832|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
105707497|NCT00105443|364590833|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
105707498|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
105707499|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
105707500|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
105707501|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
105707502|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
105707503|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
105707504|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
105707505|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
105707506|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
105707507|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
105707508|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
105707509|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
105707510|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
105707511|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
105707512|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
105707513|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
105707514|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
105707515|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
105707516|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
105707517|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
105707518|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
105707519|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
105707520|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
105707521|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
105707522|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
105707523|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
105707524|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
105707525|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
105788040|NCT00437294|364878170|FG001|Overall Study|Physician Decision|3|||
105788041|NCT00437294|364878169|FG000|Overall Study|Withdrawal by Subject|5|||
105788042|NCT00437294|364878170|FG001|Overall Study|Withdrawal by Subject|0|||
105788043|NCT00437294|364878169|FG000|Overall Study|Progressive Disease|19|||
105788044|NCT00437294|364878170|FG001|Overall Study|Progressive Disease|23|||
105360884|NCT00873730|363328099|FG000|Overall Study|Sponsor decision|1|||
105707526|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
105707527|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
105707528|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
105707529|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
105707530|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
105707531|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
105707532|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
105707533|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
105707534|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
105707535|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
105707536|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
105707537|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
105707538|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
105707539|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
105707540|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
105707541|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
105707542|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
105707543|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
105707544|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
105707545|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
105707546|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
105707547|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
105707548|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
105707549|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
105707550|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
105707551|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
105707552|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
105707553|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
105707554|NCT02164981|364590834|FG000|Started|Withdrawal by Subject|2|||
105707555|NCT02164981|364590835|FG001|Started|Withdrawal by Subject|1|||
105707556|NCT02164981|364590836|FG002|Started|Withdrawal by Subject|0|||
105707557|NCT02164981|364590834|FG000|Started|Protocol Violation|2|||
105707558|NCT02164981|364590835|FG001|Started|Protocol Violation|0|||
105707559|NCT02164981|364590836|FG002|Started|Protocol Violation|0|||
105707560|NCT02164981|364590834|FG000|Started|Adverse Event|1|||
105707561|NCT02164981|364590835|FG001|Started|Adverse Event|2|||
105707562|NCT02164981|364590836|FG002|Started|Adverse Event|0|||
105707563|NCT02164981|364590834|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
105707564|NCT02164981|364590835|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
105707565|NCT02164981|364590836|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
105707566|NCT02164981|364590834|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
105707567|NCT02164981|364590835|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
105707568|NCT02164981|364590836|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
105707569|NCT02164981|364590834|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
105707570|NCT02164981|364590835|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
105707571|NCT02164981|364590836|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
105707572|NCT01736579|364590837|FG000|Overall Study|Termination of Study by Sponsor|2|||
105707573|NCT01736579|364590838|FG001|Overall Study|Termination of Study by Sponsor|2|||
105707574|NCT01995071|364590839|FG000|Overall Study|Adverse Event|0|||
105707575|NCT01995071|364590840|FG001|Overall Study|Adverse Event|0|||
105707576|NCT01995071|364590841|FG002|Overall Study|Adverse Event|0|||
105707577|NCT01995071|364590842|FG003|Overall Study|Adverse Event|0|||
105707578|NCT01995071|364590843|FG004|Overall Study|Adverse Event|0|||
105707579|NCT01995071|364590844|FG005|Overall Study|Adverse Event|0|||
105707580|NCT01995071|364590845|FG006|Overall Study|Adverse Event|1|||
105707581|NCT01995071|364590846|FG007|Overall Study|Adverse Event|0|||
105707582|NCT01995071|364590847|FG008|Overall Study|Adverse Event|0|||
105707583|NCT01995071|364590848|FG009|Overall Study|Adverse Event|0|||
105707584|NCT01995071|364590849|FG010|Overall Study|Adverse Event|0|||
105707585|NCT01995071|364590850|FG011|Overall Study|Adverse Event|0|||
105707586|NCT01995071|364590839|FG000|Overall Study|Moved|0|||
105707587|NCT01995071|364590840|FG001|Overall Study|Moved|0|||
105707588|NCT01995071|364590841|FG002|Overall Study|Moved|1|||
105707589|NCT01995071|364590842|FG003|Overall Study|Moved|0|||
105707590|NCT01995071|364590843|FG004|Overall Study|Moved|1|||
105707591|NCT01995071|364590844|FG005|Overall Study|Moved|0|||
105707592|NCT01995071|364590845|FG006|Overall Study|Moved|0|||
105707593|NCT01995071|364590846|FG007|Overall Study|Moved|0|||
105707594|NCT01995071|364590847|FG008|Overall Study|Moved|0|||
105350720|NCT04847232|363288164|FG000|Overall Study|Withdrawal by Subject|73|||
105707595|NCT01995071|364590848|FG009|Overall Study|Moved|0|||
105707596|NCT01995071|364590849|FG010|Overall Study|Moved|1|||
105707597|NCT01995071|364590850|FG011|Overall Study|Moved|0|||
105707598|NCT01995071|364590839|FG000|Overall Study|Lost to Follow-up|1|||
105707599|NCT01995071|364590840|FG001|Overall Study|Lost to Follow-up|0|||
105707600|NCT01995071|364590841|FG002|Overall Study|Lost to Follow-up|0|||
105707601|NCT01995071|364590842|FG003|Overall Study|Lost to Follow-up|0|||
105707602|NCT01995071|364590843|FG004|Overall Study|Lost to Follow-up|0|||
105707603|NCT01995071|364590844|FG005|Overall Study|Lost to Follow-up|0|||
105707604|NCT01995071|364590845|FG006|Overall Study|Lost to Follow-up|0|||
105707605|NCT01995071|364590846|FG007|Overall Study|Lost to Follow-up|1|||
105707606|NCT01995071|364590847|FG008|Overall Study|Lost to Follow-up|1|||
105707607|NCT01995071|364590848|FG009|Overall Study|Lost to Follow-up|0|||
105707608|NCT01995071|364590849|FG010|Overall Study|Lost to Follow-up|0|||
105707609|NCT01995071|364590850|FG011|Overall Study|Lost to Follow-up|0|||
105707610|NCT01995071|364590839|FG000|Overall Study|Incarcerated|0|||
105707611|NCT01995071|364590840|FG001|Overall Study|Incarcerated|0|||
105707612|NCT01995071|364590841|FG002|Overall Study|Incarcerated|0|||
105707613|NCT01995071|364590842|FG003|Overall Study|Incarcerated|0|||
105707614|NCT01995071|364590843|FG004|Overall Study|Incarcerated|0|||
105707615|NCT01995071|364590844|FG005|Overall Study|Incarcerated|0|||
105707616|NCT01995071|364590845|FG006|Overall Study|Incarcerated|0|||
105707617|NCT01995071|364590846|FG007|Overall Study|Incarcerated|1|||
105707618|NCT01995071|364590847|FG008|Overall Study|Incarcerated|0|||
105707619|NCT01995071|364590848|FG009|Overall Study|Incarcerated|0|||
105707620|NCT01995071|364590849|FG010|Overall Study|Incarcerated|0|||
105707621|NCT01995071|364590850|FG011|Overall Study|Incarcerated|0|||
105707622|NCT04541004|364590856|FG000|Overall Study|Adverse Event|2|||
105707623|NCT00621504|364590858|FG000|Overall Study|Adverse Event|1|||
105707624|NCT00621504|364590859|FG001|Overall Study|Adverse Event|3|||
105707625|NCT00621504|364590858|FG000|Overall Study|At the request of sponsor/investigator|1|||
105707626|NCT00621504|364590859|FG001|Overall Study|At the request of sponsor/investigator|0|||
105707627|NCT00621504|364590858|FG000|Overall Study|Withdrew consent|9|||
105707628|NCT00621504|364590859|FG001|Overall Study|Withdrew consent|6|||
105707629|NCT00621504|364590858|FG000|Overall Study|Lost to Follow-up|8|||
105707630|NCT00621504|364590859|FG001|Overall Study|Lost to Follow-up|10|||
105707631|NCT00621504|364590858|FG000|Overall Study|Other|1|||
105707632|NCT00621504|364590859|FG001|Overall Study|Other|0|||
105707633|NCT00621504|364590858|FG000|Overall Study|Death|6|||
105707634|NCT00621504|364590859|FG001|Overall Study|Death|6|||
105707635|NCT04429061|364590861|FG000|Overall Study|Lost to Follow-up|62|||
105707636|NCT04429061|364590862|FG001|Overall Study|Lost to Follow-up|87|||
105707637|NCT04429061|364590861|FG000|Overall Study|Withdrawal by Subject|3|||
105707638|NCT04429061|364590862|FG001|Overall Study|Withdrawal by Subject|4|||
105707639|NCT01870401|364590871|FG000|Overall Study|Death|48|||
105707640|NCT01870401|364590872|FG001|Overall Study|Death|24|||
105707641|NCT01870401|364590871|FG000|Overall Study|Withdrawal by Subject|39|||
105707642|NCT01870401|364590872|FG001|Overall Study|Withdrawal by Subject|26|||
105707643|NCT01870401|364590871|FG000|Overall Study|Lost to Follow-up|19|||
105707644|NCT01870401|364590872|FG001|Overall Study|Lost to Follow-up|14|||
105707645|NCT01870401|364590871|FG000|Overall Study|Other|9|||
105707646|NCT01870401|364590872|FG001|Overall Study|Other|7|||
105707647|NCT01870401|364590871|FG000|Overall Study|On-going in the Study|35|||
105707648|NCT01870401|364590872|FG001|Overall Study|On-going in the Study|25|||
105707649|NCT02363686|364590875|FG000|Overall Study|Withdrawal by Subject|22|||
105707650|NCT02363686|364590875|FG000|Overall Study|incomplete FEES examinations|13|||
105707651|NCT00957008|364590879|FG000|Overall Study|Withdrawal by Subject|13|||
105707652|NCT00957008|364590880|FG001|Overall Study|Withdrawal by Subject|10|||
105707653|NCT00957008|364590881|FG002|Overall Study|Withdrawal by Subject|12|||
105707654|NCT00957008|364590882|FG003|Overall Study|Withdrawal by Subject|16|||
105707655|NCT00957008|364590879|FG000|Overall Study|Lost to Follow-up|3|||
105707656|NCT00957008|364590880|FG001|Overall Study|Lost to Follow-up|1|||
105707657|NCT00957008|364590881|FG002|Overall Study|Lost to Follow-up|3|||
105707658|NCT00957008|364590882|FG003|Overall Study|Lost to Follow-up|4|||
105707659|NCT00957008|364590879|FG000|Overall Study|Physician Decision|1|||
105707660|NCT00957008|364590880|FG001|Overall Study|Physician Decision|0|||
105707661|NCT00957008|364590881|FG002|Overall Study|Physician Decision|1|||
105707662|NCT00957008|364590882|FG003|Overall Study|Physician Decision|1|||
105707663|NCT00957008|364590879|FG000|Overall Study|Relocated; Family conflict|4|||
105707664|NCT00957008|364590880|FG001|Overall Study|Relocated; Family conflict|1|||
105707665|NCT00957008|364590881|FG002|Overall Study|Relocated; Family conflict|1|||
105707666|NCT00957008|364590882|FG003|Overall Study|Relocated; Family conflict|3|||
105707667|NCT03509350|364590889|FG000|Overall Study|Withdrawal by Subject|0|||
105707668|NCT03509350|364590890|FG001|Overall Study|Withdrawal by Subject|2|||
105707669|NCT01425203|364590891|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
105707670|NCT01425203|364590892|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
105707671|NCT01425203|364590893|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
105707672|NCT01425203|364590891|FG000|Treatment Phase|Failure at futility timepoint|8|||
105707673|NCT01425203|364590892|FG001|Treatment Phase|Failure at futility timepoint|27|||
105707674|NCT01425203|364590893|FG002|Treatment Phase|Failure at futility timepoint|0|||
105707675|NCT01425203|364590891|FG000|Treatment Phase|Other virologic failure criteria|5|||
105707676|NCT01425203|364590892|FG001|Treatment Phase|Other virologic failure criteria|3|||
105707677|NCT01425203|364590893|FG002|Treatment Phase|Other virologic failure criteria|0|||
105707678|NCT01425203|364590891|FG000|Treatment Phase|Unidentified reasons|11|||
105707679|NCT01425203|364590892|FG001|Treatment Phase|Unidentified reasons|5|||
105707680|NCT01425203|364590893|FG002|Treatment Phase|Unidentified reasons|0|||
105707681|NCT01425203|364590891|FG000|Treatment Phase|Did not receive treatment|0|||
105707682|NCT01425203|364590892|FG001|Treatment Phase|Did not receive treatment|1|||
105707683|NCT01425203|364590893|FG002|Treatment Phase|Did not receive treatment|0|||
105707684|NCT01425203|364590891|FG000|Crossover Phase|Failure at futility timepoint|0|||
105707685|NCT01425203|364590892|FG001|Crossover Phase|Failure at futility timepoint|0|||
105707686|NCT01425203|364590893|FG002|Crossover Phase|Failure at futility timepoint|3|||
105707687|NCT01425203|364590891|FG000|Crossover Phase|Other virologic failure criteria|0|||
105707688|NCT01425203|364590892|FG001|Crossover Phase|Other virologic failure criteria|0|||
105707689|NCT01425203|364590893|FG002|Crossover Phase|Other virologic failure criteria|3|||
105707690|NCT01784861|364590900|FG000|Overall Study|Adverse Event|0|||
105707691|NCT01784861|364590901|FG001|Overall Study|Adverse Event|0|||
105707692|NCT01784861|364590902|FG002|Overall Study|Adverse Event|1|||
105707693|NCT01784861|364590903|FG003|Overall Study|Adverse Event|2|||
105707694|NCT01784861|364590904|FG004|Overall Study|Adverse Event|1|||
105707695|NCT01784861|364590905|FG005|Overall Study|Adverse Event|0|||
105707696|NCT01784861|364590900|FG000|Overall Study|Withdrawal by Subject|0|||
105707697|NCT01784861|364590901|FG001|Overall Study|Withdrawal by Subject|0|||
105707698|NCT01784861|364590902|FG002|Overall Study|Withdrawal by Subject|0|||
105707699|NCT01784861|364590903|FG003|Overall Study|Withdrawal by Subject|1|||
105707700|NCT01784861|364590904|FG004|Overall Study|Withdrawal by Subject|0|||
105707701|NCT01784861|364590905|FG005|Overall Study|Withdrawal by Subject|0|||
105707702|NCT01784861|364590900|FG000|Overall Study|Physician Decision|0|||
105707703|NCT01784861|364590901|FG001|Overall Study|Physician Decision|0|||
105707704|NCT01784861|364590902|FG002|Overall Study|Physician Decision|0|||
105707705|NCT01784861|364590903|FG003|Overall Study|Physician Decision|2|||
105707706|NCT01784861|364590904|FG004|Overall Study|Physician Decision|0|||
105707707|NCT01784861|364590905|FG005|Overall Study|Physician Decision|1|||
105707708|NCT00797732|364590909|FG000|Overall Study|Withdrawal by Subject|3|||
105707709|NCT00797732|364590910|FG001|Overall Study|Withdrawal by Subject|3|||
105707710|NCT00797732|364590911|FG002|Overall Study|Withdrawal by Subject|0|||
105707711|NCT00797732|364590909|FG000|Overall Study|Lost to Follow-up|1|||
105707712|NCT00797732|364590910|FG001|Overall Study|Lost to Follow-up|0|||
105707713|NCT00797732|364590911|FG002|Overall Study|Lost to Follow-up|0|||
105707714|NCT00797732|364590909|FG000|Overall Study|Death|1|||
105707715|NCT00797732|364590910|FG001|Overall Study|Death|0|||
105707716|NCT00797732|364590911|FG002|Overall Study|Death|0|||
105707717|NCT00797732|364590909|FG000|Overall Study|Not meet inclusion criteria|0|||
105707718|NCT00797732|364590910|FG001|Overall Study|Not meet inclusion criteria|0|||
105707719|NCT00797732|364590911|FG002|Overall Study|Not meet inclusion criteria|7|||
105707720|NCT00797732|364590909|FG000|Overall Study|Excluded due to time constraints|0|||
105707721|NCT00797732|364590910|FG001|Overall Study|Excluded due to time constraints|0|||
105707722|NCT00797732|364590911|FG002|Overall Study|Excluded due to time constraints|24|||
105707723|NCT00797732|364590909|FG000|Overall Study|Refused to Participate|0|||
105707724|NCT00797732|364590910|FG001|Overall Study|Refused to Participate|0|||
105707725|NCT00797732|364590911|FG002|Overall Study|Refused to Participate|123|||
105707726|NCT02250274|364590925|FG000|Overall Study|Insufficient blood draw amount|7|||
105707727|NCT02250274|364590926|FG001|Overall Study|Insufficient blood draw amount|6|||
105707728|NCT01627899|364590931|FG000|Overall Study|Study terminated early by sponsor.|5|||
105707729|NCT00271817|364590937|FG000|Part 1|Adverse Event|68|||
105707730|NCT00271817|364590938|FG001|Part 1|Adverse Event|25|||
105707731|NCT00271817|364590939|FG002|Part 1|Adverse Event|156|||
105707732|NCT00271817|364590937|FG000|Part 1|Lost to Follow-up|6|||
105707733|NCT00271817|364590938|FG001|Part 1|Lost to Follow-up|8|||
105707734|NCT00271817|364590939|FG002|Part 1|Lost to Follow-up|24|||
105707735|NCT00271817|364590937|FG000|Part 1|Protocol Violation|5|||
105707736|NCT00271817|364590938|FG001|Part 1|Protocol Violation|4|||
105707737|NCT00271817|364590939|FG002|Part 1|Protocol Violation|7|||
105707738|NCT00271817|364590937|FG000|Part 1|Patient Moved|3|||
105707739|NCT00271817|364590938|FG001|Part 1|Patient Moved|1|||
105707740|NCT00271817|364590939|FG002|Part 1|Patient Moved|5|||
105707741|NCT00271817|364590937|FG000|Part 1|Withdrawal by Subject|23|||
105707742|NCT00271817|364590938|FG001|Part 1|Withdrawal by Subject|17|||
105707743|NCT00271817|364590939|FG002|Part 1|Withdrawal by Subject|45|||
105707744|NCT00271817|364590937|FG000|Part 1|LDL < 50 mg/dL|1|||
105707745|NCT00271817|364590938|FG001|Part 1|LDL < 50 mg/dL|4|||
105707746|NCT00271817|364590939|FG002|Part 1|LDL < 50 mg/dL|48|||
105707747|NCT00271817|364590937|FG000|Part 2|Adverse Event|0|||
105707748|NCT00271817|364590938|FG001|Part 2|Adverse Event|17|||
105707749|NCT00271817|364590939|FG002|Part 2|Adverse Event|33|||
105707750|NCT00271817|364590937|FG000|Part 2|Lack of Efficacy|0|||
105707751|NCT00271817|364590938|FG001|Part 2|Lack of Efficacy|1|||
105707752|NCT00271817|364590939|FG002|Part 2|Lack of Efficacy|6|||
105707753|NCT00271817|364590937|FG000|Part 2|Lost to Follow-up|0|||
105707754|NCT00271817|364590938|FG001|Part 2|Lost to Follow-up|6|||
105707755|NCT00271817|364590939|FG002|Part 2|Lost to Follow-up|18|||
105707756|NCT00271817|364590937|FG000|Part 2|Protocol Violation|0|||
105707757|NCT00271817|364590938|FG001|Part 2|Protocol Violation|3|||
105707758|NCT00271817|364590939|FG002|Part 2|Protocol Violation|5|||
105707759|NCT00271817|364590937|FG000|Part 2|Patient Moved|0|||
105707760|NCT00271817|364590938|FG001|Part 2|Patient Moved|0|||
105707761|NCT00271817|364590939|FG002|Part 2|Patient Moved|5|||
105707762|NCT00271817|364590937|FG000|Part 2|Withdrawal by Subject|0|||
105707763|NCT00271817|364590938|FG001|Part 2|Withdrawal by Subject|2|||
105707764|NCT00271817|364590939|FG002|Part 2|Withdrawal by Subject|13|||
105707765|NCT00271817|364590937|FG000|Part 2|LDL < 50 mg/dL|0|||
105707766|NCT00271817|364590938|FG001|Part 2|LDL < 50 mg/dL|3|||
105707767|NCT00271817|364590939|FG002|Part 2|LDL < 50 mg/dL|4|||
105707768|NCT01471782|364590942|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
105707769|NCT01471782|364590943|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
105707770|NCT01471782|364590944|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
105707771|NCT01471782|364590945|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
105707772|NCT01471782|364590946|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
105707773|NCT01471782|364590947|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
105707774|NCT01471782|364590942|FG000|Overall Study|Lack of Efficacy|1|||
105707775|NCT01471782|364590943|FG001|Overall Study|Lack of Efficacy|2|||
105707776|NCT01471782|364590944|FG002|Overall Study|Lack of Efficacy|1|||
105707777|NCT01471782|364590945|FG003|Overall Study|Lack of Efficacy|1|||
105707778|NCT01471782|364590946|FG004|Overall Study|Lack of Efficacy|5|||
105707779|NCT01471782|364590947|FG005|Overall Study|Lack of Efficacy|18|||
105707780|NCT01471782|364590942|FG000|Overall Study|Adverse Event|1|||
105707781|NCT01471782|364590943|FG001|Overall Study|Adverse Event|1|||
105707782|NCT01471782|364590944|FG002|Overall Study|Adverse Event|2|||
105707783|NCT01471782|364590945|FG003|Overall Study|Adverse Event|2|||
105707784|NCT01471782|364590946|FG004|Overall Study|Adverse Event|3|||
105707785|NCT01471782|364590947|FG005|Overall Study|Adverse Event|1|||
105707786|NCT01471782|364590942|FG000|Overall Study|Other|0|||
105707787|NCT01471782|364590943|FG001|Overall Study|Other|0|||
105707788|NCT01471782|364590944|FG002|Overall Study|Other|1|||
105707789|NCT01471782|364590945|FG003|Overall Study|Other|1|||
105707790|NCT01471782|364590946|FG004|Overall Study|Other|6|||
105707791|NCT01471782|364590947|FG005|Overall Study|Other|5|||
105707792|NCT01471782|364590942|FG000|Overall Study|Change of Chemotherapy|1|||
105707793|NCT01471782|364590943|FG001|Overall Study|Change of Chemotherapy|1|||
105707794|NCT01471782|364590944|FG002|Overall Study|Change of Chemotherapy|0|||
105707795|NCT01471782|364590945|FG003|Overall Study|Change of Chemotherapy|0|||
105707796|NCT01471782|364590946|FG004|Overall Study|Change of Chemotherapy|1|||
105707797|NCT01471782|364590947|FG005|Overall Study|Change of Chemotherapy|4|||
105707798|NCT01471782|364590942|FG000|Overall Study|Disease Relapse|0|||
105707799|NCT01471782|364590943|FG001|Overall Study|Disease Relapse|0|||
105707800|NCT01471782|364590944|FG002|Overall Study|Disease Relapse|0|||
105707801|NCT01471782|364590945|FG003|Overall Study|Disease Relapse|1|||
105707802|NCT01471782|364590946|FG004|Overall Study|Disease Relapse|2|||
105707803|NCT01471782|364590947|FG005|Overall Study|Disease Relapse|1|||
105707804|NCT01471782|364590942|FG000|Overall Study|Physician Decision|0|||
105707805|NCT01471782|364590943|FG001|Overall Study|Physician Decision|0|||
105707806|NCT01471782|364590944|FG002|Overall Study|Physician Decision|0|||
105707807|NCT01471782|364590945|FG003|Overall Study|Physician Decision|0|||
105707808|NCT01471782|364590946|FG004|Overall Study|Physician Decision|3|||
105707809|NCT01471782|364590947|FG005|Overall Study|Physician Decision|8|||
105707810|NCT01471782|364590942|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105707811|NCT01471782|364590943|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105707812|NCT01471782|364590944|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105707813|NCT01471782|364590945|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
105707814|NCT01471782|364590946|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
105707815|NCT01471782|364590947|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
105707816|NCT01471782|364590942|FG000|Overall Study|Death|0|||
105707817|NCT01471782|364590943|FG001|Overall Study|Death|0|||
105707818|NCT01471782|364590944|FG002|Overall Study|Death|0|||
105707819|NCT01471782|364590945|FG003|Overall Study|Death|0|||
105707820|NCT01471782|364590946|FG004|Overall Study|Death|0|||
105707821|NCT01471782|364590947|FG005|Overall Study|Death|1|||
105707822|NCT01425008|364590948|FG000|Dose Escalation Phase|Progressive Disease|2|||
105707823|NCT01425008|364590949|FG001|Dose Escalation Phase|Progressive Disease|3|||
105707824|NCT01425008|364590950|FG002|Dose Escalation Phase|Progressive Disease|2|||
105707825|NCT01425008|364590951|FG003|Dose Escalation Phase|Progressive Disease|3|||
105707826|NCT01425008|364590952|FG004|Dose Escalation Phase|Progressive Disease|5|||
105707827|NCT01425008|364590953|FG005|Dose Escalation Phase|Progressive Disease|4|||
105707828|NCT01425008|364590954|FG006|Dose Escalation Phase|Progressive Disease|0|||
105707829|NCT01425008|364590955|FG007|Dose Escalation Phase|Progressive Disease|2|||
105707830|NCT01425008|364590956|FG008|Dose Escalation Phase|Progressive Disease|6|||
105707831|NCT01425008|364590957|FG009|Dose Escalation Phase|Progressive Disease|2|||
105707832|NCT01425008|364590958|FG010|Dose Escalation Phase|Progressive Disease|0|||
105707833|NCT01425008|364590959|FG011|Dose Escalation Phase|Progressive Disease|0|||
105707834|NCT01425008|364590960|FG012|Dose Escalation Phase|Progressive Disease|0|||
105707835|NCT01425008|364590961|FG013|Dose Escalation Phase|Progressive Disease|0|||
105707836|NCT01425008|364590962|FG014|Dose Escalation Phase|Progressive Disease|0|||
105707837|NCT01425008|364590963|FG015|Dose Escalation Phase|Progressive Disease|0|||
105707838|NCT01425008|364590964|FG016|Dose Escalation Phase|Progressive Disease|0|||
105707839|NCT01425008|364590965|FG017|Dose Escalation Phase|Progressive Disease|0|||
105707840|NCT01425008|364590966|FG018|Dose Escalation Phase|Progressive Disease|0|||
105707841|NCT01425008|364590948|FG000|Dose Escalation Phase|Adverse Event|2|||
105707842|NCT01425008|364590949|FG001|Dose Escalation Phase|Adverse Event|0|||
105707843|NCT01425008|364590950|FG002|Dose Escalation Phase|Adverse Event|0|||
105707844|NCT01425008|364590951|FG003|Dose Escalation Phase|Adverse Event|0|||
105707845|NCT01425008|364590952|FG004|Dose Escalation Phase|Adverse Event|0|||
105707846|NCT01425008|364590953|FG005|Dose Escalation Phase|Adverse Event|2|||
105707847|NCT01425008|364590954|FG006|Dose Escalation Phase|Adverse Event|0|||
105707848|NCT01425008|364590955|FG007|Dose Escalation Phase|Adverse Event|0|||
105707849|NCT01425008|364590956|FG008|Dose Escalation Phase|Adverse Event|2|||
105707850|NCT01425008|364590957|FG009|Dose Escalation Phase|Adverse Event|0|||
105707851|NCT01425008|364590958|FG010|Dose Escalation Phase|Adverse Event|0|||
105707852|NCT01425008|364590959|FG011|Dose Escalation Phase|Adverse Event|0|||
105707853|NCT01425008|364590960|FG012|Dose Escalation Phase|Adverse Event|0|||
105707854|NCT01425008|364590961|FG013|Dose Escalation Phase|Adverse Event|0|||
105707855|NCT01425008|364590962|FG014|Dose Escalation Phase|Adverse Event|0|||
105707856|NCT01425008|364590963|FG015|Dose Escalation Phase|Adverse Event|0|||
105707857|NCT01425008|364590964|FG016|Dose Escalation Phase|Adverse Event|0|||
105707858|NCT01425008|364590965|FG017|Dose Escalation Phase|Adverse Event|0|||
105707859|NCT01425008|364590966|FG018|Dose Escalation Phase|Adverse Event|0|||
105707860|NCT01425008|364590948|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707861|NCT01425008|364590949|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707862|NCT01425008|364590950|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707863|NCT01425008|364590951|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707864|NCT01425008|364590952|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
105707865|NCT01425008|364590953|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707866|NCT01425008|364590954|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
105707867|NCT01425008|364590955|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
105707868|NCT01425008|364590956|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
105707869|NCT01425008|364590957|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707870|NCT01425008|364590958|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707871|NCT01425008|364590959|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707872|NCT01425008|364590960|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707873|NCT01425008|364590961|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105474709|NCT01349049|363751159|FG000|Overall Study|Non-compliance|0|||
105707874|NCT01425008|364590962|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707875|NCT01425008|364590963|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707876|NCT01425008|364590964|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707877|NCT01425008|364590965|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707878|NCT01425008|364590966|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707879|NCT01425008|364590948|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
105707880|NCT01425008|364590949|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
105707881|NCT01425008|364590950|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
105707882|NCT01425008|364590951|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
105707883|NCT01425008|364590952|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
105707884|NCT01425008|364590953|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
105707885|NCT01425008|364590954|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
105707886|NCT01425008|364590955|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
105707887|NCT01425008|364590956|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
105707888|NCT01425008|364590957|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
105707889|NCT01425008|364590958|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
105707890|NCT01425008|364590959|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
105707891|NCT01425008|364590960|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
105707892|NCT01425008|364590961|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
105707893|NCT01425008|364590962|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
105707894|NCT01425008|364590963|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
105707895|NCT01425008|364590964|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
105707896|NCT01425008|364590965|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
105707897|NCT01425008|364590966|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
105707898|NCT01425008|364590948|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707899|NCT01425008|364590949|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707900|NCT01425008|364590950|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
105707901|NCT01425008|364590951|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707902|NCT01425008|364590952|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707903|NCT01425008|364590953|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707904|NCT01425008|364590954|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707905|NCT01425008|364590955|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707906|NCT01425008|364590956|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
105707907|NCT01425008|364590957|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
105707908|NCT01425008|364590958|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707909|NCT01425008|364590959|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707910|NCT01425008|364590960|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707911|NCT01425008|364590961|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707912|NCT01425008|364590962|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707913|NCT01425008|364590963|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707914|NCT01425008|364590964|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707915|NCT01425008|364590965|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707916|NCT01425008|364590966|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707917|NCT01425008|364590948|FG000|Dose Escalation Phase|Other|0|||
105707918|NCT01425008|364590949|FG001|Dose Escalation Phase|Other|0|||
105707919|NCT01425008|364590950|FG002|Dose Escalation Phase|Other|0|||
105707920|NCT01425008|364590951|FG003|Dose Escalation Phase|Other|0|||
105707921|NCT01425008|364590952|FG004|Dose Escalation Phase|Other|0|||
105707922|NCT01425008|364590953|FG005|Dose Escalation Phase|Other|0|||
105707923|NCT01425008|364590954|FG006|Dose Escalation Phase|Other|0|||
105707924|NCT01425008|364590955|FG007|Dose Escalation Phase|Other|0|||
105707925|NCT01425008|364590956|FG008|Dose Escalation Phase|Other|1|||
105707926|NCT01425008|364590957|FG009|Dose Escalation Phase|Other|0|||
105707927|NCT01425008|364590958|FG010|Dose Escalation Phase|Other|0|||
105707928|NCT01425008|364590959|FG011|Dose Escalation Phase|Other|0|||
105707929|NCT01425008|364590960|FG012|Dose Escalation Phase|Other|0|||
105707930|NCT01425008|364590961|FG013|Dose Escalation Phase|Other|0|||
105707931|NCT01425008|364590962|FG014|Dose Escalation Phase|Other|0|||
105707932|NCT01425008|364590963|FG015|Dose Escalation Phase|Other|0|||
105707933|NCT01425008|364590964|FG016|Dose Escalation Phase|Other|0|||
105707934|NCT01425008|364590965|FG017|Dose Escalation Phase|Other|0|||
105707935|NCT01425008|364590966|FG018|Dose Escalation Phase|Other|0|||
105707936|NCT01425008|364590948|FG000|Dose Expansion Phase|Progressive Disease|0|||
105707937|NCT01425008|364590949|FG001|Dose Expansion Phase|Progressive Disease|0|||
105707938|NCT01425008|364590950|FG002|Dose Expansion Phase|Progressive Disease|0|||
105707939|NCT01425008|364590951|FG003|Dose Expansion Phase|Progressive Disease|0|||
105707940|NCT01425008|364590952|FG004|Dose Expansion Phase|Progressive Disease|0|||
105707941|NCT01425008|364590953|FG005|Dose Expansion Phase|Progressive Disease|0|||
105707942|NCT01425008|364590954|FG006|Dose Expansion Phase|Progressive Disease|0|||
105707943|NCT01425008|364590955|FG007|Dose Expansion Phase|Progressive Disease|0|||
105707944|NCT01425008|364590956|FG008|Dose Expansion Phase|Progressive Disease|0|||
105707945|NCT01425008|364590957|FG009|Dose Expansion Phase|Progressive Disease|0|||
105707946|NCT01425008|364590958|FG010|Dose Expansion Phase|Progressive Disease|10|||
105707947|NCT01425008|364590959|FG011|Dose Expansion Phase|Progressive Disease|4|||
105707948|NCT01425008|364590960|FG012|Dose Expansion Phase|Progressive Disease|12|||
105707949|NCT01425008|364590961|FG013|Dose Expansion Phase|Progressive Disease|1|||
105707950|NCT01425008|364590962|FG014|Dose Expansion Phase|Progressive Disease|5|||
105707951|NCT01425008|364590963|FG015|Dose Expansion Phase|Progressive Disease|8|||
105707952|NCT01425008|364590964|FG016|Dose Expansion Phase|Progressive Disease|9|||
105707953|NCT01425008|364590965|FG017|Dose Expansion Phase|Progressive Disease|2|||
105707954|NCT01425008|364590966|FG018|Dose Expansion Phase|Progressive Disease|10|||
105707955|NCT01425008|364590948|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
105707956|NCT01425008|364590949|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
105707957|NCT01425008|364590950|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
105707958|NCT01425008|364590951|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
105707959|NCT01425008|364590952|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
105707960|NCT01425008|364590953|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
105707961|NCT01425008|364590954|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
105707962|NCT01425008|364590955|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
105707963|NCT01425008|364590956|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
105707964|NCT01425008|364590957|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
105707965|NCT01425008|364590958|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
105707966|NCT01425008|364590959|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
105707967|NCT01425008|364590960|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
105707968|NCT01425008|364590961|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
105707969|NCT01425008|364590962|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
105707970|NCT01425008|364590963|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
105707971|NCT01425008|364590964|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
105707972|NCT01425008|364590965|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
105707973|NCT01425008|364590966|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
105707974|NCT01425008|364590948|FG000|Dose Expansion Phase|Other|0|||
105707975|NCT01425008|364590949|FG001|Dose Expansion Phase|Other|0|||
105707976|NCT01425008|364590950|FG002|Dose Expansion Phase|Other|0|||
105707977|NCT01425008|364590951|FG003|Dose Expansion Phase|Other|0|||
105707978|NCT01425008|364590952|FG004|Dose Expansion Phase|Other|0|||
105707979|NCT01425008|364590953|FG005|Dose Expansion Phase|Other|0|||
105707980|NCT01425008|364590954|FG006|Dose Expansion Phase|Other|0|||
105707981|NCT01425008|364590955|FG007|Dose Expansion Phase|Other|0|||
105707982|NCT01425008|364590956|FG008|Dose Expansion Phase|Other|0|||
105707983|NCT01425008|364590957|FG009|Dose Expansion Phase|Other|0|||
105707984|NCT01425008|364590958|FG010|Dose Expansion Phase|Other|0|||
105707985|NCT01425008|364590959|FG011|Dose Expansion Phase|Other|0|||
105707986|NCT01425008|364590960|FG012|Dose Expansion Phase|Other|1|||
105707987|NCT01425008|364590961|FG013|Dose Expansion Phase|Other|0|||
105707988|NCT01425008|364590962|FG014|Dose Expansion Phase|Other|0|||
105707989|NCT01425008|364590963|FG015|Dose Expansion Phase|Other|0|||
105707990|NCT01425008|364590964|FG016|Dose Expansion Phase|Other|2|||
105560558|NCT05763628|364048446|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
105560559|NCT04385368|364048447|FG000|Overall Study|Death|5|||
105560560|NCT04385368|364048448|FG001|Overall Study|Death|5|||
105560561|NCT04385368|364048447|FG000|Overall Study|Physician Decision|3|||
105560562|NCT04385368|364048448|FG001|Overall Study|Physician Decision|0|||
105560563|NCT04385368|364048447|FG000|Overall Study|Withdrawal by Subject|4|||
105560564|NCT04385368|364048448|FG001|Overall Study|Withdrawal by Subject|3|||
105560565|NCT02316769|364048449|FG000|Overall Study|Physician Decision|1|||
105560566|NCT02316769|364048450|FG001|Overall Study|Physician Decision|0|||
105560567|NCT02316769|364048449|FG000|Overall Study|Withdrawal by Subject|1|||
105560568|NCT02316769|364048450|FG001|Overall Study|Withdrawal by Subject|0|||
105560569|NCT00677235|364048451|FG000|Overall Study|Withdrawal by Subject|1|||
105560570|NCT00677235|364048452|FG001|Overall Study|Withdrawal by Subject|1|||
105560571|NCT00677235|364048451|FG000|Overall Study|Lost to Follow-up|2|||
105560572|NCT00677235|364048452|FG001|Overall Study|Lost to Follow-up|1|||
105560573|NCT00677235|364048451|FG000|Overall Study|Death|37|||
105707991|NCT01425008|364590965|FG017|Dose Expansion Phase|Other|0|||
105707992|NCT01425008|364590966|FG018|Dose Expansion Phase|Other|4|||
105560574|NCT00677235|364048452|FG001|Overall Study|Death|36|||
105560575|NCT00677235|364048451|FG000|Overall Study|Adverse Experience|1|||
105707993|NCT01425008|364590948|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
105707994|NCT01425008|364590949|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
105560576|NCT00677235|364048452|FG001|Overall Study|Adverse Experience|0|||
105560577|NCT01040260|364048453|FG000|Overall Study|Withdrawal by Subject|12|||
105560578|NCT01040260|364048454|FG001|Overall Study|Withdrawal by Subject|6|||
105707995|NCT01425008|364590950|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
105707996|NCT01425008|364590951|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
105707997|NCT01425008|364590952|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
105707998|NCT01425008|364590953|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
105707999|NCT01425008|364590954|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708000|NCT01425008|364590955|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708001|NCT01425008|364590956|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708002|NCT01425008|364590957|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708003|NCT01425008|364590958|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
105708004|NCT01425008|364590959|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
105708005|NCT01425008|364590960|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708006|NCT01425008|364590961|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708007|NCT01425008|364590962|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708008|NCT01425008|364590963|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
105708009|NCT01425008|364590964|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
105708010|NCT01425008|364590965|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708011|NCT01425008|364590966|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
105708012|NCT01425008|364590948|FG000|Dose Expansion Phase|Adverse Event|0|||
105708013|NCT01425008|364590949|FG001|Dose Expansion Phase|Adverse Event|0|||
105708014|NCT01425008|364590950|FG002|Dose Expansion Phase|Adverse Event|0|||
105708015|NCT01425008|364590951|FG003|Dose Expansion Phase|Adverse Event|0|||
105708016|NCT01425008|364590952|FG004|Dose Expansion Phase|Adverse Event|0|||
105708017|NCT01425008|364590953|FG005|Dose Expansion Phase|Adverse Event|0|||
105708018|NCT01425008|364590954|FG006|Dose Expansion Phase|Adverse Event|0|||
105708019|NCT01425008|364590955|FG007|Dose Expansion Phase|Adverse Event|0|||
105708020|NCT01425008|364590956|FG008|Dose Expansion Phase|Adverse Event|0|||
105708021|NCT01425008|364590957|FG009|Dose Expansion Phase|Adverse Event|0|||
105708022|NCT01425008|364590958|FG010|Dose Expansion Phase|Adverse Event|2|||
105708023|NCT01425008|364590959|FG011|Dose Expansion Phase|Adverse Event|3|||
105708024|NCT01425008|364590960|FG012|Dose Expansion Phase|Adverse Event|3|||
105708025|NCT01425008|364590961|FG013|Dose Expansion Phase|Adverse Event|0|||
105708026|NCT01425008|364590962|FG014|Dose Expansion Phase|Adverse Event|1|||
105708027|NCT01425008|364590963|FG015|Dose Expansion Phase|Adverse Event|1|||
105708028|NCT01425008|364590964|FG016|Dose Expansion Phase|Adverse Event|5|||
105708029|NCT01425008|364590965|FG017|Dose Expansion Phase|Adverse Event|0|||
105708030|NCT01425008|364590966|FG018|Dose Expansion Phase|Adverse Event|3|||
105708031|NCT01425008|364590948|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
105708032|NCT01425008|364590949|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
105708033|NCT01425008|364590950|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
105708034|NCT01425008|364590951|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
105708035|NCT01425008|364590952|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
105708036|NCT01425008|364590953|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
105708037|NCT01425008|364590954|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
105708038|NCT01425008|364590955|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
105708039|NCT01425008|364590956|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
105708040|NCT01425008|364590957|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
105708041|NCT01425008|364590958|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
105708042|NCT01425008|364590959|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
105708043|NCT01425008|364590960|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
105708044|NCT01425008|364590961|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
105708045|NCT01425008|364590962|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
105708046|NCT01425008|364590963|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
105708047|NCT01425008|364590964|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
105708048|NCT01425008|364590965|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
105708049|NCT01425008|364590966|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
105708050|NCT01425008|364590948|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708051|NCT01425008|364590949|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708052|NCT01425008|364590950|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708053|NCT01425008|364590951|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708054|NCT01425008|364590952|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708055|NCT01425008|364590953|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708056|NCT01425008|364590954|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708057|NCT01425008|364590955|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708058|NCT01425008|364590956|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708059|NCT01425008|364590957|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708060|NCT01425008|364590958|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708061|NCT01425008|364590959|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708062|NCT01425008|364590960|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708063|NCT01425008|364590961|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105788045|NCT00437294|364878169|FG000|Overall Study|Sponsor Decision|8|||
105788046|NCT00437294|364878170|FG001|Overall Study|Sponsor Decision|9|||
105350721|NCT04847232|363288165|FG001|Overall Study|Withdrawal by Subject|101|||
105350722|NCT04847232|363288164|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
105350723|NCT04847232|363288165|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
105350724|NCT00253370|363288172|FG000|Overall Study|Adverse Event|18|||
105350725|NCT00253370|363288172|FG000|Overall Study|Disease progression|13|||
105350726|NCT00253370|363288172|FG000|Overall Study|Death|2|||
105350727|NCT00253370|363288172|FG000|Overall Study|Withdrawal by Subject|6|||
105350728|NCT00253370|363288172|FG000|Overall Study|Non-protocol therapy|1|||
105350729|NCT00253370|363288172|FG000|Overall Study|Physician Decision|1|||
105350730|NCT00253370|363288172|FG000|Overall Study|Protocol Violation|1|||
105350731|NCT00253370|363288172|FG000|Overall Study|Abdominal pain due to disease|1|||
105350732|NCT02697591|363288174|FG000|Overall Study|Lost to Follow-up|0|||
105350733|NCT02697591|363288175|FG001|Overall Study|Lost to Follow-up|0|||
105350734|NCT02697591|363288176|FG002|Overall Study|Lost to Follow-up|0|||
105350735|NCT02697591|363288177|FG003|Overall Study|Lost to Follow-up|0|||
105350736|NCT02697591|363288178|FG004|Overall Study|Lost to Follow-up|0|||
105350737|NCT02697591|363288179|FG005|Overall Study|Lost to Follow-up|1|||
105708064|NCT01425008|364590962|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708065|NCT01425008|364590963|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708066|NCT01425008|364590964|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708067|NCT01425008|364590965|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708068|NCT01425008|364590966|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
105708069|NCT00264238|364590968|FG000|Overall Study|Protocol Violation|1|||
105708070|NCT01314716|364590969|FG000|Double-Blind Phase|Randomized but not treated|1|||
105350738|NCT02697591|363288180|FG006|Overall Study|Lost to Follow-up|1|||
105350739|NCT02697591|363288181|FG007|Overall Study|Lost to Follow-up|0|||
105708071|NCT01314716|364590970|FG001|Double-Blind Phase|Randomized but not treated|1|||
105708072|NCT01314716|364590969|FG000|Double-Blind Phase|Adverse Event|10|||
105708073|NCT01314716|364590970|FG001|Double-Blind Phase|Adverse Event|4|||
105708074|NCT01314716|364590969|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
105708075|NCT01314716|364590970|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
105708076|NCT01314716|364590969|FG000|Double-Blind Phase|Lost to Follow-up|0|||
105708077|NCT01314716|364590970|FG001|Double-Blind Phase|Lost to Follow-up|1|||
105708078|NCT01314716|364590969|FG000|Double-Blind Phase|Sponsor request|1|||
105708079|NCT01314716|364590970|FG001|Double-Blind Phase|Sponsor request|2|||
105708080|NCT01314716|364590969|FG000|Double-Blind Phase|Physician Decision|0|||
105708081|NCT01314716|364590970|FG001|Double-Blind Phase|Physician Decision|1|||
105708082|NCT01314716|364590969|FG000|Open-Label Phase|Adverse Event|4|||
105708083|NCT01314716|364590970|FG001|Open-Label Phase|Adverse Event|6|||
105708084|NCT01314716|364590969|FG000|Open-Label Phase|Withdrawal by Subject|1|||
105708085|NCT01314716|364590970|FG001|Open-Label Phase|Withdrawal by Subject|2|||
105708086|NCT01314716|364590969|FG000|Open-Label Phase|Physician Decision|5|||
105708087|NCT01314716|364590970|FG001|Open-Label Phase|Physician Decision|4|||
105708088|NCT01411085|364590973|FG000|Overall Study|Physician Decision|1|||
105708089|NCT01411085|364590973|FG000|Overall Study|Protocol Violation|1|||
105708090|NCT01411085|364590973|FG000|Overall Study|Adverse Event|1|||
105708091|NCT00562588|364590974|FG000|Overall Study|Adverse Event|40|||
105708092|NCT00562588|364590975|FG001|Overall Study|Adverse Event|58|||
105708093|NCT00562588|364590974|FG000|Overall Study|Protocol Violation|30|||
105708094|NCT00562588|364590975|FG001|Overall Study|Protocol Violation|26|||
105708095|NCT00562588|364590974|FG000|Overall Study|Lost to Follow-up|12|||
105708096|NCT00562588|364590975|FG001|Overall Study|Lost to Follow-up|4|||
105708097|NCT00562588|364590974|FG000|Overall Study|Withdrawal by Subject|10|||
105708098|NCT00562588|364590975|FG001|Overall Study|Withdrawal by Subject|9|||
105708099|NCT00562588|364590974|FG000|Overall Study|Other|0|||
105708100|NCT00562588|364590975|FG001|Overall Study|Other|2|||
105708101|NCT03164616|364590976|FG000|Overall Study|Death|250|||
105708102|NCT03164616|364590977|FG001|Overall Study|Death|264|||
105708103|NCT03164616|364590978|FG002|Overall Study|Death|279|||
105708104|NCT03164616|364590976|FG000|Overall Study|Lost to Follow-up|2|||
105708105|NCT03164616|364590977|FG001|Overall Study|Lost to Follow-up|2|||
105708106|NCT03164616|364590978|FG002|Overall Study|Lost to Follow-up|2|||
105708107|NCT03164616|364590976|FG000|Overall Study|Withdrawal by Subject|6|||
105708108|NCT03164616|364590977|FG001|Overall Study|Withdrawal by Subject|7|||
105708109|NCT03164616|364590978|FG002|Overall Study|Withdrawal by Subject|16|||
105708110|NCT02193074|364590979|FG000|Overall Study|Withdrawal by Subject|1|||
105708111|NCT02193074|364590980|FG001|Overall Study|Withdrawal by Subject|2|||
105708112|NCT02193074|364590979|FG000|Overall Study|Adverse Event|16|||
105708113|NCT02193074|364590980|FG001|Overall Study|Adverse Event|13|||
105708114|NCT02926950|364590981|FG000|Overall Study|Adverse Event|4|||
105708115|NCT02926950|364590982|FG001|Overall Study|Adverse Event|6|||
105708116|NCT02926950|364590981|FG000|Overall Study|At the participant's own request|21|||
105708117|NCT02926950|364590982|FG001|Overall Study|At the participant's own request|25|||
105708118|NCT02926950|364590981|FG000|Overall Study|Reason not Specified|17|||
105708119|NCT02926950|364590982|FG001|Overall Study|Reason not Specified|9|||
105708120|NCT02926950|364590981|FG000|Overall Study|Lost to Follow-up|7|||
105708121|NCT02926950|364590982|FG001|Overall Study|Lost to Follow-up|8|||
105708122|NCT03124563|364590983|FG000|Overall Study|Lost to Follow-up|1|||
105708123|NCT03124563|364590984|FG001|Overall Study|Lost to Follow-up|1|||
105708124|NCT03124563|364590983|FG000|Overall Study|Withdrawal by Subject|1|||
105708125|NCT03124563|364590984|FG001|Overall Study|Withdrawal by Subject|1|||
105708126|NCT01823679|364592831|FG000|Overall Study|Death|1|||
105708127|NCT00477165|364592832|FG000|Overall Study|Adverse Event|7|||
105350740|NCT02697591|363288182|FG008|Overall Study|Lost to Follow-up|0|||
105708128|NCT00477165|364592833|FG001|Overall Study|Adverse Event|2|||
105708129|NCT04682405|364592835|FG000|Overall Study|Adverse Event|0|||
105708130|NCT04682405|364592836|FG001|Overall Study|Adverse Event|1|||
105708131|NCT05048719|364592839|FG000|Overall Study|Withdrawal by Subject|2|||
105708132|NCT05048719|364592840|FG001|Overall Study|Withdrawal by Subject|1|||
105708133|NCT05048719|364592841|FG002|Overall Study|Withdrawal by Subject|3|||
105708134|NCT05048719|364592842|FG003|Overall Study|Withdrawal by Subject|1|||
105708135|NCT05048719|364592843|FG004|Overall Study|Withdrawal by Subject|0|||
105708136|NCT05048719|364592844|FG005|Overall Study|Withdrawal by Subject|2|||
105708137|NCT05048719|364592845|FG006|Overall Study|Withdrawal by Subject|1|||
105708138|NCT05048719|364592846|FG007|Overall Study|Withdrawal by Subject|1|||
105708139|NCT05048719|364592847|FG008|Overall Study|Withdrawal by Subject|0|||
105708140|NCT05048719|364592839|FG000|Overall Study|Death|1|||
105708141|NCT05048719|364592840|FG001|Overall Study|Death|0|||
105708142|NCT05048719|364592841|FG002|Overall Study|Death|0|||
105708143|NCT05048719|364592842|FG003|Overall Study|Death|0|||
105708144|NCT05048719|364592843|FG004|Overall Study|Death|0|||
105708145|NCT05048719|364592844|FG005|Overall Study|Death|0|||
105708146|NCT05048719|364592845|FG006|Overall Study|Death|0|||
105708147|NCT05048719|364592846|FG007|Overall Study|Death|0|||
105708148|NCT05048719|364592847|FG008|Overall Study|Death|0|||
105708149|NCT05048719|364592839|FG000|Overall Study|Adverse Event|0|||
105708150|NCT05048719|364592840|FG001|Overall Study|Adverse Event|1|||
105708151|NCT05048719|364592841|FG002|Overall Study|Adverse Event|2|||
105708152|NCT05048719|364592842|FG003|Overall Study|Adverse Event|0|||
105708153|NCT05048719|364592843|FG004|Overall Study|Adverse Event|1|||
105708154|NCT05048719|364592844|FG005|Overall Study|Adverse Event|0|||
105708155|NCT05048719|364592845|FG006|Overall Study|Adverse Event|0|||
105708156|NCT05048719|364592846|FG007|Overall Study|Adverse Event|0|||
105708157|NCT05048719|364592847|FG008|Overall Study|Adverse Event|0|||
105708158|NCT05048719|364592839|FG000|Overall Study|Lost to Follow-up|0|||
105474710|NCT01349049|363751160|FG001|Overall Study|Non-compliance|0|||
105708159|NCT05048719|364592840|FG001|Overall Study|Lost to Follow-up|0|||
105708160|NCT05048719|364592841|FG002|Overall Study|Lost to Follow-up|1|||
105708161|NCT05048719|364592842|FG003|Overall Study|Lost to Follow-up|3|||
105708162|NCT05048719|364592843|FG004|Overall Study|Lost to Follow-up|1|||
105708163|NCT05048719|364592844|FG005|Overall Study|Lost to Follow-up|1|||
105708164|NCT05048719|364592845|FG006|Overall Study|Lost to Follow-up|1|||
105474711|NCT01349049|363751161|FG002|Overall Study|Non-compliance|0|||
105474712|NCT01349049|363751162|FG003|Overall Study|Non-compliance|1|||
105474713|NCT01349049|363751163|FG004|Overall Study|Non-compliance|0|||
105474714|NCT01349049|363751164|FG005|Overall Study|Non-compliance|0|||
105474715|NCT01349049|363751165|FG006|Overall Study|Non-compliance|0|||
105474716|NCT01349049|363751166|FG007|Overall Study|Non-compliance|0|||
105474717|NCT01349049|363751167|FG008|Overall Study|Non-compliance|0|||
105474718|NCT01349049|363751159|FG000|Overall Study|Withdrawal by Subject|0|||
105474719|NCT01349049|363751160|FG001|Overall Study|Withdrawal by Subject|0|||
105474720|NCT01349049|363751161|FG002|Overall Study|Withdrawal by Subject|0|||
105474721|NCT01349049|363751162|FG003|Overall Study|Withdrawal by Subject|0|||
105474722|NCT01349049|363751163|FG004|Overall Study|Withdrawal by Subject|0|||
105474723|NCT01349049|363751164|FG005|Overall Study|Withdrawal by Subject|0|||
105474724|NCT01349049|363751165|FG006|Overall Study|Withdrawal by Subject|0|||
105474725|NCT01349049|363751166|FG007|Overall Study|Withdrawal by Subject|0|||
105474726|NCT01349049|363751167|FG008|Overall Study|Withdrawal by Subject|6|||
105474727|NCT01643772|363751172|FG000|Overall Study|Protocol Violation|0|||
105474728|NCT01643772|363751173|FG001|Overall Study|Protocol Violation|0|||
105474729|NCT01643772|363751174|FG002|Overall Study|Protocol Violation|0|||
105474730|NCT01643772|363751175|FG003|Overall Study|Protocol Violation|1|||
105474731|NCT01643772|363751172|FG000|Overall Study|Adverse Event|0|||
105474732|NCT01643772|363751173|FG001|Overall Study|Adverse Event|0|||
105474733|NCT01643772|363751174|FG002|Overall Study|Adverse Event|0|||
105474734|NCT01643772|363751175|FG003|Overall Study|Adverse Event|1|||
105474735|NCT01945710|363751177|FG000|Overall Study|Progressive Disease|5|||
105474736|NCT01945710|363751178|FG001|Overall Study|Progressive Disease|4|||
105474737|NCT01945710|363751179|FG002|Overall Study|Progressive Disease|3|||
105474738|NCT01945710|363751180|FG003|Overall Study|Progressive Disease|2|||
105474739|NCT01945710|363751181|FG004|Overall Study|Progressive Disease|7|||
105474740|NCT01945710|363751182|FG005|Overall Study|Progressive Disease|3|||
105474741|NCT01945710|363751183|FG006|Overall Study|Progressive Disease|19|||
105474742|NCT01945710|363751177|FG000|Overall Study|Adverse Event|0|||
105474743|NCT01945710|363751178|FG001|Overall Study|Adverse Event|1|||
105474744|NCT01945710|363751179|FG002|Overall Study|Adverse Event|0|||
105474745|NCT01945710|363751180|FG003|Overall Study|Adverse Event|0|||
105474746|NCT01945710|363751181|FG004|Overall Study|Adverse Event|0|||
105474747|NCT01945710|363751182|FG005|Overall Study|Adverse Event|0|||
105474748|NCT01945710|363751183|FG006|Overall Study|Adverse Event|0|||
105474749|NCT01945710|363751177|FG000|Overall Study|Other|2|||
105474750|NCT01945710|363751178|FG001|Overall Study|Other|0|||
105474751|NCT01945710|363751179|FG002|Overall Study|Other|3|||
105474752|NCT01945710|363751180|FG003|Overall Study|Other|1|||
105474753|NCT01945710|363751181|FG004|Overall Study|Other|1|||
105474754|NCT01945710|363751182|FG005|Overall Study|Other|0|||
105474755|NCT01945710|363751183|FG006|Overall Study|Other|4|||
105474756|NCT01945710|363751177|FG000|Overall Study|Withdrawal by Subject|0|||
105474757|NCT01945710|363751178|FG001|Overall Study|Withdrawal by Subject|1|||
105474758|NCT01945710|363751179|FG002|Overall Study|Withdrawal by Subject|1|||
105474759|NCT01945710|363751180|FG003|Overall Study|Withdrawal by Subject|0|||
105474760|NCT01945710|363751181|FG004|Overall Study|Withdrawal by Subject|1|||
105474761|NCT01945710|363751182|FG005|Overall Study|Withdrawal by Subject|0|||
105474762|NCT01945710|363751183|FG006|Overall Study|Withdrawal by Subject|0|||
105474763|NCT00588861|363751184|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
105474764|NCT00588861|363751185|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
105474765|NCT00588861|363751184|FG000|6 Months|Patients did not return for follow-up|98|||
105474766|NCT00588861|363751185|FG001|6 Months|Patients did not return for follow-up|73|||
105474767|NCT00588861|363751184|FG000|1 Year|Patients did not return for follow-up|89|||
105708165|NCT05048719|364592846|FG007|Overall Study|Lost to Follow-up|1|||
105708166|NCT05048719|364592847|FG008|Overall Study|Lost to Follow-up|0|||
105708167|NCT05048719|364592839|FG000|Overall Study|Physician Decision|0|||
105708168|NCT05048719|364592840|FG001|Overall Study|Physician Decision|0|||
105708169|NCT05048719|364592841|FG002|Overall Study|Physician Decision|0|||
105474768|NCT00588861|363751185|FG001|1 Year|Patients did not return for follow-up|82|||
105474769|NCT00588861|363751184|FG000|2 Years|Patients did not return for follow-up|92|||
105474770|NCT00588861|363751185|FG001|2 Years|Patients did not return for follow-up|87|||
105474771|NCT00588861|363751184|FG000|4 Years|Patients did not return for follow-up|91|||
105474772|NCT00588861|363751185|FG001|4 Years|Patients did not return for follow-up|103|||
105474773|NCT00588861|363751184|FG000|6 Years|Patients did not return for follow-up|104|||
105474774|NCT00588861|363751185|FG001|6 Years|Patients did not return for follow-up|109|||
105474775|NCT00588861|363751184|FG000|8 Years|Patients did not return for follow-up|105|||
105708170|NCT05048719|364592842|FG003|Overall Study|Physician Decision|0|||
105474776|NCT00588861|363751185|FG001|8 Years|Patients did not return for follow-up|114|||
105474777|NCT00588861|363751184|FG000|10 Years|Incomplete due to study termination|107|||
105474778|NCT00588861|363751185|FG001|10 Years|Incomplete due to study termination|114|||
105474779|NCT02730195|363751186|FG000|Overall Study|Withdrawal by Subject|1|||
105474780|NCT01368562|363751187|FG000|Overall Study|Adverse Event|1|||
105474781|NCT01368562|363751187|FG000|Overall Study|Disease progression|1|||
105708171|NCT05048719|364592843|FG004|Overall Study|Physician Decision|0|||
105708172|NCT05048719|364592844|FG005|Overall Study|Physician Decision|0|||
105708173|NCT05048719|364592845|FG006|Overall Study|Physician Decision|0|||
105708174|NCT05048719|364592846|FG007|Overall Study|Physician Decision|1|||
105708175|NCT05048719|364592847|FG008|Overall Study|Physician Decision|1|||
105708176|NCT05048719|364592839|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
105708177|NCT05048719|364592840|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708178|NCT05048719|364592841|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708179|NCT05048719|364592842|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708180|NCT05048719|364592843|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708181|NCT05048719|364592844|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708182|NCT05048719|364592845|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708183|NCT05048719|364592846|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708184|NCT05048719|364592847|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708185|NCT05048719|364592839|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708186|NCT05048719|364592840|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
105708187|NCT05048719|364592841|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708188|NCT05048719|364592842|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708189|NCT05048719|364592843|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708190|NCT05048719|364592844|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708191|NCT05048719|364592845|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708192|NCT05048719|364592846|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708193|NCT05048719|364592847|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708194|NCT05048719|364592839|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708195|NCT05048719|364592840|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
105708196|NCT05048719|364592841|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708197|NCT05048719|364592842|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708198|NCT05048719|364592843|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708199|NCT05048719|364592844|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708200|NCT05048719|364592845|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708201|NCT05048719|364592846|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708202|NCT05048719|364592847|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708203|NCT05048719|364592839|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708204|NCT05048719|364592840|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708205|NCT05048719|364592841|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708206|NCT05048719|364592842|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
105708207|NCT05048719|364592843|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708208|NCT05048719|364592844|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708209|NCT05048719|364592845|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708210|NCT05048719|364592846|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708211|NCT05048719|364592847|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708212|NCT05048719|364592839|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708213|NCT05048719|364592840|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708214|NCT05048719|364592841|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708215|NCT05048719|364592842|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708216|NCT05048719|364592843|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708217|NCT05048719|364592844|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
105708218|NCT05048719|364592845|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708219|NCT05048719|364592846|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708220|NCT05048719|364592847|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708221|NCT01623271|364592848|FG000|Overall Study|Withdrawal by Subject|2|||
105708222|NCT00879229|364592849|FG000|Overall Study|Study terminated by Sponsor|13|||
105708223|NCT00879229|364592850|FG001|Overall Study|Study terminated by Sponsor|12|||
105708224|NCT00879229|364592849|FG000|Overall Study|Death|4|||
105350741|NCT02697591|363288183|FG009|Overall Study|Lost to Follow-up|1|||
105350742|NCT02697591|363288174|FG000|Overall Study|Withdrawal by Subject|1|||
105350743|NCT02697591|363288175|FG001|Overall Study|Withdrawal by Subject|1|||
105350744|NCT02697591|363288176|FG002|Overall Study|Withdrawal by Subject|2|||
105350745|NCT02697591|363288177|FG003|Overall Study|Withdrawal by Subject|1|||
105350746|NCT02697591|363288178|FG004|Overall Study|Withdrawal by Subject|7|||
105350747|NCT02697591|363288179|FG005|Overall Study|Withdrawal by Subject|6|||
105350748|NCT02697591|363288180|FG006|Overall Study|Withdrawal by Subject|9|||
105350749|NCT02697591|363288181|FG007|Overall Study|Withdrawal by Subject|1|||
105350750|NCT02697591|363288182|FG008|Overall Study|Withdrawal by Subject|6|||
105350751|NCT02697591|363288183|FG009|Overall Study|Withdrawal by Subject|10|||
105350752|NCT02697591|363288174|FG000|Overall Study|Physician Decision|1|||
105350753|NCT02697591|363288175|FG001|Overall Study|Physician Decision|0|||
105350754|NCT02697591|363288176|FG002|Overall Study|Physician Decision|0|||
105350755|NCT02697591|363288177|FG003|Overall Study|Physician Decision|0|||
105350756|NCT02697591|363288178|FG004|Overall Study|Physician Decision|1|||
105350757|NCT02697591|363288179|FG005|Overall Study|Physician Decision|2|||
105350758|NCT02697591|363288180|FG006|Overall Study|Physician Decision|0|||
105350759|NCT02697591|363288181|FG007|Overall Study|Physician Decision|0|||
105350760|NCT02697591|363288182|FG008|Overall Study|Physician Decision|1|||
105350761|NCT02697591|363288183|FG009|Overall Study|Physician Decision|1|||
105350762|NCT02697591|363288174|FG000|Overall Study|Death|2|||
105350763|NCT02697591|363288175|FG001|Overall Study|Death|3|||
105350764|NCT02697591|363288176|FG002|Overall Study|Death|1|||
105350765|NCT02697591|363288177|FG003|Overall Study|Death|1|||
105350766|NCT02697591|363288178|FG004|Overall Study|Death|4|||
105350767|NCT02697591|363288179|FG005|Overall Study|Death|5|||
105350768|NCT02697591|363288180|FG006|Overall Study|Death|3|||
105350769|NCT02697591|363288181|FG007|Overall Study|Death|1|||
105350770|NCT02697591|363288182|FG008|Overall Study|Death|1|||
105350771|NCT02697591|363288183|FG009|Overall Study|Death|5|||
105350772|NCT02697591|363288174|FG000|Overall Study|Reason not Specified|0|||
105350773|NCT02697591|363288175|FG001|Overall Study|Reason not Specified|0|||
105350774|NCT02697591|363288176|FG002|Overall Study|Reason not Specified|0|||
105350775|NCT02697591|363288177|FG003|Overall Study|Reason not Specified|1|||
105350776|NCT02697591|363288178|FG004|Overall Study|Reason not Specified|1|||
105350777|NCT02697591|363288179|FG005|Overall Study|Reason not Specified|2|||
105350778|NCT02697591|363288180|FG006|Overall Study|Reason not Specified|3|||
105350779|NCT02697591|363288181|FG007|Overall Study|Reason not Specified|1|||
105350780|NCT02697591|363288182|FG008|Overall Study|Reason not Specified|1|||
105350781|NCT02697591|363288183|FG009|Overall Study|Reason not Specified|3|||
105350782|NCT00004088|363288185|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
105350783|NCT00004088|363288185|FG000|Overall Study|Withdrawal by Subject|1|||
105350784|NCT00004088|363288185|FG000|Overall Study|Protocol Violation|3|||
105350785|NCT00004088|363288185|FG000|Overall Study|Physician Decision|1|||
105350786|NCT00981058|363288186|FG000|Overall Study|Progressive Disease|38|||
105350787|NCT00981058|363288187|FG001|Overall Study|Progressive Disease|31|||
105350788|NCT00981058|363288186|FG000|Overall Study|Lost to Follow-up|3|||
105350789|NCT00981058|363288187|FG001|Overall Study|Lost to Follow-up|2|||
105350790|NCT00981058|363288186|FG000|Overall Study|Physician Decision|4|||
105350791|NCT00981058|363288187|FG001|Overall Study|Physician Decision|5|||
105350792|NCT00981058|363288186|FG000|Overall Study|Randomization Error|0|||
105350793|NCT00981058|363288187|FG001|Overall Study|Randomization Error|1|||
105350794|NCT00981058|363288186|FG000|Overall Study|Withdrawal by Subject|24|||
105350795|NCT00981058|363288187|FG001|Overall Study|Withdrawal by Subject|22|||
105350796|NCT02667587|363288188|FG000|Pre-Treatment|Not reported|1|||
105350797|NCT02667587|363288189|FG001|Pre-Treatment|Not reported|0|||
105350798|NCT02667587|363288188|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
105350799|NCT02667587|363288189|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
105350800|NCT02667587|363288188|FG000|Pre-Treatment|Participant withdrew consent|0|||
105350801|NCT02667587|363288189|FG001|Pre-Treatment|Participant withdrew consent|1|||
105708225|NCT00879229|364592850|FG001|Overall Study|Death|2|||
105708226|NCT00879229|364592849|FG000|Overall Study|Adverse Event|2|||
105350802|NCT02667587|363288188|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
105350803|NCT02667587|363288189|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
105350804|NCT02667587|363288188|FG000|End of Treatment|Disease Progression|193|||
105350805|NCT02667587|363288189|FG001|End of Treatment|Disease Progression|226|||
105350806|NCT02667587|363288188|FG000|End of Treatment|Study Drug Toxicity|75|||
105350807|NCT02667587|363288189|FG001|End of Treatment|Study Drug Toxicity|19|||
105350808|NCT02667587|363288188|FG000|End of Treatment|Death|2|||
105350809|NCT02667587|363288189|FG001|End of Treatment|Death|1|||
105350810|NCT02667587|363288188|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
105350811|NCT02667587|363288189|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
105350812|NCT02667587|363288188|FG000|End of Treatment|participant request to discontinue treatment|33|||
105350813|NCT02667587|363288189|FG001|End of Treatment|participant request to discontinue treatment|35|||
105350814|NCT02667587|363288188|FG000|End of Treatment|participant withdrew consent|5|||
105350815|NCT02667587|363288189|FG001|End of Treatment|participant withdrew consent|6|||
105474782|NCT01368562|363751187|FG000|Overall Study|Lost to Follow-up|1|||
105474783|NCT01368562|363751187|FG000|Overall Study|Death|6|||
105708227|NCT00879229|364592850|FG001|Overall Study|Adverse Event|0|||
105708228|NCT00879229|364592849|FG000|Overall Study|Withdrawal by Subject|1|||
105708229|NCT00879229|364592850|FG001|Overall Study|Withdrawal by Subject|0|||
105708230|NCT00879229|364592849|FG000|Overall Study|Clinical status did not improve|1|||
105708231|NCT00879229|364592850|FG001|Overall Study|Clinical status did not improve|0|||
105708232|NCT00879229|364592849|FG000|Overall Study|Other|1|||
105350816|NCT02667587|363288188|FG000|End of Treatment|Lost to Follow-up|1|||
105350817|NCT02667587|363288189|FG001|End of Treatment|Lost to Follow-up|2|||
105350818|NCT02667587|363288188|FG000|End of Treatment|maximum clinical benefit|4|||
105350819|NCT02667587|363288189|FG001|End of Treatment|maximum clinical benefit|4|||
105350820|NCT02667587|363288188|FG000|End of Treatment|poor or non compliant|0|||
105350821|NCT02667587|363288189|FG001|End of Treatment|poor or non compliant|1|||
105350822|NCT02667587|363288188|FG000|End of Treatment|participant no longer meets study criteria|1|||
105350823|NCT02667587|363288189|FG001|End of Treatment|participant no longer meets study criteria|1|||
105350824|NCT02667587|363288188|FG000|End of Treatment|administrative reason by sponsor|1|||
105350825|NCT02667587|363288189|FG001|End of Treatment|administrative reason by sponsor|29|||
105350826|NCT02667587|363288188|FG000|End of Treatment|other reasonse|21|||
105350827|NCT02667587|363288189|FG001|End of Treatment|other reasonse|10|||
105350828|NCT05053035|363288190|FG000|Overall Study|Withdrawal by Subject|1|||
105350829|NCT05053035|363288191|FG001|Overall Study|Withdrawal by Subject|0|||
105350830|NCT05182606|363288196|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
105350831|NCT00586508|363288197|FG000|Overall Study|Progressive disease|52|||
105350832|NCT00586508|363288198|FG001|Overall Study|Progressive disease|8|||
105350833|NCT00586508|363288197|FG000|Overall Study|Death|0|||
105350834|NCT00586508|363288198|FG001|Overall Study|Death|1|||
105350835|NCT00586508|363288197|FG000|Overall Study|Adverse Event|12|||
105350836|NCT00586508|363288198|FG001|Overall Study|Adverse Event|4|||
105350837|NCT00586508|363288197|FG000|Overall Study|Withdrawal by Subject|4|||
105350838|NCT00586508|363288198|FG001|Overall Study|Withdrawal by Subject|0|||
105350839|NCT02028169|363288205|FG000|Overall Study|Lost to Follow-up|21|||
105350840|NCT02028169|363288205|FG000|Overall Study|Lack of Efficacy|2|||
105350841|NCT02028169|363288205|FG000|Overall Study|Withdrawal by Subject|2|||
105350842|NCT02028169|363288205|FG000|Overall Study|Adverse Event|1|||
105350843|NCT02028169|363288205|FG000|Overall Study|Cessation of Drug|1|||
105350844|NCT02028169|363288205|FG000|Overall Study|Concomitant Medication Usage|1|||
105350845|NCT04266795|363288206|FG000|Overall Study|Adverse Event|10|||
105350846|NCT04266795|363288207|FG001|Overall Study|Adverse Event|19|||
105350847|NCT04266795|363288206|FG000|Overall Study|Death|7|||
105350848|NCT04266795|363288207|FG001|Overall Study|Death|8|||
105350849|NCT04266795|363288206|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
105350850|NCT04266795|363288207|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
105350851|NCT04266795|363288206|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
105350852|NCT04266795|363288207|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105350853|NCT04266795|363288206|FG000|Overall Study|Progressive Disease|12|||
105350854|NCT04266795|363288207|FG001|Overall Study|Progressive Disease|9|||
105350855|NCT04266795|363288206|FG000|Overall Study|Withdrawal by Patient|5|||
105350856|NCT04266795|363288207|FG001|Overall Study|Withdrawal by Patient|6|||
105350857|NCT04266795|363288206|FG000|Overall Study|Disease Relapse|3|||
105350858|NCT04266795|363288207|FG001|Overall Study|Disease Relapse|6|||
105350859|NCT04266795|363288206|FG000|Overall Study|Reason not Specified|12|||
105350860|NCT04266795|363288207|FG001|Overall Study|Reason not Specified|10|||
105350861|NCT04266795|363288206|FG000|Overall Study|Participants Ongoing on Treatment|25|||
105350862|NCT04266795|363288207|FG001|Overall Study|Participants Ongoing on Treatment|23|||
105474784|NCT01368562|363751187|FG000|Overall Study|Unresponsive to treatment|5|||
105474785|NCT01368562|363751187|FG000|Overall Study|Other|3|||
105474786|NCT01368562|363751187|FG000|Overall Study|Other than specified|2|||
105474787|NCT03860818|363751188|FG000|Overall Study|Death|144|||
105474788|NCT03860818|363751189|FG001|Overall Study|Death|195|||
105474789|NCT03860818|363751188|FG000|Overall Study|Graft Loss|32|||
105474790|NCT03860818|363751189|FG001|Overall Study|Graft Loss|45|||
105708233|NCT00879229|364592850|FG001|Overall Study|Other|0|||
105708234|NCT00522431|364592851|FG000|Overall Study|Adverse Event|5|||
105350863|NCT00793546|363288208|FG000|Overall Study|Death|3|||
105350864|NCT00793546|363288209|FG001|Overall Study|Death|0|||
105350865|NCT00793546|363288208|FG000|Overall Study|Lost to Follow-up|1|||
105350866|NCT00793546|363288209|FG001|Overall Study|Lost to Follow-up|0|||
105350867|NCT00793546|363288208|FG000|Overall Study|Withdrawal by Subject|1|||
105350868|NCT00793546|363288209|FG001|Overall Study|Withdrawal by Subject|1|||
105350869|NCT00793546|363288208|FG000|Overall Study|Study Terminated by Sponsor|8|||
105350870|NCT00793546|363288209|FG001|Overall Study|Study Terminated by Sponsor|27|||
105474791|NCT03126344|363751190|FG000|Overall Study|Lost to Follow-up|0|||
105708235|NCT00522431|364592851|FG000|Overall Study|Protocol Violation|2|||
105708236|NCT00522431|364592851|FG000|Overall Study|Withdrawal by Subject|2|||
105350871|NCT00793546|363288208|FG000|Overall Study|Other|1|||
105474792|NCT03126344|363751191|FG001|Overall Study|Lost to Follow-up|0|||
105708237|NCT00522431|364592851|FG000|Overall Study|Subject non-compliance|1|||
105708238|NCT00522431|364592851|FG000|Overall Study|Other/unknown|1|||
105708239|NCT01339559|364592852|FG000|Overall Study|Adverse Event|92|||
105708240|NCT01339559|364592852|FG000|Overall Study|Death|5|||
105708241|NCT01339559|364592852|FG000|Overall Study|Lack of Efficacy|164|||
105708242|NCT01339559|364592852|FG000|Overall Study|Lost to Follow-up|22|||
105708243|NCT01339559|364592852|FG000|Overall Study|Subject choice|89|||
105708244|NCT01339559|364592852|FG000|Overall Study|Protocol Violation|15|||
105708245|NCT01339559|364592852|FG000|Overall Study|Study closure at site|1|||
105708246|NCT01339559|364592852|FG000|Overall Study|Incarcerated|2|||
105708247|NCT01339559|364592852|FG000|Overall Study|Epilepsy surgery|1|||
105708248|NCT01339559|364592852|FG000|Overall Study|Pregnancy planned|2|||
105708249|NCT01339559|364592852|FG000|Overall Study|Left the country|1|||
105708250|NCT01339559|364592852|FG000|Overall Study|Investigator decision|2|||
105708251|NCT01339559|364592852|FG000|Overall Study|Patient didn't wish to continue|1|||
105708252|NCT01339559|364592852|FG000|Overall Study|PI decision|1|||
105708253|NCT03548051|364592854|FG000|Overall Study|Death|1|||
105708254|NCT03548051|364592855|FG001|Overall Study|Death|1|||
105708255|NCT03548051|364592854|FG000|Overall Study|Withdrawal by Subject|1|||
105708256|NCT03548051|364592855|FG001|Overall Study|Withdrawal by Subject|0|||
105708257|NCT00049673|364592856|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
105708258|NCT00049673|364592857|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
105708259|NCT04623242|364592861|FG000|Overall Study|Withdrawal by Subject|7|||
105708260|NCT04623242|364592862|FG001|Overall Study|Withdrawal by Subject|12|||
105474793|NCT03126344|363751192|FG002|Overall Study|Lost to Follow-up|5|||
105474794|NCT02810444|363751193|FG000|Overall Study|Screen Failures|14|||
105474795|NCT02810444|363751193|FG000|Overall Study|Withdrawal by Subject|4|||
105474796|NCT02810444|363751193|FG000|Overall Study|Adverse Event|3|||
105474797|NCT01139008|363751194|FG000|Overall Study|Withdrawal by Subject|5|||
105474798|NCT01139008|363751194|FG000|Overall Study|Non-compliant, lost product|1|||
105474799|NCT02785770|363751197|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
105350872|NCT00793546|363288209|FG001|Overall Study|Other|0|||
105474800|NCT02785770|363751198|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
105708261|NCT04623242|364592863|FG002|Overall Study|Withdrawal by Subject|5|||
105708262|NCT04623242|364592864|FG003|Overall Study|Withdrawal by Subject|7|||
105708263|NCT04623242|364592865|FG004|Overall Study|Withdrawal by Subject|0|||
105708264|NCT04623242|364592861|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
105708265|NCT04623242|364592862|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
105760703|NCT05567393|364776148|FG017|Overall Study|Voluntary Withdrawal|0|||
105760704|NCT04199793|364776151|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
105760705|NCT04199793|364776152|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
105760706|NCT04199793|364776151|FG000|Overall Study|Withdrawal by Subject|1|||
105760707|NCT04199793|364776152|FG001|Overall Study|Withdrawal by Subject|1|||
105760708|NCT01406652|364776157|FG000|Overall Study|Lost-to-follow-up|3|||
105760709|NCT01406652|364776158|FG001|Overall Study|Lost-to-follow-up|4|||
105760710|NCT01406652|364776157|FG000|Overall Study|Withdrawal by Subject|2|||
105760711|NCT01406652|364776158|FG001|Overall Study|Withdrawal by Subject|2|||
105760712|NCT01406652|364776157|FG000|Overall Study|Insufficient follow-up|5|||
105760713|NCT01406652|364776158|FG001|Overall Study|Insufficient follow-up|4|||
105760714|NCT01406652|364776157|FG000|Overall Study|Infection not sure|10|||
105760715|NCT01406652|364776158|FG001|Overall Study|Infection not sure|10|||
105760716|NCT00141037|364776159|FG000|Overall Study|Physician Decision|1|||
105760717|NCT00141037|364776160|FG001|Overall Study|Physician Decision|2|||
105760718|NCT00141037|364776159|FG000|Overall Study|Lost to Follow-up|3|||
105760719|NCT00141037|364776160|FG001|Overall Study|Lost to Follow-up|1|||
105760720|NCT00141037|364776159|FG000|Overall Study|Protocol Violation|0|||
105760721|NCT00141037|364776160|FG001|Overall Study|Protocol Violation|2|||
105760722|NCT00141037|364776159|FG000|Overall Study|Withdrawal by Subject|2|||
105760723|NCT00141037|364776160|FG001|Overall Study|Withdrawal by Subject|1|||
105760724|NCT00141037|364776159|FG000|Overall Study|Other|0|||
105760725|NCT00141037|364776160|FG001|Overall Study|Other|1|||
105760726|NCT00141037|364776159|FG000|Overall Study|Moved from area|1|||
105760727|NCT00141037|364776160|FG001|Overall Study|Moved from area|7|||
105760728|NCT00141037|364776159|FG000|Overall Study|Graft Failure|3|||
105760729|NCT00141037|364776160|FG001|Overall Study|Graft Failure|4|||
105760730|NCT03310580|364776163|FG000|Overall Study|Adverse Event|0|||
105760731|NCT03310580|364776164|FG001|Overall Study|Adverse Event|1|||
105760732|NCT03310580|364776165|FG002|Overall Study|Adverse Event|0|||
105760733|NCT00795509|364776171|FG000|Overall Study|Protocol Violation|31|||
105760734|NCT01079195|364776172|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
105760735|NCT01079195|364776172|FG000|Overall Study|No Documentation Available|437|||
105760736|NCT01079195|364776172|FG000|Overall Study|Adverse Event|157|||
105760737|NCT01079195|364776172|FG000|Overall Study|Reason Unknown|39|||
105760738|NCT01079195|364776172|FG000|Overall Study|Withdrawal by Subject|18|||
105760739|NCT01079195|364776172|FG000|Overall Study|Financial Reasons|15|||
105788047|NCT00437294|364878169|FG000|Overall Study|Protocol Violation|0|||
105788048|NCT00437294|364878170|FG001|Overall Study|Protocol Violation|1|||
105788049|NCT00437294|364878169|FG000|Overall Study|Entry criteria not met|1|||
105474801|NCT02785770|363751199|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
105708266|NCT04623242|364592863|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
105708267|NCT04623242|364592864|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
105708268|NCT04623242|364592865|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
105708269|NCT04623242|364592861|FG000|Overall Study|Subject unblinded to mutation status|0|||
105708270|NCT04623242|364592862|FG001|Overall Study|Subject unblinded to mutation status|0|||
105708271|NCT04623242|364592863|FG002|Overall Study|Subject unblinded to mutation status|0|||
105708272|NCT04623242|364592864|FG003|Overall Study|Subject unblinded to mutation status|13|||
105708273|NCT04623242|364592865|FG004|Overall Study|Subject unblinded to mutation status|0|||
105708274|NCT00452699|364592866|FG000|Overall Study|Adverse Event|10|||
105708275|NCT00452699|364592867|FG001|Overall Study|Adverse Event|3|||
105708276|NCT00452699|364592866|FG000|Overall Study|Lack of Efficacy|6|||
105708277|NCT00452699|364592867|FG001|Overall Study|Lack of Efficacy|4|||
105708278|NCT00452699|364592866|FG000|Overall Study|Lost to Follow-up|6|||
105708279|NCT00452699|364592867|FG001|Overall Study|Lost to Follow-up|9|||
105708280|NCT00452699|364592866|FG000|Overall Study|Protocol Violation|21|||
105708281|NCT00452699|364592867|FG001|Overall Study|Protocol Violation|25|||
105708282|NCT00452699|364592866|FG000|Overall Study|Withdrawal by Subject|26|||
105708283|NCT00452699|364592867|FG001|Overall Study|Withdrawal by Subject|25|||
105708284|NCT00452699|364592866|FG000|Overall Study|Other|12|||
105708285|NCT00452699|364592867|FG001|Overall Study|Other|7|||
105708286|NCT00493870|364592868|FG000|Overall Study|Lost to Follow-up|12|||
105708287|NCT00493870|364592869|FG001|Overall Study|Lost to Follow-up|15|||
105708288|NCT03733392|364592870|FG000|Overall Study|Withdrawal by Subject|11|||
105708289|NCT03733392|364592871|FG001|Overall Study|Withdrawal by Subject|1|||
105708290|NCT03733392|364592870|FG000|Overall Study|Death|1|||
105708291|NCT03733392|364592871|FG001|Overall Study|Death|0|||
105708292|NCT03733392|364592870|FG000|Overall Study|Lost to Follow-up|5|||
105708293|NCT03733392|364592871|FG001|Overall Study|Lost to Follow-up|0|||
105708294|NCT03733392|364592870|FG000|Overall Study|Protocol Violation|0|||
105708295|NCT03733392|364592871|FG001|Overall Study|Protocol Violation|1|||
105708296|NCT03733392|364592870|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
105708297|NCT03733392|364592871|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
105708298|NCT03733392|364592870|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
105708299|NCT03733392|364592871|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
105708300|NCT03733392|364592870|FG000|Overall Study|Patient Non-Compliance|2|||
105708301|NCT03733392|364592871|FG001|Overall Study|Patient Non-Compliance|1|||
105708302|NCT03733392|364592870|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
105708303|NCT03733392|364592871|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
105708304|NCT03733392|364592870|FG000|Overall Study|Withdrawal prior to procedure|5|||
105708305|NCT03733392|364592871|FG001|Overall Study|Withdrawal prior to procedure|2|||
105708306|NCT00356278|364592872|FG000|Overall Study|Withdrawal by Subject|25|||
105708307|NCT00356278|364592873|FG001|Overall Study|Withdrawal by Subject|15|||
105708308|NCT00356278|364592874|FG002|Overall Study|Withdrawal by Subject|19|||
105708309|NCT05594173|364592877|FG000|Overall Study|Adverse Event|1|||
105708310|NCT05594173|364592877|FG000|Overall Study|COVID-19 Pandemic|2|||
105708311|NCT00647556|364592878|FG000|Overall Study|Adverse Event|0|||
105708312|NCT00647556|364592879|FG001|Overall Study|Adverse Event|1|||
105708313|NCT00647556|364592878|FG000|Overall Study|Lost to Follow-up|1|||
105708314|NCT00647556|364592879|FG001|Overall Study|Lost to Follow-up|0|||
105708315|NCT00647556|364592878|FG000|Overall Study|Protocol Violation|0|||
105708316|NCT00647556|364592879|FG001|Overall Study|Protocol Violation|1|||
105708317|NCT00647556|364592878|FG000|Overall Study|Withdrawal by Subject|1|||
105708318|NCT00647556|364592879|FG001|Overall Study|Withdrawal by Subject|0|||
105708319|NCT00647556|364592878|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
105708320|NCT00647556|364592879|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
105708321|NCT00883337|364592880|FG000|Core Treatment Period|Adverse Event|9|||
105708322|NCT00883337|364592881|FG001|Core Treatment Period|Adverse Event|12|||
105708323|NCT00883337|364592882|FG002|Core Treatment Period|Adverse Event|22|||
105708324|NCT00883337|364592880|FG000|Core Treatment Period|Lack of Efficacy|7|||
105708325|NCT00883337|364592881|FG001|Core Treatment Period|Lack of Efficacy|4|||
105708326|NCT00883337|364592882|FG002|Core Treatment Period|Lack of Efficacy|2|||
105708327|NCT00883337|364592880|FG000|Core Treatment Period|Lost to Follow-up|1|||
105708328|NCT00883337|364592881|FG001|Core Treatment Period|Lost to Follow-up|1|||
105708329|NCT00883337|364592882|FG002|Core Treatment Period|Lost to Follow-up|0|||
105708330|NCT00883337|364592880|FG000|Core Treatment Period|Withdrawal by Subject|2|||
105708331|NCT00883337|364592881|FG001|Core Treatment Period|Withdrawal by Subject|2|||
105708332|NCT00883337|364592882|FG002|Core Treatment Period|Withdrawal by Subject|6|||
105708333|NCT00883337|364592880|FG000|Core Treatment Period|Wish to be pregnant|1|||
105708334|NCT00883337|364592881|FG001|Core Treatment Period|Wish to be pregnant|2|||
105350873|NCT02071082|363288214|FG000|Overall Study|Enrolled and Never Treated|1|||
105350874|NCT02071082|363288215|FG001|Overall Study|Enrolled and Never Treated|1|||
105350875|NCT02071082|363288214|FG000|Overall Study|Adverse Event|0|||
105350876|NCT02071082|363288215|FG001|Overall Study|Adverse Event|1|||
105350877|NCT02071082|363288214|FG000|Overall Study|Withdrew Consent|0|||
105350878|NCT02071082|363288215|FG001|Overall Study|Withdrew Consent|4|||
105350879|NCT02071082|363288214|FG000|Overall Study|Lost to Follow-up|1|||
105350880|NCT02071082|363288215|FG001|Overall Study|Lost to Follow-up|1|||
105350881|NCT02101359|363288216|FG000|Overall Study|Not included|23|||
105350882|NCT02101359|363288217|FG001|Overall Study|Not included|13|||
105350883|NCT02101359|363288216|FG000|Overall Study|Withdrawal by Subject|5|||
105350884|NCT02101359|363288217|FG001|Overall Study|Withdrawal by Subject|4|||
105350885|NCT02101359|363288216|FG000|Overall Study|Lost to Follow-up|1|||
105350886|NCT02101359|363288217|FG001|Overall Study|Lost to Follow-up|0|||
105350887|NCT02101359|363288216|FG000|Overall Study|Protocol Violation|0|||
105350888|NCT02101359|363288217|FG001|Overall Study|Protocol Violation|2|||
105350889|NCT00630747|363288221|FG000|Overall Study|Death|1|||
105350890|NCT00630747|363288221|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
105350891|NCT00630747|363288221|FG000|Overall Study|Returned to country of origin|1|||
105350892|NCT02732327|363288224|FG000|Overall Study|Protocol Violation|0|||
105350893|NCT02732327|363288225|FG001|Overall Study|Protocol Violation|1|||
105350894|NCT00603382|363288226|FG000|Overall Study|Adverse Event|0|||
105350895|NCT00603382|363288227|FG001|Overall Study|Adverse Event|1|||
105350896|NCT00603382|363288228|FG002|Overall Study|Adverse Event|1|||
105350897|NCT00603382|363288229|FG003|Overall Study|Adverse Event|2|||
105350898|NCT00603382|363288230|FG004|Overall Study|Adverse Event|1|||
105350899|NCT00603382|363288231|FG005|Overall Study|Adverse Event|2|||
105350900|NCT00603382|363288226|FG000|Overall Study|Lack of Efficacy|14|||
105350901|NCT00603382|363288227|FG001|Overall Study|Lack of Efficacy|9|||
105350902|NCT00603382|363288228|FG002|Overall Study|Lack of Efficacy|3|||
105708335|NCT00883337|364592882|FG002|Core Treatment Period|Wish to be pregnant|1|||
105708336|NCT00883337|364592880|FG000|Core Treatment Period|Poor compliance to protocol|0|||
105708337|NCT00883337|364592881|FG001|Core Treatment Period|Poor compliance to protocol|0|||
105708338|NCT00883337|364592882|FG002|Core Treatment Period|Poor compliance to protocol|1|||
105708339|NCT00883337|364592880|FG000|Core Treatment Period|Other than above|0|||
105708340|NCT00883337|364592881|FG001|Core Treatment Period|Other than above|1|||
105708341|NCT00883337|364592882|FG002|Core Treatment Period|Other than above|1|||
105708342|NCT00883337|364592880|FG000|Extension Treatment Period|Adverse Event|8|||
105708343|NCT00883337|364592881|FG001|Extension Treatment Period|Adverse Event|5|||
105708344|NCT00883337|364592882|FG002|Extension Treatment Period|Adverse Event|5|||
105708345|NCT00883337|364592880|FG000|Extension Treatment Period|Lack of Efficacy|8|||
105708346|NCT00883337|364592881|FG001|Extension Treatment Period|Lack of Efficacy|8|||
105708347|NCT00883337|364592882|FG002|Extension Treatment Period|Lack of Efficacy|8|||
105708348|NCT00883337|364592880|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
105708349|NCT00883337|364592881|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
105708350|NCT00883337|364592882|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
105708351|NCT00883337|364592880|FG000|Extension Treatment Period|Lost to Follow-up|1|||
105708352|NCT00883337|364592881|FG001|Extension Treatment Period|Lost to Follow-up|0|||
105708353|NCT00883337|364592882|FG002|Extension Treatment Period|Lost to Follow-up|0|||
105708354|NCT00883337|364592880|FG000|Extension Treatment Period|Other than above|10|||
105708355|NCT00883337|364592881|FG001|Extension Treatment Period|Other than above|9|||
105708356|NCT00883337|364592882|FG002|Extension Treatment Period|Other than above|5|||
105708357|NCT00687362|364592884|FG000|Overall Study|Protocol Violation|2|||
105708358|NCT00687362|364592884|FG000|Overall Study|Withdrawal by Subject|1|||
105708359|NCT00925015|364592888|FG000|Overall Study|Adverse Event|1|||
105708360|NCT00925015|364592889|FG001|Overall Study|Adverse Event|2|||
105708361|NCT00925015|364592890|FG002|Overall Study|Adverse Event|1|||
105708362|NCT00925015|364592888|FG000|Overall Study|Physician Decision|0|||
105708363|NCT00925015|364592889|FG001|Overall Study|Physician Decision|1|||
105708364|NCT00925015|364592890|FG002|Overall Study|Physician Decision|0|||
105708365|NCT00925015|364592888|FG000|Overall Study|Progressive Disease|7|||
105708366|NCT00925015|364592889|FG001|Overall Study|Progressive Disease|3|||
105350903|NCT00603382|363288229|FG003|Overall Study|Lack of Efficacy|6|||
105350904|NCT00603382|363288230|FG004|Overall Study|Lack of Efficacy|6|||
105474802|NCT02785770|363751200|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
105708367|NCT00925015|364592890|FG002|Overall Study|Progressive Disease|4|||
105708368|NCT00925015|364592888|FG000|Overall Study|Withdrawal by Subject|0|||
105350905|NCT00603382|363288231|FG005|Overall Study|Lack of Efficacy|11|||
105350906|NCT00603382|363288226|FG000|Overall Study|Protocol Violation|1|||
105350907|NCT00603382|363288227|FG001|Overall Study|Protocol Violation|0|||
105350908|NCT00603382|363288228|FG002|Overall Study|Protocol Violation|1|||
105708369|NCT00925015|364592889|FG001|Overall Study|Withdrawal by Subject|0|||
105708370|NCT00925015|364592890|FG002|Overall Study|Withdrawal by Subject|1|||
105708371|NCT00179309|364592891|FG000|Treatment|Toxicity|2|||
105708372|NCT00179309|364592892|FG001|Treatment|Toxicity|3|||
105350909|NCT00603382|363288229|FG003|Overall Study|Protocol Violation|2|||
105350910|NCT00603382|363288230|FG004|Overall Study|Protocol Violation|1|||
105350911|NCT00603382|363288231|FG005|Overall Study|Protocol Violation|0|||
105350912|NCT00603382|363288226|FG000|Overall Study|Lost to Follow-up|0|||
105350913|NCT00603382|363288227|FG001|Overall Study|Lost to Follow-up|1|||
105350914|NCT00603382|363288228|FG002|Overall Study|Lost to Follow-up|1|||
105350915|NCT00603382|363288229|FG003|Overall Study|Lost to Follow-up|1|||
105350916|NCT00603382|363288230|FG004|Overall Study|Lost to Follow-up|0|||
105350917|NCT00603382|363288231|FG005|Overall Study|Lost to Follow-up|1|||
105350918|NCT00603382|363288226|FG000|Overall Study|Physician Decision|0|||
105350919|NCT00603382|363288227|FG001|Overall Study|Physician Decision|0|||
105350920|NCT00603382|363288228|FG002|Overall Study|Physician Decision|2|||
105350921|NCT00603382|363288229|FG003|Overall Study|Physician Decision|0|||
105350922|NCT00603382|363288230|FG004|Overall Study|Physician Decision|1|||
105350923|NCT00603382|363288231|FG005|Overall Study|Physician Decision|3|||
105350924|NCT00603382|363288226|FG000|Overall Study|Withdrawal by Subject|3|||
105350925|NCT00603382|363288227|FG001|Overall Study|Withdrawal by Subject|3|||
105350926|NCT00603382|363288228|FG002|Overall Study|Withdrawal by Subject|1|||
105350927|NCT00603382|363288229|FG003|Overall Study|Withdrawal by Subject|1|||
105350928|NCT00603382|363288230|FG004|Overall Study|Withdrawal by Subject|0|||
105350929|NCT00603382|363288231|FG005|Overall Study|Withdrawal by Subject|1|||
105350930|NCT01783821|363288233|FG000|Overall Study|Screen Failure|1|||
105350931|NCT01783821|363288234|FG001|Overall Study|Screen Failure|1|||
105350932|NCT01907217|363288235|FG000|Overall Study|Withdrawal by Subject|0|||
105350933|NCT01907217|363288236|FG001|Overall Study|Withdrawal by Subject|2|||
105350934|NCT00659776|363288240|FG000|Overall Study|Withdrawal by Subject|12|||
105350935|NCT00659776|363288241|FG001|Overall Study|Withdrawal by Subject|2|||
105350936|NCT00659776|363288242|FG002|Overall Study|Withdrawal by Subject|0|||
105708373|NCT00179309|364592891|FG000|Treatment|Withdrawal by Subject|1|||
105708374|NCT00179309|364592892|FG001|Treatment|Withdrawal by Subject|2|||
105708375|NCT00179309|364592891|FG000|Treatment|Allergy|1|||
105708376|NCT00179309|364592892|FG001|Treatment|Allergy|0|||
105708377|NCT00623480|364592893|FG000|Overall Study|Lost to Follow-up|0|||
105708378|NCT00623480|364592894|FG001|Overall Study|Lost to Follow-up|1|||
105708379|NCT00623480|364592893|FG000|Overall Study|Withdrawal by Subject|2|||
105708380|NCT00623480|364592894|FG001|Overall Study|Withdrawal by Subject|4|||
105708381|NCT00623480|364592893|FG000|Overall Study|Lack of Efficacy|1|||
105708382|NCT00623480|364592894|FG001|Overall Study|Lack of Efficacy|0|||
105708383|NCT00623480|364592893|FG000|Overall Study|Non-compliant with study medication|4|||
105708384|NCT00623480|364592894|FG001|Overall Study|Non-compliant with study medication|0|||
105708385|NCT00623480|364592893|FG000|Overall Study|Protocol Violation|0|||
105708386|NCT00623480|364592894|FG001|Overall Study|Protocol Violation|1|||
105708387|NCT00623480|364592893|FG000|Overall Study|Site closed by sponsor|0|||
105708388|NCT00623480|364592894|FG001|Overall Study|Site closed by sponsor|1|||
105708389|NCT00781456|364592895|FG000|Overall Study|Adverse Event|3|||
105708390|NCT00781456|364592896|FG001|Overall Study|Adverse Event|3|||
105708391|NCT00781456|364592895|FG000|Overall Study|Withdrawal by Subject|3|||
105708392|NCT00781456|364592896|FG001|Overall Study|Withdrawal by Subject|5|||
105708393|NCT00781456|364592895|FG000|Overall Study|Protocol Violation|4|||
105708394|NCT00781456|364592896|FG001|Overall Study|Protocol Violation|1|||
105708395|NCT00781456|364592895|FG000|Overall Study|Noncompliance With Protocol|1|||
105708396|NCT00781456|364592896|FG001|Overall Study|Noncompliance With Protocol|1|||
105708397|NCT00781456|364592895|FG000|Overall Study|Lost to Follow-up|10|||
105708398|NCT00781456|364592896|FG001|Overall Study|Lost to Follow-up|5|||
105708399|NCT00781456|364592895|FG000|Overall Study|Other Reason, Unknown|0|||
105708400|NCT00781456|364592896|FG001|Overall Study|Other Reason, Unknown|1|||
105708401|NCT04677712|364592897|FG000|Overall Study|Lost to Follow-up|0|||
105708402|NCT04677712|364592898|FG001|Overall Study|Lost to Follow-up|1|||
105350937|NCT01249833|363288243|FG000|Overall Study|Lost to Follow-up|0|||
105350938|NCT01249833|363288244|FG001|Overall Study|Lost to Follow-up|1|||
105350939|NCT00350779|363288245|FG000|Overall Study|Adverse Event|4|||
105350940|NCT00350779|363288246|FG001|Overall Study|Adverse Event|2|||
105350941|NCT00350779|363288245|FG000|Overall Study|Lack of Efficacy|0|||
105708403|NCT04677712|364592899|FG002|Overall Study|Lost to Follow-up|0|||
105708404|NCT04677712|364592900|FG003|Overall Study|Lost to Follow-up|0|||
105708405|NCT04677712|364592901|FG004|Overall Study|Lost to Follow-up|0|||
105350942|NCT00350779|363288246|FG001|Overall Study|Lack of Efficacy|4|||
105350943|NCT00350779|363288245|FG000|Overall Study|Lost to Follow-up|2|||
105708406|NCT04677712|364592902|FG005|Overall Study|Lost to Follow-up|0|||
105708407|NCT01289015|364592903|FG000|Overall Study|Protocol Violation|12|||
105708408|NCT01289015|364592904|FG001|Overall Study|Protocol Violation|9|||
105708409|NCT01289015|364592903|FG000|Overall Study|Adverse Event|3|||
105708410|NCT01289015|364592904|FG001|Overall Study|Adverse Event|0|||
105708411|NCT01289015|364592903|FG000|Overall Study|Lost to Follow-up|33|||
105708412|NCT01289015|364592904|FG001|Overall Study|Lost to Follow-up|17|||
105708413|NCT01289015|364592903|FG000|Overall Study|Withdrawal by Subject|17|||
105708414|NCT01289015|364592904|FG001|Overall Study|Withdrawal by Subject|8|||
105708415|NCT01289015|364592903|FG000|Overall Study|Disease progression|1|||
105708416|NCT01289015|364592904|FG001|Overall Study|Disease progression|0|||
105708417|NCT01289015|364592903|FG000|Overall Study|Negative baseline culture and others|33|||
105708418|NCT01289015|364592904|FG001|Overall Study|Negative baseline culture and others|20|||
105708419|NCT02412787|364592905|FG000|Overall Study|Withdrawal by Subject|9|||
105708420|NCT02412787|364592905|FG000|Overall Study|Participation Terminated by Investigator|1|||
105708421|NCT02412787|364592905|FG000|Overall Study|Site Terminated by Sponsor|21|||
105708422|NCT02412787|364592905|FG000|Overall Study|Technical Problems|1|||
105708423|NCT02412787|364592905|FG000|Overall Study|Reason Not Specified|1|||
105708424|NCT00915681|364592906|FG000|Overall Study|Screening failures|46|||
105708425|NCT01970995|364592907|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
105708426|NCT01970995|364592908|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
105708427|NCT01970995|364592909|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
105708428|NCT01970995|364592907|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
105708429|NCT01970995|364592908|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
105708430|NCT01970995|364592909|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
105708431|NCT00845728|364592915|FG000|Overall Study|Abnormal laboratory value (s)|2|||
105708432|NCT00845728|364592916|FG001|Overall Study|Abnormal laboratory value (s)|2|||
105708433|NCT00845728|364592915|FG000|Overall Study|Patient's inability to use the device|4|||
105708434|NCT00845728|364592916|FG001|Overall Study|Patient's inability to use the device|6|||
105708435|NCT00845728|364592915|FG000|Overall Study|Abnormal test procedure result (s)|7|||
105708436|NCT00845728|364592916|FG001|Overall Study|Abnormal test procedure result (s)|2|||
105708437|NCT00845728|364592915|FG000|Overall Study|Lost to Follow-up|22|||
105708438|NCT00845728|364592916|FG001|Overall Study|Lost to Follow-up|13|||
105708439|NCT00845728|364592915|FG000|Overall Study|Death|24|||
105708440|NCT00845728|364592916|FG001|Overall Study|Death|26|||
105708441|NCT00845728|364592915|FG000|Overall Study|Administrative Problems|34|||
105708442|NCT00845728|364592916|FG001|Overall Study|Administrative Problems|26|||
105708443|NCT00845728|364592915|FG000|Overall Study|Protocol Violation|36|||
105708444|NCT00845728|364592916|FG001|Overall Study|Protocol Violation|24|||
105708445|NCT00845728|364592915|FG000|Overall Study|Lack of Efficacy|51|||
105708446|NCT00845728|364592916|FG001|Overall Study|Lack of Efficacy|39|||
105708447|NCT00845728|364592915|FG000|Overall Study|Adverse Event|101|||
105708448|NCT00845728|364592916|FG001|Overall Study|Adverse Event|96|||
105708449|NCT00845728|364592915|FG000|Overall Study|Withdrawal by Subject|105|||
105708450|NCT00845728|364592916|FG001|Overall Study|Withdrawal by Subject|108|||
105708451|NCT01780831|364592917|FG000|Overall Study|Withdrawal by Subject|0|||
105708452|NCT01780831|364592918|FG001|Overall Study|Withdrawal by Subject|0|||
105708453|NCT01780831|364592919|FG002|Overall Study|Withdrawal by Subject|4|||
105708454|NCT01780831|364592920|FG003|Overall Study|Withdrawal by Subject|0|||
105708455|NCT01780831|364592917|FG000|Overall Study|Lost to Follow-up|0|||
105708456|NCT01780831|364592918|FG001|Overall Study|Lost to Follow-up|0|||
105708457|NCT01780831|364592919|FG002|Overall Study|Lost to Follow-up|0|||
105708458|NCT01780831|364592920|FG003|Overall Study|Lost to Follow-up|1|||
105708459|NCT02970292|364592931|FG000|Overall Study|Physician Decision|1|||
105708460|NCT02970292|364592932|FG001|Overall Study|Physician Decision|1|||
105708461|NCT02970292|364592931|FG000|Overall Study|Withdrawal by Subject|11|||
105708462|NCT02970292|364592932|FG001|Overall Study|Withdrawal by Subject|5|||
105708463|NCT02970292|364592931|FG000|Overall Study|Noncompliance with study drug|2|||
105708464|NCT02970292|364592932|FG001|Overall Study|Noncompliance with study drug|2|||
105708465|NCT02970292|364592931|FG000|Overall Study|Adverse Event|5|||
105708466|NCT02970292|364592932|FG001|Overall Study|Adverse Event|0|||
105708467|NCT02970292|364592931|FG000|Overall Study|Lack of Efficacy|1|||
105708468|NCT02970292|364592932|FG001|Overall Study|Lack of Efficacy|0|||
105708469|NCT02970292|364592931|FG000|Overall Study|Lost to Follow-up|1|||
105350944|NCT00350779|363288246|FG001|Overall Study|Lost to Follow-up|0|||
105708470|NCT02970292|364592932|FG001|Overall Study|Lost to Follow-up|0|||
105708471|NCT02970292|364592931|FG000|Overall Study|Protocol Violation|2|||
105708472|NCT02970292|364592932|FG001|Overall Study|Protocol Violation|0|||
105708473|NCT02970292|364592931|FG000|Overall Study|Other|1|||
105708474|NCT02970292|364592932|FG001|Overall Study|Other|0|||
105708475|NCT02980224|364592937|FG000|Overall Study|Adverse Event|4|||
105708476|NCT02980224|364592938|FG001|Overall Study|Adverse Event|1|||
105708477|NCT02980224|364592937|FG000|Overall Study|Withdrawal by Subject|0|||
105708478|NCT02980224|364592938|FG001|Overall Study|Withdrawal by Subject|2|||
105708479|NCT03594227|364592943|FG000|Overall Study|Adverse Event|2|||
105708480|NCT03594227|364592944|FG001|Overall Study|Adverse Event|1|||
105708481|NCT03594227|364592945|FG002|Overall Study|Adverse Event|0|||
105708482|NCT03594227|364592946|FG003|Overall Study|Adverse Event|2|||
105708483|NCT03594227|364592943|FG000|Overall Study|Lost to Follow-up|1|||
105708484|NCT03594227|364592944|FG001|Overall Study|Lost to Follow-up|1|||
105708485|NCT03594227|364592945|FG002|Overall Study|Lost to Follow-up|1|||
105708486|NCT03594227|364592946|FG003|Overall Study|Lost to Follow-up|0|||
105708487|NCT03594227|364592943|FG000|Overall Study|Withdrawal by Subject|1|||
105708488|NCT03594227|364592944|FG001|Overall Study|Withdrawal by Subject|1|||
105708489|NCT03594227|364592945|FG002|Overall Study|Withdrawal by Subject|1|||
105708490|NCT03594227|364592946|FG003|Overall Study|Withdrawal by Subject|1|||
105708491|NCT03594227|364592943|FG000|Overall Study|Pregnancy|0|||
105708492|NCT03594227|364592944|FG001|Overall Study|Pregnancy|1|||
105708493|NCT03594227|364592945|FG002|Overall Study|Pregnancy|0|||
105708494|NCT03594227|364592946|FG003|Overall Study|Pregnancy|0|||
105708495|NCT03594227|364592943|FG000|Overall Study|Sponsor Decision|0|||
105708496|NCT03594227|364592944|FG001|Overall Study|Sponsor Decision|0|||
105708497|NCT03594227|364592945|FG002|Overall Study|Sponsor Decision|0|||
105708498|NCT03594227|364592946|FG003|Overall Study|Sponsor Decision|1|||
105708499|NCT03594227|364592943|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
105708500|NCT03594227|364592944|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
105708501|NCT03594227|364592945|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
105708502|NCT03594227|364592946|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
105708503|NCT00109707|364592947|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
105708504|NCT00109707|364592948|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
105708505|NCT00109707|364592949|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
105708506|NCT00109707|364592947|FG000|Overall Study|Abnormal laboratory values|1|||
105708507|NCT00109707|364592948|FG001|Overall Study|Abnormal laboratory values|0|||
105708508|NCT00109707|364592949|FG002|Overall Study|Abnormal laboratory values|0|||
105708509|NCT00109707|364592947|FG000|Overall Study|Administrative problems|2|||
105708510|NCT00109707|364592948|FG001|Overall Study|Administrative problems|0|||
105708511|NCT00109707|364592949|FG002|Overall Study|Administrative problems|1|||
105708512|NCT00109707|364592947|FG000|Overall Study|Adverse Event|10|||
105708513|NCT00109707|364592948|FG001|Overall Study|Adverse Event|2|||
105708514|NCT00109707|364592949|FG002|Overall Study|Adverse Event|3|||
105708515|NCT00109707|364592947|FG000|Overall Study|Death|4|||
105708516|NCT00109707|364592948|FG001|Overall Study|Death|0|||
105350945|NCT00350779|363288245|FG000|Overall Study|Physician Decision|2|||
105350946|NCT00350779|363288246|FG001|Overall Study|Physician Decision|4|||
105474803|NCT02785770|363751197|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
105708517|NCT00109707|364592949|FG002|Overall Study|Death|0|||
105708518|NCT00109707|364592947|FG000|Overall Study|Disease progression|12|||
105708519|NCT00109707|364592948|FG001|Overall Study|Disease progression|4|||
105708520|NCT00109707|364592949|FG002|Overall Study|Disease progression|3|||
105708521|NCT00109707|364592947|FG000|Overall Study|Lost to Follow-up|3|||
105708522|NCT00109707|364592948|FG001|Overall Study|Lost to Follow-up|0|||
105708523|NCT00109707|364592949|FG002|Overall Study|Lost to Follow-up|0|||
105708524|NCT00109707|364592947|FG000|Overall Study|Protocol Violation|1|||
105708525|NCT00109707|364592948|FG001|Overall Study|Protocol Violation|0|||
105708526|NCT00109707|364592949|FG002|Overall Study|Protocol Violation|0|||
105708527|NCT00109707|364592947|FG000|Overall Study|Patient withdrew consent|6|||
105708528|NCT00109707|364592948|FG001|Overall Study|Patient withdrew consent|1|||
105708529|NCT00109707|364592949|FG002|Overall Study|Patient withdrew consent|0|||
105708530|NCT02443883|364592950|FG000|Overall Study|Adverse Event|0|||
105708531|NCT02443883|364592951|FG001|Overall Study|Adverse Event|1|||
105708532|NCT02443883|364592952|FG002|Overall Study|Adverse Event|0|||
105708533|NCT02443883|364592953|FG003|Overall Study|Adverse Event|0|||
105474804|NCT02785770|363751198|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
105474805|NCT02785770|363751199|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
105474806|NCT02785770|363751200|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
105474807|NCT02785770|363751197|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
105474808|NCT02785770|363751198|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
105474809|NCT02785770|363751199|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
105474810|NCT02785770|363751200|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
105474811|NCT02338882|363751206|FG000|Overall Study|Death|1|||
105474812|NCT02338882|363751207|FG001|Overall Study|Death|0|||
105474813|NCT02338882|363751206|FG000|Overall Study|Lost to Follow-up|6|||
105474814|NCT02338882|363751207|FG001|Overall Study|Lost to Follow-up|3|||
105474815|NCT04518995|363751210|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
105474816|NCT04518995|363751211|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
105474817|NCT04518995|363751212|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
105474818|NCT04518995|363751210|FG000|Overall Study|Lack of Efficacy|2|||
105474819|NCT04518995|363751211|FG001|Overall Study|Lack of Efficacy|1|||
105474820|NCT04518995|363751212|FG002|Overall Study|Lack of Efficacy|0|||
105474821|NCT04518995|363751210|FG000|Overall Study|Non-compliance With Study Drug|0|||
105474822|NCT04518995|363751211|FG001|Overall Study|Non-compliance With Study Drug|3|||
105474823|NCT04518995|363751212|FG002|Overall Study|Non-compliance With Study Drug|2|||
105474824|NCT04518995|363751210|FG000|Overall Study|Pregnancy|0|||
105474825|NCT04518995|363751211|FG001|Overall Study|Pregnancy|0|||
105474826|NCT04518995|363751212|FG002|Overall Study|Pregnancy|1|||
105474827|NCT04518995|363751210|FG000|Overall Study|Protocol Violation|2|||
105474828|NCT04518995|363751211|FG001|Overall Study|Protocol Violation|0|||
105474829|NCT04518995|363751212|FG002|Overall Study|Protocol Violation|1|||
105474830|NCT04518995|363751210|FG000|Overall Study|Reason not Specified|4|||
105474831|NCT04518995|363751211|FG001|Overall Study|Reason not Specified|11|||
105474832|NCT04518995|363751212|FG002|Overall Study|Reason not Specified|2|||
105474833|NCT04518995|363751210|FG000|Overall Study|Lost to Follow-up|1|||
105474834|NCT04518995|363751211|FG001|Overall Study|Lost to Follow-up|10|||
105474835|NCT04518995|363751212|FG002|Overall Study|Lost to Follow-up|6|||
105474836|NCT02248675|363751213|FG000|Overall Study|Lost to Follow-up|3|||
105474837|NCT02248675|363751214|FG001|Overall Study|Lost to Follow-up|1|||
105474838|NCT00669409|363751222|FG000|Part 2|Withdrawal by Subject|0|||
105474839|NCT00669409|363751223|FG001|Part 2|Withdrawal by Subject|0|||
105474840|NCT00669409|363751224|FG002|Part 2|Withdrawal by Subject|0|||
105474841|NCT00669409|363751225|FG003|Part 2|Withdrawal by Subject|0|||
105474842|NCT00669409|363751226|FG004|Part 2|Withdrawal by Subject|0|||
105474843|NCT00669409|363751227|FG005|Part 2|Withdrawal by Subject|0|||
105474844|NCT00669409|363751228|FG006|Part 2|Withdrawal by Subject|0|||
105474845|NCT00669409|363751229|FG007|Part 2|Withdrawal by Subject|0|||
105474846|NCT00669409|363751230|FG008|Part 2|Withdrawal by Subject|0|||
105474847|NCT00669409|363751231|FG009|Part 2|Withdrawal by Subject|1|||
105474848|NCT00669409|363751232|FG010|Part 2|Withdrawal by Subject|0|||
105560579|NCT01040260|364048453|FG000|Overall Study|Lost to Follow-up|3|||
105474849|NCT00942994|363751235|FG000|Overall Study|Adverse Event|7|||
105474850|NCT00942994|363751236|FG001|Overall Study|Adverse Event|4|||
105474851|NCT00942994|363751235|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105474852|NCT00942994|363751236|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105474853|NCT00942994|363751235|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105474854|NCT00942994|363751236|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105474855|NCT00942994|363751235|FG000|Overall Study|Patient withdrew consent|5|||
105708534|NCT02443883|364592950|FG000|Overall Study|Lost to Follow-up|3|||
105474856|NCT00942994|363751236|FG001|Overall Study|Patient withdrew consent|8|||
105474857|NCT00942994|363751235|FG000|Overall Study|Lost to Follow-up|1|||
105474858|NCT00942994|363751236|FG001|Overall Study|Lost to Follow-up|4|||
105708535|NCT02443883|364592951|FG001|Overall Study|Lost to Follow-up|2|||
105708536|NCT02443883|364592952|FG002|Overall Study|Lost to Follow-up|1|||
105708537|NCT02443883|364592953|FG003|Overall Study|Lost to Follow-up|0|||
105708538|NCT02443883|364592950|FG000|Overall Study|Physician Decision|1|||
105708539|NCT02443883|364592951|FG001|Overall Study|Physician Decision|1|||
105708540|NCT02443883|364592952|FG002|Overall Study|Physician Decision|0|||
105708541|NCT02443883|364592953|FG003|Overall Study|Physician Decision|3|||
105708542|NCT02443883|364592950|FG000|Overall Study|Withdrawal by Subject|1|||
105708543|NCT02443883|364592951|FG001|Overall Study|Withdrawal by Subject|0|||
105708544|NCT02443883|364592952|FG002|Overall Study|Withdrawal by Subject|0|||
105708545|NCT02443883|364592953|FG003|Overall Study|Withdrawal by Subject|2|||
105708546|NCT02443883|364592950|FG000|Overall Study|Randomized, but never treated|1|||
105708547|NCT02443883|364592951|FG001|Overall Study|Randomized, but never treated|0|||
105708548|NCT02443883|364592952|FG002|Overall Study|Randomized, but never treated|0|||
105708549|NCT02443883|364592953|FG003|Overall Study|Randomized, but never treated|0|||
105708550|NCT00446511|364592954|FG000|Overall Study|Adverse Event|7|||
105708551|NCT00446511|364592955|FG001|Overall Study|Adverse Event|2|||
105708552|NCT00446511|364592956|FG002|Overall Study|Adverse Event|3|||
105708553|NCT00446511|364592957|FG003|Overall Study|Adverse Event|1|||
105708554|NCT00446511|364592954|FG000|Overall Study|Protocol Violation|0|||
105708555|NCT00446511|364592955|FG001|Overall Study|Protocol Violation|0|||
105708556|NCT00446511|364592956|FG002|Overall Study|Protocol Violation|0|||
105708557|NCT00446511|364592957|FG003|Overall Study|Protocol Violation|1|||
105350947|NCT00350779|363288245|FG000|Overall Study|Protocol Violation|3|||
105350948|NCT00350779|363288246|FG001|Overall Study|Protocol Violation|1|||
105350949|NCT00350779|363288245|FG000|Overall Study|Withdrawal by Subject|9|||
105350950|NCT00350779|363288246|FG001|Overall Study|Withdrawal by Subject|8|||
105350951|NCT00350779|363288245|FG000|Overall Study|Patient Moved|2|||
105350952|NCT00350779|363288246|FG001|Overall Study|Patient Moved|1|||
105350953|NCT00350779|363288245|FG000|Overall Study|Non-compliance with study procedures|0|||
105350954|NCT00350779|363288246|FG001|Overall Study|Non-compliance with study procedures|1|||
105708558|NCT00446511|364592954|FG000|Overall Study|Withdrawal by Subject|0|||
105350955|NCT02243046|363288247|FG000|Overall Study|Lost to Follow-up|1|||
105350956|NCT02243046|363288248|FG001|Overall Study|Lost to Follow-up|1|||
105350957|NCT02243046|363288249|FG002|Overall Study|Lost to Follow-up|4|||
105350958|NCT03796676|363288250|FG000|Overall Study|Adverse Event|2|||
105350959|NCT03796676|363288251|FG001|Overall Study|Adverse Event|1|||
105350960|NCT03796676|363288252|FG002|Overall Study|Adverse Event|2|||
105350961|NCT03796676|363288250|FG000|Overall Study|Lost to Follow-up|2|||
105350962|NCT03796676|363288251|FG001|Overall Study|Lost to Follow-up|1|||
105350963|NCT03796676|363288252|FG002|Overall Study|Lost to Follow-up|0|||
105350964|NCT03796676|363288250|FG000|Overall Study|Protocol Violation|0|||
105350965|NCT03796676|363288251|FG001|Overall Study|Protocol Violation|0|||
105350966|NCT03796676|363288252|FG002|Overall Study|Protocol Violation|1|||
105350967|NCT03796676|363288250|FG000|Overall Study|Withdrawal by Subject|1|||
105708559|NCT00446511|364592955|FG001|Overall Study|Withdrawal by Subject|0|||
105350968|NCT03796676|363288251|FG001|Overall Study|Withdrawal by Subject|1|||
105350969|NCT03796676|363288252|FG002|Overall Study|Withdrawal by Subject|0|||
105350970|NCT03796676|363288250|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
105350971|NCT03796676|363288251|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
105350972|NCT03796676|363288252|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
105350973|NCT00248833|363288255|FG000|Overall Study|Adverse Event|2|||
105350974|NCT00248833|363288256|FG001|Overall Study|Adverse Event|0|||
105350975|NCT00248833|363288257|FG002|Overall Study|Adverse Event|0|||
105350976|NCT00248833|363288255|FG000|Overall Study|Withdrawal by Subject|0|||
105350977|NCT00248833|363288256|FG001|Overall Study|Withdrawal by Subject|1|||
105350978|NCT00248833|363288257|FG002|Overall Study|Withdrawal by Subject|1|||
105350979|NCT00248833|363288255|FG000|Overall Study|Lost to Follow-up|1|||
105474859|NCT00942994|363751235|FG000|Overall Study|Protocol deviation|1|||
105708560|NCT00446511|364592956|FG002|Overall Study|Withdrawal by Subject|0|||
105708561|NCT00446511|364592957|FG003|Overall Study|Withdrawal by Subject|3|||
105350980|NCT00248833|363288256|FG001|Overall Study|Lost to Follow-up|1|||
105350981|NCT00248833|363288257|FG002|Overall Study|Lost to Follow-up|1|||
105350982|NCT00248833|363288255|FG000|Overall Study|Other|0|||
105350983|NCT00248833|363288256|FG001|Overall Study|Other|1|||
105350984|NCT00248833|363288257|FG002|Overall Study|Other|0|||
105350985|NCT02772809|363288258|FG000|Overall Study|not completed some tasks|6|||
105350986|NCT01905592|363288261|FG000|Overall Study|Disease Progression|51|||
105474860|NCT00942994|363751236|FG001|Overall Study|Protocol deviation|2|||
105708562|NCT00446511|364592954|FG000|Overall Study|Administrative Problems|3|||
105708563|NCT00446511|364592955|FG001|Overall Study|Administrative Problems|0|||
105708564|NCT00446511|364592956|FG002|Overall Study|Administrative Problems|4|||
105708565|NCT00446511|364592957|FG003|Overall Study|Administrative Problems|1|||
105708566|NCT01265550|364592958|FG000|Pre Randomization|Withdrawal by Subject|0|||
105708567|NCT01265550|364592959|FG001|Pre Randomization|Withdrawal by Subject|0|||
105708568|NCT01265550|364592960|FG002|Pre Randomization|Withdrawal by Subject|0|||
105708569|NCT01265550|364592961|FG003|Pre Randomization|Withdrawal by Subject|70|||
105708570|NCT01265550|364592958|FG000|Pre Randomization|Technical Exclusions|0|||
105708571|NCT01265550|364592959|FG001|Pre Randomization|Technical Exclusions|0|||
105708572|NCT01265550|364592960|FG002|Pre Randomization|Technical Exclusions|0|||
105708573|NCT01265550|364592961|FG003|Pre Randomization|Technical Exclusions|54|||
105708574|NCT01265550|364592958|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
105708575|NCT01265550|364592959|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
105708576|NCT01265550|364592960|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
105708577|NCT01265550|364592961|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
105708578|NCT01265550|364592958|FG000|Pre Randomization|Non-GERD organic disorders|0|||
105708579|NCT01265550|364592959|FG001|Pre Randomization|Non-GERD organic disorders|0|||
105708580|NCT01265550|364592960|FG002|Pre Randomization|Non-GERD organic disorders|0|||
105708581|NCT01265550|364592961|FG003|Pre Randomization|Non-GERD organic disorders|23|||
105708582|NCT01265550|364592958|FG000|Pre Randomization|Functional heartburn|0|||
105708583|NCT01265550|364592959|FG001|Pre Randomization|Functional heartburn|0|||
105708584|NCT01265550|364592960|FG002|Pre Randomization|Functional heartburn|0|||
105708585|NCT01265550|364592961|FG003|Pre Randomization|Functional heartburn|99|||
105708586|NCT00075504|364592964|FG000|Overall Study|Withdrawal by Subject|9|||
105708587|NCT00075504|364592965|FG001|Overall Study|Withdrawal by Subject|7|||
105708588|NCT03436862|364592966|FG000|Overall Study|Adverse Event|4|||
105708589|NCT03436862|364592966|FG000|Overall Study|Progressive Disease|2|||
105708590|NCT00606086|364592967|FG000|Overall Study|Adverse Event|1|||
105708591|NCT00606086|364592968|FG001|Overall Study|Adverse Event|1|||
105474861|NCT03583385|363751237|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105474862|NCT03583385|363751238|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105708592|NCT00606086|364592967|FG000|Overall Study|Lost to Follow-up|4|||
105708593|NCT00606086|364592968|FG001|Overall Study|Lost to Follow-up|8|||
105474863|NCT03583385|363751237|FG000|Treatment Period 2|Adverse Event|1|||
105474864|NCT03583385|363751238|FG001|Treatment Period 2|Adverse Event|0|||
105708594|NCT00606086|364592967|FG000|Overall Study|Protocol Violation|1|||
105708595|NCT00606086|364592968|FG001|Overall Study|Protocol Violation|0|||
105708596|NCT00606086|364592967|FG000|Overall Study|Withdrawal by Subject|5|||
105788050|NCT00437294|364878170|FG001|Overall Study|Entry criteria not met|1|||
105708597|NCT00606086|364592968|FG001|Overall Study|Withdrawal by Subject|3|||
105708598|NCT00606086|364592967|FG000|Overall Study|Non-compliance|0|||
105708599|NCT00606086|364592968|FG001|Overall Study|Non-compliance|1|||
105708600|NCT00606086|364592967|FG000|Overall Study|Randomized, not treated|1|||
105788051|NCT02660489|364878174|FG000|Overall Study|Lost to Follow-up|1|||
105708601|NCT00606086|364592968|FG001|Overall Study|Randomized, not treated|2|||
105708602|NCT03403205|364592973|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
105708603|NCT03403205|364592974|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
105708604|NCT03403205|364592975|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
105708605|NCT03403205|364592976|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
105708606|NCT03403205|364592977|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
105708607|NCT03403205|364592978|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
105708608|NCT03403205|364592973|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
105708609|NCT03403205|364592974|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105708610|NCT03403205|364592975|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
105708611|NCT03403205|364592976|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105708612|NCT03403205|364592977|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105708613|NCT03403205|364592978|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105708614|NCT03403205|364592973|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
105708615|NCT03403205|364592974|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
105708616|NCT03403205|364592975|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
105708617|NCT03403205|364592976|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
105708618|NCT03403205|364592977|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
105708619|NCT03403205|364592978|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
105708620|NCT03403205|364592973|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
105708621|NCT03403205|364592974|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
105708622|NCT03403205|364592975|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
105708623|NCT03403205|364592976|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
105708624|NCT03403205|364592977|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
105708625|NCT03403205|364592978|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
105708626|NCT03403205|364592973|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
105708627|NCT03403205|364592974|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
105708628|NCT03403205|364592975|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
105708629|NCT03403205|364592976|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
105708630|NCT03403205|364592977|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
105708631|NCT03403205|364592978|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
105708632|NCT03403205|364592973|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
105708633|NCT03403205|364592974|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
105708634|NCT03403205|364592975|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
105708635|NCT03403205|364592976|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
105708636|NCT03403205|364592977|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
105708637|NCT03403205|364592978|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
105708638|NCT03403205|364592973|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
105708639|NCT03403205|364592974|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
105708640|NCT03403205|364592975|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
105708641|NCT03403205|364592976|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
105708642|NCT03403205|364592977|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
105708643|NCT03403205|364592978|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
105708644|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
105708645|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
105708646|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
105708647|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
105708648|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
105708649|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
105708650|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
105708651|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
105708652|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
105708653|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
105708654|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
105708655|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
105708656|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Death|1|||
105708657|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Death|0|||
105708658|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Death|0|||
105708659|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Death|0|||
105708660|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Death|0|||
105708661|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Death|0|||
105708662|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
105708663|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
105708664|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
105350987|NCT01905592|363288262|FG001|Overall Study|Disease Progression|110|||
105350988|NCT01905592|363288261|FG000|Overall Study|Toxicity|1|||
105350989|NCT01905592|363288262|FG001|Overall Study|Toxicity|16|||
105708665|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
105708666|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
105708667|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
105708668|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
105708669|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
105708670|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
105708671|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
105708672|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
105708673|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
105708674|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
105708675|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
105708676|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
105708677|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
105708678|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
105708679|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
105708680|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
105708681|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
105708682|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
105708683|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
105708684|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
105708685|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
105708686|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
105708687|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
105708688|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
105708689|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
105708690|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
105708691|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
105708692|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
105708693|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
105708694|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
105708695|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
105708696|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
105708697|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
105708698|NCT00498173|364592982|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
105708699|NCT00498173|364592983|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
105708700|NCT00498173|364592984|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
105708701|NCT02289950|364592988|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
105708702|NCT02289950|364592989|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
105708703|NCT02289950|364592988|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
105708704|NCT02289950|364592989|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
105708705|NCT02289950|364592988|FG000|Overall Study|Lost to Follow-up|1|||
105708706|NCT02289950|364592989|FG001|Overall Study|Lost to Follow-up|0|||
105708707|NCT02289950|364592988|FG000|Overall Study|Physician Decision|9|||
105708708|NCT02289950|364592989|FG001|Overall Study|Physician Decision|3|||
105708709|NCT02289950|364592988|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
105708710|NCT02289950|364592989|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
105708711|NCT02289950|364592988|FG000|Overall Study|Withdrawal by Subject|1|||
105708712|NCT02289950|364592989|FG001|Overall Study|Withdrawal by Subject|3|||
105708713|NCT02289950|364592988|FG000|Overall Study|Test article held for greater than 28 days|0|||
105708714|NCT02289950|364592989|FG001|Overall Study|Test article held for greater than 28 days|1|||
105708715|NCT02289950|364592988|FG000|Overall Study|Adverse Event|11|||
105708716|NCT02289950|364592989|FG001|Overall Study|Adverse Event|3|||
105708717|NCT02289950|364592988|FG000|Overall Study|Death|1|||
105708718|NCT02289950|364592989|FG001|Overall Study|Death|1|||
105708719|NCT02289950|364592988|FG000|Overall Study|Other|5|||
105350990|NCT01905592|363288261|FG000|Overall Study|Physician Decision|0|||
105350991|NCT01905592|363288262|FG001|Overall Study|Physician Decision|2|||
105350992|NCT01905592|363288261|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
105560580|NCT01040260|364048454|FG001|Overall Study|Lost to Follow-up|5|||
105560581|NCT03575325|364048460|FG000|Overall Study|Death|1|||
105560582|NCT05711641|364048461|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
105560583|NCT05711641|364048462|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
105560584|NCT05711641|364048461|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
105560585|NCT05711641|364048462|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
105560586|NCT04495179|364048463|FG000|Overall Study|Lost to Follow-up|0|||
105560587|NCT04495179|364048464|FG001|Overall Study|Lost to Follow-up|1|||
105560588|NCT04495179|364048463|FG000|Overall Study|Withdrawal by Subject|2|||
105560589|NCT04495179|364048464|FG001|Overall Study|Withdrawal by Subject|4|||
105560590|NCT04495179|364048463|FG000|Overall Study|Study terminated by sponsor|0|||
105560591|NCT04495179|364048464|FG001|Overall Study|Study terminated by sponsor|18|||
105560592|NCT04495179|364048463|FG000|Overall Study|Death|0|||
105560593|NCT04495179|364048464|FG001|Overall Study|Death|4|||
105560594|NCT04495179|364048463|FG000|Overall Study|Adverse Event|0|||
105560595|NCT04495179|364048464|FG001|Overall Study|Adverse Event|1|||
105560596|NCT02477111|364048468|FG000|Overall Study|Death|28|||
105560597|NCT02477111|364048468|FG000|Overall Study|Withdrawal by Subject|19|||
105560598|NCT02477111|364048468|FG000|Overall Study|Lost to Follow-up|4|||
105560599|NCT00162370|364048470|FG000|Efficacy Population|Lost to Follow-up|51|||
105560600|NCT02612311|364048471|FG000|Overall Study|Adverse Event|16|||
105560601|NCT02612311|364048472|FG001|Overall Study|Adverse Event|12|||
105560602|NCT02612311|364048473|FG002|Overall Study|Adverse Event|7|||
105560603|NCT02612311|364048474|FG003|Overall Study|Adverse Event|13|||
105560604|NCT02612311|364048471|FG000|Overall Study|Death|29|||
105560605|NCT02612311|364048472|FG001|Overall Study|Death|10|||
105560606|NCT02612311|364048473|FG002|Overall Study|Death|11|||
105560607|NCT02612311|364048474|FG003|Overall Study|Death|11|||
105560608|NCT02612311|364048471|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
105560609|NCT02612311|364048472|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
105560610|NCT02612311|364048473|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
105560611|NCT02612311|364048474|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
105560612|NCT02612311|364048471|FG000|Overall Study|Investigator's Decision|11|||
105560613|NCT02612311|364048472|FG001|Overall Study|Investigator's Decision|15|||
105560614|NCT02612311|364048473|FG002|Overall Study|Investigator's Decision|6|||
105560615|NCT02612311|364048474|FG003|Overall Study|Investigator's Decision|6|||
105560616|NCT02612311|364048471|FG000|Overall Study|Lack of Efficacy|0|||
105560617|NCT02612311|364048472|FG001|Overall Study|Lack of Efficacy|0|||
105560618|NCT02612311|364048473|FG002|Overall Study|Lack of Efficacy|1|||
105560619|NCT02612311|364048474|FG003|Overall Study|Lack of Efficacy|1|||
105560620|NCT02612311|364048471|FG000|Overall Study|Lost to Follow-up|2|||
105560621|NCT02612311|364048472|FG001|Overall Study|Lost to Follow-up|2|||
105560622|NCT02612311|364048473|FG002|Overall Study|Lost to Follow-up|1|||
105560623|NCT02612311|364048474|FG003|Overall Study|Lost to Follow-up|2|||
105560624|NCT02612311|364048471|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
105560625|NCT02612311|364048472|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
105560626|NCT02612311|364048473|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
105560627|NCT02612311|364048474|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
105560628|NCT02612311|364048471|FG000|Overall Study|Site Terminated by Sponsor|29|||
105560629|NCT02612311|364048472|FG001|Overall Study|Site Terminated by Sponsor|12|||
105560630|NCT02612311|364048473|FG002|Overall Study|Site Terminated by Sponsor|13|||
105560631|NCT02612311|364048474|FG003|Overall Study|Site Terminated by Sponsor|5|||
105560632|NCT02612311|364048471|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
105560633|NCT02612311|364048472|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
105560634|NCT02612311|364048473|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
105560635|NCT02612311|364048474|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
105560636|NCT02612311|364048471|FG000|Overall Study|Reason Not Specified|3|||
105560637|NCT02612311|364048472|FG001|Overall Study|Reason Not Specified|7|||
105560638|NCT02612311|364048473|FG002|Overall Study|Reason Not Specified|4|||
105560639|NCT02612311|364048474|FG003|Overall Study|Reason Not Specified|5|||
105560640|NCT02612311|364048471|FG000|Overall Study|Unknown/Missing|10|||
105560641|NCT02612311|364048472|FG001|Overall Study|Unknown/Missing|13|||
105350993|NCT01905592|363288262|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
105560642|NCT02612311|364048473|FG002|Overall Study|Unknown/Missing|4|||
105560643|NCT02612311|364048474|FG003|Overall Study|Unknown/Missing|0|||
105560644|NCT02612311|364048471|FG000|Overall Study|Non-Compliance with Study|1|||
105560645|NCT02612311|364048472|FG001|Overall Study|Non-Compliance with Study|0|||
105560646|NCT02612311|364048473|FG002|Overall Study|Non-Compliance with Study|0|||
105560647|NCT02612311|364048474|FG003|Overall Study|Non-Compliance with Study|0|||
105560648|NCT04575051|364048475|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
105560649|NCT04575051|364048476|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
105708720|NCT02289950|364592989|FG001|Overall Study|Other|2|||
105708721|NCT02289950|364592988|FG000|Overall Study|Not Treated|2|||
105708722|NCT02289950|364592989|FG001|Overall Study|Not Treated|1|||
105708723|NCT01394939|364594454|FG000|Overall Study|Adverse Event|1|||
105708724|NCT01394939|364594455|FG001|Overall Study|Adverse Event|3|||
105708725|NCT01394939|364594456|FG002|Overall Study|Adverse Event|0|||
105708726|NCT01394939|364594457|FG003|Overall Study|Adverse Event|2|||
105708727|NCT01394939|364594454|FG000|Overall Study|Death|0|||
105708728|NCT01394939|364594455|FG001|Overall Study|Death|2|||
105708729|NCT01394939|364594456|FG002|Overall Study|Death|0|||
105708730|NCT01394939|364594457|FG003|Overall Study|Death|0|||
105708731|NCT01394939|364594454|FG000|Overall Study|Physician Decision|0|||
105708732|NCT01394939|364594455|FG001|Overall Study|Physician Decision|1|||
105708733|NCT01394939|364594456|FG002|Overall Study|Physician Decision|0|||
105708734|NCT01394939|364594457|FG003|Overall Study|Physician Decision|0|||
105708735|NCT01394939|364594454|FG000|Overall Study|Withdrawal by Subject|0|||
105708736|NCT01394939|364594455|FG001|Overall Study|Withdrawal by Subject|2|||
105708737|NCT01394939|364594456|FG002|Overall Study|Withdrawal by Subject|0|||
105708738|NCT01394939|364594457|FG003|Overall Study|Withdrawal by Subject|2|||
105708739|NCT01394939|364594454|FG000|Overall Study|Others|0|||
105708740|NCT01394939|364594455|FG001|Overall Study|Others|2|||
105708741|NCT01394939|364594456|FG002|Overall Study|Others|0|||
105708742|NCT01394939|364594457|FG003|Overall Study|Others|3|||
105708743|NCT03368170|364594458|FG000|Overall Study|Adverse Event|2|||
105708744|NCT03368170|364594459|FG001|Overall Study|Adverse Event|1|||
105708745|NCT02068547|364594461|FG000|Overall Study|Lost to Follow-up|3|||
105708746|NCT02068547|364594462|FG001|Overall Study|Lost to Follow-up|3|||
105708747|NCT02068547|364594461|FG000|Overall Study|Physician Decision|1|||
105708748|NCT02068547|364594462|FG001|Overall Study|Physician Decision|0|||
105708749|NCT03657043|364594463|FG000|Overall Study|Withdrawal by Subject|1|||
105708750|NCT03657043|364594464|FG001|Overall Study|Withdrawal by Subject|1|||
105708751|NCT03657043|364594465|FG002|Overall Study|Withdrawal by Subject|0|||
105708752|NCT03657043|364594466|FG003|Overall Study|Withdrawal by Subject|0|||
105708753|NCT03657043|364594467|FG004|Overall Study|Withdrawal by Subject|4|||
105708754|NCT03657043|364594463|FG000|Overall Study|Study closure by Sponsor|0|||
105708755|NCT03657043|364594464|FG001|Overall Study|Study closure by Sponsor|2|||
105708756|NCT03657043|364594465|FG002|Overall Study|Study closure by Sponsor|0|||
105708757|NCT03657043|364594466|FG003|Overall Study|Study closure by Sponsor|0|||
105708758|NCT03657043|364594467|FG004|Overall Study|Study closure by Sponsor|17|||
105708759|NCT03657043|364594463|FG000|Overall Study|Lost to Follow-up|0|||
105708760|NCT03657043|364594464|FG001|Overall Study|Lost to Follow-up|0|||
105708761|NCT03657043|364594465|FG002|Overall Study|Lost to Follow-up|0|||
105708762|NCT03657043|364594466|FG003|Overall Study|Lost to Follow-up|0|||
105708763|NCT03657043|364594467|FG004|Overall Study|Lost to Follow-up|4|||
105708764|NCT03657043|364594463|FG000|Overall Study|Death|6|||
105708765|NCT03657043|364594464|FG001|Overall Study|Death|5|||
105708766|NCT03657043|364594465|FG002|Overall Study|Death|0|||
105708767|NCT03657043|364594466|FG003|Overall Study|Death|0|||
105708768|NCT03657043|364594467|FG004|Overall Study|Death|53|||
105708769|NCT03657043|364594463|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
105708770|NCT03657043|364594464|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
105708771|NCT03657043|364594465|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
105708772|NCT03657043|364594466|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
105708773|NCT03657043|364594467|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
105708774|NCT03657043|364594463|FG000|Overall Study|Adverse Event|0|||
105708775|NCT03657043|364594464|FG001|Overall Study|Adverse Event|0|||
105708776|NCT03657043|364594465|FG002|Overall Study|Adverse Event|0|||
105708777|NCT03657043|364594466|FG003|Overall Study|Adverse Event|0|||
105708778|NCT03657043|364594467|FG004|Overall Study|Adverse Event|2|||
105708779|NCT03657043|364594463|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
105708780|NCT03657043|364594464|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
105708781|NCT03657043|364594465|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
105474865|NCT00387790|363751241|FG000|Overall Study|Adverse Event|5|||
105708782|NCT03657043|364594466|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
105708783|NCT03657043|364594467|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
105708784|NCT03657043|364594463|FG000|Overall Study|Withdrawal - declined follow-up|0|||
105708785|NCT03657043|364594464|FG001|Overall Study|Withdrawal - declined follow-up|0|||
105708786|NCT03657043|364594465|FG002|Overall Study|Withdrawal - declined follow-up|0|||
105708787|NCT03657043|364594466|FG003|Overall Study|Withdrawal - declined follow-up|0|||
105708788|NCT03657043|364594467|FG004|Overall Study|Withdrawal - declined follow-up|1|||
105708789|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
105708790|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
105708791|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
105708792|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
105788052|NCT02660489|364878175|FG001|Overall Study|Lost to Follow-up|1|||
105474866|NCT00387790|363751241|FG000|Overall Study|Lack of Efficacy|2|||
105474867|NCT00387790|363751241|FG000|Overall Study|Physician Decision|2|||
105474868|NCT00387790|363751241|FG000|Overall Study|Withdrawal by Subject|3|||
105474869|NCT00387790|363751241|FG000|Overall Study|Ineligible for study|2|||
105474870|NCT00545272|363751242|FG000|Overall Study|Protocol deviation|0|||
105474871|NCT00545272|363751243|FG001|Overall Study|Protocol deviation|1|||
105708793|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
105708794|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
105708795|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
105708796|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
105474872|NCT00545272|363751244|FG002|Overall Study|Protocol deviation|0|||
105474873|NCT00545272|363751245|FG003|Overall Study|Protocol deviation|1|||
105708797|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
105708798|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
105708799|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
105708800|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
105708801|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
105708802|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
105708803|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
105708804|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
105708805|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
105708806|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
105708807|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
105708808|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
105708809|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
105788053|NCT02660489|364878174|FG000|Overall Study|Adverse Event|1|||
105788054|NCT02660489|364878175|FG001|Overall Study|Adverse Event|3|||
105788055|NCT02660489|364878174|FG000|Overall Study|no rhinovirus infection|4|||
105474874|NCT00545272|363751246|FG004|Overall Study|Protocol deviation|0|||
105708810|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
105708811|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
105708812|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
105708813|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
105708814|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
105708815|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
105708816|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
105708817|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
105708818|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
105708819|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
105708820|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
105708821|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
105708822|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
105708823|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
105708824|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
105708825|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
105708826|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
105708827|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
105708828|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
105708829|NCT02831673|364594468|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
105708830|NCT02831673|364594469|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
105708831|NCT02831673|364594470|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
105708832|NCT02831673|364594471|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
105708833|NCT02831673|364594472|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
105708834|NCT02831673|364594468|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
105708835|NCT02831673|364594469|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
105708836|NCT02831673|364594470|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
105708837|NCT02831673|364594471|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
105708838|NCT02831673|364594472|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
105708839|NCT02831673|364594468|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
105708840|NCT02831673|364594469|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
105708841|NCT02831673|364594470|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
105708842|NCT02831673|364594471|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
105474875|NCT00545272|363751247|FG005|Overall Study|Protocol deviation|1|||
105708843|NCT02831673|364594472|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
105708844|NCT02831673|364594468|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
105708845|NCT02831673|364594469|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
105708846|NCT02831673|364594470|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
105708847|NCT02831673|364594471|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
105708848|NCT02831673|364594472|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
105708849|NCT02831673|364594468|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
105708850|NCT02831673|364594469|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
105708851|NCT02831673|364594470|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
105708852|NCT02831673|364594471|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
105708853|NCT02831673|364594472|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
105708854|NCT02831673|364594468|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
105708855|NCT02831673|364594469|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
105708856|NCT02831673|364594470|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
105708857|NCT02831673|364594471|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
105708858|NCT02831673|364594472|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
105708859|NCT02831673|364594468|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
105708860|NCT02831673|364594469|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
105708861|NCT02831673|364594470|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
105708862|NCT02831673|364594471|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
105708863|NCT02831673|364594472|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
105708864|NCT02831673|364594468|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
105708865|NCT02831673|364594469|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
105708866|NCT02831673|364594470|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
105708867|NCT02831673|364594471|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
105708868|NCT02831673|364594472|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
105708869|NCT02831673|364594468|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
105708870|NCT02831673|364594469|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
105708871|NCT02831673|364594470|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
105708872|NCT02831673|364594471|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
105708873|NCT02831673|364594472|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
105708874|NCT02831673|364594468|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
105708875|NCT02831673|364594469|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
105708876|NCT02831673|364594470|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
105708877|NCT02831673|364594471|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
105708878|NCT02831673|364594472|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
105708879|NCT02831673|364594468|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
105708880|NCT02831673|364594469|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
105708881|NCT02831673|364594470|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
105708882|NCT02831673|364594471|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
105708883|NCT02831673|364594472|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
105708884|NCT02831673|364594468|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
105708885|NCT02831673|364594469|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
105708886|NCT02831673|364594470|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
105708887|NCT02831673|364594471|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
105708888|NCT02831673|364594472|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
105708889|NCT03047980|364594473|FG000|Overall Study|Adverse Event|1|||
105708890|NCT01408147|364594474|FG000|Overall Study|Withdrawal by Subject|0|||
105708891|NCT01408147|364594475|FG001|Overall Study|Withdrawal by Subject|1|||
105708892|NCT02229552|364594476|FG000|Baseline|Withdrawal by Subject|6|||
105708893|NCT02229552|364594476|FG000|1-year Follow up|Withdrawal by Subject|7|||
105708894|NCT02229552|364594476|FG000|1-year Follow up|Lost to Follow-up|18|||
105708895|NCT02229552|364594476|FG000|2-Year Follow up|Withdrawal by Subject|9|||
105708896|NCT02229552|364594476|FG000|2-Year Follow up|Lost to Follow-up|17|||
105708897|NCT00746252|364594477|FG000|Overall Study|weight gain >7.5 %|1|||
105708898|NCT00746252|364594478|FG001|Overall Study|weight gain >7.5 %|2|||
105708899|NCT01049035|364594479|FG000|Overall Study|Serious adverse event|0|||
105708900|NCT01049035|364594480|FG001|Overall Study|Serious adverse event|1|||
105708901|NCT01049035|364594481|FG002|Overall Study|Serious adverse event|1|||
105708902|NCT01049035|364594482|FG003|Overall Study|Serious adverse event|2|||
105708903|NCT01049035|364594483|FG004|Overall Study|Serious adverse event|0|||
105708904|NCT01049035|364594484|FG005|Overall Study|Serious adverse event|0|||
105708905|NCT01049035|364594485|FG006|Overall Study|Serious adverse event|0|||
105708906|NCT01049035|364594479|FG000|Overall Study|Other adverse event (AE)|0|||
105708907|NCT01049035|364594480|FG001|Overall Study|Other adverse event (AE)|0|||
105708908|NCT01049035|364594481|FG002|Overall Study|Other adverse event (AE)|0|||
105708909|NCT01049035|364594482|FG003|Overall Study|Other adverse event (AE)|1|||
105708910|NCT01049035|364594483|FG004|Overall Study|Other adverse event (AE)|0|||
105708911|NCT01049035|364594484|FG005|Overall Study|Other adverse event (AE)|0|||
105708912|NCT01049035|364594485|FG006|Overall Study|Other adverse event (AE)|0|||
105708913|NCT01049035|364594479|FG000|Overall Study|Non-compliance with the protocol|12|||
105708914|NCT01049035|364594480|FG001|Overall Study|Non-compliance with the protocol|6|||
105708915|NCT01049035|364594481|FG002|Overall Study|Non-compliance with the protocol|14|||
105708916|NCT01049035|364594482|FG003|Overall Study|Non-compliance with the protocol|5|||
105708917|NCT01049035|364594483|FG004|Overall Study|Non-compliance with the protocol|3|||
105708918|NCT01049035|364594484|FG005|Overall Study|Non-compliance with the protocol|4|||
105708919|NCT01049035|364594485|FG006|Overall Study|Non-compliance with the protocol|10|||
105708920|NCT01049035|364594479|FG000|Overall Study|Lost to Follow-up|5|||
105708921|NCT01049035|364594480|FG001|Overall Study|Lost to Follow-up|4|||
105708922|NCT01049035|364594481|FG002|Overall Study|Lost to Follow-up|4|||
105708923|NCT01049035|364594482|FG003|Overall Study|Lost to Follow-up|1|||
105708924|NCT01049035|364594483|FG004|Overall Study|Lost to Follow-up|0|||
105708925|NCT01049035|364594484|FG005|Overall Study|Lost to Follow-up|3|||
105708926|NCT01049035|364594485|FG006|Overall Study|Lost to Follow-up|3|||
105708927|NCT01049035|364594479|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
105708928|NCT01049035|364594480|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
105708929|NCT01049035|364594481|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
105708930|NCT01049035|364594482|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
105708931|NCT01049035|364594483|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
105708932|NCT01049035|364594484|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
105708933|NCT01049035|364594485|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
105708934|NCT03927105|364594486|FG000|Overall Study|Death|1|||
105708935|NCT03927105|364594486|FG000|Overall Study|In observation for potential re-treatment|2|||
105708936|NCT03927105|364594486|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
105708937|NCT00082888|364594489|FG000|Overall Study|Ineligible|1|||
105708938|NCT00082888|364594490|FG001|Overall Study|Ineligible|0|||
105708939|NCT00082888|364594491|FG002|Overall Study|Ineligible|0|||
105708940|NCT02239939|364594492|FG000|Overall Study|Adverse Event|1|||
105708941|NCT02239939|364594493|FG001|Overall Study|Adverse Event|0|||
105708942|NCT02239939|364594492|FG000|Overall Study|Withdrawal by Subject|1|||
105708943|NCT02239939|364594493|FG001|Overall Study|Withdrawal by Subject|1|||
105708944|NCT02239939|364594492|FG000|Overall Study|Lost to Follow-up|0|||
105708945|NCT02239939|364594493|FG001|Overall Study|Lost to Follow-up|1|||
105708946|NCT01659320|364594494|FG000|Overall Study|Withdrawal by Subject|2|||
105708947|NCT01659320|364594494|FG000|Overall Study|Physician Decision|1|||
105708948|NCT01514682|364594495|FG000|Overall Study|Withdrawal by Subject|2|||
105708949|NCT01514682|364594496|FG001|Overall Study|Withdrawal by Subject|3|||
105708950|NCT01514682|364594495|FG000|Overall Study|Physician Decision|4|||
105708951|NCT01514682|364594496|FG001|Overall Study|Physician Decision|3|||
105708952|NCT00820898|364594499|FG000|Overall Study|Inelgible - wrong primary site|1|||
105708953|NCT02721355|364594502|FG000|Overall Study|Lost to Follow-up|6|||
105708954|NCT02721355|364594503|FG001|Overall Study|Lost to Follow-up|1|||
105708955|NCT04312009|364594504|FG000|Overall Study|Withdrawal by Subject|2|||
105708956|NCT04312009|364594505|FG001|Overall Study|Withdrawal by Subject|1|||
105708957|NCT02192827|364594506|FG000|Overall Study|Lost to Follow-up|25|||
105708958|NCT02192827|364594507|FG001|Overall Study|Lost to Follow-up|27|||
105708959|NCT02192827|364594506|FG000|Overall Study|Given additional steroids with admission|13|||
105708960|NCT02192827|364594507|FG001|Overall Study|Given additional steroids with admission|11|||
105708961|NCT00414453|364594514|FG000|Overall Study|Abnormal lab work|16|||
105708962|NCT00290433|364594517|FG000|Overall Study|Disease Progression|13|||
105708963|NCT00290433|364594517|FG000|Overall Study|Adverse Event|14|||
105708964|NCT00290433|364594517|FG000|Overall Study|Withdrawal by Subject|1|||
105708965|NCT00290433|364594517|FG000|Overall Study|Non-Compliance|1|||
105708966|NCT00290433|364594517|FG000|Overall Study|Congestive Heart Failure|1|||
105708967|NCT00290433|364594517|FG000|Overall Study|Transplant in CR|5|||
105474876|NCT00545272|363751242|FG000|Overall Study|Adverse Event|0|||
105474877|NCT00545272|363751243|FG001|Overall Study|Adverse Event|0|||
105474878|NCT00545272|363751244|FG002|Overall Study|Adverse Event|1|||
105474879|NCT00545272|363751245|FG003|Overall Study|Adverse Event|0|||
105474880|NCT00545272|363751246|FG004|Overall Study|Adverse Event|0|||
105708968|NCT00290433|364594517|FG000|Overall Study|Unrelated Infection/Death|1|||
105708969|NCT02559687|364594518|FG000|Overall Study|Death|112|||
105708970|NCT02559687|364594518|FG000|Overall Study|Sponsor Decision|5|||
105708971|NCT02559687|364594518|FG000|Overall Study|Withdrawal by Subject|4|||
105708972|NCT02264990|364594523|FG000|Overall Study|Death|255|||
105708973|NCT02264990|364594524|FG001|Overall Study|Death|250|||
105708974|NCT02264990|364594523|FG000|Overall Study|Withdrawal by Subject|4|||
105708975|NCT02264990|364594524|FG001|Overall Study|Withdrawal by Subject|5|||
105708976|NCT02264990|364594523|FG000|Overall Study|Lost to Follow-up|1|||
105708977|NCT02264990|364594524|FG001|Overall Study|Lost to Follow-up|3|||
105708978|NCT02264990|364594523|FG000|Overall Study|Other|0|||
105708979|NCT02264990|364594524|FG001|Overall Study|Other|1|||
105708980|NCT00790907|364594528|FG000|Overall Study|Adverse Event|9|||
105708981|NCT00790907|364594529|FG001|Overall Study|Adverse Event|7|||
105708982|NCT00790907|364594530|FG002|Overall Study|Adverse Event|6|||
105708983|NCT00790907|364594528|FG000|Overall Study|Physician Decision|304|||
105708984|NCT00790907|364594529|FG001|Overall Study|Physician Decision|271|||
105708985|NCT00790907|364594530|FG002|Overall Study|Physician Decision|255|||
105708986|NCT00790907|364594528|FG000|Overall Study|Withdrawal by Subject|1|||
105708987|NCT00790907|364594529|FG001|Overall Study|Withdrawal by Subject|7|||
105708988|NCT00790907|364594530|FG002|Overall Study|Withdrawal by Subject|5|||
105708989|NCT00790907|364594528|FG000|Overall Study|Bleeding Event|11|||
105708990|NCT00790907|364594529|FG001|Overall Study|Bleeding Event|16|||
105708991|NCT00790907|364594530|FG002|Overall Study|Bleeding Event|21|||
105708992|NCT00790907|364594528|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
105708993|NCT00790907|364594529|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
105708994|NCT00790907|364594530|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
105708995|NCT00790907|364594528|FG000|Overall Study|Qualifying Condition Not Present|29|||
105708996|NCT00790907|364594529|FG001|Overall Study|Qualifying Condition Not Present|14|||
105708997|NCT00790907|364594530|FG002|Overall Study|Qualifying Condition Not Present|16|||
105708998|NCT00790907|364594528|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
105350994|NCT01905592|363288261|FG000|Overall Study|Protocol Violation|0|||
105350995|NCT01905592|363288262|FG001|Overall Study|Protocol Violation|1|||
105350996|NCT01905592|363288261|FG000|Overall Study|Sponsor's decision|1|||
105350997|NCT01905592|363288262|FG001|Overall Study|Sponsor's decision|1|||
105350998|NCT01905592|363288261|FG000|Overall Study|Not treated|7|||
105350999|NCT01905592|363288262|FG001|Overall Study|Not treated|3|||
105351000|NCT01905592|363288261|FG000|Overall Study|Withdrawal by Subject|10|||
105351001|NCT01905592|363288262|FG001|Overall Study|Withdrawal by Subject|2|||
105351002|NCT05188729|363288263|FG000|Overall Study|Withdrawal by Subject|0|||
105351003|NCT05188729|363288264|FG001|Overall Study|Withdrawal by Subject|0|||
105351004|NCT05188729|363288265|FG002|Overall Study|Withdrawal by Subject|0|||
105351005|NCT05188729|363288266|FG003|Overall Study|Withdrawal by Subject|0|||
105351006|NCT05188729|363288267|FG004|Overall Study|Withdrawal by Subject|0|||
105351007|NCT05188729|363288268|FG005|Overall Study|Withdrawal by Subject|0|||
105351008|NCT05188729|363288269|FG006|Overall Study|Withdrawal by Subject|0|||
105351009|NCT05188729|363288270|FG007|Overall Study|Withdrawal by Subject|0|||
105474881|NCT00545272|363751247|FG005|Overall Study|Adverse Event|1|||
105474882|NCT00545272|363751242|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105474883|NCT00545272|363751243|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105474884|NCT00545272|363751244|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105474885|NCT00545272|363751245|FG003|Overall Study|Abnormal laboratory value(s)|0|||
105474886|NCT00545272|363751246|FG004|Overall Study|Abnormal laboratory value(s)|0|||
105474887|NCT00545272|363751247|FG005|Overall Study|Abnormal laboratory value(s)|1|||
105474888|NCT00545272|363751242|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105474889|NCT00545272|363751243|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105474890|NCT00545272|363751244|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105474891|NCT00545272|363751245|FG003|Overall Study|Abnormal test procedure result(s)|0|||
105474892|NCT00545272|363751246|FG004|Overall Study|Abnormal test procedure result(s)|1|||
105474893|NCT00545272|363751247|FG005|Overall Study|Abnormal test procedure result(s)|0|||
105474894|NCT00545272|363751242|FG000|Overall Study|Lost to Follow-up|0|||
105474895|NCT00545272|363751243|FG001|Overall Study|Lost to Follow-up|0|||
105474896|NCT00545272|363751244|FG002|Overall Study|Lost to Follow-up|0|||
105474897|NCT00545272|363751245|FG003|Overall Study|Lost to Follow-up|0|||
105474898|NCT00545272|363751246|FG004|Overall Study|Lost to Follow-up|1|||
105474899|NCT00545272|363751247|FG005|Overall Study|Lost to Follow-up|0|||
105474900|NCT04491604|363751248|FG000|Overall Study|Withdrawal by Subject|3|||
105474901|NCT02934503|363751251|FG000|Overall Study|progression of disease|3|||
105474902|NCT02934503|363751251|FG000|Overall Study|Withdrawal by Subject|1|||
105474903|NCT02314637|363751252|FG000|Overall Study|Adverse Event|4|||
105474904|NCT02314637|363751253|FG001|Overall Study|Adverse Event|8|||
105708999|NCT00790907|364594529|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
105709000|NCT00790907|364594530|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
105709001|NCT00790907|364594528|FG000|Overall Study|Did Not Receive Study Drug|10|||
105709002|NCT00790907|364594529|FG001|Overall Study|Did Not Receive Study Drug|0|||
105351010|NCT05188729|363288271|FG008|Overall Study|Withdrawal by Subject|0|||
105474905|NCT02314637|363751252|FG000|Overall Study|Lack of Efficacy|1|||
105474906|NCT02314637|363751253|FG001|Overall Study|Lack of Efficacy|0|||
105709003|NCT00790907|364594530|FG002|Overall Study|Did Not Receive Study Drug|0|||
105709004|NCT01618214|364594531|FG000|Overall Study|Adverse Event|3|||
105709005|NCT01618214|364594532|FG001|Overall Study|Adverse Event|1|||
105351011|NCT05188729|363288272|FG009|Overall Study|Withdrawal by Subject|1|||
105351012|NCT05188729|363288273|FG010|Overall Study|Withdrawal by Subject|0|||
105474907|NCT02314637|363751252|FG000|Overall Study|Physician Decision|5|||
105474908|NCT02314637|363751253|FG001|Overall Study|Physician Decision|2|||
105709006|NCT01618214|364594531|FG000|Overall Study|Lack of Efficacy|1|||
105709007|NCT01618214|364594532|FG001|Overall Study|Lack of Efficacy|1|||
105474909|NCT02314637|363751252|FG000|Overall Study|Withdrawal by Subject|5|||
105474910|NCT02314637|363751253|FG001|Overall Study|Withdrawal by Subject|4|||
105474911|NCT02314637|363751252|FG000|Overall Study|Other Reason|1|||
105474912|NCT02314637|363751253|FG001|Overall Study|Other Reason|0|||
105474913|NCT00475306|363751254|FG000|Overall Study|Protocol Violation|1|||
105474914|NCT00475306|363751255|FG001|Overall Study|Protocol Violation|1|||
105474915|NCT00475306|363751256|FG002|Overall Study|Protocol Violation|0|||
105474916|NCT00475306|363751257|FG003|Overall Study|Protocol Violation|1|||
105474917|NCT01536067|363751258|FG000|Overall Study|Disease Progression|1|||
105474918|NCT01305577|363751259|FG000|Overall Study|Adverse Event|2|||
105474919|NCT01305577|363751260|FG001|Overall Study|Adverse Event|2|||
105474920|NCT01305577|363751261|FG002|Overall Study|Adverse Event|1|||
105474921|NCT01305577|363751259|FG000|Overall Study|Withdrawal by Subject|7|||
105474922|NCT01305577|363751260|FG001|Overall Study|Withdrawal by Subject|5|||
105474923|NCT01305577|363751261|FG002|Overall Study|Withdrawal by Subject|6|||
105474924|NCT01305577|363751259|FG000|Overall Study|Lost to Follow-up|4|||
105360885|NCT00873730|363328100|FG001|Overall Study|Sponsor decision|0|||
105709008|NCT01618214|364594531|FG000|Overall Study|Protocol Violation|1|||
105709009|NCT01618214|364594532|FG001|Overall Study|Protocol Violation|4|||
105709010|NCT01618214|364594531|FG000|Overall Study|Withdrawal Criteria|1|||
105709011|NCT01618214|364594532|FG001|Overall Study|Withdrawal Criteria|2|||
105709012|NCT01618214|364594531|FG000|Overall Study|Unclassified|4|||
105709013|NCT01618214|364594532|FG001|Overall Study|Unclassified|5|||
105709014|NCT01097863|364594533|FG000|Overall Study|Discomfort|1|||
105709015|NCT01097863|364594534|FG001|Overall Study|Discomfort|0|||
105709016|NCT01097863|364594535|FG002|Overall Study|Discomfort|1|||
105709017|NCT01097863|364594533|FG000|Overall Study|Did not return for final visit|0|||
105709018|NCT01097863|364594534|FG001|Overall Study|Did not return for final visit|0|||
105709019|NCT01097863|364594535|FG002|Overall Study|Did not return for final visit|1|||
105709020|NCT00796315|364594536|FG000|Overall Study|Protocol Violation|0|||
105709021|NCT00796315|364594537|FG001|Overall Study|Protocol Violation|1|||
105709022|NCT00796315|364594538|FG002|Overall Study|Protocol Violation|0|||
105709023|NCT03847610|364594539|FG000|Overall Study|Withdrawal by Subject|1|||
105709024|NCT01627860|364594540|FG000|Overall Study|Adverse Event|9|||
105709025|NCT01627860|364594541|FG001|Overall Study|Adverse Event|4|||
105709026|NCT01627860|364594540|FG000|Overall Study|Withdrawal by Subject|2|||
105709027|NCT01627860|364594541|FG001|Overall Study|Withdrawal by Subject|1|||
105709028|NCT01627860|364594540|FG000|Overall Study|Seizure frequency doubled|0|||
105709029|NCT01627860|364594541|FG001|Overall Study|Seizure frequency doubled|1|||
105709030|NCT01627860|364594540|FG000|Overall Study|Protocol Violation|1|||
105709031|NCT01627860|364594541|FG001|Overall Study|Protocol Violation|0|||
105709032|NCT02069899|364594564|FG000|Overall Study|Adverse Event|6|||
105709033|NCT02069899|364594565|FG001|Overall Study|Adverse Event|0|||
105709034|NCT02069899|364594566|FG002|Overall Study|Adverse Event|1|||
105709035|NCT02069899|364594564|FG000|Overall Study|Withdrawal by Participant|2|||
105709036|NCT02069899|364594565|FG001|Overall Study|Withdrawal by Participant|0|||
105709037|NCT02069899|364594566|FG002|Overall Study|Withdrawal by Participant|0|||
105709038|NCT02069899|364594564|FG000|Overall Study|Lost to Follow-up|1|||
105709039|NCT02069899|364594565|FG001|Overall Study|Lost to Follow-up|0|||
105709040|NCT02069899|364594566|FG002|Overall Study|Lost to Follow-up|1|||
105709041|NCT02069899|364594564|FG000|Overall Study|Other|4|||
105709042|NCT02069899|364594565|FG001|Overall Study|Other|0|||
105709043|NCT02069899|364594566|FG002|Overall Study|Other|0|||
105709044|NCT02069899|364594564|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
105709045|NCT02069899|364594565|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
105709046|NCT02069899|364594566|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
105709047|NCT02069899|364594564|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
105709048|NCT02069899|364594565|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
105709049|NCT02069899|364594566|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
105709050|NCT01079182|364594567|FG000|Overall Study|Lost to Follow-up|1634|||
105709051|NCT01079182|364594567|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
105709052|NCT01079182|364594567|FG000|Overall Study|Lack of Efficacy|514|||
105709053|NCT01079182|364594567|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
105709054|NCT01079182|364594567|FG000|Overall Study|Reasons not Evaluated|271|||
105709055|NCT02751502|364594568|FG000|Overall Study|Lack of funding|4|||
105709056|NCT02678390|364594569|FG000|AE (1 Day)|Withdrawal by Subject|0|||
105709057|NCT02678390|364594570|FG001|AE (1 Day)|Withdrawal by Subject|1|||
105709058|NCT02508194|364594571|FG000|Overall Study|Death|5|||
105474925|NCT01305577|363751260|FG001|Overall Study|Lost to Follow-up|3|||
105474926|NCT01305577|363751261|FG002|Overall Study|Lost to Follow-up|2|||
105709059|NCT02508194|364594572|FG001|Overall Study|Death|3|||
105709060|NCT02508194|364594571|FG000|Overall Study|Lost to Follow-up|25|||
105709061|NCT02508194|364594572|FG001|Overall Study|Lost to Follow-up|18|||
105709062|NCT02508194|364594571|FG000|Overall Study|Withdrawal by Subject|20|||
105709063|NCT02508194|364594572|FG001|Overall Study|Withdrawal by Subject|18|||
105709064|NCT02508194|364594571|FG000|Overall Study|Error in Randomization|1|||
105709065|NCT02508194|364594572|FG001|Overall Study|Error in Randomization|3|||
105709066|NCT02508194|364594571|FG000|Overall Study|Principal Investigator Decision|1|||
105709067|NCT02508194|364594572|FG001|Overall Study|Principal Investigator Decision|2|||
105709068|NCT00511355|364594573|FG000|Overall Study|Adverse Event|4|||
105709069|NCT00511355|364594574|FG001|Overall Study|Adverse Event|4|||
105709070|NCT00511355|364594573|FG000|Overall Study|Pregnancy Wish|1|||
105709071|NCT00511355|364594574|FG001|Overall Study|Pregnancy Wish|0|||
105709072|NCT00511355|364594573|FG000|Overall Study|Lost to Follow-up|2|||
105709073|NCT00511355|364594574|FG001|Overall Study|Lost to Follow-up|1|||
105709074|NCT00511355|364594573|FG000|Overall Study|Other Reason|0|||
105709075|NCT00511355|364594574|FG001|Overall Study|Other Reason|1|||
105709076|NCT00511355|364594573|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
105709077|NCT00511355|364594574|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
105709078|NCT00511355|364594573|FG000|Overall Study|Withdrawal of informed consent|0|||
105709079|NCT00511355|364594574|FG001|Overall Study|Withdrawal of informed consent|1|||
105709080|NCT00511355|364594573|FG000|Overall Study|Other reason pre-treatment|0|||
105709081|NCT00511355|364594574|FG001|Overall Study|Other reason pre-treatment|1|||
105709082|NCT05574062|364594575|FG000|Pre Run-In|Screening failure|3|||
105709083|NCT05574062|364594576|FG001|Pre Run-In|Screening failure|0|||
105709084|NCT05574062|364594577|FG002|Pre Run-In|Screening failure|0|||
105709085|NCT05574062|364594578|FG003|Pre Run-In|Screening failure|0|||
105709086|NCT05574062|364594579|FG004|Pre Run-In|Screening failure|0|||
105709087|NCT05574062|364594575|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
105709088|NCT05574062|364594576|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
105709089|NCT05574062|364594577|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
105709090|NCT05574062|364594578|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
105709091|NCT05574062|364594579|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
105709092|NCT05574062|364594575|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
105709093|NCT05574062|364594576|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
105709094|NCT05574062|364594577|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
105709095|NCT05574062|364594578|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
105709096|NCT05574062|364594579|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
105709097|NCT05574062|364594575|FG000|Continuation Phase Period 1|Physician Decision|1|||
105709098|NCT05574062|364594576|FG001|Continuation Phase Period 1|Physician Decision|0|||
105709099|NCT05574062|364594577|FG002|Continuation Phase Period 1|Physician Decision|0|||
105709100|NCT05574062|364594578|FG003|Continuation Phase Period 1|Physician Decision|0|||
105709101|NCT05574062|364594579|FG004|Continuation Phase Period 1|Physician Decision|0|||
105709102|NCT05574062|364594575|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
105709103|NCT05574062|364594576|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
105709104|NCT05574062|364594577|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
105709105|NCT05574062|364594578|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
105709106|NCT05574062|364594579|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
105709107|NCT05574062|364594575|FG000|Continuation Phase Period 1|Adverse Event|1|||
105709108|NCT05574062|364594576|FG001|Continuation Phase Period 1|Adverse Event|0|||
105709109|NCT05574062|364594577|FG002|Continuation Phase Period 1|Adverse Event|0|||
105709110|NCT05574062|364594578|FG003|Continuation Phase Period 1|Adverse Event|0|||
105709111|NCT05574062|364594579|FG004|Continuation Phase Period 1|Adverse Event|0|||
105709112|NCT05574062|364594575|FG000|Continuation Phase Period 1|Death|1|||
105709113|NCT05574062|364594576|FG001|Continuation Phase Period 1|Death|0|||
105709114|NCT05574062|364594577|FG002|Continuation Phase Period 1|Death|0|||
105709115|NCT05574062|364594578|FG003|Continuation Phase Period 1|Death|0|||
105709116|NCT05574062|364594579|FG004|Continuation Phase Period 1|Death|0|||
105709117|NCT05574062|364594575|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
105709118|NCT05574062|364594576|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
105709119|NCT05574062|364594577|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
105709120|NCT05574062|364594578|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
105709121|NCT05574062|364594579|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
105709122|NCT01358864|364594580|FG000|Overall Study|Adverse Event|0|||
105709123|NCT01358864|364594581|FG001|Overall Study|Adverse Event|6|||
105709124|NCT01358864|364594582|FG002|Overall Study|Adverse Event|9|||
105360886|NCT01051557|363328103|FG000|Overall Study|Physician Decision|1|||
105709125|NCT01358864|364594583|FG003|Overall Study|Adverse Event|0|||
105709126|NCT01358864|364594584|FG004|Overall Study|Adverse Event|4|||
105709127|NCT01358864|364594585|FG005|Overall Study|Adverse Event|8|||
105709128|NCT01358864|364594586|FG006|Overall Study|Adverse Event|12|||
105709129|NCT01358864|364594587|FG007|Overall Study|Adverse Event|7|||
105709130|NCT01358864|364594580|FG000|Overall Study|Lack of Efficacy|26|||
105709131|NCT01358864|364594581|FG001|Overall Study|Lack of Efficacy|3|||
105709132|NCT01358864|364594582|FG002|Overall Study|Lack of Efficacy|4|||
105709133|NCT01358864|364594583|FG003|Overall Study|Lack of Efficacy|19|||
105709134|NCT01358864|364594584|FG004|Overall Study|Lack of Efficacy|7|||
105709135|NCT01358864|364594585|FG005|Overall Study|Lack of Efficacy|4|||
105709136|NCT01358864|364594586|FG006|Overall Study|Lack of Efficacy|49|||
105709137|NCT01358864|364594587|FG007|Overall Study|Lack of Efficacy|44|||
105709138|NCT01358864|364594580|FG000|Overall Study|Lost to Follow-up|0|||
105709139|NCT01358864|364594581|FG001|Overall Study|Lost to Follow-up|0|||
105709140|NCT01358864|364594582|FG002|Overall Study|Lost to Follow-up|1|||
105709141|NCT01358864|364594583|FG003|Overall Study|Lost to Follow-up|0|||
105709142|NCT01358864|364594584|FG004|Overall Study|Lost to Follow-up|0|||
105709143|NCT01358864|364594585|FG005|Overall Study|Lost to Follow-up|0|||
105709144|NCT01358864|364594586|FG006|Overall Study|Lost to Follow-up|0|||
105709145|NCT01358864|364594587|FG007|Overall Study|Lost to Follow-up|1|||
105709146|NCT01358864|364594580|FG000|Overall Study|Withdrawal by Subject|3|||
105709147|NCT01358864|364594581|FG001|Overall Study|Withdrawal by Subject|4|||
105709148|NCT01358864|364594582|FG002|Overall Study|Withdrawal by Subject|2|||
105709149|NCT01358864|364594583|FG003|Overall Study|Withdrawal by Subject|0|||
105709150|NCT01358864|364594584|FG004|Overall Study|Withdrawal by Subject|0|||
105709151|NCT01358864|364594585|FG005|Overall Study|Withdrawal by Subject|1|||
105709152|NCT01358864|364594586|FG006|Overall Study|Withdrawal by Subject|1|||
105709153|NCT01358864|364594587|FG007|Overall Study|Withdrawal by Subject|3|||
105709154|NCT01358864|364594580|FG000|Overall Study|Other reason not defined above|2|||
105709155|NCT01358864|364594581|FG001|Overall Study|Other reason not defined above|0|||
105709156|NCT01358864|364594582|FG002|Overall Study|Other reason not defined above|0|||
105709157|NCT01358864|364594583|FG003|Overall Study|Other reason not defined above|0|||
105709158|NCT01358864|364594584|FG004|Overall Study|Other reason not defined above|0|||
105709159|NCT01358864|364594585|FG005|Overall Study|Other reason not defined above|0|||
105709160|NCT01358864|364594586|FG006|Overall Study|Other reason not defined above|2|||
105709161|NCT01358864|364594587|FG007|Overall Study|Other reason not defined above|0|||
105709162|NCT01358864|364594580|FG000|Overall Study|Not treated|0|||
105709163|NCT01358864|364594581|FG001|Overall Study|Not treated|0|||
105709164|NCT01358864|364594582|FG002|Overall Study|Not treated|0|||
105709165|NCT01358864|364594583|FG003|Overall Study|Not treated|0|||
105709166|NCT01358864|364594584|FG004|Overall Study|Not treated|0|||
105709167|NCT01358864|364594585|FG005|Overall Study|Not treated|0|||
105709168|NCT01358864|364594586|FG006|Overall Study|Not treated|1|||
105709169|NCT01358864|364594587|FG007|Overall Study|Not treated|0|||
105709170|NCT01250379|364594589|FG000|Overall Study|Death|141|||
105709171|NCT01250379|364594590|FG001|Overall Study|Death|148|||
105709172|NCT01250379|364594589|FG000|Overall Study|Withdrawal by Subject|32|||
105709173|NCT01250379|364594590|FG001|Overall Study|Withdrawal by Subject|20|||
105709174|NCT01250379|364594589|FG000|Overall Study|Physician Decision|11|||
105709175|NCT01250379|364594590|FG001|Overall Study|Physician Decision|3|||
105709176|NCT01250379|364594589|FG000|Overall Study|Protocol Violation|2|||
105709177|NCT01250379|364594590|FG001|Overall Study|Protocol Violation|8|||
105709178|NCT01250379|364594589|FG000|Overall Study|Lost to Follow-up|9|||
105709179|NCT01250379|364594590|FG001|Overall Study|Lost to Follow-up|6|||
105709180|NCT01250379|364594589|FG000|Overall Study|Adverse Event|5|||
105709181|NCT01250379|364594590|FG001|Overall Study|Adverse Event|4|||
105709182|NCT01250379|364594589|FG000|Overall Study|Other|0|||
105709183|NCT01250379|364594590|FG001|Overall Study|Other|4|||
105709184|NCT01250379|364594589|FG000|Overall Study|Participant noncompliance|2|||
105474927|NCT01305577|363751259|FG000|Overall Study|Protocol Deviation|0|||
105474928|NCT01305577|363751260|FG001|Overall Study|Protocol Deviation|1|||
105474929|NCT01305577|363751261|FG002|Overall Study|Protocol Deviation|1|||
105709185|NCT01250379|364594590|FG001|Overall Study|Participant noncompliance|0|||
105709186|NCT01534533|364594591|FG000|Overall Study|Lost to Follow-up|3|||
105709187|NCT01534533|364594592|FG001|Overall Study|Lost to Follow-up|0|||
105709188|NCT01534533|364594593|FG002|Overall Study|Lost to Follow-up|4|||
105788056|NCT02660489|364878175|FG001|Overall Study|no rhinovirus infection|4|||
105474930|NCT03120351|363751262|FG000|Overall Study|Physician Decision|1|||
105474931|NCT03120351|363751263|FG001|Overall Study|Physician Decision|1|||
105709189|NCT01534533|364594594|FG003|Overall Study|Lost to Follow-up|3|||
105709190|NCT01534533|364594591|FG000|Overall Study|Withdrawal by Subject|5|||
105709191|NCT01534533|364594592|FG001|Overall Study|Withdrawal by Subject|3|||
105709192|NCT01534533|364594593|FG002|Overall Study|Withdrawal by Subject|4|||
105709193|NCT01534533|364594594|FG003|Overall Study|Withdrawal by Subject|1|||
105709194|NCT03505021|364594595|FG000|Overall Study|Protocol Violation|1|||
105709195|NCT03505021|364594596|FG001|Overall Study|Protocol Violation|0|||
105709196|NCT03505021|364594595|FG000|Overall Study|Death|9|||
105709197|NCT03505021|364594596|FG001|Overall Study|Death|8|||
105709198|NCT03505021|364594595|FG000|Overall Study|Consent withdrawn by subject|6|||
105709199|NCT03505021|364594596|FG001|Overall Study|Consent withdrawn by subject|1|||
105709200|NCT03505021|364594595|FG000|Overall Study|Lost to Follow-up|5|||
105709201|NCT03505021|364594596|FG001|Overall Study|Lost to Follow-up|3|||
105709202|NCT03505021|364594595|FG000|Overall Study|Adverse Event|26|||
105709203|NCT03505021|364594596|FG001|Overall Study|Adverse Event|9|||
105709204|NCT03505021|364594595|FG000|Overall Study|Disease progression|33|||
105709205|NCT03505021|364594596|FG001|Overall Study|Disease progression|17|||
105709206|NCT03505021|364594595|FG000|Overall Study|Other|11|||
105709207|NCT03505021|364594596|FG001|Overall Study|Other|5|||
105709208|NCT03505021|364594595|FG000|Overall Study|Personal reason|21|||
105709209|NCT03505021|364594596|FG001|Overall Study|Personal reason|12|||
105709210|NCT00150592|364596071|FG000|Overall Study|Adverse Event|4|||
105709211|NCT00150592|364596072|FG001|Overall Study|Adverse Event|1|||
105709212|NCT00150592|364596071|FG000|Overall Study|Protocol Violation|1|||
105709213|NCT00150592|364596072|FG001|Overall Study|Protocol Violation|0|||
105709214|NCT00150592|364596071|FG000|Overall Study|Withdrawal by Subject|1|||
105709215|NCT00150592|364596072|FG001|Overall Study|Withdrawal by Subject|2|||
105709216|NCT00150592|364596071|FG000|Overall Study|Non-compliance|1|||
105709217|NCT00150592|364596072|FG001|Overall Study|Non-compliance|0|||
105709218|NCT01783678|364596073|FG000|Overall Study|Randomized but Not Treated|0|||
105709219|NCT01783678|364596074|FG001|Overall Study|Randomized but Not Treated|0|||
105709220|NCT01783678|364596075|FG002|Overall Study|Randomized but Not Treated|0|||
105709221|NCT01783678|364596076|FG003|Overall Study|Randomized but Not Treated|1|||
105709222|NCT01783678|364596077|FG004|Overall Study|Randomized but Not Treated|0|||
105709223|NCT01783678|364596078|FG005|Overall Study|Randomized but Not Treated|0|||
105709224|NCT01783678|364596073|FG000|Overall Study|Lack of Efficacy|1|||
105709225|NCT01783678|364596074|FG001|Overall Study|Lack of Efficacy|13|||
105709226|NCT01783678|364596075|FG002|Overall Study|Lack of Efficacy|1|||
105709227|NCT01783678|364596076|FG003|Overall Study|Lack of Efficacy|3|||
105709228|NCT01783678|364596077|FG004|Overall Study|Lack of Efficacy|6|||
105709229|NCT01783678|364596078|FG005|Overall Study|Lack of Efficacy|5|||
105709230|NCT01783678|364596073|FG000|Overall Study|Lost to Follow-up|0|||
105709231|NCT01783678|364596074|FG001|Overall Study|Lost to Follow-up|4|||
105709232|NCT01783678|364596075|FG002|Overall Study|Lost to Follow-up|0|||
105709233|NCT01783678|364596076|FG003|Overall Study|Lost to Follow-up|2|||
105709234|NCT01783678|364596077|FG004|Overall Study|Lost to Follow-up|1|||
105709235|NCT01783678|364596078|FG005|Overall Study|Lost to Follow-up|0|||
105709236|NCT01783678|364596073|FG000|Overall Study|Withdrew Consent|1|||
105709237|NCT01783678|364596074|FG001|Overall Study|Withdrew Consent|1|||
105709238|NCT01783678|364596075|FG002|Overall Study|Withdrew Consent|0|||
105709239|NCT01783678|364596076|FG003|Overall Study|Withdrew Consent|2|||
105709240|NCT01783678|364596077|FG004|Overall Study|Withdrew Consent|0|||
105709241|NCT01783678|364596078|FG005|Overall Study|Withdrew Consent|0|||
105709242|NCT02049944|364596079|FG000|Overall Study|Protocol Violation|2|||
105709243|NCT00706134|364596080|FG000|Overall Study|Adverse Event|8|||
105709244|NCT00706134|364596081|FG001|Overall Study|Adverse Event|7|||
105709245|NCT00706134|364596082|FG002|Overall Study|Adverse Event|2|||
105709246|NCT00706134|364596083|FG003|Overall Study|Adverse Event|3|||
105709247|NCT00706134|364596080|FG000|Overall Study|Lost to Follow-up|0|||
105709248|NCT00706134|364596081|FG001|Overall Study|Lost to Follow-up|1|||
105709249|NCT00706134|364596082|FG002|Overall Study|Lost to Follow-up|0|||
105709250|NCT00706134|364596083|FG003|Overall Study|Lost to Follow-up|0|||
105709251|NCT00706134|364596080|FG000|Overall Study|Protocol Violation|0|||
105709252|NCT00706134|364596081|FG001|Overall Study|Protocol Violation|6|||
105709253|NCT00706134|364596082|FG002|Overall Study|Protocol Violation|0|||
105709254|NCT00706134|364596083|FG003|Overall Study|Protocol Violation|3|||
105709255|NCT00706134|364596080|FG000|Overall Study|Withdrawal by Subject|1|||
105709256|NCT00706134|364596081|FG001|Overall Study|Withdrawal by Subject|2|||
105709257|NCT00706134|364596082|FG002|Overall Study|Withdrawal by Subject|1|||
105709258|NCT00706134|364596083|FG003|Overall Study|Withdrawal by Subject|0|||
105709259|NCT00706134|364596080|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
105709260|NCT00706134|364596081|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105709261|NCT00706134|364596082|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
105709262|NCT00706134|364596083|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
105709263|NCT00706134|364596080|FG000|Overall Study|Did not meet study criteria|2|||
105709264|NCT00706134|364596081|FG001|Overall Study|Did not meet study criteria|0|||
105709265|NCT00706134|364596082|FG002|Overall Study|Did not meet study criteria|0|||
105709266|NCT00706134|364596083|FG003|Overall Study|Did not meet study criteria|0|||
105709267|NCT03691974|364596086|FG000|Overall Study|Physician Decision|1|||
105360887|NCT01051557|363328104|FG001|Overall Study|Physician Decision|0|||
105709268|NCT03691974|364596087|FG001|Overall Study|Physician Decision|0|||
105709269|NCT03691974|364596086|FG000|Overall Study|Adverse Event|1|||
105709270|NCT03691974|364596087|FG001|Overall Study|Adverse Event|0|||
105709271|NCT03691974|364596086|FG000|Overall Study|Withdrawal by Subject|11|||
105709272|NCT03691974|364596087|FG001|Overall Study|Withdrawal by Subject|9|||
105709273|NCT03691974|364596086|FG000|Overall Study|Protocol Violation|1|||
105709274|NCT03691974|364596087|FG001|Overall Study|Protocol Violation|0|||
105709275|NCT03691974|364596086|FG000|Overall Study|Lost to Follow-up|8|||
105709276|NCT03691974|364596087|FG001|Overall Study|Lost to Follow-up|7|||
105709277|NCT03468309|364596090|FG000|Overall Study|Lost to Follow-up|4|||
105709278|NCT03468309|364596090|FG000|Overall Study|Withdrawal by Subject|2|||
105709279|NCT00488982|364596091|FG000|Course 1|Physician Decision|0|||
105709280|NCT00488982|364596092|FG001|Course 1|Physician Decision|2|||
105709281|NCT00488982|364596093|FG002|Course 1|Physician Decision|4|||
105709282|NCT00488982|364596091|FG000|Course 1|Withdrawal by Subject|0|||
105709283|NCT00488982|364596092|FG001|Course 1|Withdrawal by Subject|8|||
105709284|NCT00488982|364596093|FG002|Course 1|Withdrawal by Subject|2|||
105709285|NCT00488982|364596091|FG000|Course 1|nonprotocol therapy|0|||
105709286|NCT00488982|364596092|FG001|Course 1|nonprotocol therapy|2|||
105709287|NCT00488982|364596093|FG002|Course 1|nonprotocol therapy|2|||
105709288|NCT00488982|364596091|FG000|Course 1|Adverse Event|0|||
105709289|NCT00488982|364596092|FG001|Course 1|Adverse Event|0|||
105709290|NCT00488982|364596093|FG002|Course 1|Adverse Event|6|||
105709291|NCT01485627|364596094|FG000|Overall Study|Patient withdrew|6|||
105709292|NCT01485627|364596095|FG001|Overall Study|Patient withdrew|5|||
105709293|NCT01485627|364596094|FG000|Overall Study|Patient died|3|||
105709294|NCT01485627|364596095|FG001|Overall Study|Patient died|1|||
105709295|NCT01485627|364596094|FG000|Overall Study|Patient lost to followup|0|||
105709296|NCT01485627|364596095|FG001|Overall Study|Patient lost to followup|1|||
105709297|NCT01485627|364596094|FG000|Overall Study|Caregiver withdrew|3|||
105709298|NCT01485627|364596095|FG001|Overall Study|Caregiver withdrew|3|||
105709299|NCT01485627|364596094|FG000|Overall Study|Caregiver lost to follow up|11|||
105709300|NCT01485627|364596095|FG001|Overall Study|Caregiver lost to follow up|12|||
105709301|NCT01485627|364596094|FG000|Overall Study|Caregiver died|1|||
105709302|NCT01485627|364596095|FG001|Overall Study|Caregiver died|0|||
105709303|NCT01485627|364596094|FG000|Overall Study|caregiver was not bereaved|42|||
105709304|NCT01485627|364596095|FG001|Overall Study|caregiver was not bereaved|35|||
105709305|NCT01709149|364596096|FG000|Open-label Lead-in Phase|Adverse Event|109|||
105709306|NCT01709149|364596097|FG001|Open-label Lead-in Phase|Adverse Event|0|||
105709307|NCT01709149|364596098|FG002|Open-label Lead-in Phase|Adverse Event|0|||
105709308|NCT01709149|364596096|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
105709309|NCT01709149|364596097|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
105351013|NCT05188729|363288274|FG011|Overall Study|Withdrawal by Subject|0|||
105351014|NCT05188729|363288275|FG012|Overall Study|Withdrawal by Subject|0|||
105351015|NCT05188729|363288263|FG000|Overall Study|Lost to Follow-up|0|||
105351016|NCT05188729|363288264|FG001|Overall Study|Lost to Follow-up|0|||
105351017|NCT05188729|363288265|FG002|Overall Study|Lost to Follow-up|0|||
105351018|NCT05188729|363288266|FG003|Overall Study|Lost to Follow-up|0|||
105351019|NCT05188729|363288267|FG004|Overall Study|Lost to Follow-up|0|||
105351020|NCT05188729|363288268|FG005|Overall Study|Lost to Follow-up|0|||
105351021|NCT05188729|363288269|FG006|Overall Study|Lost to Follow-up|0|||
105351022|NCT05188729|363288270|FG007|Overall Study|Lost to Follow-up|0|||
105351023|NCT05188729|363288271|FG008|Overall Study|Lost to Follow-up|0|||
105351024|NCT05188729|363288272|FG009|Overall Study|Lost to Follow-up|0|||
105351025|NCT05188729|363288273|FG010|Overall Study|Lost to Follow-up|1|||
105351026|NCT05188729|363288274|FG011|Overall Study|Lost to Follow-up|1|||
105351027|NCT05188729|363288275|FG012|Overall Study|Lost to Follow-up|0|||
105351028|NCT02824562|363289614|FG000|Overall Study|Lost to Follow-up|3|||
105351029|NCT02824562|363289615|FG001|Overall Study|Lost to Follow-up|4|||
105351030|NCT02824562|363289614|FG000|Overall Study|Death|0|||
105351031|NCT02824562|363289615|FG001|Overall Study|Death|1|||
105351032|NCT03089853|363289619|FG000|Overall Study|Lost to Follow-up|2|||
105709310|NCT01709149|364596098|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
105709311|NCT01709149|364596096|FG000|Open-label Lead-in Phase|Death|1|||
105709312|NCT01709149|364596097|FG001|Open-label Lead-in Phase|Death|0|||
105709313|NCT01709149|364596098|FG002|Open-label Lead-in Phase|Death|0|||
105709314|NCT01709149|364596096|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
105709315|NCT01709149|364596097|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
105709316|NCT01709149|364596098|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
105709317|NCT01709149|364596096|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
105709318|NCT01709149|364596097|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
105709319|NCT01709149|364596098|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
105709320|NCT01709149|364596096|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
105709321|NCT01709149|364596097|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
105709322|NCT01709149|364596098|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
105351033|NCT03089853|363289620|FG001|Overall Study|Lost to Follow-up|1|||
105351034|NCT02168777|363289621|FG000|Overall Study|Withdrawal by Subject|1|||
105351035|NCT02168777|363289622|FG001|Overall Study|Withdrawal by Subject|0|||
105351036|NCT02168777|363289623|FG002|Overall Study|Withdrawal by Subject|2|||
105351037|NCT02168777|363289621|FG000|Overall Study|Adverse Event|1|||
105351038|NCT02168777|363289622|FG001|Overall Study|Adverse Event|0|||
105709323|NCT01709149|364596096|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
105709324|NCT01709149|364596097|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
105474932|NCT02834793|363751264|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
105474933|NCT02834793|363751265|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
105474934|NCT02834793|363751266|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
105474935|NCT02834793|363751267|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
105474936|NCT02834793|363751264|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
105474937|NCT02834793|363751265|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
105474938|NCT02834793|363751266|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
105474939|NCT02834793|363751267|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
105474940|NCT02834793|363751264|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
105474941|NCT02834793|363751265|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
105474942|NCT02834793|363751266|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
105474943|NCT02834793|363751267|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
105474944|NCT02834793|363751264|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
105474945|NCT02834793|363751265|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
105474946|NCT02834793|363751266|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
105474947|NCT02834793|363751267|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
105474948|NCT02834793|363751264|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
105474949|NCT02834793|363751265|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
105474950|NCT02834793|363751266|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
105474951|NCT02834793|363751267|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
105570317|NCT03573908|364086748|FG000|Treatment Period|Other, Not Specified|4|||
105709325|NCT01709149|364596098|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
105709326|NCT01709149|364596096|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
105709327|NCT01709149|364596097|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
105709328|NCT01709149|364596098|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
105709329|NCT01709149|364596096|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
105709330|NCT01709149|364596097|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
105709331|NCT01709149|364596098|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
105709332|NCT01709149|364596096|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105709333|NCT01709149|364596097|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
105709334|NCT01709149|364596098|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105709335|NCT03245450|364596101|FG000|Overall Study|Radiological disease progression|3|||
105709336|NCT03245450|364596102|FG001|Overall Study|Radiological disease progression|3|||
105709337|NCT03245450|364596103|FG002|Overall Study|Radiological disease progression|2|||
105709338|NCT03245450|364596104|FG003|Overall Study|Radiological disease progression|2|||
105709339|NCT03245450|364596105|FG004|Overall Study|Radiological disease progression|7|||
105709340|NCT03245450|364596106|FG005|Overall Study|Radiological disease progression|6|||
105709341|NCT03245450|364596107|FG006|Overall Study|Radiological disease progression|6|||
105709342|NCT03245450|364596101|FG000|Overall Study|Clinical disease progression|0|||
105709343|NCT03245450|364596102|FG001|Overall Study|Clinical disease progression|0|||
105709344|NCT03245450|364596103|FG002|Overall Study|Clinical disease progression|1|||
105709345|NCT03245450|364596104|FG003|Overall Study|Clinical disease progression|0|||
105709346|NCT03245450|364596105|FG004|Overall Study|Clinical disease progression|0|||
105709347|NCT03245450|364596106|FG005|Overall Study|Clinical disease progression|2|||
105709348|NCT03245450|364596107|FG006|Overall Study|Clinical disease progression|0|||
105709349|NCT03245450|364596101|FG000|Overall Study|Other|0|||
105709350|NCT03245450|364596102|FG001|Overall Study|Other|0|||
105709351|NCT03245450|364596103|FG002|Overall Study|Other|0|||
105709352|NCT03245450|364596104|FG003|Overall Study|Other|1|||
105709353|NCT03245450|364596105|FG004|Overall Study|Other|1|||
105709354|NCT03245450|364596106|FG005|Overall Study|Other|1|||
105709355|NCT03245450|364596107|FG006|Overall Study|Other|1|||
105709356|NCT03245450|364596101|FG000|Overall Study|Withdrawal by Subject|0|||
105709357|NCT03245450|364596102|FG001|Overall Study|Withdrawal by Subject|1|||
105709358|NCT03245450|364596103|FG002|Overall Study|Withdrawal by Subject|0|||
105709359|NCT03245450|364596104|FG003|Overall Study|Withdrawal by Subject|0|||
105709360|NCT03245450|364596105|FG004|Overall Study|Withdrawal by Subject|0|||
105709361|NCT03245450|364596106|FG005|Overall Study|Withdrawal by Subject|0|||
105709362|NCT03245450|364596107|FG006|Overall Study|Withdrawal by Subject|0|||
105709363|NCT03245450|364596101|FG000|Overall Study|Adverse Event|0|||
105709364|NCT03245450|364596102|FG001|Overall Study|Adverse Event|0|||
105709365|NCT03245450|364596103|FG002|Overall Study|Adverse Event|0|||
105709366|NCT03245450|364596104|FG003|Overall Study|Adverse Event|0|||
105709367|NCT03245450|364596105|FG004|Overall Study|Adverse Event|1|||
105474952|NCT02834793|363751264|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
105709368|NCT03245450|364596106|FG005|Overall Study|Adverse Event|0|||
105709369|NCT03245450|364596107|FG006|Overall Study|Adverse Event|2|||
105709370|NCT02429414|364596108|FG000|Overall Study|Physician Decision|0|||
105709371|NCT02429414|364596109|FG001|Overall Study|Physician Decision|1|||
105474953|NCT02834793|363751265|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
105474954|NCT02834793|363751266|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
105709372|NCT00267748|364596110|FG000|Non-randomized Period|Progressive disease|10|||
105709373|NCT00267748|364596111|FG001|Non-randomized Period|Progressive disease|0|||
105709374|NCT00267748|364596112|FG002|Non-randomized Period|Progressive disease|0|||
105709375|NCT00267748|364596110|FG000|Non-randomized Period|Adverse Event|8|||
105709376|NCT00267748|364596111|FG001|Non-randomized Period|Adverse Event|0|||
105709377|NCT00267748|364596112|FG002|Non-randomized Period|Adverse Event|0|||
105709378|NCT00267748|364596110|FG000|Non-randomized Period|Death|1|||
105709379|NCT00267748|364596111|FG001|Non-randomized Period|Death|0|||
105709380|NCT00267748|364596112|FG002|Non-randomized Period|Death|0|||
105709381|NCT00267748|364596110|FG000|Non-randomized Period|Participant not willing to participate|1|||
105709382|NCT00267748|364596111|FG001|Non-randomized Period|Participant not willing to participate|0|||
105709383|NCT00267748|364596112|FG002|Non-randomized Period|Participant not willing to participate|0|||
105709384|NCT00267748|364596110|FG000|Non-randomized Period|Other|3|||
105709385|NCT00267748|364596111|FG001|Non-randomized Period|Other|0|||
105709386|NCT00267748|364596112|FG002|Non-randomized Period|Other|0|||
105709387|NCT00267748|364596110|FG000|Randomized Period|Death|0|||
105709388|NCT00267748|364596111|FG001|Randomized Period|Death|2|||
105709389|NCT00267748|364596112|FG002|Randomized Period|Death|3|||
105709390|NCT00267748|364596110|FG000|Randomized Period|Adverse Event|0|||
105709391|NCT00267748|364596111|FG001|Randomized Period|Adverse Event|23|||
105709392|NCT00267748|364596112|FG002|Randomized Period|Adverse Event|25|||
105709393|NCT00267748|364596110|FG000|Randomized Period|Global deterioration of health status|0|||
105709394|NCT00267748|364596111|FG001|Randomized Period|Global deterioration of health status|6|||
105709395|NCT00267748|364596112|FG002|Randomized Period|Global deterioration of health status|7|||
105709396|NCT00267748|364596110|FG000|Randomized Period|Lost to Follow-up|0|||
105709397|NCT00267748|364596111|FG001|Randomized Period|Lost to Follow-up|1|||
105709398|NCT00267748|364596112|FG002|Randomized Period|Lost to Follow-up|0|||
105709399|NCT00267748|364596110|FG000|Randomized Period|Objective progression or relapse|0|||
105709400|NCT00267748|364596111|FG001|Randomized Period|Objective progression or relapse|77|||
105709401|NCT00267748|364596112|FG002|Randomized Period|Objective progression or relapse|86|||
105709402|NCT00267748|364596110|FG000|Randomized Period|Withdrawal by Subject|0|||
105709403|NCT00267748|364596111|FG001|Randomized Period|Withdrawal by Subject|9|||
105709404|NCT00267748|364596112|FG002|Randomized Period|Withdrawal by Subject|2|||
105709405|NCT00267748|364596110|FG000|Randomized Period|Other|0|||
105709406|NCT00267748|364596111|FG001|Randomized Period|Other|9|||
105709407|NCT00267748|364596112|FG002|Randomized Period|Other|6|||
105709408|NCT00267748|364596110|FG000|Randomized Period|randomized but not treated|0|||
105709409|NCT00267748|364596111|FG001|Randomized Period|randomized but not treated|0|||
105709410|NCT00267748|364596112|FG002|Randomized Period|randomized but not treated|3|||
105709411|NCT01294800|364596113|FG000|Overall Study|Adverse Event|7|||
105709412|NCT01294800|364596114|FG001|Overall Study|Adverse Event|6|||
105709413|NCT01294800|364596115|FG002|Overall Study|Adverse Event|12|||
105709414|NCT01294800|364596116|FG003|Overall Study|Adverse Event|5|||
105709415|NCT01294800|364596113|FG000|Overall Study|Subject Withdrew Consent|2|||
105709416|NCT01294800|364596114|FG001|Overall Study|Subject Withdrew Consent|2|||
105709417|NCT01294800|364596115|FG002|Overall Study|Subject Withdrew Consent|2|||
105709418|NCT01294800|364596116|FG003|Overall Study|Subject Withdrew Consent|11|||
105709419|NCT01294800|364596113|FG000|Overall Study|Lost to Follow-up|0|||
105709420|NCT01294800|364596114|FG001|Overall Study|Lost to Follow-up|0|||
105709421|NCT01294800|364596115|FG002|Overall Study|Lost to Follow-up|1|||
105709422|NCT01294800|364596116|FG003|Overall Study|Lost to Follow-up|0|||
105709423|NCT01294800|364596113|FG000|Overall Study|Non-compliance With Protocol|0|||
105709424|NCT01294800|364596114|FG001|Overall Study|Non-compliance With Protocol|1|||
105709425|NCT01294800|364596115|FG002|Overall Study|Non-compliance With Protocol|1|||
105709426|NCT01294800|364596116|FG003|Overall Study|Non-compliance With Protocol|0|||
105709427|NCT01294800|364596113|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
105709428|NCT01294800|364596114|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
105709429|NCT01294800|364596115|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
105709430|NCT01294800|364596116|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
105709431|NCT01662895|364596126|FG000|Overall Study|Lost to Follow-up|0|||
105709432|NCT01662895|364596127|FG001|Overall Study|Lost to Follow-up|1|||
105709433|NCT01827670|364596128|FG000|Overall Study|Withdrawal of Consent|3|||
105709434|NCT01827670|364596129|FG001|Overall Study|Withdrawal of Consent|2|||
105709435|NCT01827670|364596128|FG000|Overall Study|Lost to Follow-up|0|||
105709436|NCT01827670|364596129|FG001|Overall Study|Lost to Follow-up|1|||
105709437|NCT00835237|364596131|FG000|Overall Study|Lost to Follow-up|4|||
105709438|NCT00835237|364596132|FG001|Overall Study|Lost to Follow-up|0|||
105709439|NCT00835237|364596131|FG000|Overall Study|Withdrawal by Subject|2|||
105709440|NCT00835237|364596132|FG001|Overall Study|Withdrawal by Subject|0|||
105709441|NCT01692301|364596133|FG000|Overall Study|Adverse Event|15|||
105709442|NCT01692301|364596134|FG001|Overall Study|Adverse Event|12|||
105709443|NCT01692301|364596133|FG000|Overall Study|Death|1|||
105709444|NCT01692301|364596134|FG001|Overall Study|Death|2|||
105709445|NCT01692301|364596133|FG000|Overall Study|Lack of Efficacy|0|||
105709446|NCT01692301|364596134|FG001|Overall Study|Lack of Efficacy|5|||
105709447|NCT01692301|364596133|FG000|Overall Study|Non-compliance with study treatment|1|||
105709448|NCT01692301|364596134|FG001|Overall Study|Non-compliance with study treatment|2|||
105709449|NCT01692301|364596133|FG000|Overall Study|Protocol deviation|9|||
105709450|NCT01692301|364596134|FG001|Overall Study|Protocol deviation|2|||
105709451|NCT01692301|364596133|FG000|Overall Study|Patient/guardian decision|16|||
105709452|NCT01692301|364596134|FG001|Overall Study|Patient/guardian decision|15|||
105709453|NCT01692301|364596133|FG000|Overall Study|Technical problems|0|||
105709454|NCT01692301|364596134|FG001|Overall Study|Technical problems|1|||
105474955|NCT02834793|363751267|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
105709455|NCT01692301|364596133|FG000|Overall Study|Physician Decision|2|||
105709456|NCT01692301|364596134|FG001|Overall Study|Physician Decision|2|||
105709457|NCT01692301|364596133|FG000|Overall Study|Lost to Follow-up|1|||
105709458|NCT01692301|364596134|FG001|Overall Study|Lost to Follow-up|1|||
105709459|NCT01142726|364596135|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
105709460|NCT01142726|364596136|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
105709461|NCT01142726|364596137|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
105709462|NCT01142726|364596135|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
105709463|NCT01142726|364596136|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
105709464|NCT01142726|364596137|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
105709465|NCT01142726|364596135|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
105709466|NCT01142726|364596136|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
105709467|NCT01142726|364596137|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
105709468|NCT01142726|364596135|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
105709469|NCT01142726|364596136|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
105709470|NCT01142726|364596137|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
105709471|NCT01142726|364596135|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
105709472|NCT01142726|364596136|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
105709473|NCT01142726|364596137|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
105709474|NCT01142726|364596135|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
105709475|NCT01142726|364596136|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
105709476|NCT01142726|364596137|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
105709477|NCT01142726|364596135|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
105709478|NCT01142726|364596136|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
105709479|NCT01142726|364596137|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
105709480|NCT01142726|364596135|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
105709481|NCT01142726|364596136|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
105709482|NCT01142726|364596137|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
105709483|NCT01142726|364596135|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
105709484|NCT01142726|364596136|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
105709485|NCT01142726|364596137|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
105709486|NCT01142726|364596135|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
105709487|NCT01142726|364596136|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
105709488|NCT01142726|364596137|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
105709489|NCT01142726|364596135|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
105709490|NCT01142726|364596136|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
105709491|NCT01142726|364596137|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
105709492|NCT01142726|364596135|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
105709493|NCT01142726|364596136|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
105709494|NCT01142726|364596137|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
105709495|NCT01142726|364596135|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
105709496|NCT01142726|364596136|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
105709497|NCT01142726|364596137|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
105709498|NCT01142726|364596135|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
105709499|NCT01142726|364596136|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
105709500|NCT01142726|364596137|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
105709501|NCT01142726|364596135|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
105709502|NCT01142726|364596136|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
105709503|NCT01142726|364596137|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
105709504|NCT01142726|364596135|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
105709505|NCT01142726|364596136|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
105709506|NCT01142726|364596137|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
105709507|NCT03713944|364596138|FG000|Study Treatment|Patient non-compliance|1|||
105709508|NCT03713944|364596138|FG000|Study Treatment|Alternative Cancer Therapy|3|||
105709509|NCT03713944|364596138|FG000|Study Treatment|Disease Progression|18|||
105709510|NCT03713944|364596138|FG000|Study Treatment|AE/Side Effects/Complications|2|||
105709511|NCT03713944|364596138|FG000|Study Treatment|Death|2|||
105709512|NCT03713944|364596138|FG000|Study Treatment|Withdrawal by Subject|1|||
105709513|NCT03713944|364596138|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
105474956|NCT02834793|363751264|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
105709514|NCT03713944|364596138|FG000|Study Treatment|Symptomatic Deterioration|2|||
105709515|NCT03713944|364596138|FG000|Follow up|Withdrawal by Subject|2|||
105709516|NCT03713944|364596138|FG000|Follow up|Death|11|||
105474957|NCT02834793|363751265|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
105709517|NCT03713944|364596138|FG000|Follow up|Study Terminated|3|||
105709518|NCT02111993|364596139|FG000|Overall Study|Physician Decision|5|||
105709519|NCT02111993|364596140|FG001|Overall Study|Physician Decision|4|||
105709520|NCT00293579|364596141|FG000|Overall Study|Withdrawal by Subject|1|||
105709521|NCT03694925|364596144|FG000|Overall Study|Inadequate laboratory testing|0|||
105709522|NCT03694925|364596145|FG001|Overall Study|Inadequate laboratory testing|3|||
105709523|NCT03694925|364596146|FG002|Overall Study|Inadequate laboratory testing|0|||
105709524|NCT00343889|364596160|FG000|Overall Study|Lost to Follow-up|2|||
105709525|NCT00343889|364596161|FG001|Overall Study|Lost to Follow-up|0|||
105709526|NCT00343889|364596160|FG000|Overall Study|Withdrawal by Subject|0|||
105709527|NCT00343889|364596161|FG001|Overall Study|Withdrawal by Subject|1|||
105709528|NCT00343889|364596160|FG000|Overall Study|Protocol Violation|1|||
105709529|NCT00343889|364596161|FG001|Overall Study|Protocol Violation|0|||
105709530|NCT01294579|364596162|FG000|Overall Study|Disease progression|12|||
105709531|NCT01294579|364596162|FG000|Overall Study|Adverse Event|11|||
105709532|NCT01294579|364596162|FG000|Overall Study|Study closed/terminated|3|||
105709533|NCT01294579|364596162|FG000|Overall Study|Lost to Follow-up|1|||
105709534|NCT01294579|364596162|FG000|Overall Study|Physician Decision|3|||
105709535|NCT01294579|364596162|FG000|Overall Study|Withdrawal by Subject|5|||
105709536|NCT01967537|364596165|FG000|Overall Study|Withdrawal by Subject|52|||
105709537|NCT01967537|364596165|FG000|Overall Study|Refuse treatment|2|||
105709538|NCT01967537|364596165|FG000|Overall Study|Lost to Follow-up|6|||
105709539|NCT04417894|364596168|FG000|Overall Study|Lost to Follow-up|3|||
105709540|NCT04417894|364596169|FG001|Overall Study|Lost to Follow-up|0|||
105709541|NCT04417894|364596168|FG000|Overall Study|Withdrawal by Subject|7|||
105709542|NCT04417894|364596169|FG001|Overall Study|Withdrawal by Subject|6|||
105709543|NCT04417894|364596168|FG000|Overall Study|Lack of Efficacy|3|||
105709544|NCT04417894|364596169|FG001|Overall Study|Lack of Efficacy|1|||
105709545|NCT01464307|364596170|FG000|Main Period|Death|0|||
105709546|NCT01464307|364596171|FG001|Main Period|Death|1|||
105709547|NCT01464307|364596170|FG000|Main Period|Adverse Event|6|||
105709548|NCT01464307|364596171|FG001|Main Period|Adverse Event|1|||
105709549|NCT01464307|364596170|FG000|Main Period|Lack of Efficacy|2|||
105709550|NCT01464307|364596171|FG001|Main Period|Lack of Efficacy|0|||
105709551|NCT01464307|364596170|FG000|Main Period|Withdrawal by Subject|5|||
105709552|NCT01464307|364596171|FG001|Main Period|Withdrawal by Subject|2|||
105709553|NCT01464307|364596170|FG000|Main Period|Predefined discontinuation criteria|2|||
105709554|NCT01464307|364596171|FG001|Main Period|Predefined discontinuation criteria|1|||
105709555|NCT01464307|364596170|FG000|Open-Label Extension Period|Adverse Event|15|||
105709556|NCT01464307|364596171|FG001|Open-Label Extension Period|Adverse Event|0|||
105709557|NCT01464307|364596170|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
105709558|NCT01464307|364596171|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
105709559|NCT01464307|364596170|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
105709560|NCT01464307|364596171|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
105709561|NCT01464307|364596170|FG000|Open-Label Extension Period|Death|1|||
105709562|NCT01464307|364596171|FG001|Open-Label Extension Period|Death|0|||
105709563|NCT01464307|364596170|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
105709564|NCT01464307|364596171|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
105709565|NCT01464307|364596170|FG000|Open-Label Extension Period|Non-compliance|9|||
105709566|NCT01464307|364596171|FG001|Open-Label Extension Period|Non-compliance|0|||
105709567|NCT01464307|364596170|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
105709568|NCT01464307|364596171|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
105709569|NCT03652662|364596172|FG000|Overall Study|Withdrawal by Subject|2|||
105709570|NCT03652662|364596173|FG001|Overall Study|Withdrawal by Subject|1|||
105709571|NCT03652662|364596172|FG000|Overall Study|Lost to Follow-up|1|||
105709572|NCT03652662|364596173|FG001|Overall Study|Lost to Follow-up|0|||
105709573|NCT04327388|364596174|FG000|Overall Study|Adverse Event|17|||
105709574|NCT04327388|364596175|FG001|Overall Study|Adverse Event|18|||
105709575|NCT04327388|364596176|FG002|Overall Study|Adverse Event|9|||
105709576|NCT04327388|364596174|FG000|Overall Study|Other|1|||
105709577|NCT04327388|364596175|FG001|Overall Study|Other|2|||
105709578|NCT04327388|364596176|FG002|Overall Study|Other|0|||
105709579|NCT04327388|364596174|FG000|Overall Study|Randomized and not treated|2|||
105709580|NCT04327388|364596175|FG001|Overall Study|Randomized and not treated|0|||
105709581|NCT04327388|364596176|FG002|Overall Study|Randomized and not treated|2|||
105709582|NCT00720109|364596177|FG000|Induction Period|Did not meet eligibility criteria|3|||
105709583|NCT00720109|364596178|FG001|Induction Period|Did not meet eligibility criteria|0|||
105709584|NCT00720109|364596179|FG002|Induction Period|Did not meet eligibility criteria|0|||
105709585|NCT00720109|364596177|FG000|Induction Period|Bone Marrow Transplant|2|||
105709586|NCT00720109|364596178|FG001|Induction Period|Bone Marrow Transplant|0|||
105709587|NCT00720109|364596179|FG002|Induction Period|Bone Marrow Transplant|0|||
105709588|NCT00720109|364596177|FG000|Induction Period|Physician Decision|1|||
105709589|NCT00720109|364596178|FG001|Induction Period|Physician Decision|0|||
105709590|NCT00720109|364596179|FG002|Induction Period|Physician Decision|0|||
105709591|NCT00720109|364596177|FG000|Risk Stratification Period|Adverse Event|0|||
105709592|NCT00720109|364596178|FG001|Risk Stratification Period|Adverse Event|1|||
105709593|NCT00720109|364596179|FG002|Risk Stratification Period|Adverse Event|0|||
105709594|NCT00720109|364596177|FG000|Risk Stratification Period|Physician Decision|0|||
105709595|NCT00720109|364596178|FG001|Risk Stratification Period|Physician Decision|2|||
105709596|NCT00720109|364596179|FG002|Risk Stratification Period|Physician Decision|1|||
105709597|NCT00720109|364596177|FG000|Risk Stratification Period|Bone marrow transplant|0|||
105709598|NCT00720109|364596178|FG001|Risk Stratification Period|Bone marrow transplant|9|||
105709599|NCT00720109|364596179|FG002|Risk Stratification Period|Bone marrow transplant|7|||
105709600|NCT00720109|364596177|FG000|Risk Stratification Period|Disease progression or relapse|0|||
105709601|NCT00720109|364596178|FG001|Risk Stratification Period|Disease progression or relapse|2|||
105709602|NCT00720109|364596179|FG002|Risk Stratification Period|Disease progression or relapse|0|||
105709603|NCT00720109|364596177|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
105709604|NCT00720109|364596178|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
105709605|NCT00720109|364596179|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
105709606|NCT01110200|364596180|FG000|Overall Study|Adverse Event|28|||
105709607|NCT01110200|364596181|FG001|Overall Study|Adverse Event|28|||
105709608|NCT01110200|364596180|FG000|Overall Study|Withdrawal by Subject|25|||
105709609|NCT01110200|364596181|FG001|Overall Study|Withdrawal by Subject|32|||
105709610|NCT01110200|364596180|FG000|Overall Study|Lack of Efficacy|16|||
105709611|NCT01110200|364596181|FG001|Overall Study|Lack of Efficacy|25|||
105709612|NCT01110200|364596180|FG000|Overall Study|Protocol Violation|14|||
105709613|NCT01110200|364596181|FG001|Overall Study|Protocol Violation|12|||
105709614|NCT01110200|364596180|FG000|Overall Study|Physician Decision|13|||
105709615|NCT01110200|364596181|FG001|Overall Study|Physician Decision|17|||
105709616|NCT01110200|364596180|FG000|Overall Study|Lost to Follow-up|10|||
105709617|NCT01110200|364596181|FG001|Overall Study|Lost to Follow-up|7|||
105709618|NCT03595553|364596182|FG000|Overall Study|Withdrawal by Subject|20|||
105709619|NCT03595553|364596183|FG001|Overall Study|Withdrawal by Subject|8|||
105709620|NCT03595553|364596182|FG000|Overall Study|Physician Decision|3|||
105709621|NCT03595553|364596183|FG001|Overall Study|Physician Decision|2|||
105709622|NCT03595553|364596182|FG000|Overall Study|Adverse Event|2|||
105709623|NCT03595553|364596183|FG001|Overall Study|Adverse Event|5|||
105709624|NCT03595553|364596182|FG000|Overall Study|Death|24|||
105709625|NCT03595553|364596183|FG001|Overall Study|Death|22|||
105709626|NCT03595553|364596182|FG000|Overall Study|Lost to Follow-up|6|||
105709627|NCT03595553|364596183|FG001|Overall Study|Lost to Follow-up|7|||
105709628|NCT03595553|364596182|FG000|Overall Study|Other as indicated in CSR|3|||
105709629|NCT03595553|364596183|FG001|Overall Study|Other as indicated in CSR|3|||
105709630|NCT03595553|364596182|FG000|Overall Study|Sponsor Decision|0|||
105709631|NCT03595553|364596183|FG001|Overall Study|Sponsor Decision|1|||
105709632|NCT03074474|364596186|FG000|Overall Study|Lost to Follow-up|10|||
105709633|NCT03074474|364596186|FG000|Overall Study|Withdrawal by Subject|10|||
105351039|NCT02168777|363289623|FG002|Overall Study|Adverse Event|1|||
105351040|NCT02168777|363289621|FG000|Overall Study|Disease recurrence|0|||
105351041|NCT02168777|363289622|FG001|Overall Study|Disease recurrence|0|||
105474958|NCT02834793|363751266|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
105709634|NCT03074474|364596186|FG000|Overall Study|Death|4|||
105709635|NCT03074474|364596186|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
105709636|NCT00512798|364596193|FG000|Overall Study|Death|0|||
105709637|NCT00512798|364596194|FG001|Overall Study|Death|3|||
105709638|NCT00512798|364596193|FG000|Overall Study|Adverse Event|2|||
105709639|NCT00512798|364596194|FG001|Overall Study|Adverse Event|4|||
105709640|NCT00512798|364596193|FG000|Overall Study|Progression of disease|14|||
105709641|NCT00512798|364596194|FG001|Overall Study|Progression of disease|20|||
105709642|NCT00512798|364596193|FG000|Overall Study|Withdrawal by Subject|3|||
105709643|NCT00512798|364596194|FG001|Overall Study|Withdrawal by Subject|0|||
105709644|NCT03434977|364596195|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
105709645|NCT03434977|364596196|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
105709646|NCT04899232|364596198|FG000|Screening Period|Physician Decision|1|||
105709647|NCT04899232|364596199|FG001|Screening Period|Physician Decision|0|||
105351042|NCT02168777|363289623|FG002|Overall Study|Disease recurrence|1|||
105709648|NCT04899232|364596200|FG002|Screening Period|Physician Decision|0|||
105351043|NCT02168777|363289621|FG000|Overall Study|Radiological disease progression|0|||
105709649|NCT04899232|364596198|FG000|Screening Period|Withdrawal by Subject|1|||
105709650|NCT04899232|364596199|FG001|Screening Period|Withdrawal by Subject|0|||
105709651|NCT04899232|364596200|FG002|Screening Period|Withdrawal by Subject|0|||
105709652|NCT04899232|364596198|FG000|Screening Period|Participant discharged before receiving intervention|3|||
105709653|NCT04899232|364596199|FG001|Screening Period|Participant discharged before receiving intervention|0|||
105709654|NCT04899232|364596200|FG002|Screening Period|Participant discharged before receiving intervention|0|||
105709655|NCT00936208|364596202|FG000|Overall Study|Protocol Violation|37|||
105709656|NCT00936208|364596203|FG001|Overall Study|Protocol Violation|22|||
105709657|NCT00700271|364596204|FG000|Overall Study|Adverse Event|4|||
105709658|NCT00700271|364596205|FG001|Overall Study|Adverse Event|6|||
105709659|NCT00700271|364596204|FG000|Overall Study|Protocol Violation|1|||
105709660|NCT00700271|364596205|FG001|Overall Study|Protocol Violation|0|||
105709661|NCT00700271|364596204|FG000|Overall Study|Administrative Reasons|1|||
105709662|NCT00700271|364596205|FG001|Overall Study|Administrative Reasons|0|||
105709663|NCT00700271|364596204|FG000|Overall Study|Withdrawal by Subject|6|||
105709664|NCT00700271|364596205|FG001|Overall Study|Withdrawal by Subject|4|||
105709665|NCT00700271|364596204|FG000|Overall Study|Lost to Follow-up|2|||
105709666|NCT00700271|364596205|FG001|Overall Study|Lost to Follow-up|2|||
105709667|NCT00861744|364596206|FG000|Overall Study|Adverse Event|0|||
105709668|NCT00861744|364596207|FG001|Overall Study|Adverse Event|0|||
105709669|NCT00861744|364596208|FG002|Overall Study|Adverse Event|0|||
105709670|NCT00861744|364596209|FG003|Overall Study|Adverse Event|1|||
105709671|NCT00861744|364596206|FG000|Overall Study|Lost to Follow-up|7|||
105709672|NCT00861744|364596207|FG001|Overall Study|Lost to Follow-up|19|||
105709673|NCT00861744|364596208|FG002|Overall Study|Lost to Follow-up|17|||
105709674|NCT00861744|364596209|FG003|Overall Study|Lost to Follow-up|12|||
105709675|NCT00861744|364596206|FG000|Overall Study|Withdrawal by Subject|10|||
105709676|NCT00861744|364596207|FG001|Overall Study|Withdrawal by Subject|6|||
105709677|NCT00861744|364596208|FG002|Overall Study|Withdrawal by Subject|6|||
105709678|NCT00861744|364596209|FG003|Overall Study|Withdrawal by Subject|19|||
105709679|NCT00861744|364596206|FG000|Overall Study|Protocol Violation|0|||
105709680|NCT00861744|364596207|FG001|Overall Study|Protocol Violation|1|||
105709681|NCT00861744|364596208|FG002|Overall Study|Protocol Violation|0|||
105709682|NCT00861744|364596209|FG003|Overall Study|Protocol Violation|0|||
105709683|NCT00861744|364596206|FG000|Overall Study|Migration from study area|0|||
105709684|NCT00861744|364596207|FG001|Overall Study|Migration from study area|3|||
105709685|NCT00861744|364596208|FG002|Overall Study|Migration from study area|1|||
105709686|NCT00861744|364596209|FG003|Overall Study|Migration from study area|0|||
105709687|NCT00861744|364596206|FG000|Overall Study|Blood draws|0|||
105709688|NCT00861744|364596207|FG001|Overall Study|Blood draws|0|||
105709689|NCT00861744|364596208|FG002|Overall Study|Blood draws|0|||
105709690|NCT00861744|364596209|FG003|Overall Study|Blood draws|1|||
105709691|NCT01344876|364596210|FG000|Overall Study|Adverse Event|0|||
105709692|NCT01344876|364596211|FG001|Overall Study|Adverse Event|0|||
105709693|NCT01344876|364596212|FG002|Overall Study|Adverse Event|0|||
105709694|NCT01344876|364596213|FG003|Overall Study|Adverse Event|0|||
105709695|NCT01344876|364596214|FG004|Overall Study|Adverse Event|1|||
105709696|NCT01344876|364596210|FG000|Overall Study|Withdrawal by Subject|0|||
105709697|NCT01344876|364596211|FG001|Overall Study|Withdrawal by Subject|0|||
105709698|NCT01344876|364596212|FG002|Overall Study|Withdrawal by Subject|1|||
105709699|NCT01344876|364596213|FG003|Overall Study|Withdrawal by Subject|0|||
105709700|NCT01344876|364596214|FG004|Overall Study|Withdrawal by Subject|0|||
105709701|NCT01344876|364596210|FG000|Overall Study|Definite progression of primary disease|1|||
105709702|NCT01344876|364596211|FG001|Overall Study|Definite progression of primary disease|0|||
105709703|NCT01344876|364596212|FG002|Overall Study|Definite progression of primary disease|0|||
105709704|NCT01344876|364596213|FG003|Overall Study|Definite progression of primary disease|3|||
105709705|NCT01344876|364596214|FG004|Overall Study|Definite progression of primary disease|0|||
105709706|NCT04428424|364596215|FG000|Overall Study|Does not meet entrance criteria|132|||
105709707|NCT04428424|364596215|FG000|Overall Study|Lost to Follow-up|115|||
105709708|NCT01928381|364596216|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
105709709|NCT01928381|364596217|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
105709710|NCT01928381|364596218|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
105709711|NCT01928381|364596219|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
105709712|NCT01928381|364596220|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
105788057|NCT00054639|364878176|FG000|Overall Study|Lack of Efficacy|1|||
105788058|NCT00054639|364878176|FG000|Overall Study|Physician Decision|1|||
105709713|NCT01928381|364596221|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
105709714|NCT01928381|364596222|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
105709715|NCT01928381|364596216|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
105709716|NCT01928381|364596217|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
105788059|NCT01600755|364878177|FG000|Overall Study|Withdrawal by Subject|6|||
105788060|NCT04780776|364878178|FG000|Titration Week 1-5|Lost to Follow-up|2|||
105709717|NCT01928381|364596218|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
105709718|NCT01928381|364596219|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
105709719|NCT01928381|364596220|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
105709720|NCT01928381|364596221|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
105709721|NCT01928381|364596222|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
105709722|NCT01928381|364596216|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
105709723|NCT01928381|364596217|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
105709724|NCT01928381|364596218|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
105709725|NCT01928381|364596219|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
105709726|NCT01928381|364596220|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
105709727|NCT01928381|364596221|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
105709728|NCT01928381|364596222|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
105709729|NCT01928381|364596216|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
105709730|NCT01928381|364596217|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
105709731|NCT01928381|364596218|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
105709732|NCT01928381|364596219|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
105709733|NCT01928381|364596220|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
105709734|NCT01928381|364596221|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
105709735|NCT01928381|364596222|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
105709736|NCT01928381|364596216|FG000|Part 1 - Pain Training|Protocol Violation|1|||
105709737|NCT01928381|364596217|FG001|Part 1 - Pain Training|Protocol Violation|0|||
105709738|NCT01928381|364596218|FG002|Part 1 - Pain Training|Protocol Violation|0|||
105709739|NCT01928381|364596219|FG003|Part 1 - Pain Training|Protocol Violation|0|||
105709740|NCT01928381|364596220|FG004|Part 1 - Pain Training|Protocol Violation|0|||
105709741|NCT01928381|364596221|FG005|Part 1 - Pain Training|Protocol Violation|0|||
105709742|NCT01928381|364596222|FG006|Part 1 - Pain Training|Protocol Violation|0|||
105709743|NCT01928381|364596216|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
105709744|NCT01928381|364596217|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
105709745|NCT01928381|364596218|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
105709746|NCT01928381|364596219|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
105709747|NCT01928381|364596220|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
105709748|NCT01928381|364596221|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
105709749|NCT01928381|364596222|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
105709750|NCT01928381|364596216|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
105709751|NCT01928381|364596217|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
105709752|NCT01928381|364596218|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
105709753|NCT01928381|364596219|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
105709754|NCT01928381|364596220|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
105709755|NCT01928381|364596221|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
105709756|NCT01928381|364596222|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
105709757|NCT01928381|364596216|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
105709758|NCT01928381|364596217|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
105709759|NCT01928381|364596218|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
105709760|NCT01928381|364596219|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
105709761|NCT01928381|364596220|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
105709762|NCT01928381|364596221|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
105709763|NCT01928381|364596222|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
105709764|NCT01928381|364596216|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
105709765|NCT01928381|364596217|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
105709766|NCT01928381|364596218|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
105709767|NCT01928381|364596219|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
105709768|NCT01928381|364596220|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
105709769|NCT01928381|364596221|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
105709770|NCT01928381|364596222|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
105709771|NCT01928381|364596216|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
105709772|NCT01928381|364596217|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
105709773|NCT01928381|364596218|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
105709774|NCT01928381|364596219|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
105709775|NCT01928381|364596220|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
105709776|NCT01928381|364596221|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
105709777|NCT01928381|364596222|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
105709778|NCT01928381|364596216|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
105709779|NCT01928381|364596217|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
105709780|NCT01928381|364596218|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
105709781|NCT01928381|364596219|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
105709782|NCT01928381|364596220|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
105709783|NCT01928381|364596221|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
105709784|NCT01928381|364596222|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
105709785|NCT01928381|364596216|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
105709786|NCT01928381|364596217|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
105709787|NCT01928381|364596218|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
105709788|NCT01928381|364596219|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
105709789|NCT01928381|364596220|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
105709790|NCT01928381|364596221|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
105709791|NCT01928381|364596222|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
105709792|NCT01928381|364596216|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
105709793|NCT01928381|364596217|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
105709794|NCT01928381|364596218|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
105709795|NCT01928381|364596219|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
105709796|NCT01928381|364596220|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
105709797|NCT01928381|364596221|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
105709798|NCT01928381|364596222|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
105709799|NCT01928381|364596216|FG000|Washout First Intervention|Protocol Violation|0|||
105709800|NCT01928381|364596217|FG001|Washout First Intervention|Protocol Violation|0|||
105709801|NCT01928381|364596218|FG002|Washout First Intervention|Protocol Violation|0|||
105709802|NCT01928381|364596219|FG003|Washout First Intervention|Protocol Violation|0|||
105709803|NCT01928381|364596220|FG004|Washout First Intervention|Protocol Violation|1|||
105709804|NCT01928381|364596221|FG005|Washout First Intervention|Protocol Violation|0|||
105709805|NCT01928381|364596222|FG006|Washout First Intervention|Protocol Violation|0|||
105709806|NCT01928381|364596216|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
105709807|NCT01928381|364596217|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
105709808|NCT01928381|364596218|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
105709809|NCT01928381|364596219|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
105709810|NCT01928381|364596220|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
105709811|NCT01928381|364596221|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
105709812|NCT01928381|364596222|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
105709813|NCT01928381|364596216|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
105709814|NCT01928381|364596217|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
105709815|NCT01928381|364596218|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
105709816|NCT01928381|364596219|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
105788061|NCT04780776|364878179|FG001|Titration Week 1-5|Lost to Follow-up|8|||
105788062|NCT04780776|364878178|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
105788063|NCT04780776|364878179|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
105788064|NCT04780776|364878178|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
105788065|NCT04780776|364878179|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
105474959|NCT02834793|363751267|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
105474960|NCT02834793|363751264|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
105474961|NCT02834793|363751265|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
105474962|NCT02834793|363751266|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
105474963|NCT02834793|363751267|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
105474964|NCT02834793|363751264|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
105474965|NCT02834793|363751265|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
105474966|NCT02834793|363751266|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
105474967|NCT02834793|363751267|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
105474968|NCT02834793|363751264|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
105474969|NCT02834793|363751265|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
105474970|NCT02834793|363751266|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
105474971|NCT02834793|363751267|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
105474972|NCT02834793|363751264|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
105474973|NCT02834793|363751265|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
105474974|NCT02834793|363751266|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
105474975|NCT02834793|363751267|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
105474976|NCT02834793|363751264|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
105474977|NCT02834793|363751265|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
105474978|NCT02834793|363751266|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
105474979|NCT02834793|363751267|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
105474980|NCT02834793|363751264|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
105474981|NCT02834793|363751265|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
105474982|NCT02834793|363751266|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
105474983|NCT02834793|363751267|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
105474984|NCT02834793|363751264|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
105474985|NCT02834793|363751265|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
105474986|NCT02834793|363751266|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
105474987|NCT02834793|363751267|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
105474988|NCT02834793|363751264|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
105474989|NCT02834793|363751265|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
105474990|NCT02834793|363751266|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
105474991|NCT02834793|363751267|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
105474992|NCT00905645|363751268|FG000|Overall Study|Death (not device related)|10|||
105474993|NCT00905645|363751269|FG001|Overall Study|Death (not device related)|4|||
105474994|NCT00905645|363751270|FG002|Overall Study|Death (not device related)|15|||
105474995|NCT00905645|363751271|FG003|Overall Study|Death (not device related)|8|||
105474996|NCT00905645|363751268|FG000|Overall Study|Explantation of study device(s)|78|||
105474997|NCT00905645|363751269|FG001|Overall Study|Explantation of study device(s)|47|||
105474998|NCT00905645|363751270|FG002|Overall Study|Explantation of study device(s)|28|||
105474999|NCT00905645|363751271|FG003|Overall Study|Explantation of study device(s)|21|||
105475000|NCT00905645|363751268|FG000|Overall Study|Subject Request|41|||
105475001|NCT00905645|363751269|FG001|Overall Study|Subject Request|17|||
105475002|NCT00905645|363751270|FG002|Overall Study|Subject Request|13|||
105475003|NCT00905645|363751271|FG003|Overall Study|Subject Request|11|||
105475004|NCT00905645|363751268|FG000|Overall Study|Lost to Follow-up|299|||
105475005|NCT00905645|363751269|FG001|Overall Study|Lost to Follow-up|103|||
105475006|NCT00905645|363751270|FG002|Overall Study|Lost to Follow-up|51|||
105475007|NCT00905645|363751271|FG003|Overall Study|Lost to Follow-up|12|||
105475008|NCT02136069|363751272|FG000|Overall Study|UC flare-up|1|||
105475009|NCT02136069|363751273|FG001|Overall Study|UC flare-up|0|||
105475010|NCT02136069|363751272|FG000|Overall Study|Adverse Event|6|||
105475011|NCT02136069|363751273|FG001|Overall Study|Adverse Event|8|||
105475012|NCT02136069|363751272|FG000|Overall Study|Death|0|||
105475013|NCT02136069|363751273|FG001|Overall Study|Death|1|||
105475014|NCT02136069|363751272|FG000|Overall Study|Lack of Efficacy|10|||
105475015|NCT02136069|363751273|FG001|Overall Study|Lack of Efficacy|4|||
105475016|NCT02136069|363751272|FG000|Overall Study|Lost to Follow-up|1|||
105475017|NCT02136069|363751273|FG001|Overall Study|Lost to Follow-up|0|||
105475018|NCT02136069|363751272|FG000|Overall Study|Non-Compliance|1|||
105475019|NCT02136069|363751273|FG001|Overall Study|Non-Compliance|0|||
105475020|NCT02136069|363751272|FG000|Overall Study|Physician Decision|5|||
105475021|NCT02136069|363751273|FG001|Overall Study|Physician Decision|4|||
105475022|NCT02136069|363751272|FG000|Overall Study|Withdrawal by Subject|10|||
105475023|NCT02136069|363751273|FG001|Overall Study|Withdrawal by Subject|11|||
105475024|NCT01767142|363751274|FG000|Overall Study|Lost to Follow-up|3|||
105475025|NCT02471612|363751275|FG000|Overall Study|Lost to Follow-up|2|||
105475026|NCT02722304|363751276|FG000|Overall Study|Study Terminated by Sponsor|1|||
105475027|NCT02722304|363751277|FG001|Overall Study|Study Terminated by Sponsor|0|||
105475028|NCT02722304|363751278|FG002|Overall Study|Study Terminated by Sponsor|2|||
105475029|NCT02722304|363751279|FG003|Overall Study|Study Terminated by Sponsor|1|||
105475030|NCT02722304|363751280|FG004|Overall Study|Study Terminated by Sponsor|1|||
105475031|NCT02722304|363751276|FG000|Overall Study|Other|0|||
105475032|NCT02722304|363751277|FG001|Overall Study|Other|0|||
105709817|NCT01928381|364596220|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
105709818|NCT01928381|364596221|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
105709819|NCT01928381|364596222|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
105709820|NCT04818593|364596225|FG000|Overall Study|Low Oocyte Yield|8|||
105709821|NCT04818593|364596226|FG001|Overall Study|Low Oocyte Yield|8|||
105709822|NCT04818593|364596225|FG000|Overall Study|Not ICSI Insemination|7|||
105709823|NCT04818593|364596226|FG001|Overall Study|Not ICSI Insemination|7|||
105709824|NCT04818593|364596225|FG000|Overall Study|Poor Sperm Quality|2|||
105351044|NCT02168777|363289622|FG001|Overall Study|Radiological disease progression|5|||
105351045|NCT02168777|363289623|FG002|Overall Study|Radiological disease progression|5|||
105709825|NCT04818593|364596226|FG001|Overall Study|Poor Sperm Quality|2|||
105709826|NCT04818593|364596225|FG000|Overall Study|Withdrawal by Subject|2|||
105709827|NCT04818593|364596226|FG001|Overall Study|Withdrawal by Subject|2|||
105709828|NCT04818593|364596225|FG000|Overall Study|Conversion to IUI due to low response|1|||
105709829|NCT04818593|364596226|FG001|Overall Study|Conversion to IUI due to low response|1|||
105709830|NCT01564862|364596227|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
105709831|NCT01564862|364596228|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
105709832|NCT01564862|364596229|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
105709833|NCT01564862|364596227|FG000|Overall Study|Major Protocol Deviation|3|||
105709834|NCT01564862|364596228|FG001|Overall Study|Major Protocol Deviation|3|||
105709835|NCT01564862|364596229|FG002|Overall Study|Major Protocol Deviation|4|||
105709836|NCT01564862|364596227|FG000|Overall Study|Lost to Follow-up|10|||
105709837|NCT01564862|364596228|FG001|Overall Study|Lost to Follow-up|8|||
105709838|NCT01564862|364596229|FG002|Overall Study|Lost to Follow-up|6|||
105709839|NCT01564862|364596227|FG000|Overall Study|Voluntary Withdrawal|9|||
105709840|NCT01564862|364596228|FG001|Overall Study|Voluntary Withdrawal|6|||
105709841|NCT01564862|364596229|FG002|Overall Study|Voluntary Withdrawal|8|||
105709842|NCT01564862|364596227|FG000|Overall Study|Lack of Efficacy|1|||
105709843|NCT01564862|364596228|FG001|Overall Study|Lack of Efficacy|5|||
105709844|NCT01564862|364596229|FG002|Overall Study|Lack of Efficacy|6|||
105709845|NCT01564862|364596227|FG000|Overall Study|Other reason(s)|1|||
105709846|NCT01564862|364596228|FG001|Overall Study|Other reason(s)|0|||
105709847|NCT01564862|364596229|FG002|Overall Study|Other reason(s)|0|||
105709848|NCT03809611|364596230|FG000|Overall Study|Withdrawal by Subject|1|||
105709849|NCT03809611|364596231|FG001|Overall Study|Withdrawal by Subject|1|||
105709850|NCT05032157|364598139|FG000|Overall Study|Adverse Event|12|||
105709851|NCT05032157|364598140|FG001|Overall Study|Adverse Event|7|||
105709852|NCT05032157|364598139|FG000|Overall Study|Pregnancy|0|||
105709853|NCT05032157|364598140|FG001|Overall Study|Pregnancy|2|||
105709854|NCT05032157|364598139|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105709855|NCT05032157|364598140|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
105709856|NCT05032157|364598139|FG000|Overall Study|Protocol Deviation|8|||
105709857|NCT05032157|364598140|FG001|Overall Study|Protocol Deviation|4|||
105709858|NCT05032157|364598139|FG000|Overall Study|Lost to Follow-up|1|||
105709859|NCT05032157|364598140|FG001|Overall Study|Lost to Follow-up|3|||
105709860|NCT05032157|364598139|FG000|Overall Study|Physician Decision|7|||
105709861|NCT05032157|364598140|FG001|Overall Study|Physician Decision|2|||
105351046|NCT02168777|363289621|FG000|Overall Study|Clinical disease progression|0|||
105351047|NCT02168777|363289622|FG001|Overall Study|Clinical disease progression|1|||
105351048|NCT02168777|363289623|FG002|Overall Study|Clinical disease progression|2|||
105351049|NCT02168777|363289621|FG000|Overall Study|Other reason|0|||
105351050|NCT02168777|363289622|FG001|Overall Study|Other reason|1|||
105709862|NCT05032157|364598139|FG000|Overall Study|Patient Decision|38|||
105709863|NCT05032157|364598140|FG001|Overall Study|Patient Decision|19|||
105709864|NCT02627495|364598143|FG000|Overall Study|Withdrawal by Subject|4|||
105351051|NCT02168777|363289623|FG002|Overall Study|Other reason|0|||
105475033|NCT02722304|363751278|FG002|Overall Study|Other|0|||
105475034|NCT02722304|363751279|FG003|Overall Study|Other|1|||
105475035|NCT02722304|363751280|FG004|Overall Study|Other|1|||
105709865|NCT00880893|364598144|FG000|Overall Study|Protocol Violation|13|||
105709866|NCT00880893|364598145|FG001|Overall Study|Protocol Violation|1|||
105709867|NCT00880893|364598144|FG000|Overall Study|Withdrawal by Subject|15|||
105709868|NCT00880893|364598145|FG001|Overall Study|Withdrawal by Subject|11|||
105709869|NCT00880893|364598144|FG000|Overall Study|Lost to Follow-up|76|||
105709870|NCT00880893|364598145|FG001|Overall Study|Lost to Follow-up|33|||
105709871|NCT00880893|364598144|FG000|Overall Study|Serious adverse event|3|||
105709872|NCT00880893|364598145|FG001|Overall Study|Serious adverse event|0|||
105709873|NCT00112905|364598150|FG000|Overall Study|Adverse Event|4|||
105709874|NCT00112905|364598150|FG000|Overall Study|Death|1|||
105709875|NCT00112905|364598150|FG000|Overall Study|Ineligibility|5|||
105709876|NCT00112905|364598150|FG000|Overall Study|Alternative treatment|1|||
105709877|NCT00112905|364598150|FG000|Overall Study|performance status was deteiorating|1|||
105709878|NCT03354663|364598152|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
105709879|NCT03354663|364598152|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
105709880|NCT03354663|364598152|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
105788066|NCT00593385|364878188|FG000|Overall Study|Death|14|||
105360888|NCT01051557|363328105|FG002|Overall Study|Physician Decision|0|||
105560650|NCT04575051|364048477|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
105560651|NCT04575051|364048478|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
105560652|NCT04575051|364048479|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
105560653|NCT04575051|364048475|FG000|Time Period 1|Missing follow up|1|||
105560654|NCT04575051|364048476|FG001|Time Period 1|Missing follow up|3|||
105560655|NCT04575051|364048477|FG002|Time Period 1|Missing follow up|1|||
105560656|NCT04575051|364048478|FG003|Time Period 1|Missing follow up|3|||
105560657|NCT04575051|364048479|FG004|Time Period 1|Missing follow up|2|||
105560658|NCT04575051|364048475|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
105560659|NCT04575051|364048476|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
105560660|NCT04575051|364048477|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
105560661|NCT04575051|364048478|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
105560662|NCT04575051|364048479|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
105560663|NCT04575051|364048475|FG000|Time Period 2|Missing follow up|1|||
105560664|NCT04575051|364048476|FG001|Time Period 2|Missing follow up|8|||
105560665|NCT04575051|364048477|FG002|Time Period 2|Missing follow up|7|||
105560666|NCT04575051|364048478|FG003|Time Period 2|Missing follow up|0|||
105560667|NCT04575051|364048479|FG004|Time Period 2|Missing follow up|1|||
105560668|NCT04575051|364048475|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
105560669|NCT04575051|364048476|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
105560670|NCT04575051|364048477|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
105560671|NCT04575051|364048478|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
105560672|NCT04575051|364048479|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
105560673|NCT04575051|364048475|FG000|Time Period 3|Missing follow up|8|||
105560674|NCT04575051|364048476|FG001|Time Period 3|Missing follow up|6|||
105560675|NCT04575051|364048477|FG002|Time Period 3|Missing follow up|4|||
105560676|NCT04575051|364048478|FG003|Time Period 3|Missing follow up|3|||
105560677|NCT04575051|364048479|FG004|Time Period 3|Missing follow up|0|||
105560678|NCT04575051|364048475|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
105351052|NCT01663857|363289624|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
105351053|NCT01663857|363289625|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
105351054|NCT01663857|363289626|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
105351055|NCT01663857|363289627|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
105351056|NCT01663857|363289624|FG000|Overall Study|Lost to Follow-up|0|||
105351057|NCT01663857|363289625|FG001|Overall Study|Lost to Follow-up|0|||
105351058|NCT01663857|363289626|FG002|Overall Study|Lost to Follow-up|3|||
105351059|NCT01663857|363289627|FG003|Overall Study|Lost to Follow-up|1|||
105351060|NCT04494425|363289628|FG000|Overall Study|Death|160|||
105351061|NCT04494425|363289629|FG001|Overall Study|Death|166|||
105351062|NCT04494425|363289628|FG000|Overall Study|Withdrawal by Subject|10|||
105351063|NCT04494425|363289629|FG001|Overall Study|Withdrawal by Subject|40|||
105351064|NCT04494425|363289628|FG000|Overall Study|Other|1|||
105351065|NCT04494425|363289629|FG001|Overall Study|Other|1|||
105351066|NCT04494425|363289628|FG000|Overall Study|Ongoing at the time of PCD|265|||
105351067|NCT04494425|363289629|FG001|Overall Study|Ongoing at the time of PCD|223|||
105351068|NCT03041467|363289630|FG000|Overall Study|Death|46|||
105351069|NCT03041467|363289631|FG001|Overall Study|Death|39|||
105351070|NCT03041467|363289630|FG000|Overall Study|Withdrawal by Subject|36|||
105351071|NCT03041467|363289631|FG001|Overall Study|Withdrawal by Subject|37|||
105351072|NCT03041467|363289630|FG000|Overall Study|Lost to Follow-up|6|||
105351073|NCT03041467|363289631|FG001|Overall Study|Lost to Follow-up|8|||
105351074|NCT03041467|363289630|FG000|Overall Study|Declined consent for study extension|21|||
105351075|NCT03041467|363289631|FG001|Overall Study|Declined consent for study extension|33|||
105351076|NCT03041467|363289630|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
105351077|NCT03041467|363289631|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
105351078|NCT01980628|363289634|FG000|Overall Study|Adverse Event|12|||
105351079|NCT01980628|363289634|FG000|Overall Study|Physician Decision|5|||
105351080|NCT01980628|363289634|FG000|Overall Study|Withdrawal by Subject|4|||
105351081|NCT01980628|363289634|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
105351082|NCT02474355|363289635|FG000|Overall Study|Other|43|||
105560679|NCT04575051|364048476|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
105560680|NCT04575051|364048477|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
105560681|NCT04575051|364048478|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
105560682|NCT04575051|364048479|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
105560683|NCT04575051|364048475|FG000|Time Period 4|Missing follow up|17|||
105560684|NCT04575051|364048476|FG001|Time Period 4|Missing follow up|3|||
105351083|NCT02474355|363289635|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
105351084|NCT02474355|363289635|FG000|Overall Study|Lost to Follow-up|98|||
105560685|NCT04575051|364048477|FG002|Time Period 4|Missing follow up|4|||
105560686|NCT04575051|364048478|FG003|Time Period 4|Missing follow up|2|||
105351085|NCT02474355|363289635|FG000|Overall Study|Withdrawal by Subject|124|||
105475036|NCT03462511|363751281|FG000|Overall Study|Withdrawal by Subject|2|||
105475037|NCT03462511|363751282|FG001|Overall Study|Withdrawal by Subject|3|||
105475038|NCT00435045|363751283|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
105475039|NCT00435045|363751284|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
105475040|NCT00435045|363751283|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
105475041|NCT00435045|363751284|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
105475042|NCT00435045|363751283|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
105475043|NCT00435045|363751284|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
105475044|NCT00435045|363751283|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
105475045|NCT00435045|363751284|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
105475046|NCT00435045|363751283|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
105475047|NCT00435045|363751284|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
105475048|NCT00435045|363751283|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
105475049|NCT00435045|363751284|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
105475050|NCT00435045|363751283|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
105475051|NCT00435045|363751284|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
105475052|NCT00435045|363751283|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
105475053|NCT00435045|363751284|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
105475054|NCT00435045|363751283|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
105475055|NCT00435045|363751284|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
105475056|NCT00435045|363751283|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
105475057|NCT00435045|363751284|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
105475058|NCT00435045|363751283|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
105475059|NCT00435045|363751284|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
105475060|NCT00566696|363751285|FG000|Overall Study|Met Exclusion Criteria|2|||
105475061|NCT00566696|363751285|FG000|Overall Study|Muromonab not available|1|||
105475062|NCT00566696|363751285|FG000|Overall Study|Health Status Change|1|||
105475063|NCT00566696|363751285|FG000|Overall Study|Physician Decision|1|||
105475064|NCT00566696|363751285|FG000|Overall Study|Non-Patient Donors|37|||
105475065|NCT02872935|363751286|FG000|Overall Study|Other|0|||
105475066|NCT02872935|363751287|FG001|Overall Study|Other|1|||
105475067|NCT00635999|363751288|FG000|Overall Study|Withdrawal by Subject|4|||
105475068|NCT00635999|363751289|FG001|Overall Study|Withdrawal by Subject|2|||
105475069|NCT00635999|363751290|FG002|Overall Study|Withdrawal by Subject|1|||
105475070|NCT01798849|363751291|FG000|Overall Study|Physician Decision|0|||
105475071|NCT01798849|363751292|FG001|Overall Study|Physician Decision|0|||
105475072|NCT01798849|363751293|FG002|Overall Study|Physician Decision|1|||
105475073|NCT02878798|363751294|FG000|Overall Study|Withdrawal by Subject|5|||
105475074|NCT02878798|363751295|FG001|Overall Study|Withdrawal by Subject|4|||
105475075|NCT02878798|363751294|FG000|Overall Study|Lost to Follow-up|2|||
105475076|NCT02878798|363751295|FG001|Overall Study|Lost to Follow-up|2|||
105475077|NCT02878798|363751294|FG000|Overall Study|Protocol Violation|0|||
105475078|NCT02878798|363751295|FG001|Overall Study|Protocol Violation|1|||
105475079|NCT01134705|363751296|FG000|Overall Study|Adverse Event|1|||
105475080|NCT01134705|363751297|FG001|Overall Study|Adverse Event|7|||
105475081|NCT01134705|363751296|FG000|Overall Study|Withdrawal by Subject|6|||
105475082|NCT01134705|363751297|FG001|Overall Study|Withdrawal by Subject|6|||
105475083|NCT01134705|363751296|FG000|Overall Study|Pregnancy|1|||
105475084|NCT01134705|363751297|FG001|Overall Study|Pregnancy|0|||
105475085|NCT01134705|363751296|FG000|Overall Study|Lost to Follow-up|5|||
105475086|NCT01134705|363751297|FG001|Overall Study|Lost to Follow-up|2|||
105475087|NCT01134705|363751296|FG000|Overall Study|Protocol Violation|1|||
105475088|NCT01134705|363751297|FG001|Overall Study|Protocol Violation|1|||
105475089|NCT01134705|363751296|FG000|Overall Study|Other|1|||
105475090|NCT01134705|363751297|FG001|Overall Study|Other|6|||
105475091|NCT01994889|363751298|FG000|Overall Study|Adverse Event|5|||
105475092|NCT01994889|363751299|FG001|Overall Study|Adverse Event|12|||
105475093|NCT01994889|363751300|FG002|Overall Study|Adverse Event|11|||
105475094|NCT01994889|363751298|FG000|Overall Study|Cardiac Device Implantation|0|||
105475095|NCT01994889|363751299|FG001|Overall Study|Cardiac Device Implantation|2|||
105475096|NCT01994889|363751300|FG002|Overall Study|Cardiac Device Implantation|0|||
105475097|NCT01994889|363751298|FG000|Overall Study|Organ Transplantation|1|||
105709881|NCT03354663|364598152|FG000|Completed 30-day Visit|Missed Visit|1|||
105709882|NCT01661140|364598153|FG000|Open-Label Period|Adverse Event|44|||
105475098|NCT01994889|363751299|FG001|Overall Study|Organ Transplantation|5|||
105475099|NCT01994889|363751300|FG002|Overall Study|Organ Transplantation|5|||
105475100|NCT01994889|363751298|FG000|Overall Study|No longer willing to participate|8|||
105475101|NCT01994889|363751299|FG001|Overall Study|No longer willing to participate|17|||
105475102|NCT01994889|363751300|FG002|Overall Study|No longer willing to participate|37|||
105475103|NCT01994889|363751298|FG000|Overall Study|Lost to Follow-up|0|||
105475104|NCT01994889|363751299|FG001|Overall Study|Lost to Follow-up|1|||
105475105|NCT01994889|363751300|FG002|Overall Study|Lost to Follow-up|0|||
105475106|NCT01994889|363751298|FG000|Overall Study|Protocol Violation|0|||
105475107|NCT01994889|363751299|FG001|Overall Study|Protocol Violation|1|||
105709883|NCT01661140|364598154|FG001|Open-Label Period|Adverse Event|0|||
105709884|NCT01661140|364598155|FG002|Open-Label Period|Adverse Event|0|||
105709885|NCT01661140|364598153|FG000|Open-Label Period|Protocol Violation|3|||
105351086|NCT02474355|363289635|FG000|Overall Study|Death|1361|||
105351087|NCT01066793|363289636|FG000|Overall Study|Death|4|||
105351088|NCT01066793|363289637|FG001|Overall Study|Death|1|||
105351089|NCT01066793|363289638|FG002|Overall Study|Death|1|||
105351090|NCT01066793|363289639|FG003|Overall Study|Death|0|||
105351091|NCT01066793|363289640|FG004|Overall Study|Death|0|||
105351092|NCT01066793|363289641|FG005|Overall Study|Death|0|||
105351093|NCT01066793|363289636|FG000|Overall Study|Lack of Efficacy|2|||
105351094|NCT01066793|363289637|FG001|Overall Study|Lack of Efficacy|1|||
105351095|NCT01066793|363289638|FG002|Overall Study|Lack of Efficacy|0|||
105351096|NCT01066793|363289639|FG003|Overall Study|Lack of Efficacy|0|||
105351097|NCT01066793|363289640|FG004|Overall Study|Lack of Efficacy|0|||
105351098|NCT01066793|363289641|FG005|Overall Study|Lack of Efficacy|0|||
105351099|NCT01066793|363289636|FG000|Overall Study|Lost to Follow-up|180|||
105351100|NCT01066793|363289637|FG001|Overall Study|Lost to Follow-up|39|||
105351101|NCT01066793|363289638|FG002|Overall Study|Lost to Follow-up|82|||
105351102|NCT01066793|363289639|FG003|Overall Study|Lost to Follow-up|16|||
105351103|NCT01066793|363289640|FG004|Overall Study|Lost to Follow-up|0|||
105351104|NCT01066793|363289641|FG005|Overall Study|Lost to Follow-up|1|||
105351105|NCT01066793|363289636|FG000|Overall Study|Physician Decision|3|||
105351106|NCT01066793|363289637|FG001|Overall Study|Physician Decision|0|||
105351107|NCT01066793|363289638|FG002|Overall Study|Physician Decision|0|||
105351108|NCT01066793|363289639|FG003|Overall Study|Physician Decision|0|||
105351109|NCT01066793|363289640|FG004|Overall Study|Physician Decision|0|||
105351110|NCT01066793|363289641|FG005|Overall Study|Physician Decision|0|||
105351111|NCT01066793|363289636|FG000|Overall Study|Protocol Violation|3|||
105351112|NCT01066793|363289637|FG001|Overall Study|Protocol Violation|2|||
105351113|NCT01066793|363289638|FG002|Overall Study|Protocol Violation|2|||
105351114|NCT01066793|363289639|FG003|Overall Study|Protocol Violation|0|||
105351115|NCT01066793|363289640|FG004|Overall Study|Protocol Violation|0|||
105351116|NCT01066793|363289641|FG005|Overall Study|Protocol Violation|0|||
105351117|NCT01066793|363289636|FG000|Overall Study|Withdrawal by Subject|7|||
105351118|NCT01066793|363289637|FG001|Overall Study|Withdrawal by Subject|4|||
105351119|NCT01066793|363289638|FG002|Overall Study|Withdrawal by Subject|1|||
105351120|NCT01066793|363289639|FG003|Overall Study|Withdrawal by Subject|0|||
105351121|NCT01066793|363289640|FG004|Overall Study|Withdrawal by Subject|0|||
105351122|NCT01066793|363289641|FG005|Overall Study|Withdrawal by Subject|0|||
105351123|NCT01066793|363289636|FG000|Overall Study|Early Termination|3|||
105351124|NCT01066793|363289637|FG001|Overall Study|Early Termination|0|||
105351125|NCT01066793|363289638|FG002|Overall Study|Early Termination|0|||
105351126|NCT01066793|363289639|FG003|Overall Study|Early Termination|0|||
105351127|NCT01066793|363289640|FG004|Overall Study|Early Termination|0|||
105351128|NCT01066793|363289641|FG005|Overall Study|Early Termination|0|||
105351129|NCT01066793|363289636|FG000|Overall Study|Lab test not done|7|||
105709886|NCT01661140|364598154|FG001|Open-Label Period|Protocol Violation|0|||
105709887|NCT01661140|364598155|FG002|Open-Label Period|Protocol Violation|0|||
105351130|NCT01066793|363289637|FG001|Overall Study|Lab test not done|0|||
105351131|NCT01066793|363289638|FG002|Overall Study|Lab test not done|0|||
105351132|NCT01066793|363289639|FG003|Overall Study|Lab test not done|1|||
105351133|NCT01066793|363289640|FG004|Overall Study|Lab test not done|0|||
105351134|NCT01066793|363289641|FG005|Overall Study|Lab test not done|0|||
105351135|NCT01066793|363289636|FG000|Overall Study|Miscellaneous|4|||
105351136|NCT01066793|363289637|FG001|Overall Study|Miscellaneous|5|||
105351137|NCT01066793|363289638|FG002|Overall Study|Miscellaneous|6|||
105351138|NCT01066793|363289639|FG003|Overall Study|Miscellaneous|0|||
105351139|NCT01066793|363289640|FG004|Overall Study|Miscellaneous|0|||
105351140|NCT01066793|363289641|FG005|Overall Study|Miscellaneous|0|||
105560687|NCT04575051|364048479|FG004|Time Period 4|Missing follow up|1|||
105560688|NCT04575051|364048475|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
105560689|NCT04575051|364048476|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
105560690|NCT04575051|364048477|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
105560691|NCT04575051|364048478|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
105560692|NCT04575051|364048479|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
105560693|NCT04575051|364048475|FG000|Time Period 5|Missing follow up|11|||
105560694|NCT04575051|364048476|FG001|Time Period 5|Missing follow up|8|||
105560695|NCT04575051|364048477|FG002|Time Period 5|Missing follow up|12|||
105560696|NCT04575051|364048478|FG003|Time Period 5|Missing follow up|3|||
105560697|NCT04575051|364048479|FG004|Time Period 5|Missing follow up|11|||
105560698|NCT00715429|364048480|FG000|Overall Study|Did not complete the study diary|0|||
105560699|NCT00715429|364048481|FG001|Overall Study|Did not complete the study diary|1|||
105560700|NCT00514735|364048487|FG000|Overall Study|Withdrawal by Subject|13|||
105560701|NCT00514735|364048488|FG001|Overall Study|Withdrawal by Subject|5|||
105560702|NCT00514735|364048487|FG000|Overall Study|Death|1|||
105560703|NCT00514735|364048488|FG001|Overall Study|Death|0|||
105560704|NCT00514735|364048487|FG000|Overall Study|Lost to Follow-up|0|||
105560705|NCT00514735|364048488|FG001|Overall Study|Lost to Follow-up|1|||
105560706|NCT03178266|364048489|FG000|Overall Study|Death|0|||
105560707|NCT03178266|364048490|FG001|Overall Study|Death|1|||
105560708|NCT03178266|364048489|FG000|Overall Study|Disont. Early|0|||
105560709|NCT03178266|364048490|FG001|Overall Study|Disont. Early|1|||
105560710|NCT03178266|364048489|FG000|Overall Study|Withdrawal by Subject|0|||
105560711|NCT03178266|364048490|FG001|Overall Study|Withdrawal by Subject|2|||
105560712|NCT02472964|364048491|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
105560713|NCT02472964|364048492|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
105560714|NCT02472964|364048491|FG000|Part 1 (up to Week 24)|disease progression|58|||
105560715|NCT02472964|364048492|FG001|Part 1 (up to Week 24)|disease progression|47|||
105560716|NCT02472964|364048491|FG000|Part 1 (up to Week 24)|Death|3|||
105560717|NCT02472964|364048492|FG001|Part 1 (up to Week 24)|Death|6|||
105560718|NCT02472964|364048491|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
105560719|NCT02472964|364048492|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
105560720|NCT02472964|364048491|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
105560721|NCT02472964|364048492|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
105560722|NCT02472964|364048491|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
105560723|NCT02472964|364048492|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
105560724|NCT02472964|364048491|FG000|Part 1 (up to Week 24)|Other|2|||
105560725|NCT02472964|364048492|FG001|Part 1 (up to Week 24)|Other|1|||
105560726|NCT02472964|364048491|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
105560727|NCT02472964|364048492|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
105560728|NCT02472964|364048491|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
105560729|NCT02472964|364048492|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
105560730|NCT02472964|364048491|FG000|Part 2 (Week 24-week 48)|Death|0|||
105560731|NCT02472964|364048492|FG001|Part 2 (Week 24-week 48)|Death|1|||
105560732|NCT02472964|364048491|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
105560733|NCT02472964|364048492|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
105560734|NCT02472964|364048491|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
105560735|NCT02472964|364048492|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
105560736|NCT02472964|364048491|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
105560737|NCT02472964|364048492|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
105560738|NCT02472964|364048491|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
105560739|NCT02472964|364048492|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
105560740|NCT03311373|364048498|FG000|Overall Study|Adverse Event|1|||
105560741|NCT03311373|364048498|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
105560742|NCT03311373|364048498|FG000|Overall Study|Lost to Follow-up|1|||
105560743|NCT03311373|364048498|FG000|Overall Study|Physician Decision|1|||
105560744|NCT03311373|364048498|FG000|Overall Study|Withdrawal by Subject|3|||
105560745|NCT01687257|364048499|FG000|Overall Study|Efficacy Failure|6|||
105560746|NCT01687257|364048500|FG001|Overall Study|Efficacy Failure|0|||
105560747|NCT01687257|364048501|FG002|Overall Study|Efficacy Failure|5|||
105560748|NCT01687257|364048499|FG000|Overall Study|Subject Withdrew Consent|1|||
105560749|NCT01687257|364048500|FG001|Overall Study|Subject Withdrew Consent|1|||
105560750|NCT01687257|364048501|FG002|Overall Study|Subject Withdrew Consent|1|||
105560751|NCT01687257|364048499|FG000|Overall Study|Adverse Event|1|||
105560752|NCT01687257|364048500|FG001|Overall Study|Adverse Event|0|||
105560753|NCT01687257|364048501|FG002|Overall Study|Adverse Event|0|||
105788067|NCT00593385|364878188|FG000|Overall Study|Lost to Follow-up|17|||
105709888|NCT01661140|364598153|FG000|Open-Label Period|Withdrawal by Subject|5|||
105709889|NCT01661140|364598154|FG001|Open-Label Period|Withdrawal by Subject|0|||
105709890|NCT01661140|364598155|FG002|Open-Label Period|Withdrawal by Subject|0|||
105709891|NCT01661140|364598153|FG000|Open-Label Period|Investigator Decision|3|||
105709892|NCT01661140|364598154|FG001|Open-Label Period|Investigator Decision|0|||
105709893|NCT01661140|364598155|FG002|Open-Label Period|Investigator Decision|0|||
105709894|NCT01661140|364598153|FG000|Open-Label Period|Death|1|||
105709895|NCT01661140|364598154|FG001|Open-Label Period|Death|0|||
105709896|NCT01661140|364598155|FG002|Open-Label Period|Death|0|||
105709897|NCT01661140|364598153|FG000|Open-Label Period|Administrative/Other|1|||
105709898|NCT01661140|364598154|FG001|Open-Label Period|Administrative/Other|0|||
105709899|NCT01661140|364598155|FG002|Open-Label Period|Administrative/Other|0|||
105709900|NCT01661140|364598153|FG000|Open-Label Period|Sponsor termination|16|||
105709901|NCT01661140|364598154|FG001|Open-Label Period|Sponsor termination|0|||
105709902|NCT01661140|364598155|FG002|Open-Label Period|Sponsor termination|0|||
105709903|NCT01661140|364598153|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
105709904|NCT01661140|364598154|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
105709905|NCT01661140|364598155|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
105709906|NCT01661140|364598153|FG000|Open-Label Period|Lost to Follow-up|2|||
105709907|NCT01661140|364598154|FG001|Open-Label Period|Lost to Follow-up|0|||
105709908|NCT01661140|364598155|FG002|Open-Label Period|Lost to Follow-up|0|||
105709909|NCT01661140|364598153|FG000|Double-Blind Period|Refused Treatment|0|||
105709910|NCT01661140|364598154|FG001|Double-Blind Period|Refused Treatment|0|||
105709911|NCT01661140|364598155|FG002|Double-Blind Period|Refused Treatment|1|||
105709912|NCT01661140|364598153|FG000|Double-Blind Period|Adverse Event|0|||
105709913|NCT01661140|364598154|FG001|Double-Blind Period|Adverse Event|16|||
105709914|NCT01661140|364598155|FG002|Double-Blind Period|Adverse Event|18|||
105709915|NCT01661140|364598153|FG000|Double-Blind Period|Protocol Violation|0|||
105709916|NCT01661140|364598154|FG001|Double-Blind Period|Protocol Violation|2|||
105709917|NCT01661140|364598155|FG002|Double-Blind Period|Protocol Violation|3|||
105709918|NCT01661140|364598153|FG000|Double-Blind Period|Withdrawal by Subject|0|||
105709919|NCT01661140|364598154|FG001|Double-Blind Period|Withdrawal by Subject|1|||
105709920|NCT01661140|364598155|FG002|Double-Blind Period|Withdrawal by Subject|3|||
105709921|NCT01661140|364598153|FG000|Double-Blind Period|Investigator's Decision|0|||
105709922|NCT01661140|364598154|FG001|Double-Blind Period|Investigator's Decision|1|||
105709923|NCT01661140|364598155|FG002|Double-Blind Period|Investigator's Decision|2|||
105709924|NCT01661140|364598153|FG000|Double-Blind Period|Sponsor Termination|0|||
105709925|NCT01661140|364598154|FG001|Double-Blind Period|Sponsor Termination|14|||
105709926|NCT01661140|364598155|FG002|Double-Blind Period|Sponsor Termination|17|||
105709927|NCT01661140|364598153|FG000|Double-Blind Period|Administrative/Other|0|||
105709928|NCT01661140|364598154|FG001|Double-Blind Period|Administrative/Other|7|||
105709929|NCT01661140|364598155|FG002|Double-Blind Period|Administrative/Other|6|||
105709930|NCT00691483|364598156|FG000|Overall Study|Adverse Event|14|||
105709931|NCT00691483|364598157|FG001|Overall Study|Adverse Event|6|||
105709932|NCT00691483|364598156|FG000|Overall Study|Lost to Follow-up|17|||
105709933|NCT00691483|364598157|FG001|Overall Study|Lost to Follow-up|10|||
105709934|NCT00691483|364598156|FG000|Overall Study|Withdrawal by Subject|24|||
105709935|NCT00691483|364598157|FG001|Overall Study|Withdrawal by Subject|7|||
105709936|NCT00691483|364598156|FG000|Overall Study|Other known cause|6|||
105709937|NCT00691483|364598157|FG001|Overall Study|Other known cause|1|||
105709938|NCT00691483|364598156|FG000|Overall Study|Randomized by not treated|7|||
105709939|NCT00691483|364598157|FG001|Overall Study|Randomized by not treated|1|||
105709940|NCT01391000|364598158|FG000|Overall Study|Lost to Follow-up|2|||
105709941|NCT01391000|364598159|FG001|Overall Study|Lost to Follow-up|0|||
105709942|NCT00590590|364598169|FG000|Overall Study|Lack of Efficacy|1|||
105709943|NCT00590590|364598170|FG001|Overall Study|Lack of Efficacy|2|||
105709944|NCT00590590|364598171|FG002|Overall Study|Lack of Efficacy|0|||
105709945|NCT00590590|364598169|FG000|Overall Study|Adverse Event|1|||
105709946|NCT00590590|364598170|FG001|Overall Study|Adverse Event|0|||
105709947|NCT00590590|364598171|FG002|Overall Study|Adverse Event|0|||
105709948|NCT00590590|364598169|FG000|Overall Study|Protocol Violation|0|||
105709949|NCT00590590|364598170|FG001|Overall Study|Protocol Violation|0|||
105788068|NCT00593385|364878188|FG000|Overall Study|Withdrawal by Subject|9|||
105788069|NCT00848965|364878189|FG000|Overall Study|Adverse Event|1|||
105709950|NCT00590590|364598171|FG002|Overall Study|Protocol Violation|2|||
105709951|NCT00590590|364598169|FG000|Overall Study|Lost to Follow-up|4|||
105709952|NCT00590590|364598170|FG001|Overall Study|Lost to Follow-up|1|||
105709953|NCT00590590|364598171|FG002|Overall Study|Lost to Follow-up|2|||
105788070|NCT00848965|364878189|FG000|Overall Study|Withdrawal by Subject|1|||
105788071|NCT01471197|364878194|FG000|Overall Study|Disease Progression|4|||
105351141|NCT01066793|363289636|FG000|Overall Study|Non-responders|104|||
105709954|NCT00590590|364598169|FG000|Overall Study|Withdrawal by Subject|0|||
105709955|NCT00590590|364598170|FG001|Overall Study|Withdrawal by Subject|1|||
105709956|NCT00590590|364598171|FG002|Overall Study|Withdrawal by Subject|1|||
105709957|NCT00590590|364598169|FG000|Overall Study|Did not complete due to study closure|1|||
105709958|NCT00590590|364598170|FG001|Overall Study|Did not complete due to study closure|1|||
105709959|NCT00590590|364598171|FG002|Overall Study|Did not complete due to study closure|1|||
105709960|NCT00590590|364598169|FG000|Overall Study|Did not complete study|0|||
105709961|NCT00590590|364598170|FG001|Overall Study|Did not complete study|1|||
105709962|NCT00590590|364598171|FG002|Overall Study|Did not complete study|0|||
105709963|NCT02684981|364598173|FG000|Overall Study|Permanently discontinued the treatment|157|||
105709964|NCT02684981|364598174|FG001|Overall Study|Permanently discontinued the treatment|161|||
105709965|NCT02684981|364598175|FG002|Overall Study|Permanently discontinued the treatment|110|||
105709966|NCT02684981|364598173|FG000|Overall Study|Other|83|||
105709967|NCT02684981|364598174|FG001|Overall Study|Other|49|||
105709968|NCT02684981|364598175|FG002|Overall Study|Other|17|||
105709969|NCT01745146|364598176|FG000|Overall Study|Withdrawal by Subject|1|||
105709970|NCT01745146|364598177|FG001|Overall Study|Withdrawal by Subject|3|||
105709971|NCT01745146|364598176|FG000|Overall Study|Lost to Follow-up|2|||
105709972|NCT01745146|364598177|FG001|Overall Study|Lost to Follow-up|0|||
105709973|NCT01262365|364598178|FG000|Overall Study|Lack of Efficacy|35|||
105709974|NCT01262365|364598179|FG001|Overall Study|Lack of Efficacy|30|||
105709975|NCT01262365|364598180|FG002|Overall Study|Lack of Efficacy|47|||
105709976|NCT01262365|364598178|FG000|Overall Study|Protocol Violation|3|||
105709977|NCT01262365|364598179|FG001|Overall Study|Protocol Violation|1|||
105709978|NCT01262365|364598180|FG002|Overall Study|Protocol Violation|1|||
105709979|NCT01262365|364598178|FG000|Overall Study|Lost to Follow-up|3|||
105709980|NCT01262365|364598179|FG001|Overall Study|Lost to Follow-up|7|||
105709981|NCT01262365|364598180|FG002|Overall Study|Lost to Follow-up|6|||
105709982|NCT01262365|364598178|FG000|Overall Study|Withdrawal by Subject|17|||
105709983|NCT01262365|364598179|FG001|Overall Study|Withdrawal by Subject|22|||
105709984|NCT01262365|364598180|FG002|Overall Study|Withdrawal by Subject|22|||
105709985|NCT01262365|364598178|FG000|Overall Study|Death|1|||
105709986|NCT01262365|364598179|FG001|Overall Study|Death|2|||
105709987|NCT01262365|364598180|FG002|Overall Study|Death|1|||
105709988|NCT01262365|364598178|FG000|Overall Study|Adverse Event|26|||
105709989|NCT01262365|364598179|FG001|Overall Study|Adverse Event|16|||
105709990|NCT01262365|364598180|FG002|Overall Study|Adverse Event|11|||
105709991|NCT01262365|364598178|FG000|Overall Study|sponsor decision|1|||
105709992|NCT01262365|364598179|FG001|Overall Study|sponsor decision|1|||
105351142|NCT01066793|363289637|FG001|Overall Study|Non-responders|5|||
105351143|NCT01066793|363289638|FG002|Overall Study|Non-responders|11|||
105351144|NCT01066793|363289639|FG003|Overall Study|Non-responders|25|||
105351145|NCT01066793|363289640|FG004|Overall Study|Non-responders|0|||
105351146|NCT01066793|363289641|FG005|Overall Study|Non-responders|0|||
105351147|NCT01066793|363289636|FG000|Overall Study|Other|15|||
105351148|NCT01066793|363289637|FG001|Overall Study|Other|5|||
105351149|NCT01066793|363289638|FG002|Overall Study|Other|6|||
105351150|NCT01066793|363289639|FG003|Overall Study|Other|2|||
105475108|NCT01994889|363751300|FG002|Overall Study|Protocol Violation|1|||
105475109|NCT01994889|363751298|FG000|Overall Study|Death|14|||
105475110|NCT01994889|363751299|FG001|Overall Study|Death|25|||
105475111|NCT01994889|363751300|FG002|Overall Study|Death|38|||
105475112|NCT02152956|363751302|FG000|Overall Study|Adverse Event|0|||
105475113|NCT02152956|363751303|FG001|Overall Study|Adverse Event|0|||
105475114|NCT02152956|363751304|FG002|Overall Study|Adverse Event|0|||
105475115|NCT02152956|363751305|FG003|Overall Study|Adverse Event|0|||
105475116|NCT02152956|363751306|FG004|Overall Study|Adverse Event|0|||
105475117|NCT02152956|363751307|FG005|Overall Study|Adverse Event|0|||
105709993|NCT01262365|364598180|FG002|Overall Study|sponsor decision|0|||
105709994|NCT01262365|364598178|FG000|Overall Study|Randomization error|1|||
105709995|NCT01262365|364598179|FG001|Overall Study|Randomization error|0|||
105709996|NCT01262365|364598180|FG002|Overall Study|Randomization error|2|||
105351151|NCT01066793|363289640|FG004|Overall Study|Other|0|||
105709997|NCT01262365|364598178|FG000|Overall Study|Non-compliance|1|||
105709998|NCT01262365|364598179|FG001|Overall Study|Non-compliance|0|||
105351152|NCT01066793|363289641|FG005|Overall Study|Other|0|||
105351153|NCT01066793|363289636|FG000|Overall Study|Relapse|20|||
105351154|NCT01066793|363289637|FG001|Overall Study|Relapse|8|||
105709999|NCT01262365|364598180|FG002|Overall Study|Non-compliance|2|||
105710000|NCT01262365|364598178|FG000|Overall Study|Suspected pregnancy|1|||
105710001|NCT01262365|364598179|FG001|Overall Study|Suspected pregnancy|0|||
105710002|NCT01262365|364598180|FG002|Overall Study|Suspected pregnancy|0|||
105710003|NCT01262365|364598178|FG000|Overall Study|Patient pregnant|1|||
105710004|NCT01262365|364598179|FG001|Overall Study|Patient pregnant|0|||
105710005|NCT01262365|364598180|FG002|Overall Study|Patient pregnant|1|||
105710006|NCT01262365|364598178|FG000|Overall Study|Toxicity related to study drug|0|||
105710007|NCT01262365|364598179|FG001|Overall Study|Toxicity related to study drug|1|||
105710008|NCT01262365|364598180|FG002|Overall Study|Toxicity related to study drug|0|||
105710009|NCT01262365|364598178|FG000|Overall Study|Cannot tolerate the protocol|0|||
105710010|NCT01262365|364598179|FG001|Overall Study|Cannot tolerate the protocol|1|||
105710011|NCT01262365|364598180|FG002|Overall Study|Cannot tolerate the protocol|0|||
105710012|NCT01262365|364598178|FG000|Overall Study|Patient unavailable|0|||
105710013|NCT01262365|364598179|FG001|Overall Study|Patient unavailable|0|||
105710014|NCT01262365|364598180|FG002|Overall Study|Patient unavailable|1|||
105710015|NCT00494091|364598181|FG000|Overall Study|Death|5|||
105710016|NCT00494091|364598182|FG001|Overall Study|Death|54|||
105710017|NCT00494091|364598181|FG000|Overall Study|Lost to Follow-up|0|||
105710018|NCT00494091|364598182|FG001|Overall Study|Lost to Follow-up|4|||
105710019|NCT00494091|364598181|FG000|Overall Study|Other|1|||
105710020|NCT00494091|364598182|FG001|Overall Study|Other|11|||
105710021|NCT00494091|364598181|FG000|Overall Study|Withdrawal by Subject|0|||
105710022|NCT00494091|364598182|FG001|Overall Study|Withdrawal by Subject|7|||
105710023|NCT00326898|364598186|FG000|Overall Study|Disease progression|52|||
105710024|NCT00326898|364598187|FG001|Overall Study|Disease progression|54|||
105710025|NCT00326898|364598188|FG002|Overall Study|Disease progression|102|||
105351155|NCT01066793|363289638|FG002|Overall Study|Relapse|2|||
105475118|NCT02152956|363751308|FG006|Overall Study|Adverse Event|0|||
105475119|NCT02152956|363751309|FG007|Overall Study|Adverse Event|0|||
105475120|NCT02152956|363751310|FG008|Overall Study|Adverse Event|0|||
105475121|NCT02152956|363751311|FG009|Overall Study|Adverse Event|0|||
105710026|NCT00326898|364598186|FG000|Overall Study|Adverse Event|124|||
105710027|NCT00326898|364598187|FG001|Overall Study|Adverse Event|128|||
105710028|NCT00326898|364598188|FG002|Overall Study|Adverse Event|33|||
105710029|NCT00326898|364598186|FG000|Overall Study|Death|2|||
105710030|NCT00326898|364598187|FG001|Overall Study|Death|0|||
105710031|NCT00326898|364598188|FG002|Overall Study|Death|0|||
105710032|NCT00326898|364598186|FG000|Overall Study|Withdrawal by Subject|134|||
105710033|NCT00326898|364598187|FG001|Overall Study|Withdrawal by Subject|128|||
105710034|NCT00326898|364598188|FG002|Overall Study|Withdrawal by Subject|32|||
105710035|NCT00326898|364598186|FG000|Overall Study|Alternative therapy|1|||
105710036|NCT00326898|364598187|FG001|Overall Study|Alternative therapy|0|||
105710037|NCT00326898|364598188|FG002|Overall Study|Alternative therapy|0|||
105710038|NCT00326898|364598186|FG000|Overall Study|Other complicating disease|5|||
105710039|NCT00326898|364598187|FG001|Overall Study|Other complicating disease|5|||
105710040|NCT00326898|364598188|FG002|Overall Study|Other complicating disease|4|||
105710041|NCT00326898|364598186|FG000|Overall Study|Other/Missing/Unknown|33|||
105710042|NCT00326898|364598187|FG001|Overall Study|Other/Missing/Unknown|28|||
105710043|NCT00326898|364598188|FG002|Overall Study|Other/Missing/Unknown|32|||
105710044|NCT00272038|364598189|FG000|Overall Study|withdrew before they received 2 cycles|7|||
105710045|NCT03847987|364598190|FG000|Overall Study|Lost to Follow-up|1|||
105710046|NCT03847987|364598191|FG001|Overall Study|Lost to Follow-up|0|||
105710047|NCT03847987|364598190|FG000|Overall Study|Adverse Event|2|||
105710048|NCT03847987|364598191|FG001|Overall Study|Adverse Event|0|||
105710049|NCT04161131|364598192|FG000|Overall Study|Ineligible|2|||
105710050|NCT04161131|364598192|FG000|Overall Study|Lost to Follow-up|4|||
105710051|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
105710052|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
105710053|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
105710054|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
105710055|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
105475122|NCT02152956|363751312|FG010|Overall Study|Adverse Event|0|||
105710056|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
105710057|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
105710058|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
105710059|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
105710060|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
105710061|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
105475123|NCT02152956|363751313|FG011|Overall Study|Adverse Event|4|||
105710062|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
105351156|NCT01066793|363289639|FG003|Overall Study|Relapse|3|||
105351157|NCT01066793|363289640|FG004|Overall Study|Relapse|0|||
105351158|NCT01066793|363289641|FG005|Overall Study|Relapse|0|||
105351159|NCT01066793|363289636|FG000|Overall Study|Result Not Available|1|||
105351160|NCT01066793|363289637|FG001|Overall Study|Result Not Available|0|||
105351161|NCT01066793|363289638|FG002|Overall Study|Result Not Available|0|||
105351162|NCT01066793|363289639|FG003|Overall Study|Result Not Available|0|||
105351163|NCT01066793|363289640|FG004|Overall Study|Result Not Available|0|||
105351164|NCT01066793|363289641|FG005|Overall Study|Result Not Available|0|||
105351165|NCT01066793|363289636|FG000|Overall Study|Treatment Interrupted|1|||
105351166|NCT01066793|363289637|FG001|Overall Study|Treatment Interrupted|1|||
105351167|NCT01066793|363289638|FG002|Overall Study|Treatment Interrupted|0|||
105351168|NCT01066793|363289639|FG003|Overall Study|Treatment Interrupted|0|||
105351169|NCT01066793|363289640|FG004|Overall Study|Treatment Interrupted|0|||
105351170|NCT01066793|363289641|FG005|Overall Study|Treatment Interrupted|0|||
105351171|NCT01066793|363289636|FG000|Overall Study|Treatment Never Started|18|||
105351172|NCT01066793|363289637|FG001|Overall Study|Treatment Never Started|5|||
105351173|NCT01066793|363289638|FG002|Overall Study|Treatment Never Started|4|||
105351174|NCT01066793|363289639|FG003|Overall Study|Treatment Never Started|1|||
105351175|NCT01066793|363289640|FG004|Overall Study|Treatment Never Started|0|||
105351176|NCT01066793|363289641|FG005|Overall Study|Treatment Never Started|0|||
105351177|NCT01066793|363289636|FG000|Overall Study|Treatment Stopped|2|||
105351178|NCT01066793|363289637|FG001|Overall Study|Treatment Stopped|1|||
105351179|NCT01066793|363289638|FG002|Overall Study|Treatment Stopped|0|||
105351180|NCT01066793|363289639|FG003|Overall Study|Treatment Stopped|1|||
105351181|NCT01066793|363289640|FG004|Overall Study|Treatment Stopped|0|||
105351182|NCT01066793|363289641|FG005|Overall Study|Treatment Stopped|0|||
105351183|NCT01911793|363289643|FG000|Overall Study|Physician Decision|1|||
105351184|NCT01911793|363289644|FG001|Overall Study|Physician Decision|5|||
105351185|NCT02697916|363289645|FG000|Overall Study|Death|357|||
105351186|NCT02697916|363289646|FG001|Overall Study|Death|315|||
105351187|NCT02697916|363289645|FG000|Overall Study|Withdrawal by Subject|221|||
105351188|NCT02697916|363289646|FG001|Overall Study|Withdrawal by Subject|393|||
105351189|NCT05025332|363289647|FG000|Screening|Screen failure|12|||
105351190|NCT05025332|363289647|FG000|Treatment & Follow Up|Protocol Violation|1|||
105351191|NCT05025332|363289647|FG000|Treatment & Follow Up|Adverse Event|4|||
105351192|NCT01887288|363289648|FG000|Overall Study|The study was terminated and the PI has|16|||
105351193|NCT01908582|363289649|FG000|Period 2|Physician Decision|1|||
105351194|NCT01908582|363289649|FG000|Period 2|Withdrawal by Subject|1|||
105351195|NCT00564278|363289651|FG000|Overall Study|Lost to Follow-up|35|||
105351196|NCT00564278|363289652|FG001|Overall Study|Lost to Follow-up|33|||
105351197|NCT00564278|363289651|FG000|Overall Study|Physician Decision|1|||
105351198|NCT00564278|363289652|FG001|Overall Study|Physician Decision|2|||
105351199|NCT00564278|363289651|FG000|Overall Study|Withdrawal by Subject|11|||
105351200|NCT00564278|363289652|FG001|Overall Study|Withdrawal by Subject|7|||
105351201|NCT00255840|363289653|FG000|Overall Study|Lost to Follow-up|10|||
105351202|NCT00255840|363289654|FG001|Overall Study|Lost to Follow-up|14|||
105351203|NCT00255840|363289653|FG000|Overall Study|Discontinued intervention|53|||
105351204|NCT00255840|363289654|FG001|Overall Study|Discontinued intervention|56|||
105351205|NCT05600036|363289657|FG000|Overall Study|Adverse Event|0|||
105351206|NCT05600036|363289658|FG001|Overall Study|Adverse Event|2|||
105351207|NCT05600036|363289659|FG002|Overall Study|Adverse Event|1|||
105351208|NCT05600036|363289660|FG003|Overall Study|Adverse Event|0|||
105351209|NCT05600036|363289661|FG004|Overall Study|Adverse Event|1|||
105351210|NCT05600036|363289662|FG005|Overall Study|Adverse Event|0|||
105351211|NCT05600036|363289657|FG000|Overall Study|Lost to Follow-up|0|||
105351212|NCT05600036|363289658|FG001|Overall Study|Lost to Follow-up|2|||
105710063|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
105710064|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
105710065|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
105710066|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
105710067|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
105351213|NCT05600036|363289659|FG002|Overall Study|Lost to Follow-up|1|||
105351214|NCT05600036|363289660|FG003|Overall Study|Lost to Follow-up|1|||
105351215|NCT05600036|363289661|FG004|Overall Study|Lost to Follow-up|0|||
105351216|NCT05600036|363289662|FG005|Overall Study|Lost to Follow-up|0|||
105351217|NCT05600036|363289657|FG000|Overall Study|Protocol Violation|0|||
105351218|NCT05600036|363289658|FG001|Overall Study|Protocol Violation|0|||
105351219|NCT05600036|363289659|FG002|Overall Study|Protocol Violation|2|||
105351220|NCT05600036|363289660|FG003|Overall Study|Protocol Violation|0|||
105351221|NCT05600036|363289661|FG004|Overall Study|Protocol Violation|0|||
105351222|NCT05600036|363289662|FG005|Overall Study|Protocol Violation|0|||
105351223|NCT05600036|363289657|FG000|Overall Study|Withdrawal by Subject|0|||
105351224|NCT05600036|363289658|FG001|Overall Study|Withdrawal by Subject|1|||
105351225|NCT05600036|363289659|FG002|Overall Study|Withdrawal by Subject|2|||
105351226|NCT05600036|363289660|FG003|Overall Study|Withdrawal by Subject|0|||
105351227|NCT05600036|363289661|FG004|Overall Study|Withdrawal by Subject|3|||
105710068|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
105710069|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
105710070|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
105710071|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
105710072|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
105710073|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
105710074|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
105710075|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
105710076|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
105710077|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
105710078|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
105710079|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
105710080|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
105710081|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
105710082|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
105710083|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
105710084|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
105710085|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
105710086|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
105710087|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
105710088|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
105710089|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
105710090|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
105710091|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
105710092|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
105710093|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
105710094|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
105710095|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
105710096|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
105710097|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
105710098|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
105710099|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
105710100|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
105710101|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
105710102|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
105710103|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
105710104|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
105710105|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
105710106|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
105710107|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
105710108|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
105710109|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
105710110|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
105710111|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
105710112|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
105710113|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
105710114|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
105710115|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
105710116|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
105710117|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
105710118|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
105560754|NCT01687257|364048499|FG000|Overall Study|Investigator's Discretion|0|||
105710119|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
105710120|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
105710121|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
105710122|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
105710123|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
105710124|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
105710125|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
105560755|NCT01687257|364048500|FG001|Overall Study|Investigator's Discretion|3|||
105710126|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
105710127|NCT01652287|364598199|FG000|Overall Study|Withdrawal by Subject|2|||
105710128|NCT01652287|364598200|FG001|Overall Study|Withdrawal by Subject|0|||
105710129|NCT00527605|364598201|FG000|Overall Study|Adverse Event|3|||
105710130|NCT00527605|364598202|FG001|Overall Study|Adverse Event|0|||
105710131|NCT00527605|364598201|FG000|Overall Study|Withdrawal by Subject|3|||
105710132|NCT00527605|364598202|FG001|Overall Study|Withdrawal by Subject|7|||
105710133|NCT00527605|364598201|FG000|Overall Study|Lost to Follow-up|6|||
105710134|NCT00527605|364598202|FG001|Overall Study|Lost to Follow-up|2|||
105710135|NCT00527605|364598201|FG000|Overall Study|Protocol Violation|1|||
105710136|NCT00527605|364598202|FG001|Overall Study|Protocol Violation|2|||
105710137|NCT02615990|364598207|FG000|Overall Study|study terminated|1|||
105710138|NCT02615990|364598208|FG001|Overall Study|study terminated|1|||
105710139|NCT00763139|364598209|FG000|Overall Study|Adverse Event|4|||
105710140|NCT00763139|364598210|FG001|Overall Study|Adverse Event|2|||
105710141|NCT00763139|364598209|FG000|Overall Study|Withdrawal by Subject|0|||
105710142|NCT00763139|364598210|FG001|Overall Study|Withdrawal by Subject|1|||
105710143|NCT00763139|364598209|FG000|Overall Study|med change not allowed by protocol|1|||
105710144|NCT00763139|364598210|FG001|Overall Study|med change not allowed by protocol|0|||
105710145|NCT02354703|364598211|FG000|Overall Study|Withdrawal by Subject|1|||
105710146|NCT02354703|364598212|FG001|Overall Study|Withdrawal by Subject|1|||
105710147|NCT02354703|364598213|FG002|Overall Study|Withdrawal by Subject|1|||
105710148|NCT02354703|364598214|FG003|Overall Study|Withdrawal by Subject|1|||
105710149|NCT02354703|364598211|FG000|Overall Study|Lost to Follow-up|2|||
105710150|NCT02354703|364598212|FG001|Overall Study|Lost to Follow-up|7|||
105710151|NCT02354703|364598213|FG002|Overall Study|Lost to Follow-up|9|||
105710152|NCT02354703|364598214|FG003|Overall Study|Lost to Follow-up|2|||
105710153|NCT02354703|364598211|FG000|Overall Study|Adverse Event|0|||
105710154|NCT02354703|364598212|FG001|Overall Study|Adverse Event|0|||
105710155|NCT02354703|364598213|FG002|Overall Study|Adverse Event|1|||
105710156|NCT02354703|364598214|FG003|Overall Study|Adverse Event|0|||
105710157|NCT00559507|364598222|FG000|Overall Study|Not treated, patient ineligible|3|||
105710158|NCT02889796|364598225|FG000|Overall Study|Withdrew Consent|18|||
105710159|NCT02889796|364598226|FG001|Overall Study|Withdrew Consent|29|||
105710160|NCT02889796|364598227|FG002|Overall Study|Withdrew Consent|20|||
105710161|NCT02889796|364598228|FG003|Overall Study|Withdrew Consent|1|||
105710162|NCT02889796|364598229|FG004|Overall Study|Withdrew Consent|2|||
105710163|NCT02889796|364598230|FG005|Overall Study|Withdrew Consent|35|||
105710164|NCT02889796|364598225|FG000|Overall Study|Investigator's Discretion|10|||
105710165|NCT02889796|364598226|FG001|Overall Study|Investigator's Discretion|9|||
105710166|NCT02889796|364598227|FG002|Overall Study|Investigator's Discretion|10|||
105710167|NCT02889796|364598228|FG003|Overall Study|Investigator's Discretion|3|||
105710168|NCT02889796|364598229|FG004|Overall Study|Investigator's Discretion|0|||
105710169|NCT02889796|364598230|FG005|Overall Study|Investigator's Discretion|15|||
105710170|NCT02889796|364598225|FG000|Overall Study|Adverse Event|17|||
105710171|NCT02889796|364598226|FG001|Overall Study|Adverse Event|8|||
105710172|NCT02889796|364598227|FG002|Overall Study|Adverse Event|8|||
105710173|NCT02889796|364598228|FG003|Overall Study|Adverse Event|4|||
105710174|NCT02889796|364598229|FG004|Overall Study|Adverse Event|1|||
105710175|NCT02889796|364598230|FG005|Overall Study|Adverse Event|7|||
105710176|NCT02889796|364598225|FG000|Overall Study|Lost to Follow-up|5|||
105710177|NCT02889796|364598226|FG001|Overall Study|Lost to Follow-up|7|||
105710178|NCT02889796|364598227|FG002|Overall Study|Lost to Follow-up|2|||
105710179|NCT02889796|364598228|FG003|Overall Study|Lost to Follow-up|0|||
105710180|NCT02889796|364598229|FG004|Overall Study|Lost to Follow-up|2|||
105710181|NCT02889796|364598230|FG005|Overall Study|Lost to Follow-up|6|||
105710182|NCT02889796|364598225|FG000|Overall Study|Protocol Violation|0|||
105710183|NCT02889796|364598226|FG001|Overall Study|Protocol Violation|1|||
105710184|NCT02889796|364598227|FG002|Overall Study|Protocol Violation|3|||
105710185|NCT02889796|364598228|FG003|Overall Study|Protocol Violation|0|||
105710186|NCT02889796|364598229|FG004|Overall Study|Protocol Violation|0|||
105351228|NCT05600036|363289662|FG005|Overall Study|Withdrawal by Subject|5|||
105710187|NCT02889796|364598230|FG005|Overall Study|Protocol Violation|4|||
105351229|NCT05600036|363289657|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
105351230|NCT05600036|363289658|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
105475124|NCT02152956|363751314|FG012|Overall Study|Adverse Event|0|||
105710188|NCT02889796|364598225|FG000|Overall Study|Non-compliance With Study Drug|0|||
105710189|NCT02889796|364598226|FG001|Overall Study|Non-compliance With Study Drug|2|||
105710190|NCT02889796|364598227|FG002|Overall Study|Non-compliance With Study Drug|0|||
105710191|NCT02889796|364598228|FG003|Overall Study|Non-compliance With Study Drug|0|||
105710192|NCT02889796|364598229|FG004|Overall Study|Non-compliance With Study Drug|1|||
105710193|NCT02889796|364598230|FG005|Overall Study|Non-compliance With Study Drug|2|||
105710194|NCT02889796|364598225|FG000|Overall Study|Death|1|||
105710195|NCT02889796|364598226|FG001|Overall Study|Death|1|||
105710196|NCT02889796|364598227|FG002|Overall Study|Death|0|||
105710197|NCT02889796|364598228|FG003|Overall Study|Death|1|||
105710198|NCT02889796|364598229|FG004|Overall Study|Death|0|||
105710199|NCT02889796|364598230|FG005|Overall Study|Death|1|||
105351231|NCT05600036|363289659|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
105351232|NCT05600036|363289660|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
105351233|NCT05600036|363289661|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
105351234|NCT05600036|363289662|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
105710200|NCT02889796|364598225|FG000|Overall Study|Pregnancy|0|||
105351235|NCT05600036|363289657|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
105710201|NCT02889796|364598226|FG001|Overall Study|Pregnancy|1|||
105710202|NCT02889796|364598227|FG002|Overall Study|Pregnancy|1|||
105710203|NCT02889796|364598228|FG003|Overall Study|Pregnancy|0|||
105710204|NCT02889796|364598229|FG004|Overall Study|Pregnancy|0|||
105710205|NCT02889796|364598230|FG005|Overall Study|Pregnancy|0|||
105710206|NCT02889796|364598225|FG000|Overall Study|Randomized but not Dosed|2|||
105710207|NCT02889796|364598226|FG001|Overall Study|Randomized but not Dosed|0|||
105710208|NCT02889796|364598227|FG002|Overall Study|Randomized but not Dosed|0|||
105710209|NCT02889796|364598228|FG003|Overall Study|Randomized but not Dosed|0|||
105710210|NCT02889796|364598229|FG004|Overall Study|Randomized but not Dosed|0|||
105351236|NCT05600036|363289658|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
105351237|NCT05600036|363289659|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
105351238|NCT05600036|363289660|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
105351239|NCT05600036|363289661|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
105351240|NCT05600036|363289662|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
105351241|NCT05600036|363289657|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
105351242|NCT05600036|363289658|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
105351243|NCT05600036|363289659|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
105351244|NCT05600036|363289660|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
105351245|NCT05600036|363289661|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
105351246|NCT05600036|363289662|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
105351247|NCT02776670|363289664|FG000|Overall Study|Adverse Event|0|||
105351248|NCT02776670|363289665|FG001|Overall Study|Adverse Event|2|||
105351249|NCT02776670|363289664|FG000|Overall Study|Protocol Violation|0|||
105351250|NCT02776670|363289665|FG001|Overall Study|Protocol Violation|2|||
105351251|NCT02776670|363289664|FG000|Overall Study|Withdrawal by Subject|0|||
105351252|NCT02776670|363289665|FG001|Overall Study|Withdrawal by Subject|1|||
105351253|NCT02776670|363289664|FG000|Overall Study|Other - Reason not given|0|||
105351254|NCT02776670|363289665|FG001|Overall Study|Other - Reason not given|1|||
105351255|NCT03699540|363289666|FG000|Overall Study|Lost to Follow-up|1|||
105351256|NCT00048997|363289667|FG000|Overall Study|Protocol Violation|7|||
105351257|NCT00048997|363289668|FG001|Overall Study|Protocol Violation|2|||
105351258|NCT00048997|363289667|FG000|Overall Study|Withdrawal by Subject|6|||
105475125|NCT02152956|363751302|FG000|Overall Study|Death|0|||
105710211|NCT02889796|364598230|FG005|Overall Study|Randomized but not Dosed|2|||
105710212|NCT02787863|364598233|FG000|Overall Study|Death|1|||
105710213|NCT02787863|364598234|FG001|Overall Study|Death|0|||
105710214|NCT02787863|364598235|FG002|Overall Study|Death|1|||
105710215|NCT02787863|364598236|FG003|Overall Study|Death|0|||
105710216|NCT02787863|364598237|FG004|Overall Study|Death|0|||
105710217|NCT02787863|364598238|FG005|Overall Study|Death|0|||
105710218|NCT02787863|364598239|FG006|Overall Study|Death|0|||
105710219|NCT02787863|364598240|FG007|Overall Study|Death|0|||
105710220|NCT02787863|364598233|FG000|Overall Study|Withdrawal by Subject|0|||
105560756|NCT01687257|364048501|FG002|Overall Study|Investigator's Discretion|0|||
105710221|NCT02787863|364598234|FG001|Overall Study|Withdrawal by Subject|1|||
105710222|NCT02787863|364598235|FG002|Overall Study|Withdrawal by Subject|1|||
105788072|NCT01471197|364878195|FG001|Overall Study|Disease Progression|2|||
105475126|NCT02152956|363751303|FG001|Overall Study|Death|3|||
105475127|NCT02152956|363751304|FG002|Overall Study|Death|3|||
105475128|NCT02152956|363751305|FG003|Overall Study|Death|4|||
105475129|NCT02152956|363751306|FG004|Overall Study|Death|1|||
105475130|NCT02152956|363751307|FG005|Overall Study|Death|2|||
105475131|NCT02152956|363751308|FG006|Overall Study|Death|6|||
105475132|NCT02152956|363751309|FG007|Overall Study|Death|6|||
105475133|NCT02152956|363751310|FG008|Overall Study|Death|4|||
105475134|NCT02152956|363751311|FG009|Overall Study|Death|5|||
105475135|NCT02152956|363751312|FG010|Overall Study|Death|3|||
105475136|NCT02152956|363751313|FG011|Overall Study|Death|143|||
105475137|NCT02152956|363751314|FG012|Overall Study|Death|12|||
105475138|NCT02152956|363751302|FG000|Overall Study|Lost to Follow-up|0|||
105475139|NCT02152956|363751303|FG001|Overall Study|Lost to Follow-up|1|||
105560757|NCT02238379|364048503|FG000|Overall Study|Lost to Follow-up|1|||
105560758|NCT02238379|364048504|FG001|Overall Study|Lost to Follow-up|0|||
105710223|NCT02787863|364598236|FG003|Overall Study|Withdrawal by Subject|0|||
105710224|NCT02787863|364598237|FG004|Overall Study|Withdrawal by Subject|0|||
105710225|NCT02787863|364598238|FG005|Overall Study|Withdrawal by Subject|0|||
105710226|NCT02787863|364598239|FG006|Overall Study|Withdrawal by Subject|0|||
105710227|NCT02787863|364598240|FG007|Overall Study|Withdrawal by Subject|0|||
105710228|NCT01414257|364598241|FG000|Overall Study|No Visit After First Day of Treatment|12|||
105710229|NCT01414257|364598241|FG000|Overall Study|Protocol Violation|10|||
105710230|NCT01978093|364598243|FG000|Overall Study|Death|1|||
105710231|NCT01978093|364598244|FG001|Overall Study|Death|0|||
105710232|NCT01978093|364598243|FG000|Overall Study|Adverse Event|0|||
105710233|NCT01978093|364598244|FG001|Overall Study|Adverse Event|5|||
105710234|NCT01978093|364598243|FG000|Overall Study|Protocol Violation|8|||
105710235|NCT01978093|364598244|FG001|Overall Study|Protocol Violation|2|||
105710236|NCT01978093|364598243|FG000|Overall Study|Withdrawal by Subject|29|||
105710237|NCT01978093|364598244|FG001|Overall Study|Withdrawal by Subject|25|||
105710238|NCT01978093|364598243|FG000|Overall Study|Lost to Follow-up|11|||
105710239|NCT01978093|364598244|FG001|Overall Study|Lost to Follow-up|15|||
105710240|NCT01978093|364598243|FG000|Overall Study|Migrated/moved from study area|11|||
105710241|NCT01978093|364598244|FG001|Overall Study|Migrated/moved from study area|13|||
105710242|NCT01978093|364598243|FG000|Overall Study|Loss of kaiser coverage|4|||
105710243|NCT01978093|364598244|FG001|Overall Study|Loss of kaiser coverage|10|||
105710244|NCT01978093|364598243|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
105710245|NCT01978093|364598244|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
105710246|NCT01978093|364598243|FG000|Overall Study|Mother lost custody of child|0|||
105710247|NCT01978093|364598244|FG001|Overall Study|Mother lost custody of child|1|||
105710248|NCT01978093|364598243|FG000|Overall Study|Child was in care of grandmother|0|||
105710249|NCT01978093|364598244|FG001|Overall Study|Child was in care of grandmother|1|||
105710250|NCT01978093|364598243|FG000|Overall Study|N/A for vaccine administration|0|||
105710251|NCT01978093|364598244|FG001|Overall Study|N/A for vaccine administration|1|||
105710252|NCT01784965|364598249|FG000|Overall Study|Withdrawal by Subject|6|||
105710253|NCT01784965|364598250|FG001|Overall Study|Withdrawal by Subject|3|||
105710254|NCT01784965|364598249|FG000|Overall Study|Adverse Event|0|||
105710255|NCT01784965|364598250|FG001|Overall Study|Adverse Event|8|||
105710256|NCT02469090|364598251|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
105710257|NCT02469090|364598252|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
105710258|NCT02469090|364598253|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
105710259|NCT02469090|364598251|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
105710260|NCT02469090|364598252|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
105710261|NCT02469090|364598253|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
105710262|NCT02469090|364598251|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
105710263|NCT02469090|364598252|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
105710264|NCT02469090|364598253|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
105710265|NCT02469090|364598251|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
105710266|NCT02469090|364598252|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
105710267|NCT02469090|364598253|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
105710268|NCT02469090|364598251|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
105710269|NCT02469090|364598252|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
105710270|NCT02469090|364598253|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
105710271|NCT02469090|364598251|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
105710272|NCT02469090|364598252|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
105710273|NCT02469090|364598253|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
105710274|NCT02469090|364598251|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
105710275|NCT02469090|364598252|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
105710276|NCT02469090|364598253|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
105710277|NCT02469090|364598251|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
105710278|NCT02469090|364598252|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
105710279|NCT02469090|364598253|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
105710280|NCT03286842|364598254|FG000|Overall Study|Patients rolled over to another study|80|||
105710281|NCT01098071|364598258|FG000|Overall Study|Surgery (adenoidectomy)|2|||
105710282|NCT01098071|364598258|FG000|Overall Study|Lost to Follow-up|13|||
105710283|NCT01895322|364598262|FG000|Overall Study|Adverse Event|1|||
105710284|NCT01895322|364598262|FG000|Overall Study|Withdrawal by Subject|2|||
105710285|NCT01895322|364598262|FG000|Overall Study|Protocol Violation|10|||
105710286|NCT01926782|364598263|FG000|Overall Study|Participant moved|2|||
105710287|NCT01926782|364598264|FG001|Overall Study|Participant moved|0|||
105710288|NCT01926782|364598265|FG002|Overall Study|Participant moved|1|||
105710289|NCT01926782|364598266|FG003|Overall Study|Participant moved|1|||
105710290|NCT01926782|364598267|FG004|Overall Study|Participant moved|0|||
105360889|NCT01051557|363328106|FG003|Overall Study|Physician Decision|0|||
105710291|NCT01926782|364598268|FG005|Overall Study|Participant moved|3|||
105788073|NCT01471197|364878194|FG000|Overall Study|Death|1|||
105710292|NCT01926782|364598263|FG000|Overall Study|Physician Decision|0|||
105710293|NCT01926782|364598264|FG001|Overall Study|Physician Decision|2|||
105710294|NCT01926782|364598265|FG002|Overall Study|Physician Decision|1|||
105788074|NCT01471197|364878195|FG001|Overall Study|Death|0|||
105710295|NCT01926782|364598266|FG003|Overall Study|Physician Decision|1|||
105788075|NCT01471197|364878194|FG000|Overall Study|Study Drug Toxicity|1|||
105710296|NCT01926782|364598267|FG004|Overall Study|Physician Decision|0|||
105788076|NCT01471197|364878195|FG001|Overall Study|Study Drug Toxicity|0|||
105710297|NCT01926782|364598268|FG005|Overall Study|Physician Decision|0|||
105710298|NCT01926782|364598263|FG000|Overall Study|Other than specified|2|||
105710299|NCT01926782|364598264|FG001|Overall Study|Other than specified|3|||
105710300|NCT01926782|364598265|FG002|Overall Study|Other than specified|5|||
105710301|NCT01926782|364598266|FG003|Overall Study|Other than specified|12|||
105710302|NCT01926782|364598267|FG004|Overall Study|Other than specified|4|||
105710303|NCT01926782|364598268|FG005|Overall Study|Other than specified|11|||
105710304|NCT01926782|364598263|FG000|Overall Study|Adverse Event|13|||
105710305|NCT01926782|364598264|FG001|Overall Study|Adverse Event|4|||
105710306|NCT01926782|364598265|FG002|Overall Study|Adverse Event|17|||
105710307|NCT01926782|364598266|FG003|Overall Study|Adverse Event|4|||
105710308|NCT01926782|364598267|FG004|Overall Study|Adverse Event|3|||
105710309|NCT01926782|364598268|FG005|Overall Study|Adverse Event|14|||
105710310|NCT01926782|364598263|FG000|Overall Study|Poor compliance to protocol|5|||
105710311|NCT01926782|364598264|FG001|Overall Study|Poor compliance to protocol|3|||
105710312|NCT01926782|364598265|FG002|Overall Study|Poor compliance to protocol|8|||
105710313|NCT01926782|364598266|FG003|Overall Study|Poor compliance to protocol|0|||
105710314|NCT01926782|364598267|FG004|Overall Study|Poor compliance to protocol|1|||
105710315|NCT01926782|364598268|FG005|Overall Study|Poor compliance to protocol|6|||
105710316|NCT01926782|364598263|FG000|Overall Study|Randomized and not treated|0|||
105710317|NCT01926782|364598264|FG001|Overall Study|Randomized and not treated|0|||
105710318|NCT01926782|364598265|FG002|Overall Study|Randomized and not treated|0|||
105710319|NCT01926782|364598266|FG003|Overall Study|Randomized and not treated|1|||
105710320|NCT01926782|364598267|FG004|Overall Study|Randomized and not treated|0|||
105710321|NCT01926782|364598268|FG005|Overall Study|Randomized and not treated|0|||
105710322|NCT01926782|364598263|FG000|Overall Study|Withdrawal by Subject|6|||
105710323|NCT01926782|364598264|FG001|Overall Study|Withdrawal by Subject|1|||
105710324|NCT01926782|364598265|FG002|Overall Study|Withdrawal by Subject|8|||
105710325|NCT01926782|364598266|FG003|Overall Study|Withdrawal by Subject|1|||
105710326|NCT01926782|364598267|FG004|Overall Study|Withdrawal by Subject|0|||
105710327|NCT01926782|364598268|FG005|Overall Study|Withdrawal by Subject|5|||
105710328|NCT01926782|364598263|FG000|Overall Study|Related to study drug administration|0|||
105710329|NCT01926782|364598264|FG001|Overall Study|Related to study drug administration|0|||
105710330|NCT01926782|364598265|FG002|Overall Study|Related to study drug administration|0|||
105710331|NCT01926782|364598266|FG003|Overall Study|Related to study drug administration|0|||
105710332|NCT01926782|364598267|FG004|Overall Study|Related to study drug administration|0|||
105710333|NCT01926782|364598268|FG005|Overall Study|Related to study drug administration|2|||
105710334|NCT02275338|364598271|FG000|Overall Study|Adverse Event|15|||
105710335|NCT02275338|364598271|FG000|Overall Study|Lack of Efficacy|3|||
105710336|NCT02275338|364598271|FG000|Overall Study|Withdrawal by Subject|4|||
105710337|NCT02275338|364598271|FG000|Overall Study|Disease progression (death)|1|||
105710338|NCT02275338|364598271|FG000|Overall Study|Ineligible to start Phase 2|4|||
105710339|NCT02275338|364598271|FG000|Overall Study|Reason not specified|5|||
105710340|NCT02275338|364598271|FG000|Overall Study|Does not meet entry criteria|1|||
105710341|NCT00382993|364598272|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
105710342|NCT00382993|364598273|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
105710343|NCT00382993|364598272|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
105710344|NCT00382993|364598273|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
105710345|NCT00382993|364598272|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
105710346|NCT00382993|364598273|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
105710347|NCT00382993|364598272|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
105710348|NCT00382993|364598273|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
105710349|NCT00382993|364598272|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
105710350|NCT00382993|364598273|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
105710351|NCT00382993|364598272|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
105710352|NCT00382993|364598273|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
105710353|NCT00382993|364598272|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
105710354|NCT00382993|364598273|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
105710355|NCT00382993|364598272|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
105710356|NCT00382993|364598273|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
105710357|NCT00382993|364598272|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
105710358|NCT00382993|364598273|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
105710359|NCT00382993|364598272|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
105710360|NCT00382993|364598273|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
105710361|NCT01857869|364598276|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
105710362|NCT01857869|364598277|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
105710363|NCT01857869|364598278|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
105710364|NCT01857869|364598279|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
105710365|NCT01857869|364598280|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
105710366|NCT01857869|364598281|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
105710367|NCT01857869|364598282|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
105710368|NCT01857869|364598283|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
105710369|NCT01857869|364598284|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
105710370|NCT01857869|364598285|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
105710371|NCT01857869|364598276|FG000|Primary/Challenge Phase|Pregnancy|1|||
105710372|NCT01857869|364598277|FG001|Primary/Challenge Phase|Pregnancy|0|||
105710373|NCT01857869|364598278|FG002|Primary/Challenge Phase|Pregnancy|0|||
105710374|NCT01857869|364598279|FG003|Primary/Challenge Phase|Pregnancy|0|||
105710375|NCT01857869|364598280|FG004|Primary/Challenge Phase|Pregnancy|0|||
105710376|NCT01857869|364598281|FG005|Primary/Challenge Phase|Pregnancy|0|||
105710377|NCT01857869|364598282|FG006|Primary/Challenge Phase|Pregnancy|0|||
105710378|NCT01857869|364598283|FG007|Primary/Challenge Phase|Pregnancy|0|||
105710379|NCT01857869|364598284|FG008|Primary/Challenge Phase|Pregnancy|0|||
105710380|NCT01857869|364598285|FG009|Primary/Challenge Phase|Pregnancy|0|||
105710381|NCT01857869|364598276|FG000|Primary/Challenge Phase|Protocol Violation|1|||
105710382|NCT01857869|364598277|FG001|Primary/Challenge Phase|Protocol Violation|0|||
105710383|NCT01857869|364598278|FG002|Primary/Challenge Phase|Protocol Violation|0|||
105710384|NCT01857869|364598279|FG003|Primary/Challenge Phase|Protocol Violation|0|||
105710385|NCT01857869|364598280|FG004|Primary/Challenge Phase|Protocol Violation|0|||
105710386|NCT01857869|364598281|FG005|Primary/Challenge Phase|Protocol Violation|0|||
105710387|NCT01857869|364598282|FG006|Primary/Challenge Phase|Protocol Violation|0|||
105710388|NCT01857869|364598283|FG007|Primary/Challenge Phase|Protocol Violation|0|||
105710389|NCT01857869|364598284|FG008|Primary/Challenge Phase|Protocol Violation|0|||
105710390|NCT01857869|364598285|FG009|Primary/Challenge Phase|Protocol Violation|0|||
105710391|NCT01857869|364598276|FG000|Primary/Challenge Phase|Other|1|||
105710392|NCT01857869|364598277|FG001|Primary/Challenge Phase|Other|1|||
105710393|NCT01857869|364598278|FG002|Primary/Challenge Phase|Other|0|||
105710394|NCT01857869|364598279|FG003|Primary/Challenge Phase|Other|0|||
105710395|NCT01857869|364598280|FG004|Primary/Challenge Phase|Other|0|||
105710396|NCT01857869|364598281|FG005|Primary/Challenge Phase|Other|0|||
105710397|NCT01857869|364598282|FG006|Primary/Challenge Phase|Other|0|||
105710398|NCT01857869|364598283|FG007|Primary/Challenge Phase|Other|0|||
105710399|NCT01857869|364598284|FG008|Primary/Challenge Phase|Other|0|||
105710400|NCT01857869|364598285|FG009|Primary/Challenge Phase|Other|0|||
105710401|NCT01857869|364598276|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710402|NCT01857869|364598277|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710403|NCT01857869|364598278|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710404|NCT01857869|364598279|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
105710405|NCT01857869|364598280|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710406|NCT01857869|364598281|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710407|NCT01857869|364598282|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710408|NCT01857869|364598283|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710409|NCT01857869|364598284|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710410|NCT01857869|364598285|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710411|NCT01857869|364598276|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710412|NCT01857869|364598277|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710413|NCT01857869|364598278|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710414|NCT01857869|364598279|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
105710415|NCT01857869|364598280|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710416|NCT01857869|364598281|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710417|NCT01857869|364598282|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710418|NCT01857869|364598283|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710419|NCT01857869|364598284|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710420|NCT01857869|364598285|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710421|NCT03298022|364598286|FG000|Overall Study|Lack of Efficacy|4|||
105710422|NCT03298022|364598286|FG000|Overall Study|Withdrawal by Subject|7|||
105710423|NCT03298022|364598286|FG000|Overall Study|Adverse Event|1|||
105710424|NCT03298022|364598286|FG000|Overall Study|disease relapse|1|||
105710425|NCT01445769|364598287|FG000|Overall Study|Consent Withdrawn|2|||
105710426|NCT01445769|364598287|FG000|Overall Study|Disease Progression|1|||
105710427|NCT01445769|364598287|FG000|Overall Study|Lost to Follow-up|5|||
105710428|NCT03099707|364598288|FG000|Overall Study|Withdrawal by Subject|0|||
105710429|NCT03099707|364598289|FG001|Overall Study|Withdrawal by Subject|3|||
105710430|NCT03099707|364598288|FG000|Overall Study|Lost to Follow-up|0|||
105710431|NCT03099707|364598289|FG001|Overall Study|Lost to Follow-up|1|||
105710432|NCT00262873|364598292|FG000|Overall Study|Adverse Event|3|||
105710433|NCT00262873|364598292|FG000|Overall Study|Withdrawal by Subject|5|||
105710434|NCT00487539|364598293|FG000|Overall Study|Adverse Event|3|||
105710435|NCT00487539|364598294|FG001|Overall Study|Adverse Event|2|||
105710436|NCT00487539|364598295|FG002|Overall Study|Adverse Event|1|||
105710437|NCT00487539|364598296|FG003|Overall Study|Adverse Event|1|||
105710438|NCT00487539|364598293|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105710439|NCT00487539|364598294|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105710440|NCT00487539|364598295|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105710441|NCT00487539|364598296|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
105710442|NCT00487539|364598293|FG000|Overall Study|Other|3|||
105710443|NCT00487539|364598294|FG001|Overall Study|Other|1|||
105710444|NCT00487539|364598295|FG002|Overall Study|Other|2|||
105710445|NCT00487539|364598296|FG003|Overall Study|Other|2|||
105710446|NCT00903175|364598297|FG000|Period 1 - First Line|Adverse Event|36|||
105710447|NCT00903175|364598298|FG001|Period 1 - First Line|Adverse Event|50|||
105710448|NCT00903175|364598297|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
105710449|NCT00903175|364598298|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
105710450|NCT00903175|364598297|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
105710451|NCT00903175|364598298|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
105710452|NCT00903175|364598297|FG000|Period 1 - First Line|Protocol Violation|3|||
105710453|NCT00903175|364598298|FG001|Period 1 - First Line|Protocol Violation|3|||
105710454|NCT00903175|364598297|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
105710455|NCT00903175|364598298|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
105710456|NCT00903175|364598297|FG000|Period 1 - First Line|Administrative problems|12|||
105710457|NCT00903175|364598298|FG001|Period 1 - First Line|Administrative problems|13|||
105710458|NCT00903175|364598297|FG000|Period 1 - First Line|Death|17|||
105710459|NCT00903175|364598298|FG001|Period 1 - First Line|Death|10|||
105710460|NCT00903175|364598297|FG000|Period 2 - Second Line|Missing|1|||
105710461|NCT00903175|364598298|FG001|Period 2 - Second Line|Missing|0|||
105710462|NCT00903175|364598297|FG000|Period 2 - Second Line|Adverse Event|16|||
105710463|NCT00903175|364598298|FG001|Period 2 - Second Line|Adverse Event|20|||
105710464|NCT00903175|364598297|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
105710465|NCT00903175|364598298|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
105710466|NCT00903175|364598297|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
105710467|NCT00903175|364598298|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
105710468|NCT00903175|364598297|FG000|Period 2 - Second Line|Administrative problems|19|||
105360890|NCT01051557|363328107|FG004|Overall Study|Physician Decision|0|||
105710469|NCT00903175|364598298|FG001|Period 2 - Second Line|Administrative problems|9|||
105710470|NCT00903175|364598297|FG000|Period 2 - Second Line|Death|5|||
105710471|NCT00903175|364598298|FG001|Period 2 - Second Line|Death|2|||
105710472|NCT00516737|364598301|FG000|Overall Study|Lost to Follow-up|2|||
105710473|NCT00516737|364598302|FG001|Overall Study|Lost to Follow-up|0|||
105710474|NCT00516737|364598301|FG000|Overall Study|Physician Decision|0|||
105710475|NCT00516737|364598302|FG001|Overall Study|Physician Decision|1|||
105710476|NCT00516737|364598301|FG000|Overall Study|Withdrawal by Subject|0|||
105710477|NCT00516737|364598302|FG001|Overall Study|Withdrawal by Subject|1|||
105710478|NCT00516737|364598301|FG000|Overall Study|Lack of Qualifying Event|9|||
105710479|NCT00516737|364598302|FG001|Overall Study|Lack of Qualifying Event|6|||
105710480|NCT01035905|364598303|FG000|Overall Study|Lack of Efficacy|1|||
105710481|NCT01035905|364598304|FG001|Overall Study|Lack of Efficacy|1|||
105710482|NCT01844895|364598305|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
105710483|NCT01844895|364598305|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
105710484|NCT01844895|364598305|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
105710485|NCT01844895|364598305|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
105710486|NCT01844895|364598305|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
105710487|NCT01844895|364598305|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
105710488|NCT01844895|364598305|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
105710489|NCT00874120|364601298|FG000|First Intervention|Adverse Event|0|||
105710490|NCT00874120|364601299|FG001|First Intervention|Adverse Event|1|||
105710491|NCT00874120|364601298|FG000|First Intervention|Withdrawal by Subject|2|||
105710492|NCT00874120|364601299|FG001|First Intervention|Withdrawal by Subject|0|||
105710493|NCT00874120|364601298|FG000|First Intervention|Lost to Follow-up|0|||
105710494|NCT00874120|364601299|FG001|First Intervention|Lost to Follow-up|1|||
105710495|NCT00874120|364601298|FG000|First Intervention|Protocol Violation|3|||
105710496|NCT00874120|364601299|FG001|First Intervention|Protocol Violation|0|||
105710497|NCT00874120|364601298|FG000|First Intervention|positive drug test|1|||
105710498|NCT00874120|364601299|FG001|First Intervention|positive drug test|0|||
105710499|NCT00874120|364601298|FG000|Second Intervention|Withdrawal by Subject|1|||
105710500|NCT00874120|364601299|FG001|Second Intervention|Withdrawal by Subject|0|||
105710501|NCT00874120|364601298|FG000|Second Intervention|Protocol Violation|1|||
105710502|NCT00874120|364601299|FG001|Second Intervention|Protocol Violation|0|||
105710503|NCT02404103|364601305|FG000|Overall Study|Adverse Event|1|||
105710504|NCT02404103|364601306|FG001|Overall Study|Adverse Event|0|||
105710505|NCT02404103|364601305|FG000|Overall Study|Lost to Follow-up|3|||
105710506|NCT02404103|364601306|FG001|Overall Study|Lost to Follow-up|3|||
105710507|NCT02543528|364601307|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
105710508|NCT02543528|364601308|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
105710509|NCT02543528|364601309|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
105710510|NCT02543528|364601310|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
105710511|NCT02543528|364601311|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
105710512|NCT02543528|364601307|FG000|Adaptation Period|Lens Handling Difficultes|0|||
105710513|NCT02543528|364601308|FG001|Adaptation Period|Lens Handling Difficultes|0|||
105710514|NCT02543528|364601309|FG002|Adaptation Period|Lens Handling Difficultes|0|||
105710515|NCT02543528|364601310|FG003|Adaptation Period|Lens Handling Difficultes|0|||
105710516|NCT02543528|364601311|FG004|Adaptation Period|Lens Handling Difficultes|8|||
105710517|NCT02543528|364601307|FG000|Adaptation Period|Lost to Follow-up|0|||
105710518|NCT02543528|364601308|FG001|Adaptation Period|Lost to Follow-up|0|||
105710519|NCT02543528|364601309|FG002|Adaptation Period|Lost to Follow-up|0|||
105710520|NCT02543528|364601310|FG003|Adaptation Period|Lost to Follow-up|0|||
105710521|NCT02543528|364601311|FG004|Adaptation Period|Lost to Follow-up|14|||
105710522|NCT02543528|364601307|FG000|Adaptation Period|Adverse Event|0|||
105710523|NCT02543528|364601308|FG001|Adaptation Period|Adverse Event|0|||
105710524|NCT02543528|364601309|FG002|Adaptation Period|Adverse Event|0|||
105710525|NCT02543528|364601310|FG003|Adaptation Period|Adverse Event|0|||
105710526|NCT02543528|364601311|FG004|Adaptation Period|Adverse Event|2|||
105710527|NCT02543528|364601307|FG000|Extended Wear Period|Adverse Event|17|||
105710528|NCT02543528|364601308|FG001|Extended Wear Period|Adverse Event|11|||
105710529|NCT02543528|364601309|FG002|Extended Wear Period|Adverse Event|16|||
105710530|NCT02543528|364601310|FG003|Extended Wear Period|Adverse Event|3|||
105710531|NCT02543528|364601311|FG004|Extended Wear Period|Adverse Event|0|||
105710532|NCT02543528|364601307|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
105710533|NCT02543528|364601308|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
105710534|NCT02543528|364601309|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
105710535|NCT02543528|364601310|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
105710536|NCT02543528|364601311|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
105710537|NCT02543528|364601307|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
105710538|NCT02543528|364601308|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
105710539|NCT02543528|364601309|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
105710540|NCT02543528|364601310|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
105710541|NCT02543528|364601311|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
105710542|NCT02543528|364601307|FG000|Extended Wear Period|Lost to Follow-up|0|||
105710543|NCT02543528|364601308|FG001|Extended Wear Period|Lost to Follow-up|1|||
105710544|NCT02543528|364601309|FG002|Extended Wear Period|Lost to Follow-up|2|||
105475140|NCT02152956|363751304|FG002|Overall Study|Lost to Follow-up|0|||
105710545|NCT02543528|364601310|FG003|Extended Wear Period|Lost to Follow-up|1|||
105710546|NCT02543528|364601311|FG004|Extended Wear Period|Lost to Follow-up|0|||
105710547|NCT02543528|364601307|FG000|Extended Wear Period|Withdrawal by Subject|10|||
105710548|NCT02543528|364601308|FG001|Extended Wear Period|Withdrawal by Subject|9|||
105710549|NCT02543528|364601309|FG002|Extended Wear Period|Withdrawal by Subject|4|||
105710550|NCT02543528|364601310|FG003|Extended Wear Period|Withdrawal by Subject|5|||
105710551|NCT02543528|364601311|FG004|Extended Wear Period|Withdrawal by Subject|0|||
105710552|NCT00328627|364601312|FG000|Overall Study|Hyperglycemic Rescue|41|||
105710553|NCT00328627|364601313|FG001|Overall Study|Hyperglycemic Rescue|18|||
105710554|NCT00328627|364601314|FG002|Overall Study|Hyperglycemic Rescue|16|||
105710555|NCT00328627|364601315|FG003|Overall Study|Hyperglycemic Rescue|13|||
105710556|NCT00328627|364601316|FG004|Overall Study|Hyperglycemic Rescue|6|||
105710557|NCT00328627|364601317|FG005|Overall Study|Hyperglycemic Rescue|5|||
105710558|NCT00328627|364601318|FG006|Overall Study|Hyperglycemic Rescue|19|||
105710559|NCT00328627|364601319|FG007|Overall Study|Hyperglycemic Rescue|6|||
105710560|NCT00328627|364601320|FG008|Overall Study|Hyperglycemic Rescue|6|||
105710561|NCT00328627|364601321|FG009|Overall Study|Hyperglycemic Rescue|11|||
105710562|NCT00328627|364601322|FG010|Overall Study|Hyperglycemic Rescue|3|||
105710563|NCT00328627|364601323|FG011|Overall Study|Hyperglycemic Rescue|2|||
105710564|NCT00328627|364601312|FG000|Overall Study|Adverse Event|3|||
105710565|NCT00328627|364601313|FG001|Overall Study|Adverse Event|1|||
105710566|NCT00328627|364601314|FG002|Overall Study|Adverse Event|2|||
105710567|NCT00328627|364601315|FG003|Overall Study|Adverse Event|3|||
105710568|NCT00328627|364601316|FG004|Overall Study|Adverse Event|1|||
105710569|NCT00328627|364601317|FG005|Overall Study|Adverse Event|2|||
105710570|NCT00328627|364601318|FG006|Overall Study|Adverse Event|1|||
105475141|NCT02152956|363751305|FG003|Overall Study|Lost to Follow-up|0|||
105710571|NCT00328627|364601319|FG007|Overall Study|Adverse Event|2|||
105710572|NCT00328627|364601320|FG008|Overall Study|Adverse Event|0|||
105710573|NCT00328627|364601321|FG009|Overall Study|Adverse Event|7|||
105710574|NCT00328627|364601322|FG010|Overall Study|Adverse Event|5|||
105710575|NCT00328627|364601323|FG011|Overall Study|Adverse Event|4|||
105710576|NCT00328627|364601312|FG000|Overall Study|Protocol Violation|2|||
105710577|NCT00328627|364601313|FG001|Overall Study|Protocol Violation|2|||
105710578|NCT00328627|364601314|FG002|Overall Study|Protocol Violation|2|||
105710579|NCT00328627|364601315|FG003|Overall Study|Protocol Violation|8|||
105710580|NCT00328627|364601316|FG004|Overall Study|Protocol Violation|5|||
105710581|NCT00328627|364601317|FG005|Overall Study|Protocol Violation|5|||
105710582|NCT00328627|364601318|FG006|Overall Study|Protocol Violation|6|||
105710583|NCT00328627|364601319|FG007|Overall Study|Protocol Violation|2|||
105710584|NCT00328627|364601320|FG008|Overall Study|Protocol Violation|1|||
105710585|NCT00328627|364601321|FG009|Overall Study|Protocol Violation|4|||
105710586|NCT00328627|364601322|FG010|Overall Study|Protocol Violation|6|||
105710587|NCT00328627|364601323|FG011|Overall Study|Protocol Violation|2|||
105710588|NCT00328627|364601312|FG000|Overall Study|Lost to Follow-up|4|||
105710589|NCT00328627|364601313|FG001|Overall Study|Lost to Follow-up|2|||
105710590|NCT00328627|364601314|FG002|Overall Study|Lost to Follow-up|2|||
105710591|NCT00328627|364601315|FG003|Overall Study|Lost to Follow-up|4|||
105710592|NCT00328627|364601316|FG004|Overall Study|Lost to Follow-up|0|||
105710593|NCT00328627|364601317|FG005|Overall Study|Lost to Follow-up|2|||
105710594|NCT00328627|364601318|FG006|Overall Study|Lost to Follow-up|3|||
105710595|NCT00328627|364601319|FG007|Overall Study|Lost to Follow-up|0|||
105710596|NCT00328627|364601320|FG008|Overall Study|Lost to Follow-up|3|||
105710597|NCT00328627|364601321|FG009|Overall Study|Lost to Follow-up|2|||
105710598|NCT00328627|364601322|FG010|Overall Study|Lost to Follow-up|0|||
105710599|NCT00328627|364601323|FG011|Overall Study|Lost to Follow-up|1|||
105710600|NCT00328627|364601312|FG000|Overall Study|Withdrawal by Subject|5|||
105710601|NCT00328627|364601313|FG001|Overall Study|Withdrawal by Subject|4|||
105710602|NCT00328627|364601314|FG002|Overall Study|Withdrawal by Subject|5|||
105710603|NCT00328627|364601315|FG003|Overall Study|Withdrawal by Subject|6|||
105710604|NCT00328627|364601316|FG004|Overall Study|Withdrawal by Subject|2|||
105710605|NCT00328627|364601317|FG005|Overall Study|Withdrawal by Subject|5|||
105710606|NCT00328627|364601318|FG006|Overall Study|Withdrawal by Subject|4|||
105710607|NCT00328627|364601319|FG007|Overall Study|Withdrawal by Subject|4|||
105710608|NCT00328627|364601320|FG008|Overall Study|Withdrawal by Subject|4|||
105710609|NCT00328627|364601321|FG009|Overall Study|Withdrawal by Subject|5|||
105710610|NCT00328627|364601322|FG010|Overall Study|Withdrawal by Subject|2|||
105710611|NCT00328627|364601323|FG011|Overall Study|Withdrawal by Subject|7|||
105710612|NCT00328627|364601312|FG000|Overall Study|Pregnancy|0|||
105710613|NCT00328627|364601313|FG001|Overall Study|Pregnancy|1|||
105710614|NCT00328627|364601314|FG002|Overall Study|Pregnancy|0|||
105710615|NCT00328627|364601315|FG003|Overall Study|Pregnancy|0|||
105710616|NCT00328627|364601316|FG004|Overall Study|Pregnancy|0|||
105710617|NCT00328627|364601317|FG005|Overall Study|Pregnancy|0|||
105710618|NCT00328627|364601318|FG006|Overall Study|Pregnancy|0|||
105710619|NCT00328627|364601319|FG007|Overall Study|Pregnancy|0|||
105710620|NCT00328627|364601320|FG008|Overall Study|Pregnancy|0|||
105710621|NCT00328627|364601321|FG009|Overall Study|Pregnancy|0|||
105710622|NCT00328627|364601322|FG010|Overall Study|Pregnancy|0|||
105710623|NCT00328627|364601323|FG011|Overall Study|Pregnancy|0|||
105710624|NCT00328627|364601312|FG000|Overall Study|Physician Decision|4|||
105710625|NCT00328627|364601313|FG001|Overall Study|Physician Decision|3|||
105710626|NCT00328627|364601314|FG002|Overall Study|Physician Decision|1|||
105351259|NCT00048997|363289668|FG001|Overall Study|Withdrawal by Subject|1|||
105351260|NCT01404949|363289678|FG000|Overall Study|Not Treated|1|||
105710627|NCT00328627|364601315|FG003|Overall Study|Physician Decision|2|||
105710628|NCT00328627|364601316|FG004|Overall Study|Physician Decision|1|||
105710629|NCT00328627|364601317|FG005|Overall Study|Physician Decision|1|||
105710630|NCT00328627|364601318|FG006|Overall Study|Physician Decision|1|||
105710631|NCT00328627|364601319|FG007|Overall Study|Physician Decision|0|||
105710632|NCT00328627|364601320|FG008|Overall Study|Physician Decision|3|||
105710633|NCT00328627|364601321|FG009|Overall Study|Physician Decision|2|||
105710634|NCT00328627|364601322|FG010|Overall Study|Physician Decision|1|||
105710635|NCT00328627|364601323|FG011|Overall Study|Physician Decision|0|||
105710636|NCT00328627|364601312|FG000|Overall Study|Other|0|||
105710637|NCT00328627|364601313|FG001|Overall Study|Other|0|||
105710638|NCT00328627|364601314|FG002|Overall Study|Other|0|||
105710639|NCT00328627|364601315|FG003|Overall Study|Other|1|||
105710640|NCT00328627|364601316|FG004|Overall Study|Other|0|||
105710641|NCT00328627|364601317|FG005|Overall Study|Other|0|||
105710642|NCT00328627|364601318|FG006|Overall Study|Other|1|||
105710643|NCT00328627|364601319|FG007|Overall Study|Other|0|||
105710644|NCT00328627|364601320|FG008|Overall Study|Other|0|||
105710645|NCT00328627|364601321|FG009|Overall Study|Other|1|||
105710646|NCT00328627|364601322|FG010|Overall Study|Other|1|||
105710647|NCT00328627|364601323|FG011|Overall Study|Other|0|||
105710648|NCT01662440|364601324|FG000|Overall Study|Adverse Event|1|||
105710649|NCT01662440|364601325|FG001|Overall Study|Adverse Event|0|||
105475142|NCT02152956|363751306|FG004|Overall Study|Lost to Follow-up|0|||
105475143|NCT02152956|363751307|FG005|Overall Study|Lost to Follow-up|0|||
105475144|NCT02152956|363751308|FG006|Overall Study|Lost to Follow-up|0|||
105475145|NCT02152956|363751309|FG007|Overall Study|Lost to Follow-up|0|||
105475146|NCT02152956|363751310|FG008|Overall Study|Lost to Follow-up|0|||
105475147|NCT02152956|363751311|FG009|Overall Study|Lost to Follow-up|0|||
105475148|NCT02152956|363751312|FG010|Overall Study|Lost to Follow-up|0|||
105475149|NCT02152956|363751313|FG011|Overall Study|Lost to Follow-up|3|||
105560759|NCT00441090|364048507|FG000|Overall Study|Adverse Event|0|||
105710650|NCT01662440|364601326|FG002|Overall Study|Adverse Event|0|||
105710651|NCT01662440|364601327|FG003|Overall Study|Adverse Event|1|||
105710652|NCT01662440|364601324|FG000|Overall Study|Death|0|||
105710653|NCT01662440|364601325|FG001|Overall Study|Death|1|||
105710654|NCT01662440|364601326|FG002|Overall Study|Death|0|||
105710655|NCT01662440|364601327|FG003|Overall Study|Death|0|||
105710656|NCT01662440|364601324|FG000|Overall Study|Lost to Follow-up|2|||
105710657|NCT01662440|364601325|FG001|Overall Study|Lost to Follow-up|2|||
105710658|NCT01662440|364601326|FG002|Overall Study|Lost to Follow-up|4|||
105710659|NCT01662440|364601327|FG003|Overall Study|Lost to Follow-up|1|||
105710660|NCT01662440|364601324|FG000|Overall Study|Subject moved to another country.|0|||
105710661|NCT01662440|364601325|FG001|Overall Study|Subject moved to another country.|1|||
105710662|NCT01662440|364601326|FG002|Overall Study|Subject moved to another country.|0|||
105710663|NCT01662440|364601327|FG003|Overall Study|Subject moved to another country.|0|||
105710664|NCT01662440|364601324|FG000|Overall Study|Protocol Violation|1|||
105710665|NCT01662440|364601325|FG001|Overall Study|Protocol Violation|0|||
105710666|NCT01662440|364601326|FG002|Overall Study|Protocol Violation|0|||
105710667|NCT01662440|364601327|FG003|Overall Study|Protocol Violation|0|||
105710668|NCT01662440|364601324|FG000|Overall Study|Withdrawal by Subject|5|||
105710669|NCT01662440|364601325|FG001|Overall Study|Withdrawal by Subject|2|||
105710670|NCT01662440|364601326|FG002|Overall Study|Withdrawal by Subject|2|||
105710671|NCT01662440|364601327|FG003|Overall Study|Withdrawal by Subject|2|||
105710672|NCT01765673|364601328|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
105710673|NCT00971945|364601333|FG000|Overall Study|Progressive Disease|3|||
105710674|NCT00971945|364601333|FG000|Overall Study|Change in treatment policy|1|||
105710675|NCT00971945|364601333|FG000|Overall Study|Other reasons|2|||
105710676|NCT01535729|364601338|FG000|Overall Study|Withdrawal by Subject|2|||
105710677|NCT01535729|364601338|FG000|Overall Study|Disease progression|230|||
105710678|NCT01535729|364601338|FG000|Overall Study|Discontinued treatment|25|||
105710679|NCT01535729|364601338|FG000|Overall Study|Lost to Follow-up|8|||
105710680|NCT01535729|364601338|FG000|Overall Study|Death|52|||
105710681|NCT01535729|364601338|FG000|Overall Study|Other|19|||
105710682|NCT01535729|364601338|FG000|Overall Study|Did not sign informed consent|1|||
105710683|NCT01535729|364601338|FG000|Overall Study|No previous chemotherapy|33|||
105710684|NCT01535729|364601338|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
105710685|NCT01535729|364601338|FG000|Overall Study|Protocol Violation|11|||
105710686|NCT01535729|364601338|FG000|Overall Study|Screening failure|1|||
105710687|NCT01535729|364601338|FG000|Overall Study|Not treated|9|||
105710688|NCT01535729|364601338|FG000|Overall Study|No participant record available|5|||
105710689|NCT01592760|364601341|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
105710690|NCT01592760|364601342|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
105710691|NCT01592760|364601343|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
105710692|NCT01363986|364601344|FG000|Overall Study|Disease progression|1|||
105710693|NCT01637142|364601345|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
105710694|NCT00130832|364601346|FG000|Overall Study|Adverse Event|1|||
105710695|NCT00130832|364601347|FG001|Overall Study|Adverse Event|1|||
105710696|NCT00130832|364601346|FG000|Overall Study|Lost to Follow-up|1|||
105710697|NCT00130832|364601347|FG001|Overall Study|Lost to Follow-up|2|||
105710698|NCT00130832|364601346|FG000|Overall Study|Protocol Violation|6|||
105710699|NCT00130832|364601347|FG001|Overall Study|Protocol Violation|8|||
105710700|NCT00130832|364601346|FG000|Overall Study|Withdrawal by Subject|6|||
105710701|NCT00130832|364601347|FG001|Overall Study|Withdrawal by Subject|1|||
105710702|NCT00130832|364601346|FG000|Overall Study|Moved|2|||
105710703|NCT00130832|364601347|FG001|Overall Study|Moved|2|||
105710704|NCT00130832|364601346|FG000|Overall Study|Other|0|||
105710705|NCT00130832|364601347|FG001|Overall Study|Other|3|||
105710706|NCT03905863|364601348|FG000|Overall Study|Adverse Event|2|||
105710707|NCT03905863|364601349|FG001|Overall Study|Adverse Event|4|||
105710708|NCT03905863|364601348|FG000|Overall Study|Withdrawal by Subject|2|||
105788077|NCT00779857|364878202|FG000|Overall Study|Death|1|||
105475150|NCT02152956|363751314|FG012|Overall Study|Lost to Follow-up|0|||
105710709|NCT03905863|364601349|FG001|Overall Study|Withdrawal by Subject|2|||
105710710|NCT03905863|364601348|FG000|Overall Study|Physician Decision|0|||
105710711|NCT03905863|364601349|FG001|Overall Study|Physician Decision|3|||
105710712|NCT03905863|364601348|FG000|Overall Study|Lost to Follow-up|1|||
105710713|NCT03905863|364601349|FG001|Overall Study|Lost to Follow-up|0|||
105710714|NCT03905863|364601348|FG000|Overall Study|Protocol Violation|0|||
105710715|NCT03905863|364601349|FG001|Overall Study|Protocol Violation|2|||
105710716|NCT03905863|364601348|FG000|Overall Study|Death|0|||
105710717|NCT03905863|364601349|FG001|Overall Study|Death|1|||
105710718|NCT02111564|364601351|FG000|Overall Study|Death|109|||
105710719|NCT02111564|364601352|FG001|Overall Study|Death|120|||
105710720|NCT02111564|364601351|FG000|Overall Study|Lost to Follow-up|2|||
105710721|NCT02111564|364601352|FG001|Overall Study|Lost to Follow-up|3|||
105710722|NCT02111564|364601351|FG000|Overall Study|Withdrawal by Subject|20|||
105710723|NCT02111564|364601352|FG001|Overall Study|Withdrawal by Subject|20|||
105710724|NCT02944448|364601353|FG000|Overall Study|Adverse Event|37|||
105710725|NCT02944448|364601354|FG001|Overall Study|Adverse Event|6|||
105710726|NCT02944448|364601353|FG000|Overall Study|Lack of Efficacy|8|||
105710727|NCT02944448|364601354|FG001|Overall Study|Lack of Efficacy|5|||
105710728|NCT02944448|364601353|FG000|Overall Study|Lost to Follow-up|3|||
105710729|NCT02944448|364601354|FG001|Overall Study|Lost to Follow-up|1|||
105710730|NCT02944448|364601353|FG000|Overall Study|Protocol Violation|25|||
105710731|NCT02944448|364601354|FG001|Overall Study|Protocol Violation|7|||
105710732|NCT02944448|364601353|FG000|Overall Study|Withdrawal by Subject|14|||
105710733|NCT02944448|364601354|FG001|Overall Study|Withdrawal by Subject|4|||
105710734|NCT02944448|364601353|FG000|Overall Study|Sponsor did not supply drug in time|0|||
105710735|NCT02944448|364601354|FG001|Overall Study|Sponsor did not supply drug in time|1|||
105710736|NCT02944448|364601353|FG000|Overall Study|Noncompliant with dosing|1|||
105710737|NCT02944448|364601354|FG001|Overall Study|Noncompliant with dosing|0|||
105710738|NCT02944448|364601353|FG000|Overall Study|Abnormal laboratory values|1|||
105710739|NCT02944448|364601354|FG001|Overall Study|Abnormal laboratory values|0|||
105710740|NCT02468648|364601355|FG000|Overall Study|Death|1|||
105710741|NCT01368835|364601356|FG000|Overall Study|Inclusion criteria/photography quality|22|||
105710742|NCT01368835|364601356|FG000|Overall Study|Lost to Follow-up|11|||
105710743|NCT01678144|364601359|FG000|Stage 1: MAR Classic|Adverse Event|1|||
105710744|NCT03118297|364601360|FG000|Overall Study|Lost to Follow-up|0|||
105710745|NCT03118297|364601361|FG001|Overall Study|Lost to Follow-up|2|||
105710746|NCT01882907|364601362|FG000|Overall Study|Adverse Event|3|||
105710747|NCT01882907|364601363|FG001|Overall Study|Adverse Event|1|||
105710748|NCT01882907|364601362|FG000|Overall Study|Lack of Efficacy|0|||
105710749|NCT01882907|364601363|FG001|Overall Study|Lack of Efficacy|3|||
105710750|NCT01882907|364601362|FG000|Overall Study|Lost to Follow-up|1|||
105710751|NCT01882907|364601363|FG001|Overall Study|Lost to Follow-up|4|||
105710752|NCT01882907|364601362|FG000|Overall Study|Protocol Violation|10|||
105710753|NCT01882907|364601363|FG001|Overall Study|Protocol Violation|14|||
105710754|NCT01882907|364601362|FG000|Overall Study|Withdrawal by Subject|0|||
105710755|NCT01882907|364601363|FG001|Overall Study|Withdrawal by Subject|6|||
105710756|NCT01777152|364601365|FG000|Overall Study|Withdrawal by Subject|22|||
105710757|NCT01777152|364601366|FG001|Overall Study|Withdrawal by Subject|16|||
105710758|NCT01777152|364601365|FG000|Overall Study|Lost to Follow-up|3|||
105710759|NCT01777152|364601366|FG001|Overall Study|Lost to Follow-up|5|||
105710760|NCT01777152|364601365|FG000|Overall Study|Death|68|||
105710761|NCT01777152|364601366|FG001|Overall Study|Death|89|||
105710762|NCT01777152|364601365|FG000|Overall Study|Not eligible, no study drug received|1|||
105710763|NCT01777152|364601366|FG001|Overall Study|Not eligible, no study drug received|0|||
105710764|NCT01777152|364601365|FG000|Overall Study|Change of diagnosis|1|||
105710765|NCT01777152|364601366|FG001|Overall Study|Change of diagnosis|0|||
105710766|NCT00424827|364601371|FG000|Overall Study|Adverse Event|1|||
105788078|NCT00779857|364878202|FG000|Overall Study|Withdrawal by Subject|3|||
105788079|NCT00779857|364878202|FG000|Overall Study|Missed Visit|2|||
105788080|NCT00620776|364878207|FG000|Overall Study|Did not receive treatment|3|||
105788081|NCT00620776|364878208|FG001|Overall Study|Did not receive treatment|5|||
105788082|NCT00620776|364878207|FG000|Overall Study|Adverse Event|2|||
105788083|NCT00620776|364878208|FG001|Overall Study|Adverse Event|3|||
105560760|NCT00441090|364048508|FG001|Overall Study|Adverse Event|1|||
105560761|NCT00441090|364048509|FG002|Overall Study|Adverse Event|1|||
105560762|NCT00441090|364048510|FG003|Overall Study|Adverse Event|0|||
105710767|NCT03446885|364601376|FG000|Overall Study|Lost to Follow-up|1|||
105710768|NCT03446885|364601377|FG001|Overall Study|Lost to Follow-up|0|||
105710769|NCT03446885|364601376|FG000|Overall Study|Did not complete entire visit|1|||
105710770|NCT03446885|364601377|FG001|Overall Study|Did not complete entire visit|0|||
105710771|NCT03132636|364601381|FG000|Overall Study|Adverse Event|1|||
105710772|NCT03132636|364601382|FG001|Overall Study|Adverse Event|2|||
105710773|NCT03132636|364601381|FG000|Overall Study|Death|4|||
105710774|NCT03132636|364601382|FG001|Overall Study|Death|7|||
105710775|NCT03132636|364601381|FG000|Overall Study|Lost to Follow-up|3|||
105710776|NCT03132636|364601382|FG001|Overall Study|Lost to Follow-up|2|||
105710777|NCT03132636|364601381|FG000|Overall Study|Non compliance with protocol by participant|1|||
105710778|NCT03132636|364601382|FG001|Overall Study|Non compliance with protocol by participant|1|||
105710779|NCT03132636|364601381|FG000|Overall Study|Subject decision|1|||
105710780|NCT03132636|364601382|FG001|Overall Study|Subject decision|9|||
105710781|NCT03132636|364601381|FG000|Overall Study|Sponsor decision|0|||
105710782|NCT03132636|364601382|FG001|Overall Study|Sponsor decision|1|||
105710783|NCT03132636|364601381|FG000|Overall Study|Physician Decision|1|||
105710784|NCT03132636|364601382|FG001|Overall Study|Physician Decision|0|||
105710785|NCT03132636|364601381|FG000|Overall Study|Progressive disease|33|||
105710786|NCT03132636|364601382|FG001|Overall Study|Progressive disease|36|||
105710787|NCT03132636|364601381|FG000|Overall Study|Withdrawal of consent|2|||
105710788|NCT03132636|364601382|FG001|Overall Study|Withdrawal of consent|5|||
105710789|NCT03132636|364601381|FG000|Overall Study|Did not re-consent|1|||
105710790|NCT03132636|364601382|FG001|Overall Study|Did not re-consent|0|||
105710791|NCT03132636|364601381|FG000|Overall Study|Lost insurance coverage|1|||
105710792|NCT03132636|364601382|FG001|Overall Study|Lost insurance coverage|0|||
105710793|NCT03132636|364601381|FG000|Overall Study|Related to radiological outcomes|0|||
105710794|NCT03132636|364601382|FG001|Overall Study|Related to radiological outcomes|1|||
105710795|NCT03132636|364601381|FG000|Overall Study|Unable to come to site for continued visits|0|||
105710796|NCT03132636|364601382|FG001|Overall Study|Unable to come to site for continued visits|1|||
105710797|NCT03178487|364601388|FG000|Period 1|Adverse Event|1|||
105710798|NCT03178487|364601389|FG001|Period 1|Adverse Event|2|||
105710799|NCT03178487|364601388|FG000|Period 1|Withdrawal by Subject|2|||
105710800|NCT03178487|364601389|FG001|Period 1|Withdrawal by Subject|1|||
105710801|NCT03178487|364601388|FG000|Period 1|Lost to Follow-up|1|||
105710802|NCT03178487|364601389|FG001|Period 1|Lost to Follow-up|0|||
105710803|NCT03178487|364601388|FG000|Period 1|Other|0|||
105710804|NCT03178487|364601389|FG001|Period 1|Other|1|||
105710805|NCT03178487|364601388|FG000|Period 2|Adverse Event|4|||
105710806|NCT03178487|364601389|FG001|Period 2|Adverse Event|4|||
105710807|NCT03178487|364601388|FG000|Period 2|Withdrawal by Subject|6|||
105710808|NCT03178487|364601389|FG001|Period 2|Withdrawal by Subject|6|||
105710809|NCT03178487|364601388|FG000|Period 2|Lost to Follow-up|2|||
105710810|NCT03178487|364601389|FG001|Period 2|Lost to Follow-up|2|||
105710811|NCT03178487|364601388|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
105710812|NCT03178487|364601389|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
105710813|NCT03178487|364601388|FG000|Period 2|Other|8|||
105710814|NCT03178487|364601389|FG001|Period 2|Other|7|||
105710815|NCT01453855|364601390|FG000|Overall Study|Adverse Event|3|||
105710816|NCT01453855|364601391|FG001|Overall Study|Adverse Event|4|||
105710817|NCT01453855|364601390|FG000|Overall Study|Lost to Follow-up|2|||
105710818|NCT01453855|364601391|FG001|Overall Study|Lost to Follow-up|1|||
105710819|NCT01453855|364601390|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
105710820|NCT01453855|364601391|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
105710821|NCT01453855|364601390|FG000|Overall Study|Noncompliance|1|||
105710822|NCT01453855|364601391|FG001|Overall Study|Noncompliance|0|||
105710823|NCT01453855|364601390|FG000|Overall Study|Inadequate Control of IOP|1|||
105710824|NCT01453855|364601391|FG001|Overall Study|Inadequate Control of IOP|5|||
105710825|NCT01453855|364601390|FG000|Overall Study|Other|0|||
105710826|NCT01453855|364601391|FG001|Overall Study|Other|1|||
105710827|NCT03655756|364601398|FG000|Overall Study|Death|1|||
105710828|NCT00252057|364601399|FG000|Overall Study|Withdrawal by Subject|2|||
105710829|NCT00252057|364601400|FG001|Overall Study|Withdrawal by Subject|5|||
105710830|NCT00252057|364601399|FG000|Overall Study|Death|1|||
105710831|NCT00252057|364601400|FG001|Overall Study|Death|2|||
105710832|NCT00252057|364601399|FG000|Overall Study|Participant previously enrolled|0|||
105710833|NCT00252057|364601400|FG001|Overall Study|Participant previously enrolled|1|||
105710834|NCT03948178|364601404|FG000|Overall Study|Protocol Violation|1|||
105710835|NCT03948178|364601404|FG000|Overall Study|Lost to Follow-up|2|||
105710836|NCT03948178|364601404|FG000|Overall Study|Withdrawal by Subject|2|||
105710837|NCT03948178|364601404|FG000|Overall Study|Reason not known|2|||
105710838|NCT03948178|364601404|FG000|Overall Study|Personal reason|14|||
105710839|NCT03948178|364601404|FG000|Overall Study|Disease progression|30|||
105710840|NCT03948178|364601404|FG000|Overall Study|Adverse Event|12|||
105710841|NCT03948178|364601404|FG000|Overall Study|Sponsor terminated study|164|||
105710842|NCT04607733|364601410|FG000|Overall Study|Lost to Follow-up|1|||
105710843|NCT04607733|364601411|FG001|Overall Study|Lost to Follow-up|0|||
105710844|NCT04607733|364601412|FG002|Overall Study|Lost to Follow-up|0|||
105710845|NCT04607733|364601413|FG003|Overall Study|Lost to Follow-up|1|||
105710846|NCT04607733|364601414|FG004|Overall Study|Lost to Follow-up|1|||
105710847|NCT04607733|364601415|FG005|Overall Study|Lost to Follow-up|0|||
105710848|NCT04607733|364601410|FG000|Overall Study|Withdrawal by Subject|0|||
105710849|NCT04607733|364601411|FG001|Overall Study|Withdrawal by Subject|0|||
105351261|NCT02007278|363289679|FG000|Overall Study|Failure to comply with an eligibility|0|||
105475151|NCT02152956|363751302|FG000|Overall Study|Withdrawal by Subject|1|||
105475152|NCT02152956|363751303|FG001|Overall Study|Withdrawal by Subject|0|||
105475153|NCT02152956|363751304|FG002|Overall Study|Withdrawal by Subject|1|||
105710850|NCT04607733|364601412|FG002|Overall Study|Withdrawal by Subject|0|||
105710851|NCT04607733|364601413|FG003|Overall Study|Withdrawal by Subject|0|||
105710852|NCT04607733|364601414|FG004|Overall Study|Withdrawal by Subject|1|||
105710853|NCT04607733|364601415|FG005|Overall Study|Withdrawal by Subject|0|||
105351262|NCT02007278|363289680|FG001|Overall Study|Failure to comply with an eligibility|1|||
105788084|NCT00620776|364878207|FG000|Overall Study|Lack of Efficacy|2|||
105475154|NCT02152956|363751305|FG003|Overall Study|Withdrawal by Subject|0|||
105710854|NCT01847885|364601439|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
105560763|NCT00441090|364048511|FG004|Overall Study|Adverse Event|0|||
105710855|NCT01847885|364601440|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
105710856|NCT01847885|364601441|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
105710857|NCT01847885|364601439|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
105710858|NCT01847885|364601440|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
105710859|NCT01847885|364601441|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
105710860|NCT01847885|364601439|FG000|Initial Enrollment (Consented)|Screen failure|39|||
105710861|NCT01847885|364601440|FG001|Initial Enrollment (Consented)|Screen failure|0|||
105710862|NCT01847885|364601441|FG002|Initial Enrollment (Consented)|Screen failure|0|||
105710863|NCT01847885|364601439|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
105710864|NCT01847885|364601440|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
105710865|NCT01847885|364601441|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
105710866|NCT01847885|364601439|FG000|Randomization|Protocol Violation|0|||
105710867|NCT01847885|364601440|FG001|Randomization|Protocol Violation|1|||
105710868|NCT01847885|364601441|FG002|Randomization|Protocol Violation|0|||
105710869|NCT01847885|364601439|FG000|Randomization|Withdrawal by Subject|0|||
105710870|NCT01847885|364601440|FG001|Randomization|Withdrawal by Subject|0|||
105710871|NCT01847885|364601441|FG002|Randomization|Withdrawal by Subject|2|||
105710872|NCT01847885|364601439|FG000|Randomization|Screen Failure|0|||
105475155|NCT02152956|363751306|FG004|Overall Study|Withdrawal by Subject|2|||
105475156|NCT02152956|363751307|FG005|Overall Study|Withdrawal by Subject|2|||
105475157|NCT02152956|363751308|FG006|Overall Study|Withdrawal by Subject|0|||
105475158|NCT02152956|363751309|FG007|Overall Study|Withdrawal by Subject|0|||
105475159|NCT02152956|363751310|FG008|Overall Study|Withdrawal by Subject|1|||
105560764|NCT00441090|364048507|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
105560765|NCT00441090|364048508|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
105560766|NCT00441090|364048509|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
105560767|NCT00441090|364048510|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
105560768|NCT00441090|364048511|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
105560769|NCT00441090|364048507|FG000|Overall Study|Withdrawal by Subject|1|||
105560770|NCT00441090|364048508|FG001|Overall Study|Withdrawal by Subject|0|||
105560771|NCT00441090|364048509|FG002|Overall Study|Withdrawal by Subject|1|||
105560772|NCT00441090|364048510|FG003|Overall Study|Withdrawal by Subject|0|||
105560773|NCT00441090|364048511|FG004|Overall Study|Withdrawal by Subject|0|||
105560774|NCT00441090|364048507|FG000|Overall Study|Lack of Efficacy|1|||
105560775|NCT00441090|364048508|FG001|Overall Study|Lack of Efficacy|0|||
105560776|NCT00441090|364048509|FG002|Overall Study|Lack of Efficacy|0|||
105560777|NCT00441090|364048510|FG003|Overall Study|Lack of Efficacy|0|||
105560778|NCT00441090|364048511|FG004|Overall Study|Lack of Efficacy|0|||
105560779|NCT00605280|364048512|FG000|Year 1|Protocol Violation|0|||
105560780|NCT00605280|364048513|FG001|Year 1|Protocol Violation|0|||
105560781|NCT00605280|364048514|FG002|Year 1|Protocol Violation|0|||
105560782|NCT00605280|364048515|FG003|Year 1|Protocol Violation|1|||
105560783|NCT00605280|364048512|FG000|Year 1|Adverse Event|3|||
105560784|NCT00605280|364048513|FG001|Year 1|Adverse Event|1|||
105560785|NCT00605280|364048514|FG002|Year 1|Adverse Event|1|||
105560786|NCT00605280|364048515|FG003|Year 1|Adverse Event|5|||
105560787|NCT00605280|364048512|FG000|Year 1|Physician Decision|7|||
105560788|NCT00605280|364048513|FG001|Year 1|Physician Decision|4|||
105560789|NCT00605280|364048514|FG002|Year 1|Physician Decision|0|||
105560790|NCT00605280|364048515|FG003|Year 1|Physician Decision|6|||
105560791|NCT00605280|364048512|FG000|Year 1|Withdrawal by Subject|2|||
105560792|NCT00605280|364048513|FG001|Year 1|Withdrawal by Subject|4|||
105560793|NCT00605280|364048514|FG002|Year 1|Withdrawal by Subject|0|||
105560794|NCT00605280|364048515|FG003|Year 1|Withdrawal by Subject|4|||
105560795|NCT00605280|364048512|FG000|Year 1|Other|2|||
105560796|NCT00605280|364048513|FG001|Year 1|Other|1|||
105710873|NCT01847885|364601440|FG001|Randomization|Screen Failure|3|||
105710874|NCT01847885|364601441|FG002|Randomization|Screen Failure|0|||
105710875|NCT02941627|364601444|FG000|Overall Study|Death|1|||
105710876|NCT02941627|364601444|FG000|Overall Study|Surgical failure|1|||
105360891|NCT01051557|363328108|FG005|Overall Study|Physician Decision|0|||
105475160|NCT02152956|363751311|FG009|Overall Study|Withdrawal by Subject|0|||
105475161|NCT02152956|363751312|FG010|Overall Study|Withdrawal by Subject|0|||
105475162|NCT02152956|363751313|FG011|Overall Study|Withdrawal by Subject|4|||
105560797|NCT00605280|364048514|FG002|Year 1|Other|0|||
105560798|NCT00605280|364048515|FG003|Year 1|Other|1|||
105560799|NCT00605280|364048512|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
105560800|NCT00605280|364048513|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
105560801|NCT00605280|364048514|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
105560802|NCT00605280|364048515|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
105560803|NCT00605280|364048512|FG000|Year 2|Adverse Event|4|||
105560804|NCT00605280|364048513|FG001|Year 2|Adverse Event|0|||
105560805|NCT00605280|364048514|FG002|Year 2|Adverse Event|2|||
105710877|NCT02941627|364601444|FG000|Overall Study|cholesteatoma prevented implantation|1|||
105710878|NCT00411554|364601445|FG000|Overall Study|Adverse Event|2|||
105710879|NCT00411554|364601446|FG001|Overall Study|Adverse Event|4|||
105351263|NCT02007278|363289679|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
105351264|NCT02007278|363289680|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
105351265|NCT02007278|363289679|FG000|Overall Study|Incorrect medication administration|1|||
105351266|NCT02007278|363289680|FG001|Overall Study|Incorrect medication administration|0|||
105351267|NCT02007278|363289679|FG000|Overall Study|Mis-randomization|1|||
105351268|NCT02007278|363289680|FG001|Overall Study|Mis-randomization|1|||
105351269|NCT03304184|363289682|FG000|Overall Study|Withdrawal by Subject|1|||
105351270|NCT03304184|363289683|FG001|Overall Study|Withdrawal by Subject|2|||
105351271|NCT02886884|363289684|FG000|Follow-up|Withdrawal by Subject|0|||
105351272|NCT02886884|363289685|FG001|Follow-up|Withdrawal by Subject|0|||
105351273|NCT02886884|363289686|FG002|Follow-up|Withdrawal by Subject|0|||
105351274|NCT02886884|363289687|FG003|Follow-up|Withdrawal by Subject|1|||
105351275|NCT02112877|363289690|FG000|Overall Study|Withdrawal by Subject|1|||
105351276|NCT02112877|363289691|FG001|Overall Study|Withdrawal by Subject|7|||
105351277|NCT02112877|363289690|FG000|Overall Study|Visit Missed|1|||
105351278|NCT02112877|363289691|FG001|Overall Study|Visit Missed|6|||
105351279|NCT01693185|363289692|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
105351280|NCT01693185|363289693|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
105351281|NCT00076999|363289700|FG000|Overall Study|Adverse Event|2|||
105351282|NCT00076999|363289701|FG001|Overall Study|Adverse Event|8|||
105351283|NCT00076999|363289702|FG002|Overall Study|Adverse Event|6|||
105351284|NCT00076999|363289703|FG003|Overall Study|Adverse Event|0|||
105351285|NCT00076999|363289704|FG004|Overall Study|Adverse Event|2|||
105351286|NCT00076999|363289700|FG000|Overall Study|Protocol Violation|0|||
105351287|NCT00076999|363289701|FG001|Overall Study|Protocol Violation|3|||
105351288|NCT00076999|363289702|FG002|Overall Study|Protocol Violation|4|||
105351289|NCT00076999|363289703|FG003|Overall Study|Protocol Violation|0|||
105351290|NCT00076999|363289704|FG004|Overall Study|Protocol Violation|9|||
105710880|NCT00411554|364601445|FG000|Overall Study|Lack of Efficacy|2|||
105710881|NCT00411554|364601446|FG001|Overall Study|Lack of Efficacy|5|||
105710882|NCT00411554|364601445|FG000|Overall Study|Withdrawal by Subject|3|||
105710883|NCT00411554|364601446|FG001|Overall Study|Withdrawal by Subject|0|||
105710884|NCT00411554|364601445|FG000|Overall Study|Patient Moved|1|||
105710885|NCT00411554|364601446|FG001|Overall Study|Patient Moved|0|||
105710886|NCT00774345|364601447|FG000|Pre-treatment|Other reasons|2|||
105710887|NCT00774345|364601448|FG001|Pre-treatment|Other reasons|0|||
105710888|NCT00774345|364601447|FG000|Treatment|Adverse Event|61|||
105710889|NCT00774345|364601448|FG001|Treatment|Adverse Event|15|||
105710890|NCT00774345|364601447|FG000|Treatment|Progressive Disease without histologic transformation|51|||
105710891|NCT00774345|364601448|FG001|Treatment|Progressive Disease without histologic transformation|111|||
105710892|NCT00774345|364601447|FG000|Treatment|Progressive Disease with histologic transformation|4|||
105710893|NCT00774345|364601448|FG001|Treatment|Progressive Disease with histologic transformation|2|||
105710894|NCT00774345|364601447|FG000|Treatment|Withdrawal by Subject|5|||
105710895|NCT00774345|364601448|FG001|Treatment|Withdrawal by Subject|2|||
105710896|NCT00774345|364601447|FG000|Treatment|Lost to Follow-up|1|||
105710897|NCT00774345|364601448|FG001|Treatment|Lost to Follow-up|1|||
105710898|NCT00774345|364601447|FG000|Treatment|Death|4|||
105710899|NCT00774345|364601448|FG001|Treatment|Death|0|||
105710900|NCT00774345|364601447|FG000|Treatment|Other Reasons|32|||
105710901|NCT00774345|364601448|FG001|Treatment|Other Reasons|26|||
105710902|NCT02161211|364601449|FG000|Overall Study|Lost to Follow-up|21|||
105710903|NCT02161211|364601450|FG001|Overall Study|Lost to Follow-up|27|||
105710904|NCT02161211|364601451|FG002|Overall Study|Lost to Follow-up|21|||
105710905|NCT02161211|364601449|FG000|Overall Study|Dropped|12|||
105351291|NCT00076999|363289700|FG000|Overall Study|Lost to Follow-up|2|||
105351292|NCT00076999|363289701|FG001|Overall Study|Lost to Follow-up|1|||
105351293|NCT00076999|363289702|FG002|Overall Study|Lost to Follow-up|0|||
105351294|NCT00076999|363289703|FG003|Overall Study|Lost to Follow-up|0|||
105351295|NCT00076999|363289704|FG004|Overall Study|Lost to Follow-up|0|||
105351296|NCT00076999|363289700|FG000|Overall Study|Withdrawal by Subject|0|||
105351297|NCT00076999|363289701|FG001|Overall Study|Withdrawal by Subject|4|||
105351298|NCT00076999|363289702|FG002|Overall Study|Withdrawal by Subject|3|||
105351299|NCT00076999|363289703|FG003|Overall Study|Withdrawal by Subject|0|||
105351300|NCT00076999|363289704|FG004|Overall Study|Withdrawal by Subject|1|||
105351301|NCT00076999|363289700|FG000|Overall Study|Other reason (not specified)|8|||
105351302|NCT00076999|363289701|FG001|Overall Study|Other reason (not specified)|8|||
105710906|NCT02161211|364601450|FG001|Overall Study|Dropped|5|||
105710907|NCT02161211|364601451|FG002|Overall Study|Dropped|9|||
105710908|NCT01422239|364601452|FG000|Overall Study|Lost to Follow-up|4|||
105710909|NCT01422239|364601453|FG001|Overall Study|Lost to Follow-up|3|||
105710910|NCT03167073|364601457|FG000|Overall Study|Stillbirth|1|||
105710911|NCT03167073|364601458|FG001|Overall Study|Stillbirth|0|||
105710912|NCT01276236|364601459|FG000|Overall Study|Lack of Efficacy|2|||
105710913|NCT01276236|364601459|FG000|Overall Study|Withdrawal by Subject|4|||
105710914|NCT01400451|364601460|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
105710915|NCT01400451|364601461|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
105710916|NCT01400451|364601462|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
105710917|NCT01400451|364601460|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
105788085|NCT00620776|364878208|FG001|Overall Study|Lack of Efficacy|1|||
105788086|NCT00620776|364878207|FG000|Overall Study|Lost to Follow-up|2|||
105788087|NCT00620776|364878208|FG001|Overall Study|Lost to Follow-up|5|||
105788088|NCT00620776|364878207|FG000|Overall Study|Withdrawal by Subject|3|||
105788089|NCT00620776|364878208|FG001|Overall Study|Withdrawal by Subject|2|||
105788090|NCT03253809|364878209|FG000|Overall Study|Unable to obtain study related data|14|||
105788091|NCT00455923|364878213|FG000|Overall Study|Pregnancy|0|||
105351303|NCT00076999|363289702|FG002|Overall Study|Other reason (not specified)|4|||
105351304|NCT00076999|363289703|FG003|Overall Study|Other reason (not specified)|1|||
105351305|NCT00076999|363289704|FG004|Overall Study|Other reason (not specified)|13|||
105351306|NCT00187278|363289705|FG000|Overall Study|Protocol Violation|10|||
105351307|NCT00187278|363289706|FG001|Overall Study|Protocol Violation|13|||
105351308|NCT02735096|363289707|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
105351309|NCT00380718|363289708|FG000|Overall Study|Adverse Event|1|||
105351310|NCT00380718|363289708|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
105351311|NCT00621517|363289715|FG000|Overall Study|Lost to Follow-up|3|||
105351312|NCT00621517|363289716|FG001|Overall Study|Lost to Follow-up|3|||
105560806|NCT00605280|364048515|FG003|Year 2|Adverse Event|4|||
105560807|NCT00605280|364048512|FG000|Year 2|Physician Decision|11|||
105560808|NCT00605280|364048513|FG001|Year 2|Physician Decision|6|||
105560809|NCT00605280|364048514|FG002|Year 2|Physician Decision|4|||
105560810|NCT00605280|364048515|FG003|Year 2|Physician Decision|11|||
105560811|NCT00605280|364048512|FG000|Year 2|Withdrawal by Subject|4|||
105560812|NCT00605280|364048513|FG001|Year 2|Withdrawal by Subject|0|||
105560813|NCT00605280|364048514|FG002|Year 2|Withdrawal by Subject|0|||
105560814|NCT00605280|364048515|FG003|Year 2|Withdrawal by Subject|4|||
105560815|NCT00605280|364048512|FG000|Year 2|Other|1|||
105560816|NCT00605280|364048513|FG001|Year 2|Other|0|||
105710918|NCT01400451|364601461|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
105710919|NCT01400451|364601462|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
105710920|NCT01400451|364601460|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
105710921|NCT01400451|364601461|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
105710922|NCT01400451|364601462|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
105710923|NCT01400451|364601460|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
105788092|NCT00455923|364878214|FG001|Overall Study|Pregnancy|2|||
105351313|NCT00621517|363289715|FG000|Overall Study|Withdrawal by Subject|3|||
105351314|NCT00621517|363289716|FG001|Overall Study|Withdrawal by Subject|4|||
105351315|NCT00621517|363289715|FG000|Overall Study|Adverse Event|1|||
105351316|NCT00621517|363289716|FG001|Overall Study|Adverse Event|0|||
105351317|NCT01048099|363289717|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
105351318|NCT01048099|363289717|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
105351319|NCT01863732|363289718|FG000|Overall Study|Adverse Event|2|||
105351320|NCT01863732|363289719|FG001|Overall Study|Adverse Event|0|||
105351321|NCT01863732|363289720|FG002|Overall Study|Adverse Event|3|||
105351322|NCT01863732|363289721|FG003|Overall Study|Adverse Event|3|||
105351323|NCT01863732|363289718|FG000|Overall Study|Lack of Efficacy|1|||
105351324|NCT01863732|363289719|FG001|Overall Study|Lack of Efficacy|0|||
105351325|NCT01863732|363289720|FG002|Overall Study|Lack of Efficacy|2|||
105351326|NCT01863732|363289721|FG003|Overall Study|Lack of Efficacy|1|||
105351327|NCT01863732|363289718|FG000|Overall Study|Lost to Follow-up|2|||
105351328|NCT01863732|363289719|FG001|Overall Study|Lost to Follow-up|2|||
105351329|NCT01863732|363289720|FG002|Overall Study|Lost to Follow-up|1|||
105351330|NCT01863732|363289721|FG003|Overall Study|Lost to Follow-up|1|||
105351331|NCT01863732|363289718|FG000|Overall Study|Physician Decision|1|||
105351332|NCT01863732|363289719|FG001|Overall Study|Physician Decision|0|||
105351333|NCT01863732|363289720|FG002|Overall Study|Physician Decision|1|||
105351334|NCT01863732|363289721|FG003|Overall Study|Physician Decision|0|||
105351335|NCT01863732|363289718|FG000|Overall Study|Pregnancy|0|||
105351336|NCT01863732|363289719|FG001|Overall Study|Pregnancy|0|||
105351337|NCT01863732|363289720|FG002|Overall Study|Pregnancy|0|||
105351338|NCT01863732|363289721|FG003|Overall Study|Pregnancy|1|||
105351339|NCT01863732|363289718|FG000|Overall Study|Technical problems|0|||
105351340|NCT01863732|363289719|FG001|Overall Study|Technical problems|1|||
105351341|NCT01863732|363289720|FG002|Overall Study|Technical problems|1|||
105351342|NCT01863732|363289721|FG003|Overall Study|Technical problems|0|||
105351343|NCT01863732|363289718|FG000|Overall Study|Subject/guardian decision|6|||
105351344|NCT01863732|363289719|FG001|Overall Study|Subject/guardian decision|9|||
105351345|NCT01863732|363289720|FG002|Overall Study|Subject/guardian decision|3|||
105351346|NCT01863732|363289721|FG003|Overall Study|Subject/guardian decision|1|||
105351347|NCT01863732|363289718|FG000|Overall Study|Death|1|||
105351348|NCT01863732|363289719|FG001|Overall Study|Death|0|||
105351349|NCT01863732|363289720|FG002|Overall Study|Death|0|||
105351350|NCT01863732|363289721|FG003|Overall Study|Death|1|||
105560817|NCT00605280|364048514|FG002|Year 2|Other|0|||
105560818|NCT00605280|364048515|FG003|Year 2|Other|1|||
105560819|NCT00605280|364048512|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
105560820|NCT00605280|364048513|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
105710924|NCT01400451|364601461|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
105788093|NCT00455923|364878213|FG000|Overall Study|Other|3|||
105710925|NCT01400451|364601462|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
105710926|NCT01400451|364601460|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
105710927|NCT01400451|364601461|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
105710928|NCT01400451|364601462|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
105710929|NCT02799069|364601465|FG000|Overall Study|Adverse Event|0|||
105710930|NCT02799069|364601466|FG001|Overall Study|Adverse Event|2|||
105710931|NCT02799069|364601467|FG002|Overall Study|Adverse Event|2|||
105710932|NCT02799069|364601465|FG000|Overall Study|Lack of Efficacy|2|||
105710933|NCT02799069|364601466|FG001|Overall Study|Lack of Efficacy|0|||
105710934|NCT02799069|364601467|FG002|Overall Study|Lack of Efficacy|0|||
105788094|NCT00455923|364878214|FG001|Overall Study|Other|1|||
105788095|NCT04964960|364878215|FG000|Overall Study|Withdrawal by Subject|1|||
105788096|NCT02319642|364878216|FG000|Overall Study|Adverse Event|2|||
105788097|NCT02319642|364878217|FG001|Overall Study|Adverse Event|4|||
105788098|NCT02319642|364878216|FG000|Overall Study|Lack of Efficacy|1|||
105788099|NCT02319642|364878217|FG001|Overall Study|Lack of Efficacy|1|||
105788100|NCT02319642|364878216|FG000|Overall Study|Withdrawal by Subject|1|||
105788101|NCT02319642|364878217|FG001|Overall Study|Withdrawal by Subject|1|||
105788102|NCT05275673|364878218|FG000|Overall Study|Study Termination by Sponsor|2|||
105788103|NCT05275673|364878219|FG001|Overall Study|Study Termination by Sponsor|3|||
105788104|NCT05275673|364878218|FG000|Overall Study|Death|1|||
105788105|NCT05275673|364878219|FG001|Overall Study|Death|0|||
105788106|NCT05275673|364878218|FG000|Overall Study|Withdrawal by Subject|1|||
105351351|NCT00508157|363289722|FG000|Overall Study|Adverse Event|0|||
105351352|NCT00508157|363289723|FG001|Overall Study|Adverse Event|1|||
105788107|NCT05275673|364878219|FG001|Overall Study|Withdrawal by Subject|0|||
105788108|NCT03426995|364878220|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788109|NCT03426995|364878221|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788110|NCT03426995|364878222|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
105788111|NCT03426995|364878223|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105351353|NCT00508157|363289722|FG000|Overall Study|Subject Withdrew Consent|1|||
105351354|NCT00508157|363289723|FG001|Overall Study|Subject Withdrew Consent|0|||
105351355|NCT00508157|363289722|FG000|Overall Study|Lost to Follow-up|1|||
105351356|NCT00508157|363289723|FG001|Overall Study|Lost to Follow-up|0|||
105351357|NCT00508157|363289722|FG000|Overall Study|Subject no longer met study criteria|0|||
105351358|NCT00508157|363289723|FG001|Overall Study|Subject no longer met study criteria|1|||
105351359|NCT00508157|363289722|FG000|Overall Study|Other known cause|0|||
105351360|NCT00508157|363289723|FG001|Overall Study|Other known cause|1|||
105351361|NCT01156051|363289724|FG000|Overall Study|Lost to Follow-up|1|||
105351362|NCT01156051|363289725|FG001|Overall Study|Lost to Follow-up|0|||
105351363|NCT01156051|363289724|FG000|Overall Study|patient not compliant with protocol|0|||
105351364|NCT01156051|363289725|FG001|Overall Study|patient not compliant with protocol|1|||
105475163|NCT02152956|363751314|FG012|Overall Study|Withdrawal by Subject|0|||
105475164|NCT02152956|363751302|FG000|Overall Study|Physician Decision|0|||
105475165|NCT02152956|363751303|FG001|Overall Study|Physician Decision|0|||
105475166|NCT02152956|363751304|FG002|Overall Study|Physician Decision|0|||
105351365|NCT01428115|363289727|FG000|Overall Study|Lack of Efficacy|3|||
105351366|NCT01428115|363289727|FG000|Overall Study|Lost to Follow-up|10|||
105351367|NCT01428115|363289727|FG000|Overall Study|Pregnancy|1|||
105351368|NCT01428115|363289727|FG000|Overall Study|Protocol Violation|3|||
105351369|NCT01428115|363289727|FG000|Overall Study|Withdrawal by Subject|4|||
105351370|NCT02179749|363289728|FG000|Overall Study|Adverse Event|0|||
105351371|NCT02179749|363289729|FG001|Overall Study|Adverse Event|0|||
105475167|NCT02152956|363751305|FG003|Overall Study|Physician Decision|0|||
105475168|NCT02152956|363751306|FG004|Overall Study|Physician Decision|0|||
105475169|NCT02152956|363751307|FG005|Overall Study|Physician Decision|0|||
105710935|NCT02799069|364601465|FG000|Overall Study|Lost to Follow-up|1|||
105351372|NCT02179749|363289730|FG002|Overall Study|Adverse Event|1|||
105351373|NCT02179749|363289728|FG000|Overall Study|Withdrawal by Subject|0|||
105475170|NCT02152956|363751308|FG006|Overall Study|Physician Decision|0|||
105475171|NCT02152956|363751309|FG007|Overall Study|Physician Decision|0|||
105475172|NCT02152956|363751310|FG008|Overall Study|Physician Decision|0|||
105475173|NCT02152956|363751311|FG009|Overall Study|Physician Decision|0|||
105710936|NCT02799069|364601466|FG001|Overall Study|Lost to Follow-up|1|||
105710937|NCT02799069|364601467|FG002|Overall Study|Lost to Follow-up|0|||
105710938|NCT02799069|364601465|FG000|Overall Study|Withdrawal by Subject|4|||
105560821|NCT00605280|364048514|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
105560822|NCT00605280|364048515|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
105560823|NCT00605280|364048512|FG000|Year 3 Extension|Adverse Event|2|||
105560824|NCT00605280|364048513|FG001|Year 3 Extension|Adverse Event|0|||
105560825|NCT00605280|364048514|FG002|Year 3 Extension|Adverse Event|0|||
105560826|NCT00605280|364048515|FG003|Year 3 Extension|Adverse Event|2|||
105560827|NCT00605280|364048512|FG000|Year 3 Extension|Physician Decision|0|||
105560828|NCT00605280|364048513|FG001|Year 3 Extension|Physician Decision|0|||
105560829|NCT00605280|364048514|FG002|Year 3 Extension|Physician Decision|0|||
105560830|NCT00605280|364048515|FG003|Year 3 Extension|Physician Decision|2|||
105560831|NCT00605280|364048512|FG000|Year 3 Extension|Withdrawal by Subject|2|||
105560832|NCT00605280|364048513|FG001|Year 3 Extension|Withdrawal by Subject|0|||
105560833|NCT00605280|364048514|FG002|Year 3 Extension|Withdrawal by Subject|0|||
105560834|NCT00605280|364048515|FG003|Year 3 Extension|Withdrawal by Subject|5|||
105560835|NCT00605280|364048512|FG000|Year 3 Extension|Other|2|||
105560836|NCT00605280|364048513|FG001|Year 3 Extension|Other|0|||
105560837|NCT00605280|364048514|FG002|Year 3 Extension|Other|0|||
105560838|NCT00605280|364048515|FG003|Year 3 Extension|Other|0|||
105560839|NCT00605280|364048512|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
105560840|NCT00605280|364048513|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
105560841|NCT00605280|364048514|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
105560842|NCT00605280|364048515|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
105560843|NCT00810264|364048516|FG000|Overall Study|Lost to Follow-up|191|||
105560844|NCT00810264|364048516|FG000|Overall Study|Withdrawal by subject or physician|721|||
105560845|NCT00810264|364048516|FG000|Overall Study|Death|641|||
105560846|NCT00538590|364048517|FG000|Overall Study|Death|1|||
105560847|NCT00538590|364048518|FG001|Overall Study|Death|0|||
105560848|NCT01256567|364048519|FG000|Overall Study|Withdrawal by Subject|1|||
105560849|NCT00671931|364048528|FG000|Overall Study|Physician Decision|1|||
105560850|NCT00671931|364048529|FG001|Overall Study|Physician Decision|0|||
105560851|NCT00671931|364048530|FG002|Overall Study|Physician Decision|0|||
105560852|NCT00671931|364048531|FG003|Overall Study|Physician Decision|2|||
105560853|NCT00671931|364048532|FG004|Overall Study|Physician Decision|1|||
105560854|NCT02151266|364048533|FG000|Overall Study|Lost to Follow-up|1|||
105560855|NCT02151266|364048534|FG001|Overall Study|Lost to Follow-up|4|||
105560856|NCT02151266|364048535|FG002|Overall Study|Lost to Follow-up|1|||
105560857|NCT02151266|364048533|FG000|Overall Study|Did NOT receive intervention|3|||
105560858|NCT02151266|364048534|FG001|Overall Study|Did NOT receive intervention|6|||
105560859|NCT02151266|364048535|FG002|Overall Study|Did NOT receive intervention|2|||
105560860|NCT02151266|364048533|FG000|Overall Study|Not able to exercise|4|||
105560861|NCT02151266|364048534|FG001|Overall Study|Not able to exercise|5|||
105560862|NCT02151266|364048535|FG002|Overall Study|Not able to exercise|4|||
105560863|NCT01169675|364048536|FG000|Overall Study|Progressive disease|13|||
105710939|NCT02799069|364601466|FG001|Overall Study|Withdrawal by Subject|4|||
105710940|NCT02799069|364601467|FG002|Overall Study|Withdrawal by Subject|3|||
105710941|NCT02799069|364601465|FG000|Overall Study|Protocol Violation|1|||
105710942|NCT02799069|364601466|FG001|Overall Study|Protocol Violation|0|||
105710943|NCT02799069|364601467|FG002|Overall Study|Protocol Violation|2|||
105560864|NCT01169675|364048537|FG001|Overall Study|Progressive disease|2|||
105560865|NCT01169675|364048538|FG002|Overall Study|Progressive disease|5|||
105560866|NCT01169675|364048539|FG003|Overall Study|Progressive disease|15|||
105560867|NCT01169675|364048540|FG004|Overall Study|Progressive disease|1|||
105560868|NCT01169675|364048536|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
105560869|NCT01169675|364048537|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105560870|NCT01169675|364048538|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105560871|NCT01169675|364048539|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105560872|NCT01169675|364048540|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
105560873|NCT01169675|364048536|FG000|Overall Study|Adverse Event|5|||
105560874|NCT01169675|364048537|FG001|Overall Study|Adverse Event|1|||
105710944|NCT00848354|364601468|FG000|Phase 1|Adverse Event|5|||
105710945|NCT00848354|364601469|FG001|Phase 1|Adverse Event|4|||
105475174|NCT02152956|363751312|FG010|Overall Study|Physician Decision|0|||
105475175|NCT02152956|363751313|FG011|Overall Study|Physician Decision|1|||
105475176|NCT02152956|363751314|FG012|Overall Study|Physician Decision|0|||
105475177|NCT02152956|363751302|FG000|Overall Study|Study terminated by sponsor|0|||
105475178|NCT02152956|363751303|FG001|Overall Study|Study terminated by sponsor|0|||
105475179|NCT02152956|363751304|FG002|Overall Study|Study terminated by sponsor|0|||
105475180|NCT02152956|363751305|FG003|Overall Study|Study terminated by sponsor|0|||
105475181|NCT02152956|363751306|FG004|Overall Study|Study terminated by sponsor|0|||
105475182|NCT02152956|363751307|FG005|Overall Study|Study terminated by sponsor|0|||
105475183|NCT02152956|363751308|FG006|Overall Study|Study terminated by sponsor|0|||
105475184|NCT02152956|363751309|FG007|Overall Study|Study terminated by sponsor|0|||
105475185|NCT02152956|363751310|FG008|Overall Study|Study terminated by sponsor|0|||
105475186|NCT02152956|363751311|FG009|Overall Study|Study terminated by sponsor|0|||
105475187|NCT02152956|363751312|FG010|Overall Study|Study terminated by sponsor|0|||
105475188|NCT02152956|363751313|FG011|Overall Study|Study terminated by sponsor|29|||
105475189|NCT02152956|363751314|FG012|Overall Study|Study terminated by sponsor|0|||
105475190|NCT02152956|363751302|FG000|Overall Study|progressive disease|0|||
105475191|NCT02152956|363751303|FG001|Overall Study|progressive disease|0|||
105475192|NCT02152956|363751304|FG002|Overall Study|progressive disease|0|||
105475193|NCT02152956|363751305|FG003|Overall Study|progressive disease|0|||
105475194|NCT02152956|363751306|FG004|Overall Study|progressive disease|0|||
105475195|NCT02152956|363751307|FG005|Overall Study|progressive disease|0|||
105475196|NCT02152956|363751308|FG006|Overall Study|progressive disease|0|||
105475197|NCT02152956|363751309|FG007|Overall Study|progressive disease|0|||
105475198|NCT02152956|363751310|FG008|Overall Study|progressive disease|1|||
105475199|NCT02152956|363751311|FG009|Overall Study|progressive disease|0|||
105475200|NCT02152956|363751312|FG010|Overall Study|progressive disease|0|||
105475201|NCT02152956|363751313|FG011|Overall Study|progressive disease|1|||
105475202|NCT02152956|363751314|FG012|Overall Study|progressive disease|0|||
105475203|NCT00612807|363751315|FG000|Overall Study|Withdrawal by Subject|2|||
105475204|NCT00612807|363751316|FG001|Overall Study|Withdrawal by Subject|0|||
105475205|NCT01215097|363751317|FG000|Overall Study|Adverse Event|1|||
105475206|NCT01215097|363751318|FG001|Overall Study|Adverse Event|3|||
105475207|NCT01215097|363751317|FG000|Overall Study|Protocol Violation|0|||
105475208|NCT01215097|363751318|FG001|Overall Study|Protocol Violation|2|||
105475209|NCT01215097|363751317|FG000|Overall Study|Lost to Follow-up|2|||
105475210|NCT01215097|363751318|FG001|Overall Study|Lost to Follow-up|0|||
105475211|NCT01215097|363751317|FG000|Overall Study|Withdrawal by Subject|6|||
105475212|NCT01215097|363751318|FG001|Overall Study|Withdrawal by Subject|3|||
105475213|NCT01215097|363751317|FG000|Overall Study|Lack of Efficacy|0|||
105475214|NCT01215097|363751318|FG001|Overall Study|Lack of Efficacy|3|||
105475215|NCT01215097|363751317|FG000|Overall Study|patient's refusal to come|2|||
105475216|NCT01215097|363751318|FG001|Overall Study|patient's refusal to come|2|||
105475217|NCT01215097|363751317|FG000|Overall Study|patient's private reason|1|||
105475218|NCT01215097|363751318|FG001|Overall Study|patient's private reason|1|||
105475219|NCT01818752|363751319|FG000|Overall Study|Adverse Event|64|||
105475220|NCT01818752|363751320|FG001|Overall Study|Adverse Event|74|||
105475221|NCT01818752|363751319|FG000|Overall Study|Death|14|||
105475222|NCT01818752|363751320|FG001|Overall Study|Death|18|||
105475223|NCT01818752|363751319|FG000|Overall Study|Non-compliance|16|||
105475224|NCT01818752|363751320|FG001|Overall Study|Non-compliance|20|||
105475225|NCT01818752|363751319|FG000|Overall Study|Withdrawal by Subject|15|||
105475226|NCT01818752|363751320|FG001|Overall Study|Withdrawal by Subject|14|||
105360892|NCT01051557|363328109|FG006|Overall Study|Physician Decision|0|||
105475227|NCT01818752|363751319|FG000|Overall Study|Physician Decision|9|||
105475228|NCT01818752|363751320|FG001|Overall Study|Physician Decision|8|||
105475229|NCT01818752|363751319|FG000|Overall Study|Disease Progression|54|||
105475230|NCT01818752|363751320|FG001|Overall Study|Disease Progression|48|||
105475231|NCT01818752|363751319|FG000|Overall Study|Other|7|||
105475232|NCT01818752|363751320|FG001|Overall Study|Other|8|||
105475233|NCT01818752|363751319|FG000|Overall Study|Continuing Treatment|1|||
105475234|NCT01818752|363751320|FG001|Overall Study|Continuing Treatment|4|||
105475235|NCT01818752|363751319|FG000|Overall Study|Randomized but not Dosed|7|||
105475236|NCT01818752|363751320|FG001|Overall Study|Randomized but not Dosed|4|||
105710946|NCT00848354|364601468|FG000|Phase 1|Discontinuation of study by sponsor|2|||
105710947|NCT00848354|364601469|FG001|Phase 1|Discontinuation of study by sponsor|1|||
105710948|NCT00848354|364601468|FG000|Phase 1|Failed to return|0|||
105710949|NCT00848354|364601469|FG001|Phase 1|Failed to return|1|||
105710950|NCT00848354|364601468|FG000|Phase 1|Lost to Follow-up|1|||
105710951|NCT00848354|364601469|FG001|Phase 1|Lost to Follow-up|1|||
105710952|NCT00848354|364601468|FG000|Phase 1|Unspecified Reason|1|||
105710953|NCT00848354|364601469|FG001|Phase 1|Unspecified Reason|1|||
105710954|NCT00848354|364601468|FG000|Phase 1|Protocol Violation|1|||
105710955|NCT00848354|364601469|FG001|Phase 1|Protocol Violation|1|||
105710956|NCT00848354|364601468|FG000|Phase 1|Withdrawal by Subject|2|||
105475237|NCT02228980|363751321|FG000|Overall Study|Adverse Event|14|||
105475238|NCT02228980|363751322|FG001|Overall Study|Adverse Event|0|||
105475239|NCT02228980|363751323|FG002|Overall Study|Adverse Event|0|||
105475240|NCT02228980|363751324|FG003|Overall Study|Adverse Event|0|||
105475241|NCT02228980|363751321|FG000|Overall Study|Protocol Violation|7|||
105475242|NCT02228980|363751322|FG001|Overall Study|Protocol Violation|0|||
105475243|NCT02228980|363751323|FG002|Overall Study|Protocol Violation|0|||
105475244|NCT02228980|363751324|FG003|Overall Study|Protocol Violation|0|||
105475245|NCT02228980|363751321|FG000|Overall Study|Withdrawal by Subject|3|||
105710957|NCT00848354|364601469|FG001|Phase 1|Withdrawal by Subject|4|||
105710958|NCT00848354|364601468|FG000|Phase 1|Lack of Efficacy|0|||
105710959|NCT00848354|364601469|FG001|Phase 1|Lack of Efficacy|1|||
105475246|NCT02228980|363751322|FG001|Overall Study|Withdrawal by Subject|3|||
105475247|NCT02228980|363751323|FG002|Overall Study|Withdrawal by Subject|2|||
105475248|NCT02228980|363751324|FG003|Overall Study|Withdrawal by Subject|3|||
105475249|NCT04270370|363751325|FG000|Overall Study|Lost to Follow-up|1|||
105475250|NCT04270370|363751326|FG001|Overall Study|Lost to Follow-up|0|||
105475251|NCT04270370|363751327|FG002|Overall Study|Lost to Follow-up|0|||
105475252|NCT04270370|363751328|FG003|Overall Study|Lost to Follow-up|0|||
105710960|NCT00848354|364601468|FG000|Phase 2 Year 1|Adverse Event|7|||
105710961|NCT00848354|364601469|FG001|Phase 2 Year 1|Adverse Event|2|||
105710962|NCT00848354|364601468|FG000|Phase 2 Year 1|Death|1|||
105710963|NCT00848354|364601469|FG001|Phase 2 Year 1|Death|0|||
105710964|NCT00848354|364601468|FG000|Phase 2 Year 1|Failed to Return|1|||
105710965|NCT00848354|364601469|FG001|Phase 2 Year 1|Failed to Return|1|||
105710966|NCT00848354|364601468|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
105710967|NCT00848354|364601469|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
105710968|NCT00848354|364601468|FG000|Phase 2 Year 1|Unspecified Reason|3|||
105710969|NCT00848354|364601469|FG001|Phase 2 Year 1|Unspecified Reason|0|||
105710970|NCT00848354|364601468|FG000|Phase 2 Year 1|Protocol Violation|4|||
105710971|NCT00848354|364601469|FG001|Phase 2 Year 1|Protocol Violation|1|||
105710972|NCT00848354|364601468|FG000|Phase 2 Year 1|Subject Request|1|||
105710973|NCT00848354|364601469|FG001|Phase 2 Year 1|Subject Request|2|||
105351374|NCT02179749|363289729|FG001|Overall Study|Withdrawal by Subject|0|||
105710974|NCT00848354|364601468|FG000|Phase 2 Year 2|Adverse Event|12|||
105351375|NCT02179749|363289730|FG002|Overall Study|Withdrawal by Subject|1|||
105351376|NCT00494221|363289731|FG000|Overall Study|Death|15|||
105351377|NCT00494221|363289732|FG001|Overall Study|Death|9|||
105351378|NCT00494221|363289733|FG002|Overall Study|Death|14|||
105351379|NCT00494221|363289731|FG000|Overall Study|Withdrawal by Subject|1|||
105351380|NCT00494221|363289732|FG001|Overall Study|Withdrawal by Subject|2|||
105351381|NCT00494221|363289733|FG002|Overall Study|Withdrawal by Subject|0|||
105351382|NCT00467558|363289737|FG000|Overall Study|Lost to Follow-up|2|||
105351383|NCT00467558|363289738|FG001|Overall Study|Lost to Follow-up|0|||
105351384|NCT01709864|363291951|FG000|Overall Study|Physician Decision|0|||
105351385|NCT01709864|363291952|FG001|Overall Study|Physician Decision|1|||
105351386|NCT01709864|363291951|FG000|Overall Study|subject/guardian decision|5|||
105351387|NCT01709864|363291952|FG001|Overall Study|subject/guardian decision|6|||
105351388|NCT01709864|363291951|FG000|Overall Study|Lost to Follow-up|1|||
105351389|NCT01709864|363291952|FG001|Overall Study|Lost to Follow-up|0|||
105351390|NCT01709864|363291951|FG000|Overall Study|non-compliance with study treatment|1|||
105351391|NCT01709864|363291952|FG001|Overall Study|non-compliance with study treatment|1|||
105351392|NCT01709864|363291951|FG000|Overall Study|Adverse Event|0|||
105351393|NCT01709864|363291952|FG001|Overall Study|Adverse Event|2|||
105351394|NCT01709864|363291951|FG000|Overall Study|Death|0|||
105351395|NCT01709864|363291952|FG001|Overall Study|Death|1|||
105351396|NCT01709409|363291956|FG000|Overall Study|Protocol Violation|1|||
105351397|NCT01709409|363291957|FG001|Overall Study|Protocol Violation|0|||
105351398|NCT02815267|363291961|FG000|Double-Blind Phase|Adverse Event|0|||
105351399|NCT02815267|363291962|FG001|Double-Blind Phase|Adverse Event|3|||
105351400|NCT02815267|363291961|FG000|Double-Blind Phase|Lost to Follow-up|17|||
105351401|NCT02815267|363291962|FG001|Double-Blind Phase|Lost to Follow-up|9|||
105351402|NCT02815267|363291961|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
105351403|NCT02815267|363291962|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
105351404|NCT02815267|363291961|FG000|Double-Blind Phase|Protocol Violation|3|||
105351405|NCT02815267|363291962|FG001|Double-Blind Phase|Protocol Violation|2|||
105351406|NCT02815267|363291961|FG000|Double-Blind Phase|Site withdrawal|1|||
105351407|NCT02815267|363291962|FG001|Double-Blind Phase|Site withdrawal|6|||
105351408|NCT02815267|363291961|FG000|Double-Blind Phase|Received a disallowed medication|1|||
105351409|NCT02815267|363291962|FG001|Double-Blind Phase|Received a disallowed medication|1|||
105351410|NCT02815267|363291961|FG000|Open-Label Phase|Adverse Event|1|||
105351411|NCT02815267|363291962|FG001|Open-Label Phase|Adverse Event|1|||
105351412|NCT02815267|363291961|FG000|Open-Label Phase|Lost to Follow-up|23|||
105351413|NCT02815267|363291962|FG001|Open-Label Phase|Lost to Follow-up|9|||
105351414|NCT02815267|363291961|FG000|Open-Label Phase|Withdrawal by Subject|24|||
105351415|NCT02815267|363291962|FG001|Open-Label Phase|Withdrawal by Subject|13|||
105351416|NCT02815267|363291961|FG000|Open-Label Phase|Protocol Violation|0|||
105351417|NCT02815267|363291962|FG001|Open-Label Phase|Protocol Violation|1|||
105351418|NCT02815267|363291961|FG000|Open-Label Phase|Administrative|21|||
105351419|NCT02815267|363291962|FG001|Open-Label Phase|Administrative|12|||
105351420|NCT02815267|363291961|FG000|Open-Label Phase|Other|2|||
105351421|NCT02815267|363291962|FG001|Open-Label Phase|Other|5|||
105351422|NCT01375374|363291965|FG000|Overall Study|Adverse Event|1|||
105351423|NCT00070564|363291966|FG000|Overall Study|Progression|2|||
105351424|NCT00070564|363291967|FG001|Overall Study|Progression|4|||
105351425|NCT00070564|363291968|FG002|Overall Study|Progression|7|||
105351426|NCT00070564|363291969|FG003|Overall Study|Progression|7|||
105351427|NCT00070564|363291970|FG004|Overall Study|Progression|1|||
105351428|NCT00070564|363291971|FG005|Overall Study|Progression|0|||
105710975|NCT00848354|364601469|FG001|Phase 2 Year 2|Adverse Event|2|||
105351429|NCT00070564|363291966|FG000|Overall Study|Delinquent|1|||
105351430|NCT00070564|363291967|FG001|Overall Study|Delinquent|4|||
105351431|NCT00070564|363291968|FG002|Overall Study|Delinquent|2|||
105788112|NCT03426995|364878224|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105351432|NCT00070564|363291969|FG003|Overall Study|Delinquent|0|||
105351433|NCT00070564|363291970|FG004|Overall Study|Delinquent|0|||
105351434|NCT00070564|363291971|FG005|Overall Study|Delinquent|0|||
105351435|NCT00070564|363291966|FG000|Overall Study|Adverse Event|150|||
105351436|NCT00070564|363291967|FG001|Overall Study|Adverse Event|142|||
105351437|NCT00070564|363291968|FG002|Overall Study|Adverse Event|120|||
105351438|NCT00070564|363291969|FG003|Overall Study|Adverse Event|108|||
105351439|NCT00070564|363291970|FG004|Overall Study|Adverse Event|63|||
105710976|NCT00848354|364601468|FG000|Phase 2 Year 2|Death|2|||
105710977|NCT00848354|364601469|FG001|Phase 2 Year 2|Death|0|||
105560875|NCT01169675|364048538|FG002|Overall Study|Adverse Event|2|||
105560876|NCT01169675|364048539|FG003|Overall Study|Adverse Event|0|||
105560877|NCT01169675|364048540|FG004|Overall Study|Adverse Event|0|||
105560878|NCT01169675|364048536|FG000|Overall Study|Withdrawal by Subject|1|||
105560879|NCT01169675|364048537|FG001|Overall Study|Withdrawal by Subject|0|||
105560880|NCT01169675|364048538|FG002|Overall Study|Withdrawal by Subject|0|||
105560881|NCT01169675|364048539|FG003|Overall Study|Withdrawal by Subject|1|||
105560882|NCT01169675|364048540|FG004|Overall Study|Withdrawal by Subject|2|||
105560883|NCT01169675|364048536|FG000|Overall Study|Other Reason Not Defined Above|0|||
105560884|NCT01169675|364048537|FG001|Overall Study|Other Reason Not Defined Above|0|||
105560885|NCT01169675|364048538|FG002|Overall Study|Other Reason Not Defined Above|0|||
105560886|NCT01169675|364048539|FG003|Overall Study|Other Reason Not Defined Above|1|||
105560887|NCT01169675|364048540|FG004|Overall Study|Other Reason Not Defined Above|1|||
105560888|NCT02816138|364048541|FG000|Overall Study|Adverse Event|1|||
105560889|NCT02291679|364048542|FG000|Overall Study|Adverse Event|2|||
105560890|NCT02291679|364048543|FG001|Overall Study|Adverse Event|12|||
105560891|NCT02291679|364048544|FG002|Overall Study|Adverse Event|19|||
105560892|NCT02291679|364048542|FG000|Overall Study|Protocol Violation|5|||
105560893|NCT02291679|364048543|FG001|Overall Study|Protocol Violation|1|||
105560894|NCT02291679|364048544|FG002|Overall Study|Protocol Violation|7|||
105560895|NCT02291679|364048542|FG000|Overall Study|Withdrew Consent|18|||
105560896|NCT02291679|364048543|FG001|Overall Study|Withdrew Consent|10|||
105560897|NCT02291679|364048544|FG002|Overall Study|Withdrew Consent|15|||
105560898|NCT02291679|364048542|FG000|Overall Study|Lost to Follow-up|12|||
105560899|NCT02291679|364048543|FG001|Overall Study|Lost to Follow-up|10|||
105560900|NCT02291679|364048544|FG002|Overall Study|Lost to Follow-up|9|||
105560901|NCT02291679|364048542|FG000|Overall Study|Insufficient Therapeutic Response|5|||
105560902|NCT02291679|364048543|FG001|Overall Study|Insufficient Therapeutic Response|5|||
105560903|NCT02291679|364048544|FG002|Overall Study|Insufficient Therapeutic Response|7|||
105560904|NCT02291679|364048542|FG000|Overall Study|Other|2|||
105560905|NCT02291679|364048543|FG001|Overall Study|Other|4|||
105560906|NCT02291679|364048544|FG002|Overall Study|Other|2|||
105560907|NCT03657277|364048545|FG000|Overall Study|Physician Decision|2|||
105560908|NCT03657277|364048545|FG000|Overall Study|Lost to Follow-up|1|||
105560909|NCT03657277|364048545|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
105560910|NCT01024608|364048546|FG000|Overall Study|Adverse Event|1|||
105560911|NCT01024608|364048547|FG001|Overall Study|Adverse Event|0|||
105560912|NCT01024608|364048546|FG000|Overall Study|Withdrawal by Subject|1|||
105560913|NCT01024608|364048547|FG001|Overall Study|Withdrawal by Subject|0|||
105560914|NCT01024608|364048546|FG000|Overall Study|Lost to Follow-up|0|||
105560915|NCT01024608|364048547|FG001|Overall Study|Lost to Follow-up|1|||
105560916|NCT01024608|364048546|FG000|Overall Study|Protocol Violation|0|||
105560917|NCT01024608|364048547|FG001|Overall Study|Protocol Violation|3|||
105560918|NCT01024608|364048546|FG000|Overall Study|Never received study treatment|2|||
105560919|NCT01024608|364048547|FG001|Overall Study|Never received study treatment|0|||
105560920|NCT01951625|364048550|FG000|Treatment Period|Protocol Violation|2|||
105560921|NCT01951625|364048551|FG001|Treatment Period|Protocol Violation|0|||
105560922|NCT01951625|364048552|FG002|Treatment Period|Protocol Violation|1|||
105560923|NCT01951625|364048553|FG003|Treatment Period|Protocol Violation|3|||
105560924|NCT01951625|364048554|FG004|Treatment Period|Protocol Violation|2|||
105560925|NCT01951625|364048550|FG000|Treatment Period|Physician Decision|0|||
105560926|NCT01951625|364048551|FG001|Treatment Period|Physician Decision|0|||
105560927|NCT01951625|364048552|FG002|Treatment Period|Physician Decision|0|||
105560928|NCT01951625|364048553|FG003|Treatment Period|Physician Decision|0|||
105560929|NCT01951625|364048554|FG004|Treatment Period|Physician Decision|1|||
105560930|NCT01951625|364048550|FG000|Treatment Period|Protocol driven decision point|0|||
105560931|NCT01951625|364048551|FG001|Treatment Period|Protocol driven decision point|5|||
105560932|NCT01951625|364048552|FG002|Treatment Period|Protocol driven decision point|0|||
105560933|NCT01951625|364048553|FG003|Treatment Period|Protocol driven decision point|2|||
105560934|NCT01951625|364048554|FG004|Treatment Period|Protocol driven decision point|1|||
105560935|NCT01951625|364048550|FG000|Treatment Period|Non compliance with study drug|1|||
105560936|NCT01951625|364048551|FG001|Treatment Period|Non compliance with study drug|2|||
105560937|NCT01951625|364048552|FG002|Treatment Period|Non compliance with study drug|2|||
105560938|NCT01951625|364048553|FG003|Treatment Period|Non compliance with study drug|0|||
105560939|NCT01951625|364048554|FG004|Treatment Period|Non compliance with study drug|0|||
105560940|NCT01951625|364048550|FG000|Treatment Period|Death|3|||
105560941|NCT01951625|364048551|FG001|Treatment Period|Death|2|||
105560942|NCT01951625|364048552|FG002|Treatment Period|Death|2|||
105710978|NCT00848354|364601468|FG000|Phase 2 Year 2|Failed to return|3|||
105710979|NCT00848354|364601469|FG001|Phase 2 Year 2|Failed to return|0|||
105710980|NCT00848354|364601468|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
105710981|NCT00848354|364601469|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
105710982|NCT00848354|364601468|FG000|Phase 2 Year 2|Unspecified Reason|1|||
105710983|NCT00848354|364601469|FG001|Phase 2 Year 2|Unspecified Reason|0|||
105710984|NCT00848354|364601468|FG000|Phase 2 Year 2|Protocol Violation|1|||
105710985|NCT00848354|364601469|FG001|Phase 2 Year 2|Protocol Violation|1|||
105710986|NCT00848354|364601468|FG000|Phase 2 Year 2|Subject Request|1|||
105710987|NCT00848354|364601469|FG001|Phase 2 Year 2|Subject Request|1|||
105710988|NCT00848354|364601468|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
105710989|NCT00848354|364601469|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
105710990|NCT01972074|364601470|FG000|Overall Study|Adverse Event|4|||
105710991|NCT01972074|364601471|FG001|Overall Study|Adverse Event|1|||
105710992|NCT01972074|364601472|FG002|Overall Study|Adverse Event|0|||
105710993|NCT01972074|364601470|FG000|Overall Study|Lack of Efficacy|1|||
105710994|NCT01972074|364601471|FG001|Overall Study|Lack of Efficacy|1|||
105710995|NCT01972074|364601472|FG002|Overall Study|Lack of Efficacy|0|||
105806511|NCT03038113|364949005|FG005|Overall Study|Withdrawal by Subject|0|||
105710996|NCT01972074|364601470|FG000|Overall Study|Lost to Follow-up|0|||
105710997|NCT01972074|364601471|FG001|Overall Study|Lost to Follow-up|1|||
105710998|NCT01972074|364601472|FG002|Overall Study|Lost to Follow-up|1|||
105710999|NCT01972074|364601470|FG000|Overall Study|Withdrawal by Subject|1|||
105560943|NCT01951625|364048553|FG003|Treatment Period|Death|1|||
105560944|NCT01951625|364048554|FG004|Treatment Period|Death|2|||
105560945|NCT01951625|364048550|FG000|Treatment Period|Adverse Event|7|||
105560946|NCT01951625|364048551|FG001|Treatment Period|Adverse Event|10|||
105560947|NCT01951625|364048552|FG002|Treatment Period|Adverse Event|9|||
105560948|NCT01951625|364048553|FG003|Treatment Period|Adverse Event|8|||
105560949|NCT01951625|364048554|FG004|Treatment Period|Adverse Event|8|||
105560950|NCT01951625|364048550|FG000|Treatment Period|Withdrawal by Subject|5|||
105560951|NCT01951625|364048551|FG001|Treatment Period|Withdrawal by Subject|2|||
105560952|NCT01951625|364048552|FG002|Treatment Period|Withdrawal by Subject|1|||
105560953|NCT01951625|364048553|FG003|Treatment Period|Withdrawal by Subject|7|||
105560954|NCT01951625|364048554|FG004|Treatment Period|Withdrawal by Subject|3|||
105560955|NCT01951625|364048550|FG000|Treatment Period|Lost to Follow-up|1|||
105560956|NCT01951625|364048551|FG001|Treatment Period|Lost to Follow-up|0|||
105560957|NCT01951625|364048552|FG002|Treatment Period|Lost to Follow-up|0|||
105560958|NCT01951625|364048553|FG003|Treatment Period|Lost to Follow-up|1|||
105560959|NCT01951625|364048554|FG004|Treatment Period|Lost to Follow-up|0|||
105560960|NCT01951625|364048550|FG000|Follow Up Period|Non-compliance with study drug|1|||
105560961|NCT01951625|364048551|FG001|Follow Up Period|Non-compliance with study drug|0|||
105560962|NCT01951625|364048552|FG002|Follow Up Period|Non-compliance with study drug|0|||
105560963|NCT01951625|364048553|FG003|Follow Up Period|Non-compliance with study drug|0|||
105560964|NCT01951625|364048554|FG004|Follow Up Period|Non-compliance with study drug|0|||
105560965|NCT01951625|364048550|FG000|Follow Up Period|Death|1|||
105560966|NCT01951625|364048551|FG001|Follow Up Period|Death|3|||
105560967|NCT01951625|364048552|FG002|Follow Up Period|Death|2|||
105560968|NCT01951625|364048553|FG003|Follow Up Period|Death|2|||
105560969|NCT01951625|364048554|FG004|Follow Up Period|Death|1|||
105560970|NCT01951625|364048550|FG000|Follow Up Period|Logistical difficulties|1|||
105560971|NCT01951625|364048551|FG001|Follow Up Period|Logistical difficulties|2|||
105560972|NCT01951625|364048552|FG002|Follow Up Period|Logistical difficulties|0|||
105560973|NCT01951625|364048553|FG003|Follow Up Period|Logistical difficulties|0|||
105560974|NCT01951625|364048554|FG004|Follow Up Period|Logistical difficulties|0|||
105560975|NCT01951625|364048550|FG000|Follow Up Period|Adverse Event|0|||
105560976|NCT01951625|364048551|FG001|Follow Up Period|Adverse Event|3|||
105560977|NCT01951625|364048552|FG002|Follow Up Period|Adverse Event|2|||
105560978|NCT01951625|364048553|FG003|Follow Up Period|Adverse Event|3|||
105560979|NCT01951625|364048554|FG004|Follow Up Period|Adverse Event|5|||
105560980|NCT01951625|364048550|FG000|Follow Up Period|Withdrawal by Subject|4|||
105560981|NCT01951625|364048551|FG001|Follow Up Period|Withdrawal by Subject|1|||
105560982|NCT01951625|364048552|FG002|Follow Up Period|Withdrawal by Subject|0|||
105560983|NCT01951625|364048553|FG003|Follow Up Period|Withdrawal by Subject|5|||
105560984|NCT01951625|364048554|FG004|Follow Up Period|Withdrawal by Subject|3|||
105560985|NCT01951625|364048550|FG000|Follow Up Period|Lost to Follow-up|1|||
105560986|NCT01951625|364048551|FG001|Follow Up Period|Lost to Follow-up|0|||
105560987|NCT01951625|364048552|FG002|Follow Up Period|Lost to Follow-up|0|||
105560988|NCT01951625|364048553|FG003|Follow Up Period|Lost to Follow-up|1|||
105560989|NCT01951625|364048554|FG004|Follow Up Period|Lost to Follow-up|1|||
105560990|NCT05073133|364048555|FG000|Overall Study|Death|2|||
105560991|NCT01377480|364050338|FG000|Overall Study|Protocol Violation|0|||
105560992|NCT01377480|364050339|FG001|Overall Study|Protocol Violation|0|||
105560993|NCT01377480|364050340|FG002|Overall Study|Protocol Violation|0|||
105560994|NCT01377480|364050341|FG003|Overall Study|Protocol Violation|4|||
105560995|NCT01377480|364050338|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
105560996|NCT01377480|364050339|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
105560997|NCT01377480|364050340|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
105560998|NCT01377480|364050341|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
105560999|NCT01377480|364050338|FG000|Overall Study|Withdrawal by Subject|0|||
105561000|NCT01377480|364050339|FG001|Overall Study|Withdrawal by Subject|0|||
105561001|NCT01377480|364050340|FG002|Overall Study|Withdrawal by Subject|1|||
105561002|NCT01377480|364050341|FG003|Overall Study|Withdrawal by Subject|0|||
105561003|NCT01377480|364050338|FG000|Overall Study|Serious adverse event|0|||
105561004|NCT01377480|364050339|FG001|Overall Study|Serious adverse event|0|||
105561005|NCT01377480|364050340|FG002|Overall Study|Serious adverse event|1|||
105561006|NCT01377480|364050341|FG003|Overall Study|Serious adverse event|1|||
105561007|NCT01377480|364050338|FG000|Overall Study|Other|0|||
105561008|NCT01377480|364050339|FG001|Overall Study|Other|0|||
105351440|NCT00070564|363291971|FG005|Overall Study|Adverse Event|36|||
105351441|NCT00070564|363291966|FG000|Overall Study|Death|4|||
105351442|NCT00070564|363291967|FG001|Overall Study|Death|1|||
105351443|NCT00070564|363291968|FG002|Overall Study|Death|5|||
105351444|NCT00070564|363291969|FG003|Overall Study|Death|3|||
105351445|NCT00070564|363291970|FG004|Overall Study|Death|0|||
105351446|NCT00070564|363291971|FG005|Overall Study|Death|1|||
105351447|NCT00070564|363291966|FG000|Overall Study|Other, not protocol specified|17|||
105351448|NCT00070564|363291967|FG001|Overall Study|Other, not protocol specified|15|||
105351449|NCT00070564|363291968|FG002|Overall Study|Other, not protocol specified|14|||
105351450|NCT00070564|363291969|FG003|Overall Study|Other, not protocol specified|19|||
105351451|NCT00070564|363291970|FG004|Overall Study|Other, not protocol specified|6|||
105351452|NCT00070564|363291971|FG005|Overall Study|Other, not protocol specified|7|||
105351453|NCT00070564|363291966|FG000|Overall Study|Withdrawal by Subject|26|||
105351454|NCT00070564|363291967|FG001|Overall Study|Withdrawal by Subject|37|||
105351455|NCT00070564|363291968|FG002|Overall Study|Withdrawal by Subject|23|||
105351456|NCT00070564|363291969|FG003|Overall Study|Withdrawal by Subject|30|||
105475253|NCT04270370|363751329|FG004|Overall Study|Lost to Follow-up|0|||
105475254|NCT04270370|363751330|FG005|Overall Study|Lost to Follow-up|0|||
105475255|NCT04270370|363751331|FG006|Overall Study|Lost to Follow-up|0|||
105475256|NCT04270370|363751332|FG007|Overall Study|Lost to Follow-up|0|||
105475257|NCT04270370|363751333|FG008|Overall Study|Lost to Follow-up|1|||
105475258|NCT04270370|363751334|FG009|Overall Study|Lost to Follow-up|0|||
105475259|NCT04270370|363751335|FG010|Overall Study|Lost to Follow-up|0|||
105475260|NCT04270370|363751336|FG011|Overall Study|Lost to Follow-up|0|||
105475261|NCT01324141|363751337|FG000|Overall Study|Declined to participate before treatment started|1|||
105475262|NCT01324141|363751337|FG000|Overall Study|Disease progression on study|1|||
105475263|NCT00750152|363751338|FG000|Overall Study|Adverse Event|2|||
105475264|NCT00750152|363751339|FG001|Overall Study|Adverse Event|1|||
105475265|NCT00750152|363751338|FG000|Overall Study|Lost to Follow-up|8|||
105475266|NCT00750152|363751339|FG001|Overall Study|Lost to Follow-up|13|||
105475267|NCT00750152|363751338|FG000|Overall Study|Withdrawal by Subject|3|||
105475268|NCT00750152|363751339|FG001|Overall Study|Withdrawal by Subject|3|||
105475269|NCT00750152|363751338|FG000|Overall Study|Physician Decision|1|||
105475270|NCT00750152|363751339|FG001|Overall Study|Physician Decision|1|||
105475271|NCT00750152|363751338|FG000|Overall Study|Non-compliance|0|||
105475272|NCT00750152|363751339|FG001|Overall Study|Non-compliance|1|||
105475273|NCT00750152|363751338|FG000|Overall Study|Termination by sponsor|1|||
105475274|NCT00750152|363751339|FG001|Overall Study|Termination by sponsor|0|||
105475275|NCT00750152|363751338|FG000|Overall Study|Other|7|||
105475276|NCT00750152|363751339|FG001|Overall Study|Other|8|||
105475277|NCT00715910|363751346|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
105475278|NCT00715910|363751347|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
105475279|NCT00715910|363751348|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
105475280|NCT00715910|363751349|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
105475281|NCT00715910|363751350|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
105475282|NCT00715910|363751351|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
105475283|NCT00715910|363751346|FG000|Booster and ESFU Phase|Other|0|||
105475284|NCT00715910|363751347|FG001|Booster and ESFU Phase|Other|0|||
105475285|NCT00715910|363751348|FG002|Booster and ESFU Phase|Other|0|||
105475286|NCT00715910|363751349|FG003|Booster and ESFU Phase|Other|5|||
105475287|NCT00715910|363751350|FG004|Booster and ESFU Phase|Other|1|||
105475288|NCT00715910|363751351|FG005|Booster and ESFU Phase|Other|0|||
105475289|NCT01097005|363751360|FG000|Overall Study|Case Report Form not collected|18|||
105475290|NCT01097005|363751360|FG000|Overall Study|Subjects cannot visit the hospital|1|||
105475291|NCT01097005|363751360|FG000|Overall Study|Poor medication compliance|1|||
105475292|NCT01097005|363751360|FG000|Overall Study|No examination data available|244|||
105475293|NCT01097005|363751360|FG000|Overall Study|Deviation from exclusion criteria|37|||
105475294|NCT01097005|363751360|FG000|Overall Study|Adverse Event|14|||
105475295|NCT01097005|363751360|FG000|Overall Study|Discontinuance by complication|50|||
105475296|NCT03425253|363751363|FG000|Overall Study|Adverse Event|2|||
105475297|NCT03425253|363751363|FG000|Overall Study|Lost to Follow-up|3|||
105475298|NCT03425253|363751363|FG000|Overall Study|Withdrew Consent|6|||
105475299|NCT03425253|363751363|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
105475300|NCT03844945|363753299|FG000|Overall Study|Adverse Event|1|||
105475301|NCT03844945|363753300|FG001|Overall Study|Adverse Event|1|||
105475302|NCT03844945|363753301|FG002|Overall Study|Adverse Event|4|||
105475303|NCT03844945|363753302|FG003|Overall Study|Adverse Event|0|||
105475304|NCT03844945|363753299|FG000|Overall Study|Withdrawal by Subject|0|||
105351457|NCT00070564|363291970|FG004|Overall Study|Withdrawal by Subject|8|||
105475305|NCT03844945|363753300|FG001|Overall Study|Withdrawal by Subject|0|||
105475306|NCT03844945|363753301|FG002|Overall Study|Withdrawal by Subject|1|||
105475307|NCT03844945|363753302|FG003|Overall Study|Withdrawal by Subject|0|||
105475308|NCT03844945|363753299|FG000|Overall Study|Lack of Efficacy|0|||
105475309|NCT03844945|363753300|FG001|Overall Study|Lack of Efficacy|0|||
105475310|NCT03844945|363753301|FG002|Overall Study|Lack of Efficacy|0|||
105475311|NCT03844945|363753302|FG003|Overall Study|Lack of Efficacy|1|||
105561009|NCT01377480|364050340|FG002|Overall Study|Other|7|||
105351458|NCT00070564|363291971|FG005|Overall Study|Withdrawal by Subject|8|||
105351459|NCT00070564|363291966|FG000|Overall Study|Not reported|0|||
105351460|NCT00070564|363291967|FG001|Overall Study|Not reported|0|||
105351461|NCT00070564|363291968|FG002|Overall Study|Not reported|0|||
105351462|NCT00070564|363291969|FG003|Overall Study|Not reported|0|||
105351463|NCT00070564|363291970|FG004|Overall Study|Not reported|1|||
105351464|NCT00070564|363291971|FG005|Overall Study|Not reported|0|||
105351465|NCT03077607|363291972|FG000|Period 1 (15 Days)|Adverse Event|1|||
105351466|NCT03077607|363291973|FG001|Period 1 (15 Days)|Adverse Event|0|||
105351467|NCT03077607|363291972|FG000|Period 1 (15 Days)|Death|1|||
105351468|NCT03077607|363291973|FG001|Period 1 (15 Days)|Death|0|||
105351469|NCT03077607|363291972|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
105351470|NCT03077607|363291973|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
105351471|NCT03077607|363291972|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
105351472|NCT03077607|363291973|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
105351473|NCT01006590|363291974|FG000|Overall Study|Adverse Event|2|||
105351474|NCT01006590|363291975|FG001|Overall Study|Adverse Event|3|||
105351475|NCT01006590|363291974|FG000|Overall Study|Death|1|||
105351476|NCT01006590|363291975|FG001|Overall Study|Death|1|||
105351477|NCT01006590|363291974|FG000|Overall Study|Lost to Follow-up|1|||
105351478|NCT01006590|363291975|FG001|Overall Study|Lost to Follow-up|1|||
105351479|NCT01006590|363291974|FG000|Overall Study|Protocol Violation|1|||
105351480|NCT01006590|363291975|FG001|Overall Study|Protocol Violation|0|||
105351481|NCT01006590|363291974|FG000|Overall Study|Withdrawal by Subject|4|||
105351482|NCT01006590|363291975|FG001|Overall Study|Withdrawal by Subject|2|||
105351483|NCT01006590|363291974|FG000|Overall Study|Study specific discontinuation criteria|16|||
105351484|NCT01006590|363291975|FG001|Overall Study|Study specific discontinuation criteria|23|||
105351485|NCT01006590|363291974|FG000|Overall Study|Other|3|||
105351486|NCT01006590|363291975|FG001|Overall Study|Other|2|||
105351487|NCT00482170|363291992|FG000|Overall Study|Adverse Event|5|||
105351488|NCT00482170|363291993|FG001|Overall Study|Adverse Event|14|||
105351489|NCT00482170|363291992|FG000|Overall Study|Withdrawal by Subject|6|||
105351490|NCT00482170|363291993|FG001|Overall Study|Withdrawal by Subject|1|||
105351491|NCT00482170|363291992|FG000|Overall Study|Protocol Violation|2|||
105351492|NCT00482170|363291993|FG001|Overall Study|Protocol Violation|3|||
105351493|NCT00482170|363291992|FG000|Overall Study|Lost to Follow-up|2|||
105351494|NCT00482170|363291993|FG001|Overall Study|Lost to Follow-up|0|||
105351495|NCT00482170|363291992|FG000|Overall Study|Unspecified reason|0|||
105351496|NCT00482170|363291993|FG001|Overall Study|Unspecified reason|2|||
105351497|NCT00592592|363291994|FG000|Overall Study|Patient found ineligible upon chart review|1|||
105351498|NCT00703118|363291995|FG000|Overall Study|Adverse Event|1|||
105351499|NCT00703118|363291996|FG001|Overall Study|Adverse Event|2|||
105351500|NCT00703118|363291997|FG002|Overall Study|Adverse Event|2|||
105351501|NCT00703118|363291995|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
105351502|NCT00703118|363291996|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
105351503|NCT00703118|363291997|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
105351504|NCT00703118|363291995|FG000|Overall Study|Lost to Follow-up|6|||
105351505|NCT00703118|363291996|FG001|Overall Study|Lost to Follow-up|4|||
105351506|NCT00703118|363291997|FG002|Overall Study|Lost to Follow-up|4|||
105351507|NCT00703118|363291995|FG000|Overall Study|Withdrawal by Subject|8|||
105351508|NCT00703118|363291996|FG001|Overall Study|Withdrawal by Subject|7|||
105351509|NCT00703118|363291997|FG002|Overall Study|Withdrawal by Subject|13|||
105351510|NCT00703118|363291995|FG000|Overall Study|Other|0|||
105351511|NCT00703118|363291996|FG001|Overall Study|Other|0|||
105351512|NCT00703118|363291997|FG002|Overall Study|Other|1|||
105351513|NCT01618916|363291998|FG000|Overall Study|Adverse Event|1|||
105351514|NCT01618916|363291999|FG001|Overall Study|Adverse Event|0|||
105351515|NCT01618916|363292000|FG002|Overall Study|Adverse Event|0|||
105351516|NCT01618916|363292001|FG003|Overall Study|Adverse Event|0|||
105351517|NCT01618916|363292002|FG004|Overall Study|Adverse Event|0|||
105351518|NCT01618916|363292003|FG005|Overall Study|Adverse Event|0|||
105351519|NCT01618916|363291998|FG000|Overall Study|Withdrawal by Subject|0|||
105351520|NCT01618916|363291999|FG001|Overall Study|Withdrawal by Subject|1|||
105351521|NCT01618916|363292000|FG002|Overall Study|Withdrawal by Subject|1|||
105351522|NCT01618916|363292001|FG003|Overall Study|Withdrawal by Subject|0|||
105351523|NCT01618916|363292002|FG004|Overall Study|Withdrawal by Subject|1|||
105351524|NCT01618916|363292003|FG005|Overall Study|Withdrawal by Subject|0|||
105351525|NCT01618916|363291998|FG000|Overall Study|Lost to Follow-up|1|||
105351526|NCT01618916|363291999|FG001|Overall Study|Lost to Follow-up|0|||
105788113|NCT03426995|364878225|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105351527|NCT01618916|363292000|FG002|Overall Study|Lost to Follow-up|0|||
105351528|NCT01618916|363292001|FG003|Overall Study|Lost to Follow-up|2|||
105351529|NCT01618916|363292002|FG004|Overall Study|Lost to Follow-up|0|||
105351530|NCT01618916|363292003|FG005|Overall Study|Lost to Follow-up|0|||
105351531|NCT01853696|363292004|FG000|Overall Study|Withdrawal by Subject|1|||
105351532|NCT01853696|363292005|FG001|Overall Study|Withdrawal by Subject|1|||
105351533|NCT01853696|363292004|FG000|Overall Study|Lost to Follow-up|5|||
105351534|NCT01853696|363292005|FG001|Overall Study|Lost to Follow-up|4|||
105475312|NCT02160899|363753307|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
105475313|NCT02160899|363753308|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
105475314|NCT02160899|363753309|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
105475315|NCT02160899|363753310|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
105475316|NCT02160899|363753311|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
105475317|NCT02160899|363753312|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
105475318|NCT04129151|363753313|FG000|Overall Study|Adverse Event|1|||
105475319|NCT04129151|363753313|FG000|Overall Study|Disease Progression|7|||
105475320|NCT04129151|363753313|FG000|Overall Study|Study closure|1|||
105475321|NCT02051933|363753316|FG000|Overall Study|Physician Decision|0|||
105475322|NCT02051933|363753317|FG001|Overall Study|Physician Decision|1|||
105475323|NCT00798759|363753318|FG000|Overall Study|Adverse Event|3|||
105475324|NCT00798759|363753319|FG001|Overall Study|Adverse Event|3|||
105475325|NCT00798759|363753318|FG000|Overall Study|Lost to Follow-up|1|||
105475326|NCT00798759|363753319|FG001|Overall Study|Lost to Follow-up|1|||
105475327|NCT00798759|363753318|FG000|Overall Study|Protocol Violation|4|||
105475328|NCT00798759|363753319|FG001|Overall Study|Protocol Violation|8|||
105475329|NCT00798759|363753318|FG000|Overall Study|Other|0|||
105475330|NCT00798759|363753319|FG001|Overall Study|Other|1|||
105475331|NCT00095940|363753320|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
105475332|NCT00095940|363753321|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
105475333|NCT00095940|363753322|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
105475334|NCT00095940|363753323|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
105351535|NCT02005627|363292008|FG000|Overall Study|Lost to Follow-up|1|||
105351536|NCT02005627|363292009|FG001|Overall Study|Lost to Follow-up|2|||
105351537|NCT02005627|363292008|FG000|Overall Study|Withdrawal by Subject|1|||
105351538|NCT02005627|363292009|FG001|Overall Study|Withdrawal by Subject|2|||
105351539|NCT00269477|363292014|FG000|Overall Study|Protocol Violation|5|||
105351540|NCT00269477|363292015|FG001|Overall Study|Protocol Violation|5|||
105351541|NCT00269477|363292016|FG002|Overall Study|Protocol Violation|1|||
105351542|NCT00269477|363292017|FG003|Overall Study|Protocol Violation|0|||
105351543|NCT00269477|363292014|FG000|Overall Study|Missed post-vaccination blood draw|0|||
105351544|NCT00269477|363292015|FG001|Overall Study|Missed post-vaccination blood draw|1|||
105351545|NCT00269477|363292016|FG002|Overall Study|Missed post-vaccination blood draw|0|||
105351546|NCT00269477|363292017|FG003|Overall Study|Missed post-vaccination blood draw|0|||
105351547|NCT00431067|363292018|FG000|Overall Study|Other Adverse Event|9|||
105351548|NCT00431067|363292018|FG000|Overall Study|Progressive disease|30|||
105351549|NCT00431067|363292018|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
105351550|NCT01084538|363292027|FG000|Overall Study|Drug not available|30|||
105351551|NCT01084538|363292027|FG000|Overall Study|Adverse Event|9|||
105351552|NCT01084538|363292027|FG000|Overall Study|Kidney transplant|6|||
105475335|NCT00095940|363753324|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
105475336|NCT00095940|363753325|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
105475337|NCT00095940|363753326|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
105475338|NCT00095940|363753327|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
105475339|NCT00095940|363753328|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
105475340|NCT00095940|363753320|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
105475341|NCT00095940|363753321|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
105475342|NCT00095940|363753322|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
105475343|NCT00095940|363753323|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
105475344|NCT00095940|363753324|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
105475345|NCT00095940|363753325|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
105475346|NCT00095940|363753326|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
105475347|NCT00095940|363753327|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
105475348|NCT00095940|363753328|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
105475349|NCT00095940|363753320|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
105475350|NCT00095940|363753321|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
105475351|NCT00095940|363753322|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
105475352|NCT00095940|363753323|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
105475353|NCT00095940|363753324|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
105475354|NCT00095940|363753325|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
105475355|NCT00095940|363753326|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
105475356|NCT00095940|363753327|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
105475357|NCT00095940|363753328|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
105475358|NCT00373113|363753330|FG000|Overall Study|Death|1|||
105475359|NCT00373113|363753331|FG001|Overall Study|Death|7|||
105475360|NCT00373113|363753330|FG000|Overall Study|Adverse Event|38|||
105475361|NCT00373113|363753331|FG001|Overall Study|Adverse Event|24|||
105475362|NCT00373113|363753330|FG000|Overall Study|Study terminated by sponsor|9|||
105475363|NCT00373113|363753331|FG001|Overall Study|Study terminated by sponsor|1|||
105475364|NCT00373113|363753330|FG000|Overall Study|Global deterioration of health status|10|||
105475365|NCT00373113|363753331|FG001|Overall Study|Global deterioration of health status|7|||
105475366|NCT00373113|363753330|FG000|Overall Study|Lost to Follow-up|1|||
105475367|NCT00373113|363753331|FG001|Overall Study|Lost to Follow-up|3|||
105475368|NCT00373113|363753330|FG000|Overall Study|Objective progression or relapse|150|||
105475369|NCT00373113|363753331|FG001|Overall Study|Objective progression or relapse|169|||
105475370|NCT00373113|363753330|FG000|Overall Study|Other|14|||
105475371|NCT00373113|363753331|FG001|Overall Study|Other|17|||
105475372|NCT00373113|363753330|FG000|Overall Study|Protocol Violation|5|||
105475373|NCT00373113|363753331|FG001|Overall Study|Protocol Violation|1|||
105475374|NCT00373113|363753330|FG000|Overall Study|Withdrawal by Subject|10|||
105475375|NCT00373113|363753331|FG001|Overall Study|Withdrawal by Subject|15|||
105475376|NCT04248491|363753332|FG000|Overall Study|Lost to Follow-up|1|||
105475377|NCT04248491|363753333|FG001|Overall Study|Lost to Follow-up|0|||
105475378|NCT00444678|363753340|FG000|Overall Study|Toxicity|11|||
105475379|NCT00444678|363753340|FG000|Overall Study|Disease Progression|12|||
105475380|NCT00444678|363753340|FG000|Overall Study|Death|3|||
105475381|NCT00444678|363753340|FG000|Overall Study|Physician Decision|3|||
105475382|NCT00444678|363753340|FG000|Overall Study|Withdrawal by Subject|2|||
105475383|NCT00606905|363753341|FG000|Overall Study|No Pregnancy|9|||
105475384|NCT00606905|363753342|FG001|Overall Study|No Pregnancy|6|||
105475385|NCT00606905|363753341|FG000|Overall Study|Non-Index Pregnancy|1|||
105475386|NCT00606905|363753342|FG001|Overall Study|Non-Index Pregnancy|4|||
105475387|NCT00606905|363753341|FG000|Overall Study|Withdrew|5|||
105475388|NCT00606905|363753342|FG001|Overall Study|Withdrew|5|||
105561010|NCT01377480|364050341|FG003|Overall Study|Other|6|||
105351553|NCT01084538|363292027|FG000|Overall Study|Serious Adverse Event|3|||
105475389|NCT01727024|363753362|FG000|Period 1|Lost to Follow-up|1|||
105351554|NCT01084538|363292027|FG000|Overall Study|Lack of effectiveness|2|||
105351555|NCT01084538|363292027|FG000|Overall Study|Patient noncompliance|2|||
105351556|NCT01084538|363292027|FG000|Overall Study|Hyperphosphatemia|2|||
105351557|NCT01084538|363292027|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
105351558|NCT01084538|363292027|FG000|Overall Study|Change of residence|2|||
105351559|NCT01084538|363292027|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
105351560|NCT01084538|363292027|FG000|Overall Study|Reason unknown|8|||
105351561|NCT00073008|363292032|FG000|Overall Study|Missing|6|||
105351562|NCT00073008|363292033|FG001|Overall Study|Missing|6|||
105561011|NCT00593567|364050342|FG000|Overall Study|Adverse Event|2|||
105561012|NCT00593567|364050343|FG001|Overall Study|Adverse Event|0|||
105561013|NCT00593567|364050342|FG000|Overall Study|Physician Decision|2|||
105561014|NCT00593567|364050343|FG001|Overall Study|Physician Decision|0|||
105561015|NCT00593567|364050342|FG000|Overall Study|Protocol Violation|13|||
105561016|NCT00593567|364050343|FG001|Overall Study|Protocol Violation|7|||
105561017|NCT00593567|364050342|FG000|Overall Study|Lack of Efficacy|2|||
105561018|NCT00593567|364050343|FG001|Overall Study|Lack of Efficacy|1|||
105561019|NCT00593567|364050342|FG000|Overall Study|Withdrawal by Subject|1|||
105561020|NCT00593567|364050343|FG001|Overall Study|Withdrawal by Subject|2|||
105561021|NCT03576768|364050346|FG000|Overall Study|Lost to Follow-up|3|||
105561022|NCT03576768|364050347|FG001|Overall Study|Lost to Follow-up|3|||
105561023|NCT03576768|364050348|FG002|Overall Study|Lost to Follow-up|0|||
105561024|NCT03576768|364050349|FG003|Overall Study|Lost to Follow-up|0|||
105351563|NCT00073008|363292032|FG000|Overall Study|Withdrawal by Subject|2|||
105351564|NCT00073008|363292033|FG001|Overall Study|Withdrawal by Subject|2|||
105351565|NCT00073008|363292032|FG000|Overall Study|Lost to Follow-up|1|||
105475390|NCT01727024|363753363|FG001|Period 1|Lost to Follow-up|1|||
105475391|NCT01727024|363753362|FG000|Period 1|Withdrawal by Subject|2|||
105475392|NCT01727024|363753363|FG001|Period 1|Withdrawal by Subject|3|||
105475393|NCT05194579|363753366|FG000|Overall Study|Lost to Follow-up|2|||
105475394|NCT05194579|363753367|FG001|Overall Study|Lost to Follow-up|3|||
105475395|NCT05194579|363753366|FG000|Overall Study|Withdrawal by Subject|3|||
105475396|NCT05194579|363753367|FG001|Overall Study|Withdrawal by Subject|4|||
105475397|NCT05194579|363753366|FG000|Overall Study|Refused further study procedures|0|||
105475398|NCT05194579|363753367|FG001|Overall Study|Refused further study procedures|1|||
105475399|NCT05194579|363753366|FG000|Overall Study|Protocol deviation|1|||
105475400|NCT05194579|363753367|FG001|Overall Study|Protocol deviation|0|||
105475401|NCT03890666|363753372|FG000|Overall Study|Withdrawal by Subject|0|||
105475402|NCT03890666|363753373|FG001|Overall Study|Withdrawal by Subject|1|||
105475403|NCT03890666|363753372|FG000|Overall Study|Protocol deviation|1|||
105475404|NCT03890666|363753373|FG001|Overall Study|Protocol deviation|4|||
105475405|NCT03890666|363753372|FG000|Overall Study|Lost to Follow-up|2|||
105475406|NCT03890666|363753373|FG001|Overall Study|Lost to Follow-up|5|||
105475407|NCT03890666|363753372|FG000|Overall Study|Other than specified|1|||
105475408|NCT03890666|363753373|FG001|Overall Study|Other than specified|8|||
105475409|NCT02925416|363753374|FG000|Overall Study|Adverse Event|2|||
105475410|NCT02925416|363753375|FG001|Overall Study|Adverse Event|0|||
105475411|NCT01639729|363753376|FG000|Overall Study|Withdrawal by Subject|1|||
105475412|NCT01639729|363753377|FG001|Overall Study|Withdrawal by Subject|0|||
105475413|NCT01639729|363753378|FG002|Overall Study|Withdrawal by Subject|1|||
105475414|NCT01639729|363753379|FG003|Overall Study|Withdrawal by Subject|1|||
105475415|NCT01639729|363753380|FG004|Overall Study|Withdrawal by Subject|0|||
105475416|NCT01639729|363753381|FG005|Overall Study|Withdrawal by Subject|0|||
105475417|NCT03052426|363753384|FG000|Overall Study|Withdrawal by Subject|0|||
105475418|NCT03052426|363753385|FG001|Overall Study|Withdrawal by Subject|1|||
105475419|NCT03052426|363753386|FG002|Overall Study|Withdrawal by Subject|0|||
105475420|NCT03052426|363753384|FG000|Overall Study|Lost to Follow-up|2|||
105475421|NCT03052426|363753385|FG001|Overall Study|Lost to Follow-up|0|||
105475422|NCT03052426|363753386|FG002|Overall Study|Lost to Follow-up|1|||
105475423|NCT03083990|363753387|FG000|Overall Study|Adverse Event|1|||
105475424|NCT03083990|363753388|FG001|Overall Study|Adverse Event|0|||
105475425|NCT00984620|363753389|FG000|Overall Study|Adverse Event|5|||
105475426|NCT00984620|363753390|FG001|Overall Study|Adverse Event|5|||
105475427|NCT00984620|363753389|FG000|Overall Study|Lost to Follow-up|1|||
105475428|NCT00984620|363753390|FG001|Overall Study|Lost to Follow-up|1|||
105475429|NCT00984620|363753389|FG000|Overall Study|Withdrawal by Subject|0|||
105475430|NCT00984620|363753390|FG001|Overall Study|Withdrawal by Subject|2|||
105475431|NCT00984620|363753389|FG000|Overall Study|reason other than listed above|0|||
105475432|NCT00984620|363753390|FG001|Overall Study|reason other than listed above|4|||
105475433|NCT01018810|363753391|FG000|Overall Study|Withdrawal by Subject|0|||
105475434|NCT01018810|363753392|FG001|Overall Study|Withdrawal by Subject|1|||
105475435|NCT01018810|363753393|FG002|Overall Study|Withdrawal by Subject|0|||
105475436|NCT01018810|363753394|FG003|Overall Study|Withdrawal by Subject|0|||
105561025|NCT00590902|364050350|FG000|Overall Study|Death|1|||
105475437|NCT01018810|363753395|FG004|Overall Study|Withdrawal by Subject|0|||
105475438|NCT01018810|363753391|FG000|Overall Study|Sponsor Decision|2|||
105475439|NCT01018810|363753392|FG001|Overall Study|Sponsor Decision|0|||
105561026|NCT00785291|364050354|FG000|Overall Study|Never began treatment|8|||
105351566|NCT00073008|363292033|FG001|Overall Study|Lost to Follow-up|3|||
105351567|NCT00073008|363292032|FG000|Overall Study|Death|46|||
105351568|NCT00073008|363292033|FG001|Overall Study|Death|47|||
105351569|NCT00073008|363292032|FG000|Overall Study|"Other selected on Case Report Form"|7|||
105351570|NCT00073008|363292033|FG001|Overall Study|"Other selected on Case Report Form"|5|||
105351571|NCT03337048|363292036|FG000|Overall Study|Withdrawal by Subject|2|||
105351572|NCT03337048|363292037|FG001|Overall Study|Withdrawal by Subject|0|||
105351573|NCT03337048|363292038|FG002|Overall Study|Withdrawal by Subject|0|||
105351574|NCT02791438|363292040|FG000|Treatment Period|Adverse Event|1|||
105351575|NCT02791438|363292041|FG001|Treatment Period|Adverse Event|0|||
105351576|NCT02791438|363292040|FG000|Treatment Period|Withdrawal by Subject|0|||
105351577|NCT02791438|363292041|FG001|Treatment Period|Withdrawal by Subject|1|||
105351578|NCT02791438|363292040|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
105351579|NCT02791438|363292041|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
105351580|NCT01952080|363292044|FG000|Overall Study|Withdrawal by Subject|0|||
105351581|NCT01952080|363292045|FG001|Overall Study|Withdrawal by Subject|0|||
105351582|NCT01952080|363292046|FG002|Overall Study|Withdrawal by Subject|0|||
105351583|NCT01952080|363292047|FG003|Overall Study|Withdrawal by Subject|1|||
105351584|NCT01952080|363292044|FG000|Overall Study|Protocol Non-compliance|0|||
105351585|NCT01952080|363292045|FG001|Overall Study|Protocol Non-compliance|1|||
105351586|NCT01952080|363292046|FG002|Overall Study|Protocol Non-compliance|0|||
105475440|NCT01018810|363753393|FG002|Overall Study|Sponsor Decision|1|||
105475441|NCT01018810|363753394|FG003|Overall Study|Sponsor Decision|1|||
105475442|NCT01018810|363753395|FG004|Overall Study|Sponsor Decision|1|||
105475443|NCT04145219|363753396|FG000|Overall Study|Adverse Event|18|||
105475444|NCT04145219|363753397|FG001|Overall Study|Adverse Event|6|||
105475445|NCT04145219|363753396|FG000|Overall Study|Lost to Follow-up|2|||
105475446|NCT04145219|363753397|FG001|Overall Study|Lost to Follow-up|3|||
105475447|NCT04145219|363753396|FG000|Overall Study|Physician Decision|0|||
105475448|NCT04145219|363753397|FG001|Overall Study|Physician Decision|2|||
105475449|NCT04145219|363753396|FG000|Overall Study|Withdrawal by Subject|12|||
105475450|NCT04145219|363753397|FG001|Overall Study|Withdrawal by Subject|8|||
105475451|NCT04145219|363753396|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
105475452|NCT04145219|363753397|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
105475453|NCT01640314|363753398|FG000|Overall Study|Protocol Violation|0|||
105475454|NCT01640314|363753399|FG001|Overall Study|Protocol Violation|1|||
105475455|NCT02424578|363753401|FG000|Overall Study|Withdrawal by Subject|0|||
105475456|NCT02424578|363753402|FG001|Overall Study|Withdrawal by Subject|1|||
105475457|NCT00706342|363753407|FG000|Overall Study|Adverse Event|3|||
105475458|NCT00706342|363753407|FG000|Overall Study|Not responding to treatment|2|||
105475459|NCT00706342|363753407|FG000|Overall Study|Withdrawn due to failure to respond|1|||
105475460|NCT00706342|363753407|FG000|Overall Study|Death|1|||
105475461|NCT00706342|363753407|FG000|Overall Study|Withdrew from the study on his own.|1|||
105475462|NCT00706342|363753407|FG000|Overall Study|Investigator discretion|2|||
105475463|NCT00706342|363753407|FG000|Overall Study|Non-responder Week 12|1|||
105475464|NCT00706342|363753407|FG000|Overall Study|Ongoing|6|||
105475465|NCT00706342|363753407|FG000|Overall Study|WIthdrawal of consent|1|||
105475466|NCT00910299|363753409|FG000|Overall Study|Withdrawal by Subject|16|||
105475467|NCT00910299|363753410|FG001|Overall Study|Withdrawal by Subject|13|||
105475468|NCT00910299|363753409|FG000|Overall Study|Sponsor Decision|58|||
105475469|NCT00910299|363753410|FG001|Overall Study|Sponsor Decision|60|||
105475470|NCT00910299|363753409|FG000|Overall Study|Didn't receive any study drug|2|||
105475471|NCT00910299|363753410|FG001|Overall Study|Didn't receive any study drug|1|||
105475472|NCT01419197|363753411|FG000|Overall Study|Death|247|||
105475473|NCT01419197|363753412|FG001|Overall Study|Death|122|||
105475474|NCT01419197|363753411|FG000|Overall Study|Physician Decision|4|||
105475475|NCT01419197|363753412|FG001|Overall Study|Physician Decision|4|||
105475476|NCT01419197|363753411|FG000|Overall Study|Non-compliance|3|||
105475477|NCT01419197|363753412|FG001|Overall Study|Non-compliance|1|||
105475478|NCT01419197|363753411|FG000|Overall Study|Withdrawal by Subject|33|||
105475479|NCT01419197|363753412|FG001|Overall Study|Withdrawal by Subject|32|||
105475480|NCT01419197|363753411|FG000|Overall Study|Study Completed by Sponsor|103|||
105475481|NCT01419197|363753412|FG001|Overall Study|Study Completed by Sponsor|34|||
105475482|NCT01419197|363753411|FG000|Overall Study|Reason Not Specified|0|||
105475483|NCT01419197|363753412|FG001|Overall Study|Reason Not Specified|1|||
105475484|NCT01419197|363753411|FG000|Overall Study|Lost to Follow-up|14|||
105475485|NCT01419197|363753412|FG001|Overall Study|Lost to Follow-up|4|||
105475486|NCT01781299|363753413|FG000|Overall Study|Withdrawal by Subject|0|||
105475487|NCT01781299|363753414|FG001|Overall Study|Withdrawal by Subject|1|||
105475488|NCT00653939|363753419|FG000|Overall Study|Adverse Event|1|||
105475489|NCT00653939|363753420|FG001|Overall Study|Adverse Event|3|||
105475490|NCT00653939|363753419|FG000|Overall Study|Withdrawal by Subject|3|||
105351587|NCT01952080|363292047|FG003|Overall Study|Protocol Non-compliance|0|||
105351588|NCT03172364|363292048|FG000|Overall Study|Adverse Event|1|||
105351589|NCT03172364|363292049|FG001|Overall Study|Adverse Event|1|||
105351590|NCT03172364|363292048|FG000|Overall Study|Protocol Violation|1|||
105475491|NCT00653939|363753420|FG001|Overall Study|Withdrawal by Subject|3|||
105351591|NCT03172364|363292049|FG001|Overall Study|Protocol Violation|0|||
105351592|NCT04503668|363292050|FG000|Overall Study|Incomplete data|4|||
105351593|NCT04503668|363292051|FG001|Overall Study|Incomplete data|3|||
105351594|NCT04503668|363292050|FG000|Overall Study|Withdrawal by Subject|1|||
105351595|NCT04503668|363292051|FG001|Overall Study|Withdrawal by Subject|1|||
105351596|NCT04503668|363292050|FG000|Overall Study|Adverse Event|2|||
105351597|NCT04503668|363292051|FG001|Overall Study|Adverse Event|0|||
105351598|NCT03782974|363292052|FG000|Overall Study|Withdrawal by Subject|7|||
105351599|NCT03782974|363292053|FG001|Overall Study|Withdrawal by Subject|7|||
105351600|NCT03782974|363292052|FG000|Overall Study|Pregnancy|1|||
105351601|NCT03782974|363292053|FG001|Overall Study|Pregnancy|0|||
105351602|NCT02333383|363292055|FG000|Overall Study|Adalimumab discontinuation|21|||
105351603|NCT02333383|363292055|FG000|Overall Study|Lost to Follow-up|15|||
105351604|NCT02333383|363292055|FG000|Overall Study|Withdrawal by Subject|3|||
105351605|NCT02333383|363292055|FG000|Overall Study|Transfer to another hospital|2|||
105351606|NCT01994902|363292056|FG000|Test Period 1|Withdrawal by Subject|3|||
105351607|NCT01994902|363292057|FG001|Test Period 1|Withdrawal by Subject|0|||
105351608|NCT01994902|363292056|FG000|Test Period 1|device deficiency with adverse event|0|||
105351609|NCT01994902|363292057|FG001|Test Period 1|device deficiency with adverse event|1|||
105351610|NCT01994902|363292056|FG000|Test Period 1|Adverse Event|2|||
105711000|NCT01972074|364601471|FG001|Overall Study|Withdrawal by Subject|1|||
105711001|NCT01972074|364601472|FG002|Overall Study|Withdrawal by Subject|1|||
105711002|NCT01972074|364601470|FG000|Overall Study|Scanner Unavailable|0|||
105711003|NCT01972074|364601471|FG001|Overall Study|Scanner Unavailable|0|||
105711004|NCT01972074|364601472|FG002|Overall Study|Scanner Unavailable|1|||
105711005|NCT01496066|364604384|FG000|Overall Study|Lost to Follow-up|8|||
105711006|NCT01496066|364604385|FG001|Overall Study|Lost to Follow-up|5|||
105711007|NCT01496066|364604384|FG000|Overall Study|Explant|3|||
105711008|NCT01496066|364604385|FG001|Overall Study|Explant|0|||
105711009|NCT01496066|364604384|FG000|Overall Study|Death|1|||
105711010|NCT01496066|364604385|FG001|Overall Study|Death|4|||
105711011|NCT02926209|364604386|FG000|Study Cohort|Poor Bowel Preparation|1|||
105711012|NCT02926209|364604387|FG001|Study Cohort|Poor Bowel Preparation|0|||
105711013|NCT00253630|364604388|FG000|Overall Study|ineligible|2|||
105711014|NCT03237065|364604389|FG000|Overall Study|Adverse Event|0|||
105711015|NCT03237065|364604390|FG001|Overall Study|Adverse Event|2|||
105711016|NCT03237065|364604389|FG000|Overall Study|Protocol Violation|0|||
105711017|NCT03237065|364604390|FG001|Overall Study|Protocol Violation|1|||
105711018|NCT03237065|364604389|FG000|Overall Study|Withdrawal by Subject|3|||
105711019|NCT03237065|364604390|FG001|Overall Study|Withdrawal by Subject|0|||
105711020|NCT03237065|364604389|FG000|Overall Study|Lost to Follow-up|1|||
105711021|NCT03237065|364604390|FG001|Overall Study|Lost to Follow-up|0|||
105711022|NCT03237065|364604389|FG000|Overall Study|Unable to obtain venous access|0|||
105711023|NCT03237065|364604390|FG001|Overall Study|Unable to obtain venous access|1|||
105711024|NCT00429858|364604391|FG000|Overall Study|Withdrawal by Subject|1|||
105711025|NCT00429858|364604391|FG000|Overall Study|Study Termination|1|||
105711026|NCT01587079|364604392|FG000|Overall Study|Protocol-specified criteria|9|||
105711027|NCT01587079|364604392|FG000|Overall Study|Protocol Violation|5|||
105711028|NCT01587079|364604392|FG000|Overall Study|Lost to Follow-up|2|||
105711029|NCT01587079|364604392|FG000|Overall Study|Physician Decision|2|||
105711030|NCT01587079|364604392|FG000|Overall Study|Withdrawal by Subject|7|||
105711031|NCT01587079|364604392|FG000|Overall Study|Adverse Event|14|||
105711032|NCT00705939|364604393|FG000|Overall Study|Protocol Violation|0|||
105711033|NCT00705939|364604394|FG001|Overall Study|Protocol Violation|0|||
105711034|NCT00705939|364604395|FG002|Overall Study|Protocol Violation|1|||
105711035|NCT00705939|364604393|FG000|Overall Study|Withdrawal by Subject|0|||
105711036|NCT00705939|364604394|FG001|Overall Study|Withdrawal by Subject|1|||
105711037|NCT00705939|364604395|FG002|Overall Study|Withdrawal by Subject|3|||
105711038|NCT00705939|364604393|FG000|Overall Study|Physician Decision|0|||
105711039|NCT00705939|364604394|FG001|Overall Study|Physician Decision|1|||
105711040|NCT00705939|364604395|FG002|Overall Study|Physician Decision|0|||
105711041|NCT01537211|364604400|FG000|Overall Study|Lost to Follow-up|0|||
105711042|NCT01537211|364604401|FG001|Overall Study|Lost to Follow-up|1|||
105351611|NCT01994902|363292057|FG001|Test Period 1|Adverse Event|1|||
105711043|NCT04418765|364604402|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
105351612|NCT01994902|363292056|FG000|Test Period 1|Lack of Efficacy|0|||
105351613|NCT01994902|363292057|FG001|Test Period 1|Lack of Efficacy|1|||
105351614|NCT01994902|363292056|FG000|Test Period 1|bag too small|1|||
105351615|NCT01994902|363292057|FG001|Test Period 1|bag too small|0|||
105351616|NCT01994902|363292056|FG000|Test Period 2|Withdrawal by Subject|0|||
105475492|NCT00653939|363753419|FG000|Overall Study|Physician Decision|4|||
105711044|NCT04418765|364604403|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
105711045|NCT04418765|364604404|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
105711046|NCT04418765|364604402|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
105711047|NCT04418765|364604403|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
105711048|NCT04418765|364604404|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
105711049|NCT04418765|364604402|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
105351617|NCT01994902|363292057|FG001|Test Period 2|Withdrawal by Subject|2|||
105351618|NCT01994902|363292056|FG000|Test Period 2|Lack of Efficacy|0|||
105351619|NCT01994902|363292057|FG001|Test Period 2|Lack of Efficacy|1|||
105351620|NCT01994902|363292056|FG000|Test Period 2|Other|0|||
105351621|NCT01994902|363292057|FG001|Test Period 2|Other|3|||
105351622|NCT03597139|363292058|FG000|Overall Study|Adverse Event|3|||
105351623|NCT03597139|363292059|FG001|Overall Study|Adverse Event|0|||
105351624|NCT03597139|363292058|FG000|Overall Study|Protocol Non-compliance|1|||
105351625|NCT03597139|363292059|FG001|Overall Study|Protocol Non-compliance|0|||
105351626|NCT00382109|363292060|FG000|Overall Study|Adverse Event|3|||
105351627|NCT00382109|363292061|FG001|Overall Study|Adverse Event|0|||
105351628|NCT00382109|363292060|FG000|Overall Study|Physician Decision|6|||
105351629|NCT00382109|363292061|FG001|Overall Study|Physician Decision|1|||
105351630|NCT00382109|363292060|FG000|Overall Study|Withdrawal by Subject|1|||
105351631|NCT00382109|363292061|FG001|Overall Study|Withdrawal by Subject|0|||
105351632|NCT00382109|363292060|FG000|Overall Study|ineligible|2|||
105351633|NCT00382109|363292061|FG001|Overall Study|ineligible|0|||
105351634|NCT00382109|363292060|FG000|Overall Study|Other|0|||
105351635|NCT00382109|363292061|FG001|Overall Study|Other|2|||
105351636|NCT00382109|363292060|FG000|Overall Study|consent withdrawal|0|||
105351637|NCT00382109|363292061|FG001|Overall Study|consent withdrawal|1|||
105351638|NCT02756364|363292063|FG000|Overall Study|Site Terminated by Sponsor|24|||
105351639|NCT02756364|363292064|FG001|Overall Study|Site Terminated by Sponsor|30|||
105351640|NCT02756364|363292065|FG002|Overall Study|Site Terminated by Sponsor|21|||
105351641|NCT02756364|363292063|FG000|Overall Study|Death|20|||
105351642|NCT02756364|363292064|FG001|Overall Study|Death|15|||
105351643|NCT02756364|363292065|FG002|Overall Study|Death|18|||
105351644|NCT02756364|363292063|FG000|Overall Study|Withdrawal by Patient|2|||
105351645|NCT02756364|363292064|FG001|Overall Study|Withdrawal by Patient|1|||
105351646|NCT02756364|363292065|FG002|Overall Study|Withdrawal by Patient|8|||
105351647|NCT02756364|363292063|FG000|Overall Study|Lost to Follow-up|0|||
105351648|NCT02756364|363292064|FG001|Overall Study|Lost to Follow-up|1|||
105351649|NCT02756364|363292065|FG002|Overall Study|Lost to Follow-up|1|||
105351650|NCT03275389|363292069|FG000|Overall Study|Lost to Follow-up|10|||
105351651|NCT03275389|363292070|FG001|Overall Study|Lost to Follow-up|10|||
105351652|NCT03275389|363292071|FG002|Overall Study|Lost to Follow-up|19|||
105351653|NCT03275389|363292072|FG003|Overall Study|Lost to Follow-up|12|||
105351654|NCT03275389|363292073|FG004|Overall Study|Lost to Follow-up|11|||
105351655|NCT03275389|363292074|FG005|Overall Study|Lost to Follow-up|12|||
105351656|NCT03275389|363292075|FG006|Overall Study|Lost to Follow-up|21|||
105351657|NCT03275389|363292076|FG007|Overall Study|Lost to Follow-up|15|||
105351658|NCT03275389|363292077|FG008|Overall Study|Lost to Follow-up|12|||
105351659|NCT03275389|363292078|FG009|Overall Study|Lost to Follow-up|14|||
105351660|NCT03275389|363292069|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
105351661|NCT03275389|363292070|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
105351662|NCT03275389|363292071|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
105351663|NCT03275389|363292072|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
105351664|NCT03275389|363292073|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
105351665|NCT03275389|363292074|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
105351666|NCT03275389|363292075|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
105351667|NCT03275389|363292076|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
105351668|NCT03275389|363292077|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
105351669|NCT03275389|363292078|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
105351670|NCT03275389|363292069|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
105351671|NCT03275389|363292070|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105351672|NCT03275389|363292071|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105351673|NCT03275389|363292072|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
105351674|NCT03275389|363292073|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
105351675|NCT03275389|363292074|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
105351676|NCT03275389|363292075|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
105351677|NCT03275389|363292076|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
105351678|NCT03275389|363292077|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
105351679|NCT03275389|363292078|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
105475493|NCT00653939|363753420|FG001|Overall Study|Physician Decision|0|||
105351680|NCT03275389|363292069|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105351681|NCT03275389|363292070|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
105475494|NCT00653939|363753419|FG000|Overall Study|Disease Progression|2|||
105475495|NCT00653939|363753420|FG001|Overall Study|Disease Progression|3|||
105351682|NCT03275389|363292071|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105351683|NCT03275389|363292072|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
105351684|NCT03275389|363292073|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105351685|NCT03275389|363292074|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105475496|NCT00653939|363753419|FG000|Overall Study|Other|2|||
105475497|NCT00653939|363753420|FG001|Overall Study|Other|6|||
105351686|NCT03275389|363292075|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105475498|NCT02032238|363753421|FG000|Overall Study|Lost to Follow-up|2|||
105351687|NCT03275389|363292076|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105351688|NCT03275389|363292077|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105351689|NCT03275389|363292078|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105351690|NCT03275389|363292069|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105351691|NCT03275389|363292070|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105351692|NCT03275389|363292071|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
105351693|NCT03275389|363292072|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105351694|NCT03275389|363292073|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105351695|NCT03275389|363292074|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105351696|NCT03275389|363292075|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105351697|NCT03275389|363292076|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105351698|NCT03275389|363292077|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105351699|NCT03275389|363292078|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
105351700|NCT03275389|363292069|FG000|Overall Study|Other|0|||
105351701|NCT03275389|363292070|FG001|Overall Study|Other|4|||
105351702|NCT03275389|363292071|FG002|Overall Study|Other|3|||
105351703|NCT03275389|363292072|FG003|Overall Study|Other|2|||
105351704|NCT03275389|363292073|FG004|Overall Study|Other|2|||
105351705|NCT03275389|363292074|FG005|Overall Study|Other|2|||
105351706|NCT03275389|363292075|FG006|Overall Study|Other|0|||
105351707|NCT03275389|363292076|FG007|Overall Study|Other|0|||
105351708|NCT03275389|363292077|FG008|Overall Study|Other|1|||
105351709|NCT03275389|363292078|FG009|Overall Study|Other|0|||
105351710|NCT00448812|363292079|FG000|Year 2|Missed visit but remained in study|4|||
105351711|NCT00448812|363292080|FG001|Year 2|Missed visit but remained in study|1|||
105351712|NCT00448812|363292079|FG000|Year 3|Withdrawal by Subject|1|||
105351713|NCT00448812|363292080|FG001|Year 3|Withdrawal by Subject|3|||
105351714|NCT00448812|363292079|FG000|Year 3|Lost to Follow-up|1|||
105351715|NCT00448812|363292080|FG001|Year 3|Lost to Follow-up|0|||
105351716|NCT00448812|363292079|FG000|Year 3|Missed visit but remained in study|2|||
105351717|NCT00448812|363292080|FG001|Year 3|Missed visit but remained in study|0|||
105351718|NCT00448812|363292079|FG000|Year 5|Missed visit but remained in study|1|||
105351719|NCT00448812|363292080|FG001|Year 5|Missed visit but remained in study|0|||
105351720|NCT03035916|363292081|FG000|Overall Study|Puncture failed|0|||
105351721|NCT03035916|363292082|FG001|Overall Study|Puncture failed|2|||
105351722|NCT03035916|363292083|FG002|Overall Study|Puncture failed|0|||
105351723|NCT02452554|363292084|FG000|Overall Study|Death|2|||
105351724|NCT02452554|363292085|FG001|Overall Study|Death|1|||
105351725|NCT02452554|363292086|FG002|Overall Study|Death|0|||
105351726|NCT02452554|363292087|FG003|Overall Study|Death|0|||
105351727|NCT02452554|363292088|FG004|Overall Study|Death|0|||
105351728|NCT02452554|363292089|FG005|Overall Study|Death|0|||
105351729|NCT02452554|363292084|FG000|Overall Study|Lack of Efficacy|13|||
105351730|NCT02452554|363292085|FG001|Overall Study|Lack of Efficacy|14|||
105475499|NCT02032238|363753422|FG001|Overall Study|Lost to Follow-up|0|||
105475500|NCT00612105|363753423|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
105475501|NCT00612105|363753424|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
105475502|NCT00612105|363753423|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
105475503|NCT00612105|363753424|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
105475504|NCT00612105|363753423|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
105475505|NCT00612105|363753424|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
105475506|NCT00612105|363753423|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
105475507|NCT00612105|363753424|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
105475508|NCT00612105|363753423|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
105475509|NCT00612105|363753424|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
105475510|NCT00612105|363753423|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
105475511|NCT00612105|363753424|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
105475512|NCT00612105|363753423|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
105475513|NCT00612105|363753424|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
105351731|NCT02452554|363292086|FG002|Overall Study|Lack of Efficacy|9|||
105351732|NCT02452554|363292087|FG003|Overall Study|Lack of Efficacy|1|||
105351733|NCT02452554|363292088|FG004|Overall Study|Lack of Efficacy|5|||
105351734|NCT02452554|363292089|FG005|Overall Study|Lack of Efficacy|8|||
105351735|NCT02452554|363292084|FG000|Overall Study|Physician Decision|0|||
105351736|NCT02452554|363292085|FG001|Overall Study|Physician Decision|1|||
105351737|NCT02452554|363292086|FG002|Overall Study|Physician Decision|0|||
105351738|NCT02452554|363292087|FG003|Overall Study|Physician Decision|0|||
105351739|NCT02452554|363292088|FG004|Overall Study|Physician Decision|0|||
105351740|NCT02452554|363292089|FG005|Overall Study|Physician Decision|0|||
105351741|NCT02452554|363292084|FG000|Overall Study|Withdrawal by Subject|1|||
105351742|NCT02452554|363292085|FG001|Overall Study|Withdrawal by Subject|0|||
105351743|NCT02452554|363292086|FG002|Overall Study|Withdrawal by Subject|2|||
105351744|NCT02452554|363292087|FG003|Overall Study|Withdrawal by Subject|0|||
105360893|NCT01051557|363328103|FG000|Overall Study|disease progression|3|||
105711050|NCT04418765|364604403|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
105711051|NCT04418765|364604404|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
105711052|NCT04418765|364604402|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
105711053|NCT04418765|364604403|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
105711054|NCT04418765|364604404|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
105351745|NCT02452554|363292088|FG004|Overall Study|Withdrawal by Subject|0|||
105351746|NCT02452554|363292089|FG005|Overall Study|Withdrawal by Subject|1|||
105351747|NCT02452554|363292084|FG000|Overall Study|Ineligible|0|||
105351748|NCT02452554|363292085|FG001|Overall Study|Ineligible|1|||
105351749|NCT02452554|363292086|FG002|Overall Study|Ineligible|0|||
105351750|NCT02452554|363292087|FG003|Overall Study|Ineligible|0|||
105351751|NCT02452554|363292088|FG004|Overall Study|Ineligible|0|||
105351752|NCT02452554|363292089|FG005|Overall Study|Ineligible|0|||
105351753|NCT02452554|363292084|FG000|Overall Study|Never Received Treatment|1|||
105351754|NCT02452554|363292085|FG001|Overall Study|Never Received Treatment|0|||
105351755|NCT02452554|363292086|FG002|Overall Study|Never Received Treatment|0|||
105351756|NCT02452554|363292087|FG003|Overall Study|Never Received Treatment|0|||
105351757|NCT02452554|363292088|FG004|Overall Study|Never Received Treatment|0|||
105351758|NCT02452554|363292089|FG005|Overall Study|Never Received Treatment|0|||
105351759|NCT00594386|363292090|FG000|Overall Study|Major protocol violation|2|||
105351760|NCT00594386|363292090|FG000|Overall Study|Lack of Efficacy|12|||
105351761|NCT00594386|363292090|FG000|Overall Study|Adverse Event|68|||
105561027|NCT00785291|364050355|FG001|Overall Study|Never began treatment|4|||
105711055|NCT04418765|364604402|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
105475514|NCT00612105|363753423|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
105475515|NCT00612105|363753424|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
105475516|NCT00612105|363753423|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
105475517|NCT00612105|363753424|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
105475518|NCT00612105|363753423|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
105475519|NCT00612105|363753424|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
105475520|NCT00612105|363753423|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
105475521|NCT00612105|363753424|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
105475522|NCT00612105|363753423|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
105475523|NCT00612105|363753424|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
105475524|NCT02929407|363753428|FG000|Overall Study|Adverse Event|1|||
105475525|NCT00743106|363753430|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
105475526|NCT00743106|363753431|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
105475527|NCT00246740|363753438|FG000|Initial Enrollment|Death|1|||
105475528|NCT00246740|363753439|FG001|Initial Enrollment|Death|0|||
105475529|NCT00246740|363753438|FG000|Initial Enrollment|Additional surgery scheduled|0|||
105475530|NCT00246740|363753439|FG001|Initial Enrollment|Additional surgery scheduled|2|||
105475531|NCT00246740|363753438|FG000|Initial Enrollment|Surgery schedule change|4|||
105475532|NCT00246740|363753439|FG001|Initial Enrollment|Surgery schedule change|4|||
105475533|NCT00246740|363753438|FG000|Initial Enrollment|Other|1|||
105475534|NCT00246740|363753439|FG001|Initial Enrollment|Other|2|||
105475535|NCT00934440|363753440|FG000|Overall Study|Lost to Follow-up|1|||
105475536|NCT03158285|363753443|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
105475537|NCT03158285|363753444|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
105475538|NCT03158285|363753445|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
105475539|NCT03158285|363753443|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
105475540|NCT03158285|363753444|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
105475541|NCT03158285|363753445|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
105475542|NCT03158285|363753443|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
105475543|NCT03158285|363753444|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
105711056|NCT04418765|364604403|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
105711057|NCT04418765|364604404|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
105711058|NCT04418765|364604402|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
105711059|NCT04418765|364604403|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
105711060|NCT04418765|364604404|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
105711061|NCT04418765|364604402|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
105711062|NCT04418765|364604403|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
105711063|NCT04418765|364604404|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
105711064|NCT04418765|364604402|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
105711065|NCT04418765|364604403|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
105711066|NCT04418765|364604404|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
105711067|NCT04418765|364604402|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
105711068|NCT04418765|364604403|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
105711069|NCT04418765|364604404|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
105711070|NCT04418765|364604402|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
105711071|NCT04418765|364604403|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
105711072|NCT04418765|364604404|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
105711073|NCT04418765|364604402|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
105711074|NCT04418765|364604403|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
105475544|NCT03158285|363753445|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
105475545|NCT03158285|363753443|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
105475546|NCT03158285|363753444|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
105475547|NCT03158285|363753445|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
105475548|NCT03158285|363753443|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
105475549|NCT03158285|363753444|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
105475550|NCT03158285|363753445|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
105475551|NCT03158285|363753443|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
105475552|NCT03158285|363753444|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
105475553|NCT03158285|363753445|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
105475554|NCT03158285|363753443|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
105475555|NCT03158285|363753444|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
105711075|NCT04418765|364604404|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
105711076|NCT04418765|364604402|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
105475556|NCT03158285|363753445|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
105475557|NCT03158285|363753443|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
105711077|NCT04418765|364604403|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
105711078|NCT04418765|364604404|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
105711079|NCT04418765|364604402|FG000|Extension Period (48 Weeks)|Other than specified|0|||
105711080|NCT04418765|364604403|FG001|Extension Period (48 Weeks)|Other than specified|5|||
105711081|NCT04418765|364604404|FG002|Extension Period (48 Weeks)|Other than specified|2|||
105711082|NCT02062658|364604405|FG000|Overall Study|Withdrawal by Subject|1|||
105711083|NCT02062658|364604405|FG000|Overall Study|Lack of Efficacy|1|||
105711084|NCT01789970|364604406|FG000|Open-label Titration Period|Adverse Event|68|||
105711085|NCT01789970|364604407|FG001|Open-label Titration Period|Adverse Event|0|||
105711086|NCT01789970|364604408|FG002|Open-label Titration Period|Adverse Event|0|||
105711087|NCT01789970|364604406|FG000|Open-label Titration Period|Lack of Efficacy|31|||
105711088|NCT01789970|364604407|FG001|Open-label Titration Period|Lack of Efficacy|0|||
105351762|NCT00594386|363292090|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
105351763|NCT00594386|363292090|FG000|Overall Study|Subject withdrew consent|35|||
105351764|NCT00594386|363292090|FG000|Overall Study|Study ended per sponsor|115|||
105351765|NCT00594386|363292090|FG000|Overall Study|Lost to Follow-up|6|||
105351766|NCT00594386|363292090|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
105351767|NCT00594386|363292090|FG000|Overall Study|Other: Subject moved to Seattle|1|||
105351768|NCT00594386|363292090|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
105351769|NCT00594386|363292090|FG000|Overall Study|Other: Study terminated per investigator|2|||
105351770|NCT00594386|363292090|FG000|Overall Study|Other: Sponsor closure of study|1|||
105351771|NCT00594386|363292090|FG000|Overall Study|Other: Site terminated participation|1|||
105351772|NCT00594386|363292090|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
105351773|NCT00594386|363292090|FG000|Overall Study|Other: Loss of drivers license|1|||
105351774|NCT01402986|363292091|FG000|Overall Study|Withdrawal by Subject|7|||
105351775|NCT01402986|363292092|FG001|Overall Study|Withdrawal by Subject|10|||
105351776|NCT01402986|363292093|FG002|Overall Study|Withdrawal by Subject|7|||
105351777|NCT01402986|363292094|FG003|Overall Study|Withdrawal by Subject|13|||
105351778|NCT01402986|363292091|FG000|Overall Study|Death|0|||
105351779|NCT01402986|363292092|FG001|Overall Study|Death|0|||
105351780|NCT01402986|363292093|FG002|Overall Study|Death|0|||
105351781|NCT01402986|363292094|FG003|Overall Study|Death|2|||
105351782|NCT01402986|363292091|FG000|Overall Study|Lost to Follow-up|0|||
105351783|NCT01402986|363292092|FG001|Overall Study|Lost to Follow-up|0|||
105351784|NCT01402986|363292093|FG002|Overall Study|Lost to Follow-up|0|||
105351785|NCT01402986|363292094|FG003|Overall Study|Lost to Follow-up|1|||
105351786|NCT01402986|363292091|FG000|Overall Study|Other|2|||
105351787|NCT01402986|363292092|FG001|Overall Study|Other|5|||
105351788|NCT01402986|363292093|FG002|Overall Study|Other|1|||
105351789|NCT01402986|363292094|FG003|Overall Study|Other|6|||
105351790|NCT01085084|363292095|FG000|Overall Study|Withdrawal by Subject|1|||
105351791|NCT01085084|363292096|FG001|Overall Study|Withdrawal by Subject|0|||
105351792|NCT01085084|363292097|FG002|Overall Study|Withdrawal by Subject|0|||
105351793|NCT01085084|363292095|FG000|Overall Study|Lost to Follow-up|2|||
105351794|NCT01085084|363292096|FG001|Overall Study|Lost to Follow-up|1|||
105351795|NCT01085084|363292097|FG002|Overall Study|Lost to Follow-up|1|||
105351796|NCT01085084|363292095|FG000|Overall Study|Adverse Event|4|||
105351797|NCT01085084|363292096|FG001|Overall Study|Adverse Event|3|||
105351798|NCT01085084|363292097|FG002|Overall Study|Adverse Event|6|||
105351799|NCT01085084|363292095|FG000|Overall Study|Treatment Failure|0|||
105351800|NCT01085084|363292096|FG001|Overall Study|Treatment Failure|1|||
105351801|NCT01085084|363292097|FG002|Overall Study|Treatment Failure|2|||
105711089|NCT01789970|364604408|FG002|Open-label Titration Period|Lack of Efficacy|0|||
105351802|NCT02634983|363292098|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
105351803|NCT02634983|363292099|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
105351804|NCT03749109|363292100|FG000|Overall Study|Adverse Event|2|||
105351805|NCT03749109|363292101|FG001|Overall Study|Adverse Event|0|||
105351806|NCT02636439|363292105|FG000|Overall Study|Adverse Event|2|||
105351807|NCT02636439|363292106|FG001|Overall Study|Adverse Event|2|||
105351808|NCT02636439|363292105|FG000|Overall Study|Lost to Follow-up|1|||
105351809|NCT02636439|363292106|FG001|Overall Study|Lost to Follow-up|0|||
105351810|NCT02636439|363292105|FG000|Overall Study|Non-compliance|1|||
105788114|NCT03426995|364878226|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788115|NCT03426995|364878227|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105351811|NCT02636439|363292106|FG001|Overall Study|Non-compliance|1|||
105351812|NCT02636439|363292105|FG000|Overall Study|Personal reasons|2|||
105351813|NCT02636439|363292106|FG001|Overall Study|Personal reasons|0|||
105351814|NCT02494401|363292107|FG000|Overall Study|Lost to Follow-up|22|||
105351815|NCT02494401|363292108|FG001|Overall Study|Lost to Follow-up|25|||
105351816|NCT02494401|363292107|FG000|Overall Study|Withdrawal by Subject|3|||
105475558|NCT03158285|363753444|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
105475559|NCT03158285|363753445|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
105351817|NCT02494401|363292108|FG001|Overall Study|Withdrawal by Subject|2|||
105351818|NCT01393106|363293707|FG000|Overall Study|Adverse Event|3|||
105351819|NCT01393106|363293707|FG000|Overall Study|Withdrawal by Subject|1|||
105351820|NCT01393106|363293707|FG000|Overall Study|Lack of Efficacy|1|||
105711090|NCT01789970|364604406|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
105711091|NCT01789970|364604407|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
105711092|NCT01789970|364604408|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
105711093|NCT01789970|364604406|FG000|Open-label Titration Period|Protocol Violation|18|||
105711094|NCT01789970|364604407|FG001|Open-label Titration Period|Protocol Violation|0|||
105711095|NCT01789970|364604408|FG002|Open-label Titration Period|Protocol Violation|0|||
105711096|NCT01789970|364604406|FG000|Open-label Titration Period|Lost to Follow-up|5|||
105711097|NCT01789970|364604407|FG001|Open-label Titration Period|Lost to Follow-up|0|||
105711098|NCT01789970|364604408|FG002|Open-label Titration Period|Lost to Follow-up|0|||
105351821|NCT01744483|363293708|FG000|Overall Study|Death|9|||
105351822|NCT01744483|363293709|FG001|Overall Study|Death|4|||
105351823|NCT01744483|363293710|FG002|Overall Study|Death|11|||
105711099|NCT01789970|364604406|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
105711100|NCT01789970|364604407|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
105711101|NCT01789970|364604408|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
105711102|NCT01789970|364604406|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
105711103|NCT01789970|364604407|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
105711104|NCT01789970|364604408|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
105711105|NCT01789970|364604406|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
105711106|NCT01789970|364604407|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
105711107|NCT01789970|364604408|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
105711108|NCT01789970|364604406|FG000|Open-label Titration Period|Pregnancy|2|||
105711109|NCT01789970|364604407|FG001|Open-label Titration Period|Pregnancy|0|||
105711110|NCT01789970|364604408|FG002|Open-label Titration Period|Pregnancy|0|||
105711111|NCT01789970|364604406|FG000|Open-label Titration Period|Other|76|||
105711112|NCT01789970|364604407|FG001|Open-label Titration Period|Other|0|||
105711113|NCT01789970|364604408|FG002|Open-label Titration Period|Other|0|||
105711114|NCT01789970|364604406|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
105711115|NCT01789970|364604407|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
105711116|NCT01789970|364604408|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
105711117|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
105711118|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
105711119|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
105711120|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
105711121|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
105711122|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
105711123|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
105711124|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
105711125|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
105711126|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
105711127|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
105711128|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
105711129|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
105711130|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
105711131|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
105711132|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
105711133|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
105711134|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
105711135|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
105351824|NCT01744483|363293708|FG000|Overall Study|Lost to Follow-up|8|||
105351825|NCT01744483|363293709|FG001|Overall Study|Lost to Follow-up|9|||
105475560|NCT03158285|363753443|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
105711136|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
105711137|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
105351826|NCT01744483|363293710|FG002|Overall Study|Lost to Follow-up|11|||
105351827|NCT01744483|363293708|FG000|Overall Study|Protocol Violation|1|||
105711138|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
105711139|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
105711140|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
105711141|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
105711142|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
105711143|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
105711144|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
105711145|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
105711146|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
105806512|NCT03038113|364949006|FG006|Overall Study|Withdrawal by Subject|0|||
105711147|NCT03345472|364604410|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
105711148|NCT03345472|364604410|FG000|Implant to 3 Months|Physician Decision|1|||
105711149|NCT03345472|364604410|FG000|Implant to 3 Months|Adverse Event|1|||
105711150|NCT03345472|364604410|FG000|3 Months to 12 Months|Physician Decision|3|||
105475561|NCT03158285|363753444|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
105475562|NCT03158285|363753445|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
105475563|NCT03158285|363753443|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
105475564|NCT03158285|363753444|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
105475565|NCT03158285|363753445|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
105475566|NCT03158285|363753443|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
105475567|NCT03158285|363753444|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
105475568|NCT03158285|363753445|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
105475569|NCT03158285|363753443|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
105475570|NCT03158285|363753444|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
105475571|NCT03158285|363753445|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
105475572|NCT03158285|363753443|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
105475573|NCT03158285|363753444|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
105475574|NCT03158285|363753445|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
105475575|NCT03158285|363753443|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
105475576|NCT03158285|363753444|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
105475577|NCT03158285|363753445|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
105475578|NCT03158285|363753443|FG000|Active Treatment Period: Week 52-100|Death|1|||
105475579|NCT03158285|363753444|FG001|Active Treatment Period: Week 52-100|Death|0|||
105475580|NCT03158285|363753445|FG002|Active Treatment Period: Week 52-100|Death|0|||
105475581|NCT03158285|363753443|FG000|Active Treatment Period: Week 52-100|Other|4|||
105475582|NCT03158285|363753444|FG001|Active Treatment Period: Week 52-100|Other|1|||
105475583|NCT03158285|363753445|FG002|Active Treatment Period: Week 52-100|Other|0|||
105475584|NCT00870584|363753451|FG000|Overall Study|Adverse Event|3|||
105475585|NCT00870584|363753452|FG001|Overall Study|Adverse Event|3|||
105475586|NCT00870584|363753451|FG000|Overall Study|Withdrawal by Subject|6|||
105475587|NCT00870584|363753452|FG001|Overall Study|Withdrawal by Subject|7|||
105475588|NCT00870584|363753451|FG000|Overall Study|Lost to Follow-up|5|||
105475589|NCT00870584|363753452|FG001|Overall Study|Lost to Follow-up|1|||
105475590|NCT00870584|363753451|FG000|Overall Study|Protocol Deviation|2|||
105475591|NCT00870584|363753452|FG001|Overall Study|Protocol Deviation|2|||
105475592|NCT01601652|363753459|FG000|Overall Study|Death|1|||
105475593|NCT01395524|363755207|FG000|Overall Study|Non-compliance with study schedule|1|||
105475594|NCT01395524|363755208|FG001|Overall Study|Non-compliance with study schedule|0|||
105475595|NCT01395524|363755209|FG002|Overall Study|Non-compliance with study schedule|1|||
105711151|NCT03345472|364604410|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
105711152|NCT03345472|364604410|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
105711153|NCT03345472|364604410|FG000|3 Months to 12 Months|Adverse Event|1|||
105711154|NCT03345472|364604410|FG000|3 Months to 12 Months|Death|1|||
105475596|NCT01395524|363755207|FG000|Overall Study|Lost to Follow-up|3|||
105475597|NCT01395524|363755208|FG001|Overall Study|Lost to Follow-up|1|||
105475598|NCT01395524|363755209|FG002|Overall Study|Lost to Follow-up|1|||
105475599|NCT01395524|363755207|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
105561028|NCT00785291|364050356|FG002|Overall Study|Never began treatment|4|||
105561029|NCT00785291|364050354|FG000|Overall Study|Adverse Event|39|||
105561030|NCT00785291|364050355|FG001|Overall Study|Adverse Event|70|||
105561031|NCT00785291|364050356|FG002|Overall Study|Adverse Event|56|||
105475600|NCT01395524|363755208|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
105475601|NCT01395524|363755209|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
105475602|NCT01395524|363755207|FG000|Overall Study|Severe noncompliance with protocol|1|||
105475603|NCT01395524|363755208|FG001|Overall Study|Severe noncompliance with protocol|0|||
105561032|NCT00785291|364050354|FG000|Overall Study|Death|7|||
105561033|NCT00785291|364050355|FG001|Overall Study|Death|4|||
105561034|NCT00785291|364050356|FG002|Overall Study|Death|3|||
105561035|NCT00785291|364050354|FG000|Overall Study|Withdrawal by Subject|35|||
105561036|NCT00785291|364050355|FG001|Overall Study|Withdrawal by Subject|36|||
105561037|NCT00785291|364050356|FG002|Overall Study|Withdrawal by Subject|17|||
105561038|NCT00785291|364050354|FG000|Overall Study|Alternative Therapy|12|||
105711155|NCT01121393|364604411|FG000|Overall Study|Progressive disease|201|||
105711156|NCT01121393|364604412|FG001|Overall Study|Progressive disease|20|||
105788116|NCT03426995|364878228|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788117|NCT03426995|364878229|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105561039|NCT00785291|364050355|FG001|Overall Study|Alternative Therapy|6|||
105561040|NCT00785291|364050356|FG002|Overall Study|Alternative Therapy|7|||
105561041|NCT00785291|364050354|FG000|Overall Study|Complicating illness|6|||
105561042|NCT00785291|364050355|FG001|Overall Study|Complicating illness|4|||
105561043|NCT00785291|364050356|FG002|Overall Study|Complicating illness|4|||
105711157|NCT01121393|364604411|FG000|Overall Study|Other Adverse events|24|||
105711158|NCT01121393|364604412|FG001|Overall Study|Other Adverse events|45|||
105561044|NCT00785291|364050354|FG000|Overall Study|Other Medical Reasons|29|||
105561045|NCT00785291|364050355|FG001|Overall Study|Other Medical Reasons|25|||
105561046|NCT00785291|364050356|FG002|Overall Study|Other Medical Reasons|15|||
105561047|NCT04050865|364050357|FG000|Overall Study|Adverse Event|1|||
105561048|NCT04050865|364050358|FG001|Overall Study|Adverse Event|0|||
105561049|NCT04050865|364050357|FG000|Overall Study|no insert|1|||
105561050|NCT04050865|364050358|FG001|Overall Study|no insert|0|||
105561051|NCT04050865|364050357|FG000|Overall Study|Only 1 insert|2|||
105561052|NCT04050865|364050358|FG001|Overall Study|Only 1 insert|3|||
105561053|NCT04050865|364050357|FG000|Overall Study|Physician Decision|0|||
105561054|NCT04050865|364050358|FG001|Overall Study|Physician Decision|1|||
105561055|NCT04050865|364050357|FG000|Overall Study|Withdrawal by Subject|0|||
105561056|NCT04050865|364050358|FG001|Overall Study|Withdrawal by Subject|1|||
105561057|NCT00428090|364050369|FG000|Overall Study|Adverse Event|10|||
105561058|NCT00428090|364050370|FG001|Overall Study|Adverse Event|8|||
105561059|NCT00428090|364050371|FG002|Overall Study|Adverse Event|10|||
105561060|NCT00428090|364050372|FG003|Overall Study|Adverse Event|11|||
105561061|NCT00428090|364050369|FG000|Overall Study|Lost to Follow-up|3|||
105561062|NCT00428090|364050370|FG001|Overall Study|Lost to Follow-up|6|||
105561063|NCT00428090|364050371|FG002|Overall Study|Lost to Follow-up|1|||
105561064|NCT00428090|364050372|FG003|Overall Study|Lost to Follow-up|4|||
105351828|NCT01744483|363293709|FG001|Overall Study|Protocol Violation|2|||
105561065|NCT00428090|364050369|FG000|Overall Study|Protocol Violation|3|||
105561066|NCT00428090|364050370|FG001|Overall Study|Protocol Violation|1|||
105561067|NCT00428090|364050371|FG002|Overall Study|Protocol Violation|3|||
105561068|NCT00428090|364050372|FG003|Overall Study|Protocol Violation|3|||
105561069|NCT00428090|364050369|FG000|Overall Study|Withdrawal by Subject|10|||
105561070|NCT00428090|364050370|FG001|Overall Study|Withdrawal by Subject|12|||
105561071|NCT00428090|364050371|FG002|Overall Study|Withdrawal by Subject|15|||
105561072|NCT00428090|364050372|FG003|Overall Study|Withdrawal by Subject|5|||
105561073|NCT00428090|364050369|FG000|Overall Study|Sponsor terminated study|0|||
105561074|NCT00428090|364050370|FG001|Overall Study|Sponsor terminated study|1|||
105561075|NCT00428090|364050371|FG002|Overall Study|Sponsor terminated study|0|||
105561076|NCT00428090|364050372|FG003|Overall Study|Sponsor terminated study|0|||
105561077|NCT00428090|364050369|FG000|Overall Study|Non-compliance|4|||
105561078|NCT00428090|364050370|FG001|Overall Study|Non-compliance|0|||
105561079|NCT00428090|364050371|FG002|Overall Study|Non-compliance|1|||
105561080|NCT00428090|364050372|FG003|Overall Study|Non-compliance|3|||
105561081|NCT00428090|364050369|FG000|Overall Study|Par. did not returned to visit|1|||
105561082|NCT00428090|364050370|FG001|Overall Study|Par. did not returned to visit|0|||
105561083|NCT00428090|364050371|FG002|Overall Study|Par. did not returned to visit|0|||
105561084|NCT00428090|364050372|FG003|Overall Study|Par. did not returned to visit|1|||
105561085|NCT00428090|364050369|FG000|Overall Study|Follow-Up visit not possible|1|||
105561086|NCT00428090|364050370|FG001|Overall Study|Follow-Up visit not possible|0|||
105561087|NCT00428090|364050371|FG002|Overall Study|Follow-Up visit not possible|0|||
105561088|NCT00428090|364050372|FG003|Overall Study|Follow-Up visit not possible|0|||
105561089|NCT00428090|364050369|FG000|Overall Study|Prohibited medication used for SAE|1|||
105351829|NCT01744483|363293710|FG002|Overall Study|Protocol Violation|1|||
105351830|NCT01744483|363293708|FG000|Overall Study|Withdrawal by Subject|4|||
105351831|NCT01744483|363293709|FG001|Overall Study|Withdrawal by Subject|6|||
105351832|NCT01744483|363293710|FG002|Overall Study|Withdrawal by Subject|2|||
105351833|NCT01744483|363293708|FG000|Overall Study|No ICU Admit|5|||
105351834|NCT01744483|363293709|FG001|Overall Study|No ICU Admit|1|||
105561090|NCT00428090|364050370|FG001|Overall Study|Prohibited medication used for SAE|0|||
105561091|NCT00428090|364050371|FG002|Overall Study|Prohibited medication used for SAE|0|||
105561092|NCT00428090|364050372|FG003|Overall Study|Prohibited medication used for SAE|0|||
105711159|NCT01121393|364604411|FG000|Overall Study|Non-compliant with protocol|0|||
105711160|NCT01121393|364604412|FG001|Overall Study|Non-compliant with protocol|3|||
105711161|NCT01121393|364604411|FG000|Overall Study|Lost to Follow-up|1|||
105711162|NCT01121393|364604412|FG001|Overall Study|Lost to Follow-up|0|||
105711163|NCT01121393|364604411|FG000|Overall Study|Refused cont. medication|7|||
105711164|NCT01121393|364604412|FG001|Overall Study|Refused cont. medication|7|||
105711165|NCT01121393|364604411|FG000|Overall Study|Not treated|3|||
105711166|NCT01121393|364604412|FG001|Overall Study|Not treated|9|||
105711167|NCT01121393|364604411|FG000|Overall Study|Other than listed|6|||
105711168|NCT01121393|364604412|FG001|Overall Study|Other than listed|0|||
105711169|NCT02161562|364604413|FG000|Overall Study|Withdrawal by Subject|5|||
105711170|NCT02161562|364604414|FG001|Overall Study|Withdrawal by Subject|8|||
105711171|NCT02161562|364604413|FG000|Overall Study|Protocol Violation|9|||
105711172|NCT02161562|364604414|FG001|Overall Study|Protocol Violation|4|||
105711173|NCT02161562|364604413|FG000|Overall Study|Pregnancy|1|||
105711174|NCT02161562|364604414|FG001|Overall Study|Pregnancy|2|||
105711175|NCT02161562|364604413|FG000|Overall Study|Lost to Follow-up|3|||
105711176|NCT02161562|364604414|FG001|Overall Study|Lost to Follow-up|1|||
105711177|NCT02161562|364604413|FG000|Overall Study|Lack of Efficacy|4|||
105711178|NCT02161562|364604414|FG001|Overall Study|Lack of Efficacy|1|||
105711179|NCT02161562|364604413|FG000|Overall Study|Adverse Event|1|||
105711180|NCT02161562|364604414|FG001|Overall Study|Adverse Event|1|||
105711181|NCT02161562|364604413|FG000|Overall Study|Participant moved back to home country|1|||
105711182|NCT02161562|364604414|FG001|Overall Study|Participant moved back to home country|0|||
105711183|NCT02161562|364604413|FG000|Overall Study|Withdrew due to being out of the country|1|||
105711184|NCT02161562|364604414|FG001|Overall Study|Withdrew due to being out of the country|0|||
105711185|NCT02161562|364604413|FG000|Overall Study|Participant moved out of province|1|||
105711186|NCT02161562|364604414|FG001|Overall Study|Participant moved out of province|0|||
105561093|NCT00428090|364050369|FG000|Overall Study|Death of par.|1|||
105711187|NCT01100944|364604415|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
105711188|NCT01100944|364604416|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
105711189|NCT01100944|364604417|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
105711190|NCT01100944|364604415|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
105711191|NCT01100944|364604416|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
105711192|NCT01100944|364604417|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
105711193|NCT01100944|364604415|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
105711194|NCT01100944|364604416|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
105711195|NCT01100944|364604417|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
105711196|NCT01100944|364604415|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
105711197|NCT01100944|364604416|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
105475604|NCT01395524|363755209|FG002|Overall Study|Severe noncompliance with protocol|0|||
105475605|NCT01395524|363755207|FG000|Overall Study|Adverse Event|4|||
105475606|NCT01395524|363755208|FG001|Overall Study|Adverse Event|4|||
105475607|NCT01395524|363755209|FG002|Overall Study|Adverse Event|3|||
105475608|NCT01395524|363755207|FG000|Overall Study|Death|1|||
105475609|NCT01395524|363755208|FG001|Overall Study|Death|0|||
105475610|NCT01395524|363755209|FG002|Overall Study|Death|0|||
105475611|NCT01395524|363755207|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
105475612|NCT01395524|363755208|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
105475613|NCT01395524|363755209|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
105475614|NCT01395524|363755207|FG000|Overall Study|Withdrawal by Subject|4|||
105475615|NCT01395524|363755208|FG001|Overall Study|Withdrawal by Subject|8|||
105475616|NCT01395524|363755209|FG002|Overall Study|Withdrawal by Subject|8|||
105475617|NCT01395524|363755207|FG000|Overall Study|Did not receive treatment|1|||
105475618|NCT01395524|363755208|FG001|Overall Study|Did not receive treatment|1|||
105475619|NCT01395524|363755209|FG002|Overall Study|Did not receive treatment|3|||
105475620|NCT01395524|363755207|FG000|Overall Study|Subject had spinal surgery|0|||
105475621|NCT01395524|363755208|FG001|Overall Study|Subject had spinal surgery|0|||
105475622|NCT01395524|363755209|FG002|Overall Study|Subject had spinal surgery|1|||
105475623|NCT01124864|363755210|FG000|Overall Study|Follow up phase competed as per protocol|18|||
105475624|NCT01124864|363755211|FG001|Overall Study|Follow up phase competed as per protocol|22|||
105475625|NCT01124864|363755212|FG002|Overall Study|Follow up phase competed as per protocol|24|||
105475626|NCT01124864|363755213|FG003|Overall Study|Follow up phase competed as per protocol|18|||
105475627|NCT01124864|363755214|FG004|Overall Study|Follow up phase competed as per protocol|26|||
105475628|NCT01124864|363755215|FG005|Overall Study|Follow up phase competed as per protocol|2|||
105475629|NCT01124864|363755210|FG000|Overall Study|Death|6|||
105475630|NCT01124864|363755211|FG001|Overall Study|Death|9|||
105475631|NCT01124864|363755212|FG002|Overall Study|Death|6|||
105475632|NCT01124864|363755213|FG003|Overall Study|Death|2|||
105475633|NCT01124864|363755214|FG004|Overall Study|Death|1|||
105475634|NCT01124864|363755215|FG005|Overall Study|Death|0|||
105475635|NCT01124864|363755210|FG000|Overall Study|Withdrawal by Subject|2|||
105475636|NCT01124864|363755211|FG001|Overall Study|Withdrawal by Subject|3|||
105475637|NCT01124864|363755212|FG002|Overall Study|Withdrawal by Subject|4|||
105475638|NCT01124864|363755213|FG003|Overall Study|Withdrawal by Subject|0|||
105475639|NCT01124864|363755214|FG004|Overall Study|Withdrawal by Subject|2|||
105475640|NCT01124864|363755215|FG005|Overall Study|Withdrawal by Subject|1|||
105475641|NCT01124864|363755210|FG000|Overall Study|Lost to Follow-up|1|||
105475642|NCT01124864|363755211|FG001|Overall Study|Lost to Follow-up|1|||
105475643|NCT01124864|363755212|FG002|Overall Study|Lost to Follow-up|0|||
105711198|NCT01100944|364604417|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
105475644|NCT01124864|363755213|FG003|Overall Study|Lost to Follow-up|1|||
105475645|NCT01124864|363755214|FG004|Overall Study|Lost to Follow-up|0|||
105475646|NCT01124864|363755215|FG005|Overall Study|Lost to Follow-up|0|||
105475647|NCT01124864|363755210|FG000|Overall Study|Protocol Violation|1|||
105475648|NCT01124864|363755211|FG001|Overall Study|Protocol Violation|0|||
105475649|NCT01124864|363755212|FG002|Overall Study|Protocol Violation|0|||
105711199|NCT04372927|364604418|FG000|Overall Study|Death|1|||
105561094|NCT00428090|364050370|FG001|Overall Study|Death of par.|0|||
105561095|NCT00428090|364050371|FG002|Overall Study|Death of par.|1|||
105561096|NCT00428090|364050372|FG003|Overall Study|Death of par.|0|||
105561097|NCT00428090|364050369|FG000|Overall Study|Visit 7 exceed the visit window|0|||
105561098|NCT00428090|364050370|FG001|Overall Study|Visit 7 exceed the visit window|1|||
105561099|NCT00428090|364050371|FG002|Overall Study|Visit 7 exceed the visit window|0|||
105561100|NCT00428090|364050372|FG003|Overall Study|Visit 7 exceed the visit window|0|||
105561101|NCT00428090|364050369|FG000|Overall Study|Medical monitor terminated par.|0|||
105561102|NCT00428090|364050370|FG001|Overall Study|Medical monitor terminated par.|1|||
105561103|NCT00428090|364050371|FG002|Overall Study|Medical monitor terminated par.|0|||
105561104|NCT00428090|364050372|FG003|Overall Study|Medical monitor terminated par.|0|||
105561105|NCT00428090|364050369|FG000|Overall Study|Mental status of par. was|0|||
105561106|NCT00428090|364050370|FG001|Overall Study|Mental status of par. was|1|||
105561107|NCT00428090|364050371|FG002|Overall Study|Mental status of par. was|0|||
105561108|NCT00428090|364050372|FG003|Overall Study|Mental status of par. was|0|||
105561109|NCT00428090|364050369|FG000|Overall Study|Worsening of AD|0|||
105561110|NCT00428090|364050370|FG001|Overall Study|Worsening of AD|0|||
105561111|NCT00428090|364050371|FG002|Overall Study|Worsening of AD|1|||
105561112|NCT00428090|364050372|FG003|Overall Study|Worsening of AD|0|||
105561113|NCT00428090|364050369|FG000|Overall Study|Excluded for concerning QTc value|0|||
105561114|NCT00428090|364050370|FG001|Overall Study|Excluded for concerning QTc value|0|||
105561115|NCT00428090|364050371|FG002|Overall Study|Excluded for concerning QTc value|1|||
105561116|NCT00428090|364050372|FG003|Overall Study|Excluded for concerning QTc value|0|||
105561117|NCT00428090|364050369|FG000|Overall Study|Insufficient AD documentation|0|||
105561118|NCT00428090|364050370|FG001|Overall Study|Insufficient AD documentation|0|||
105561119|NCT00428090|364050371|FG002|Overall Study|Insufficient AD documentation|1|||
105561120|NCT00428090|364050372|FG003|Overall Study|Insufficient AD documentation|0|||
105561121|NCT00428090|364050369|FG000|Overall Study|High MMSE scores|0|||
105561122|NCT00428090|364050370|FG001|Overall Study|High MMSE scores|0|||
105561123|NCT00428090|364050371|FG002|Overall Study|High MMSE scores|1|||
105561124|NCT00428090|364050372|FG003|Overall Study|High MMSE scores|0|||
105561125|NCT00428090|364050369|FG000|Overall Study|Deterioration of cognitive status|0|||
105561126|NCT00428090|364050370|FG001|Overall Study|Deterioration of cognitive status|0|||
105561127|NCT00428090|364050371|FG002|Overall Study|Deterioration of cognitive status|1|||
105561128|NCT00428090|364050372|FG003|Overall Study|Deterioration of cognitive status|0|||
105561129|NCT00428090|364050369|FG000|Overall Study|Serious adverse event|0|||
105561130|NCT00428090|364050370|FG001|Overall Study|Serious adverse event|0|||
105561131|NCT00428090|364050371|FG002|Overall Study|Serious adverse event|1|||
105561132|NCT00428090|364050372|FG003|Overall Study|Serious adverse event|0|||
105561133|NCT00428090|364050369|FG000|Overall Study|Excluded for heart insufficiency|0|||
105561134|NCT00428090|364050370|FG001|Overall Study|Excluded for heart insufficiency|0|||
105561135|NCT00428090|364050371|FG002|Overall Study|Excluded for heart insufficiency|1|||
105561136|NCT00428090|364050372|FG003|Overall Study|Excluded for heart insufficiency|0|||
105561137|NCT00428090|364050369|FG000|Overall Study|Raised Creatinine Value|0|||
105561138|NCT00428090|364050370|FG001|Overall Study|Raised Creatinine Value|0|||
105561139|NCT00428090|364050371|FG002|Overall Study|Raised Creatinine Value|0|||
105561140|NCT00428090|364050372|FG003|Overall Study|Raised Creatinine Value|1|||
105561141|NCT03409666|364050373|FG000|Overall Study|Physician Decision|0|||
105561142|NCT03409666|364050374|FG001|Overall Study|Physician Decision|1|||
105561143|NCT03409666|364050373|FG000|Overall Study|Protocol Violation|0|||
105561144|NCT03409666|364050374|FG001|Overall Study|Protocol Violation|3|||
105561145|NCT00512148|364050375|FG000|Primay Study Period|Withdrawal by Subject|1|||
105561146|NCT00677833|364050378|FG000|Overall Study|Withdrawal by Subject|4|||
105561147|NCT00677833|364050379|FG001|Overall Study|Withdrawal by Subject|0|||
105561148|NCT00677833|364050380|FG002|Overall Study|Withdrawal by Subject|1|||
105561149|NCT00677833|364050381|FG003|Overall Study|Withdrawal by Subject|3|||
105561150|NCT00677833|364050378|FG000|Overall Study|Lost to Follow-up|0|||
105561151|NCT00677833|364050379|FG001|Overall Study|Lost to Follow-up|0|||
105561152|NCT00677833|364050380|FG002|Overall Study|Lost to Follow-up|1|||
105561153|NCT00677833|364050381|FG003|Overall Study|Lost to Follow-up|0|||
105561154|NCT02001194|364050383|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
105561155|NCT02001194|364050384|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
105561156|NCT02001194|364050385|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
105561157|NCT02001194|364050386|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
105561158|NCT02001194|364050383|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
105561159|NCT02001194|364050384|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
105561160|NCT02001194|364050385|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
105711200|NCT01665807|364604421|FG000|Overall Study|Withdrawal by Subject|2|||
105711201|NCT01665807|364604422|FG001|Overall Study|Withdrawal by Subject|0|||
105711202|NCT01665807|364604423|FG002|Overall Study|Withdrawal by Subject|1|||
105711203|NCT01639833|364604427|FG000|Overall Study|Death|4|||
105711204|NCT01639833|364604428|FG001|Overall Study|Death|2|||
105711205|NCT01639833|364604427|FG000|Overall Study|Withdrawal by Subject|2|||
105711206|NCT01639833|364604428|FG001|Overall Study|Withdrawal by Subject|2|||
105561161|NCT02001194|364050386|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
105711207|NCT02450578|364604431|FG000|Overall Study|ECG abnormality so not treated|1|||
105711208|NCT02450578|364604432|FG001|Overall Study|ECG abnormality so not treated|0|||
105711209|NCT02450578|364604433|FG002|Overall Study|ECG abnormality so not treated|0|||
105351835|NCT01744483|363293710|FG002|Overall Study|No ICU Admit|2|||
105351836|NCT01744483|363293708|FG000|Overall Study|Routed to OSH|2|||
105351837|NCT01744483|363293709|FG001|Overall Study|Routed to OSH|0|||
105351838|NCT01744483|363293710|FG002|Overall Study|Routed to OSH|1|||
105351839|NCT03015194|363293711|FG000|Overall Study|Death|10|||
105351840|NCT03015194|363293711|FG000|Overall Study|Withdrawal by Subject|2|||
105351841|NCT02469168|363293714|FG000|Overall Study|Trial closed|1|||
105351842|NCT02469168|363293715|FG001|Overall Study|Trial closed|0|||
105351843|NCT02412878|363293716|FG000|Overall Study|Withdrawal by Subject|19|||
105351844|NCT02412878|363293717|FG001|Overall Study|Withdrawal by Subject|10|||
105351845|NCT02412878|363293716|FG000|Overall Study|Lost to Follow-up|2|||
105351846|NCT02412878|363293717|FG001|Overall Study|Lost to Follow-up|3|||
105351847|NCT03488563|363293724|FG000|Overall Study|Lost to Follow-up|7|||
105351848|NCT03488563|363293725|FG001|Overall Study|Lost to Follow-up|6|||
105351849|NCT03488563|363293726|FG002|Overall Study|Lost to Follow-up|7|||
105351850|NCT03488563|363293724|FG000|Overall Study|Withdrawal by Subject|8|||
105351851|NCT03488563|363293725|FG001|Overall Study|Withdrawal by Subject|7|||
105351852|NCT03488563|363293726|FG002|Overall Study|Withdrawal by Subject|7|||
105351853|NCT03488563|363293724|FG000|Overall Study|Physician Decision|0|||
105351854|NCT03488563|363293725|FG001|Overall Study|Physician Decision|0|||
105351855|NCT03488563|363293726|FG002|Overall Study|Physician Decision|1|||
105351856|NCT03488563|363293724|FG000|Overall Study|Protocol Violation|3|||
105351857|NCT03488563|363293725|FG001|Overall Study|Protocol Violation|2|||
105351858|NCT03488563|363293726|FG002|Overall Study|Protocol Violation|6|||
105351859|NCT03488563|363293724|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
105351860|NCT03488563|363293725|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
105351861|NCT03488563|363293726|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
105351862|NCT03488563|363293724|FG000|Overall Study|Use of prohibited medication|2|||
105351863|NCT03488563|363293725|FG001|Overall Study|Use of prohibited medication|0|||
105351864|NCT03488563|363293726|FG002|Overall Study|Use of prohibited medication|0|||
105351865|NCT03488563|363293724|FG000|Overall Study|Adverse Event|1|||
105351866|NCT03488563|363293725|FG001|Overall Study|Adverse Event|0|||
105351867|NCT03488563|363293726|FG002|Overall Study|Adverse Event|1|||
105351868|NCT03488563|363293724|FG000|Overall Study|Subject returned for ET visit|0|||
105561162|NCT02606279|364050393|FG000|Overall Study|Lost to Follow-up|0|||
105561163|NCT02606279|364050394|FG001|Overall Study|Lost to Follow-up|1|||
105711210|NCT02450578|364604434|FG003|Overall Study|ECG abnormality so not treated|0|||
105351869|NCT03488563|363293725|FG001|Overall Study|Subject returned for ET visit|1|||
105351870|NCT03488563|363293726|FG002|Overall Study|Subject returned for ET visit|0|||
105711211|NCT02574637|364604435|FG000|Double-blind Period|Adverse Event|1|||
105711212|NCT02574637|364604436|FG001|Double-blind Period|Adverse Event|0|||
105711213|NCT02574637|364604437|FG002|Double-blind Period|Adverse Event|0|||
105351871|NCT03488563|363293724|FG000|Overall Study|Sponsor's decision|0|||
105475650|NCT01124864|363755213|FG003|Overall Study|Protocol Violation|0|||
105475651|NCT01124864|363755214|FG004|Overall Study|Protocol Violation|1|||
105475652|NCT01124864|363755215|FG005|Overall Study|Protocol Violation|0|||
105475653|NCT02551991|363755218|FG000|Overall Study|Death|5|||
105475654|NCT02551991|363755219|FG001|Overall Study|Death|7|||
105475655|NCT02551991|363755220|FG002|Overall Study|Death|8|||
105475656|NCT02551991|363755221|FG003|Overall Study|Death|7|||
105475657|NCT02551991|363755222|FG004|Overall Study|Death|17|||
105475658|NCT02551991|363755218|FG000|Overall Study|Withdrawal by Subject|1|||
105475659|NCT02551991|363755219|FG001|Overall Study|Withdrawal by Subject|0|||
105475660|NCT02551991|363755220|FG002|Overall Study|Withdrawal by Subject|0|||
105475661|NCT02551991|363755221|FG003|Overall Study|Withdrawal by Subject|0|||
105475662|NCT02551991|363755222|FG004|Overall Study|Withdrawal by Subject|2|||
105711214|NCT02574637|364604438|FG003|Double-blind Period|Adverse Event|0|||
105711215|NCT02574637|364604439|FG004|Double-blind Period|Adverse Event|0|||
105711216|NCT02574637|364604440|FG005|Double-blind Period|Adverse Event|0|||
105711217|NCT02574637|364604441|FG006|Double-blind Period|Adverse Event|0|||
105711218|NCT02574637|364604442|FG007|Double-blind Period|Adverse Event|0|||
105711219|NCT02574637|364604443|FG008|Double-blind Period|Adverse Event|0|||
105711220|NCT02574637|364604444|FG009|Double-blind Period|Adverse Event|0|||
105711221|NCT02574637|364604435|FG000|Double-blind Period|Lack of Efficacy|0|||
105475663|NCT02551991|363755218|FG000|Overall Study|Lost to Follow-up|0|||
105711222|NCT02574637|364604436|FG001|Double-blind Period|Lack of Efficacy|0|||
105711223|NCT02574637|364604437|FG002|Double-blind Period|Lack of Efficacy|2|||
105711224|NCT02574637|364604438|FG003|Double-blind Period|Lack of Efficacy|0|||
105561164|NCT02690974|364050395|FG000|Overall Study|Adverse Event|16|||
105561165|NCT02690974|364050395|FG000|Overall Study|Death|9|||
105561166|NCT02690974|364050395|FG000|Overall Study|Subject/guardian decision|4|||
105561167|NCT02690974|364050395|FG000|Overall Study|Lost to Follow-up|3|||
105561168|NCT02690974|364050395|FG000|Overall Study|Withdrawal of Informed Consent|3|||
105561169|NCT02690974|364050395|FG000|Overall Study|Physician Decision|2|||
105711225|NCT02574637|364604439|FG004|Double-blind Period|Lack of Efficacy|0|||
105711226|NCT02574637|364604440|FG005|Double-blind Period|Lack of Efficacy|0|||
105711227|NCT02574637|364604441|FG006|Double-blind Period|Lack of Efficacy|0|||
105711228|NCT02574637|364604442|FG007|Double-blind Period|Lack of Efficacy|0|||
105711229|NCT02574637|364604443|FG008|Double-blind Period|Lack of Efficacy|0|||
105711230|NCT02574637|364604444|FG009|Double-blind Period|Lack of Efficacy|0|||
105711231|NCT02574637|364604435|FG000|Double-blind Period|Protocol Deviation|1|||
105711232|NCT02574637|364604436|FG001|Double-blind Period|Protocol Deviation|0|||
105711233|NCT02574637|364604437|FG002|Double-blind Period|Protocol Deviation|0|||
105711234|NCT02574637|364604438|FG003|Double-blind Period|Protocol Deviation|0|||
105711235|NCT02574637|364604439|FG004|Double-blind Period|Protocol Deviation|0|||
105475664|NCT02551991|363755219|FG001|Overall Study|Lost to Follow-up|0|||
105475665|NCT02551991|363755220|FG002|Overall Study|Lost to Follow-up|1|||
105561170|NCT02690974|364050395|FG000|Overall Study|Non-compliance with study treatment|1|||
105561171|NCT02690974|364050395|FG000|Overall Study|Protocol-defined stopping criteria|1|||
105711236|NCT02574637|364604440|FG005|Double-blind Period|Protocol Deviation|0|||
105711237|NCT02574637|364604441|FG006|Double-blind Period|Protocol Deviation|0|||
105711238|NCT02574637|364604442|FG007|Double-blind Period|Protocol Deviation|0|||
105711239|NCT02574637|364604443|FG008|Double-blind Period|Protocol Deviation|0|||
105711240|NCT02574637|364604444|FG009|Double-blind Period|Protocol Deviation|0|||
105711241|NCT02574637|364604435|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
105711242|NCT02574637|364604436|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
105788118|NCT03426995|364878230|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788119|NCT03426995|364878231|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105475666|NCT02551991|363755221|FG003|Overall Study|Lost to Follow-up|0|||
105475667|NCT02551991|363755222|FG004|Overall Study|Lost to Follow-up|0|||
105475668|NCT02551991|363755218|FG000|Overall Study|Sponsor Decision|1|||
105561172|NCT02690974|364050395|FG000|Overall Study|Protocol Deviation|1|||
105561173|NCT00522301|364050400|FG000|Overall Study|Withdrawal by Subject|1|||
105475669|NCT02551991|363755219|FG001|Overall Study|Sponsor Decision|0|||
105475670|NCT02551991|363755220|FG002|Overall Study|Sponsor Decision|1|||
105475671|NCT02551991|363755221|FG003|Overall Study|Sponsor Decision|0|||
105475672|NCT02551991|363755222|FG004|Overall Study|Sponsor Decision|5|||
105475673|NCT02551991|363755218|FG000|Overall Study|Other|0|||
105475674|NCT02551991|363755219|FG001|Overall Study|Other|0|||
105475675|NCT02551991|363755220|FG002|Overall Study|Other|0|||
105475676|NCT02551991|363755221|FG003|Overall Study|Other|0|||
105475677|NCT02551991|363755222|FG004|Overall Study|Other|1|||
105711243|NCT02574637|364604437|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
105711244|NCT02574637|364604438|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
105711245|NCT02574637|364604439|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
105711246|NCT02574637|364604440|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
105711247|NCT02574637|364604441|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
105711248|NCT02574637|364604442|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
105711249|NCT02574637|364604443|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
105711250|NCT02574637|364604444|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
105711251|NCT02574637|364604435|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
105711252|NCT02574637|364604436|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
105711253|NCT02574637|364604437|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
105711254|NCT02574637|364604438|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
105711255|NCT02574637|364604439|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
105711256|NCT02574637|364604440|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
105711257|NCT02574637|364604441|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
105711258|NCT02574637|364604442|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
105351872|NCT03488563|363293725|FG001|Overall Study|Sponsor's decision|0|||
105351873|NCT03488563|363293726|FG002|Overall Study|Sponsor's decision|1|||
105351874|NCT00329745|363293727|FG000|Overall Study|Protocol Violation|1|||
105711259|NCT02574637|364604443|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
105711260|NCT02574637|364604444|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
105351875|NCT00329745|363293728|FG001|Overall Study|Protocol Violation|0|||
105351876|NCT00329745|363293727|FG000|Overall Study|Withdrawal by Subject|0|||
105351877|NCT00329745|363293728|FG001|Overall Study|Withdrawal by Subject|1|||
105351878|NCT00329745|363293727|FG000|Overall Study|Lost to Follow-up|86|||
105351879|NCT00329745|363293728|FG001|Overall Study|Lost to Follow-up|101|||
105351880|NCT04165135|363293729|FG000|Overall Study|Protocol Violation|10|||
105351881|NCT04165135|363293729|FG000|Overall Study|Participants withdrawal of consent|5|||
105351882|NCT03517449|363293734|FG000|Overall Study|Death|184|||
105351883|NCT03517449|363293735|FG001|Overall Study|Death|236|||
105351884|NCT03517449|363293734|FG000|Overall Study|Lost to Follow-up|0|||
105351885|NCT03517449|363293735|FG001|Overall Study|Lost to Follow-up|2|||
105351886|NCT03517449|363293734|FG000|Overall Study|Withdrawal by Subject|7|||
105351887|NCT03517449|363293735|FG001|Overall Study|Withdrawal by Subject|26|||
105711261|NCT02574637|364604435|FG000|Double-blind Period|Reason Not Specified|0|||
105711262|NCT02574637|364604436|FG001|Double-blind Period|Reason Not Specified|0|||
105711263|NCT02574637|364604437|FG002|Double-blind Period|Reason Not Specified|0|||
105711264|NCT02574637|364604438|FG003|Double-blind Period|Reason Not Specified|1|||
105711265|NCT02574637|364604439|FG004|Double-blind Period|Reason Not Specified|0|||
105711266|NCT02574637|364604440|FG005|Double-blind Period|Reason Not Specified|0|||
105711267|NCT02574637|364604441|FG006|Double-blind Period|Reason Not Specified|0|||
105711268|NCT02574637|364604442|FG007|Double-blind Period|Reason Not Specified|0|||
105711269|NCT02574637|364604443|FG008|Double-blind Period|Reason Not Specified|0|||
105711270|NCT02574637|364604444|FG009|Double-blind Period|Reason Not Specified|0|||
105711271|NCT02574637|364604435|FG000|Open-label (OL) Period|Adverse Event|0|||
105711272|NCT02574637|364604436|FG001|Open-label (OL) Period|Adverse Event|0|||
105711273|NCT02574637|364604437|FG002|Open-label (OL) Period|Adverse Event|0|||
105711274|NCT02574637|364604438|FG003|Open-label (OL) Period|Adverse Event|0|||
105711275|NCT02574637|364604439|FG004|Open-label (OL) Period|Adverse Event|0|||
105711276|NCT02574637|364604440|FG005|Open-label (OL) Period|Adverse Event|0|||
105711277|NCT02574637|364604441|FG006|Open-label (OL) Period|Adverse Event|0|||
105788120|NCT03426995|364878232|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105351888|NCT03517449|363293734|FG000|Overall Study|Participants Ongoing|220|||
105351889|NCT03517449|363293735|FG001|Overall Study|Participants Ongoing|152|||
105351890|NCT04521114|363293736|FG000|Overall Study|Lost to Follow-up|1|||
105351891|NCT04521114|363293737|FG001|Overall Study|Lost to Follow-up|2|||
105351892|NCT04521114|363293738|FG002|Overall Study|Lost to Follow-up|0|||
105351893|NCT04521114|363293736|FG000|Overall Study|Withdrawal by Subject|1|||
105351894|NCT04521114|363293737|FG001|Overall Study|Withdrawal by Subject|2|||
105351895|NCT04521114|363293738|FG002|Overall Study|Withdrawal by Subject|2|||
105351896|NCT04521114|363293736|FG000|Overall Study|Adverse Event|1|||
105351897|NCT04521114|363293737|FG001|Overall Study|Adverse Event|0|||
105351898|NCT04521114|363293738|FG002|Overall Study|Adverse Event|0|||
105351899|NCT04521114|363293736|FG000|Overall Study|Sponsor Wish|1|||
105351900|NCT04521114|363293737|FG001|Overall Study|Sponsor Wish|0|||
105788121|NCT03426995|364878233|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105351901|NCT04521114|363293738|FG002|Overall Study|Sponsor Wish|0|||
105711278|NCT02574637|364604442|FG007|Open-label (OL) Period|Adverse Event|0|||
105711279|NCT02574637|364604443|FG008|Open-label (OL) Period|Adverse Event|1|||
105711280|NCT02574637|364604444|FG009|Open-label (OL) Period|Adverse Event|0|||
105351902|NCT04521114|363293736|FG000|Overall Study|Withdrawal of Consent|2|||
105351903|NCT04521114|363293737|FG001|Overall Study|Withdrawal of Consent|2|||
105351904|NCT04521114|363293738|FG002|Overall Study|Withdrawal of Consent|0|||
105351905|NCT03003000|363293742|FG000|Overall Study|Adverse Event|1|||
105351906|NCT03003000|363293743|FG001|Overall Study|Adverse Event|2|||
105351907|NCT03003000|363293744|FG002|Overall Study|Adverse Event|3|||
105351908|NCT03003000|363293742|FG000|Overall Study|Lack of Efficacy|1|||
105711281|NCT02574637|364604435|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
105711282|NCT02574637|364604436|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
105711283|NCT02574637|364604437|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
105711284|NCT02574637|364604438|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
105711285|NCT02574637|364604439|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
105711286|NCT02574637|364604440|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
105711287|NCT02574637|364604441|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
105711288|NCT02574637|364604442|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
105711289|NCT02574637|364604443|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
105711290|NCT02574637|364604444|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
105711291|NCT02574637|364604435|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
105711292|NCT02574637|364604436|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
105711293|NCT02574637|364604437|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
105711294|NCT02574637|364604438|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
105711295|NCT02574637|364604439|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
105711296|NCT02574637|364604440|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
105711297|NCT02574637|364604441|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
105711298|NCT02574637|364604442|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
105711299|NCT02574637|364604443|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
105711300|NCT02574637|364604444|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
105711301|NCT00662792|364604446|FG000|Period 1|Personal Reasons|0|||
105711302|NCT00662792|364604447|FG001|Period 1|Personal Reasons|0|||
105711303|NCT00662792|364604448|FG002|Period 1|Personal Reasons|1|||
105711304|NCT00662792|364604449|FG003|Period 1|Personal Reasons|0|||
105711305|NCT00662792|364604446|FG000|Period 1|Refused continuing medication|0|||
105711306|NCT00662792|364604447|FG001|Period 1|Refused continuing medication|1|||
105711307|NCT00662792|364604448|FG002|Period 1|Refused continuing medication|1|||
105711308|NCT00662792|364604449|FG003|Period 1|Refused continuing medication|0|||
105711309|NCT00662792|364604446|FG000|Period 1|Lost to Follow-up|1|||
105711310|NCT00662792|364604447|FG001|Period 1|Lost to Follow-up|0|||
105711311|NCT00662792|364604448|FG002|Period 1|Lost to Follow-up|0|||
105711312|NCT00662792|364604449|FG003|Period 1|Lost to Follow-up|0|||
105711313|NCT00662792|364604446|FG000|Period 1|Other adverse event (AE)|0|||
105711314|NCT00662792|364604447|FG001|Period 1|Other adverse event (AE)|2|||
105561174|NCT00522301|364050400|FG000|Overall Study|Adverse Event|5|||
105561175|NCT01666951|364050401|FG000|Overall Study|Not dosed|1|||
105561176|NCT01666951|364050402|FG001|Overall Study|Not dosed|1|||
105561177|NCT02052310|364050405|FG000|Overall Study|Death|64|||
105561178|NCT02052310|364050406|FG001|Overall Study|Death|54|||
105561179|NCT02052310|364050405|FG000|Overall Study|Withdrawal by Subject|37|||
105561180|NCT02052310|364050406|FG001|Overall Study|Withdrawal by Subject|49|||
105561181|NCT02052310|364050405|FG000|Overall Study|Other than specified|32|||
105561182|NCT02052310|364050406|FG001|Overall Study|Other than specified|29|||
105561183|NCT02052310|364050405|FG000|Overall Study|Adverse Event|29|||
105561184|NCT02052310|364050406|FG001|Overall Study|Adverse Event|22|||
105561185|NCT02052310|364050405|FG000|Overall Study|Kidney Transplant|23|||
105561186|NCT02052310|364050406|FG001|Overall Study|Kidney Transplant|29|||
105561187|NCT02052310|364050405|FG000|Overall Study|Physician Decision|14|||
105561188|NCT02052310|364050406|FG001|Overall Study|Physician Decision|7|||
105711315|NCT00662792|364604448|FG002|Period 1|Other adverse event (AE)|0|||
105711316|NCT00662792|364604449|FG003|Period 1|Other adverse event (AE)|0|||
105711317|NCT00662792|364604446|FG000|Period 1|Worsening of disease under study (AE)|1|||
105711318|NCT00662792|364604447|FG001|Period 1|Worsening of disease under study (AE)|3|||
105711319|NCT00662792|364604448|FG002|Period 1|Worsening of disease under study (AE)|2|||
105788122|NCT03426995|364878234|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105561189|NCT02052310|364050405|FG000|Overall Study|Lack of Efficacy|6|||
105351909|NCT03003000|363293743|FG001|Overall Study|Lack of Efficacy|0|||
105351910|NCT03003000|363293744|FG002|Overall Study|Lack of Efficacy|0|||
105351911|NCT03003000|363293742|FG000|Overall Study|Non-compliant with protocol|0|||
105351912|NCT03003000|363293743|FG001|Overall Study|Non-compliant with protocol|1|||
105711320|NCT00662792|364604449|FG003|Period 1|Worsening of disease under study (AE)|0|||
105711321|NCT00662792|364604446|FG000|Period 1|Not treated|0|||
105711322|NCT00662792|364604447|FG001|Period 1|Not treated|1|||
105351913|NCT03003000|363293744|FG002|Overall Study|Non-compliant with protocol|1|||
105351914|NCT03003000|363293742|FG000|Overall Study|Refused to continue medication|2|||
105351915|NCT03003000|363293743|FG001|Overall Study|Refused to continue medication|0|||
105351916|NCT03003000|363293744|FG002|Overall Study|Refused to continue medication|0|||
105351917|NCT03003000|363293742|FG000|Overall Study|Other than listed|1|||
105351918|NCT03003000|363293743|FG001|Overall Study|Other than listed|1|||
105351919|NCT03003000|363293744|FG002|Overall Study|Other than listed|1|||
105351920|NCT03230838|363293747|FG000|Overall Study|Withdrawal by Subject|3|||
105351921|NCT03230838|363293748|FG001|Overall Study|Withdrawal by Subject|0|||
105351922|NCT03230838|363293747|FG000|Overall Study|Temperature excursion|1|||
105351923|NCT03230838|363293748|FG001|Overall Study|Temperature excursion|0|||
105351924|NCT01915771|363293749|FG000|Day 1|Withdrawal by Subject|1|||
105351925|NCT01915771|363293749|FG000|Day 15|Withdrawal by Subject|1|||
105351926|NCT03420222|363293750|FG000|Overall Study|Withdrawal by Subject|5|||
105351927|NCT03420222|363293751|FG001|Overall Study|Withdrawal by Subject|0|||
105351928|NCT03420222|363293750|FG000|Overall Study|Physician Decision|0|||
105351929|NCT03420222|363293751|FG001|Overall Study|Physician Decision|1|||
105351930|NCT02697734|363293754|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
105351931|NCT02697734|363293755|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
105351932|NCT02697734|363293754|FG000|Core Phase - up to Week 48|Adverse Event|1|||
105351933|NCT02697734|363293755|FG001|Core Phase - up to Week 48|Adverse Event|2|||
105351934|NCT02697734|363293754|FG000|Core Phase - up to Week 48|Physician Decision|1|||
105351935|NCT02697734|363293755|FG001|Core Phase - up to Week 48|Physician Decision|0|||
105475678|NCT00265148|363755223|FG000|Overall Study|Adverse Event|2|||
105475679|NCT00265148|363755224|FG001|Overall Study|Adverse Event|2|||
105475680|NCT00265148|363755223|FG000|Overall Study|Lack of Efficacy|0|||
105475681|NCT00265148|363755224|FG001|Overall Study|Lack of Efficacy|2|||
105475682|NCT00265148|363755223|FG000|Overall Study|Protocol Violation|3|||
105475683|NCT00265148|363755224|FG001|Overall Study|Protocol Violation|2|||
105475684|NCT00265148|363755223|FG000|Overall Study|Lost to Follow-up|0|||
105475685|NCT00265148|363755224|FG001|Overall Study|Lost to Follow-up|1|||
105475686|NCT00265148|363755223|FG000|Overall Study|Withdrawal by Subject|2|||
105475687|NCT00265148|363755224|FG001|Overall Study|Withdrawal by Subject|1|||
105475688|NCT00265148|363755223|FG000|Overall Study|Physician Decision|1|||
105475689|NCT00265148|363755224|FG001|Overall Study|Physician Decision|0|||
105475690|NCT00265148|363755223|FG000|Overall Study|Increasing frailty|0|||
105475691|NCT00265148|363755224|FG001|Overall Study|Increasing frailty|1|||
105475692|NCT00265148|363755223|FG000|Overall Study|Subject chose to change of the dose|1|||
105475693|NCT00265148|363755224|FG001|Overall Study|Subject chose to change of the dose|0|||
105475694|NCT01311024|363755225|FG000|Overall Study|Protocol Violation|35|||
105475695|NCT01311024|363755226|FG001|Overall Study|Protocol Violation|22|||
105475696|NCT00591318|363755233|FG000|Overall Study|Lack of Efficacy|2|||
105475697|NCT00591318|363755234|FG001|Overall Study|Lack of Efficacy|0|||
105475698|NCT00591318|363755233|FG000|Overall Study|Adverse Event|2|||
105475699|NCT00591318|363755234|FG001|Overall Study|Adverse Event|0|||
105475700|NCT04074161|363755235|FG000|Overall Study|Withdrawal by Subject|2|||
105475701|NCT04074161|363755236|FG001|Overall Study|Withdrawal by Subject|4|||
105475702|NCT04074161|363755237|FG002|Overall Study|Withdrawal by Subject|1|||
105475703|NCT04074161|363755235|FG000|Overall Study|Lost to Follow-up|4|||
105475704|NCT04074161|363755236|FG001|Overall Study|Lost to Follow-up|5|||
105475705|NCT04074161|363755237|FG002|Overall Study|Lost to Follow-up|3|||
105475706|NCT03595228|363755240|FG000|Overall Study|Death|2|||
105475707|NCT03595228|363755240|FG000|Overall Study|Lack of Efficacy|13|||
105475708|NCT03595228|363755240|FG000|Overall Study|Withdrawal by Subject|3|||
105475709|NCT03595228|363755240|FG000|Overall Study|Withdrawal by Sponsor|1|||
105475710|NCT00200356|363755241|FG000|Overall Study|Lack of Efficacy|3|||
105475711|NCT00200356|363755242|FG001|Overall Study|Lack of Efficacy|3|||
105475712|NCT00200356|363755241|FG000|Overall Study|Protocol Violation|4|||
105475713|NCT00200356|363755242|FG001|Overall Study|Protocol Violation|4|||
105475714|NCT00200356|363755241|FG000|Overall Study|Nontreatment|1|||
105561190|NCT02052310|364050406|FG001|Overall Study|Lack of Efficacy|1|||
105711323|NCT00662792|364604448|FG002|Period 1|Not treated|0|||
105351936|NCT02697734|363293754|FG000|Optional Extension Phase|Adverse Event|5|||
105351937|NCT02697734|363293755|FG001|Optional Extension Phase|Adverse Event|1|||
105475715|NCT00200356|363755242|FG001|Overall Study|Nontreatment|0|||
105475716|NCT02059291|363755249|FG000|Epoch 2|Lack of Efficacy|0|||
105475717|NCT02059291|363755250|FG001|Epoch 2|Lack of Efficacy|0|||
105475718|NCT02059291|363755251|FG002|Epoch 2|Lack of Efficacy|0|||
105475719|NCT02059291|363755252|FG003|Epoch 2|Lack of Efficacy|1|||
105475720|NCT02059291|363755253|FG004|Epoch 2|Lack of Efficacy|0|||
105475721|NCT02059291|363755254|FG005|Epoch 2|Lack of Efficacy|1|||
105475722|NCT02059291|363755255|FG006|Epoch 2|Lack of Efficacy|0|||
105561191|NCT02052310|364050405|FG000|Overall Study|Site Terminated by Sponsor|5|||
105561192|NCT02052310|364050406|FG001|Overall Study|Site Terminated by Sponsor|13|||
105561193|NCT02052310|364050405|FG000|Overall Study|Lost to Follow-up|4|||
105561194|NCT02052310|364050406|FG001|Overall Study|Lost to Follow-up|2|||
105561195|NCT02052310|364050405|FG000|Overall Study|Protocol Violation|1|||
105561196|NCT02052310|364050406|FG001|Overall Study|Protocol Violation|6|||
105561197|NCT00152464|364050407|FG000|Overall Study|Adverse Event|3|||
105561198|NCT00152464|364050408|FG001|Overall Study|Adverse Event|6|||
105561199|NCT00152464|364050407|FG000|Overall Study|Lost to Follow-up|8|||
105561200|NCT00152464|364050408|FG001|Overall Study|Lost to Follow-up|4|||
105561201|NCT00152464|364050407|FG000|Overall Study|Protocol Violation|3|||
105561202|NCT00152464|364050408|FG001|Overall Study|Protocol Violation|1|||
105561203|NCT00152464|364050407|FG000|Overall Study|Withdrawal by Subject|21|||
105561204|NCT00152464|364050408|FG001|Overall Study|Withdrawal by Subject|22|||
105561205|NCT00152464|364050407|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
105561206|NCT00152464|364050408|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
105561207|NCT00152464|364050407|FG000|Overall Study|Eczema deterioration|0|||
105561208|NCT00152464|364050408|FG001|Overall Study|Eczema deterioration|1|||
105561209|NCT00152464|364050407|FG000|Overall Study|Parent decision|1|||
105561210|NCT00152464|364050408|FG001|Overall Study|Parent decision|1|||
105561211|NCT00152464|364050407|FG000|Overall Study|Investigator decision|1|||
105561212|NCT00152464|364050408|FG001|Overall Study|Investigator decision|0|||
105561213|NCT00152464|364050407|FG000|Overall Study|Lack of Efficacy|1|||
105561214|NCT00152464|364050408|FG001|Overall Study|Lack of Efficacy|0|||
105561215|NCT00152464|364050407|FG000|Overall Study|Eczema poorly controlled|1|||
105561216|NCT00152464|364050408|FG001|Overall Study|Eczema poorly controlled|0|||
105561217|NCT00152464|364050407|FG000|Overall Study|Patient relocated|1|||
105561218|NCT00152464|364050408|FG001|Overall Study|Patient relocated|0|||
105561219|NCT01644734|364050409|FG000|Overall Study|Adverse Event|4|||
105561220|NCT01644734|364050409|FG000|Overall Study|Lost to Follow-up|17|||
105561221|NCT01644734|364050409|FG000|Overall Study|Reasons other than stated above|7|||
105561222|NCT01644734|364050409|FG000|Overall Study|Missing documentation|238|||
105561223|NCT01410474|364050410|FG000|Overall Study|Withdrawal by Subject|0|||
105561224|NCT01410474|364050411|FG001|Overall Study|Withdrawal by Subject|1|||
105561225|NCT02428296|364050412|FG000|Overall Study|Adverse Event|7|||
105561226|NCT02428296|364050412|FG000|Overall Study|Withdrawal by Subject|2|||
105561227|NCT00620750|364050413|FG000|Overall Study|Lost to Follow-up|25|||
105561228|NCT04477187|364050414|FG000|Overall Study|Lost to Follow-up|2|||
105561229|NCT03232983|364050418|FG000|Period 1|Physician Decision|0|||
105561230|NCT03232983|364050419|FG001|Period 1|Physician Decision|0|||
105561231|NCT03232983|364050420|FG002|Period 1|Physician Decision|1|||
105561232|NCT03232983|364050421|FG003|Period 1|Physician Decision|0|||
105561233|NCT03232983|364050418|FG000|Washout Period 2|Physician Decision|0|||
105561234|NCT03232983|364050419|FG001|Washout Period 2|Physician Decision|0|||
105561235|NCT03232983|364050420|FG002|Washout Period 2|Physician Decision|1|||
105561236|NCT03232983|364050421|FG003|Washout Period 2|Physician Decision|0|||
105561237|NCT03232983|364050418|FG000|Washout Period 2|Withdrawal by Subject|0|||
105561238|NCT03232983|364050419|FG001|Washout Period 2|Withdrawal by Subject|0|||
105561239|NCT03232983|364050420|FG002|Washout Period 2|Withdrawal by Subject|0|||
105561240|NCT03232983|364050421|FG003|Washout Period 2|Withdrawal by Subject|1|||
105561241|NCT03232983|364050418|FG000|Period 4|Withdrawal by Subject|1|||
105561242|NCT03232983|364050419|FG001|Period 4|Withdrawal by Subject|0|||
105561243|NCT03232983|364050420|FG002|Period 4|Withdrawal by Subject|0|||
105561244|NCT03232983|364050421|FG003|Period 4|Withdrawal by Subject|0|||
105561245|NCT01615328|364050422|FG000|Overall Study|Lost to Follow-up|3|||
105561246|NCT01615328|364050423|FG001|Overall Study|Lost to Follow-up|5|||
105561247|NCT00430248|364050426|FG000|Overall Study|Adverse Event|49|||
105561248|NCT00430248|364050427|FG001|Overall Study|Adverse Event|61|||
105561249|NCT00430248|364050428|FG002|Overall Study|Adverse Event|64|||
105711324|NCT00662792|364604449|FG003|Period 1|Not treated|0|||
105711325|NCT00662792|364604446|FG000|Period 2|Worsening of disease under study|1|||
105711326|NCT00662792|364604447|FG001|Period 2|Worsening of disease under study|0|||
105711327|NCT00662792|364604448|FG002|Period 2|Worsening of disease under study|0|||
105711328|NCT00662792|364604449|FG003|Period 2|Worsening of disease under study|3|||
105711329|NCT00662792|364604446|FG000|Period 3|Refused continuing medication|1|||
105561250|NCT00430248|364050426|FG000|Overall Study|Protocol Violation|10|||
105561251|NCT00430248|364050427|FG001|Overall Study|Protocol Violation|2|||
105561252|NCT00430248|364050428|FG002|Overall Study|Protocol Violation|4|||
105561253|NCT00430248|364050426|FG000|Overall Study|Personal Reasons|12|||
105561254|NCT00430248|364050427|FG001|Overall Study|Personal Reasons|24|||
105561255|NCT00430248|364050428|FG002|Overall Study|Personal Reasons|9|||
105561256|NCT00430248|364050426|FG000|Overall Study|Lost to Follow-up|28|||
105561257|NCT00430248|364050427|FG001|Overall Study|Lost to Follow-up|33|||
105561258|NCT00430248|364050428|FG002|Overall Study|Lost to Follow-up|28|||
105561259|NCT00430248|364050426|FG000|Overall Study|Therapeutic Failure|1|||
105711330|NCT00662792|364604447|FG001|Period 3|Refused continuing medication|0|||
105561260|NCT00430248|364050427|FG001|Overall Study|Therapeutic Failure|1|||
105561261|NCT00430248|364050428|FG002|Overall Study|Therapeutic Failure|1|||
105711331|NCT00662792|364604448|FG002|Period 3|Refused continuing medication|1|||
105711332|NCT00662792|364604449|FG003|Period 3|Refused continuing medication|0|||
105711333|NCT00662792|364604446|FG000|Period 3|Other adverse event (AE)|0|||
105711334|NCT00662792|364604447|FG001|Period 3|Other adverse event (AE)|0|||
105711335|NCT00662792|364604448|FG002|Period 3|Other adverse event (AE)|1|||
105711336|NCT00662792|364604449|FG003|Period 3|Other adverse event (AE)|1|||
105711337|NCT00662792|364604446|FG000|Period 4|Refused continuing medication|0|||
105711338|NCT00662792|364604447|FG001|Period 4|Refused continuing medication|1|||
105711339|NCT00662792|364604448|FG002|Period 4|Refused continuing medication|0|||
105711340|NCT00662792|364604449|FG003|Period 4|Refused continuing medication|0|||
105711341|NCT00662792|364604446|FG000|Period 4|Other adverse event (AE)|1|||
105711342|NCT00662792|364604447|FG001|Period 4|Other adverse event (AE)|0|||
105711343|NCT00662792|364604448|FG002|Period 4|Other adverse event (AE)|0|||
105711344|NCT00662792|364604449|FG003|Period 4|Other adverse event (AE)|0|||
105711345|NCT00662792|364604446|FG000|Period 4|Worsening of disease under study (AE)|0|||
105711346|NCT00662792|364604447|FG001|Period 4|Worsening of disease under study (AE)|0|||
105711347|NCT00662792|364604448|FG002|Period 4|Worsening of disease under study (AE)|0|||
105351938|NCT02697734|363293754|FG000|Optional Extension Phase|Physician Decision|0|||
105351939|NCT02697734|363293755|FG001|Optional Extension Phase|Physician Decision|1|||
105351940|NCT02334384|363293757|FG000|Overall Study|Lost to Follow-up|1|||
105351941|NCT02334384|363293758|FG001|Overall Study|Lost to Follow-up|1|||
105711348|NCT00662792|364604449|FG003|Period 4|Worsening of disease under study (AE)|1|||
105711349|NCT02706730|364604450|FG000|Overall Study|Adverse Event|3|||
105711350|NCT02706730|364604450|FG000|Overall Study|Lack of Efficacy|5|||
105711351|NCT02706730|364604450|FG000|Overall Study|Withdrawal by Subject|11|||
105711352|NCT02706730|364604450|FG000|Overall Study|Study Terminated by Sponsor|11|||
105711353|NCT02706730|364604450|FG000|Overall Study|Subject chose not to receive injection|3|||
105711354|NCT00094055|364604451|FG000|Overall Study|Adverse Event|11|||
105711355|NCT00094055|364604451|FG000|Overall Study|Death|4|||
105711356|NCT00094055|364604451|FG000|Overall Study|Lack of Efficacy|17|||
105711357|NCT00094055|364604451|FG000|Overall Study|Lost to Follow-up|2|||
105711358|NCT00094055|364604451|FG000|Overall Study|progressive disease|2|||
105711359|NCT00094055|364604451|FG000|Overall Study|clinical progression|1|||
105711360|NCT00094055|364604451|FG000|Overall Study|roll-over to another study|14|||
105711361|NCT00094055|364604451|FG000|Overall Study|Withdrawal by Subject|9|||
105711362|NCT01999582|364604452|FG000|Overall Study|Withdrawal by Subject|0|||
105351942|NCT02651688|363293759|FG000|Overall Study|Non-compliance|0|||
105351943|NCT02651688|363293760|FG001|Overall Study|Non-compliance|0|||
105351944|NCT02651688|363293761|FG002|Overall Study|Non-compliance|1|||
105475723|NCT02059291|363755256|FG007|Epoch 2|Lack of Efficacy|0|||
105475724|NCT02059291|363755257|FG008|Epoch 2|Lack of Efficacy|0|||
105711363|NCT01999582|364604453|FG001|Overall Study|Withdrawal by Subject|0|||
105711364|NCT01999582|364604454|FG002|Overall Study|Withdrawal by Subject|0|||
105711365|NCT01999582|364604455|FG003|Overall Study|Withdrawal by Subject|1|||
105711366|NCT01999582|364604456|FG004|Overall Study|Withdrawal by Subject|0|||
105711367|NCT01999582|364604457|FG005|Overall Study|Withdrawal by Subject|0|||
105475725|NCT02059291|363755258|FG009|Epoch 2|Lack of Efficacy|0|||
105475726|NCT02059291|363755259|FG010|Epoch 2|Lack of Efficacy|0|||
105711368|NCT01999582|364604452|FG000|Overall Study|Adverse Event|0|||
105711369|NCT01999582|364604453|FG001|Overall Study|Adverse Event|0|||
105711370|NCT01999582|364604454|FG002|Overall Study|Adverse Event|3|||
105711371|NCT01999582|364604455|FG003|Overall Study|Adverse Event|0|||
105711372|NCT01999582|364604456|FG004|Overall Study|Adverse Event|1|||
105475727|NCT02059291|363755260|FG011|Epoch 2|Lack of Efficacy|0|||
105475728|NCT02059291|363755261|FG012|Epoch 2|Lack of Efficacy|0|||
105475729|NCT02059291|363755262|FG013|Epoch 2|Lack of Efficacy|0|||
105475730|NCT02059291|363755263|FG014|Epoch 2|Lack of Efficacy|0|||
105475731|NCT02059291|363755264|FG015|Epoch 2|Lack of Efficacy|0|||
105475732|NCT02059291|363755265|FG016|Epoch 2|Lack of Efficacy|0|||
105475733|NCT02059291|363755266|FG017|Epoch 2|Lack of Efficacy|0|||
105475734|NCT02059291|363755267|FG018|Epoch 2|Lack of Efficacy|0|||
105475735|NCT02059291|363755268|FG019|Epoch 2|Lack of Efficacy|0|||
105475736|NCT02059291|363755269|FG020|Epoch 2|Lack of Efficacy|0|||
105475737|NCT02059291|363755270|FG021|Epoch 2|Lack of Efficacy|0|||
105475738|NCT02059291|363755271|FG022|Epoch 2|Lack of Efficacy|0|||
105475739|NCT02059291|363755272|FG023|Epoch 2|Lack of Efficacy|0|||
105475740|NCT02059291|363755273|FG024|Epoch 2|Lack of Efficacy|0|||
105475741|NCT02059291|363755249|FG000|Epoch 2|Adverse Event|0|||
105475742|NCT02059291|363755250|FG001|Epoch 2|Adverse Event|0|||
105475743|NCT02059291|363755251|FG002|Epoch 2|Adverse Event|1|||
105475744|NCT02059291|363755252|FG003|Epoch 2|Adverse Event|1|||
105475745|NCT02059291|363755253|FG004|Epoch 2|Adverse Event|0|||
105475746|NCT02059291|363755254|FG005|Epoch 2|Adverse Event|0|||
105475747|NCT02059291|363755255|FG006|Epoch 2|Adverse Event|0|||
105475748|NCT02059291|363755256|FG007|Epoch 2|Adverse Event|1|||
105475749|NCT02059291|363755257|FG008|Epoch 2|Adverse Event|1|||
105475750|NCT02059291|363755258|FG009|Epoch 2|Adverse Event|0|||
105475751|NCT02059291|363755259|FG010|Epoch 2|Adverse Event|0|||
105475752|NCT02059291|363755260|FG011|Epoch 2|Adverse Event|0|||
105475753|NCT02059291|363755261|FG012|Epoch 2|Adverse Event|0|||
105475754|NCT02059291|363755262|FG013|Epoch 2|Adverse Event|0|||
105475755|NCT02059291|363755263|FG014|Epoch 2|Adverse Event|0|||
105475756|NCT02059291|363755264|FG015|Epoch 2|Adverse Event|0|||
105475757|NCT02059291|363755265|FG016|Epoch 2|Adverse Event|0|||
105475758|NCT02059291|363755266|FG017|Epoch 2|Adverse Event|0|||
105475759|NCT02059291|363755267|FG018|Epoch 2|Adverse Event|0|||
105475760|NCT02059291|363755268|FG019|Epoch 2|Adverse Event|0|||
105475761|NCT02059291|363755269|FG020|Epoch 2|Adverse Event|0|||
105475762|NCT02059291|363755270|FG021|Epoch 2|Adverse Event|0|||
105475763|NCT02059291|363755271|FG022|Epoch 2|Adverse Event|0|||
105475764|NCT02059291|363755272|FG023|Epoch 2|Adverse Event|0|||
105475765|NCT02059291|363755273|FG024|Epoch 2|Adverse Event|0|||
105475766|NCT02059291|363755249|FG000|Epoch 2|Withdrawal by Subject|0|||
105475767|NCT02059291|363755250|FG001|Epoch 2|Withdrawal by Subject|1|||
105475768|NCT02059291|363755251|FG002|Epoch 2|Withdrawal by Subject|0|||
105475769|NCT02059291|363755252|FG003|Epoch 2|Withdrawal by Subject|0|||
105475770|NCT02059291|363755253|FG004|Epoch 2|Withdrawal by Subject|0|||
105475771|NCT02059291|363755254|FG005|Epoch 2|Withdrawal by Subject|1|||
105475772|NCT02059291|363755255|FG006|Epoch 2|Withdrawal by Subject|0|||
105475773|NCT02059291|363755256|FG007|Epoch 2|Withdrawal by Subject|0|||
105475774|NCT02059291|363755257|FG008|Epoch 2|Withdrawal by Subject|1|||
105475775|NCT02059291|363755258|FG009|Epoch 2|Withdrawal by Subject|0|||
105475776|NCT02059291|363755259|FG010|Epoch 2|Withdrawal by Subject|0|||
105475777|NCT02059291|363755260|FG011|Epoch 2|Withdrawal by Subject|0|||
105475778|NCT02059291|363755261|FG012|Epoch 2|Withdrawal by Subject|0|||
105475779|NCT02059291|363755262|FG013|Epoch 2|Withdrawal by Subject|0|||
105475780|NCT02059291|363755263|FG014|Epoch 2|Withdrawal by Subject|0|||
105475781|NCT02059291|363755264|FG015|Epoch 2|Withdrawal by Subject|0|||
105475782|NCT02059291|363755265|FG016|Epoch 2|Withdrawal by Subject|0|||
105475783|NCT02059291|363755266|FG017|Epoch 2|Withdrawal by Subject|0|||
105475784|NCT02059291|363755267|FG018|Epoch 2|Withdrawal by Subject|0|||
105475785|NCT02059291|363755268|FG019|Epoch 2|Withdrawal by Subject|0|||
105475786|NCT02059291|363755269|FG020|Epoch 2|Withdrawal by Subject|0|||
105475787|NCT02059291|363755270|FG021|Epoch 2|Withdrawal by Subject|0|||
105475788|NCT02059291|363755271|FG022|Epoch 2|Withdrawal by Subject|0|||
105475789|NCT02059291|363755272|FG023|Epoch 2|Withdrawal by Subject|0|||
105711373|NCT01999582|364604457|FG005|Overall Study|Adverse Event|0|||
105711374|NCT01999582|364604452|FG000|Overall Study|Other Reasons|1|||
105475790|NCT02059291|363755273|FG024|Epoch 2|Withdrawal by Subject|0|||
105475791|NCT02059291|363755249|FG000|Epoch 3|Physician Decision|0|||
105475792|NCT02059291|363755250|FG001|Epoch 3|Physician Decision|0|||
105475793|NCT02059291|363755251|FG002|Epoch 3|Physician Decision|0|||
105475794|NCT02059291|363755252|FG003|Epoch 3|Physician Decision|0|||
105475795|NCT02059291|363755253|FG004|Epoch 3|Physician Decision|0|||
105475796|NCT02059291|363755254|FG005|Epoch 3|Physician Decision|0|||
105475797|NCT02059291|363755255|FG006|Epoch 3|Physician Decision|0|||
105475798|NCT02059291|363755256|FG007|Epoch 3|Physician Decision|0|||
105475799|NCT02059291|363755257|FG008|Epoch 3|Physician Decision|0|||
105475800|NCT02059291|363755258|FG009|Epoch 3|Physician Decision|0|||
105475801|NCT02059291|363755259|FG010|Epoch 3|Physician Decision|0|||
105475802|NCT02059291|363755260|FG011|Epoch 3|Physician Decision|0|||
105475803|NCT02059291|363755261|FG012|Epoch 3|Physician Decision|0|||
105475804|NCT02059291|363755262|FG013|Epoch 3|Physician Decision|1|||
105561262|NCT00430248|364050426|FG000|Overall Study|Withdrawal by Subject|14|||
105561263|NCT00430248|364050427|FG001|Overall Study|Withdrawal by Subject|20|||
105561264|NCT00430248|364050428|FG002|Overall Study|Withdrawal by Subject|16|||
105561265|NCT00430248|364050426|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105561266|NCT00430248|364050427|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
105561267|NCT00430248|364050428|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105561268|NCT00430248|364050426|FG000|Overall Study|Gout Flare|3|||
105561269|NCT00430248|364050427|FG001|Overall Study|Gout Flare|7|||
105561270|NCT00430248|364050428|FG002|Overall Study|Gout Flare|2|||
105561271|NCT00430248|364050426|FG000|Overall Study|Reason Not Specified|8|||
105561272|NCT00430248|364050427|FG001|Overall Study|Reason Not Specified|8|||
105561273|NCT00430248|364050428|FG002|Overall Study|Reason Not Specified|11|||
105561274|NCT00002558|364050431|FG000|Overall Study|Withdrawal by Subject|0|||
105561275|NCT00002558|364050432|FG001|Overall Study|Withdrawal by Subject|1|||
105561276|NCT01949870|364050433|FG000|Overall Study|Lack of Efficacy|2|||
105711375|NCT01999582|364604453|FG001|Overall Study|Other Reasons|0|||
105711376|NCT01999582|364604454|FG002|Overall Study|Other Reasons|3|||
105711377|NCT01999582|364604455|FG003|Overall Study|Other Reasons|1|||
105711378|NCT01999582|364604456|FG004|Overall Study|Other Reasons|1|||
105711379|NCT01999582|364604457|FG005|Overall Study|Other Reasons|2|||
105711380|NCT01999582|364604452|FG000|Overall Study|Protocol Violation|1|||
105711381|NCT01999582|364604453|FG001|Overall Study|Protocol Violation|0|||
105711382|NCT01999582|364604454|FG002|Overall Study|Protocol Violation|0|||
105711383|NCT01999582|364604455|FG003|Overall Study|Protocol Violation|0|||
105711384|NCT01999582|364604456|FG004|Overall Study|Protocol Violation|0|||
105711385|NCT01999582|364604457|FG005|Overall Study|Protocol Violation|1|||
105711386|NCT01999582|364604452|FG000|Overall Study|Lack of Efficacy|1|||
105711387|NCT01999582|364604453|FG001|Overall Study|Lack of Efficacy|3|||
105711388|NCT01999582|364604454|FG002|Overall Study|Lack of Efficacy|0|||
105711389|NCT01999582|364604455|FG003|Overall Study|Lack of Efficacy|1|||
105561277|NCT01949870|364050433|FG000|Overall Study|Adverse Event|1|||
105561278|NCT01949870|364050433|FG000|Overall Study|Study termination|1|||
105561279|NCT01949870|364050433|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
105561280|NCT02436330|364050435|FG000|Cohort 1|Lost to Follow-up|5|||
105561281|NCT02436330|364050436|FG001|Cohort 1|Lost to Follow-up|2|||
105561282|NCT02436330|364050435|FG000|Cohort 1|Withdrawal by Subject|0|||
105561283|NCT02436330|364050436|FG001|Cohort 1|Withdrawal by Subject|1|||
105561284|NCT02436330|364050435|FG000|Cohort 2|Lost to Follow-up|2|||
105561285|NCT02436330|364050436|FG001|Cohort 2|Lost to Follow-up|0|||
105561286|NCT02436330|364050435|FG000|Cohort 2|Withdrawal by Subject|2|||
105561287|NCT02436330|364050436|FG001|Cohort 2|Withdrawal by Subject|3|||
105711390|NCT01999582|364604456|FG004|Overall Study|Lack of Efficacy|0|||
105711391|NCT01999582|364604457|FG005|Overall Study|Lack of Efficacy|0|||
105561288|NCT02436330|364050435|FG000|Cohort 3|Lost to Follow-up|1|||
105561289|NCT02436330|364050436|FG001|Cohort 3|Lost to Follow-up|0|||
105561290|NCT02436330|364050435|FG000|Cohort 3|Withdrawal by Subject|4|||
105561291|NCT02436330|364050436|FG001|Cohort 3|Withdrawal by Subject|0|||
105561292|NCT02436330|364050435|FG000|Cohort 4|Lost to Follow-up|1|||
105561293|NCT02436330|364050436|FG001|Cohort 4|Lost to Follow-up|0|||
105711392|NCT02347176|364604458|FG000|Overall Study|Lost to Follow-up|2|||
105711393|NCT02347176|364604459|FG001|Overall Study|Lost to Follow-up|3|||
105711394|NCT02347176|364604460|FG002|Overall Study|Lost to Follow-up|1|||
105711395|NCT02347176|364604461|FG003|Overall Study|Lost to Follow-up|1|||
105711396|NCT02347176|364604458|FG000|Overall Study|Withdrawal by Subject|9|||
105711397|NCT02347176|364604459|FG001|Overall Study|Withdrawal by Subject|5|||
105711398|NCT02347176|364604460|FG002|Overall Study|Withdrawal by Subject|5|||
105711399|NCT02347176|364604461|FG003|Overall Study|Withdrawal by Subject|3|||
105711400|NCT02347176|364604458|FG000|Overall Study|Other|1|||
105711401|NCT02347176|364604459|FG001|Overall Study|Other|2|||
105711402|NCT02347176|364604460|FG002|Overall Study|Other|2|||
105711403|NCT02347176|364604461|FG003|Overall Study|Other|0|||
105711404|NCT03603496|364604463|FG000|Overall Study|Death|19|||
105711405|NCT03603496|364604464|FG001|Overall Study|Death|24|||
105711406|NCT03603496|364604463|FG000|Overall Study|Lost to Follow-up|141|||
105711407|NCT03603496|364604464|FG001|Overall Study|Lost to Follow-up|141|||
105711408|NCT03603496|364604463|FG000|Overall Study|Withdrawal by Subject|26|||
105711409|NCT03603496|364604464|FG001|Overall Study|Withdrawal by Subject|20|||
105711410|NCT00699907|364604467|FG000|Overall Study|Withdrawal by Subject|2|||
105711411|NCT00699907|364604468|FG001|Overall Study|Withdrawal by Subject|1|||
105711412|NCT00699907|364604469|FG002|Overall Study|Withdrawal by Subject|0|||
105711413|NCT00699907|364604467|FG000|Overall Study|No usable sample|0|||
105711414|NCT00699907|364604468|FG001|Overall Study|No usable sample|9|||
105711415|NCT00699907|364604469|FG002|Overall Study|No usable sample|8|||
105711416|NCT01081795|364604470|FG000|Overall Study|Adverse Event|18|||
105711417|NCT01081795|364604471|FG001|Overall Study|Adverse Event|23|||
105711418|NCT01081795|364604472|FG002|Overall Study|Adverse Event|6|||
105711419|NCT01081795|364604470|FG000|Overall Study|Lack of Efficacy|7|||
105711420|NCT01081795|364604471|FG001|Overall Study|Lack of Efficacy|5|||
105711421|NCT01081795|364604472|FG002|Overall Study|Lack of Efficacy|19|||
105711422|NCT01081795|364604470|FG000|Overall Study|Subject's schedule|1|||
105711423|NCT01081795|364604471|FG001|Overall Study|Subject's schedule|1|||
105711424|NCT01081795|364604472|FG002|Overall Study|Subject's schedule|2|||
105711425|NCT01081795|364604470|FG000|Overall Study|Revocation of informed consent|2|||
105711426|NCT01081795|364604471|FG001|Overall Study|Revocation of informed consent|0|||
105711427|NCT01081795|364604472|FG002|Overall Study|Revocation of informed consent|0|||
105711428|NCT01081795|364604470|FG000|Overall Study|Ineligible for participation|1|||
105711429|NCT01081795|364604471|FG001|Overall Study|Ineligible for participation|0|||
105711430|NCT01081795|364604472|FG002|Overall Study|Ineligible for participation|0|||
105711431|NCT01081795|364604470|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
105711432|NCT01081795|364604471|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
105711433|NCT01081795|364604472|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
105711434|NCT01081795|364604470|FG000|Overall Study|Using drug with restricted days of use|2|||
105711435|NCT01081795|364604471|FG001|Overall Study|Using drug with restricted days of use|3|||
105711436|NCT01081795|364604472|FG002|Overall Study|Using drug with restricted days of use|2|||
105711437|NCT01081795|364604470|FG000|Overall Study|Other|1|||
105711438|NCT01081795|364604471|FG001|Overall Study|Other|2|||
105711439|NCT01081795|364604472|FG002|Overall Study|Other|0|||
105711440|NCT02462473|364604473|FG000|Overall Study|Death|1|||
105711441|NCT02462473|364604473|FG000|Overall Study|Other|3|||
105711442|NCT00661271|364604474|FG000|Overall Study|Lost to Follow-up|28|||
105711443|NCT00661271|364604475|FG001|Overall Study|Lost to Follow-up|25|||
105711444|NCT03728309|364604480|FG000|Overall Study|Randomized but not Treated|0|||
105711445|NCT03728309|364604481|FG001|Overall Study|Randomized but not Treated|1|||
105711446|NCT03728309|364604480|FG000|Overall Study|Adverse Event|0|||
105711447|NCT03728309|364604481|FG001|Overall Study|Adverse Event|1|||
105711448|NCT03728309|364604480|FG000|Overall Study|Withdrawal by Subject|2|||
105711449|NCT03728309|364604481|FG001|Overall Study|Withdrawal by Subject|8|||
105711450|NCT03728309|364604480|FG000|Overall Study|Lost to Follow-up|9|||
105711451|NCT03728309|364604481|FG001|Overall Study|Lost to Follow-up|10|||
105711452|NCT03728309|364604480|FG000|Overall Study|Protocol Deviation|0|||
105711453|NCT03728309|364604481|FG001|Overall Study|Protocol Deviation|1|||
105711454|NCT03728309|364604480|FG000|Overall Study|Due to COVID|1|||
105561294|NCT02436330|364050435|FG000|Cohort 4|Withdrawal by Subject|1|||
105561295|NCT02436330|364050436|FG001|Cohort 4|Withdrawal by Subject|0|||
105561296|NCT02436330|364050435|FG000|Cohort 5|Lost to Follow-up|3|||
105561297|NCT02436330|364050436|FG001|Cohort 5|Lost to Follow-up|2|||
105561298|NCT02436330|364050435|FG000|Cohort 5|Withdrawal by Subject|3|||
105561299|NCT02436330|364050436|FG001|Cohort 5|Withdrawal by Subject|2|||
105561300|NCT02436330|364050435|FG000|Cohort 6|Lost to Follow-up|2|||
105561301|NCT02436330|364050436|FG001|Cohort 6|Lost to Follow-up|0|||
105561302|NCT02436330|364050435|FG000|Cohort 6|Withdrawal by Subject|1|||
105561303|NCT02436330|364050436|FG001|Cohort 6|Withdrawal by Subject|1|||
105561304|NCT02230956|364050437|FG000|Overall Study|Adverse Event|1|||
105561305|NCT02230956|364050438|FG001|Overall Study|Adverse Event|1|||
105561306|NCT02230956|364050439|FG002|Overall Study|Adverse Event|0|||
105561307|NCT02230956|364050437|FG000|Overall Study|Lack of Efficacy|1|||
105561308|NCT02230956|364050438|FG001|Overall Study|Lack of Efficacy|1|||
105561309|NCT02230956|364050439|FG002|Overall Study|Lack of Efficacy|1|||
105561310|NCT02230956|364050437|FG000|Overall Study|Lost to Follow-up|1|||
105561311|NCT02230956|364050438|FG001|Overall Study|Lost to Follow-up|1|||
105561312|NCT02230956|364050439|FG002|Overall Study|Lost to Follow-up|2|||
105561313|NCT02230956|364050437|FG000|Overall Study|Personal Reasons|2|||
105561314|NCT02230956|364050438|FG001|Overall Study|Personal Reasons|1|||
105561315|NCT02230956|364050439|FG002|Overall Study|Personal Reasons|1|||
105561316|NCT02230956|364050437|FG000|Overall Study|Protocol Violation|0|||
105561317|NCT02230956|364050438|FG001|Overall Study|Protocol Violation|1|||
105561318|NCT02230956|364050439|FG002|Overall Study|Protocol Violation|1|||
105561319|NCT02230956|364050437|FG000|Overall Study|Other Miscellaneous Reason|0|||
105561320|NCT02230956|364050438|FG001|Overall Study|Other Miscellaneous Reason|1|||
105561321|NCT02230956|364050439|FG002|Overall Study|Other Miscellaneous Reason|2|||
105561322|NCT04570436|364050442|FG000|Overall Study|Adverse Event|0|||
105561323|NCT04570436|364050443|FG001|Overall Study|Adverse Event|0|||
105561324|NCT04570436|364050444|FG002|Overall Study|Adverse Event|1|||
105561325|NCT04570436|364050445|FG003|Overall Study|Adverse Event|0|||
105561326|NCT04570436|364050446|FG004|Overall Study|Adverse Event|0|||
105561327|NCT04570436|364050447|FG005|Overall Study|Adverse Event|0|||
105561328|NCT04570436|364050448|FG006|Overall Study|Adverse Event|0|||
105561329|NCT04570436|364050449|FG007|Overall Study|Adverse Event|0|||
105561330|NCT04570436|364050450|FG008|Overall Study|Adverse Event|0|||
105561331|NCT04570436|364050451|FG009|Overall Study|Adverse Event|0|||
105561332|NCT04570436|364050442|FG000|Overall Study|Physician Decision|1|||
105561333|NCT04570436|364050443|FG001|Overall Study|Physician Decision|0|||
105561334|NCT04570436|364050444|FG002|Overall Study|Physician Decision|0|||
105561335|NCT04570436|364050445|FG003|Overall Study|Physician Decision|0|||
105561336|NCT04570436|364050446|FG004|Overall Study|Physician Decision|0|||
105561337|NCT04570436|364050447|FG005|Overall Study|Physician Decision|0|||
105561338|NCT04570436|364050448|FG006|Overall Study|Physician Decision|0|||
105561339|NCT04570436|364050449|FG007|Overall Study|Physician Decision|0|||
105561340|NCT04570436|364050450|FG008|Overall Study|Physician Decision|0|||
105561341|NCT04570436|364050451|FG009|Overall Study|Physician Decision|0|||
105561342|NCT00658567|364050454|FG000|Overall Study|Adverse Event|5|||
105561343|NCT00658567|364050455|FG001|Overall Study|Adverse Event|2|||
105561344|NCT00658567|364050456|FG002|Overall Study|Adverse Event|3|||
105561345|NCT00658567|364050454|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
105561346|NCT00658567|364050455|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
105561347|NCT00658567|364050456|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
105561348|NCT00658567|364050454|FG000|Overall Study|Physician Decision|0|||
105561349|NCT00658567|364050455|FG001|Overall Study|Physician Decision|1|||
105561350|NCT00658567|364050456|FG002|Overall Study|Physician Decision|0|||
105561351|NCT00658567|364050454|FG000|Overall Study|At Discretion of Sponsor|1|||
105561352|NCT00658567|364050455|FG001|Overall Study|At Discretion of Sponsor|1|||
105561353|NCT00658567|364050456|FG002|Overall Study|At Discretion of Sponsor|1|||
105561354|NCT00611858|364050460|FG000|Overall Study|Adverse Event|2|||
105561355|NCT00611858|364050460|FG000|Overall Study|Withdrawal by Subject|2|||
105561356|NCT03583554|364050464|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
105711455|NCT03728309|364604481|FG001|Overall Study|Due to COVID|3|||
105711456|NCT02436876|364604484|FG000|Overall Study|Lost to Follow-up|0|||
105561357|NCT03583554|364050465|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
105561358|NCT03583554|364050466|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
105561359|NCT00689221|364050468|FG000|Overall Study|Ongoing at cut-off date|39|||
105561360|NCT00689221|364050469|FG001|Overall Study|Ongoing at cut-off date|36|||
105561361|NCT00584727|364050470|FG000|First Intervention|Discontinuation|0|||
105561362|NCT00584727|364050471|FG001|First Intervention|Discontinuation|0|||
105561363|NCT00584727|364050472|FG002|First Intervention|Discontinuation|1|||
105561364|NCT00584727|364050473|FG003|First Intervention|Discontinuation|0|||
105561365|NCT00584727|364050474|FG004|First Intervention|Discontinuation|0|||
105561366|NCT00584727|364050475|FG005|First Intervention|Discontinuation|0|||
105561367|NCT00584727|364050470|FG000|Third Intervention|Protocol Violation|0|||
105561368|NCT00584727|364050471|FG001|Third Intervention|Protocol Violation|0|||
105561369|NCT00584727|364050472|FG002|Third Intervention|Protocol Violation|1|||
105561370|NCT00584727|364050473|FG003|Third Intervention|Protocol Violation|0|||
105561371|NCT00584727|364050474|FG004|Third Intervention|Protocol Violation|4|||
105561372|NCT00584727|364050475|FG005|Third Intervention|Protocol Violation|2|||
105561373|NCT03923933|364050476|FG000|Overall Study|Lost to Follow-up|1|||
105561374|NCT03923933|364050477|FG001|Overall Study|Lost to Follow-up|0|||
105561375|NCT03923933|364050476|FG000|Overall Study|Withdrawal by Subject|0|||
105561376|NCT03923933|364050477|FG001|Overall Study|Withdrawal by Subject|1|||
105561377|NCT00419263|364050478|FG000|Overall Study|Lost to Follow-up|2|||
105561378|NCT00419263|364050479|FG001|Overall Study|Lost to Follow-up|1|||
105561379|NCT00419263|364050480|FG002|Overall Study|Lost to Follow-up|1|||
105561380|NCT00419263|364050478|FG000|Overall Study|Randomized in Error, Not Treated|1|||
105561381|NCT00419263|364050479|FG001|Overall Study|Randomized in Error, Not Treated|1|||
105561382|NCT00419263|364050480|FG002|Overall Study|Randomized in Error, Not Treated|0|||
105561383|NCT00419263|364050478|FG000|Overall Study|Adverse Event|0|||
105561384|NCT00419263|364050479|FG001|Overall Study|Adverse Event|0|||
105561385|NCT00419263|364050480|FG002|Overall Study|Adverse Event|1|||
105561386|NCT00419263|364050478|FG000|Overall Study|Withdrawal by Subject|0|||
105561387|NCT00419263|364050479|FG001|Overall Study|Withdrawal by Subject|0|||
105561388|NCT00419263|364050480|FG002|Overall Study|Withdrawal by Subject|1|||
105561389|NCT00862134|364050481|FG000|Overall Study|Death|1|||
105561390|NCT00862134|364050482|FG001|Overall Study|Death|0|||
105561391|NCT00862134|364050481|FG000|Overall Study|Physician Decision|0|||
105711457|NCT02436876|364604485|FG001|Overall Study|Lost to Follow-up|1|||
105711458|NCT02436876|364604486|FG002|Overall Study|Lost to Follow-up|1|||
105711459|NCT02436876|364604487|FG003|Overall Study|Lost to Follow-up|1|||
105711460|NCT02436876|364604484|FG000|Overall Study|Withdrawal by Subject|1|||
105475805|NCT02059291|363755263|FG014|Epoch 3|Physician Decision|0|||
105475806|NCT02059291|363755264|FG015|Epoch 3|Physician Decision|1|||
105475807|NCT02059291|363755265|FG016|Epoch 3|Physician Decision|0|||
105475808|NCT02059291|363755266|FG017|Epoch 3|Physician Decision|0|||
105475809|NCT02059291|363755267|FG018|Epoch 3|Physician Decision|0|||
105475810|NCT02059291|363755268|FG019|Epoch 3|Physician Decision|0|||
105475811|NCT02059291|363755269|FG020|Epoch 3|Physician Decision|0|||
105475812|NCT02059291|363755270|FG021|Epoch 3|Physician Decision|0|||
105475813|NCT02059291|363755271|FG022|Epoch 3|Physician Decision|0|||
105475814|NCT02059291|363755272|FG023|Epoch 3|Physician Decision|0|||
105475815|NCT02059291|363755273|FG024|Epoch 3|Physician Decision|0|||
105475816|NCT02059291|363755249|FG000|Epoch 3|Adverse Event|0|||
105475817|NCT02059291|363755250|FG001|Epoch 3|Adverse Event|0|||
105475818|NCT02059291|363755251|FG002|Epoch 3|Adverse Event|0|||
105475819|NCT02059291|363755252|FG003|Epoch 3|Adverse Event|0|||
105475820|NCT02059291|363755253|FG004|Epoch 3|Adverse Event|0|||
105475821|NCT02059291|363755254|FG005|Epoch 3|Adverse Event|0|||
105475822|NCT02059291|363755255|FG006|Epoch 3|Adverse Event|0|||
105475823|NCT02059291|363755256|FG007|Epoch 3|Adverse Event|0|||
105475824|NCT02059291|363755257|FG008|Epoch 3|Adverse Event|0|||
105475825|NCT02059291|363755258|FG009|Epoch 3|Adverse Event|0|||
105475826|NCT02059291|363755259|FG010|Epoch 3|Adverse Event|0|||
105475827|NCT02059291|363755260|FG011|Epoch 3|Adverse Event|0|||
105475828|NCT02059291|363755261|FG012|Epoch 3|Adverse Event|0|||
105475829|NCT02059291|363755262|FG013|Epoch 3|Adverse Event|0|||
105475830|NCT02059291|363755263|FG014|Epoch 3|Adverse Event|0|||
105475831|NCT02059291|363755264|FG015|Epoch 3|Adverse Event|1|||
105475832|NCT02059291|363755265|FG016|Epoch 3|Adverse Event|0|||
105475833|NCT02059291|363755266|FG017|Epoch 3|Adverse Event|0|||
105475834|NCT02059291|363755267|FG018|Epoch 3|Adverse Event|0|||
105475835|NCT02059291|363755268|FG019|Epoch 3|Adverse Event|0|||
105475836|NCT02059291|363755269|FG020|Epoch 3|Adverse Event|0|||
105561392|NCT00862134|364050482|FG001|Overall Study|Physician Decision|1|||
105561393|NCT00862134|364050481|FG000|Overall Study|Withdrawal by Subject|1|||
105561394|NCT00862134|364050482|FG001|Overall Study|Withdrawal by Subject|2|||
105475837|NCT02059291|363755270|FG021|Epoch 3|Adverse Event|0|||
105561395|NCT00862134|364050481|FG000|Overall Study|Sponsor terminated study|5|||
105561396|NCT00862134|364050482|FG001|Overall Study|Sponsor terminated study|7|||
105561397|NCT00862134|364050481|FG000|Overall Study|Adverse Event|2|||
105561398|NCT00862134|364050482|FG001|Overall Study|Adverse Event|2|||
105561399|NCT00862134|364050481|FG000|Overall Study|Withdrew prior to dosing|2|||
105561400|NCT00862134|364050482|FG001|Overall Study|Withdrew prior to dosing|0|||
105561401|NCT02191267|364050483|FG000|Overall Study|Withdrawal by Subject|1|||
105711461|NCT02436876|364604485|FG001|Overall Study|Withdrawal by Subject|0|||
105711462|NCT02436876|364604486|FG002|Overall Study|Withdrawal by Subject|0|||
105475838|NCT02059291|363755271|FG022|Epoch 3|Adverse Event|0|||
105475839|NCT02059291|363755272|FG023|Epoch 3|Adverse Event|0|||
105475840|NCT02059291|363755273|FG024|Epoch 3|Adverse Event|0|||
105475841|NCT02059291|363755249|FG000|Epoch 3|Lack of Efficacy|0|||
105475842|NCT02059291|363755250|FG001|Epoch 3|Lack of Efficacy|0|||
105475843|NCT02059291|363755251|FG002|Epoch 3|Lack of Efficacy|0|||
105475844|NCT02059291|363755252|FG003|Epoch 3|Lack of Efficacy|0|||
105711463|NCT02436876|364604487|FG003|Overall Study|Withdrawal by Subject|1|||
105711464|NCT02436876|364604484|FG000|Overall Study|Physician Decision|0|||
105711465|NCT02436876|364604485|FG001|Overall Study|Physician Decision|2|||
105711466|NCT02436876|364604486|FG002|Overall Study|Physician Decision|1|||
105711467|NCT02436876|364604487|FG003|Overall Study|Physician Decision|0|||
105711468|NCT02436876|364604484|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
105711469|NCT02436876|364604485|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
105711470|NCT02436876|364604486|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
105711471|NCT02436876|364604487|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
105711472|NCT00953758|364604488|FG000|Overall Study|Death|2|||
105711473|NCT00953758|364604489|FG001|Overall Study|Death|0|||
105351945|NCT02651688|363293759|FG000|Overall Study|Principal Investigator (PI) decision|0|||
105351946|NCT02651688|363293760|FG001|Overall Study|Principal Investigator (PI) decision|2|||
105351947|NCT02651688|363293761|FG002|Overall Study|Principal Investigator (PI) decision|0|||
105351948|NCT02651688|363293759|FG000|Overall Study|Lost to Follow-up|1|||
105351949|NCT02651688|363293760|FG001|Overall Study|Lost to Follow-up|3|||
105351950|NCT02651688|363293761|FG002|Overall Study|Lost to Follow-up|0|||
105351951|NCT02651688|363293759|FG000|Overall Study|Withdrawal by Subject|1|||
105351952|NCT02651688|363293760|FG001|Overall Study|Withdrawal by Subject|0|||
105351953|NCT02651688|363293761|FG002|Overall Study|Withdrawal by Subject|2|||
105351954|NCT00055497|363293762|FG000|Overall Study|Adverse Event|1|||
105351955|NCT00055497|363293763|FG001|Overall Study|Adverse Event|1|||
105351956|NCT00055497|363293764|FG002|Overall Study|Adverse Event|1|||
105351957|NCT00055497|363293765|FG003|Overall Study|Adverse Event|28|||
105351958|NCT00055497|363293762|FG000|Overall Study|Withdrawal by Subject|3|||
105351959|NCT00055497|363293763|FG001|Overall Study|Withdrawal by Subject|1|||
105351960|NCT00055497|363293764|FG002|Overall Study|Withdrawal by Subject|1|||
105351961|NCT00055497|363293765|FG003|Overall Study|Withdrawal by Subject|15|||
105351962|NCT00055497|363293762|FG000|Overall Study|Lost to Follow-up|0|||
105351963|NCT00055497|363293763|FG001|Overall Study|Lost to Follow-up|1|||
105351964|NCT00055497|363293764|FG002|Overall Study|Lost to Follow-up|0|||
105351965|NCT00055497|363293765|FG003|Overall Study|Lost to Follow-up|5|||
105351966|NCT00055497|363293762|FG000|Overall Study|Protocol Violation|0|||
105351967|NCT00055497|363293763|FG001|Overall Study|Protocol Violation|0|||
105351968|NCT00055497|363293764|FG002|Overall Study|Protocol Violation|0|||
105351969|NCT00055497|363293765|FG003|Overall Study|Protocol Violation|3|||
105351970|NCT00055497|363293762|FG000|Overall Study|Lack of Efficacy|1|||
105351971|NCT00055497|363293763|FG001|Overall Study|Lack of Efficacy|0|||
105475845|NCT02059291|363755253|FG004|Epoch 3|Lack of Efficacy|0|||
105475846|NCT02059291|363755254|FG005|Epoch 3|Lack of Efficacy|0|||
105475847|NCT02059291|363755255|FG006|Epoch 3|Lack of Efficacy|0|||
105475848|NCT02059291|363755256|FG007|Epoch 3|Lack of Efficacy|0|||
105475849|NCT02059291|363755257|FG008|Epoch 3|Lack of Efficacy|0|||
105475850|NCT02059291|363755258|FG009|Epoch 3|Lack of Efficacy|0|||
105475851|NCT02059291|363755259|FG010|Epoch 3|Lack of Efficacy|0|||
105475852|NCT02059291|363755260|FG011|Epoch 3|Lack of Efficacy|0|||
105475853|NCT02059291|363755261|FG012|Epoch 3|Lack of Efficacy|0|||
105475854|NCT02059291|363755262|FG013|Epoch 3|Lack of Efficacy|0|||
105475855|NCT02059291|363755263|FG014|Epoch 3|Lack of Efficacy|0|||
105475856|NCT02059291|363755264|FG015|Epoch 3|Lack of Efficacy|3|||
105475857|NCT02059291|363755265|FG016|Epoch 3|Lack of Efficacy|0|||
105475858|NCT02059291|363755266|FG017|Epoch 3|Lack of Efficacy|0|||
105475859|NCT02059291|363755267|FG018|Epoch 3|Lack of Efficacy|0|||
105475860|NCT02059291|363755268|FG019|Epoch 3|Lack of Efficacy|0|||
105475861|NCT02059291|363755269|FG020|Epoch 3|Lack of Efficacy|0|||
105475862|NCT02059291|363755270|FG021|Epoch 3|Lack of Efficacy|0|||
105475863|NCT02059291|363755271|FG022|Epoch 3|Lack of Efficacy|0|||
105475864|NCT02059291|363755272|FG023|Epoch 3|Lack of Efficacy|0|||
105475865|NCT02059291|363755273|FG024|Epoch 3|Lack of Efficacy|0|||
105475866|NCT02059291|363755249|FG000|Epoch 3|Withdrawal by Subject|0|||
105475867|NCT02059291|363755250|FG001|Epoch 3|Withdrawal by Subject|0|||
105475868|NCT02059291|363755251|FG002|Epoch 3|Withdrawal by Subject|0|||
105711474|NCT00953758|364604490|FG002|Overall Study|Death|1|||
105711475|NCT00953758|364604491|FG003|Overall Study|Death|1|||
105711476|NCT00953758|364604492|FG004|Overall Study|Death|1|||
105711477|NCT00953758|364604493|FG005|Overall Study|Death|1|||
105711478|NCT00953758|364604494|FG006|Overall Study|Death|1|||
105475869|NCT02059291|363755252|FG003|Epoch 3|Withdrawal by Subject|0|||
105711479|NCT00953758|364604495|FG007|Overall Study|Death|3|||
105711480|NCT00953758|364604496|FG008|Overall Study|Death|1|||
105351972|NCT00055497|363293764|FG002|Overall Study|Lack of Efficacy|0|||
105351973|NCT00055497|363293765|FG003|Overall Study|Lack of Efficacy|27|||
105351974|NCT00055497|363293762|FG000|Overall Study|Administrative Reasons|0|||
105351975|NCT00055497|363293763|FG001|Overall Study|Administrative Reasons|0|||
105351976|NCT00055497|363293764|FG002|Overall Study|Administrative Reasons|0|||
105475870|NCT02059291|363755253|FG004|Epoch 3|Withdrawal by Subject|0|||
105475871|NCT02059291|363755254|FG005|Epoch 3|Withdrawal by Subject|0|||
105475872|NCT02059291|363755255|FG006|Epoch 3|Withdrawal by Subject|0|||
105475873|NCT02059291|363755256|FG007|Epoch 3|Withdrawal by Subject|0|||
105475874|NCT02059291|363755257|FG008|Epoch 3|Withdrawal by Subject|0|||
105711481|NCT00953758|364604497|FG009|Overall Study|Death|0|||
105711482|NCT00953758|364604488|FG000|Overall Study|Participant refused further follow-up|0|||
105711483|NCT00953758|364604489|FG001|Overall Study|Participant refused further follow-up|0|||
105711484|NCT00953758|364604490|FG002|Overall Study|Participant refused further follow-up|1|||
105711485|NCT00953758|364604491|FG003|Overall Study|Participant refused further follow-up|0|||
105711486|NCT00953758|364604492|FG004|Overall Study|Participant refused further follow-up|3|||
105711487|NCT00953758|364604493|FG005|Overall Study|Participant refused further follow-up|0|||
105711488|NCT00953758|364604494|FG006|Overall Study|Participant refused further follow-up|0|||
105711489|NCT00953758|364604495|FG007|Overall Study|Participant refused further follow-up|0|||
105711490|NCT00953758|364604496|FG008|Overall Study|Participant refused further follow-up|1|||
105711491|NCT00953758|364604497|FG009|Overall Study|Participant refused further follow-up|0|||
105711492|NCT00953758|364604488|FG000|Overall Study|Lost to Follow-up|0|||
105711493|NCT00953758|364604489|FG001|Overall Study|Lost to Follow-up|0|||
105711494|NCT00953758|364604490|FG002|Overall Study|Lost to Follow-up|0|||
105711495|NCT00953758|364604491|FG003|Overall Study|Lost to Follow-up|1|||
105711496|NCT00953758|364604492|FG004|Overall Study|Lost to Follow-up|0|||
105711497|NCT00953758|364604493|FG005|Overall Study|Lost to Follow-up|0|||
105711498|NCT00953758|364604494|FG006|Overall Study|Lost to Follow-up|0|||
105711499|NCT00953758|364604495|FG007|Overall Study|Lost to Follow-up|1|||
105711500|NCT00953758|364604496|FG008|Overall Study|Lost to Follow-up|0|||
105711501|NCT00953758|364604497|FG009|Overall Study|Lost to Follow-up|1|||
105711502|NCT00953758|364604488|FG000|Overall Study|Physician Decision|0|||
105711503|NCT00953758|364604489|FG001|Overall Study|Physician Decision|0|||
105351977|NCT00055497|363293765|FG003|Overall Study|Administrative Reasons|1|||
105351978|NCT00055497|363293762|FG000|Overall Study|Other|0|||
105351979|NCT00055497|363293763|FG001|Overall Study|Other|0|||
105351980|NCT00055497|363293764|FG002|Overall Study|Other|0|||
105351981|NCT00055497|363293765|FG003|Overall Study|Other|11|||
105351982|NCT01370616|363293767|FG000|Overall Study|Adverse Event|11|||
105351983|NCT01370616|363293768|FG001|Overall Study|Adverse Event|16|||
105351984|NCT01370616|363293767|FG000|Overall Study|Death|1|||
105351985|NCT01370616|363293768|FG001|Overall Study|Death|0|||
105351986|NCT01370616|363293767|FG000|Overall Study|Lack of Efficacy|6|||
105351987|NCT01370616|363293768|FG001|Overall Study|Lack of Efficacy|2|||
105351988|NCT01370616|363293767|FG000|Overall Study|Lost to Follow-up|0|||
105351989|NCT01370616|363293768|FG001|Overall Study|Lost to Follow-up|3|||
105351990|NCT01370616|363293767|FG000|Overall Study|Physician Decision|6|||
105351991|NCT01370616|363293768|FG001|Overall Study|Physician Decision|6|||
105351992|NCT01370616|363293767|FG000|Overall Study|Progressive Disease|0|||
105351993|NCT01370616|363293768|FG001|Overall Study|Progressive Disease|1|||
105351994|NCT01370616|363293767|FG000|Overall Study|Recovery|1|||
105351995|NCT01370616|363293768|FG001|Overall Study|Recovery|0|||
105351996|NCT01370616|363293767|FG000|Overall Study|Technical Problems|3|||
105351997|NCT01370616|363293768|FG001|Overall Study|Technical Problems|5|||
105351998|NCT01370616|363293767|FG000|Overall Study|Withdrawal by Subject|34|||
105351999|NCT01370616|363293768|FG001|Overall Study|Withdrawal by Subject|34|||
105352000|NCT00731731|363293769|FG000|Overall Study|Protocol Violation|0|||
105352001|NCT00731731|363293770|FG001|Overall Study|Protocol Violation|0|||
105352002|NCT00731731|363293771|FG002|Overall Study|Protocol Violation|1|||
105352003|NCT00731731|363293769|FG000|Overall Study|Cancel prior to treatment|0|||
105352004|NCT00731731|363293770|FG001|Overall Study|Cancel prior to treatment|0|||
105352005|NCT00731731|363293771|FG002|Overall Study|Cancel prior to treatment|2|||
105352006|NCT03970200|363293772|FG000|Overall Study|Death|2|||
105352007|NCT03970200|363293773|FG001|Overall Study|Death|2|||
105352008|NCT03970200|363293774|FG002|Overall Study|Death|1|||
105352009|NCT03970200|363293772|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
105352010|NCT03970200|363293773|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
105352011|NCT03970200|363293774|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
105352012|NCT01429441|363293775|FG000|Overall Study|Adverse Event|5|||
105352013|NCT01429441|363293776|FG001|Overall Study|Adverse Event|1|||
105352014|NCT01429441|363293775|FG000|Overall Study|Death|0|||
105352015|NCT01429441|363293776|FG001|Overall Study|Death|2|||
105352016|NCT01429441|363293775|FG000|Overall Study|Lost to Follow-up|5|||
105352017|NCT01429441|363293776|FG001|Overall Study|Lost to Follow-up|2|||
105352018|NCT01429441|363293775|FG000|Overall Study|Physician Decision|1|||
105352019|NCT01429441|363293776|FG001|Overall Study|Physician Decision|0|||
105711504|NCT00953758|364604490|FG002|Overall Study|Physician Decision|0|||
105711505|NCT00953758|364604491|FG003|Overall Study|Physician Decision|0|||
105711506|NCT00953758|364604492|FG004|Overall Study|Physician Decision|1|||
105711507|NCT00953758|364604493|FG005|Overall Study|Physician Decision|0|||
105352020|NCT01429441|363293775|FG000|Overall Study|Withdrawal by Subject|27|||
105352021|NCT01429441|363293776|FG001|Overall Study|Withdrawal by Subject|18|||
105352022|NCT03469999|363293779|FG000|Overall Study|Lost to Follow-up|2|||
105352023|NCT00913770|363293784|FG000|Overall Study|Unable to contact|24|||
105352024|NCT00913770|363293785|FG001|Overall Study|Unable to contact|19|||
105352025|NCT00913770|363293786|FG002|Overall Study|Unable to contact|13|||
105352026|NCT00913770|363293784|FG000|Overall Study|Refused|11|||
105352027|NCT00913770|363293785|FG001|Overall Study|Refused|10|||
105352028|NCT00913770|363293786|FG002|Overall Study|Refused|8|||
105475875|NCT02059291|363755258|FG009|Epoch 3|Withdrawal by Subject|0|||
105475876|NCT02059291|363755259|FG010|Epoch 3|Withdrawal by Subject|0|||
105475877|NCT02059291|363755260|FG011|Epoch 3|Withdrawal by Subject|0|||
105475878|NCT02059291|363755261|FG012|Epoch 3|Withdrawal by Subject|0|||
105475879|NCT02059291|363755262|FG013|Epoch 3|Withdrawal by Subject|0|||
105475880|NCT02059291|363755263|FG014|Epoch 3|Withdrawal by Subject|0|||
105475881|NCT02059291|363755264|FG015|Epoch 3|Withdrawal by Subject|1|||
105475882|NCT02059291|363755265|FG016|Epoch 3|Withdrawal by Subject|0|||
105475883|NCT02059291|363755266|FG017|Epoch 3|Withdrawal by Subject|0|||
105475884|NCT02059291|363755267|FG018|Epoch 3|Withdrawal by Subject|0|||
105475885|NCT02059291|363755268|FG019|Epoch 3|Withdrawal by Subject|0|||
105475886|NCT02059291|363755269|FG020|Epoch 3|Withdrawal by Subject|0|||
105475887|NCT02059291|363755270|FG021|Epoch 3|Withdrawal by Subject|0|||
105475888|NCT02059291|363755271|FG022|Epoch 3|Withdrawal by Subject|0|||
105475889|NCT02059291|363755272|FG023|Epoch 3|Withdrawal by Subject|0|||
105475890|NCT02059291|363755273|FG024|Epoch 3|Withdrawal by Subject|0|||
105475891|NCT02059291|363755249|FG000|Epoch 4|Adverse Event|0|||
105475892|NCT02059291|363755250|FG001|Epoch 4|Adverse Event|0|||
105475893|NCT02059291|363755251|FG002|Epoch 4|Adverse Event|0|||
105475894|NCT02059291|363755252|FG003|Epoch 4|Adverse Event|0|||
105475895|NCT02059291|363755253|FG004|Epoch 4|Adverse Event|0|||
105475896|NCT02059291|363755254|FG005|Epoch 4|Adverse Event|0|||
105475897|NCT02059291|363755255|FG006|Epoch 4|Adverse Event|0|||
105475898|NCT02059291|363755256|FG007|Epoch 4|Adverse Event|0|||
105475899|NCT02059291|363755257|FG008|Epoch 4|Adverse Event|0|||
105352029|NCT02669667|363293792|FG000|Overall Study|Lost to Follow-up|0|||
105352030|NCT02669667|363293793|FG001|Overall Study|Lost to Follow-up|0|||
105352031|NCT02669667|363293794|FG002|Overall Study|Lost to Follow-up|0|||
105352032|NCT02669667|363293795|FG003|Overall Study|Lost to Follow-up|0|||
105352033|NCT02669667|363293796|FG004|Overall Study|Lost to Follow-up|0|||
105352034|NCT02669667|363293797|FG005|Overall Study|Lost to Follow-up|1|||
105352035|NCT02669667|363293798|FG006|Overall Study|Lost to Follow-up|0|||
105352036|NCT00840034|363293799|FG000|Acute Treatment Phase|Adverse Event|6|||
105475900|NCT02059291|363755258|FG009|Epoch 4|Adverse Event|0|||
105475901|NCT02059291|363755259|FG010|Epoch 4|Adverse Event|0|||
105475902|NCT02059291|363755260|FG011|Epoch 4|Adverse Event|0|||
105475903|NCT02059291|363755261|FG012|Epoch 4|Adverse Event|0|||
105711508|NCT00953758|364604494|FG006|Overall Study|Physician Decision|0|||
105711509|NCT00953758|364604495|FG007|Overall Study|Physician Decision|0|||
105711510|NCT00953758|364604496|FG008|Overall Study|Physician Decision|0|||
105711511|NCT00953758|364604497|FG009|Overall Study|Physician Decision|0|||
105711512|NCT00953758|364604488|FG000|Overall Study|Disease progression|0|||
105711513|NCT00953758|364604489|FG001|Overall Study|Disease progression|0|||
105711514|NCT00953758|364604490|FG002|Overall Study|Disease progression|0|||
105711515|NCT00953758|364604491|FG003|Overall Study|Disease progression|0|||
105711516|NCT00953758|364604492|FG004|Overall Study|Disease progression|1|||
105711517|NCT00953758|364604493|FG005|Overall Study|Disease progression|0|||
105711518|NCT00953758|364604494|FG006|Overall Study|Disease progression|0|||
105711519|NCT00953758|364604495|FG007|Overall Study|Disease progression|0|||
105711520|NCT00953758|364604496|FG008|Overall Study|Disease progression|0|||
105711521|NCT00953758|364604497|FG009|Overall Study|Disease progression|0|||
105711522|NCT00953758|364604488|FG000|Overall Study|Participant went for transplant|0|||
105711523|NCT00953758|364604489|FG001|Overall Study|Participant went for transplant|0|||
105711524|NCT00953758|364604490|FG002|Overall Study|Participant went for transplant|0|||
105711525|NCT00953758|364604491|FG003|Overall Study|Participant went for transplant|0|||
105711526|NCT00953758|364604492|FG004|Overall Study|Participant went for transplant|0|||
105711527|NCT00953758|364604493|FG005|Overall Study|Participant went for transplant|0|||
105711528|NCT00953758|364604494|FG006|Overall Study|Participant went for transplant|0|||
105352037|NCT00840034|363293800|FG001|Acute Treatment Phase|Adverse Event|8|||
105352038|NCT00840034|363293799|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
105475904|NCT02059291|363755262|FG013|Epoch 4|Adverse Event|0|||
105475905|NCT02059291|363755263|FG014|Epoch 4|Adverse Event|0|||
105475906|NCT02059291|363755264|FG015|Epoch 4|Adverse Event|0|||
105475907|NCT02059291|363755265|FG016|Epoch 4|Adverse Event|1|||
105475908|NCT02059291|363755266|FG017|Epoch 4|Adverse Event|0|||
105561402|NCT02191267|364050484|FG001|Overall Study|Withdrawal by Subject|0|||
105711529|NCT00953758|364604495|FG007|Overall Study|Participant went for transplant|0|||
105711530|NCT00953758|364604496|FG008|Overall Study|Participant went for transplant|1|||
105711531|NCT00953758|364604497|FG009|Overall Study|Participant went for transplant|0|||
105711532|NCT01536860|364604498|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
105711533|NCT01536860|364604499|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
105352039|NCT00840034|363293800|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
105352040|NCT00840034|363293799|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
105475909|NCT02059291|363755267|FG018|Epoch 4|Adverse Event|0|||
105475910|NCT02059291|363755268|FG019|Epoch 4|Adverse Event|0|||
105475911|NCT02059291|363755269|FG020|Epoch 4|Adverse Event|0|||
105475912|NCT02059291|363755270|FG021|Epoch 4|Adverse Event|0|||
105475913|NCT02059291|363755271|FG022|Epoch 4|Adverse Event|1|||
105475914|NCT02059291|363755272|FG023|Epoch 4|Adverse Event|0|||
105475915|NCT02059291|363755273|FG024|Epoch 4|Adverse Event|0|||
105711534|NCT01536860|364604500|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
105475916|NCT02059291|363755249|FG000|Epoch 4|Pregnancy|0|||
105475917|NCT02059291|363755250|FG001|Epoch 4|Pregnancy|0|||
105711535|NCT01707693|364604501|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
105711536|NCT01707693|364604502|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
105711537|NCT01707693|364604501|FG000|Overall Study Allocation|Protocol Violation|4|||
105711538|NCT01707693|364604502|FG001|Overall Study Allocation|Protocol Violation|3|||
105711539|NCT01707693|364604501|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
105711540|NCT01707693|364604502|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
105711541|NCT01707693|364604501|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
105711542|NCT01707693|364604502|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
105711543|NCT01703858|364604503|FG000|Overall Study|Withdrawal by Subject|0|||
105788123|NCT03426995|364878235|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788124|NCT03426995|364878236|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788125|NCT03426995|364878237|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105475918|NCT02059291|363755251|FG002|Epoch 4|Pregnancy|0|||
105475919|NCT02059291|363755252|FG003|Epoch 4|Pregnancy|0|||
105475920|NCT02059291|363755253|FG004|Epoch 4|Pregnancy|0|||
105475921|NCT02059291|363755254|FG005|Epoch 4|Pregnancy|0|||
105475922|NCT02059291|363755255|FG006|Epoch 4|Pregnancy|0|||
105475923|NCT02059291|363755256|FG007|Epoch 4|Pregnancy|0|||
105475924|NCT02059291|363755257|FG008|Epoch 4|Pregnancy|0|||
105475925|NCT02059291|363755258|FG009|Epoch 4|Pregnancy|0|||
105475926|NCT02059291|363755259|FG010|Epoch 4|Pregnancy|0|||
105475927|NCT02059291|363755260|FG011|Epoch 4|Pregnancy|0|||
105475928|NCT02059291|363755261|FG012|Epoch 4|Pregnancy|0|||
105711544|NCT01703858|364604504|FG001|Overall Study|Withdrawal by Subject|1|||
105711545|NCT01703858|364604505|FG002|Overall Study|Withdrawal by Subject|0|||
105711546|NCT01290692|364604510|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
105711547|NCT00993031|364604514|FG000|Overall Study|Death|0|||
105711548|NCT00993031|364604515|FG001|Overall Study|Death|1|||
105711549|NCT00993031|364604514|FG000|Overall Study|Physician Decision|0|||
105711550|NCT00993031|364604515|FG001|Overall Study|Physician Decision|2|||
105711551|NCT00993031|364604514|FG000|Overall Study|Withdrawal by Subject|3|||
105711552|NCT00993031|364604515|FG001|Overall Study|Withdrawal by Subject|3|||
105711553|NCT00993031|364604514|FG000|Overall Study|Lost to Follow-up|19|||
105711554|NCT00993031|364604515|FG001|Overall Study|Lost to Follow-up|13|||
105711555|NCT03115151|364604516|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
105711556|NCT03115151|364604517|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
105711557|NCT03115151|364604516|FG000|Overall Study|Epidural catheter removal|1|||
105711558|NCT03115151|364604517|FG001|Overall Study|Epidural catheter removal|0|||
105711559|NCT03115151|364604516|FG000|Overall Study|Withdrawal by Subject|0|||
105711560|NCT03115151|364604517|FG001|Overall Study|Withdrawal by Subject|1|||
105711561|NCT03115151|364604516|FG000|Overall Study|Intervention not received according to the protocol.|1|||
105711562|NCT03115151|364604517|FG001|Overall Study|Intervention not received according to the protocol.|1|||
105711563|NCT03115151|364604516|FG000|Overall Study|Physician Decision|1|||
105711564|NCT03115151|364604517|FG001|Overall Study|Physician Decision|0|||
105711565|NCT03115151|364604516|FG000|Overall Study|Randomization not applied|1|||
105711566|NCT03115151|364604517|FG001|Overall Study|Randomization not applied|1|||
105711567|NCT02971670|364604523|FG000|Overall Study|Withdrawal by Subject|4|||
105711568|NCT02971670|364604524|FG001|Overall Study|Withdrawal by Subject|1|||
105711569|NCT02971670|364604525|FG002|Overall Study|Withdrawal by Subject|1|||
105711570|NCT02971670|364604526|FG003|Overall Study|Withdrawal by Subject|2|||
105711571|NCT00288080|364604527|FG000|Overall Study|Withdrawal by Subject|1|||
105711572|NCT00288080|364604528|FG001|Overall Study|Withdrawal by Subject|3|||
105711573|NCT00288080|364604527|FG000|Overall Study|Protocol Violation|25|||
105711574|NCT00288080|364604528|FG001|Overall Study|Protocol Violation|20|||
105711575|NCT01543087|364604529|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
105711576|NCT01543087|364604530|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
105711577|NCT01543087|364604531|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
105711578|NCT01543087|364604532|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
105475929|NCT02059291|363755262|FG013|Epoch 4|Pregnancy|0|||
105475930|NCT02059291|363755263|FG014|Epoch 4|Pregnancy|0|||
105475931|NCT02059291|363755264|FG015|Epoch 4|Pregnancy|0|||
105475932|NCT02059291|363755265|FG016|Epoch 4|Pregnancy|1|||
105475933|NCT02059291|363755266|FG017|Epoch 4|Pregnancy|0|||
105475934|NCT02059291|363755267|FG018|Epoch 4|Pregnancy|0|||
105711579|NCT01543087|364604533|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
105711580|NCT01543087|364604534|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
105711581|NCT01543087|364604529|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
105711582|NCT01543087|364604530|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
105711583|NCT01543087|364604531|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
105711584|NCT01543087|364604532|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
105711585|NCT01543087|364604533|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
105711586|NCT01543087|364604534|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
105711587|NCT01543087|364604529|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
105711588|NCT01543087|364604530|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
105711589|NCT01543087|364604531|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
105711590|NCT01543087|364604532|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
105711591|NCT01543087|364604533|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
105711592|NCT01543087|364604534|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
105806513|NCT03038113|364949007|FG007|Overall Study|Withdrawal by Subject|0|||
105475935|NCT02059291|363755268|FG019|Epoch 4|Pregnancy|0|||
105475936|NCT02059291|363755269|FG020|Epoch 4|Pregnancy|0|||
105711593|NCT01543087|364604529|FG000|Stage 1 (48 Months)|Other than specified|5|||
105711594|NCT01543087|364604530|FG001|Stage 1 (48 Months)|Other than specified|0|||
105711595|NCT01543087|364604531|FG002|Stage 1 (48 Months)|Other than specified|9|||
105711596|NCT01543087|364604532|FG003|Stage 1 (48 Months)|Other than specified|0|||
105711597|NCT01543087|364604533|FG004|Stage 1 (48 Months)|Other than specified|0|||
105475937|NCT02059291|363755270|FG021|Epoch 4|Pregnancy|0|||
105475938|NCT02059291|363755271|FG022|Epoch 4|Pregnancy|0|||
105475939|NCT02059291|363755272|FG023|Epoch 4|Pregnancy|0|||
105475940|NCT02059291|363755273|FG024|Epoch 4|Pregnancy|0|||
105475941|NCT02059291|363755249|FG000|Epoch 4|Withdrawal by Subject|0|||
105475942|NCT02059291|363755250|FG001|Epoch 4|Withdrawal by Subject|0|||
105475943|NCT02059291|363755251|FG002|Epoch 4|Withdrawal by Subject|0|||
105711598|NCT01543087|364604534|FG005|Stage 1 (48 Months)|Other than specified|0|||
105711599|NCT01543087|364604529|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
105711600|NCT01543087|364604530|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
105711601|NCT01543087|364604531|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
105711602|NCT01543087|364604532|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
105711603|NCT01543087|364604533|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
105711604|NCT01543087|364604534|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
105711605|NCT01543087|364604529|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
105711606|NCT01543087|364604530|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
105711607|NCT01543087|364604531|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
105711608|NCT01543087|364604532|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
105711609|NCT01543087|364604533|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
105711610|NCT01543087|364604534|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
105711611|NCT01543087|364604529|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
105711612|NCT01543087|364604530|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
105711613|NCT01543087|364604531|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
105711614|NCT01543087|364604532|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
105711615|NCT01543087|364604533|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
105711616|NCT01543087|364604534|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
105711617|NCT00706030|364604537|FG000|Overall Study|Disease Progression|4|||
105475944|NCT02059291|363755252|FG003|Epoch 4|Withdrawal by Subject|0|||
105475945|NCT02059291|363755253|FG004|Epoch 4|Withdrawal by Subject|0|||
105711618|NCT00706030|364604538|FG001|Overall Study|Disease Progression|6|||
105711619|NCT00706030|364604539|FG002|Overall Study|Disease Progression|46|||
105711620|NCT00706030|364604540|FG003|Overall Study|Disease Progression|12|||
105711621|NCT00706030|364604537|FG000|Overall Study|Adverse Event|1|||
105711622|NCT00706030|364604538|FG001|Overall Study|Adverse Event|0|||
105711623|NCT00706030|364604539|FG002|Overall Study|Adverse Event|4|||
105711624|NCT00706030|364604540|FG003|Overall Study|Adverse Event|2|||
105711625|NCT00706030|364604537|FG000|Overall Study|Withdrawal by Subject|1|||
105711626|NCT00706030|364604538|FG001|Overall Study|Withdrawal by Subject|0|||
105711627|NCT00706030|364604539|FG002|Overall Study|Withdrawal by Subject|2|||
105711628|NCT00706030|364604540|FG003|Overall Study|Withdrawal by Subject|0|||
105711629|NCT00706030|364604537|FG000|Overall Study|Physician Decision|0|||
105475946|NCT02059291|363755254|FG005|Epoch 4|Withdrawal by Subject|0|||
105475947|NCT02059291|363755255|FG006|Epoch 4|Withdrawal by Subject|0|||
105475948|NCT02059291|363755256|FG007|Epoch 4|Withdrawal by Subject|0|||
105475949|NCT02059291|363755257|FG008|Epoch 4|Withdrawal by Subject|0|||
105475950|NCT02059291|363755258|FG009|Epoch 4|Withdrawal by Subject|0|||
105475951|NCT02059291|363755259|FG010|Epoch 4|Withdrawal by Subject|0|||
105475952|NCT02059291|363755260|FG011|Epoch 4|Withdrawal by Subject|0|||
105475953|NCT02059291|363755261|FG012|Epoch 4|Withdrawal by Subject|0|||
105475954|NCT02059291|363755262|FG013|Epoch 4|Withdrawal by Subject|0|||
105475955|NCT02059291|363755263|FG014|Epoch 4|Withdrawal by Subject|0|||
105475956|NCT02059291|363755264|FG015|Epoch 4|Withdrawal by Subject|0|||
105475957|NCT02059291|363755265|FG016|Epoch 4|Withdrawal by Subject|0|||
105475958|NCT02059291|363755266|FG017|Epoch 4|Withdrawal by Subject|0|||
105475959|NCT02059291|363755267|FG018|Epoch 4|Withdrawal by Subject|0|||
105475960|NCT02059291|363755268|FG019|Epoch 4|Withdrawal by Subject|0|||
105475961|NCT02059291|363755269|FG020|Epoch 4|Withdrawal by Subject|1|||
105475962|NCT02059291|363755270|FG021|Epoch 4|Withdrawal by Subject|0|||
105475963|NCT02059291|363755271|FG022|Epoch 4|Withdrawal by Subject|0|||
105475964|NCT02059291|363755272|FG023|Epoch 4|Withdrawal by Subject|0|||
105475965|NCT02059291|363755273|FG024|Epoch 4|Withdrawal by Subject|0|||
105475966|NCT02059291|363755249|FG000|Epoch 4|Lack of Efficacy|0|||
105475967|NCT02059291|363755250|FG001|Epoch 4|Lack of Efficacy|0|||
105475968|NCT02059291|363755251|FG002|Epoch 4|Lack of Efficacy|0|||
105475969|NCT02059291|363755252|FG003|Epoch 4|Lack of Efficacy|0|||
105711630|NCT00706030|364604538|FG001|Overall Study|Physician Decision|0|||
105711631|NCT00706030|364604539|FG002|Overall Study|Physician Decision|2|||
105711632|NCT00706030|364604540|FG003|Overall Study|Physician Decision|0|||
105711633|NCT00706030|364604537|FG000|Overall Study|Not recorded|0|||
105711634|NCT00706030|364604538|FG001|Overall Study|Not recorded|0|||
105711635|NCT00706030|364604539|FG002|Overall Study|Not recorded|2|||
105711636|NCT00706030|364604540|FG003|Overall Study|Not recorded|0|||
105711637|NCT00706030|364604537|FG000|Overall Study|Protocol Violation|0|||
105711638|NCT00706030|364604538|FG001|Overall Study|Protocol Violation|0|||
105711639|NCT00706030|364604539|FG002|Overall Study|Protocol Violation|1|||
105711640|NCT00706030|364604540|FG003|Overall Study|Protocol Violation|1|||
105711641|NCT00706030|364604537|FG000|Overall Study|Failed to return|0|||
105711642|NCT00706030|364604538|FG001|Overall Study|Failed to return|0|||
105711643|NCT00706030|364604539|FG002|Overall Study|Failed to return|1|||
105711644|NCT00706030|364604540|FG003|Overall Study|Failed to return|0|||
105711645|NCT00706030|364604537|FG000|Overall Study|Symptomatic Deterioration|0|||
105711646|NCT00706030|364604538|FG001|Overall Study|Symptomatic Deterioration|0|||
105711647|NCT00706030|364604539|FG002|Overall Study|Symptomatic Deterioration|1|||
105711648|NCT00706030|364604540|FG003|Overall Study|Symptomatic Deterioration|0|||
105711649|NCT00706030|364604537|FG000|Overall Study|No treatment received|0|||
105711650|NCT00706030|364604538|FG001|Overall Study|No treatment received|0|||
105711651|NCT00706030|364604539|FG002|Overall Study|No treatment received|0|||
105711652|NCT00706030|364604540|FG003|Overall Study|No treatment received|1|||
105711653|NCT00706030|364604537|FG000|Overall Study|Death|0|||
105711654|NCT00706030|364604538|FG001|Overall Study|Death|0|||
105711655|NCT00706030|364604539|FG002|Overall Study|Death|1|||
105711656|NCT00706030|364604540|FG003|Overall Study|Death|0|||
105711657|NCT05779072|364604542|FG000|Overall Study|Lost to Follow-up|0|||
105711658|NCT05779072|364604543|FG001|Overall Study|Lost to Follow-up|1|||
105711659|NCT05779072|364604542|FG000|Overall Study|Withdrawal by Subject|1|||
105711660|NCT05779072|364604543|FG001|Overall Study|Withdrawal by Subject|5|||
105711661|NCT02435849|364604544|FG000|Overall Study|Death|23|||
105711662|NCT02435849|364604545|FG001|Overall Study|Death|0|||
105711663|NCT02435849|364604544|FG000|Overall Study|Lack of Efficacy|10|||
105711664|NCT02435849|364604545|FG001|Overall Study|Lack of Efficacy|0|||
105711665|NCT02435849|364604544|FG000|Overall Study|New therapy for study indication|8|||
105711666|NCT02435849|364604545|FG001|Overall Study|New therapy for study indication|0|||
105711667|NCT02435849|364604544|FG000|Overall Study|Subject/guardian decision|5|||
105475970|NCT02059291|363755253|FG004|Epoch 4|Lack of Efficacy|0|||
105711668|NCT02435849|364604545|FG001|Overall Study|Subject/guardian decision|1|||
105711669|NCT02435849|364604544|FG000|Overall Study|Lost to Follow-up|1|||
105475971|NCT02059291|363755254|FG005|Epoch 4|Lack of Efficacy|0|||
105475972|NCT02059291|363755255|FG006|Epoch 4|Lack of Efficacy|0|||
105475973|NCT02059291|363755256|FG007|Epoch 4|Lack of Efficacy|0|||
105475974|NCT02059291|363755257|FG008|Epoch 4|Lack of Efficacy|0|||
105475975|NCT02059291|363755258|FG009|Epoch 4|Lack of Efficacy|0|||
105475976|NCT02059291|363755259|FG010|Epoch 4|Lack of Efficacy|0|||
105711670|NCT02435849|364604545|FG001|Overall Study|Lost to Follow-up|0|||
105711671|NCT02435849|364604544|FG000|Overall Study|Physician Decision|1|||
105711672|NCT02435849|364604545|FG001|Overall Study|Physician Decision|0|||
105711673|NCT01017952|364604546|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
105711674|NCT01017952|364604547|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105711675|NCT01017952|364604548|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105711676|NCT01017952|364604549|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105788126|NCT03426995|364878238|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788127|NCT03426995|364878220|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788128|NCT03426995|364878221|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788129|NCT03426995|364878222|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788130|NCT03426995|364878223|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788131|NCT03426995|364878224|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788132|NCT03426995|364878225|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
105788133|NCT03426995|364878226|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788134|NCT03426995|364878227|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788135|NCT03426995|364878228|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788136|NCT03426995|364878229|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788137|NCT03426995|364878230|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788138|NCT03426995|364878231|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788139|NCT03426995|364878232|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788140|NCT03426995|364878233|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788141|NCT03426995|364878234|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788142|NCT03426995|364878235|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788143|NCT03426995|364878236|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788144|NCT03426995|364878237|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788145|NCT03426995|364878238|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788146|NCT03426995|364878220|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788147|NCT03426995|364878221|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788148|NCT03426995|364878222|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788149|NCT03426995|364878223|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788150|NCT03426995|364878224|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
105788151|NCT03426995|364878225|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
105711677|NCT01017952|364604550|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105711678|NCT01017952|364604546|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
105711679|NCT01017952|364604547|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
105711680|NCT01017952|364604548|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
105711681|NCT01017952|364604549|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
105711682|NCT01017952|364604550|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
105711683|NCT01017952|364604546|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
105711684|NCT01017952|364604547|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
105711685|NCT01017952|364604548|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
105711686|NCT01017952|364604549|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
105711687|NCT01017952|364604550|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
105711688|NCT01017952|364604546|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
105711689|NCT01017952|364604547|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105711690|NCT01017952|364604548|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105711691|NCT01017952|364604549|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105711692|NCT01017952|364604550|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105711693|NCT01017952|364604546|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
105711694|NCT01017952|364604547|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
105711695|NCT01017952|364604548|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
105711696|NCT01017952|364604549|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
105711697|NCT01017952|364604550|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
105711698|NCT01017952|364604546|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
105711699|NCT01017952|364604547|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105711700|NCT01017952|364604548|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105711701|NCT01017952|364604549|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105711702|NCT01017952|364604550|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105711703|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
105711704|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
105711705|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
105711706|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
105352041|NCT00840034|363293800|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
105352042|NCT00840034|363293799|FG000|Acute Treatment Phase|Physician Decision|0|||
105352043|NCT00840034|363293800|FG001|Acute Treatment Phase|Physician Decision|1|||
105352044|NCT00840034|363293799|FG000|Acute Treatment Phase|Protocol Violation|2|||
105352045|NCT00840034|363293800|FG001|Acute Treatment Phase|Protocol Violation|4|||
105352046|NCT00840034|363293799|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
105352047|NCT00840034|363293800|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
105352048|NCT00840034|363293799|FG000|Taper Phase|Adverse Event|1|||
105352049|NCT00840034|363293800|FG001|Taper Phase|Adverse Event|0|||
105352050|NCT00840034|363293799|FG000|Taper Phase|Lost to Follow-up|1|||
105352051|NCT00840034|363293800|FG001|Taper Phase|Lost to Follow-up|1|||
105352052|NCT00840034|363293799|FG000|Taper Phase|Withdrawal by Subject|1|||
105352053|NCT00840034|363293800|FG001|Taper Phase|Withdrawal by Subject|1|||
105352054|NCT00394771|363293801|FG000|Overall Study|Did not meet protocol requirements|1|||
105352055|NCT00394771|363293802|FG001|Overall Study|Did not meet protocol requirements|0|||
105475977|NCT02059291|363755260|FG011|Epoch 4|Lack of Efficacy|0|||
105475978|NCT02059291|363755261|FG012|Epoch 4|Lack of Efficacy|0|||
105475979|NCT02059291|363755262|FG013|Epoch 4|Lack of Efficacy|0|||
105475980|NCT02059291|363755263|FG014|Epoch 4|Lack of Efficacy|0|||
105475981|NCT02059291|363755264|FG015|Epoch 4|Lack of Efficacy|0|||
105475982|NCT02059291|363755265|FG016|Epoch 4|Lack of Efficacy|0|||
105352056|NCT00394771|363293803|FG002|Overall Study|Did not meet protocol requirements|2|||
105711707|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
105711708|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
105711709|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
105711710|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
105711711|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
105711712|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
105711713|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
105711714|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
105711715|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
105711716|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
105711717|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
105711718|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
105711719|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
105711720|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
105711721|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
105711722|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
105711723|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
105711724|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
105711725|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
105711726|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
105711727|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
105711728|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
105561403|NCT02191267|364050485|FG002|Overall Study|Withdrawal by Subject|0|||
105561404|NCT00316082|364050486|FG000|Overall Study|Lack of Efficacy|2|||
105561405|NCT00316082|364050487|FG001|Overall Study|Lack of Efficacy|3|||
105711729|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
105711730|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
105711731|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
105711732|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
105711733|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105711734|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
105711735|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
105475983|NCT02059291|363755266|FG017|Epoch 4|Lack of Efficacy|0|||
105475984|NCT02059291|363755267|FG018|Epoch 4|Lack of Efficacy|0|||
105475985|NCT02059291|363755268|FG019|Epoch 4|Lack of Efficacy|0|||
105475986|NCT02059291|363755269|FG020|Epoch 4|Lack of Efficacy|0|||
105475987|NCT02059291|363755270|FG021|Epoch 4|Lack of Efficacy|0|||
105475988|NCT02059291|363755271|FG022|Epoch 4|Lack of Efficacy|0|||
105475989|NCT02059291|363755272|FG023|Epoch 4|Lack of Efficacy|1|||
105475990|NCT02059291|363755273|FG024|Epoch 4|Lack of Efficacy|0|||
105475991|NCT03531632|363755274|FG000|Overall Study|Adverse Event|0|||
105475992|NCT03531632|363755275|FG001|Overall Study|Adverse Event|0|||
105475993|NCT03531632|363755276|FG002|Overall Study|Adverse Event|1|||
105475994|NCT03531632|363755274|FG000|Overall Study|Death|4|||
105475995|NCT03531632|363755275|FG001|Overall Study|Death|0|||
105475996|NCT03531632|363755276|FG002|Overall Study|Death|14|||
105475997|NCT03531632|363755274|FG000|Overall Study|Study Terminated|1|||
105475998|NCT03531632|363755275|FG001|Overall Study|Study Terminated|3|||
105352057|NCT00394771|363293804|FG003|Overall Study|Did not meet protocol requirements|0|||
105352058|NCT00394771|363293801|FG000|Overall Study|Protocol Violation|2|||
105352059|NCT00394771|363293802|FG001|Overall Study|Protocol Violation|4|||
105352060|NCT00394771|363293803|FG002|Overall Study|Protocol Violation|9|||
105352061|NCT00394771|363293804|FG003|Overall Study|Protocol Violation|7|||
105352062|NCT00394771|363293801|FG000|Overall Study|Withdrawal by Subject|10|||
105352063|NCT00394771|363293802|FG001|Overall Study|Withdrawal by Subject|6|||
105352064|NCT00394771|363293803|FG002|Overall Study|Withdrawal by Subject|8|||
105352065|NCT00394771|363293804|FG003|Overall Study|Withdrawal by Subject|12|||
105352066|NCT00394771|363293801|FG000|Overall Study|Adverse Event|10|||
105475999|NCT03531632|363755276|FG002|Overall Study|Study Terminated|11|||
105476000|NCT03241368|363755277|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
105476001|NCT03241368|363755277|FG000|Overall Study|Lost to Follow-up|1|||
105476002|NCT03241368|363755277|FG000|Overall Study|Physician Decision|6|||
105476003|NCT03241368|363755277|FG000|Overall Study|Withdrawal by Subject|6|||
105476004|NCT03241368|363755277|FG000|Overall Study|Protocol Violation|1|||
105476005|NCT00470834|363755278|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
105476006|NCT00470834|363755279|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
105476007|NCT00470834|363755278|FG000|Treatment Period (18 Months)|Adverse Event|7|||
105476008|NCT00470834|363755279|FG001|Treatment Period (18 Months)|Adverse Event|6|||
105476009|NCT00470834|363755278|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
105476010|NCT00470834|363755279|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
105476011|NCT00470834|363755278|FG000|Treatment Period (18 Months)|Physician Decision|4|||
105711736|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
105711737|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
105711738|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
105711739|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
105711740|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
105711741|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
105711742|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
105711743|NCT02387580|364604553|FG000|Overall Study|Withdrawal by Subject|0|||
105711744|NCT02387580|364604554|FG001|Overall Study|Withdrawal by Subject|0|||
105711745|NCT02387580|364604555|FG002|Overall Study|Withdrawal by Subject|0|||
105711746|NCT02387580|364604556|FG003|Overall Study|Withdrawal by Subject|1|||
105711747|NCT02387580|364604557|FG004|Overall Study|Withdrawal by Subject|0|||
105711748|NCT02387580|364604558|FG005|Overall Study|Withdrawal by Subject|0|||
105711749|NCT03461757|364604561|FG000|Overall Study|Adverse Event|1|||
105711750|NCT03461757|364604562|FG001|Overall Study|Adverse Event|0|||
105711751|NCT03461757|364604561|FG000|Overall Study|Lost to Follow-up|13|||
105711752|NCT03461757|364604562|FG001|Overall Study|Lost to Follow-up|7|||
105711753|NCT03461757|364604561|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
105711754|NCT03461757|364604562|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
105711755|NCT03461757|364604561|FG000|Overall Study|Non-compliance with study treatment|0|||
105711756|NCT03461757|364604562|FG001|Overall Study|Non-compliance with study treatment|1|||
105788152|NCT03426995|364878226|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105352067|NCT00394771|363293802|FG001|Overall Study|Adverse Event|5|||
105476012|NCT00470834|363755279|FG001|Treatment Period (18 Months)|Physician Decision|4|||
105476013|NCT00470834|363755278|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
105476014|NCT00470834|363755279|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
105711757|NCT03461757|364604561|FG000|Overall Study|Pregnancy|2|||
105711758|NCT03461757|364604562|FG001|Overall Study|Pregnancy|0|||
105711759|NCT03461757|364604561|FG000|Overall Study|Protocol Violation|1|||
105352068|NCT00394771|363293803|FG002|Overall Study|Adverse Event|12|||
105476015|NCT00470834|363755278|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
105352069|NCT00394771|363293804|FG003|Overall Study|Adverse Event|8|||
105476016|NCT00470834|363755279|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
105476017|NCT00470834|363755278|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
105476018|NCT00470834|363755279|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
105476019|NCT00470834|363755278|FG000|Treatment Period (18 Months)|Non-compliance|1|||
105352070|NCT00394771|363293801|FG000|Overall Study|Participant pregnant|0|||
105352071|NCT00394771|363293802|FG001|Overall Study|Participant pregnant|1|||
105352072|NCT00394771|363293803|FG002|Overall Study|Participant pregnant|2|||
105352073|NCT00394771|363293804|FG003|Overall Study|Participant pregnant|2|||
105352074|NCT00394771|363293801|FG000|Overall Study|Lost to Follow-up|15|||
105352075|NCT00394771|363293802|FG001|Overall Study|Lost to Follow-up|15|||
105352076|NCT00394771|363293803|FG002|Overall Study|Lost to Follow-up|13|||
105352077|NCT00394771|363293804|FG003|Overall Study|Lost to Follow-up|10|||
105352078|NCT00394771|363293801|FG000|Overall Study|Other|3|||
105352079|NCT00394771|363293802|FG001|Overall Study|Other|3|||
105352080|NCT00394771|363293803|FG002|Overall Study|Other|1|||
105352081|NCT00394771|363293804|FG003|Overall Study|Other|0|||
105352082|NCT00564395|363293812|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
105352083|NCT00564395|363293813|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
105352084|NCT00564395|363293812|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
105352085|NCT00564395|363293813|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
105352086|NCT02984267|363293815|FG000|Overall Study|Protocol Violation|1|||
105352087|NCT02984267|363293816|FG001|Overall Study|Protocol Violation|0|||
105352088|NCT02984267|363293815|FG000|Overall Study|Withdrawal by Subject|0|||
105352089|NCT02984267|363293816|FG001|Overall Study|Withdrawal by Subject|1|||
105352090|NCT00742027|363293817|FG000|Overall Study|Disease Progression|76|||
105352091|NCT00742027|363293817|FG000|Overall Study|New Cancer Therapy|19|||
105352092|NCT00742027|363293817|FG000|Overall Study|Withdrawal by Subject|18|||
105352093|NCT00742027|363293817|FG000|Overall Study|Death|7|||
105352094|NCT00742027|363293817|FG000|Overall Study|Lost to Follow-up|4|||
105352095|NCT00742027|363293817|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
105352096|NCT00742027|363293817|FG000|Overall Study|Missing|2|||
105352097|NCT00742027|363293817|FG000|Overall Study|Administrative Problems|1|||
105352098|NCT02634710|363293818|FG000|Overall Study|Death|4|||
105352099|NCT00520767|363293822|FG000|Overall Study|Death|2|||
105352100|NCT04811664|363293825|FG000|Overall Study|Lost to Follow-up|78|||
105352101|NCT04811664|363293826|FG001|Overall Study|Lost to Follow-up|125|||
105352102|NCT04811664|363293827|FG002|Overall Study|Lost to Follow-up|46|||
105352103|NCT04811664|363293825|FG000|Overall Study|Withdrawal by Subject|39|||
105352104|NCT04811664|363293826|FG001|Overall Study|Withdrawal by Subject|76|||
105352105|NCT04811664|363293827|FG002|Overall Study|Withdrawal by Subject|12|||
105352106|NCT04811664|363293825|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
105352107|NCT04811664|363293826|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
105352108|NCT04811664|363293827|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
105352109|NCT04811664|363293825|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
105352110|NCT04811664|363293826|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
105352111|NCT04811664|363293827|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
105352112|NCT04811664|363293825|FG000|Overall Study|Protocol Violation|0|||
105352113|NCT04811664|363293826|FG001|Overall Study|Protocol Violation|5|||
105352114|NCT04811664|363293827|FG002|Overall Study|Protocol Violation|11|||
105352115|NCT04811664|363293825|FG000|Overall Study|Study Terminated by Sponsor|4|||
105352116|NCT04811664|363293826|FG001|Overall Study|Study Terminated by Sponsor|3|||
105352117|NCT04811664|363293827|FG002|Overall Study|Study Terminated by Sponsor|34|||
105352118|NCT04811664|363293825|FG000|Overall Study|Early Study Closure|3|||
105352119|NCT04811664|363293826|FG001|Overall Study|Early Study Closure|7|||
105352120|NCT04811664|363293827|FG002|Overall Study|Early Study Closure|79|||
105352121|NCT04811664|363293825|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
105352122|NCT04811664|363293826|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
105352123|NCT04811664|363293827|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
105352124|NCT02717442|363293828|FG000|Overall Study|Study Terminated by Sponsor|31|||
105352125|NCT02717442|363293829|FG001|Overall Study|Study Terminated by Sponsor|29|||
105352126|NCT02717442|363293828|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
105352127|NCT02717442|363293829|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
105352128|NCT02717442|363293828|FG000|Overall Study|Other - Not Specified|2|||
105352129|NCT02717442|363293829|FG001|Overall Study|Other - Not Specified|0|||
105352130|NCT00534105|363293833|FG000|Overall Study|Lost to Follow-up|23|||
105352131|NCT00534105|363293834|FG001|Overall Study|Lost to Follow-up|39|||
105352132|NCT00723697|363293835|FG000|Overall Study|Physician questionnaires not received|2|||
105352133|NCT00723697|363293835|FG000|Overall Study|Missing Informed Consent Form|10|||
105561406|NCT00316082|364050488|FG002|Overall Study|Lack of Efficacy|3|||
105352134|NCT00723697|363293835|FG000|Overall Study|Other exclusion criteria applied|6|||
105352135|NCT02774005|363293836|FG000|Overall Study|Adverse Event|8|||
105352136|NCT02774005|363293836|FG000|Overall Study|Withdrawal by Subject|23|||
105352137|NCT02774005|363293836|FG000|Overall Study|Lost to Follow-up|7|||
105352138|NCT02774005|363293836|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
105352139|NCT02774005|363293836|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
105352140|NCT02774005|363293836|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
105352141|NCT02774005|363293836|FG000|Overall Study|Death|1|||
105711760|NCT03461757|364604562|FG001|Overall Study|Protocol Violation|1|||
105711761|NCT03461757|364604561|FG000|Overall Study|Withdrawal by Subject|7|||
105711762|NCT03461757|364604562|FG001|Overall Study|Withdrawal by Subject|7|||
105711763|NCT03461757|364604561|FG000|Overall Study|Other Reasons|1|||
105711764|NCT03461757|364604562|FG001|Overall Study|Other Reasons|4|||
105711765|NCT00879697|364604563|FG000|Overall Study|Physician Decision|2|||
105711766|NCT00879697|364604564|FG001|Overall Study|Physician Decision|2|||
105711767|NCT00993928|364604565|FG000|Overall Study|Withdrawal by Subject|4|||
105711768|NCT00993928|364604566|FG001|Overall Study|Withdrawal by Subject|7|||
105788153|NCT03426995|364878227|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788154|NCT03426995|364878228|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788155|NCT03426995|364878229|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105711769|NCT00993928|364604565|FG000|Overall Study|ineligible|1|||
105711770|NCT00993928|364604566|FG001|Overall Study|ineligible|0|||
105476020|NCT00470834|363755279|FG001|Treatment Period (18 Months)|Non-compliance|0|||
105476021|NCT00470834|363755278|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
105476022|NCT00470834|363755279|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
105476023|NCT00470834|363755278|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
105476024|NCT00470834|363755279|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
105476025|NCT00470834|363755278|FG000|Extension Period (24 Months)|Adverse Event|3|||
105476026|NCT00470834|363755279|FG001|Extension Period (24 Months)|Adverse Event|4|||
105476027|NCT00470834|363755278|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
105476028|NCT00470834|363755279|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
105476029|NCT00470834|363755278|FG000|Extension Period (24 Months)|Physician Decision|4|||
105561407|NCT00316082|364050489|FG003|Overall Study|Lack of Efficacy|4|||
105711771|NCT00866307|364604569|FG000|Induction|Adverse Event|5|||
105476030|NCT00470834|363755279|FG001|Extension Period (24 Months)|Physician Decision|3|||
105476031|NCT00470834|363755278|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
105476032|NCT00470834|363755279|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
105711772|NCT00866307|364604570|FG001|Induction|Adverse Event|0|||
105711773|NCT00866307|364604571|FG002|Induction|Adverse Event|0|||
105711774|NCT00866307|364604569|FG000|Induction|Death|2|||
105711775|NCT00866307|364604570|FG001|Induction|Death|0|||
105711776|NCT00866307|364604571|FG002|Induction|Death|0|||
105711777|NCT00866307|364604569|FG000|Induction|Physician Decision|5|||
105711778|NCT00866307|364604570|FG001|Induction|Physician Decision|0|||
105711779|NCT00866307|364604571|FG002|Induction|Physician Decision|0|||
105711780|NCT00866307|364604569|FG000|Induction|Progressive Disease|1|||
105711781|NCT00866307|364604570|FG001|Induction|Progressive Disease|0|||
105711782|NCT00866307|364604571|FG002|Induction|Progressive Disease|0|||
105711783|NCT00866307|364604569|FG000|Induction|Identification of Patients with Day 29 M|3|||
105711784|NCT00866307|364604570|FG001|Induction|Identification of Patients with Day 29 M|0|||
105711785|NCT00866307|364604571|FG002|Induction|Identification of Patients with Day 29 M|0|||
105711786|NCT00866307|364604569|FG000|Induction|Inadequate cytognetic samples th|1|||
105711787|NCT00866307|364604570|FG001|Induction|Inadequate cytognetic samples th|0|||
105711788|NCT00866307|364604571|FG002|Induction|Inadequate cytognetic samples th|0|||
105711789|NCT00866307|364604569|FG000|Induction|Improper post-induction consent|2|||
105711790|NCT00866307|364604570|FG001|Induction|Improper post-induction consent|0|||
105711791|NCT00866307|364604571|FG002|Induction|Improper post-induction consent|0|||
105711792|NCT00866307|364604569|FG000|Induction|Study was closed at the time|1|||
105711793|NCT00866307|364604570|FG001|Induction|Study was closed at the time|0|||
105711794|NCT00866307|364604571|FG002|Induction|Study was closed at the time|0|||
105711795|NCT00866307|364604569|FG000|Consolidation/Maintenance|Adverse Event|0|||
105711796|NCT00866307|364604570|FG001|Consolidation/Maintenance|Adverse Event|0|||
105711797|NCT00866307|364604571|FG002|Consolidation/Maintenance|Adverse Event|8|||
105711798|NCT00866307|364604569|FG000|Consolidation/Maintenance|Death|0|||
105711799|NCT00866307|364604570|FG001|Consolidation/Maintenance|Death|0|||
105711800|NCT00866307|364604571|FG002|Consolidation/Maintenance|Death|1|||
105711801|NCT00866307|364604569|FG000|Consolidation/Maintenance|Physician Decision|0|||
105711802|NCT00866307|364604570|FG001|Consolidation/Maintenance|Physician Decision|3|||
105711803|NCT00866307|364604571|FG002|Consolidation/Maintenance|Physician Decision|2|||
105711804|NCT00866307|364604569|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
105711805|NCT00866307|364604570|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
105711806|NCT00866307|364604571|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
105711807|NCT00866307|364604569|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
105711808|NCT00866307|364604570|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
105711809|NCT00866307|364604571|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
105711810|NCT00866307|364604569|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
105711811|NCT00866307|364604570|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
105711812|NCT00866307|364604571|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
105711813|NCT00866307|364604569|FG000|Consolidation/Maintenance|Therapy error|0|||
105711814|NCT00866307|364604570|FG001|Consolidation/Maintenance|Therapy error|1|||
105711815|NCT00866307|364604571|FG002|Consolidation/Maintenance|Therapy error|0|||
105711816|NCT00866307|364604569|FG000|Consolidation/Maintenance|Non-compliance|0|||
105711817|NCT00866307|364604570|FG001|Consolidation/Maintenance|Non-compliance|0|||
105561408|NCT00316082|364050490|FG004|Overall Study|Lack of Efficacy|6|||
105561409|NCT00316082|364050486|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
105711818|NCT00866307|364604571|FG002|Consolidation/Maintenance|Non-compliance|1|||
105711819|NCT00866307|364604569|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
105711820|NCT00866307|364604570|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
105711821|NCT00866307|364604571|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
105711822|NCT02286947|364604572|FG000|Overall Study|Withdrawal by Subject|2|||
105711823|NCT01687712|364604573|FG000|Cycle 1|Not Biochemically Pregnant|386|||
105711824|NCT01687712|364604574|FG001|Cycle 1|Not Biochemically Pregnant|348|||
105711825|NCT01687712|364604573|FG000|Cycle 1|Early Pregnancy Loss|43|||
105360894|NCT01051557|363328104|FG001|Overall Study|disease progression|3|||
105476033|NCT00470834|363755278|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
105352142|NCT02774005|363293836|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
105352143|NCT02774005|363293836|FG000|Overall Study|Lack of compliance with study medication|4|||
105352144|NCT02774005|363293836|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
105352145|NCT02774005|363293836|FG000|Overall Study|another study|1|||
105352146|NCT02774005|363293836|FG000|Overall Study|cardiologist imposed travel restriction|1|||
105352147|NCT01289574|363293837|FG000|Overall Study|Lack of Efficacy|4|||
105352148|NCT01289574|363293838|FG001|Overall Study|Lack of Efficacy|0|||
105352149|NCT01289574|363293839|FG002|Overall Study|Lack of Efficacy|1|||
105352150|NCT01289574|363293837|FG000|Overall Study|Lost to Follow-up|2|||
105352151|NCT01289574|363293838|FG001|Overall Study|Lost to Follow-up|0|||
105352152|NCT01289574|363293839|FG002|Overall Study|Lost to Follow-up|1|||
105352153|NCT01289574|363293837|FG000|Overall Study|Withdrawal by Subject|1|||
105352154|NCT01289574|363293838|FG001|Overall Study|Withdrawal by Subject|1|||
105352155|NCT01289574|363293839|FG002|Overall Study|Withdrawal by Subject|1|||
105352156|NCT01289574|363293837|FG000|Overall Study|Adverse Event|0|||
105352157|NCT01289574|363293838|FG001|Overall Study|Adverse Event|1|||
105352158|NCT01289574|363293839|FG002|Overall Study|Adverse Event|0|||
105352159|NCT01289574|363293837|FG000|Overall Study|Subject wanted alternate treatment|0|||
105352160|NCT01289574|363293838|FG001|Overall Study|Subject wanted alternate treatment|1|||
105352161|NCT01289574|363293839|FG002|Overall Study|Subject wanted alternate treatment|0|||
105352162|NCT02432144|363293842|FG000|Overall Study|Participant Non-Compliance|1|||
105352163|NCT00978341|363293843|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
105352164|NCT00978341|363293844|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
105352165|NCT01554163|363293845|FG000|Overall Study|Adverse Event|3|||
105352166|NCT01554163|363293846|FG001|Overall Study|Adverse Event|0|||
105352167|NCT01554163|363293845|FG000|Overall Study|Lack of Efficacy|1|||
105352168|NCT01554163|363293846|FG001|Overall Study|Lack of Efficacy|0|||
105352169|NCT01554163|363293845|FG000|Overall Study|Lost to Follow-up|1|||
105352170|NCT01554163|363293846|FG001|Overall Study|Lost to Follow-up|0|||
105352171|NCT01554163|363293845|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105352172|NCT01554163|363293846|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105352173|NCT01554163|363293845|FG000|Overall Study|Protocol Violation|0|||
105352174|NCT01554163|363293846|FG001|Overall Study|Protocol Violation|4|||
105352175|NCT01554163|363293845|FG000|Overall Study|Withdrawal by Subject|1|||
105352176|NCT01554163|363293846|FG001|Overall Study|Withdrawal by Subject|5|||
105352177|NCT01554163|363293845|FG000|Overall Study|Not Treated|1|||
105352178|NCT01554163|363293846|FG001|Overall Study|Not Treated|0|||
105352179|NCT01483599|363293847|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
105352180|NCT01483599|363293848|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105352181|NCT01483599|363293849|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105352182|NCT01483599|363293850|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
105352183|NCT01483599|363293851|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
105352184|NCT01483599|363293852|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
105352185|NCT01483599|363293853|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
105352186|NCT01483599|363293854|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105352187|NCT01483599|363293855|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105352188|NCT01483599|363293856|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105352189|NCT01483599|363293857|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105352190|NCT01483599|363293858|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105352191|NCT01483599|363293859|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105476034|NCT00470834|363755279|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
105476035|NCT00470834|363755278|FG000|Extension Period (24 Months)|Non-compliance|0|||
105476036|NCT00470834|363755279|FG001|Extension Period (24 Months)|Non-compliance|1|||
105476037|NCT00470834|363755278|FG000|Extension Period (24 Months)|Disease Progression|0|||
105476038|NCT00470834|363755279|FG001|Extension Period (24 Months)|Disease Progression|1|||
105476039|NCT06351371|363755282|FG000|Overall Study|Mutation Status Not Confirmed|9|||
105352192|NCT01483599|363293860|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105352193|NCT01483599|363293847|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105352194|NCT01483599|363293848|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
105352195|NCT01483599|363293849|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105352196|NCT01483599|363293850|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
105476040|NCT06351371|363755282|FG000|Overall Study|Ineligible|1|||
105476041|NCT06351371|363755282|FG000|Overall Study|Adverse Event|4|||
105352197|NCT01483599|363293851|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105352198|NCT01483599|363293852|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105352199|NCT01483599|363293853|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
105352200|NCT01483599|363293854|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105352201|NCT01483599|363293855|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105352202|NCT01483599|363293856|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105352203|NCT01483599|363293857|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105352204|NCT01483599|363293858|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105352205|NCT01483599|363293859|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105352206|NCT01483599|363293860|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105352207|NCT01483599|363293847|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
105352208|NCT01483599|363293848|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105352209|NCT01483599|363293849|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105352210|NCT01483599|363293850|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105352211|NCT01483599|363293851|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105352212|NCT01483599|363293852|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105352213|NCT01483599|363293853|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105352214|NCT01483599|363293854|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105352215|NCT01483599|363293855|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105352216|NCT01483599|363293856|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105352217|NCT01483599|363293857|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105352218|NCT01483599|363293858|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105352219|NCT01483599|363293859|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105352220|NCT01483599|363293860|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105352221|NCT01483599|363293847|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
105352222|NCT01483599|363293848|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
105352223|NCT01483599|363293849|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
105352224|NCT01483599|363293850|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
105352225|NCT01483599|363293851|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
105352226|NCT01483599|363293852|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
105352227|NCT01483599|363293853|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
105352228|NCT01483599|363293854|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
105352229|NCT01483599|363293855|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
105352230|NCT01483599|363293856|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
105352231|NCT01483599|363293857|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
105352232|NCT01483599|363293858|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
105352233|NCT01483599|363293859|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
105352234|NCT01483599|363293860|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
105352235|NCT01483599|363293847|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
105352236|NCT01483599|363293848|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
105352237|NCT01483599|363293849|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
105352238|NCT01483599|363293850|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
105352239|NCT01483599|363293851|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
105352240|NCT01483599|363293852|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
105352241|NCT01483599|363293853|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
105352242|NCT01483599|363293854|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
105352243|NCT01483599|363293855|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
105352244|NCT01483599|363293856|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
105352245|NCT01483599|363293857|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
105352246|NCT01483599|363293858|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
105352247|NCT01483599|363293859|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
105352248|NCT01483599|363293860|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
105352249|NCT01483599|363293847|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105352250|NCT01483599|363293848|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105352251|NCT01483599|363293849|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105352252|NCT01483599|363293850|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105352253|NCT01483599|363293851|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105352254|NCT01483599|363293852|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105352255|NCT01483599|363293853|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105352256|NCT01483599|363293854|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
105352257|NCT01483599|363293855|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
105352258|NCT01483599|363293856|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105352259|NCT01483599|363293857|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105352260|NCT01483599|363293858|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105352261|NCT01483599|363293859|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
105360895|NCT01051557|363328105|FG002|Overall Study|disease progression|5|||
105476042|NCT06351371|363755282|FG000|Overall Study|Death|1|||
105476043|NCT06351371|363755282|FG000|Overall Study|Disease progression|14|||
105711826|NCT01687712|364604574|FG001|Cycle 1|Early Pregnancy Loss|60|||
105711827|NCT01687712|364604573|FG000|Cycle 1|Ectopic Pregnancy|5|||
105352262|NCT01483599|363293860|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
105352263|NCT01483599|363293847|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105352264|NCT01483599|363293848|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105352265|NCT01483599|363293849|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105352266|NCT01483599|363293850|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105352267|NCT01483599|363293851|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105352268|NCT01483599|363293852|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105352269|NCT01483599|363293853|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105352270|NCT01483599|363293854|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105352271|NCT01483599|363293855|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
105352272|NCT01483599|363293856|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105352273|NCT01483599|363293857|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105352274|NCT01483599|363293858|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
105352275|NCT01483599|363293859|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105352276|NCT01483599|363293860|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
105352277|NCT01483599|363293847|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105561410|NCT00316082|364050487|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
105561411|NCT00316082|364050488|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
105561412|NCT00316082|364050489|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
105711828|NCT01687712|364604574|FG001|Cycle 1|Ectopic Pregnancy|5|||
105711829|NCT01687712|364604573|FG000|Cycle 1|Heterotropic Pregnancy|1|||
105711830|NCT01687712|364604574|FG001|Cycle 1|Heterotropic Pregnancy|0|||
105711831|NCT01687712|364604573|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
105711832|NCT01687712|364604574|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
105711833|NCT01687712|364604573|FG000|Cycle 1|Abortion|3|||
105711834|NCT01687712|364604574|FG001|Cycle 1|Abortion|0|||
105711835|NCT01687712|364604573|FG000|Cycle 1|Intrauterine Fetal Death|0|||
105711836|NCT01687712|364604574|FG001|Cycle 1|Intrauterine Fetal Death|1|||
105711837|NCT01687712|364604573|FG000|Cycle 1|Lost to Follow-up|1|||
105711838|NCT01687712|364604574|FG001|Cycle 1|Lost to Follow-up|1|||
105711839|NCT01687712|364604573|FG000|Cycle 2|Not Biochemically Pregnant|74|||
105711840|NCT01687712|364604574|FG001|Cycle 2|Not Biochemically Pregnant|77|||
105711841|NCT01687712|364604573|FG000|Cycle 2|Early Pregnancy Loss|18|||
105711842|NCT01687712|364604574|FG001|Cycle 2|Early Pregnancy Loss|16|||
105711843|NCT01687712|364604573|FG000|Cycle 2|Ectopic Pregnancy|0|||
105711844|NCT01687712|364604574|FG001|Cycle 2|Ectopic Pregnancy|1|||
105711845|NCT01687712|364604573|FG000|Cycle 2|Still Birth|1|||
105711846|NCT01687712|364604574|FG001|Cycle 2|Still Birth|0|||
105711847|NCT01687712|364604573|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
105711848|NCT01687712|364604574|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
105711849|NCT01687712|364604573|FG000|Cycle 3|Not Biochemically Pregnant|21|||
105711850|NCT01687712|364604574|FG001|Cycle 3|Not Biochemically Pregnant|22|||
105711851|NCT01687712|364604573|FG000|Cycle 3|Early Pregnancy Loss|1|||
105561413|NCT00316082|364050490|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
105561414|NCT00316082|364050486|FG000|Overall Study|Lost to Follow-up|7|||
105561415|NCT00316082|364050487|FG001|Overall Study|Lost to Follow-up|6|||
105561416|NCT00316082|364050488|FG002|Overall Study|Lost to Follow-up|7|||
105561417|NCT00316082|364050489|FG003|Overall Study|Lost to Follow-up|8|||
105711852|NCT01687712|364604574|FG001|Cycle 3|Early Pregnancy Loss|2|||
105711853|NCT01687712|364604573|FG000|Cycle 3|Ectopic Pregnancy|1|||
105711854|NCT01687712|364604574|FG001|Cycle 3|Ectopic Pregnancy|0|||
105711855|NCT01687712|364604573|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
105561418|NCT00316082|364050490|FG004|Overall Study|Lost to Follow-up|6|||
105561419|NCT00316082|364050486|FG000|Overall Study|Poor/noncompliance|6|||
105561420|NCT00316082|364050487|FG001|Overall Study|Poor/noncompliance|1|||
105561421|NCT00316082|364050488|FG002|Overall Study|Poor/noncompliance|4|||
105561422|NCT00316082|364050489|FG003|Overall Study|Poor/noncompliance|1|||
105711856|NCT01687712|364604574|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
105711857|NCT03979274|364604577|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105711858|NCT03979274|364604578|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105711859|NCT02573155|364604579|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
105711860|NCT02573155|364604580|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
105711861|NCT02573155|364604579|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
105711862|NCT02573155|364604580|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
105711863|NCT02573155|364604579|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
105711864|NCT02573155|364604580|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
105711865|NCT02573155|364604579|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
105711866|NCT02573155|364604580|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
105711867|NCT02573155|364604579|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
105711868|NCT02573155|364604580|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
105476044|NCT06351371|363755282|FG000|Overall Study|Withdrawal by Subject|3|||
105476045|NCT06351371|363755282|FG000|Overall Study|Physician Decision|3|||
105476046|NCT00787267|363755283|FG000|Overall Study|Screen failure/Ineligible|10|||
105476047|NCT00787267|363755283|FG000|Overall Study|No Reason Provided|1|||
105476048|NCT00787267|363755283|FG000|Overall Study|Withdrawal by Subject|1|||
105476049|NCT01788215|363755285|FG000|Overall Study|Withdrawal by Subject|0|||
105476050|NCT01788215|363755286|FG001|Overall Study|Withdrawal by Subject|1|||
105476051|NCT01788215|363755285|FG000|Overall Study|Lost to Follow-up|2|||
105476052|NCT01788215|363755286|FG001|Overall Study|Lost to Follow-up|0|||
105476053|NCT03116152|363755287|FG000|Overall Study|Disease Progression|49|||
105476054|NCT03116152|363755288|FG001|Overall Study|Disease Progression|47|||
105476055|NCT03116152|363755287|FG000|Overall Study|Death|5|||
105476056|NCT03116152|363755288|FG001|Overall Study|Death|2|||
105476057|NCT03116152|363755287|FG000|Overall Study|Adverse Event|21|||
105476058|NCT03116152|363755288|FG001|Overall Study|Adverse Event|7|||
105476059|NCT03116152|363755287|FG000|Overall Study|Protocol Violation|2|||
105476060|NCT03116152|363755288|FG001|Overall Study|Protocol Violation|2|||
105476061|NCT03116152|363755287|FG000|Overall Study|Withdrawal by Subject|0|||
105476062|NCT03116152|363755288|FG001|Overall Study|Withdrawal by Subject|1|||
105476063|NCT03116152|363755287|FG000|Overall Study|Physician Decision|3|||
105476064|NCT03116152|363755288|FG001|Overall Study|Physician Decision|2|||
105476065|NCT03116152|363755287|FG000|Overall Study|other|11|||
105476066|NCT03116152|363755288|FG001|Overall Study|other|34|||
105476067|NCT00275340|363755289|FG000|Overall Study|Lost to Follow-up|2|||
105476068|NCT00275340|363755290|FG001|Overall Study|Lost to Follow-up|4|||
105476069|NCT01950013|363755291|FG000|Overall Study|Withdrawal by Subject|0|||
105476070|NCT01950013|363755292|FG001|Overall Study|Withdrawal by Subject|2|||
105476071|NCT01950013|363755293|FG002|Overall Study|Withdrawal by Subject|0|||
105476072|NCT02379637|363755297|FG000|Overall Study|Protocol Violation|0|||
105476073|NCT02379637|363755298|FG001|Overall Study|Protocol Violation|1|||
105476074|NCT02379637|363755297|FG000|Overall Study|Adverse Event|1|||
105476075|NCT02379637|363755298|FG001|Overall Study|Adverse Event|0|||
105476076|NCT02379637|363755297|FG000|Overall Study|Withdrawal by Subject|1|||
105476077|NCT02379637|363755298|FG001|Overall Study|Withdrawal by Subject|0|||
105476078|NCT02365480|363755299|FG000|Overall Study|Withdrawal by Subject|2|||
105476079|NCT02365480|363755300|FG001|Overall Study|Withdrawal by Subject|0|||
105476080|NCT03091348|363755301|FG000|Overall Study|Lost to Follow-up|2|||
105476081|NCT03091348|363755302|FG001|Overall Study|Lost to Follow-up|1|||
105476082|NCT02791763|363755303|FG000|Overall Study|Protocol Violation|0|||
105476083|NCT02791763|363755304|FG001|Overall Study|Protocol Violation|0|||
105476084|NCT02791763|363755305|FG002|Overall Study|Protocol Violation|1|||
105476085|NCT02791763|363755303|FG000|Overall Study|Withdrawal by Subject|5|||
105476086|NCT02791763|363755304|FG001|Overall Study|Withdrawal by Subject|1|||
105476087|NCT02791763|363755305|FG002|Overall Study|Withdrawal by Subject|0|||
105476088|NCT02791763|363755303|FG000|Overall Study|Physician Decision|0|||
105476089|NCT02791763|363755304|FG001|Overall Study|Physician Decision|1|||
105711869|NCT02573155|364604579|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
105476090|NCT02791763|363755305|FG002|Overall Study|Physician Decision|0|||
105476091|NCT02791763|363755303|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
105476092|NCT02791763|363755304|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
105476093|NCT02791763|363755305|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
105476094|NCT02791763|363755303|FG000|Overall Study|Cancer event|1|||
105476095|NCT02791763|363755304|FG001|Overall Study|Cancer event|3|||
105476096|NCT02791763|363755305|FG002|Overall Study|Cancer event|0|||
105476097|NCT02791763|363755303|FG000|Overall Study|Participant had renal transplant|3|||
105476098|NCT02791763|363755304|FG001|Overall Study|Participant had renal transplant|0|||
105476099|NCT02791763|363755305|FG002|Overall Study|Participant had renal transplant|0|||
105476100|NCT02791763|363755303|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
105476101|NCT02791763|363755304|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
105476102|NCT02791763|363755305|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
105711870|NCT02573155|364604580|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
105711871|NCT02573155|364604579|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
105711872|NCT02573155|364604580|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
105711873|NCT02573155|364604579|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
105711874|NCT02573155|364604580|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
105711875|NCT01681433|364604581|FG000|Overall Study|Lack of Efficacy|23|||
105711876|NCT01681433|364604582|FG001|Overall Study|Lack of Efficacy|23|||
105711877|NCT01681433|364604581|FG000|Overall Study|Withdrawal by Subject|5|||
105711878|NCT01681433|364604582|FG001|Overall Study|Withdrawal by Subject|5|||
105711879|NCT01681433|364604581|FG000|Overall Study|Protocol Violation|2|||
105711880|NCT01681433|364604582|FG001|Overall Study|Protocol Violation|0|||
105711881|NCT01681433|364604581|FG000|Overall Study|Adverse Event|2|||
105711882|NCT01681433|364604582|FG001|Overall Study|Adverse Event|4|||
105711883|NCT01681433|364604581|FG000|Overall Study|Lost to Follow-up|0|||
105711884|NCT01681433|364604582|FG001|Overall Study|Lost to Follow-up|1|||
105711885|NCT00730639|364604583|FG000|Overall Study|Adverse Event|3|||
105711886|NCT00730639|364604584|FG001|Overall Study|Adverse Event|0|||
105711887|NCT00730639|364604585|FG002|Overall Study|Adverse Event|9|||
105711888|NCT00730639|364604586|FG003|Overall Study|Adverse Event|8|||
105711889|NCT00730639|364604587|FG004|Overall Study|Adverse Event|23|||
105711890|NCT00730639|364604583|FG000|Overall Study|Complete Response|0|||
105711891|NCT00730639|364604584|FG001|Overall Study|Complete Response|0|||
105711892|NCT00730639|364604585|FG002|Overall Study|Complete Response|2|||
105711893|NCT00730639|364604586|FG003|Overall Study|Complete Response|2|||
105711894|NCT00730639|364604587|FG004|Overall Study|Complete Response|1|||
105711895|NCT00730639|364604583|FG000|Overall Study|Completed Maximum Cycles|0|||
105711896|NCT00730639|364604584|FG001|Overall Study|Completed Maximum Cycles|0|||
105711897|NCT00730639|364604585|FG002|Overall Study|Completed Maximum Cycles|11|||
105711898|NCT00730639|364604586|FG003|Overall Study|Completed Maximum Cycles|3|||
105788156|NCT03426995|364878230|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788157|NCT03426995|364878231|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788158|NCT03426995|364878232|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788159|NCT03426995|364878233|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788160|NCT03426995|364878234|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788161|NCT03426995|364878235|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788162|NCT03426995|364878236|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788163|NCT03426995|364878237|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788164|NCT03426995|364878238|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788165|NCT03426995|364878220|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788166|NCT03426995|364878221|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788167|NCT03426995|364878222|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788168|NCT03426995|364878223|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788169|NCT03426995|364878224|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788170|NCT03426995|364878225|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788171|NCT03426995|364878226|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788172|NCT03426995|364878227|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788173|NCT03426995|364878228|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788174|NCT03426995|364878229|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788175|NCT03426995|364878230|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
105788176|NCT03426995|364878231|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788177|NCT03426995|364878232|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788178|NCT03426995|364878233|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788179|NCT03426995|364878234|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788180|NCT03426995|364878235|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788181|NCT03426995|364878236|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788182|NCT03426995|364878237|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788183|NCT03426995|364878238|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788184|NCT03426995|364878220|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105711899|NCT00730639|364604587|FG004|Overall Study|Completed Maximum Cycles|6|||
105561423|NCT00316082|364050490|FG004|Overall Study|Poor/noncompliance|4|||
105711900|NCT00730639|364604583|FG000|Overall Study|Death|0|||
105711901|NCT00730639|364604584|FG001|Overall Study|Death|0|||
105711902|NCT00730639|364604585|FG002|Overall Study|Death|0|||
105711903|NCT00730639|364604586|FG003|Overall Study|Death|0|||
105711904|NCT00730639|364604587|FG004|Overall Study|Death|2|||
105711905|NCT00730639|364604583|FG000|Overall Study|Disease Progression|12|||
105711906|NCT00730639|364604584|FG001|Overall Study|Disease Progression|13|||
105711907|NCT00730639|364604585|FG002|Overall Study|Disease Progression|48|||
105711908|NCT00730639|364604586|FG003|Overall Study|Disease Progression|32|||
105711909|NCT00730639|364604587|FG004|Overall Study|Disease Progression|88|||
105561424|NCT00316082|364050486|FG000|Overall Study|Adverse Event|4|||
105561425|NCT00316082|364050487|FG001|Overall Study|Adverse Event|2|||
105561426|NCT00316082|364050488|FG002|Overall Study|Adverse Event|5|||
105561427|NCT00316082|364050489|FG003|Overall Study|Adverse Event|1|||
105561428|NCT00316082|364050490|FG004|Overall Study|Adverse Event|3|||
105561429|NCT00316082|364050486|FG000|Overall Study|Subject no longer meets study criteria|3|||
105561430|NCT00316082|364050487|FG001|Overall Study|Subject no longer meets study criteria|1|||
105561431|NCT00316082|364050488|FG002|Overall Study|Subject no longer meets study criteria|2|||
105561432|NCT00316082|364050489|FG003|Overall Study|Subject no longer meets study criteria|2|||
105561433|NCT00316082|364050490|FG004|Overall Study|Subject no longer meets study criteria|1|||
105561434|NCT00316082|364050486|FG000|Overall Study|Physician Decision|1|||
105561435|NCT00316082|364050487|FG001|Overall Study|Physician Decision|1|||
105561436|NCT00316082|364050488|FG002|Overall Study|Physician Decision|2|||
105561437|NCT00316082|364050489|FG003|Overall Study|Physician Decision|1|||
105561438|NCT00316082|364050490|FG004|Overall Study|Physician Decision|1|||
105561439|NCT00316082|364050486|FG000|Overall Study|Death|0|||
105561440|NCT00316082|364050487|FG001|Overall Study|Death|0|||
105561441|NCT00316082|364050488|FG002|Overall Study|Death|1|||
105561442|NCT00316082|364050489|FG003|Overall Study|Death|0|||
105561443|NCT00316082|364050490|FG004|Overall Study|Death|0|||
105561444|NCT00316082|364050486|FG000|Overall Study|Administrative reason by sponsor|0|||
105561445|NCT00316082|364050487|FG001|Overall Study|Administrative reason by sponsor|0|||
105561446|NCT00316082|364050488|FG002|Overall Study|Administrative reason by sponsor|1|||
105561447|NCT00316082|364050489|FG003|Overall Study|Administrative reason by sponsor|0|||
105561448|NCT00316082|364050490|FG004|Overall Study|Administrative reason by sponsor|0|||
105561449|NCT01693068|364050495|FG000|Randomization Period|On-study|2|||
105561450|NCT01693068|364050496|FG001|Randomization Period|On-study|5|||
105561451|NCT01693068|364050497|FG002|Randomization Period|On-study|0|||
105561452|NCT01693068|364050495|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
105561453|NCT01693068|364050496|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
105561454|NCT01693068|364050497|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
105561455|NCT01939548|364050498|FG000|Overall Study|Non compliance|0|||
105561456|NCT01939548|364050499|FG001|Overall Study|Non compliance|2|||
105561457|NCT01939548|364050500|FG002|Overall Study|Non compliance|0|||
105561458|NCT01939548|364050498|FG000|Overall Study|Study Terminated by Sponsor|17|||
105711910|NCT00730639|364604583|FG000|Overall Study|non-specified|0|||
105711911|NCT00730639|364604584|FG001|Overall Study|non-specified|0|||
105711912|NCT00730639|364604585|FG002|Overall Study|non-specified|4|||
105711913|NCT00730639|364604586|FG003|Overall Study|non-specified|2|||
105711914|NCT00730639|364604587|FG004|Overall Study|non-specified|3|||
105788185|NCT03426995|364878221|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788186|NCT03426995|364878222|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788187|NCT03426995|364878223|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788188|NCT03426995|364878224|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788189|NCT03426995|364878225|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788190|NCT03426995|364878226|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788191|NCT03426995|364878227|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
105788192|NCT03426995|364878228|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788193|NCT03426995|364878229|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788194|NCT03426995|364878230|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788195|NCT03426995|364878231|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788196|NCT03426995|364878232|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788197|NCT03426995|364878233|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788198|NCT03426995|364878234|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788199|NCT03426995|364878235|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788200|NCT03426995|364878236|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788201|NCT03426995|364878237|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788202|NCT03426995|364878238|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788203|NCT03426995|364878220|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788204|NCT03426995|364878221|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788205|NCT03426995|364878222|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788206|NCT03426995|364878223|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105561459|NCT01939548|364050499|FG001|Overall Study|Study Terminated by Sponsor|19|||
105561460|NCT01939548|364050500|FG002|Overall Study|Study Terminated by Sponsor|12|||
105561461|NCT01939548|364050498|FG000|Overall Study|Insufficient Clinical Response|1|||
105561462|NCT01939548|364050499|FG001|Overall Study|Insufficient Clinical Response|0|||
105711915|NCT00730639|364604583|FG000|Overall Study|Protocol Violation|0|||
105711916|NCT00730639|364604584|FG001|Overall Study|Protocol Violation|0|||
105561463|NCT01939548|364050500|FG002|Overall Study|Insufficient Clinical Response|0|||
105711917|NCT00730639|364604585|FG002|Overall Study|Protocol Violation|1|||
105711918|NCT00730639|364604586|FG003|Overall Study|Protocol Violation|0|||
105788207|NCT03426995|364878224|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105711919|NCT00730639|364604587|FG004|Overall Study|Protocol Violation|0|||
105360896|NCT01051557|363328106|FG003|Overall Study|disease progression|2|||
105476103|NCT02791763|363755303|FG000|Overall Study|Adverse Event|12|||
105788208|NCT03426995|364878225|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788209|NCT03426995|364878226|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788210|NCT03426995|364878227|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788211|NCT03426995|364878228|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788212|NCT03426995|364878229|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788213|NCT03426995|364878230|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788214|NCT03426995|364878231|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788215|NCT03426995|364878232|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788216|NCT03426995|364878233|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788217|NCT03426995|364878234|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
105788218|NCT03426995|364878235|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
105788219|NCT03426995|364878236|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788220|NCT03426995|364878237|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788221|NCT03426995|364878238|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788222|NCT03426995|364878220|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788223|NCT03426995|364878221|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788224|NCT03426995|364878222|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788225|NCT03426995|364878223|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788226|NCT03426995|364878224|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788227|NCT03426995|364878225|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788228|NCT03426995|364878226|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788229|NCT03426995|364878227|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105711920|NCT00730639|364604583|FG000|Overall Study|Withdrawal by Subject|0|||
105711921|NCT00730639|364604584|FG001|Overall Study|Withdrawal by Subject|0|||
105711922|NCT00730639|364604585|FG002|Overall Study|Withdrawal by Subject|6|||
105711923|NCT00730639|364604586|FG003|Overall Study|Withdrawal by Subject|3|||
105711924|NCT00730639|364604587|FG004|Overall Study|Withdrawal by Subject|4|||
105711925|NCT00730639|364604583|FG000|Overall Study|Treatment on-going|2|||
105711926|NCT00730639|364604584|FG001|Overall Study|Treatment on-going|5|||
105711927|NCT00730639|364604585|FG002|Overall Study|Treatment on-going|5|||
105711928|NCT00730639|364604586|FG003|Overall Study|Treatment on-going|4|||
105711929|NCT00730639|364604587|FG004|Overall Study|Treatment on-going|4|||
105711930|NCT01060059|364604588|FG000|Overall Study|Adverse Event|1|||
105711931|NCT01060059|364604589|FG001|Overall Study|Adverse Event|1|||
105711932|NCT01060059|364604588|FG000|Overall Study|Death|2|||
105711933|NCT01060059|364604589|FG001|Overall Study|Death|3|||
105711934|NCT01060059|364604588|FG000|Overall Study|Lost to Follow-up|18|||
105711935|NCT01060059|364604589|FG001|Overall Study|Lost to Follow-up|34|||
105711936|NCT01060059|364604588|FG000|Overall Study|entry criteria not met|4|||
105711937|NCT01060059|364604589|FG001|Overall Study|entry criteria not met|3|||
105711938|NCT01060059|364604588|FG000|Overall Study|Withdrawal by Subject|35|||
105711939|NCT01060059|364604589|FG001|Overall Study|Withdrawal by Subject|23|||
105711940|NCT01060059|364604588|FG000|Overall Study|lack of glycemic control|2|||
105711941|NCT01060059|364604589|FG001|Overall Study|lack of glycemic control|1|||
105788230|NCT03426995|364878228|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788231|NCT03426995|364878229|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105711942|NCT01060059|364604588|FG000|Overall Study|lack of compliance|5|||
105711943|NCT01060059|364604589|FG001|Overall Study|lack of compliance|2|||
105711944|NCT02665286|364604590|FG000|Overall Study|Lost to Follow-up|3|||
105711945|NCT02665286|364604591|FG001|Overall Study|Lost to Follow-up|2|||
105711946|NCT02665286|364604592|FG002|Overall Study|Lost to Follow-up|1|||
105711947|NCT02270242|364604601|FG000|Overall Study|Withdrawal by Subject|18|||
105788232|NCT03426995|364878230|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105476104|NCT02791763|363755304|FG001|Overall Study|Adverse Event|13|||
105476105|NCT02791763|363755305|FG002|Overall Study|Adverse Event|7|||
105476106|NCT03179605|363755306|FG000|Overall Study|Withdrawal by Subject|1|||
105476107|NCT00146848|363755311|FG000|Pre-randomization|Death|19|||
105476108|NCT00146848|363755312|FG001|Pre-randomization|Death|0|||
105476109|NCT00146848|363755313|FG002|Pre-randomization|Death|0|||
105476110|NCT00146848|363755311|FG000|Pre-randomization|Lost to Follow-up|70|||
105476111|NCT00146848|363755312|FG001|Pre-randomization|Lost to Follow-up|0|||
105476112|NCT00146848|363755313|FG002|Pre-randomization|Lost to Follow-up|0|||
105711948|NCT02270242|364604602|FG001|Overall Study|Withdrawal by Subject|25|||
105711949|NCT02270242|364604601|FG000|Overall Study|Lost to Follow-up|41|||
105711950|NCT02270242|364604602|FG001|Overall Study|Lost to Follow-up|27|||
105711951|NCT02270242|364604601|FG000|Overall Study|Physician Decision|0|||
105711952|NCT02270242|364604602|FG001|Overall Study|Physician Decision|1|||
105711953|NCT00644787|364604607|FG000|Period 1: Titration Phase|Adverse Event|11|||
105711954|NCT00644787|364604608|FG001|Period 1: Titration Phase|Adverse Event|0|||
105711955|NCT00644787|364604609|FG002|Period 1: Titration Phase|Adverse Event|0|||
105711956|NCT00644787|364604607|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
105711957|NCT00644787|364604608|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
105711958|NCT00644787|364604609|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
105476113|NCT00146848|363755311|FG000|Pre-randomization|Physician Decision|8|||
105476114|NCT00146848|363755312|FG001|Pre-randomization|Physician Decision|0|||
105476115|NCT00146848|363755313|FG002|Pre-randomization|Physician Decision|0|||
105711959|NCT00644787|364604607|FG000|Period 1: Titration Phase|Physician Decision|1|||
105711960|NCT00644787|364604608|FG001|Period 1: Titration Phase|Physician Decision|0|||
105711961|NCT00644787|364604609|FG002|Period 1: Titration Phase|Physician Decision|0|||
105711962|NCT00644787|364604607|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
105788233|NCT03426995|364878231|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105476116|NCT00146848|363755311|FG000|Pre-randomization|Protocol Violation|172|||
105476117|NCT00146848|363755312|FG001|Pre-randomization|Protocol Violation|0|||
105476118|NCT00146848|363755313|FG002|Pre-randomization|Protocol Violation|0|||
105476119|NCT00146848|363755311|FG000|Pre-randomization|Withdrawal by Subject|40|||
105476120|NCT00146848|363755312|FG001|Pre-randomization|Withdrawal by Subject|0|||
105476121|NCT00146848|363755313|FG002|Pre-randomization|Withdrawal by Subject|0|||
105476122|NCT00146848|363755311|FG000|Post-randomization|Lost to Follow-up|12|||
105711963|NCT00644787|364604608|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
105476123|NCT00146848|363755312|FG001|Post-randomization|Lost to Follow-up|15|||
105476124|NCT00146848|363755313|FG002|Post-randomization|Lost to Follow-up|12|||
105711964|NCT00644787|364604609|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
105711965|NCT00644787|364604607|FG000|Period 1: Titration Phase|Worsening of complications|1|||
105788234|NCT03426995|364878232|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788235|NCT03426995|364878233|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788236|NCT03426995|364878234|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
105788237|NCT03426995|364878235|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
105788238|NCT03426995|364878236|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788239|NCT03426995|364878237|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788240|NCT03426995|364878238|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788241|NCT04505592|364878239|FG000|Overall Study|Death|2|||
105788242|NCT04505592|364878240|FG001|Overall Study|Death|1|||
105788243|NCT00145119|364878257|FG000|Overall Study|Death|45|||
105788244|NCT02411656|364878260|FG000|Overall Study|Adverse Event|4|||
105788245|NCT02411656|364878260|FG000|Overall Study|Clinical Progression|33|||
105788246|NCT03179462|364878262|FG000|Overall Study|screening failure|1|||
105788247|NCT03179462|364878263|FG001|Overall Study|screening failure|2|||
105788248|NCT03179462|364878264|FG002|Overall Study|screening failure|0|||
105788249|NCT04636437|364878265|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
105788250|NCT04636437|364878266|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
105788251|NCT04636437|364878267|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
105788252|NCT04636437|364878265|FG000|Overall Study|Started weight loss drug/program|2|||
105788253|NCT04636437|364878266|FG001|Overall Study|Started weight loss drug/program|1|||
105788254|NCT04636437|364878267|FG002|Overall Study|Started weight loss drug/program|1|||
105788255|NCT04636437|364878265|FG000|Overall Study|Lost to Follow-up|3|||
105788256|NCT04636437|364878266|FG001|Overall Study|Lost to Follow-up|1|||
105788257|NCT04636437|364878267|FG002|Overall Study|Lost to Follow-up|4|||
105788258|NCT04636437|364878265|FG000|Overall Study|Participant or physician decision|3|||
105788259|NCT04636437|364878266|FG001|Overall Study|Participant or physician decision|1|||
105788260|NCT04636437|364878267|FG002|Overall Study|Participant or physician decision|1|||
105788261|NCT00352664|364878271|FG000|Overall Study|Withdrawal by Subject|7|||
105788262|NCT00352664|364878272|FG001|Overall Study|Withdrawal by Subject|0|||
105788263|NCT04410978|364878281|FG000|Overall Study|Poor compliance to protocol|2|||
105788264|NCT04410978|364878282|FG001|Overall Study|Poor compliance to protocol|4|||
105788265|NCT04410978|364878281|FG000|Overall Study|Withdrawal by Subject|64|||
105788266|NCT04410978|364878282|FG001|Overall Study|Withdrawal by Subject|66|||
105788267|NCT04410978|364878281|FG000|Overall Study|Other|6|||
105788268|NCT04410978|364878282|FG001|Overall Study|Other|7|||
105788269|NCT04410978|364878281|FG000|Overall Study|Missing study status|1|||
105788270|NCT04410978|364878282|FG001|Overall Study|Missing study status|0|||
105788307|NCT00526227|364878299|FG000|Overall Study|Device not implanted|1|||
105788308|NCT00526227|364878299|FG000|Overall Study|Death|1|||
105788309|NCT03222856|364878300|FG000|Overall Study|Adverse Event|6|||
105788310|NCT03222856|364878300|FG000|Overall Study|Death|1|||
105711966|NCT00644787|364604608|FG001|Period 1: Titration Phase|Worsening of complications|0|||
105711967|NCT00644787|364604609|FG002|Period 1: Titration Phase|Worsening of complications|0|||
105711968|NCT00644787|364604607|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
105711969|NCT00644787|364604608|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
105711970|NCT00644787|364604609|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
105711971|NCT00644787|364604607|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
105711972|NCT00644787|364604608|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
105711973|NCT00644787|364604609|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
105711974|NCT00644787|364604607|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
105711975|NCT00644787|364604608|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
105711976|NCT00644787|364604609|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
105711977|NCT00644787|364604607|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
105711978|NCT00644787|364604608|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
105711979|NCT00644787|364604609|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
105711980|NCT00644787|364604607|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
105711981|NCT00644787|364604608|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
105711982|NCT00644787|364604609|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
105711983|NCT00644787|364604607|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
105711984|NCT00644787|364604608|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
105711985|NCT00644787|364604609|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
105711986|NCT00644787|364604607|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
105711987|NCT00644787|364604608|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
105711988|NCT00644787|364604609|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
105711989|NCT03355300|364604610|FG000|Overall Study|Physician Decision|0|||
105711990|NCT03355300|364604611|FG001|Overall Study|Physician Decision|1|||
105711991|NCT03355300|364604610|FG000|Overall Study|Lack of Efficacy|2|||
105711992|NCT03355300|364604611|FG001|Overall Study|Lack of Efficacy|1|||
105788311|NCT00157820|364878301|FG000|Randomized|Physician Decision|4|||
105476125|NCT00146848|363755311|FG000|Post-randomization|Withdrawn|26|||
105476126|NCT00146848|363755312|FG001|Post-randomization|Withdrawn|32|||
105711993|NCT03355300|364604610|FG000|Overall Study|Other reason|1|||
105788312|NCT00157820|364878302|FG001|Randomized|Physician Decision|2|||
105476127|NCT00146848|363755313|FG002|Post-randomization|Withdrawn|27|||
105711994|NCT03355300|364604611|FG001|Overall Study|Other reason|0|||
105711995|NCT01489527|364604613|FG000|Overall Study|Pregnancy|9|||
105711996|NCT01489527|364604614|FG001|Overall Study|Pregnancy|14|||
105711997|NCT01489527|364604613|FG000|Overall Study|Participant moved|6|||
105711998|NCT01489527|364604614|FG001|Overall Study|Participant moved|7|||
105711999|NCT01489527|364604613|FG000|Overall Study|Withdrawal by Subject|0|||
105712000|NCT01489527|364604614|FG001|Overall Study|Withdrawal by Subject|4|||
105712001|NCT01489527|364604613|FG000|Overall Study|Lost to Follow-up|5|||
105712002|NCT01489527|364604614|FG001|Overall Study|Lost to Follow-up|1|||
105712003|NCT01489527|364604613|FG000|Overall Study|Procedures|1|||
105712004|NCT01489527|364604614|FG001|Overall Study|Procedures|0|||
105712005|NCT01489527|364604613|FG000|Overall Study|Not compliant|1|||
105712006|NCT01489527|364604614|FG001|Overall Study|Not compliant|0|||
105712007|NCT03048422|364604615|FG000|Overall Study|Death|1|||
105712008|NCT03048422|364604616|FG001|Overall Study|Death|0|||
105712009|NCT03048422|364604617|FG002|Overall Study|Death|0|||
105712010|NCT03048422|364604615|FG000|Overall Study|Lost to Follow-up|5|||
105712011|NCT03048422|364604616|FG001|Overall Study|Lost to Follow-up|0|||
105712012|NCT03048422|364604617|FG002|Overall Study|Lost to Follow-up|1|||
105712013|NCT03048422|364604615|FG000|Overall Study|Withdrawal by Subject|5|||
105712014|NCT03048422|364604616|FG001|Overall Study|Withdrawal by Subject|7|||
105712015|NCT03048422|364604617|FG002|Overall Study|Withdrawal by Subject|4|||
105712016|NCT03048422|364604615|FG000|Overall Study|Moved|3|||
105712017|NCT03048422|364604616|FG001|Overall Study|Moved|2|||
105712018|NCT03048422|364604617|FG002|Overall Study|Moved|2|||
105712019|NCT03048422|364604615|FG000|Overall Study|Noncompliant with Study Requirements|2|||
105712020|NCT03048422|364604616|FG001|Overall Study|Noncompliant with Study Requirements|1|||
105712021|NCT03048422|364604617|FG002|Overall Study|Noncompliant with Study Requirements|2|||
105712022|NCT03048422|364604615|FG000|Overall Study|Not Able to Get to Clinic|1|||
105712023|NCT03048422|364604616|FG001|Overall Study|Not Able to Get to Clinic|0|||
105712024|NCT03048422|364604617|FG002|Overall Study|Not Able to Get to Clinic|0|||
105712025|NCT01984268|364604618|FG000|Overall Study|Study Terminated|15|||
105712026|NCT01761266|364605936|FG000|Overall Study|Death|415|||
105712027|NCT01761266|364605937|FG001|Overall Study|Death|402|||
105712028|NCT01761266|364605936|FG000|Overall Study|Lost to Follow-up|8|||
105712029|NCT01761266|364605937|FG001|Overall Study|Lost to Follow-up|12|||
105712030|NCT01761266|364605936|FG000|Overall Study|Withdrawal by Subject|14|||
105712031|NCT01761266|364605937|FG001|Overall Study|Withdrawal by Subject|10|||
105712032|NCT01761266|364605936|FG000|Overall Study|Sponsor Decision|41|||
105712033|NCT01761266|364605937|FG001|Overall Study|Sponsor Decision|52|||
105712034|NCT02600507|364605938|FG000|Overall Study|Adverse Event|3|||
105712035|NCT02600507|364605939|FG001|Overall Study|Adverse Event|15|||
105712036|NCT02600507|364605940|FG002|Overall Study|Adverse Event|5|||
105712037|NCT02600507|364605938|FG000|Overall Study|Lack of Efficacy|3|||
105712038|NCT02600507|364605939|FG001|Overall Study|Lack of Efficacy|8|||
105712039|NCT02600507|364605940|FG002|Overall Study|Lack of Efficacy|5|||
105712040|NCT02600507|364605938|FG000|Overall Study|Lost to Follow-up|3|||
105712041|NCT02600507|364605939|FG001|Overall Study|Lost to Follow-up|5|||
105712042|NCT02600507|364605940|FG002|Overall Study|Lost to Follow-up|2|||
105712043|NCT02600507|364605938|FG000|Overall Study|Protocol Violation|12|||
105712044|NCT02600507|364605939|FG001|Overall Study|Protocol Violation|4|||
105712045|NCT02600507|364605940|FG002|Overall Study|Protocol Violation|4|||
105712046|NCT02600507|364605938|FG000|Overall Study|Physician Decision|1|||
105712047|NCT02600507|364605939|FG001|Overall Study|Physician Decision|0|||
105712048|NCT02600507|364605940|FG002|Overall Study|Physician Decision|1|||
105712049|NCT02600507|364605938|FG000|Overall Study|Withdrawal by Subject|7|||
105712050|NCT02600507|364605939|FG001|Overall Study|Withdrawal by Subject|11|||
105712051|NCT02600507|364605940|FG002|Overall Study|Withdrawal by Subject|7|||
105712052|NCT02600507|364605938|FG000|Overall Study|Other|0|||
105360897|NCT01051557|363328107|FG004|Overall Study|disease progression|4|||
105712053|NCT02600507|364605939|FG001|Overall Study|Other|1|||
105712054|NCT02600507|364605940|FG002|Overall Study|Other|1|||
105712055|NCT00605085|364605943|FG000|Overall Study|Withdrawal by Subject|8|||
105712056|NCT00605085|364605944|FG001|Overall Study|Withdrawal by Subject|5|||
105712057|NCT00605085|364605943|FG000|Overall Study|Adverse Event|9|||
105712058|NCT00605085|364605944|FG001|Overall Study|Adverse Event|5|||
105712059|NCT00605085|364605943|FG000|Overall Study|Pregnancy|2|||
105712060|NCT00605085|364605944|FG001|Overall Study|Pregnancy|0|||
105712061|NCT00605085|364605943|FG000|Overall Study|Protocol Violation|3|||
105712062|NCT00605085|364605944|FG001|Overall Study|Protocol Violation|2|||
105712063|NCT00605085|364605943|FG000|Overall Study|Lost to Follow-up|10|||
105712064|NCT00605085|364605944|FG001|Overall Study|Lost to Follow-up|5|||
105712065|NCT00605085|364605943|FG000|Overall Study|administrative reasons|18|||
105712066|NCT00605085|364605944|FG001|Overall Study|administrative reasons|8|||
105712067|NCT03257267|364605945|FG000|Overall Study|Adverse Event|17|||
105712068|NCT03257267|364605946|FG001|Overall Study|Adverse Event|7|||
105712069|NCT03257267|364605945|FG000|Overall Study|Death|96|||
105712070|NCT03257267|364605946|FG001|Overall Study|Death|98|||
105712071|NCT03257267|364605945|FG000|Overall Study|Lost to Follow-up|2|||
105712072|NCT03257267|364605946|FG001|Overall Study|Lost to Follow-up|2|||
105712073|NCT03257267|364605945|FG000|Overall Study|Non-compliance with Study Drug|0|||
105712074|NCT03257267|364605946|FG001|Overall Study|Non-compliance with Study Drug|2|||
105712075|NCT03257267|364605945|FG000|Overall Study|Participant Decision|35|||
105712076|NCT03257267|364605946|FG001|Overall Study|Participant Decision|43|||
105712077|NCT03257267|364605945|FG000|Overall Study|Sponsor Decision|1|||
105712078|NCT03257267|364605946|FG001|Overall Study|Sponsor Decision|0|||
105712079|NCT03257267|364605945|FG000|Overall Study|Physician Decision|1|||
105712080|NCT03257267|364605946|FG001|Overall Study|Physician Decision|3|||
105712081|NCT03257267|364605945|FG000|Overall Study|Disease Progression|109|||
105712082|NCT03257267|364605946|FG001|Overall Study|Disease Progression|121|||
105712083|NCT03257267|364605945|FG000|Overall Study|Withdrawal by Subject|8|||
105712084|NCT03257267|364605946|FG001|Overall Study|Withdrawal by Subject|26|||
105712085|NCT03257267|364605945|FG000|Overall Study|Other|0|||
105712086|NCT03257267|364605946|FG001|Overall Study|Other|2|||
105712087|NCT04872101|364605947|FG000|Overall Study|Withdrawal by Subject|10|||
105712088|NCT04872101|364605948|FG001|Overall Study|Withdrawal by Subject|16|||
105712089|NCT04872101|364605947|FG000|Overall Study|Lack of Efficacy|6|||
105712090|NCT04872101|364605948|FG001|Overall Study|Lack of Efficacy|14|||
105712091|NCT04872101|364605947|FG000|Overall Study|Adverse Event|1|||
105712092|NCT04872101|364605948|FG001|Overall Study|Adverse Event|6|||
105712093|NCT04872101|364605947|FG000|Overall Study|Lost to Follow-up|2|||
105712094|NCT04872101|364605948|FG001|Overall Study|Lost to Follow-up|1|||
105712095|NCT04872101|364605947|FG000|Overall Study|Pregnancy|2|||
105476128|NCT02636361|363755314|FG000|Period 4|Physician Decision|0|||
105712096|NCT04872101|364605948|FG001|Overall Study|Pregnancy|0|||
105712097|NCT04872101|364605947|FG000|Overall Study|Prohibited Medication|1|||
105712098|NCT04872101|364605948|FG001|Overall Study|Prohibited Medication|0|||
105712099|NCT04872101|364605947|FG000|Overall Study|Not dosed|1|||
105712100|NCT04872101|364605948|FG001|Overall Study|Not dosed|0|||
105712101|NCT00132132|364605949|FG000|Overall Study|Lost to Follow-up|7|||
105712102|NCT00132132|364605950|FG001|Overall Study|Lost to Follow-up|2|||
105712103|NCT02118792|364605955|FG000|Overall Study|Withdrawal by Subject|6|||
105712104|NCT02118792|364605956|FG001|Overall Study|Withdrawal by Subject|3|||
105788313|NCT00157820|364878303|FG002|Randomized|Physician Decision|3|||
105788314|NCT00157820|364878301|FG000|Randomized|Withdrawal by Subject|1|||
105712105|NCT02118792|364605955|FG000|Overall Study|Lost to Follow-up|4|||
105712106|NCT02118792|364605956|FG001|Overall Study|Lost to Follow-up|4|||
105712107|NCT02118792|364605955|FG000|Overall Study|Adverse Event|5|||
105712108|NCT02118792|364605956|FG001|Overall Study|Adverse Event|4|||
105712109|NCT02118792|364605955|FG000|Overall Study|Withdrawal by parent/guardian|14|||
105712110|NCT02118792|364605956|FG001|Overall Study|Withdrawal by parent/guardian|20|||
105788315|NCT00157820|364878302|FG001|Randomized|Withdrawal by Subject|2|||
105712111|NCT02118792|364605955|FG000|Overall Study|Other|1|||
105712112|NCT02118792|364605956|FG001|Overall Study|Other|6|||
105712113|NCT02118792|364605955|FG000|Overall Study|Randomised but not treated|1|||
105788316|NCT00157820|364878303|FG002|Randomized|Withdrawal by Subject|3|||
105712114|NCT02118792|364605956|FG001|Overall Study|Randomised but not treated|0|||
105712115|NCT02450487|364605969|FG000|Overall Study|Lost to Follow-up|3|||
105712116|NCT01562548|364605972|FG000|Overall Study|Lost to Follow-up|0|||
105712117|NCT01562548|364605973|FG001|Overall Study|Lost to Follow-up|0|||
105712118|NCT01562548|364605974|FG002|Overall Study|Lost to Follow-up|1|||
105712119|NCT01562548|364605975|FG003|Overall Study|Lost to Follow-up|0|||
105712120|NCT02296242|364605976|FG000|Overall Study|Death|1|||
105712121|NCT02296242|364605977|FG001|Overall Study|Death|1|||
105712122|NCT02296242|364605978|FG002|Overall Study|Death|1|||
105712123|NCT02296242|364605979|FG003|Overall Study|Death|1|||
105712124|NCT02296242|364605980|FG004|Overall Study|Death|1|||
105712125|NCT02296242|364605976|FG000|Overall Study|Withdrawal by Subject|0|||
105712126|NCT02296242|364605977|FG001|Overall Study|Withdrawal by Subject|0|||
105712127|NCT02296242|364605978|FG002|Overall Study|Withdrawal by Subject|1|||
105712128|NCT02296242|364605979|FG003|Overall Study|Withdrawal by Subject|1|||
105712129|NCT02296242|364605980|FG004|Overall Study|Withdrawal by Subject|3|||
105712130|NCT02296242|364605976|FG000|Overall Study|Disease Progression|1|||
105712131|NCT02296242|364605977|FG001|Overall Study|Disease Progression|3|||
105712132|NCT02296242|364605978|FG002|Overall Study|Disease Progression|2|||
105712133|NCT02296242|364605979|FG003|Overall Study|Disease Progression|8|||
105712134|NCT02296242|364605980|FG004|Overall Study|Disease Progression|11|||
105712135|NCT02296242|364605976|FG000|Overall Study|Unacceptable Toxicity|0|||
105712136|NCT02296242|364605977|FG001|Overall Study|Unacceptable Toxicity|0|||
105712137|NCT02296242|364605978|FG002|Overall Study|Unacceptable Toxicity|0|||
105712138|NCT02296242|364605979|FG003|Overall Study|Unacceptable Toxicity|0|||
105712139|NCT02296242|364605980|FG004|Overall Study|Unacceptable Toxicity|1|||
105712140|NCT02296242|364605976|FG000|Overall Study|Patient Condition Changed|0|||
105712141|NCT02296242|364605977|FG001|Overall Study|Patient Condition Changed|0|||
105712142|NCT02296242|364605978|FG002|Overall Study|Patient Condition Changed|2|||
105712143|NCT02296242|364605979|FG003|Overall Study|Patient Condition Changed|0|||
105712144|NCT02296242|364605980|FG004|Overall Study|Patient Condition Changed|1|||
105712145|NCT02296242|364605976|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
105712146|NCT02296242|364605977|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
105712147|NCT02296242|364605978|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
105712148|NCT02296242|364605979|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
105712149|NCT02296242|364605980|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
105712150|NCT02296242|364605976|FG000|Overall Study|Lost to Follow-up|1|||
105712151|NCT02296242|364605977|FG001|Overall Study|Lost to Follow-up|0|||
105712152|NCT02296242|364605978|FG002|Overall Study|Lost to Follow-up|0|||
105712153|NCT02296242|364605979|FG003|Overall Study|Lost to Follow-up|0|||
105712154|NCT02296242|364605980|FG004|Overall Study|Lost to Follow-up|0|||
105712155|NCT02296242|364605976|FG000|Overall Study|Need for Hydroxyurea|2|||
105712156|NCT02296242|364605977|FG001|Overall Study|Need for Hydroxyurea|0|||
105712157|NCT02296242|364605978|FG002|Overall Study|Need for Hydroxyurea|0|||
105712158|NCT02296242|364605979|FG003|Overall Study|Need for Hydroxyurea|0|||
105712159|NCT02296242|364605980|FG004|Overall Study|Need for Hydroxyurea|0|||
105712160|NCT02296242|364605976|FG000|Overall Study|Screened for Other Protocol|0|||
105712161|NCT02296242|364605977|FG001|Overall Study|Screened for Other Protocol|1|||
105712162|NCT02296242|364605978|FG002|Overall Study|Screened for Other Protocol|0|||
105712163|NCT02296242|364605979|FG003|Overall Study|Screened for Other Protocol|0|||
105712164|NCT02296242|364605980|FG004|Overall Study|Screened for Other Protocol|0|||
105712165|NCT02296242|364605976|FG000|Overall Study|Physician Decision|0|||
105712166|NCT02296242|364605977|FG001|Overall Study|Physician Decision|1|||
105712167|NCT02296242|364605978|FG002|Overall Study|Physician Decision|0|||
105712168|NCT02296242|364605979|FG003|Overall Study|Physician Decision|1|||
105712169|NCT02296242|364605980|FG004|Overall Study|Physician Decision|0|||
105712170|NCT02296242|364605976|FG000|Overall Study|Alternative Treatment|0|||
105712171|NCT02296242|364605977|FG001|Overall Study|Alternative Treatment|0|||
105712172|NCT02296242|364605978|FG002|Overall Study|Alternative Treatment|0|||
105712173|NCT02296242|364605979|FG003|Overall Study|Alternative Treatment|1|||
105712174|NCT02296242|364605980|FG004|Overall Study|Alternative Treatment|0|||
105712175|NCT02296242|364605976|FG000|Overall Study|Adverse Event|0|||
105712176|NCT02296242|364605977|FG001|Overall Study|Adverse Event|0|||
105712177|NCT02296242|364605978|FG002|Overall Study|Adverse Event|0|||
105712178|NCT02296242|364605979|FG003|Overall Study|Adverse Event|1|||
105712179|NCT02296242|364605980|FG004|Overall Study|Adverse Event|0|||
105712180|NCT02296242|364605976|FG000|Overall Study|Lack of Efficacy|0|||
105712181|NCT02296242|364605977|FG001|Overall Study|Lack of Efficacy|0|||
105712182|NCT02296242|364605978|FG002|Overall Study|Lack of Efficacy|0|||
105712183|NCT02296242|364605979|FG003|Overall Study|Lack of Efficacy|0|||
105712184|NCT02296242|364605980|FG004|Overall Study|Lack of Efficacy|3|||
105712185|NCT03021642|364605983|FG000|Washout Period (21 Days)|Adverse Event|1|||
105712186|NCT03021642|364605984|FG001|Washout Period (21 Days)|Adverse Event|1|||
105712187|NCT02499029|364605985|FG000|Overall Study|Lost to Follow-up|2|||
105712188|NCT02499029|364605986|FG001|Overall Study|Lost to Follow-up|2|||
105712189|NCT02499029|364605985|FG000|Overall Study|Physician Decision|2|||
105712190|NCT02499029|364605986|FG001|Overall Study|Physician Decision|1|||
105712191|NCT02499029|364605985|FG000|Overall Study|Death|1|||
105712192|NCT02499029|364605986|FG001|Overall Study|Death|0|||
105712193|NCT04317274|364605987|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
105712194|NCT04317274|364605988|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
105712195|NCT04317274|364605989|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
105712196|NCT04317274|364605990|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
105712197|NCT01164722|364605991|FG000|Overall Study|Adverse Event|0|||
105712198|NCT01164722|364605992|FG001|Overall Study|Adverse Event|1|||
105712199|NCT01164722|364605991|FG000|Overall Study|Withdrawal by Subject|3|||
105712200|NCT01164722|364605992|FG001|Overall Study|Withdrawal by Subject|4|||
105712201|NCT01164722|364605991|FG000|Overall Study|Lost to Follow-up|3|||
105712202|NCT01164722|364605992|FG001|Overall Study|Lost to Follow-up|6|||
105712203|NCT01164722|364605991|FG000|Overall Study|met protocol criteria for non-treatment|11|||
105712204|NCT01164722|364605992|FG001|Overall Study|met protocol criteria for non-treatment|1|||
105712205|NCT01164722|364605991|FG000|Overall Study|enrolled on other study, concomitant med|1|||
105712206|NCT01164722|364605992|FG001|Overall Study|enrolled on other study, concomitant med|3|||
105712207|NCT00193063|364605993|FG000|Overall Study|Lack of Efficacy|3|||
105712208|NCT00193063|364605993|FG000|Overall Study|Adverse Event|1|||
105712209|NCT01064167|364605995|FG000|Overall Study|Protocol Violation|14|||
105712210|NCT01064167|364605996|FG001|Overall Study|Protocol Violation|15|||
105712211|NCT04849780|364605997|FG000|Period 1|Covid-19 Related|1|||
105712212|NCT04849780|364605998|FG001|Period 1|Covid-19 Related|0|||
105712213|NCT04849780|364605997|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
105712214|NCT04849780|364605998|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
105712215|NCT04849780|364605997|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
105712216|NCT04849780|364605998|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
105712217|NCT02682901|364605999|FG000|Overall Study|Adverse Event|10|||
105712218|NCT02682901|364606000|FG001|Overall Study|Adverse Event|3|||
105712219|NCT02682901|364605999|FG000|Overall Study|Lack of Efficacy|0|||
105712220|NCT02682901|364606000|FG001|Overall Study|Lack of Efficacy|1|||
105712221|NCT01298492|364606001|FG000|Overall Study|Death|2|||
105712222|NCT01298492|364606001|FG000|Overall Study|Insufficient Clinical Response|22|||
105712223|NCT01298492|364606001|FG000|Overall Study|Lost to Follow-up|12|||
105712224|NCT01298492|364606001|FG000|Overall Study|Withdrawal by Subject|47|||
105712225|NCT01298492|364606001|FG000|Overall Study|Other (Unspecified)|7|||
105712226|NCT01298492|364606001|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
105712227|NCT01298492|364606001|FG000|Overall Study|Protocol Violation|2|||
105712228|NCT01298492|364606001|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
105712229|NCT01298492|364606001|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
105712230|NCT03870555|364606002|FG000|Period 3 (2 Days)|Adverse Event|1|||
105712231|NCT03870555|364606003|FG001|Period 3 (2 Days)|Adverse Event|0|||
105712232|NCT03870555|364606004|FG002|Period 3 (2 Days)|Adverse Event|0|||
105788317|NCT00157820|364878301|FG000|Randomized|Protocol Violation|2|||
105352278|NCT01483599|363293848|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105712233|NCT03984305|364606006|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
105712234|NCT03984305|364606007|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
105712235|NCT03984305|364606006|FG000|Overall Study|Withdrawal by Subject|3|||
105712236|NCT03984305|364606007|FG001|Overall Study|Withdrawal by Subject|3|||
105712237|NCT03984305|364606006|FG000|Overall Study|Lost to Follow-up|1|||
105712238|NCT03984305|364606007|FG001|Overall Study|Lost to Follow-up|0|||
105712239|NCT01656434|364606008|FG000|Overall Study|Adverse Event|199|||
105712240|NCT01656434|364606009|FG001|Overall Study|Adverse Event|63|||
105712241|NCT01656434|364606008|FG000|Overall Study|Enrollment terminated at trial site|2|||
105712242|NCT01656434|364606009|FG001|Overall Study|Enrollment terminated at trial site|0|||
105712243|NCT01656434|364606008|FG000|Overall Study|Lost to Follow-up|309|||
105476129|NCT02636361|363755315|FG001|Period 4|Physician Decision|0|||
105476130|NCT02636361|363755316|FG002|Period 4|Physician Decision|0|||
105476131|NCT02636361|363755317|FG003|Period 4|Physician Decision|1|||
105476132|NCT02636361|363755318|FG004|Period 4|Physician Decision|0|||
105476133|NCT00119678|363755319|FG000|Double-blind Treatment Period|Death|1|||
105476134|NCT00119678|363755320|FG001|Double-blind Treatment Period|Death|0|||
105476135|NCT00119678|363755319|FG000|Double-blind Treatment Period|Adverse Event|7|||
105476136|NCT00119678|363755320|FG001|Double-blind Treatment Period|Adverse Event|1|||
105476137|NCT00119678|363755319|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
105476138|NCT00119678|363755320|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
105476139|NCT00119678|363755319|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
105476140|NCT00119678|363755320|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
105476141|NCT00119678|363755319|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
105476142|NCT00119678|363755320|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
105476143|NCT00119678|363755319|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
105476144|NCT00119678|363755320|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
105476145|NCT00119678|363755319|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
105476146|NCT00119678|363755320|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
105476147|NCT00119678|363755319|FG000|Double-blind Treatment Period|Pregnancy|0|||
105476148|NCT00119678|363755320|FG001|Double-blind Treatment Period|Pregnancy|2|||
105476149|NCT00119678|363755319|FG000|Double-blind Treatment Period|Not treated|1|||
105788318|NCT00157820|364878302|FG001|Randomized|Protocol Violation|1|||
105788319|NCT00157820|364878303|FG002|Randomized|Protocol Violation|2|||
105476150|NCT00119678|363755320|FG001|Double-blind Treatment Period|Not treated|2|||
105476151|NCT00119678|363755319|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
105476152|NCT00119678|363755320|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
105476153|NCT00119678|363755319|FG000|Open-label Treatment Period|Death|1|||
105476154|NCT00119678|363755320|FG001|Open-label Treatment Period|Death|0|||
105476155|NCT00119678|363755319|FG000|Open-label Treatment Period|Adverse Event|3|||
105476156|NCT00119678|363755320|FG001|Open-label Treatment Period|Adverse Event|0|||
105476157|NCT00119678|363755319|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
105788320|NCT00157820|364878301|FG000|1st 8 Month|Death|7|||
105788321|NCT00157820|364878302|FG001|1st 8 Month|Death|8|||
105788322|NCT00157820|364878303|FG002|1st 8 Month|Death|3|||
105788323|NCT00157820|364878301|FG000|1st 8 Month|Lost to Follow-up|1|||
105788324|NCT00157820|364878302|FG001|1st 8 Month|Lost to Follow-up|2|||
105788325|NCT00157820|364878303|FG002|1st 8 Month|Lost to Follow-up|1|||
105788326|NCT00157820|364878301|FG000|1st 8 Month|Premature cross-over|0|||
105788327|NCT00157820|364878302|FG001|1st 8 Month|Premature cross-over|2|||
105788328|NCT00157820|364878303|FG002|1st 8 Month|Premature cross-over|2|||
105788329|NCT00157820|364878301|FG000|2nd 8 Months|Death|3|||
105788330|NCT00157820|364878302|FG001|2nd 8 Months|Death|1|||
105788331|NCT00157820|364878303|FG002|2nd 8 Months|Death|3|||
105788332|NCT00157820|364878301|FG000|2nd 8 Months|Lost to Follow-up|1|||
105788333|NCT00157820|364878302|FG001|2nd 8 Months|Lost to Follow-up|5|||
105476158|NCT00119678|363755320|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
105476159|NCT00119678|363755319|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
105476160|NCT00119678|363755320|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
105561464|NCT01939548|364050498|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
105561465|NCT01939548|364050499|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
105561466|NCT01939548|364050500|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
105561467|NCT01939548|364050498|FG000|Overall Study|Withdrawal by Subject|4|||
105561468|NCT01939548|364050499|FG001|Overall Study|Withdrawal by Subject|4|||
105561469|NCT01939548|364050500|FG002|Overall Study|Withdrawal by Subject|1|||
105561470|NCT01939548|364050498|FG000|Overall Study|Protocol Violation|7|||
105561471|NCT01939548|364050499|FG001|Overall Study|Protocol Violation|6|||
105561472|NCT01939548|364050500|FG002|Overall Study|Protocol Violation|5|||
105561473|NCT01939548|364050498|FG000|Overall Study|Lost to Follow-up|5|||
105561474|NCT01939548|364050499|FG001|Overall Study|Lost to Follow-up|5|||
105561475|NCT01939548|364050500|FG002|Overall Study|Lost to Follow-up|3|||
105561476|NCT01939548|364050498|FG000|Overall Study|Adverse Event|2|||
105561477|NCT01939548|364050499|FG001|Overall Study|Adverse Event|9|||
105561478|NCT01939548|364050500|FG002|Overall Study|Adverse Event|7|||
105561479|NCT01939548|364050498|FG000|Overall Study|Death|0|||
105561480|NCT01939548|364050499|FG001|Overall Study|Death|0|||
105788334|NCT00157820|364878303|FG002|2nd 8 Months|Lost to Follow-up|2|||
105788335|NCT00157820|364878301|FG000|2nd 8 Months|Premature cross-over|1|||
105788336|NCT00157820|364878302|FG001|2nd 8 Months|Premature cross-over|7|||
105360898|NCT01051557|363328108|FG005|Overall Study|disease progression|3|||
105476161|NCT00119678|363755319|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
105476162|NCT00119678|363755320|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
105561481|NCT01939548|364050500|FG002|Overall Study|Death|1|||
105561482|NCT01939548|364050498|FG000|Overall Study|Participant dropped|0|||
105561483|NCT01939548|364050499|FG001|Overall Study|Participant dropped|0|||
105561484|NCT01939548|364050500|FG002|Overall Study|Participant dropped|1|||
105788337|NCT00157820|364878303|FG002|2nd 8 Months|Premature cross-over|9|||
105712244|NCT01656434|364606009|FG001|Overall Study|Lost to Follow-up|76|||
105712245|NCT01656434|364606008|FG000|Overall Study|Site discontinued study participation|24|||
105712246|NCT01656434|364606009|FG001|Overall Study|Site discontinued study participation|9|||
105712247|NCT01656434|364606008|FG000|Overall Study|Screen failure|2|||
105712248|NCT01656434|364606009|FG001|Overall Study|Screen failure|0|||
105712249|NCT01656434|364606008|FG000|Overall Study|Protocol Violation|7|||
105712250|NCT01656434|364606009|FG001|Overall Study|Protocol Violation|0|||
105712251|NCT01656434|364606008|FG000|Overall Study|Pregnancy wish|18|||
105476163|NCT00119678|363755319|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
105476164|NCT00119678|363755320|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
105476165|NCT00119678|363755319|FG000|Open-label Treatment Period|Pregnancy|1|||
105476166|NCT00119678|363755320|FG001|Open-label Treatment Period|Pregnancy|0|||
105476167|NCT00119678|363755319|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
105476168|NCT00119678|363755320|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
105476169|NCT01761240|363755326|FG000|Overall Study|Progressive disease:radiology assessment|3|||
105476170|NCT01761240|363755327|FG001|Overall Study|Progressive disease:radiology assessment|3|||
105476171|NCT01761240|363755328|FG002|Overall Study|Progressive disease:radiology assessment|0|||
105476172|NCT01761240|363755329|FG003|Overall Study|Progressive disease:radiology assessment|0|||
105476173|NCT01761240|363755330|FG004|Overall Study|Progressive disease:radiology assessment|0|||
105476174|NCT01761240|363755326|FG000|Overall Study|Progressive disease:clinical assessment|0|||
105476175|NCT01761240|363755327|FG001|Overall Study|Progressive disease:clinical assessment|0|||
105476176|NCT01761240|363755328|FG002|Overall Study|Progressive disease:clinical assessment|3|||
105476177|NCT01761240|363755329|FG003|Overall Study|Progressive disease:clinical assessment|1|||
105476178|NCT01761240|363755330|FG004|Overall Study|Progressive disease:clinical assessment|0|||
105476179|NCT01761240|363755326|FG000|Overall Study|Withdrawal by Subject|0|||
105476180|NCT01761240|363755327|FG001|Overall Study|Withdrawal by Subject|0|||
105476181|NCT01761240|363755328|FG002|Overall Study|Withdrawal by Subject|0|||
105476182|NCT01761240|363755329|FG003|Overall Study|Withdrawal by Subject|3|||
105476183|NCT01761240|363755330|FG004|Overall Study|Withdrawal by Subject|1|||
105476184|NCT01761240|363755326|FG000|Overall Study|Adverse Event|0|||
105476185|NCT01761240|363755327|FG001|Overall Study|Adverse Event|0|||
105476186|NCT01761240|363755328|FG002|Overall Study|Adverse Event|0|||
105476187|NCT01761240|363755329|FG003|Overall Study|Adverse Event|1|||
105476188|NCT01761240|363755330|FG004|Overall Study|Adverse Event|6|||
105476189|NCT01761240|363755326|FG000|Overall Study|Death|0|||
105476190|NCT01761240|363755327|FG001|Overall Study|Death|1|||
105476191|NCT01761240|363755328|FG002|Overall Study|Death|1|||
105476192|NCT01761240|363755329|FG003|Overall Study|Death|2|||
105476193|NCT01761240|363755330|FG004|Overall Study|Death|1|||
105476194|NCT01761240|363755326|FG000|Overall Study|Non-compliance|0|||
105476195|NCT01761240|363755327|FG001|Overall Study|Non-compliance|0|||
105476196|NCT01761240|363755328|FG002|Overall Study|Non-compliance|1|||
105476197|NCT01761240|363755329|FG003|Overall Study|Non-compliance|0|||
105476198|NCT01761240|363755330|FG004|Overall Study|Non-compliance|0|||
105476199|NCT00539188|363755331|FG000|Overall Study|Withdrawal by Subject|1|||
105476200|NCT00539188|363755332|FG001|Overall Study|Withdrawal by Subject|0|||
105476201|NCT00539188|363755331|FG000|Overall Study|Lost to Follow-up|2|||
105476202|NCT00539188|363755332|FG001|Overall Study|Lost to Follow-up|1|||
105476203|NCT04784442|363755335|FG000|Overall Study|Adverse Event|1|||
105476204|NCT04784442|363755336|FG001|Overall Study|Adverse Event|0|||
105476205|NCT04784442|363755337|FG002|Overall Study|Adverse Event|2|||
105476206|NCT04784442|363755338|FG003|Overall Study|Adverse Event|1|||
105476207|NCT04784442|363755335|FG000|Overall Study|Protocol Violation|1|||
105476208|NCT04784442|363755336|FG001|Overall Study|Protocol Violation|0|||
105476209|NCT04784442|363755337|FG002|Overall Study|Protocol Violation|0|||
105476210|NCT04784442|363755338|FG003|Overall Study|Protocol Violation|0|||
105476211|NCT04784442|363755335|FG000|Overall Study|Non-compliance with study drug|1|||
105476212|NCT04784442|363755336|FG001|Overall Study|Non-compliance with study drug|0|||
105476213|NCT04784442|363755337|FG002|Overall Study|Non-compliance with study drug|0|||
105476214|NCT04784442|363755338|FG003|Overall Study|Non-compliance with study drug|0|||
105476215|NCT00509145|363755339|FG000|Overall Study|Death|0|||
105476216|NCT00509145|363755340|FG001|Overall Study|Death|2|||
105476217|NCT00509145|363755339|FG000|Overall Study|Adverse Event|42|||
105476218|NCT00509145|363755340|FG001|Overall Study|Adverse Event|28|||
105476219|NCT00509145|363755339|FG000|Overall Study|Withdrawal by Subject|32|||
105476220|NCT00509145|363755340|FG001|Overall Study|Withdrawal by Subject|38|||
105476221|NCT00509145|363755339|FG000|Overall Study|Physician Decision|11|||
105476222|NCT00509145|363755340|FG001|Overall Study|Physician Decision|14|||
105561485|NCT01939548|364050498|FG000|Overall Study|Participant unwilling to continue|0|||
105561486|NCT01939548|364050499|FG001|Overall Study|Participant unwilling to continue|1|||
105561487|NCT01939548|364050500|FG002|Overall Study|Participant unwilling to continue|0|||
105561488|NCT01939548|364050498|FG000|Overall Study|Participant withdrew consent|0|||
105561489|NCT01939548|364050499|FG001|Overall Study|Participant withdrew consent|2|||
105561490|NCT01939548|364050500|FG002|Overall Study|Participant withdrew consent|0|||
105561491|NCT01939548|364050498|FG000|Overall Study|Did not complete follow-up|0|||
105561492|NCT01939548|364050499|FG001|Overall Study|Did not complete follow-up|1|||
105561493|NCT01939548|364050500|FG002|Overall Study|Did not complete follow-up|0|||
105561494|NCT00981084|364050501|FG000|Post Intervention (Data Analysis)|poor effort|1|||
105476223|NCT00509145|363755339|FG000|Overall Study|Protocol Violation|1|||
105476224|NCT00509145|363755340|FG001|Overall Study|Protocol Violation|6|||
105476225|NCT00509145|363755339|FG000|Overall Study|Pregnancy|3|||
105476226|NCT00509145|363755340|FG001|Overall Study|Pregnancy|8|||
105360899|NCT01051557|363328109|FG006|Overall Study|disease progression|1|||
105476227|NCT00509145|363755339|FG000|Overall Study|Lost to Follow-up|6|||
105476228|NCT00509145|363755340|FG001|Overall Study|Lost to Follow-up|5|||
105476229|NCT00509145|363755339|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
105476230|NCT00509145|363755340|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
105712252|NCT01656434|364606009|FG001|Overall Study|Pregnancy wish|6|||
105712253|NCT01656434|364606008|FG000|Overall Study|Pregnancy|45|||
105712254|NCT01656434|364606009|FG001|Overall Study|Pregnancy|10|||
105712255|NCT01656434|364606008|FG000|Overall Study|Physician Decision|7|||
105712256|NCT01656434|364606009|FG001|Overall Study|Physician Decision|2|||
105712257|NCT01656434|364606008|FG000|Overall Study|Non-compliance with study drug|48|||
105712258|NCT01656434|364606009|FG001|Overall Study|Non-compliance with study drug|9|||
105712259|NCT01656434|364606008|FG000|Overall Study|Study terminated by sponsor|1501|||
105712260|NCT01656434|364606009|FG001|Overall Study|Study terminated by sponsor|348|||
105712261|NCT01656434|364606008|FG000|Overall Study|Participant discontinued; drug related|13|||
105712262|NCT01656434|364606009|FG001|Overall Study|Participant discontinued; drug related|4|||
105712263|NCT01656434|364606008|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
105712264|NCT01656434|364606009|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
105712265|NCT01656434|364606008|FG000|Overall Study|Non-compliance with protocol|39|||
105712266|NCT01656434|364606009|FG001|Overall Study|Non-compliance with protocol|15|||
105712267|NCT01656434|364606008|FG000|Overall Study|Participant moved|40|||
105712268|NCT01656434|364606009|FG001|Overall Study|Participant moved|12|||
105712269|NCT01656434|364606008|FG000|Overall Study|Participant withdrew consent|28|||
105712270|NCT01656434|364606009|FG001|Overall Study|Participant withdrew consent|9|||
105712271|NCT01656434|364606008|FG000|Overall Study|Withdrawal by Subject|64|||
105712272|NCT01656434|364606009|FG001|Overall Study|Withdrawal by Subject|7|||
105712273|NCT01235962|364606010|FG000|Overall Study|Withdrawal by Subject|20|||
105712274|NCT01235962|364606011|FG001|Overall Study|Withdrawal by Subject|19|||
105712275|NCT01235962|364606012|FG002|Overall Study|Withdrawal by Subject|62|||
105712276|NCT01235962|364606013|FG003|Overall Study|Withdrawal by Subject|49|||
105712277|NCT01235962|364606010|FG000|Overall Study|Lost to Follow-up|21|||
105712278|NCT01235962|364606011|FG001|Overall Study|Lost to Follow-up|16|||
105712279|NCT01235962|364606012|FG002|Overall Study|Lost to Follow-up|47|||
105712280|NCT01235962|364606013|FG003|Overall Study|Lost to Follow-up|32|||
105712281|NCT01235962|364606010|FG000|Overall Study|Physician Decision|5|||
105712282|NCT01235962|364606011|FG001|Overall Study|Physician Decision|0|||
105712283|NCT01235962|364606012|FG002|Overall Study|Physician Decision|9|||
105712284|NCT01235962|364606013|FG003|Overall Study|Physician Decision|5|||
105712285|NCT01580397|364606014|FG000|Overall Study|Lack of Efficacy|14|||
105712286|NCT00357500|364606017|FG000|Overall Study|Adverse Event|3|||
105712287|NCT00357500|364606017|FG000|Overall Study|Withdrawal by Subject|5|||
105712288|NCT00357500|364606017|FG000|Overall Study|Progressive Disease|65|||
105712289|NCT00357500|364606017|FG000|Overall Study|Not Started Protocol Therapy|4|||
105712290|NCT03033875|364606018|FG000|Overall Study|Withdrawal by Subject|5|||
105712291|NCT03033875|364606019|FG001|Overall Study|Withdrawal by Subject|9|||
105712292|NCT03033875|364606020|FG002|Overall Study|Withdrawal by Subject|4|||
105712293|NCT03033875|364606018|FG000|Overall Study|Other|14|||
105712294|NCT03033875|364606019|FG001|Overall Study|Other|15|||
105788338|NCT02087865|364880004|FG000|Overall Study|Withdrawal by Subject|6|||
105788339|NCT02087865|364880005|FG001|Overall Study|Withdrawal by Subject|0|||
105788340|NCT02087865|364880006|FG002|Overall Study|Withdrawal by Subject|1|||
105788341|NCT02087865|364880004|FG000|Overall Study|Lost to Follow-up|0|||
105788342|NCT02087865|364880005|FG001|Overall Study|Lost to Follow-up|0|||
105788343|NCT02087865|364880006|FG002|Overall Study|Lost to Follow-up|1|||
105788344|NCT02087865|364880004|FG000|Overall Study|Drug Non-compliance|0|||
105788345|NCT02087865|364880005|FG001|Overall Study|Drug Non-compliance|2|||
105788346|NCT02087865|364880006|FG002|Overall Study|Drug Non-compliance|0|||
105788347|NCT02087865|364880004|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
105788348|NCT02087865|364880005|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
105788349|NCT02087865|364880006|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
105788350|NCT03839693|364880007|FG000|Overall Study|Lost to Follow-up|0|||
105788351|NCT03839693|364880008|FG001|Overall Study|Lost to Follow-up|2|||
105788352|NCT03839693|364880009|FG002|Overall Study|Lost to Follow-up|2|||
105788353|NCT03839693|364880007|FG000|Overall Study|Withdrawal by Subject|1|||
105788354|NCT03839693|364880008|FG001|Overall Study|Withdrawal by Subject|0|||
105788355|NCT03839693|364880009|FG002|Overall Study|Withdrawal by Subject|2|||
105788356|NCT03839693|364880007|FG000|Overall Study|subject moved out of the area|1|||
105788357|NCT03839693|364880008|FG001|Overall Study|subject moved out of the area|0|||
105788358|NCT03839693|364880009|FG002|Overall Study|subject moved out of the area|0|||
105788359|NCT00700115|364880018|FG000|Overall Study|Withdrawal by Subject|1|||
105788360|NCT00700115|364880019|FG001|Overall Study|Withdrawal by Subject|0|||
105788361|NCT00700115|364880018|FG000|Overall Study|Lost to Follow-up|0|||
105788362|NCT00700115|364880019|FG001|Overall Study|Lost to Follow-up|1|||
105788363|NCT02983305|364880024|FG000|Overall Study|incomplete data|2|||
105788364|NCT02983305|364880025|FG001|Overall Study|incomplete data|0|||
105788365|NCT00822237|364880028|FG000|Dose 1 Vaccination|Not vaccinated|3|||
105788366|NCT00822237|364880029|FG001|Dose 1 Vaccination|Not vaccinated|0|||
105788367|NCT00822237|364880028|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
105788368|NCT00822237|364880029|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
105788369|NCT00822237|364880028|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
105788370|NCT00822237|364880029|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
105788371|NCT00822237|364880028|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
105788372|NCT00822237|364880029|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
105788373|NCT00822237|364880028|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
105788374|NCT00822237|364880029|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
105788375|NCT03433482|364880030|FG000|Overall Study|Lost to Follow-up|1|||
105788376|NCT03433482|364880031|FG001|Overall Study|Lost to Follow-up|0|||
105788377|NCT03433482|364880032|FG002|Overall Study|Lost to Follow-up|1|||
105788378|NCT03433482|364880033|FG003|Overall Study|Lost to Follow-up|1|||
105788379|NCT03433482|364880030|FG000|Overall Study|Withdrawal by Subject|0|||
105788380|NCT03433482|364880031|FG001|Overall Study|Withdrawal by Subject|0|||
105788381|NCT03433482|364880032|FG002|Overall Study|Withdrawal by Subject|1|||
105788382|NCT03433482|364880033|FG003|Overall Study|Withdrawal by Subject|0|||
105788383|NCT03433482|364880030|FG000|Overall Study|Unknown reason|0|||
105788384|NCT03433482|364880031|FG001|Overall Study|Unknown reason|0|||
105788385|NCT03433482|364880032|FG002|Overall Study|Unknown reason|2|||
105788386|NCT03433482|364880033|FG003|Overall Study|Unknown reason|0|||
105788387|NCT00953017|364880037|FG000|Overall Study|DId not show up for colonoscopy|4|||
105788388|NCT00953017|364880038|FG001|Overall Study|DId not show up for colonoscopy|4|||
105788389|NCT00953017|364880039|FG002|Overall Study|DId not show up for colonoscopy|5|||
105788390|NCT00953017|364880040|FG003|Overall Study|DId not show up for colonoscopy|4|||
105788391|NCT00953017|364880037|FG000|Overall Study|Incomplete data|1|||
105788392|NCT00953017|364880038|FG001|Overall Study|Incomplete data|1|||
105788393|NCT00953017|364880039|FG002|Overall Study|Incomplete data|0|||
105788394|NCT00953017|364880040|FG003|Overall Study|Incomplete data|0|||
105788395|NCT00953017|364880037|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
105788396|NCT00953017|364880038|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
105788397|NCT00953017|364880039|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
105788398|NCT00953017|364880040|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
105476231|NCT00509145|363755339|FG000|Overall Study|Other|6|||
105476232|NCT00509145|363755340|FG001|Overall Study|Other|6|||
105476233|NCT02969655|363755341|FG000|Overall Study|Withdrawal by Subject|3|||
105788399|NCT00953017|364880037|FG000|Overall Study|Brown stool prior to procedure|0|||
105788400|NCT00953017|364880038|FG001|Overall Study|Brown stool prior to procedure|0|||
105788401|NCT00953017|364880039|FG002|Overall Study|Brown stool prior to procedure|1|||
105788402|NCT00953017|364880040|FG003|Overall Study|Brown stool prior to procedure|0|||
105788403|NCT01473602|364880042|FG000|Overall Study|Adverse Event|1|||
105788404|NCT01473602|364880043|FG001|Overall Study|Adverse Event|2|||
105788405|NCT01473602|364880042|FG000|Overall Study|Death|0|||
105788406|NCT01473602|364880043|FG001|Overall Study|Death|1|||
105788407|NCT01473602|364880042|FG000|Overall Study|Lost to Follow-up|1|||
105476234|NCT02969655|363755342|FG001|Overall Study|Withdrawal by Subject|2|||
105476235|NCT02969655|363755341|FG000|Overall Study|Physician Decision|4|||
105788408|NCT01473602|364880043|FG001|Overall Study|Lost to Follow-up|1|||
105712295|NCT03033875|364606020|FG002|Overall Study|Other|8|||
105712296|NCT02695628|364606022|FG000|Overall Study|Withdrawal by Subject|1|||
105712297|NCT02301403|364606023|FG000|Overall Study|Withdrawal by Subject|28|||
105712298|NCT02301403|364606024|FG001|Overall Study|Withdrawal by Subject|41|||
105712299|NCT00903929|364606025|FG000|Overall Study|Withdrawal by Subject|0|||
105712300|NCT00903929|364606026|FG001|Overall Study|Withdrawal by Subject|0|||
105712301|NCT00903929|364606027|FG002|Overall Study|Withdrawal by Subject|1|||
105712302|NCT00903929|364606028|FG003|Overall Study|Withdrawal by Subject|2|||
105712303|NCT00903929|364606025|FG000|Overall Study|Adverse Event|0|||
105712304|NCT00903929|364606026|FG001|Overall Study|Adverse Event|0|||
105712305|NCT00903929|364606027|FG002|Overall Study|Adverse Event|0|||
105712306|NCT00903929|364606028|FG003|Overall Study|Adverse Event|1|||
105712307|NCT01913483|364606031|FG000|Overall Study|Withdrawal by Subject|1|||
105712308|NCT01913483|364606032|FG001|Overall Study|Withdrawal by Subject|2|||
105712309|NCT01913483|364606031|FG000|Overall Study|Lost to Follow-up|6|||
105712310|NCT01913483|364606032|FG001|Overall Study|Lost to Follow-up|3|||
105712311|NCT01913483|364606031|FG000|Overall Study|Death|14|||
105712312|NCT01913483|364606032|FG001|Overall Study|Death|17|||
105712313|NCT03434379|364606037|FG000|Global Period|Lost to Follow-up|3|||
105712314|NCT03434379|364606038|FG001|Global Period|Lost to Follow-up|6|||
105712315|NCT03434379|364606039|FG002|Global Period|Lost to Follow-up|0|||
105712316|NCT03434379|364606040|FG003|Global Period|Lost to Follow-up|0|||
105712317|NCT03434379|364606037|FG000|Global Period|Death|115|||
105712318|NCT03434379|364606038|FG001|Global Period|Death|228|||
105712319|NCT03434379|364606039|FG002|Global Period|Death|0|||
105712320|NCT03434379|364606040|FG003|Global Period|Death|0|||
105712321|NCT03434379|364606037|FG000|Global Period|Withdrawal by Subject|20|||
105712322|NCT03434379|364606038|FG001|Global Period|Withdrawal by Subject|21|||
105712323|NCT03434379|364606039|FG002|Global Period|Withdrawal by Subject|0|||
105712324|NCT03434379|364606040|FG003|Global Period|Withdrawal by Subject|0|||
105712325|NCT03434379|364606037|FG000|Global Period|Reason Unspecified|0|||
105712326|NCT03434379|364606038|FG001|Global Period|Reason Unspecified|1|||
105712327|NCT03434379|364606039|FG002|Global Period|Reason Unspecified|0|||
105712328|NCT03434379|364606040|FG003|Global Period|Reason Unspecified|0|||
105712329|NCT03434379|364606037|FG000|Global Period|Study Ended by Sponsor|26|||
105712330|NCT03434379|364606038|FG001|Global Period|Study Ended by Sponsor|80|||
105712331|NCT03434379|364606039|FG002|Global Period|Study Ended by Sponsor|0|||
105712332|NCT03434379|364606040|FG003|Global Period|Study Ended by Sponsor|0|||
105476236|NCT02969655|363755342|FG001|Overall Study|Physician Decision|3|||
105476237|NCT02969655|363755341|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
105476238|NCT02969655|363755342|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
105476239|NCT02969655|363755341|FG000|Overall Study|Adverse Event|10|||
105712333|NCT03434379|364606037|FG000|Global Period|Physician Decision|1|||
105712334|NCT03434379|364606038|FG001|Global Period|Physician Decision|0|||
105712335|NCT03434379|364606039|FG002|Global Period|Physician Decision|0|||
105712336|NCT03434379|364606040|FG003|Global Period|Physician Decision|0|||
105712337|NCT03434379|364606037|FG000|China Extension Period|Lost to Follow-up|0|||
105712338|NCT03434379|364606038|FG001|China Extension Period|Lost to Follow-up|0|||
105712339|NCT03434379|364606039|FG002|China Extension Period|Lost to Follow-up|2|||
105712340|NCT03434379|364606040|FG003|China Extension Period|Lost to Follow-up|3|||
105712341|NCT03434379|364606037|FG000|China Extension Period|Death|0|||
105476240|NCT02969655|363755342|FG001|Overall Study|Adverse Event|8|||
105476241|NCT02560025|363755343|FG000|Overall Study|Ineligible after consent/ registration|3|||
105712342|NCT03434379|364606038|FG001|China Extension Period|Death|0|||
105712343|NCT03434379|364606039|FG002|China Extension Period|Death|46|||
105712344|NCT03434379|364606040|FG003|China Extension Period|Death|88|||
105712345|NCT03434379|364606037|FG000|China Extension Period|Withdrawal by Subject|0|||
105712346|NCT03434379|364606038|FG001|China Extension Period|Withdrawal by Subject|0|||
105712347|NCT03434379|364606039|FG002|China Extension Period|Withdrawal by Subject|8|||
105712348|NCT03434379|364606040|FG003|China Extension Period|Withdrawal by Subject|6|||
105712349|NCT03434379|364606037|FG000|China Extension Period|Study Ended by Sponsor|0|||
105712350|NCT03434379|364606038|FG001|China Extension Period|Study Ended by Sponsor|0|||
105712351|NCT03434379|364606039|FG002|China Extension Period|Study Ended by Sponsor|5|||
105712352|NCT03434379|364606040|FG003|China Extension Period|Study Ended by Sponsor|36|||
105712353|NCT03064841|364606041|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
105712354|NCT03064841|364606041|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
105712355|NCT03064841|364606041|FG000|Overall Study|Screen failure|2|||
105712356|NCT00454805|364606044|FG000|Overall Study|Withdrawal by Subject|9|||
105712357|NCT00454805|364606045|FG001|Overall Study|Withdrawal by Subject|2|||
105712358|NCT00454805|364606044|FG000|Overall Study|Death|0|||
105712359|NCT00454805|364606045|FG001|Overall Study|Death|2|||
105712360|NCT00454805|364606044|FG000|Overall Study|Disease progression|16|||
105712361|NCT00454805|364606045|FG001|Overall Study|Disease progression|19|||
105712362|NCT00454805|364606044|FG000|Overall Study|In order to begin radiotherapy|1|||
105712363|NCT00454805|364606045|FG001|Overall Study|In order to begin radiotherapy|0|||
105712364|NCT03920670|364606046|FG000|Overall Study|Protocol Violation|2|||
105712365|NCT03920670|364606047|FG001|Overall Study|Protocol Violation|2|||
105712366|NCT03920670|364606046|FG000|Overall Study|Adverse Event|1|||
105712367|NCT03920670|364606047|FG001|Overall Study|Adverse Event|0|||
105712368|NCT03208231|364606058|FG000|Overall Study|Death|1|||
105712369|NCT03208231|364606059|FG001|Overall Study|Death|2|||
105712370|NCT03208231|364606058|FG000|Overall Study|Moved and unable to get to clinic|1|||
105712371|NCT03208231|364606059|FG001|Overall Study|Moved and unable to get to clinic|0|||
105712372|NCT03208231|364606058|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
105712373|NCT03208231|364606059|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
105712374|NCT01777581|364606062|FG000|Overall Study|Lost to Follow-up|1|||
105712375|NCT01777581|364606063|FG001|Overall Study|Lost to Follow-up|1|||
105712376|NCT01777581|364606062|FG000|Overall Study|Adverse Event|2|||
105712377|NCT01777581|364606063|FG001|Overall Study|Adverse Event|0|||
105352279|NCT01483599|363293849|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105476242|NCT00402740|363755345|FG000|Overall Study|Withdrawal by Subject|18|||
105476243|NCT00402740|363755345|FG000|Overall Study|Death|50|||
105476244|NCT00402740|363755345|FG000|Overall Study|Lost to Follow-up|6|||
105476245|NCT00402740|363755345|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
105712378|NCT01777581|364606062|FG000|Overall Study|Lack of Efficacy|0|||
105712379|NCT01777581|364606063|FG001|Overall Study|Lack of Efficacy|1|||
105712380|NCT03864653|364606077|FG000|Overall Study|Withdrawal by Subject|1|||
105712381|NCT02321436|364606078|FG000|Overall Study|Withdrawal by Subject|1|||
105712382|NCT02321436|364606079|FG001|Overall Study|Withdrawal by Subject|0|||
105712383|NCT02321436|364606078|FG000|Overall Study|Lost to Follow-up|0|||
105712384|NCT02321436|364606079|FG001|Overall Study|Lost to Follow-up|1|||
105712385|NCT00817531|364607662|FG000|Overall Study|Adverse Event|1|||
105712386|NCT00817531|364607662|FG000|Overall Study|Lack of Efficacy|1|||
105712387|NCT03325673|364607663|FG000|Overall Study|Adverse Event|4|||
105712388|NCT03325673|364607664|FG001|Overall Study|Adverse Event|0|||
105712389|NCT00618748|364607672|FG000|Overall Study|Adverse Event|4|||
105712390|NCT00618748|364607673|FG001|Overall Study|Adverse Event|3|||
105712391|NCT00618748|364607674|FG002|Overall Study|Adverse Event|8|||
105712392|NCT00618748|364607672|FG000|Overall Study|Physician Decision|3|||
105712393|NCT00618748|364607673|FG001|Overall Study|Physician Decision|1|||
105712394|NCT00618748|364607674|FG002|Overall Study|Physician Decision|1|||
105712395|NCT00618748|364607672|FG000|Overall Study|Withdrawal by Subject|4|||
105712396|NCT00618748|364607673|FG001|Overall Study|Withdrawal by Subject|1|||
105712397|NCT00618748|364607674|FG002|Overall Study|Withdrawal by Subject|5|||
105788409|NCT01473602|364880042|FG000|Overall Study|Withdrawal by Subject|5|||
105788410|NCT01473602|364880043|FG001|Overall Study|Withdrawal by Subject|4|||
105788411|NCT01473602|364880042|FG000|Overall Study|Physician Decision|1|||
105712398|NCT02814565|364607675|FG000|Overall Study|Lack of Efficacy|0|||
105712399|NCT02814565|364607676|FG001|Overall Study|Lack of Efficacy|1|||
105712400|NCT02814565|364607675|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
105712401|NCT02814565|364607676|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
105712402|NCT03472560|364607677|FG000|Overall Study|Subject transfer to continuation protocol|0|||
105712403|NCT03472560|364607678|FG001|Overall Study|Subject transfer to continuation protocol|1|||
105712404|NCT03472560|364607677|FG000|Overall Study|Withdrawal by Subject|4|||
105712405|NCT03472560|364607678|FG001|Overall Study|Withdrawal by Subject|0|||
105712406|NCT03472560|364607677|FG000|Overall Study|Progressive disease|24|||
105712407|NCT03472560|364607678|FG001|Overall Study|Progressive disease|8|||
105712408|NCT03472560|364607677|FG000|Overall Study|Physician Decision|1|||
105712409|NCT03472560|364607678|FG001|Overall Study|Physician Decision|0|||
105712410|NCT03472560|364607677|FG000|Overall Study|Death|7|||
105712411|NCT03472560|364607678|FG001|Overall Study|Death|4|||
105712412|NCT03472560|364607677|FG000|Overall Study|Adverse Event|5|||
105712413|NCT03472560|364607678|FG001|Overall Study|Adverse Event|3|||
105712414|NCT03472560|364607677|FG000|Overall Study|Global deterioration of health status|0|||
105712415|NCT03472560|364607678|FG001|Overall Study|Global deterioration of health status|4|||
105712416|NCT02479802|364607679|FG000|Overall Study|Lost to Follow-up|1|||
105712417|NCT02479802|364607679|FG000|Overall Study|Adverse Event|1|||
105712418|NCT03124784|364607682|FG000|Overall Study|Adverse Event|1|||
105712419|NCT03124784|364607682|FG000|Overall Study|Computer/Equip Malfunction|1|||
105712420|NCT02792842|364607684|FG000|Overall Study|Adverse Event|4|||
105712421|NCT02792842|364607685|FG001|Overall Study|Adverse Event|2|||
105712422|NCT02792842|364607686|FG002|Overall Study|Adverse Event|3|||
105712423|NCT02792842|364607684|FG000|Overall Study|Withdrawal by Subject|0|||
105712424|NCT02792842|364607685|FG001|Overall Study|Withdrawal by Subject|1|||
105712425|NCT02792842|364607686|FG002|Overall Study|Withdrawal by Subject|2|||
105712426|NCT02792842|364607684|FG000|Overall Study|Lost to Follow-up|0|||
105712427|NCT02792842|364607685|FG001|Overall Study|Lost to Follow-up|0|||
105712428|NCT02792842|364607686|FG002|Overall Study|Lost to Follow-up|1|||
105712429|NCT02792842|364607684|FG000|Overall Study|Schedule delay|0|||
105712430|NCT02792842|364607685|FG001|Overall Study|Schedule delay|1|||
105712431|NCT02792842|364607686|FG002|Overall Study|Schedule delay|1|||
105712432|NCT01790048|364607688|FG000|Overall Study|Incorrect Age|9|||
105712433|NCT01790048|364607689|FG001|Overall Study|Incorrect Age|14|||
105712434|NCT01790048|364607688|FG000|Overall Study|data entry error|0|||
105788412|NCT01473602|364880043|FG001|Overall Study|Physician Decision|0|||
105788413|NCT03735680|364880046|FG000|Overall Study|Withdrawal by Subject|0|||
105788414|NCT03735680|364880047|FG001|Overall Study|Withdrawal by Subject|1|||
105788415|NCT03735680|364880048|FG002|Overall Study|Withdrawal by Subject|0|||
105788416|NCT03735680|364880049|FG003|Overall Study|Withdrawal by Subject|0|||
105788417|NCT03735680|364880050|FG004|Overall Study|Withdrawal by Subject|0|||
105788418|NCT03735680|364880051|FG005|Overall Study|Withdrawal by Subject|1|||
105788419|NCT03735680|364880046|FG000|Overall Study|Patient unable or unwilling to continue|0|||
105788420|NCT03735680|364880047|FG001|Overall Study|Patient unable or unwilling to continue|0|||
105788421|NCT03735680|364880048|FG002|Overall Study|Patient unable or unwilling to continue|1|||
105788422|NCT03735680|364880049|FG003|Overall Study|Patient unable or unwilling to continue|0|||
105788423|NCT03735680|364880050|FG004|Overall Study|Patient unable or unwilling to continue|0|||
105788424|NCT03735680|364880051|FG005|Overall Study|Patient unable or unwilling to continue|0|||
105788425|NCT01100073|364880052|FG000|Overall Study|Lack of Efficacy|4|||
105476246|NCT00402740|363755345|FG000|Overall Study|Subject disposition unknown.|1|||
105476247|NCT01028300|363755346|FG000|Overall Study|Study Terminated|4|||
105476248|NCT02703337|363755349|FG000|Period One (Part A)|Withdrawal by Subject|0|||
105476249|NCT02703337|363755350|FG001|Period One (Part A)|Withdrawal by Subject|0|||
105476250|NCT02703337|363755351|FG002|Period One (Part A)|Withdrawal by Subject|0|||
105712435|NCT01790048|364607689|FG001|Overall Study|data entry error|1|||
105712436|NCT01790048|364607688|FG000|Overall Study|Other|0|||
105712437|NCT01790048|364607689|FG001|Overall Study|Other|2|||
105712438|NCT01790048|364607688|FG000|Overall Study|SAM at Enrollment|2|||
105712439|NCT01790048|364607689|FG001|Overall Study|SAM at Enrollment|0|||
105712440|NCT01790048|364607688|FG000|Overall Study|Measurement error|1|||
105788426|NCT01100073|364880052|FG000|Overall Study|Insufficient Tolerability|21|||
105788427|NCT01100073|364880052|FG000|Overall Study|Withdrawal by Subject|13|||
105788428|NCT01100073|364880052|FG000|Overall Study|Lost to Follow-up|39|||
105788429|NCT01100073|364880052|FG000|Overall Study|Lack of effect + patient's wish|2|||
105788430|NCT01100073|364880052|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
105476251|NCT02703337|363755352|FG003|Period One (Part A)|Withdrawal by Subject|0|||
105712441|NCT01790048|364607689|FG001|Overall Study|Measurement error|0|||
105712442|NCT00159432|364607690|FG000|Overall Study|Adverse Event|1|||
105712443|NCT00159432|364607690|FG000|Overall Study|Death|1|||
105712444|NCT00159432|364607690|FG000|Overall Study|Lack of Efficacy|8|||
105712445|NCT01415752|364607694|FG000|Induction (Step 1)|Ineligible|4|||
105788431|NCT01100073|364880052|FG000|Overall Study|Other|8|||
105712446|NCT01415752|364607695|FG001|Induction (Step 1)|Ineligible|3|||
105712447|NCT01415752|364607696|FG002|Induction (Step 1)|Ineligible|4|||
105712448|NCT01415752|364607697|FG003|Induction (Step 1)|Ineligible|4|||
105712449|NCT01415752|364607694|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
105712450|NCT01415752|364607695|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
105712451|NCT01415752|364607696|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
105712452|NCT01415752|364607697|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
105712453|NCT01415752|364607694|FG000|Maintenance (Step 2)|Adverse Event|3|||
105712454|NCT01415752|364607695|FG001|Maintenance (Step 2)|Adverse Event|4|||
105712455|NCT01415752|364607696|FG002|Maintenance (Step 2)|Adverse Event|9|||
105712456|NCT01415752|364607697|FG003|Maintenance (Step 2)|Adverse Event|6|||
105712457|NCT01415752|364607694|FG000|Maintenance (Step 2)|Death|1|||
105712458|NCT01415752|364607695|FG001|Maintenance (Step 2)|Death|1|||
105712459|NCT01415752|364607696|FG002|Maintenance (Step 2)|Death|2|||
105712460|NCT01415752|364607697|FG003|Maintenance (Step 2)|Death|0|||
105712461|NCT01415752|364607694|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
105712462|NCT01415752|364607695|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
105712463|NCT01415752|364607696|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
105712464|NCT01415752|364607697|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
105712465|NCT01415752|364607694|FG000|Maintenance (Step 2)|Alternative therapy|0|||
105712466|NCT01415752|364607695|FG001|Maintenance (Step 2)|Alternative therapy|1|||
105712467|NCT01415752|364607696|FG002|Maintenance (Step 2)|Alternative therapy|0|||
105712468|NCT01415752|364607697|FG003|Maintenance (Step 2)|Alternative therapy|0|||
105712469|NCT01415752|364607694|FG000|Maintenance (Step 2)|Other reasons|3|||
105712470|NCT01415752|364607695|FG001|Maintenance (Step 2)|Other reasons|6|||
105712471|NCT01415752|364607696|FG002|Maintenance (Step 2)|Other reasons|4|||
105712472|NCT01415752|364607697|FG003|Maintenance (Step 2)|Other reasons|6|||
105712473|NCT01415752|364607694|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
105712474|NCT01415752|364607695|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
105712475|NCT01415752|364607696|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
105712476|NCT01415752|364607697|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
105712477|NCT01415752|364607694|FG000|Maintenance (Step 2)|ineligible|1|||
105712478|NCT01415752|364607695|FG001|Maintenance (Step 2)|ineligible|1|||
105712479|NCT01415752|364607696|FG002|Maintenance (Step 2)|ineligible|1|||
105712480|NCT01415752|364607697|FG003|Maintenance (Step 2)|ineligible|0|||
105712481|NCT01415752|364607694|FG000|Maintenance (Step 2)|Missing|4|||
105712482|NCT01415752|364607695|FG001|Maintenance (Step 2)|Missing|1|||
105712483|NCT01415752|364607696|FG002|Maintenance (Step 2)|Missing|4|||
105712484|NCT01415752|364607697|FG003|Maintenance (Step 2)|Missing|3|||
105712485|NCT00584194|364607698|FG000|Overall Study|Other|135|||
105712486|NCT01391507|364607699|FG000|Overall Study|Death|0|||
105712487|NCT01391507|364607700|FG001|Overall Study|Death|0|||
105712488|NCT01391507|364607701|FG002|Overall Study|Death|0|||
105712489|NCT01391507|364607702|FG003|Overall Study|Death|1|||
105712490|NCT01391507|364607699|FG000|Overall Study|Adverse Event|1|||
105712491|NCT01391507|364607700|FG001|Overall Study|Adverse Event|1|||
105712492|NCT01391507|364607701|FG002|Overall Study|Adverse Event|2|||
105712493|NCT01391507|364607702|FG003|Overall Study|Adverse Event|2|||
105712494|NCT01391507|364607699|FG000|Overall Study|Withdrawal by Subject|1|||
105712495|NCT01391507|364607700|FG001|Overall Study|Withdrawal by Subject|2|||
105712496|NCT01391507|364607701|FG002|Overall Study|Withdrawal by Subject|1|||
105712497|NCT01391507|364607702|FG003|Overall Study|Withdrawal by Subject|1|||
105712498|NCT01391507|364607699|FG000|Overall Study|Lack of Efficacy|0|||
105712499|NCT01391507|364607700|FG001|Overall Study|Lack of Efficacy|0|||
105712500|NCT01391507|364607701|FG002|Overall Study|Lack of Efficacy|0|||
105712501|NCT01391507|364607702|FG003|Overall Study|Lack of Efficacy|1|||
105712502|NCT01391507|364607699|FG000|Overall Study|Protocol Violation|2|||
105712503|NCT01391507|364607700|FG001|Overall Study|Protocol Violation|1|||
105712504|NCT01391507|364607701|FG002|Overall Study|Protocol Violation|1|||
105712505|NCT01391507|364607702|FG003|Overall Study|Protocol Violation|2|||
105712506|NCT03529773|364607705|FG000|Overall Study|Adverse Event|0|||
105712507|NCT03529773|364607706|FG001|Overall Study|Adverse Event|0|||
105712508|NCT03529773|364607707|FG002|Overall Study|Adverse Event|0|||
105712509|NCT03529773|364607708|FG003|Overall Study|Adverse Event|0|||
105712510|NCT03529773|364607709|FG004|Overall Study|Adverse Event|0|||
105712511|NCT03529773|364607710|FG005|Overall Study|Adverse Event|0|||
105712512|NCT03529773|364607711|FG006|Overall Study|Adverse Event|0|||
105712513|NCT03529773|364607712|FG007|Overall Study|Adverse Event|0|||
105712514|NCT03529773|364607713|FG008|Overall Study|Adverse Event|0|||
105712515|NCT03529773|364607714|FG009|Overall Study|Adverse Event|0|||
105712516|NCT03529773|364607715|FG010|Overall Study|Adverse Event|0|||
105712517|NCT03529773|364607716|FG011|Overall Study|Adverse Event|0|||
105712518|NCT03529773|364607717|FG012|Overall Study|Adverse Event|0|||
105712519|NCT03529773|364607718|FG013|Overall Study|Adverse Event|0|||
105712520|NCT03529773|364607719|FG014|Overall Study|Adverse Event|0|||
105712521|NCT03529773|364607720|FG015|Overall Study|Adverse Event|0|||
105712522|NCT03529773|364607721|FG016|Overall Study|Adverse Event|0|||
105712523|NCT03529773|364607722|FG017|Overall Study|Adverse Event|0|||
105712524|NCT03529773|364607723|FG018|Overall Study|Adverse Event|0|||
105712525|NCT03529773|364607724|FG019|Overall Study|Adverse Event|0|||
105712526|NCT03529773|364607725|FG020|Overall Study|Adverse Event|0|||
105712527|NCT03529773|364607726|FG021|Overall Study|Adverse Event|0|||
105712528|NCT03529773|364607727|FG022|Overall Study|Adverse Event|0|||
105712529|NCT03529773|364607728|FG023|Overall Study|Adverse Event|0|||
105712530|NCT03529773|364607729|FG024|Overall Study|Adverse Event|0|||
105712531|NCT03529773|364607730|FG025|Overall Study|Adverse Event|0|||
105712532|NCT03529773|364607731|FG026|Overall Study|Adverse Event|0|||
105712533|NCT03529773|364607732|FG027|Overall Study|Adverse Event|0|||
105712534|NCT03529773|364607733|FG028|Overall Study|Adverse Event|0|||
105712535|NCT03529773|364607734|FG029|Overall Study|Adverse Event|0|||
105712536|NCT03529773|364607735|FG030|Overall Study|Adverse Event|1|||
105712537|NCT03529773|364607736|FG031|Overall Study|Adverse Event|0|||
105712538|NCT03529773|364607737|FG032|Overall Study|Adverse Event|0|||
105712539|NCT03529773|364607738|FG033|Overall Study|Adverse Event|0|||
105712540|NCT03529773|364607739|FG034|Overall Study|Adverse Event|0|||
105712541|NCT03529773|364607740|FG035|Overall Study|Adverse Event|1|||
105712542|NCT03529773|364607741|FG036|Overall Study|Adverse Event|0|||
105712543|NCT03529773|364607742|FG037|Overall Study|Adverse Event|0|||
105712544|NCT03529773|364607743|FG038|Overall Study|Adverse Event|1|||
105712545|NCT03529773|364607744|FG039|Overall Study|Adverse Event|1|||
105712546|NCT03529773|364607705|FG000|Overall Study|Death|0|||
105712547|NCT03529773|364607706|FG001|Overall Study|Death|0|||
105712548|NCT03529773|364607707|FG002|Overall Study|Death|0|||
105788432|NCT01100073|364880052|FG000|Overall Study|Missing|5|||
105788433|NCT02526017|364880053|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105788434|NCT02526017|364880054|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105788435|NCT02526017|364880055|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105712549|NCT03529773|364607708|FG003|Overall Study|Death|0|||
105712550|NCT03529773|364607709|FG004|Overall Study|Death|0|||
105712551|NCT03529773|364607710|FG005|Overall Study|Death|0|||
105712552|NCT03529773|364607711|FG006|Overall Study|Death|0|||
105712553|NCT03529773|364607712|FG007|Overall Study|Death|0|||
105712554|NCT03529773|364607713|FG008|Overall Study|Death|0|||
105712555|NCT03529773|364607714|FG009|Overall Study|Death|0|||
105712556|NCT03529773|364607715|FG010|Overall Study|Death|0|||
105712557|NCT03529773|364607716|FG011|Overall Study|Death|0|||
105712558|NCT03529773|364607717|FG012|Overall Study|Death|1|||
105712559|NCT03529773|364607718|FG013|Overall Study|Death|0|||
105712560|NCT03529773|364607719|FG014|Overall Study|Death|0|||
105712561|NCT03529773|364607720|FG015|Overall Study|Death|0|||
105712562|NCT03529773|364607721|FG016|Overall Study|Death|0|||
105712563|NCT03529773|364607722|FG017|Overall Study|Death|0|||
105712564|NCT03529773|364607723|FG018|Overall Study|Death|0|||
105712565|NCT03529773|364607724|FG019|Overall Study|Death|1|||
105712566|NCT03529773|364607725|FG020|Overall Study|Death|0|||
105712567|NCT03529773|364607726|FG021|Overall Study|Death|0|||
105712568|NCT03529773|364607727|FG022|Overall Study|Death|1|||
105712569|NCT03529773|364607728|FG023|Overall Study|Death|0|||
105712570|NCT03529773|364607729|FG024|Overall Study|Death|0|||
105712571|NCT03529773|364607730|FG025|Overall Study|Death|0|||
105712572|NCT03529773|364607731|FG026|Overall Study|Death|0|||
105712573|NCT03529773|364607732|FG027|Overall Study|Death|0|||
105712574|NCT03529773|364607733|FG028|Overall Study|Death|0|||
105712575|NCT03529773|364607734|FG029|Overall Study|Death|0|||
105712576|NCT03529773|364607735|FG030|Overall Study|Death|0|||
105712577|NCT03529773|364607736|FG031|Overall Study|Death|0|||
105712578|NCT03529773|364607737|FG032|Overall Study|Death|0|||
105788436|NCT02526017|364880056|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105712579|NCT03529773|364607738|FG033|Overall Study|Death|1|||
105712580|NCT03529773|364607739|FG034|Overall Study|Death|1|||
105712581|NCT03529773|364607740|FG035|Overall Study|Death|0|||
105712582|NCT03529773|364607741|FG036|Overall Study|Death|1|||
105712583|NCT03529773|364607742|FG037|Overall Study|Death|0|||
105712584|NCT03529773|364607743|FG038|Overall Study|Death|0|||
105712585|NCT03529773|364607744|FG039|Overall Study|Death|0|||
105712586|NCT03529773|364607705|FG000|Overall Study|Lost to Follow-up|0|||
105712587|NCT03529773|364607706|FG001|Overall Study|Lost to Follow-up|0|||
105712588|NCT03529773|364607707|FG002|Overall Study|Lost to Follow-up|1|||
105712589|NCT03529773|364607708|FG003|Overall Study|Lost to Follow-up|0|||
105712590|NCT03529773|364607709|FG004|Overall Study|Lost to Follow-up|1|||
105712591|NCT03529773|364607710|FG005|Overall Study|Lost to Follow-up|1|||
105712592|NCT03529773|364607711|FG006|Overall Study|Lost to Follow-up|0|||
105712593|NCT03529773|364607712|FG007|Overall Study|Lost to Follow-up|0|||
105712594|NCT03529773|364607713|FG008|Overall Study|Lost to Follow-up|0|||
105712595|NCT03529773|364607714|FG009|Overall Study|Lost to Follow-up|0|||
105712596|NCT03529773|364607715|FG010|Overall Study|Lost to Follow-up|0|||
105712597|NCT03529773|364607716|FG011|Overall Study|Lost to Follow-up|0|||
105712598|NCT03529773|364607717|FG012|Overall Study|Lost to Follow-up|0|||
105712599|NCT03529773|364607718|FG013|Overall Study|Lost to Follow-up|1|||
105712600|NCT03529773|364607719|FG014|Overall Study|Lost to Follow-up|4|||
105712601|NCT03529773|364607720|FG015|Overall Study|Lost to Follow-up|1|||
105712602|NCT03529773|364607721|FG016|Overall Study|Lost to Follow-up|1|||
105712603|NCT03529773|364607722|FG017|Overall Study|Lost to Follow-up|0|||
105712604|NCT03529773|364607723|FG018|Overall Study|Lost to Follow-up|1|||
105712605|NCT03529773|364607724|FG019|Overall Study|Lost to Follow-up|1|||
105712606|NCT03529773|364607725|FG020|Overall Study|Lost to Follow-up|2|||
105712607|NCT03529773|364607726|FG021|Overall Study|Lost to Follow-up|4|||
105712608|NCT03529773|364607727|FG022|Overall Study|Lost to Follow-up|3|||
105712609|NCT03529773|364607728|FG023|Overall Study|Lost to Follow-up|4|||
105712610|NCT03529773|364607729|FG024|Overall Study|Lost to Follow-up|3|||
105712611|NCT03529773|364607730|FG025|Overall Study|Lost to Follow-up|5|||
105712612|NCT03529773|364607731|FG026|Overall Study|Lost to Follow-up|5|||
105712613|NCT03529773|364607732|FG027|Overall Study|Lost to Follow-up|0|||
105712614|NCT03529773|364607733|FG028|Overall Study|Lost to Follow-up|0|||
105712615|NCT03529773|364607734|FG029|Overall Study|Lost to Follow-up|0|||
105712616|NCT03529773|364607735|FG030|Overall Study|Lost to Follow-up|1|||
105712617|NCT03529773|364607736|FG031|Overall Study|Lost to Follow-up|0|||
105712618|NCT03529773|364607737|FG032|Overall Study|Lost to Follow-up|0|||
105712619|NCT03529773|364607738|FG033|Overall Study|Lost to Follow-up|1|||
105712620|NCT03529773|364607739|FG034|Overall Study|Lost to Follow-up|1|||
105712621|NCT03529773|364607740|FG035|Overall Study|Lost to Follow-up|0|||
105712622|NCT03529773|364607741|FG036|Overall Study|Lost to Follow-up|0|||
105712623|NCT03529773|364607742|FG037|Overall Study|Lost to Follow-up|3|||
105712624|NCT03529773|364607743|FG038|Overall Study|Lost to Follow-up|1|||
105712625|NCT03529773|364607744|FG039|Overall Study|Lost to Follow-up|1|||
105712626|NCT03529773|364607705|FG000|Overall Study|No longer meets eligibility criteria|0|||
105712627|NCT03529773|364607706|FG001|Overall Study|No longer meets eligibility criteria|0|||
105712628|NCT03529773|364607707|FG002|Overall Study|No longer meets eligibility criteria|0|||
105712629|NCT03529773|364607708|FG003|Overall Study|No longer meets eligibility criteria|0|||
105712630|NCT03529773|364607709|FG004|Overall Study|No longer meets eligibility criteria|0|||
105712631|NCT03529773|364607710|FG005|Overall Study|No longer meets eligibility criteria|0|||
105712632|NCT03529773|364607711|FG006|Overall Study|No longer meets eligibility criteria|0|||
105712633|NCT03529773|364607712|FG007|Overall Study|No longer meets eligibility criteria|0|||
105712634|NCT03529773|364607713|FG008|Overall Study|No longer meets eligibility criteria|0|||
105712635|NCT03529773|364607714|FG009|Overall Study|No longer meets eligibility criteria|0|||
105712636|NCT03529773|364607715|FG010|Overall Study|No longer meets eligibility criteria|0|||
105712637|NCT03529773|364607716|FG011|Overall Study|No longer meets eligibility criteria|0|||
105712638|NCT03529773|364607717|FG012|Overall Study|No longer meets eligibility criteria|0|||
105712639|NCT03529773|364607718|FG013|Overall Study|No longer meets eligibility criteria|0|||
105712640|NCT03529773|364607719|FG014|Overall Study|No longer meets eligibility criteria|0|||
105712641|NCT03529773|364607720|FG015|Overall Study|No longer meets eligibility criteria|0|||
105712642|NCT03529773|364607721|FG016|Overall Study|No longer meets eligibility criteria|0|||
105712643|NCT03529773|364607722|FG017|Overall Study|No longer meets eligibility criteria|0|||
105712644|NCT03529773|364607723|FG018|Overall Study|No longer meets eligibility criteria|0|||
105712645|NCT03529773|364607724|FG019|Overall Study|No longer meets eligibility criteria|0|||
105712646|NCT03529773|364607725|FG020|Overall Study|No longer meets eligibility criteria|0|||
105712647|NCT03529773|364607726|FG021|Overall Study|No longer meets eligibility criteria|0|||
105712648|NCT03529773|364607727|FG022|Overall Study|No longer meets eligibility criteria|1|||
105712649|NCT03529773|364607728|FG023|Overall Study|No longer meets eligibility criteria|0|||
105712650|NCT03529773|364607729|FG024|Overall Study|No longer meets eligibility criteria|0|||
105712651|NCT03529773|364607730|FG025|Overall Study|No longer meets eligibility criteria|0|||
105712652|NCT03529773|364607731|FG026|Overall Study|No longer meets eligibility criteria|0|||
105712653|NCT03529773|364607732|FG027|Overall Study|No longer meets eligibility criteria|0|||
105712654|NCT03529773|364607733|FG028|Overall Study|No longer meets eligibility criteria|0|||
105712655|NCT03529773|364607734|FG029|Overall Study|No longer meets eligibility criteria|0|||
105712656|NCT03529773|364607735|FG030|Overall Study|No longer meets eligibility criteria|0|||
105712657|NCT03529773|364607736|FG031|Overall Study|No longer meets eligibility criteria|0|||
105712658|NCT03529773|364607737|FG032|Overall Study|No longer meets eligibility criteria|0|||
105712659|NCT03529773|364607738|FG033|Overall Study|No longer meets eligibility criteria|0|||
105712660|NCT03529773|364607739|FG034|Overall Study|No longer meets eligibility criteria|0|||
105712661|NCT03529773|364607740|FG035|Overall Study|No longer meets eligibility criteria|0|||
105712662|NCT03529773|364607741|FG036|Overall Study|No longer meets eligibility criteria|0|||
105712663|NCT03529773|364607742|FG037|Overall Study|No longer meets eligibility criteria|0|||
105712664|NCT03529773|364607743|FG038|Overall Study|No longer meets eligibility criteria|1|||
105712665|NCT03529773|364607744|FG039|Overall Study|No longer meets eligibility criteria|0|||
105712666|NCT03529773|364607705|FG000|Overall Study|Other|0|||
105712667|NCT03529773|364607706|FG001|Overall Study|Other|0|||
105712668|NCT03529773|364607707|FG002|Overall Study|Other|0|||
105712669|NCT03529773|364607708|FG003|Overall Study|Other|0|||
105712670|NCT03529773|364607709|FG004|Overall Study|Other|0|||
105712671|NCT03529773|364607710|FG005|Overall Study|Other|0|||
105712672|NCT03529773|364607711|FG006|Overall Study|Other|0|||
105712673|NCT03529773|364607712|FG007|Overall Study|Other|0|||
105712674|NCT03529773|364607713|FG008|Overall Study|Other|0|||
105712675|NCT03529773|364607714|FG009|Overall Study|Other|0|||
105712676|NCT03529773|364607715|FG010|Overall Study|Other|0|||
105712677|NCT03529773|364607716|FG011|Overall Study|Other|0|||
105712678|NCT03529773|364607717|FG012|Overall Study|Other|1|||
105712679|NCT03529773|364607718|FG013|Overall Study|Other|0|||
105712680|NCT03529773|364607719|FG014|Overall Study|Other|2|||
105712681|NCT03529773|364607720|FG015|Overall Study|Other|0|||
105712682|NCT03529773|364607721|FG016|Overall Study|Other|0|||
105712683|NCT03529773|364607722|FG017|Overall Study|Other|3|||
105712684|NCT03529773|364607723|FG018|Overall Study|Other|0|||
105712685|NCT03529773|364607724|FG019|Overall Study|Other|0|||
105712686|NCT03529773|364607725|FG020|Overall Study|Other|1|||
105712687|NCT03529773|364607726|FG021|Overall Study|Other|0|||
105712688|NCT03529773|364607727|FG022|Overall Study|Other|1|||
105712689|NCT03529773|364607728|FG023|Overall Study|Other|0|||
105712690|NCT03529773|364607729|FG024|Overall Study|Other|3|||
105788437|NCT02526017|364880057|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
105712691|NCT03529773|364607730|FG025|Overall Study|Other|2|||
105712692|NCT03529773|364607731|FG026|Overall Study|Other|2|||
105712693|NCT03529773|364607732|FG027|Overall Study|Other|0|||
105712694|NCT03529773|364607733|FG028|Overall Study|Other|0|||
105712695|NCT03529773|364607734|FG029|Overall Study|Other|0|||
105712696|NCT03529773|364607735|FG030|Overall Study|Other|0|||
105712697|NCT03529773|364607736|FG031|Overall Study|Other|0|||
105712698|NCT03529773|364607737|FG032|Overall Study|Other|0|||
105712699|NCT03529773|364607738|FG033|Overall Study|Other|0|||
105712700|NCT03529773|364607739|FG034|Overall Study|Other|1|||
105712701|NCT03529773|364607740|FG035|Overall Study|Other|1|||
105712702|NCT03529773|364607741|FG036|Overall Study|Other|0|||
105712703|NCT03529773|364607742|FG037|Overall Study|Other|0|||
105712704|NCT03529773|364607743|FG038|Overall Study|Other|0|||
105712705|NCT03529773|364607744|FG039|Overall Study|Other|0|||
105712706|NCT03529773|364607705|FG000|Overall Study|Physician Decision|0|||
105712707|NCT03529773|364607706|FG001|Overall Study|Physician Decision|0|||
105712708|NCT03529773|364607707|FG002|Overall Study|Physician Decision|0|||
105712709|NCT03529773|364607708|FG003|Overall Study|Physician Decision|0|||
105712710|NCT03529773|364607709|FG004|Overall Study|Physician Decision|0|||
105712711|NCT03529773|364607710|FG005|Overall Study|Physician Decision|0|||
105712712|NCT03529773|364607711|FG006|Overall Study|Physician Decision|0|||
105712713|NCT03529773|364607712|FG007|Overall Study|Physician Decision|0|||
105712714|NCT03529773|364607713|FG008|Overall Study|Physician Decision|0|||
105712715|NCT03529773|364607714|FG009|Overall Study|Physician Decision|0|||
105712716|NCT03529773|364607715|FG010|Overall Study|Physician Decision|0|||
105712717|NCT03529773|364607716|FG011|Overall Study|Physician Decision|0|||
105788438|NCT02526017|364880058|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105788439|NCT02526017|364880059|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105788440|NCT02526017|364880060|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105788441|NCT02526017|364880061|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105788442|NCT04621227|364880075|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
105788443|NCT04621227|364880075|FG000|Period 3 (29 Days)|Adverse Event|1|||
105788444|NCT04621227|364880075|FG000|Period 8 (2 Days)|Adverse Event|1|||
105788445|NCT00938392|364880076|FG000|Overall Study|Adverse Event|0|||
105788446|NCT00938392|364880077|FG001|Overall Study|Adverse Event|1|||
105788447|NCT00938392|364880076|FG000|Overall Study|Withdrawal by Subject|0|||
105788448|NCT00938392|364880077|FG001|Overall Study|Withdrawal by Subject|1|||
105788449|NCT00938392|364880076|FG000|Overall Study|Lost to Follow-up|2|||
105788450|NCT00938392|364880077|FG001|Overall Study|Lost to Follow-up|2|||
105788451|NCT00124709|364880081|FG000|Overall Study|Randomized but did not take medication|3|||
105788452|NCT00124709|364880082|FG001|Overall Study|Randomized but did not take medication|1|||
105788453|NCT00124709|364880081|FG000|Overall Study|Adverse Event|3|||
105788454|NCT00124709|364880082|FG001|Overall Study|Adverse Event|0|||
105788455|NCT00124709|364880081|FG000|Overall Study|Lack of Efficacy|5|||
105788456|NCT00124709|364880082|FG001|Overall Study|Lack of Efficacy|10|||
105788457|NCT00124709|364880081|FG000|Overall Study|Protocol Violation|3|||
105788458|NCT00124709|364880082|FG001|Overall Study|Protocol Violation|5|||
105788459|NCT00124709|364880081|FG000|Overall Study|Withdrawal by Subject|127|||
105788460|NCT00124709|364880082|FG001|Overall Study|Withdrawal by Subject|136|||
105788461|NCT00124709|364880081|FG000|Overall Study|Lost to Follow-up|114|||
105788462|NCT00124709|364880082|FG001|Overall Study|Lost to Follow-up|120|||
105788463|NCT00122954|364880083|FG000|Overall Study|Withdrawal by Subject|2|||
105788464|NCT00122954|364880084|FG001|Overall Study|Withdrawal by Subject|2|||
105788465|NCT00122954|364880083|FG000|Overall Study|Protocol Violation|0|||
105788466|NCT00122954|364880084|FG001|Overall Study|Protocol Violation|1|||
105788467|NCT00558831|364880087|FG000|Overall Study|Lost to Follow-up|1|||
105476252|NCT02703337|363755353|FG004|Period One (Part A)|Withdrawal by Subject|1|||
105476253|NCT02703337|363755354|FG005|Period One (Part A)|Withdrawal by Subject|0|||
105712718|NCT03529773|364607717|FG012|Overall Study|Physician Decision|0|||
105712719|NCT03529773|364607718|FG013|Overall Study|Physician Decision|0|||
105712720|NCT03529773|364607719|FG014|Overall Study|Physician Decision|0|||
105712721|NCT03529773|364607720|FG015|Overall Study|Physician Decision|0|||
105712722|NCT03529773|364607721|FG016|Overall Study|Physician Decision|0|||
105712723|NCT03529773|364607722|FG017|Overall Study|Physician Decision|0|||
105712724|NCT03529773|364607723|FG018|Overall Study|Physician Decision|0|||
105788468|NCT04633434|364880090|FG000|Overall Study|Lost to Follow-up|32|||
105788469|NCT04633434|364880091|FG001|Overall Study|Lost to Follow-up|32|||
105788470|NCT04888377|364880092|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
105788471|NCT04888377|364880093|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
105788472|NCT04888377|364880092|FG000|Overall Study|Physician Decision|6|||
105712725|NCT03529773|364607724|FG019|Overall Study|Physician Decision|1|||
105712726|NCT03529773|364607725|FG020|Overall Study|Physician Decision|1|||
105712727|NCT03529773|364607726|FG021|Overall Study|Physician Decision|0|||
105712728|NCT03529773|364607727|FG022|Overall Study|Physician Decision|0|||
105712729|NCT03529773|364607728|FG023|Overall Study|Physician Decision|0|||
105788473|NCT04888377|364880093|FG001|Overall Study|Physician Decision|6|||
105788474|NCT04888377|364880092|FG000|Overall Study|Withdrawal by Subject|7|||
105788475|NCT04888377|364880093|FG001|Overall Study|Withdrawal by Subject|3|||
105788476|NCT00526162|364880094|FG000|Overall Study|Device not implanted|3|||
105788477|NCT05279807|364880095|FG000|Overall Study|Withdrawal by Subject|1|||
105788478|NCT05279807|364880096|FG001|Overall Study|Withdrawal by Subject|0|||
105788479|NCT05279807|364880095|FG000|Overall Study|Adverse Event|0|||
105712730|NCT03529773|364607729|FG024|Overall Study|Physician Decision|0|||
105712731|NCT03529773|364607730|FG025|Overall Study|Physician Decision|0|||
105712732|NCT03529773|364607731|FG026|Overall Study|Physician Decision|0|||
105712733|NCT03529773|364607732|FG027|Overall Study|Physician Decision|0|||
105712734|NCT03529773|364607733|FG028|Overall Study|Physician Decision|0|||
105712735|NCT03529773|364607734|FG029|Overall Study|Physician Decision|0|||
105712736|NCT03529773|364607735|FG030|Overall Study|Physician Decision|0|||
105712737|NCT03529773|364607736|FG031|Overall Study|Physician Decision|0|||
105712738|NCT03529773|364607737|FG032|Overall Study|Physician Decision|0|||
105712739|NCT03529773|364607738|FG033|Overall Study|Physician Decision|0|||
105712740|NCT03529773|364607739|FG034|Overall Study|Physician Decision|0|||
105712741|NCT03529773|364607740|FG035|Overall Study|Physician Decision|0|||
105712742|NCT03529773|364607741|FG036|Overall Study|Physician Decision|0|||
105712743|NCT03529773|364607742|FG037|Overall Study|Physician Decision|0|||
105712744|NCT03529773|364607743|FG038|Overall Study|Physician Decision|0|||
105712745|NCT03529773|364607744|FG039|Overall Study|Physician Decision|0|||
105712746|NCT03529773|364607705|FG000|Overall Study|Protocol Violation|0|||
105712747|NCT03529773|364607706|FG001|Overall Study|Protocol Violation|0|||
105712748|NCT03529773|364607707|FG002|Overall Study|Protocol Violation|0|||
105712749|NCT03529773|364607708|FG003|Overall Study|Protocol Violation|0|||
105712750|NCT03529773|364607709|FG004|Overall Study|Protocol Violation|0|||
105712751|NCT03529773|364607710|FG005|Overall Study|Protocol Violation|0|||
105712752|NCT03529773|364607711|FG006|Overall Study|Protocol Violation|0|||
105712753|NCT03529773|364607712|FG007|Overall Study|Protocol Violation|0|||
105712754|NCT03529773|364607713|FG008|Overall Study|Protocol Violation|0|||
105712755|NCT03529773|364607714|FG009|Overall Study|Protocol Violation|0|||
105712756|NCT03529773|364607715|FG010|Overall Study|Protocol Violation|0|||
105712757|NCT03529773|364607716|FG011|Overall Study|Protocol Violation|0|||
105712758|NCT03529773|364607717|FG012|Overall Study|Protocol Violation|0|||
105712759|NCT03529773|364607718|FG013|Overall Study|Protocol Violation|0|||
105712760|NCT03529773|364607719|FG014|Overall Study|Protocol Violation|0|||
105712761|NCT03529773|364607720|FG015|Overall Study|Protocol Violation|0|||
105712762|NCT03529773|364607721|FG016|Overall Study|Protocol Violation|0|||
105712763|NCT03529773|364607722|FG017|Overall Study|Protocol Violation|0|||
105712764|NCT03529773|364607723|FG018|Overall Study|Protocol Violation|0|||
105712765|NCT03529773|364607724|FG019|Overall Study|Protocol Violation|0|||
105712766|NCT03529773|364607725|FG020|Overall Study|Protocol Violation|0|||
105712767|NCT03529773|364607726|FG021|Overall Study|Protocol Violation|0|||
105712768|NCT03529773|364607727|FG022|Overall Study|Protocol Violation|0|||
105712769|NCT03529773|364607728|FG023|Overall Study|Protocol Violation|0|||
105712770|NCT03529773|364607729|FG024|Overall Study|Protocol Violation|0|||
105712771|NCT03529773|364607730|FG025|Overall Study|Protocol Violation|0|||
105712772|NCT03529773|364607731|FG026|Overall Study|Protocol Violation|0|||
105712773|NCT03529773|364607732|FG027|Overall Study|Protocol Violation|0|||
105712774|NCT03529773|364607733|FG028|Overall Study|Protocol Violation|0|||
105712775|NCT03529773|364607734|FG029|Overall Study|Protocol Violation|0|||
105712776|NCT03529773|364607735|FG030|Overall Study|Protocol Violation|1|||
105712777|NCT03529773|364607736|FG031|Overall Study|Protocol Violation|0|||
105712778|NCT03529773|364607737|FG032|Overall Study|Protocol Violation|0|||
105712779|NCT03529773|364607738|FG033|Overall Study|Protocol Violation|0|||
105712780|NCT03529773|364607739|FG034|Overall Study|Protocol Violation|0|||
105712781|NCT03529773|364607740|FG035|Overall Study|Protocol Violation|0|||
105712782|NCT03529773|364607741|FG036|Overall Study|Protocol Violation|0|||
105712783|NCT03529773|364607742|FG037|Overall Study|Protocol Violation|0|||
105712784|NCT03529773|364607743|FG038|Overall Study|Protocol Violation|0|||
105712785|NCT03529773|364607744|FG039|Overall Study|Protocol Violation|0|||
105712786|NCT03529773|364607705|FG000|Overall Study|Withdrawal by Subject|0|||
105712787|NCT03529773|364607706|FG001|Overall Study|Withdrawal by Subject|0|||
105712788|NCT03529773|364607707|FG002|Overall Study|Withdrawal by Subject|0|||
105712789|NCT03529773|364607708|FG003|Overall Study|Withdrawal by Subject|0|||
105712790|NCT03529773|364607709|FG004|Overall Study|Withdrawal by Subject|0|||
105712791|NCT03529773|364607710|FG005|Overall Study|Withdrawal by Subject|0|||
105712792|NCT03529773|364607711|FG006|Overall Study|Withdrawal by Subject|0|||
105712793|NCT03529773|364607712|FG007|Overall Study|Withdrawal by Subject|1|||
105712794|NCT03529773|364607713|FG008|Overall Study|Withdrawal by Subject|0|||
105712795|NCT03529773|364607714|FG009|Overall Study|Withdrawal by Subject|1|||
105712796|NCT03529773|364607715|FG010|Overall Study|Withdrawal by Subject|1|||
105712797|NCT03529773|364607716|FG011|Overall Study|Withdrawal by Subject|0|||
105712798|NCT03529773|364607717|FG012|Overall Study|Withdrawal by Subject|0|||
105712799|NCT03529773|364607718|FG013|Overall Study|Withdrawal by Subject|0|||
105712800|NCT03529773|364607719|FG014|Overall Study|Withdrawal by Subject|0|||
105712801|NCT03529773|364607720|FG015|Overall Study|Withdrawal by Subject|3|||
105712802|NCT03529773|364607721|FG016|Overall Study|Withdrawal by Subject|0|||
105712803|NCT03529773|364607722|FG017|Overall Study|Withdrawal by Subject|2|||
105712804|NCT03529773|364607723|FG018|Overall Study|Withdrawal by Subject|3|||
105712805|NCT03529773|364607724|FG019|Overall Study|Withdrawal by Subject|1|||
105712806|NCT03529773|364607725|FG020|Overall Study|Withdrawal by Subject|3|||
105712807|NCT03529773|364607726|FG021|Overall Study|Withdrawal by Subject|1|||
105712808|NCT03529773|364607727|FG022|Overall Study|Withdrawal by Subject|1|||
105712809|NCT03529773|364607728|FG023|Overall Study|Withdrawal by Subject|2|||
105712810|NCT03529773|364607729|FG024|Overall Study|Withdrawal by Subject|2|||
105712811|NCT03529773|364607730|FG025|Overall Study|Withdrawal by Subject|4|||
105712812|NCT03529773|364607731|FG026|Overall Study|Withdrawal by Subject|2|||
105712813|NCT03529773|364607732|FG027|Overall Study|Withdrawal by Subject|1|||
105712814|NCT03529773|364607733|FG028|Overall Study|Withdrawal by Subject|1|||
105712815|NCT03529773|364607734|FG029|Overall Study|Withdrawal by Subject|0|||
105712816|NCT03529773|364607735|FG030|Overall Study|Withdrawal by Subject|0|||
105712817|NCT03529773|364607736|FG031|Overall Study|Withdrawal by Subject|0|||
105712818|NCT03529773|364607737|FG032|Overall Study|Withdrawal by Subject|0|||
105712819|NCT03529773|364607738|FG033|Overall Study|Withdrawal by Subject|0|||
105712820|NCT03529773|364607739|FG034|Overall Study|Withdrawal by Subject|1|||
105712821|NCT03529773|364607740|FG035|Overall Study|Withdrawal by Subject|2|||
105712822|NCT03529773|364607741|FG036|Overall Study|Withdrawal by Subject|0|||
105712823|NCT03529773|364607742|FG037|Overall Study|Withdrawal by Subject|2|||
105712824|NCT03529773|364607743|FG038|Overall Study|Withdrawal by Subject|1|||
105712825|NCT03529773|364607744|FG039|Overall Study|Withdrawal by Subject|1|||
105712826|NCT03529773|364607705|FG000|Overall Study|Screen Failure|0|||
105712827|NCT03529773|364607706|FG001|Overall Study|Screen Failure|0|||
105712828|NCT03529773|364607707|FG002|Overall Study|Screen Failure|0|||
105712829|NCT03529773|364607708|FG003|Overall Study|Screen Failure|0|||
105712830|NCT03529773|364607709|FG004|Overall Study|Screen Failure|0|||
105712831|NCT03529773|364607710|FG005|Overall Study|Screen Failure|0|||
105712832|NCT03529773|364607711|FG006|Overall Study|Screen Failure|0|||
105712833|NCT03529773|364607712|FG007|Overall Study|Screen Failure|0|||
105712834|NCT03529773|364607713|FG008|Overall Study|Screen Failure|0|||
105712835|NCT03529773|364607714|FG009|Overall Study|Screen Failure|0|||
105712836|NCT03529773|364607715|FG010|Overall Study|Screen Failure|0|||
105712837|NCT03529773|364607716|FG011|Overall Study|Screen Failure|0|||
105712838|NCT03529773|364607717|FG012|Overall Study|Screen Failure|0|||
105712839|NCT03529773|364607718|FG013|Overall Study|Screen Failure|0|||
105712840|NCT03529773|364607719|FG014|Overall Study|Screen Failure|0|||
105712841|NCT03529773|364607720|FG015|Overall Study|Screen Failure|0|||
105712842|NCT03529773|364607721|FG016|Overall Study|Screen Failure|0|||
105712843|NCT03529773|364607722|FG017|Overall Study|Screen Failure|0|||
105712844|NCT03529773|364607723|FG018|Overall Study|Screen Failure|0|||
105712845|NCT03529773|364607724|FG019|Overall Study|Screen Failure|0|||
105712846|NCT03529773|364607725|FG020|Overall Study|Screen Failure|0|||
105712847|NCT03529773|364607726|FG021|Overall Study|Screen Failure|0|||
105712848|NCT03529773|364607727|FG022|Overall Study|Screen Failure|0|||
105712849|NCT03529773|364607728|FG023|Overall Study|Screen Failure|0|||
105712850|NCT03529773|364607729|FG024|Overall Study|Screen Failure|0|||
105712851|NCT03529773|364607730|FG025|Overall Study|Screen Failure|0|||
105712852|NCT03529773|364607731|FG026|Overall Study|Screen Failure|0|||
105712853|NCT03529773|364607732|FG027|Overall Study|Screen Failure|0|||
105712854|NCT03529773|364607733|FG028|Overall Study|Screen Failure|0|||
105712855|NCT03529773|364607734|FG029|Overall Study|Screen Failure|0|||
105712856|NCT03529773|364607735|FG030|Overall Study|Screen Failure|0|||
105712857|NCT03529773|364607736|FG031|Overall Study|Screen Failure|0|||
105788480|NCT05279807|364880096|FG001|Overall Study|Adverse Event|1|||
105352280|NCT01483599|363293850|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105352281|NCT01483599|363293851|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105476254|NCT02703337|363755355|FG006|Period One (Part A)|Withdrawal by Subject|0|||
105476255|NCT02703337|363755356|FG007|Period One (Part A)|Withdrawal by Subject|0|||
105476256|NCT01214395|363755362|FG000|Overall Study|All patients had infection|5|||
105712858|NCT03529773|364607737|FG032|Overall Study|Screen Failure|0|||
105712859|NCT03529773|364607738|FG033|Overall Study|Screen Failure|0|||
105712860|NCT03529773|364607739|FG034|Overall Study|Screen Failure|0|||
105712861|NCT03529773|364607740|FG035|Overall Study|Screen Failure|0|||
105712862|NCT03529773|364607741|FG036|Overall Study|Screen Failure|1|||
105712863|NCT03529773|364607742|FG037|Overall Study|Screen Failure|1|||
105476257|NCT02034409|363755363|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
105476258|NCT02034409|363755364|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
105476259|NCT02034409|363755363|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
105476260|NCT02034409|363755364|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
105476261|NCT02034409|363755363|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
105476262|NCT02034409|363755364|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
105476263|NCT02034409|363755363|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
105476264|NCT02034409|363755364|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
105476265|NCT02034409|363755363|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
105476266|NCT02034409|363755364|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
105476267|NCT02034409|363755363|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
105476268|NCT02034409|363755364|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
105476269|NCT00946153|363755365|FG000|Phase 2|Adverse Event|0|||
105476270|NCT00946153|363755366|FG001|Phase 2|Adverse Event|0|||
105476271|NCT00946153|363755367|FG002|Phase 2|Adverse Event|0|||
105476272|NCT00946153|363755368|FG003|Phase 2|Adverse Event|0|||
105476273|NCT00946153|363755369|FG004|Phase 2|Adverse Event|6|||
105476274|NCT00946153|363755365|FG000|Phase 2|Need more reduction of dose|0|||
105476275|NCT00946153|363755366|FG001|Phase 2|Need more reduction of dose|0|||
105476276|NCT00946153|363755367|FG002|Phase 2|Need more reduction of dose|0|||
105476277|NCT00946153|363755368|FG003|Phase 2|Need more reduction of dose|0|||
105476278|NCT00946153|363755369|FG004|Phase 2|Need more reduction of dose|2|||
105476279|NCT00946153|363755365|FG000|Phase 2|Physician Decision|0|||
105476280|NCT00946153|363755366|FG001|Phase 2|Physician Decision|0|||
105476281|NCT00946153|363755367|FG002|Phase 2|Physician Decision|0|||
105476282|NCT00946153|363755368|FG003|Phase 2|Physician Decision|0|||
105476283|NCT00946153|363755369|FG004|Phase 2|Physician Decision|1|||
105476284|NCT00946153|363755365|FG000|Phase 2|14 days washout for recovery due to AE|0|||
105476285|NCT00946153|363755366|FG001|Phase 2|14 days washout for recovery due to AE|0|||
105476286|NCT00946153|363755367|FG002|Phase 2|14 days washout for recovery due to AE|0|||
105476287|NCT00946153|363755368|FG003|Phase 2|14 days washout for recovery due to AE|0|||
105476288|NCT00946153|363755369|FG004|Phase 2|14 days washout for recovery due to AE|4|||
105476289|NCT01030666|363755370|FG000|Overall Study|Lost to Follow-up|3|||
105476290|NCT01030666|363755371|FG001|Overall Study|Lost to Follow-up|2|||
105476291|NCT00934843|363755372|FG000|Overall Study|Protocol Violation|0|||
105476292|NCT00934843|363755373|FG001|Overall Study|Protocol Violation|1|||
105476293|NCT03698591|363755376|FG000|Overall Study|Withdrawal by Subject|2|||
105476294|NCT03698591|363755377|FG001|Overall Study|Withdrawal by Subject|2|||
105476295|NCT03698591|363755376|FG000|Overall Study|Failed drug screen|1|||
105476296|NCT03698591|363755377|FG001|Overall Study|Failed drug screen|1|||
105476297|NCT03698591|363755376|FG000|Overall Study|Failed health screen|0|||
105476298|NCT03698591|363755377|FG001|Overall Study|Failed health screen|1|||
105476299|NCT03698591|363755376|FG000|Overall Study|Ineligible for financial compensation|1|||
105476300|NCT03698591|363755377|FG001|Overall Study|Ineligible for financial compensation|0|||
105476301|NCT03698591|363755376|FG000|Overall Study|Equipment Error|1|||
105476302|NCT03698591|363755377|FG001|Overall Study|Equipment Error|0|||
105476303|NCT03698591|363755376|FG000|Overall Study|Could not establish TMS dosage|0|||
105476304|NCT03698591|363755377|FG001|Overall Study|Could not establish TMS dosage|1|||
105476305|NCT01011309|363755379|FG000|Overall Study|Adverse Event|2|||
105476306|NCT01011309|363755380|FG001|Overall Study|Adverse Event|1|||
105476307|NCT01011309|363755381|FG002|Overall Study|Adverse Event|2|||
105476308|NCT01011309|363755379|FG000|Overall Study|Lack of Efficacy|0|||
105476309|NCT01011309|363755380|FG001|Overall Study|Lack of Efficacy|1|||
105712864|NCT03529773|364607743|FG038|Overall Study|Screen Failure|0|||
105712865|NCT03529773|364607744|FG039|Overall Study|Screen Failure|1|||
105712866|NCT03529773|364607705|FG000|Overall Study|Randomized but not vaccinated|0|||
105476310|NCT01011309|363755381|FG002|Overall Study|Lack of Efficacy|0|||
105712867|NCT03529773|364607706|FG001|Overall Study|Randomized but not vaccinated|0|||
105712868|NCT03529773|364607707|FG002|Overall Study|Randomized but not vaccinated|0|||
105712869|NCT03529773|364607708|FG003|Overall Study|Randomized but not vaccinated|0|||
105712870|NCT03529773|364607709|FG004|Overall Study|Randomized but not vaccinated|0|||
105712871|NCT03529773|364607710|FG005|Overall Study|Randomized but not vaccinated|0|||
105712872|NCT03529773|364607711|FG006|Overall Study|Randomized but not vaccinated|0|||
105712873|NCT03529773|364607712|FG007|Overall Study|Randomized but not vaccinated|0|||
105476311|NCT01011309|363755379|FG000|Overall Study|Protocol Violation|0|||
105476312|NCT01011309|363755380|FG001|Overall Study|Protocol Violation|1|||
105476313|NCT01011309|363755381|FG002|Overall Study|Protocol Violation|3|||
105476314|NCT01338298|363755394|FG000|Overall Study|Withdrawal by Subject|1|||
105476315|NCT01338298|363755395|FG001|Overall Study|Withdrawal by Subject|1|||
105476316|NCT01338298|363755394|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
105476317|NCT01338298|363755395|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
105712874|NCT03529773|364607713|FG008|Overall Study|Randomized but not vaccinated|0|||
105712875|NCT03529773|364607714|FG009|Overall Study|Randomized but not vaccinated|0|||
105712876|NCT03529773|364607715|FG010|Overall Study|Randomized but not vaccinated|0|||
105788481|NCT05279807|364880095|FG000|Overall Study|Laboratory Abnormal Results|1|||
105788482|NCT05279807|364880096|FG001|Overall Study|Laboratory Abnormal Results|0|||
105788483|NCT03526549|364880098|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
105788484|NCT03526549|364880099|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
105788485|NCT03526549|364880098|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
105788486|NCT03526549|364880099|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
105788487|NCT03526549|364880098|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
105788488|NCT03526549|364880099|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
105788489|NCT03526549|364880098|FG000|Open-label Phase|Adverse Event|4|||
105788490|NCT03526549|364880099|FG001|Open-label Phase|Adverse Event|0|||
105788491|NCT03526549|364880098|FG000|Open-label Phase|Withdrawal by Subject|54|||
105788492|NCT03526549|364880099|FG001|Open-label Phase|Withdrawal by Subject|0|||
105788493|NCT03526549|364880098|FG000|Open-label Phase|Lost to Follow-up|35|||
105788494|NCT03526549|364880099|FG001|Open-label Phase|Lost to Follow-up|0|||
105788495|NCT03526549|364880098|FG000|Open-label Phase|Other than Specified|5|||
105788496|NCT03526549|364880099|FG001|Open-label Phase|Other than Specified|0|||
105788497|NCT00478933|364880102|FG000|Overall Study|Protocol Violation|22|||
105788498|NCT00478933|364880102|FG000|Overall Study|Informed consent not verified|3|||
105788499|NCT00478933|364880102|FG000|Overall Study|Inadequate data available|53|||
105788500|NCT03586427|364880103|FG000|Overall Study|Lost to Follow-up|0|||
105788501|NCT03586427|364880104|FG001|Overall Study|Lost to Follow-up|3|||
105788502|NCT03586427|364880105|FG002|Overall Study|Lost to Follow-up|1|||
105788503|NCT03586427|364880106|FG003|Overall Study|Lost to Follow-up|3|||
105788504|NCT03586427|364880107|FG004|Overall Study|Lost to Follow-up|3|||
105788505|NCT03586427|364880103|FG000|Overall Study|Withdrawal by Subject|0|||
105476318|NCT01338298|363755394|FG000|Overall Study|Administrative error|0|||
105476319|NCT01338298|363755395|FG001|Overall Study|Administrative error|1|||
105476320|NCT01338298|363755394|FG000|Overall Study|Positive symptom worsening|1|||
105712877|NCT03529773|364607716|FG011|Overall Study|Randomized but not vaccinated|0|||
105712878|NCT03529773|364607717|FG012|Overall Study|Randomized but not vaccinated|0|||
105712879|NCT03529773|364607718|FG013|Overall Study|Randomized but not vaccinated|0|||
105712880|NCT03529773|364607719|FG014|Overall Study|Randomized but not vaccinated|0|||
105712881|NCT03529773|364607720|FG015|Overall Study|Randomized but not vaccinated|0|||
105712882|NCT03529773|364607721|FG016|Overall Study|Randomized but not vaccinated|0|||
105712883|NCT03529773|364607722|FG017|Overall Study|Randomized but not vaccinated|1|||
105712884|NCT03529773|364607723|FG018|Overall Study|Randomized but not vaccinated|0|||
105712885|NCT03529773|364607724|FG019|Overall Study|Randomized but not vaccinated|0|||
105712886|NCT03529773|364607725|FG020|Overall Study|Randomized but not vaccinated|0|||
105712887|NCT03529773|364607726|FG021|Overall Study|Randomized but not vaccinated|0|||
105712888|NCT03529773|364607727|FG022|Overall Study|Randomized but not vaccinated|0|||
105712889|NCT03529773|364607728|FG023|Overall Study|Randomized but not vaccinated|0|||
105712890|NCT03529773|364607729|FG024|Overall Study|Randomized but not vaccinated|0|||
105712891|NCT03529773|364607730|FG025|Overall Study|Randomized but not vaccinated|0|||
105712892|NCT03529773|364607731|FG026|Overall Study|Randomized but not vaccinated|0|||
105712893|NCT03529773|364607732|FG027|Overall Study|Randomized but not vaccinated|1|||
105352282|NCT01483599|363293852|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105712894|NCT03529773|364607733|FG028|Overall Study|Randomized but not vaccinated|0|||
105712895|NCT03529773|364607734|FG029|Overall Study|Randomized but not vaccinated|0|||
105788506|NCT03586427|364880104|FG001|Overall Study|Withdrawal by Subject|1|||
105788507|NCT03586427|364880105|FG002|Overall Study|Withdrawal by Subject|2|||
105788508|NCT03586427|364880106|FG003|Overall Study|Withdrawal by Subject|1|||
105788509|NCT03586427|364880107|FG004|Overall Study|Withdrawal by Subject|1|||
105788510|NCT03586427|364880103|FG000|Overall Study|Adverse Event|0|||
105788511|NCT03586427|364880104|FG001|Overall Study|Adverse Event|0|||
105788512|NCT03586427|364880105|FG002|Overall Study|Adverse Event|1|||
105788513|NCT03586427|364880106|FG003|Overall Study|Adverse Event|0|||
105476321|NCT01338298|363755395|FG001|Overall Study|Positive symptom worsening|0|||
105476322|NCT01338298|363755394|FG000|Overall Study|Depressive symptoms and nausea|1|||
105476323|NCT01338298|363755395|FG001|Overall Study|Depressive symptoms and nausea|0|||
105476324|NCT01338298|363755394|FG000|Overall Study|Non-adherence|1|||
105476325|NCT01338298|363755395|FG001|Overall Study|Non-adherence|0|||
105476326|NCT00557856|363755399|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
105476327|NCT00557856|363755400|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
105476328|NCT00557856|363755401|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
105476329|NCT00557856|363755402|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
105476330|NCT00557856|363755403|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
105476331|NCT00557856|363755404|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
105476332|NCT00557856|363755405|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
105476333|NCT00557856|363755406|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
105476334|NCT00557856|363755407|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
105476335|NCT00557856|363755399|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
105476336|NCT00557856|363755400|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
105476337|NCT00557856|363755401|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
105476338|NCT00557856|363755402|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
105476339|NCT00557856|363755403|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
105476340|NCT00557856|363755404|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
105476341|NCT00557856|363755405|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
105476342|NCT00557856|363755406|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
105476343|NCT00557856|363755407|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
105712896|NCT03529773|364607735|FG030|Overall Study|Randomized but not vaccinated|0|||
105712897|NCT03529773|364607736|FG031|Overall Study|Randomized but not vaccinated|0|||
105712898|NCT03529773|364607737|FG032|Overall Study|Randomized but not vaccinated|0|||
105712899|NCT03529773|364607738|FG033|Overall Study|Randomized but not vaccinated|0|||
105712900|NCT03529773|364607739|FG034|Overall Study|Randomized but not vaccinated|0|||
105712901|NCT03529773|364607740|FG035|Overall Study|Randomized but not vaccinated|0|||
105712902|NCT03529773|364607741|FG036|Overall Study|Randomized but not vaccinated|0|||
105712903|NCT03529773|364607742|FG037|Overall Study|Randomized but not vaccinated|0|||
105712904|NCT03529773|364607743|FG038|Overall Study|Randomized but not vaccinated|0|||
105712905|NCT03529773|364607744|FG039|Overall Study|Randomized but not vaccinated|0|||
105712906|NCT01340209|364607745|FG000|Overall Study|Adverse Event|1|||
105712907|NCT01340209|364607746|FG001|Overall Study|Adverse Event|1|||
105712908|NCT01340209|364607747|FG002|Overall Study|Adverse Event|2|||
105712909|NCT01340209|364607745|FG000|Overall Study|Protocol Violation|1|||
105712910|NCT01340209|364607746|FG001|Overall Study|Protocol Violation|2|||
105712911|NCT01340209|364607747|FG002|Overall Study|Protocol Violation|1|||
105712912|NCT01340209|364607745|FG000|Overall Study|Withdrawal by Subject|0|||
105712913|NCT01340209|364607746|FG001|Overall Study|Withdrawal by Subject|0|||
105712914|NCT01340209|364607747|FG002|Overall Study|Withdrawal by Subject|1|||
105712915|NCT01340209|364607745|FG000|Overall Study|Other reason not defined above|3|||
105712916|NCT01340209|364607746|FG001|Overall Study|Other reason not defined above|5|||
105712917|NCT01340209|364607747|FG002|Overall Study|Other reason not defined above|4|||
105712918|NCT00209339|364607750|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
105712919|NCT00209339|364607750|FG000|At 12 Months Follow-up|Death|1|||
105712920|NCT00209339|364607750|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
105712921|NCT00209339|364607750|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
105712922|NCT00209339|364607750|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
105712923|NCT00209339|364607750|FG000|At 24 Months Follow-up|Death|1|||
105712924|NCT00209339|364607750|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
105712925|NCT00209339|364607750|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
105712926|NCT00209339|364607750|FG000|At 4 Years Follow-up|Death|1|||
105712927|NCT00209339|364607750|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
105712928|NCT00209339|364607750|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
105712929|NCT00209339|364607750|FG000|At 5 Years Follow-up|Death|1|||
105476344|NCT00557856|363755399|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
105476345|NCT00557856|363755400|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
105476346|NCT00557856|363755401|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
105476347|NCT00557856|363755402|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
105476348|NCT00557856|363755403|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
105476349|NCT00557856|363755404|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
105476350|NCT00557856|363755405|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
105476351|NCT00557856|363755406|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
105476352|NCT00557856|363755407|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
105476353|NCT00557856|363755399|FG000|Part 1: Dose Escalation Phase|Other|0|||
105476354|NCT00557856|363755400|FG001|Part 1: Dose Escalation Phase|Other|0|||
105476355|NCT00557856|363755401|FG002|Part 1: Dose Escalation Phase|Other|1|||
105476356|NCT00557856|363755402|FG003|Part 1: Dose Escalation Phase|Other|1|||
105476357|NCT00557856|363755403|FG004|Part 1: Dose Escalation Phase|Other|0|||
105476358|NCT00557856|363755404|FG005|Part 1: Dose Escalation Phase|Other|0|||
105476359|NCT00557856|363755405|FG006|Part 1: Dose Escalation Phase|Other|0|||
105476360|NCT00557856|363755406|FG007|Part 1: Dose Escalation Phase|Other|1|||
105476361|NCT00557856|363755407|FG008|Part 1: Dose Escalation Phase|Other|0|||
105476362|NCT00557856|363755399|FG000|Part 1: Dose Escalation Phase|Death|0|||
105476363|NCT00557856|363755400|FG001|Part 1: Dose Escalation Phase|Death|0|||
105476364|NCT00557856|363755401|FG002|Part 1: Dose Escalation Phase|Death|0|||
105476365|NCT00557856|363755402|FG003|Part 1: Dose Escalation Phase|Death|0|||
105476366|NCT00557856|363755403|FG004|Part 1: Dose Escalation Phase|Death|0|||
105476367|NCT00557856|363755404|FG005|Part 1: Dose Escalation Phase|Death|1|||
105476368|NCT00557856|363755405|FG006|Part 1: Dose Escalation Phase|Death|0|||
105476369|NCT00557856|363755406|FG007|Part 1: Dose Escalation Phase|Death|0|||
105476370|NCT00557856|363755407|FG008|Part 1: Dose Escalation Phase|Death|0|||
105476371|NCT00557856|363755399|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
105476372|NCT00557856|363755400|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
105476373|NCT00557856|363755401|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
105476374|NCT00557856|363755402|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
105476375|NCT00557856|363755403|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
105476376|NCT00557856|363755404|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
105476377|NCT00557856|363755405|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
105476378|NCT00557856|363755406|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
105476379|NCT00557856|363755407|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
105476380|NCT00557856|363755399|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
105476381|NCT00557856|363755400|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
105476382|NCT00557856|363755401|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
105712930|NCT02268058|364607752|FG000|Overall Study|Protocol Violation|1|||
105712931|NCT02268058|364607753|FG001|Overall Study|Protocol Violation|0|||
105476383|NCT00557856|363755402|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
105476384|NCT00557856|363755403|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
105476385|NCT00557856|363755404|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
105476386|NCT00557856|363755405|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
105476387|NCT00557856|363755406|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
105476388|NCT00557856|363755407|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
105561495|NCT00981084|364050502|FG001|Post Intervention (Data Analysis)|poor effort|1|||
105561496|NCT00981084|364050501|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
105712932|NCT02268058|364607754|FG002|Overall Study|Protocol Violation|0|||
105712933|NCT02268058|364607755|FG003|Overall Study|Protocol Violation|0|||
105712934|NCT01903837|364607757|FG000|Part A|Withdrawal by Subject|4|||
105712935|NCT01903837|364607758|FG001|Part A|Withdrawal by Subject|9|||
105712936|NCT01903837|364607759|FG002|Part A|Withdrawal by Subject|8|||
105712937|NCT01903837|364607760|FG003|Part A|Withdrawal by Subject|5|||
105712938|NCT01903837|364607757|FG000|Part A|Adverse Event|3|||
105712939|NCT01903837|364607758|FG001|Part A|Adverse Event|6|||
105712940|NCT01903837|364607759|FG002|Part A|Adverse Event|9|||
105712941|NCT01903837|364607760|FG003|Part A|Adverse Event|6|||
105712942|NCT01903837|364607757|FG000|Part A|Lost to Follow-up|9|||
105712943|NCT01903837|364607758|FG001|Part A|Lost to Follow-up|7|||
105712944|NCT01903837|364607759|FG002|Part A|Lost to Follow-up|7|||
105712945|NCT01903837|364607760|FG003|Part A|Lost to Follow-up|2|||
105712946|NCT01903837|364607757|FG000|Part A|Non-compliance with study drug|1|||
105712947|NCT01903837|364607758|FG001|Part A|Non-compliance with study drug|4|||
105712948|NCT01903837|364607759|FG002|Part A|Non-compliance with study drug|4|||
105712949|NCT01903837|364607760|FG003|Part A|Non-compliance with study drug|0|||
105712950|NCT01903837|364607757|FG000|Part A|Physician Decision|1|||
105712951|NCT01903837|364607758|FG001|Part A|Physician Decision|1|||
105712952|NCT01903837|364607759|FG002|Part A|Physician Decision|0|||
105712953|NCT01903837|364607760|FG003|Part A|Physician Decision|0|||
105712954|NCT01903837|364607757|FG000|Part A|Protocol Violation|1|||
105712955|NCT01903837|364607758|FG001|Part A|Protocol Violation|1|||
105712956|NCT01903837|364607759|FG002|Part A|Protocol Violation|0|||
105712957|NCT01903837|364607760|FG003|Part A|Protocol Violation|0|||
105712958|NCT01903837|364607757|FG000|Part B|Lost to Follow-up|0|||
105712959|NCT01903837|364607758|FG001|Part B|Lost to Follow-up|3|||
105712960|NCT01903837|364607759|FG002|Part B|Lost to Follow-up|3|||
105712961|NCT01903837|364607760|FG003|Part B|Lost to Follow-up|4|||
105712962|NCT01903837|364607757|FG000|Part B|Withdrawal by Subject|1|||
105712963|NCT01903837|364607758|FG001|Part B|Withdrawal by Subject|2|||
105712964|NCT01903837|364607759|FG002|Part B|Withdrawal by Subject|0|||
105712965|NCT01903837|364607760|FG003|Part B|Withdrawal by Subject|3|||
105712966|NCT01903837|364607757|FG000|Part B|Adverse Event|3|||
105712967|NCT01903837|364607758|FG001|Part B|Adverse Event|0|||
105712968|NCT01903837|364607759|FG002|Part B|Adverse Event|2|||
105712969|NCT01903837|364607760|FG003|Part B|Adverse Event|0|||
105712970|NCT01903837|364607757|FG000|Part B|Non-compliance with study drug|2|||
105712971|NCT01903837|364607758|FG001|Part B|Non-compliance with study drug|0|||
105712972|NCT01903837|364607759|FG002|Part B|Non-compliance with study drug|0|||
105712973|NCT01903837|364607760|FG003|Part B|Non-compliance with study drug|1|||
105712974|NCT01903837|364607757|FG000|Part B|Incarceration|2|||
105712975|NCT01903837|364607758|FG001|Part B|Incarceration|0|||
105712976|NCT01903837|364607759|FG002|Part B|Incarceration|0|||
105712977|NCT01903837|364607760|FG003|Part B|Incarceration|1|||
105712978|NCT01903837|364607757|FG000|Part B|Physician Decision|1|||
105712979|NCT01903837|364607758|FG001|Part B|Physician Decision|0|||
105712980|NCT01903837|364607759|FG002|Part B|Physician Decision|0|||
105712981|NCT01903837|364607760|FG003|Part B|Physician Decision|2|||
105712982|NCT01903837|364607757|FG000|Part B|Lack of Efficacy|0|||
105712983|NCT01903837|364607758|FG001|Part B|Lack of Efficacy|1|||
105712984|NCT01903837|364607759|FG002|Part B|Lack of Efficacy|0|||
105712985|NCT01903837|364607760|FG003|Part B|Lack of Efficacy|0|||
105712986|NCT05048342|364607761|FG000|Overall Study|Adverse Event|1|||
105712987|NCT05048342|364607761|FG000|Overall Study|Subject decision|2|||
105712988|NCT01441063|364607762|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
105712989|NCT01441063|364607762|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
105712990|NCT02623335|364607764|FG000|Overall Study|Death|8|||
105712991|NCT02623335|364607765|FG001|Overall Study|Death|7|||
105712992|NCT02623335|364607764|FG000|Overall Study|Lost to Follow-up|15|||
105712993|NCT02623335|364607765|FG001|Overall Study|Lost to Follow-up|23|||
105712994|NCT02623335|364607764|FG000|Overall Study|Withdrawal by Subject|2|||
105712995|NCT02623335|364607765|FG001|Overall Study|Withdrawal by Subject|5|||
105712996|NCT02623335|364607764|FG000|Overall Study|Protocol Violation|2|||
105712997|NCT02623335|364607765|FG001|Overall Study|Protocol Violation|1|||
105712998|NCT00430508|364607774|FG000|Overall Study|Adverse Event|2|||
105712999|NCT00430508|364607775|FG001|Overall Study|Adverse Event|3|||
105713000|NCT00430508|364607776|FG002|Overall Study|Adverse Event|5|||
105713001|NCT00430508|364607777|FG003|Overall Study|Adverse Event|3|||
105713002|NCT00430508|364607774|FG000|Overall Study|Withdrawal by Subject|0|||
105713003|NCT00430508|364607775|FG001|Overall Study|Withdrawal by Subject|1|||
105713004|NCT00430508|364607776|FG002|Overall Study|Withdrawal by Subject|1|||
105713005|NCT00430508|364607777|FG003|Overall Study|Withdrawal by Subject|1|||
105713006|NCT00430508|364607774|FG000|Overall Study|responder at visit 4|0|||
105713007|NCT00430508|364607775|FG001|Overall Study|responder at visit 4|0|||
105713008|NCT00430508|364607776|FG002|Overall Study|responder at visit 4|2|||
105713009|NCT00430508|364607777|FG003|Overall Study|responder at visit 4|0|||
105713010|NCT00430508|364607774|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
105713011|NCT00430508|364607775|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
105713012|NCT00430508|364607776|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
105713013|NCT00430508|364607777|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
105713014|NCT00430508|364607774|FG000|Overall Study|Other|1|||
105713015|NCT00430508|364607775|FG001|Overall Study|Other|1|||
105713016|NCT00430508|364607776|FG002|Overall Study|Other|3|||
105713017|NCT00430508|364607777|FG003|Overall Study|Other|0|||
105713018|NCT00999908|364607778|FG000|Treatment Period 1|Subject withdrew consent|2|||
105713019|NCT00999908|364607779|FG001|Treatment Period 1|Subject withdrew consent|0|||
105713020|NCT00999908|364607780|FG002|Treatment Period 1|Subject withdrew consent|0|||
105713021|NCT00999908|364607778|FG000|Treatment Period 2|Protocol Violation|1|||
105713022|NCT00999908|364607779|FG001|Treatment Period 2|Protocol Violation|0|||
105713023|NCT00999908|364607780|FG002|Treatment Period 2|Protocol Violation|0|||
105713024|NCT02809833|364607784|FG000|Overall Study|Death|3|||
105713025|NCT02809833|364607784|FG000|Overall Study|Intolerance|54|||
105713026|NCT02809833|364607784|FG000|Overall Study|Lack of Efficacy|89|||
105713027|NCT02809833|364607784|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
105713028|NCT02809833|364607784|FG000|Overall Study|Noncompliance|1|||
105713029|NCT02809833|364607784|FG000|Overall Study|Withdrawal by Subject|34|||
105713030|NCT02809833|364607784|FG000|Overall Study|Lost to Follow-up|35|||
105713031|NCT02809833|364607784|FG000|Overall Study|Adverse Event (AE)|24|||
105713032|NCT02809833|364607784|FG000|Overall Study|Other|5|||
105713033|NCT02809833|364607784|FG000|Overall Study|Missing Information|52|||
105713034|NCT03261531|364607785|FG000|Overall Study|Withdrawal by Subject|4|||
105713035|NCT00927095|364607786|FG000|Overall Study|Adverse Event|3|||
105713036|NCT00927095|364607787|FG001|Overall Study|Adverse Event|1|||
105713037|NCT00927095|364607788|FG002|Overall Study|Adverse Event|0|||
105713038|NCT00927095|364607786|FG000|Overall Study|Withdrawal by Subject|2|||
105713039|NCT00927095|364607787|FG001|Overall Study|Withdrawal by Subject|1|||
105713040|NCT00927095|364607788|FG002|Overall Study|Withdrawal by Subject|1|||
105713041|NCT00927095|364607786|FG000|Overall Study|Physician Decision|1|||
105713042|NCT00927095|364607787|FG001|Overall Study|Physician Decision|2|||
105713043|NCT00927095|364607788|FG002|Overall Study|Physician Decision|1|||
105476389|NCT00557856|363755399|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
105713044|NCT02556255|364607789|FG000|Overall Study|Lost to Follow-up|4|||
105713045|NCT00744874|364607790|FG000|Overall Study|Lost to Follow-up|1|||
105713046|NCT00744874|364607790|FG000|Overall Study|Withdrawal by Subject|1|||
105713047|NCT00744874|364607790|FG000|Overall Study|Study Device not available at procedure|1|||
105713048|NCT00744874|364607790|FG000|Overall Study|Unable to accomodate schedule|1|||
105713049|NCT01834729|364607798|FG000|Overall Study|Did not return bowel diaries|0|||
105713050|NCT01834729|364607799|FG001|Overall Study|Did not return bowel diaries|0|||
105713051|NCT01834729|364607800|FG002|Overall Study|Did not return bowel diaries|3|||
105713052|NCT01834729|364607801|FG003|Overall Study|Did not return bowel diaries|0|||
105713053|NCT01834729|364607798|FG000|Overall Study|Withdrawal by Subject|1|||
105713054|NCT01834729|364607799|FG001|Overall Study|Withdrawal by Subject|1|||
105713055|NCT01834729|364607800|FG002|Overall Study|Withdrawal by Subject|0|||
105713056|NCT01834729|364607801|FG003|Overall Study|Withdrawal by Subject|0|||
105713057|NCT01834729|364607798|FG000|Overall Study|Adverse Event|0|||
105713058|NCT01834729|364607799|FG001|Overall Study|Adverse Event|0|||
105713059|NCT01834729|364607800|FG002|Overall Study|Adverse Event|0|||
105713060|NCT01834729|364607801|FG003|Overall Study|Adverse Event|2|||
105713061|NCT01127165|364607802|FG000|Overall Study|Adverse Event|2|||
105713062|NCT01127165|364607803|FG001|Overall Study|Adverse Event|2|||
105713063|NCT01127165|364607802|FG000|Overall Study|Lack of Efficacy|10|||
105713064|NCT01127165|364607803|FG001|Overall Study|Lack of Efficacy|8|||
105713065|NCT01127165|364607802|FG000|Overall Study|Lost to Follow-up|3|||
105713066|NCT01127165|364607803|FG001|Overall Study|Lost to Follow-up|5|||
105713067|NCT01127165|364607802|FG000|Overall Study|Withdrawal by Subject|1|||
105713068|NCT01127165|364607803|FG001|Overall Study|Withdrawal by Subject|3|||
105713069|NCT01127165|364607802|FG000|Overall Study|Protocol Violation|0|||
105713070|NCT01127165|364607803|FG001|Overall Study|Protocol Violation|1|||
105713071|NCT00379795|364607804|FG000|Overall Study|Death|31|||
105713072|NCT00379795|364607805|FG001|Overall Study|Death|8|||
105713073|NCT00379795|364607806|FG002|Overall Study|Death|6|||
105713074|NCT00379795|364607807|FG003|Overall Study|Death|4|||
105713075|NCT00379795|364607808|FG004|Overall Study|Death|7|||
105713076|NCT00379795|364607804|FG000|Overall Study|Adverse Event|17|||
105713077|NCT00379795|364607805|FG001|Overall Study|Adverse Event|3|||
105713078|NCT00379795|364607806|FG002|Overall Study|Adverse Event|3|||
105713079|NCT00379795|364607807|FG003|Overall Study|Adverse Event|1|||
105713080|NCT00379795|364607808|FG004|Overall Study|Adverse Event|4|||
105713081|NCT00379795|364607804|FG000|Overall Study|Lost to Follow-up|8|||
105713082|NCT00379795|364607805|FG001|Overall Study|Lost to Follow-up|1|||
105713083|NCT00379795|364607806|FG002|Overall Study|Lost to Follow-up|2|||
105713084|NCT00379795|364607807|FG003|Overall Study|Lost to Follow-up|1|||
105713085|NCT00379795|364607808|FG004|Overall Study|Lost to Follow-up|4|||
105713086|NCT00379795|364607804|FG000|Overall Study|Physician Decision|25|||
105713087|NCT00379795|364607805|FG001|Overall Study|Physician Decision|0|||
105713088|NCT00379795|364607806|FG002|Overall Study|Physician Decision|2|||
105713089|NCT00379795|364607807|FG003|Overall Study|Physician Decision|2|||
105713090|NCT00379795|364607808|FG004|Overall Study|Physician Decision|2|||
105713091|NCT00379795|364607804|FG000|Overall Study|Withdrawal by Subject|94|||
105713092|NCT00379795|364607805|FG001|Overall Study|Withdrawal by Subject|11|||
105713093|NCT00379795|364607806|FG002|Overall Study|Withdrawal by Subject|19|||
105713094|NCT00379795|364607807|FG003|Overall Study|Withdrawal by Subject|7|||
105713095|NCT00379795|364607808|FG004|Overall Study|Withdrawal by Subject|14|||
105713096|NCT00379795|364607804|FG000|Overall Study|Subject non-compliance|7|||
105713097|NCT00379795|364607805|FG001|Overall Study|Subject non-compliance|2|||
105713098|NCT00379795|364607806|FG002|Overall Study|Subject non-compliance|0|||
105713099|NCT00379795|364607807|FG003|Overall Study|Subject non-compliance|0|||
105713100|NCT00379795|364607808|FG004|Overall Study|Subject non-compliance|1|||
105713101|NCT00379795|364607804|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
105713102|NCT00379795|364607805|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
105713103|NCT00379795|364607806|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
105713104|NCT00379795|364607807|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
105713105|NCT00379795|364607808|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
105713106|NCT00379795|364607804|FG000|Overall Study|Subjects condition mandated intervention|34|||
105713107|NCT00379795|364607805|FG001|Overall Study|Subjects condition mandated intervention|9|||
105713108|NCT00379795|364607806|FG002|Overall Study|Subjects condition mandated intervention|7|||
105713109|NCT00379795|364607807|FG003|Overall Study|Subjects condition mandated intervention|5|||
105713110|NCT00379795|364607808|FG004|Overall Study|Subjects condition mandated intervention|7|||
105713111|NCT00379795|364607804|FG000|Overall Study|Sponsor's decision|257|||
105713112|NCT00379795|364607805|FG001|Overall Study|Sponsor's decision|17|||
105713113|NCT00379795|364607806|FG002|Overall Study|Sponsor's decision|54|||
105713114|NCT00379795|364607807|FG003|Overall Study|Sponsor's decision|47|||
105713115|NCT00379795|364607808|FG004|Overall Study|Sponsor's decision|10|||
105713116|NCT00725075|364607809|FG000|Overall Study|Use of Excluded Medication|0|||
105713117|NCT00725075|364607810|FG001|Overall Study|Use of Excluded Medication|1|||
105713118|NCT00725075|364607811|FG002|Overall Study|Use of Excluded Medication|0|||
105476390|NCT00557856|363755400|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
105476391|NCT00557856|363755401|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
105476392|NCT00557856|363755402|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
105476393|NCT00557856|363755403|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
105476394|NCT00557856|363755404|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
105476395|NCT00557856|363755405|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
105476396|NCT00557856|363755406|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
105476397|NCT00557856|363755407|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
105476398|NCT00557856|363755399|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
105476399|NCT00557856|363755400|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
105476400|NCT00557856|363755401|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
105476401|NCT00557856|363755402|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
105476402|NCT00557856|363755403|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
105476403|NCT00557856|363755404|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
105476404|NCT00557856|363755405|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
105476405|NCT00557856|363755406|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
105476406|NCT00557856|363755407|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
105476407|NCT00557856|363755399|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
105476408|NCT00557856|363755400|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
105476409|NCT00557856|363755401|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
105476410|NCT00557856|363755402|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
105476411|NCT00557856|363755403|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
105476412|NCT00557856|363755404|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
105476413|NCT00557856|363755405|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
105476414|NCT00557856|363755406|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
105476415|NCT00557856|363755407|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
105476416|NCT00557856|363755399|FG000|Part 2: Exploratory Phase|Other|0|||
105476417|NCT00557856|363755400|FG001|Part 2: Exploratory Phase|Other|0|||
105476418|NCT00557856|363755401|FG002|Part 2: Exploratory Phase|Other|0|||
105476419|NCT00557856|363755402|FG003|Part 2: Exploratory Phase|Other|0|||
105476420|NCT00557856|363755403|FG004|Part 2: Exploratory Phase|Other|0|||
105476421|NCT00557856|363755404|FG005|Part 2: Exploratory Phase|Other|0|||
105476422|NCT00557856|363755405|FG006|Part 2: Exploratory Phase|Other|0|||
105476423|NCT00557856|363755406|FG007|Part 2: Exploratory Phase|Other|0|||
105476424|NCT00557856|363755407|FG008|Part 2: Exploratory Phase|Other|1|||
105476425|NCT00557856|363755399|FG000|Part 2: Exploratory Phase|Death|0|||
105476426|NCT00557856|363755400|FG001|Part 2: Exploratory Phase|Death|0|||
105476427|NCT00557856|363755401|FG002|Part 2: Exploratory Phase|Death|0|||
105476428|NCT00557856|363755402|FG003|Part 2: Exploratory Phase|Death|0|||
105476429|NCT00557856|363755403|FG004|Part 2: Exploratory Phase|Death|0|||
105476430|NCT00557856|363755404|FG005|Part 2: Exploratory Phase|Death|0|||
105476431|NCT00557856|363755405|FG006|Part 2: Exploratory Phase|Death|0|||
105476432|NCT00557856|363755406|FG007|Part 2: Exploratory Phase|Death|0|||
105476433|NCT00557856|363755407|FG008|Part 2: Exploratory Phase|Death|2|||
105476434|NCT00557856|363755399|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
105476435|NCT00557856|363755400|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
105476436|NCT00557856|363755401|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
105476437|NCT00557856|363755402|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
105476438|NCT00557856|363755403|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
105476439|NCT00557856|363755404|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
105476440|NCT00557856|363755405|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
105476441|NCT00557856|363755406|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
105476442|NCT00557856|363755407|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
105476443|NCT00881868|363755408|FG000|Overall Study|Adverse Event|0|||
105476444|NCT00881868|363755409|FG001|Overall Study|Adverse Event|1|||
105476445|NCT00881868|363755408|FG000|Overall Study|Lost to Follow-up|2|||
105476446|NCT00881868|363755409|FG001|Overall Study|Lost to Follow-up|1|||
105476447|NCT00881868|363755408|FG000|Overall Study|Physician Decision|4|||
105476448|NCT00881868|363755409|FG001|Overall Study|Physician Decision|0|||
105476449|NCT00881868|363755408|FG000|Overall Study|Protocol Violation|2|||
105476450|NCT00881868|363755409|FG001|Overall Study|Protocol Violation|0|||
105476451|NCT01217307|363756744|FG000|Overall Study|Withdrawal by Subject|0|||
105476452|NCT01217307|363756745|FG001|Overall Study|Withdrawal by Subject|1|||
105476453|NCT01657461|363756746|FG000|Overall Study|Death|9|||
105476454|NCT01657461|363756747|FG001|Overall Study|Death|12|||
105476455|NCT01657461|363756746|FG000|Overall Study|Lost to Follow-up|0|||
105476456|NCT01657461|363756747|FG001|Overall Study|Lost to Follow-up|3|||
105476457|NCT01657461|363756746|FG000|Overall Study|Physician Decision|0|||
105476458|NCT01657461|363756747|FG001|Overall Study|Physician Decision|2|||
105476459|NCT01657461|363756746|FG000|Overall Study|Withdrawal by Subject|1|||
105476460|NCT01657461|363756747|FG001|Overall Study|Withdrawal by Subject|3|||
105476461|NCT01868542|363756748|FG000|Overall Study|Protocol Violation|0|||
105476462|NCT01868542|363756749|FG001|Overall Study|Protocol Violation|1|||
105476463|NCT01868542|363756748|FG000|Overall Study|Unclassified|0|||
105476464|NCT01868542|363756749|FG001|Overall Study|Unclassified|1|||
105476465|NCT02156271|363756755|FG000|Overall Study|Physician Decision|4|||
105476466|NCT02156271|363756756|FG001|Overall Study|Physician Decision|3|||
105476467|NCT01221285|363756759|FG000|Overall Study|Withdrawal by Subject|1|||
105476468|NCT02123251|363756760|FG000|Overall Study|Death|1|||
105476469|NCT02123251|363756761|FG001|Overall Study|Death|1|||
105476470|NCT02123251|363756760|FG000|Overall Study|Withdrawal by Subject|0|||
105476471|NCT02123251|363756761|FG001|Overall Study|Withdrawal by Subject|3|||
105476472|NCT02123251|363756760|FG000|Overall Study|Lost Medicaid eligibility|29|||
105476473|NCT02123251|363756761|FG001|Overall Study|Lost Medicaid eligibility|22|||
105476474|NCT02123251|363756760|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
105476475|NCT02123251|363756761|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
105476476|NCT00409331|363756765|FG000|Overall Study|Physician Decision|1|||
105476477|NCT04657666|363756768|FG000|Period 1|Withdrawal of participant consent|2|||
105476478|NCT04657666|363756769|FG001|Period 1|Withdrawal of participant consent|1|||
105476479|NCT04657666|363756768|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
105476480|NCT04657666|363756769|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
105476481|NCT04657666|363756768|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
105476482|NCT04657666|363756769|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
105476483|NCT04657666|363756768|FG000|Period 2|Other|2|||
105476484|NCT04657666|363756769|FG001|Period 2|Other|0|||
105476485|NCT04657666|363756768|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
105476486|NCT04657666|363756769|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
105476487|NCT03319745|363756770|FG000|Overall Study|Death|1|||
105476488|NCT03319745|363756770|FG000|Overall Study|Toxicity Precluding Surgery|1|||
105476489|NCT01120782|363756771|FG000|Overall Study|Test article shipping error|11|||
105476490|NCT03255629|363756772|FG000|Overall Study|Adverse Event|1|||
105713119|NCT00725075|364607809|FG000|Overall Study|Protocol Violation|0|||
105713120|NCT00725075|364607810|FG001|Overall Study|Protocol Violation|0|||
105713121|NCT00725075|364607811|FG002|Overall Study|Protocol Violation|1|||
105713122|NCT00725075|364607809|FG000|Overall Study|Lost to Follow-up|1|||
105713123|NCT00725075|364607810|FG001|Overall Study|Lost to Follow-up|0|||
105713124|NCT00725075|364607811|FG002|Overall Study|Lost to Follow-up|0|||
105713125|NCT00725075|364607809|FG000|Overall Study|Withdrawal by Subject|4|||
105713126|NCT00725075|364607810|FG001|Overall Study|Withdrawal by Subject|5|||
105713127|NCT00725075|364607811|FG002|Overall Study|Withdrawal by Subject|4|||
105713128|NCT00725075|364607809|FG000|Overall Study|Adverse Event|2|||
105713129|NCT00725075|364607810|FG001|Overall Study|Adverse Event|1|||
105713130|NCT00725075|364607811|FG002|Overall Study|Adverse Event|1|||
105713131|NCT00725075|364607809|FG000|Overall Study|Worsening of Disease|2|||
105713132|NCT00725075|364607810|FG001|Overall Study|Worsening of Disease|1|||
105713133|NCT00725075|364607811|FG002|Overall Study|Worsening of Disease|2|||
105713134|NCT00725075|364607809|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
105713135|NCT00725075|364607810|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
105713136|NCT00725075|364607811|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
105713137|NCT00725075|364607809|FG000|Overall Study|Other|1|||
105713138|NCT00725075|364607810|FG001|Overall Study|Other|0|||
105713139|NCT00725075|364607811|FG002|Overall Study|Other|0|||
105713140|NCT02340663|364607812|FG000|Overall Study|Lost to Follow-up|1|||
105713141|NCT02340663|364607813|FG001|Overall Study|Lost to Follow-up|0|||
105713142|NCT02340663|364607812|FG000|Overall Study|Protocol Violation|1|||
105713143|NCT02340663|364607813|FG001|Overall Study|Protocol Violation|0|||
105713144|NCT02340663|364607812|FG000|Overall Study|Withdrawal by Subject|3|||
105713145|NCT02340663|364607813|FG001|Overall Study|Withdrawal by Subject|1|||
105713146|NCT00352105|364607814|FG000|Overall Study|Death|5|||
105713147|NCT00352105|364607814|FG000|Overall Study|Withdrawal by Subject|5|||
105713148|NCT00352105|364607814|FG000|Overall Study|Lack of Efficacy|9|||
105713149|NCT00352105|364607814|FG000|Overall Study|Adverse Event|19|||
105476491|NCT03255629|363756773|FG001|Overall Study|Adverse Event|0|||
105476492|NCT03255629|363756772|FG000|Overall Study|did not experience hypoglycemia|2|||
105561497|NCT00981084|364050502|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
105561498|NCT02276222|364050503|FG000|Overall Study|Adverse Event|62|||
105561499|NCT02276222|364050504|FG001|Overall Study|Adverse Event|11|||
105713150|NCT00352105|364607814|FG000|Overall Study|Protocol Violation|2|||
105713151|NCT02004873|364607817|FG000|Overall Study|Implant unsuccessful|6|||
105713152|NCT02004873|364607817|FG000|Overall Study|Awaiting 6-month visit|390|||
105713153|NCT02004873|364607817|FG000|Overall Study|Missed 6-month visit|4|||
105713154|NCT02004873|364607817|FG000|Overall Study|Death|23|||
105713155|NCT02004873|364607817|FG000|Overall Study|Withdrawal by Subject|1|||
105713156|NCT00044512|364607818|FG000|Follow Up|Lost to Follow-up|2|||
105476493|NCT03255629|363756773|FG001|Overall Study|did not experience hypoglycemia|1|||
105476494|NCT02082340|363756774|FG000|Overall Study|Lost to Follow-up|1|||
105476495|NCT02082340|363756775|FG001|Overall Study|Lost to Follow-up|1|||
105476496|NCT01625260|363756776|FG000|Overall Study|Adverse Event|3|||
105476497|NCT01625260|363756777|FG001|Overall Study|Adverse Event|0|||
105713157|NCT01614093|364607826|FG000|Overall Study|Withdrawal by Subject|1|||
105713158|NCT01816243|364607827|FG000|Overall Study|Adverse Event|6|||
105713159|NCT01816243|364607827|FG000|Overall Study|Lost to Follow-up|1|||
105713160|NCT01816243|364607827|FG000|Overall Study|Lack of Efficacy|1|||
105713161|NCT01816243|364607827|FG000|Overall Study|Not eligible for the study|1|||
105713162|NCT01816243|364607827|FG000|Overall Study|Amputation|3|||
105713163|NCT03891901|364607828|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
105713164|NCT03891901|364607829|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713165|NCT03891901|364607830|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713166|NCT03891901|364607831|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713167|NCT03891901|364607832|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713168|NCT03891901|364607833|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713169|NCT03891901|364607834|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713170|NCT03891901|364607835|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713171|NCT03891901|364607836|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713172|NCT03891901|364607828|FG000|Overall Study|Adverse Event|2|||
105713173|NCT03891901|364607829|FG001|Overall Study|Adverse Event|2|||
105476498|NCT01625260|363756776|FG000|Overall Study|Study Terminated by Investigator|2|||
105713174|NCT03891901|364607830|FG002|Overall Study|Adverse Event|0|||
105713175|NCT03891901|364607831|FG003|Overall Study|Adverse Event|0|||
105713176|NCT03891901|364607832|FG004|Overall Study|Adverse Event|0|||
105713177|NCT03891901|364607833|FG005|Overall Study|Adverse Event|0|||
105713178|NCT03891901|364607834|FG006|Overall Study|Adverse Event|0|||
105713179|NCT03891901|364607835|FG007|Overall Study|Adverse Event|0|||
105713180|NCT03891901|364607836|FG008|Overall Study|Adverse Event|0|||
105713181|NCT03891901|364607828|FG000|Overall Study|Poor venous access|1|||
105713182|NCT03891901|364607829|FG001|Overall Study|Poor venous access|0|||
105713183|NCT03891901|364607830|FG002|Overall Study|Poor venous access|0|||
105713184|NCT03891901|364607831|FG003|Overall Study|Poor venous access|0|||
105713185|NCT03891901|364607832|FG004|Overall Study|Poor venous access|0|||
105713186|NCT03891901|364607833|FG005|Overall Study|Poor venous access|0|||
105713187|NCT03891901|364607834|FG006|Overall Study|Poor venous access|0|||
105713188|NCT03891901|364607835|FG007|Overall Study|Poor venous access|0|||
105476499|NCT01625260|363756777|FG001|Overall Study|Study Terminated by Investigator|0|||
105476500|NCT01625260|363756776|FG000|Overall Study|Disease Progression|2|||
105476501|NCT01625260|363756777|FG001|Overall Study|Disease Progression|0|||
105476502|NCT01625260|363756776|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
105476503|NCT01625260|363756777|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
105713189|NCT03891901|364607836|FG008|Overall Study|Poor venous access|0|||
105713190|NCT03891901|364607828|FG000|Overall Study|Withdrawal by Subject|0|||
105713191|NCT03891901|364607829|FG001|Overall Study|Withdrawal by Subject|2|||
105713192|NCT03891901|364607830|FG002|Overall Study|Withdrawal by Subject|0|||
105713193|NCT03891901|364607831|FG003|Overall Study|Withdrawal by Subject|0|||
105713194|NCT03891901|364607832|FG004|Overall Study|Withdrawal by Subject|0|||
105713195|NCT03891901|364607833|FG005|Overall Study|Withdrawal by Subject|0|||
105713196|NCT03891901|364607834|FG006|Overall Study|Withdrawal by Subject|0|||
105713197|NCT03891901|364607835|FG007|Overall Study|Withdrawal by Subject|0|||
105713198|NCT03891901|364607836|FG008|Overall Study|Withdrawal by Subject|0|||
105713199|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
105713200|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
105713201|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
105713202|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
105713203|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
105713204|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
105713205|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
105713206|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
105713207|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
105713208|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
105713209|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
105713210|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
105713211|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
105713212|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
105713213|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
105713214|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
105713215|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
105713216|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
105713217|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
105713218|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
105713219|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
105713220|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
105713221|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
105713222|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
105713223|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
105713224|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
105713225|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
105713226|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
105713227|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
105713228|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
105713229|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
105713230|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
105713231|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
105713232|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
105713233|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
105713234|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
105713235|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
105713236|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
105713237|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
105713238|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
105713239|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
105713240|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
105713241|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
105713242|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
105713243|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
105713244|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
105713245|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
105713246|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
105713247|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
105713248|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
105713249|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
105713250|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
105713251|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
105788514|NCT03586427|364880107|FG004|Overall Study|Adverse Event|0|||
105788515|NCT03586427|364880103|FG000|Overall Study|Protocol Violation|0|||
105788516|NCT03586427|364880104|FG001|Overall Study|Protocol Violation|0|||
105788517|NCT03586427|364880105|FG002|Overall Study|Protocol Violation|1|||
105788518|NCT03586427|364880106|FG003|Overall Study|Protocol Violation|0|||
105788519|NCT03586427|364880107|FG004|Overall Study|Protocol Violation|1|||
105352283|NCT01483599|363293853|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105476504|NCT00635219|363756778|FG000|Overall Study|Adverse Event|12|||
105476505|NCT00635219|363756779|FG001|Overall Study|Adverse Event|10|||
105476506|NCT00635219|363756780|FG002|Overall Study|Adverse Event|18|||
105476507|NCT00635219|363756781|FG003|Overall Study|Adverse Event|15|||
105476508|NCT00635219|363756782|FG004|Overall Study|Adverse Event|19|||
105476509|NCT00635219|363756778|FG000|Overall Study|Lack of Efficacy|5|||
105476510|NCT00635219|363756779|FG001|Overall Study|Lack of Efficacy|6|||
105476511|NCT00635219|363756780|FG002|Overall Study|Lack of Efficacy|3|||
105476512|NCT00635219|363756781|FG003|Overall Study|Lack of Efficacy|4|||
105476513|NCT00635219|363756782|FG004|Overall Study|Lack of Efficacy|6|||
105476514|NCT00635219|363756778|FG000|Overall Study|Non-compliance With Study Product|0|||
105476515|NCT00635219|363756779|FG001|Overall Study|Non-compliance With Study Product|0|||
105476516|NCT00635219|363756780|FG002|Overall Study|Non-compliance With Study Product|0|||
105476517|NCT00635219|363756781|FG003|Overall Study|Non-compliance With Study Product|2|||
105476518|NCT00635219|363756782|FG004|Overall Study|Non-compliance With Study Product|1|||
105476519|NCT00635219|363756778|FG000|Overall Study|Protocol Violation|0|||
105476520|NCT00635219|363756779|FG001|Overall Study|Protocol Violation|2|||
105476521|NCT00635219|363756780|FG002|Overall Study|Protocol Violation|3|||
105476522|NCT00635219|363756781|FG003|Overall Study|Protocol Violation|2|||
105476523|NCT00635219|363756782|FG004|Overall Study|Protocol Violation|4|||
105476524|NCT00635219|363756778|FG000|Overall Study|Withdrawal of Consent|8|||
105476525|NCT00635219|363756779|FG001|Overall Study|Withdrawal of Consent|6|||
105476526|NCT00635219|363756780|FG002|Overall Study|Withdrawal of Consent|8|||
105476527|NCT00635219|363756781|FG003|Overall Study|Withdrawal of Consent|11|||
105476528|NCT00635219|363756782|FG004|Overall Study|Withdrawal of Consent|8|||
105476529|NCT00635219|363756778|FG000|Overall Study|Lost to Follow-up|0|||
105476530|NCT00635219|363756779|FG001|Overall Study|Lost to Follow-up|0|||
105476531|NCT00635219|363756780|FG002|Overall Study|Lost to Follow-up|2|||
105476532|NCT00635219|363756781|FG003|Overall Study|Lost to Follow-up|0|||
105476533|NCT00635219|363756782|FG004|Overall Study|Lost to Follow-up|3|||
105476534|NCT00635219|363756778|FG000|Overall Study|Administrative or Other Reasons|0|||
105476535|NCT00635219|363756779|FG001|Overall Study|Administrative or Other Reasons|1|||
105476536|NCT00635219|363756780|FG002|Overall Study|Administrative or Other Reasons|1|||
105476537|NCT00635219|363756781|FG003|Overall Study|Administrative or Other Reasons|0|||
105476538|NCT00635219|363756782|FG004|Overall Study|Administrative or Other Reasons|1|||
105476539|NCT02238080|363756785|FG000|Overall Study|Death|13|||
105561500|NCT02276222|364050503|FG000|Overall Study|Death|3|||
105561501|NCT02276222|364050504|FG001|Overall Study|Death|4|||
105561502|NCT02276222|364050503|FG000|Overall Study|Lack of Efficacy|13|||
105713252|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
105713253|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
105713254|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
105713255|NCT03742037|364607837|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
105713256|NCT03742037|364607838|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
105713257|NCT03742037|364607839|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
105713258|NCT03742037|364607840|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
105713259|NCT03742037|364607841|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
105713260|NCT03742037|364607842|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
105713261|NCT03742037|364607843|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
105713262|NCT03742037|364607837|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
105713263|NCT03742037|364607838|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
105713264|NCT03742037|364607839|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
105713265|NCT03742037|364607840|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
105713266|NCT03742037|364607841|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
105713267|NCT03742037|364607842|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
105713268|NCT03742037|364607843|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
105713269|NCT03742037|364607837|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
105713270|NCT03742037|364607838|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
105713271|NCT03742037|364607839|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
105713272|NCT03742037|364607840|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
105713273|NCT03742037|364607841|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
105713274|NCT03742037|364607842|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
105713275|NCT03742037|364607843|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
105713276|NCT03742037|364607837|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
105713277|NCT03742037|364607838|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
105713278|NCT03742037|364607839|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
105713279|NCT03742037|364607840|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
105713280|NCT03742037|364607841|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
105713281|NCT03742037|364607842|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
105352284|NCT01483599|363293854|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105713282|NCT03742037|364607843|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
105713283|NCT03742037|364607837|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
105713284|NCT03742037|364607838|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
105713285|NCT03742037|364607839|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
105713286|NCT03742037|364607840|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
105713287|NCT03742037|364607841|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
105713288|NCT03742037|364607842|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
105713289|NCT03742037|364607843|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
105713290|NCT03742037|364607837|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
105713291|NCT03742037|364607838|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
105713292|NCT03742037|364607839|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
105713293|NCT03742037|364607840|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
105713294|NCT03742037|364607841|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
105713295|NCT03742037|364607842|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
105713296|NCT03742037|364607843|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
105713297|NCT03742037|364607837|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
105713298|NCT03742037|364607838|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
105713299|NCT03742037|364607839|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
105713300|NCT03742037|364607840|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
105713301|NCT03742037|364607841|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
105713302|NCT03742037|364607842|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
105713303|NCT03742037|364607843|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
105713304|NCT00482014|364609598|FG000|Overall Study|Withdrawal by Subject|1|||
105713305|NCT00482014|364609599|FG001|Overall Study|Withdrawal by Subject|2|||
105713306|NCT00482014|364609600|FG002|Overall Study|Withdrawal by Subject|3|||
105713307|NCT00482014|364609601|FG003|Overall Study|Withdrawal by Subject|4|||
105713308|NCT00482014|364609598|FG000|Overall Study|Adverse Event|3|||
105713309|NCT00482014|364609599|FG001|Overall Study|Adverse Event|0|||
105713310|NCT00482014|364609600|FG002|Overall Study|Adverse Event|2|||
105713311|NCT00482014|364609601|FG003|Overall Study|Adverse Event|8|||
105713312|NCT00482014|364609598|FG000|Overall Study|Death|1|||
105713313|NCT00482014|364609599|FG001|Overall Study|Death|2|||
105713314|NCT00482014|364609600|FG002|Overall Study|Death|1|||
105713315|NCT00482014|364609601|FG003|Overall Study|Death|4|||
105713316|NCT00482014|364609598|FG000|Overall Study|Lack of Efficacy|1|||
105713317|NCT00482014|364609599|FG001|Overall Study|Lack of Efficacy|0|||
105713318|NCT00482014|364609600|FG002|Overall Study|Lack of Efficacy|4|||
105713319|NCT00482014|364609601|FG003|Overall Study|Lack of Efficacy|6|||
105713320|NCT00482014|364609598|FG000|Overall Study|Sponsor Decision|1|||
105713321|NCT00482014|364609599|FG001|Overall Study|Sponsor Decision|2|||
105713322|NCT00482014|364609600|FG002|Overall Study|Sponsor Decision|1|||
105713323|NCT00482014|364609601|FG003|Overall Study|Sponsor Decision|1|||
105713324|NCT01284114|364609602|FG000|Overall Study|viral infection|1|||
105713325|NCT01284114|364609602|FG000|Overall Study|From the results of ALLTITUDE study|1|||
105713326|NCT01284114|364609602|FG000|Overall Study|Symptomatic hypotension|1|||
105713327|NCT01284114|364609602|FG000|Overall Study|dizziness|1|||
105713328|NCT00598975|364609603|FG000|Overall Study|Adverse Event|1|||
105713329|NCT00598975|364609604|FG001|Overall Study|Adverse Event|1|||
105713330|NCT00598975|364609603|FG000|Overall Study|Brain metastases|1|||
105713331|NCT00598975|364609604|FG001|Overall Study|Brain metastases|0|||
105713332|NCT00598975|364609603|FG000|Overall Study|Withdrawal by Subject|1|||
105713333|NCT00598975|364609604|FG001|Overall Study|Withdrawal by Subject|1|||
105713334|NCT00598975|364609603|FG000|Overall Study|Withdrawal of consent|0|||
105713335|NCT00598975|364609604|FG001|Overall Study|Withdrawal of consent|1|||
105788520|NCT03586427|364880103|FG000|Overall Study|Noncompliance with study drug|0|||
105713336|NCT00598975|364609603|FG000|Overall Study|Disease progression|8|||
105713337|NCT00598975|364609604|FG001|Overall Study|Disease progression|3|||
105713338|NCT00598975|364609603|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
105713339|NCT00598975|364609604|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
105713340|NCT03445000|364609605|FG000|Overall Study|Disease progression|8|||
105713341|NCT03445000|364609605|FG000|Overall Study|Adverse Event|3|||
105713342|NCT03445000|364609605|FG000|Overall Study|Death|2|||
105713343|NCT03445000|364609605|FG000|Overall Study|Physician Decision|1|||
105713344|NCT03409744|364609606|FG000|Overall Study|Death|2|||
105713345|NCT03409744|364609606|FG000|Overall Study|Physician Decision|5|||
105713346|NCT03409744|364609606|FG000|Overall Study|Pregnancy|1|||
105713347|NCT03409744|364609606|FG000|Overall Study|Lost to Follow-up|1|||
105476540|NCT02238080|363756785|FG000|Overall Study|Treatment interrupted|6|||
105476541|NCT02238080|363756785|FG000|Overall Study|Withdrawal by Subject|2|||
105476542|NCT02238080|363756785|FG000|Overall Study|Other|4|||
105476543|NCT01598129|363756786|FG000|Overall Study|Disease progression|6|||
105476544|NCT01598129|363756786|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
105476545|NCT01598129|363756786|FG000|Overall Study|Withdrawal by Subject|1|||
105476546|NCT02123472|363756787|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
105476547|NCT02123472|363756788|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
105476548|NCT02433080|363756790|FG000|Overall Study|Lost to Follow-up|1|||
105476549|NCT02433080|363756791|FG001|Overall Study|Lost to Follow-up|2|||
105476550|NCT02433080|363756790|FG000|Overall Study|Withdrawal by Subject|0|||
105476551|NCT02433080|363756791|FG001|Overall Study|Withdrawal by Subject|2|||
105476552|NCT01363349|363756798|FG000|Overall Study|Adverse Event|6|||
105476553|NCT01363349|363756799|FG001|Overall Study|Adverse Event|7|||
105476554|NCT01363349|363756798|FG000|Overall Study|Lack of Efficacy|3|||
105476555|NCT01363349|363756799|FG001|Overall Study|Lack of Efficacy|10|||
105476556|NCT01363349|363756798|FG000|Overall Study|Non compliance/Protocol deviations|2|||
105476557|NCT01363349|363756799|FG001|Overall Study|Non compliance/Protocol deviations|2|||
105476558|NCT01363349|363756798|FG000|Overall Study|Withdrawal by Subject|14|||
105476559|NCT01363349|363756799|FG001|Overall Study|Withdrawal by Subject|6|||
105561503|NCT02276222|364050504|FG001|Overall Study|Lack of Efficacy|3|||
105561504|NCT02276222|364050503|FG000|Overall Study|Protocol Violation|3|||
105561505|NCT02276222|364050504|FG001|Overall Study|Protocol Violation|2|||
105561506|NCT02276222|364050503|FG000|Overall Study|Withdrawal by Subject|79|||
105561507|NCT02276222|364050504|FG001|Overall Study|Withdrawal by Subject|33|||
105561508|NCT02276222|364050503|FG000|Overall Study|non compliance with study medication|6|||
105561509|NCT02276222|364050504|FG001|Overall Study|non compliance with study medication|2|||
105713348|NCT03409744|364609606|FG000|Overall Study|Protocol Violation|1|||
105713349|NCT00264004|364609608|FG000|Overall Study|Adverse Event|2|||
105713350|NCT00264004|364609609|FG001|Overall Study|Adverse Event|3|||
105713351|NCT00264004|364609610|FG002|Overall Study|Adverse Event|6|||
105713352|NCT00264004|364609611|FG003|Overall Study|Adverse Event|4|||
105713353|NCT00264004|364609608|FG000|Overall Study|Withdrawal by Subject|0|||
105713354|NCT00264004|364609609|FG001|Overall Study|Withdrawal by Subject|1|||
105713355|NCT00264004|364609610|FG002|Overall Study|Withdrawal by Subject|2|||
105713356|NCT00264004|364609611|FG003|Overall Study|Withdrawal by Subject|2|||
105713357|NCT00264004|364609608|FG000|Overall Study|Other|2|||
105713358|NCT00264004|364609609|FG001|Overall Study|Other|2|||
105713359|NCT00264004|364609610|FG002|Overall Study|Other|0|||
105713360|NCT00264004|364609611|FG003|Overall Study|Other|3|||
105713361|NCT00264004|364609608|FG000|Overall Study|Development study specific disc. crit.|1|||
105713362|NCT00264004|364609609|FG001|Overall Study|Development study specific disc. crit.|0|||
105713363|NCT00264004|364609610|FG002|Overall Study|Development study specific disc. crit.|1|||
105713364|NCT00264004|364609611|FG003|Overall Study|Development study specific disc. crit.|0|||
105713365|NCT00264004|364609608|FG000|Overall Study|Cond. under inv. worsened|9|||
105713366|NCT00264004|364609609|FG001|Overall Study|Cond. under inv. worsened|5|||
105713367|NCT00264004|364609610|FG002|Overall Study|Cond. under inv. worsened|3|||
105713368|NCT00264004|364609611|FG003|Overall Study|Cond. under inv. worsened|4|||
105713369|NCT00264004|364609608|FG000|Overall Study|Not treated|3|||
105713370|NCT00264004|364609609|FG001|Overall Study|Not treated|0|||
105713371|NCT00264004|364609610|FG002|Overall Study|Not treated|2|||
105713372|NCT00264004|364609611|FG003|Overall Study|Not treated|2|||
105713373|NCT02787850|364609612|FG000|Overall Study|Withdrawal by Subject|0|||
105713374|NCT02787850|364609613|FG001|Overall Study|Withdrawal by Subject|1|||
105713375|NCT03718143|364609614|FG000|Overall Study|Death|1|||
105713376|NCT03718143|364609615|FG001|Overall Study|Death|0|||
105713377|NCT03718143|364609616|FG002|Overall Study|Death|0|||
105713378|NCT03718143|364609614|FG000|Overall Study|Progression of Disease|1|||
105713379|NCT03718143|364609615|FG001|Overall Study|Progression of Disease|0|||
105713380|NCT03718143|364609616|FG002|Overall Study|Progression of Disease|0|||
105713381|NCT03718143|364609614|FG000|Overall Study|Withdrawal of Informed Consent|1|||
105713382|NCT03718143|364609615|FG001|Overall Study|Withdrawal of Informed Consent|2|||
105476560|NCT01363349|363756798|FG000|Overall Study|Lost to Follow-up|5|||
105713383|NCT03718143|364609616|FG002|Overall Study|Withdrawal of Informed Consent|1|||
105713384|NCT02921971|364609620|FG000|Overall Study|Adverse Event|1|||
105713385|NCT02921971|364609621|FG001|Overall Study|Adverse Event|2|||
105713386|NCT02921971|364609620|FG000|Overall Study|Lack of Efficacy|3|||
105713387|NCT02921971|364609621|FG001|Overall Study|Lack of Efficacy|1|||
105713388|NCT02921971|364609620|FG000|Overall Study|Other than specified above|2|||
105713389|NCT02921971|364609621|FG001|Overall Study|Other than specified above|1|||
105713390|NCT02105454|364609624|FG000|Overall Study|Withdrawal by Subject|1|||
105713391|NCT02322710|364609625|FG000|Overall Study|No efficacy assessment post-baseline|0|||
105788521|NCT03586427|364880104|FG001|Overall Study|Noncompliance with study drug|0|||
105788522|NCT03586427|364880105|FG002|Overall Study|Noncompliance with study drug|1|||
105713392|NCT02322710|364609626|FG001|Overall Study|No efficacy assessment post-baseline|1|||
105788523|NCT03586427|364880106|FG003|Overall Study|Noncompliance with study drug|0|||
105788524|NCT03586427|364880107|FG004|Overall Study|Noncompliance with study drug|0|||
105788525|NCT03193996|364880110|FG000|Overall Study|Withdrawal by Subject|4|||
105788526|NCT03193996|364880110|FG000|Overall Study|Lost to Follow-up|4|||
105788527|NCT03193996|364880110|FG000|Overall Study|Physician Decision|2|||
105788528|NCT03193996|364880110|FG000|Overall Study|Pregnancy|1|||
105788529|NCT03193996|364880110|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
105788530|NCT03193996|364880110|FG000|Overall Study|Complicating disease|1|||
105788531|NCT00423137|364880111|FG000|Overall Study|Lost to Follow-up|0|||
105788532|NCT00423137|364880112|FG001|Overall Study|Lost to Follow-up|0|||
105788533|NCT00423137|364880113|FG002|Overall Study|Lost to Follow-up|1|||
105788534|NCT00423137|364880114|FG003|Overall Study|Lost to Follow-up|0|||
105476561|NCT01363349|363756799|FG001|Overall Study|Lost to Follow-up|6|||
105476562|NCT01363349|363756798|FG000|Overall Study|Not reported|36|||
105476563|NCT01363349|363756799|FG001|Overall Study|Not reported|37|||
105476564|NCT01363349|363756798|FG000|Overall Study|missing|1|||
105476565|NCT01363349|363756799|FG001|Overall Study|missing|2|||
105476566|NCT01989208|363756805|FG000|200 mg (7 Days)|Protocol Violation|0|||
105476567|NCT01989208|363756806|FG001|200 mg (7 Days)|Protocol Violation|1|||
105476568|NCT00080899|363756807|FG000|Overall Study|Adverse Event|1|||
105476569|NCT02640508|363756809|FG000|Overall Study|Death|19|||
105476570|NCT02640508|363756809|FG000|Overall Study|Withdrawal by Subject|8|||
105476571|NCT02640508|363756809|FG000|Overall Study|Physician Decision|1|||
105476572|NCT02640508|363756809|FG000|Overall Study|Lost to Follow-up|1|||
105476573|NCT04343235|363756810|FG000|Overall Study|Lost to Follow-up|3|||
105476574|NCT04343235|363756811|FG001|Overall Study|Lost to Follow-up|2|||
105476575|NCT01763996|363756812|FG000|Treatment Period 2|Adverse Event|0|||
105788535|NCT00423137|364880111|FG000|Overall Study|Protocol Violation|0|||
105788536|NCT00423137|364880112|FG001|Overall Study|Protocol Violation|0|||
105788537|NCT00423137|364880113|FG002|Overall Study|Protocol Violation|0|||
105352285|NCT01483599|363293855|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
105476576|NCT01763996|363756813|FG001|Treatment Period 2|Adverse Event|1|||
105476577|NCT00865280|363756814|FG000|Overall Study|Withdrawal by Subject|4|||
105713393|NCT02322710|364609625|FG000|Overall Study|Protocol Violation|20|||
105713394|NCT02322710|364609626|FG001|Overall Study|Protocol Violation|25|||
105713395|NCT02740478|364609627|FG000|Overall Study|Withdrawal by Subject|1|||
105713396|NCT04316585|364609629|FG000|Overall Study|Adverse Event|2|||
105788538|NCT00423137|364880114|FG003|Overall Study|Protocol Violation|1|||
105788539|NCT00423137|364880111|FG000|Overall Study|Adverse Event Study disease worse|1|||
105713397|NCT04316585|364609630|FG001|Overall Study|Adverse Event|1|||
105713398|NCT04316585|364609629|FG000|Overall Study|Lost to Follow-up|1|||
105713399|NCT04316585|364609630|FG001|Overall Study|Lost to Follow-up|0|||
105713400|NCT04316585|364609629|FG000|Overall Study|Withdrawal by Subject|2|||
105713401|NCT04316585|364609630|FG001|Overall Study|Withdrawal by Subject|3|||
105713402|NCT04316585|364609629|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
105713403|NCT04316585|364609630|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
105713404|NCT04316585|364609629|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
105713405|NCT04316585|364609630|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
105713406|NCT02605642|364609634|FG000|Overall Study|Other|11|||
105713407|NCT02605642|364609635|FG001|Overall Study|Other|1|||
105713408|NCT02605642|364609634|FG000|Overall Study|Participant non-compliance|2|||
105713409|NCT02605642|364609635|FG001|Overall Study|Participant non-compliance|4|||
105713410|NCT02605642|364609634|FG000|Overall Study|Physician Decision|10|||
105713411|NCT02605642|364609635|FG001|Overall Study|Physician Decision|0|||
105713412|NCT02605642|364609634|FG000|Overall Study|Lost to Follow-up|12|||
105713413|NCT02605642|364609635|FG001|Overall Study|Lost to Follow-up|1|||
105713414|NCT02605642|364609634|FG000|Overall Study|Adverse Event|14|||
105561510|NCT02276222|364050503|FG000|Overall Study|sponsor decision|0|||
105561511|NCT02276222|364050504|FG001|Overall Study|sponsor decision|3|||
105561512|NCT02276222|364050503|FG000|Overall Study|Lost to Follow-up|15|||
105561513|NCT02276222|364050504|FG001|Overall Study|Lost to Follow-up|5|||
105561514|NCT02276222|364050503|FG000|Overall Study|Physician Decision|2|||
105561515|NCT02276222|364050504|FG001|Overall Study|Physician Decision|1|||
105561516|NCT02276222|364050503|FG000|Overall Study|sheduling conflict|1|||
105561517|NCT02276222|364050504|FG001|Overall Study|sheduling conflict|0|||
105561518|NCT02276222|364050503|FG000|Overall Study|subject withdrew after randomization|1|||
105561519|NCT02276222|364050504|FG001|Overall Study|subject withdrew after randomization|0|||
105561520|NCT03645759|364050505|FG000|Overall Study|Lost to Follow-up|3|||
105561521|NCT03645759|364050506|FG001|Overall Study|Lost to Follow-up|2|||
105561522|NCT02412137|364050507|FG000|Overall Study|Withdrawal by Subject|2|||
105561523|NCT02412137|364050508|FG001|Overall Study|Withdrawal by Subject|0|||
105561524|NCT02412137|364050507|FG000|Overall Study|Lost to Follow-up|21|||
105561525|NCT02412137|364050508|FG001|Overall Study|Lost to Follow-up|14|||
105561526|NCT02412137|364050507|FG000|Overall Study|Physician Decision|28|||
105561527|NCT02412137|364050508|FG001|Overall Study|Physician Decision|9|||
105561528|NCT04981678|364050515|FG000|Overall Study|Lost to Follow-up|0|||
105561529|NCT04981678|364050516|FG001|Overall Study|Lost to Follow-up|1|||
105561530|NCT03355326|364050517|FG000|Overall Study|Protocol Violation|3|||
105561531|NCT03355326|364050518|FG001|Overall Study|Protocol Violation|3|||
105561532|NCT01323530|364052142|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
105561533|NCT01323530|364052143|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
105561534|NCT01323530|364052144|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
105561535|NCT01323530|364052145|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
105561536|NCT01323530|364052146|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
105561537|NCT01323530|364052147|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
105561538|NCT01323530|364052148|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
105561539|NCT01323530|364052142|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
105561540|NCT01323530|364052143|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
105561541|NCT01323530|364052144|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
105561542|NCT01323530|364052145|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
105561543|NCT01323530|364052146|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
105561544|NCT01323530|364052147|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
105561545|NCT01323530|364052148|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
105561546|NCT01323530|364052142|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
105561547|NCT01323530|364052143|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
105561548|NCT01323530|364052144|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
105561549|NCT01323530|364052145|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
105561550|NCT01323530|364052146|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
105561551|NCT01323530|364052147|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
105561552|NCT01323530|364052148|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
105561553|NCT01323530|364052142|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
105561554|NCT01323530|364052143|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
105561555|NCT01323530|364052144|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
105561556|NCT01323530|364052145|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
105561557|NCT01323530|364052146|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
105561558|NCT01323530|364052147|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
105561559|NCT01323530|364052148|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
105561560|NCT01323530|364052142|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
105561561|NCT01323530|364052143|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
105713415|NCT02605642|364609635|FG001|Overall Study|Adverse Event|2|||
105713416|NCT02605642|364609634|FG000|Overall Study|Withdrawal by Subject|23|||
105713417|NCT02605642|364609635|FG001|Overall Study|Withdrawal by Subject|2|||
105713418|NCT02605642|364609634|FG000|Overall Study|Lack of response|24|||
105713419|NCT02605642|364609635|FG001|Overall Study|Lack of response|11|||
105713420|NCT00984204|364609643|FG000|Overall Study|Death|1|||
105713421|NCT00984204|364609643|FG000|Overall Study|Lost to Follow-up|4|||
105713422|NCT00984204|364609643|FG000|Overall Study|Lack of Efficacy|10|||
105713423|NCT01449708|364609646|FG000|Overall Study|Protocol Violation|0|||
105713424|NCT01449708|364609647|FG001|Overall Study|Protocol Violation|1|||
105713425|NCT01449708|364609646|FG000|Overall Study|surgical complication|1|||
105713426|NCT01449708|364609647|FG001|Overall Study|surgical complication|2|||
105713427|NCT01449708|364609646|FG000|Overall Study|respiratory failure|1|||
105713428|NCT01449708|364609647|FG001|Overall Study|respiratory failure|0|||
105713429|NCT00975156|364609648|FG000|Overall Study|Protocol Violation|0|||
105713430|NCT00975156|364609649|FG001|Overall Study|Protocol Violation|1|||
105713431|NCT00223496|364609650|FG000|Overall Study|screen failure|9|||
105713432|NCT00223496|364609650|FG000|Overall Study|Lost to Follow-up|4|||
105713433|NCT00223496|364609650|FG000|Overall Study|Lack of Efficacy|6|||
105713434|NCT00223496|364609650|FG000|Overall Study|Withdrawal by Subject|1|||
105713435|NCT00223496|364609650|FG000|Overall Study|Physician Decision|2|||
105713436|NCT01407926|364609652|FG000|Overall Study|Lost to Follow-up|55|||
105476578|NCT00865280|363756815|FG001|Overall Study|Withdrawal by Subject|1|||
105476579|NCT00865280|363756814|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
105476580|NCT00865280|363756815|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
105476581|NCT00865280|363756814|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
105476582|NCT00865280|363756815|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
105476583|NCT00865280|363756814|FG000|Overall Study|Exclusion Condition|1|||
105476584|NCT00865280|363756815|FG001|Overall Study|Exclusion Condition|0|||
105476585|NCT00865280|363756814|FG000|Overall Study|Adverse Event|0|||
105476586|NCT00865280|363756815|FG001|Overall Study|Adverse Event|1|||
105476587|NCT01616693|363756816|FG000|Evaluated for Safety|Physician Decision|1|||
105476588|NCT01616693|363756817|FG001|Evaluated for Safety|Physician Decision|0|||
105476589|NCT01616693|363756818|FG002|Evaluated for Safety|Physician Decision|1|||
105476590|NCT01616693|363756819|FG003|Evaluated for Safety|Physician Decision|0|||
105476591|NCT01616693|363756816|FG000|Received Both Vaccines|Adverse Event|2|||
105476592|NCT01616693|363756817|FG001|Received Both Vaccines|Adverse Event|0|||
105476593|NCT01616693|363756818|FG002|Received Both Vaccines|Adverse Event|0|||
105476594|NCT01616693|363756819|FG003|Received Both Vaccines|Adverse Event|0|||
105476595|NCT01616693|363756816|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
105476596|NCT01616693|363756817|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
105476597|NCT01616693|363756818|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
105476598|NCT01616693|363756819|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
105476599|NCT01616693|363756816|FG000|Received Both Vaccines|Lost to Follow-up|4|||
105476600|NCT01616693|363756817|FG001|Received Both Vaccines|Lost to Follow-up|3|||
105476601|NCT01616693|363756818|FG002|Received Both Vaccines|Lost to Follow-up|4|||
105476602|NCT01616693|363756819|FG003|Received Both Vaccines|Lost to Follow-up|4|||
105476603|NCT01616693|363756816|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
105476604|NCT01616693|363756817|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
105476605|NCT01616693|363756818|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
105476606|NCT01616693|363756819|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
105476607|NCT04556383|363756820|FG000|PCP|Lack of Efficacy|28|||
105476608|NCT04556383|363756821|FG001|PCP|Lack of Efficacy|23|||
105476609|NCT04556383|363756822|FG002|PCP|Lack of Efficacy|23|||
105476610|NCT04556383|363756823|FG003|PCP|Lack of Efficacy|0|||
105476611|NCT04556383|363756820|FG000|PCP|Study terminated by sponsor|15|||
105476612|NCT04556383|363756821|FG001|PCP|Study terminated by sponsor|13|||
105476613|NCT04556383|363756822|FG002|PCP|Study terminated by sponsor|16|||
105476614|NCT04556383|363756823|FG003|PCP|Study terminated by sponsor|0|||
105476615|NCT04556383|363756820|FG000|PCP|Withdrawal by Subject|8|||
105476616|NCT04556383|363756821|FG001|PCP|Withdrawal by Subject|6|||
105476617|NCT04556383|363756822|FG002|PCP|Withdrawal by Subject|6|||
105476618|NCT04556383|363756823|FG003|PCP|Withdrawal by Subject|0|||
105476619|NCT04556383|363756820|FG000|PCP|Adverse Event|1|||
105476620|NCT04556383|363756821|FG001|PCP|Adverse Event|7|||
105476621|NCT04556383|363756822|FG002|PCP|Adverse Event|7|||
105713437|NCT05131204|364609653|FG000|Overall Study|Sponsor request|2|||
105713438|NCT05131204|364609654|FG001|Overall Study|Sponsor request|1|||
105713439|NCT01534676|364609655|FG000|Overall Study|Study closed due to poor enrollment|2|||
105713440|NCT01534676|364609656|FG001|Overall Study|Study closed due to poor enrollment|1|||
105713441|NCT01885000|364609658|FG000|Overall Study|Adverse Event|1|||
105713442|NCT01885000|364609659|FG001|Overall Study|Adverse Event|0|||
105713443|NCT01885000|364609658|FG000|Overall Study|Withdrawal by Subject|1|||
105713444|NCT01885000|364609659|FG001|Overall Study|Withdrawal by Subject|1|||
105713445|NCT01885000|364609658|FG000|Overall Study|Protocol Violation|0|||
105713446|NCT01885000|364609659|FG001|Overall Study|Protocol Violation|1|||
105713447|NCT05702515|364609660|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
105713448|NCT01396005|364609661|FG000|Overall Study|Withdrawal by Subject|0|||
105713449|NCT01396005|364609662|FG001|Overall Study|Withdrawal by Subject|1|||
105713450|NCT01396005|364609661|FG000|Overall Study|Non-compliance with protocol|0|||
105713451|NCT01396005|364609662|FG001|Overall Study|Non-compliance with protocol|1|||
105713452|NCT03757988|364609663|FG000|Overall Study|Withdrawal by Subject|1|||
105713453|NCT03946670|364609664|FG000|Overall Study|Progressive Disease|26|||
105713454|NCT03946670|364609665|FG001|Overall Study|Progressive Disease|23|||
105713455|NCT03946670|364609664|FG000|Overall Study|Adverse Event|7|||
105713456|NCT03946670|364609665|FG001|Overall Study|Adverse Event|9|||
105713457|NCT03946670|364609664|FG000|Overall Study|Death|5|||
105713458|NCT03946670|364609665|FG001|Overall Study|Death|6|||
105713459|NCT03946670|364609664|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
105713460|NCT03946670|364609665|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
105713461|NCT03946670|364609664|FG000|Overall Study|Subject Decision|4|||
105713462|NCT03946670|364609665|FG001|Overall Study|Subject Decision|4|||
105713463|NCT03946670|364609664|FG000|Overall Study|Physician Decision|3|||
105476622|NCT04556383|363756823|FG003|PCP|Adverse Event|0|||
105713464|NCT03946670|364609665|FG001|Overall Study|Physician Decision|3|||
105788540|NCT00423137|364880112|FG001|Overall Study|Adverse Event Study disease worse|0|||
105476623|NCT04556383|363756820|FG000|PCP|Other, Not Specified|1|||
105713465|NCT03946670|364609664|FG000|Overall Study|New Therapy for Study Indication|1|||
105713466|NCT03946670|364609665|FG001|Overall Study|New Therapy for Study Indication|0|||
105713467|NCT03946670|364609664|FG000|Overall Study|Not treated|1|||
105713468|NCT03946670|364609665|FG001|Overall Study|Not treated|1|||
105713469|NCT01239160|364609666|FG000|Overall Study|Lost to Follow-up|3|||
105713470|NCT01239160|364609667|FG001|Overall Study|Lost to Follow-up|5|||
105713471|NCT01239160|364609668|FG002|Overall Study|Lost to Follow-up|0|||
105713472|NCT01239160|364609666|FG000|Overall Study|Withdrawal by Subject|17|||
105713473|NCT01239160|364609667|FG001|Overall Study|Withdrawal by Subject|6|||
105476624|NCT04556383|363756821|FG001|PCP|Other, Not Specified|2|||
105476625|NCT04556383|363756822|FG002|PCP|Other, Not Specified|1|||
105476626|NCT04556383|363756823|FG003|PCP|Other, Not Specified|0|||
105476627|NCT04556383|363756820|FG000|PCP|Protocol Violation|1|||
105476628|NCT04556383|363756821|FG001|PCP|Protocol Violation|0|||
105476629|NCT04556383|363756822|FG002|PCP|Protocol Violation|1|||
105476630|NCT04556383|363756823|FG003|PCP|Protocol Violation|0|||
105476631|NCT04556383|363756820|FG000|PCP|Lost to Follow-up|1|||
105476632|NCT04556383|363756821|FG001|PCP|Lost to Follow-up|0|||
105476633|NCT04556383|363756822|FG002|PCP|Lost to Follow-up|0|||
105476634|NCT04556383|363756823|FG003|PCP|Lost to Follow-up|0|||
105476635|NCT04556383|363756820|FG000|PCP|Physician Decision|0|||
105476636|NCT04556383|363756821|FG001|PCP|Physician Decision|1|||
105476637|NCT04556383|363756822|FG002|PCP|Physician Decision|0|||
105476638|NCT04556383|363756823|FG003|PCP|Physician Decision|0|||
105476639|NCT04556383|363756820|FG000|PCP|Site terminated by sponsor|0|||
105476640|NCT04556383|363756821|FG001|PCP|Site terminated by sponsor|1|||
105476641|NCT04556383|363756822|FG002|PCP|Site terminated by sponsor|0|||
105476642|NCT04556383|363756823|FG003|PCP|Site terminated by sponsor|0|||
105476643|NCT04556383|363756820|FG000|OLE|Study terminated by sponsor|0|||
105476644|NCT04556383|363756821|FG001|OLE|Study terminated by sponsor|0|||
105476645|NCT04556383|363756822|FG002|OLE|Study terminated by sponsor|0|||
105476646|NCT04556383|363756823|FG003|OLE|Study terminated by sponsor|68|||
105476647|NCT04556383|363756820|FG000|OLE|Withdrawal by Subject|0|||
105476648|NCT04556383|363756821|FG001|OLE|Withdrawal by Subject|0|||
105476649|NCT04556383|363756822|FG002|OLE|Withdrawal by Subject|0|||
105476650|NCT04556383|363756823|FG003|OLE|Withdrawal by Subject|10|||
105476651|NCT04556383|363756820|FG000|OLE|Lack of Efficacy|0|||
105476652|NCT04556383|363756821|FG001|OLE|Lack of Efficacy|0|||
105561562|NCT01323530|364052144|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
105561563|NCT01323530|364052145|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
105561564|NCT01323530|364052146|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
105476653|NCT04556383|363756822|FG002|OLE|Lack of Efficacy|0|||
105476654|NCT04556383|363756823|FG003|OLE|Lack of Efficacy|7|||
105476655|NCT04556383|363756820|FG000|OLE|Adverse Event|0|||
105476656|NCT04556383|363756821|FG001|OLE|Adverse Event|0|||
105476657|NCT04556383|363756822|FG002|OLE|Adverse Event|0|||
105476658|NCT04556383|363756823|FG003|OLE|Adverse Event|2|||
105476659|NCT04556383|363756820|FG000|OLE|Other, Not Specified|0|||
105476660|NCT04556383|363756821|FG001|OLE|Other, Not Specified|0|||
105713474|NCT01239160|364609668|FG002|Overall Study|Withdrawal by Subject|2|||
105713475|NCT01239160|364609666|FG000|Overall Study|Physician Decision|5|||
105713476|NCT01239160|364609667|FG001|Overall Study|Physician Decision|7|||
105713477|NCT01239160|364609668|FG002|Overall Study|Physician Decision|2|||
105713478|NCT01239160|364609666|FG000|Overall Study|Early Termination Due to Study Closure|0|||
105476661|NCT04556383|363756822|FG002|OLE|Other, Not Specified|0|||
105476662|NCT04556383|363756823|FG003|OLE|Other, Not Specified|2|||
105476663|NCT04556383|363756820|FG000|OLE|Death|0|||
105476664|NCT04556383|363756821|FG001|OLE|Death|0|||
105476665|NCT04556383|363756822|FG002|OLE|Death|0|||
105476666|NCT04556383|363756823|FG003|OLE|Death|1|||
105713479|NCT01239160|364609667|FG001|Overall Study|Early Termination Due to Study Closure|1|||
105713480|NCT01239160|364609668|FG002|Overall Study|Early Termination Due to Study Closure|6|||
105713481|NCT02475655|364609669|FG000|Overall Study|Lost to Follow-up|0|||
105713482|NCT02475655|364609670|FG001|Overall Study|Lost to Follow-up|1|||
105713483|NCT00577993|364609690|FG000|Overall Study|Adverse Event|1|||
105713484|NCT00577993|364609691|FG001|Overall Study|Adverse Event|0|||
105713485|NCT00577993|364609692|FG002|Overall Study|Adverse Event|0|||
105713486|NCT00577993|364609690|FG000|Overall Study|Death|0|||
105713487|NCT00577993|364609691|FG001|Overall Study|Death|1|||
105713488|NCT00577993|364609692|FG002|Overall Study|Death|1|||
105713489|NCT00577993|364609690|FG000|Overall Study|Lack of Efficacy|0|||
105713490|NCT00577993|364609691|FG001|Overall Study|Lack of Efficacy|1|||
105713491|NCT00577993|364609692|FG002|Overall Study|Lack of Efficacy|0|||
105713492|NCT00577993|364609690|FG000|Overall Study|Protocol Violation|2|||
105713493|NCT00577993|364609691|FG001|Overall Study|Protocol Violation|3|||
105713494|NCT00577993|364609692|FG002|Overall Study|Protocol Violation|0|||
105713495|NCT00577993|364609690|FG000|Overall Study|Withdrawal by Subject|1|||
105713496|NCT00577993|364609691|FG001|Overall Study|Withdrawal by Subject|0|||
105713497|NCT00577993|364609692|FG002|Overall Study|Withdrawal by Subject|2|||
105713498|NCT00577993|364609690|FG000|Overall Study|Conversion|2|||
105713499|NCT00577993|364609691|FG001|Overall Study|Conversion|5|||
105713500|NCT00577993|364609692|FG002|Overall Study|Conversion|0|||
105713501|NCT00577993|364609690|FG000|Overall Study|Uninsured|1|||
105788541|NCT00423137|364880113|FG002|Overall Study|Adverse Event Study disease worse|3|||
105788542|NCT00423137|364880114|FG003|Overall Study|Adverse Event Study disease worse|1|||
105788543|NCT00423137|364880111|FG000|Overall Study|Adverse Event Other|0|||
105788544|NCT00423137|364880112|FG001|Overall Study|Adverse Event Other|0|||
105788545|NCT00423137|364880113|FG002|Overall Study|Adverse Event Other|2|||
105788546|NCT00423137|364880114|FG003|Overall Study|Adverse Event Other|0|||
105788547|NCT00348348|364880115|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
105788548|NCT00348348|364880116|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
105788549|NCT00348348|364880115|FG000|Overall Study|Lack of Efficacy|1|||
105788550|NCT00348348|364880116|FG001|Overall Study|Lack of Efficacy|1|||
105788551|NCT00348348|364880115|FG000|Overall Study|Lost to Follow-up|8|||
105788552|NCT00348348|364880116|FG001|Overall Study|Lost to Follow-up|10|||
105788553|NCT00348348|364880115|FG000|Overall Study|Withdrawal by Subject|4|||
105788554|NCT00348348|364880116|FG001|Overall Study|Withdrawal by Subject|1|||
105788555|NCT00348348|364880115|FG000|Overall Study|Other|7|||
105788556|NCT00348348|364880116|FG001|Overall Study|Other|4|||
105788557|NCT00348348|364880115|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
105788558|NCT00348348|364880116|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
105788559|NCT00348348|364880115|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
105788560|NCT00348348|364880116|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
105788561|NCT00348348|364880115|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
105788562|NCT00348348|364880116|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
105788563|NCT00348348|364880115|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
105788564|NCT00348348|364880116|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
105788565|NCT00348348|364880115|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
105788566|NCT00348348|364880116|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
105788567|NCT00348348|364880115|FG000|Overall Study|Adverse event probably related to study|1|||
105788568|NCT00348348|364880116|FG001|Overall Study|Adverse event probably related to study|0|||
105788569|NCT03710824|364880117|FG000|Overall Study|Withdrawal by Subject|1|||
105788570|NCT03710824|364880117|FG000|Overall Study|Lost to Follow-up|3|||
105788571|NCT03710824|364880117|FG000|Overall Study|Adverse Event|25|||
105788572|NCT03710824|364880117|FG000|Overall Study|Treatment discontinuation|2|||
105788573|NCT03358407|364880118|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105788574|NCT03358407|364880119|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105788575|NCT03358407|364880120|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
105788576|NCT03358407|364880121|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105788577|NCT03358407|364880122|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105788578|NCT03358407|364880123|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105788579|NCT03358407|364880124|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105788580|NCT03358407|364880125|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105713502|NCT00577993|364609691|FG001|Overall Study|Uninsured|0|||
105713503|NCT00577993|364609692|FG002|Overall Study|Uninsured|0|||
105713504|NCT03033745|364609697|FG000|Overall Study|Protocol Violation|0|||
105713505|NCT03033745|364609698|FG001|Overall Study|Protocol Violation|0|||
105713506|NCT03033745|364609699|FG002|Overall Study|Protocol Violation|1|||
105788581|NCT03358407|364880126|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105713507|NCT03033745|364609697|FG000|Overall Study|Adverse Event|1|||
105713508|NCT03033745|364609698|FG001|Overall Study|Adverse Event|0|||
105713509|NCT03033745|364609699|FG002|Overall Study|Adverse Event|1|||
105713510|NCT03033745|364609697|FG000|Overall Study|Withdrawal by Subject|0|||
105713511|NCT03033745|364609698|FG001|Overall Study|Withdrawal by Subject|1|||
105713512|NCT03033745|364609699|FG002|Overall Study|Withdrawal by Subject|0|||
105476667|NCT04556383|363756820|FG000|OLE|Lost to Follow-up|0|||
105476668|NCT04556383|363756821|FG001|OLE|Lost to Follow-up|0|||
105476669|NCT04556383|363756822|FG002|OLE|Lost to Follow-up|0|||
105476670|NCT04556383|363756823|FG003|OLE|Lost to Follow-up|1|||
105713513|NCT00684515|364609703|FG000|Overall Study|Adverse Event|3|||
105713514|NCT00684515|364609704|FG001|Overall Study|Adverse Event|3|||
105713515|NCT00684515|364609705|FG002|Overall Study|Adverse Event|1|||
105713516|NCT00684515|364609703|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
105713517|NCT00684515|364609704|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
105713518|NCT00684515|364609705|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
105476671|NCT01510769|363756824|FG000|Overall Study|Adverse Event|7|||
105476672|NCT01510769|363756825|FG001|Overall Study|Adverse Event|6|||
105476673|NCT01510769|363756826|FG002|Overall Study|Adverse Event|4|||
105476674|NCT01510769|363756824|FG000|Overall Study|Gout Flare|0|||
105476675|NCT01510769|363756825|FG001|Overall Study|Gout Flare|3|||
105476676|NCT01510769|363756826|FG002|Overall Study|Gout Flare|1|||
105476677|NCT01510769|363756824|FG000|Overall Study|Protocol Violation|11|||
105476678|NCT01510769|363756825|FG001|Overall Study|Protocol Violation|10|||
105476679|NCT01510769|363756826|FG002|Overall Study|Protocol Violation|9|||
105476680|NCT01510769|363756824|FG000|Overall Study|Lost to Follow-up|5|||
105476681|NCT01510769|363756825|FG001|Overall Study|Lost to Follow-up|1|||
105476682|NCT01510769|363756826|FG002|Overall Study|Lost to Follow-up|5|||
105476683|NCT01510769|363756824|FG000|Overall Study|Withdrawal by Subject|3|||
105476684|NCT01510769|363756825|FG001|Overall Study|Withdrawal by Subject|4|||
105476685|NCT01510769|363756826|FG002|Overall Study|Withdrawal by Subject|3|||
105476686|NCT01510769|363756824|FG000|Overall Study|Death|1|||
105476687|NCT01510769|363756825|FG001|Overall Study|Death|1|||
105476688|NCT01510769|363756826|FG002|Overall Study|Death|0|||
105476689|NCT00929643|363756827|FG000|Overall Study|Protocol Violation|2|||
105476690|NCT02874144|363756828|FG000|Overall Study|Lost to Follow-up|3|||
105476691|NCT02874144|363756829|FG001|Overall Study|Lost to Follow-up|5|||
105713519|NCT04016311|364609708|FG000|Overall Study|Withdrawal by Subject|1|||
105476692|NCT01014910|363756831|FG000|Overall Study|Withdrawal by Subject|0|||
105476693|NCT01014910|363756832|FG001|Overall Study|Withdrawal by Subject|2|||
105713520|NCT04016311|364609709|FG001|Overall Study|Withdrawal by Subject|0|||
105713521|NCT04029519|364609711|FG000|Overall Study|Protocol Violation|1|||
105713522|NCT04029519|364609711|FG000|Overall Study|Withdrawal by Subject|3|||
105713523|NCT04029519|364609711|FG000|Overall Study|Lost to Follow-up|1|||
105713524|NCT03222349|364609712|FG000|Overall Study|Treatment B not done|5|||
105713525|NCT03222349|364609713|FG001|Overall Study|Treatment B not done|0|||
105713526|NCT03222349|364609712|FG000|Overall Study|Lost to Follow-up|1|||
105713527|NCT03222349|364609713|FG001|Overall Study|Lost to Follow-up|2|||
105713528|NCT03222349|364609712|FG000|Overall Study|Withdrawal by Subject|1|||
105713529|NCT03222349|364609713|FG001|Overall Study|Withdrawal by Subject|0|||
105713530|NCT03222349|364609712|FG000|Overall Study|Treatment A not done|0|||
105713531|NCT03222349|364609713|FG001|Overall Study|Treatment A not done|5|||
105713532|NCT03222349|364609712|FG000|Overall Study|Study terminated by sponsor|1|||
105561565|NCT01323530|364052147|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
105561566|NCT01323530|364052148|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
105561567|NCT01323530|364052142|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
105561568|NCT01323530|364052143|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
105561569|NCT01323530|364052144|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
105561570|NCT01323530|364052145|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
105561571|NCT01323530|364052146|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
105561572|NCT01323530|364052147|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
105561573|NCT01323530|364052148|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
105561574|NCT01323530|364052142|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
105561575|NCT01323530|364052143|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
105561576|NCT01323530|364052144|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
105561577|NCT01323530|364052145|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
105561578|NCT01323530|364052146|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
105561579|NCT01323530|364052147|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
105561580|NCT01323530|364052148|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
105561581|NCT01323530|364052142|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
105561582|NCT01323530|364052143|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
105561583|NCT01323530|364052144|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
105561584|NCT01323530|364052145|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
105561585|NCT01323530|364052146|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
105561586|NCT01323530|364052147|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
105561587|NCT01323530|364052148|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
105561588|NCT00437645|364052151|FG000|Overall Study|Adverse Event|15|||
105561589|NCT00437645|364052152|FG001|Overall Study|Adverse Event|84|||
105561590|NCT00437645|364052151|FG000|Overall Study|Withdrawal by Subject|10|||
105561591|NCT00437645|364052152|FG001|Overall Study|Withdrawal by Subject|22|||
105561592|NCT00437645|364052151|FG000|Overall Study|Protocol Violation|3|||
105561593|NCT00437645|364052152|FG001|Overall Study|Protocol Violation|3|||
105561594|NCT00437645|364052151|FG000|Overall Study|Lost to Follow-up|2|||
105561595|NCT00437645|364052152|FG001|Overall Study|Lost to Follow-up|3|||
105561596|NCT00437645|364052151|FG000|Overall Study|Administrative problems|2|||
105561597|NCT00437645|364052152|FG001|Overall Study|Administrative problems|1|||
105561598|NCT00437645|364052151|FG000|Overall Study|Lack of Efficacy|2|||
105561599|NCT00437645|364052152|FG001|Overall Study|Lack of Efficacy|1|||
105561600|NCT00437645|364052151|FG000|Overall Study|Condition no longer requires study drug|1|||
105561601|NCT00437645|364052152|FG001|Overall Study|Condition no longer requires study drug|1|||
105561602|NCT04791761|364052155|FG000|Overall Study|Lost to Follow-up|8|||
105561603|NCT04791761|364052156|FG001|Overall Study|Lost to Follow-up|6|||
105561604|NCT04791761|364052157|FG002|Overall Study|Lost to Follow-up|10|||
105713533|NCT03222349|364609713|FG001|Overall Study|Study terminated by sponsor|0|||
105476694|NCT00486811|363756833|FG000|Overall Study|Adverse Event|28|||
105476695|NCT00486811|363756834|FG001|Overall Study|Adverse Event|60|||
105476696|NCT00486811|363756835|FG002|Overall Study|Adverse Event|135|||
105476697|NCT00486811|363756833|FG000|Overall Study|Lack of Efficacy|34|||
105476698|NCT00486811|363756834|FG001|Overall Study|Lack of Efficacy|14|||
105476699|NCT00486811|363756835|FG002|Overall Study|Lack of Efficacy|7|||
105476700|NCT00486811|363756833|FG000|Overall Study|Lost to Follow-up|4|||
105476701|NCT00486811|363756834|FG001|Overall Study|Lost to Follow-up|6|||
105476702|NCT00486811|363756835|FG002|Overall Study|Lost to Follow-up|4|||
105476703|NCT00486811|363756833|FG000|Overall Study|Withdrawal by Subject|33|||
105476704|NCT00486811|363756834|FG001|Overall Study|Withdrawal by Subject|44|||
105476705|NCT00486811|363756835|FG002|Overall Study|Withdrawal by Subject|58|||
105476706|NCT00486811|363756833|FG000|Overall Study|Study drug non-compliant|5|||
105476707|NCT00486811|363756834|FG001|Overall Study|Study drug non-compliant|6|||
105476708|NCT00486811|363756835|FG002|Overall Study|Study drug non-compliant|3|||
105713534|NCT01699087|364609716|FG000|Overall Study|Lost to Follow-up|7|||
105713535|NCT01699087|364609716|FG000|Overall Study|Screen failure (prior to treatment)|15|||
105713536|NCT01699087|364609716|FG000|Overall Study|Unable to make future visits|2|||
105713537|NCT00070941|364609717|FG000|Overall Study|Adverse Event|10|||
105713538|NCT00070941|364609718|FG001|Overall Study|Adverse Event|8|||
105713539|NCT00070941|364609719|FG002|Overall Study|Adverse Event|4|||
105713540|NCT02064387|364609720|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713541|NCT02064387|364609721|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713542|NCT02064387|364609722|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713543|NCT02064387|364609723|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713544|NCT02064387|364609724|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713545|NCT02064387|364609725|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713546|NCT02064387|364609726|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713547|NCT02064387|364609727|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
105713548|NCT02064387|364609728|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713549|NCT02064387|364609729|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
105713550|NCT02064387|364609730|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713551|NCT02064387|364609731|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713552|NCT02064387|364609720|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713553|NCT02064387|364609721|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713554|NCT02064387|364609722|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713555|NCT02064387|364609723|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713556|NCT02064387|364609724|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713557|NCT02064387|364609725|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713558|NCT02064387|364609726|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713559|NCT02064387|364609727|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
105713560|NCT02064387|364609728|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713561|NCT02064387|364609729|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713562|NCT02064387|364609730|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713563|NCT02064387|364609731|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713564|NCT02064387|364609720|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713565|NCT02064387|364609721|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713566|NCT02064387|364609722|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713567|NCT02064387|364609723|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713568|NCT02064387|364609724|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713569|NCT02064387|364609725|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713570|NCT02064387|364609726|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713571|NCT02064387|364609727|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713572|NCT02064387|364609728|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
105713573|NCT02064387|364609729|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713574|NCT02064387|364609730|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713575|NCT02064387|364609731|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713576|NCT02064387|364609720|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
105713577|NCT02064387|364609721|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
105713578|NCT02064387|364609722|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
105713579|NCT02064387|364609723|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
105713580|NCT02064387|364609724|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
105713581|NCT02064387|364609725|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
105713582|NCT02064387|364609726|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
105476709|NCT00486811|363756833|FG000|Overall Study|All other|18|||
105476710|NCT00486811|363756834|FG001|Overall Study|All other|11|||
105476711|NCT00486811|363756835|FG002|Overall Study|All other|7|||
105713583|NCT02064387|364609727|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
105713584|NCT02064387|364609728|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
105561605|NCT04791761|364052155|FG000|Overall Study|Withdrawal by Subject|0|||
105561606|NCT04791761|364052156|FG001|Overall Study|Withdrawal by Subject|1|||
105561607|NCT04791761|364052157|FG002|Overall Study|Withdrawal by Subject|1|||
105561608|NCT04791761|364052155|FG000|Overall Study|Protocol Violation|0|||
105561609|NCT04791761|364052156|FG001|Overall Study|Protocol Violation|1|||
105561610|NCT04791761|364052157|FG002|Overall Study|Protocol Violation|1|||
105561611|NCT01756352|364052159|FG000|Overall Study|moved away and lost to followup|1|||
105788582|NCT03358407|364880127|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105561612|NCT04279314|364052160|FG000|Overall Study|Adverse Event|55|||
105561613|NCT04279314|364052160|FG000|Overall Study|Withdrawal by Subject|5|||
105561614|NCT04279314|364052160|FG000|Overall Study|Lack of Efficacy|5|||
105561615|NCT04279314|364052160|FG000|Overall Study|Protocol Violation|3|||
105561616|NCT04279314|364052160|FG000|Overall Study|Other (not COVID-19 related)|2|||
105561617|NCT00999466|364052163|FG000|Main Part|Withdrawal by Subject|0|||
105561618|NCT00999466|364052164|FG001|Main Part|Withdrawal by Subject|0|||
105561619|NCT00999466|364052165|FG002|Main Part|Withdrawal by Subject|2|||
105561620|NCT00999466|364052163|FG000|Main Part|Adverse Event|0|||
105561621|NCT00999466|364052164|FG001|Main Part|Adverse Event|4|||
105561622|NCT00999466|364052165|FG002|Main Part|Adverse Event|2|||
105561623|NCT00499031|364052166|FG000|Overall Study|Improper pre-protocol treatment|1|||
105561624|NCT00499031|364052166|FG000|Overall Study|Required test not done|1|||
105561625|NCT00499031|364052166|FG000|Overall Study|Never treated|1|||
105561626|NCT03382782|364052169|FG000|Cohort 1|Withdrawal by Subject|11|||
105561627|NCT03382782|364052170|FG001|Cohort 1|Withdrawal by Subject|5|||
105561628|NCT03382782|364052171|FG002|Cohort 1|Withdrawal by Subject|0|||
105561629|NCT03382782|364052169|FG000|Cohort 2|Withdrawal by Subject|1|||
105561630|NCT03382782|364052170|FG001|Cohort 2|Withdrawal by Subject|1|||
105561631|NCT03382782|364052171|FG002|Cohort 2|Withdrawal by Subject|0|||
105561632|NCT03382782|364052169|FG000|Cohort 3|Withdrawal by Subject|1|||
105561633|NCT03382782|364052170|FG001|Cohort 3|Withdrawal by Subject|2|||
105713585|NCT02064387|364609729|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
105561634|NCT03382782|364052171|FG002|Cohort 3|Withdrawal by Subject|0|||
105561635|NCT01357616|364052172|FG000|Overall Study|Adverse Event|1|||
105561636|NCT01357616|364052173|FG001|Overall Study|Adverse Event|1|||
105561637|NCT01357616|364052172|FG000|Overall Study|Lost to Follow-up|4|||
105561638|NCT01357616|364052173|FG001|Overall Study|Lost to Follow-up|3|||
105561639|NCT01357616|364052172|FG000|Overall Study|Protocol Violation|0|||
105561640|NCT01357616|364052173|FG001|Overall Study|Protocol Violation|2|||
105561641|NCT01357616|364052172|FG000|Overall Study|Inadequate Control of IOP|1|||
105713586|NCT02064387|364609730|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
105713587|NCT02064387|364609731|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
105713588|NCT02064387|364609720|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713589|NCT02064387|364609721|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713590|NCT02064387|364609722|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713591|NCT02064387|364609723|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713592|NCT02064387|364609724|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713593|NCT02064387|364609725|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713594|NCT02064387|364609726|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713595|NCT02064387|364609727|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713596|NCT02064387|364609728|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713597|NCT02064387|364609729|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713598|NCT02064387|364609730|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
105713599|NCT02064387|364609731|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713600|NCT00756938|364609736|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
105713601|NCT00756938|364609737|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
105713602|NCT00756938|364609738|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
105713603|NCT00756938|364609739|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
105713604|NCT00756938|364609736|FG000|12-week Base Study|Protocol Violation|0|||
105713605|NCT00756938|364609737|FG001|12-week Base Study|Protocol Violation|0|||
105352286|NCT01483599|363293856|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105561642|NCT01357616|364052173|FG001|Overall Study|Inadequate Control of IOP|2|||
105561643|NCT01357616|364052172|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
105561644|NCT01357616|364052173|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
105713606|NCT00756938|364609738|FG002|12-week Base Study|Protocol Violation|1|||
105713607|NCT00756938|364609739|FG003|12-week Base Study|Protocol Violation|0|||
105713608|NCT00756938|364609736|FG000|12-week Base Study|Lost to Follow-up|1|||
105713609|NCT00756938|364609737|FG001|12-week Base Study|Lost to Follow-up|0|||
105713610|NCT00756938|364609738|FG002|12-week Base Study|Lost to Follow-up|0|||
105713611|NCT00756938|364609739|FG003|12-week Base Study|Lost to Follow-up|0|||
105713612|NCT00756938|364609736|FG000|Optional Extension|Lack of Efficacy|0|||
105713613|NCT00756938|364609737|FG001|Optional Extension|Lack of Efficacy|0|||
105713614|NCT00756938|364609738|FG002|Optional Extension|Lack of Efficacy|0|||
105713615|NCT00756938|364609739|FG003|Optional Extension|Lack of Efficacy|1|||
105713616|NCT00756938|364609736|FG000|Optional Extension|End of Study|0|||
105713617|NCT00756938|364609737|FG001|Optional Extension|End of Study|0|||
105713618|NCT00756938|364609738|FG002|Optional Extension|End of Study|0|||
105713619|NCT00756938|364609739|FG003|Optional Extension|End of Study|11|||
105713620|NCT00756938|364609736|FG000|Optional Extension|Protocol-specific criteria met|0|||
105713621|NCT00756938|364609737|FG001|Optional Extension|Protocol-specific criteria met|0|||
105713622|NCT00756938|364609738|FG002|Optional Extension|Protocol-specific criteria met|0|||
105713623|NCT00756938|364609739|FG003|Optional Extension|Protocol-specific criteria met|9|||
105713624|NCT00756938|364609736|FG000|Optional Extension|Physician Decision|0|||
105713625|NCT00756938|364609737|FG001|Optional Extension|Physician Decision|0|||
105713626|NCT00756938|364609738|FG002|Optional Extension|Physician Decision|0|||
105713627|NCT00756938|364609739|FG003|Optional Extension|Physician Decision|3|||
105713628|NCT00756938|364609736|FG000|Optional Extension|Lost to Follow-up|0|||
105713629|NCT00756938|364609737|FG001|Optional Extension|Lost to Follow-up|0|||
105713630|NCT00756938|364609738|FG002|Optional Extension|Lost to Follow-up|0|||
105713631|NCT00756938|364609739|FG003|Optional Extension|Lost to Follow-up|1|||
105713632|NCT00756938|364609736|FG000|Optional Extension|Protocol Violation|0|||
105713633|NCT00756938|364609737|FG001|Optional Extension|Protocol Violation|0|||
105713634|NCT00756938|364609738|FG002|Optional Extension|Protocol Violation|0|||
105713635|NCT00756938|364609739|FG003|Optional Extension|Protocol Violation|1|||
105713636|NCT00756938|364609736|FG000|Optional Extension|Withdrawal by Subject|0|||
105713637|NCT00756938|364609737|FG001|Optional Extension|Withdrawal by Subject|0|||
105476712|NCT02445794|363756836|FG000|Overall Study|Adverse Event|0|||
105476713|NCT02445794|363756837|FG001|Overall Study|Adverse Event|0|||
105476714|NCT02445794|363756838|FG002|Overall Study|Adverse Event|2|||
105476715|NCT02445794|363756839|FG003|Overall Study|Adverse Event|0|||
105476716|NCT03753789|363756840|FG000|Overall Study|Withdrawal by Subject|2|||
105476717|NCT01136785|363756845|FG000|Overall Study|Protocol Violation|2|||
105476718|NCT01136785|363756846|FG001|Overall Study|Protocol Violation|1|||
105476719|NCT01590758|363756850|FG000|Overall Study|Withdrawal by Subject|0|||
105476720|NCT01590758|363756851|FG001|Overall Study|Withdrawal by Subject|3|||
105476721|NCT01590758|363756850|FG000|Overall Study|Physician Decision|1|||
105476722|NCT01590758|363756851|FG001|Overall Study|Physician Decision|2|||
105476723|NCT01590758|363756850|FG000|Overall Study|Lost to Follow-up|4|||
105476724|NCT01590758|363756851|FG001|Overall Study|Lost to Follow-up|2|||
105476725|NCT02756806|363756852|FG000|Overall Study|Study terminated early|5|||
105476726|NCT02717832|363756854|FG000|Overall Study|Inability to place IV|3|||
105476727|NCT01711216|363756855|FG000|Overall Study|Adverse Event|4|||
105476728|NCT01711216|363756855|FG000|Overall Study|Pregnancy|56|||
105476729|NCT01711216|363756855|FG000|Overall Study|Withdrawal by Subject|6|||
105476730|NCT01711216|363756855|FG000|Overall Study|Lost to Follow-up|46|||
105476731|NCT01711216|363756855|FG000|Overall Study|variety of other minor reasons|83|||
105476732|NCT01711216|363756855|FG000|Overall Study|no reason specified|22|||
105476733|NCT02259088|363756856|FG000|Overall Study|Adverse Event|6|||
105476734|NCT02259088|363756857|FG001|Overall Study|Adverse Event|4|||
105476735|NCT02259088|363756856|FG000|Overall Study|Lost to Follow-up|2|||
105476736|NCT02259088|363756857|FG001|Overall Study|Lost to Follow-up|0|||
105476737|NCT02259088|363756856|FG000|Overall Study|Death|2|||
105476738|NCT02259088|363756857|FG001|Overall Study|Death|0|||
105476739|NCT02259088|363756856|FG000|Overall Study|Physician Decision|5|||
105476740|NCT02259088|363756857|FG001|Overall Study|Physician Decision|2|||
105476741|NCT02259088|363756856|FG000|Overall Study|Protocol deviation|5|||
105713638|NCT00756938|364609738|FG002|Optional Extension|Withdrawal by Subject|0|||
105713639|NCT00756938|364609739|FG003|Optional Extension|Withdrawal by Subject|10|||
105713640|NCT00756938|364609736|FG000|Optional Extension|Adverse Event|0|||
105713641|NCT00756938|364609737|FG001|Optional Extension|Adverse Event|0|||
105713642|NCT00756938|364609738|FG002|Optional Extension|Adverse Event|0|||
105713643|NCT00756938|364609739|FG003|Optional Extension|Adverse Event|1|||
105476742|NCT02259088|363756857|FG001|Overall Study|Protocol deviation|0|||
105476743|NCT02259088|363756856|FG000|Overall Study|Subject/guardian decision|8|||
105713644|NCT02302963|364609740|FG000|Overall Study|Withdrawal by Subject|2|||
105713645|NCT02302963|364609741|FG001|Overall Study|Withdrawal by Subject|1|||
105713646|NCT02302963|364609740|FG000|Overall Study|Steroid injection|0|||
105713647|NCT02302963|364609741|FG001|Overall Study|Steroid injection|1|||
105713648|NCT02302963|364609740|FG000|Overall Study|Physician Decision|1|||
105713649|NCT02302963|364609741|FG001|Overall Study|Physician Decision|0|||
105713650|NCT02319044|364609747|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
105713651|NCT02319044|364609748|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
105713652|NCT02319044|364609749|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
105713653|NCT02319044|364609747|FG000|Overall Study|Withdrawal by Subject|3|||
105713654|NCT02319044|364609748|FG001|Overall Study|Withdrawal by Subject|3|||
105713655|NCT02319044|364609749|FG002|Overall Study|Withdrawal by Subject|6|||
105713656|NCT02319044|364609747|FG000|Overall Study|Condition under investigation worsened|100|||
105713657|NCT02319044|364609748|FG001|Overall Study|Condition under investigation worsened|50|||
105713658|NCT02319044|364609749|FG002|Overall Study|Condition under investigation worsened|46|||
105713659|NCT02319044|364609747|FG000|Overall Study|Adverse Event|17|||
105713660|NCT02319044|364609748|FG001|Overall Study|Adverse Event|2|||
105713661|NCT02319044|364609749|FG002|Overall Study|Adverse Event|8|||
105713662|NCT02319044|364609747|FG000|Overall Study|Study specific discontinuation criteria|2|||
105713663|NCT02319044|364609748|FG001|Overall Study|Study specific discontinuation criteria|2|||
105713664|NCT02319044|364609749|FG002|Overall Study|Study specific discontinuation criteria|1|||
105713665|NCT02319044|364609747|FG000|Overall Study|Not treated|0|||
105713666|NCT02319044|364609748|FG001|Overall Study|Not treated|2|||
105713667|NCT02319044|364609749|FG002|Overall Study|Not treated|2|||
105713668|NCT03551743|364609750|FG000|Overall Study|Adverse Event|1|||
105713669|NCT03551743|364609751|FG001|Overall Study|Adverse Event|0|||
105713670|NCT03551743|364609752|FG002|Overall Study|Adverse Event|0|||
105713671|NCT03551743|364609753|FG003|Overall Study|Adverse Event|0|||
105713672|NCT03551743|364609750|FG000|Overall Study|Withdrawal by Subject|1|||
105713673|NCT03551743|364609751|FG001|Overall Study|Withdrawal by Subject|0|||
105713674|NCT03551743|364609752|FG002|Overall Study|Withdrawal by Subject|0|||
105788583|NCT03358407|364880118|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105713675|NCT03551743|364609753|FG003|Overall Study|Withdrawal by Subject|0|||
105713676|NCT01145066|364609754|FG000|Overall Study|To resume NSAIDs|2|||
105713677|NCT01145066|364609755|FG001|Overall Study|To resume NSAIDs|2|||
105713678|NCT01145066|364609756|FG002|Overall Study|To resume NSAIDs|1|||
105713679|NCT01145066|364609754|FG000|Overall Study|Non-related surgery|0|||
105713680|NCT01145066|364609755|FG001|Overall Study|Non-related surgery|0|||
105713681|NCT01145066|364609756|FG002|Overall Study|Non-related surgery|1|||
105713682|NCT01145066|364609754|FG000|Overall Study|Withdrawal by Subject|0|||
105713683|NCT01145066|364609755|FG001|Overall Study|Withdrawal by Subject|0|||
105713684|NCT01145066|364609756|FG002|Overall Study|Withdrawal by Subject|2|||
105713685|NCT01145066|364609754|FG000|Overall Study|To start new med|1|||
105713686|NCT01145066|364609755|FG001|Overall Study|To start new med|0|||
105713687|NCT01145066|364609756|FG002|Overall Study|To start new med|0|||
105713688|NCT01145066|364609754|FG000|Overall Study|problems swallowing capsule|1|||
105713689|NCT01145066|364609755|FG001|Overall Study|problems swallowing capsule|0|||
105713690|NCT01145066|364609756|FG002|Overall Study|problems swallowing capsule|0|||
105713691|NCT01145066|364609754|FG000|Overall Study|Abdominal discomfort|0|||
105713692|NCT01145066|364609755|FG001|Overall Study|Abdominal discomfort|1|||
105713693|NCT01145066|364609756|FG002|Overall Study|Abdominal discomfort|0|||
105713694|NCT01145066|364609754|FG000|Overall Study|Low platelet count|0|||
105713695|NCT01145066|364609755|FG001|Overall Study|Low platelet count|1|||
105713696|NCT01145066|364609756|FG002|Overall Study|Low platelet count|0|||
105713697|NCT00217087|364609757|FG000|Overall Study|decided to have esophagectomy|1|||
105713698|NCT00217087|364609758|FG001|Overall Study|decided to have esophagectomy|2|||
105713699|NCT00217087|364609757|FG000|Overall Study|completed less than 12 months return|10|||
105713700|NCT00217087|364609758|FG001|Overall Study|completed less than 12 months return|18|||
105713701|NCT01634555|364609767|FG000|Overall Study|Adverse Event|3|||
105713702|NCT01634555|364609767|FG000|Overall Study|Physician Decision|1|||
105713703|NCT01031446|364609774|FG000|Overall Study|Disease Progression|38|||
105713704|NCT01031446|364609774|FG000|Overall Study|Adverse Event|9|||
105713705|NCT01031446|364609774|FG000|Overall Study|Physician Decision|4|||
105713706|NCT01031446|364609774|FG000|Overall Study|Withdrawal by Subject|3|||
105713707|NCT01031446|364609774|FG000|Overall Study|Still on treatment|1|||
105713708|NCT00772668|364609777|FG000|Overall Study|Physician Decision|3|||
105713709|NCT01227902|364611898|FG000|Overall Study|Adverse Event|12|||
105713710|NCT01227902|364611899|FG001|Overall Study|Adverse Event|8|||
105713711|NCT01227902|364611900|FG002|Overall Study|Adverse Event|11|||
105713712|NCT01227902|364611901|FG003|Overall Study|Adverse Event|4|||
105713713|NCT01227902|364611898|FG000|Overall Study|Lack of Efficacy|1|||
105713714|NCT01227902|364611899|FG001|Overall Study|Lack of Efficacy|2|||
105713715|NCT01227902|364611900|FG002|Overall Study|Lack of Efficacy|2|||
105713716|NCT01227902|364611901|FG003|Overall Study|Lack of Efficacy|1|||
105713717|NCT01227902|364611898|FG000|Overall Study|Protocol Violation|1|||
105713718|NCT01227902|364611899|FG001|Overall Study|Protocol Violation|0|||
105713719|NCT01227902|364611900|FG002|Overall Study|Protocol Violation|0|||
105713720|NCT01227902|364611901|FG003|Overall Study|Protocol Violation|0|||
105713721|NCT01227902|364611898|FG000|Overall Study|Lost to Follow-up|0|||
105713722|NCT01227902|364611899|FG001|Overall Study|Lost to Follow-up|0|||
105713723|NCT01227902|364611900|FG002|Overall Study|Lost to Follow-up|1|||
105713724|NCT01227902|364611901|FG003|Overall Study|Lost to Follow-up|2|||
105713725|NCT01227902|364611898|FG000|Overall Study|Physician Decision|0|||
105713726|NCT01227902|364611899|FG001|Overall Study|Physician Decision|1|||
105713727|NCT01227902|364611900|FG002|Overall Study|Physician Decision|1|||
105713728|NCT01227902|364611901|FG003|Overall Study|Physician Decision|0|||
105713729|NCT01227902|364611898|FG000|Overall Study|Withdrawal by Subject|4|||
105713730|NCT01227902|364611899|FG001|Overall Study|Withdrawal by Subject|2|||
105713731|NCT01227902|364611900|FG002|Overall Study|Withdrawal by Subject|4|||
105713732|NCT01227902|364611901|FG003|Overall Study|Withdrawal by Subject|3|||
105713733|NCT01178138|364611904|FG000|Overall Study|Lost to Follow-up|8|||
105713734|NCT01178138|364611904|FG000|Overall Study|Withdrawal by Subject|7|||
105713735|NCT01178138|364611904|FG000|Overall Study|Physician Decision|8|||
105713736|NCT02634580|364611915|FG000|Double-blind Treatment Period|Subject Request|1|||
105713737|NCT02634580|364611916|FG001|Double-blind Treatment Period|Subject Request|0|||
105713738|NCT02634580|364611917|FG002|Double-blind Treatment Period|Subject Request|1|||
105713739|NCT02634580|364611918|FG003|Double-blind Treatment Period|Subject Request|1|||
105713740|NCT02634580|364611915|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
105476744|NCT02259088|363756857|FG001|Overall Study|Subject/guardian decision|8|||
105476745|NCT01033448|363756858|FG000|Overall Study|Withdrawal by Subject|4|||
105476746|NCT01033448|363756858|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
105476747|NCT01033448|363756858|FG000|Overall Study|Lost to Follow-up|3|||
105476748|NCT01033448|363756858|FG000|Overall Study|Withdrew due to other reasons|3|||
105476749|NCT01033448|363756858|FG000|Overall Study|Unknown disposition|1|||
105476750|NCT00439738|363756859|FG000|Overall Study|Withdrawal by Subject|16|||
105476751|NCT00439738|363756860|FG001|Overall Study|Withdrawal by Subject|13|||
105476752|NCT00439738|363756859|FG000|Overall Study|Adverse Event|6|||
105476753|NCT00439738|363756860|FG001|Overall Study|Adverse Event|4|||
105476754|NCT00439738|363756859|FG000|Overall Study|Lost to Follow-up|5|||
105476755|NCT00439738|363756860|FG001|Overall Study|Lost to Follow-up|6|||
105476756|NCT00439738|363756859|FG000|Overall Study|Protocol Violation|6|||
105476757|NCT00439738|363756860|FG001|Overall Study|Protocol Violation|3|||
105476758|NCT00439738|363756859|FG000|Overall Study|Lack of Efficacy|2|||
105476759|NCT00439738|363756860|FG001|Overall Study|Lack of Efficacy|2|||
105476760|NCT00439738|363756859|FG000|Overall Study|Abnormal Lab Values|1|||
105476761|NCT00439738|363756860|FG001|Overall Study|Abnormal Lab Values|0|||
105476762|NCT03976648|363756863|FG000|Overall Study|Adverse Event|0|||
105476763|NCT03976648|363756864|FG001|Overall Study|Adverse Event|2|||
105476764|NCT03976648|363756863|FG000|Overall Study|Study terminated by sponsor|21|||
105713741|NCT02634580|364611916|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
105713742|NCT02634580|364611917|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
105713743|NCT02634580|364611918|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
105713744|NCT00197054|364611922|FG000|Overall Study|Withdrawal by Subject|9|||
105788584|NCT03358407|364880119|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105476765|NCT03976648|363756864|FG001|Overall Study|Study terminated by sponsor|8|||
105476766|NCT03645434|363756867|FG000|Period 1|Adverse Event|0|||
105476767|NCT03645434|363756868|FG001|Period 1|Adverse Event|0|||
105476768|NCT03645434|363756869|FG002|Period 1|Adverse Event|0|||
105476769|NCT03645434|363756870|FG003|Period 1|Adverse Event|1|||
105476770|NCT03645434|363756871|FG004|Period 1|Adverse Event|0|||
105713745|NCT00197054|364611923|FG001|Overall Study|Withdrawal by Subject|3|||
105713746|NCT00197054|364611924|FG002|Overall Study|Withdrawal by Subject|3|||
105713747|NCT00197054|364611922|FG000|Overall Study|Moved from area|7|||
105713748|NCT00197054|364611923|FG001|Overall Study|Moved from area|14|||
105713749|NCT00197054|364611924|FG002|Overall Study|Moved from area|9|||
105713750|NCT00197054|364611922|FG000|Overall Study|Lost to Follow-up|1|||
105713751|NCT00197054|364611923|FG001|Overall Study|Lost to Follow-up|4|||
105476771|NCT03645434|363756872|FG005|Period 1|Adverse Event|0|||
105713752|NCT00197054|364611924|FG002|Overall Study|Lost to Follow-up|0|||
105713753|NCT00323557|364611925|FG000|Overall Study|Physician Decision|1|||
105713754|NCT00323557|364611926|FG001|Overall Study|Physician Decision|0|||
105713755|NCT00272987|364611927|FG000|Overall Study|Adverse Event|1|||
105713756|NCT00272987|364611928|FG001|Overall Study|Adverse Event|0|||
105713757|NCT00272987|364611929|FG002|Overall Study|Adverse Event|0|||
105713758|NCT00272987|364611927|FG000|Overall Study|Lost to Follow-up|3|||
105476772|NCT03645434|363756867|FG000|Period 1|COPD exacerbation|0|||
105476773|NCT03645434|363756868|FG001|Period 1|COPD exacerbation|0|||
105476774|NCT03645434|363756869|FG002|Period 1|COPD exacerbation|0|||
105476775|NCT03645434|363756870|FG003|Period 1|COPD exacerbation|0|||
105476776|NCT03645434|363756871|FG004|Period 1|COPD exacerbation|1|||
105476777|NCT03645434|363756872|FG005|Period 1|COPD exacerbation|0|||
105476778|NCT01182844|363756873|FG000|Overall Study|Withdrawal by Subject|0|||
105476779|NCT01182844|363756874|FG001|Overall Study|Withdrawal by Subject|2|||
105476780|NCT01379508|363756875|FG000|Treatment to Week 104|Adverse Event|2|||
105476781|NCT01379508|363756876|FG001|Treatment to Week 104|Adverse Event|0|||
105476782|NCT01379508|363756877|FG002|Treatment to Week 104|Adverse Event|5|||
105476783|NCT01379508|363756878|FG003|Treatment to Week 104|Adverse Event|0|||
105476784|NCT01379508|363756875|FG000|Treatment to Week 104|Abnormal lab value|1|||
105476785|NCT01379508|363756876|FG001|Treatment to Week 104|Abnormal lab value|0|||
105476786|NCT01379508|363756877|FG002|Treatment to Week 104|Abnormal lab value|0|||
105476787|NCT01379508|363756878|FG003|Treatment to Week 104|Abnormal lab value|0|||
105476788|NCT01379508|363756875|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
105476789|NCT01379508|363756876|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
105476790|NCT01379508|363756877|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
105476791|NCT01379508|363756878|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
105476792|NCT01379508|363756875|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
105476793|NCT01379508|363756876|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
105476794|NCT01379508|363756877|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
105476795|NCT01379508|363756878|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
105476796|NCT01379508|363756875|FG000|Treatment to Week 104|Lost to Follow-up|5|||
105476797|NCT01379508|363756876|FG001|Treatment to Week 104|Lost to Follow-up|0|||
105476798|NCT01379508|363756877|FG002|Treatment to Week 104|Lost to Follow-up|3|||
105476799|NCT01379508|363756878|FG003|Treatment to Week 104|Lost to Follow-up|0|||
105476800|NCT01379508|363756875|FG000|Treatment to Week 104|Administrative problems|3|||
105476801|NCT01379508|363756876|FG001|Treatment to Week 104|Administrative problems|1|||
105476802|NCT01379508|363756877|FG002|Treatment to Week 104|Administrative problems|0|||
105561645|NCT01357616|364052172|FG000|Overall Study|Withdrawal by Subject|1|||
105476803|NCT01379508|363756878|FG003|Treatment to Week 104|Administrative problems|0|||
105476804|NCT01379508|363756875|FG000|Treatment to Week 104|Protocol Violation|1|||
105476805|NCT01379508|363756876|FG001|Treatment to Week 104|Protocol Violation|1|||
105561646|NCT01357616|364052173|FG001|Overall Study|Withdrawal by Subject|0|||
105561647|NCT03255824|364052176|FG000|Overall Study|Under-sedation|2|||
105476806|NCT01379508|363756877|FG002|Treatment to Week 104|Protocol Violation|1|||
105561648|NCT03255824|364052177|FG001|Overall Study|Under-sedation|1|||
105476807|NCT01379508|363756878|FG003|Treatment to Week 104|Protocol Violation|0|||
105476808|NCT01379508|363756875|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
105561649|NCT03284788|364052179|FG000|Overall Study|Withdrawal by Subject|2|||
105713759|NCT00272987|364611928|FG001|Overall Study|Lost to Follow-up|1|||
105713760|NCT00272987|364611929|FG002|Overall Study|Lost to Follow-up|1|||
105713761|NCT00272987|364611927|FG000|Overall Study|Withdrawal by Subject|1|||
105561650|NCT01690130|364052183|FG000|Overall Study|Subject have cancelled visit.|1|||
105561651|NCT01690130|364052184|FG001|Overall Study|Subject have cancelled visit.|0|||
105561652|NCT02565914|364052185|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
105561653|NCT02565914|364052185|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
105788585|NCT03358407|364880120|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788586|NCT03358407|364880121|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788587|NCT03358407|364880122|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
105788588|NCT03358407|364880123|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788589|NCT03358407|364880124|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788590|NCT03358407|364880125|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788591|NCT03358407|364880126|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788592|NCT03358407|364880127|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788593|NCT03358407|364880118|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788594|NCT03358407|364880119|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788595|NCT03358407|364880120|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788596|NCT03358407|364880121|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788597|NCT03358407|364880122|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788598|NCT03358407|364880123|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
105788599|NCT03358407|364880124|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788600|NCT03358407|364880125|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
105788601|NCT03358407|364880126|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788602|NCT03358407|364880127|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788603|NCT03358407|364880118|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788604|NCT03358407|364880119|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788605|NCT03358407|364880120|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788606|NCT03358407|364880121|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788607|NCT03358407|364880122|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788608|NCT03358407|364880123|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
105788609|NCT03358407|364880124|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788610|NCT03358407|364880125|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
105788611|NCT03358407|364880126|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788612|NCT03358407|364880127|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788613|NCT03358407|364880118|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788614|NCT03358407|364880119|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788615|NCT03358407|364880120|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788616|NCT03358407|364880121|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788617|NCT03358407|364880122|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788618|NCT03358407|364880123|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
105788619|NCT03358407|364880124|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
105788620|NCT03358407|364880125|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788621|NCT03358407|364880126|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788622|NCT03358407|364880127|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788623|NCT03358407|364880118|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
105788624|NCT03358407|364880119|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
105788625|NCT03358407|364880120|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
105788626|NCT03358407|364880121|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
105788627|NCT03358407|364880122|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
105788628|NCT03358407|364880123|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
105788629|NCT03358407|364880124|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
105788630|NCT03358407|364880125|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
105788631|NCT03358407|364880126|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
105788632|NCT03358407|364880127|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
105788633|NCT04640168|364880128|FG000|Overall Study|Withdrawal by Subject|8|||
105788634|NCT04640168|364880129|FG001|Overall Study|Withdrawal by Subject|7|||
105788635|NCT04640168|364880128|FG000|Overall Study|Lost to Follow-up|1|||
105788636|NCT04640168|364880129|FG001|Overall Study|Lost to Follow-up|0|||
105788637|NCT04640168|364880128|FG000|Overall Study|Enrolled but not treated|12|||
105788638|NCT04640168|364880129|FG001|Overall Study|Enrolled but not treated|12|||
105788639|NCT02940392|364880130|FG000|Overall Study|Lost to Follow-up|3|||
105788640|NCT02940392|364880130|FG000|Overall Study|Retreatment|3|||
105788641|NCT02940392|364880130|FG000|Overall Study|Death|2|||
105788642|NCT03205046|364880131|FG000|Overall Study|Death|10|||
105788643|NCT03205046|364880132|FG001|Overall Study|Death|6|||
105788644|NCT03205046|364880131|FG000|Overall Study|Withdrawal by Subject|1|||
105788645|NCT03205046|364880132|FG001|Overall Study|Withdrawal by Subject|2|||
105788646|NCT03205046|364880131|FG000|Overall Study|Lost to Follow-up|0|||
105788647|NCT03205046|364880132|FG001|Overall Study|Lost to Follow-up|1|||
105788648|NCT03205046|364880131|FG000|Overall Study|Study terminated by sponsor|2|||
105788649|NCT03205046|364880132|FG001|Overall Study|Study terminated by sponsor|1|||
105788650|NCT03992456|364880135|FG000|Overall Study|Withdrawal by Subject|1|||
105788651|NCT03992456|364880136|FG001|Overall Study|Withdrawal by Subject|0|||
105788652|NCT03992456|364880135|FG000|Overall Study|Disease progression|4|||
105788653|NCT03992456|364880136|FG001|Overall Study|Disease progression|5|||
105788654|NCT03992456|364880135|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
105788655|NCT03992456|364880136|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
105788656|NCT04882085|364880153|FG000|Overall Study|Death|6|||
105788657|NCT04882085|364880154|FG001|Overall Study|Death|9|||
105788658|NCT04882085|364880153|FG000|Overall Study|Withdrawal by Subject|0|||
105788659|NCT04882085|364880154|FG001|Overall Study|Withdrawal by Subject|3|||
105788660|NCT04882085|364880153|FG000|Overall Study|Randomized not treated|1|||
105788661|NCT04882085|364880154|FG001|Overall Study|Randomized not treated|0|||
105788662|NCT03593525|364880155|FG000|Overall Study|Withdrawal by Subject|1|||
105788663|NCT03593525|364880156|FG001|Overall Study|Withdrawal by Subject|0|||
105788664|NCT03593525|364880155|FG000|Overall Study|Lost to Follow-up|7|||
105788665|NCT03593525|364880156|FG001|Overall Study|Lost to Follow-up|5|||
105788666|NCT05939388|364880157|FG000|Overall Study|Lost to Follow-up|1|||
105788667|NCT01602380|364880162|FG000|Overall Study|Death|147|||
105788668|NCT01602380|364880163|FG001|Overall Study|Death|145|||
105788669|NCT01602380|364880162|FG000|Overall Study|Withdrawal by Subject|39|||
105788670|NCT01602380|364880163|FG001|Overall Study|Withdrawal by Subject|41|||
105788671|NCT01602380|364880162|FG000|Overall Study|Lost to Follow-up|15|||
105788672|NCT01602380|364880163|FG001|Overall Study|Lost to Follow-up|12|||
105788673|NCT01602380|364880162|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
105788674|NCT01602380|364880163|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
105788675|NCT01602380|364880162|FG000|Overall Study|Other|2|||
105788676|NCT01602380|364880163|FG001|Overall Study|Other|0|||
105788677|NCT00828009|364880164|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
105788678|NCT00828009|364880164|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
105788679|NCT00828009|364880164|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
105788680|NCT00828009|364880164|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
105788681|NCT00828009|364880164|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
105788682|NCT00828009|364880164|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
105788683|NCT00828009|364880164|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
105788684|NCT00828009|364880164|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
105788685|NCT00828009|364880164|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
105788686|NCT00828009|364880164|FG000|Step 2 - Maintenance Therapy|Death|1|||
105788687|NCT00828009|364880164|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
105788688|NCT00828009|364880164|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
105788689|NCT00828009|364880164|FG000|Step 2 - Maintenance Therapy|Other|1|||
105788690|NCT02062385|364880165|FG000|Overall Study|Adverse Event|19|||
105788691|NCT02062385|364880166|FG001|Overall Study|Adverse Event|13|||
105788692|NCT02062385|364880167|FG002|Overall Study|Adverse Event|1|||
105788693|NCT02062385|364880168|FG003|Overall Study|Adverse Event|0|||
105788694|NCT02062385|364880165|FG000|Overall Study|Protocol Violation|1|||
105788695|NCT02062385|364880166|FG001|Overall Study|Protocol Violation|0|||
105788696|NCT02062385|364880167|FG002|Overall Study|Protocol Violation|0|||
105788697|NCT02062385|364880168|FG003|Overall Study|Protocol Violation|0|||
105788698|NCT02062385|364880165|FG000|Overall Study|Incomplete EPI by database lock|2|||
105788699|NCT02062385|364880166|FG001|Overall Study|Incomplete EPI by database lock|0|||
105788700|NCT02062385|364880167|FG002|Overall Study|Incomplete EPI by database lock|0|||
105788701|NCT02062385|364880168|FG003|Overall Study|Incomplete EPI by database lock|0|||
105788702|NCT02062385|364880165|FG000|Overall Study|Moved|10|||
105788703|NCT02062385|364880166|FG001|Overall Study|Moved|11|||
105788704|NCT02062385|364880167|FG002|Overall Study|Moved|1|||
105788705|NCT02062385|364880168|FG003|Overall Study|Moved|0|||
105788706|NCT02062385|364880165|FG000|Overall Study|Withdrawn by parent/guardian|46|||
105788707|NCT02062385|364880166|FG001|Overall Study|Withdrawn by parent/guardian|41|||
105788708|NCT02062385|364880167|FG002|Overall Study|Withdrawn by parent/guardian|9|||
105788709|NCT02062385|364880168|FG003|Overall Study|Withdrawn by parent/guardian|8|||
105788710|NCT02062385|364880165|FG000|Overall Study|Death|0|||
105788711|NCT02062385|364880166|FG001|Overall Study|Death|0|||
105788712|NCT02062385|364880167|FG002|Overall Study|Death|0|||
105476809|NCT01379508|363756876|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
105476810|NCT01379508|363756877|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
105476811|NCT01379508|363756878|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
105788713|NCT02062385|364880168|FG003|Overall Study|Death|1|||
105788714|NCT02062385|364880165|FG000|Overall Study|Lost to Follow-up|0|||
105788715|NCT02062385|364880166|FG001|Overall Study|Lost to Follow-up|0|||
105788716|NCT02062385|364880167|FG002|Overall Study|Lost to Follow-up|1|||
105788717|NCT02062385|364880168|FG003|Overall Study|Lost to Follow-up|0|||
105788718|NCT03188991|364880169|FG000|Overall Study|Withdrawal by Subject|0|||
105788719|NCT03188991|364880170|FG001|Overall Study|Withdrawal by Subject|0|||
105476812|NCT01379508|363756875|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
105476813|NCT01379508|363756876|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
105476814|NCT01379508|363756877|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
105476815|NCT01379508|363756878|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
105476816|NCT01379508|363756875|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
105788720|NCT03188991|364880171|FG002|Overall Study|Withdrawal by Subject|0|||
105788721|NCT03188991|364880172|FG003|Overall Study|Withdrawal by Subject|1|||
105788722|NCT01721369|364880175|FG000|Overall Study|Not initial etiological diagnosis|12|||
105788723|NCT01300741|364881954|FG000|Overall Study|Lens deposits|1|||
105788724|NCT01300741|364881954|FG000|Overall Study|Lost to Follow-up|1|||
105788725|NCT01300741|364881954|FG000|Overall Study|Discomfort|1|||
105788726|NCT02325414|364881955|FG000|Overall Study|Withdrawal by Subject|3|||
105788727|NCT02325414|364881956|FG001|Overall Study|Withdrawal by Subject|1|||
105788728|NCT02325414|364881955|FG000|Overall Study|Lost to Follow-up|5|||
105788729|NCT02325414|364881956|FG001|Overall Study|Lost to Follow-up|5|||
105788730|NCT00726882|364881958|FG000|Overall Study|Withdrawal by Subject|5|||
105788731|NCT00726882|364881958|FG000|Overall Study|Lost to Follow-up|7|||
105788732|NCT00726882|364881958|FG000|Overall Study|Other|10|||
105788733|NCT00560573|364881959|FG000|Overall Study|Death|4|||
105788734|NCT00560573|364881960|FG001|Overall Study|Death|1|||
105788735|NCT00560573|364881961|FG002|Overall Study|Death|4|||
105788736|NCT00560573|364881962|FG003|Overall Study|Death|5|||
105788737|NCT00560573|364881963|FG004|Overall Study|Death|1|||
105788738|NCT00560573|364881964|FG005|Overall Study|Death|10|||
105788739|NCT00560573|364881959|FG000|Overall Study|Lost to Follow-up|0|||
105788740|NCT00560573|364881960|FG001|Overall Study|Lost to Follow-up|0|||
105788741|NCT00560573|364881961|FG002|Overall Study|Lost to Follow-up|0|||
105788742|NCT00560573|364881962|FG003|Overall Study|Lost to Follow-up|1|||
105788743|NCT00560573|364881963|FG004|Overall Study|Lost to Follow-up|1|||
105788744|NCT00560573|364881964|FG005|Overall Study|Lost to Follow-up|0|||
105788745|NCT00560573|364881959|FG000|Overall Study|Withdrawal by Subject|0|||
105788746|NCT00560573|364881960|FG001|Overall Study|Withdrawal by Subject|0|||
105788747|NCT00560573|364881961|FG002|Overall Study|Withdrawal by Subject|0|||
105788748|NCT00560573|364881962|FG003|Overall Study|Withdrawal by Subject|1|||
105476817|NCT01379508|363756876|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
105476818|NCT01379508|363756877|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
105476819|NCT01379508|363756878|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
105476820|NCT01379508|363756875|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
105476821|NCT01379508|363756876|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
105476822|NCT01379508|363756877|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
105476823|NCT01379508|363756878|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
105476824|NCT01451437|363756879|FG000|Overall Study|Adverse Event|0|||
105476825|NCT01451437|363756880|FG001|Overall Study|Adverse Event|0|||
105476826|NCT01451437|363756881|FG002|Overall Study|Adverse Event|0|||
105476827|NCT01451437|363756882|FG003|Overall Study|Adverse Event|0|||
105476828|NCT01451437|363756883|FG004|Overall Study|Adverse Event|0|||
105476829|NCT01451437|363756884|FG005|Overall Study|Adverse Event|1|||
105476830|NCT01451437|363756885|FG006|Overall Study|Adverse Event|1|||
105476831|NCT01451437|363756886|FG007|Overall Study|Adverse Event|2|||
105476832|NCT01451437|363756887|FG008|Overall Study|Adverse Event|1|||
105476833|NCT01451437|363756879|FG000|Overall Study|Physician Decision|1|||
105476834|NCT01451437|363756880|FG001|Overall Study|Physician Decision|1|||
105476835|NCT01451437|363756881|FG002|Overall Study|Physician Decision|2|||
105476836|NCT01451437|363756882|FG003|Overall Study|Physician Decision|0|||
105476837|NCT01451437|363756883|FG004|Overall Study|Physician Decision|0|||
105476838|NCT01451437|363756884|FG005|Overall Study|Physician Decision|0|||
105476839|NCT01451437|363756885|FG006|Overall Study|Physician Decision|0|||
105476840|NCT01451437|363756886|FG007|Overall Study|Physician Decision|0|||
105476841|NCT01451437|363756887|FG008|Overall Study|Physician Decision|0|||
105476842|NCT01451437|363756879|FG000|Overall Study|Disease Progression|0|||
105476843|NCT01451437|363756880|FG001|Overall Study|Disease Progression|0|||
105476844|NCT01451437|363756881|FG002|Overall Study|Disease Progression|1|||
105476845|NCT01451437|363756882|FG003|Overall Study|Disease Progression|1|||
105476846|NCT01451437|363756883|FG004|Overall Study|Disease Progression|3|||
105476847|NCT01451437|363756884|FG005|Overall Study|Disease Progression|2|||
105476848|NCT01451437|363756885|FG006|Overall Study|Disease Progression|3|||
105788749|NCT00560573|364881963|FG004|Overall Study|Withdrawal by Subject|1|||
105476849|NCT01451437|363756886|FG007|Overall Study|Disease Progression|1|||
105476850|NCT01451437|363756887|FG008|Overall Study|Disease Progression|3|||
105476851|NCT01451437|363756879|FG000|Overall Study|Protocol Violation|0|||
105476852|NCT01451437|363756880|FG001|Overall Study|Protocol Violation|0|||
105788750|NCT00560573|364881964|FG005|Overall Study|Withdrawal by Subject|0|||
105476853|NCT01451437|363756881|FG002|Overall Study|Protocol Violation|0|||
105788751|NCT00560573|364881959|FG000|Overall Study|Other|2|||
105788752|NCT00560573|364881960|FG001|Overall Study|Other|2|||
105788753|NCT00560573|364881961|FG002|Overall Study|Other|2|||
105788754|NCT00560573|364881962|FG003|Overall Study|Other|3|||
105788755|NCT00560573|364881963|FG004|Overall Study|Other|3|||
105788756|NCT00560573|364881964|FG005|Overall Study|Other|3|||
105713762|NCT00272987|364611928|FG001|Overall Study|Withdrawal by Subject|0|||
105713763|NCT00272987|364611929|FG002|Overall Study|Withdrawal by Subject|3|||
105713764|NCT00272987|364611927|FG000|Overall Study|Sponsor Terminated study|0|||
105713765|NCT00272987|364611928|FG001|Overall Study|Sponsor Terminated study|1|||
105713766|NCT00272987|364611929|FG002|Overall Study|Sponsor Terminated study|1|||
105713767|NCT00272987|364611927|FG000|Overall Study|Disease progression|1|||
105713768|NCT00272987|364611928|FG001|Overall Study|Disease progression|1|||
105713769|NCT00272987|364611929|FG002|Overall Study|Disease progression|2|||
105713770|NCT00272987|364611927|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
105713771|NCT00272987|364611928|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
105713772|NCT00272987|364611929|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
105713773|NCT00272987|364611927|FG000|Overall Study|Death|1|||
105713774|NCT00272987|364611928|FG001|Overall Study|Death|0|||
105713775|NCT00272987|364611929|FG002|Overall Study|Death|0|||
105713776|NCT02918019|364611930|FG000|Overall Study|Death|0|||
105713777|NCT02918019|364611931|FG001|Overall Study|Death|0|||
105713778|NCT02918019|364611932|FG002|Overall Study|Death|1|||
105713779|NCT02918019|364611933|FG003|Overall Study|Death|0|||
105713780|NCT02918019|364611930|FG000|Overall Study|Lost to Follow-up|1|||
105713781|NCT02918019|364611931|FG001|Overall Study|Lost to Follow-up|1|||
105713782|NCT02918019|364611932|FG002|Overall Study|Lost to Follow-up|0|||
105713783|NCT02918019|364611933|FG003|Overall Study|Lost to Follow-up|1|||
105713784|NCT02918019|364611930|FG000|Overall Study|Principal investigator request|0|||
105713785|NCT02918019|364611931|FG001|Overall Study|Principal investigator request|0|||
105713786|NCT02918019|364611932|FG002|Overall Study|Principal investigator request|0|||
105713787|NCT02918019|364611933|FG003|Overall Study|Principal investigator request|1|||
105713788|NCT02918019|364611930|FG000|Overall Study|Physician Decision|1|||
105713789|NCT02918019|364611931|FG001|Overall Study|Physician Decision|3|||
105713790|NCT02918019|364611932|FG002|Overall Study|Physician Decision|2|||
105713791|NCT02918019|364611933|FG003|Overall Study|Physician Decision|0|||
105713792|NCT02918019|364611930|FG000|Overall Study|Protocol deviation|1|||
105713793|NCT02918019|364611931|FG001|Overall Study|Protocol deviation|1|||
105713794|NCT02918019|364611932|FG002|Overall Study|Protocol deviation|0|||
105713795|NCT02918019|364611933|FG003|Overall Study|Protocol deviation|2|||
105713796|NCT02918019|364611930|FG000|Overall Study|Withdrawal by Subject|3|||
105713797|NCT02918019|364611931|FG001|Overall Study|Withdrawal by Subject|4|||
105713798|NCT02918019|364611932|FG002|Overall Study|Withdrawal by Subject|6|||
105713799|NCT02918019|364611933|FG003|Overall Study|Withdrawal by Subject|4|||
105713800|NCT02918019|364611930|FG000|Overall Study|Adverse Event|0|||
105713801|NCT02918019|364611931|FG001|Overall Study|Adverse Event|1|||
105713802|NCT02918019|364611932|FG002|Overall Study|Adverse Event|0|||
105713803|NCT02918019|364611933|FG003|Overall Study|Adverse Event|1|||
105713804|NCT04823949|364611934|FG000|Overall Study|Withdrawal by Subject|0|||
105713805|NCT04823949|364611935|FG001|Overall Study|Withdrawal by Subject|4|||
105713806|NCT04823949|364611934|FG000|Overall Study|Physician Decision|0|||
105713807|NCT04823949|364611935|FG001|Overall Study|Physician Decision|1|||
105713808|NCT02474082|364611938|FG000|Overall Study|Adverse Event|2|||
105713809|NCT02474082|364611939|FG001|Overall Study|Adverse Event|32|||
105713810|NCT02474082|364611938|FG000|Overall Study|Withdrawal of informed consent|1|||
105713811|NCT02474082|364611939|FG001|Overall Study|Withdrawal of informed consent|11|||
105713812|NCT02474082|364611938|FG000|Overall Study|Lost to Follow-up|2|||
105713813|NCT02474082|364611939|FG001|Overall Study|Lost to Follow-up|2|||
105713814|NCT02474082|364611938|FG000|Overall Study|Dose tapering not achieved|0|||
105713815|NCT02474082|364611939|FG001|Overall Study|Dose tapering not achieved|4|||
105713816|NCT02474082|364611938|FG000|Overall Study|Participant/guardian decision|1|||
105713817|NCT02474082|364611939|FG001|Overall Study|Participant/guardian decision|2|||
105713818|NCT02474082|364611938|FG000|Overall Study|Non-compliance with study treatment|0|||
105713819|NCT02474082|364611939|FG001|Overall Study|Non-compliance with study treatment|2|||
105713820|NCT02474082|364611938|FG000|Overall Study|Protocol deviation|0|||
105713821|NCT02474082|364611939|FG001|Overall Study|Protocol deviation|1|||
105713822|NCT00797823|364611943|FG000|First Period (Initial Randomization)|Physician Decision|1|||
105713823|NCT00797823|364611944|FG001|First Period (Initial Randomization)|Physician Decision|0|||
105713824|NCT00797823|364611945|FG002|First Period (Initial Randomization)|Physician Decision|0|||
105713825|NCT02568046|364611946|FG000|Overall Study|Adverse Event|0|||
105713826|NCT02568046|364611947|FG001|Overall Study|Adverse Event|1|||
105713827|NCT02568046|364611946|FG000|Overall Study|Death|2|||
105713828|NCT02568046|364611947|FG001|Overall Study|Death|0|||
105713829|NCT02568046|364611946|FG000|Overall Study|Progressive Disease|1|||
105713830|NCT02568046|364611947|FG001|Overall Study|Progressive Disease|0|||
105713831|NCT02568046|364611946|FG000|Overall Study|Withdrawal by Subject|2|||
105713832|NCT02568046|364611947|FG001|Overall Study|Withdrawal by Subject|1|||
105713833|NCT02568046|364611946|FG000|Overall Study|Other Events|0|||
105713834|NCT02568046|364611947|FG001|Overall Study|Other Events|1|||
105713835|NCT00408694|364611948|FG000|Overall Study|Ineligible|1|||
105713836|NCT00408694|364611948|FG000|Overall Study|No protocol treatment|1|||
105713837|NCT00523991|364611949|FG000|Overall Study|Adverse Event|6|||
105713838|NCT00523991|364611950|FG001|Overall Study|Adverse Event|5|||
105713839|NCT00523991|364611949|FG000|Overall Study|Protocol Violation|1|||
105713840|NCT00523991|364611950|FG001|Overall Study|Protocol Violation|4|||
105713841|NCT00523991|364611949|FG000|Overall Study|Lost to Follow-up|4|||
105713842|NCT00523991|364611950|FG001|Overall Study|Lost to Follow-up|1|||
105713843|NCT00523991|364611949|FG000|Overall Study|Withdrawal by Subject|7|||
105713844|NCT00523991|364611950|FG001|Overall Study|Withdrawal by Subject|17|||
105713845|NCT00523991|364611949|FG000|Overall Study|Other reason (not specified)|3|||
105713846|NCT00523991|364611950|FG001|Overall Study|Other reason (not specified)|0|||
105713847|NCT01700192|364611951|FG000|Overall Study|Adverse Event|73|||
105713848|NCT01700192|364611952|FG001|Overall Study|Adverse Event|18|||
105713849|NCT01700192|364611951|FG000|Overall Study|Lack of Efficacy|1|||
105713850|NCT01700192|364611952|FG001|Overall Study|Lack of Efficacy|0|||
105788757|NCT00560573|364881959|FG000|Overall Study|Enrolled, not treated|0|||
105788758|NCT00560573|364881960|FG001|Overall Study|Enrolled, not treated|0|||
105788759|NCT00560573|364881961|FG002|Overall Study|Enrolled, not treated|0|||
105788760|NCT00560573|364881962|FG003|Overall Study|Enrolled, not treated|0|||
105788761|NCT00560573|364881963|FG004|Overall Study|Enrolled, not treated|1|||
105788762|NCT00560573|364881964|FG005|Overall Study|Enrolled, not treated|0|||
105788763|NCT01339273|364881965|FG000|Overall Study|Lost to Follow-up|8|||
105788764|NCT01339273|364881966|FG001|Overall Study|Lost to Follow-up|8|||
105788765|NCT00344968|364881967|FG000|Overall Study|Adverse Event|5|||
105788766|NCT00344968|364881968|FG001|Overall Study|Adverse Event|4|||
105788767|NCT00344968|364881969|FG002|Overall Study|Adverse Event|15|||
105788768|NCT00344968|364881967|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
105788769|NCT00344968|364881968|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105476854|NCT01451437|363756882|FG003|Overall Study|Protocol Violation|0|||
105476855|NCT01451437|363756883|FG004|Overall Study|Protocol Violation|0|||
105476856|NCT01451437|363756884|FG005|Overall Study|Protocol Violation|0|||
105476857|NCT01451437|363756885|FG006|Overall Study|Protocol Violation|1|||
105788770|NCT00344968|364881969|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
105788771|NCT00344968|364881967|FG000|Overall Study|Protocol Violation|2|||
105788772|NCT00344968|364881968|FG001|Overall Study|Protocol Violation|2|||
105788773|NCT00344968|364881969|FG002|Overall Study|Protocol Violation|5|||
105788774|NCT00344968|364881967|FG000|Overall Study|Withdrawal by Subject|14|||
105788775|NCT00344968|364881968|FG001|Overall Study|Withdrawal by Subject|31|||
105788776|NCT00344968|364881969|FG002|Overall Study|Withdrawal by Subject|27|||
105788777|NCT00344968|364881967|FG000|Overall Study|Lost to Follow-up|24|||
105788778|NCT00344968|364881968|FG001|Overall Study|Lost to Follow-up|37|||
105788779|NCT00344968|364881969|FG002|Overall Study|Lost to Follow-up|37|||
105476858|NCT01451437|363756886|FG007|Overall Study|Protocol Violation|0|||
105476859|NCT01451437|363756887|FG008|Overall Study|Protocol Violation|0|||
105476860|NCT01451437|363756879|FG000|Overall Study|Withdrawal by Subject|0|||
105476861|NCT01451437|363756880|FG001|Overall Study|Withdrawal by Subject|0|||
105476862|NCT01451437|363756881|FG002|Overall Study|Withdrawal by Subject|0|||
105476863|NCT01451437|363756882|FG003|Overall Study|Withdrawal by Subject|0|||
105788780|NCT00344968|364881967|FG000|Overall Study|Death|11|||
105788781|NCT00344968|364881968|FG001|Overall Study|Death|27|||
105476864|NCT01451437|363756883|FG004|Overall Study|Withdrawal by Subject|1|||
105476865|NCT01451437|363756884|FG005|Overall Study|Withdrawal by Subject|0|||
105476866|NCT01451437|363756885|FG006|Overall Study|Withdrawal by Subject|1|||
105476867|NCT01451437|363756886|FG007|Overall Study|Withdrawal by Subject|0|||
105476868|NCT01451437|363756887|FG008|Overall Study|Withdrawal by Subject|0|||
105476869|NCT01256294|363759192|FG000|Overall Study|Adverse Event|1|||
105476870|NCT01256294|363759193|FG001|Overall Study|Adverse Event|0|||
105476871|NCT01256294|363759192|FG000|Overall Study|Withdrawal by Subject|1|||
105476872|NCT01256294|363759193|FG001|Overall Study|Withdrawal by Subject|1|||
105476873|NCT01256294|363759192|FG000|Overall Study|Protocol deviation|2|||
105476874|NCT01256294|363759193|FG001|Overall Study|Protocol deviation|1|||
105476875|NCT04681352|363759194|FG000|Overall Study|Lost to Follow-up|2|||
105476876|NCT04681352|363759194|FG000|Overall Study|Withdrawal by Subject|22|||
105476877|NCT01282463|363759195|FG000|Overall Study|Lost to Follow-up|1|||
105476878|NCT01282463|363759196|FG001|Overall Study|Lost to Follow-up|0|||
105476879|NCT01282463|363759197|FG002|Overall Study|Lost to Follow-up|0|||
105476880|NCT01282463|363759195|FG000|Overall Study|Withdrawal by Subject|6|||
105476881|NCT01282463|363759196|FG001|Overall Study|Withdrawal by Subject|2|||
105476882|NCT01282463|363759197|FG002|Overall Study|Withdrawal by Subject|3|||
105476883|NCT01282463|363759195|FG000|Overall Study|"Never Treated Death"|0|||
105476884|NCT01282463|363759196|FG001|Overall Study|"Never Treated Death"|1|||
105476885|NCT01282463|363759197|FG002|Overall Study|"Never Treated Death"|0|||
105561654|NCT02565914|364052185|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
105788782|NCT00344968|364881969|FG002|Overall Study|Death|31|||
105788783|NCT00344968|364881967|FG000|Overall Study|Other|0|||
105788784|NCT00344968|364881968|FG001|Overall Study|Other|1|||
105788785|NCT00344968|364881969|FG002|Overall Study|Other|0|||
105788786|NCT00518531|364881974|FG000|Treatment Period 1|Adverse Event|5|||
105788787|NCT00518531|364881975|FG001|Treatment Period 1|Adverse Event|0|||
105788788|NCT00518531|364881974|FG000|Treatment Period 1|Lost to Follow-up|5|||
105788789|NCT00518531|364881975|FG001|Treatment Period 1|Lost to Follow-up|3|||
105788790|NCT00518531|364881974|FG000|Treatment Period 1|Physician Decision|1|||
105788791|NCT00518531|364881975|FG001|Treatment Period 1|Physician Decision|0|||
105476886|NCT01282463|363759195|FG000|Overall Study|"Never Treated PD"|0|||
105476887|NCT01282463|363759196|FG001|Overall Study|"Never Treated PD"|1|||
105476888|NCT01282463|363759197|FG002|Overall Study|"Never Treated PD"|0|||
105476889|NCT01282463|363759195|FG000|Overall Study|Protocol Violation|0|||
105476890|NCT01282463|363759196|FG001|Overall Study|Protocol Violation|0|||
105476891|NCT01282463|363759197|FG002|Overall Study|Protocol Violation|1|||
105476892|NCT01282463|363759195|FG000|Overall Study|Physician Decision|1|||
105476893|NCT01282463|363759196|FG001|Overall Study|Physician Decision|0|||
105476894|NCT01282463|363759197|FG002|Overall Study|Physician Decision|0|||
105788792|NCT00518531|364881974|FG000|Treatment Period 1|Protocol Violation|2|||
105713851|NCT01700192|364611951|FG000|Overall Study|Lost to Follow-up|42|||
105713852|NCT01700192|364611952|FG001|Overall Study|Lost to Follow-up|29|||
105713853|NCT01700192|364611951|FG000|Overall Study|Noncompliance with study drug|0|||
105713854|NCT01700192|364611952|FG001|Overall Study|Noncompliance with study drug|5|||
105713855|NCT01700192|364611951|FG000|Overall Study|Physician Decision|2|||
105713856|NCT01700192|364611952|FG001|Overall Study|Physician Decision|3|||
105713857|NCT01700192|364611951|FG000|Overall Study|Pregnancy|1|||
105713858|NCT01700192|364611952|FG001|Overall Study|Pregnancy|4|||
105713859|NCT01700192|364611951|FG000|Overall Study|Progressive disease|1|||
105713860|NCT01700192|364611952|FG001|Overall Study|Progressive disease|0|||
105713861|NCT01700192|364611951|FG000|Overall Study|Protocol Violation|3|||
105713862|NCT01700192|364611952|FG001|Overall Study|Protocol Violation|4|||
105713863|NCT01700192|364611951|FG000|Overall Study|Technical problems|0|||
105713864|NCT01700192|364611952|FG001|Overall Study|Technical problems|1|||
105713865|NCT01700192|364611951|FG000|Overall Study|Withdrawal by Subject|56|||
105713866|NCT01700192|364611952|FG001|Overall Study|Withdrawal by Subject|64|||
105713867|NCT01700192|364611951|FG000|Overall Study|Never received study drug|1|||
105713868|NCT01700192|364611952|FG001|Overall Study|Never received study drug|0|||
105713869|NCT03403192|364611955|FG000|Overall Study|Lost to Follow-up|1|||
105713870|NCT03403192|364611956|FG001|Overall Study|Lost to Follow-up|2|||
105713871|NCT03403192|364611957|FG002|Overall Study|Lost to Follow-up|0|||
105713872|NCT03403192|364611958|FG003|Overall Study|Lost to Follow-up|0|||
105713873|NCT03403192|364611955|FG000|Overall Study|Unable to respond|0|||
105713874|NCT03403192|364611956|FG001|Overall Study|Unable to respond|1|||
105713875|NCT03403192|364611957|FG002|Overall Study|Unable to respond|0|||
105713876|NCT03403192|364611958|FG003|Overall Study|Unable to respond|0|||
105713877|NCT03403192|364611955|FG000|Overall Study|Incomplete|3|||
105713878|NCT03403192|364611956|FG001|Overall Study|Incomplete|1|||
105713879|NCT03403192|364611957|FG002|Overall Study|Incomplete|3|||
105713880|NCT03403192|364611958|FG003|Overall Study|Incomplete|6|||
105713881|NCT02486757|364611959|FG000|Overall Study|Lost to Follow-up|1|||
105713882|NCT02793232|364611960|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
105713883|NCT02793232|364611961|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
105713884|NCT02793232|364611962|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
105713885|NCT02793232|364611963|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
105713886|NCT02793232|364611964|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
105713887|NCT02793232|364611965|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
105713888|NCT02793232|364611966|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
105713889|NCT02793232|364611967|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
105713890|NCT02793232|364611968|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
105713891|NCT04673786|364611969|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
105713892|NCT04673786|364611970|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
105713893|NCT04673786|364611971|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
105713894|NCT04673786|364611969|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
105713895|NCT04673786|364611970|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
105713896|NCT04673786|364611971|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
105713897|NCT04673786|364611969|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
105713898|NCT04673786|364611970|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
105713899|NCT04673786|364611971|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
105713900|NCT04673786|364611969|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
105713901|NCT04673786|364611970|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
105713902|NCT04673786|364611971|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
105713903|NCT04673786|364611969|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
105713904|NCT04673786|364611970|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
105713905|NCT04673786|364611971|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
105713906|NCT04673786|364611969|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
105713907|NCT04673786|364611970|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
105713908|NCT04673786|364611971|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
105713909|NCT02979431|364611972|FG000|Overall Study|Parent/guardian withdrew consent|2|||
105713910|NCT02979431|364611973|FG001|Overall Study|Parent/guardian withdrew consent|1|||
105713911|NCT02979431|364611974|FG002|Overall Study|Parent/guardian withdrew consent|1|||
105713912|NCT02979431|364611975|FG003|Overall Study|Parent/guardian withdrew consent|1|||
105713913|NCT02979431|364611972|FG000|Overall Study|Randomized but received no study drug|1|||
105713914|NCT02979431|364611973|FG001|Overall Study|Randomized but received no study drug|1|||
105713915|NCT02979431|364611974|FG002|Overall Study|Randomized but received no study drug|0|||
105713916|NCT02979431|364611975|FG003|Overall Study|Randomized but received no study drug|0|||
105713917|NCT02979431|364611972|FG000|Overall Study|Adverse Event|0|||
105713918|NCT02979431|364611973|FG001|Overall Study|Adverse Event|0|||
105713919|NCT02979431|364611974|FG002|Overall Study|Adverse Event|1|||
105713920|NCT02979431|364611975|FG003|Overall Study|Adverse Event|0|||
105713921|NCT02979431|364611972|FG000|Overall Study|Subject left country after Day14|1|||
105713922|NCT02979431|364611973|FG001|Overall Study|Subject left country after Day14|0|||
105713923|NCT02979431|364611974|FG002|Overall Study|Subject left country after Day14|0|||
105713924|NCT02979431|364611975|FG003|Overall Study|Subject left country after Day14|0|||
105713925|NCT03543410|364611976|FG000|Overall Study|Adverse Event|10|||
105713926|NCT03543410|364611977|FG001|Overall Study|Adverse Event|8|||
105713927|NCT03543410|364611978|FG002|Overall Study|Adverse Event|2|||
105713928|NCT03543410|364611976|FG000|Overall Study|Lack of Efficacy|0|||
105713929|NCT03543410|364611977|FG001|Overall Study|Lack of Efficacy|1|||
105713930|NCT03543410|364611978|FG002|Overall Study|Lack of Efficacy|0|||
105713931|NCT03543410|364611976|FG000|Overall Study|Lost to Follow-up|0|||
105713932|NCT03543410|364611977|FG001|Overall Study|Lost to Follow-up|1|||
105713933|NCT03543410|364611978|FG002|Overall Study|Lost to Follow-up|0|||
105713934|NCT03543410|364611976|FG000|Overall Study|Withdrawal by Subject|5|||
105713935|NCT03543410|364611977|FG001|Overall Study|Withdrawal by Subject|2|||
105713936|NCT03543410|364611978|FG002|Overall Study|Withdrawal by Subject|8|||
105713937|NCT03543410|364611976|FG000|Overall Study|Protocol Violation|0|||
105713938|NCT03543410|364611977|FG001|Overall Study|Protocol Violation|1|||
105713939|NCT03543410|364611978|FG002|Overall Study|Protocol Violation|0|||
105713940|NCT03543410|364611976|FG000|Overall Study|Due to COVID-19|4|||
105713941|NCT03543410|364611977|FG001|Overall Study|Due to COVID-19|0|||
105713942|NCT03543410|364611978|FG002|Overall Study|Due to COVID-19|2|||
105713943|NCT03543410|364611976|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
105713944|NCT03543410|364611977|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
105713945|NCT03543410|364611978|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
105713946|NCT03543410|364611976|FG000|Overall Study|Not Due to COVID-19|2|||
105713947|NCT03543410|364611977|FG001|Overall Study|Not Due to COVID-19|0|||
105713948|NCT03543410|364611978|FG002|Overall Study|Not Due to COVID-19|1|||
105713949|NCT02883244|364611979|FG000|Overall Study|Lost to Follow-up|0|||
105713950|NCT02883244|364611980|FG001|Overall Study|Lost to Follow-up|1|||
105713951|NCT02435914|364611981|FG000|Overall Study|Ocular Adverse Event|1|||
105713952|NCT02435914|364611982|FG001|Overall Study|Ocular Adverse Event|0|||
105713953|NCT02435914|364611983|FG002|Overall Study|Ocular Adverse Event|0|||
105713954|NCT02435914|364611984|FG003|Overall Study|Ocular Adverse Event|0|||
105713955|NCT02435914|364611981|FG000|Overall Study|Withdrawal by Subject|0|||
105713956|NCT02435914|364611982|FG001|Overall Study|Withdrawal by Subject|1|||
105713957|NCT02435914|364611983|FG002|Overall Study|Withdrawal by Subject|0|||
105713958|NCT02435914|364611984|FG003|Overall Study|Withdrawal by Subject|0|||
105713959|NCT02435914|364611981|FG000|Overall Study|Other Miscellaneous Reason|0|||
105713960|NCT02435914|364611982|FG001|Overall Study|Other Miscellaneous Reason|0|||
105713961|NCT02435914|364611983|FG002|Overall Study|Other Miscellaneous Reason|1|||
105713962|NCT02435914|364611984|FG003|Overall Study|Other Miscellaneous Reason|0|||
105713963|NCT01353703|364611985|FG000|Overall Study|Migrated/moved from study area|1|||
105713964|NCT01353703|364611986|FG001|Overall Study|Migrated/moved from study area|0|||
105713965|NCT01405053|364611998|FG000|Overall Study|Adverse Event|3|||
105713966|NCT01405053|364611999|FG001|Overall Study|Adverse Event|0|||
105713967|NCT01405053|364611998|FG000|Overall Study|Lost to Follow-up|0|||
105713968|NCT01405053|364611999|FG001|Overall Study|Lost to Follow-up|1|||
105713969|NCT01405053|364611998|FG000|Overall Study|Participant choice|2|||
105713970|NCT01405053|364611999|FG001|Overall Study|Participant choice|1|||
105713971|NCT01405053|364611998|FG000|Overall Study|Inadequate therapeutic effect|2|||
105713972|NCT01405053|364611999|FG001|Overall Study|Inadequate therapeutic effect|1|||
105713973|NCT01405053|364611998|FG000|Overall Study|Withdrawal by Subject|3|||
105713974|NCT01405053|364611999|FG001|Overall Study|Withdrawal by Subject|4|||
105713975|NCT01405053|364611998|FG000|Overall Study|Other|0|||
105713976|NCT01405053|364611999|FG001|Overall Study|Other|1|||
105713977|NCT04871711|364612000|FG000|Overall Study|Withdrawal by Subject|11|||
105713978|NCT04871711|364612001|FG001|Overall Study|Withdrawal by Subject|5|||
105713979|NCT04871711|364612000|FG000|Overall Study|Lack of Efficacy|5|||
105713980|NCT04871711|364612001|FG001|Overall Study|Lack of Efficacy|7|||
105713981|NCT04871711|364612000|FG000|Overall Study|Adverse Event|2|||
105713982|NCT04871711|364612001|FG001|Overall Study|Adverse Event|6|||
105713983|NCT04871711|364612000|FG000|Overall Study|Various reasons|2|||
105713984|NCT04871711|364612001|FG001|Overall Study|Various reasons|1|||
105713985|NCT04871711|364612000|FG000|Overall Study|Lost to Follow-up|0|||
105713986|NCT04871711|364612001|FG001|Overall Study|Lost to Follow-up|2|||
105713987|NCT01665144|364612002|FG000|Core Part|Withdrawal by Subject|96|||
105713988|NCT01665144|364612003|FG001|Core Part|Withdrawal by Subject|77|||
105713989|NCT01665144|364612004|FG002|Core Part|Withdrawal by Subject|0|||
105713990|NCT01665144|364612002|FG000|Core Part|Adverse Event|45|||
105713991|NCT01665144|364612003|FG001|Core Part|Adverse Event|18|||
105713992|NCT01665144|364612004|FG002|Core Part|Adverse Event|0|||
105713993|NCT01665144|364612002|FG000|Core Part|Lack of Efficacy|16|||
105713994|NCT01665144|364612003|FG001|Core Part|Lack of Efficacy|11|||
105713995|NCT01665144|364612004|FG002|Core Part|Lack of Efficacy|0|||
105713996|NCT01665144|364612002|FG000|Core Part|Lost to Follow-up|9|||
105713997|NCT01665144|364612003|FG001|Core Part|Lost to Follow-up|8|||
105713998|NCT01665144|364612004|FG002|Core Part|Lost to Follow-up|0|||
105713999|NCT01665144|364612002|FG000|Core Part|Physician Decision|13|||
105714000|NCT01665144|364612003|FG001|Core Part|Physician Decision|1|||
105714001|NCT01665144|364612004|FG002|Core Part|Physician Decision|0|||
105788793|NCT00518531|364881975|FG001|Treatment Period 1|Protocol Violation|0|||
105788794|NCT00518531|364881974|FG000|Treatment Period 1|Withdrawal by Subject|4|||
105788795|NCT00518531|364881975|FG001|Treatment Period 1|Withdrawal by Subject|6|||
105788796|NCT00518531|364881974|FG000|Treatment Period 1|Early crossover|1|||
105788797|NCT00518531|364881975|FG001|Treatment Period 1|Early crossover|3|||
105788798|NCT00518531|364881974|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105788799|NCT00518531|364881975|FG001|Treatment Period 2|Withdrawal by Subject|8|||
105788800|NCT00518531|364881974|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
105788801|NCT00518531|364881975|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
105788802|NCT00518531|364881974|FG000|Treatment Period 2|Adverse Event|1|||
105788803|NCT00518531|364881975|FG001|Treatment Period 2|Adverse Event|7|||
105788804|NCT00518531|364881974|FG000|Treatment Period 2|Protocol-specified criteria|0|||
105788805|NCT00518531|364881975|FG001|Treatment Period 2|Protocol-specified criteria|1|||
105788806|NCT00518531|364881974|FG000|Treatment Period 2|Non-compliance|1|||
105788807|NCT00518531|364881975|FG001|Treatment Period 2|Non-compliance|2|||
105788808|NCT00968539|364881976|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
105788809|NCT00968539|364881977|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
105788810|NCT01976663|364881980|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
105788811|NCT01976663|364881980|FG000|Overall Study|Personal Reasons|6|||
105788812|NCT01976663|364881980|FG000|Overall Study|Withdrawal by Subject|4|||
105788813|NCT01976663|364881980|FG000|Overall Study|Screen Failure|3|||
105788814|NCT01976663|364881980|FG000|Overall Study|Adverse Event|2|||
105788815|NCT01976663|364881980|FG000|Overall Study|Lost to Follow-up|3|||
105788816|NCT05981365|364881981|FG000|Period 1|Adverse Event|1|||
105788817|NCT05981365|364881982|FG001|Period 1|Adverse Event|0|||
105788818|NCT03772574|364881983|FG000|Overall Study|Protocol Violation|2|||
105788819|NCT03772574|364881984|FG001|Overall Study|Protocol Violation|0|||
105788820|NCT03772574|364881985|FG002|Overall Study|Protocol Violation|0|||
105788821|NCT03772574|364881983|FG000|Overall Study|Discomfort|0|||
105788822|NCT03772574|364881984|FG001|Overall Study|Discomfort|5|||
105788823|NCT03772574|364881985|FG002|Overall Study|Discomfort|4|||
105788824|NCT02116309|364881991|FG000|Overall Study|Lost to Follow-up|0|||
105788825|NCT02116309|364881992|FG001|Overall Study|Lost to Follow-up|1|||
105788826|NCT00471237|364881993|FG000|Overall Study|Adverse Event|6|||
105788827|NCT00471237|364881994|FG001|Overall Study|Adverse Event|5|||
105788828|NCT00471237|364881995|FG002|Overall Study|Adverse Event|4|||
105714002|NCT01665144|364612002|FG000|Core Part|Progressive disease|8|||
105714003|NCT01665144|364612003|FG001|Core Part|Progressive disease|4|||
105714004|NCT01665144|364612004|FG002|Core Part|Progressive disease|0|||
105714005|NCT01665144|364612002|FG000|Core Part|Non-compliance with study treatment|5|||
105714006|NCT01665144|364612003|FG001|Core Part|Non-compliance with study treatment|0|||
105714007|NCT01665144|364612004|FG002|Core Part|Non-compliance with study treatment|0|||
105714008|NCT01665144|364612002|FG000|Core Part|Death|3|||
105714009|NCT01665144|364612003|FG001|Core Part|Death|1|||
105714010|NCT01665144|364612004|FG002|Core Part|Death|0|||
105714011|NCT01665144|364612002|FG000|Core Part|Protocol deviation|3|||
105714012|NCT01665144|364612003|FG001|Core Part|Protocol deviation|1|||
105714013|NCT01665144|364612004|FG002|Core Part|Protocol deviation|0|||
105714014|NCT01665144|364612002|FG000|Core Part|New therapy for study indication|2|||
105714015|NCT01665144|364612003|FG001|Core Part|New therapy for study indication|1|||
105714016|NCT01665144|364612004|FG002|Core Part|New therapy for study indication|0|||
105714017|NCT01665144|364612002|FG000|Core Part|Technical problems|2|||
105714018|NCT01665144|364612003|FG001|Core Part|Technical problems|0|||
105714019|NCT01665144|364612004|FG002|Core Part|Technical problems|0|||
105714020|NCT01665144|364612002|FG000|Extension Part|Patient/guardian decision|180|||
105714021|NCT01665144|364612003|FG001|Extension Part|Patient/guardian decision|0|||
105714022|NCT01665144|364612004|FG002|Extension Part|Patient/guardian decision|98|||
105714023|NCT01665144|364612002|FG000|Extension Part|Adverse Event|104|||
105714024|NCT01665144|364612003|FG001|Extension Part|Adverse Event|0|||
105714025|NCT01665144|364612004|FG002|Extension Part|Adverse Event|59|||
105714026|NCT01665144|364612002|FG000|Extension Part|Study closed early|42|||
105714027|NCT01665144|364612003|FG001|Extension Part|Study closed early|0|||
105714028|NCT01665144|364612004|FG002|Extension Part|Study closed early|19|||
105714029|NCT01665144|364612002|FG000|Extension Part|Progressive disease|36|||
105714030|NCT01665144|364612003|FG001|Extension Part|Progressive disease|0|||
105714031|NCT01665144|364612004|FG002|Extension Part|Progressive disease|14|||
105714032|NCT01665144|364612002|FG000|Extension Part|Lack of Efficacy|37|||
105714033|NCT01665144|364612003|FG001|Extension Part|Lack of Efficacy|0|||
105714034|NCT01665144|364612004|FG002|Extension Part|Lack of Efficacy|12|||
105788829|NCT00471237|364881996|FG003|Overall Study|Adverse Event|8|||
105788830|NCT00471237|364881997|FG004|Overall Study|Adverse Event|7|||
105788831|NCT00471237|364881998|FG005|Overall Study|Adverse Event|5|||
105788832|NCT00471237|364881999|FG006|Overall Study|Adverse Event|0|||
105788833|NCT00471237|364881993|FG000|Overall Study|Lost to Follow-up|1|||
105788834|NCT00471237|364881994|FG001|Overall Study|Lost to Follow-up|1|||
105788835|NCT00471237|364881995|FG002|Overall Study|Lost to Follow-up|0|||
105788836|NCT00471237|364881996|FG003|Overall Study|Lost to Follow-up|2|||
105788837|NCT00471237|364881997|FG004|Overall Study|Lost to Follow-up|3|||
105788838|NCT00471237|364881998|FG005|Overall Study|Lost to Follow-up|0|||
105788839|NCT00471237|364881999|FG006|Overall Study|Lost to Follow-up|0|||
105788840|NCT00471237|364881993|FG000|Overall Study|Protocol Violation|3|||
105788841|NCT00471237|364881994|FG001|Overall Study|Protocol Violation|6|||
105788842|NCT00471237|364881995|FG002|Overall Study|Protocol Violation|3|||
105788843|NCT00471237|364881996|FG003|Overall Study|Protocol Violation|2|||
105788844|NCT00471237|364881997|FG004|Overall Study|Protocol Violation|2|||
105788845|NCT00471237|364881998|FG005|Overall Study|Protocol Violation|4|||
105788846|NCT00471237|364881999|FG006|Overall Study|Protocol Violation|1|||
105788847|NCT00471237|364881993|FG000|Overall Study|Withdrawal by Subject|8|||
105788848|NCT00471237|364881994|FG001|Overall Study|Withdrawal by Subject|6|||
105788849|NCT00471237|364881995|FG002|Overall Study|Withdrawal by Subject|5|||
105788850|NCT00471237|364881996|FG003|Overall Study|Withdrawal by Subject|8|||
105788851|NCT00471237|364881997|FG004|Overall Study|Withdrawal by Subject|7|||
105788852|NCT00471237|364881998|FG005|Overall Study|Withdrawal by Subject|4|||
105788853|NCT00471237|364881999|FG006|Overall Study|Withdrawal by Subject|2|||
105788854|NCT00471237|364881993|FG000|Overall Study|Sponsor terminated study|20|||
105788855|NCT00471237|364881994|FG001|Overall Study|Sponsor terminated study|23|||
105788856|NCT00471237|364881995|FG002|Overall Study|Sponsor terminated study|19|||
105788857|NCT00471237|364881996|FG003|Overall Study|Sponsor terminated study|22|||
105788858|NCT00471237|364881997|FG004|Overall Study|Sponsor terminated study|18|||
105788859|NCT00471237|364881998|FG005|Overall Study|Sponsor terminated study|24|||
105788860|NCT00471237|364881999|FG006|Overall Study|Sponsor terminated study|0|||
105788861|NCT00471237|364881993|FG000|Overall Study|Non-compliance|0|||
105788862|NCT00471237|364881994|FG001|Overall Study|Non-compliance|1|||
105788863|NCT00471237|364881995|FG002|Overall Study|Non-compliance|0|||
105788864|NCT00471237|364881996|FG003|Overall Study|Non-compliance|1|||
105788865|NCT00471237|364881997|FG004|Overall Study|Non-compliance|0|||
105788866|NCT00471237|364881998|FG005|Overall Study|Non-compliance|0|||
105788867|NCT00471237|364881999|FG006|Overall Study|Non-compliance|0|||
105788868|NCT00471237|364881993|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
105788869|NCT00471237|364881994|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
105788870|NCT00471237|364881995|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
105788871|NCT00471237|364881996|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
105788872|NCT00471237|364881997|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
105788873|NCT00471237|364881998|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
105788874|NCT00471237|364881999|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
105788875|NCT00471237|364881993|FG000|Overall Study|Early stopping due to non-efficacy|1|||
105788876|NCT00471237|364881994|FG001|Overall Study|Early stopping due to non-efficacy|0|||
105788877|NCT00471237|364881995|FG002|Overall Study|Early stopping due to non-efficacy|0|||
105788878|NCT00471237|364881996|FG003|Overall Study|Early stopping due to non-efficacy|0|||
105788879|NCT00471237|364881997|FG004|Overall Study|Early stopping due to non-efficacy|1|||
105788880|NCT00471237|364881998|FG005|Overall Study|Early stopping due to non-efficacy|0|||
105788881|NCT00471237|364881999|FG006|Overall Study|Early stopping due to non-efficacy|0|||
105788882|NCT00471237|364881993|FG000|Overall Study|Participant planned to travel to abraod|1|||
105788883|NCT00471237|364881994|FG001|Overall Study|Participant planned to travel to abraod|0|||
105788884|NCT00471237|364881995|FG002|Overall Study|Participant planned to travel to abraod|0|||
105788885|NCT00471237|364881996|FG003|Overall Study|Participant planned to travel to abraod|0|||
105788886|NCT00471237|364881997|FG004|Overall Study|Participant planned to travel to abraod|0|||
105788887|NCT00471237|364881998|FG005|Overall Study|Participant planned to travel to abraod|1|||
105788888|NCT00471237|364881999|FG006|Overall Study|Participant planned to travel to abraod|0|||
105788889|NCT00471237|364881993|FG000|Overall Study|High parathyroid hormone|0|||
105788890|NCT00471237|364881994|FG001|Overall Study|High parathyroid hormone|0|||
105788891|NCT00471237|364881995|FG002|Overall Study|High parathyroid hormone|1|||
105788892|NCT00471237|364881996|FG003|Overall Study|High parathyroid hormone|0|||
105788893|NCT00471237|364881997|FG004|Overall Study|High parathyroid hormone|0|||
105788894|NCT00471237|364881998|FG005|Overall Study|High parathyroid hormone|0|||
105788895|NCT00471237|364881999|FG006|Overall Study|High parathyroid hormone|0|||
105788896|NCT00471237|364881993|FG000|Overall Study|Participant lost medication|0|||
105788897|NCT00471237|364881994|FG001|Overall Study|Participant lost medication|0|||
105788898|NCT00471237|364881995|FG002|Overall Study|Participant lost medication|0|||
105788899|NCT00471237|364881996|FG003|Overall Study|Participant lost medication|0|||
105788900|NCT00471237|364881997|FG004|Overall Study|Participant lost medication|1|||
105788901|NCT00471237|364881998|FG005|Overall Study|Participant lost medication|0|||
105788902|NCT00471237|364881999|FG006|Overall Study|Participant lost medication|0|||
105788903|NCT00471237|364881993|FG000|Overall Study|Administration of prohibited medicine|0|||
105788904|NCT00471237|364881994|FG001|Overall Study|Administration of prohibited medicine|0|||
105788905|NCT00471237|364881995|FG002|Overall Study|Administration of prohibited medicine|0|||
105788906|NCT00471237|364881996|FG003|Overall Study|Administration of prohibited medicine|0|||
105788907|NCT00471237|364881997|FG004|Overall Study|Administration of prohibited medicine|1|||
105788908|NCT00471237|364881998|FG005|Overall Study|Administration of prohibited medicine|0|||
105788909|NCT00471237|364881999|FG006|Overall Study|Administration of prohibited medicine|0|||
105788910|NCT00471237|364881993|FG000|Overall Study|Participant shifted residence|0|||
105788911|NCT00471237|364881994|FG001|Overall Study|Participant shifted residence|0|||
105788912|NCT00471237|364881995|FG002|Overall Study|Participant shifted residence|0|||
105788913|NCT00471237|364881996|FG003|Overall Study|Participant shifted residence|0|||
105788914|NCT00471237|364881997|FG004|Overall Study|Participant shifted residence|1|||
105788915|NCT00471237|364881998|FG005|Overall Study|Participant shifted residence|0|||
105788916|NCT00471237|364881999|FG006|Overall Study|Participant shifted residence|0|||
105788917|NCT00471237|364881993|FG000|Overall Study|Participant's decision|0|||
105788918|NCT00471237|364881994|FG001|Overall Study|Participant's decision|0|||
105788919|NCT00471237|364881995|FG002|Overall Study|Participant's decision|0|||
105788920|NCT00471237|364881996|FG003|Overall Study|Participant's decision|0|||
105788921|NCT00471237|364881997|FG004|Overall Study|Participant's decision|0|||
105788922|NCT00471237|364881998|FG005|Overall Study|Participant's decision|1|||
105788923|NCT00471237|364881999|FG006|Overall Study|Participant's decision|0|||
105788924|NCT02329834|364882002|FG000|Overall Study|Physician Decision|1|||
105788925|NCT02329834|364882003|FG001|Overall Study|Physician Decision|0|||
105788926|NCT00924313|364882004|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
105788927|NCT01317199|364882009|FG000|Dose-escalation Phase 1|Physician Decision|5|||
105788928|NCT01317199|364882010|FG001|Dose-escalation Phase 1|Physician Decision|0|||
105788929|NCT01317199|364882011|FG002|Dose-escalation Phase 1|Physician Decision|0|||
105788930|NCT01317199|364882012|FG003|Dose-escalation Phase 1|Physician Decision|0|||
105788931|NCT01317199|364882009|FG000|Dose-escalation Phase 1|Disease progression|1|||
105788932|NCT01317199|364882010|FG001|Dose-escalation Phase 1|Disease progression|0|||
105788933|NCT01317199|364882011|FG002|Dose-escalation Phase 1|Disease progression|0|||
105788934|NCT01317199|364882012|FG003|Dose-escalation Phase 1|Disease progression|0|||
105788935|NCT01317199|364882009|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
105788936|NCT01317199|364882010|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
105788937|NCT01317199|364882011|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
105788938|NCT01317199|364882012|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
105788939|NCT01317199|364882009|FG000|Randomized Phase 2|Disease progression|0|||
105788940|NCT01317199|364882010|FG001|Randomized Phase 2|Disease progression|3|||
105476895|NCT01239992|363759198|FG000|Overall Study|Withdrawal by Subject|2|||
105476896|NCT02894502|363759207|FG000|Baseline|Withdrawal by Subject|24|||
105476897|NCT02894502|363759208|FG001|Baseline|Withdrawal by Subject|31|||
105476898|NCT02894502|363759209|FG002|Baseline|Withdrawal by Subject|36|||
105476899|NCT02894502|363759207|FG000|Baseline|Death|3|||
105476900|NCT02894502|363759208|FG001|Baseline|Death|1|||
105476901|NCT02894502|363759209|FG002|Baseline|Death|9|||
105476902|NCT02894502|363759207|FG000|First Follow up|Withdrawal by Subject|32|||
105476903|NCT02894502|363759208|FG001|First Follow up|Withdrawal by Subject|29|||
105476904|NCT02894502|363759209|FG002|First Follow up|Withdrawal by Subject|37|||
105476905|NCT02894502|363759207|FG000|First Follow up|Death|2|||
105476906|NCT02894502|363759208|FG001|First Follow up|Death|2|||
105476907|NCT02894502|363759209|FG002|First Follow up|Death|3|||
105476908|NCT02894502|363759207|FG000|Second Follow up|Withdrawal by Subject|13|||
105476909|NCT02894502|363759208|FG001|Second Follow up|Withdrawal by Subject|15|||
105476910|NCT02894502|363759209|FG002|Second Follow up|Withdrawal by Subject|13|||
105476911|NCT02894502|363759207|FG000|Second Follow up|Death|2|||
105476912|NCT02894502|363759208|FG001|Second Follow up|Death|3|||
105476913|NCT02894502|363759209|FG002|Second Follow up|Death|1|||
105476914|NCT02894502|363759207|FG000|Third Follow up|Withdrawal by Subject|5|||
105476915|NCT02894502|363759208|FG001|Third Follow up|Withdrawal by Subject|6|||
105476916|NCT02894502|363759209|FG002|Third Follow up|Withdrawal by Subject|3|||
105476917|NCT02894502|363759207|FG000|Third Follow up|Death|1|||
105476918|NCT02894502|363759208|FG001|Third Follow up|Death|1|||
105476919|NCT02894502|363759209|FG002|Third Follow up|Death|0|||
105476920|NCT00966875|363759212|FG000|Part A|Adverse Event|2|||
105476921|NCT00966875|363759213|FG001|Part A|Adverse Event|1|||
105476922|NCT00966875|363759214|FG002|Part A|Adverse Event|0|||
105476923|NCT00966875|363759215|FG003|Part A|Adverse Event|1|||
105476924|NCT00966875|363759216|FG004|Part A|Adverse Event|0|||
105561655|NCT02565914|364052185|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
105788941|NCT01317199|364882011|FG002|Randomized Phase 2|Disease progression|7|||
105788942|NCT01317199|364882012|FG003|Randomized Phase 2|Disease progression|5|||
105476925|NCT00966875|363759217|FG005|Part A|Adverse Event|1|||
105476926|NCT00966875|363759218|FG006|Part A|Adverse Event|0|||
105476927|NCT00966875|363759219|FG007|Part A|Adverse Event|3|||
105476928|NCT00966875|363759220|FG008|Part A|Adverse Event|3|||
105476929|NCT00966875|363759212|FG000|Part A|Entry Criteria|0|||
105476930|NCT00966875|363759213|FG001|Part A|Entry Criteria|0|||
105476931|NCT00966875|363759214|FG002|Part A|Entry Criteria|0|||
105476932|NCT00966875|363759215|FG003|Part A|Entry Criteria|0|||
105476933|NCT00966875|363759216|FG004|Part A|Entry Criteria|0|||
105788943|NCT01317199|364882009|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
105788944|NCT01317199|364882010|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
105788945|NCT01317199|364882011|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
105788946|NCT01317199|364882012|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
105788947|NCT01317199|364882009|FG000|Randomized Phase 2|Adverse Event|0|||
105788948|NCT01317199|364882010|FG001|Randomized Phase 2|Adverse Event|0|||
105788949|NCT01317199|364882011|FG002|Randomized Phase 2|Adverse Event|0|||
105788950|NCT01317199|364882012|FG003|Randomized Phase 2|Adverse Event|1|||
105788951|NCT01317199|364882009|FG000|Randomized Phase 2|Comorbidities|0|||
105788952|NCT01317199|364882010|FG001|Randomized Phase 2|Comorbidities|2|||
105788953|NCT01317199|364882011|FG002|Randomized Phase 2|Comorbidities|2|||
105788954|NCT01317199|364882012|FG003|Randomized Phase 2|Comorbidities|2|||
105788955|NCT01317199|364882009|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
105788956|NCT01317199|364882010|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
105788957|NCT01317199|364882011|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
105788958|NCT01317199|364882012|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
105788959|NCT01317199|364882009|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
105788960|NCT01317199|364882010|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
105788961|NCT01317199|364882011|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
105788962|NCT01317199|364882012|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
105788963|NCT01317199|364882009|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
105788964|NCT01317199|364882010|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
105788965|NCT01317199|364882011|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
105788966|NCT01317199|364882012|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
105788967|NCT01317199|364882009|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
105788968|NCT01317199|364882010|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
105788969|NCT01317199|364882011|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
105788970|NCT01317199|364882012|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
105788971|NCT01353209|364882013|FG000|Overall Study|Adverse Event|1|||
105788972|NCT01353209|364882014|FG001|Overall Study|Adverse Event|1|||
105788973|NCT01301625|364882017|FG000|Overall Study|Death|5|||
105788974|NCT01301625|364882017|FG000|Overall Study|Not Due|21|||
105788975|NCT01301625|364882017|FG000|Overall Study|Expected|8|||
105788976|NCT01301625|364882017|FG000|Overall Study|Lost to Follow-up|1|||
105788977|NCT00627094|364882021|FG000|Overall Study|Adverse Event|8|||
105788978|NCT00627094|364882022|FG001|Overall Study|Adverse Event|7|||
105788979|NCT00627094|364882021|FG000|Overall Study|Lost to Follow-up|1|||
105788980|NCT00627094|364882022|FG001|Overall Study|Lost to Follow-up|0|||
105788981|NCT00627094|364882021|FG000|Overall Study|Withdrawal by Subject|1|||
105788982|NCT00627094|364882022|FG001|Overall Study|Withdrawal by Subject|1|||
105788983|NCT00627094|364882021|FG000|Overall Study|ulcer healed|1|||
105788984|NCT00627094|364882022|FG001|Overall Study|ulcer healed|7|||
105788985|NCT00627094|364882021|FG000|Overall Study|Other reason|1|||
105788986|NCT00627094|364882022|FG001|Overall Study|Other reason|0|||
105788987|NCT04366258|364882023|FG000|Baseline Assessments|Screen Failure|21|||
105788988|NCT04366258|364882023|FG000|Baseline Assessments|Early Termination|3|||
105788989|NCT00183170|364882026|FG000|First Intervention|Did not complete study|1|||
105788990|NCT00183170|364882027|FG001|First Intervention|Did not complete study|0|||
105788991|NCT00183170|364882026|FG000|First Intervention|Did not meet targeted BrAC|1|||
105788992|NCT00183170|364882027|FG001|First Intervention|Did not meet targeted BrAC|0|||
105788993|NCT00183170|364882026|FG000|Washout 1 Week|Did not complete study|6|||
105788994|NCT00183170|364882027|FG001|Washout 1 Week|Did not complete study|8|||
105788995|NCT00183170|364882026|FG000|Second Intervention|Did not complete study|1|||
105788996|NCT00183170|364882027|FG001|Second Intervention|Did not complete study|0|||
105788997|NCT00183170|364882026|FG000|Second Intervention|Did not meet targeted BrAC|0|||
105788998|NCT00183170|364882027|FG001|Second Intervention|Did not meet targeted BrAC|2|||
105788999|NCT04983589|364882028|FG000|Overall Study|Withdrawal by Subject|0|||
105789000|NCT04983589|364882029|FG001|Overall Study|Withdrawal by Subject|3|||
105789001|NCT04983589|364882028|FG000|Overall Study|COVID-19 Infection|1|||
105789002|NCT04983589|364882029|FG001|Overall Study|COVID-19 Infection|0|||
105789003|NCT04983589|364882028|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
105789004|NCT04983589|364882029|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
105789005|NCT04764669|364882032|FG000|Overall Study|Adverse Event|1|||
105789006|NCT04764669|364882033|FG001|Overall Study|Adverse Event|0|||
105789007|NCT04764669|364882034|FG002|Overall Study|Adverse Event|1|||
105789008|NCT04764669|364882035|FG003|Overall Study|Adverse Event|0|||
105789009|NCT04764669|364882032|FG000|Overall Study|Subject Choice|0|||
105789010|NCT04764669|364882033|FG001|Overall Study|Subject Choice|0|||
105789011|NCT04764669|364882034|FG002|Overall Study|Subject Choice|1|||
105789012|NCT04764669|364882035|FG003|Overall Study|Subject Choice|0|||
105789013|NCT04764669|364882032|FG000|Overall Study|Withdrawal by Subject|2|||
105789014|NCT04764669|364882033|FG001|Overall Study|Withdrawal by Subject|0|||
105789015|NCT04764669|364882034|FG002|Overall Study|Withdrawal by Subject|0|||
105476934|NCT00966875|363759217|FG005|Part A|Entry Criteria|2|||
105789016|NCT04764669|364882035|FG003|Overall Study|Withdrawal by Subject|0|||
105789017|NCT03919669|364882036|FG000|Overall Study|Withdrawal by Subject|1|||
105789018|NCT03919669|364882037|FG001|Overall Study|Withdrawal by Subject|0|||
105714035|NCT01665144|364612002|FG000|Extension Part|Physician Decision|29|||
105714036|NCT01665144|364612003|FG001|Extension Part|Physician Decision|0|||
105714037|NCT01665144|364612004|FG002|Extension Part|Physician Decision|13|||
105714038|NCT01665144|364612002|FG000|Extension Part|Technical problems|20|||
105714039|NCT01665144|364612003|FG001|Extension Part|Technical problems|0|||
105714040|NCT01665144|364612004|FG002|Extension Part|Technical problems|8|||
105714041|NCT01665144|364612002|FG000|Extension Part|Death|20|||
105714042|NCT01665144|364612003|FG001|Extension Part|Death|0|||
105714043|NCT01665144|364612004|FG002|Extension Part|Death|4|||
105714044|NCT01665144|364612002|FG000|Extension Part|Missing|12|||
105714045|NCT01665144|364612003|FG001|Extension Part|Missing|0|||
105789019|NCT03919669|364882038|FG002|Overall Study|Withdrawal by Subject|0|||
105789020|NCT00877799|364882042|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
105789021|NCT00877799|364882043|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
105789022|NCT00877799|364882044|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
105789023|NCT00877799|364882045|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
105789024|NCT00877799|364882046|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
105789025|NCT00877799|364882042|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
105789026|NCT00877799|364882043|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
105789027|NCT00877799|364882044|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
105789028|NCT00877799|364882045|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
105789029|NCT00877799|364882046|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
105789030|NCT00877799|364882042|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
105789031|NCT00877799|364882043|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
105789032|NCT00877799|364882044|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
105561656|NCT02565914|364052185|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
105561657|NCT02565914|364052185|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
105561658|NCT02565914|364052185|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
105561659|NCT02565914|364052185|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
105561660|NCT02565914|364052185|FG000|Part A (Up to 96 Weeks)|Other|18|||
105789033|NCT00877799|364882045|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
105789034|NCT00877799|364882046|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
105789035|NCT00877799|364882042|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
105789036|NCT00877799|364882043|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
105789037|NCT00877799|364882044|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
105789038|NCT00877799|364882045|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
105789039|NCT00877799|364882046|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
105789040|NCT00877799|364882042|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
105789041|NCT00877799|364882043|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
105789042|NCT00877799|364882044|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
105789043|NCT00877799|364882045|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
105789044|NCT00877799|364882046|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
105789045|NCT02331680|364882050|FG000|Overall Study|Adverse Event|3|||
105789046|NCT02331680|364882051|FG001|Overall Study|Adverse Event|0|||
105789047|NCT02331680|364882052|FG002|Overall Study|Adverse Event|2|||
105789048|NCT02331680|364882050|FG000|Overall Study|Physician Decision|1|||
105789049|NCT02331680|364882051|FG001|Overall Study|Physician Decision|1|||
105789050|NCT02331680|364882052|FG002|Overall Study|Physician Decision|2|||
105789051|NCT02331680|364882050|FG000|Overall Study|Withdrawal by Subject|0|||
105789052|NCT02331680|364882051|FG001|Overall Study|Withdrawal by Subject|1|||
105789053|NCT02331680|364882052|FG002|Overall Study|Withdrawal by Subject|2|||
105789054|NCT02331680|364882050|FG000|Overall Study|Met withdrawal criteria|2|||
105789055|NCT02331680|364882051|FG001|Overall Study|Met withdrawal criteria|2|||
105789056|NCT02331680|364882052|FG002|Overall Study|Met withdrawal criteria|5|||
105789057|NCT02331680|364882050|FG000|Overall Study|Non-compliance with study drug|0|||
105789058|NCT02331680|364882051|FG001|Overall Study|Non-compliance with study drug|0|||
105789059|NCT02331680|364882052|FG002|Overall Study|Non-compliance with study drug|1|||
105789060|NCT02331680|364882050|FG000|Overall Study|Protocol Violation|0|||
105789061|NCT02331680|364882051|FG001|Overall Study|Protocol Violation|0|||
105789062|NCT02331680|364882052|FG002|Overall Study|Protocol Violation|3|||
105789063|NCT00650806|364882053|FG000|Overall Study|Adverse Event|0|||
105789064|NCT00650806|364882054|FG001|Overall Study|Adverse Event|5|||
105789065|NCT00650806|364882055|FG002|Overall Study|Adverse Event|3|||
105714046|NCT01665144|364612004|FG002|Extension Part|Missing|6|||
105714047|NCT01665144|364612002|FG000|Extension Part|Lost to Follow-up|9|||
105714048|NCT01665144|364612003|FG001|Extension Part|Lost to Follow-up|0|||
105561661|NCT02565914|364052185|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
105714049|NCT01665144|364612004|FG002|Extension Part|Lost to Follow-up|5|||
105714050|NCT01665144|364612002|FG000|Extension Part|New therapy for study indication|3|||
105714051|NCT01665144|364612003|FG001|Extension Part|New therapy for study indication|0|||
105714052|NCT01665144|364612004|FG002|Extension Part|New therapy for study indication|2|||
105714053|NCT01665144|364612002|FG000|Extension Part|Protocol deviation|3|||
105714054|NCT01665144|364612003|FG001|Extension Part|Protocol deviation|0|||
105714055|NCT01665144|364612004|FG002|Extension Part|Protocol deviation|0|||
105714056|NCT00654498|364612009|FG000|Overall Study|Not Treated|1|||
105714057|NCT00654498|364612010|FG001|Overall Study|Not Treated|0|||
105714058|NCT00654498|364612009|FG000|Overall Study|Adverse Event|6|||
105714059|NCT00654498|364612010|FG001|Overall Study|Adverse Event|1|||
105714060|NCT00654498|364612009|FG000|Overall Study|Protocol Violation|1|||
105714061|NCT00654498|364612010|FG001|Overall Study|Protocol Violation|1|||
105714062|NCT00654498|364612009|FG000|Overall Study|Lost to Follow-up|1|||
105714063|NCT00654498|364612010|FG001|Overall Study|Lost to Follow-up|5|||
105714064|NCT00654498|364612009|FG000|Overall Study|Withdrawal by Subject|1|||
105714065|NCT00654498|364612010|FG001|Overall Study|Withdrawal by Subject|0|||
105714066|NCT00654498|364612009|FG000|Overall Study|Other reason not defined above|4|||
105714067|NCT00654498|364612010|FG001|Overall Study|Other reason not defined above|5|||
105714068|NCT03179436|364612013|FG000|Overall Study|Withdrawal by Subject|1|||
105714069|NCT03179436|364612014|FG001|Overall Study|Withdrawal by Subject|0|||
105789066|NCT00650806|364882056|FG003|Overall Study|Adverse Event|4|||
105789067|NCT00650806|364882053|FG000|Overall Study|Lost to Follow-up|7|||
105789068|NCT00650806|364882054|FG001|Overall Study|Lost to Follow-up|6|||
105789069|NCT00650806|364882055|FG002|Overall Study|Lost to Follow-up|11|||
105789070|NCT00650806|364882056|FG003|Overall Study|Lost to Follow-up|10|||
105789071|NCT00650806|364882053|FG000|Overall Study|Protocol Violation|0|||
105789072|NCT00650806|364882054|FG001|Overall Study|Protocol Violation|0|||
105789073|NCT00650806|364882055|FG002|Overall Study|Protocol Violation|0|||
105789074|NCT00650806|364882056|FG003|Overall Study|Protocol Violation|1|||
105789075|NCT00650806|364882053|FG000|Overall Study|Pregnancy|0|||
105789076|NCT00650806|364882054|FG001|Overall Study|Pregnancy|0|||
105789077|NCT00650806|364882055|FG002|Overall Study|Pregnancy|0|||
105789078|NCT00650806|364882056|FG003|Overall Study|Pregnancy|1|||
105789079|NCT00650806|364882053|FG000|Overall Study|Withdrawal by Subject|7|||
105789080|NCT00650806|364882054|FG001|Overall Study|Withdrawal by Subject|5|||
105789081|NCT00650806|364882055|FG002|Overall Study|Withdrawal by Subject|8|||
105789082|NCT00650806|364882056|FG003|Overall Study|Withdrawal by Subject|6|||
105789083|NCT00650806|364882053|FG000|Overall Study|Noncompliance with study drug regimen|1|||
105789084|NCT00650806|364882054|FG001|Overall Study|Noncompliance with study drug regimen|1|||
105789085|NCT00650806|364882055|FG002|Overall Study|Noncompliance with study drug regimen|0|||
105789086|NCT00650806|364882056|FG003|Overall Study|Noncompliance with study drug regimen|0|||
105789087|NCT00650806|364882053|FG000|Overall Study|Study terminated by sponsor|2|||
105789088|NCT00650806|364882054|FG001|Overall Study|Study terminated by sponsor|3|||
105789089|NCT00650806|364882055|FG002|Overall Study|Study terminated by sponsor|5|||
105789090|NCT00650806|364882056|FG003|Overall Study|Study terminated by sponsor|4|||
105789091|NCT00650806|364882053|FG000|Overall Study|Other|1|||
105789092|NCT00650806|364882054|FG001|Overall Study|Other|1|||
105789093|NCT00650806|364882055|FG002|Overall Study|Other|2|||
105789094|NCT00650806|364882056|FG003|Overall Study|Other|0|||
105789095|NCT01329562|364882059|FG000|Overall Study|Protocol Violation|5|||
105789096|NCT01329562|364882060|FG001|Overall Study|Protocol Violation|3|||
105789097|NCT01329562|364882059|FG000|Overall Study|Lost to Follow-up|1|||
105789098|NCT01329562|364882060|FG001|Overall Study|Lost to Follow-up|1|||
105789099|NCT01329562|364882059|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
105789100|NCT01329562|364882060|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
105789101|NCT01329562|364882059|FG000|Overall Study|Physician Decision|0|||
105789102|NCT01329562|364882060|FG001|Overall Study|Physician Decision|1|||
105789103|NCT01381068|364882063|FG000|Overall Study|Death|1|||
105789104|NCT01381068|364882064|FG001|Overall Study|Death|0|||
105789105|NCT03539952|364882072|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
105789106|NCT03539952|364882073|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
105789107|NCT03539952|364882072|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
105789108|NCT03539952|364882073|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
105789109|NCT03539952|364882072|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
105789110|NCT03539952|364882073|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
105789111|NCT03539952|364882072|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
105789112|NCT03539952|364882073|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
105789113|NCT03539952|364882072|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
105789114|NCT03539952|364882073|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
105789115|NCT03539952|364882072|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
105789116|NCT03539952|364882073|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
105789117|NCT03539952|364882072|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
105789118|NCT03539952|364882073|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
105789119|NCT04066894|364882074|FG000|Overall Study|Lack of Efficacy|1|||
105714070|NCT03179436|364612015|FG002|Overall Study|Withdrawal by Subject|0|||
105714071|NCT03179436|364612016|FG003|Overall Study|Withdrawal by Subject|4|||
105714072|NCT03179436|364612017|FG004|Overall Study|Withdrawal by Subject|2|||
105789120|NCT04066894|364882074|FG000|Overall Study|Screen Failure|1|||
105789121|NCT00690573|364882081|FG000|Overall Study|Lack of Efficacy|8|||
105476935|NCT00966875|363759218|FG006|Part A|Entry Criteria|0|||
105476936|NCT00966875|363759219|FG007|Part A|Entry Criteria|0|||
105476937|NCT00966875|363759220|FG008|Part A|Entry Criteria|0|||
105476938|NCT00966875|363759212|FG000|Part A|Lack of Efficacy|0|||
105476939|NCT00966875|363759213|FG001|Part A|Lack of Efficacy|1|||
105476940|NCT00966875|363759214|FG002|Part A|Lack of Efficacy|0|||
105476941|NCT00966875|363759215|FG003|Part A|Lack of Efficacy|0|||
105476942|NCT00966875|363759216|FG004|Part A|Lack of Efficacy|0|||
105476943|NCT00966875|363759217|FG005|Part A|Lack of Efficacy|0|||
105476944|NCT00966875|363759218|FG006|Part A|Lack of Efficacy|4|||
105476945|NCT00966875|363759219|FG007|Part A|Lack of Efficacy|0|||
105476946|NCT00966875|363759220|FG008|Part A|Lack of Efficacy|0|||
105476947|NCT00966875|363759212|FG000|Part A|Lost to Follow-up|2|||
105476948|NCT00966875|363759213|FG001|Part A|Lost to Follow-up|0|||
105476949|NCT00966875|363759214|FG002|Part A|Lost to Follow-up|0|||
105476950|NCT00966875|363759215|FG003|Part A|Lost to Follow-up|0|||
105476951|NCT00966875|363759216|FG004|Part A|Lost to Follow-up|0|||
105476952|NCT00966875|363759217|FG005|Part A|Lost to Follow-up|1|||
105476953|NCT00966875|363759218|FG006|Part A|Lost to Follow-up|0|||
105476954|NCT00966875|363759219|FG007|Part A|Lost to Follow-up|0|||
105476955|NCT00966875|363759220|FG008|Part A|Lost to Follow-up|0|||
105476956|NCT00966875|363759212|FG000|Part A|Parent/Caregiver Decision|0|||
105476957|NCT00966875|363759213|FG001|Part A|Parent/Caregiver Decision|0|||
105476958|NCT00966875|363759214|FG002|Part A|Parent/Caregiver Decision|0|||
105476959|NCT00966875|363759215|FG003|Part A|Parent/Caregiver Decision|1|||
105476960|NCT00966875|363759216|FG004|Part A|Parent/Caregiver Decision|0|||
105476961|NCT00966875|363759217|FG005|Part A|Parent/Caregiver Decision|0|||
105476962|NCT00966875|363759218|FG006|Part A|Parent/Caregiver Decision|0|||
105476963|NCT00966875|363759219|FG007|Part A|Parent/Caregiver Decision|0|||
105476964|NCT00966875|363759220|FG008|Part A|Parent/Caregiver Decision|0|||
105476965|NCT00966875|363759212|FG000|Part A|Physician Decision|0|||
105476966|NCT00966875|363759213|FG001|Part A|Physician Decision|0|||
105476967|NCT00966875|363759214|FG002|Part A|Physician Decision|0|||
105476968|NCT00966875|363759215|FG003|Part A|Physician Decision|0|||
105476969|NCT00966875|363759216|FG004|Part A|Physician Decision|1|||
105476970|NCT00966875|363759217|FG005|Part A|Physician Decision|0|||
105476971|NCT00966875|363759218|FG006|Part A|Physician Decision|1|||
105476972|NCT00966875|363759219|FG007|Part A|Physician Decision|0|||
105476973|NCT00966875|363759220|FG008|Part A|Physician Decision|2|||
105476974|NCT00966875|363759212|FG000|Part A|Sponsor Decision|0|||
105476975|NCT00966875|363759213|FG001|Part A|Sponsor Decision|0|||
105476976|NCT00966875|363759214|FG002|Part A|Sponsor Decision|1|||
105476977|NCT00966875|363759215|FG003|Part A|Sponsor Decision|0|||
105476978|NCT00966875|363759216|FG004|Part A|Sponsor Decision|1|||
105476979|NCT00966875|363759217|FG005|Part A|Sponsor Decision|0|||
105476980|NCT00966875|363759218|FG006|Part A|Sponsor Decision|0|||
105476981|NCT00966875|363759219|FG007|Part A|Sponsor Decision|2|||
105476982|NCT00966875|363759220|FG008|Part A|Sponsor Decision|1|||
105476983|NCT00966875|363759212|FG000|Part A|Withdrawal by Subject|2|||
105476984|NCT00966875|363759213|FG001|Part A|Withdrawal by Subject|2|||
105476985|NCT00966875|363759214|FG002|Part A|Withdrawal by Subject|1|||
105476986|NCT00966875|363759215|FG003|Part A|Withdrawal by Subject|1|||
105789122|NCT00690573|364882081|FG000|Overall Study|Withdrawal by Subject|1|||
105789123|NCT01977482|364882082|FG000|Overall Study|Adverse Event|0|||
105789124|NCT01977482|364882083|FG001|Overall Study|Adverse Event|1|||
105789125|NCT01977482|364882084|FG002|Overall Study|Adverse Event|1|||
105789126|NCT01977482|364882085|FG003|Overall Study|Adverse Event|0|||
105789127|NCT01977482|364882086|FG004|Overall Study|Adverse Event|2|||
105789128|NCT01977482|364882087|FG005|Overall Study|Adverse Event|0|||
105789129|NCT01977482|364882082|FG000|Overall Study|Lost to Follow-up|1|||
105789130|NCT01977482|364882083|FG001|Overall Study|Lost to Follow-up|0|||
105789131|NCT01977482|364882084|FG002|Overall Study|Lost to Follow-up|0|||
105789132|NCT01977482|364882085|FG003|Overall Study|Lost to Follow-up|0|||
105789133|NCT01977482|364882086|FG004|Overall Study|Lost to Follow-up|0|||
105789134|NCT01977482|364882087|FG005|Overall Study|Lost to Follow-up|0|||
105789135|NCT01977482|364882082|FG000|Overall Study|Physician Decision|0|||
105789136|NCT01977482|364882083|FG001|Overall Study|Physician Decision|1|||
105789137|NCT01977482|364882084|FG002|Overall Study|Physician Decision|0|||
105789138|NCT01977482|364882085|FG003|Overall Study|Physician Decision|0|||
105789139|NCT01977482|364882086|FG004|Overall Study|Physician Decision|0|||
105789140|NCT01977482|364882087|FG005|Overall Study|Physician Decision|0|||
105789141|NCT01977482|364882082|FG000|Overall Study|Protocol Violation|0|||
105789142|NCT01977482|364882083|FG001|Overall Study|Protocol Violation|0|||
105789143|NCT01977482|364882084|FG002|Overall Study|Protocol Violation|1|||
105789144|NCT01977482|364882085|FG003|Overall Study|Protocol Violation|0|||
105789145|NCT01977482|364882086|FG004|Overall Study|Protocol Violation|0|||
105789146|NCT01977482|364882087|FG005|Overall Study|Protocol Violation|0|||
105789147|NCT01977482|364882082|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
105789148|NCT01977482|364882083|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
105789149|NCT01977482|364882084|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
105789150|NCT01977482|364882085|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
105561662|NCT02565914|364052185|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
105561663|NCT02565914|364052185|FG000|Part B (Up to 96 Weeks)|Other|1|||
105561664|NCT02565914|364052185|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
105561665|NCT02565914|364052185|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
105561666|NCT02565914|364052185|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
105561667|NCT02565914|364052185|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
105561668|NCT02565914|364052185|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
105561669|NCT02565914|364052185|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
105561670|NCT02565914|364052185|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
105561671|NCT02565914|364052185|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
105561672|NCT02565914|364052185|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
105561673|NCT02565914|364052185|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
105561674|NCT02565914|364052185|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
105561675|NCT02565914|364052185|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
105561676|NCT05159622|364052186|FG000|Overall Study|Lost to Follow-up|4|||
105561677|NCT05159622|364052187|FG001|Overall Study|Lost to Follow-up|5|||
105561678|NCT03338894|364052190|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
105561679|NCT00863655|364052191|FG000|Overall Study|Protocol Violation|4|||
105561680|NCT00863655|364052192|FG001|Overall Study|Protocol Violation|0|||
105561681|NCT00863655|364052191|FG000|Overall Study|Adverse Event|52|||
105561682|NCT00863655|364052192|FG001|Overall Study|Adverse Event|8|||
105561683|NCT00863655|364052191|FG000|Overall Study|Withdrawal by Subject|47|||
105561684|NCT00863655|364052192|FG001|Overall Study|Withdrawal by Subject|7|||
105561685|NCT00863655|364052191|FG000|Overall Study|Administrative problems|1|||
105561686|NCT00863655|364052192|FG001|Overall Study|Administrative problems|0|||
105561687|NCT00863655|364052191|FG000|Overall Study|Death|7|||
105561688|NCT00863655|364052192|FG001|Overall Study|Death|1|||
105561689|NCT00863655|364052191|FG000|Overall Study|New cancer therapy|5|||
105561690|NCT00863655|364052192|FG001|Overall Study|New cancer therapy|1|||
105561691|NCT00863655|364052191|FG000|Overall Study|Disease progression|364|||
105561692|NCT00863655|364052192|FG001|Overall Study|Disease progression|221|||
105789151|NCT01977482|364882086|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
105789152|NCT01977482|364882087|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
105789153|NCT01977482|364882082|FG000|Overall Study|Withdrawal by Subject|2|||
105789154|NCT01977482|364882083|FG001|Overall Study|Withdrawal by Subject|4|||
105789155|NCT01977482|364882084|FG002|Overall Study|Withdrawal by Subject|1|||
105789156|NCT01977482|364882085|FG003|Overall Study|Withdrawal by Subject|3|||
105789157|NCT01977482|364882086|FG004|Overall Study|Withdrawal by Subject|1|||
105789158|NCT01977482|364882087|FG005|Overall Study|Withdrawal by Subject|5|||
105789159|NCT01361308|364883288|FG000|Overall Study|Withdrawal by Subject|9|||
105789160|NCT01361308|364883289|FG001|Overall Study|Withdrawal by Subject|13|||
105789161|NCT01361308|364883288|FG000|Overall Study|Physician Decision|3|||
105789162|NCT01361308|364883289|FG001|Overall Study|Physician Decision|3|||
105789163|NCT01361308|364883288|FG000|Overall Study|Lack of Efficacy|2|||
105789164|NCT01361308|364883289|FG001|Overall Study|Lack of Efficacy|0|||
105789165|NCT01361308|364883288|FG000|Overall Study|Protocol Violation|1|||
105789166|NCT01361308|364883289|FG001|Overall Study|Protocol Violation|0|||
105789167|NCT01361308|364883288|FG000|Overall Study|Lost to Follow-up|5|||
105789168|NCT01361308|364883289|FG001|Overall Study|Lost to Follow-up|4|||
105789169|NCT01361308|364883288|FG000|Overall Study|Adverse Event|8|||
105561693|NCT00863655|364052191|FG000|Overall Study|Treatment completed as per protocol|5|||
105561694|NCT00863655|364052192|FG001|Overall Study|Treatment completed as per protocol|1|||
105561695|NCT02157779|364052195|FG000|Overall Study|Logistical|9|||
105561696|NCT02157779|364052196|FG001|Overall Study|Logistical|3|||
105561697|NCT02157779|364052195|FG000|Overall Study|Stopped attending, reason unknown|11|||
105561698|NCT02157779|364052196|FG001|Overall Study|Stopped attending, reason unknown|7|||
105561699|NCT02157779|364052195|FG000|Overall Study|No response to outreach after Baseline|1|||
105789170|NCT01361308|364883289|FG001|Overall Study|Adverse Event|4|||
105789171|NCT01361308|364883288|FG000|Overall Study|Eligibility Criteria Not Met|2|||
105789172|NCT01361308|364883289|FG001|Overall Study|Eligibility Criteria Not Met|3|||
105789173|NCT01361308|364883288|FG000|Overall Study|Failed C-SSRS|5|||
105789174|NCT01361308|364883289|FG001|Overall Study|Failed C-SSRS|2|||
105789175|NCT01361308|364883288|FG000|Overall Study|Other|0|||
105789176|NCT01361308|364883289|FG001|Overall Study|Other|1|||
105561700|NCT02157779|364052196|FG001|Overall Study|No response to outreach after Baseline|1|||
105561701|NCT02157779|364052195|FG000|Overall Study|Moved|1|||
105561702|NCT02157779|364052196|FG001|Overall Study|Moved|0|||
105561703|NCT02157779|364052195|FG000|Overall Study|Medical|1|||
105789177|NCT02503215|364883294|FG000|Overall Study|Unable to wear compression stockings|1|||
105789178|NCT02503215|364883294|FG000|Overall Study|Unable to use positive airway pressure|2|||
105789179|NCT01319994|364883295|FG000|Overall Study|Protocol Violation|7|||
105789180|NCT01319994|364883296|FG001|Overall Study|Protocol Violation|6|||
105789181|NCT01605370|364883297|FG000|Overall Study|Adverse Event|1|||
105789182|NCT01605370|364883298|FG001|Overall Study|Adverse Event|0|||
105789183|NCT01165424|364883300|FG000|Overall Study|Clinical adverse experiences|1|||
105789184|NCT01165424|364883300|FG000|Overall Study|Laboratory adverse experiences|1|||
105789185|NCT01165424|364883300|FG000|Overall Study|Did not meet entry criteria|1|||
105789186|NCT01165424|364883300|FG000|Overall Study|Participant moved (relocated)|1|||
105789187|NCT00978120|364883301|FG000|Overall Study|Death|0|||
105789188|NCT00978120|364883302|FG001|Overall Study|Death|0|||
105789189|NCT00978120|364883303|FG002|Overall Study|Death|0|||
105789190|NCT00978120|364883304|FG003|Overall Study|Death|1|||
105789191|NCT00978120|364883301|FG000|Overall Study|Lost to Follow-up|0|||
105789192|NCT00978120|364883302|FG001|Overall Study|Lost to Follow-up|0|||
105789193|NCT00978120|364883303|FG002|Overall Study|Lost to Follow-up|3|||
105789194|NCT00978120|364883304|FG003|Overall Study|Lost to Follow-up|0|||
105789195|NCT00978120|364883301|FG000|Overall Study|Withdrawal by Subject|2|||
105789196|NCT00978120|364883302|FG001|Overall Study|Withdrawal by Subject|0|||
105789197|NCT00978120|364883303|FG002|Overall Study|Withdrawal by Subject|0|||
105789198|NCT00978120|364883304|FG003|Overall Study|Withdrawal by Subject|0|||
105789199|NCT00978120|364883301|FG000|Overall Study|Moved out of state|0|||
105789200|NCT00978120|364883302|FG001|Overall Study|Moved out of state|0|||
105789201|NCT00978120|364883303|FG002|Overall Study|Moved out of state|0|||
105789202|NCT00978120|364883304|FG003|Overall Study|Moved out of state|1|||
105789203|NCT02871921|364883305|FG000|Overall Study|Withdrawal by Subject|34|||
105789204|NCT02871921|364883306|FG001|Overall Study|Withdrawal by Subject|27|||
105789205|NCT02871921|364883307|FG002|Overall Study|Withdrawal by Subject|27|||
105476987|NCT00966875|363759216|FG004|Part A|Withdrawal by Subject|3|||
105789206|NCT02871921|364883308|FG003|Overall Study|Withdrawal by Subject|30|||
105789207|NCT00320801|364883312|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
105789208|NCT00320801|364883313|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
105789209|NCT00320801|364883314|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
105789210|NCT00320801|364883315|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
105789211|NCT00320801|364883312|FG000|Open-label Run-in Period|Adverse Event|33|||
105789212|NCT00320801|364883313|FG001|Open-label Run-in Period|Adverse Event|0|||
105789213|NCT00320801|364883314|FG002|Open-label Run-in Period|Adverse Event|0|||
105789214|NCT00320801|364883315|FG003|Open-label Run-in Period|Adverse Event|0|||
105789215|NCT00320801|364883312|FG000|Open-label Run-in Period|Administrative|10|||
105789216|NCT00320801|364883313|FG001|Open-label Run-in Period|Administrative|0|||
105789217|NCT00320801|364883314|FG002|Open-label Run-in Period|Administrative|0|||
105789218|NCT00320801|364883315|FG003|Open-label Run-in Period|Administrative|0|||
105789219|NCT00320801|364883312|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
105789220|NCT00320801|364883313|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
105789221|NCT00320801|364883314|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
105789222|NCT00320801|364883315|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
105789223|NCT00320801|364883312|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
105789224|NCT00320801|364883313|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
105789225|NCT00320801|364883314|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
105789226|NCT00320801|364883315|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
105789227|NCT00320801|364883312|FG000|Open-label Run-in Period|Did not qualify|1|||
105789228|NCT00320801|364883313|FG001|Open-label Run-in Period|Did not qualify|0|||
105789229|NCT00320801|364883314|FG002|Open-label Run-in Period|Did not qualify|0|||
105789230|NCT00320801|364883315|FG003|Open-label Run-in Period|Did not qualify|0|||
105789231|NCT00320801|364883312|FG000|Double-blind Phase|Withdrawal by Subject|0|||
105476988|NCT00966875|363759217|FG005|Part A|Withdrawal by Subject|0|||
105476989|NCT00966875|363759218|FG006|Part A|Withdrawal by Subject|5|||
105476990|NCT00966875|363759219|FG007|Part A|Withdrawal by Subject|1|||
105476991|NCT00966875|363759220|FG008|Part A|Withdrawal by Subject|1|||
105476992|NCT00966875|363759212|FG000|Part A|Protocol Violation|0|||
105476993|NCT00966875|363759213|FG001|Part A|Protocol Violation|0|||
105476994|NCT00966875|363759214|FG002|Part A|Protocol Violation|0|||
105476995|NCT00966875|363759215|FG003|Part A|Protocol Violation|0|||
105476996|NCT00966875|363759216|FG004|Part A|Protocol Violation|0|||
105476997|NCT00966875|363759217|FG005|Part A|Protocol Violation|0|||
105561704|NCT02157779|364052196|FG001|Overall Study|Medical|0|||
105561705|NCT02157779|364052195|FG000|Overall Study|Legal issue|1|||
105789232|NCT00320801|364883313|FG001|Double-blind Phase|Withdrawal by Subject|0|||
105476998|NCT00966875|363759218|FG006|Part A|Protocol Violation|2|||
105561706|NCT02157779|364052196|FG001|Overall Study|Legal issue|0|||
105476999|NCT00966875|363759219|FG007|Part A|Protocol Violation|1|||
105561707|NCT02570126|364052205|FG000|Overall Study|Lost to Follow-up|2|||
105561708|NCT02570126|364052206|FG001|Overall Study|Lost to Follow-up|0|||
105789233|NCT00320801|364883314|FG002|Double-blind Phase|Withdrawal by Subject|1|||
105789234|NCT00320801|364883315|FG003|Double-blind Phase|Withdrawal by Subject|0|||
105789235|NCT00320801|364883312|FG000|Double-blind Phase|Adverse Event|0|||
105789236|NCT00320801|364883313|FG001|Double-blind Phase|Adverse Event|2|||
105789237|NCT00320801|364883314|FG002|Double-blind Phase|Adverse Event|8|||
105789238|NCT00320801|364883315|FG003|Double-blind Phase|Adverse Event|0|||
105789239|NCT00320801|364883312|FG000|Double-blind Phase|Administrative|0|||
105789240|NCT00320801|364883313|FG001|Double-blind Phase|Administrative|0|||
105477000|NCT00966875|363759220|FG008|Part A|Protocol Violation|1|||
105477001|NCT00966875|363759212|FG000|Part B|Adverse Event|0|||
105561709|NCT02570126|364052205|FG000|Overall Study|Unable To Arrange Visit 3|1|||
105789241|NCT00320801|364883314|FG002|Double-blind Phase|Administrative|4|||
105789242|NCT00320801|364883315|FG003|Double-blind Phase|Administrative|0|||
105789243|NCT00320801|364883312|FG000|Double-blind Phase|Lack of Efficacy|0|||
105789244|NCT00320801|364883313|FG001|Double-blind Phase|Lack of Efficacy|9|||
105789245|NCT00320801|364883314|FG002|Double-blind Phase|Lack of Efficacy|1|||
105789246|NCT00320801|364883315|FG003|Double-blind Phase|Lack of Efficacy|0|||
105789247|NCT00320801|364883312|FG000|Extension Phase|Withdrawal by Subject|0|||
105789248|NCT00320801|364883313|FG001|Extension Phase|Withdrawal by Subject|0|||
105789249|NCT00320801|364883314|FG002|Extension Phase|Withdrawal by Subject|0|||
105789250|NCT00320801|364883315|FG003|Extension Phase|Withdrawal by Subject|6|||
105789251|NCT00320801|364883312|FG000|Extension Phase|Adverse Event|0|||
105789252|NCT00320801|364883313|FG001|Extension Phase|Adverse Event|0|||
105789253|NCT00320801|364883314|FG002|Extension Phase|Adverse Event|0|||
105789254|NCT00320801|364883315|FG003|Extension Phase|Adverse Event|8|||
105789255|NCT00320801|364883312|FG000|Extension Phase|Administrative|0|||
105789256|NCT00320801|364883313|FG001|Extension Phase|Administrative|0|||
105789257|NCT00320801|364883314|FG002|Extension Phase|Administrative|0|||
105789258|NCT00320801|364883315|FG003|Extension Phase|Administrative|29|||
105789259|NCT00320801|364883312|FG000|Extension Phase|Lack of Efficacy|0|||
105789260|NCT00320801|364883313|FG001|Extension Phase|Lack of Efficacy|0|||
105789261|NCT00320801|364883314|FG002|Extension Phase|Lack of Efficacy|0|||
105789262|NCT00320801|364883315|FG003|Extension Phase|Lack of Efficacy|2|||
105789263|NCT00320801|364883312|FG000|Extension Phase|Lost to Follow-up|0|||
105789264|NCT00320801|364883313|FG001|Extension Phase|Lost to Follow-up|0|||
105789265|NCT00320801|364883314|FG002|Extension Phase|Lost to Follow-up|0|||
105789266|NCT00320801|364883315|FG003|Extension Phase|Lost to Follow-up|3|||
105789267|NCT00337727|364883316|FG000|Overall Study|Adverse Event|5|||
105789268|NCT00337727|364883317|FG001|Overall Study|Adverse Event|3|||
105789269|NCT00337727|364883316|FG000|Overall Study|Lost to Follow-up|5|||
105789270|NCT00337727|364883317|FG001|Overall Study|Lost to Follow-up|4|||
105789271|NCT00337727|364883316|FG000|Overall Study|Physician Decision|1|||
105789272|NCT00337727|364883317|FG001|Overall Study|Physician Decision|0|||
105789273|NCT00337727|364883316|FG000|Overall Study|Protocol Violation|4|||
105789274|NCT00337727|364883317|FG001|Overall Study|Protocol Violation|0|||
105789275|NCT00337727|364883316|FG000|Overall Study|Withdrawal by Subject|3|||
105789276|NCT00337727|364883317|FG001|Overall Study|Withdrawal by Subject|5|||
105789277|NCT00577031|364883319|FG000|Overall Study|Adverse Event|52|||
105789278|NCT00577031|364883319|FG000|Overall Study|Progression of disease|93|||
105789279|NCT00577031|364883319|FG000|Overall Study|Protocol Violation|5|||
105789280|NCT00577031|364883319|FG000|Overall Study|Participant withdrew consent|13|||
105789281|NCT00577031|364883319|FG000|Overall Study|Participant non-compliance|5|||
105789282|NCT00577031|364883319|FG000|Overall Study|Need for surgery|17|||
105789283|NCT00577031|364883319|FG000|Overall Study|Medical decision|14|||
105789284|NCT00577031|364883319|FG000|Overall Study|Death|6|||
105789285|NCT00943826|364883320|FG000|Concurrent Phase|Adverse Event|50|||
105789286|NCT00943826|364883321|FG001|Concurrent Phase|Adverse Event|27|||
105789287|NCT00943826|364883320|FG000|Concurrent Phase|Withdrew consent|3|||
105789288|NCT00943826|364883321|FG001|Concurrent Phase|Withdrew consent|7|||
105789289|NCT00943826|364883320|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
105789290|NCT00943826|364883321|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
105789291|NCT00943826|364883320|FG000|Concurrent Phase|Administrative reasons|2|||
105789292|NCT00943826|364883321|FG001|Concurrent Phase|Administrative reasons|1|||
105789293|NCT00943826|364883320|FG000|Concurrent Phase|Protocol Violation|1|||
105789294|NCT00943826|364883321|FG001|Concurrent Phase|Protocol Violation|0|||
105789295|NCT00943826|364883320|FG000|Maintenance Phase|Adverse Event|31|||
105789296|NCT00943826|364883321|FG001|Maintenance Phase|Adverse Event|30|||
105789297|NCT00943826|364883320|FG000|Maintenance Phase|Withdrew consent|2|||
105789298|NCT00943826|364883321|FG001|Maintenance Phase|Withdrew consent|4|||
105789299|NCT00943826|364883320|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
105789300|NCT00943826|364883321|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
105789301|NCT00943826|364883320|FG000|Maintenance Phase|Administrative reasons|4|||
105789302|NCT00943826|364883321|FG001|Maintenance Phase|Administrative reasons|1|||
105789303|NCT00943826|364883320|FG000|Maintenance Phase|Failure to return|0|||
105789304|NCT00943826|364883321|FG001|Maintenance Phase|Failure to return|1|||
105789305|NCT00943826|364883320|FG000|Monotherapy Phase|Adverse Event|42|||
105789306|NCT00943826|364883321|FG001|Monotherapy Phase|Adverse Event|5|||
105789307|NCT00943826|364883320|FG000|Monotherapy Phase|Administrative reasons|11|||
105789308|NCT00943826|364883321|FG001|Monotherapy Phase|Administrative reasons|5|||
105789309|NCT00943826|364883320|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
105789310|NCT00943826|364883321|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
105789311|NCT00943826|364883320|FG000|Monotherapy Phase|Withdrew Consent|2|||
105789312|NCT00943826|364883321|FG001|Monotherapy Phase|Withdrew Consent|3|||
105789313|NCT00943826|364883320|FG000|Monotherapy Phase|Failure to return|2|||
105789314|NCT00943826|364883321|FG001|Monotherapy Phase|Failure to return|1|||
105789315|NCT00943826|364883320|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
105789316|NCT00943826|364883321|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
105789317|NCT00943826|364883320|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
105789318|NCT00943826|364883321|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
105789319|NCT00943826|364883320|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
105789320|NCT00943826|364883321|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
105789321|NCT00943826|364883320|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
105789322|NCT00943826|364883321|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
105789323|NCT04113746|364883322|FG000|Overall Study|Lost to Follow-up|4|||
105789324|NCT04113746|364883323|FG001|Overall Study|Lost to Follow-up|4|||
105789325|NCT01977625|364883324|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
105789326|NCT01977625|364883325|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
105789327|NCT01977625|364883324|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
105789328|NCT01977625|364883325|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
105789329|NCT00326625|364883326|FG000|Overall Study|Adverse Event|20|||
105789330|NCT00326625|364883327|FG001|Overall Study|Adverse Event|9|||
105789331|NCT00326625|364883326|FG000|Overall Study|Withdrawal by Subject|15|||
105789332|NCT00326625|364883327|FG001|Overall Study|Withdrawal by Subject|12|||
105789333|NCT00326625|364883326|FG000|Overall Study|Death|18|||
105789334|NCT00326625|364883327|FG001|Overall Study|Death|16|||
105789335|NCT00326625|364883326|FG000|Overall Study|Lost to Follow-up|1|||
105789336|NCT00326625|364883327|FG001|Overall Study|Lost to Follow-up|0|||
105789337|NCT00326625|364883326|FG000|Overall Study|prescheduled medical intervention|0|||
105789338|NCT00326625|364883327|FG001|Overall Study|prescheduled medical intervention|1|||
105789339|NCT02594384|364883328|FG000|Overall Study|Disease Progression|3|||
105789340|NCT02594384|364883329|FG001|Overall Study|Disease Progression|7|||
105789341|NCT02594384|364883330|FG002|Overall Study|Disease Progression|0|||
105789342|NCT02594384|364883331|FG003|Overall Study|Disease Progression|2|||
105789343|NCT02594384|364883332|FG004|Overall Study|Disease Progression|2|||
105789344|NCT02594384|364883333|FG005|Overall Study|Disease Progression|12|||
105789345|NCT02594384|364883334|FG006|Overall Study|Disease Progression|5|||
105789346|NCT02594384|364883335|FG007|Overall Study|Disease Progression|5|||
105789347|NCT02594384|364883328|FG000|Overall Study|Adverse Event|0|||
105789348|NCT02594384|364883329|FG001|Overall Study|Adverse Event|1|||
105789349|NCT02594384|364883330|FG002|Overall Study|Adverse Event|4|||
105789350|NCT02594384|364883331|FG003|Overall Study|Adverse Event|1|||
105789351|NCT02594384|364883332|FG004|Overall Study|Adverse Event|0|||
105789352|NCT02594384|364883333|FG005|Overall Study|Adverse Event|6|||
105789353|NCT02594384|364883334|FG006|Overall Study|Adverse Event|1|||
105789354|NCT02594384|364883335|FG007|Overall Study|Adverse Event|1|||
105789355|NCT02594384|364883328|FG000|Overall Study|Withdrawal by Subject|0|||
105789356|NCT02594384|364883329|FG001|Overall Study|Withdrawal by Subject|0|||
105789357|NCT02594384|364883330|FG002|Overall Study|Withdrawal by Subject|0|||
105789358|NCT02594384|364883331|FG003|Overall Study|Withdrawal by Subject|1|||
105789359|NCT02594384|364883332|FG004|Overall Study|Withdrawal by Subject|0|||
105789360|NCT02594384|364883333|FG005|Overall Study|Withdrawal by Subject|0|||
105789361|NCT02594384|364883334|FG006|Overall Study|Withdrawal by Subject|0|||
105789362|NCT02594384|364883335|FG007|Overall Study|Withdrawal by Subject|1|||
105789363|NCT02594384|364883328|FG000|Overall Study|Physician Decision|0|||
105789364|NCT02594384|364883329|FG001|Overall Study|Physician Decision|0|||
105789365|NCT02594384|364883330|FG002|Overall Study|Physician Decision|0|||
105789366|NCT02594384|364883331|FG003|Overall Study|Physician Decision|0|||
105789367|NCT02594384|364883332|FG004|Overall Study|Physician Decision|0|||
105789368|NCT02594384|364883333|FG005|Overall Study|Physician Decision|1|||
105789369|NCT02594384|364883334|FG006|Overall Study|Physician Decision|2|||
105789370|NCT02594384|364883335|FG007|Overall Study|Physician Decision|0|||
105789371|NCT02594384|364883328|FG000|Overall Study|Progressive Leukocytosis|0|||
105789372|NCT02594384|364883329|FG001|Overall Study|Progressive Leukocytosis|0|||
105789373|NCT02594384|364883330|FG002|Overall Study|Progressive Leukocytosis|1|||
105789374|NCT02594384|364883331|FG003|Overall Study|Progressive Leukocytosis|0|||
105789375|NCT02594384|364883332|FG004|Overall Study|Progressive Leukocytosis|0|||
105789376|NCT02594384|364883333|FG005|Overall Study|Progressive Leukocytosis|0|||
105789377|NCT02594384|364883334|FG006|Overall Study|Progressive Leukocytosis|0|||
105789378|NCT02594384|364883335|FG007|Overall Study|Progressive Leukocytosis|0|||
105789379|NCT02594384|364883328|FG000|Overall Study|Lack of Efficacy|0|||
105789380|NCT02594384|364883329|FG001|Overall Study|Lack of Efficacy|0|||
105789381|NCT02594384|364883330|FG002|Overall Study|Lack of Efficacy|0|||
105789382|NCT02594384|364883331|FG003|Overall Study|Lack of Efficacy|0|||
105789383|NCT02594384|364883332|FG004|Overall Study|Lack of Efficacy|1|||
105789384|NCT02594384|364883333|FG005|Overall Study|Lack of Efficacy|0|||
105789385|NCT02594384|364883334|FG006|Overall Study|Lack of Efficacy|0|||
105789386|NCT02594384|364883335|FG007|Overall Study|Lack of Efficacy|0|||
105789387|NCT02594384|364883328|FG000|Overall Study|Substantial noncompliance|0|||
105789388|NCT02594384|364883329|FG001|Overall Study|Substantial noncompliance|0|||
105789389|NCT02594384|364883330|FG002|Overall Study|Substantial noncompliance|0|||
105789390|NCT02594384|364883331|FG003|Overall Study|Substantial noncompliance|0|||
105789391|NCT02594384|364883332|FG004|Overall Study|Substantial noncompliance|0|||
105789392|NCT02594384|364883333|FG005|Overall Study|Substantial noncompliance|0|||
105789393|NCT02594384|364883334|FG006|Overall Study|Substantial noncompliance|1|||
105789394|NCT02594384|364883335|FG007|Overall Study|Substantial noncompliance|0|||
105789395|NCT00491322|364883336|FG000|Overall Study|Protocol Violation|1|||
105789396|NCT00491322|364883337|FG001|Overall Study|Protocol Violation|0|||
105789397|NCT00491322|364883336|FG000|Overall Study|Pregnancy|0|||
105789398|NCT00491322|364883337|FG001|Overall Study|Pregnancy|1|||
105789399|NCT00538473|364883338|FG000|Overall Study|Adverse Event|1|||
105789400|NCT00538473|364883339|FG001|Overall Study|Adverse Event|0|||
105789401|NCT02279888|364883340|FG000|Overall Study|Death|326|||
105789402|NCT02279888|364883340|FG000|Overall Study|Withdrawal by Subject|38|||
105789403|NCT02279888|364883340|FG000|Overall Study|Lost to Follow-up|21|||
105789404|NCT02279888|364883340|FG000|Overall Study|Physician Decision|62|||
105789405|NCT02279888|364883340|FG000|Overall Study|Subject Non-compliance|43|||
105789406|NCT02279888|364883340|FG000|Overall Study|Not implanted|14|||
105789407|NCT02279888|364883340|FG000|Overall Study|Visit not performed|26|||
105789408|NCT01891669|364883341|FG000|Overall Study|Death|0|||
105789409|NCT01891669|364883342|FG001|Overall Study|Death|0|||
105789410|NCT01891669|364883343|FG002|Overall Study|Death|0|||
105789411|NCT01891669|364883344|FG003|Overall Study|Death|0|||
105789412|NCT01891669|364883345|FG004|Overall Study|Death|0|||
105789413|NCT01891669|364883346|FG005|Overall Study|Death|0|||
105789414|NCT01891669|364883347|FG006|Overall Study|Death|0|||
105789415|NCT01891669|364883348|FG007|Overall Study|Death|1|||
105789416|NCT01891669|364883349|FG008|Overall Study|Death|0|||
105789417|NCT01891669|364883350|FG009|Overall Study|Death|1|||
105789418|NCT01891669|364883341|FG000|Overall Study|Withdrawal by Subject|1|||
105789419|NCT01891669|364883342|FG001|Overall Study|Withdrawal by Subject|1|||
105789420|NCT01891669|364883343|FG002|Overall Study|Withdrawal by Subject|0|||
105789421|NCT01891669|364883344|FG003|Overall Study|Withdrawal by Subject|0|||
105789422|NCT01891669|364883345|FG004|Overall Study|Withdrawal by Subject|0|||
105789423|NCT01891669|364883346|FG005|Overall Study|Withdrawal by Subject|0|||
105789424|NCT01891669|364883347|FG006|Overall Study|Withdrawal by Subject|1|||
105477002|NCT00966875|363759213|FG001|Part B|Adverse Event|1|||
105477003|NCT00966875|363759214|FG002|Part B|Adverse Event|1|||
105477004|NCT00966875|363759215|FG003|Part B|Adverse Event|0|||
105477005|NCT00966875|363759216|FG004|Part B|Adverse Event|1|||
105477006|NCT00966875|363759217|FG005|Part B|Adverse Event|0|||
105477007|NCT00966875|363759218|FG006|Part B|Adverse Event|5|||
105561710|NCT02570126|364052206|FG001|Overall Study|Unable To Arrange Visit 3|0|||
105561711|NCT02570126|364052205|FG000|Overall Study|Violation Of Procedures GSK|0|||
105561712|NCT02570126|364052206|FG001|Overall Study|Violation Of Procedures GSK|1|||
105561713|NCT02570126|364052205|FG000|Overall Study|Protocol Violation|0|||
105561714|NCT02570126|364052206|FG001|Overall Study|Protocol Violation|1|||
105561715|NCT02570126|364052205|FG000|Overall Study|Withdrawal by Subject|3|||
105561716|NCT02570126|364052206|FG001|Overall Study|Withdrawal by Subject|7|||
105561717|NCT00815295|364052207|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
105561718|NCT00815295|364052208|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
105561719|NCT00815295|364052209|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
105561720|NCT00917579|364052210|FG000|Washout >= 2 Weeks|Adverse Event|1|||
105561721|NCT00917579|364052211|FG001|Washout >= 2 Weeks|Adverse Event|0|||
105561722|NCT00917579|364052210|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
105561723|NCT00917579|364052211|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
105561724|NCT01137474|364052214|FG000|Overall Study|Adverse Event|3|||
105561725|NCT01137474|364052215|FG001|Overall Study|Adverse Event|5|||
105561726|NCT01137474|364052216|FG002|Overall Study|Adverse Event|1|||
105561727|NCT01137474|364052217|FG003|Overall Study|Adverse Event|3|||
105561728|NCT01137474|364052214|FG000|Overall Study|Withdrawal by Subject|7|||
105561729|NCT01137474|364052215|FG001|Overall Study|Withdrawal by Subject|2|||
105789425|NCT01891669|364883348|FG007|Overall Study|Withdrawal by Subject|2|||
105477008|NCT00966875|363759219|FG007|Part B|Adverse Event|2|||
105477009|NCT00966875|363759220|FG008|Part B|Adverse Event|2|||
105477010|NCT00966875|363759212|FG000|Part B|Death|0|||
105477011|NCT00966875|363759213|FG001|Part B|Death|0|||
105477012|NCT00966875|363759214|FG002|Part B|Death|1|||
105477013|NCT00966875|363759215|FG003|Part B|Death|0|||
105477014|NCT00966875|363759216|FG004|Part B|Death|0|||
105477015|NCT00966875|363759217|FG005|Part B|Death|0|||
105477016|NCT00966875|363759218|FG006|Part B|Death|0|||
105477017|NCT00966875|363759219|FG007|Part B|Death|1|||
105477018|NCT00966875|363759220|FG008|Part B|Death|0|||
105477019|NCT00966875|363759212|FG000|Part B|Lack of Efficacy|2|||
105477020|NCT00966875|363759213|FG001|Part B|Lack of Efficacy|1|||
105477021|NCT00966875|363759214|FG002|Part B|Lack of Efficacy|1|||
105477022|NCT00966875|363759215|FG003|Part B|Lack of Efficacy|1|||
105477023|NCT00966875|363759216|FG004|Part B|Lack of Efficacy|2|||
105477024|NCT00966875|363759217|FG005|Part B|Lack of Efficacy|3|||
105477025|NCT00966875|363759218|FG006|Part B|Lack of Efficacy|12|||
105477026|NCT00966875|363759219|FG007|Part B|Lack of Efficacy|9|||
105477027|NCT00966875|363759220|FG008|Part B|Lack of Efficacy|6|||
105477028|NCT00966875|363759212|FG000|Part B|Lost to Follow-up|0|||
105477029|NCT00966875|363759213|FG001|Part B|Lost to Follow-up|0|||
105477030|NCT00966875|363759214|FG002|Part B|Lost to Follow-up|0|||
105477031|NCT00966875|363759215|FG003|Part B|Lost to Follow-up|1|||
105477032|NCT00966875|363759216|FG004|Part B|Lost to Follow-up|0|||
105477033|NCT00966875|363759217|FG005|Part B|Lost to Follow-up|0|||
105477034|NCT00966875|363759218|FG006|Part B|Lost to Follow-up|0|||
105477035|NCT00966875|363759219|FG007|Part B|Lost to Follow-up|0|||
105477036|NCT00966875|363759220|FG008|Part B|Lost to Follow-up|1|||
105477037|NCT00966875|363759212|FG000|Part B|Physician Decision|0|||
105477038|NCT00966875|363759213|FG001|Part B|Physician Decision|0|||
105561730|NCT01137474|364052216|FG002|Overall Study|Withdrawal by Subject|6|||
105561731|NCT01137474|364052217|FG003|Overall Study|Withdrawal by Subject|9|||
105561732|NCT01137474|364052214|FG000|Overall Study|No longer met study criteria|6|||
105789426|NCT01891669|364883349|FG008|Overall Study|Withdrawal by Subject|1|||
105477039|NCT00966875|363759214|FG002|Part B|Physician Decision|1|||
105477040|NCT00966875|363759215|FG003|Part B|Physician Decision|0|||
105477041|NCT00966875|363759216|FG004|Part B|Physician Decision|2|||
105477042|NCT00966875|363759217|FG005|Part B|Physician Decision|1|||
105477043|NCT00966875|363759218|FG006|Part B|Physician Decision|0|||
105477044|NCT00966875|363759219|FG007|Part B|Physician Decision|0|||
105477045|NCT00966875|363759220|FG008|Part B|Physician Decision|2|||
105561733|NCT01137474|364052215|FG001|Overall Study|No longer met study criteria|1|||
105561734|NCT01137474|364052216|FG002|Overall Study|No longer met study criteria|0|||
105561735|NCT01137474|364052217|FG003|Overall Study|No longer met study criteria|5|||
105561736|NCT01137474|364052214|FG000|Overall Study|Lost to Follow-up|5|||
105561737|NCT01137474|364052215|FG001|Overall Study|Lost to Follow-up|1|||
105477046|NCT00966875|363759212|FG000|Part B|Sponsor Decision|1|||
105477047|NCT00966875|363759213|FG001|Part B|Sponsor Decision|0|||
105477048|NCT00966875|363759214|FG002|Part B|Sponsor Decision|0|||
105477049|NCT00966875|363759215|FG003|Part B|Sponsor Decision|0|||
105477050|NCT00966875|363759216|FG004|Part B|Sponsor Decision|0|||
105477051|NCT00966875|363759217|FG005|Part B|Sponsor Decision|1|||
105477052|NCT00966875|363759218|FG006|Part B|Sponsor Decision|0|||
105477053|NCT00966875|363759219|FG007|Part B|Sponsor Decision|2|||
105477054|NCT00966875|363759220|FG008|Part B|Sponsor Decision|1|||
105477055|NCT00966875|363759212|FG000|Part B|Withdrawal by Subject|2|||
105789427|NCT01891669|364883350|FG009|Overall Study|Withdrawal by Subject|1|||
105789428|NCT01891669|364883341|FG000|Overall Study|Other|1|||
105789429|NCT01891669|364883342|FG001|Overall Study|Other|0|||
105789430|NCT01891669|364883343|FG002|Overall Study|Other|0|||
105789431|NCT01891669|364883344|FG003|Overall Study|Other|0|||
105789432|NCT01891669|364883345|FG004|Overall Study|Other|0|||
105789433|NCT01891669|364883346|FG005|Overall Study|Other|0|||
105789434|NCT01891669|364883347|FG006|Overall Study|Other|0|||
105789435|NCT01891669|364883348|FG007|Overall Study|Other|1|||
105789436|NCT01891669|364883349|FG008|Overall Study|Other|0|||
105789437|NCT01891669|364883350|FG009|Overall Study|Other|0|||
105789438|NCT03843775|364883351|FG000|Overall Study|Adverse Event|1|||
105789439|NCT03843775|364883352|FG001|Overall Study|Adverse Event|1|||
105789440|NCT03843775|364883351|FG000|Overall Study|Lack of Efficacy|2|||
105789441|NCT03843775|364883352|FG001|Overall Study|Lack of Efficacy|6|||
105789442|NCT03843775|364883351|FG000|Overall Study|Withdrawal by Subject|0|||
105789443|NCT03843775|364883352|FG001|Overall Study|Withdrawal by Subject|1|||
105789444|NCT04150107|364883353|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
105789445|NCT04150107|364883354|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
105789446|NCT04150107|364883353|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
105789447|NCT04150107|364883354|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
105789448|NCT03930615|364883358|FG000|Overall Study|Death|9|||
105789449|NCT03930615|364883359|FG001|Overall Study|Death|3|||
105789450|NCT03930615|364883358|FG000|Overall Study|Lost to Follow-up|1|||
105789451|NCT03930615|364883359|FG001|Overall Study|Lost to Follow-up|2|||
105789452|NCT03930615|364883358|FG000|Overall Study|Physician Decision|3|||
105789453|NCT03930615|364883359|FG001|Overall Study|Physician Decision|4|||
105789454|NCT03930615|364883358|FG000|Overall Study|Withdrawal by Subject|13|||
105789455|NCT03930615|364883359|FG001|Overall Study|Withdrawal by Subject|2|||
105789456|NCT03930615|364883358|FG000|Overall Study|Not treated|1|||
105789457|NCT03930615|364883359|FG001|Overall Study|Not treated|1|||
105789458|NCT04611152|364883362|FG000|Overall Study|Adverse Event|9|||
105789459|NCT04611152|364883363|FG001|Overall Study|Adverse Event|8|||
105789460|NCT04611152|364883362|FG000|Overall Study|Non-compliance with study schedule|1|||
105789461|NCT04611152|364883363|FG001|Overall Study|Non-compliance with study schedule|3|||
105789462|NCT04611152|364883362|FG000|Overall Study|Withdrawal by Subject|5|||
105789463|NCT04611152|364883363|FG001|Overall Study|Withdrawal by Subject|6|||
105789464|NCT04611152|364883362|FG000|Overall Study|Lost to Follow-up|11|||
105789465|NCT04611152|364883363|FG001|Overall Study|Lost to Follow-up|2|||
105789466|NCT04456998|364883364|FG000|Overall Study|Adverse Event|0|||
105789467|NCT04456998|364883365|FG001|Overall Study|Adverse Event|4|||
105789468|NCT04456998|364883364|FG000|Overall Study|Protocol Deviation|0|||
105789469|NCT04456998|364883365|FG001|Overall Study|Protocol Deviation|1|||
105789470|NCT04456998|364883364|FG000|Overall Study|Withdrawal by Subject|0|||
105789471|NCT04456998|364883365|FG001|Overall Study|Withdrawal by Subject|1|||
105789472|NCT00956813|364883369|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
105789473|NCT00956813|364883370|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
105789474|NCT00956813|364883369|FG000|Flaxseed and Placebo|Ineligible|3|||
105789475|NCT00956813|364883370|FG001|Flaxseed and Placebo|Ineligible|1|||
105789476|NCT03707145|364883373|FG000|Overall Study|Lost to Follow-up|0|||
105789477|NCT03707145|364883374|FG001|Overall Study|Lost to Follow-up|1|||
105789478|NCT03707145|364883375|FG002|Overall Study|Lost to Follow-up|1|||
105789479|NCT03707145|364883376|FG003|Overall Study|Lost to Follow-up|0|||
105714073|NCT03179436|364612018|FG005|Overall Study|Withdrawal by Subject|2|||
105714074|NCT03179436|364612019|FG006|Overall Study|Withdrawal by Subject|5|||
105714075|NCT03179436|364612020|FG007|Overall Study|Withdrawal by Subject|0|||
105714076|NCT03179436|364612021|FG008|Overall Study|Withdrawal by Subject|3|||
105714077|NCT03179436|364612022|FG009|Overall Study|Withdrawal by Subject|0|||
105714078|NCT03179436|364612023|FG010|Overall Study|Withdrawal by Subject|0|||
105789480|NCT04455620|364883377|FG000|Overall Study|Withdrawal by Subject|0|||
105789481|NCT04455620|364883378|FG001|Overall Study|Withdrawal by Subject|0|||
105789482|NCT04455620|364883379|FG002|Overall Study|Withdrawal by Subject|2|||
105714079|NCT03179436|364612024|FG011|Overall Study|Withdrawal by Subject|0|||
105714080|NCT03179436|364612013|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105714081|NCT03179436|364612014|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105714082|NCT03179436|364612015|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105714083|NCT03179436|364612016|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
105714084|NCT03179436|364612017|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
105714085|NCT03179436|364612018|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
105714086|NCT03179436|364612019|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
105714087|NCT03179436|364612020|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
105714088|NCT03179436|364612021|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
105714089|NCT03179436|364612022|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
105714090|NCT03179436|364612023|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
105714091|NCT03179436|364612024|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
105714092|NCT03179436|364612013|FG000|Overall Study|Sponsor Decision|0|||
105714093|NCT03179436|364612014|FG001|Overall Study|Sponsor Decision|0|||
105714094|NCT03179436|364612015|FG002|Overall Study|Sponsor Decision|1|||
105714095|NCT03179436|364612016|FG003|Overall Study|Sponsor Decision|3|||
105714096|NCT03179436|364612017|FG004|Overall Study|Sponsor Decision|9|||
105714097|NCT03179436|364612018|FG005|Overall Study|Sponsor Decision|7|||
105714098|NCT03179436|364612019|FG006|Overall Study|Sponsor Decision|2|||
105714099|NCT03179436|364612020|FG007|Overall Study|Sponsor Decision|4|||
105714100|NCT03179436|364612021|FG008|Overall Study|Sponsor Decision|23|||
105714101|NCT03179436|364612022|FG009|Overall Study|Sponsor Decision|6|||
105714102|NCT03179436|364612023|FG010|Overall Study|Sponsor Decision|7|||
105714103|NCT03179436|364612024|FG011|Overall Study|Sponsor Decision|5|||
105714104|NCT03179436|364612013|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714105|NCT03179436|364612014|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
105714106|NCT03179436|364612015|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714107|NCT03179436|364612016|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714108|NCT03179436|364612017|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714109|NCT03179436|364612018|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
105714110|NCT03179436|364612019|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714111|NCT03179436|364612020|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
105789483|NCT04455620|364883380|FG003|Overall Study|Withdrawal by Subject|0|||
105789484|NCT04455620|364883381|FG004|Overall Study|Withdrawal by Subject|1|||
105789485|NCT04455620|364883377|FG000|Overall Study|Lost to Follow-up|0|||
105789486|NCT04455620|364883378|FG001|Overall Study|Lost to Follow-up|0|||
105789487|NCT04455620|364883379|FG002|Overall Study|Lost to Follow-up|1|||
105714112|NCT03179436|364612021|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
105789488|NCT04455620|364883380|FG003|Overall Study|Lost to Follow-up|1|||
105789489|NCT04455620|364883381|FG004|Overall Study|Lost to Follow-up|0|||
105789490|NCT04455620|364883377|FG000|Overall Study|Death|1|||
105789491|NCT04455620|364883378|FG001|Overall Study|Death|6|||
105714113|NCT03179436|364612022|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714114|NCT03179436|364612023|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714115|NCT03179436|364612024|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714116|NCT03179436|364612013|FG000|Overall Study|Lost to Follow-up|1|||
105714117|NCT03179436|364612014|FG001|Overall Study|Lost to Follow-up|0|||
105714118|NCT03179436|364612015|FG002|Overall Study|Lost to Follow-up|0|||
105714119|NCT03179436|364612016|FG003|Overall Study|Lost to Follow-up|1|||
105477056|NCT00966875|363759213|FG001|Part B|Withdrawal by Subject|1|||
105789492|NCT04455620|364883379|FG002|Overall Study|Death|20|||
105789493|NCT04455620|364883380|FG003|Overall Study|Death|1|||
105789494|NCT04455620|364883381|FG004|Overall Study|Death|7|||
105477057|NCT00966875|363759214|FG002|Part B|Withdrawal by Subject|2|||
105477058|NCT00966875|363759215|FG003|Part B|Withdrawal by Subject|1|||
105477059|NCT00966875|363759216|FG004|Part B|Withdrawal by Subject|2|||
105477060|NCT00966875|363759217|FG005|Part B|Withdrawal by Subject|1|||
105477061|NCT00966875|363759218|FG006|Part B|Withdrawal by Subject|4|||
105477062|NCT00966875|363759219|FG007|Part B|Withdrawal by Subject|5|||
105477063|NCT00966875|363759220|FG008|Part B|Withdrawal by Subject|5|||
105477064|NCT00966875|363759212|FG000|Part B|Entry Criteria|0|||
105477065|NCT00966875|363759213|FG001|Part B|Entry Criteria|0|||
105477066|NCT00966875|363759214|FG002|Part B|Entry Criteria|0|||
105477067|NCT00966875|363759215|FG003|Part B|Entry Criteria|0|||
105714120|NCT03179436|364612017|FG004|Overall Study|Lost to Follow-up|0|||
105714121|NCT03179436|364612018|FG005|Overall Study|Lost to Follow-up|1|||
105714122|NCT03179436|364612019|FG006|Overall Study|Lost to Follow-up|0|||
105714123|NCT03179436|364612020|FG007|Overall Study|Lost to Follow-up|0|||
105714124|NCT03179436|364612021|FG008|Overall Study|Lost to Follow-up|1|||
105714125|NCT03179436|364612022|FG009|Overall Study|Lost to Follow-up|1|||
105714126|NCT03179436|364612023|FG010|Overall Study|Lost to Follow-up|0|||
105714127|NCT03179436|364612024|FG011|Overall Study|Lost to Follow-up|0|||
105714128|NCT03179436|364612013|FG000|Overall Study|Death|12|||
105714129|NCT03179436|364612014|FG001|Overall Study|Death|17|||
105714130|NCT03179436|364612015|FG002|Overall Study|Death|7|||
105714131|NCT03179436|364612016|FG003|Overall Study|Death|32|||
105714132|NCT03179436|364612017|FG004|Overall Study|Death|29|||
105477068|NCT00966875|363759216|FG004|Part B|Entry Criteria|0|||
105477069|NCT00966875|363759217|FG005|Part B|Entry Criteria|0|||
105477070|NCT00966875|363759218|FG006|Part B|Entry Criteria|1|||
105477071|NCT00966875|363759219|FG007|Part B|Entry Criteria|0|||
105477072|NCT00966875|363759220|FG008|Part B|Entry Criteria|1|||
105477073|NCT01206322|363759221|FG000|Overall Study|Adverse Event|0|||
105477074|NCT01206322|363759222|FG001|Overall Study|Adverse Event|0|||
105714133|NCT03179436|364612018|FG005|Overall Study|Death|30|||
105714134|NCT03179436|364612019|FG006|Overall Study|Death|33|||
105714135|NCT03179436|364612020|FG007|Overall Study|Death|9|||
105714136|NCT03179436|364612021|FG008|Overall Study|Death|84|||
105714137|NCT03179436|364612022|FG009|Overall Study|Death|33|||
105714138|NCT03179436|364612023|FG010|Overall Study|Death|22|||
105714139|NCT03179436|364612024|FG011|Overall Study|Death|15|||
105714140|NCT01462266|364612025|FG000|Overall Study|Adverse Event|7|||
105714141|NCT01462266|364612026|FG001|Overall Study|Adverse Event|6|||
105714142|NCT01462266|364612025|FG000|Overall Study|Death|2|||
105714143|NCT01462266|364612026|FG001|Overall Study|Death|1|||
105714144|NCT01462266|364612025|FG000|Overall Study|Lack of Efficacy|0|||
105714145|NCT01462266|364612026|FG001|Overall Study|Lack of Efficacy|2|||
105714146|NCT01462266|364612025|FG000|Overall Study|Lost to Follow-up|4|||
105714147|NCT01462266|364612026|FG001|Overall Study|Lost to Follow-up|3|||
105714148|NCT01462266|364612025|FG000|Overall Study|Non-compliance with study drug|3|||
105714149|NCT01462266|364612026|FG001|Overall Study|Non-compliance with study drug|0|||
105477075|NCT01206322|363759223|FG002|Overall Study|Adverse Event|0|||
105477076|NCT01206322|363759224|FG003|Overall Study|Adverse Event|1|||
105561738|NCT01137474|364052216|FG002|Overall Study|Lost to Follow-up|0|||
105477077|NCT01425463|363759230|FG000|Overall Study|Adverse Event|5|||
105477078|NCT01425463|363759231|FG001|Overall Study|Adverse Event|7|||
105477079|NCT01425463|363759230|FG000|Overall Study|Lack of Efficacy|1|||
105477080|NCT01425463|363759231|FG001|Overall Study|Lack of Efficacy|1|||
105477081|NCT01425463|363759230|FG000|Overall Study|Protocol Violation|2|||
105714150|NCT01462266|364612025|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
105714151|NCT01462266|364612026|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
105714152|NCT01462266|364612025|FG000|Overall Study|Physician Decision|2|||
105714153|NCT01462266|364612026|FG001|Overall Study|Physician Decision|5|||
105714154|NCT01462266|364612025|FG000|Overall Study|Protocol Violation|1|||
105714155|NCT01462266|364612026|FG001|Overall Study|Protocol Violation|3|||
105714156|NCT01462266|364612025|FG000|Overall Study|Withdrawal by Subject|7|||
105477082|NCT01425463|363759231|FG001|Overall Study|Protocol Violation|2|||
105714157|NCT01462266|364612026|FG001|Overall Study|Withdrawal by Subject|2|||
105714158|NCT01462266|364612025|FG000|Overall Study|Screen failure|1|||
105714159|NCT01462266|364612026|FG001|Overall Study|Screen failure|1|||
105714160|NCT01106846|364612027|FG000|Overall Study|Change in surgical procedure|0|||
105714161|NCT01106846|364612028|FG001|Overall Study|Change in surgical procedure|1|||
105714162|NCT00803179|364612031|FG000|Overall Study|Lost to Follow-up|3|||
105714163|NCT00546052|364612033|FG000|Overall Study|Adverse Event|47|||
105714164|NCT00546052|364612033|FG000|Overall Study|Lost to Follow-up|144|||
105714165|NCT00546052|364612033|FG000|Overall Study|Protocol Violation|9|||
105714166|NCT00546052|364612033|FG000|Overall Study|Withdrawal by Subject|20|||
105714167|NCT00546052|364612033|FG000|Overall Study|Non Compliance|7|||
105714168|NCT01445678|364612037|FG000|Overall Study|Adverse Event|12|||
105714169|NCT01445678|364612038|FG001|Overall Study|Adverse Event|8|||
105714170|NCT01445678|364612037|FG000|Overall Study|Lack of Efficacy|0|||
105714171|NCT01445678|364612038|FG001|Overall Study|Lack of Efficacy|2|||
105714172|NCT01445678|364612037|FG000|Overall Study|Lost to Follow-up|8|||
105714173|NCT01445678|364612038|FG001|Overall Study|Lost to Follow-up|5|||
105714174|NCT01445678|364612037|FG000|Overall Study|Protocol Violation|1|||
105714175|NCT01445678|364612038|FG001|Overall Study|Protocol Violation|1|||
105714176|NCT01445678|364612037|FG000|Overall Study|Withdrawal by Subject|9|||
105714177|NCT01445678|364612038|FG001|Overall Study|Withdrawal by Subject|5|||
105714178|NCT02482129|364612039|FG000|Overall Study|Adverse Event-prior to treatment|0|||
105714179|NCT02482129|364612040|FG001|Overall Study|Adverse Event-prior to treatment|1|||
105714180|NCT02482129|364612039|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
105714181|NCT02482129|364612040|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
105714182|NCT02482129|364612039|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
105714183|NCT02482129|364612040|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
105714184|NCT02482129|364612039|FG000|Overall Study|Criteria not met-prior to treatment|1|||
105714185|NCT02482129|364612040|FG001|Overall Study|Criteria not met-prior to treatment|0|||
105714186|NCT02482129|364612039|FG000|Overall Study|Adverse Event|1|||
105714187|NCT02482129|364612040|FG001|Overall Study|Adverse Event|0|||
105714188|NCT02482129|364612039|FG000|Overall Study|Withdrawal by Subject|2|||
105714189|NCT02482129|364612040|FG001|Overall Study|Withdrawal by Subject|0|||
105714190|NCT02482129|364612039|FG000|Overall Study|Criteria not met|1|||
105714191|NCT02482129|364612040|FG001|Overall Study|Criteria not met|0|||
105714192|NCT01738971|364612041|FG000|Overall Study|Lost to Follow-up|19|||
105714193|NCT01738971|364612042|FG001|Overall Study|Lost to Follow-up|30|||
105714194|NCT01738971|364612043|FG002|Overall Study|Lost to Follow-up|17|||
105714195|NCT02447848|364612048|FG000|Overall Study|Patient discharged|3|||
105714196|NCT02447848|364612048|FG000|Overall Study|Lack of Efficacy|4|||
105714197|NCT02447848|364612048|FG000|Overall Study|Withdrawal by Subject|4|||
105714198|NCT01877083|364612049|FG000|Treatment Phase|Disease Progression|10|||
105714199|NCT01877083|364612049|FG000|Treatment Phase|Clinical Progression|1|||
105714200|NCT01877083|364612049|FG000|Treatment Phase|Adverse Event|6|||
105714201|NCT01877083|364612049|FG000|Treatment Phase|Withdrawal by Subject|2|||
105714202|NCT01877083|364612049|FG000|Treatment Phase|Lost to Follow-up|1|||
105714203|NCT01877083|364612049|FG000|Extension Phase|Disease Progression|3|||
105714204|NCT01877083|364612049|FG000|Extension Phase|Adverse Event|2|||
105714205|NCT00429585|364612050|FG000|Overall Study|Death|1|||
105714206|NCT00429585|364612051|FG001|Overall Study|Death|0|||
105714207|NCT00429585|364612050|FG000|Overall Study|Lost to Follow-up|27|||
105714208|NCT00429585|364612051|FG001|Overall Study|Lost to Follow-up|20|||
105714209|NCT00429585|364612050|FG000|Overall Study|Physician Decision|2|||
105714210|NCT00429585|364612051|FG001|Overall Study|Physician Decision|0|||
105714211|NCT01582308|364612052|FG000|Period 1|Withdrawal by Subject|0|||
105714212|NCT01582308|364612053|FG001|Period 1|Withdrawal by Subject|0|||
105714213|NCT01582308|364612054|FG002|Period 1|Withdrawal by Subject|0|||
105714214|NCT01582308|364612055|FG003|Period 1|Withdrawal by Subject|0|||
105714215|NCT01582308|364612056|FG004|Period 1|Withdrawal by Subject|0|||
105714216|NCT01582308|364612057|FG005|Period 1|Withdrawal by Subject|0|||
105714217|NCT01582308|364612058|FG006|Period 1|Withdrawal by Subject|1|||
105714218|NCT01582308|364612059|FG007|Period 1|Withdrawal by Subject|0|||
105714219|NCT01582308|364612060|FG008|Period 1|Withdrawal by Subject|0|||
105714220|NCT01582308|364612061|FG009|Period 1|Withdrawal by Subject|0|||
105714221|NCT01582308|364612052|FG000|10-day Washout Following Period 1|Physician Decision|0|||
105714222|NCT01582308|364612053|FG001|10-day Washout Following Period 1|Physician Decision|0|||
105714223|NCT01582308|364612054|FG002|10-day Washout Following Period 1|Physician Decision|0|||
105714224|NCT01582308|364612055|FG003|10-day Washout Following Period 1|Physician Decision|0|||
105714225|NCT01582308|364612056|FG004|10-day Washout Following Period 1|Physician Decision|1|||
105714226|NCT01582308|364612057|FG005|10-day Washout Following Period 1|Physician Decision|0|||
105714227|NCT01582308|364612058|FG006|10-day Washout Following Period 1|Physician Decision|0|||
105714228|NCT01582308|364612059|FG007|10-day Washout Following Period 1|Physician Decision|0|||
105714229|NCT01582308|364612060|FG008|10-day Washout Following Period 1|Physician Decision|0|||
105714230|NCT01582308|364612061|FG009|10-day Washout Following Period 1|Physician Decision|0|||
105477083|NCT01425463|363759230|FG000|Overall Study|Lost to Follow-up|5|||
105477084|NCT01425463|363759231|FG001|Overall Study|Lost to Follow-up|2|||
105477085|NCT01425463|363759230|FG000|Overall Study|Withdrawal by Subject|7|||
105477086|NCT01425463|363759231|FG001|Overall Study|Withdrawal by Subject|5|||
105477087|NCT01425463|363759230|FG000|Overall Study|Unknown Reason|4|||
105477088|NCT01425463|363759231|FG001|Overall Study|Unknown Reason|7|||
105477089|NCT00668733|363759232|FG000|Overall Study|Lost to Follow-up|2|||
105477090|NCT00668733|363759233|FG001|Overall Study|Lost to Follow-up|3|||
105477091|NCT00668733|363759232|FG000|Overall Study|Withdrawal by Subject|0|||
105477092|NCT00668733|363759233|FG001|Overall Study|Withdrawal by Subject|4|||
105477093|NCT02386189|363759236|FG000|Overall Study|Lost to Follow-up|2|||
105477094|NCT02386189|363759237|FG001|Overall Study|Lost to Follow-up|3|||
105477095|NCT02386189|363759236|FG000|Overall Study|Withdrawal by Subject|1|||
105477096|NCT02386189|363759237|FG001|Overall Study|Withdrawal by Subject|0|||
105477097|NCT02386189|363759236|FG000|Overall Study|Death|1|||
105477098|NCT02386189|363759237|FG001|Overall Study|Death|0|||
105477099|NCT03700684|363759242|FG000|Overall Study|COVID-19|0|||
105477100|NCT03700684|363759243|FG001|Overall Study|COVID-19|0|||
105477101|NCT03700684|363759244|FG002|Overall Study|COVID-19|2|||
105477102|NCT03206788|363759247|FG000|Overall Study|Withdrawal by Subject|0|||
105477103|NCT03206788|363759248|FG001|Overall Study|Withdrawal by Subject|1|||
105477104|NCT03206788|363759247|FG000|Overall Study|Adverse Event|0|||
105477105|NCT03206788|363759248|FG001|Overall Study|Adverse Event|1|||
105477106|NCT03206788|363759247|FG000|Overall Study|Physician Decision|0|||
105477107|NCT03206788|363759248|FG001|Overall Study|Physician Decision|1|||
105477108|NCT00361634|363759249|FG000|Overall Study|Lost to Follow-up|1|||
105477109|NCT00361634|363759249|FG000|Overall Study|Withdrawal by Subject|1|||
105477110|NCT00388583|363759250|FG000|Overall Study|Protocol Violation|1|||
105477111|NCT00388583|363759251|FG001|Overall Study|Protocol Violation|0|||
105477112|NCT00388583|363759250|FG000|Overall Study|Withdrawal by Subject|3|||
105477113|NCT00388583|363759251|FG001|Overall Study|Withdrawal by Subject|3|||
105477114|NCT00388583|363759250|FG000|Overall Study|Serious Adverse Event|2|||
105477115|NCT00388583|363759251|FG001|Overall Study|Serious Adverse Event|0|||
105477116|NCT00388583|363759250|FG000|Overall Study|Did not receive vaccine|0|||
105477117|NCT00388583|363759251|FG001|Overall Study|Did not receive vaccine|1|||
105477118|NCT02366091|363759252|FG000|Overall Study|Withdrawal by Subject|3|||
105477119|NCT02366091|363759253|FG001|Overall Study|Withdrawal by Subject|7|||
105477120|NCT02366091|363759254|FG002|Overall Study|Withdrawal by Subject|3|||
105477121|NCT02366091|363759255|FG003|Overall Study|Withdrawal by Subject|1|||
105477122|NCT00759564|363759257|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
105477123|NCT00759564|363759258|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
105477124|NCT00759564|363759259|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
105477125|NCT00759564|363759260|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
105477126|NCT00759564|363759261|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
105477127|NCT00357760|363759266|FG000|Overall Study|Disease progression|44|||
105477128|NCT00357760|363759267|FG001|Overall Study|Disease progression|17|||
105477129|NCT00357760|363759266|FG000|Overall Study|Adverse Event|10|||
105477130|NCT00357760|363759267|FG001|Overall Study|Adverse Event|7|||
105477131|NCT00357760|363759266|FG000|Overall Study|Death|0|||
105477132|NCT00357760|363759267|FG001|Overall Study|Death|3|||
105561739|NCT01137474|364052217|FG003|Overall Study|Lost to Follow-up|2|||
105714231|NCT01582308|364612052|FG000|Period 4|Physician Decision|1|||
105714232|NCT01582308|364612053|FG001|Period 4|Physician Decision|0|||
105714233|NCT01582308|364612054|FG002|Period 4|Physician Decision|0|||
105714234|NCT01582308|364612055|FG003|Period 4|Physician Decision|0|||
105714235|NCT01582308|364612056|FG004|Period 4|Physician Decision|0|||
105714236|NCT01582308|364612057|FG005|Period 4|Physician Decision|1|||
105714237|NCT01582308|364612058|FG006|Period 4|Physician Decision|0|||
105714238|NCT01582308|364612059|FG007|Period 4|Physician Decision|0|||
105714239|NCT01582308|364612060|FG008|Period 4|Physician Decision|0|||
105714240|NCT01582308|364612061|FG009|Period 4|Physician Decision|1|||
105714241|NCT01790503|364613858|FG000|Overall Study|Adverse Event|1|||
105714242|NCT01790503|364613859|FG001|Overall Study|Adverse Event|0|||
105714243|NCT01790503|364613860|FG002|Overall Study|Adverse Event|0|||
105714244|NCT01790503|364613861|FG003|Overall Study|Adverse Event|0|||
105714245|NCT01790503|364613862|FG004|Overall Study|Adverse Event|0|||
105477133|NCT00357760|363759266|FG000|Overall Study|Alternative therapy|1|||
105477134|NCT00357760|363759267|FG001|Overall Study|Alternative therapy|0|||
105477135|NCT00357760|363759266|FG000|Overall Study|Withdrawal by Subject|0|||
105477136|NCT00357760|363759267|FG001|Overall Study|Withdrawal by Subject|2|||
105477137|NCT00357760|363759266|FG000|Overall Study|Never started treatment|2|||
105477138|NCT00357760|363759267|FG001|Overall Study|Never started treatment|1|||
105714246|NCT01790503|364613863|FG005|Overall Study|Adverse Event|2|||
105477139|NCT00357760|363759266|FG000|Overall Study|Ineligible|0|||
105477140|NCT00357760|363759267|FG001|Overall Study|Ineligible|2|||
105561740|NCT01137474|364052214|FG000|Overall Study|Lack of Efficacy|0|||
105714247|NCT01790503|364613864|FG006|Overall Study|Adverse Event|0|||
105714248|NCT01790503|364613865|FG007|Overall Study|Adverse Event|0|||
105477141|NCT00357760|363759266|FG000|Overall Study|Physician Decision|2|||
105714249|NCT01790503|364613866|FG008|Overall Study|Adverse Event|2|||
105714250|NCT01790503|364613867|FG009|Overall Study|Adverse Event|4|||
105714251|NCT01790503|364613868|FG010|Overall Study|Adverse Event|7|||
105714252|NCT01790503|364613858|FG000|Overall Study|Withdrawal by Subject|0|||
105714253|NCT01790503|364613859|FG001|Overall Study|Withdrawal by Subject|0|||
105714254|NCT01790503|364613860|FG002|Overall Study|Withdrawal by Subject|1|||
105714255|NCT01790503|364613861|FG003|Overall Study|Withdrawal by Subject|1|||
105714256|NCT01790503|364613862|FG004|Overall Study|Withdrawal by Subject|1|||
105714257|NCT01790503|364613863|FG005|Overall Study|Withdrawal by Subject|2|||
105714258|NCT01790503|364613864|FG006|Overall Study|Withdrawal by Subject|1|||
105714259|NCT01790503|364613865|FG007|Overall Study|Withdrawal by Subject|0|||
105714260|NCT01790503|364613866|FG008|Overall Study|Withdrawal by Subject|0|||
105714261|NCT01790503|364613867|FG009|Overall Study|Withdrawal by Subject|0|||
105714262|NCT01790503|364613868|FG010|Overall Study|Withdrawal by Subject|1|||
105714263|NCT01790503|364613858|FG000|Overall Study|Disease progression|2|||
105714264|NCT01790503|364613859|FG001|Overall Study|Disease progression|1|||
105714265|NCT01790503|364613860|FG002|Overall Study|Disease progression|0|||
105714266|NCT01790503|364613861|FG003|Overall Study|Disease progression|1|||
105714267|NCT01790503|364613862|FG004|Overall Study|Disease progression|2|||
105714268|NCT01790503|364613863|FG005|Overall Study|Disease progression|1|||
105714269|NCT01790503|364613864|FG006|Overall Study|Disease progression|0|||
105714270|NCT01790503|364613865|FG007|Overall Study|Disease progression|1|||
105714271|NCT01790503|364613866|FG008|Overall Study|Disease progression|0|||
105714272|NCT01790503|364613867|FG009|Overall Study|Disease progression|17|||
105714273|NCT01790503|364613868|FG010|Overall Study|Disease progression|7|||
105714274|NCT01790503|364613858|FG000|Overall Study|Protocol Violation|0|||
105714275|NCT01790503|364613859|FG001|Overall Study|Protocol Violation|0|||
105714276|NCT01790503|364613860|FG002|Overall Study|Protocol Violation|0|||
105714277|NCT01790503|364613861|FG003|Overall Study|Protocol Violation|0|||
105714278|NCT01790503|364613862|FG004|Overall Study|Protocol Violation|0|||
105714279|NCT01790503|364613863|FG005|Overall Study|Protocol Violation|0|||
105714280|NCT01790503|364613864|FG006|Overall Study|Protocol Violation|0|||
105714281|NCT01790503|364613865|FG007|Overall Study|Protocol Violation|0|||
105714282|NCT01790503|364613866|FG008|Overall Study|Protocol Violation|0|||
105714283|NCT01790503|364613867|FG009|Overall Study|Protocol Violation|1|||
105714284|NCT01790503|364613868|FG010|Overall Study|Protocol Violation|0|||
105714285|NCT01790503|364613858|FG000|Overall Study|Physician Decision|0|||
105714286|NCT01790503|364613859|FG001|Overall Study|Physician Decision|0|||
105714287|NCT01790503|364613860|FG002|Overall Study|Physician Decision|0|||
105714288|NCT01790503|364613861|FG003|Overall Study|Physician Decision|0|||
105714289|NCT01790503|364613862|FG004|Overall Study|Physician Decision|0|||
105714290|NCT01790503|364613863|FG005|Overall Study|Physician Decision|0|||
105714291|NCT01790503|364613864|FG006|Overall Study|Physician Decision|0|||
105714292|NCT01790503|364613865|FG007|Overall Study|Physician Decision|0|||
105714293|NCT01790503|364613866|FG008|Overall Study|Physician Decision|0|||
105714294|NCT01790503|364613867|FG009|Overall Study|Physician Decision|1|||
105714295|NCT01790503|364613868|FG010|Overall Study|Physician Decision|1|||
105714296|NCT01790503|364613858|FG000|Overall Study|Death|0|||
105714297|NCT01790503|364613859|FG001|Overall Study|Death|0|||
105714298|NCT01790503|364613860|FG002|Overall Study|Death|0|||
105714299|NCT01790503|364613861|FG003|Overall Study|Death|0|||
105714300|NCT01790503|364613862|FG004|Overall Study|Death|0|||
105714301|NCT01790503|364613863|FG005|Overall Study|Death|0|||
105714302|NCT01790503|364613864|FG006|Overall Study|Death|0|||
105714303|NCT01790503|364613865|FG007|Overall Study|Death|0|||
105714304|NCT01790503|364613866|FG008|Overall Study|Death|0|||
105714305|NCT01790503|364613867|FG009|Overall Study|Death|1|||
105714306|NCT01790503|364613868|FG010|Overall Study|Death|0|||
105714307|NCT01790503|364613858|FG000|Overall Study|Non Compliance|0|||
105714308|NCT01790503|364613859|FG001|Overall Study|Non Compliance|0|||
105714309|NCT01790503|364613860|FG002|Overall Study|Non Compliance|0|||
105714310|NCT01790503|364613861|FG003|Overall Study|Non Compliance|0|||
105714311|NCT01790503|364613862|FG004|Overall Study|Non Compliance|1|||
105714312|NCT01790503|364613863|FG005|Overall Study|Non Compliance|0|||
105714313|NCT01790503|364613864|FG006|Overall Study|Non Compliance|0|||
105714314|NCT01790503|364613865|FG007|Overall Study|Non Compliance|0|||
105714315|NCT01790503|364613866|FG008|Overall Study|Non Compliance|0|||
105714316|NCT01790503|364613867|FG009|Overall Study|Non Compliance|0|||
105714317|NCT01790503|364613868|FG010|Overall Study|Non Compliance|0|||
105714318|NCT01790503|364613858|FG000|Overall Study|Other|0|||
105714319|NCT01790503|364613859|FG001|Overall Study|Other|0|||
105714320|NCT01790503|364613860|FG002|Overall Study|Other|0|||
105714321|NCT01790503|364613861|FG003|Overall Study|Other|0|||
105714322|NCT01790503|364613862|FG004|Overall Study|Other|1|||
105714323|NCT01790503|364613863|FG005|Overall Study|Other|0|||
105714324|NCT01790503|364613864|FG006|Overall Study|Other|0|||
105714325|NCT01790503|364613865|FG007|Overall Study|Other|0|||
105714326|NCT01790503|364613866|FG008|Overall Study|Other|1|||
105714327|NCT01790503|364613867|FG009|Overall Study|Other|2|||
105714328|NCT01790503|364613868|FG010|Overall Study|Other|0|||
105714329|NCT01934140|364613869|FG000|Persistence Phase (Year 6-10)|Other|24|||
105714330|NCT01934140|364613870|FG001|Persistence Phase (Year 6-10)|Other|6|||
105714331|NCT01934140|364613869|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
105714332|NCT01934140|364613870|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
105714333|NCT01934140|364613869|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
105714334|NCT01934140|364613870|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
105714335|NCT01934140|364613869|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
105714336|NCT01934140|364613870|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
105714337|NCT01934140|364613869|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
105714338|NCT01934140|364613870|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
105714339|NCT01934140|364613869|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
105714340|NCT01934140|364613870|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
105714341|NCT01934140|364613869|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
105714342|NCT01934140|364613870|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
105714343|NCT01934140|364613869|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
105714344|NCT01934140|364613870|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
105714345|NCT01268293|364613871|FG000|Overall Study|Disease progression|7|||
105714346|NCT01268293|364613871|FG000|Overall Study|Adverse Event|1|||
105714347|NCT01268293|364613871|FG000|Overall Study|Subject choice|1|||
105714348|NCT03269344|364613872|FG000|Overall Study|Protocol Violation|4|||
105714349|NCT03269344|364613873|FG001|Overall Study|Protocol Violation|3|||
105714350|NCT02597855|364613874|FG000|Overall Study|Lost to Follow-up|2|||
105714351|NCT02597855|364613875|FG001|Overall Study|Lost to Follow-up|1|||
105714352|NCT00200850|364613876|FG000|Overall Study|relocation|1|||
105714353|NCT00200850|364613877|FG001|Overall Study|relocation|0|||
105714354|NCT00200850|364613878|FG002|Overall Study|relocation|1|||
105714355|NCT00200850|364613876|FG000|Overall Study|too busy|1|||
105714356|NCT00200850|364613877|FG001|Overall Study|too busy|0|||
105714357|NCT00200850|364613878|FG002|Overall Study|too busy|0|||
105714358|NCT00200850|364613876|FG000|Overall Study|Pregnancy|0|||
105714359|NCT00200850|364613877|FG001|Overall Study|Pregnancy|0|||
105714360|NCT00200850|364613878|FG002|Overall Study|Pregnancy|1|||
105714361|NCT00200850|364613876|FG000|Overall Study|Poor adherence|0|||
105714362|NCT00200850|364613877|FG001|Overall Study|Poor adherence|0|||
105714363|NCT00200850|364613878|FG002|Overall Study|Poor adherence|1|||
105714364|NCT00200850|364613876|FG000|Overall Study|optic neuritis|0|||
105714365|NCT00200850|364613877|FG001|Overall Study|optic neuritis|0|||
105714366|NCT00200850|364613878|FG002|Overall Study|optic neuritis|1|||
105714367|NCT00200850|364613876|FG000|Overall Study|Adverse Event|1|||
105714368|NCT00200850|364613877|FG001|Overall Study|Adverse Event|1|||
105714369|NCT00200850|364613878|FG002|Overall Study|Adverse Event|2|||
105714370|NCT00805740|364613879|FG000|Overall Study|Death|7|||
105714371|NCT00805740|364613880|FG001|Overall Study|Death|4|||
105714372|NCT00805740|364613879|FG000|Overall Study|Withdrawal by Subject|1|||
105714373|NCT00805740|364613880|FG001|Overall Study|Withdrawal by Subject|0|||
105714374|NCT00805740|364613879|FG000|Overall Study|Lost to Follow-up|1|||
105714375|NCT00805740|364613880|FG001|Overall Study|Lost to Follow-up|0|||
105352287|NCT01483599|363293857|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
105477142|NCT00357760|363759267|FG001|Overall Study|Physician Decision|1|||
105714376|NCT00805740|364613879|FG000|Overall Study|Randomized, but not treated|2|||
105714377|NCT00805740|364613880|FG001|Overall Study|Randomized, but not treated|0|||
105714378|NCT01946178|364613884|FG000|Overall Study|Pregnancy|1|||
105714379|NCT01946178|364613884|FG000|Overall Study|Lost to Follow-up|1|||
105714380|NCT01285908|364613887|FG000|Baseline Measurement|unable to insert catheter|1|||
105714381|NCT01285908|364613888|FG001|Baseline Measurement|unable to insert catheter|0|||
105714382|NCT01285908|364613889|FG002|Baseline Measurement|unable to insert catheter|0|||
105714383|NCT01285908|364613887|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
105714384|NCT01285908|364613888|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
105714385|NCT01285908|364613889|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
105714386|NCT01285908|364613887|FG000|Baseline Measurement|unable to tolerate procedure|1|||
105714387|NCT01285908|364613888|FG001|Baseline Measurement|unable to tolerate procedure|0|||
105714388|NCT01285908|364613889|FG002|Baseline Measurement|unable to tolerate procedure|0|||
105714389|NCT00493038|364613890|FG000|Treatment|Adverse Event|8|||
105477143|NCT00357760|363759266|FG000|Overall Study|Protocol Violation|0|||
105477144|NCT00357760|363759267|FG001|Overall Study|Protocol Violation|1|||
105714390|NCT00493038|364613891|FG001|Treatment|Adverse Event|4|||
105714391|NCT00493038|364613890|FG000|Treatment|Lost to Follow-up|5|||
105714392|NCT00493038|364613891|FG001|Treatment|Lost to Follow-up|3|||
105477145|NCT00357760|363759266|FG000|Overall Study|To receive hospice care|0|||
105714393|NCT00493038|364613890|FG000|Treatment|Withdrawal by Subject|11|||
105714394|NCT00493038|364613891|FG001|Treatment|Withdrawal by Subject|12|||
105714395|NCT00493038|364613890|FG000|Treatment|Other|0|||
105714396|NCT00493038|364613891|FG001|Treatment|Other|1|||
105714397|NCT00493038|364613890|FG000|Follow-up|Lost to Follow-up|1|||
105714398|NCT00493038|364613891|FG001|Follow-up|Lost to Follow-up|0|||
105714399|NCT00608985|364613896|FG000|Overall Study|Adverse Event|2|||
105714400|NCT00608985|364613897|FG001|Overall Study|Adverse Event|7|||
105714401|NCT00608985|364613898|FG002|Overall Study|Adverse Event|4|||
105714402|NCT00608985|364613899|FG003|Overall Study|Adverse Event|6|||
105714403|NCT00608985|364613896|FG000|Overall Study|Administrative/Other|7|||
105714404|NCT00608985|364613897|FG001|Overall Study|Administrative/Other|4|||
105714405|NCT00608985|364613898|FG002|Overall Study|Administrative/Other|1|||
105714406|NCT00608985|364613899|FG003|Overall Study|Administrative/Other|2|||
105714407|NCT00608985|364613896|FG000|Overall Study|Withdrawal of Consent|5|||
105714408|NCT00608985|364613897|FG001|Overall Study|Withdrawal of Consent|1|||
105714409|NCT00608985|364613898|FG002|Overall Study|Withdrawal of Consent|1|||
105714410|NCT00608985|364613899|FG003|Overall Study|Withdrawal of Consent|1|||
105714411|NCT00608985|364613896|FG000|Overall Study|Lost to Follow-up|2|||
105714412|NCT00608985|364613897|FG001|Overall Study|Lost to Follow-up|1|||
105714413|NCT00608985|364613898|FG002|Overall Study|Lost to Follow-up|0|||
105714414|NCT00608985|364613899|FG003|Overall Study|Lost to Follow-up|0|||
105714415|NCT00094757|364613904|FG000|Overall Study|Adverse Event|11|||
105714416|NCT00094757|364613905|FG001|Overall Study|Adverse Event|9|||
105714417|NCT00094757|364613906|FG002|Overall Study|Adverse Event|6|||
105714418|NCT00094757|364613904|FG000|Overall Study|Lack of Efficacy|11|||
105714419|NCT00094757|364613905|FG001|Overall Study|Lack of Efficacy|15|||
105714420|NCT00094757|364613906|FG002|Overall Study|Lack of Efficacy|8|||
105714421|NCT00094757|364613904|FG000|Overall Study|Lost to Follow-up|3|||
105714422|NCT00094757|364613905|FG001|Overall Study|Lost to Follow-up|5|||
105714423|NCT00094757|364613906|FG002|Overall Study|Lost to Follow-up|6|||
105714424|NCT00094757|364613904|FG000|Overall Study|Patient Moved|2|||
105714425|NCT00094757|364613905|FG001|Overall Study|Patient Moved|1|||
105714426|NCT00094757|364613906|FG002|Overall Study|Patient Moved|1|||
105714427|NCT00094757|364613904|FG000|Overall Study|Protocol Violation|8|||
105714428|NCT00094757|364613905|FG001|Overall Study|Protocol Violation|5|||
105714429|NCT00094757|364613906|FG002|Overall Study|Protocol Violation|3|||
105714430|NCT00094757|364613904|FG000|Overall Study|Withdrawal by Subject|14|||
105714431|NCT00094757|364613905|FG001|Overall Study|Withdrawal by Subject|21|||
105714432|NCT00094757|364613906|FG002|Overall Study|Withdrawal by Subject|5|||
105714433|NCT00094757|364613904|FG000|Overall Study|Other|3|||
105714434|NCT00094757|364613905|FG001|Overall Study|Other|3|||
105714435|NCT00094757|364613906|FG002|Overall Study|Other|1|||
105714436|NCT00094757|364613904|FG000|Overall Study|Protocol specified discontinuation|1|||
105714437|NCT00094757|364613905|FG001|Overall Study|Protocol specified discontinuation|3|||
105714438|NCT00094757|364613906|FG002|Overall Study|Protocol specified discontinuation|0|||
105714439|NCT02239263|364613907|FG000|Overall Study|Protocol Violation|6|||
105714440|NCT01058096|364613908|FG000|Double-blind Treatment Phase|Adverse Event|11|||
105714441|NCT01058096|364613909|FG001|Double-blind Treatment Phase|Adverse Event|15|||
105714442|NCT01058096|364613908|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
105714443|NCT01058096|364613909|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
105714444|NCT01058096|364613908|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
105789495|NCT04455620|364883377|FG000|Overall Study|Study Termination|0|||
105789496|NCT04455620|364883378|FG001|Overall Study|Study Termination|2|||
105714445|NCT01058096|364613909|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
105714446|NCT01058096|364613908|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
105714447|NCT01058096|364613909|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
105714448|NCT01058096|364613908|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
105714449|NCT01058096|364613909|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
105714450|NCT01058096|364613908|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
105789497|NCT04455620|364883379|FG002|Overall Study|Study Termination|1|||
105714451|NCT01058096|364613909|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
105714452|NCT00087646|364613914|FG000|Overall Study|Adverse Event|37|||
105714453|NCT00087646|364613915|FG001|Overall Study|Adverse Event|6|||
105714454|NCT00087646|364613916|FG002|Overall Study|Adverse Event|18|||
105714455|NCT00087646|364613917|FG003|Overall Study|Adverse Event|20|||
105714456|NCT00087646|364613914|FG000|Overall Study|Death|0|||
105714457|NCT00087646|364613915|FG001|Overall Study|Death|1|||
105714458|NCT00087646|364613916|FG002|Overall Study|Death|0|||
105714459|NCT00087646|364613917|FG003|Overall Study|Death|0|||
105714460|NCT00087646|364613914|FG000|Overall Study|Withdrawal by Subject|6|||
105714461|NCT00087646|364613915|FG001|Overall Study|Withdrawal by Subject|1|||
105714462|NCT00087646|364613916|FG002|Overall Study|Withdrawal by Subject|2|||
105714463|NCT00087646|364613917|FG003|Overall Study|Withdrawal by Subject|2|||
105714464|NCT00087646|364613914|FG000|Overall Study|Insufficient therapeutic response|64|||
105714465|NCT00087646|364613915|FG001|Overall Study|Insufficient therapeutic response|24|||
105714466|NCT00087646|364613916|FG002|Overall Study|Insufficient therapeutic response|38|||
105714467|NCT00087646|364613917|FG003|Overall Study|Insufficient therapeutic response|51|||
105714468|NCT00087646|364613914|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
105714469|NCT00087646|364613915|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
105714470|NCT00087646|364613916|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
105714471|NCT00087646|364613917|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
105714472|NCT00087646|364613914|FG000|Overall Study|Failure to Return|5|||
105714473|NCT00087646|364613915|FG001|Overall Study|Failure to Return|2|||
105714474|NCT00087646|364613916|FG002|Overall Study|Failure to Return|2|||
105714475|NCT00087646|364613917|FG003|Overall Study|Failure to Return|3|||
105714476|NCT00087646|364613914|FG000|Overall Study|Administrative/Other|6|||
105714477|NCT00087646|364613915|FG001|Overall Study|Administrative/Other|1|||
105714478|NCT00087646|364613916|FG002|Overall Study|Administrative/Other|1|||
105714479|NCT00087646|364613917|FG003|Overall Study|Administrative/Other|2|||
105714480|NCT00087646|364613914|FG000|Overall Study|Other Protocol Violation|3|||
105714481|NCT00087646|364613915|FG001|Overall Study|Other Protocol Violation|1|||
105714482|NCT00087646|364613916|FG002|Overall Study|Other Protocol Violation|0|||
105714483|NCT00087646|364613917|FG003|Overall Study|Other Protocol Violation|0|||
105714484|NCT00087646|364613914|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
105714485|NCT00087646|364613915|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
105714486|NCT00087646|364613916|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
105714487|NCT00087646|364613917|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
105714488|NCT02532855|364613918|FG000|Overall Study|Lost to Follow-up|4|||
105714489|NCT02532855|364613919|FG001|Overall Study|Lost to Follow-up|3|||
105714490|NCT02532855|364613918|FG000|Overall Study|Withdrawal by Subject|4|||
105714491|NCT02532855|364613919|FG001|Overall Study|Withdrawal by Subject|8|||
105714492|NCT02902120|364613920|FG000|Overall Study|Lack of Efficacy|1|||
105714493|NCT02551159|364613928|FG000|Overall Study|Death|352|||
105714494|NCT02551159|364613929|FG001|Overall Study|Death|174|||
105714495|NCT02551159|364613930|FG002|Overall Study|Death|161|||
105714496|NCT02551159|364613928|FG000|Overall Study|Withdrawal by Subject|8|||
105714497|NCT02551159|364613929|FG001|Overall Study|Withdrawal by Subject|5|||
105714498|NCT02551159|364613930|FG002|Overall Study|Withdrawal by Subject|16|||
105714499|NCT02551159|364613928|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
105714500|NCT02551159|364613929|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
105714501|NCT02551159|364613930|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
105714502|NCT00268242|364613931|FG000|Overall Study|Death|1|||
105714503|NCT02175680|364613937|FG000|Overall Study|non-compliance|1|||
105561741|NCT01137474|364052215|FG001|Overall Study|Lack of Efficacy|0|||
105561742|NCT01137474|364052216|FG002|Overall Study|Lack of Efficacy|0|||
105714504|NCT02175680|364613937|FG000|Overall Study|other non-medical reason|1|||
105714505|NCT02526550|364613942|FG000|Overall Study|Lost to Follow-up|1|||
105714506|NCT00091832|364613943|FG000|Overall Study|Physician Decision|1|||
105714507|NCT00091832|364613944|FG001|Overall Study|Physician Decision|0|||
105714508|NCT00091832|364613945|FG002|Overall Study|Physician Decision|0|||
105714509|NCT00091832|364613946|FG003|Overall Study|Physician Decision|0|||
105714510|NCT00091832|364613947|FG004|Overall Study|Physician Decision|0|||
105714511|NCT00091832|364613948|FG005|Overall Study|Physician Decision|0|||
105714512|NCT00091832|364613943|FG000|Overall Study|Adverse Event|0|||
105714513|NCT00091832|364613944|FG001|Overall Study|Adverse Event|0|||
105714514|NCT00091832|364613945|FG002|Overall Study|Adverse Event|0|||
105714515|NCT00091832|364613946|FG003|Overall Study|Adverse Event|1|||
105714516|NCT00091832|364613947|FG004|Overall Study|Adverse Event|3|||
105714517|NCT00091832|364613948|FG005|Overall Study|Adverse Event|0|||
105714518|NCT00091832|364613943|FG000|Overall Study|Withdrawal by Subject|4|||
105714519|NCT00091832|364613944|FG001|Overall Study|Withdrawal by Subject|5|||
105714520|NCT00091832|364613945|FG002|Overall Study|Withdrawal by Subject|0|||
105714521|NCT00091832|364613946|FG003|Overall Study|Withdrawal by Subject|1|||
105714522|NCT00091832|364613947|FG004|Overall Study|Withdrawal by Subject|3|||
105561743|NCT01137474|364052217|FG003|Overall Study|Lack of Efficacy|2|||
105789498|NCT04455620|364883380|FG003|Overall Study|Study Termination|0|||
105789499|NCT04455620|364883381|FG004|Overall Study|Study Termination|6|||
105789500|NCT01023022|364883384|FG000|Overall Study|Death|5|||
105789501|NCT01023022|364883384|FG000|Overall Study|Lost to Follow-up|7|||
105789502|NCT01023022|364883384|FG000|Overall Study|due to technical issues|2|||
105789503|NCT03917654|364883385|FG000|Year 1|Withdrawal by Subject|1|||
105477146|NCT00357760|363759267|FG001|Overall Study|To receive hospice care|1|||
105477147|NCT02353143|363759268|FG000|Overall Study|Withdrawal by Subject|1|||
105714523|NCT00091832|364613948|FG005|Overall Study|Withdrawal by Subject|1|||
105714524|NCT00091832|364613943|FG000|Overall Study|Death|6|||
105714525|NCT00091832|364613944|FG001|Overall Study|Death|4|||
105714526|NCT00091832|364613945|FG002|Overall Study|Death|5|||
105714527|NCT00091832|364613946|FG003|Overall Study|Death|8|||
105714528|NCT00091832|364613947|FG004|Overall Study|Death|5|||
105714529|NCT00091832|364613948|FG005|Overall Study|Death|6|||
105714530|NCT00091832|364613943|FG000|Overall Study|Disease Progression|2|||
105714531|NCT00091832|364613944|FG001|Overall Study|Disease Progression|0|||
105714532|NCT00091832|364613945|FG002|Overall Study|Disease Progression|0|||
105714533|NCT00091832|364613946|FG003|Overall Study|Disease Progression|1|||
105714534|NCT00091832|364613947|FG004|Overall Study|Disease Progression|1|||
105714535|NCT00091832|364613948|FG005|Overall Study|Disease Progression|2|||
105714536|NCT00091832|364613943|FG000|Overall Study|Ineligibility Determined|0|||
105714537|NCT00091832|364613944|FG001|Overall Study|Ineligibility Determined|0|||
105714538|NCT00091832|364613945|FG002|Overall Study|Ineligibility Determined|1|||
105714539|NCT00091832|364613946|FG003|Overall Study|Ineligibility Determined|0|||
105714540|NCT00091832|364613947|FG004|Overall Study|Ineligibility Determined|1|||
105714541|NCT00091832|364613948|FG005|Overall Study|Ineligibility Determined|0|||
105714542|NCT00091832|364613943|FG000|Overall Study|Lost to Follow-up|1|||
105714543|NCT00091832|364613944|FG001|Overall Study|Lost to Follow-up|0|||
105714544|NCT00091832|364613945|FG002|Overall Study|Lost to Follow-up|3|||
105714545|NCT00091832|364613946|FG003|Overall Study|Lost to Follow-up|3|||
105714546|NCT00091832|364613947|FG004|Overall Study|Lost to Follow-up|2|||
105714547|NCT00091832|364613948|FG005|Overall Study|Lost to Follow-up|1|||
105714548|NCT00091832|364613943|FG000|Overall Study|Noncompliance|0|||
105714549|NCT00091832|364613944|FG001|Overall Study|Noncompliance|1|||
105714550|NCT00091832|364613945|FG002|Overall Study|Noncompliance|0|||
105714551|NCT00091832|364613946|FG003|Overall Study|Noncompliance|0|||
105714552|NCT00091832|364613947|FG004|Overall Study|Noncompliance|0|||
105714553|NCT00091832|364613948|FG005|Overall Study|Noncompliance|0|||
105714554|NCT00091832|364613943|FG000|Overall Study|Other|0|||
105714555|NCT00091832|364613944|FG001|Overall Study|Other|1|||
105714556|NCT00091832|364613945|FG002|Overall Study|Other|2|||
105714557|NCT00091832|364613946|FG003|Overall Study|Other|0|||
105714558|NCT00091832|364613947|FG004|Overall Study|Other|0|||
105714559|NCT00091832|364613948|FG005|Overall Study|Other|0|||
105714560|NCT00091832|364613943|FG000|Overall Study|Protocol Violation|0|||
105714561|NCT00091832|364613944|FG001|Overall Study|Protocol Violation|0|||
105477148|NCT02353143|363759269|FG001|Overall Study|Withdrawal by Subject|0|||
105477149|NCT02353143|363759270|FG002|Overall Study|Withdrawal by Subject|0|||
105477150|NCT02353143|363759271|FG003|Overall Study|Withdrawal by Subject|0|||
105477151|NCT02353143|363759272|FG004|Overall Study|Withdrawal by Subject|1|||
105477152|NCT02353143|363759273|FG005|Overall Study|Withdrawal by Subject|0|||
105477153|NCT02353143|363759274|FG006|Overall Study|Withdrawal by Subject|0|||
105561744|NCT01137474|364052214|FG000|Overall Study|Other|3|||
105714562|NCT00091832|364613945|FG002|Overall Study|Protocol Violation|1|||
105714563|NCT00091832|364613946|FG003|Overall Study|Protocol Violation|0|||
105714564|NCT00091832|364613947|FG004|Overall Study|Protocol Violation|0|||
105714565|NCT00091832|364613948|FG005|Overall Study|Protocol Violation|1|||
105714566|NCT00915343|364613949|FG000|Part B - Open Label Period|Treatment switch|0|||
105714567|NCT00915343|364613950|FG001|Part B - Open Label Period|Treatment switch|0|||
105714568|NCT00915343|364613951|FG002|Part B - Open Label Period|Treatment switch|1|||
105714569|NCT00915343|364613949|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
105714570|NCT00915343|364613950|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
105477154|NCT02353143|363759275|FG007|Overall Study|Withdrawal by Subject|1|||
105477155|NCT02353143|363759276|FG008|Overall Study|Withdrawal by Subject|1|||
105714571|NCT00915343|364613951|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
105714572|NCT01920711|364613952|FG000|Overall Study|Death|347|||
105714573|NCT01920711|364613953|FG001|Overall Study|Death|356|||
105714574|NCT01920711|364613952|FG000|Overall Study|Lost to Follow-up|13|||
105714575|NCT01920711|364613953|FG001|Overall Study|Lost to Follow-up|14|||
105714576|NCT01920711|364613952|FG000|Overall Study|Withdrawal by Subject|4|||
105714577|NCT01920711|364613953|FG001|Overall Study|Withdrawal by Subject|3|||
105714578|NCT00626093|364613955|FG000|Overall Study|Lost to Follow-up|5|||
105714579|NCT00626093|364613955|FG000|Overall Study|Death|1|||
105714580|NCT00626093|364613955|FG000|Overall Study|Physician Decision|4|||
105714581|NCT00626093|364613955|FG000|Overall Study|Withdrawal by Subject|6|||
105714582|NCT00626093|364613955|FG000|Overall Study|Protocol Violation|1|||
105789504|NCT03917654|364883386|FG001|Year 1|Withdrawal by Subject|0|||
105789505|NCT03917654|364883387|FG002|Year 1|Withdrawal by Subject|0|||
105789506|NCT03917654|364883388|FG003|Year 1|Withdrawal by Subject|0|||
105714583|NCT00626093|364613955|FG000|Overall Study|One of the required devices not implante|6|||
105714584|NCT01282229|364613956|FG000|Overall Study|Protocol Violation|2|||
105714585|NCT00573794|364613963|FG000|Overall Study|Adverse Event|81|||
105714586|NCT00573794|364613963|FG000|Overall Study|Withdrew Consent|90|||
105714587|NCT00573794|364613963|FG000|Overall Study|Lost to Follow-up|13|||
105714588|NCT00573794|364613963|FG000|Overall Study|Protocol Violation|6|||
105714589|NCT00573794|364613963|FG000|Overall Study|Lack of Efficacy|94|||
105714590|NCT00573794|364613963|FG000|Overall Study|Other|46|||
105714591|NCT02026063|364613964|FG000|Overall Study|Physician Decision|0|||
105714592|NCT02026063|364613965|FG001|Overall Study|Physician Decision|10|||
105714593|NCT02026063|364613964|FG000|Overall Study|Noncompliance with Study Drug|1|||
105714594|NCT02026063|364613965|FG001|Overall Study|Noncompliance with Study Drug|1|||
105714595|NCT02026063|364613964|FG000|Overall Study|Withdrawal of Consent|1|||
105714596|NCT02026063|364613965|FG001|Overall Study|Withdrawal of Consent|6|||
105714597|NCT02026063|364613964|FG000|Overall Study|Adverse Event|5|||
105714598|NCT02026063|364613965|FG001|Overall Study|Adverse Event|20|||
105714599|NCT02026063|364613964|FG000|Overall Study|Lack of Efficacy|0|||
105714600|NCT02026063|364613965|FG001|Overall Study|Lack of Efficacy|4|||
105714601|NCT02026063|364613964|FG000|Overall Study|Lost to Follow-up|0|||
105714602|NCT02026063|364613965|FG001|Overall Study|Lost to Follow-up|1|||
105714603|NCT02026063|364613964|FG000|Overall Study|Reason not Specified|2|||
105714604|NCT02026063|364613965|FG001|Overall Study|Reason not Specified|7|||
105714605|NCT02154087|364613966|FG000|Overall Study|Study Termination|1|||
105714606|NCT03687502|364613969|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
105714607|NCT03687502|364613969|FG000|Overall Study|Lumason not available|1|||
105714608|NCT01116544|364613974|FG000|Overall Study|Protocol Violation|1|||
105714609|NCT01116544|364613975|FG001|Overall Study|Protocol Violation|0|||
105714610|NCT01116544|364613974|FG000|Overall Study|Withdrawal by Subject|1|||
105714611|NCT01116544|364613975|FG001|Overall Study|Withdrawal by Subject|1|||
105714612|NCT00486278|364613976|FG000|Overall Study|Adverse Event|5|||
105714613|NCT00486278|364613976|FG000|Overall Study|Withdrawal by Subject|2|||
105714614|NCT00486278|364613976|FG000|Overall Study|Physician Decision|2|||
105714615|NCT01724528|364613977|FG000|Overall Study|Death|3|||
105714616|NCT01724528|364613978|FG001|Overall Study|Death|0|||
105714617|NCT01724528|364613977|FG000|Overall Study|Withdrawal by Subject|0|||
105714618|NCT01724528|364613978|FG001|Overall Study|Withdrawal by Subject|2|||
105714619|NCT01724528|364613977|FG000|Overall Study|Protocol Violation|0|||
105714620|NCT01724528|364613978|FG001|Overall Study|Protocol Violation|1|||
105714621|NCT01724528|364613977|FG000|Overall Study|Patient refused to attend last visit|1|||
105714622|NCT01724528|364613978|FG001|Overall Study|Patient refused to attend last visit|0|||
105714623|NCT05501119|364613987|FG000|Overall Study|Withdrawal by Subject|2|||
105714624|NCT05501119|364613987|FG000|Overall Study|Lost to Follow-up|5|||
105714625|NCT02183519|364613988|FG000|Overall Study|computer error|3|||
105714626|NCT02183519|364613989|FG001|Overall Study|computer error|0|||
105714627|NCT02183519|364613988|FG000|Overall Study|Did not respond to cough inducter|0|||
105714628|NCT02183519|364613989|FG001|Overall Study|Did not respond to cough inducter|3|||
105714629|NCT01725750|364613990|FG000|Overall Study|Adverse Event|1|||
105714630|NCT01725750|364613991|FG001|Overall Study|Adverse Event|0|||
105714631|NCT01725750|364613990|FG000|Overall Study|Lost to Follow-up|1|||
105714632|NCT01725750|364613991|FG001|Overall Study|Lost to Follow-up|1|||
105714633|NCT01725750|364613990|FG000|Overall Study|Withdrawal by Subject|0|||
105714634|NCT01725750|364613991|FG001|Overall Study|Withdrawal by Subject|9|||
105714635|NCT02542072|364613992|FG000|First Intervention (1 Month)|Adverse Event|1|||
105714636|NCT02542072|364613993|FG001|First Intervention (1 Month)|Adverse Event|1|||
105714637|NCT02542072|364613992|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
105714638|NCT02542072|364613993|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
105714639|NCT02542072|364613992|FG000|First Intervention (1 Month)|Lens discomfort|1|||
105477156|NCT02353143|363759268|FG000|Overall Study|Lack of Efficacy|2|||
105714640|NCT02542072|364613993|FG001|First Intervention (1 Month)|Lens discomfort|2|||
105714641|NCT02542072|364613992|FG000|First Intervention (1 Month)|Protocol Violation|1|||
105714642|NCT02542072|364613993|FG001|First Intervention (1 Month)|Protocol Violation|0|||
105714643|NCT02542072|364613992|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
105714644|NCT02542072|364613993|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
105714645|NCT02542072|364613992|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
105714646|NCT02542072|364613993|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
105714647|NCT04556617|364613999|FG000|Overall Study|progressive disease|0|||
105714648|NCT04556617|364614000|FG001|Overall Study|progressive disease|2|||
105714649|NCT04556617|364614001|FG002|Overall Study|progressive disease|2|||
105714650|NCT04556617|364614002|FG003|Overall Study|progressive disease|1|||
105714651|NCT04556617|364614003|FG004|Overall Study|progressive disease|1|||
105714652|NCT04556617|364613999|FG000|Overall Study|Physician Decision|0|||
105714653|NCT04556617|364614000|FG001|Overall Study|Physician Decision|0|||
105714654|NCT04556617|364614001|FG002|Overall Study|Physician Decision|2|||
105477157|NCT02353143|363759269|FG001|Overall Study|Lack of Efficacy|1|||
105477158|NCT02353143|363759270|FG002|Overall Study|Lack of Efficacy|2|||
105714655|NCT04556617|364614002|FG003|Overall Study|Physician Decision|0|||
105714656|NCT04556617|364614003|FG004|Overall Study|Physician Decision|0|||
105714657|NCT04556617|364613999|FG000|Overall Study|Adverse Event|0|||
105714658|NCT04556617|364614000|FG001|Overall Study|Adverse Event|0|||
105714659|NCT04556617|364614001|FG002|Overall Study|Adverse Event|2|||
105714660|NCT04556617|364614002|FG003|Overall Study|Adverse Event|3|||
105714661|NCT04556617|364614003|FG004|Overall Study|Adverse Event|0|||
105714662|NCT04556617|364613999|FG000|Overall Study|Withdrawal by Subject|0|||
105714663|NCT04556617|364614000|FG001|Overall Study|Withdrawal by Subject|2|||
105714664|NCT04556617|364614001|FG002|Overall Study|Withdrawal by Subject|1|||
105714665|NCT04556617|364614002|FG003|Overall Study|Withdrawal by Subject|1|||
105714666|NCT04556617|364614003|FG004|Overall Study|Withdrawal by Subject|0|||
105714667|NCT04556617|364613999|FG000|Overall Study|PSA increase|0|||
105714668|NCT04556617|364614000|FG001|Overall Study|PSA increase|1|||
105714669|NCT04556617|364614001|FG002|Overall Study|PSA increase|0|||
105714670|NCT04556617|364614002|FG003|Overall Study|PSA increase|0|||
105714671|NCT04556617|364614003|FG004|Overall Study|PSA increase|0|||
105714672|NCT04556617|364613999|FG000|Overall Study|Sponsor study termination|1|||
105714673|NCT04556617|364614000|FG001|Overall Study|Sponsor study termination|0|||
105714674|NCT04556617|364614001|FG002|Overall Study|Sponsor study termination|0|||
105714675|NCT04556617|364614002|FG003|Overall Study|Sponsor study termination|0|||
105714676|NCT04556617|364614003|FG004|Overall Study|Sponsor study termination|0|||
105714677|NCT04949841|364614004|FG000|Overall Study|Adverse Event|7|||
105714678|NCT04949841|364614004|FG000|Overall Study|Death|1|||
105714679|NCT04949841|364614004|FG000|Overall Study|Withdrawal by Subject|52|||
105714680|NCT04949841|364614004|FG000|Overall Study|Pregnancy|4|||
105714681|NCT04949841|364614004|FG000|Overall Study|Lost to Follow-up|9|||
105714682|NCT04949841|364614004|FG000|Overall Study|Lack of Efficacy|55|||
105714683|NCT04949841|364614004|FG000|Overall Study|Various reasons|9|||
105714684|NCT02937350|364614011|FG000|Overall Study|Withdrawal by Subject|0|||
105714685|NCT02937350|364614012|FG001|Overall Study|Withdrawal by Subject|1|||
105714686|NCT02937350|364614013|FG002|Overall Study|Withdrawal by Subject|0|||
105714687|NCT02419508|364614014|FG000|Overall Study|Adverse Event|9|||
105714688|NCT02419508|364614015|FG001|Overall Study|Adverse Event|3|||
105714689|NCT02419508|364614014|FG000|Overall Study|Withdrawal by Subject|1|||
105714690|NCT02419508|364614015|FG001|Overall Study|Withdrawal by Subject|0|||
105714691|NCT02419508|364614014|FG000|Overall Study|Other - Reason not specified|0|||
105714692|NCT02419508|364614015|FG001|Overall Study|Other - Reason not specified|1|||
105714693|NCT04811716|364614016|FG000|Overall Study|Withdrawal by Subject|2|||
105714694|NCT04811716|364614017|FG001|Overall Study|Withdrawal by Subject|0|||
105714695|NCT02531646|364614022|FG000|Overall Study|equip. image processing issue|5|||
105714696|NCT02531646|364614023|FG001|Overall Study|equip. image processing issue|1|||
105714697|NCT02531646|364614024|FG002|Overall Study|equip. image processing issue|0|||
105714698|NCT00768898|364615545|FG000|Overall Study|Unrelated injury|1|||
105714699|NCT00768898|364615545|FG000|Overall Study|Headache|1|||
105714700|NCT02527707|364615546|FG000|Overall Study|Adverse Event|1|||
105714701|NCT02527707|364615546|FG000|Overall Study|Adverse Event|1|||
105714702|NCT03686397|364615547|FG000|Overall Study|Lack of Efficacy|3|||
105714703|NCT03686397|364615548|FG001|Overall Study|Lack of Efficacy|5|||
105714704|NCT03686397|364615547|FG000|Overall Study|Adverse Event|0|||
105714705|NCT03686397|364615548|FG001|Overall Study|Adverse Event|1|||
105714706|NCT03686397|364615547|FG000|Overall Study|Protocol Violation|0|||
105714707|NCT03686397|364615548|FG001|Overall Study|Protocol Violation|1|||
105714708|NCT03686397|364615547|FG000|Overall Study|Withdrawal by Subject|0|||
105714709|NCT03686397|364615548|FG001|Overall Study|Withdrawal by Subject|1|||
105714710|NCT03686397|364615547|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
105714711|NCT03686397|364615548|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
105714712|NCT00930059|364615549|FG000|Overall Study|Death|1|||
105714713|NCT00930059|364615550|FG001|Overall Study|Death|0|||
105714714|NCT00930059|364615549|FG000|Overall Study|Did not meet entrance criteria|1|||
105714715|NCT00930059|364615550|FG001|Overall Study|Did not meet entrance criteria|1|||
105714716|NCT00930059|364615549|FG000|Overall Study|Withdrawal by Subject|3|||
105714717|NCT00930059|364615550|FG001|Overall Study|Withdrawal by Subject|4|||
105714718|NCT00930059|364615549|FG000|Overall Study|Other|1|||
105714719|NCT00930059|364615550|FG001|Overall Study|Other|0|||
105714720|NCT00930059|364615549|FG000|Overall Study|1 site terminated by sponsor|1|||
105714721|NCT00930059|364615550|FG001|Overall Study|1 site terminated by sponsor|1|||
105714722|NCT00930059|364615549|FG000|Overall Study|Adverse Event|1|||
105714723|NCT00930059|364615550|FG001|Overall Study|Adverse Event|6|||
105714724|NCT01299766|364615554|FG000|Overall Study|Death|5|||
105714725|NCT01299766|364615555|FG001|Overall Study|Death|4|||
105714726|NCT01299766|364615554|FG000|Overall Study|Withdrawal by Subject|29|||
105714727|NCT01299766|364615555|FG001|Overall Study|Withdrawal by Subject|19|||
105714728|NCT03988907|364615558|FG000|Overall Study|Unable to complete visit|0|||
105714729|NCT03988907|364615559|FG001|Overall Study|Unable to complete visit|1|||
105714730|NCT01430442|364615563|FG000|Overall Study|Subject Withdrew Consent|3|||
105714731|NCT01430442|364615564|FG001|Overall Study|Subject Withdrew Consent|0|||
105714732|NCT01430442|364615565|FG002|Overall Study|Subject Withdrew Consent|1|||
105714733|NCT01430442|364615566|FG003|Overall Study|Subject Withdrew Consent|0|||
105714734|NCT01430442|364615567|FG004|Overall Study|Subject Withdrew Consent|2|||
105714735|NCT01430442|364615568|FG005|Overall Study|Subject Withdrew Consent|1|||
105714736|NCT01430442|364615569|FG006|Overall Study|Subject Withdrew Consent|5|||
105714737|NCT01430442|364615570|FG007|Overall Study|Subject Withdrew Consent|2|||
105714738|NCT01430442|364615563|FG000|Overall Study|Lost to Follow-up|2|||
105714739|NCT01430442|364615564|FG001|Overall Study|Lost to Follow-up|0|||
105714740|NCT01430442|364615565|FG002|Overall Study|Lost to Follow-up|1|||
105714741|NCT01430442|364615566|FG003|Overall Study|Lost to Follow-up|2|||
105714742|NCT01430442|364615567|FG004|Overall Study|Lost to Follow-up|2|||
105714743|NCT01430442|364615568|FG005|Overall Study|Lost to Follow-up|1|||
105714744|NCT01430442|364615569|FG006|Overall Study|Lost to Follow-up|5|||
105714745|NCT01430442|364615570|FG007|Overall Study|Lost to Follow-up|1|||
105714746|NCT01430442|364615563|FG000|Overall Study|Pregnancy|1|||
105714747|NCT01430442|364615564|FG001|Overall Study|Pregnancy|0|||
105714748|NCT01430442|364615565|FG002|Overall Study|Pregnancy|0|||
105714749|NCT01430442|364615566|FG003|Overall Study|Pregnancy|0|||
105714750|NCT01430442|364615567|FG004|Overall Study|Pregnancy|0|||
105714751|NCT01430442|364615568|FG005|Overall Study|Pregnancy|1|||
105714752|NCT01430442|364615569|FG006|Overall Study|Pregnancy|0|||
105714753|NCT01430442|364615570|FG007|Overall Study|Pregnancy|0|||
105714754|NCT01430442|364615563|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
105714755|NCT01430442|364615564|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
105714756|NCT01430442|364615565|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
105714757|NCT01430442|364615566|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
105714758|NCT01430442|364615567|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
105714759|NCT01430442|364615568|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
105714760|NCT01430442|364615569|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
105714761|NCT01430442|364615570|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
105714762|NCT01641939|364615571|FG000|Overall Study|Death|90|||
105714763|NCT01641939|364615572|FG001|Overall Study|Death|187|||
105714764|NCT01641939|364615573|FG002|Overall Study|Death|61|||
105714765|NCT01641939|364615571|FG000|Overall Study|Lost to Follow-up|3|||
105714766|NCT01641939|364615572|FG001|Overall Study|Lost to Follow-up|2|||
105714767|NCT01641939|364615573|FG002|Overall Study|Lost to Follow-up|1|||
105714768|NCT01641939|364615571|FG000|Overall Study|Withdrawal by Subject|14|||
105714769|NCT01641939|364615572|FG001|Overall Study|Withdrawal by Subject|11|||
105714770|NCT01641939|364615573|FG002|Overall Study|Withdrawal by Subject|5|||
105714771|NCT01641939|364615571|FG000|Overall Study|Study Terminated by Sponsor|10|||
105714772|NCT01641939|364615572|FG001|Overall Study|Study Terminated by Sponsor|28|||
105714773|NCT01641939|364615573|FG002|Overall Study|Study Terminated by Sponsor|3|||
105789507|NCT03917654|364883389|FG004|Year 1|Withdrawal by Subject|0|||
105789508|NCT03917654|364883390|FG005|Year 1|Withdrawal by Subject|1|||
105789509|NCT03917654|364883391|FG006|Year 1|Withdrawal by Subject|6|||
105789510|NCT03917654|364883392|FG007|Year 1|Withdrawal by Subject|2|||
105714774|NCT00568555|364615575|FG000|Overall Study|Withdrawal by Subject|1|||
105714775|NCT00568555|364615576|FG001|Overall Study|Withdrawal by Subject|1|||
105714776|NCT00699348|364615579|FG000|Overall Study|Death|6|||
105714777|NCT00699348|364615579|FG000|Overall Study|Adverse Event|15|||
105714778|NCT00699348|364615579|FG000|Overall Study|Withdrawal by Subject|11|||
105789511|NCT03917654|364883393|FG008|Year 1|Withdrawal by Subject|5|||
105714779|NCT00699348|364615579|FG000|Overall Study|Protocol Violation|10|||
105714780|NCT00699348|364615579|FG000|Overall Study|Lack of Efficacy|8|||
105714781|NCT00699348|364615579|FG000|Overall Study|Failure to return|1|||
105714782|NCT00699348|364615579|FG000|Overall Study|Blood transfusion|24|||
105789512|NCT03917654|364883394|FG009|Year 1|Withdrawal by Subject|3|||
105714783|NCT00699348|364615579|FG000|Overall Study|Renal transplantation|10|||
105714784|NCT00699348|364615579|FG000|Overall Study|Other|5|||
105714785|NCT00716976|364615580|FG000|Overall Study|Adverse Event|2|||
105714786|NCT00716976|364615581|FG001|Overall Study|Adverse Event|0|||
105714787|NCT00716976|364615580|FG000|Overall Study|Death|1|||
105714788|NCT00716976|364615581|FG001|Overall Study|Death|0|||
105714789|NCT00716976|364615580|FG000|Overall Study|Physician Decision|2|||
105714790|NCT00716976|364615581|FG001|Overall Study|Physician Decision|2|||
105477159|NCT02353143|363759271|FG003|Overall Study|Lack of Efficacy|4|||
105714791|NCT00716976|364615580|FG000|Overall Study|Withdrawal by Subject|5|||
105714792|NCT00716976|364615581|FG001|Overall Study|Withdrawal by Subject|1|||
105477160|NCT02353143|363759272|FG004|Overall Study|Lack of Efficacy|13|||
105477161|NCT02353143|363759273|FG005|Overall Study|Lack of Efficacy|2|||
105477162|NCT02353143|363759274|FG006|Overall Study|Lack of Efficacy|2|||
105477163|NCT02353143|363759275|FG007|Overall Study|Lack of Efficacy|2|||
105477164|NCT02353143|363759276|FG008|Overall Study|Lack of Efficacy|1|||
105477165|NCT02353143|363759268|FG000|Overall Study|reason not specified|1|||
105477166|NCT02353143|363759269|FG001|Overall Study|reason not specified|2|||
105477167|NCT02353143|363759270|FG002|Overall Study|reason not specified|0|||
105477168|NCT02353143|363759271|FG003|Overall Study|reason not specified|0|||
105477169|NCT02353143|363759272|FG004|Overall Study|reason not specified|6|||
105477170|NCT02353143|363759273|FG005|Overall Study|reason not specified|1|||
105477171|NCT02353143|363759274|FG006|Overall Study|reason not specified|0|||
105477172|NCT02353143|363759275|FG007|Overall Study|reason not specified|3|||
105477173|NCT02353143|363759276|FG008|Overall Study|reason not specified|1|||
105477174|NCT02353143|363759268|FG000|Overall Study|Physician Decision|0|||
105477175|NCT02353143|363759269|FG001|Overall Study|Physician Decision|4|||
105477176|NCT02353143|363759270|FG002|Overall Study|Physician Decision|2|||
105477177|NCT02353143|363759271|FG003|Overall Study|Physician Decision|3|||
105477178|NCT02353143|363759272|FG004|Overall Study|Physician Decision|4|||
105477179|NCT02353143|363759273|FG005|Overall Study|Physician Decision|0|||
105477180|NCT02353143|363759274|FG006|Overall Study|Physician Decision|1|||
105477181|NCT02353143|363759275|FG007|Overall Study|Physician Decision|2|||
105477182|NCT02353143|363759276|FG008|Overall Study|Physician Decision|0|||
105477183|NCT02353143|363759268|FG000|Overall Study|Adverse Event|0|||
105477184|NCT02353143|363759269|FG001|Overall Study|Adverse Event|0|||
105714793|NCT00716976|364615580|FG000|Overall Study|Premature discontinuation cisplatin|5|||
105714794|NCT00716976|364615581|FG001|Overall Study|Premature discontinuation cisplatin|4|||
105477185|NCT02353143|363759270|FG002|Overall Study|Adverse Event|1|||
105477186|NCT02353143|363759271|FG003|Overall Study|Adverse Event|0|||
105477187|NCT02353143|363759272|FG004|Overall Study|Adverse Event|1|||
105477188|NCT02353143|363759273|FG005|Overall Study|Adverse Event|1|||
105477189|NCT02353143|363759274|FG006|Overall Study|Adverse Event|0|||
105477190|NCT02353143|363759275|FG007|Overall Study|Adverse Event|0|||
105477191|NCT02353143|363759276|FG008|Overall Study|Adverse Event|0|||
105714795|NCT00716976|364615580|FG000|Overall Study|Radiation during protocol|1|||
105714796|NCT00716976|364615581|FG001|Overall Study|Radiation during protocol|0|||
105789513|NCT03917654|364883395|FG010|Year 1|Withdrawal by Subject|1|||
105789514|NCT03917654|364883396|FG011|Year 1|Withdrawal by Subject|0|||
105789515|NCT03917654|364883385|FG000|Year 1|Travel|0|||
105789516|NCT03917654|364883386|FG001|Year 1|Travel|1|||
105789517|NCT03917654|364883387|FG002|Year 1|Travel|1|||
105789518|NCT03917654|364883388|FG003|Year 1|Travel|0|||
105789519|NCT03917654|364883389|FG004|Year 1|Travel|4|||
105789520|NCT03917654|364883390|FG005|Year 1|Travel|4|||
105789521|NCT03917654|364883391|FG006|Year 1|Travel|10|||
105789522|NCT03917654|364883392|FG007|Year 1|Travel|8|||
105789523|NCT03917654|364883393|FG008|Year 1|Travel|2|||
105789524|NCT03917654|364883394|FG009|Year 1|Travel|5|||
105789525|NCT03917654|364883395|FG010|Year 1|Travel|3|||
105789526|NCT03917654|364883396|FG011|Year 1|Travel|3|||
105789527|NCT03917654|364883385|FG000|Year 1|Subject moved away from site|0|||
105789528|NCT03917654|364883386|FG001|Year 1|Subject moved away from site|1|||
105789529|NCT03917654|364883387|FG002|Year 1|Subject moved away from site|0|||
105789530|NCT03917654|364883388|FG003|Year 1|Subject moved away from site|0|||
105789531|NCT03917654|364883389|FG004|Year 1|Subject moved away from site|0|||
105789532|NCT03917654|364883390|FG005|Year 1|Subject moved away from site|0|||
105789533|NCT03917654|364883391|FG006|Year 1|Subject moved away from site|1|||
105477192|NCT02353143|363759268|FG000|Overall Study|patient receiving other treatment for AML|0|||
105477193|NCT02353143|363759269|FG001|Overall Study|patient receiving other treatment for AML|0|||
105477194|NCT02353143|363759270|FG002|Overall Study|patient receiving other treatment for AML|1|||
105477195|NCT02353143|363759271|FG003|Overall Study|patient receiving other treatment for AML|0|||
105477196|NCT02353143|363759272|FG004|Overall Study|patient receiving other treatment for AML|0|||
105477197|NCT02353143|363759273|FG005|Overall Study|patient receiving other treatment for AML|0|||
105477198|NCT02353143|363759274|FG006|Overall Study|patient receiving other treatment for AML|0|||
105477199|NCT02353143|363759275|FG007|Overall Study|patient receiving other treatment for AML|0|||
105477200|NCT02353143|363759276|FG008|Overall Study|patient receiving other treatment for AML|0|||
105477201|NCT02353143|363759268|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
105477202|NCT02353143|363759269|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
105477203|NCT02353143|363759270|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
105477204|NCT02353143|363759271|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
105477205|NCT02353143|363759272|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
105477206|NCT02353143|363759273|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
105477207|NCT02353143|363759274|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
105477208|NCT02353143|363759275|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
105477209|NCT02353143|363759276|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
105477210|NCT03672097|363759278|FG000|Period 1|Withdrawal by Subject|2|||
105477211|NCT03672097|363759278|FG000|Period 1|Adverse Event|1|||
105477212|NCT03672097|363759278|FG000|Period 1|Did not receive treatment|1|||
105477213|NCT03672097|363759278|FG000|Period 2|Withdrawal by Subject|3|||
105477214|NCT03672097|363759278|FG000|Period 2|Other|1|||
105477215|NCT01290796|363759279|FG000|Overall Study|Lost to Follow-up|21|||
105477216|NCT01290796|363759279|FG000|Overall Study|Withdrawal by Subject|4|||
105477217|NCT01290796|363759279|FG000|Overall Study|Physician Decision|2|||
105477218|NCT01290796|363759279|FG000|Overall Study|Secondary Surgical Intervention|2|||
105477219|NCT01290796|363759279|FG000|Overall Study|Withdrawal by Sponsor|1|||
105477220|NCT02709538|363759281|FG000|Overall Study|Adverse Event|13|||
105477221|NCT02709538|363759282|FG001|Overall Study|Adverse Event|2|||
105477222|NCT02709538|363759283|FG002|Overall Study|Adverse Event|3|||
105477223|NCT02709538|363759281|FG000|Overall Study|Lack of Efficacy|1|||
105477224|NCT02709538|363759282|FG001|Overall Study|Lack of Efficacy|0|||
105477225|NCT02709538|363759283|FG002|Overall Study|Lack of Efficacy|0|||
105477226|NCT02709538|363759281|FG000|Overall Study|Lost to Follow-up|24|||
105477227|NCT02709538|363759282|FG001|Overall Study|Lost to Follow-up|8|||
105477228|NCT02709538|363759283|FG002|Overall Study|Lost to Follow-up|4|||
105477229|NCT02709538|363759281|FG000|Overall Study|Physician Decision|1|||
105477230|NCT02709538|363759282|FG001|Overall Study|Physician Decision|0|||
105561745|NCT01137474|364052215|FG001|Overall Study|Other|1|||
105561746|NCT01137474|364052216|FG002|Overall Study|Other|0|||
105561747|NCT01137474|364052217|FG003|Overall Study|Other|0|||
105477231|NCT02709538|363759283|FG002|Overall Study|Physician Decision|0|||
105561748|NCT01137474|364052214|FG000|Overall Study|Pregnancy|0|||
105477232|NCT02709538|363759281|FG000|Overall Study|Withdrawal by Subject|40|||
105477233|NCT02709538|363759282|FG001|Overall Study|Withdrawal by Subject|7|||
105477234|NCT02709538|363759283|FG002|Overall Study|Withdrawal by Subject|4|||
105477235|NCT02709538|363759281|FG000|Overall Study|Non-compliance with study procedures|5|||
105561749|NCT01137474|364052215|FG001|Overall Study|Pregnancy|1|||
105561750|NCT01137474|364052216|FG002|Overall Study|Pregnancy|0|||
105561751|NCT01137474|364052217|FG003|Overall Study|Pregnancy|0|||
105789534|NCT03917654|364883392|FG007|Year 1|Subject moved away from site|2|||
105789535|NCT03917654|364883393|FG008|Year 1|Subject moved away from site|1|||
105789536|NCT03917654|364883394|FG009|Year 1|Subject moved away from site|0|||
105789537|NCT03917654|364883395|FG010|Year 1|Subject moved away from site|0|||
105789538|NCT03917654|364883396|FG011|Year 1|Subject moved away from site|3|||
105789539|NCT03917654|364883385|FG000|Year 1|Spouse/Family member request|0|||
105477236|NCT02709538|363759282|FG001|Overall Study|Non-compliance with study procedures|0|||
105477237|NCT02709538|363759283|FG002|Overall Study|Non-compliance with study procedures|0|||
105477238|NCT02709538|363759281|FG000|Overall Study|Non-compliance with study drug|2|||
105477239|NCT02709538|363759282|FG001|Overall Study|Non-compliance with study drug|0|||
105714797|NCT00716976|364615580|FG000|Overall Study|Ineligibles|4|||
105477240|NCT02709538|363759283|FG002|Overall Study|Non-compliance with study drug|0|||
105477241|NCT02709538|363759281|FG000|Overall Study|Protocol deviation|10|||
105477242|NCT02709538|363759282|FG001|Overall Study|Protocol deviation|4|||
105477243|NCT02709538|363759283|FG002|Overall Study|Protocol deviation|4|||
105477244|NCT02709538|363759281|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
105477245|NCT02709538|363759282|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
105477246|NCT02709538|363759283|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
105477247|NCT02709538|363759281|FG000|Overall Study|Other|16|||
105477248|NCT02709538|363759282|FG001|Overall Study|Other|7|||
105477249|NCT02709538|363759283|FG002|Overall Study|Other|5|||
105477250|NCT00835211|363759284|FG000|First Intervention|Withdrawal by Subject|0|||
105477251|NCT00835211|363759285|FG001|First Intervention|Withdrawal by Subject|1|||
105477252|NCT00835211|363759284|FG000|Washout: 7 Days|Adverse Event|2|||
105477253|NCT00835211|363759285|FG001|Washout: 7 Days|Adverse Event|1|||
105477254|NCT00835211|363759284|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
105477255|NCT00835211|363759285|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
105477256|NCT03087617|363759286|FG000|Overall Study|Lost to Follow-up|32|||
105477257|NCT03087617|363759287|FG001|Overall Study|Lost to Follow-up|30|||
105477258|NCT03087617|363759288|FG002|Overall Study|Lost to Follow-up|30|||
105477259|NCT03087617|363759289|FG003|Overall Study|Lost to Follow-up|39|||
105477260|NCT02343549|363759290|FG000|Overall Study|Death|11|||
105477261|NCT02343549|363759290|FG000|Overall Study|Withdrawal by Subject|2|||
105477262|NCT02160041|363759291|FG000|Overall Study|Adverse Event|11|||
105477263|NCT02160041|363759291|FG000|Overall Study|Death|2|||
105477264|NCT02160041|363759291|FG000|Overall Study|disease progression|57|||
105477265|NCT02160041|363759291|FG000|Overall Study|Protocol Violation|1|||
105477266|NCT02160041|363759291|FG000|Overall Study|non-compliance with study|1|||
105477267|NCT02160041|363759291|FG000|Overall Study|Physician Decision|3|||
105477268|NCT02160041|363759291|FG000|Overall Study|Withdrawal by Subject|8|||
105477269|NCT02160041|363759291|FG000|Overall Study|study terminated by by sponsor|1|||
105477270|NCT01090323|363759292|FG000|Overall Study|Adverse Event|12|||
105477271|NCT01090323|363759293|FG001|Overall Study|Adverse Event|2|||
105477272|NCT01090323|363759292|FG000|Overall Study|Abnormal Lab Values|3|||
105477273|NCT01090323|363759293|FG001|Overall Study|Abnormal Lab Values|1|||
105477274|NCT01090323|363759292|FG000|Overall Study|Abnormal Test Procedure Results|2|||
105477275|NCT01090323|363759293|FG001|Overall Study|Abnormal Test Procedure Results|0|||
105477276|NCT01090323|363759292|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105477277|NCT01090323|363759293|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105477278|NCT01090323|363759292|FG000|Overall Study|Condition no longer requires drug|5|||
105477279|NCT01090323|363759293|FG001|Overall Study|Condition no longer requires drug|4|||
105477280|NCT01090323|363759292|FG000|Overall Study|Protocol Violation|2|||
105477281|NCT01090323|363759293|FG001|Overall Study|Protocol Violation|1|||
105477282|NCT01090323|363759292|FG000|Overall Study|Withdrew consent|33|||
105477283|NCT01090323|363759293|FG001|Overall Study|Withdrew consent|11|||
105477284|NCT01090323|363759292|FG000|Overall Study|Lost to Follow-up|11|||
105714798|NCT00716976|364615581|FG001|Overall Study|Ineligibles|2|||
105477285|NCT01090323|363759293|FG001|Overall Study|Lost to Follow-up|6|||
105477286|NCT01090323|363759292|FG000|Overall Study|Administrative problems|6|||
105477287|NCT01090323|363759293|FG001|Overall Study|Administrative problems|4|||
105477288|NCT01090323|363759292|FG000|Overall Study|Death|1|||
105477289|NCT01090323|363759293|FG001|Overall Study|Death|2|||
105714799|NCT00122135|364615587|FG000|Overall Study|Withdrawal by Subject|3|||
105789540|NCT03917654|364883386|FG001|Year 1|Spouse/Family member request|0|||
105789541|NCT03917654|364883387|FG002|Year 1|Spouse/Family member request|1|||
105789542|NCT03917654|364883388|FG003|Year 1|Spouse/Family member request|0|||
105789543|NCT03917654|364883389|FG004|Year 1|Spouse/Family member request|1|||
105789544|NCT03917654|364883390|FG005|Year 1|Spouse/Family member request|0|||
105789545|NCT03917654|364883391|FG006|Year 1|Spouse/Family member request|0|||
105789546|NCT03917654|364883392|FG007|Year 1|Spouse/Family member request|2|||
105789547|NCT03917654|364883393|FG008|Year 1|Spouse/Family member request|0|||
105789548|NCT03917654|364883394|FG009|Year 1|Spouse/Family member request|0|||
105789549|NCT03917654|364883395|FG010|Year 1|Spouse/Family member request|0|||
105789550|NCT03917654|364883396|FG011|Year 1|Spouse/Family member request|1|||
105789551|NCT03917654|364883385|FG000|Year 1|Death|0|||
105714800|NCT00122135|364615588|FG001|Overall Study|Withdrawal by Subject|0|||
105714801|NCT00860158|364615591|FG000|Overall Study|Study Terminated|1|||
105714802|NCT05499520|364615597|FG000|Overall Study|Lost to Follow-up|0|||
105714803|NCT05499520|364615598|FG001|Overall Study|Lost to Follow-up|0|||
105714804|NCT05499520|364615599|FG002|Overall Study|Lost to Follow-up|38|||
105714805|NCT05499520|364615600|FG003|Overall Study|Lost to Follow-up|41|||
105714806|NCT05499520|364615601|FG004|Overall Study|Lost to Follow-up|46|||
105714807|NCT05499520|364615602|FG005|Overall Study|Lost to Follow-up|0|||
105714808|NCT05499520|364615603|FG006|Overall Study|Lost to Follow-up|31|||
105714809|NCT05499520|364615604|FG007|Overall Study|Lost to Follow-up|45|||
105714810|NCT05499520|364615605|FG008|Overall Study|Lost to Follow-up|42|||
105714811|NCT05499520|364615606|FG009|Overall Study|Lost to Follow-up|0|||
105714812|NCT05499520|364615607|FG010|Overall Study|Lost to Follow-up|0|||
105714813|NCT05499520|364615608|FG011|Overall Study|Lost to Follow-up|37|||
105714814|NCT05499520|364615609|FG012|Overall Study|Lost to Follow-up|53|||
105714815|NCT05499520|364615610|FG013|Overall Study|Lost to Follow-up|49|||
105714816|NCT05499520|364615611|FG014|Overall Study|Lost to Follow-up|0|||
105714817|NCT05499520|364615612|FG015|Overall Study|Lost to Follow-up|36|||
105714818|NCT05499520|364615613|FG016|Overall Study|Lost to Follow-up|58|||
105714819|NCT05499520|364615614|FG017|Overall Study|Lost to Follow-up|53|||
105714820|NCT02770326|364615621|FG000|Overall Study|Death|3|||
105714821|NCT02770326|364615621|FG000|Overall Study|Lost to Follow-up|1|||
105714822|NCT01613326|364615622|FG000|Overall Study|Adverse Event|7|||
105714823|NCT01613326|364615623|FG001|Overall Study|Adverse Event|5|||
105714824|NCT01613326|364615622|FG000|Overall Study|Withdrawal by Subject|3|||
105714825|NCT01613326|364615623|FG001|Overall Study|Withdrawal by Subject|4|||
105714826|NCT01613326|364615622|FG000|Overall Study|Abnormal test procedure result(s)|2|||
105714827|NCT01613326|364615623|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105714828|NCT01613326|364615622|FG000|Overall Study|inability to use device|1|||
105714829|NCT01613326|364615623|FG001|Overall Study|inability to use device|0|||
105714830|NCT01613326|364615622|FG000|Overall Study|Lack of Efficacy|0|||
105714831|NCT01613326|364615623|FG001|Overall Study|Lack of Efficacy|1|||
105714832|NCT01613326|364615622|FG000|Overall Study|Lost to Follow-up|0|||
105714833|NCT01613326|364615623|FG001|Overall Study|Lost to Follow-up|1|||
105714834|NCT01613326|364615622|FG000|Overall Study|Administrative|0|||
105714835|NCT01613326|364615623|FG001|Overall Study|Administrative|2|||
105714836|NCT01613326|364615622|FG000|Overall Study|Protocol Violation|0|||
105714837|NCT01613326|364615623|FG001|Overall Study|Protocol Violation|1|||
105714838|NCT02971202|364615626|FG000|Overall Study|Pregnancy|1|||
105714839|NCT02971202|364615627|FG001|Overall Study|Pregnancy|0|||
105714840|NCT02971202|364615628|FG002|Overall Study|Pregnancy|0|||
105714841|NCT02971202|364615626|FG000|Overall Study|screen fail after consent|1|||
105789552|NCT03917654|364883386|FG001|Year 1|Death|0|||
105789553|NCT03917654|364883387|FG002|Year 1|Death|0|||
105789554|NCT03917654|364883388|FG003|Year 1|Death|0|||
105789555|NCT03917654|364883389|FG004|Year 1|Death|0|||
105714842|NCT02971202|364615627|FG001|Overall Study|screen fail after consent|0|||
105714843|NCT02971202|364615628|FG002|Overall Study|screen fail after consent|1|||
105714844|NCT03980938|364615631|FG000|Treatment Period 1|Study Terminated|1|||
105714845|NCT03980938|364615632|FG001|Treatment Period 1|Study Terminated|1|||
105714846|NCT03980938|364615631|FG000|Treatment Period 2|Study Terminated|2|||
105714847|NCT03980938|364615632|FG001|Treatment Period 2|Study Terminated|2|||
105714848|NCT02723201|364615633|FG000|Second Intervention Period|Protocol Violation|1|||
105714849|NCT02723201|364615634|FG001|Second Intervention Period|Protocol Violation|0|||
105714850|NCT02723201|364615635|FG002|Second Intervention Period|Protocol Violation|0|||
105714851|NCT02723201|364615633|FG000|Second Intervention Period|Adverse Event|1|||
105714852|NCT02723201|364615634|FG001|Second Intervention Period|Adverse Event|0|||
105714853|NCT02723201|364615635|FG002|Second Intervention Period|Adverse Event|0|||
105714854|NCT01445535|364615636|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
105714855|NCT01445535|364615637|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
105714856|NCT01445535|364615638|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
105714857|NCT01445535|364615639|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
105714858|NCT01445535|364615636|FG000|Overall Study|Disease progression|1|||
105714859|NCT01445535|364615637|FG001|Overall Study|Disease progression|0|||
105714860|NCT01445535|364615638|FG002|Overall Study|Disease progression|1|||
105714861|NCT01445535|364615639|FG003|Overall Study|Disease progression|0|||
105714862|NCT01445535|364615636|FG000|Overall Study|PI discretion|0|||
105714863|NCT01445535|364615637|FG001|Overall Study|PI discretion|0|||
105714864|NCT01445535|364615638|FG002|Overall Study|PI discretion|0|||
105714865|NCT01445535|364615639|FG003|Overall Study|PI discretion|1|||
105714866|NCT02908880|364615642|FG000|Overall Study|Lost to Follow-up|4|||
105714867|NCT02908880|364615642|FG000|Overall Study|Explantation of the device|1|||
105714868|NCT02908880|364615642|FG000|Overall Study|Withdrawal by Subject|17|||
105714869|NCT02908880|364615642|FG000|Overall Study|Death|5|||
105714870|NCT02421887|364615643|FG000|Overall Study|Lost to Follow-up|5|||
105714871|NCT02421887|364615644|FG001|Overall Study|Lost to Follow-up|0|||
105714872|NCT02421887|364615643|FG000|Overall Study|Withdrawal by Subject|8|||
105714873|NCT02421887|364615644|FG001|Overall Study|Withdrawal by Subject|5|||
105714874|NCT02421887|364615643|FG000|Overall Study|Physician Decision|2|||
105714875|NCT02421887|364615644|FG001|Overall Study|Physician Decision|4|||
105714876|NCT02421887|364615643|FG000|Overall Study|Adverse Event|2|||
105714877|NCT02421887|364615644|FG001|Overall Study|Adverse Event|0|||
105714878|NCT03569202|364615648|FG000|Part 3|Physician Decision|1|||
105714879|NCT03569202|364615649|FG001|Part 3|Physician Decision|0|||
105714880|NCT03569202|364615648|FG000|Part 3|Other|1|||
105714881|NCT03569202|364615649|FG001|Part 3|Other|1|||
105714882|NCT00420511|364615650|FG000|Overall Study|Adverse Event|1|||
105714883|NCT00420511|364615651|FG001|Overall Study|Adverse Event|1|||
105714884|NCT00420511|364615650|FG000|Overall Study|Lost to Follow-up|1|||
105714885|NCT00420511|364615651|FG001|Overall Study|Lost to Follow-up|0|||
105714886|NCT01467492|364615652|FG000|Overall Study|Withdrawal by Subject|6|||
105714887|NCT01467492|364615653|FG001|Overall Study|Withdrawal by Subject|4|||
105714888|NCT01467492|364615652|FG000|Overall Study|Study Terminated by Sponsor|6|||
105714889|NCT01467492|364615653|FG001|Overall Study|Study Terminated by Sponsor|4|||
105714890|NCT01467492|364615652|FG000|Overall Study|Adverse Event|4|||
105714891|NCT01467492|364615653|FG001|Overall Study|Adverse Event|3|||
105714892|NCT01467492|364615652|FG000|Overall Study|Lost to Follow-up|3|||
105714893|NCT01467492|364615653|FG001|Overall Study|Lost to Follow-up|2|||
105714894|NCT01467492|364615652|FG000|Overall Study|Undefined|2|||
105714895|NCT01467492|364615653|FG001|Overall Study|Undefined|0|||
105714896|NCT01467492|364615652|FG000|Overall Study|Enrolled But Not Treated|1|||
105714897|NCT01467492|364615653|FG001|Overall Study|Enrolled But Not Treated|0|||
105714898|NCT00491179|364615655|FG000|Overall Study|Adverse Event|5|||
105714899|NCT00491179|364615656|FG001|Overall Study|Adverse Event|1|||
105714900|NCT00491179|364615655|FG000|Overall Study|Withdrawal by Subject|2|||
105714901|NCT00491179|364615656|FG001|Overall Study|Withdrawal by Subject|1|||
105789556|NCT03917654|364883390|FG005|Year 1|Death|0|||
105789557|NCT03917654|364883391|FG006|Year 1|Death|0|||
105714902|NCT01622569|364615657|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
105714903|NCT01622569|364615658|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
105714904|NCT01622569|364615659|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
105714905|NCT01622569|364615660|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
105714906|NCT01622569|364615657|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
105714907|NCT01622569|364615658|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
105714908|NCT01622569|364615659|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
105714909|NCT01622569|364615660|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
105714910|NCT01622569|364615657|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
105714911|NCT01622569|364615658|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
105714912|NCT01622569|364615659|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
105714913|NCT01622569|364615660|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
105714914|NCT01622569|364615657|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
105714915|NCT01622569|364615658|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
105714916|NCT01622569|364615659|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
105714917|NCT01622569|364615660|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
105714918|NCT01622569|364615657|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
105714919|NCT01622569|364615658|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
105714920|NCT01622569|364615659|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
105714921|NCT01622569|364615660|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
105714922|NCT01622569|364615657|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
105714923|NCT01622569|364615658|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
105714924|NCT01622569|364615659|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
105714925|NCT01622569|364615660|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
105714926|NCT01622569|364615657|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
105714927|NCT01622569|364615658|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
105714928|NCT01622569|364615659|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
105714929|NCT01622569|364615660|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
105714930|NCT01622569|364615657|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
105714931|NCT01622569|364615658|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
105714932|NCT01622569|364615659|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
105714933|NCT01622569|364615660|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
105714934|NCT01491178|364615663|FG000|Overall Study|Adverse Event|1016|||
105714935|NCT01491178|364615663|FG000|Overall Study|Improvement of NVAF|210|||
105714936|NCT01491178|364615663|FG000|Overall Study|To conduct invasive treatment|59|||
105714937|NCT01491178|364615663|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
105714938|NCT01491178|364615663|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
105714939|NCT01491178|364615663|FG000|Overall Study|To take a contraindication|20|||
105714940|NCT01491178|364615663|FG000|Overall Study|Other than specified above|657|||
105714941|NCT04142983|364615666|FG000|Overall Study|Lost to Follow-up|73|||
105714942|NCT04142983|364615666|FG000|Overall Study|Withdrawal by Subject|10|||
105714943|NCT04142983|364615666|FG000|Overall Study|Physician Decision|1|||
105714944|NCT04142983|364615666|FG000|Overall Study|Adverse Event|1|||
105714945|NCT04142983|364615666|FG000|Overall Study|No longer eligible|4|||
105714946|NCT04142983|364615666|FG000|Overall Study|Screen Failure|10|||
105714947|NCT00257010|364615667|FG000|Overall Study|Lack of Efficacy|11|||
105714948|NCT00257010|364615667|FG000|Overall Study|Lost to Follow-up|53|||
105714949|NCT00257010|364615667|FG000|Overall Study|Withdrawal by Subject|34|||
105714950|NCT00257010|364615667|FG000|Overall Study|Adverse Event|10|||
105714951|NCT00257010|364615667|FG000|Overall Study|various|11|||
105714952|NCT00257010|364615667|FG000|Overall Study|no headache reported|9|||
105714953|NCT00448708|364615673|FG000|Overall Study|Death|21|||
105714954|NCT00448708|364615674|FG001|Overall Study|Death|17|||
105714955|NCT00448708|364615673|FG000|Overall Study|Withdrawal by Subject|8|||
105789558|NCT03917654|364883392|FG007|Year 1|Death|0|||
105714956|NCT00448708|364615674|FG001|Overall Study|Withdrawal by Subject|4|||
105714957|NCT00448708|364615673|FG000|Overall Study|Lost to Follow-up|6|||
105714958|NCT00448708|364615674|FG001|Overall Study|Lost to Follow-up|8|||
105714959|NCT00448708|364615673|FG000|Overall Study|not listed|0|||
105714960|NCT00448708|364615674|FG001|Overall Study|not listed|2|||
105714961|NCT03665285|364615676|FG000|Overall Study|Started New Anticancer Treatment|1|||
105714962|NCT03665285|364615677|FG001|Overall Study|Started New Anticancer Treatment|1|||
105714963|NCT03665285|364615678|FG002|Overall Study|Started New Anticancer Treatment|2|||
105714964|NCT03665285|364615679|FG003|Overall Study|Started New Anticancer Treatment|4|||
105714965|NCT03665285|364615680|FG004|Overall Study|Started New Anticancer Treatment|1|||
105714966|NCT03665285|364615681|FG005|Overall Study|Started New Anticancer Treatment|1|||
105714967|NCT03665285|364615682|FG006|Overall Study|Started New Anticancer Treatment|2|||
105714968|NCT03665285|364615683|FG007|Overall Study|Started New Anticancer Treatment|15|||
105714969|NCT03665285|364615684|FG008|Overall Study|Started New Anticancer Treatment|1|||
105714970|NCT03665285|364615676|FG000|Overall Study|Disease Progression|0|||
105714971|NCT03665285|364615677|FG001|Overall Study|Disease Progression|0|||
105714972|NCT03665285|364615678|FG002|Overall Study|Disease Progression|3|||
105714973|NCT03665285|364615679|FG003|Overall Study|Disease Progression|1|||
105714974|NCT03665285|364615680|FG004|Overall Study|Disease Progression|0|||
105714975|NCT03665285|364615681|FG005|Overall Study|Disease Progression|0|||
105714976|NCT03665285|364615682|FG006|Overall Study|Disease Progression|0|||
105714977|NCT03665285|364615683|FG007|Overall Study|Disease Progression|7|||
105714978|NCT03665285|364615684|FG008|Overall Study|Disease Progression|1|||
105714979|NCT03665285|364615676|FG000|Overall Study|Hospice|0|||
105714980|NCT03665285|364615677|FG001|Overall Study|Hospice|0|||
105714981|NCT03665285|364615678|FG002|Overall Study|Hospice|0|||
105714982|NCT03665285|364615679|FG003|Overall Study|Hospice|0|||
105714983|NCT03665285|364615680|FG004|Overall Study|Hospice|0|||
105714984|NCT03665285|364615681|FG005|Overall Study|Hospice|0|||
105714985|NCT03665285|364615682|FG006|Overall Study|Hospice|0|||
105714986|NCT03665285|364615683|FG007|Overall Study|Hospice|2|||
105714987|NCT03665285|364615684|FG008|Overall Study|Hospice|0|||
105714988|NCT03665285|364615676|FG000|Overall Study|Withdrawal by Subject|0|||
105714989|NCT03665285|364615677|FG001|Overall Study|Withdrawal by Subject|0|||
105714990|NCT03665285|364615678|FG002|Overall Study|Withdrawal by Subject|0|||
105789559|NCT03917654|364883393|FG008|Year 1|Death|1|||
105714991|NCT03665285|364615679|FG003|Overall Study|Withdrawal by Subject|0|||
105789560|NCT03917654|364883394|FG009|Year 1|Death|1|||
105789561|NCT03917654|364883395|FG010|Year 1|Death|0|||
105714992|NCT03665285|364615680|FG004|Overall Study|Withdrawal by Subject|1|||
105714993|NCT03665285|364615681|FG005|Overall Study|Withdrawal by Subject|0|||
105714994|NCT03665285|364615682|FG006|Overall Study|Withdrawal by Subject|0|||
105714995|NCT03665285|364615683|FG007|Overall Study|Withdrawal by Subject|2|||
105714996|NCT03665285|364615684|FG008|Overall Study|Withdrawal by Subject|0|||
105714997|NCT03665285|364615676|FG000|Overall Study|Physician Decision|0|||
105714998|NCT03665285|364615677|FG001|Overall Study|Physician Decision|0|||
105714999|NCT03665285|364615678|FG002|Overall Study|Physician Decision|0|||
105715000|NCT03665285|364615679|FG003|Overall Study|Physician Decision|0|||
105715001|NCT03665285|364615680|FG004|Overall Study|Physician Decision|0|||
105715002|NCT03665285|364615681|FG005|Overall Study|Physician Decision|0|||
105715003|NCT03665285|364615682|FG006|Overall Study|Physician Decision|0|||
105715004|NCT03665285|364615683|FG007|Overall Study|Physician Decision|2|||
105789562|NCT03917654|364883396|FG011|Year 1|Death|0|||
105789563|NCT03917654|364883385|FG000|Year 1|Lost to Follow-up|0|||
105789564|NCT03917654|364883386|FG001|Year 1|Lost to Follow-up|0|||
105789565|NCT03917654|364883387|FG002|Year 1|Lost to Follow-up|0|||
105789566|NCT03917654|364883388|FG003|Year 1|Lost to Follow-up|0|||
105789567|NCT03917654|364883389|FG004|Year 1|Lost to Follow-up|0|||
105477290|NCT01090323|363759292|FG000|Overall Study|Stopped end of core|7|||
105477291|NCT01090323|363759293|FG001|Overall Study|Stopped end of core|0|||
105477292|NCT01090323|363759292|FG000|Overall Study|Stopped end of extension 1#|3|||
105477293|NCT01090323|363759293|FG001|Overall Study|Stopped end of extension 1#|1|||
105477294|NCT01864005|363759294|FG000|Overall Study|Protocol Violation|0|||
105715005|NCT03665285|364615684|FG008|Overall Study|Physician Decision|0|||
105715006|NCT00763321|364615685|FG000|Open-label Period|Adverse Event|24|||
105715007|NCT00763321|364615686|FG001|Open-label Period|Adverse Event|0|||
105715008|NCT00763321|364615687|FG002|Open-label Period|Adverse Event|0|||
105715009|NCT00763321|364615685|FG000|Open-label Period|Lost to Follow-up|14|||
105715010|NCT00763321|364615686|FG001|Open-label Period|Lost to Follow-up|0|||
105715011|NCT00763321|364615687|FG002|Open-label Period|Lost to Follow-up|0|||
105715012|NCT00763321|364615685|FG000|Open-label Period|Withdrawal by Subject|7|||
105715013|NCT00763321|364615686|FG001|Open-label Period|Withdrawal by Subject|0|||
105715014|NCT00763321|364615687|FG002|Open-label Period|Withdrawal by Subject|0|||
105715015|NCT00763321|364615685|FG000|Open-label Period|Subject noncompliant|7|||
105715016|NCT00763321|364615686|FG001|Open-label Period|Subject noncompliant|0|||
105715017|NCT00763321|364615687|FG002|Open-label Period|Subject noncompliant|0|||
105789568|NCT03917654|364883390|FG005|Year 1|Lost to Follow-up|0|||
105789569|NCT03917654|364883391|FG006|Year 1|Lost to Follow-up|2|||
105789570|NCT03917654|364883392|FG007|Year 1|Lost to Follow-up|0|||
105715018|NCT00763321|364615685|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
105715019|NCT00763321|364615686|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
105715020|NCT00763321|364615687|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
105715021|NCT00763321|364615685|FG000|Open-label Period|Lack of Efficacy|2|||
105715022|NCT00763321|364615686|FG001|Open-label Period|Lack of Efficacy|0|||
105715023|NCT00763321|364615687|FG002|Open-label Period|Lack of Efficacy|0|||
105715024|NCT00763321|364615685|FG000|Open-label Period|Other|4|||
105715025|NCT00763321|364615686|FG001|Open-label Period|Other|0|||
105715026|NCT00763321|364615687|FG002|Open-label Period|Other|0|||
105715027|NCT00763321|364615685|FG000|Double-blind Period|Lack of Efficacy|0|||
105715028|NCT00763321|364615686|FG001|Double-blind Period|Lack of Efficacy|9|||
105715029|NCT00763321|364615687|FG002|Double-blind Period|Lack of Efficacy|17|||
105715030|NCT00763321|364615685|FG000|Double-blind Period|Adverse Event|0|||
105715031|NCT00763321|364615686|FG001|Double-blind Period|Adverse Event|4|||
105715032|NCT00763321|364615687|FG002|Double-blind Period|Adverse Event|4|||
105789571|NCT03917654|364883393|FG008|Year 1|Lost to Follow-up|0|||
105789572|NCT03917654|364883394|FG009|Year 1|Lost to Follow-up|0|||
105789573|NCT03917654|364883395|FG010|Year 1|Lost to Follow-up|0|||
105789574|NCT03917654|364883396|FG011|Year 1|Lost to Follow-up|0|||
105789575|NCT03917654|364883385|FG000|Year 1|Missed visits|0|||
105789576|NCT03917654|364883386|FG001|Year 1|Missed visits|0|||
105789577|NCT03917654|364883387|FG002|Year 1|Missed visits|0|||
105789578|NCT03917654|364883388|FG003|Year 1|Missed visits|0|||
105789579|NCT03917654|364883389|FG004|Year 1|Missed visits|0|||
105789580|NCT03917654|364883390|FG005|Year 1|Missed visits|0|||
105789581|NCT03917654|364883391|FG006|Year 1|Missed visits|0|||
105789582|NCT03917654|364883392|FG007|Year 1|Missed visits|0|||
105789583|NCT03917654|364883393|FG008|Year 1|Missed visits|0|||
105789584|NCT03917654|364883394|FG009|Year 1|Missed visits|0|||
105789585|NCT03917654|364883395|FG010|Year 1|Missed visits|1|||
105789586|NCT03917654|364883396|FG011|Year 1|Missed visits|1|||
105789587|NCT03917654|364883385|FG000|Year 1|Pregnancy|0|||
105789588|NCT03917654|364883386|FG001|Year 1|Pregnancy|0|||
105789589|NCT03917654|364883387|FG002|Year 1|Pregnancy|0|||
105789590|NCT03917654|364883388|FG003|Year 1|Pregnancy|0|||
105789591|NCT03917654|364883389|FG004|Year 1|Pregnancy|0|||
105715033|NCT00763321|364615685|FG000|Double-blind Period|Lost to Follow-up|0|||
105477295|NCT01864005|363759295|FG001|Overall Study|Protocol Violation|1|||
105477296|NCT01864005|363759294|FG000|Overall Study|Withdrawal by Subject|0|||
105715034|NCT00763321|364615686|FG001|Double-blind Period|Lost to Follow-up|4|||
105789592|NCT03917654|364883390|FG005|Year 1|Pregnancy|0|||
105789593|NCT03917654|364883391|FG006|Year 1|Pregnancy|0|||
105789594|NCT03917654|364883392|FG007|Year 1|Pregnancy|1|||
105789595|NCT03917654|364883393|FG008|Year 1|Pregnancy|0|||
105789596|NCT03917654|364883394|FG009|Year 1|Pregnancy|1|||
105789597|NCT03917654|364883395|FG010|Year 1|Pregnancy|0|||
105789598|NCT03917654|364883396|FG011|Year 1|Pregnancy|0|||
105789599|NCT03917654|364883385|FG000|Year 2|Travel|1|||
105789600|NCT03917654|364883386|FG001|Year 2|Travel|0|||
105789601|NCT03917654|364883387|FG002|Year 2|Travel|0|||
105789602|NCT03917654|364883388|FG003|Year 2|Travel|0|||
105715035|NCT00763321|364615687|FG002|Double-blind Period|Lost to Follow-up|2|||
105715036|NCT00763321|364615685|FG000|Double-blind Period|Withdrawal by Subject|0|||
105715037|NCT00763321|364615686|FG001|Double-blind Period|Withdrawal by Subject|2|||
105715038|NCT00763321|364615687|FG002|Double-blind Period|Withdrawal by Subject|3|||
105715039|NCT00763321|364615685|FG000|Double-blind Period|Other|0|||
105715040|NCT00763321|364615686|FG001|Double-blind Period|Other|2|||
105715041|NCT00763321|364615687|FG002|Double-blind Period|Other|3|||
105715042|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
105715043|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
105715044|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
105715045|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Death|28|||
105715046|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Death|0|||
105715047|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Death|0|||
105715048|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
105715049|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
105715050|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
105561752|NCT01137474|364052214|FG000|Overall Study|Administrative reason by sponsor|0|||
105715051|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
105789603|NCT03917654|364883389|FG004|Year 2|Travel|1|||
105789604|NCT03917654|364883390|FG005|Year 2|Travel|1|||
105789605|NCT03917654|364883391|FG006|Year 2|Travel|2|||
105789606|NCT03917654|364883392|FG007|Year 2|Travel|1|||
105789607|NCT03917654|364883393|FG008|Year 2|Travel|0|||
105789608|NCT03917654|364883394|FG009|Year 2|Travel|1|||
105789609|NCT03917654|364883395|FG010|Year 2|Travel|0|||
105789610|NCT03917654|364883396|FG011|Year 2|Travel|1|||
105789611|NCT03917654|364883385|FG000|Year 2|Married|1|||
105789612|NCT03917654|364883386|FG001|Year 2|Married|0|||
105789613|NCT03917654|364883387|FG002|Year 2|Married|0|||
105789614|NCT03917654|364883388|FG003|Year 2|Married|0|||
105789615|NCT03917654|364883389|FG004|Year 2|Married|0|||
105789616|NCT03917654|364883390|FG005|Year 2|Married|0|||
105789617|NCT03917654|364883391|FG006|Year 2|Married|1|||
105789618|NCT03917654|364883392|FG007|Year 2|Married|1|||
105789619|NCT03917654|364883393|FG008|Year 2|Married|0|||
105789620|NCT03917654|364883394|FG009|Year 2|Married|0|||
105789621|NCT03917654|364883395|FG010|Year 2|Married|0|||
105789622|NCT03917654|364883396|FG011|Year 2|Married|0|||
105789623|NCT03917654|364883385|FG000|Year 2|Subject moved away from site|1|||
105789624|NCT03917654|364883386|FG001|Year 2|Subject moved away from site|0|||
105789625|NCT03917654|364883387|FG002|Year 2|Subject moved away from site|0|||
105789626|NCT03917654|364883388|FG003|Year 2|Subject moved away from site|0|||
105789627|NCT03917654|364883389|FG004|Year 2|Subject moved away from site|1|||
105789628|NCT03917654|364883390|FG005|Year 2|Subject moved away from site|0|||
105789629|NCT03917654|364883391|FG006|Year 2|Subject moved away from site|2|||
105789630|NCT03917654|364883392|FG007|Year 2|Subject moved away from site|3|||
105789631|NCT03917654|364883393|FG008|Year 2|Subject moved away from site|0|||
105789632|NCT03917654|364883394|FG009|Year 2|Subject moved away from site|2|||
105789633|NCT03917654|364883395|FG010|Year 2|Subject moved away from site|0|||
105789634|NCT03917654|364883396|FG011|Year 2|Subject moved away from site|1|||
105789635|NCT03917654|364883385|FG000|Year 2|Year 2 Screening failure|0|||
105789636|NCT03917654|364883386|FG001|Year 2|Year 2 Screening failure|1|||
105789637|NCT03917654|364883387|FG002|Year 2|Year 2 Screening failure|0|||
105789638|NCT03917654|364883388|FG003|Year 2|Year 2 Screening failure|0|||
105789639|NCT03917654|364883389|FG004|Year 2|Year 2 Screening failure|2|||
105789640|NCT03917654|364883390|FG005|Year 2|Year 2 Screening failure|0|||
105789641|NCT03917654|364883391|FG006|Year 2|Year 2 Screening failure|4|||
105789642|NCT03917654|364883392|FG007|Year 2|Year 2 Screening failure|3|||
105789643|NCT03917654|364883393|FG008|Year 2|Year 2 Screening failure|10|||
105715052|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
105715053|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
105715054|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
105715055|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
105715056|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
105715057|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
105715058|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
105715059|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
105715060|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
105715061|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
105715062|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
105715063|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Other|11|||
105715064|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Other|0|||
105715065|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Other|0|||
105715066|NCT00820755|364615688|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
105715067|NCT00820755|364615689|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
105715068|NCT00820755|364615690|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
105715069|NCT00946309|364615693|FG000|Overall Study|Protocol Violation|1|||
105715070|NCT00946309|364615694|FG001|Overall Study|Protocol Violation|0|||
105715071|NCT00946309|364615693|FG000|Overall Study|Lost to Follow-up|0|||
105715072|NCT00946309|364615694|FG001|Overall Study|Lost to Follow-up|1|||
105789644|NCT03917654|364883394|FG009|Year 2|Year 2 Screening failure|2|||
105789645|NCT03917654|364883395|FG010|Year 2|Year 2 Screening failure|1|||
105715073|NCT00946309|364615693|FG000|Overall Study|Procedure cancelled/discontinued|0|||
105789646|NCT03917654|364883396|FG011|Year 2|Year 2 Screening failure|1|||
105789647|NCT03917654|364883385|FG000|Year 2|Death|0|||
105789648|NCT03917654|364883386|FG001|Year 2|Death|0|||
105789649|NCT03917654|364883387|FG002|Year 2|Death|0|||
105789650|NCT03917654|364883388|FG003|Year 2|Death|0|||
105789651|NCT03917654|364883389|FG004|Year 2|Death|0|||
105789652|NCT03917654|364883390|FG005|Year 2|Death|1|||
105789653|NCT03917654|364883391|FG006|Year 2|Death|0|||
105789654|NCT03917654|364883392|FG007|Year 2|Death|0|||
105789655|NCT03917654|364883393|FG008|Year 2|Death|1|||
105789656|NCT03917654|364883394|FG009|Year 2|Death|1|||
105789657|NCT03917654|364883395|FG010|Year 2|Death|0|||
105789658|NCT03917654|364883396|FG011|Year 2|Death|0|||
105789659|NCT03917654|364883385|FG000|Year 2|Withdrawal by Subject|0|||
105789660|NCT03917654|364883386|FG001|Year 2|Withdrawal by Subject|0|||
105789661|NCT03917654|364883387|FG002|Year 2|Withdrawal by Subject|0|||
105789662|NCT03917654|364883388|FG003|Year 2|Withdrawal by Subject|0|||
105789663|NCT03917654|364883389|FG004|Year 2|Withdrawal by Subject|0|||
105789664|NCT03917654|364883390|FG005|Year 2|Withdrawal by Subject|0|||
105789665|NCT03917654|364883391|FG006|Year 2|Withdrawal by Subject|3|||
105789666|NCT03917654|364883392|FG007|Year 2|Withdrawal by Subject|0|||
105789667|NCT03917654|364883393|FG008|Year 2|Withdrawal by Subject|2|||
105789668|NCT03917654|364883394|FG009|Year 2|Withdrawal by Subject|5|||
105789669|NCT03917654|364883395|FG010|Year 2|Withdrawal by Subject|0|||
105789670|NCT03917654|364883396|FG011|Year 2|Withdrawal by Subject|0|||
105789671|NCT03917654|364883385|FG000|Year 2|Spouse/family member request|0|||
105789672|NCT03917654|364883386|FG001|Year 2|Spouse/family member request|0|||
105789673|NCT03917654|364883387|FG002|Year 2|Spouse/family member request|0|||
105789674|NCT03917654|364883388|FG003|Year 2|Spouse/family member request|0|||
105789675|NCT03917654|364883389|FG004|Year 2|Spouse/family member request|0|||
105789676|NCT03917654|364883390|FG005|Year 2|Spouse/family member request|0|||
105789677|NCT03917654|364883391|FG006|Year 2|Spouse/family member request|1|||
105789678|NCT03917654|364883392|FG007|Year 2|Spouse/family member request|0|||
105352288|NCT01483599|363293858|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105352289|NCT01483599|363293859|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105352290|NCT01483599|363293860|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
105352291|NCT01483599|363293847|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105352292|NCT01483599|363293848|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105352293|NCT01483599|363293849|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105352294|NCT01483599|363293850|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105352295|NCT01483599|363293851|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105352296|NCT01483599|363293852|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105352297|NCT01483599|363293853|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105352298|NCT01483599|363293854|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105352299|NCT01483599|363293855|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
105352300|NCT01483599|363293856|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105352301|NCT01483599|363293857|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105352302|NCT01483599|363293858|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105352303|NCT01483599|363293859|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
105477297|NCT01864005|363759295|FG001|Overall Study|Withdrawal by Subject|1|||
105789679|NCT03917654|364883393|FG008|Year 2|Spouse/family member request|0|||
105789680|NCT03917654|364883394|FG009|Year 2|Spouse/family member request|0|||
105789681|NCT03917654|364883395|FG010|Year 2|Spouse/family member request|0|||
105789682|NCT03917654|364883396|FG011|Year 2|Spouse/family member request|0|||
105715074|NCT00946309|364615694|FG001|Overall Study|Procedure cancelled/discontinued|3|||
105715075|NCT00603915|364615696|FG000|Overall Study|Physician Decision|1|||
105715076|NCT02474329|364615697|FG000|Overall Study|Withdraw or did not contribute data.|13|||
105715077|NCT01356589|364615698|FG000|Overall Study|Enrolled, but not treated|3|||
105715078|NCT01356589|364615698|FG000|Overall Study|Dose data not recorded|2|||
105715079|NCT03110900|364615707|FG000|Overall Study|Sponsor withdrew|1|||
105715080|NCT03110900|364615708|FG001|Overall Study|Sponsor withdrew|1|||
105715081|NCT02307370|364615709|FG000|Overall Study|Death|5|||
105715082|NCT02307370|364615709|FG000|Overall Study|Lost to Follow-up|1|||
105715083|NCT02307370|364615709|FG000|Overall Study|Withdrawal by Subject|1|||
105715084|NCT02307370|364615709|FG000|Overall Study|Declined Addendum ICF|6|||
105715085|NCT02307370|364615709|FG000|Overall Study|No response during telephone contact|5|||
105715086|NCT02307370|364615709|FG000|Overall Study|Protocol Violation|1|||
105715087|NCT03064763|364617476|FG000|Overall Study|Lost to Follow-up|1|||
105715088|NCT03064763|364617476|FG000|Overall Study|Death|8|||
105715089|NCT00403260|364617477|FG000|Overall Study|Adverse Event|5|||
105715090|NCT00403260|364617478|FG001|Overall Study|Adverse Event|4|||
105715091|NCT00403260|364617477|FG000|Overall Study|Withdrawal by Subject|5|||
105715092|NCT00403260|364617478|FG001|Overall Study|Withdrawal by Subject|6|||
105715093|NCT00403260|364617477|FG000|Overall Study|Lost to Follow-up|49|||
105715094|NCT00403260|364617478|FG001|Overall Study|Lost to Follow-up|25|||
105715095|NCT00403260|364617477|FG000|Overall Study|Re-appearance of P. falciparum|34|||
105715096|NCT00403260|364617478|FG001|Overall Study|Re-appearance of P. falciparum|25|||
105715097|NCT00403260|364617477|FG000|Overall Study|P. vivax infection|26|||
105715098|NCT00403260|364617478|FG001|Overall Study|P. vivax infection|4|||
105715099|NCT00403260|364617477|FG000|Overall Study|Mixed infection with P. vivax|2|||
105715100|NCT00403260|364617478|FG001|Overall Study|Mixed infection with P. vivax|0|||
105715101|NCT00403260|364617477|FG000|Overall Study|Mixed infection with P. falciparum|1|||
105715102|NCT00403260|364617478|FG001|Overall Study|Mixed infection with P. falciparum|0|||
105715103|NCT00403260|364617477|FG000|Overall Study|P. vivax infection at screening|1|||
105715104|NCT00403260|364617478|FG001|Overall Study|P. vivax infection at screening|0|||
105715105|NCT00403260|364617477|FG000|Overall Study|P. ovale infection|1|||
105715106|NCT00403260|364617478|FG001|Overall Study|P. ovale infection|0|||
105715107|NCT00403260|364617477|FG000|Overall Study|Gametocyte re-appearance|1|||
105715108|NCT00403260|364617478|FG001|Overall Study|Gametocyte re-appearance|1|||
105715109|NCT00403260|364617477|FG000|Overall Study|Withdrawn from study accidentally|0|||
105715110|NCT00403260|364617478|FG001|Overall Study|Withdrawn from study accidentally|1|||
105715111|NCT00935883|364617481|FG000|Treatment Period|Physician Decision|1|||
105715112|NCT00935883|364617482|FG001|Treatment Period|Physician Decision|0|||
105715113|NCT00935883|364617481|FG000|Treatment Period|Withdrawal by Subject|0|||
105715114|NCT00935883|364617482|FG001|Treatment Period|Withdrawal by Subject|2|||
105789683|NCT03917654|364883385|FG000|Year 2|Lost to Follow-up|0|||
105789684|NCT03917654|364883386|FG001|Year 2|Lost to Follow-up|0|||
105789685|NCT03917654|364883387|FG002|Year 2|Lost to Follow-up|0|||
105789686|NCT03917654|364883388|FG003|Year 2|Lost to Follow-up|0|||
105789687|NCT03917654|364883389|FG004|Year 2|Lost to Follow-up|0|||
105789688|NCT03917654|364883390|FG005|Year 2|Lost to Follow-up|0|||
105789689|NCT03917654|364883391|FG006|Year 2|Lost to Follow-up|1|||
105789690|NCT03917654|364883392|FG007|Year 2|Lost to Follow-up|0|||
105715115|NCT01337973|364617485|FG000|Overall Study|Lost to Follow-up|2|||
105715116|NCT01337973|364617486|FG001|Overall Study|Lost to Follow-up|4|||
105715117|NCT01337973|364617487|FG002|Overall Study|Lost to Follow-up|3|||
105715118|NCT01337973|364617485|FG000|Overall Study|Death|1|||
105715119|NCT01337973|364617486|FG001|Overall Study|Death|2|||
105715120|NCT01337973|364617487|FG002|Overall Study|Death|1|||
105715121|NCT01337973|364617485|FG000|Overall Study|Withdrawal by Subject|10|||
105715122|NCT01337973|364617486|FG001|Overall Study|Withdrawal by Subject|8|||
105715123|NCT01337973|364617487|FG002|Overall Study|Withdrawal by Subject|4|||
105715124|NCT01337973|364617485|FG000|Overall Study|missing data on primary outcome|3|||
105715125|NCT01337973|364617486|FG001|Overall Study|missing data on primary outcome|1|||
105715126|NCT01337973|364617487|FG002|Overall Study|missing data on primary outcome|3|||
105715127|NCT00168831|364617491|FG000|Overall Study|Adverse Event|36|||
105715128|NCT00168831|364617492|FG001|Overall Study|Adverse Event|47|||
105715129|NCT00168831|364617493|FG002|Overall Study|Adverse Event|74|||
105715130|NCT00168831|364617491|FG000|Overall Study|Lost to Follow-up|5|||
105715131|NCT00168831|364617492|FG001|Overall Study|Lost to Follow-up|6|||
105715132|NCT00168831|364617493|FG002|Overall Study|Lost to Follow-up|4|||
105715133|NCT00168831|364617491|FG000|Overall Study|Withdrawal by Subject|7|||
105715134|NCT00168831|364617492|FG001|Overall Study|Withdrawal by Subject|14|||
105715135|NCT00168831|364617493|FG002|Overall Study|Withdrawal by Subject|19|||
105715136|NCT00168831|364617491|FG000|Overall Study|Protocol Violation|6|||
105715137|NCT00168831|364617492|FG001|Overall Study|Protocol Violation|11|||
105715138|NCT00168831|364617493|FG002|Overall Study|Protocol Violation|11|||
105715139|NCT00168831|364617491|FG000|Overall Study|Other|6|||
105715140|NCT00168831|364617492|FG001|Overall Study|Other|3|||
105715141|NCT00168831|364617493|FG002|Overall Study|Other|6|||
105789691|NCT03917654|364883393|FG008|Year 2|Lost to Follow-up|1|||
105789692|NCT03917654|364883394|FG009|Year 2|Lost to Follow-up|0|||
105789693|NCT03917654|364883395|FG010|Year 2|Lost to Follow-up|0|||
105561753|NCT01137474|364052215|FG001|Overall Study|Administrative reason by sponsor|1|||
105477298|NCT01864005|363759294|FG000|Overall Study|Incorrect enrolment|1|||
105477299|NCT01864005|363759295|FG001|Overall Study|Incorrect enrolment|0|||
105477300|NCT01864005|363759294|FG000|Overall Study|Disease need|1|||
105477301|NCT01864005|363759295|FG001|Overall Study|Disease need|1|||
105477302|NCT01864005|363759294|FG000|Overall Study|Need GP IIb/IIIa|1|||
105477303|NCT01864005|363759295|FG001|Overall Study|Need GP IIb/IIIa|3|||
105561754|NCT01137474|364052216|FG002|Overall Study|Administrative reason by sponsor|0|||
105561755|NCT01137474|364052217|FG003|Overall Study|Administrative reason by sponsor|0|||
105561756|NCT04683926|364052218|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
105561757|NCT04683926|364052219|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
105561758|NCT04683926|364052220|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
105561759|NCT04683926|364052221|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
105561760|NCT02740049|364052222|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
105561761|NCT01256411|364052223|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
105561762|NCT01256411|364052224|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
105561763|NCT01256411|364052225|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
105561764|NCT01256411|364052226|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
105715142|NCT01505894|364617495|FG000|Overall Study|Adverse Event|1|||
105715143|NCT01505894|364617496|FG001|Overall Study|Adverse Event|0|||
105477304|NCT00763698|363759296|FG000|Overall Study|Unsuccessful Implant|5|||
105477305|NCT00763698|363759296|FG000|Overall Study|Death|4|||
105477306|NCT00763698|363759296|FG000|Overall Study|Withdrawal by Subject|1|||
105477307|NCT00006409|363759297|FG000|Baseline|Protocol Violation|48|||
105477308|NCT00006409|363759298|FG001|Baseline|Protocol Violation|70|||
105477309|NCT00006409|363759299|FG002|Baseline|Protocol Violation|0|||
105477310|NCT00006409|363759300|FG003|Baseline|Protocol Violation|0|||
105477311|NCT00006409|363759301|FG004|Baseline|Protocol Violation|0|||
105477312|NCT00006409|363759302|FG005|Baseline|Protocol Violation|0|||
105477313|NCT00006409|363759297|FG000|Post-2 Year Intervention|Protocol Violation|0|||
105477314|NCT00006409|363759298|FG001|Post-2 Year Intervention|Protocol Violation|0|||
105477315|NCT00006409|363759299|FG002|Post-2 Year Intervention|Protocol Violation|251|||
105477316|NCT00006409|363759300|FG003|Post-2 Year Intervention|Protocol Violation|168|||
105477317|NCT00006409|363759301|FG004|Post-2 Year Intervention|Protocol Violation|0|||
105477318|NCT00006409|363759302|FG005|Post-2 Year Intervention|Protocol Violation|0|||
105715144|NCT01505894|364617497|FG002|Overall Study|Adverse Event|0|||
105715145|NCT01505894|364617498|FG003|Overall Study|Adverse Event|0|||
105477319|NCT00006409|363759297|FG000|Post-3 Year Intervention|Protocol Violation|0|||
105477320|NCT00006409|363759298|FG001|Post-3 Year Intervention|Protocol Violation|0|||
105477321|NCT00006409|363759299|FG002|Post-3 Year Intervention|Protocol Violation|0|||
105477322|NCT00006409|363759300|FG003|Post-3 Year Intervention|Protocol Violation|0|||
105715146|NCT01505894|364617499|FG004|Overall Study|Adverse Event|0|||
105715147|NCT01505894|364617500|FG005|Overall Study|Adverse Event|0|||
105715148|NCT01505894|364617501|FG006|Overall Study|Adverse Event|0|||
105715149|NCT01505894|364617502|FG007|Overall Study|Adverse Event|0|||
105715150|NCT01505894|364617503|FG008|Overall Study|Adverse Event|0|||
105715151|NCT01505894|364617495|FG000|Overall Study|Other than specified|0|||
105715152|NCT01505894|364617496|FG001|Overall Study|Other than specified|0|||
105715153|NCT01505894|364617497|FG002|Overall Study|Other than specified|0|||
105715154|NCT01505894|364617498|FG003|Overall Study|Other than specified|0|||
105715155|NCT01505894|364617499|FG004|Overall Study|Other than specified|1|||
105715156|NCT01505894|364617500|FG005|Overall Study|Other than specified|0|||
105715157|NCT01505894|364617501|FG006|Overall Study|Other than specified|0|||
105715158|NCT01505894|364617502|FG007|Overall Study|Other than specified|0|||
105715159|NCT01505894|364617503|FG008|Overall Study|Other than specified|0|||
105715160|NCT02009878|364617504|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
105715161|NCT02009878|364617505|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
105715162|NCT02009878|364617506|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
105715163|NCT03823391|364617507|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
105715164|NCT03823391|364617508|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
105715165|NCT03823391|364617507|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
105715166|NCT03823391|364617508|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
105715167|NCT04269395|364617510|FG000|Overall Study|Lost to Follow-up|1|||
105715168|NCT04269395|364617511|FG001|Overall Study|Lost to Follow-up|0|||
105715169|NCT04269395|364617510|FG000|Overall Study|Study terminated by Sponsor|13|||
105715170|NCT04269395|364617511|FG001|Overall Study|Study terminated by Sponsor|10|||
105715171|NCT00584233|364617512|FG000|Overall Study|Withdrawal by Subject|5|||
105715172|NCT00584233|364617512|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
105715173|NCT02222714|364617513|FG000|Overall Study|Death|0|||
105715174|NCT02222714|364617514|FG001|Overall Study|Death|2|||
105715175|NCT02222714|364617515|FG002|Overall Study|Death|3|||
105715176|NCT02222714|364617516|FG003|Overall Study|Death|4|||
105715177|NCT02222714|364617517|FG004|Overall Study|Death|6|||
105715178|NCT02222714|364617513|FG000|Overall Study|Withdrawal by Subject|0|||
105715179|NCT02222714|364617514|FG001|Overall Study|Withdrawal by Subject|0|||
105715180|NCT02222714|364617515|FG002|Overall Study|Withdrawal by Subject|1|||
105715181|NCT02222714|364617516|FG003|Overall Study|Withdrawal by Subject|0|||
105715182|NCT02222714|364617517|FG004|Overall Study|Withdrawal by Subject|1|||
105715183|NCT01940484|364617519|FG000|Overall Study|Withdrawal by Subject|3|||
105715184|NCT01940484|364617519|FG000|Overall Study|Underwent transplantation|4|||
105715185|NCT01940484|364617519|FG000|Overall Study|Death|2|||
105715186|NCT01940484|364617519|FG000|Overall Study|Adverse Event|1|||
105715187|NCT02658448|364617520|FG000|Overall Study|Lost to Follow-up|1|||
105715188|NCT03106779|364617521|FG000|Overall Study|Lack of Efficacy|33|||
105715189|NCT03106779|364617522|FG001|Overall Study|Lack of Efficacy|24|||
105715190|NCT03106779|364617521|FG000|Overall Study|Adverse Event|8|||
105715191|NCT03106779|364617522|FG001|Overall Study|Adverse Event|16|||
105715192|NCT03106779|364617521|FG000|Overall Study|Physician Decision|10|||
105715193|NCT03106779|364617522|FG001|Overall Study|Physician Decision|6|||
105715194|NCT03106779|364617521|FG000|Overall Study|Patient/guardian decision|4|||
105715195|NCT03106779|364617522|FG001|Overall Study|Patient/guardian decision|3|||
105715196|NCT03106779|364617521|FG000|Overall Study|Progressive disease|1|||
105715197|NCT03106779|364617522|FG001|Overall Study|Progressive disease|3|||
105715198|NCT03106779|364617521|FG000|Overall Study|Lost to Follow-up|1|||
105715199|NCT03106779|364617522|FG001|Overall Study|Lost to Follow-up|2|||
105715200|NCT03106779|364617521|FG000|Overall Study|Death|1|||
105715201|NCT03106779|364617522|FG001|Overall Study|Death|0|||
105715202|NCT03106779|364617521|FG000|Overall Study|Protocol Violation|1|||
105715203|NCT03106779|364617522|FG001|Overall Study|Protocol Violation|0|||
105715204|NCT03106779|364617521|FG000|Overall Study|Not treated|1|||
105715205|NCT03106779|364617522|FG001|Overall Study|Not treated|0|||
105715206|NCT01604512|364617523|FG000|Overall Study|Withdrawal by Subject|3|||
105715207|NCT01604512|364617523|FG000|Overall Study|Not treated|4|||
105715208|NCT05030311|364617524|FG000|Overall Study|Technical problems|0|||
105715209|NCT05030311|364617525|FG001|Overall Study|Technical problems|1|||
105715210|NCT05030311|364617524|FG000|Overall Study|Withdrawal by Subject|31|||
105715211|NCT05030311|364617525|FG001|Overall Study|Withdrawal by Subject|17|||
105715212|NCT05030311|364617524|FG000|Overall Study|Adverse Event|13|||
105715213|NCT05030311|364617525|FG001|Overall Study|Adverse Event|5|||
105715214|NCT05030311|364617524|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105715215|NCT05030311|364617525|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105715216|NCT05030311|364617524|FG000|Overall Study|Physician Decision|5|||
105715217|NCT05030311|364617525|FG001|Overall Study|Physician Decision|2|||
105715218|NCT05030311|364617524|FG000|Overall Study|Lost to Follow-up|5|||
105715219|NCT05030311|364617525|FG001|Overall Study|Lost to Follow-up|1|||
105715220|NCT05030311|364617524|FG000|Overall Study|Protocol Violation|4|||
105715221|NCT05030311|364617525|FG001|Overall Study|Protocol Violation|4|||
105715222|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
105715223|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
105715224|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
105715225|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
105715226|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
105715227|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
105715228|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
105715229|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
105715230|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
105715231|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
105715232|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
105715233|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
105715234|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
105715235|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
105715236|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
105715237|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
105715238|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
105715239|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
105715240|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
105715241|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
105715242|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
105715243|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
105715244|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
105715245|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
105715246|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
105715247|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
105715248|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
105715249|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
105715250|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
105715251|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
105715252|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
105715253|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
105715254|NCT04652804|364617528|FG000|Overall Study|Ineligible post randomization|1|||
105715255|NCT04652804|364617529|FG001|Overall Study|Ineligible post randomization|0|||
105715256|NCT04652804|364617530|FG002|Overall Study|Ineligible post randomization|1|||
105715257|NCT04652804|364617531|FG003|Overall Study|Ineligible post randomization|0|||
105715258|NCT04652804|364617532|FG004|Overall Study|Ineligible post randomization|1|||
105715259|NCT04652804|364617533|FG005|Overall Study|Ineligible post randomization|1|||
105715260|NCT04652804|364617528|FG000|Overall Study|Missing SVR lab results|2|||
105715261|NCT04652804|364617529|FG001|Overall Study|Missing SVR lab results|0|||
105715262|NCT04652804|364617530|FG002|Overall Study|Missing SVR lab results|0|||
105715263|NCT04652804|364617531|FG003|Overall Study|Missing SVR lab results|0|||
105715264|NCT04652804|364617532|FG004|Overall Study|Missing SVR lab results|0|||
105715265|NCT04652804|364617533|FG005|Overall Study|Missing SVR lab results|0|||
105715266|NCT04093531|364617534|FG000|Overall Study|failed screening|4|||
105715267|NCT01764633|364617535|FG000|Overall Study|Withdrawal by Subject|105|||
105715268|NCT01764633|364617536|FG001|Overall Study|Withdrawal by Subject|88|||
105715269|NCT01764633|364617535|FG000|Overall Study|Lost to Follow-up|13|||
105715270|NCT01764633|364617536|FG001|Overall Study|Lost to Follow-up|5|||
105715271|NCT00704964|364617537|FG000|Overall Study|Not completed on time|328|||
105715272|NCT02217566|364617540|FG000|Overall Study|Lost to Follow-up|2|||
105715273|NCT02217566|364617540|FG000|Overall Study|Death|3|||
105715274|NCT02217566|364617540|FG000|Overall Study|Early study termination|6|||
105715275|NCT00364689|364617541|FG000|Overall Study|Lost to Follow-up|1|||
105715276|NCT00684957|364617546|FG000|Overall Study|Withdrawal by Subject|1|||
105715277|NCT00684957|364617547|FG001|Overall Study|Withdrawal by Subject|1|||
105715278|NCT00684957|364617546|FG000|Overall Study|Lost to Follow-up|1|||
105715279|NCT00684957|364617547|FG001|Overall Study|Lost to Follow-up|0|||
105715280|NCT00191451|364617548|FG000|Overall Study|Withdrawal by Subject|2|||
105715281|NCT00191451|364617549|FG001|Overall Study|Withdrawal by Subject|3|||
105715282|NCT00191451|364617550|FG002|Overall Study|Withdrawal by Subject|5|||
105715283|NCT00191451|364617548|FG000|Overall Study|Physician Decision|2|||
105715284|NCT00191451|364617549|FG001|Overall Study|Physician Decision|9|||
105715285|NCT00191451|364617550|FG002|Overall Study|Physician Decision|6|||
105715286|NCT00191451|364617548|FG000|Overall Study|Sponsor Decision|1|||
105715287|NCT00191451|364617549|FG001|Overall Study|Sponsor Decision|0|||
105715288|NCT00191451|364617550|FG002|Overall Study|Sponsor Decision|0|||
105715289|NCT00191451|364617548|FG000|Overall Study|Ineligible|0|||
105715290|NCT00191451|364617549|FG001|Overall Study|Ineligible|1|||
105715291|NCT00191451|364617550|FG002|Overall Study|Ineligible|0|||
105715292|NCT00191451|364617548|FG000|Overall Study|Reason Not Specified|2|||
105715293|NCT00191451|364617549|FG001|Overall Study|Reason Not Specified|1|||
105715294|NCT00191451|364617550|FG002|Overall Study|Reason Not Specified|3|||
105715295|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
105715296|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
105715297|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
105715298|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
105715299|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
105715300|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
105715301|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
105715302|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
105715303|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
105715304|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
105715305|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
105715306|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
105715307|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
105715308|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
105715309|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
105715310|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
105715311|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
105715312|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
105715313|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
105715314|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
105715315|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
105715316|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
105715317|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
105715318|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
105715319|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Death|2|||
105715320|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Death|1|||
105715321|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Death|2|||
105715322|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Graft loss|0|||
105715323|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Graft loss|2|||
105715324|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Graft loss|0|||
105715325|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
105715326|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
105715327|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
105715328|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Missing|2|||
105715329|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Missing|0|||
105715330|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Missing|0|||
105715331|NCT01114529|364617551|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
105715332|NCT01114529|364617552|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
105715333|NCT01114529|364617553|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
105715334|NCT01114529|364617551|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
105715335|NCT01114529|364617552|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
105715336|NCT01114529|364617553|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
105715337|NCT01114529|364617551|FG000|Completed Study Phase at Month 24|Death|8|||
105715338|NCT01114529|364617552|FG001|Completed Study Phase at Month 24|Death|5|||
105715339|NCT01114529|364617553|FG002|Completed Study Phase at Month 24|Death|4|||
105715340|NCT01114529|364617551|FG000|Completed Study Phase at Month 24|Other|2|||
105715341|NCT01114529|364617552|FG001|Completed Study Phase at Month 24|Other|0|||
105715342|NCT01114529|364617553|FG002|Completed Study Phase at Month 24|Other|0|||
105715343|NCT01114529|364617551|FG000|Completed Study Phase at Month 24|Missing|2|||
105715344|NCT01114529|364617552|FG001|Completed Study Phase at Month 24|Missing|0|||
105715345|NCT01114529|364617553|FG002|Completed Study Phase at Month 24|Missing|0|||
105715346|NCT00331409|364617557|FG000|Overall Study|Lack of Efficacy|4|||
105715347|NCT04428411|364617558|FG000|Overall Study|Lost to Follow-up|114|||
105715348|NCT00634569|364617559|FG000|Overall Study|Withdrawal by Subject|0|||
105715349|NCT00634569|364617560|FG001|Overall Study|Withdrawal by Subject|4|||
105715350|NCT00634569|364617559|FG000|Overall Study|Physician Decision|0|||
105715351|NCT00634569|364617560|FG001|Overall Study|Physician Decision|1|||
105715352|NCT01163786|364617561|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
105715353|NCT01163786|364617561|FG000|Treatment With Bortezomib|Adverse Event|2|||
105715354|NCT01163786|364617561|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
105715355|NCT01212185|364617563|FG000|Overall Study|Protocol Violation|2|||
105715356|NCT01212185|364617564|FG001|Overall Study|Protocol Violation|1|||
105715357|NCT02614079|364617565|FG000|Overall Study|Withdrawal by Subject|1|||
105715358|NCT03555266|364617566|FG000|Overall Study|Protocol Violation|6|||
105715359|NCT03555266|364617567|FG001|Overall Study|Protocol Violation|4|||
105715360|NCT00132730|364617571|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
105715361|NCT00132730|364617572|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
105715362|NCT00132730|364617573|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
105715363|NCT00132730|364617574|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
105715364|NCT00132730|364617575|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
105715365|NCT00132730|364617576|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
105715366|NCT00132730|364617571|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
105715367|NCT00132730|364617572|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
105789694|NCT03917654|364883396|FG011|Year 2|Lost to Follow-up|1|||
105789695|NCT03917654|364883385|FG000|Year 2|Adverse Event|0|||
105789696|NCT03917654|364883386|FG001|Year 2|Adverse Event|0|||
105789697|NCT03917654|364883387|FG002|Year 2|Adverse Event|0|||
105789698|NCT03917654|364883388|FG003|Year 2|Adverse Event|0|||
105789699|NCT03917654|364883389|FG004|Year 2|Adverse Event|0|||
105789700|NCT03917654|364883390|FG005|Year 2|Adverse Event|0|||
105789701|NCT03917654|364883391|FG006|Year 2|Adverse Event|0|||
105789702|NCT03917654|364883392|FG007|Year 2|Adverse Event|0|||
105789703|NCT03917654|364883393|FG008|Year 2|Adverse Event|0|||
105789704|NCT03917654|364883394|FG009|Year 2|Adverse Event|1|||
105789705|NCT03917654|364883395|FG010|Year 2|Adverse Event|0|||
105789706|NCT03917654|364883396|FG011|Year 2|Adverse Event|0|||
105789707|NCT00905437|364883398|FG000|Overall Study|Adverse Event|3|||
105715368|NCT00132730|364617573|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
105715369|NCT00132730|364617574|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
105715370|NCT00132730|364617575|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
105715371|NCT00132730|364617576|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
105477323|NCT00006409|363759301|FG004|Post-3 Year Intervention|Protocol Violation|62|||
105477324|NCT00006409|363759302|FG005|Post-3 Year Intervention|Protocol Violation|62|||
105477325|NCT02743611|363759303|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
105477326|NCT02743611|363759304|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
105477327|NCT02743611|363759305|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
105477328|NCT02743611|363759306|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
105477329|NCT02410343|363759311|FG000|Core Period (24 Weeks)|Adverse Event|1|||
105477330|NCT02410343|363759312|FG001|Core Period (24 Weeks)|Adverse Event|0|||
105715372|NCT00132730|364617571|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
105715373|NCT00132730|364617572|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
105715374|NCT00132730|364617573|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
105715375|NCT00132730|364617574|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
105715376|NCT00132730|364617575|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
105715377|NCT00132730|364617576|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
105715378|NCT00132730|364617571|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
105715379|NCT00132730|364617572|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
105715380|NCT00132730|364617573|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
105715381|NCT00132730|364617574|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
105715382|NCT00132730|364617575|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
105715383|NCT00132730|364617576|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
105715384|NCT00132730|364617571|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
105715385|NCT00132730|364617572|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
105715386|NCT00132730|364617573|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
105715387|NCT00132730|364617574|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
105715388|NCT00132730|364617575|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
105715389|NCT00132730|364617576|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
105715390|NCT00132730|364617571|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
105715391|NCT00132730|364617572|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
105715392|NCT00132730|364617573|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
105715393|NCT00132730|364617574|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
105715394|NCT00132730|364617575|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
105715395|NCT00132730|364617576|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
105715396|NCT00132730|364617571|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
105715397|NCT00132730|364617572|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
105715398|NCT00132730|364617573|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
105715399|NCT00132730|364617574|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
105715400|NCT00132730|364617575|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
105715401|NCT00132730|364617576|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
105715402|NCT00132730|364617571|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
105715403|NCT00132730|364617572|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
105715404|NCT00132730|364617573|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
105715405|NCT00132730|364617574|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
105715406|NCT00132730|364617575|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
105715407|NCT00132730|364617576|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
105789708|NCT00905437|364883399|FG001|Overall Study|Adverse Event|2|||
105477331|NCT02410343|363759311|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
105477332|NCT02410343|363759312|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
105477333|NCT02410343|363759311|FG000|Extension Period (12 Months)|Adverse Event|1|||
105477334|NCT02410343|363759312|FG001|Extension Period (12 Months)|Adverse Event|0|||
105477335|NCT02410343|363759311|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
105477336|NCT02410343|363759312|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
105477337|NCT00228553|363759316|FG000|Overall Study|Adverse Event|112|||
105477338|NCT00228553|363759316|FG000|Overall Study|Lack of Efficacy|34|||
105477339|NCT00228553|363759316|FG000|Overall Study|Lost to Follow-up|67|||
105477340|NCT00228553|363759316|FG000|Overall Study|Physician Decision|48|||
105477341|NCT00228553|363759316|FG000|Overall Study|Protocol Violation|6|||
105715408|NCT00132730|364617571|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
105715409|NCT00132730|364617572|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
105715410|NCT00132730|364617573|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
105715411|NCT00132730|364617574|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
105715412|NCT00132730|364617575|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
105715413|NCT00132730|364617576|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
105715414|NCT00132730|364617571|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
105715415|NCT00132730|364617572|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
105715416|NCT00132730|364617573|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
105715417|NCT00132730|364617574|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
105715418|NCT00132730|364617575|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
105715419|NCT00132730|364617576|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
105715420|NCT00132730|364617571|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
105715421|NCT00132730|364617572|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
105715422|NCT00132730|364617573|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
105789709|NCT00905437|364883398|FG000|Overall Study|Lost to Follow-up|0|||
105477342|NCT00228553|363759316|FG000|Overall Study|Withdrawal by Subject|115|||
105477343|NCT00228553|363759316|FG000|Overall Study|Pregnancy|2|||
105477344|NCT00228553|363759316|FG000|Overall Study|Miscellaneous|46|||
105477345|NCT00271505|363759318|FG000|Overall Study|Screen Failure|3|||
105477346|NCT00271505|363759318|FG000|Overall Study|Adverse Event|1|||
105477347|NCT00271505|363759318|FG000|Overall Study|Death|1|||
105477348|NCT03704636|363759321|FG000|Overall Study|Inadequate Venous Flow|3|||
105477349|NCT02720042|363759322|FG000|Overall Study|Death|3|||
105477350|NCT02720042|363759322|FG000|Overall Study|Lost to Follow-up|4|||
105477351|NCT02720042|363759322|FG000|Overall Study|Withdrawal by Subject|1|||
105477352|NCT02720042|363759322|FG000|Overall Study|Physician Decision|3|||
105477353|NCT02720042|363759322|FG000|Overall Study|Phasix Mesh explanted|1|||
105477354|NCT02720042|363759322|FG000|Overall Study|unable due to non-study-related illness|3|||
105477355|NCT02674204|363759326|FG000|Overall Study|Adverse Event|1|||
105477356|NCT02674204|363759327|FG001|Overall Study|Adverse Event|0|||
105477357|NCT02466659|363759330|FG000|Overall Study|Lost to Follow-up|5|||
105477358|NCT02466659|363759331|FG001|Overall Study|Lost to Follow-up|2|||
105715423|NCT00132730|364617574|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
105715424|NCT00132730|364617575|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
105715425|NCT00132730|364617576|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
105477359|NCT04345367|363759332|FG000|Overall Study|Other|3|||
105789710|NCT00905437|364883399|FG001|Overall Study|Lost to Follow-up|1|||
105477360|NCT04345367|363759333|FG001|Overall Study|Other|4|||
105477361|NCT04345367|363759332|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
105477362|NCT04345367|363759333|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
105477363|NCT04345367|363759332|FG000|Overall Study|Withdrawal by Subject|11|||
105477364|NCT04345367|363759333|FG001|Overall Study|Withdrawal by Subject|11|||
105477365|NCT04345367|363759332|FG000|Overall Study|Protocol Violation|4|||
105477366|NCT04345367|363759333|FG001|Overall Study|Protocol Violation|3|||
105477367|NCT04345367|363759332|FG000|Overall Study|Lost to Follow-up|2|||
105477368|NCT04345367|363759333|FG001|Overall Study|Lost to Follow-up|4|||
105477369|NCT04345367|363759332|FG000|Overall Study|Lack of Efficacy|2|||
105477370|NCT04345367|363759333|FG001|Overall Study|Lack of Efficacy|0|||
105715426|NCT00132730|364617571|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
105715427|NCT00132730|364617572|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
105789711|NCT00905437|364883398|FG000|Overall Study|Withdrawal by Subject|0|||
105789712|NCT00905437|364883399|FG001|Overall Study|Withdrawal by Subject|1|||
105789713|NCT00905437|364883398|FG000|Overall Study|Other|5|||
105789714|NCT00905437|364883399|FG001|Overall Study|Other|6|||
105789715|NCT00903409|364883400|FG000|Overall Study|Adverse Event|11|||
105789716|NCT00903409|364883401|FG001|Overall Study|Adverse Event|9|||
105789717|NCT00903409|364883400|FG000|Overall Study|Non-compliance with Protocol|1|||
105789718|NCT00903409|364883401|FG001|Overall Study|Non-compliance with Protocol|1|||
105789719|NCT00903409|364883400|FG000|Overall Study|Laboratory Abnormality|2|||
105789720|NCT00903409|364883401|FG001|Overall Study|Laboratory Abnormality|0|||
105715428|NCT00132730|364617573|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
105715429|NCT00132730|364617574|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
105715430|NCT00132730|364617575|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
105715431|NCT00132730|364617576|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
105715432|NCT00090545|364617580|FG000|Overall Study|Disease progression on study|21|||
105715433|NCT00090545|364617581|FG001|Overall Study|Disease progression on study|17|||
105715434|NCT00090545|364617580|FG000|Overall Study|Refused further treatment|1|||
105715435|NCT00090545|364617581|FG001|Overall Study|Refused further treatment|4|||
105715436|NCT00090545|364617580|FG000|Overall Study|Death|0|||
105715437|NCT00090545|364617581|FG001|Overall Study|Death|1|||
105715438|NCT00090545|364617580|FG000|Overall Study|Adverse Event|0|||
105715439|NCT00090545|364617581|FG001|Overall Study|Adverse Event|2|||
105715440|NCT00441545|364617582|FG000|First Intervention|Adverse Event|6|||
105715441|NCT00441545|364617583|FG001|First Intervention|Adverse Event|5|||
105715442|NCT00441545|364617582|FG000|First Intervention|Protocol Violation|2|||
105715443|NCT00441545|364617583|FG001|First Intervention|Protocol Violation|2|||
105715444|NCT00441545|364617582|FG000|First Intervention|Withdrawal by Subject|3|||
105715445|NCT00441545|364617583|FG001|First Intervention|Withdrawal by Subject|3|||
105715446|NCT00441545|364617582|FG000|First Intervention|Kidney transplant|1|||
105715447|NCT00441545|364617583|FG001|First Intervention|Kidney transplant|1|||
105715448|NCT00441545|364617582|FG000|First Intervention|Lack of Efficacy|2|||
105715449|NCT00441545|364617583|FG001|First Intervention|Lack of Efficacy|0|||
105715450|NCT00441545|364617582|FG000|First Intervention|Subject exceeded safety criteria|0|||
105715451|NCT00441545|364617583|FG001|First Intervention|Subject exceeded safety criteria|1|||
105715452|NCT00441545|364617582|FG000|First Intervention|Subject met an exclusionary criteria|1|||
105715453|NCT00441545|364617583|FG001|First Intervention|Subject met an exclusionary criteria|0|||
105715454|NCT00441545|364617582|FG000|First Intervention|Extended hospitalization|1|||
105715455|NCT00441545|364617583|FG001|First Intervention|Extended hospitalization|0|||
105715456|NCT00441545|364617582|FG000|First Intervention|Site error|1|||
105715457|NCT00441545|364617583|FG001|First Intervention|Site error|0|||
105715458|NCT00441545|364617582|FG000|First Intervention|Sponsor's request|1|||
105715459|NCT00441545|364617583|FG001|First Intervention|Sponsor's request|0|||
105715460|NCT00441545|364617582|FG000|Second Intervention|Adverse Event|5|||
105715461|NCT00441545|364617583|FG001|Second Intervention|Adverse Event|2|||
105789721|NCT00903409|364883400|FG000|Overall Study|Withdrawal by Subject|8|||
105477371|NCT04345367|363759332|FG000|Overall Study|Death|2|||
105715462|NCT00441545|364617582|FG000|Second Intervention|Protocol Violation|4|||
105715463|NCT00441545|364617583|FG001|Second Intervention|Protocol Violation|1|||
105715464|NCT00441545|364617582|FG000|Second Intervention|Withdrawal by Subject|1|||
105715465|NCT00441545|364617583|FG001|Second Intervention|Withdrawal by Subject|1|||
105715466|NCT00441545|364617582|FG000|Second Intervention|Kidney Transplant|1|||
105715467|NCT00441545|364617583|FG001|Second Intervention|Kidney Transplant|1|||
105715468|NCT00441545|364617582|FG000|Second Intervention|Lack of Efficacy|0|||
105715469|NCT00441545|364617583|FG001|Second Intervention|Lack of Efficacy|1|||
105715470|NCT00441545|364617582|FG000|Second Intervention|Subject exceeded safety criteria|1|||
105715471|NCT00441545|364617583|FG001|Second Intervention|Subject exceeded safety criteria|0|||
105715472|NCT00441545|364617582|FG000|Second Intervention|Subject moved|0|||
105715473|NCT00441545|364617583|FG001|Second Intervention|Subject moved|1|||
105477372|NCT04345367|363759333|FG001|Overall Study|Death|0|||
105477373|NCT04345367|363759332|FG000|Overall Study|Adverse Event|10|||
105477374|NCT04345367|363759333|FG001|Overall Study|Adverse Event|9|||
105715474|NCT01463098|364617585|FG000|Part A (11 Days)|Participant Choice|2|||
105715475|NCT01463098|364617586|FG001|Part A (11 Days)|Participant Choice|0|||
105715476|NCT01463098|364617587|FG002|Part A (11 Days)|Participant Choice|0|||
105715477|NCT01463098|364617588|FG003|Part A (11 Days)|Participant Choice|0|||
105715478|NCT01463098|364617589|FG004|Part A (11 Days)|Participant Choice|0|||
105789722|NCT00903409|364883401|FG001|Overall Study|Withdrawal by Subject|8|||
105789723|NCT00903409|364883400|FG000|Overall Study|Other|2|||
105789724|NCT00903409|364883401|FG001|Overall Study|Other|3|||
105715479|NCT01463098|364617590|FG005|Part A (11 Days)|Participant Choice|0|||
105789725|NCT00903409|364883400|FG000|Overall Study|Lost to Follow-up|2|||
105715480|NCT01463098|364617591|FG006|Part A (11 Days)|Participant Choice|0|||
105715481|NCT01463098|364617592|FG007|Part A (11 Days)|Participant Choice|0|||
105715482|NCT01463098|364617593|FG008|Part A (11 Days)|Participant Choice|1|||
105715483|NCT01463098|364617594|FG009|Part A (11 Days)|Participant Choice|0|||
105715484|NCT01463098|364617595|FG010|Part A (11 Days)|Participant Choice|0|||
105715485|NCT01463098|364617596|FG011|Part A (11 Days)|Participant Choice|0|||
105715486|NCT01463098|364617597|FG012|Part A (11 Days)|Participant Choice|0|||
105715487|NCT01463098|364617598|FG013|Part A (11 Days)|Participant Choice|0|||
105715488|NCT01463098|364617585|FG000|Part A (11 Days)|Lost to Follow-up|0|||
105715489|NCT01463098|364617586|FG001|Part A (11 Days)|Lost to Follow-up|0|||
105715490|NCT01463098|364617587|FG002|Part A (11 Days)|Lost to Follow-up|0|||
105715491|NCT01463098|364617588|FG003|Part A (11 Days)|Lost to Follow-up|0|||
105715492|NCT01463098|364617589|FG004|Part A (11 Days)|Lost to Follow-up|1|||
105715493|NCT01463098|364617590|FG005|Part A (11 Days)|Lost to Follow-up|0|||
105715494|NCT01463098|364617591|FG006|Part A (11 Days)|Lost to Follow-up|0|||
105715495|NCT01463098|364617592|FG007|Part A (11 Days)|Lost to Follow-up|0|||
105715496|NCT01463098|364617593|FG008|Part A (11 Days)|Lost to Follow-up|0|||
105715497|NCT01463098|364617594|FG009|Part A (11 Days)|Lost to Follow-up|0|||
105715498|NCT01463098|364617595|FG010|Part A (11 Days)|Lost to Follow-up|0|||
105715499|NCT01463098|364617596|FG011|Part A (11 Days)|Lost to Follow-up|0|||
105715500|NCT01463098|364617597|FG012|Part A (11 Days)|Lost to Follow-up|0|||
105715501|NCT01463098|364617598|FG013|Part A (11 Days)|Lost to Follow-up|0|||
105715502|NCT01463098|364617585|FG000|Part B (11 Days)|Participant Choice|0|||
105715503|NCT01463098|364617586|FG001|Part B (11 Days)|Participant Choice|0|||
105789726|NCT00903409|364883401|FG001|Overall Study|Lost to Follow-up|6|||
105789727|NCT02268214|364883402|FG000|Overall Study|Subject no longer meets study criteria|0|||
105789728|NCT02268214|364883403|FG001|Overall Study|Subject no longer meets study criteria|2|||
105789729|NCT02268214|364883404|FG002|Overall Study|Subject no longer meets study criteria|0|||
105789730|NCT02268214|364883402|FG000|Overall Study|Pregnancy|2|||
105789731|NCT02268214|364883403|FG001|Overall Study|Pregnancy|2|||
105789732|NCT02268214|364883404|FG002|Overall Study|Pregnancy|1|||
105789733|NCT02268214|364883402|FG000|Overall Study|Lost to Follow-up|3|||
105789734|NCT02268214|364883403|FG001|Overall Study|Lost to Follow-up|3|||
105789735|NCT02268214|364883404|FG002|Overall Study|Lost to Follow-up|4|||
105789736|NCT02268214|364883402|FG000|Overall Study|Lack of Efficacy|1|||
105789737|NCT02268214|364883403|FG001|Overall Study|Lack of Efficacy|0|||
105789738|NCT02268214|364883404|FG002|Overall Study|Lack of Efficacy|2|||
105789739|NCT02268214|364883402|FG000|Overall Study|Adverse Event|11|||
105789740|NCT02268214|364883403|FG001|Overall Study|Adverse Event|14|||
105789741|NCT02268214|364883404|FG002|Overall Study|Adverse Event|9|||
105789742|NCT02268214|364883402|FG000|Overall Study|Withdrawal by Subject|4|||
105789743|NCT02268214|364883403|FG001|Overall Study|Withdrawal by Subject|5|||
105789744|NCT02268214|364883404|FG002|Overall Study|Withdrawal by Subject|10|||
105789745|NCT02268214|364883402|FG000|Overall Study|Subject request to discontinue treatment|10|||
105789746|NCT02268214|364883403|FG001|Overall Study|Subject request to discontinue treatment|8|||
105789747|NCT02268214|364883404|FG002|Overall Study|Subject request to discontinue treatment|6|||
105789748|NCT02268214|364883402|FG000|Overall Study|Poor/non-compliance|2|||
105789749|NCT02268214|364883403|FG001|Overall Study|Poor/non-compliance|1|||
105789750|NCT02268214|364883404|FG002|Overall Study|Poor/non-compliance|2|||
105789751|NCT02268214|364883402|FG000|Overall Study|Other reasons|7|||
105789752|NCT02268214|364883403|FG001|Overall Study|Other reasons|3|||
105789753|NCT02268214|364883404|FG002|Overall Study|Other reasons|3|||
105789754|NCT02268214|364883402|FG000|Overall Study|Not entering long-term period|2|||
105789755|NCT02268214|364883403|FG001|Overall Study|Not entering long-term period|3|||
105789756|NCT02268214|364883404|FG002|Overall Study|Not entering long-term period|5|||
105789757|NCT04625413|364883409|FG000|Overall Study|Hospice|2|||
105789758|NCT04625413|364883409|FG000|Overall Study|Distress|1|||
105789759|NCT04625413|364883409|FG000|Overall Study|Not feeling well|1|||
105789760|NCT01283282|364883413|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
105715504|NCT01463098|364617587|FG002|Part B (11 Days)|Participant Choice|0|||
105715505|NCT01463098|364617588|FG003|Part B (11 Days)|Participant Choice|0|||
105715506|NCT01463098|364617589|FG004|Part B (11 Days)|Participant Choice|0|||
105715507|NCT01463098|364617590|FG005|Part B (11 Days)|Participant Choice|0|||
105715508|NCT01463098|364617591|FG006|Part B (11 Days)|Participant Choice|0|||
105715509|NCT01463098|364617592|FG007|Part B (11 Days)|Participant Choice|0|||
105715510|NCT01463098|364617593|FG008|Part B (11 Days)|Participant Choice|0|||
105715511|NCT01463098|364617594|FG009|Part B (11 Days)|Participant Choice|0|||
105715512|NCT01463098|364617595|FG010|Part B (11 Days)|Participant Choice|0|||
105789761|NCT01283282|364883414|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
105789762|NCT01283282|364883413|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
105789763|NCT01283282|364883414|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
105789764|NCT01283282|364883413|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
105789765|NCT01283282|364883414|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
105789766|NCT00777920|364883415|FG000|Overall Study|Adverse Event|39|||
105715513|NCT01463098|364617596|FG011|Part B (11 Days)|Participant Choice|1|||
105715514|NCT01463098|364617597|FG012|Part B (11 Days)|Participant Choice|0|||
105715515|NCT01463098|364617598|FG013|Part B (11 Days)|Participant Choice|0|||
105715516|NCT00939692|364617606|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
105715517|NCT00939692|364617607|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
105715518|NCT00939692|364617606|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
105715519|NCT00939692|364617607|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
105715520|NCT04451330|364617608|FG000|Overall Study|Adverse Event|1|||
105715521|NCT04451330|364617609|FG001|Overall Study|Adverse Event|2|||
105715522|NCT04451330|364617608|FG000|Overall Study|Lost to Follow-up|5|||
105715523|NCT04451330|364617609|FG001|Overall Study|Lost to Follow-up|0|||
105715524|NCT04451330|364617608|FG000|Overall Study|Withdrawal by Subject|3|||
105715525|NCT04451330|364617609|FG001|Overall Study|Withdrawal by Subject|1|||
105715526|NCT04451330|364617608|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105715527|NCT04451330|364617609|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105715528|NCT04451330|364617608|FG000|Overall Study|Other than specified|0|||
105715529|NCT04451330|364617609|FG001|Overall Study|Other than specified|1|||
105715530|NCT02769624|364617610|FG000|Overall Study|Lost to Follow-up|0|||
105715531|NCT02769624|364617611|FG001|Overall Study|Lost to Follow-up|1|||
105715532|NCT03175549|364617612|FG000|Overall Study|Lost to Follow-up|2|||
105715533|NCT03175549|364617613|FG001|Overall Study|Lost to Follow-up|2|||
105715534|NCT03175549|364617612|FG000|Overall Study|Medication non-compliance|2|||
105715535|NCT03175549|364617613|FG001|Overall Study|Medication non-compliance|2|||
105715536|NCT00130286|364617614|FG000|Overall Study|Withdrawal by Subject|0|||
105715537|NCT00130286|364617615|FG001|Overall Study|Withdrawal by Subject|1|||
105715538|NCT00130286|364617616|FG002|Overall Study|Withdrawal by Subject|2|||
105715539|NCT00130286|364617617|FG003|Overall Study|Withdrawal by Subject|2|||
105715540|NCT00130286|364617614|FG000|Overall Study|Adverse Event|0|||
105715541|NCT00130286|364617615|FG001|Overall Study|Adverse Event|0|||
105715542|NCT00130286|364617616|FG002|Overall Study|Adverse Event|2|||
105715543|NCT00130286|364617617|FG003|Overall Study|Adverse Event|0|||
105715544|NCT00130286|364617614|FG000|Overall Study|Missing lab specimens|0|||
105715545|NCT00130286|364617615|FG001|Overall Study|Missing lab specimens|2|||
105715546|NCT00130286|364617616|FG002|Overall Study|Missing lab specimens|0|||
105715547|NCT00130286|364617617|FG003|Overall Study|Missing lab specimens|0|||
105715548|NCT02154425|364617618|FG000|Screening Period|Adverse Event|1|||
105715549|NCT00508391|364617624|FG000|First Treatment|Withdrawal by Subject|6|||
105715550|NCT00508391|364617625|FG001|First Treatment|Withdrawal by Subject|3|||
105715551|NCT00508391|364617624|FG000|Second Treatment|Withdrawal by Subject|2|||
105715552|NCT00508391|364617625|FG001|Second Treatment|Withdrawal by Subject|0|||
105715553|NCT00865020|364617634|FG000|Overall Study|Withdrawal by Subject|22|||
105715554|NCT00865020|364617635|FG001|Overall Study|Withdrawal by Subject|16|||
105561765|NCT01256411|364052227|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
105561766|NCT01256411|364052228|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
105561767|NCT01256411|364052223|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
105561768|NCT01256411|364052224|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
105715555|NCT00865020|364617634|FG000|Overall Study|Adverse Event|9|||
105715556|NCT00865020|364617635|FG001|Overall Study|Adverse Event|14|||
105715557|NCT00865020|364617634|FG000|Overall Study|Abnormal test procedure result(s)|6|||
105715558|NCT00865020|364617635|FG001|Overall Study|Abnormal test procedure result(s)|8|||
105715559|NCT00865020|364617634|FG000|Overall Study|Lost to Follow-up|6|||
105715560|NCT00865020|364617635|FG001|Overall Study|Lost to Follow-up|4|||
105715561|NCT00865020|364617634|FG000|Overall Study|Protocol deviation|4|||
105715562|NCT00865020|364617635|FG001|Overall Study|Protocol deviation|1|||
105715563|NCT00865020|364617634|FG000|Overall Study|Administrative problems|0|||
105715564|NCT00865020|364617635|FG001|Overall Study|Administrative problems|2|||
105715565|NCT00865020|364617634|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105715566|NCT00865020|364617635|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105715567|NCT00865020|364617634|FG000|Overall Study|Death|0|||
105715568|NCT00865020|364617635|FG001|Overall Study|Death|1|||
105715569|NCT00865020|364617634|FG000|Overall Study|Randomized but discontinued|2|||
105715570|NCT00865020|364617635|FG001|Overall Study|Randomized but discontinued|4|||
105715571|NCT03641560|364617636|FG000|Overall Study|Withdrawal by Subject|6|||
105715572|NCT03641560|364617636|FG000|Overall Study|Progressive disease|40|||
105715573|NCT03641560|364617636|FG000|Overall Study|Death|6|||
105715574|NCT04002310|364619275|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
105715575|NCT04002310|364619276|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
105715576|NCT04002310|364619277|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
105715577|NCT04002310|364619278|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
105715578|NCT04002310|364619279|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
105715579|NCT02949128|364619280|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
105715580|NCT02949128|364619280|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
105715581|NCT02949128|364619280|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
105715582|NCT02949128|364619280|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
105715583|NCT02949128|364619280|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
105715584|NCT02949128|364619280|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
105715585|NCT02949128|364619280|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
105715586|NCT02949128|364619280|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
105715587|NCT02949128|364619280|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
105715588|NCT02949128|364619280|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
105715589|NCT02152345|364619283|FG000|Overall Study|Case Cancellations|2|||
105715590|NCT02152345|364619284|FG001|Overall Study|Case Cancellations|4|||
105715591|NCT02152345|364619283|FG000|Overall Study|Withdrawal by Subject|2|||
105715592|NCT02152345|364619284|FG001|Overall Study|Withdrawal by Subject|1|||
105715593|NCT03160560|364619288|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
105715594|NCT03160560|364619289|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
105715595|NCT03160560|364619290|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
105715596|NCT03160560|364619291|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
105715597|NCT03160560|364619288|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
105715598|NCT03160560|364619289|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
105715599|NCT03160560|364619290|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
105715600|NCT03160560|364619291|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
105715601|NCT02810964|364619293|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
105715602|NCT02810964|364619294|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
105715603|NCT02810964|364619293|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
105715604|NCT02810964|364619294|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
105715605|NCT02810964|364619293|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
105715606|NCT02810964|364619294|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
105715607|NCT02810964|364619293|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
105715608|NCT02810964|364619294|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
105715609|NCT00772629|364619298|FG000|Overall Study|Subject was not vaccinated|1|||
105715610|NCT00772629|364619299|FG001|Overall Study|Subject was not vaccinated|0|||
105715611|NCT02894840|364619302|FG000|Overall Study|Lost to Follow-up|1|||
105715612|NCT02894840|364619303|FG001|Overall Study|Lost to Follow-up|0|||
105715613|NCT02894840|364619304|FG002|Overall Study|Lost to Follow-up|3|||
105715614|NCT02894840|364619305|FG003|Overall Study|Lost to Follow-up|0|||
105715615|NCT05162066|364619310|FG000|Overall Study|Adverse Event|1|||
105715616|NCT05162066|364619311|FG001|Overall Study|Adverse Event|0|||
105715617|NCT05162066|364619312|FG002|Overall Study|Adverse Event|0|||
105715618|NCT05162066|364619310|FG000|Overall Study|Perceived lack of efficacy|1|||
105715619|NCT05162066|364619311|FG001|Overall Study|Perceived lack of efficacy|0|||
105715620|NCT05162066|364619312|FG002|Overall Study|Perceived lack of efficacy|0|||
105715621|NCT01072344|364619313|FG000|Overall Study|Relasped-reached end point|7|||
105715622|NCT01072344|364619314|FG001|Overall Study|Relasped-reached end point|12|||
105715623|NCT01072344|364619313|FG000|Overall Study|Protocol Violation|1|||
105715624|NCT01072344|364619314|FG001|Overall Study|Protocol Violation|2|||
105715625|NCT01072344|364619313|FG000|Overall Study|Lost to Follow-up|3|||
105715626|NCT01072344|364619314|FG001|Overall Study|Lost to Follow-up|4|||
105715627|NCT03969875|364619315|FG000|Overall Study|did not receive allocated intervention|3|||
105715628|NCT03969875|364619316|FG001|Overall Study|did not receive allocated intervention|3|||
105715629|NCT03969875|364619317|FG002|Overall Study|did not receive allocated intervention|4|||
105715630|NCT03969875|364619315|FG000|Overall Study|Protocol Violation|4|||
105715631|NCT03969875|364619316|FG001|Overall Study|Protocol Violation|2|||
105715632|NCT03969875|364619317|FG002|Overall Study|Protocol Violation|2|||
105715633|NCT01871090|364619326|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
105715634|NCT01871090|364619327|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
105715635|NCT01871090|364619326|FG000|Overall Study|Interrogation not completed correctly|1|||
105715636|NCT01871090|364619327|FG001|Overall Study|Interrogation not completed correctly|0|||
105715637|NCT01871090|364619326|FG000|Overall Study|Subject Non-Compliance|0|||
105715638|NCT01871090|364619327|FG001|Overall Study|Subject Non-Compliance|1|||
105715639|NCT00808444|364619333|FG000|Overall Study|Withdrawal by Subject|1|||
105715640|NCT00808444|364619334|FG001|Overall Study|Withdrawal by Subject|0|||
105715641|NCT00808444|364619333|FG000|Overall Study|Lost to Follow-up|0|||
105715642|NCT00808444|364619334|FG001|Overall Study|Lost to Follow-up|1|||
105715643|NCT03502330|364619335|FG000|Overall Study|Adverse Event|2|||
105715644|NCT03502330|364619336|FG001|Overall Study|Adverse Event|1|||
105715645|NCT03502330|364619337|FG002|Overall Study|Adverse Event|0|||
105715646|NCT03502330|364619338|FG003|Overall Study|Adverse Event|0|||
105715647|NCT03502330|364619339|FG004|Overall Study|Adverse Event|1|||
105715648|NCT03502330|364619340|FG005|Overall Study|Adverse Event|0|||
105715649|NCT03502330|364619341|FG006|Overall Study|Adverse Event|1|||
105715650|NCT03502330|364619342|FG007|Overall Study|Adverse Event|1|||
105715651|NCT03502330|364619343|FG008|Overall Study|Adverse Event|0|||
105715652|NCT03502330|364619335|FG000|Overall Study|Lack of Efficacy|1|||
105477375|NCT01578850|363759334|FG000|Period 1|Insufficient Clinical Response|1|||
105477376|NCT01578850|363759335|FG001|Period 1|Insufficient Clinical Response|0|||
105477377|NCT01578850|363759336|FG002|Period 1|Insufficient Clinical Response|0|||
105477378|NCT01578850|363759334|FG000|Period 1|Adverse Event|11|||
105715653|NCT03502330|364619336|FG001|Overall Study|Lack of Efficacy|5|||
105715654|NCT03502330|364619337|FG002|Overall Study|Lack of Efficacy|3|||
105715655|NCT03502330|364619338|FG003|Overall Study|Lack of Efficacy|5|||
105715656|NCT03502330|364619339|FG004|Overall Study|Lack of Efficacy|1|||
105715657|NCT03502330|364619340|FG005|Overall Study|Lack of Efficacy|5|||
105715658|NCT03502330|364619341|FG006|Overall Study|Lack of Efficacy|5|||
105715659|NCT03502330|364619342|FG007|Overall Study|Lack of Efficacy|6|||
105715660|NCT03502330|364619343|FG008|Overall Study|Lack of Efficacy|0|||
105715661|NCT03502330|364619335|FG000|Overall Study|Physician Decision|0|||
105715662|NCT03502330|364619336|FG001|Overall Study|Physician Decision|0|||
105715663|NCT03502330|364619337|FG002|Overall Study|Physician Decision|0|||
105715664|NCT03502330|364619338|FG003|Overall Study|Physician Decision|0|||
105715665|NCT03502330|364619339|FG004|Overall Study|Physician Decision|1|||
105715666|NCT03502330|364619340|FG005|Overall Study|Physician Decision|0|||
105477379|NCT01578850|363759335|FG001|Period 1|Adverse Event|0|||
105477380|NCT01578850|363759336|FG002|Period 1|Adverse Event|0|||
105477381|NCT01578850|363759334|FG000|Period 1|Death|1|||
105477382|NCT01578850|363759335|FG001|Period 1|Death|0|||
105477383|NCT01578850|363759336|FG002|Period 1|Death|0|||
105789767|NCT00777920|364883415|FG000|Overall Study|Withdrawal of Consent|4|||
105789768|NCT00777920|364883415|FG000|Overall Study|Lost to Follow-up|1|||
105789769|NCT00777920|364883415|FG000|Overall Study|Investigator's discretion|1|||
105789770|NCT00777920|364883415|FG000|Overall Study|Clinical status did not improve|1|||
105789771|NCT00777920|364883415|FG000|Overall Study|Other, not specified|4|||
105789772|NCT03878108|364883416|FG000|Overall Study|Adverse Event|1|||
105789773|NCT03878108|364883417|FG001|Overall Study|Adverse Event|0|||
105789774|NCT00795886|364883421|FG000|Overall Study|Death|10|||
105789775|NCT05554471|364883422|FG000|Overall Study|Physician Decision|2|||
105789776|NCT05554471|364883423|FG001|Overall Study|Physician Decision|1|||
105789777|NCT05554471|364883422|FG000|Overall Study|Lost to Follow-up|2|||
105789778|NCT05554471|364883423|FG001|Overall Study|Lost to Follow-up|1|||
105715667|NCT03502330|364619341|FG006|Overall Study|Physician Decision|0|||
105715668|NCT03502330|364619342|FG007|Overall Study|Physician Decision|0|||
105715669|NCT03502330|364619343|FG008|Overall Study|Physician Decision|0|||
105715670|NCT03502330|364619335|FG000|Overall Study|Withdrawal by Subject|0|||
105715671|NCT03502330|364619336|FG001|Overall Study|Withdrawal by Subject|0|||
105715672|NCT03502330|364619337|FG002|Overall Study|Withdrawal by Subject|0|||
105789779|NCT05554471|364883422|FG000|Overall Study|Death|0|||
105789780|NCT05554471|364883423|FG001|Overall Study|Death|1|||
105789781|NCT01608321|364883424|FG000|Overall Study|Withdrawal by Subject|1|||
105789782|NCT01608321|364883425|FG001|Overall Study|Withdrawal by Subject|0|||
105789783|NCT01298661|364883426|FG000|Overall Study|Withdrawal by Subject|2|||
105477384|NCT01578850|363759334|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
105477385|NCT01578850|363759335|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
105477386|NCT01578850|363759336|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
105477387|NCT01578850|363759334|FG000|Period 1|Withdrawal by Subject|9|||
105477388|NCT01578850|363759335|FG001|Period 1|Withdrawal by Subject|0|||
105477389|NCT01578850|363759336|FG002|Period 1|Withdrawal by Subject|0|||
105477390|NCT01578850|363759334|FG000|Period 1|Study Terminated by Sponsor|3|||
105715673|NCT03502330|364619338|FG003|Overall Study|Withdrawal by Subject|0|||
105789784|NCT01298661|364883427|FG001|Overall Study|Withdrawal by Subject|0|||
105477391|NCT01578850|363759335|FG001|Period 1|Study Terminated by Sponsor|0|||
105789785|NCT01298661|364883428|FG002|Overall Study|Withdrawal by Subject|2|||
105789786|NCT01525407|364883429|FG000|Overall Study|Change in recipient treatment plan|2|||
105789787|NCT01525407|364883430|FG001|Overall Study|Change in recipient treatment plan|2|||
105789788|NCT01525407|364883429|FG000|Overall Study|Withdrawal by Subject|0|||
105477392|NCT01578850|363759336|FG002|Period 1|Study Terminated by Sponsor|0|||
105477393|NCT01578850|363759334|FG000|Period 2|Insufficient Clinical Response|0|||
105477394|NCT01578850|363759335|FG001|Period 2|Insufficient Clinical Response|1|||
105477395|NCT01578850|363759336|FG002|Period 2|Insufficient Clinical Response|0|||
105477396|NCT01578850|363759334|FG000|Period 2|Adverse Event|0|||
105477397|NCT01578850|363759335|FG001|Period 2|Adverse Event|3|||
105477398|NCT01578850|363759336|FG002|Period 2|Adverse Event|6|||
105477399|NCT01578850|363759334|FG000|Period 2|Lost to Follow-up|0|||
105477400|NCT01578850|363759335|FG001|Period 2|Lost to Follow-up|1|||
105715674|NCT03502330|364619339|FG004|Overall Study|Withdrawal by Subject|0|||
105789789|NCT01525407|364883430|FG001|Overall Study|Withdrawal by Subject|1|||
105477401|NCT01578850|363759336|FG002|Period 2|Lost to Follow-up|2|||
105477402|NCT01578850|363759334|FG000|Period 2|Withdrawal by Subject|0|||
105477403|NCT01578850|363759335|FG001|Period 2|Withdrawal by Subject|2|||
105477404|NCT01578850|363759336|FG002|Period 2|Withdrawal by Subject|2|||
105715675|NCT03502330|364619340|FG005|Overall Study|Withdrawal by Subject|1|||
105789790|NCT01525407|364883429|FG000|Overall Study|Transplant was delayed|0|||
105477405|NCT01578850|363759334|FG000|Period 2|Study Terminated by Sponsor|0|||
105477406|NCT01578850|363759335|FG001|Period 2|Study Terminated by Sponsor|5|||
105477407|NCT01578850|363759336|FG002|Period 2|Study Terminated by Sponsor|4|||
105715676|NCT03502330|364619341|FG006|Overall Study|Withdrawal by Subject|0|||
105715677|NCT03502330|364619342|FG007|Overall Study|Withdrawal by Subject|1|||
105715678|NCT03502330|364619343|FG008|Overall Study|Withdrawal by Subject|0|||
105715679|NCT03502330|364619335|FG000|Overall Study|Death|0|||
105715680|NCT03502330|364619336|FG001|Overall Study|Death|0|||
105715681|NCT03502330|364619337|FG002|Overall Study|Death|0|||
105715682|NCT03502330|364619338|FG003|Overall Study|Death|0|||
105715683|NCT03502330|364619339|FG004|Overall Study|Death|0|||
105715684|NCT03502330|364619340|FG005|Overall Study|Death|0|||
105715685|NCT03502330|364619341|FG006|Overall Study|Death|2|||
105715686|NCT03502330|364619342|FG007|Overall Study|Death|0|||
105715687|NCT03502330|364619343|FG008|Overall Study|Death|0|||
105715688|NCT01461044|364619344|FG000|Overall Study|Death|58|||
105715689|NCT01461044|364619345|FG001|Overall Study|Death|35|||
105715690|NCT01461044|364619344|FG000|Overall Study|Lost to Follow-up|12|||
105715691|NCT01461044|364619345|FG001|Overall Study|Lost to Follow-up|5|||
105715692|NCT00669617|364619353|FG000|Period 1|Withdrawal by Subject|0|||
105715693|NCT00669617|364619354|FG001|Period 1|Withdrawal by Subject|0|||
105715694|NCT00669617|364619355|FG002|Period 1|Withdrawal by Subject|1|||
105715695|NCT00669617|364619356|FG003|Period 1|Withdrawal by Subject|0|||
105715696|NCT00669617|364619357|FG004|Period 1|Withdrawal by Subject|0|||
105715697|NCT00669617|364619353|FG000|Period 1|Protocol Deviation|0|||
105715698|NCT00669617|364619354|FG001|Period 1|Protocol Deviation|0|||
105715699|NCT00669617|364619355|FG002|Period 1|Protocol Deviation|0|||
105715700|NCT00669617|364619356|FG003|Period 1|Protocol Deviation|0|||
105715701|NCT00669617|364619357|FG004|Period 1|Protocol Deviation|1|||
105715702|NCT00669617|364619353|FG000|Period 3|Lost to Follow-up|1|||
105715703|NCT00669617|364619354|FG001|Period 3|Lost to Follow-up|0|||
105715704|NCT00669617|364619355|FG002|Period 3|Lost to Follow-up|0|||
105715705|NCT00669617|364619356|FG003|Period 3|Lost to Follow-up|0|||
105715706|NCT00669617|364619357|FG004|Period 3|Lost to Follow-up|0|||
105715707|NCT03068325|364619358|FG000|Overall Study|Lost to Follow-up|5|||
105715708|NCT00840827|364619361|FG000|Overall Study|Adverse Event|1|||
105715709|NCT00840827|364619361|FG000|Overall Study|Lack of Efficacy|4|||
105715710|NCT00840827|364619361|FG000|Overall Study|Physician Decision|1|||
105715711|NCT02415712|364619362|FG000|Overall Study|Protocol Violation|16|||
105715712|NCT01668654|364619363|FG000|Overall Study|Study Closed/Terminated|3|||
105715713|NCT01668654|364619363|FG000|Overall Study|Withdrawal by Subject|1|||
105715714|NCT04557384|364619364|FG000|Overall Study|Study Terminated by Sponsor|1|||
105715715|NCT04557384|364619364|FG000|Overall Study|Death|1|||
105715716|NCT03806127|364619366|FG000|Overall Study|Withdrawal by Subject|4|||
105715717|NCT03806127|364619367|FG001|Overall Study|Withdrawal by Subject|5|||
105715718|NCT03806127|364619366|FG000|Overall Study|Protocol Violation|3|||
105715719|NCT03806127|364619367|FG001|Overall Study|Protocol Violation|1|||
105715720|NCT03806127|364619366|FG000|Overall Study|Adverse Event|3|||
105715721|NCT03806127|364619367|FG001|Overall Study|Adverse Event|0|||
105715722|NCT03806127|364619366|FG000|Overall Study|Unable to Complete Procedures|0|||
105715723|NCT03806127|364619367|FG001|Overall Study|Unable to Complete Procedures|1|||
105715724|NCT03806127|364619366|FG000|Overall Study|Pregnancy|0|||
105715725|NCT03806127|364619367|FG001|Overall Study|Pregnancy|1|||
105715726|NCT03806127|364619366|FG000|Overall Study|Lost to Follow-up|5|||
105715727|NCT03806127|364619367|FG001|Overall Study|Lost to Follow-up|1|||
105715728|NCT03806127|364619366|FG000|Overall Study|Physician Decision|1|||
105715729|NCT03806127|364619367|FG001|Overall Study|Physician Decision|1|||
105715730|NCT03806127|364619366|FG000|Overall Study|Could Not Come Due to Covid|1|||
105715731|NCT03806127|364619367|FG001|Overall Study|Could Not Come Due to Covid|0|||
105715732|NCT03806127|364619366|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
105715733|NCT03806127|364619367|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
105715734|NCT03806127|364619366|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
105715735|NCT03806127|364619367|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
105715736|NCT03806127|364619366|FG000|Overall Study|Covid 19 Restrictions|2|||
105715737|NCT03806127|364619367|FG001|Overall Study|Covid 19 Restrictions|0|||
105715738|NCT03806127|364619366|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
105715739|NCT03806127|364619367|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
105715740|NCT03806127|364619366|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
105715741|NCT03806127|364619367|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
105715742|NCT00454779|364619368|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
105715743|NCT00454779|364619369|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
105715744|NCT00454779|364619368|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
105715745|NCT00454779|364619369|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
105715746|NCT00454779|364619368|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
105715747|NCT00454779|364619369|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
105715748|NCT00454779|364619368|FG000|First-line Treatment Phase|Protocol Violation|0|||
105715749|NCT00454779|364619369|FG001|First-line Treatment Phase|Protocol Violation|1|||
105715750|NCT00454779|364619368|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
105715751|NCT00454779|364619369|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
105715752|NCT00454779|364619368|FG000|First-line Treatment Phase|Ongoing|1|||
105715753|NCT00454779|364619369|FG001|First-line Treatment Phase|Ongoing|0|||
105715754|NCT00454779|364619368|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
105715755|NCT00454779|364619369|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
105715756|NCT00454779|364619368|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
105715757|NCT00454779|364619369|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
105715758|NCT00454779|364619368|FG000|Second-line Treatment Phase|Ongoing|0|||
105715759|NCT00454779|364619369|FG001|Second-line Treatment Phase|Ongoing|1|||
105715760|NCT02397473|364619370|FG000|Treatment Phase|Adverse Event|1|||
105715761|NCT02397473|364619371|FG001|Treatment Phase|Adverse Event|2|||
105715762|NCT02397473|364619370|FG000|Treatment Phase|Lack of Efficacy|8|||
105715763|NCT02397473|364619371|FG001|Treatment Phase|Lack of Efficacy|1|||
105715764|NCT02397473|364619370|FG000|Treatment Phase|Lost to Follow-up|1|||
105715765|NCT02397473|364619371|FG001|Treatment Phase|Lost to Follow-up|0|||
105715766|NCT02397473|364619370|FG000|Treatment Phase|Withdrawal by Subject|2|||
105715767|NCT02397473|364619371|FG001|Treatment Phase|Withdrawal by Subject|1|||
105715768|NCT02397473|364619370|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
105715769|NCT02397473|364619371|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
105715770|NCT02397473|364619370|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
105715771|NCT02397473|364619371|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
105715772|NCT02397473|364619370|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
105715773|NCT02397473|364619371|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
105715774|NCT02397473|364619370|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
105715775|NCT02397473|364619371|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
105715776|NCT02397473|364619370|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
105715777|NCT02397473|364619371|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
105715778|NCT05425563|364619372|FG000|Overall Study|Withdrawal by Subject|17|||
105715779|NCT03634800|364619373|FG000|Overall Study|Adverse Event|1|||
105715780|NCT03634800|364619373|FG000|Overall Study|Disease Progression|4|||
105715781|NCT03634800|364619373|FG000|Overall Study|Withdrawal by Subject|1|||
105715782|NCT00643994|364619374|FG000|Overall Study|Death|24|||
105715783|NCT00643994|364619374|FG000|Overall Study|Lost to Follow-up|72|||
105715784|NCT00343512|364619377|FG000|Overall Study|Withdrawal by Subject|2|||
105715785|NCT00440726|364619381|FG000|Phase 1|Dose-Limiting Toxicity|0|||
105715786|NCT00440726|364619382|FG001|Phase 1|Dose-Limiting Toxicity|1|||
105715787|NCT00440726|364619383|FG002|Phase 1|Dose-Limiting Toxicity|0|||
105715788|NCT00440726|364619381|FG000|Phase 1|Physician Decision|1|||
105715789|NCT00440726|364619382|FG001|Phase 1|Physician Decision|0|||
105715790|NCT00440726|364619383|FG002|Phase 1|Physician Decision|0|||
105715791|NCT00440726|364619381|FG000|Phase 2|Death|0|||
105715792|NCT00440726|364619382|FG001|Phase 2|Death|0|||
105715793|NCT00440726|364619383|FG002|Phase 2|Death|1|||
105715794|NCT00440726|364619381|FG000|Phase 2|Adverse Event|0|||
105715795|NCT00440726|364619382|FG001|Phase 2|Adverse Event|0|||
105715796|NCT00440726|364619383|FG002|Phase 2|Adverse Event|1|||
105715797|NCT02167945|364619387|FG000|Overall Study|Adverse Event|16|||
105715798|NCT02167945|364619387|FG000|Overall Study|Withdrew Consent|42|||
105715799|NCT02167945|364619387|FG000|Overall Study|Lost to Follow-up|122|||
105715800|NCT02167945|364619387|FG000|Overall Study|COVID-19 logistical restrictions|6|||
105715801|NCT02167945|364619387|FG000|Overall Study|Other, not specified|63|||
105715802|NCT01554579|364619388|FG000|Overall Study|Adverse Event|6|||
105715803|NCT01554579|364619389|FG001|Overall Study|Adverse Event|25|||
105715804|NCT01554579|364619388|FG000|Overall Study|Lack of Efficacy|2|||
105715805|NCT01554579|364619389|FG001|Overall Study|Lack of Efficacy|1|||
105715806|NCT01554579|364619388|FG000|Overall Study|Withdrawal by Subject|2|||
105715807|NCT01554579|364619389|FG001|Overall Study|Withdrawal by Subject|1|||
105715808|NCT01192347|364619390|FG000|Overall Study|Death|3|||
105715809|NCT01192347|364619390|FG000|Overall Study|Lost to Follow-up|3|||
105715810|NCT01192347|364619390|FG000|Overall Study|Withdrawal by Subject|1|||
105715811|NCT01192347|364619390|FG000|Overall Study|Adverse Event|1|||
105715812|NCT01192347|364619390|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
105715813|NCT01192347|364619390|FG000|Overall Study|Patient seen in different hospital|1|||
105715814|NCT01192347|364619390|FG000|Overall Study|Patient not visiting hospital regularly|1|||
105715815|NCT01192347|364619390|FG000|Overall Study|Patient did not show up for visits|1|||
105715816|NCT00234039|364619391|FG000|Overall Study|Adverse Event|2|||
105715817|NCT00234039|364619391|FG000|Overall Study|Progression/relapse|34|||
105715818|NCT00234039|364619391|FG000|Overall Study|Other - Not Protocol Specified|3|||
105352304|NCT01483599|363293860|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
105715819|NCT00234039|364619391|FG000|Overall Study|Ineligible|9|||
105715820|NCT00234039|364619391|FG000|Overall Study|No Protocol Treatment Received|2|||
105715821|NCT01808612|364619392|FG000|Treatment Period|Adverse Event|8|||
105715822|NCT01808612|364619393|FG001|Treatment Period|Adverse Event|4|||
105715823|NCT01808612|364619394|FG002|Treatment Period|Adverse Event|3|||
105715824|NCT01808612|364619392|FG000|Treatment Period|Lost to Follow-up|2|||
105715825|NCT01808612|364619393|FG001|Treatment Period|Lost to Follow-up|2|||
105715826|NCT01808612|364619394|FG002|Treatment Period|Lost to Follow-up|1|||
105715827|NCT01808612|364619392|FG000|Treatment Period|Protocol Violation|1|||
105715828|NCT01808612|364619393|FG001|Treatment Period|Protocol Violation|0|||
105561769|NCT01256411|364052225|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
105561770|NCT01256411|364052226|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
105561771|NCT01256411|364052227|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
105789791|NCT01525407|364883430|FG001|Overall Study|Transplant was delayed|1|||
105789792|NCT01525407|364883429|FG000|Overall Study|Delay in Transplant|1|||
105789793|NCT01525407|364883430|FG001|Overall Study|Delay in Transplant|0|||
105789794|NCT05257109|364883431|FG000|Overall Study|Withdrawal by Subject|1|||
105561772|NCT01256411|364052228|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
105561773|NCT01256411|364052223|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
105561774|NCT01256411|364052224|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
105561775|NCT01256411|364052225|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
105561776|NCT01256411|364052226|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
105561777|NCT01256411|364052227|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
105561778|NCT01256411|364052228|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
105561779|NCT01256411|364052223|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
105561780|NCT01256411|364052224|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
105561781|NCT01256411|364052225|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
105715829|NCT01808612|364619394|FG002|Treatment Period|Protocol Violation|0|||
105715830|NCT01808612|364619392|FG000|Treatment Period|Withdrawal by Subject|1|||
105715831|NCT01808612|364619393|FG001|Treatment Period|Withdrawal by Subject|0|||
105715832|NCT01808612|364619394|FG002|Treatment Period|Withdrawal by Subject|4|||
105715833|NCT01808612|364619392|FG000|Treatment Period|Physician Decision|1|||
105715834|NCT01808612|364619393|FG001|Treatment Period|Physician Decision|0|||
105715835|NCT01808612|364619394|FG002|Treatment Period|Physician Decision|4|||
105715836|NCT01808612|364619392|FG000|Treatment Period|Sponsor Decision|1|||
105715837|NCT01808612|364619393|FG001|Treatment Period|Sponsor Decision|0|||
105561782|NCT01256411|364052226|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
105561783|NCT01256411|364052227|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
105561784|NCT01256411|364052228|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
105561785|NCT01256411|364052223|FG000|Extension by Maximum Treatment|Adverse Event|4|||
105789795|NCT05257109|364883432|FG001|Overall Study|Withdrawal by Subject|0|||
105789796|NCT05257109|364883433|FG002|Overall Study|Withdrawal by Subject|0|||
105789797|NCT05257109|364883434|FG003|Overall Study|Withdrawal by Subject|0|||
105715838|NCT01808612|364619394|FG002|Treatment Period|Sponsor Decision|0|||
105715839|NCT01808612|364619392|FG000|Treatment Period|Lack of Efficacy|1|||
105715840|NCT01808612|364619393|FG001|Treatment Period|Lack of Efficacy|1|||
105715841|NCT01808612|364619394|FG002|Treatment Period|Lack of Efficacy|2|||
105715842|NCT01808612|364619392|FG000|Discontinuation Period|Adverse Event|1|||
105715843|NCT01808612|364619393|FG001|Discontinuation Period|Adverse Event|0|||
105715844|NCT01808612|364619394|FG002|Discontinuation Period|Adverse Event|0|||
105715845|NCT01808612|364619392|FG000|Discontinuation Period|Physician Decision|1|||
105561786|NCT01256411|364052224|FG001|Extension by Maximum Treatment|Adverse Event|2|||
105715846|NCT01808612|364619393|FG001|Discontinuation Period|Physician Decision|0|||
105715847|NCT01808612|364619394|FG002|Discontinuation Period|Physician Decision|0|||
105789798|NCT00563706|364884920|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
105789799|NCT00563706|364884921|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
105715848|NCT01808612|364619392|FG000|Discontinuation Period|Lost to Follow-up|0|||
105715849|NCT01808612|364619393|FG001|Discontinuation Period|Lost to Follow-up|1|||
105715850|NCT01808612|364619394|FG002|Discontinuation Period|Lost to Follow-up|0|||
105715851|NCT03739528|364619396|FG000|Overall Study|Not treated|8|||
105715852|NCT03739528|364619397|FG001|Overall Study|Not treated|12|||
105715853|NCT03739528|364619396|FG000|Overall Study|Treatment and study discontinued|6|||
105715854|NCT03739528|364619397|FG001|Overall Study|Treatment and study discontinued|2|||
105715855|NCT03739528|364619396|FG000|Overall Study|Treatment discontinued + study completed|1|||
105715856|NCT03739528|364619397|FG001|Overall Study|Treatment discontinued + study completed|3|||
105715857|NCT01046695|364619398|FG000|Overall Study|Subject had a pacemaker|0|||
105715858|NCT01046695|364619399|FG001|Overall Study|Subject had a pacemaker|1|||
105715859|NCT01046695|364619398|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
105715860|NCT01046695|364619399|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
105715861|NCT04303000|364619400|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
105715862|NCT04303000|364619401|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
105715863|NCT04303000|364619402|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
105715864|NCT04178772|364619403|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
105715865|NCT04178772|364619403|FG000|Overall Study|study terminated early due to COVID-19|7|||
105715866|NCT00880256|364619410|FG000|Overall Study|Lost to Follow-up|28|||
105715867|NCT01225562|364619413|FG000|Overall Study|Withdrawal by Subject|52|||
105715868|NCT01225562|364619414|FG001|Overall Study|Withdrawal by Subject|50|||
105715869|NCT01225562|364619415|FG002|Overall Study|Withdrawal by Subject|52|||
105715870|NCT01225562|364619413|FG000|Overall Study|Lost to Follow-up|3|||
105715871|NCT01225562|364619414|FG001|Overall Study|Lost to Follow-up|6|||
105789800|NCT00563706|364884922|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
105789801|NCT00563706|364884923|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
105715872|NCT01225562|364619415|FG002|Overall Study|Lost to Follow-up|1|||
105715873|NCT02629159|364619420|FG000|Overall Study|Adverse Event|17|||
105715874|NCT02629159|364619421|FG001|Overall Study|Adverse Event|20|||
105715875|NCT02629159|364619422|FG002|Overall Study|Adverse Event|22|||
105715876|NCT02629159|364619420|FG000|Overall Study|Withdrawal by Subject|22|||
105715877|NCT02629159|364619421|FG001|Overall Study|Withdrawal by Subject|11|||
105715878|NCT02629159|364619422|FG002|Overall Study|Withdrawal by Subject|15|||
105715879|NCT02629159|364619420|FG000|Overall Study|Lost to Follow-up|7|||
105715880|NCT02629159|364619421|FG001|Overall Study|Lost to Follow-up|4|||
105715881|NCT02629159|364619422|FG002|Overall Study|Lost to Follow-up|5|||
105715882|NCT02629159|364619420|FG000|Overall Study|Lack of Efficacy|4|||
105715883|NCT02629159|364619421|FG001|Overall Study|Lack of Efficacy|0|||
105715884|NCT02629159|364619422|FG002|Overall Study|Lack of Efficacy|1|||
105715885|NCT02629159|364619420|FG000|Overall Study|Other|6|||
105715886|NCT02629159|364619421|FG001|Overall Study|Other|4|||
105715887|NCT02629159|364619422|FG002|Overall Study|Other|8|||
105715888|NCT00565617|364619423|FG000|Overall Study|Withdrawal by Subject|1|||
105715889|NCT01890421|364619424|FG000|Overall Study|Adverse Event|1|||
105715890|NCT01890421|364619424|FG000|Overall Study|Other reason|10|||
105715891|NCT01446419|364619425|FG000|Overall Study|Death|1|||
105715892|NCT01446419|364619426|FG001|Overall Study|Death|0|||
105715893|NCT01446419|364619425|FG000|Overall Study|Withdrawal by Subject|1|||
105715894|NCT01446419|364619426|FG001|Overall Study|Withdrawal by Subject|1|||
105715895|NCT01446419|364619425|FG000|Overall Study|Terminated per protocol|3|||
105715896|NCT01446419|364619426|FG001|Overall Study|Terminated per protocol|0|||
105715897|NCT00464178|364619427|FG000|Overall Study|Protocol Violation|1|||
105715898|NCT00464178|364619427|FG000|Overall Study|Withdrawal by Subject|1|||
105715899|NCT04506294|364619428|FG000|Overall Study|Lost to Follow-up|70|||
105715900|NCT04506294|364619429|FG001|Overall Study|Lost to Follow-up|20|||
105715901|NCT04506294|364619428|FG000|Overall Study|Withdrawal by Subject|16|||
105715902|NCT04506294|364619429|FG001|Overall Study|Withdrawal by Subject|2|||
105715903|NCT02317562|364619433|FG000|Overall Study|Physician Decision|1|||
105715904|NCT02317562|364619433|FG000|Overall Study|early termination of the study|8|||
105715905|NCT02317562|364619433|FG000|Overall Study|Lack of Efficacy|4|||
105715906|NCT02317562|364619433|FG000|Overall Study|Withdrawal by Subject|1|||
105715907|NCT00911989|364619434|FG000|Overall Study|Adverse Event|1|||
105715908|NCT02445586|364619437|FG000|Overall Study|Death|14|||
105715909|NCT02445586|364619437|FG000|Overall Study|Withdrawal by Subject|13|||
105715910|NCT02445586|364619437|FG000|Overall Study|Disease Progression|10|||
105715911|NCT02445586|364619437|FG000|Overall Study|Protocol Violation|1|||
105715912|NCT02445586|364619437|FG000|Overall Study|Medical Condition|1|||
105715913|NCT00428597|364619442|FG000|Overall Study|Randomized but not treated|3|||
105715914|NCT00428597|364619443|FG001|Overall Study|Randomized but not treated|3|||
105715915|NCT00428597|364619442|FG000|Overall Study|Objective Progression or Relapse|19|||
105715916|NCT00428597|364619443|FG001|Overall Study|Objective Progression or Relapse|47|||
105715917|NCT00428597|364619442|FG000|Overall Study|Study Terminated by Sponsor|41|||
105715918|NCT00428597|364619443|FG001|Overall Study|Study Terminated by Sponsor|16|||
105715919|NCT00428597|364619442|FG000|Overall Study|Adverse Event|15|||
105715920|NCT00428597|364619443|FG001|Overall Study|Adverse Event|7|||
105715921|NCT00428597|364619442|FG000|Overall Study|Global Deterioration of Health Status|1|||
105715922|NCT00428597|364619443|FG001|Overall Study|Global Deterioration of Health Status|5|||
105715923|NCT00428597|364619442|FG000|Overall Study|Protocol Violation|2|||
105715924|NCT00428597|364619443|FG001|Overall Study|Protocol Violation|1|||
105715925|NCT00428597|364619442|FG000|Overall Study|Withdrawal by Subject|2|||
105715926|NCT00428597|364619443|FG001|Overall Study|Withdrawal by Subject|1|||
105715927|NCT00428597|364619442|FG000|Overall Study|Other|1|||
105715928|NCT00428597|364619443|FG001|Overall Study|Other|1|||
105715929|NCT00428597|364619442|FG000|Overall Study|Lost to Follow-up|0|||
105715930|NCT00428597|364619443|FG001|Overall Study|Lost to Follow-up|1|||
105715931|NCT00428597|364619442|FG000|Overall Study|Pregnancy|1|||
105715932|NCT00428597|364619443|FG001|Overall Study|Pregnancy|0|||
105715933|NCT00428597|364619442|FG000|Overall Study|Death|1|||
105715934|NCT00428597|364619443|FG001|Overall Study|Death|3|||
105715935|NCT03519971|364619444|FG000|Overall Study|Death|142|||
105715936|NCT03519971|364619445|FG001|Overall Study|Death|69|||
105715937|NCT03519971|364619444|FG000|Overall Study|Lost to Follow-up|0|||
105715938|NCT03519971|364619445|FG001|Overall Study|Lost to Follow-up|1|||
105715939|NCT03519971|364619444|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
105715940|NCT03519971|364619445|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
105715941|NCT03519971|364619444|FG000|Overall Study|Withdrawal by Subject|3|||
105715942|NCT03519971|364619445|FG001|Overall Study|Withdrawal by Subject|2|||
105715943|NCT03519971|364619444|FG000|Overall Study|Other|1|||
105715944|NCT03519971|364619445|FG001|Overall Study|Other|0|||
105715945|NCT01078805|364619449|FG000|Overall Study|Clinically significant abnormal lab|5|||
105715946|NCT01078805|364619449|FG000|Overall Study|Death|134|||
105715947|NCT01078805|364619449|FG000|Overall Study|Lost to Follow-up|676|||
105715948|NCT01078805|364619449|FG000|Overall Study|Physician Decision|169|||
105715949|NCT01078805|364619449|FG000|Overall Study|Serious adverse event|26|||
105715950|NCT01078805|364619449|FG000|Overall Study|Sponsor decision|46|||
105715951|NCT01078805|364619449|FG000|Overall Study|Withdrawal by Subject|739|||
105715952|NCT01078805|364619449|FG000|Overall Study|Other|173|||
105715953|NCT01078805|364619449|FG000|Overall Study|Didn't take study drug|82|||
105715954|NCT01609842|364619450|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
105715955|NCT01609842|364619451|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
105715956|NCT05168267|364619452|FG000|Overall Study|Withdrawal by Subject|2|||
105715957|NCT05168267|364619453|FG001|Overall Study|Withdrawal by Subject|1|||
105715958|NCT05168267|364619452|FG000|Overall Study|Withdrawn by Therapist|1|||
105715959|NCT05168267|364619453|FG001|Overall Study|Withdrawn by Therapist|1|||
105715960|NCT05168267|364619452|FG000|Overall Study|Left Facility|1|||
105715961|NCT05168267|364619453|FG001|Overall Study|Left Facility|0|||
105715962|NCT05702736|364619461|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
105715963|NCT05702736|364619462|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
105715964|NCT05702736|364619461|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
105715965|NCT05702736|364619462|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
105715966|NCT01182428|364619463|FG000|Overall Study|Physician Decision|1|||
105715967|NCT01182428|364619464|FG001|Overall Study|Physician Decision|0|||
105715968|NCT01182428|364619463|FG000|Overall Study|Lost to Follow-up|9|||
105715969|NCT01182428|364619464|FG001|Overall Study|Lost to Follow-up|1|||
105715970|NCT01182428|364619463|FG000|Overall Study|Withdrawal by Subject|1|||
105715971|NCT01182428|364619464|FG001|Overall Study|Withdrawal by Subject|0|||
105715972|NCT03631706|364619465|FG000|Overall Study|Randomized, not treated|1|||
105715973|NCT03631706|364619466|FG001|Overall Study|Randomized, not treated|0|||
105715974|NCT04484285|364621711|FG000|Overall Study|Unable to operate stimulator|3|||
105715975|NCT04484285|364621712|FG001|Overall Study|Unable to operate stimulator|0|||
105715976|NCT06272370|364621713|FG000|Overall Study|Lost to Follow-up|0|||
105715977|NCT06272370|364621714|FG001|Overall Study|Lost to Follow-up|3|||
105715978|NCT06272370|364621715|FG002|Overall Study|Lost to Follow-up|1|||
105715979|NCT06272370|364621716|FG003|Overall Study|Lost to Follow-up|1|||
105715980|NCT05888103|364621717|FG000|Overall Study|Participant decision|3|||
105715981|NCT05888103|364621718|FG001|Overall Study|Participant decision|3|||
105715982|NCT04439175|364621719|FG000|Overall Study|Never started treatment|4|||
105715983|NCT04439175|364621719|FG000|Overall Study|Ineligible|5|||
105715984|NCT04439175|364621719|FG000|Overall Study|Adverse Event|6|||
105715985|NCT04439175|364621719|FG000|Overall Study|Death|4|||
105715986|NCT04439175|364621719|FG000|Overall Study|Disease progression|44|||
105715987|NCT04439175|364621719|FG000|Overall Study|Withdrawal by Subject|4|||
105715988|NCT04439175|364621719|FG000|Overall Study|Alternative Therapy|1|||
105715989|NCT04439175|364621719|FG000|Overall Study|Other|2|||
105715990|NCT05280756|364621720|FG000|Overall Study|Lost to Follow-up|1|||
105715991|NCT05280756|364621721|FG001|Overall Study|Lost to Follow-up|1|||
105715992|NCT02363478|364621726|FG000|Overall Study|Lost to Follow-up|4|||
105715993|NCT02363478|364621726|FG000|Overall Study|Adverse Event|4|||
105715994|NCT00542997|364621729|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
105715995|NCT00542997|364621729|FG000|Wash in / Wash Out Period|Adverse Event|3|||
105715996|NCT00542997|364621729|FG000|Efficacy Period|Adverse Event|3|||
105715997|NCT00352534|364621730|FG000|Initial Staging|Ineligible|8|||
105715998|NCT00352534|364621731|FG001|Initial Staging|Ineligible|9|||
105715999|NCT00352534|364621732|FG002|Initial Staging|Ineligible|0|||
105716000|NCT00352534|364621733|FG003|Initial Staging|Ineligible|0|||
105716001|NCT00352534|364621734|FG004|Initial Staging|Ineligible|0|||
105716002|NCT00352534|364621735|FG005|Initial Staging|Ineligible|0|||
105716003|NCT00352534|364621736|FG006|Initial Staging|Ineligible|0|||
105716004|NCT00352534|364621730|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
105716005|NCT00352534|364621731|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
105716006|NCT00352534|364621732|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
105716007|NCT00352534|364621733|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
105716008|NCT00352534|364621734|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
105716009|NCT00352534|364621735|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
105716010|NCT00352534|364621736|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
105716011|NCT00352534|364621730|FG000|Final Risk Group Assignment|Physician Decision|0|||
105716012|NCT00352534|364621731|FG001|Final Risk Group Assignment|Physician Decision|0|||
105716013|NCT00352534|364621732|FG002|Final Risk Group Assignment|Physician Decision|0|||
105716014|NCT00352534|364621733|FG003|Final Risk Group Assignment|Physician Decision|0|||
105716015|NCT00352534|364621734|FG004|Final Risk Group Assignment|Physician Decision|0|||
105716016|NCT00352534|364621735|FG005|Final Risk Group Assignment|Physician Decision|8|||
105716017|NCT00352534|364621736|FG006|Final Risk Group Assignment|Physician Decision|0|||
105716018|NCT00352534|364621730|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
105716019|NCT00352534|364621731|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
105716020|NCT00352534|364621732|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
105716021|NCT00352534|364621733|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
105716022|NCT00352534|364621734|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
105716023|NCT00352534|364621735|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
105716024|NCT00352534|364621736|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
105716025|NCT00352534|364621730|FG000|Final Risk Group Assignment|Ineligible|0|||
105716026|NCT00352534|364621731|FG001|Final Risk Group Assignment|Ineligible|0|||
105716027|NCT00352534|364621732|FG002|Final Risk Group Assignment|Ineligible|3|||
105716028|NCT00352534|364621733|FG003|Final Risk Group Assignment|Ineligible|1|||
105716029|NCT00352534|364621734|FG004|Final Risk Group Assignment|Ineligible|0|||
105716030|NCT00352534|364621735|FG005|Final Risk Group Assignment|Ineligible|13|||
105716031|NCT00352534|364621736|FG006|Final Risk Group Assignment|Ineligible|0|||
105716032|NCT00352534|364621730|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
105716033|NCT00352534|364621731|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
105716034|NCT00352534|364621732|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
105716035|NCT00352534|364621733|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
105716036|NCT00352534|364621734|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
105716037|NCT00352534|364621735|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
105716038|NCT00352534|364621736|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
105716039|NCT00352534|364621730|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
105716040|NCT00352534|364621731|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
105716041|NCT00352534|364621732|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
105716042|NCT00352534|364621733|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
105716043|NCT00352534|364621734|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
105716044|NCT00352534|364621735|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
105716045|NCT00352534|364621736|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
105716046|NCT00352534|364621730|FG000|Final Risk Group Assignment|Death|0|||
105716047|NCT00352534|364621731|FG001|Final Risk Group Assignment|Death|0|||
105716048|NCT00352534|364621732|FG002|Final Risk Group Assignment|Death|0|||
105716049|NCT00352534|364621733|FG003|Final Risk Group Assignment|Death|0|||
105716050|NCT00352534|364621734|FG004|Final Risk Group Assignment|Death|0|||
105716051|NCT00352534|364621735|FG005|Final Risk Group Assignment|Death|2|||
105716052|NCT00352534|364621736|FG006|Final Risk Group Assignment|Death|0|||
105716053|NCT01602341|364621739|FG000|Overall Study|Adverse Event|0|||
105716054|NCT01602341|364621740|FG001|Overall Study|Adverse Event|1|||
105716055|NCT01916980|364621741|FG000|Overall Study|Adverse Event|4|||
105716056|NCT01916980|364621742|FG001|Overall Study|Adverse Event|2|||
105716057|NCT01916980|364621741|FG000|Overall Study|Lack of Efficacy|2|||
105716058|NCT01916980|364621742|FG001|Overall Study|Lack of Efficacy|2|||
105716059|NCT01916980|364621741|FG000|Overall Study|Withdrawal by Subject|1|||
105716060|NCT01916980|364621742|FG001|Overall Study|Withdrawal by Subject|0|||
105716061|NCT02090855|364621743|FG000|Overall Study|no evaluable Standard of Truth results|2|||
105716062|NCT03786432|364621745|FG000|Overall Study|Screen Failure after consent|1|||
105716063|NCT03786432|364621745|FG000|Overall Study|Lost to Follow-up|4|||
105716064|NCT03786432|364621745|FG000|Overall Study|did not complete 12 month CT scan|1|||
105716065|NCT00388947|364621746|FG000|Overall Study|Protocol Violation|47|||
105716066|NCT03038308|364621747|FG000|Overall Study|Surgical resection|1|||
105716067|NCT03038308|364621747|FG000|Overall Study|Withdrawal by Subject|2|||
105716068|NCT03038308|364621747|FG000|Overall Study|Lost to Follow-up|1|||
105716069|NCT00544869|364621749|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
105716070|NCT00544869|364621750|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
105716071|NCT00544869|364621751|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
105716072|NCT00544869|364621749|FG000|Overall Study|Adverse Event|6|||
105716073|NCT00544869|364621750|FG001|Overall Study|Adverse Event|1|||
105716074|NCT00544869|364621751|FG002|Overall Study|Adverse Event|0|||
105716075|NCT00544869|364621749|FG000|Overall Study|Lack of Efficacy|1|||
105716076|NCT00544869|364621750|FG001|Overall Study|Lack of Efficacy|1|||
105716077|NCT00544869|364621751|FG002|Overall Study|Lack of Efficacy|0|||
105716078|NCT00544869|364621749|FG000|Overall Study|Physician Decision|2|||
105716079|NCT00544869|364621750|FG001|Overall Study|Physician Decision|0|||
105716080|NCT00544869|364621751|FG002|Overall Study|Physician Decision|0|||
105716081|NCT00619502|364621752|FG000|Overall Study|Lost to Follow-up|8|||
105716082|NCT00619502|364621753|FG001|Overall Study|Lost to Follow-up|10|||
105716083|NCT01354028|364621754|FG000|Overall Study|Physician Decision|0|||
105716084|NCT01354028|364621755|FG001|Overall Study|Physician Decision|2|||
105716085|NCT01354028|364621754|FG000|Overall Study|Discharged before study start|2|||
105716086|NCT01354028|364621755|FG001|Overall Study|Discharged before study start|2|||
105716087|NCT01354028|364621754|FG000|Overall Study|No quiet alert state|0|||
105716088|NCT01354028|364621755|FG001|Overall Study|No quiet alert state|1|||
105716089|NCT00667576|364621756|FG000|Overall Study|Withdrawal by Subject|1|||
105716090|NCT00667576|364621757|FG001|Overall Study|Withdrawal by Subject|0|||
105716091|NCT00667576|364621758|FG002|Overall Study|Withdrawal by Subject|1|||
105716092|NCT00667576|364621759|FG003|Overall Study|Withdrawal by Subject|1|||
105716093|NCT00667576|364621760|FG004|Overall Study|Withdrawal by Subject|1|||
105716094|NCT00667576|364621756|FG000|Overall Study|Adverse Event|1|||
105716095|NCT00667576|364621757|FG001|Overall Study|Adverse Event|1|||
105716096|NCT00667576|364621758|FG002|Overall Study|Adverse Event|0|||
105716097|NCT00667576|364621759|FG003|Overall Study|Adverse Event|0|||
105716098|NCT00667576|364621760|FG004|Overall Study|Adverse Event|0|||
105716099|NCT00667576|364621756|FG000|Overall Study|Lost to Follow-up|0|||
105716100|NCT00667576|364621757|FG001|Overall Study|Lost to Follow-up|0|||
105716101|NCT00667576|364621758|FG002|Overall Study|Lost to Follow-up|1|||
105716102|NCT00667576|364621759|FG003|Overall Study|Lost to Follow-up|0|||
105716103|NCT00667576|364621760|FG004|Overall Study|Lost to Follow-up|0|||
105716104|NCT00667576|364621756|FG000|Overall Study|Protocol Violation|0|||
105716105|NCT00667576|364621757|FG001|Overall Study|Protocol Violation|0|||
105716106|NCT00667576|364621758|FG002|Overall Study|Protocol Violation|0|||
105716107|NCT00667576|364621759|FG003|Overall Study|Protocol Violation|1|||
105716108|NCT00667576|364621760|FG004|Overall Study|Protocol Violation|0|||
105716109|NCT00667576|364621756|FG000|Overall Study|Physician Decision|0|||
105716110|NCT00667576|364621757|FG001|Overall Study|Physician Decision|0|||
105716111|NCT00667576|364621758|FG002|Overall Study|Physician Decision|0|||
105716112|NCT00667576|364621759|FG003|Overall Study|Physician Decision|1|||
105716113|NCT00667576|364621760|FG004|Overall Study|Physician Decision|0|||
105716114|NCT00667576|364621756|FG000|Overall Study|Missed Visit|0|||
105716115|NCT00667576|364621757|FG001|Overall Study|Missed Visit|0|||
105716116|NCT00667576|364621758|FG002|Overall Study|Missed Visit|0|||
105716117|NCT00667576|364621759|FG003|Overall Study|Missed Visit|1|||
105716118|NCT00667576|364621760|FG004|Overall Study|Missed Visit|0|||
105716119|NCT03968419|364621761|FG000|Treatment Period|Adverse Event|0|||
105716120|NCT03968419|364621762|FG001|Treatment Period|Adverse Event|0|||
105716121|NCT03968419|364621763|FG002|Treatment Period|Adverse Event|1|||
105716122|NCT03968419|364621761|FG000|Safety Follow-up Period|Death|3|||
105716123|NCT03968419|364621762|FG001|Safety Follow-up Period|Death|2|||
105716124|NCT03968419|364621763|FG002|Safety Follow-up Period|Death|1|||
105716125|NCT03968419|364621761|FG000|Safety Follow-up Period|Subject Decision|2|||
105716126|NCT03968419|364621762|FG001|Safety Follow-up Period|Subject Decision|1|||
105716127|NCT03968419|364621763|FG002|Safety Follow-up Period|Subject Decision|0|||
105716128|NCT00925600|364621764|FG000|Overall Study|Withdrawal by Subject|16|||
105716129|NCT00925600|364621765|FG001|Overall Study|Withdrawal by Subject|14|||
105716130|NCT00925600|364621764|FG000|Overall Study|Death|4|||
105716131|NCT00925600|364621765|FG001|Overall Study|Death|3|||
105716132|NCT00925600|364621764|FG000|Overall Study|Lost to Follow-up|2|||
105716133|NCT00925600|364621765|FG001|Overall Study|Lost to Follow-up|2|||
105716134|NCT00925600|364621764|FG000|Overall Study|Disease Progression|1|||
105716135|NCT00925600|364621765|FG001|Overall Study|Disease Progression|3|||
105716136|NCT00925600|364621764|FG000|Overall Study|Administrative Decision|1|||
105716137|NCT00925600|364621765|FG001|Overall Study|Administrative Decision|1|||
105716138|NCT00925600|364621764|FG000|Overall Study|Noncompliance|2|||
105716139|NCT00925600|364621765|FG001|Overall Study|Noncompliance|0|||
105716140|NCT00925600|364621764|FG000|Overall Study|Ineligibility Determined|2|||
105716141|NCT00925600|364621765|FG001|Overall Study|Ineligibility Determined|0|||
105716142|NCT00925600|364621764|FG000|Overall Study|Protocol Deviation|0|||
105716143|NCT00925600|364621765|FG001|Overall Study|Protocol Deviation|1|||
105789802|NCT00563706|364884924|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
105716144|NCT00925600|364621764|FG000|Overall Study|Requirement for Alternative Therapy|0|||
105716145|NCT00925600|364621765|FG001|Overall Study|Requirement for Alternative Therapy|1|||
105716146|NCT00925600|364621764|FG000|Overall Study|Other|3|||
105716147|NCT00925600|364621765|FG001|Overall Study|Other|1|||
105716148|NCT00925600|364621764|FG000|Overall Study|Adverse Event|1|||
105716149|NCT00925600|364621765|FG001|Overall Study|Adverse Event|2|||
105716150|NCT05512949|364621766|FG000|Overall Study|Lost to Follow-up|4|||
105716151|NCT05512949|364621767|FG001|Overall Study|Lost to Follow-up|6|||
105716152|NCT05512949|364621768|FG002|Overall Study|Lost to Follow-up|2|||
105716153|NCT05512949|364621766|FG000|Overall Study|Protocol Violation|0|||
105716154|NCT05512949|364621767|FG001|Overall Study|Protocol Violation|0|||
105716155|NCT05512949|364621768|FG002|Overall Study|Protocol Violation|1|||
105716156|NCT05512949|364621766|FG000|Overall Study|Withdrawal by Subject|1|||
105716157|NCT05512949|364621767|FG001|Overall Study|Withdrawal by Subject|1|||
105716158|NCT05512949|364621768|FG002|Overall Study|Withdrawal by Subject|2|||
105716159|NCT05512949|364621766|FG000|Overall Study|Completion status unknown|1|||
105716160|NCT05512949|364621767|FG001|Overall Study|Completion status unknown|3|||
105716161|NCT05512949|364621768|FG002|Overall Study|Completion status unknown|0|||
105716162|NCT03593915|364621769|FG000|Overall Study|Adverse Event|0|||
105716163|NCT03593915|364621770|FG001|Overall Study|Adverse Event|0|||
105716164|NCT03593915|364621771|FG002|Overall Study|Adverse Event|0|||
105716165|NCT03593915|364621772|FG003|Overall Study|Adverse Event|1|||
105716166|NCT03593915|364621773|FG004|Overall Study|Adverse Event|0|||
105716167|NCT03593915|364621774|FG005|Overall Study|Adverse Event|0|||
105716168|NCT03593915|364621769|FG000|Overall Study|Physician Decision|0|||
105716169|NCT03593915|364621770|FG001|Overall Study|Physician Decision|0|||
105716170|NCT03593915|364621771|FG002|Overall Study|Physician Decision|0|||
105716171|NCT03593915|364621772|FG003|Overall Study|Physician Decision|0|||
105716172|NCT03593915|364621773|FG004|Overall Study|Physician Decision|0|||
105716173|NCT03593915|364621774|FG005|Overall Study|Physician Decision|1|||
105716174|NCT02002975|364621775|FG000|Overall Study|Case Report Forms Uncollected|135|||
105716175|NCT02002975|364621775|FG000|Overall Study|Protocol Deviation|437|||
105716176|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
105716177|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
105716178|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
105716179|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
105716180|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
105716181|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
105716182|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
105716183|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
105716184|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
105716185|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
105789803|NCT00563706|364884925|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
105789804|NCT00563706|364884926|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
105789805|NCT00563706|364884927|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
105716186|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
105716187|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
105716188|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
105716189|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
105716190|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
105716191|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
105716192|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
105716193|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
105716194|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
105716195|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
105716196|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
105716197|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
105716198|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
105789806|NCT00563706|364884928|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
105561787|NCT01256411|364052225|FG002|Extension by Maximum Treatment|Adverse Event|1|||
105561788|NCT01256411|364052226|FG003|Extension by Maximum Treatment|Adverse Event|0|||
105716199|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
105716200|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
105716201|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
105716202|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
105716203|NCT04660643|364621776|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
105716204|NCT04660643|364621777|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
105716205|NCT04660643|364621778|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
105716206|NCT04660643|364621776|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
105716207|NCT04660643|364621777|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
105716208|NCT04660643|364621778|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
105716209|NCT04660643|364621776|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
105716210|NCT04660643|364621777|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
105716211|NCT04660643|364621778|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
105716212|NCT04660643|364621776|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
105716213|NCT04660643|364621777|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
105716214|NCT04660643|364621778|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
105716215|NCT04660643|364621776|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
105716216|NCT04660643|364621777|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
105716217|NCT04660643|364621778|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
105716218|NCT04660643|364621776|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
105716219|NCT04660643|364621777|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
105716220|NCT04660643|364621778|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
105716221|NCT04660643|364621776|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
105716222|NCT04660643|364621777|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
105716223|NCT04660643|364621778|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
105716224|NCT00167245|364621783|FG000|Overall Study|Lost to Follow-up|20|||
105716225|NCT00167245|364621784|FG001|Overall Study|Lost to Follow-up|31|||
105716226|NCT00167245|364621783|FG000|Overall Study|Withdrawal by Subject|5|||
105716227|NCT00167245|364621784|FG001|Overall Study|Withdrawal by Subject|8|||
105716228|NCT00167245|364621783|FG000|Overall Study|Incarcerated|3|||
105716229|NCT00167245|364621784|FG001|Overall Study|Incarcerated|2|||
105716230|NCT00167245|364621783|FG000|Overall Study|Drowsy|1|||
105716231|NCT00167245|364621784|FG001|Overall Study|Drowsy|0|||
105716232|NCT01307033|364621785|FG000|8-week Double-blind Period|Adverse Event|2|||
105716233|NCT01307033|364621786|FG001|8-week Double-blind Period|Adverse Event|0|||
105716234|NCT01307033|364621787|FG002|8-week Double-blind Period|Adverse Event|0|||
105716235|NCT01307033|364621788|FG003|8-week Double-blind Period|Adverse Event|0|||
105561789|NCT01256411|364052227|FG004|Extension by Maximum Treatment|Adverse Event|0|||
105716236|NCT01307033|364621785|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
105716237|NCT01307033|364621786|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
105716238|NCT01307033|364621787|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
105716239|NCT01307033|364621788|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
105716240|NCT01307033|364621785|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
105716241|NCT01307033|364621786|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
105716242|NCT01307033|364621787|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
105716243|NCT01307033|364621788|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
105716244|NCT01307033|364621785|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
105716245|NCT01307033|364621786|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
105716246|NCT01307033|364621787|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
105716247|NCT01307033|364621788|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
105716248|NCT01307033|364621785|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
105716249|NCT01307033|364621786|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
105716250|NCT01307033|364621787|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
105716251|NCT01307033|364621788|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
105716252|NCT01307033|364621785|FG000|44-week Open-label Extension|Adverse Event|0|||
105716253|NCT01307033|364621786|FG001|44-week Open-label Extension|Adverse Event|0|||
105716254|NCT01307033|364621787|FG002|44-week Open-label Extension|Adverse Event|2|||
105716255|NCT01307033|364621788|FG003|44-week Open-label Extension|Adverse Event|1|||
105716256|NCT01307033|364621785|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
105716257|NCT01307033|364621786|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
105716258|NCT01307033|364621787|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
105716259|NCT01307033|364621788|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
105716260|NCT01307033|364621785|FG000|44-week Open-label Extension|Physician Decision|0|||
105716261|NCT01307033|364621786|FG001|44-week Open-label Extension|Physician Decision|0|||
105789807|NCT00563706|364884920|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
105789808|NCT00563706|364884921|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
105789809|NCT00563706|364884922|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
105716262|NCT01307033|364621787|FG002|44-week Open-label Extension|Physician Decision|1|||
105716263|NCT01307033|364621788|FG003|44-week Open-label Extension|Physician Decision|0|||
105716264|NCT01307033|364621785|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
105716265|NCT01307033|364621786|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
105716266|NCT01307033|364621787|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
105789810|NCT00563706|364884923|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
105561790|NCT01256411|364052228|FG005|Extension by Maximum Treatment|Adverse Event|0|||
105561791|NCT01256411|364052223|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
105561792|NCT01256411|364052224|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
105561793|NCT01256411|364052225|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
105561794|NCT01256411|364052226|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
105561795|NCT01256411|364052227|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
105561796|NCT01256411|364052228|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
105561797|NCT01256411|364052223|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
105561798|NCT01256411|364052224|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
105561799|NCT01256411|364052225|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
105561800|NCT01256411|364052226|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
105561801|NCT01256411|364052227|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
105561802|NCT01256411|364052228|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
105561803|NCT01256411|364052223|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
105561804|NCT01256411|364052224|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
105561805|NCT01256411|364052225|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
105561806|NCT01256411|364052226|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
105561807|NCT01256411|364052227|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
105561808|NCT01256411|364052228|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
105561809|NCT01256411|364052223|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
105561810|NCT01256411|364052224|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
105561811|NCT01256411|364052225|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
105561812|NCT01256411|364052226|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
105561813|NCT01256411|364052227|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
105561814|NCT01256411|364052228|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
105561815|NCT01256411|364052223|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
105561816|NCT01256411|364052224|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
105561817|NCT01256411|364052225|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
105561818|NCT01256411|364052226|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
105561819|NCT01256411|364052227|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
105561820|NCT01256411|364052228|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
105561821|NCT04721925|364052229|FG000|2-Month Assessment|Lost to Follow-up|5|||
105561822|NCT04721925|364052230|FG001|2-Month Assessment|Lost to Follow-up|3|||
105561823|NCT04721925|364052229|FG000|4-Month Assessment|Lost to Follow-up|3|||
105561824|NCT04721925|364052230|FG001|4-Month Assessment|Lost to Follow-up|6|||
105561825|NCT00929162|364052232|FG000|Overall Study|Adverse Event|8|||
105561826|NCT00929162|364052233|FG001|Overall Study|Adverse Event|5|||
105561827|NCT00929162|364052232|FG000|Overall Study|Withdrawal by Subject|3|||
105561828|NCT00929162|364052233|FG001|Overall Study|Withdrawal by Subject|1|||
105561829|NCT00929162|364052232|FG000|Overall Study|Protocol Violation|32|||
105561830|NCT00929162|364052233|FG001|Overall Study|Protocol Violation|30|||
105561831|NCT00929162|364052232|FG000|Overall Study|Other termination reason|5|||
105561832|NCT00929162|364052233|FG001|Overall Study|Other termination reason|6|||
105561833|NCT01362439|364052236|FG000|Overall Study|Adverse Event|1|||
105561834|NCT01362439|364052236|FG000|Overall Study|Lack of Efficacy|3|||
105561835|NCT01362439|364052236|FG000|Overall Study|Lost to Follow-up|2|||
105561836|NCT01362439|364052236|FG000|Overall Study|Study medication non-compliant|1|||
105561837|NCT01362439|364052236|FG000|Overall Study|Participant who withdrew consent|8|||
105561838|NCT02454101|364052237|FG000|Overall Study|Adverse Event|2|||
105561839|NCT02454101|364052238|FG001|Overall Study|Adverse Event|3|||
105561840|NCT02454101|364052237|FG000|Overall Study|Lost to Follow-up|3|||
105561841|NCT02454101|364052238|FG001|Overall Study|Lost to Follow-up|4|||
105561842|NCT02342886|364052239|FG000|Overall Study|Treatment non-compliance|1|||
105561843|NCT02342886|364052240|FG001|Overall Study|Treatment non-compliance|0|||
105716267|NCT01307033|364621788|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
105716268|NCT01307033|364621785|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
105716269|NCT01307033|364621786|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
105716270|NCT01307033|364621787|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
105716271|NCT01307033|364621788|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
105716272|NCT01307033|364621785|FG000|44-week Open-label Extension|Death|0|||
105716273|NCT01307033|364621786|FG001|44-week Open-label Extension|Death|0|||
105716274|NCT01307033|364621787|FG002|44-week Open-label Extension|Death|0|||
105716275|NCT01307033|364621788|FG003|44-week Open-label Extension|Death|1|||
105716276|NCT01231555|364621789|FG000|Overall Study|Study terminated|8|||
105716277|NCT01231555|364621790|FG001|Overall Study|Study terminated|5|||
105716278|NCT01231555|364621791|FG002|Overall Study|Study terminated|8|||
105716279|NCT01231555|364621789|FG000|Overall Study|Withdrawal by Subject|0|||
105716280|NCT01231555|364621790|FG001|Overall Study|Withdrawal by Subject|2|||
105789811|NCT00563706|364884924|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
105716281|NCT01231555|364621791|FG002|Overall Study|Withdrawal by Subject|0|||
105716282|NCT00804687|364621792|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
105716283|NCT00804687|364621793|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
105716284|NCT00804687|364621794|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
105716285|NCT00804687|364621795|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
105716286|NCT00804687|364621796|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
105716287|NCT00804687|364621797|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
105716288|NCT00804687|364621792|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
105716289|NCT00804687|364621793|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
105716290|NCT00804687|364621794|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
105716291|NCT00804687|364621795|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
105716292|NCT00804687|364621796|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
105716293|NCT00804687|364621797|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
105716294|NCT00804687|364621792|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
105716295|NCT00804687|364621793|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
105716296|NCT00804687|364621794|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
105789812|NCT00563706|364884925|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
105789813|NCT00563706|364884926|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
105789814|NCT00563706|364884927|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
105789815|NCT00563706|364884928|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
105789816|NCT00563706|364884920|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
105789817|NCT00563706|364884921|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
105789818|NCT00563706|364884922|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
105789819|NCT00563706|364884923|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
105789820|NCT00563706|364884924|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
105789821|NCT00563706|364884925|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
105789822|NCT00563706|364884926|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
105789823|NCT00563706|364884927|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
105789824|NCT00563706|364884928|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
105789825|NCT00563706|364884920|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
105789826|NCT00563706|364884921|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
105789827|NCT00563706|364884922|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
105789828|NCT00563706|364884923|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
105789829|NCT00563706|364884924|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
105789830|NCT00563706|364884925|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
105789831|NCT00563706|364884926|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
105789832|NCT00563706|364884927|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
105789833|NCT00563706|364884928|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
105789834|NCT00563706|364884920|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
105789835|NCT00563706|364884921|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
105789836|NCT00563706|364884922|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
105716297|NCT00804687|364621795|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
105716298|NCT00804687|364621796|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
105716299|NCT00804687|364621797|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
105716300|NCT00804687|364621792|FG000|Period 5: Treatment Period|Positive drug test|1|||
105716301|NCT00804687|364621793|FG001|Period 5: Treatment Period|Positive drug test|0|||
105716302|NCT00804687|364621794|FG002|Period 5: Treatment Period|Positive drug test|0|||
105716303|NCT00804687|364621795|FG003|Period 5: Treatment Period|Positive drug test|0|||
105716304|NCT00804687|364621796|FG004|Period 5: Treatment Period|Positive drug test|0|||
105716305|NCT00804687|364621797|FG005|Period 5: Treatment Period|Positive drug test|0|||
105716306|NCT00947531|364621798|FG000|Overall Study|Withdrawal by Subject|10|||
105716307|NCT00947531|364621799|FG001|Overall Study|Withdrawal by Subject|7|||
105789837|NCT00563706|364884923|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
105789838|NCT00563706|364884924|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
105789839|NCT00563706|364884925|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
105789840|NCT00563706|364884926|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
105716308|NCT00947531|364621798|FG000|Overall Study|Administrative Reason|0|||
105716309|NCT00947531|364621799|FG001|Overall Study|Administrative Reason|1|||
105716310|NCT00947531|364621798|FG000|Overall Study|Adverse Event|2|||
105716311|NCT00947531|364621799|FG001|Overall Study|Adverse Event|2|||
105716312|NCT00947531|364621798|FG000|Overall Study|Lack of Efficacy|1|||
105716313|NCT00947531|364621799|FG001|Overall Study|Lack of Efficacy|0|||
105716314|NCT00947531|364621798|FG000|Overall Study|Other|1|||
105716315|NCT00947531|364621799|FG001|Overall Study|Other|1|||
105716316|NCT01773421|364621801|FG000|Treatment Phase|Other|0|||
105716317|NCT01773421|364621802|FG001|Treatment Phase|Other|0|||
105716318|NCT01773421|364621803|FG002|Treatment Phase|Other|2|||
105716319|NCT01773421|364621804|FG003|Treatment Phase|Other|0|||
105716320|NCT01773421|364621805|FG004|Treatment Phase|Other|0|||
105716321|NCT01773421|364621806|FG005|Treatment Phase|Other|0|||
105716322|NCT01773421|364621807|FG006|Treatment Phase|Other|0|||
105716323|NCT01773421|364621801|FG000|Treatment Phase|Adverse Event|0|||
105716324|NCT01773421|364621802|FG001|Treatment Phase|Adverse Event|0|||
105716325|NCT01773421|364621803|FG002|Treatment Phase|Adverse Event|3|||
105716326|NCT01773421|364621804|FG003|Treatment Phase|Adverse Event|1|||
105716327|NCT01773421|364621805|FG004|Treatment Phase|Adverse Event|0|||
105716328|NCT01773421|364621806|FG005|Treatment Phase|Adverse Event|0|||
105716329|NCT01773421|364621807|FG006|Treatment Phase|Adverse Event|0|||
105716330|NCT01773421|364621801|FG000|Treatment Phase|Withdrawal by Subject|0|||
105716331|NCT01773421|364621802|FG001|Treatment Phase|Withdrawal by Subject|0|||
105716332|NCT01773421|364621803|FG002|Treatment Phase|Withdrawal by Subject|1|||
105716333|NCT01773421|364621804|FG003|Treatment Phase|Withdrawal by Subject|1|||
105716334|NCT01773421|364621805|FG004|Treatment Phase|Withdrawal by Subject|0|||
105716335|NCT01773421|364621806|FG005|Treatment Phase|Withdrawal by Subject|0|||
105716336|NCT01773421|364621807|FG006|Treatment Phase|Withdrawal by Subject|0|||
105716337|NCT01773421|364621801|FG000|Extension Phase|Other|0|||
105716338|NCT01773421|364621802|FG001|Extension Phase|Other|0|||
105716339|NCT01773421|364621803|FG002|Extension Phase|Other|0|||
105716340|NCT01773421|364621804|FG003|Extension Phase|Other|0|||
105716341|NCT01773421|364621805|FG004|Extension Phase|Other|1|||
105716342|NCT01773421|364621806|FG005|Extension Phase|Other|2|||
105716343|NCT01773421|364621807|FG006|Extension Phase|Other|0|||
105716344|NCT01773421|364621801|FG000|Extension Phase|Adverse Event|0|||
105716345|NCT01773421|364621802|FG001|Extension Phase|Adverse Event|0|||
105716346|NCT01773421|364621803|FG002|Extension Phase|Adverse Event|0|||
105716347|NCT01773421|364621804|FG003|Extension Phase|Adverse Event|0|||
105716348|NCT01773421|364621805|FG004|Extension Phase|Adverse Event|2|||
105716349|NCT01773421|364621806|FG005|Extension Phase|Adverse Event|0|||
105716350|NCT01773421|364621807|FG006|Extension Phase|Adverse Event|0|||
105716351|NCT02327260|364621808|FG000|Overall Study|Lost to Follow-up|2|||
105716352|NCT02327260|364621809|FG001|Overall Study|Lost to Follow-up|3|||
105716353|NCT02327260|364621810|FG002|Overall Study|Lost to Follow-up|2|||
105716354|NCT02327260|364621808|FG000|Overall Study|invalid phone number|1|||
105716355|NCT02327260|364621809|FG001|Overall Study|invalid phone number|1|||
105716356|NCT02327260|364621810|FG002|Overall Study|invalid phone number|0|||
105716357|NCT02327260|364621808|FG000|Overall Study|non-adherence to protocol|2|||
105716358|NCT02327260|364621809|FG001|Overall Study|non-adherence to protocol|0|||
105789841|NCT00563706|364884927|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
105716359|NCT02327260|364621810|FG002|Overall Study|non-adherence to protocol|0|||
105716360|NCT02327260|364621808|FG000|Overall Study|cognitive concerns|1|||
105716361|NCT02327260|364621809|FG001|Overall Study|cognitive concerns|0|||
105716362|NCT02327260|364621810|FG002|Overall Study|cognitive concerns|0|||
105716363|NCT00688909|364621811|FG000|Overall Study|Adverse Event|28|||
105716364|NCT00688909|364621811|FG000|Overall Study|Patient withdrew consent|2|||
105716365|NCT00688909|364621811|FG000|Overall Study|Administrative problems|1|||
105716366|NCT00688909|364621811|FG000|Overall Study|Protocol Violation|2|||
105716367|NCT01220414|364621814|FG000|Overall Study|Withdrawal by Subject|1|||
105716368|NCT01220414|364621815|FG001|Overall Study|Withdrawal by Subject|0|||
105716369|NCT01220414|364621816|FG002|Overall Study|Withdrawal by Subject|0|||
105716370|NCT01220414|364621817|FG003|Overall Study|Withdrawal by Subject|1|||
105716371|NCT02804763|364621818|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
105716372|NCT02804763|364621819|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
105477408|NCT01578850|363759334|FG000|Period 2|Unspecified Reasons|0|||
105716373|NCT02804763|364621820|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
105716374|NCT02804763|364621821|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
105716375|NCT02804763|364621818|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
105716376|NCT02804763|364621819|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
105716377|NCT02804763|364621820|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
105716378|NCT02804763|364621821|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
105716379|NCT02804763|364621818|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
105716380|NCT02804763|364621819|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
105716381|NCT02804763|364621820|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
105716382|NCT02804763|364621821|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
105716383|NCT02804763|364621818|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
105716384|NCT02804763|364621819|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
105716385|NCT02804763|364621820|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
105716386|NCT02804763|364621821|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
105716387|NCT02804763|364621818|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
105716388|NCT02804763|364621819|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
105716389|NCT02804763|364621820|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
105716390|NCT02804763|364621821|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
105716391|NCT02804763|364621818|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
105716392|NCT02804763|364621819|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
105716393|NCT02804763|364621820|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
105716394|NCT02804763|364621821|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
105716395|NCT00700180|364621838|FG000|Overall Study|Death|99|||
105716396|NCT00700180|364621839|FG001|Overall Study|Death|114|||
105716397|NCT00700180|364621838|FG000|Overall Study|Alive on treatment|5|||
105716398|NCT00700180|364621839|FG001|Overall Study|Alive on treatment|3|||
105716399|NCT00700180|364621838|FG000|Overall Study|Alive in follow-up|46|||
105716400|NCT00700180|364621839|FG001|Overall Study|Alive in follow-up|27|||
105716401|NCT00700180|364621838|FG000|Overall Study|Lost to Follow-up|4|||
105716402|NCT00700180|364621839|FG001|Overall Study|Lost to Follow-up|5|||
105716403|NCT02939131|364621841|FG000|Overall Study|Unable to get to clinic|6|||
105716404|NCT02939131|364621842|FG001|Overall Study|Unable to get to clinic|4|||
105716405|NCT02939131|364621841|FG000|Overall Study|Lost to Follow-up|2|||
105716406|NCT02939131|364621842|FG001|Overall Study|Lost to Follow-up|4|||
105716407|NCT02939131|364621841|FG000|Overall Study|severe debilitation|1|||
105716408|NCT02939131|364621842|FG001|Overall Study|severe debilitation|0|||
105716409|NCT02939131|364621841|FG000|Overall Study|Other|0|||
105716410|NCT02939131|364621842|FG001|Overall Study|Other|1|||
105716411|NCT02939131|364621841|FG000|Overall Study|not willing to adhere to protocol|2|||
105716412|NCT02939131|364621842|FG001|Overall Study|not willing to adhere to protocol|0|||
105716413|NCT03588741|364621843|FG000|Overall Study|Withdrawal by Subject|1|||
105716414|NCT03706365|364621845|FG000|Overall Study|Lost to Follow-up|7|||
105716415|NCT03706365|364621846|FG001|Overall Study|Lost to Follow-up|0|||
105716416|NCT03706365|364621845|FG000|Overall Study|Withdrawal by Subject|17|||
105716417|NCT03706365|364621846|FG001|Overall Study|Withdrawal by Subject|15|||
105716418|NCT03706365|364621845|FG000|Overall Study|On Study Treatment|51|||
105716419|NCT03706365|364621846|FG001|Overall Study|On Study Treatment|51|||
105716420|NCT00793793|364621847|FG000|Overall Study|Adverse Event|0|||
105716421|NCT00793793|364621848|FG001|Overall Study|Adverse Event|0|||
105716422|NCT00793793|364621849|FG002|Overall Study|Adverse Event|1|||
105716423|NCT00793793|364621850|FG003|Overall Study|Adverse Event|1|||
105716424|NCT00793793|364621851|FG004|Overall Study|Adverse Event|0|||
105716425|NCT00793793|364621852|FG005|Overall Study|Adverse Event|1|||
105716426|NCT00793793|364621853|FG006|Overall Study|Adverse Event|2|||
105716427|NCT00793793|364621854|FG007|Overall Study|Adverse Event|0|||
105716428|NCT00793793|364621855|FG008|Overall Study|Adverse Event|0|||
105716429|NCT00793793|364621856|FG009|Overall Study|Adverse Event|0|||
105716430|NCT00793793|364621857|FG010|Overall Study|Adverse Event|0|||
105716431|NCT00793793|364621858|FG011|Overall Study|Adverse Event|2|||
105716432|NCT00793793|364621847|FG000|Overall Study|Protocol Violation|0|||
105716433|NCT00793793|364621848|FG001|Overall Study|Protocol Violation|0|||
105716434|NCT00793793|364621849|FG002|Overall Study|Protocol Violation|0|||
105789842|NCT00563706|364884928|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
105789843|NCT00706901|364884933|FG000|Overall Study|Lost to Follow-up|2|||
105789844|NCT00706901|364884934|FG001|Overall Study|Lost to Follow-up|3|||
105789845|NCT00706901|364884935|FG002|Overall Study|Lost to Follow-up|2|||
105789846|NCT00706901|364884933|FG000|Overall Study|Withdrawal by Subject|4|||
105789847|NCT00706901|364884934|FG001|Overall Study|Withdrawal by Subject|2|||
105789848|NCT00706901|364884935|FG002|Overall Study|Withdrawal by Subject|5|||
105789849|NCT00706901|364884933|FG000|Overall Study|In Jail|1|||
105789850|NCT00706901|364884934|FG001|Overall Study|In Jail|0|||
105789851|NCT00706901|364884935|FG002|Overall Study|In Jail|1|||
105789852|NCT00706901|364884933|FG000|Overall Study|Death|1|||
105716435|NCT00793793|364621850|FG003|Overall Study|Protocol Violation|1|||
105716436|NCT00793793|364621851|FG004|Overall Study|Protocol Violation|0|||
105716437|NCT00793793|364621852|FG005|Overall Study|Protocol Violation|0|||
105716438|NCT00793793|364621853|FG006|Overall Study|Protocol Violation|0|||
105716439|NCT00793793|364621854|FG007|Overall Study|Protocol Violation|0|||
105716440|NCT00793793|364621855|FG008|Overall Study|Protocol Violation|0|||
105716441|NCT00793793|364621856|FG009|Overall Study|Protocol Violation|0|||
105716442|NCT00793793|364621857|FG010|Overall Study|Protocol Violation|0|||
105716443|NCT00793793|364621858|FG011|Overall Study|Protocol Violation|0|||
105716444|NCT00793793|364621847|FG000|Overall Study|Lost to Follow-up|0|||
105716445|NCT00793793|364621848|FG001|Overall Study|Lost to Follow-up|0|||
105716446|NCT00793793|364621849|FG002|Overall Study|Lost to Follow-up|1|||
105716447|NCT00793793|364621850|FG003|Overall Study|Lost to Follow-up|0|||
105716448|NCT00793793|364621851|FG004|Overall Study|Lost to Follow-up|0|||
105716449|NCT00793793|364621852|FG005|Overall Study|Lost to Follow-up|0|||
105716450|NCT00793793|364621853|FG006|Overall Study|Lost to Follow-up|0|||
105716451|NCT00793793|364621854|FG007|Overall Study|Lost to Follow-up|0|||
105716452|NCT00793793|364621855|FG008|Overall Study|Lost to Follow-up|1|||
105716453|NCT00793793|364621856|FG009|Overall Study|Lost to Follow-up|3|||
105716454|NCT00793793|364621857|FG010|Overall Study|Lost to Follow-up|1|||
105716455|NCT00793793|364621858|FG011|Overall Study|Lost to Follow-up|0|||
105716456|NCT00793793|364621847|FG000|Overall Study|Withdrawal by Subject|0|||
105716457|NCT00793793|364621848|FG001|Overall Study|Withdrawal by Subject|0|||
105716458|NCT00793793|364621849|FG002|Overall Study|Withdrawal by Subject|0|||
105716459|NCT00793793|364621850|FG003|Overall Study|Withdrawal by Subject|0|||
105716460|NCT00793793|364621851|FG004|Overall Study|Withdrawal by Subject|1|||
105716461|NCT00793793|364621852|FG005|Overall Study|Withdrawal by Subject|0|||
105716462|NCT00793793|364621853|FG006|Overall Study|Withdrawal by Subject|0|||
105716463|NCT00793793|364621854|FG007|Overall Study|Withdrawal by Subject|0|||
105716464|NCT00793793|364621855|FG008|Overall Study|Withdrawal by Subject|1|||
105716465|NCT00793793|364621856|FG009|Overall Study|Withdrawal by Subject|0|||
105716466|NCT00793793|364621857|FG010|Overall Study|Withdrawal by Subject|0|||
105716467|NCT00793793|364621858|FG011|Overall Study|Withdrawal by Subject|0|||
105716468|NCT00793793|364621847|FG000|Overall Study|reason not specified|0|||
105716469|NCT00793793|364621848|FG001|Overall Study|reason not specified|1|||
105716470|NCT00793793|364621849|FG002|Overall Study|reason not specified|0|||
105716471|NCT00793793|364621850|FG003|Overall Study|reason not specified|1|||
105716472|NCT00793793|364621851|FG004|Overall Study|reason not specified|1|||
105716473|NCT00793793|364621852|FG005|Overall Study|reason not specified|1|||
105716474|NCT00793793|364621853|FG006|Overall Study|reason not specified|2|||
105716475|NCT00793793|364621854|FG007|Overall Study|reason not specified|0|||
105716476|NCT00793793|364621855|FG008|Overall Study|reason not specified|7|||
105716477|NCT00793793|364621856|FG009|Overall Study|reason not specified|6|||
105716478|NCT00793793|364621857|FG010|Overall Study|reason not specified|2|||
105716479|NCT00793793|364621858|FG011|Overall Study|reason not specified|4|||
105716480|NCT02487108|364621859|FG000|Overall Study|Adverse Event|1|||
105716481|NCT02487108|364621860|FG001|Overall Study|Adverse Event|6|||
105716482|NCT02487108|364621861|FG002|Overall Study|Adverse Event|12|||
105716483|NCT02487108|364621862|FG003|Overall Study|Adverse Event|6|||
105789853|NCT00706901|364884934|FG001|Overall Study|Death|0|||
105789854|NCT00706901|364884935|FG002|Overall Study|Death|0|||
105716484|NCT02487108|364621859|FG000|Overall Study|Withdrawal by Subject|8|||
105716485|NCT02487108|364621860|FG001|Overall Study|Withdrawal by Subject|5|||
105716486|NCT02487108|364621861|FG002|Overall Study|Withdrawal by Subject|5|||
105716487|NCT02487108|364621862|FG003|Overall Study|Withdrawal by Subject|0|||
105716488|NCT02487108|364621859|FG000|Overall Study|Non-compliance to study medication|3|||
105716489|NCT02487108|364621860|FG001|Overall Study|Non-compliance to study medication|2|||
105716490|NCT02487108|364621861|FG002|Overall Study|Non-compliance to study medication|5|||
105789855|NCT01646268|364884936|FG000|Overall Study|Adverse Event|6|||
105789856|NCT01646268|364884937|FG001|Overall Study|Adverse Event|7|||
105789857|NCT01646268|364884936|FG000|Overall Study|Lack of Efficacy|1|||
105789858|NCT01646268|364884937|FG001|Overall Study|Lack of Efficacy|3|||
105789859|NCT01646268|364884936|FG000|Overall Study|Protocol Violation|0|||
105716491|NCT02487108|364621862|FG003|Overall Study|Non-compliance to study medication|4|||
105716492|NCT02487108|364621859|FG000|Overall Study|Protocol Violation|1|||
105716493|NCT02487108|364621860|FG001|Overall Study|Protocol Violation|1|||
105716494|NCT02487108|364621861|FG002|Overall Study|Protocol Violation|2|||
105716495|NCT02487108|364621862|FG003|Overall Study|Protocol Violation|0|||
105716496|NCT02487108|364621859|FG000|Overall Study|Non-compliance to study procedures|0|||
105716497|NCT02487108|364621860|FG001|Overall Study|Non-compliance to study procedures|0|||
105716498|NCT02487108|364621861|FG002|Overall Study|Non-compliance to study procedures|0|||
105716499|NCT02487108|364621862|FG003|Overall Study|Non-compliance to study procedures|1|||
105716500|NCT02487108|364621859|FG000|Overall Study|Other than specified|3|||
105716501|NCT02487108|364621860|FG001|Overall Study|Other than specified|2|||
105716502|NCT02487108|364621861|FG002|Overall Study|Other than specified|2|||
105716503|NCT02487108|364621862|FG003|Overall Study|Other than specified|0|||
105716504|NCT00469612|364621863|FG000|Overall Study|Study terminated before data collected|2|||
105716505|NCT00469612|364621864|FG001|Overall Study|Study terminated before data collected|0|||
105716506|NCT02720757|364621865|FG000|Overall Study|Other reason|5|||
105716507|NCT02720757|364621865|FG000|Overall Study|Loss of contact|4|||
105716508|NCT02720757|364621865|FG000|Overall Study|Informed consent withdrawal|1|||
105716509|NCT02720757|364621865|FG000|Overall Study|Patients wish to withdraw|2|||
105716510|NCT02720757|364621865|FG000|Overall Study|Missing|3|||
105716511|NCT02720757|364621865|FG000|Overall Study|General exclusion|3|||
105716512|NCT00463476|364621866|FG000|Overall Study|Withdrawal by Subject|1|||
105716513|NCT00463476|364621867|FG001|Overall Study|Withdrawal by Subject|2|||
105789860|NCT01646268|364884937|FG001|Overall Study|Protocol Violation|1|||
105789861|NCT01646268|364884936|FG000|Overall Study|Withdrawal by Subject|2|||
105716514|NCT00463476|364621866|FG000|Overall Study|Lost to Follow-up|1|||
105716515|NCT00463476|364621867|FG001|Overall Study|Lost to Follow-up|1|||
105716516|NCT01001702|364621868|FG000|Overall Study|Lost to Follow-up|7|||
105716517|NCT01001702|364621868|FG000|Overall Study|Adverse Event|7|||
105716518|NCT01001702|364621868|FG000|Overall Study|Sponsor Discontinued Study|4|||
105716519|NCT01001702|364621868|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
105789862|NCT01646268|364884937|FG001|Overall Study|Withdrawal by Subject|5|||
105716520|NCT01001702|364621868|FG000|Overall Study|Investigator withdrew Subject|10|||
105716521|NCT01001702|364621868|FG000|Overall Study|Withdrawal by Subject|19|||
105716522|NCT01001702|364621868|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
105716523|NCT02624492|364621869|FG000|Overall Study|Adverse Event|2|||
105716524|NCT02624492|364621870|FG001|Overall Study|Adverse Event|2|||
105716525|NCT02624492|364621871|FG002|Overall Study|Adverse Event|2|||
105716526|NCT02624492|364621869|FG000|Overall Study|Progressive disease|0|||
105716527|NCT02624492|364621870|FG001|Overall Study|Progressive disease|2|||
105716528|NCT02624492|364621871|FG002|Overall Study|Progressive disease|3|||
105716529|NCT03653390|364621872|FG000|Overall Study|Lost to Follow-up|12|||
105716530|NCT03653390|364621873|FG001|Overall Study|Lost to Follow-up|8|||
105716531|NCT03653390|364621874|FG002|Overall Study|Lost to Follow-up|7|||
105716532|NCT03653390|364621872|FG000|Overall Study|Withdrawal by Subject|6|||
105716533|NCT03653390|364621873|FG001|Overall Study|Withdrawal by Subject|1|||
105716534|NCT03653390|364621874|FG002|Overall Study|Withdrawal by Subject|1|||
105716535|NCT03653390|364621872|FG000|Overall Study|Death|1|||
105716536|NCT03653390|364621873|FG001|Overall Study|Death|0|||
105716537|NCT03653390|364621874|FG002|Overall Study|Death|0|||
105716538|NCT03653390|364621872|FG000|Overall Study|Paper Survey Lost|1|||
105716539|NCT03653390|364621873|FG001|Overall Study|Paper Survey Lost|0|||
105716540|NCT03653390|364621874|FG002|Overall Study|Paper Survey Lost|0|||
105716541|NCT05099640|364621877|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
105716542|NCT05099640|364621878|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
105716543|NCT05099640|364621879|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
105716544|NCT05099640|364621877|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
105716545|NCT05099640|364621878|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
105789863|NCT01646268|364884936|FG000|Overall Study|Other|2|||
105789864|NCT01646268|364884937|FG001|Overall Study|Other|0|||
105789865|NCT01519635|364884942|FG000|Overall Study|Withdrawal by Subject|0|||
105789866|NCT01519635|364884943|FG001|Overall Study|Withdrawal by Subject|1|||
105789867|NCT01519635|364884942|FG000|Overall Study|No possibility to put a catheter|1|||
105789868|NCT01519635|364884943|FG001|Overall Study|No possibility to put a catheter|2|||
105789869|NCT00594568|364884945|FG000|Initial Treatment|Adverse Event|51|||
105789870|NCT00594568|364884946|FG001|Initial Treatment|Adverse Event|121|||
105789871|NCT00594568|364884947|FG002|Initial Treatment|Adverse Event|144|||
105789872|NCT00594568|364884945|FG000|Initial Treatment|Death|6|||
105789873|NCT00594568|364884946|FG001|Initial Treatment|Death|11|||
105789874|NCT00594568|364884947|FG002|Initial Treatment|Death|15|||
105789875|NCT00594568|364884945|FG000|Initial Treatment|Lost to Follow-up|4|||
105789876|NCT00594568|364884946|FG001|Initial Treatment|Lost to Follow-up|1|||
105789877|NCT00594568|364884947|FG002|Initial Treatment|Lost to Follow-up|4|||
105789878|NCT00594568|364884945|FG000|Initial Treatment|Physician Decision|3|||
105789879|NCT00594568|364884946|FG001|Initial Treatment|Physician Decision|2|||
105789880|NCT00594568|364884947|FG002|Initial Treatment|Physician Decision|4|||
105789881|NCT00594568|364884945|FG000|Initial Treatment|Protocol Violation|2|||
105789882|NCT00594568|364884946|FG001|Initial Treatment|Protocol Violation|2|||
105789883|NCT00594568|364884947|FG002|Initial Treatment|Protocol Violation|5|||
105716546|NCT05099640|364621879|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
105716547|NCT05099640|364621877|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
105716548|NCT05099640|364621878|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
105716549|NCT05099640|364621879|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
105716550|NCT05099640|364621877|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
105716551|NCT05099640|364621878|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
105716552|NCT05099640|364621879|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
105716553|NCT05099640|364621877|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
105716554|NCT05099640|364621878|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
105716555|NCT05099640|364621879|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
105716556|NCT05099640|364621877|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
105716557|NCT05099640|364621878|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
105716558|NCT05099640|364621879|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
105789884|NCT00594568|364884945|FG000|Initial Treatment|Withdrawal by Subject|25|||
105789885|NCT00594568|364884946|FG001|Initial Treatment|Withdrawal by Subject|31|||
105789886|NCT00594568|364884947|FG002|Initial Treatment|Withdrawal by Subject|46|||
105789887|NCT00594568|364884945|FG000|Initial Treatment|Sponsor decision|193|||
105789888|NCT00594568|364884946|FG001|Initial Treatment|Sponsor decision|142|||
105789889|NCT00594568|364884947|FG002|Initial Treatment|Sponsor decision|147|||
105789890|NCT00594568|364884945|FG000|Initial Treatment|Caregiver decision|21|||
105789891|NCT00594568|364884946|FG001|Initial Treatment|Caregiver decision|36|||
105789892|NCT00594568|364884947|FG002|Initial Treatment|Caregiver decision|36|||
105716559|NCT03882424|364621880|FG000|Overall Study|Lost to Follow-up|3|||
105716560|NCT03882424|364621881|FG001|Overall Study|Lost to Follow-up|0|||
105716561|NCT03882424|364621882|FG002|Overall Study|Lost to Follow-up|0|||
105716562|NCT03882424|364621880|FG000|Overall Study|schedule conflict|1|||
105716563|NCT03882424|364621881|FG001|Overall Study|schedule conflict|0|||
105716564|NCT03882424|364621882|FG002|Overall Study|schedule conflict|0|||
105716565|NCT00236080|364621883|FG000|Overall Study|Adverse Event|0|||
105789893|NCT00594568|364884945|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
105789894|NCT00594568|364884946|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
105789895|NCT00594568|364884947|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
105789896|NCT00594568|364884945|FG000|Initial Treatment|Entry criteria exclusion|0|||
105789897|NCT00594568|364884946|FG001|Initial Treatment|Entry criteria exclusion|1|||
105716566|NCT00236080|364621884|FG001|Overall Study|Adverse Event|0|||
105716567|NCT00236080|364621885|FG002|Overall Study|Adverse Event|3|||
105716568|NCT00236080|364621886|FG003|Overall Study|Adverse Event|1|||
105716569|NCT00236080|364621887|FG004|Overall Study|Adverse Event|0|||
105716570|NCT00236080|364621883|FG000|Overall Study|Lost to Follow-up|0|||
105716571|NCT00236080|364621884|FG001|Overall Study|Lost to Follow-up|1|||
105716572|NCT00236080|364621885|FG002|Overall Study|Lost to Follow-up|0|||
105716573|NCT00236080|364621886|FG003|Overall Study|Lost to Follow-up|0|||
105716574|NCT00236080|364621887|FG004|Overall Study|Lost to Follow-up|0|||
105789898|NCT00594568|364884947|FG002|Initial Treatment|Entry criteria exclusion|1|||
105789899|NCT00594568|364884945|FG000|Delayed Start|Death|0|||
105789900|NCT00594568|364884946|FG001|Delayed Start|Death|0|||
105789901|NCT00594568|364884947|FG002|Delayed Start|Death|1|||
105789902|NCT00594568|364884945|FG000|Delayed Start|Adverse Event|12|||
105789903|NCT00594568|364884946|FG001|Delayed Start|Adverse Event|2|||
105789904|NCT00594568|364884947|FG002|Delayed Start|Adverse Event|2|||
105789905|NCT00594568|364884945|FG000|Delayed Start|Withdrawal by Subject|4|||
105789906|NCT00594568|364884946|FG001|Delayed Start|Withdrawal by Subject|3|||
105789907|NCT00594568|364884947|FG002|Delayed Start|Withdrawal by Subject|0|||
105789908|NCT00594568|364884945|FG000|Delayed Start|Physician Decision|0|||
105789909|NCT00594568|364884946|FG001|Delayed Start|Physician Decision|0|||
105716575|NCT00236080|364621883|FG000|Overall Study|Physician Decision|1|||
105716576|NCT00236080|364621884|FG001|Overall Study|Physician Decision|0|||
105716577|NCT00236080|364621885|FG002|Overall Study|Physician Decision|1|||
105716578|NCT00236080|364621886|FG003|Overall Study|Physician Decision|1|||
105716579|NCT00236080|364621887|FG004|Overall Study|Physician Decision|1|||
105716580|NCT00236080|364621883|FG000|Overall Study|Withdrawal by Subject|1|||
105716581|NCT00236080|364621884|FG001|Overall Study|Withdrawal by Subject|0|||
105716582|NCT00236080|364621885|FG002|Overall Study|Withdrawal by Subject|0|||
105716583|NCT00236080|364621886|FG003|Overall Study|Withdrawal by Subject|0|||
105716584|NCT00236080|364621887|FG004|Overall Study|Withdrawal by Subject|0|||
105716585|NCT00236080|364621883|FG000|Overall Study|Miscellaneous|0|||
105716586|NCT00236080|364621884|FG001|Overall Study|Miscellaneous|0|||
105716587|NCT00236080|364621885|FG002|Overall Study|Miscellaneous|1|||
105716588|NCT00236080|364621886|FG003|Overall Study|Miscellaneous|0|||
105716589|NCT00236080|364621887|FG004|Overall Study|Miscellaneous|0|||
105716590|NCT02400255|364621888|FG000|Overall Study|Relapse|4|||
105716591|NCT02400255|364621889|FG001|Overall Study|Relapse|1|||
105716592|NCT02400255|364621890|FG002|Overall Study|Relapse|1|||
105716593|NCT02400255|364621891|FG003|Overall Study|Relapse|2|||
105716594|NCT02400255|364621888|FG000|Overall Study|Adverse Event|6|||
105716595|NCT02400255|364621889|FG001|Overall Study|Adverse Event|3|||
105716596|NCT02400255|364621890|FG002|Overall Study|Adverse Event|0|||
105716597|NCT02400255|364621891|FG003|Overall Study|Adverse Event|0|||
105716598|NCT02400255|364621888|FG000|Overall Study|Physician Decision|6|||
105716599|NCT02400255|364621889|FG001|Overall Study|Physician Decision|0|||
105716600|NCT02400255|364621890|FG002|Overall Study|Physician Decision|0|||
105716601|NCT02400255|364621891|FG003|Overall Study|Physician Decision|0|||
105716602|NCT02400255|364621888|FG000|Overall Study|Loss of insurance|1|||
105716603|NCT02400255|364621889|FG001|Overall Study|Loss of insurance|0|||
105716604|NCT02400255|364621890|FG002|Overall Study|Loss of insurance|0|||
105716605|NCT02400255|364621891|FG003|Overall Study|Loss of insurance|0|||
105716606|NCT01214044|364621892|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
105716607|NCT01214044|364621892|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
105716608|NCT01214044|364621892|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
105716609|NCT01214044|364621892|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
105716610|NCT01214044|364621892|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
105716611|NCT01214044|364621892|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
105716612|NCT00944034|364621893|FG000|Overall Study|Inappropriate enrollment|0|||
105716613|NCT00944034|364621894|FG001|Overall Study|Inappropriate enrollment|1|||
105716614|NCT00944034|364621895|FG002|Overall Study|Inappropriate enrollment|0|||
105716615|NCT00944034|364621896|FG003|Overall Study|Inappropriate enrollment|1|||
105716616|NCT00944034|364621897|FG004|Overall Study|Inappropriate enrollment|2|||
105716617|NCT00944034|364621898|FG005|Overall Study|Inappropriate enrollment|1|||
105716618|NCT00944034|364621899|FG006|Overall Study|Inappropriate enrollment|0|||
105716619|NCT00944034|364621900|FG007|Overall Study|Inappropriate enrollment|0|||
105716620|NCT00944034|364621901|FG008|Overall Study|Inappropriate enrollment|1|||
105716621|NCT00944034|364621902|FG009|Overall Study|Inappropriate enrollment|1|||
105716622|NCT00944034|364621903|FG010|Overall Study|Inappropriate enrollment|0|||
105716623|NCT00944034|364621904|FG011|Overall Study|Inappropriate enrollment|0|||
105716624|NCT00944034|364621893|FG000|Overall Study|Withdrawal by Subject|3|||
105716625|NCT00944034|364621894|FG001|Overall Study|Withdrawal by Subject|2|||
105716626|NCT00944034|364621895|FG002|Overall Study|Withdrawal by Subject|6|||
105716627|NCT00944034|364621896|FG003|Overall Study|Withdrawal by Subject|2|||
105716628|NCT00944034|364621897|FG004|Overall Study|Withdrawal by Subject|5|||
105716629|NCT00944034|364621898|FG005|Overall Study|Withdrawal by Subject|8|||
105789910|NCT00594568|364884947|FG002|Delayed Start|Physician Decision|1|||
105789911|NCT00594568|364884945|FG000|Delayed Start|Lost to Follow-up|0|||
105789912|NCT00594568|364884946|FG001|Delayed Start|Lost to Follow-up|0|||
105789913|NCT00594568|364884947|FG002|Delayed Start|Lost to Follow-up|1|||
105789914|NCT00594568|364884945|FG000|Delayed Start|Caregiver Decision|5|||
105789915|NCT00594568|364884946|FG001|Delayed Start|Caregiver Decision|6|||
105789916|NCT00594568|364884947|FG002|Delayed Start|Caregiver Decision|2|||
105789917|NCT00594568|364884945|FG000|Delayed Start|Sponsor Decision|77|||
105789918|NCT00594568|364884946|FG001|Delayed Start|Sponsor Decision|66|||
105789919|NCT00594568|364884947|FG002|Delayed Start|Sponsor Decision|59|||
105716630|NCT00944034|364621899|FG006|Overall Study|Withdrawal by Subject|2|||
105716631|NCT00944034|364621900|FG007|Overall Study|Withdrawal by Subject|2|||
105716632|NCT00944034|364621901|FG008|Overall Study|Withdrawal by Subject|3|||
105716633|NCT00944034|364621902|FG009|Overall Study|Withdrawal by Subject|4|||
105716634|NCT00944034|364621903|FG010|Overall Study|Withdrawal by Subject|0|||
105716635|NCT00944034|364621904|FG011|Overall Study|Withdrawal by Subject|4|||
105716636|NCT00944034|364621893|FG000|Overall Study|Lost to Follow-up|0|||
105716637|NCT00944034|364621894|FG001|Overall Study|Lost to Follow-up|4|||
105716638|NCT00944034|364621895|FG002|Overall Study|Lost to Follow-up|2|||
105716639|NCT00944034|364621896|FG003|Overall Study|Lost to Follow-up|0|||
105789920|NCT00594568|364884945|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
105789921|NCT00594568|364884946|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
105789922|NCT00594568|364884947|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
105789923|NCT00594568|364884945|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
105789924|NCT00594568|364884946|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
105789925|NCT00594568|364884947|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
105789926|NCT00594568|364884945|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
105789927|NCT00594568|364884946|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
105789928|NCT00594568|364884947|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
105789929|NCT00594568|364884945|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
105789930|NCT00594568|364884946|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
105789931|NCT00594568|364884947|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
105789932|NCT00594568|364884945|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
105789933|NCT00594568|364884946|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
105789934|NCT00594568|364884947|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
105789935|NCT00594568|364884945|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
105789936|NCT00594568|364884946|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
105789937|NCT00594568|364884947|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
105789938|NCT04478994|364884948|FG000|Overall Study|Withdrawal by Subject|1|||
105789939|NCT04478994|364884949|FG001|Overall Study|Withdrawal by Subject|1|||
105716640|NCT00944034|364621897|FG004|Overall Study|Lost to Follow-up|5|||
105716641|NCT00944034|364621898|FG005|Overall Study|Lost to Follow-up|7|||
105716642|NCT00944034|364621899|FG006|Overall Study|Lost to Follow-up|0|||
105716643|NCT00944034|364621900|FG007|Overall Study|Lost to Follow-up|1|||
105716644|NCT00944034|364621901|FG008|Overall Study|Lost to Follow-up|5|||
105789940|NCT00299546|364884950|FG000|Overall Study|Death|3|||
105789941|NCT00299546|364884951|FG001|Overall Study|Death|2|||
105789942|NCT00299546|364884952|FG002|Overall Study|Death|0|||
105789943|NCT00299546|364884950|FG000|Overall Study|Lost to Follow-up|2|||
105789944|NCT00299546|364884951|FG001|Overall Study|Lost to Follow-up|2|||
105789945|NCT00299546|364884952|FG002|Overall Study|Lost to Follow-up|5|||
105789946|NCT00299546|364884950|FG000|Overall Study|Adverse Event|37|||
105789947|NCT00299546|364884951|FG001|Overall Study|Adverse Event|22|||
105789948|NCT00299546|364884952|FG002|Overall Study|Adverse Event|27|||
105789949|NCT00299546|364884950|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
105789950|NCT00299546|364884951|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
105789951|NCT00299546|364884952|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
105716645|NCT00944034|364621902|FG009|Overall Study|Lost to Follow-up|1|||
105716646|NCT00944034|364621903|FG010|Overall Study|Lost to Follow-up|1|||
105716647|NCT00944034|364621904|FG011|Overall Study|Lost to Follow-up|0|||
105716648|NCT00944034|364621893|FG000|Overall Study|Death|0|||
105716649|NCT00944034|364621894|FG001|Overall Study|Death|0|||
105716650|NCT00944034|364621895|FG002|Overall Study|Death|1|||
105716651|NCT00944034|364621896|FG003|Overall Study|Death|0|||
105789952|NCT00299546|364884950|FG000|Overall Study|Other|24|||
105716652|NCT00944034|364621897|FG004|Overall Study|Death|0|||
105716653|NCT00944034|364621898|FG005|Overall Study|Death|0|||
105716654|NCT00944034|364621899|FG006|Overall Study|Death|0|||
105789953|NCT00299546|364884951|FG001|Overall Study|Other|26|||
105789954|NCT00299546|364884952|FG002|Overall Study|Other|19|||
105789955|NCT00299546|364884950|FG000|Overall Study|Not treated|0|||
105789956|NCT00299546|364884951|FG001|Overall Study|Not treated|1|||
105789957|NCT00299546|364884952|FG002|Overall Study|Not treated|1|||
105789958|NCT03099265|364884953|FG000|Overall Study|Adverse Event|1|||
105789959|NCT01656850|364884958|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
105716655|NCT00944034|364621900|FG007|Overall Study|Death|0|||
105716656|NCT00944034|364621901|FG008|Overall Study|Death|0|||
105716657|NCT00944034|364621902|FG009|Overall Study|Death|0|||
105716658|NCT00944034|364621903|FG010|Overall Study|Death|0|||
105716659|NCT00944034|364621904|FG011|Overall Study|Death|0|||
105716660|NCT00944034|364621893|FG000|Overall Study|Protocol Violation|2|||
105716661|NCT00944034|364621894|FG001|Overall Study|Protocol Violation|0|||
105716662|NCT00944034|364621895|FG002|Overall Study|Protocol Violation|0|||
105716663|NCT00944034|364621896|FG003|Overall Study|Protocol Violation|1|||
105716664|NCT00944034|364621897|FG004|Overall Study|Protocol Violation|2|||
105716665|NCT00944034|364621898|FG005|Overall Study|Protocol Violation|3|||
105716666|NCT00944034|364621899|FG006|Overall Study|Protocol Violation|0|||
105716667|NCT00944034|364621900|FG007|Overall Study|Protocol Violation|1|||
105716668|NCT00944034|364621901|FG008|Overall Study|Protocol Violation|1|||
105716669|NCT00944034|364621902|FG009|Overall Study|Protocol Violation|4|||
105716670|NCT00944034|364621903|FG010|Overall Study|Protocol Violation|0|||
105716671|NCT00944034|364621904|FG011|Overall Study|Protocol Violation|0|||
105716672|NCT00944034|364621893|FG000|Overall Study|Unable to classify|0|||
105716673|NCT00944034|364621894|FG001|Overall Study|Unable to classify|0|||
105716674|NCT00944034|364621895|FG002|Overall Study|Unable to classify|0|||
105716675|NCT00944034|364621896|FG003|Overall Study|Unable to classify|0|||
105716676|NCT00944034|364621897|FG004|Overall Study|Unable to classify|0|||
105716677|NCT00944034|364621898|FG005|Overall Study|Unable to classify|1|||
105716678|NCT00944034|364621899|FG006|Overall Study|Unable to classify|1|||
105716679|NCT00944034|364621900|FG007|Overall Study|Unable to classify|1|||
105716680|NCT00944034|364621901|FG008|Overall Study|Unable to classify|0|||
105716681|NCT00944034|364621902|FG009|Overall Study|Unable to classify|0|||
105716682|NCT00944034|364621903|FG010|Overall Study|Unable to classify|0|||
105716683|NCT00944034|364621904|FG011|Overall Study|Unable to classify|0|||
105716684|NCT00944034|364621893|FG000|Overall Study|Administrative reason|0|||
105716685|NCT00944034|364621894|FG001|Overall Study|Administrative reason|0|||
105716686|NCT00944034|364621895|FG002|Overall Study|Administrative reason|0|||
105716687|NCT00944034|364621896|FG003|Overall Study|Administrative reason|0|||
105716688|NCT00944034|364621897|FG004|Overall Study|Administrative reason|0|||
105716689|NCT00944034|364621898|FG005|Overall Study|Administrative reason|0|||
105716690|NCT00944034|364621899|FG006|Overall Study|Administrative reason|1|||
105716691|NCT00944034|364621900|FG007|Overall Study|Administrative reason|0|||
105716692|NCT00944034|364621901|FG008|Overall Study|Administrative reason|0|||
105716693|NCT00944034|364621902|FG009|Overall Study|Administrative reason|0|||
105716694|NCT00944034|364621903|FG010|Overall Study|Administrative reason|0|||
105716695|NCT00944034|364621904|FG011|Overall Study|Administrative reason|0|||
105716696|NCT01961544|364621905|FG000|Overall Study|Protocol Violation|1|||
105716697|NCT01961544|364621905|FG000|Overall Study|Withdrawal by Subject|7|||
105716698|NCT01961544|364621905|FG000|Overall Study|Adverse Event|1|||
105716699|NCT01961544|364621905|FG000|Overall Study|Physician Decision|2|||
105716700|NCT01961544|364621905|FG000|Overall Study|Poor Tolerance|1|||
105716701|NCT01961544|364621905|FG000|Overall Study|Aggravation of Steral Pain|1|||
105716702|NCT01500057|364621908|FG000|Overall Study|Lost to Follow-up|6|||
105716703|NCT01500057|364621909|FG001|Overall Study|Lost to Follow-up|4|||
105716704|NCT01960855|364621911|FG000|Overall Study|Subject noncompliant|1|||
105716705|NCT01960855|364621912|FG001|Overall Study|Subject noncompliant|0|||
105716706|NCT01960855|364621913|FG002|Overall Study|Subject noncompliant|0|||
105716707|NCT01960855|364621914|FG003|Overall Study|Subject noncompliant|0|||
105716708|NCT01960855|364621915|FG004|Overall Study|Subject noncompliant|0|||
105716709|NCT01960855|364621911|FG000|Overall Study|Adverse Event|2|||
105716710|NCT01960855|364621912|FG001|Overall Study|Adverse Event|0|||
105716711|NCT01960855|364621913|FG002|Overall Study|Adverse Event|6|||
105716712|NCT01960855|364621914|FG003|Overall Study|Adverse Event|2|||
105716713|NCT01960855|364621915|FG004|Overall Study|Adverse Event|2|||
105716714|NCT01960855|364621911|FG000|Overall Study|Lack of Efficacy|1|||
105716715|NCT01960855|364621912|FG001|Overall Study|Lack of Efficacy|1|||
105716716|NCT01960855|364621913|FG002|Overall Study|Lack of Efficacy|0|||
105716717|NCT01960855|364621914|FG003|Overall Study|Lack of Efficacy|0|||
105716718|NCT01960855|364621915|FG004|Overall Study|Lack of Efficacy|0|||
105716719|NCT01960855|364621911|FG000|Overall Study|Other|2|||
105716720|NCT01960855|364621912|FG001|Overall Study|Other|1|||
105716721|NCT01960855|364621913|FG002|Overall Study|Other|1|||
105716722|NCT01960855|364621914|FG003|Overall Study|Other|1|||
105716723|NCT01960855|364621915|FG004|Overall Study|Other|0|||
105716724|NCT01960855|364621911|FG000|Overall Study|Consent withdrawn by subject|3|||
105716725|NCT01960855|364621912|FG001|Overall Study|Consent withdrawn by subject|1|||
105716726|NCT01960855|364621913|FG002|Overall Study|Consent withdrawn by subject|2|||
105716727|NCT01960855|364621914|FG003|Overall Study|Consent withdrawn by subject|1|||
105716728|NCT01960855|364621915|FG004|Overall Study|Consent withdrawn by subject|1|||
105716729|NCT01960855|364621911|FG000|Overall Study|Lost to Follow-up|2|||
105716730|NCT01960855|364621912|FG001|Overall Study|Lost to Follow-up|1|||
105716731|NCT01960855|364621913|FG002|Overall Study|Lost to Follow-up|0|||
105716732|NCT01960855|364621914|FG003|Overall Study|Lost to Follow-up|0|||
105716733|NCT01960855|364621915|FG004|Overall Study|Lost to Follow-up|2|||
105716734|NCT00695565|364621919|FG000|Overall Study|Lost to Follow-up|4|||
105716735|NCT00695565|364621920|FG001|Overall Study|Lost to Follow-up|4|||
105716736|NCT00695565|364621919|FG000|Overall Study|Adverse Event|3|||
105716737|NCT00695565|364621920|FG001|Overall Study|Adverse Event|1|||
105716738|NCT00695565|364621919|FG000|Overall Study|Protocol Violation|3|||
105716739|NCT00695565|364621920|FG001|Overall Study|Protocol Violation|1|||
105716740|NCT00695565|364621919|FG000|Overall Study|Withdrawal by Subject|1|||
105716741|NCT00695565|364621920|FG001|Overall Study|Withdrawal by Subject|1|||
105716742|NCT00695565|364621919|FG000|Overall Study|Lack of Efficacy|1|||
105716743|NCT00695565|364621920|FG001|Overall Study|Lack of Efficacy|1|||
105716744|NCT00695565|364621919|FG000|Overall Study|Subject did not follow instructions|1|||
105716745|NCT00695565|364621920|FG001|Overall Study|Subject did not follow instructions|1|||
105716746|NCT00500682|364621921|FG000|Overall Study|Adverse Event|37|||
105716747|NCT00500682|364621922|FG001|Overall Study|Adverse Event|29|||
105716748|NCT00500682|364621921|FG000|Overall Study|Death|25|||
105716749|NCT00500682|364621922|FG001|Overall Study|Death|16|||
105716750|NCT00500682|364621921|FG000|Overall Study|Lost to Follow-up|11|||
105716751|NCT00500682|364621922|FG001|Overall Study|Lost to Follow-up|11|||
105716752|NCT00500682|364621921|FG000|Overall Study|Physician Decision|6|||
105716753|NCT00500682|364621922|FG001|Overall Study|Physician Decision|10|||
105716754|NCT00500682|364621921|FG000|Overall Study|Pregnancy|2|||
105716755|NCT00500682|364621922|FG001|Overall Study|Pregnancy|0|||
105716756|NCT00500682|364621921|FG000|Overall Study|Protocol Violation|1|||
105716757|NCT00500682|364621922|FG001|Overall Study|Protocol Violation|3|||
105716758|NCT00500682|364621921|FG000|Overall Study|Withdrawal by Subject|80|||
105716759|NCT00500682|364621922|FG001|Overall Study|Withdrawal by Subject|74|||
105716760|NCT00500682|364621921|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
105716761|NCT00500682|364621922|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
105716762|NCT02320487|364621925|FG000|Overall Study|Reason not Specified|1|||
105716763|NCT02320487|364621925|FG000|Overall Study|Physician Decision|5|||
105716764|NCT02320487|364621925|FG000|Overall Study|Withdrawal by Subject|1|||
105716765|NCT02320487|364621925|FG000|Overall Study|Death|3|||
105716766|NCT02320487|364621925|FG000|Overall Study|Adverse Event|11|||
105716767|NCT03344003|364621926|FG000|Overall Study|Switched to alternative treatment|1|||
105716768|NCT03344003|364621927|FG001|Overall Study|Switched to alternative treatment|0|||
105716769|NCT03344003|364621926|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
105716770|NCT03344003|364621927|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
105716771|NCT02661594|364623529|FG000|Overall Study|Protocol Violation|1|||
105716772|NCT02661594|364623530|FG001|Overall Study|Protocol Violation|0|||
105716773|NCT02661594|364623531|FG002|Overall Study|Protocol Violation|1|||
105716774|NCT02661594|364623532|FG003|Overall Study|Protocol Violation|0|||
105716775|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716776|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
105716777|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716778|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716779|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716780|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
105716781|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
105716782|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
105716783|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
105716784|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
105716785|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
105716786|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
105716787|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
105716788|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
105716789|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
105716790|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
105716791|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
105716792|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
105716793|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
105716794|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
105716795|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716796|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716797|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716798|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
105716799|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716800|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
105789960|NCT01656850|364884959|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
105789961|NCT02674568|364884960|FG000|Overall Study|Withdrawal by Subject|5|||
105789962|NCT02674568|364884960|FG000|Overall Study|Death|303|||
105789963|NCT02674568|364884960|FG000|Overall Study|Physician Decision|2|||
105789964|NCT02674568|364884960|FG000|Overall Study|Lost to Follow-up|9|||
105789965|NCT02674568|364884960|FG000|Overall Study|Other, Not Specified|20|||
105789966|NCT02916056|364884963|FG000|Overall Study|Adverse Event|6|||
105789967|NCT02916056|364884963|FG000|Overall Study|Lost to Follow-up|1|||
105789968|NCT02916056|364884963|FG000|Overall Study|Other|12|||
105789969|NCT02916056|364884963|FG000|Overall Study|Protocol Violation|1|||
105789970|NCT02916056|364884963|FG000|Overall Study|Withdrawal by Subject|8|||
105789971|NCT02916056|364884963|FG000|Overall Study|Study Terminated by Sponsor|269|||
105789972|NCT00685763|364884965|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
105789973|NCT00685763|364884965|FG000|Overall Study|Protocol Violation|1|||
105789974|NCT01741259|364884968|FG000|Overall Study|Protocol Violation|6|||
105789975|NCT01741259|364884969|FG001|Overall Study|Protocol Violation|4|||
105789976|NCT01741259|364884968|FG000|Overall Study|Withdrawal by Subject|0|||
105789977|NCT01741259|364884969|FG001|Overall Study|Withdrawal by Subject|2|||
105716801|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
105716802|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
105716803|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
105716804|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
105716805|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
105716806|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
105716807|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
105716808|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
105716809|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
105716810|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
105716811|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
105716812|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
105716813|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
105716814|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
105716815|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
105716816|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
105716817|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
105716818|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
105716819|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
105716820|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716821|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716822|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
105716823|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716824|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716825|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
105716826|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
105716827|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
105716828|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
105716829|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
105716830|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
105716831|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
105716832|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
105716833|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
105716834|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
105716835|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
105716836|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
105716837|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
105716838|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
105789978|NCT04341727|364884978|FG000|Overall Study|Withdrawal by Subject|0|||
105789979|NCT04341727|364884979|FG001|Overall Study|Withdrawal by Subject|0|||
105789980|NCT04341727|364884980|FG002|Overall Study|Withdrawal by Subject|1|||
105789981|NCT04341727|364884981|FG003|Overall Study|Withdrawal by Subject|0|||
105789982|NCT04341727|364884978|FG000|Overall Study|Lost to Follow-up|0|||
105789983|NCT04341727|364884979|FG001|Overall Study|Lost to Follow-up|0|||
105789984|NCT04341727|364884980|FG002|Overall Study|Lost to Follow-up|0|||
105789985|NCT04341727|364884981|FG003|Overall Study|Lost to Follow-up|1|||
105789986|NCT00564486|364884982|FG000|Overall Study|Adverse Event|0|||
105789987|NCT00564486|364884983|FG001|Overall Study|Adverse Event|1|||
105789988|NCT00564486|364884984|FG002|Overall Study|Adverse Event|0|||
105789989|NCT00564486|364884985|FG003|Overall Study|Adverse Event|0|||
105789990|NCT00564486|364884982|FG000|Overall Study|Withdrawal by Subject|4|||
105789991|NCT00564486|364884983|FG001|Overall Study|Withdrawal by Subject|0|||
105789992|NCT00564486|364884984|FG002|Overall Study|Withdrawal by Subject|0|||
105561844|NCT02342886|364052241|FG002|Overall Study|Treatment non-compliance|0|||
105561845|NCT02342886|364052242|FG003|Overall Study|Treatment non-compliance|1|||
105561846|NCT02342886|364052243|FG004|Overall Study|Treatment non-compliance|0|||
105561847|NCT02342886|364052239|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
105561848|NCT02342886|364052240|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
105789993|NCT00564486|364884985|FG003|Overall Study|Withdrawal by Subject|5|||
105789994|NCT00564486|364884982|FG000|Overall Study|Subject refused to have blood drawn|0|||
105789995|NCT00564486|364884983|FG001|Overall Study|Subject refused to have blood drawn|0|||
105789996|NCT00564486|364884984|FG002|Overall Study|Subject refused to have blood drawn|1|||
105789997|NCT00564486|364884985|FG003|Overall Study|Subject refused to have blood drawn|0|||
105789998|NCT00564486|364884982|FG000|Overall Study|Lost to Follow-up|3|||
105789999|NCT00564486|364884983|FG001|Overall Study|Lost to Follow-up|0|||
105790000|NCT00564486|364884984|FG002|Overall Study|Lost to Follow-up|2|||
105790001|NCT00564486|364884985|FG003|Overall Study|Lost to Follow-up|2|||
105790002|NCT00494234|364884994|FG000|Overall Study|Withdrawal by Subject|1|||
105790003|NCT00494234|364884995|FG001|Overall Study|Withdrawal by Subject|0|||
105790004|NCT00494234|364884994|FG000|Overall Study|Disease progression|11|||
105790005|NCT00494234|364884995|FG001|Overall Study|Disease progression|8|||
105790006|NCT00494234|364884994|FG000|Overall Study|Death|2|||
105790007|NCT00494234|364884995|FG001|Overall Study|Death|1|||
105790008|NCT03292731|364884996|FG000|Overall Study|Protocol Violation|4|||
105790009|NCT03292731|364884997|FG001|Overall Study|Protocol Violation|11|||
105790010|NCT03292731|364884998|FG002|Overall Study|Protocol Violation|1|||
105790011|NCT01298362|364885003|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
105790012|NCT01298362|364885004|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
105790013|NCT03237325|364885007|FG000|Overall Study|Lost to Follow-up|3|||
105561849|NCT02342886|364052241|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
105790014|NCT03237325|364885008|FG001|Overall Study|Lost to Follow-up|5|||
105790015|NCT03237325|364885007|FG000|Overall Study|Physician Decision|2|||
105790016|NCT03237325|364885008|FG001|Overall Study|Physician Decision|4|||
105790017|NCT03237325|364885007|FG000|Overall Study|Withdrawal by Subject|9|||
105790018|NCT03237325|364885008|FG001|Overall Study|Withdrawal by Subject|12|||
105561850|NCT02342886|364052242|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
105790019|NCT03237325|364885007|FG000|Overall Study|Noncompliance with Study Procedures|1|||
105790020|NCT03237325|364885008|FG001|Overall Study|Noncompliance with Study Procedures|1|||
105790021|NCT03237325|364885007|FG000|Overall Study|Termination by Sponsor|0|||
105790022|NCT03237325|364885008|FG001|Overall Study|Termination by Sponsor|1|||
105790023|NCT03237325|364885007|FG000|Overall Study|Reason other than described|0|||
105790024|NCT03237325|364885008|FG001|Overall Study|Reason other than described|2|||
105790025|NCT02684370|364885009|FG000|Part A|Adverse Event|2|||
105790026|NCT02684370|364885010|FG001|Part A|Adverse Event|0|||
105790027|NCT02684370|364885011|FG002|Part A|Adverse Event|1|||
105790028|NCT02684370|364885012|FG003|Part A|Adverse Event|0|||
105790029|NCT02684370|364885013|FG004|Part A|Adverse Event|0|||
105790030|NCT02684370|364885014|FG005|Part A|Adverse Event|0|||
105790031|NCT02684370|364885009|FG000|Part A|Lost to Follow-up|1|||
105790032|NCT02684370|364885010|FG001|Part A|Lost to Follow-up|1|||
105790033|NCT02684370|364885011|FG002|Part A|Lost to Follow-up|0|||
105790034|NCT02684370|364885012|FG003|Part A|Lost to Follow-up|0|||
105790035|NCT02684370|364885013|FG004|Part A|Lost to Follow-up|0|||
105790036|NCT02684370|364885014|FG005|Part A|Lost to Follow-up|0|||
105790037|NCT02684370|364885009|FG000|Part A|Subject Withdrawal|1|||
105790038|NCT02684370|364885010|FG001|Part A|Subject Withdrawal|0|||
105790039|NCT02684370|364885011|FG002|Part A|Subject Withdrawal|3|||
105790040|NCT02684370|364885012|FG003|Part A|Subject Withdrawal|0|||
105790041|NCT02684370|364885013|FG004|Part A|Subject Withdrawal|0|||
105790042|NCT02684370|364885014|FG005|Part A|Subject Withdrawal|0|||
105790043|NCT02684370|364885009|FG000|Part A|Other|0|||
105790044|NCT02684370|364885010|FG001|Part A|Other|0|||
105790045|NCT02684370|364885011|FG002|Part A|Other|1|||
105790046|NCT02684370|364885012|FG003|Part A|Other|0|||
105790047|NCT02684370|364885013|FG004|Part A|Other|0|||
105790048|NCT02684370|364885014|FG005|Part A|Other|0|||
105790049|NCT02684370|364885009|FG000|Part B|Adverse Event|0|||
105790050|NCT02684370|364885010|FG001|Part B|Adverse Event|0|||
105790051|NCT02684370|364885011|FG002|Part B|Adverse Event|0|||
105790052|NCT02684370|364885012|FG003|Part B|Adverse Event|0|||
105790053|NCT02684370|364885013|FG004|Part B|Adverse Event|2|||
105790054|NCT02684370|364885014|FG005|Part B|Adverse Event|1|||
105790055|NCT02684370|364885009|FG000|Part B|Lost to Follow-up|0|||
105790056|NCT02684370|364885010|FG001|Part B|Lost to Follow-up|0|||
105790057|NCT02684370|364885011|FG002|Part B|Lost to Follow-up|0|||
105790058|NCT02684370|364885012|FG003|Part B|Lost to Follow-up|1|||
105790059|NCT02684370|364885013|FG004|Part B|Lost to Follow-up|2|||
105790060|NCT02684370|364885014|FG005|Part B|Lost to Follow-up|5|||
105790061|NCT02684370|364885009|FG000|Part B|Subject Withdrawal|0|||
105790062|NCT02684370|364885010|FG001|Part B|Subject Withdrawal|0|||
105790063|NCT02684370|364885011|FG002|Part B|Subject Withdrawal|0|||
105790064|NCT02684370|364885012|FG003|Part B|Subject Withdrawal|1|||
105790065|NCT02684370|364885013|FG004|Part B|Subject Withdrawal|1|||
105790066|NCT02684370|364885014|FG005|Part B|Subject Withdrawal|2|||
105790067|NCT01012609|364885015|FG000|Overall Study|Withdrawal by Subject|1|||
105790068|NCT01012609|364885016|FG001|Overall Study|Withdrawal by Subject|1|||
105790069|NCT01453296|364885017|FG000|Treatment Period 1|Adverse Event|0|||
105790070|NCT01453296|364885018|FG001|Treatment Period 1|Adverse Event|1|||
105790071|NCT01453296|364885017|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
105790072|NCT01453296|364885018|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
105790073|NCT01453296|364885017|FG000|Treatment Period 2|Adverse Event|1|||
105790074|NCT01453296|364885018|FG001|Treatment Period 2|Adverse Event|0|||
105790075|NCT01453296|364885017|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105790076|NCT01453296|364885018|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105790077|NCT04139642|364885019|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
105790078|NCT04139642|364885020|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
105790079|NCT00585468|364885021|FG000|First Intervention|Withdrawal by Subject|1|||
105790080|NCT00585468|364885022|FG001|First Intervention|Withdrawal by Subject|1|||
105790081|NCT00762073|364885029|FG000|Overall Study|Lack of Efficacy|1|||
105790082|NCT00762073|364885030|FG001|Overall Study|Lack of Efficacy|1|||
105790083|NCT00762073|364885031|FG002|Overall Study|Lack of Efficacy|0|||
105790084|NCT00762073|364885032|FG003|Overall Study|Lack of Efficacy|0|||
105790085|NCT00762073|364885029|FG000|Overall Study|Adverse Event|1|||
105790086|NCT00762073|364885030|FG001|Overall Study|Adverse Event|0|||
105790087|NCT00762073|364885031|FG002|Overall Study|Adverse Event|1|||
105790088|NCT00762073|364885032|FG003|Overall Study|Adverse Event|1|||
105790089|NCT00762073|364885029|FG000|Overall Study|Significant Subject Noncompliance|0|||
105790090|NCT00762073|364885030|FG001|Overall Study|Significant Subject Noncompliance|1|||
105790091|NCT00762073|364885031|FG002|Overall Study|Significant Subject Noncompliance|0|||
105790092|NCT00762073|364885032|FG003|Overall Study|Significant Subject Noncompliance|1|||
105790093|NCT00762073|364885029|FG000|Overall Study|Withdrawal by Subject|1|||
105790094|NCT00762073|364885030|FG001|Overall Study|Withdrawal by Subject|2|||
105790095|NCT00762073|364885031|FG002|Overall Study|Withdrawal by Subject|1|||
105790096|NCT00762073|364885032|FG003|Overall Study|Withdrawal by Subject|1|||
105790097|NCT00762073|364885029|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
105790098|NCT00762073|364885030|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
105790099|NCT00762073|364885031|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
105716839|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
105716840|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
105716841|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716842|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
105716843|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716844|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716845|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
105716846|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
105716847|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
105716848|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
105716849|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
105716850|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
105716851|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
105716852|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
105716853|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
105716854|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
105716855|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
105716856|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
105716857|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
105716858|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
105716859|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
105716860|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
105716861|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
105716862|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
105716863|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
105716864|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
105716865|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
105716866|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
105716867|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
105716868|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
105716869|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
105716870|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
105716871|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
105716872|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
105716873|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
105716874|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
105716875|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
105716876|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
105716877|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
105716878|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
105716879|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
105716880|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
105716881|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
105716882|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
105716883|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
105716884|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
105716885|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
105716886|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
105716887|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
105716888|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
105716889|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
105716890|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716891|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
105716892|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716893|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716894|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716895|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
105716896|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
105716897|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
105716898|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
105716899|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
105716900|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
105716901|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
105790100|NCT00762073|364885032|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
105790101|NCT01068418|364885033|FG000|Overall Study|Physician Decision|12|||
105790102|NCT03155269|364885036|FG000|Overall Study|Withdrawal by Subject|4|||
105790103|NCT03155269|364885037|FG001|Overall Study|Withdrawal by Subject|5|||
105790104|NCT03155269|364885036|FG000|Overall Study|Lost to Follow-up|1|||
105790105|NCT03155269|364885037|FG001|Overall Study|Lost to Follow-up|2|||
105790106|NCT02181673|364885038|FG000|Up to Week 24|Adverse Event|2|||
105790107|NCT02181673|364885039|FG001|Up to Week 24|Adverse Event|0|||
105790108|NCT02181673|364885040|FG002|Up to Week 24|Adverse Event|3|||
105790109|NCT02181673|364885038|FG000|Up to Week 24|Death|1|||
105790110|NCT02181673|364885039|FG001|Up to Week 24|Death|0|||
105790111|NCT02181673|364885040|FG002|Up to Week 24|Death|0|||
105790112|NCT02181673|364885038|FG000|Up to Week 24|Lack of Efficacy|1|||
105790113|NCT02181673|364885039|FG001|Up to Week 24|Lack of Efficacy|0|||
105790114|NCT02181673|364885040|FG002|Up to Week 24|Lack of Efficacy|0|||
105790115|NCT02181673|364885038|FG000|Up to Week 24|Lost to Follow-up|1|||
105790116|NCT02181673|364885039|FG001|Up to Week 24|Lost to Follow-up|0|||
105790117|NCT02181673|364885040|FG002|Up to Week 24|Lost to Follow-up|0|||
105790118|NCT02181673|364885038|FG000|Up to Week 24|Physician Decision|0|||
105790119|NCT02181673|364885039|FG001|Up to Week 24|Physician Decision|0|||
105790120|NCT02181673|364885040|FG002|Up to Week 24|Physician Decision|3|||
105790121|NCT02181673|364885038|FG000|Up to Week 24|Withdrawal by Subject|10|||
105790122|NCT02181673|364885039|FG001|Up to Week 24|Withdrawal by Subject|0|||
105790123|NCT02181673|364885040|FG002|Up to Week 24|Withdrawal by Subject|1|||
105790124|NCT02181673|364885038|FG000|Up to Week 24|Other|2|||
105790125|NCT02181673|364885039|FG001|Up to Week 24|Other|0|||
105790126|NCT02181673|364885040|FG002|Up to Week 24|Other|3|||
105790127|NCT02181673|364885038|FG000|Up to Week 24|Randomized not Treated|0|||
105790128|NCT02181673|364885039|FG001|Up to Week 24|Randomized not Treated|0|||
105790129|NCT02181673|364885040|FG002|Up to Week 24|Randomized not Treated|1|||
105790130|NCT02181673|364885038|FG000|Week 24-Week 60|Adverse Event|0|||
105790131|NCT02181673|364885039|FG001|Week 24-Week 60|Adverse Event|4|||
105790132|NCT02181673|364885040|FG002|Week 24-Week 60|Adverse Event|10|||
105790133|NCT02181673|364885038|FG000|Week 24-Week 60|Other|0|||
105790134|NCT02181673|364885039|FG001|Week 24-Week 60|Other|2|||
105790135|NCT02181673|364885040|FG002|Week 24-Week 60|Other|1|||
105790136|NCT02181673|364885038|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
105790137|NCT02181673|364885039|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
105790138|NCT02181673|364885040|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
105790139|NCT02181673|364885038|FG000|Week 24-Week 60|Pregnancy|0|||
105790140|NCT02181673|364885039|FG001|Week 24-Week 60|Pregnancy|0|||
105790141|NCT02181673|364885040|FG002|Week 24-Week 60|Pregnancy|1|||
105790142|NCT02181673|364885038|FG000|Week 24-Week 60|Lack of Efficacy|0|||
105790143|NCT02181673|364885039|FG001|Week 24-Week 60|Lack of Efficacy|0|||
105790144|NCT02181673|364885040|FG002|Week 24-Week 60|Lack of Efficacy|1|||
105790145|NCT02181673|364885038|FG000|Week 24-Week 60|Lost to Follow-up|0|||
105790146|NCT02181673|364885039|FG001|Week 24-Week 60|Lost to Follow-up|0|||
105790147|NCT02181673|364885040|FG002|Week 24-Week 60|Lost to Follow-up|1|||
105790148|NCT02181673|364885038|FG000|Week 24-Week 60|Physician Decision|0|||
105790149|NCT02181673|364885039|FG001|Week 24-Week 60|Physician Decision|0|||
105790150|NCT02181673|364885040|FG002|Week 24-Week 60|Physician Decision|1|||
105790151|NCT00433771|364885041|FG000|Overall Study|screen fail|14|||
105561851|NCT02342886|364052243|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
105561852|NCT02342886|364052239|FG000|Overall Study|Adverse event/specific toxicity|4|||
105561853|NCT02342886|364052240|FG001|Overall Study|Adverse event/specific toxicity|3|||
105790152|NCT00433771|364885041|FG000|Overall Study|Treated and later found to be ineligible|2|||
105790153|NCT00433771|364885041|FG000|Overall Study|Death|2|||
105790154|NCT00433771|364885041|FG000|Overall Study|Failure to deploy stent|1|||
105790155|NCT00138658|364885042|FG000|Overall Study|Adverse Event|23|||
105790156|NCT00138658|364885042|FG000|Overall Study|Death|1|||
105790157|NCT00138658|364885042|FG000|Overall Study|Disease Progression|21|||
105790158|NCT00138658|364885042|FG000|Overall Study|Physician Decision|11|||
105790159|NCT00138658|364885042|FG000|Overall Study|Withdrawal by Subject|5|||
105790160|NCT00539006|364885050|FG000|Pre-treatment|Other|0|||
105790161|NCT00539006|364885051|FG001|Pre-treatment|Other|1|||
105790162|NCT00539006|364885052|FG002|Pre-treatment|Other|0|||
105790163|NCT00539006|364885053|FG003|Pre-treatment|Other|0|||
105790164|NCT00539006|364885050|FG000|Treatment Period 1|Lost to Follow-up|0|||
105790165|NCT00539006|364885051|FG001|Treatment Period 1|Lost to Follow-up|0|||
105790166|NCT00539006|364885052|FG002|Treatment Period 1|Lost to Follow-up|1|||
105790167|NCT00539006|364885053|FG003|Treatment Period 1|Lost to Follow-up|0|||
105790168|NCT00539006|364885050|FG000|Treatment Period 1|Protocol Violation|0|||
105790169|NCT00539006|364885051|FG001|Treatment Period 1|Protocol Violation|0|||
105790170|NCT00539006|364885052|FG002|Treatment Period 1|Protocol Violation|1|||
105790171|NCT00539006|364885053|FG003|Treatment Period 1|Protocol Violation|0|||
105790172|NCT00539006|364885050|FG000|Treatment Period 1|Lack of Efficacy|0|||
105790173|NCT00539006|364885051|FG001|Treatment Period 1|Lack of Efficacy|0|||
105790174|NCT00539006|364885052|FG002|Treatment Period 1|Lack of Efficacy|0|||
105716902|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
105716903|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
105716904|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
105716905|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716906|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716907|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716908|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716909|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
105716910|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
105716911|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
105716912|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
105716913|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
105716914|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
105716915|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
105716916|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
105716917|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
105716918|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
105716919|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
105716920|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
105716921|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
105716922|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
105716923|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
105716924|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
105716925|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
105716926|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
105716927|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
105716928|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
105716929|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
105716930|NCT00254566|364623538|FG000|Overall Study|Death|1|||
105716931|NCT00254566|364623539|FG001|Overall Study|Death|0|||
105716932|NCT00254566|364623538|FG000|Overall Study|Adverse Event|5|||
105716933|NCT00254566|364623539|FG001|Overall Study|Adverse Event|4|||
105716934|NCT00254566|364623538|FG000|Overall Study|Lack of Efficacy|12|||
105716935|NCT00254566|364623539|FG001|Overall Study|Lack of Efficacy|9|||
105716936|NCT00254566|364623538|FG000|Overall Study|Other|1|||
105716937|NCT00254566|364623539|FG001|Overall Study|Other|5|||
105716938|NCT00254566|364623538|FG000|Overall Study|Withdrawal by Subject|5|||
105716939|NCT00254566|364623539|FG001|Overall Study|Withdrawal by Subject|6|||
105716940|NCT00254566|364623538|FG000|Overall Study|Lost to Follow-up|7|||
105716941|NCT00254566|364623539|FG001|Overall Study|Lost to Follow-up|2|||
105716942|NCT01169779|364623540|FG000|Overall Study|Adverse Event|3|||
105716943|NCT01169779|364623541|FG001|Overall Study|Adverse Event|11|||
105716944|NCT01169779|364623540|FG000|Overall Study|Lack of Efficacy|1|||
105716945|NCT01169779|364623541|FG001|Overall Study|Lack of Efficacy|0|||
105716946|NCT01169779|364623540|FG000|Overall Study|Protocol Violation|1|||
105716947|NCT01169779|364623541|FG001|Overall Study|Protocol Violation|1|||
105716948|NCT01169779|364623540|FG000|Overall Study|Withdrawal by Subject|3|||
105716949|NCT01169779|364623541|FG001|Overall Study|Withdrawal by Subject|2|||
105716950|NCT01169779|364623540|FG000|Overall Study|Familial and personal reasons|3|||
105716951|NCT01169779|364623541|FG001|Overall Study|Familial and personal reasons|3|||
105716952|NCT00548548|364623542|FG000|Overall Study|Death|345|||
105716953|NCT00548548|364623543|FG001|Overall Study|Death|348|||
105716954|NCT00548548|364623542|FG000|Overall Study|Lost to Follow-up|17|||
105716955|NCT00548548|364623543|FG001|Overall Study|Lost to Follow-up|18|||
105716956|NCT01061008|364623546|FG000|Overall Study|Badiocephalic fistula failed|3|||
105716957|NCT01061008|364623547|FG001|Overall Study|Badiocephalic fistula failed|2|||
105716958|NCT01061008|364623546|FG000|Overall Study|Death|1|||
105716959|NCT01061008|364623547|FG001|Overall Study|Death|0|||
105716960|NCT01061008|364623546|FG000|Overall Study|Withdrawal by Subject|1|||
105790175|NCT00539006|364885053|FG003|Treatment Period 1|Lack of Efficacy|1|||
105716961|NCT01061008|364623547|FG001|Overall Study|Withdrawal by Subject|3|||
105716962|NCT01061008|364623546|FG000|Overall Study|Unable to exercise following surgery|1|||
105716963|NCT01061008|364623547|FG001|Overall Study|Unable to exercise following surgery|0|||
105716964|NCT01061008|364623546|FG000|Overall Study|Adverse Event|0|||
105790176|NCT00539006|364885050|FG000|Washout|Adverse Event|2|||
105716965|NCT01061008|364623547|FG001|Overall Study|Adverse Event|1|||
105716966|NCT00648167|364623550|FG000|Overall Study|Adverse Event|6|||
105716967|NCT00648167|364623550|FG000|Overall Study|unable to swallow tablets|1|||
105716968|NCT01688050|364623551|FG000|Overall Study|Death|7|||
105716969|NCT01688050|364623551|FG000|Overall Study|Conversion to open repair|1|||
105716970|NCT01688050|364623551|FG000|Overall Study|Lost to Follow-up|13|||
105716971|NCT01688050|364623551|FG000|Overall Study|Withdrawal by Subject|10|||
105716972|NCT00927368|364623552|FG000|Overall Study|enrollment in another study|1|||
105716973|NCT00927368|364623553|FG001|Overall Study|enrollment in another study|1|||
105716974|NCT00927368|364623554|FG002|Overall Study|enrollment in another study|2|||
105716975|NCT00927368|364623552|FG000|Overall Study|Lost to Follow-up|4|||
105716976|NCT00927368|364623553|FG001|Overall Study|Lost to Follow-up|0|||
105716977|NCT00927368|364623554|FG002|Overall Study|Lost to Follow-up|0|||
105716978|NCT00927368|364623552|FG000|Overall Study|equipment failure|1|||
105716979|NCT00927368|364623553|FG001|Overall Study|equipment failure|0|||
105716980|NCT00927368|364623554|FG002|Overall Study|equipment failure|0|||
105716981|NCT00927368|364623552|FG000|Overall Study|ineligible post randomization|0|||
105716982|NCT00927368|364623553|FG001|Overall Study|ineligible post randomization|3|||
105716983|NCT00927368|364623554|FG002|Overall Study|ineligible post randomization|1|||
105716984|NCT00927368|364623552|FG000|Overall Study|cancellation of surgery|0|||
105716985|NCT00927368|364623553|FG001|Overall Study|cancellation of surgery|1|||
105716986|NCT00927368|364623554|FG002|Overall Study|cancellation of surgery|2|||
105716987|NCT03683394|364623555|FG000|Overall Study|Withdrawal by Subject|4|||
105716988|NCT03683394|364623556|FG001|Overall Study|Withdrawal by Subject|8|||
105716989|NCT03683394|364623555|FG000|Overall Study|Lost to Follow-up|7|||
105716990|NCT03683394|364623556|FG001|Overall Study|Lost to Follow-up|0|||
105716991|NCT03683394|364623555|FG000|Overall Study|Death|3|||
105716992|NCT03683394|364623556|FG001|Overall Study|Death|1|||
105716993|NCT03072160|364623557|FG000|Overall Study|Adverse Event|3|||
105716994|NCT03072160|364623558|FG001|Overall Study|Adverse Event|1|||
105716995|NCT03072160|364623557|FG000|Overall Study|Refused further treatment|6|||
105716996|NCT03072160|364623558|FG001|Overall Study|Refused further treatment|1|||
105716997|NCT03072160|364623557|FG000|Overall Study|Physician Decision|1|||
105716998|NCT03072160|364623558|FG001|Overall Study|Physician Decision|0|||
105716999|NCT03072160|364623557|FG000|Overall Study|Disease progression on study|1|||
105717000|NCT03072160|364623558|FG001|Overall Study|Disease progression on study|1|||
105717001|NCT03072160|364623557|FG000|Overall Study|No contact|0|||
105717002|NCT03072160|364623558|FG001|Overall Study|No contact|1|||
105717003|NCT04276207|364623559|FG000|Period 1|Withdrawal by Subject|0|||
105717004|NCT04276207|364623560|FG001|Period 1|Withdrawal by Subject|1|||
105717005|NCT00395967|364623562|FG000|Treatment Period|Failed Mobilization|1|||
105717006|NCT00395967|364623562|FG000|Follow-up Period|Death|1|||
105717007|NCT00395967|364623562|FG000|Follow-up Period|Lost to Follow-up|1|||
105717008|NCT03118947|364623563|FG000|Overall Study|Adverse Event|7|||
105717009|NCT03118947|364623563|FG000|Overall Study|Death|3|||
105717010|NCT03118947|364623563|FG000|Overall Study|Lack of Efficacy|4|||
105717011|NCT03118947|364623563|FG000|Overall Study|Non-compliance with study drug|1|||
105717012|NCT03118947|364623563|FG000|Overall Study|Protocol Violation|2|||
105717013|NCT03118947|364623563|FG000|Overall Study|Withdrawal by Subject|3|||
105717014|NCT03118947|364623563|FG000|Overall Study|Withdrawal by caregiver|3|||
105717015|NCT03118947|364623563|FG000|Overall Study|Change in patient's living situation|4|||
105717016|NCT03118947|364623563|FG000|Overall Study|Lost to Follow-up|2|||
105717017|NCT00179959|364623564|FG000|Overall Study|Lost to Follow-up|3|||
105717018|NCT00179959|364623565|FG001|Overall Study|Lost to Follow-up|1|||
105717019|NCT00179959|364623564|FG000|Overall Study|Withdrawal by Subject|3|||
105717020|NCT00179959|364623565|FG001|Overall Study|Withdrawal by Subject|2|||
105717021|NCT01262976|364623566|FG000|Up to Month 2|Serious Adverse Event|0|||
105717022|NCT01262976|364623567|FG001|Up to Month 2|Serious Adverse Event|0|||
105717023|NCT01262976|364623568|FG002|Up to Month 2|Serious Adverse Event|1|||
105717024|NCT01262976|364623569|FG003|Up to Month 2|Serious Adverse Event|0|||
105717025|NCT01262976|364623570|FG004|Up to Month 2|Serious Adverse Event|0|||
105717026|NCT01262976|364623571|FG005|Up to Month 2|Serious Adverse Event|0|||
105717027|NCT01262976|364623566|FG000|Up to Month 2|Withdrawal by Subject|1|||
105717028|NCT01262976|364623567|FG001|Up to Month 2|Withdrawal by Subject|0|||
105717029|NCT01262976|364623568|FG002|Up to Month 2|Withdrawal by Subject|0|||
105717030|NCT01262976|364623569|FG003|Up to Month 2|Withdrawal by Subject|0|||
105561854|NCT02342886|364052241|FG002|Overall Study|Adverse event/specific toxicity|11|||
105561855|NCT02342886|364052242|FG003|Overall Study|Adverse event/specific toxicity|2|||
105561856|NCT02342886|364052243|FG004|Overall Study|Adverse event/specific toxicity|1|||
105561857|NCT02342886|364052239|FG000|Overall Study|Lost to Follow-up|1|||
105561858|NCT02342886|364052240|FG001|Overall Study|Lost to Follow-up|0|||
105561859|NCT02342886|364052241|FG002|Overall Study|Lost to Follow-up|0|||
105717031|NCT01262976|364623570|FG004|Up to Month 2|Withdrawal by Subject|0|||
105717032|NCT01262976|364623571|FG005|Up to Month 2|Withdrawal by Subject|0|||
105717033|NCT01262976|364623566|FG000|Up to Month 2|Migrated/moved from study area|0|||
105717034|NCT01262976|364623567|FG001|Up to Month 2|Migrated/moved from study area|1|||
105717035|NCT01262976|364623568|FG002|Up to Month 2|Migrated/moved from study area|0|||
105717036|NCT01262976|364623569|FG003|Up to Month 2|Migrated/moved from study area|0|||
105717037|NCT01262976|364623570|FG004|Up to Month 2|Migrated/moved from study area|1|||
105717038|NCT01262976|364623571|FG005|Up to Month 2|Migrated/moved from study area|1|||
105717039|NCT01262976|364623566|FG000|Up to Month 2|Lost to Follow-up|1|||
105717040|NCT01262976|364623567|FG001|Up to Month 2|Lost to Follow-up|0|||
105717041|NCT01262976|364623568|FG002|Up to Month 2|Lost to Follow-up|0|||
105717042|NCT01262976|364623569|FG003|Up to Month 2|Lost to Follow-up|1|||
105717043|NCT01262976|364623570|FG004|Up to Month 2|Lost to Follow-up|1|||
105717044|NCT01262976|364623571|FG005|Up to Month 2|Lost to Follow-up|1|||
105717045|NCT01262976|364623566|FG000|Up to Month 2|Other|1|||
105790177|NCT00539006|364885051|FG001|Washout|Adverse Event|1|||
105790178|NCT00539006|364885052|FG002|Washout|Adverse Event|0|||
105790179|NCT00539006|364885053|FG003|Washout|Adverse Event|0|||
105790180|NCT00539006|364885050|FG000|Washout|Protocol Violation|1|||
105790181|NCT00539006|364885051|FG001|Washout|Protocol Violation|1|||
105790182|NCT00539006|364885052|FG002|Washout|Protocol Violation|0|||
105790183|NCT00539006|364885053|FG003|Washout|Protocol Violation|0|||
105790184|NCT00539006|364885050|FG000|Washout|Withdrawal by Subject|0|||
105790185|NCT00539006|364885051|FG001|Washout|Withdrawal by Subject|2|||
105790186|NCT00539006|364885052|FG002|Washout|Withdrawal by Subject|0|||
105790187|NCT00539006|364885053|FG003|Washout|Withdrawal by Subject|0|||
105790188|NCT00539006|364885050|FG000|Washout|Failed to meet continuation criteria|16|||
105790189|NCT00539006|364885051|FG001|Washout|Failed to meet continuation criteria|5|||
105790190|NCT00539006|364885052|FG002|Washout|Failed to meet continuation criteria|14|||
105790191|NCT00539006|364885053|FG003|Washout|Failed to meet continuation criteria|6|||
105790192|NCT00539006|364885050|FG000|Washout|Other|1|||
105790193|NCT00539006|364885051|FG001|Washout|Other|1|||
105561860|NCT02342886|364052242|FG003|Overall Study|Lost to Follow-up|0|||
105561861|NCT02342886|364052243|FG004|Overall Study|Lost to Follow-up|0|||
105717046|NCT01262976|364623567|FG001|Up to Month 2|Other|0|||
105717047|NCT01262976|364623568|FG002|Up to Month 2|Other|0|||
105717048|NCT01262976|364623569|FG003|Up to Month 2|Other|1|||
105717049|NCT01262976|364623570|FG004|Up to Month 2|Other|0|||
105717050|NCT01262976|364623571|FG005|Up to Month 2|Other|2|||
105717051|NCT01262976|364623566|FG000|Up to Month 7|Serious Adverse Event|0|||
105717052|NCT01262976|364623567|FG001|Up to Month 7|Serious Adverse Event|0|||
105717053|NCT01262976|364623568|FG002|Up to Month 7|Serious Adverse Event|2|||
105717054|NCT01262976|364623569|FG003|Up to Month 7|Serious Adverse Event|0|||
105717055|NCT01262976|364623570|FG004|Up to Month 7|Serious Adverse Event|0|||
105717056|NCT01262976|364623571|FG005|Up to Month 7|Serious Adverse Event|0|||
105717057|NCT01262976|364623566|FG000|Up to Month 7|Withdrawal by Subject|1|||
105717058|NCT01262976|364623567|FG001|Up to Month 7|Withdrawal by Subject|0|||
105717059|NCT01262976|364623568|FG002|Up to Month 7|Withdrawal by Subject|0|||
105717060|NCT01262976|364623569|FG003|Up to Month 7|Withdrawal by Subject|0|||
105790194|NCT00539006|364885052|FG002|Washout|Other|2|||
105790195|NCT00539006|364885053|FG003|Washout|Other|3|||
105790196|NCT00539006|364885050|FG000|Treatment Period 2|Protocol Violation|1|||
105790197|NCT00539006|364885051|FG001|Treatment Period 2|Protocol Violation|0|||
105790198|NCT00539006|364885052|FG002|Treatment Period 2|Protocol Violation|0|||
105790199|NCT00539006|364885053|FG003|Treatment Period 2|Protocol Violation|0|||
105561862|NCT02342886|364052239|FG000|Overall Study|Death|1|||
105717061|NCT01262976|364623570|FG004|Up to Month 7|Withdrawal by Subject|0|||
105717062|NCT01262976|364623571|FG005|Up to Month 7|Withdrawal by Subject|0|||
105717063|NCT01262976|364623566|FG000|Up to Month 7|Migrated/moved from study area|0|||
105790200|NCT00539006|364885050|FG000|Treatment Period 2|Other|0|||
105790201|NCT00539006|364885051|FG001|Treatment Period 2|Other|1|||
105790202|NCT00539006|364885052|FG002|Treatment Period 2|Other|0|||
105561863|NCT02342886|364052240|FG001|Overall Study|Death|2|||
105717064|NCT01262976|364623567|FG001|Up to Month 7|Migrated/moved from study area|0|||
105717065|NCT01262976|364623568|FG002|Up to Month 7|Migrated/moved from study area|1|||
105717066|NCT01262976|364623569|FG003|Up to Month 7|Migrated/moved from study area|3|||
105790203|NCT00539006|364885053|FG003|Treatment Period 2|Other|0|||
105790204|NCT03733301|364885054|FG000|Overall Study|Screen Fail|1|||
105790205|NCT03733301|364885055|FG001|Overall Study|Screen Fail|0|||
105790206|NCT03733301|364885056|FG002|Overall Study|Screen Fail|0|||
105790207|NCT03733301|364885054|FG000|Overall Study|Non-compliance|1|||
105717067|NCT01262976|364623570|FG004|Up to Month 7|Migrated/moved from study area|1|||
105717068|NCT01262976|364623571|FG005|Up to Month 7|Migrated/moved from study area|1|||
105717069|NCT01262976|364623566|FG000|Up to Month 7|Lost to Follow-up|1|||
105717070|NCT01262976|364623567|FG001|Up to Month 7|Lost to Follow-up|0|||
105717071|NCT01262976|364623568|FG002|Up to Month 7|Lost to Follow-up|1|||
105717072|NCT01262976|364623569|FG003|Up to Month 7|Lost to Follow-up|3|||
105717073|NCT01262976|364623570|FG004|Up to Month 7|Lost to Follow-up|1|||
105717074|NCT01262976|364623571|FG005|Up to Month 7|Lost to Follow-up|3|||
105717075|NCT01262976|364623566|FG000|Up to Month 7|Other|3|||
105717076|NCT01262976|364623567|FG001|Up to Month 7|Other|0|||
105717077|NCT01262976|364623568|FG002|Up to Month 7|Other|2|||
105717078|NCT01262976|364623569|FG003|Up to Month 7|Other|0|||
105717079|NCT01262976|364623570|FG004|Up to Month 7|Other|0|||
105717080|NCT01262976|364623571|FG005|Up to Month 7|Other|0|||
105717081|NCT01262976|364623566|FG000|Up to Year 1|Serious Adverse Event|0|||
105717082|NCT01262976|364623567|FG001|Up to Year 1|Serious Adverse Event|0|||
105717083|NCT01262976|364623568|FG002|Up to Year 1|Serious Adverse Event|2|||
105717084|NCT01262976|364623569|FG003|Up to Year 1|Serious Adverse Event|0|||
105717085|NCT01262976|364623570|FG004|Up to Year 1|Serious Adverse Event|0|||
105717086|NCT01262976|364623571|FG005|Up to Year 1|Serious Adverse Event|0|||
105717087|NCT01262976|364623566|FG000|Up to Year 1|Withdrawal by Subject|1|||
105717088|NCT01262976|364623567|FG001|Up to Year 1|Withdrawal by Subject|0|||
105717089|NCT01262976|364623568|FG002|Up to Year 1|Withdrawal by Subject|0|||
105717090|NCT01262976|364623569|FG003|Up to Year 1|Withdrawal by Subject|0|||
105717091|NCT01262976|364623570|FG004|Up to Year 1|Withdrawal by Subject|0|||
105717092|NCT01262976|364623571|FG005|Up to Year 1|Withdrawal by Subject|0|||
105717093|NCT01262976|364623566|FG000|Up to Year 1|Migrated/moved from study area|1|||
105717094|NCT01262976|364623567|FG001|Up to Year 1|Migrated/moved from study area|0|||
105717095|NCT01262976|364623568|FG002|Up to Year 1|Migrated/moved from study area|0|||
105717096|NCT01262976|364623569|FG003|Up to Year 1|Migrated/moved from study area|3|||
105717097|NCT01262976|364623570|FG004|Up to Year 1|Migrated/moved from study area|3|||
105717098|NCT01262976|364623571|FG005|Up to Year 1|Migrated/moved from study area|2|||
105717099|NCT01262976|364623566|FG000|Up to Year 1|Lost to Follow-up|4|||
105717100|NCT01262976|364623567|FG001|Up to Year 1|Lost to Follow-up|0|||
105717101|NCT01262976|364623568|FG002|Up to Year 1|Lost to Follow-up|0|||
105717102|NCT01262976|364623569|FG003|Up to Year 1|Lost to Follow-up|1|||
105790208|NCT03733301|364885055|FG001|Overall Study|Non-compliance|0|||
105790209|NCT03733301|364885056|FG002|Overall Study|Non-compliance|0|||
105790210|NCT03733301|364885054|FG000|Overall Study|Lack of Efficacy|2|||
105717103|NCT01262976|364623570|FG004|Up to Year 1|Lost to Follow-up|6|||
105717104|NCT01262976|364623571|FG005|Up to Year 1|Lost to Follow-up|5|||
105717105|NCT01262976|364623566|FG000|Up to Year 1|Other|3|||
105717106|NCT01262976|364623567|FG001|Up to Year 1|Other|1|||
105717107|NCT01262976|364623568|FG002|Up to Year 1|Other|0|||
105717108|NCT01262976|364623569|FG003|Up to Year 1|Other|0|||
105717109|NCT01262976|364623570|FG004|Up to Year 1|Other|2|||
105717110|NCT01262976|364623571|FG005|Up to Year 1|Other|1|||
105717111|NCT01262976|364623566|FG000|Up to Year 1|Subjects with unknown completion status|0|||
105561864|NCT02342886|364052241|FG002|Overall Study|Death|1|||
105561865|NCT02342886|364052242|FG003|Overall Study|Death|0|||
105717112|NCT01262976|364623567|FG001|Up to Year 1|Subjects with unknown completion status|0|||
105717113|NCT01262976|364623568|FG002|Up to Year 1|Subjects with unknown completion status|1|||
105717114|NCT01262976|364623569|FG003|Up to Year 1|Subjects with unknown completion status|0|||
105717115|NCT01262976|364623570|FG004|Up to Year 1|Subjects with unknown completion status|0|||
105717116|NCT01262976|364623571|FG005|Up to Year 1|Subjects with unknown completion status|1|||
105717117|NCT01262976|364623566|FG000|Up to Year 2|Serious Adverse Event|0|||
105717118|NCT01262976|364623567|FG001|Up to Year 2|Serious Adverse Event|0|||
105790211|NCT03733301|364885055|FG001|Overall Study|Lack of Efficacy|3|||
105717119|NCT01262976|364623568|FG002|Up to Year 2|Serious Adverse Event|2|||
105717120|NCT01262976|364623569|FG003|Up to Year 2|Serious Adverse Event|0|||
105717121|NCT01262976|364623570|FG004|Up to Year 2|Serious Adverse Event|0|||
105717122|NCT01262976|364623571|FG005|Up to Year 2|Serious Adverse Event|0|||
105717123|NCT01262976|364623566|FG000|Up to Year 2|Withdrawal by Subject|1|||
105717124|NCT01262976|364623567|FG001|Up to Year 2|Withdrawal by Subject|0|||
105352305|NCT01483599|363293847|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
105717125|NCT01262976|364623568|FG002|Up to Year 2|Withdrawal by Subject|0|||
105717126|NCT01262976|364623569|FG003|Up to Year 2|Withdrawal by Subject|0|||
105717127|NCT01262976|364623570|FG004|Up to Year 2|Withdrawal by Subject|0|||
105717128|NCT01262976|364623571|FG005|Up to Year 2|Withdrawal by Subject|0|||
105717129|NCT01262976|364623566|FG000|Up to Year 2|Migrated/moved from study area|0|||
105717130|NCT01262976|364623567|FG001|Up to Year 2|Migrated/moved from study area|0|||
105717131|NCT01262976|364623568|FG002|Up to Year 2|Migrated/moved from study area|0|||
105717132|NCT01262976|364623569|FG003|Up to Year 2|Migrated/moved from study area|2|||
105717133|NCT01262976|364623570|FG004|Up to Year 2|Migrated/moved from study area|1|||
105717134|NCT01262976|364623571|FG005|Up to Year 2|Migrated/moved from study area|2|||
105717135|NCT01262976|364623566|FG000|Up to Year 2|Lost to Follow-up|1|||
105717136|NCT01262976|364623567|FG001|Up to Year 2|Lost to Follow-up|1|||
105717137|NCT01262976|364623568|FG002|Up to Year 2|Lost to Follow-up|2|||
105717138|NCT01262976|364623569|FG003|Up to Year 2|Lost to Follow-up|2|||
105717139|NCT01262976|364623570|FG004|Up to Year 2|Lost to Follow-up|3|||
105717140|NCT01262976|364623571|FG005|Up to Year 2|Lost to Follow-up|3|||
105717141|NCT01262976|364623566|FG000|Up to Year 2|Subjects with unknown completion status|0|||
105717142|NCT01262976|364623567|FG001|Up to Year 2|Subjects with unknown completion status|0|||
105717143|NCT01262976|364623568|FG002|Up to Year 2|Subjects with unknown completion status|1|||
105717144|NCT01262976|364623569|FG003|Up to Year 2|Subjects with unknown completion status|0|||
105717145|NCT01262976|364623570|FG004|Up to Year 2|Subjects with unknown completion status|0|||
105717146|NCT01262976|364623571|FG005|Up to Year 2|Subjects with unknown completion status|0|||
105717147|NCT01262976|364623566|FG000|Up to Year 2|Other|3|||
105717148|NCT01262976|364623567|FG001|Up to Year 2|Other|0|||
105717149|NCT01262976|364623568|FG002|Up to Year 2|Other|0|||
105717150|NCT01262976|364623569|FG003|Up to Year 2|Other|0|||
105717151|NCT01262976|364623570|FG004|Up to Year 2|Other|0|||
105717152|NCT01262976|364623571|FG005|Up to Year 2|Other|0|||
105717153|NCT01262976|364623566|FG000|Up to Year 3|Serious Adverse Event|0|||
105717154|NCT01262976|364623567|FG001|Up to Year 3|Serious Adverse Event|0|||
105717155|NCT01262976|364623568|FG002|Up to Year 3|Serious Adverse Event|2|||
105717156|NCT01262976|364623569|FG003|Up to Year 3|Serious Adverse Event|0|||
105717157|NCT01262976|364623570|FG004|Up to Year 3|Serious Adverse Event|0|||
105717158|NCT01262976|364623571|FG005|Up to Year 3|Serious Adverse Event|0|||
105717159|NCT01262976|364623566|FG000|Up to Year 3|Withdrawal by Subject|1|||
105717160|NCT01262976|364623567|FG001|Up to Year 3|Withdrawal by Subject|0|||
105717161|NCT01262976|364623568|FG002|Up to Year 3|Withdrawal by Subject|0|||
105717162|NCT01262976|364623569|FG003|Up to Year 3|Withdrawal by Subject|0|||
105717163|NCT01262976|364623570|FG004|Up to Year 3|Withdrawal by Subject|0|||
105717164|NCT01262976|364623571|FG005|Up to Year 3|Withdrawal by Subject|0|||
105717165|NCT01262976|364623566|FG000|Up to Year 3|Migrated/moved from study area|0|||
105717166|NCT01262976|364623567|FG001|Up to Year 3|Migrated/moved from study area|0|||
105790212|NCT03733301|364885056|FG002|Overall Study|Lack of Efficacy|0|||
105790213|NCT03733301|364885054|FG000|Overall Study|Adverse Event|0|||
105790214|NCT03733301|364885055|FG001|Overall Study|Adverse Event|1|||
105717167|NCT01262976|364623568|FG002|Up to Year 3|Migrated/moved from study area|0|||
105717168|NCT01262976|364623569|FG003|Up to Year 3|Migrated/moved from study area|2|||
105717169|NCT01262976|364623570|FG004|Up to Year 3|Migrated/moved from study area|1|||
105717170|NCT01262976|364623571|FG005|Up to Year 3|Migrated/moved from study area|1|||
105717171|NCT01262976|364623566|FG000|Up to Year 3|Lost to Follow-up|2|||
105717172|NCT01262976|364623567|FG001|Up to Year 3|Lost to Follow-up|2|||
105717173|NCT01262976|364623568|FG002|Up to Year 3|Lost to Follow-up|4|||
105717174|NCT01262976|364623569|FG003|Up to Year 3|Lost to Follow-up|3|||
105717175|NCT01262976|364623570|FG004|Up to Year 3|Lost to Follow-up|1|||
105717176|NCT01262976|364623571|FG005|Up to Year 3|Lost to Follow-up|3|||
105717177|NCT01262976|364623566|FG000|Up to Year 3|Subjects with unknown completion status|0|||
105717178|NCT01262976|364623567|FG001|Up to Year 3|Subjects with unknown completion status|0|||
105717179|NCT01262976|364623568|FG002|Up to Year 3|Subjects with unknown completion status|1|||
105717180|NCT01262976|364623569|FG003|Up to Year 3|Subjects with unknown completion status|0|||
105717181|NCT01262976|364623570|FG004|Up to Year 3|Subjects with unknown completion status|0|||
105717182|NCT01262976|364623571|FG005|Up to Year 3|Subjects with unknown completion status|0|||
105717183|NCT01262976|364623566|FG000|Up to Year 3|Other|3|||
105717184|NCT01262976|364623567|FG001|Up to Year 3|Other|0|||
105717185|NCT01262976|364623568|FG002|Up to Year 3|Other|0|||
105717186|NCT01262976|364623569|FG003|Up to Year 3|Other|0|||
105717187|NCT01262976|364623570|FG004|Up to Year 3|Other|0|||
105717188|NCT01262976|364623571|FG005|Up to Year 3|Other|0|||
105717189|NCT02690194|364623574|FG000|Overall Study|Withdrawal by Subject|1|||
105717190|NCT02690194|364623575|FG001|Overall Study|Withdrawal by Subject|4|||
105717191|NCT02690194|364623576|FG002|Overall Study|Withdrawal by Subject|0|||
105717192|NCT01987908|364623577|FG000|Placebo Lead-in Period|Adverse Event|2|||
105717193|NCT01987908|364623578|FG001|Placebo Lead-in Period|Adverse Event|0|||
105717194|NCT01987908|364623579|FG002|Placebo Lead-in Period|Adverse Event|0|||
105717195|NCT01987908|364623577|FG000|Placebo Lead-in Period|Physician Decision|2|||
105717196|NCT01987908|364623578|FG001|Placebo Lead-in Period|Physician Decision|0|||
105717197|NCT01987908|364623579|FG002|Placebo Lead-in Period|Physician Decision|0|||
105717198|NCT01987908|364623577|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
105717199|NCT01987908|364623578|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
105717200|NCT01987908|364623579|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
105717201|NCT01987908|364623577|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
105717202|NCT01987908|364623578|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
105717203|NCT01987908|364623579|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
105717204|NCT01987908|364623577|FG000|Treatment Period|Adverse Event|0|||
105717205|NCT01987908|364623578|FG001|Treatment Period|Adverse Event|1|||
105717206|NCT01987908|364623579|FG002|Treatment Period|Adverse Event|1|||
105717207|NCT01987908|364623577|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
105717208|NCT01987908|364623578|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
105717209|NCT01987908|364623579|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
105717210|NCT01987908|364623577|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
105717211|NCT01987908|364623578|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
105717212|NCT01987908|364623579|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
105717213|NCT01528787|364623580|FG000|Overall Study|Withdrawal by Subject|0|||
105717214|NCT01528787|364623581|FG001|Overall Study|Withdrawal by Subject|0|||
105717215|NCT01528787|364623582|FG002|Overall Study|Withdrawal by Subject|0|||
105717216|NCT01528787|364623583|FG003|Overall Study|Withdrawal by Subject|1|||
105717217|NCT01528787|364623580|FG000|Overall Study|Family Emergency|0|||
105717218|NCT01528787|364623581|FG001|Overall Study|Family Emergency|0|||
105717219|NCT01528787|364623582|FG002|Overall Study|Family Emergency|1|||
105717220|NCT01528787|364623583|FG003|Overall Study|Family Emergency|0|||
105717221|NCT00354601|364623592|FG000|Overall Study|Protocol Violation|1|||
105717222|NCT00354601|364623592|FG000|Overall Study|progression|1|||
105717223|NCT01551693|364623594|FG000|Overall Study|Disease Progression|1|||
105717224|NCT01551693|364623595|FG001|Overall Study|Disease Progression|0|||
105717225|NCT01551693|364623594|FG000|Overall Study|Adverse Event|0|||
105717226|NCT01551693|364623595|FG001|Overall Study|Adverse Event|1|||
105717227|NCT01551693|364623594|FG000|Overall Study|Withdrawal by Subject|0|||
105717228|NCT01551693|364623595|FG001|Overall Study|Withdrawal by Subject|1|||
105717229|NCT03603652|364623596|FG000|Overall Study|Death|2|||
105717230|NCT03213366|364623599|FG000|Overall Study|Lost to Follow-up|9|||
105717231|NCT03213366|364623600|FG001|Overall Study|Lost to Follow-up|4|||
105717232|NCT00666926|364623601|FG000|Overall Study|Adverse Event|0|||
105717233|NCT00666926|364623602|FG001|Overall Study|Adverse Event|0|||
105717234|NCT00666926|364623603|FG002|Overall Study|Adverse Event|0|||
105717235|NCT00666926|364623604|FG003|Overall Study|Adverse Event|0|||
105717236|NCT00666926|364623605|FG004|Overall Study|Adverse Event|0|||
105790215|NCT03733301|364885056|FG002|Overall Study|Adverse Event|3|||
105790216|NCT03733301|364885054|FG000|Overall Study|Withdrawal by Subject|3|||
105790217|NCT03733301|364885055|FG001|Overall Study|Withdrawal by Subject|5|||
105790218|NCT03733301|364885056|FG002|Overall Study|Withdrawal by Subject|1|||
105790219|NCT04637815|364885057|FG000|Overall Study|Death|1|||
105790220|NCT04637815|364885058|FG001|Overall Study|Death|0|||
105790221|NCT04637815|364885057|FG000|Overall Study|Lost to Follow-up|5|||
105790222|NCT04637815|364885058|FG001|Overall Study|Lost to Follow-up|2|||
105790223|NCT00209560|364885061|FG000|Overall Study|Lack of Efficacy|1|||
105790224|NCT00209560|364885062|FG001|Overall Study|Lack of Efficacy|0|||
105790225|NCT03280628|364886920|FG000|Overall Study|Lost to Follow-up|8|||
105790226|NCT03280628|364886921|FG001|Overall Study|Lost to Follow-up|6|||
105790227|NCT03280628|364886922|FG002|Overall Study|Lost to Follow-up|11|||
105790228|NCT00347776|364886923|FG000|1.5 Month Follow-up|Death|2|||
105790229|NCT00347776|364886924|FG001|1.5 Month Follow-up|Death|0|||
105790230|NCT00347776|364886925|FG002|1.5 Month Follow-up|Death|0|||
105790231|NCT00347776|364886923|FG000|1.5 Month Follow-up|reached the endpoint|12|||
105790232|NCT00347776|364886924|FG001|1.5 Month Follow-up|reached the endpoint|8|||
105790233|NCT00347776|364886925|FG002|1.5 Month Follow-up|reached the endpoint|12|||
105790234|NCT00347776|364886923|FG000|6 Month Follow-up|Death|2|||
105790235|NCT00347776|364886924|FG001|6 Month Follow-up|Death|1|||
105790236|NCT00347776|364886925|FG002|6 Month Follow-up|Death|3|||
105790237|NCT00347776|364886923|FG000|6 Month Follow-up|reached endpont|20|||
105790238|NCT00347776|364886924|FG001|6 Month Follow-up|reached endpont|12|||
105790239|NCT00347776|364886925|FG002|6 Month Follow-up|reached endpont|15|||
105790240|NCT00347776|364886923|FG000|12 Month Follow-up|Lost to Follow-up|7|||
105790241|NCT00347776|364886924|FG001|12 Month Follow-up|Lost to Follow-up|6|||
105790242|NCT00347776|364886925|FG002|12 Month Follow-up|Lost to Follow-up|6|||
105790243|NCT00347776|364886923|FG000|12 Month Follow-up|Death|3|||
105790244|NCT00347776|364886924|FG001|12 Month Follow-up|Death|4|||
105790245|NCT00347776|364886925|FG002|12 Month Follow-up|Death|4|||
105790246|NCT00347776|364886923|FG000|12 Month Follow-up|Reached endpoint|13|||
105790247|NCT00347776|364886924|FG001|12 Month Follow-up|Reached endpoint|6|||
105790248|NCT00347776|364886925|FG002|12 Month Follow-up|Reached endpoint|9|||
105790249|NCT01340794|364886926|FG000|Overall Study|Withdrawal by Subject|0|||
105790250|NCT01340794|364886927|FG001|Overall Study|Withdrawal by Subject|1|||
105790251|NCT00457249|364886928|FG000|Overall Study|Lost to Follow-up|3|||
105790252|NCT00457249|364886929|FG001|Overall Study|Lost to Follow-up|0|||
105790253|NCT00457249|364886928|FG000|Overall Study|Protocol Violation|4|||
105790254|NCT00457249|364886929|FG001|Overall Study|Protocol Violation|1|||
105790255|NCT00457249|364886928|FG000|Overall Study|Withdrawal by Subject|3|||
105790256|NCT00457249|364886929|FG001|Overall Study|Withdrawal by Subject|1|||
105790257|NCT00457249|364886928|FG000|Overall Study|Serious Adverse Events|2|||
105790258|NCT00457249|364886929|FG001|Overall Study|Serious Adverse Events|0|||
105790259|NCT00396318|364886930|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
105717237|NCT00666926|364623606|FG005|Overall Study|Adverse Event|0|||
105717238|NCT00666926|364623607|FG006|Overall Study|Adverse Event|0|||
105717239|NCT00666926|364623608|FG007|Overall Study|Adverse Event|0|||
105717240|NCT00666926|364623609|FG008|Overall Study|Adverse Event|0|||
105717241|NCT00666926|364623610|FG009|Overall Study|Adverse Event|2|||
105717242|NCT00666926|364623611|FG010|Overall Study|Adverse Event|2|||
105717243|NCT00666926|364623612|FG011|Overall Study|Adverse Event|2|||
105717244|NCT00666926|364623613|FG012|Overall Study|Adverse Event|0|||
105717245|NCT00666926|364623614|FG013|Overall Study|Adverse Event|1|||
105717246|NCT00666926|364623615|FG014|Overall Study|Adverse Event|0|||
105717247|NCT00666926|364623616|FG015|Overall Study|Adverse Event|0|||
105717248|NCT00666926|364623601|FG000|Overall Study|Laboratory abnormality|0|||
105717249|NCT00666926|364623602|FG001|Overall Study|Laboratory abnormality|0|||
105717250|NCT00666926|364623603|FG002|Overall Study|Laboratory abnormality|0|||
105717251|NCT00666926|364623604|FG003|Overall Study|Laboratory abnormality|0|||
105717252|NCT00666926|364623605|FG004|Overall Study|Laboratory abnormality|0|||
105717253|NCT00666926|364623606|FG005|Overall Study|Laboratory abnormality|0|||
105790260|NCT00326118|364886931|FG000|Active Phase|Withdrawal by Subject|4|||
105717254|NCT00666926|364623607|FG006|Overall Study|Laboratory abnormality|0|||
105717255|NCT00666926|364623608|FG007|Overall Study|Laboratory abnormality|0|||
105790261|NCT00326118|364886932|FG001|Active Phase|Withdrawal by Subject|1|||
105790262|NCT01118949|364886933|FG000|Overall Study|Adverse Event|5|||
105717256|NCT00666926|364623609|FG008|Overall Study|Laboratory abnormality|0|||
105790263|NCT01118949|364886933|FG000|Overall Study|Withdrawal by Subject|4|||
105717257|NCT00666926|364623610|FG009|Overall Study|Laboratory abnormality|0|||
105717258|NCT00666926|364623611|FG010|Overall Study|Laboratory abnormality|1|||
105790264|NCT00290511|364886939|FG000|Overall Study|Adverse Event|1|||
105790265|NCT00290511|364886939|FG000|Overall Study|Death|1|||
105790266|NCT00290511|364886939|FG000|Overall Study|Physician Decision|1|||
105790267|NCT00290511|364886939|FG000|Overall Study|Withdrawal by Subject|1|||
105790268|NCT03255226|364886940|FG000|Overall Study|Adverse Event|2|||
105790269|NCT03255226|364886940|FG000|Overall Study|Physician Decision|3|||
105790270|NCT03255226|364886940|FG000|Overall Study|Withdrawal by Subject|1|||
105790271|NCT03255226|364886940|FG000|Overall Study|Serum or blood sodium increased|4|||
105790272|NCT03255226|364886940|FG000|Overall Study|Serum or blood potassium increased|4|||
105790273|NCT00602927|364886941|FG000|Period 1: 13 Days|Protocol Violation|2|||
105790274|NCT00602927|364886942|FG001|Period 1: 13 Days|Protocol Violation|4|||
105790275|NCT00602927|364886941|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
105790276|NCT00602927|364886942|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
105790277|NCT00602927|364886941|FG000|Period 1: 13 Days|Time|1|||
105790278|NCT00602927|364886942|FG001|Period 1: 13 Days|Time|0|||
105790279|NCT00602927|364886941|FG000|Period 1: 13 Days|Claustrophobia|0|||
105790280|NCT00602927|364886942|FG001|Period 1: 13 Days|Claustrophobia|1|||
105790281|NCT00602927|364886941|FG000|Period 2: 14 Days|Protocol Violation|0|||
105790282|NCT00602927|364886942|FG001|Period 2: 14 Days|Protocol Violation|2|||
105790283|NCT00602927|364886941|FG000|Period 3: 13 Days|Protocol Violation|0|||
105790284|NCT00602927|364886942|FG001|Period 3: 13 Days|Protocol Violation|1|||
105790285|NCT00602927|364886941|FG000|Period 3: 13 Days|MRI data quality|2|||
105790286|NCT00602927|364886942|FG001|Period 3: 13 Days|MRI data quality|2|||
105790287|NCT05378269|364886943|FG000|Overall Study|Protocol Violation|1|||
105790288|NCT05378269|364886944|FG001|Overall Study|Protocol Violation|0|||
105790289|NCT05378269|364886945|FG002|Overall Study|Protocol Violation|2|||
105790290|NCT05378269|364886946|FG003|Overall Study|Protocol Violation|0|||
105790291|NCT05378269|364886947|FG004|Overall Study|Protocol Violation|0|||
105790292|NCT01728376|364886948|FG000|Overall Study|Adverse Event|1|||
105790293|NCT01728376|364886949|FG001|Overall Study|Adverse Event|1|||
105790294|NCT01728376|364886950|FG002|Overall Study|Adverse Event|1|||
105790295|NCT01728376|364886951|FG003|Overall Study|Adverse Event|1|||
105790296|NCT01728376|364886952|FG004|Overall Study|Adverse Event|1|||
105790297|NCT01728376|364886953|FG005|Overall Study|Adverse Event|0|||
105790298|NCT01728376|364886948|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
105790299|NCT01728376|364886949|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
105790300|NCT01728376|364886950|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
105790301|NCT01728376|364886951|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
105790302|NCT01728376|364886952|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
105790303|NCT01728376|364886953|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
105790304|NCT01728376|364886948|FG000|Overall Study|No relevant bacteria|2|||
105790305|NCT01728376|364886949|FG001|Overall Study|No relevant bacteria|0|||
105790306|NCT01728376|364886950|FG002|Overall Study|No relevant bacteria|0|||
105790307|NCT01728376|364886951|FG003|Overall Study|No relevant bacteria|0|||
105790308|NCT01728376|364886952|FG004|Overall Study|No relevant bacteria|1|||
105790309|NCT01728376|364886953|FG005|Overall Study|No relevant bacteria|1|||
105790310|NCT01728376|364886948|FG000|Overall Study|Did not receive treatment|0|||
105790311|NCT01728376|364886949|FG001|Overall Study|Did not receive treatment|1|||
105790312|NCT01728376|364886950|FG002|Overall Study|Did not receive treatment|0|||
105790313|NCT01728376|364886951|FG003|Overall Study|Did not receive treatment|0|||
105790314|NCT01728376|364886952|FG004|Overall Study|Did not receive treatment|0|||
105790315|NCT01728376|364886953|FG005|Overall Study|Did not receive treatment|0|||
105790316|NCT01728376|364886948|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
105790317|NCT01728376|364886949|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
105790318|NCT01728376|364886950|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
105790319|NCT01728376|364886951|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
105790320|NCT01728376|364886952|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
105790321|NCT01728376|364886953|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
105790322|NCT01035229|364886954|FG000|Overall Study|Adverse Event|61|||
105790323|NCT01035229|364886955|FG001|Overall Study|Adverse Event|14|||
105790324|NCT01035229|364886954|FG000|Overall Study|Withdrawal by Subject|20|||
105790325|NCT01035229|364886955|FG001|Overall Study|Withdrawal by Subject|7|||
105790326|NCT01035229|364886954|FG000|Overall Study|Lost to Follow-up|1|||
105790327|NCT01035229|364886955|FG001|Overall Study|Lost to Follow-up|0|||
105790328|NCT01035229|364886954|FG000|Overall Study|Administrative problems|1|||
105790329|NCT01035229|364886955|FG001|Overall Study|Administrative problems|1|||
105790330|NCT01035229|364886954|FG000|Overall Study|Death|13|||
105790331|NCT01035229|364886955|FG001|Overall Study|Death|5|||
105790332|NCT01035229|364886954|FG000|Overall Study|New cancer therapy|2|||
105790333|NCT01035229|364886955|FG001|Overall Study|New cancer therapy|0|||
105790334|NCT01035229|364886954|FG000|Overall Study|Protocol Violation|0|||
105790335|NCT01035229|364886955|FG001|Overall Study|Protocol Violation|2|||
105790336|NCT01035229|364886954|FG000|Overall Study|Sponsor's decision to end study|3|||
105790337|NCT01035229|364886955|FG001|Overall Study|Sponsor's decision to end study|3|||
105790338|NCT01035229|364886954|FG000|Overall Study|Disease Progression|261|||
105790339|NCT01035229|364886955|FG001|Overall Study|Disease Progression|152|||
105790340|NCT03862807|364886966|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
105790341|NCT04362761|364886967|FG000|Part A (48 Weeks)|Adverse Event|2|||
105790342|NCT04362761|364886967|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
105790343|NCT04362761|364886967|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
105790344|NCT04362761|364886967|FG000|Part A (48 Weeks)|Other|5|||
105790345|NCT04362761|364886967|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
105790346|NCT04362761|364886967|FG000|Part B (86 Weeks)|Other|4|||
105790347|NCT00684645|364886968|FG000|Overall Study|Death|2|||
105790348|NCT00684645|364886968|FG000|Overall Study|Progressive disease|67|||
105717259|NCT00666926|364623612|FG011|Overall Study|Laboratory abnormality|0|||
105717260|NCT00666926|364623613|FG012|Overall Study|Laboratory abnormality|0|||
105717261|NCT00666926|364623614|FG013|Overall Study|Laboratory abnormality|0|||
105717262|NCT00666926|364623615|FG014|Overall Study|Laboratory abnormality|0|||
105717263|NCT00666926|364623616|FG015|Overall Study|Laboratory abnormality|1|||
105717264|NCT00666926|364623601|FG000|Overall Study|Lack of Efficacy|0|||
105717265|NCT00666926|364623602|FG001|Overall Study|Lack of Efficacy|0|||
105717266|NCT00666926|364623603|FG002|Overall Study|Lack of Efficacy|0|||
105717267|NCT00666926|364623604|FG003|Overall Study|Lack of Efficacy|0|||
105717268|NCT00666926|364623605|FG004|Overall Study|Lack of Efficacy|0|||
105717269|NCT00666926|364623606|FG005|Overall Study|Lack of Efficacy|1|||
105717270|NCT00666926|364623607|FG006|Overall Study|Lack of Efficacy|0|||
105717271|NCT00666926|364623608|FG007|Overall Study|Lack of Efficacy|0|||
105717272|NCT00666926|364623609|FG008|Overall Study|Lack of Efficacy|0|||
105717273|NCT00666926|364623610|FG009|Overall Study|Lack of Efficacy|0|||
105717274|NCT00666926|364623611|FG010|Overall Study|Lack of Efficacy|0|||
105717275|NCT00666926|364623612|FG011|Overall Study|Lack of Efficacy|1|||
105717276|NCT00666926|364623613|FG012|Overall Study|Lack of Efficacy|0|||
105717277|NCT00666926|364623614|FG013|Overall Study|Lack of Efficacy|0|||
105717278|NCT00666926|364623615|FG014|Overall Study|Lack of Efficacy|0|||
105717279|NCT00666926|364623616|FG015|Overall Study|Lack of Efficacy|0|||
105717280|NCT00666926|364623601|FG000|Overall Study|Lost to Follow-up|0|||
105717281|NCT00666926|364623602|FG001|Overall Study|Lost to Follow-up|0|||
105717282|NCT00666926|364623603|FG002|Overall Study|Lost to Follow-up|0|||
105717283|NCT00666926|364623604|FG003|Overall Study|Lost to Follow-up|1|||
105717284|NCT00666926|364623605|FG004|Overall Study|Lost to Follow-up|0|||
105717285|NCT00666926|364623606|FG005|Overall Study|Lost to Follow-up|0|||
105717286|NCT00666926|364623607|FG006|Overall Study|Lost to Follow-up|0|||
105717287|NCT00666926|364623608|FG007|Overall Study|Lost to Follow-up|0|||
105717288|NCT00666926|364623609|FG008|Overall Study|Lost to Follow-up|0|||
105717289|NCT00666926|364623610|FG009|Overall Study|Lost to Follow-up|0|||
105717290|NCT00666926|364623611|FG010|Overall Study|Lost to Follow-up|0|||
105717291|NCT00666926|364623612|FG011|Overall Study|Lost to Follow-up|0|||
105717292|NCT00666926|364623613|FG012|Overall Study|Lost to Follow-up|0|||
105717293|NCT00666926|364623614|FG013|Overall Study|Lost to Follow-up|0|||
105717294|NCT00666926|364623615|FG014|Overall Study|Lost to Follow-up|0|||
105717295|NCT00666926|364623616|FG015|Overall Study|Lost to Follow-up|0|||
105717296|NCT00666926|364623601|FG000|Overall Study|Other|2|||
105717297|NCT00666926|364623602|FG001|Overall Study|Other|4|||
105717298|NCT00666926|364623603|FG002|Overall Study|Other|3|||
105717299|NCT00666926|364623604|FG003|Overall Study|Other|3|||
105717300|NCT00666926|364623605|FG004|Overall Study|Other|3|||
105717301|NCT00666926|364623606|FG005|Overall Study|Other|3|||
105717302|NCT00666926|364623607|FG006|Overall Study|Other|4|||
105717303|NCT00666926|364623608|FG007|Overall Study|Other|0|||
105717304|NCT00666926|364623609|FG008|Overall Study|Other|3|||
105717305|NCT00666926|364623610|FG009|Overall Study|Other|5|||
105717306|NCT00666926|364623611|FG010|Overall Study|Other|3|||
105717307|NCT00666926|364623612|FG011|Overall Study|Other|26|||
105717308|NCT00666926|364623613|FG012|Overall Study|Other|3|||
105717309|NCT00666926|364623614|FG013|Overall Study|Other|2|||
105717310|NCT00666926|364623615|FG014|Overall Study|Other|4|||
105717311|NCT00666926|364623616|FG015|Overall Study|Other|4|||
105717312|NCT00666926|364623601|FG000|Overall Study|Withdrawal by Subject|0|||
105717313|NCT00666926|364623602|FG001|Overall Study|Withdrawal by Subject|0|||
105717314|NCT00666926|364623603|FG002|Overall Study|Withdrawal by Subject|0|||
105717315|NCT00666926|364623604|FG003|Overall Study|Withdrawal by Subject|0|||
105717316|NCT00666926|364623605|FG004|Overall Study|Withdrawal by Subject|0|||
105717317|NCT00666926|364623606|FG005|Overall Study|Withdrawal by Subject|0|||
105717318|NCT00666926|364623607|FG006|Overall Study|Withdrawal by Subject|0|||
105717319|NCT00666926|364623608|FG007|Overall Study|Withdrawal by Subject|1|||
105717320|NCT00666926|364623609|FG008|Overall Study|Withdrawal by Subject|0|||
105717321|NCT00666926|364623610|FG009|Overall Study|Withdrawal by Subject|3|||
105717322|NCT00666926|364623611|FG010|Overall Study|Withdrawal by Subject|0|||
105717323|NCT00666926|364623612|FG011|Overall Study|Withdrawal by Subject|3|||
105717324|NCT00666926|364623613|FG012|Overall Study|Withdrawal by Subject|0|||
105717325|NCT00666926|364623614|FG013|Overall Study|Withdrawal by Subject|1|||
105717326|NCT00666926|364623615|FG014|Overall Study|Withdrawal by Subject|3|||
105717327|NCT00666926|364623616|FG015|Overall Study|Withdrawal by Subject|3|||
105717328|NCT00666926|364623601|FG000|Overall Study|Death|0|||
105717329|NCT00666926|364623602|FG001|Overall Study|Death|0|||
105717330|NCT00666926|364623603|FG002|Overall Study|Death|0|||
105717331|NCT00666926|364623604|FG003|Overall Study|Death|0|||
105717332|NCT00666926|364623605|FG004|Overall Study|Death|0|||
105717333|NCT00666926|364623606|FG005|Overall Study|Death|0|||
105477409|NCT01578850|363759335|FG001|Period 2|Unspecified Reasons|1|||
105717334|NCT00666926|364623607|FG006|Overall Study|Death|0|||
105717335|NCT00666926|364623608|FG007|Overall Study|Death|0|||
105717336|NCT00666926|364623609|FG008|Overall Study|Death|0|||
105717337|NCT00666926|364623610|FG009|Overall Study|Death|0|||
105717338|NCT00666926|364623611|FG010|Overall Study|Death|0|||
105717339|NCT00666926|364623612|FG011|Overall Study|Death|1|||
105561866|NCT02342886|364052243|FG004|Overall Study|Death|1|||
105717340|NCT00666926|364623613|FG012|Overall Study|Death|0|||
105717341|NCT00666926|364623614|FG013|Overall Study|Death|0|||
105717342|NCT00666926|364623615|FG014|Overall Study|Death|0|||
105717343|NCT00666926|364623616|FG015|Overall Study|Death|0|||
105717344|NCT01727258|364623617|FG000|Overall Study|Adverse Event|0|||
105717345|NCT01727258|364623618|FG001|Overall Study|Adverse Event|2|||
105717346|NCT01727258|364623619|FG002|Overall Study|Adverse Event|0|||
105717347|NCT01727258|364623617|FG000|Overall Study|Noncompliance with Study Drug|0|||
105717348|NCT01727258|364623618|FG001|Overall Study|Noncompliance with Study Drug|0|||
105717349|NCT01727258|364623619|FG002|Overall Study|Noncompliance with Study Drug|1|||
105717350|NCT01727258|364623617|FG000|Overall Study|Withdrawal by Subject|1|||
105717351|NCT01727258|364623618|FG001|Overall Study|Withdrawal by Subject|1|||
105717352|NCT01727258|364623619|FG002|Overall Study|Withdrawal by Subject|0|||
105717353|NCT01727258|364623617|FG000|Overall Study|Lost to Follow-up|1|||
105717354|NCT01727258|364623618|FG001|Overall Study|Lost to Follow-up|0|||
105717355|NCT01727258|364623619|FG002|Overall Study|Lost to Follow-up|0|||
105717356|NCT02058147|364623620|FG000|Overall Study|Randomized but not treated|0|||
105717357|NCT02058147|364623621|FG001|Overall Study|Randomized but not treated|0|||
105717358|NCT02058147|364623622|FG002|Overall Study|Randomized but not treated|1|||
105717359|NCT02058147|364623620|FG000|Overall Study|Adverse Event|12|||
105717360|NCT02058147|364623621|FG001|Overall Study|Adverse Event|9|||
105717361|NCT02058147|364623622|FG002|Overall Study|Adverse Event|21|||
105717362|NCT02058147|364623620|FG000|Overall Study|Lack of Efficacy|1|||
105717363|NCT02058147|364623621|FG001|Overall Study|Lack of Efficacy|0|||
105717364|NCT02058147|364623622|FG002|Overall Study|Lack of Efficacy|3|||
105717365|NCT02058147|364623620|FG000|Overall Study|Poor compliance to protocol|8|||
105717366|NCT02058147|364623621|FG001|Overall Study|Poor compliance to protocol|9|||
105717367|NCT02058147|364623622|FG002|Overall Study|Poor compliance to protocol|4|||
105717368|NCT02058147|364623620|FG000|Overall Study|Other than specified|8|||
105717369|NCT02058147|364623621|FG001|Overall Study|Other than specified|9|||
105717370|NCT02058147|364623622|FG002|Overall Study|Other than specified|0|||
105717371|NCT01486199|364623623|FG000|Two Year Period Between Study Days|Physician Decision|1|||
105717372|NCT01486199|364623624|FG001|Two Year Period Between Study Days|Physician Decision|0|||
105717373|NCT02471716|364623625|FG000|Overall Study|Withdrawal by Subject|0|||
105717374|NCT02471716|364623626|FG001|Overall Study|Withdrawal by Subject|1|||
105717375|NCT02471716|364623627|FG002|Overall Study|Withdrawal by Subject|0|||
105717376|NCT02471716|364623628|FG003|Overall Study|Withdrawal by Subject|2|||
105717377|NCT02471716|364623629|FG004|Overall Study|Withdrawal by Subject|5|||
105717378|NCT02471716|364623625|FG000|Overall Study|Study Terminiated by sponsor|0|||
105717379|NCT02471716|364623626|FG001|Overall Study|Study Terminiated by sponsor|0|||
105717380|NCT02471716|364623627|FG002|Overall Study|Study Terminiated by sponsor|0|||
105790349|NCT00684645|364886968|FG000|Overall Study|Adverse Event|27|||
105790350|NCT00684645|364886968|FG000|Overall Study|Lost to Follow-up|3|||
105790351|NCT00684645|364886968|FG000|Overall Study|Other|15|||
105790352|NCT00057330|364886975|FG000|Overall Study|Adverse Event|9|||
105790353|NCT00057330|364886976|FG001|Overall Study|Adverse Event|12|||
105790354|NCT00057330|364886975|FG000|Overall Study|Death|1|||
105790355|NCT00057330|364886976|FG001|Overall Study|Death|0|||
105790356|NCT00057330|364886975|FG000|Overall Study|Protocol Violation|1|||
105790357|NCT00057330|364886976|FG001|Overall Study|Protocol Violation|1|||
105790358|NCT00057330|364886975|FG000|Overall Study|Withdrawal by Subject|115|||
105790359|NCT00057330|364886976|FG001|Overall Study|Withdrawal by Subject|84|||
105790360|NCT00057330|364886975|FG000|Overall Study|Lost to Follow-up|745|||
105790361|NCT00057330|364886976|FG001|Overall Study|Lost to Follow-up|617|||
105790362|NCT00057330|364886975|FG000|Overall Study|Physician Decision|1|||
105790363|NCT00057330|364886976|FG001|Overall Study|Physician Decision|0|||
105790364|NCT00057330|364886975|FG000|Overall Study|Other|260|||
105790365|NCT00057330|364886976|FG001|Overall Study|Other|206|||
105790366|NCT00798707|364886979|FG000|Overall Study|Adverse Event|6|||
105790367|NCT00798707|364886980|FG001|Overall Study|Adverse Event|8|||
105790368|NCT00798707|364886981|FG002|Overall Study|Adverse Event|8|||
105790369|NCT00798707|364886979|FG000|Overall Study|Failed to return|2|||
105790370|NCT00798707|364886980|FG001|Overall Study|Failed to return|2|||
105790371|NCT00798707|364886981|FG002|Overall Study|Failed to return|0|||
105790372|NCT00798707|364886979|FG000|Overall Study|Investigator|0|||
105790373|NCT00798707|364886980|FG001|Overall Study|Investigator|1|||
105790374|NCT00798707|364886981|FG002|Overall Study|Investigator|2|||
105790375|NCT00798707|364886979|FG000|Overall Study|Lack of Efficacy|2|||
105790376|NCT00798707|364886980|FG001|Overall Study|Lack of Efficacy|2|||
105790377|NCT00798707|364886981|FG002|Overall Study|Lack of Efficacy|1|||
105790378|NCT00798707|364886979|FG000|Overall Study|Lost to Follow-up|5|||
105790379|NCT00798707|364886980|FG001|Overall Study|Lost to Follow-up|6|||
105790380|NCT00798707|364886981|FG002|Overall Study|Lost to Follow-up|6|||
105790381|NCT00798707|364886979|FG000|Overall Study|Other|0|||
105790382|NCT00798707|364886980|FG001|Overall Study|Other|1|||
105790383|NCT00798707|364886981|FG002|Overall Study|Other|0|||
105790384|NCT00798707|364886979|FG000|Overall Study|Protocol Violation|4|||
105790385|NCT00798707|364886980|FG001|Overall Study|Protocol Violation|0|||
105790386|NCT00798707|364886981|FG002|Overall Study|Protocol Violation|2|||
105790387|NCT00798707|364886979|FG000|Overall Study|Withdrawal by Subject|3|||
105790388|NCT00798707|364886980|FG001|Overall Study|Withdrawal by Subject|8|||
105790389|NCT00798707|364886981|FG002|Overall Study|Withdrawal by Subject|2|||
105790390|NCT00798707|364886979|FG000|Overall Study|Randomized not treated|4|||
105790391|NCT00798707|364886980|FG001|Overall Study|Randomized not treated|5|||
105790392|NCT00798707|364886981|FG002|Overall Study|Randomized not treated|1|||
105790393|NCT01473589|364886984|FG000|Overall Study|Adverse Event|1|||
105790394|NCT01473589|364886985|FG001|Overall Study|Adverse Event|1|||
105790395|NCT01473589|364886984|FG000|Overall Study|Death|2|||
105790396|NCT01473589|364886985|FG001|Overall Study|Death|0|||
105790397|NCT01473589|364886984|FG000|Overall Study|Lost to Follow-up|2|||
105790398|NCT01473589|364886985|FG001|Overall Study|Lost to Follow-up|2|||
105790399|NCT01473589|364886984|FG000|Overall Study|Protocol Violation|1|||
105477410|NCT01578850|363759336|FG002|Period 2|Unspecified Reasons|0|||
105477411|NCT00744042|363759337|FG000|Overall Study|Withdrawal by Subject|1|||
105790400|NCT01473589|364886985|FG001|Overall Study|Protocol Violation|0|||
105477412|NCT03060551|363759345|FG000|Overall Study|Withdrawal by Subject|1|||
105477413|NCT03060551|363759345|FG000|Overall Study|Adverse Event|1|||
105477414|NCT01642615|363759346|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
105790401|NCT01473589|364886984|FG000|Overall Study|Withdrawal by Subject|5|||
105790402|NCT01473589|364886985|FG001|Overall Study|Withdrawal by Subject|11|||
105790403|NCT01473589|364886984|FG000|Overall Study|Physician Decision|0|||
105790404|NCT01473589|364886985|FG001|Overall Study|Physician Decision|1|||
105790405|NCT01473589|364886984|FG000|Overall Study|Entry criteria not met|0|||
105790406|NCT01473589|364886985|FG001|Overall Study|Entry criteria not met|1|||
105790407|NCT01607398|364886989|FG000|Overall Study|Adverse Event|0|||
105790408|NCT01607398|364886990|FG001|Overall Study|Adverse Event|2|||
105790409|NCT01607398|364886989|FG000|Overall Study|Severe COPD|2|||
105790410|NCT01607398|364886990|FG001|Overall Study|Severe COPD|0|||
105790411|NCT01491737|364886996|FG000|Overall Study|Withdrawal by Subject|20|||
105717381|NCT02471716|364623628|FG003|Overall Study|Study Terminiated by sponsor|1|||
105717382|NCT02471716|364623629|FG004|Overall Study|Study Terminiated by sponsor|0|||
105717383|NCT02471716|364623625|FG000|Overall Study|Lost to Follow-up|0|||
105717384|NCT02471716|364623626|FG001|Overall Study|Lost to Follow-up|0|||
105717385|NCT02471716|364623627|FG002|Overall Study|Lost to Follow-up|0|||
105717386|NCT02471716|364623628|FG003|Overall Study|Lost to Follow-up|3|||
105717387|NCT02471716|364623629|FG004|Overall Study|Lost to Follow-up|2|||
105717388|NCT02471716|364623625|FG000|Overall Study|Death|0|||
105717389|NCT02471716|364623626|FG001|Overall Study|Death|0|||
105717390|NCT02471716|364623627|FG002|Overall Study|Death|0|||
105717391|NCT02471716|364623628|FG003|Overall Study|Death|1|||
105717392|NCT02471716|364623629|FG004|Overall Study|Death|0|||
105717393|NCT02471716|364623625|FG000|Overall Study|Other|0|||
105717394|NCT02471716|364623626|FG001|Overall Study|Other|0|||
105717395|NCT02471716|364623627|FG002|Overall Study|Other|0|||
105717396|NCT02471716|364623628|FG003|Overall Study|Other|8|||
105717397|NCT02471716|364623629|FG004|Overall Study|Other|9|||
105717398|NCT03604445|364623633|FG000|Overall Study|Death|0|||
105717399|NCT03604445|364623634|FG001|Overall Study|Death|0|||
105717400|NCT03604445|364623635|FG002|Overall Study|Death|0|||
105717401|NCT03604445|364623636|FG003|Overall Study|Death|0|||
105717402|NCT03604445|364623637|FG004|Overall Study|Death|0|||
105717403|NCT03604445|364623638|FG005|Overall Study|Death|0|||
105717404|NCT03604445|364623639|FG006|Overall Study|Death|0|||
105717405|NCT03604445|364623640|FG007|Overall Study|Death|0|||
105717406|NCT03604445|364623641|FG008|Overall Study|Death|1|||
105717407|NCT03604445|364623633|FG000|Overall Study|Withdrawal by Subject|0|||
105717408|NCT03604445|364623634|FG001|Overall Study|Withdrawal by Subject|0|||
105717409|NCT03604445|364623635|FG002|Overall Study|Withdrawal by Subject|0|||
105717410|NCT03604445|364623636|FG003|Overall Study|Withdrawal by Subject|0|||
105717411|NCT03604445|364623637|FG004|Overall Study|Withdrawal by Subject|0|||
105717412|NCT03604445|364623638|FG005|Overall Study|Withdrawal by Subject|0|||
105717413|NCT03604445|364623639|FG006|Overall Study|Withdrawal by Subject|1|||
105717414|NCT03604445|364623640|FG007|Overall Study|Withdrawal by Subject|0|||
105717415|NCT03604445|364623641|FG008|Overall Study|Withdrawal by Subject|0|||
105717416|NCT03604445|364623633|FG000|Overall Study|Missing visit|0|||
105717417|NCT03604445|364623634|FG001|Overall Study|Missing visit|0|||
105717418|NCT03604445|364623635|FG002|Overall Study|Missing visit|0|||
105717419|NCT03604445|364623636|FG003|Overall Study|Missing visit|0|||
105717420|NCT03604445|364623637|FG004|Overall Study|Missing visit|0|||
105717421|NCT03604445|364623638|FG005|Overall Study|Missing visit|1|||
105717422|NCT03604445|364623639|FG006|Overall Study|Missing visit|0|||
105717423|NCT03604445|364623640|FG007|Overall Study|Missing visit|1|||
105717424|NCT03604445|364623641|FG008|Overall Study|Missing visit|0|||
105717425|NCT03604445|364623633|FG000|Overall Study|Adverse Event|0|||
105717426|NCT03604445|364623634|FG001|Overall Study|Adverse Event|0|||
105717427|NCT03604445|364623635|FG002|Overall Study|Adverse Event|0|||
105717428|NCT03604445|364623636|FG003|Overall Study|Adverse Event|1|||
105717429|NCT03604445|364623637|FG004|Overall Study|Adverse Event|0|||
105717430|NCT03604445|364623638|FG005|Overall Study|Adverse Event|0|||
105717431|NCT03604445|364623639|FG006|Overall Study|Adverse Event|0|||
105717432|NCT03604445|364623640|FG007|Overall Study|Adverse Event|0|||
105717433|NCT03604445|364623641|FG008|Overall Study|Adverse Event|1|||
105717434|NCT01014585|364623648|FG000|Overall Study|Adverse Event|0|||
105717435|NCT01014585|364623649|FG001|Overall Study|Adverse Event|2|||
105717436|NCT01014585|364623650|FG002|Overall Study|Adverse Event|0|||
105717437|NCT01014585|364623651|FG003|Overall Study|Adverse Event|3|||
105717438|NCT01014585|364623648|FG000|Overall Study|Withdrawal by Subject|2|||
105790412|NCT01491737|364886997|FG001|Overall Study|Withdrawal by Subject|17|||
105790413|NCT01491737|364886996|FG000|Overall Study|Lost to Follow-up|2|||
105717439|NCT01014585|364623649|FG001|Overall Study|Withdrawal by Subject|0|||
105717440|NCT01014585|364623650|FG002|Overall Study|Withdrawal by Subject|1|||
105717441|NCT01014585|364623651|FG003|Overall Study|Withdrawal by Subject|3|||
105717442|NCT01014585|364623648|FG000|Overall Study|Lost to Follow-up|0|||
105717443|NCT01014585|364623649|FG001|Overall Study|Lost to Follow-up|0|||
105717444|NCT01014585|364623650|FG002|Overall Study|Lost to Follow-up|0|||
105717445|NCT01014585|364623651|FG003|Overall Study|Lost to Follow-up|2|||
105717446|NCT01014585|364623648|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
105717447|NCT01014585|364623649|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
105717448|NCT01014585|364623650|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
105790414|NCT01491737|364886997|FG001|Overall Study|Lost to Follow-up|10|||
105717449|NCT01014585|364623651|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
105717450|NCT00713219|364623655|FG000|Overall Study|Death|1|||
105717451|NCT00713219|364623655|FG000|Overall Study|Protocol Violation|1|||
105717452|NCT02817087|364623656|FG000|Overall Study|Withdrawal by Subject|2|||
105717453|NCT02817087|364623657|FG001|Overall Study|Withdrawal by Subject|0|||
105717454|NCT01557166|364623667|FG000|Overall Study|Adverse Event|20|||
105717455|NCT01557166|364623668|FG001|Overall Study|Adverse Event|6|||
105717456|NCT01557166|364623667|FG000|Overall Study|Lack of Efficacy|2|||
105790415|NCT01491737|364886996|FG000|Overall Study|Death|63|||
105790416|NCT01491737|364886997|FG001|Overall Study|Death|57|||
105790417|NCT01491737|364886996|FG000|Overall Study|Study Termination by Sponsor|36|||
105790418|NCT01491737|364886997|FG001|Overall Study|Study Termination by Sponsor|36|||
105790419|NCT01491737|364886996|FG000|Overall Study|Reason Not Specified|8|||
105790420|NCT01491737|364886997|FG001|Overall Study|Reason Not Specified|9|||
105790421|NCT00297882|364887004|FG000|Day 14|Lack of Efficacy|12|||
105790422|NCT00297882|364887005|FG001|Day 14|Lack of Efficacy|49|||
105790423|NCT00297882|364887004|FG000|Day 28|Lost to Follow-up|13|||
105790424|NCT00297882|364887005|FG001|Day 28|Lost to Follow-up|23|||
105790425|NCT00297882|364887004|FG000|Day 28|Lack of Efficacy|3|||
105790426|NCT00297882|364887005|FG001|Day 28|Lack of Efficacy|0|||
105790427|NCT04242264|364887006|FG000|Overall Study|Lost to Follow-up|2|||
105790428|NCT04242264|364887007|FG001|Overall Study|Lost to Follow-up|2|||
105790429|NCT04242264|364887008|FG002|Overall Study|Lost to Follow-up|1|||
105790430|NCT04242264|364887009|FG003|Overall Study|Lost to Follow-up|1|||
105790431|NCT04242264|364887006|FG000|Overall Study|Withdrawal by Subject|1|||
105790432|NCT04242264|364887007|FG001|Overall Study|Withdrawal by Subject|0|||
105790433|NCT04242264|364887008|FG002|Overall Study|Withdrawal by Subject|0|||
105790434|NCT04242264|364887009|FG003|Overall Study|Withdrawal by Subject|0|||
105790435|NCT00578448|364887010|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
105790436|NCT00578448|364887010|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
105790437|NCT00578448|364887010|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
105790438|NCT00578448|364887010|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
105790439|NCT01976104|364887011|FG000|Overall Study|Adverse Event|0|||
105790440|NCT01976104|364887012|FG001|Overall Study|Adverse Event|0|||
105790441|NCT01976104|364887013|FG002|Overall Study|Adverse Event|1|||
105790442|NCT01976104|364887014|FG003|Overall Study|Adverse Event|0|||
105790443|NCT01976104|364887011|FG000|Overall Study|Lost to Follow-up|3|||
105790444|NCT01976104|364887012|FG001|Overall Study|Lost to Follow-up|0|||
105790445|NCT01976104|364887013|FG002|Overall Study|Lost to Follow-up|1|||
105790446|NCT01976104|364887014|FG003|Overall Study|Lost to Follow-up|1|||
105790447|NCT01976104|364887011|FG000|Overall Study|Subject Choice|0|||
105790448|NCT01976104|364887012|FG001|Overall Study|Subject Choice|1|||
105717457|NCT01557166|364623668|FG001|Overall Study|Lack of Efficacy|1|||
105717458|NCT01557166|364623667|FG000|Overall Study|Protocol Violation|8|||
105717459|NCT01557166|364623668|FG001|Overall Study|Protocol Violation|5|||
105717460|NCT01557166|364623667|FG000|Overall Study|Withdrawn consent|12|||
105717461|NCT01557166|364623668|FG001|Overall Study|Withdrawn consent|20|||
105717462|NCT01557166|364623667|FG000|Overall Study|Target dose not tolerated|1|||
105717463|NCT01557166|364623668|FG001|Overall Study|Target dose not tolerated|0|||
105717464|NCT01557166|364623667|FG000|Overall Study|Psychiatric disorder|1|||
105717465|NCT01557166|364623668|FG001|Overall Study|Psychiatric disorder|0|||
105717466|NCT01557166|364623667|FG000|Overall Study|Unclassified|2|||
105717467|NCT01557166|364623668|FG001|Overall Study|Unclassified|5|||
105717468|NCT05847686|364624949|FG000|Overall Study|Withdrawal by Subject|3|||
105717469|NCT02554929|364624952|FG000|Overall Study|Lost to Follow-up|4|||
105717470|NCT02554929|364624953|FG001|Overall Study|Lost to Follow-up|4|||
105717471|NCT02554929|364624952|FG000|Overall Study|Withdrawal by Subject|2|||
105717472|NCT02554929|364624953|FG001|Overall Study|Withdrawal by Subject|8|||
105717473|NCT04439279|364624954|FG000|Overall Study|Adverse Event|7|||
105717474|NCT04439279|364624954|FG000|Overall Study|Death|4|||
105717475|NCT04439279|364624954|FG000|Overall Study|Disease progression|17|||
105717476|NCT04439279|364624954|FG000|Overall Study|Complicating disease|3|||
105717477|NCT04439279|364624954|FG000|Overall Study|Withdrawal by Subject|2|||
105717478|NCT04439279|364624954|FG000|Overall Study|Ineligible|1|||
105717479|NCT04439279|364624954|FG000|Overall Study|Treatment still ongoing|1|||
105717480|NCT00546364|364624955|FG000|Overall Study|Disease progression|5|||
105717481|NCT00546364|364624956|FG001|Overall Study|Disease progression|11|||
105717482|NCT00546364|364624957|FG002|Overall Study|Disease progression|8|||
105717483|NCT00546364|364624955|FG000|Overall Study|Completed and off treatment|1|||
105717484|NCT00546364|364624956|FG001|Overall Study|Completed and off treatment|0|||
105717485|NCT00546364|364624957|FG002|Overall Study|Completed and off treatment|2|||
105717486|NCT00546364|364624955|FG000|Overall Study|Administrative reason by sponsor|1|||
105717487|NCT00546364|364624956|FG001|Overall Study|Administrative reason by sponsor|0|||
105717488|NCT00546364|364624957|FG002|Overall Study|Administrative reason by sponsor|0|||
105717489|NCT00546364|364624955|FG000|Overall Study|Poor compliance/noncompliance|0|||
105717490|NCT00546364|364624956|FG001|Overall Study|Poor compliance/noncompliance|0|||
105717491|NCT00546364|364624957|FG002|Overall Study|Poor compliance/noncompliance|1|||
105717492|NCT00546364|364624955|FG000|Overall Study|No longer meets study criteria|1|||
105717493|NCT00546364|364624956|FG001|Overall Study|No longer meets study criteria|1|||
105717494|NCT00546364|364624957|FG002|Overall Study|No longer meets study criteria|0|||
105717495|NCT00546364|364624955|FG000|Overall Study|Withdrawal by Subject|5|||
105717496|NCT00546364|364624956|FG001|Overall Study|Withdrawal by Subject|6|||
105717497|NCT00546364|364624957|FG002|Overall Study|Withdrawal by Subject|3|||
105717498|NCT00546364|364624955|FG000|Overall Study|Prior taxotere|1|||
105717499|NCT00546364|364624956|FG001|Overall Study|Prior taxotere|0|||
105717500|NCT00546364|364624957|FG002|Overall Study|Prior taxotere|0|||
105717501|NCT00546364|364624955|FG000|Overall Study|Mixed response|1|||
105717502|NCT00546364|364624956|FG001|Overall Study|Mixed response|0|||
105717503|NCT00546364|364624957|FG002|Overall Study|Mixed response|0|||
105717504|NCT00546364|364624955|FG000|Overall Study|Palliative treatment|1|||
105717505|NCT00546364|364624956|FG001|Overall Study|Palliative treatment|0|||
105717506|NCT00546364|364624957|FG002|Overall Study|Palliative treatment|1|||
105717507|NCT00546364|364624955|FG000|Overall Study|Target lesions resected|1|||
105717508|NCT00546364|364624956|FG001|Overall Study|Target lesions resected|0|||
105717509|NCT00546364|364624957|FG002|Overall Study|Target lesions resected|0|||
105717510|NCT00546364|364624955|FG000|Overall Study|Physician Decision|0|||
105717511|NCT00546364|364624956|FG001|Overall Study|Physician Decision|0|||
105717512|NCT00546364|364624957|FG002|Overall Study|Physician Decision|1|||
105717513|NCT00546364|364624955|FG000|Overall Study|Sponsor decision|0|||
105717514|NCT00546364|364624956|FG001|Overall Study|Sponsor decision|0|||
105717515|NCT00546364|364624957|FG002|Overall Study|Sponsor decision|1|||
105717516|NCT03521791|364624958|FG000|Overall Study|Protocol Violation|7|||
105717517|NCT03521791|364624959|FG001|Overall Study|Protocol Violation|17|||
105717518|NCT01777763|364624972|FG000|Overall Study|Adverse Event|2|||
105717519|NCT01777763|364624973|FG001|Overall Study|Adverse Event|32|||
105717520|NCT01777763|364624972|FG000|Overall Study|Protocol Violation|1|||
105717521|NCT01777763|364624973|FG001|Overall Study|Protocol Violation|7|||
105717522|NCT01777763|364624972|FG000|Overall Study|Withdrawal by Subject|0|||
105717523|NCT01777763|364624973|FG001|Overall Study|Withdrawal by Subject|2|||
105717524|NCT01777763|364624972|FG000|Overall Study|Treatment Failure|1|||
105717525|NCT01777763|364624973|FG001|Overall Study|Treatment Failure|6|||
105717526|NCT01390389|364624974|FG000|Overall Study|Withdrawal by Subject|2|||
105717527|NCT01390389|364624975|FG001|Overall Study|Withdrawal by Subject|0|||
105717528|NCT01390389|364624974|FG000|Overall Study|Screen Fail|2|||
105717529|NCT01390389|364624975|FG001|Overall Study|Screen Fail|1|||
105717530|NCT01974817|364624976|FG000|Overall Study|Death|4|||
105717531|NCT01974817|364624976|FG000|Overall Study|Lost to Follow-up|2|||
105717532|NCT01974817|364624976|FG000|Overall Study|Protocol Violation|2|||
105717533|NCT01171820|364624983|FG000|Overall Study|Death|3|||
105717534|NCT01171820|364624984|FG001|Overall Study|Death|3|||
105717535|NCT01171820|364624983|FG000|Overall Study|Lost to Follow-up|0|||
105717536|NCT01171820|364624984|FG001|Overall Study|Lost to Follow-up|1|||
105717537|NCT01171820|364624983|FG000|Overall Study|Withdrawal by Subject|2|||
105717538|NCT01171820|364624984|FG001|Overall Study|Withdrawal by Subject|0|||
105717539|NCT01171820|364624983|FG000|Overall Study|Physician Decision|0|||
105717540|NCT01171820|364624984|FG001|Overall Study|Physician Decision|1|||
105717541|NCT01171820|364624983|FG000|Overall Study|1-Year Missed Visit|1|||
105717542|NCT01171820|364624984|FG001|Overall Study|1-Year Missed Visit|1|||
105717543|NCT02663895|364624985|FG000|Overall Study|Adverse Event|3|||
105717544|NCT02663895|364624985|FG000|Overall Study|Physician Decision|2|||
105717545|NCT02663895|364624985|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
105717546|NCT02663895|364624985|FG000|Overall Study|Withdrawal by Subject|1|||
105717547|NCT01400932|364624986|FG000|Overall Study|Adverse Event|10|||
105717548|NCT01400932|364624987|FG001|Overall Study|Adverse Event|5|||
105717549|NCT01400932|364624986|FG000|Overall Study|Lack of Efficacy|0|||
105717550|NCT01400932|364624987|FG001|Overall Study|Lack of Efficacy|3|||
105717551|NCT01400932|364624986|FG000|Overall Study|Withdrawal by Subject|2|||
105717552|NCT01400932|364624987|FG001|Overall Study|Withdrawal by Subject|6|||
105717553|NCT01400932|364624986|FG000|Overall Study|Lost to Follow-up|1|||
105717554|NCT01400932|364624987|FG001|Overall Study|Lost to Follow-up|0|||
105717555|NCT01400932|364624986|FG000|Overall Study|Protocol Deviation|0|||
105717556|NCT01400932|364624987|FG001|Overall Study|Protocol Deviation|1|||
105717557|NCT01400932|364624986|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105717558|NCT01400932|364624987|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
105717559|NCT04574999|364624988|FG000|Overall Study|Adverse Event|1|||
105717560|NCT04574999|364624989|FG001|Overall Study|Adverse Event|0|||
105717561|NCT04574999|364624988|FG000|Overall Study|Lack of Efficacy|2|||
105717562|NCT04574999|364624989|FG001|Overall Study|Lack of Efficacy|3|||
105717563|NCT04574999|364624988|FG000|Overall Study|Protocol Violation|1|||
105717564|NCT04574999|364624989|FG001|Overall Study|Protocol Violation|0|||
105717565|NCT04574999|364624988|FG000|Overall Study|Withdrawal by Subject|2|||
105717566|NCT04574999|364624989|FG001|Overall Study|Withdrawal by Subject|2|||
105717567|NCT04574999|364624988|FG000|Overall Study|Lost to Follow-up|1|||
105717568|NCT04574999|364624989|FG001|Overall Study|Lost to Follow-up|0|||
105717569|NCT04574999|364624988|FG000|Overall Study|Personal problems|1|||
105717570|NCT04574999|364624989|FG001|Overall Study|Personal problems|0|||
105717571|NCT04574999|364624988|FG000|Overall Study|Previous planned surgery|1|||
105717572|NCT04574999|364624989|FG001|Overall Study|Previous planned surgery|0|||
105717573|NCT04656990|364624990|FG000|Baseline|pandemic|20|||
105717574|NCT04656990|364624991|FG001|Baseline|pandemic|24|||
105717575|NCT04656990|364624990|FG000|Follow Up Period|Lost to Follow-up|61|||
105717576|NCT04656990|364624991|FG001|Follow Up Period|Lost to Follow-up|73|||
105717577|NCT00988247|364624992|FG000|Overall Study|Adverse Event|17|||
105717578|NCT00988247|364624993|FG001|Overall Study|Adverse Event|3|||
105790449|NCT01976104|364887013|FG002|Overall Study|Subject Choice|0|||
105717579|NCT00988247|364624992|FG000|Overall Study|Withdrawal by Subject|44|||
105717580|NCT00988247|364624993|FG001|Overall Study|Withdrawal by Subject|13|||
105717581|NCT00988247|364624992|FG000|Overall Study|Pregnancy|1|||
105717582|NCT00988247|364624993|FG001|Overall Study|Pregnancy|2|||
105717583|NCT00988247|364624992|FG000|Overall Study|Lost to Follow-up|11|||
105717584|NCT00988247|364624993|FG001|Overall Study|Lost to Follow-up|2|||
105717585|NCT00988247|364624992|FG000|Overall Study|Protocol Violation|4|||
105717586|NCT00988247|364624993|FG001|Overall Study|Protocol Violation|5|||
105717587|NCT00988247|364624992|FG000|Overall Study|Sponsor requested withdrawal|3|||
105717588|NCT00988247|364624993|FG001|Overall Study|Sponsor requested withdrawal|1|||
105717589|NCT00988247|364624992|FG000|Overall Study|Other|3|||
105717590|NCT00988247|364624993|FG001|Overall Study|Other|0|||
105717591|NCT04173741|364624994|FG000|Overall Study|IVC measurement cannot be done|1|||
105717592|NCT04173741|364624995|FG001|Overall Study|IVC measurement cannot be done|1|||
105717593|NCT02522767|364624998|FG000|Double-blind|Withdrawal by Subject|8|||
105717594|NCT02522767|364624999|FG001|Double-blind|Withdrawal by Subject|11|||
105717595|NCT02522767|364624998|FG000|Double-blind|Lost to Follow-up|1|||
105717596|NCT02522767|364624999|FG001|Double-blind|Lost to Follow-up|0|||
105717597|NCT02522767|364624998|FG000|Double-blind|Adverse Event|1|||
105717598|NCT02522767|364624999|FG001|Double-blind|Adverse Event|10|||
105717599|NCT02522767|364624998|FG000|Double-blind|Protocol Violation|0|||
105717600|NCT02522767|364624999|FG001|Double-blind|Protocol Violation|1|||
105717601|NCT02522767|364624998|FG000|Double-blind|Lack of Efficacy|0|||
105717602|NCT02522767|364624999|FG001|Double-blind|Lack of Efficacy|2|||
105717603|NCT02522767|364624998|FG000|Double-blind|Protocol Deviation|1|||
105717604|NCT02522767|364624999|FG001|Double-blind|Protocol Deviation|0|||
105717605|NCT02522767|364624998|FG000|Open-label|Withdrawal by Subject|2|||
105717606|NCT02522767|364624999|FG001|Open-label|Withdrawal by Subject|3|||
105717607|NCT02522767|364624998|FG000|Open-label|Lost to Follow-up|0|||
105717608|NCT02522767|364624999|FG001|Open-label|Lost to Follow-up|1|||
105717609|NCT02522767|364624998|FG000|Open-label|Adverse Event|2|||
105717610|NCT02522767|364624999|FG001|Open-label|Adverse Event|1|||
105717611|NCT02522767|364624998|FG000|Open-label|Lack of Efficacy|1|||
105717612|NCT02522767|364624999|FG001|Open-label|Lack of Efficacy|1|||
105717613|NCT02522767|364624998|FG000|Open-label|Protocol Violation|0|||
105717614|NCT02522767|364624999|FG001|Open-label|Protocol Violation|1|||
105717615|NCT02494596|364625000|FG000|Overall Study|Insufficient Therapeutic Response|3|||
105717616|NCT02494596|364625001|FG001|Overall Study|Insufficient Therapeutic Response|3|||
105717617|NCT02494596|364625002|FG002|Overall Study|Insufficient Therapeutic Response|1|||
105717618|NCT02494596|364625000|FG000|Overall Study|Adverse Event|0|||
105717619|NCT02494596|364625001|FG001|Overall Study|Adverse Event|1|||
105717620|NCT02494596|364625002|FG002|Overall Study|Adverse Event|0|||
105717621|NCT02494596|364625000|FG000|Overall Study|Refused Treatment|0|||
105717622|NCT02494596|364625001|FG001|Overall Study|Refused Treatment|1|||
105717623|NCT02494596|364625002|FG002|Overall Study|Refused Treatment|0|||
105717624|NCT00059202|364625003|FG000|Overall Study|Withdrawal by Subject|5|||
105717625|NCT00059202|364625004|FG001|Overall Study|Withdrawal by Subject|9|||
105561867|NCT02342886|364052239|FG000|Overall Study|Withdrawal by Subject|0|||
105561868|NCT02342886|364052240|FG001|Overall Study|Withdrawal by Subject|1|||
105717626|NCT00059202|364625003|FG000|Overall Study|Protocol Violation|1|||
105717627|NCT00059202|364625004|FG001|Overall Study|Protocol Violation|3|||
105717628|NCT00059202|364625003|FG000|Overall Study|drug toxicity|0|||
105717629|NCT00059202|364625004|FG001|Overall Study|drug toxicity|3|||
105717630|NCT03502187|364625008|FG000|Overall Study|Withdrawal by Subject|4|||
105717631|NCT03502187|364625009|FG001|Overall Study|Withdrawal by Subject|3|||
105717632|NCT03502187|364625010|FG002|Overall Study|Withdrawal by Subject|3|||
105717633|NCT03502187|364625008|FG000|Overall Study|Lost to Follow-up|5|||
105717634|NCT03502187|364625009|FG001|Overall Study|Lost to Follow-up|4|||
105717635|NCT03502187|364625010|FG002|Overall Study|Lost to Follow-up|5|||
105717636|NCT00214461|364625011|FG000|Overall Study|Adverse Event|0|||
105717637|NCT00214461|364625012|FG001|Overall Study|Adverse Event|0|||
105717638|NCT00214461|364625013|FG002|Overall Study|Adverse Event|1|||
105717639|NCT00214461|364625014|FG003|Overall Study|Adverse Event|1|||
105717640|NCT00214461|364625011|FG000|Overall Study|Withdrawal by Subject|0|||
105717641|NCT00214461|364625012|FG001|Overall Study|Withdrawal by Subject|0|||
105717642|NCT00214461|364625013|FG002|Overall Study|Withdrawal by Subject|1|||
105717643|NCT00214461|364625014|FG003|Overall Study|Withdrawal by Subject|0|||
105717644|NCT02908100|364625015|FG000|Overall Study|Adverse Event|7|||
105717645|NCT02908100|364625016|FG001|Overall Study|Adverse Event|6|||
105717646|NCT02908100|364625017|FG002|Overall Study|Adverse Event|9|||
105717647|NCT02908100|364625015|FG000|Overall Study|Death|2|||
105717648|NCT02908100|364625016|FG001|Overall Study|Death|0|||
105717649|NCT02908100|364625017|FG002|Overall Study|Death|0|||
105717650|NCT02908100|364625015|FG000|Overall Study|Lack of Efficacy|2|||
105717651|NCT02908100|364625016|FG001|Overall Study|Lack of Efficacy|3|||
105717652|NCT02908100|364625017|FG002|Overall Study|Lack of Efficacy|3|||
105717653|NCT02908100|364625015|FG000|Overall Study|Lost to Follow-up|0|||
105717654|NCT02908100|364625016|FG001|Overall Study|Lost to Follow-up|1|||
105717655|NCT02908100|364625017|FG002|Overall Study|Lost to Follow-up|2|||
105790450|NCT01976104|364887014|FG003|Overall Study|Subject Choice|1|||
105790451|NCT01976104|364887011|FG000|Overall Study|Withdrawal by Subject|3|||
105790452|NCT01976104|364887012|FG001|Overall Study|Withdrawal by Subject|0|||
105790453|NCT01976104|364887013|FG002|Overall Study|Withdrawal by Subject|0|||
105790454|NCT01976104|364887014|FG003|Overall Study|Withdrawal by Subject|1|||
105790455|NCT01976104|364887011|FG000|Overall Study|Other|0|||
105790456|NCT01976104|364887012|FG001|Overall Study|Other|1|||
105790457|NCT01976104|364887013|FG002|Overall Study|Other|0|||
105790458|NCT01976104|364887014|FG003|Overall Study|Other|0|||
105790459|NCT03901352|364887020|FG000|Double-blind Phase|Adverse Event|6|||
105790460|NCT03901352|364887021|FG001|Double-blind Phase|Adverse Event|4|||
105790461|NCT03901352|364887020|FG000|Double-blind Phase|Death|1|||
105790462|NCT03901352|364887021|FG001|Double-blind Phase|Death|0|||
105790463|NCT03901352|364887020|FG000|Double-blind Phase|Lack of Efficacy|0|||
105790464|NCT03901352|364887021|FG001|Double-blind Phase|Lack of Efficacy|1|||
105790465|NCT03901352|364887020|FG000|Double-blind Phase|Protocol Violation|0|||
105790466|NCT03901352|364887021|FG001|Double-blind Phase|Protocol Violation|1|||
105790467|NCT03901352|364887020|FG000|Double-blind Phase|Withdrawal by Subject|10|||
105790468|NCT03901352|364887021|FG001|Double-blind Phase|Withdrawal by Subject|8|||
105790469|NCT03901352|364887020|FG000|Open-label Extension Phase|Adverse Event|24|||
105790470|NCT03901352|364887021|FG001|Open-label Extension Phase|Adverse Event|0|||
105790471|NCT03901352|364887020|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
105790472|NCT03901352|364887021|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
105790473|NCT03901352|364887020|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
105790474|NCT03901352|364887021|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
105790475|NCT03901352|364887020|FG000|Open-label Extension Phase|Other|1|||
105790476|NCT03901352|364887021|FG001|Open-label Extension Phase|Other|0|||
105790477|NCT06067191|364887022|FG000|Overall Study|Withdrawal by Subject|0|||
105790478|NCT06067191|364887023|FG001|Overall Study|Withdrawal by Subject|1|||
105790479|NCT02886494|364887025|FG000|Overall Study|Adverse Event|1|||
105790480|NCT02886494|364887026|FG001|Overall Study|Adverse Event|0|||
105790481|NCT02886494|364887025|FG000|Overall Study|Withdrawal by Subject|12|||
105790482|NCT02886494|364887026|FG001|Overall Study|Withdrawal by Subject|3|||
105790483|NCT02886494|364887025|FG000|Overall Study|Protocol Violation|4|||
105352306|NCT01483599|363293848|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
105352307|NCT01483599|363293849|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
105352308|NCT01483599|363293850|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
105352309|NCT01483599|363293851|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
105717656|NCT02908100|364625015|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105717657|NCT02908100|364625016|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105717658|NCT02908100|364625017|FG002|Overall Study|Non-Compliance With Study Drug|2|||
105717659|NCT02908100|364625015|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
105717660|NCT02908100|364625016|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
105717661|NCT02908100|364625017|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
105717662|NCT02908100|364625015|FG000|Overall Study|Physician Decision|0|||
105717663|NCT02908100|364625016|FG001|Overall Study|Physician Decision|1|||
105717664|NCT02908100|364625017|FG002|Overall Study|Physician Decision|0|||
105717665|NCT02908100|364625015|FG000|Overall Study|Pregnancy|1|||
105717666|NCT02908100|364625016|FG001|Overall Study|Pregnancy|2|||
105717667|NCT02908100|364625017|FG002|Overall Study|Pregnancy|0|||
105717668|NCT02908100|364625015|FG000|Overall Study|Withdrawal by Subject|8|||
105717669|NCT02908100|364625016|FG001|Overall Study|Withdrawal by Subject|7|||
105717670|NCT02908100|364625017|FG002|Overall Study|Withdrawal by Subject|5|||
105717671|NCT02908100|364625015|FG000|Overall Study|Randomised in Error|1|||
105717672|NCT02908100|364625016|FG001|Overall Study|Randomised in Error|0|||
105717673|NCT02908100|364625017|FG002|Overall Study|Randomised in Error|0|||
105717674|NCT02024971|364625018|FG000|Overall Study|Data Not Available|30|||
105717675|NCT02024971|364625018|FG000|Overall Study|Lost to Follow-up|6|||
105717676|NCT02631538|364625019|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
105717677|NCT02631538|364625020|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
105717678|NCT02631538|364625021|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
105352310|NCT01483599|363293852|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
105352311|NCT01483599|363293853|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
105352312|NCT01483599|363293854|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
105717679|NCT02631538|364625022|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
105717680|NCT02631538|364625019|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
105717681|NCT02631538|364625020|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
105717682|NCT02631538|364625021|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
105352313|NCT01483599|363293855|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
105352314|NCT01483599|363293856|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
105790484|NCT02886494|364887026|FG001|Overall Study|Protocol Violation|1|||
105790485|NCT00807040|364887029|FG000|Overall Study|Death|24|||
105790486|NCT00807040|364887030|FG001|Overall Study|Death|29|||
105352315|NCT01483599|363293857|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
105790487|NCT00807040|364887029|FG000|Overall Study|Withdrawal by Subject|8|||
105790488|NCT00807040|364887030|FG001|Overall Study|Withdrawal by Subject|6|||
105352316|NCT01483599|363293858|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
105352317|NCT01483599|363293859|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
105352318|NCT01483599|363293860|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
105352319|NCT00966355|363293863|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
105352320|NCT00966355|363293864|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
105352321|NCT00966355|363293865|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
105352322|NCT00966355|363293863|FG000|Overall Study|newly diagnosed advanced HCC|11|||
105352323|NCT00966355|363293864|FG001|Overall Study|newly diagnosed advanced HCC|12|||
105352324|NCT00966355|363293865|FG002|Overall Study|newly diagnosed advanced HCC|10|||
105352325|NCT00966355|363293863|FG000|Overall Study|Lost to Follow-up|5|||
105352326|NCT00966355|363293864|FG001|Overall Study|Lost to Follow-up|4|||
105352327|NCT00966355|363293865|FG002|Overall Study|Lost to Follow-up|3|||
105352328|NCT02552888|363293866|FG000|Overall Study|Lost to Follow-up|1|||
105352329|NCT02552888|363293867|FG001|Overall Study|Lost to Follow-up|1|||
105352330|NCT02227368|363295539|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
105352331|NCT02227368|363295540|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
105352332|NCT02227368|363295539|FG000|Overall Study|Lost to Follow-up|1|||
105352333|NCT02227368|363295540|FG001|Overall Study|Lost to Follow-up|0|||
105352334|NCT02227368|363295539|FG000|Overall Study|Adverse Event|1|||
105352335|NCT02227368|363295540|FG001|Overall Study|Adverse Event|0|||
105352336|NCT01687283|363295544|FG000|Overall Study|Adverse Event|11|||
105352337|NCT01687283|363295545|FG001|Overall Study|Adverse Event|4|||
105352338|NCT01687283|363295544|FG000|Overall Study|Lack of Efficacy|3|||
105352339|NCT01687283|363295545|FG001|Overall Study|Lack of Efficacy|1|||
105352340|NCT01687283|363295544|FG000|Overall Study|Protocol Violation|1|||
105352341|NCT01687283|363295545|FG001|Overall Study|Protocol Violation|3|||
105352342|NCT01687283|363295544|FG000|Overall Study|protocol defined stopping criteria|8|||
105352343|NCT01687283|363295545|FG001|Overall Study|protocol defined stopping criteria|10|||
105352344|NCT01687283|363295544|FG000|Overall Study|Lost to Follow-up|1|||
105352345|NCT01687283|363295545|FG001|Overall Study|Lost to Follow-up|1|||
105352346|NCT01687283|363295544|FG000|Overall Study|Investigator discretion|2|||
105352347|NCT01687283|363295545|FG001|Overall Study|Investigator discretion|0|||
105717683|NCT02631538|364625022|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
105717684|NCT02631538|364625019|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
105717685|NCT02631538|364625020|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
105717686|NCT02631538|364625021|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
105717687|NCT02631538|364625022|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
105717688|NCT02631538|364625019|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
105717689|NCT02631538|364625020|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
105717690|NCT02631538|364625021|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
105717691|NCT02631538|364625022|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
105717692|NCT02631538|364625019|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
105717693|NCT02631538|364625020|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
105717694|NCT02631538|364625021|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
105717695|NCT02631538|364625022|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
105717696|NCT02631538|364625019|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
105717697|NCT02631538|364625020|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
105717698|NCT02631538|364625021|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
105717699|NCT02631538|364625022|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
105717700|NCT00559273|364625023|FG000|Correction Period (20 Weeks)|Death|3|||
105717701|NCT00559273|364625024|FG001|Correction Period (20 Weeks)|Death|4|||
105717702|NCT00559273|364625023|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
105717703|NCT00559273|364625024|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
105717704|NCT00559273|364625023|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
105717705|NCT00559273|364625024|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
105717706|NCT00559273|364625023|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
105717707|NCT00559273|364625024|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
105717708|NCT00559273|364625023|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
105717709|NCT00559273|364625024|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
105717710|NCT00559273|364625023|FG000|Evaluation Period (8 Weeks)|Death|1|||
105717711|NCT00559273|364625024|FG001|Evaluation Period (8 Weeks)|Death|3|||
105717712|NCT00559273|364625023|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
105717713|NCT00559273|364625024|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
105717714|NCT00559273|364625023|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
105717715|NCT00559273|364625024|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
105717716|NCT00559273|364625023|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
105352348|NCT01687283|363295544|FG000|Overall Study|Withdrawal by Subject|9|||
105352349|NCT01687283|363295545|FG001|Overall Study|Withdrawal by Subject|8|||
105352350|NCT02913105|363295546|FG000|Overall Study|Adverse Event|11|||
105352351|NCT02913105|363295547|FG001|Overall Study|Adverse Event|0|||
105352352|NCT02913105|363295548|FG002|Overall Study|Adverse Event|4|||
105477415|NCT01642615|363759347|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
105477416|NCT01642615|363759348|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
105477417|NCT01642615|363759346|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
105477418|NCT01642615|363759347|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
105717717|NCT00559273|364625024|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
105717718|NCT00189462|364625025|FG000|Overall Study|Lack of Efficacy|5|||
105717719|NCT00189462|364625026|FG001|Overall Study|Lack of Efficacy|1|||
105717720|NCT00189462|364625025|FG000|Overall Study|Lost to Follow-up|18|||
105717721|NCT00189462|364625026|FG001|Overall Study|Lost to Follow-up|20|||
105717722|NCT01262625|364625029|FG000|Overall Study|Administrative Error|1|||
105717723|NCT01262625|364625030|FG001|Overall Study|Administrative Error|1|||
105717724|NCT01262625|364625029|FG000|Overall Study|Site Closed|1|||
105717725|NCT01262625|364625030|FG001|Overall Study|Site Closed|0|||
105717726|NCT01869348|364625032|FG000|Overall Study|Withdrawal by Subject|1|||
105717727|NCT01869348|364625033|FG001|Overall Study|Withdrawal by Subject|1|||
105717728|NCT02789657|364625034|FG000|Overall Study|Withdrawal by Subject|2|||
105717729|NCT02789657|364625035|FG001|Overall Study|Withdrawal by Subject|0|||
105717730|NCT02789657|364625036|FG002|Overall Study|Withdrawal by Subject|0|||
105717731|NCT02789657|364625037|FG003|Overall Study|Withdrawal by Subject|0|||
105717732|NCT03075163|364625038|FG000|Overall Study|not eligible for treatment limb|138|||
105717733|NCT03075163|364625039|FG001|Overall Study|not eligible for treatment limb|138|||
105717734|NCT01900002|364625045|FG000|Overall Study|Withdrawal by Subject|2|||
105717735|NCT01900002|364625045|FG000|Overall Study|ineligible for Y-90|4|||
105717736|NCT02908516|364625046|FG000|Overall Study|Study Terminated|3|||
105717737|NCT02908516|364625047|FG001|Overall Study|Study Terminated|3|||
105717738|NCT01384292|364625050|FG000|Part B|Severe non-compliance to protocol|1|||
105717739|NCT01384292|364625051|FG001|Part B|Severe non-compliance to protocol|0|||
105717740|NCT01384292|364625052|FG002|Part B|Severe non-compliance to protocol|0|||
105717741|NCT01948830|364625053|FG000|Overall Study|Physician Decision|1|||
105717742|NCT01948830|364625054|FG001|Overall Study|Physician Decision|3|||
105717743|NCT01948830|364625053|FG000|Overall Study|Protocol deviation|1|||
105717744|NCT01948830|364625054|FG001|Overall Study|Protocol deviation|2|||
105717745|NCT01948830|364625053|FG000|Overall Study|Lost to Follow-up|5|||
105717746|NCT01948830|364625054|FG001|Overall Study|Lost to Follow-up|4|||
105717747|NCT01948830|364625053|FG000|Overall Study|Withdrawal by Subject|14|||
105717748|NCT01948830|364625054|FG001|Overall Study|Withdrawal by Subject|17|||
105717749|NCT01948830|364625053|FG000|Overall Study|Adverse Event|9|||
105717750|NCT01948830|364625054|FG001|Overall Study|Adverse Event|2|||
105717751|NCT01948830|364625053|FG000|Overall Study|Death|3|||
105717752|NCT01948830|364625054|FG001|Overall Study|Death|4|||
105717753|NCT03969888|364625055|FG000|Overall Study|Never Received Study Drug|0|||
105717754|NCT03969888|364625056|FG001|Overall Study|Never Received Study Drug|0|||
105717755|NCT03969888|364625057|FG002|Overall Study|Never Received Study Drug|1|||
105717756|NCT03969888|364625058|FG003|Overall Study|Never Received Study Drug|0|||
105717757|NCT03969888|364625059|FG004|Overall Study|Never Received Study Drug|0|||
105717758|NCT03969888|364625060|FG005|Overall Study|Never Received Study Drug|0|||
105717759|NCT03969888|364625061|FG006|Overall Study|Never Received Study Drug|1|||
105717760|NCT03969888|364625062|FG007|Overall Study|Never Received Study Drug|0|||
105717761|NCT03969888|364625055|FG000|Overall Study|Reason Not Specified|0|||
105717762|NCT03969888|364625056|FG001|Overall Study|Reason Not Specified|0|||
105717763|NCT03969888|364625057|FG002|Overall Study|Reason Not Specified|0|||
105717764|NCT03969888|364625058|FG003|Overall Study|Reason Not Specified|0|||
105717765|NCT03969888|364625059|FG004|Overall Study|Reason Not Specified|0|||
105717766|NCT03969888|364625060|FG005|Overall Study|Reason Not Specified|0|||
105717767|NCT03969888|364625061|FG006|Overall Study|Reason Not Specified|0|||
105717768|NCT03969888|364625062|FG007|Overall Study|Reason Not Specified|1|||
105717769|NCT02867761|364625065|FG000|Overall Study|Participant withdrawn by investigator|0|||
105717770|NCT02867761|364625066|FG001|Overall Study|Participant withdrawn by investigator|1|||
105717771|NCT02867761|364625065|FG000|Overall Study|Lost to Follow-up|25|||
105717772|NCT02867761|364625066|FG001|Overall Study|Lost to Follow-up|18|||
105717773|NCT02867761|364625065|FG000|Overall Study|Unable to complete protocol|3|||
105717774|NCT02867761|364625066|FG001|Overall Study|Unable to complete protocol|7|||
105717775|NCT01931059|364625067|FG000|Day 1|Pregnancy|0|||
105717776|NCT01931059|364625068|FG001|Day 1|Pregnancy|1|||
105717777|NCT01931059|364625067|FG000|Day3|Lost to Follow-up|1|||
105717778|NCT01931059|364625068|FG001|Day3|Lost to Follow-up|0|||
105717779|NCT02440581|364625069|FG000|Overall Study|Death|0|||
105717780|NCT02440581|364625070|FG001|Overall Study|Death|0|||
105717781|NCT02440581|364625071|FG002|Overall Study|Death|7|||
105717782|NCT02440581|364625072|FG003|Overall Study|Death|5|||
105717783|NCT02440581|364625069|FG000|Overall Study|Transplanted|1|||
105717784|NCT02440581|364625070|FG001|Overall Study|Transplanted|0|||
105717785|NCT02440581|364625071|FG002|Overall Study|Transplanted|3|||
105717786|NCT02440581|364625072|FG003|Overall Study|Transplanted|2|||
105717787|NCT02440581|364625069|FG000|Overall Study|Withdrawal by Subject|4|||
105717788|NCT02440581|364625070|FG001|Overall Study|Withdrawal by Subject|11|||
105717789|NCT02440581|364625071|FG002|Overall Study|Withdrawal by Subject|3|||
105717790|NCT02440581|364625072|FG003|Overall Study|Withdrawal by Subject|7|||
105717791|NCT00787787|364625073|FG000|Overall Study|Lack of Efficacy|4|||
105717792|NCT00787787|364625073|FG000|Overall Study|Adverse Event|3|||
105717793|NCT03828487|364625074|FG000|Overall Study|Physician Decision|1|||
105717794|NCT01412957|364625075|FG000|Overall Study|Withdrawal by Subject|6|||
105717795|NCT01412957|364625076|FG001|Overall Study|Withdrawal by Subject|22|||
105717796|NCT01412957|364625075|FG000|Overall Study|Lost to Follow-up|7|||
105717797|NCT01412957|364625076|FG001|Overall Study|Lost to Follow-up|2|||
105717798|NCT01412957|364625075|FG000|Overall Study|Death|136|||
105717799|NCT01412957|364625076|FG001|Overall Study|Death|133|||
105717800|NCT01990261|364625078|FG000|Overall Study|Death Before Treatment Start|2|||
105717801|NCT01990261|364625078|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
105717802|NCT01990261|364625078|FG000|Overall Study|Death From other Causes|1|||
105717803|NCT01990261|364625078|FG000|Overall Study|Disease Progression (PD)|8|||
105717804|NCT01990261|364625078|FG000|Overall Study|PD Before Treatment Start|1|||
105717805|NCT01990261|364625078|FG000|Overall Study|Dossier not Approved|1|||
105717806|NCT01990261|364625078|FG000|Overall Study|Lost to Follow-up|2|||
105717807|NCT04698629|364625087|FG000|Overall Study|Adverse Event|1|||
105717808|NCT00670007|364626850|FG000|Overall Study|Drug abuse|1|||
105717809|NCT00670007|364626850|FG000|Overall Study|Lung transplant|1|||
105717810|NCT00670007|364626850|FG000|Overall Study|Travel/Vacation|1|||
105717811|NCT00670007|364626850|FG000|Overall Study|Adverse event, serious fatal|1|||
105717812|NCT00670007|364626850|FG000|Overall Study|Adverse Event|1|||
105717813|NCT00670007|364626850|FG000|Overall Study|Withdrawal by Subject|4|||
105717814|NCT01070329|364626855|FG000|Overall Study|Adverse Event|13|||
105717815|NCT01070329|364626856|FG001|Overall Study|Adverse Event|10|||
105717816|NCT01070329|364626855|FG000|Overall Study|Lost to Follow-up|22|||
105717817|NCT01070329|364626856|FG001|Overall Study|Lost to Follow-up|12|||
105717818|NCT01070329|364626855|FG000|Overall Study|Withdrawal by Subject|9|||
105717819|NCT01070329|364626856|FG001|Overall Study|Withdrawal by Subject|11|||
105717820|NCT01070329|364626855|FG000|Overall Study|Protocol Violation|3|||
105717821|NCT01070329|364626856|FG001|Overall Study|Protocol Violation|8|||
105717822|NCT01070329|364626855|FG000|Overall Study|Lack of Efficacy|2|||
105717823|NCT01070329|364626856|FG001|Overall Study|Lack of Efficacy|6|||
105717824|NCT01070329|364626855|FG000|Overall Study|Physician Decision|2|||
105717825|NCT01070329|364626856|FG001|Overall Study|Physician Decision|1|||
105717826|NCT01070329|364626855|FG000|Overall Study|Entry Criteria Not Met|1|||
105717827|NCT01070329|364626856|FG001|Overall Study|Entry Criteria Not Met|0|||
105717828|NCT01070329|364626855|FG000|Overall Study|Sponsor Decision|0|||
105717829|NCT01070329|364626856|FG001|Overall Study|Sponsor Decision|1|||
105717830|NCT00605267|364626857|FG000|Overall Study|Adverse Event|0|||
105717831|NCT00605267|364626858|FG001|Overall Study|Adverse Event|1|||
105717832|NCT00605267|364626857|FG000|Overall Study|Lack of Efficacy|1|||
105717833|NCT00605267|364626858|FG001|Overall Study|Lack of Efficacy|5|||
105717834|NCT00605267|364626857|FG000|Overall Study|Withdrawal by Subject|2|||
105717835|NCT00605267|364626858|FG001|Overall Study|Withdrawal by Subject|3|||
105717836|NCT01084551|364626860|FG000|Overall Study|Adverse Event|2|||
105717837|NCT01084551|364626861|FG001|Overall Study|Adverse Event|9|||
105717838|NCT01084551|364626862|FG002|Overall Study|Adverse Event|4|||
105717839|NCT01084551|364626860|FG000|Overall Study|Lack of Efficacy|2|||
105717840|NCT01084551|364626861|FG001|Overall Study|Lack of Efficacy|0|||
105717841|NCT01084551|364626862|FG002|Overall Study|Lack of Efficacy|1|||
105717842|NCT01084551|364626860|FG000|Overall Study|Withdrawal by Subject|2|||
105717843|NCT01084551|364626861|FG001|Overall Study|Withdrawal by Subject|1|||
105717844|NCT01084551|364626862|FG002|Overall Study|Withdrawal by Subject|0|||
105717845|NCT01084551|364626860|FG000|Overall Study|Protocol Violation|2|||
105717846|NCT01084551|364626861|FG001|Overall Study|Protocol Violation|4|||
105717847|NCT01084551|364626862|FG002|Overall Study|Protocol Violation|0|||
105717848|NCT01084551|364626860|FG000|Overall Study|Lost to Follow-up|0|||
105717849|NCT01084551|364626861|FG001|Overall Study|Lost to Follow-up|0|||
105717850|NCT01084551|364626862|FG002|Overall Study|Lost to Follow-up|3|||
105717851|NCT01084551|364626860|FG000|Overall Study|Physician Decision|1|||
105717852|NCT01084551|364626861|FG001|Overall Study|Physician Decision|0|||
105717853|NCT01084551|364626862|FG002|Overall Study|Physician Decision|0|||
105717854|NCT01705691|364626864|FG000|Overall Study|Death|1|||
105717855|NCT01705691|364626865|FG001|Overall Study|Death|2|||
105477419|NCT01642615|363759348|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
105477420|NCT01642615|363759346|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
105477421|NCT01642615|363759347|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
105790489|NCT00807040|364887029|FG000|Overall Study|Lost to Follow-up|4|||
105790490|NCT00807040|364887030|FG001|Overall Study|Lost to Follow-up|6|||
105790491|NCT00890409|364887033|FG000|Overall Study|Lost to Follow-up|20|||
105790492|NCT00890409|364887034|FG001|Overall Study|Lost to Follow-up|21|||
105790493|NCT01067339|364887035|FG000|Overall Study|Withdrawal by Subject|6|||
105790494|NCT01067339|364887036|FG001|Overall Study|Withdrawal by Subject|5|||
105790495|NCT00244881|364887038|FG000|Overall Study|Withdrawal by Subject|3|||
105790496|NCT00077766|364887039|FG000|Overall Study|Adverse Event|1|||
105790497|NCT00077766|364887040|FG001|Overall Study|Adverse Event|1|||
105790498|NCT00077766|364887039|FG000|Overall Study|Withdrawal by Subject|4|||
105790499|NCT00077766|364887040|FG001|Overall Study|Withdrawal by Subject|3|||
105790500|NCT00077766|364887039|FG000|Overall Study|Death|12|||
105790501|NCT00077766|364887040|FG001|Overall Study|Death|10|||
105790502|NCT00077766|364887039|FG000|Overall Study|Lost to Follow-up|2|||
105790503|NCT00077766|364887040|FG001|Overall Study|Lost to Follow-up|0|||
105790504|NCT00077766|364887039|FG000|Overall Study|Protocol Violation|1|||
105477422|NCT01642615|363759348|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
105477423|NCT01642615|363759346|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
105477424|NCT01642615|363759347|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
105477425|NCT01642615|363759348|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
105477426|NCT01642615|363759346|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
105477427|NCT01642615|363759347|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
105717856|NCT01705691|364626864|FG000|Overall Study|Withdrawal by Subject|1|||
105717857|NCT01705691|364626865|FG001|Overall Study|Withdrawal by Subject|2|||
105717858|NCT01705691|364626864|FG000|Overall Study|Lost to Follow-up|1|||
105717859|NCT01705691|364626865|FG001|Overall Study|Lost to Follow-up|1|||
105717860|NCT01705691|364626864|FG000|Overall Study|Other|0|||
105717861|NCT01705691|364626865|FG001|Overall Study|Other|1|||
105717862|NCT00841763|364626866|FG000|Overall Study|Withdrawal by Subject|60|||
105717863|NCT00841763|364626867|FG001|Overall Study|Withdrawal by Subject|17|||
105717864|NCT00841763|364626868|FG002|Overall Study|Withdrawal by Subject|4|||
105717865|NCT00841763|364626869|FG003|Overall Study|Withdrawal by Subject|1|||
105717866|NCT00841763|364626866|FG000|Overall Study|Adverse Event|9|||
105717867|NCT00841763|364626867|FG001|Overall Study|Adverse Event|10|||
105717868|NCT00841763|364626868|FG002|Overall Study|Adverse Event|3|||
105717869|NCT00841763|364626869|FG003|Overall Study|Adverse Event|2|||
105717870|NCT00841763|364626866|FG000|Overall Study|Lost to Follow-up|63|||
105717871|NCT00841763|364626867|FG001|Overall Study|Lost to Follow-up|25|||
105717872|NCT00841763|364626868|FG002|Overall Study|Lost to Follow-up|0|||
105717873|NCT00841763|364626869|FG003|Overall Study|Lost to Follow-up|0|||
105717874|NCT00841763|364626866|FG000|Overall Study|Protocol Violation|20|||
105717875|NCT00841763|364626867|FG001|Overall Study|Protocol Violation|3|||
105717876|NCT00841763|364626868|FG002|Overall Study|Protocol Violation|1|||
105717877|NCT00841763|364626869|FG003|Overall Study|Protocol Violation|0|||
105717878|NCT00841763|364626866|FG000|Overall Study|Administrative Reasons|3|||
105717879|NCT00841763|364626867|FG001|Overall Study|Administrative Reasons|1|||
105717880|NCT00841763|364626868|FG002|Overall Study|Administrative Reasons|0|||
105717881|NCT00841763|364626869|FG003|Overall Study|Administrative Reasons|0|||
105717882|NCT00841763|364626866|FG000|Overall Study|Unable to Classify|7|||
105717883|NCT00841763|364626867|FG001|Overall Study|Unable to Classify|1|||
105717884|NCT00841763|364626868|FG002|Overall Study|Unable to Classify|0|||
105717885|NCT00841763|364626869|FG003|Overall Study|Unable to Classify|0|||
105717886|NCT01482910|364626870|FG000|Overall Study|Adverse Event|6|||
105717887|NCT01482910|364626871|FG001|Overall Study|Adverse Event|5|||
105790505|NCT00077766|364887040|FG001|Overall Study|Protocol Violation|0|||
105717888|NCT01482910|364626870|FG000|Overall Study|Lost to Follow-up|0|||
105717889|NCT01482910|364626871|FG001|Overall Study|Lost to Follow-up|1|||
105717890|NCT01482910|364626870|FG000|Overall Study|Protocol Violation|1|||
105790506|NCT00077766|364887039|FG000|Overall Study|Kidney Transplantation|9|||
105352353|NCT02913105|363295546|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105352354|NCT02913105|363295547|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105352355|NCT02913105|363295548|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105352356|NCT02913105|363295546|FG000|Overall Study|Reason Not Specified|3|||
105352357|NCT02913105|363295547|FG001|Overall Study|Reason Not Specified|1|||
105352358|NCT02913105|363295548|FG002|Overall Study|Reason Not Specified|1|||
105352359|NCT02913105|363295546|FG000|Overall Study|Physician Decision|1|||
105352360|NCT02913105|363295547|FG001|Overall Study|Physician Decision|1|||
105352361|NCT02913105|363295548|FG002|Overall Study|Physician Decision|0|||
105352362|NCT02913105|363295546|FG000|Overall Study|Withdrawal by Subject|0|||
105352363|NCT02913105|363295547|FG001|Overall Study|Withdrawal by Subject|3|||
105352364|NCT02913105|363295548|FG002|Overall Study|Withdrawal by Subject|1|||
105352365|NCT01421147|363295550|FG000|Treatment Period|Adverse Event|2|||
105352366|NCT01421147|363295551|FG001|Treatment Period|Adverse Event|3|||
105352367|NCT01421147|363295550|FG000|Treatment Period|Lost to Follow-up|2|||
105352368|NCT01421147|363295551|FG001|Treatment Period|Lost to Follow-up|1|||
105352369|NCT01421147|363295550|FG000|Treatment Period|Physician Decision|2|||
105352370|NCT01421147|363295551|FG001|Treatment Period|Physician Decision|2|||
105352371|NCT01421147|363295550|FG000|Treatment Period|Withdrawal by Subject|10|||
105352372|NCT01421147|363295551|FG001|Treatment Period|Withdrawal by Subject|5|||
105352373|NCT01421147|363295550|FG000|Extension Period|Adverse Event|0|||
105352374|NCT01421147|363295551|FG001|Extension Period|Adverse Event|2|||
105790507|NCT00077766|364887040|FG001|Overall Study|Kidney Transplantation|5|||
105790508|NCT00077766|364887039|FG000|Overall Study|Transplantation|5|||
105790509|NCT00077766|364887040|FG001|Overall Study|Transplantation|1|||
105790510|NCT00077766|364887039|FG000|Overall Study|Investigators Discretion|1|||
105790511|NCT00077766|364887040|FG001|Overall Study|Investigators Discretion|0|||
105352375|NCT01421147|363295550|FG000|Extension Period|Death|0|||
105352376|NCT01421147|363295551|FG001|Extension Period|Death|1|||
105352377|NCT01421147|363295550|FG000|Extension Period|Lost to Follow-up|2|||
105352378|NCT01421147|363295551|FG001|Extension Period|Lost to Follow-up|5|||
105477428|NCT01642615|363759348|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
105477429|NCT01642615|363759346|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
105717891|NCT01482910|364626871|FG001|Overall Study|Protocol Violation|1|||
105717892|NCT01482910|364626870|FG000|Overall Study|Withdrawal by Subject|7|||
105717893|NCT01482910|364626871|FG001|Overall Study|Withdrawal by Subject|2|||
105717894|NCT01482910|364626870|FG000|Overall Study|Death|1|||
105717895|NCT01482910|364626871|FG001|Overall Study|Death|0|||
105717896|NCT03370770|364626873|FG000|Overall Study|Patient was followed in another hospital center|1|||
105717897|NCT03370770|364626873|FG000|Overall Study|Progressive Disease|98|||
105717898|NCT03370770|364626873|FG000|Overall Study|Adverse Event|2|||
105717899|NCT03370770|364626873|FG000|Overall Study|Death|5|||
105717900|NCT04067518|364626874|FG000|Overall Study|Adverse Event|1|||
105717901|NCT04067518|364626875|FG001|Overall Study|Adverse Event|3|||
105717902|NCT04067518|364626874|FG000|Overall Study|Screen failures|0|||
105717903|NCT04067518|364626875|FG001|Overall Study|Screen failures|1|||
105717904|NCT04067518|364626874|FG000|Overall Study|Enrolled but not treated|0|||
105717905|NCT04067518|364626875|FG001|Overall Study|Enrolled but not treated|1|||
105717906|NCT00110019|364626876|FG000|Overall Study|Lack of Efficacy|253|||
105717907|NCT00110019|364626877|FG001|Overall Study|Lack of Efficacy|285|||
105717908|NCT00110019|364626876|FG000|Overall Study|Adverse Event|61|||
105717909|NCT00110019|364626877|FG001|Overall Study|Adverse Event|40|||
105790512|NCT00077766|364887039|FG000|Overall Study|Participant's decision|1|||
105790513|NCT00077766|364887040|FG001|Overall Study|Participant's decision|0|||
105790514|NCT00077766|364887039|FG000|Overall Study|Dialysis Discontinued|1|||
105790515|NCT00077766|364887040|FG001|Overall Study|Dialysis Discontinued|0|||
105790516|NCT00077766|364887039|FG000|Overall Study|Dialysis|0|||
105352379|NCT01421147|363295550|FG000|Extension Period|Physician Decision|1|||
105352380|NCT01421147|363295551|FG001|Extension Period|Physician Decision|0|||
105352381|NCT01421147|363295550|FG000|Extension Period|Withdrawal by Subject|5|||
105352382|NCT01421147|363295551|FG001|Extension Period|Withdrawal by Subject|3|||
105352383|NCT03307837|363295558|FG000|Overall Study|Withdrawal by Subject|0|||
105352384|NCT03307837|363295559|FG001|Overall Study|Withdrawal by Subject|0|||
105352385|NCT03307837|363295560|FG002|Overall Study|Withdrawal by Subject|1|||
105717910|NCT00110019|364626876|FG000|Overall Study|Death|13|||
105717911|NCT00110019|364626877|FG001|Overall Study|Death|15|||
105717912|NCT00110019|364626876|FG000|Overall Study|Withdrawal by Subject|21|||
105790517|NCT00077766|364887040|FG001|Overall Study|Dialysis|1|||
105561869|NCT02342886|364052241|FG002|Overall Study|Withdrawal by Subject|0|||
105717913|NCT00110019|364626877|FG001|Overall Study|Withdrawal by Subject|9|||
105717914|NCT00110019|364626876|FG000|Overall Study|alternative therapy|5|||
105717915|NCT00110019|364626877|FG001|Overall Study|alternative therapy|1|||
105717916|NCT00110019|364626876|FG000|Overall Study|complicating disease|1|||
105717917|NCT00110019|364626877|FG001|Overall Study|complicating disease|1|||
105717918|NCT00110019|364626876|FG000|Overall Study|symptom deterioration|13|||
105717919|NCT00110019|364626877|FG001|Overall Study|symptom deterioration|16|||
105717920|NCT00110019|364626876|FG000|Overall Study|Not start protocol therapy|17|||
105717921|NCT00110019|364626877|FG001|Overall Study|Not start protocol therapy|16|||
105717922|NCT00110019|364626876|FG000|Overall Study|other reasons|22|||
105717923|NCT00110019|364626877|FG001|Overall Study|other reasons|30|||
105717924|NCT05655377|364626880|FG000|Overall Study|Withdrawal by Subject|2|||
105717925|NCT01109940|364626882|FG000|Overall Study|Administrative problems|2|||
105717926|NCT01109940|364626883|FG001|Overall Study|Administrative problems|0|||
105717927|NCT01109940|364626884|FG002|Overall Study|Administrative problems|0|||
105790518|NCT00077766|364887039|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
105561870|NCT02342886|364052242|FG003|Overall Study|Withdrawal by Subject|1|||
105790519|NCT00077766|364887040|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
105790520|NCT00077766|364887039|FG000|Overall Study|Started Nocturnal Dialysis|0|||
105717928|NCT01109940|364626885|FG003|Overall Study|Administrative problems|0|||
105790521|NCT00077766|364887040|FG001|Overall Study|Started Nocturnal Dialysis|1|||
105717929|NCT01109940|364626882|FG000|Overall Study|Serious Adverse Event|2|||
105717930|NCT01109940|364626883|FG001|Overall Study|Serious Adverse Event|1|||
105717931|NCT01109940|364626884|FG002|Overall Study|Serious Adverse Event|0|||
105717932|NCT01109940|364626885|FG003|Overall Study|Serious Adverse Event|0|||
105717933|NCT01109940|364626882|FG000|Overall Study|Lost to Follow-up|1|||
105717934|NCT01109940|364626883|FG001|Overall Study|Lost to Follow-up|0|||
105717935|NCT01109940|364626884|FG002|Overall Study|Lost to Follow-up|0|||
105717936|NCT01109940|364626885|FG003|Overall Study|Lost to Follow-up|0|||
105717937|NCT01109940|364626882|FG000|Overall Study|Patient withdrew consent|1|||
105717938|NCT01109940|364626883|FG001|Overall Study|Patient withdrew consent|1|||
105717939|NCT01109940|364626884|FG002|Overall Study|Patient withdrew consent|0|||
105717940|NCT01109940|364626885|FG003|Overall Study|Patient withdrew consent|0|||
105717941|NCT01109940|364626882|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105717942|NCT01109940|364626883|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105717943|NCT01109940|364626884|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
105717944|NCT01109940|364626885|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
105717945|NCT01552681|364626888|FG000|Overall Study|Withdrawal by Subject|4|||
105717946|NCT01552681|364626889|FG001|Overall Study|Withdrawal by Subject|0|||
105352386|NCT03307837|363295561|FG003|Overall Study|Withdrawal by Subject|0|||
105717947|NCT01552681|364626888|FG000|Overall Study|Physician Decision|1|||
105717948|NCT01552681|364626889|FG001|Overall Study|Physician Decision|0|||
105717949|NCT01552681|364626888|FG000|Overall Study|Subject moved away|0|||
105717950|NCT01552681|364626889|FG001|Overall Study|Subject moved away|1|||
105717951|NCT00849667|364626899|FG000|Overall Study|Withdrawal by Subject|16|||
105717952|NCT00849667|364626900|FG001|Overall Study|Withdrawal by Subject|33|||
105717953|NCT00849667|364626901|FG002|Overall Study|Withdrawal by Subject|35|||
105717954|NCT00849667|364626899|FG000|Overall Study|Lost to Follow-up|8|||
105717955|NCT00849667|364626900|FG001|Overall Study|Lost to Follow-up|8|||
105717956|NCT00849667|364626901|FG002|Overall Study|Lost to Follow-up|8|||
105717957|NCT00849667|364626899|FG000|Overall Study|Adverse Event|1|||
105717958|NCT00849667|364626900|FG001|Overall Study|Adverse Event|2|||
105717959|NCT00849667|364626901|FG002|Overall Study|Adverse Event|0|||
105717960|NCT00849667|364626899|FG000|Overall Study|Other|18|||
105717961|NCT00849667|364626900|FG001|Overall Study|Other|19|||
105717962|NCT00849667|364626901|FG002|Overall Study|Other|18|||
105717963|NCT00849667|364626899|FG000|Overall Study|Progressive disease|119|||
105717964|NCT00849667|364626900|FG001|Overall Study|Progressive disease|100|||
105717965|NCT00849667|364626901|FG002|Overall Study|Progressive disease|112|||
105717966|NCT00849667|364626899|FG000|Overall Study|Sponsor decision|208|||
105717967|NCT00849667|364626900|FG001|Overall Study|Sponsor decision|204|||
105717968|NCT00849667|364626901|FG002|Overall Study|Sponsor decision|190|||
105717969|NCT00849667|364626899|FG000|Overall Study|Investigator discretion|0|||
105717970|NCT00849667|364626900|FG001|Overall Study|Investigator discretion|0|||
105717971|NCT00849667|364626901|FG002|Overall Study|Investigator discretion|1|||
105717972|NCT00553462|364626905|FG000|Overall Study|Adverse Event|4|||
105717973|NCT00553462|364626905|FG000|Overall Study|Progression|4|||
105717974|NCT00553462|364626905|FG000|Overall Study|Withdrawal by Subject|5|||
105717975|NCT00553462|364626905|FG000|Overall Study|Physician Decision|1|||
105717976|NCT01728779|364626906|FG000|Overall Study|Withdrawal by Subject|1|||
105717977|NCT00624520|364626907|FG000|Overall Study|Withdrawal by Subject|12|||
105717978|NCT00624520|364626908|FG001|Overall Study|Withdrawal by Subject|7|||
105717979|NCT00624520|364626907|FG000|Overall Study|Death|0|||
105717980|NCT00624520|364626908|FG001|Overall Study|Death|1|||
105717981|NCT02796755|364626909|FG000|Overall Study|Adverse Event|2|||
105717982|NCT02796755|364626910|FG001|Overall Study|Adverse Event|0|||
105717983|NCT00110994|364626911|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
105717984|NCT00110994|364626912|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
105717985|NCT00110994|364626911|FG000|Double-blind (DB) Treatment|Death|1|||
105717986|NCT00110994|364626912|FG001|Double-blind (DB) Treatment|Death|0|||
105790522|NCT00077766|364887039|FG000|Overall Study|Stop Dialysis|0|||
105717987|NCT00110994|364626911|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
105790523|NCT00077766|364887040|FG001|Overall Study|Stop Dialysis|1|||
105790524|NCT00077766|364887039|FG000|Overall Study|Participants Vacation|2|||
105790525|NCT00077766|364887040|FG001|Overall Study|Participants Vacation|1|||
105790526|NCT02335411|364887041|FG000|Overall Study|Death|223|||
105790527|NCT02335411|364887042|FG001|Overall Study|Death|22|||
105790528|NCT02335411|364887043|FG002|Overall Study|Death|26|||
105790529|NCT02335411|364887041|FG000|Overall Study|Physician Decision|3|||
105790530|NCT02335411|364887042|FG001|Overall Study|Physician Decision|0|||
105790531|NCT02335411|364887043|FG002|Overall Study|Physician Decision|0|||
105790532|NCT02335411|364887041|FG000|Overall Study|Protocol Violation|1|||
105790533|NCT02335411|364887042|FG001|Overall Study|Protocol Violation|0|||
105790534|NCT02335411|364887043|FG002|Overall Study|Protocol Violation|0|||
105790535|NCT02335411|364887041|FG000|Overall Study|Withdrawal by Subject|11|||
105790536|NCT02335411|364887042|FG001|Overall Study|Withdrawal by Subject|0|||
105790537|NCT02335411|364887043|FG002|Overall Study|Withdrawal by Subject|3|||
105477430|NCT01642615|363759347|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
105477431|NCT01642615|363759348|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
105477432|NCT01642615|363759346|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
105477433|NCT01642615|363759347|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
105477434|NCT01642615|363759348|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
105790538|NCT02335411|364887041|FG000|Overall Study|Sponsor Decision|12|||
105790539|NCT02335411|364887042|FG001|Overall Study|Sponsor Decision|3|||
105790540|NCT02335411|364887043|FG002|Overall Study|Sponsor Decision|2|||
105790541|NCT02335411|364887041|FG000|Overall Study|Adverse Event|9|||
105790542|NCT02335411|364887042|FG001|Overall Study|Adverse Event|0|||
105477435|NCT01642615|363759346|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
105477436|NCT01642615|363759347|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
105477437|NCT01642615|363759348|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
105477438|NCT01642615|363759346|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
105477439|NCT01642615|363759347|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
105477440|NCT01642615|363759348|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
105477441|NCT00978757|363759351|FG000|Overall Study|Physician Decision|1|||
105477442|NCT00978757|363759352|FG001|Overall Study|Physician Decision|3|||
105477443|NCT00781885|363759353|FG000|Overall Study|Physician Decision|1|||
105477444|NCT01755026|363759354|FG000|Overall Study|Adverse Event|1|||
105477445|NCT01755026|363759355|FG001|Overall Study|Adverse Event|0|||
105477446|NCT01755026|363759354|FG000|Overall Study|Withdrawal by Subject|1|||
105477447|NCT01755026|363759355|FG001|Overall Study|Withdrawal by Subject|1|||
105477448|NCT01185353|363759361|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
105477449|NCT01185353|363759362|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
105477450|NCT01185353|363759363|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
105477451|NCT01185353|363759364|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
105477452|NCT01185353|363759365|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
105477453|NCT01185353|363759366|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
105477454|NCT01185353|363759367|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
105477455|NCT01185353|363759368|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
105477456|NCT01185353|363759369|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
105477457|NCT01185353|363759370|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
105477458|NCT01185353|363759361|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
105477459|NCT01185353|363759362|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
105717988|NCT00110994|364626912|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
105717989|NCT00110994|364626911|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
105717990|NCT00110994|364626912|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
105717991|NCT00110994|364626911|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
105717992|NCT00110994|364626912|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
105717993|NCT00110994|364626911|FG000|Double-blind (DB) Treatment|other reasons|2|||
105717994|NCT00110994|364626912|FG001|Double-blind (DB) Treatment|other reasons|3|||
105717995|NCT00110994|364626911|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
105717996|NCT00110994|364626912|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
105717997|NCT00110994|364626911|FG000|Active Follow-up|Other reasons|0|||
105717998|NCT00110994|364626912|FG001|Active Follow-up|Other reasons|2|||
105717999|NCT00110994|364626911|FG000|Long Term Follow-up|Death|19|||
105718000|NCT00110994|364626912|FG001|Long Term Follow-up|Death|17|||
105718001|NCT03433781|364626913|FG000|Overall Study|Progression of Disease|1|||
105718002|NCT03433781|364626914|FG001|Overall Study|Progression of Disease|0|||
105718003|NCT03433781|364626915|FG002|Overall Study|Progression of Disease|0|||
105718004|NCT03433781|364626913|FG000|Overall Study|Physician Decision|0|||
105718005|NCT03433781|364626914|FG001|Overall Study|Physician Decision|1|||
105718006|NCT03433781|364626915|FG002|Overall Study|Physician Decision|0|||
105718007|NCT02772757|364626918|FG000|Overall Study|Withdrawal by Subject|1|||
105718008|NCT02772757|364626919|FG001|Overall Study|Withdrawal by Subject|0|||
105718009|NCT02772757|364626920|FG002|Overall Study|Withdrawal by Subject|1|||
105718010|NCT02772757|364626918|FG000|Overall Study|Protocol Violation|0|||
105718011|NCT02772757|364626919|FG001|Overall Study|Protocol Violation|0|||
105718012|NCT02772757|364626920|FG002|Overall Study|Protocol Violation|1|||
105718013|NCT02772757|364626918|FG000|Overall Study|Physician Decision|0|||
105718014|NCT02772757|364626919|FG001|Overall Study|Physician Decision|3|||
105718015|NCT02772757|364626920|FG002|Overall Study|Physician Decision|3|||
105718016|NCT04698525|364626925|FG000|Overall Study|Lost to Follow-up|1|||
105718017|NCT04698525|364626926|FG001|Overall Study|Lost to Follow-up|2|||
105718018|NCT04698525|364626925|FG000|Overall Study|Three suffered of Covid-19|2|||
105718019|NCT04698525|364626926|FG001|Overall Study|Three suffered of Covid-19|1|||
105718020|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Adverse Event|21|||
105718021|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Adverse Event|6|||
105718022|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
105718023|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
105718024|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
105718025|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
105718026|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
105718027|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
105718028|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Physician Decision|0|||
105718029|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Physician Decision|3|||
105718030|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
105718031|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
105718032|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
105718033|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
105718034|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Subject Decision|26|||
105718035|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Subject Decision|28|||
105718036|NCT00510276|364626928|FG000|Extension Open-Label Phase|Adverse Event|9|||
105718037|NCT00510276|364626929|FG001|Extension Open-Label Phase|Adverse Event|18|||
105718038|NCT00510276|364626928|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
105718039|NCT00510276|364626929|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
105718040|NCT00510276|364626928|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
105718041|NCT00510276|364626929|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
105718042|NCT00510276|364626928|FG000|Extension Open-Label Phase|Physician Decision|2|||
105718043|NCT00510276|364626929|FG001|Extension Open-Label Phase|Physician Decision|3|||
105718044|NCT00510276|364626928|FG000|Extension Open-Label Phase|Protocol Violation|0|||
105718045|NCT00510276|364626929|FG001|Extension Open-Label Phase|Protocol Violation|1|||
105718046|NCT00510276|364626928|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
105718047|NCT00510276|364626929|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
105718048|NCT00510276|364626928|FG000|Extension Open-Label Phase|Subject Decision|7|||
105352387|NCT03307837|363295562|FG004|Overall Study|Withdrawal by Subject|0|||
105352388|NCT03307837|363295563|FG005|Overall Study|Withdrawal by Subject|1|||
105352389|NCT03307837|363295558|FG000|Overall Study|Lost to Follow-up|1|||
105352390|NCT03307837|363295559|FG001|Overall Study|Lost to Follow-up|1|||
105352391|NCT03307837|363295560|FG002|Overall Study|Lost to Follow-up|0|||
105352392|NCT03307837|363295561|FG003|Overall Study|Lost to Follow-up|0|||
105352393|NCT03307837|363295562|FG004|Overall Study|Lost to Follow-up|0|||
105352394|NCT03307837|363295563|FG005|Overall Study|Lost to Follow-up|1|||
105477460|NCT01185353|363759363|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
105477461|NCT01185353|363759364|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
105477462|NCT01185353|363759365|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
105718049|NCT00510276|364626929|FG001|Extension Open-Label Phase|Subject Decision|9|||
105718050|NCT00531960|364626935|FG000|Overall Study|Adverse Event|5|||
105477463|NCT01185353|363759366|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
105477464|NCT01185353|363759367|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
105477465|NCT01185353|363759368|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
105477466|NCT01185353|363759369|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
105477467|NCT01185353|363759370|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
105477468|NCT01185353|363759361|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
105477469|NCT01185353|363759362|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
105477470|NCT01185353|363759363|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
105477471|NCT01185353|363759364|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
105477472|NCT01185353|363759365|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
105477473|NCT01185353|363759366|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
105477474|NCT01185353|363759367|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
105477475|NCT01185353|363759368|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
105477476|NCT01185353|363759369|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
105477477|NCT01185353|363759370|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
105477478|NCT01185353|363759361|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
105477479|NCT01185353|363759362|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
105477480|NCT01185353|363759363|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
105477481|NCT01185353|363759364|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
105477482|NCT01185353|363759365|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
105477483|NCT01185353|363759366|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
105477484|NCT01185353|363759367|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
105477485|NCT01185353|363759368|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
105477486|NCT01185353|363759369|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
105477487|NCT01185353|363759370|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
105477488|NCT01185353|363759361|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
105718051|NCT00531960|364626936|FG001|Overall Study|Adverse Event|4|||
105718052|NCT00531960|364626935|FG000|Overall Study|Death|3|||
105718053|NCT00531960|364626936|FG001|Overall Study|Death|2|||
105718054|NCT00531960|364626935|FG000|Overall Study|Lack of Efficacy|42|||
105790543|NCT02335411|364887043|FG002|Overall Study|Adverse Event|0|||
105352395|NCT03246061|363295566|FG000|Overall Study|Still in follow-up|15|||
105352396|NCT03246061|363295567|FG001|Overall Study|Still in follow-up|21|||
105352397|NCT01698268|363295568|FG000|Overall Study|Physician Decision|2|||
105477489|NCT01185353|363759362|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
105477490|NCT01185353|363759363|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
105352398|NCT01698268|363295569|FG001|Overall Study|Physician Decision|1|||
105352399|NCT02263729|363295575|FG000|Overall Study|Lost to Follow-up|1|||
105352400|NCT02263729|363295576|FG001|Overall Study|Lost to Follow-up|1|||
105352401|NCT01928199|363295577|FG000|Overall Study|Lost to Follow-up|2|||
105352402|NCT01928199|363295578|FG001|Overall Study|Lost to Follow-up|1|||
105352403|NCT01928199|363295577|FG000|Overall Study|Withdrawal by Subject|3|||
105352404|NCT01928199|363295578|FG001|Overall Study|Withdrawal by Subject|5|||
105352405|NCT01502956|363295580|FG000|Overall Study|Death|0|||
105352406|NCT01502956|363295581|FG001|Overall Study|Death|2|||
105352407|NCT01502956|363295580|FG000|Overall Study|Lost to Follow-up|14|||
105352408|NCT01502956|363295581|FG001|Overall Study|Lost to Follow-up|11|||
105352409|NCT01502956|363295580|FG000|Overall Study|Physician Decision|2|||
105352410|NCT01502956|363295581|FG001|Overall Study|Physician Decision|3|||
105352411|NCT01502956|363295580|FG000|Overall Study|Withdrawal by Subject|8|||
105790544|NCT00938015|364887044|FG000|Overall Study|Death|2|||
105790545|NCT00938015|364887044|FG000|Overall Study|Lost to Follow-up|32|||
105790546|NCT00938015|364887044|FG000|Overall Study|Adverse Event|32|||
105790547|NCT00938015|364887044|FG000|Overall Study|Non-responder|52|||
105352412|NCT01502956|363295581|FG001|Overall Study|Withdrawal by Subject|10|||
105352413|NCT01026818|363295582|FG000|Screening Period|Entry Criteria Not Met|105|||
105352414|NCT01026818|363295583|FG001|Screening Period|Entry Criteria Not Met|0|||
105352415|NCT01026818|363295584|FG002|Screening Period|Entry Criteria Not Met|0|||
105352416|NCT01026818|363295585|FG003|Screening Period|Entry Criteria Not Met|0|||
105352417|NCT01026818|363295582|FG000|Screening Period|Withdrawal by Subject|49|||
105352418|NCT01026818|363295583|FG001|Screening Period|Withdrawal by Subject|0|||
105352419|NCT01026818|363295584|FG002|Screening Period|Withdrawal by Subject|0|||
105352420|NCT01026818|363295585|FG003|Screening Period|Withdrawal by Subject|0|||
105352421|NCT01026818|363295582|FG000|Screening Period|Protocol Deviation|3|||
105352422|NCT01026818|363295583|FG001|Screening Period|Protocol Deviation|0|||
105352423|NCT01026818|363295584|FG002|Screening Period|Protocol Deviation|0|||
105718055|NCT00531960|364626936|FG001|Overall Study|Lack of Efficacy|41|||
105718056|NCT00531960|364626935|FG000|Overall Study|Violation of Selection Criteria|2|||
105718057|NCT00531960|364626936|FG001|Overall Study|Violation of Selection Criteria|0|||
105718058|NCT00531960|364626935|FG000|Overall Study|Refused Treatment|5|||
105718059|NCT00531960|364626936|FG001|Overall Study|Refused Treatment|6|||
105718060|NCT00531960|364626935|FG000|Overall Study|Other|4|||
105718061|NCT00531960|364626936|FG001|Overall Study|Other|10|||
105718062|NCT03183128|364626939|FG000|Overall Study|Adverse Event|1|||
105718063|NCT03183128|364626940|FG001|Overall Study|Adverse Event|2|||
105718064|NCT03183128|364626939|FG000|Overall Study|Withdrawal by Subject|1|||
105718065|NCT03183128|364626940|FG001|Overall Study|Withdrawal by Subject|8|||
105718066|NCT03183128|364626939|FG000|Overall Study|Protocol Violation|2|||
105718067|NCT03183128|364626940|FG001|Overall Study|Protocol Violation|0|||
105718068|NCT03183128|364626939|FG000|Overall Study|Lack of Efficacy|4|||
105718069|NCT03183128|364626940|FG001|Overall Study|Lack of Efficacy|27|||
105718070|NCT03183128|364626939|FG000|Overall Study|Lost to Follow-up|1|||
105718071|NCT03183128|364626940|FG001|Overall Study|Lost to Follow-up|0|||
105718072|NCT03183128|364626939|FG000|Overall Study|Death|2|||
105718073|NCT03183128|364626940|FG001|Overall Study|Death|0|||
105718074|NCT03183128|364626939|FG000|Overall Study|Physician Decision|1|||
105718075|NCT03183128|364626940|FG001|Overall Study|Physician Decision|0|||
105718076|NCT00330187|364626941|FG000|Overall Study|Lost to Follow-up|12|||
105718077|NCT00330187|364626942|FG001|Overall Study|Lost to Follow-up|13|||
105718078|NCT00330187|364626943|FG002|Overall Study|Lost to Follow-up|14|||
105718079|NCT00330187|364626944|FG003|Overall Study|Lost to Follow-up|10|||
105718080|NCT00330187|364626941|FG000|Overall Study|Withdrawal by Subject|8|||
105790548|NCT00938015|364887044|FG000|Overall Study|Reason not related to Etanercept|29|||
105790549|NCT01886105|364887045|FG000|Overall Study|Lack of Efficacy|3|||
105790550|NCT01876901|364887046|FG000|Overall Study|Protocol Violation|10|||
105790551|NCT01876901|364887047|FG001|Overall Study|Protocol Violation|2|||
105352424|NCT01026818|363295585|FG003|Screening Period|Protocol Deviation|0|||
105352425|NCT01026818|363295582|FG000|Screening Period|Adverse Event|2|||
105718081|NCT00330187|364626942|FG001|Overall Study|Withdrawal by Subject|5|||
105790552|NCT01876901|364887046|FG000|Overall Study|No or other surgical intervention|7|||
105718082|NCT00330187|364626943|FG002|Overall Study|Withdrawal by Subject|4|||
105718083|NCT00330187|364626944|FG003|Overall Study|Withdrawal by Subject|4|||
105718084|NCT01481896|364626947|FG000|Overall Study|Lost to Follow-up|12|||
105790553|NCT01876901|364887047|FG001|Overall Study|No or other surgical intervention|5|||
105352426|NCT01026818|363295583|FG001|Screening Period|Adverse Event|0|||
105352427|NCT01026818|363295584|FG002|Screening Period|Adverse Event|0|||
105352428|NCT01026818|363295585|FG003|Screening Period|Adverse Event|0|||
105352429|NCT01026818|363295582|FG000|Screening Period|Physician Decision|1|||
105352430|NCT01026818|363295583|FG001|Screening Period|Physician Decision|0|||
105352431|NCT01026818|363295584|FG002|Screening Period|Physician Decision|0|||
105352432|NCT01026818|363295585|FG003|Screening Period|Physician Decision|0|||
105718085|NCT01818726|364626948|FG000|Overall Study|Administrative reasons|5|||
105718086|NCT01818726|364626949|FG001|Overall Study|Administrative reasons|1|||
105718087|NCT01818726|364626948|FG000|Overall Study|Withdrawal by Subject|0|||
105790554|NCT03186794|364887048|FG000|Overall Study|Physician Decision|2|||
105718088|NCT01818726|364626949|FG001|Overall Study|Withdrawal by Subject|1|||
105718089|NCT01818726|364626948|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
105718090|NCT01818726|364626949|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
105718091|NCT01162421|364626950|FG000|Overall Study|Did not receive study drug|2|||
105718092|NCT01162421|364626951|FG001|Overall Study|Did not receive study drug|1|||
105718093|NCT01162421|364626950|FG000|Overall Study|Adverse Event|2|||
105718094|NCT01162421|364626951|FG001|Overall Study|Adverse Event|5|||
105718095|NCT01162421|364626950|FG000|Overall Study|Lost to Follow-up|0|||
105718096|NCT01162421|364626951|FG001|Overall Study|Lost to Follow-up|2|||
105718097|NCT01162421|364626950|FG000|Overall Study|Lack of Efficacy|2|||
105718098|NCT01162421|364626951|FG001|Overall Study|Lack of Efficacy|2|||
105718099|NCT01162421|364626950|FG000|Overall Study|Other|2|||
105718100|NCT01162421|364626951|FG001|Overall Study|Other|3|||
105718101|NCT03336502|364626952|FG000|Overall Study|Physician Decision|0|||
105718102|NCT03336502|364626953|FG001|Overall Study|Physician Decision|1|||
105718103|NCT03336502|364626952|FG000|Overall Study|Prohibited Drugs|1|||
105718104|NCT03336502|364626953|FG001|Overall Study|Prohibited Drugs|1|||
105718105|NCT03336502|364626952|FG000|Overall Study|Death|1|||
105718106|NCT03336502|364626953|FG001|Overall Study|Death|2|||
105718107|NCT03336502|364626952|FG000|Overall Study|Adverse Event|2|||
105718108|NCT03336502|364626953|FG001|Overall Study|Adverse Event|5|||
105718109|NCT01133171|364626959|FG000|Overall Study|Withdrawal by Subject|1|||
105718110|NCT01133171|364626960|FG001|Overall Study|Withdrawal by Subject|2|||
105718111|NCT01133171|364626961|FG002|Overall Study|Withdrawal by Subject|0|||
105718112|NCT01375764|364626962|FG000|Overall Study|Lost to Follow-up|0|||
105718113|NCT01375764|364626963|FG001|Overall Study|Lost to Follow-up|1|||
105718114|NCT01375764|364626964|FG002|Overall Study|Lost to Follow-up|0|||
105718115|NCT01375764|364626965|FG003|Overall Study|Lost to Follow-up|0|||
105718116|NCT01375764|364626966|FG004|Overall Study|Lost to Follow-up|0|||
105718117|NCT01375764|364626962|FG000|Overall Study|Withdrawal by Subject|2|||
105718118|NCT01375764|364626963|FG001|Overall Study|Withdrawal by Subject|0|||
105718119|NCT01375764|364626964|FG002|Overall Study|Withdrawal by Subject|0|||
105718120|NCT01375764|364626965|FG003|Overall Study|Withdrawal by Subject|0|||
105718121|NCT01375764|364626966|FG004|Overall Study|Withdrawal by Subject|1|||
105718122|NCT01375764|364626962|FG000|Overall Study|Other|0|||
105718123|NCT01375764|364626963|FG001|Overall Study|Other|0|||
105718124|NCT01375764|364626964|FG002|Overall Study|Other|0|||
105718125|NCT01375764|364626965|FG003|Overall Study|Other|1|||
105718126|NCT01375764|364626966|FG004|Overall Study|Other|0|||
105718127|NCT01465659|364626969|FG000|Completed 1 Cycle of Treatment|Death|0|||
105718128|NCT01465659|364626970|FG001|Completed 1 Cycle of Treatment|Death|1|||
105718129|NCT01465659|364626971|FG002|Completed 1 Cycle of Treatment|Death|0|||
105718130|NCT01465659|364626972|FG003|Completed 1 Cycle of Treatment|Death|0|||
105718131|NCT01465659|364626969|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
105561871|NCT02342886|364052243|FG004|Overall Study|Withdrawal by Subject|0|||
105718132|NCT01465659|364626970|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
105718133|NCT01465659|364626971|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
105718134|NCT01465659|364626972|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
105718135|NCT01465659|364626969|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
105718136|NCT01465659|364626970|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
105718137|NCT01465659|364626971|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
105718138|NCT01465659|364626972|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
105718139|NCT01465659|364626969|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
105718140|NCT01465659|364626970|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
105718141|NCT01465659|364626971|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
105718142|NCT01465659|364626972|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
105718143|NCT01465659|364626969|FG000|Completed Follow for 1 Year|Death|6|||
105718144|NCT01465659|364626970|FG001|Completed Follow for 1 Year|Death|3|||
105718145|NCT01465659|364626971|FG002|Completed Follow for 1 Year|Death|2|||
105790555|NCT03186794|364887048|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
105790556|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
105790557|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
105790558|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Death|5|||
105790559|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Death|2|||
105790560|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
105790561|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
105790562|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
105790563|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
105790564|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
105790565|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
105790566|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Relapse|1|||
105790567|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Relapse|0|||
105790568|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
105790569|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
105790570|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
105790571|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
105790572|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
105790573|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
105790574|NCT00111007|364887050|FG000|Active Follow-up|Adverse Event|1|||
105790575|NCT00111007|364887051|FG001|Active Follow-up|Adverse Event|0|||
105790576|NCT00111007|364887050|FG000|Active Follow-up|Death|2|||
105790577|NCT00111007|364887051|FG001|Active Follow-up|Death|0|||
105790578|NCT00111007|364887050|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
105790579|NCT00111007|364887051|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
105790580|NCT00111007|364887050|FG000|Long Term Follow-up|Death|34|||
105790581|NCT00111007|364887051|FG001|Long Term Follow-up|Death|39|||
105790582|NCT00111007|364887050|FG000|Long Term Follow-up|Lost to Follow-up|1|||
105790583|NCT00111007|364887051|FG001|Long Term Follow-up|Lost to Follow-up|1|||
105790584|NCT00111007|364887050|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
105790585|NCT00111007|364887051|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
105790586|NCT00111007|364887050|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
105790587|NCT00111007|364887051|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
105790588|NCT00111007|364887050|FG000|Long Term Follow-up|Missing|10|||
105790589|NCT00111007|364887051|FG001|Long Term Follow-up|Missing|3|||
105790590|NCT00440193|364887052|FG000|Treatment Period|Adverse Event|74|||
105790591|NCT00440193|364887053|FG001|Treatment Period|Adverse Event|67|||
105790592|NCT00440193|364887052|FG000|Treatment Period|Death|19|||
105790593|NCT00440193|364887053|FG001|Treatment Period|Death|22|||
105790594|NCT00440193|364887052|FG000|Treatment Period|Lack of Efficacy|0|||
105790595|NCT00440193|364887053|FG001|Treatment Period|Lack of Efficacy|1|||
105790596|NCT00440193|364887052|FG000|Treatment Period|Lost to Follow-up|12|||
105790597|NCT00440193|364887053|FG001|Treatment Period|Lost to Follow-up|18|||
105790598|NCT00440193|364887052|FG000|Treatment Period|Physician Decision|3|||
105790599|NCT00440193|364887053|FG001|Treatment Period|Physician Decision|6|||
105790600|NCT00440193|364887052|FG000|Treatment Period|Protocol Violation|16|||
105790601|NCT00440193|364887053|FG001|Treatment Period|Protocol Violation|19|||
105790602|NCT00440193|364887052|FG000|Treatment Period|Withdrawal by Subject|36|||
105790603|NCT00440193|364887053|FG001|Treatment Period|Withdrawal by Subject|77|||
105718146|NCT01465659|364626972|FG003|Completed Follow for 1 Year|Death|4|||
105718147|NCT02149810|364626984|FG000|Overall Study|Physician Decision|1|||
105790604|NCT00440193|364887052|FG000|Treatment Period|Clinical endpoint reached|28|||
105561872|NCT02342886|364052239|FG000|Overall Study|Investigator/sponsor decision|0|||
105718148|NCT02149810|364626985|FG001|Overall Study|Physician Decision|2|||
105718149|NCT02149810|364626984|FG000|Overall Study|Lost to Follow-up|2|||
105790605|NCT00440193|364887053|FG001|Treatment Period|Clinical endpoint reached|25|||
105790606|NCT00440193|364887052|FG000|Treatment Period|Study terminated by sponsor|102|||
105718150|NCT02149810|364626985|FG001|Overall Study|Lost to Follow-up|1|||
105718151|NCT02149810|364626984|FG000|Overall Study|Withdrawal by Subject|5|||
105718152|NCT02149810|364626985|FG001|Overall Study|Withdrawal by Subject|1|||
105718153|NCT01469000|364626986|FG000|Overall Study|Withdrawal by Subject|16|||
105718154|NCT01469000|364626987|FG001|Overall Study|Withdrawal by Subject|3|||
105718155|NCT01469000|364626986|FG000|Overall Study|Sponsor Decision|4|||
105718156|NCT01469000|364626987|FG001|Overall Study|Sponsor Decision|1|||
105718157|NCT01959165|364626989|FG000|Overall Study|Adverse Event|0|||
105718158|NCT01959165|364626990|FG001|Overall Study|Adverse Event|0|||
105718159|NCT01959165|364626991|FG002|Overall Study|Adverse Event|0|||
105718160|NCT01959165|364626992|FG003|Overall Study|Adverse Event|1|||
105718161|NCT01959165|364626989|FG000|Overall Study|Lack of Efficacy|1|||
105718162|NCT01959165|364626990|FG001|Overall Study|Lack of Efficacy|0|||
105718163|NCT01959165|364626991|FG002|Overall Study|Lack of Efficacy|0|||
105718164|NCT01959165|364626992|FG003|Overall Study|Lack of Efficacy|0|||
105718165|NCT01959165|364626989|FG000|Overall Study|overdose|0|||
105718166|NCT01959165|364626990|FG001|Overall Study|overdose|0|||
105718167|NCT01959165|364626991|FG002|Overall Study|overdose|0|||
105718168|NCT01959165|364626992|FG003|Overall Study|overdose|1|||
105718169|NCT01959165|364626989|FG000|Overall Study|Welfare recipient|0|||
105718170|NCT01959165|364626990|FG001|Overall Study|Welfare recipient|1|||
105718171|NCT01959165|364626991|FG002|Overall Study|Welfare recipient|0|||
105718172|NCT01959165|364626992|FG003|Overall Study|Welfare recipient|0|||
105718173|NCT00769119|364626993|FG000|Overall Study|Voluntary discontinuation|0|||
105718174|NCT00769119|364626994|FG001|Overall Study|Voluntary discontinuation|2|||
105718175|NCT00769119|364626993|FG000|Overall Study|Adverse Event|1|||
105718176|NCT00769119|364626994|FG001|Overall Study|Adverse Event|1|||
105718177|NCT00769119|364626993|FG000|Overall Study|Disallowed medication|1|||
105718178|NCT00769119|364626994|FG001|Overall Study|Disallowed medication|0|||
105718179|NCT00686647|364626997|FG000|Overall Study|Lost to Follow-up|1|||
105718180|NCT00686647|364626997|FG000|Overall Study|Death|1|||
105718181|NCT04082663|364627001|FG000|Overall Study|Adverse Event|6|||
105718182|NCT04082663|364627001|FG000|Overall Study|Lost to Follow-up|1|||
105718183|NCT00578643|364627002|FG000|Overall Study|Death|1|||
105718184|NCT00578643|364627002|FG000|Overall Study|Lost to Follow-up|1|||
105718185|NCT00705263|364627003|FG000|Overall Study|Withdrawal by Subject|2|||
105718186|NCT01752023|364627004|FG000|Overall Study|Physician Decision|2|||
105718187|NCT01752023|364627005|FG001|Overall Study|Physician Decision|1|||
105718188|NCT03430986|364627011|FG000|24-week Control Period|Adverse Event|1|||
105718189|NCT03430986|364627012|FG001|24-week Control Period|Adverse Event|0|||
105718190|NCT03430986|364627011|FG000|24-week Control Period|Lost to Follow-up|2|||
105718191|NCT03430986|364627012|FG001|24-week Control Period|Lost to Follow-up|2|||
105718192|NCT03430986|364627011|FG000|24-week Control Period|Withdrawal by Participant|5|||
105718193|NCT03430986|364627012|FG001|24-week Control Period|Withdrawal by Participant|0|||
105718194|NCT03430986|364627011|FG000|24-week Control Period|Protocol Deviation|0|||
105718195|NCT03430986|364627012|FG001|24-week Control Period|Protocol Deviation|2|||
105718196|NCT03430986|364627011|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
105718197|NCT03430986|364627012|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
105718198|NCT03430986|364627011|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
105718199|NCT03430986|364627012|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
105718200|NCT01583374|364627016|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
105718201|NCT01583374|364627017|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
105718202|NCT01583374|364627018|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
105718203|NCT01583374|364627019|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105718204|NCT01583374|364627020|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105718205|NCT01583374|364627021|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105718206|NCT01583374|364627022|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105718207|NCT01583374|364627023|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105718208|NCT01583374|364627024|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105718209|NCT01583374|364627016|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
105718210|NCT01583374|364627017|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
105718211|NCT01583374|364627018|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
105718212|NCT01583374|364627019|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105718213|NCT01583374|364627020|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105718214|NCT01583374|364627021|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105718215|NCT01583374|364627022|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105718216|NCT01583374|364627023|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105718217|NCT01583374|364627024|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105718218|NCT01583374|364627016|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
105718219|NCT01583374|364627017|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
105718220|NCT01583374|364627018|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105718221|NCT01583374|364627019|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105790607|NCT00440193|364887053|FG001|Treatment Period|Study terminated by sponsor|94|||
105790608|NCT00440193|364887052|FG000|Treatment Period|Protocol driven decision point|2|||
105790609|NCT00440193|364887053|FG001|Treatment Period|Protocol driven decision point|2|||
105790610|NCT00440193|364887052|FG000|Treatment Period|Switch to commercial drug|0|||
105790611|NCT00440193|364887053|FG001|Treatment Period|Switch to commercial drug|2|||
105790612|NCT00440193|364887052|FG000|Treatment Period|Technical problems|1|||
105790613|NCT00440193|364887053|FG001|Treatment Period|Technical problems|1|||
105790614|NCT00440193|364887052|FG000|Treatment Period|Participant convenience|5|||
105790615|NCT00440193|364887053|FG001|Treatment Period|Participant convenience|2|||
105790616|NCT00440193|364887052|FG000|Treatment Period|Participant did not receive treatment|7|||
105790617|NCT00440193|364887053|FG001|Treatment Period|Participant did not receive treatment|13|||
105790618|NCT00440193|364887052|FG000|Treatment Period|Site closed by investigator|0|||
105790619|NCT00440193|364887053|FG001|Treatment Period|Site closed by investigator|2|||
105790620|NCT00440193|364887052|FG000|Observational Period|Adverse Event|2|||
105790621|NCT00440193|364887053|FG001|Observational Period|Adverse Event|2|||
105790622|NCT00440193|364887052|FG000|Observational Period|Death|15|||
105790623|NCT00440193|364887053|FG001|Observational Period|Death|20|||
105790624|NCT00440193|364887052|FG000|Observational Period|Lost to Follow-up|12|||
105790625|NCT00440193|364887053|FG001|Observational Period|Lost to Follow-up|8|||
105790626|NCT00440193|364887052|FG000|Observational Period|Protocol Violation|1|||
105718222|NCT01583374|364627020|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105718223|NCT01583374|364627021|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105718224|NCT01583374|364627022|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105718225|NCT01583374|364627023|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105718226|NCT01583374|364627024|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105718227|NCT01583374|364627016|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
105718228|NCT01583374|364627017|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
105718229|NCT01583374|364627018|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
105718230|NCT01583374|364627019|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105718231|NCT01583374|364627020|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105718232|NCT01583374|364627021|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105718233|NCT01583374|364627022|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105718234|NCT01583374|364627023|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105718235|NCT01583374|364627024|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105718236|NCT01583374|364627016|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
105718237|NCT01583374|364627017|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
105718238|NCT01583374|364627018|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
105718239|NCT01583374|364627019|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
105718240|NCT01583374|364627020|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
105718241|NCT01583374|364627021|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
105718242|NCT01583374|364627022|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
105790627|NCT00440193|364887053|FG001|Observational Period|Protocol Violation|0|||
105718243|NCT01583374|364627023|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
105718244|NCT01583374|364627024|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
105718245|NCT01583374|364627016|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105790628|NCT00440193|364887052|FG000|Observational Period|Withdrawal by Subject|11|||
105790629|NCT00440193|364887053|FG001|Observational Period|Withdrawal by Subject|8|||
105790630|NCT00440193|364887052|FG000|Observational Period|Physician Decision|1|||
105790631|NCT00440193|364887053|FG001|Observational Period|Physician Decision|0|||
105790632|NCT00440193|364887052|FG000|Observational Period|Clinical endpoint reached|1|||
105790633|NCT00440193|364887053|FG001|Observational Period|Clinical endpoint reached|0|||
105790634|NCT00440193|364887052|FG000|Observational Period|Participant convenience|2|||
105790635|NCT00440193|364887053|FG001|Observational Period|Participant convenience|0|||
105790636|NCT03075826|364887055|FG000|Overall Study|Withdrawal by Subject|1|||
105790637|NCT03075826|364887055|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
105790638|NCT01071278|364887056|FG000|Overall Study|Premature Discontinuation|254|||
105790639|NCT01071278|364887056|FG000|Overall Study|Completion Status Unknown|459|||
105790640|NCT03078192|364887057|FG000|Overall Study|Withdrawal by Subject|2|||
105718246|NCT01583374|364627017|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105718247|NCT01583374|364627018|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
105718248|NCT01583374|364627019|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105718249|NCT01583374|364627020|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105718250|NCT01583374|364627021|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105718251|NCT01583374|364627022|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105718252|NCT01583374|364627023|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105718253|NCT01583374|364627024|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105718254|NCT01583374|364627016|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718255|NCT01583374|364627017|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
105718256|NCT01583374|364627018|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718257|NCT01583374|364627019|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718258|NCT01583374|364627020|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718259|NCT01583374|364627021|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718260|NCT01583374|364627022|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718261|NCT01583374|364627023|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718262|NCT01583374|364627024|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718263|NCT01583374|364627016|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105718264|NCT01583374|364627017|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105718265|NCT01583374|364627018|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105718266|NCT01583374|364627019|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105718267|NCT01583374|364627020|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105718268|NCT01583374|364627021|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105718269|NCT01583374|364627022|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105790641|NCT03078192|364887058|FG001|Overall Study|Withdrawal by Subject|1|||
105790642|NCT03078192|364887057|FG000|Overall Study|screen failure|0|||
105790643|NCT03078192|364887058|FG001|Overall Study|screen failure|3|||
105790644|NCT02061293|364887059|FG000|Overall Study|Elevated Blood Pressure|1|||
105790645|NCT02061293|364887060|FG001|Overall Study|Elevated Blood Pressure|1|||
105790646|NCT02184988|364887061|FG000|Overall Study|Pregnancy|2|||
105790647|NCT02184988|364887061|FG000|Overall Study|Adverse Event|2|||
105790648|NCT02184988|364887061|FG000|Overall Study|moving away/travelling/unable to complet|6|||
105790649|NCT02184988|364887061|FG000|Overall Study|work scheduling issues|4|||
105790650|NCT02184988|364887061|FG000|Overall Study|various other reasons|9|||
105790651|NCT02184988|364887061|FG000|Overall Study|Lost to Follow-up|32|||
105790652|NCT01058707|364887062|FG000|Overall Study|Disease Progression|15|||
105790653|NCT01058707|364887063|FG001|Overall Study|Disease Progression|20|||
105790654|NCT01058707|364887064|FG002|Overall Study|Disease Progression|20|||
105790655|NCT01058707|364887065|FG003|Overall Study|Disease Progression|15|||
105790656|NCT01058707|364887066|FG004|Overall Study|Disease Progression|23|||
105790657|NCT01058707|364887067|FG005|Overall Study|Disease Progression|10|||
105790658|NCT01058707|364887068|FG006|Overall Study|Disease Progression|12|||
105790659|NCT01058707|364887062|FG000|Overall Study|Adverse Event|11|||
105790660|NCT01058707|364887063|FG001|Overall Study|Adverse Event|4|||
105790661|NCT01058707|364887064|FG002|Overall Study|Adverse Event|7|||
105790662|NCT01058707|364887065|FG003|Overall Study|Adverse Event|6|||
105790663|NCT01058707|364887066|FG004|Overall Study|Adverse Event|7|||
105790664|NCT01058707|364887067|FG005|Overall Study|Adverse Event|3|||
105790665|NCT01058707|364887068|FG006|Overall Study|Adverse Event|1|||
105790666|NCT01058707|364887062|FG000|Overall Study|Subject Decision|5|||
105790667|NCT01058707|364887063|FG001|Overall Study|Subject Decision|3|||
105790668|NCT01058707|364887064|FG002|Overall Study|Subject Decision|3|||
105790669|NCT01058707|364887065|FG003|Overall Study|Subject Decision|1|||
105790670|NCT01058707|364887066|FG004|Overall Study|Subject Decision|2|||
105790671|NCT01058707|364887067|FG005|Overall Study|Subject Decision|3|||
105790672|NCT01058707|364887068|FG006|Overall Study|Subject Decision|6|||
105790673|NCT01058707|364887062|FG000|Overall Study|Lost to Follow-up|0|||
105790674|NCT01058707|364887063|FG001|Overall Study|Lost to Follow-up|0|||
105790675|NCT01058707|364887064|FG002|Overall Study|Lost to Follow-up|1|||
105790676|NCT01058707|364887065|FG003|Overall Study|Lost to Follow-up|0|||
105790677|NCT01058707|364887066|FG004|Overall Study|Lost to Follow-up|0|||
105790678|NCT01058707|364887067|FG005|Overall Study|Lost to Follow-up|0|||
105790679|NCT01058707|364887068|FG006|Overall Study|Lost to Follow-up|0|||
105790680|NCT01058707|364887062|FG000|Overall Study|Reason Not Specified|0|||
105790681|NCT01058707|364887063|FG001|Overall Study|Reason Not Specified|3|||
105790682|NCT01058707|364887064|FG002|Overall Study|Reason Not Specified|2|||
105790683|NCT01058707|364887065|FG003|Overall Study|Reason Not Specified|0|||
105790684|NCT01058707|364887066|FG004|Overall Study|Reason Not Specified|7|||
105790685|NCT01058707|364887067|FG005|Overall Study|Reason Not Specified|1|||
105790686|NCT01058707|364887068|FG006|Overall Study|Reason Not Specified|7|||
105790687|NCT00483717|364887073|FG000|Overall Study|Protocol Violation|5|||
105790688|NCT00483717|364887074|FG001|Overall Study|Protocol Violation|7|||
105790689|NCT00483717|364887073|FG000|Overall Study|Time of dosing missing|1|||
105790690|NCT00483717|364887074|FG001|Overall Study|Time of dosing missing|1|||
105352433|NCT01026818|363295582|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
105352434|NCT01026818|363295583|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
105790691|NCT00483717|364887073|FG000|Overall Study|No treatment for migraine|16|||
105477491|NCT01185353|363759364|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
105477492|NCT01185353|363759365|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
105477493|NCT01185353|363759366|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
105477494|NCT01185353|363759367|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
105477495|NCT01185353|363759368|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
105477496|NCT01185353|363759369|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
105477497|NCT01185353|363759370|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
105477498|NCT01185353|363759361|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
105477499|NCT01185353|363759362|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
105477500|NCT01185353|363759363|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
105477501|NCT01185353|363759364|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
105477502|NCT01185353|363759365|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
105477503|NCT01185353|363759366|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
105477504|NCT01185353|363759367|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
105477505|NCT01185353|363759368|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
105477506|NCT01185353|363759369|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
105477507|NCT01185353|363759370|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
105477508|NCT01185353|363759361|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
105477509|NCT01185353|363759362|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
105477510|NCT01185353|363759363|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
105477511|NCT01185353|363759364|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
105477512|NCT01185353|363759365|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
105477513|NCT01185353|363759366|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
105477514|NCT01185353|363759367|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
105477515|NCT01185353|363759368|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
105477516|NCT01185353|363759369|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
105477517|NCT01185353|363759370|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
105477518|NCT01185353|363759361|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
105477519|NCT01185353|363759362|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
105477520|NCT01185353|363759363|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
105477521|NCT01185353|363759364|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
105477522|NCT01185353|363759365|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
105477523|NCT01185353|363759366|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
105477524|NCT01185353|363759367|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
105477525|NCT01185353|363759368|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
105477526|NCT01185353|363759369|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
105477527|NCT01185353|363759370|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
105477528|NCT01185353|363759361|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
105477529|NCT01185353|363759362|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
105477530|NCT01185353|363759363|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
105477531|NCT01185353|363759364|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
105477532|NCT01185353|363759365|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
105477533|NCT01185353|363759366|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
105477534|NCT01185353|363759367|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
105477535|NCT01185353|363759368|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
105477536|NCT01185353|363759369|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
105477537|NCT01185353|363759370|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
105477538|NCT01185353|363759361|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
105477539|NCT01185353|363759362|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
105477540|NCT01185353|363759363|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
105477541|NCT01185353|363759364|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
105477542|NCT01185353|363759365|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
105477543|NCT01185353|363759366|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
105477544|NCT01185353|363759367|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
105477545|NCT01185353|363759368|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
105477546|NCT01185353|363759369|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
105477547|NCT01185353|363759370|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
105477548|NCT01185353|363759361|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
105718270|NCT01583374|364627023|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
105718271|NCT01583374|364627024|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105718272|NCT01583374|364627016|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
105718273|NCT01583374|364627017|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
105718274|NCT01583374|364627018|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
105718275|NCT01583374|364627019|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
105718276|NCT01583374|364627020|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
105718277|NCT01583374|364627021|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
105477549|NCT01185353|363759362|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
105718278|NCT01583374|364627022|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
105718279|NCT01583374|364627023|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
105718280|NCT01583374|364627024|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
105718281|NCT01583374|364627016|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
105718282|NCT01583374|364627017|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
105718283|NCT01583374|364627018|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
105718284|NCT01583374|364627019|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
105477550|NCT01185353|363759363|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
105477551|NCT01185353|363759364|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
105718285|NCT01583374|364627020|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
105718286|NCT01583374|364627021|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
105718287|NCT01583374|364627022|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
105718288|NCT01583374|364627023|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
105718289|NCT01583374|364627024|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
105718290|NCT01583374|364627016|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
105718291|NCT01583374|364627017|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
105718292|NCT01583374|364627018|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
105718293|NCT01583374|364627019|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
105718294|NCT01583374|364627020|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
105718295|NCT01583374|364627021|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
105718296|NCT01583374|364627022|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
105718297|NCT01583374|364627023|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
105718298|NCT01583374|364627024|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
105718299|NCT01583374|364627016|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
105718300|NCT01583374|364627017|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
105718301|NCT01583374|364627018|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
105718302|NCT01583374|364627019|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
105718303|NCT01583374|364627020|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
105718304|NCT01583374|364627021|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
105718305|NCT01583374|364627022|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
105718306|NCT01583374|364627023|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
105718307|NCT01583374|364627024|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
105718308|NCT01583374|364627016|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
105352435|NCT01026818|363295584|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
105477552|NCT01185353|363759365|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
105718309|NCT01583374|364627017|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
105718310|NCT01583374|364627018|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
105718311|NCT01583374|364627019|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
105718312|NCT01583374|364627020|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
105477553|NCT01185353|363759366|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
105477554|NCT01185353|363759367|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
105477555|NCT01185353|363759368|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
105790692|NCT00483717|364887074|FG001|Overall Study|No treatment for migraine|13|||
105790693|NCT00483717|364887073|FG000|Overall Study|Lost to Follow-up|1|||
105790694|NCT00483717|364887074|FG001|Overall Study|Lost to Follow-up|0|||
105790695|NCT00483717|364887073|FG000|Overall Study|Withdrawal by Subject|1|||
105790696|NCT00483717|364887074|FG001|Overall Study|Withdrawal by Subject|0|||
105790697|NCT01682681|364887075|FG000|Overall Study|Lack of Efficacy|62|||
105790698|NCT01682681|364887075|FG000|Overall Study|Withdrawal by Subject|1|||
105790699|NCT01682681|364887075|FG000|Overall Study|Moved to other hospital|10|||
105790700|NCT01682681|364887075|FG000|Overall Study|Lost to Follow-up|174|||
105790701|NCT01682681|364887075|FG000|Overall Study|Adverse Event|46|||
105790702|NCT01682681|364887075|FG000|Overall Study|tapering of topiramate|5|||
105790703|NCT01682681|364887075|FG000|Overall Study|Other|21|||
105790704|NCT01682681|364887075|FG000|Overall Study|Low compliance|13|||
105790705|NCT01843660|364887079|FG000|Overall Study|Other|30|||
105790706|NCT00625846|364888368|FG000|Overall Study|Withdrawal by Subject|2|||
105790707|NCT00625846|364888369|FG001|Overall Study|Withdrawal by Subject|0|||
105790708|NCT00625846|364888370|FG002|Overall Study|Withdrawal by Subject|1|||
105790709|NCT00625846|364888371|FG003|Overall Study|Withdrawal by Subject|2|||
105352436|NCT01026818|363295585|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
105352437|NCT01026818|363295582|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
105790710|NCT02353572|364888376|FG000|Overall Study|Withdrawal by Subject|1|||
105352438|NCT01026818|363295583|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
105352439|NCT01026818|363295584|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
105352440|NCT01026818|363295585|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
105352441|NCT01026818|363295582|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
105352442|NCT01026818|363295583|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
105352443|NCT01026818|363295584|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
105352444|NCT01026818|363295585|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
105352445|NCT01026818|363295582|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
105352446|NCT01026818|363295583|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
105352447|NCT01026818|363295584|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
105352448|NCT01026818|363295585|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
105352449|NCT01026818|363295582|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
105352450|NCT01026818|363295583|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
105790711|NCT02353572|364888376|FG000|Overall Study|Study terminated|2|||
105790712|NCT00769132|364888381|FG000|Period 1|Adverse Event|1|||
105790713|NCT00769132|364888382|FG001|Period 1|Adverse Event|0|||
105790714|NCT00769132|364888383|FG002|Period 1|Adverse Event|0|||
105790715|NCT00769132|364888384|FG003|Period 1|Adverse Event|1|||
105790716|NCT00769132|364888381|FG000|Period 2|Withdrawal by Subject|0|||
105790717|NCT00769132|364888382|FG001|Period 2|Withdrawal by Subject|0|||
105790718|NCT00769132|364888383|FG002|Period 2|Withdrawal by Subject|0|||
105790719|NCT00769132|364888384|FG003|Period 2|Withdrawal by Subject|1|||
105790720|NCT00769132|364888381|FG000|Period 3|Withdrawal by Subject|1|||
105790721|NCT00769132|364888382|FG001|Period 3|Withdrawal by Subject|0|||
105790722|NCT00769132|364888383|FG002|Period 3|Withdrawal by Subject|0|||
105790723|NCT00769132|364888384|FG003|Period 3|Withdrawal by Subject|0|||
105790724|NCT00769132|364888381|FG000|Period 4|Withdrawal by Subject|0|||
105790725|NCT00769132|364888382|FG001|Period 4|Withdrawal by Subject|1|||
105790726|NCT00769132|364888383|FG002|Period 4|Withdrawal by Subject|0|||
105790727|NCT00769132|364888384|FG003|Period 4|Withdrawal by Subject|0|||
105790728|NCT02230332|364888387|FG000|Overall Study|Adverse Event|2|||
105790729|NCT02230332|364888388|FG001|Overall Study|Adverse Event|1|||
105790730|NCT02230332|364888387|FG000|Overall Study|Lost to Follow-up|1|||
105790731|NCT02230332|364888388|FG001|Overall Study|Lost to Follow-up|0|||
105790732|NCT02230332|364888387|FG000|Overall Study|Protocol Violation|1|||
105790733|NCT02230332|364888388|FG001|Overall Study|Protocol Violation|0|||
105790734|NCT00557830|364888389|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
105790735|NCT00557830|364888390|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
105790736|NCT00557830|364888391|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
105790737|NCT00557830|364888389|FG000|Screening Treatment Phase|Adverse Event|2|||
105790738|NCT00557830|364888390|FG001|Screening Treatment Phase|Adverse Event|0|||
105790739|NCT00557830|364888391|FG002|Screening Treatment Phase|Adverse Event|0|||
105790740|NCT00557830|364888389|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
105790741|NCT00557830|364888390|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
105790742|NCT00557830|364888391|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
105790743|NCT01803464|364888393|FG000|Overall Study|Incomplete data|0|||
105790744|NCT01803464|364888394|FG001|Overall Study|Incomplete data|0|||
105790745|NCT01803464|364888395|FG002|Overall Study|Incomplete data|4|||
105790746|NCT01803464|364888396|FG003|Overall Study|Incomplete data|0|||
105790747|NCT01803464|364888393|FG000|Overall Study|Withdrawal by Subject|1|||
105790748|NCT01803464|364888394|FG001|Overall Study|Withdrawal by Subject|0|||
105790749|NCT01803464|364888395|FG002|Overall Study|Withdrawal by Subject|0|||
105790750|NCT01803464|364888396|FG003|Overall Study|Withdrawal by Subject|0|||
105790751|NCT03099161|364888397|FG000|Overall Study|Adverse Event|0|||
105790752|NCT03099161|364888398|FG001|Overall Study|Adverse Event|0|||
105790753|NCT03099161|364888399|FG002|Overall Study|Adverse Event|2|||
105790754|NCT03099161|364888397|FG000|Overall Study|Physician Decision|2|||
105790755|NCT03099161|364888398|FG001|Overall Study|Physician Decision|0|||
105790756|NCT03099161|364888399|FG002|Overall Study|Physician Decision|0|||
105790757|NCT03099161|364888397|FG000|Overall Study|Progressive Disease|1|||
105790758|NCT03099161|364888398|FG001|Overall Study|Progressive Disease|4|||
105790759|NCT03099161|364888399|FG002|Overall Study|Progressive Disease|1|||
105352451|NCT01026818|363295584|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
105790760|NCT01833897|364888400|FG000|Overall Study|Lack of Efficacy|1|||
105790761|NCT01257737|364888402|FG000|Overall Study|Lost to Follow-up|1|||
105790762|NCT01257737|364888403|FG001|Overall Study|Lost to Follow-up|2|||
105790763|NCT01257737|364888402|FG000|Overall Study|Liver transplant|1|||
105790764|NCT01257737|364888403|FG001|Overall Study|Liver transplant|0|||
105790765|NCT01257737|364888402|FG000|Overall Study|Relocation out of the country|0|||
105790766|NCT01257737|364888403|FG001|Overall Study|Relocation out of the country|1|||
105790767|NCT01257737|364888402|FG000|Overall Study|Withdrew from study|0|||
105790768|NCT01257737|364888403|FG001|Overall Study|Withdrew from study|1|||
105561873|NCT02342886|364052240|FG001|Overall Study|Investigator/sponsor decision|2|||
105561874|NCT02342886|364052241|FG002|Overall Study|Investigator/sponsor decision|0|||
105718313|NCT01583374|364627021|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
105718314|NCT01583374|364627022|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
105718315|NCT01583374|364627023|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
105718316|NCT01583374|364627024|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
105718317|NCT01583374|364627016|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
105718318|NCT01583374|364627017|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
105718319|NCT01583374|364627018|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
105718320|NCT01583374|364627019|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
105561875|NCT02342886|364052242|FG003|Overall Study|Investigator/sponsor decision|3|||
105718321|NCT01583374|364627020|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
105718322|NCT01583374|364627021|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
105352452|NCT01026818|363295585|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
105352453|NCT01026818|363295582|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
105352454|NCT01026818|363295583|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
105352455|NCT01026818|363295584|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
105352456|NCT01026818|363295585|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
105352457|NCT01026818|363295582|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
105352458|NCT01026818|363295583|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
105352459|NCT01026818|363295584|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
105352460|NCT01026818|363295585|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
105352461|NCT01026818|363295582|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
105352462|NCT01026818|363295583|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
105352463|NCT01026818|363295584|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
105352464|NCT01026818|363295585|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
105352465|NCT01026818|363295582|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
105352466|NCT01026818|363295583|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
105352467|NCT01026818|363295584|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
105352468|NCT01026818|363295585|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
105352469|NCT01026818|363295582|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
105352470|NCT01026818|363295583|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
105352471|NCT01026818|363295584|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
105352472|NCT01026818|363295585|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
105352473|NCT01026818|363295582|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
105352474|NCT01026818|363295583|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
105352475|NCT01026818|363295584|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
105352476|NCT01026818|363295585|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
105352477|NCT01026818|363295582|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
105352478|NCT01026818|363295583|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
105352479|NCT01026818|363295584|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
105352480|NCT01026818|363295585|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
105352481|NCT01026818|363295582|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
105352482|NCT01026818|363295583|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
105352483|NCT01026818|363295584|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
105352484|NCT01026818|363295585|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
105352485|NCT01026818|363295582|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
105352486|NCT01026818|363295583|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
105352487|NCT01026818|363295584|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
105352488|NCT01026818|363295585|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
105352489|NCT01026818|363295582|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
105352490|NCT01026818|363295583|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
105352491|NCT01026818|363295584|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
105352492|NCT01026818|363295585|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
105352493|NCT01026818|363295582|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
105352494|NCT01026818|363295583|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
105352495|NCT01026818|363295584|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
105352496|NCT01026818|363295585|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
105477556|NCT01185353|363759369|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
105477557|NCT01185353|363759370|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
105718323|NCT01583374|364627022|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
105718324|NCT01583374|364627023|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
105718325|NCT01583374|364627024|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
105718326|NCT01583374|364627016|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
105718327|NCT01583374|364627017|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
105718328|NCT01583374|364627018|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
105718329|NCT01583374|364627019|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
105718330|NCT01583374|364627020|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
105718331|NCT01583374|364627021|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
105718332|NCT01583374|364627022|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
105718333|NCT01583374|364627023|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
105718334|NCT01583374|364627024|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
105718335|NCT01583374|364627016|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
105718336|NCT01583374|364627017|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
105718337|NCT01583374|364627018|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
105718338|NCT01583374|364627019|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
105718339|NCT01583374|364627020|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
105790769|NCT02723786|364888411|FG000|Overall Study|Lost to Follow-up|1|||
105790770|NCT00806416|364888413|FG000|Period 1 - Part I|Adverse Event|0|||
105790771|NCT00806416|364888414|FG001|Period 1 - Part I|Adverse Event|1|||
105790772|NCT00806416|364888415|FG002|Period 1 - Part I|Adverse Event|0|||
105790773|NCT00806416|364888416|FG003|Period 1 - Part I|Adverse Event|0|||
105790774|NCT00806416|364888413|FG000|Period 1 - Part I|Lost to Follow-up|0|||
105790775|NCT00806416|364888414|FG001|Period 1 - Part I|Lost to Follow-up|2|||
105790776|NCT00806416|364888415|FG002|Period 1 - Part I|Lost to Follow-up|0|||
105790777|NCT00806416|364888416|FG003|Period 1 - Part I|Lost to Follow-up|0|||
105790778|NCT00806416|364888413|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
105790779|NCT00806416|364888414|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
105790780|NCT00806416|364888415|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
105790781|NCT00806416|364888416|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
105790782|NCT00806416|364888413|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
105790783|NCT00806416|364888414|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
105790784|NCT00806416|364888415|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
105790785|NCT00806416|364888416|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
105790786|NCT03345485|364888421|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
105790787|NCT03345485|364888422|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
105790788|NCT03345485|364888423|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
105790789|NCT03345485|364888424|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
105790790|NCT03345485|364888425|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
105790791|NCT03345485|364888426|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
105790792|NCT03345485|364888427|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
105790793|NCT03345485|364888428|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
105790794|NCT03345485|364888429|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
105790795|NCT03345485|364888430|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
105477558|NCT01185353|363759361|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
105477559|NCT01185353|363759362|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
105790796|NCT03345485|364888431|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
105790797|NCT03345485|364888432|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
105790798|NCT03345485|364888433|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
105790799|NCT02985515|364888434|FG000|Olfaction Testing|Lost to Follow-up|0|||
105790800|NCT02985515|364888435|FG001|Olfaction Testing|Lost to Follow-up|5|||
105790801|NCT02985515|364888434|FG000|Olfaction Testing|Protocol Violation|0|||
105790802|NCT02985515|364888435|FG001|Olfaction Testing|Protocol Violation|3|||
105790803|NCT01610284|364888438|FG000|Randomization Phase|Adverse Event|1|||
105790804|NCT01610284|364888439|FG001|Randomization Phase|Adverse Event|0|||
105790805|NCT01610284|364888438|FG000|Randomization Phase|Physician Decision|1|||
105790806|NCT01610284|364888439|FG001|Randomization Phase|Physician Decision|1|||
105790807|NCT01610284|364888438|FG000|Randomization Phase|Death|0|||
105790808|NCT01610284|364888439|FG001|Randomization Phase|Death|1|||
105790809|NCT01610284|364888438|FG000|Treatment Phase|Adverse Event|80|||
105790810|NCT01610284|364888439|FG001|Treatment Phase|Adverse Event|12|||
105790811|NCT01610284|364888438|FG000|Treatment Phase|Lost to Follow-up|1|||
105790812|NCT01610284|364888439|FG001|Treatment Phase|Lost to Follow-up|0|||
105790813|NCT01610284|364888438|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
105790814|NCT01610284|364888439|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
105790815|NCT01610284|364888438|FG000|Treatment Phase|Physician Decision|27|||
105790816|NCT01610284|364888439|FG001|Treatment Phase|Physician Decision|24|||
105477560|NCT01185353|363759363|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
105790817|NCT01610284|364888438|FG000|Treatment Phase|Progressive Disease|377|||
105790818|NCT01610284|364888439|FG001|Treatment Phase|Progressive Disease|486|||
105790819|NCT01610284|364888438|FG000|Treatment Phase|Protocol Deviation|2|||
105790820|NCT01610284|364888439|FG001|Treatment Phase|Protocol Deviation|3|||
105718340|NCT01583374|364627021|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
105718341|NCT01583374|364627022|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
105718342|NCT01583374|364627023|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
105718343|NCT01583374|364627024|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
105718344|NCT01583374|364627016|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
105718345|NCT01583374|364627017|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
105718346|NCT01583374|364627018|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
105718347|NCT01583374|364627019|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
105718348|NCT01583374|364627020|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
105718349|NCT01583374|364627021|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
105718350|NCT01583374|364627022|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
105718351|NCT01583374|364627023|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
105718352|NCT01583374|364627024|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
105718353|NCT01583374|364627016|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
105718354|NCT01583374|364627017|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
105718355|NCT01583374|364627018|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
105718356|NCT01583374|364627019|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
105718357|NCT01583374|364627020|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
105718358|NCT01583374|364627021|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
105718359|NCT01583374|364627022|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
105718360|NCT01583374|364627023|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
105718361|NCT01583374|364627024|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
105718362|NCT01583374|364627016|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
105718363|NCT01583374|364627017|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
105718364|NCT01583374|364627018|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
105352497|NCT01026818|363295582|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
105352498|NCT01026818|363295583|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
105352499|NCT01026818|363295584|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
105352500|NCT01026818|363295585|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
105352501|NCT01026818|363295582|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
105352502|NCT01026818|363295583|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
105352503|NCT01026818|363295584|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
105352504|NCT01026818|363295585|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
105352505|NCT01026818|363295582|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
105352506|NCT01026818|363295583|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
105352507|NCT01026818|363295584|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
105352508|NCT01026818|363295585|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
105352509|NCT01760447|363295586|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
105352510|NCT01760447|363295587|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
105352511|NCT01760447|363295588|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
105352512|NCT01760447|363295589|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
105352513|NCT01760447|363295586|FG000|Weeks 0-20|Withdrawal by Subject|2|||
105352514|NCT01760447|363295587|FG001|Weeks 0-20|Withdrawal by Subject|0|||
105352515|NCT01760447|363295588|FG002|Weeks 0-20|Withdrawal by Subject|1|||
105352516|NCT01760447|363295589|FG003|Weeks 0-20|Withdrawal by Subject|0|||
105352517|NCT01760447|363295586|FG000|Weeks 0-20|Lost to Follow-up|1|||
105352518|NCT01760447|363295587|FG001|Weeks 0-20|Lost to Follow-up|0|||
105352519|NCT01760447|363295588|FG002|Weeks 0-20|Lost to Follow-up|1|||
105718365|NCT01583374|364627019|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
105718366|NCT01583374|364627020|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
105718367|NCT01583374|364627021|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
105718368|NCT01583374|364627022|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
105718369|NCT01583374|364627023|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
105718370|NCT01583374|364627024|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
105718371|NCT01292057|364627027|FG000|Overall Study|Protocol Violation|1|||
105718372|NCT01292057|364627028|FG001|Overall Study|Protocol Violation|1|||
105718373|NCT01292057|364627027|FG000|Overall Study|Lost to Follow-up|1|||
105718374|NCT01292057|364627028|FG001|Overall Study|Lost to Follow-up|1|||
105718375|NCT01986062|364627029|FG000|Overall Study|Lost to Follow-up|1|||
105718376|NCT01986062|364627030|FG001|Overall Study|Lost to Follow-up|0|||
105718377|NCT01986062|364627029|FG000|Overall Study|Withdrawal by Subject|0|||
105718378|NCT01986062|364627030|FG001|Overall Study|Withdrawal by Subject|1|||
105718379|NCT01827384|364627033|FG000|Overall Study|Switched to alternative treatment|0|||
105718380|NCT01827384|364627034|FG001|Overall Study|Switched to alternative treatment|0|||
105718381|NCT01827384|364627035|FG002|Overall Study|Switched to alternative treatment|0|||
105718382|NCT01827384|364627036|FG003|Overall Study|Switched to alternative treatment|0|||
105718383|NCT01827384|364627037|FG004|Overall Study|Switched to alternative treatment|0|||
105718384|NCT01827384|364627038|FG005|Overall Study|Switched to alternative treatment|0|||
105718385|NCT01827384|364627039|FG006|Overall Study|Switched to alternative treatment|0|||
105718386|NCT01827384|364627040|FG007|Overall Study|Switched to alternative treatment|0|||
105718387|NCT01827384|364627041|FG008|Overall Study|Switched to alternative treatment|0|||
105718388|NCT01827384|364627042|FG009|Overall Study|Switched to alternative treatment|0|||
105718389|NCT01827384|364627043|FG010|Overall Study|Switched to alternative treatment|0|||
105718390|NCT01827384|364627044|FG011|Overall Study|Switched to alternative treatment|0|||
105718391|NCT01827384|364627045|FG012|Overall Study|Switched to alternative treatment|0|||
105718392|NCT01827384|364627046|FG013|Overall Study|Switched to alternative treatment|2|||
105718393|NCT01827384|364627033|FG000|Overall Study|Disease progression before treatment|0|||
105718394|NCT01827384|364627034|FG001|Overall Study|Disease progression before treatment|0|||
105718395|NCT01827384|364627035|FG002|Overall Study|Disease progression before treatment|0|||
105718396|NCT01827384|364627036|FG003|Overall Study|Disease progression before treatment|0|||
105718397|NCT01827384|364627037|FG004|Overall Study|Disease progression before treatment|0|||
105718398|NCT01827384|364627038|FG005|Overall Study|Disease progression before treatment|0|||
105718399|NCT01827384|364627039|FG006|Overall Study|Disease progression before treatment|0|||
105718400|NCT01827384|364627040|FG007|Overall Study|Disease progression before treatment|0|||
105718401|NCT01827384|364627041|FG008|Overall Study|Disease progression before treatment|0|||
105718402|NCT01827384|364627042|FG009|Overall Study|Disease progression before treatment|0|||
105718403|NCT01827384|364627043|FG010|Overall Study|Disease progression before treatment|0|||
105352520|NCT01760447|363295589|FG003|Weeks 0-20|Lost to Follow-up|1|||
105352521|NCT01760447|363295586|FG000|Weeks 0-20|Randomized but not treated|0|||
105352522|NCT01760447|363295587|FG001|Weeks 0-20|Randomized but not treated|0|||
105352523|NCT01760447|363295588|FG002|Weeks 0-20|Randomized but not treated|2|||
105352524|NCT01760447|363295589|FG003|Weeks 0-20|Randomized but not treated|0|||
105352525|NCT01760447|363295586|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
105352526|NCT01760447|363295587|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
105718404|NCT01827384|364627044|FG011|Overall Study|Disease progression before treatment|0|||
105718405|NCT01827384|364627045|FG012|Overall Study|Disease progression before treatment|0|||
105790821|NCT01610284|364888438|FG000|Treatment Phase|Study terminated by Sponsor|18|||
105790822|NCT01610284|364888439|FG001|Treatment Phase|Study terminated by Sponsor|15|||
105790823|NCT01610284|364888438|FG000|Treatment Phase|Subject/Guardian Decision|55|||
105790824|NCT01610284|364888439|FG001|Treatment Phase|Subject/Guardian Decision|23|||
105790825|NCT01610284|364888438|FG000|Treatment Phase|Death|6|||
105790826|NCT01610284|364888439|FG001|Treatment Phase|Death|5|||
105790827|NCT01610284|364888438|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
105790828|NCT01610284|364888439|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105790829|NCT01610284|364888438|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
105790830|NCT01610284|364888439|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
105790831|NCT01610284|364888438|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
105790832|NCT01610284|364888439|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
105790833|NCT01610284|364888438|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
105790834|NCT01610284|364888439|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
105790835|NCT01610284|364888438|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
105790836|NCT01610284|364888439|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
105790837|NCT01610284|364888438|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
105790838|NCT01610284|364888439|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
105790839|NCT01856257|364888440|FG000|Overall Study|Death|2|||
105790840|NCT01856257|364888441|FG001|Overall Study|Death|0|||
105790841|NCT01856257|364888442|FG002|Overall Study|Death|0|||
105790842|NCT01856257|364888443|FG003|Overall Study|Death|0|||
105790843|NCT01856257|364888440|FG000|Overall Study|Physician Decision|0|||
105790844|NCT01856257|364888441|FG001|Overall Study|Physician Decision|0|||
105790845|NCT01856257|364888442|FG002|Overall Study|Physician Decision|0|||
105790846|NCT01856257|364888443|FG003|Overall Study|Physician Decision|1|||
105790847|NCT01856257|364888440|FG000|Overall Study|Withdrawal by Subject|1|||
105352527|NCT01760447|363295588|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
105352528|NCT01760447|363295589|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
105352529|NCT01760447|363295586|FG000|Weeks 20-54|Withdrawal by Subject|2|||
105352530|NCT01760447|363295587|FG001|Weeks 20-54|Withdrawal by Subject|1|||
105352531|NCT01760447|363295588|FG002|Weeks 20-54|Withdrawal by Subject|1|||
105352532|NCT01760447|363295589|FG003|Weeks 20-54|Withdrawal by Subject|2|||
105790848|NCT01856257|364888441|FG001|Overall Study|Withdrawal by Subject|1|||
105352533|NCT01760447|363295586|FG000|Weeks 20-54|Lost to Follow-up|0|||
105352534|NCT01760447|363295587|FG001|Weeks 20-54|Lost to Follow-up|0|||
105352535|NCT01760447|363295588|FG002|Weeks 20-54|Lost to Follow-up|1|||
105352536|NCT01760447|363295589|FG003|Weeks 20-54|Lost to Follow-up|2|||
105352537|NCT04575584|363295590|FG000|Overall Study|Death|6|||
105352538|NCT04575584|363295591|FG001|Overall Study|Death|4|||
105352539|NCT04575584|363295592|FG002|Overall Study|Death|6|||
105352540|NCT04575584|363295593|FG003|Overall Study|Death|2|||
105352541|NCT04575584|363295594|FG004|Overall Study|Death|0|||
105352542|NCT04575584|363295595|FG005|Overall Study|Death|0|||
105352543|NCT04575584|363295590|FG000|Overall Study|Lost to Follow-up|1|||
105352544|NCT04575584|363295591|FG001|Overall Study|Lost to Follow-up|1|||
105352545|NCT04575584|363295592|FG002|Overall Study|Lost to Follow-up|1|||
105352546|NCT04575584|363295593|FG003|Overall Study|Lost to Follow-up|1|||
105352547|NCT04575584|363295594|FG004|Overall Study|Lost to Follow-up|0|||
105352548|NCT04575584|363295595|FG005|Overall Study|Lost to Follow-up|0|||
105352549|NCT04575584|363295590|FG000|Overall Study|Physician Decision|0|||
105352550|NCT04575584|363295591|FG001|Overall Study|Physician Decision|1|||
105352551|NCT04575584|363295592|FG002|Overall Study|Physician Decision|1|||
105352552|NCT04575584|363295593|FG003|Overall Study|Physician Decision|1|||
105352553|NCT04575584|363295594|FG004|Overall Study|Physician Decision|0|||
105352554|NCT04575584|363295595|FG005|Overall Study|Physician Decision|0|||
105352555|NCT04575584|363295590|FG000|Overall Study|Withdrawal by Subject|7|||
105352556|NCT04575584|363295591|FG001|Overall Study|Withdrawal by Subject|9|||
105352557|NCT04575584|363295592|FG002|Overall Study|Withdrawal by Subject|5|||
105352558|NCT04575584|363295593|FG003|Overall Study|Withdrawal by Subject|3|||
105352559|NCT04575584|363295594|FG004|Overall Study|Withdrawal by Subject|0|||
105352560|NCT04575584|363295595|FG005|Overall Study|Withdrawal by Subject|0|||
105352561|NCT04575584|363295590|FG000|Overall Study|Not recorded|0|||
105790849|NCT01856257|364888442|FG002|Overall Study|Withdrawal by Subject|0|||
105790850|NCT01856257|364888443|FG003|Overall Study|Withdrawal by Subject|0|||
105790851|NCT01856257|364888440|FG000|Overall Study|Donor complication|0|||
105790852|NCT01856257|364888441|FG001|Overall Study|Donor complication|0|||
105790853|NCT01856257|364888442|FG002|Overall Study|Donor complication|0|||
105352562|NCT04575584|363295591|FG001|Overall Study|Not recorded|0|||
105352563|NCT04575584|363295592|FG002|Overall Study|Not recorded|0|||
105790854|NCT01856257|364888443|FG003|Overall Study|Donor complication|1|||
105352564|NCT04575584|363295593|FG003|Overall Study|Not recorded|1|||
105352565|NCT04575584|363295594|FG004|Overall Study|Not recorded|0|||
105352566|NCT04575584|363295595|FG005|Overall Study|Not recorded|0|||
105352567|NCT00582426|363295600|FG000|Overall Study|Lost to Follow-up|0|||
105352568|NCT00582426|363295601|FG001|Overall Study|Lost to Follow-up|2|||
105352569|NCT00582426|363295600|FG000|Overall Study|Adverse Event|4|||
105790855|NCT01157065|364888444|FG000|Overall Study|Death|0|||
105790856|NCT01157065|364888445|FG001|Overall Study|Death|1|||
105790857|NCT01265875|364888446|FG000|Overall Study|Uncooperative/unreliable|1|||
105790858|NCT04409509|364888447|FG000|Overall Study|Failure to meet randomization requirement|1|||
105790859|NCT04409509|364888448|FG001|Overall Study|Failure to meet randomization requirement|0|||
105352570|NCT00582426|363295601|FG001|Overall Study|Adverse Event|2|||
105352571|NCT00582426|363295600|FG000|Overall Study|Protocol Violation|6|||
105352572|NCT00582426|363295601|FG001|Overall Study|Protocol Violation|2|||
105352573|NCT00582426|363295600|FG000|Overall Study|Death|4|||
105352574|NCT00582426|363295601|FG001|Overall Study|Death|3|||
105352575|NCT00582426|363295600|FG000|Overall Study|Withdrawal by Subject|3|||
105352576|NCT00582426|363295601|FG001|Overall Study|Withdrawal by Subject|2|||
105352577|NCT00582426|363295600|FG000|Overall Study|Disease Progression|2|||
105352578|NCT00582426|363295601|FG001|Overall Study|Disease Progression|2|||
105352579|NCT00582426|363295600|FG000|Overall Study|Use of illicit drugs|1|||
105352580|NCT00582426|363295601|FG001|Overall Study|Use of illicit drugs|0|||
105352581|NCT02164318|363295606|FG000|Overall Study|Withdrawal by Subject|0|||
105352582|NCT02164318|363295607|FG001|Overall Study|Withdrawal by Subject|1|||
105352583|NCT02164318|363295608|FG002|Overall Study|Withdrawal by Subject|0|||
105352584|NCT02164318|363295609|FG003|Overall Study|Withdrawal by Subject|1|||
105352585|NCT02335346|363295628|FG000|Overall Study|Adverse Event|11|||
105352586|NCT02335346|363295628|FG000|Overall Study|Withdrawal by Subject|1|||
105352587|NCT00290693|363295629|FG000|Overall Study|Withdrawal by Subject|2|||
105352588|NCT03326518|363295630|FG000|Overall Study|Protocol Violation|1|||
105352589|NCT03326518|363295631|FG001|Overall Study|Protocol Violation|0|||
105352590|NCT03326518|363295632|FG002|Overall Study|Protocol Violation|0|||
105352591|NCT03326518|363295630|FG000|Overall Study|Withdrawal by Subject|1|||
105352592|NCT03326518|363295631|FG001|Overall Study|Withdrawal by Subject|0|||
105352593|NCT03326518|363295632|FG002|Overall Study|Withdrawal by Subject|0|||
105352594|NCT03326518|363295630|FG000|Overall Study|Lost to Follow-up|1|||
105352595|NCT03326518|363295631|FG001|Overall Study|Lost to Follow-up|0|||
105352596|NCT03326518|363295632|FG002|Overall Study|Lost to Follow-up|1|||
105352597|NCT03594955|363295633|FG000|Overall Study|Adverse Event|1|||
105352598|NCT03594955|363295633|FG000|Overall Study|Progressive disease|5|||
105352599|NCT03594955|363295633|FG000|Overall Study|Sponsor's decision|1|||
105352600|NCT02065518|363295634|FG000|Overall Study|Lost to Follow-up|3|||
105352601|NCT02065518|363295635|FG001|Overall Study|Lost to Follow-up|4|||
105352602|NCT02065518|363295636|FG002|Overall Study|Lost to Follow-up|0|||
105352603|NCT02065518|363295637|FG003|Overall Study|Lost to Follow-up|3|||
105352604|NCT02065518|363295634|FG000|Overall Study|Withdrawal by Subject|3|||
105352605|NCT02065518|363295635|FG001|Overall Study|Withdrawal by Subject|4|||
105352606|NCT02065518|363295636|FG002|Overall Study|Withdrawal by Subject|9|||
105352607|NCT02065518|363295637|FG003|Overall Study|Withdrawal by Subject|2|||
105790860|NCT04409509|364888447|FG000|Overall Study|Adverse Event|0|||
105790861|NCT04409509|364888448|FG001|Overall Study|Adverse Event|1|||
105790862|NCT04409509|364888447|FG000|Overall Study|Death|11|||
105352608|NCT03042910|363295638|FG000|Overall Study|Adverse Event|1|||
105790863|NCT04409509|364888448|FG001|Overall Study|Death|10|||
105790864|NCT04409509|364888447|FG000|Overall Study|Non-compliance with study drug|0|||
105352609|NCT03042910|363295638|FG000|Overall Study|Disease Progression|2|||
105352610|NCT03042910|363295638|FG000|Overall Study|Withdrawal by Subject|3|||
105352611|NCT03042910|363295638|FG000|Overall Study|Enrolled but not treated|1|||
105352612|NCT02756819|363295639|FG000|Overall Study|Lost for observation|23|||
105352613|NCT02756819|363295639|FG000|Overall Study|Patient's unwillingness|16|||
105352614|NCT02756819|363295639|FG000|Overall Study|Insufficient efficacy|2|||
105352615|NCT02756819|363295639|FG000|Overall Study|Adverse Event|2|||
105352616|NCT02756819|363295639|FG000|Overall Study|Reason not Specified|9|||
105352617|NCT03297021|363295642|FG000|Overall Study|Incomplete/illegible data sheet|4|||
105352618|NCT03297021|363295643|FG001|Overall Study|Incomplete/illegible data sheet|2|||
105352619|NCT03297021|363295644|FG002|Overall Study|Incomplete/illegible data sheet|3|||
105352620|NCT03297021|363295642|FG000|Overall Study|Missing Post-Op Data|1|||
105352621|NCT03297021|363295643|FG001|Overall Study|Missing Post-Op Data|2|||
105352622|NCT03297021|363295644|FG002|Overall Study|Missing Post-Op Data|1|||
105718406|NCT01827384|364627046|FG013|Overall Study|Disease progression before treatment|4|||
105718407|NCT01827384|364627033|FG000|Overall Study|Ineligible|0|||
105718408|NCT01827384|364627034|FG001|Overall Study|Ineligible|0|||
105718409|NCT01827384|364627035|FG002|Overall Study|Ineligible|0|||
105718410|NCT01827384|364627036|FG003|Overall Study|Ineligible|0|||
105718411|NCT01827384|364627037|FG004|Overall Study|Ineligible|0|||
105352623|NCT00948922|363295645|FG000|Overall Study|Did not start study treatment|2|||
105352624|NCT00948922|363295646|FG001|Overall Study|Did not start study treatment|5|||
105352625|NCT00948922|363295647|FG002|Overall Study|Did not start study treatment|0|||
105352626|NCT00948922|363295645|FG000|Overall Study|Withdrawal by Subject|0|||
105352627|NCT00948922|363295646|FG001|Overall Study|Withdrawal by Subject|2|||
105352628|NCT00948922|363295647|FG002|Overall Study|Withdrawal by Subject|1|||
105352629|NCT00948922|363295645|FG000|Overall Study|Death|3|||
105352630|NCT00948922|363295646|FG001|Overall Study|Death|0|||
105352631|NCT00948922|363295647|FG002|Overall Study|Death|0|||
105352632|NCT00948922|363295645|FG000|Overall Study|Disease progression|0|||
105352633|NCT00948922|363295646|FG001|Overall Study|Disease progression|1|||
105352634|NCT00948922|363295647|FG002|Overall Study|Disease progression|0|||
105352635|NCT00948922|363295645|FG000|Overall Study|Insurance issues|1|||
105477561|NCT01185353|363759364|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
105477562|NCT01185353|363759365|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
105477563|NCT01185353|363759366|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
105477564|NCT01185353|363759367|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
105477565|NCT01185353|363759368|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
105477566|NCT01185353|363759369|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
105352636|NCT00948922|363295646|FG001|Overall Study|Insurance issues|0|||
105352637|NCT00948922|363295647|FG002|Overall Study|Insurance issues|0|||
105477567|NCT01185353|363759370|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
105718412|NCT01827384|364627038|FG005|Overall Study|Ineligible|0|||
105718413|NCT01827384|364627039|FG006|Overall Study|Ineligible|0|||
105718414|NCT01827384|364627040|FG007|Overall Study|Ineligible|0|||
105352638|NCT00948922|363295645|FG000|Overall Study|Transplant eligibility issues|2|||
105352639|NCT00948922|363295646|FG001|Overall Study|Transplant eligibility issues|3|||
105352640|NCT00948922|363295647|FG002|Overall Study|Transplant eligibility issues|0|||
105477568|NCT01185353|363759361|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
105718415|NCT01827384|364627041|FG008|Overall Study|Ineligible|0|||
105718416|NCT01827384|364627042|FG009|Overall Study|Ineligible|0|||
105790865|NCT04409509|364888448|FG001|Overall Study|Non-compliance with study drug|1|||
105790866|NCT04409509|364888447|FG000|Overall Study|Lost to Follow-up|0|||
105790867|NCT04409509|364888448|FG001|Overall Study|Lost to Follow-up|3|||
105790868|NCT04409509|364888447|FG000|Overall Study|Withdrawal by Subject|0|||
105790869|NCT04409509|364888448|FG001|Overall Study|Withdrawal by Subject|3|||
105790870|NCT04409509|364888447|FG000|Overall Study|Randomized by mistake|0|||
105790871|NCT04409509|364888448|FG001|Overall Study|Randomized by mistake|1|||
105790872|NCT04409509|364888447|FG000|Overall Study|Other|1|||
105790873|NCT04409509|364888448|FG001|Overall Study|Other|1|||
105790874|NCT02325739|364888449|FG000|Phase I Part|Adverse Event|1|||
105790875|NCT02325739|364888450|FG001|Phase I Part|Adverse Event|0|||
105790876|NCT02325739|364888451|FG002|Phase I Part|Adverse Event|1|||
105790877|NCT02325739|364888452|FG003|Phase I Part|Adverse Event|2|||
105790878|NCT02325739|364888453|FG004|Phase I Part|Adverse Event|3|||
105790879|NCT02325739|364888454|FG005|Phase I Part|Adverse Event|1|||
105790880|NCT02325739|364888455|FG006|Phase I Part|Adverse Event|0|||
105790881|NCT02325739|364888456|FG007|Phase I Part|Adverse Event|2|||
105790882|NCT02325739|364888457|FG008|Phase I Part|Adverse Event|0|||
105790883|NCT02325739|364888458|FG009|Phase I Part|Adverse Event|0|||
105790884|NCT02325739|364888459|FG010|Phase I Part|Adverse Event|0|||
105790885|NCT02325739|364888449|FG000|Phase I Part|Progressive disease|9|||
105790886|NCT02325739|364888450|FG001|Phase I Part|Progressive disease|6|||
105790887|NCT02325739|364888451|FG002|Phase I Part|Progressive disease|3|||
105790888|NCT02325739|364888452|FG003|Phase I Part|Progressive disease|23|||
105790889|NCT02325739|364888453|FG004|Phase I Part|Progressive disease|14|||
105790890|NCT02325739|364888454|FG005|Phase I Part|Progressive disease|6|||
105790891|NCT02325739|364888455|FG006|Phase I Part|Progressive disease|6|||
105790892|NCT02325739|364888456|FG007|Phase I Part|Progressive disease|3|||
105790893|NCT02325739|364888457|FG008|Phase I Part|Progressive disease|0|||
105790894|NCT02325739|364888458|FG009|Phase I Part|Progressive disease|0|||
105790895|NCT02325739|364888459|FG010|Phase I Part|Progressive disease|0|||
105790896|NCT02325739|364888449|FG000|Phase I Part|Subject/guardian decision|1|||
105790897|NCT02325739|364888450|FG001|Phase I Part|Subject/guardian decision|0|||
105790898|NCT02325739|364888451|FG002|Phase I Part|Subject/guardian decision|1|||
105790899|NCT02325739|364888452|FG003|Phase I Part|Subject/guardian decision|1|||
105790900|NCT02325739|364888453|FG004|Phase I Part|Subject/guardian decision|0|||
105790901|NCT02325739|364888454|FG005|Phase I Part|Subject/guardian decision|0|||
105790902|NCT02325739|364888455|FG006|Phase I Part|Subject/guardian decision|0|||
105790903|NCT02325739|364888456|FG007|Phase I Part|Subject/guardian decision|1|||
105790904|NCT02325739|364888457|FG008|Phase I Part|Subject/guardian decision|0|||
105790905|NCT02325739|364888458|FG009|Phase I Part|Subject/guardian decision|0|||
105790906|NCT02325739|364888459|FG010|Phase I Part|Subject/guardian decision|0|||
105790907|NCT02325739|364888449|FG000|Phase I Part|Death|0|||
105790908|NCT02325739|364888450|FG001|Phase I Part|Death|0|||
105790909|NCT02325739|364888451|FG002|Phase I Part|Death|0|||
105790910|NCT02325739|364888452|FG003|Phase I Part|Death|0|||
105790911|NCT02325739|364888453|FG004|Phase I Part|Death|2|||
105790912|NCT02325739|364888454|FG005|Phase I Part|Death|0|||
105790913|NCT02325739|364888455|FG006|Phase I Part|Death|0|||
105790914|NCT02325739|364888456|FG007|Phase I Part|Death|0|||
105790915|NCT02325739|364888457|FG008|Phase I Part|Death|0|||
105790916|NCT02325739|364888458|FG009|Phase I Part|Death|0|||
105790917|NCT02325739|364888459|FG010|Phase I Part|Death|0|||
105790918|NCT02325739|364888449|FG000|Phase II Part|Adverse Event|0|||
105790919|NCT02325739|364888450|FG001|Phase II Part|Adverse Event|0|||
105790920|NCT02325739|364888451|FG002|Phase II Part|Adverse Event|0|||
105790921|NCT02325739|364888452|FG003|Phase II Part|Adverse Event|0|||
105718417|NCT01827384|364627043|FG010|Overall Study|Ineligible|0|||
105718418|NCT01827384|364627044|FG011|Overall Study|Ineligible|0|||
105718419|NCT01827384|364627045|FG012|Overall Study|Ineligible|0|||
105718420|NCT01827384|364627046|FG013|Overall Study|Ineligible|19|||
105790922|NCT02325739|364888453|FG004|Phase II Part|Adverse Event|0|||
105790923|NCT02325739|364888454|FG005|Phase II Part|Adverse Event|0|||
105790924|NCT02325739|364888455|FG006|Phase II Part|Adverse Event|0|||
105790925|NCT02325739|364888456|FG007|Phase II Part|Adverse Event|0|||
105790926|NCT02325739|364888457|FG008|Phase II Part|Adverse Event|4|||
105790927|NCT02325739|364888458|FG009|Phase II Part|Adverse Event|5|||
105790928|NCT02325739|364888459|FG010|Phase II Part|Adverse Event|1|||
105790929|NCT02325739|364888449|FG000|Phase II Part|Physician Decision|0|||
105790930|NCT02325739|364888450|FG001|Phase II Part|Physician Decision|0|||
105718421|NCT01827384|364627033|FG000|Overall Study|Participant died before treatment|0|||
105718422|NCT01827384|364627034|FG001|Overall Study|Participant died before treatment|0|||
105718423|NCT01827384|364627035|FG002|Overall Study|Participant died before treatment|0|||
105718424|NCT01827384|364627036|FG003|Overall Study|Participant died before treatment|0|||
105718425|NCT01827384|364627037|FG004|Overall Study|Participant died before treatment|0|||
105718426|NCT01827384|364627038|FG005|Overall Study|Participant died before treatment|0|||
105718427|NCT01827384|364627039|FG006|Overall Study|Participant died before treatment|0|||
105718428|NCT01827384|364627040|FG007|Overall Study|Participant died before treatment|0|||
105718429|NCT01827384|364627041|FG008|Overall Study|Participant died before treatment|0|||
105718430|NCT01827384|364627042|FG009|Overall Study|Participant died before treatment|0|||
105718431|NCT01827384|364627043|FG010|Overall Study|Participant died before treatment|0|||
105718432|NCT01827384|364627044|FG011|Overall Study|Participant died before treatment|0|||
105718433|NCT01827384|364627045|FG012|Overall Study|Participant died before treatment|0|||
105718434|NCT01827384|364627046|FG013|Overall Study|Participant died before treatment|5|||
105718435|NCT01827384|364627033|FG000|Overall Study|Insufficient tumor cells|0|||
105718436|NCT01827384|364627034|FG001|Overall Study|Insufficient tumor cells|0|||
105718437|NCT01827384|364627035|FG002|Overall Study|Insufficient tumor cells|0|||
105718438|NCT01827384|364627036|FG003|Overall Study|Insufficient tumor cells|0|||
105718439|NCT01827384|364627037|FG004|Overall Study|Insufficient tumor cells|0|||
105718440|NCT01827384|364627038|FG005|Overall Study|Insufficient tumor cells|0|||
105718441|NCT01827384|364627039|FG006|Overall Study|Insufficient tumor cells|0|||
105718442|NCT01827384|364627040|FG007|Overall Study|Insufficient tumor cells|0|||
105718443|NCT01827384|364627041|FG008|Overall Study|Insufficient tumor cells|0|||
105718444|NCT01827384|364627042|FG009|Overall Study|Insufficient tumor cells|0|||
105718445|NCT01827384|364627043|FG010|Overall Study|Insufficient tumor cells|0|||
105718446|NCT01827384|364627044|FG011|Overall Study|Insufficient tumor cells|0|||
105790931|NCT02325739|364888451|FG002|Phase II Part|Physician Decision|0|||
105718447|NCT01827384|364627045|FG012|Overall Study|Insufficient tumor cells|0|||
105718448|NCT01827384|364627046|FG013|Overall Study|Insufficient tumor cells|13|||
105718449|NCT01827384|364627033|FG000|Overall Study|No actionable mutation|0|||
105718450|NCT01827384|364627034|FG001|Overall Study|No actionable mutation|0|||
105718451|NCT01827384|364627035|FG002|Overall Study|No actionable mutation|0|||
105718452|NCT01827384|364627036|FG003|Overall Study|No actionable mutation|0|||
105718453|NCT01827384|364627037|FG004|Overall Study|No actionable mutation|0|||
105477569|NCT01185353|363759362|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
105477570|NCT01185353|363759363|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
105477571|NCT01185353|363759364|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
105477572|NCT01185353|363759365|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
105477573|NCT01185353|363759366|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
105477574|NCT01185353|363759367|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
105477575|NCT01185353|363759368|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
105477576|NCT01185353|363759369|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
105477577|NCT01185353|363759370|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
105477578|NCT01185353|363759361|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
105477579|NCT01185353|363759362|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
105477580|NCT01185353|363759363|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
105477581|NCT01185353|363759364|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
105477582|NCT01185353|363759365|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
105477583|NCT01185353|363759366|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
105477584|NCT01185353|363759367|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
105477585|NCT01185353|363759368|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
105477586|NCT01185353|363759369|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
105477587|NCT01185353|363759370|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
105477588|NCT01185353|363759361|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
105477589|NCT01185353|363759362|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
105477590|NCT01185353|363759363|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
105477591|NCT01185353|363759364|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
105477592|NCT01185353|363759365|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
105477593|NCT01185353|363759366|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
105477594|NCT01185353|363759367|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
105477595|NCT01185353|363759368|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
105477596|NCT01185353|363759369|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
105477597|NCT01185353|363759370|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
105477598|NCT01185353|363759361|FG000|Part C (Weeks 24 Through 76)|Death|0|||
105477599|NCT01185353|363759362|FG001|Part C (Weeks 24 Through 76)|Death|0|||
105477600|NCT01185353|363759363|FG002|Part C (Weeks 24 Through 76)|Death|0|||
105477601|NCT01185353|363759364|FG003|Part C (Weeks 24 Through 76)|Death|0|||
105477602|NCT01185353|363759365|FG004|Part C (Weeks 24 Through 76)|Death|0|||
105477603|NCT01185353|363759366|FG005|Part C (Weeks 24 Through 76)|Death|0|||
105477604|NCT01185353|363759367|FG006|Part C (Weeks 24 Through 76)|Death|0|||
105477605|NCT01185353|363759368|FG007|Part C (Weeks 24 Through 76)|Death|0|||
105477606|NCT01185353|363759369|FG008|Part C (Weeks 24 Through 76)|Death|0|||
105477607|NCT01185353|363759370|FG009|Part C (Weeks 24 Through 76)|Death|1|||
105477608|NCT01185353|363759361|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
105477609|NCT01185353|363759362|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
105477610|NCT01185353|363759363|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
105477611|NCT01185353|363759364|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
105477612|NCT01185353|363759365|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
105477613|NCT01185353|363759366|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
105477614|NCT01185353|363759367|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
105477615|NCT01185353|363759368|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
105477616|NCT01185353|363759369|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
105477617|NCT01185353|363759370|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
105477618|NCT01185353|363759361|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
105477619|NCT01185353|363759362|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
105477620|NCT01185353|363759363|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
105477621|NCT01185353|363759364|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
105477622|NCT01185353|363759365|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
105477623|NCT01185353|363759366|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
105477624|NCT01185353|363759367|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
105477625|NCT01185353|363759368|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
105477626|NCT01185353|363759369|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
105477627|NCT01185353|363759370|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
105477628|NCT01185353|363759361|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
105477629|NCT01185353|363759362|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
105477630|NCT01185353|363759363|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
105477631|NCT01185353|363759364|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
105477632|NCT01185353|363759365|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
105477633|NCT01185353|363759366|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
105477634|NCT01185353|363759367|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
105477635|NCT01185353|363759368|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
105477636|NCT01185353|363759369|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
105477637|NCT01185353|363759370|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
105477638|NCT01185353|363759361|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
105790932|NCT02325739|364888452|FG003|Phase II Part|Physician Decision|0|||
105790933|NCT02325739|364888453|FG004|Phase II Part|Physician Decision|0|||
105477639|NCT01185353|363759362|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
105477640|NCT01185353|363759363|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
105477641|NCT01185353|363759364|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
105477642|NCT01185353|363759365|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
105477643|NCT01185353|363759366|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
105477644|NCT01185353|363759367|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
105477645|NCT01185353|363759368|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
105477646|NCT01185353|363759369|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
105477647|NCT01185353|363759370|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
105477648|NCT01185353|363759361|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
105477649|NCT01185353|363759362|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
105477650|NCT01185353|363759363|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
105477651|NCT01185353|363759364|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
105477652|NCT01185353|363759365|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
105477653|NCT01185353|363759366|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
105477654|NCT01185353|363759367|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
105477655|NCT01185353|363759368|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
105477656|NCT01185353|363759369|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
105477657|NCT01185353|363759370|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
105477658|NCT01185353|363759361|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
105477659|NCT01185353|363759362|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
105477660|NCT01185353|363759363|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
105477661|NCT01185353|363759364|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
105477662|NCT01185353|363759365|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
105477663|NCT01185353|363759366|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
105477664|NCT01185353|363759367|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
105477665|NCT01185353|363759368|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
105477666|NCT01185353|363759369|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
105477667|NCT01185353|363759370|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
105477668|NCT01144299|363759373|FG000|Overall Study|Lost to Follow-up|1|||
105477669|NCT01144299|363759374|FG001|Overall Study|Lost to Follow-up|0|||
105477670|NCT01144299|363759373|FG000|Overall Study|Withdrawal by Subject|1|||
105477671|NCT01144299|363759374|FG001|Overall Study|Withdrawal by Subject|0|||
105477672|NCT01699867|363759377|FG000|Overall Study|Screening Failure|3|||
105477673|NCT01375075|363759378|FG000|Overall Study|Adverse Event|0|||
105477674|NCT01375075|363759379|FG001|Overall Study|Adverse Event|0|||
105477675|NCT01375075|363759380|FG002|Overall Study|Adverse Event|3|||
105477676|NCT01375075|363759381|FG003|Overall Study|Adverse Event|1|||
105477677|NCT01375075|363759382|FG004|Overall Study|Adverse Event|0|||
105477678|NCT01375075|363759383|FG005|Overall Study|Adverse Event|1|||
105477679|NCT01375075|363759378|FG000|Overall Study|Entry Criterion Not Met|1|||
105477680|NCT01375075|363759379|FG001|Overall Study|Entry Criterion Not Met|0|||
105477681|NCT01375075|363759380|FG002|Overall Study|Entry Criterion Not Met|0|||
105477682|NCT01375075|363759381|FG003|Overall Study|Entry Criterion Not Met|0|||
105477683|NCT01375075|363759382|FG004|Overall Study|Entry Criterion Not Met|0|||
105477684|NCT01375075|363759383|FG005|Overall Study|Entry Criterion Not Met|1|||
105477685|NCT01375075|363759378|FG000|Overall Study|Withdrawal by Subject|0|||
105477686|NCT01375075|363759379|FG001|Overall Study|Withdrawal by Subject|1|||
105477687|NCT01375075|363759380|FG002|Overall Study|Withdrawal by Subject|0|||
105477688|NCT01375075|363759381|FG003|Overall Study|Withdrawal by Subject|0|||
105477689|NCT01375075|363759382|FG004|Overall Study|Withdrawal by Subject|0|||
105477690|NCT01375075|363759383|FG005|Overall Study|Withdrawal by Subject|1|||
105477691|NCT00831493|363759387|FG000|Overall Study|Intractable nausea and vomiting|1|||
105477692|NCT00243841|363759390|FG000|Overall Study|Physician Decision|0|||
105477693|NCT00243841|363759391|FG001|Overall Study|Physician Decision|0|||
105477694|NCT00243841|363759392|FG002|Overall Study|Physician Decision|1|||
105477695|NCT00243841|363759393|FG003|Overall Study|Physician Decision|0|||
105477696|NCT00243841|363759394|FG004|Overall Study|Physician Decision|0|||
105477697|NCT00243841|363759395|FG005|Overall Study|Physician Decision|2|||
105477698|NCT03255083|363759396|FG000|Overall Study|Clinical progression|1|||
105477699|NCT03255083|363759397|FG001|Overall Study|Clinical progression|0|||
105477700|NCT03255083|363759398|FG002|Overall Study|Clinical progression|0|||
105477701|NCT03255083|363759399|FG003|Overall Study|Clinical progression|0|||
105477702|NCT03255083|363759396|FG000|Overall Study|Adverse Event|0|||
105477703|NCT03255083|363759397|FG001|Overall Study|Adverse Event|1|||
105477704|NCT03255083|363759398|FG002|Overall Study|Adverse Event|0|||
105477705|NCT03255083|363759399|FG003|Overall Study|Adverse Event|0|||
105477706|NCT03255083|363759396|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
105477707|NCT03255083|363759397|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
105477708|NCT03255083|363759398|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
105477709|NCT03255083|363759399|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
105477710|NCT03255083|363759396|FG000|Overall Study|Withdrawal by Subject|1|||
105477711|NCT03255083|363759397|FG001|Overall Study|Withdrawal by Subject|1|||
105352641|NCT00948922|363295645|FG000|Overall Study|Not evaluable at time of analysis|0|||
105718454|NCT01827384|364627038|FG005|Overall Study|No actionable mutation|0|||
105718455|NCT01827384|364627039|FG006|Overall Study|No actionable mutation|0|||
105718456|NCT01827384|364627040|FG007|Overall Study|No actionable mutation|0|||
105718457|NCT01827384|364627041|FG008|Overall Study|No actionable mutation|0|||
105718458|NCT01827384|364627042|FG009|Overall Study|No actionable mutation|0|||
105718459|NCT01827384|364627043|FG010|Overall Study|No actionable mutation|0|||
105477712|NCT03255083|363759398|FG002|Overall Study|Withdrawal by Subject|1|||
105718460|NCT01827384|364627044|FG011|Overall Study|No actionable mutation|0|||
105477713|NCT03255083|363759399|FG003|Overall Study|Withdrawal by Subject|0|||
105477714|NCT02537015|363759400|FG000|Overall Study|Adverse Event|3|||
105477715|NCT02537015|363759400|FG000|Overall Study|Withdrawal by Subject|2|||
105477716|NCT02537015|363759400|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105477717|NCT01808092|363759401|FG000|Overall Study|Death|39|||
105477718|NCT01808092|363759402|FG001|Overall Study|Death|29|||
105477719|NCT01808092|363759401|FG000|Overall Study|Lost to Follow-up|3|||
105477720|NCT01808092|363759402|FG001|Overall Study|Lost to Follow-up|7|||
105477721|NCT01808092|363759401|FG000|Overall Study|Withdrawal by Subject|9|||
105477722|NCT01808092|363759402|FG001|Overall Study|Withdrawal by Subject|4|||
105477723|NCT01808092|363759401|FG000|Overall Study|Other Eligibility criteria|3|||
105477724|NCT01808092|363759402|FG001|Overall Study|Other Eligibility criteria|5|||
105477725|NCT01330017|363761351|FG000|Overall Study|Adverse Event|0|||
105477726|NCT01330017|363761352|FG001|Overall Study|Adverse Event|1|||
105477727|NCT01330017|363761353|FG002|Overall Study|Adverse Event|1|||
105477728|NCT01330017|363761354|FG003|Overall Study|Adverse Event|4|||
105477729|NCT01330017|363761355|FG004|Overall Study|Adverse Event|0|||
105477730|NCT01330017|363761351|FG000|Overall Study|Withdrawal by Subject|0|||
105477731|NCT01330017|363761352|FG001|Overall Study|Withdrawal by Subject|0|||
105477732|NCT01330017|363761353|FG002|Overall Study|Withdrawal by Subject|1|||
105477733|NCT01330017|363761354|FG003|Overall Study|Withdrawal by Subject|0|||
105477734|NCT01330017|363761355|FG004|Overall Study|Withdrawal by Subject|1|||
105477735|NCT01330017|363761351|FG000|Overall Study|Lost to Follow-up|0|||
105477736|NCT01330017|363761352|FG001|Overall Study|Lost to Follow-up|0|||
105477737|NCT01330017|363761353|FG002|Overall Study|Lost to Follow-up|1|||
105477738|NCT01330017|363761354|FG003|Overall Study|Lost to Follow-up|0|||
105477739|NCT01330017|363761355|FG004|Overall Study|Lost to Follow-up|0|||
105477740|NCT01330017|363761351|FG000|Overall Study|Protocol Violation|0|||
105477741|NCT01330017|363761352|FG001|Overall Study|Protocol Violation|0|||
105477742|NCT01330017|363761353|FG002|Overall Study|Protocol Violation|0|||
105477743|NCT01330017|363761354|FG003|Overall Study|Protocol Violation|1|||
105477744|NCT01330017|363761355|FG004|Overall Study|Protocol Violation|0|||
105477745|NCT01330017|363761351|FG000|Overall Study|Unknown Reason|5|||
105477746|NCT01330017|363761352|FG001|Overall Study|Unknown Reason|3|||
105477747|NCT01330017|363761353|FG002|Overall Study|Unknown Reason|5|||
105477748|NCT01330017|363761354|FG003|Overall Study|Unknown Reason|7|||
105477749|NCT01330017|363761355|FG004|Overall Study|Unknown Reason|2|||
105477750|NCT01888432|363761356|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
105477751|NCT01888432|363761357|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
105477752|NCT01888432|363761356|FG000|12-month Analysis (FAS)|Physician Decision|1|||
105477753|NCT01888432|363761357|FG001|12-month Analysis (FAS)|Physician Decision|1|||
105477754|NCT01888432|363761356|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
105477755|NCT01888432|363761357|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
105477756|NCT01888432|363761356|FG000|12-month Analysis (FAS)|Death|4|||
105477757|NCT01888432|363761357|FG001|12-month Analysis (FAS)|Death|3|||
105477758|NCT01888432|363761356|FG000|24-month Analysis (FAS)|Graft loss|0|||
105477759|NCT01888432|363761357|FG001|24-month Analysis (FAS)|Graft loss|1|||
105477760|NCT01888432|363761356|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
105477761|NCT01888432|363761357|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
105477762|NCT01888432|363761356|FG000|24-month Analysis (FAS)|Physician Decision|2|||
105477763|NCT01888432|363761357|FG001|24-month Analysis (FAS)|Physician Decision|4|||
105477764|NCT01888432|363761356|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
105477765|NCT01888432|363761357|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
105477766|NCT01888432|363761356|FG000|24-month Analysis (FAS)|Death|8|||
105477767|NCT01888432|363761357|FG001|24-month Analysis (FAS)|Death|4|||
105477768|NCT01888432|363761356|FG000|36-month Analysis (Extension)|Death|1|||
105477769|NCT01888432|363761357|FG001|36-month Analysis (Extension)|Death|0|||
105477770|NCT00130247|363761360|FG000|Overall Study|Pregnancy|1|||
105477771|NCT00130247|363761361|FG001|Overall Study|Pregnancy|0|||
105477772|NCT00130247|363761360|FG000|Overall Study|Post-randomization exclusion|1|||
105477773|NCT00130247|363761361|FG001|Overall Study|Post-randomization exclusion|2|||
105477774|NCT00130247|363761360|FG000|Overall Study|Not compliant with DOT|0|||
105477775|NCT00130247|363761361|FG001|Overall Study|Not compliant with DOT|2|||
105477776|NCT01696929|363761362|FG000|Overall Study|Physician Decision|1|||
105477777|NCT02522624|363761363|FG000|Overall Study|Technical failure|1|||
105477778|NCT02522624|363761364|FG001|Overall Study|Technical failure|0|||
105352642|NCT00948922|363295646|FG001|Overall Study|Not evaluable at time of analysis|3|||
105352643|NCT00948922|363295647|FG002|Overall Study|Not evaluable at time of analysis|0|||
105352644|NCT00217581|363295648|FG000|Overall Study|Withdrawal by Subject|1|||
105352645|NCT02087943|363295650|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
105352646|NCT02087943|363295651|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
105352647|NCT02087943|363295652|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
105352648|NCT02087943|363295653|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
105352649|NCT02087943|363295654|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
105352650|NCT02087943|363295650|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
105352651|NCT02087943|363295651|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
105352652|NCT02087943|363295652|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
105352653|NCT02087943|363295653|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
105352654|NCT02087943|363295654|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
105352655|NCT02087943|363295650|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
105352656|NCT02087943|363295651|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
105352657|NCT02087943|363295652|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
105718461|NCT01827384|364627045|FG012|Overall Study|No actionable mutation|0|||
105718462|NCT01827384|364627046|FG013|Overall Study|No actionable mutation|73|||
105718463|NCT01827384|364627033|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
105718464|NCT01827384|364627034|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
105718465|NCT01827384|364627035|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
105718466|NCT01827384|364627036|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
105718467|NCT01827384|364627037|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
105718468|NCT01827384|364627038|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
105718469|NCT01827384|364627039|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
105718470|NCT01827384|364627040|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
105718471|NCT01827384|364627041|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
105718472|NCT01827384|364627042|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
105718473|NCT01827384|364627043|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
105718474|NCT01827384|364627044|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
105718475|NCT01827384|364627045|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
105718476|NCT01827384|364627046|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
105718477|NCT02425098|364627048|FG000|Overall Study|Lost to Follow-up|7|||
105718478|NCT02425098|364627049|FG001|Overall Study|Lost to Follow-up|7|||
105718479|NCT02425098|364627048|FG000|Overall Study|Withdrawal by Subject|4|||
105718480|NCT02425098|364627049|FG001|Overall Study|Withdrawal by Subject|8|||
105718481|NCT02425098|364627048|FG000|Overall Study|Pregnancy|2|||
105718482|NCT02425098|364627049|FG001|Overall Study|Pregnancy|0|||
105718483|NCT02425098|364627048|FG000|Overall Study|Reason not Specified|0|||
105718484|NCT02425098|364627049|FG001|Overall Study|Reason not Specified|1|||
105718485|NCT02324270|364628705|FG000|Overall Study|Withdrawal by Subject|0|||
105718486|NCT02324270|364628706|FG001|Overall Study|Withdrawal by Subject|1|||
105718487|NCT02324270|364628707|FG002|Overall Study|Withdrawal by Subject|0|||
105718488|NCT02324270|364628705|FG000|Overall Study|Lost to Follow-up|4|||
105718489|NCT02324270|364628706|FG001|Overall Study|Lost to Follow-up|3|||
105718490|NCT02324270|364628707|FG002|Overall Study|Lost to Follow-up|4|||
105718491|NCT02324270|364628705|FG000|Overall Study|Protocol Violation|0|||
105718492|NCT02324270|364628706|FG001|Overall Study|Protocol Violation|1|||
105718493|NCT02324270|364628707|FG002|Overall Study|Protocol Violation|1|||
105718494|NCT02324270|364628705|FG000|Overall Study|Non Compliance with Study Drug|1|||
105718495|NCT02324270|364628706|FG001|Overall Study|Non Compliance with Study Drug|2|||
105718496|NCT02324270|364628707|FG002|Overall Study|Non Compliance with Study Drug|0|||
105477779|NCT03254108|363761365|FG000|Overall Study|Adverse Event|0|||
105477780|NCT03254108|363761366|FG001|Overall Study|Adverse Event|2|||
105718497|NCT00680836|364628708|FG000|Overall Study|Withdrawal by Subject|3|||
105477781|NCT03254108|363761367|FG002|Overall Study|Adverse Event|0|||
105477782|NCT03254108|363761368|FG003|Overall Study|Adverse Event|1|||
105477783|NCT03254108|363761369|FG004|Overall Study|Adverse Event|1|||
105477784|NCT03254108|363761365|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
105477785|NCT03254108|363761366|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
105477786|NCT03254108|363761367|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
105477787|NCT03254108|363761368|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
105477788|NCT03254108|363761369|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
105477789|NCT01325337|363761370|FG000|Overall Study|Adverse Event|0|||
105477790|NCT01325337|363761371|FG001|Overall Study|Adverse Event|2|||
105718498|NCT00680836|364628709|FG001|Overall Study|Withdrawal by Subject|0|||
105718499|NCT00680836|364628708|FG000|Overall Study|Lost to Follow-up|3|||
105718500|NCT00680836|364628709|FG001|Overall Study|Lost to Follow-up|1|||
105718501|NCT00680836|364628708|FG000|Overall Study|Physician Decision|2|||
105718502|NCT00680836|364628709|FG001|Overall Study|Physician Decision|1|||
105718503|NCT04187092|364628710|FG000|Overall Study|Lost to Follow-up|1|||
105718504|NCT04187092|364628711|FG001|Overall Study|Lost to Follow-up|1|||
105718505|NCT04187092|364628710|FG000|Overall Study|Withdrawal by Subject|1|||
105718506|NCT04187092|364628711|FG001|Overall Study|Withdrawal by Subject|1|||
105718507|NCT04187092|364628710|FG000|Overall Study|Adverse Event|0|||
105718508|NCT04187092|364628711|FG001|Overall Study|Adverse Event|1|||
105718509|NCT00771472|364628712|FG000|Overall Study|Physician Decision|2|||
105718510|NCT00771472|364628713|FG001|Overall Study|Physician Decision|3|||
105718511|NCT00771472|364628712|FG000|Overall Study|Progressive Disease|3|||
105718512|NCT00771472|364628713|FG001|Overall Study|Progressive Disease|1|||
105718513|NCT00771472|364628712|FG000|Overall Study|Protocol Violation|1|||
105718514|NCT00771472|364628713|FG001|Overall Study|Protocol Violation|0|||
105718515|NCT00880750|364628719|FG000|First Intervention|Adverse Event|1|||
105718516|NCT00880750|364628720|FG001|First Intervention|Adverse Event|0|||
105718517|NCT00880750|364628719|FG000|First Intervention|Unable to collect urine|4|||
105718518|NCT00880750|364628720|FG001|First Intervention|Unable to collect urine|0|||
105718519|NCT00880750|364628719|FG000|First Intervention|Non-compliance with meals|0|||
105718520|NCT00880750|364628720|FG001|First Intervention|Non-compliance with meals|1|||
105718521|NCT00880750|364628719|FG000|First Intervention|Withdrawal by Subject|2|||
105718522|NCT00880750|364628720|FG001|First Intervention|Withdrawal by Subject|0|||
105718523|NCT00880750|364628719|FG000|First Intervention|Lost to Follow-up|2|||
105718524|NCT00880750|364628720|FG001|First Intervention|Lost to Follow-up|0|||
105718525|NCT00880750|364628719|FG000|Second Intervention|Withdrawal by Subject|2|||
105718526|NCT00880750|364628720|FG001|Second Intervention|Withdrawal by Subject|2|||
105718527|NCT00880750|364628719|FG000|Second Intervention|Protocol Violation|1|||
105718528|NCT00880750|364628720|FG001|Second Intervention|Protocol Violation|0|||
105718529|NCT00880750|364628719|FG000|Second Intervention|Unable to collect urine|1|||
105718530|NCT00880750|364628720|FG001|Second Intervention|Unable to collect urine|0|||
105718531|NCT00483327|364628723|FG000|Overall Study|Adverse Event|1|||
105718532|NCT00483327|364628723|FG000|Overall Study|Withdrawal by Subject|3|||
105718533|NCT00483327|364628723|FG000|Overall Study|Lost to Follow-up|4|||
105718534|NCT00483327|364628723|FG000|Overall Study|Patient Non Compliance|2|||
105718535|NCT01891643|364628724|FG000|Overall Study|Adverse event unrelated to study drug|2|||
105718536|NCT01891643|364628725|FG001|Overall Study|Adverse event unrelated to study drug|5|||
105718537|NCT01891643|364628724|FG000|Overall Study|Disease Progression|4|||
105718538|NCT01891643|364628725|FG001|Overall Study|Disease Progression|3|||
105718539|NCT01891643|364628724|FG000|Overall Study|Study Drug Toxicity|3|||
105718540|NCT01891643|364628725|FG001|Overall Study|Study Drug Toxicity|0|||
105718541|NCT01891643|364628724|FG000|Overall Study|Maximum Clinical Benefit|0|||
105718542|NCT01891643|364628725|FG001|Overall Study|Maximum Clinical Benefit|1|||
105718543|NCT01891643|364628724|FG000|Overall Study|Poor/Non-compliance|0|||
105718544|NCT01891643|364628725|FG001|Overall Study|Poor/Non-compliance|1|||
105718545|NCT01891643|364628724|FG000|Overall Study|Participant request to discontinue|1|||
105718546|NCT01891643|364628725|FG001|Overall Study|Participant request to discontinue|0|||
105718547|NCT04188197|364628726|FG000|Overall Study|Lost to Follow-up|4|||
105718548|NCT04188197|364628727|FG001|Overall Study|Lost to Follow-up|1|||
105352658|NCT02087943|363295653|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
105352659|NCT02087943|363295654|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
105352660|NCT02087943|363295650|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
105352661|NCT02087943|363295651|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
105352662|NCT02087943|363295652|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
105352663|NCT02087943|363295653|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
105352664|NCT02087943|363295654|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
105352665|NCT02087943|363295650|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
105352666|NCT02087943|363295651|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
105352667|NCT02087943|363295652|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
105352668|NCT02087943|363295653|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
105352669|NCT02087943|363295654|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
105352670|NCT02087943|363295650|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
105352671|NCT02087943|363295651|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
105352672|NCT02087943|363295652|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
105352673|NCT02087943|363295653|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
105352674|NCT02087943|363295654|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
105352675|NCT02087943|363295650|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
105352676|NCT02087943|363295651|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
105352677|NCT02087943|363295652|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
105352678|NCT02087943|363295653|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
105352679|NCT02087943|363295654|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
105352680|NCT02087943|363295650|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
105352681|NCT02087943|363295651|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
105352682|NCT02087943|363295652|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
105352683|NCT02087943|363295653|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
105352684|NCT02087943|363295654|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
105477791|NCT01325337|363761372|FG002|Overall Study|Adverse Event|2|||
105718549|NCT04188197|364628726|FG000|Overall Study|Withdrawal by Subject|1|||
105718550|NCT04188197|364628727|FG001|Overall Study|Withdrawal by Subject|1|||
105718551|NCT04188197|364628726|FG000|Overall Study|Pregnancy|0|||
105718552|NCT04188197|364628727|FG001|Overall Study|Pregnancy|1|||
105718553|NCT01246206|364628730|FG000|Overall Study|Patient did not receive study regiments.|1|||
105718554|NCT02965716|364628731|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
105718555|NCT02965716|364628732|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
105718556|NCT02965716|364628731|FG000|Overall Study|Progression/Relapse|8|||
105718557|NCT02965716|364628732|FG001|Overall Study|Progression/Relapse|16|||
105718558|NCT02965716|364628731|FG000|Overall Study|Death|1|||
105718559|NCT02965716|364628732|FG001|Overall Study|Death|0|||
105718560|NCT02965716|364628731|FG000|Overall Study|Not Protocol Specified|1|||
105352685|NCT02087943|363295650|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
105718561|NCT02965716|364628732|FG001|Overall Study|Not Protocol Specified|3|||
105790934|NCT02325739|364888454|FG005|Phase II Part|Physician Decision|0|||
105790935|NCT02325739|364888455|FG006|Phase II Part|Physician Decision|0|||
105790936|NCT02325739|364888456|FG007|Phase II Part|Physician Decision|0|||
105790937|NCT02325739|364888457|FG008|Phase II Part|Physician Decision|0|||
105790938|NCT02325739|364888458|FG009|Phase II Part|Physician Decision|1|||
105790939|NCT02325739|364888459|FG010|Phase II Part|Physician Decision|0|||
105790940|NCT02325739|364888449|FG000|Phase II Part|Progressive disease|0|||
105790941|NCT02325739|364888450|FG001|Phase II Part|Progressive disease|0|||
105790942|NCT02325739|364888451|FG002|Phase II Part|Progressive disease|0|||
105790943|NCT02325739|364888452|FG003|Phase II Part|Progressive disease|0|||
105790944|NCT02325739|364888453|FG004|Phase II Part|Progressive disease|0|||
105790945|NCT02325739|364888454|FG005|Phase II Part|Progressive disease|0|||
105790946|NCT02325739|364888455|FG006|Phase II Part|Progressive disease|0|||
105790947|NCT02325739|364888456|FG007|Phase II Part|Progressive disease|0|||
105790948|NCT02325739|364888457|FG008|Phase II Part|Progressive disease|22|||
105790949|NCT02325739|364888458|FG009|Phase II Part|Progressive disease|29|||
105790950|NCT02325739|364888459|FG010|Phase II Part|Progressive disease|18|||
105790951|NCT02325739|364888449|FG000|Phase II Part|Subject/guardian decision|0|||
105790952|NCT02325739|364888450|FG001|Phase II Part|Subject/guardian decision|0|||
105790953|NCT02325739|364888451|FG002|Phase II Part|Subject/guardian decision|0|||
105790954|NCT02325739|364888452|FG003|Phase II Part|Subject/guardian decision|0|||
105790955|NCT02325739|364888453|FG004|Phase II Part|Subject/guardian decision|0|||
105790956|NCT02325739|364888454|FG005|Phase II Part|Subject/guardian decision|0|||
105790957|NCT02325739|364888455|FG006|Phase II Part|Subject/guardian decision|0|||
105790958|NCT02325739|364888456|FG007|Phase II Part|Subject/guardian decision|0|||
105790959|NCT02325739|364888457|FG008|Phase II Part|Subject/guardian decision|4|||
105790960|NCT02325739|364888458|FG009|Phase II Part|Subject/guardian decision|1|||
105790961|NCT02325739|364888459|FG010|Phase II Part|Subject/guardian decision|1|||
105790962|NCT00227591|364888460|FG000|Overall Study|Withdrawal by Subject|1|||
105790963|NCT02341482|364888461|FG000|Overall Study|Adverse Event|1|||
105790964|NCT02057549|364888465|FG000|Overall Study|Lost to Follow-up|1|||
105790965|NCT02057549|364888466|FG001|Overall Study|Lost to Follow-up|0|||
105790966|NCT02057549|364888465|FG000|Overall Study|Physician Decision|1|||
105790967|NCT02057549|364888466|FG001|Overall Study|Physician Decision|0|||
105790968|NCT02057549|364888465|FG000|Overall Study|Withdrawal by Subject|1|||
105790969|NCT02057549|364888466|FG001|Overall Study|Withdrawal by Subject|0|||
105790970|NCT01418365|364888467|FG000|First Intervention|Withdrawal by Subject|0|||
105790971|NCT01418365|364888468|FG001|First Intervention|Withdrawal by Subject|1|||
105790972|NCT01418365|364888467|FG000|First Intervention|Non-compliance|1|||
105790973|NCT01418365|364888468|FG001|First Intervention|Non-compliance|0|||
105790974|NCT01418365|364888467|FG000|Second Intervention|Withdrawal by Subject|0|||
105790975|NCT01418365|364888468|FG001|Second Intervention|Withdrawal by Subject|1|||
105790976|NCT00530621|364888481|FG000|Overall Study|Adverse Event|11|||
105790977|NCT00530621|364888482|FG001|Overall Study|Adverse Event|8|||
105790978|NCT00530621|364888481|FG000|Overall Study|Physician Decision|2|||
105790979|NCT00530621|364888482|FG001|Overall Study|Physician Decision|4|||
105790980|NCT00530621|364888481|FG000|Overall Study|Progressive Disease (PD)|47|||
105790981|NCT00530621|364888482|FG001|Overall Study|Progressive Disease (PD)|40|||
105790982|NCT00530621|364888481|FG000|Overall Study|Sponsor Decision|12|||
105790983|NCT00530621|364888482|FG001|Overall Study|Sponsor Decision|15|||
105790984|NCT00530621|364888481|FG000|Overall Study|Subject Decision|4|||
105790985|NCT00530621|364888482|FG001|Overall Study|Subject Decision|7|||
105790986|NCT00530621|364888481|FG000|Overall Study|Death|3|||
105790987|NCT00530621|364888482|FG001|Overall Study|Death|6|||
105790988|NCT00530621|364888481|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
105790989|NCT00530621|364888482|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
105790990|NCT00518011|364888483|FG000|Overall Study|Death|1|||
105790991|NCT00518011|364888484|FG001|Overall Study|Death|1|||
105790992|NCT00518011|364888483|FG000|Overall Study|Adverse Event|2|||
105790993|NCT00518011|364888484|FG001|Overall Study|Adverse Event|3|||
105790994|NCT00518011|364888483|FG000|Overall Study|Disease Progression|2|||
105790995|NCT00518011|364888484|FG001|Overall Study|Disease Progression|2|||
105790996|NCT00518011|364888483|FG000|Overall Study|Other Reasons|3|||
105790997|NCT00518011|364888484|FG001|Overall Study|Other Reasons|2|||
105790998|NCT00518011|364888483|FG000|Overall Study|Withdrawal by Subject|1|||
105790999|NCT00518011|364888484|FG001|Overall Study|Withdrawal by Subject|0|||
105791000|NCT02596009|364888485|FG000|Overall Study|Administrative problems|0|||
105791001|NCT02596009|364888486|FG001|Overall Study|Administrative problems|1|||
105791002|NCT02596009|364888487|FG002|Overall Study|Administrative problems|0|||
105791003|NCT02596009|364888488|FG003|Overall Study|Administrative problems|0|||
105791004|NCT02596009|364888489|FG004|Overall Study|Administrative problems|0|||
105791005|NCT02596009|364888490|FG005|Overall Study|Administrative problems|0|||
105791006|NCT02998645|364888491|FG000|Treatment Period 1|Adverse Event|6|||
105791007|NCT02998645|364888491|FG000|Treatment Period 1|Death|5|||
105791008|NCT02998645|364888491|FG000|Treatment Period 1|Technical Problems|4|||
105791009|NCT02998645|364888491|FG000|Treatment Period 1|Lack of Efficacy|2|||
105791010|NCT02998645|364888491|FG000|Treatment Period 1|Progressive disease|1|||
105791011|NCT02998645|364888491|FG000|Treatment Period 1|Subject/guardian decision|1|||
105791012|NCT02998645|364888491|FG000|Treatment Period 2|Lack of Efficacy|5|||
105791013|NCT02998645|364888491|FG000|Treatment Period 2|Adverse Event|2|||
105791014|NCT02998645|364888491|FG000|Treatment Period 2|Progressive disease|2|||
105791015|NCT02998645|364888491|FG000|Treatment Period 2|Physician Decision|1|||
105791016|NCT03644927|364888499|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
105791017|NCT03644927|364888500|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
105791018|NCT02864953|364888506|FG000|Overall Study|Adverse Event|22|||
105791019|NCT02864953|364888507|FG001|Overall Study|Adverse Event|19|||
105791020|NCT02864953|364888506|FG000|Overall Study|Withdrawal by Subject|1|||
105791021|NCT02864953|364888507|FG001|Overall Study|Withdrawal by Subject|0|||
105791022|NCT02864953|364888506|FG000|Overall Study|Physician Decision|4|||
105791023|NCT02864953|364888507|FG001|Overall Study|Physician Decision|2|||
105791024|NCT02864953|364888506|FG000|Overall Study|Death|3|||
105791025|NCT02864953|364888507|FG001|Overall Study|Death|13|||
105791026|NCT02864953|364888506|FG000|Overall Study|Reason not specified|14|||
105791027|NCT02864953|364888507|FG001|Overall Study|Reason not specified|12|||
105791028|NCT02864953|364888506|FG000|Overall Study|Withdrew Prior to Dosing|9|||
105791029|NCT02864953|364888507|FG001|Overall Study|Withdrew Prior to Dosing|8|||
105791030|NCT03075215|364888511|FG000|12-Month Primary Endpoint|Death|152|||
105791031|NCT03075215|364888511|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
105791032|NCT03075215|364888511|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
105791033|NCT03075215|364888511|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
105791034|NCT00752895|364888512|FG000|Overall Study|Withdrawal by Subject|8|||
105791035|NCT00752895|364888513|FG001|Overall Study|Withdrawal by Subject|3|||
105791036|NCT03746080|364890499|FG000|Overall Study|In follow up|2|||
105791037|NCT03746080|364890499|FG000|Overall Study|Death|15|||
105791038|NCT02094573|364890500|FG000|Overall Study|Adverse Event|4|||
105791039|NCT02094573|364890501|FG001|Overall Study|Adverse Event|14|||
105791040|NCT02094573|364890500|FG000|Overall Study|Clinical Progressive Disease|9|||
105791041|NCT02094573|364890501|FG001|Overall Study|Clinical Progressive Disease|13|||
105791042|NCT02094573|364890500|FG000|Overall Study|Death|11|||
105791043|NCT02094573|364890501|FG001|Overall Study|Death|3|||
105791044|NCT02094573|364890500|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
105791045|NCT02094573|364890501|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
105791046|NCT02094573|364890500|FG000|Overall Study|Non-compliance with Study Drug|1|||
105791047|NCT02094573|364890501|FG001|Overall Study|Non-compliance with Study Drug|1|||
105791048|NCT02094573|364890500|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
105791049|NCT02094573|364890501|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
105791050|NCT02094573|364890500|FG000|Overall Study|Physician Decision|4|||
105791051|NCT02094573|364890501|FG001|Overall Study|Physician Decision|4|||
105791052|NCT02094573|364890500|FG000|Overall Study|Site Terminated by Sponsor|10|||
105791053|NCT02094573|364890501|FG001|Overall Study|Site Terminated by Sponsor|17|||
105791054|NCT02094573|364890500|FG000|Overall Study|Withdrawal by Subject|6|||
105791055|NCT02094573|364890501|FG001|Overall Study|Withdrawal by Subject|8|||
105791056|NCT02094573|364890500|FG000|Overall Study|Randomized but not Treated|3|||
105791057|NCT02094573|364890501|FG001|Overall Study|Randomized but not Treated|0|||
105791058|NCT02875340|364890502|FG000|Overall Study|Death|2|||
105791059|NCT02875340|364890502|FG000|Overall Study|Withdrawal by Subject|2|||
105791060|NCT02875340|364890502|FG000|Overall Study|Physician Decision|3|||
105791061|NCT02875340|364890502|FG000|Overall Study|Adverse Event|1|||
105791062|NCT01160770|364890505|FG000|Overall Study|Adverse Event|10|||
105791063|NCT01160770|364890505|FG000|Overall Study|Protocol Violation|2|||
105791064|NCT01160770|364890505|FG000|Overall Study|Subject/parent/caregiver request|33|||
105791065|NCT01160770|364890505|FG000|Overall Study|Physician Decision|1|||
105791066|NCT01160770|364890505|FG000|Overall Study|Lost to Follow-up|7|||
105791067|NCT01160770|364890505|FG000|Overall Study|Study termination or sponsor request|1|||
105791068|NCT01160770|364890505|FG000|Overall Study|Death|9|||
105791069|NCT01160770|364890505|FG000|Overall Study|Lack of Efficacy|15|||
105791070|NCT01160770|364890505|FG000|Overall Study|Other Reasons|1|||
105791071|NCT03457727|364890506|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
105791072|NCT03457727|364890507|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
105791073|NCT03457727|364890508|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
105791074|NCT03457727|364890509|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
105791075|NCT01513759|364890510|FG000|Overall Study|Protocol Violation|4|||
105791076|NCT01513759|364890510|FG000|Overall Study|Death during catheter placement|1|||
105791077|NCT03722849|364890514|FG000|Overall Study|Withdrawal by Subject|1|||
105791078|NCT03722849|364890515|FG001|Overall Study|Withdrawal by Subject|1|||
105791079|NCT02118896|364890518|FG000|Overall Study|Death|4|||
105477792|NCT01325337|363761373|FG003|Overall Study|Adverse Event|1|||
105477793|NCT01325337|363761374|FG004|Overall Study|Adverse Event|2|||
105477794|NCT01325337|363761370|FG000|Overall Study|Lost to Follow-up|2|||
105477795|NCT01325337|363761371|FG001|Overall Study|Lost to Follow-up|2|||
105718562|NCT04047797|364628733|FG000|Overall Study|Progressive Disease|1|||
105718563|NCT03523351|364628734|FG000|Overall Study|Death|13|||
105718564|NCT03523351|364628735|FG001|Overall Study|Death|11|||
105718565|NCT03523351|364628734|FG000|Overall Study|Lost to Follow-up|2|||
105718566|NCT03523351|364628735|FG001|Overall Study|Lost to Follow-up|3|||
105718567|NCT03523351|364628734|FG000|Overall Study|Withdrawal by Subject|4|||
105718568|NCT03523351|364628735|FG001|Overall Study|Withdrawal by Subject|0|||
105718569|NCT03523351|364628734|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
105718570|NCT03523351|364628735|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
105718571|NCT01097629|364628736|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
105718572|NCT01097629|364628737|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
105718573|NCT01097629|364628738|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
105718574|NCT01097629|364628739|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105718575|NCT01097629|364628740|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105718576|NCT01097629|364628741|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105718577|NCT01097629|364628742|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105718578|NCT01097629|364628743|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105718579|NCT01097629|364628736|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
105718580|NCT01097629|364628737|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
105718581|NCT01097629|364628738|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
105718582|NCT01097629|364628739|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105718583|NCT01097629|364628740|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105718584|NCT01097629|364628741|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105718585|NCT01097629|364628742|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105718586|NCT01097629|364628743|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105718587|NCT01097629|364628736|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
105718588|NCT01097629|364628737|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
105718589|NCT01097629|364628738|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
105718590|NCT01097629|364628739|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105718591|NCT01097629|364628740|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105718592|NCT01097629|364628741|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105718593|NCT01097629|364628742|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105718594|NCT01097629|364628743|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105718595|NCT01097629|364628736|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
105718596|NCT01097629|364628737|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
105718597|NCT01097629|364628738|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
105718598|NCT01097629|364628739|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105718599|NCT01097629|364628740|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105718600|NCT01097629|364628741|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105718601|NCT01097629|364628742|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105718602|NCT01097629|364628743|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105718603|NCT01097629|364628736|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
105718604|NCT01097629|364628737|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
105718605|NCT01097629|364628738|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
105718606|NCT01097629|364628739|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105718607|NCT01097629|364628740|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105718608|NCT01097629|364628741|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105718609|NCT01097629|364628742|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105718610|NCT01097629|364628743|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105718611|NCT01097629|364628736|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
105718612|NCT01097629|364628737|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
105718613|NCT01097629|364628738|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105718614|NCT01097629|364628739|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105718615|NCT01097629|364628740|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105718616|NCT01097629|364628741|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105477796|NCT01325337|363761372|FG002|Overall Study|Lost to Follow-up|2|||
105718617|NCT01097629|364628742|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105791080|NCT02118896|364890519|FG001|Overall Study|Death|0|||
105477797|NCT01325337|363761373|FG003|Overall Study|Lost to Follow-up|1|||
105477798|NCT01325337|363761374|FG004|Overall Study|Lost to Follow-up|2|||
105477799|NCT01325337|363761370|FG000|Overall Study|Personal Reasons|2|||
105477800|NCT01325337|363761371|FG001|Overall Study|Personal Reasons|5|||
105477801|NCT01325337|363761372|FG002|Overall Study|Personal Reasons|4|||
105718618|NCT01097629|364628743|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105718619|NCT01097629|364628736|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
105718620|NCT01097629|364628737|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
105718621|NCT01097629|364628738|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
105718622|NCT01097629|364628739|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105718623|NCT01097629|364628740|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105718624|NCT01097629|364628741|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105718625|NCT01097629|364628742|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105718626|NCT01097629|364628743|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105718627|NCT01097629|364628736|FG000|DB RO Phase|Withdrawal by Subject|0|||
105718628|NCT01097629|364628737|FG001|DB RO Phase|Withdrawal by Subject|0|||
105718629|NCT01097629|364628738|FG002|DB RO Phase|Withdrawal by Subject|0|||
105718630|NCT01097629|364628739|FG003|DB RO Phase|Withdrawal by Subject|0|||
105718631|NCT01097629|364628740|FG004|DB RO Phase|Withdrawal by Subject|0|||
105718632|NCT01097629|364628741|FG005|DB RO Phase|Withdrawal by Subject|0|||
105718633|NCT01097629|364628742|FG006|DB RO Phase|Withdrawal by Subject|0|||
105718634|NCT01097629|364628743|FG007|DB RO Phase|Withdrawal by Subject|1|||
105718635|NCT01097629|364628736|FG000|DB RO Phase|Protocol Violation|0|||
105718636|NCT01097629|364628737|FG001|DB RO Phase|Protocol Violation|0|||
105718637|NCT01097629|364628738|FG002|DB RO Phase|Protocol Violation|0|||
105718638|NCT01097629|364628739|FG003|DB RO Phase|Protocol Violation|1|||
105718639|NCT01097629|364628740|FG004|DB RO Phase|Protocol Violation|0|||
105718640|NCT01097629|364628741|FG005|DB RO Phase|Protocol Violation|1|||
105718641|NCT01097629|364628742|FG006|DB RO Phase|Protocol Violation|1|||
105718642|NCT01097629|364628743|FG007|DB RO Phase|Protocol Violation|0|||
105718643|NCT01097629|364628736|FG000|DB RO Phase|Lost to Follow-up|0|||
105718644|NCT01097629|364628737|FG001|DB RO Phase|Lost to Follow-up|0|||
105718645|NCT01097629|364628738|FG002|DB RO Phase|Lost to Follow-up|0|||
105718646|NCT01097629|364628739|FG003|DB RO Phase|Lost to Follow-up|0|||
105718647|NCT01097629|364628740|FG004|DB RO Phase|Lost to Follow-up|0|||
105718648|NCT01097629|364628741|FG005|DB RO Phase|Lost to Follow-up|0|||
105718649|NCT01097629|364628742|FG006|DB RO Phase|Lost to Follow-up|2|||
105718650|NCT01097629|364628743|FG007|DB RO Phase|Lost to Follow-up|0|||
105718651|NCT00365989|364628747|FG000|Overall Study|Withdrawal by Subject|1|||
105718652|NCT00365989|364628747|FG000|Overall Study|Non-compliance|1|||
105352686|NCT02087943|363295651|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
105352687|NCT02087943|363295652|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
105352688|NCT02087943|363295653|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
105352689|NCT02087943|363295654|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
105352690|NCT02087943|363295650|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
105352691|NCT02087943|363295651|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
105352692|NCT02087943|363295652|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
105352693|NCT02087943|363295653|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
105352694|NCT02087943|363295654|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
105352695|NCT06226649|363295657|FG000|Overall Study|Withdrawal by Subject|4|||
105352696|NCT06226649|363295658|FG001|Overall Study|Withdrawal by Subject|1|||
105352697|NCT03739710|363295659|FG000|Overall Study|Screen Failed|81|||
105352698|NCT00715520|363295664|FG000|Overall Study|Screen failure|8|||
105352699|NCT00715520|363295665|FG001|Overall Study|Screen failure|1|||
105352700|NCT00715520|363295666|FG002|Overall Study|Screen failure|1|||
105352701|NCT00715520|363295664|FG000|Overall Study|Withdrawal by Subject|2|||
105352702|NCT00715520|363295665|FG001|Overall Study|Withdrawal by Subject|0|||
105352703|NCT00715520|363295666|FG002|Overall Study|Withdrawal by Subject|1|||
105352704|NCT03332095|363295667|FG000|Overall Study|Lost to Follow-up|1|||
105352705|NCT03332095|363295668|FG001|Overall Study|Lost to Follow-up|0|||
105352706|NCT03332095|363295667|FG000|Overall Study|Pregnancy|0|||
105352707|NCT03332095|363295668|FG001|Overall Study|Pregnancy|1|||
105352708|NCT01597492|363295669|FG000|Overall Study|Withdrawal by Subject|1|||
105352709|NCT01597492|363295670|FG001|Overall Study|Withdrawal by Subject|2|||
105352710|NCT01597492|363295669|FG000|Overall Study|Adverse Event|3|||
105352711|NCT01597492|363295670|FG001|Overall Study|Adverse Event|0|||
105352712|NCT01597492|363295669|FG000|Overall Study|Lost to Follow-up|0|||
105352713|NCT01597492|363295670|FG001|Overall Study|Lost to Follow-up|2|||
105352714|NCT01597492|363295669|FG000|Overall Study|Other Reason|2|||
105352715|NCT01597492|363295670|FG001|Overall Study|Other Reason|0|||
105352716|NCT00496587|363295673|FG000|Overall Study|Adverse Event|2|||
105352717|NCT00496587|363295673|FG000|Overall Study|Progressive Disease|24|||
105352718|NCT00496587|363295673|FG000|Overall Study|Withdrawal by Subject|2|||
105352719|NCT00496587|363295673|FG000|Overall Study|Death|1|||
105352720|NCT00496587|363295673|FG000|Overall Study|Complications unrelated|2|||
105352721|NCT00548249|363295676|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
105352722|NCT00548249|363295677|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
105352723|NCT00548249|363295678|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
105352724|NCT00548249|363295679|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
105352725|NCT00548249|363295680|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
105352726|NCT00548249|363295676|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
105352727|NCT00548249|363295677|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
105352728|NCT00548249|363295678|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
105352729|NCT00548249|363295679|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
105352730|NCT00548249|363295680|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
105352731|NCT00548249|363295676|FG000|Overall Study|Protocol Violation|1|||
105352732|NCT00548249|363295677|FG001|Overall Study|Protocol Violation|1|||
105352733|NCT00548249|363295678|FG002|Overall Study|Protocol Violation|4|||
105352734|NCT00548249|363295679|FG003|Overall Study|Protocol Violation|0|||
105352735|NCT00548249|363295680|FG004|Overall Study|Protocol Violation|3|||
105352736|NCT00548249|363295676|FG000|Overall Study|Miscellaneous|2|||
105352737|NCT00548249|363295677|FG001|Overall Study|Miscellaneous|3|||
105718653|NCT00623831|364628748|FG000|Overall Study|Withdrawal by Subject|1|||
105718654|NCT00623831|364628749|FG001|Overall Study|Withdrawal by Subject|0|||
105718655|NCT00623831|364628748|FG000|Overall Study|Progressive Disease|0|||
105718656|NCT00623831|364628749|FG001|Overall Study|Progressive Disease|1|||
105718657|NCT00282243|364628750|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
105718658|NCT00282243|364628750|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
105718659|NCT00282243|364628750|FG000|Extension Treatment Period|Adverse Event|15|||
105718660|NCT00282243|364628750|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
105718661|NCT00282243|364628750|FG000|Extension Treatment Period|Non-compliance|2|||
105718662|NCT00282243|364628750|FG000|Extension Treatment Period|Physician Decision|1|||
105352738|NCT00548249|363295678|FG002|Overall Study|Miscellaneous|2|||
105352739|NCT00548249|363295679|FG003|Overall Study|Miscellaneous|0|||
105718663|NCT00317044|364628751|FG000|Overall Study|Protocol Violation|28|||
105718664|NCT00317044|364628752|FG001|Overall Study|Protocol Violation|22|||
105718665|NCT00317044|364628753|FG002|Overall Study|Protocol Violation|20|||
105718666|NCT00317044|364628751|FG000|Overall Study|Adverse Event|4|||
105352740|NCT00548249|363295680|FG004|Overall Study|Miscellaneous|2|||
105352741|NCT00548249|363295676|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
105352742|NCT00548249|363295677|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
105352743|NCT00548249|363295678|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
105352744|NCT00548249|363295679|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
105352745|NCT00548249|363295680|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
105718667|NCT00317044|364628752|FG001|Overall Study|Adverse Event|7|||
105561876|NCT02342886|364052243|FG004|Overall Study|Investigator/sponsor decision|1|||
105791081|NCT02118896|364890520|FG002|Overall Study|Death|4|||
105791082|NCT02118896|364890521|FG003|Overall Study|Death|6|||
105791083|NCT02118896|364890522|FG004|Overall Study|Death|3|||
105791084|NCT02118896|364890523|FG005|Overall Study|Death|1|||
105791085|NCT02118896|364890524|FG006|Overall Study|Death|0|||
105791086|NCT02118896|364890525|FG007|Overall Study|Death|0|||
105791087|NCT02118896|364890526|FG008|Overall Study|Death|0|||
105561877|NCT02342886|364052239|FG000|Overall Study|Pregnancy|0|||
105791088|NCT02118896|364890527|FG009|Overall Study|Death|0|||
105561878|NCT02342886|364052240|FG001|Overall Study|Pregnancy|0|||
105791089|NCT02118896|364890518|FG000|Overall Study|Adverse Event|5|||
105718668|NCT00317044|364628753|FG002|Overall Study|Adverse Event|4|||
105718669|NCT00317044|364628751|FG000|Overall Study|Withdrawal by Subject|10|||
105718670|NCT00317044|364628752|FG001|Overall Study|Withdrawal by Subject|7|||
105718671|NCT00317044|364628753|FG002|Overall Study|Withdrawal by Subject|12|||
105718672|NCT00317044|364628751|FG000|Overall Study|Lost to Follow-up|0|||
105718673|NCT00317044|364628752|FG001|Overall Study|Lost to Follow-up|2|||
105718674|NCT00317044|364628753|FG002|Overall Study|Lost to Follow-up|3|||
105718675|NCT00317044|364628751|FG000|Overall Study|Multiple Reasons|6|||
105718676|NCT00317044|364628752|FG001|Overall Study|Multiple Reasons|2|||
105718677|NCT00317044|364628753|FG002|Overall Study|Multiple Reasons|6|||
105718678|NCT02863848|364628756|FG000|Overall Study|Lost to Follow-up|1|||
105718679|NCT02863848|364628757|FG001|Overall Study|Lost to Follow-up|1|||
105718680|NCT02863848|364628756|FG000|Overall Study|Protocol Violation|1|||
105718681|NCT02863848|364628757|FG001|Overall Study|Protocol Violation|2|||
105718682|NCT02318095|364628758|FG000|Overall Study|Adverse Event|1|||
105718683|NCT02000622|364628762|FG000|Overall Study|Withdrawal by Subject|5|||
105718684|NCT02000622|364628763|FG001|Overall Study|Withdrawal by Subject|7|||
105718685|NCT02000622|364628762|FG000|Overall Study|Lost to Follow-up|4|||
105791090|NCT02118896|364890519|FG001|Overall Study|Adverse Event|4|||
105791091|NCT02118896|364890520|FG002|Overall Study|Adverse Event|4|||
105791092|NCT02118896|364890521|FG003|Overall Study|Adverse Event|5|||
105791093|NCT02118896|364890522|FG004|Overall Study|Adverse Event|5|||
105791094|NCT02118896|364890523|FG005|Overall Study|Adverse Event|9|||
105791095|NCT02118896|364890524|FG006|Overall Study|Adverse Event|1|||
105791096|NCT02118896|364890525|FG007|Overall Study|Adverse Event|1|||
105791097|NCT02118896|364890526|FG008|Overall Study|Adverse Event|4|||
105791098|NCT02118896|364890527|FG009|Overall Study|Adverse Event|0|||
105791099|NCT02118896|364890518|FG000|Overall Study|Consent withdrawn|2|||
105791100|NCT02118896|364890519|FG001|Overall Study|Consent withdrawn|0|||
105791101|NCT02118896|364890520|FG002|Overall Study|Consent withdrawn|3|||
105791102|NCT02118896|364890521|FG003|Overall Study|Consent withdrawn|4|||
105791103|NCT02118896|364890522|FG004|Overall Study|Consent withdrawn|1|||
105791104|NCT02118896|364890523|FG005|Overall Study|Consent withdrawn|4|||
105791105|NCT02118896|364890524|FG006|Overall Study|Consent withdrawn|0|||
105791106|NCT02118896|364890525|FG007|Overall Study|Consent withdrawn|0|||
105791107|NCT02118896|364890526|FG008|Overall Study|Consent withdrawn|0|||
105791108|NCT02118896|364890527|FG009|Overall Study|Consent withdrawn|0|||
105791109|NCT02118896|364890518|FG000|Overall Study|Non-compliance|2|||
105791110|NCT02118896|364890519|FG001|Overall Study|Non-compliance|1|||
105791111|NCT02118896|364890520|FG002|Overall Study|Non-compliance|1|||
105791112|NCT02118896|364890521|FG003|Overall Study|Non-compliance|5|||
105791113|NCT02118896|364890522|FG004|Overall Study|Non-compliance|0|||
105791114|NCT02118896|364890523|FG005|Overall Study|Non-compliance|1|||
105791115|NCT02118896|364890524|FG006|Overall Study|Non-compliance|0|||
105791116|NCT02118896|364890525|FG007|Overall Study|Non-compliance|1|||
105791117|NCT02118896|364890526|FG008|Overall Study|Non-compliance|0|||
105352746|NCT00548249|363295676|FG000|Overall Study|Adverse Event|2|||
105352747|NCT00548249|363295677|FG001|Overall Study|Adverse Event|2|||
105352748|NCT00548249|363295678|FG002|Overall Study|Adverse Event|0|||
105352749|NCT00548249|363295679|FG003|Overall Study|Adverse Event|1|||
105352750|NCT00548249|363295680|FG004|Overall Study|Adverse Event|1|||
105352751|NCT00548249|363295676|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
105718686|NCT02000622|364628763|FG001|Overall Study|Lost to Follow-up|0|||
105718687|NCT02000622|364628762|FG000|Overall Study|Death|159|||
105718688|NCT02000622|364628763|FG001|Overall Study|Death|73|||
105718689|NCT02000622|364628762|FG000|Overall Study|Withdrawn due to site closure|1|||
105352752|NCT00548249|363295677|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
105352753|NCT00548249|363295678|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
105352754|NCT00548249|363295679|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
105352755|NCT00548249|363295680|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
105352756|NCT00548249|363295676|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
105352757|NCT00548249|363295677|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
105352758|NCT00548249|363295678|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
105352759|NCT00548249|363295679|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
105352760|NCT00548249|363295680|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
105352761|NCT00548249|363295676|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
105352762|NCT00548249|363295677|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
105352763|NCT00548249|363295678|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
105352764|NCT00548249|363295679|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
105352765|NCT00548249|363295680|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
105352766|NCT00548249|363295676|FG000|Overall Study|Prolonged hospitalization|0|||
105352767|NCT00548249|363295677|FG001|Overall Study|Prolonged hospitalization|0|||
105352768|NCT00548249|363295678|FG002|Overall Study|Prolonged hospitalization|2|||
105352769|NCT00548249|363295679|FG003|Overall Study|Prolonged hospitalization|1|||
105352770|NCT00548249|363295680|FG004|Overall Study|Prolonged hospitalization|0|||
105352771|NCT00548249|363295676|FG000|Overall Study|Withdrawal by Subject|2|||
105352772|NCT00548249|363295677|FG001|Overall Study|Withdrawal by Subject|0|||
105352773|NCT00548249|363295678|FG002|Overall Study|Withdrawal by Subject|0|||
105352774|NCT00548249|363295679|FG003|Overall Study|Withdrawal by Subject|0|||
105352775|NCT00548249|363295680|FG004|Overall Study|Withdrawal by Subject|0|||
105352776|NCT00548249|363295676|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
105352777|NCT00548249|363295677|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
105352778|NCT00548249|363295678|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
105352779|NCT00548249|363295679|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
105352780|NCT00548249|363295680|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
105352781|NCT00548249|363295676|FG000|Overall Study|Sponsor's request|0|||
105352782|NCT00548249|363295677|FG001|Overall Study|Sponsor's request|0|||
105352783|NCT00548249|363295678|FG002|Overall Study|Sponsor's request|0|||
105352784|NCT00548249|363295679|FG003|Overall Study|Sponsor's request|1|||
105352785|NCT00548249|363295680|FG004|Overall Study|Sponsor's request|0|||
105352786|NCT00938587|363295681|FG000|Overall Study|Adverse Event|2|||
105352787|NCT00938587|363295682|FG001|Overall Study|Adverse Event|0|||
105352788|NCT00938587|363295683|FG002|Overall Study|Adverse Event|0|||
105352789|NCT00938587|363295684|FG003|Overall Study|Adverse Event|2|||
105352790|NCT00938587|363295681|FG000|Overall Study|Did not meet entrance criteria|0|||
105352791|NCT00938587|363295682|FG001|Overall Study|Did not meet entrance criteria|0|||
105352792|NCT00938587|363295683|FG002|Overall Study|Did not meet entrance criteria|1|||
105352793|NCT00938587|363295684|FG003|Overall Study|Did not meet entrance criteria|0|||
105352794|NCT00938587|363295681|FG000|Overall Study|Withdrawal by Subject|1|||
105352795|NCT00938587|363295682|FG001|Overall Study|Withdrawal by Subject|1|||
105352796|NCT00938587|363295683|FG002|Overall Study|Withdrawal by Subject|0|||
105352797|NCT00938587|363295684|FG003|Overall Study|Withdrawal by Subject|0|||
105352798|NCT02191046|363295685|FG000|Overall Study|low compliance|5|||
105352799|NCT02191046|363295686|FG001|Overall Study|low compliance|1|||
105718690|NCT02000622|364628763|FG001|Overall Study|Withdrawn due to site closure|0|||
105718691|NCT02162862|364628764|FG000|Overall Study|Lost to Follow-up|0|||
105718692|NCT02162862|364628765|FG001|Overall Study|Lost to Follow-up|11|||
105352800|NCT04527978|363295692|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
105352801|NCT04527978|363295693|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
105718693|NCT02162862|364628766|FG002|Overall Study|Lost to Follow-up|0|||
105718694|NCT02162862|364628764|FG000|Overall Study|Subject did not feel the med was needed|0|||
105718695|NCT02162862|364628765|FG001|Overall Study|Subject did not feel the med was needed|0|||
105791118|NCT02118896|364890527|FG009|Overall Study|Non-compliance|0|||
105352802|NCT01578499|363295694|FG000|Overall Study|Reason not Specified|0|||
105352803|NCT01578499|363295695|FG001|Overall Study|Reason not Specified|1|||
105352804|NCT01578499|363295694|FG000|Overall Study|Lost to Follow-up|2|||
105352805|NCT01578499|363295695|FG001|Overall Study|Lost to Follow-up|1|||
105352806|NCT01578499|363295694|FG000|Overall Study|Withdrawal by Subject|10|||
105718696|NCT02162862|364628766|FG002|Overall Study|Subject did not feel the med was needed|4|||
105791119|NCT02118896|364890518|FG000|Overall Study|Pregnancy|1|||
105718697|NCT05195528|364628767|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
105718698|NCT05195528|364628768|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
105718699|NCT05195528|364628769|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
105718700|NCT05195528|364628770|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
105718701|NCT05195528|364628771|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
105718702|NCT05195528|364628767|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
105718703|NCT05195528|364628768|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
105718704|NCT05195528|364628769|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
105718705|NCT05195528|364628770|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
105718706|NCT05195528|364628771|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
105718707|NCT05195528|364628767|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
105718708|NCT05195528|364628768|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
105718709|NCT05195528|364628769|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
105718710|NCT05195528|364628770|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
105718711|NCT05195528|364628771|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
105718712|NCT05195528|364628767|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
105718713|NCT05195528|364628768|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
105718714|NCT05195528|364628769|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
105718715|NCT05195528|364628770|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
105718716|NCT05195528|364628771|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
105718717|NCT05195528|364628767|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
105718718|NCT05195528|364628768|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
105718719|NCT05195528|364628769|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
105718720|NCT05195528|364628770|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
105718721|NCT05195528|364628771|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
105718722|NCT05195528|364628767|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
105718723|NCT05195528|364628768|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
105718724|NCT05195528|364628769|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
105718725|NCT05195528|364628770|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
105718726|NCT05195528|364628771|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
105718727|NCT05195528|364628767|FG000|Placebo-controlled Treatment Period|Other|0|||
105718728|NCT05195528|364628768|FG001|Placebo-controlled Treatment Period|Other|0|||
105718729|NCT05195528|364628769|FG002|Placebo-controlled Treatment Period|Other|1|||
105718730|NCT05195528|364628770|FG003|Placebo-controlled Treatment Period|Other|0|||
105718731|NCT05195528|364628771|FG004|Placebo-controlled Treatment Period|Other|0|||
105718732|NCT05195528|364628767|FG000|Extension Period|PTE or AE or SAE|0|||
105718733|NCT05195528|364628768|FG001|Extension Period|PTE or AE or SAE|4|||
105718734|NCT05195528|364628769|FG002|Extension Period|PTE or AE or SAE|5|||
105718735|NCT05195528|364628770|FG003|Extension Period|PTE or AE or SAE|4|||
105718736|NCT05195528|364628771|FG004|Extension Period|PTE or AE or SAE|4|||
105718737|NCT05195528|364628767|FG000|Extension Period|Protocol Violation|0|||
105718738|NCT05195528|364628768|FG001|Extension Period|Protocol Violation|2|||
105718739|NCT05195528|364628769|FG002|Extension Period|Protocol Violation|1|||
105718740|NCT05195528|364628770|FG003|Extension Period|Protocol Violation|0|||
105718741|NCT05195528|364628771|FG004|Extension Period|Protocol Violation|1|||
105718742|NCT05195528|364628767|FG000|Extension Period|Lost to Follow-up|0|||
105718743|NCT05195528|364628768|FG001|Extension Period|Lost to Follow-up|6|||
105718744|NCT05195528|364628769|FG002|Extension Period|Lost to Follow-up|13|||
105718745|NCT05195528|364628770|FG003|Extension Period|Lost to Follow-up|3|||
105718746|NCT05195528|364628771|FG004|Extension Period|Lost to Follow-up|7|||
105718747|NCT05195528|364628767|FG000|Extension Period|Withdrawal by Subject|0|||
105718748|NCT05195528|364628768|FG001|Extension Period|Withdrawal by Subject|12|||
105718749|NCT05195528|364628769|FG002|Extension Period|Withdrawal by Subject|9|||
105718750|NCT05195528|364628770|FG003|Extension Period|Withdrawal by Subject|6|||
105718751|NCT05195528|364628771|FG004|Extension Period|Withdrawal by Subject|5|||
105718752|NCT05195528|364628767|FG000|Extension Period|Lack of Efficacy|0|||
105718753|NCT05195528|364628768|FG001|Extension Period|Lack of Efficacy|3|||
105718754|NCT05195528|364628769|FG002|Extension Period|Lack of Efficacy|0|||
105718755|NCT05195528|364628770|FG003|Extension Period|Lack of Efficacy|0|||
105718756|NCT05195528|364628771|FG004|Extension Period|Lack of Efficacy|2|||
105352807|NCT01578499|363295695|FG001|Overall Study|Withdrawal by Subject|16|||
105352808|NCT01578499|363295694|FG000|Overall Study|Death|20|||
105352809|NCT01578499|363295695|FG001|Overall Study|Death|25|||
105352810|NCT01578499|363295694|FG000|Overall Study|Died and End of Study Page not Completed|2|||
105352811|NCT01578499|363295695|FG001|Overall Study|Died and End of Study Page not Completed|0|||
105352812|NCT02670382|363295696|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
105352813|NCT02670382|363295697|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
105352814|NCT00830518|363295698|FG000|Overall Study|Progressive Disease|18|||
105352815|NCT00830518|363295699|FG001|Overall Study|Progressive Disease|8|||
105352816|NCT00830518|363295698|FG000|Overall Study|Symptomatic Deterioration|4|||
105352817|NCT00830518|363295699|FG001|Overall Study|Symptomatic Deterioration|1|||
105352818|NCT00830518|363295698|FG000|Overall Study|Adverse Event|14|||
105352819|NCT00830518|363295699|FG001|Overall Study|Adverse Event|1|||
105352820|NCT00830518|363295698|FG000|Overall Study|Withdrawal by Patient|2|||
105352821|NCT00830518|363295699|FG001|Overall Study|Withdrawal by Patient|0|||
105352822|NCT00830518|363295698|FG000|Overall Study|Reason not Specified|8|||
105718757|NCT05195528|364628767|FG000|Extension Period|Not Treated|0|||
105791120|NCT02118896|364890519|FG001|Overall Study|Pregnancy|1|||
105791121|NCT02118896|364890520|FG002|Overall Study|Pregnancy|0|||
105791122|NCT02118896|364890521|FG003|Overall Study|Pregnancy|0|||
105791123|NCT02118896|364890522|FG004|Overall Study|Pregnancy|1|||
105791124|NCT02118896|364890523|FG005|Overall Study|Pregnancy|3|||
105791125|NCT02118896|364890524|FG006|Overall Study|Pregnancy|1|||
105791126|NCT02118896|364890525|FG007|Overall Study|Pregnancy|0|||
105791127|NCT02118896|364890526|FG008|Overall Study|Pregnancy|0|||
105791128|NCT02118896|364890527|FG009|Overall Study|Pregnancy|0|||
105791129|NCT02118896|364890518|FG000|Overall Study|Lost to Follow-up|1|||
105791130|NCT02118896|364890519|FG001|Overall Study|Lost to Follow-up|2|||
105791131|NCT02118896|364890520|FG002|Overall Study|Lost to Follow-up|1|||
105791132|NCT02118896|364890521|FG003|Overall Study|Lost to Follow-up|0|||
105791133|NCT02118896|364890522|FG004|Overall Study|Lost to Follow-up|2|||
105791134|NCT02118896|364890523|FG005|Overall Study|Lost to Follow-up|1|||
105791135|NCT02118896|364890524|FG006|Overall Study|Lost to Follow-up|0|||
105791136|NCT02118896|364890525|FG007|Overall Study|Lost to Follow-up|0|||
105791137|NCT02118896|364890526|FG008|Overall Study|Lost to Follow-up|0|||
105791138|NCT02118896|364890527|FG009|Overall Study|Lost to Follow-up|0|||
105791139|NCT02118896|364890518|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
105791140|NCT02118896|364890519|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
105791141|NCT02118896|364890520|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
105791142|NCT02118896|364890521|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
105791143|NCT02118896|364890522|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
105791144|NCT02118896|364890523|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
105791145|NCT02118896|364890524|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
105718758|NCT05195528|364628768|FG001|Extension Period|Not Treated|0|||
105718759|NCT05195528|364628769|FG002|Extension Period|Not Treated|2|||
105718760|NCT05195528|364628770|FG003|Extension Period|Not Treated|3|||
105718761|NCT05195528|364628771|FG004|Extension Period|Not Treated|0|||
105718762|NCT05195528|364628767|FG000|Extension Period|Other|0|||
105718763|NCT05195528|364628768|FG001|Extension Period|Other|1|||
105718764|NCT05195528|364628769|FG002|Extension Period|Other|1|||
105718765|NCT05195528|364628770|FG003|Extension Period|Other|0|||
105718766|NCT05195528|364628771|FG004|Extension Period|Other|0|||
105718767|NCT00950170|364628772|FG000|Overall Study|Parent/Legal Guardian Request|1|||
105718768|NCT00950170|364628772|FG000|Overall Study|Adverse Event|2|||
105718769|NCT00950170|364628772|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
105718770|NCT02367521|364628775|FG000|Overall Study|severe headache after intervention|2|||
105718771|NCT02367521|364628776|FG001|Overall Study|severe headache after intervention|0|||
105718772|NCT02367521|364628775|FG000|Overall Study|unable to find transportation|2|||
105718773|NCT02367521|364628776|FG001|Overall Study|unable to find transportation|0|||
105718774|NCT00430755|364628779|FG000|Overall Study|Withdrawal by Subject|53|||
105718775|NCT03575104|364628782|FG000|Overall Study|Adverse Event|4|||
105791146|NCT02118896|364890525|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
105791147|NCT02118896|364890526|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
105791148|NCT02118896|364890527|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
105352823|NCT00830518|363295699|FG001|Overall Study|Reason not Specified|1|||
105718776|NCT03575104|364628783|FG001|Overall Study|Adverse Event|3|||
105718777|NCT03575104|364628784|FG002|Overall Study|Adverse Event|4|||
105718778|NCT03575104|364628782|FG000|Overall Study|Withdrawal by Subject|13|||
105718779|NCT03575104|364628783|FG001|Overall Study|Withdrawal by Subject|16|||
105718780|NCT03575104|364628784|FG002|Overall Study|Withdrawal by Subject|11|||
105718781|NCT03575104|364628782|FG000|Overall Study|Other reasons|6|||
105718782|NCT03575104|364628783|FG001|Overall Study|Other reasons|8|||
105718783|NCT03575104|364628784|FG002|Overall Study|Other reasons|6|||
105718784|NCT03575104|364628782|FG000|Overall Study|Lost to Follow-up|1|||
105718785|NCT03575104|364628783|FG001|Overall Study|Lost to Follow-up|2|||
105718786|NCT03575104|364628784|FG002|Overall Study|Lost to Follow-up|1|||
105718787|NCT04684420|364628785|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105718788|NCT04684420|364628786|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105718789|NCT04684420|364628787|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
105718790|NCT04684420|364628788|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
105718791|NCT04684420|364628785|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
105718792|NCT04684420|364628786|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
105718793|NCT04684420|364628787|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
105718794|NCT04684420|364628788|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
105718795|NCT01279057|364628795|FG000|Overall Study|Adverse Event|1|||
105718796|NCT01279057|364628796|FG001|Overall Study|Adverse Event|0|||
105718797|NCT01279057|364628797|FG002|Overall Study|Adverse Event|1|||
105718798|NCT01279057|364628795|FG000|Overall Study|Insufficient therapeutic response|0|||
105718799|NCT01279057|364628796|FG001|Overall Study|Insufficient therapeutic response|0|||
105718800|NCT01279057|364628797|FG002|Overall Study|Insufficient therapeutic response|1|||
105718801|NCT01279057|364628795|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
105718802|NCT01279057|364628796|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
105718803|NCT01279057|364628797|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
105718804|NCT01279057|364628795|FG000|Overall Study|Withdrew consent|2|||
105718805|NCT01279057|364628796|FG001|Overall Study|Withdrew consent|0|||
105718806|NCT01279057|364628797|FG002|Overall Study|Withdrew consent|1|||
105718807|NCT01279057|364628795|FG000|Overall Study|Pregnancy|0|||
105718808|NCT01279057|364628796|FG001|Overall Study|Pregnancy|1|||
105718809|NCT01279057|364628797|FG002|Overall Study|Pregnancy|0|||
105718810|NCT01279057|364628795|FG000|Overall Study|Other|3|||
105718811|NCT01279057|364628796|FG001|Overall Study|Other|3|||
105718812|NCT01279057|364628797|FG002|Overall Study|Other|0|||
105718813|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
105718814|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
105718815|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
105718816|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
105718817|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
105718818|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
105718819|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
105718820|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
105718821|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
105718822|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
105718823|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
105718824|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
105718825|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
105718826|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
105718827|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
105718828|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
105718829|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
105718830|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
105718831|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
105718832|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
105718833|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
105718834|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
105718835|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
105718836|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
105718837|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
105718838|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
105718839|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
105718840|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
105561879|NCT02342886|364052241|FG002|Overall Study|Pregnancy|2|||
105718841|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
105718842|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
105718843|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
105718844|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
105718845|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
105791149|NCT02118896|364890518|FG000|Overall Study|Prohibited medication|0|||
105718846|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
105477802|NCT01325337|363761373|FG003|Overall Study|Personal Reasons|8|||
105477803|NCT01325337|363761374|FG004|Overall Study|Personal Reasons|3|||
105477804|NCT01325337|363761370|FG000|Overall Study|Withdrawal by Subject|1|||
105477805|NCT01325337|363761371|FG001|Overall Study|Withdrawal by Subject|0|||
105477806|NCT01325337|363761372|FG002|Overall Study|Withdrawal by Subject|1|||
105477807|NCT01325337|363761373|FG003|Overall Study|Withdrawal by Subject|0|||
105477808|NCT01325337|363761374|FG004|Overall Study|Withdrawal by Subject|1|||
105477809|NCT01106092|363761375|FG000|Overall Study|Withdrawal by Subject|0|||
105477810|NCT01106092|363761376|FG001|Overall Study|Withdrawal by Subject|0|||
105477811|NCT01106092|363761377|FG002|Overall Study|Withdrawal by Subject|0|||
105477812|NCT01106092|363761378|FG003|Overall Study|Withdrawal by Subject|1|||
105477813|NCT00220779|363761389|FG000|Overall Study|Adverse Event|1|||
105477814|NCT00220779|363761390|FG001|Overall Study|Adverse Event|0|||
105791150|NCT02118896|364890519|FG001|Overall Study|Prohibited medication|0|||
105791151|NCT02118896|364890520|FG002|Overall Study|Prohibited medication|0|||
105791152|NCT02118896|364890521|FG003|Overall Study|Prohibited medication|0|||
105791153|NCT02118896|364890522|FG004|Overall Study|Prohibited medication|1|||
105791154|NCT02118896|364890523|FG005|Overall Study|Prohibited medication|3|||
105791155|NCT02118896|364890524|FG006|Overall Study|Prohibited medication|0|||
105791156|NCT02118896|364890525|FG007|Overall Study|Prohibited medication|0|||
105791157|NCT02118896|364890526|FG008|Overall Study|Prohibited medication|0|||
105791158|NCT02118896|364890527|FG009|Overall Study|Prohibited medication|0|||
105477815|NCT00220779|363761391|FG002|Overall Study|Adverse Event|0|||
105477816|NCT00220779|363761389|FG000|Overall Study|Withdrawal by Subject|1|||
105477817|NCT00220779|363761390|FG001|Overall Study|Withdrawal by Subject|4|||
105477818|NCT00220779|363761391|FG002|Overall Study|Withdrawal by Subject|1|||
105477819|NCT00220779|363761389|FG000|Overall Study|Non-compliance|1|||
105477820|NCT00220779|363761390|FG001|Overall Study|Non-compliance|0|||
105477821|NCT00220779|363761391|FG002|Overall Study|Non-compliance|0|||
105477822|NCT00220779|363761389|FG000|Overall Study|Too time consuming|1|||
105477823|NCT00220779|363761390|FG001|Overall Study|Too time consuming|0|||
105477824|NCT00220779|363761391|FG002|Overall Study|Too time consuming|0|||
105477825|NCT00220779|363761389|FG000|Overall Study|Pregnancy|0|||
105477826|NCT00220779|363761390|FG001|Overall Study|Pregnancy|0|||
105477827|NCT00220779|363761391|FG002|Overall Study|Pregnancy|2|||
105477828|NCT00220779|363761389|FG000|Overall Study|Lack of Efficacy|3|||
105477829|NCT00220779|363761390|FG001|Overall Study|Lack of Efficacy|0|||
105791159|NCT02118896|364890518|FG000|Overall Study|Miscellaneous|1|||
105791160|NCT02118896|364890519|FG001|Overall Study|Miscellaneous|2|||
105791161|NCT02118896|364890520|FG002|Overall Study|Miscellaneous|0|||
105791162|NCT02118896|364890521|FG003|Overall Study|Miscellaneous|2|||
105791163|NCT02118896|364890522|FG004|Overall Study|Miscellaneous|0|||
105791164|NCT02118896|364890523|FG005|Overall Study|Miscellaneous|4|||
105791165|NCT02118896|364890524|FG006|Overall Study|Miscellaneous|0|||
105791166|NCT02118896|364890525|FG007|Overall Study|Miscellaneous|0|||
105477830|NCT00220779|363761391|FG002|Overall Study|Lack of Efficacy|1|||
105477831|NCT03390101|363761392|FG000|Weeks 0-12|Withdrawal by Subject|0|||
105477832|NCT03390101|363761393|FG001|Weeks 0-12|Withdrawal by Subject|1|||
105477833|NCT03390101|363761394|FG002|Weeks 0-12|Withdrawal by Subject|1|||
105477834|NCT03390101|363761392|FG000|Weeks 0-12|Lost to Follow-up|0|||
105477835|NCT03390101|363761393|FG001|Weeks 0-12|Lost to Follow-up|1|||
105477836|NCT03390101|363761394|FG002|Weeks 0-12|Lost to Follow-up|0|||
105477837|NCT03390101|363761392|FG000|Weeks 12-54|Withdrawal by Subject|0|||
105791167|NCT02118896|364890526|FG008|Overall Study|Miscellaneous|0|||
105791168|NCT02118896|364890527|FG009|Overall Study|Miscellaneous|0|||
105718847|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
105718848|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
105718849|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
105718850|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
105718851|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
105718852|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
105718853|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
105718854|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
105718855|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
105718856|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
105718857|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
105791169|NCT04221373|364890535|FG000|Overall Study|Physician Decision|4|||
105791170|NCT04221373|364890536|FG001|Overall Study|Physician Decision|0|||
105791171|NCT05102162|364890542|FG000|Overall Study|Withdrawal by Subject|3|||
105791172|NCT05102162|364890543|FG001|Overall Study|Withdrawal by Subject|0|||
105791173|NCT05102162|364890542|FG000|Overall Study|Baseline cultures negative|4|||
105791174|NCT05102162|364890543|FG001|Overall Study|Baseline cultures negative|2|||
105791175|NCT05102162|364890542|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
105791176|NCT05102162|364890543|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
105791177|NCT05102162|364890542|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
105791178|NCT05102162|364890543|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
105791179|NCT00572910|364890546|FG000|Overall Study|Adverse Event|1|||
105791180|NCT00572910|364890547|FG001|Overall Study|Adverse Event|2|||
105791181|NCT00572910|364890548|FG002|Overall Study|Adverse Event|0|||
105791182|NCT00572910|364890549|FG003|Overall Study|Adverse Event|2|||
105791183|NCT00572910|364890550|FG004|Overall Study|Adverse Event|0|||
105791184|NCT00572910|364890551|FG005|Overall Study|Adverse Event|0|||
105791185|NCT00572910|364890552|FG006|Overall Study|Adverse Event|4|||
105791186|NCT00572910|364890553|FG007|Overall Study|Adverse Event|2|||
105791187|NCT00572910|364890554|FG008|Overall Study|Adverse Event|1|||
105791188|NCT00572910|364890555|FG009|Overall Study|Adverse Event|3|||
105791189|NCT00572910|364890556|FG010|Overall Study|Adverse Event|2|||
105791190|NCT00572910|364890546|FG000|Overall Study|Lost to Follow-up|0|||
105791191|NCT00572910|364890547|FG001|Overall Study|Lost to Follow-up|1|||
105791192|NCT00572910|364890548|FG002|Overall Study|Lost to Follow-up|1|||
105791193|NCT00572910|364890549|FG003|Overall Study|Lost to Follow-up|2|||
105791194|NCT00572910|364890550|FG004|Overall Study|Lost to Follow-up|1|||
105791195|NCT00572910|364890551|FG005|Overall Study|Lost to Follow-up|0|||
105791196|NCT00572910|364890552|FG006|Overall Study|Lost to Follow-up|0|||
105791197|NCT00572910|364890553|FG007|Overall Study|Lost to Follow-up|0|||
105791198|NCT00572910|364890554|FG008|Overall Study|Lost to Follow-up|0|||
105791199|NCT00572910|364890555|FG009|Overall Study|Lost to Follow-up|1|||
105791200|NCT00572910|364890556|FG010|Overall Study|Lost to Follow-up|0|||
105791201|NCT00572910|364890546|FG000|Overall Study|Withdrawal by Subject|3|||
105791202|NCT00572910|364890547|FG001|Overall Study|Withdrawal by Subject|0|||
105791203|NCT00572910|364890548|FG002|Overall Study|Withdrawal by Subject|1|||
105791204|NCT00572910|364890549|FG003|Overall Study|Withdrawal by Subject|0|||
105791205|NCT00572910|364890550|FG004|Overall Study|Withdrawal by Subject|1|||
105791206|NCT00572910|364890551|FG005|Overall Study|Withdrawal by Subject|3|||
105791207|NCT00572910|364890552|FG006|Overall Study|Withdrawal by Subject|0|||
105791208|NCT00572910|364890553|FG007|Overall Study|Withdrawal by Subject|2|||
105791209|NCT00572910|364890554|FG008|Overall Study|Withdrawal by Subject|2|||
105791210|NCT00572910|364890555|FG009|Overall Study|Withdrawal by Subject|2|||
105791211|NCT00572910|364890556|FG010|Overall Study|Withdrawal by Subject|1|||
105791212|NCT00669110|364890557|FG000|Overall Study|Adverse Event|4|||
105791213|NCT00669110|364890558|FG001|Overall Study|Adverse Event|3|||
105477838|NCT03390101|363761393|FG001|Weeks 12-54|Withdrawal by Subject|3|||
105477839|NCT03390101|363761394|FG002|Weeks 12-54|Withdrawal by Subject|1|||
105477840|NCT03390101|363761392|FG000|Weeks 12-54|Pregnancy|1|||
105477841|NCT03390101|363761393|FG001|Weeks 12-54|Pregnancy|0|||
105718858|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
105718859|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
105791214|NCT00669110|364890557|FG000|Overall Study|Caregiver request|3|||
105791215|NCT00669110|364890558|FG001|Overall Study|Caregiver request|2|||
105791216|NCT00669110|364890557|FG000|Overall Study|Physician Decision|0|||
105791217|NCT00669110|364890558|FG001|Overall Study|Physician Decision|1|||
105718860|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
105718861|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
105791218|NCT00669110|364890557|FG000|Overall Study|Lost to Follow-up|1|||
105791219|NCT00669110|364890558|FG001|Overall Study|Lost to Follow-up|0|||
105477842|NCT03390101|363761394|FG002|Weeks 12-54|Pregnancy|0|||
105791220|NCT00669110|364890557|FG000|Overall Study|Protocol Violation|0|||
105791221|NCT00669110|364890558|FG001|Overall Study|Protocol Violation|5|||
105791222|NCT00669110|364890557|FG000|Overall Study|Withdrawal by Subject|0|||
105791223|NCT00669110|364890558|FG001|Overall Study|Withdrawal by Subject|2|||
105791224|NCT00127192|364890559|FG000|Overall Study|Adverse Event|0|||
105791225|NCT00127192|364890560|FG001|Overall Study|Adverse Event|1|||
105791226|NCT00127192|364890561|FG002|Overall Study|Adverse Event|1|||
105791227|NCT00127192|364890562|FG003|Overall Study|Adverse Event|1|||
105791228|NCT00127192|364890563|FG004|Overall Study|Adverse Event|0|||
105791229|NCT00127192|364890559|FG000|Overall Study|Lack of Efficacy|2|||
105791230|NCT00127192|364890560|FG001|Overall Study|Lack of Efficacy|0|||
105791231|NCT00127192|364890561|FG002|Overall Study|Lack of Efficacy|0|||
105791232|NCT00127192|364890562|FG003|Overall Study|Lack of Efficacy|0|||
105791233|NCT00127192|364890563|FG004|Overall Study|Lack of Efficacy|2|||
105791234|NCT00127192|364890559|FG000|Overall Study|Withdrawal by Subject|0|||
105791235|NCT00127192|364890560|FG001|Overall Study|Withdrawal by Subject|0|||
105791236|NCT00127192|364890561|FG002|Overall Study|Withdrawal by Subject|1|||
105791237|NCT00127192|364890562|FG003|Overall Study|Withdrawal by Subject|0|||
105791238|NCT00127192|364890563|FG004|Overall Study|Withdrawal by Subject|3|||
105791239|NCT00127192|364890559|FG000|Overall Study|Adverse event in pre-treatment period|1|||
105791240|NCT00127192|364890560|FG001|Overall Study|Adverse event in pre-treatment period|0|||
105791241|NCT00127192|364890561|FG002|Overall Study|Adverse event in pre-treatment period|0|||
105791242|NCT00127192|364890562|FG003|Overall Study|Adverse event in pre-treatment period|0|||
105791243|NCT00127192|364890563|FG004|Overall Study|Adverse event in pre-treatment period|0|||
105791244|NCT01870921|364890565|FG000|Overall Study|Subject decision|80|||
105791245|NCT01870921|364890565|FG000|Overall Study|Severe non-compliance to protocol|7|||
105791246|NCT01870921|364890565|FG000|Overall Study|Subject Lost to Follow up|2|||
105791247|NCT01870921|364890565|FG000|Overall Study|Other|1|||
105791248|NCT03359473|364890568|FG000|Overall Study|Adverse Event|0|||
105791249|NCT03359473|364890569|FG001|Overall Study|Adverse Event|2|||
105791250|NCT03359473|364890570|FG002|Overall Study|Adverse Event|5|||
105791251|NCT03359473|364890571|FG003|Overall Study|Adverse Event|3|||
105791252|NCT03359473|364890568|FG000|Overall Study|Lost to Follow-up|0|||
105791253|NCT03359473|364890569|FG001|Overall Study|Lost to Follow-up|1|||
105791254|NCT03359473|364890570|FG002|Overall Study|Lost to Follow-up|0|||
105791255|NCT03359473|364890571|FG003|Overall Study|Lost to Follow-up|0|||
105791256|NCT03359473|364890568|FG000|Overall Study|Physician Decision|0|||
105791257|NCT03359473|364890569|FG001|Overall Study|Physician Decision|1|||
105791258|NCT03359473|364890570|FG002|Overall Study|Physician Decision|0|||
105791259|NCT03359473|364890571|FG003|Overall Study|Physician Decision|1|||
105791260|NCT03359473|364890568|FG000|Overall Study|Withdrawal by Subject|1|||
105791261|NCT03359473|364890569|FG001|Overall Study|Withdrawal by Subject|2|||
105791262|NCT03359473|364890570|FG002|Overall Study|Withdrawal by Subject|1|||
105791263|NCT03359473|364890571|FG003|Overall Study|Withdrawal by Subject|0|||
105791264|NCT03359473|364890568|FG000|Overall Study|Protocol-defined stopping criteria|1|||
105791265|NCT03359473|364890569|FG001|Overall Study|Protocol-defined stopping criteria|0|||
105791266|NCT03359473|364890570|FG002|Overall Study|Protocol-defined stopping criteria|0|||
105791267|NCT03359473|364890571|FG003|Overall Study|Protocol-defined stopping criteria|1|||
105791268|NCT01125358|364890572|FG000|Overall Study|Adverse Event|3|||
105791269|NCT01125358|364890573|FG001|Overall Study|Adverse Event|0|||
105791270|NCT01125358|364890574|FG002|Overall Study|Adverse Event|0|||
105791271|NCT01125358|364890575|FG003|Overall Study|Adverse Event|2|||
105791272|NCT01125358|364890572|FG000|Overall Study|Perceived Lack of Efficacy|6|||
105791273|NCT01125358|364890573|FG001|Overall Study|Perceived Lack of Efficacy|3|||
105791274|NCT01125358|364890574|FG002|Overall Study|Perceived Lack of Efficacy|7|||
105791275|NCT01125358|364890575|FG003|Overall Study|Perceived Lack of Efficacy|4|||
105791276|NCT01125358|364890572|FG000|Overall Study|Protocol Violation|1|||
105791277|NCT01125358|364890573|FG001|Overall Study|Protocol Violation|0|||
105791278|NCT01125358|364890574|FG002|Overall Study|Protocol Violation|0|||
105791279|NCT01125358|364890575|FG003|Overall Study|Protocol Violation|0|||
105791280|NCT01125358|364890572|FG000|Overall Study|Sponsor Decision|0|||
105791281|NCT01125358|364890573|FG001|Overall Study|Sponsor Decision|0|||
105791282|NCT01125358|364890574|FG002|Overall Study|Sponsor Decision|1|||
105791283|NCT01125358|364890575|FG003|Overall Study|Sponsor Decision|1|||
105791284|NCT01125358|364890572|FG000|Overall Study|Withdrawal by Subject|2|||
105791285|NCT01125358|364890573|FG001|Overall Study|Withdrawal by Subject|1|||
105791286|NCT01125358|364890574|FG002|Overall Study|Withdrawal by Subject|1|||
105791287|NCT01125358|364890575|FG003|Overall Study|Withdrawal by Subject|1|||
105791288|NCT00742859|364890576|FG000|Overall Study|Adverse Event|5|||
105791289|NCT00742859|364890577|FG001|Overall Study|Adverse Event|6|||
105791290|NCT00742859|364890578|FG002|Overall Study|Adverse Event|3|||
105791291|NCT00742859|364890579|FG003|Overall Study|Adverse Event|1|||
105791292|NCT00742859|364890576|FG000|Overall Study|Death|1|||
105791293|NCT00742859|364890577|FG001|Overall Study|Death|0|||
105791294|NCT00742859|364890578|FG002|Overall Study|Death|0|||
105791295|NCT00742859|364890579|FG003|Overall Study|Death|1|||
105791296|NCT00742859|364890576|FG000|Overall Study|Physician Decision|1|||
105791297|NCT00742859|364890577|FG001|Overall Study|Physician Decision|2|||
105791298|NCT00742859|364890578|FG002|Overall Study|Physician Decision|0|||
105791299|NCT00742859|364890579|FG003|Overall Study|Physician Decision|0|||
105791300|NCT00742859|364890576|FG000|Overall Study|Withdrawal by Subject|4|||
105791301|NCT00742859|364890577|FG001|Overall Study|Withdrawal by Subject|2|||
105791302|NCT00742859|364890578|FG002|Overall Study|Withdrawal by Subject|4|||
105791303|NCT00742859|364890579|FG003|Overall Study|Withdrawal by Subject|1|||
105352824|NCT01215435|363295703|FG000|Overall Study|Adverse Event|1|||
105352825|NCT01215435|363295704|FG001|Overall Study|Adverse Event|0|||
105477843|NCT03390101|363761392|FG000|Weeks 12-54|Adverse Event|2|||
105477844|NCT03390101|363761393|FG001|Weeks 12-54|Adverse Event|1|||
105477845|NCT03390101|363761394|FG002|Weeks 12-54|Adverse Event|1|||
105477846|NCT01511055|363761395|FG000|Overall Study|Withdrawal by Subject|6|||
105718862|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
105718863|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
105477847|NCT02052414|363761399|FG000|Overall Study|Adverse Event|12|||
105477848|NCT02052414|363761399|FG000|Overall Study|Lack of Efficacy|2|||
105718864|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
105477849|NCT02052414|363761399|FG000|Overall Study|Withdrawal by Subject|3|||
105477850|NCT02151773|363761400|FG000|Overall Study|Protocol Deviation|64|||
105791304|NCT00742859|364890576|FG000|Overall Study|Endpoint|0|||
105791305|NCT00742859|364890577|FG001|Overall Study|Endpoint|1|||
105791306|NCT00742859|364890578|FG002|Overall Study|Endpoint|1|||
105791307|NCT00742859|364890579|FG003|Overall Study|Endpoint|2|||
105791308|NCT00742859|364890576|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
105791309|NCT00742859|364890577|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
105791310|NCT00742859|364890578|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
105791311|NCT00742859|364890579|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
105791312|NCT00742859|364890576|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
105791313|NCT00742859|364890577|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
105791314|NCT00742859|364890578|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
105791315|NCT00742859|364890579|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
105791316|NCT00742859|364890576|FG000|Overall Study|Sponsor request patient out of town|0|||
105791317|NCT00742859|364890577|FG001|Overall Study|Sponsor request patient out of town|0|||
105791318|NCT00742859|364890578|FG002|Overall Study|Sponsor request patient out of town|1|||
105791319|NCT00742859|364890579|FG003|Overall Study|Sponsor request patient out of town|1|||
105791320|NCT00742859|364890576|FG000|Overall Study|Site error|0|||
105791321|NCT00742859|364890577|FG001|Overall Study|Site error|0|||
105791322|NCT00742859|364890578|FG002|Overall Study|Site error|1|||
105791323|NCT00742859|364890579|FG003|Overall Study|Site error|1|||
105791324|NCT03409328|364890585|FG000|Overall Study|Lost to Follow-up|6|||
105791325|NCT03409328|364890586|FG001|Overall Study|Lost to Follow-up|3|||
105791326|NCT01306968|364890587|FG000|Overall Study|Lost to Follow-up|1|||
105791327|NCT01306968|364890588|FG001|Overall Study|Lost to Follow-up|1|||
105791328|NCT01306968|364890589|FG002|Overall Study|Lost to Follow-up|0|||
105791329|NCT01306968|364890590|FG003|Overall Study|Lost to Follow-up|0|||
105791330|NCT01306968|364890587|FG000|Overall Study|Physician Decision|0|||
105791331|NCT01306968|364890588|FG001|Overall Study|Physician Decision|1|||
105791332|NCT01306968|364890589|FG002|Overall Study|Physician Decision|0|||
105791333|NCT01306968|364890590|FG003|Overall Study|Physician Decision|0|||
105791334|NCT01306968|364890587|FG000|Overall Study|Relocated and left active duty|0|||
105791335|NCT01306968|364890588|FG001|Overall Study|Relocated and left active duty|1|||
105791336|NCT01306968|364890589|FG002|Overall Study|Relocated and left active duty|1|||
105791337|NCT01306968|364890590|FG003|Overall Study|Relocated and left active duty|1|||
105791338|NCT01306968|364890587|FG000|Overall Study|Withdrew - time commitment|0|||
105791339|NCT01306968|364890588|FG001|Overall Study|Withdrew - time commitment|0|||
105791340|NCT01306968|364890589|FG002|Overall Study|Withdrew - time commitment|0|||
105791341|NCT01306968|364890590|FG003|Overall Study|Withdrew - time commitment|2|||
105791342|NCT01306968|364890587|FG000|Overall Study|Withdrew over privacy concerns|0|||
105791343|NCT01306968|364890588|FG001|Overall Study|Withdrew over privacy concerns|0|||
105791344|NCT01306968|364890589|FG002|Overall Study|Withdrew over privacy concerns|0|||
105791345|NCT01306968|364890590|FG003|Overall Study|Withdrew over privacy concerns|1|||
105791346|NCT03128931|364890591|FG000|Overall Study|Physician Decision|1|||
105791347|NCT03128931|364890591|FG000|Overall Study|Equipment Issues|3|||
105791348|NCT04993339|364890592|FG000|Overall Study|Lost to Follow-up|0|||
105791349|NCT04993339|364890593|FG001|Overall Study|Lost to Follow-up|1|||
105791350|NCT04993339|364890592|FG000|Overall Study|no MRI scan|3|||
105791351|NCT04993339|364890593|FG001|Overall Study|no MRI scan|1|||
105791352|NCT04798027|364890596|FG000|Overall Study|Protocol Violation|0|||
105791353|NCT04798027|364890597|FG001|Overall Study|Protocol Violation|0|||
105791354|NCT04798027|364890598|FG002|Overall Study|Protocol Violation|0|||
105791355|NCT04798027|364890599|FG003|Overall Study|Protocol Violation|0|||
105791356|NCT04798027|364890600|FG004|Overall Study|Protocol Violation|1|||
105791357|NCT04798027|364890601|FG005|Overall Study|Protocol Violation|0|||
105791358|NCT04798027|364890602|FG006|Overall Study|Protocol Violation|0|||
105791359|NCT04798027|364890603|FG007|Overall Study|Protocol Violation|1|||
105791360|NCT04798027|364890604|FG008|Overall Study|Protocol Violation|0|||
105791361|NCT04798027|364890596|FG000|Overall Study|Withdrawal by Subject|1|||
105791362|NCT04798027|364890597|FG001|Overall Study|Withdrawal by Subject|0|||
105791363|NCT04798027|364890598|FG002|Overall Study|Withdrawal by Subject|1|||
105791364|NCT04798027|364890599|FG003|Overall Study|Withdrawal by Subject|1|||
105791365|NCT04798027|364890600|FG004|Overall Study|Withdrawal by Subject|1|||
105791366|NCT04798027|364890601|FG005|Overall Study|Withdrawal by Subject|1|||
105791367|NCT04798027|364890602|FG006|Overall Study|Withdrawal by Subject|3|||
105791368|NCT04798027|364890603|FG007|Overall Study|Withdrawal by Subject|2|||
105477851|NCT00395343|363761401|FG000|Overall Study|Adverse Event|13|||
105477852|NCT00395343|363761402|FG001|Overall Study|Adverse Event|5|||
105477853|NCT00395343|363761401|FG000|Overall Study|Lack of Efficacy|0|||
105477854|NCT00395343|363761402|FG001|Overall Study|Lack of Efficacy|1|||
105477855|NCT00395343|363761401|FG000|Overall Study|Lost to Follow-up|4|||
105477856|NCT00395343|363761402|FG001|Overall Study|Lost to Follow-up|4|||
105477857|NCT00395343|363761401|FG000|Overall Study|Physician Decision|2|||
105477858|NCT00395343|363761402|FG001|Overall Study|Physician Decision|4|||
105477859|NCT00395343|363761401|FG000|Overall Study|Protocol Violation|6|||
105477860|NCT00395343|363761402|FG001|Overall Study|Protocol Violation|8|||
105477861|NCT00395343|363761401|FG000|Overall Study|Withdrawal by Subject|11|||
105477862|NCT00395343|363761402|FG001|Overall Study|Withdrawal by Subject|12|||
105477863|NCT00395343|363761401|FG000|Overall Study|Other|5|||
105718865|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
105718866|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
105718867|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
105718868|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
105718869|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
105718870|NCT04088409|364628801|FG000|Part A|Withdrawal by Subject|2|||
105718871|NCT04088409|364628802|FG001|Part A|Withdrawal by Subject|1|||
105718872|NCT04088409|364628801|FG000|Part A|Did Not Meet Randomization Criteria|2|||
105718873|NCT04088409|364628802|FG001|Part A|Did Not Meet Randomization Criteria|0|||
105718874|NCT04088409|364628801|FG000|Part A|Lack of Efficacy|9|||
105718875|NCT04088409|364628802|FG001|Part A|Lack of Efficacy|0|||
105718876|NCT04088409|364628801|FG000|Part A|Lost to Follow-up|1|||
105718877|NCT04088409|364628802|FG001|Part A|Lost to Follow-up|0|||
105718878|NCT04088409|364628801|FG000|Part A|Adverse Event|1|||
105718879|NCT04088409|364628802|FG001|Part A|Adverse Event|0|||
105718880|NCT04088409|364628801|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
105718881|NCT04088409|364628802|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
105718882|NCT04088409|364628801|FG000|Part B|Ongoing Treatment|10|||
105718883|NCT04088409|364628802|FG001|Part B|Ongoing Treatment|0|||
105718884|NCT00400400|364628803|FG000|Overall Study|Adverse Event|9|||
105718885|NCT00400400|364628804|FG001|Overall Study|Adverse Event|8|||
105718886|NCT00400400|364628803|FG000|Overall Study|Protocol Violation|2|||
105718887|NCT00400400|364628804|FG001|Overall Study|Protocol Violation|0|||
105718888|NCT00400400|364628803|FG000|Overall Study|Withdrawal by Subject|1|||
105718889|NCT00400400|364628804|FG001|Overall Study|Withdrawal by Subject|3|||
105718890|NCT00400400|364628803|FG000|Overall Study|Administrative Problem|1|||
105718891|NCT00400400|364628804|FG001|Overall Study|Administrative Problem|0|||
105718892|NCT00400400|364628803|FG000|Overall Study|Lost to Follow-up|0|||
105718893|NCT00400400|364628804|FG001|Overall Study|Lost to Follow-up|1|||
105718894|NCT00400400|364628803|FG000|Overall Study|Did not receive study drug|1|||
105718895|NCT00400400|364628804|FG001|Overall Study|Did not receive study drug|3|||
105718896|NCT04426695|364628805|FG000|Overall Study|Death|2|||
105718897|NCT04426695|364628806|FG001|Overall Study|Death|0|||
105718898|NCT04426695|364628807|FG002|Overall Study|Death|1|||
105477864|NCT00395343|363761402|FG001|Overall Study|Other|2|||
105718899|NCT04426695|364628808|FG003|Overall Study|Death|27|||
105718900|NCT04426695|364628809|FG004|Overall Study|Death|25|||
105718901|NCT04426695|364628810|FG005|Overall Study|Death|21|||
105718902|NCT04426695|364628811|FG006|Overall Study|Death|42|||
105718903|NCT04426695|364628812|FG007|Overall Study|Death|23|||
105718904|NCT04426695|364628813|FG008|Overall Study|Death|37|||
105718905|NCT04426695|364628814|FG009|Overall Study|Death|14|||
105718906|NCT04426695|364628815|FG010|Overall Study|Death|8|||
105718907|NCT04426695|364628816|FG011|Overall Study|Death|7|||
105352826|NCT01215435|363295703|FG000|Overall Study|Protocol Violation|2|||
105477865|NCT01463007|363761405|FG000|Overall Study|Physician Decision|1|||
105477866|NCT00615901|363761406|FG000|Overall Study|Withdrawal by Subject|2|||
105477867|NCT00615901|363761406|FG000|Overall Study|Adverse Event|7|||
105477868|NCT01250496|363761407|FG000|Overall Study|Study terminated|124|||
105718908|NCT04426695|364628817|FG012|Overall Study|Death|13|||
105718909|NCT04426695|364628818|FG013|Overall Study|Death|25|||
105718910|NCT04426695|364628819|FG014|Overall Study|Death|19|||
105718911|NCT04426695|364628820|FG015|Overall Study|Death|7|||
105718912|NCT04426695|364628821|FG016|Overall Study|Death|8|||
105718913|NCT04426695|364628822|FG017|Overall Study|Death|4|||
105718914|NCT04426695|364628805|FG000|Overall Study|Lost to Follow-up|2|||
105718915|NCT04426695|364628806|FG001|Overall Study|Lost to Follow-up|4|||
105718916|NCT04426695|364628807|FG002|Overall Study|Lost to Follow-up|1|||
105352827|NCT01215435|363295704|FG001|Overall Study|Protocol Violation|0|||
105718917|NCT04426695|364628808|FG003|Overall Study|Lost to Follow-up|19|||
105718918|NCT04426695|364628809|FG004|Overall Study|Lost to Follow-up|10|||
105718919|NCT04426695|364628810|FG005|Overall Study|Lost to Follow-up|14|||
105718920|NCT04426695|364628811|FG006|Overall Study|Lost to Follow-up|5|||
105718921|NCT04426695|364628812|FG007|Overall Study|Lost to Follow-up|14|||
105561880|NCT02342886|364052242|FG003|Overall Study|Pregnancy|0|||
105561881|NCT02342886|364052243|FG004|Overall Study|Pregnancy|0|||
105561882|NCT02342886|364052239|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
105561883|NCT02342886|364052240|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
105561884|NCT02342886|364052241|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
105561885|NCT02342886|364052242|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
105561886|NCT02342886|364052243|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
105561887|NCT02342886|364052239|FG000|Overall Study|Protocol Violation|0|||
105561888|NCT02342886|364052240|FG001|Overall Study|Protocol Violation|0|||
105561889|NCT02342886|364052241|FG002|Overall Study|Protocol Violation|0|||
105561890|NCT02342886|364052242|FG003|Overall Study|Protocol Violation|2|||
105561891|NCT02342886|364052243|FG004|Overall Study|Protocol Violation|0|||
105561892|NCT01328080|364052244|FG000|Overall Study|Lost to Follow-up|5|||
105561893|NCT00045305|364052245|FG000|Overall Study|Lack of Efficacy|6|||
105561894|NCT00045305|364052245|FG000|Overall Study|Adverse Event|3|||
105561895|NCT00045305|364052245|FG000|Overall Study|Death|3|||
105561896|NCT00045305|364052245|FG000|Overall Study|site error|2|||
105561897|NCT02216773|364052251|FG000|Overall Study|Disease progression|4|||
105718922|NCT04426695|364628813|FG008|Overall Study|Lost to Follow-up|10|||
105718923|NCT04426695|364628814|FG009|Overall Study|Lost to Follow-up|11|||
105718924|NCT04426695|364628815|FG010|Overall Study|Lost to Follow-up|12|||
105718925|NCT04426695|364628816|FG011|Overall Study|Lost to Follow-up|6|||
105718926|NCT04426695|364628817|FG012|Overall Study|Lost to Follow-up|2|||
105561898|NCT02216773|364052252|FG001|Overall Study|Disease progression|2|||
105561899|NCT02216773|364052251|FG000|Overall Study|Insufficient FLRV|4|||
105718927|NCT04426695|364628818|FG013|Overall Study|Lost to Follow-up|2|||
105718928|NCT04426695|364628819|FG014|Overall Study|Lost to Follow-up|2|||
105718929|NCT04426695|364628820|FG015|Overall Study|Lost to Follow-up|0|||
105718930|NCT04426695|364628821|FG016|Overall Study|Lost to Follow-up|0|||
105718931|NCT04426695|364628822|FG017|Overall Study|Lost to Follow-up|0|||
105718932|NCT04426695|364628805|FG000|Overall Study|Participant Decision|1|||
105718933|NCT04426695|364628806|FG001|Overall Study|Participant Decision|2|||
105718934|NCT04426695|364628807|FG002|Overall Study|Participant Decision|2|||
105718935|NCT04426695|364628808|FG003|Overall Study|Participant Decision|12|||
105718936|NCT04426695|364628809|FG004|Overall Study|Participant Decision|18|||
105718937|NCT04426695|364628810|FG005|Overall Study|Participant Decision|22|||
105718938|NCT04426695|364628811|FG006|Overall Study|Participant Decision|13|||
105718939|NCT04426695|364628812|FG007|Overall Study|Participant Decision|13|||
105718940|NCT04426695|364628813|FG008|Overall Study|Participant Decision|10|||
105718941|NCT04426695|364628814|FG009|Overall Study|Participant Decision|15|||
105718942|NCT04426695|364628815|FG010|Overall Study|Participant Decision|16|||
105718943|NCT04426695|364628816|FG011|Overall Study|Participant Decision|17|||
105718944|NCT04426695|364628817|FG012|Overall Study|Participant Decision|2|||
105718945|NCT04426695|364628818|FG013|Overall Study|Participant Decision|1|||
105718946|NCT04426695|364628819|FG014|Overall Study|Participant Decision|2|||
105718947|NCT04426695|364628820|FG015|Overall Study|Participant Decision|0|||
105718948|NCT04426695|364628821|FG016|Overall Study|Participant Decision|0|||
105718949|NCT04426695|364628822|FG017|Overall Study|Participant Decision|0|||
105718950|NCT04426695|364628805|FG000|Overall Study|Adverse Event|0|||
105718951|NCT04426695|364628806|FG001|Overall Study|Adverse Event|0|||
105718952|NCT04426695|364628807|FG002|Overall Study|Adverse Event|0|||
105718953|NCT04426695|364628808|FG003|Overall Study|Adverse Event|0|||
105718954|NCT04426695|364628809|FG004|Overall Study|Adverse Event|0|||
105718955|NCT04426695|364628810|FG005|Overall Study|Adverse Event|0|||
105718956|NCT04426695|364628811|FG006|Overall Study|Adverse Event|0|||
105718957|NCT04426695|364628812|FG007|Overall Study|Adverse Event|1|||
105718958|NCT04426695|364628813|FG008|Overall Study|Adverse Event|0|||
105718959|NCT04426695|364628814|FG009|Overall Study|Adverse Event|0|||
105718960|NCT04426695|364628815|FG010|Overall Study|Adverse Event|1|||
105718961|NCT04426695|364628816|FG011|Overall Study|Adverse Event|1|||
105718962|NCT04426695|364628817|FG012|Overall Study|Adverse Event|0|||
105718963|NCT04426695|364628818|FG013|Overall Study|Adverse Event|0|||
105718964|NCT04426695|364628819|FG014|Overall Study|Adverse Event|0|||
105718965|NCT04426695|364628820|FG015|Overall Study|Adverse Event|0|||
105718966|NCT04426695|364628821|FG016|Overall Study|Adverse Event|0|||
105718967|NCT04426695|364628822|FG017|Overall Study|Adverse Event|0|||
105718968|NCT04426695|364628805|FG000|Overall Study|Sponsor Request|0|||
105718969|NCT04426695|364628806|FG001|Overall Study|Sponsor Request|0|||
105718970|NCT04426695|364628807|FG002|Overall Study|Sponsor Request|0|||
105718971|NCT04426695|364628808|FG003|Overall Study|Sponsor Request|0|||
105718972|NCT04426695|364628809|FG004|Overall Study|Sponsor Request|0|||
105718973|NCT04426695|364628810|FG005|Overall Study|Sponsor Request|0|||
105718974|NCT04426695|364628811|FG006|Overall Study|Sponsor Request|1|||
105718975|NCT04426695|364628812|FG007|Overall Study|Sponsor Request|0|||
105718976|NCT04426695|364628813|FG008|Overall Study|Sponsor Request|0|||
105718977|NCT04426695|364628814|FG009|Overall Study|Sponsor Request|0|||
105718978|NCT04426695|364628815|FG010|Overall Study|Sponsor Request|0|||
105718979|NCT04426695|364628816|FG011|Overall Study|Sponsor Request|0|||
105718980|NCT04426695|364628817|FG012|Overall Study|Sponsor Request|0|||
105718981|NCT04426695|364628818|FG013|Overall Study|Sponsor Request|0|||
105718982|NCT04426695|364628819|FG014|Overall Study|Sponsor Request|0|||
105718983|NCT04426695|364628820|FG015|Overall Study|Sponsor Request|0|||
105718984|NCT04426695|364628821|FG016|Overall Study|Sponsor Request|0|||
105718985|NCT04426695|364628822|FG017|Overall Study|Sponsor Request|0|||
105718986|NCT04426695|364628805|FG000|Overall Study|Physician Decision|0|||
105718987|NCT04426695|364628806|FG001|Overall Study|Physician Decision|0|||
105718988|NCT04426695|364628807|FG002|Overall Study|Physician Decision|0|||
105718989|NCT04426695|364628808|FG003|Overall Study|Physician Decision|0|||
105718990|NCT04426695|364628809|FG004|Overall Study|Physician Decision|0|||
105718991|NCT04426695|364628810|FG005|Overall Study|Physician Decision|0|||
105718992|NCT04426695|364628811|FG006|Overall Study|Physician Decision|0|||
105718993|NCT04426695|364628812|FG007|Overall Study|Physician Decision|0|||
105718994|NCT04426695|364628813|FG008|Overall Study|Physician Decision|0|||
105718995|NCT04426695|364628814|FG009|Overall Study|Physician Decision|1|||
105718996|NCT04426695|364628815|FG010|Overall Study|Physician Decision|0|||
105718997|NCT04426695|364628816|FG011|Overall Study|Physician Decision|0|||
105718998|NCT04426695|364628817|FG012|Overall Study|Physician Decision|1|||
105718999|NCT04426695|364628818|FG013|Overall Study|Physician Decision|0|||
105719000|NCT04426695|364628819|FG014|Overall Study|Physician Decision|0|||
105719001|NCT04426695|364628820|FG015|Overall Study|Physician Decision|0|||
105719002|NCT04426695|364628821|FG016|Overall Study|Physician Decision|0|||
105719003|NCT04426695|364628822|FG017|Overall Study|Physician Decision|0|||
105719004|NCT04426695|364628805|FG000|Overall Study|Randomized but Never Treated|3|||
105719005|NCT04426695|364628806|FG001|Overall Study|Randomized but Never Treated|1|||
105561900|NCT02216773|364052252|FG001|Overall Study|Insufficient FLRV|0|||
105561901|NCT02216773|364052251|FG000|Overall Study|Abandoned|4|||
105561902|NCT02216773|364052252|FG001|Overall Study|Abandoned|3|||
105561903|NCT04274894|364052253|FG000|Overall Study|Adverse Event|7|||
105719006|NCT04426695|364628807|FG002|Overall Study|Randomized but Never Treated|0|||
105561904|NCT04274894|364052253|FG000|Overall Study|Withdrew consent|5|||
105561905|NCT04274894|364052253|FG000|Overall Study|Lost to Follow-up|9|||
105561906|NCT04274894|364052253|FG000|Overall Study|COVID-19 infection|1|||
105561907|NCT04274894|364052253|FG000|Overall Study|Other, not specified|20|||
105561908|NCT03649230|364052257|FG000|Overall Study|Adverse Event|12|||
105561909|NCT03649230|364052257|FG000|Overall Study|Death|8|||
105561910|NCT03649230|364052257|FG000|Overall Study|Withdrawal by Subject|6|||
105561911|NCT03649230|364052257|FG000|Overall Study|Physician Decision|5|||
105561912|NCT03649230|364052257|FG000|Overall Study|Disease progression|5|||
105561913|NCT03649230|364052257|FG000|Overall Study|Switched to non-HEC|5|||
105561914|NCT03649230|364052257|FG000|Overall Study|Chemotherapy discontinued|4|||
105561915|NCT03649230|364052257|FG000|Overall Study|Received only 3 HEC cycles|4|||
105561916|NCT03649230|364052257|FG000|Overall Study|Screen Failure|3|||
105561917|NCT03649230|364052257|FG000|Overall Study|Patient stopped treatment|2|||
105561918|NCT03649230|364052257|FG000|Overall Study|Protocol Violation|1|||
105561919|NCT03649230|364052257|FG000|Overall Study|Non-compliance|1|||
105561920|NCT03649230|364052257|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
105561921|NCT04510675|364052258|FG000|Overall Study|Withdrawal by Subject|5|||
105561922|NCT01563536|364052269|FG000|Overall Study|Withdrawal by Subject|0|||
105561923|NCT01563536|364052270|FG001|Overall Study|Withdrawal by Subject|2|||
105719007|NCT04426695|364628808|FG003|Overall Study|Randomized but Never Treated|4|||
105719008|NCT04426695|364628809|FG004|Overall Study|Randomized but Never Treated|5|||
105719009|NCT04426695|364628810|FG005|Overall Study|Randomized but Never Treated|5|||
105719010|NCT04426695|364628811|FG006|Overall Study|Randomized but Never Treated|4|||
105719011|NCT04426695|364628812|FG007|Overall Study|Randomized but Never Treated|6|||
105719012|NCT04426695|364628813|FG008|Overall Study|Randomized but Never Treated|6|||
105719013|NCT04426695|364628814|FG009|Overall Study|Randomized but Never Treated|3|||
105719014|NCT04426695|364628815|FG010|Overall Study|Randomized but Never Treated|3|||
105719015|NCT04426695|364628816|FG011|Overall Study|Randomized but Never Treated|6|||
105719016|NCT04426695|364628817|FG012|Overall Study|Randomized but Never Treated|1|||
105719017|NCT04426695|364628818|FG013|Overall Study|Randomized but Never Treated|2|||
105719018|NCT04426695|364628819|FG014|Overall Study|Randomized but Never Treated|0|||
105719019|NCT04426695|364628820|FG015|Overall Study|Randomized but Never Treated|0|||
105719020|NCT04426695|364628821|FG016|Overall Study|Randomized but Never Treated|0|||
105719021|NCT04426695|364628822|FG017|Overall Study|Randomized but Never Treated|0|||
105719022|NCT00675025|364628825|FG000|Overall Study|Study Terminated by Sponsor|38|||
105719023|NCT00675025|364628826|FG001|Overall Study|Study Terminated by Sponsor|42|||
105719024|NCT00675025|364628825|FG000|Overall Study|Adverse Event|6|||
105719025|NCT00675025|364628826|FG001|Overall Study|Adverse Event|11|||
105719026|NCT00675025|364628825|FG000|Overall Study|Lost to Follow-up|6|||
105719027|NCT00675025|364628826|FG001|Overall Study|Lost to Follow-up|4|||
105719028|NCT00675025|364628825|FG000|Overall Study|Withdrawal by Subject|4|||
105719029|NCT00675025|364628826|FG001|Overall Study|Withdrawal by Subject|6|||
105719030|NCT00441792|364628827|FG000|Overall Study|Lost to Follow-up|0|||
105719031|NCT00441792|364628828|FG001|Overall Study|Lost to Follow-up|2|||
105719032|NCT01731678|364628831|FG000|Overall Study|Withdrawal by Subject|3|||
105719033|NCT01731678|364628831|FG000|Overall Study|Did not meet inclusion criteria|1|||
105719034|NCT01731678|364628831|FG000|Overall Study|RMT too high, making TMS difficult|3|||
105719035|NCT00888355|364628832|FG000|Overall Study|Adverse Event|10|||
105719036|NCT00888355|364628833|FG001|Overall Study|Adverse Event|0|||
105719037|NCT00888355|364628834|FG002|Overall Study|Adverse Event|3|||
105719038|NCT00888355|364628835|FG003|Overall Study|Adverse Event|3|||
105719039|NCT00888355|364628832|FG000|Overall Study|Lack of Efficacy|9|||
105719040|NCT00888355|364628833|FG001|Overall Study|Lack of Efficacy|2|||
105719041|NCT00888355|364628834|FG002|Overall Study|Lack of Efficacy|5|||
105719042|NCT00888355|364628835|FG003|Overall Study|Lack of Efficacy|2|||
105719043|NCT00888355|364628832|FG000|Overall Study|Lost to Follow-up|0|||
105719044|NCT00888355|364628833|FG001|Overall Study|Lost to Follow-up|2|||
105719045|NCT00888355|364628834|FG002|Overall Study|Lost to Follow-up|2|||
105719046|NCT00888355|364628835|FG003|Overall Study|Lost to Follow-up|0|||
105719047|NCT00888355|364628832|FG000|Overall Study|Protocol Violation|3|||
105719048|NCT00888355|364628833|FG001|Overall Study|Protocol Violation|2|||
105561924|NCT01563536|364052269|FG000|Overall Study|Lost to Follow-up|1|||
105561925|NCT01563536|364052270|FG001|Overall Study|Lost to Follow-up|0|||
105561926|NCT01860703|364052272|FG000|Overall Study|Adverse Event|1|||
105561927|NCT01860703|364052273|FG001|Overall Study|Adverse Event|4|||
105561928|NCT01860703|364052274|FG002|Overall Study|Adverse Event|0|||
105719049|NCT00888355|364628834|FG002|Overall Study|Protocol Violation|1|||
105719050|NCT00888355|364628835|FG003|Overall Study|Protocol Violation|2|||
105719051|NCT00888355|364628832|FG000|Overall Study|Withdrawal by Subject|0|||
105561929|NCT01860703|364052275|FG003|Overall Study|Adverse Event|2|||
105561930|NCT01860703|364052272|FG000|Overall Study|Withdrawal by Subject|0|||
105791369|NCT04798027|364890604|FG008|Overall Study|Withdrawal by Subject|2|||
105791370|NCT04798027|364890596|FG000|Overall Study|Lost to Follow-up|1|||
105791371|NCT04798027|364890597|FG001|Overall Study|Lost to Follow-up|3|||
105477869|NCT01250496|363761408|FG001|Overall Study|Study terminated|124|||
105719052|NCT00888355|364628833|FG001|Overall Study|Withdrawal by Subject|3|||
105719053|NCT00888355|364628834|FG002|Overall Study|Withdrawal by Subject|1|||
105719054|NCT00888355|364628835|FG003|Overall Study|Withdrawal by Subject|3|||
105719055|NCT01573910|364628836|FG000|Overall Study|Adverse Event|4|||
105719056|NCT01573910|364628837|FG001|Overall Study|Adverse Event|4|||
105719057|NCT01573910|364628836|FG000|Overall Study|Lost to Follow-up|2|||
105719058|NCT01573910|364628837|FG001|Overall Study|Lost to Follow-up|1|||
105719059|NCT01573910|364628836|FG000|Overall Study|Withdrawal by Subject|0|||
105719060|NCT01573910|364628837|FG001|Overall Study|Withdrawal by Subject|1|||
105719061|NCT01573910|364628836|FG000|Overall Study|Protocol Violation|3|||
105719062|NCT01573910|364628837|FG001|Overall Study|Protocol Violation|0|||
105719063|NCT01573910|364628836|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
105719064|NCT01573910|364628837|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
105719065|NCT02251912|364628838|FG000|Overall Study|Withdrawal by Subject|2|||
105719066|NCT02251912|364628839|FG001|Overall Study|Withdrawal by Subject|3|||
105719067|NCT02251912|364628838|FG000|Overall Study|Adverse Event|0|||
105719068|NCT02251912|364628839|FG001|Overall Study|Adverse Event|2|||
105719069|NCT00364182|364628842|FG000|First Intervention|Secondary prophylaxis|1|||
105719070|NCT00364182|364628843|FG001|First Intervention|Secondary prophylaxis|0|||
105719071|NCT00364182|364628844|FG002|First Intervention|Secondary prophylaxis|0|||
105719072|NCT00364182|364628842|FG000|First Intervention|Withdrawal by Subject|2|||
105719073|NCT00364182|364628843|FG001|First Intervention|Withdrawal by Subject|0|||
105719074|NCT00364182|364628844|FG002|First Intervention|Withdrawal by Subject|0|||
105719075|NCT00364182|364628842|FG000|Second Intervention|non-compliance|0|||
105719076|NCT00364182|364628843|FG001|Second Intervention|non-compliance|1|||
105719077|NCT00364182|364628844|FG002|Second Intervention|non-compliance|1|||
105719078|NCT00364182|364628842|FG000|Second Intervention|Protocol Violation|0|||
105719079|NCT00364182|364628843|FG001|Second Intervention|Protocol Violation|1|||
105719080|NCT00364182|364628844|FG002|Second Intervention|Protocol Violation|0|||
105719081|NCT00364182|364628842|FG000|Second Intervention|Adverse Event|0|||
105719082|NCT00364182|364628843|FG001|Second Intervention|Adverse Event|0|||
105719083|NCT00364182|364628844|FG002|Second Intervention|Adverse Event|1|||
105719084|NCT00364182|364628842|FG000|Third Intervention|non-compliance|0|||
105719085|NCT00364182|364628843|FG001|Third Intervention|non-compliance|1|||
105719086|NCT00364182|364628844|FG002|Third Intervention|non-compliance|0|||
105719087|NCT00364182|364628842|FG000|Third Intervention|Lost to Follow-up|0|||
105719088|NCT00364182|364628843|FG001|Third Intervention|Lost to Follow-up|0|||
105719089|NCT00364182|364628844|FG002|Third Intervention|Lost to Follow-up|1|||
105719090|NCT02601573|364628848|FG000|Overall Study|Lost to Follow-up|0|||
105719091|NCT02601573|364628849|FG001|Overall Study|Lost to Follow-up|3|||
105719092|NCT02601573|364628850|FG002|Overall Study|Lost to Follow-up|1|||
105719093|NCT02601573|364628851|FG003|Overall Study|Lost to Follow-up|0|||
105719094|NCT02601573|364628852|FG004|Overall Study|Lost to Follow-up|2|||
105719095|NCT02601573|364628848|FG000|Overall Study|Withdrawal by Subject|0|||
105719096|NCT02601573|364628849|FG001|Overall Study|Withdrawal by Subject|1|||
105719097|NCT02601573|364628850|FG002|Overall Study|Withdrawal by Subject|0|||
105719098|NCT02601573|364628851|FG003|Overall Study|Withdrawal by Subject|1|||
105719099|NCT02601573|364628852|FG004|Overall Study|Withdrawal by Subject|0|||
105719100|NCT00712348|364628854|FG000|Overall Study|Withdrawal by Subject|1|||
105719101|NCT00291551|364628855|FG000|Overall Study|Death|7|||
105719102|NCT00291551|364628855|FG000|Overall Study|Withdrawal by Subject|6|||
105719103|NCT01671280|364628856|FG000|Overall Study|Withdrawal by Subject|2|||
105719104|NCT01988090|364628857|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
105719105|NCT01988090|364628858|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
105719106|NCT01988090|364628857|FG000|Start Treament After Randomization|Protocol Violation|0|||
105719107|NCT01988090|364628858|FG001|Start Treament After Randomization|Protocol Violation|1|||
105719108|NCT01988090|364628857|FG000|Complete Study After Start|Withdrawal by Subject|2|||
105719109|NCT01988090|364628858|FG001|Complete Study After Start|Withdrawal by Subject|0|||
105719110|NCT01988090|364628857|FG000|Complete Study After Start|Protocol Violation|1|||
105719111|NCT01988090|364628858|FG001|Complete Study After Start|Protocol Violation|1|||
105719112|NCT03094195|364628859|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
105719113|NCT03094195|364628860|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
105719114|NCT03094195|364628861|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
105719115|NCT03094195|364628862|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105719116|NCT03094195|364628863|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105719117|NCT03094195|364628864|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105719118|NCT03094195|364628865|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105791372|NCT04798027|364890598|FG002|Overall Study|Lost to Follow-up|0|||
105791373|NCT04798027|364890599|FG003|Overall Study|Lost to Follow-up|0|||
105791374|NCT04798027|364890600|FG004|Overall Study|Lost to Follow-up|0|||
105791375|NCT04798027|364890601|FG005|Overall Study|Lost to Follow-up|1|||
105791376|NCT04798027|364890602|FG006|Overall Study|Lost to Follow-up|0|||
105791377|NCT04798027|364890603|FG007|Overall Study|Lost to Follow-up|0|||
105791378|NCT04798027|364890604|FG008|Overall Study|Lost to Follow-up|1|||
105791379|NCT04798027|364890596|FG000|Overall Study|Withdrawal by Sponsor|8|||
105791380|NCT04798027|364890597|FG001|Overall Study|Withdrawal by Sponsor|22|||
105791381|NCT04798027|364890598|FG002|Overall Study|Withdrawal by Sponsor|9|||
105791382|NCT04798027|364890599|FG003|Overall Study|Withdrawal by Sponsor|26|||
105791383|NCT04798027|364890600|FG004|Overall Study|Withdrawal by Sponsor|24|||
105791384|NCT04798027|364890601|FG005|Overall Study|Withdrawal by Sponsor|11|||
105791385|NCT04798027|364890602|FG006|Overall Study|Withdrawal by Sponsor|25|||
105791386|NCT04798027|364890603|FG007|Overall Study|Withdrawal by Sponsor|26|||
105791387|NCT04798027|364890604|FG008|Overall Study|Withdrawal by Sponsor|11|||
105791388|NCT03868059|364890611|FG000|Overall Study|Adverse Event|3|||
105791389|NCT03868059|364890611|FG000|Overall Study|Lost to Follow-up|3|||
105791390|NCT03868059|364890611|FG000|Overall Study|Withdrawal by Subject|6|||
105791391|NCT02949219|364890613|FG000|Overall Study|Withdrawal by Subject|1|||
105791392|NCT03494816|364890614|FG000|Overall Study|Protocol Violation|2|||
105791393|NCT03494816|364890614|FG000|Overall Study|Physician Decision|2|||
105791394|NCT03494816|364890614|FG000|Overall Study|Did not start trial treatment|1|||
105791395|NCT03494816|364890614|FG000|Overall Study|Adverse Event|1|||
105791396|NCT00633217|364890619|FG000|Overall Study|Adverse Event|5|||
105791397|NCT00633217|364890620|FG001|Overall Study|Adverse Event|9|||
105791398|NCT00633217|364890619|FG000|Overall Study|Lack of Efficacy|0|||
105791399|NCT00633217|364890620|FG001|Overall Study|Lack of Efficacy|2|||
105791400|NCT00633217|364890619|FG000|Overall Study|Protocol Violation|3|||
105791401|NCT00633217|364890620|FG001|Overall Study|Protocol Violation|7|||
105791402|NCT00633217|364890619|FG000|Overall Study|Lost to Follow-up|2|||
105791403|NCT00633217|364890620|FG001|Overall Study|Lost to Follow-up|2|||
105791404|NCT00633217|364890619|FG000|Overall Study|Investigator Discretion|2|||
105791405|NCT00633217|364890620|FG001|Overall Study|Investigator Discretion|0|||
105791406|NCT00633217|364890619|FG000|Overall Study|Withdrew Consent|3|||
105791407|NCT00633217|364890620|FG001|Overall Study|Withdrew Consent|3|||
105791408|NCT00314262|364890621|FG000|Overall Study|Adverse Event|2|||
105791409|NCT00314262|364890621|FG000|Overall Study|Withdrawal by Subject|2|||
105791410|NCT00314262|364890621|FG000|Overall Study|Physician Decision|1|||
105791411|NCT00083226|364890622|FG000|Overall Study|Lack of Efficacy|19|||
105561931|NCT01860703|364052273|FG001|Overall Study|Withdrawal by Subject|1|||
105561932|NCT01860703|364052274|FG002|Overall Study|Withdrawal by Subject|0|||
105561933|NCT01860703|364052275|FG003|Overall Study|Withdrawal by Subject|0|||
105791412|NCT00083226|364890622|FG000|Overall Study|Adverse Event|9|||
105791413|NCT00083226|364890622|FG000|Overall Study|Death|4|||
105791414|NCT00083226|364890622|FG000|Overall Study|Withdrawal by Subject|4|||
105791415|NCT00083226|364890622|FG000|Overall Study|Other|2|||
105791416|NCT00083226|364890622|FG000|Overall Study|ineligible or not receiving treatment|4|||
105791417|NCT00909857|364890623|FG000|Overall Study|Withdrawal by Subject|6|||
105791418|NCT00909857|364890624|FG001|Overall Study|Withdrawal by Subject|10|||
105791419|NCT00909857|364890623|FG000|Overall Study|Adverse Event|5|||
105791420|NCT00909857|364890624|FG001|Overall Study|Adverse Event|5|||
105791421|NCT00909857|364890623|FG000|Overall Study|Lost to Follow-up|2|||
105791422|NCT00909857|364890624|FG001|Overall Study|Lost to Follow-up|5|||
105719119|NCT03094195|364628866|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105719120|NCT03094195|364628859|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
105719121|NCT03094195|364628860|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
105719122|NCT03094195|364628861|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
105719123|NCT03094195|364628862|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105719124|NCT03094195|364628863|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105719125|NCT03094195|364628864|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105719126|NCT03094195|364628865|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105719127|NCT03094195|364628866|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105719128|NCT03094195|364628859|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105719129|NCT03094195|364628860|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105719130|NCT03094195|364628861|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
105719131|NCT03094195|364628862|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105719132|NCT03094195|364628863|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105719133|NCT03094195|364628864|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105719134|NCT03094195|364628865|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105719135|NCT03094195|364628866|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105719136|NCT03094195|364628859|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105719137|NCT03094195|364628860|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
105719138|NCT03094195|364628861|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
105719139|NCT03094195|364628862|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105719140|NCT03094195|364628863|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105719141|NCT03094195|364628864|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105719142|NCT03094195|364628865|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105719143|NCT03094195|364628866|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105561934|NCT01860703|364052272|FG000|Overall Study|Personal reason|1|||
105561935|NCT01860703|364052273|FG001|Overall Study|Personal reason|0|||
105719144|NCT01961115|364628867|FG000|Overall Study|Disease Progression|1|||
105561936|NCT01860703|364052274|FG002|Overall Study|Personal reason|1|||
105719145|NCT01961115|364628868|FG001|Overall Study|Disease Progression|0|||
105561937|NCT01860703|364052275|FG003|Overall Study|Personal reason|0|||
105561938|NCT00450411|364052276|FG000|Overall Study|Protocol Violation|6|||
105561939|NCT00450411|364052276|FG000|Overall Study|No protocol treatment|2|||
105561940|NCT00344461|364052282|FG000|Overall Study|Adverse Event|6|||
105561941|NCT00344461|364052282|FG000|Overall Study|Death|1|||
105561942|NCT00344461|364052282|FG000|Overall Study|Lack of Efficacy|2|||
105561943|NCT00344461|364052282|FG000|Overall Study|Lost to Follow-up|2|||
105561944|NCT00344461|364052282|FG000|Overall Study|Physician Decision|2|||
105561945|NCT00344461|364052282|FG000|Overall Study|Protocol Violation|6|||
105719146|NCT01961115|364628869|FG002|Overall Study|Disease Progression|3|||
105719147|NCT01961115|364628867|FG000|Overall Study|Adverse Event|1|||
105719148|NCT01961115|364628868|FG001|Overall Study|Adverse Event|0|||
105719149|NCT01961115|364628869|FG002|Overall Study|Adverse Event|1|||
105719150|NCT03887130|364628870|FG000|Overall Study|Progressive disease|23|||
105719151|NCT03887130|364628871|FG001|Overall Study|Progressive disease|14|||
105719152|NCT03887130|364628872|FG002|Overall Study|Progressive disease|7|||
105719153|NCT03887130|364628870|FG000|Overall Study|Protocol Violation|3|||
105719154|NCT03887130|364628871|FG001|Overall Study|Protocol Violation|1|||
105719155|NCT03887130|364628872|FG002|Overall Study|Protocol Violation|2|||
105719156|NCT03887130|364628870|FG000|Overall Study|Drug related toxicity|7|||
105719157|NCT03887130|364628871|FG001|Overall Study|Drug related toxicity|7|||
105719158|NCT03887130|364628872|FG002|Overall Study|Drug related toxicity|13|||
105719159|NCT03887130|364628870|FG000|Overall Study|Non drug related toxicity|3|||
105719160|NCT03887130|364628871|FG001|Overall Study|Non drug related toxicity|0|||
105719161|NCT03887130|364628872|FG002|Overall Study|Non drug related toxicity|0|||
105719162|NCT03887130|364628870|FG000|Overall Study|Death|2|||
105719163|NCT03887130|364628871|FG001|Overall Study|Death|2|||
105719164|NCT03887130|364628872|FG002|Overall Study|Death|1|||
105719165|NCT03887130|364628870|FG000|Overall Study|Withdrawal by Subject|7|||
105719166|NCT03887130|364628871|FG001|Overall Study|Withdrawal by Subject|6|||
105719167|NCT03887130|364628872|FG002|Overall Study|Withdrawal by Subject|11|||
105719168|NCT03887130|364628870|FG000|Overall Study|other reason|6|||
105719169|NCT03887130|364628871|FG001|Overall Study|other reason|20|||
105719170|NCT03887130|364628872|FG002|Overall Study|other reason|17|||
105719171|NCT05900115|364631617|FG000|Overall Study|Lost to Follow-up|129|||
105719172|NCT05900115|364631618|FG001|Overall Study|Lost to Follow-up|98|||
105719173|NCT00618722|364631619|FG000|Overall Study|Refusal of Treatment|0|||
105719174|NCT00618722|364631620|FG001|Overall Study|Refusal of Treatment|0|||
105719175|NCT00618722|364631621|FG002|Overall Study|Refusal of Treatment|1|||
105719176|NCT00618722|364631622|FG003|Overall Study|Refusal of Treatment|0|||
105719177|NCT00618722|364631619|FG000|Overall Study|Patient Request|1|||
105719178|NCT00618722|364631620|FG001|Overall Study|Patient Request|1|||
105719179|NCT00618722|364631621|FG002|Overall Study|Patient Request|1|||
105719180|NCT00618722|364631622|FG003|Overall Study|Patient Request|1|||
105719181|NCT00618722|364631619|FG000|Overall Study|Inability to Complete Study Procedure|0|||
105719182|NCT00618722|364631620|FG001|Overall Study|Inability to Complete Study Procedure|1|||
105719183|NCT00618722|364631621|FG002|Overall Study|Inability to Complete Study Procedure|0|||
105719184|NCT00618722|364631622|FG003|Overall Study|Inability to Complete Study Procedure|0|||
105719185|NCT00618722|364631619|FG000|Overall Study|Lost to Follow-up|2|||
105719186|NCT00618722|364631620|FG001|Overall Study|Lost to Follow-up|0|||
105719187|NCT00618722|364631621|FG002|Overall Study|Lost to Follow-up|0|||
105719188|NCT00618722|364631622|FG003|Overall Study|Lost to Follow-up|2|||
105719189|NCT00618722|364631619|FG000|Overall Study|Miscellaneous Reasons|0|||
105719190|NCT00618722|364631620|FG001|Overall Study|Miscellaneous Reasons|0|||
105719191|NCT00618722|364631621|FG002|Overall Study|Miscellaneous Reasons|1|||
105719192|NCT00618722|364631622|FG003|Overall Study|Miscellaneous Reasons|1|||
105719193|NCT00200057|364631625|FG000|Overall Study|Lack of Efficacy|3|||
105719194|NCT00200057|364631625|FG000|Overall Study|Exited due to terminal illness of PI|2|||
105719195|NCT00200057|364631625|FG000|Overall Study|Withdrawal by Subject|1|||
105719196|NCT00200057|364631625|FG000|Overall Study|Change in medical condition|1|||
105719197|NCT00200057|364631625|FG000|Overall Study|Infection|1|||
105719198|NCT00200057|364631625|FG000|Overall Study|Death|1|||
105719199|NCT01059448|364631627|FG000|Overall Study|Adverse Event|1|||
105719200|NCT01059448|364631628|FG001|Overall Study|Adverse Event|3|||
105719201|NCT01059448|364631629|FG002|Overall Study|Adverse Event|0|||
105719202|NCT01059448|364631630|FG003|Overall Study|Adverse Event|1|||
105719203|NCT01059448|364631627|FG000|Overall Study|Withdrawal by Subject|2|||
105719204|NCT01059448|364631628|FG001|Overall Study|Withdrawal by Subject|0|||
105719205|NCT01059448|364631629|FG002|Overall Study|Withdrawal by Subject|2|||
105719206|NCT01059448|364631630|FG003|Overall Study|Withdrawal by Subject|4|||
105719207|NCT01059448|364631627|FG000|Overall Study|Disease Progression|2|||
105791423|NCT00909857|364890623|FG000|Overall Study|Protocol Violation|2|||
105719208|NCT01059448|364631628|FG001|Overall Study|Disease Progression|1|||
105719209|NCT01059448|364631629|FG002|Overall Study|Disease Progression|4|||
105719210|NCT01059448|364631630|FG003|Overall Study|Disease Progression|2|||
105561946|NCT00344461|364052282|FG000|Overall Study|Withdrawal by Subject|2|||
105719211|NCT01059448|364631627|FG000|Overall Study|Administrative Decision|43|||
105719212|NCT01059448|364631628|FG001|Overall Study|Administrative Decision|49|||
105791424|NCT00909857|364890624|FG001|Overall Study|Protocol Violation|1|||
105791425|NCT00909857|364890623|FG000|Overall Study|Pregnancy|1|||
105791426|NCT00909857|364890624|FG001|Overall Study|Pregnancy|0|||
105791427|NCT00909857|364890623|FG000|Overall Study|Other|1|||
105791428|NCT00909857|364890624|FG001|Overall Study|Other|0|||
105791429|NCT00909857|364890623|FG000|Overall Study|Did not receive study medication|19|||
105791430|NCT00909857|364890624|FG001|Overall Study|Did not receive study medication|24|||
105791431|NCT00604175|364890625|FG000|Entry Through Week 28|Death|2|||
105791432|NCT00604175|364890626|FG001|Entry Through Week 28|Death|0|||
105791433|NCT00604175|364890627|FG002|Entry Through Week 28|Death|0|||
105791434|NCT00604175|364890625|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
105791435|NCT00604175|364890626|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
105791436|NCT00604175|364890627|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
105791437|NCT00604175|364890625|FG000|Entry Through Week 28|Lost to Follow-up|4|||
105791438|NCT00604175|364890626|FG001|Entry Through Week 28|Lost to Follow-up|3|||
105791439|NCT00604175|364890627|FG002|Entry Through Week 28|Lost to Follow-up|0|||
105791440|NCT00604175|364890625|FG000|Entry Through Week 28|Ineligible|1|||
105791441|NCT00604175|364890626|FG001|Entry Through Week 28|Ineligible|0|||
105791442|NCT00604175|364890627|FG002|Entry Through Week 28|Ineligible|0|||
105791443|NCT00604175|364890625|FG000|Entry Through Week 28|Did not start intervention|2|||
105791444|NCT00604175|364890626|FG001|Entry Through Week 28|Did not start intervention|0|||
105791445|NCT00604175|364890627|FG002|Entry Through Week 28|Did not start intervention|1|||
105791446|NCT00604175|364890625|FG000|Week 29 Through Week 72|Death|0|||
105791447|NCT00604175|364890626|FG001|Week 29 Through Week 72|Death|0|||
105791448|NCT00604175|364890627|FG002|Week 29 Through Week 72|Death|1|||
105791449|NCT00604175|364890625|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
105791450|NCT00604175|364890626|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
105791451|NCT00604175|364890627|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
105791452|NCT00604175|364890625|FG000|Week 29 Through Week 72|Site closure|0|||
105791453|NCT00604175|364890626|FG001|Week 29 Through Week 72|Site closure|1|||
105791454|NCT00604175|364890627|FG002|Week 29 Through Week 72|Site closure|0|||
105791455|NCT00604175|364890625|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
105791456|NCT00604175|364890626|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
105791457|NCT00604175|364890627|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
105791458|NCT02044094|364890628|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
105791459|NCT02044094|364890628|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
105791460|NCT02044094|364890628|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
105791461|NCT02044094|364890628|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
105791462|NCT02044094|364890628|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
105791463|NCT02044094|364890628|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
105791464|NCT02044094|364890628|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
105791465|NCT02044094|364890628|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
105791466|NCT03353415|364890631|FG000|Masked CGM Wear|Lost to Follow-up|2|||
105791467|NCT03353415|364890631|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
105791468|NCT03205163|364890632|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
105791469|NCT03205163|364890633|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
105791470|NCT02332655|364890634|FG000|Overall Study|Lack of Efficacy|1|||
105791471|NCT01876082|364891905|FG000|Overall Study|Withdrawal by Subject|0|||
105791472|NCT01876082|364891906|FG001|Overall Study|Withdrawal by Subject|2|||
105791473|NCT01876082|364891905|FG000|Overall Study|Protocol Violation|1|||
105791474|NCT01876082|364891906|FG001|Overall Study|Protocol Violation|0|||
105791475|NCT01876082|364891905|FG000|Overall Study|Adverse Event|1|||
105719213|NCT01059448|364631629|FG002|Overall Study|Administrative Decision|45|||
105719214|NCT01059448|364631630|FG003|Overall Study|Administrative Decision|46|||
105719215|NCT01059448|364631627|FG000|Overall Study|Lost to Follow-up|0|||
105719216|NCT01059448|364631628|FG001|Overall Study|Lost to Follow-up|0|||
105719217|NCT01059448|364631629|FG002|Overall Study|Lost to Follow-up|2|||
105719218|NCT01059448|364631630|FG003|Overall Study|Lost to Follow-up|0|||
105719219|NCT01059448|364631627|FG000|Overall Study|Death|0|||
105719220|NCT01059448|364631628|FG001|Overall Study|Death|1|||
105719221|NCT01059448|364631629|FG002|Overall Study|Death|0|||
105719222|NCT01059448|364631630|FG003|Overall Study|Death|0|||
105791476|NCT01876082|364891906|FG001|Overall Study|Adverse Event|1|||
105791477|NCT01876082|364891905|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
105791478|NCT01876082|364891906|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
105791479|NCT01392469|364891909|FG000|Overall Study|Adverse Event|2|||
105791480|NCT01392469|364891909|FG000|Overall Study|Withdrawal by Subject|1|||
105791481|NCT01392469|364891909|FG000|Overall Study|Protocol Violation|1|||
105791482|NCT01017731|364891910|FG000|Overall Study|Lost to Follow-up|2|||
105791483|NCT01017731|364891910|FG000|Overall Study|Withdrawal by Subject|3|||
105719223|NCT01059448|364631627|FG000|Overall Study|Other|1|||
105791484|NCT01017731|364891910|FG000|Overall Study|Physician Decision|2|||
105791485|NCT01017731|364891910|FG000|Overall Study|Adverse Event|1|||
105791486|NCT00359073|364891911|FG000|Overall Study|Withdrawal by Subject|1|||
105791487|NCT00359073|364891912|FG001|Overall Study|Withdrawal by Subject|1|||
105791488|NCT00359073|364891911|FG000|Overall Study|Eligibility criteria no longer met|3|||
105791489|NCT00359073|364891912|FG001|Overall Study|Eligibility criteria no longer met|0|||
105791490|NCT00359073|364891911|FG000|Overall Study|developed RV16 antibody|0|||
105791491|NCT00359073|364891912|FG001|Overall Study|developed RV16 antibody|1|||
105791492|NCT00698009|364891921|FG000|Overall Study|Withdrawal by Subject|1|||
105791493|NCT00929201|364891922|FG000|Period 1|Withdrawal by Subject|0|||
105791494|NCT00929201|364891923|FG001|Period 1|Withdrawal by Subject|1|||
105791495|NCT03606109|364891924|FG000|Overall Study|Lost to Follow-up|2|||
105791496|NCT03606109|364891925|FG001|Overall Study|Lost to Follow-up|1|||
105791497|NCT04311411|364891926|FG000|Overall Study|Adverse Event|2|||
105791498|NCT04311411|364891927|FG001|Overall Study|Adverse Event|3|||
105791499|NCT04311411|364891928|FG002|Overall Study|Adverse Event|2|||
105791500|NCT04311411|364891926|FG000|Overall Study|Withdrawal by Subject|3|||
105791501|NCT04311411|364891927|FG001|Overall Study|Withdrawal by Subject|3|||
105791502|NCT04311411|364891928|FG002|Overall Study|Withdrawal by Subject|0|||
105791503|NCT00630994|364891929|FG000|Overall Study|Adverse Event|1|||
105791504|NCT00630994|364891929|FG000|Overall Study|Disease Progression|1|||
105791505|NCT00630994|364891929|FG000|Overall Study|Lack of Efficacy|1|||
105791506|NCT00630994|364891929|FG000|Overall Study|Other|1|||
105791507|NCT03669640|364891930|FG000|Overall Study|Study Terminated by Sponsor|0|||
105791508|NCT03669640|364891931|FG001|Overall Study|Study Terminated by Sponsor|0|||
105791509|NCT03669640|364891932|FG002|Overall Study|Study Terminated by Sponsor|0|||
105791510|NCT03669640|364891933|FG003|Overall Study|Study Terminated by Sponsor|0|||
105791511|NCT03669640|364891934|FG004|Overall Study|Study Terminated by Sponsor|1|||
105791512|NCT03669640|364891935|FG005|Overall Study|Study Terminated by Sponsor|0|||
105791513|NCT03669640|364891930|FG000|Overall Study|Lost to Follow-up|0|||
105791514|NCT03669640|364891931|FG001|Overall Study|Lost to Follow-up|0|||
105791515|NCT03669640|364891932|FG002|Overall Study|Lost to Follow-up|2|||
105791516|NCT03669640|364891933|FG003|Overall Study|Lost to Follow-up|0|||
105791517|NCT03669640|364891934|FG004|Overall Study|Lost to Follow-up|0|||
105791518|NCT03669640|364891935|FG005|Overall Study|Lost to Follow-up|0|||
105791519|NCT03669640|364891930|FG000|Overall Study|Death|0|||
105791520|NCT03669640|364891931|FG001|Overall Study|Death|0|||
105791521|NCT03669640|364891932|FG002|Overall Study|Death|1|||
105791522|NCT03669640|364891933|FG003|Overall Study|Death|0|||
105791523|NCT03669640|364891934|FG004|Overall Study|Death|0|||
105791524|NCT03669640|364891935|FG005|Overall Study|Death|0|||
105791525|NCT03669640|364891930|FG000|Overall Study|Withdrawal by Subject|1|||
105791526|NCT03669640|364891931|FG001|Overall Study|Withdrawal by Subject|2|||
105791527|NCT03669640|364891932|FG002|Overall Study|Withdrawal by Subject|1|||
105791528|NCT03669640|364891933|FG003|Overall Study|Withdrawal by Subject|0|||
105791529|NCT03669640|364891934|FG004|Overall Study|Withdrawal by Subject|1|||
105791530|NCT03669640|364891935|FG005|Overall Study|Withdrawal by Subject|3|||
105791531|NCT03669640|364891930|FG000|Overall Study|Protocol Violation|1|||
105791532|NCT03669640|364891931|FG001|Overall Study|Protocol Violation|0|||
105791533|NCT03669640|364891932|FG002|Overall Study|Protocol Violation|0|||
105791534|NCT03669640|364891933|FG003|Overall Study|Protocol Violation|0|||
105791535|NCT03669640|364891934|FG004|Overall Study|Protocol Violation|0|||
105791536|NCT03669640|364891935|FG005|Overall Study|Protocol Violation|0|||
105791537|NCT03669640|364891930|FG000|Overall Study|Physician Decision|0|||
105791538|NCT03669640|364891931|FG001|Overall Study|Physician Decision|2|||
105791539|NCT03669640|364891932|FG002|Overall Study|Physician Decision|0|||
105791540|NCT03669640|364891933|FG003|Overall Study|Physician Decision|0|||
105791541|NCT03669640|364891934|FG004|Overall Study|Physician Decision|0|||
105791542|NCT03669640|364891935|FG005|Overall Study|Physician Decision|0|||
105791543|NCT03669640|364891930|FG000|Overall Study|Disease Relapse|1|||
105791544|NCT03669640|364891931|FG001|Overall Study|Disease Relapse|0|||
105791545|NCT03669640|364891932|FG002|Overall Study|Disease Relapse|0|||
105791546|NCT03669640|364891933|FG003|Overall Study|Disease Relapse|0|||
105791547|NCT03669640|364891934|FG004|Overall Study|Disease Relapse|0|||
105791548|NCT03669640|364891935|FG005|Overall Study|Disease Relapse|0|||
105791549|NCT03669640|364891930|FG000|Overall Study|Adverse Event|2|||
105791550|NCT03669640|364891931|FG001|Overall Study|Adverse Event|1|||
105791551|NCT03669640|364891932|FG002|Overall Study|Adverse Event|0|||
105791552|NCT03669640|364891933|FG003|Overall Study|Adverse Event|0|||
105791553|NCT03669640|364891934|FG004|Overall Study|Adverse Event|1|||
105791554|NCT03669640|364891935|FG005|Overall Study|Adverse Event|0|||
105791555|NCT03286426|364891936|FG000|Overall Study|Physician Decision|3|||
105791556|NCT00826176|364891937|FG000|Overall Study|Lost to Follow-up|1|||
105791557|NCT00826176|364891938|FG001|Overall Study|Lost to Follow-up|0|||
105791558|NCT00826176|364891937|FG000|Overall Study|Subject Withdrew Consent|3|||
105791559|NCT00826176|364891938|FG001|Overall Study|Subject Withdrew Consent|0|||
105791560|NCT00826176|364891937|FG000|Overall Study|Administrative|9|||
105791561|NCT00826176|364891938|FG001|Overall Study|Administrative|0|||
105791562|NCT04484805|364891940|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
105791563|NCT04484805|364891941|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
105791564|NCT04484805|364891940|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
105791565|NCT04484805|364891941|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
105791566|NCT03927989|364891942|FG000|Overall Study|Withdrawal by Subject|0|||
105791567|NCT03927989|364891943|FG001|Overall Study|Withdrawal by Subject|1|||
105791568|NCT03130777|364891944|FG000|Overall Study|Death|0|||
105791569|NCT03130777|364891945|FG001|Overall Study|Death|1|||
105791570|NCT03130777|364891944|FG000|Overall Study|Did not meet eligibility criteria|1|||
105791571|NCT03130777|364891945|FG001|Overall Study|Did not meet eligibility criteria|0|||
105791572|NCT00924820|364891948|FG000|Overall Study|Death|2|||
105791573|NCT00924820|364891948|FG000|Overall Study|Ineligible, Screen Failure|5|||
105791574|NCT00761969|364891949|FG000|Overall Study|Death|112|||
105791575|NCT00761969|364891950|FG001|Overall Study|Death|47|||
105791576|NCT00761969|364891949|FG000|Overall Study|Lost to Follow-up|88|||
105791577|NCT00761969|364891950|FG001|Overall Study|Lost to Follow-up|93|||
105791578|NCT01826201|364891952|FG000|Overall Study|Non compliance with protocol|4|||
105791579|NCT01615822|364891955|FG000|Period 1|Withdrawal by Subject|0|||
105791580|NCT01615822|364891956|FG001|Period 1|Withdrawal by Subject|1|||
105791581|NCT01615822|364891957|FG002|Period 1|Withdrawal by Subject|0|||
105791582|NCT01615822|364891955|FG000|Period 1|Adverse Event|1|||
105791583|NCT01615822|364891956|FG001|Period 1|Adverse Event|1|||
105791584|NCT01615822|364891957|FG002|Period 1|Adverse Event|0|||
105791585|NCT01615822|364891955|FG000|Period 2|Lost to Follow-up|0|||
105791586|NCT01615822|364891956|FG001|Period 2|Lost to Follow-up|1|||
105791587|NCT01615822|364891957|FG002|Period 2|Lost to Follow-up|2|||
105791588|NCT01965431|364891958|FG000|Overall Study|Adverse Event|0|||
105791589|NCT01965431|364891959|FG001|Overall Study|Adverse Event|1|||
105791590|NCT01965431|364891960|FG002|Overall Study|Adverse Event|0|||
105791591|NCT01965431|364891961|FG003|Overall Study|Adverse Event|0|||
105791592|NCT01965431|364891962|FG004|Overall Study|Adverse Event|0|||
105791593|NCT01965431|364891963|FG005|Overall Study|Adverse Event|0|||
105791594|NCT01965431|364891958|FG000|Overall Study|Other than stated above|6|||
105791595|NCT01965431|364891959|FG001|Overall Study|Other than stated above|5|||
105791596|NCT01965431|364891960|FG002|Overall Study|Other than stated above|6|||
105791597|NCT01965431|364891961|FG003|Overall Study|Other than stated above|6|||
105791598|NCT01965431|364891962|FG004|Overall Study|Other than stated above|6|||
105791599|NCT01965431|364891963|FG005|Overall Study|Other than stated above|6|||
105791600|NCT02787785|364891966|FG000|Overall Study|Death|3|||
105791601|NCT02787785|364891967|FG001|Overall Study|Death|4|||
105791602|NCT02787785|364891966|FG000|Overall Study|Lost to Follow-up|1|||
105791603|NCT02787785|364891967|FG001|Overall Study|Lost to Follow-up|1|||
105791604|NCT02787785|364891966|FG000|Overall Study|Withdrawal by Subject|0|||
105791605|NCT02787785|364891967|FG001|Overall Study|Withdrawal by Subject|5|||
105791606|NCT00902265|364891968|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
105791607|NCT00902265|364891968|FG000|Overall Study|Adverse Event|2|||
105791608|NCT00902265|364891968|FG000|Overall Study|Lack of Efficacy|2|||
105791609|NCT00902265|364891968|FG000|Overall Study|Protocol Violation|1|||
105791610|NCT02050373|364891969|FG000|Overall Study|Adverse Event|4|||
105791611|NCT02050373|364891970|FG001|Overall Study|Adverse Event|7|||
105791612|NCT02050373|364891969|FG000|Overall Study|Death|3|||
105791613|NCT02050373|364891970|FG001|Overall Study|Death|3|||
105791614|NCT03981614|364891971|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
105791615|NCT03981614|364891972|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
105791616|NCT03981614|364891973|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
105791617|NCT03901339|364891974|FG000|Overall Study|Death|220|||
105791618|NCT03901339|364891975|FG001|Overall Study|Death|192|||
105791619|NCT03901339|364891974|FG000|Overall Study|Informed consent withdrawn|13|||
105791620|NCT03901339|364891975|FG001|Overall Study|Informed consent withdrawn|40|||
105791621|NCT03901339|364891974|FG000|Overall Study|Sponsor request|30|||
105791622|NCT03901339|364891975|FG001|Overall Study|Sponsor request|23|||
105791623|NCT03901339|364891974|FG000|Overall Study|Reason not specified|5|||
105791624|NCT03901339|364891975|FG001|Overall Study|Reason not specified|7|||
105791625|NCT03901339|364891974|FG000|Overall Study|Lost to Follow-up|4|||
105791626|NCT03901339|364891975|FG001|Overall Study|Lost to Follow-up|7|||
105791627|NCT03901339|364891974|FG000|Overall Study|Covid19|0|||
105791628|NCT03901339|364891975|FG001|Overall Study|Covid19|2|||
105791629|NCT02861534|364891979|FG000|Overall Study|Death|541|||
105791630|NCT02861534|364891980|FG001|Overall Study|Death|552|||
105791631|NCT02861534|364891979|FG000|Overall Study|Lost to Follow-up|14|||
105791632|NCT02861534|364891980|FG001|Overall Study|Lost to Follow-up|14|||
105791633|NCT02861534|364891979|FG000|Overall Study|Site Terminated by Sponsor|4|||
105791634|NCT02861534|364891980|FG001|Overall Study|Site Terminated by Sponsor|3|||
105791635|NCT02861534|364891979|FG000|Overall Study|Withdrawal by Subject|15|||
105791636|NCT02861534|364891980|FG001|Overall Study|Withdrawal by Subject|18|||
105791637|NCT02860039|364891983|FG000|Overall Study|Death|4|||
105791638|NCT02860039|364891984|FG001|Overall Study|Death|0|||
105719224|NCT01059448|364631628|FG001|Overall Study|Other|1|||
105719225|NCT01059448|364631629|FG002|Overall Study|Other|0|||
105719226|NCT01059448|364631630|FG003|Overall Study|Other|1|||
105719227|NCT00132041|364631631|FG000|Baseline|Ineligible|6|||
105719228|NCT00132041|364631631|FG000|3 Months Post Ablation|Transplant|1|||
105719229|NCT00132041|364631631|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
105719230|NCT00132041|364631631|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
105719231|NCT00132041|364631631|FG000|6 Months Post Ablation|Death|2|||
105719232|NCT00132041|364631631|FG000|6 Months Post Ablation|Transplant|6|||
105719233|NCT00132041|364631631|FG000|9 Months Post Ablation|Death|1|||
105719234|NCT00132041|364631631|FG000|9 Months Post Ablation|Transplant|1|||
105719235|NCT00132041|364631631|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
105719236|NCT00132041|364631631|FG000|12 Months Post Ablation|Death|1|||
105719237|NCT00132041|364631631|FG000|12 Months Post Ablation|Transplant|1|||
105719238|NCT00132041|364631631|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
105719239|NCT00132041|364631631|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
105719240|NCT00132041|364631631|FG000|15 Months Post Ablation|Death|1|||
105719241|NCT00132041|364631631|FG000|15 Months Post Ablation|Transplant|5|||
105719242|NCT00132041|364631631|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
105719243|NCT00132041|364631631|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
105719244|NCT00132041|364631631|FG000|18 Months Post Ablation|Transplant|1|||
105719245|NCT00132041|364631631|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
105719246|NCT00132041|364631631|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
105719247|NCT00832819|364631632|FG000|Overall Study|Adverse Event|0|||
105719248|NCT00832819|364631633|FG001|Overall Study|Adverse Event|1|||
105719249|NCT00832819|364631634|FG002|Overall Study|Adverse Event|0|||
105719250|NCT00832819|364631632|FG000|Overall Study|Protocol Violation|0|||
105719251|NCT00832819|364631633|FG001|Overall Study|Protocol Violation|0|||
105719252|NCT00832819|364631634|FG002|Overall Study|Protocol Violation|1|||
105719253|NCT01276821|364631635|FG000|Overall Study|Protocol Violation|0|||
105719254|NCT01276821|364631636|FG001|Overall Study|Protocol Violation|1|||
105719255|NCT00270894|364631637|FG000|Overall Study|Adverse Event|1|||
105719256|NCT00270894|364631637|FG000|Overall Study|Withdrawal by Subject|1|||
105719257|NCT01748071|364631638|FG000|Overall Study|Adverse Event|2|||
105719258|NCT01748071|364631639|FG001|Overall Study|Adverse Event|2|||
105719259|NCT01748071|364631640|FG002|Overall Study|Adverse Event|0|||
105719260|NCT06441877|364631641|FG000|Overall Study|Withdrawal by Subject|0|||
105719261|NCT06441877|364631642|FG001|Overall Study|Withdrawal by Subject|2|||
105719262|NCT06441877|364631643|FG002|Overall Study|Withdrawal by Subject|0|||
105719263|NCT06441877|364631644|FG003|Overall Study|Withdrawal by Subject|0|||
105719264|NCT00600171|364631645|FG000|Overall Study|Adverse Event|0|||
105719265|NCT00600171|364631646|FG001|Overall Study|Adverse Event|1|||
105719266|NCT00600171|364631647|FG002|Overall Study|Adverse Event|0|||
105719267|NCT00600171|364631648|FG003|Overall Study|Adverse Event|0|||
105719268|NCT00600171|364631649|FG004|Overall Study|Adverse Event|1|||
105719269|NCT00600171|364631650|FG005|Overall Study|Adverse Event|0|||
105719270|NCT00600171|364631645|FG000|Overall Study|Lack of Efficacy|9|||
105719271|NCT00600171|364631646|FG001|Overall Study|Lack of Efficacy|12|||
105719272|NCT00600171|364631647|FG002|Overall Study|Lack of Efficacy|3|||
105719273|NCT00600171|364631648|FG003|Overall Study|Lack of Efficacy|5|||
105719274|NCT00600171|364631649|FG004|Overall Study|Lack of Efficacy|4|||
105719275|NCT00600171|364631650|FG005|Overall Study|Lack of Efficacy|0|||
105719276|NCT00600171|364631645|FG000|Overall Study|Protocol Violation|1|||
105719277|NCT00600171|364631646|FG001|Overall Study|Protocol Violation|2|||
105719278|NCT00600171|364631647|FG002|Overall Study|Protocol Violation|0|||
105719279|NCT00600171|364631648|FG003|Overall Study|Protocol Violation|1|||
105719280|NCT00600171|364631649|FG004|Overall Study|Protocol Violation|0|||
105719281|NCT00600171|364631650|FG005|Overall Study|Protocol Violation|0|||
105719282|NCT00600171|364631645|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
105719283|NCT00600171|364631646|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105719284|NCT00600171|364631647|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
105719285|NCT00600171|364631648|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
105719286|NCT00600171|364631649|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
105719287|NCT00600171|364631650|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
105719288|NCT00600171|364631645|FG000|Overall Study|Withdrawal by Subject|3|||
105719289|NCT00600171|364631646|FG001|Overall Study|Withdrawal by Subject|0|||
105719290|NCT00600171|364631647|FG002|Overall Study|Withdrawal by Subject|0|||
105719291|NCT00600171|364631648|FG003|Overall Study|Withdrawal by Subject|1|||
105719292|NCT00600171|364631649|FG004|Overall Study|Withdrawal by Subject|1|||
105719293|NCT00600171|364631650|FG005|Overall Study|Withdrawal by Subject|1|||
105719294|NCT00600171|364631645|FG000|Overall Study|Physician Decision|0|||
105719295|NCT00600171|364631646|FG001|Overall Study|Physician Decision|1|||
105719296|NCT00600171|364631647|FG002|Overall Study|Physician Decision|0|||
105719297|NCT00600171|364631648|FG003|Overall Study|Physician Decision|1|||
105719298|NCT00600171|364631649|FG004|Overall Study|Physician Decision|0|||
105719299|NCT00600171|364631650|FG005|Overall Study|Physician Decision|2|||
105719300|NCT00600171|364631645|FG000|Overall Study|Lost to Follow-up|0|||
105719301|NCT00600171|364631646|FG001|Overall Study|Lost to Follow-up|0|||
105719302|NCT00600171|364631647|FG002|Overall Study|Lost to Follow-up|0|||
105719303|NCT00600171|364631648|FG003|Overall Study|Lost to Follow-up|1|||
105719304|NCT00600171|364631649|FG004|Overall Study|Lost to Follow-up|0|||
105719305|NCT00600171|364631650|FG005|Overall Study|Lost to Follow-up|0|||
105719306|NCT02913313|364631651|FG000|Overall Study|DISEASE PROGRESSION|1|||
105719307|NCT02913313|364631652|FG001|Overall Study|DISEASE PROGRESSION|2|||
105719308|NCT02913313|364631653|FG002|Overall Study|DISEASE PROGRESSION|2|||
105719309|NCT02913313|364631654|FG003|Overall Study|DISEASE PROGRESSION|4|||
105719310|NCT02913313|364631655|FG004|Overall Study|DISEASE PROGRESSION|6|||
105719311|NCT02913313|364631656|FG005|Overall Study|DISEASE PROGRESSION|4|||
105719312|NCT02913313|364631657|FG006|Overall Study|DISEASE PROGRESSION|19|||
105719313|NCT02913313|364631658|FG007|Overall Study|DISEASE PROGRESSION|3|||
105719314|NCT02913313|364631659|FG008|Overall Study|DISEASE PROGRESSION|4|||
105719315|NCT02913313|364631660|FG009|Overall Study|DISEASE PROGRESSION|4|||
105719316|NCT02913313|364631661|FG010|Overall Study|DISEASE PROGRESSION|11|||
105719317|NCT02913313|364631662|FG011|Overall Study|DISEASE PROGRESSION|5|||
105719318|NCT02913313|364631663|FG012|Overall Study|DISEASE PROGRESSION|14|||
105719319|NCT02913313|364631664|FG013|Overall Study|DISEASE PROGRESSION|3|||
105719320|NCT02913313|364631651|FG000|Overall Study|Not Reported|0|||
105719321|NCT02913313|364631652|FG001|Overall Study|Not Reported|0|||
105719322|NCT02913313|364631653|FG002|Overall Study|Not Reported|0|||
105719323|NCT02913313|364631654|FG003|Overall Study|Not Reported|0|||
105719324|NCT02913313|364631655|FG004|Overall Study|Not Reported|1|||
105719325|NCT02913313|364631656|FG005|Overall Study|Not Reported|0|||
105719326|NCT02913313|364631657|FG006|Overall Study|Not Reported|0|||
105719327|NCT02913313|364631658|FG007|Overall Study|Not Reported|0|||
105719328|NCT02913313|364631659|FG008|Overall Study|Not Reported|0|||
105719329|NCT02913313|364631660|FG009|Overall Study|Not Reported|0|||
105719330|NCT02913313|364631661|FG010|Overall Study|Not Reported|4|||
105719331|NCT02913313|364631662|FG011|Overall Study|Not Reported|0|||
105719332|NCT02913313|364631663|FG012|Overall Study|Not Reported|0|||
105719333|NCT02913313|364631664|FG013|Overall Study|Not Reported|0|||
105719334|NCT02913313|364631651|FG000|Overall Study|Other reasons|0|||
105719335|NCT02913313|364631652|FG001|Overall Study|Other reasons|0|||
105719336|NCT02913313|364631653|FG002|Overall Study|Other reasons|0|||
105719337|NCT02913313|364631654|FG003|Overall Study|Other reasons|0|||
105719338|NCT02913313|364631655|FG004|Overall Study|Other reasons|1|||
105719339|NCT02913313|364631656|FG005|Overall Study|Other reasons|0|||
105719340|NCT02913313|364631657|FG006|Overall Study|Other reasons|0|||
105719341|NCT02913313|364631658|FG007|Overall Study|Other reasons|0|||
105719342|NCT02913313|364631659|FG008|Overall Study|Other reasons|0|||
105719343|NCT02913313|364631660|FG009|Overall Study|Other reasons|0|||
105719344|NCT02913313|364631661|FG010|Overall Study|Other reasons|1|||
105719345|NCT02913313|364631662|FG011|Overall Study|Other reasons|0|||
105719346|NCT02913313|364631663|FG012|Overall Study|Other reasons|0|||
105719347|NCT02913313|364631664|FG013|Overall Study|Other reasons|0|||
105719348|NCT02913313|364631651|FG000|Overall Study|Withdrawal by Subject|0|||
105719349|NCT02913313|364631652|FG001|Overall Study|Withdrawal by Subject|0|||
105719350|NCT02913313|364631653|FG002|Overall Study|Withdrawal by Subject|1|||
105719351|NCT02913313|364631654|FG003|Overall Study|Withdrawal by Subject|0|||
105719352|NCT02913313|364631655|FG004|Overall Study|Withdrawal by Subject|0|||
105719353|NCT02913313|364631656|FG005|Overall Study|Withdrawal by Subject|0|||
105719354|NCT02913313|364631657|FG006|Overall Study|Withdrawal by Subject|1|||
105719355|NCT02913313|364631658|FG007|Overall Study|Withdrawal by Subject|1|||
105719356|NCT02913313|364631659|FG008|Overall Study|Withdrawal by Subject|0|||
105719357|NCT02913313|364631660|FG009|Overall Study|Withdrawal by Subject|0|||
105719358|NCT02913313|364631661|FG010|Overall Study|Withdrawal by Subject|1|||
105791639|NCT02860039|364891983|FG000|Overall Study|Lost to Follow-up|2|||
105561947|NCT00636610|364052283|FG000|Overall Study|Adverse Event|4|||
105561948|NCT00636610|364052284|FG001|Overall Study|Adverse Event|4|||
105561949|NCT00636610|364052283|FG000|Overall Study|Death|6|||
105719359|NCT02913313|364631662|FG011|Overall Study|Withdrawal by Subject|0|||
105719360|NCT02913313|364631663|FG012|Overall Study|Withdrawal by Subject|0|||
105719361|NCT02913313|364631664|FG013|Overall Study|Withdrawal by Subject|0|||
105719362|NCT02913313|364631651|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719363|NCT02913313|364631652|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719364|NCT02913313|364631653|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719365|NCT02913313|364631654|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719366|NCT02913313|364631655|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719367|NCT02913313|364631656|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719368|NCT02913313|364631657|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719369|NCT02913313|364631658|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719370|NCT02913313|364631659|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105561950|NCT00636610|364052284|FG001|Overall Study|Death|3|||
105719371|NCT02913313|364631660|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719372|NCT02913313|364631661|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
105719373|NCT02913313|364631662|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719374|NCT02913313|364631663|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
105719375|NCT02913313|364631664|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
105719376|NCT02913313|364631651|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
105719377|NCT02913313|364631652|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
105719378|NCT02913313|364631653|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
105719379|NCT02913313|364631654|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
105719380|NCT02913313|364631655|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
105719381|NCT02913313|364631656|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
105719382|NCT02913313|364631657|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
105719383|NCT02913313|364631658|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
105719384|NCT02913313|364631659|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
105719385|NCT02913313|364631660|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
105719386|NCT02913313|364631661|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
105719387|NCT02913313|364631662|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
105719388|NCT02913313|364631663|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
105719389|NCT02913313|364631664|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
105719390|NCT02411448|364631669|FG000|Overall Study|Withdrawal by Subject|1|||
105719391|NCT02411448|364631670|FG001|Overall Study|Withdrawal by Subject|14|||
105719392|NCT02411448|364631671|FG002|Overall Study|Withdrawal by Subject|9|||
105719393|NCT02411448|364631669|FG000|Overall Study|Other|0|||
105719394|NCT02411448|364631670|FG001|Overall Study|Other|2|||
105719395|NCT02411448|364631671|FG002|Overall Study|Other|0|||
105719396|NCT02411448|364631669|FG000|Overall Study|Did not receive study treatment|0|||
105719397|NCT02411448|364631670|FG001|Overall Study|Did not receive study treatment|3|||
105719398|NCT02411448|364631671|FG002|Overall Study|Did not receive study treatment|0|||
105719399|NCT02411448|364631669|FG000|Overall Study|Alive on study treatment|3|||
105719400|NCT02411448|364631670|FG001|Overall Study|Alive on study treatment|64|||
105719401|NCT02411448|364631671|FG002|Overall Study|Alive on study treatment|43|||
105719402|NCT02771522|364631678|FG000|Overall Study|Lost to Follow-up|3|||
105719403|NCT02771522|364631678|FG000|Overall Study|Withdrawal by Subject|2|||
105719404|NCT02771522|364631678|FG000|Overall Study|No white spot lesions|3|||
105719405|NCT00934102|364631680|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
105719406|NCT00934102|364631681|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
105719407|NCT00934102|364631682|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
105719408|NCT00792298|364631683|FG000|Treatment Period 1|Adverse Event|0|||
105719409|NCT00792298|364631684|FG001|Treatment Period 1|Adverse Event|1|||
105719410|NCT00792298|364631685|FG002|Treatment Period 1|Adverse Event|0|||
105719411|NCT00792298|364631686|FG003|Treatment Period 1|Adverse Event|1|||
105719412|NCT00792298|364631687|FG004|Treatment Period 1|Adverse Event|0|||
105719413|NCT00792298|364631688|FG005|Treatment Period 1|Adverse Event|1|||
105719414|NCT00792298|364631689|FG006|Treatment Period 1|Adverse Event|1|||
105719415|NCT00792298|364631690|FG007|Treatment Period 1|Adverse Event|0|||
105719416|NCT00792298|364631683|FG000|Treatment Period 1|Lack of Efficacy|0|||
105719417|NCT00792298|364631684|FG001|Treatment Period 1|Lack of Efficacy|0|||
105719418|NCT00792298|364631685|FG002|Treatment Period 1|Lack of Efficacy|1|||
105719419|NCT00792298|364631686|FG003|Treatment Period 1|Lack of Efficacy|0|||
105719420|NCT00792298|364631687|FG004|Treatment Period 1|Lack of Efficacy|0|||
105719421|NCT00792298|364631688|FG005|Treatment Period 1|Lack of Efficacy|0|||
105719422|NCT00792298|364631689|FG006|Treatment Period 1|Lack of Efficacy|0|||
105719423|NCT00792298|364631690|FG007|Treatment Period 1|Lack of Efficacy|0|||
105719424|NCT00792298|364631683|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105719425|NCT00792298|364631684|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105719426|NCT00792298|364631685|FG002|Treatment Period 1|Withdrawal by Subject|1|||
105719427|NCT00792298|364631686|FG003|Treatment Period 1|Withdrawal by Subject|2|||
105719428|NCT00792298|364631687|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105719429|NCT00792298|364631688|FG005|Treatment Period 1|Withdrawal by Subject|2|||
105719430|NCT00792298|364631689|FG006|Treatment Period 1|Withdrawal by Subject|1|||
105719431|NCT00792298|364631690|FG007|Treatment Period 1|Withdrawal by Subject|0|||
105719432|NCT00792298|364631683|FG000|Treatment Period 1|Lost to Follow-up|0|||
105719433|NCT00792298|364631684|FG001|Treatment Period 1|Lost to Follow-up|0|||
105719434|NCT00792298|364631685|FG002|Treatment Period 1|Lost to Follow-up|0|||
105719435|NCT00792298|364631686|FG003|Treatment Period 1|Lost to Follow-up|0|||
105719436|NCT00792298|364631687|FG004|Treatment Period 1|Lost to Follow-up|0|||
105719437|NCT00792298|364631688|FG005|Treatment Period 1|Lost to Follow-up|0|||
105719438|NCT00792298|364631689|FG006|Treatment Period 1|Lost to Follow-up|1|||
105719439|NCT00792298|364631690|FG007|Treatment Period 1|Lost to Follow-up|0|||
105719440|NCT00792298|364631683|FG000|Treatment Period 1|Physician Decision|0|||
105719441|NCT00792298|364631684|FG001|Treatment Period 1|Physician Decision|0|||
105719442|NCT00792298|364631685|FG002|Treatment Period 1|Physician Decision|0|||
105719443|NCT00792298|364631686|FG003|Treatment Period 1|Physician Decision|1|||
105719444|NCT00792298|364631687|FG004|Treatment Period 1|Physician Decision|0|||
105719445|NCT00792298|364631688|FG005|Treatment Period 1|Physician Decision|0|||
105719446|NCT00792298|364631689|FG006|Treatment Period 1|Physician Decision|1|||
105719447|NCT00792298|364631690|FG007|Treatment Period 1|Physician Decision|0|||
105719448|NCT00792298|364631683|FG000|Treatment Period 1|Protocol Violation|0|||
105719449|NCT00792298|364631684|FG001|Treatment Period 1|Protocol Violation|0|||
105719450|NCT00792298|364631685|FG002|Treatment Period 1|Protocol Violation|0|||
105719451|NCT00792298|364631686|FG003|Treatment Period 1|Protocol Violation|0|||
105719452|NCT00792298|364631687|FG004|Treatment Period 1|Protocol Violation|0|||
105719453|NCT00792298|364631688|FG005|Treatment Period 1|Protocol Violation|0|||
105719454|NCT00792298|364631689|FG006|Treatment Period 1|Protocol Violation|0|||
105719455|NCT00792298|364631690|FG007|Treatment Period 1|Protocol Violation|1|||
105719456|NCT00792298|364631683|FG000|Washout|Adverse Event|0|||
105719457|NCT00792298|364631684|FG001|Washout|Adverse Event|0|||
105719458|NCT00792298|364631685|FG002|Washout|Adverse Event|0|||
105719459|NCT00792298|364631686|FG003|Washout|Adverse Event|0|||
105719460|NCT00792298|364631687|FG004|Washout|Adverse Event|0|||
105791640|NCT02860039|364891984|FG001|Overall Study|Lost to Follow-up|2|||
105791641|NCT02860039|364891983|FG000|Overall Study|Protocol Violation|3|||
105791642|NCT02860039|364891984|FG001|Overall Study|Protocol Violation|1|||
105791643|NCT02860039|364891983|FG000|Overall Study|Withdrawal by Subject|1|||
105791644|NCT02860039|364891984|FG001|Overall Study|Withdrawal by Subject|0|||
105791645|NCT02860039|364891983|FG000|Overall Study|Not otherwise eligible|1|||
105791646|NCT02860039|364891984|FG001|Overall Study|Not otherwise eligible|1|||
105791647|NCT03170271|364891987|FG000|Overall Study|Adverse Event|7|||
105791648|NCT03170271|364891988|FG001|Overall Study|Adverse Event|2|||
105791649|NCT03170271|364891987|FG000|Overall Study|Lost to Follow-up|0|||
105791650|NCT03170271|364891988|FG001|Overall Study|Lost to Follow-up|1|||
105791651|NCT03170271|364891987|FG000|Overall Study|Physician Decision|1|||
105791652|NCT03170271|364891988|FG001|Overall Study|Physician Decision|0|||
105791653|NCT03170271|364891987|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
105791654|NCT03170271|364891988|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
105791655|NCT03170271|364891987|FG000|Overall Study|Withdrawal by Subject|17|||
105791656|NCT03170271|364891988|FG001|Overall Study|Withdrawal by Subject|5|||
105791657|NCT03170271|364891987|FG000|Overall Study|Other|2|||
105791658|NCT03170271|364891988|FG001|Overall Study|Other|2|||
105791659|NCT03170271|364891987|FG000|Overall Study|Randomized in error|4|||
105791660|NCT03170271|364891988|FG001|Overall Study|Randomized in error|0|||
105791661|NCT03123120|364891991|FG000|Overall Study|Lost to Follow-up|0|||
105791662|NCT03123120|364891992|FG001|Overall Study|Lost to Follow-up|1|||
105791663|NCT03123120|364891991|FG000|Overall Study|Withdrawal by Subject|0|||
105791664|NCT03123120|364891992|FG001|Overall Study|Withdrawal by Subject|1|||
105791665|NCT00203892|364891995|FG000|Overall Study|Physician Decision|1|||
105791666|NCT00203892|364891996|FG001|Overall Study|Physician Decision|2|||
105791667|NCT00203892|364891997|FG002|Overall Study|Physician Decision|0|||
105791668|NCT00203892|364891995|FG000|Overall Study|Death|1|||
105791669|NCT00203892|364891996|FG001|Overall Study|Death|0|||
105791670|NCT00203892|364891997|FG002|Overall Study|Death|0|||
105791671|NCT01036594|364892011|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
105791672|NCT01036594|364892012|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
105791673|NCT01036594|364892011|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
105791674|NCT01036594|364892012|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
105791675|NCT01036594|364892011|FG000|Week 12 Evaluation|Adverse Event|5|||
105791676|NCT01036594|364892012|FG001|Week 12 Evaluation|Adverse Event|0|||
105791677|NCT01036594|364892011|FG000|Week 12 Evaluation|Physician Decision|1|||
105791678|NCT01036594|364892012|FG001|Week 12 Evaluation|Physician Decision|0|||
105791679|NCT01036594|364892011|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
105791680|NCT01036594|364892012|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
105791681|NCT01036594|364892011|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
105791682|NCT01036594|364892012|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
105791683|NCT01036594|364892011|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
105791684|NCT01036594|364892012|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
105791685|NCT01036594|364892011|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
105791686|NCT01036594|364892012|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
105791687|NCT01036594|364892011|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
105791688|NCT01036594|364892012|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
105791689|NCT02380248|364892020|FG000|Overall Study|Lost to Follow-up|11|||
105791690|NCT02380248|364892020|FG000|Overall Study|Withdrawal by Subject|3|||
105791691|NCT00285012|364892021|FG000|Assigned to Study Treatment (Tx)|Other|2|||
105791692|NCT00285012|364892022|FG001|Assigned to Study Treatment (Tx)|Other|3|||
105791693|NCT00285012|364892021|FG000|Received Study Tx|Death|2|||
105791694|NCT00285012|364892022|FG001|Received Study Tx|Death|1|||
105791695|NCT00285012|364892021|FG000|Received Study Tx|Adverse Event|5|||
105791696|NCT00285012|364892022|FG001|Received Study Tx|Adverse Event|11|||
105791697|NCT00285012|364892021|FG000|Received Study Tx|Lack of Efficacy|0|||
105791698|NCT00285012|364892022|FG001|Received Study Tx|Lack of Efficacy|3|||
105791699|NCT00285012|364892021|FG000|Received Study Tx|Lost to Follow-up|29|||
105791700|NCT00285012|364892022|FG001|Received Study Tx|Lost to Follow-up|31|||
105791701|NCT00285012|364892021|FG000|Received Study Tx|Withdrawal by Subject|31|||
105791702|NCT00285012|364892022|FG001|Received Study Tx|Withdrawal by Subject|43|||
105791703|NCT00285012|364892021|FG000|Received Study Tx|Other|5|||
105791704|NCT00285012|364892022|FG001|Received Study Tx|Other|5|||
105791705|NCT00061568|364892023|FG000|Overall Study|Lost to Follow-up|12|||
105791706|NCT00061568|364892024|FG001|Overall Study|Lost to Follow-up|0|||
105791707|NCT00061568|364892023|FG000|Overall Study|Death|6|||
105791708|NCT00061568|364892024|FG001|Overall Study|Death|0|||
105791709|NCT00061568|364892023|FG000|Overall Study|Withdrawal by Subject|1|||
105791710|NCT00061568|364892024|FG001|Overall Study|Withdrawal by Subject|0|||
105791711|NCT00797316|364892025|FG000|Overall Study|Administrative problems|1|||
105791712|NCT00797316|364892026|FG001|Overall Study|Administrative problems|0|||
105791713|NCT00797316|364892025|FG000|Overall Study|Adverse Event|5|||
105791714|NCT00797316|364892026|FG001|Overall Study|Adverse Event|3|||
105791715|NCT00797316|364892025|FG000|Overall Study|Lost to Follow-up|4|||
105791716|NCT00797316|364892026|FG001|Overall Study|Lost to Follow-up|8|||
105791717|NCT00797316|364892025|FG000|Overall Study|Protocol Deviation|1|||
105791718|NCT00797316|364892026|FG001|Overall Study|Protocol Deviation|2|||
105791719|NCT00797316|364892025|FG000|Overall Study|Patient withdrew consent|12|||
105791720|NCT00797316|364892026|FG001|Overall Study|Patient withdrew consent|6|||
105791721|NCT00797316|364892025|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105791722|NCT00797316|364892026|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
105791723|NCT02873195|364892029|FG000|Overall Study|Ineligible|5|||
105791724|NCT02873195|364892030|FG001|Overall Study|Ineligible|0|||
105791725|NCT00096031|364892037|FG000|Overall Study|Adverse Event|3|||
105791726|NCT00096031|364892037|FG000|Overall Study|Lack of Efficacy|42|||
105791727|NCT00096031|364892037|FG000|Overall Study|Death|4|||
105791728|NCT00096031|364892037|FG000|Overall Study|Withdrawal by Subject|1|||
105791729|NCT00096031|364892037|FG000|Overall Study|Ineligible|8|||
105791730|NCT00096031|364892037|FG000|Overall Study|Not protocol specified|5|||
105791731|NCT01126359|364892038|FG000|First Intervention (20-minutes)|Physician Decision|0|||
105791732|NCT01126359|364892039|FG001|First Intervention (20-minutes)|Physician Decision|1|||
105791733|NCT00902486|364892040|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
105791734|NCT00902486|364892041|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
105791735|NCT00902486|364892042|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
105791736|NCT00902486|364892043|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
105791737|NCT00902486|364892044|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
105791738|NCT00902486|364892045|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
105791739|NCT00902486|364892040|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
105791740|NCT00902486|364892041|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
105791741|NCT00902486|364892042|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
105791742|NCT00902486|364892043|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
105791743|NCT00902486|364892044|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
105791744|NCT00902486|364892045|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
105791745|NCT00902486|364892040|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
105791746|NCT00902486|364892041|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
105791747|NCT00902486|364892042|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
105791748|NCT00902486|364892043|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
105791749|NCT00902486|364892044|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
105791750|NCT00902486|364892045|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
105791751|NCT00902486|364892040|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
105791752|NCT00902486|364892041|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
105791753|NCT00902486|364892042|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
105791754|NCT00902486|364892043|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
105791755|NCT00902486|364892044|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
105561951|NCT00636610|364052283|FG000|Overall Study|Physician decision to withdraw patient|15|||
105719461|NCT00792298|364631688|FG005|Washout|Adverse Event|1|||
105719462|NCT00792298|364631689|FG006|Washout|Adverse Event|0|||
105719463|NCT00792298|364631690|FG007|Washout|Adverse Event|0|||
105719464|NCT00792298|364631683|FG000|Washout|Withdrawal by Subject|0|||
105719465|NCT00792298|364631684|FG001|Washout|Withdrawal by Subject|0|||
105719466|NCT00792298|364631685|FG002|Washout|Withdrawal by Subject|1|||
105719467|NCT00792298|364631686|FG003|Washout|Withdrawal by Subject|0|||
105719468|NCT00792298|364631687|FG004|Washout|Withdrawal by Subject|0|||
105719469|NCT00792298|364631688|FG005|Washout|Withdrawal by Subject|1|||
105719470|NCT00792298|364631689|FG006|Washout|Withdrawal by Subject|0|||
105719471|NCT00792298|364631690|FG007|Washout|Withdrawal by Subject|0|||
105719472|NCT00792298|364631683|FG000|Treatment Period 2|Lack of Efficacy|0|||
105719473|NCT00792298|364631684|FG001|Treatment Period 2|Lack of Efficacy|0|||
105719474|NCT00792298|364631685|FG002|Treatment Period 2|Lack of Efficacy|0|||
105719475|NCT00792298|364631686|FG003|Treatment Period 2|Lack of Efficacy|0|||
105719476|NCT00792298|364631687|FG004|Treatment Period 2|Lack of Efficacy|1|||
105719477|NCT00792298|364631688|FG005|Treatment Period 2|Lack of Efficacy|0|||
105719478|NCT00792298|364631689|FG006|Treatment Period 2|Lack of Efficacy|0|||
105719479|NCT00792298|364631690|FG007|Treatment Period 2|Lack of Efficacy|0|||
105719480|NCT00792298|364631683|FG000|Treatment Period 2|Physician Decision|0|||
105719481|NCT00792298|364631684|FG001|Treatment Period 2|Physician Decision|0|||
105791756|NCT00902486|364892045|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
105791757|NCT00902486|364892040|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
105791758|NCT00902486|364892041|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
105791759|NCT00902486|364892042|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
105719482|NCT00792298|364631685|FG002|Treatment Period 2|Physician Decision|0|||
105719483|NCT00792298|364631686|FG003|Treatment Period 2|Physician Decision|0|||
105719484|NCT00792298|364631687|FG004|Treatment Period 2|Physician Decision|0|||
105719485|NCT00792298|364631688|FG005|Treatment Period 2|Physician Decision|0|||
105719486|NCT00792298|364631689|FG006|Treatment Period 2|Physician Decision|1|||
105719487|NCT00792298|364631690|FG007|Treatment Period 2|Physician Decision|0|||
105561952|NCT00636610|364052284|FG001|Overall Study|Physician decision to withdraw patient|9|||
105719488|NCT00792298|364631683|FG000|Treatment Period 2|Pregnancy|0|||
105719489|NCT00792298|364631684|FG001|Treatment Period 2|Pregnancy|0|||
105719490|NCT00792298|364631685|FG002|Treatment Period 2|Pregnancy|1|||
105719491|NCT00792298|364631686|FG003|Treatment Period 2|Pregnancy|0|||
105719492|NCT00792298|364631687|FG004|Treatment Period 2|Pregnancy|0|||
105719493|NCT00792298|364631688|FG005|Treatment Period 2|Pregnancy|0|||
105719494|NCT00792298|364631689|FG006|Treatment Period 2|Pregnancy|0|||
105719495|NCT00792298|364631690|FG007|Treatment Period 2|Pregnancy|0|||
105719496|NCT00792298|364631683|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105719497|NCT00792298|364631684|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105719498|NCT00792298|364631685|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105719499|NCT00792298|364631686|FG003|Treatment Period 2|Withdrawal by Subject|2|||
105719500|NCT00792298|364631687|FG004|Treatment Period 2|Withdrawal by Subject|1|||
105719501|NCT00792298|364631688|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105719502|NCT00792298|364631689|FG006|Treatment Period 2|Withdrawal by Subject|0|||
105719503|NCT00792298|364631690|FG007|Treatment Period 2|Withdrawal by Subject|2|||
105719504|NCT04258579|364631696|FG000|Overall Study|Withdrawal by Subject|7|||
105719505|NCT04258579|364631696|FG000|Overall Study|Lost to Follow-up|3|||
105719506|NCT04258579|364631696|FG000|Overall Study|Protocol Violation|2|||
105719507|NCT04258579|364631696|FG000|Overall Study|Adverse Event|1|||
105719508|NCT02388295|364631697|FG000|Dose Escalation Week 1|Adverse Event|1|||
105719509|NCT02388295|364631698|FG001|Dose Escalation Week 1|Adverse Event|2|||
105719510|NCT02388295|364631699|FG002|Dose Escalation Week 1|Adverse Event|1|||
105719511|NCT02388295|364631697|FG000|Dose Escalation Week 1|Determined not eligible|1|||
105719512|NCT02388295|364631698|FG001|Dose Escalation Week 1|Determined not eligible|1|||
105719513|NCT02388295|364631699|FG002|Dose Escalation Week 1|Determined not eligible|1|||
105719514|NCT02388295|364631697|FG000|Dose Escalation Week 2|Protocol Violation|0|||
105719515|NCT02388295|364631698|FG001|Dose Escalation Week 2|Protocol Violation|1|||
105719516|NCT02388295|364631699|FG002|Dose Escalation Week 2|Protocol Violation|0|||
105719517|NCT02388295|364631697|FG000|Dose Escalation Week 2|Determined not eligible|1|||
105719518|NCT02388295|364631698|FG001|Dose Escalation Week 2|Determined not eligible|1|||
105719519|NCT02388295|364631699|FG002|Dose Escalation Week 2|Determined not eligible|1|||
105719520|NCT02388295|364631697|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
105719521|NCT02388295|364631698|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
105719522|NCT02388295|364631699|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
105719523|NCT04007159|364631700|FG000|Induction Phase|(missed study visits)|16|||
105719524|NCT04007159|364631700|FG000|Induction Phase|Withdrawal by Subject|4|||
105719525|NCT04007159|364631700|FG000|Induction Phase|Adverse Event|2|||
105719526|NCT04007159|364631700|FG000|Challenge Phase|missed study visits|3|||
105719527|NCT02076165|364631701|FG000|Overall Study|Lost to Follow-up|7|||
105719528|NCT02076165|364631702|FG001|Overall Study|Lost to Follow-up|5|||
105719529|NCT02076165|364631701|FG000|Overall Study|Refused follow-up assessment|1|||
105719530|NCT02076165|364631702|FG001|Overall Study|Refused follow-up assessment|1|||
105719531|NCT04134494|364631706|FG000|Overall Study|Lost to Follow-up|2|||
105719532|NCT01756274|364631707|FG000|Overall Study|Protocol Violation|2|||
105719533|NCT01756274|364631707|FG000|Overall Study|Laboratory error|1|||
105719534|NCT01879410|364631713|FG000|Overall Study|Adverse Event|9|||
105719535|NCT01879410|364631714|FG001|Overall Study|Adverse Event|14|||
105719536|NCT01879410|364631713|FG000|Overall Study|Lack of Efficacy|4|||
105719537|NCT01879410|364631714|FG001|Overall Study|Lack of Efficacy|6|||
105719538|NCT01879410|364631713|FG000|Overall Study|Protocol Violation|1|||
105719539|NCT01879410|364631714|FG001|Overall Study|Protocol Violation|7|||
105719540|NCT01879410|364631713|FG000|Overall Study|Lost to Follow-up|2|||
105719541|NCT01879410|364631714|FG001|Overall Study|Lost to Follow-up|1|||
105719542|NCT01879410|364631713|FG000|Overall Study|Withdrawal by Subject|7|||
105719543|NCT01879410|364631714|FG001|Overall Study|Withdrawal by Subject|8|||
105719544|NCT01879410|364631713|FG000|Overall Study|Randomised in Error|1|||
105719545|NCT01879410|364631714|FG001|Overall Study|Randomised in Error|2|||
105719546|NCT02649634|364631715|FG000|Overall Study|Withdrawal by Subject|3|||
105719547|NCT02649634|364631716|FG001|Overall Study|Withdrawal by Subject|5|||
105719548|NCT02649634|364631715|FG000|Overall Study|Lost to Follow-up|0|||
105719549|NCT02649634|364631716|FG001|Overall Study|Lost to Follow-up|1|||
105806514|NCT03038113|364949008|FG008|Overall Study|Withdrawal by Subject|0|||
105719550|NCT01670994|364631717|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
105719551|NCT01670994|364631718|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
105719552|NCT01670994|364631717|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
105719553|NCT01670994|364631718|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
105719554|NCT01670994|364631717|FG000|Overall Study|Patient experienced DLT|0|||
105719555|NCT01670994|364631718|FG001|Overall Study|Patient experienced DLT|1|||
105719556|NCT01318122|364631719|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105719557|NCT01318122|364631720|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105477870|NCT01589653|363761409|FG000|Overall Study|Protocol Violation|3|||
105477871|NCT01589653|363761410|FG001|Overall Study|Protocol Violation|1|||
105477872|NCT01589653|363761409|FG000|Overall Study|Withdrawal criteria|4|||
105477873|NCT01589653|363761410|FG001|Overall Study|Withdrawal criteria|7|||
105477874|NCT01589653|363761409|FG000|Overall Study|Unclassified|0|||
105477875|NCT01589653|363761410|FG001|Overall Study|Unclassified|3|||
105477876|NCT00945906|363761412|FG000|Overall Study|Withdrawal by Subject|1|||
105477877|NCT00945906|363761412|FG000|Overall Study|Did not want to return for last visit|2|||
105477878|NCT00945906|363761412|FG000|Overall Study|Unable to return for last visit|2|||
105477879|NCT00945906|363761412|FG000|Overall Study|Moved to another country|2|||
105477880|NCT01317550|363761414|FG000|Overall Study|Withdrawal by Subject|1|||
105477881|NCT01317550|363761415|FG001|Overall Study|Withdrawal by Subject|0|||
105477882|NCT01317550|363761416|FG002|Overall Study|Withdrawal by Subject|0|||
105477883|NCT01317550|363761417|FG003|Overall Study|Withdrawal by Subject|0|||
105477884|NCT01317550|363761414|FG000|Overall Study|Lack of compliance study med|1|||
105477885|NCT01317550|363761415|FG001|Overall Study|Lack of compliance study med|0|||
105477886|NCT01317550|363761416|FG002|Overall Study|Lack of compliance study med|0|||
105477887|NCT01317550|363761417|FG003|Overall Study|Lack of compliance study med|0|||
105477888|NCT00910624|363761421|FG000|Treatment Phase|Adverse Event|2|||
105477889|NCT00910624|363761422|FG001|Treatment Phase|Adverse Event|6|||
105477890|NCT00910624|363761423|FG002|Treatment Phase|Adverse Event|6|||
105477891|NCT00910624|363761424|FG003|Treatment Phase|Adverse Event|0|||
105477892|NCT00910624|363761421|FG000|Treatment Phase|Treatment Failure|23|||
105477893|NCT00910624|363761422|FG001|Treatment Phase|Treatment Failure|10|||
105477894|NCT00910624|363761423|FG002|Treatment Phase|Treatment Failure|0|||
105477895|NCT00910624|363761424|FG003|Treatment Phase|Treatment Failure|0|||
105477896|NCT00910624|363761421|FG000|Treatment Phase|Lost to Follow-up|0|||
105477897|NCT00910624|363761422|FG001|Treatment Phase|Lost to Follow-up|0|||
105477898|NCT00910624|363761423|FG002|Treatment Phase|Lost to Follow-up|1|||
105477899|NCT00910624|363761424|FG003|Treatment Phase|Lost to Follow-up|0|||
105719558|NCT01318122|364631721|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
105719559|NCT01318122|364631722|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
105719560|NCT01318122|364631719|FG000|Enrolled - Long-Term Extension Study|Other|1|||
105719561|NCT01318122|364631720|FG001|Enrolled - Long-Term Extension Study|Other|0|||
105719562|NCT01318122|364631721|FG002|Enrolled - Long-Term Extension Study|Other|0|||
105719563|NCT01318122|364631722|FG003|Enrolled - Long-Term Extension Study|Other|0|||
105477900|NCT00910624|363761421|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
105477901|NCT00910624|363761422|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
105477902|NCT00910624|363761423|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
105477903|NCT00910624|363761424|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
105477904|NCT00910624|363761421|FG000|Treatment Phase|Withdrawal by Subject|2|||
105477905|NCT00910624|363761422|FG001|Treatment Phase|Withdrawal by Subject|1|||
105477906|NCT00910624|363761423|FG002|Treatment Phase|Withdrawal by Subject|0|||
105477907|NCT00910624|363761424|FG003|Treatment Phase|Withdrawal by Subject|0|||
105477908|NCT00910624|363761421|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
105477909|NCT00910624|363761422|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
105477910|NCT00910624|363761423|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
105477911|NCT00910624|363761424|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
105477912|NCT00910624|363761421|FG000|Follow-Up Phase|Adverse Event|0|||
105477913|NCT00910624|363761422|FG001|Follow-Up Phase|Adverse Event|0|||
105477914|NCT00910624|363761423|FG002|Follow-Up Phase|Adverse Event|1|||
105477915|NCT00910624|363761424|FG003|Follow-Up Phase|Adverse Event|0|||
105719564|NCT01318122|364631719|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
105719565|NCT01318122|364631720|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
105791760|NCT00902486|364892043|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
105477916|NCT00910624|363761421|FG000|Follow-Up Phase|Lost to Follow-up|3|||
105477917|NCT00910624|363761422|FG001|Follow-Up Phase|Lost to Follow-up|1|||
105477918|NCT00910624|363761423|FG002|Follow-Up Phase|Lost to Follow-up|2|||
105791761|NCT00902486|364892044|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
105477919|NCT00910624|363761424|FG003|Follow-Up Phase|Lost to Follow-up|0|||
105477920|NCT00910624|363761421|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
105477921|NCT00910624|363761422|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
105477922|NCT00910624|363761423|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
105477923|NCT00910624|363761424|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
105477924|NCT00910624|363761421|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
105477925|NCT00910624|363761422|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
105477926|NCT00910624|363761423|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
105477927|NCT00910624|363761424|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
105477928|NCT00910624|363761421|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
105477929|NCT00910624|363761422|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
105719566|NCT01318122|364631721|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
105719567|NCT01318122|364631722|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
105719568|NCT01318122|364631719|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
105719569|NCT01318122|364631720|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105719570|NCT01318122|364631721|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105719571|NCT01318122|364631722|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105719572|NCT01318122|364631719|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105719573|NCT01318122|364631720|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
105719574|NCT01318122|364631721|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105719575|NCT01318122|364631722|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
105719576|NCT01318122|364631719|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
105719577|NCT01318122|364631720|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
105719578|NCT01318122|364631721|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
105719579|NCT01318122|364631722|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
105719580|NCT04897867|364631725|FG000|Overall Study|Withdrawal of Consent|1|||
105719581|NCT04897867|364631725|FG000|Overall Study|Pregnancy|1|||
105719582|NCT04897867|364631725|FG000|Overall Study|Lost to Follow-up|7|||
105719583|NCT04897867|364631725|FG000|Overall Study|Reason not Specified|2|||
105719584|NCT00802360|364631729|FG000|Overall Study|Stimulation failure|4|||
105719585|NCT00802360|364631730|FG001|Overall Study|Stimulation failure|0|||
105719586|NCT00802360|364631731|FG002|Overall Study|Stimulation failure|3|||
105719587|NCT00802360|364631732|FG003|Overall Study|Stimulation failure|3|||
105719588|NCT00802360|364631729|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
105719589|NCT00802360|364631730|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
105719590|NCT00802360|364631731|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
105719591|NCT00802360|364631732|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
105719592|NCT00802360|364631729|FG000|Overall Study|Cycle cancelled|0|||
105719593|NCT00802360|364631730|FG001|Overall Study|Cycle cancelled|1|||
105719594|NCT00802360|364631731|FG002|Overall Study|Cycle cancelled|1|||
105719595|NCT00802360|364631732|FG003|Overall Study|Cycle cancelled|1|||
105719596|NCT00802360|364631729|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
105719597|NCT00802360|364631730|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
105719598|NCT00802360|364631731|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
105719599|NCT00802360|364631732|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
105719600|NCT00802360|364631729|FG000|Overall Study|No positive serum pregnancy|17|||
105719601|NCT00802360|364631730|FG001|Overall Study|No positive serum pregnancy|20|||
105719602|NCT00802360|364631731|FG002|Overall Study|No positive serum pregnancy|14|||
105719603|NCT00802360|364631732|FG003|Overall Study|No positive serum pregnancy|10|||
105719604|NCT00802360|364631729|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
105719605|NCT00802360|364631730|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
105719606|NCT00802360|364631731|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
105719607|NCT00802360|364631732|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
105719608|NCT00802360|364631729|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
105719609|NCT00802360|364631730|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
105719610|NCT00802360|364631731|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
105791762|NCT00902486|364892045|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
105791763|NCT00902486|364892040|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
105791764|NCT00902486|364892041|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
105791765|NCT00902486|364892042|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
105791766|NCT00902486|364892043|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
105791767|NCT00902486|364892044|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
105791768|NCT00902486|364892045|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
105791769|NCT00902486|364892040|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
105791770|NCT00902486|364892041|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
105791771|NCT00902486|364892042|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
105791772|NCT00902486|364892043|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
105791773|NCT00902486|364892044|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
105791774|NCT00902486|364892045|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
105791775|NCT00902486|364892040|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
105791776|NCT00902486|364892041|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
105791777|NCT00902486|364892042|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
105791778|NCT00902486|364892043|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
105791779|NCT00902486|364892044|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
105791780|NCT00902486|364892045|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
105791781|NCT00902486|364892040|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
105791782|NCT00902486|364892041|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
105791783|NCT00902486|364892042|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
105791784|NCT00902486|364892043|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
105791785|NCT00902486|364892044|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
105791786|NCT00902486|364892045|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
105791787|NCT00902486|364892040|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
105791788|NCT00902486|364892041|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
105719611|NCT00802360|364631732|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
105719612|NCT00802360|364631729|FG000|Overall Study|Other|2|||
105719613|NCT00802360|364631730|FG001|Overall Study|Other|3|||
105719614|NCT00802360|364631731|FG002|Overall Study|Other|6|||
105719615|NCT00802360|364631732|FG003|Overall Study|Other|3|||
105719616|NCT02041962|364631733|FG000|Overall Study|Lost Aetna Coverage|43|||
105719617|NCT02041962|364631734|FG001|Overall Study|Lost Aetna Coverage|40|||
105719618|NCT02041962|364631733|FG000|Overall Study|Death|1|||
105719619|NCT02041962|364631734|FG001|Overall Study|Death|1|||
105719620|NCT02041962|364631733|FG000|Overall Study|Lost to Follow-up|37|||
105719621|NCT02041962|364631734|FG001|Overall Study|Lost to Follow-up|32|||
105719622|NCT02041962|364631733|FG000|Overall Study|Withdrawal by Subject|0|||
105719623|NCT02041962|364631734|FG001|Overall Study|Withdrawal by Subject|11|||
105719624|NCT01756456|364631735|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
105719625|NCT01756456|364631736|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
105719626|NCT01756456|364631737|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
105719627|NCT01756456|364631738|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
105719628|NCT01756456|364631739|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
105719629|NCT01756456|364631740|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
105719630|NCT01756456|364631735|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
105719631|NCT01756456|364631736|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
105719632|NCT01756456|364631737|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
105719633|NCT01756456|364631738|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
105719634|NCT01756456|364631739|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
105719635|NCT01756456|364631740|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
105719636|NCT01756456|364631735|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
105719637|NCT01756456|364631736|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
105719638|NCT01756456|364631737|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
105719639|NCT01756456|364631738|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
105719640|NCT01756456|364631739|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
105719641|NCT01756456|364631740|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
105719642|NCT01756456|364631735|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
105719643|NCT01756456|364631736|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
105719644|NCT01756456|364631737|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
105719645|NCT01756456|364631738|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
105719646|NCT01756456|364631739|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
105719647|NCT01756456|364631740|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
105719648|NCT01756456|364631735|FG000|Treatment Period: Phase I/II|Other causes|0|||
105719649|NCT01756456|364631736|FG001|Treatment Period: Phase I/II|Other causes|0|||
105719650|NCT01756456|364631737|FG002|Treatment Period: Phase I/II|Other causes|0|||
105719651|NCT01756456|364631738|FG003|Treatment Period: Phase I/II|Other causes|1|||
105719652|NCT01756456|364631739|FG004|Treatment Period: Phase I/II|Other causes|2|||
105719653|NCT01756456|364631740|FG005|Treatment Period: Phase I/II|Other causes|2|||
105719654|NCT01756456|364631735|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
105719655|NCT01756456|364631736|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
105719656|NCT01756456|364631737|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
105719657|NCT01756456|364631738|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
105719658|NCT01756456|364631739|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
105719659|NCT01756456|364631740|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
105719660|NCT01756456|364631735|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
105719661|NCT01756456|364631736|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
105719662|NCT01756456|364631737|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
105719663|NCT01756456|364631738|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
105719664|NCT01756456|364631739|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
105791789|NCT00902486|364892042|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
105791790|NCT00902486|364892043|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
105791791|NCT00902486|364892044|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
105791792|NCT00902486|364892045|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
105791793|NCT00902486|364892040|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
105791794|NCT00902486|364892041|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
105791795|NCT00902486|364892042|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
105791796|NCT00902486|364892043|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
105791797|NCT00902486|364892044|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
105791798|NCT00902486|364892045|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
105791799|NCT00005879|364892048|FG000|Overall Study|Withdrawal by Subject|8|||
105791800|NCT00005879|364892049|FG001|Overall Study|Withdrawal by Subject|10|||
105791801|NCT05022121|364892051|FG000|Overall Study|Lack of Efficacy|1|||
105791802|NCT05022121|364892052|FG001|Overall Study|Lack of Efficacy|0|||
105791803|NCT05022121|364892051|FG000|Overall Study|Lost to Follow-up|0|||
105791804|NCT05022121|364892052|FG001|Overall Study|Lost to Follow-up|2|||
105791805|NCT02395536|364892053|FG000|Overall Study|Lost to Follow-up|4|||
105791806|NCT02395536|364892054|FG001|Overall Study|Lost to Follow-up|4|||
105791807|NCT02395536|364892053|FG000|Overall Study|Death|2|||
105791808|NCT02395536|364892054|FG001|Overall Study|Death|0|||
105791809|NCT02395536|364892053|FG000|Overall Study|Physician Decision|4|||
105791810|NCT02395536|364892054|FG001|Overall Study|Physician Decision|6|||
105791811|NCT02395536|364892053|FG000|Overall Study|Withdrawal by Subject|9|||
105791812|NCT02395536|364892054|FG001|Overall Study|Withdrawal by Subject|17|||
105791813|NCT02395536|364892053|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
105791814|NCT02395536|364892054|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
105791815|NCT02395536|364892053|FG000|Overall Study|Insurance issue|0|||
105791816|NCT02395536|364892054|FG001|Overall Study|Insurance issue|1|||
105791817|NCT00131937|364892055|FG000|Overall Study|Adverse Event|3|||
105791818|NCT00131937|364892055|FG000|Overall Study|Withdrawal by Subject|2|||
105791819|NCT00131937|364892055|FG000|Overall Study|Physician Decision|1|||
105791820|NCT00131937|364892055|FG000|Overall Study|Disease Progression|7|||
105791821|NCT00131937|364892055|FG000|Overall Study|Alternative therapy|1|||
105791822|NCT00648739|364894294|FG000|Overall Study|Adverse Event|1|||
105791823|NCT00648739|364894295|FG001|Overall Study|Adverse Event|0|||
105791824|NCT00648739|364894296|FG002|Overall Study|Adverse Event|1|||
105791825|NCT00648739|364894297|FG003|Overall Study|Adverse Event|2|||
105791826|NCT00648739|364894298|FG004|Overall Study|Adverse Event|1|||
105791827|NCT00648739|364894299|FG005|Overall Study|Adverse Event|0|||
105791828|NCT00648739|364894300|FG006|Overall Study|Adverse Event|0|||
105791829|NCT00648739|364894294|FG000|Overall Study|Withdrawal by Subject|1|||
105791830|NCT00648739|364894295|FG001|Overall Study|Withdrawal by Subject|0|||
105791831|NCT00648739|364894296|FG002|Overall Study|Withdrawal by Subject|1|||
105791832|NCT00648739|364894297|FG003|Overall Study|Withdrawal by Subject|0|||
105791833|NCT00648739|364894298|FG004|Overall Study|Withdrawal by Subject|0|||
105791834|NCT00648739|364894299|FG005|Overall Study|Withdrawal by Subject|2|||
105791835|NCT00648739|364894300|FG006|Overall Study|Withdrawal by Subject|0|||
105791836|NCT00648739|364894294|FG000|Overall Study|Lack of Efficacy|0|||
105719665|NCT01756456|364631740|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
105719666|NCT01756456|364631735|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
105719667|NCT01756456|364631736|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
105719668|NCT01756456|364631737|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
105719669|NCT01756456|364631738|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
105719670|NCT01756456|364631739|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
105719671|NCT01756456|364631740|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
105719672|NCT01756456|364631735|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
105719673|NCT01756456|364631736|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
105719674|NCT01756456|364631737|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
105719675|NCT01756456|364631738|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
105719676|NCT01756456|364631739|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
105719677|NCT01756456|364631740|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
105719678|NCT01756456|364631735|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
105719679|NCT01756456|364631736|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
105719680|NCT01756456|364631737|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
105719681|NCT01756456|364631738|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
105719682|NCT01756456|364631739|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
105719683|NCT01756456|364631740|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
105719684|NCT01756456|364631735|FG000|Follow Up Period Phase I/II|Other causes|0|||
105719685|NCT01756456|364631736|FG001|Follow Up Period Phase I/II|Other causes|0|||
105719686|NCT01756456|364631737|FG002|Follow Up Period Phase I/II|Other causes|0|||
105719687|NCT01756456|364631738|FG003|Follow Up Period Phase I/II|Other causes|1|||
105719688|NCT01756456|364631739|FG004|Follow Up Period Phase I/II|Other causes|3|||
105719689|NCT01756456|364631740|FG005|Follow Up Period Phase I/II|Other causes|5|||
105719690|NCT00611247|364631750|FG000|Overall Study|Death|1|||
105719691|NCT00611247|364631751|FG001|Overall Study|Death|5|||
105719692|NCT00611247|364631750|FG000|Overall Study|Lack of Efficacy|1|||
105719693|NCT00611247|364631751|FG001|Overall Study|Lack of Efficacy|16|||
105719694|NCT01285349|364631754|FG000|Overall Study|Lost to Follow-up|27|||
105719695|NCT01285349|364631755|FG001|Overall Study|Lost to Follow-up|20|||
105719696|NCT01285349|364631756|FG002|Overall Study|Lost to Follow-up|27|||
105719697|NCT00243659|364631757|FG000|Overall Study|Withdrawal by Subject|1|||
105719698|NCT00243659|364631758|FG001|Overall Study|Withdrawal by Subject|1|||
105719699|NCT00243659|364631757|FG000|Overall Study|Protocol Violation|1|||
105719700|NCT00243659|364631758|FG001|Overall Study|Protocol Violation|2|||
105719701|NCT03310970|364631759|FG000|Overall Study|Withdrawal by Subject|0|||
105719702|NCT03310970|364631760|FG001|Overall Study|Withdrawal by Subject|1|||
105719703|NCT01273064|364631761|FG000|Overall Study|Adverse Event|5|||
105719704|NCT01273064|364631762|FG001|Overall Study|Adverse Event|1|||
105719705|NCT01273064|364631763|FG002|Overall Study|Adverse Event|3|||
105719706|NCT01273064|364631764|FG003|Overall Study|Adverse Event|2|||
105719707|NCT01273064|364631765|FG004|Overall Study|Adverse Event|1|||
105719708|NCT01273064|364631761|FG000|Overall Study|Withdrawal by Subject|4|||
105719709|NCT01273064|364631762|FG001|Overall Study|Withdrawal by Subject|2|||
105719710|NCT01273064|364631763|FG002|Overall Study|Withdrawal by Subject|2|||
105719711|NCT01273064|364631764|FG003|Overall Study|Withdrawal by Subject|2|||
105719712|NCT01273064|364631765|FG004|Overall Study|Withdrawal by Subject|0|||
105719713|NCT01273064|364631761|FG000|Overall Study|Study Termination|13|||
105719714|NCT01273064|364631762|FG001|Overall Study|Study Termination|27|||
105719715|NCT01273064|364631763|FG002|Overall Study|Study Termination|26|||
105719716|NCT01273064|364631764|FG003|Overall Study|Study Termination|16|||
105719717|NCT01273064|364631765|FG004|Overall Study|Study Termination|8|||
105719718|NCT01273064|364631761|FG000|Overall Study|Lost to Follow-up|1|||
105719719|NCT01273064|364631762|FG001|Overall Study|Lost to Follow-up|0|||
105719720|NCT01273064|364631763|FG002|Overall Study|Lost to Follow-up|0|||
105719721|NCT01273064|364631764|FG003|Overall Study|Lost to Follow-up|0|||
105719722|NCT01273064|364631765|FG004|Overall Study|Lost to Follow-up|0|||
105719723|NCT01273064|364631761|FG000|Overall Study|Physician Decision|0|||
105719724|NCT01273064|364631762|FG001|Overall Study|Physician Decision|0|||
105719725|NCT01273064|364631763|FG002|Overall Study|Physician Decision|0|||
105719726|NCT01273064|364631764|FG003|Overall Study|Physician Decision|0|||
105719727|NCT01273064|364631765|FG004|Overall Study|Physician Decision|1|||
105791837|NCT00648739|364894295|FG001|Overall Study|Lack of Efficacy|0|||
105719728|NCT04666038|364631769|FG000|Overall Study|Progressive Disease|2|||
105719729|NCT04666038|364631770|FG001|Overall Study|Progressive Disease|0|||
105719730|NCT04666038|364631769|FG000|Overall Study|Death|38|||
105719731|NCT04666038|364631770|FG001|Overall Study|Death|32|||
105719732|NCT04666038|364631769|FG000|Overall Study|Withdrawal by Subject|10|||
105719733|NCT04666038|364631770|FG001|Overall Study|Withdrawal by Subject|19|||
105791838|NCT00648739|364894296|FG002|Overall Study|Lack of Efficacy|0|||
105791839|NCT00648739|364894297|FG003|Overall Study|Lack of Efficacy|0|||
105791840|NCT00648739|364894298|FG004|Overall Study|Lack of Efficacy|1|||
105791841|NCT00648739|364894299|FG005|Overall Study|Lack of Efficacy|2|||
105561953|NCT00636610|364052283|FG000|Overall Study|Subject decision to withdraw|15|||
105561954|NCT00636610|364052284|FG001|Overall Study|Subject decision to withdraw|11|||
105561955|NCT00636610|364052283|FG000|Overall Study|Disease progression - radiographic|41|||
105561956|NCT00636610|364052284|FG001|Overall Study|Disease progression - radiographic|51|||
105561957|NCT00636610|364052283|FG000|Overall Study|Disease progression - clinical|8|||
105561958|NCT00636610|364052284|FG001|Overall Study|Disease progression - clinical|3|||
105561959|NCT00636610|364052283|FG000|Overall Study|Reason for discontinuation not available|3|||
105561960|NCT00636610|364052284|FG001|Overall Study|Reason for discontinuation not available|2|||
105561961|NCT00313820|364052286|FG000|Assigned to Treatment|Other|1|||
105561962|NCT00313820|364052287|FG001|Assigned to Treatment|Other|0|||
105561963|NCT00313820|364052286|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
105561964|NCT00313820|364052287|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
105561965|NCT00313820|364052286|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
105561966|NCT00313820|364052287|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
105561967|NCT00313820|364052286|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
105561968|NCT00313820|364052287|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
105561969|NCT00313820|364052286|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
105561970|NCT00313820|364052287|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
105561971|NCT00313820|364052286|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
105561972|NCT00313820|364052287|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
105561973|NCT01515748|364052288|FG000|Overall Study|Withdrawal by Subject|32|||
105561974|NCT01515748|364052289|FG001|Overall Study|Withdrawal by Subject|41|||
105561975|NCT01515748|364052288|FG000|Overall Study|Lost to Follow-up|2|||
105561976|NCT01515748|364052289|FG001|Overall Study|Lost to Follow-up|4|||
105561977|NCT01515748|364052288|FG000|Overall Study|Other than specified above|5|||
105561978|NCT01515748|364052289|FG001|Overall Study|Other than specified above|10|||
105561979|NCT03221387|364052292|FG000|Overall Study|Lost to Follow-up|1|||
105561980|NCT03221387|364052292|FG000|Overall Study|Lung transplant|1|||
105561981|NCT03260868|364052293|FG000|Overall Study|Poor Compliance to Protocol|0|||
105561982|NCT03260868|364052294|FG001|Overall Study|Poor Compliance to Protocol|2|||
105561983|NCT03260868|364052293|FG000|Overall Study|Study Terminated By Sponsor|2|||
105561984|NCT03260868|364052294|FG001|Overall Study|Study Terminated By Sponsor|1|||
105561985|NCT03260868|364052293|FG000|Overall Study|Other than specified above|1|||
105561986|NCT03260868|364052294|FG001|Overall Study|Other than specified above|0|||
105561987|NCT04839965|364052295|FG000|Overall Study|Death|6|||
105561988|NCT04839965|364052296|FG001|Overall Study|Death|6|||
105561989|NCT04839965|364052295|FG000|Overall Study|Lost to Follow-up|1|||
105561990|NCT04839965|364052296|FG001|Overall Study|Lost to Follow-up|0|||
105561991|NCT02048072|364052297|FG000|Overall Study|Adverse Event|3|||
105561992|NCT02048072|364052297|FG000|Overall Study|Lost to Follow-up|1|||
105561993|NCT04102579|364052298|FG000|Overall Study|Withdrawal by Subject|3|||
105561994|NCT04102579|364052299|FG001|Overall Study|Withdrawal by Subject|4|||
105561995|NCT04102579|364052298|FG000|Overall Study|Lost to Follow-up|0|||
105791842|NCT00648739|364894300|FG006|Overall Study|Lack of Efficacy|0|||
105561996|NCT04102579|364052299|FG001|Overall Study|Lost to Follow-up|1|||
105561997|NCT04102579|364052298|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
105561998|NCT04102579|364052299|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
105791843|NCT00648739|364894294|FG000|Overall Study|Investigator Considered it Advisable|0|||
105791844|NCT00648739|364894295|FG001|Overall Study|Investigator Considered it Advisable|0|||
105791845|NCT00648739|364894296|FG002|Overall Study|Investigator Considered it Advisable|0|||
105791846|NCT00648739|364894297|FG003|Overall Study|Investigator Considered it Advisable|0|||
105791847|NCT00648739|364894298|FG004|Overall Study|Investigator Considered it Advisable|0|||
105791848|NCT00648739|364894299|FG005|Overall Study|Investigator Considered it Advisable|1|||
105791849|NCT00648739|364894300|FG006|Overall Study|Investigator Considered it Advisable|1|||
105791850|NCT00648739|364894294|FG000|Overall Study|Death|0|||
105791851|NCT00648739|364894295|FG001|Overall Study|Death|1|||
105791852|NCT00648739|364894296|FG002|Overall Study|Death|0|||
105791853|NCT00648739|364894297|FG003|Overall Study|Death|0|||
105791854|NCT00648739|364894298|FG004|Overall Study|Death|0|||
105791855|NCT00648739|364894299|FG005|Overall Study|Death|0|||
105791856|NCT00648739|364894300|FG006|Overall Study|Death|0|||
105791857|NCT00648739|364894294|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
105791858|NCT00648739|364894295|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
105791859|NCT00648739|364894296|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
105791860|NCT00648739|364894297|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
105791861|NCT00648739|364894298|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
105791862|NCT00648739|364894299|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
105791863|NCT00648739|364894300|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
105791864|NCT00648739|364894294|FG000|Overall Study|Follow-up Visits Not Completed|0|||
105791865|NCT00648739|364894295|FG001|Overall Study|Follow-up Visits Not Completed|1|||
105791866|NCT00648739|364894296|FG002|Overall Study|Follow-up Visits Not Completed|0|||
105791867|NCT00648739|364894297|FG003|Overall Study|Follow-up Visits Not Completed|0|||
105791868|NCT00648739|364894298|FG004|Overall Study|Follow-up Visits Not Completed|0|||
105791869|NCT00648739|364894299|FG005|Overall Study|Follow-up Visits Not Completed|0|||
105791870|NCT00648739|364894300|FG006|Overall Study|Follow-up Visits Not Completed|0|||
105791871|NCT03387423|364894301|FG000|Overall Study|Lost to Follow-up|16|||
105791872|NCT03387423|364894302|FG001|Overall Study|Lost to Follow-up|12|||
105791873|NCT03387423|364894303|FG002|Overall Study|Lost to Follow-up|1|||
105791874|NCT03387423|364894304|FG003|Overall Study|Lost to Follow-up|0|||
105791875|NCT03387423|364894301|FG000|Overall Study|Other|0|||
105791876|NCT03387423|364894302|FG001|Overall Study|Other|3|||
105791877|NCT03387423|364894303|FG002|Overall Study|Other|0|||
105791878|NCT03387423|364894304|FG003|Overall Study|Other|0|||
105791879|NCT03387423|364894301|FG000|Overall Study|Administrative Reason|166|||
105791880|NCT03387423|364894302|FG001|Overall Study|Administrative Reason|89|||
105791881|NCT03387423|364894303|FG002|Overall Study|Administrative Reason|17|||
105791882|NCT03387423|364894304|FG003|Overall Study|Administrative Reason|19|||
105791883|NCT03387423|364894301|FG000|Overall Study|Revocation Consent|76|||
105791884|NCT03387423|364894302|FG001|Overall Study|Revocation Consent|32|||
105791885|NCT03387423|364894303|FG002|Overall Study|Revocation Consent|3|||
105791886|NCT03387423|364894304|FG003|Overall Study|Revocation Consent|5|||
105791887|NCT01371006|364894305|FG000|Overall Study|Adverse Event|1|||
105791888|NCT01371006|364894306|FG001|Overall Study|Adverse Event|0|||
105791889|NCT02856282|364894307|FG000|Overall Study|Withdrawal by Subject|1|||
105791890|NCT02074982|364894308|FG000|Overall Study|Adverse Event|15|||
105791891|NCT02074982|364894309|FG001|Overall Study|Adverse Event|7|||
105791892|NCT02074982|364894308|FG000|Overall Study|Lack of Efficacy|6|||
105791893|NCT02074982|364894309|FG001|Overall Study|Lack of Efficacy|1|||
105791894|NCT02074982|364894308|FG000|Overall Study|Lost to Follow-up|9|||
105791895|NCT02074982|364894309|FG001|Overall Study|Lost to Follow-up|10|||
105791896|NCT02074982|364894308|FG000|Overall Study|Non-compliance with study treatment|0|||
105791897|NCT02074982|364894309|FG001|Overall Study|Non-compliance with study treatment|2|||
105791898|NCT02074982|364894308|FG000|Overall Study|Physician Decision|1|||
105791899|NCT02074982|364894309|FG001|Overall Study|Physician Decision|1|||
105791900|NCT02074982|364894308|FG000|Overall Study|Pregnancy|1|||
105791901|NCT02074982|364894309|FG001|Overall Study|Pregnancy|2|||
105791902|NCT02074982|364894308|FG000|Overall Study|Protocol deviation|4|||
105791903|NCT02074982|364894309|FG001|Overall Study|Protocol deviation|3|||
105791904|NCT02074982|364894308|FG000|Overall Study|Technical problems|0|||
105791905|NCT02074982|364894309|FG001|Overall Study|Technical problems|2|||
105791906|NCT02074982|364894308|FG000|Overall Study|Subject/guardian decision|15|||
105719734|NCT04666038|364631769|FG000|Overall Study|Lost to Follow-up|0|||
105719735|NCT04666038|364631770|FG001|Overall Study|Lost to Follow-up|2|||
105719736|NCT04666038|364631769|FG000|Overall Study|On Study Treatment|46|||
105719737|NCT04666038|364631770|FG001|Overall Study|On Study Treatment|5|||
105719738|NCT04666038|364631769|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
105719739|NCT04666038|364631770|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
105719740|NCT03595280|364631774|FG000|Overall Study|Lost to Follow-up|6|||
105719741|NCT03595280|364631775|FG001|Overall Study|Lost to Follow-up|9|||
105719742|NCT03595280|364631776|FG002|Overall Study|Lost to Follow-up|15|||
105719743|NCT02658812|364631777|FG000|Overall Study|Disease Progression|7|||
105719744|NCT02658812|364631777|FG000|Overall Study|Unrelated to study treatment|1|||
105719745|NCT02658812|364631777|FG000|Overall Study|Adverse Event|1|||
105719746|NCT01818297|364631778|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
105719747|NCT01818297|364631779|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
105719748|NCT01818297|364631778|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
105719749|NCT01818297|364631779|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
105719750|NCT01818297|364631778|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
105719751|NCT01818297|364631779|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
105719752|NCT01512264|364631780|FG000|Overall Study|Lost to Follow-up|0|||
105719753|NCT01512264|364631781|FG001|Overall Study|Lost to Follow-up|0|||
105719754|NCT01512264|364631782|FG002|Overall Study|Lost to Follow-up|0|||
105719755|NCT01512264|364631783|FG003|Overall Study|Lost to Follow-up|1|||
105719756|NCT01194440|364631784|FG000|Baseline (First Dose)|Reason not specified|4|||
105719757|NCT01194440|364631784|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
105719758|NCT01194440|364631784|FG000|Baseline (First Dose)|Change in therapy|1|||
105719759|NCT01194440|364631784|FG000|Baseline (First Dose)|Adverse Event|1|||
105719760|NCT01194440|364631784|FG000|6-months (2nd Dose)|Change in therapy|4|||
105719761|NCT00584870|364631785|FG000|Overall Study|Adverse Event|4|||
105719762|NCT00584870|364631786|FG001|Overall Study|Adverse Event|3|||
105719763|NCT00584870|364631787|FG002|Overall Study|Adverse Event|2|||
105719764|NCT00584870|364631785|FG000|Overall Study|Lost to Follow-up|4|||
105719765|NCT00584870|364631786|FG001|Overall Study|Lost to Follow-up|1|||
105719766|NCT00584870|364631787|FG002|Overall Study|Lost to Follow-up|1|||
105719767|NCT00584870|364631785|FG000|Overall Study|Lack of Efficacy|7|||
105719768|NCT00584870|364631786|FG001|Overall Study|Lack of Efficacy|14|||
105719769|NCT00584870|364631787|FG002|Overall Study|Lack of Efficacy|8|||
105719770|NCT00584870|364631785|FG000|Overall Study|Withdrawal by Subject|10|||
105719771|NCT00584870|364631786|FG001|Overall Study|Withdrawal by Subject|5|||
105719772|NCT00584870|364631787|FG002|Overall Study|Withdrawal by Subject|3|||
105719773|NCT00584870|364631785|FG000|Overall Study|Protocol Violation|1|||
105719774|NCT00584870|364631786|FG001|Overall Study|Protocol Violation|1|||
105719775|NCT00584870|364631787|FG002|Overall Study|Protocol Violation|2|||
105719776|NCT00584870|364631785|FG000|Overall Study|Did not met entrance criteria|1|||
105719777|NCT00584870|364631786|FG001|Overall Study|Did not met entrance criteria|0|||
105719778|NCT00584870|364631787|FG002|Overall Study|Did not met entrance criteria|0|||
105719779|NCT00584870|364631785|FG000|Overall Study|Other|2|||
105719780|NCT00584870|364631786|FG001|Overall Study|Other|0|||
105719781|NCT00584870|364631787|FG002|Overall Study|Other|0|||
105719782|NCT00584870|364631785|FG000|Overall Study|Randomized but not treated|0|||
105719783|NCT00584870|364631786|FG001|Overall Study|Randomized but not treated|1|||
105719784|NCT00584870|364631787|FG002|Overall Study|Randomized but not treated|2|||
105719785|NCT00854828|364631788|FG000|Overall Study|Death|1|||
105719786|NCT00854828|364631789|FG001|Overall Study|Death|0|||
105719787|NCT00854828|364631790|FG002|Overall Study|Death|0|||
105719788|NCT00854828|364631791|FG003|Overall Study|Death|0|||
105719789|NCT00854828|364631788|FG000|Overall Study|Withdrawal by Subject|1|||
105719790|NCT00854828|364631789|FG001|Overall Study|Withdrawal by Subject|1|||
105719791|NCT00854828|364631790|FG002|Overall Study|Withdrawal by Subject|0|||
105719792|NCT00854828|364631791|FG003|Overall Study|Withdrawal by Subject|9|||
105719793|NCT00854828|364631788|FG000|Overall Study|Missed 24mo visit|1|||
105719794|NCT00854828|364631789|FG001|Overall Study|Missed 24mo visit|1|||
105719795|NCT00854828|364631790|FG002|Overall Study|Missed 24mo visit|8|||
105719796|NCT00854828|364631791|FG003|Overall Study|Missed 24mo visit|8|||
105719797|NCT04957290|364631793|FG000|Overall Study|Progressive disease|3|||
105719798|NCT04957290|364631794|FG001|Overall Study|Progressive disease|3|||
105352828|NCT01215435|363295703|FG000|Overall Study|Withdrawal Criteria|8|||
105352829|NCT01215435|363295704|FG001|Overall Study|Withdrawal Criteria|11|||
105719799|NCT04957290|364631795|FG002|Overall Study|Progressive disease|2|||
105719800|NCT04957290|364631796|FG003|Overall Study|Progressive disease|0|||
105719801|NCT04957290|364631797|FG004|Overall Study|Progressive disease|0|||
105719802|NCT04957290|364631798|FG005|Overall Study|Progressive disease|0|||
105719803|NCT04957290|364631793|FG000|Overall Study|Withdrawal by Subject|1|||
105719804|NCT04957290|364631794|FG001|Overall Study|Withdrawal by Subject|0|||
105719805|NCT04957290|364631795|FG002|Overall Study|Withdrawal by Subject|1|||
105719806|NCT04957290|364631796|FG003|Overall Study|Withdrawal by Subject|0|||
105719807|NCT04957290|364631797|FG004|Overall Study|Withdrawal by Subject|0|||
105719808|NCT04957290|364631798|FG005|Overall Study|Withdrawal by Subject|0|||
105719809|NCT04957290|364631793|FG000|Overall Study|Death|0|||
105719810|NCT04957290|364631794|FG001|Overall Study|Death|2|||
105719811|NCT04957290|364631795|FG002|Overall Study|Death|1|||
105719812|NCT04957290|364631796|FG003|Overall Study|Death|0|||
105719813|NCT04957290|364631797|FG004|Overall Study|Death|0|||
105719814|NCT04957290|364631798|FG005|Overall Study|Death|0|||
105719815|NCT04957290|364631793|FG000|Overall Study|non compliance with study drug|0|||
105719816|NCT04957290|364631794|FG001|Overall Study|non compliance with study drug|1|||
105719817|NCT04957290|364631795|FG002|Overall Study|non compliance with study drug|0|||
105719818|NCT04957290|364631796|FG003|Overall Study|non compliance with study drug|0|||
105719819|NCT04957290|364631797|FG004|Overall Study|non compliance with study drug|0|||
105719820|NCT04957290|364631798|FG005|Overall Study|non compliance with study drug|0|||
105719821|NCT04957290|364631793|FG000|Overall Study|none specified.|0|||
105719822|NCT04957290|364631794|FG001|Overall Study|none specified.|1|||
105719823|NCT04957290|364631795|FG002|Overall Study|none specified.|2|||
105719824|NCT04957290|364631796|FG003|Overall Study|none specified.|0|||
105719825|NCT04957290|364631797|FG004|Overall Study|none specified.|0|||
105719826|NCT04957290|364631798|FG005|Overall Study|none specified.|0|||
105719827|NCT04957290|364631793|FG000|Overall Study|unacceptable toxicity|0|||
105719828|NCT04957290|364631794|FG001|Overall Study|unacceptable toxicity|0|||
105791907|NCT02074982|364894309|FG001|Overall Study|Subject/guardian decision|24|||
105561999|NCT04102579|364052298|FG000|Overall Study|Other than Specified|1|||
105562000|NCT04102579|364052299|FG001|Overall Study|Other than Specified|0|||
105719829|NCT04957290|364631795|FG002|Overall Study|unacceptable toxicity|1|||
105791908|NCT02074982|364894308|FG000|Overall Study|Death|0|||
105791909|NCT02074982|364894309|FG001|Overall Study|Death|2|||
105791910|NCT01819467|364894310|FG000|Overall Study|Physician Decision|20|||
105791911|NCT01819467|364894311|FG001|Overall Study|Physician Decision|9|||
105791912|NCT03256526|364894312|FG000|Overall Study|Adverse Event|1|||
105791913|NCT03256526|364894313|FG001|Overall Study|Adverse Event|0|||
105791914|NCT03256526|364894314|FG002|Overall Study|Adverse Event|1|||
105791915|NCT03256526|364894312|FG000|Overall Study|Lost to Follow-up|1|||
105791916|NCT03256526|364894313|FG001|Overall Study|Lost to Follow-up|0|||
105791917|NCT03256526|364894314|FG002|Overall Study|Lost to Follow-up|2|||
105791918|NCT03533608|364894317|FG000|Overall Study|Withdrawal by Subject|3|||
105791919|NCT03533608|364894317|FG000|Overall Study|Physician Decision|2|||
105791920|NCT02325401|364894322|FG000|Overall Study|Withdrawal by Subject|0|||
105791921|NCT02325401|364894323|FG001|Overall Study|Withdrawal by Subject|1|||
105791922|NCT02325401|364894324|FG002|Overall Study|Withdrawal by Subject|1|||
105791923|NCT01817764|364894325|FG000|Overall Study|Adverse Event|7|||
105791924|NCT01817764|364894326|FG001|Overall Study|Adverse Event|10|||
105791925|NCT01817764|364894325|FG000|Overall Study|Lack of Efficacy|9|||
105791926|NCT01817764|364894326|FG001|Overall Study|Lack of Efficacy|7|||
105791927|NCT01817764|364894325|FG000|Overall Study|Protocol Violation|7|||
105791928|NCT01817764|364894326|FG001|Overall Study|Protocol Violation|5|||
105791929|NCT01817764|364894325|FG000|Overall Study|Lost to Follow-up|1|||
105791930|NCT01817764|364894326|FG001|Overall Study|Lost to Follow-up|4|||
105791931|NCT01817764|364894325|FG000|Overall Study|Withdrawal by Subject|10|||
105791932|NCT01817764|364894326|FG001|Overall Study|Withdrawal by Subject|12|||
105791933|NCT03514121|364894327|FG000|Overall Study|Withdrawal by Subject|0|||
105791934|NCT03514121|364894328|FG001|Overall Study|Withdrawal by Subject|0|||
105791935|NCT03514121|364894329|FG002|Overall Study|Withdrawal by Subject|0|||
105791936|NCT03514121|364894330|FG003|Overall Study|Withdrawal by Subject|0|||
105562001|NCT04102579|364052298|FG000|Overall Study|Not Dosed with Study Drug|0|||
105719830|NCT04957290|364631796|FG003|Overall Study|unacceptable toxicity|0|||
105719831|NCT04957290|364631797|FG004|Overall Study|unacceptable toxicity|0|||
105719832|NCT04957290|364631798|FG005|Overall Study|unacceptable toxicity|0|||
105719833|NCT04957290|364631793|FG000|Overall Study|Adverse Event|0|||
105719834|NCT04957290|364631794|FG001|Overall Study|Adverse Event|0|||
105719835|NCT04957290|364631795|FG002|Overall Study|Adverse Event|1|||
105719836|NCT04957290|364631796|FG003|Overall Study|Adverse Event|0|||
105719837|NCT04957290|364631797|FG004|Overall Study|Adverse Event|0|||
105719838|NCT04957290|364631798|FG005|Overall Study|Adverse Event|0|||
105719839|NCT04957290|364631793|FG000|Overall Study|study terminated by sponsor|0|||
105719840|NCT04957290|364631794|FG001|Overall Study|study terminated by sponsor|0|||
105719841|NCT04957290|364631795|FG002|Overall Study|study terminated by sponsor|2|||
105719842|NCT04957290|364631796|FG003|Overall Study|study terminated by sponsor|0|||
105719843|NCT04957290|364631797|FG004|Overall Study|study terminated by sponsor|0|||
105719844|NCT04957290|364631798|FG005|Overall Study|study terminated by sponsor|0|||
105719845|NCT03682120|364631799|FG000|Overall Study|Lost to Follow-up|11|||
105719846|NCT03682120|364631800|FG001|Overall Study|Lost to Follow-up|4|||
105719847|NCT03682120|364631801|FG002|Overall Study|Lost to Follow-up|5|||
105719848|NCT03682120|364631802|FG003|Overall Study|Lost to Follow-up|2|||
105719849|NCT03682120|364631799|FG000|Overall Study|Physician Decision|1|||
105719850|NCT03682120|364631800|FG001|Overall Study|Physician Decision|0|||
105719851|NCT03682120|364631801|FG002|Overall Study|Physician Decision|0|||
105719852|NCT03682120|364631802|FG003|Overall Study|Physician Decision|0|||
105719853|NCT03682120|364631799|FG000|Overall Study|Withdrawal by Subject|1|||
105719854|NCT03682120|364631800|FG001|Overall Study|Withdrawal by Subject|2|||
105719855|NCT03682120|364631801|FG002|Overall Study|Withdrawal by Subject|3|||
105719856|NCT03682120|364631802|FG003|Overall Study|Withdrawal by Subject|0|||
105719857|NCT03682120|364631799|FG000|Overall Study|Death|0|||
105719858|NCT03682120|364631800|FG001|Overall Study|Death|1|||
105791937|NCT03514121|364894331|FG004|Overall Study|Withdrawal by Subject|1|||
105791938|NCT03514121|364894332|FG005|Overall Study|Withdrawal by Subject|2|||
105791939|NCT03514121|364894333|FG006|Overall Study|Withdrawal by Subject|1|||
105791940|NCT03514121|364894334|FG007|Overall Study|Withdrawal by Subject|1|||
105719859|NCT03682120|364631801|FG002|Overall Study|Death|0|||
105719860|NCT03682120|364631802|FG003|Overall Study|Death|0|||
105719861|NCT03682120|364631799|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
105791941|NCT03514121|364894335|FG008|Overall Study|Withdrawal by Subject|7|||
105791942|NCT03514121|364894336|FG009|Overall Study|Withdrawal by Subject|2|||
105791943|NCT03514121|364894327|FG000|Overall Study|Death|0|||
105791944|NCT03514121|364894328|FG001|Overall Study|Death|0|||
105719862|NCT03682120|364631800|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
105719863|NCT03682120|364631801|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
105719864|NCT03682120|364631802|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
105719865|NCT03158220|364631803|FG000|Overall Study|Screen Failure|0|||
105791945|NCT03514121|364894329|FG002|Overall Study|Death|0|||
105791946|NCT03514121|364894330|FG003|Overall Study|Death|0|||
105791947|NCT03514121|364894331|FG004|Overall Study|Death|0|||
105791948|NCT03514121|364894332|FG005|Overall Study|Death|3|||
105791949|NCT03514121|364894333|FG006|Overall Study|Death|2|||
105791950|NCT03514121|364894334|FG007|Overall Study|Death|1|||
105791951|NCT03514121|364894335|FG008|Overall Study|Death|26|||
105791952|NCT03514121|364894336|FG009|Overall Study|Death|3|||
105791953|NCT03514121|364894327|FG000|Overall Study|Lost to Follow-up|0|||
105791954|NCT03514121|364894328|FG001|Overall Study|Lost to Follow-up|0|||
105791955|NCT03514121|364894329|FG002|Overall Study|Lost to Follow-up|1|||
105791956|NCT03514121|364894330|FG003|Overall Study|Lost to Follow-up|0|||
105791957|NCT03514121|364894331|FG004|Overall Study|Lost to Follow-up|0|||
105791958|NCT03514121|364894332|FG005|Overall Study|Lost to Follow-up|0|||
105791959|NCT03514121|364894333|FG006|Overall Study|Lost to Follow-up|0|||
105791960|NCT03514121|364894334|FG007|Overall Study|Lost to Follow-up|0|||
105791961|NCT03514121|364894335|FG008|Overall Study|Lost to Follow-up|1|||
105791962|NCT03514121|364894336|FG009|Overall Study|Lost to Follow-up|0|||
105562002|NCT04102579|364052299|FG001|Overall Study|Not Dosed with Study Drug|1|||
105791963|NCT03514121|364894327|FG000|Overall Study|Adverse Event|0|||
105791964|NCT03514121|364894328|FG001|Overall Study|Adverse Event|0|||
105791965|NCT03514121|364894329|FG002|Overall Study|Adverse Event|0|||
105791966|NCT03514121|364894330|FG003|Overall Study|Adverse Event|0|||
105791967|NCT03514121|364894331|FG004|Overall Study|Adverse Event|0|||
105791968|NCT03514121|364894332|FG005|Overall Study|Adverse Event|0|||
105791969|NCT03514121|364894333|FG006|Overall Study|Adverse Event|1|||
105791970|NCT03514121|364894334|FG007|Overall Study|Adverse Event|0|||
105791971|NCT03514121|364894335|FG008|Overall Study|Adverse Event|0|||
105791972|NCT03514121|364894336|FG009|Overall Study|Adverse Event|0|||
105791973|NCT03514121|364894327|FG000|Overall Study|Other|0|||
105791974|NCT03514121|364894328|FG001|Overall Study|Other|1|||
105791975|NCT03514121|364894329|FG002|Overall Study|Other|1|||
105791976|NCT03514121|364894330|FG003|Overall Study|Other|0|||
105791977|NCT03514121|364894331|FG004|Overall Study|Other|1|||
105791978|NCT03514121|364894332|FG005|Overall Study|Other|2|||
105791979|NCT03514121|364894333|FG006|Overall Study|Other|3|||
105791980|NCT03514121|364894334|FG007|Overall Study|Other|2|||
105791981|NCT03514121|364894335|FG008|Overall Study|Other|7|||
105791982|NCT03514121|364894336|FG009|Overall Study|Other|3|||
105791983|NCT03514121|364894327|FG000|Overall Study|Study termination by Sponsor|0|||
105791984|NCT03514121|364894328|FG001|Overall Study|Study termination by Sponsor|0|||
105791985|NCT03514121|364894329|FG002|Overall Study|Study termination by Sponsor|0|||
105791986|NCT03514121|364894330|FG003|Overall Study|Study termination by Sponsor|0|||
105719866|NCT03158220|364631804|FG001|Overall Study|Screen Failure|1|||
105719867|NCT03158220|364631803|FG000|Overall Study|Withdrawal by Subject|8|||
105719868|NCT03158220|364631804|FG001|Overall Study|Withdrawal by Subject|9|||
105719869|NCT03158220|364631803|FG000|Overall Study|Status unknown|0|||
105719870|NCT03158220|364631804|FG001|Overall Study|Status unknown|1|||
105719871|NCT03158220|364631803|FG000|Overall Study|Lost to Follow-up|8|||
105719872|NCT03158220|364631804|FG001|Overall Study|Lost to Follow-up|5|||
105719873|NCT03158220|364631803|FG000|Overall Study|Physician Decision|1|||
105719874|NCT03158220|364631804|FG001|Overall Study|Physician Decision|0|||
105719875|NCT00996203|364631805|FG000|Overall Study|Adverse Event|3|||
105719876|NCT00996203|364631805|FG000|Overall Study|Lost to Follow-up|1|||
105719877|NCT00996203|364631805|FG000|Overall Study|Lack of Efficacy|1|||
105719878|NCT00996203|364631805|FG000|Overall Study|Protocol Violation|2|||
105719879|NCT03308188|364631806|FG000|Overall Study|Withdrawal by Subject|0|||
105719880|NCT03308188|364631807|FG001|Overall Study|Withdrawal by Subject|3|||
105719881|NCT03308188|364631806|FG000|Overall Study|Death|0|||
105719882|NCT03308188|364631807|FG001|Overall Study|Death|1|||
105719883|NCT01791855|364631808|FG000|Overall Study|Adverse Event|0|||
105791987|NCT03514121|364894331|FG004|Overall Study|Study termination by Sponsor|0|||
105791988|NCT03514121|364894332|FG005|Overall Study|Study termination by Sponsor|0|||
105719884|NCT01791855|364631809|FG001|Overall Study|Adverse Event|0|||
105719885|NCT01791855|364631810|FG002|Overall Study|Adverse Event|0|||
105791989|NCT03514121|364894333|FG006|Overall Study|Study termination by Sponsor|0|||
105791990|NCT03514121|364894334|FG007|Overall Study|Study termination by Sponsor|0|||
105791991|NCT03514121|364894335|FG008|Overall Study|Study termination by Sponsor|11|||
105791992|NCT03514121|364894336|FG009|Overall Study|Study termination by Sponsor|3|||
105791993|NCT03514121|364894327|FG000|Overall Study|Investigator decision|0|||
105791994|NCT03514121|364894328|FG001|Overall Study|Investigator decision|0|||
105719886|NCT01791855|364631811|FG003|Overall Study|Adverse Event|1|||
105719887|NCT01791855|364631808|FG000|Overall Study|Randomized, not treated|0|||
105719888|NCT01791855|364631809|FG001|Overall Study|Randomized, not treated|1|||
105719889|NCT01791855|364631810|FG002|Overall Study|Randomized, not treated|0|||
105719890|NCT01791855|364631811|FG003|Overall Study|Randomized, not treated|0|||
105719891|NCT03686969|364631812|FG000|Overall Study|Study terminated|1|||
105719892|NCT03686969|364631813|FG001|Overall Study|Study terminated|0|||
105719893|NCT00848120|364631815|FG000|Overall Study|Adverse Event|1|||
105719894|NCT00560755|364631816|FG000|Overall Study|Protocol Violation|15|||
105719895|NCT00560755|364631816|FG000|Overall Study|Withdrawal by Subject|26|||
105719896|NCT00560755|364631816|FG000|Overall Study|Lost to Follow-up|9|||
105719897|NCT00560755|364631816|FG000|Overall Study|Adverse Event|8|||
105719898|NCT00560755|364631816|FG000|Overall Study|Physician Decision|2|||
105562003|NCT05899686|364052300|FG000|Overall Study|Protocol Violation|1|||
105562004|NCT00289887|364053597|FG000|Overall Study|Adverse Event|3|||
105719899|NCT00772447|364631820|FG000|Overall Study|Withdrawal by Subject|9|||
105719900|NCT00772447|364631821|FG001|Overall Study|Withdrawal by Subject|5|||
105719901|NCT00772447|364631820|FG000|Overall Study|Physician Decision|4|||
105719902|NCT00772447|364631821|FG001|Overall Study|Physician Decision|8|||
105719903|NCT00772447|364631820|FG000|Overall Study|Lost to Follow-up|2|||
105719904|NCT00772447|364631821|FG001|Overall Study|Lost to Follow-up|4|||
105791995|NCT03514121|364894329|FG002|Overall Study|Investigator decision|0|||
105791996|NCT03514121|364894330|FG003|Overall Study|Investigator decision|0|||
105791997|NCT03514121|364894331|FG004|Overall Study|Investigator decision|0|||
105791998|NCT03514121|364894332|FG005|Overall Study|Investigator decision|0|||
105791999|NCT03514121|364894333|FG006|Overall Study|Investigator decision|0|||
105792000|NCT03514121|364894334|FG007|Overall Study|Investigator decision|0|||
105792001|NCT03514121|364894335|FG008|Overall Study|Investigator decision|1|||
105792002|NCT03514121|364894336|FG009|Overall Study|Investigator decision|0|||
105792003|NCT04930536|364894337|FG000|Overall Study|Adverse Event|1|||
105792004|NCT04930536|364894338|FG001|Overall Study|Adverse Event|0|||
105792005|NCT04930536|364894337|FG000|Overall Study|Disease Progression|2|||
105792006|NCT04930536|364894338|FG001|Overall Study|Disease Progression|0|||
105792007|NCT04930536|364894337|FG000|Overall Study|Patient Decision|4|||
105792008|NCT04930536|364894338|FG001|Overall Study|Patient Decision|2|||
105719905|NCT00772447|364631820|FG000|Overall Study|incorrect enrolment|3|||
105719906|NCT00772447|364631821|FG001|Overall Study|incorrect enrolment|4|||
105719907|NCT00772447|364631820|FG000|Overall Study|Protocol Violation|0|||
105719908|NCT00772447|364631821|FG001|Overall Study|Protocol Violation|1|||
105719909|NCT00772447|364631820|FG000|Overall Study|all others|2|||
105719910|NCT00772447|364631821|FG001|Overall Study|all others|2|||
105719911|NCT01957137|364631851|FG000|Randomized Portion|Adverse Event|1|||
105719912|NCT01957137|364631851|FG000|Randomized Portion|Withdrawal by Subject|1|||
105719913|NCT00927563|364631852|FG000|Overall Study|Lost to Follow-up|1|||
105719914|NCT00927563|364631852|FG000|Overall Study|Withdrawal by Subject|1|||
105719915|NCT02497001|364631855|FG000|Overall Study|Lost to Follow-up|10|||
105719916|NCT02497001|364631856|FG001|Overall Study|Lost to Follow-up|2|||
105719917|NCT02497001|364631857|FG002|Overall Study|Lost to Follow-up|0|||
105719918|NCT02497001|364631858|FG003|Overall Study|Lost to Follow-up|2|||
105719919|NCT02497001|364631855|FG000|Overall Study|Adverse Event|28|||
105719920|NCT02497001|364631856|FG001|Overall Study|Adverse Event|30|||
105719921|NCT02497001|364631857|FG002|Overall Study|Adverse Event|11|||
105719922|NCT02497001|364631858|FG003|Overall Study|Adverse Event|11|||
105719923|NCT02497001|364631855|FG000|Overall Study|Withdrawal by Subject|14|||
105792009|NCT04930536|364894337|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
105792010|NCT04930536|364894338|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
105792011|NCT00398632|364894339|FG000|Overall Study|Withdrawal by Subject|1|||
105792012|NCT00398632|364894339|FG000|Overall Study|Lack of Efficacy|1|||
105719924|NCT02497001|364631856|FG001|Overall Study|Withdrawal by Subject|37|||
105719925|NCT02497001|364631857|FG002|Overall Study|Withdrawal by Subject|19|||
105792013|NCT03692078|364894343|FG000|Overall Study|Adverse Event|0|||
105792014|NCT03692078|364894344|FG001|Overall Study|Adverse Event|0|||
105792015|NCT03692078|364894345|FG002|Overall Study|Adverse Event|0|||
105792016|NCT03692078|364894346|FG003|Overall Study|Adverse Event|0|||
105792017|NCT03692078|364894347|FG004|Overall Study|Adverse Event|0|||
105792018|NCT03692078|364894348|FG005|Overall Study|Adverse Event|1|||
105792019|NCT03692078|364894349|FG006|Overall Study|Adverse Event|0|||
105792020|NCT03692078|364894343|FG000|Overall Study|Enrollment Closed|5|||
105792021|NCT03692078|364894344|FG001|Overall Study|Enrollment Closed|0|||
105792022|NCT03692078|364894345|FG002|Overall Study|Enrollment Closed|0|||
105792023|NCT03692078|364894346|FG003|Overall Study|Enrollment Closed|0|||
105719926|NCT02497001|364631858|FG003|Overall Study|Withdrawal by Subject|15|||
105719927|NCT02497001|364631855|FG000|Overall Study|Physician Decision|5|||
105719928|NCT02497001|364631856|FG001|Overall Study|Physician Decision|11|||
105719929|NCT02497001|364631857|FG002|Overall Study|Physician Decision|5|||
105719930|NCT02497001|364631858|FG003|Overall Study|Physician Decision|1|||
105719931|NCT02497001|364631855|FG000|Overall Study|subjects that were not treated|1|||
105792024|NCT03692078|364894347|FG004|Overall Study|Enrollment Closed|0|||
105792025|NCT03692078|364894348|FG005|Overall Study|Enrollment Closed|0|||
105792026|NCT03692078|364894349|FG006|Overall Study|Enrollment Closed|0|||
105792027|NCT03692078|364894343|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
105792028|NCT03692078|364894344|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
105719932|NCT02497001|364631856|FG001|Overall Study|subjects that were not treated|2|||
105719933|NCT02497001|364631857|FG002|Overall Study|subjects that were not treated|2|||
105719934|NCT02497001|364631858|FG003|Overall Study|subjects that were not treated|1|||
105719935|NCT02497001|364631855|FG000|Overall Study|Major Protocol Deviation|3|||
105719936|NCT02497001|364631856|FG001|Overall Study|Major Protocol Deviation|4|||
105719937|NCT02497001|364631857|FG002|Overall Study|Major Protocol Deviation|4|||
105719938|NCT02497001|364631858|FG003|Overall Study|Major Protocol Deviation|4|||
105792029|NCT03692078|364894345|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
105792030|NCT03692078|364894346|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
105792031|NCT03692078|364894347|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
105792032|NCT03692078|364894348|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
105719939|NCT02497001|364631855|FG000|Overall Study|Lack of Efficacy|10|||
105719940|NCT02497001|364631856|FG001|Overall Study|Lack of Efficacy|16|||
105719941|NCT02497001|364631857|FG002|Overall Study|Lack of Efficacy|6|||
105719942|NCT02497001|364631858|FG003|Overall Study|Lack of Efficacy|6|||
105719943|NCT02497001|364631855|FG000|Overall Study|Protocol Violation|3|||
105719944|NCT02497001|364631856|FG001|Overall Study|Protocol Violation|1|||
105719945|NCT02497001|364631857|FG002|Overall Study|Protocol Violation|3|||
105719946|NCT02497001|364631858|FG003|Overall Study|Protocol Violation|1|||
105719947|NCT02899156|364631861|FG000|Overall Study|Death|1|||
105719948|NCT02899156|364631862|FG001|Overall Study|Death|0|||
105352830|NCT01215435|363295703|FG000|Overall Study|Lost to Follow-up|3|||
105719949|NCT02899156|364631861|FG000|Overall Study|Physician Decision|0|||
105719950|NCT02899156|364631862|FG001|Overall Study|Physician Decision|1|||
105719951|NCT00054132|364631863|FG000|Overall Study|Not Treated|1|||
105719952|NCT01468987|364631864|FG000|Overall Study|Adverse Event|12|||
105719953|NCT01468987|364631865|FG001|Overall Study|Adverse Event|9|||
105719954|NCT01468987|364631864|FG000|Overall Study|Death|4|||
105719955|NCT01468987|364631865|FG001|Overall Study|Death|1|||
105719956|NCT01468987|364631864|FG000|Overall Study|Lost to Follow-up|10|||
105719957|NCT01468987|364631865|FG001|Overall Study|Lost to Follow-up|5|||
105719958|NCT01468987|364631864|FG000|Overall Study|Protocol Violation|8|||
105477930|NCT00910624|363761423|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
105562005|NCT00289887|364053598|FG001|Overall Study|Adverse Event|3|||
105719959|NCT01468987|364631865|FG001|Overall Study|Protocol Violation|2|||
105719960|NCT01468987|364631864|FG000|Overall Study|Withdrawal by Subject|28|||
105719961|NCT01468987|364631865|FG001|Overall Study|Withdrawal by Subject|28|||
105719962|NCT01468987|364631864|FG000|Overall Study|Physician Decision|8|||
105719963|NCT01468987|364631865|FG001|Overall Study|Physician Decision|15|||
105719964|NCT01468987|364631864|FG000|Overall Study|Sponsor Decision|1|||
105719965|NCT01468987|364631865|FG001|Overall Study|Sponsor Decision|0|||
105719966|NCT01795547|364631866|FG000|Overall Study|Adverse Event|16|||
105719967|NCT01795547|364631867|FG001|Overall Study|Adverse Event|27|||
105719968|NCT01795547|364631866|FG000|Overall Study|Lack of Efficacy|8|||
105477931|NCT00910624|363761424|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
105477932|NCT00910624|363761421|FG000|Follow-Up Phase|Administrative|0|||
105477933|NCT00910624|363761422|FG001|Follow-Up Phase|Administrative|1|||
105477934|NCT00910624|363761423|FG002|Follow-Up Phase|Administrative|1|||
105477935|NCT00910624|363761424|FG003|Follow-Up Phase|Administrative|0|||
105719969|NCT01795547|364631867|FG001|Overall Study|Lack of Efficacy|3|||
105719970|NCT01795547|364631866|FG000|Overall Study|Protocol Violation|6|||
105719971|NCT01795547|364631867|FG001|Overall Study|Protocol Violation|4|||
105719972|NCT01795547|364631866|FG000|Overall Study|Lost to Follow-up|2|||
105719973|NCT01795547|364631867|FG001|Overall Study|Lost to Follow-up|5|||
105719974|NCT01795547|364631866|FG000|Overall Study|Withdrawal of consent|7|||
105719975|NCT01795547|364631867|FG001|Overall Study|Withdrawal of consent|12|||
105719976|NCT01795547|364631866|FG000|Overall Study|Not Treated|4|||
105477936|NCT00859638|363761425|FG000|Overall Study|Lost to Follow-up|6|||
105477937|NCT00859638|363761426|FG001|Overall Study|Lost to Follow-up|1|||
105477938|NCT00859638|363761425|FG000|Overall Study|Withdrawal by Subject|3|||
105562006|NCT00289887|364053597|FG000|Overall Study|Lack of Efficacy|3|||
105562007|NCT00289887|364053598|FG001|Overall Study|Lack of Efficacy|11|||
105562008|NCT00289887|364053597|FG000|Overall Study|Lost to Follow-up|3|||
105477939|NCT00859638|363761426|FG001|Overall Study|Withdrawal by Subject|2|||
105719977|NCT01795547|364631867|FG001|Overall Study|Not Treated|10|||
105719978|NCT01795547|364631866|FG000|Overall Study|Non-compliance with IMP|1|||
105719979|NCT01795547|364631867|FG001|Overall Study|Non-compliance with IMP|1|||
105719980|NCT01795547|364631866|FG000|Overall Study|Others|4|||
105719981|NCT01795547|364631867|FG001|Overall Study|Others|1|||
105719982|NCT01795547|364631866|FG000|Overall Study|Not stated|0|||
105719983|NCT01795547|364631867|FG001|Overall Study|Not stated|1|||
105719984|NCT04722991|364631870|FG000|Overall Study|Adverse Event|12|||
105719985|NCT04722991|364631871|FG001|Overall Study|Adverse Event|4|||
105719986|NCT04722991|364631870|FG000|Overall Study|Death|2|||
105719987|NCT04722991|364631871|FG001|Overall Study|Death|0|||
105719988|NCT04722991|364631870|FG000|Overall Study|Lost to Follow-up|1|||
105719989|NCT04722991|364631871|FG001|Overall Study|Lost to Follow-up|1|||
105719990|NCT04722991|364631870|FG000|Overall Study|Withdrawal cirterion met|2|||
105719991|NCT04722991|364631871|FG001|Overall Study|Withdrawal cirterion met|2|||
105719992|NCT04722991|364631870|FG000|Overall Study|Other|1|||
105719993|NCT04722991|364631871|FG001|Overall Study|Other|0|||
105719994|NCT04722991|364631870|FG000|Overall Study|Non-compliance|0|||
105719995|NCT04722991|364631871|FG001|Overall Study|Non-compliance|1|||
105719996|NCT04722991|364631870|FG000|Overall Study|Withdrawal by Subject|0|||
105719997|NCT04722991|364631871|FG001|Overall Study|Withdrawal by Subject|1|||
105719998|NCT03186989|364631872|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105719999|NCT03186989|364631873|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105720000|NCT03186989|364631874|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
105720001|NCT03186989|364631875|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
105720002|NCT03186989|364631876|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
105720003|NCT03186989|364631877|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105477940|NCT00859638|363761425|FG000|Overall Study|Ill health|1|||
105477941|NCT00859638|363761426|FG001|Overall Study|Ill health|1|||
105477942|NCT00412373|363761427|FG000|Overall Study|Adverse Event|8|||
105477943|NCT00412373|363761428|FG001|Overall Study|Adverse Event|13|||
105477944|NCT00412373|363761427|FG000|Overall Study|Lack of Efficacy|16|||
105477945|NCT00412373|363761428|FG001|Overall Study|Lack of Efficacy|22|||
105477946|NCT00412373|363761427|FG000|Overall Study|Lost to Follow-up|7|||
105477947|NCT00412373|363761428|FG001|Overall Study|Lost to Follow-up|13|||
105477948|NCT00412373|363761427|FG000|Overall Study|Withdrawal by Subject|8|||
105477949|NCT00412373|363761428|FG001|Overall Study|Withdrawal by Subject|27|||
105477950|NCT00412373|363761427|FG000|Overall Study|Other|2|||
105477951|NCT00412373|363761428|FG001|Overall Study|Other|2|||
105477952|NCT02969408|363761430|FG000|Overall Study|Adverse Event|2|||
105477953|NCT02969408|363761430|FG000|Overall Study|Withdrawal by Subject|8|||
105477954|NCT02969408|363761430|FG000|Overall Study|Lost to Follow-up|4|||
105477955|NCT02969408|363761430|FG000|Overall Study|Protocol Violation|1|||
105477956|NCT02969408|363761430|FG000|Overall Study|Other than specified|1|||
105477957|NCT01104376|363761431|FG000|Overall Study|Withdrawal by Subject|15|||
105477958|NCT01104376|363761431|FG000|Overall Study|Consented but excluded after labs|13|||
105477959|NCT00797966|363761432|FG000|Phase A|Lost to Follow-up|0|||
105477960|NCT00797966|363761433|FG001|Phase A|Lost to Follow-up|0|||
105477961|NCT00797966|363761434|FG002|Phase A|Lost to Follow-up|0|||
105477962|NCT00797966|363761435|FG003|Phase A|Lost to Follow-up|0|||
105477963|NCT00797966|363761436|FG004|Phase A|Lost to Follow-up|33|||
105477964|NCT00797966|363761437|FG005|Phase A|Lost to Follow-up|0|||
105477965|NCT00797966|363761432|FG000|Phase A|Adverse Event|0|||
105477966|NCT00797966|363761433|FG001|Phase A|Adverse Event|0|||
105477967|NCT00797966|363761434|FG002|Phase A|Adverse Event|0|||
105477968|NCT00797966|363761435|FG003|Phase A|Adverse Event|0|||
105477969|NCT00797966|363761436|FG004|Phase A|Adverse Event|46|||
105477970|NCT00797966|363761437|FG005|Phase A|Adverse Event|0|||
105477971|NCT00797966|363761432|FG000|Phase A|Met withdrawal criteria|0|||
105477972|NCT00797966|363761433|FG001|Phase A|Met withdrawal criteria|0|||
105477973|NCT00797966|363761434|FG002|Phase A|Met withdrawal criteria|0|||
105477974|NCT00797966|363761435|FG003|Phase A|Met withdrawal criteria|0|||
105477975|NCT00797966|363761436|FG004|Phase A|Met withdrawal criteria|4|||
105477976|NCT00797966|363761437|FG005|Phase A|Met withdrawal criteria|0|||
105477977|NCT00797966|363761432|FG000|Phase A|Physician Decision|0|||
105477978|NCT00797966|363761433|FG001|Phase A|Physician Decision|0|||
105477979|NCT00797966|363761434|FG002|Phase A|Physician Decision|0|||
105477980|NCT00797966|363761435|FG003|Phase A|Physician Decision|0|||
105477981|NCT00797966|363761436|FG004|Phase A|Physician Decision|13|||
105477982|NCT00797966|363761437|FG005|Phase A|Physician Decision|0|||
105477983|NCT00797966|363761432|FG000|Phase A|Withdrawal by Subject|0|||
105477984|NCT00797966|363761433|FG001|Phase A|Withdrawal by Subject|0|||
105477985|NCT00797966|363761434|FG002|Phase A|Withdrawal by Subject|0|||
105477986|NCT00797966|363761435|FG003|Phase A|Withdrawal by Subject|0|||
105477987|NCT00797966|363761436|FG004|Phase A|Withdrawal by Subject|33|||
105477988|NCT00797966|363761437|FG005|Phase A|Withdrawal by Subject|0|||
105477989|NCT00797966|363761432|FG000|Phase A|Protocol deviation|0|||
105477990|NCT00797966|363761433|FG001|Phase A|Protocol deviation|0|||
105477991|NCT00797966|363761434|FG002|Phase A|Protocol deviation|0|||
105720004|NCT03186989|364631878|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105720005|NCT03186989|364631879|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105477992|NCT00797966|363761435|FG003|Phase A|Protocol deviation|0|||
105477993|NCT00797966|363761436|FG004|Phase A|Protocol deviation|56|||
105477994|NCT00797966|363761437|FG005|Phase A|Protocol deviation|0|||
105477995|NCT00797966|363761432|FG000|Phase B|Lost to Follow-up|0|||
105477996|NCT00797966|363761433|FG001|Phase B|Lost to Follow-up|1|||
105477997|NCT00797966|363761434|FG002|Phase B|Lost to Follow-up|3|||
105477998|NCT00797966|363761435|FG003|Phase B|Lost to Follow-up|0|||
105477999|NCT00797966|363761436|FG004|Phase B|Lost to Follow-up|0|||
105478000|NCT00797966|363761437|FG005|Phase B|Lost to Follow-up|0|||
105478001|NCT00797966|363761432|FG000|Phase B|Adverse Event|2|||
105478002|NCT00797966|363761433|FG001|Phase B|Adverse Event|1|||
105478003|NCT00797966|363761434|FG002|Phase B|Adverse Event|3|||
105478004|NCT00797966|363761435|FG003|Phase B|Adverse Event|1|||
105478005|NCT00797966|363761436|FG004|Phase B|Adverse Event|0|||
105478006|NCT00797966|363761437|FG005|Phase B|Adverse Event|0|||
105478007|NCT00797966|363761432|FG000|Phase B|Met Withdrawal Criteria|3|||
105562009|NCT00289887|364053598|FG001|Overall Study|Lost to Follow-up|3|||
105562010|NCT00289887|364053597|FG000|Overall Study|Protocol Violation|3|||
105562011|NCT00289887|364053598|FG001|Overall Study|Protocol Violation|1|||
105720006|NCT03186989|364631880|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105720007|NCT03186989|364631881|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105720008|NCT03186989|364631882|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105720009|NCT03186989|364631872|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720010|NCT03186989|364631873|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720011|NCT03186989|364631874|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720012|NCT03186989|364631875|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720013|NCT03186989|364631876|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720014|NCT03186989|364631877|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
105720015|NCT03186989|364631878|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720016|NCT03186989|364631879|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720017|NCT03186989|364631880|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720018|NCT03186989|364631881|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720019|NCT03186989|364631882|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720020|NCT03186989|364631872|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720021|NCT03186989|364631873|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720022|NCT03186989|364631874|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720023|NCT03186989|364631875|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720024|NCT03186989|364631876|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720025|NCT03186989|364631877|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720026|NCT03186989|364631878|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
105720027|NCT03186989|364631879|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720028|NCT03186989|364631880|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720029|NCT03186989|364631881|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720030|NCT03186989|364631882|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720031|NCT03186989|364631872|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720032|NCT03186989|364631873|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720033|NCT03186989|364631874|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720034|NCT03186989|364631875|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720035|NCT03186989|364631876|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720036|NCT03186989|364631877|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
105720037|NCT03186989|364631878|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
105720038|NCT03186989|364631879|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720039|NCT03186989|364631880|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
105720040|NCT03186989|364631881|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720041|NCT03186989|364631882|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720042|NCT00413959|364631883|FG000|Overall Study|Pt had only one cycle.|1|||
105720043|NCT01459614|364631888|FG000|Overall Study|Adverse Event|1|||
105720044|NCT01459614|364631889|FG001|Overall Study|Adverse Event|0|||
105720045|NCT01506882|364631890|FG000|Overall Study|Lack of Efficacy|4|||
105720046|NCT01506882|364631891|FG001|Overall Study|Lack of Efficacy|3|||
105720047|NCT01506882|364631890|FG000|Overall Study|Lost to Follow-up|1|||
105720048|NCT01506882|364631891|FG001|Overall Study|Lost to Follow-up|0|||
105720049|NCT01506882|364631890|FG000|Overall Study|Withdrawal by Subject|9|||
105720050|NCT01506882|364631891|FG001|Overall Study|Withdrawal by Subject|3|||
105720051|NCT01506882|364631890|FG000|Overall Study|SAE, non-fatal|2|||
105720052|NCT01506882|364631891|FG001|Overall Study|SAE, non-fatal|0|||
105720053|NCT01506882|364631890|FG000|Overall Study|AE, non-serious non-fatal|3|||
105720054|NCT01506882|364631891|FG001|Overall Study|AE, non-serious non-fatal|1|||
105720055|NCT01506882|364631890|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
105720056|NCT01506882|364631891|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
105720057|NCT01506882|364631890|FG000|Overall Study|Other Reason|2|||
105720058|NCT01506882|364631891|FG001|Overall Study|Other Reason|0|||
105720059|NCT00630331|364631892|FG000|Overall Study|Death|2|||
105720060|NCT00630331|364631893|FG001|Overall Study|Death|1|||
105720061|NCT00630331|364631894|FG002|Overall Study|Death|1|||
105720062|NCT00630331|364631892|FG000|Overall Study|Adverse Event|1|||
105562012|NCT00289887|364053597|FG000|Overall Study|Withdrawal by Subject|3|||
105720063|NCT00630331|364631893|FG001|Overall Study|Adverse Event|0|||
105720064|NCT00630331|364631894|FG002|Overall Study|Adverse Event|0|||
105720065|NCT00630331|364631892|FG000|Overall Study|Withdrawal by Subject|12|||
105720066|NCT00630331|364631893|FG001|Overall Study|Withdrawal by Subject|7|||
105720067|NCT00630331|364631894|FG002|Overall Study|Withdrawal by Subject|5|||
105720068|NCT00630331|364631892|FG000|Overall Study|Lost to Follow-up|175|||
105562013|NCT00289887|364053598|FG001|Overall Study|Withdrawal by Subject|8|||
105562014|NCT00289887|364053597|FG000|Overall Study|Other|7|||
105720069|NCT00630331|364631893|FG001|Overall Study|Lost to Follow-up|143|||
105720070|NCT00630331|364631894|FG002|Overall Study|Lost to Follow-up|170|||
105720071|NCT00630331|364631892|FG000|Overall Study|Inappropriate enrollment|3|||
105720072|NCT00630331|364631893|FG001|Overall Study|Inappropriate enrollment|6|||
105720073|NCT00630331|364631894|FG002|Overall Study|Inappropriate enrollment|3|||
105720074|NCT00630331|364631892|FG000|Overall Study|Unable to classify|9|||
105720075|NCT00630331|364631893|FG001|Overall Study|Unable to classify|4|||
105720076|NCT00630331|364631894|FG002|Overall Study|Unable to classify|3|||
105720077|NCT00630331|364631892|FG000|Overall Study|Protocol Violation|4|||
105720078|NCT00630331|364631893|FG001|Overall Study|Protocol Violation|5|||
105720079|NCT00630331|364631894|FG002|Overall Study|Protocol Violation|6|||
105720080|NCT00821678|364631897|FG000|Overall Study|Withdrawal by Subject|8|||
105720081|NCT00821678|364631898|FG001|Overall Study|Withdrawal by Subject|0|||
105720082|NCT00821678|364631897|FG000|Overall Study|Lost to Follow-up|13|||
105720083|NCT00821678|364631898|FG001|Overall Study|Lost to Follow-up|12|||
105720084|NCT00821678|364631897|FG000|Overall Study|Death|0|||
105720085|NCT00821678|364631898|FG001|Overall Study|Death|2|||
105760740|NCT01079195|364776172|FG000|Overall Study|Lack of Effectiveness|12|||
105760741|NCT01079195|364776172|FG000|Overall Study|Physician Decision|4|||
105760742|NCT01079195|364776172|FG000|Overall Study|Improved Status of Participant|4|||
105760743|NCT01079195|364776172|FG000|Overall Study|No Follow-up Documentation Available|4|||
105760744|NCT01079195|364776172|FG000|Overall Study|Non-compliance|2|||
105760745|NCT02671760|364776174|FG000|Overall Study|Lost to Follow-up|0|||
105760746|NCT02671760|364776175|FG001|Overall Study|Lost to Follow-up|1|||
105760747|NCT02671760|364776176|FG002|Overall Study|Lost to Follow-up|0|||
105760748|NCT01576406|364776183|FG000|Overall Study|Lost to Follow-up|1|||
105760749|NCT01576406|364776184|FG001|Overall Study|Lost to Follow-up|2|||
105760750|NCT01576406|364776185|FG002|Overall Study|Lost to Follow-up|0|||
105760751|NCT01576406|364776186|FG003|Overall Study|Lost to Follow-up|0|||
105760752|NCT01576406|364776187|FG004|Overall Study|Lost to Follow-up|0|||
105760753|NCT01576406|364776188|FG005|Overall Study|Lost to Follow-up|0|||
105760754|NCT01576406|364776183|FG000|Overall Study|Death|3|||
105760755|NCT01576406|364776184|FG001|Overall Study|Death|4|||
105760756|NCT01576406|364776185|FG002|Overall Study|Death|8|||
105760757|NCT01576406|364776186|FG003|Overall Study|Death|5|||
105760758|NCT01576406|364776187|FG004|Overall Study|Death|7|||
105760759|NCT01576406|364776188|FG005|Overall Study|Death|9|||
105760760|NCT01576406|364776183|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
105760761|NCT01576406|364776184|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
105760762|NCT01576406|364776185|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
105760763|NCT01576406|364776186|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
105760764|NCT01576406|364776187|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
105760765|NCT01576406|364776188|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
105760766|NCT01576406|364776183|FG000|Overall Study|Withdrawal the consent|2|||
105760767|NCT01576406|364776184|FG001|Overall Study|Withdrawal the consent|2|||
105792033|NCT03692078|364894349|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
105792034|NCT03692078|364894343|FG000|Overall Study|Withdrawal by Subject|0|||
105792035|NCT03692078|364894344|FG001|Overall Study|Withdrawal by Subject|2|||
105792036|NCT03692078|364894345|FG002|Overall Study|Withdrawal by Subject|0|||
105792037|NCT03692078|364894346|FG003|Overall Study|Withdrawal by Subject|1|||
105792038|NCT03692078|364894347|FG004|Overall Study|Withdrawal by Subject|5|||
105792039|NCT03692078|364894348|FG005|Overall Study|Withdrawal by Subject|3|||
105792040|NCT03692078|364894349|FG006|Overall Study|Withdrawal by Subject|3|||
105792041|NCT03576131|364894350|FG000|Overall Study|Investigator decision|0|||
105792042|NCT03576131|364894351|FG001|Overall Study|Investigator decision|0|||
105792043|NCT03576131|364894352|FG002|Overall Study|Investigator decision|0|||
105792044|NCT03576131|364894353|FG003|Overall Study|Investigator decision|1|||
105792045|NCT03576131|364894354|FG004|Overall Study|Investigator decision|0|||
105792046|NCT03576131|364894355|FG005|Overall Study|Investigator decision|1|||
105792047|NCT03576131|364894356|FG006|Overall Study|Investigator decision|0|||
105792048|NCT03576131|364894357|FG007|Overall Study|Investigator decision|0|||
105792049|NCT03576131|364894350|FG000|Overall Study|Withdrawal by Subject|1|||
105792050|NCT03576131|364894351|FG001|Overall Study|Withdrawal by Subject|1|||
105792051|NCT03576131|364894352|FG002|Overall Study|Withdrawal by Subject|0|||
105478008|NCT00797966|363761433|FG001|Phase B|Met Withdrawal Criteria|3|||
105792052|NCT03576131|364894353|FG003|Overall Study|Withdrawal by Subject|1|||
105792053|NCT03576131|364894354|FG004|Overall Study|Withdrawal by Subject|2|||
105792054|NCT03576131|364894355|FG005|Overall Study|Withdrawal by Subject|3|||
105792055|NCT03576131|364894356|FG006|Overall Study|Withdrawal by Subject|1|||
105792056|NCT03576131|364894357|FG007|Overall Study|Withdrawal by Subject|0|||
105792057|NCT03576131|364894350|FG000|Overall Study|Death|3|||
105792058|NCT03576131|364894351|FG001|Overall Study|Death|3|||
105792059|NCT03576131|364894352|FG002|Overall Study|Death|1|||
105792060|NCT03576131|364894353|FG003|Overall Study|Death|5|||
105792061|NCT03576131|364894354|FG004|Overall Study|Death|4|||
105792062|NCT03576131|364894355|FG005|Overall Study|Death|1|||
105792063|NCT03576131|364894356|FG006|Overall Study|Death|0|||
105792064|NCT03576131|364894357|FG007|Overall Study|Death|1|||
105792065|NCT03576131|364894350|FG000|Overall Study|New anti-cancer treatment|5|||
105792066|NCT03576131|364894351|FG001|Overall Study|New anti-cancer treatment|1|||
105792067|NCT03576131|364894352|FG002|Overall Study|New anti-cancer treatment|2|||
105792068|NCT03576131|364894353|FG003|Overall Study|New anti-cancer treatment|3|||
105792069|NCT03576131|364894354|FG004|Overall Study|New anti-cancer treatment|0|||
105792070|NCT03576131|364894355|FG005|Overall Study|New anti-cancer treatment|0|||
105792071|NCT03576131|364894356|FG006|Overall Study|New anti-cancer treatment|0|||
105792072|NCT03576131|364894357|FG007|Overall Study|New anti-cancer treatment|0|||
105792073|NCT03576131|364894350|FG000|Overall Study|Unspecified reason|0|||
105792074|NCT03576131|364894351|FG001|Overall Study|Unspecified reason|0|||
105792075|NCT03576131|364894352|FG002|Overall Study|Unspecified reason|1|||
105792076|NCT03576131|364894353|FG003|Overall Study|Unspecified reason|1|||
105792077|NCT03576131|364894354|FG004|Overall Study|Unspecified reason|1|||
105792078|NCT03576131|364894355|FG005|Overall Study|Unspecified reason|1|||
105792079|NCT03576131|364894356|FG006|Overall Study|Unspecified reason|0|||
105792080|NCT03576131|364894357|FG007|Overall Study|Unspecified reason|0|||
105792081|NCT03576131|364894350|FG000|Overall Study|Subject non-compliance|0|||
105792082|NCT03576131|364894351|FG001|Overall Study|Subject non-compliance|0|||
105792083|NCT03576131|364894352|FG002|Overall Study|Subject non-compliance|0|||
105792084|NCT03576131|364894353|FG003|Overall Study|Subject non-compliance|0|||
105792085|NCT03576131|364894354|FG004|Overall Study|Subject non-compliance|0|||
105792086|NCT03576131|364894355|FG005|Overall Study|Subject non-compliance|1|||
105792087|NCT03576131|364894356|FG006|Overall Study|Subject non-compliance|0|||
105792088|NCT03576131|364894357|FG007|Overall Study|Subject non-compliance|0|||
105792089|NCT04285983|364894358|FG000|Overall Study|Protocol Violation|6|||
105792090|NCT01569594|364894361|FG000|Overall Study|Physician Decision|4|||
105792091|NCT01569594|364894361|FG000|Overall Study|Death|13|||
105792092|NCT01569594|364894361|FG000|Overall Study|Lost to Follow-up|22|||
105792093|NCT01569594|364894361|FG000|Overall Study|Adverse Event|2|||
105792094|NCT01569594|364894361|FG000|Overall Study|Withdrawal by Subject|13|||
105792095|NCT01569594|364894361|FG000|Overall Study|Other|4|||
105792096|NCT01569594|364894361|FG000|Overall Study|No ECM used|9|||
105792097|NCT00422058|364894362|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
105792098|NCT00422058|364894363|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
105792099|NCT00422058|364894364|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
105792100|NCT00422058|364894365|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
105792101|NCT00422058|364894366|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
105792102|NCT00422058|364894367|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
105792103|NCT00422058|364894362|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
105792104|NCT00422058|364894363|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
105792105|NCT00422058|364894364|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
105792106|NCT00422058|364894365|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
105792107|NCT00422058|364894366|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
105792108|NCT00422058|364894367|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
105792109|NCT00422058|364894362|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
105792110|NCT00422058|364894363|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
105792111|NCT00422058|364894364|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
105792112|NCT00422058|364894365|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
105792113|NCT00422058|364894366|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
105792114|NCT00422058|364894367|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
105720086|NCT00778830|364633899|FG000|Overall Study|Ongoing at data cut-off|0|||
105720087|NCT00778830|364633900|FG001|Overall Study|Ongoing at data cut-off|1|||
105720088|NCT02338843|364633901|FG000|Overall Study|Adverse Event|2|||
105720089|NCT02338843|364633902|FG001|Overall Study|Adverse Event|1|||
105720090|NCT02338843|364633901|FG000|Overall Study|Death|40|||
105720091|NCT02338843|364633902|FG001|Overall Study|Death|53|||
105720092|NCT02338843|364633901|FG000|Overall Study|Physician Decision|1|||
105720093|NCT02338843|364633902|FG001|Overall Study|Physician Decision|0|||
105720094|NCT02338843|364633901|FG000|Overall Study|Withdrawal by Subject|0|||
105720095|NCT02338843|364633902|FG001|Overall Study|Withdrawal by Subject|2|||
105720096|NCT02338843|364633901|FG000|Overall Study|Subject Recovered|0|||
105720097|NCT02338843|364633902|FG001|Overall Study|Subject Recovered|2|||
105720098|NCT02338843|364633901|FG000|Overall Study|Discontinued prior to randomizat|1|||
105720099|NCT02338843|364633902|FG001|Overall Study|Discontinued prior to randomizat|0|||
105720100|NCT02591615|364633903|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
105720101|NCT02591615|364633904|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
105720102|NCT02591615|364633905|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
105720103|NCT02591615|364633906|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
105720104|NCT02591615|364633903|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
105720105|NCT02591615|364633904|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
105720106|NCT02591615|364633905|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
105720107|NCT02591615|364633906|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
105720108|NCT02591615|364633903|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
105720109|NCT02591615|364633904|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
105720110|NCT02591615|364633905|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
105720111|NCT02591615|364633906|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
105720112|NCT02591615|364633903|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
105720113|NCT02591615|364633904|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
105720114|NCT02591615|364633905|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
105720115|NCT02591615|364633906|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
105720116|NCT02591615|364633903|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
105720117|NCT02591615|364633904|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
105720118|NCT02591615|364633905|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
105720119|NCT02591615|364633906|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
105720120|NCT02591615|364633903|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
105720121|NCT02591615|364633904|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
105720122|NCT02591615|364633905|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
105792115|NCT00422058|364894362|FG000|Double-Blind, Week 0-20|Other|11|||
105478009|NCT00797966|363761434|FG002|Phase B|Met Withdrawal Criteria|6|||
105720123|NCT02591615|364633906|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
105720124|NCT02591615|364633903|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
105720125|NCT02591615|364633904|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
105720126|NCT02591615|364633905|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
105720127|NCT02591615|364633906|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
105720128|NCT02591615|364633903|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
105720129|NCT02591615|364633904|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
105792116|NCT00422058|364894363|FG001|Double-Blind, Week 0-20|Other|3|||
105792117|NCT00422058|364894364|FG002|Double-Blind, Week 0-20|Other|8|||
105792118|NCT00422058|364894365|FG003|Double-Blind, Week 0-20|Other|8|||
105720130|NCT02591615|364633905|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
105720131|NCT02591615|364633906|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
105720132|NCT02591615|364633903|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
105792119|NCT00422058|364894366|FG004|Double-Blind, Week 0-20|Other|4|||
105792120|NCT00422058|364894367|FG005|Double-Blind, Week 0-20|Other|10|||
105720133|NCT02591615|364633904|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
105720134|NCT02591615|364633905|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
105720135|NCT02591615|364633906|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
105720136|NCT02591615|364633903|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
105720137|NCT02591615|364633904|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
105720138|NCT02591615|364633905|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
105720139|NCT02591615|364633906|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
105720140|NCT02591615|364633903|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
105720141|NCT02591615|364633904|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
105720142|NCT02591615|364633905|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
105720143|NCT02591615|364633906|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
105720144|NCT02591615|364633903|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
105720145|NCT02591615|364633904|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
105720146|NCT02591615|364633905|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
105720147|NCT02591615|364633906|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
105720148|NCT02591615|364633903|FG000|Maintenance MK-3475|Adverse Event|0|||
105720149|NCT02591615|364633904|FG001|Maintenance MK-3475|Adverse Event|3|||
105720150|NCT02591615|364633905|FG002|Maintenance MK-3475|Adverse Event|1|||
105720151|NCT02591615|364633906|FG003|Maintenance MK-3475|Adverse Event|2|||
105792121|NCT00422058|364894362|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
105792122|NCT00422058|364894363|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
105792123|NCT00422058|364894364|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
105792124|NCT00422058|364894365|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
105792125|NCT00422058|364894366|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
105792126|NCT00422058|364894367|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
105792127|NCT00422058|364894362|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
105792128|NCT00422058|364894363|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
105792129|NCT00422058|364894364|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
105792130|NCT00422058|364894365|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
105792131|NCT00422058|364894366|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
105792132|NCT00422058|364894367|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
105792133|NCT00422058|364894362|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
105792134|NCT00422058|364894363|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
105792135|NCT00422058|364894364|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
105792136|NCT00422058|364894365|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
105792137|NCT00422058|364894366|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
105792138|NCT00422058|364894367|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
105792139|NCT00422058|364894362|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
105792140|NCT00422058|364894363|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
105792141|NCT00422058|364894364|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
105792142|NCT00422058|364894365|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
105792143|NCT00422058|364894366|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
105792144|NCT00422058|364894367|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
105792145|NCT00422058|364894362|FG000|Open-Label Extension, Week 20-104|Other|13|||
105792146|NCT00422058|364894363|FG001|Open-Label Extension, Week 20-104|Other|14|||
105792147|NCT00422058|364894364|FG002|Open-Label Extension, Week 20-104|Other|6|||
105792148|NCT00422058|364894365|FG003|Open-Label Extension, Week 20-104|Other|13|||
105792149|NCT00422058|364894366|FG004|Open-Label Extension, Week 20-104|Other|16|||
105792150|NCT00422058|364894367|FG005|Open-Label Extension, Week 20-104|Other|18|||
105792151|NCT00054275|364894371|FG000|Overall Study|Withdrawal by Subject|4|||
105792152|NCT00054275|364894371|FG000|Overall Study|Adverse Event|5|||
105792153|NCT00054275|364894371|FG000|Overall Study|Progressive disease in cycle 1|1|||
105792154|NCT00054275|364894371|FG000|Overall Study|Physician Decision|1|||
105792155|NCT02780115|364894372|FG000|Overall Study|Withdrawal by Subject|0|||
105792156|NCT02780115|364894373|FG001|Overall Study|Withdrawal by Subject|1|||
105792157|NCT02780115|364894374|FG002|Overall Study|Withdrawal by Subject|1|||
105792158|NCT02780115|364894375|FG003|Overall Study|Withdrawal by Subject|0|||
105478010|NCT00797966|363761435|FG003|Phase B|Met Withdrawal Criteria|1|||
105478011|NCT00797966|363761436|FG004|Phase B|Met Withdrawal Criteria|0|||
105720152|NCT02591615|364633903|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
105792159|NCT02780115|364894376|FG004|Overall Study|Withdrawal by Subject|0|||
105792160|NCT02780115|364894372|FG000|Overall Study|Adverse Event|0|||
105792161|NCT02780115|364894373|FG001|Overall Study|Adverse Event|0|||
105478012|NCT00797966|363761437|FG005|Phase B|Met Withdrawal Criteria|0|||
105720153|NCT02591615|364633904|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
105352831|NCT01215435|363295704|FG001|Overall Study|Lost to Follow-up|0|||
105352832|NCT01215435|363295703|FG000|Overall Study|Unclassified|5|||
105352833|NCT01215435|363295704|FG001|Overall Study|Unclassified|5|||
105352834|NCT01270321|363296985|FG000|Overall Study|Death|3|||
105352835|NCT01270321|363296986|FG001|Overall Study|Death|1|||
105720154|NCT02591615|364633905|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
105720155|NCT02591615|364633906|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
105720156|NCT02591615|364633903|FG000|Maintenance MK-3475|Death|0|||
105720157|NCT02591615|364633904|FG001|Maintenance MK-3475|Death|1|||
105720158|NCT02591615|364633905|FG002|Maintenance MK-3475|Death|1|||
105720159|NCT02591615|364633906|FG003|Maintenance MK-3475|Death|0|||
105720160|NCT02591615|364633903|FG000|Maintenance MK-3475|Physician discretion|0|||
105720161|NCT02591615|364633904|FG001|Maintenance MK-3475|Physician discretion|0|||
105720162|NCT02591615|364633905|FG002|Maintenance MK-3475|Physician discretion|1|||
105720163|NCT02591615|364633906|FG003|Maintenance MK-3475|Physician discretion|0|||
105720164|NCT02591615|364633903|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
105720165|NCT02591615|364633904|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
105720166|NCT02591615|364633905|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
105720167|NCT02591615|364633906|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
105720168|NCT02591615|364633903|FG000|Maintenance MK-3475|In active treatment|2|||
105720169|NCT02591615|364633904|FG001|Maintenance MK-3475|In active treatment|0|||
105720170|NCT02591615|364633905|FG002|Maintenance MK-3475|In active treatment|0|||
105720171|NCT02591615|364633906|FG003|Maintenance MK-3475|In active treatment|1|||
105720172|NCT02107703|364633907|FG000|Overall Study|Withdrawal by Subject|46|||
105720173|NCT02107703|364633908|FG001|Overall Study|Withdrawal by Subject|21|||
105720174|NCT02107703|364633907|FG000|Overall Study|Lost to Follow-up|20|||
105720175|NCT02107703|364633908|FG001|Overall Study|Lost to Follow-up|9|||
105720176|NCT02107703|364633907|FG000|Overall Study|On study treatment/follow up|48|||
105720177|NCT02107703|364633908|FG001|Overall Study|On study treatment/follow up|5|||
105720178|NCT01583179|364633909|FG000|Overall Study|Screen failure|1|||
105720179|NCT01583179|364633910|FG001|Overall Study|Screen failure|2|||
105720180|NCT03609619|364633912|FG000|Overall Study|Adverse Event|1|||
105720181|NCT03609619|364633913|FG001|Overall Study|Adverse Event|0|||
105720182|NCT03609619|364633912|FG000|Overall Study|Lack of Efficacy|1|||
105720183|NCT03609619|364633913|FG001|Overall Study|Lack of Efficacy|2|||
105720184|NCT03609619|364633912|FG000|Overall Study|Protocol Violation|5|||
105720185|NCT03609619|364633913|FG001|Overall Study|Protocol Violation|0|||
105720186|NCT03609619|364633912|FG000|Overall Study|Withdrawal by Subject|2|||
105720187|NCT03609619|364633913|FG001|Overall Study|Withdrawal by Subject|3|||
105720188|NCT03609619|364633912|FG000|Overall Study|Lost to Follow-up|1|||
105720189|NCT03609619|364633913|FG001|Overall Study|Lost to Follow-up|1|||
105720190|NCT00956943|364633914|FG000|Overall Study|Lost to Follow-up|9|||
105720191|NCT00956943|364633915|FG001|Overall Study|Lost to Follow-up|10|||
105720192|NCT02613208|364633916|FG000|Overall Study|Withdrawal by Subject|1|||
105720193|NCT02613208|364633916|FG000|Overall Study|Change of address|2|||
105720194|NCT02613208|364633916|FG000|Overall Study|Physician Decision|2|||
105720195|NCT02613208|364633916|FG000|Overall Study|Lost to Follow-up|5|||
105720196|NCT02613208|364633916|FG000|Overall Study|Death|37|||
105720197|NCT03244059|364633917|FG000|Specific Aim 1|Physician Decision|1|||
105720198|NCT03244059|364633918|FG001|Specific Aim 1|Physician Decision|0|||
105720199|NCT03244059|364633917|FG000|Specific Aim 2|Physician Decision|1|||
105720200|NCT03244059|364633918|FG001|Specific Aim 2|Physician Decision|0|||
105720201|NCT00686127|364633924|FG000|Overall Study|Withdrawal by Subject|14|||
105720202|NCT00686127|364633925|FG001|Overall Study|Withdrawal by Subject|6|||
105720203|NCT00066690|364633926|FG000|Overall Study|Adverse Event|145|||
105720204|NCT00066690|364633927|FG001|Overall Study|Adverse Event|58|||
105720205|NCT00066690|364633928|FG002|Overall Study|Adverse Event|126|||
105720206|NCT00066690|364633926|FG000|Overall Study|Death|3|||
105720207|NCT00066690|364633927|FG001|Overall Study|Death|0|||
105720208|NCT00066690|364633928|FG002|Overall Study|Death|2|||
105720209|NCT00066690|364633926|FG000|Overall Study|Lack of Efficacy|114|||
105720210|NCT00066690|364633927|FG001|Overall Study|Lack of Efficacy|110|||
105720211|NCT00066690|364633928|FG002|Overall Study|Lack of Efficacy|76|||
105720212|NCT00066690|364633926|FG000|Overall Study|Lost to Follow-up|40|||
105720213|NCT00066690|364633927|FG001|Overall Study|Lost to Follow-up|21|||
105720214|NCT00066690|364633928|FG002|Overall Study|Lost to Follow-up|29|||
105720215|NCT00066690|364633926|FG000|Overall Study|Withdrawal by Subject|50|||
105720216|NCT00066690|364633927|FG001|Overall Study|Withdrawal by Subject|55|||
105720217|NCT00066690|364633928|FG002|Overall Study|Withdrawal by Subject|49|||
105720218|NCT00066690|364633926|FG000|Overall Study|Treatment Ongoing|246|||
105720219|NCT00066690|364633927|FG001|Overall Study|Treatment Ongoing|278|||
105720220|NCT00066690|364633928|FG002|Overall Study|Treatment Ongoing|282|||
105720221|NCT00379340|364633931|FG000|Overall Study|Death|0|||
105720222|NCT00379340|364633932|FG001|Overall Study|Death|0|||
105720223|NCT00379340|364633933|FG002|Overall Study|Death|0|||
105720224|NCT00379340|364633934|FG003|Overall Study|Death|2|||
105720225|NCT00379340|364633935|FG004|Overall Study|Death|0|||
105720226|NCT00379340|364633931|FG000|Overall Study|Lack of Efficacy|6|||
105720227|NCT00379340|364633932|FG001|Overall Study|Lack of Efficacy|1|||
105720228|NCT00379340|364633933|FG002|Overall Study|Lack of Efficacy|0|||
105720229|NCT00379340|364633934|FG003|Overall Study|Lack of Efficacy|4|||
105720230|NCT00379340|364633935|FG004|Overall Study|Lack of Efficacy|3|||
105720231|NCT00379340|364633931|FG000|Overall Study|Physician Decision|6|||
105720232|NCT00379340|364633932|FG001|Overall Study|Physician Decision|2|||
105720233|NCT00379340|364633933|FG002|Overall Study|Physician Decision|1|||
105720234|NCT00379340|364633934|FG003|Overall Study|Physician Decision|2|||
105720235|NCT00379340|364633935|FG004|Overall Study|Physician Decision|3|||
105720236|NCT00379340|364633931|FG000|Overall Study|Withdrawal by Subject|0|||
105720237|NCT00379340|364633932|FG001|Overall Study|Withdrawal by Subject|0|||
105720238|NCT00379340|364633933|FG002|Overall Study|Withdrawal by Subject|0|||
105720239|NCT00379340|364633934|FG003|Overall Study|Withdrawal by Subject|1|||
105720240|NCT00379340|364633935|FG004|Overall Study|Withdrawal by Subject|0|||
105720241|NCT00379340|364633931|FG000|Overall Study|Refusal of further protocol therapy|1|||
105720242|NCT00379340|364633932|FG001|Overall Study|Refusal of further protocol therapy|0|||
105720243|NCT00379340|364633933|FG002|Overall Study|Refusal of further protocol therapy|1|||
105720244|NCT00379340|364633934|FG003|Overall Study|Refusal of further protocol therapy|1|||
105720245|NCT00379340|364633935|FG004|Overall Study|Refusal of further protocol therapy|7|||
105792162|NCT02780115|364894374|FG002|Overall Study|Adverse Event|0|||
105792163|NCT02780115|364894375|FG003|Overall Study|Adverse Event|1|||
105720246|NCT00379340|364633931|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
105720247|NCT00379340|364633932|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
105720248|NCT00379340|364633933|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
105720249|NCT00379340|364633934|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
105720250|NCT00379340|364633935|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
105720251|NCT00379340|364633931|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
105720252|NCT00379340|364633932|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
105720253|NCT00379340|364633933|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
105792164|NCT02780115|364894376|FG004|Overall Study|Adverse Event|1|||
105792165|NCT01179191|364894377|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
105792166|NCT01179191|364894377|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
105792167|NCT01179191|364894377|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
105792168|NCT01179191|364894377|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
105792169|NCT01179191|364894377|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
105792170|NCT01179191|364894377|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
105792171|NCT01179191|364894377|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
105792172|NCT01179191|364894377|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
105792173|NCT01179191|364894377|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
105792174|NCT01179191|364894377|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
105792175|NCT01179191|364894377|FG000|Maintenance Phase (8 Weeks)|Other|66|||
105792176|NCT00592007|364894383|FG000|Overall Study|Withdrawal by Subject|1|||
105792177|NCT00592007|364894383|FG000|Overall Study|patient ineligible (out of lab range)|1|||
105792178|NCT00457418|364894384|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
105792179|NCT00457418|364894384|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
105792180|NCT00457418|364894384|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
105792181|NCT00457418|364894384|FG000|Post PK Maintenance|Adverse Event|10|||
105792182|NCT00457418|364894384|FG000|Post PK Maintenance|Progression of Disease|6|||
105792183|NCT00457418|364894384|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
105792184|NCT00457418|364894384|FG000|Post PK Maintenance|Lost to Follow-up|1|||
105792185|NCT04054011|364894385|FG000|Overall Study|COVID|3|||
105792186|NCT00595127|364894386|FG000|Overall Study|Death|6|||
105792187|NCT00595127|364894386|FG000|Overall Study|Relapsed|3|||
105792188|NCT00595127|364894386|FG000|Overall Study|joined another trial|1|||
105792189|NCT01785472|364894387|FG000|Overall Study|Adverse Event|5|||
105792190|NCT01785472|364894388|FG001|Overall Study|Adverse Event|4|||
105720254|NCT00379340|364633934|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
105720255|NCT00379340|364633935|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
105720256|NCT02159807|364633938|FG000|Overall Study|Adverse Event|0|||
105720257|NCT02159807|364633939|FG001|Overall Study|Adverse Event|0|||
105792191|NCT01785472|364894389|FG002|Overall Study|Adverse Event|6|||
105792192|NCT01785472|364894387|FG000|Overall Study|Lack of Efficacy|2|||
105792193|NCT01785472|364894388|FG001|Overall Study|Lack of Efficacy|0|||
105720258|NCT02159807|364633940|FG002|Overall Study|Adverse Event|1|||
105720259|NCT02159807|364633938|FG000|Overall Study|No CSF|1|||
105720260|NCT02159807|364633939|FG001|Overall Study|No CSF|1|||
105720261|NCT02159807|364633940|FG002|Overall Study|No CSF|1|||
105720262|NCT02159807|364633938|FG000|Overall Study|elevated blood pressure|0|||
105720263|NCT02159807|364633939|FG001|Overall Study|elevated blood pressure|0|||
105720264|NCT02159807|364633940|FG002|Overall Study|elevated blood pressure|1|||
105720265|NCT01552902|364633941|FG000|Overall Study|Adverse Event|1|||
105720266|NCT01552902|364633942|FG001|Overall Study|Adverse Event|15|||
105792194|NCT01785472|364894389|FG002|Overall Study|Lack of Efficacy|1|||
105792195|NCT01785472|364894387|FG000|Overall Study|Lost to Follow-up|1|||
105720267|NCT01552902|364633943|FG002|Overall Study|Adverse Event|14|||
105720268|NCT01552902|364633941|FG000|Overall Study|Protocol Violation|3|||
105720269|NCT01552902|364633942|FG001|Overall Study|Protocol Violation|3|||
105720270|NCT01552902|364633943|FG002|Overall Study|Protocol Violation|3|||
105720271|NCT01552902|364633941|FG000|Overall Study|Lack of Efficacy|4|||
105792196|NCT01785472|364894388|FG001|Overall Study|Lost to Follow-up|2|||
105792197|NCT01785472|364894389|FG002|Overall Study|Lost to Follow-up|0|||
105792198|NCT01785472|364894387|FG000|Overall Study|Physician Decision|1|||
105792199|NCT01785472|364894388|FG001|Overall Study|Physician Decision|1|||
105792200|NCT01785472|364894389|FG002|Overall Study|Physician Decision|1|||
105792201|NCT01785472|364894387|FG000|Overall Study|Protocol deviation|0|||
105720272|NCT01552902|364633942|FG001|Overall Study|Lack of Efficacy|3|||
105720273|NCT01552902|364633943|FG002|Overall Study|Lack of Efficacy|1|||
105720274|NCT01552902|364633941|FG000|Overall Study|Withdrawal by Subject|1|||
105720275|NCT01552902|364633942|FG001|Overall Study|Withdrawal by Subject|9|||
105720276|NCT01552902|364633943|FG002|Overall Study|Withdrawal by Subject|6|||
105720277|NCT01552902|364633941|FG000|Overall Study|Lost to Follow-up|1|||
105720278|NCT01552902|364633942|FG001|Overall Study|Lost to Follow-up|3|||
105720279|NCT01552902|364633943|FG002|Overall Study|Lost to Follow-up|6|||
105720280|NCT01552902|364633941|FG000|Overall Study|Other|3|||
105720281|NCT01552902|364633942|FG001|Overall Study|Other|4|||
105720282|NCT01552902|364633943|FG002|Overall Study|Other|3|||
105720283|NCT01254669|364633947|FG000|Overall Study|Withdrawal by Subject|0|||
105720284|NCT01254669|364633948|FG001|Overall Study|Withdrawal by Subject|1|||
105720285|NCT01254669|364633947|FG000|Overall Study|time constraint|2|||
105720286|NCT01254669|364633948|FG001|Overall Study|time constraint|2|||
105720287|NCT01254669|364633947|FG000|Overall Study|called to clinic during intervention|1|||
105720288|NCT01254669|364633948|FG001|Overall Study|called to clinic during intervention|1|||
105720289|NCT00542191|364633952|FG000|Overall Study|Death|3|||
105720290|NCT00103012|364633953|FG000|Overall Study|Withdrawal by Subject|2|||
105720291|NCT00103012|364633954|FG001|Overall Study|Withdrawal by Subject|1|||
105720292|NCT00103012|364633955|FG002|Overall Study|Withdrawal by Subject|2|||
105720293|NCT00103012|364633953|FG000|Overall Study|Pregnancy|1|||
105720294|NCT00103012|364633954|FG001|Overall Study|Pregnancy|0|||
105720295|NCT00103012|364633955|FG002|Overall Study|Pregnancy|0|||
105720296|NCT00103012|364633953|FG000|Overall Study|Adverse Event|0|||
105720297|NCT00103012|364633954|FG001|Overall Study|Adverse Event|0|||
105720298|NCT00103012|364633955|FG002|Overall Study|Adverse Event|1|||
105720299|NCT00103012|364633953|FG000|Overall Study|Subject non-compliant with medications|0|||
105720300|NCT00103012|364633954|FG001|Overall Study|Subject non-compliant with medications|0|||
105720301|NCT00103012|364633955|FG002|Overall Study|Subject non-compliant with medications|1|||
105720302|NCT02357420|364633956|FG000|Overall Study|Adverse Event|3|||
105720303|NCT02357420|364633957|FG001|Overall Study|Adverse Event|3|||
105720304|NCT02357420|364633958|FG002|Overall Study|Adverse Event|8|||
105720305|NCT02357420|364633959|FG003|Overall Study|Adverse Event|9|||
105720306|NCT02357420|364633956|FG000|Overall Study|Investigator Decision|1|||
105720307|NCT02357420|364633957|FG001|Overall Study|Investigator Decision|0|||
105720308|NCT02357420|364633958|FG002|Overall Study|Investigator Decision|0|||
105720309|NCT02357420|364633959|FG003|Overall Study|Investigator Decision|0|||
105720310|NCT02357420|364633956|FG000|Overall Study|Prohibited Medication|1|||
105720311|NCT02357420|364633957|FG001|Overall Study|Prohibited Medication|1|||
105720312|NCT02357420|364633958|FG002|Overall Study|Prohibited Medication|0|||
105720313|NCT02357420|364633959|FG003|Overall Study|Prohibited Medication|0|||
105720314|NCT02357420|364633956|FG000|Overall Study|Protocol Non-compliance|0|||
105720315|NCT02357420|364633957|FG001|Overall Study|Protocol Non-compliance|0|||
105720316|NCT02357420|364633958|FG002|Overall Study|Protocol Non-compliance|0|||
105720317|NCT02357420|364633959|FG003|Overall Study|Protocol Non-compliance|1|||
105720318|NCT02357420|364633956|FG000|Overall Study|Withdrawn Consent|4|||
105720319|NCT02357420|364633957|FG001|Overall Study|Withdrawn Consent|8|||
105720320|NCT02357420|364633958|FG002|Overall Study|Withdrawn Consent|6|||
105720321|NCT02357420|364633959|FG003|Overall Study|Withdrawn Consent|6|||
105720322|NCT02357420|364633956|FG000|Overall Study|Lost to Follow-up|3|||
105720323|NCT02357420|364633957|FG001|Overall Study|Lost to Follow-up|0|||
105720324|NCT02357420|364633958|FG002|Overall Study|Lost to Follow-up|2|||
105720325|NCT02357420|364633959|FG003|Overall Study|Lost to Follow-up|3|||
105720326|NCT03624946|364633963|FG000|Overall Study|Lost to Follow-up|0|||
105720327|NCT03624946|364633964|FG001|Overall Study|Lost to Follow-up|1|||
105720328|NCT01925209|364633965|FG000|Treatment Epoch|Physician Decision|1|||
105792202|NCT01785472|364894388|FG001|Overall Study|Protocol deviation|2|||
105792203|NCT01785472|364894389|FG002|Overall Study|Protocol deviation|2|||
105792204|NCT01785472|364894387|FG000|Overall Study|Subject/guardian decision|15|||
105792205|NCT01785472|364894388|FG001|Overall Study|Subject/guardian decision|10|||
105792206|NCT01785472|364894389|FG002|Overall Study|Subject/guardian decision|11|||
105720329|NCT01925209|364633966|FG001|Treatment Epoch|Physician Decision|0|||
105720330|NCT01925209|364633967|FG002|Treatment Epoch|Physician Decision|0|||
105720331|NCT01925209|364633968|FG003|Treatment Epoch|Physician Decision|0|||
105720332|NCT01925209|364633965|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
105720333|NCT01925209|364633966|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
105792207|NCT01785472|364894387|FG000|Overall Study|Technical problems|0|||
105792208|NCT01785472|364894388|FG001|Overall Study|Technical problems|0|||
105792209|NCT01785472|364894389|FG002|Overall Study|Technical problems|1|||
105478013|NCT00797966|363761432|FG000|Phase B|Physician Decision|1|||
105720334|NCT01925209|364633967|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
105792210|NCT02086968|364894392|FG000|Overall Study|Adverse Event|1|||
105352836|NCT01270321|363296987|FG002|Overall Study|Death|4|||
105720335|NCT01925209|364633968|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
105720336|NCT01925209|364633965|FG000|Treatment Epoch|Death|1|||
105720337|NCT01925209|364633966|FG001|Treatment Epoch|Death|0|||
105720338|NCT01925209|364633967|FG002|Treatment Epoch|Death|0|||
105720339|NCT01925209|364633968|FG003|Treatment Epoch|Death|0|||
105792211|NCT02086968|364894393|FG001|Overall Study|Adverse Event|5|||
105478014|NCT00797966|363761433|FG001|Phase B|Physician Decision|0|||
105478015|NCT00797966|363761434|FG002|Phase B|Physician Decision|3|||
105478016|NCT00797966|363761435|FG003|Phase B|Physician Decision|1|||
105478017|NCT00797966|363761436|FG004|Phase B|Physician Decision|0|||
105720340|NCT01925209|364633965|FG000|Treatment Epoch|Protocol deviation|0|||
105720341|NCT01925209|364633966|FG001|Treatment Epoch|Protocol deviation|0|||
105720342|NCT01925209|364633967|FG002|Treatment Epoch|Protocol deviation|1|||
105720343|NCT01925209|364633968|FG003|Treatment Epoch|Protocol deviation|1|||
105720344|NCT01925209|364633965|FG000|Treatment Epoch|Withdrawal by Subject|4|||
105720345|NCT01925209|364633966|FG001|Treatment Epoch|Withdrawal by Subject|3|||
105720346|NCT01925209|364633967|FG002|Treatment Epoch|Withdrawal by Subject|3|||
105720347|NCT01925209|364633968|FG003|Treatment Epoch|Withdrawal by Subject|2|||
105720348|NCT01925209|364633965|FG000|Treatment Epoch|Adverse Event|3|||
105720349|NCT01925209|364633966|FG001|Treatment Epoch|Adverse Event|5|||
105720350|NCT01925209|364633967|FG002|Treatment Epoch|Adverse Event|3|||
105720351|NCT01925209|364633968|FG003|Treatment Epoch|Adverse Event|1|||
105720352|NCT01925209|364633965|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
105720353|NCT01925209|364633966|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
105720354|NCT01925209|364633967|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
105720355|NCT01925209|364633968|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
105720356|NCT01925209|364633965|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
105720357|NCT01925209|364633966|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
105720358|NCT01925209|364633967|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
105720359|NCT01925209|364633968|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
105720360|NCT01925209|364633965|FG000|Follow-up|Adverse Event|1|||
105720361|NCT01925209|364633966|FG001|Follow-up|Adverse Event|4|||
105720362|NCT01925209|364633967|FG002|Follow-up|Adverse Event|0|||
105720363|NCT01925209|364633968|FG003|Follow-up|Adverse Event|1|||
105720364|NCT01925209|364633965|FG000|Follow-up|Physician Decision|0|||
105720365|NCT01925209|364633966|FG001|Follow-up|Physician Decision|0|||
105720366|NCT01925209|364633967|FG002|Follow-up|Physician Decision|1|||
105720367|NCT01925209|364633968|FG003|Follow-up|Physician Decision|0|||
105720368|NCT01925209|364633965|FG000|Follow-up|Non-compliance with study treatment|0|||
105720369|NCT01925209|364633966|FG001|Follow-up|Non-compliance with study treatment|0|||
105720370|NCT01925209|364633967|FG002|Follow-up|Non-compliance with study treatment|0|||
105720371|NCT01925209|364633968|FG003|Follow-up|Non-compliance with study treatment|1|||
105720372|NCT01925209|364633965|FG000|Follow-up|Withdrawal by Subject|0|||
105720373|NCT01925209|364633966|FG001|Follow-up|Withdrawal by Subject|2|||
105720374|NCT01925209|364633967|FG002|Follow-up|Withdrawal by Subject|0|||
105720375|NCT01925209|364633968|FG003|Follow-up|Withdrawal by Subject|2|||
105720376|NCT01299727|364633972|FG000|Overall Study|Withdrawal by Subject|1|||
105720377|NCT01299727|364633973|FG001|Overall Study|Withdrawal by Subject|0|||
105720378|NCT01299727|364633974|FG002|Overall Study|Withdrawal by Subject|0|||
105720379|NCT01299727|364633972|FG000|Overall Study|Adverse Event|0|||
105720380|NCT01299727|364633973|FG001|Overall Study|Adverse Event|0|||
105720381|NCT01299727|364633974|FG002|Overall Study|Adverse Event|1|||
105720382|NCT01299727|364633972|FG000|Overall Study|Completed the Treatment Period|3|||
105720383|NCT01299727|364633973|FG001|Overall Study|Completed the Treatment Period|4|||
105720384|NCT01299727|364633974|FG002|Overall Study|Completed the Treatment Period|3|||
105720385|NCT03486392|364633980|FG000|Overall Study|Lost to Follow-up|0|||
105720386|NCT03486392|364633981|FG001|Overall Study|Lost to Follow-up|0|||
105720387|NCT03486392|364633982|FG002|Overall Study|Lost to Follow-up|8|||
105720388|NCT03486392|364633983|FG003|Overall Study|Lost to Follow-up|5|||
105720389|NCT03486392|364633984|FG004|Overall Study|Lost to Follow-up|2|||
105720390|NCT03486392|364633980|FG000|Overall Study|Withdrawal by Subject|3|||
105720391|NCT03486392|364633981|FG001|Overall Study|Withdrawal by Subject|0|||
105720392|NCT03486392|364633982|FG002|Overall Study|Withdrawal by Subject|6|||
105720393|NCT03486392|364633983|FG003|Overall Study|Withdrawal by Subject|4|||
105720394|NCT03486392|364633984|FG004|Overall Study|Withdrawal by Subject|1|||
105720395|NCT03486392|364633980|FG000|Overall Study|Death|0|||
105720396|NCT03486392|364633981|FG001|Overall Study|Death|0|||
105720397|NCT03486392|364633982|FG002|Overall Study|Death|0|||
105720398|NCT03486392|364633983|FG003|Overall Study|Death|0|||
105720399|NCT03486392|364633984|FG004|Overall Study|Death|1|||
105720400|NCT03157531|364633986|FG000|Overall Study|Death|2|||
105478018|NCT00797966|363761437|FG005|Phase B|Physician Decision|0|||
105478019|NCT00797966|363761432|FG000|Phase B|Withdrawal by Subject|1|||
105720401|NCT03157531|364633986|FG000|Overall Study|Lost to Follow-up|4|||
105720402|NCT00331006|364633987|FG000|Screening Phase|Withdrawal by Subject|1|||
105720403|NCT00331006|364633987|FG000|Screening Phase|enrollment halted|1|||
105720404|NCT00331006|364633987|FG000|Screening Phase|Lost to Follow-up|1|||
105720405|NCT00331006|364633987|FG000|Screening Phase|Ineligible for treatment phase|4|||
105720406|NCT00331006|364633987|FG000|Treatment Phase|Withdrawal by Subject|1|||
105720407|NCT00331006|364633987|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
105720408|NCT00331006|364633987|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
105720409|NCT03804684|364633988|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
105478020|NCT00797966|363761433|FG001|Phase B|Withdrawal by Subject|4|||
105478021|NCT00797966|363761434|FG002|Phase B|Withdrawal by Subject|3|||
105478022|NCT00797966|363761435|FG003|Phase B|Withdrawal by Subject|3|||
105478023|NCT00797966|363761436|FG004|Phase B|Withdrawal by Subject|0|||
105720410|NCT03804684|364633989|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
105720411|NCT01950819|364633994|FG000|Overall Study|Graft Loss|35|||
105720412|NCT01950819|364633995|FG001|Overall Study|Graft Loss|30|||
105720413|NCT01950819|364633994|FG000|Overall Study|Death|29|||
105720414|NCT01950819|364633995|FG001|Overall Study|Death|34|||
105720415|NCT01950819|364633994|FG000|Overall Study|Subject / Gardian decision|54|||
105720416|NCT01950819|364633995|FG001|Overall Study|Subject / Gardian decision|51|||
105720417|NCT01950819|364633994|FG000|Overall Study|technical problems|2|||
105720418|NCT01950819|364633995|FG001|Overall Study|technical problems|0|||
105720419|NCT01950819|364633994|FG000|Overall Study|Pregnancy|0|||
105720420|NCT01950819|364633995|FG001|Overall Study|Pregnancy|2|||
105720421|NCT01950819|364633994|FG000|Overall Study|Lost to Follow-up|9|||
105720422|NCT01950819|364633995|FG001|Overall Study|Lost to Follow-up|17|||
105720423|NCT01360645|364633997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
105720424|NCT01360645|364633998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
105720425|NCT01360645|364633999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
105720426|NCT01360645|364634000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
105720427|NCT01360645|364633997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
105720428|NCT01360645|364633998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
105720429|NCT01360645|364633999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
105720430|NCT01360645|364634000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
105720431|NCT01360645|364633997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
105720432|NCT01360645|364633998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
105720433|NCT01360645|364633999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
105720434|NCT01360645|364634000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
105720435|NCT01360645|364633997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
105720436|NCT01360645|364633998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
105720437|NCT01360645|364633999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
105720438|NCT01360645|364634000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
105720439|NCT01360645|364633997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
105720440|NCT01360645|364633998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
105720441|NCT01360645|364633999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
105720442|NCT01360645|364634000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
105720443|NCT01360645|364633997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
105720444|NCT01360645|364633998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
105720445|NCT01360645|364633999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
105720446|NCT01360645|364634000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
105720447|NCT01360645|364633997|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
105720448|NCT01360645|364633998|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
105720449|NCT01360645|364633999|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
105720450|NCT01360645|364634000|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
105720451|NCT01360645|364633997|FG000|Phase B (6 Weeks)|Adverse Event|0|||
105720452|NCT01360645|364633998|FG001|Phase B (6 Weeks)|Adverse Event|6|||
105720453|NCT01360645|364633999|FG002|Phase B (6 Weeks)|Adverse Event|0|||
105720454|NCT01360645|364634000|FG003|Phase B (6 Weeks)|Adverse Event|0|||
105720455|NCT01360645|364633997|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
105720456|NCT01360645|364633998|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
105720457|NCT01360645|364633999|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
105720458|NCT01360645|364634000|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
105720459|NCT01360645|364633997|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
105720460|NCT01360645|364633998|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
105720461|NCT01360645|364633999|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
105720462|NCT01360645|364634000|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
105720463|NCT01360645|364633997|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
105720464|NCT01360645|364633998|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
105720465|NCT01360645|364633999|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
105720466|NCT01360645|364634000|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
105720467|NCT01360645|364633997|FG000|Phase A+|Lost to Follow-up|0|||
105720468|NCT01360645|364633998|FG001|Phase A+|Lost to Follow-up|0|||
105720469|NCT01360645|364633999|FG002|Phase A+|Lost to Follow-up|0|||
105478024|NCT00797966|363761437|FG005|Phase B|Withdrawal by Subject|0|||
105478025|NCT00797966|363761432|FG000|Phase B|Protocol Deviation|4|||
105478026|NCT00797966|363761433|FG001|Phase B|Protocol Deviation|8|||
105720470|NCT01360645|364634000|FG003|Phase A+|Lost to Follow-up|7|||
105478027|NCT00797966|363761434|FG002|Phase B|Protocol Deviation|2|||
105478028|NCT00797966|363761435|FG003|Phase B|Protocol Deviation|6|||
105720471|NCT01360645|364633997|FG000|Phase A+|Adverse Event|0|||
105720472|NCT01360645|364633998|FG001|Phase A+|Adverse Event|0|||
105720473|NCT01360645|364633999|FG002|Phase A+|Adverse Event|0|||
105478029|NCT00797966|363761436|FG004|Phase B|Protocol Deviation|0|||
105478030|NCT00797966|363761437|FG005|Phase B|Protocol Deviation|0|||
105478031|NCT00797966|363761432|FG000|Phase B|Lack of Efficacy|0|||
105478032|NCT00797966|363761433|FG001|Phase B|Lack of Efficacy|1|||
105478033|NCT00797966|363761434|FG002|Phase B|Lack of Efficacy|1|||
105478034|NCT00797966|363761435|FG003|Phase B|Lack of Efficacy|4|||
105478035|NCT00797966|363761436|FG004|Phase B|Lack of Efficacy|0|||
105478036|NCT00797966|363761437|FG005|Phase B|Lack of Efficacy|0|||
105478037|NCT00797966|363761432|FG000|Phase A+|Lost to Follow-up|0|||
105478038|NCT00797966|363761433|FG001|Phase A+|Lost to Follow-up|0|||
105792212|NCT02086968|364894392|FG000|Overall Study|Lost to Follow-up|2|||
105792213|NCT02086968|364894393|FG001|Overall Study|Lost to Follow-up|3|||
105792214|NCT02086968|364894392|FG000|Overall Study|Study drug received outside protocol|0|||
105792215|NCT02086968|364894393|FG001|Overall Study|Study drug received outside protocol|1|||
105792216|NCT02086968|364894392|FG000|Overall Study|Physician Decision|4|||
105792217|NCT02086968|364894393|FG001|Overall Study|Physician Decision|0|||
105792218|NCT02086968|364894392|FG000|Overall Study|Withdrawal by Subject|1|||
105792219|NCT02086968|364894393|FG001|Overall Study|Withdrawal by Subject|4|||
105792220|NCT02297438|364894396|FG000|Overall Study|Death|79|||
105792221|NCT02297438|364894397|FG001|Overall Study|Death|86|||
105792222|NCT02297438|364894396|FG000|Overall Study|Lost to Follow-up|9|||
105792223|NCT02297438|364894397|FG001|Overall Study|Lost to Follow-up|7|||
105792224|NCT02297438|364894396|FG000|Overall Study|Withdrawal by Subject|7|||
105792225|NCT02297438|364894397|FG001|Overall Study|Withdrawal by Subject|0|||
105792226|NCT02297438|364894396|FG000|Overall Study|Other|9|||
105792227|NCT02297438|364894397|FG001|Overall Study|Other|5|||
105792228|NCT02297438|364894396|FG000|Overall Study|Ongoing|65|||
105792229|NCT02297438|364894397|FG001|Overall Study|Ongoing|73|||
105792230|NCT04856917|364894400|FG000|Overall Study|Withdrawal by Subject|4|||
105792231|NCT04856917|364894401|FG001|Overall Study|Withdrawal by Subject|3|||
105792232|NCT04856917|364894402|FG002|Overall Study|Withdrawal by Subject|1|||
105792233|NCT04856917|364894400|FG000|Overall Study|Lost to Follow-up|3|||
105792234|NCT04856917|364894401|FG001|Overall Study|Lost to Follow-up|1|||
105792235|NCT04856917|364894402|FG002|Overall Study|Lost to Follow-up|1|||
105792236|NCT04856917|364894400|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
105792237|NCT04856917|364894401|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
105792238|NCT04856917|364894402|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
105792239|NCT04856917|364894400|FG000|Overall Study|Other|1|||
105792240|NCT04856917|364894401|FG001|Overall Study|Other|1|||
105792241|NCT04856917|364894402|FG002|Overall Study|Other|0|||
105792242|NCT00537056|364894404|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
105792243|NCT01244516|364894408|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
105792244|NCT01244516|364894409|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
105792245|NCT01244516|364894410|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
105792246|NCT01244516|364894408|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
105792247|NCT01244516|364894409|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
105792248|NCT01244516|364894410|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
105792249|NCT01244516|364894408|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
105792250|NCT01244516|364894409|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
105792251|NCT01244516|364894410|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
105792252|NCT01244516|364894408|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
105792253|NCT01244516|364894409|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
105792254|NCT01244516|364894410|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
105792255|NCT01244516|364894408|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
105792256|NCT01244516|364894409|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
105792257|NCT01244516|364894410|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
105792258|NCT01244516|364894408|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
105792259|NCT01244516|364894409|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
105792260|NCT01244516|364894410|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
105792261|NCT01244516|364894408|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
105792262|NCT01244516|364894409|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
105792263|NCT01244516|364894410|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
105792264|NCT03466060|364894411|FG000|Period 1|Test Lens Damage|0|||
105792265|NCT03466060|364894412|FG001|Period 1|Test Lens Damage|2|||
105478039|NCT00797966|363761434|FG002|Phase A+|Lost to Follow-up|0|||
105478040|NCT00797966|363761435|FG003|Phase A+|Lost to Follow-up|0|||
105720474|NCT01360645|364634000|FG003|Phase A+|Adverse Event|2|||
105720475|NCT01360645|364633997|FG000|Phase A+|Met Withdrawal Criteria|0|||
105720476|NCT01360645|364633998|FG001|Phase A+|Met Withdrawal Criteria|0|||
105720477|NCT01360645|364633999|FG002|Phase A+|Met Withdrawal Criteria|0|||
105720478|NCT01360645|364634000|FG003|Phase A+|Met Withdrawal Criteria|4|||
105720479|NCT01360645|364633997|FG000|Phase A+|Physician Decision|0|||
105720480|NCT01360645|364633998|FG001|Phase A+|Physician Decision|0|||
105720481|NCT01360645|364633999|FG002|Phase A+|Physician Decision|0|||
105720482|NCT01360645|364634000|FG003|Phase A+|Physician Decision|2|||
105720483|NCT01360645|364633997|FG000|Phase A+|Withdrawal by Subject|0|||
105720484|NCT01360645|364633998|FG001|Phase A+|Withdrawal by Subject|0|||
105720485|NCT01360645|364633999|FG002|Phase A+|Withdrawal by Subject|0|||
105720486|NCT01360645|364634000|FG003|Phase A+|Withdrawal by Subject|5|||
105720487|NCT01360645|364633997|FG000|Phase A+|Protocol Deviation|0|||
105720488|NCT01360645|364633998|FG001|Phase A+|Protocol Deviation|0|||
105720489|NCT01360645|364633999|FG002|Phase A+|Protocol Deviation|0|||
105720490|NCT01360645|364634000|FG003|Phase A+|Protocol Deviation|4|||
105720491|NCT00773279|364634001|FG000|Period 1|Adverse Event|2|||
105720492|NCT00773279|364634002|FG001|Period 1|Adverse Event|1|||
105720493|NCT00773279|364634001|FG000|Period 1|Lack of Efficacy|0|||
105720494|NCT00773279|364634002|FG001|Period 1|Lack of Efficacy|2|||
105720495|NCT00773279|364634001|FG000|Period 1|Unclassified|5|||
105720496|NCT00773279|364634002|FG001|Period 1|Unclassified|1|||
105720497|NCT00773279|364634001|FG000|Period 2|Adverse Event|0|||
105720498|NCT00773279|364634002|FG001|Period 2|Adverse Event|1|||
105720499|NCT00773279|364634001|FG000|Period 2|Lack of Efficacy|1|||
105720500|NCT00773279|364634002|FG001|Period 2|Lack of Efficacy|0|||
105720501|NCT00773279|364634001|FG000|Period 2|Protocol Violation|0|||
105720502|NCT00773279|364634002|FG001|Period 2|Protocol Violation|3|||
105720503|NCT00773279|364634001|FG000|Period 2|Unclassified|2|||
105720504|NCT00773279|364634002|FG001|Period 2|Unclassified|2|||
105720505|NCT02211261|364634003|FG000|Overall Study|Withdrawal by Subject|0|||
105720506|NCT02211261|364634004|FG001|Overall Study|Withdrawal by Subject|0|||
105720507|NCT02211261|364634005|FG002|Overall Study|Withdrawal by Subject|1|||
105720508|NCT02211261|364634006|FG003|Overall Study|Withdrawal by Subject|0|||
105720509|NCT02211261|364634007|FG004|Overall Study|Withdrawal by Subject|2|||
105720510|NCT02211261|364634008|FG005|Overall Study|Withdrawal by Subject|0|||
105720511|NCT02211261|364634009|FG006|Overall Study|Withdrawal by Subject|0|||
105720512|NCT02211261|364634010|FG007|Overall Study|Withdrawal by Subject|0|||
105720513|NCT02211261|364634011|FG008|Overall Study|Withdrawal by Subject|0|||
105720514|NCT02211261|364634012|FG009|Overall Study|Withdrawal by Subject|0|||
105720515|NCT02211261|364634013|FG010|Overall Study|Withdrawal by Subject|0|||
105720516|NCT02211261|364634003|FG000|Overall Study|Other|0|||
105720517|NCT02211261|364634004|FG001|Overall Study|Other|0|||
105720518|NCT02211261|364634005|FG002|Overall Study|Other|0|||
105720519|NCT02211261|364634006|FG003|Overall Study|Other|0|||
105720520|NCT02211261|364634007|FG004|Overall Study|Other|0|||
105720521|NCT02211261|364634008|FG005|Overall Study|Other|1|||
105720522|NCT02211261|364634009|FG006|Overall Study|Other|0|||
105720523|NCT02211261|364634010|FG007|Overall Study|Other|0|||
105720524|NCT02211261|364634011|FG008|Overall Study|Other|0|||
105720525|NCT02211261|364634012|FG009|Overall Study|Other|2|||
105720526|NCT02211261|364634013|FG010|Overall Study|Other|0|||
105720527|NCT02211261|364634003|FG000|Overall Study|Lost to Follow-up|0|||
105720528|NCT02211261|364634004|FG001|Overall Study|Lost to Follow-up|0|||
105720529|NCT02211261|364634005|FG002|Overall Study|Lost to Follow-up|0|||
105720530|NCT02211261|364634006|FG003|Overall Study|Lost to Follow-up|0|||
105720531|NCT02211261|364634007|FG004|Overall Study|Lost to Follow-up|0|||
105720532|NCT02211261|364634008|FG005|Overall Study|Lost to Follow-up|0|||
105720533|NCT02211261|364634009|FG006|Overall Study|Lost to Follow-up|0|||
105720534|NCT02211261|364634010|FG007|Overall Study|Lost to Follow-up|1|||
105720535|NCT02211261|364634011|FG008|Overall Study|Lost to Follow-up|0|||
105720536|NCT02211261|364634012|FG009|Overall Study|Lost to Follow-up|0|||
105720537|NCT02211261|364634013|FG010|Overall Study|Lost to Follow-up|0|||
105720538|NCT01737931|364634014|FG000|Overall Study|Withdrawal by Subject|0|||
105720539|NCT01737931|364634015|FG001|Overall Study|Withdrawal by Subject|1|||
105720540|NCT01737931|364634016|FG002|Overall Study|Withdrawal by Subject|1|||
105720541|NCT01737931|364634014|FG000|Overall Study|Physician Decision|0|||
105720542|NCT01737931|364634015|FG001|Overall Study|Physician Decision|1|||
105720543|NCT01737931|364634016|FG002|Overall Study|Physician Decision|0|||
105720544|NCT04336163|364634017|FG000|Overall Study|Lost to Follow-up|55|||
105720545|NCT04336163|364634018|FG001|Overall Study|Lost to Follow-up|0|||
105720546|NCT03258814|364634019|FG000|Overall Study|Early Termination|4|||
105720547|NCT03258814|364634020|FG001|Overall Study|Early Termination|3|||
105720548|NCT03258814|364634021|FG002|Overall Study|Early Termination|10|||
105720549|NCT00480857|364634022|FG000|Overall Study|Lack of Efficacy|2|||
105720550|NCT02266433|364634023|FG000|Overall Study|Lost to Follow-up|54|||
105720551|NCT02266433|364634024|FG001|Overall Study|Lost to Follow-up|46|||
105720552|NCT02266433|364634023|FG000|Overall Study|Withdrawal by Subject|5|||
105720553|NCT02266433|364634024|FG001|Overall Study|Withdrawal by Subject|7|||
105720554|NCT01015833|364634027|FG000|Overall Study|Death|1|||
105720555|NCT01015833|364634028|FG001|Overall Study|Death|0|||
105720556|NCT01015833|364634027|FG000|Overall Study|Withdrawal by Subject|3|||
105720557|NCT01015833|364634028|FG001|Overall Study|Withdrawal by Subject|2|||
105720558|NCT01015833|364634027|FG000|Overall Study|Adverse Event|0|||
105720559|NCT01015833|364634028|FG001|Overall Study|Adverse Event|1|||
105720560|NCT01015833|364634027|FG000|Overall Study|Physician Decision|2|||
105720561|NCT01015833|364634028|FG001|Overall Study|Physician Decision|0|||
105720562|NCT01015833|364634027|FG000|Overall Study|Symptomatic deterioration|0|||
105720563|NCT01015833|364634028|FG001|Overall Study|Symptomatic deterioration|1|||
105720564|NCT01015833|364634027|FG000|Overall Study|Other|5|||
105720565|NCT01015833|364634028|FG001|Overall Study|Other|1|||
105720566|NCT01015833|364634027|FG000|Overall Study|Motor Vehicle Accidents|1|||
105720567|NCT01015833|364634028|FG001|Overall Study|Motor Vehicle Accidents|0|||
105720568|NCT01015833|364634027|FG000|Overall Study|Did not start treatment|1|||
105720569|NCT01015833|364634028|FG001|Overall Study|Did not start treatment|0|||
105720570|NCT00481065|364634029|FG000|Overall Study|Adverse event or death|1|||
105720571|NCT00481065|364634030|FG001|Overall Study|Adverse event or death|1|||
105720572|NCT00481065|364634031|FG002|Overall Study|Adverse event or death|3|||
105720573|NCT00481065|364634032|FG003|Overall Study|Adverse event or death|0|||
105720574|NCT00481065|364634033|FG004|Overall Study|Adverse event or death|2|||
105720575|NCT00481065|364634034|FG005|Overall Study|Adverse event or death|0|||
105720576|NCT00481065|364634035|FG006|Overall Study|Adverse event or death|1|||
105720577|NCT00481065|364634036|FG007|Overall Study|Adverse event or death|1|||
105720578|NCT00481065|364634029|FG000|Overall Study|Withdrawal by Subject|11|||
105720579|NCT00481065|364634030|FG001|Overall Study|Withdrawal by Subject|12|||
105720580|NCT00481065|364634031|FG002|Overall Study|Withdrawal by Subject|7|||
105720581|NCT00481065|364634032|FG003|Overall Study|Withdrawal by Subject|11|||
105720582|NCT00481065|364634033|FG004|Overall Study|Withdrawal by Subject|13|||
105720583|NCT00481065|364634034|FG005|Overall Study|Withdrawal by Subject|12|||
105720584|NCT00481065|364634035|FG006|Overall Study|Withdrawal by Subject|9|||
105720585|NCT00481065|364634036|FG007|Overall Study|Withdrawal by Subject|10|||
105720586|NCT00481065|364634029|FG000|Overall Study|Lost to Follow-up|4|||
105720587|NCT00481065|364634030|FG001|Overall Study|Lost to Follow-up|2|||
105720588|NCT00481065|364634031|FG002|Overall Study|Lost to Follow-up|4|||
105720589|NCT00481065|364634032|FG003|Overall Study|Lost to Follow-up|3|||
105720590|NCT00481065|364634033|FG004|Overall Study|Lost to Follow-up|3|||
105720591|NCT00481065|364634034|FG005|Overall Study|Lost to Follow-up|3|||
105720592|NCT00481065|364634035|FG006|Overall Study|Lost to Follow-up|2|||
105720593|NCT00481065|364634036|FG007|Overall Study|Lost to Follow-up|5|||
105720594|NCT00481065|364634029|FG000|Overall Study|Inappropriate enrollment|4|||
105720595|NCT00481065|364634030|FG001|Overall Study|Inappropriate enrollment|0|||
105720596|NCT00481065|364634031|FG002|Overall Study|Inappropriate enrollment|2|||
105720597|NCT00481065|364634032|FG003|Overall Study|Inappropriate enrollment|0|||
105720598|NCT00481065|364634033|FG004|Overall Study|Inappropriate enrollment|2|||
105720599|NCT00481065|364634034|FG005|Overall Study|Inappropriate enrollment|1|||
105720600|NCT00481065|364634035|FG006|Overall Study|Inappropriate enrollment|0|||
105720601|NCT00481065|364634036|FG007|Overall Study|Inappropriate enrollment|1|||
105720602|NCT00481065|364634029|FG000|Overall Study|Administrative reason|0|||
105720603|NCT00481065|364634030|FG001|Overall Study|Administrative reason|0|||
105720604|NCT00481065|364634031|FG002|Overall Study|Administrative reason|0|||
105720605|NCT00481065|364634032|FG003|Overall Study|Administrative reason|0|||
105720606|NCT00481065|364634033|FG004|Overall Study|Administrative reason|0|||
105720607|NCT00481065|364634034|FG005|Overall Study|Administrative reason|2|||
105720608|NCT00481065|364634035|FG006|Overall Study|Administrative reason|1|||
105720609|NCT00481065|364634036|FG007|Overall Study|Administrative reason|0|||
105720610|NCT00481065|364634029|FG000|Overall Study|Protocol Violation|2|||
105720611|NCT00481065|364634030|FG001|Overall Study|Protocol Violation|1|||
105720612|NCT00481065|364634031|FG002|Overall Study|Protocol Violation|1|||
105720613|NCT00481065|364634032|FG003|Overall Study|Protocol Violation|1|||
105720614|NCT00481065|364634033|FG004|Overall Study|Protocol Violation|2|||
105720615|NCT00481065|364634034|FG005|Overall Study|Protocol Violation|6|||
105720616|NCT00481065|364634035|FG006|Overall Study|Protocol Violation|3|||
105720617|NCT00481065|364634036|FG007|Overall Study|Protocol Violation|2|||
105720618|NCT00481065|364634029|FG000|Overall Study|Unable to classify|0|||
105720619|NCT00481065|364634030|FG001|Overall Study|Unable to classify|1|||
105720620|NCT00481065|364634031|FG002|Overall Study|Unable to classify|2|||
105720621|NCT00481065|364634032|FG003|Overall Study|Unable to classify|0|||
105720622|NCT00481065|364634033|FG004|Overall Study|Unable to classify|1|||
105720623|NCT00481065|364634034|FG005|Overall Study|Unable to classify|0|||
105720624|NCT00481065|364634035|FG006|Overall Study|Unable to classify|0|||
105720625|NCT00481065|364634036|FG007|Overall Study|Unable to classify|0|||
105720626|NCT01439945|364634043|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
105720627|NCT01439945|364634044|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
105720628|NCT01439945|364634045|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
105720629|NCT01439945|364634046|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
105720630|NCT01439945|364634043|FG000|Double-Blind Treatment Phase|Ineligible|1|||
105720631|NCT01439945|364634044|FG001|Double-Blind Treatment Phase|Ineligible|2|||
105720632|NCT01439945|364634045|FG002|Double-Blind Treatment Phase|Ineligible|0|||
105720633|NCT01439945|364634046|FG003|Double-Blind Treatment Phase|Ineligible|1|||
105720634|NCT01497262|364634047|FG000|Overall Study|Abnormal Lab Values|4|||
105720635|NCT01497262|364634047|FG000|Overall Study|Abnormal Test Procedure Result|1|||
105720636|NCT01497262|364634047|FG000|Overall Study|Physician Decision|1|||
105720637|NCT01497262|364634047|FG000|Overall Study|Withdrawal by Subject|2|||
105720638|NCT01497262|364634047|FG000|Overall Study|Adverse Event|2|||
105720639|NCT01497262|364634047|FG000|Overall Study|Protocol Violation|1|||
105720640|NCT02949830|364634048|FG000|Overall Study|Adverse Event|1|||
105720641|NCT02949830|364634048|FG000|Overall Study|Withdrawal by Subject|1|||
105720642|NCT01290887|364634049|FG000|Overall Study|Adverse Event|6|||
105720643|NCT01290887|364634050|FG001|Overall Study|Adverse Event|11|||
105720644|NCT01290887|364634049|FG000|Overall Study|Lack of Efficacy|4|||
105720645|NCT01290887|364634050|FG001|Overall Study|Lack of Efficacy|5|||
105720646|NCT01290887|364634049|FG000|Overall Study|Withdrawal by Subject|26|||
105720647|NCT01290887|364634050|FG001|Overall Study|Withdrawal by Subject|32|||
105720648|NCT01290887|364634049|FG000|Overall Study|Protocol Violation|2|||
105720649|NCT01290887|364634050|FG001|Overall Study|Protocol Violation|1|||
105720650|NCT01290887|364634049|FG000|Overall Study|Lost to Follow-up|4|||
105792266|NCT03466060|364894413|FG002|Period 1|Test Lens Damage|0|||
105792267|NCT03466060|364894414|FG003|Period 1|Test Lens Damage|0|||
105792268|NCT03466060|364894415|FG004|Period 1|Test Lens Damage|0|||
105792269|NCT03466060|364894416|FG005|Period 1|Test Lens Damage|0|||
105792270|NCT03466060|364894411|FG000|Period 1|Withdrawal by Subject|0|||
105792271|NCT03466060|364894412|FG001|Period 1|Withdrawal by Subject|0|||
105792272|NCT03466060|364894413|FG002|Period 1|Withdrawal by Subject|2|||
105792273|NCT03466060|364894414|FG003|Period 1|Withdrawal by Subject|0|||
105792274|NCT03466060|364894415|FG004|Period 1|Withdrawal by Subject|0|||
105792275|NCT03466060|364894416|FG005|Period 1|Withdrawal by Subject|0|||
105792276|NCT03466060|364894411|FG000|Period 1|Lost to Follow-up|0|||
105792277|NCT03466060|364894412|FG001|Period 1|Lost to Follow-up|0|||
105792278|NCT03466060|364894413|FG002|Period 1|Lost to Follow-up|0|||
105792279|NCT03466060|364894414|FG003|Period 1|Lost to Follow-up|1|||
105792280|NCT03466060|364894415|FG004|Period 1|Lost to Follow-up|0|||
105792281|NCT03466060|364894416|FG005|Period 1|Lost to Follow-up|0|||
105792282|NCT03466060|364894411|FG000|Period 1|Grade 2 Conjunctivitis|0|||
105792283|NCT03466060|364894412|FG001|Period 1|Grade 2 Conjunctivitis|0|||
105792284|NCT03466060|364894413|FG002|Period 1|Grade 2 Conjunctivitis|1|||
105792285|NCT03466060|364894414|FG003|Period 1|Grade 2 Conjunctivitis|0|||
105792286|NCT03466060|364894415|FG004|Period 1|Grade 2 Conjunctivitis|0|||
105792287|NCT03466060|364894416|FG005|Period 1|Grade 2 Conjunctivitis|0|||
105792288|NCT03466060|364894411|FG000|Period 2|Lens Handling Difficulties|0|||
105792289|NCT03466060|364894412|FG001|Period 2|Lens Handling Difficulties|0|||
105792290|NCT03466060|364894413|FG002|Period 2|Lens Handling Difficulties|1|||
105792291|NCT03466060|364894414|FG003|Period 2|Lens Handling Difficulties|0|||
105792292|NCT03466060|364894415|FG004|Period 2|Lens Handling Difficulties|0|||
105792293|NCT03466060|364894416|FG005|Period 2|Lens Handling Difficulties|0|||
105792294|NCT00556166|364894417|FG000|Overall Study|Withdrawal by Subject|1|||
105792295|NCT05302414|364894418|FG000|Pretest to Posttest|Lost to Follow-up|12|||
105792296|NCT05302414|364894419|FG001|Pretest to Posttest|Lost to Follow-up|8|||
105792297|NCT05302414|364894420|FG002|Pretest to Posttest|Lost to Follow-up|8|||
105792298|NCT05302414|364894418|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
105792299|NCT05302414|364894419|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
105792300|NCT05302414|364894420|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
105792301|NCT01102972|364894423|FG000|Overall Study|Adverse Event|8|||
105792302|NCT01102972|364894424|FG001|Overall Study|Adverse Event|2|||
105792303|NCT01102972|364894423|FG000|Overall Study|Lack of Efficacy|2|||
105792304|NCT01102972|364894424|FG001|Overall Study|Lack of Efficacy|1|||
105792305|NCT01102972|364894423|FG000|Overall Study|Protocol Violation|1|||
105792306|NCT01102972|364894424|FG001|Overall Study|Protocol Violation|0|||
105792307|NCT01102972|364894423|FG000|Overall Study|Lost to Follow-up|10|||
105792308|NCT01102972|364894424|FG001|Overall Study|Lost to Follow-up|5|||
105792309|NCT01102972|364894423|FG000|Overall Study|Investigator Discretion|2|||
105792310|NCT01102972|364894424|FG001|Overall Study|Investigator Discretion|0|||
105792311|NCT01102972|364894423|FG000|Overall Study|Withdrawal by Subject|6|||
105792312|NCT01102972|364894424|FG001|Overall Study|Withdrawal by Subject|6|||
105792313|NCT04935931|364894432|FG000|Overall Study|Withdrawal by Subject|1|||
105792314|NCT05168657|364894433|FG000|Overall Study|Adverse Event|0|||
105792315|NCT05168657|364894434|FG001|Overall Study|Adverse Event|0|||
105792316|NCT05168657|364894435|FG002|Overall Study|Adverse Event|1|||
105792317|NCT05168657|364894436|FG003|Overall Study|Adverse Event|0|||
105792318|NCT05168657|364894437|FG004|Overall Study|Adverse Event|0|||
105792319|NCT05168657|364894438|FG005|Overall Study|Adverse Event|0|||
105792320|NCT05168657|364894439|FG006|Overall Study|Adverse Event|0|||
105792321|NCT05168657|364894440|FG007|Overall Study|Adverse Event|0|||
105792322|NCT00962013|364894441|FG000|Overall Study|Did not have surgery|1|||
105792323|NCT00962013|364894441|FG000|Overall Study|Death|8|||
105792324|NCT00962013|364894441|FG000|Overall Study|Lost to Follow-up|12|||
105792325|NCT00962013|364894441|FG000|Overall Study|Unable/Unwilling to return|6|||
105792326|NCT00962013|364894441|FG000|Overall Study|Withdrawal by Subject|8|||
105792327|NCT00962013|364894441|FG000|Overall Study|Removal of study device|3|||
105792328|NCT00962013|364894441|FG000|Overall Study|Site Termination|24|||
105792329|NCT00962013|364894441|FG000|Overall Study|No 5 year evaluation|6|||
105792330|NCT04797637|364894446|FG000|Overall Study|Lost to Follow-up|23|||
105792331|NCT04797637|364894447|FG001|Overall Study|Lost to Follow-up|32|||
105792332|NCT04797637|364894446|FG000|Overall Study|Withdrawal by Subject|0|||
105792333|NCT04797637|364894447|FG001|Overall Study|Withdrawal by Subject|1|||
105792334|NCT00621309|364894448|FG000|Overall Study|Withdrawal by Subject|2|||
105792335|NCT00621309|364894449|FG001|Overall Study|Withdrawal by Subject|0|||
105792336|NCT00621309|364894450|FG002|Overall Study|Withdrawal by Subject|1|||
105792337|NCT00621309|364894451|FG003|Overall Study|Withdrawal by Subject|1|||
105792338|NCT00621309|364894452|FG004|Overall Study|Withdrawal by Subject|1|||
105792339|NCT00621309|364894453|FG005|Overall Study|Withdrawal by Subject|1|||
105792340|NCT03252756|364894458|FG000|Overall Study|Protocol Violation|2|||
105792341|NCT03252756|364894459|FG001|Overall Study|Protocol Violation|4|||
105792342|NCT03252756|364894458|FG000|Overall Study|COVID-19 Pandemic|1|||
105792343|NCT03252756|364894459|FG001|Overall Study|COVID-19 Pandemic|1|||
105792344|NCT03252756|364894458|FG000|Overall Study|Study Drug Expiration|0|||
105720651|NCT01290887|364634050|FG001|Overall Study|Lost to Follow-up|4|||
105720652|NCT01290887|364634049|FG000|Overall Study|Non-compliance to study procedures|0|||
105720653|NCT01290887|364634050|FG001|Overall Study|Non-compliance to study procedures|1|||
105720654|NCT01290887|364634049|FG000|Overall Study|Non-compliance to study medications|1|||
105720655|NCT01290887|364634050|FG001|Overall Study|Non-compliance to study medications|0|||
105720656|NCT01290887|364634049|FG000|Overall Study|Sponsor closure of study|420|||
105720657|NCT01290887|364634050|FG001|Overall Study|Sponsor closure of study|476|||
105720658|NCT01290887|364634049|FG000|Overall Study|Other|3|||
105720659|NCT01290887|364634050|FG001|Overall Study|Other|6|||
105720660|NCT05032950|364634051|FG000|Overall Study|Adverse Event|0|||
105720661|NCT05032950|364634052|FG001|Overall Study|Adverse Event|0|||
105720662|NCT05032950|364634053|FG002|Overall Study|Adverse Event|1|||
105720663|NCT05032950|364634054|FG003|Overall Study|Adverse Event|1|||
105720664|NCT05032950|364634055|FG004|Overall Study|Adverse Event|0|||
105720665|NCT05032950|364634056|FG005|Overall Study|Adverse Event|0|||
105720666|NCT02116621|364634060|FG000|Baseline|Withdrawal by Subject|0|||
105720667|NCT02116621|364634061|FG001|Baseline|Withdrawal by Subject|4|||
105720668|NCT02116621|364634060|FG000|Three Month Follow-up|Death|1|||
105720669|NCT02116621|364634061|FG001|Three Month Follow-up|Death|1|||
105720670|NCT02116621|364634060|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
105720671|NCT02116621|364634061|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
105720672|NCT02116621|364634060|FG000|Three Month Follow-up|Lost to Follow-up|0|||
105720673|NCT02116621|364634061|FG001|Three Month Follow-up|Lost to Follow-up|1|||
105720674|NCT02116621|364634060|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
105720675|NCT02116621|364634061|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
105720676|NCT02116621|364634060|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
105720677|NCT02116621|364634061|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
105720678|NCT02116621|364634060|FG000|Six Month Follow-up|Lost to Follow-up|2|||
105720679|NCT02116621|364634061|FG001|Six Month Follow-up|Lost to Follow-up|1|||
105720680|NCT02116621|364634060|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
105720681|NCT02116621|364634061|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
105720682|NCT02116621|364634060|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
105720683|NCT02116621|364634061|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
105720684|NCT02116621|364634060|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
105720685|NCT02116621|364634061|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
105720686|NCT02116621|364634060|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
105720687|NCT02116621|364634061|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
105720688|NCT02116621|364634060|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
105720689|NCT02116621|364634061|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
105720690|NCT02901431|364634062|FG000|PK Part|Adverse Event|0|||
105720691|NCT02901431|364634063|FG001|PK Part|Adverse Event|1|||
105720692|NCT02901431|364634064|FG002|PK Part|Adverse Event|0|||
105720693|NCT02901431|364634065|FG003|PK Part|Adverse Event|0|||
105720694|NCT02901431|364634066|FG004|PK Part|Adverse Event|0|||
105720695|NCT02901431|364634067|FG005|PK Part|Adverse Event|0|||
105720696|NCT02901431|364634068|FG006|PK Part|Adverse Event|0|||
105720697|NCT02901431|364634069|FG007|PK Part|Adverse Event|0|||
105720698|NCT02901431|364634070|FG008|PK Part|Adverse Event|0|||
105720699|NCT02901431|364634071|FG009|PK Part|Adverse Event|0|||
105720700|NCT02901431|364634072|FG010|PK Part|Adverse Event|0|||
105720701|NCT02901431|364634073|FG011|PK Part|Adverse Event|0|||
105720702|NCT02901431|364634074|FG012|PK Part|Adverse Event|0|||
105720703|NCT02901431|364634062|FG000|PK Part|Lost to Follow-up|0|||
105720704|NCT02901431|364634063|FG001|PK Part|Lost to Follow-up|0|||
105720705|NCT02901431|364634064|FG002|PK Part|Lost to Follow-up|1|||
105720706|NCT02901431|364634065|FG003|PK Part|Lost to Follow-up|0|||
105720707|NCT02901431|364634066|FG004|PK Part|Lost to Follow-up|0|||
105720708|NCT02901431|364634067|FG005|PK Part|Lost to Follow-up|0|||
105720709|NCT02901431|364634068|FG006|PK Part|Lost to Follow-up|0|||
105720710|NCT02901431|364634069|FG007|PK Part|Lost to Follow-up|0|||
105720711|NCT02901431|364634070|FG008|PK Part|Lost to Follow-up|0|||
105720712|NCT02901431|364634071|FG009|PK Part|Lost to Follow-up|0|||
105720713|NCT02901431|364634072|FG010|PK Part|Lost to Follow-up|0|||
105720714|NCT02901431|364634073|FG011|PK Part|Lost to Follow-up|0|||
105720715|NCT02901431|364634074|FG012|PK Part|Lost to Follow-up|0|||
105720716|NCT02901431|364634062|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
105720717|NCT02901431|364634063|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105792345|NCT03252756|364894459|FG001|Overall Study|Study Drug Expiration|1|||
105792346|NCT03239340|364894460|FG000|Overall Study|Other|26|||
105720718|NCT02901431|364634064|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720719|NCT02901431|364634065|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720720|NCT02901431|364634066|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720721|NCT02901431|364634067|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720722|NCT02901431|364634068|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720723|NCT02901431|364634069|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720724|NCT02901431|364634070|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720725|NCT02901431|364634071|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720726|NCT02901431|364634072|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105792347|NCT03239340|364894460|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
105792348|NCT03239340|364894460|FG000|Overall Study|Death|40|||
105792349|NCT03239340|364894460|FG000|Overall Study|Lost to Follow-up|2|||
105792350|NCT03239340|364894460|FG000|Overall Study|Physician Decision|16|||
105792351|NCT03239340|364894460|FG000|Overall Study|Withdrawal by Subject|27|||
105792352|NCT01640964|364894464|FG000|Overall Study|Lost to Follow-up|0|||
105792353|NCT01640964|364894465|FG001|Overall Study|Lost to Follow-up|0|||
105792354|NCT01640964|364894466|FG002|Overall Study|Lost to Follow-up|1|||
105792355|NCT01640964|364894464|FG000|Overall Study|Protocol Deviation|1|||
105792356|NCT01640964|364894465|FG001|Overall Study|Protocol Deviation|1|||
105792357|NCT01640964|364894466|FG002|Overall Study|Protocol Deviation|2|||
105792358|NCT02787746|364894467|FG000|Overall Study|Adverse Event|42|||
105792359|NCT02787746|364894467|FG000|Overall Study|Withdrawal by Subject|65|||
105792360|NCT02787746|364894467|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
105792361|NCT04822701|364894470|FG000|Overall Study|Not treated|2|||
105792362|NCT04822701|364894471|FG001|Overall Study|Not treated|0|||
105720727|NCT02901431|364634073|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720728|NCT02901431|364634074|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720729|NCT02901431|364634062|FG000|PK Part|Pending dose confirmation|0|||
105720730|NCT02901431|364634063|FG001|PK Part|Pending dose confirmation|1|||
105720731|NCT02901431|364634064|FG002|PK Part|Pending dose confirmation|0|||
105720732|NCT02901431|364634065|FG003|PK Part|Pending dose confirmation|0|||
105720733|NCT02901431|364634066|FG004|PK Part|Pending dose confirmation|0|||
105720734|NCT02901431|364634067|FG005|PK Part|Pending dose confirmation|0|||
105720735|NCT02901431|364634068|FG006|PK Part|Pending dose confirmation|0|||
105720736|NCT02901431|364634069|FG007|PK Part|Pending dose confirmation|0|||
105720737|NCT02901431|364634070|FG008|PK Part|Pending dose confirmation|0|||
105720738|NCT02901431|364634071|FG009|PK Part|Pending dose confirmation|0|||
105720739|NCT02901431|364634072|FG010|PK Part|Pending dose confirmation|0|||
105720740|NCT02901431|364634073|FG011|PK Part|Pending dose confirmation|0|||
105720741|NCT02901431|364634074|FG012|PK Part|Pending dose confirmation|0|||
105720742|NCT02901431|364634062|FG000|PK Part|8 weeks of treatment ran out|2|||
105720743|NCT02901431|364634063|FG001|PK Part|8 weeks of treatment ran out|0|||
105720744|NCT02901431|364634064|FG002|PK Part|8 weeks of treatment ran out|0|||
105720745|NCT02901431|364634065|FG003|PK Part|8 weeks of treatment ran out|0|||
105720746|NCT02901431|364634066|FG004|PK Part|8 weeks of treatment ran out|0|||
105720747|NCT02901431|364634067|FG005|PK Part|8 weeks of treatment ran out|0|||
105720748|NCT02901431|364634068|FG006|PK Part|8 weeks of treatment ran out|0|||
105720749|NCT02901431|364634069|FG007|PK Part|8 weeks of treatment ran out|0|||
105720750|NCT02901431|364634070|FG008|PK Part|8 weeks of treatment ran out|0|||
105720751|NCT02901431|364634071|FG009|PK Part|8 weeks of treatment ran out|0|||
105720752|NCT02901431|364634072|FG010|PK Part|8 weeks of treatment ran out|0|||
105720753|NCT02901431|364634073|FG011|PK Part|8 weeks of treatment ran out|0|||
105720754|NCT02901431|364634074|FG012|PK Part|8 weeks of treatment ran out|0|||
105720755|NCT02901431|364634062|FG000|PK Part|Stopped treatment after 8 weeks|1|||
105720756|NCT02901431|364634063|FG001|PK Part|Stopped treatment after 8 weeks|0|||
105720757|NCT02901431|364634064|FG002|PK Part|Stopped treatment after 8 weeks|1|||
105792363|NCT04822701|364894470|FG000|Overall Study|Lost to Follow-up|1|||
105792364|NCT04822701|364894471|FG001|Overall Study|Lost to Follow-up|0|||
105792365|NCT04822701|364894470|FG000|Overall Study|Withdrawal by Subject|1|||
105720758|NCT02901431|364634065|FG003|PK Part|Stopped treatment after 8 weeks|0|||
105792366|NCT04822701|364894471|FG001|Overall Study|Withdrawal by Subject|0|||
105792367|NCT03505606|364896337|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
105720759|NCT02901431|364634066|FG004|PK Part|Stopped treatment after 8 weeks|0|||
105720760|NCT02901431|364634067|FG005|PK Part|Stopped treatment after 8 weeks|0|||
105720761|NCT02901431|364634068|FG006|PK Part|Stopped treatment after 8 weeks|0|||
105720762|NCT02901431|364634069|FG007|PK Part|Stopped treatment after 8 weeks|0|||
105720763|NCT02901431|364634070|FG008|PK Part|Stopped treatment after 8 weeks|0|||
105720764|NCT02901431|364634071|FG009|PK Part|Stopped treatment after 8 weeks|0|||
105720765|NCT02901431|364634072|FG010|PK Part|Stopped treatment after 8 weeks|0|||
105720766|NCT02901431|364634073|FG011|PK Part|Stopped treatment after 8 weeks|0|||
105720767|NCT02901431|364634074|FG012|PK Part|Stopped treatment after 8 weeks|0|||
105720768|NCT02901431|364634062|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
105720769|NCT02901431|364634063|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720770|NCT02901431|364634064|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
105720771|NCT02901431|364634065|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720772|NCT02901431|364634066|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720773|NCT02901431|364634067|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720774|NCT02901431|364634068|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720775|NCT02901431|364634069|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720776|NCT02901431|364634070|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720777|NCT02901431|364634071|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720778|NCT02901431|364634072|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720779|NCT02901431|364634073|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720780|NCT02901431|364634074|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720781|NCT02901431|364634062|FG000|PK Part|Discontinued per Sponsor|0|||
105720782|NCT02901431|364634063|FG001|PK Part|Discontinued per Sponsor|3|||
105720783|NCT02901431|364634064|FG002|PK Part|Discontinued per Sponsor|0|||
105720784|NCT02901431|364634065|FG003|PK Part|Discontinued per Sponsor|0|||
105720785|NCT02901431|364634066|FG004|PK Part|Discontinued per Sponsor|0|||
105720786|NCT02901431|364634067|FG005|PK Part|Discontinued per Sponsor|0|||
105720787|NCT02901431|364634068|FG006|PK Part|Discontinued per Sponsor|0|||
105720788|NCT02901431|364634069|FG007|PK Part|Discontinued per Sponsor|0|||
105720789|NCT02901431|364634070|FG008|PK Part|Discontinued per Sponsor|0|||
105720790|NCT02901431|364634071|FG009|PK Part|Discontinued per Sponsor|0|||
105720791|NCT02901431|364634072|FG010|PK Part|Discontinued per Sponsor|0|||
105720792|NCT02901431|364634073|FG011|PK Part|Discontinued per Sponsor|0|||
105720793|NCT02901431|364634074|FG012|PK Part|Discontinued per Sponsor|0|||
105720794|NCT02901431|364634062|FG000|PK Part|Withdrawal by Subject|1|||
105720795|NCT02901431|364634063|FG001|PK Part|Withdrawal by Subject|1|||
105720796|NCT02901431|364634064|FG002|PK Part|Withdrawal by Subject|3|||
105720797|NCT02901431|364634065|FG003|PK Part|Withdrawal by Subject|0|||
105720798|NCT02901431|364634066|FG004|PK Part|Withdrawal by Subject|0|||
105720799|NCT02901431|364634067|FG005|PK Part|Withdrawal by Subject|0|||
105720800|NCT02901431|364634068|FG006|PK Part|Withdrawal by Subject|0|||
105720801|NCT02901431|364634069|FG007|PK Part|Withdrawal by Subject|0|||
105720802|NCT02901431|364634070|FG008|PK Part|Withdrawal by Subject|0|||
105720803|NCT02901431|364634071|FG009|PK Part|Withdrawal by Subject|0|||
105720804|NCT02901431|364634072|FG010|PK Part|Withdrawal by Subject|0|||
105720805|NCT02901431|364634073|FG011|PK Part|Withdrawal by Subject|0|||
105720806|NCT02901431|364634074|FG012|PK Part|Withdrawal by Subject|0|||
105720807|NCT02901431|364634062|FG000|Main Treatment Part|Adverse Event|0|||
105720808|NCT02901431|364634063|FG001|Main Treatment Part|Adverse Event|0|||
105720809|NCT02901431|364634064|FG002|Main Treatment Part|Adverse Event|0|||
105720810|NCT02901431|364634065|FG003|Main Treatment Part|Adverse Event|3|||
105720811|NCT02901431|364634066|FG004|Main Treatment Part|Adverse Event|3|||
105720812|NCT02901431|364634067|FG005|Main Treatment Part|Adverse Event|4|||
105720813|NCT02901431|364634068|FG006|Main Treatment Part|Adverse Event|1|||
105792368|NCT03505606|364896338|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
105720814|NCT02901431|364634069|FG007|Main Treatment Part|Adverse Event|0|||
105720815|NCT02901431|364634070|FG008|Main Treatment Part|Adverse Event|0|||
105720816|NCT02901431|364634071|FG009|Main Treatment Part|Adverse Event|0|||
105720817|NCT02901431|364634072|FG010|Main Treatment Part|Adverse Event|0|||
105720818|NCT02901431|364634073|FG011|Main Treatment Part|Adverse Event|0|||
105720819|NCT02901431|364634074|FG012|Main Treatment Part|Adverse Event|0|||
105720820|NCT02901431|364634062|FG000|Main Treatment Part|Lack of Efficacy|0|||
105792369|NCT03505606|364896339|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
105792370|NCT03505606|364896337|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
105792371|NCT03505606|364896338|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
105792372|NCT03505606|364896339|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
105792373|NCT03505606|364896337|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
105792374|NCT03505606|364896338|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
105792375|NCT03505606|364896339|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
105792376|NCT03505606|364896337|FG000|Overall Study|Poor compliance with refractive correction|0|||
105792377|NCT03505606|364896338|FG001|Overall Study|Poor compliance with refractive correction|0|||
105792378|NCT03505606|364896339|FG002|Overall Study|Poor compliance with refractive correction|1|||
105792379|NCT03505606|364896337|FG000|Overall Study|Insufficient anisometropia|0|||
105792380|NCT03505606|364896338|FG001|Overall Study|Insufficient anisometropia|0|||
105792381|NCT03505606|364896339|FG002|Overall Study|Insufficient anisometropia|2|||
105792382|NCT03505606|364896337|FG000|Overall Study|Ectopia Lentis|0|||
105792383|NCT03505606|364896338|FG001|Overall Study|Ectopia Lentis|0|||
105792384|NCT03505606|364896339|FG002|Overall Study|Ectopia Lentis|1|||
105792385|NCT03505606|364896337|FG000|Overall Study|alternation of amblyopic eye|0|||
105792386|NCT03505606|364896338|FG001|Overall Study|alternation of amblyopic eye|1|||
105792387|NCT03505606|364896339|FG002|Overall Study|alternation of amblyopic eye|0|||
105792388|NCT01808508|364896340|FG000|Overall Study|Lost to Follow-up|1|||
105792389|NCT01808508|364896341|FG001|Overall Study|Lost to Follow-up|0|||
105792390|NCT01808508|364896342|FG002|Overall Study|Lost to Follow-up|0|||
105792391|NCT02525627|364896343|FG000|Overall Study|Revision|1|||
105792392|NCT02525627|364896344|FG001|Overall Study|Revision|1|||
105792393|NCT02525627|364896343|FG000|Overall Study|Withdrawal by Subject|1|||
105792394|NCT02525627|364896344|FG001|Overall Study|Withdrawal by Subject|2|||
105792395|NCT02525627|364896343|FG000|Overall Study|Death|1|||
105792396|NCT02525627|364896344|FG001|Overall Study|Death|0|||
105792397|NCT02525627|364896343|FG000|Overall Study|Site terminated|11|||
105792398|NCT02525627|364896344|FG001|Overall Study|Site terminated|10|||
105792399|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
105792400|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
105792401|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
105352837|NCT01270321|363296985|FG000|Overall Study|Adverse Event|7|||
105792402|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
105792403|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
105792404|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
105792405|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
105792406|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
105792407|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
105792408|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
105792409|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
105792410|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
105792411|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
105792412|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
105792413|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
105792414|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
105792415|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
105792416|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
105792417|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
105792418|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
105792419|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
105792420|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
105792421|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
105792422|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
105792423|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
105792424|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
105792425|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
105792426|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
105792427|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
105792428|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
105792429|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
105792430|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
105792431|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
105792432|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
105792433|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
105792434|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
105792435|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
105792436|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
105792437|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
105792438|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
105792439|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
105792440|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
105792441|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
105792442|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
105792443|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
105792444|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
105792445|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
105792446|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
105792447|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
105792448|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
105792449|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
105792450|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
105792451|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
105792452|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
105792453|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
105478041|NCT00797966|363761436|FG004|Phase A+|Lost to Follow-up|0|||
105478042|NCT00797966|363761437|FG005|Phase A+|Lost to Follow-up|9|||
105478043|NCT00797966|363761432|FG000|Phase A+|Met withdrawal criteria|0|||
105478044|NCT00797966|363761433|FG001|Phase A+|Met withdrawal criteria|0|||
105478045|NCT00797966|363761434|FG002|Phase A+|Met withdrawal criteria|0|||
105478046|NCT00797966|363761435|FG003|Phase A+|Met withdrawal criteria|0|||
105478047|NCT00797966|363761436|FG004|Phase A+|Met withdrawal criteria|0|||
105478048|NCT00797966|363761437|FG005|Phase A+|Met withdrawal criteria|5|||
105478049|NCT00797966|363761432|FG000|Phase A+|Withdrawal by Subject|0|||
105478050|NCT00797966|363761433|FG001|Phase A+|Withdrawal by Subject|0|||
105478051|NCT00797966|363761434|FG002|Phase A+|Withdrawal by Subject|0|||
105478052|NCT00797966|363761435|FG003|Phase A+|Withdrawal by Subject|0|||
105478053|NCT00797966|363761436|FG004|Phase A+|Withdrawal by Subject|0|||
105478054|NCT00797966|363761437|FG005|Phase A+|Withdrawal by Subject|6|||
105478055|NCT00797966|363761432|FG000|Phase A+|Adverse Event|0|||
105478056|NCT00797966|363761433|FG001|Phase A+|Adverse Event|0|||
105478057|NCT00797966|363761434|FG002|Phase A+|Adverse Event|0|||
105792454|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
105792455|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
105792456|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
105792457|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
105792458|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
105792459|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
105792460|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
105792461|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
105792462|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
105792463|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
105792464|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
105792465|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
105792466|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
105792467|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
105792468|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
105792469|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
105792470|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
105792471|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
105792472|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
105792473|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
105792474|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
105792475|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
105792476|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
105792477|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
105792478|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
105792479|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
105792480|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
105792481|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
105792482|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
105792483|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
105792484|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
105792485|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
105792486|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
105792487|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
105792488|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
105792489|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
105792490|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
105720821|NCT02901431|364634063|FG001|Main Treatment Part|Lack of Efficacy|0|||
105720822|NCT02901431|364634064|FG002|Main Treatment Part|Lack of Efficacy|0|||
105720823|NCT02901431|364634065|FG003|Main Treatment Part|Lack of Efficacy|1|||
105720824|NCT02901431|364634066|FG004|Main Treatment Part|Lack of Efficacy|0|||
105720825|NCT02901431|364634067|FG005|Main Treatment Part|Lack of Efficacy|0|||
105720826|NCT02901431|364634068|FG006|Main Treatment Part|Lack of Efficacy|0|||
105720827|NCT02901431|364634069|FG007|Main Treatment Part|Lack of Efficacy|0|||
105720828|NCT02901431|364634070|FG008|Main Treatment Part|Lack of Efficacy|0|||
105720829|NCT02901431|364634071|FG009|Main Treatment Part|Lack of Efficacy|0|||
105720830|NCT02901431|364634072|FG010|Main Treatment Part|Lack of Efficacy|0|||
105720831|NCT02901431|364634073|FG011|Main Treatment Part|Lack of Efficacy|0|||
105720832|NCT02901431|364634074|FG012|Main Treatment Part|Lack of Efficacy|0|||
105720833|NCT02901431|364634062|FG000|Main Treatment Part|Lost to Follow-up|0|||
105720834|NCT02901431|364634063|FG001|Main Treatment Part|Lost to Follow-up|0|||
105720835|NCT02901431|364634064|FG002|Main Treatment Part|Lost to Follow-up|0|||
105720836|NCT02901431|364634065|FG003|Main Treatment Part|Lost to Follow-up|3|||
105720837|NCT02901431|364634066|FG004|Main Treatment Part|Lost to Follow-up|1|||
105720838|NCT02901431|364634067|FG005|Main Treatment Part|Lost to Follow-up|2|||
105720839|NCT02901431|364634068|FG006|Main Treatment Part|Lost to Follow-up|3|||
105720840|NCT02901431|364634069|FG007|Main Treatment Part|Lost to Follow-up|0|||
105720841|NCT02901431|364634070|FG008|Main Treatment Part|Lost to Follow-up|0|||
105720842|NCT02901431|364634071|FG009|Main Treatment Part|Lost to Follow-up|0|||
105720843|NCT02901431|364634072|FG010|Main Treatment Part|Lost to Follow-up|0|||
105720844|NCT02901431|364634073|FG011|Main Treatment Part|Lost to Follow-up|0|||
105720845|NCT02901431|364634074|FG012|Main Treatment Part|Lost to Follow-up|0|||
105720846|NCT02901431|364634062|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
105720847|NCT02901431|364634063|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
105720848|NCT02901431|364634064|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
105720849|NCT02901431|364634065|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
105720850|NCT02901431|364634066|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
105720851|NCT02901431|364634067|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
105720852|NCT02901431|364634068|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
105720853|NCT02901431|364634069|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
105720854|NCT02901431|364634070|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
105720855|NCT02901431|364634071|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
105720856|NCT02901431|364634072|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
105720857|NCT02901431|364634073|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
105720858|NCT02901431|364634074|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
105720859|NCT02901431|364634062|FG000|Main Treatment Part|Physician Decision|0|||
105720860|NCT02901431|364634063|FG001|Main Treatment Part|Physician Decision|0|||
105720861|NCT02901431|364634064|FG002|Main Treatment Part|Physician Decision|0|||
105720862|NCT02901431|364634065|FG003|Main Treatment Part|Physician Decision|1|||
105720863|NCT02901431|364634066|FG004|Main Treatment Part|Physician Decision|0|||
105720864|NCT02901431|364634067|FG005|Main Treatment Part|Physician Decision|0|||
105720865|NCT02901431|364634068|FG006|Main Treatment Part|Physician Decision|1|||
105720866|NCT02901431|364634069|FG007|Main Treatment Part|Physician Decision|0|||
105720867|NCT02901431|364634070|FG008|Main Treatment Part|Physician Decision|0|||
105720868|NCT02901431|364634071|FG009|Main Treatment Part|Physician Decision|0|||
105720869|NCT02901431|364634072|FG010|Main Treatment Part|Physician Decision|0|||
105720870|NCT02901431|364634073|FG011|Main Treatment Part|Physician Decision|0|||
105720871|NCT02901431|364634074|FG012|Main Treatment Part|Physician Decision|0|||
105720872|NCT02901431|364634062|FG000|Main Treatment Part|Withdrawal by Subject|0|||
105720873|NCT02901431|364634063|FG001|Main Treatment Part|Withdrawal by Subject|0|||
105792491|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
105720874|NCT02901431|364634064|FG002|Main Treatment Part|Withdrawal by Subject|0|||
105720875|NCT02901431|364634065|FG003|Main Treatment Part|Withdrawal by Subject|18|||
105720876|NCT02901431|364634066|FG004|Main Treatment Part|Withdrawal by Subject|3|||
105720877|NCT02901431|364634067|FG005|Main Treatment Part|Withdrawal by Subject|5|||
105720878|NCT02901431|364634068|FG006|Main Treatment Part|Withdrawal by Subject|6|||
105720879|NCT02901431|364634069|FG007|Main Treatment Part|Withdrawal by Subject|0|||
105720880|NCT02901431|364634070|FG008|Main Treatment Part|Withdrawal by Subject|0|||
105720881|NCT02901431|364634071|FG009|Main Treatment Part|Withdrawal by Subject|0|||
105720882|NCT02901431|364634072|FG010|Main Treatment Part|Withdrawal by Subject|0|||
105720883|NCT02901431|364634073|FG011|Main Treatment Part|Withdrawal by Subject|0|||
105720884|NCT02901431|364634074|FG012|Main Treatment Part|Withdrawal by Subject|0|||
105720885|NCT02901431|364634062|FG000|Open Label Part|Adverse Event|0|||
105720886|NCT02901431|364634063|FG001|Open Label Part|Adverse Event|0|||
105720887|NCT02901431|364634064|FG002|Open Label Part|Adverse Event|0|||
105720888|NCT02901431|364634065|FG003|Open Label Part|Adverse Event|0|||
105720889|NCT02901431|364634066|FG004|Open Label Part|Adverse Event|0|||
105720890|NCT02901431|364634067|FG005|Open Label Part|Adverse Event|0|||
105720891|NCT02901431|364634068|FG006|Open Label Part|Adverse Event|0|||
105720892|NCT02901431|364634069|FG007|Open Label Part|Adverse Event|0|||
105720893|NCT02901431|364634070|FG008|Open Label Part|Adverse Event|4|||
105720894|NCT02901431|364634071|FG009|Open Label Part|Adverse Event|4|||
105720895|NCT02901431|364634072|FG010|Open Label Part|Adverse Event|0|||
105720896|NCT02901431|364634073|FG011|Open Label Part|Adverse Event|4|||
105720897|NCT02901431|364634074|FG012|Open Label Part|Adverse Event|1|||
105720898|NCT02901431|364634062|FG000|Open Label Part|Lost to Follow-up|0|||
105720899|NCT02901431|364634063|FG001|Open Label Part|Lost to Follow-up|0|||
105720900|NCT02901431|364634064|FG002|Open Label Part|Lost to Follow-up|0|||
105720901|NCT02901431|364634065|FG003|Open Label Part|Lost to Follow-up|0|||
105720902|NCT02901431|364634066|FG004|Open Label Part|Lost to Follow-up|0|||
105720903|NCT02901431|364634067|FG005|Open Label Part|Lost to Follow-up|0|||
105720904|NCT02901431|364634068|FG006|Open Label Part|Lost to Follow-up|0|||
105720905|NCT02901431|364634069|FG007|Open Label Part|Lost to Follow-up|0|||
105720906|NCT02901431|364634070|FG008|Open Label Part|Lost to Follow-up|2|||
105720907|NCT02901431|364634071|FG009|Open Label Part|Lost to Follow-up|2|||
105720908|NCT02901431|364634072|FG010|Open Label Part|Lost to Follow-up|1|||
105720909|NCT02901431|364634073|FG011|Open Label Part|Lost to Follow-up|1|||
105720910|NCT02901431|364634074|FG012|Open Label Part|Lost to Follow-up|1|||
105720911|NCT02901431|364634062|FG000|Open Label Part|Physician Decision|0|||
105720912|NCT02901431|364634063|FG001|Open Label Part|Physician Decision|0|||
105720913|NCT02901431|364634064|FG002|Open Label Part|Physician Decision|0|||
105720914|NCT02901431|364634065|FG003|Open Label Part|Physician Decision|0|||
105720915|NCT02901431|364634066|FG004|Open Label Part|Physician Decision|0|||
105720916|NCT02901431|364634067|FG005|Open Label Part|Physician Decision|0|||
105720917|NCT02901431|364634068|FG006|Open Label Part|Physician Decision|0|||
105720918|NCT02901431|364634069|FG007|Open Label Part|Physician Decision|0|||
105720919|NCT02901431|364634070|FG008|Open Label Part|Physician Decision|1|||
105720920|NCT02901431|364634071|FG009|Open Label Part|Physician Decision|1|||
105720921|NCT02901431|364634072|FG010|Open Label Part|Physician Decision|0|||
105720922|NCT02901431|364634073|FG011|Open Label Part|Physician Decision|0|||
105720923|NCT02901431|364634074|FG012|Open Label Part|Physician Decision|0|||
105720924|NCT02901431|364634062|FG000|Open Label Part|Study Terminated By Sponsor|0|||
105720925|NCT02901431|364634063|FG001|Open Label Part|Study Terminated By Sponsor|0|||
105720926|NCT02901431|364634064|FG002|Open Label Part|Study Terminated By Sponsor|0|||
105720927|NCT02901431|364634065|FG003|Open Label Part|Study Terminated By Sponsor|0|||
105720928|NCT02901431|364634066|FG004|Open Label Part|Study Terminated By Sponsor|0|||
105720929|NCT02901431|364634067|FG005|Open Label Part|Study Terminated By Sponsor|0|||
105720930|NCT02901431|364634068|FG006|Open Label Part|Study Terminated By Sponsor|0|||
105720931|NCT02901431|364634069|FG007|Open Label Part|Study Terminated By Sponsor|0|||
105720932|NCT02901431|364634070|FG008|Open Label Part|Study Terminated By Sponsor|35|||
105720933|NCT02901431|364634071|FG009|Open Label Part|Study Terminated By Sponsor|12|||
105720934|NCT02901431|364634072|FG010|Open Label Part|Study Terminated By Sponsor|21|||
105720935|NCT02901431|364634073|FG011|Open Label Part|Study Terminated By Sponsor|31|||
105720936|NCT02901431|364634074|FG012|Open Label Part|Study Terminated By Sponsor|0|||
105720937|NCT02901431|364634062|FG000|Open Label Part|Withdrawal by Subject|0|||
105720938|NCT02901431|364634063|FG001|Open Label Part|Withdrawal by Subject|0|||
105720939|NCT02901431|364634064|FG002|Open Label Part|Withdrawal by Subject|0|||
105720940|NCT02901431|364634065|FG003|Open Label Part|Withdrawal by Subject|0|||
105720941|NCT02901431|364634066|FG004|Open Label Part|Withdrawal by Subject|0|||
105720942|NCT02901431|364634067|FG005|Open Label Part|Withdrawal by Subject|0|||
105720943|NCT02901431|364634068|FG006|Open Label Part|Withdrawal by Subject|0|||
105720944|NCT02901431|364634069|FG007|Open Label Part|Withdrawal by Subject|0|||
105720945|NCT02901431|364634070|FG008|Open Label Part|Withdrawal by Subject|6|||
105720946|NCT02901431|364634071|FG009|Open Label Part|Withdrawal by Subject|5|||
105720947|NCT02901431|364634072|FG010|Open Label Part|Withdrawal by Subject|7|||
105720948|NCT02901431|364634073|FG011|Open Label Part|Withdrawal by Subject|3|||
105720949|NCT02901431|364634074|FG012|Open Label Part|Withdrawal by Subject|1|||
105720950|NCT02330419|364634077|FG000|Overall Study|Lost to Follow-up|3|||
105720951|NCT02330419|364634078|FG001|Overall Study|Lost to Follow-up|7|||
105720952|NCT04640766|364634080|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
105720953|NCT00393718|364636311|FG000|Overall Study|Adverse Event|20|||
105720954|NCT00393718|364636312|FG001|Overall Study|Adverse Event|8|||
105720955|NCT00393718|364636311|FG000|Overall Study|Protocol Violation|1|||
105720956|NCT00393718|364636312|FG001|Overall Study|Protocol Violation|2|||
105352838|NCT01270321|363296986|FG001|Overall Study|Adverse Event|9|||
105352839|NCT01270321|363296987|FG002|Overall Study|Adverse Event|5|||
105352840|NCT04003623|363296988|FG000|Overall Study|Withdrawal by Subject|1|||
105352841|NCT04003623|363296989|FG001|Overall Study|Withdrawal by Subject|0|||
105352842|NCT04228965|363296990|FG000|Overall Study|Lost to Follow-up|26|||
105352843|NCT04228965|363296991|FG001|Overall Study|Lost to Follow-up|11|||
105352844|NCT04228965|363296990|FG000|Overall Study|Withdrawal by Subject|18|||
105352845|NCT04228965|363296991|FG001|Overall Study|Withdrawal by Subject|5|||
105352846|NCT02190721|363296994|FG000|Overall Study|Patient was out of the city|0|||
105352847|NCT02190721|363296995|FG001|Overall Study|Patient was out of the city|1|||
105352848|NCT02190721|363296996|FG002|Overall Study|Patient was out of the city|0|||
105352849|NCT01212159|363296997|FG000|Overall Study|Withdrawal by Subject|12|||
105352850|NCT01212159|363296998|FG001|Overall Study|Withdrawal by Subject|12|||
105352851|NCT01306214|363296999|FG000|Overall Study|Death|0|||
105352852|NCT01306214|363297000|FG001|Overall Study|Death|0|||
105352853|NCT01306214|363297001|FG002|Overall Study|Death|1|||
105352854|NCT01306214|363296999|FG000|Overall Study|Lost to Follow-up|3|||
105352855|NCT01306214|363297000|FG001|Overall Study|Lost to Follow-up|5|||
105562015|NCT00289887|364053598|FG001|Overall Study|Other|3|||
105562016|NCT03320018|364053607|FG000|Treatment Period|Withdrawal by Subject|1|||
105562017|NCT03320018|364053608|FG001|Treatment Period|Withdrawal by Subject|0|||
105562018|NCT03320018|364053607|FG000|Day 90 Follow up|Death|0|||
105562019|NCT03320018|364053608|FG001|Day 90 Follow up|Death|1|||
105562020|NCT01699022|364053611|FG000|Overall Study|Early discontinuation from the study|3|||
105562021|NCT04605978|364053618|FG000|Overall Study|Adverse Event|2|||
105562022|NCT04605978|364053619|FG001|Overall Study|Adverse Event|1|||
105562023|NCT04605978|364053618|FG000|Overall Study|Withdrawal nonmedical reason|1|||
105562024|NCT04605978|364053619|FG001|Overall Study|Withdrawal nonmedical reason|1|||
105562025|NCT02583425|364053620|FG000|Screening|Did not meet entry criteria|12|||
105562026|NCT02583425|364053620|FG000|Baseline|Did not meet continued criteria|5|||
105562027|NCT02583425|364053620|FG000|Treatment Period|Adverse Event|1|||
105562028|NCT02548455|364053625|FG000|Overall Study|Withdrawal by Subject|27|||
105562029|NCT02548455|364053625|FG000|Overall Study|Death|26|||
105562030|NCT02548455|364053625|FG000|Overall Study|Lost to Follow-up|14|||
105562031|NCT02548455|364053625|FG000|Overall Study|Visit not completed|173|||
105562032|NCT02123108|364053631|FG000|Overall Study|Death|2|||
105562033|NCT02123108|364053632|FG001|Overall Study|Death|3|||
105562034|NCT00594854|364053638|FG000|Overall Study|Study terminated|7|||
105720957|NCT00393718|364636311|FG000|Overall Study|Lack of Efficacy|10|||
105720958|NCT00393718|364636312|FG001|Overall Study|Lack of Efficacy|9|||
105720959|NCT00393718|364636311|FG000|Overall Study|Hypoglycaemia|3|||
105720960|NCT00393718|364636312|FG001|Overall Study|Hypoglycaemia|2|||
105720961|NCT00393718|364636311|FG000|Overall Study|Subject decision|5|||
105720962|NCT00393718|364636312|FG001|Overall Study|Subject decision|0|||
105720963|NCT00393718|364636311|FG000|Overall Study|Withdrawal of consent|2|||
105720964|NCT00393718|364636312|FG001|Overall Study|Withdrawal of consent|1|||
105562035|NCT00594854|364053639|FG001|Overall Study|Study terminated|10|||
105562036|NCT04212091|364053640|FG000|Overall Study|Lost to Follow-up|0|||
105720965|NCT00393718|364636311|FG000|Overall Study|Missed measurement|1|||
105562037|NCT04212091|364053641|FG001|Overall Study|Lost to Follow-up|0|||
105562038|NCT04212091|364053642|FG002|Overall Study|Lost to Follow-up|0|||
105562039|NCT04212091|364053643|FG003|Overall Study|Lost to Follow-up|0|||
105720966|NCT00393718|364636312|FG001|Overall Study|Missed measurement|0|||
105562040|NCT04212091|364053644|FG004|Overall Study|Lost to Follow-up|1|||
105562041|NCT04212091|364053645|FG005|Overall Study|Lost to Follow-up|1|||
105562042|NCT04212091|364053640|FG000|Overall Study|Participant unable to adhere to visit|0|||
105562043|NCT04212091|364053641|FG001|Overall Study|Participant unable to adhere to visit|0|||
105562044|NCT04212091|364053642|FG002|Overall Study|Participant unable to adhere to visit|0|||
105562045|NCT04212091|364053643|FG003|Overall Study|Participant unable to adhere to visit|0|||
105562046|NCT04212091|364053644|FG004|Overall Study|Participant unable to adhere to visit|1|||
105562047|NCT04212091|364053645|FG005|Overall Study|Participant unable to adhere to visit|0|||
105562048|NCT02660827|364053649|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
105562049|NCT02660827|364053649|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
105562050|NCT02660827|364053649|FG000|From Study to End of Continued Access|Adverse Event|3|||
105562051|NCT02660827|364053649|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
105562052|NCT02660827|364053649|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
105562053|NCT02660827|364053649|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
105562054|NCT02660827|364053649|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
105720967|NCT00393718|364636311|FG000|Overall Study|Move|1|||
105720968|NCT00393718|364636312|FG001|Overall Study|Move|0|||
105720969|NCT00883493|364636313|FG000|Overall Study|Adverse Event|11|||
105720970|NCT00883493|364636314|FG001|Overall Study|Adverse Event|12|||
105720971|NCT00883493|364636313|FG000|Overall Study|Lack of Efficacy|4|||
105720972|NCT00883493|364636314|FG001|Overall Study|Lack of Efficacy|3|||
105720973|NCT00883493|364636313|FG000|Overall Study|Lost to Follow-up|7|||
105720974|NCT00883493|364636314|FG001|Overall Study|Lost to Follow-up|6|||
105720975|NCT00883493|364636313|FG000|Overall Study|Withdrawal by Subject|11|||
105720976|NCT00883493|364636314|FG001|Overall Study|Withdrawal by Subject|20|||
105720977|NCT00883493|364636313|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
105720978|NCT00883493|364636314|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
105720979|NCT00883493|364636313|FG000|Overall Study|Study specific disc. criteria|2|||
105720980|NCT00883493|364636314|FG001|Overall Study|Study specific disc. criteria|0|||
105720981|NCT00883493|364636313|FG000|Overall Study|Other|5|||
105720982|NCT00883493|364636314|FG001|Overall Study|Other|3|||
105720983|NCT01427309|364636316|FG000|Overall Study|Lost to Follow-up|130|||
105720984|NCT01427309|364636317|FG001|Overall Study|Lost to Follow-up|145|||
105720985|NCT01427309|364636318|FG002|Overall Study|Lost to Follow-up|122|||
105720986|NCT01427309|364636319|FG003|Overall Study|Lost to Follow-up|135|||
105720987|NCT01427309|364636316|FG000|Overall Study|Protocol Violation|42|||
105720988|NCT01427309|364636317|FG001|Overall Study|Protocol Violation|69|||
105720989|NCT01427309|364636318|FG002|Overall Study|Protocol Violation|125|||
105720990|NCT01427309|364636319|FG003|Overall Study|Protocol Violation|124|||
105720991|NCT01427309|364636316|FG000|Overall Study|Adverse Event|0|||
105720992|NCT01427309|364636317|FG001|Overall Study|Adverse Event|0|||
105720993|NCT01427309|364636318|FG002|Overall Study|Adverse Event|3|||
105720994|NCT01427309|364636319|FG003|Overall Study|Adverse Event|1|||
105720995|NCT01427309|364636316|FG000|Overall Study|Serious adverse event|52|||
105720996|NCT01427309|364636317|FG001|Overall Study|Serious adverse event|45|||
105720997|NCT01427309|364636318|FG002|Overall Study|Serious adverse event|50|||
105720998|NCT01427309|364636319|FG003|Overall Study|Serious adverse event|61|||
105720999|NCT01427309|364636316|FG000|Overall Study|Withdrawal by Subject|148|||
105721000|NCT01427309|364636317|FG001|Overall Study|Withdrawal by Subject|148|||
105721001|NCT01427309|364636318|FG002|Overall Study|Withdrawal by Subject|61|||
105721002|NCT01427309|364636319|FG003|Overall Study|Withdrawal by Subject|55|||
105721003|NCT01354132|364636320|FG000|Randomization|Physician Decision|1|||
105721004|NCT01354132|364636321|FG001|Randomization|Physician Decision|0|||
105721005|NCT01354132|364636320|FG000|Randomization|Withdrawal by Subject|0|||
105721006|NCT01354132|364636321|FG001|Randomization|Withdrawal by Subject|1|||
105721007|NCT01354132|364636320|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
105721008|NCT01354132|364636321|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
105721009|NCT01354132|364636320|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
105562055|NCT02660827|364053649|FG000|Period 2: Continued Access Period|Adverse Event|3|||
105721010|NCT01354132|364636321|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
105562056|NCT01812655|364053650|FG000|Overall Study|Protocol Violation|1|||
105562057|NCT01812655|364053651|FG001|Overall Study|Protocol Violation|1|||
105721011|NCT01354132|364636320|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
105721012|NCT01354132|364636321|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
105721013|NCT00603239|364636322|FG000|Overall Study|Adverse Event|4|||
105721014|NCT00603239|364636323|FG001|Overall Study|Adverse Event|1|||
105721015|NCT00603239|364636322|FG000|Overall Study|Entry criteria not met|0|||
105721016|NCT00603239|364636323|FG001|Overall Study|Entry criteria not met|1|||
105721017|NCT00603239|364636322|FG000|Overall Study|Loss of glucose control|3|||
105721018|NCT00603239|364636323|FG001|Overall Study|Loss of glucose control|0|||
105721019|NCT00603239|364636322|FG000|Overall Study|Lost to Follow-up|2|||
105721020|NCT00603239|364636323|FG001|Overall Study|Lost to Follow-up|1|||
105721021|NCT00603239|364636322|FG000|Overall Study|Physician Decision|2|||
105562058|NCT01812655|364053652|FG002|Overall Study|Protocol Violation|0|||
105562059|NCT01428076|364053654|FG000|Overall Study|Adverse Event|0|||
105562060|NCT01428076|364053655|FG001|Overall Study|Adverse Event|1|||
105562061|NCT04198805|364053656|FG000|Overall Study|Death|0|||
105562062|NCT04198805|364053657|FG001|Overall Study|Death|0|||
105562063|NCT04198805|364053658|FG002|Overall Study|Death|0|||
105562064|NCT04198805|364053659|FG003|Overall Study|Death|1|||
105562065|NCT04198805|364053656|FG000|Overall Study|Early Termination|8|||
105562066|NCT04198805|364053657|FG001|Overall Study|Early Termination|4|||
105562067|NCT04198805|364053658|FG002|Overall Study|Early Termination|6|||
105562068|NCT04198805|364053659|FG003|Overall Study|Early Termination|9|||
105562069|NCT02114151|364053660|FG000|Overall Study|Death|1|||
105562070|NCT02114151|364053660|FG000|Overall Study|Lost to Follow-up|1|||
105562071|NCT02114151|364053660|FG000|Overall Study|Withdrawal by Subject|5|||
105562072|NCT01666808|364053661|FG000|Overall Study|Lost to Follow-up|9|||
105562073|NCT01666808|364053662|FG001|Overall Study|Lost to Follow-up|15|||
105562074|NCT01666808|364053661|FG000|Overall Study|Withdrawal by Subject|3|||
105562075|NCT01666808|364053662|FG001|Overall Study|Withdrawal by Subject|1|||
105562076|NCT01666808|364053661|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
105562077|NCT01666808|364053662|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
105562078|NCT02638948|364053665|FG000|Overall Study|Withdrawal by Subject|4|||
105562079|NCT02638948|364053666|FG001|Overall Study|Withdrawal by Subject|5|||
105562080|NCT02638948|364053667|FG002|Overall Study|Withdrawal by Subject|3|||
105562081|NCT02638948|364053668|FG003|Overall Study|Withdrawal by Subject|1|||
105562082|NCT02638948|364053665|FG000|Overall Study|Administrative Reason by Sponsor|0|||
105562083|NCT02638948|364053666|FG001|Overall Study|Administrative Reason by Sponsor|1|||
105562084|NCT02638948|364053667|FG002|Overall Study|Administrative Reason by Sponsor|0|||
105562085|NCT02638948|364053668|FG003|Overall Study|Administrative Reason by Sponsor|4|||
105562086|NCT02638948|364053665|FG000|Overall Study|Adverse Event|0|||
105562087|NCT02638948|364053666|FG001|Overall Study|Adverse Event|0|||
105562088|NCT02638948|364053667|FG002|Overall Study|Adverse Event|1|||
105562089|NCT02638948|364053668|FG003|Overall Study|Adverse Event|1|||
105562090|NCT02638948|364053665|FG000|Overall Study|Lack of Efficacy|1|||
105562091|NCT02638948|364053666|FG001|Overall Study|Lack of Efficacy|1|||
105562092|NCT02638948|364053667|FG002|Overall Study|Lack of Efficacy|0|||
105562093|NCT02638948|364053668|FG003|Overall Study|Lack of Efficacy|0|||
105562094|NCT02638948|364053665|FG000|Overall Study|Lost to Follow-up|0|||
105562095|NCT02638948|364053666|FG001|Overall Study|Lost to Follow-up|0|||
105562096|NCT02638948|364053667|FG002|Overall Study|Lost to Follow-up|1|||
105562097|NCT02638948|364053668|FG003|Overall Study|Lost to Follow-up|1|||
105562098|NCT02638948|364053665|FG000|Overall Study|Poor/Non-Compliance|0|||
105562099|NCT02638948|364053666|FG001|Overall Study|Poor/Non-Compliance|2|||
105562100|NCT02638948|364053667|FG002|Overall Study|Poor/Non-Compliance|1|||
105562101|NCT02638948|364053668|FG003|Overall Study|Poor/Non-Compliance|0|||
105562102|NCT02638948|364053665|FG000|Overall Study|Participant no longer met study criteria|0|||
105562103|NCT02638948|364053666|FG001|Overall Study|Participant no longer met study criteria|1|||
105562104|NCT02638948|364053667|FG002|Overall Study|Participant no longer met study criteria|0|||
105562105|NCT02638948|364053668|FG003|Overall Study|Participant no longer met study criteria|0|||
105562106|NCT02638948|364053665|FG000|Overall Study|Other than specified above|4|||
105562107|NCT02638948|364053666|FG001|Overall Study|Other than specified above|1|||
105562108|NCT02638948|364053667|FG002|Overall Study|Other than specified above|1|||
105562109|NCT02638948|364053668|FG003|Overall Study|Other than specified above|1|||
105562110|NCT01830127|364053674|FG000|Overall Study|Adverse Event|1|||
105792492|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
105792493|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
105562111|NCT01830127|364053675|FG001|Overall Study|Adverse Event|6|||
105562112|NCT01830127|364053674|FG000|Overall Study|Lack of Efficacy|3|||
105562113|NCT01830127|364053675|FG001|Overall Study|Lack of Efficacy|0|||
105562114|NCT01830127|364053674|FG000|Overall Study|Withdrawal by Subject|1|||
105562115|NCT01830127|364053675|FG001|Overall Study|Withdrawal by Subject|1|||
105562116|NCT01830127|364053674|FG000|Overall Study|Other reason not defined above|0|||
105562117|NCT01830127|364053675|FG001|Overall Study|Other reason not defined above|2|||
105562118|NCT00567190|364053676|FG000|Overall Study|Death|235|||
105562119|NCT00567190|364053677|FG001|Overall Study|Death|280|||
105562120|NCT00567190|364053676|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
105562121|NCT00567190|364053677|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
105562122|NCT00553696|364053686|FG000|Overall Study|Adverse Event|2|||
105352856|NCT01306214|363297001|FG002|Overall Study|Lost to Follow-up|4|||
105792494|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
105352857|NCT01306214|363296999|FG000|Overall Study|Withdrawal by Subject|24|||
105562123|NCT00553696|364053687|FG001|Overall Study|Adverse Event|4|||
105562124|NCT00553696|364053688|FG002|Overall Study|Adverse Event|0|||
105562125|NCT00553696|364053689|FG003|Overall Study|Adverse Event|1|||
105562126|NCT00553696|364053686|FG000|Overall Study|Global deterioration of health status|0|||
105562127|NCT00553696|364053687|FG001|Overall Study|Global deterioration of health status|2|||
105562128|NCT00553696|364053688|FG002|Overall Study|Global deterioration of health status|0|||
105721022|NCT00603239|364636323|FG001|Overall Study|Physician Decision|0|||
105721023|NCT00603239|364636322|FG000|Overall Study|Protocol Violation|2|||
105721024|NCT00603239|364636323|FG001|Overall Study|Protocol Violation|0|||
105721025|NCT00603239|364636322|FG000|Overall Study|Subject decision|2|||
105721026|NCT00603239|364636323|FG001|Overall Study|Subject decision|1|||
105721027|NCT03617705|364636324|FG000|Overall Study|Withdrawal by Subject|2|||
105721028|NCT03617705|364636324|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
105721029|NCT03617705|364636324|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
105721030|NCT00928070|364636325|FG000|Overall Study|Lost to Follow-up|1|||
105721031|NCT00928070|364636326|FG001|Overall Study|Lost to Follow-up|2|||
105721032|NCT00928070|364636325|FG000|Overall Study|Withdrawal by Subject|10|||
105721033|NCT00928070|364636326|FG001|Overall Study|Withdrawal by Subject|3|||
105721034|NCT00928070|364636325|FG000|Overall Study|Adverse Event|14|||
105721035|NCT00928070|364636326|FG001|Overall Study|Adverse Event|26|||
105721036|NCT00928070|364636325|FG000|Overall Study|Lack of Efficacy|9|||
105721037|NCT00928070|364636326|FG001|Overall Study|Lack of Efficacy|5|||
105721038|NCT00928070|364636325|FG000|Overall Study|Did not meet entrance criteria|16|||
105721039|NCT00928070|364636326|FG001|Overall Study|Did not meet entrance criteria|9|||
105721040|NCT00928070|364636325|FG000|Overall Study|Protocol Violation|6|||
105721041|NCT00928070|364636326|FG001|Overall Study|Protocol Violation|5|||
105721042|NCT00928070|364636325|FG000|Overall Study|Randomized but not treated|2|||
105721043|NCT00928070|364636326|FG001|Overall Study|Randomized but not treated|2|||
105721044|NCT00928070|364636325|FG000|Overall Study|Other|5|||
105721045|NCT00928070|364636326|FG001|Overall Study|Other|5|||
105721046|NCT04233229|364636327|FG000|Overall Study|Withdrawal by Subject|0|||
105721047|NCT04233229|364636328|FG001|Overall Study|Withdrawal by Subject|1|||
105721048|NCT04233229|364636327|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
105721049|NCT04233229|364636328|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
105721050|NCT04233229|364636327|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
105721051|NCT04233229|364636328|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
105721052|NCT00862251|364636329|FG000|Overall Study|Adverse Event|8|||
105721053|NCT00862251|364636330|FG001|Overall Study|Adverse Event|3|||
105721054|NCT00862251|364636331|FG002|Overall Study|Adverse Event|1|||
105721055|NCT00862251|364636329|FG000|Overall Study|Lost to Follow-up|0|||
105721056|NCT00862251|364636330|FG001|Overall Study|Lost to Follow-up|0|||
105721057|NCT00862251|364636331|FG002|Overall Study|Lost to Follow-up|1|||
105721058|NCT00862251|364636329|FG000|Overall Study|Protocol Violation|2|||
105721059|NCT00862251|364636330|FG001|Overall Study|Protocol Violation|0|||
105721060|NCT00862251|364636331|FG002|Overall Study|Protocol Violation|1|||
105721061|NCT00862251|364636329|FG000|Overall Study|Withdrawal by Subject|9|||
105721062|NCT00862251|364636330|FG001|Overall Study|Withdrawal by Subject|2|||
105721063|NCT00862251|364636331|FG002|Overall Study|Withdrawal by Subject|6|||
105721064|NCT01570244|364636336|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
105721065|NCT03093155|364636340|FG000|Overall Study|Not Eligible|1|||
105721066|NCT03093155|364636341|FG001|Overall Study|Not Eligible|0|||
105721067|NCT03093155|364636340|FG000|Overall Study|Withdrawal by Subject|0|||
105721068|NCT03093155|364636341|FG001|Overall Study|Withdrawal by Subject|1|||
105721069|NCT02429856|364636342|FG000|Overall Study|Death|12|||
105721070|NCT02429856|364636343|FG001|Overall Study|Death|13|||
105721071|NCT02429856|364636342|FG000|Overall Study|Lost to Follow-up|6|||
105721072|NCT02429856|364636343|FG001|Overall Study|Lost to Follow-up|5|||
105721073|NCT02429856|364636342|FG000|Overall Study|Withdrawal by Subject|1|||
105721074|NCT02429856|364636343|FG001|Overall Study|Withdrawal by Subject|1|||
105721075|NCT00888238|364636353|FG000|Washout Period After Period 2|Adverse Event|0|||
105721076|NCT00888238|364636354|FG001|Washout Period After Period 2|Adverse Event|0|||
105721077|NCT00888238|364636355|FG002|Washout Period After Period 2|Adverse Event|1|||
105721078|NCT03751111|364636356|FG000|Overall Study|Lack of Efficacy|9|||
105721079|NCT03751111|364636357|FG001|Overall Study|Lack of Efficacy|30|||
105721080|NCT03751111|364636356|FG000|Overall Study|Adverse Event|3|||
105721081|NCT03751111|364636357|FG001|Overall Study|Adverse Event|2|||
105352858|NCT01306214|363297000|FG001|Overall Study|Withdrawal by Subject|22|||
105352859|NCT01306214|363297001|FG002|Overall Study|Withdrawal by Subject|16|||
105478058|NCT00797966|363761435|FG003|Phase A+|Adverse Event|0|||
105478059|NCT00797966|363761436|FG004|Phase A+|Adverse Event|0|||
105721082|NCT00974220|364636358|FG000|Treatment Period 1|Adverse Event|2|||
105721083|NCT00974220|364636359|FG001|Treatment Period 1|Adverse Event|1|||
105721084|NCT00974220|364636358|FG000|Treatment Period 1|noncompliant subjects|0|||
105721085|NCT00974220|364636359|FG001|Treatment Period 1|noncompliant subjects|1|||
105721086|NCT02921425|364636360|FG000|Overall Study|Protocol Violation|9|||
105721087|NCT01227967|364636361|FG000|Overall Study|Protocol Violation|3|||
105721088|NCT01227967|364636362|FG001|Overall Study|Protocol Violation|1|||
105721089|NCT01227967|364636361|FG000|Overall Study|Death|0|||
105721090|NCT01227967|364636362|FG001|Overall Study|Death|1|||
105721091|NCT01227967|364636361|FG000|Overall Study|Lost to Follow-up|8|||
105721092|NCT01227967|364636362|FG001|Overall Study|Lost to Follow-up|3|||
105721093|NCT01227967|364636361|FG000|Overall Study|Withdrawal by Subject|4|||
105721094|NCT01227967|364636362|FG001|Overall Study|Withdrawal by Subject|3|||
105721095|NCT01227967|364636361|FG000|Overall Study|Physician Decision|0|||
105721096|NCT01227967|364636362|FG001|Overall Study|Physician Decision|1|||
105721097|NCT01227967|364636361|FG000|Overall Study|Never Started Treatment|0|||
105721098|NCT01227967|364636362|FG001|Overall Study|Never Started Treatment|4|||
105721099|NCT01227967|364636361|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
105721100|NCT01227967|364636362|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
105721101|NCT03068715|364636363|FG000|Overall Study|No longer met inclusion criteria|1|||
105721102|NCT03068715|364636364|FG001|Overall Study|No longer met inclusion criteria|0|||
105721103|NCT00977470|364636368|FG000|Overall Study|Lack of Efficacy|32|||
105721104|NCT00977470|364636369|FG001|Overall Study|Lack of Efficacy|30|||
105721105|NCT00977470|364636368|FG000|Overall Study|Physician Decision|2|||
105721106|NCT00977470|364636369|FG001|Overall Study|Physician Decision|0|||
105721107|NCT00977470|364636368|FG000|Overall Study|Adverse Event|1|||
105721108|NCT00977470|364636369|FG001|Overall Study|Adverse Event|2|||
105721109|NCT00977470|364636368|FG000|Overall Study|Protocol Violation|1|||
105721110|NCT00977470|364636369|FG001|Overall Study|Protocol Violation|0|||
105721111|NCT00977470|364636368|FG000|Overall Study|Withdrawal by Subject|0|||
105721112|NCT00977470|364636369|FG001|Overall Study|Withdrawal by Subject|2|||
105721113|NCT00977470|364636368|FG000|Overall Study|Death|0|||
105721114|NCT00977470|364636369|FG001|Overall Study|Death|2|||
105721115|NCT00977470|364636368|FG000|Overall Study|clinical decline|0|||
105721116|NCT00977470|364636369|FG001|Overall Study|clinical decline|1|||
105721117|NCT00977470|364636368|FG000|Overall Study|prolonged recovery post-surgery|0|||
105721118|NCT00977470|364636369|FG001|Overall Study|prolonged recovery post-surgery|1|||
105721119|NCT00977470|364636368|FG000|Overall Study|Still on-study|2|||
105721120|NCT00977470|364636369|FG001|Overall Study|Still on-study|0|||
105721121|NCT01264939|364636370|FG000|Overall Study|Adverse Event|1|||
105721122|NCT01264939|364636371|FG001|Overall Study|Adverse Event|3|||
105721123|NCT01264939|364636370|FG000|Overall Study|Lost to Follow-up|0|||
105721124|NCT01264939|364636371|FG001|Overall Study|Lost to Follow-up|3|||
105721125|NCT01264939|364636370|FG000|Overall Study|Physician Decision|1|||
105721126|NCT01264939|364636371|FG001|Overall Study|Physician Decision|1|||
105721127|NCT01264939|364636370|FG000|Overall Study|Patient/Guardian Decision|8|||
105721128|NCT01264939|364636371|FG001|Overall Study|Patient/Guardian Decision|10|||
105721129|NCT01264939|364636370|FG000|Overall Study|Disease Progression|8|||
105721130|NCT01264939|364636371|FG001|Overall Study|Disease Progression|11|||
105721131|NCT01107444|364636372|FG000|Overall Study|Withdrawal by Subject|8|||
105721132|NCT01107444|364636373|FG001|Overall Study|Withdrawal by Subject|12|||
105721133|NCT01107444|364636372|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
105721134|NCT01107444|364636373|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
105721135|NCT01171612|364636375|FG000|Overall Study|Lost to Follow-up|51|||
105721136|NCT00737529|364636383|FG000|Overall Study|Disease Progression|95|||
105721137|NCT00737529|364636383|FG000|Overall Study|Adverse Event|24|||
105721138|NCT00737529|364636383|FG000|Overall Study|Withdrawal by Subject|5|||
105721139|NCT00737529|364636383|FG000|Overall Study|Death|4|||
105721140|NCT00737529|364636383|FG000|Overall Study|Protocol Violation|1|||
105721141|NCT00737529|364636383|FG000|Overall Study|Other|4|||
105792495|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
105478060|NCT00797966|363761437|FG005|Phase A+|Adverse Event|4|||
105721142|NCT01145560|364636384|FG000|Overall Study|Withdrawal by Subject|2|||
105721143|NCT01145560|364636385|FG001|Overall Study|Withdrawal by Subject|1|||
105721144|NCT01145560|364636386|FG002|Overall Study|Withdrawal by Subject|0|||
105721145|NCT01145560|364636384|FG000|Overall Study|Lost to Follow-up|1|||
105721146|NCT01145560|364636385|FG001|Overall Study|Lost to Follow-up|1|||
105721147|NCT01145560|364636386|FG002|Overall Study|Lost to Follow-up|1|||
105721148|NCT01145560|364636384|FG000|Overall Study|No study drug by 24h after organ failure|1|||
105721149|NCT01145560|364636385|FG001|Overall Study|No study drug by 24h after organ failure|0|||
105721150|NCT01145560|364636386|FG002|Overall Study|No study drug by 24h after organ failure|0|||
105562129|NCT00553696|364053689|FG003|Overall Study|Global deterioration of health status|0|||
105562130|NCT00553696|364053686|FG000|Overall Study|Objective progression or relapse|2|||
105562131|NCT00553696|364053687|FG001|Overall Study|Objective progression or relapse|9|||
105562132|NCT00553696|364053688|FG002|Overall Study|Objective progression or relapse|6|||
105562133|NCT00553696|364053689|FG003|Overall Study|Objective progression or relapse|0|||
105562134|NCT00553696|364053686|FG000|Overall Study|Withdrawal by Subject|0|||
105562135|NCT00553696|364053687|FG001|Overall Study|Withdrawal by Subject|1|||
105562136|NCT00553696|364053688|FG002|Overall Study|Withdrawal by Subject|0|||
105562137|NCT00553696|364053689|FG003|Overall Study|Withdrawal by Subject|0|||
105562138|NCT00686881|364053690|FG000|Overall Study|Withdrawal by Subject|11|||
105562139|NCT00686881|364053691|FG001|Overall Study|Withdrawal by Subject|18|||
105562140|NCT00686881|364053690|FG000|Overall Study|Lost to Follow-up|0|||
105562141|NCT00686881|364053691|FG001|Overall Study|Lost to Follow-up|1|||
105562142|NCT00686881|364053690|FG000|Overall Study|Treatment-related adverse event|10|||
105562143|NCT00686881|364053691|FG001|Overall Study|Treatment-related adverse event|9|||
105562144|NCT00686881|364053690|FG000|Overall Study|Met discontinuation criteria|5|||
105562145|NCT00686881|364053691|FG001|Overall Study|Met discontinuation criteria|0|||
105562146|NCT00686881|364053690|FG000|Overall Study|Onset of malignant tumor|11|||
105562147|NCT00686881|364053691|FG001|Overall Study|Onset of malignant tumor|11|||
105562148|NCT00686881|364053690|FG000|Overall Study|Lack of Efficacy|4|||
105562149|NCT00686881|364053691|FG001|Overall Study|Lack of Efficacy|3|||
105562150|NCT00686881|364053690|FG000|Overall Study|Physician Decision|1|||
105562151|NCT00686881|364053691|FG001|Overall Study|Physician Decision|0|||
105562152|NCT00686881|364053690|FG000|Overall Study|Circumstances of site|1|||
105562153|NCT00686881|364053691|FG001|Overall Study|Circumstances of site|1|||
105562154|NCT00686881|364053690|FG000|Overall Study|Did not meet protocol eligibility|1|||
105562155|NCT00686881|364053691|FG001|Overall Study|Did not meet protocol eligibility|0|||
105562156|NCT00686881|364053690|FG000|Overall Study|Irregular visits|1|||
105721151|NCT01145560|364636384|FG000|Overall Study|Accidental unblinding of study treatment|0|||
105721152|NCT01145560|364636385|FG001|Overall Study|Accidental unblinding of study treatment|1|||
105721153|NCT01145560|364636386|FG002|Overall Study|Accidental unblinding of study treatment|0|||
105721154|NCT01145560|364636384|FG000|Overall Study|False insurance information|0|||
105721155|NCT01145560|364636385|FG001|Overall Study|False insurance information|1|||
105721156|NCT01145560|364636386|FG002|Overall Study|False insurance information|0|||
105721157|NCT01145560|364636384|FG000|Overall Study|Withdrawal of therapy|0|||
105721158|NCT01145560|364636385|FG001|Overall Study|Withdrawal of therapy|0|||
105721159|NCT01145560|364636386|FG002|Overall Study|Withdrawal of therapy|1|||
105721160|NCT04062214|364636389|FG000|Week 12|Death|1|||
105721161|NCT04062214|364636390|FG001|Week 12|Death|1|||
105721162|NCT04062214|364636389|FG000|Week 12|Withdrawal by Subject|14|||
105721163|NCT04062214|364636390|FG001|Week 12|Withdrawal by Subject|13|||
105721164|NCT04062214|364636389|FG000|Week 12|Lost to Follow-up|55|||
105721165|NCT04062214|364636390|FG001|Week 12|Lost to Follow-up|68|||
105721166|NCT04062214|364636389|FG000|Week 12|Intermittent missing|31|||
105721167|NCT04062214|364636390|FG001|Week 12|Intermittent missing|29|||
105721168|NCT04062214|364636389|FG000|Week 36|Withdrawal by Subject|4|||
105721169|NCT04062214|364636390|FG001|Week 36|Withdrawal by Subject|5|||
105721170|NCT04062214|364636389|FG000|Week 36|Lost to Follow-up|50|||
105721171|NCT04062214|364636390|FG001|Week 36|Lost to Follow-up|46|||
105721172|NCT04062214|364636389|FG000|Week 36|Death|0|||
105721173|NCT04062214|364636390|FG001|Week 36|Death|1|||
105721174|NCT02452762|364636391|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
105721175|NCT02452762|364636392|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
105721176|NCT02452762|364636391|FG000|Overall Study|Withdrawal by Subject|1|||
105721177|NCT02452762|364636392|FG001|Overall Study|Withdrawal by Subject|0|||
105721178|NCT02292212|364636394|FG000|ViE Phase|Withdrawal by Subject|1|||
105721179|NCT02292212|364636394|FG000|ViE Phase|Protocol Violation|2|||
105721180|NCT02675075|364636395|FG000|Overall Study|Lost to Follow-up|3|||
105721181|NCT02675075|364636396|FG001|Overall Study|Lost to Follow-up|0|||
105721182|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721183|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721184|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721185|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
105721186|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105562157|NCT00686881|364053691|FG001|Overall Study|Irregular visits|0|||
105562158|NCT00686881|364053690|FG000|Overall Study|Study discontinuation|35|||
105562159|NCT00686881|364053691|FG001|Overall Study|Study discontinuation|32|||
105721187|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
105721188|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105478061|NCT00797966|363761432|FG000|Phase A+|Protocol deviation|0|||
105478062|NCT00797966|363761433|FG001|Phase A+|Protocol deviation|0|||
105478063|NCT00797966|363761434|FG002|Phase A+|Protocol deviation|0|||
105478064|NCT00797966|363761435|FG003|Phase A+|Protocol deviation|0|||
105478065|NCT00797966|363761436|FG004|Phase A+|Protocol deviation|0|||
105478066|NCT00797966|363761437|FG005|Phase A+|Protocol deviation|4|||
105478067|NCT00640224|363761438|FG000|Overall Study|Lost to Follow-up|5|||
105478068|NCT00640224|363761439|FG001|Overall Study|Lost to Follow-up|2|||
105478069|NCT00640224|363761440|FG002|Overall Study|Lost to Follow-up|0|||
105478070|NCT00640224|363761441|FG003|Overall Study|Lost to Follow-up|0|||
105478071|NCT00640224|363761438|FG000|Overall Study|Withdrawal by Subject|1|||
105478072|NCT00640224|363761439|FG001|Overall Study|Withdrawal by Subject|0|||
105478073|NCT00640224|363761440|FG002|Overall Study|Withdrawal by Subject|0|||
105478074|NCT00640224|363761441|FG003|Overall Study|Withdrawal by Subject|0|||
105478075|NCT00640224|363761438|FG000|Overall Study|Headaches|0|||
105478076|NCT00640224|363761439|FG001|Overall Study|Headaches|1|||
105478077|NCT00640224|363761440|FG002|Overall Study|Headaches|0|||
105478078|NCT00640224|363761441|FG003|Overall Study|Headaches|0|||
105478079|NCT02937584|363761447|FG000|Period 1|Adverse Event|1|||
105478080|NCT02937584|363761448|FG001|Period 1|Adverse Event|2|||
105478081|NCT02937584|363761447|FG000|Washout|Adverse Event|0|||
105478082|NCT02937584|363761448|FG001|Washout|Adverse Event|1|||
105478083|NCT01883453|363761449|FG000|Overall Study|No episode of common cold|25|||
105478084|NCT01883453|363761450|FG001|Overall Study|No episode of common cold|23|||
105478085|NCT01024309|363761455|FG000|Overall Study|Physician Decision|4|||
105478086|NCT01024309|363761456|FG001|Overall Study|Physician Decision|0|||
105478087|NCT01024309|363761455|FG000|Overall Study|Withdrawal by Subject|4|||
105478088|NCT01024309|363761456|FG001|Overall Study|Withdrawal by Subject|4|||
105478089|NCT02745145|363761457|FG000|Overall Study|Adverse Event|1|||
105478090|NCT02745145|363761458|FG001|Overall Study|Adverse Event|0|||
105478091|NCT02745145|363761459|FG002|Overall Study|Adverse Event|0|||
105478092|NCT02745145|363761457|FG000|Overall Study|Death|0|||
105478093|NCT02745145|363761458|FG001|Overall Study|Death|1|||
105478094|NCT02745145|363761459|FG002|Overall Study|Death|0|||
105478095|NCT02745145|363761457|FG000|Overall Study|Progressive disease|0|||
105478096|NCT02745145|363761458|FG001|Overall Study|Progressive disease|0|||
105478097|NCT02745145|363761459|FG002|Overall Study|Progressive disease|1|||
105478098|NCT02745145|363761457|FG000|Overall Study|Withdrew consent|1|||
105478099|NCT02745145|363761458|FG001|Overall Study|Withdrew consent|1|||
105478100|NCT02745145|363761459|FG002|Overall Study|Withdrew consent|1|||
105478101|NCT02745145|363761457|FG000|Overall Study|Study Termination|8|||
105478102|NCT02745145|363761458|FG001|Overall Study|Study Termination|3|||
105478103|NCT02745145|363761459|FG002|Overall Study|Study Termination|7|||
105478104|NCT02238067|363761460|FG000|Overall Study|Not completed survey at Month 6|45|||
105478105|NCT01853839|363761462|FG000|Overall Study|Violated inclusion criteria|2|||
105478106|NCT01853839|363761462|FG000|Overall Study|Not meet ITT population definition|58|||
105478107|NCT01853839|363761462|FG000|Overall Study|End of treatment visit too early|33|||
105478108|NCT01853839|363761462|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
105478109|NCT00280748|363761463|FG000|Overall Study|Decline in performance|3|||
105478110|NCT00280748|363761463|FG000|Overall Study|Extra-cranial disease progression|1|||
105478111|NCT00946985|363761464|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
105478112|NCT00946985|363761464|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
105478113|NCT00946985|363761464|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
105478114|NCT00946985|363761464|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
105478115|NCT00946985|363761464|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
105478116|NCT00946985|363761464|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
105478117|NCT00946985|363761464|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
105478118|NCT00946985|363761464|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
105478119|NCT00946985|363761464|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
105478120|NCT00171834|363761465|FG000|Overall Study|Adverse Event|2|||
105478121|NCT00171834|363761466|FG001|Overall Study|Adverse Event|1|||
105478122|NCT00171834|363761467|FG002|Overall Study|Adverse Event|3|||
105478123|NCT00171834|363761468|FG003|Overall Study|Adverse Event|2|||
105478124|NCT00171834|363761469|FG004|Overall Study|Adverse Event|2|||
105478125|NCT00171834|363761470|FG005|Overall Study|Adverse Event|15|||
105478126|NCT00171834|363761471|FG006|Overall Study|Adverse Event|1|||
105478127|NCT00171834|363761465|FG000|Overall Study|Withdrawal by Subject|0|||
105478128|NCT00171834|363761466|FG001|Overall Study|Withdrawal by Subject|2|||
105478129|NCT00171834|363761467|FG002|Overall Study|Withdrawal by Subject|0|||
105478130|NCT00171834|363761468|FG003|Overall Study|Withdrawal by Subject|1|||
105478131|NCT00171834|363761469|FG004|Overall Study|Withdrawal by Subject|1|||
105478132|NCT00171834|363761470|FG005|Overall Study|Withdrawal by Subject|1|||
105478133|NCT00171834|363761471|FG006|Overall Study|Withdrawal by Subject|0|||
105478134|NCT00171834|363761465|FG000|Overall Study|Death from study indication|0|||
105478135|NCT00171834|363761466|FG001|Overall Study|Death from study indication|1|||
105478136|NCT00171834|363761467|FG002|Overall Study|Death from study indication|0|||
105721189|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105562160|NCT00686881|364053690|FG000|Overall Study|Never received study drug|2|||
105478137|NCT00171834|363761468|FG003|Overall Study|Death from study indication|0|||
105478138|NCT00171834|363761469|FG004|Overall Study|Death from study indication|1|||
105478139|NCT00171834|363761470|FG005|Overall Study|Death from study indication|0|||
105478140|NCT00171834|363761471|FG006|Overall Study|Death from study indication|0|||
105478141|NCT00171834|363761465|FG000|Overall Study|Disease Progression|4|||
105478142|NCT00171834|363761466|FG001|Overall Study|Disease Progression|8|||
105478143|NCT00171834|363761467|FG002|Overall Study|Disease Progression|8|||
105478144|NCT00171834|363761468|FG003|Overall Study|Disease Progression|9|||
105478145|NCT00171834|363761469|FG004|Overall Study|Disease Progression|2|||
105478146|NCT00171834|363761470|FG005|Overall Study|Disease Progression|18|||
105478147|NCT00171834|363761471|FG006|Overall Study|Disease Progression|3|||
105478148|NCT00171834|363761465|FG000|Overall Study|Treatment Duration Completed|0|||
105478149|NCT00171834|363761466|FG001|Overall Study|Treatment Duration Completed|0|||
105478150|NCT00171834|363761467|FG002|Overall Study|Treatment Duration Completed|1|||
105478151|NCT00171834|363761468|FG003|Overall Study|Treatment Duration Completed|0|||
105562161|NCT00686881|364053691|FG001|Overall Study|Never received study drug|6|||
105562162|NCT02925676|364053692|FG000|Overall Study|Withdrawal by Subject|1|||
105562163|NCT00541450|364053696|FG000|Phase A|Adverse Event|3|||
105562164|NCT00541450|364053697|FG001|Phase A|Adverse Event|0|||
105562165|NCT00541450|364053696|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
105562166|NCT00541450|364053697|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
105562167|NCT00541450|364053696|FG000|Phase A|Hyperglycemia|0|||
105562168|NCT00541450|364053697|FG001|Phase A|Hyperglycemia|1|||
105562169|NCT00541450|364053696|FG000|Phase A|Lost to Follow-up|6|||
105562170|NCT00541450|364053697|FG001|Phase A|Lost to Follow-up|4|||
105562171|NCT00541450|364053696|FG000|Phase A|Physician Decision|2|||
105562172|NCT00541450|364053697|FG001|Phase A|Physician Decision|0|||
105562173|NCT00541450|364053696|FG000|Phase A|Protocol Violation|2|||
105562174|NCT00541450|364053697|FG001|Phase A|Protocol Violation|3|||
105562175|NCT00541450|364053696|FG000|Phase A|Withdrawal by Subject|7|||
105562176|NCT00541450|364053697|FG001|Phase A|Withdrawal by Subject|7|||
105562177|NCT00541450|364053696|FG000|Phase B|Adverse Event|6|||
105562178|NCT00541450|364053697|FG001|Phase B|Adverse Event|6|||
105562179|NCT00541450|364053696|FG000|Phase B|Hyperglycemia|10|||
105562180|NCT00541450|364053697|FG001|Phase B|Hyperglycemia|9|||
105562181|NCT00541450|364053696|FG000|Phase B|Lost to Follow-up|6|||
105562182|NCT00541450|364053697|FG001|Phase B|Lost to Follow-up|4|||
105562183|NCT00541450|364053696|FG000|Phase B|Physician Decision|4|||
105562184|NCT00541450|364053697|FG001|Phase B|Physician Decision|2|||
105562185|NCT00541450|364053696|FG000|Phase B|Pregnancy|0|||
105562186|NCT00541450|364053697|FG001|Phase B|Pregnancy|1|||
105562187|NCT00541450|364053696|FG000|Phase B|Protocol Violation|3|||
105562188|NCT00541450|364053697|FG001|Phase B|Protocol Violation|3|||
105562189|NCT00541450|364053696|FG000|Phase B|Withdrawal by Subject|8|||
105562190|NCT00541450|364053697|FG001|Phase B|Withdrawal by Subject|6|||
105562191|NCT01298999|364053698|FG000|Overall Study|Physician Decision|0|||
105562192|NCT01298999|364053699|FG001|Overall Study|Physician Decision|1|||
105562193|NCT01298999|364053698|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
105562194|NCT01298999|364053699|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
105562195|NCT00803452|364053703|FG000|Overall Study|Adverse Event|0|||
105562196|NCT00803452|364053704|FG001|Overall Study|Adverse Event|2|||
105562197|NCT00803452|364053703|FG000|Overall Study|Lost to Follow-up|0|||
105562198|NCT00803452|364053704|FG001|Overall Study|Lost to Follow-up|3|||
105562199|NCT02365519|364053708|FG000|Randomized and Treated|Adverse Event|0|||
105562200|NCT02365519|364053709|FG001|Randomized and Treated|Adverse Event|1|||
105562201|NCT02365519|364053710|FG002|Randomized and Treated|Adverse Event|0|||
105562202|NCT02365519|364053708|FG000|Randomized and Treated|Withdrawal by Subject|0|||
105562203|NCT02365519|364053709|FG001|Randomized and Treated|Withdrawal by Subject|1|||
105562204|NCT02365519|364053710|FG002|Randomized and Treated|Withdrawal by Subject|1|||
105562205|NCT02355028|364053711|FG000|Overall Study|Adverse Event|2|||
105562206|NCT02355028|364053712|FG001|Overall Study|Adverse Event|0|||
105562207|NCT02355028|364053711|FG000|Overall Study|Withdrawal by Subject|1|||
105562208|NCT02355028|364053712|FG001|Overall Study|Withdrawal by Subject|1|||
105562209|NCT02355028|364053711|FG000|Overall Study|Deemed ineligible after randomization|8|||
105562210|NCT02355028|364053712|FG001|Overall Study|Deemed ineligible after randomization|4|||
105562211|NCT03419364|364053713|FG000|Overall Study|Delivery due to maternal condition|2|||
105562212|NCT03419364|364053714|FG001|Overall Study|Delivery due to maternal condition|0|||
105562213|NCT03419364|364053715|FG002|Overall Study|Delivery due to maternal condition|0|||
105562214|NCT01648270|364053716|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
105562215|NCT02170025|364053717|FG000|Overall Study|Adverse Event|2|||
105562216|NCT02170025|364053718|FG001|Overall Study|Adverse Event|0|||
105562217|NCT00572195|364053719|FG000|Overall Study|Withdrawal by Subject|50|||
105478152|NCT00171834|363761469|FG004|Overall Study|Treatment Duration Completed|2|||
105562218|NCT00572195|364053719|FG000|Overall Study|Death|9|||
105562219|NCT00572195|364053719|FG000|Overall Study|Adverse Event|4|||
105562220|NCT00572195|364053719|FG000|Overall Study|Lost to Follow-up|5|||
105562221|NCT03360942|364053724|FG000|Overall Study|Device explanted|2|||
105792496|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
105792497|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
105721190|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721191|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721192|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721193|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721194|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721195|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721196|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721197|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721198|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721199|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721200|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721201|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721202|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721203|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721204|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721205|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
105721206|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
105721207|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
105721208|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
105721209|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
105721210|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
105721211|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
105721212|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721213|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721214|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721215|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721216|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721217|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721218|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721219|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721220|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721221|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721222|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721223|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721224|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721225|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721226|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721227|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721228|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
105721229|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
105721230|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
105721231|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
105721232|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
105721233|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
105721234|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
105721235|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
105721236|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721237|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721238|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721239|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721240|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721241|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721242|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721243|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721244|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721245|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721246|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721247|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721248|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721249|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721250|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721251|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721252|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721253|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
105721254|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721255|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
105721256|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721257|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721258|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721259|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721260|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721261|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721262|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721263|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721264|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721265|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721266|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721267|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721268|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721269|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721270|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721271|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721272|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721273|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721274|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
105721275|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721276|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721277|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
105721278|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721279|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721280|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721281|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721282|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721283|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721284|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721285|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721286|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721287|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721288|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721289|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721290|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721291|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721292|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721293|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721294|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721295|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721296|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721297|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721298|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721299|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
105721300|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721301|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105792498|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
105721302|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721303|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721304|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721305|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721306|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721307|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721308|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721309|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721310|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721311|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721312|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721313|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721314|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721315|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721316|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721317|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721318|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721319|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721320|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721321|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721322|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
105721323|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721324|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721325|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721326|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721327|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721328|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721329|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721330|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721331|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721332|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721333|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721334|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721335|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721336|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721337|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721338|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721339|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721340|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721341|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721342|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721343|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721344|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721345|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721346|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
105721347|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721348|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721349|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721350|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721351|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721352|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721353|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105562222|NCT03360942|364053724|FG000|Overall Study|Study closure|1|||
105562223|NCT03360942|364053724|FG000|Overall Study|Withdrawal by Subject|2|||
105562224|NCT00657618|364053727|FG000|Overall Study|Adverse Event|32|||
105562225|NCT00657618|364053727|FG000|Overall Study|Withdrawal by Subject|8|||
105562226|NCT00657618|364053727|FG000|Overall Study|negative for leishmaniasis|2|||
105721354|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721355|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721356|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721357|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721358|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721359|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721360|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721361|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721362|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721363|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721364|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721365|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721366|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721367|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
105721368|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721369|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
105721370|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
105721371|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721372|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721373|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721374|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721375|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721376|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721377|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721378|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721379|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721380|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721381|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721382|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721383|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721384|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721385|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721386|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721387|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721388|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721389|NCT00896532|364636397|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721390|NCT00896532|364636398|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721391|NCT00896532|364636399|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721392|NCT00896532|364636400|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721393|NCT00896532|364636401|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721394|NCT00896532|364636402|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721395|NCT00896532|364636403|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721396|NCT00896532|364636404|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721397|NCT00896532|364636405|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
105721398|NCT00896532|364636406|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721399|NCT00896532|364636407|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721400|NCT00896532|364636408|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721401|NCT00896532|364636409|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721402|NCT00896532|364636410|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721403|NCT00896532|364636411|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721404|NCT00896532|364636412|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721405|NCT00896532|364636413|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721406|NCT00896532|364636414|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721407|NCT00896532|364636415|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721408|NCT00896532|364636416|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721409|NCT00896532|364636417|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721410|NCT00896532|364636418|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721411|NCT00896532|364636419|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721412|NCT00896532|364636397|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721413|NCT00896532|364636398|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721414|NCT00896532|364636399|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105792499|NCT00464308|364896352|FG000|Overall Study|Adverse Event|22|||
105792500|NCT00464308|364896353|FG001|Overall Study|Adverse Event|27|||
105792501|NCT00464308|364896354|FG002|Overall Study|Adverse Event|16|||
105792502|NCT00464308|364896352|FG000|Overall Study|Lost to Follow-up|29|||
105792503|NCT00464308|364896353|FG001|Overall Study|Lost to Follow-up|19|||
105792504|NCT00464308|364896354|FG002|Overall Study|Lost to Follow-up|20|||
105792505|NCT00464308|364896352|FG000|Overall Study|Patient discontinued and other reasons|17|||
105792506|NCT00464308|364896353|FG001|Overall Study|Patient discontinued and other reasons|17|||
105721415|NCT00896532|364636400|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721416|NCT00896532|364636401|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721417|NCT00896532|364636402|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105478153|NCT00171834|363761470|FG005|Overall Study|Treatment Duration Completed|1|||
105478154|NCT00171834|363761471|FG006|Overall Study|Treatment Duration Completed|0|||
105478155|NCT01516034|363761472|FG000|Overall Study|Physician Decision|1|||
105478156|NCT01516034|363761472|FG000|Overall Study|Lack of Efficacy|7|||
105478157|NCT02929498|363761473|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
105478158|NCT02929498|363761474|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
105478159|NCT02929498|363761475|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
105478160|NCT02929498|363761473|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
105478161|NCT02929498|363761474|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
105478162|NCT02929498|363761475|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
105478163|NCT02744040|363761478|FG000|Overall Study|Withdrawal by Subject|3|||
105478164|NCT02744040|363761479|FG001|Overall Study|Withdrawal by Subject|2|||
105478165|NCT02744040|363761480|FG002|Overall Study|Withdrawal by Subject|2|||
105478166|NCT02744040|363761478|FG000|Overall Study|Physician Decision|0|||
105478167|NCT02744040|363761479|FG001|Overall Study|Physician Decision|8|||
105478168|NCT02744040|363761480|FG002|Overall Study|Physician Decision|13|||
105478169|NCT02744040|363761478|FG000|Overall Study|Lost to Follow-up|3|||
105478170|NCT02744040|363761479|FG001|Overall Study|Lost to Follow-up|1|||
105478171|NCT02744040|363761480|FG002|Overall Study|Lost to Follow-up|7|||
105478172|NCT01008423|363761481|FG000|Overall Study|Adverse Event|13|||
105478173|NCT01008423|363761482|FG001|Overall Study|Adverse Event|6|||
105478174|NCT01008423|363761481|FG000|Overall Study|Withdrawal by Subject|4|||
105478175|NCT01008423|363761482|FG001|Overall Study|Withdrawal by Subject|7|||
105478176|NCT01008423|363761481|FG000|Overall Study|Lost to Follow-up|0|||
105478177|NCT01008423|363761482|FG001|Overall Study|Lost to Follow-up|2|||
105478178|NCT01008423|363761481|FG000|Overall Study|Low Cortisol|0|||
105478179|NCT01008423|363761482|FG001|Overall Study|Low Cortisol|1|||
105478180|NCT01008423|363761481|FG000|Overall Study|Lack of Efficacy|0|||
105478181|NCT01008423|363761482|FG001|Overall Study|Lack of Efficacy|5|||
105478182|NCT01008423|363761481|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
105478183|NCT01008423|363761482|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
105478184|NCT01008423|363761481|FG000|Overall Study|Personal Conflict|1|||
105478185|NCT01008423|363761482|FG001|Overall Study|Personal Conflict|0|||
105478186|NCT01008423|363761481|FG000|Overall Study|Other|0|||
105478187|NCT01008423|363761482|FG001|Overall Study|Other|1|||
105478188|NCT03288142|363761487|FG000|Overall Study|Lost to Follow-up|22|||
105478189|NCT03288142|363761488|FG001|Overall Study|Lost to Follow-up|15|||
105478190|NCT01700387|363761489|FG000|Overall Study|Withdrawal by Subject|1|||
105478191|NCT01700387|363761490|FG001|Overall Study|Withdrawal by Subject|2|||
105478192|NCT01700387|363761489|FG000|Overall Study|Adverse Event|1|||
105478193|NCT01700387|363761490|FG001|Overall Study|Adverse Event|1|||
105478194|NCT01700387|363761489|FG000|Overall Study|Lost to Follow-up|2|||
105478195|NCT01700387|363761490|FG001|Overall Study|Lost to Follow-up|1|||
105478196|NCT03041129|363761493|FG000|Overall Study|Withdrawal by Subject|2|||
105478197|NCT03041129|363761494|FG001|Overall Study|Withdrawal by Subject|0|||
105478198|NCT03041129|363761495|FG002|Overall Study|Withdrawal by Subject|0|||
105478199|NCT03041129|363761496|FG003|Overall Study|Withdrawal by Subject|0|||
105478200|NCT01031836|363764177|FG000|Stage I|Adverse Event|1|||
105478201|NCT01031836|363764178|FG001|Stage I|Adverse Event|1|||
105478202|NCT01031836|363764179|FG002|Stage I|Adverse Event|0|||
105478203|NCT01031836|363764180|FG003|Stage I|Adverse Event|0|||
105478204|NCT01031836|363764181|FG004|Stage I|Adverse Event|0|||
105478205|NCT01031836|363764182|FG005|Stage I|Adverse Event|0|||
105478206|NCT01031836|363764177|FG000|Stage I|Other|0|||
105478207|NCT01031836|363764178|FG001|Stage I|Other|1|||
105478208|NCT01031836|363764179|FG002|Stage I|Other|0|||
105478209|NCT01031836|363764180|FG003|Stage I|Other|0|||
105478210|NCT01031836|363764181|FG004|Stage I|Other|0|||
105478211|NCT01031836|363764182|FG005|Stage I|Other|1|||
105478212|NCT01031836|363764177|FG000|Stage II|Adverse Event|0|||
105478213|NCT01031836|363764178|FG001|Stage II|Adverse Event|0|||
105478214|NCT01031836|363764179|FG002|Stage II|Adverse Event|2|||
105478215|NCT01031836|363764180|FG003|Stage II|Adverse Event|2|||
105478216|NCT01031836|363764181|FG004|Stage II|Adverse Event|1|||
105478217|NCT01031836|363764182|FG005|Stage II|Adverse Event|1|||
105478218|NCT01031836|363764177|FG000|Stage II|Other|2|||
105478219|NCT01031836|363764178|FG001|Stage II|Other|0|||
105478220|NCT01031836|363764179|FG002|Stage II|Other|0|||
105478221|NCT01031836|363764180|FG003|Stage II|Other|1|||
105478222|NCT01031836|363764181|FG004|Stage II|Other|1|||
105478223|NCT01031836|363764182|FG005|Stage II|Other|0|||
105478224|NCT04473235|363764183|FG000|Overall Study|Lost to Follow-up|6|||
105478225|NCT04473235|363764184|FG001|Overall Study|Lost to Follow-up|5|||
105478226|NCT04473235|363764183|FG000|Overall Study|Declined continuation|2|||
105562227|NCT00657618|364053727|FG000|Overall Study|didn't start due to schedule conflicts|1|||
105562228|NCT04128293|364055843|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
105562229|NCT04128293|364055844|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
105562230|NCT04128293|364055845|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
105562231|NCT04128293|364055846|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
105562232|NCT03466086|364055849|FG000|Period 1|Sponsor decision due to study timeline|1|||
105562233|NCT03466086|364055850|FG001|Period 1|Sponsor decision due to study timeline|0|||
105562234|NCT03466086|364055849|FG000|Period 1|Withdrawal by Subject|1|||
105562235|NCT03466086|364055850|FG001|Period 1|Withdrawal by Subject|0|||
105562236|NCT02054806|364055851|FG000|Overall Study|Sponsor Decision|31|||
105562237|NCT02054806|364055851|FG000|Overall Study|Withdrawal by Subject|43|||
105562238|NCT02054806|364055851|FG000|Overall Study|Protocol Violation|2|||
105562239|NCT02054806|364055851|FG000|Overall Study|Lost to Follow-up|10|||
105562240|NCT02054806|364055851|FG000|Overall Study|Death|391|||
105562241|NCT01132326|364055852|FG000|Overall Study|Lack of Efficacy|25|||
105562242|NCT01132326|364055852|FG000|Overall Study|Adverse Event|37|||
105562243|NCT01132326|364055852|FG000|Overall Study|Protocol Violation|1|||
105562244|NCT01132326|364055852|FG000|Overall Study|Lost to Follow-up|16|||
105562245|NCT01132326|364055852|FG000|Overall Study|Withdrawal by Subject|40|||
105562246|NCT01132326|364055852|FG000|Overall Study|Physician Decision|10|||
105562247|NCT01132326|364055852|FG000|Overall Study|Study Termination|80|||
105562248|NCT01132326|364055852|FG000|Overall Study|Declining Health|1|||
105562249|NCT01132326|364055852|FG000|Overall Study|Pregnancy|1|||
105562250|NCT01132326|364055852|FG000|Overall Study|Caregiver Withdrew Consent|1|||
105562251|NCT01132326|364055852|FG000|Overall Study|Death|5|||
105562252|NCT01132326|364055852|FG000|Overall Study|Subject Unable to Come To Visits|1|||
105562253|NCT00952367|364055853|FG000|Overall Study|Withdrawal by Subject|2|||
105562254|NCT00952367|364055853|FG000|Overall Study|Noncoordination|1|||
105721418|NCT00896532|364636403|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721419|NCT00896532|364636404|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721420|NCT00896532|364636405|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721421|NCT00896532|364636406|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721422|NCT00896532|364636407|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721423|NCT00896532|364636408|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721424|NCT00896532|364636409|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
105721425|NCT00896532|364636410|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721426|NCT00896532|364636411|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721427|NCT00896532|364636412|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721428|NCT00896532|364636413|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721429|NCT00896532|364636414|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721430|NCT00896532|364636415|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721431|NCT00896532|364636416|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721432|NCT00896532|364636417|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721433|NCT00896532|364636418|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721434|NCT00896532|364636419|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721435|NCT00896532|364636397|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721436|NCT00896532|364636398|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721437|NCT00896532|364636399|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105562255|NCT00952367|364055853|FG000|Overall Study|Protocol Violation|3|||
105562256|NCT00781391|364055856|FG000|Overall Study|never received study drug|24|||
105562257|NCT00781391|364055857|FG001|Overall Study|never received study drug|23|||
105562258|NCT00781391|364055858|FG002|Overall Study|never received study drug|32|||
105792507|NCT00464308|364896354|FG002|Overall Study|Patient discontinued and other reasons|23|||
105562259|NCT00781391|364055856|FG000|Overall Study|Protocol Violation|19|||
105562260|NCT00781391|364055857|FG001|Overall Study|Protocol Violation|17|||
105562261|NCT00781391|364055858|FG002|Overall Study|Protocol Violation|20|||
105562262|NCT00781391|364055856|FG000|Overall Study|Death|789|||
105562263|NCT00781391|364055857|FG001|Overall Study|Death|730|||
105562264|NCT00781391|364055858|FG002|Overall Study|Death|706|||
105562265|NCT00781391|364055856|FG000|Overall Study|Withdrawal by Subject|47|||
105562266|NCT00781391|364055857|FG001|Overall Study|Withdrawal by Subject|37|||
105562267|NCT00781391|364055858|FG002|Overall Study|Withdrawal by Subject|25|||
105562268|NCT00781391|364055856|FG000|Overall Study|Lost to Follow-up|0|||
105562269|NCT00781391|364055857|FG001|Overall Study|Lost to Follow-up|0|||
105562270|NCT00781391|364055858|FG002|Overall Study|Lost to Follow-up|1|||
105562271|NCT04535947|364055859|FG000|Overall Study|Adverse Event|1|||
105562272|NCT04535947|364055860|FG001|Overall Study|Adverse Event|4|||
105562273|NCT04535947|364055859|FG000|Overall Study|Other reasons not specified|2|||
105562274|NCT04535947|364055860|FG001|Overall Study|Other reasons not specified|0|||
105562275|NCT04535947|364055859|FG000|Overall Study|Withdrawal by Subject|1|||
105562276|NCT04535947|364055860|FG001|Overall Study|Withdrawal by Subject|1|||
105562277|NCT03802123|364055861|FG000|Overall Study|Withdrawal by Subject|3|||
105562278|NCT03802123|364055861|FG000|Overall Study|Physician Decision|1|||
105562279|NCT03802123|364055861|FG000|Overall Study|Subject moved to hospice care|1|||
105562280|NCT03802123|364055861|FG000|Overall Study|technician error|1|||
105562281|NCT03802123|364055861|FG000|Overall Study|Death|3|||
105562282|NCT01274182|364055862|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
105562283|NCT01274182|364055863|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105562284|NCT01274182|364055864|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
105562285|NCT01274182|364055862|FG000|Overall Study|Adverse Event|4|||
105562286|NCT01274182|364055863|FG001|Overall Study|Adverse Event|5|||
105562287|NCT01274182|364055864|FG002|Overall Study|Adverse Event|3|||
105721438|NCT00896532|364636400|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721439|NCT00896532|364636401|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721440|NCT00896532|364636402|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721441|NCT00896532|364636403|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721442|NCT00896532|364636404|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721443|NCT00896532|364636405|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721444|NCT00896532|364636406|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721445|NCT00896532|364636407|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
105721446|NCT00896532|364636408|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721447|NCT00896532|364636409|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
105721448|NCT00896532|364636410|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721449|NCT00896532|364636411|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721450|NCT00896532|364636412|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105562288|NCT01274182|364055862|FG000|Overall Study|Withdrawal by Subject|5|||
105562289|NCT01274182|364055863|FG001|Overall Study|Withdrawal by Subject|5|||
105562290|NCT01274182|364055864|FG002|Overall Study|Withdrawal by Subject|3|||
105562291|NCT01274182|364055862|FG000|Overall Study|Lost to Follow-up|2|||
105562292|NCT01274182|364055863|FG001|Overall Study|Lost to Follow-up|3|||
105562293|NCT01274182|364055864|FG002|Overall Study|Lost to Follow-up|1|||
105562294|NCT01274182|364055862|FG000|Overall Study|Protocol Violation|3|||
105562295|NCT01274182|364055863|FG001|Overall Study|Protocol Violation|2|||
105562296|NCT01274182|364055864|FG002|Overall Study|Protocol Violation|0|||
105562297|NCT01274182|364055862|FG000|Overall Study|Death|1|||
105562298|NCT01274182|364055863|FG001|Overall Study|Death|0|||
105562299|NCT01274182|364055864|FG002|Overall Study|Death|1|||
105562300|NCT00645164|364055865|FG000|Overall Study|Lost to Follow-up|2|||
105562301|NCT00645164|364055865|FG000|Overall Study|Withdrawal by Subject|4|||
105562302|NCT00645164|364055865|FG000|Overall Study|Protocol Violation|1|||
105562303|NCT01822587|364055866|FG000|Overall Study|Lost to Follow-up|7|||
105562304|NCT01822587|364055867|FG001|Overall Study|Lost to Follow-up|9|||
105562305|NCT01822587|364055868|FG002|Overall Study|Lost to Follow-up|12|||
105562306|NCT01822587|364055866|FG000|Overall Study|Physician Decision|9|||
105562307|NCT01822587|364055867|FG001|Overall Study|Physician Decision|6|||
105562308|NCT01822587|364055868|FG002|Overall Study|Physician Decision|6|||
105721451|NCT00896532|364636413|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721452|NCT00896532|364636414|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721453|NCT00896532|364636415|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721454|NCT00896532|364636416|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721455|NCT00896532|364636417|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105792508|NCT00464308|364896352|FG000|Overall Study|Physician Decision|1|||
105562309|NCT02355002|364055869|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
105562310|NCT02355002|364055870|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
105562311|NCT02355002|364055869|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
105562312|NCT02355002|364055870|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
105562313|NCT02355002|364055869|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
105562314|NCT02355002|364055870|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
105792509|NCT00464308|364896353|FG001|Overall Study|Physician Decision|0|||
105721456|NCT00896532|364636418|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721457|NCT00896532|364636419|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721458|NCT00896532|364636397|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721459|NCT00896532|364636398|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721460|NCT00896532|364636399|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721461|NCT00896532|364636400|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721462|NCT00896532|364636401|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721463|NCT00896532|364636402|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721464|NCT00896532|364636403|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721465|NCT00896532|364636404|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721466|NCT00896532|364636405|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721467|NCT00896532|364636406|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721468|NCT00896532|364636407|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721469|NCT00896532|364636408|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721470|NCT00896532|364636409|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
105721471|NCT00896532|364636410|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
105721472|NCT00896532|364636411|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721473|NCT00896532|364636412|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721474|NCT00896532|364636413|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721475|NCT00896532|364636414|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721476|NCT00896532|364636415|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721477|NCT00896532|364636416|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721478|NCT00896532|364636417|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721479|NCT00896532|364636418|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721480|NCT00896532|364636419|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721481|NCT00896532|364636397|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
105721482|NCT00896532|364636398|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
105721483|NCT00896532|364636399|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
105721484|NCT00896532|364636400|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
105721485|NCT00896532|364636401|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
105721486|NCT00896532|364636402|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
105721487|NCT00896532|364636403|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
105721488|NCT00896532|364636404|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
105721489|NCT00896532|364636405|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
105721490|NCT00896532|364636406|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
105792510|NCT00464308|364896354|FG002|Overall Study|Physician Decision|0|||
105721491|NCT00896532|364636407|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
105721492|NCT00896532|364636408|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
105721493|NCT00896532|364636409|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
105721494|NCT00896532|364636410|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
105721495|NCT00896532|364636411|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
105721496|NCT00896532|364636412|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
105721497|NCT00896532|364636413|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
105721498|NCT00896532|364636414|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
105721499|NCT00896532|364636415|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
105721500|NCT00896532|364636416|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
105721501|NCT00896532|364636417|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
105721502|NCT00896532|364636418|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
105721503|NCT00896532|364636419|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
105721504|NCT00896532|364636397|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721505|NCT00896532|364636398|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721506|NCT00896532|364636399|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721507|NCT00896532|364636400|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721508|NCT00896532|364636401|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721509|NCT00896532|364636402|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721510|NCT00896532|364636403|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721511|NCT00896532|364636404|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721512|NCT00896532|364636405|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721513|NCT00896532|364636406|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721514|NCT00896532|364636407|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721515|NCT00896532|364636408|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721516|NCT00896532|364636409|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721517|NCT00896532|364636410|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721518|NCT00896532|364636411|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721519|NCT00896532|364636412|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
105721520|NCT00896532|364636413|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
105721521|NCT00896532|364636414|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721522|NCT00896532|364636415|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721523|NCT00896532|364636416|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721524|NCT00896532|364636417|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721525|NCT00896532|364636418|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721526|NCT00896532|364636419|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721527|NCT00896532|364636397|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721528|NCT00896532|364636398|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721529|NCT00896532|364636399|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721530|NCT00896532|364636400|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721531|NCT00896532|364636401|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721532|NCT00896532|364636402|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721533|NCT00896532|364636403|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721534|NCT00896532|364636404|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721535|NCT00896532|364636405|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721536|NCT00896532|364636406|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721537|NCT00896532|364636407|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721538|NCT00896532|364636408|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721539|NCT00896532|364636409|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721540|NCT00896532|364636410|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721541|NCT00896532|364636411|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721542|NCT00896532|364636412|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
105721543|NCT00896532|364636413|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
105721544|NCT00896532|364636414|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
105721545|NCT00896532|364636415|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721546|NCT00896532|364636416|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721547|NCT00896532|364636417|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721548|NCT00896532|364636418|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721549|NCT00896532|364636419|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721550|NCT00896532|364636397|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721551|NCT00896532|364636398|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721552|NCT00896532|364636399|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721553|NCT00896532|364636400|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105562315|NCT02355002|364055869|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
105562316|NCT02355002|364055870|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
105562317|NCT02355002|364055869|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
105562318|NCT02355002|364055870|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
105562319|NCT02355002|364055869|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
105562320|NCT02355002|364055870|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
105562321|NCT02355002|364055869|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
105562322|NCT02355002|364055870|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
105562323|NCT00708916|364055871|FG000|Overall Study|Subject Noncompliance|2|||
105562324|NCT00708916|364055871|FG000|Overall Study|Adverse Event|2|||
105562325|NCT00952822|364055872|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
105562326|NCT00952822|364055873|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
105562327|NCT00952822|364055874|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
105562328|NCT00952822|364055875|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
105562329|NCT00952822|364055872|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
105562330|NCT00952822|364055873|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
105562331|NCT00952822|364055874|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
105562332|NCT00952822|364055875|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
105562333|NCT04860518|364055877|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
105562334|NCT04860518|364055878|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
105562335|NCT02835339|364055879|FG000|Overall Study|Did not receive allocated intervention|13|||
105562336|NCT02835339|364055880|FG001|Overall Study|Did not receive allocated intervention|16|||
105562337|NCT01077544|364055881|FG000|Overall Study|New Cancer Therapy|3|||
105562338|NCT01077544|364055882|FG001|Overall Study|New Cancer Therapy|3|||
105562339|NCT01077544|364055881|FG000|Overall Study|Adverse Event|0|||
105562340|NCT01077544|364055882|FG001|Overall Study|Adverse Event|1|||
105562341|NCT01077544|364055881|FG000|Overall Study|Disease Progression|0|||
105562342|NCT01077544|364055882|FG001|Overall Study|Disease Progression|1|||
105562343|NCT03574597|364055893|FG000|Overall Study|Withdrawal by Subject|67|||
105562344|NCT03574597|364055894|FG001|Overall Study|Withdrawal by Subject|96|||
105562345|NCT03574597|364055893|FG000|Overall Study|Lost to Follow-up|192|||
105562346|NCT03574597|364055894|FG001|Overall Study|Lost to Follow-up|188|||
105562347|NCT01368965|364055895|FG000|Overall Study|Lost to Follow-up|12|||
105562348|NCT02618967|364055896|FG000|Overall Study|Lost to Follow-up|0|||
105562349|NCT02618967|364055897|FG001|Overall Study|Lost to Follow-up|0|||
105562350|NCT02618967|364055898|FG002|Overall Study|Lost to Follow-up|1|||
105562351|NCT02618967|364055899|FG003|Overall Study|Lost to Follow-up|0|||
105562352|NCT02618967|364055900|FG004|Overall Study|Lost to Follow-up|2|||
105562353|NCT02618967|364055901|FG005|Overall Study|Lost to Follow-up|0|||
105562354|NCT02618967|364055902|FG006|Overall Study|Lost to Follow-up|0|||
105562355|NCT02618967|364055903|FG007|Overall Study|Lost to Follow-up|0|||
105562356|NCT02618967|364055896|FG000|Overall Study|Withdrawal by Subject|1|||
105562357|NCT02618967|364055897|FG001|Overall Study|Withdrawal by Subject|0|||
105562358|NCT02618967|364055898|FG002|Overall Study|Withdrawal by Subject|0|||
105562359|NCT02618967|364055899|FG003|Overall Study|Withdrawal by Subject|0|||
105562360|NCT02618967|364055900|FG004|Overall Study|Withdrawal by Subject|0|||
105562361|NCT02618967|364055901|FG005|Overall Study|Withdrawal by Subject|0|||
105562362|NCT02618967|364055902|FG006|Overall Study|Withdrawal by Subject|0|||
105562363|NCT02618967|364055903|FG007|Overall Study|Withdrawal by Subject|0|||
105562364|NCT02061202|364055904|FG000|Overall Study|Lost to Follow-up|1|||
105562365|NCT02061202|364055905|FG001|Overall Study|Lost to Follow-up|1|||
105562366|NCT00569582|364055916|FG000|Overall Study|Withdrawal by Subject|5|||
105562367|NCT00569582|364055916|FG000|Overall Study|Death|2|||
105562368|NCT00569582|364055916|FG000|Overall Study|Adverse Event|7|||
105562369|NCT00569582|364055916|FG000|Overall Study|Subject was too ill to travel.|1|||
105562370|NCT00569582|364055916|FG000|Overall Study|Subject was non-compliant.|1|||
105562371|NCT01533493|364055920|FG000|Overall Study|Adverse Event|2|||
105562372|NCT01533493|364055921|FG001|Overall Study|Adverse Event|1|||
105562373|NCT01533493|364055920|FG000|Overall Study|Withdrawal by Subject|1|||
105562374|NCT01533493|364055921|FG001|Overall Study|Withdrawal by Subject|2|||
105562375|NCT01533493|364055920|FG000|Overall Study|Lost to Follow-up|2|||
105792511|NCT01721200|364896355|FG000|Overall Study|Lost to Follow-up|3|||
105792512|NCT01721200|364896356|FG001|Overall Study|Lost to Follow-up|5|||
105792513|NCT03926728|364896357|FG000|Overall Study|Withdrawal by Subject|0|||
105562376|NCT01533493|364055921|FG001|Overall Study|Lost to Follow-up|0|||
105562377|NCT02355743|364055922|FG000|Overall Study|Withdrawal by Subject|1|||
105562378|NCT02355743|364055922|FG000|Overall Study|Lost to Follow-up|1|||
105562379|NCT04085328|364055935|FG000|Overall Study|Witihdrew Consent|16|||
105562380|NCT04085328|364055936|FG001|Overall Study|Witihdrew Consent|16|||
105562381|NCT04085328|364055935|FG000|Overall Study|Adverse Event|8|||
105562382|NCT04085328|364055936|FG001|Overall Study|Adverse Event|7|||
105792514|NCT03926728|364896358|FG001|Overall Study|Withdrawal by Subject|1|||
105721554|NCT00896532|364636401|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721555|NCT00896532|364636402|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721556|NCT00896532|364636403|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721557|NCT00896532|364636404|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721558|NCT00896532|364636405|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721559|NCT00896532|364636406|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721560|NCT00896532|364636407|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721561|NCT00896532|364636408|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721562|NCT00896532|364636409|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721563|NCT00896532|364636410|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721564|NCT00896532|364636411|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721565|NCT00896532|364636412|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721566|NCT00896532|364636413|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
105721567|NCT00896532|364636414|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721568|NCT00896532|364636415|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721569|NCT00896532|364636416|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721570|NCT00896532|364636417|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721571|NCT00896532|364636418|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721572|NCT00896532|364636419|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721573|NCT00896532|364636397|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
105721574|NCT00896532|364636398|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
105721575|NCT00896532|364636399|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
105721576|NCT00896532|364636400|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
105721577|NCT00896532|364636401|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
105721578|NCT00896532|364636402|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
105721579|NCT00896532|364636403|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
105721580|NCT00896532|364636404|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
105721581|NCT00896532|364636405|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
105721582|NCT00896532|364636406|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
105721583|NCT00896532|364636407|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
105721584|NCT00896532|364636408|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
105721585|NCT00896532|364636409|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
105721586|NCT00896532|364636410|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
105721587|NCT00896532|364636411|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
105721588|NCT00896532|364636412|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
105721589|NCT00896532|364636413|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
105721590|NCT00896532|364636414|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
105721591|NCT00896532|364636415|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
105721592|NCT00896532|364636416|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
105721593|NCT00896532|364636417|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
105721594|NCT00896532|364636418|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
105721595|NCT00896532|364636419|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
105721596|NCT00896532|364636397|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721597|NCT00896532|364636398|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721598|NCT00896532|364636399|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721599|NCT00896532|364636400|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721600|NCT00896532|364636401|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721601|NCT00896532|364636402|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721602|NCT00896532|364636403|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721603|NCT00896532|364636404|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721604|NCT00896532|364636405|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721605|NCT00896532|364636406|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105562383|NCT04085328|364055935|FG000|Overall Study|Lost to Follow-up|7|||
105562384|NCT04085328|364055936|FG001|Overall Study|Lost to Follow-up|2|||
105562385|NCT04085328|364055935|FG000|Overall Study|Physician Decision|0|||
105562386|NCT04085328|364055936|FG001|Overall Study|Physician Decision|1|||
105562387|NCT04085328|364055935|FG000|Overall Study|Pregnancy|0|||
105562388|NCT04085328|364055936|FG001|Overall Study|Pregnancy|1|||
105562389|NCT04085328|364055935|FG000|Overall Study|Reasons Related to COVID-19|5|||
105562390|NCT04085328|364055936|FG001|Overall Study|Reasons Related to COVID-19|8|||
105562391|NCT04085328|364055935|FG000|Overall Study|Did not meet inclusion criteria|1|||
105562392|NCT04085328|364055936|FG001|Overall Study|Did not meet inclusion criteria|1|||
105562393|NCT04085328|364055935|FG000|Overall Study|Early termination|1|||
105562394|NCT04085328|364055936|FG001|Overall Study|Early termination|0|||
105562395|NCT02753595|364055937|FG000|Overall Study|Sponsor termination|2|||
105562396|NCT02753595|364055938|FG001|Overall Study|Sponsor termination|2|||
105562397|NCT02782169|364055944|FG000|Overall Study|Lost to Follow-up|1|||
105562398|NCT02782169|364055945|FG001|Overall Study|Lost to Follow-up|2|||
105562399|NCT01800968|364055949|FG000|Overall Study|Death|23|||
105562400|NCT01800968|364055950|FG001|Overall Study|Death|16|||
105562401|NCT01800968|364055949|FG000|Overall Study|Lost to Follow-up|5|||
105562402|NCT01800968|364055950|FG001|Overall Study|Lost to Follow-up|7|||
105562403|NCT01800968|364055949|FG000|Overall Study|Withdrawal by Subject|7|||
105562404|NCT01800968|364055950|FG001|Overall Study|Withdrawal by Subject|9|||
105562405|NCT01800968|364055949|FG000|Overall Study|Physician Decision|1|||
105562406|NCT01800968|364055950|FG001|Overall Study|Physician Decision|0|||
105562407|NCT03266770|364055952|FG000|Overall Study|Physician Decision|3|||
105562408|NCT03266770|364055952|FG000|Overall Study|Insufficient study supplies|1|||
105562409|NCT03266770|364055952|FG000|Overall Study|Adverse Event|1|||
105562410|NCT02279043|364055953|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
105562411|NCT02279043|364055954|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
105562412|NCT02279043|364055955|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
105562413|NCT02279043|364055953|FG000|Overall Study|Lost to Follow-up|46|||
105562414|NCT02279043|364055954|FG001|Overall Study|Lost to Follow-up|88|||
105562415|NCT02279043|364055955|FG002|Overall Study|Lost to Follow-up|0|||
105562416|NCT00490282|364055956|FG000|Overall Study|Withdrawal by Subject|3|||
105562417|NCT02657031|364055960|FG000|Overall Study|Adverse Event|1|||
105562418|NCT02657031|364055961|FG001|Overall Study|Adverse Event|2|||
105562419|NCT00977665|364055964|FG000|Overall Study|Withdrawal by Subject|1|||
105562420|NCT00977665|364055965|FG001|Overall Study|Withdrawal by Subject|3|||
105562421|NCT00977665|364055964|FG000|Overall Study|Physician Decision|2|||
105562422|NCT00977665|364055965|FG001|Overall Study|Physician Decision|1|||
105562423|NCT00977665|364055964|FG000|Overall Study|Sponsor requested withdrawal|0|||
105562424|NCT00977665|364055965|FG001|Overall Study|Sponsor requested withdrawal|1|||
105562425|NCT00977665|364055964|FG000|Overall Study|Lost to Follow-up|1|||
105562426|NCT00977665|364055965|FG001|Overall Study|Lost to Follow-up|0|||
105562427|NCT00977665|364055964|FG000|Overall Study|Death|3|||
105562428|NCT00977665|364055965|FG001|Overall Study|Death|2|||
105562429|NCT00977665|364055964|FG000|Overall Study|Adverse Event|14|||
105562430|NCT00977665|364055965|FG001|Overall Study|Adverse Event|7|||
105562431|NCT00977665|364055964|FG000|Overall Study|Treatment failure|0|||
105562432|NCT00977665|364055965|FG001|Overall Study|Treatment failure|1|||
105562433|NCT01330433|364055966|FG000|Overall Study|Death|1|||
105562434|NCT01330433|364055967|FG001|Overall Study|Death|3|||
105562435|NCT01330433|364055966|FG000|Overall Study|Lost to Follow-up|1|||
105562436|NCT01330433|364055967|FG001|Overall Study|Lost to Follow-up|0|||
105562437|NCT03078816|364055971|FG000|Overall Study|Withdrawal by Subject|1|||
105562438|NCT01494584|364055972|FG000|Overall Study|Study Closed/Terminated|1|||
105562439|NCT01499082|364055973|FG000|Overall Study|Randomized but not Treated|0|||
105562440|NCT01499082|364055974|FG001|Overall Study|Randomized but not Treated|1|||
105562441|NCT01499082|364055973|FG000|Overall Study|Adverse Event|12|||
105562442|NCT01499082|364055974|FG001|Overall Study|Adverse Event|16|||
105562443|NCT01499082|364055973|FG000|Overall Study|Lack of Efficacy|1|||
105562444|NCT01499082|364055974|FG001|Overall Study|Lack of Efficacy|1|||
105562445|NCT01499082|364055973|FG000|Overall Study|Protocol Violation|6|||
105721606|NCT00896532|364636407|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721607|NCT00896532|364636408|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105562446|NCT01499082|364055974|FG001|Overall Study|Protocol Violation|8|||
105562447|NCT01499082|364055973|FG000|Overall Study|Diverse Reasons|18|||
105562448|NCT01499082|364055974|FG001|Overall Study|Diverse Reasons|14|||
105562449|NCT01499082|364055973|FG000|Overall Study|Site Closure for Noncompliance|5|||
105562450|NCT01499082|364055974|FG001|Overall Study|Site Closure for Noncompliance|2|||
105562451|NCT01499082|364055973|FG000|Overall Study|Hypoglycemia|2|||
105562452|NCT01499082|364055974|FG001|Overall Study|Hypoglycemia|3|||
105562453|NCT01499082|364055973|FG000|Overall Study|Lost to Follow-up|1|||
105562454|NCT01499082|364055974|FG001|Overall Study|Lost to Follow-up|3|||
105562455|NCT03599349|364055975|FG000|Overall Study|Lost to Follow-up|1|||
105562456|NCT00696410|364055978|FG000|Overall Study|Lost to Follow-up|2|||
105562457|NCT00696410|364055979|FG001|Overall Study|Lost to Follow-up|0|||
105562458|NCT00696410|364055978|FG000|Overall Study|Withdrawal by Subject|8|||
105792515|NCT03926728|364896359|FG002|Overall Study|Withdrawal by Subject|1|||
105792516|NCT03926728|364896360|FG003|Overall Study|Withdrawal by Subject|0|||
105792517|NCT03926728|364896361|FG004|Overall Study|Withdrawal by Subject|0|||
105792518|NCT03926728|364896362|FG005|Overall Study|Withdrawal by Subject|1|||
105792519|NCT03926728|364896363|FG006|Overall Study|Withdrawal by Subject|1|||
105792520|NCT03926728|364896364|FG007|Overall Study|Withdrawal by Subject|0|||
105792521|NCT03926728|364896365|FG008|Overall Study|Withdrawal by Subject|0|||
105792522|NCT03926728|364896366|FG009|Overall Study|Withdrawal by Subject|1|||
105792523|NCT03926728|364896367|FG010|Overall Study|Withdrawal by Subject|0|||
105792524|NCT03926728|364896368|FG011|Overall Study|Withdrawal by Subject|0|||
105721608|NCT00896532|364636409|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721609|NCT00896532|364636410|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721610|NCT00896532|364636411|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721611|NCT00896532|364636412|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721612|NCT00896532|364636413|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
105721613|NCT00896532|364636414|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721614|NCT00896532|364636415|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721615|NCT00896532|364636416|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721616|NCT00896532|364636417|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721617|NCT00896532|364636418|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721618|NCT00896532|364636419|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721619|NCT00896532|364636397|FG000|Months 48-72: Follow-on Phase|Death|0|||
105721620|NCT00896532|364636398|FG001|Months 48-72: Follow-on Phase|Death|0|||
105721621|NCT00896532|364636399|FG002|Months 48-72: Follow-on Phase|Death|0|||
105721622|NCT00896532|364636400|FG003|Months 48-72: Follow-on Phase|Death|0|||
105721623|NCT00896532|364636401|FG004|Months 48-72: Follow-on Phase|Death|0|||
105721624|NCT00896532|364636402|FG005|Months 48-72: Follow-on Phase|Death|0|||
105721625|NCT00896532|364636403|FG006|Months 48-72: Follow-on Phase|Death|0|||
105721626|NCT00896532|364636404|FG007|Months 48-72: Follow-on Phase|Death|0|||
105721627|NCT00896532|364636405|FG008|Months 48-72: Follow-on Phase|Death|0|||
105721628|NCT00896532|364636406|FG009|Months 48-72: Follow-on Phase|Death|0|||
105721629|NCT00896532|364636407|FG010|Months 48-72: Follow-on Phase|Death|0|||
105721630|NCT00896532|364636408|FG011|Months 48-72: Follow-on Phase|Death|0|||
105721631|NCT00896532|364636409|FG012|Months 48-72: Follow-on Phase|Death|0|||
105721632|NCT00896532|364636410|FG013|Months 48-72: Follow-on Phase|Death|0|||
105721633|NCT00896532|364636411|FG014|Months 48-72: Follow-on Phase|Death|0|||
105721634|NCT00896532|364636412|FG015|Months 48-72: Follow-on Phase|Death|0|||
105721635|NCT00896532|364636413|FG016|Months 48-72: Follow-on Phase|Death|0|||
105721636|NCT00896532|364636414|FG017|Months 48-72: Follow-on Phase|Death|0|||
105721637|NCT00896532|364636415|FG018|Months 48-72: Follow-on Phase|Death|1|||
105721638|NCT00896532|364636416|FG019|Months 48-72: Follow-on Phase|Death|0|||
105721639|NCT00896532|364636417|FG020|Months 48-72: Follow-on Phase|Death|0|||
105721640|NCT00896532|364636418|FG021|Months 48-72: Follow-on Phase|Death|0|||
105721641|NCT00896532|364636419|FG022|Months 48-72: Follow-on Phase|Death|0|||
105721642|NCT00896532|364636397|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721643|NCT00896532|364636398|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721644|NCT00896532|364636399|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721645|NCT00896532|364636400|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721646|NCT00896532|364636401|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721647|NCT00896532|364636402|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721648|NCT00896532|364636403|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721649|NCT00896532|364636404|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721650|NCT00896532|364636405|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721651|NCT00896532|364636406|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721652|NCT00896532|364636407|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721653|NCT00896532|364636408|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721654|NCT00896532|364636409|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721655|NCT00896532|364636410|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721656|NCT00896532|364636411|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721657|NCT00896532|364636412|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721658|NCT00896532|364636413|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721659|NCT00896532|364636414|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721660|NCT00896532|364636415|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721661|NCT00896532|364636416|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105792525|NCT03869684|364896371|FG000|Overall Study|Adverse Event|0|||
105792526|NCT03869684|364896372|FG001|Overall Study|Adverse Event|3|||
105792527|NCT03869684|364896373|FG002|Overall Study|Adverse Event|1|||
105792528|NCT03869684|364896371|FG000|Overall Study|Withdrawal by Subject|1|||
105792529|NCT03869684|364896372|FG001|Overall Study|Withdrawal by Subject|0|||
105721662|NCT00896532|364636417|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721663|NCT00896532|364636418|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
105721664|NCT00896532|364636419|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721665|NCT00896532|364636397|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721666|NCT00896532|364636398|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721667|NCT00896532|364636399|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721668|NCT00896532|364636400|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721669|NCT00896532|364636401|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721670|NCT00896532|364636402|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721671|NCT00896532|364636403|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721672|NCT00896532|364636404|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721673|NCT00896532|364636405|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721674|NCT00896532|364636406|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721675|NCT00896532|364636407|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721676|NCT00896532|364636408|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721677|NCT00896532|364636409|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721678|NCT00896532|364636410|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721679|NCT00896532|364636411|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721680|NCT00896532|364636412|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721681|NCT00896532|364636413|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721682|NCT00896532|364636414|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721683|NCT00896532|364636415|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721684|NCT00896532|364636416|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105352860|NCT01306214|363296999|FG000|Overall Study|Not treated|1|||
105721685|NCT00896532|364636417|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105478227|NCT04473235|363764184|FG001|Overall Study|Declined continuation|0|||
105478228|NCT04473235|363764183|FG000|Overall Study|Physician Decision|1|||
105478229|NCT04473235|363764184|FG001|Overall Study|Physician Decision|1|||
105478230|NCT04473235|363764183|FG000|Overall Study|Protocol Violation|10|||
105478231|NCT04473235|363764184|FG001|Overall Study|Protocol Violation|6|||
105478232|NCT01754402|363764185|FG000|Overall Study|Death|0|||
105478233|NCT01754402|363764186|FG001|Overall Study|Death|0|||
105721686|NCT00896532|364636418|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
105721687|NCT00896532|364636419|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721688|NCT02411747|364636420|FG000|Overall Study|Withdrawal by Subject|1|||
105721689|NCT02411747|364636421|FG001|Overall Study|Withdrawal by Subject|0|||
105721690|NCT02411747|364636420|FG000|Overall Study|Protocol Violation|2|||
105721691|NCT02411747|364636421|FG001|Overall Study|Protocol Violation|4|||
105721692|NCT01176916|364636422|FG000|Overall Study|Adverse Event|61|||
105721693|NCT01176916|364636422|FG000|Overall Study|Death|1|||
105721694|NCT01176916|364636422|FG000|Overall Study|Lost to Follow-up|15|||
105721695|NCT01176916|364636422|FG000|Overall Study|Objective progression or relapse|17|||
105721696|NCT01176916|364636422|FG000|Overall Study|Protocol Violation|24|||
105721697|NCT01176916|364636422|FG000|Overall Study|Withdrawal by Subject|37|||
105721698|NCT01176916|364636422|FG000|Overall Study|Other|6|||
105721699|NCT01176916|364636422|FG000|Overall Study|Withdrawal prior to Treatment|6|||
105721700|NCT00675597|364636423|FG000|Overall Study|Withdrawal by Subject|3|||
105721701|NCT00631137|364636424|FG000|Overall Study|Withdrawal by Subject|1|||
105721702|NCT00631137|364636425|FG001|Overall Study|Withdrawal by Subject|0|||
105721703|NCT04223609|364636427|FG000|Overall Study|Adverse Event|0|||
105721704|NCT04223609|364636428|FG001|Overall Study|Adverse Event|1|||
105721705|NCT04223609|364636427|FG000|Overall Study|Missed last visit|0|||
105721706|NCT04223609|364636428|FG001|Overall Study|Missed last visit|1|||
105721707|NCT03437447|364636429|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105721708|NCT03437447|364636430|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105721709|NCT03437447|364636431|FG002|Treatment Period 1|Withdrawal by Subject|1|||
105721710|NCT01275222|364636434|FG000|Phase l by Treatment|Adverse Event|1|||
105721711|NCT01275222|364636435|FG001|Phase l by Treatment|Adverse Event|4|||
105721712|NCT01275222|364636436|FG002|Phase l by Treatment|Adverse Event|2|||
105721713|NCT01275222|364636437|FG003|Phase l by Treatment|Adverse Event|3|||
105721714|NCT01275222|364636438|FG004|Phase l by Treatment|Adverse Event|0|||
105721715|NCT01275222|364636439|FG005|Phase l by Treatment|Adverse Event|0|||
105721716|NCT01275222|364636434|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
105721717|NCT01275222|364636435|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
105721718|NCT01275222|364636436|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
105721719|NCT01275222|364636437|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
105721720|NCT01275222|364636438|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
105721721|NCT01275222|364636439|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
105721722|NCT01275222|364636434|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
105721723|NCT01275222|364636435|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
105721724|NCT01275222|364636436|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
105478234|NCT01754402|363764187|FG002|Overall Study|Death|1|||
105478235|NCT01754402|363764185|FG000|Overall Study|Adverse Event|2|||
105478236|NCT01754402|363764186|FG001|Overall Study|Adverse Event|2|||
105478237|NCT01754402|363764187|FG002|Overall Study|Adverse Event|1|||
105478238|NCT01754402|363764185|FG000|Overall Study|Withdrawal by Subject|0|||
105478239|NCT01754402|363764186|FG001|Overall Study|Withdrawal by Subject|0|||
105478240|NCT01754402|363764187|FG002|Overall Study|Withdrawal by Subject|1|||
105478241|NCT01754402|363764185|FG000|Overall Study|Lack of Efficacy|0|||
105478242|NCT01754402|363764186|FG001|Overall Study|Lack of Efficacy|0|||
105478243|NCT01754402|363764187|FG002|Overall Study|Lack of Efficacy|1|||
105478244|NCT00109590|363764188|FG000|Overall Study|Lost to Follow-up|1|||
105478245|NCT00109590|363764189|FG001|Overall Study|Lost to Follow-up|0|||
105478246|NCT00109590|363764190|FG002|Overall Study|Lost to Follow-up|1|||
105478247|NCT00109590|363764188|FG000|Overall Study|Never Started Treatment|1|||
105478248|NCT00109590|363764189|FG001|Overall Study|Never Started Treatment|2|||
105478249|NCT00109590|363764190|FG002|Overall Study|Never Started Treatment|3|||
105478250|NCT00490529|363764191|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
105478251|NCT00490529|363764191|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
105478252|NCT00490529|363764191|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
105478253|NCT00490529|363764191|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
105478254|NCT00490529|363764191|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
105478255|NCT00490529|363764191|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
105478256|NCT02617485|363764192|FG000|Treatment and Observation Period|Adverse Event|9|||
105478257|NCT02617485|363764193|FG001|Treatment and Observation Period|Adverse Event|1|||
105721725|NCT01275222|364636437|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
105721726|NCT01275222|364636438|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
105721727|NCT01275222|364636439|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
105721728|NCT01275222|364636434|FG000|Phase l by Treatment|Disease progression|12|||
105721729|NCT01275222|364636435|FG001|Phase l by Treatment|Disease progression|8|||
105721730|NCT01275222|364636436|FG002|Phase l by Treatment|Disease progression|2|||
105721731|NCT01275222|364636437|FG003|Phase l by Treatment|Disease progression|5|||
105721732|NCT01275222|364636438|FG004|Phase l by Treatment|Disease progression|0|||
105721733|NCT01275222|364636439|FG005|Phase l by Treatment|Disease progression|0|||
105721734|NCT01275222|364636434|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
105721735|NCT01275222|364636435|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
105721736|NCT01275222|364636436|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
105721737|NCT01275222|364636437|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
105721738|NCT01275222|364636438|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
105721739|NCT01275222|364636439|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
105721740|NCT01275222|364636434|FG000|Phase l by Treatment|Death|0|||
105721741|NCT01275222|364636435|FG001|Phase l by Treatment|Death|1|||
105721742|NCT01275222|364636436|FG002|Phase l by Treatment|Death|0|||
105721743|NCT01275222|364636437|FG003|Phase l by Treatment|Death|1|||
105721744|NCT01275222|364636438|FG004|Phase l by Treatment|Death|0|||
105721745|NCT01275222|364636439|FG005|Phase l by Treatment|Death|0|||
105721746|NCT01275222|364636434|FG000|Phase ll by Stratum|Adverse Event|0|||
105721747|NCT01275222|364636435|FG001|Phase ll by Stratum|Adverse Event|0|||
105721748|NCT01275222|364636436|FG002|Phase ll by Stratum|Adverse Event|0|||
105721749|NCT01275222|364636437|FG003|Phase ll by Stratum|Adverse Event|0|||
105721750|NCT01275222|364636438|FG004|Phase ll by Stratum|Adverse Event|2|||
105721751|NCT01275222|364636439|FG005|Phase ll by Stratum|Adverse Event|10|||
105721752|NCT01275222|364636434|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
105721753|NCT01275222|364636435|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
105721754|NCT01275222|364636436|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
105721755|NCT01275222|364636437|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
105721756|NCT01275222|364636438|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
105721757|NCT01275222|364636439|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
105721758|NCT01275222|364636434|FG000|Phase ll by Stratum|Disease progression|0|||
105721759|NCT01275222|364636435|FG001|Phase ll by Stratum|Disease progression|0|||
105721760|NCT01275222|364636436|FG002|Phase ll by Stratum|Disease progression|0|||
105721761|NCT01275222|364636437|FG003|Phase ll by Stratum|Disease progression|0|||
105721762|NCT01275222|364636438|FG004|Phase ll by Stratum|Disease progression|23|||
105721763|NCT01275222|364636439|FG005|Phase ll by Stratum|Disease progression|31|||
105721764|NCT01275222|364636434|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
105721765|NCT01275222|364636435|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
105721766|NCT01275222|364636436|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
105721767|NCT01275222|364636437|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
105721768|NCT01275222|364636438|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
105721769|NCT01275222|364636439|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
105721770|NCT01275222|364636434|FG000|Phase ll by Stratum|Death|0|||
105721771|NCT01275222|364636435|FG001|Phase ll by Stratum|Death|0|||
105721772|NCT01275222|364636436|FG002|Phase ll by Stratum|Death|0|||
105721773|NCT01275222|364636437|FG003|Phase ll by Stratum|Death|0|||
105721774|NCT01275222|364636438|FG004|Phase ll by Stratum|Death|1|||
105721775|NCT01275222|364636439|FG005|Phase ll by Stratum|Death|1|||
105721776|NCT00591734|364636440|FG000|Overall Study|Lack of Efficacy|35|||
105721777|NCT00591734|364636440|FG000|Overall Study|Adverse Event|5|||
105721778|NCT00591734|364636440|FG000|Overall Study|Physician Decision|5|||
105721779|NCT00591734|364636440|FG000|Overall Study|Intercurrent Illness|8|||
105721780|NCT01661790|364636441|FG000|Overall Study|Lost to Follow-up|0|||
105721781|NCT01661790|364636442|FG001|Overall Study|Lost to Follow-up|2|||
105721782|NCT02764541|364636443|FG000|Overall Study|Withdrawal by Subject|0|||
105721783|NCT02764541|364636444|FG001|Overall Study|Withdrawal by Subject|0|||
105721784|NCT02764541|364636445|FG002|Overall Study|Withdrawal by Subject|0|||
105721785|NCT02764541|364636446|FG003|Overall Study|Withdrawal by Subject|0|||
105721786|NCT02764541|364636447|FG004|Overall Study|Withdrawal by Subject|1|||
105721787|NCT02764541|364636448|FG005|Overall Study|Withdrawal by Subject|1|||
105721788|NCT02764541|364636449|FG006|Overall Study|Withdrawal by Subject|0|||
105721789|NCT02764541|364636450|FG007|Overall Study|Withdrawal by Subject|1|||
105478258|NCT02617485|363764192|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
105478259|NCT02617485|363764193|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
105478260|NCT02617485|363764192|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
105478261|NCT02617485|363764193|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
105478262|NCT02617485|363764192|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
105478263|NCT02617485|363764193|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
105478264|NCT02617485|363764192|FG000|Treatment and Observation Period|Physician Decision|0|||
105478265|NCT02617485|363764193|FG001|Treatment and Observation Period|Physician Decision|1|||
105478266|NCT02617485|363764192|FG000|Follow-up Period|Adverse Event|1|||
105478267|NCT02617485|363764193|FG001|Follow-up Period|Adverse Event|0|||
105478268|NCT02617485|363764192|FG000|Follow-up Period|Withdrawal by Subject|1|||
105478269|NCT02617485|363764193|FG001|Follow-up Period|Withdrawal by Subject|0|||
105478270|NCT02617485|363764192|FG000|Follow-up Period|Disease progression|2|||
105478271|NCT02617485|363764193|FG001|Follow-up Period|Disease progression|1|||
105478272|NCT02617485|363764192|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
105478273|NCT02617485|363764193|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
105478274|NCT02617485|363764192|FG000|Follow-up Period|Patient needed radiotherapy|9|||
105478275|NCT02617485|363764193|FG001|Follow-up Period|Patient needed radiotherapy|5|||
105478276|NCT02617485|363764192|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
105478277|NCT02617485|363764193|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
105478278|NCT00791076|363764194|FG000|Overall Study|Study was terminated,PI left institution|8|||
105478279|NCT00281658|363764195|FG000|Randomized Phase|Adverse Event|0|||
105478280|NCT00281658|363764196|FG001|Randomized Phase|Adverse Event|2|||
105478281|NCT00281658|363764197|FG002|Randomized Phase|Adverse Event|0|||
105478282|NCT00281658|363764198|FG003|Randomized Phase|Adverse Event|0|||
105478283|NCT00281658|363764195|FG000|Randomized Phase|Lost to Follow-up|34|||
105478284|NCT00281658|363764196|FG001|Randomized Phase|Lost to Follow-up|27|||
105478285|NCT00281658|363764197|FG002|Randomized Phase|Lost to Follow-up|0|||
105478286|NCT00281658|363764198|FG003|Randomized Phase|Lost to Follow-up|0|||
105478287|NCT00281658|363764195|FG000|Randomized Phase|Withdrawal by Subject|8|||
105478288|NCT00281658|363764196|FG001|Randomized Phase|Withdrawal by Subject|7|||
105478289|NCT00281658|363764197|FG002|Randomized Phase|Withdrawal by Subject|0|||
105478290|NCT00281658|363764198|FG003|Randomized Phase|Withdrawal by Subject|0|||
105478291|NCT00281658|363764195|FG000|Randomized Phase|Study closed/terminated|1|||
105478292|NCT00281658|363764196|FG001|Randomized Phase|Study closed/terminated|1|||
105478293|NCT00281658|363764197|FG002|Randomized Phase|Study closed/terminated|0|||
105478294|NCT00281658|363764198|FG003|Randomized Phase|Study closed/terminated|0|||
105478295|NCT00281658|363764195|FG000|Randomized Phase|Disease progression|36|||
105478296|NCT00281658|363764196|FG001|Randomized Phase|Disease progression|27|||
105478297|NCT00281658|363764197|FG002|Randomized Phase|Disease progression|0|||
105478298|NCT00281658|363764198|FG003|Randomized Phase|Disease progression|0|||
105478299|NCT00281658|363764195|FG000|Randomized Phase|Physician Decision|1|||
105478300|NCT00281658|363764196|FG001|Randomized Phase|Physician Decision|1|||
105478301|NCT00281658|363764197|FG002|Randomized Phase|Physician Decision|0|||
105478302|NCT00281658|363764198|FG003|Randomized Phase|Physician Decision|0|||
105478303|NCT00281658|363764195|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
105478304|NCT00281658|363764196|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
105478305|NCT00281658|363764197|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
105478306|NCT00281658|363764198|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
105478307|NCT00281658|363764195|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
105478308|NCT00281658|363764196|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
105478309|NCT00281658|363764197|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
105478310|NCT00281658|363764198|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
105478311|NCT00281658|363764195|FG000|Randomized Phase|Treatment ongoing|1|||
105478312|NCT00281658|363764196|FG001|Randomized Phase|Treatment ongoing|0|||
105478313|NCT00281658|363764197|FG002|Randomized Phase|Treatment ongoing|0|||
105478314|NCT00281658|363764198|FG003|Randomized Phase|Treatment ongoing|0|||
105478315|NCT00281658|363764195|FG000|Open Label Phase|Adverse Event|0|||
105478316|NCT00281658|363764196|FG001|Open Label Phase|Adverse Event|0|||
105478317|NCT00281658|363764197|FG002|Open Label Phase|Adverse Event|1|||
105478318|NCT00281658|363764198|FG003|Open Label Phase|Adverse Event|0|||
105478319|NCT00281658|363764195|FG000|Open Label Phase|Lost to Follow-up|0|||
105478320|NCT00281658|363764196|FG001|Open Label Phase|Lost to Follow-up|0|||
105478321|NCT00281658|363764197|FG002|Open Label Phase|Lost to Follow-up|16|||
105478322|NCT00281658|363764198|FG003|Open Label Phase|Lost to Follow-up|2|||
105478323|NCT00281658|363764195|FG000|Open Label Phase|Withdrawal by Subject|0|||
105478324|NCT00281658|363764196|FG001|Open Label Phase|Withdrawal by Subject|0|||
105478325|NCT00281658|363764197|FG002|Open Label Phase|Withdrawal by Subject|3|||
105562459|NCT00696410|364055979|FG001|Overall Study|Withdrawal by Subject|0|||
105562460|NCT00696410|364055978|FG000|Overall Study|Physician Decision|3|||
105562461|NCT00696410|364055979|FG001|Overall Study|Physician Decision|0|||
105562462|NCT02495025|364055984|FG000|Overall Study|Lost to Follow-up|21|||
105562463|NCT02495025|364055985|FG001|Overall Study|Lost to Follow-up|14|||
105562464|NCT02495025|364055984|FG000|Overall Study|Withdrawal by Subject|5|||
105562465|NCT02495025|364055985|FG001|Overall Study|Withdrawal by Subject|0|||
105562466|NCT01592370|364055996|FG000|Overall Study|Disease Progression|62|||
105562467|NCT01592370|364055997|FG001|Overall Study|Disease Progression|16|||
105562468|NCT01592370|364055998|FG002|Overall Study|Disease Progression|52|||
105562469|NCT01592370|364055999|FG003|Overall Study|Disease Progression|3|||
105562470|NCT01592370|364056000|FG004|Overall Study|Disease Progression|3|||
105562471|NCT01592370|364056001|FG005|Overall Study|Disease Progression|31|||
105562472|NCT01592370|364056002|FG006|Overall Study|Disease Progression|14|||
105562473|NCT01592370|364055996|FG000|Overall Study|Study Drug Toxicity|14|||
105562474|NCT01592370|364055997|FG001|Overall Study|Study Drug Toxicity|3|||
105721790|NCT02764541|364636443|FG000|Overall Study|Adverse Event|1|||
105721791|NCT02764541|364636444|FG001|Overall Study|Adverse Event|0|||
105721792|NCT02764541|364636445|FG002|Overall Study|Adverse Event|0|||
105721793|NCT02764541|364636446|FG003|Overall Study|Adverse Event|0|||
105721794|NCT02764541|364636447|FG004|Overall Study|Adverse Event|0|||
105721795|NCT02764541|364636448|FG005|Overall Study|Adverse Event|0|||
105721796|NCT02764541|364636449|FG006|Overall Study|Adverse Event|1|||
105721797|NCT02764541|364636450|FG007|Overall Study|Adverse Event|0|||
105721798|NCT02764541|364636443|FG000|Overall Study|Metastasis|1|||
105721799|NCT02764541|364636444|FG001|Overall Study|Metastasis|0|||
105721800|NCT02764541|364636445|FG002|Overall Study|Metastasis|0|||
105721801|NCT02764541|364636446|FG003|Overall Study|Metastasis|0|||
105721802|NCT02764541|364636447|FG004|Overall Study|Metastasis|0|||
105721803|NCT02764541|364636448|FG005|Overall Study|Metastasis|0|||
105721804|NCT02764541|364636449|FG006|Overall Study|Metastasis|0|||
105721805|NCT02764541|364636450|FG007|Overall Study|Metastasis|0|||
105721806|NCT02764541|364636443|FG000|Overall Study|Disease progression|1|||
105721807|NCT02764541|364636444|FG001|Overall Study|Disease progression|1|||
105721808|NCT02764541|364636445|FG002|Overall Study|Disease progression|0|||
105721809|NCT02764541|364636446|FG003|Overall Study|Disease progression|0|||
105721810|NCT02764541|364636447|FG004|Overall Study|Disease progression|0|||
105721811|NCT02764541|364636448|FG005|Overall Study|Disease progression|0|||
105721812|NCT02764541|364636449|FG006|Overall Study|Disease progression|0|||
105721813|NCT02764541|364636450|FG007|Overall Study|Disease progression|1|||
105721814|NCT02764541|364636443|FG000|Overall Study|Protocol Violation|0|||
105721815|NCT02764541|364636444|FG001|Overall Study|Protocol Violation|0|||
105721816|NCT02764541|364636445|FG002|Overall Study|Protocol Violation|0|||
105721817|NCT02764541|364636446|FG003|Overall Study|Protocol Violation|1|||
105721818|NCT02764541|364636447|FG004|Overall Study|Protocol Violation|0|||
105721819|NCT02764541|364636448|FG005|Overall Study|Protocol Violation|1|||
105721820|NCT02764541|364636449|FG006|Overall Study|Protocol Violation|0|||
105721821|NCT02764541|364636450|FG007|Overall Study|Protocol Violation|0|||
105721822|NCT02764541|364636443|FG000|Overall Study|Physician Decision|0|||
105721823|NCT02764541|364636444|FG001|Overall Study|Physician Decision|0|||
105352861|NCT01306214|363297000|FG001|Overall Study|Not treated|1|||
105562475|NCT01592370|364055998|FG002|Overall Study|Study Drug Toxicity|0|||
105562476|NCT01592370|364055999|FG003|Overall Study|Study Drug Toxicity|0|||
105562477|NCT01592370|364056000|FG004|Overall Study|Study Drug Toxicity|0|||
105562478|NCT01592370|364056001|FG005|Overall Study|Study Drug Toxicity|0|||
105562479|NCT01592370|364056002|FG006|Overall Study|Study Drug Toxicity|1|||
105562480|NCT01592370|364055996|FG000|Overall Study|AE unrelated to study drug|4|||
105562481|NCT01592370|364055997|FG001|Overall Study|AE unrelated to study drug|3|||
105562482|NCT01592370|364055998|FG002|Overall Study|AE unrelated to study drug|0|||
105721824|NCT02764541|364636445|FG002|Overall Study|Physician Decision|0|||
105721825|NCT02764541|364636446|FG003|Overall Study|Physician Decision|1|||
105721826|NCT02764541|364636447|FG004|Overall Study|Physician Decision|0|||
105721827|NCT02764541|364636448|FG005|Overall Study|Physician Decision|0|||
105721828|NCT02764541|364636449|FG006|Overall Study|Physician Decision|0|||
105721829|NCT02764541|364636450|FG007|Overall Study|Physician Decision|1|||
105721830|NCT02764541|364636443|FG000|Overall Study|Three Cycles completed before surgery|0|||
105721831|NCT02764541|364636444|FG001|Overall Study|Three Cycles completed before surgery|0|||
105721832|NCT02764541|364636445|FG002|Overall Study|Three Cycles completed before surgery|0|||
105721833|NCT02764541|364636446|FG003|Overall Study|Three Cycles completed before surgery|1|||
105721834|NCT02764541|364636447|FG004|Overall Study|Three Cycles completed before surgery|0|||
105721835|NCT02764541|364636448|FG005|Overall Study|Three Cycles completed before surgery|0|||
105721836|NCT02764541|364636449|FG006|Overall Study|Three Cycles completed before surgery|0|||
105721837|NCT02764541|364636450|FG007|Overall Study|Three Cycles completed before surgery|0|||
105721838|NCT02764541|364636443|FG000|Overall Study|Patient Compliance|0|||
105721839|NCT02764541|364636444|FG001|Overall Study|Patient Compliance|0|||
105721840|NCT02764541|364636445|FG002|Overall Study|Patient Compliance|1|||
105721841|NCT02764541|364636446|FG003|Overall Study|Patient Compliance|0|||
105721842|NCT02764541|364636447|FG004|Overall Study|Patient Compliance|0|||
105721843|NCT02764541|364636448|FG005|Overall Study|Patient Compliance|0|||
105721844|NCT02764541|364636449|FG006|Overall Study|Patient Compliance|0|||
105721845|NCT02764541|364636450|FG007|Overall Study|Patient Compliance|0|||
105721846|NCT02764541|364636443|FG000|Overall Study|Death|0|||
105721847|NCT02764541|364636444|FG001|Overall Study|Death|0|||
105721848|NCT02764541|364636445|FG002|Overall Study|Death|0|||
105721849|NCT02764541|364636446|FG003|Overall Study|Death|0|||
105721850|NCT02764541|364636447|FG004|Overall Study|Death|0|||
105721851|NCT02764541|364636448|FG005|Overall Study|Death|0|||
105721852|NCT02764541|364636449|FG006|Overall Study|Death|1|||
105721853|NCT02764541|364636450|FG007|Overall Study|Death|0|||
105721854|NCT02764541|364636443|FG000|Overall Study|Insurance reasons|0|||
105721855|NCT02764541|364636444|FG001|Overall Study|Insurance reasons|0|||
105721856|NCT02764541|364636445|FG002|Overall Study|Insurance reasons|0|||
105721857|NCT02764541|364636446|FG003|Overall Study|Insurance reasons|0|||
105721858|NCT02764541|364636447|FG004|Overall Study|Insurance reasons|0|||
105721859|NCT02764541|364636448|FG005|Overall Study|Insurance reasons|0|||
105721860|NCT02764541|364636449|FG006|Overall Study|Insurance reasons|1|||
105721861|NCT02764541|364636450|FG007|Overall Study|Insurance reasons|0|||
105721862|NCT00355121|364636451|FG000|Overall Study|Did not receive study vaccine|1|||
105721863|NCT00355121|364636452|FG001|Overall Study|Did not receive study vaccine|0|||
105721864|NCT00355121|364636453|FG002|Overall Study|Did not receive study vaccine|1|||
105721865|NCT00355121|364636451|FG000|Overall Study|Adverse Event|0|||
105721866|NCT00355121|364636452|FG001|Overall Study|Adverse Event|1|||
105721867|NCT00355121|364636453|FG002|Overall Study|Adverse Event|0|||
105721868|NCT00355121|364636451|FG000|Overall Study|Protocol Violation|7|||
105721869|NCT00355121|364636452|FG001|Overall Study|Protocol Violation|9|||
105721870|NCT00355121|364636453|FG002|Overall Study|Protocol Violation|1|||
105721871|NCT00355121|364636451|FG000|Overall Study|Lost to Follow-up|4|||
105721872|NCT00355121|364636452|FG001|Overall Study|Lost to Follow-up|7|||
105721873|NCT00355121|364636453|FG002|Overall Study|Lost to Follow-up|1|||
105721874|NCT00355121|364636451|FG000|Overall Study|Withdrawal by Subject|9|||
105721875|NCT00355121|364636452|FG001|Overall Study|Withdrawal by Subject|10|||
105721876|NCT00355121|364636453|FG002|Overall Study|Withdrawal by Subject|2|||
105721877|NCT00355121|364636451|FG000|Overall Study|Serious adverse events|0|||
105721878|NCT00355121|364636452|FG001|Overall Study|Serious adverse events|2|||
105721879|NCT00355121|364636453|FG002|Overall Study|Serious adverse events|0|||
105721880|NCT02040142|364636457|FG000|Overall Study|Lost to Follow-up|5|||
105721881|NCT02040142|364636457|FG000|Overall Study|Death|17|||
105721882|NCT02040142|364636457|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
105721883|NCT03952559|364636464|FG000|Double Blind Treatment Period|Adverse Event|0|||
105721884|NCT03952559|364636465|FG001|Double Blind Treatment Period|Adverse Event|2|||
105721885|NCT03952559|364636466|FG002|Double Blind Treatment Period|Adverse Event|1|||
105721886|NCT03952559|364636467|FG003|Double Blind Treatment Period|Adverse Event|0|||
105721887|NCT03952559|364636468|FG004|Double Blind Treatment Period|Adverse Event|1|||
105721888|NCT03952559|364636464|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
105721889|NCT03952559|364636465|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
105721890|NCT03952559|364636466|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
105721891|NCT03952559|364636467|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
105721892|NCT03952559|364636468|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
105721893|NCT03952559|364636464|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
105721894|NCT03952559|364636465|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
105562483|NCT01592370|364055999|FG003|Overall Study|AE unrelated to study drug|0|||
105562484|NCT01592370|364056000|FG004|Overall Study|AE unrelated to study drug|0|||
105562485|NCT01592370|364056001|FG005|Overall Study|AE unrelated to study drug|0|||
105562486|NCT01592370|364056002|FG006|Overall Study|AE unrelated to study drug|1|||
105721895|NCT03952559|364636466|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
105721896|NCT03952559|364636467|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
105721897|NCT03952559|364636468|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
105721898|NCT03952559|364636464|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
105721899|NCT03952559|364636465|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
105721900|NCT03952559|364636466|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
105721901|NCT03952559|364636467|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
105721902|NCT03952559|364636468|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
105721903|NCT01870739|364636469|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
105721904|NCT01870739|364636470|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
105721905|NCT01870739|364636469|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
105721906|NCT01870739|364636470|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
105721907|NCT01870739|364636469|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
105721908|NCT01870739|364636470|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
105721909|NCT01870739|364636469|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
105721910|NCT01870739|364636470|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
105721911|NCT01870739|364636469|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
105721912|NCT01870739|364636470|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
105721913|NCT01870739|364636469|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
105721914|NCT01870739|364636470|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
105721915|NCT01870739|364636469|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
105721916|NCT01870739|364636470|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
105721917|NCT03538743|364636471|FG000|Overall Study|Adverse Event|0|||
105721918|NCT03538743|364636472|FG001|Overall Study|Adverse Event|0|||
105721919|NCT03538743|364636473|FG002|Overall Study|Adverse Event|1|||
105721920|NCT03538743|364636474|FG003|Overall Study|Adverse Event|1|||
105721921|NCT03538743|364636475|FG004|Overall Study|Adverse Event|0|||
105721922|NCT03538743|364636476|FG005|Overall Study|Adverse Event|0|||
105721923|NCT03538743|364636477|FG006|Overall Study|Adverse Event|0|||
105721924|NCT03538743|364636478|FG007|Overall Study|Adverse Event|0|||
105721925|NCT03538743|364636479|FG008|Overall Study|Adverse Event|0|||
105721926|NCT03538743|364636471|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
105721927|NCT03538743|364636472|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
105721928|NCT03538743|364636473|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
105721929|NCT03538743|364636474|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
105721930|NCT03538743|364636475|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
105721931|NCT03538743|364636476|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
105721932|NCT03538743|364636477|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
105721933|NCT03538743|364636478|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
105721934|NCT03538743|364636479|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
105721935|NCT03538743|364636471|FG000|Overall Study|Withdrawal by Subject|0|||
105721936|NCT03538743|364636472|FG001|Overall Study|Withdrawal by Subject|0|||
105721937|NCT03538743|364636473|FG002|Overall Study|Withdrawal by Subject|0|||
105721938|NCT03538743|364636474|FG003|Overall Study|Withdrawal by Subject|1|||
105721939|NCT03538743|364636475|FG004|Overall Study|Withdrawal by Subject|0|||
105721940|NCT03538743|364636476|FG005|Overall Study|Withdrawal by Subject|0|||
105721941|NCT03538743|364636477|FG006|Overall Study|Withdrawal by Subject|0|||
105721942|NCT03538743|364636478|FG007|Overall Study|Withdrawal by Subject|0|||
105721943|NCT03538743|364636479|FG008|Overall Study|Withdrawal by Subject|0|||
105721944|NCT01955707|364636480|FG000|Overall Study|Adverse Event|1|||
105721945|NCT01955707|364636481|FG001|Overall Study|Adverse Event|2|||
105721946|NCT01955707|364636480|FG000|Overall Study|Lost to Follow-up|2|||
105721947|NCT01955707|364636481|FG001|Overall Study|Lost to Follow-up|1|||
105721948|NCT01955707|364636480|FG000|Overall Study|Withdrawal by Subject|0|||
105721949|NCT01955707|364636481|FG001|Overall Study|Withdrawal by Subject|3|||
105721950|NCT01955707|364636480|FG000|Overall Study|Death|13|||
105721951|NCT01955707|364636481|FG001|Overall Study|Death|14|||
105721952|NCT01955707|364636480|FG000|Overall Study|Other|4|||
105721953|NCT01955707|364636481|FG001|Overall Study|Other|2|||
105721954|NCT01671345|364636482|FG000|Overall Study|Lost to Follow-up|10|||
105721955|NCT01671345|364636483|FG001|Overall Study|Lost to Follow-up|6|||
105721956|NCT01671345|364636482|FG000|Overall Study|visit with non-participating physician|3|||
105721957|NCT01671345|364636483|FG001|Overall Study|visit with non-participating physician|3|||
105721958|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
105721959|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
105721960|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
105721961|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
105721962|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
105721963|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
105721964|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
105721965|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
105721966|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
105721967|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
105721968|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
105721969|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
105721970|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
105721971|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
105721972|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
105721973|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
105721974|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
105721975|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
105721976|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
105721977|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
105721978|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
105721979|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
105721980|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
105721981|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
105721982|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
105721983|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
105721984|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
105721985|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
105721986|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
105721987|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
105721988|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
105721989|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
105721990|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
105721991|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
105721992|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
105721993|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
105721994|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
105721995|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
105721996|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
105721997|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
105721998|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
105721999|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
105722000|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
105722001|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
105722002|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
105722003|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
105722004|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
105722005|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
105722006|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
105562487|NCT01592370|364055996|FG000|Overall Study|Request to discontinue study treatment|5|||
105562488|NCT01592370|364055997|FG001|Overall Study|Request to discontinue study treatment|0|||
105562489|NCT01592370|364055998|FG002|Overall Study|Request to discontinue study treatment|2|||
105562490|NCT01592370|364055999|FG003|Overall Study|Request to discontinue study treatment|0|||
105562491|NCT01592370|364056000|FG004|Overall Study|Request to discontinue study treatment|1|||
105562492|NCT01592370|364056001|FG005|Overall Study|Request to discontinue study treatment|2|||
105562493|NCT01592370|364056002|FG006|Overall Study|Request to discontinue study treatment|0|||
105562494|NCT01592370|364055996|FG000|Overall Study|Withdrew consent|1|||
105562495|NCT01592370|364055997|FG001|Overall Study|Withdrew consent|2|||
105562496|NCT01592370|364055998|FG002|Overall Study|Withdrew consent|1|||
105562497|NCT01592370|364055999|FG003|Overall Study|Withdrew consent|1|||
105562498|NCT01592370|364056000|FG004|Overall Study|Withdrew consent|0|||
105562499|NCT01592370|364056001|FG005|Overall Study|Withdrew consent|0|||
105562500|NCT01592370|364056002|FG006|Overall Study|Withdrew consent|0|||
105562501|NCT01592370|364055996|FG000|Overall Study|Maximum clinical benefit|11|||
105562502|NCT01592370|364055997|FG001|Overall Study|Maximum clinical benefit|1|||
105562503|NCT01592370|364055998|FG002|Overall Study|Maximum clinical benefit|7|||
105562504|NCT01592370|364055999|FG003|Overall Study|Maximum clinical benefit|1|||
105562505|NCT01592370|364056000|FG004|Overall Study|Maximum clinical benefit|0|||
105562506|NCT01592370|364056001|FG005|Overall Study|Maximum clinical benefit|0|||
105562507|NCT01592370|364056002|FG006|Overall Study|Maximum clinical benefit|0|||
105562508|NCT01592370|364055996|FG000|Overall Study|No longer meets study criteria|1|||
105562509|NCT01592370|364055997|FG001|Overall Study|No longer meets study criteria|0|||
105562510|NCT01592370|364055998|FG002|Overall Study|No longer meets study criteria|0|||
105562511|NCT01592370|364055999|FG003|Overall Study|No longer meets study criteria|0|||
105562512|NCT01592370|364056000|FG004|Overall Study|No longer meets study criteria|0|||
105562513|NCT01592370|364056001|FG005|Overall Study|No longer meets study criteria|0|||
105562514|NCT01592370|364056002|FG006|Overall Study|No longer meets study criteria|0|||
105792530|NCT03869684|364896373|FG002|Overall Study|Withdrawal by Subject|0|||
105792531|NCT03869684|364896371|FG000|Overall Study|Lost to Follow-up|1|||
105562515|NCT01592370|364055996|FG000|Overall Study|Other Reasons|6|||
105562516|NCT01592370|364055997|FG001|Overall Study|Other Reasons|0|||
105562517|NCT01592370|364055998|FG002|Overall Study|Other Reasons|10|||
105562518|NCT01592370|364055999|FG003|Overall Study|Other Reasons|0|||
105792532|NCT03869684|364896372|FG001|Overall Study|Lost to Follow-up|0|||
105722007|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
105722008|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
105722009|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
105722010|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
105722011|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
105722012|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
105722013|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
105722014|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
105722015|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
105722016|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
105722017|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
105722018|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
105722019|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
105722020|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
105722021|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
105722022|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
105722023|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
105722024|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
105722025|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
105722026|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
105722027|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
105722028|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
105722029|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
105722030|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
105722031|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
105722032|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
105722033|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
105722034|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
105722035|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
105722036|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
105722037|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
105722038|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
105722039|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
105722040|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
105722041|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
105722042|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Death|0|||
105722043|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Death|0|||
105722044|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Death|0|||
105722045|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Death|2|||
105722046|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Death|0|||
105722047|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Death|0|||
105722048|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
105722049|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
105722050|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
105722051|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
105478326|NCT00281658|363764198|FG003|Open Label Phase|Withdrawal by Subject|2|||
105722052|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
105478327|NCT00281658|363764195|FG000|Open Label Phase|Disease progression|0|||
105478328|NCT00281658|363764196|FG001|Open Label Phase|Disease progression|0|||
105478329|NCT00281658|363764197|FG002|Open Label Phase|Disease progression|18|||
105478330|NCT00281658|363764198|FG003|Open Label Phase|Disease progression|0|||
105478331|NCT00281658|363764195|FG000|Open Label Phase|Physician Decision|0|||
105478332|NCT00281658|363764196|FG001|Open Label Phase|Physician Decision|0|||
105478333|NCT00281658|363764197|FG002|Open Label Phase|Physician Decision|1|||
105478334|NCT00281658|363764198|FG003|Open Label Phase|Physician Decision|0|||
105478335|NCT00281658|363764195|FG000|Open Label Phase|Relocation of patient|0|||
105722053|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
105478336|NCT00281658|363764196|FG001|Open Label Phase|Relocation of patient|0|||
105722054|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
105478337|NCT00281658|363764197|FG002|Open Label Phase|Relocation of patient|1|||
105478338|NCT00281658|363764198|FG003|Open Label Phase|Relocation of patient|0|||
105722055|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
105722056|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
105722057|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
105722058|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
105722059|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
105722060|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
105722061|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
105722062|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
105722063|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
105722064|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
105722065|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
105722066|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
105722067|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
105722068|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
105722069|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
105722070|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
105722071|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
105722072|NCT03313050|364636490|FG000|Stage 2: 12 Months|Adverse Event|0|||
105478339|NCT00281658|363764195|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
105478340|NCT00281658|363764196|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
105478341|NCT00281658|363764197|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
105478342|NCT00281658|363764198|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
105478343|NCT00507728|363764199|FG000|Randomization to Month 3|Lost to Follow-up|15|||
105478344|NCT00507728|363764200|FG001|Randomization to Month 3|Lost to Follow-up|14|||
105478345|NCT00507728|363764201|FG002|Randomization to Month 3|Lost to Follow-up|20|||
105478346|NCT00507728|363764199|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
105562519|NCT01592370|364056000|FG004|Overall Study|Other Reasons|0|||
105562520|NCT01592370|364056001|FG005|Overall Study|Other Reasons|1|||
105562521|NCT01592370|364056002|FG006|Overall Study|Other Reasons|0|||
105562522|NCT03538951|364056003|FG000|Overall Study|Withdrawal by Subject|1|||
105562523|NCT03538951|364056004|FG001|Overall Study|Withdrawal by Subject|2|||
105562524|NCT03076970|364057432|FG000|Washout Period 2|Adverse Event|0|||
105562525|NCT03076970|364057433|FG001|Washout Period 2|Adverse Event|0|||
105562526|NCT03076970|364057434|FG002|Washout Period 2|Adverse Event|0|||
105562527|NCT03076970|364057435|FG003|Washout Period 2|Adverse Event|0|||
105562528|NCT03076970|364057436|FG004|Washout Period 2|Adverse Event|1|||
105562529|NCT03076970|364057437|FG005|Washout Period 2|Adverse Event|0|||
105562530|NCT03076970|364057432|FG000|Period 3|Withdrawal by Subject|0|||
105722073|NCT03313050|364636491|FG001|Stage 2: 12 Months|Adverse Event|0|||
105478347|NCT00507728|363764200|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
105478348|NCT00507728|363764201|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
105478349|NCT04590248|363764202|FG000|Overall Study|Lost to Follow-up|1|||
105478350|NCT04590248|363764202|FG000|Overall Study|Withdrawal by Subject|16|||
105478351|NCT04590248|363764202|FG000|Overall Study|Other|2|||
105478352|NCT00813943|363764207|FG000|Overall Study|Ongoing at cut-off date|5|||
105478353|NCT00813943|363764208|FG001|Overall Study|Ongoing at cut-off date|5|||
105478354|NCT00813943|363764209|FG002|Overall Study|Ongoing at cut-off date|3|||
105478355|NCT01343693|363764210|FG000|Overall Study|Lost to Follow-up|9|||
105478356|NCT02704143|363764211|FG000|Overall Study|disease progression|10|||
105478357|NCT01235598|363764212|FG000|Overall Study|Adverse Event|0|||
105478358|NCT01235598|363764213|FG001|Overall Study|Adverse Event|3|||
105478359|NCT01235598|363764212|FG000|Overall Study|Lack of Efficacy|0|||
105478360|NCT01235598|363764213|FG001|Overall Study|Lack of Efficacy|1|||
105478361|NCT01235598|363764212|FG000|Overall Study|Withdrawal by Subject|1|||
105478362|NCT01235598|363764213|FG001|Overall Study|Withdrawal by Subject|0|||
105478363|NCT03680742|363764214|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
105478364|NCT04605991|363764221|FG000|Overall Study|Adverse Event|5|||
105478365|NCT04605991|363764221|FG000|Overall Study|Lack of Efficacy|1|||
105478366|NCT04605991|363764221|FG000|Overall Study|Lost to Follow-up|8|||
105478367|NCT04605991|363764221|FG000|Overall Study|Physician Decision|4|||
105478368|NCT04605991|363764221|FG000|Overall Study|Withdrawal by Subject|14|||
105478369|NCT04605991|363764221|FG000|Overall Study|Non-compliance with study|1|||
105478370|NCT01410357|363764222|FG000|Overall Study|Death|2|||
105478371|NCT01410357|363764223|FG001|Overall Study|Death|1|||
105478372|NCT01410357|363764222|FG000|Overall Study|Withdrawal by Subject|1|||
105478373|NCT01410357|363764223|FG001|Overall Study|Withdrawal by Subject|2|||
105478374|NCT01410357|363764222|FG000|Overall Study|Lost to Follow-up|23|||
105562531|NCT03076970|364057433|FG001|Period 3|Withdrawal by Subject|0|||
105562532|NCT03076970|364057434|FG002|Period 3|Withdrawal by Subject|0|||
105562533|NCT03076970|364057435|FG003|Period 3|Withdrawal by Subject|0|||
105562534|NCT03076970|364057436|FG004|Period 3|Withdrawal by Subject|0|||
105562535|NCT03076970|364057437|FG005|Period 3|Withdrawal by Subject|1|||
105722074|NCT03313050|364636492|FG002|Stage 2: 12 Months|Adverse Event|0|||
105722075|NCT03313050|364636493|FG003|Stage 2: 12 Months|Adverse Event|1|||
105722076|NCT03313050|364636490|FG000|Stage 2: 12 Months|Death|0|||
105722077|NCT03313050|364636491|FG001|Stage 2: 12 Months|Death|0|||
105722078|NCT03313050|364636492|FG002|Stage 2: 12 Months|Death|3|||
105722079|NCT03313050|364636493|FG003|Stage 2: 12 Months|Death|0|||
105722080|NCT03313050|364636490|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
105722081|NCT03313050|364636491|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
105722082|NCT03313050|364636492|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
105722083|NCT03313050|364636493|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
105722084|NCT03313050|364636490|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
105722085|NCT03313050|364636491|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
105722086|NCT03313050|364636492|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
105722087|NCT03313050|364636493|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
105722088|NCT03313050|364636490|FG000|Stage 2: 12 Months|Protocol deviation|0|||
105722089|NCT03313050|364636491|FG001|Stage 2: 12 Months|Protocol deviation|0|||
105722090|NCT03313050|364636492|FG002|Stage 2: 12 Months|Protocol deviation|7|||
105722091|NCT03313050|364636493|FG003|Stage 2: 12 Months|Protocol deviation|7|||
105722092|NCT03313050|364636490|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
105722093|NCT03313050|364636491|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
105722094|NCT03313050|364636492|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
105722095|NCT03313050|364636493|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
105722096|NCT03313050|364636490|FG000|Stage 2: 12 Months|Other|0|||
105722097|NCT03313050|364636491|FG001|Stage 2: 12 Months|Other|0|||
105722098|NCT03313050|364636492|FG002|Stage 2: 12 Months|Other|0|||
105722099|NCT03313050|364636493|FG003|Stage 2: 12 Months|Other|1|||
105722100|NCT01291017|364636494|FG000|Overall Study|Lost to Follow-up|2|||
105722101|NCT01291017|364636494|FG000|Overall Study|Withdrawal by Subject|3|||
105722102|NCT02847598|364636495|FG000|Overall Study|Adverse Event|0|||
105722103|NCT02847598|364636496|FG001|Overall Study|Adverse Event|0|||
105722104|NCT02847598|364636497|FG002|Overall Study|Adverse Event|0|||
105722105|NCT02847598|364636498|FG003|Overall Study|Adverse Event|0|||
105722106|NCT02847598|364636499|FG004|Overall Study|Adverse Event|0|||
105722107|NCT02847598|364636500|FG005|Overall Study|Adverse Event|0|||
105722108|NCT02847598|364636501|FG006|Overall Study|Adverse Event|0|||
105722109|NCT02847598|364636502|FG007|Overall Study|Adverse Event|1|||
105722110|NCT02847598|364636495|FG000|Overall Study|Consent withdrawn|2|||
105722111|NCT02847598|364636496|FG001|Overall Study|Consent withdrawn|0|||
105722112|NCT02847598|364636497|FG002|Overall Study|Consent withdrawn|0|||
105722113|NCT02847598|364636498|FG003|Overall Study|Consent withdrawn|4|||
105722114|NCT02847598|364636499|FG004|Overall Study|Consent withdrawn|3|||
105722115|NCT02847598|364636500|FG005|Overall Study|Consent withdrawn|2|||
105722116|NCT02847598|364636501|FG006|Overall Study|Consent withdrawn|1|||
105722117|NCT02847598|364636502|FG007|Overall Study|Consent withdrawn|3|||
105722118|NCT02847598|364636495|FG000|Overall Study|Death|3|||
105722119|NCT02847598|364636496|FG001|Overall Study|Death|0|||
105722120|NCT02847598|364636497|FG002|Overall Study|Death|0|||
105722121|NCT02847598|364636498|FG003|Overall Study|Death|0|||
105722122|NCT02847598|364636499|FG004|Overall Study|Death|0|||
105722123|NCT02847598|364636500|FG005|Overall Study|Death|0|||
105722124|NCT02847598|364636501|FG006|Overall Study|Death|0|||
105722125|NCT02847598|364636502|FG007|Overall Study|Death|0|||
105722126|NCT02847598|364636495|FG000|Overall Study|Lost to Follow-up|0|||
105722127|NCT02847598|364636496|FG001|Overall Study|Lost to Follow-up|0|||
105722128|NCT02847598|364636497|FG002|Overall Study|Lost to Follow-up|0|||
105722129|NCT02847598|364636498|FG003|Overall Study|Lost to Follow-up|0|||
105562536|NCT03076970|364057432|FG000|Period 3|Failure to meet I/E criteria|0|||
105562537|NCT03076970|364057433|FG001|Period 3|Failure to meet I/E criteria|0|||
105722130|NCT02847598|364636499|FG004|Overall Study|Lost to Follow-up|0|||
105722131|NCT02847598|364636500|FG005|Overall Study|Lost to Follow-up|1|||
105722132|NCT02847598|364636501|FG006|Overall Study|Lost to Follow-up|1|||
105722133|NCT02847598|364636502|FG007|Overall Study|Lost to Follow-up|0|||
105722134|NCT02292771|364636503|FG000|Overall Study|Withdrawal by Subject|2|||
105722135|NCT02292771|364636504|FG001|Overall Study|Withdrawal by Subject|1|||
105722136|NCT02292771|364636503|FG000|Overall Study|Lost to Follow-up|2|||
105722137|NCT02292771|364636504|FG001|Overall Study|Lost to Follow-up|1|||
105722138|NCT04280081|364636508|FG000|Overall Study|Adverse Event|4|||
105722139|NCT04280081|364636508|FG000|Overall Study|Death|2|||
105722140|NCT04280081|364636508|FG000|Overall Study|Progressive Disease|6|||
105722141|NCT06119191|364636509|FG000|Overall Study|Adverse Event|0|||
105562538|NCT03076970|364057434|FG002|Period 3|Failure to meet I/E criteria|0|||
105562539|NCT03076970|364057435|FG003|Period 3|Failure to meet I/E criteria|0|||
105722142|NCT06119191|364636510|FG001|Overall Study|Adverse Event|1|||
105722143|NCT06119191|364636509|FG000|Overall Study|Protocol Violation|1|||
105722144|NCT06119191|364636510|FG001|Overall Study|Protocol Violation|0|||
105722145|NCT02911688|364638624|FG000|Washout|Lost to Follow-up|1|||
105722146|NCT02911688|364638625|FG001|Washout|Lost to Follow-up|1|||
105722147|NCT02911688|364638624|FG000|Washout|Withdrawal by Subject|0|||
105562540|NCT03076970|364057436|FG004|Period 3|Failure to meet I/E criteria|1|||
105562541|NCT03076970|364057437|FG005|Period 3|Failure to meet I/E criteria|0|||
105562542|NCT01345630|364057438|FG000|Overall Study|Adverse Event|22|||
105562543|NCT01345630|364057439|FG001|Overall Study|Adverse Event|23|||
105562544|NCT01345630|364057438|FG000|Overall Study|Lost to Follow-up|17|||
105562545|NCT01345630|364057439|FG001|Overall Study|Lost to Follow-up|16|||
105562546|NCT01345630|364057438|FG000|Overall Study|Protocol Violation|4|||
105562547|NCT01345630|364057439|FG001|Overall Study|Protocol Violation|1|||
105562548|NCT01345630|364057438|FG000|Overall Study|Medication error without associated AE|0|||
105562549|NCT01345630|364057439|FG001|Overall Study|Medication error without associated AE|1|||
105562550|NCT01345630|364057438|FG000|Overall Study|Study terminated by sponsor|254|||
105562551|NCT01345630|364057439|FG001|Overall Study|Study terminated by sponsor|285|||
105562552|NCT01345630|364057438|FG000|Overall Study|Other reasons|6|||
105562553|NCT01345630|364057439|FG001|Overall Study|Other reasons|8|||
105562554|NCT01345630|364057438|FG000|Overall Study|Withdrawn due to pregnancy|1|||
105562555|NCT01345630|364057439|FG001|Overall Study|Withdrawn due to pregnancy|2|||
105562556|NCT01345630|364057438|FG000|Overall Study|No longer willing to participate|9|||
105562557|NCT01345630|364057439|FG001|Overall Study|No longer willing to participate|12|||
105562558|NCT01345630|364057438|FG000|Overall Study|Insufficient clinical response|48|||
105562559|NCT01345630|364057439|FG001|Overall Study|Insufficient clinical response|11|||
105562560|NCT02543658|364057440|FG000|Overall Study|Lack of Efficacy|0|||
105562561|NCT02543658|364057441|FG001|Overall Study|Lack of Efficacy|4|||
105562562|NCT00789815|364057442|FG000|Overall Study|Protocol Violation|6|||
105562563|NCT00789815|364057443|FG001|Overall Study|Protocol Violation|1|||
105562564|NCT00789815|364057442|FG000|Overall Study|Intubation due to massive bleeding|1|||
105562565|NCT00789815|364057443|FG001|Overall Study|Intubation due to massive bleeding|0|||
105562566|NCT01111123|364057450|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
105562567|NCT01111123|364057451|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
105562568|NCT01111123|364057450|FG000|Maintenance Phase|Lost to Follow-up|0|||
105562569|NCT01111123|364057451|FG001|Maintenance Phase|Lost to Follow-up|2|||
105562570|NCT03092375|364057456|FG000|Overall Study|Lack of Efficacy|0|||
105562571|NCT03092375|364057457|FG001|Overall Study|Lack of Efficacy|1|||
105562572|NCT03092375|364057458|FG002|Overall Study|Lack of Efficacy|1|||
105562573|NCT03092375|364057459|FG003|Overall Study|Lack of Efficacy|0|||
105562574|NCT01266850|364057461|FG000|Overall Study|Lost to Follow-up|19|||
105562575|NCT01266850|364057462|FG001|Overall Study|Lost to Follow-up|19|||
105562576|NCT01266850|364057463|FG002|Overall Study|Lost to Follow-up|13|||
105562577|NCT01266850|364057464|FG003|Overall Study|Lost to Follow-up|13|||
105562578|NCT01266850|364057465|FG004|Overall Study|Lost to Follow-up|12|||
105562579|NCT01266850|364057461|FG000|Overall Study|Withdrawal by Subject|8|||
105562580|NCT01266850|364057462|FG001|Overall Study|Withdrawal by Subject|9|||
105562581|NCT01266850|364057463|FG002|Overall Study|Withdrawal by Subject|6|||
105562582|NCT01266850|364057464|FG003|Overall Study|Withdrawal by Subject|9|||
105562583|NCT01266850|364057465|FG004|Overall Study|Withdrawal by Subject|12|||
105562584|NCT01266850|364057461|FG000|Overall Study|Physician Decision|3|||
105562585|NCT01266850|364057462|FG001|Overall Study|Physician Decision|6|||
105562586|NCT01266850|364057463|FG002|Overall Study|Physician Decision|4|||
105562587|NCT01266850|364057464|FG003|Overall Study|Physician Decision|4|||
105562588|NCT01266850|364057465|FG004|Overall Study|Physician Decision|3|||
105562589|NCT01266850|364057461|FG000|Overall Study|Protocol Violation|0|||
105562590|NCT01266850|364057462|FG001|Overall Study|Protocol Violation|1|||
105562591|NCT01266850|364057463|FG002|Overall Study|Protocol Violation|0|||
105562592|NCT01266850|364057464|FG003|Overall Study|Protocol Violation|1|||
105562593|NCT01266850|364057465|FG004|Overall Study|Protocol Violation|2|||
105562594|NCT01266850|364057461|FG000|Overall Study|Adverse Event|0|||
105562595|NCT01266850|364057462|FG001|Overall Study|Adverse Event|0|||
105562596|NCT01266850|364057463|FG002|Overall Study|Adverse Event|0|||
105562597|NCT01266850|364057464|FG003|Overall Study|Adverse Event|0|||
105562598|NCT01266850|364057465|FG004|Overall Study|Adverse Event|1|||
105562599|NCT01266850|364057461|FG000|Overall Study|Site Closure|0|||
105562600|NCT01266850|364057462|FG001|Overall Study|Site Closure|1|||
105562601|NCT01266850|364057463|FG002|Overall Study|Site Closure|1|||
105562602|NCT01266850|364057464|FG003|Overall Study|Site Closure|1|||
105562603|NCT01266850|364057465|FG004|Overall Study|Site Closure|0|||
105562604|NCT00553501|364057466|FG000|Overall Study|Adverse Event|2|||
105562605|NCT00553501|364057466|FG000|Overall Study|Death|1|||
105562606|NCT00553501|364057466|FG000|Overall Study|Progression|1|||
105562607|NCT00224770|364057470|FG000|Overall Study|Lost to Follow-up|4|||
105562608|NCT00224770|364057471|FG001|Overall Study|Lost to Follow-up|2|||
105562609|NCT00224770|364057472|FG002|Overall Study|Lost to Follow-up|0|||
105562610|NCT00662857|364057473|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
105562611|NCT00662857|364057474|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
105562612|NCT00662857|364057473|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
105562613|NCT00662857|364057474|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
105562614|NCT00662857|364057473|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
105562615|NCT00662857|364057474|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
105562616|NCT03315143|364057475|FG000|Overall Study|Death|240|||
105562617|NCT03315143|364057476|FG001|Overall Study|Death|246|||
105562618|NCT03315143|364057475|FG000|Overall Study|Withdrawal by Subject|57|||
105562619|NCT03315143|364057476|FG001|Overall Study|Withdrawal by Subject|68|||
105562620|NCT03315143|364057475|FG000|Overall Study|Site Terminated by Sponsor|256|||
105562621|NCT03315143|364057476|FG001|Overall Study|Site Terminated by Sponsor|282|||
105562622|NCT03315143|364057475|FG000|Overall Study|Study Terminated by Sponsor|4723|||
105562623|NCT03315143|364057476|FG001|Overall Study|Study Terminated by Sponsor|4664|||
105562624|NCT03315143|364057475|FG000|Overall Study|Reason not Specified|16|||
105562625|NCT03315143|364057476|FG001|Overall Study|Reason not Specified|32|||
105562626|NCT03040713|364057477|FG000|Overall Study|Positive amyloid scan|3|||
105562627|NCT00337272|364057478|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
105562628|NCT00337272|364057479|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
105562629|NCT00337272|364057478|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
105562630|NCT00337272|364057479|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
105562631|NCT00337272|364057478|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
105562632|NCT00337272|364057479|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
105562633|NCT00337272|364057478|FG000|Treatment Period|Non-compliance|1|||
105562634|NCT00337272|364057479|FG001|Treatment Period|Non-compliance|1|||
105562635|NCT00337272|364057478|FG000|Treatment Period|Withdrawal by Subject|0|||
105562636|NCT00337272|364057479|FG001|Treatment Period|Withdrawal by Subject|1|||
105562637|NCT00337272|364057478|FG000|Withdrawal Period|Non-compliance|0|||
105562638|NCT00337272|364057479|FG001|Withdrawal Period|Non-compliance|1|||
105562639|NCT01662063|364057482|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
105562640|NCT01662063|364057483|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
105562641|NCT01662063|364057484|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
105562642|NCT01662063|364057482|FG000|Overall Study|Lack of Efficacy|1|||
105562643|NCT01662063|364057483|FG001|Overall Study|Lack of Efficacy|6|||
105562644|NCT01662063|364057484|FG002|Overall Study|Lack of Efficacy|0|||
105562645|NCT01662063|364057482|FG000|Overall Study|Lost to Follow-up|0|||
105562646|NCT01662063|364057483|FG001|Overall Study|Lost to Follow-up|4|||
105562647|NCT01662063|364057484|FG002|Overall Study|Lost to Follow-up|0|||
105562648|NCT01662063|364057482|FG000|Overall Study|Protocol Violation|1|||
105562649|NCT01662063|364057483|FG001|Overall Study|Protocol Violation|0|||
105562650|NCT01662063|364057484|FG002|Overall Study|Protocol Violation|0|||
105562651|NCT01662063|364057482|FG000|Overall Study|Withdrawal by Subject|2|||
105562652|NCT01662063|364057483|FG001|Overall Study|Withdrawal by Subject|4|||
105562653|NCT01662063|364057484|FG002|Overall Study|Withdrawal by Subject|1|||
105562654|NCT01662063|364057482|FG000|Overall Study|Physician Decision|0|||
105562655|NCT01662063|364057483|FG001|Overall Study|Physician Decision|2|||
105562656|NCT01662063|364057484|FG002|Overall Study|Physician Decision|0|||
105722148|NCT02911688|364638625|FG001|Washout|Withdrawal by Subject|1|||
105722149|NCT00809328|364638626|FG000|Overall Study|Lack of Efficacy|18|||
105722150|NCT00809328|364638626|FG000|Overall Study|Adverse Event|6|||
105722151|NCT00809328|364638626|FG000|Overall Study|Protocol Violation|3|||
105722152|NCT00809328|364638626|FG000|Overall Study|Withdrawal by Subject|2|||
105722153|NCT01524991|364638629|FG000|Overall Study|Adverse Event|12|||
105722154|NCT01524991|364638629|FG000|Overall Study|Death|1|||
105722155|NCT01524991|364638629|FG000|Overall Study|Disease ProgressionDu|17|||
105722156|NCT01524991|364638629|FG000|Overall Study|Other complicating disease|1|||
105722157|NCT01524991|364638629|FG000|Overall Study|Withdrawal by Subject|2|||
105722158|NCT01524991|364638629|FG000|Overall Study|Symptomatic Deterioration|1|||
105722159|NCT01805180|364638632|FG000|Lead-in Donor Phase|screen failure|1|||
105722160|NCT01805180|364638633|FG001|Lead-in Donor Phase|screen failure|0|||
105722161|NCT01805180|364638634|FG002|Lead-in Donor Phase|screen failure|0|||
105722162|NCT02472847|364638637|FG000|Overall Study|Withdrawal by Subject|1|||
105722163|NCT02472847|364638638|FG001|Overall Study|Withdrawal by Subject|5|||
105722164|NCT00398112|364638639|FG000|Overall Study|Adverse Event|4|||
105562657|NCT01662063|364057482|FG000|Overall Study|Other|0|||
105562658|NCT01662063|364057483|FG001|Overall Study|Other|1|||
105562659|NCT01662063|364057484|FG002|Overall Study|Other|0|||
105722165|NCT00398112|364638639|FG000|Overall Study|Disease progression|9|||
105722166|NCT00398112|364638639|FG000|Overall Study|Alternative treatment|1|||
105722167|NCT00398112|364638639|FG000|Overall Study|Withdrawal by Subject|3|||
105722168|NCT00398112|364638639|FG000|Overall Study|Death|1|||
105722169|NCT00008385|364638640|FG000|Overall Study|Off treatment reasons not reported|79|||
105722170|NCT00008385|364638641|FG001|Overall Study|Off treatment reasons not reported|70|||
105562660|NCT00293267|364057489|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
105722171|NCT00008385|364638640|FG000|Overall Study|Progressive disease|52|||
105722172|NCT00008385|364638641|FG001|Overall Study|Progressive disease|117|||
105478375|NCT01410357|363764223|FG001|Overall Study|Lost to Follow-up|21|||
105722173|NCT00008385|364638640|FG000|Overall Study|Adverse Event|8|||
105722174|NCT00008385|364638641|FG001|Overall Study|Adverse Event|20|||
105722175|NCT00008385|364638640|FG000|Overall Study|Death|12|||
105722176|NCT00008385|364638641|FG001|Overall Study|Death|18|||
105722177|NCT00008385|364638640|FG000|Overall Study|Withdrawal by Subject|67|||
105722178|NCT00008385|364638641|FG001|Overall Study|Withdrawal by Subject|157|||
105722179|NCT00008385|364638640|FG000|Overall Study|Start non-protocol therapy|3|||
105722180|NCT00008385|364638641|FG001|Overall Study|Start non-protocol therapy|1|||
105722181|NCT00008385|364638640|FG000|Overall Study|Other complicating disease|17|||
105722182|NCT00008385|364638641|FG001|Overall Study|Other complicating disease|30|||
105722183|NCT00008385|364638640|FG000|Overall Study|Maximum dose reached|0|||
105722184|NCT00008385|364638641|FG001|Overall Study|Maximum dose reached|2|||
105722185|NCT00008385|364638640|FG000|Overall Study|Other|105|||
105722186|NCT00008385|364638641|FG001|Overall Study|Other|212|||
105722187|NCT00008385|364638640|FG000|Overall Study|Not start protocol therapy|44|||
105722188|NCT00008385|364638641|FG001|Overall Study|Not start protocol therapy|175|||
105722189|NCT05148884|364638642|FG000|Overall Study|Withdrawal by Subject|3|||
105722190|NCT05148884|364638643|FG001|Overall Study|Withdrawal by Subject|0|||
105722191|NCT05148884|364638642|FG000|Overall Study|Deep brain stimulation operation|0|||
105722192|NCT05148884|364638643|FG001|Overall Study|Deep brain stimulation operation|1|||
105722193|NCT00582556|364638644|FG000|Overall Study|Withdrawal by Subject|0|||
105722194|NCT00582556|364638645|FG001|Overall Study|Withdrawal by Subject|1|||
105722195|NCT00582556|364638646|FG002|Overall Study|Withdrawal by Subject|1|||
105722196|NCT00582556|364638644|FG000|Overall Study|Physician Decision|0|||
105722197|NCT00582556|364638645|FG001|Overall Study|Physician Decision|0|||
105722198|NCT00582556|364638646|FG002|Overall Study|Physician Decision|1|||
105722199|NCT01993888|364638649|FG000|Overall Study|Death|1|||
105722200|NCT01993888|364638650|FG001|Overall Study|Death|1|||
105722201|NCT01993888|364638649|FG000|Overall Study|Lost to Follow-up|1|||
105722202|NCT01993888|364638650|FG001|Overall Study|Lost to Follow-up|1|||
105722203|NCT01993888|364638649|FG000|Overall Study|Withdrawal by Subject|0|||
105722204|NCT01993888|364638650|FG001|Overall Study|Withdrawal by Subject|1|||
105722205|NCT01341457|364638651|FG000|Overall Study|Adverse Event|2|||
105722206|NCT01341457|364638652|FG001|Overall Study|Adverse Event|0|||
105722207|NCT00851903|364638653|FG000|Overall Study|Withdrawal by Subject|2|||
105722208|NCT03116113|364638656|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
105722209|NCT03116113|364638657|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
105722210|NCT03116113|364638658|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
105722211|NCT03116113|364638659|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
105722212|NCT03116113|364638660|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
105722213|NCT03116113|364638661|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
105722214|NCT03116113|364638662|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
105722215|NCT03116113|364638663|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
105722216|NCT03116113|364638664|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
105722217|NCT03480802|364638667|FG000|Overall Study|Lost to Follow-up|5|||
105722218|NCT03480802|364638668|FG001|Overall Study|Lost to Follow-up|1|||
105722219|NCT03480802|364638667|FG000|Overall Study|Withdrawal by Subject|2|||
105722220|NCT03480802|364638668|FG001|Overall Study|Withdrawal by Subject|1|||
105722221|NCT03480802|364638667|FG000|Overall Study|Relocated|0|||
105722222|NCT03480802|364638668|FG001|Overall Study|Relocated|1|||
105722223|NCT04437511|364638673|FG000|Overall Study|Adverse Event|50|||
105722224|NCT04437511|364638674|FG001|Overall Study|Adverse Event|21|||
105722225|NCT04437511|364638673|FG000|Overall Study|Death|15|||
105722226|NCT04437511|364638674|FG001|Overall Study|Death|10|||
105722227|NCT04437511|364638673|FG000|Overall Study|Lost to Follow-up|11|||
105722228|NCT04437511|364638674|FG001|Overall Study|Lost to Follow-up|11|||
105722229|NCT04437511|364638673|FG000|Overall Study|Physician Decision|19|||
105722230|NCT04437511|364638674|FG001|Overall Study|Physician Decision|10|||
105722231|NCT04437511|364638673|FG000|Overall Study|Progressive Disease|4|||
105722232|NCT04437511|364638674|FG001|Overall Study|Progressive Disease|7|||
105722233|NCT04437511|364638673|FG000|Overall Study|Withdrawal by Subject|111|||
105722234|NCT04437511|364638674|FG001|Overall Study|Withdrawal by Subject|94|||
105722235|NCT04437511|364638673|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
105722236|NCT04437511|364638674|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
105722237|NCT04437511|364638673|FG000|Overall Study|Continuing Study|7|||
105478376|NCT01523275|363764224|FG000|Overall Study|Lost to Follow-up|1|||
105722238|NCT04437511|364638674|FG001|Overall Study|Continuing Study|5|||
105478377|NCT01523275|363764225|FG001|Overall Study|Lost to Follow-up|2|||
105722239|NCT01874353|364638676|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
105722240|NCT01874353|364638677|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
105722241|NCT01874353|364638678|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
105722242|NCT01874353|364638679|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
105722243|NCT01874353|364638676|FG000|Overall Study|Lost to Follow-up|2|||
105562661|NCT00293267|364057490|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
105562662|NCT00293267|364057489|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
105562663|NCT00293267|364057490|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
105562664|NCT00293267|364057489|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
105562665|NCT00293267|364057490|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
105562666|NCT00293267|364057489|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
105562667|NCT00293267|364057490|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
105562668|NCT00293267|364057489|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
105562669|NCT00293267|364057490|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
105562670|NCT00293267|364057489|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
105562671|NCT00293267|364057490|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
105562672|NCT00293267|364057489|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
105562673|NCT00293267|364057490|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
105562674|NCT00293267|364057489|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
105562675|NCT00293267|364057490|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
105562676|NCT00293267|364057489|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
105562677|NCT00293267|364057490|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
105478378|NCT01523275|363764224|FG000|Overall Study|Withdrawal by Subject|1|||
105478379|NCT01523275|363764225|FG001|Overall Study|Withdrawal by Subject|0|||
105478380|NCT03263702|363764226|FG000|Overall Study|Lost to Follow-up|2|||
105478381|NCT03263702|363764227|FG001|Overall Study|Lost to Follow-up|2|||
105478382|NCT03263702|363764226|FG000|Overall Study|Withdrawal by Subject|1|||
105478383|NCT03263702|363764227|FG001|Overall Study|Withdrawal by Subject|2|||
105478384|NCT03598114|363764228|FG000|Overall Study|Staff turnover/left the program|3|||
105478385|NCT03598114|363764229|FG001|Overall Study|Staff turnover/left the program|39|||
105478386|NCT02527200|363764230|FG000|Overall Study|Withdrawal by Subject|3|||
105478387|NCT02527200|363764231|FG001|Overall Study|Withdrawal by Subject|2|||
105478388|NCT02527200|363764232|FG002|Overall Study|Withdrawal by Subject|1|||
105478389|NCT02527200|363764233|FG003|Overall Study|Withdrawal by Subject|0|||
105478390|NCT02527200|363764230|FG000|Overall Study|Unclassified|0|||
105478391|NCT02527200|363764231|FG001|Overall Study|Unclassified|1|||
105478392|NCT02527200|363764232|FG002|Overall Study|Unclassified|0|||
105478393|NCT02527200|363764233|FG003|Overall Study|Unclassified|0|||
105478394|NCT02527200|363764230|FG000|Overall Study|Lost to Follow-up|0|||
105478395|NCT02527200|363764231|FG001|Overall Study|Lost to Follow-up|0|||
105478396|NCT02527200|363764232|FG002|Overall Study|Lost to Follow-up|1|||
105478397|NCT02527200|363764233|FG003|Overall Study|Lost to Follow-up|0|||
105478398|NCT00874939|363764235|FG000|Overall Study|Study terminated|4|||
105478399|NCT02870933|363764236|FG000|Overall Study|Death|2|||
105478400|NCT02870933|363764237|FG001|Overall Study|Death|1|||
105478401|NCT02870933|363764236|FG000|Overall Study|Withdrawal by Subject|0|||
105478402|NCT02870933|363764237|FG001|Overall Study|Withdrawal by Subject|1|||
105478403|NCT00689117|363764238|FG000|Overall Study|Adverse Event|6|||
105478404|NCT00689117|363764239|FG001|Overall Study|Adverse Event|0|||
105478405|NCT00689117|363764240|FG002|Overall Study|Adverse Event|5|||
105478406|NCT00689117|363764241|FG003|Overall Study|Adverse Event|0|||
105478407|NCT00689117|363764238|FG000|Overall Study|Lost to Follow-up|26|||
105478408|NCT00689117|363764239|FG001|Overall Study|Lost to Follow-up|19|||
105478409|NCT00689117|363764240|FG002|Overall Study|Lost to Follow-up|17|||
105478410|NCT00689117|363764241|FG003|Overall Study|Lost to Follow-up|11|||
105478411|NCT00689117|363764238|FG000|Overall Study|Lack of Efficacy|1|||
105478412|NCT00689117|363764239|FG001|Overall Study|Lack of Efficacy|2|||
105478413|NCT00689117|363764240|FG002|Overall Study|Lack of Efficacy|2|||
105478414|NCT00689117|363764241|FG003|Overall Study|Lack of Efficacy|2|||
105478415|NCT00689117|363764238|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
105478416|NCT00689117|363764239|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
105478417|NCT00689117|363764240|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
105478418|NCT00689117|363764241|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
105478419|NCT00689117|363764238|FG000|Overall Study|Withdrawal by Subject|19|||
105722244|NCT01874353|364638677|FG001|Overall Study|Lost to Follow-up|2|||
105722245|NCT01874353|364638678|FG002|Overall Study|Lost to Follow-up|2|||
105722246|NCT01874353|364638679|FG003|Overall Study|Lost to Follow-up|0|||
105722247|NCT01874353|364638676|FG000|Overall Study|Death|110|||
105722248|NCT01874353|364638677|FG001|Overall Study|Death|60|||
105722249|NCT01874353|364638678|FG002|Overall Study|Death|13|||
105722250|NCT01874353|364638679|FG003|Overall Study|Death|7|||
105722251|NCT01874353|364638676|FG000|Overall Study|Withdrawal by Subject|13|||
105722252|NCT01874353|364638677|FG001|Overall Study|Withdrawal by Subject|11|||
105722253|NCT01874353|364638678|FG002|Overall Study|Withdrawal by Subject|0|||
105722254|NCT01874353|364638679|FG003|Overall Study|Withdrawal by Subject|0|||
105722255|NCT01323478|364638680|FG000|Overall Study|Adverse Event|7|||
105478420|NCT00689117|363764239|FG001|Overall Study|Withdrawal by Subject|18|||
105478421|NCT00689117|363764240|FG002|Overall Study|Withdrawal by Subject|26|||
105478422|NCT00689117|363764241|FG003|Overall Study|Withdrawal by Subject|13|||
105478423|NCT00689117|363764238|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
105478424|NCT00689117|363764239|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
105478425|NCT00689117|363764240|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
105478426|NCT00689117|363764241|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
105478427|NCT00689117|363764238|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
105478428|NCT00689117|363764239|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
105722256|NCT01323478|364638680|FG000|Overall Study|Lack of Efficacy|4|||
105722257|NCT01323478|364638680|FG000|Overall Study|Non-compliance With Study Product|3|||
105722258|NCT01323478|364638680|FG000|Overall Study|Protocol Violation|1|||
105722259|NCT01323478|364638680|FG000|Overall Study|Withdrawal of Consent|1|||
105722260|NCT01323478|364638680|FG000|Overall Study|Administrative or Other Reasons|8|||
105722261|NCT01256177|364638681|FG000|Overall Study|Withdrawal by Subject|23|||
105722262|NCT01256177|364638682|FG001|Overall Study|Withdrawal by Subject|22|||
105722263|NCT01256177|364638681|FG000|Overall Study|Lost to Follow-up|2|||
105722264|NCT01256177|364638682|FG001|Overall Study|Lost to Follow-up|2|||
105722265|NCT01256177|364638681|FG000|Overall Study|Adverse Event|8|||
105722266|NCT01256177|364638682|FG001|Overall Study|Adverse Event|9|||
105722267|NCT01256177|364638681|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
105722268|NCT01256177|364638682|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
105722269|NCT01256177|364638681|FG000|Overall Study|Condition under Investigation Worsened|1|||
105722270|NCT01256177|364638682|FG001|Overall Study|Condition under Investigation Worsened|0|||
105722271|NCT01256177|364638681|FG000|Overall Study|Lack of Efficacy|11|||
105722272|NCT01256177|364638682|FG001|Overall Study|Lack of Efficacy|2|||
105722273|NCT01256177|364638681|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
105722274|NCT01256177|364638682|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
105722275|NCT01596257|364638684|FG000|Overall Study|Inadequate Collection|23|||
105722276|NCT01596257|364638685|FG001|Overall Study|Inadequate Collection|19|||
105722277|NCT02507349|364638686|FG000|Overall Study|Death|12|||
105722278|NCT02507349|364638687|FG001|Overall Study|Death|16|||
105722279|NCT02507349|364638686|FG000|Overall Study|Withdrawal by Subject|1|||
105722280|NCT02507349|364638687|FG001|Overall Study|Withdrawal by Subject|1|||
105722281|NCT02507349|364638686|FG000|Overall Study|Lost to Follow-up|174|||
105722282|NCT02507349|364638687|FG001|Overall Study|Lost to Follow-up|144|||
105722283|NCT05172544|364638696|FG000|Overall Study|Withdrawal by Subject|1|||
105722284|NCT05172544|364638697|FG001|Overall Study|Withdrawal by Subject|0|||
105722285|NCT05172544|364638698|FG002|Overall Study|Withdrawal by Subject|0|||
105722286|NCT05172544|364638696|FG000|Overall Study|Physician Decision|0|||
105722287|NCT05172544|364638697|FG001|Overall Study|Physician Decision|0|||
105722288|NCT05172544|364638698|FG002|Overall Study|Physician Decision|1|||
105722289|NCT01662648|364638699|FG000|Overall Study|Death|1|||
105722290|NCT01662648|364638700|FG001|Overall Study|Death|3|||
105722291|NCT01662648|364638699|FG000|Overall Study|Adverse Event|40|||
105722292|NCT01662648|364638700|FG001|Overall Study|Adverse Event|37|||
105722293|NCT01662648|364638699|FG000|Overall Study|Lack of Efficacy|17|||
105722294|NCT01662648|364638700|FG001|Overall Study|Lack of Efficacy|16|||
105722295|NCT01662648|364638699|FG000|Overall Study|Participant ineligible to continue trial|1|||
105722296|NCT01662648|364638700|FG001|Overall Study|Participant ineligible to continue trial|1|||
105722297|NCT01662648|364638699|FG000|Overall Study|Lost to Follow-up|24|||
105722298|NCT01662648|364638700|FG001|Overall Study|Lost to Follow-up|36|||
105722299|NCT01662648|364638699|FG000|Overall Study|Withdrawal by Subject|36|||
105722300|NCT01662648|364638700|FG001|Overall Study|Withdrawal by Subject|53|||
105722301|NCT01662648|364638699|FG000|Overall Study|Participant non-compliant|16|||
105722302|NCT01662648|364638700|FG001|Overall Study|Participant non-compliant|20|||
105722303|NCT01662648|364638699|FG000|Overall Study|Other|8|||
105722304|NCT01662648|364638700|FG001|Overall Study|Other|11|||
105722305|NCT01662648|364638699|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
105722306|NCT01662648|364638700|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
105722307|NCT01662648|364638699|FG000|Overall Study|LOE and other reason unspecified|1|||
105722308|NCT01662648|364638700|FG001|Overall Study|LOE and other reason unspecified|0|||
105722309|NCT01662648|364638699|FG000|Overall Study|LOE and Participant non-compliant|0|||
105478429|NCT00689117|363764240|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105478430|NCT00689117|363764241|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105478431|NCT00689117|363764238|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
105478432|NCT00689117|363764239|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
105478433|NCT00689117|363764240|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
105722310|NCT01662648|364638700|FG001|Overall Study|LOE and Participant non-compliant|1|||
105722311|NCT01850615|364638701|FG000|Overall Study|Protocol Violation|4|||
105722312|NCT01850615|364638702|FG001|Overall Study|Protocol Violation|1|||
105478434|NCT00689117|363764241|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
105722313|NCT01850615|364638701|FG000|Overall Study|Adverse Event|2|||
105722314|NCT01850615|364638702|FG001|Overall Study|Adverse Event|1|||
105722315|NCT01850615|364638701|FG000|Overall Study|Withdrawal by Subject|3|||
105722316|NCT01850615|364638702|FG001|Overall Study|Withdrawal by Subject|1|||
105722317|NCT01850615|364638701|FG000|Overall Study|Lost to Follow-up|0|||
105722318|NCT01850615|364638702|FG001|Overall Study|Lost to Follow-up|1|||
105722319|NCT01850615|364638701|FG000|Overall Study|Unclassified|0|||
105792533|NCT03869684|364896373|FG002|Overall Study|Lost to Follow-up|0|||
105792534|NCT03869684|364896371|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
105792535|NCT03869684|364896372|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
105792536|NCT03869684|364896373|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
105792537|NCT01005680|364896374|FG000|Overall Study|Lost to Follow-up|4|||
105792538|NCT01005680|364896375|FG001|Overall Study|Lost to Follow-up|6|||
105792539|NCT01005680|364896374|FG000|Overall Study|Withdrawal by Subject|1|||
105792540|NCT01005680|364896375|FG001|Overall Study|Withdrawal by Subject|4|||
105792541|NCT01005680|364896374|FG000|Overall Study|Physician Decision|1|||
105792542|NCT01005680|364896375|FG001|Overall Study|Physician Decision|1|||
105792543|NCT04840901|364896378|FG000|Overall Study|Lost to Follow-up|3|||
105792544|NCT04840901|364896379|FG001|Overall Study|Lost to Follow-up|1|||
105792545|NCT04840901|364896378|FG000|Overall Study|Moved|1|||
105792546|NCT04840901|364896379|FG001|Overall Study|Moved|0|||
105792547|NCT04840901|364896378|FG000|Overall Study|Unable to comply with study schedule|0|||
105792548|NCT04840901|364896379|FG001|Overall Study|Unable to comply with study schedule|1|||
105792549|NCT04840901|364896378|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
105792550|NCT04840901|364896379|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
105792551|NCT01268683|364896382|FG000|Overall Study|Lost to Follow-up|1|||
105792552|NCT01268683|364896382|FG000|Overall Study|Death|1|||
105792553|NCT02216214|364896383|FG000|Overall Study|Randomized Never Received Study Drug|1|||
105792554|NCT02216214|364896384|FG001|Overall Study|Randomized Never Received Study Drug|0|||
105792555|NCT02216214|364896383|FG000|Overall Study|Adverse Event|10|||
105792556|NCT02216214|364896384|FG001|Overall Study|Adverse Event|8|||
105792557|NCT02216214|364896383|FG000|Overall Study|Lack of Efficacy|2|||
105792558|NCT02216214|364896384|FG001|Overall Study|Lack of Efficacy|2|||
105792559|NCT02216214|364896383|FG000|Overall Study|Lost to Follow-up|3|||
105792560|NCT02216214|364896384|FG001|Overall Study|Lost to Follow-up|2|||
105792561|NCT02216214|364896383|FG000|Overall Study|Protocol Violation|4|||
105792562|NCT02216214|364896384|FG001|Overall Study|Protocol Violation|2|||
105478435|NCT00689117|363764238|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
105478436|NCT00689117|363764239|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
105478437|NCT00689117|363764240|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
105478438|NCT00689117|363764241|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
105478439|NCT00689117|363764238|FG000|Overall Study|Use of Prohibitive Medication|2|||
105478440|NCT00689117|363764239|FG001|Overall Study|Use of Prohibitive Medication|1|||
105478441|NCT00689117|363764240|FG002|Overall Study|Use of Prohibitive Medication|3|||
105478442|NCT00689117|363764241|FG003|Overall Study|Use of Prohibitive Medication|0|||
105478443|NCT00689117|363764238|FG000|Overall Study|Pregnancy|0|||
105478444|NCT00689117|363764239|FG001|Overall Study|Pregnancy|2|||
105478445|NCT00689117|363764240|FG002|Overall Study|Pregnancy|0|||
105478446|NCT00689117|363764241|FG003|Overall Study|Pregnancy|2|||
105478447|NCT00689117|363764238|FG000|Overall Study|Incarceration|2|||
105478448|NCT00689117|363764239|FG001|Overall Study|Incarceration|0|||
105478449|NCT00689117|363764240|FG002|Overall Study|Incarceration|0|||
105562678|NCT00293267|364057489|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
105792563|NCT02216214|364896383|FG000|Overall Study|Withdrawal by Subject|22|||
105478450|NCT00689117|363764241|FG003|Overall Study|Incarceration|0|||
105478451|NCT00689117|363764238|FG000|Overall Study|Fear of Birth Defects|0|||
105722320|NCT01850615|364638702|FG001|Overall Study|Unclassified|1|||
105722321|NCT00332202|364638704|FG000|Overall Study|Adverse Event|72|||
105722322|NCT00332202|364638705|FG001|Overall Study|Adverse Event|28|||
105722323|NCT00332202|364638704|FG000|Overall Study|Lost to Follow-up|2|||
105722324|NCT00332202|364638705|FG001|Overall Study|Lost to Follow-up|1|||
105722325|NCT00332202|364638704|FG000|Overall Study|Physician Decision|6|||
105722326|NCT00332202|364638705|FG001|Overall Study|Physician Decision|8|||
105722327|NCT00332202|364638704|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
105722328|NCT00332202|364638705|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
105722329|NCT00332202|364638704|FG000|Overall Study|Protocol Violation|7|||
105722330|NCT00332202|364638705|FG001|Overall Study|Protocol Violation|2|||
105722331|NCT00332202|364638704|FG000|Overall Study|Sponsor Decision|1|||
105722332|NCT00332202|364638705|FG001|Overall Study|Sponsor Decision|2|||
105722333|NCT00332202|364638704|FG000|Overall Study|Withdrawal by Subject|36|||
105722334|NCT00332202|364638705|FG001|Overall Study|Withdrawal by Subject|17|||
105722335|NCT00332202|364638704|FG000|Overall Study|Progressive Disease|106|||
105722336|NCT00332202|364638705|FG001|Overall Study|Progressive Disease|60|||
105722337|NCT00332202|364638704|FG000|Overall Study|Death|5|||
105722338|NCT00332202|364638705|FG001|Overall Study|Death|2|||
105722339|NCT00490542|364638707|FG000|Overall Study|Lost to Follow-up|3|||
105722340|NCT00490542|364638708|FG001|Overall Study|Lost to Follow-up|0|||
105722341|NCT00490542|364638707|FG000|Overall Study|Adverse Event|3|||
105722342|NCT00490542|364638708|FG001|Overall Study|Adverse Event|3|||
105722343|NCT00490542|364638707|FG000|Overall Study|Lack of Efficacy|1|||
105722344|NCT00490542|364638708|FG001|Overall Study|Lack of Efficacy|1|||
105722345|NCT04696861|364638709|FG000|Overall Study|Death|1|||
105722346|NCT04696861|364638710|FG001|Overall Study|Death|0|||
105722347|NCT04696861|364638709|FG000|Overall Study|Lost to Follow-up|3|||
105722348|NCT04696861|364638710|FG001|Overall Study|Lost to Follow-up|0|||
105722349|NCT01813890|364638712|FG000|Overall Study|Adverse Event|0|||
105722350|NCT01813890|364638713|FG001|Overall Study|Adverse Event|3|||
105722351|NCT01813890|364638714|FG002|Overall Study|Adverse Event|4|||
105722352|NCT01813890|364638712|FG000|Overall Study|Lack of Efficacy|9|||
105722353|NCT01813890|364638713|FG001|Overall Study|Lack of Efficacy|1|||
105722354|NCT01813890|364638714|FG002|Overall Study|Lack of Efficacy|2|||
105722355|NCT04439123|364638715|FG000|Overall Study|Adverse Event|11|||
105722356|NCT04439123|364638715|FG000|Overall Study|Death|1|||
105722357|NCT04439123|364638715|FG000|Overall Study|Disease progression|19|||
105722358|NCT04439123|364638715|FG000|Overall Study|Withdrawal by Subject|2|||
105722359|NCT04439123|364638715|FG000|Overall Study|Still on treatment|2|||
105722360|NCT04343651|364638716|FG000|Overall Study|Physician Decision|2|||
105722361|NCT04343651|364638717|FG001|Overall Study|Physician Decision|1|||
105722362|NCT04343651|364638716|FG000|Overall Study|Lost to Follow-up|2|||
105722363|NCT04343651|364638717|FG001|Overall Study|Lost to Follow-up|1|||
105722364|NCT04343651|364638716|FG000|Overall Study|Protocol Violation|4|||
105722365|NCT04343651|364638717|FG001|Overall Study|Protocol Violation|6|||
105722366|NCT04343651|364638716|FG000|Overall Study|Missing|3|||
105722367|NCT04343651|364638717|FG001|Overall Study|Missing|9|||
105722368|NCT04343651|364638716|FG000|Overall Study|Withdrawal by Subject|0|||
105722369|NCT04343651|364638717|FG001|Overall Study|Withdrawal by Subject|4|||
105722370|NCT04343651|364638716|FG000|Overall Study|Death|0|||
105722371|NCT04343651|364638717|FG001|Overall Study|Death|1|||
105722372|NCT04343651|364638716|FG000|Overall Study|Did not start treatment|1|||
105722373|NCT04343651|364638717|FG001|Overall Study|Did not start treatment|1|||
105722374|NCT04343651|364638716|FG000|Overall Study|Patient did not complete visits 3-6|0|||
105722375|NCT04343651|364638717|FG001|Overall Study|Patient did not complete visits 3-6|1|||
105722376|NCT02246621|364638718|FG000|Overall Study|Withdrawal by Subject|28|||
105722377|NCT02246621|364638719|FG001|Overall Study|Withdrawal by Subject|16|||
105722378|NCT02246621|364638718|FG000|Overall Study|Lost to Follow-up|1|||
105722379|NCT02246621|364638719|FG001|Overall Study|Lost to Follow-up|0|||
105722380|NCT02246621|364638718|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
105722381|NCT02246621|364638719|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
105722382|NCT02875223|364638720|FG000|Overall Study|Other reasons|0|||
105722383|NCT02875223|364638721|FG001|Overall Study|Other reasons|0|||
105722384|NCT02875223|364638722|FG002|Overall Study|Other reasons|1|||
105722385|NCT02875223|364638723|FG003|Overall Study|Other reasons|0|||
105722386|NCT02875223|364638724|FG004|Overall Study|Other reasons|1|||
105722387|NCT02875223|364638725|FG005|Overall Study|Other reasons|2|||
105722388|NCT02875223|364638726|FG006|Overall Study|Other reasons|0|||
105722389|NCT02875223|364638727|FG007|Overall Study|Other reasons|2|||
105722390|NCT02875223|364638728|FG008|Overall Study|Other reasons|0|||
105722391|NCT02875223|364638729|FG009|Overall Study|Other reasons|0|||
105722392|NCT02875223|364638730|FG010|Overall Study|Other reasons|0|||
105722393|NCT02875223|364638731|FG011|Overall Study|Other reasons|0|||
105722394|NCT02875223|364638732|FG012|Overall Study|Other reasons|0|||
105722395|NCT02875223|364638720|FG000|Overall Study|Withdrawal by Subject|0|||
105722396|NCT02875223|364638721|FG001|Overall Study|Withdrawal by Subject|0|||
105562679|NCT00293267|364057490|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
105562680|NCT00293267|364057489|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
105562681|NCT00293267|364057490|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
105562682|NCT00293267|364057489|FG000|Extension - Double-Blind Week 49-156|Death|3|||
105562683|NCT00293267|364057490|FG001|Extension - Double-Blind Week 49-156|Death|0|||
105562684|NCT00293267|364057489|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
105562685|NCT00293267|364057490|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
105562686|NCT00293267|364057489|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
105562687|NCT00293267|364057490|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
105562688|NCT00293267|364057489|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
105562689|NCT00293267|364057490|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
105562690|NCT00293267|364057489|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
105562691|NCT00293267|364057490|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
105562692|NCT00293267|364057489|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
105562693|NCT00293267|364057490|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
105562694|NCT00293267|364057489|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
105562695|NCT00293267|364057490|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
105562696|NCT00293267|364057489|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
105562697|NCT00293267|364057490|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
105562698|NCT00293267|364057489|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
105562699|NCT00293267|364057490|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
105562700|NCT00293267|364057489|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
105562701|NCT00293267|364057490|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
105562702|NCT00293267|364057489|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
105562703|NCT00293267|364057490|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
105562704|NCT00293267|364057489|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
105562705|NCT00293267|364057490|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
105562706|NCT00293267|364057489|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
105562707|NCT00293267|364057490|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
105562708|NCT00293267|364057489|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
105562709|NCT00293267|364057490|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
105562710|NCT00293267|364057489|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
105562711|NCT00293267|364057490|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
105562712|NCT00293267|364057489|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
105562713|NCT00293267|364057490|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
105562714|NCT00293267|364057489|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
105562715|NCT00293267|364057490|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
105562716|NCT01050816|364057491|FG000|Overall Study|Lost to Follow-up|2|||
105562717|NCT01050816|364057491|FG000|Overall Study|patient's refusal|2|||
105562718|NCT00677352|364057494|FG000|Treatment Phase|Adverse Event|14|||
105478452|NCT00689117|363764239|FG001|Overall Study|Fear of Birth Defects|0|||
105478453|NCT00689117|363764240|FG002|Overall Study|Fear of Birth Defects|1|||
105478454|NCT00689117|363764241|FG003|Overall Study|Fear of Birth Defects|0|||
105478455|NCT00689117|363764238|FG000|Overall Study|Transportation|1|||
105478456|NCT00689117|363764239|FG001|Overall Study|Transportation|0|||
105478457|NCT00689117|363764240|FG002|Overall Study|Transportation|0|||
105478458|NCT00689117|363764241|FG003|Overall Study|Transportation|0|||
105478459|NCT00689117|363764238|FG000|Overall Study|Patient Withdrew from Study|0|||
105478460|NCT00689117|363764239|FG001|Overall Study|Patient Withdrew from Study|0|||
105478461|NCT00689117|363764240|FG002|Overall Study|Patient Withdrew from Study|0|||
105478462|NCT00689117|363764241|FG003|Overall Study|Patient Withdrew from Study|1|||
105478463|NCT00689117|363764238|FG000|Overall Study|Personal Reason|0|||
105478464|NCT00689117|363764239|FG001|Overall Study|Personal Reason|1|||
105478465|NCT00689117|363764240|FG002|Overall Study|Personal Reason|0|||
105478466|NCT00689117|363764241|FG003|Overall Study|Personal Reason|0|||
105478467|NCT00689117|363764238|FG000|Overall Study|Dispensing Error|0|||
105478468|NCT00689117|363764239|FG001|Overall Study|Dispensing Error|1|||
105478469|NCT00689117|363764240|FG002|Overall Study|Dispensing Error|0|||
105478470|NCT00689117|363764241|FG003|Overall Study|Dispensing Error|0|||
105478471|NCT01332799|363764247|FG000|Overall Study|Insufficient funding|10|||
105478472|NCT01332799|363764248|FG001|Overall Study|Insufficient funding|10|||
105478473|NCT00294762|363764258|FG000|Overall Study|Did not receive study treatment|3|||
105478474|NCT00294762|363764259|FG001|Overall Study|Did not receive study treatment|3|||
105478475|NCT00505076|363764261|FG000|Overall Study|Adverse Event|1|||
105478476|NCT00505076|363764262|FG001|Overall Study|Adverse Event|0|||
105478477|NCT00505076|363764263|FG002|Overall Study|Adverse Event|1|||
105478478|NCT00505076|363764261|FG000|Overall Study|Protocol Violation|2|||
105478479|NCT00505076|363764262|FG001|Overall Study|Protocol Violation|1|||
105478480|NCT00505076|363764263|FG002|Overall Study|Protocol Violation|2|||
105478481|NCT00505076|363764261|FG000|Overall Study|Withdrawal by Subject|0|||
105722397|NCT02875223|364638722|FG002|Overall Study|Withdrawal by Subject|0|||
105722398|NCT02875223|364638723|FG003|Overall Study|Withdrawal by Subject|0|||
105722399|NCT02875223|364638724|FG004|Overall Study|Withdrawal by Subject|1|||
105722400|NCT02875223|364638725|FG005|Overall Study|Withdrawal by Subject|1|||
105722401|NCT02875223|364638726|FG006|Overall Study|Withdrawal by Subject|0|||
105722402|NCT02875223|364638727|FG007|Overall Study|Withdrawal by Subject|0|||
105722403|NCT02875223|364638728|FG008|Overall Study|Withdrawal by Subject|1|||
105722404|NCT02875223|364638729|FG009|Overall Study|Withdrawal by Subject|0|||
105722405|NCT02875223|364638730|FG010|Overall Study|Withdrawal by Subject|0|||
105722406|NCT02875223|364638731|FG011|Overall Study|Withdrawal by Subject|0|||
105722407|NCT02875223|364638732|FG012|Overall Study|Withdrawal by Subject|0|||
105722408|NCT02875223|364638720|FG000|Overall Study|Progressive disease|0|||
105722409|NCT02875223|364638721|FG001|Overall Study|Progressive disease|0|||
105722410|NCT02875223|364638722|FG002|Overall Study|Progressive disease|1|||
105722411|NCT02875223|364638723|FG003|Overall Study|Progressive disease|0|||
105722412|NCT02875223|364638724|FG004|Overall Study|Progressive disease|0|||
105722413|NCT02875223|364638725|FG005|Overall Study|Progressive disease|0|||
105722414|NCT02875223|364638726|FG006|Overall Study|Progressive disease|0|||
105722415|NCT02875223|364638727|FG007|Overall Study|Progressive disease|0|||
105722416|NCT02875223|364638728|FG008|Overall Study|Progressive disease|0|||
105722417|NCT02875223|364638729|FG009|Overall Study|Progressive disease|12|||
105722418|NCT02875223|364638730|FG010|Overall Study|Progressive disease|2|||
105722419|NCT02875223|364638731|FG011|Overall Study|Progressive disease|3|||
105722420|NCT02875223|364638732|FG012|Overall Study|Progressive disease|6|||
105722421|NCT02875223|364638720|FG000|Overall Study|Death|4|||
105722422|NCT02875223|364638721|FG001|Overall Study|Death|4|||
105722423|NCT02875223|364638722|FG002|Overall Study|Death|3|||
105722424|NCT02875223|364638723|FG003|Overall Study|Death|4|||
105722425|NCT02875223|364638724|FG004|Overall Study|Death|2|||
105722426|NCT02875223|364638725|FG005|Overall Study|Death|3|||
105722427|NCT02875223|364638726|FG006|Overall Study|Death|5|||
105722428|NCT02875223|364638727|FG007|Overall Study|Death|7|||
105722429|NCT02875223|364638728|FG008|Overall Study|Death|3|||
105722430|NCT02875223|364638729|FG009|Overall Study|Death|2|||
105722431|NCT02875223|364638730|FG010|Overall Study|Death|0|||
105722432|NCT02875223|364638731|FG011|Overall Study|Death|0|||
105722433|NCT02875223|364638732|FG012|Overall Study|Death|0|||
105722434|NCT02875223|364638720|FG000|Overall Study|Lost to Follow-up|0|||
105722435|NCT02875223|364638721|FG001|Overall Study|Lost to Follow-up|1|||
105722436|NCT02875223|364638722|FG002|Overall Study|Lost to Follow-up|1|||
105722437|NCT02875223|364638723|FG003|Overall Study|Lost to Follow-up|0|||
105722438|NCT02875223|364638724|FG004|Overall Study|Lost to Follow-up|1|||
105722439|NCT02875223|364638725|FG005|Overall Study|Lost to Follow-up|0|||
105722440|NCT02875223|364638726|FG006|Overall Study|Lost to Follow-up|1|||
105722441|NCT02875223|364638727|FG007|Overall Study|Lost to Follow-up|1|||
105722442|NCT02875223|364638728|FG008|Overall Study|Lost to Follow-up|0|||
105722443|NCT02875223|364638729|FG009|Overall Study|Lost to Follow-up|0|||
105722444|NCT02875223|364638730|FG010|Overall Study|Lost to Follow-up|0|||
105722445|NCT02875223|364638731|FG011|Overall Study|Lost to Follow-up|0|||
105722446|NCT02875223|364638732|FG012|Overall Study|Lost to Follow-up|0|||
105722447|NCT01565980|364638735|FG000|Overall Study|Death|1|||
105722448|NCT01565980|364638736|FG001|Overall Study|Death|0|||
105722449|NCT01565980|364638735|FG000|Overall Study|Lost to Follow-up|1|||
105722450|NCT01565980|364638736|FG001|Overall Study|Lost to Follow-up|0|||
105722451|NCT01565980|364638735|FG000|Overall Study|health complications|1|||
105722452|NCT01565980|364638736|FG001|Overall Study|health complications|1|||
105722453|NCT01565980|364638735|FG000|Overall Study|stopped medical treatment|1|||
105722454|NCT01565980|364638736|FG001|Overall Study|stopped medical treatment|0|||
105722455|NCT01565980|364638735|FG000|Overall Study|Withdrawal by Subject|0|||
105722456|NCT01565980|364638736|FG001|Overall Study|Withdrawal by Subject|3|||
105722457|NCT01929135|364638740|FG000|Overall Study|Lost to Follow-up|1|||
105722458|NCT01929135|364638741|FG001|Overall Study|Lost to Follow-up|1|||
105722459|NCT02078219|364638751|FG000|Overall Study|Other|2|||
105722460|NCT02078219|364638752|FG001|Overall Study|Other|2|||
105722461|NCT02078219|364638753|FG002|Overall Study|Other|3|||
105722462|NCT02078219|364638754|FG003|Overall Study|Other|0|||
105722463|NCT02078219|364638755|FG004|Overall Study|Other|1|||
105722464|NCT02078219|364638751|FG000|Overall Study|Withdrawal by Subject|0|||
105722465|NCT02078219|364638752|FG001|Overall Study|Withdrawal by Subject|1|||
105722466|NCT02078219|364638753|FG002|Overall Study|Withdrawal by Subject|0|||
105722467|NCT02078219|364638754|FG003|Overall Study|Withdrawal by Subject|1|||
105722468|NCT02078219|364638755|FG004|Overall Study|Withdrawal by Subject|1|||
105722469|NCT02078219|364638751|FG000|Overall Study|Protocol Violation|0|||
105722470|NCT02078219|364638752|FG001|Overall Study|Protocol Violation|0|||
105352862|NCT01306214|363297001|FG002|Overall Study|Not treated|1|||
105722471|NCT02078219|364638753|FG002|Overall Study|Protocol Violation|0|||
105722472|NCT02078219|364638754|FG003|Overall Study|Protocol Violation|1|||
105562719|NCT00677352|364057495|FG001|Treatment Phase|Adverse Event|22|||
105562720|NCT00677352|364057494|FG000|Treatment Phase|Lack of Efficacy|2|||
105562721|NCT00677352|364057495|FG001|Treatment Phase|Lack of Efficacy|3|||
105562722|NCT00677352|364057494|FG000|Treatment Phase|Lost to Follow-up|0|||
105562723|NCT00677352|364057495|FG001|Treatment Phase|Lost to Follow-up|1|||
105562724|NCT00677352|364057494|FG000|Treatment Phase|Withdrawal by Subject|7|||
105562725|NCT00677352|364057495|FG001|Treatment Phase|Withdrawal by Subject|7|||
105562726|NCT00677352|364057494|FG000|Treatment Phase|Physician Decision|1|||
105562727|NCT00677352|364057495|FG001|Treatment Phase|Physician Decision|0|||
105562728|NCT00677352|364057494|FG000|Treatment Phase|Pregnancy|0|||
105562729|NCT00677352|364057495|FG001|Treatment Phase|Pregnancy|1|||
105562730|NCT00677352|364057494|FG000|Treatment Phase|Protocol Violation|1|||
105562731|NCT00677352|364057495|FG001|Treatment Phase|Protocol Violation|1|||
105562732|NCT00677352|364057494|FG000|Treatment Phase|Transference or work related matter|0|||
105562733|NCT00677352|364057495|FG001|Treatment Phase|Transference or work related matter|5|||
105562734|NCT00677352|364057494|FG000|Treatment Phase|Not treated|0|||
105562735|NCT00677352|364057495|FG001|Treatment Phase|Not treated|2|||
105562736|NCT00677352|364057494|FG000|Tapering Phase|Adverse Event|1|||
105562737|NCT00677352|364057495|FG001|Tapering Phase|Adverse Event|5|||
105562738|NCT00677352|364057494|FG000|Tapering Phase|Withdrawal by Subject|5|||
105562739|NCT00677352|364057495|FG001|Tapering Phase|Withdrawal by Subject|3|||
105562740|NCT00677352|364057494|FG000|Tapering Phase|Pregnancy|0|||
105562741|NCT00677352|364057495|FG001|Tapering Phase|Pregnancy|1|||
105562742|NCT00677352|364057494|FG000|Tapering Phase|Job transfer|0|||
105562743|NCT00677352|364057495|FG001|Tapering Phase|Job transfer|1|||
105562744|NCT02182973|364057496|FG000|Overall Study|Withdrawal by Subject|3|||
105562745|NCT02182973|364057497|FG001|Overall Study|Withdrawal by Subject|0|||
105562746|NCT01235546|364057498|FG000|Overall Study|Staff error, medication not administered|1|||
105562747|NCT01235546|364057499|FG001|Overall Study|Staff error, medication not administered|0|||
105562748|NCT01235546|364057498|FG000|Overall Study|Protocol Violation|1|||
105562749|NCT01235546|364057499|FG001|Overall Study|Protocol Violation|1|||
105562750|NCT01123382|364057500|FG000|Overall Study|Withdrawal by Subject|1|||
105562751|NCT01123382|364057501|FG001|Overall Study|Withdrawal by Subject|4|||
105562752|NCT01123382|364057500|FG000|Overall Study|Lost to Follow-up|1|||
105562753|NCT01123382|364057501|FG001|Overall Study|Lost to Follow-up|2|||
105562754|NCT00238433|364057502|FG000|Overall Study|Screen failure|1|||
105562755|NCT00238433|364057502|FG000|Overall Study|Lost to Follow-up|1|||
105562756|NCT00238433|364057502|FG000|Overall Study|Death|1|||
105562757|NCT02274857|364057503|FG000|Overall Study|Adverse Event|1|||
105562758|NCT02274857|364057504|FG001|Overall Study|Adverse Event|0|||
105562759|NCT02274857|364057503|FG000|Overall Study|Death|1|||
105562760|NCT02274857|364057504|FG001|Overall Study|Death|2|||
105562761|NCT02274857|364057503|FG000|Overall Study|Lost to Follow-up|3|||
105792564|NCT02216214|364896384|FG001|Overall Study|Withdrawal by Subject|20|||
105562762|NCT02274857|364057504|FG001|Overall Study|Lost to Follow-up|0|||
105792565|NCT02216214|364896383|FG000|Overall Study|Study Terminated By Sponsor|0|||
105792566|NCT02216214|364896384|FG001|Overall Study|Study Terminated By Sponsor|1|||
105792567|NCT02216214|364896383|FG000|Overall Study|Miscellaneous|1|||
105792568|NCT02216214|364896384|FG001|Overall Study|Miscellaneous|1|||
105792569|NCT00713830|364896387|FG000|Overall Study|Adverse Event|23|||
105792570|NCT00713830|364896388|FG001|Overall Study|Adverse Event|71|||
105792571|NCT00713830|364896387|FG000|Overall Study|Lack of Efficacy|24|||
105792572|NCT00713830|364896388|FG001|Overall Study|Lack of Efficacy|16|||
105562763|NCT02274857|364057503|FG000|Overall Study|Physician Decision|2|||
105562764|NCT02274857|364057504|FG001|Overall Study|Physician Decision|0|||
105562765|NCT02274857|364057503|FG000|Overall Study|Trial screen failure|0|||
105562766|NCT02274857|364057504|FG001|Overall Study|Trial screen failure|2|||
105562767|NCT02274857|364057503|FG000|Overall Study|Withdrawal by Subject|11|||
105562768|NCT02274857|364057504|FG001|Overall Study|Withdrawal by Subject|2|||
105562769|NCT02274857|364057503|FG000|Overall Study|Other|2|||
105562770|NCT02274857|364057504|FG001|Overall Study|Other|0|||
105562771|NCT00716092|364057507|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
105562772|NCT00716092|364057508|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
105792573|NCT00713830|364896387|FG000|Overall Study|Lost to Follow-up|2|||
105562773|NCT00716092|364057509|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
105562774|NCT00330174|364057510|FG000|Overall Study|Withdrawal by Subject|7|||
105562775|NCT00330174|364057511|FG001|Overall Study|Withdrawal by Subject|7|||
105562776|NCT00330174|364057510|FG000|Overall Study|Lost to Follow-up|4|||
105562777|NCT00330174|364057511|FG001|Overall Study|Lost to Follow-up|1|||
105792574|NCT00713830|364896388|FG001|Overall Study|Lost to Follow-up|9|||
105562778|NCT00330174|364057510|FG000|Overall Study|Clinical deterioration|1|||
105562779|NCT00330174|364057511|FG001|Overall Study|Clinical deterioration|2|||
105562780|NCT00330174|364057510|FG000|Overall Study|Excessive missed visits|3|||
105562781|NCT00330174|364057511|FG001|Overall Study|Excessive missed visits|8|||
105562782|NCT00330174|364057510|FG000|Overall Study|Miscellaneous reasons|7|||
105792575|NCT00713830|364896387|FG000|Overall Study|Withdrawal by Subject|13|||
105562783|NCT00330174|364057511|FG001|Overall Study|Miscellaneous reasons|1|||
105562784|NCT01896869|364057512|FG000|Overall Study|Withdrawal by Subject|0|||
105562785|NCT01896869|364057513|FG001|Overall Study|Withdrawal by Subject|6|||
105562786|NCT01896869|364057512|FG000|Overall Study|Lost to Follow-up|1|||
105562787|NCT01896869|364057513|FG001|Overall Study|Lost to Follow-up|0|||
105562788|NCT00117676|364057517|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
105562789|NCT00117676|364057518|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
105562790|NCT00117676|364057517|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
105562791|NCT00117676|364057518|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
105562792|NCT00117676|364057517|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
105562793|NCT00117676|364057518|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
105562794|NCT00117676|364057517|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
105562795|NCT00117676|364057518|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
105562796|NCT00117676|364057517|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
105562797|NCT00117676|364057518|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
105562798|NCT00117676|364057517|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
105562799|NCT00117676|364057518|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
105562800|NCT00117676|364057517|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
105562801|NCT00117676|364057518|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
105562802|NCT00117676|364057517|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
105562803|NCT00117676|364057518|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
105562804|NCT00117676|364057517|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
105562805|NCT00117676|364057518|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
105562806|NCT00117676|364057517|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
105562807|NCT00117676|364057518|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
105562808|NCT00117676|364057517|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
105562809|NCT00117676|364057518|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
105562810|NCT00117676|364057517|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
105562811|NCT00117676|364057518|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
105562812|NCT00117676|364057517|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
105562813|NCT00117676|364057518|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
105562814|NCT00117676|364057517|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
105562815|NCT00117676|364057518|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
105562816|NCT00117676|364057517|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
105562817|NCT00117676|364057518|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
105562818|NCT00117676|364057517|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
105562819|NCT00117676|364057518|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
105562820|NCT00117676|364057517|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
105562821|NCT00117676|364057518|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
105562822|NCT00117676|364057517|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
105562823|NCT00117676|364057518|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
105562824|NCT00117676|364057517|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
105562825|NCT00117676|364057518|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
105562826|NCT00117676|364057517|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
105562827|NCT00117676|364057518|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
105562828|NCT00117676|364057517|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
105562829|NCT00117676|364057518|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
105562830|NCT00117676|364057517|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
105562831|NCT00117676|364057518|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
105562832|NCT00117676|364057517|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
105722473|NCT02078219|364638755|FG004|Overall Study|Protocol Violation|0|||
105722474|NCT02078219|364638751|FG000|Overall Study|Death|0|||
105722475|NCT02078219|364638752|FG001|Overall Study|Death|0|||
105722476|NCT02078219|364638753|FG002|Overall Study|Death|0|||
105722477|NCT02078219|364638754|FG003|Overall Study|Death|1|||
105722478|NCT02078219|364638755|FG004|Overall Study|Death|0|||
105722479|NCT02078219|364638751|FG000|Overall Study|Adverse Event|1|||
105722480|NCT02078219|364638752|FG001|Overall Study|Adverse Event|1|||
105722481|NCT02078219|364638753|FG002|Overall Study|Adverse Event|3|||
105722482|NCT02078219|364638754|FG003|Overall Study|Adverse Event|1|||
105722483|NCT02078219|364638755|FG004|Overall Study|Adverse Event|0|||
105722484|NCT03283085|364638762|FG000|Overall Study|Adverse Event|18|||
105722485|NCT03283085|364638763|FG001|Overall Study|Adverse Event|3|||
105722486|NCT03283085|364638764|FG002|Overall Study|Adverse Event|13|||
105722487|NCT03283085|364638765|FG003|Overall Study|Adverse Event|0|||
105562833|NCT00117676|364057518|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
105562834|NCT00117676|364057517|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
105562835|NCT00117676|364057518|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
105562836|NCT00117676|364057517|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
105562837|NCT00117676|364057518|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
105562838|NCT00117676|364057517|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
105562839|NCT00117676|364057518|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
105562840|NCT00117676|364057517|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
105562841|NCT00117676|364057518|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
105562842|NCT00117676|364057517|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
105562843|NCT00117676|364057518|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
105562844|NCT00117676|364057517|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
105562845|NCT00117676|364057518|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
105562846|NCT00117676|364057517|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
105562847|NCT00117676|364057518|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
105562848|NCT00117676|364057517|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
105562849|NCT00117676|364057518|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
105562850|NCT00117676|364057517|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
105562851|NCT00117676|364057518|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
105562852|NCT00117676|364057517|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
105562853|NCT00117676|364057518|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
105562854|NCT00117676|364057517|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
105562855|NCT00117676|364057518|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
105562856|NCT00117676|364057517|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
105562857|NCT00117676|364057518|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
105562858|NCT01281644|364057519|FG000|Overall Study|Lost to Follow-up|3|||
105562859|NCT01281644|364057519|FG000|Overall Study|Withdrawal by Subject|2|||
105562860|NCT02110901|364057520|FG000|Overall Study|Death|6|||
105562861|NCT02110901|364057521|FG001|Overall Study|Death|3|||
105562862|NCT02110901|364057520|FG000|Overall Study|Lost to Follow-up|12|||
105562863|NCT02110901|364057521|FG001|Overall Study|Lost to Follow-up|8|||
105562864|NCT02110901|364057520|FG000|Overall Study|Withdrawal by Subject|7|||
105562865|NCT02110901|364057521|FG001|Overall Study|Withdrawal by Subject|3|||
105562866|NCT02110901|364057520|FG000|Overall Study|received a kidney transplant|5|||
105562867|NCT02110901|364057521|FG001|Overall Study|received a kidney transplant|0|||
105562868|NCT02831257|364057522|FG000|Overall Study|Lack of Efficacy|3|||
105562869|NCT02831257|364057522|FG000|Overall Study|Adverse Event|2|||
105562870|NCT02831257|364057522|FG000|Overall Study|Physician Decision|1|||
105562871|NCT02831257|364057522|FG000|Overall Study|Withdrawal by Subject|6|||
105562872|NCT01058304|364057523|FG000|Overall Study|Withdrawal by Subject|8|||
105562873|NCT01058304|364057524|FG001|Overall Study|Withdrawal by Subject|5|||
105562874|NCT01058304|364057523|FG000|Overall Study|Lost to Follow-up|13|||
105562875|NCT01058304|364057524|FG001|Overall Study|Lost to Follow-up|16|||
105722488|NCT03283085|364638766|FG004|Overall Study|Adverse Event|0|||
105722489|NCT03283085|364638767|FG005|Overall Study|Adverse Event|5|||
105722490|NCT03283085|364638762|FG000|Overall Study|Death|0|||
105722491|NCT03283085|364638763|FG001|Overall Study|Death|0|||
105722492|NCT03283085|364638764|FG002|Overall Study|Death|3|||
105722493|NCT03283085|364638765|FG003|Overall Study|Death|1|||
105722494|NCT03283085|364638766|FG004|Overall Study|Death|0|||
105722495|NCT03283085|364638767|FG005|Overall Study|Death|0|||
105722496|NCT03283085|364638762|FG000|Overall Study|Withdrawal by Subject|42|||
105722497|NCT03283085|364638763|FG001|Overall Study|Withdrawal by Subject|21|||
105722498|NCT03283085|364638764|FG002|Overall Study|Withdrawal by Subject|66|||
105722499|NCT03283085|364638765|FG003|Overall Study|Withdrawal by Subject|3|||
105722500|NCT03283085|364638766|FG004|Overall Study|Withdrawal by Subject|3|||
105722501|NCT03283085|364638767|FG005|Overall Study|Withdrawal by Subject|5|||
105722502|NCT03283085|364638762|FG000|Overall Study|Physician Decision|14|||
105722503|NCT03283085|364638763|FG001|Overall Study|Physician Decision|8|||
105722504|NCT03283085|364638764|FG002|Overall Study|Physician Decision|19|||
105722505|NCT03283085|364638765|FG003|Overall Study|Physician Decision|0|||
105722506|NCT03283085|364638766|FG004|Overall Study|Physician Decision|0|||
105722507|NCT03283085|364638767|FG005|Overall Study|Physician Decision|2|||
105722508|NCT03283085|364638762|FG000|Overall Study|Site Terminated by Sponsor|1|||
105722509|NCT03283085|364638763|FG001|Overall Study|Site Terminated by Sponsor|0|||
105722510|NCT03283085|364638764|FG002|Overall Study|Site Terminated by Sponsor|3|||
105722511|NCT03283085|364638765|FG003|Overall Study|Site Terminated by Sponsor|0|||
105722512|NCT03283085|364638766|FG004|Overall Study|Site Terminated by Sponsor|0|||
105722513|NCT03283085|364638767|FG005|Overall Study|Site Terminated by Sponsor|0|||
105722514|NCT03283085|364638762|FG000|Overall Study|Lost to Follow-up|2|||
105722515|NCT03283085|364638763|FG001|Overall Study|Lost to Follow-up|0|||
105722516|NCT03283085|364638764|FG002|Overall Study|Lost to Follow-up|2|||
105562876|NCT01058304|364057523|FG000|Overall Study|Developed exclusion criterion|6|||
105562877|NCT01058304|364057524|FG001|Overall Study|Developed exclusion criterion|12|||
105562878|NCT01820559|364057525|FG000|Overall Study|Adverse Event|4|||
105562879|NCT01820559|364057526|FG001|Overall Study|Adverse Event|6|||
105562880|NCT01820559|364057527|FG002|Overall Study|Adverse Event|13|||
105562881|NCT01820559|364057525|FG000|Overall Study|Withdrawal by Subject|1|||
105562882|NCT01820559|364057526|FG001|Overall Study|Withdrawal by Subject|2|||
105562883|NCT01820559|364057527|FG002|Overall Study|Withdrawal by Subject|5|||
105562884|NCT01820559|364057525|FG000|Overall Study|Protocol Violation|2|||
105722517|NCT03283085|364638765|FG003|Overall Study|Lost to Follow-up|0|||
105722518|NCT03283085|364638766|FG004|Overall Study|Lost to Follow-up|0|||
105722519|NCT03283085|364638767|FG005|Overall Study|Lost to Follow-up|1|||
105722520|NCT03283085|364638762|FG000|Overall Study|Pregnancy|0|||
105722521|NCT03283085|364638763|FG001|Overall Study|Pregnancy|0|||
105722522|NCT03283085|364638764|FG002|Overall Study|Pregnancy|1|||
105722523|NCT03283085|364638765|FG003|Overall Study|Pregnancy|0|||
105722524|NCT03283085|364638766|FG004|Overall Study|Pregnancy|0|||
105722525|NCT03283085|364638767|FG005|Overall Study|Pregnancy|0|||
105722526|NCT03283085|364638762|FG000|Overall Study|Lack of Efficacy|12|||
105722527|NCT03283085|364638763|FG001|Overall Study|Lack of Efficacy|6|||
105722528|NCT03283085|364638764|FG002|Overall Study|Lack of Efficacy|24|||
105722529|NCT03283085|364638765|FG003|Overall Study|Lack of Efficacy|1|||
105722530|NCT03283085|364638766|FG004|Overall Study|Lack of Efficacy|1|||
105722531|NCT03283085|364638767|FG005|Overall Study|Lack of Efficacy|0|||
105722532|NCT03283085|364638762|FG000|Overall Study|Reason not Specified|0|||
105722533|NCT03283085|364638763|FG001|Overall Study|Reason not Specified|4|||
105722534|NCT03283085|364638764|FG002|Overall Study|Reason not Specified|8|||
105722535|NCT03283085|364638765|FG003|Overall Study|Reason not Specified|0|||
105722536|NCT03283085|364638766|FG004|Overall Study|Reason not Specified|0|||
105722537|NCT03283085|364638767|FG005|Overall Study|Reason not Specified|1|||
105722538|NCT03136107|364638768|FG000|Overall Study|Other (Not specified)|1|||
105722539|NCT01237951|364638773|FG000|Overall Study|Death|1|||
105722540|NCT01817790|364638776|FG000|Overall Study|Adverse Event|0|||
105722541|NCT01817790|364638777|FG001|Overall Study|Adverse Event|2|||
105722542|NCT01817790|364638776|FG000|Overall Study|Lost to Follow-up|0|||
105722543|NCT01817790|364638777|FG001|Overall Study|Lost to Follow-up|1|||
105722544|NCT01817790|364638776|FG000|Overall Study|Protocol Violation|2|||
105722545|NCT01817790|364638777|FG001|Overall Study|Protocol Violation|1|||
105722546|NCT01817790|364638776|FG000|Overall Study|Withdrawal by Subject|1|||
105722547|NCT01817790|364638777|FG001|Overall Study|Withdrawal by Subject|3|||
105722548|NCT01817790|364638776|FG000|Overall Study|Other: Could not attend appointment|1|||
105722549|NCT01817790|364638777|FG001|Overall Study|Other: Could not attend appointment|1|||
105722550|NCT02382133|364638778|FG000|Overall Study|Death|22|||
105722551|NCT02382133|364638778|FG000|Overall Study|transfer out of ICU|4|||
105722552|NCT02382133|364638778|FG000|Overall Study|Physician Decision|2|||
105722553|NCT02382133|364638778|FG000|Overall Study|arterial catheter loss|4|||
105722554|NCT02382133|364638778|FG000|Overall Study|pressure injury both sites|1|||
105722555|NCT00655928|364638779|FG000|Overall Study|Withdrawal by Subject|2|||
105722556|NCT00655928|364638780|FG001|Overall Study|Withdrawal by Subject|1|||
105722557|NCT00655928|364638779|FG000|Overall Study|Physician Decision|1|||
105722558|NCT00655928|364638780|FG001|Overall Study|Physician Decision|1|||
105722559|NCT01976806|364638781|FG000|Overall Study|Lost to Follow-up|1|||
105722560|NCT01976806|364638782|FG001|Overall Study|Lost to Follow-up|4|||
105722561|NCT01976806|364638781|FG000|Overall Study|Adverse Event|1|||
105722562|NCT01976806|364638782|FG001|Overall Study|Adverse Event|1|||
105722563|NCT01976806|364638781|FG000|Overall Study|Withdrawal by Subject|1|||
105722564|NCT01976806|364638782|FG001|Overall Study|Withdrawal by Subject|1|||
105722565|NCT03636906|364638784|FG000|Overall Study|Adverse Event|0|||
105722566|NCT03636906|364638785|FG001|Overall Study|Adverse Event|0|||
105722567|NCT03636906|364638786|FG002|Overall Study|Adverse Event|1|||
105722568|NCT03636906|364638784|FG000|Overall Study|Lost to Follow-up|1|||
105722569|NCT03636906|364638785|FG001|Overall Study|Lost to Follow-up|0|||
105722570|NCT03636906|364638786|FG002|Overall Study|Lost to Follow-up|0|||
105722571|NCT03636906|364638784|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
105722572|NCT03636906|364638785|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
105722573|NCT03636906|364638786|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
105722574|NCT03636906|364638784|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
105722575|NCT03636906|364638785|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105722576|NCT03636906|364638786|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
105722577|NCT03636906|364638784|FG000|Overall Study|Other|0|||
105722578|NCT03636906|364638785|FG001|Overall Study|Other|0|||
105722579|NCT03636906|364638786|FG002|Overall Study|Other|1|||
105722580|NCT02654002|364638788|FG000|Overall Study|Adverse Event|0|||
105722581|NCT02654002|364638789|FG001|Overall Study|Adverse Event|0|||
105722582|NCT02654002|364638790|FG002|Overall Study|Adverse Event|0|||
105722583|NCT02654002|364638791|FG003|Overall Study|Adverse Event|0|||
105722584|NCT02654002|364638792|FG004|Overall Study|Adverse Event|0|||
105722585|NCT02654002|364638793|FG005|Overall Study|Adverse Event|0|||
105722586|NCT02654002|364638794|FG006|Overall Study|Adverse Event|1|||
105722587|NCT02654002|364638795|FG007|Overall Study|Adverse Event|0|||
105722588|NCT02654002|364638796|FG008|Overall Study|Adverse Event|0|||
105722589|NCT02654002|364638788|FG000|Overall Study|Withdrew Consent|0|||
105722590|NCT02654002|364638789|FG001|Overall Study|Withdrew Consent|0|||
105722591|NCT02654002|364638790|FG002|Overall Study|Withdrew Consent|0|||
105722592|NCT02654002|364638791|FG003|Overall Study|Withdrew Consent|0|||
105722593|NCT02654002|364638792|FG004|Overall Study|Withdrew Consent|0|||
105722594|NCT02654002|364638793|FG005|Overall Study|Withdrew Consent|1|||
105722595|NCT02654002|364638794|FG006|Overall Study|Withdrew Consent|0|||
105722596|NCT02654002|364638795|FG007|Overall Study|Withdrew Consent|1|||
105722597|NCT02654002|364638796|FG008|Overall Study|Withdrew Consent|0|||
105722598|NCT02848833|364638802|FG000|Overall Study|subject who are duplicated|1|||
105722599|NCT02848833|364638802|FG000|Overall Study|have not taken the study drug|11|||
105722600|NCT02848833|364638802|FG000|Overall Study|follow-up failure|6|||
105722601|NCT02848833|364638802|FG000|Overall Study|Protocol Violation|119|||
105722602|NCT03690869|364638803|FG000|Overall Study|Adverse Event|0|||
105722603|NCT03690869|364638804|FG001|Overall Study|Adverse Event|0|||
105722604|NCT03690869|364638805|FG002|Overall Study|Adverse Event|0|||
105722605|NCT03690869|364638806|FG003|Overall Study|Adverse Event|1|||
105722606|NCT03690869|364638807|FG004|Overall Study|Adverse Event|0|||
105722607|NCT03690869|364638808|FG005|Overall Study|Adverse Event|0|||
105722608|NCT03690869|364638809|FG006|Overall Study|Adverse Event|0|||
105722609|NCT03690869|364638810|FG007|Overall Study|Adverse Event|1|||
105722610|NCT03690869|364638811|FG008|Overall Study|Adverse Event|0|||
105722611|NCT03690869|364638812|FG009|Overall Study|Adverse Event|1|||
105722612|NCT03690869|364638803|FG000|Overall Study|Death|1|||
105722613|NCT03690869|364638804|FG001|Overall Study|Death|1|||
105722614|NCT03690869|364638805|FG002|Overall Study|Death|1|||
105722615|NCT03690869|364638806|FG003|Overall Study|Death|4|||
105722616|NCT03690869|364638807|FG004|Overall Study|Death|2|||
105722617|NCT03690869|364638808|FG005|Overall Study|Death|5|||
105722618|NCT03690869|364638809|FG006|Overall Study|Death|3|||
105722619|NCT03690869|364638810|FG007|Overall Study|Death|2|||
105722620|NCT03690869|364638811|FG008|Overall Study|Death|0|||
105722621|NCT03690869|364638812|FG009|Overall Study|Death|3|||
105722622|NCT03690869|364638803|FG000|Overall Study|Lost to Follow-up|0|||
105722623|NCT03690869|364638804|FG001|Overall Study|Lost to Follow-up|0|||
105722624|NCT03690869|364638805|FG002|Overall Study|Lost to Follow-up|1|||
105722625|NCT03690869|364638806|FG003|Overall Study|Lost to Follow-up|0|||
105478482|NCT00505076|363764262|FG001|Overall Study|Withdrawal by Subject|1|||
105722626|NCT03690869|364638807|FG004|Overall Study|Lost to Follow-up|0|||
105722627|NCT03690869|364638808|FG005|Overall Study|Lost to Follow-up|0|||
105722628|NCT03690869|364638809|FG006|Overall Study|Lost to Follow-up|0|||
105722629|NCT03690869|364638810|FG007|Overall Study|Lost to Follow-up|0|||
105722630|NCT03690869|364638811|FG008|Overall Study|Lost to Follow-up|0|||
105722631|NCT03690869|364638812|FG009|Overall Study|Lost to Follow-up|0|||
105722632|NCT03690869|364638803|FG000|Overall Study|Other Treatment|1|||
105722633|NCT03690869|364638804|FG001|Overall Study|Other Treatment|1|||
105722634|NCT03690869|364638805|FG002|Overall Study|Other Treatment|1|||
105722635|NCT03690869|364638806|FG003|Overall Study|Other Treatment|2|||
105722636|NCT03690869|364638807|FG004|Overall Study|Other Treatment|3|||
105722637|NCT03690869|364638808|FG005|Overall Study|Other Treatment|1|||
105722638|NCT03690869|364638809|FG006|Overall Study|Other Treatment|2|||
105722639|NCT03690869|364638810|FG007|Overall Study|Other Treatment|7|||
105722640|NCT03690869|364638811|FG008|Overall Study|Other Treatment|0|||
105722641|NCT03690869|364638812|FG009|Overall Study|Other Treatment|3|||
105722642|NCT03690869|364638803|FG000|Overall Study|Physician Decision|0|||
105722643|NCT03690869|364638804|FG001|Overall Study|Physician Decision|1|||
105722644|NCT03690869|364638805|FG002|Overall Study|Physician Decision|0|||
105722645|NCT03690869|364638806|FG003|Overall Study|Physician Decision|0|||
105722646|NCT03690869|364638807|FG004|Overall Study|Physician Decision|0|||
105722647|NCT03690869|364638808|FG005|Overall Study|Physician Decision|0|||
105722648|NCT03690869|364638809|FG006|Overall Study|Physician Decision|0|||
105722649|NCT03690869|364638810|FG007|Overall Study|Physician Decision|0|||
105722650|NCT03690869|364638811|FG008|Overall Study|Physician Decision|0|||
105562885|NCT01820559|364057526|FG001|Overall Study|Protocol Violation|1|||
105562886|NCT01820559|364057527|FG002|Overall Study|Protocol Violation|3|||
105562887|NCT01820559|364057525|FG000|Overall Study|Subject's non-compliance|1|||
105722651|NCT03690869|364638812|FG009|Overall Study|Physician Decision|0|||
105722652|NCT03690869|364638803|FG000|Overall Study|Progressive Disease|1|||
105722653|NCT03690869|364638804|FG001|Overall Study|Progressive Disease|2|||
105722654|NCT03690869|364638805|FG002|Overall Study|Progressive Disease|0|||
105722655|NCT03690869|364638806|FG003|Overall Study|Progressive Disease|1|||
105722656|NCT03690869|364638807|FG004|Overall Study|Progressive Disease|0|||
105722657|NCT03690869|364638808|FG005|Overall Study|Progressive Disease|0|||
105722658|NCT03690869|364638809|FG006|Overall Study|Progressive Disease|0|||
105722659|NCT03690869|364638810|FG007|Overall Study|Progressive Disease|0|||
105722660|NCT03690869|364638811|FG008|Overall Study|Progressive Disease|1|||
105722661|NCT03690869|364638812|FG009|Overall Study|Progressive Disease|1|||
105722662|NCT03690869|364638803|FG000|Overall Study|Subject Decision|0|||
105722663|NCT03690869|364638804|FG001|Overall Study|Subject Decision|0|||
105722664|NCT03690869|364638805|FG002|Overall Study|Subject Decision|0|||
105722665|NCT03690869|364638806|FG003|Overall Study|Subject Decision|1|||
105722666|NCT03690869|364638807|FG004|Overall Study|Subject Decision|0|||
105722667|NCT03690869|364638808|FG005|Overall Study|Subject Decision|0|||
105722668|NCT03690869|364638809|FG006|Overall Study|Subject Decision|0|||
105722669|NCT03690869|364638810|FG007|Overall Study|Subject Decision|1|||
105722670|NCT03690869|364638811|FG008|Overall Study|Subject Decision|0|||
105722671|NCT03690869|364638812|FG009|Overall Study|Subject Decision|0|||
105722672|NCT04167345|364638813|FG000|Overall Study|Other|1|||
105722673|NCT04167345|364638814|FG001|Overall Study|Other|1|||
105722674|NCT04167345|364638815|FG002|Overall Study|Other|0|||
105722675|NCT04167345|364638816|FG003|Overall Study|Other|0|||
105722676|NCT04167345|364638817|FG004|Overall Study|Other|0|||
105722677|NCT03124459|364640852|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
105722678|NCT03124459|364640853|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
105722679|NCT03124459|364640854|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
105722680|NCT03124459|364640855|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
105722681|NCT03124459|364640856|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
105722682|NCT03124459|364640857|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
105722683|NCT03124459|364640852|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
105722684|NCT03124459|364640853|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
105722685|NCT03124459|364640854|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
105722686|NCT03124459|364640855|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
105722687|NCT03124459|364640856|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
105722688|NCT03124459|364640857|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
105722689|NCT03124459|364640852|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
105722690|NCT03124459|364640853|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
105722691|NCT03124459|364640854|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
105722692|NCT03124459|364640855|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
105352863|NCT03959488|363297002|FG000|Season 1|Other|6|||
105352864|NCT03959488|363297003|FG001|Season 1|Other|7|||
105352865|NCT03959488|363297004|FG002|Season 1|Other|0|||
105352866|NCT03959488|363297005|FG003|Season 1|Other|0|||
105722693|NCT03124459|364640856|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
105722694|NCT03124459|364640857|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
105722695|NCT03124459|364640852|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
105722696|NCT03124459|364640853|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
105722697|NCT03124459|364640854|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
105722698|NCT03124459|364640855|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
105722699|NCT03124459|364640856|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
105722700|NCT03124459|364640857|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
105722701|NCT03124459|364640852|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
105352867|NCT03959488|363297006|FG004|Season 1|Other|0|||
105722702|NCT03124459|364640853|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
105722703|NCT03124459|364640854|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
105722704|NCT03124459|364640855|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
105722705|NCT03124459|364640856|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
105722706|NCT03124459|364640857|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
105722707|NCT03124459|364640852|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
105722708|NCT03124459|364640853|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
105722709|NCT03124459|364640854|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
105722710|NCT03124459|364640855|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
105722711|NCT03124459|364640856|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
105722712|NCT03124459|364640857|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
105722713|NCT05742984|364640858|FG000|Overall Study|Adverse Event|0|||
105722714|NCT05742984|364640859|FG001|Overall Study|Adverse Event|0|||
105722715|NCT05742984|364640860|FG002|Overall Study|Adverse Event|1|||
105722716|NCT05742984|364640861|FG003|Overall Study|Adverse Event|0|||
105722717|NCT05742984|364640862|FG004|Overall Study|Adverse Event|1|||
105722718|NCT05742984|364640863|FG005|Overall Study|Adverse Event|1|||
105722719|NCT05742984|364640858|FG000|Overall Study|Withdrawal by Subject|0|||
105722720|NCT05742984|364640859|FG001|Overall Study|Withdrawal by Subject|1|||
105722721|NCT05742984|364640860|FG002|Overall Study|Withdrawal by Subject|0|||
105722722|NCT05742984|364640861|FG003|Overall Study|Withdrawal by Subject|0|||
105722723|NCT05742984|364640862|FG004|Overall Study|Withdrawal by Subject|0|||
105722724|NCT05742984|364640863|FG005|Overall Study|Withdrawal by Subject|2|||
105722725|NCT05019131|364640867|FG000|Overall Study|Lost to Follow-up|0|||
105722726|NCT05019131|364640868|FG001|Overall Study|Lost to Follow-up|3|||
105722727|NCT03822884|364640869|FG000|Overall Study|Withdrawal by Subject|0|||
105722728|NCT03822884|364640870|FG001|Overall Study|Withdrawal by Subject|0|||
105722729|NCT03822884|364640871|FG002|Overall Study|Withdrawal by Subject|0|||
105722730|NCT03822884|364640872|FG003|Overall Study|Withdrawal by Subject|0|||
105722731|NCT03822884|364640873|FG004|Overall Study|Withdrawal by Subject|1|||
105722732|NCT03822884|364640874|FG005|Overall Study|Withdrawal by Subject|0|||
105722733|NCT00191854|364640878|FG000|Overall Study|Death|26|||
105722734|NCT00191854|364640879|FG001|Overall Study|Death|23|||
105722735|NCT00191854|364640880|FG002|Overall Study|Death|29|||
105722736|NCT00191854|364640878|FG000|Overall Study|Lost to Follow-up|7|||
105722737|NCT00191854|364640879|FG001|Overall Study|Lost to Follow-up|5|||
105722738|NCT00191854|364640880|FG002|Overall Study|Lost to Follow-up|5|||
105722739|NCT00191854|364640878|FG000|Overall Study|Withdrawal by Subject|4|||
105722740|NCT00191854|364640879|FG001|Overall Study|Withdrawal by Subject|2|||
105722741|NCT00191854|364640880|FG002|Overall Study|Withdrawal by Subject|3|||
105722742|NCT00191854|364640878|FG000|Overall Study|Sponsor Decision|0|||
105722743|NCT00191854|364640879|FG001|Overall Study|Sponsor Decision|0|||
105722744|NCT00191854|364640880|FG002|Overall Study|Sponsor Decision|1|||
105722745|NCT00191854|364640878|FG000|Overall Study|Screen Failure|0|||
105722746|NCT00191854|364640879|FG001|Overall Study|Screen Failure|0|||
105722747|NCT00191854|364640880|FG002|Overall Study|Screen Failure|1|||
105722748|NCT00408005|364640883|FG000|Induction|Adverse Event|19|||
105722749|NCT00408005|364640884|FG001|Induction|Adverse Event|3|||
105722750|NCT00408005|364640885|FG002|Induction|Adverse Event|0|||
105722751|NCT00408005|364640886|FG003|Induction|Adverse Event|0|||
105722752|NCT00408005|364640887|FG004|Induction|Adverse Event|0|||
105722753|NCT00408005|364640888|FG005|Induction|Adverse Event|0|||
105722754|NCT00408005|364640889|FG006|Induction|Adverse Event|0|||
105722755|NCT00408005|364640890|FG007|Induction|Adverse Event|0|||
105722756|NCT00408005|364640883|FG000|Induction|Death|6|||
105722757|NCT00408005|364640884|FG001|Induction|Death|0|||
105478483|NCT00505076|363764263|FG002|Overall Study|Withdrawal by Subject|2|||
105478484|NCT04093024|363764264|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
105722758|NCT00408005|364640885|FG002|Induction|Death|0|||
105722759|NCT00408005|364640886|FG003|Induction|Death|0|||
105722760|NCT00408005|364640887|FG004|Induction|Death|0|||
105722761|NCT00408005|364640888|FG005|Induction|Death|0|||
105722762|NCT00408005|364640889|FG006|Induction|Death|0|||
105722763|NCT00408005|364640890|FG007|Induction|Death|0|||
105722764|NCT00408005|364640883|FG000|Induction|Physician Decision|83|||
105722765|NCT00408005|364640884|FG001|Induction|Physician Decision|9|||
105722766|NCT00408005|364640885|FG002|Induction|Physician Decision|0|||
105722767|NCT00408005|364640886|FG003|Induction|Physician Decision|0|||
105722768|NCT00408005|364640887|FG004|Induction|Physician Decision|0|||
105722769|NCT00408005|364640888|FG005|Induction|Physician Decision|0|||
105722770|NCT00408005|364640889|FG006|Induction|Physician Decision|0|||
105722771|NCT00408005|364640890|FG007|Induction|Physician Decision|0|||
105722772|NCT00408005|364640883|FG000|Induction|Withdrawal by Subject|2|||
105722773|NCT00408005|364640884|FG001|Induction|Withdrawal by Subject|4|||
105722774|NCT00408005|364640885|FG002|Induction|Withdrawal by Subject|0|||
105722775|NCT00408005|364640886|FG003|Induction|Withdrawal by Subject|0|||
105722776|NCT00408005|364640887|FG004|Induction|Withdrawal by Subject|0|||
105722777|NCT00408005|364640888|FG005|Induction|Withdrawal by Subject|0|||
105722778|NCT00408005|364640889|FG006|Induction|Withdrawal by Subject|0|||
105792576|NCT00713830|364896388|FG001|Overall Study|Withdrawal by Subject|23|||
105792577|NCT00713830|364896387|FG000|Overall Study|Poor Compliance to Protocol|7|||
105792578|NCT00713830|364896388|FG001|Overall Study|Poor Compliance to Protocol|14|||
105792579|NCT00713830|364896387|FG000|Overall Study|Familial and Personal Reasons|9|||
105792580|NCT00713830|364896388|FG001|Overall Study|Familial and Personal Reasons|34|||
105792581|NCT00713830|364896387|FG000|Overall Study|Sponsor Decision|4|||
105792582|NCT00713830|364896388|FG001|Overall Study|Sponsor Decision|10|||
105792583|NCT01988337|364896389|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
105792584|NCT04854707|364896394|FG000|Overall Study|Lack of Efficacy|78|||
105792585|NCT04854707|364896395|FG001|Overall Study|Lack of Efficacy|59|||
105792586|NCT04854707|364896396|FG002|Overall Study|Lack of Efficacy|30|||
105792587|NCT04527549|364896397|FG000|Overall Study|Withdrawal by Subject|1|||
105792588|NCT04527549|364896398|FG001|Overall Study|Withdrawal by Subject|1|||
105792589|NCT02628418|364896401|FG000|Overall Study|Lost to Follow-up|1|||
105792590|NCT02628418|364896402|FG001|Overall Study|Lost to Follow-up|2|||
105792591|NCT00424632|364896403|FG000|Overall Study|Death|0|||
105792592|NCT00424632|364896404|FG001|Overall Study|Death|0|||
105792593|NCT00424632|364896405|FG002|Overall Study|Death|0|||
105792594|NCT00424632|364896406|FG003|Overall Study|Death|0|||
105792595|NCT00424632|364896407|FG004|Overall Study|Death|0|||
105792596|NCT00424632|364896408|FG005|Overall Study|Death|2|||
105792597|NCT00424632|364896409|FG006|Overall Study|Death|0|||
105792598|NCT00424632|364896410|FG007|Overall Study|Death|0|||
105792599|NCT00424632|364896411|FG008|Overall Study|Death|0|||
105792600|NCT00424632|364896412|FG009|Overall Study|Death|0|||
105792601|NCT00424632|364896403|FG000|Overall Study|Adverse Event|0|||
105792602|NCT00424632|364896404|FG001|Overall Study|Adverse Event|0|||
105792603|NCT00424632|364896405|FG002|Overall Study|Adverse Event|0|||
105792604|NCT00424632|364896406|FG003|Overall Study|Adverse Event|0|||
105792605|NCT00424632|364896407|FG004|Overall Study|Adverse Event|0|||
105792606|NCT00424632|364896408|FG005|Overall Study|Adverse Event|0|||
105792607|NCT00424632|364896409|FG006|Overall Study|Adverse Event|0|||
105792608|NCT00424632|364896410|FG007|Overall Study|Adverse Event|0|||
105792609|NCT00424632|364896411|FG008|Overall Study|Adverse Event|3|||
105792610|NCT00424632|364896412|FG009|Overall Study|Adverse Event|2|||
105792611|NCT00424632|364896403|FG000|Overall Study|Global deterioration of health status|0|||
105792612|NCT00424632|364896404|FG001|Overall Study|Global deterioration of health status|0|||
105792613|NCT00424632|364896405|FG002|Overall Study|Global deterioration of health status|0|||
105792614|NCT00424632|364896406|FG003|Overall Study|Global deterioration of health status|1|||
105792615|NCT00424632|364896407|FG004|Overall Study|Global deterioration of health status|1|||
105792616|NCT00424632|364896408|FG005|Overall Study|Global deterioration of health status|0|||
105722779|NCT00408005|364640890|FG007|Induction|Withdrawal by Subject|0|||
105722780|NCT00408005|364640883|FG000|Induction|Ineligible|33|||
105722781|NCT00408005|364640884|FG001|Induction|Ineligible|14|||
105722782|NCT00408005|364640885|FG002|Induction|Ineligible|0|||
105722783|NCT00408005|364640886|FG003|Induction|Ineligible|0|||
105722784|NCT00408005|364640887|FG004|Induction|Ineligible|0|||
105722785|NCT00408005|364640888|FG005|Induction|Ineligible|0|||
105722786|NCT00408005|364640889|FG006|Induction|Ineligible|0|||
105722787|NCT00408005|364640890|FG007|Induction|Ineligible|0|||
105722788|NCT00408005|364640883|FG000|Induction|Refusal of Further Protocol Therapy|225|||
105722789|NCT00408005|364640884|FG001|Induction|Refusal of Further Protocol Therapy|44|||
105722790|NCT00408005|364640885|FG002|Induction|Refusal of Further Protocol Therapy|0|||
105722791|NCT00408005|364640886|FG003|Induction|Refusal of Further Protocol Therapy|0|||
105722792|NCT00408005|364640887|FG004|Induction|Refusal of Further Protocol Therapy|0|||
105722793|NCT00408005|364640888|FG005|Induction|Refusal of Further Protocol Therapy|0|||
105722794|NCT00408005|364640889|FG006|Induction|Refusal of Further Protocol Therapy|0|||
105722795|NCT00408005|364640890|FG007|Induction|Refusal of Further Protocol Therapy|0|||
105722796|NCT00408005|364640883|FG000|Induction|Entered another COG therapeutic protocol|4|||
105722797|NCT00408005|364640884|FG001|Induction|Entered another COG therapeutic protocol|0|||
105722798|NCT00408005|364640885|FG002|Induction|Entered another COG therapeutic protocol|0|||
105722799|NCT00408005|364640886|FG003|Induction|Entered another COG therapeutic protocol|0|||
105722800|NCT00408005|364640887|FG004|Induction|Entered another COG therapeutic protocol|0|||
105722801|NCT00408005|364640888|FG005|Induction|Entered another COG therapeutic protocol|0|||
105722802|NCT00408005|364640889|FG006|Induction|Entered another COG therapeutic protocol|0|||
105792617|NCT00424632|364896409|FG006|Overall Study|Global deterioration of health status|0|||
105722803|NCT00408005|364640890|FG007|Induction|Entered another COG therapeutic protocol|0|||
105722804|NCT00408005|364640883|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
105722805|NCT00408005|364640884|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
105792618|NCT00424632|364896410|FG007|Overall Study|Global deterioration of health status|0|||
105792619|NCT00424632|364896411|FG008|Overall Study|Global deterioration of health status|0|||
105792620|NCT00424632|364896412|FG009|Overall Study|Global deterioration of health status|0|||
105792621|NCT00424632|364896403|FG000|Overall Study|Objective progression or relapse|1|||
105792622|NCT00424632|364896404|FG001|Overall Study|Objective progression or relapse|1|||
105792623|NCT00424632|364896405|FG002|Overall Study|Objective progression or relapse|1|||
105792624|NCT00424632|364896406|FG003|Overall Study|Objective progression or relapse|2|||
105792625|NCT00424632|364896407|FG004|Overall Study|Objective progression or relapse|2|||
105792626|NCT00424632|364896408|FG005|Overall Study|Objective progression or relapse|13|||
105792627|NCT00424632|364896409|FG006|Overall Study|Objective progression or relapse|7|||
105792628|NCT00424632|364896410|FG007|Overall Study|Objective progression or relapse|3|||
105792629|NCT00424632|364896411|FG008|Overall Study|Objective progression or relapse|12|||
105792630|NCT00424632|364896412|FG009|Overall Study|Objective progression or relapse|4|||
105792631|NCT00424632|364896403|FG000|Overall Study|Other|0|||
105792632|NCT00424632|364896404|FG001|Overall Study|Other|0|||
105792633|NCT00424632|364896405|FG002|Overall Study|Other|0|||
105792634|NCT00424632|364896406|FG003|Overall Study|Other|1|||
105792635|NCT00424632|364896407|FG004|Overall Study|Other|0|||
105792636|NCT00424632|364896408|FG005|Overall Study|Other|0|||
105792637|NCT00424632|364896409|FG006|Overall Study|Other|0|||
105792638|NCT00424632|364896410|FG007|Overall Study|Other|0|||
105792639|NCT00424632|364896411|FG008|Overall Study|Other|1|||
105792640|NCT00424632|364896412|FG009|Overall Study|Other|0|||
105792641|NCT01215955|364896416|FG000|Overall Study|Adverse Event|1|||
105792642|NCT01215955|364896417|FG001|Overall Study|Adverse Event|4|||
105792643|NCT01215955|364896418|FG002|Overall Study|Adverse Event|2|||
105792644|NCT01215955|364896419|FG003|Overall Study|Adverse Event|3|||
105792645|NCT01215955|364896416|FG000|Overall Study|Death|2|||
105792646|NCT01215955|364896417|FG001|Overall Study|Death|0|||
105792647|NCT01215955|364896418|FG002|Overall Study|Death|1|||
105792648|NCT01215955|364896419|FG003|Overall Study|Death|3|||
105792649|NCT01215955|364896416|FG000|Overall Study|Entry Criteria Not Met|1|||
105792650|NCT01215955|364896417|FG001|Overall Study|Entry Criteria Not Met|3|||
105792651|NCT01215955|364896418|FG002|Overall Study|Entry Criteria Not Met|4|||
105792652|NCT01215955|364896419|FG003|Overall Study|Entry Criteria Not Met|7|||
105792653|NCT01215955|364896416|FG000|Overall Study|Lack of Efficacy|1|||
105792654|NCT01215955|364896417|FG001|Overall Study|Lack of Efficacy|2|||
105722806|NCT00408005|364640885|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
105722807|NCT00408005|364640886|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
105722808|NCT00408005|364640887|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
105722809|NCT00408005|364640888|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
105722810|NCT00408005|364640889|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
105722811|NCT00408005|364640890|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
105722812|NCT00408005|364640883|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
105722813|NCT00408005|364640884|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
105722814|NCT00408005|364640885|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
105722815|NCT00408005|364640886|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
105722816|NCT00408005|364640887|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
105722817|NCT00408005|364640888|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
105722818|NCT00408005|364640889|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
105722819|NCT00408005|364640890|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
105722820|NCT00408005|364640883|FG000|Induction|Progressive Disease|0|||
105722821|NCT00408005|364640884|FG001|Induction|Progressive Disease|1|||
105722822|NCT00408005|364640885|FG002|Induction|Progressive Disease|0|||
105722823|NCT00408005|364640886|FG003|Induction|Progressive Disease|0|||
105722824|NCT00408005|364640887|FG004|Induction|Progressive Disease|0|||
105722825|NCT00408005|364640888|FG005|Induction|Progressive Disease|0|||
105722826|NCT00408005|364640889|FG006|Induction|Progressive Disease|0|||
105722827|NCT00408005|364640890|FG007|Induction|Progressive Disease|0|||
105722828|NCT00408005|364640883|FG000|Induction|Inevaluable|18|||
105722829|NCT00408005|364640884|FG001|Induction|Inevaluable|14|||
105722830|NCT00408005|364640885|FG002|Induction|Inevaluable|0|||
105722831|NCT00408005|364640886|FG003|Induction|Inevaluable|0|||
105722832|NCT00408005|364640887|FG004|Induction|Inevaluable|0|||
105722833|NCT00408005|364640888|FG005|Induction|Inevaluable|0|||
105722834|NCT00408005|364640889|FG006|Induction|Inevaluable|0|||
105722835|NCT00408005|364640890|FG007|Induction|Inevaluable|0|||
105722836|NCT00408005|364640883|FG000|Induction|Failed to Complete Randomization|3|||
105722837|NCT00408005|364640884|FG001|Induction|Failed to Complete Randomization|2|||
105722838|NCT00408005|364640885|FG002|Induction|Failed to Complete Randomization|0|||
105722839|NCT00408005|364640886|FG003|Induction|Failed to Complete Randomization|0|||
105722840|NCT00408005|364640887|FG004|Induction|Failed to Complete Randomization|0|||
105722841|NCT00408005|364640888|FG005|Induction|Failed to Complete Randomization|0|||
105722842|NCT00408005|364640889|FG006|Induction|Failed to Complete Randomization|0|||
105792655|NCT01215955|364896418|FG002|Overall Study|Lack of Efficacy|1|||
105792656|NCT01215955|364896419|FG003|Overall Study|Lack of Efficacy|0|||
105792657|NCT01215955|364896416|FG000|Overall Study|Lost to Follow-up|4|||
105792658|NCT01215955|364896417|FG001|Overall Study|Lost to Follow-up|4|||
105792659|NCT01215955|364896418|FG002|Overall Study|Lost to Follow-up|8|||
105792660|NCT01215955|364896419|FG003|Overall Study|Lost to Follow-up|9|||
105792661|NCT01215955|364896416|FG000|Overall Study|Physician Decision|4|||
105722843|NCT00408005|364640890|FG007|Induction|Failed to Complete Randomization|0|||
105722844|NCT00408005|364640883|FG000|Induction|Protocol Deviation|3|||
105722845|NCT00408005|364640884|FG001|Induction|Protocol Deviation|1|||
105722846|NCT00408005|364640885|FG002|Induction|Protocol Deviation|0|||
105722847|NCT00408005|364640886|FG003|Induction|Protocol Deviation|0|||
105722848|NCT00408005|364640887|FG004|Induction|Protocol Deviation|0|||
105722849|NCT00408005|364640888|FG005|Induction|Protocol Deviation|0|||
105722850|NCT00408005|364640889|FG006|Induction|Protocol Deviation|0|||
105722851|NCT00408005|364640890|FG007|Induction|Protocol Deviation|0|||
105722852|NCT00408005|364640883|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
105722853|NCT00408005|364640884|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
105722854|NCT00408005|364640885|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
105722855|NCT00408005|364640886|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
105722856|NCT00408005|364640887|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
105722857|NCT00408005|364640888|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
105722858|NCT00408005|364640889|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
105722859|NCT00408005|364640890|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
105722860|NCT00408005|364640883|FG000|Induction|Recurrent leukemia|1|||
105722861|NCT00408005|364640884|FG001|Induction|Recurrent leukemia|0|||
105722862|NCT00408005|364640885|FG002|Induction|Recurrent leukemia|0|||
105722863|NCT00408005|364640886|FG003|Induction|Recurrent leukemia|0|||
105722864|NCT00408005|364640887|FG004|Induction|Recurrent leukemia|0|||
105722865|NCT00408005|364640888|FG005|Induction|Recurrent leukemia|0|||
105722866|NCT00408005|364640889|FG006|Induction|Recurrent leukemia|0|||
105722867|NCT00408005|364640890|FG007|Induction|Recurrent leukemia|0|||
105722868|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
105722869|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
105722870|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
105722871|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
105722872|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
105722873|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
105722874|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
105722875|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
105722876|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
105722877|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
105722878|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
105722879|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
105722880|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
105722881|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
105722882|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
105722883|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
105722884|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
105722885|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
105722886|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
105722887|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
105722888|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
105722889|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
105722890|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
105722891|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
105722892|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
105722893|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
105722894|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
105722895|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
105722896|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
105722897|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
105722898|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
105722899|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
105722900|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
105562888|NCT01820559|364057526|FG001|Overall Study|Subject's non-compliance|0|||
105722901|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
105722902|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
105722903|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
105722904|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
105722905|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
105722906|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
105722907|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
105722908|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
105722909|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
105722910|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
105722911|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
105722912|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
105722913|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
105722914|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
105722915|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
105722916|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
105722917|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
105722918|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
105722919|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
105722920|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
105722921|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
105722922|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
105722923|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
105722924|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
105722925|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
105722926|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
105722927|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
105722928|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
105722929|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
105722930|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
105722931|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
105722932|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
105722933|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
105722934|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
105722935|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
105722936|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
105722937|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
105722938|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
105722939|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
105722940|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
105722941|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
105722942|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
105722943|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
105722944|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
105722945|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
105722946|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
105722947|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
105722948|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
105722949|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
105722950|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
105722951|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
105722952|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
105722953|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
105722954|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
105722955|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
105722956|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
105722957|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
105722958|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
105722959|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
105722960|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
105722961|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
105722962|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
105722963|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
105722964|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
105722965|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
105722966|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
105722967|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
105722968|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
105722969|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
105722970|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
105722971|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
105722972|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
105722973|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
105722974|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
105722975|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
105722976|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
105722977|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
105722978|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
105722979|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
105722980|NCT06118385|364640891|FG000|Overall Study|Protocol Violation|0|||
105722981|NCT06118385|364640892|FG001|Overall Study|Protocol Violation|0|||
105722982|NCT06118385|364640893|FG002|Overall Study|Protocol Violation|0|||
105722983|NCT06118385|364640894|FG003|Overall Study|Protocol Violation|0|||
105722984|NCT06118385|364640895|FG004|Overall Study|Protocol Violation|0|||
105722985|NCT06118385|364640896|FG005|Overall Study|Protocol Violation|0|||
105722986|NCT06118385|364640897|FG006|Overall Study|Protocol Violation|0|||
105722987|NCT06118385|364640898|FG007|Overall Study|Protocol Violation|0|||
105722988|NCT06118385|364640899|FG008|Overall Study|Protocol Violation|1|||
105722989|NCT06118385|364640900|FG009|Overall Study|Protocol Violation|0|||
105722990|NCT06118385|364640901|FG010|Overall Study|Protocol Violation|0|||
105722991|NCT06118385|364640902|FG011|Overall Study|Protocol Violation|0|||
105722992|NCT06118385|364640891|FG000|Overall Study|Out-of-range blood tests|0|||
105722993|NCT06118385|364640892|FG001|Overall Study|Out-of-range blood tests|0|||
105722994|NCT06118385|364640893|FG002|Overall Study|Out-of-range blood tests|0|||
105722995|NCT06118385|364640894|FG003|Overall Study|Out-of-range blood tests|0|||
105722996|NCT06118385|364640895|FG004|Overall Study|Out-of-range blood tests|0|||
105722997|NCT06118385|364640896|FG005|Overall Study|Out-of-range blood tests|0|||
105722998|NCT06118385|364640897|FG006|Overall Study|Out-of-range blood tests|0|||
105722999|NCT06118385|364640898|FG007|Overall Study|Out-of-range blood tests|0|||
105723000|NCT06118385|364640899|FG008|Overall Study|Out-of-range blood tests|1|||
105723001|NCT06118385|364640900|FG009|Overall Study|Out-of-range blood tests|0|||
105723002|NCT06118385|364640901|FG010|Overall Study|Out-of-range blood tests|0|||
105723003|NCT06118385|364640902|FG011|Overall Study|Out-of-range blood tests|0|||
105723004|NCT01701258|364640903|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
105723005|NCT01701258|364640904|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
105723006|NCT01701258|364640905|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
105723007|NCT01701258|364640906|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
105723008|NCT01701258|364640907|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
105723009|NCT01701258|364640908|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
105723010|NCT01701258|364640909|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
105723011|NCT01701258|364640910|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
105723012|NCT01701258|364640911|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
105723013|NCT01701258|364640912|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
105723014|NCT01701258|364640913|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
105723015|NCT01701258|364640914|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
105723016|NCT01701258|364640915|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
105723017|NCT01701258|364640903|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
105723018|NCT01701258|364640904|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
105723019|NCT01701258|364640905|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
105723020|NCT01701258|364640906|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
105723021|NCT01701258|364640907|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
105723022|NCT01701258|364640908|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
105723023|NCT01701258|364640909|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
105723024|NCT01701258|364640910|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
105723025|NCT01701258|364640911|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
105723026|NCT01701258|364640912|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
105723027|NCT01701258|364640913|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
105723028|NCT01701258|364640914|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
105723029|NCT01701258|364640915|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
105723030|NCT01701258|364640903|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
105723031|NCT01701258|364640904|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
105723032|NCT01701258|364640905|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
105562889|NCT01820559|364057527|FG002|Overall Study|Subject's non-compliance|2|||
105562890|NCT01820559|364057525|FG000|Overall Study|Lost to Follow-up|3|||
105792662|NCT01215955|364896417|FG001|Overall Study|Physician Decision|10|||
105792663|NCT01215955|364896418|FG002|Overall Study|Physician Decision|8|||
105792664|NCT01215955|364896419|FG003|Overall Study|Physician Decision|11|||
105792665|NCT01215955|364896416|FG000|Overall Study|Protocol Violation|17|||
105792666|NCT01215955|364896417|FG001|Overall Study|Protocol Violation|13|||
105792667|NCT01215955|364896418|FG002|Overall Study|Protocol Violation|8|||
105792668|NCT01215955|364896419|FG003|Overall Study|Protocol Violation|8|||
105792669|NCT01215955|364896416|FG000|Overall Study|Sponsor Decision|1|||
105792670|NCT01215955|364896417|FG001|Overall Study|Sponsor Decision|2|||
105792671|NCT01215955|364896418|FG002|Overall Study|Sponsor Decision|0|||
105792672|NCT01215955|364896419|FG003|Overall Study|Sponsor Decision|1|||
105792673|NCT01215955|364896416|FG000|Overall Study|Withdrawal by Subject|14|||
105792674|NCT01215955|364896417|FG001|Overall Study|Withdrawal by Subject|15|||
105792675|NCT01215955|364896418|FG002|Overall Study|Withdrawal by Subject|13|||
105792676|NCT01215955|364896419|FG003|Overall Study|Withdrawal by Subject|9|||
105792677|NCT01215955|364896416|FG000|Overall Study|Quality Issues|0|||
105792678|NCT01215955|364896417|FG001|Overall Study|Quality Issues|0|||
105792679|NCT01215955|364896418|FG002|Overall Study|Quality Issues|3|||
105792680|NCT01215955|364896419|FG003|Overall Study|Quality Issues|2|||
105792681|NCT00445458|364896420|FG000|Overall Study|Disease Progression|3|||
105792682|NCT00445458|364896421|FG001|Overall Study|Disease Progression|4|||
105792683|NCT00445458|364896422|FG002|Overall Study|Disease Progression|54|||
105792684|NCT00445458|364896423|FG003|Overall Study|Disease Progression|27|||
105792685|NCT00445458|364896420|FG000|Overall Study|Withdrawal by Subject|0|||
105792686|NCT00445458|364896421|FG001|Overall Study|Withdrawal by Subject|0|||
105792687|NCT00445458|364896422|FG002|Overall Study|Withdrawal by Subject|7|||
105792688|NCT00445458|364896423|FG003|Overall Study|Withdrawal by Subject|0|||
105792689|NCT00445458|364896420|FG000|Overall Study|Adverse Event|0|||
105792690|NCT00445458|364896421|FG001|Overall Study|Adverse Event|0|||
105792691|NCT00445458|364896422|FG002|Overall Study|Adverse Event|3|||
105792692|NCT00445458|364896423|FG003|Overall Study|Adverse Event|0|||
105792693|NCT00445458|364896420|FG000|Overall Study|Death|0|||
105792694|NCT00445458|364896421|FG001|Overall Study|Death|1|||
105792695|NCT00445458|364896422|FG002|Overall Study|Death|2|||
105792696|NCT00445458|364896423|FG003|Overall Study|Death|0|||
105792697|NCT00445458|364896420|FG000|Overall Study|Physician Decision|0|||
105792698|NCT00445458|364896421|FG001|Overall Study|Physician Decision|0|||
105792699|NCT00445458|364896422|FG002|Overall Study|Physician Decision|1|||
105792700|NCT00445458|364896423|FG003|Overall Study|Physician Decision|1|||
105792701|NCT00445458|364896420|FG000|Overall Study|Surgery|0|||
105792702|NCT00445458|364896421|FG001|Overall Study|Surgery|0|||
105792703|NCT00445458|364896422|FG002|Overall Study|Surgery|1|||
105792704|NCT00445458|364896423|FG003|Overall Study|Surgery|0|||
105792705|NCT03972709|364896424|FG000|Overall Study|Withdrawal by Subject|18|||
105792706|NCT03972709|364896425|FG001|Overall Study|Withdrawal by Subject|7|||
105792707|NCT03972709|364896426|FG002|Overall Study|Withdrawal by Subject|14|||
105792708|NCT03972709|364896424|FG000|Overall Study|Study Terminated by Sponsor|48|||
105792709|NCT03972709|364896425|FG001|Overall Study|Study Terminated by Sponsor|25|||
105792710|NCT03972709|364896426|FG002|Overall Study|Study Terminated by Sponsor|50|||
105792711|NCT03972709|364896424|FG000|Overall Study|Physician Decision|1|||
105792712|NCT03972709|364896425|FG001|Overall Study|Physician Decision|0|||
105792713|NCT03972709|364896426|FG002|Overall Study|Physician Decision|0|||
105792714|NCT03972709|364896424|FG000|Overall Study|COVID-19|0|||
105792715|NCT03972709|364896425|FG001|Overall Study|COVID-19|1|||
105792716|NCT03972709|364896426|FG002|Overall Study|COVID-19|1|||
105792717|NCT03972709|364896424|FG000|Overall Study|Lost to Follow-up|6|||
105792718|NCT03972709|364896425|FG001|Overall Study|Lost to Follow-up|1|||
105792719|NCT03972709|364896426|FG002|Overall Study|Lost to Follow-up|2|||
105792720|NCT03972709|364896424|FG000|Overall Study|Death|5|||
105792721|NCT03972709|364896425|FG001|Overall Study|Death|1|||
105792722|NCT03972709|364896426|FG002|Overall Study|Death|4|||
105478485|NCT04093024|363764265|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
105478486|NCT04093024|363764264|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
105478487|NCT04093024|363764265|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
105478488|NCT04093024|363764264|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
105792723|NCT03972709|364896424|FG000|Overall Study|Adverse Event|3|||
105792724|NCT03972709|364896425|FG001|Overall Study|Adverse Event|1|||
105792725|NCT03972709|364896426|FG002|Overall Study|Adverse Event|4|||
105792726|NCT03972709|364896424|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
105792727|NCT03972709|364896425|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
105792728|NCT03972709|364896426|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
105792729|NCT03972709|364896424|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
105792730|NCT03972709|364896425|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
105792731|NCT03972709|364896426|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
105792732|NCT03972709|364896424|FG000|Overall Study|Subject Unable to be Contacted|0|||
105792733|NCT03972709|364896425|FG001|Overall Study|Subject Unable to be Contacted|1|||
105562891|NCT01820559|364057526|FG001|Overall Study|Lost to Follow-up|2|||
105723033|NCT01701258|364640906|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
105723034|NCT01701258|364640907|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
105723035|NCT01701258|364640908|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
105723036|NCT01701258|364640909|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
105723037|NCT01701258|364640910|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
105723038|NCT01701258|364640911|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
105723039|NCT01701258|364640912|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
105723040|NCT01701258|364640913|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
105723041|NCT01701258|364640914|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
105723042|NCT01701258|364640915|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
105723043|NCT01701258|364640903|FG000|Assessment and Scheduling|Investigator Terminated|2|||
105723044|NCT01701258|364640904|FG001|Assessment and Scheduling|Investigator Terminated|0|||
105723045|NCT01701258|364640905|FG002|Assessment and Scheduling|Investigator Terminated|0|||
105723046|NCT01701258|364640906|FG003|Assessment and Scheduling|Investigator Terminated|0|||
105723047|NCT01701258|364640907|FG004|Assessment and Scheduling|Investigator Terminated|0|||
105723048|NCT01701258|364640908|FG005|Assessment and Scheduling|Investigator Terminated|0|||
105723049|NCT01701258|364640909|FG006|Assessment and Scheduling|Investigator Terminated|0|||
105723050|NCT01701258|364640910|FG007|Assessment and Scheduling|Investigator Terminated|0|||
105723051|NCT01701258|364640911|FG008|Assessment and Scheduling|Investigator Terminated|0|||
105723052|NCT01701258|364640912|FG009|Assessment and Scheduling|Investigator Terminated|0|||
105723053|NCT01701258|364640913|FG010|Assessment and Scheduling|Investigator Terminated|0|||
105723054|NCT01701258|364640914|FG011|Assessment and Scheduling|Investigator Terminated|0|||
105723055|NCT01701258|364640915|FG012|Assessment and Scheduling|Investigator Terminated|0|||
105723056|NCT01848145|364640916|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
105723057|NCT01848145|364640916|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
105723058|NCT01848145|364640916|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
105723059|NCT01848145|364640916|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
105723060|NCT01848145|364640916|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
105723061|NCT01848145|364640916|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
105723062|NCT01848145|364640916|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
105723063|NCT03041311|364640922|FG000|Overall Study|Death|39|||
105723064|NCT03041311|364640923|FG001|Overall Study|Death|42|||
105723065|NCT03041311|364640922|FG000|Overall Study|Lost to Follow-up|0|||
105723066|NCT03041311|364640923|FG001|Overall Study|Lost to Follow-up|1|||
105723067|NCT03041311|364640922|FG000|Overall Study|Withdrawal by Subject|8|||
105723068|NCT03041311|364640923|FG001|Overall Study|Withdrawal by Subject|5|||
105723069|NCT03041311|364640922|FG000|Overall Study|Sponsor Terminated Study|2|||
105723070|NCT03041311|364640923|FG001|Overall Study|Sponsor Terminated Study|4|||
105723071|NCT03041311|364640922|FG000|Overall Study|Disease Progression|3|||
105723072|NCT03041311|364640923|FG001|Overall Study|Disease Progression|1|||
105723073|NCT03041311|364640922|FG000|Overall Study|Randomized in error, did not receive drug|2|||
105723074|NCT03041311|364640923|FG001|Overall Study|Randomized in error, did not receive drug|0|||
105723075|NCT04398732|364640924|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
105723076|NCT00556426|364640925|FG000|Overall Study|Withdrawal by Subject|3|||
105723077|NCT00556426|364640925|FG000|Overall Study|Death|6|||
105723078|NCT00474240|364640929|FG000|Overall Study|Withdrawal by Subject|1|||
105723079|NCT00474240|364640930|FG001|Overall Study|Withdrawal by Subject|1|||
105723080|NCT00474240|364640931|FG002|Overall Study|Withdrawal by Subject|0|||
105723081|NCT00474240|364640932|FG003|Overall Study|Withdrawal by Subject|2|||
105723082|NCT00474240|364640933|FG004|Overall Study|Withdrawal by Subject|3|||
105723083|NCT00474240|364640934|FG005|Overall Study|Withdrawal by Subject|1|||
105723084|NCT00474240|364640929|FG000|Overall Study|Adverse Event|0|||
105723085|NCT00474240|364640930|FG001|Overall Study|Adverse Event|0|||
105723086|NCT00474240|364640931|FG002|Overall Study|Adverse Event|9|||
105723087|NCT00474240|364640932|FG003|Overall Study|Adverse Event|14|||
105723088|NCT00474240|364640933|FG004|Overall Study|Adverse Event|5|||
105723089|NCT00474240|364640934|FG005|Overall Study|Adverse Event|16|||
105723090|NCT00474240|364640929|FG000|Overall Study|Removed due to lab value|0|||
105723091|NCT00474240|364640930|FG001|Overall Study|Removed due to lab value|0|||
105723092|NCT00474240|364640931|FG002|Overall Study|Removed due to lab value|0|||
105562892|NCT01820559|364057527|FG002|Overall Study|Lost to Follow-up|2|||
105723093|NCT00474240|364640932|FG003|Overall Study|Removed due to lab value|0|||
105723094|NCT00474240|364640933|FG004|Overall Study|Removed due to lab value|0|||
105723095|NCT00474240|364640934|FG005|Overall Study|Removed due to lab value|1|||
105792734|NCT03972709|364896426|FG002|Overall Study|Subject Unable to be Contacted|0|||
105792735|NCT03972709|364896424|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
105792736|NCT03972709|364896425|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
105792737|NCT03972709|364896426|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
105792738|NCT03972709|364896424|FG000|Overall Study|Subject Moved|0|||
105792739|NCT03972709|364896425|FG001|Overall Study|Subject Moved|1|||
105792740|NCT03972709|364896426|FG002|Overall Study|Subject Moved|0|||
105792741|NCT03972709|364896424|FG000|Overall Study|Missed Study Visits|1|||
105792742|NCT03972709|364896425|FG001|Overall Study|Missed Study Visits|0|||
105792743|NCT03972709|364896426|FG002|Overall Study|Missed Study Visits|0|||
105792744|NCT03159611|364896427|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
105792745|NCT03159611|364896428|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
105792746|NCT03159611|364896427|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
105792747|NCT03159611|364896428|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
105478489|NCT04093024|363764265|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
105723096|NCT02054702|364640935|FG000|Overall Study|Lost to Follow-up|3|||
105723097|NCT02054702|364640936|FG001|Overall Study|Lost to Follow-up|5|||
105723098|NCT02054702|364640935|FG000|Overall Study|Adverse Event|3|||
105723099|NCT02054702|364640936|FG001|Overall Study|Adverse Event|1|||
105723100|NCT02054702|364640935|FG000|Overall Study|Met Withdrawal Criteria|4|||
105723101|NCT02054702|364640936|FG001|Overall Study|Met Withdrawal Criteria|1|||
105723102|NCT02054702|364640935|FG000|Overall Study|Physician Decision|0|||
105723103|NCT02054702|364640936|FG001|Overall Study|Physician Decision|1|||
105723104|NCT02054702|364640935|FG000|Overall Study|Withdrawal by Subject|14|||
105723105|NCT02054702|364640936|FG001|Overall Study|Withdrawal by Subject|4|||
105723106|NCT02347631|364640939|FG000|First Intervention (2 Months)|Adverse Event|1|||
105723107|NCT02347631|364640940|FG001|First Intervention (2 Months)|Adverse Event|1|||
105723108|NCT02347631|364640939|FG000|First Intervention (2 Months)|Pregnancy|1|||
105723109|NCT02347631|364640940|FG001|First Intervention (2 Months)|Pregnancy|0|||
105723110|NCT02347631|364640939|FG000|First Intervention (2 Months)|Moved out of area|0|||
105723111|NCT02347631|364640940|FG001|First Intervention (2 Months)|Moved out of area|2|||
105723112|NCT02347631|364640939|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
105723113|NCT02347631|364640940|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
105723114|NCT02347631|364640939|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
105723115|NCT02347631|364640940|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
105723116|NCT02347631|364640939|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
105723117|NCT02347631|364640940|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
105723118|NCT02347631|364640939|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
105723119|NCT02347631|364640940|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
105723120|NCT02347631|364640939|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
105723121|NCT02347631|364640940|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
105723122|NCT02304926|364640942|FG000|Overall Study|Lost to Follow-up|2|||
105723123|NCT02304926|364640943|FG001|Overall Study|Lost to Follow-up|1|||
105723124|NCT01147926|364640952|FG000|Overall Study|Subject Withdrew Consent|9|||
105723125|NCT01147926|364640953|FG001|Overall Study|Subject Withdrew Consent|10|||
105723126|NCT01147926|364640952|FG000|Overall Study|Adverse Event|7|||
105723127|NCT01147926|364640953|FG001|Overall Study|Adverse Event|6|||
105723128|NCT01147926|364640952|FG000|Overall Study|Subject Non-Compliant|5|||
105723129|NCT01147926|364640953|FG001|Overall Study|Subject Non-Compliant|4|||
105723130|NCT01147926|364640952|FG000|Overall Study|Principal investigator left hospital|1|||
105723131|NCT01147926|364640953|FG001|Overall Study|Principal investigator left hospital|3|||
105723132|NCT01147926|364640952|FG000|Overall Study|Selection criteria not met|3|||
105723133|NCT01147926|364640953|FG001|Overall Study|Selection criteria not met|1|||
105723134|NCT01147926|364640952|FG000|Overall Study|Lost to Follow-up|0|||
105723135|NCT01147926|364640953|FG001|Overall Study|Lost to Follow-up|2|||
105723136|NCT01147926|364640952|FG000|Overall Study|Sponsor's Decision|0|||
105723137|NCT01147926|364640953|FG001|Overall Study|Sponsor's Decision|1|||
105723138|NCT01147926|364640952|FG000|Overall Study|Lack of Efficacy|1|||
105723139|NCT01147926|364640953|FG001|Overall Study|Lack of Efficacy|0|||
105723140|NCT01147926|364640952|FG000|Overall Study|Too busy, no time for study|1|||
105723141|NCT01147926|364640953|FG001|Overall Study|Too busy, no time for study|0|||
105723142|NCT01147926|364640952|FG000|Overall Study|Went on holiday|0|||
105723143|NCT01147926|364640953|FG001|Overall Study|Went on holiday|1|||
105723144|NCT01147926|364640952|FG000|Overall Study|Colonoscopy result|0|||
105723145|NCT01147926|364640953|FG001|Overall Study|Colonoscopy result|1|||
105723146|NCT03417440|364640954|FG000|Overall Study|Lost to Follow-up|0|||
105723147|NCT03417440|364640955|FG001|Overall Study|Lost to Follow-up|1|||
105723148|NCT03417440|364640956|FG002|Overall Study|Lost to Follow-up|0|||
105723149|NCT03417440|364640957|FG003|Overall Study|Lost to Follow-up|0|||
105723150|NCT03417440|364640958|FG004|Overall Study|Lost to Follow-up|1|||
105792748|NCT03159611|364896427|FG000|Overall Study|Protocol Violation|7|||
105792749|NCT03159611|364896428|FG001|Overall Study|Protocol Violation|4|||
105792750|NCT03159611|364896427|FG000|Overall Study|Adverse Event|1|||
105792751|NCT03159611|364896428|FG001|Overall Study|Adverse Event|0|||
105792752|NCT03159611|364896427|FG000|Overall Study|Withdrawal by Subject|1|||
105792753|NCT03159611|364896428|FG001|Overall Study|Withdrawal by Subject|1|||
105792754|NCT03159611|364896427|FG000|Overall Study|Non-compliance with protocol requirement|3|||
105792755|NCT03159611|364896428|FG001|Overall Study|Non-compliance with protocol requirement|2|||
105792756|NCT03159611|364896427|FG000|Overall Study|Inability to perform procedures|1|||
105792757|NCT03159611|364896428|FG001|Overall Study|Inability to perform procedures|0|||
105792758|NCT04732728|364896429|FG000|Overall Study|Death|12|||
105792759|NCT04732728|364896429|FG000|Overall Study|Withdrawn|136|||
105792760|NCT01984229|364896430|FG000|Safety Follow-up Period|Adverse Event|1|||
105792761|NCT01984229|364896431|FG001|Safety Follow-up Period|Adverse Event|1|||
105792762|NCT01984229|364896430|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
105792763|NCT01984229|364896431|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
105792764|NCT02575807|364896438|FG000|Overall Study|Death|8|||
105792765|NCT02575807|364896439|FG001|Overall Study|Death|3|||
105792766|NCT02575807|364896440|FG002|Overall Study|Death|7|||
105792767|NCT02575807|364896441|FG003|Overall Study|Death|0|||
105792768|NCT02575807|364896442|FG004|Overall Study|Death|1|||
105792769|NCT02575807|364896438|FG000|Overall Study|Study terminated by Sponsor|0|||
105792770|NCT02575807|364896439|FG001|Overall Study|Study terminated by Sponsor|1|||
105792771|NCT02575807|364896440|FG002|Overall Study|Study terminated by Sponsor|7|||
105792772|NCT02575807|364896441|FG003|Overall Study|Study terminated by Sponsor|0|||
105792773|NCT02575807|364896442|FG004|Overall Study|Study terminated by Sponsor|1|||
105792774|NCT02575807|364896438|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
105792775|NCT02575807|364896439|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
105792776|NCT02575807|364896440|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
105792777|NCT02575807|364896441|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
105792778|NCT02575807|364896442|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
105792779|NCT02575807|364896438|FG000|Overall Study|Terminated due to physician decision|0|||
105792780|NCT02575807|364896439|FG001|Overall Study|Terminated due to physician decision|0|||
105792781|NCT02575807|364896440|FG002|Overall Study|Terminated due to physician decision|1|||
105792782|NCT02575807|364896441|FG003|Overall Study|Terminated due to physician decision|0|||
105792783|NCT02575807|364896442|FG004|Overall Study|Terminated due to physician decision|0|||
105792784|NCT02575807|364896438|FG000|Overall Study|Subject ineligible - medical implant|0|||
105792785|NCT02575807|364896439|FG001|Overall Study|Subject ineligible - medical implant|0|||
105792786|NCT02575807|364896440|FG002|Overall Study|Subject ineligible - medical implant|0|||
105792787|NCT02575807|364896441|FG003|Overall Study|Subject ineligible - medical implant|1|||
105792788|NCT02575807|364896442|FG004|Overall Study|Subject ineligible - medical implant|0|||
105792789|NCT02575807|364896438|FG000|Overall Study|Withdrawal by Subject|0|||
105792790|NCT02575807|364896439|FG001|Overall Study|Withdrawal by Subject|0|||
105792791|NCT02575807|364896440|FG002|Overall Study|Withdrawal by Subject|1|||
105792792|NCT02575807|364896441|FG003|Overall Study|Withdrawal by Subject|1|||
105792793|NCT02575807|364896442|FG004|Overall Study|Withdrawal by Subject|2|||
105792794|NCT03319368|364896443|FG000|Overall Study|Discharge swabs not collected from resident|57|||
105792795|NCT03319368|364896444|FG001|Overall Study|Discharge swabs not collected from resident|46|||
105792796|NCT03000075|364896445|FG000|Part A|Adverse Event|4|||
105792797|NCT03000075|364896446|FG001|Part A|Adverse Event|0|||
105792798|NCT03000075|364896447|FG002|Part A|Adverse Event|0|||
105792799|NCT03000075|364896448|FG003|Part A|Adverse Event|0|||
105792800|NCT03000075|364896449|FG004|Part A|Adverse Event|0|||
105792801|NCT03000075|364896450|FG005|Part A|Adverse Event|0|||
105792802|NCT03000075|364896451|FG006|Part A|Adverse Event|0|||
105792803|NCT03000075|364896445|FG000|Part B|Not dosed due to AE|0|||
105792804|NCT03000075|364896446|FG001|Part B|Not dosed due to AE|0|||
105792805|NCT03000075|364896447|FG002|Part B|Not dosed due to AE|0|||
105792806|NCT03000075|364896448|FG003|Part B|Not dosed due to AE|0|||
105792807|NCT03000075|364896449|FG004|Part B|Not dosed due to AE|0|||
105792808|NCT03000075|364896450|FG005|Part B|Not dosed due to AE|2|||
105792809|NCT03000075|364896451|FG006|Part B|Not dosed due to AE|1|||
105792810|NCT03000075|364896445|FG000|Part B|Adverse Event|0|||
105792811|NCT03000075|364896446|FG001|Part B|Adverse Event|0|||
105792812|NCT03000075|364896447|FG002|Part B|Adverse Event|0|||
105792813|NCT03000075|364896448|FG003|Part B|Adverse Event|0|||
105792814|NCT03000075|364896449|FG004|Part B|Adverse Event|1|||
105792815|NCT03000075|364896450|FG005|Part B|Adverse Event|0|||
105792816|NCT03000075|364896451|FG006|Part B|Adverse Event|0|||
105352868|NCT03959488|363297002|FG000|Season 1|Withdrawal by parent/guardian|43|||
105792817|NCT02180659|364896452|FG000|Overall Study|Adverse Event|1|||
105792818|NCT02180659|364896453|FG001|Overall Study|Adverse Event|0|||
105792819|NCT02180659|364896452|FG000|Overall Study|Lost to Follow-up|4|||
105792820|NCT02180659|364896453|FG001|Overall Study|Lost to Follow-up|2|||
105792821|NCT02180659|364896452|FG000|Overall Study|Subject incarcerated during conduct|1|||
105352869|NCT03959488|363297003|FG001|Season 1|Withdrawal by parent/guardian|28|||
105792822|NCT02180659|364896453|FG001|Overall Study|Subject incarcerated during conduct|0|||
105792823|NCT02180659|364896452|FG000|Overall Study|Withdrawal by Subject|0|||
105352870|NCT03959488|363297004|FG002|Season 1|Withdrawal by parent/guardian|0|||
105792824|NCT02180659|364896453|FG001|Overall Study|Withdrawal by Subject|2|||
105792825|NCT02180659|364896452|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
105723151|NCT03417440|364640959|FG005|Overall Study|Lost to Follow-up|0|||
105723152|NCT03417440|364640960|FG006|Overall Study|Lost to Follow-up|0|||
105723153|NCT03417440|364640961|FG007|Overall Study|Lost to Follow-up|0|||
105723154|NCT03417440|364640954|FG000|Overall Study|Withdrawal by Subject|2|||
105723155|NCT03417440|364640955|FG001|Overall Study|Withdrawal by Subject|0|||
105723156|NCT03417440|364640956|FG002|Overall Study|Withdrawal by Subject|2|||
105723157|NCT03417440|364640957|FG003|Overall Study|Withdrawal by Subject|1|||
105723158|NCT03417440|364640958|FG004|Overall Study|Withdrawal by Subject|1|||
105723159|NCT03417440|364640959|FG005|Overall Study|Withdrawal by Subject|0|||
105723160|NCT03417440|364640960|FG006|Overall Study|Withdrawal by Subject|0|||
105723161|NCT03417440|364640961|FG007|Overall Study|Withdrawal by Subject|1|||
105723162|NCT01032629|364640968|FG000|Overall Study|Closed Site|21|||
105723163|NCT01032629|364640969|FG001|Overall Study|Closed Site|18|||
105723164|NCT01032629|364640970|FG002|Overall Study|Closed Site|16|||
105723165|NCT01032629|364640968|FG000|Overall Study|Withdrawal by Subject|50|||
105723166|NCT01032629|364640969|FG001|Overall Study|Withdrawal by Subject|36|||
105723167|NCT01032629|364640970|FG002|Overall Study|Withdrawal by Subject|35|||
105723168|NCT01032629|364640968|FG000|Overall Study|Lost to Follow-up|74|||
105723169|NCT01032629|364640969|FG001|Overall Study|Lost to Follow-up|47|||
105723170|NCT01032629|364640970|FG002|Overall Study|Lost to Follow-up|37|||
105723171|NCT03371355|364640971|FG000|Overall Study|Investigator judgment|0|||
105723172|NCT03371355|364640972|FG001|Overall Study|Investigator judgment|0|||
105723173|NCT03371355|364640973|FG002|Overall Study|Investigator judgment|1|||
105723174|NCT03371355|364640974|FG003|Overall Study|Investigator judgment|1|||
105723175|NCT03371355|364640971|FG000|Overall Study|Voluntary withdrawal|1|||
105723176|NCT03371355|364640972|FG001|Overall Study|Voluntary withdrawal|0|||
105723177|NCT03371355|364640973|FG002|Overall Study|Voluntary withdrawal|1|||
105723178|NCT03371355|364640974|FG003|Overall Study|Voluntary withdrawal|2|||
105723179|NCT03371355|364640971|FG000|Overall Study|Adverse Event|0|||
105723180|NCT03371355|364640972|FG001|Overall Study|Adverse Event|1|||
105723181|NCT03371355|364640973|FG002|Overall Study|Adverse Event|2|||
105723182|NCT03371355|364640974|FG003|Overall Study|Adverse Event|3|||
105723183|NCT03371355|364640971|FG000|Overall Study|Reason not Specified|0|||
105723184|NCT03371355|364640972|FG001|Overall Study|Reason not Specified|1|||
105723185|NCT03371355|364640973|FG002|Overall Study|Reason not Specified|0|||
105723186|NCT03371355|364640974|FG003|Overall Study|Reason not Specified|1|||
105723187|NCT03403400|364640977|FG000|Overall Study|Lost to Follow-up|1|||
105723188|NCT03403400|364640978|FG001|Overall Study|Lost to Follow-up|0|||
105723189|NCT03403400|364640979|FG002|Overall Study|Lost to Follow-up|1|||
105723190|NCT03403400|364640977|FG000|Overall Study|Hospitalization|1|||
105723191|NCT03403400|364640978|FG001|Overall Study|Hospitalization|0|||
105723192|NCT03403400|364640979|FG002|Overall Study|Hospitalization|0|||
105723193|NCT03403400|364640977|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
105723194|NCT03403400|364640978|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
105723195|NCT03403400|364640979|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
105723196|NCT01763164|364640980|FG000|Treatment Phase|Participant/Guardian decision|26|||
105723197|NCT01763164|364640981|FG001|Treatment Phase|Participant/Guardian decision|14|||
105723198|NCT01763164|364640980|FG000|Treatment Phase|Protocol Violation|1|||
105723199|NCT01763164|364640981|FG001|Treatment Phase|Protocol Violation|1|||
105723200|NCT01763164|364640980|FG000|Treatment Phase|Progressive Disease|142|||
105723201|NCT01763164|364640981|FG001|Treatment Phase|Progressive Disease|76|||
105723202|NCT01763164|364640980|FG000|Treatment Phase|Physician Decision|24|||
105723203|NCT01763164|364640981|FG001|Treatment Phase|Physician Decision|13|||
105723204|NCT01763164|364640980|FG000|Treatment Phase|Death|10|||
105723205|NCT01763164|364640981|FG001|Treatment Phase|Death|1|||
105723206|NCT01763164|364640980|FG000|Treatment Phase|Adverse Event|66|||
105723207|NCT01763164|364640981|FG001|Treatment Phase|Adverse Event|8|||
105562893|NCT01820559|364057525|FG000|Overall Study|At sponsor request|0|||
105723208|NCT01763164|364640980|FG000|Treatment Phase|Randomized but not Treated|0|||
105723209|NCT01763164|364640981|FG001|Treatment Phase|Randomized but not Treated|19|||
105723210|NCT01763164|364640980|FG000|Treatment Phase|Other|0|||
105723211|NCT01763164|364640981|FG001|Treatment Phase|Other|1|||
105723212|NCT01763164|364640980|FG000|Follow up Phase|New therapy for study indication|12|||
105562894|NCT01820559|364057526|FG001|Overall Study|At sponsor request|0|||
105723213|NCT01763164|364640981|FG001|Follow up Phase|New therapy for study indication|3|||
105723214|NCT01763164|364640980|FG000|Follow up Phase|Death|21|||
105723215|NCT01763164|364640981|FG001|Follow up Phase|Death|4|||
105723216|NCT01763164|364640980|FG000|Follow up Phase|Subject/guardian decision|9|||
105723217|NCT01763164|364640981|FG001|Follow up Phase|Subject/guardian decision|2|||
105723218|NCT01763164|364640980|FG000|Follow up Phase|Progressive disease|127|||
105723219|NCT01763164|364640981|FG001|Follow up Phase|Progressive disease|62|||
105723220|NCT01763164|364640980|FG000|Follow up Phase|Physician Decision|10|||
105723221|NCT01763164|364640981|FG001|Follow up Phase|Physician Decision|3|||
105723222|NCT01763164|364640980|FG000|Follow up Phase|Lost to Follow-up|1|||
105723223|NCT01763164|364640981|FG001|Follow up Phase|Lost to Follow-up|0|||
105723224|NCT01763164|364640980|FG000|Follow up Phase|Adverse Event|17|||
105723225|NCT01763164|364640981|FG001|Follow up Phase|Adverse Event|1|||
105723226|NCT01526148|364640993|FG000|Overall Study|Adverse Event|6|||
105723227|NCT01526148|364640994|FG001|Overall Study|Adverse Event|5|||
105723228|NCT01526148|364640993|FG000|Overall Study|Lost to Follow-up|3|||
105723229|NCT01526148|364640994|FG001|Overall Study|Lost to Follow-up|6|||
105723230|NCT01526148|364640993|FG000|Overall Study|Withdrawal by Subject|2|||
105723231|NCT01526148|364640994|FG001|Overall Study|Withdrawal by Subject|0|||
105723232|NCT01526148|364640993|FG000|Overall Study|Unstable Medical Condition|1|||
105723233|NCT01526148|364640994|FG001|Overall Study|Unstable Medical Condition|0|||
105723234|NCT01526148|364640993|FG000|Overall Study|Unable to discontinue concomitant med|1|||
105723235|NCT01526148|364640994|FG001|Overall Study|Unable to discontinue concomitant med|0|||
105723236|NCT01526148|364640993|FG000|Overall Study|Moved out of state|1|||
105723237|NCT01526148|364640994|FG001|Overall Study|Moved out of state|0|||
105723238|NCT01526148|364640993|FG000|Overall Study|Incarcerated|0|||
105723239|NCT01526148|364640994|FG001|Overall Study|Incarcerated|2|||
105723240|NCT03529409|364640997|FG000|Randomized|Lost to Follow-up|0|||
105723241|NCT03529409|364640998|FG001|Randomized|Lost to Follow-up|0|||
105723242|NCT03529409|364640999|FG002|Randomized|Lost to Follow-up|4|||
105723243|NCT03529409|364640997|FG000|Randomized|Excluded|0|||
105723244|NCT03529409|364640998|FG001|Randomized|Excluded|0|||
105723245|NCT03529409|364640999|FG002|Randomized|Excluded|1|||
105723246|NCT03529409|364640997|FG000|Post-treatment Assessment|Death|1|||
105723247|NCT03529409|364640998|FG001|Post-treatment Assessment|Death|0|||
105723248|NCT03529409|364640999|FG002|Post-treatment Assessment|Death|0|||
105723249|NCT03529409|364640997|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
105723250|NCT03529409|364640998|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
105723251|NCT03529409|364640999|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
105723252|NCT03529409|364640997|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
105723253|NCT03529409|364640998|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
105723254|NCT03529409|364640999|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
105723255|NCT03529409|364640997|FG000|Follow-up Assessment|Death|1|||
105723256|NCT03529409|364640998|FG001|Follow-up Assessment|Death|0|||
105723257|NCT03529409|364640999|FG002|Follow-up Assessment|Death|0|||
105723258|NCT03529409|364640997|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
105723259|NCT03529409|364640998|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
105723260|NCT03529409|364640999|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
105723261|NCT03898063|364641000|FG000|Overall Study|Withdrawal by Subject|10|||
105723262|NCT03898063|364641001|FG001|Overall Study|Withdrawal by Subject|8|||
105723263|NCT02305563|364641002|FG000|Treatment Period|Disease progression|0|||
105723264|NCT02305563|364641003|FG001|Treatment Period|Disease progression|0|||
105723265|NCT02305563|364641004|FG002|Treatment Period|Disease progression|15|||
105723266|NCT02305563|364641005|FG003|Treatment Period|Disease progression|6|||
105723267|NCT02305563|364641006|FG004|Treatment Period|Disease progression|6|||
105723268|NCT02305563|364641002|FG000|Treatment Period|Study drug toxicity|0|||
105723269|NCT02305563|364641003|FG001|Treatment Period|Study drug toxicity|0|||
105723270|NCT02305563|364641004|FG002|Treatment Period|Study drug toxicity|0|||
105723271|NCT02305563|364641005|FG003|Treatment Period|Study drug toxicity|1|||
105723272|NCT02305563|364641006|FG004|Treatment Period|Study drug toxicity|2|||
105723273|NCT02305563|364641002|FG000|Treatment Period|Death|0|||
105723274|NCT02305563|364641003|FG001|Treatment Period|Death|0|||
105723275|NCT02305563|364641004|FG002|Treatment Period|Death|1|||
105723276|NCT02305563|364641005|FG003|Treatment Period|Death|2|||
105723277|NCT02305563|364641006|FG004|Treatment Period|Death|1|||
105723278|NCT02305563|364641002|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
105723279|NCT02305563|364641003|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
105723280|NCT02305563|364641004|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
105723281|NCT02305563|364641005|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
105723282|NCT02305563|364641006|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
105723283|NCT02305563|364641002|FG000|Treatment Period|Participant request to stop therapy|0|||
105723284|NCT02305563|364641003|FG001|Treatment Period|Participant request to stop therapy|2|||
105723285|NCT02305563|364641004|FG002|Treatment Period|Participant request to stop therapy|0|||
105723286|NCT02305563|364641005|FG003|Treatment Period|Participant request to stop therapy|1|||
105723287|NCT02305563|364641006|FG004|Treatment Period|Participant request to stop therapy|0|||
105723288|NCT02305563|364641002|FG000|Treatment Period|Participant withdrew consent|0|||
105723289|NCT02305563|364641003|FG001|Treatment Period|Participant withdrew consent|0|||
105723290|NCT02305563|364641004|FG002|Treatment Period|Participant withdrew consent|1|||
105723291|NCT02305563|364641005|FG003|Treatment Period|Participant withdrew consent|1|||
105723292|NCT02305563|364641006|FG004|Treatment Period|Participant withdrew consent|1|||
105723293|NCT02305563|364641002|FG000|Treatment Period|Maximum clinical benefit|0|||
105723294|NCT02305563|364641003|FG001|Treatment Period|Maximum clinical benefit|0|||
105723295|NCT02305563|364641004|FG002|Treatment Period|Maximum clinical benefit|0|||
105723296|NCT02305563|364641005|FG003|Treatment Period|Maximum clinical benefit|0|||
105723297|NCT02305563|364641006|FG004|Treatment Period|Maximum clinical benefit|1|||
105723298|NCT02305563|364641002|FG000|Treatment Period|Poor/non-compliance|0|||
105723299|NCT02305563|364641003|FG001|Treatment Period|Poor/non-compliance|0|||
105723300|NCT02305563|364641004|FG002|Treatment Period|Poor/non-compliance|0|||
105723301|NCT02305563|364641005|FG003|Treatment Period|Poor/non-compliance|0|||
105723302|NCT02305563|364641006|FG004|Treatment Period|Poor/non-compliance|1|||
105723303|NCT02305563|364641002|FG000|Treatment Period|Administrative reason by Sponsor|0|||
105723304|NCT02305563|364641003|FG001|Treatment Period|Administrative reason by Sponsor|0|||
105723305|NCT02305563|364641004|FG002|Treatment Period|Administrative reason by Sponsor|0|||
105723306|NCT02305563|364641005|FG003|Treatment Period|Administrative reason by Sponsor|0|||
105723307|NCT02305563|364641006|FG004|Treatment Period|Administrative reason by Sponsor|1|||
105723308|NCT02305563|364641002|FG000|Treatment Period|other reason|2|||
105723309|NCT02305563|364641003|FG001|Treatment Period|other reason|0|||
105723310|NCT02305563|364641004|FG002|Treatment Period|other reason|2|||
105723311|NCT02305563|364641005|FG003|Treatment Period|other reason|2|||
105723312|NCT02305563|364641006|FG004|Treatment Period|other reason|1|||
105723313|NCT02305563|364641002|FG000|Treatment Period|Randomized but not treated|0|||
105723314|NCT02305563|364641003|FG001|Treatment Period|Randomized but not treated|0|||
105723315|NCT02305563|364641004|FG002|Treatment Period|Randomized but not treated|0|||
105723316|NCT02305563|364641005|FG003|Treatment Period|Randomized but not treated|0|||
105723317|NCT02305563|364641006|FG004|Treatment Period|Randomized but not treated|2|||
105723318|NCT02305563|364641002|FG000|Treatment Period|added ULO, then disease progression|0|||
105723319|NCT02305563|364641003|FG001|Treatment Period|added ULO, then disease progression|0|||
105723320|NCT02305563|364641004|FG002|Treatment Period|added ULO, then disease progression|0|||
105723321|NCT02305563|364641005|FG003|Treatment Period|added ULO, then disease progression|0|||
105723322|NCT02305563|364641006|FG004|Treatment Period|added ULO, then disease progression|4|||
105723323|NCT02305563|364641002|FG000|Treatment Period|added ULO; then other reason|0|||
105723324|NCT02305563|364641003|FG001|Treatment Period|added ULO; then other reason|0|||
105723325|NCT02305563|364641004|FG002|Treatment Period|added ULO; then other reason|0|||
105723326|NCT02305563|364641005|FG003|Treatment Period|added ULO; then other reason|0|||
105723327|NCT02305563|364641006|FG004|Treatment Period|added ULO; then other reason|1|||
105723328|NCT02305563|364641002|FG000|Treatment Period|added ULO, then request to stop|0|||
105723329|NCT02305563|364641003|FG001|Treatment Period|added ULO, then request to stop|0|||
105723330|NCT02305563|364641004|FG002|Treatment Period|added ULO, then request to stop|0|||
105723331|NCT02305563|364641005|FG003|Treatment Period|added ULO, then request to stop|0|||
105723332|NCT02305563|364641006|FG004|Treatment Period|added ULO, then request to stop|1|||
105723333|NCT02305563|364641002|FG000|Follow-up Period|Death|0|||
105723334|NCT02305563|364641003|FG001|Follow-up Period|Death|0|||
105723335|NCT02305563|364641004|FG002|Follow-up Period|Death|5|||
105723336|NCT02305563|364641005|FG003|Follow-up Period|Death|4|||
105723337|NCT02305563|364641006|FG004|Follow-up Period|Death|7|||
105723338|NCT02305563|364641002|FG000|Follow-up Period|Participant withdrew consent|0|||
105723339|NCT02305563|364641003|FG001|Follow-up Period|Participant withdrew consent|0|||
105723340|NCT02305563|364641004|FG002|Follow-up Period|Participant withdrew consent|2|||
105723341|NCT02305563|364641005|FG003|Follow-up Period|Participant withdrew consent|1|||
105723342|NCT02305563|364641006|FG004|Follow-up Period|Participant withdrew consent|0|||
105723343|NCT02305563|364641002|FG000|Follow-up Period|other reason|0|||
105723344|NCT02305563|364641003|FG001|Follow-up Period|other reason|0|||
105723345|NCT02305563|364641004|FG002|Follow-up Period|other reason|0|||
105723346|NCT02305563|364641005|FG003|Follow-up Period|other reason|0|||
105723347|NCT02305563|364641006|FG004|Follow-up Period|other reason|1|||
105723348|NCT02305563|364641002|FG000|Follow-up Period|Followup no longer required per protocol|3|||
105723349|NCT02305563|364641003|FG001|Follow-up Period|Followup no longer required per protocol|3|||
105723350|NCT02305563|364641004|FG002|Follow-up Period|Followup no longer required per protocol|4|||
105723351|NCT02305563|364641005|FG003|Follow-up Period|Followup no longer required per protocol|1|||
105723352|NCT02305563|364641006|FG004|Follow-up Period|Followup no longer required per protocol|4|||
105723353|NCT00642642|364641007|FG000|Treatment & Follow Up|Adverse Event|2|||
105723354|NCT00642642|364641007|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
105723355|NCT00642642|364641007|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
105723356|NCT02959814|364641008|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
105723357|NCT02959814|364641008|FG000|Overall Study|Excluded based on anatomical criteria|2|||
105723358|NCT02959814|364641008|FG000|Overall Study|Protocol Violation|7|||
105723359|NCT02959814|364641008|FG000|Overall Study|FFR not measured|2|||
105723360|NCT02959814|364641008|FG000|Overall Study|In-procedure QFR not computed|6|||
105723361|NCT02959814|364641008|FG000|Overall Study|Excluded by FFR core-lab|24|||
105723362|NCT01889602|364641011|FG000|First Intervention|Adverse Event|1|||
105723363|NCT01889602|364641012|FG001|First Intervention|Adverse Event|1|||
105723364|NCT01889602|364641013|FG002|First Intervention|Adverse Event|1|||
105723365|NCT01889602|364641011|FG000|First Intervention|Protocol Violation|0|||
105723366|NCT01889602|364641012|FG001|First Intervention|Protocol Violation|1|||
105723367|NCT01889602|364641013|FG002|First Intervention|Protocol Violation|1|||
105723368|NCT01889602|364641011|FG000|First Intervention|Study ending|0|||
105723369|NCT01889602|364641012|FG001|First Intervention|Study ending|1|||
105723370|NCT01889602|364641013|FG002|First Intervention|Study ending|0|||
105723371|NCT01889602|364641011|FG000|Second Intervention|Adverse Event|0|||
105723372|NCT01889602|364641012|FG001|Second Intervention|Adverse Event|0|||
105723373|NCT01889602|364641013|FG002|Second Intervention|Adverse Event|1|||
105723374|NCT01889602|364641011|FG000|Second Intervention|Study ending|1|||
105723375|NCT01889602|364641012|FG001|Second Intervention|Study ending|0|||
105723376|NCT01889602|364641013|FG002|Second Intervention|Study ending|0|||
105723377|NCT01889602|364641011|FG000|Second Intervention|Withdrawal by Subject|0|||
105723378|NCT01889602|364641012|FG001|Second Intervention|Withdrawal by Subject|0|||
105723379|NCT01889602|364641013|FG002|Second Intervention|Withdrawal by Subject|1|||
105723380|NCT01889602|364641011|FG000|Third Intervention|Protocol Violation|1|||
105723381|NCT01889602|364641012|FG001|Third Intervention|Protocol Violation|0|||
105723382|NCT01889602|364641013|FG002|Third Intervention|Protocol Violation|0|||
105723383|NCT01889602|364641011|FG000|Third Intervention|Withdrawal by Subject|2|||
105723384|NCT01889602|364641012|FG001|Third Intervention|Withdrawal by Subject|2|||
105723385|NCT01889602|364641013|FG002|Third Intervention|Withdrawal by Subject|0|||
105723386|NCT00961961|364641014|FG000|Phase I|Withdrawal by Subject|7|||
105723387|NCT00961961|364641015|FG001|Phase I|Withdrawal by Subject|0|||
105723388|NCT00961961|364641016|FG002|Phase I|Withdrawal by Subject|0|||
105723389|NCT00961961|364641017|FG003|Phase I|Withdrawal by Subject|0|||
105723390|NCT00961961|364641014|FG000|Phase I|Lost to Follow-up|10|||
105723391|NCT00961961|364641015|FG001|Phase I|Lost to Follow-up|0|||
105723392|NCT00961961|364641016|FG002|Phase I|Lost to Follow-up|0|||
105723393|NCT00961961|364641017|FG003|Phase I|Lost to Follow-up|0|||
105723394|NCT00961961|364641014|FG000|Phase I|Lack of Efficacy|94|||
105723395|NCT00961961|364641015|FG001|Phase I|Lack of Efficacy|0|||
105723396|NCT00961961|364641016|FG002|Phase I|Lack of Efficacy|0|||
105723397|NCT00961961|364641017|FG003|Phase I|Lack of Efficacy|0|||
105723398|NCT00961961|364641014|FG000|Phase I|Adverse Event|7|||
105723399|NCT00961961|364641015|FG001|Phase I|Adverse Event|0|||
105723400|NCT00961961|364641016|FG002|Phase I|Adverse Event|0|||
105723401|NCT00961961|364641017|FG003|Phase I|Adverse Event|0|||
105723402|NCT00961961|364641014|FG000|Phase I|Physician Decision|8|||
105723403|NCT00961961|364641015|FG001|Phase I|Physician Decision|0|||
105723404|NCT00961961|364641016|FG002|Phase I|Physician Decision|0|||
105723405|NCT00961961|364641017|FG003|Phase I|Physician Decision|0|||
105723406|NCT00961961|364641014|FG000|Phase II|Lost to Follow-up|0|||
105723407|NCT00961961|364641015|FG001|Phase II|Lost to Follow-up|0|||
105723408|NCT00961961|364641016|FG002|Phase II|Lost to Follow-up|10|||
105723409|NCT00961961|364641017|FG003|Phase II|Lost to Follow-up|7|||
105723410|NCT00961961|364641014|FG000|Phase II|Adverse Event|0|||
105723411|NCT00961961|364641015|FG001|Phase II|Adverse Event|0|||
105723412|NCT00961961|364641016|FG002|Phase II|Adverse Event|0|||
105723413|NCT00961961|364641017|FG003|Phase II|Adverse Event|1|||
105723414|NCT00961961|364641014|FG000|Phase II|Physician Decision|0|||
105723415|NCT00961961|364641015|FG001|Phase II|Physician Decision|0|||
105723416|NCT00961961|364641016|FG002|Phase II|Physician Decision|1|||
105723417|NCT00961961|364641017|FG003|Phase II|Physician Decision|0|||
105723418|NCT00961961|364641014|FG000|Phase II|Withdrawal by Subject|0|||
105723419|NCT00961961|364641015|FG001|Phase II|Withdrawal by Subject|0|||
105723420|NCT00961961|364641016|FG002|Phase II|Withdrawal by Subject|1|||
105723421|NCT00961961|364641017|FG003|Phase II|Withdrawal by Subject|0|||
105723422|NCT01511445|364641018|FG000|Overall Study|Lost to Follow-up|3|||
105723423|NCT01511445|364641019|FG001|Overall Study|Lost to Follow-up|1|||
105723424|NCT01511445|364641018|FG000|Overall Study|Protocol Violation|1|||
105723425|NCT01511445|364641019|FG001|Overall Study|Protocol Violation|3|||
105723426|NCT01511445|364641018|FG000|Overall Study|Protocol Violation|1|||
105723427|NCT01511445|364641019|FG001|Overall Study|Protocol Violation|0|||
105723428|NCT01245673|364641022|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
105723429|NCT04752384|364641023|FG000|Overall Study|Withdrawal by Subject|1|||
105723430|NCT04752384|364641023|FG000|Overall Study|Death|1|||
105723431|NCT01468311|364641024|FG000|Overall Study|mobilization failure|1|||
105723432|NCT01468311|364641024|FG000|Overall Study|Withdrawal by Subject|1|||
105723433|NCT00924703|364641025|FG000|Overall Study|Withdrawal by Subject|11|||
105723434|NCT00924703|364641025|FG000|Overall Study|Physician Decision|5|||
105723435|NCT00924703|364641025|FG000|Overall Study|Lost to Follow-up|3|||
105723436|NCT00924703|364641025|FG000|Overall Study|Adverse Event|2|||
105723437|NCT00924703|364641025|FG000|Overall Study|Withdrawal by Sponsor|1|||
105723438|NCT00666562|364641026|FG000|Overall Study|Withdrawal by Subject|0|||
105723439|NCT00666562|364641027|FG001|Overall Study|Withdrawal by Subject|1|||
105723440|NCT00666562|364641028|FG002|Overall Study|Withdrawal by Subject|0|||
105723441|NCT00666562|364641026|FG000|Overall Study|Concomitant Medication|0|||
105723442|NCT00666562|364641027|FG001|Overall Study|Concomitant Medication|1|||
105723443|NCT00666562|364641028|FG002|Overall Study|Concomitant Medication|0|||
105723444|NCT04906707|364641029|FG000|Overall Study|Withdrawal by Subject|2|||
105723445|NCT04906707|364641030|FG001|Overall Study|Withdrawal by Subject|0|||
105723446|NCT04906707|364641029|FG000|Overall Study|Withdrawal due to PI decision|1|||
105723447|NCT04906707|364641030|FG001|Overall Study|Withdrawal due to PI decision|0|||
105723448|NCT04906707|364641029|FG000|Overall Study|Lost to Follow-up|0|||
105723449|NCT04906707|364641030|FG001|Overall Study|Lost to Follow-up|1|||
105723450|NCT00891202|364641032|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
105723451|NCT00891202|364641033|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
105792826|NCT02180659|364896453|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
105792827|NCT00824993|364896454|FG000|Overall Study|Withdrawal by Subject|1|||
105792828|NCT00824993|364896455|FG001|Overall Study|Withdrawal by Subject|1|||
105792829|NCT00824993|364896454|FG000|Overall Study|Malignancy Relapse|9|||
105792830|NCT00824993|364896455|FG001|Overall Study|Malignancy Relapse|10|||
105792831|NCT00824993|364896454|FG000|Overall Study|Rapid Bone Loss|0|||
105792832|NCT00824993|364896455|FG001|Overall Study|Rapid Bone Loss|1|||
105792833|NCT00824993|364896454|FG000|Overall Study|Non-Compliant|2|||
105792834|NCT00824993|364896455|FG001|Overall Study|Non-Compliant|1|||
105792835|NCT00824993|364896454|FG000|Overall Study|Insurance Issue|2|||
105792836|NCT00824993|364896455|FG001|Overall Study|Insurance Issue|1|||
105792837|NCT00824993|364896454|FG000|Overall Study|Death|0|||
105792838|NCT00824993|364896455|FG001|Overall Study|Death|3|||
105792839|NCT01495793|364896456|FG000|Overall Study|Lost to Follow-up|1|||
105792840|NCT01495793|364896456|FG000|Overall Study|Violation of inclusion criteria|1|||
105792841|NCT00834366|364896457|FG000|Treatment Period 1|Adverse Event|1|||
105792842|NCT00834366|364896458|FG001|Treatment Period 1|Adverse Event|1|||
105792843|NCT01275170|364896464|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
105792844|NCT01275170|364896465|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
105792845|NCT01275170|364896466|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
105792846|NCT01275170|364896467|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
105792847|NCT01275170|364896468|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
105792848|NCT01275170|364896469|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
105792849|NCT01275170|364896470|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
105792850|NCT01275170|364896471|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
105792851|NCT03940742|364896472|FG000|Overall Study|Lost to Follow-up|0|||
105792852|NCT03940742|364896473|FG001|Overall Study|Lost to Follow-up|0|||
105792853|NCT03940742|364896474|FG002|Overall Study|Lost to Follow-up|0|||
105792854|NCT03940742|364896475|FG003|Overall Study|Lost to Follow-up|1|||
105792855|NCT03252015|364896479|FG000|Overall Study|Withdrawal by Subject|0|||
105792856|NCT03252015|364896480|FG001|Overall Study|Withdrawal by Subject|1|||
105792857|NCT03252015|364896481|FG002|Overall Study|Withdrawal by Subject|1|||
105792858|NCT03252015|364896482|FG003|Overall Study|Withdrawal by Subject|0|||
105792859|NCT03252015|364896479|FG000|Overall Study|Adverse Event|1|||
105792860|NCT03252015|364896480|FG001|Overall Study|Adverse Event|0|||
105792861|NCT03252015|364896481|FG002|Overall Study|Adverse Event|0|||
105792862|NCT03252015|364896482|FG003|Overall Study|Adverse Event|1|||
105792863|NCT00390572|364896483|FG000|Overall Study|Lost to Follow-up|8|||
105792864|NCT00390572|364896484|FG001|Overall Study|Lost to Follow-up|4|||
105792865|NCT00390572|364896483|FG000|Overall Study|health condition|0|||
105792866|NCT00390572|364896484|FG001|Overall Study|health condition|1|||
105792867|NCT03107715|364896485|FG000|Overall Study|did not deliver at the home hospital|4|||
105792868|NCT03107715|364896486|FG001|Overall Study|did not deliver at the home hospital|6|||
105792869|NCT03107715|364896485|FG000|Overall Study|infant stillborn|0|||
105792870|NCT03107715|364896486|FG001|Overall Study|infant stillborn|1|||
105792871|NCT02149199|364896494|FG000|Overall Study|Study specific withdrawal criteria|4|||
105723452|NCT00891202|364641034|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
105723453|NCT00891202|364641035|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
105792872|NCT02149199|364896495|FG001|Overall Study|Study specific withdrawal criteria|21|||
105792873|NCT02149199|364896496|FG002|Overall Study|Study specific withdrawal criteria|6|||
105792874|NCT02149199|364896494|FG000|Overall Study|Other|20|||
105792875|NCT02149199|364896495|FG001|Overall Study|Other|25|||
105792876|NCT02149199|364896496|FG002|Overall Study|Other|20|||
105792877|NCT02149199|364896494|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
105792878|NCT02149199|364896495|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
105723454|NCT00891202|364641032|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
105723455|NCT00891202|364641033|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
105723456|NCT00891202|364641034|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
105723457|NCT00891202|364641035|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
105723458|NCT00891202|364641032|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
105723459|NCT00891202|364641033|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
105723460|NCT00891202|364641034|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
105723461|NCT00891202|364641035|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
105723462|NCT00891202|364641032|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
105723463|NCT00891202|364641033|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
105723464|NCT00891202|364641034|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
105723465|NCT00891202|364641035|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
105723466|NCT00684177|364641036|FG000|Overall Study|Adverse Event|4|||
105723467|NCT00684177|364641037|FG001|Overall Study|Adverse Event|3|||
105723468|NCT00684177|364641036|FG000|Overall Study|Lack of Efficacy|10|||
105723469|NCT00684177|364641037|FG001|Overall Study|Lack of Efficacy|15|||
105723470|NCT00684177|364641036|FG000|Overall Study|Protocol Violation|1|||
105723471|NCT00684177|364641037|FG001|Overall Study|Protocol Violation|0|||
105723472|NCT00684177|364641036|FG000|Overall Study|Lost to Follow-up|2|||
105723473|NCT00684177|364641037|FG001|Overall Study|Lost to Follow-up|1|||
105723474|NCT00684177|364641036|FG000|Overall Study|Physician Decision|2|||
105723475|NCT00684177|364641037|FG001|Overall Study|Physician Decision|0|||
105723476|NCT00684177|364641036|FG000|Overall Study|Withdrawal by Subject|1|||
105723477|NCT00684177|364641037|FG001|Overall Study|Withdrawal by Subject|2|||
105723478|NCT00684177|364641036|FG000|Overall Study|Other|1|||
105723479|NCT00684177|364641037|FG001|Overall Study|Other|2|||
105723480|NCT04211337|364641038|FG000|Overall Study|On Treatment|175|||
105723481|NCT04211337|364641039|FG001|Overall Study|On Treatment|40|||
105723482|NCT04211337|364641038|FG000|Overall Study|Withdrawal by Subject|0|||
105723483|NCT04211337|364641039|FG001|Overall Study|Withdrawal by Subject|2|||
105723484|NCT04980391|364641050|FG000|Overall Study|Death|0|||
105723485|NCT04980391|364641051|FG001|Overall Study|Death|0|||
105723486|NCT04980391|364641052|FG002|Overall Study|Death|1|||
105723487|NCT04980391|364641053|FG003|Overall Study|Death|1|||
105723488|NCT04980391|364641050|FG000|Overall Study|Lost to Follow-up|3|||
105723489|NCT04980391|364641051|FG001|Overall Study|Lost to Follow-up|3|||
105723490|NCT04980391|364641052|FG002|Overall Study|Lost to Follow-up|2|||
105723491|NCT04980391|364641053|FG003|Overall Study|Lost to Follow-up|3|||
105723492|NCT04980391|364641050|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
105723493|NCT04980391|364641051|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
105723494|NCT04980391|364641052|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
105723495|NCT04980391|364641053|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
105723496|NCT04980391|364641050|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105723497|NCT04980391|364641051|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105723498|NCT04980391|364641052|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
105723499|NCT04980391|364641053|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105723500|NCT04980391|364641050|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
105723501|NCT04980391|364641051|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
105723502|NCT04980391|364641052|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
105723503|NCT04980391|364641053|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
105723504|NCT04025632|364642569|FG000|Overall Study|Adverse Event|1|||
105723505|NCT04025632|364642570|FG001|Overall Study|Adverse Event|1|||
105723506|NCT04025632|364642569|FG000|Overall Study|Withdrawal by Subject|1|||
105723507|NCT04025632|364642570|FG001|Overall Study|Withdrawal by Subject|1|||
105723508|NCT04025632|364642569|FG000|Overall Study|Study Terminated by Sponsor|10|||
105723509|NCT04025632|364642570|FG001|Overall Study|Study Terminated by Sponsor|9|||
105723510|NCT04025632|364642569|FG000|Overall Study|Physician Decision|3|||
105723511|NCT04025632|364642570|FG001|Overall Study|Physician Decision|1|||
105723512|NCT00376961|364642571|FG000|Initial Registration|Adverse Event|1|||
105723513|NCT00376961|364642572|FG001|Initial Registration|Adverse Event|0|||
105723514|NCT00376961|364642571|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
105723515|NCT00376961|364642572|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
105723516|NCT00376961|364642571|FG000|Initial Registration|Progression/relapse|1|||
105723517|NCT00376961|364642572|FG001|Initial Registration|Progression/relapse|0|||
105723518|NCT00376961|364642571|FG000|Initial Registration|Ineligible|3|||
105723519|NCT00376961|364642572|FG001|Initial Registration|Ineligible|0|||
105723520|NCT00376961|364642571|FG000|Maintenance|Adverse Event|0|||
105723521|NCT00376961|364642572|FG001|Maintenance|Adverse Event|1|||
105352871|NCT03959488|363297005|FG003|Season 1|Withdrawal by parent/guardian|0|||
105723522|NCT00376961|364642571|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
105723523|NCT00376961|364642572|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
105723524|NCT00376961|364642571|FG000|Maintenance|Progression/relapse|0|||
105723525|NCT00376961|364642572|FG001|Maintenance|Progression/relapse|18|||
105723526|NCT00376961|364642571|FG000|Maintenance|Ineligible|0|||
105723527|NCT00376961|364642572|FG001|Maintenance|Ineligible|3|||
105723528|NCT02185521|364642582|FG000|Overall Study|Withdrawal by Subject|1|||
105723529|NCT02185521|364642582|FG000|Overall Study|Protocol Violation|1|||
105723530|NCT00496366|364642585|FG000|Overall Study|Death|1|||
105723531|NCT05211336|364642591|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
105723532|NCT05211336|364642592|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
105723533|NCT05211336|364642591|FG000|Overall Study|Progressive disease|0|||
105723534|NCT05211336|364642592|FG001|Overall Study|Progressive disease|4|||
105723535|NCT05211336|364642591|FG000|Overall Study|Death due to myocardial infarction|0|||
105723536|NCT05211336|364642592|FG001|Overall Study|Death due to myocardial infarction|1|||
105723537|NCT05211336|364642591|FG000|Overall Study|Death due to unknown cause|0|||
105723538|NCT05211336|364642592|FG001|Overall Study|Death due to unknown cause|1|||
105723539|NCT05211336|364642591|FG000|Overall Study|Worsening kidney function and quality of response|0|||
105723540|NCT05211336|364642592|FG001|Overall Study|Worsening kidney function and quality of response|1|||
105723541|NCT03902080|364642596|FG000|Overall Study|Adverse Event|17|||
105723542|NCT03902080|364642597|FG001|Overall Study|Adverse Event|15|||
105723543|NCT03902080|364642596|FG000|Overall Study|Withdrawal by Subject|28|||
105723544|NCT03902080|364642597|FG001|Overall Study|Withdrawal by Subject|35|||
105723545|NCT03902080|364642596|FG000|Overall Study|Lost to Follow-up|6|||
105723546|NCT03902080|364642597|FG001|Overall Study|Lost to Follow-up|7|||
105723547|NCT03902080|364642596|FG000|Overall Study|Other|3|||
105723548|NCT03902080|364642597|FG001|Overall Study|Other|5|||
105723549|NCT03902080|364642596|FG000|Overall Study|Non compliance|4|||
105723550|NCT03902080|364642597|FG001|Overall Study|Non compliance|3|||
105723551|NCT03902080|364642596|FG000|Overall Study|Physician Decision|5|||
105723552|NCT03902080|364642597|FG001|Overall Study|Physician Decision|1|||
105723553|NCT03902080|364642596|FG000|Overall Study|Protocol Violation|3|||
105723554|NCT03902080|364642597|FG001|Overall Study|Protocol Violation|3|||
105723555|NCT03902080|364642596|FG000|Overall Study|Lack of Efficacy|1|||
105723556|NCT03902080|364642597|FG001|Overall Study|Lack of Efficacy|3|||
105723557|NCT03902080|364642596|FG000|Overall Study|Withdrawn prior to dosing|0|||
105723558|NCT03902080|364642597|FG001|Overall Study|Withdrawn prior to dosing|1|||
105723559|NCT00332709|364642598|FG000|Overall Study|Adverse Event|11|||
105723560|NCT00332709|364642599|FG001|Overall Study|Adverse Event|14|||
105723561|NCT00332709|364642598|FG000|Overall Study|Withdrawal by Subject|2|||
105723562|NCT00332709|364642599|FG001|Overall Study|Withdrawal by Subject|3|||
105723563|NCT00332709|364642598|FG000|Overall Study|Lost to Follow-up|2|||
105723564|NCT00332709|364642599|FG001|Overall Study|Lost to Follow-up|0|||
105723565|NCT00332709|364642598|FG000|Overall Study|Administrative Problems|0|||
105723566|NCT00332709|364642599|FG001|Overall Study|Administrative Problems|3|||
105723567|NCT00332709|364642598|FG000|Overall Study|Abnormal test procedure result|1|||
105723568|NCT00332709|364642599|FG001|Overall Study|Abnormal test procedure result|0|||
105723569|NCT01409928|364642601|FG000|Overall Study|Physician Decision|12|||
105723570|NCT01703000|364642602|FG000|Overall Study|Death|1|||
105723571|NCT00434967|364642605|FG000|Overall Study|Adverse Event|2|||
105723572|NCT00434967|364642606|FG001|Overall Study|Adverse Event|4|||
105723573|NCT00434967|364642607|FG002|Overall Study|Adverse Event|3|||
105723574|NCT00434967|364642608|FG003|Overall Study|Adverse Event|3|||
105723575|NCT00434967|364642605|FG000|Overall Study|Lost to Follow-up|0|||
105723576|NCT00434967|364642606|FG001|Overall Study|Lost to Follow-up|0|||
105723577|NCT00434967|364642607|FG002|Overall Study|Lost to Follow-up|1|||
105723578|NCT00434967|364642608|FG003|Overall Study|Lost to Follow-up|0|||
105723579|NCT00434967|364642605|FG000|Overall Study|Withdrawal by Subject|2|||
105723580|NCT00434967|364642606|FG001|Overall Study|Withdrawal by Subject|2|||
105723581|NCT00434967|364642607|FG002|Overall Study|Withdrawal by Subject|4|||
105723582|NCT00434967|364642608|FG003|Overall Study|Withdrawal by Subject|6|||
105723583|NCT00434967|364642605|FG000|Overall Study|Randomized in error|0|||
105723584|NCT00434967|364642606|FG001|Overall Study|Randomized in error|0|||
105723585|NCT00434967|364642607|FG002|Overall Study|Randomized in error|0|||
105723586|NCT00434967|364642608|FG003|Overall Study|Randomized in error|1|||
105723587|NCT00434967|364642605|FG000|Overall Study|Protocol Violation|0|||
105723588|NCT00434967|364642606|FG001|Overall Study|Protocol Violation|1|||
105723589|NCT00434967|364642607|FG002|Overall Study|Protocol Violation|0|||
105723590|NCT00434967|364642608|FG003|Overall Study|Protocol Violation|1|||
105723591|NCT00434967|364642605|FG000|Overall Study|Physician Decision|1|||
105723592|NCT00434967|364642606|FG001|Overall Study|Physician Decision|1|||
105723593|NCT00434967|364642607|FG002|Overall Study|Physician Decision|1|||
105723594|NCT00434967|364642608|FG003|Overall Study|Physician Decision|0|||
105723595|NCT00434967|364642605|FG000|Overall Study|Patient Disposition Challenges|2|||
105723596|NCT00434967|364642606|FG001|Overall Study|Patient Disposition Challenges|0|||
105723597|NCT00434967|364642607|FG002|Overall Study|Patient Disposition Challenges|0|||
105723598|NCT00434967|364642608|FG003|Overall Study|Patient Disposition Challenges|3|||
105723599|NCT00432237|364642609|FG000|Overall Study|Adverse Event|0|||
105723600|NCT00432237|364642610|FG001|Overall Study|Adverse Event|0|||
105723601|NCT00432237|364642611|FG002|Overall Study|Adverse Event|0|||
105723602|NCT00432237|364642612|FG003|Overall Study|Adverse Event|1|||
105723603|NCT00432237|364642609|FG000|Overall Study|Lack of Efficacy|0|||
105723604|NCT00432237|364642610|FG001|Overall Study|Lack of Efficacy|0|||
105723605|NCT00432237|364642611|FG002|Overall Study|Lack of Efficacy|0|||
105723606|NCT00432237|364642612|FG003|Overall Study|Lack of Efficacy|1|||
105723607|NCT00432237|364642609|FG000|Overall Study|Lost to Follow-up|10|||
105723608|NCT00432237|364642610|FG001|Overall Study|Lost to Follow-up|10|||
105723609|NCT00432237|364642611|FG002|Overall Study|Lost to Follow-up|18|||
105723610|NCT00432237|364642612|FG003|Overall Study|Lost to Follow-up|18|||
105792879|NCT02149199|364896496|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
105792880|NCT02149199|364896494|FG000|Overall Study|Withdrawal by Subject|75|||
105792881|NCT02149199|364896495|FG001|Overall Study|Withdrawal by Subject|93|||
105792882|NCT02149199|364896496|FG002|Overall Study|Withdrawal by Subject|77|||
105792883|NCT02149199|364896494|FG000|Overall Study|Protocol Violation|16|||
105792884|NCT02149199|364896495|FG001|Overall Study|Protocol Violation|13|||
105792885|NCT02149199|364896496|FG002|Overall Study|Protocol Violation|15|||
105792886|NCT02149199|364896494|FG000|Overall Study|Lost to Follow-up|3|||
105792887|NCT02149199|364896495|FG001|Overall Study|Lost to Follow-up|12|||
105792888|NCT02149199|364896496|FG002|Overall Study|Lost to Follow-up|11|||
105792889|NCT02149199|364896494|FG000|Overall Study|Death|0|||
105792890|NCT02149199|364896495|FG001|Overall Study|Death|0|||
105792891|NCT02149199|364896496|FG002|Overall Study|Death|1|||
105792892|NCT02149199|364896494|FG000|Overall Study|Adverse Event|6|||
105792893|NCT02149199|364896495|FG001|Overall Study|Adverse Event|15|||
105792894|NCT02149199|364896496|FG002|Overall Study|Adverse Event|9|||
105792895|NCT01907516|364896498|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
105792896|NCT01907516|364896499|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
105792897|NCT01907516|364896498|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
105792898|NCT01907516|364896499|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
105792899|NCT01907516|364896498|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
105792900|NCT01907516|364896499|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
105792901|NCT01907516|364896498|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
105792902|NCT01907516|364896499|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
105792903|NCT02392377|364896506|FG000|Overall Study|Withdrawal by Subject|0|||
105792904|NCT02392377|364896507|FG001|Overall Study|Withdrawal by Subject|1|||
105792905|NCT00242567|364898659|FG000|Overall Study|Adverse Event|70|||
105792906|NCT00242567|364898660|FG001|Overall Study|Adverse Event|43|||
105792907|NCT00242567|364898659|FG000|Overall Study|Disease Progression|17|||
105792908|NCT00242567|364898660|FG001|Overall Study|Disease Progression|22|||
105792909|NCT00242567|364898659|FG000|Overall Study|Symptomatic deterioration|9|||
105792910|NCT00242567|364898660|FG001|Overall Study|Symptomatic deterioration|3|||
105792911|NCT00242567|364898659|FG000|Overall Study|Lack of Efficacy|2|||
105792912|NCT00242567|364898660|FG001|Overall Study|Lack of Efficacy|2|||
105792913|NCT00242567|364898659|FG000|Overall Study|Lost to Follow-up|9|||
105792914|NCT00242567|364898660|FG001|Overall Study|Lost to Follow-up|19|||
105792915|NCT00242567|364898659|FG000|Overall Study|Withdrawal by Subject|33|||
105792916|NCT00242567|364898660|FG001|Overall Study|Withdrawal by Subject|28|||
105792917|NCT00242567|364898659|FG000|Overall Study|Protocol Violation|12|||
105792918|NCT00242567|364898660|FG001|Overall Study|Protocol Violation|12|||
105792919|NCT00242567|364898659|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
105792920|NCT00242567|364898660|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
105792921|NCT00242567|364898659|FG000|Overall Study|Other|14|||
105792922|NCT00242567|364898660|FG001|Overall Study|Other|9|||
105792923|NCT01186744|364898661|FG000|Overall Study|Lack of Efficacy|156|||
105792924|NCT01186744|364898662|FG001|Overall Study|Lack of Efficacy|99|||
105792925|NCT01186744|364898663|FG002|Overall Study|Lack of Efficacy|0|||
105792926|NCT01186744|364898664|FG003|Overall Study|Lack of Efficacy|2|||
105792927|NCT01186744|364898665|FG004|Overall Study|Lack of Efficacy|2|||
105792928|NCT01186744|364898666|FG005|Overall Study|Lack of Efficacy|5|||
105792929|NCT01186744|364898661|FG000|Overall Study|Protocol Violation|1|||
105792930|NCT01186744|364898662|FG001|Overall Study|Protocol Violation|2|||
105792931|NCT01186744|364898663|FG002|Overall Study|Protocol Violation|0|||
105792932|NCT01186744|364898664|FG003|Overall Study|Protocol Violation|1|||
105792933|NCT01186744|364898665|FG004|Overall Study|Protocol Violation|1|||
105792934|NCT01186744|364898666|FG005|Overall Study|Protocol Violation|2|||
105792935|NCT01186744|364898661|FG000|Overall Study|Lost to Follow-up|15|||
105792936|NCT01186744|364898662|FG001|Overall Study|Lost to Follow-up|16|||
105792937|NCT01186744|364898663|FG002|Overall Study|Lost to Follow-up|2|||
105792938|NCT01186744|364898664|FG003|Overall Study|Lost to Follow-up|1|||
105792939|NCT01186744|364898665|FG004|Overall Study|Lost to Follow-up|1|||
105792940|NCT01186744|364898666|FG005|Overall Study|Lost to Follow-up|4|||
105792941|NCT01186744|364898661|FG000|Overall Study|Screen failure|1|||
105792942|NCT01186744|364898662|FG001|Overall Study|Screen failure|1|||
105792943|NCT01186744|364898663|FG002|Overall Study|Screen failure|0|||
105792944|NCT01186744|364898664|FG003|Overall Study|Screen failure|1|||
105562895|NCT01820559|364057527|FG002|Overall Study|At sponsor request|1|||
105792945|NCT01186744|364898665|FG004|Overall Study|Screen failure|0|||
105792946|NCT01186744|364898666|FG005|Overall Study|Screen failure|0|||
105792947|NCT01186744|364898661|FG000|Overall Study|Withdrawal by Subject|14|||
105792948|NCT01186744|364898662|FG001|Overall Study|Withdrawal by Subject|10|||
105792949|NCT01186744|364898663|FG002|Overall Study|Withdrawal by Subject|2|||
105792950|NCT01186744|364898664|FG003|Overall Study|Withdrawal by Subject|5|||
105792951|NCT01186744|364898665|FG004|Overall Study|Withdrawal by Subject|0|||
105792952|NCT01186744|364898666|FG005|Overall Study|Withdrawal by Subject|6|||
105792953|NCT01186744|364898661|FG000|Overall Study|Study terminated by Sponsor|1|||
105792954|NCT01186744|364898662|FG001|Overall Study|Study terminated by Sponsor|0|||
105792955|NCT01186744|364898663|FG002|Overall Study|Study terminated by Sponsor|0|||
105723611|NCT00432237|364642609|FG000|Overall Study|Physician Decision|1|||
105723612|NCT00432237|364642610|FG001|Overall Study|Physician Decision|3|||
105723613|NCT00432237|364642611|FG002|Overall Study|Physician Decision|2|||
105723614|NCT00432237|364642612|FG003|Overall Study|Physician Decision|1|||
105723615|NCT00432237|364642609|FG000|Overall Study|Pregnancy|0|||
105723616|NCT00432237|364642610|FG001|Overall Study|Pregnancy|1|||
105723617|NCT00432237|364642611|FG002|Overall Study|Pregnancy|0|||
105723618|NCT00432237|364642612|FG003|Overall Study|Pregnancy|0|||
105723619|NCT00432237|364642609|FG000|Overall Study|Protocol Violation|13|||
105723620|NCT00432237|364642610|FG001|Overall Study|Protocol Violation|10|||
105723621|NCT00432237|364642611|FG002|Overall Study|Protocol Violation|11|||
105723622|NCT00432237|364642612|FG003|Overall Study|Protocol Violation|8|||
105723623|NCT00432237|364642609|FG000|Overall Study|Withdrawal by Subject|5|||
105723624|NCT00432237|364642610|FG001|Overall Study|Withdrawal by Subject|6|||
105723625|NCT00432237|364642611|FG002|Overall Study|Withdrawal by Subject|9|||
105723626|NCT00432237|364642612|FG003|Overall Study|Withdrawal by Subject|11|||
105723627|NCT00432237|364642609|FG000|Overall Study|Lack of Qualifying Event|38|||
105723628|NCT00432237|364642610|FG001|Overall Study|Lack of Qualifying Event|71|||
105723629|NCT00432237|364642611|FG002|Overall Study|Lack of Qualifying Event|69|||
105723630|NCT00432237|364642612|FG003|Overall Study|Lack of Qualifying Event|84|||
105723631|NCT03293654|364642613|FG000|Overall Study|Lost to Follow-up|0|||
105723632|NCT03293654|364642614|FG001|Overall Study|Lost to Follow-up|1|||
105723633|NCT03293654|364642615|FG002|Overall Study|Lost to Follow-up|0|||
105723634|NCT04284787|364642616|FG000|Overall Study|Disease Progression|9|||
105723635|NCT04284787|364642617|FG001|Overall Study|Disease Progression|12|||
105723636|NCT04284787|364642616|FG000|Overall Study|Physician Decision|12|||
105723637|NCT04284787|364642617|FG001|Overall Study|Physician Decision|7|||
105723638|NCT04284787|364642616|FG000|Overall Study|Transplant|5|||
105723639|NCT04284787|364642617|FG001|Overall Study|Transplant|4|||
105723640|NCT04284787|364642616|FG000|Overall Study|Death|1|||
105723641|NCT04284787|364642617|FG001|Overall Study|Death|2|||
105723642|NCT04284787|364642616|FG000|Overall Study|Adverse Event|0|||
105723643|NCT04284787|364642617|FG001|Overall Study|Adverse Event|4|||
105723644|NCT04284787|364642616|FG000|Overall Study|Non-adherence|2|||
105723645|NCT04284787|364642617|FG001|Overall Study|Non-adherence|0|||
105723646|NCT04284787|364642616|FG000|Overall Study|Lack of Efficacy|2|||
105723647|NCT04284787|364642617|FG001|Overall Study|Lack of Efficacy|0|||
105723648|NCT05254418|364642618|FG000|Overall Study|Adverse Event|2|||
105723649|NCT03155997|364642619|FG000|Overall Study|Withdrawal by Subject|119|||
105723650|NCT03155997|364642620|FG001|Overall Study|Withdrawal by Subject|134|||
105723651|NCT03155997|364642619|FG000|Overall Study|Lost to Follow-up|12|||
105723652|NCT03155997|364642620|FG001|Overall Study|Lost to Follow-up|13|||
105723653|NCT03155997|364642619|FG000|Overall Study|Missing disposition data|0|||
105723654|NCT03155997|364642620|FG001|Overall Study|Missing disposition data|1|||
105723655|NCT03155997|364642619|FG000|Overall Study|On study treatment|2027|||
105723656|NCT03155997|364642620|FG001|Overall Study|On study treatment|2074|||
105723657|NCT03093402|364642622|FG000|Overall Study|Lost to Follow-up|1|||
105723658|NCT03093402|364642623|FG001|Overall Study|Lost to Follow-up|0|||
105723659|NCT03093402|364642624|FG002|Overall Study|Lost to Follow-up|0|||
105723660|NCT03093402|364642625|FG003|Overall Study|Lost to Follow-up|0|||
105723661|NCT03093402|364642622|FG000|Overall Study|Withdrawal by Subject|3|||
105723662|NCT03093402|364642623|FG001|Overall Study|Withdrawal by Subject|3|||
105723663|NCT03093402|364642624|FG002|Overall Study|Withdrawal by Subject|0|||
105723664|NCT03093402|364642625|FG003|Overall Study|Withdrawal by Subject|1|||
105723665|NCT03093402|364642622|FG000|Overall Study|Withdrew prior to dosing|2|||
105723666|NCT03093402|364642623|FG001|Overall Study|Withdrew prior to dosing|1|||
105723667|NCT03093402|364642624|FG002|Overall Study|Withdrew prior to dosing|2|||
105723668|NCT03093402|364642625|FG003|Overall Study|Withdrew prior to dosing|3|||
105723669|NCT03093402|364642622|FG000|Overall Study|Ineligible for study|1|||
105723670|NCT03093402|364642623|FG001|Overall Study|Ineligible for study|0|||
105723671|NCT03093402|364642624|FG002|Overall Study|Ineligible for study|0|||
105723672|NCT03093402|364642625|FG003|Overall Study|Ineligible for study|0|||
105723673|NCT03093402|364642622|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
105723674|NCT03093402|364642623|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
105723675|NCT03093402|364642624|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
105723676|NCT03093402|364642625|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
105723677|NCT02886702|364642628|FG000|Overall Study|Other|4|||
105723678|NCT02886702|364642629|FG001|Overall Study|Other|3|||
105723679|NCT02886702|364642630|FG002|Overall Study|Other|9|||
105723680|NCT02886702|364642628|FG000|Overall Study|Withdrawal by Subject|24|||
105723681|NCT02886702|364642629|FG001|Overall Study|Withdrawal by Subject|18|||
105723682|NCT02886702|364642630|FG002|Overall Study|Withdrawal by Subject|22|||
105792956|NCT01186744|364898664|FG003|Overall Study|Study terminated by Sponsor|0|||
105792957|NCT01186744|364898665|FG004|Overall Study|Study terminated by Sponsor|0|||
105792958|NCT01186744|364898666|FG005|Overall Study|Study terminated by Sponsor|0|||
105792959|NCT01186744|364898661|FG000|Overall Study|Other|9|||
105792960|NCT01186744|364898662|FG001|Overall Study|Other|10|||
105792961|NCT01186744|364898663|FG002|Overall Study|Other|1|||
105792962|NCT01186744|364898664|FG003|Overall Study|Other|2|||
105792963|NCT01186744|364898665|FG004|Overall Study|Other|1|||
105792964|NCT01186744|364898666|FG005|Overall Study|Other|5|||
105792965|NCT01186744|364898661|FG000|Overall Study|Adverse Event|10|||
105792966|NCT01186744|364898662|FG001|Overall Study|Adverse Event|14|||
105792967|NCT01186744|364898663|FG002|Overall Study|Adverse Event|1|||
105792968|NCT01186744|364898664|FG003|Overall Study|Adverse Event|0|||
105792969|NCT01186744|364898665|FG004|Overall Study|Adverse Event|1|||
105792970|NCT01186744|364898666|FG005|Overall Study|Adverse Event|4|||
105792971|NCT01186744|364898661|FG000|Overall Study|Death|1|||
105792972|NCT01186744|364898662|FG001|Overall Study|Death|0|||
105792973|NCT01186744|364898663|FG002|Overall Study|Death|0|||
105792974|NCT01186744|364898664|FG003|Overall Study|Death|0|||
105792975|NCT01186744|364898665|FG004|Overall Study|Death|0|||
105792976|NCT01186744|364898666|FG005|Overall Study|Death|0|||
105792977|NCT02729545|364898667|FG000|Overall Study|Pregnancy|1|||
105792978|NCT02729545|364898668|FG001|Overall Study|Pregnancy|1|||
105792979|NCT02729545|364898667|FG000|Overall Study|Lost to Follow-up|0|||
105792980|NCT02729545|364898668|FG001|Overall Study|Lost to Follow-up|1|||
105792981|NCT02729545|364898667|FG000|Overall Study|Withdrawal by Subject|2|||
105792982|NCT02729545|364898668|FG001|Overall Study|Withdrawal by Subject|3|||
105792983|NCT05553600|364898669|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
105792984|NCT05553600|364898670|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
105792985|NCT05553600|364898671|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
105792986|NCT05553600|364898672|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
105792987|NCT05553600|364898669|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
105792988|NCT05553600|364898670|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
105792989|NCT05553600|364898671|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
105792990|NCT05553600|364898672|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
105792991|NCT05553600|364898669|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
105792992|NCT05553600|364898670|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
105792993|NCT05553600|364898671|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
105792994|NCT05553600|364898672|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
105792995|NCT05553600|364898669|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
105792996|NCT05553600|364898670|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
105792997|NCT05553600|364898671|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
105792998|NCT05553600|364898672|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
105792999|NCT05553600|364898669|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
105793000|NCT05553600|364898670|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
105793001|NCT05553600|364898671|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
105793002|NCT05553600|364898672|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
105793003|NCT05553600|364898669|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
105793004|NCT05553600|364898670|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
105793005|NCT05553600|364898671|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
105793006|NCT05553600|364898672|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
105793007|NCT05553600|364898669|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
105793008|NCT05553600|364898670|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
105793009|NCT05553600|364898671|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
105793010|NCT05553600|364898672|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
105793011|NCT05553600|364898669|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
105793012|NCT05553600|364898670|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
105793013|NCT05553600|364898671|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
105793014|NCT05553600|364898672|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
105793015|NCT05553600|364898669|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
105793016|NCT05553600|364898670|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
105793017|NCT05553600|364898671|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
105793018|NCT05553600|364898672|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
105793019|NCT05553600|364898669|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
105793020|NCT05553600|364898670|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
105793021|NCT05553600|364898671|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
105793022|NCT05553600|364898672|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
105793023|NCT05553600|364898669|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
105562896|NCT01820559|364057525|FG000|Overall Study|Lack of Efficacy|3|||
105723683|NCT02886702|364642628|FG000|Overall Study|Significant Worsening of Condition|0|||
105723684|NCT02886702|364642629|FG001|Overall Study|Significant Worsening of Condition|1|||
105723685|NCT02886702|364642630|FG002|Overall Study|Significant Worsening of Condition|0|||
105723686|NCT02886702|364642628|FG000|Overall Study|Protocol Violation|2|||
105723687|NCT02886702|364642629|FG001|Overall Study|Protocol Violation|2|||
105723688|NCT02886702|364642630|FG002|Overall Study|Protocol Violation|1|||
105723689|NCT02886702|364642628|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105723690|NCT02886702|364642629|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105723691|NCT02886702|364642630|FG002|Overall Study|Non-Compliance With Study Drug|4|||
105723692|NCT02886702|364642628|FG000|Overall Study|Lost to Follow-up|11|||
105723693|NCT02886702|364642629|FG001|Overall Study|Lost to Follow-up|13|||
105723694|NCT02886702|364642630|FG002|Overall Study|Lost to Follow-up|8|||
105723695|NCT02886702|364642628|FG000|Overall Study|Lack of Efficacy|3|||
105723696|NCT02886702|364642629|FG001|Overall Study|Lack of Efficacy|4|||
105723697|NCT02886702|364642630|FG002|Overall Study|Lack of Efficacy|5|||
105723698|NCT02886702|364642628|FG000|Overall Study|Adverse Event|4|||
105723699|NCT02886702|364642629|FG001|Overall Study|Adverse Event|9|||
105723700|NCT02886702|364642630|FG002|Overall Study|Adverse Event|3|||
105723701|NCT02886702|364642628|FG000|Overall Study|Administrative Reasons|0|||
105723702|NCT02886702|364642629|FG001|Overall Study|Administrative Reasons|0|||
105723703|NCT02886702|364642630|FG002|Overall Study|Administrative Reasons|1|||
105723704|NCT00501228|364642634|FG000|Overall Study|Withdrawal by Subject|1|||
105723705|NCT02318784|364642635|FG000|Overall Study|Adverse Event|13|||
105723706|NCT02318784|364642635|FG000|Overall Study|Death|2|||
105723707|NCT02318784|364642635|FG000|Overall Study|Progressive Disease|37|||
105723708|NCT02318784|364642635|FG000|Overall Study|Withdrawal by Subject|10|||
105723709|NCT00781365|364642638|FG000|Overall Study|Withdrawal by Subject|13|||
105723710|NCT00781365|364642639|FG001|Overall Study|Withdrawal by Subject|8|||
105723711|NCT00781365|364642638|FG000|Overall Study|Did Not Attend Visit|20|||
105723712|NCT00781365|364642639|FG001|Overall Study|Did Not Attend Visit|28|||
105723713|NCT00781365|364642638|FG000|Overall Study|Language barrier|1|||
105723714|NCT00781365|364642639|FG001|Overall Study|Language barrier|0|||
105723715|NCT03304522|364642640|FG000|Overall Study|Adverse Event|0|||
105723716|NCT03304522|364642641|FG001|Overall Study|Adverse Event|4|||
105723717|NCT03304522|364642640|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
105723718|NCT03304522|364642641|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
105723719|NCT03304522|364642640|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
105723720|NCT03304522|364642641|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
105723721|NCT03304522|364642640|FG000|Overall Study|Other|0|||
105723722|NCT03304522|364642641|FG001|Overall Study|Other|1|||
105723723|NCT00486603|364642643|FG000|Overall Study|Withdrawal by Subject|1|||
105723724|NCT00486603|364642644|FG001|Overall Study|Withdrawal by Subject|0|||
105723725|NCT00486603|364642645|FG002|Overall Study|Withdrawal by Subject|0|||
105723726|NCT00486603|364642646|FG003|Overall Study|Withdrawal by Subject|0|||
105723727|NCT00486603|364642647|FG004|Overall Study|Withdrawal by Subject|0|||
105723728|NCT00486603|364642643|FG000|Overall Study|Physician Decision|0|||
105723729|NCT00486603|364642644|FG001|Overall Study|Physician Decision|1|||
105723730|NCT00486603|364642645|FG002|Overall Study|Physician Decision|0|||
105723731|NCT00486603|364642646|FG003|Overall Study|Physician Decision|0|||
105723732|NCT00486603|364642647|FG004|Overall Study|Physician Decision|0|||
105723733|NCT01295125|364642650|FG000|Overall Study|Study stopped prematurely|9|||
105723734|NCT01157117|364642651|FG000|Overall Study|Dosing Symptoms|0|||
105723735|NCT01157117|364642652|FG001|Overall Study|Dosing Symptoms|4|||
105723736|NCT01157117|364642653|FG002|Overall Study|Dosing Symptoms|0|||
105723737|NCT01157117|364642651|FG000|Overall Study|Withdrawal by Subject|4|||
105723738|NCT01157117|364642652|FG001|Overall Study|Withdrawal by Subject|1|||
105723739|NCT01157117|364642653|FG002|Overall Study|Withdrawal by Subject|1|||
105723740|NCT01157117|364642651|FG000|Overall Study|Lack of Efficacy|1|||
105723741|NCT01157117|364642652|FG001|Overall Study|Lack of Efficacy|1|||
105723742|NCT01157117|364642653|FG002|Overall Study|Lack of Efficacy|0|||
105723743|NCT01157117|364642651|FG000|Overall Study|Lost to Follow-up|0|||
105723744|NCT01157117|364642652|FG001|Overall Study|Lost to Follow-up|0|||
105723745|NCT01157117|364642653|FG002|Overall Study|Lost to Follow-up|1|||
105723746|NCT01157117|364642651|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
105723747|NCT01157117|364642652|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
105723748|NCT01157117|364642653|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
105723749|NCT03514914|364642654|FG000|Overall Study|Death|3|||
105723750|NCT03514914|364642655|FG001|Overall Study|Death|3|||
105723751|NCT03514914|364642654|FG000|Overall Study|Lost to Follow-up|117|||
105723752|NCT03514914|364642655|FG001|Overall Study|Lost to Follow-up|89|||
105723753|NCT00885365|364642657|FG000|4 Weeks ON Treatment|Adverse Event|2|||
105723754|NCT00885365|364642658|FG001|4 Weeks ON Treatment|Adverse Event|4|||
105723755|NCT00885365|364642657|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
105723756|NCT00885365|364642658|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
105723757|NCT00885365|364642657|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
105723758|NCT00885365|364642658|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
105723759|NCT01824979|364642659|FG000|Overall Study|Withdrawal by Subject|5|||
105723760|NCT01824979|364642660|FG001|Overall Study|Withdrawal by Subject|0|||
105723761|NCT01824979|364642659|FG000|Overall Study|Physician Decision|2|||
105723762|NCT01824979|364642660|FG001|Overall Study|Physician Decision|0|||
105723763|NCT01824979|364642659|FG000|Overall Study|Protocol Violation|6|||
105723764|NCT01824979|364642660|FG001|Overall Study|Protocol Violation|13|||
105723765|NCT01355289|364642661|FG000|Core Study|Adverse Event, Non-Fatal|1|||
105723766|NCT01355289|364642662|FG001|Core Study|Adverse Event, Non-Fatal|0|||
105723767|NCT01355289|364642663|FG002|Core Study|Adverse Event, Non-Fatal|0|||
105723768|NCT01355289|364642664|FG003|Core Study|Adverse Event, Non-Fatal|0|||
105723769|NCT01355289|364642665|FG004|Core Study|Adverse Event, Non-Fatal|0|||
105723770|NCT01355289|364642661|FG000|Core Study|Inadequate Therapeutic Effect|0|||
105723771|NCT01355289|364642662|FG001|Core Study|Inadequate Therapeutic Effect|0|||
105723772|NCT01355289|364642663|FG002|Core Study|Inadequate Therapeutic Effect|0|||
105723773|NCT01355289|364642664|FG003|Core Study|Inadequate Therapeutic Effect|1|||
105723774|NCT01355289|364642665|FG004|Core Study|Inadequate Therapeutic Effect|0|||
105723775|NCT01355289|364642661|FG000|Core Study|Other|0|||
105723776|NCT01355289|364642662|FG001|Core Study|Other|0|||
105723777|NCT01355289|364642663|FG002|Core Study|Other|0|||
105723778|NCT01355289|364642664|FG003|Core Study|Other|1|||
105723779|NCT01355289|364642665|FG004|Core Study|Other|0|||
105723780|NCT01355289|364642661|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
105723781|NCT01355289|364642662|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
105723782|NCT01355289|364642663|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
105723783|NCT01355289|364642664|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
105723784|NCT01355289|364642665|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
105723785|NCT01355289|364642661|FG000|Open Label Extension|Lost to Follow-up|0|||
105723786|NCT01355289|364642662|FG001|Open Label Extension|Lost to Follow-up|0|||
105723787|NCT01355289|364642663|FG002|Open Label Extension|Lost to Follow-up|0|||
105723788|NCT01355289|364642664|FG003|Open Label Extension|Lost to Follow-up|0|||
105723789|NCT01355289|364642665|FG004|Open Label Extension|Lost to Follow-up|1|||
105723790|NCT01355289|364642661|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
105723791|NCT01355289|364642662|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
105723792|NCT01355289|364642663|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
105723793|NCT01355289|364642664|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
105723794|NCT01355289|364642665|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
105723795|NCT01355289|364642661|FG000|Open Label Extension|Other|0|||
105723796|NCT01355289|364642662|FG001|Open Label Extension|Other|0|||
105723797|NCT01355289|364642663|FG002|Open Label Extension|Other|0|||
105723798|NCT01355289|364642664|FG003|Open Label Extension|Other|0|||
105723799|NCT01355289|364642665|FG004|Open Label Extension|Other|3|||
105723800|NCT01451645|364642669|FG000|Overall Study|Protocol Violation|1|||
105723801|NCT01451645|364642670|FG001|Overall Study|Protocol Violation|0|||
105723802|NCT01451645|364642669|FG000|Overall Study|Adverse Event|0|||
105352872|NCT03959488|363297006|FG004|Season 1|Withdrawal by parent/guardian|0|||
105352873|NCT03959488|363297002|FG000|Season 1|Due to COVID-19 pandemic|2|||
105352874|NCT03959488|363297003|FG001|Season 1|Due to COVID-19 pandemic|3|||
105352875|NCT03959488|363297004|FG002|Season 1|Due to COVID-19 pandemic|0|||
105352876|NCT03959488|363297005|FG003|Season 1|Due to COVID-19 pandemic|0|||
105352877|NCT03959488|363297006|FG004|Season 1|Due to COVID-19 pandemic|0|||
105352878|NCT03959488|363297002|FG000|Season 1|Lost to Follow-up|17|||
105352879|NCT03959488|363297003|FG001|Season 1|Lost to Follow-up|7|||
105352880|NCT03959488|363297004|FG002|Season 1|Lost to Follow-up|0|||
105352881|NCT03959488|363297005|FG003|Season 1|Lost to Follow-up|0|||
105352882|NCT03959488|363297006|FG004|Season 1|Lost to Follow-up|0|||
105352883|NCT03959488|363297002|FG000|Season 1|Death|5|||
105352884|NCT03959488|363297003|FG001|Season 1|Death|1|||
105562897|NCT01820559|364057526|FG001|Overall Study|Lack of Efficacy|2|||
105352885|NCT03959488|363297004|FG002|Season 1|Death|0|||
105352886|NCT03959488|363297005|FG003|Season 1|Death|0|||
105352887|NCT03959488|363297006|FG004|Season 1|Death|0|||
105352888|NCT03959488|363297002|FG000|Season 2|Other|0|||
105352889|NCT03959488|363297003|FG001|Season 2|Other|0|||
105352890|NCT03959488|363297004|FG002|Season 2|Other|2|||
105352891|NCT03959488|363297005|FG003|Season 2|Other|0|||
105352892|NCT03959488|363297006|FG004|Season 2|Other|0|||
105352893|NCT03959488|363297002|FG000|Season 2|Withdrawal by parent/guardian|0|||
105352894|NCT03959488|363297003|FG001|Season 2|Withdrawal by parent/guardian|0|||
105352895|NCT03959488|363297004|FG002|Season 2|Withdrawal by parent/guardian|3|||
105352896|NCT03959488|363297005|FG003|Season 2|Withdrawal by parent/guardian|1|||
105723803|NCT01451645|364642670|FG001|Overall Study|Adverse Event|3|||
105352897|NCT03959488|363297006|FG004|Season 2|Withdrawal by parent/guardian|1|||
105352898|NCT03959488|363297002|FG000|Season 2|Lost to Follow-up|0|||
105352899|NCT03959488|363297003|FG001|Season 2|Lost to Follow-up|0|||
105352900|NCT03959488|363297004|FG002|Season 2|Lost to Follow-up|1|||
105352901|NCT03959488|363297005|FG003|Season 2|Lost to Follow-up|0|||
105562898|NCT01820559|364057527|FG002|Overall Study|Lack of Efficacy|3|||
105723804|NCT01451645|364642669|FG000|Overall Study|Withdrawal by Subject|4|||
105723805|NCT01451645|364642670|FG001|Overall Study|Withdrawal by Subject|2|||
105723806|NCT01451645|364642669|FG000|Overall Study|Lost to Follow-up|4|||
105723807|NCT01451645|364642670|FG001|Overall Study|Lost to Follow-up|3|||
105478490|NCT04093024|363764264|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
105478491|NCT04093024|363764265|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
105478492|NCT03642132|363764266|FG000|Chemotherapy Period|Adverse Event|1|||
105352902|NCT03959488|363297006|FG004|Season 2|Lost to Follow-up|1|||
105352903|NCT01641471|363297009|FG000|Overall Study|Withdrawal by Subject|19|||
105478493|NCT03642132|363764267|FG001|Chemotherapy Period|Adverse Event|1|||
105478494|NCT03642132|363764268|FG002|Chemotherapy Period|Adverse Event|0|||
105723808|NCT02706938|364642673|FG000|First Period, 6 Weeks|Adverse Event|8|||
105723809|NCT02706938|364642674|FG001|First Period, 6 Weeks|Adverse Event|0|||
105723810|NCT02706938|364642673|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
105723811|NCT02706938|364642674|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
105723812|NCT02706938|364642673|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
105723813|NCT02706938|364642674|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
105723814|NCT02706938|364642673|FG000|Second Period, 6 Weeks|Adverse Event|0|||
105723815|NCT02706938|364642674|FG001|Second Period, 6 Weeks|Adverse Event|7|||
105723816|NCT02706938|364642673|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
105723817|NCT02706938|364642674|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
105723818|NCT01838044|364642679|FG000|Overall Study|Adverse Event|4|||
105723819|NCT01838044|364642680|FG001|Overall Study|Adverse Event|6|||
105723820|NCT01838044|364642679|FG000|Overall Study|Protocol Violation|3|||
105723821|NCT01838044|364642680|FG001|Overall Study|Protocol Violation|3|||
105723822|NCT01838044|364642679|FG000|Overall Study|Withdrawal by Subject|0|||
105723823|NCT01838044|364642680|FG001|Overall Study|Withdrawal by Subject|2|||
105723824|NCT01838044|364642679|FG000|Overall Study|Insufficient clinical response|1|||
105723825|NCT01838044|364642680|FG001|Overall Study|Insufficient clinical response|2|||
105723826|NCT01838044|364642679|FG000|Overall Study|Medication error without associated AE|0|||
105723827|NCT01838044|364642680|FG001|Overall Study|Medication error without associated AE|1|||
105723828|NCT01838044|364642679|FG000|Overall Study|Lost to Follow-up|0|||
105723829|NCT01838044|364642680|FG001|Overall Study|Lost to Follow-up|2|||
105723830|NCT03838484|364642684|FG000|Overall Study|Lost to Follow-up|0|||
105723831|NCT03838484|364642685|FG001|Overall Study|Lost to Follow-up|1|||
105723832|NCT03838484|364642686|FG002|Overall Study|Lost to Follow-up|0|||
105723833|NCT03838484|364642687|FG003|Overall Study|Lost to Follow-up|0|||
105723834|NCT01413958|364642689|FG000|Overall Study|Lost to Follow-up|0|||
105723835|NCT01413958|364642690|FG001|Overall Study|Lost to Follow-up|1|||
105723836|NCT02207907|364642699|FG000|Overall Study|Lost to Follow-up|3|||
105723837|NCT02207907|364642700|FG001|Overall Study|Lost to Follow-up|1|||
105478495|NCT03642132|363764266|FG000|Chemotherapy Period|Physician's decision|4|||
105723838|NCT02207907|364642699|FG000|Overall Study|Withdrawal by Subject|5|||
105723839|NCT02207907|364642700|FG001|Overall Study|Withdrawal by Subject|6|||
105723840|NCT02207907|364642699|FG000|Overall Study|Did not meet study criteria|3|||
105723841|NCT02207907|364642700|FG001|Overall Study|Did not meet study criteria|0|||
105723842|NCT02207907|364642699|FG000|Overall Study|Pregnancy|0|||
105723843|NCT02207907|364642700|FG001|Overall Study|Pregnancy|1|||
105723844|NCT00158184|364642701|FG000|Overall Study|personal issues|3|||
105723845|NCT00158184|364642702|FG001|Overall Study|personal issues|1|||
105723846|NCT00158184|364642701|FG000|Overall Study|failed for follow unit/study rules|2|||
105723847|NCT00158184|364642702|FG001|Overall Study|failed for follow unit/study rules|0|||
105723848|NCT00158184|364642701|FG000|Overall Study|Adverse Event|1|||
105723849|NCT00158184|364642702|FG001|Overall Study|Adverse Event|1|||
105723850|NCT02700984|364642703|FG000|Overall Study|Death|2|||
105723851|NCT02700984|364642704|FG001|Overall Study|Death|1|||
105723852|NCT02700984|364642703|FG000|Overall Study|Lost to Follow-up|2|||
105723853|NCT02700984|364642704|FG001|Overall Study|Lost to Follow-up|1|||
105723854|NCT02700984|364642703|FG000|Overall Study|Physician Decision|0|||
105723855|NCT02700984|364642704|FG001|Overall Study|Physician Decision|1|||
105723856|NCT02700984|364642703|FG000|Overall Study|Withdrawal by Subject|8|||
105723857|NCT02700984|364642704|FG001|Overall Study|Withdrawal by Subject|9|||
105723858|NCT02700984|364642703|FG000|Overall Study|Reason not specified|3|||
105723859|NCT02700984|364642704|FG001|Overall Study|Reason not specified|2|||
105723860|NCT05340504|364642705|FG000|Overall Study|Withdrawal by Subject|1|||
105723861|NCT05340504|364642706|FG001|Overall Study|Withdrawal by Subject|0|||
105723862|NCT00473876|364642707|FG000|Overall Study|Lost to Follow-up|3|||
105723863|NCT00473876|364642708|FG001|Overall Study|Lost to Follow-up|1|||
105723864|NCT00348140|364642709|FG000|Overall Study|Adverse Event|46|||
105723865|NCT00348140|364642710|FG001|Overall Study|Adverse Event|49|||
105723866|NCT00348140|364642711|FG002|Overall Study|Adverse Event|78|||
105723867|NCT00348140|364642709|FG000|Overall Study|Lost to Follow-up|4|||
105723868|NCT00348140|364642710|FG001|Overall Study|Lost to Follow-up|4|||
105723869|NCT00348140|364642711|FG002|Overall Study|Lost to Follow-up|4|||
105723870|NCT00348140|364642709|FG000|Overall Study|Protocol Violation|12|||
105723871|NCT00348140|364642710|FG001|Overall Study|Protocol Violation|13|||
105723872|NCT00348140|364642711|FG002|Overall Study|Protocol Violation|14|||
105723873|NCT00348140|364642709|FG000|Overall Study|Withdrawal by Subject|32|||
105723874|NCT00348140|364642710|FG001|Overall Study|Withdrawal by Subject|40|||
105723875|NCT00348140|364642711|FG002|Overall Study|Withdrawal by Subject|40|||
105723876|NCT00348140|364642709|FG000|Overall Study|Non-compliance|8|||
105723877|NCT00348140|364642710|FG001|Overall Study|Non-compliance|13|||
105723878|NCT00348140|364642711|FG002|Overall Study|Non-compliance|5|||
105723879|NCT00348140|364642709|FG000|Overall Study|Participant at risk due to study drug|2|||
105723880|NCT00348140|364642710|FG001|Overall Study|Participant at risk due to study drug|0|||
105723881|NCT00348140|364642711|FG002|Overall Study|Participant at risk due to study drug|0|||
105723882|NCT00348140|364642709|FG000|Overall Study|Conditional medication increased dose|1|||
105793024|NCT05553600|364898670|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
105793025|NCT05553600|364898671|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
105793026|NCT05553600|364898672|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
105793027|NCT05553600|364898669|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
105793028|NCT05553600|364898670|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
105793029|NCT05553600|364898671|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
105793030|NCT05553600|364898672|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
105793031|NCT01956123|364898673|FG000|COS Cycle 2|Protocol Violation|8|||
105793032|NCT01956123|364898674|FG001|COS Cycle 2|Protocol Violation|3|||
105793033|NCT01956123|364898675|FG002|COS Cycle 2|Protocol Violation|0|||
105793034|NCT01956123|364898676|FG003|COS Cycle 2|Protocol Violation|0|||
105793035|NCT01956123|364898673|FG000|COS Cycle 2|Adverse Event|3|||
105793036|NCT01956123|364898674|FG001|COS Cycle 2|Adverse Event|4|||
105793037|NCT01956123|364898675|FG002|COS Cycle 2|Adverse Event|0|||
105793038|NCT01956123|364898676|FG003|COS Cycle 2|Adverse Event|0|||
105793039|NCT01956123|364898673|FG000|COS Cycle 2|Personal Reasons|2|||
105793040|NCT01956123|364898674|FG001|COS Cycle 2|Personal Reasons|0|||
105793041|NCT01956123|364898675|FG002|COS Cycle 2|Personal Reasons|0|||
105793042|NCT01956123|364898676|FG003|COS Cycle 2|Personal Reasons|0|||
105793043|NCT01956123|364898673|FG000|COS Cycle 2|Withdrawal by Subject|1|||
105793044|NCT01956123|364898674|FG001|COS Cycle 2|Withdrawal by Subject|0|||
105793045|NCT01956123|364898675|FG002|COS Cycle 2|Withdrawal by Subject|0|||
105793046|NCT01956123|364898676|FG003|COS Cycle 2|Withdrawal by Subject|0|||
105793047|NCT01956123|364898673|FG000|COS Cycle 3|Protocol Violation|0|||
105793048|NCT01956123|364898674|FG001|COS Cycle 3|Protocol Violation|0|||
105793049|NCT01956123|364898675|FG002|COS Cycle 3|Protocol Violation|2|||
105793050|NCT01956123|364898676|FG003|COS Cycle 3|Protocol Violation|1|||
105793051|NCT01956123|364898673|FG000|COS Cycle 3|Adverse Event|0|||
105793052|NCT01956123|364898674|FG001|COS Cycle 3|Adverse Event|0|||
105793053|NCT01956123|364898675|FG002|COS Cycle 3|Adverse Event|3|||
105793054|NCT01956123|364898676|FG003|COS Cycle 3|Adverse Event|0|||
105793055|NCT01956123|364898673|FG000|COS Cycle 3|Personal Reasons|0|||
105793056|NCT01956123|364898674|FG001|COS Cycle 3|Personal Reasons|0|||
105793057|NCT01956123|364898675|FG002|COS Cycle 3|Personal Reasons|1|||
105793058|NCT01956123|364898676|FG003|COS Cycle 3|Personal Reasons|0|||
105793059|NCT01956123|364898673|FG000|COS Cycle 3|Withdrawal by Subject|0|||
105793060|NCT01956123|364898674|FG001|COS Cycle 3|Withdrawal by Subject|0|||
105793061|NCT01956123|364898675|FG002|COS Cycle 3|Withdrawal by Subject|0|||
105723883|NCT00348140|364642710|FG001|Overall Study|Conditional medication increased dose|0|||
105723884|NCT00348140|364642711|FG002|Overall Study|Conditional medication increased dose|0|||
105723885|NCT00348140|364642709|FG000|Overall Study|Caregiver related|4|||
105723886|NCT00348140|364642710|FG001|Overall Study|Caregiver related|7|||
105723887|NCT00348140|364642711|FG002|Overall Study|Caregiver related|3|||
105723888|NCT00348140|364642709|FG000|Overall Study|Participant hospitalised|3|||
105723889|NCT00348140|364642710|FG001|Overall Study|Participant hospitalised|0|||
105723890|NCT00348140|364642711|FG002|Overall Study|Participant hospitalised|0|||
105723891|NCT00348140|364642709|FG000|Overall Study|Efficacy related|1|||
105723892|NCT00348140|364642710|FG001|Overall Study|Efficacy related|1|||
105723893|NCT00348140|364642711|FG002|Overall Study|Efficacy related|0|||
105723894|NCT00348140|364642709|FG000|Overall Study|Administration related|3|||
105723895|NCT00348140|364642710|FG001|Overall Study|Administration related|1|||
105723896|NCT00348140|364642711|FG002|Overall Study|Administration related|1|||
105723897|NCT00348140|364642709|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
105723898|NCT00348140|364642710|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
105723899|NCT00348140|364642711|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
105723900|NCT00348140|364642709|FG000|Overall Study|Participant unwell|1|||
105723901|NCT00348140|364642710|FG001|Overall Study|Participant unwell|0|||
105723902|NCT00348140|364642711|FG002|Overall Study|Participant unwell|0|||
105723903|NCT00348140|364642709|FG000|Overall Study|Screen failure|1|||
105723904|NCT00348140|364642710|FG001|Overall Study|Screen failure|0|||
105723905|NCT00348140|364642711|FG002|Overall Study|Screen failure|0|||
105793062|NCT01956123|364898676|FG003|COS Cycle 3|Withdrawal by Subject|1|||
105793063|NCT01432600|364898677|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
105793064|NCT01432600|364898678|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
105793065|NCT01432600|364898679|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
105793066|NCT02545868|364898686|FG000|Overall Study|Lack of Efficacy|1|||
105793067|NCT02545868|364898687|FG001|Overall Study|Lack of Efficacy|1|||
105793068|NCT02545868|364898688|FG002|Overall Study|Lack of Efficacy|0|||
105793069|NCT02545868|364898686|FG000|Overall Study|Lost to Follow-up|1|||
105793070|NCT02545868|364898687|FG001|Overall Study|Lost to Follow-up|5|||
105723906|NCT00348140|364642709|FG000|Overall Study|Investigator decided to discontinue|4|||
105723907|NCT00348140|364642710|FG001|Overall Study|Investigator decided to discontinue|1|||
105723908|NCT00348140|364642711|FG002|Overall Study|Investigator decided to discontinue|4|||
105723909|NCT00348140|364642709|FG000|Overall Study|Decided to discontinue on their own|1|||
105723910|NCT00348140|364642710|FG001|Overall Study|Decided to discontinue on their own|4|||
105793071|NCT02545868|364898688|FG002|Overall Study|Lost to Follow-up|1|||
105793072|NCT02545868|364898686|FG000|Overall Study|Non-compliance|1|||
105793073|NCT02545868|364898687|FG001|Overall Study|Non-compliance|1|||
105723911|NCT00348140|364642711|FG002|Overall Study|Decided to discontinue on their own|1|||
105723912|NCT00348140|364642709|FG000|Overall Study|Use of prohibited drug|1|||
105723913|NCT00348140|364642710|FG001|Overall Study|Use of prohibited drug|0|||
105723914|NCT00348140|364642711|FG002|Overall Study|Use of prohibited drug|2|||
105723915|NCT00348140|364642709|FG000|Overall Study|Disease progression|1|||
105723916|NCT00348140|364642710|FG001|Overall Study|Disease progression|2|||
105723917|NCT00348140|364642711|FG002|Overall Study|Disease progression|5|||
105723918|NCT00348140|364642709|FG000|Overall Study|Increased risk of cardiac infarction|0|||
105723919|NCT00348140|364642710|FG001|Overall Study|Increased risk of cardiac infarction|1|||
105723920|NCT00348140|364642711|FG002|Overall Study|Increased risk of cardiac infarction|0|||
105723921|NCT00348140|364642709|FG000|Overall Study|Serious adverse event|0|||
105723922|NCT00348140|364642710|FG001|Overall Study|Serious adverse event|1|||
105723923|NCT00348140|364642711|FG002|Overall Study|Serious adverse event|0|||
105723924|NCT00348140|364642709|FG000|Overall Study|Abnormal ECG|0|||
105723925|NCT00348140|364642710|FG001|Overall Study|Abnormal ECG|1|||
105723926|NCT00348140|364642711|FG002|Overall Study|Abnormal ECG|3|||
105723927|NCT00348140|364642709|FG000|Overall Study|Participant died|0|||
105723928|NCT00348140|364642710|FG001|Overall Study|Participant died|1|||
105723929|NCT00348140|364642711|FG002|Overall Study|Participant died|0|||
105723930|NCT00348140|364642709|FG000|Overall Study|Exclusion criteria met|0|||
105723931|NCT00348140|364642710|FG001|Overall Study|Exclusion criteria met|0|||
105723932|NCT00348140|364642711|FG002|Overall Study|Exclusion criteria met|1|||
105723933|NCT00348140|364642709|FG000|Overall Study|Memory declined|0|||
105723934|NCT00348140|364642710|FG001|Overall Study|Memory declined|0|||
105723935|NCT00348140|364642711|FG002|Overall Study|Memory declined|1|||
105723936|NCT00755079|364642716|FG000|Overall Study|Lost to Follow-up|1|||
105723937|NCT00755079|364642717|FG001|Overall Study|Lost to Follow-up|3|||
105723938|NCT00755079|364642716|FG000|Overall Study|Adverse Event|0|||
105723939|NCT00755079|364642717|FG001|Overall Study|Adverse Event|1|||
105723940|NCT00755079|364642716|FG000|Overall Study|Withdrawal by Subject|0|||
105723941|NCT00755079|364642717|FG001|Overall Study|Withdrawal by Subject|2|||
105723942|NCT00706628|364642719|FG000|Overall Study|Other Adverse Event|16|||
105723943|NCT00706628|364642720|FG001|Overall Study|Other Adverse Event|5|||
105723944|NCT00706628|364642721|FG002|Overall Study|Other Adverse Event|5|||
105723945|NCT00706628|364642722|FG003|Overall Study|Other Adverse Event|2|||
105723946|NCT00706628|364642719|FG000|Overall Study|Non compliant with protocol|0|||
105723947|NCT00706628|364642720|FG001|Overall Study|Non compliant with protocol|1|||
105723948|NCT00706628|364642721|FG002|Overall Study|Non compliant with protocol|0|||
105723949|NCT00706628|364642722|FG003|Overall Study|Non compliant with protocol|0|||
105723950|NCT00706628|364642719|FG000|Overall Study|Consent withdrawn|6|||
105723951|NCT00706628|364642720|FG001|Overall Study|Consent withdrawn|1|||
105723952|NCT00706628|364642721|FG002|Overall Study|Consent withdrawn|3|||
105723953|NCT00706628|364642722|FG003|Overall Study|Consent withdrawn|0|||
105723954|NCT00706628|364642719|FG000|Overall Study|Progressive disease|20|||
105723955|NCT00706628|364642720|FG001|Overall Study|Progressive disease|13|||
105723956|NCT00706628|364642721|FG002|Overall Study|Progressive disease|8|||
105723957|NCT00706628|364642722|FG003|Overall Study|Progressive disease|1|||
105723958|NCT00706628|364642719|FG000|Overall Study|Other than those stated above|4|||
105723959|NCT00706628|364642720|FG001|Overall Study|Other than those stated above|0|||
105723960|NCT00706628|364642721|FG002|Overall Study|Other than those stated above|0|||
105723961|NCT00706628|364642722|FG003|Overall Study|Other than those stated above|0|||
105723962|NCT00706628|364642719|FG000|Overall Study|Not treated|1|||
105723963|NCT00706628|364642720|FG001|Overall Study|Not treated|1|||
105723964|NCT00706628|364642721|FG002|Overall Study|Not treated|0|||
105723965|NCT00706628|364642722|FG003|Overall Study|Not treated|0|||
105723966|NCT00868790|364642723|FG000|Period 1|Adverse Event|1|||
105723967|NCT00868790|364642724|FG001|Period 1|Adverse Event|0|||
105723968|NCT00868790|364642725|FG002|Period 1|Adverse Event|0|||
105723969|NCT00868790|364642726|FG003|Period 1|Adverse Event|0|||
105723970|NCT00868790|364642727|FG004|Period 1|Adverse Event|0|||
105723971|NCT00868790|364642728|FG005|Period 1|Adverse Event|0|||
105723972|NCT00868790|364642729|FG006|Period 1|Adverse Event|0|||
105723973|NCT00868790|364642730|FG007|Period 1|Adverse Event|3|||
105723974|NCT00868790|364642731|FG008|Period 1|Adverse Event|1|||
105723975|NCT00868790|364642732|FG009|Period 1|Adverse Event|0|||
105478496|NCT03642132|363764267|FG001|Chemotherapy Period|Physician's decision|1|||
105478497|NCT03642132|363764268|FG002|Chemotherapy Period|Physician's decision|0|||
105478498|NCT03642132|363764266|FG000|Chemotherapy Period|Progressive disease|0|||
105478499|NCT03642132|363764267|FG001|Chemotherapy Period|Progressive disease|0|||
105478500|NCT03642132|363764268|FG002|Chemotherapy Period|Progressive disease|1|||
105723976|NCT00868790|364642733|FG010|Period 1|Adverse Event|0|||
105723977|NCT00868790|364642734|FG011|Period 1|Adverse Event|0|||
105723978|NCT00868790|364642735|FG012|Period 1|Adverse Event|0|||
105723979|NCT00868790|364642736|FG013|Period 1|Adverse Event|1|||
105723980|NCT00868790|364642723|FG000|Period 1|Protocol Violation|1|||
105723981|NCT00868790|364642724|FG001|Period 1|Protocol Violation|0|||
105723982|NCT00868790|364642725|FG002|Period 1|Protocol Violation|0|||
105723983|NCT00868790|364642726|FG003|Period 1|Protocol Violation|0|||
105723984|NCT00868790|364642727|FG004|Period 1|Protocol Violation|0|||
105723985|NCT00868790|364642728|FG005|Period 1|Protocol Violation|0|||
105723986|NCT00868790|364642729|FG006|Period 1|Protocol Violation|0|||
105723987|NCT00868790|364642730|FG007|Period 1|Protocol Violation|0|||
105723988|NCT00868790|364642731|FG008|Period 1|Protocol Violation|0|||
105723989|NCT00868790|364642732|FG009|Period 1|Protocol Violation|0|||
105723990|NCT00868790|364642733|FG010|Period 1|Protocol Violation|0|||
105723991|NCT00868790|364642734|FG011|Period 1|Protocol Violation|0|||
105723992|NCT00868790|364642735|FG012|Period 1|Protocol Violation|0|||
105723993|NCT00868790|364642736|FG013|Period 1|Protocol Violation|0|||
105723994|NCT00868790|364642723|FG000|Period 1|Withdrawal by Subject|0|||
105723995|NCT00868790|364642724|FG001|Period 1|Withdrawal by Subject|1|||
105723996|NCT00868790|364642725|FG002|Period 1|Withdrawal by Subject|0|||
105723997|NCT00868790|364642726|FG003|Period 1|Withdrawal by Subject|0|||
105723998|NCT00868790|364642727|FG004|Period 1|Withdrawal by Subject|0|||
105723999|NCT00868790|364642728|FG005|Period 1|Withdrawal by Subject|0|||
105724000|NCT00868790|364642729|FG006|Period 1|Withdrawal by Subject|0|||
105724001|NCT00868790|364642730|FG007|Period 1|Withdrawal by Subject|0|||
105724002|NCT00868790|364642731|FG008|Period 1|Withdrawal by Subject|0|||
105724003|NCT00868790|364642732|FG009|Period 1|Withdrawal by Subject|0|||
105724004|NCT00868790|364642733|FG010|Period 1|Withdrawal by Subject|0|||
105724005|NCT00868790|364642734|FG011|Period 1|Withdrawal by Subject|0|||
105724006|NCT00868790|364642735|FG012|Period 1|Withdrawal by Subject|0|||
105724007|NCT00868790|364642736|FG013|Period 1|Withdrawal by Subject|1|||
105724008|NCT00868790|364642723|FG000|Period 1|Abnormal Triglycerides|0|||
105724009|NCT00868790|364642724|FG001|Period 1|Abnormal Triglycerides|0|||
105724010|NCT00868790|364642725|FG002|Period 1|Abnormal Triglycerides|0|||
105724011|NCT00868790|364642726|FG003|Period 1|Abnormal Triglycerides|0|||
105724012|NCT00868790|364642727|FG004|Period 1|Abnormal Triglycerides|1|||
105724013|NCT00868790|364642728|FG005|Period 1|Abnormal Triglycerides|0|||
105724014|NCT00868790|364642729|FG006|Period 1|Abnormal Triglycerides|0|||
105724015|NCT00868790|364642730|FG007|Period 1|Abnormal Triglycerides|0|||
105724016|NCT00868790|364642731|FG008|Period 1|Abnormal Triglycerides|0|||
105724017|NCT00868790|364642732|FG009|Period 1|Abnormal Triglycerides|0|||
105724018|NCT00868790|364642733|FG010|Period 1|Abnormal Triglycerides|0|||
105724019|NCT00868790|364642734|FG011|Period 1|Abnormal Triglycerides|0|||
105724020|NCT00868790|364642735|FG012|Period 1|Abnormal Triglycerides|0|||
105724021|NCT00868790|364642736|FG013|Period 1|Abnormal Triglycerides|0|||
105724022|NCT00868790|364642723|FG000|Period 1|Lost to Follow-up|0|||
105724023|NCT00868790|364642724|FG001|Period 1|Lost to Follow-up|0|||
105724024|NCT00868790|364642725|FG002|Period 1|Lost to Follow-up|0|||
105724025|NCT00868790|364642726|FG003|Period 1|Lost to Follow-up|0|||
105724026|NCT00868790|364642727|FG004|Period 1|Lost to Follow-up|0|||
105724027|NCT00868790|364642728|FG005|Period 1|Lost to Follow-up|1|||
105724028|NCT00868790|364642729|FG006|Period 1|Lost to Follow-up|0|||
105724029|NCT00868790|364642730|FG007|Period 1|Lost to Follow-up|0|||
105724030|NCT00868790|364642731|FG008|Period 1|Lost to Follow-up|0|||
105724031|NCT00868790|364642732|FG009|Period 1|Lost to Follow-up|0|||
105724032|NCT00868790|364642733|FG010|Period 1|Lost to Follow-up|0|||
105724033|NCT00868790|364642734|FG011|Period 1|Lost to Follow-up|0|||
105724034|NCT00868790|364642735|FG012|Period 1|Lost to Follow-up|0|||
105724035|NCT00868790|364642736|FG013|Period 1|Lost to Follow-up|0|||
105724036|NCT00868790|364642723|FG000|Period 2|Adverse Event|0|||
105724037|NCT00868790|364642724|FG001|Period 2|Adverse Event|0|||
105724038|NCT00868790|364642725|FG002|Period 2|Adverse Event|0|||
105724039|NCT00868790|364642726|FG003|Period 2|Adverse Event|0|||
105724040|NCT00868790|364642727|FG004|Period 2|Adverse Event|0|||
105724041|NCT00868790|364642728|FG005|Period 2|Adverse Event|0|||
105478501|NCT03642132|363764266|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
105724042|NCT00868790|364642729|FG006|Period 2|Adverse Event|0|||
105724043|NCT00868790|364642730|FG007|Period 2|Adverse Event|0|||
105724044|NCT00868790|364642731|FG008|Period 2|Adverse Event|1|||
105724045|NCT00868790|364642732|FG009|Period 2|Adverse Event|0|||
105478502|NCT03642132|363764267|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
105724046|NCT00868790|364642733|FG010|Period 2|Adverse Event|0|||
105724047|NCT00868790|364642734|FG011|Period 2|Adverse Event|0|||
105724048|NCT00868790|364642735|FG012|Period 2|Adverse Event|0|||
105724049|NCT00868790|364642736|FG013|Period 2|Adverse Event|0|||
105724050|NCT00868790|364642723|FG000|Period 2|Lost to Follow-up|0|||
105793074|NCT02545868|364898688|FG002|Overall Study|Non-compliance|1|||
105793075|NCT02545868|364898686|FG000|Overall Study|Treatment change|21|||
105793076|NCT02545868|364898687|FG001|Overall Study|Treatment change|19|||
105793077|NCT02545868|364898688|FG002|Overall Study|Treatment change|22|||
105793078|NCT02545868|364898686|FG000|Overall Study|Physician Decision|1|||
105793079|NCT02545868|364898687|FG001|Overall Study|Physician Decision|1|||
105793080|NCT02545868|364898688|FG002|Overall Study|Physician Decision|1|||
105724051|NCT00868790|364642724|FG001|Period 2|Lost to Follow-up|1|||
105724052|NCT00868790|364642725|FG002|Period 2|Lost to Follow-up|0|||
105724053|NCT00868790|364642726|FG003|Period 2|Lost to Follow-up|0|||
105724054|NCT00868790|364642727|FG004|Period 2|Lost to Follow-up|0|||
105724055|NCT00868790|364642728|FG005|Period 2|Lost to Follow-up|1|||
105724056|NCT00868790|364642729|FG006|Period 2|Lost to Follow-up|0|||
105724057|NCT00868790|364642730|FG007|Period 2|Lost to Follow-up|0|||
105724058|NCT00868790|364642731|FG008|Period 2|Lost to Follow-up|0|||
105724059|NCT00868790|364642732|FG009|Period 2|Lost to Follow-up|0|||
105724060|NCT00868790|364642733|FG010|Period 2|Lost to Follow-up|0|||
105724061|NCT00868790|364642734|FG011|Period 2|Lost to Follow-up|0|||
105724062|NCT00868790|364642735|FG012|Period 2|Lost to Follow-up|0|||
105724063|NCT00868790|364642736|FG013|Period 2|Lost to Follow-up|0|||
105724064|NCT00868790|364642723|FG000|Period 2|Withdrawal by Subject|0|||
105724065|NCT00868790|364642724|FG001|Period 2|Withdrawal by Subject|0|||
105724066|NCT00868790|364642725|FG002|Period 2|Withdrawal by Subject|0|||
105724067|NCT00868790|364642726|FG003|Period 2|Withdrawal by Subject|0|||
105724068|NCT00868790|364642727|FG004|Period 2|Withdrawal by Subject|0|||
105724069|NCT00868790|364642728|FG005|Period 2|Withdrawal by Subject|0|||
105724070|NCT00868790|364642729|FG006|Period 2|Withdrawal by Subject|0|||
105724071|NCT00868790|364642730|FG007|Period 2|Withdrawal by Subject|0|||
105724072|NCT00868790|364642731|FG008|Period 2|Withdrawal by Subject|1|||
105724073|NCT00868790|364642732|FG009|Period 2|Withdrawal by Subject|0|||
105724074|NCT00868790|364642733|FG010|Period 2|Withdrawal by Subject|0|||
105724075|NCT00868790|364642734|FG011|Period 2|Withdrawal by Subject|0|||
105724076|NCT00868790|364642735|FG012|Period 2|Withdrawal by Subject|0|||
105724077|NCT00868790|364642736|FG013|Period 2|Withdrawal by Subject|1|||
105724078|NCT00868790|364642723|FG000|Period 3|Adverse Event|0|||
105724079|NCT00868790|364642724|FG001|Period 3|Adverse Event|0|||
105724080|NCT00868790|364642725|FG002|Period 3|Adverse Event|0|||
105724081|NCT00868790|364642726|FG003|Period 3|Adverse Event|0|||
105724082|NCT00868790|364642727|FG004|Period 3|Adverse Event|0|||
105724083|NCT00868790|364642728|FG005|Period 3|Adverse Event|0|||
105724084|NCT00868790|364642729|FG006|Period 3|Adverse Event|0|||
105724085|NCT00868790|364642730|FG007|Period 3|Adverse Event|0|||
105724086|NCT00868790|364642731|FG008|Period 3|Adverse Event|0|||
105724087|NCT00868790|364642732|FG009|Period 3|Adverse Event|1|||
105724088|NCT00868790|364642733|FG010|Period 3|Adverse Event|0|||
105724089|NCT00868790|364642734|FG011|Period 3|Adverse Event|0|||
105724090|NCT00868790|364642735|FG012|Period 3|Adverse Event|0|||
105724091|NCT00868790|364642736|FG013|Period 3|Adverse Event|0|||
105724092|NCT00868790|364642723|FG000|Period 3|Protocol Violation|0|||
105724093|NCT00868790|364642724|FG001|Period 3|Protocol Violation|0|||
105724094|NCT00868790|364642725|FG002|Period 3|Protocol Violation|0|||
105724095|NCT00868790|364642726|FG003|Period 3|Protocol Violation|0|||
105724096|NCT00868790|364642727|FG004|Period 3|Protocol Violation|0|||
105724097|NCT00868790|364642728|FG005|Period 3|Protocol Violation|0|||
105724098|NCT00868790|364642729|FG006|Period 3|Protocol Violation|0|||
105724099|NCT00868790|364642730|FG007|Period 3|Protocol Violation|0|||
105724100|NCT00868790|364642731|FG008|Period 3|Protocol Violation|0|||
105724101|NCT00868790|364642732|FG009|Period 3|Protocol Violation|0|||
105793081|NCT02545868|364898686|FG000|Overall Study|Withdrawal by Subject|6|||
105793082|NCT02545868|364898687|FG001|Overall Study|Withdrawal by Subject|7|||
105793083|NCT02545868|364898688|FG002|Overall Study|Withdrawal by Subject|9|||
105478503|NCT03642132|363764268|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
105478504|NCT03642132|363764266|FG000|Chemotherapy Period|Other|1|||
105478505|NCT03642132|363764267|FG001|Chemotherapy Period|Other|0|||
105478506|NCT03642132|363764268|FG002|Chemotherapy Period|Other|2|||
105724102|NCT00868790|364642733|FG010|Period 3|Protocol Violation|1|||
105793084|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Adverse Event|2|||
105793085|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Adverse Event|0|||
105793086|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Adverse Event|0|||
105724103|NCT00868790|364642734|FG011|Period 3|Protocol Violation|0|||
105724104|NCT00868790|364642735|FG012|Period 3|Protocol Violation|0|||
105724105|NCT00868790|364642736|FG013|Period 3|Protocol Violation|0|||
105724106|NCT00868790|364642723|FG000|Period 3|Study Terminated by Sponsor|0|||
105724107|NCT00868790|364642724|FG001|Period 3|Study Terminated by Sponsor|0|||
105724108|NCT00868790|364642725|FG002|Period 3|Study Terminated by Sponsor|0|||
105793087|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Adverse Event|0|||
105793088|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
105724109|NCT00868790|364642726|FG003|Period 3|Study Terminated by Sponsor|1|||
105724110|NCT00868790|364642727|FG004|Period 3|Study Terminated by Sponsor|0|||
105724111|NCT00868790|364642728|FG005|Period 3|Study Terminated by Sponsor|0|||
105724112|NCT00868790|364642729|FG006|Period 3|Study Terminated by Sponsor|0|||
105478507|NCT03642132|363764266|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
105478508|NCT03642132|363764267|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
105724113|NCT00868790|364642730|FG007|Period 3|Study Terminated by Sponsor|0|||
105724114|NCT00868790|364642731|FG008|Period 3|Study Terminated by Sponsor|0|||
105724115|NCT00868790|364642732|FG009|Period 3|Study Terminated by Sponsor|0|||
105724116|NCT00868790|364642733|FG010|Period 3|Study Terminated by Sponsor|0|||
105724117|NCT00868790|364642734|FG011|Period 3|Study Terminated by Sponsor|0|||
105724118|NCT00868790|364642735|FG012|Period 3|Study Terminated by Sponsor|0|||
105724119|NCT00868790|364642736|FG013|Period 3|Study Terminated by Sponsor|0|||
105724120|NCT00868790|364642723|FG000|Period 4|Adverse Event|0|||
105724121|NCT00868790|364642724|FG001|Period 4|Adverse Event|0|||
105724122|NCT00868790|364642725|FG002|Period 4|Adverse Event|0|||
105724123|NCT00868790|364642726|FG003|Period 4|Adverse Event|0|||
105724124|NCT00868790|364642727|FG004|Period 4|Adverse Event|0|||
105724125|NCT00868790|364642728|FG005|Period 4|Adverse Event|0|||
105724126|NCT00868790|364642729|FG006|Period 4|Adverse Event|0|||
105724127|NCT00868790|364642730|FG007|Period 4|Adverse Event|1|||
105724128|NCT00868790|364642731|FG008|Period 4|Adverse Event|0|||
105724129|NCT00868790|364642732|FG009|Period 4|Adverse Event|0|||
105724130|NCT00868790|364642733|FG010|Period 4|Adverse Event|1|||
105724131|NCT00868790|364642734|FG011|Period 4|Adverse Event|0|||
105724132|NCT00868790|364642735|FG012|Period 4|Adverse Event|1|||
105724133|NCT00868790|364642736|FG013|Period 4|Adverse Event|0|||
105724134|NCT00868790|364642723|FG000|Period 4|Lost to Follow-up|0|||
105724135|NCT00868790|364642724|FG001|Period 4|Lost to Follow-up|0|||
105724136|NCT00868790|364642725|FG002|Period 4|Lost to Follow-up|0|||
105724137|NCT00868790|364642726|FG003|Period 4|Lost to Follow-up|0|||
105724138|NCT00868790|364642727|FG004|Period 4|Lost to Follow-up|0|||
105724139|NCT00868790|364642728|FG005|Period 4|Lost to Follow-up|0|||
105724140|NCT00868790|364642729|FG006|Period 4|Lost to Follow-up|0|||
105724141|NCT00868790|364642730|FG007|Period 4|Lost to Follow-up|1|||
105724142|NCT00868790|364642731|FG008|Period 4|Lost to Follow-up|0|||
105724143|NCT00868790|364642732|FG009|Period 4|Lost to Follow-up|0|||
105724144|NCT00868790|364642733|FG010|Period 4|Lost to Follow-up|0|||
105724145|NCT00868790|364642734|FG011|Period 4|Lost to Follow-up|0|||
105724146|NCT00868790|364642735|FG012|Period 4|Lost to Follow-up|0|||
105724147|NCT00868790|364642736|FG013|Period 4|Lost to Follow-up|0|||
105724148|NCT00868790|364642723|FG000|Period 4|Study Terminated by Sponsor|2|||
105724149|NCT00868790|364642724|FG001|Period 4|Study Terminated by Sponsor|0|||
105724150|NCT00868790|364642725|FG002|Period 4|Study Terminated by Sponsor|0|||
105724151|NCT00868790|364642726|FG003|Period 4|Study Terminated by Sponsor|0|||
105724152|NCT00868790|364642727|FG004|Period 4|Study Terminated by Sponsor|0|||
105724153|NCT00868790|364642728|FG005|Period 4|Study Terminated by Sponsor|0|||
105724154|NCT00868790|364642729|FG006|Period 4|Study Terminated by Sponsor|0|||
105724155|NCT00868790|364642730|FG007|Period 4|Study Terminated by Sponsor|1|||
105724156|NCT00868790|364642731|FG008|Period 4|Study Terminated by Sponsor|2|||
105724157|NCT00868790|364642732|FG009|Period 4|Study Terminated by Sponsor|0|||
105724158|NCT00868790|364642733|FG010|Period 4|Study Terminated by Sponsor|2|||
105724159|NCT00868790|364642734|FG011|Period 4|Study Terminated by Sponsor|1|||
105724160|NCT00868790|364642735|FG012|Period 4|Study Terminated by Sponsor|0|||
105724161|NCT00868790|364642736|FG013|Period 4|Study Terminated by Sponsor|1|||
105724162|NCT00868790|364642723|FG000|Period 4|Abnormal ALT/AST|0|||
105724163|NCT00868790|364642724|FG001|Period 4|Abnormal ALT/AST|0|||
105724164|NCT00868790|364642725|FG002|Period 4|Abnormal ALT/AST|1|||
105478509|NCT03642132|363764268|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
105478510|NCT03642132|363764266|FG000|Maintenance Period|Adverse Event|1|||
105724165|NCT00868790|364642726|FG003|Period 4|Abnormal ALT/AST|0|||
105724166|NCT00868790|364642727|FG004|Period 4|Abnormal ALT/AST|0|||
105724167|NCT00868790|364642728|FG005|Period 4|Abnormal ALT/AST|0|||
105724168|NCT00868790|364642729|FG006|Period 4|Abnormal ALT/AST|0|||
105724169|NCT00868790|364642730|FG007|Period 4|Abnormal ALT/AST|0|||
105724170|NCT00868790|364642731|FG008|Period 4|Abnormal ALT/AST|0|||
105724171|NCT00868790|364642732|FG009|Period 4|Abnormal ALT/AST|0|||
105724172|NCT00868790|364642733|FG010|Period 4|Abnormal ALT/AST|0|||
105724173|NCT00868790|364642734|FG011|Period 4|Abnormal ALT/AST|0|||
105724174|NCT00868790|364642735|FG012|Period 4|Abnormal ALT/AST|0|||
105724175|NCT00868790|364642736|FG013|Period 4|Abnormal ALT/AST|0|||
105724176|NCT00868790|364642723|FG000|Post-study|Withdrawal by Subject|0|||
105478511|NCT03642132|363764267|FG001|Maintenance Period|Adverse Event|2|||
105724177|NCT00868790|364642724|FG001|Post-study|Withdrawal by Subject|0|||
105724178|NCT00868790|364642725|FG002|Post-study|Withdrawal by Subject|0|||
105724179|NCT00868790|364642726|FG003|Post-study|Withdrawal by Subject|0|||
105478512|NCT03642132|363764268|FG002|Maintenance Period|Adverse Event|0|||
105478513|NCT03642132|363764266|FG000|Maintenance Period|Non-compliance with study drug|0|||
105478514|NCT03642132|363764267|FG001|Maintenance Period|Non-compliance with study drug|0|||
105478515|NCT03642132|363764268|FG002|Maintenance Period|Non-compliance with study drug|1|||
105478516|NCT03642132|363764266|FG000|Maintenance Period|Physician's decision|2|||
105478517|NCT03642132|363764267|FG001|Maintenance Period|Physician's decision|2|||
105478518|NCT03642132|363764268|FG002|Maintenance Period|Physician's decision|2|||
105478519|NCT03642132|363764266|FG000|Maintenance Period|Progressive disease|9|||
105478520|NCT03642132|363764267|FG001|Maintenance Period|Progressive disease|3|||
105793089|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
105793090|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
105793091|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
105793092|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
105793093|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
105793094|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
105793095|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
105793096|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Physician Decision|1|||
105793097|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Physician Decision|0|||
105793098|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Physician Decision|0|||
105793099|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Physician Decision|0|||
105793100|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Pregnancy|1|||
105793101|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Pregnancy|0|||
105793102|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Pregnancy|0|||
105793103|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Pregnancy|0|||
105793104|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
105793105|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
105793106|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
105793107|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
105793108|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
105793109|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
105793110|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
105793111|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
105793112|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
105793113|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
105793114|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
105793115|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
105793116|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
105793117|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
105793118|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
105793119|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
105793120|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Not Treated|1|||
105793121|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Not Treated|0|||
105793122|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Not Treated|0|||
105793123|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Not Treated|0|||
105793124|NCT04057573|364898689|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
105793125|NCT04057573|364898690|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
105724180|NCT00868790|364642727|FG004|Post-study|Withdrawal by Subject|1|||
105724181|NCT00868790|364642728|FG005|Post-study|Withdrawal by Subject|0|||
105724182|NCT00868790|364642729|FG006|Post-study|Withdrawal by Subject|0|||
105724183|NCT00868790|364642730|FG007|Post-study|Withdrawal by Subject|0|||
105724184|NCT00868790|364642731|FG008|Post-study|Withdrawal by Subject|0|||
105724185|NCT00868790|364642732|FG009|Post-study|Withdrawal by Subject|0|||
105724186|NCT00868790|364642733|FG010|Post-study|Withdrawal by Subject|0|||
105724187|NCT00868790|364642734|FG011|Post-study|Withdrawal by Subject|0|||
105724188|NCT00868790|364642735|FG012|Post-study|Withdrawal by Subject|0|||
105724189|NCT00868790|364642736|FG013|Post-study|Withdrawal by Subject|0|||
105724190|NCT00868790|364642723|FG000|Post-study|Excluded Medication|0|||
105724191|NCT00868790|364642724|FG001|Post-study|Excluded Medication|0|||
105724192|NCT00868790|364642725|FG002|Post-study|Excluded Medication|0|||
105724193|NCT00868790|364642726|FG003|Post-study|Excluded Medication|0|||
105724194|NCT00868790|364642727|FG004|Post-study|Excluded Medication|0|||
105478521|NCT03642132|363764268|FG002|Maintenance Period|Progressive disease|6|||
105724195|NCT00868790|364642728|FG005|Post-study|Excluded Medication|0|||
105724196|NCT00868790|364642729|FG006|Post-study|Excluded Medication|0|||
105724197|NCT00868790|364642730|FG007|Post-study|Excluded Medication|2|||
105724198|NCT00868790|364642731|FG008|Post-study|Excluded Medication|0|||
105724199|NCT00868790|364642732|FG009|Post-study|Excluded Medication|1|||
105724200|NCT00868790|364642733|FG010|Post-study|Excluded Medication|0|||
105724201|NCT00868790|364642734|FG011|Post-study|Excluded Medication|0|||
105724202|NCT00868790|364642735|FG012|Post-study|Excluded Medication|0|||
105724203|NCT00868790|364642736|FG013|Post-study|Excluded Medication|0|||
105793126|NCT04057573|364898691|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
105793127|NCT04057573|364898692|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
105793128|NCT04057573|364898689|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
105793129|NCT04057573|364898690|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
105793130|NCT04057573|364898691|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
105478522|NCT03642132|363764266|FG000|Maintenance Period|Other|0|||
105724204|NCT03377634|364642739|FG000|Study Period|Adverse Event|1|||
105724205|NCT03377634|364642740|FG001|Study Period|Adverse Event|0|||
105724206|NCT03377634|364642739|FG000|Study Period|Withdrawal by Subject|1|||
105724207|NCT03377634|364642740|FG001|Study Period|Withdrawal by Subject|0|||
105724208|NCT01475734|364644205|FG000|Overall Study|Withdrawal by Subject|1|||
105724209|NCT01475734|364644206|FG001|Overall Study|Withdrawal by Subject|0|||
105724210|NCT01475734|364644205|FG000|Overall Study|Protocol Violation|1|||
105724211|NCT01475734|364644206|FG001|Overall Study|Protocol Violation|0|||
105724212|NCT01475734|364644205|FG000|Overall Study|Physician Decision|0|||
105724213|NCT01475734|364644206|FG001|Overall Study|Physician Decision|1|||
105724214|NCT01147497|364644217|FG000|Overall Study|failed insertion|2|||
105724215|NCT01147497|364644218|FG001|Overall Study|failed insertion|0|||
105724216|NCT01700829|364644221|FG000|Overall Study|Withdrawal by Subject|1|||
105724217|NCT01700829|364644222|FG001|Overall Study|Withdrawal by Subject|1|||
105724218|NCT03367871|364644223|FG000|Overall Study|Lost to Follow-up|1|||
105724219|NCT02013544|364644225|FG000|Overall Study|Adverse Event|5|||
105724220|NCT02013544|364644226|FG001|Overall Study|Adverse Event|5|||
105724221|NCT02013544|364644225|FG000|Overall Study|Lost to Follow-up|2|||
105724222|NCT02013544|364644226|FG001|Overall Study|Lost to Follow-up|3|||
105724223|NCT02013544|364644225|FG000|Overall Study|Withdrawal by Subject|2|||
105724224|NCT02013544|364644226|FG001|Overall Study|Withdrawal by Subject|8|||
105724225|NCT02013544|364644225|FG000|Overall Study|Physician Decision|0|||
105724226|NCT02013544|364644226|FG001|Overall Study|Physician Decision|1|||
105724227|NCT02013544|364644225|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
105724228|NCT02013544|364644226|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
105724229|NCT00238264|364644227|FG000|Overall Study|Death|7|||
105724230|NCT00238264|364644227|FG000|Overall Study|Lost to Follow-up|18|||
105724231|NCT00238264|364644227|FG000|Overall Study|Withdrawal by Subject|4|||
105724232|NCT00238264|364644227|FG000|Overall Study|Ineligible|7|||
105724233|NCT00891735|364644228|FG000|Overall Study|Adverse Event|2|||
105724234|NCT00891735|364644229|FG001|Overall Study|Adverse Event|0|||
105724235|NCT00891735|364644230|FG002|Overall Study|Adverse Event|2|||
105724236|NCT00891735|364644231|FG003|Overall Study|Adverse Event|0|||
105724237|NCT00891735|364644228|FG000|Overall Study|Death|8|||
105724238|NCT00891735|364644229|FG001|Overall Study|Death|5|||
105724239|NCT00891735|364644230|FG002|Overall Study|Death|4|||
105724240|NCT00891735|364644231|FG003|Overall Study|Death|5|||
105724241|NCT00891735|364644228|FG000|Overall Study|Lost to Follow-up|2|||
105724242|NCT00891735|364644229|FG001|Overall Study|Lost to Follow-up|2|||
105724243|NCT00891735|364644230|FG002|Overall Study|Lost to Follow-up|2|||
105724244|NCT00891735|364644231|FG003|Overall Study|Lost to Follow-up|2|||
105724245|NCT00891735|364644228|FG000|Overall Study|Physician's decision to withdraw patient|1|||
105724246|NCT00891735|364644229|FG001|Overall Study|Physician's decision to withdraw patient|0|||
105724247|NCT00891735|364644230|FG002|Overall Study|Physician's decision to withdraw patient|0|||
105724248|NCT00891735|364644231|FG003|Overall Study|Physician's decision to withdraw patient|0|||
105724249|NCT00891735|364644228|FG000|Overall Study|Patient's decision to withdraw|4|||
105724250|NCT00891735|364644229|FG001|Overall Study|Patient's decision to withdraw|9|||
105724251|NCT00891735|364644230|FG002|Overall Study|Patient's decision to withdraw|4|||
105724252|NCT00891735|364644231|FG003|Overall Study|Patient's decision to withdraw|8|||
105724253|NCT01085682|364644234|FG000|Overall Study|Withdrawal by Subject|25|||
105724254|NCT01085682|364644235|FG001|Overall Study|Withdrawal by Subject|25|||
105724255|NCT00813995|364644236|FG000|Overall Study|Clinical adverse event|9|||
105724256|NCT00813995|364644237|FG001|Overall Study|Clinical adverse event|3|||
105724257|NCT00813995|364644236|FG000|Overall Study|Laboratory adverse event|0|||
105724258|NCT00813995|364644237|FG001|Overall Study|Laboratory adverse event|2|||
105724259|NCT00813995|364644236|FG000|Overall Study|Lack of Efficacy|1|||
105724260|NCT00813995|364644237|FG001|Overall Study|Lack of Efficacy|0|||
105724261|NCT00813995|364644236|FG000|Overall Study|Lost to Follow-up|4|||
105724262|NCT00813995|364644237|FG001|Overall Study|Lost to Follow-up|2|||
105724263|NCT00813995|364644236|FG000|Overall Study|Other reason|2|||
105724264|NCT00813995|364644237|FG001|Overall Study|Other reason|2|||
105724265|NCT00813995|364644236|FG000|Overall Study|Protocol Violation|3|||
105478523|NCT03642132|363764267|FG001|Maintenance Period|Other|0|||
105478524|NCT03642132|363764268|FG002|Maintenance Period|Other|3|||
105724266|NCT00813995|364644237|FG001|Overall Study|Protocol Violation|2|||
105724267|NCT00813995|364644236|FG000|Overall Study|Subject moved|4|||
105724268|NCT00813995|364644237|FG001|Overall Study|Subject moved|0|||
105478525|NCT03642132|363764266|FG000|Maintenance Period|Withdrawal by Subject|1|||
105724269|NCT00813995|364644236|FG000|Overall Study|Withdrawal by Subject|0|||
105724270|NCT00813995|364644237|FG001|Overall Study|Withdrawal by Subject|5|||
105724271|NCT01614964|364644238|FG000|Overall Study|Withdrawal by Subject|2|||
105478526|NCT03642132|363764267|FG001|Maintenance Period|Withdrawal by Subject|1|||
105478527|NCT03642132|363764268|FG002|Maintenance Period|Withdrawal by Subject|2|||
105724272|NCT01614964|364644239|FG001|Overall Study|Withdrawal by Subject|0|||
105724273|NCT01614964|364644238|FG000|Overall Study|Lost to Follow-up|3|||
105724274|NCT01614964|364644239|FG001|Overall Study|Lost to Follow-up|0|||
105724275|NCT00619957|364644242|FG000|Month 24 Double-Blind|Adverse Event|9|||
105724276|NCT00619957|364644243|FG001|Month 24 Double-Blind|Adverse Event|7|||
105724277|NCT00619957|364644242|FG000|Month 24 Double-Blind|Protocol Violation|1|||
105724278|NCT00619957|364644243|FG001|Month 24 Double-Blind|Protocol Violation|0|||
105724279|NCT00619957|364644242|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
105724280|NCT00619957|364644243|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
105724281|NCT00619957|364644242|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
105724282|NCT00619957|364644243|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
105724283|NCT00619957|364644242|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
105724284|NCT00619957|364644243|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
105724285|NCT00619957|364644242|FG000|Month 48 Open-Label|Adverse Event|4|||
105724286|NCT00619957|364644243|FG001|Month 48 Open-Label|Adverse Event|4|||
105724287|NCT00619957|364644242|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
105724288|NCT00619957|364644243|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
105724289|NCT00619957|364644242|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
105724290|NCT00619957|364644243|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
105724291|NCT00727402|364644244|FG000|Overall Study|Physician Decision|116|||
105724292|NCT00723957|364644245|FG000|Overall Study|Adverse event unrelated to study drug|1|||
105724293|NCT00723957|364644246|FG001|Overall Study|Adverse event unrelated to study drug|4|||
105724294|NCT00723957|364644245|FG000|Overall Study|Death|3|||
105724295|NCT00723957|364644246|FG001|Overall Study|Death|4|||
105724296|NCT00723957|364644245|FG000|Overall Study|Disease progression|27|||
105724297|NCT00723957|364644246|FG001|Overall Study|Disease progression|25|||
105724298|NCT00723957|364644245|FG000|Overall Study|Maximum clinical benefit|4|||
105724299|NCT00723957|364644246|FG001|Overall Study|Maximum clinical benefit|5|||
105724300|NCT00723957|364644245|FG000|Overall Study|Investigator decision|1|||
105724301|NCT00723957|364644246|FG001|Overall Study|Investigator decision|1|||
105724302|NCT00723957|364644245|FG000|Overall Study|Study drug toxicity|4|||
105724303|NCT00723957|364644246|FG001|Overall Study|Study drug toxicity|6|||
105724304|NCT00723957|364644245|FG000|Overall Study|Withdrawal by Subject|7|||
105724305|NCT00723957|364644246|FG001|Overall Study|Withdrawal by Subject|5|||
105724306|NCT00723957|364644245|FG000|Overall Study|Reason not analyzed|1|||
105724307|NCT00723957|364644246|FG001|Overall Study|Reason not analyzed|0|||
105724308|NCT00723957|364644245|FG000|Overall Study|Never received treatment|3|||
105724309|NCT00723957|364644246|FG001|Overall Study|Never received treatment|3|||
105724310|NCT00519077|364644247|FG000|Overall Study|Death|6|||
105724311|NCT00519077|364644247|FG000|Overall Study|Other|2|||
105724312|NCT05681715|364644250|FG000|Training Period (6-weeks)|Adverse Event|3|||
105724313|NCT05681715|364644251|FG001|Training Period (6-weeks)|Adverse Event|0|||
105724314|NCT05681715|364644252|FG002|Training Period (6-weeks)|Adverse Event|0|||
105724315|NCT05681715|364644250|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
105724316|NCT05681715|364644251|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
105724317|NCT05681715|364644252|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
105724318|NCT05681715|364644250|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
105724319|NCT05681715|364644251|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
105724320|NCT05681715|364644252|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
105724321|NCT05681715|364644250|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
105724322|NCT05681715|364644251|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
105724323|NCT05681715|364644252|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
105724324|NCT05681715|364644250|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
105724325|NCT05681715|364644251|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
105724326|NCT05681715|364644252|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
105724327|NCT05681715|364644250|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
105724328|NCT05681715|364644251|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
105724329|NCT05681715|364644252|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
105724330|NCT05681715|364644250|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
105724331|NCT05681715|364644251|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
105724332|NCT05681715|364644252|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
105724333|NCT05681715|364644250|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
105724334|NCT05681715|364644251|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
105724335|NCT05681715|364644252|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
105724336|NCT01709331|364644253|FG000|Overall Study|Adverse Event|1|||
105793131|NCT04057573|364898692|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
105793132|NCT04057573|364898689|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
105793133|NCT04057573|364898690|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
105793134|NCT04057573|364898691|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
105793135|NCT04057573|364898692|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
105793136|NCT04057573|364898689|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
105793137|NCT04057573|364898690|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
105793138|NCT04057573|364898691|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
105793139|NCT04057573|364898692|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
105793140|NCT04057573|364898689|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
105793141|NCT04057573|364898690|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
105793142|NCT04057573|364898691|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
105724337|NCT03896295|364644260|FG000|Overall Study|Adverse Event|0|||
105724338|NCT03896295|364644261|FG001|Overall Study|Adverse Event|1|||
105724339|NCT03896295|364644260|FG000|Overall Study|COVID-19|7|||
105724340|NCT03896295|364644261|FG001|Overall Study|COVID-19|29|||
105724341|NCT01651780|364644262|FG000|Overall Study|Physician decision: No 30-day visit|2|||
105724342|NCT01651780|364644263|FG001|Overall Study|Physician decision: No 30-day visit|1|||
105724343|NCT01651780|364644262|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
105793143|NCT04057573|364898692|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
105793144|NCT04465916|364898693|FG000|Overall Study|Withdrawal by Subject|0|||
105793145|NCT04465916|364898694|FG001|Overall Study|Withdrawal by Subject|1|||
105793146|NCT03286400|364898695|FG000|Overall Study|Death|10|||
105793147|NCT03286400|364898695|FG000|Overall Study|Lost to Follow-up|10|||
105793148|NCT03286400|364898695|FG000|Overall Study|Physician Decision|1|||
105793149|NCT03286400|364898695|FG000|Overall Study|Scheduling difficulty|4|||
105793150|NCT03079869|364898698|FG000|Overall Study|Adverse Event|6|||
105793151|NCT03079869|364898699|FG001|Overall Study|Adverse Event|8|||
105793152|NCT03079869|364898698|FG000|Overall Study|Withdrawal by Subject|4|||
105793153|NCT03079869|364898699|FG001|Overall Study|Withdrawal by Subject|1|||
105793154|NCT03079869|364898698|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
105793155|NCT03079869|364898699|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
105793156|NCT03976076|364898700|FG000|Overall Study|Withdrawal by Subject|2|||
105793157|NCT02411110|364898704|FG000|Treatment Period 1|Adverse Event|4|||
105793158|NCT02411110|364898705|FG001|Treatment Period 1|Adverse Event|2|||
105793159|NCT02411110|364898704|FG000|Treatment Period 1|Lost to Follow-up|1|||
105793160|NCT02411110|364898705|FG001|Treatment Period 1|Lost to Follow-up|0|||
105793161|NCT02411110|364898704|FG000|Treatment Period 1|Personal Reasons|2|||
105793162|NCT02411110|364898705|FG001|Treatment Period 1|Personal Reasons|5|||
105793163|NCT02411110|364898704|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
105793164|NCT02411110|364898705|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
105793165|NCT02411110|364898704|FG000|Treatment Period 2|Adverse Event|1|||
105793166|NCT02411110|364898705|FG001|Treatment Period 2|Adverse Event|0|||
105793167|NCT02411110|364898704|FG000|Treatment Period 2|Lost to Follow-up|0|||
105793168|NCT02411110|364898705|FG001|Treatment Period 2|Lost to Follow-up|2|||
105793169|NCT02411110|364898704|FG000|Treatment Period 2|Personal Reasons|0|||
105793170|NCT02411110|364898705|FG001|Treatment Period 2|Personal Reasons|2|||
105793171|NCT00759174|364898714|FG000|Overall Study|Other|0|||
105793172|NCT00759174|364898715|FG001|Overall Study|Other|2|||
105793173|NCT01643928|364898716|FG000|Overall Study|Lost to Follow-up|1|||
105793174|NCT01643928|364898717|FG001|Overall Study|Lost to Follow-up|0|||
105793175|NCT01643928|364898718|FG002|Overall Study|Lost to Follow-up|2|||
105793176|NCT01643928|364898719|FG003|Overall Study|Lost to Follow-up|0|||
105793177|NCT01643928|364898720|FG004|Overall Study|Lost to Follow-up|0|||
105793178|NCT01643928|364898716|FG000|Overall Study|Withdrawal by Subject|2|||
105793179|NCT01643928|364898717|FG001|Overall Study|Withdrawal by Subject|0|||
105793180|NCT01643928|364898718|FG002|Overall Study|Withdrawal by Subject|0|||
105793181|NCT01643928|364898719|FG003|Overall Study|Withdrawal by Subject|1|||
105724344|NCT01651780|364644263|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
105724345|NCT01651780|364644262|FG000|Overall Study|Withdrawal by Subject|2|||
105793182|NCT01643928|364898720|FG004|Overall Study|Withdrawal by Subject|0|||
105793183|NCT01643928|364898716|FG000|Overall Study|Pregnancy|0|||
105793184|NCT01643928|364898717|FG001|Overall Study|Pregnancy|0|||
105793185|NCT01643928|364898718|FG002|Overall Study|Pregnancy|0|||
105793186|NCT01643928|364898719|FG003|Overall Study|Pregnancy|1|||
105724346|NCT01651780|364644263|FG001|Overall Study|Withdrawal by Subject|0|||
105724347|NCT01651780|364644262|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
105793187|NCT01643928|364898720|FG004|Overall Study|Pregnancy|0|||
105793188|NCT01643928|364898716|FG000|Overall Study|Other|5|||
105793189|NCT01643928|364898717|FG001|Overall Study|Other|1|||
105793190|NCT01643928|364898718|FG002|Overall Study|Other|1|||
105793191|NCT01643928|364898719|FG003|Overall Study|Other|0|||
105793192|NCT01643928|364898720|FG004|Overall Study|Other|0|||
105793193|NCT01643928|364898716|FG000|Overall Study|Adverse Event|2|||
105793194|NCT01643928|364898717|FG001|Overall Study|Adverse Event|1|||
105793195|NCT01643928|364898718|FG002|Overall Study|Adverse Event|0|||
105793196|NCT01643928|364898719|FG003|Overall Study|Adverse Event|1|||
105793197|NCT01643928|364898720|FG004|Overall Study|Adverse Event|2|||
105793198|NCT00996632|364898725|FG000|Overall Study|Physician Decision|0|||
105793199|NCT00996632|364898726|FG001|Overall Study|Physician Decision|0|||
105793200|NCT05354206|364898727|FG000|Overall Study|Withdrawal by Subject|1|||
105793201|NCT05354206|364898728|FG001|Overall Study|Withdrawal by Subject|0|||
105793202|NCT01414062|364898731|FG000|Overall Study|Lost to Follow-up|3|||
105793203|NCT01414062|364898732|FG001|Overall Study|Lost to Follow-up|2|||
105793204|NCT01414062|364898731|FG000|Overall Study|Left Country|1|||
105793205|NCT01414062|364898732|FG001|Overall Study|Left Country|1|||
105793206|NCT01414062|364898731|FG000|Overall Study|Family Disapproval|1|||
105793207|NCT01414062|364898732|FG001|Overall Study|Family Disapproval|0|||
105793208|NCT01414062|364898731|FG000|Overall Study|Withdrawal by Subject|0|||
105793209|NCT01414062|364898732|FG001|Overall Study|Withdrawal by Subject|1|||
105793210|NCT04936334|364898733|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
105793211|NCT01563029|364898734|FG000|Overall Study|Adverse Event|1|||
105793212|NCT01563029|364898735|FG001|Overall Study|Adverse Event|0|||
105793213|NCT01563029|364898736|FG002|Overall Study|Adverse Event|1|||
105793214|NCT01563029|364898737|FG003|Overall Study|Adverse Event|2|||
105793215|NCT01563029|364898738|FG004|Overall Study|Adverse Event|1|||
105793216|NCT01563029|364898734|FG000|Overall Study|Lack of Efficacy|42|||
105793217|NCT01563029|364898735|FG001|Overall Study|Lack of Efficacy|16|||
105793218|NCT01563029|364898736|FG002|Overall Study|Lack of Efficacy|23|||
105793219|NCT01563029|364898737|FG003|Overall Study|Lack of Efficacy|21|||
105793220|NCT01563029|364898738|FG004|Overall Study|Lack of Efficacy|19|||
105793221|NCT01563029|364898734|FG000|Overall Study|Protocol Violation|1|||
105793222|NCT01563029|364898735|FG001|Overall Study|Protocol Violation|2|||
105793223|NCT01563029|364898736|FG002|Overall Study|Protocol Violation|3|||
105793224|NCT01563029|364898737|FG003|Overall Study|Protocol Violation|1|||
105793225|NCT01563029|364898738|FG004|Overall Study|Protocol Violation|3|||
105793226|NCT01563029|364898734|FG000|Overall Study|Protocol defined stopping criteria|1|||
105793227|NCT01563029|364898735|FG001|Overall Study|Protocol defined stopping criteria|0|||
105793228|NCT01563029|364898736|FG002|Overall Study|Protocol defined stopping criteria|0|||
105793229|NCT01563029|364898737|FG003|Overall Study|Protocol defined stopping criteria|0|||
105793230|NCT01563029|364898738|FG004|Overall Study|Protocol defined stopping criteria|0|||
105793231|NCT01563029|364898734|FG000|Overall Study|Lost to Follow-up|1|||
105793232|NCT01563029|364898735|FG001|Overall Study|Lost to Follow-up|0|||
105793233|NCT01563029|364898736|FG002|Overall Study|Lost to Follow-up|1|||
105793234|NCT01563029|364898737|FG003|Overall Study|Lost to Follow-up|1|||
105793235|NCT01563029|364898738|FG004|Overall Study|Lost to Follow-up|1|||
105724348|NCT01651780|364644263|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105724349|NCT01651780|364644262|FG000|Overall Study|Lost to Follow-up|1|||
105724350|NCT01651780|364644263|FG001|Overall Study|Lost to Follow-up|2|||
105724351|NCT01651780|364644262|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
105724352|NCT01651780|364644263|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
105724353|NCT01628926|364644264|FG000|Overall Study|Adverse Event|13|||
105724354|NCT01628926|364644265|FG001|Overall Study|Adverse Event|11|||
105724355|NCT01628926|364644266|FG002|Overall Study|Adverse Event|9|||
105724356|NCT01628926|364644264|FG000|Overall Study|Lack of Efficacy|2|||
105724357|NCT01628926|364644265|FG001|Overall Study|Lack of Efficacy|1|||
105724358|NCT01628926|364644266|FG002|Overall Study|Lack of Efficacy|5|||
105724359|NCT01628926|364644264|FG000|Overall Study|Withdrawal by Subject|6|||
105724360|NCT01628926|364644265|FG001|Overall Study|Withdrawal by Subject|4|||
105724361|NCT01628926|364644266|FG002|Overall Study|Withdrawal by Subject|2|||
105724362|NCT01628926|364644264|FG000|Overall Study|Protocol Violation|0|||
105724363|NCT01628926|364644265|FG001|Overall Study|Protocol Violation|1|||
105724364|NCT01628926|364644266|FG002|Overall Study|Protocol Violation|0|||
105724365|NCT01628926|364644264|FG000|Overall Study|Discontinuation criteria|3|||
105724366|NCT01628926|364644265|FG001|Overall Study|Discontinuation criteria|4|||
105724367|NCT01628926|364644266|FG002|Overall Study|Discontinuation criteria|0|||
105724368|NCT01628926|364644264|FG000|Overall Study|Physician Decision|2|||
105724369|NCT01628926|364644265|FG001|Overall Study|Physician Decision|2|||
105724370|NCT01628926|364644266|FG002|Overall Study|Physician Decision|1|||
105793236|NCT01563029|364898734|FG000|Overall Study|Physician Decision|3|||
105793237|NCT01563029|364898735|FG001|Overall Study|Physician Decision|5|||
105793238|NCT01563029|364898736|FG002|Overall Study|Physician Decision|2|||
105793239|NCT01563029|364898737|FG003|Overall Study|Physician Decision|4|||
105793240|NCT01563029|364898738|FG004|Overall Study|Physician Decision|2|||
105793241|NCT01563029|364898734|FG000|Overall Study|Withdrawal by Subject|4|||
105793242|NCT01563029|364898735|FG001|Overall Study|Withdrawal by Subject|1|||
105793243|NCT01563029|364898736|FG002|Overall Study|Withdrawal by Subject|3|||
105793244|NCT01563029|364898737|FG003|Overall Study|Withdrawal by Subject|4|||
105793245|NCT01563029|364898738|FG004|Overall Study|Withdrawal by Subject|3|||
105793246|NCT03069365|364898741|FG000|Overall Study|Adverse Event|1|||
105793247|NCT04057118|364898744|FG000|Overall Study|Adverse Event|1|||
105724371|NCT03029832|364644267|FG000|Overall Study|Safety Follow-Up Completed|2|||
105724372|NCT03029832|364644268|FG001|Overall Study|Safety Follow-Up Completed|0|||
105724373|NCT03029832|364644267|FG000|Overall Study|Death due to Disease Progression|1|||
105724374|NCT03029832|364644268|FG001|Overall Study|Death due to Disease Progression|0|||
105724375|NCT03029832|364644267|FG000|Overall Study|Study Terminated By Sponsor|1|||
105724376|NCT03029832|364644268|FG001|Overall Study|Study Terminated By Sponsor|1|||
105724377|NCT01412229|364644269|FG000|Overall Study|Physician Decision|1|||
105724378|NCT04373460|364644270|FG000|Overall Study|Did not receive tranfusion|18|||
105724379|NCT04373460|364644271|FG001|Overall Study|Did not receive tranfusion|26|||
105724380|NCT00454207|364644272|FG000|Overall Study|Adverse Event|3|||
105724381|NCT00454207|364644273|FG001|Overall Study|Adverse Event|1|||
105724382|NCT00454207|364644272|FG000|Overall Study|Lack of Efficacy|1|||
105724383|NCT00454207|364644273|FG001|Overall Study|Lack of Efficacy|0|||
105724384|NCT00454207|364644272|FG000|Overall Study|Protocol Violation|0|||
105724385|NCT00454207|364644273|FG001|Overall Study|Protocol Violation|1|||
105724386|NCT00700804|364644282|FG000|Overall Study|Withdrawal by Subject|1|||
105724387|NCT00700804|364644283|FG001|Overall Study|Withdrawal by Subject|2|||
105724388|NCT00700804|364644282|FG000|Overall Study|Protocol Violation|1|||
105724389|NCT00700804|364644283|FG001|Overall Study|Protocol Violation|1|||
105724390|NCT00700804|364644282|FG000|Overall Study|Loose Stools|1|||
105724391|NCT00700804|364644283|FG001|Overall Study|Loose Stools|1|||
105724392|NCT00151892|364644284|FG000|Overall Study|Lack of Efficacy|50|||
105724393|NCT00151892|364644285|FG001|Overall Study|Lack of Efficacy|57|||
105724394|NCT00151892|364644284|FG000|Overall Study|Patient request|10|||
105724395|NCT00151892|364644285|FG001|Overall Study|Patient request|7|||
105724396|NCT00151892|364644284|FG000|Overall Study|Lost to Follow-up|5|||
105724397|NCT00151892|364644285|FG001|Overall Study|Lost to Follow-up|10|||
105724398|NCT00151892|364644284|FG000|Overall Study|Adverse Event|6|||
105724399|NCT00151892|364644285|FG001|Overall Study|Adverse Event|3|||
105724400|NCT00151892|364644284|FG000|Overall Study|Protocol Violation|3|||
105724401|NCT00151892|364644285|FG001|Overall Study|Protocol Violation|3|||
105724402|NCT00151892|364644284|FG000|Overall Study|Non-compliance|0|||
105724403|NCT00151892|364644285|FG001|Overall Study|Non-compliance|1|||
105724404|NCT00151892|364644284|FG000|Overall Study|Pregnancy|0|||
105724405|NCT00151892|364644285|FG001|Overall Study|Pregnancy|1|||
105724406|NCT00151892|364644284|FG000|Overall Study|Did not return for a visit|1|||
105724407|NCT00151892|364644285|FG001|Overall Study|Did not return for a visit|0|||
105724408|NCT00151892|364644284|FG000|Overall Study|Used prohibited corticosteroids|1|||
105724409|NCT00151892|364644285|FG001|Overall Study|Used prohibited corticosteroids|0|||
105724410|NCT00151892|364644284|FG000|Overall Study|Lack of study medication at center|0|||
105724411|NCT00151892|364644285|FG001|Overall Study|Lack of study medication at center|1|||
105724412|NCT00404092|364644286|FG000|Overall Study|Death|1|||
105724413|NCT00404092|364644287|FG001|Overall Study|Death|0|||
105724414|NCT00404092|364644288|FG002|Overall Study|Death|0|||
105724415|NCT00404092|364644289|FG003|Overall Study|Death|0|||
105724416|NCT00404092|364644286|FG000|Overall Study|Adverse Event|0|||
105724417|NCT00404092|364644287|FG001|Overall Study|Adverse Event|0|||
105724418|NCT00404092|364644288|FG002|Overall Study|Adverse Event|1|||
105724419|NCT00404092|364644289|FG003|Overall Study|Adverse Event|0|||
105724420|NCT00484315|364644292|FG000|12-Month Clinical Follow-up|Death|6|||
105724421|NCT00484315|364644293|FG001|12-Month Clinical Follow-up|Death|2|||
105724422|NCT00484315|364644292|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
105724423|NCT00484315|364644293|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
105724424|NCT00484315|364644292|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
105724425|NCT00484315|364644293|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
105724426|NCT00484315|364644292|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
105724427|NCT00484315|364644293|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
105724428|NCT00484315|364644292|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
105724429|NCT00484315|364644293|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
105724430|NCT00484315|364644292|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
105724431|NCT00484315|364644293|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
105724432|NCT00484315|364644292|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
105724433|NCT00484315|364644293|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
105724434|NCT00943683|364644294|FG000|Overall Study|Adverse Event|3|||
105724435|NCT00943683|364644295|FG001|Overall Study|Adverse Event|3|||
105724436|NCT00943683|364644294|FG000|Overall Study|Lost to Follow-up|1|||
105724437|NCT00943683|364644295|FG001|Overall Study|Lost to Follow-up|1|||
105724438|NCT00943683|364644294|FG000|Overall Study|Protocol Violation|1|||
105724439|NCT00943683|364644295|FG001|Overall Study|Protocol Violation|2|||
105724440|NCT00943683|364644294|FG000|Overall Study|Withdrawal by Subject|1|||
105724441|NCT00943683|364644295|FG001|Overall Study|Withdrawal by Subject|0|||
105724442|NCT00943683|364644294|FG000|Overall Study|Patient Moved|1|||
105724443|NCT00943683|364644295|FG001|Overall Study|Patient Moved|0|||
105724444|NCT02500537|364644296|FG000|Overall Study|Death|2|||
105793248|NCT04057118|364898745|FG001|Overall Study|Adverse Event|0|||
105793249|NCT04057118|364898746|FG002|Overall Study|Adverse Event|1|||
105793250|NCT04057118|364898747|FG003|Overall Study|Adverse Event|1|||
105793251|NCT04057118|364898744|FG000|Overall Study|Physician Decision|0|||
105793252|NCT04057118|364898745|FG001|Overall Study|Physician Decision|0|||
105793253|NCT04057118|364898746|FG002|Overall Study|Physician Decision|1|||
105793254|NCT04057118|364898747|FG003|Overall Study|Physician Decision|1|||
105793255|NCT04057118|364898744|FG000|Overall Study|Withdrawal by Subject|2|||
105793256|NCT04057118|364898745|FG001|Overall Study|Withdrawal by Subject|2|||
105793257|NCT04057118|364898746|FG002|Overall Study|Withdrawal by Subject|0|||
105793258|NCT04057118|364898747|FG003|Overall Study|Withdrawal by Subject|2|||
105793259|NCT04057118|364898744|FG000|Overall Study|Not Specific|0|||
105793260|NCT04057118|364898745|FG001|Overall Study|Not Specific|0|||
105793261|NCT04057118|364898746|FG002|Overall Study|Not Specific|1|||
105793262|NCT04057118|364898747|FG003|Overall Study|Not Specific|1|||
105793263|NCT04635631|364898748|FG000|Overall Study|Adverse Event|1|||
105793264|NCT04635631|364898748|FG000|Overall Study|Progressive disease|13|||
105793265|NCT04635631|364898748|FG000|Overall Study|Withdrawal by Subject|1|||
105793266|NCT00916617|364898754|FG000|Overall Study|Adverse Event|3|||
105793267|NCT00916617|364898755|FG001|Overall Study|Adverse Event|2|||
105793268|NCT00916617|364898756|FG002|Overall Study|Adverse Event|6|||
105793269|NCT00916617|364898757|FG003|Overall Study|Adverse Event|3|||
105793270|NCT00916617|364898754|FG000|Overall Study|Withdrawal by Subject|3|||
105793271|NCT00916617|364898755|FG001|Overall Study|Withdrawal by Subject|2|||
105793272|NCT00916617|364898756|FG002|Overall Study|Withdrawal by Subject|0|||
105793273|NCT00916617|364898757|FG003|Overall Study|Withdrawal by Subject|1|||
105793274|NCT00916617|364898754|FG000|Overall Study|Caregiver Request|3|||
105793275|NCT00916617|364898755|FG001|Overall Study|Caregiver Request|2|||
105793276|NCT00916617|364898756|FG002|Overall Study|Caregiver Request|1|||
105793277|NCT00916617|364898757|FG003|Overall Study|Caregiver Request|0|||
105793278|NCT00916617|364898754|FG000|Overall Study|Physician Decision|1|||
105793279|NCT00916617|364898755|FG001|Overall Study|Physician Decision|1|||
105793280|NCT00916617|364898756|FG002|Overall Study|Physician Decision|0|||
105793281|NCT00916617|364898757|FG003|Overall Study|Physician Decision|0|||
105793282|NCT00916617|364898754|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
105793283|NCT00916617|364898755|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
105793284|NCT00916617|364898756|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
105793285|NCT00916617|364898757|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
105793286|NCT00916617|364898754|FG000|Overall Study|Lost to Follow-up|2|||
105793287|NCT00916617|364898755|FG001|Overall Study|Lost to Follow-up|1|||
105793288|NCT00916617|364898756|FG002|Overall Study|Lost to Follow-up|0|||
105793289|NCT00916617|364898757|FG003|Overall Study|Lost to Follow-up|0|||
105793290|NCT00916617|364898754|FG000|Overall Study|Lack of Efficacy|1|||
105793291|NCT00916617|364898755|FG001|Overall Study|Lack of Efficacy|0|||
105793292|NCT00916617|364898756|FG002|Overall Study|Lack of Efficacy|0|||
105793293|NCT00916617|364898757|FG003|Overall Study|Lack of Efficacy|0|||
105793294|NCT00916617|364898754|FG000|Overall Study|Other|2|||
105793295|NCT00916617|364898755|FG001|Overall Study|Other|0|||
105793296|NCT00916617|364898756|FG002|Overall Study|Other|0|||
105793297|NCT00916617|364898757|FG003|Overall Study|Other|2|||
105793298|NCT00499252|364898759|FG000|Overall Study|Adverse Event|3|||
105793299|NCT00499252|364898759|FG000|Overall Study|Refused further treatment|2|||
105793300|NCT00499252|364898759|FG000|Overall Study|Ineligible|4|||
105793301|NCT00499252|364898759|FG000|Overall Study|<no further label>|3|||
105793302|NCT01569074|364898763|FG000|Overall Study|Study stopped|6|||
105793303|NCT01569074|364898764|FG001|Overall Study|Study stopped|6|||
105793304|NCT01569074|364898765|FG002|Overall Study|Study stopped|8|||
105793305|NCT01569074|364898766|FG003|Overall Study|Study stopped|7|||
105793306|NCT01569074|364898767|FG004|Overall Study|Study stopped|7|||
105793307|NCT01569074|364898763|FG000|Overall Study|Study-specific discontinuation criteria|0|||
105793308|NCT01569074|364898764|FG001|Overall Study|Study-specific discontinuation criteria|1|||
105793309|NCT01569074|364898765|FG002|Overall Study|Study-specific discontinuation criteria|0|||
105793310|NCT01569074|364898766|FG003|Overall Study|Study-specific discontinuation criteria|0|||
105793311|NCT01569074|364898767|FG004|Overall Study|Study-specific discontinuation criteria|0|||
105793312|NCT01569074|364898763|FG000|Overall Study|Severe non-compliance to protocol|0|||
105793313|NCT01569074|364898764|FG001|Overall Study|Severe non-compliance to protocol|0|||
105793314|NCT01569074|364898765|FG002|Overall Study|Severe non-compliance to protocol|1|||
105793315|NCT01569074|364898766|FG003|Overall Study|Severe non-compliance to protocol|0|||
105793316|NCT01569074|364898767|FG004|Overall Study|Severe non-compliance to protocol|0|||
105793317|NCT01569074|364898763|FG000|Overall Study|eg change in circumstances|0|||
105793318|NCT01569074|364898764|FG001|Overall Study|eg change in circumstances|2|||
105793319|NCT01569074|364898765|FG002|Overall Study|eg change in circumstances|0|||
105793320|NCT01569074|364898766|FG003|Overall Study|eg change in circumstances|1|||
105793321|NCT01569074|364898767|FG004|Overall Study|eg change in circumstances|1|||
105793322|NCT01569074|364898763|FG000|Overall Study|Adverse Event|1|||
105793323|NCT01569074|364898764|FG001|Overall Study|Adverse Event|0|||
105793324|NCT01569074|364898765|FG002|Overall Study|Adverse Event|3|||
105793325|NCT01569074|364898766|FG003|Overall Study|Adverse Event|0|||
105724445|NCT02500537|364644297|FG001|Overall Study|Death|0|||
105724446|NCT02500537|364644296|FG000|Overall Study|Lost to Follow-up|0|||
105724447|NCT02500537|364644297|FG001|Overall Study|Lost to Follow-up|1|||
105724448|NCT02500537|364644296|FG000|Overall Study|Withdrawal by Subject|1|||
105724449|NCT02500537|364644297|FG001|Overall Study|Withdrawal by Subject|0|||
105724450|NCT04672083|364644298|FG000|Overall Study|Lost to Follow-up|1|||
105724451|NCT04672083|364644299|FG001|Overall Study|Lost to Follow-up|0|||
105724452|NCT04672083|364644300|FG002|Overall Study|Lost to Follow-up|0|||
105724453|NCT04672083|364644301|FG003|Overall Study|Lost to Follow-up|0|||
105724454|NCT04672083|364644302|FG004|Overall Study|Lost to Follow-up|0|||
105724455|NCT01551745|364644303|FG000|Overall Study|Withdrawal by Subject|1|||
105724456|NCT01551745|364644303|FG000|Overall Study|Disease Progression|2|||
105724457|NCT02048904|364644304|FG000|Overall Study|Withdrawal by Subject|7|||
105724458|NCT02048904|364644304|FG000|Overall Study|Physician Decision|70|||
105724459|NCT00749190|364644305|FG000|Overall Study|Adverse Event|0|||
105724460|NCT00749190|364644306|FG001|Overall Study|Adverse Event|2|||
105724461|NCT00749190|364644307|FG002|Overall Study|Adverse Event|0|||
105724462|NCT00749190|364644308|FG003|Overall Study|Adverse Event|4|||
105724463|NCT00749190|364644309|FG004|Overall Study|Adverse Event|0|||
105724464|NCT00749190|364644310|FG005|Overall Study|Adverse Event|3|||
105724465|NCT00749190|364644311|FG006|Overall Study|Adverse Event|0|||
105724466|NCT00749190|364644305|FG000|Overall Study|Lack of Efficacy|3|||
105724467|NCT00749190|364644306|FG001|Overall Study|Lack of Efficacy|1|||
105724468|NCT00749190|364644307|FG002|Overall Study|Lack of Efficacy|1|||
105724469|NCT00749190|364644308|FG003|Overall Study|Lack of Efficacy|0|||
105724470|NCT00749190|364644309|FG004|Overall Study|Lack of Efficacy|0|||
105724471|NCT00749190|364644310|FG005|Overall Study|Lack of Efficacy|1|||
105724472|NCT00749190|364644311|FG006|Overall Study|Lack of Efficacy|0|||
105793326|NCT01569074|364898767|FG004|Overall Study|Adverse Event|0|||
105793327|NCT01360021|364898768|FG000|Overall Study|Eligibility criteria + other|2|||
105793328|NCT01360021|364898769|FG001|Overall Study|Eligibility criteria + other|1|||
105793329|NCT01360021|364898770|FG002|Overall Study|Eligibility criteria + other|1|||
105793330|NCT01360021|364898768|FG000|Overall Study|Protocol Violation|0|||
105793331|NCT01360021|364898769|FG001|Overall Study|Protocol Violation|0|||
105793332|NCT01360021|364898770|FG002|Overall Study|Protocol Violation|1|||
105793333|NCT01360021|364898768|FG000|Overall Study|Withdrawal by Subject|4|||
105793334|NCT01360021|364898769|FG001|Overall Study|Withdrawal by Subject|0|||
105793335|NCT01360021|364898770|FG002|Overall Study|Withdrawal by Subject|2|||
105793336|NCT01360021|364898768|FG000|Overall Study|Adverse Event|2|||
105793337|NCT01360021|364898769|FG001|Overall Study|Adverse Event|3|||
105793338|NCT01360021|364898770|FG002|Overall Study|Adverse Event|3|||
105793339|NCT00110084|364898771|FG000|Overall Study|Adverse Event|9|||
105793340|NCT00110084|364898771|FG000|Overall Study|Death|1|||
105793341|NCT00110084|364898771|FG000|Overall Study|Patient Refusal|10|||
105793342|NCT00110084|364898771|FG000|Overall Study|Alternate Therapy|5|||
105793343|NCT00110084|364898771|FG000|Overall Study|Intercurrent Illness|1|||
105793344|NCT00110084|364898771|FG000|Overall Study|Other|2|||
105793345|NCT03224234|364898772|FG000|Main Study|Lost to Follow-up|5|||
105793346|NCT03224234|364898773|FG001|Main Study|Lost to Follow-up|5|||
105793347|NCT05016765|364898774|FG000|Overall Study|Lost to Follow-up|4|||
105793348|NCT01612780|364898775|FG000|Overall Study|Treatment not completed|1|||
105793349|NCT01612780|364898775|FG000|Overall Study|Withdrawal by Subject|5|||
105793350|NCT03020966|364898776|FG000|Overall Study|Withdrawal by Subject|2|||
105724473|NCT00749190|364644305|FG000|Overall Study|Withdrawal by Subject|2|||
105724474|NCT00749190|364644306|FG001|Overall Study|Withdrawal by Subject|1|||
105724475|NCT00749190|364644307|FG002|Overall Study|Withdrawal by Subject|0|||
105724476|NCT00749190|364644308|FG003|Overall Study|Withdrawal by Subject|0|||
105724477|NCT00749190|364644309|FG004|Overall Study|Withdrawal by Subject|0|||
105724478|NCT00749190|364644310|FG005|Overall Study|Withdrawal by Subject|1|||
105724479|NCT00749190|364644311|FG006|Overall Study|Withdrawal by Subject|0|||
105724480|NCT00749190|364644305|FG000|Overall Study|Protocol Violation|0|||
105724481|NCT00749190|364644306|FG001|Overall Study|Protocol Violation|1|||
105724482|NCT00749190|364644307|FG002|Overall Study|Protocol Violation|0|||
105724483|NCT00749190|364644308|FG003|Overall Study|Protocol Violation|0|||
105724484|NCT00749190|364644309|FG004|Overall Study|Protocol Violation|0|||
105724485|NCT00749190|364644310|FG005|Overall Study|Protocol Violation|0|||
105724486|NCT00749190|364644311|FG006|Overall Study|Protocol Violation|1|||
105724487|NCT00749190|364644305|FG000|Overall Study|Other reason not defined above|0|||
105724488|NCT00749190|364644306|FG001|Overall Study|Other reason not defined above|0|||
105724489|NCT00749190|364644307|FG002|Overall Study|Other reason not defined above|0|||
105724490|NCT00749190|364644308|FG003|Overall Study|Other reason not defined above|1|||
105724491|NCT00749190|364644309|FG004|Overall Study|Other reason not defined above|0|||
105724492|NCT00749190|364644310|FG005|Overall Study|Other reason not defined above|0|||
105724493|NCT00749190|364644311|FG006|Overall Study|Other reason not defined above|0|||
105724494|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
105724495|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
105724496|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
105724497|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
105793351|NCT03020966|364898777|FG001|Overall Study|Withdrawal by Subject|0|||
105793352|NCT03664024|364898781|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
105793353|NCT03664024|364898781|FG000|Overall Study|Lost to Follow-up|2|||
105793354|NCT03664024|364898781|FG000|Overall Study|Withdrawal by Subject|2|||
105724498|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
105724499|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
105724500|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
105724501|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
105724502|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
105724503|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
105724504|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
105724505|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
105793355|NCT03664024|364898781|FG000|Overall Study|Death|80|||
105724506|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
105724507|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
105724508|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
105793356|NCT01060007|364898784|FG000|Overall Study|Withdrawal by Subject|1|||
105478528|NCT03642132|363764266|FG000|Follow-up Period|Other|0|||
105724509|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
105793357|NCT01060007|364898784|FG000|Overall Study|Inevaluable for response at surgery|3|||
105793358|NCT01071083|364898797|FG000|Overall Study|Adverse Event|1|||
105793359|NCT01071083|364898798|FG001|Overall Study|Adverse Event|0|||
105478529|NCT03642132|363764267|FG001|Follow-up Period|Other|0|||
105793360|NCT01071083|364898799|FG002|Overall Study|Adverse Event|1|||
105793361|NCT01071083|364898800|FG003|Overall Study|Adverse Event|0|||
105724510|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
105724511|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
105724512|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
105724513|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
105724514|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Death|0|||
105724515|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Death|1|||
105724516|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Death|0|||
105724517|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Death|0|||
105724518|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Death|0|||
105724519|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
105724520|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
105724521|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
105724522|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
105724523|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
105724524|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
105724525|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
105724526|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
105724527|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
105724528|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
105724529|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
105724530|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
105724531|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
105724532|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
105724533|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
105724534|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Other|1|||
105724535|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Other|2|||
105724536|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Other|0|||
105724537|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Other|0|||
105724538|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Other|0|||
105724539|NCT05087030|364644320|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
105724540|NCT05087030|364644321|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
105724541|NCT05087030|364644322|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
105724542|NCT05087030|364644323|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
105724543|NCT05087030|364644324|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
105724544|NCT04429022|364644329|FG000|Overall Study|Protocol Violation|18|||
105724545|NCT04429022|364644330|FG001|Overall Study|Protocol Violation|1|||
105724546|NCT00998738|364644331|FG000|Overall Study|Uknown|1|||
105724547|NCT00045032|364644333|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
105724548|NCT00045032|364644334|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
105724549|NCT00045032|364644335|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
105724550|NCT00045032|364644333|FG000|Overall Study|Death|22|||
105724551|NCT00045032|364644334|FG001|Overall Study|Death|24|||
105724552|NCT00045032|364644335|FG002|Overall Study|Death|17|||
105724553|NCT00045032|364644333|FG000|Overall Study|Insufficient Therapeutic Response|542|||
105724554|NCT00045032|364644334|FG001|Overall Study|Insufficient Therapeutic Response|437|||
105724555|NCT00045032|364644335|FG002|Overall Study|Insufficient Therapeutic Response|445|||
105724556|NCT00045032|364644333|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
105724557|NCT00045032|364644334|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
105724558|NCT00045032|364644335|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
105724559|NCT00045032|364644333|FG000|Overall Study|Other Protocol Violation|2|||
105724560|NCT00045032|364644334|FG001|Overall Study|Other Protocol Violation|0|||
105724561|NCT00045032|364644335|FG002|Overall Study|Other Protocol Violation|1|||
105724562|NCT00045032|364644333|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
105724563|NCT00045032|364644334|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
105724564|NCT00045032|364644335|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
105724565|NCT00045032|364644333|FG000|Overall Study|Failure to Return|57|||
105724566|NCT00045032|364644334|FG001|Overall Study|Failure to Return|62|||
105724567|NCT00045032|364644335|FG002|Overall Study|Failure to Return|61|||
105724568|NCT00045032|364644333|FG000|Overall Study|Other|93|||
105724569|NCT00045032|364644334|FG001|Overall Study|Other|84|||
105724570|NCT00045032|364644335|FG002|Overall Study|Other|105|||
105724571|NCT02689492|364646426|FG000|Overall Study|Lost to Follow-up|61|||
105724572|NCT02689492|364646426|FG000|Overall Study|Withdrawal by Subject|11|||
105724573|NCT02689492|364646426|FG000|Overall Study|Death|9|||
105724574|NCT02689492|364646426|FG000|Overall Study|Physician Decision|2|||
105724575|NCT02689492|364646426|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
105724576|NCT02689492|364646426|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
105478530|NCT03642132|363764268|FG002|Follow-up Period|Other|1|||
105724577|NCT02689492|364646426|FG000|Overall Study|Other than listed|1|||
105724578|NCT00500266|364646427|FG000|Overall Study|Death|3|||
105724579|NCT00500266|364646427|FG000|Overall Study|Lost to Follow-up|3|||
105793362|NCT01071083|364898801|FG004|Overall Study|Adverse Event|1|||
105793363|NCT01071083|364898797|FG000|Overall Study|Withdrawal by Subject|3|||
105793364|NCT01071083|364898798|FG001|Overall Study|Withdrawal by Subject|0|||
105793365|NCT01071083|364898799|FG002|Overall Study|Withdrawal by Subject|2|||
105793366|NCT01071083|364898800|FG003|Overall Study|Withdrawal by Subject|0|||
105793367|NCT01071083|364898801|FG004|Overall Study|Withdrawal by Subject|3|||
105793368|NCT01071083|364898797|FG000|Overall Study|Physician Decision|1|||
105793369|NCT01071083|364898798|FG001|Overall Study|Physician Decision|0|||
105793370|NCT01071083|364898799|FG002|Overall Study|Physician Decision|0|||
105793371|NCT01071083|364898800|FG003|Overall Study|Physician Decision|1|||
105793372|NCT01071083|364898801|FG004|Overall Study|Physician Decision|1|||
105793373|NCT01071083|364898797|FG000|Overall Study|Early Rescue|1|||
105793374|NCT01071083|364898798|FG001|Overall Study|Early Rescue|0|||
105793375|NCT01071083|364898799|FG002|Overall Study|Early Rescue|0|||
105793376|NCT01071083|364898800|FG003|Overall Study|Early Rescue|0|||
105793377|NCT01071083|364898801|FG004|Overall Study|Early Rescue|1|||
105793378|NCT01071083|364898797|FG000|Overall Study|Subject Moved|0|||
105793379|NCT01071083|364898798|FG001|Overall Study|Subject Moved|1|||
105793380|NCT01071083|364898799|FG002|Overall Study|Subject Moved|0|||
105793381|NCT01071083|364898800|FG003|Overall Study|Subject Moved|0|||
105793382|NCT01071083|364898801|FG004|Overall Study|Subject Moved|0|||
105793383|NCT01071083|364898797|FG000|Overall Study|Images Not Usable (Motion)|0|||
105793384|NCT01071083|364898798|FG001|Overall Study|Images Not Usable (Motion)|1|||
105793385|NCT01071083|364898799|FG002|Overall Study|Images Not Usable (Motion)|0|||
105793386|NCT01071083|364898800|FG003|Overall Study|Images Not Usable (Motion)|0|||
105724580|NCT00500266|364646427|FG000|Overall Study|Withdrawal by Subject|3|||
105724581|NCT00500266|364646427|FG000|Overall Study|Assigned, not treated|4|||
105724582|NCT00023322|364646428|FG000|Overall Study|Lost to Follow-up|1|||
105724583|NCT00110305|364646429|FG000|Overall Study|Adverse Event|46|||
105724584|NCT00110305|364646430|FG001|Overall Study|Adverse Event|13|||
105724585|NCT00110305|364646429|FG000|Overall Study|Sponsors Decision|1|||
105724586|NCT00110305|364646430|FG001|Overall Study|Sponsors Decision|0|||
105724587|NCT00110305|364646429|FG000|Overall Study|Subject Non-Compliant|9|||
105724588|NCT00110305|364646430|FG001|Overall Study|Subject Non-Compliant|2|||
105724589|NCT00110305|364646429|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
105724590|NCT00110305|364646430|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
105724591|NCT00110305|364646429|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
105724592|NCT00110305|364646430|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
105724593|NCT00110305|364646429|FG000|Overall Study|Protocol Violation|0|||
105724594|NCT00110305|364646430|FG001|Overall Study|Protocol Violation|1|||
105724595|NCT00110305|364646429|FG000|Overall Study|Withdrawal by Subject|7|||
105724596|NCT00110305|364646430|FG001|Overall Study|Withdrawal by Subject|7|||
105724597|NCT00110305|364646429|FG000|Overall Study|Lost to Follow-up|20|||
105724598|NCT00110305|364646430|FG001|Overall Study|Lost to Follow-up|3|||
105724599|NCT00110305|364646429|FG000|Overall Study|Other|8|||
105724600|NCT00110305|364646430|FG001|Overall Study|Other|2|||
105724601|NCT03658889|364646438|FG000|Overall Study|Protocol Violation|2|||
105724602|NCT03658889|364646439|FG001|Overall Study|Protocol Violation|0|||
105724603|NCT01028352|364646442|FG000|Overall Study|Ineligible due to baseline average pain|5|||
105724604|NCT01028352|364646442|FG000|Overall Study|Withdrawal by Subject|1|||
105724605|NCT01903876|364646443|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
105724606|NCT01903876|364646444|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
105724607|NCT01903876|364646443|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
105724608|NCT01903876|364646444|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
105724609|NCT02612909|364646449|FG000|Phase 2|Withdrawal by Subject|2|||
105724610|NCT02612909|364646450|FG001|Phase 2|Withdrawal by Subject|5|||
105724611|NCT02612909|364646451|FG002|Phase 2|Withdrawal by Subject|0|||
105724612|NCT02612909|364646452|FG003|Phase 2|Withdrawal by Subject|0|||
105724613|NCT02612909|364646453|FG004|Phase 2|Withdrawal by Subject|0|||
105724614|NCT02612909|364646449|FG000|Phase 2|Pregnancy|0|||
105724615|NCT02612909|364646450|FG001|Phase 2|Pregnancy|0|||
105724616|NCT02612909|364646451|FG002|Phase 2|Pregnancy|1|||
105793387|NCT01071083|364898801|FG004|Overall Study|Images Not Usable (Motion)|0|||
105724617|NCT02612909|364646452|FG003|Phase 2|Pregnancy|0|||
105724618|NCT02612909|364646453|FG004|Phase 2|Pregnancy|0|||
105724619|NCT02612909|364646449|FG000|Phase 3|Withdrawal by Subject|0|||
105724620|NCT02612909|364646450|FG001|Phase 3|Withdrawal by Subject|0|||
105724621|NCT02612909|364646451|FG002|Phase 3|Withdrawal by Subject|0|||
105724622|NCT02612909|364646452|FG003|Phase 3|Withdrawal by Subject|1|||
105724623|NCT02612909|364646453|FG004|Phase 3|Withdrawal by Subject|0|||
105724624|NCT01717638|364646454|FG000|Overall Study|Lost to Follow-up|0|||
105724625|NCT01717638|364646455|FG001|Overall Study|Lost to Follow-up|0|||
105724626|NCT01717638|364646456|FG002|Overall Study|Lost to Follow-up|0|||
105724627|NCT01717638|364646457|FG003|Overall Study|Lost to Follow-up|0|||
105724628|NCT01717638|364646458|FG004|Overall Study|Lost to Follow-up|0|||
105793388|NCT01071083|364898797|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
105793389|NCT01071083|364898798|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
105724629|NCT01717638|364646459|FG005|Overall Study|Lost to Follow-up|1|||
105724630|NCT01717638|364646460|FG006|Overall Study|Lost to Follow-up|0|||
105724631|NCT01717638|364646461|FG007|Overall Study|Lost to Follow-up|0|||
105724632|NCT01717638|364646462|FG008|Overall Study|Lost to Follow-up|0|||
105724633|NCT01717638|364646463|FG009|Overall Study|Lost to Follow-up|0|||
105724634|NCT01717638|364646464|FG010|Overall Study|Lost to Follow-up|0|||
105724635|NCT01717638|364646465|FG011|Overall Study|Lost to Follow-up|0|||
105724636|NCT01717638|364646466|FG012|Overall Study|Lost to Follow-up|0|||
105724637|NCT01717638|364646454|FG000|Overall Study|Father in hospital|0|||
105724638|NCT01717638|364646455|FG001|Overall Study|Father in hospital|0|||
105724639|NCT01717638|364646456|FG002|Overall Study|Father in hospital|0|||
105724640|NCT01717638|364646457|FG003|Overall Study|Father in hospital|0|||
105724641|NCT01717638|364646458|FG004|Overall Study|Father in hospital|0|||
105724642|NCT01717638|364646459|FG005|Overall Study|Father in hospital|0|||
105724643|NCT01717638|364646460|FG006|Overall Study|Father in hospital|0|||
105724644|NCT01717638|364646461|FG007|Overall Study|Father in hospital|0|||
105724645|NCT01717638|364646462|FG008|Overall Study|Father in hospital|0|||
105724646|NCT01717638|364646463|FG009|Overall Study|Father in hospital|0|||
105724647|NCT01717638|364646464|FG010|Overall Study|Father in hospital|0|||
105724648|NCT01717638|364646465|FG011|Overall Study|Father in hospital|0|||
105724649|NCT01717638|364646466|FG012|Overall Study|Father in hospital|1|||
105724650|NCT01717638|364646454|FG000|Overall Study|Withdrawal by Subject|0|||
105724651|NCT01717638|364646455|FG001|Overall Study|Withdrawal by Subject|1|||
105724652|NCT01717638|364646456|FG002|Overall Study|Withdrawal by Subject|1|||
105724653|NCT01717638|364646457|FG003|Overall Study|Withdrawal by Subject|0|||
105724654|NCT01717638|364646458|FG004|Overall Study|Withdrawal by Subject|1|||
105724655|NCT01717638|364646459|FG005|Overall Study|Withdrawal by Subject|0|||
105724656|NCT01717638|364646460|FG006|Overall Study|Withdrawal by Subject|2|||
105724657|NCT01717638|364646461|FG007|Overall Study|Withdrawal by Subject|1|||
105724658|NCT01717638|364646462|FG008|Overall Study|Withdrawal by Subject|2|||
105724659|NCT01717638|364646463|FG009|Overall Study|Withdrawal by Subject|1|||
105724660|NCT01717638|364646464|FG010|Overall Study|Withdrawal by Subject|0|||
105724661|NCT01717638|364646465|FG011|Overall Study|Withdrawal by Subject|0|||
105724662|NCT01717638|364646466|FG012|Overall Study|Withdrawal by Subject|18|||
105724663|NCT03312218|364646468|FG000|Overall Study|Never signed in to access the app|54|||
105724664|NCT03312218|364646469|FG001|Overall Study|Never signed in to access the app|58|||
105724665|NCT02300129|364646470|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
105724666|NCT02300129|364646471|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
105724667|NCT02300129|364646472|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
105724668|NCT02300129|364646473|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
105724669|NCT02300129|364646470|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
105724670|NCT02300129|364646471|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
105724671|NCT02300129|364646472|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
105724672|NCT02300129|364646473|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
105724673|NCT02300129|364646470|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
105724674|NCT02300129|364646471|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
105724675|NCT02300129|364646472|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
105724676|NCT02300129|364646473|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
105724677|NCT00450580|364646476|FG000|Overall Study|Adverse Event|5|||
105724678|NCT00450580|364646477|FG001|Overall Study|Adverse Event|7|||
105724679|NCT00450580|364646476|FG000|Overall Study|Lost to Follow-up|4|||
105724680|NCT00450580|364646477|FG001|Overall Study|Lost to Follow-up|5|||
105724681|NCT00450580|364646476|FG000|Overall Study|Withdrawal by Subject|2|||
105724682|NCT00450580|364646477|FG001|Overall Study|Withdrawal by Subject|2|||
105793390|NCT01071083|364898799|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
105793391|NCT01071083|364898800|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
105793392|NCT01071083|364898801|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
105793393|NCT01071083|364898797|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
105793394|NCT01071083|364898798|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
105793395|NCT01071083|364898799|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
105793396|NCT01071083|364898800|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
105793397|NCT01071083|364898801|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
105724683|NCT00450580|364646476|FG000|Overall Study|Protocol Violation|1|||
105724684|NCT00450580|364646477|FG001|Overall Study|Protocol Violation|1|||
105793398|NCT01071083|364898797|FG000|Overall Study|Subject Refused to Continue|1|||
105793399|NCT01071083|364898798|FG001|Overall Study|Subject Refused to Continue|0|||
105793400|NCT01071083|364898799|FG002|Overall Study|Subject Refused to Continue|0|||
105724685|NCT00450580|364646476|FG000|Overall Study|Protocol-defined virologic failure|1|||
105724686|NCT00450580|364646477|FG001|Overall Study|Protocol-defined virologic failure|0|||
105724687|NCT00450580|364646476|FG000|Overall Study|Could not comply with scheduled visits|1|||
105724688|NCT00450580|364646477|FG001|Overall Study|Could not comply with scheduled visits|0|||
105724689|NCT00450580|364646476|FG000|Overall Study|Patient went to Brazil|1|||
105724690|NCT00450580|364646477|FG001|Overall Study|Patient went to Brazil|0|||
105724691|NCT00450580|364646476|FG000|Overall Study|Patient could not swallow Norvir|1|||
105793401|NCT01071083|364898800|FG003|Overall Study|Subject Refused to Continue|0|||
105793402|NCT01071083|364898801|FG004|Overall Study|Subject Refused to Continue|0|||
105793403|NCT03087773|364898804|FG000|Overall Study|Withdrawal by Subject|8|||
105793404|NCT03087773|364898805|FG001|Overall Study|Withdrawal by Subject|4|||
105793405|NCT03087773|364898804|FG000|Overall Study|Lost to Follow-up|12|||
105793406|NCT03087773|364898805|FG001|Overall Study|Lost to Follow-up|8|||
105793407|NCT00728988|364898806|FG000|Overall Study|Not Treated|2|||
105793408|NCT00728988|364898807|FG001|Overall Study|Not Treated|2|||
105724692|NCT00450580|364646477|FG001|Overall Study|Patient could not swallow Norvir|0|||
105724693|NCT00450580|364646476|FG000|Overall Study|Withdrawal due to pregnancy|0|||
105724694|NCT00450580|364646477|FG001|Overall Study|Withdrawal due to pregnancy|1|||
105724695|NCT03539432|364646478|FG000|Overall Study|Lost to Follow-up|0|||
105724696|NCT03539432|364646479|FG001|Overall Study|Lost to Follow-up|1|||
105724697|NCT02443402|364646480|FG000|Overall Study|Withdrawal by Subject|3|||
105724698|NCT02443402|364646481|FG001|Overall Study|Withdrawal by Subject|1|||
105724699|NCT02443402|364646480|FG000|Overall Study|Screen Failure|1|||
105724700|NCT02443402|364646481|FG001|Overall Study|Screen Failure|2|||
105724701|NCT01934504|364646482|FG000|Overall Study|Protocol Deviation|0|||
105724702|NCT01934504|364646483|FG001|Overall Study|Protocol Deviation|0|||
105724703|NCT01934504|364646484|FG002|Overall Study|Protocol Deviation|0|||
105724704|NCT01934504|364646485|FG003|Overall Study|Protocol Deviation|2|||
105724705|NCT01934504|364646482|FG000|Overall Study|Study Terminated by Sponsor|1|||
105724706|NCT01934504|364646483|FG001|Overall Study|Study Terminated by Sponsor|0|||
105724707|NCT01934504|364646484|FG002|Overall Study|Study Terminated by Sponsor|5|||
105724708|NCT01934504|364646485|FG003|Overall Study|Study Terminated by Sponsor|5|||
105724709|NCT04889209|364646488|FG000|All Cohorts Except 15E|Adverse Event|0|||
105724710|NCT04889209|364646489|FG001|All Cohorts Except 15E|Adverse Event|0|||
105724711|NCT04889209|364646490|FG002|All Cohorts Except 15E|Adverse Event|0|||
105724712|NCT04889209|364646491|FG003|All Cohorts Except 15E|Adverse Event|0|||
105724713|NCT04889209|364646492|FG004|All Cohorts Except 15E|Adverse Event|0|||
105724714|NCT04889209|364646493|FG005|All Cohorts Except 15E|Adverse Event|0|||
105724715|NCT04889209|364646494|FG006|All Cohorts Except 15E|Adverse Event|1|||
105724716|NCT04889209|364646495|FG007|All Cohorts Except 15E|Adverse Event|0|||
105724717|NCT04889209|364646496|FG008|All Cohorts Except 15E|Adverse Event|0|||
105724718|NCT04889209|364646497|FG009|All Cohorts Except 15E|Adverse Event|0|||
105724719|NCT04889209|364646498|FG010|All Cohorts Except 15E|Adverse Event|0|||
105724720|NCT04889209|364646499|FG011|All Cohorts Except 15E|Adverse Event|0|||
105724721|NCT04889209|364646500|FG012|All Cohorts Except 15E|Adverse Event|0|||
105724722|NCT04889209|364646501|FG013|All Cohorts Except 15E|Adverse Event|0|||
105724723|NCT04889209|364646502|FG014|All Cohorts Except 15E|Adverse Event|0|||
105724724|NCT04889209|364646503|FG015|All Cohorts Except 15E|Adverse Event|0|||
105724725|NCT04889209|364646504|FG016|All Cohorts Except 15E|Adverse Event|0|||
105724726|NCT04889209|364646505|FG017|All Cohorts Except 15E|Adverse Event|0|||
105724727|NCT04889209|364646488|FG000|All Cohorts Except 15E|Death|0|||
105724728|NCT04889209|364646489|FG001|All Cohorts Except 15E|Death|1|||
105724729|NCT04889209|364646490|FG002|All Cohorts Except 15E|Death|0|||
105724730|NCT04889209|364646491|FG003|All Cohorts Except 15E|Death|0|||
105724731|NCT04889209|364646492|FG004|All Cohorts Except 15E|Death|0|||
105724732|NCT04889209|364646493|FG005|All Cohorts Except 15E|Death|0|||
105724733|NCT04889209|364646494|FG006|All Cohorts Except 15E|Death|0|||
105724734|NCT04889209|364646495|FG007|All Cohorts Except 15E|Death|0|||
105724735|NCT04889209|364646496|FG008|All Cohorts Except 15E|Death|0|||
105724736|NCT04889209|364646497|FG009|All Cohorts Except 15E|Death|0|||
105724737|NCT04889209|364646498|FG010|All Cohorts Except 15E|Death|0|||
105724738|NCT04889209|364646499|FG011|All Cohorts Except 15E|Death|0|||
105724739|NCT04889209|364646500|FG012|All Cohorts Except 15E|Death|0|||
105724740|NCT04889209|364646501|FG013|All Cohorts Except 15E|Death|0|||
105724741|NCT04889209|364646502|FG014|All Cohorts Except 15E|Death|0|||
105724742|NCT04889209|364646503|FG015|All Cohorts Except 15E|Death|0|||
105724743|NCT04889209|364646504|FG016|All Cohorts Except 15E|Death|0|||
105724744|NCT04889209|364646505|FG017|All Cohorts Except 15E|Death|0|||
105793409|NCT00728988|364898806|FG000|Overall Study|Death|1|||
105724745|NCT04889209|364646488|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
105724746|NCT04889209|364646489|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
105724747|NCT04889209|364646490|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
105793410|NCT00728988|364898807|FG001|Overall Study|Death|1|||
105793411|NCT00728988|364898806|FG000|Overall Study|Adverse Event|3|||
105724748|NCT04889209|364646491|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
105724749|NCT04889209|364646492|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
105724750|NCT04889209|364646493|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
105724751|NCT04889209|364646494|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
105793412|NCT00728988|364898807|FG001|Overall Study|Adverse Event|2|||
105724752|NCT04889209|364646495|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
105724753|NCT04889209|364646496|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
105724754|NCT04889209|364646497|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
105793413|NCT00728988|364898806|FG000|Overall Study|Other|85|||
105724755|NCT04889209|364646498|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
105724756|NCT04889209|364646499|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
105793414|NCT00728988|364898807|FG001|Overall Study|Other|77|||
105562899|NCT03205371|364057528|FG000|Overall Study|Withdrawal by Subject|4|||
105562900|NCT03205371|364057529|FG001|Overall Study|Withdrawal by Subject|1|||
105724757|NCT04889209|364646500|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
105724758|NCT04889209|364646501|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
105562901|NCT03205371|364057530|FG002|Overall Study|Withdrawal by Subject|0|||
105562902|NCT03205371|364057531|FG003|Overall Study|Withdrawal by Subject|0|||
105562903|NCT03205371|364057532|FG004|Overall Study|Withdrawal by Subject|0|||
105562904|NCT03205371|364057533|FG005|Overall Study|Withdrawal by Subject|0|||
105562905|NCT03205371|364057534|FG006|Overall Study|Withdrawal by Subject|4|||
105562906|NCT03205371|364057535|FG007|Overall Study|Withdrawal by Subject|0|||
105562907|NCT03205371|364057536|FG008|Overall Study|Withdrawal by Subject|2|||
105724759|NCT04889209|364646502|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
105724760|NCT04889209|364646503|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
105724761|NCT04889209|364646504|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
105724762|NCT04889209|364646505|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
105724763|NCT04889209|364646488|FG000|All Cohorts Except 15E|Physician Decision|0|||
105724764|NCT04889209|364646489|FG001|All Cohorts Except 15E|Physician Decision|0|||
105724765|NCT04889209|364646490|FG002|All Cohorts Except 15E|Physician Decision|0|||
105724766|NCT04889209|364646491|FG003|All Cohorts Except 15E|Physician Decision|0|||
105724767|NCT04889209|364646492|FG004|All Cohorts Except 15E|Physician Decision|1|||
105724768|NCT04889209|364646493|FG005|All Cohorts Except 15E|Physician Decision|0|||
105724769|NCT04889209|364646494|FG006|All Cohorts Except 15E|Physician Decision|0|||
105724770|NCT04889209|364646495|FG007|All Cohorts Except 15E|Physician Decision|1|||
105724771|NCT04889209|364646496|FG008|All Cohorts Except 15E|Physician Decision|0|||
105724772|NCT04889209|364646497|FG009|All Cohorts Except 15E|Physician Decision|1|||
105724773|NCT04889209|364646498|FG010|All Cohorts Except 15E|Physician Decision|0|||
105724774|NCT04889209|364646499|FG011|All Cohorts Except 15E|Physician Decision|1|||
105724775|NCT04889209|364646500|FG012|All Cohorts Except 15E|Physician Decision|1|||
105724776|NCT04889209|364646501|FG013|All Cohorts Except 15E|Physician Decision|0|||
105724777|NCT04889209|364646502|FG014|All Cohorts Except 15E|Physician Decision|0|||
105724778|NCT04889209|364646503|FG015|All Cohorts Except 15E|Physician Decision|0|||
105724779|NCT04889209|364646504|FG016|All Cohorts Except 15E|Physician Decision|0|||
105724780|NCT04889209|364646505|FG017|All Cohorts Except 15E|Physician Decision|0|||
105724781|NCT04889209|364646488|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
105724782|NCT04889209|364646489|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
105724783|NCT04889209|364646490|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
105724784|NCT04889209|364646491|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
105724785|NCT04889209|364646492|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
105724786|NCT04889209|364646493|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724787|NCT04889209|364646494|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724788|NCT04889209|364646495|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
105724789|NCT04889209|364646496|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724790|NCT04889209|364646497|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724791|NCT04889209|364646498|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724792|NCT04889209|364646499|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724793|NCT04889209|364646500|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724794|NCT04889209|364646501|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
105724795|NCT04889209|364646502|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
105724796|NCT04889209|364646503|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
105724797|NCT04889209|364646504|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724798|NCT04889209|364646505|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
105724799|NCT04889209|364646488|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
105724800|NCT04889209|364646489|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
105724801|NCT04889209|364646490|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724802|NCT04889209|364646491|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724803|NCT04889209|364646492|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724804|NCT04889209|364646493|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
105724805|NCT04889209|364646494|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724806|NCT04889209|364646495|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
105724807|NCT04889209|364646496|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724808|NCT04889209|364646497|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
105760768|NCT01576406|364776185|FG002|Overall Study|Withdrawal the consent|5|||
105562908|NCT03205371|364057537|FG009|Overall Study|Withdrawal by Subject|0|||
105562909|NCT03205371|364057538|FG010|Overall Study|Withdrawal by Subject|0|||
105760769|NCT01576406|364776186|FG003|Overall Study|Withdrawal the consent|1|||
105760770|NCT01576406|364776187|FG004|Overall Study|Withdrawal the consent|1|||
105760771|NCT01576406|364776188|FG005|Overall Study|Withdrawal the consent|3|||
105760772|NCT01576406|364776183|FG000|Overall Study|Other|0|||
105793415|NCT00728988|364898806|FG000|Overall Study|Withdrawal by Subject|2|||
105793416|NCT00728988|364898807|FG001|Overall Study|Withdrawal by Subject|6|||
105793417|NCT02756078|364898813|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
105793418|NCT02756078|364898814|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
105793419|NCT02756078|364898813|FG000|Period 1|Lost to Follow-up|0|||
105793420|NCT02756078|364898814|FG001|Period 1|Lost to Follow-up|2|||
105793421|NCT02756078|364898813|FG000|Period 1|Protocol Violation|0|||
105793422|NCT02756078|364898814|FG001|Period 1|Protocol Violation|1|||
105793423|NCT02756078|364898813|FG000|Period 1|Adverse Event|1|||
105793424|NCT02756078|364898814|FG001|Period 1|Adverse Event|10|||
105793425|NCT02756078|364898813|FG000|Period 1|Withdrawal by Subject|6|||
105793426|NCT02756078|364898814|FG001|Period 1|Withdrawal by Subject|6|||
105793427|NCT02756078|364898813|FG000|Period 1|Lens Discomfort|2|||
105793428|NCT02756078|364898814|FG001|Period 1|Lens Discomfort|2|||
105793429|NCT02756078|364898813|FG000|Period 2|Adverse Event|3|||
105793430|NCT02756078|364898814|FG001|Period 2|Adverse Event|5|||
105793431|NCT02756078|364898813|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
105793432|NCT02756078|364898814|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
105793433|NCT02756078|364898813|FG000|Period 2|Withdrawal by Subject|3|||
105793434|NCT02756078|364898814|FG001|Period 2|Withdrawal by Subject|1|||
105793435|NCT03701516|364898818|FG000|Period 1|Lost to Follow-up|0|||
105793436|NCT03701516|364898819|FG001|Period 1|Lost to Follow-up|1|||
105793437|NCT03701516|364898818|FG000|Period 1|Adverse Event|0|||
105793438|NCT03701516|364898819|FG001|Period 1|Adverse Event|2|||
105793439|NCT03701516|364898818|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
105793440|NCT03701516|364898819|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
105793441|NCT03701516|364898818|FG000|Period 1|Non Compliance to Protocol|2|||
105793442|NCT03701516|364898819|FG001|Period 1|Non Compliance to Protocol|1|||
105793443|NCT03701516|364898818|FG000|Period 1|Withdrawal by Subject|0|||
105793444|NCT03701516|364898819|FG001|Period 1|Withdrawal by Subject|1|||
105793445|NCT03701516|364898818|FG000|Period 2|failed to meet all eligibility creiteria|1|||
105793446|NCT03701516|364898819|FG001|Period 2|failed to meet all eligibility creiteria|0|||
105793447|NCT03701516|364898818|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
105793448|NCT03701516|364898819|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
105793449|NCT01591499|364898820|FG000|Baseline Visit|Withdrawal by Subject|0|||
105793450|NCT01591499|364898821|FG001|Baseline Visit|Withdrawal by Subject|2|||
105793451|NCT01591499|364898822|FG002|Baseline Visit|Withdrawal by Subject|0|||
105793452|NCT01591499|364898823|FG003|Baseline Visit|Withdrawal by Subject|2|||
105793453|NCT01591499|364898820|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
105793454|NCT01591499|364898821|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
105793455|NCT01591499|364898822|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
105793456|NCT01591499|364898823|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
105793457|NCT01591499|364898820|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
105793458|NCT01591499|364898821|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
105793459|NCT01591499|364898822|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
105793460|NCT01591499|364898823|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
105793461|NCT02032823|364898824|FG000|Overall Study|Death|75|||
105793462|NCT02032823|364898825|FG001|Overall Study|Death|109|||
105793463|NCT02032823|364898824|FG000|Overall Study|Lost to Follow-up|18|||
105793464|NCT02032823|364898825|FG001|Overall Study|Lost to Follow-up|17|||
105793465|NCT02032823|364898824|FG000|Overall Study|Withdrawal by Subject|70|||
105793466|NCT02032823|364898825|FG001|Overall Study|Withdrawal by Subject|53|||
105793467|NCT02032823|364898824|FG000|Overall Study|Ongoing study at data cut-off|755|||
105793468|NCT02032823|364898825|FG001|Overall Study|Ongoing study at data cut-off|731|||
105793469|NCT02032823|364898824|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
105793470|NCT02032823|364898825|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
105793471|NCT03428217|364898826|FG000|Overall Study|Death|89|||
105793472|NCT03428217|364898827|FG001|Overall Study|Death|93|||
105793473|NCT03428217|364898826|FG000|Overall Study|Withdrawal by Subject|8|||
105793474|NCT03428217|364898827|FG001|Overall Study|Withdrawal by Subject|7|||
105793475|NCT03428217|364898826|FG000|Overall Study|Lost to Follow-up|1|||
105793476|NCT03428217|364898827|FG001|Overall Study|Lost to Follow-up|3|||
105793477|NCT03428217|364898826|FG000|Overall Study|Study terminated by sponsor|124|||
105793478|NCT03428217|364898827|FG001|Overall Study|Study terminated by sponsor|118|||
105793479|NCT03428217|364898826|FG000|Overall Study|Other, Not Specified|1|||
105793480|NCT03428217|364898827|FG001|Overall Study|Other, Not Specified|0|||
105793481|NCT00689273|364898830|FG000|Overall Study|Adverse Event|3|||
105793482|NCT00689273|364898831|FG001|Overall Study|Adverse Event|1|||
105793483|NCT00689273|364898830|FG000|Overall Study|Lack of Efficacy|3|||
105793484|NCT00689273|364898831|FG001|Overall Study|Lack of Efficacy|0|||
105793485|NCT00689273|364898830|FG000|Overall Study|Lost to Follow-up|0|||
105793486|NCT00689273|364898831|FG001|Overall Study|Lost to Follow-up|2|||
105793487|NCT00689273|364898830|FG000|Overall Study|Other|6|||
105793488|NCT00689273|364898831|FG001|Overall Study|Other|2|||
105793489|NCT00689273|364898830|FG000|Overall Study|Randomized but not Treated|1|||
105793490|NCT00689273|364898831|FG001|Overall Study|Randomized but not Treated|0|||
105793491|NCT03526679|364900670|FG000|Overall Study|still under treatment|2|||
105793492|NCT01325701|364900671|FG000|Overall Study|Adverse Event|12|||
105793493|NCT01325701|364900672|FG001|Overall Study|Adverse Event|0|||
105793494|NCT01325701|364900671|FG000|Overall Study|Protocol Violation|1|||
105793495|NCT01325701|364900672|FG001|Overall Study|Protocol Violation|0|||
105793496|NCT01325701|364900671|FG000|Overall Study|Physician Decision|2|||
105793497|NCT01325701|364900672|FG001|Overall Study|Physician Decision|2|||
105793498|NCT01325701|364900671|FG000|Overall Study|Withdrawal by Subject|2|||
105793499|NCT01325701|364900672|FG001|Overall Study|Withdrawal by Subject|1|||
105793500|NCT01325701|364900671|FG000|Overall Study|Rollerover Extension Study|4|||
105793501|NCT01325701|364900672|FG001|Overall Study|Rollerover Extension Study|0|||
105793502|NCT02406742|364900675|FG000|Overall Study|Progression of Disease|5|||
105793503|NCT02406742|364900676|FG001|Overall Study|Progression of Disease|1|||
105793504|NCT02406742|364900677|FG002|Overall Study|Progression of Disease|6|||
105793505|NCT02406742|364900675|FG000|Overall Study|Adverse Event|3|||
105793506|NCT02406742|364900676|FG001|Overall Study|Adverse Event|0|||
105793507|NCT02406742|364900677|FG002|Overall Study|Adverse Event|2|||
105793508|NCT02406742|364900675|FG000|Overall Study|Death|1|||
105793509|NCT02406742|364900676|FG001|Overall Study|Death|0|||
105793510|NCT02406742|364900677|FG002|Overall Study|Death|0|||
105793511|NCT02406742|364900675|FG000|Overall Study|Lack of Efficacy|0|||
105793512|NCT02406742|364900676|FG001|Overall Study|Lack of Efficacy|0|||
105793513|NCT02406742|364900677|FG002|Overall Study|Lack of Efficacy|1|||
105793514|NCT02406742|364900675|FG000|Overall Study|Withdrawal by Participant|1|||
105793515|NCT02406742|364900676|FG001|Overall Study|Withdrawal by Participant|2|||
105352904|NCT01641471|363297010|FG001|Overall Study|Withdrawal by Subject|19|||
105352905|NCT01641471|363297009|FG000|Overall Study|Lost to Follow-up|2|||
105352906|NCT01641471|363297010|FG001|Overall Study|Lost to Follow-up|4|||
105352907|NCT01641471|363297009|FG000|Overall Study|Protocol Violation|2|||
105724809|NCT04889209|364646498|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724810|NCT04889209|364646499|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724811|NCT04889209|364646500|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724812|NCT04889209|364646501|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724813|NCT04889209|364646502|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724814|NCT04889209|364646503|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724815|NCT04889209|364646504|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724816|NCT04889209|364646505|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
105724817|NCT04889209|364646488|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724818|NCT04889209|364646489|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724819|NCT04889209|364646490|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724820|NCT04889209|364646491|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
105724821|NCT04889209|364646492|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724822|NCT04889209|364646493|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724823|NCT04889209|364646494|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724824|NCT04889209|364646495|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724825|NCT04889209|364646496|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724826|NCT04889209|364646497|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724827|NCT04889209|364646498|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724828|NCT04889209|364646499|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724829|NCT04889209|364646500|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724830|NCT04889209|364646501|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724831|NCT04889209|364646502|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724832|NCT04889209|364646503|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724833|NCT04889209|364646504|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724834|NCT04889209|364646505|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724835|NCT04889209|364646488|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724836|NCT04889209|364646489|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105793516|NCT02406742|364900677|FG002|Overall Study|Withdrawal by Participant|0|||
105352908|NCT01641471|363297010|FG001|Overall Study|Protocol Violation|4|||
105793517|NCT02406742|364900675|FG000|Overall Study|Physician Decision|1|||
105793518|NCT02406742|364900676|FG001|Overall Study|Physician Decision|2|||
105793519|NCT02406742|364900677|FG002|Overall Study|Physician Decision|1|||
105793520|NCT02406742|364900675|FG000|Overall Study|Transition to other treatment|2|||
105352909|NCT01548768|363297011|FG000|Overall Study|Withdrawal by Subject|0|||
105352910|NCT01548768|363297012|FG001|Overall Study|Withdrawal by Subject|2|||
105352911|NCT01548768|363297013|FG002|Overall Study|Withdrawal by Subject|1|||
105793521|NCT02406742|364900676|FG001|Overall Study|Transition to other treatment|0|||
105478531|NCT03642132|363764266|FG000|Follow-up Period|Withdrawal by Subject|1|||
105478532|NCT03642132|363764267|FG001|Follow-up Period|Withdrawal by Subject|2|||
105724837|NCT04889209|364646490|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724838|NCT04889209|364646491|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724839|NCT04889209|364646492|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
105724840|NCT04889209|364646493|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724841|NCT04889209|364646494|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
105724842|NCT04889209|364646495|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
105724843|NCT04889209|364646496|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724844|NCT04889209|364646497|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
105724845|NCT04889209|364646498|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
105724846|NCT04889209|364646499|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724847|NCT04889209|364646500|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
105724848|NCT04889209|364646501|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724849|NCT04889209|364646502|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724850|NCT04889209|364646503|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724851|NCT04889209|364646504|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
105724852|NCT04889209|364646505|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724853|NCT04889209|364646488|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724854|NCT04889209|364646489|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724855|NCT04889209|364646490|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724856|NCT04889209|364646491|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724857|NCT04889209|364646492|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724858|NCT04889209|364646493|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724859|NCT04889209|364646494|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724860|NCT04889209|364646495|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724861|NCT04889209|364646496|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724862|NCT04889209|364646497|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724863|NCT04889209|364646498|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724864|NCT04889209|364646499|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724865|NCT04889209|364646500|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724866|NCT04889209|364646501|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724867|NCT04889209|364646502|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724868|NCT04889209|364646503|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724869|NCT04889209|364646504|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724870|NCT04889209|364646505|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
105724871|NCT04889209|364646488|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724872|NCT04889209|364646489|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724873|NCT04889209|364646490|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724874|NCT04889209|364646491|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724875|NCT04889209|364646492|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724876|NCT04889209|364646493|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724877|NCT04889209|364646494|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724878|NCT04889209|364646495|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724879|NCT04889209|364646496|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724880|NCT04889209|364646497|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724881|NCT04889209|364646498|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724882|NCT04889209|364646499|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724883|NCT04889209|364646500|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724884|NCT04889209|364646501|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724885|NCT04889209|364646502|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724886|NCT04889209|364646503|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724887|NCT04889209|364646504|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724888|NCT04889209|364646505|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
105724889|NCT04889209|364646488|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724890|NCT04889209|364646489|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724891|NCT04889209|364646490|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105793522|NCT02406742|364900677|FG002|Overall Study|Transition to other treatment|1|||
105478533|NCT03642132|363764268|FG002|Follow-up Period|Withdrawal by Subject|0|||
105793523|NCT02406742|364900675|FG000|Overall Study|Other Reasons|1|||
105793524|NCT02406742|364900676|FG001|Overall Study|Other Reasons|11|||
105793525|NCT02406742|364900677|FG002|Overall Study|Other Reasons|5|||
105478534|NCT03642132|363764266|FG000|Follow-up Period|Study terminated by sponsor|1|||
105724892|NCT04889209|364646491|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724893|NCT04889209|364646492|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724894|NCT04889209|364646493|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724895|NCT04889209|364646494|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724896|NCT04889209|364646495|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724897|NCT04889209|364646496|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724898|NCT04889209|364646497|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724899|NCT04889209|364646498|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724900|NCT04889209|364646499|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724901|NCT04889209|364646500|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724902|NCT04889209|364646501|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724903|NCT04889209|364646502|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
105724904|NCT04889209|364646503|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724905|NCT04889209|364646504|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724906|NCT04889209|364646505|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724907|NCT02786901|364646506|FG000|Overall Study|Adverse Event|1|||
105724908|NCT02786901|364646507|FG001|Overall Study|Adverse Event|1|||
105724909|NCT02786901|364646508|FG002|Overall Study|Adverse Event|2|||
105724910|NCT02786901|364646506|FG000|Overall Study|Physician Decision|1|||
105724911|NCT02786901|364646507|FG001|Overall Study|Physician Decision|0|||
105724912|NCT02786901|364646508|FG002|Overall Study|Physician Decision|0|||
105724913|NCT02786901|364646506|FG000|Overall Study|Rescue Therapy Use|71|||
105724914|NCT02786901|364646507|FG001|Overall Study|Rescue Therapy Use|49|||
105724915|NCT02786901|364646508|FG002|Overall Study|Rescue Therapy Use|33|||
105724916|NCT02786901|364646506|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
105724917|NCT02786901|364646507|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
105724918|NCT02786901|364646508|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
105724919|NCT02786901|364646506|FG000|Overall Study|Disallowed medication|1|||
105724920|NCT02786901|364646507|FG001|Overall Study|Disallowed medication|1|||
105724921|NCT02786901|364646508|FG002|Overall Study|Disallowed medication|0|||
105724922|NCT02786901|364646506|FG000|Overall Study|Randomized in error|2|||
105724923|NCT02786901|364646507|FG001|Overall Study|Randomized in error|0|||
105724924|NCT02786901|364646508|FG002|Overall Study|Randomized in error|1|||
105724925|NCT01075178|364646509|FG000|Subject Matching|eligible but not matched|130|||
105724926|NCT01075178|364646510|FG001|Subject Matching|eligible but not matched|403|||
105724927|NCT01075178|364646509|FG000|Subject Chart Review|died before chart review period|0|||
105724928|NCT01075178|364646510|FG001|Subject Chart Review|died before chart review period|2|||
105724929|NCT01075178|364646509|FG000|Subject Chart Review|no data collected due to site closure|3|||
105724930|NCT01075178|364646510|FG001|Subject Chart Review|no data collected due to site closure|4|||
105724931|NCT01075178|364646509|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
105724932|NCT01075178|364646510|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
105724933|NCT00763009|364646512|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
105724934|NCT01111604|364646514|FG000|Overall Study|Lost to Follow-up|0|||
105724935|NCT01111604|364646515|FG001|Overall Study|Lost to Follow-up|0|||
105724936|NCT01111604|364646516|FG002|Overall Study|Lost to Follow-up|1|||
105724937|NCT01111604|364646514|FG000|Overall Study|Withdrew Consent|3|||
105724938|NCT01111604|364646515|FG001|Overall Study|Withdrew Consent|0|||
105724939|NCT01111604|364646516|FG002|Overall Study|Withdrew Consent|2|||
105724940|NCT01111604|364646514|FG000|Overall Study|Withdrawal by Subject|2|||
105724941|NCT01111604|364646515|FG001|Overall Study|Withdrawal by Subject|0|||
105724942|NCT01111604|364646516|FG002|Overall Study|Withdrawal by Subject|0|||
105724943|NCT01111604|364646514|FG000|Overall Study|Death|1|||
105724944|NCT01111604|364646515|FG001|Overall Study|Death|0|||
105724945|NCT01111604|364646516|FG002|Overall Study|Death|0|||
105724946|NCT01111604|364646514|FG000|Overall Study|Met Exclusion Criteria|2|||
105724947|NCT01111604|364646515|FG001|Overall Study|Met Exclusion Criteria|0|||
105724948|NCT01111604|364646516|FG002|Overall Study|Met Exclusion Criteria|0|||
105724949|NCT00316264|364646518|FG000|Overall Study|Lost to Follow-up|0|||
105724950|NCT00316264|364646519|FG001|Overall Study|Lost to Follow-up|1|||
105724951|NCT00316264|364646520|FG002|Overall Study|Lost to Follow-up|0|||
105724952|NCT00316264|364646518|FG000|Overall Study|Withdrawal of Consent|3|||
105724953|NCT00316264|364646519|FG001|Overall Study|Withdrawal of Consent|5|||
105724954|NCT00316264|364646520|FG002|Overall Study|Withdrawal of Consent|6|||
105724955|NCT00316264|364646518|FG000|Overall Study|Death|2|||
105724956|NCT00316264|364646519|FG001|Overall Study|Death|0|||
105724957|NCT00316264|364646520|FG002|Overall Study|Death|0|||
105724958|NCT00316264|364646518|FG000|Overall Study|Other|1|||
105724959|NCT00316264|364646519|FG001|Overall Study|Other|1|||
105724960|NCT00316264|364646520|FG002|Overall Study|Other|0|||
105724961|NCT00607048|364646521|FG000|Overall Study|Adverse Event|0|||
105724962|NCT00607048|364646522|FG001|Overall Study|Adverse Event|1|||
105793526|NCT02367729|364900679|FG000|Overall Study|Organic disorder diagnosed|2|||
105724963|NCT00607048|364646523|FG002|Overall Study|Adverse Event|0|||
105724964|NCT00607048|364646524|FG003|Overall Study|Adverse Event|0|||
105724965|NCT00607048|364646525|FG004|Overall Study|Adverse Event|4|||
105724966|NCT00607048|364646526|FG005|Overall Study|Adverse Event|0|||
105724967|NCT00607048|364646521|FG000|Overall Study|Global deterioration of health|1|||
105724968|NCT00607048|364646522|FG001|Overall Study|Global deterioration of health|0|||
105724969|NCT00607048|364646523|FG002|Overall Study|Global deterioration of health|0|||
105724970|NCT00607048|364646524|FG003|Overall Study|Global deterioration of health|0|||
105724971|NCT00607048|364646525|FG004|Overall Study|Global deterioration of health|0|||
105724972|NCT00607048|364646526|FG005|Overall Study|Global deterioration of health|0|||
105724973|NCT00607048|364646521|FG000|Overall Study|Objective disease progression - relapse|1|||
105724974|NCT00607048|364646522|FG001|Overall Study|Objective disease progression - relapse|2|||
105724975|NCT00607048|364646523|FG002|Overall Study|Objective disease progression - relapse|4|||
105724976|NCT00607048|364646524|FG003|Overall Study|Objective disease progression - relapse|2|||
105724977|NCT00607048|364646525|FG004|Overall Study|Objective disease progression - relapse|2|||
105724978|NCT00607048|364646526|FG005|Overall Study|Objective disease progression - relapse|2|||
105724979|NCT00607048|364646521|FG000|Overall Study|Withdrawal by Subject|0|||
105724980|NCT00607048|364646522|FG001|Overall Study|Withdrawal by Subject|0|||
105724981|NCT00607048|364646523|FG002|Overall Study|Withdrawal by Subject|0|||
105724982|NCT00607048|364646524|FG003|Overall Study|Withdrawal by Subject|1|||
105724983|NCT00607048|364646525|FG004|Overall Study|Withdrawal by Subject|0|||
105724984|NCT00607048|364646526|FG005|Overall Study|Withdrawal by Subject|2|||
105724985|NCT00607048|364646521|FG000|Overall Study|Other|1|||
105724986|NCT00607048|364646522|FG001|Overall Study|Other|1|||
105724987|NCT00607048|364646523|FG002|Overall Study|Other|0|||
105724988|NCT00607048|364646524|FG003|Overall Study|Other|0|||
105724989|NCT00607048|364646525|FG004|Overall Study|Other|0|||
105724990|NCT00607048|364646526|FG005|Overall Study|Other|1|||
105724991|NCT02620020|364646527|FG000|Overall Study|Adverse Event|8|||
105724992|NCT02620020|364646528|FG001|Overall Study|Adverse Event|4|||
105724993|NCT02620020|364646529|FG002|Overall Study|Adverse Event|3|||
105724994|NCT02620020|364646530|FG003|Overall Study|Adverse Event|5|||
105724995|NCT02620020|364646527|FG000|Overall Study|Lost to Follow-up|4|||
105724996|NCT02620020|364646528|FG001|Overall Study|Lost to Follow-up|8|||
105724997|NCT02620020|364646529|FG002|Overall Study|Lost to Follow-up|1|||
105724998|NCT02620020|364646530|FG003|Overall Study|Lost to Follow-up|4|||
105724999|NCT02620020|364646527|FG000|Overall Study|Physician Decision|7|||
105725000|NCT02620020|364646528|FG001|Overall Study|Physician Decision|4|||
105725001|NCT02620020|364646529|FG002|Overall Study|Physician Decision|3|||
105725002|NCT02620020|364646530|FG003|Overall Study|Physician Decision|4|||
105725003|NCT02620020|364646527|FG000|Overall Study|Protocol Violation|5|||
105725004|NCT02620020|364646528|FG001|Overall Study|Protocol Violation|2|||
105725005|NCT02620020|364646529|FG002|Overall Study|Protocol Violation|1|||
105725006|NCT02620020|364646530|FG003|Overall Study|Protocol Violation|1|||
105725007|NCT02620020|364646527|FG000|Overall Study|Withdrawal by Subject|20|||
105725008|NCT02620020|364646528|FG001|Overall Study|Withdrawal by Subject|16|||
105725009|NCT02620020|364646529|FG002|Overall Study|Withdrawal by Subject|17|||
105725010|NCT02620020|364646530|FG003|Overall Study|Withdrawal by Subject|12|||
105725011|NCT02620020|364646527|FG000|Overall Study|Death|0|||
105725012|NCT02620020|364646528|FG001|Overall Study|Death|1|||
105725013|NCT02620020|364646529|FG002|Overall Study|Death|0|||
105725014|NCT02620020|364646530|FG003|Overall Study|Death|0|||
105725015|NCT02868892|364646531|FG000|Overall Study|Investigator left site and no follow-up|6|||
105725016|NCT01025635|364646532|FG000|Overall Study|Withdrawal by Subject|6|||
105725017|NCT01025635|364646533|FG001|Overall Study|Withdrawal by Subject|7|||
105725018|NCT01025635|364646532|FG000|Overall Study|Protocol Violation|4|||
105725019|NCT01025635|364646533|FG001|Overall Study|Protocol Violation|2|||
105725020|NCT01025635|364646532|FG000|Overall Study|Lack of Efficacy|0|||
105725021|NCT01025635|364646533|FG001|Overall Study|Lack of Efficacy|1|||
105725022|NCT01025635|364646532|FG000|Overall Study|Lost to Follow-up|9|||
105725023|NCT01025635|364646533|FG001|Overall Study|Lost to Follow-up|13|||
105725024|NCT01025635|364646532|FG000|Overall Study|Reason not known|4|||
105725025|NCT01025635|364646533|FG001|Overall Study|Reason not known|2|||
105725026|NCT02928952|364646535|FG000|Overall Study|Lost to Follow-up|5|||
105725027|NCT02928952|364646536|FG001|Overall Study|Lost to Follow-up|5|||
105725028|NCT02928952|364646535|FG000|Overall Study|Withdrawal by Subject|5|||
105725029|NCT02928952|364646536|FG001|Overall Study|Withdrawal by Subject|1|||
105725030|NCT02928952|364646535|FG000|Overall Study|Physician Decision|0|||
105725031|NCT02928952|364646536|FG001|Overall Study|Physician Decision|1|||
105725032|NCT02393209|364646541|FG000|Overall Study|Study Terminated by Sponsor|1|||
105725033|NCT02393209|364646542|FG001|Overall Study|Study Terminated by Sponsor|1|||
105725034|NCT02393209|364646543|FG002|Overall Study|Study Terminated by Sponsor|0|||
105725035|NCT02393209|364646544|FG003|Overall Study|Study Terminated by Sponsor|0|||
105725036|NCT02393209|364646541|FG000|Overall Study|Withdrawal by Patient|1|||
105725037|NCT02393209|364646542|FG001|Overall Study|Withdrawal by Patient|0|||
105725038|NCT02393209|364646543|FG002|Overall Study|Withdrawal by Patient|0|||
105725039|NCT02393209|364646544|FG003|Overall Study|Withdrawal by Patient|0|||
105725040|NCT02393209|364646541|FG000|Overall Study|Death|2|||
105725041|NCT02393209|364646542|FG001|Overall Study|Death|2|||
105725042|NCT02393209|364646543|FG002|Overall Study|Death|0|||
105725043|NCT02393209|364646544|FG003|Overall Study|Death|0|||
105725044|NCT02393209|364646541|FG000|Overall Study|Death due to Disease Progression|2|||
105725045|NCT02393209|364646542|FG001|Overall Study|Death due to Disease Progression|2|||
105725046|NCT02393209|364646543|FG002|Overall Study|Death due to Disease Progression|0|||
105725047|NCT02393209|364646544|FG003|Overall Study|Death due to Disease Progression|0|||
105725048|NCT02393209|364646541|FG000|Overall Study|Death from Legionella Infection|0|||
105725049|NCT02393209|364646542|FG001|Overall Study|Death from Legionella Infection|1|||
105725050|NCT02393209|364646543|FG002|Overall Study|Death from Legionella Infection|0|||
105725051|NCT02393209|364646544|FG003|Overall Study|Death from Legionella Infection|0|||
105725052|NCT02393209|364646541|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
105725053|NCT02393209|364646542|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
105725054|NCT02393209|364646543|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
105725055|NCT02393209|364646544|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
105725056|NCT02393209|364646541|FG000|Overall Study|Lost to Follow-up|0|||
105725057|NCT02393209|364646542|FG001|Overall Study|Lost to Follow-up|1|||
105725058|NCT02393209|364646543|FG002|Overall Study|Lost to Follow-up|0|||
105725059|NCT02393209|364646544|FG003|Overall Study|Lost to Follow-up|0|||
105725060|NCT03545282|364646545|FG000|Overall Study|Lost to Follow-up|15|||
105725061|NCT03545282|364646546|FG001|Overall Study|Lost to Follow-up|10|||
105725062|NCT03545282|364646545|FG000|Overall Study|Withdrawal by Subject|2|||
105725063|NCT03545282|364646546|FG001|Overall Study|Withdrawal by Subject|2|||
105725064|NCT02582671|364646547|FG000|Overall Study|Failure to return|1|||
105725065|NCT02582671|364646547|FG000|Overall Study|Other, not specified|1|||
105725066|NCT01287104|364646548|FG000|Overall Study|Patient developed progressive disease|1|||
105725067|NCT01287104|364646549|FG001|Overall Study|Patient developed progressive disease|1|||
105725068|NCT01287104|364646550|FG002|Overall Study|Patient developed progressive disease|3|||
105725069|NCT01287104|364646551|FG003|Overall Study|Patient developed progressive disease|2|||
105725070|NCT01287104|364646548|FG000|Overall Study|Donor anaphylaxis|0|||
105725071|NCT01287104|364646549|FG001|Overall Study|Donor anaphylaxis|1|||
105725072|NCT01287104|364646550|FG002|Overall Study|Donor anaphylaxis|0|||
105725073|NCT01287104|364646551|FG003|Overall Study|Donor anaphylaxis|1|||
105725074|NCT01287104|364646548|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
105725075|NCT01287104|364646549|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
105725076|NCT01287104|364646550|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
105725077|NCT01287104|364646551|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
105725078|NCT01287104|364646548|FG000|Overall Study|Low donor chimerism|0|||
105725079|NCT01287104|364646549|FG001|Overall Study|Low donor chimerism|1|||
105725080|NCT01287104|364646550|FG002|Overall Study|Low donor chimerism|0|||
105725081|NCT01287104|364646551|FG003|Overall Study|Low donor chimerism|0|||
105725082|NCT01287104|364646548|FG000|Overall Study|NK cells did not meet release criteria|0|||
105725083|NCT01287104|364646549|FG001|Overall Study|NK cells did not meet release criteria|1|||
105725084|NCT01287104|364646550|FG002|Overall Study|NK cells did not meet release criteria|0|||
105725085|NCT01287104|364646551|FG003|Overall Study|NK cells did not meet release criteria|0|||
105725086|NCT00098787|364646556|FG000|Overall Study|Never started treatment|3|||
105725087|NCT00098787|364646557|FG001|Overall Study|Never started treatment|2|||
105725088|NCT00098787|364646558|FG002|Overall Study|Never started treatment|1|||
105725089|NCT00098787|364646556|FG000|Overall Study|Ineligible|9|||
105725090|NCT00098787|364646557|FG001|Overall Study|Ineligible|7|||
105725091|NCT00098787|364646558|FG002|Overall Study|Ineligible|3|||
105725092|NCT00098787|364646556|FG000|Overall Study|Disease progression|28|||
105725093|NCT00098787|364646557|FG001|Overall Study|Disease progression|17|||
105725094|NCT00098787|364646558|FG002|Overall Study|Disease progression|23|||
105352912|NCT01548768|363297014|FG003|Overall Study|Withdrawal by Subject|0|||
105352913|NCT01548768|363297011|FG000|Overall Study|Physician Decision|1|||
105352914|NCT01548768|363297012|FG001|Overall Study|Physician Decision|0|||
105352915|NCT01548768|363297013|FG002|Overall Study|Physician Decision|0|||
105352916|NCT01548768|363297014|FG003|Overall Study|Physician Decision|0|||
105352917|NCT01548768|363297011|FG000|Overall Study|Adverse Event|0|||
105352918|NCT01548768|363297012|FG001|Overall Study|Adverse Event|0|||
105352919|NCT01548768|363297013|FG002|Overall Study|Adverse Event|0|||
105352920|NCT01548768|363297014|FG003|Overall Study|Adverse Event|1|||
105352921|NCT01548768|363297011|FG000|Overall Study|Non-Compliance|0|||
105352922|NCT01548768|363297012|FG001|Overall Study|Non-Compliance|0|||
105352923|NCT01548768|363297013|FG002|Overall Study|Non-Compliance|0|||
105352924|NCT01548768|363297014|FG003|Overall Study|Non-Compliance|3|||
105352925|NCT02769312|363297017|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
105352926|NCT02769312|363297018|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
105352927|NCT02769312|363297017|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
105352928|NCT02769312|363297018|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
105352929|NCT02769312|363297017|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
105725095|NCT00098787|364646556|FG000|Overall Study|Adverse Event|8|||
105725096|NCT00098787|364646557|FG001|Overall Study|Adverse Event|17|||
105725097|NCT00098787|364646558|FG002|Overall Study|Adverse Event|8|||
105725098|NCT00098787|364646556|FG000|Overall Study|Death|6|||
105725099|NCT00098787|364646557|FG001|Overall Study|Death|1|||
105725100|NCT00098787|364646558|FG002|Overall Study|Death|0|||
105725101|NCT00098787|364646556|FG000|Overall Study|Withdrawal by Subject|4|||
105725102|NCT00098787|364646557|FG001|Overall Study|Withdrawal by Subject|12|||
105725103|NCT00098787|364646558|FG002|Overall Study|Withdrawal by Subject|6|||
105725104|NCT00098787|364646556|FG000|Overall Study|Alternative therapy|8|||
105725105|NCT00098787|364646557|FG001|Overall Study|Alternative therapy|13|||
105725106|NCT00098787|364646558|FG002|Overall Study|Alternative therapy|13|||
105725107|NCT00098787|364646556|FG000|Overall Study|Other|7|||
105725108|NCT00098787|364646557|FG001|Overall Study|Other|6|||
105725109|NCT00098787|364646558|FG002|Overall Study|Other|9|||
105725110|NCT02203149|364646562|FG000|Part 1|Adverse Event|0|||
105725111|NCT02203149|364646563|FG001|Part 1|Adverse Event|1|||
105725112|NCT02203149|364646564|FG002|Part 1|Adverse Event|0|||
105725113|NCT02203149|364646565|FG003|Part 1|Adverse Event|0|||
105725114|NCT02203149|364646566|FG004|Part 1|Adverse Event|0|||
105725115|NCT02203149|364646562|FG000|Part 2|Death|0|||
105725116|NCT02203149|364646563|FG001|Part 2|Death|0|||
105725117|NCT02203149|364646564|FG002|Part 2|Death|1|||
105725118|NCT02203149|364646565|FG003|Part 2|Death|1|||
105725119|NCT02203149|364646566|FG004|Part 2|Death|0|||
105725120|NCT02203149|364646562|FG000|Part 2|Withdrawal by Subject|0|||
105725121|NCT02203149|364646563|FG001|Part 2|Withdrawal by Subject|0|||
105725122|NCT02203149|364646564|FG002|Part 2|Withdrawal by Subject|0|||
105725123|NCT02203149|364646565|FG003|Part 2|Withdrawal by Subject|1|||
105725124|NCT02203149|364646566|FG004|Part 2|Withdrawal by Subject|0|||
105725125|NCT02203149|364646562|FG000|Part 2|Adverse Event|0|||
105725126|NCT02203149|364646563|FG001|Part 2|Adverse Event|0|||
105725127|NCT02203149|364646564|FG002|Part 2|Adverse Event|0|||
105725128|NCT02203149|364646565|FG003|Part 2|Adverse Event|1|||
105725129|NCT02203149|364646566|FG004|Part 2|Adverse Event|1|||
105725130|NCT01360996|364646567|FG000|Overall Study|Withdrawal by Subject|4|||
105725131|NCT01360996|364646568|FG001|Overall Study|Withdrawal by Subject|3|||
105725132|NCT01360996|364646569|FG002|Overall Study|Withdrawal by Subject|2|||
105725133|NCT01360996|364646567|FG000|Overall Study|Noncompliant|2|||
105725134|NCT01360996|364646568|FG001|Overall Study|Noncompliant|0|||
105725135|NCT01360996|364646569|FG002|Overall Study|Noncompliant|0|||
105725136|NCT03168867|364646571|FG000|Overall Study|Withdrawal by Subject|1|||
105725137|NCT03168867|364646572|FG001|Overall Study|Withdrawal by Subject|5|||
105725138|NCT04964258|364646573|FG000|Overall Study|Lost to Follow-up|1|||
105725139|NCT04964258|364646574|FG001|Overall Study|Lost to Follow-up|0|||
105725140|NCT04964258|364646575|FG002|Overall Study|Lost to Follow-up|0|||
105725141|NCT04964258|364646576|FG003|Overall Study|Lost to Follow-up|0|||
105793527|NCT02367729|364900680|FG001|Overall Study|Organic disorder diagnosed|1|||
105352930|NCT02769312|363297018|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
105352931|NCT02769312|363297017|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
105562910|NCT03205371|364057539|FG011|Overall Study|Withdrawal by Subject|1|||
105352932|NCT02769312|363297018|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
105725142|NCT04964258|364646577|FG004|Overall Study|Lost to Follow-up|0|||
105725143|NCT04964258|364646578|FG005|Overall Study|Lost to Follow-up|1|||
105725144|NCT04964258|364646579|FG006|Overall Study|Lost to Follow-up|0|||
105725145|NCT04964258|364646580|FG007|Overall Study|Lost to Follow-up|0|||
105725146|NCT04964258|364646581|FG008|Overall Study|Lost to Follow-up|0|||
105725147|NCT04964258|364646582|FG009|Overall Study|Lost to Follow-up|0|||
105725148|NCT04964258|364646583|FG010|Overall Study|Lost to Follow-up|0|||
105725149|NCT01173653|364646585|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
105725150|NCT01173653|364646586|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
105725151|NCT04439344|364646590|FG000|Overall Study|Never started threapy|3|||
105725152|NCT04439344|364646590|FG000|Overall Study|Ineligible|3|||
105478535|NCT03642132|363764267|FG001|Follow-up Period|Study terminated by sponsor|0|||
105478536|NCT03642132|363764268|FG002|Follow-up Period|Study terminated by sponsor|1|||
105478537|NCT03642132|363764266|FG000|Follow-up Period|Lack of Efficacy|1|||
105478538|NCT03642132|363764267|FG001|Follow-up Period|Lack of Efficacy|0|||
105478539|NCT03642132|363764268|FG002|Follow-up Period|Lack of Efficacy|0|||
105478540|NCT03642132|363764266|FG000|Follow-up Period|Death|1|||
105478541|NCT03642132|363764267|FG001|Follow-up Period|Death|0|||
105478542|NCT03642132|363764268|FG002|Follow-up Period|Death|2|||
105478543|NCT03642132|363764266|FG000|Follow-up Period|Adverse Event|1|||
105478544|NCT03642132|363764267|FG001|Follow-up Period|Adverse Event|0|||
105478545|NCT03642132|363764268|FG002|Follow-up Period|Adverse Event|0|||
105478546|NCT00647270|363764275|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
105478547|NCT00647270|363764276|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
105478548|NCT00647270|363764277|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
105478549|NCT00647270|363764275|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
105478550|NCT00647270|363764276|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
105478551|NCT00647270|363764277|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
105478552|NCT00647270|363764275|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
105478553|NCT00647270|363764276|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
105725153|NCT04439344|364646590|FG000|Overall Study|Adverse Event|13|||
105725154|NCT04439344|364646590|FG000|Overall Study|Death|2|||
105725155|NCT04439344|364646590|FG000|Overall Study|Disease progression|29|||
105725156|NCT04439344|364646590|FG000|Overall Study|Withdrawal by Subject|2|||
105725157|NCT04439344|364646590|FG000|Overall Study|Alternative therapy|1|||
105725158|NCT02115308|364646592|FG000|Overall Study|Safety Screening|2|||
105725159|NCT02115308|364646593|FG001|Overall Study|Safety Screening|2|||
105725160|NCT03440944|364646596|FG000|Overall Study|Physician Decision|1|||
105725161|NCT03440944|364646597|FG001|Overall Study|Physician Decision|0|||
105725162|NCT03440944|364646596|FG000|Overall Study|No Acceptable Vasculature|0|||
105725163|NCT03440944|364646597|FG001|Overall Study|No Acceptable Vasculature|1|||
105725164|NCT03871491|364646598|FG000|Overall Study|Withdrawal by Subject|14|||
105725165|NCT03871491|364646599|FG001|Overall Study|Withdrawal by Subject|14|||
105725166|NCT03871491|364646600|FG002|Overall Study|Withdrawal by Subject|14|||
105725167|NCT03871491|364646601|FG003|Overall Study|Withdrawal by Subject|14|||
105725168|NCT03871491|364646598|FG000|Overall Study|Physician Decision|0|||
105725169|NCT03871491|364646599|FG001|Overall Study|Physician Decision|0|||
105725170|NCT03871491|364646600|FG002|Overall Study|Physician Decision|1|||
105725171|NCT03871491|364646601|FG003|Overall Study|Physician Decision|1|||
105725172|NCT03871491|364646598|FG000|Overall Study|Lost to Follow-up|50|||
105725173|NCT03871491|364646599|FG001|Overall Study|Lost to Follow-up|15|||
105725174|NCT03871491|364646600|FG002|Overall Study|Lost to Follow-up|36|||
105725175|NCT03871491|364646601|FG003|Overall Study|Lost to Follow-up|11|||
105725176|NCT02495948|364646604|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
105725177|NCT02495948|364646605|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
105725178|NCT02495948|364646604|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
105725179|NCT02495948|364646605|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
105725180|NCT01444300|364646606|FG000|Overall Study|Adverse Event|4|||
105725181|NCT01444300|364646607|FG001|Overall Study|Adverse Event|0|||
105725182|NCT02582658|364646608|FG000|Overall Study|Failure to Return|10|||
105725183|NCT02582658|364646608|FG000|Overall Study|Insufficient Virological Response|2|||
105725184|NCT02582658|364646608|FG000|Overall Study|Withdrawn Consent|1|||
105725185|NCT02582658|364646608|FG000|Overall Study|Death|1|||
105725186|NCT02582658|364646608|FG000|Overall Study|Not further specified|11|||
105725187|NCT01769105|364646609|FG000|First Intervention|Protocol Violation|2|||
105725188|NCT01769105|364646610|FG001|First Intervention|Protocol Violation|2|||
105725189|NCT01769105|364646609|FG000|Cross-over|Lost to Follow-up|5|||
105725190|NCT01769105|364646610|FG001|Cross-over|Lost to Follow-up|0|||
105725191|NCT04194944|364646611|FG000|Overall Study|Lost to Follow-up|3|||
105478554|NCT00647270|363764277|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
105478555|NCT00647270|363764275|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
105478556|NCT00647270|363764276|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
105478557|NCT00647270|363764277|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
105478558|NCT00647270|363764275|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
105562911|NCT03205371|364057528|FG000|Overall Study|Lost to Follow-up|0|||
105725192|NCT04194944|364646612|FG001|Overall Study|Lost to Follow-up|0|||
105725193|NCT04194944|364646611|FG000|Overall Study|Withdrawal by Subject|2|||
105725194|NCT04194944|364646612|FG001|Overall Study|Withdrawal by Subject|2|||
105725195|NCT04194944|364646611|FG000|Overall Study|On Treatment|93|||
105562912|NCT03205371|364057529|FG001|Overall Study|Lost to Follow-up|0|||
105725196|NCT04194944|364646612|FG001|Overall Study|On Treatment|30|||
105725197|NCT00127127|364648961|FG000|Overall Study|Adverse Event|0|||
105725198|NCT00127127|364648962|FG001|Overall Study|Adverse Event|2|||
105725199|NCT00127127|364648963|FG002|Overall Study|Adverse Event|0|||
105725200|NCT00127127|364648964|FG003|Overall Study|Adverse Event|1|||
105793528|NCT02367729|364900679|FG000|Overall Study|Adverse Event|1|||
105793529|NCT02367729|364900680|FG001|Overall Study|Adverse Event|2|||
105793530|NCT02367729|364900679|FG000|Overall Study|Withdrawal by Subject|0|||
105793531|NCT02367729|364900680|FG001|Overall Study|Withdrawal by Subject|5|||
105793532|NCT00388674|364900681|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
105793533|NCT00388674|364900682|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
105793534|NCT00388674|364900681|FG000|Initial Treatment|Adverse Event|22|||
105793535|NCT00388674|364900682|FG001|Initial Treatment|Adverse Event|87|||
105793536|NCT00388674|364900681|FG000|Initial Treatment|Death|215|||
105793537|NCT00388674|364900682|FG001|Initial Treatment|Death|216|||
105793538|NCT00388674|364900681|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
105793539|NCT00388674|364900682|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
105793540|NCT00388674|364900681|FG000|Initial Treatment|HCC|12|||
105793541|NCT00388674|364900682|FG001|Initial Treatment|HCC|20|||
105793542|NCT00388674|364900681|FG000|Initial Treatment|Lost to Follow-up|526|||
105793543|NCT00388674|364900682|FG001|Initial Treatment|Lost to Follow-up|624|||
105793544|NCT00388674|364900681|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
105793545|NCT00388674|364900682|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
105793546|NCT00388674|364900681|FG000|Initial Treatment|Never Treated with Study Medication|1|||
105793547|NCT00388674|364900682|FG001|Initial Treatment|Never Treated with Study Medication|7|||
105793548|NCT00388674|364900681|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
105793549|NCT00388674|364900682|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
105793550|NCT00388674|364900681|FG000|Initial Treatment|Not Defined|125|||
105793551|NCT00388674|364900682|FG001|Initial Treatment|Not Defined|172|||
105793552|NCT00388674|364900681|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
105793553|NCT00388674|364900682|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
105793554|NCT00388674|364900681|FG000|Initial Treatment|Pregnancy|26|||
105793555|NCT00388674|364900682|FG001|Initial Treatment|Pregnancy|16|||
105793556|NCT00388674|364900681|FG000|Initial Treatment|Study Drug Toxicity|5|||
105793557|NCT00388674|364900682|FG001|Initial Treatment|Study Drug Toxicity|92|||
105793558|NCT00388674|364900681|FG000|Initial Treatment|Participant Request|501|||
105793559|NCT00388674|364900682|FG001|Initial Treatment|Participant Request|673|||
105793560|NCT00388674|364900681|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
105793561|NCT00388674|364900682|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
105793562|NCT00388674|364900681|FG000|Initial Treatment|Not Reported|10|||
105793563|NCT00388674|364900682|FG001|Initial Treatment|Not Reported|12|||
105793564|NCT00388674|364900681|FG000|End of Study|Administrative Reason By Sponsor|299|||
105793565|NCT00388674|364900682|FG001|End of Study|Administrative Reason By Sponsor|253|||
105793566|NCT00388674|364900681|FG000|End of Study|Death|239|||
105793567|NCT00388674|364900682|FG001|End of Study|Death|262|||
105793568|NCT00388674|364900681|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
105793569|NCT00388674|364900682|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
105793570|NCT00388674|364900681|FG000|End of Study|HCC|8|||
105793571|NCT00388674|364900682|FG001|End of Study|HCC|7|||
105793572|NCT00388674|364900681|FG000|End of Study|Lost to Follow-up|587|||
105793573|NCT00388674|364900682|FG001|End of Study|Lost to Follow-up|715|||
105793574|NCT00388674|364900681|FG000|End of Study|Malignancy (Non-HCC)|1|||
105352933|NCT02769312|363297017|FG000|Follow-up|Lost to Follow-up|1|||
105793575|NCT00388674|364900682|FG001|End of Study|Malignancy (Non-HCC)|1|||
105793576|NCT00388674|364900681|FG000|End of Study|Non-Study Related Comorbidities|3|||
105793577|NCT00388674|364900682|FG001|End of Study|Non-Study Related Comorbidities|4|||
105793578|NCT00388674|364900681|FG000|End of Study|Not Defined|135|||
105793579|NCT00388674|364900682|FG001|End of Study|Not Defined|214|||
105725201|NCT00127127|364648961|FG000|Overall Study|Lack of Efficacy|1|||
105725202|NCT00127127|364648962|FG001|Overall Study|Lack of Efficacy|3|||
105725203|NCT00127127|364648963|FG002|Overall Study|Lack of Efficacy|0|||
105725204|NCT00127127|364648964|FG003|Overall Study|Lack of Efficacy|2|||
105725205|NCT01412879|364648967|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
105725206|NCT01412879|364648968|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
105725207|NCT01412879|364648969|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
105725208|NCT01412879|364648967|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
105725209|NCT01412879|364648968|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
105725210|NCT01412879|364648969|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
105725211|NCT01412879|364648967|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
105725212|NCT01412879|364648968|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
105725213|NCT01412879|364648969|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
105725214|NCT01412879|364648967|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
105725215|NCT01412879|364648968|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
105725216|NCT01412879|364648969|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
105725217|NCT01412879|364648967|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
105725218|NCT01412879|364648968|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
105725219|NCT01412879|364648969|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
105725220|NCT04840667|364648970|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
105725221|NCT03195894|364648971|FG000|Overall Study|"An example is Started other treatment."|4|||
105725222|NCT03195894|364648972|FG001|Overall Study|"An example is Started other treatment."|5|||
105725223|NCT03195894|364648971|FG000|Overall Study|Withdrawal by Subject|15|||
105725224|NCT03195894|364648972|FG001|Overall Study|Withdrawal by Subject|4|||
105725225|NCT03195894|364648971|FG000|Overall Study|Lost to Follow-up|14|||
105725226|NCT03195894|364648972|FG001|Overall Study|Lost to Follow-up|19|||
105725227|NCT00162773|364648973|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
105725228|NCT04439266|364648976|FG000|Overall Study|Ineligible|1|||
105725229|NCT04439266|364648976|FG000|Overall Study|Adverse Event|1|||
105725230|NCT04439266|364648976|FG000|Overall Study|Death|1|||
105725231|NCT04439266|364648976|FG000|Overall Study|Disease progression|1|||
105725232|NCT04439266|364648976|FG000|Overall Study|Still on treatment|1|||
105725233|NCT02725788|364648979|FG000|Overall Study|Lost to Follow-up|1|||
105725234|NCT02725788|364648980|FG001|Overall Study|Lost to Follow-up|1|||
105725235|NCT02725788|364648979|FG000|Overall Study|Protocol Violation|0|||
105725236|NCT02725788|364648980|FG001|Overall Study|Protocol Violation|1|||
105725237|NCT03049449|364648985|FG000|Overall Study|Did not receive treatment.|0|||
105725238|NCT03049449|364648986|FG001|Overall Study|Did not receive treatment.|0|||
105725239|NCT03049449|364648987|FG002|Overall Study|Did not receive treatment.|0|||
105725240|NCT03049449|364648988|FG003|Overall Study|Did not receive treatment.|0|||
105725241|NCT03049449|364648989|FG004|Overall Study|Did not receive treatment.|0|||
105725242|NCT03049449|364648990|FG005|Overall Study|Did not receive treatment.|0|||
105725243|NCT03049449|364648991|FG006|Overall Study|Did not receive treatment.|0|||
105725244|NCT03049449|364648992|FG007|Overall Study|Did not receive treatment.|0|||
105725245|NCT03049449|364648993|FG008|Overall Study|Did not receive treatment.|1|||
105760773|NCT01576406|364776184|FG001|Overall Study|Other|0|||
105793580|NCT00388674|364900681|FG000|End of Study|Participant Withdrew Consent|437|||
105793581|NCT00388674|364900682|FG001|End of Study|Participant Withdrew Consent|673|||
105793582|NCT00388674|364900681|FG000|End of Study|No Off-Treatment Status Data|22|||
105562913|NCT03205371|364057530|FG002|Overall Study|Lost to Follow-up|0|||
105793583|NCT00388674|364900682|FG001|End of Study|No Off-Treatment Status Data|30|||
105562914|NCT03205371|364057531|FG003|Overall Study|Lost to Follow-up|0|||
105793584|NCT00388674|364900681|FG000|End of Study|Not Reported|0|||
105478559|NCT00647270|363764276|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
105725246|NCT03049449|364648994|FG009|Overall Study|Did not receive treatment.|0|||
105725247|NCT03049449|364648985|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
105725248|NCT03049449|364648986|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
105478560|NCT00647270|363764277|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
105725249|NCT03049449|364648987|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
105725250|NCT03049449|364648988|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
105725251|NCT03049449|364648989|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
105725252|NCT03049449|364648990|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
105725253|NCT03049449|364648991|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
105725254|NCT03049449|364648992|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
105725255|NCT03049449|364648993|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
105725256|NCT03049449|364648994|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
105725257|NCT03049449|364648985|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725258|NCT03049449|364648986|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725259|NCT03049449|364648987|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725260|NCT03049449|364648988|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725261|NCT03049449|364648989|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725262|NCT03049449|364648990|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725263|NCT03049449|364648991|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725264|NCT03049449|364648992|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
105725265|NCT03049449|364648993|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725266|NCT03049449|364648994|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
105725267|NCT02731742|364648997|FG000|Overall Study|Death|1|||
105725268|NCT02731742|364648998|FG001|Overall Study|Death|2|||
105725269|NCT02731742|364648999|FG002|Overall Study|Death|5|||
105725270|NCT02731742|364649000|FG003|Overall Study|Death|0|||
105725271|NCT02731742|364648997|FG000|Overall Study|Physician Decision|0|||
105725272|NCT02731742|364648998|FG001|Overall Study|Physician Decision|0|||
105725273|NCT02731742|364648999|FG002|Overall Study|Physician Decision|0|||
105725274|NCT02731742|364649000|FG003|Overall Study|Physician Decision|1|||
105725275|NCT02731742|364648997|FG000|Overall Study|Study Terminated by Sponsor|2|||
105725276|NCT02731742|364648998|FG001|Overall Study|Study Terminated by Sponsor|1|||
105725277|NCT02731742|364648999|FG002|Overall Study|Study Terminated by Sponsor|1|||
105725278|NCT02731742|364649000|FG003|Overall Study|Study Terminated by Sponsor|1|||
105725279|NCT00502840|364649003|FG000|Overall Study|Adverse Event|5|||
105725280|NCT00502840|364649003|FG000|Overall Study|Additional or changed therapy|48|||
105725281|NCT00502840|364649003|FG000|Overall Study|Lack of Efficacy|11|||
105725282|NCT00502840|364649003|FG000|Overall Study|Protocol Violation|4|||
105725283|NCT00502840|364649003|FG000|Overall Study|Withdrawal by Subject|5|||
105725284|NCT00502840|364649003|FG000|Overall Study|Lost to Follow-up|6|||
105725285|NCT00502840|364649003|FG000|Overall Study|Administrative problems|1|||
105725286|NCT00502840|364649003|FG000|Overall Study|Other|20|||
105725287|NCT00331760|364649004|FG000|Overall Study|Ineligible / no protocol treatment|15|||
105725288|NCT00331760|364649005|FG001|Overall Study|Ineligible / no protocol treatment|8|||
105725289|NCT00826514|364649007|FG000|Overall Study|Adverse Event|1|||
105725290|NCT00826514|364649008|FG001|Overall Study|Adverse Event|1|||
105725291|NCT00826514|364649007|FG000|Overall Study|Lack of Efficacy|0|||
105725292|NCT00826514|364649008|FG001|Overall Study|Lack of Efficacy|1|||
105725293|NCT00826514|364649007|FG000|Overall Study|Withdrawal by Subject|2|||
105725294|NCT00826514|364649008|FG001|Overall Study|Withdrawal by Subject|3|||
105725295|NCT03926143|364649011|FG000|Overall Study|Physician Decision|3|||
105725296|NCT03926143|364649011|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
105725297|NCT03926143|364649011|FG000|Overall Study|Adverse Event|2|||
105725298|NCT03926143|364649011|FG000|Overall Study|Progressive disease|3|||
105725299|NCT02978222|364649013|FG000|Overall Study|Withdrawal by Subject|2|||
105725300|NCT02978222|364649014|FG001|Overall Study|Withdrawal by Subject|2|||
105725301|NCT02978222|364649013|FG000|Overall Study|Physician Decision|2|||
105725302|NCT02978222|364649014|FG001|Overall Study|Physician Decision|0|||
105725303|NCT02978222|364649013|FG000|Overall Study|Adverse Event|0|||
105725304|NCT02978222|364649014|FG001|Overall Study|Adverse Event|1|||
105725305|NCT02978222|364649013|FG000|Overall Study|Death|1|||
105725306|NCT02978222|364649014|FG001|Overall Study|Death|0|||
105725307|NCT02978222|364649013|FG000|Overall Study|Disease Progression|32|||
105725308|NCT02978222|364649014|FG001|Overall Study|Disease Progression|32|||
105725309|NCT02978222|364649013|FG000|Overall Study|Early Study Termination|24|||
105725310|NCT02978222|364649014|FG001|Overall Study|Early Study Termination|21|||
105725311|NCT01686568|364649015|FG000|Main Study|Withdrawal by Subject|1|||
105725312|NCT01686568|364649016|FG001|Main Study|Withdrawal by Subject|3|||
105725313|NCT01686568|364649015|FG000|Main Study|Noncompliance with protocol|0|||
105725314|NCT01686568|364649016|FG001|Main Study|Noncompliance with protocol|1|||
105725315|NCT01686568|364649015|FG000|Main Study|Liver enzymes above range of exclusion|1|||
105793585|NCT00388674|364900682|FG001|End of Study|Not Reported|1|||
105793586|NCT01260194|364900691|FG000|Overall Study|Withdrawal of Consent|1|||
105793587|NCT03387735|364900692|FG000|Overall Study|Lost to Follow-up|4|||
105793588|NCT03387735|364900693|FG001|Overall Study|Lost to Follow-up|8|||
105793589|NCT03387735|364900692|FG000|Overall Study|Death|4|||
105793590|NCT03387735|364900693|FG001|Overall Study|Death|8|||
105793591|NCT01447628|364900694|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
105793592|NCT01447628|364900695|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
105793593|NCT01447628|364900696|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
105793594|NCT01447628|364900697|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
105793595|NCT05674721|364900700|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
105793596|NCT05674721|364900701|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
105793597|NCT05674721|364900700|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
105793598|NCT05674721|364900701|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
105793599|NCT03891875|364900702|FG000|Overall Study|Withdrawal by Subject|20|||
105793600|NCT03891875|364900703|FG001|Overall Study|Withdrawal by Subject|3|||
105793601|NCT03891875|364900702|FG000|Overall Study|Adverse Event|10|||
105793602|NCT03891875|364900703|FG001|Overall Study|Adverse Event|4|||
105793603|NCT03891875|364900702|FG000|Overall Study|Physician Decision|1|||
105793604|NCT03891875|364900703|FG001|Overall Study|Physician Decision|1|||
105793605|NCT03891875|364900702|FG000|Overall Study|Protocol Violation|1|||
105793606|NCT03891875|364900703|FG001|Overall Study|Protocol Violation|0|||
105793607|NCT03891875|364900702|FG000|Overall Study|Lost to Follow-up|1|||
105793608|NCT03891875|364900703|FG001|Overall Study|Lost to Follow-up|0|||
105793609|NCT03891875|364900702|FG000|Overall Study|COVID-19 infection|1|||
105793610|NCT03891875|364900703|FG001|Overall Study|COVID-19 infection|0|||
105793611|NCT02017535|364900707|FG000|Overall Study|Withdrawal by Subject|1|||
105793612|NCT02017535|364900708|FG001|Overall Study|Withdrawal by Subject|0|||
105793613|NCT02017535|364900709|FG002|Overall Study|Withdrawal by Subject|0|||
105793614|NCT02017535|364900710|FG003|Overall Study|Withdrawal by Subject|0|||
105793615|NCT04088734|364900711|FG000|Overall Study|Other, Not Specified|5|||
105793616|NCT00835068|364900714|FG000|Overall Study|Death|1|||
105793617|NCT00835068|364900715|FG001|Overall Study|Death|0|||
105793618|NCT00835068|364900714|FG000|Overall Study|Adverse Event|0|||
105793619|NCT00835068|364900715|FG001|Overall Study|Adverse Event|1|||
105793620|NCT00835068|364900714|FG000|Overall Study|Other|8|||
105793621|NCT00835068|364900715|FG001|Overall Study|Other|0|||
105793622|NCT00835068|364900714|FG000|Overall Study|Withdrawal by Subject|1|||
105793623|NCT00835068|364900715|FG001|Overall Study|Withdrawal by Subject|0|||
105793624|NCT00664066|364900716|FG000|Overall Study|Study terminated|3|||
105793625|NCT03014570|364900719|FG000|Overall Study|COVID-19 Restrictions|38|||
105793626|NCT03014570|364900720|FG001|Overall Study|COVID-19 Restrictions|24|||
105793627|NCT03014570|364900719|FG000|Overall Study|Death|70|||
105793628|NCT03014570|364900720|FG001|Overall Study|Death|79|||
105793629|NCT03014570|364900719|FG000|Overall Study|Transfer from facility|11|||
105793630|NCT03014570|364900720|FG001|Overall Study|Transfer from facility|14|||
105793631|NCT03014570|364900719|FG000|Overall Study|Hospitalized|5|||
105793632|NCT03014570|364900720|FG001|Overall Study|Hospitalized|3|||
105793633|NCT03014570|364900719|FG000|Overall Study|Transfer within facility|1|||
105793634|NCT03014570|364900720|FG001|Overall Study|Transfer within facility|0|||
105793635|NCT03014570|364900719|FG000|Overall Study|Site refusal|0|||
105793636|NCT03014570|364900720|FG001|Overall Study|Site refusal|11|||
105793637|NCT00090259|364900721|FG000|Overall Study|Lost to Follow-up|30|||
105793638|NCT00090259|364900722|FG001|Overall Study|Lost to Follow-up|26|||
105793639|NCT00090259|364900721|FG000|Overall Study|Withdrawal by Subject|21|||
105793640|NCT00090259|364900722|FG001|Overall Study|Withdrawal by Subject|15|||
105793641|NCT00090259|364900721|FG000|Overall Study|Investigator site closed|11|||
105793642|NCT00090259|364900722|FG001|Overall Study|Investigator site closed|7|||
105793643|NCT03083639|364900725|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
105793644|NCT03083639|364900726|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
105793645|NCT03083639|364900725|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
105793646|NCT03083639|364900726|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
105793647|NCT02666768|364900728|FG000|Overall Study|Withdrawal by Subject|4|||
105793648|NCT01488071|364900729|FG000|Overall Study|Adverse Event|15|||
105793649|NCT01488071|364900730|FG001|Overall Study|Adverse Event|23|||
105793650|NCT01488071|364900729|FG000|Overall Study|Lack of Efficacy|11|||
105793651|NCT01488071|364900730|FG001|Overall Study|Lack of Efficacy|17|||
105793652|NCT01488071|364900729|FG000|Overall Study|Non-compliance with study drug|2|||
105793653|NCT01488071|364900730|FG001|Overall Study|Non-compliance with study drug|0|||
105793654|NCT01488071|364900729|FG000|Overall Study|Protocol Violation|5|||
105793655|NCT01488071|364900730|FG001|Overall Study|Protocol Violation|7|||
105793656|NCT01488071|364900729|FG000|Overall Study|Withdrawal of Consent|14|||
105793657|NCT01488071|364900730|FG001|Overall Study|Withdrawal of Consent|12|||
105793658|NCT01488071|364900729|FG000|Overall Study|Lost to Follow-up|1|||
105793659|NCT01488071|364900730|FG001|Overall Study|Lost to Follow-up|0|||
105793660|NCT01488071|364900729|FG000|Overall Study|Administrative or Other Reason(s)|5|||
105793661|NCT01488071|364900730|FG001|Overall Study|Administrative or Other Reason(s)|4|||
105352934|NCT02769312|363297018|FG001|Follow-up|Lost to Follow-up|1|||
105793662|NCT03889197|364900731|FG000|Overall Study|Withdrawal by Subject|1|||
105793663|NCT03889197|364900732|FG001|Overall Study|Withdrawal by Subject|0|||
105793664|NCT03889197|364900731|FG000|Overall Study|Physician Decision|0|||
105793665|NCT03889197|364900732|FG001|Overall Study|Physician Decision|1|||
105793666|NCT03889197|364900731|FG000|Overall Study|met exclusion criteria|0|||
105793667|NCT03889197|364900732|FG001|Overall Study|met exclusion criteria|1|||
105793668|NCT03889197|364900731|FG000|Overall Study|Protocol Violation|1|||
105793669|NCT03889197|364900732|FG001|Overall Study|Protocol Violation|0|||
105793670|NCT05899218|364900733|FG000|Overall Study|Lost to Follow-up|2|||
105793671|NCT05899218|364900734|FG001|Overall Study|Lost to Follow-up|2|||
105793672|NCT05899218|364900733|FG000|Overall Study|deemed ineligible out of country|1|||
105793673|NCT05899218|364900734|FG001|Overall Study|deemed ineligible out of country|0|||
105793674|NCT02304302|364900737|FG000|Overall Study|Adverse Event|2|||
105793675|NCT02304302|364900738|FG001|Overall Study|Adverse Event|3|||
105793676|NCT02304302|364900737|FG000|Overall Study|Lost to Follow-up|1|||
105793677|NCT02304302|364900738|FG001|Overall Study|Lost to Follow-up|4|||
105793678|NCT02304302|364900737|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
105793679|NCT02304302|364900738|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
105793680|NCT02392559|364900739|FG000|Overall Study|Withdrawal by Subject|0|||
105793681|NCT02392559|364900740|FG001|Overall Study|Withdrawal by Subject|1|||
105793682|NCT01345058|364900741|FG000|Overall Study|Withdrawal by Subject|1|||
105793683|NCT01345058|364900742|FG001|Overall Study|Withdrawal by Subject|0|||
105793684|NCT01345058|364900741|FG000|Overall Study|Participant Reported Increase in Events|1|||
105793685|NCT01345058|364900742|FG001|Overall Study|Participant Reported Increase in Events|0|||
105793686|NCT01345058|364900741|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
105793687|NCT01345058|364900742|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
105793688|NCT01345058|364900741|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
105793689|NCT01345058|364900742|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
105793690|NCT01345058|364900741|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
105793691|NCT01345058|364900742|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
105793692|NCT01892020|364900744|FG000|Period 1|Adverse Event|1|||
105793693|NCT01892020|364900745|FG001|Period 1|Adverse Event|1|||
105793694|NCT01892020|364900744|FG000|Period 1|Protocol Violation|2|||
105352935|NCT04126317|363297019|FG000|Overall Study|Adverse Event|0|||
105352936|NCT04126317|363297020|FG001|Overall Study|Adverse Event|1|||
105352937|NCT04126317|363297019|FG000|Overall Study|Withdrawal by Subject|4|||
105725316|NCT01686568|364649016|FG001|Main Study|Liver enzymes above range of exclusion|0|||
105725317|NCT01686568|364649015|FG000|Sub-Study|Not consented for sub-study|2|||
105725318|NCT01686568|364649016|FG001|Sub-Study|Not consented for sub-study|2|||
105725319|NCT01071070|364649018|FG000|Overall Study|Adverse Event|0|||
105725320|NCT01071070|364649019|FG001|Overall Study|Adverse Event|3|||
105725321|NCT01071070|364649018|FG000|Overall Study|Withdrawal by Subject|1|||
105725322|NCT01071070|364649019|FG001|Overall Study|Withdrawal by Subject|0|||
105725323|NCT01071070|364649018|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
105725324|NCT01071070|364649019|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
105725325|NCT01071070|364649018|FG000|Overall Study|Hypercalcemia|1|||
105725326|NCT01071070|364649019|FG001|Overall Study|Hypercalcemia|0|||
105725327|NCT00860470|364649020|FG000|Overall Study|Death|6|||
105725328|NCT00860470|364649021|FG001|Overall Study|Death|10|||
105725329|NCT00860470|364649020|FG000|Overall Study|Moved away|8|||
105725330|NCT00860470|364649021|FG001|Overall Study|Moved away|10|||
105725331|NCT00860470|364649020|FG000|Overall Study|Lost to Follow-up|34|||
105725332|NCT00860470|364649021|FG001|Overall Study|Lost to Follow-up|39|||
105725333|NCT02209506|364649035|FG000|Overall Study|Withdrawal by Subject|0|||
105793695|NCT01892020|364900745|FG001|Period 1|Protocol Violation|4|||
105793696|NCT01892020|364900744|FG000|Period 1|Unclassified|0|||
105352938|NCT04126317|363297020|FG001|Overall Study|Withdrawal by Subject|1|||
105793697|NCT01892020|364900745|FG001|Period 1|Unclassified|1|||
105352939|NCT01796301|363297021|FG000|Overall Study|Withdrawal by Subject|15|||
105352940|NCT01796301|363297022|FG001|Overall Study|Withdrawal by Subject|15|||
105352941|NCT01796301|363297021|FG000|Overall Study|Lost to Follow-up|3|||
105352942|NCT01796301|363297022|FG001|Overall Study|Lost to Follow-up|3|||
105352943|NCT01796301|363297021|FG000|Overall Study|Death|0|||
105352944|NCT01796301|363297022|FG001|Overall Study|Death|1|||
105725334|NCT02209506|364649036|FG001|Overall Study|Withdrawal by Subject|0|||
105352945|NCT01796301|363297021|FG000|Overall Study|Decision by Sponsor|0|||
105478561|NCT00647270|363764275|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
105725335|NCT02209506|364649037|FG002|Overall Study|Withdrawal by Subject|0|||
105725336|NCT02209506|364649038|FG003|Overall Study|Withdrawal by Subject|0|||
105725337|NCT02209506|364649039|FG004|Overall Study|Withdrawal by Subject|1|||
105793698|NCT01892020|364900744|FG000|Period 2|Protocol Violation|1|||
105793699|NCT01892020|364900745|FG001|Period 2|Protocol Violation|0|||
105793700|NCT00402779|364900747|FG000|Overall Study|Screen Failure|77|||
105725338|NCT01276288|364649040|FG000|Overall Study|Adverse Event|1|||
105725339|NCT01276288|364649041|FG001|Overall Study|Adverse Event|1|||
105352946|NCT01796301|363297022|FG001|Overall Study|Decision by Sponsor|1|||
105352947|NCT01108237|363297023|FG000|Overall Study|No alignment data|2|||
105352948|NCT01108237|363297024|FG001|Overall Study|No alignment data|15|||
105352949|NCT01108237|363297023|FG000|Overall Study|Did not meet criteria for analysis|7|||
105352950|NCT01108237|363297024|FG001|Overall Study|Did not meet criteria for analysis|0|||
105352951|NCT00694356|363297032|FG000|Overall Study|Adverse Event|1|||
105352952|NCT00694356|363297033|FG001|Overall Study|Adverse Event|0|||
105352953|NCT00694356|363297034|FG002|Overall Study|Adverse Event|0|||
105352954|NCT00694356|363297032|FG000|Overall Study|Progressive Disease|2|||
105352955|NCT00694356|363297033|FG001|Overall Study|Progressive Disease|6|||
105352956|NCT00694356|363297034|FG002|Overall Study|Progressive Disease|6|||
105352957|NCT01090050|363297035|FG000|Overall Study|Lost to Follow-up|0|||
105352958|NCT01090050|363297036|FG001|Overall Study|Lost to Follow-up|1|||
105352959|NCT01090050|363297035|FG000|Overall Study|Lack of Efficacy|1|||
105352960|NCT01090050|363297036|FG001|Overall Study|Lack of Efficacy|5|||
105352961|NCT01090050|363297035|FG000|Overall Study|Physician Decision|0|||
105352962|NCT01090050|363297036|FG001|Overall Study|Physician Decision|1|||
105352963|NCT02232061|363297037|FG000|Overall Study|Administrative problems|1|||
105352964|NCT02232061|363297037|FG000|Overall Study|Withdrawal by Subject|1|||
105352965|NCT00560703|363297038|FG000|Overall Study|Adverse Event|0|||
105725340|NCT01276288|364649042|FG002|Overall Study|Adverse Event|0|||
105725341|NCT01276288|364649043|FG003|Overall Study|Adverse Event|0|||
105725342|NCT01276288|364649040|FG000|Overall Study|not treated|1|||
105725343|NCT01276288|364649041|FG001|Overall Study|not treated|0|||
105725344|NCT01276288|364649042|FG002|Overall Study|not treated|0|||
105725345|NCT01276288|364649043|FG003|Overall Study|not treated|0|||
105725346|NCT04348851|364649044|FG000|Post-Test 1|Withdrawal by Subject|0|||
105725347|NCT04348851|364649045|FG001|Post-Test 1|Withdrawal by Subject|1|||
105725348|NCT04348851|364649046|FG002|Post-Test 1|Withdrawal by Subject|0|||
105725349|NCT04348851|364649047|FG003|Post-Test 1|Withdrawal by Subject|0|||
105725350|NCT04348851|364649044|FG000|Post-Test 1|Lost to Follow-up|0|||
105725351|NCT04348851|364649045|FG001|Post-Test 1|Lost to Follow-up|1|||
105725352|NCT04348851|364649046|FG002|Post-Test 1|Lost to Follow-up|0|||
105725353|NCT04348851|364649047|FG003|Post-Test 1|Lost to Follow-up|0|||
105725354|NCT04348851|364649044|FG000|Post-Test 2|Stroke survivor death|0|||
105725355|NCT04348851|364649045|FG001|Post-Test 2|Stroke survivor death|1|||
105725356|NCT04348851|364649046|FG002|Post-Test 2|Stroke survivor death|0|||
105725357|NCT04348851|364649047|FG003|Post-Test 2|Stroke survivor death|1|||
105725358|NCT01454076|364649048|FG000|Overall Study|Other|2|||
105725359|NCT01454076|364649049|FG001|Overall Study|Other|0|||
105725360|NCT01454076|364649050|FG002|Overall Study|Other|0|||
105725361|NCT01454076|364649051|FG003|Overall Study|Other|1|||
105725362|NCT01454076|364649052|FG004|Overall Study|Other|2|||
105725363|NCT01454076|364649048|FG000|Overall Study|Withdrawal by Subject|3|||
105725364|NCT01454076|364649049|FG001|Overall Study|Withdrawal by Subject|4|||
105725365|NCT01454076|364649050|FG002|Overall Study|Withdrawal by Subject|2|||
105725366|NCT01454076|364649051|FG003|Overall Study|Withdrawal by Subject|1|||
105725367|NCT01454076|364649052|FG004|Overall Study|Withdrawal by Subject|2|||
105725368|NCT01454076|364649048|FG000|Overall Study|Adverse Event|8|||
105725369|NCT01454076|364649049|FG001|Overall Study|Adverse Event|2|||
105725370|NCT01454076|364649050|FG002|Overall Study|Adverse Event|7|||
105725371|NCT01454076|364649051|FG003|Overall Study|Adverse Event|0|||
105725372|NCT01454076|364649052|FG004|Overall Study|Adverse Event|2|||
105725373|NCT02965378|364649053|FG000|Overall Study|Progression|16|||
105725374|NCT02965378|364649054|FG001|Overall Study|Progression|4|||
105725375|NCT02965378|364649053|FG000|Overall Study|Adverse Event|5|||
105725376|NCT02965378|364649054|FG001|Overall Study|Adverse Event|2|||
105725377|NCT02965378|364649053|FG000|Overall Study|Death|2|||
105725378|NCT02965378|364649054|FG001|Overall Study|Death|0|||
105725379|NCT02965378|364649053|FG000|Overall Study|Refusal|2|||
105725380|NCT02965378|364649054|FG001|Overall Study|Refusal|1|||
105725381|NCT02965378|364649053|FG000|Overall Study|Not protocol specified|0|||
105725382|NCT02965378|364649054|FG001|Overall Study|Not protocol specified|2|||
105725383|NCT05292755|364649059|FG000|Overall Study|Lost to Follow-up|5|||
105725384|NCT05292755|364649060|FG001|Overall Study|Lost to Follow-up|9|||
105725385|NCT04525703|364649061|FG000|Overall Study|Lost to Follow-up|6|||
105725386|NCT04525703|364649062|FG001|Overall Study|Lost to Follow-up|15|||
105352966|NCT00560703|363297039|FG001|Overall Study|Adverse Event|2|||
105352967|NCT00560703|363297038|FG000|Overall Study|Protocol Violation|0|||
105352968|NCT00560703|363297039|FG001|Overall Study|Protocol Violation|2|||
105352969|NCT00560703|363297038|FG000|Overall Study|Withdrawal by Subject|0|||
105725387|NCT04525703|364649063|FG002|Overall Study|Lost to Follow-up|8|||
105725388|NCT01478958|364649064|FG000|Overall Study|Withdrawal by Subject|1|||
105725389|NCT01478958|364649065|FG001|Overall Study|Withdrawal by Subject|1|||
105725390|NCT01478958|364649066|FG002|Overall Study|Withdrawal by Subject|1|||
105725391|NCT01478958|364649064|FG000|Overall Study|Weight loss|1|||
105725392|NCT01478958|364649065|FG001|Overall Study|Weight loss|0|||
105352970|NCT00560703|363297039|FG001|Overall Study|Withdrawal by Subject|1|||
105352971|NCT00560703|363297038|FG000|Overall Study|non-compliance|0|||
105725393|NCT01478958|364649066|FG002|Overall Study|Weight loss|0|||
105725394|NCT01478958|364649064|FG000|Overall Study|Re-located|0|||
105725395|NCT01478958|364649065|FG001|Overall Study|Re-located|1|||
105725396|NCT01478958|364649066|FG002|Overall Study|Re-located|0|||
105725397|NCT01478958|364649064|FG000|Overall Study|Unable to comply|0|||
105725398|NCT01478958|364649065|FG001|Overall Study|Unable to comply|0|||
105725399|NCT01478958|364649066|FG002|Overall Study|Unable to comply|2|||
105725400|NCT02909153|364649067|FG000|Overall Study|Withdrawal by Subject|0|||
105725401|NCT02909153|364649068|FG001|Overall Study|Withdrawal by Subject|1|||
105725402|NCT02909153|364649069|FG002|Overall Study|Withdrawal by Subject|0|||
105725403|NCT02909153|364649070|FG003|Overall Study|Withdrawal by Subject|0|||
105725404|NCT02909153|364649071|FG004|Overall Study|Withdrawal by Subject|0|||
105725405|NCT01193686|364649072|FG000|Overall Study|Withdrawal by Subject|4|||
105725406|NCT01193686|364649073|FG001|Overall Study|Withdrawal by Subject|1|||
105725407|NCT01193686|364649072|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
105725408|NCT01193686|364649073|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
105725409|NCT03401749|364649074|FG000|Overall Study|Lost to Follow-up|20|||
105725410|NCT03401749|364649075|FG001|Overall Study|Lost to Follow-up|16|||
105725411|NCT03401749|364649076|FG002|Overall Study|Lost to Follow-up|26|||
105725412|NCT00432809|364649079|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
105725413|NCT00432809|364649080|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
105725414|NCT00432809|364649081|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
105725415|NCT00432809|364649079|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
105725416|NCT00432809|364649080|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
105725417|NCT00432809|364649081|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
105725418|NCT01147809|364649082|FG000|Phase I (168 Days)|Adverse Event|0|||
105725419|NCT01147809|364649083|FG001|Phase I (168 Days)|Adverse Event|0|||
105725420|NCT01147809|364649084|FG002|Phase I (168 Days)|Adverse Event|0|||
105725421|NCT01147809|364649085|FG003|Phase I (168 Days)|Adverse Event|1|||
105725422|NCT01147809|364649086|FG004|Phase I (168 Days)|Adverse Event|0|||
105725423|NCT01147809|364649087|FG005|Phase I (168 Days)|Adverse Event|0|||
105725424|NCT01147809|364649082|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
105725425|NCT01147809|364649083|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
105725426|NCT01147809|364649084|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
105725427|NCT01147809|364649085|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
105725428|NCT01147809|364649086|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
105725429|NCT01147809|364649087|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
105725430|NCT01147809|364649082|FG000|Phase I (168 Days)|Physician Decision|0|||
105725431|NCT01147809|364649083|FG001|Phase I (168 Days)|Physician Decision|1|||
105725432|NCT01147809|364649084|FG002|Phase I (168 Days)|Physician Decision|2|||
105725433|NCT01147809|364649085|FG003|Phase I (168 Days)|Physician Decision|0|||
105725434|NCT01147809|364649086|FG004|Phase I (168 Days)|Physician Decision|0|||
105725435|NCT01147809|364649087|FG005|Phase I (168 Days)|Physician Decision|0|||
105725436|NCT01147809|364649082|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
105725437|NCT01147809|364649083|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
105725438|NCT01147809|364649084|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
105725439|NCT01147809|364649085|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
105725440|NCT01147809|364649086|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
105725441|NCT01147809|364649087|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
105725442|NCT01147809|364649082|FG000|Phase II (168 Days)|Adverse Event|0|||
105725443|NCT01147809|364649083|FG001|Phase II (168 Days)|Adverse Event|0|||
105725444|NCT01147809|364649084|FG002|Phase II (168 Days)|Adverse Event|0|||
105725445|NCT01147809|364649085|FG003|Phase II (168 Days)|Adverse Event|0|||
105725446|NCT01147809|364649086|FG004|Phase II (168 Days)|Adverse Event|3|||
105725447|NCT01147809|364649087|FG005|Phase II (168 Days)|Adverse Event|6|||
105725448|NCT01147809|364649082|FG000|Phase II (168 Days)|Protocol Violation|0|||
105725449|NCT01147809|364649083|FG001|Phase II (168 Days)|Protocol Violation|0|||
105725450|NCT01147809|364649084|FG002|Phase II (168 Days)|Protocol Violation|0|||
105725451|NCT01147809|364649085|FG003|Phase II (168 Days)|Protocol Violation|0|||
105725452|NCT01147809|364649086|FG004|Phase II (168 Days)|Protocol Violation|0|||
105725453|NCT01147809|364649087|FG005|Phase II (168 Days)|Protocol Violation|1|||
105725454|NCT01147809|364649082|FG000|Phase II (168 Days)|Physician Decision|0|||
105725455|NCT01147809|364649083|FG001|Phase II (168 Days)|Physician Decision|0|||
105725456|NCT01147809|364649084|FG002|Phase II (168 Days)|Physician Decision|0|||
105352972|NCT00560703|363297039|FG001|Overall Study|non-compliance|1|||
105352973|NCT00339833|363297040|FG000|Overall Study|Withdrawal by Subject|1|||
105352974|NCT00339833|363297041|FG001|Overall Study|Withdrawal by Subject|2|||
105352975|NCT00339833|363297040|FG000|Overall Study|toothache|0|||
105352976|NCT00339833|363297041|FG001|Overall Study|toothache|1|||
105352977|NCT00339833|363297040|FG000|Overall Study|indigestion|0|||
105352978|NCT00339833|363297041|FG001|Overall Study|indigestion|1|||
105725457|NCT01147809|364649085|FG003|Phase II (168 Days)|Physician Decision|0|||
105725458|NCT01147809|364649086|FG004|Phase II (168 Days)|Physician Decision|5|||
105725459|NCT01147809|364649087|FG005|Phase II (168 Days)|Physician Decision|11|||
105725460|NCT01147809|364649082|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
105725461|NCT01147809|364649083|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
105725462|NCT01147809|364649084|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
105725463|NCT01147809|364649085|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
105725464|NCT01147809|364649086|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
105793701|NCT00402779|364900748|FG001|Overall Study|Screen Failure|76|||
105793702|NCT02508649|364900751|FG000|Overall Study|Withdrawal by Subject|4|||
105793703|NCT02508649|364900752|FG001|Overall Study|Withdrawal by Subject|6|||
105793704|NCT02508649|364900753|FG002|Overall Study|Withdrawal by Subject|5|||
105793705|NCT02508649|364900754|FG003|Overall Study|Withdrawal by Subject|6|||
105793706|NCT02508649|364900751|FG000|Overall Study|Investigator withdrew the subject|1|||
105793707|NCT02508649|364900752|FG001|Overall Study|Investigator withdrew the subject|2|||
105793708|NCT02508649|364900753|FG002|Overall Study|Investigator withdrew the subject|1|||
105793709|NCT02508649|364900754|FG003|Overall Study|Investigator withdrew the subject|0|||
105793710|NCT02508649|364900751|FG000|Overall Study|Post randomization screening failure|12|||
105793711|NCT02508649|364900752|FG001|Overall Study|Post randomization screening failure|4|||
105793712|NCT02508649|364900753|FG002|Overall Study|Post randomization screening failure|9|||
105793713|NCT02508649|364900754|FG003|Overall Study|Post randomization screening failure|3|||
105793714|NCT02508649|364900751|FG000|Overall Study|Lost to Follow-up|1|||
105793715|NCT02508649|364900752|FG001|Overall Study|Lost to Follow-up|1|||
105793716|NCT02508649|364900753|FG002|Overall Study|Lost to Follow-up|0|||
105793717|NCT02508649|364900754|FG003|Overall Study|Lost to Follow-up|1|||
105793718|NCT00567996|364900755|FG000|Overall Study|Adverse Event|18|||
105793719|NCT00567996|364900756|FG001|Overall Study|Adverse Event|16|||
105793720|NCT00567996|364900757|FG002|Overall Study|Adverse Event|13|||
105793721|NCT00567996|364900755|FG000|Overall Study|Protocol Deviation|9|||
105793722|NCT00567996|364900756|FG001|Overall Study|Protocol Deviation|11|||
105793723|NCT00567996|364900757|FG002|Overall Study|Protocol Deviation|13|||
105793724|NCT00567996|364900755|FG000|Overall Study|Withdrawal by Subject|8|||
105793725|NCT00567996|364900756|FG001|Overall Study|Withdrawal by Subject|12|||
105793726|NCT00567996|364900757|FG002|Overall Study|Withdrawal by Subject|22|||
105793727|NCT00567996|364900755|FG000|Overall Study|Abnormal Lab value(s)|2|||
105793728|NCT00567996|364900756|FG001|Overall Study|Abnormal Lab value(s)|1|||
105793729|NCT00567996|364900757|FG002|Overall Study|Abnormal Lab value(s)|2|||
105793730|NCT00567996|364900755|FG000|Overall Study|Abnormal test procedure result(s)|2|||
105793731|NCT00567996|364900756|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105793732|NCT00567996|364900757|FG002|Overall Study|Abnormal test procedure result(s)|1|||
105793733|NCT00567996|364900755|FG000|Overall Study|Lost to Follow-up|2|||
105793734|NCT00567996|364900756|FG001|Overall Study|Lost to Follow-up|5|||
105793735|NCT00567996|364900757|FG002|Overall Study|Lost to Follow-up|2|||
105793736|NCT00567996|364900755|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105793737|NCT00567996|364900756|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105793738|NCT00567996|364900757|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
105793739|NCT00567996|364900755|FG000|Overall Study|Administrative problems|1|||
105793740|NCT00567996|364900756|FG001|Overall Study|Administrative problems|1|||
105793741|NCT00567996|364900757|FG002|Overall Study|Administrative problems|0|||
105793742|NCT00567996|364900755|FG000|Overall Study|Death|1|||
105793743|NCT00567996|364900756|FG001|Overall Study|Death|0|||
105793744|NCT00567996|364900757|FG002|Overall Study|Death|2|||
105793745|NCT00567996|364900755|FG000|Overall Study|Patient's inability to use the device|0|||
105793746|NCT00567996|364900756|FG001|Overall Study|Patient's inability to use the device|1|||
105793747|NCT00567996|364900757|FG002|Overall Study|Patient's inability to use the device|0|||
105793748|NCT03594175|364900758|FG000|Overall Study|Not treated|8|||
105793749|NCT03594175|364900759|FG001|Overall Study|Not treated|1|||
105793750|NCT03594175|364900760|FG002|Overall Study|Not treated|5|||
105793751|NCT03594175|364900758|FG000|Overall Study|Adverse Event|3|||
105793752|NCT03594175|364900759|FG001|Overall Study|Adverse Event|0|||
105793753|NCT03594175|364900760|FG002|Overall Study|Adverse Event|0|||
105793754|NCT03594175|364900758|FG000|Overall Study|Withdrawal by Subject|3|||
105793755|NCT03594175|364900759|FG001|Overall Study|Withdrawal by Subject|0|||
105793756|NCT03594175|364900760|FG002|Overall Study|Withdrawal by Subject|0|||
105793757|NCT03594175|364900758|FG000|Overall Study|Protocol Violation|2|||
105793758|NCT03594175|364900759|FG001|Overall Study|Protocol Violation|2|||
105793759|NCT03594175|364900760|FG002|Overall Study|Protocol Violation|2|||
105793760|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793761|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793762|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793763|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
105793764|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
105793765|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793766|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793767|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793768|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793769|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
105793770|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793771|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105562915|NCT03205371|364057532|FG004|Overall Study|Lost to Follow-up|0|||
105562916|NCT03205371|364057533|FG005|Overall Study|Lost to Follow-up|0|||
105562917|NCT03205371|364057534|FG006|Overall Study|Lost to Follow-up|5|||
105562918|NCT03205371|364057535|FG007|Overall Study|Lost to Follow-up|2|||
105562919|NCT03205371|364057536|FG008|Overall Study|Lost to Follow-up|3|||
105562920|NCT03205371|364057537|FG009|Overall Study|Lost to Follow-up|0|||
105562921|NCT03205371|364057538|FG010|Overall Study|Lost to Follow-up|0|||
105562922|NCT03205371|364057539|FG011|Overall Study|Lost to Follow-up|0|||
105562923|NCT03205371|364057528|FG000|Overall Study|Protocol Violation|0|||
105562924|NCT03205371|364057529|FG001|Overall Study|Protocol Violation|0|||
105562925|NCT03205371|364057530|FG002|Overall Study|Protocol Violation|0|||
105562926|NCT03205371|364057531|FG003|Overall Study|Protocol Violation|0|||
105562927|NCT03205371|364057532|FG004|Overall Study|Protocol Violation|0|||
105725465|NCT01147809|364649087|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
105725466|NCT01147809|364649082|FG000|Phase II (168 Days)|Ongoing|0|||
105562928|NCT03205371|364057533|FG005|Overall Study|Protocol Violation|0|||
105562929|NCT03205371|364057534|FG006|Overall Study|Protocol Violation|1|||
105562930|NCT03205371|364057535|FG007|Overall Study|Protocol Violation|0|||
105562931|NCT03205371|364057536|FG008|Overall Study|Protocol Violation|0|||
105725467|NCT01147809|364649083|FG001|Phase II (168 Days)|Ongoing|0|||
105725468|NCT01147809|364649084|FG002|Phase II (168 Days)|Ongoing|0|||
105725469|NCT01147809|364649085|FG003|Phase II (168 Days)|Ongoing|0|||
105725470|NCT01147809|364649086|FG004|Phase II (168 Days)|Ongoing|1|||
105725471|NCT01147809|364649087|FG005|Phase II (168 Days)|Ongoing|0|||
105725472|NCT03040024|364649088|FG000|Overall Study|Adverse Event|0|||
105725473|NCT03040024|364649089|FG001|Overall Study|Adverse Event|1|||
105725474|NCT03040024|364649090|FG002|Overall Study|Adverse Event|0|||
105725475|NCT03040024|364649088|FG000|Overall Study|Death|0|||
105725476|NCT03040024|364649089|FG001|Overall Study|Death|1|||
105725477|NCT03040024|364649090|FG002|Overall Study|Death|0|||
105725478|NCT03040024|364649088|FG000|Overall Study|Physician Decision|0|||
105725479|NCT03040024|364649089|FG001|Overall Study|Physician Decision|0|||
105725480|NCT03040024|364649090|FG002|Overall Study|Physician Decision|1|||
105725481|NCT01499290|364649091|FG000|Overall Study|Withdrawal by Subject|22|||
105725482|NCT01499290|364649092|FG001|Overall Study|Withdrawal by Subject|15|||
105725483|NCT01499290|364649091|FG000|Overall Study|Not specified in study report|11|||
105725484|NCT01499290|364649092|FG001|Overall Study|Not specified in study report|5|||
105725485|NCT01499290|364649091|FG000|Overall Study|Condition improved/subject recovered|1|||
105725486|NCT01499290|364649092|FG001|Overall Study|Condition improved/subject recovered|0|||
105725487|NCT01499290|364649091|FG000|Overall Study|Lack of Efficacy|7|||
105725488|NCT01499290|364649092|FG001|Overall Study|Lack of Efficacy|8|||
105725489|NCT01499290|364649091|FG000|Overall Study|Adverse Event|14|||
105725490|NCT01499290|364649092|FG001|Overall Study|Adverse Event|7|||
105725491|NCT04433117|364649093|FG000|Overall Study|Withdrawal by Subject|1|||
105725492|NCT04433117|364649094|FG001|Overall Study|Withdrawal by Subject|0|||
105725493|NCT01051739|364649095|FG000|Overall Study|Death|3|||
105725494|NCT01051739|364649096|FG001|Overall Study|Death|3|||
105725495|NCT01051739|364649095|FG000|Overall Study|Withdrawal by Subject|25|||
105725496|NCT01051739|364649096|FG001|Overall Study|Withdrawal by Subject|10|||
105725497|NCT01967225|364649098|FG000|Overall Study|Adverse Event|3|||
105725498|NCT01967225|364649099|FG001|Overall Study|Adverse Event|1|||
105725499|NCT01967225|364649098|FG000|Overall Study|Withdrawal by Subject|2|||
105725500|NCT01967225|364649099|FG001|Overall Study|Withdrawal by Subject|1|||
105725501|NCT01967225|364649098|FG000|Overall Study|Lack of Efficacy|1|||
105725502|NCT01967225|364649099|FG001|Overall Study|Lack of Efficacy|1|||
105725503|NCT01967225|364649098|FG000|Overall Study|Switching to other therapy|2|||
105725504|NCT01967225|364649099|FG001|Overall Study|Switching to other therapy|0|||
105725505|NCT01967225|364649098|FG000|Overall Study|Protocol driven decision point|1|||
105725506|NCT01967225|364649099|FG001|Overall Study|Protocol driven decision point|0|||
105725507|NCT01967225|364649098|FG000|Overall Study|Logistical difficulties|1|||
105725508|NCT01967225|364649099|FG001|Overall Study|Logistical difficulties|0|||
105725509|NCT01967225|364649098|FG000|Overall Study|Protocol Violation|2|||
105725510|NCT01967225|364649099|FG001|Overall Study|Protocol Violation|0|||
105725511|NCT02209766|364649100|FG000|Overall Study|Withdrawal by Subject|0|||
105725512|NCT02209766|364649101|FG001|Overall Study|Withdrawal by Subject|0|||
105725513|NCT02209766|364649102|FG002|Overall Study|Withdrawal by Subject|0|||
105725514|NCT02209766|364649103|FG003|Overall Study|Withdrawal by Subject|1|||
105725515|NCT02209766|364649104|FG004|Overall Study|Withdrawal by Subject|0|||
105725516|NCT02700451|364649105|FG000|Overall Study|Protocol Violation|2|||
105725517|NCT02700451|364649106|FG001|Overall Study|Protocol Violation|2|||
105725518|NCT02700451|364649107|FG002|Overall Study|Protocol Violation|3|||
105725519|NCT02700451|364649105|FG000|Overall Study|Discontinued intervention|14|||
105725520|NCT02700451|364649106|FG001|Overall Study|Discontinued intervention|15|||
105725521|NCT02700451|364649107|FG002|Overall Study|Discontinued intervention|14|||
105725522|NCT02272790|364649110|FG000|Overall Study|Physician Decision|0|||
105725523|NCT02272790|364649111|FG001|Overall Study|Physician Decision|1|||
105725524|NCT02272790|364649112|FG002|Overall Study|Physician Decision|0|||
105725525|NCT02272790|364649113|FG003|Overall Study|Physician Decision|0|||
105725526|NCT02272790|364649114|FG004|Overall Study|Physician Decision|0|||
105725527|NCT02272790|364649115|FG005|Overall Study|Physician Decision|0|||
105725528|NCT01926626|364649118|FG000|Overall Study|Withdrawal by Subject|15|||
105725529|NCT01926626|364649118|FG000|Overall Study|Lost to Follow-up|7|||
105725530|NCT01587989|364649125|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
105725531|NCT01587989|364649126|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
105725532|NCT01587989|364649127|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
105725533|NCT01587989|364649125|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
105725534|NCT01587989|364649126|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
105725535|NCT01587989|364649127|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
105725536|NCT01587989|364649125|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
105725537|NCT01587989|364649126|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
105725538|NCT01587989|364649127|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
105725539|NCT01587989|364649125|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
105725540|NCT01587989|364649126|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
105725541|NCT01587989|364649127|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
105725542|NCT01587989|364649125|FG000|Randomized Study Treatment|Screening failure|0|||
105725543|NCT01587989|364649126|FG001|Randomized Study Treatment|Screening failure|1|||
105725544|NCT01587989|364649127|FG002|Randomized Study Treatment|Screening failure|0|||
105725545|NCT01587989|364649125|FG000|Randomized Study Treatment|Physician Decision|0|||
105725546|NCT01587989|364649126|FG001|Randomized Study Treatment|Physician Decision|0|||
105725547|NCT01587989|364649127|FG002|Randomized Study Treatment|Physician Decision|1|||
105725548|NCT03665038|364649131|FG000|Overall Study|Lost to Follow-up|0|||
105725549|NCT03665038|364649132|FG001|Overall Study|Lost to Follow-up|0|||
105725550|NCT03665038|364649133|FG002|Overall Study|Lost to Follow-up|1|||
105725551|NCT03946449|364649138|FG000|Treatment Extension II|Rolled over to another study|0|||
105725552|NCT03946449|364649139|FG001|Treatment Extension II|Rolled over to another study|0|||
105725553|NCT03946449|364649140|FG002|Treatment Extension II|Rolled over to another study|2|||
105725554|NCT03946449|364649138|FG000|Treatment Extension II|Withdrawal by Subject|0|||
105725555|NCT03946449|364649139|FG001|Treatment Extension II|Withdrawal by Subject|0|||
105725556|NCT03946449|364649140|FG002|Treatment Extension II|Withdrawal by Subject|1|||
105725557|NCT02581995|364649141|FG000|Overall Study|Unspecified other|3|||
105725558|NCT02581995|364649141|FG000|Overall Study|Adverse Event|6|||
105725559|NCT02581995|364649141|FG000|Overall Study|Lost to Follow-up|5|||
105725560|NCT02581995|364649141|FG000|Overall Study|Withdrawal by participant|12|||
105725561|NCT02581995|364649141|FG000|Overall Study|Physician Decision|1|||
105725562|NCT02581995|364649141|FG000|Overall Study|Death|4|||
105725563|NCT03896581|364650393|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
105725564|NCT03896581|364650394|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
105725565|NCT03896581|364650393|FG000|Overall Study|Withdrawal by Subject|4|||
105725566|NCT03896581|364650394|FG001|Overall Study|Withdrawal by Subject|1|||
105725567|NCT03896581|364650393|FG000|Overall Study|Lost to Follow-up|1|||
105725568|NCT03896581|364650394|FG001|Overall Study|Lost to Follow-up|0|||
105725569|NCT03896581|364650393|FG000|Overall Study|Lack of Efficacy|2|||
105725570|NCT03896581|364650394|FG001|Overall Study|Lack of Efficacy|1|||
105725571|NCT03896581|364650393|FG000|Overall Study|Adverse event, non-fatal|0|||
105725572|NCT03896581|364650394|FG001|Overall Study|Adverse event, non-fatal|2|||
105725573|NCT03219164|364650395|FG000|Overall Study|Study Terminated by Sponsor|16|||
105725574|NCT03219164|364650396|FG001|Overall Study|Study Terminated by Sponsor|12|||
105725575|NCT03219164|364650395|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
105725576|NCT03219164|364650396|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
105725577|NCT03219164|364650395|FG000|Overall Study|Lost to Follow-up|1|||
105725578|NCT03219164|364650396|FG001|Overall Study|Lost to Follow-up|1|||
105725579|NCT03219164|364650395|FG000|Overall Study|Adverse Event|1|||
105725580|NCT03219164|364650396|FG001|Overall Study|Adverse Event|0|||
105725581|NCT03219164|364650395|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105725582|NCT03219164|364650396|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105725583|NCT03219164|364650395|FG000|Overall Study|Protocol Violation|0|||
105725584|NCT03219164|364650396|FG001|Overall Study|Protocol Violation|1|||
105725585|NCT03219164|364650395|FG000|Overall Study|Withdrew Assent|1|||
105725586|NCT03219164|364650396|FG001|Overall Study|Withdrew Assent|0|||
105725587|NCT00522392|364650400|FG000|Overall Study|Disease progression|0|||
105725588|NCT00522392|364650401|FG001|Overall Study|Disease progression|3|||
105725589|NCT00522392|364650400|FG000|Overall Study|Adverse Event|7|||
105725590|NCT00522392|364650401|FG001|Overall Study|Adverse Event|7|||
105725591|NCT00522392|364650400|FG000|Overall Study|Withdrawal by Subject|1|||
105725592|NCT00522392|364650401|FG001|Overall Study|Withdrawal by Subject|1|||
105725593|NCT00522392|364650400|FG000|Overall Study|Physician Decision|0|||
105725594|NCT00522392|364650401|FG001|Overall Study|Physician Decision|1|||
105725595|NCT00522392|364650400|FG000|Overall Study|Non-compliance|0|||
105725596|NCT00522392|364650401|FG001|Overall Study|Non-compliance|1|||
105725597|NCT02292849|364650404|FG000|Overall Study|Lost to Follow-up|0|||
105725598|NCT02292849|364650405|FG001|Overall Study|Lost to Follow-up|2|||
105725599|NCT02292849|364650406|FG002|Overall Study|Lost to Follow-up|2|||
105725600|NCT02292849|364650404|FG000|Overall Study|Physician Decision|4|||
105725601|NCT02292849|364650405|FG001|Overall Study|Physician Decision|0|||
105725602|NCT02292849|364650406|FG002|Overall Study|Physician Decision|0|||
105725603|NCT04938648|364650407|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
105725604|NCT04938648|364650408|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
105725605|NCT04938648|364650407|FG000|Overall Study|Patient too ill|0|||
105725606|NCT04938648|364650408|FG001|Overall Study|Patient too ill|1|||
105725607|NCT04938648|364650407|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
105725608|NCT04938648|364650408|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
105725609|NCT04938648|364650407|FG000|Overall Study|Patient did not have memory problems|1|||
105725610|NCT04938648|364650408|FG001|Overall Study|Patient did not have memory problems|1|||
105725611|NCT04938648|364650407|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
105725612|NCT04938648|364650408|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
105725613|NCT04938648|364650407|FG000|Overall Study|Care partner could not be reached|0|||
105725614|NCT04938648|364650408|FG001|Overall Study|Care partner could not be reached|1|||
105725615|NCT04938648|364650407|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
105725616|NCT04938648|364650408|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
105725617|NCT04938648|364650407|FG000|Overall Study|Withdrawal by Subject|2|||
105725618|NCT04938648|364650408|FG001|Overall Study|Withdrawal by Subject|1|||
105725619|NCT01287754|364650411|FG000|Overall Study|Death|2|||
105725620|NCT01287754|364650412|FG001|Overall Study|Death|12|||
105725621|NCT01287754|364650411|FG000|Overall Study|Lost to Follow-up|1|||
105725622|NCT01287754|364650412|FG001|Overall Study|Lost to Follow-up|6|||
105725623|NCT01287754|364650411|FG000|Overall Study|Protocol Violation|0|||
105725624|NCT01287754|364650412|FG001|Overall Study|Protocol Violation|3|||
105725625|NCT02362035|364650413|FG000|Overall Study|Death|67|||
105725626|NCT02362035|364650413|FG000|Overall Study|Lost to Follow-up|3|||
105725627|NCT02362035|364650413|FG000|Overall Study|Adverse Event|1|||
105725628|NCT02362035|364650413|FG000|Overall Study|Physician Decision|1|||
105725629|NCT02362035|364650413|FG000|Overall Study|Subject started another cancer therapy|10|||
105725630|NCT02362035|364650413|FG000|Overall Study|Study terminated by sponsor|45|||
105725631|NCT02362035|364650413|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
105725632|NCT02362035|364650413|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
105793772|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
105793773|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
105793774|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
105793775|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
105562932|NCT03205371|364057537|FG009|Overall Study|Protocol Violation|0|||
105562933|NCT03205371|364057538|FG010|Overall Study|Protocol Violation|0|||
105562934|NCT03205371|364057539|FG011|Overall Study|Protocol Violation|0|||
105562935|NCT03205371|364057528|FG000|Overall Study|Adverse Event|0|||
105562936|NCT03205371|364057529|FG001|Overall Study|Adverse Event|0|||
105562937|NCT03205371|364057530|FG002|Overall Study|Adverse Event|0|||
105562938|NCT03205371|364057531|FG003|Overall Study|Adverse Event|0|||
105562939|NCT03205371|364057532|FG004|Overall Study|Adverse Event|0|||
105562940|NCT03205371|364057533|FG005|Overall Study|Adverse Event|0|||
105562941|NCT03205371|364057534|FG006|Overall Study|Adverse Event|0|||
105562942|NCT03205371|364057535|FG007|Overall Study|Adverse Event|1|||
105562943|NCT03205371|364057536|FG008|Overall Study|Adverse Event|0|||
105562944|NCT03205371|364057537|FG009|Overall Study|Adverse Event|0|||
105562945|NCT03205371|364057538|FG010|Overall Study|Adverse Event|0|||
105562946|NCT03205371|364057539|FG011|Overall Study|Adverse Event|0|||
105562947|NCT03172702|364057542|FG000|Overall Study|Adverse Event|9|||
105562948|NCT03172702|364057542|FG000|Overall Study|Death|2|||
105562949|NCT03172702|364057542|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
105562950|NCT03172702|364057542|FG000|Overall Study|Withdrawal by Subject|5|||
105562951|NCT03172702|364057542|FG000|Overall Study|Other|2|||
105562952|NCT02954354|364057543|FG000|Overall Study|Adverse Event|2|||
105562953|NCT02954354|364057544|FG001|Overall Study|Adverse Event|2|||
105562954|NCT02954354|364057545|FG002|Overall Study|Adverse Event|4|||
105562955|NCT02954354|364057543|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
105562956|NCT02954354|364057544|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
105562957|NCT02954354|364057545|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
105562958|NCT02954354|364057543|FG000|Overall Study|Lack of Efficacy|0|||
105562959|NCT02954354|364057544|FG001|Overall Study|Lack of Efficacy|2|||
105562960|NCT02954354|364057545|FG002|Overall Study|Lack of Efficacy|0|||
105562961|NCT02954354|364057543|FG000|Overall Study|Withdrawal by Subject|17|||
105562962|NCT02954354|364057544|FG001|Overall Study|Withdrawal by Subject|9|||
105562963|NCT02954354|364057545|FG002|Overall Study|Withdrawal by Subject|11|||
105562964|NCT02954354|364057543|FG000|Overall Study|Lost to Follow-up|12|||
105725633|NCT02362035|364650413|FG000|Overall Study|Disease progression|11|||
105725634|NCT02362035|364650413|FG000|Overall Study|Withdrawal by Subject|20|||
105725635|NCT05040971|364650420|FG000|Overall Study|Withdrawal by Subject|0|||
105725636|NCT05040971|364650421|FG001|Overall Study|Withdrawal by Subject|2|||
105725637|NCT05040971|364650420|FG000|Overall Study|Lost to Follow-up|8|||
105725638|NCT05040971|364650421|FG001|Overall Study|Lost to Follow-up|3|||
105725639|NCT05040971|364650420|FG000|Overall Study|Death|2|||
105562965|NCT02954354|364057544|FG001|Overall Study|Lost to Follow-up|5|||
105562966|NCT02954354|364057545|FG002|Overall Study|Lost to Follow-up|0|||
105562967|NCT02954354|364057543|FG000|Overall Study|Miscellaneous|2|||
105562968|NCT02954354|364057544|FG001|Overall Study|Miscellaneous|2|||
105562969|NCT02954354|364057545|FG002|Overall Study|Miscellaneous|1|||
105562970|NCT00771810|364057546|FG000|Overall Study|Adverse Event|3|||
105562971|NCT00771810|364057547|FG001|Overall Study|Adverse Event|0|||
105562972|NCT00771810|364057548|FG002|Overall Study|Adverse Event|2|||
105725640|NCT05040971|364650421|FG001|Overall Study|Death|0|||
105725641|NCT02601950|364650422|FG000|Overall Study|Participant enrolled in rollover study|0|||
105725642|NCT02601950|364650423|FG001|Overall Study|Participant enrolled in rollover study|0|||
105725643|NCT02601950|364650424|FG002|Overall Study|Participant enrolled in rollover study|1|||
105725644|NCT02601950|364650425|FG003|Overall Study|Participant enrolled in rollover study|0|||
105725645|NCT02601950|364650426|FG004|Overall Study|Participant enrolled in rollover study|1|||
105725646|NCT02601950|364650427|FG005|Overall Study|Participant enrolled in rollover study|1|||
105725647|NCT02601950|364650428|FG006|Overall Study|Participant enrolled in rollover study|1|||
105725648|NCT02601950|364650429|FG007|Overall Study|Participant enrolled in rollover study|0|||
105725649|NCT02601950|364650422|FG000|Overall Study|Disease progression - radiological|21|||
105725650|NCT02601950|364650423|FG001|Overall Study|Disease progression - radiological|26|||
105725651|NCT02601950|364650424|FG002|Overall Study|Disease progression - radiological|22|||
105725652|NCT02601950|364650425|FG003|Overall Study|Disease progression - radiological|11|||
105725653|NCT02601950|364650426|FG004|Overall Study|Disease progression - radiological|46|||
105725654|NCT02601950|364650427|FG005|Overall Study|Disease progression - radiological|52|||
105725655|NCT02601950|364650428|FG006|Overall Study|Disease progression - radiological|7|||
105725656|NCT02601950|364650429|FG007|Overall Study|Disease progression - radiological|5|||
105725657|NCT02601950|364650422|FG000|Overall Study|Disease progression - clinical|3|||
105725658|NCT02601950|364650423|FG001|Overall Study|Disease progression - clinical|5|||
105725659|NCT02601950|364650424|FG002|Overall Study|Disease progression - clinical|4|||
105725660|NCT02601950|364650425|FG003|Overall Study|Disease progression - clinical|2|||
105725661|NCT02601950|364650426|FG004|Overall Study|Disease progression - clinical|6|||
105725662|NCT02601950|364650427|FG005|Overall Study|Disease progression - clinical|6|||
105725663|NCT02601950|364650428|FG006|Overall Study|Disease progression - clinical|5|||
105725664|NCT02601950|364650429|FG007|Overall Study|Disease progression - clinical|1|||
105725665|NCT02601950|364650422|FG000|Overall Study|Death|6|||
105352979|NCT00339833|363297040|FG000|Overall Study|Chest pain|0|||
105352980|NCT00339833|363297041|FG001|Overall Study|Chest pain|1|||
105352981|NCT00339833|363297040|FG000|Overall Study|minor infection|0|||
105352982|NCT00339833|363297041|FG001|Overall Study|minor infection|1|||
105352983|NCT00339833|363297040|FG000|Overall Study|Poor venous access|2|||
105352984|NCT00339833|363297041|FG001|Overall Study|Poor venous access|2|||
105352985|NCT00339833|363297040|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
105352986|NCT00339833|363297041|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
105352987|NCT00339833|363297040|FG000|Overall Study|Error in data records|1|||
105352988|NCT00339833|363297041|FG001|Overall Study|Error in data records|0|||
105352989|NCT03484403|363297042|FG000|Overall Study|Withdrawal by Subject|6|||
105352990|NCT03484403|363297043|FG001|Overall Study|Withdrawal by Subject|4|||
105352991|NCT02131636|363297044|FG000|Overall Study|Personal Reasons|4|||
105352992|NCT02131636|363297045|FG001|Overall Study|Personal Reasons|4|||
105352993|NCT02131636|363297044|FG000|Overall Study|Lost to Follow-up|4|||
105352994|NCT02131636|363297045|FG001|Overall Study|Lost to Follow-up|0|||
105352995|NCT02131636|363297044|FG000|Overall Study|Adverse Event|4|||
105352996|NCT02131636|363297045|FG001|Overall Study|Adverse Event|1|||
105352997|NCT03836209|363297046|FG000|Overall Study|Adverse Event|5|||
105352998|NCT03836209|363297047|FG001|Overall Study|Adverse Event|2|||
105352999|NCT03836209|363297046|FG000|Overall Study|Death|4|||
105353000|NCT03836209|363297047|FG001|Overall Study|Death|1|||
105353001|NCT03836209|363297046|FG000|Overall Study|Lack of Efficacy|7|||
105353002|NCT03836209|363297047|FG001|Overall Study|Lack of Efficacy|10|||
105353003|NCT03836209|363297046|FG000|Overall Study|Physician Decision|7|||
105353004|NCT03836209|363297047|FG001|Overall Study|Physician Decision|11|||
105353005|NCT03836209|363297046|FG000|Overall Study|Protocol Violation|0|||
105353006|NCT03836209|363297047|FG001|Overall Study|Protocol Violation|3|||
105353007|NCT03836209|363297046|FG000|Overall Study|Withdrawal by Subject|2|||
105353008|NCT03836209|363297047|FG001|Overall Study|Withdrawal by Subject|10|||
105725666|NCT02601950|364650423|FG001|Overall Study|Death|0|||
105725667|NCT02601950|364650424|FG002|Overall Study|Death|3|||
105725668|NCT02601950|364650425|FG003|Overall Study|Death|1|||
105725669|NCT02601950|364650426|FG004|Overall Study|Death|4|||
105725670|NCT02601950|364650427|FG005|Overall Study|Death|1|||
105725671|NCT02601950|364650428|FG006|Overall Study|Death|0|||
105725672|NCT02601950|364650429|FG007|Overall Study|Death|0|||
105353009|NCT03836209|363297046|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
105725673|NCT02601950|364650422|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
105725674|NCT02601950|364650423|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
105725675|NCT02601950|364650424|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
105725676|NCT02601950|364650425|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
105725677|NCT02601950|364650426|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
105725678|NCT02601950|364650427|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
105353010|NCT03836209|363297047|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
105353011|NCT01753115|363297048|FG000|Overall Study|Lost to Follow-up|3|||
105725679|NCT02601950|364650428|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
105725680|NCT02601950|364650429|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
105725681|NCT02601950|364650422|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
105725682|NCT02601950|364650423|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
105725683|NCT02601950|364650424|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
105725684|NCT02601950|364650425|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
105725685|NCT02601950|364650426|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
105725686|NCT02601950|364650427|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
105725687|NCT02601950|364650428|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
105353012|NCT01753115|363297049|FG001|Overall Study|Lost to Follow-up|6|||
105353013|NCT01753115|363297050|FG002|Overall Study|Lost to Follow-up|8|||
105353014|NCT01753115|363297048|FG000|Overall Study|Withdrawal by Subject|6|||
105353015|NCT01753115|363297049|FG001|Overall Study|Withdrawal by Subject|5|||
105353016|NCT01753115|363297050|FG002|Overall Study|Withdrawal by Subject|6|||
105353017|NCT01753115|363297048|FG000|Overall Study|Subject non-compliant|3|||
105353018|NCT01753115|363297049|FG001|Overall Study|Subject non-compliant|3|||
105353019|NCT01753115|363297050|FG002|Overall Study|Subject non-compliant|0|||
105353020|NCT01753115|363297048|FG000|Overall Study|Used excluded drug|0|||
105353021|NCT01753115|363297049|FG001|Overall Study|Used excluded drug|1|||
105353022|NCT01753115|363297050|FG002|Overall Study|Used excluded drug|0|||
105353023|NCT00631163|363297051|FG000|Number of Participants in Year 1|Adverse Event|12|||
105353024|NCT00631163|363297051|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
105353025|NCT00631163|363297051|FG000|Number of Participants in Year 1|Death|6|||
105353026|NCT00631163|363297051|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
105353027|NCT00631163|363297051|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
105353028|NCT00631163|363297051|FG000|Number of Participants in Year 1|Administrative problems|6|||
105353029|NCT00631163|363297051|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
105353030|NCT00631163|363297051|FG000|Number of Participants in Year 2|Adverse Event|1|||
105353031|NCT00631163|363297051|FG000|Number of Participants in Year 2|Protocol Violation|1|||
105353032|NCT00631163|363297051|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
105353033|NCT02714036|363297052|FG000|Overall Study|Adverse Event|9|||
105353034|NCT02714036|363297053|FG001|Overall Study|Adverse Event|2|||
105353035|NCT02714036|363297052|FG000|Overall Study|Withdrawal by Subject|3|||
105353036|NCT02714036|363297053|FG001|Overall Study|Withdrawal by Subject|2|||
105353037|NCT02290925|363297054|FG000|First Period of Three Months|Lost to Follow-up|2|||
105353038|NCT02290925|363297055|FG001|First Period of Three Months|Lost to Follow-up|1|||
105353039|NCT02290925|363297054|FG000|First Period of Three Months|Death|1|||
105353040|NCT02290925|363297055|FG001|First Period of Three Months|Death|0|||
105353041|NCT02290925|363297054|FG000|First Period of Three Months|Insulin Started|1|||
105353042|NCT02290925|363297055|FG001|First Period of Three Months|Insulin Started|1|||
105353043|NCT02290925|363297054|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
105353044|NCT02290925|363297055|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
105353045|NCT02290925|363297054|FG000|Second Period of 3 Months|insulin started|0|||
105353046|NCT02290925|363297055|FG001|Second Period of 3 Months|insulin started|1|||
105353047|NCT00624832|363297056|FG000|Overall Study|Adverse Event|0|||
105725688|NCT02601950|364650429|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
105725689|NCT02601950|364650422|FG000|Overall Study|Non-compliance|0|||
105725690|NCT02601950|364650423|FG001|Overall Study|Non-compliance|1|||
105725691|NCT02601950|364650424|FG002|Overall Study|Non-compliance|0|||
105725692|NCT02601950|364650425|FG003|Overall Study|Non-compliance|0|||
105725693|NCT02601950|364650426|FG004|Overall Study|Non-compliance|0|||
105725694|NCT02601950|364650427|FG005|Overall Study|Non-compliance|1|||
105725695|NCT02601950|364650428|FG006|Overall Study|Non-compliance|1|||
105725696|NCT02601950|364650429|FG007|Overall Study|Non-compliance|0|||
105725697|NCT02601950|364650422|FG000|Overall Study|Participant refused further study treatment|0|||
105725698|NCT02601950|364650423|FG001|Overall Study|Participant refused further study treatment|1|||
105725699|NCT02601950|364650424|FG002|Overall Study|Participant refused further study treatment|1|||
105725700|NCT02601950|364650425|FG003|Overall Study|Participant refused further study treatment|0|||
105725701|NCT02601950|364650426|FG004|Overall Study|Participant refused further study treatment|2|||
105725702|NCT02601950|364650427|FG005|Overall Study|Participant refused further study treatment|2|||
105725703|NCT02601950|364650428|FG006|Overall Study|Participant refused further study treatment|2|||
105725704|NCT02601950|364650429|FG007|Overall Study|Participant refused further study treatment|1|||
105725705|NCT02601950|364650422|FG000|Overall Study|Investigator discretion|1|||
105725706|NCT02601950|364650423|FG001|Overall Study|Investigator discretion|0|||
105725707|NCT02601950|364650424|FG002|Overall Study|Investigator discretion|1|||
105353048|NCT00624832|363297057|FG001|Overall Study|Adverse Event|1|||
105353049|NCT00624832|363297058|FG002|Overall Study|Adverse Event|0|||
105353050|NCT00624832|363297059|FG003|Overall Study|Adverse Event|1|||
105353051|NCT00624832|363297056|FG000|Overall Study|Abnormal Laboratory Value|2|||
105725708|NCT02601950|364650425|FG003|Overall Study|Investigator discretion|0|||
105725709|NCT02601950|364650426|FG004|Overall Study|Investigator discretion|1|||
105793776|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
105353052|NCT00624832|363297057|FG001|Overall Study|Abnormal Laboratory Value|0|||
105353053|NCT00624832|363297058|FG002|Overall Study|Abnormal Laboratory Value|0|||
105353054|NCT00624832|363297059|FG003|Overall Study|Abnormal Laboratory Value|0|||
105353055|NCT03624569|363297061|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
105353056|NCT03624569|363297062|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
105353057|NCT03624569|363297061|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
105353058|NCT03624569|363297062|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
105353059|NCT01557517|363297063|FG000|Overall Study|Death|1|||
105353060|NCT01557517|363297064|FG001|Overall Study|Death|0|||
105353061|NCT01557517|363297063|FG000|Overall Study|Refused further treatment|0|||
105353062|NCT01557517|363297064|FG001|Overall Study|Refused further treatment|2|||
105353063|NCT01557517|363297063|FG000|Overall Study|Adverse Event|0|||
105353064|NCT01557517|363297064|FG001|Overall Study|Adverse Event|2|||
105353065|NCT01557517|363297063|FG000|Overall Study|Pt declined before treatment started|1|||
105353066|NCT01557517|363297064|FG001|Overall Study|Pt declined before treatment started|0|||
105353067|NCT01204918|363297071|FG000|Overall Study|Withdrawal by Subject|4|||
105353068|NCT01204918|363297072|FG001|Overall Study|Withdrawal by Subject|10|||
105353069|NCT01204918|363297073|FG002|Overall Study|Withdrawal by Subject|5|||
105353070|NCT03004924|363297076|FG000|Overall Study|Adverse Event|6|||
105353071|NCT03004924|363297077|FG001|Overall Study|Adverse Event|5|||
105353072|NCT03004924|363297078|FG002|Overall Study|Adverse Event|10|||
105353073|NCT03004924|363297076|FG000|Overall Study|Protocol Violation|4|||
105353074|NCT03004924|363297077|FG001|Overall Study|Protocol Violation|0|||
105353075|NCT03004924|363297078|FG002|Overall Study|Protocol Violation|1|||
105353076|NCT03004924|363297076|FG000|Overall Study|Withdrawal by Subject|5|||
105353077|NCT03004924|363297077|FG001|Overall Study|Withdrawal by Subject|3|||
105353078|NCT03004924|363297078|FG002|Overall Study|Withdrawal by Subject|5|||
105353079|NCT03004924|363297076|FG000|Overall Study|Lost to Follow-up|6|||
105353080|NCT03004924|363297077|FG001|Overall Study|Lost to Follow-up|1|||
105353081|NCT03004924|363297078|FG002|Overall Study|Lost to Follow-up|4|||
105353082|NCT03004924|363297076|FG000|Overall Study|Lack of Efficacy|2|||
105353083|NCT03004924|363297077|FG001|Overall Study|Lack of Efficacy|4|||
105353084|NCT03004924|363297078|FG002|Overall Study|Lack of Efficacy|2|||
105353085|NCT03004924|363297076|FG000|Overall Study|Physician Decision|1|||
105353086|NCT03004924|363297077|FG001|Overall Study|Physician Decision|0|||
105353087|NCT03004924|363297078|FG002|Overall Study|Physician Decision|1|||
105353088|NCT03004924|363297076|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105353089|NCT03004924|363297077|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105353090|NCT03004924|363297078|FG002|Overall Study|Withdrawal by parent/guardian|2|||
105353091|NCT03004924|363297076|FG000|Overall Study|Screen Failure|1|||
105353092|NCT03004924|363297077|FG001|Overall Study|Screen Failure|0|||
105353093|NCT03004924|363297078|FG002|Overall Study|Screen Failure|0|||
105353094|NCT03004924|363297076|FG000|Overall Study|Pregnancy|0|||
105353095|NCT03004924|363297077|FG001|Overall Study|Pregnancy|1|||
105353096|NCT03004924|363297078|FG002|Overall Study|Pregnancy|0|||
105353097|NCT03004924|363297076|FG000|Overall Study|Terminated by Sponsor|0|||
105353098|NCT03004924|363297077|FG001|Overall Study|Terminated by Sponsor|0|||
105353099|NCT03004924|363297078|FG002|Overall Study|Terminated by Sponsor|1|||
105353100|NCT03004924|363297076|FG000|Overall Study|Missed Study Visit|0|||
105353101|NCT03004924|363297077|FG001|Overall Study|Missed Study Visit|0|||
105353102|NCT03004924|363297078|FG002|Overall Study|Missed Study Visit|2|||
105353103|NCT03004924|363297076|FG000|Overall Study|HSV1 Positive|1|||
105353104|NCT03004924|363297077|FG001|Overall Study|HSV1 Positive|0|||
105353105|NCT03004924|363297078|FG002|Overall Study|HSV1 Positive|0|||
105725710|NCT02601950|364650427|FG005|Overall Study|Investigator discretion|1|||
105725711|NCT02601950|364650428|FG006|Overall Study|Investigator discretion|1|||
105725712|NCT02601950|364650429|FG007|Overall Study|Investigator discretion|0|||
105725713|NCT02601950|364650422|FG000|Overall Study|Other|0|||
105725714|NCT02601950|364650423|FG001|Overall Study|Other|0|||
105478562|NCT00647270|363764276|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
105478563|NCT00647270|363764277|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
105725715|NCT02601950|364650424|FG002|Overall Study|Other|0|||
105353106|NCT00438256|363297079|FG000|Overall Study|Ineligible for Resection|2|||
105478564|NCT00647270|363764275|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
105478565|NCT00647270|363764276|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
105478566|NCT00647270|363764277|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
105725716|NCT02601950|364650425|FG003|Overall Study|Other|0|||
105725717|NCT02601950|364650426|FG004|Overall Study|Other|2|||
105725718|NCT02601950|364650427|FG005|Overall Study|Other|2|||
105353107|NCT00438256|363297080|FG001|Overall Study|Ineligible for Resection|1|||
105353108|NCT00438256|363297081|FG002|Overall Study|Ineligible for Resection|1|||
105353109|NCT00438256|363297082|FG003|Overall Study|Ineligible for Resection|7|||
105353110|NCT00438256|363297079|FG000|Overall Study|Excluded final Diagnosis|0|||
105353111|NCT00438256|363297080|FG001|Overall Study|Excluded final Diagnosis|0|||
105725719|NCT02601950|364650428|FG006|Overall Study|Other|1|||
105725720|NCT02601950|364650429|FG007|Overall Study|Other|0|||
105793777|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
105725721|NCT05817045|364650430|FG000|Overall Study|Protocol Violation|0|||
105725722|NCT05817045|364650431|FG001|Overall Study|Protocol Violation|3|||
105725723|NCT05817045|364650430|FG000|Overall Study|Withdrawal by Subject|10|||
105725724|NCT05817045|364650431|FG001|Overall Study|Withdrawal by Subject|7|||
105725725|NCT05817045|364650430|FG000|Overall Study|Physician Decision|3|||
105725726|NCT05817045|364650431|FG001|Overall Study|Physician Decision|0|||
105725727|NCT05817045|364650430|FG000|Overall Study|Lost to Follow-up|0|||
105725728|NCT05817045|364650431|FG001|Overall Study|Lost to Follow-up|1|||
105725729|NCT05817045|364650430|FG000|Overall Study|Device Deficiency|1|||
105725730|NCT05817045|364650431|FG001|Overall Study|Device Deficiency|0|||
105725731|NCT05817045|364650430|FG000|Overall Study|System Error|1|||
105725732|NCT05817045|364650431|FG001|Overall Study|System Error|0|||
105725733|NCT01725165|364650434|FG000|Overall Study|Death|11|||
105725734|NCT01725165|364650435|FG001|Overall Study|Death|18|||
105725735|NCT02983604|364650436|FG000|Overall Study|Enrolled but not Treated|0|||
105725736|NCT02983604|364650437|FG001|Overall Study|Enrolled but not Treated|0|||
105725737|NCT02983604|364650438|FG002|Overall Study|Enrolled but not Treated|1|||
105725738|NCT02983604|364650439|FG003|Overall Study|Enrolled but not Treated|0|||
105725739|NCT00355264|364650440|FG000|Extension (Variable Duration)|Adverse Event|1|||
105725740|NCT00355264|364650440|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
105725741|NCT03663166|364650441|FG000|Overall Study|Withdrawal by Subject|1|||
105725742|NCT02537678|364650445|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
105725743|NCT02537678|364650446|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
105725744|NCT02537678|364650445|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
105725745|NCT02537678|364650446|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
105725746|NCT02537678|364650445|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
105725747|NCT02537678|364650446|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
105725748|NCT02537678|364650445|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
105725749|NCT02537678|364650446|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
105725750|NCT02537678|364650445|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
105725751|NCT02537678|364650446|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
105725752|NCT02537678|364650445|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
105725753|NCT02537678|364650446|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
105725754|NCT02537678|364650445|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
105725755|NCT02537678|364650446|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
105725756|NCT03075839|364650448|FG000|Overall Study|Lost to Follow-up|4|||
105725757|NCT04052139|364650449|FG000|Overall Study|Lost to Follow-up|2|||
105725758|NCT04052139|364650450|FG001|Overall Study|Lost to Follow-up|0|||
105725759|NCT04052139|364650451|FG002|Overall Study|Lost to Follow-up|0|||
105725760|NCT04052139|364650449|FG000|Overall Study|Withdrawal by Subject|1|||
105725761|NCT04052139|364650450|FG001|Overall Study|Withdrawal by Subject|0|||
105725762|NCT04052139|364650451|FG002|Overall Study|Withdrawal by Subject|0|||
105725763|NCT00707577|364650452|FG000|Overall Study|Withdrawal by Subject|3|||
105725764|NCT00707577|364650453|FG001|Overall Study|Withdrawal by Subject|2|||
105725765|NCT00707577|364650452|FG000|Overall Study|Lost to Follow-up|34|||
105725766|NCT00707577|364650453|FG001|Overall Study|Lost to Follow-up|25|||
105725767|NCT00707577|364650452|FG000|Overall Study|Left employment|13|||
105725768|NCT00707577|364650453|FG001|Overall Study|Left employment|10|||
105725769|NCT00707577|364650452|FG000|Overall Study|Pregnancy|4|||
105725770|NCT00707577|364650453|FG001|Overall Study|Pregnancy|1|||
105725771|NCT00190775|364650454|FG000|Overall Study|Adverse Event|57|||
105725772|NCT00190775|364650455|FG001|Overall Study|Adverse Event|22|||
105725773|NCT00190775|364650454|FG000|Overall Study|Satisfactory Response|1|||
105725774|NCT00190775|364650455|FG001|Overall Study|Satisfactory Response|0|||
105725775|NCT00190775|364650454|FG000|Overall Study|Lack of Efficacy|28|||
105725776|NCT00190775|364650455|FG001|Overall Study|Lack of Efficacy|32|||
105725777|NCT00190775|364650454|FG000|Overall Study|Lost to Follow-up|31|||
105725778|NCT00190775|364650455|FG001|Overall Study|Lost to Follow-up|23|||
105725779|NCT00190775|364650454|FG000|Overall Study|Participant Moved|0|||
105725780|NCT00190775|364650455|FG001|Overall Study|Participant Moved|1|||
105725781|NCT00190775|364650454|FG000|Overall Study|Withdrawal by Subject|24|||
105725782|NCT00190775|364650455|FG001|Overall Study|Withdrawal by Subject|13|||
105725783|NCT00190775|364650454|FG000|Overall Study|Sponsor Decision|1|||
105725784|NCT00190775|364650455|FG001|Overall Study|Sponsor Decision|0|||
105725785|NCT00190775|364650454|FG000|Overall Study|Physician Decision|3|||
105725786|NCT00190775|364650455|FG001|Overall Study|Physician Decision|0|||
105725787|NCT00190775|364650454|FG000|Overall Study|Noncompliance|3|||
105725788|NCT00190775|364650455|FG001|Overall Study|Noncompliance|5|||
105725789|NCT00190775|364650454|FG000|Overall Study|Protocol Violation|0|||
105725790|NCT00190775|364650455|FG001|Overall Study|Protocol Violation|1|||
105725791|NCT00190775|364650454|FG000|Overall Study|Exclusion Criteria Met|1|||
105725792|NCT00190775|364650455|FG001|Overall Study|Exclusion Criteria Met|3|||
105725793|NCT00709202|364650461|FG000|Overall Study|Withdrawal by Subject|6|||
105725794|NCT00709202|364650462|FG001|Overall Study|Withdrawal by Subject|6|||
105725795|NCT02344576|364650463|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
105725796|NCT02344576|364650464|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
105725797|NCT02344576|364650465|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
105725798|NCT02344576|364650466|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
105725799|NCT02344576|364650463|FG000|1-Month Follow-Up|Death|13|||
105725800|NCT02344576|364650464|FG001|1-Month Follow-Up|Death|8|||
105725801|NCT02344576|364650465|FG002|1-Month Follow-Up|Death|0|||
105725802|NCT02344576|364650466|FG003|1-Month Follow-Up|Death|0|||
105725803|NCT02344576|364650463|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
105725804|NCT02344576|364650464|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
105725805|NCT02344576|364650465|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
105725806|NCT02344576|364650466|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
105725807|NCT02344576|364650463|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
105725808|NCT02344576|364650464|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
105725809|NCT02344576|364650465|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
105725810|NCT02344576|364650466|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
105725811|NCT02344576|364650463|FG000|6-Month Follow-Up|Death|14|||
105725812|NCT02344576|364650464|FG001|6-Month Follow-Up|Death|14|||
105725813|NCT02344576|364650465|FG002|6-Month Follow-Up|Death|0|||
105725814|NCT02344576|364650466|FG003|6-Month Follow-Up|Death|0|||
105725815|NCT02344576|364650463|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
105725816|NCT02344576|364650464|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
105725817|NCT02344576|364650465|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
105725818|NCT02344576|364650466|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
105725819|NCT02344576|364650463|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
105725820|NCT02344576|364650464|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
105725821|NCT02344576|364650465|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
105725822|NCT02344576|364650466|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
105725823|NCT03832387|364650483|FG000|Overall Study|Protocol Violation|2|||
105725824|NCT03832387|364650484|FG001|Overall Study|Protocol Violation|6|||
105725825|NCT03832387|364650483|FG000|Overall Study|EXCLUSION CRITERIA|3|||
105725826|NCT03832387|364650484|FG001|Overall Study|EXCLUSION CRITERIA|1|||
105725827|NCT02337387|364650485|FG000|Overall Study|Adverse Event|0|||
105725828|NCT02337387|364650486|FG001|Overall Study|Adverse Event|1|||
105725829|NCT02337387|364650487|FG002|Overall Study|Adverse Event|0|||
105725830|NCT02337387|364650488|FG003|Overall Study|Adverse Event|0|||
105725831|NCT02337387|364650485|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
105725832|NCT02337387|364650486|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
105725833|NCT02337387|364650487|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
105725834|NCT02337387|364650488|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
105725835|NCT02853760|364650489|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
105725836|NCT02853760|364650490|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
105725837|NCT02853760|364650491|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
105725838|NCT02853760|364650492|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
105725839|NCT02853760|364650493|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
105760774|NCT01576406|364776185|FG002|Overall Study|Other|2|||
105760775|NCT01576406|364776186|FG003|Overall Study|Other|2|||
105760776|NCT01576406|364776187|FG004|Overall Study|Other|0|||
105760777|NCT01576406|364776188|FG005|Overall Study|Other|0|||
105760778|NCT03726333|364776191|FG000|Overall Study|Progressive Disease|0|||
105760779|NCT03726333|364776192|FG001|Overall Study|Progressive Disease|0|||
105725840|NCT02853760|364650494|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
105725841|NCT00981526|364650495|FG000|Overall Study|Withdrawal by Subject|0|||
105725842|NCT00981526|364650496|FG001|Overall Study|Withdrawal by Subject|2|||
105725843|NCT00981526|364650495|FG000|Overall Study|Physician Decision|4|||
105725844|NCT00981526|364650496|FG001|Overall Study|Physician Decision|4|||
105725845|NCT01243268|364650497|FG000|Overall Study|Lost to Follow-up|4|||
105725846|NCT01243268|364650497|FG000|Overall Study|Protocol Violation|51|||
105725847|NCT01243268|364650497|FG000|Overall Study|Deviation with contract date|7|||
105725848|NCT01243268|364650497|FG000|Overall Study|Duplicate subject|2|||
105725849|NCT01564784|364650498|FG000|Overall Study|Other|1|||
105725850|NCT01564784|364650499|FG001|Overall Study|Other|0|||
105725851|NCT01564784|364650498|FG000|Overall Study|Subject refused further follow-up|1|||
105725852|NCT01564784|364650499|FG001|Overall Study|Subject refused further follow-up|6|||
105725853|NCT01564784|364650498|FG000|Overall Study|Lost to Follow-up|1|||
105725854|NCT01564784|364650499|FG001|Overall Study|Lost to Follow-up|1|||
105725855|NCT01564784|364650498|FG000|Overall Study|Death|131|||
105725856|NCT01564784|364650499|FG001|Overall Study|Death|126|||
105725857|NCT00784758|364650500|FG000|Overall Study|Withdrawal by Subject|3|||
105725858|NCT00784758|364650501|FG001|Overall Study|Withdrawal by Subject|0|||
105725859|NCT00784758|364650500|FG000|Overall Study|Adverse Event|1|||
105725860|NCT00784758|364650501|FG001|Overall Study|Adverse Event|0|||
105725861|NCT05202808|364650504|FG000|Overall Study|Lost to Follow-up|3|||
105725862|NCT05202808|364650505|FG001|Overall Study|Lost to Follow-up|1|||
105725863|NCT04439331|364650506|FG000|Overall Study|Never Start Protocol Therapy|2|||
105725864|NCT04439331|364650506|FG000|Overall Study|Ineligible|2|||
105725865|NCT04439331|364650506|FG000|Overall Study|Mutation Status Not Confirmed|1|||
105725866|NCT04439331|364650506|FG000|Overall Study|Adverse Event|1|||
105725867|NCT04439331|364650506|FG000|Overall Study|Death|1|||
105725868|NCT04439331|364650506|FG000|Overall Study|Disease Progression|20|||
105725869|NCT04439331|364650506|FG000|Overall Study|Withdrawal by Subject|6|||
105725870|NCT04439331|364650506|FG000|Overall Study|Physician Decision|1|||
105725871|NCT04439331|364650506|FG000|Overall Study|Other Complicating Disease|1|||
105725872|NCT01822561|364650508|FG000|Overall Study|Withdrawal by Subject|2|||
105725873|NCT01523873|364650517|FG000|Overall Study|Protocol Violation|422|||
105725874|NCT00275561|364650518|FG000|Overall Study|Withdrawal by Subject|0|||
105725875|NCT00275561|364650519|FG001|Overall Study|Withdrawal by Subject|1|||
105725876|NCT00275561|364650518|FG000|Overall Study|Travel|1|||
105725877|NCT00275561|364650519|FG001|Overall Study|Travel|1|||
105725878|NCT00275561|364650518|FG000|Overall Study|Scheduling|1|||
105725879|NCT00275561|364650519|FG001|Overall Study|Scheduling|2|||
105725880|NCT00275561|364650518|FG000|Overall Study|Family Issues|0|||
105725881|NCT00275561|364650519|FG001|Overall Study|Family Issues|2|||
105725882|NCT02711553|364650524|FG000|Overall Study|Withdrawal by Subject|2|||
105725883|NCT02711553|364650525|FG001|Overall Study|Withdrawal by Subject|1|||
105725884|NCT02711553|364650526|FG002|Overall Study|Withdrawal by Subject|1|||
105725885|NCT02711553|364650527|FG003|Overall Study|Withdrawal by Subject|0|||
105725886|NCT02711553|364650524|FG000|Overall Study|Lost to Follow-up|3|||
105725887|NCT02711553|364650525|FG001|Overall Study|Lost to Follow-up|3|||
105725888|NCT02711553|364650526|FG002|Overall Study|Lost to Follow-up|6|||
105725889|NCT02711553|364650527|FG003|Overall Study|Lost to Follow-up|3|||
105725890|NCT02711553|364650524|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
105725891|NCT02711553|364650525|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
105725892|NCT02711553|364650526|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
105725893|NCT02711553|364650527|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
105725894|NCT02029976|364653354|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
105725895|NCT02029976|364653355|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
105725896|NCT02029976|364653354|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
105725897|NCT02029976|364653355|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
105725898|NCT02029976|364653354|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
105725899|NCT02029976|364653355|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
105725900|NCT02029976|364653354|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
105725901|NCT02029976|364653355|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
105725902|NCT02732951|364653356|FG000|Overall Study|Other than listed|1|||
105725903|NCT02732951|364653357|FG001|Overall Study|Other than listed|0|||
105725904|NCT02732951|364653356|FG000|Overall Study|Lost to Follow-up|0|||
105725905|NCT02732951|364653357|FG001|Overall Study|Lost to Follow-up|1|||
105725906|NCT02732951|364653356|FG000|Overall Study|Adverse Event|4|||
105725907|NCT02732951|364653357|FG001|Overall Study|Adverse Event|4|||
105725908|NCT02732951|364653356|FG000|Overall Study|Protocol Violation|0|||
105725909|NCT02732951|364653357|FG001|Overall Study|Protocol Violation|1|||
105725910|NCT01750918|364653358|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
105725911|NCT01750918|364653359|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
105725912|NCT01750918|364653360|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
105725913|NCT01750918|364653361|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
105725914|NCT01750918|364653362|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
105725915|NCT01750918|364653363|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
105725916|NCT01750918|364653364|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
105725917|NCT01750918|364653365|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
105725918|NCT01750918|364653358|FG000|Overall Study|Lost to Follow-up|0|||
105725919|NCT01750918|364653359|FG001|Overall Study|Lost to Follow-up|0|||
105725920|NCT01750918|364653360|FG002|Overall Study|Lost to Follow-up|2|||
105725921|NCT01750918|364653361|FG003|Overall Study|Lost to Follow-up|2|||
105725922|NCT01750918|364653362|FG004|Overall Study|Lost to Follow-up|0|||
105725923|NCT01750918|364653363|FG005|Overall Study|Lost to Follow-up|0|||
105725924|NCT01750918|364653364|FG006|Overall Study|Lost to Follow-up|0|||
105725925|NCT01750918|364653365|FG007|Overall Study|Lost to Follow-up|1|||
105725926|NCT01750918|364653358|FG000|Overall Study|Withdrawal by Subject|0|||
105725927|NCT01750918|364653359|FG001|Overall Study|Withdrawal by Subject|0|||
105725928|NCT01750918|364653360|FG002|Overall Study|Withdrawal by Subject|1|||
105725929|NCT01750918|364653361|FG003|Overall Study|Withdrawal by Subject|2|||
105725930|NCT01750918|364653362|FG004|Overall Study|Withdrawal by Subject|1|||
105725931|NCT01750918|364653363|FG005|Overall Study|Withdrawal by Subject|1|||
105725932|NCT01750918|364653364|FG006|Overall Study|Withdrawal by Subject|2|||
105725933|NCT01750918|364653365|FG007|Overall Study|Withdrawal by Subject|2|||
105725934|NCT00075881|364653367|FG000|Overall Study|Lack of Efficacy|18|||
105725935|NCT00075881|364653367|FG000|Overall Study|Adverse Event|7|||
105725936|NCT00075881|364653367|FG000|Overall Study|Death|1|||
105725937|NCT00075881|364653367|FG000|Overall Study|Withdrawal by Subject|2|||
105725938|NCT00075881|364653367|FG000|Overall Study|Protocol Violation|4|||
105725939|NCT00075881|364653367|FG000|Overall Study|other complicating disease|3|||
105725940|NCT00075881|364653367|FG000|Overall Study|other|4|||
105725941|NCT00075881|364653367|FG000|Overall Study|missing data|2|||
105725942|NCT00075881|364653367|FG000|Overall Study|Ineligible|1|||
105725943|NCT00075881|364653367|FG000|Overall Study|never start protocol therapy|1|||
105725944|NCT05047523|364653374|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
105725945|NCT05047523|364653375|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
105725946|NCT05047523|364653376|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
105725947|NCT05047523|364653377|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
105725948|NCT05047523|364653378|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
105725949|NCT05047523|364653379|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
105725950|NCT05047523|364653374|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
105725951|NCT05047523|364653375|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
105725952|NCT05047523|364653376|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
105725953|NCT05047523|364653377|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
105725954|NCT05047523|364653378|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
105725955|NCT05047523|364653379|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
105725956|NCT05047523|364653374|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
105725957|NCT05047523|364653375|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
105725958|NCT05047523|364653376|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
105725959|NCT05047523|364653377|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
105725960|NCT05047523|364653378|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
105725961|NCT05047523|364653379|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
105725962|NCT05047523|364653374|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
105725963|NCT05047523|364653375|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105725964|NCT05047523|364653376|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105725965|NCT05047523|364653377|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105725966|NCT05047523|364653378|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105725967|NCT05047523|364653379|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105725968|NCT05047523|364653374|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
105725969|NCT05047523|364653375|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
105725970|NCT05047523|364653376|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
105725971|NCT05047523|364653377|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
105725972|NCT05047523|364653378|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
105725973|NCT05047523|364653379|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
105353112|NCT00438256|363297081|FG002|Overall Study|Excluded final Diagnosis|0|||
105562973|NCT00771810|364057546|FG000|Overall Study|Lost to Follow-up|0|||
105562974|NCT00771810|364057547|FG001|Overall Study|Lost to Follow-up|0|||
105725974|NCT05047523|364653374|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
105725975|NCT05047523|364653375|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
105725976|NCT05047523|364653376|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
105725977|NCT05047523|364653377|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
105725978|NCT05047523|364653378|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
105725979|NCT05047523|364653379|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
105725980|NCT00215150|364653385|FG000|Open Label Phase|Lost to Follow-up|7|||
105725981|NCT00215150|364653385|FG000|Open Label Phase|Withdrawal by Subject|1|||
105725982|NCT00215150|364653385|FG000|Open Label Phase|Did not complete a post base visit|13|||
105562975|NCT00771810|364057548|FG002|Overall Study|Lost to Follow-up|1|||
105725983|NCT00215150|364653385|FG000|Open Label Phase|Did not meet randomization criteria|9|||
105725984|NCT00215150|364653385|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
105725985|NCT00215150|364653385|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
105725986|NCT00215150|364653385|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
105725987|NCT00206726|364653386|FG000|Overall Study|Delayed recovery of blood counts|1|||
105725988|NCT00206726|364653386|FG000|Overall Study|Progressive disease or relapsed disease|18|||
105725989|NCT00206726|364653386|FG000|Overall Study|Placed on new protocol|1|||
105725990|NCT00206726|364653386|FG000|Overall Study|Bone marrow transplant|1|||
105725991|NCT00206726|364653386|FG000|Overall Study|Adverse Event|17|||
105725992|NCT00206726|364653386|FG000|Overall Study|Death|4|||
105725993|NCT00206726|364653386|FG000|Overall Study|Protocol Violation|1|||
105725994|NCT00206726|364653386|FG000|Overall Study|Withdrawal by Subject|8|||
105725995|NCT00260208|364653390|FG000|Overall Study|Subject withdrew consent|11|||
105725996|NCT00260208|364653391|FG001|Overall Study|Subject withdrew consent|7|||
105725997|NCT00260208|364653390|FG000|Overall Study|Lost to Follow-up|6|||
105725998|NCT00260208|364653391|FG001|Overall Study|Lost to Follow-up|1|||
105725999|NCT00260208|364653390|FG000|Overall Study|Death|12|||
105726000|NCT00260208|364653391|FG001|Overall Study|Death|10|||
105726001|NCT00260208|364653390|FG000|Overall Study|Missing|18|||
105726002|NCT00260208|364653391|FG001|Overall Study|Missing|16|||
105726003|NCT04317690|364653392|FG000|Overall Study|did not have complete information for primary outcome|0|||
105726004|NCT04317690|364653393|FG001|Overall Study|did not have complete information for primary outcome|4|||
105726005|NCT04317690|364653394|FG002|Overall Study|did not have complete information for primary outcome|0|||
105726006|NCT04317690|364653395|FG003|Overall Study|did not have complete information for primary outcome|2|||
105726007|NCT04317690|364653396|FG004|Overall Study|did not have complete information for primary outcome|0|||
105726008|NCT02091440|364653397|FG000|Overall Study|Death|2|||
105726009|NCT03323749|364653398|FG000|Double-blind Period|Lost to Follow-up|4|||
105726010|NCT03323749|364653399|FG001|Double-blind Period|Lost to Follow-up|5|||
105726011|NCT03323749|364653398|FG000|Double-blind Period|Adverse Event|3|||
105726012|NCT03323749|364653399|FG001|Double-blind Period|Adverse Event|1|||
105726013|NCT03323749|364653398|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
105726014|NCT03323749|364653399|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
105726015|NCT03323749|364653398|FG000|Open-Label Period|Adverse Event|3|||
105726016|NCT03323749|364653399|FG001|Open-Label Period|Adverse Event|10|||
105726017|NCT03323749|364653398|FG000|Open-Label Period|Withdrawal by Subject|7|||
105726018|NCT03323749|364653399|FG001|Open-Label Period|Withdrawal by Subject|5|||
105726019|NCT03263091|364653400|FG000|OL Component|Withdrawal by Subject|1|||
105726020|NCT03263091|364653401|FG001|OL Component|Withdrawal by Subject|1|||
105726021|NCT03263091|364653402|FG002|OL Component|Withdrawal by Subject|0|||
105726022|NCT03263091|364653403|FG003|OL Component|Withdrawal by Subject|0|||
105726023|NCT03263091|364653404|FG004|OL Component|Withdrawal by Subject|0|||
105726024|NCT03263091|364653405|FG005|OL Component|Withdrawal by Subject|0|||
105726025|NCT03263091|364653400|FG000|OL Component|Physician Decision|0|||
105726026|NCT03263091|364653401|FG001|OL Component|Physician Decision|1|||
105726027|NCT03263091|364653402|FG002|OL Component|Physician Decision|2|||
105726028|NCT03263091|364653403|FG003|OL Component|Physician Decision|0|||
105726029|NCT03263091|364653404|FG004|OL Component|Physician Decision|0|||
105726030|NCT03263091|364653405|FG005|OL Component|Physician Decision|0|||
105726031|NCT03263091|364653400|FG000|OL Component|Death|1|||
105726032|NCT03263091|364653401|FG001|OL Component|Death|0|||
105726033|NCT03263091|364653402|FG002|OL Component|Death|0|||
105562976|NCT00771810|364057546|FG000|Overall Study|Physician Decision|1|||
105726034|NCT03263091|364653403|FG003|OL Component|Death|0|||
105726035|NCT03263091|364653404|FG004|OL Component|Death|0|||
105726036|NCT03263091|364653405|FG005|OL Component|Death|0|||
105726037|NCT03263091|364653400|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
105726038|NCT03263091|364653401|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
105726039|NCT03263091|364653402|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
105726040|NCT03263091|364653403|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
105726041|NCT03263091|364653404|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
105726042|NCT03263091|364653405|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
105726043|NCT03263091|364653400|FG000|OL High-EPO Component|Physician Decision|0|||
105726044|NCT03263091|364653401|FG001|OL High-EPO Component|Physician Decision|0|||
105726045|NCT03263091|364653402|FG002|OL High-EPO Component|Physician Decision|0|||
105562977|NCT00771810|364057547|FG001|Overall Study|Physician Decision|2|||
105726046|NCT03263091|364653403|FG003|OL High-EPO Component|Physician Decision|1|||
105726047|NCT03263091|364653404|FG004|OL High-EPO Component|Physician Decision|0|||
105726048|NCT03263091|364653405|FG005|OL High-EPO Component|Physician Decision|0|||
105726049|NCT03263091|364653400|FG000|OL High-EPO Component|Death|0|||
105726050|NCT03263091|364653401|FG001|OL High-EPO Component|Death|0|||
105726051|NCT03263091|364653402|FG002|OL High-EPO Component|Death|0|||
105726052|NCT03263091|364653403|FG003|OL High-EPO Component|Death|3|||
105726053|NCT03263091|364653404|FG004|OL High-EPO Component|Death|0|||
105726054|NCT03263091|364653405|FG005|OL High-EPO Component|Death|0|||
105562978|NCT00771810|364057548|FG002|Overall Study|Physician Decision|2|||
105793778|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793779|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793780|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793781|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793782|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793783|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793784|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
105793785|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793786|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793787|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793788|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
105793789|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793790|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793791|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793792|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
105793793|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
105793794|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
105793795|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
105793796|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
105793797|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793798|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
105793799|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793800|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793801|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793802|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793803|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
105793804|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793805|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793806|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793807|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793808|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793809|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793810|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793811|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793812|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
105793813|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793814|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793815|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
105793816|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793817|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793818|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793819|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793820|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793821|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793822|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793823|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793824|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793825|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793826|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793827|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
105793828|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793829|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793830|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
105793831|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793832|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793833|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
105793834|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
105353113|NCT00438256|363297082|FG003|Overall Study|Excluded final Diagnosis|2|||
105353114|NCT02324699|363297083|FG000|Overall Study|study terminated|1|||
105353115|NCT02155322|363297087|FG000|Overall Study|Adverse Event|1|||
105353116|NCT02155322|363297087|FG000|Overall Study|Physician Decision|1|||
105353117|NCT02155322|363297087|FG000|Overall Study|Relapse/Recurrence|8|||
105793835|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793836|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
105793837|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
105793838|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793839|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
105793840|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793841|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793842|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
105793843|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793844|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793845|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793846|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
105793847|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793848|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
105793849|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
105793850|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
105793851|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
105793852|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
105793853|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
105793854|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793855|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793856|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
105793857|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
105793858|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793859|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793860|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793861|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793862|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
105793863|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
105793864|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
105793865|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793866|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
105793867|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793868|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
105793869|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793870|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
105793871|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
105793872|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
105793873|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793874|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793875|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793876|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793877|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793878|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
105793879|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793880|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793881|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793882|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793883|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
105793884|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793885|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793886|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793887|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793888|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793889|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793890|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793891|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793892|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793893|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
105793894|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
105793895|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
105793896|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
105793897|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
105353118|NCT02155322|363297087|FG000|Overall Study|Withdrawal by Subject|4|||
105353119|NCT00460746|363297088|FG000|Overall Study|Adverse Event|1|||
105353120|NCT00460746|363297088|FG000|Overall Study|Lost to Follow-up|1|||
105353121|NCT01603394|363297089|FG000|Overall Study|Adverse Event|1|||
105353122|NCT04399538|363297091|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
105726055|NCT03263091|364653400|FG000|DB Component|Withdrawal by Subject|0|||
105726056|NCT03263091|364653401|FG001|DB Component|Withdrawal by Subject|0|||
105726057|NCT03263091|364653402|FG002|DB Component|Withdrawal by Subject|0|||
105726058|NCT03263091|364653403|FG003|DB Component|Withdrawal by Subject|0|||
105726059|NCT03263091|364653404|FG004|DB Component|Withdrawal by Subject|22|||
105726060|NCT03263091|364653405|FG005|DB Component|Withdrawal by Subject|8|||
105726061|NCT03263091|364653400|FG000|DB Component|Physician Decision|0|||
105726062|NCT03263091|364653401|FG001|DB Component|Physician Decision|0|||
105726063|NCT03263091|364653402|FG002|DB Component|Physician Decision|0|||
105726064|NCT03263091|364653403|FG003|DB Component|Physician Decision|0|||
105726065|NCT03263091|364653404|FG004|DB Component|Physician Decision|3|||
105726066|NCT03263091|364653405|FG005|DB Component|Physician Decision|1|||
105726067|NCT03263091|364653400|FG000|DB Component|Adverse Event|0|||
105726068|NCT03263091|364653401|FG001|DB Component|Adverse Event|0|||
105726069|NCT03263091|364653402|FG002|DB Component|Adverse Event|0|||
105726070|NCT03263091|364653403|FG003|DB Component|Adverse Event|0|||
105726071|NCT03263091|364653404|FG004|DB Component|Adverse Event|2|||
105726072|NCT03263091|364653405|FG005|DB Component|Adverse Event|1|||
105726073|NCT03263091|364653400|FG000|DB Component|Lost to Follow-up|0|||
105726074|NCT03263091|364653401|FG001|DB Component|Lost to Follow-up|0|||
105726075|NCT03263091|364653402|FG002|DB Component|Lost to Follow-up|0|||
105726076|NCT03263091|364653403|FG003|DB Component|Lost to Follow-up|0|||
105726077|NCT03263091|364653404|FG004|DB Component|Lost to Follow-up|2|||
105726078|NCT03263091|364653405|FG005|DB Component|Lost to Follow-up|1|||
105726079|NCT03263091|364653400|FG000|DB Component|Death|0|||
105726080|NCT03263091|364653401|FG001|DB Component|Death|0|||
105726081|NCT03263091|364653402|FG002|DB Component|Death|0|||
105726082|NCT03263091|364653403|FG003|DB Component|Death|0|||
105726083|NCT03263091|364653404|FG004|DB Component|Death|7|||
105726084|NCT03263091|364653405|FG005|DB Component|Death|4|||
105726085|NCT03263091|364653400|FG000|DB Component|Other than specified|0|||
105726086|NCT03263091|364653401|FG001|DB Component|Other than specified|0|||
105726087|NCT03263091|364653402|FG002|DB Component|Other than specified|0|||
105726088|NCT03263091|364653403|FG003|DB Component|Other than specified|0|||
105726089|NCT03263091|364653404|FG004|DB Component|Other than specified|8|||
105726090|NCT03263091|364653405|FG005|DB Component|Other than specified|6|||
105726091|NCT02468193|364653406|FG000|Overall Study|Adverse Event|4|||
105726092|NCT02468193|364653406|FG000|Overall Study|Subject/ Guardian decision|2|||
105726093|NCT01719757|364653407|FG000|Overall Study|Adverse Event|38|||
105726094|NCT01719757|364653407|FG000|Overall Study|Withdrawal by Subject|15|||
105726095|NCT01719757|364653407|FG000|Overall Study|Lost to Follow-up|20|||
105726096|NCT01719757|364653407|FG000|Overall Study|Protocol Violation|1|||
105726097|NCT01719757|364653407|FG000|Overall Study|well controlled pain|27|||
105726098|NCT00824564|364653422|FG000|Overall Study|Lost to Follow-up|5|||
105726099|NCT00824564|364653423|FG001|Overall Study|Lost to Follow-up|7|||
105726100|NCT00824564|364653422|FG000|Overall Study|Withdrawal by Subject|1|||
105726101|NCT00824564|364653423|FG001|Overall Study|Withdrawal by Subject|1|||
105726102|NCT00824564|364653422|FG000|Overall Study|Other|1|||
105726103|NCT00824564|364653423|FG001|Overall Study|Other|2|||
105726104|NCT00824564|364653422|FG000|Overall Study|Randomized, but not treated|1|||
105562979|NCT00771810|364057546|FG000|Overall Study|Protocol Violation|0|||
105562980|NCT00771810|364057547|FG001|Overall Study|Protocol Violation|1|||
105562981|NCT00771810|364057548|FG002|Overall Study|Protocol Violation|1|||
105562982|NCT00771810|364057546|FG000|Overall Study|Withdrawal by Subject|1|||
105562983|NCT00771810|364057547|FG001|Overall Study|Withdrawal by Subject|2|||
105562984|NCT00771810|364057548|FG002|Overall Study|Withdrawal by Subject|0|||
105562985|NCT00771810|364057546|FG000|Overall Study|Other|0|||
105562986|NCT00771810|364057547|FG001|Overall Study|Other|0|||
105726105|NCT00824564|364653423|FG001|Overall Study|Randomized, but not treated|0|||
105353123|NCT04399538|363297092|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
105726106|NCT00486902|364653425|FG000|Overall Study|Withdrawal by Subject|1|||
105726107|NCT00486902|364653426|FG001|Overall Study|Withdrawal by Subject|2|||
105726108|NCT00486902|364653425|FG000|Overall Study|decision for postpartum tubal ligation|3|||
105726109|NCT00486902|364653426|FG001|Overall Study|decision for postpartum tubal ligation|1|||
105726110|NCT00486902|364653425|FG000|Overall Study|spinal anesthetic protocal violation|1|||
105726111|NCT00486902|364653426|FG001|Overall Study|spinal anesthetic protocal violation|1|||
105726112|NCT00486902|364653425|FG000|Overall Study|Did not meet inclusion criteria|1|||
105726113|NCT00486902|364653426|FG001|Overall Study|Did not meet inclusion criteria|0|||
105562987|NCT00771810|364057548|FG002|Overall Study|Other|1|||
105760780|NCT03726333|364776193|FG002|Overall Study|Progressive Disease|1|||
105760781|NCT03726333|364776194|FG003|Overall Study|Progressive Disease|0|||
105760782|NCT03726333|364776195|FG004|Overall Study|Progressive Disease|0|||
105760783|NCT03627494|364776197|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
105760784|NCT03627494|364776198|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
105478567|NCT03337490|363764278|FG000|Overall Study|Withdrawal by Subject|1|||
105478568|NCT03337490|363764279|FG001|Overall Study|Withdrawal by Subject|0|||
105478569|NCT03337490|363764280|FG002|Overall Study|Withdrawal by Subject|0|||
105478570|NCT03337490|363764278|FG000|Overall Study|Lack of Efficacy|10|||
105478571|NCT03337490|363764279|FG001|Overall Study|Lack of Efficacy|12|||
105478572|NCT03337490|363764280|FG002|Overall Study|Lack of Efficacy|35|||
105478573|NCT03337490|363764278|FG000|Overall Study|Physician Decision|0|||
105478574|NCT03337490|363764279|FG001|Overall Study|Physician Decision|1|||
105478575|NCT03337490|363764280|FG002|Overall Study|Physician Decision|0|||
105478576|NCT03337490|363764278|FG000|Overall Study|Lost to Follow-up|0|||
105478577|NCT03337490|363764279|FG001|Overall Study|Lost to Follow-up|1|||
105478578|NCT03337490|363764280|FG002|Overall Study|Lost to Follow-up|0|||
105478579|NCT04493892|363764281|FG000|Overall Study|Withdrawal by Subject|15|||
105478580|NCT01541397|363764284|FG000|Overall Study|Study ended prior to data collection|4|||
105478581|NCT01541397|363764285|FG001|Overall Study|Study ended prior to data collection|2|||
105478582|NCT02267317|363764286|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
105478583|NCT02267317|363764287|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
105478584|NCT02267317|363764288|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
105478585|NCT02267317|363764289|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
105478586|NCT02267317|363764290|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
105478587|NCT02267317|363764291|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
105478588|NCT02267317|363764286|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
105478589|NCT02267317|363764287|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
105478590|NCT02267317|363764288|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
105478591|NCT02267317|363764289|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
105478592|NCT02267317|363764290|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
105478593|NCT02267317|363764291|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
105478594|NCT01128621|363764294|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
105478595|NCT01128621|363764295|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
105726114|NCT00486902|364653425|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
105726115|NCT00486902|364653426|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
105726116|NCT03615222|364653431|FG000|Overall Study|Ineligible|26|||
105726117|NCT03615222|364653431|FG000|Overall Study|Withdrawal by Subject|7|||
105726118|NCT03615222|364653431|FG000|Overall Study|Death|1|||
105726119|NCT01552057|364653432|FG000|Overall Study|Adverse Event|14|||
105726120|NCT01552057|364653433|FG001|Overall Study|Adverse Event|15|||
105726121|NCT01552057|364653432|FG000|Overall Study|Lack of Efficacy|8|||
105726122|NCT01552057|364653433|FG001|Overall Study|Lack of Efficacy|23|||
105726123|NCT01552057|364653432|FG000|Overall Study|Withdrawal by Subject|5|||
105726124|NCT01552057|364653433|FG001|Overall Study|Withdrawal by Subject|8|||
105726125|NCT01552057|364653432|FG000|Overall Study|Entry Criteria Not Met|2|||
105726126|NCT01552057|364653433|FG001|Overall Study|Entry Criteria Not Met|2|||
105726127|NCT01552057|364653432|FG000|Overall Study|Physician Decision|1|||
105726128|NCT01552057|364653433|FG001|Overall Study|Physician Decision|0|||
105726129|NCT00476086|364653434|FG000|Overall Study|Alternative therapy|1|||
105726130|NCT00476086|364653434|FG000|Overall Study|Progressive Disease|4|||
105726131|NCT04178590|364653435|FG000|Overall Study|Pregnancy|1|||
105726132|NCT04178590|364653435|FG000|Overall Study|Lost to Follow-up|1|||
105726133|NCT00996840|364653436|FG000|Overall Study|Adverse Event|0|||
105726134|NCT00996840|364653437|FG001|Overall Study|Adverse Event|1|||
105726135|NCT00996840|364653438|FG002|Overall Study|Adverse Event|0|||
105726136|NCT00996840|364653439|FG003|Overall Study|Adverse Event|0|||
105726137|NCT00996840|364653440|FG004|Overall Study|Adverse Event|0|||
105726138|NCT00996840|364653436|FG000|Overall Study|Physician Decision|0|||
105726139|NCT00996840|364653437|FG001|Overall Study|Physician Decision|0|||
105726140|NCT00996840|364653438|FG002|Overall Study|Physician Decision|1|||
105726141|NCT00996840|364653439|FG003|Overall Study|Physician Decision|1|||
105726142|NCT00996840|364653440|FG004|Overall Study|Physician Decision|2|||
105726143|NCT00996840|364653436|FG000|Overall Study|Withdrawal by Subject|1|||
105726144|NCT00996840|364653437|FG001|Overall Study|Withdrawal by Subject|1|||
105726145|NCT00996840|364653438|FG002|Overall Study|Withdrawal by Subject|0|||
105478596|NCT00233454|363764299|FG000|Overall Study|Death|6|||
105478597|NCT04224688|363764300|FG000|Overall Study|Withdrawal by Subject|1|||
105478598|NCT04224688|363764301|FG001|Overall Study|Withdrawal by Subject|3|||
105478599|NCT04224688|363764300|FG000|Overall Study|Lack of Efficacy|1|||
105726146|NCT00996840|364653439|FG003|Overall Study|Withdrawal by Subject|0|||
105726147|NCT00996840|364653440|FG004|Overall Study|Withdrawal by Subject|0|||
105726148|NCT01389245|364653441|FG000|Overall Study|Protocol Violation|10|||
105726149|NCT01389245|364653441|FG000|Overall Study|Lost to Follow-up|3|||
105726150|NCT01389245|364653441|FG000|Overall Study|Withdrawal by Subject|2|||
105478600|NCT04224688|363764301|FG001|Overall Study|Lack of Efficacy|1|||
105478601|NCT04224688|363764300|FG000|Overall Study|Adverse event, not fatal|0|||
105726151|NCT01485614|364653443|FG000|Randomization|Not Treated|1|||
105726152|NCT01485614|364653444|FG001|Randomization|Not Treated|0|||
105726153|NCT01485614|364653445|FG002|Randomization|Not Treated|0|||
105726154|NCT01485614|364653446|FG003|Randomization|Not Treated|0|||
105726155|NCT01485614|364653443|FG000|Weeks 0-20|Lost to Follow-up|2|||
105726156|NCT01485614|364653444|FG001|Weeks 0-20|Lost to Follow-up|0|||
105726157|NCT01485614|364653445|FG002|Weeks 0-20|Lost to Follow-up|0|||
105726158|NCT01485614|364653446|FG003|Weeks 0-20|Lost to Follow-up|0|||
105726159|NCT01485614|364653443|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
105726160|NCT01485614|364653444|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
105726161|NCT01485614|364653445|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
105726162|NCT01485614|364653446|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
105726163|NCT01485614|364653443|FG000|Weeks 0-20|Withdrawal by Subject|3|||
105726164|NCT01485614|364653444|FG001|Weeks 0-20|Withdrawal by Subject|2|||
105726165|NCT01485614|364653445|FG002|Weeks 0-20|Withdrawal by Subject|1|||
105726166|NCT01485614|364653446|FG003|Weeks 0-20|Withdrawal by Subject|0|||
105726167|NCT01485614|364653443|FG000|Weeks 20-54|Lost to Follow-up|4|||
105726168|NCT01485614|364653444|FG001|Weeks 20-54|Lost to Follow-up|3|||
105726169|NCT01485614|364653445|FG002|Weeks 20-54|Lost to Follow-up|1|||
105726170|NCT01485614|364653446|FG003|Weeks 20-54|Lost to Follow-up|0|||
105726171|NCT01485614|364653443|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
105726172|NCT01485614|364653444|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
105726173|NCT01485614|364653445|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
105726174|NCT01485614|364653446|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
105726175|NCT01485614|364653443|FG000|Weeks 20-54|Withdrawal by Subject|5|||
105726176|NCT01485614|364653444|FG001|Weeks 20-54|Withdrawal by Subject|3|||
105726177|NCT01485614|364653445|FG002|Weeks 20-54|Withdrawal by Subject|0|||
105726178|NCT01485614|364653446|FG003|Weeks 20-54|Withdrawal by Subject|0|||
105726179|NCT04125680|364653447|FG000|Overall Study|Lost to Follow-up|15|||
105726180|NCT01562028|364653448|FG000|Overall Study|Withdrawal by Subject|1|||
105726181|NCT01562028|364653449|FG001|Overall Study|Withdrawal by Subject|1|||
105726182|NCT01562028|364653448|FG000|Overall Study|Lost to Follow-up|2|||
105726183|NCT01562028|364653449|FG001|Overall Study|Lost to Follow-up|1|||
105726184|NCT00364793|364653450|FG000|Overall Study|Adverse Event|2|||
105726185|NCT00364793|364653451|FG001|Overall Study|Adverse Event|0|||
105726186|NCT00364793|364653452|FG002|Overall Study|Adverse Event|0|||
105726187|NCT00364793|364653453|FG003|Overall Study|Adverse Event|0|||
105726188|NCT00364793|364653450|FG000|Overall Study|Death|1|||
105726189|NCT00364793|364653451|FG001|Overall Study|Death|0|||
105726190|NCT00364793|364653452|FG002|Overall Study|Death|1|||
105726191|NCT00364793|364653453|FG003|Overall Study|Death|0|||
105726192|NCT00364793|364653450|FG000|Overall Study|Lack of Efficacy|3|||
105726193|NCT00364793|364653451|FG001|Overall Study|Lack of Efficacy|3|||
105353124|NCT04399538|363297093|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
105353125|NCT04399538|363297094|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
105353126|NCT04399538|363297095|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
105353127|NCT04399538|363297091|FG000|Double-Blind Treatment|Adverse Event|0|||
105353128|NCT04399538|363297092|FG001|Double-Blind Treatment|Adverse Event|0|||
105353129|NCT04399538|363297093|FG002|Double-Blind Treatment|Adverse Event|0|||
105726194|NCT00364793|364653452|FG002|Overall Study|Lack of Efficacy|1|||
105562988|NCT03804710|364057549|FG000|Overall Study|Adverse Event|0|||
105562989|NCT03804710|364057550|FG001|Overall Study|Adverse Event|3|||
105562990|NCT03804710|364057549|FG000|Overall Study|Withdrawal by Subject|2|||
105562991|NCT03804710|364057550|FG001|Overall Study|Withdrawal by Subject|1|||
105562992|NCT03804710|364057549|FG000|Overall Study|Other|0|||
105562993|NCT03804710|364057550|FG001|Overall Study|Other|1|||
105562994|NCT02515279|364057551|FG000|Overall Study|Adverse Event|7|||
105562995|NCT02515279|364057551|FG000|Overall Study|Lack of Efficacy|31|||
105562996|NCT02515279|364057551|FG000|Overall Study|Lost to Follow-up|9|||
105562997|NCT02515279|364057551|FG000|Overall Study|Withdrawal by Subject|18|||
105726195|NCT00364793|364653453|FG003|Overall Study|Lack of Efficacy|1|||
105726196|NCT00364793|364653450|FG000|Overall Study|Lost to Follow-up|1|||
105726197|NCT00364793|364653451|FG001|Overall Study|Lost to Follow-up|0|||
105726198|NCT00364793|364653452|FG002|Overall Study|Lost to Follow-up|2|||
105478602|NCT04224688|363764301|FG001|Overall Study|Adverse event, not fatal|2|||
105478603|NCT04224688|363764300|FG000|Overall Study|COVID-19|0|||
105478604|NCT04224688|363764301|FG001|Overall Study|COVID-19|1|||
105478605|NCT01689532|363764307|FG000|Overall Study|Adverse Event|9|||
105478606|NCT01689532|363764308|FG001|Overall Study|Adverse Event|5|||
105478607|NCT01689532|363764307|FG000|Overall Study|Lack of Efficacy|2|||
105478608|NCT01689532|363764308|FG001|Overall Study|Lack of Efficacy|2|||
105478609|NCT01689532|363764307|FG000|Overall Study|Withdrawal by Subject|1|||
105478610|NCT01689532|363764308|FG001|Overall Study|Withdrawal by Subject|2|||
105478611|NCT01689532|363764307|FG000|Overall Study|Physician Decision|2|||
105478612|NCT01689532|363764308|FG001|Overall Study|Physician Decision|0|||
105478613|NCT00796445|363764309|FG000|Overall Study|Protocol Violation|5|||
105478614|NCT00796445|363764310|FG001|Overall Study|Protocol Violation|3|||
105478615|NCT00796445|363764309|FG000|Overall Study|Adverse event, serious fatal|10|||
105478616|NCT00796445|363764310|FG001|Overall Study|Adverse event, serious fatal|5|||
105478617|NCT00796445|363764309|FG000|Overall Study|Adverse event, non-fatal|4|||
105478618|NCT00796445|363764310|FG001|Overall Study|Adverse event, non-fatal|0|||
105478619|NCT00796445|363764309|FG000|Overall Study|Disease progression/recurrence|537|||
105478620|NCT00796445|363764310|FG001|Overall Study|Disease progression/recurrence|268|||
105478621|NCT00796445|363764309|FG000|Overall Study|Other|10|||
105478622|NCT00796445|363764310|FG001|Overall Study|Other|7|||
105478623|NCT00796445|363764309|FG000|Overall Study|Withdrawal by Subject|18|||
105478624|NCT00796445|363764310|FG001|Overall Study|Withdrawal by Subject|9|||
105478625|NCT00796445|363764309|FG000|Overall Study|Invalid Informed Consent Form|1|||
105478626|NCT00796445|363764310|FG001|Overall Study|Invalid Informed Consent Form|0|||
105562998|NCT02515279|364057551|FG000|Overall Study|End-of-treatment visit not attended|17|||
105562999|NCT02515279|364057551|FG000|Overall Study|Other|22|||
105478627|NCT02208063|363764311|FG000|Overall Study|Death|3|||
105478628|NCT02208063|363764312|FG001|Overall Study|Death|5|||
105478629|NCT02208063|363764311|FG000|Overall Study|Not Specified in report|3|||
105478630|NCT02208063|363764312|FG001|Overall Study|Not Specified in report|4|||
105478631|NCT02208063|363764311|FG000|Overall Study|Withdrawal by Subject|5|||
105478632|NCT02208063|363764312|FG001|Overall Study|Withdrawal by Subject|2|||
105478633|NCT02208063|363764311|FG000|Overall Study|Lost to Follow-up|1|||
105563000|NCT02953938|364057554|FG000|Overall Study|Adverse Event|0|||
105563001|NCT02953938|364057555|FG001|Overall Study|Adverse Event|1|||
105563002|NCT02953938|364057554|FG000|Overall Study|Withdrawal by Subject|1|||
105563003|NCT02953938|364057555|FG001|Overall Study|Withdrawal by Subject|1|||
105563004|NCT01338025|364057563|FG000|Overall Study|Unexpected closure of study|10|||
105563005|NCT01338025|364057564|FG001|Overall Study|Unexpected closure of study|9|||
105563006|NCT01338025|364057563|FG000|Overall Study|Withdrawal by Subject|0|||
105726199|NCT00364793|364653453|FG003|Overall Study|Lost to Follow-up|0|||
105726200|NCT00364793|364653450|FG000|Overall Study|Poor or non-compliance|1|||
105726201|NCT00364793|364653451|FG001|Overall Study|Poor or non-compliance|1|||
105726202|NCT00364793|364653452|FG002|Overall Study|Poor or non-compliance|0|||
105726203|NCT00364793|364653453|FG003|Overall Study|Poor or non-compliance|1|||
105726204|NCT00364793|364653450|FG000|Overall Study|No longer meets criteria|0|||
105726205|NCT00364793|364653451|FG001|Overall Study|No longer meets criteria|0|||
105726206|NCT00364793|364653452|FG002|Overall Study|No longer meets criteria|0|||
105726207|NCT00364793|364653453|FG003|Overall Study|No longer meets criteria|1|||
105726208|NCT00364793|364653450|FG000|Overall Study|Withdrawal by Subject|0|||
105726209|NCT00364793|364653451|FG001|Overall Study|Withdrawal by Subject|1|||
105726210|NCT00364793|364653452|FG002|Overall Study|Withdrawal by Subject|0|||
105726211|NCT00364793|364653453|FG003|Overall Study|Withdrawal by Subject|0|||
105726212|NCT01919307|364653454|FG000|Overall Study|Withdrawal by Subject|9|||
105726213|NCT02582515|364653457|FG000|Overall Study|Withdrawal by Subject|0|||
105726214|NCT02582515|364653458|FG001|Overall Study|Withdrawal by Subject|1|||
105478634|NCT02208063|363764312|FG001|Overall Study|Lost to Follow-up|0|||
105478635|NCT03180619|363764316|FG000|Overall Study|Withdrew Consent|5|||
105478636|NCT03180619|363764317|FG001|Overall Study|Withdrew Consent|0|||
105478637|NCT03180619|363764318|FG002|Overall Study|Withdrew Consent|2|||
105478638|NCT03180619|363764316|FG000|Overall Study|Death|2|||
105478639|NCT03180619|363764317|FG001|Overall Study|Death|1|||
105726215|NCT00775021|364653462|FG000|First Intervention|Lost to Follow-up|1|||
105478640|NCT03180619|363764318|FG002|Overall Study|Death|2|||
105478641|NCT03180619|363764316|FG000|Overall Study|Adverse Event|2|||
105478642|NCT03180619|363764317|FG001|Overall Study|Adverse Event|0|||
105478643|NCT03180619|363764318|FG002|Overall Study|Adverse Event|1|||
105726216|NCT00775021|364653463|FG001|First Intervention|Lost to Follow-up|0|||
105478644|NCT03180619|363764316|FG000|Overall Study|Investigator's discretion|2|||
105478645|NCT03180619|363764317|FG001|Overall Study|Investigator's discretion|0|||
105478646|NCT03180619|363764318|FG002|Overall Study|Investigator's discretion|1|||
105478647|NCT01433289|363764319|FG000|Overall Study|Pregnancy|0|||
105478648|NCT01433289|363764320|FG001|Overall Study|Pregnancy|1|||
105478649|NCT01433289|363764321|FG002|Overall Study|Pregnancy|0|||
105478650|NCT01433289|363764322|FG003|Overall Study|Pregnancy|0|||
105478651|NCT04620798|363764325|FG000|Overall Study|Lost to Follow-up|126|||
105726217|NCT00775021|364653462|FG000|Second Intervention|Adverse Event|0|||
105793898|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
105793899|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
105793900|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
105793901|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
105793902|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
105793903|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
105793904|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
105793905|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
105793906|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
105793907|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
105793908|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
105793909|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
105793910|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
105793911|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
105793912|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793913|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793914|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793915|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793916|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793917|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793918|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105353130|NCT04399538|363297094|FG003|Double-Blind Treatment|Adverse Event|0|||
105353131|NCT04399538|363297095|FG004|Double-Blind Treatment|Adverse Event|1|||
105353132|NCT04399538|363297091|FG000|Follow-Up|Adverse Event|0|||
105353133|NCT04399538|363297092|FG001|Follow-Up|Adverse Event|0|||
105353134|NCT04399538|363297093|FG002|Follow-Up|Adverse Event|0|||
105353135|NCT04399538|363297094|FG003|Follow-Up|Adverse Event|0|||
105353136|NCT04399538|363297095|FG004|Follow-Up|Adverse Event|1|||
105353137|NCT04399538|363297091|FG000|Follow-Up|Withdrawal by Subject|0|||
105353138|NCT04399538|363297092|FG001|Follow-Up|Withdrawal by Subject|0|||
105353139|NCT04399538|363297093|FG002|Follow-Up|Withdrawal by Subject|0|||
105353140|NCT04399538|363297094|FG003|Follow-Up|Withdrawal by Subject|2|||
105353141|NCT04399538|363297095|FG004|Follow-Up|Withdrawal by Subject|0|||
105353142|NCT00636961|363297100|FG000|Period 1|Administrative problems|1|||
105353143|NCT00636961|363297101|FG001|Period 1|Administrative problems|1|||
105353144|NCT00636961|363297100|FG000|Period 2|Adverse Event|1|||
105353145|NCT00636961|363297101|FG001|Period 2|Adverse Event|0|||
105353146|NCT00856843|363297102|FG000|Overall Study|Withdrawal by Subject|1|||
105353147|NCT00856843|363297103|FG001|Overall Study|Withdrawal by Subject|5|||
105353148|NCT00856843|363297102|FG000|Overall Study|Lack of Efficacy|1|||
105353149|NCT00856843|363297103|FG001|Overall Study|Lack of Efficacy|0|||
105353150|NCT02685072|363297105|FG000|Treatment Period|Lost to Follow-up|12|||
105353151|NCT02685072|363297106|FG001|Treatment Period|Lost to Follow-up|6|||
105353152|NCT02685072|363297105|FG000|Treatment Period|Withdrawal by Subject|1|||
105353153|NCT02685072|363297106|FG001|Treatment Period|Withdrawal by Subject|3|||
105793919|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793920|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793921|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793922|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
105793923|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793924|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793925|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793926|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793927|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793928|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793929|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793930|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793931|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
105793932|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
105353154|NCT02685072|363297105|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
105353155|NCT02685072|363297106|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
105353156|NCT00262002|363297107|FG000|Overall Study|Adverse Event|2|||
105478652|NCT04620798|363764326|FG001|Overall Study|Lost to Follow-up|138|||
105793933|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
105793934|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
105353157|NCT00262002|363297108|FG001|Overall Study|Adverse Event|1|||
105353158|NCT00262002|363297109|FG002|Overall Study|Adverse Event|0|||
105353159|NCT00262002|363297110|FG003|Overall Study|Adverse Event|0|||
105353160|NCT00262002|363297111|FG004|Overall Study|Adverse Event|0|||
105353161|NCT00262002|363297112|FG005|Overall Study|Adverse Event|1|||
105353162|NCT00262002|363297113|FG006|Overall Study|Adverse Event|0|||
105353163|NCT00262002|363297107|FG000|Overall Study|Withdrawal by Subject|4|||
105353164|NCT00262002|363297108|FG001|Overall Study|Withdrawal by Subject|2|||
105478653|NCT00862641|363764331|FG000|Overall Study|Randomized, but drug not received|1|||
105478654|NCT00862641|363764332|FG001|Overall Study|Randomized, but drug not received|4|||
105478655|NCT00862641|363764333|FG002|Overall Study|Randomized, but drug not received|1|||
105478656|NCT00862641|363764334|FG003|Overall Study|Randomized, but drug not received|4|||
105478657|NCT00475982|363764338|FG000|Overall Study|surgery rescheduled|7|||
105478658|NCT00475982|363764339|FG001|Overall Study|surgery rescheduled|3|||
105478659|NCT01105767|363764340|FG000|Overall Study|Lost to Follow-up|1160|||
105478660|NCT01105767|363764341|FG001|Overall Study|Lost to Follow-up|1614|||
105478661|NCT01105767|363764342|FG002|Overall Study|Lost to Follow-up|1184|||
105478662|NCT00796523|363764343|FG000|Overall Study|Lost to Follow-up|9|||
105478663|NCT00796523|363764344|FG001|Overall Study|Lost to Follow-up|7|||
105478664|NCT00096356|363764347|FG000|Overall Study|Adverse Event|11|||
105478665|NCT00096356|363764348|FG001|Overall Study|Adverse Event|9|||
105478666|NCT00096356|363764347|FG000|Overall Study|Physician Decision|5|||
105478667|NCT00096356|363764348|FG001|Overall Study|Physician Decision|3|||
105478668|NCT00096356|363764347|FG000|Overall Study|Withdrawal by Subject|17|||
105478669|NCT00096356|363764348|FG001|Overall Study|Withdrawal by Subject|23|||
105478670|NCT00096356|363764347|FG000|Overall Study|Lack of Efficacy|1|||
105478671|NCT00096356|363764348|FG001|Overall Study|Lack of Efficacy|0|||
105478672|NCT00096356|363764347|FG000|Overall Study|multiple reasons|10|||
105478673|NCT00096356|363764348|FG001|Overall Study|multiple reasons|18|||
105478674|NCT01576159|363764352|FG000|Overall Study|Withdrawal by Subject|0|||
105478675|NCT01576159|363764353|FG001|Overall Study|Withdrawal by Subject|1|||
105478676|NCT01576159|363764354|FG002|Overall Study|Withdrawal by Subject|0|||
105478677|NCT01576159|363764355|FG003|Overall Study|Withdrawal by Subject|0|||
105478678|NCT01576159|363764352|FG000|Overall Study|Physician Decision|0|||
105478679|NCT01576159|363764353|FG001|Overall Study|Physician Decision|0|||
105478680|NCT01576159|363764354|FG002|Overall Study|Physician Decision|1|||
105478681|NCT01576159|363764355|FG003|Overall Study|Physician Decision|0|||
105478682|NCT01576159|363764352|FG000|Overall Study|Lost to Follow-up|0|||
105478683|NCT01576159|363764353|FG001|Overall Study|Lost to Follow-up|0|||
105478684|NCT01576159|363764354|FG002|Overall Study|Lost to Follow-up|0|||
105478685|NCT01576159|363764355|FG003|Overall Study|Lost to Follow-up|1|||
105478686|NCT01576159|363764352|FG000|Overall Study|Protocol Violation|1|||
105478687|NCT01576159|363764353|FG001|Overall Study|Protocol Violation|0|||
105478688|NCT01576159|363764354|FG002|Overall Study|Protocol Violation|0|||
105478689|NCT01576159|363764355|FG003|Overall Study|Protocol Violation|0|||
105726218|NCT00775021|364653463|FG001|Second Intervention|Adverse Event|1|||
105726219|NCT05027802|364653477|FG000|Overall Study|Adverse Event|2|||
105726220|NCT05027802|364653477|FG000|Overall Study|Withdrawal by Subject|18|||
105726221|NCT05027802|364653477|FG000|Overall Study|Death|2|||
105726222|NCT05027802|364653477|FG000|Overall Study|Other|1|||
105726223|NCT00382967|364653478|FG000|Overall Study|Protocol Violation|1|||
105726224|NCT00382967|364653479|FG001|Overall Study|Protocol Violation|1|||
105726225|NCT02690701|364653489|FG000|Treatment Period 1|Adverse Event|2|||
105726226|NCT02690701|364653490|FG001|Treatment Period 1|Adverse Event|2|||
105726227|NCT02690701|364653489|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105353165|NCT00262002|363297109|FG002|Overall Study|Withdrawal by Subject|0|||
105353166|NCT00262002|363297110|FG003|Overall Study|Withdrawal by Subject|1|||
105353167|NCT00262002|363297111|FG004|Overall Study|Withdrawal by Subject|2|||
105353168|NCT00262002|363297112|FG005|Overall Study|Withdrawal by Subject|2|||
105353169|NCT00262002|363297113|FG006|Overall Study|Withdrawal by Subject|2|||
105353170|NCT00262002|363297107|FG000|Overall Study|Lost to Follow-up|2|||
105353171|NCT00262002|363297108|FG001|Overall Study|Lost to Follow-up|0|||
105353172|NCT00262002|363297109|FG002|Overall Study|Lost to Follow-up|0|||
105353173|NCT00262002|363297110|FG003|Overall Study|Lost to Follow-up|2|||
105353174|NCT00262002|363297111|FG004|Overall Study|Lost to Follow-up|0|||
105353175|NCT00262002|363297112|FG005|Overall Study|Lost to Follow-up|1|||
105353176|NCT00262002|363297113|FG006|Overall Study|Lost to Follow-up|0|||
105353177|NCT00262002|363297107|FG000|Overall Study|Inapropriate enrollment|0|||
105353178|NCT00262002|363297108|FG001|Overall Study|Inapropriate enrollment|1|||
105353179|NCT00262002|363297109|FG002|Overall Study|Inapropriate enrollment|0|||
105353180|NCT00262002|363297110|FG003|Overall Study|Inapropriate enrollment|0|||
105353181|NCT00262002|363297111|FG004|Overall Study|Inapropriate enrollment|0|||
105478690|NCT00960570|363764356|FG000|21 Day Washout Period|Adverse Event|1|||
105478691|NCT00960570|363764356|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
105478692|NCT00960570|363764356|FG000|1 Day Period Between Dosing|Adverse Event|2|||
105726228|NCT02690701|364653490|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105353182|NCT00262002|363297112|FG005|Overall Study|Inapropriate enrollment|0|||
105478693|NCT00960570|363764356|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
105478694|NCT01457352|363764357|FG000|Period 1|Adverse Event|2|||
105478695|NCT01457352|363764358|FG001|Period 1|Adverse Event|0|||
105353183|NCT00262002|363297113|FG006|Overall Study|Inapropriate enrollment|0|||
105353184|NCT00262002|363297107|FG000|Overall Study|Protocol Violation|3|||
105478696|NCT01457352|363764357|FG000|Period 1|Withdrawal by Subject|2|||
105478697|NCT01457352|363764358|FG001|Period 1|Withdrawal by Subject|0|||
105726229|NCT02690701|364653489|FG000|Treatment Period 2|Adverse Event|2|||
105726230|NCT02690701|364653490|FG001|Treatment Period 2|Adverse Event|0|||
105726231|NCT02690701|364653489|FG000|Treatment Period 2|Lack of Efficacy|1|||
105478698|NCT01457352|363764357|FG000|Period 1|Physician Decision|2|||
105478699|NCT01457352|363764358|FG001|Period 1|Physician Decision|0|||
105478700|NCT01457352|363764357|FG000|Period 1|MS related disease progression|1|||
105478701|NCT01457352|363764358|FG001|Period 1|MS related disease progression|0|||
105478702|NCT01457352|363764357|FG000|Period 1|Withdrawn|1|||
105478703|NCT01457352|363764358|FG001|Period 1|Withdrawn|0|||
105478704|NCT01457352|363764357|FG000|Period 1|withdrew per sponsor|1|||
105478705|NCT01457352|363764358|FG001|Period 1|withdrew per sponsor|0|||
105478706|NCT01457352|363764357|FG000|Period 1|Protocol Violation|4|||
105478707|NCT01457352|363764358|FG001|Period 1|Protocol Violation|0|||
105478708|NCT01457352|363764357|FG000|Period 1|Did not meet eligibility criteria|3|||
105478709|NCT01457352|363764358|FG001|Period 1|Did not meet eligibility criteria|0|||
105478710|NCT01457352|363764357|FG000|Period 2|Withdrawal by Subject|23|||
105478711|NCT01457352|363764358|FG001|Period 2|Withdrawal by Subject|0|||
105478712|NCT01457352|363764357|FG000|Period 2|Adverse Event|22|||
105478713|NCT01457352|363764358|FG001|Period 2|Adverse Event|0|||
105478714|NCT01457352|363764357|FG000|Period 2|no analysis|10|||
105478715|NCT01457352|363764358|FG001|Period 2|no analysis|0|||
105478716|NCT01457352|363764357|FG000|Period 2|Lack of Efficacy|8|||
105478717|NCT01457352|363764358|FG001|Period 2|Lack of Efficacy|0|||
105478718|NCT01457352|363764357|FG000|Period 2|Protocol Violation|4|||
105478719|NCT01457352|363764358|FG001|Period 2|Protocol Violation|0|||
105478720|NCT01457352|363764357|FG000|Period 2|Sponsor's withdrawal|7|||
105478721|NCT01457352|363764358|FG001|Period 2|Sponsor's withdrawal|0|||
105478722|NCT01457352|363764357|FG000|Period 2|Lost to Follow-up|1|||
105478723|NCT01457352|363764358|FG001|Period 2|Lost to Follow-up|0|||
105478724|NCT01457352|363764357|FG000|Period 2|dose change|1|||
105478725|NCT01457352|363764358|FG001|Period 2|dose change|0|||
105478726|NCT01457352|363764357|FG000|Period 2|Physician Decision|1|||
105478727|NCT01457352|363764358|FG001|Period 2|Physician Decision|0|||
105478728|NCT01457352|363764357|FG000|Period 2|Did not meet eligibility criteria|3|||
105478729|NCT01457352|363764358|FG001|Period 2|Did not meet eligibility criteria|0|||
105478730|NCT01457352|363764357|FG000|Period 3|Adverse Event|1|||
105478731|NCT01457352|363764358|FG001|Period 3|Adverse Event|1|||
105478732|NCT01457352|363764357|FG000|Period 3|Withdrawal by Subject|0|||
105478733|NCT01457352|363764358|FG001|Period 3|Withdrawal by Subject|2|||
105478734|NCT01457352|363764357|FG000|Period 3|incorrect treatment|0|||
105478735|NCT01457352|363764358|FG001|Period 3|incorrect treatment|1|||
105478736|NCT01457352|363764357|FG000|Period 3|Sponsor's withdrawal|0|||
105478737|NCT01457352|363764358|FG001|Period 3|Sponsor's withdrawal|1|||
105478738|NCT03254459|363765893|FG000|Overall Study|Adverse Event|7|||
105478739|NCT03254459|363765894|FG001|Overall Study|Adverse Event|20|||
105478740|NCT03254459|363765893|FG000|Overall Study|Withdrawal by Subject Consent|3|||
105478741|NCT03254459|363765894|FG001|Overall Study|Withdrawal by Subject Consent|1|||
105478742|NCT03254459|363765893|FG000|Overall Study|Lost to Follow-up|0|||
105478743|NCT03254459|363765894|FG001|Overall Study|Lost to Follow-up|1|||
105478744|NCT03254459|363765893|FG000|Overall Study|Miscellaneous|0|||
105478745|NCT03254459|363765894|FG001|Overall Study|Miscellaneous|1|||
105478746|NCT00727441|363765897|FG000|Overall Study|Disease Progression|11|||
105478747|NCT00727441|363765898|FG001|Overall Study|Disease Progression|14|||
105478748|NCT00727441|363765899|FG002|Overall Study|Disease Progression|17|||
105478749|NCT00727441|363765897|FG000|Overall Study|Eligibility|7|||
105478750|NCT00727441|363765898|FG001|Overall Study|Eligibility|5|||
105478751|NCT00727441|363765899|FG002|Overall Study|Eligibility|7|||
105478752|NCT00727441|363765897|FG000|Overall Study|Death|0|||
105478753|NCT00727441|363765898|FG001|Overall Study|Death|1|||
105478754|NCT00727441|363765899|FG002|Overall Study|Death|1|||
105478755|NCT00727441|363765897|FG000|Overall Study|Physician Decision|0|||
105478756|NCT00727441|363765898|FG001|Overall Study|Physician Decision|1|||
105726232|NCT02690701|364653490|FG001|Treatment Period 2|Lack of Efficacy|0|||
105726233|NCT02690701|364653489|FG000|Treatment Period 2|Lost to Follow-up|0|||
105726234|NCT02690701|364653490|FG001|Treatment Period 2|Lost to Follow-up|2|||
105478757|NCT00727441|363765899|FG002|Overall Study|Physician Decision|0|||
105726235|NCT02690701|364653489|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105726236|NCT02690701|364653490|FG001|Treatment Period 2|Withdrawal by Subject|2|||
105478758|NCT00727441|363765897|FG000|Overall Study|Withdrawal by Subject|0|||
105478759|NCT00727441|363765898|FG001|Overall Study|Withdrawal by Subject|1|||
105478760|NCT00727441|363765899|FG002|Overall Study|Withdrawal by Subject|0|||
105478761|NCT00745849|363765900|FG000|First Intervention|Withdrawal by Subject|0|||
105478762|NCT00745849|363765901|FG001|First Intervention|Withdrawal by Subject|1|||
105478763|NCT00745849|363765900|FG000|First Intervention|Lost to Follow-up|1|||
105478764|NCT00745849|363765901|FG001|First Intervention|Lost to Follow-up|1|||
105478765|NCT00745849|363765900|FG000|Second Intervention|Lost to Follow-up|2|||
105478766|NCT00745849|363765901|FG001|Second Intervention|Lost to Follow-up|1|||
105726237|NCT02690701|364653489|FG000|Treatment Period 2|Protocol Violation|0|||
105478767|NCT02600871|363765902|FG000|Overall Study|Lost to Follow-up|13|||
105478768|NCT02600871|363765903|FG001|Overall Study|Lost to Follow-up|10|||
105478769|NCT00617669|363765904|FG000|Overall Study|Withdrawal by Subject|71|||
105478770|NCT00617669|363765905|FG001|Overall Study|Withdrawal by Subject|77|||
105726238|NCT02690701|364653490|FG001|Treatment Period 2|Protocol Violation|1|||
105353185|NCT00262002|363297108|FG001|Overall Study|Protocol Violation|2|||
105353186|NCT00262002|363297109|FG002|Overall Study|Protocol Violation|0|||
105353187|NCT00262002|363297110|FG003|Overall Study|Protocol Violation|2|||
105353188|NCT00262002|363297111|FG004|Overall Study|Protocol Violation|5|||
105353189|NCT00262002|363297112|FG005|Overall Study|Protocol Violation|3|||
105353190|NCT00262002|363297113|FG006|Overall Study|Protocol Violation|2|||
105353191|NCT00262002|363297107|FG000|Overall Study|Unable to classify|0|||
105353192|NCT00262002|363297108|FG001|Overall Study|Unable to classify|0|||
105353193|NCT00262002|363297109|FG002|Overall Study|Unable to classify|0|||
105353194|NCT00262002|363297110|FG003|Overall Study|Unable to classify|0|||
105353195|NCT00262002|363297111|FG004|Overall Study|Unable to classify|0|||
105726239|NCT01672957|364653492|FG000|Overall Study|Protocol Violation|48|||
105726240|NCT01672957|364653492|FG000|Overall Study|Death|2|||
105726241|NCT01672957|364653492|FG000|Overall Study|ICF Signed After Transplantation|5|||
105726242|NCT01442181|364653494|FG000|Overall Study|patient refused surgery|1|||
105726243|NCT01442181|364653495|FG001|Overall Study|patient refused surgery|0|||
105726244|NCT01442181|364653494|FG000|Overall Study|no insurance for surgery|1|||
105726245|NCT01442181|364653495|FG001|Overall Study|no insurance for surgery|0|||
105726246|NCT01442181|364653494|FG000|Overall Study|low ejection factor|0|||
105726247|NCT01442181|364653495|FG001|Overall Study|low ejection factor|1|||
105726248|NCT01442181|364653494|FG000|Overall Study|Lost to Follow-up|1|||
105726249|NCT01442181|364653495|FG001|Overall Study|Lost to Follow-up|1|||
105726250|NCT01442181|364653494|FG000|Overall Study|patient in an additional study|1|||
105726251|NCT01442181|364653495|FG001|Overall Study|patient in an additional study|0|||
105726252|NCT01442181|364653494|FG000|Overall Study|atrial fibrillation not noted|0|||
105353196|NCT00262002|363297112|FG005|Overall Study|Unable to classify|0|||
105353197|NCT00262002|363297113|FG006|Overall Study|Unable to classify|2|||
105353198|NCT03885999|363297114|FG000|Overall Study|Adverse Event|1|||
105726253|NCT01442181|364653495|FG001|Overall Study|atrial fibrillation not noted|1|||
105726254|NCT01658514|364653496|FG000|Overall Study|Protocol Violation|1|||
105793935|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
105793936|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
105793937|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
105793938|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
105353199|NCT01451554|363297115|FG000|Overall Study|Withdrawal by Subject|14|||
105353200|NCT01451554|363297116|FG001|Overall Study|Withdrawal by Subject|9|||
105353201|NCT01790516|363297117|FG000|Overall Study|Physician Decision|1|||
105563007|NCT01338025|364057564|FG001|Overall Study|Withdrawal by Subject|2|||
105563008|NCT01338025|364057563|FG000|Overall Study|Found ineligible after starting|1|||
105563009|NCT01338025|364057564|FG001|Overall Study|Found ineligible after starting|0|||
105563010|NCT04349280|364057565|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
105563011|NCT04349280|364057566|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
105563012|NCT04349280|364057565|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
105563013|NCT04349280|364057566|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
105563014|NCT04349280|364057565|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
105563015|NCT04349280|364057566|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
105563016|NCT02532179|364059440|FG000|Overall Study|Lost to Follow-up|1|||
105563017|NCT02532179|364059440|FG000|Overall Study|Pregnancy|1|||
105563018|NCT02532179|364059440|FG000|Overall Study|Subject received depot steroid injection|1|||
105353202|NCT01790516|363297118|FG001|Overall Study|Physician Decision|0|||
105353203|NCT02749799|363297119|FG000|Overall Study|Adverse Event|2|||
105353204|NCT02749799|363297119|FG000|Overall Study|Lost to Follow-up|4|||
105353205|NCT02749799|363297119|FG000|Overall Study|Protocol Violation|1|||
105353206|NCT02749799|363297119|FG000|Overall Study|Withdrawal by Subject|1|||
105353207|NCT03178851|363297120|FG000|Overall Study|Death|48|||
105353208|NCT03178851|363297121|FG001|Overall Study|Death|2|||
105353209|NCT03178851|363297122|FG002|Overall Study|Death|25|||
105353210|NCT03178851|363297120|FG000|Overall Study|Withdrawal by Subject|8|||
105563019|NCT01337674|364059443|FG000|Treatment Period 1|Adverse Event|0|||
105563020|NCT01337674|364059444|FG001|Treatment Period 1|Adverse Event|1|||
105563021|NCT01337674|364059445|FG002|Treatment Period 1|Adverse Event|0|||
105563022|NCT01337674|364059446|FG003|Treatment Period 1|Adverse Event|0|||
105726255|NCT01658514|364653497|FG001|Overall Study|Protocol Violation|0|||
105726256|NCT01658514|364653498|FG002|Overall Study|Protocol Violation|2|||
105726257|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
105726258|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
105353211|NCT03178851|363297121|FG001|Overall Study|Withdrawal by Subject|0|||
105478771|NCT00617669|363765904|FG000|Overall Study|Lost to Follow-up|3|||
105478772|NCT00617669|363765905|FG001|Overall Study|Lost to Follow-up|2|||
105478773|NCT00617669|363765904|FG000|Overall Study|Adverse Event|87|||
105478774|NCT00617669|363765905|FG001|Overall Study|Adverse Event|76|||
105478775|NCT00617669|363765904|FG000|Overall Study|Protocol Violation|2|||
105478776|NCT00617669|363765905|FG001|Overall Study|Protocol Violation|3|||
105478777|NCT00617669|363765904|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
105478778|NCT00617669|363765905|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
105478779|NCT00617669|363765904|FG000|Overall Study|Patients randomized but not treated|2|||
105563023|NCT01337674|364059443|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
105563024|NCT01337674|364059444|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
105563025|NCT01337674|364059445|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
105563026|NCT01337674|364059446|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
105563027|NCT01337674|364059443|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105563028|NCT01337674|364059444|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105563029|NCT01337674|364059445|FG002|Treatment Period 2|Withdrawal by Subject|1|||
105563030|NCT01337674|364059446|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105563031|NCT00119405|364059447|FG000|Overall Study|Withdrawal by Subject|1|||
105563032|NCT01735201|364059448|FG000|Overall Study|Adverse Event|1|||
105563033|NCT01735201|364059449|FG001|Overall Study|Adverse Event|1|||
105563034|NCT01735201|364059450|FG002|Overall Study|Adverse Event|0|||
105563035|NCT01735201|364059451|FG003|Overall Study|Adverse Event|1|||
105563036|NCT01735201|364059452|FG004|Overall Study|Adverse Event|1|||
105563037|NCT01735201|364059453|FG005|Overall Study|Adverse Event|3|||
105563038|NCT01735201|364059454|FG006|Overall Study|Adverse Event|2|||
105726259|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
105726260|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
105726261|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
105726262|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
105726263|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
105726264|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
105726265|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
105726266|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
105726267|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
105726268|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
105726269|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
105726270|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
105726271|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
105726272|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
105726273|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
105726274|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
105726275|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
105726276|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
105726277|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
105726278|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
105726279|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
105726280|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
105726281|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
105726282|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
105726283|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
105726284|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
105726285|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
105726286|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
105726287|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
105726288|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
105726289|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
105726290|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
105726291|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
105726292|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
105726293|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
105726294|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
105726295|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
105563039|NCT01735201|364059455|FG007|Overall Study|Adverse Event|1|||
105563040|NCT01735201|364059448|FG000|Overall Study|Personal Reasons|1|||
105726296|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
105726297|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
105726298|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
105563041|NCT01735201|364059449|FG001|Overall Study|Personal Reasons|0|||
105793939|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
105793940|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
105793941|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
105793942|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
105793943|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
105793944|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
105793945|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
105793946|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
105793947|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
105793948|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
105793949|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
105793950|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
105793951|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
105793952|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
105793953|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
105793954|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
105793955|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
105793956|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
105793957|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
105793958|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
105793959|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
105793960|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
105793961|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
105793962|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
105793963|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
105793964|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
105793965|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
105793966|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
105793967|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
105793968|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
105793969|NCT01915498|364900761|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793970|NCT01915498|364900762|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793971|NCT01915498|364900763|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793972|NCT01915498|364900764|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793973|NCT01915498|364900765|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793974|NCT01915498|364900766|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793975|NCT01915498|364900767|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793976|NCT01915498|364900768|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793977|NCT01915498|364900769|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793978|NCT01915498|364900770|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793979|NCT01915498|364900771|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793980|NCT01915498|364900772|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793981|NCT01915498|364900773|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793982|NCT01915498|364900774|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793983|NCT01915498|364900775|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793984|NCT01915498|364900776|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793985|NCT01915498|364900777|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793986|NCT01915498|364900778|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793987|NCT01915498|364900779|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
105793988|NCT01915498|364900761|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793989|NCT01915498|364900762|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793990|NCT01915498|364900763|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793991|NCT01915498|364900764|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793992|NCT01915498|364900765|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793993|NCT01915498|364900766|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105726299|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
105726300|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
105726301|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
105726302|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
105726303|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
105726304|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
105726305|NCT01624142|364653505|FG000|Overall Study|Withdrawal by Subject|14|||
105726306|NCT01624142|364653506|FG001|Overall Study|Withdrawal by Subject|4|||
105726307|NCT01624142|364653505|FG000|Overall Study|Death|3|||
105726308|NCT01624142|364653506|FG001|Overall Study|Death|6|||
105726309|NCT01624142|364653505|FG000|Overall Study|Study Closure|12|||
105726310|NCT01624142|364653506|FG001|Overall Study|Study Closure|6|||
105726311|NCT01624142|364653505|FG000|Overall Study|Lost to Follow-up|2|||
105726312|NCT01624142|364653506|FG001|Overall Study|Lost to Follow-up|0|||
105726313|NCT01624142|364653505|FG000|Overall Study|Other|1|||
105726314|NCT01624142|364653506|FG001|Overall Study|Other|0|||
105726315|NCT02747004|364653507|FG000|Overall Study|Withdrawal by Subject|8|||
105726316|NCT02747004|364653508|FG001|Overall Study|Withdrawal by Subject|5|||
105726317|NCT02747004|364653509|FG002|Overall Study|Withdrawal by Subject|4|||
105726318|NCT02747004|364653507|FG000|Overall Study|Lost to Follow-up|1|||
105726319|NCT02747004|364653508|FG001|Overall Study|Lost to Follow-up|2|||
105726320|NCT02747004|364653509|FG002|Overall Study|Lost to Follow-up|2|||
105726321|NCT02747004|364653507|FG000|Overall Study|on study treatment/follow-up|48|||
105726322|NCT02747004|364653508|FG001|Overall Study|on study treatment/follow-up|42|||
105726323|NCT02747004|364653509|FG002|Overall Study|on study treatment/follow-up|41|||
105726324|NCT00686543|364653510|FG000|Overall Study|Adverse Event|9|||
105726325|NCT00686543|364653511|FG001|Overall Study|Adverse Event|1|||
105726326|NCT00686543|364653512|FG002|Overall Study|Adverse Event|3|||
105726327|NCT00686543|364653513|FG003|Overall Study|Adverse Event|2|||
105726328|NCT00686543|364653510|FG000|Overall Study|Withdrawal by Subject|2|||
105726329|NCT00686543|364653511|FG001|Overall Study|Withdrawal by Subject|0|||
105726330|NCT00686543|364653512|FG002|Overall Study|Withdrawal by Subject|0|||
105726331|NCT00686543|364653513|FG003|Overall Study|Withdrawal by Subject|0|||
105726332|NCT00686543|364653510|FG000|Overall Study|Protocol Violation|3|||
105726333|NCT00686543|364653511|FG001|Overall Study|Protocol Violation|0|||
105726334|NCT00686543|364653512|FG002|Overall Study|Protocol Violation|2|||
105726335|NCT00686543|364653513|FG003|Overall Study|Protocol Violation|1|||
105726336|NCT00609622|364653514|FG000|Overall Study|Adverse Event|14|||
105726337|NCT00609622|364653515|FG001|Overall Study|Adverse Event|10|||
105726338|NCT00609622|364653514|FG000|Overall Study|Withdrawal by Subject|4|||
105726339|NCT00609622|364653515|FG001|Overall Study|Withdrawal by Subject|20|||
105726340|NCT00609622|364653514|FG000|Overall Study|Death|1|||
105563042|NCT01735201|364059450|FG002|Overall Study|Personal Reasons|0|||
105726341|NCT00609622|364653515|FG001|Overall Study|Death|4|||
105726342|NCT00609622|364653514|FG000|Overall Study|Protocol Violation|1|||
105726343|NCT00609622|364653515|FG001|Overall Study|Protocol Violation|1|||
105726344|NCT00609622|364653514|FG000|Overall Study|Objective progression or relapse|47|||
105726345|NCT00609622|364653515|FG001|Overall Study|Objective progression or relapse|41|||
105726346|NCT00609622|364653514|FG000|Overall Study|Study terminated by sponsor|16|||
105726347|NCT00609622|364653515|FG001|Overall Study|Study terminated by sponsor|3|||
105726348|NCT00609622|364653514|FG000|Overall Study|Other|7|||
105726349|NCT00609622|364653515|FG001|Overall Study|Other|14|||
105563043|NCT01735201|364059451|FG003|Overall Study|Personal Reasons|0|||
105563044|NCT01735201|364059452|FG004|Overall Study|Personal Reasons|0|||
105563045|NCT01735201|364059453|FG005|Overall Study|Personal Reasons|0|||
105563046|NCT01735201|364059454|FG006|Overall Study|Personal Reasons|0|||
105563047|NCT01735201|364059455|FG007|Overall Study|Personal Reasons|0|||
105563048|NCT01735201|364059448|FG000|Overall Study|Protocol Violation|1|||
105563049|NCT01735201|364059449|FG001|Overall Study|Protocol Violation|0|||
105563050|NCT01735201|364059450|FG002|Overall Study|Protocol Violation|0|||
105563051|NCT01735201|364059451|FG003|Overall Study|Protocol Violation|0|||
105563052|NCT01735201|364059452|FG004|Overall Study|Protocol Violation|0|||
105563053|NCT01735201|364059453|FG005|Overall Study|Protocol Violation|0|||
105563054|NCT01735201|364059454|FG006|Overall Study|Protocol Violation|0|||
105563055|NCT01735201|364059455|FG007|Overall Study|Protocol Violation|0|||
105726350|NCT00609622|364653514|FG000|Overall Study|Global deterioration of health status|6|||
105726351|NCT00609622|364653515|FG001|Overall Study|Global deterioration of health status|2|||
105726352|NCT00752986|364653519|FG000|Overall Study|Withdrawal by Subject|2|||
105726353|NCT00752986|364653520|FG001|Overall Study|Withdrawal by Subject|1|||
105726354|NCT00752986|364653521|FG002|Overall Study|Withdrawal by Subject|2|||
105726355|NCT00752986|364653519|FG000|Overall Study|Protocol Violation|3|||
105726356|NCT00752986|364653520|FG001|Overall Study|Protocol Violation|0|||
105563056|NCT01735201|364059448|FG000|Overall Study|Other Miscellaneous Reasons|0|||
105563057|NCT01735201|364059449|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105563058|NCT01735201|364059450|FG002|Overall Study|Other Miscellaneous Reasons|0|||
105563059|NCT01735201|364059451|FG003|Overall Study|Other Miscellaneous Reasons|1|||
105563060|NCT01735201|364059452|FG004|Overall Study|Other Miscellaneous Reasons|0|||
105563061|NCT01735201|364059453|FG005|Overall Study|Other Miscellaneous Reasons|2|||
105563062|NCT01735201|364059454|FG006|Overall Study|Other Miscellaneous Reasons|1|||
105563063|NCT01735201|364059455|FG007|Overall Study|Other Miscellaneous Reasons|1|||
105726357|NCT00752986|364653521|FG002|Overall Study|Protocol Violation|0|||
105726358|NCT00947349|364653526|FG000|Triple Treatment Combination Period|Adverse Event|0|||
105726359|NCT00947349|364653527|FG001|Triple Treatment Combination Period|Adverse Event|1|||
105563064|NCT01553318|364059458|FG000|Overall Study|Protocol Violation|3|||
105563065|NCT01553318|364059459|FG001|Overall Study|Protocol Violation|2|||
105563066|NCT00939484|364059464|FG000|Overall Study|Progression/Relapse|8|||
105563067|NCT00939484|364059465|FG001|Overall Study|Progression/Relapse|20|||
105563068|NCT00939484|364059466|FG002|Overall Study|Progression/Relapse|3|||
105563069|NCT04493931|364059476|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
105563070|NCT04493931|364059477|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
105563071|NCT04493931|364059478|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
105563072|NCT04493931|364059479|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
105563073|NCT04493931|364059480|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
105563074|NCT04493931|364059481|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
105563075|NCT04493931|364059482|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
105563076|NCT04493931|364059476|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
105563077|NCT04493931|364059477|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
105726360|NCT00947349|364653528|FG002|Triple Treatment Combination Period|Adverse Event|0|||
105726361|NCT00947349|364653529|FG003|Triple Treatment Combination Period|Adverse Event|0|||
105726362|NCT00947349|364653526|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
105353212|NCT03178851|363297122|FG002|Overall Study|Withdrawal by Subject|0|||
105353213|NCT03178851|363297120|FG000|Overall Study|Lost to Follow-up|5|||
105353214|NCT03178851|363297121|FG001|Overall Study|Lost to Follow-up|2|||
105353215|NCT03178851|363297122|FG002|Overall Study|Lost to Follow-up|0|||
105353216|NCT03178851|363297120|FG000|Overall Study|Adverse Event|0|||
105353217|NCT03178851|363297121|FG001|Overall Study|Adverse Event|0|||
105353218|NCT03178851|363297122|FG002|Overall Study|Adverse Event|1|||
105353219|NCT03178851|363297120|FG000|Overall Study|Study Termination by Sponsor|31|||
105563078|NCT04493931|364059478|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
105563079|NCT04493931|364059479|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
105563080|NCT04493931|364059480|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
105726363|NCT00947349|364653527|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
105793994|NCT01915498|364900767|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105563081|NCT04493931|364059481|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
105563082|NCT04493931|364059482|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
105563083|NCT04493931|364059476|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
105726364|NCT00947349|364653528|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
105726365|NCT00947349|364653529|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
105353220|NCT03178851|363297121|FG001|Overall Study|Study Termination by Sponsor|7|||
105353221|NCT03178851|363297122|FG002|Overall Study|Study Termination by Sponsor|26|||
105478780|NCT00617669|363765905|FG001|Overall Study|Patients randomized but not treated|3|||
105478781|NCT03328182|363765906|FG000|Overall Study|Withdrawal by Subject|1|||
105478782|NCT03328182|363765906|FG000|Overall Study|Protocol Violation|2|||
105478783|NCT03328182|363765906|FG000|Overall Study|No Product Evaluated|1|||
105478784|NCT01964755|363765907|FG000|Overall Study|Death|2|||
105478785|NCT01012219|363765908|FG000|Period 1|Withdrawal by Subject|1|||
105478786|NCT01012219|363765908|FG000|Period 2|Withdrawal by Subject|1|||
105478787|NCT00003590|363765911|FG000|Overall Study|Ineligible Patient|1|||
105478788|NCT00003590|363765911|FG000|Overall Study|Adverse Event|7|||
105478789|NCT00003590|363765911|FG000|Overall Study|Withdrawal by Subject|1|||
105478790|NCT00003590|363765911|FG000|Overall Study|Lack of Efficacy|11|||
105478791|NCT00003590|363765911|FG000|Overall Study|Death|1|||
105478792|NCT00003590|363765911|FG000|Overall Study|Physician Decision|1|||
105478793|NCT01909791|363765915|FG000|Overall Study|Death|9|||
105478794|NCT01909791|363765916|FG001|Overall Study|Death|8|||
105478795|NCT01909791|363765917|FG002|Overall Study|Death|4|||
105478796|NCT01909791|363765915|FG000|Overall Study|Withdrawal by Subject|5|||
105478797|NCT01909791|363765916|FG001|Overall Study|Withdrawal by Subject|9|||
105478798|NCT01909791|363765917|FG002|Overall Study|Withdrawal by Subject|13|||
105478799|NCT01909791|363765915|FG000|Overall Study|Lost to Follow-up|5|||
105478800|NCT01909791|363765916|FG001|Overall Study|Lost to Follow-up|11|||
105478801|NCT01909791|363765917|FG002|Overall Study|Lost to Follow-up|10|||
105478802|NCT01909791|363765915|FG000|Overall Study|Missed Visit|2|||
105478803|NCT01909791|363765916|FG001|Overall Study|Missed Visit|0|||
105478804|NCT01909791|363765917|FG002|Overall Study|Missed Visit|1|||
105478805|NCT01236547|363765919|FG000|Overall Study|Protocol Violation|0|||
105478806|NCT01236547|363765920|FG001|Overall Study|Protocol Violation|1|||
105478807|NCT01236547|363765921|FG002|Overall Study|Protocol Violation|1|||
105478808|NCT01236547|363765922|FG003|Overall Study|Protocol Violation|6|||
105478809|NCT01236547|363765923|FG004|Overall Study|Protocol Violation|12|||
105478810|NCT01022398|363765928|FG000|Overall Study|Study terminated|2|||
105478811|NCT01022398|363765929|FG001|Overall Study|Study terminated|2|||
105478812|NCT00870103|363765930|FG000|Overall Study|Physician Decision|2|||
105478813|NCT00870103|363765930|FG000|Overall Study|Lost to Follow-up|2|||
105478814|NCT03179202|363765931|FG000|Overall Study|Screen Failure|67|||
105478815|NCT03179202|363765931|FG000|Overall Study|Subject Lost to Follow Up|12|||
105478816|NCT03179202|363765931|FG000|Overall Study|Withdrawal by Subject|7|||
105478817|NCT03179202|363765931|FG000|Overall Study|Adverse Event|3|||
105478818|NCT03179202|363765931|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
105478819|NCT03179202|363765931|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
105478820|NCT03595618|363765935|FG000|Overall Study|Adverse Event|16|||
105478821|NCT03595618|363765936|FG001|Overall Study|Adverse Event|17|||
105478822|NCT03595618|363765937|FG002|Overall Study|Adverse Event|20|||
105478823|NCT03595618|363765938|FG003|Overall Study|Adverse Event|8|||
105478824|NCT03595618|363765935|FG000|Overall Study|Withdrawal by Subject|12|||
105478825|NCT03595618|363765936|FG001|Overall Study|Withdrawal by Subject|14|||
105478826|NCT03595618|363765937|FG002|Overall Study|Withdrawal by Subject|14|||
105478827|NCT03595618|363765938|FG003|Overall Study|Withdrawal by Subject|10|||
105478828|NCT03595618|363765935|FG000|Overall Study|Lost to Follow-up|6|||
105478829|NCT03595618|363765936|FG001|Overall Study|Lost to Follow-up|4|||
105478830|NCT03595618|363765937|FG002|Overall Study|Lost to Follow-up|5|||
105478831|NCT03595618|363765938|FG003|Overall Study|Lost to Follow-up|6|||
105478832|NCT03595618|363765935|FG000|Overall Study|Protocol Violation|2|||
105478833|NCT03595618|363765936|FG001|Overall Study|Protocol Violation|0|||
105478834|NCT03595618|363765937|FG002|Overall Study|Protocol Violation|6|||
105478835|NCT03595618|363765938|FG003|Overall Study|Protocol Violation|2|||
105478836|NCT03595618|363765935|FG000|Overall Study|Physician Decision|0|||
105478837|NCT03595618|363765936|FG001|Overall Study|Physician Decision|0|||
105478838|NCT03595618|363765937|FG002|Overall Study|Physician Decision|1|||
105478839|NCT03595618|363765938|FG003|Overall Study|Physician Decision|2|||
105478840|NCT03595618|363765935|FG000|Overall Study|Miscellaneous|7|||
105478841|NCT03595618|363765936|FG001|Overall Study|Miscellaneous|5|||
105478842|NCT03595618|363765937|FG002|Overall Study|Miscellaneous|10|||
105478843|NCT03595618|363765938|FG003|Overall Study|Miscellaneous|6|||
105478844|NCT01782469|363765942|FG000|Overall Study|Lost to Follow-up|1|||
105478845|NCT02184572|363765947|FG000|Overall Study|Lost to Follow-up|29|||
105478846|NCT02184572|363765948|FG001|Overall Study|Lost to Follow-up|21|||
105478847|NCT02184572|363765947|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
105478848|NCT02184572|363765948|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
105478849|NCT02184572|363765947|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
105478850|NCT02184572|363765948|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
105563084|NCT04493931|364059477|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
105563085|NCT04493931|364059478|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
105563086|NCT04493931|364059479|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
105563087|NCT04493931|364059480|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
105563088|NCT04493931|364059481|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
105563089|NCT04493931|364059482|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
105563090|NCT04493931|364059476|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
105563091|NCT04493931|364059477|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
105563092|NCT04493931|364059478|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
105563093|NCT04493931|364059479|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
105563094|NCT04493931|364059480|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
105563095|NCT04493931|364059481|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
105563096|NCT04493931|364059482|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
105563097|NCT00409682|364059483|FG000|Open-label Induction Period|Adverse Event|1|||
105563098|NCT00409682|364059484|FG001|Open-label Induction Period|Adverse Event|0|||
105563099|NCT00409682|364059485|FG002|Open-label Induction Period|Adverse Event|0|||
105563100|NCT00409682|364059483|FG000|Open-label Induction Period|Lack of Efficacy|1|||
105563101|NCT00409682|364059484|FG001|Open-label Induction Period|Lack of Efficacy|0|||
105563102|NCT00409682|364059485|FG002|Open-label Induction Period|Lack of Efficacy|0|||
105563103|NCT00409682|364059483|FG000|Open-label Induction Period|Protocol Violation|1|||
105563104|NCT00409682|364059484|FG001|Open-label Induction Period|Protocol Violation|0|||
105563105|NCT00409682|364059485|FG002|Open-label Induction Period|Protocol Violation|0|||
105563106|NCT00409682|364059483|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
105563107|NCT00409682|364059484|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
105563108|NCT00409682|364059485|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
105563109|NCT00409682|364059483|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
105563110|NCT00409682|364059484|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
105563111|NCT00409682|364059485|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
105563112|NCT00409682|364059483|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
105563113|NCT00409682|364059484|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
105563114|NCT00409682|364059485|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
105563115|NCT00409682|364059483|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
105563116|NCT00409682|364059484|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
105563117|NCT00409682|364059485|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
105563118|NCT00409682|364059483|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
105563119|NCT00409682|364059484|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
105563120|NCT00409682|364059485|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
105563121|NCT00409682|364059483|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
105563122|NCT00409682|364059484|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
105563123|NCT00409682|364059485|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
105563124|NCT00409682|364059483|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
105563125|NCT00409682|364059484|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
105563126|NCT00409682|364059485|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
105563127|NCT02657317|364059491|FG000|Overall Study|Withdrawal by Subject|2|||
105563128|NCT02657317|364059492|FG001|Overall Study|Withdrawal by Subject|0|||
105563129|NCT02657317|364059491|FG000|Overall Study|Lost to Follow-up|3|||
105563130|NCT02657317|364059492|FG001|Overall Study|Lost to Follow-up|3|||
105563131|NCT01201811|364059493|FG000|Overall Study|Adverse Event|6|||
105563132|NCT01201811|364059493|FG000|Overall Study|Disease progression|3|||
105563133|NCT01201811|364059493|FG000|Overall Study|Withdrawal by Subject|3|||
105563134|NCT01201811|364059493|FG000|Overall Study|Death|4|||
105563135|NCT01201811|364059493|FG000|Overall Study|Treatment Failure|2|||
105563136|NCT01201811|364059493|FG000|Overall Study|Physician Decision|1|||
105563137|NCT03494166|364059494|FG000|Overall Study|Death|0|||
105563138|NCT03494166|364059495|FG001|Overall Study|Death|0|||
105563139|NCT03494166|364059496|FG002|Overall Study|Death|0|||
105563140|NCT03494166|364059497|FG003|Overall Study|Death|1|||
105563141|NCT03494166|364059498|FG004|Overall Study|Death|3|||
105563142|NCT03494166|364059499|FG005|Overall Study|Death|0|||
105563143|NCT03494166|364059494|FG000|Overall Study|Lost to Follow-up|2|||
105563144|NCT03494166|364059495|FG001|Overall Study|Lost to Follow-up|2|||
105563145|NCT03494166|364059496|FG002|Overall Study|Lost to Follow-up|2|||
105563146|NCT03494166|364059497|FG003|Overall Study|Lost to Follow-up|2|||
105563147|NCT03494166|364059498|FG004|Overall Study|Lost to Follow-up|14|||
105563148|NCT03494166|364059499|FG005|Overall Study|Lost to Follow-up|0|||
105563149|NCT03494166|364059494|FG000|Overall Study|Withdrawal by Subject|10|||
105563150|NCT03494166|364059495|FG001|Overall Study|Withdrawal by Subject|7|||
105563151|NCT03494166|364059496|FG002|Overall Study|Withdrawal by Subject|0|||
105563152|NCT03494166|364059497|FG003|Overall Study|Withdrawal by Subject|5|||
105563153|NCT03494166|364059498|FG004|Overall Study|Withdrawal by Subject|3|||
105793995|NCT01915498|364900768|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793996|NCT01915498|364900769|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793997|NCT01915498|364900770|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793998|NCT01915498|364900771|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793999|NCT01915498|364900772|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105794000|NCT01915498|364900773|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105794001|NCT01915498|364900774|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105794002|NCT01915498|364900775|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105794003|NCT01915498|364900776|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105794004|NCT01915498|364900777|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105794005|NCT01915498|364900778|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105794006|NCT01915498|364900779|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
105794007|NCT01915498|364900761|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794008|NCT01915498|364900762|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794009|NCT01915498|364900763|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794010|NCT01915498|364900764|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794011|NCT01915498|364900765|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794012|NCT01915498|364900766|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794013|NCT01915498|364900767|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794014|NCT01915498|364900768|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794015|NCT01915498|364900769|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794016|NCT01915498|364900770|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794017|NCT01915498|364900771|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794018|NCT01915498|364900772|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794019|NCT01915498|364900773|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794020|NCT01915498|364900774|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794021|NCT01915498|364900775|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794022|NCT01915498|364900776|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794023|NCT01915498|364900777|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794024|NCT01915498|364900778|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794025|NCT01915498|364900779|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
105794026|NCT05004181|364900781|FG000|Overall Study|Withdrawal of consent|0|||
105794027|NCT05004181|364900782|FG001|Overall Study|Withdrawal of consent|0|||
105794028|NCT05004181|364900783|FG002|Overall Study|Withdrawal of consent|1|||
105794029|NCT05004181|364900784|FG003|Overall Study|Withdrawal of consent|3|||
105794030|NCT05004181|364900785|FG004|Overall Study|Withdrawal of consent|3|||
105794031|NCT05004181|364900786|FG005|Overall Study|Withdrawal of consent|0|||
105794032|NCT05004181|364900787|FG006|Overall Study|Withdrawal of consent|30|||
105794033|NCT05004181|364900788|FG007|Overall Study|Withdrawal of consent|9|||
105794034|NCT05004181|364900789|FG008|Overall Study|Withdrawal of consent|3|||
105794035|NCT05004181|364900790|FG009|Overall Study|Withdrawal of consent|2|||
105794036|NCT05004181|364900791|FG010|Overall Study|Withdrawal of consent|5|||
105794037|NCT05004181|364900792|FG011|Overall Study|Withdrawal of consent|1|||
105794038|NCT05004181|364900781|FG000|Overall Study|Lost to Follow-up|2|||
105794039|NCT05004181|364900782|FG001|Overall Study|Lost to Follow-up|4|||
105794040|NCT05004181|364900783|FG002|Overall Study|Lost to Follow-up|2|||
105794041|NCT05004181|364900784|FG003|Overall Study|Lost to Follow-up|3|||
105794042|NCT05004181|364900785|FG004|Overall Study|Lost to Follow-up|5|||
105794043|NCT05004181|364900786|FG005|Overall Study|Lost to Follow-up|2|||
105794044|NCT05004181|364900787|FG006|Overall Study|Lost to Follow-up|15|||
105794045|NCT05004181|364900788|FG007|Overall Study|Lost to Follow-up|12|||
105794046|NCT05004181|364900789|FG008|Overall Study|Lost to Follow-up|38|||
105794047|NCT05004181|364900790|FG009|Overall Study|Lost to Follow-up|6|||
105794048|NCT05004181|364900791|FG010|Overall Study|Lost to Follow-up|6|||
105794049|NCT05004181|364900792|FG011|Overall Study|Lost to Follow-up|0|||
105794050|NCT05004181|364900781|FG000|Overall Study|Death|0|||
105794051|NCT05004181|364900782|FG001|Overall Study|Death|0|||
105794052|NCT05004181|364900783|FG002|Overall Study|Death|0|||
105794053|NCT05004181|364900784|FG003|Overall Study|Death|0|||
105794054|NCT05004181|364900785|FG004|Overall Study|Death|0|||
105794055|NCT05004181|364900786|FG005|Overall Study|Death|0|||
105794056|NCT05004181|364900787|FG006|Overall Study|Death|1|||
105794057|NCT05004181|364900788|FG007|Overall Study|Death|0|||
105794058|NCT05004181|364900789|FG008|Overall Study|Death|2|||
105794059|NCT05004181|364900790|FG009|Overall Study|Death|0|||
105794060|NCT05004181|364900791|FG010|Overall Study|Death|0|||
105794061|NCT05004181|364900792|FG011|Overall Study|Death|0|||
105794062|NCT05004181|364900781|FG000|Overall Study|Physician Decision|0|||
105794063|NCT05004181|364900782|FG001|Overall Study|Physician Decision|0|||
105794064|NCT05004181|364900783|FG002|Overall Study|Physician Decision|0|||
105794065|NCT05004181|364900784|FG003|Overall Study|Physician Decision|0|||
105353222|NCT02669043|363297123|FG000|Overall Study|Didn't meet I/E criteria|4|||
105478851|NCT02184572|363765947|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
105478852|NCT02184572|363765948|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
105478853|NCT02184572|363765947|FG000|Overall Study|Traveling Outside The Country|1|||
105478854|NCT02184572|363765948|FG001|Overall Study|Traveling Outside The Country|0|||
105478855|NCT02184572|363765947|FG000|Overall Study|Withdrawal by Subject|14|||
105478856|NCT02184572|363765948|FG001|Overall Study|Withdrawal by Subject|9|||
105478857|NCT00638183|363765952|FG000|Overall Study|Adverse Event|23|||
105478858|NCT00638183|363765952|FG000|Overall Study|Lack of Efficacy|14|||
105563154|NCT03494166|364059499|FG005|Overall Study|Withdrawal by Subject|17|||
105563155|NCT03494166|364059494|FG000|Overall Study|Screen failure|1|||
105563156|NCT03494166|364059495|FG001|Overall Study|Screen failure|0|||
105563157|NCT03494166|364059496|FG002|Overall Study|Screen failure|0|||
105563158|NCT03494166|364059497|FG003|Overall Study|Screen failure|0|||
105563159|NCT03494166|364059498|FG004|Overall Study|Screen failure|1|||
105563160|NCT03494166|364059499|FG005|Overall Study|Screen failure|0|||
105563161|NCT01755702|364059504|FG000|Wash Out Period I|Other Reason|3|||
105563162|NCT01755702|364059504|FG000|Washout Period II|Other Reason|5|||
105563163|NCT00691938|364059505|FG000|Overall Study|QTc prolongation|1|||
105563164|NCT00691938|364059506|FG001|Overall Study|QTc prolongation|0|||
105794066|NCT05004181|364900785|FG004|Overall Study|Physician Decision|0|||
105794067|NCT05004181|364900786|FG005|Overall Study|Physician Decision|0|||
105478859|NCT00638183|363765952|FG000|Overall Study|Physician Decision|9|||
105478860|NCT00638183|363765952|FG000|Overall Study|Lost to Follow-up|46|||
105478861|NCT00638183|363765952|FG000|Overall Study|Other reason not defined above|27|||
105478862|NCT02350764|363765953|FG000|Overall Study|Adverse Event|4|||
105563165|NCT00691938|364059507|FG002|Overall Study|QTc prolongation|0|||
105478863|NCT02350764|363765953|FG000|Overall Study|Death|3|||
105478864|NCT02350764|363765953|FG000|Overall Study|Physician Decision|2|||
105478865|NCT02350764|363765953|FG000|Overall Study|Withdrawal by Subject|2|||
105478866|NCT02395172|363765956|FG000|Overall Study|Participants randomized but not treated|3|||
105563166|NCT00691938|364059508|FG003|Overall Study|QTc prolongation|0|||
105563167|NCT00691938|364059509|FG004|Overall Study|QTc prolongation|0|||
105563168|NCT00691938|364059510|FG005|Overall Study|QTc prolongation|0|||
105563169|NCT00691938|364059511|FG006|Overall Study|QTc prolongation|0|||
105794068|NCT05004181|364900787|FG006|Overall Study|Physician Decision|2|||
105563170|NCT01780935|364059517|FG000|Overall Study|Admin problems due to early termination|321|||
105563171|NCT01780935|364059518|FG001|Overall Study|Admin problems due to early termination|309|||
105563172|NCT01780935|364059517|FG000|Overall Study|Adverse Event|2|||
105563173|NCT01780935|364059518|FG001|Overall Study|Adverse Event|4|||
105563174|NCT01780935|364059517|FG000|Overall Study|Death|1|||
105563175|NCT01780935|364059518|FG001|Overall Study|Death|6|||
105563176|NCT01780935|364059517|FG000|Overall Study|Lost to Follow-up|2|||
105563177|NCT01780935|364059518|FG001|Overall Study|Lost to Follow-up|6|||
105563178|NCT01780935|364059517|FG000|Overall Study|Physician Decision|1|||
105563179|NCT01780935|364059518|FG001|Overall Study|Physician Decision|1|||
105563180|NCT01780935|364059517|FG000|Overall Study|Protocol deviation|0|||
105563181|NCT01780935|364059518|FG001|Overall Study|Protocol deviation|1|||
105563182|NCT01780935|364059517|FG000|Overall Study|Patient withdrew consent|8|||
105563183|NCT01780935|364059518|FG001|Overall Study|Patient withdrew consent|9|||
105563184|NCT01844284|364059519|FG000|Overall Study|Lost to Follow-up|12|||
105563185|NCT01844284|364059520|FG001|Overall Study|Lost to Follow-up|7|||
105563186|NCT02975973|364059538|FG000|Overall Study|Adverse Event|1|||
105563187|NCT02975973|364059539|FG001|Overall Study|Adverse Event|1|||
105563188|NCT02975973|364059540|FG002|Overall Study|Adverse Event|1|||
105563189|NCT02975973|364059541|FG003|Overall Study|Adverse Event|0|||
105563190|NCT03685591|364059549|FG000|Overall Study|Global Deterioration of Health Status|0|||
105563191|NCT03685591|364059550|FG001|Overall Study|Global Deterioration of Health Status|0|||
105563192|NCT03685591|364059551|FG002|Overall Study|Global Deterioration of Health Status|0|||
105563193|NCT03685591|364059552|FG003|Overall Study|Global Deterioration of Health Status|1|||
105563194|NCT03685591|364059553|FG004|Overall Study|Global Deterioration of Health Status|2|||
105563195|NCT03685591|364059554|FG005|Overall Study|Global Deterioration of Health Status|4|||
105563196|NCT03685591|364059555|FG006|Overall Study|Global Deterioration of Health Status|1|||
105563197|NCT03685591|364059556|FG007|Overall Study|Global Deterioration of Health Status|1|||
105563198|NCT03685591|364059557|FG008|Overall Study|Global Deterioration of Health Status|0|||
105563199|NCT03685591|364059549|FG000|Overall Study|Progressive Disease|1|||
105563200|NCT03685591|364059550|FG001|Overall Study|Progressive Disease|1|||
105563201|NCT03685591|364059551|FG002|Overall Study|Progressive Disease|0|||
105563202|NCT03685591|364059552|FG003|Overall Study|Progressive Disease|3|||
105563203|NCT03685591|364059553|FG004|Overall Study|Progressive Disease|5|||
105563204|NCT03685591|364059554|FG005|Overall Study|Progressive Disease|4|||
105563205|NCT03685591|364059555|FG006|Overall Study|Progressive Disease|3|||
105563206|NCT03685591|364059556|FG007|Overall Study|Progressive Disease|2|||
105563207|NCT03685591|364059557|FG008|Overall Study|Progressive Disease|1|||
105563208|NCT03685591|364059549|FG000|Overall Study|Other|0|||
105563209|NCT03685591|364059550|FG001|Overall Study|Other|0|||
105563210|NCT03685591|364059551|FG002|Overall Study|Other|1|||
105563211|NCT03685591|364059552|FG003|Overall Study|Other|0|||
105563212|NCT03685591|364059553|FG004|Overall Study|Other|2|||
105563213|NCT03685591|364059554|FG005|Overall Study|Other|3|||
105563214|NCT03685591|364059555|FG006|Overall Study|Other|0|||
105563215|NCT03685591|364059556|FG007|Overall Study|Other|0|||
105563216|NCT03685591|364059557|FG008|Overall Study|Other|0|||
105563217|NCT03685591|364059549|FG000|Overall Study|Withdrawal by Subject|0|||
105563218|NCT03685591|364059550|FG001|Overall Study|Withdrawal by Subject|0|||
105563219|NCT03685591|364059551|FG002|Overall Study|Withdrawal by Subject|0|||
105563220|NCT03685591|364059552|FG003|Overall Study|Withdrawal by Subject|0|||
105563221|NCT03685591|364059553|FG004|Overall Study|Withdrawal by Subject|3|||
105563222|NCT03685591|364059554|FG005|Overall Study|Withdrawal by Subject|2|||
105563223|NCT03685591|364059555|FG006|Overall Study|Withdrawal by Subject|0|||
105563224|NCT03685591|364059556|FG007|Overall Study|Withdrawal by Subject|0|||
105563225|NCT03685591|364059557|FG008|Overall Study|Withdrawal by Subject|1|||
105726366|NCT00947349|364653526|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
105726367|NCT00947349|364653527|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
105726368|NCT00947349|364653528|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
105726369|NCT00947349|364653529|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
105726370|NCT00947349|364653526|FG000|Overall Study Standard of Care|Other|0|||
105726371|NCT00947349|364653527|FG001|Overall Study Standard of Care|Other|0|||
105563226|NCT03685591|364059549|FG000|Overall Study|Adverse Event|0|||
105563227|NCT03685591|364059550|FG001|Overall Study|Adverse Event|0|||
105563228|NCT03685591|364059551|FG002|Overall Study|Adverse Event|0|||
105563229|NCT03685591|364059552|FG003|Overall Study|Adverse Event|1|||
105563230|NCT03685591|364059553|FG004|Overall Study|Adverse Event|1|||
105563231|NCT03685591|364059554|FG005|Overall Study|Adverse Event|4|||
105563232|NCT03685591|364059555|FG006|Overall Study|Adverse Event|0|||
105563233|NCT03685591|364059556|FG007|Overall Study|Adverse Event|1|||
105563234|NCT03685591|364059557|FG008|Overall Study|Adverse Event|1|||
105563235|NCT01218126|364059558|FG000|Overall Study|Adverse Event|8|||
105563236|NCT01218126|364059559|FG001|Overall Study|Adverse Event|10|||
105563237|NCT01218126|364059560|FG002|Overall Study|Adverse Event|12|||
105563238|NCT01218126|364059561|FG003|Overall Study|Adverse Event|16|||
105726372|NCT00947349|364653528|FG002|Overall Study Standard of Care|Other|0|||
105726373|NCT00947349|364653529|FG003|Overall Study Standard of Care|Other|1|||
105794069|NCT05004181|364900788|FG007|Overall Study|Physician Decision|0|||
105794070|NCT05004181|364900789|FG008|Overall Study|Physician Decision|7|||
105794071|NCT05004181|364900790|FG009|Overall Study|Physician Decision|0|||
105794072|NCT05004181|364900791|FG010|Overall Study|Physician Decision|0|||
105794073|NCT05004181|364900792|FG011|Overall Study|Physician Decision|0|||
105794074|NCT05004181|364900781|FG000|Overall Study|Withdrawal by Subject|2|||
105794075|NCT05004181|364900782|FG001|Overall Study|Withdrawal by Subject|3|||
105794076|NCT05004181|364900783|FG002|Overall Study|Withdrawal by Subject|2|||
105794077|NCT05004181|364900784|FG003|Overall Study|Withdrawal by Subject|2|||
105794078|NCT05004181|364900785|FG004|Overall Study|Withdrawal by Subject|4|||
105794079|NCT05004181|364900786|FG005|Overall Study|Withdrawal by Subject|2|||
105794080|NCT05004181|364900787|FG006|Overall Study|Withdrawal by Subject|4|||
105794081|NCT05004181|364900788|FG007|Overall Study|Withdrawal by Subject|22|||
105794082|NCT05004181|364900789|FG008|Overall Study|Withdrawal by Subject|8|||
105794083|NCT05004181|364900790|FG009|Overall Study|Withdrawal by Subject|1|||
105794084|NCT05004181|364900791|FG010|Overall Study|Withdrawal by Subject|3|||
105794085|NCT05004181|364900792|FG011|Overall Study|Withdrawal by Subject|2|||
105794086|NCT05004181|364900781|FG000|Overall Study|Protocol Violation|2|||
105794087|NCT05004181|364900782|FG001|Overall Study|Protocol Violation|3|||
105794088|NCT05004181|364900783|FG002|Overall Study|Protocol Violation|0|||
105794089|NCT05004181|364900784|FG003|Overall Study|Protocol Violation|0|||
105794090|NCT05004181|364900785|FG004|Overall Study|Protocol Violation|1|||
105794091|NCT05004181|364900786|FG005|Overall Study|Protocol Violation|0|||
105794092|NCT05004181|364900787|FG006|Overall Study|Protocol Violation|16|||
105794093|NCT05004181|364900788|FG007|Overall Study|Protocol Violation|18|||
105794094|NCT05004181|364900789|FG008|Overall Study|Protocol Violation|2|||
105794095|NCT05004181|364900790|FG009|Overall Study|Protocol Violation|2|||
105794096|NCT05004181|364900791|FG010|Overall Study|Protocol Violation|2|||
105794097|NCT05004181|364900792|FG011|Overall Study|Protocol Violation|1|||
105794098|NCT05004181|364900781|FG000|Overall Study|Not further specified|1|||
105794099|NCT05004181|364900782|FG001|Overall Study|Not further specified|0|||
105794100|NCT05004181|364900783|FG002|Overall Study|Not further specified|0|||
105794101|NCT05004181|364900784|FG003|Overall Study|Not further specified|0|||
105794102|NCT05004181|364900785|FG004|Overall Study|Not further specified|0|||
105794103|NCT05004181|364900786|FG005|Overall Study|Not further specified|0|||
105794104|NCT05004181|364900787|FG006|Overall Study|Not further specified|1|||
105794105|NCT05004181|364900788|FG007|Overall Study|Not further specified|0|||
105794106|NCT05004181|364900789|FG008|Overall Study|Not further specified|2|||
105794107|NCT05004181|364900790|FG009|Overall Study|Not further specified|1|||
105794108|NCT05004181|364900791|FG010|Overall Study|Not further specified|0|||
105794109|NCT05004181|364900792|FG011|Overall Study|Not further specified|1|||
105794110|NCT00883129|364900795|FG000|Overall Study|Adverse Event|7|||
105794111|NCT00883129|364900796|FG001|Overall Study|Adverse Event|15|||
105794112|NCT00883129|364900795|FG000|Overall Study|Withdrawal by Subject|8|||
105794113|NCT00883129|364900796|FG001|Overall Study|Withdrawal by Subject|9|||
105794114|NCT00883129|364900795|FG000|Overall Study|Non-compliance|3|||
105794115|NCT00883129|364900796|FG001|Overall Study|Non-compliance|6|||
105794116|NCT00883129|364900795|FG000|Overall Study|Lost to Follow-up|1|||
105794117|NCT00883129|364900796|FG001|Overall Study|Lost to Follow-up|2|||
105794118|NCT00883129|364900795|FG000|Overall Study|Death|1|||
105794119|NCT00883129|364900796|FG001|Overall Study|Death|2|||
105794120|NCT00883129|364900795|FG000|Overall Study|Defined Treatment Failure|0|||
105794121|NCT00883129|364900796|FG001|Overall Study|Defined Treatment Failure|2|||
105794122|NCT01966107|364900797|FG000|Overall Study|excluded from FAS|21|||
105794123|NCT01966107|364900798|FG001|Overall Study|excluded from FAS|20|||
105794124|NCT01966107|364900797|FG000|Overall Study|discontinued treatment|345|||
105794125|NCT01966107|364900798|FG001|Overall Study|discontinued treatment|372|||
105563239|NCT01218126|364059558|FG000|Overall Study|Lack of Efficacy|7|||
105563240|NCT01218126|364059559|FG001|Overall Study|Lack of Efficacy|2|||
105563241|NCT01218126|364059560|FG002|Overall Study|Lack of Efficacy|2|||
105563242|NCT01218126|364059561|FG003|Overall Study|Lack of Efficacy|6|||
105563243|NCT01218126|364059558|FG000|Overall Study|Protocol Violation|5|||
105794126|NCT01966107|364900797|FG000|Overall Study|due to study closure|164|||
105794127|NCT01966107|364900798|FG001|Overall Study|due to study closure|186|||
105794128|NCT01966107|364900797|FG000|Overall Study|withdrew from the study|272|||
105794129|NCT01966107|364900798|FG001|Overall Study|withdrew from the study|303|||
105794130|NCT01556165|364900802|FG000|Overall Study|Adverse Event|5|||
105794131|NCT01556165|364900803|FG001|Overall Study|Adverse Event|3|||
105794132|NCT01556165|364900802|FG000|Overall Study|Protocol Violation|0|||
105794133|NCT01556165|364900803|FG001|Overall Study|Protocol Violation|3|||
105794134|NCT01556165|364900802|FG000|Overall Study|Withdrawal of Consent|7|||
105563244|NCT01218126|364059559|FG001|Overall Study|Protocol Violation|2|||
105563245|NCT01218126|364059560|FG002|Overall Study|Protocol Violation|2|||
105794135|NCT01556165|364900803|FG001|Overall Study|Withdrawal of Consent|1|||
105794136|NCT00891527|364902165|FG000|Overall Study|Withdrawal by Subject|2|||
105794137|NCT03993288|364902168|FG000|Overall Study|Lost to Follow-up|2|||
105794138|NCT03993288|364902169|FG001|Overall Study|Lost to Follow-up|1|||
105794139|NCT03993288|364902168|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
105478867|NCT02395172|363765957|FG001|Overall Study|Participants randomized but not treated|31|||
105478868|NCT00717236|363765958|FG000|Double-Blind Period|Adverse Event|33|||
105478869|NCT00717236|363765959|FG001|Double-Blind Period|Adverse Event|6|||
105478870|NCT00717236|363765958|FG000|Double-Blind Period|Lack of Efficacy|6|||
105478871|NCT00717236|363765959|FG001|Double-Blind Period|Lack of Efficacy|6|||
105478872|NCT00717236|363765958|FG000|Double-Blind Period|Lost to Follow-up|3|||
105478873|NCT00717236|363765959|FG001|Double-Blind Period|Lost to Follow-up|5|||
105478874|NCT00717236|363765958|FG000|Double-Blind Period|Withdrawal by Subject|10|||
105478875|NCT00717236|363765959|FG001|Double-Blind Period|Withdrawal by Subject|2|||
105478876|NCT00717236|363765958|FG000|Double-Blind Period|Loss of efficacy|3|||
105478877|NCT00717236|363765959|FG001|Double-Blind Period|Loss of efficacy|0|||
105478878|NCT00717236|363765958|FG000|Double-Blind Period|Other: Death|1|||
105478879|NCT00717236|363765959|FG001|Double-Blind Period|Other: Death|0|||
105478880|NCT00717236|363765958|FG000|Double-Blind Period|Other: Pregnancy|1|||
105563246|NCT01218126|364059561|FG003|Overall Study|Protocol Violation|3|||
105563247|NCT01218126|364059558|FG000|Overall Study|Protocol-defined stopping criteria|1|||
105563248|NCT01218126|364059559|FG001|Overall Study|Protocol-defined stopping criteria|1|||
105563249|NCT01218126|364059560|FG002|Overall Study|Protocol-defined stopping criteria|0|||
105563250|NCT01218126|364059561|FG003|Overall Study|Protocol-defined stopping criteria|0|||
105563251|NCT01218126|364059558|FG000|Overall Study|Lost to Follow-up|0|||
105563252|NCT01218126|364059559|FG001|Overall Study|Lost to Follow-up|0|||
105563253|NCT01218126|364059560|FG002|Overall Study|Lost to Follow-up|0|||
105563254|NCT01218126|364059561|FG003|Overall Study|Lost to Follow-up|2|||
105563255|NCT01218126|364059558|FG000|Overall Study|Physician Decision|1|||
105563256|NCT01218126|364059559|FG001|Overall Study|Physician Decision|2|||
105563257|NCT01218126|364059560|FG002|Overall Study|Physician Decision|4|||
105563258|NCT01218126|364059561|FG003|Overall Study|Physician Decision|2|||
105563259|NCT01218126|364059558|FG000|Overall Study|Withdrawal by Subject|2|||
105563260|NCT01218126|364059559|FG001|Overall Study|Withdrawal by Subject|5|||
105563261|NCT01218126|364059560|FG002|Overall Study|Withdrawal by Subject|4|||
105563262|NCT01218126|364059561|FG003|Overall Study|Withdrawal by Subject|6|||
105563263|NCT00500903|364059562|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
105563264|NCT00500903|364059563|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
105563265|NCT00500903|364059564|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
105563266|NCT00500903|364059562|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
105563267|NCT00500903|364059563|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
105563268|NCT00500903|364059564|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
105563269|NCT00500903|364059562|FG000|Overall Study|Progressive Disease|41|||
105563270|NCT00500903|364059563|FG001|Overall Study|Progressive Disease|2|||
105563271|NCT00500903|364059564|FG002|Overall Study|Progressive Disease|15|||
105563272|NCT00500903|364059562|FG000|Overall Study|Patient Declined Further Treatment|0|||
105563273|NCT00500903|364059563|FG001|Overall Study|Patient Declined Further Treatment|0|||
105563274|NCT00500903|364059564|FG002|Overall Study|Patient Declined Further Treatment|3|||
105563275|NCT00500903|364059562|FG000|Overall Study|Symptomatic Deterioration|2|||
105563276|NCT00500903|364059563|FG001|Overall Study|Symptomatic Deterioration|0|||
105563277|NCT00500903|364059564|FG002|Overall Study|Symptomatic Deterioration|0|||
105563278|NCT00500903|364059562|FG000|Overall Study|Reason Not Specified|10|||
105563279|NCT00500903|364059563|FG001|Overall Study|Reason Not Specified|0|||
105563280|NCT00500903|364059564|FG002|Overall Study|Reason Not Specified|2|||
105563281|NCT00698646|364059569|FG000|Overall Study|Adverse Event|8|||
105563282|NCT00698646|364059570|FG001|Overall Study|Adverse Event|7|||
105563283|NCT00698646|364059571|FG002|Overall Study|Adverse Event|8|||
105563284|NCT00698646|364059569|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
105563285|NCT00698646|364059570|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
105563286|NCT00698646|364059571|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
105563287|NCT00698646|364059569|FG000|Overall Study|Protocol Deviation|6|||
105563288|NCT00698646|364059570|FG001|Overall Study|Protocol Deviation|2|||
105563289|NCT00698646|364059571|FG002|Overall Study|Protocol Deviation|3|||
105563290|NCT00698646|364059569|FG000|Overall Study|Withdrawal by Subject|10|||
105563291|NCT00698646|364059570|FG001|Overall Study|Withdrawal by Subject|11|||
105563292|NCT00698646|364059571|FG002|Overall Study|Withdrawal by Subject|8|||
105563293|NCT00698646|364059569|FG000|Overall Study|Lost to Follow-up|0|||
105563294|NCT00698646|364059570|FG001|Overall Study|Lost to Follow-up|0|||
105563295|NCT00698646|364059571|FG002|Overall Study|Lost to Follow-up|2|||
105478881|NCT00717236|363765959|FG001|Double-Blind Period|Other: Pregnancy|0|||
105478882|NCT00717236|363765958|FG000|Double-Blind Period|Other: Protocol Violation|2|||
105563296|NCT00698646|364059569|FG000|Overall Study|Administrative problems|1|||
105478883|NCT00717236|363765959|FG001|Double-Blind Period|Other: Protocol Violation|0|||
105478884|NCT00717236|363765958|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
105478885|NCT00717236|363765959|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
105478886|NCT00717236|363765958|FG000|Double-Blind Period|Other: Site withdrew|2|||
105478887|NCT00717236|363765959|FG001|Double-Blind Period|Other: Site withdrew|0|||
105478888|NCT00717236|363765958|FG000|Double-Blind Period|Other: Screening failure|1|||
105478889|NCT00717236|363765959|FG001|Double-Blind Period|Other: Screening failure|0|||
105478890|NCT00717236|363765958|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
105478891|NCT00717236|363765959|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
105563297|NCT00698646|364059570|FG001|Overall Study|Administrative problems|0|||
105563298|NCT00698646|364059571|FG002|Overall Study|Administrative problems|1|||
105563299|NCT00279201|364059572|FG000|Initiation|Death|1|||
105563300|NCT00279201|364059573|FG001|Initiation|Death|5|||
105563301|NCT00279201|364059574|FG002|Initiation|Death|0|||
105563302|NCT00279201|364059575|FG003|Initiation|Death|0|||
105563303|NCT00279201|364059576|FG004|Initiation|Death|0|||
105563304|NCT00279201|364059577|FG005|Initiation|Death|0|||
105563305|NCT00279201|364059572|FG000|Initiation|Adverse Event|6|||
105563306|NCT00279201|364059573|FG001|Initiation|Adverse Event|15|||
105563307|NCT00279201|364059574|FG002|Initiation|Adverse Event|0|||
105563308|NCT00279201|364059575|FG003|Initiation|Adverse Event|0|||
105563309|NCT00279201|364059576|FG004|Initiation|Adverse Event|0|||
105563310|NCT00279201|364059577|FG005|Initiation|Adverse Event|0|||
105563311|NCT00279201|364059572|FG000|Initiation|Lost to Follow-up|42|||
105563312|NCT00279201|364059573|FG001|Initiation|Lost to Follow-up|41|||
105563313|NCT00279201|364059574|FG002|Initiation|Lost to Follow-up|0|||
105563314|NCT00279201|364059575|FG003|Initiation|Lost to Follow-up|0|||
105563315|NCT00279201|364059576|FG004|Initiation|Lost to Follow-up|0|||
105563316|NCT00279201|364059577|FG005|Initiation|Lost to Follow-up|0|||
105563317|NCT00279201|364059572|FG000|Initiation|Entry Criteria Exclusion|7|||
105563318|NCT00279201|364059573|FG001|Initiation|Entry Criteria Exclusion|9|||
105563319|NCT00279201|364059574|FG002|Initiation|Entry Criteria Exclusion|0|||
105563320|NCT00279201|364059575|FG003|Initiation|Entry Criteria Exclusion|0|||
105563321|NCT00279201|364059576|FG004|Initiation|Entry Criteria Exclusion|0|||
105563322|NCT00279201|364059577|FG005|Initiation|Entry Criteria Exclusion|0|||
105563323|NCT00279201|364059572|FG000|Initiation|Protocol Violation|9|||
105563324|NCT00279201|364059573|FG001|Initiation|Protocol Violation|10|||
105563325|NCT00279201|364059574|FG002|Initiation|Protocol Violation|0|||
105563326|NCT00279201|364059575|FG003|Initiation|Protocol Violation|0|||
105563327|NCT00279201|364059576|FG004|Initiation|Protocol Violation|0|||
105563328|NCT00279201|364059577|FG005|Initiation|Protocol Violation|0|||
105563329|NCT00279201|364059572|FG000|Initiation|Withdrawal by Subject|35|||
105563330|NCT00279201|364059573|FG001|Initiation|Withdrawal by Subject|41|||
105563331|NCT00279201|364059574|FG002|Initiation|Withdrawal by Subject|0|||
105563332|NCT00279201|364059575|FG003|Initiation|Withdrawal by Subject|0|||
105563333|NCT00279201|364059576|FG004|Initiation|Withdrawal by Subject|0|||
105563334|NCT00279201|364059577|FG005|Initiation|Withdrawal by Subject|0|||
105563335|NCT00279201|364059572|FG000|Initiation|Physician Decision|15|||
105563336|NCT00279201|364059573|FG001|Initiation|Physician Decision|18|||
105563337|NCT00279201|364059574|FG002|Initiation|Physician Decision|0|||
105563338|NCT00279201|364059575|FG003|Initiation|Physician Decision|0|||
105726374|NCT00538681|364653530|FG000|Overall Study|Progressive Disease|7|||
105726375|NCT00538681|364653531|FG001|Overall Study|Progressive Disease|0|||
105563339|NCT00279201|364059576|FG004|Initiation|Physician Decision|0|||
105563340|NCT00279201|364059577|FG005|Initiation|Physician Decision|0|||
105726376|NCT00538681|364653532|FG002|Overall Study|Progressive Disease|1|||
105563341|NCT00279201|364059572|FG000|Initiation|Sponsor Decision|13|||
105563342|NCT00279201|364059573|FG001|Initiation|Sponsor Decision|5|||
105563343|NCT00279201|364059574|FG002|Initiation|Sponsor Decision|0|||
105563344|NCT00279201|364059575|FG003|Initiation|Sponsor Decision|0|||
105563345|NCT00279201|364059576|FG004|Initiation|Sponsor Decision|0|||
105563346|NCT00279201|364059577|FG005|Initiation|Sponsor Decision|0|||
105563347|NCT00279201|364059572|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
105563348|NCT00279201|364059573|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
105563349|NCT00279201|364059574|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
105794140|NCT03993288|364902169|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
105794141|NCT03993288|364902168|FG000|Overall Study|wrong randomization|0|||
105794142|NCT03993288|364902169|FG001|Overall Study|wrong randomization|1|||
105794143|NCT03993288|364902168|FG000|Overall Study|improper enrollment|0|||
105794144|NCT03993288|364902169|FG001|Overall Study|improper enrollment|1|||
105794145|NCT03993288|364902168|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
105794146|NCT03993288|364902169|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
105794147|NCT03993288|364902168|FG000|Overall Study|developed SAE|2|||
105794148|NCT03993288|364902169|FG001|Overall Study|developed SAE|0|||
105794149|NCT03993288|364902168|FG000|Overall Study|consent withdrawal|1|||
105794150|NCT03993288|364902169|FG001|Overall Study|consent withdrawal|0|||
105794151|NCT03993288|364902168|FG000|Overall Study|did not follow the treatment schedule|1|||
105794152|NCT03993288|364902169|FG001|Overall Study|did not follow the treatment schedule|0|||
105794153|NCT03993288|364902168|FG000|Overall Study|did not follow the treatment regimen|1|||
105794154|NCT03993288|364902169|FG001|Overall Study|did not follow the treatment regimen|0|||
105794155|NCT03993288|364902168|FG000|Overall Study|Adverse Event|1|||
105794156|NCT03993288|364902169|FG001|Overall Study|Adverse Event|0|||
105794157|NCT03993288|364902168|FG000|Overall Study|Withdrawal by Subject|1|||
105794158|NCT03993288|364902169|FG001|Overall Study|Withdrawal by Subject|1|||
105794159|NCT00915473|364902171|FG000|Screening|Withdrawal by Subject|1|||
105563350|NCT00279201|364059575|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
105563351|NCT00279201|364059576|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
105563352|NCT00279201|364059577|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
105563353|NCT00279201|364059572|FG000|Maintenance|Lack of Efficacy|32|||
105563354|NCT00279201|364059573|FG001|Maintenance|Lack of Efficacy|30|||
105794160|NCT00915473|364902172|FG001|Screening|Withdrawal by Subject|0|||
105794161|NCT00915473|364902171|FG000|4-week Follow Up|Lost to Follow-up|1|||
105794162|NCT00915473|364902172|FG001|4-week Follow Up|Lost to Follow-up|5|||
105794163|NCT03515837|364902173|FG000|Overall Study|Death|219|||
105794164|NCT03515837|364902174|FG001|Overall Study|Death|227|||
105794165|NCT03515837|364902173|FG000|Overall Study|Lost to Follow-up|0|||
105794166|NCT03515837|364902174|FG001|Overall Study|Lost to Follow-up|1|||
105794167|NCT03515837|364902173|FG000|Overall Study|Withdrawal by Subject|0|||
105794168|NCT03515837|364902174|FG001|Overall Study|Withdrawal by Subject|4|||
105794169|NCT03515837|364902173|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
105353223|NCT02510820|363298474|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
105794170|NCT03515837|364902174|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
105563355|NCT00279201|364059574|FG002|Maintenance|Lack of Efficacy|0|||
105563356|NCT00279201|364059575|FG003|Maintenance|Lack of Efficacy|0|||
105563357|NCT00279201|364059576|FG004|Maintenance|Lack of Efficacy|0|||
105563358|NCT00279201|364059577|FG005|Maintenance|Lack of Efficacy|0|||
105794171|NCT00819091|364902175|FG000|Overall Study|Adverse Event|3|||
105353224|NCT02510820|363298475|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
105353225|NCT02510820|363298474|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
105353226|NCT02510820|363298475|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
105794172|NCT00819091|364902176|FG001|Overall Study|Adverse Event|5|||
105353227|NCT03046056|363298476|FG000|Overall Study|Non-responder at Week 10|6|||
105353228|NCT03046056|363298477|FG001|Overall Study|Non-responder at Week 10|6|||
105353229|NCT03046056|363298478|FG002|Overall Study|Non-responder at Week 10|4|||
105353230|NCT03046056|363298476|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
105478892|NCT00717236|363765958|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
105478893|NCT00717236|363765959|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
105478894|NCT00717236|363765958|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
105478895|NCT00717236|363765959|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
105478896|NCT00717236|363765958|FG000|Double-Blind Period|Other: History of cancer|1|||
105478897|NCT00717236|363765959|FG001|Double-Blind Period|Other: History of cancer|0|||
105478898|NCT00717236|363765958|FG000|Double-Blind Period|Other: Sponsor request|1|||
105478899|NCT00717236|363765959|FG001|Double-Blind Period|Other: Sponsor request|0|||
105478900|NCT00717236|363765958|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
105478901|NCT00717236|363765959|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
105478902|NCT00717236|363765958|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
105478903|NCT00717236|363765959|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
105478904|NCT00717236|363765958|FG000|Double-Blind Period|Other: Subject moved|1|||
105478905|NCT00717236|363765959|FG001|Double-Blind Period|Other: Subject moved|1|||
105478906|NCT00717236|363765958|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
105478907|NCT00717236|363765959|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
105478908|NCT00717236|363765958|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
105478909|NCT00717236|363765959|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
105478910|NCT00717236|363765958|FG000|Double-Blind Period|Other: Transportation problems|0|||
105478911|NCT00717236|363765959|FG001|Double-Blind Period|Other: Transportation problems|1|||
105478912|NCT00717236|363765958|FG000|Double-Blind Period|Other: Investigator Decision|0|||
105478913|NCT00717236|363765959|FG001|Double-Blind Period|Other: Investigator Decision|1|||
105478914|NCT00717236|363765958|FG000|Open-Label Period|Adverse Event|29|||
105478915|NCT00717236|363765959|FG001|Open-Label Period|Adverse Event|4|||
105478916|NCT00717236|363765958|FG000|Open-Label Period|Lack of Efficacy|30|||
105478917|NCT00717236|363765959|FG001|Open-Label Period|Lack of Efficacy|8|||
105478918|NCT00717236|363765958|FG000|Open-Label Period|Lost to Follow-up|28|||
105478919|NCT00717236|363765959|FG001|Open-Label Period|Lost to Follow-up|4|||
105478920|NCT00717236|363765958|FG000|Open-Label Period|Withdrawal by Subject|20|||
105478921|NCT00717236|363765959|FG001|Open-Label Period|Withdrawal by Subject|2|||
105478922|NCT00717236|363765958|FG000|Open-Label Period|Loss of Efficacy|6|||
105478923|NCT00717236|363765959|FG001|Open-Label Period|Loss of Efficacy|1|||
105478924|NCT00717236|363765958|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
105478925|NCT00717236|363765959|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
105478926|NCT00717236|363765958|FG000|Open-Label Period|Other: Lack of Compliance|1|||
105478927|NCT00717236|363765959|FG001|Open-Label Period|Other: Lack of Compliance|1|||
105478928|NCT00717236|363765958|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
105478929|NCT00717236|363765959|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
105478930|NCT00717236|363765958|FG000|Open-Label Period|Other: Moved|1|||
105478931|NCT00717236|363765959|FG001|Open-Label Period|Other: Moved|0|||
105478932|NCT00717236|363765958|FG000|Open-Label Period|Other: Investigator Decision|1|||
105478933|NCT00717236|363765959|FG001|Open-Label Period|Other: Investigator Decision|0|||
105478934|NCT00717236|363765958|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
105478935|NCT00717236|363765959|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
105478936|NCT00717236|363765958|FG000|Open-Label Period|Other: Sponsor Request|3|||
105563359|NCT00279201|364059572|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
105563360|NCT00279201|364059573|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
105563361|NCT00279201|364059574|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
105563362|NCT00279201|364059575|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
105563363|NCT00279201|364059576|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
105563364|NCT00279201|364059577|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
105563365|NCT00279201|364059572|FG000|Maintenance|Adverse Event|4|||
105563366|NCT00279201|364059573|FG001|Maintenance|Adverse Event|4|||
105563367|NCT00279201|364059574|FG002|Maintenance|Adverse Event|0|||
105563368|NCT00279201|364059575|FG003|Maintenance|Adverse Event|0|||
105563369|NCT00279201|364059576|FG004|Maintenance|Adverse Event|0|||
105563370|NCT00279201|364059577|FG005|Maintenance|Adverse Event|0|||
105563371|NCT00279201|364059572|FG000|Maintenance|Death|4|||
105563372|NCT00279201|364059573|FG001|Maintenance|Death|4|||
105563373|NCT00279201|364059574|FG002|Maintenance|Death|0|||
105563374|NCT00279201|364059575|FG003|Maintenance|Death|0|||
105563375|NCT00279201|364059576|FG004|Maintenance|Death|0|||
105563376|NCT00279201|364059577|FG005|Maintenance|Death|0|||
105563377|NCT00279201|364059572|FG000|Maintenance|Lost to Follow-up|17|||
105563378|NCT00279201|364059573|FG001|Maintenance|Lost to Follow-up|13|||
105563379|NCT00279201|364059574|FG002|Maintenance|Lost to Follow-up|0|||
105563380|NCT00279201|364059575|FG003|Maintenance|Lost to Follow-up|0|||
105563381|NCT00279201|364059576|FG004|Maintenance|Lost to Follow-up|0|||
105563382|NCT00279201|364059577|FG005|Maintenance|Lost to Follow-up|0|||
105563383|NCT00279201|364059572|FG000|Maintenance|Entry Criteria Exclusion|1|||
105563384|NCT00279201|364059573|FG001|Maintenance|Entry Criteria Exclusion|4|||
105563385|NCT00279201|364059574|FG002|Maintenance|Entry Criteria Exclusion|0|||
105563386|NCT00279201|364059575|FG003|Maintenance|Entry Criteria Exclusion|0|||
105563387|NCT00279201|364059576|FG004|Maintenance|Entry Criteria Exclusion|0|||
105563388|NCT00279201|364059577|FG005|Maintenance|Entry Criteria Exclusion|0|||
105563389|NCT00279201|364059572|FG000|Maintenance|Protocol Violation|16|||
105563390|NCT00279201|364059573|FG001|Maintenance|Protocol Violation|24|||
105563391|NCT00279201|364059574|FG002|Maintenance|Protocol Violation|0|||
105563392|NCT00279201|364059575|FG003|Maintenance|Protocol Violation|0|||
105563393|NCT00279201|364059576|FG004|Maintenance|Protocol Violation|0|||
105563394|NCT00279201|364059577|FG005|Maintenance|Protocol Violation|0|||
105563395|NCT00279201|364059572|FG000|Maintenance|Withdrawal by Subject|18|||
105563396|NCT00279201|364059573|FG001|Maintenance|Withdrawal by Subject|18|||
105563397|NCT00279201|364059574|FG002|Maintenance|Withdrawal by Subject|0|||
105563398|NCT00279201|364059575|FG003|Maintenance|Withdrawal by Subject|0|||
105563399|NCT00279201|364059576|FG004|Maintenance|Withdrawal by Subject|0|||
105563400|NCT00279201|364059577|FG005|Maintenance|Withdrawal by Subject|0|||
105563401|NCT00279201|364059572|FG000|Maintenance|Physician Decision|9|||
105563402|NCT00279201|364059573|FG001|Maintenance|Physician Decision|9|||
105563403|NCT00279201|364059574|FG002|Maintenance|Physician Decision|0|||
105563404|NCT00279201|364059575|FG003|Maintenance|Physician Decision|0|||
105563405|NCT00279201|364059576|FG004|Maintenance|Physician Decision|0|||
105563406|NCT00279201|364059577|FG005|Maintenance|Physician Decision|0|||
105563407|NCT00279201|364059572|FG000|Maintenance|Sponsor Decision|4|||
105563408|NCT00279201|364059573|FG001|Maintenance|Sponsor Decision|0|||
105563409|NCT00279201|364059574|FG002|Maintenance|Sponsor Decision|0|||
105563410|NCT00279201|364059575|FG003|Maintenance|Sponsor Decision|0|||
105563411|NCT00279201|364059576|FG004|Maintenance|Sponsor Decision|0|||
105563412|NCT00279201|364059577|FG005|Maintenance|Sponsor Decision|0|||
105563413|NCT00279201|364059572|FG000|Maintenance|HbA1c>7.5%|123|||
105563414|NCT00279201|364059573|FG001|Maintenance|HbA1c>7.5%|126|||
105563415|NCT00279201|364059574|FG002|Maintenance|HbA1c>7.5%|0|||
105563416|NCT00279201|364059575|FG003|Maintenance|HbA1c>7.5%|0|||
105563417|NCT00279201|364059576|FG004|Maintenance|HbA1c>7.5%|0|||
105563418|NCT00279201|364059577|FG005|Maintenance|HbA1c>7.5%|0|||
105563419|NCT00279201|364059572|FG000|Intensification Addendum|Withdrawal by Subject|0|||
105563420|NCT00279201|364059573|FG001|Intensification Addendum|Withdrawal by Subject|0|||
105563421|NCT00279201|364059574|FG002|Intensification Addendum|Withdrawal by Subject|12|||
105563422|NCT00279201|364059575|FG003|Intensification Addendum|Withdrawal by Subject|14|||
105563423|NCT00279201|364059576|FG004|Intensification Addendum|Withdrawal by Subject|9|||
105478937|NCT00717236|363765959|FG001|Open-Label Period|Other: Sponsor Request|0|||
105478938|NCT00717236|363765958|FG000|Open-Label Period|Other: Cataract Surgery|1|||
105478939|NCT00717236|363765959|FG001|Open-Label Period|Other: Cataract Surgery|0|||
105478940|NCT00717236|363765958|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
105478941|NCT00717236|363765959|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
105478942|NCT00717236|363765958|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
105478943|NCT00717236|363765959|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
105478944|NCT00717236|363765958|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
105478945|NCT00717236|363765959|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
105478946|NCT00783198|363765966|FG000|Overall Study|Adverse Event|15|||
105478947|NCT00783198|363765967|FG001|Overall Study|Adverse Event|19|||
105478948|NCT00783198|363765968|FG002|Overall Study|Adverse Event|3|||
105478949|NCT00783198|363765966|FG000|Overall Study|Lost to Follow-up|11|||
105478950|NCT00783198|363765967|FG001|Overall Study|Lost to Follow-up|1|||
105478951|NCT00783198|363765968|FG002|Overall Study|Lost to Follow-up|7|||
105478952|NCT00783198|363765966|FG000|Overall Study|Withdrawal by Subject|22|||
105478953|NCT00783198|363765967|FG001|Overall Study|Withdrawal by Subject|14|||
105478954|NCT00783198|363765968|FG002|Overall Study|Withdrawal by Subject|20|||
105478955|NCT00783198|363765966|FG000|Overall Study|Noncompliance with protocol|7|||
105478956|NCT00783198|363765967|FG001|Overall Study|Noncompliance with protocol|7|||
105478957|NCT00783198|363765968|FG002|Overall Study|Noncompliance with protocol|10|||
105478958|NCT00783198|363765966|FG000|Overall Study|Did not meet protocol eligibility|0|||
105478959|NCT00783198|363765967|FG001|Overall Study|Did not meet protocol eligibility|1|||
105478960|NCT00783198|363765968|FG002|Overall Study|Did not meet protocol eligibility|0|||
105478961|NCT00783198|363765966|FG000|Overall Study|Administrative|2|||
105478962|NCT00783198|363765967|FG001|Overall Study|Administrative|1|||
105478963|NCT00783198|363765968|FG002|Overall Study|Administrative|2|||
105478964|NCT01765218|363765969|FG000|Overall Study|Protocol Violation|1|||
105563424|NCT00279201|364059577|FG005|Intensification Addendum|Withdrawal by Subject|18|||
105563425|NCT00279201|364059572|FG000|Intensification Addendum|Lost to Follow-up|0|||
105563426|NCT00279201|364059573|FG001|Intensification Addendum|Lost to Follow-up|0|||
105563427|NCT00279201|364059574|FG002|Intensification Addendum|Lost to Follow-up|4|||
105563428|NCT00279201|364059575|FG003|Intensification Addendum|Lost to Follow-up|6|||
105563429|NCT00279201|364059576|FG004|Intensification Addendum|Lost to Follow-up|7|||
105563430|NCT00279201|364059577|FG005|Intensification Addendum|Lost to Follow-up|7|||
105563431|NCT00279201|364059572|FG000|Intensification Addendum|Protocol Violation|0|||
105563432|NCT00279201|364059573|FG001|Intensification Addendum|Protocol Violation|0|||
105563433|NCT00279201|364059574|FG002|Intensification Addendum|Protocol Violation|2|||
105563434|NCT00279201|364059575|FG003|Intensification Addendum|Protocol Violation|2|||
105563435|NCT00279201|364059576|FG004|Intensification Addendum|Protocol Violation|6|||
105563436|NCT00279201|364059577|FG005|Intensification Addendum|Protocol Violation|6|||
105563437|NCT00279201|364059572|FG000|Intensification Addendum|Adverse Event|0|||
105563438|NCT00279201|364059573|FG001|Intensification Addendum|Adverse Event|0|||
105563439|NCT00279201|364059574|FG002|Intensification Addendum|Adverse Event|0|||
105563440|NCT00279201|364059575|FG003|Intensification Addendum|Adverse Event|4|||
105563441|NCT00279201|364059576|FG004|Intensification Addendum|Adverse Event|1|||
105563442|NCT00279201|364059577|FG005|Intensification Addendum|Adverse Event|3|||
105563443|NCT00279201|364059572|FG000|Intensification Addendum|Physician Decision|0|||
105563444|NCT00279201|364059573|FG001|Intensification Addendum|Physician Decision|0|||
105563445|NCT00279201|364059574|FG002|Intensification Addendum|Physician Decision|4|||
105563446|NCT00279201|364059575|FG003|Intensification Addendum|Physician Decision|1|||
105563447|NCT00279201|364059576|FG004|Intensification Addendum|Physician Decision|3|||
105563448|NCT00279201|364059577|FG005|Intensification Addendum|Physician Decision|2|||
105563449|NCT00279201|364059572|FG000|Intensification Addendum|Sponsor Decision|0|||
105794173|NCT00819091|364902175|FG000|Overall Study|Protocol Violation|0|||
105794174|NCT00819091|364902176|FG001|Overall Study|Protocol Violation|1|||
105478965|NCT01765218|363765970|FG001|Overall Study|Protocol Violation|2|||
105478966|NCT00852371|363765974|FG000|Overall Study|Lost to Follow-up|2|||
105563450|NCT00279201|364059573|FG001|Intensification Addendum|Sponsor Decision|0|||
105563451|NCT00279201|364059574|FG002|Intensification Addendum|Sponsor Decision|0|||
105563452|NCT00279201|364059575|FG003|Intensification Addendum|Sponsor Decision|0|||
105563453|NCT00279201|364059576|FG004|Intensification Addendum|Sponsor Decision|1|||
105563454|NCT00279201|364059577|FG005|Intensification Addendum|Sponsor Decision|1|||
105563455|NCT00279201|364059572|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
105563456|NCT00279201|364059573|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
105563457|NCT00279201|364059574|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
105794175|NCT00819091|364902175|FG000|Overall Study|Lost to Follow-up|2|||
105478967|NCT00852371|363765975|FG001|Overall Study|Lost to Follow-up|3|||
105478968|NCT00852371|363765976|FG002|Overall Study|Lost to Follow-up|4|||
105478969|NCT00852371|363765977|FG003|Overall Study|Lost to Follow-up|2|||
105478970|NCT04525885|363765978|FG000|Overall Study|Screen Failure|1|||
105478971|NCT04525885|363765979|FG001|Overall Study|Screen Failure|0|||
105794176|NCT00819091|364902176|FG001|Overall Study|Lost to Follow-up|0|||
105563458|NCT00279201|364059575|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
105563459|NCT00279201|364059576|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
105563460|NCT00279201|364059577|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
105563461|NCT00279201|364059572|FG000|Intensification Addendum|Lack of Efficacy|0|||
105563462|NCT00279201|364059573|FG001|Intensification Addendum|Lack of Efficacy|0|||
105563463|NCT00279201|364059574|FG002|Intensification Addendum|Lack of Efficacy|0|||
105563464|NCT00279201|364059575|FG003|Intensification Addendum|Lack of Efficacy|1|||
105563465|NCT00279201|364059576|FG004|Intensification Addendum|Lack of Efficacy|1|||
105563466|NCT00279201|364059577|FG005|Intensification Addendum|Lack of Efficacy|0|||
105563467|NCT00279201|364059572|FG000|Intensification Addendum|Death|0|||
105563468|NCT00279201|364059573|FG001|Intensification Addendum|Death|0|||
105563469|NCT00279201|364059574|FG002|Intensification Addendum|Death|0|||
105563470|NCT00279201|364059575|FG003|Intensification Addendum|Death|0|||
105563471|NCT00279201|364059576|FG004|Intensification Addendum|Death|1|||
105563472|NCT00279201|364059577|FG005|Intensification Addendum|Death|0|||
105563473|NCT02686034|364059579|FG000|Run-In Period 1|Eligibility|12|||
105563474|NCT02686034|364059580|FG001|Run-In Period 1|Eligibility|10|||
105563475|NCT02686034|364059579|FG000|Run-In Period 1|Withdrawal by Subject|4|||
105563476|NCT02686034|364059580|FG001|Run-In Period 1|Withdrawal by Subject|3|||
105563477|NCT02686034|364059579|FG000|Run-In Period 1|Lost to Follow-up|4|||
105563478|NCT02686034|364059580|FG001|Run-In Period 1|Lost to Follow-up|4|||
105563479|NCT02686034|364059579|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
105563480|NCT02686034|364059580|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
105563481|NCT02686034|364059579|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
105563482|NCT02686034|364059580|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
105563483|NCT02686034|364059579|FG000|Randomized Controlled Period 2|Adverse Event|0|||
105563484|NCT02686034|364059580|FG001|Randomized Controlled Period 2|Adverse Event|2|||
105563485|NCT02686034|364059579|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
105563486|NCT02686034|364059580|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
105563487|NCT02686034|364059579|FG000|Open Label Period 3|Lost to Follow-up|0|||
105563488|NCT02686034|364059580|FG001|Open Label Period 3|Lost to Follow-up|1|||
105563489|NCT00552084|364059581|FG000|Overall Study|Adverse Event|2|||
105563490|NCT00552084|364059582|FG001|Overall Study|Adverse Event|3|||
105563491|NCT00552084|364059581|FG000|Overall Study|Withdrawal by Subject|4|||
105563492|NCT00552084|364059582|FG001|Overall Study|Withdrawal by Subject|5|||
105563493|NCT00552084|364059581|FG000|Overall Study|Protocol Violation|1|||
105563494|NCT00552084|364059582|FG001|Overall Study|Protocol Violation|0|||
105563495|NCT00552084|364059581|FG000|Overall Study|change in anti-arrythmic drug|1|||
105563496|NCT00552084|364059582|FG001|Overall Study|change in anti-arrythmic drug|1|||
105563497|NCT04225988|364059583|FG000|Overall Study|Withdrawal by Subject|2|||
105563498|NCT04225988|364059584|FG001|Overall Study|Withdrawal by Subject|0|||
105563499|NCT01525602|364059585|FG000|Overall Study|Adverse Event|1|||
105563500|NCT01525602|364059586|FG001|Overall Study|Adverse Event|0|||
105563501|NCT01525602|364059587|FG002|Overall Study|Adverse Event|1|||
105563502|NCT01525602|364059588|FG003|Overall Study|Adverse Event|1|||
105563503|NCT01525602|364059589|FG004|Overall Study|Adverse Event|3|||
105563504|NCT01525602|364059590|FG005|Overall Study|Adverse Event|3|||
105563505|NCT01525602|364059591|FG006|Overall Study|Adverse Event|0|||
105563506|NCT01525602|364059592|FG007|Overall Study|Adverse Event|1|||
105563507|NCT01525602|364059585|FG000|Overall Study|Disease progression|6|||
105563508|NCT01525602|364059586|FG001|Overall Study|Disease progression|3|||
105794177|NCT00819091|364902175|FG000|Overall Study|Withdrawal by Subject|1|||
105563509|NCT01525602|364059587|FG002|Overall Study|Disease progression|2|||
105563510|NCT01525602|364059588|FG003|Overall Study|Disease progression|5|||
105563511|NCT01525602|364059589|FG004|Overall Study|Disease progression|22|||
105563512|NCT01525602|364059590|FG005|Overall Study|Disease progression|2|||
105563513|NCT01525602|364059591|FG006|Overall Study|Disease progression|3|||
105563514|NCT01525602|364059592|FG007|Overall Study|Disease progression|3|||
105563515|NCT01525602|364059585|FG000|Overall Study|Clinical progression|2|||
105563516|NCT01525602|364059586|FG001|Overall Study|Clinical progression|0|||
105794178|NCT00819091|364902176|FG001|Overall Study|Withdrawal by Subject|2|||
105794179|NCT00819091|364902175|FG000|Overall Study|Other|1|||
105794180|NCT00819091|364902176|FG001|Overall Study|Other|2|||
105794181|NCT01788163|364902177|FG000|Overall Study|Other|53|||
105794182|NCT01788163|364902178|FG001|Overall Study|Other|0|||
105794183|NCT01788163|364902179|FG002|Overall Study|Other|0|||
105794184|NCT01788163|364902180|FG003|Overall Study|Other|0|||
105794185|NCT01788163|364902181|FG004|Overall Study|Other|0|||
105794186|NCT01788163|364902182|FG005|Overall Study|Other|7|||
105794187|NCT01788163|364902183|FG006|Overall Study|Other|1|||
105794188|NCT01788163|364902184|FG007|Overall Study|Other|48|||
105794189|NCT01788163|364902185|FG008|Overall Study|Other|15|||
105794190|NCT01788163|364902177|FG000|Overall Study|Withdrawal by Subject|2|||
105794191|NCT01788163|364902178|FG001|Overall Study|Withdrawal by Subject|0|||
105794192|NCT01788163|364902179|FG002|Overall Study|Withdrawal by Subject|0|||
105794193|NCT01788163|364902180|FG003|Overall Study|Withdrawal by Subject|0|||
105794194|NCT01788163|364902181|FG004|Overall Study|Withdrawal by Subject|0|||
105794195|NCT01788163|364902182|FG005|Overall Study|Withdrawal by Subject|0|||
105794196|NCT01788163|364902183|FG006|Overall Study|Withdrawal by Subject|0|||
105794197|NCT01788163|364902184|FG007|Overall Study|Withdrawal by Subject|0|||
105794198|NCT01788163|364902185|FG008|Overall Study|Withdrawal by Subject|1|||
105794199|NCT00545441|364902186|FG000|Overall Study|Fistula draining at 6 months|2|||
105794200|NCT00545441|364902187|FG001|Overall Study|Fistula draining at 6 months|4|||
105563517|NCT01525602|364059587|FG002|Overall Study|Clinical progression|0|||
105563518|NCT01525602|364059588|FG003|Overall Study|Clinical progression|0|||
105563519|NCT01525602|364059589|FG004|Overall Study|Clinical progression|0|||
105563520|NCT01525602|364059590|FG005|Overall Study|Clinical progression|0|||
105563521|NCT01525602|364059591|FG006|Overall Study|Clinical progression|1|||
105563522|NCT01525602|364059592|FG007|Overall Study|Clinical progression|1|||
105563523|NCT01525602|364059585|FG000|Overall Study|Non-compliance|0|||
105563524|NCT01525602|364059586|FG001|Overall Study|Non-compliance|0|||
105563525|NCT01525602|364059587|FG002|Overall Study|Non-compliance|0|||
105794201|NCT00545441|364902186|FG000|Overall Study|Lost to Follow-up|9|||
105794202|NCT00545441|364902187|FG001|Overall Study|Lost to Follow-up|5|||
105794203|NCT00545441|364902186|FG000|Overall Study|Technical failure|0|||
105794204|NCT00545441|364902187|FG001|Overall Study|Technical failure|1|||
105794205|NCT00545441|364902186|FG000|Overall Study|Withdrawal by Subject|1|||
105478972|NCT04525885|363765980|FG002|Overall Study|Screen Failure|0|||
105478973|NCT04525885|363765978|FG000|Overall Study|Withdrawal by Subject|14|||
105478974|NCT04525885|363765979|FG001|Overall Study|Withdrawal by Subject|6|||
105478975|NCT04525885|363765980|FG002|Overall Study|Withdrawal by Subject|20|||
105478976|NCT04525885|363765978|FG000|Overall Study|Physician Decision|1|||
105478977|NCT04525885|363765979|FG001|Overall Study|Physician Decision|0|||
105478978|NCT04525885|363765980|FG002|Overall Study|Physician Decision|1|||
105478979|NCT02576145|363765984|FG000|Overall Study|Adverse Event|1|||
105478980|NCT02576145|363765985|FG001|Overall Study|Adverse Event|0|||
105478981|NCT02576145|363765984|FG000|Overall Study|Withdrawal by Subject|1|||
105478982|NCT02576145|363765985|FG001|Overall Study|Withdrawal by Subject|0|||
105478983|NCT02576145|363765984|FG000|Overall Study|Acute rejection|1|||
105478984|NCT02576145|363765985|FG001|Overall Study|Acute rejection|0|||
105478985|NCT02576145|363765984|FG000|Overall Study|Tetanus Titers Decreased|0|||
105478986|NCT02576145|363765985|FG001|Overall Study|Tetanus Titers Decreased|1|||
105478987|NCT02660138|363765988|FG000|Overall Study|Adverse Event|0|||
105478988|NCT02660138|363765989|FG001|Overall Study|Adverse Event|3|||
105478989|NCT02660138|363765990|FG002|Overall Study|Adverse Event|2|||
105563526|NCT01525602|364059588|FG003|Overall Study|Non-compliance|0|||
105563527|NCT01525602|364059589|FG004|Overall Study|Non-compliance|1|||
105563528|NCT01525602|364059590|FG005|Overall Study|Non-compliance|0|||
105563529|NCT01525602|364059591|FG006|Overall Study|Non-compliance|0|||
105563530|NCT01525602|364059592|FG007|Overall Study|Non-compliance|0|||
105563531|NCT01525602|364059585|FG000|Overall Study|Withdrawal by Subject|0|||
105563532|NCT01525602|364059586|FG001|Overall Study|Withdrawal by Subject|0|||
105563533|NCT01525602|364059587|FG002|Overall Study|Withdrawal by Subject|0|||
105563534|NCT01525602|364059588|FG003|Overall Study|Withdrawal by Subject|0|||
105563535|NCT01525602|364059589|FG004|Overall Study|Withdrawal by Subject|3|||
105563536|NCT01525602|364059590|FG005|Overall Study|Withdrawal by Subject|1|||
105563537|NCT01525602|364059591|FG006|Overall Study|Withdrawal by Subject|0|||
105563538|NCT01525602|364059592|FG007|Overall Study|Withdrawal by Subject|1|||
105563539|NCT01525602|364059585|FG000|Overall Study|Physician Decision|0|||
105563540|NCT01525602|364059586|FG001|Overall Study|Physician Decision|0|||
105563541|NCT01525602|364059587|FG002|Overall Study|Physician Decision|0|||
105563542|NCT01525602|364059588|FG003|Overall Study|Physician Decision|0|||
105563543|NCT01525602|364059589|FG004|Overall Study|Physician Decision|3|||
105563544|NCT01525602|364059590|FG005|Overall Study|Physician Decision|0|||
105563545|NCT01525602|364059591|FG006|Overall Study|Physician Decision|1|||
105563546|NCT01525602|364059592|FG007|Overall Study|Physician Decision|0|||
105563547|NCT01525602|364059585|FG000|Overall Study|Death|0|||
105563548|NCT01525602|364059586|FG001|Overall Study|Death|0|||
105563549|NCT01525602|364059587|FG002|Overall Study|Death|0|||
105563550|NCT01525602|364059588|FG003|Overall Study|Death|0|||
105563551|NCT01525602|364059589|FG004|Overall Study|Death|1|||
105563552|NCT01525602|364059590|FG005|Overall Study|Death|1|||
105563553|NCT01525602|364059591|FG006|Overall Study|Death|0|||
105563554|NCT01525602|364059592|FG007|Overall Study|Death|0|||
105563555|NCT01525602|364059585|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
105563556|NCT01525602|364059586|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
105563557|NCT01525602|364059587|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
105563558|NCT01525602|364059588|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
105563559|NCT01525602|364059589|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
105563560|NCT01525602|364059590|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
105563561|NCT01525602|364059591|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
105563562|NCT01525602|364059592|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
105563563|NCT03017079|364059596|FG000|Overall Study|Physician Decision|1|||
105563564|NCT03017079|364059597|FG001|Overall Study|Physician Decision|1|||
105563565|NCT03017079|364059596|FG000|Overall Study|Death|3|||
105563566|NCT03017079|364059597|FG001|Overall Study|Death|2|||
105563567|NCT03017079|364059596|FG000|Overall Study|Lack of Efficacy|2|||
105563568|NCT03017079|364059597|FG001|Overall Study|Lack of Efficacy|2|||
105563569|NCT03017079|364059596|FG000|Overall Study|Protocol Violation|0|||
105563570|NCT03017079|364059597|FG001|Overall Study|Protocol Violation|1|||
105563571|NCT04120233|364059602|FG000|Overall Study|Adverse Event|0|||
105563572|NCT04120233|364059603|FG001|Overall Study|Adverse Event|0|||
105563573|NCT04120233|364059604|FG002|Overall Study|Adverse Event|0|||
105563574|NCT04120233|364059605|FG003|Overall Study|Adverse Event|0|||
105563575|NCT04120233|364059606|FG004|Overall Study|Adverse Event|1|||
105563576|NCT04120233|364059607|FG005|Overall Study|Adverse Event|0|||
105563577|NCT01194570|364061157|FG000|Overall Study|Adverse Event|22|||
105563578|NCT01194570|364061158|FG001|Overall Study|Adverse Event|40|||
105563579|NCT01194570|364061157|FG000|Overall Study|Death|6|||
105563580|NCT01194570|364061158|FG001|Overall Study|Death|20|||
105563581|NCT01194570|364061157|FG000|Overall Study|Lack of Efficacy|32|||
105563582|NCT01194570|364061158|FG001|Overall Study|Lack of Efficacy|33|||
105563583|NCT01194570|364061157|FG000|Overall Study|Lost to Follow-up|4|||
105563584|NCT01194570|364061158|FG001|Overall Study|Lost to Follow-up|15|||
105563585|NCT01194570|364061157|FG000|Overall Study|Non-Compliance|2|||
105563586|NCT01194570|364061158|FG001|Overall Study|Non-Compliance|2|||
105563587|NCT01194570|364061157|FG000|Overall Study|Non-Compliance With Study Drug|2|||
105478990|NCT02660138|363765988|FG000|Overall Study|Lack of Efficacy|1|||
105478991|NCT02660138|363765989|FG001|Overall Study|Lack of Efficacy|2|||
105478992|NCT02660138|363765990|FG002|Overall Study|Lack of Efficacy|1|||
105478993|NCT02660138|363765988|FG000|Overall Study|Withdrawal by Subject|7|||
105478994|NCT02660138|363765989|FG001|Overall Study|Withdrawal by Subject|6|||
105478995|NCT02660138|363765990|FG002|Overall Study|Withdrawal by Subject|6|||
105478996|NCT02660138|363765988|FG000|Overall Study|Lost to Follow-up|4|||
105478997|NCT02660138|363765989|FG001|Overall Study|Lost to Follow-up|4|||
105478998|NCT02660138|363765990|FG002|Overall Study|Lost to Follow-up|1|||
105478999|NCT02660138|363765988|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
105479000|NCT02660138|363765989|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
105479001|NCT02660138|363765990|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
105479002|NCT02660138|363765988|FG000|Overall Study|Other|1|||
105479003|NCT02660138|363765989|FG001|Overall Study|Other|1|||
105479004|NCT02660138|363765990|FG002|Overall Study|Other|0|||
105479005|NCT02660138|363765988|FG000|Overall Study|Not treated|0|||
105479006|NCT02660138|363765989|FG001|Overall Study|Not treated|1|||
105479007|NCT02660138|363765990|FG002|Overall Study|Not treated|0|||
105479008|NCT02270944|363765992|FG000|Overall Study|Lost to Follow-up|9|||
105479009|NCT02270944|363765993|FG001|Overall Study|Lost to Follow-up|4|||
105479010|NCT02270944|363765992|FG000|Overall Study|Withdrawal by Subject|2|||
105479011|NCT02270944|363765993|FG001|Overall Study|Withdrawal by Subject|1|||
105479012|NCT01978938|363765994|FG000|Overall Study|Lost to Follow-up|12|||
105479013|NCT01978938|363765995|FG001|Overall Study|Lost to Follow-up|6|||
105479014|NCT01978938|363765994|FG000|Overall Study|Withdrawal by Subject|8|||
105479015|NCT01978938|363765995|FG001|Overall Study|Withdrawal by Subject|4|||
105479016|NCT01978938|363765994|FG000|Overall Study|Adverse Event, non-fatal|2|||
105479017|NCT01978938|363765995|FG001|Overall Study|Adverse Event, non-fatal|1|||
105479018|NCT01978938|363765994|FG000|Overall Study|Participant noncompliance|1|||
105479019|NCT01978938|363765995|FG001|Overall Study|Participant noncompliance|1|||
105479020|NCT01978938|363765994|FG000|Overall Study|Did not meet inclusion criteria|0|||
105479021|NCT01978938|363765995|FG001|Overall Study|Did not meet inclusion criteria|1|||
105479022|NCT01978938|363765994|FG000|Overall Study|Previously scheduled procedure|0|||
105479023|NCT01978938|363765995|FG001|Overall Study|Previously scheduled procedure|1|||
105479024|NCT00095147|363765996|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
105479025|NCT00095147|363765997|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
105479026|NCT00095147|363765998|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
105479027|NCT00095147|363765999|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
105479028|NCT00095147|363766000|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
105479029|NCT00095147|363765996|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
105479030|NCT00095147|363765997|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
105479031|NCT00095147|363765998|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
105479032|NCT00095147|363765999|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
105479033|NCT00095147|363766000|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
105479034|NCT00095147|363765996|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
105479035|NCT00095147|363765997|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
105479036|NCT00095147|363765998|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
105479037|NCT00095147|363765999|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
105479038|NCT00095147|363766000|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
105479039|NCT00095147|363765996|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
105563588|NCT01194570|364061158|FG001|Overall Study|Non-Compliance With Study Drug|2|||
105563589|NCT01194570|364061157|FG000|Overall Study|Other|18|||
105563590|NCT01194570|364061158|FG001|Overall Study|Other|47|||
105563591|NCT01194570|364061157|FG000|Overall Study|Physician Decision|10|||
105563592|NCT01194570|364061158|FG001|Overall Study|Physician Decision|25|||
105563593|NCT01194570|364061157|FG000|Overall Study|Protocol Violation|1|||
105563594|NCT01194570|364061158|FG001|Overall Study|Protocol Violation|2|||
105563595|NCT01194570|364061157|FG000|Overall Study|Study Terminated By Sponsor|0|||
105563596|NCT01194570|364061158|FG001|Overall Study|Study Terminated By Sponsor|1|||
105563597|NCT01194570|364061157|FG000|Overall Study|Withdrawal by Subject|57|||
105563598|NCT01194570|364061158|FG001|Overall Study|Withdrawal by Subject|82|||
105563599|NCT01194570|364061157|FG000|Overall Study|Pregnancy|1|||
105794206|NCT00545441|364902187|FG001|Overall Study|Withdrawal by Subject|1|||
105794207|NCT00545441|364902186|FG000|Overall Study|Persistence or recurrence of fistula|5|||
105563600|NCT01194570|364061158|FG001|Overall Study|Pregnancy|1|||
105563601|NCT01224925|364061159|FG000|Overall Study|Lost to Follow-up|3|||
105563602|NCT01224925|364061160|FG001|Overall Study|Lost to Follow-up|2|||
105563603|NCT00989092|364061165|FG000|Overall Study|Physician Decision|9|||
105479040|NCT00095147|363765997|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
105479041|NCT00095147|363765998|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
105479042|NCT00095147|363765999|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
105479043|NCT00095147|363766000|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
105479044|NCT00095147|363765996|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
105563604|NCT00989092|364061166|FG001|Overall Study|Physician Decision|6|||
105563605|NCT00989092|364061165|FG000|Overall Study|Adverse Event|20|||
105563606|NCT00989092|364061166|FG001|Overall Study|Adverse Event|1|||
105563607|NCT00989092|364061165|FG000|Overall Study|Chemotherapy initiated|12|||
105563608|NCT00989092|364061166|FG001|Overall Study|Chemotherapy initiated|4|||
105563609|NCT00989092|364061165|FG000|Overall Study|Withdrawal by Subject|17|||
105563610|NCT00989092|364061166|FG001|Overall Study|Withdrawal by Subject|9|||
105563611|NCT00989092|364061165|FG000|Overall Study|Death|14|||
105563612|NCT00989092|364061166|FG001|Overall Study|Death|2|||
105563613|NCT00989092|364061165|FG000|Overall Study|Ineligibility determined|3|||
105563614|NCT00989092|364061166|FG001|Overall Study|Ineligibility determined|3|||
105563615|NCT00989092|364061165|FG000|Overall Study|Lost to Follow-up|6|||
105563616|NCT00989092|364061166|FG001|Overall Study|Lost to Follow-up|2|||
105563617|NCT00989092|364061165|FG000|Overall Study|Other|3|||
105563618|NCT00989092|364061166|FG001|Overall Study|Other|1|||
105563619|NCT00989092|364061165|FG000|Overall Study|Protocol deviation|2|||
105563620|NCT00989092|364061166|FG001|Overall Study|Protocol deviation|0|||
105563621|NCT00989092|364061165|FG000|Overall Study|Erythropoietin therapy initiated|2|||
105563622|NCT00989092|364061166|FG001|Overall Study|Erythropoietin therapy initiated|0|||
105563623|NCT00989092|364061165|FG000|Overall Study|Did not receive study drug|2|||
105563624|NCT00989092|364061166|FG001|Overall Study|Did not receive study drug|0|||
105563625|NCT00415610|364061174|FG000|Overall Study|Death|3|||
105563626|NCT00415610|364061175|FG001|Overall Study|Death|2|||
105563627|NCT00415610|364061176|FG002|Overall Study|Death|5|||
105563628|NCT00526630|364061177|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
105563629|NCT00526630|364061178|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
105563630|NCT00526630|364061177|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
105563631|NCT00526630|364061178|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
105563632|NCT00549757|364061179|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
105563633|NCT00549757|364061180|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
105563634|NCT00549757|364061179|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
105726377|NCT00538681|364653533|FG003|Overall Study|Progressive Disease|0|||
105726378|NCT00538681|364653530|FG000|Overall Study|Sponsor Decision|1|||
105726379|NCT00538681|364653531|FG001|Overall Study|Sponsor Decision|3|||
105726380|NCT00538681|364653532|FG002|Overall Study|Sponsor Decision|8|||
105726381|NCT00538681|364653533|FG003|Overall Study|Sponsor Decision|9|||
105726382|NCT00538681|364653530|FG000|Overall Study|Adverse Event|1|||
105726383|NCT00538681|364653531|FG001|Overall Study|Adverse Event|1|||
105726384|NCT00538681|364653532|FG002|Overall Study|Adverse Event|1|||
105726385|NCT00538681|364653533|FG003|Overall Study|Adverse Event|0|||
105726386|NCT00538681|364653530|FG000|Overall Study|Death|0|||
105726387|NCT00538681|364653531|FG001|Overall Study|Death|0|||
105726388|NCT00538681|364653532|FG002|Overall Study|Death|1|||
105726389|NCT00538681|364653533|FG003|Overall Study|Death|1|||
105726390|NCT00538681|364653530|FG000|Overall Study|Investigator Decision|0|||
105726391|NCT00538681|364653531|FG001|Overall Study|Investigator Decision|0|||
105726392|NCT00538681|364653532|FG002|Overall Study|Investigator Decision|0|||
105726393|NCT00538681|364653533|FG003|Overall Study|Investigator Decision|1|||
105726394|NCT05369806|364653538|FG000|Overall Study|Lost to Follow-up|1|||
105726395|NCT02370121|364653542|FG000|Overall Study|Lost to Follow-up|1|||
105726396|NCT02370121|364653543|FG001|Overall Study|Lost to Follow-up|1|||
105726397|NCT01392183|364653547|FG000|First Drug Administration|Adverse Event|3|||
105726398|NCT01392183|364653548|FG001|First Drug Administration|Adverse Event|2|||
105726399|NCT01392183|364653547|FG000|First Drug Administration|Death|1|||
105726400|NCT01392183|364653548|FG001|First Drug Administration|Death|0|||
105726401|NCT01392183|364653547|FG000|First Drug Administration|Withdrawal by Subject|10|||
105726402|NCT01392183|364653548|FG001|First Drug Administration|Withdrawal by Subject|17|||
105726403|NCT04321343|364653549|FG000|Overall Study|Adverse Event|0|||
105726404|NCT04321343|364653550|FG001|Overall Study|Adverse Event|0|||
105726405|NCT04321343|364653551|FG002|Overall Study|Adverse Event|1|||
105726406|NCT04321343|364653552|FG003|Overall Study|Adverse Event|0|||
105726407|NCT04321343|364653549|FG000|Overall Study|Death|0|||
105726408|NCT04321343|364653550|FG001|Overall Study|Death|0|||
105479045|NCT00095147|363765997|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
105479046|NCT00095147|363765998|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
105479047|NCT00095147|363765999|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
105479048|NCT00095147|363766000|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
105479049|NCT00095147|363765996|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
105479050|NCT00095147|363765997|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
105479051|NCT00095147|363765998|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
105479052|NCT00095147|363765999|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
105479053|NCT00095147|363766000|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
105479054|NCT00095147|363765996|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
105479055|NCT00095147|363765997|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
105479056|NCT00095147|363765998|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
105479057|NCT00095147|363765999|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
105479058|NCT00095147|363766000|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
105479059|NCT00095147|363765996|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
105479060|NCT00095147|363765997|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
105479061|NCT00095147|363765998|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
105479062|NCT00095147|363765999|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
105479063|NCT00095147|363766000|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
105479064|NCT00095147|363765996|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
105479065|NCT00095147|363765997|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
105726409|NCT04321343|364653551|FG002|Overall Study|Death|0|||
105726410|NCT04321343|364653552|FG003|Overall Study|Death|1|||
105726411|NCT04321343|364653549|FG000|Overall Study|Pregnancy|1|||
105726412|NCT04321343|364653550|FG001|Overall Study|Pregnancy|0|||
105726413|NCT04321343|364653551|FG002|Overall Study|Pregnancy|0|||
105726414|NCT04321343|364653552|FG003|Overall Study|Pregnancy|0|||
105726415|NCT04321343|364653549|FG000|Overall Study|Protocol Violation|1|||
105726416|NCT04321343|364653550|FG001|Overall Study|Protocol Violation|1|||
105726417|NCT04321343|364653551|FG002|Overall Study|Protocol Violation|1|||
105726418|NCT04321343|364653552|FG003|Overall Study|Protocol Violation|1|||
105726419|NCT04321343|364653549|FG000|Overall Study|Withdrawal by Subject|0|||
105726420|NCT04321343|364653550|FG001|Overall Study|Withdrawal by Subject|6|||
105726421|NCT04321343|364653551|FG002|Overall Study|Withdrawal by Subject|0|||
105726422|NCT04321343|364653552|FG003|Overall Study|Withdrawal by Subject|2|||
105726423|NCT04321343|364653549|FG000|Overall Study|Lost to Follow-up|2|||
105726424|NCT04321343|364653550|FG001|Overall Study|Lost to Follow-up|2|||
105726425|NCT04321343|364653551|FG002|Overall Study|Lost to Follow-up|1|||
105726426|NCT04321343|364653552|FG003|Overall Study|Lost to Follow-up|3|||
105726427|NCT03476239|364653554|FG000|Overall Study|Withdrawal by Subject|10|||
105726428|NCT03476239|364653554|FG000|Overall Study|Death|80|||
105726429|NCT03476239|364653554|FG000|Overall Study|Lost to Follow-up|8|||
105726430|NCT02328014|364655475|FG000|Overall Study|Adverse Event|1|||
105726431|NCT02328014|364655476|FG001|Overall Study|Adverse Event|0|||
105726432|NCT02328014|364655477|FG002|Overall Study|Adverse Event|0|||
105794208|NCT00545441|364902187|FG001|Overall Study|Persistence or recurrence of fistula|2|||
105794209|NCT00545441|364902186|FG000|Overall Study|Patients were not treated|1|||
105479066|NCT00095147|363765998|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
105563635|NCT00549757|364061180|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
105563636|NCT00549757|364061179|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
105563637|NCT00549757|364061180|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
105563638|NCT00549757|364061179|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
105479067|NCT00095147|363765999|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
105479068|NCT00095147|363766000|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
105563639|NCT00549757|364061180|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
105563640|NCT00549757|364061179|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
105563641|NCT00549757|364061180|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
105563642|NCT00549757|364061179|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
105563643|NCT00549757|364061180|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
105563644|NCT00549757|364061179|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
105563645|NCT00549757|364061180|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
105563646|NCT00549757|364061179|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
105563647|NCT00549757|364061180|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
105726433|NCT02328014|364655478|FG003|Overall Study|Adverse Event|1|||
105726434|NCT02328014|364655475|FG000|Overall Study|Death|0|||
105726435|NCT02328014|364655476|FG001|Overall Study|Death|0|||
105726436|NCT02328014|364655477|FG002|Overall Study|Death|0|||
105794210|NCT00545441|364902187|FG001|Overall Study|Patients were not treated|3|||
105726437|NCT02328014|364655478|FG003|Overall Study|Death|4|||
105726438|NCT02328014|364655475|FG000|Overall Study|Physician Decision|0|||
105479069|NCT00095147|363765996|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
105479070|NCT00095147|363765997|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
105479071|NCT00095147|363765998|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
105479072|NCT00095147|363765999|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
105479073|NCT00095147|363766000|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
105479074|NCT00095147|363765996|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
105479075|NCT00095147|363765997|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
105479076|NCT00095147|363765998|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
105353231|NCT03046056|363298477|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
105353232|NCT03046056|363298478|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
105353233|NCT03046056|363298476|FG000|Overall Study|Adverse Event|1|||
105353234|NCT03046056|363298477|FG001|Overall Study|Adverse Event|5|||
105353235|NCT03046056|363298478|FG002|Overall Study|Adverse Event|0|||
105479077|NCT00095147|363765999|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
105353236|NCT03046056|363298476|FG000|Overall Study|Non-compliance With Study Drug|0|||
105353237|NCT03046056|363298477|FG001|Overall Study|Non-compliance With Study Drug|0|||
105353238|NCT03046056|363298478|FG002|Overall Study|Non-compliance With Study Drug|2|||
105353239|NCT03046056|363298476|FG000|Overall Study|Protocol Violation|1|||
105479078|NCT00095147|363766000|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
105563648|NCT00549757|364061179|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
105563649|NCT00549757|364061180|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
105563650|NCT00549757|364061179|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
105563651|NCT00549757|364061180|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
105563652|NCT00549757|364061179|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
105563653|NCT00549757|364061180|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
105563654|NCT00549757|364061179|FG000|Extension Period (in Average 9 Months)|Death|143|||
105563655|NCT00549757|364061180|FG001|Extension Period (in Average 9 Months)|Death|136|||
105726439|NCT02328014|364655476|FG001|Overall Study|Physician Decision|0|||
105726440|NCT02328014|364655477|FG002|Overall Study|Physician Decision|0|||
105563656|NCT00549757|364061179|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
105563657|NCT00549757|364061180|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
105563658|NCT00549757|364061179|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
105563659|NCT00549757|364061180|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
105563660|NCT00549757|364061179|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
105563661|NCT00549757|364061180|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
105563662|NCT01301391|364061181|FG000|Overall Study|Death|13|||
105563663|NCT01301391|364061181|FG000|Overall Study|Lost to Follow-up|3|||
105563664|NCT01301391|364061181|FG000|Overall Study|Physician Decision|2|||
105563665|NCT01301391|364061181|FG000|Overall Study|Sponsor's decision|8|||
105563666|NCT04020341|364061183|FG000|Overall Study|Adverse Event|8|||
105563667|NCT04020341|364061184|FG001|Overall Study|Adverse Event|6|||
105563668|NCT04020341|364061183|FG000|Overall Study|Lost to Follow-up|8|||
105563669|NCT04020341|364061184|FG001|Overall Study|Lost to Follow-up|2|||
105563670|NCT04020341|364061183|FG000|Overall Study|Withdrawal by Subject|16|||
105563671|NCT04020341|364061184|FG001|Overall Study|Withdrawal by Subject|16|||
105563672|NCT04020341|364061183|FG000|Overall Study|Participant not able to swallow the tablet|1|||
105563673|NCT04020341|364061184|FG001|Overall Study|Participant not able to swallow the tablet|0|||
105563674|NCT04020341|364061183|FG000|Overall Study|Physician Decision|0|||
105563675|NCT04020341|364061184|FG001|Overall Study|Physician Decision|2|||
105563676|NCT04020341|364061183|FG000|Overall Study|Protocol Deviation|0|||
105563677|NCT04020341|364061184|FG001|Overall Study|Protocol Deviation|2|||
105563678|NCT01814748|364061187|FG000|Overall Study|Lost to Follow-up|1|||
105563679|NCT01814748|364061188|FG001|Overall Study|Lost to Follow-up|2|||
105563680|NCT01814748|364061187|FG000|Overall Study|Study site terminated by sponsor|1|||
105563681|NCT01814748|364061188|FG001|Overall Study|Study site terminated by sponsor|1|||
105563682|NCT01814748|364061187|FG000|Overall Study|Withdrawal by Subject|6|||
105563683|NCT01814748|364061188|FG001|Overall Study|Withdrawal by Subject|4|||
105353240|NCT03046056|363298477|FG001|Overall Study|Protocol Violation|1|||
105563684|NCT04044456|364061189|FG000|Overall Study|Lost to Follow-up|4|||
105563685|NCT04044456|364061190|FG001|Overall Study|Lost to Follow-up|1|||
105563686|NCT04044456|364061189|FG000|Overall Study|Withdrawal by Subject|1|||
105563687|NCT04044456|364061190|FG001|Overall Study|Withdrawal by Subject|0|||
105563688|NCT01972529|364061191|FG000|Overall Study|Adverse Event|0|||
105726441|NCT02328014|364655478|FG003|Overall Study|Physician Decision|1|||
105726442|NCT02328014|364655475|FG000|Overall Study|Disease Progression|1|||
105726443|NCT02328014|364655476|FG001|Overall Study|Disease Progression|0|||
105726444|NCT02328014|364655477|FG002|Overall Study|Disease Progression|1|||
105726445|NCT02328014|364655478|FG003|Overall Study|Disease Progression|3|||
105726446|NCT02328014|364655475|FG000|Overall Study|Study Terminated by Sponsor|4|||
105794211|NCT03443973|364902188|FG000|Double-blind Treatment Period|Adverse Event|5|||
105353241|NCT03046056|363298478|FG002|Overall Study|Protocol Violation|0|||
105794212|NCT03443973|364902189|FG001|Double-blind Treatment Period|Adverse Event|19|||
105726447|NCT02328014|364655476|FG001|Overall Study|Study Terminated by Sponsor|1|||
105726448|NCT02328014|364655477|FG002|Overall Study|Study Terminated by Sponsor|1|||
105726449|NCT02328014|364655478|FG003|Overall Study|Study Terminated by Sponsor|0|||
105726450|NCT02328014|364655475|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
105726451|NCT02328014|364655476|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
105726452|NCT02328014|364655477|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
105726453|NCT02328014|364655478|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
105726454|NCT02328014|364655475|FG000|Overall Study|Withdrawal by Subject|0|||
105726455|NCT02328014|364655476|FG001|Overall Study|Withdrawal by Subject|0|||
105726456|NCT02328014|364655477|FG002|Overall Study|Withdrawal by Subject|0|||
105726457|NCT02328014|364655478|FG003|Overall Study|Withdrawal by Subject|1|||
105726458|NCT01431287|364655479|FG000|Overall Study|not treated|0|||
105726459|NCT01431287|364655480|FG001|Overall Study|not treated|0|||
105726460|NCT01431287|364655481|FG002|Overall Study|not treated|1|||
105726461|NCT01431287|364655482|FG003|Overall Study|not treated|0|||
105726462|NCT01431287|364655483|FG004|Overall Study|not treated|0|||
105726463|NCT01431287|364655479|FG000|Overall Study|Adverse Event|59|||
105479079|NCT00095147|363765996|FG000|Long-term Extension Period|Death|0|||
105479080|NCT00095147|363765997|FG001|Long-term Extension Period|Death|0|||
105479081|NCT00095147|363765998|FG002|Long-term Extension Period|Death|0|||
105479082|NCT00095147|363765999|FG003|Long-term Extension Period|Death|0|||
105479083|NCT00095147|363766000|FG004|Long-term Extension Period|Death|3|||
105479084|NCT00095147|363765996|FG000|Long-term Extension Period|Adverse Event|0|||
105479085|NCT00095147|363765997|FG001|Long-term Extension Period|Adverse Event|0|||
105479086|NCT00095147|363765998|FG002|Long-term Extension Period|Adverse Event|0|||
105479087|NCT00095147|363765999|FG003|Long-term Extension Period|Adverse Event|0|||
105479088|NCT00095147|363766000|FG004|Long-term Extension Period|Adverse Event|11|||
105479089|NCT00095147|363765996|FG000|Long-term Extension Period|Lack of Efficacy|0|||
105479090|NCT00095147|363765997|FG001|Long-term Extension Period|Lack of Efficacy|0|||
105479091|NCT00095147|363765998|FG002|Long-term Extension Period|Lack of Efficacy|0|||
105479092|NCT00095147|363765999|FG003|Long-term Extension Period|Lack of Efficacy|0|||
105479093|NCT00095147|363766000|FG004|Long-term Extension Period|Lack of Efficacy|9|||
105479094|NCT00095147|363765996|FG000|Long-term Extension Period|Lost to Follow-up|0|||
105479095|NCT00095147|363765997|FG001|Long-term Extension Period|Lost to Follow-up|0|||
105479096|NCT00095147|363765998|FG002|Long-term Extension Period|Lost to Follow-up|0|||
105479097|NCT00095147|363765999|FG003|Long-term Extension Period|Lost to Follow-up|0|||
105479098|NCT00095147|363766000|FG004|Long-term Extension Period|Lost to Follow-up|6|||
105479099|NCT00095147|363765996|FG000|Long-term Extension Period|Withdrawal of consent|0|||
105479100|NCT00095147|363765997|FG001|Long-term Extension Period|Withdrawal of consent|0|||
105479101|NCT00095147|363765998|FG002|Long-term Extension Period|Withdrawal of consent|0|||
105479102|NCT00095147|363765999|FG003|Long-term Extension Period|Withdrawal of consent|0|||
105479103|NCT00095147|363766000|FG004|Long-term Extension Period|Withdrawal of consent|12|||
105479104|NCT00095147|363765996|FG000|Long-term Extension Period|Pregnancy|0|||
105479105|NCT00095147|363765997|FG001|Long-term Extension Period|Pregnancy|0|||
105479106|NCT00095147|363765998|FG002|Long-term Extension Period|Pregnancy|0|||
105479107|NCT00095147|363765999|FG003|Long-term Extension Period|Pregnancy|0|||
105479108|NCT00095147|363766000|FG004|Long-term Extension Period|Pregnancy|1|||
105479109|NCT00095147|363765996|FG000|Long-term Extension Period|No longer meets study criteria|0|||
105479110|NCT00095147|363765997|FG001|Long-term Extension Period|No longer meets study criteria|0|||
105479111|NCT00095147|363765998|FG002|Long-term Extension Period|No longer meets study criteria|0|||
105479112|NCT00095147|363765999|FG003|Long-term Extension Period|No longer meets study criteria|0|||
105479113|NCT00095147|363766000|FG004|Long-term Extension Period|No longer meets study criteria|1|||
105479114|NCT00095147|363765996|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
105479115|NCT00095147|363765997|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
105479116|NCT00095147|363765998|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
105479117|NCT00095147|363765999|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
105479118|NCT00095147|363766000|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
105479119|NCT00095147|363765996|FG000|Long-term Extension Period|Leaving country|0|||
105479120|NCT00095147|363765997|FG001|Long-term Extension Period|Leaving country|0|||
105479121|NCT00095147|363765998|FG002|Long-term Extension Period|Leaving country|0|||
105479122|NCT00095147|363765999|FG003|Long-term Extension Period|Leaving country|0|||
105479123|NCT00095147|363766000|FG004|Long-term Extension Period|Leaving country|1|||
105479124|NCT00952380|363766001|FG000|Overall Study|Other|0|||
105479125|NCT00952380|363766002|FG001|Overall Study|Other|0|||
105479126|NCT00952380|363766003|FG002|Overall Study|Other|0|||
105479127|NCT00952380|363766004|FG003|Overall Study|Other|0|||
105479128|NCT00952380|363766005|FG004|Overall Study|Other|1|||
105479129|NCT00952380|363766001|FG000|Overall Study|Withdrawal by Subject|0|||
105479130|NCT00952380|363766002|FG001|Overall Study|Withdrawal by Subject|0|||
105726464|NCT01431287|364655480|FG001|Overall Study|Adverse Event|57|||
105726465|NCT01431287|364655481|FG002|Overall Study|Adverse Event|53|||
105726466|NCT01431287|364655482|FG003|Overall Study|Adverse Event|33|||
105726467|NCT01431287|364655483|FG004|Overall Study|Adverse Event|41|||
105563689|NCT01972529|364061192|FG001|Overall Study|Adverse Event|1|||
105794213|NCT03443973|364902190|FG002|Double-blind Treatment Period|Adverse Event|0|||
105794214|NCT03443973|364902191|FG003|Double-blind Treatment Period|Adverse Event|0|||
105563690|NCT01972529|364061193|FG002|Overall Study|Adverse Event|0|||
105563691|NCT01972529|364061194|FG003|Overall Study|Adverse Event|0|||
105563692|NCT01972529|364061191|FG000|Overall Study|Lost to Follow-up|1|||
105563693|NCT01972529|364061192|FG001|Overall Study|Lost to Follow-up|0|||
105563694|NCT01972529|364061193|FG002|Overall Study|Lost to Follow-up|0|||
105563695|NCT01972529|364061194|FG003|Overall Study|Lost to Follow-up|0|||
105563696|NCT01972529|364061191|FG000|Overall Study|Participant Choice|0|||
105563697|NCT01972529|364061192|FG001|Overall Study|Participant Choice|1|||
105563698|NCT01972529|364061193|FG002|Overall Study|Participant Choice|0|||
105563699|NCT01972529|364061194|FG003|Overall Study|Participant Choice|0|||
105563700|NCT01972529|364061191|FG000|Overall Study|Withdrawl of Consent|1|||
105563701|NCT01972529|364061192|FG001|Overall Study|Withdrawl of Consent|2|||
105563702|NCT01972529|364061193|FG002|Overall Study|Withdrawl of Consent|0|||
105563703|NCT01972529|364061194|FG003|Overall Study|Withdrawl of Consent|1|||
105563704|NCT01972529|364061191|FG000|Overall Study|Other|0|||
105563705|NCT01972529|364061192|FG001|Overall Study|Other|0|||
105563706|NCT01972529|364061193|FG002|Overall Study|Other|0|||
105563707|NCT01972529|364061194|FG003|Overall Study|Other|2|||
105563708|NCT01972529|364061191|FG000|Overall Study|Not treated|0|||
105563709|NCT01972529|364061192|FG001|Overall Study|Not treated|1|||
105563710|NCT01972529|364061193|FG002|Overall Study|Not treated|2|||
105563711|NCT01972529|364061194|FG003|Overall Study|Not treated|1|||
105563712|NCT01591382|364061195|FG000|Overall Study|Discharged Prior to Study Completion|2|||
105563713|NCT01591382|364061196|FG001|Overall Study|Discharged Prior to Study Completion|1|||
105563714|NCT01591382|364061195|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
105563715|NCT01591382|364061196|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
105563716|NCT01059630|364061207|FG000|Overall Study|Death|100|||
105563717|NCT01059630|364061208|FG001|Overall Study|Death|84|||
105563718|NCT01059630|364061207|FG000|Overall Study|Lost to Follow-up|4|||
105563719|NCT01059630|364061208|FG001|Overall Study|Lost to Follow-up|1|||
105563720|NCT01059630|364061207|FG000|Overall Study|Physician Decision|2|||
105563721|NCT01059630|364061208|FG001|Overall Study|Physician Decision|4|||
105563722|NCT01059630|364061207|FG000|Overall Study|Withdrawal by Subject|21|||
105563723|NCT01059630|364061208|FG001|Overall Study|Withdrawal by Subject|14|||
105563724|NCT02403180|364061209|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
105563725|NCT02403180|364061210|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
105563726|NCT02403180|364061209|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
105563727|NCT02403180|364061210|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
105563728|NCT01113502|364061214|FG000|Overall Study|Withdrawal by Subject|1|||
105563729|NCT01113502|364061215|FG001|Overall Study|Withdrawal by Subject|0|||
105563730|NCT01113502|364061216|FG002|Overall Study|Withdrawal by Subject|1|||
105563731|NCT01113502|364061217|FG003|Overall Study|Withdrawal by Subject|1|||
105563732|NCT01113502|364061218|FG004|Overall Study|Withdrawal by Subject|0|||
105563733|NCT01113502|364061214|FG000|Overall Study|Adverse Event|0|||
105563734|NCT01113502|364061215|FG001|Overall Study|Adverse Event|0|||
105563735|NCT01113502|364061216|FG002|Overall Study|Adverse Event|3|||
105563736|NCT01113502|364061217|FG003|Overall Study|Adverse Event|2|||
105563737|NCT01113502|364061218|FG004|Overall Study|Adverse Event|0|||
105563738|NCT00118716|364061222|FG000|Overall Study|Adverse Event|2|||
105563739|NCT00118716|364061223|FG001|Overall Study|Adverse Event|7|||
105794215|NCT03443973|364902188|FG000|Double-blind Treatment Period|Death|5|||
105794216|NCT03443973|364902189|FG001|Double-blind Treatment Period|Death|7|||
105794217|NCT03443973|364902190|FG002|Double-blind Treatment Period|Death|0|||
105794218|NCT03443973|364902191|FG003|Double-blind Treatment Period|Death|0|||
105794219|NCT03443973|364902188|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
105794220|NCT03443973|364902189|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
105794221|NCT03443973|364902190|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
105794222|NCT03443973|364902191|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
105794223|NCT03443973|364902188|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
105794224|NCT03443973|364902189|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
105794225|NCT03443973|364902190|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
105794226|NCT03443973|364902191|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
105794227|NCT03443973|364902188|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
105794228|NCT03443973|364902189|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
105563740|NCT00118716|364061222|FG000|Overall Study|Protocol Violation|5|||
105563741|NCT00118716|364061223|FG001|Overall Study|Protocol Violation|4|||
105563742|NCT00118716|364061222|FG000|Overall Study|Withdrawal by Subject|0|||
105563743|NCT00118716|364061223|FG001|Overall Study|Withdrawal by Subject|1|||
105563744|NCT00118716|364061222|FG000|Overall Study|Exacerbation|2|||
105563745|NCT00118716|364061223|FG001|Overall Study|Exacerbation|2|||
105563746|NCT00118716|364061222|FG000|Overall Study|Discontinued by sponsor|1|||
105563747|NCT00118716|364061223|FG001|Overall Study|Discontinued by sponsor|1|||
105794229|NCT03443973|364902190|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
105479131|NCT00952380|363766003|FG002|Overall Study|Withdrawal by Subject|1|||
105479132|NCT00952380|363766004|FG003|Overall Study|Withdrawal by Subject|0|||
105479133|NCT00952380|363766005|FG004|Overall Study|Withdrawal by Subject|2|||
105479134|NCT00952380|363766001|FG000|Overall Study|Adverse Event|0|||
105479135|NCT00952380|363766002|FG001|Overall Study|Adverse Event|1|||
105479136|NCT00952380|363766003|FG002|Overall Study|Adverse Event|0|||
105479137|NCT00952380|363766004|FG003|Overall Study|Adverse Event|0|||
105479138|NCT00952380|363766005|FG004|Overall Study|Adverse Event|3|||
105479139|NCT00952380|363766001|FG000|Overall Study|Physician Decision|0|||
105479140|NCT00952380|363766002|FG001|Overall Study|Physician Decision|0|||
105479141|NCT00952380|363766003|FG002|Overall Study|Physician Decision|1|||
105479142|NCT00952380|363766004|FG003|Overall Study|Physician Decision|2|||
105479143|NCT00952380|363766005|FG004|Overall Study|Physician Decision|0|||
105479144|NCT00952380|363766001|FG000|Overall Study|Non-compliant to protocol|0|||
105479145|NCT00952380|363766002|FG001|Overall Study|Non-compliant to protocol|0|||
105479146|NCT00952380|363766003|FG002|Overall Study|Non-compliant to protocol|0|||
105479147|NCT00952380|363766004|FG003|Overall Study|Non-compliant to protocol|1|||
105479148|NCT00952380|363766005|FG004|Overall Study|Non-compliant to protocol|0|||
105479149|NCT00160667|363766006|FG000|Overall Study|Adverse Event|3|||
105479150|NCT00160667|363766007|FG001|Overall Study|Adverse Event|1|||
105479151|NCT00160667|363766008|FG002|Overall Study|Adverse Event|4|||
105479152|NCT00160667|363766006|FG000|Overall Study|Withdrawal by Subject|2|||
105479153|NCT00160667|363766007|FG001|Overall Study|Withdrawal by Subject|0|||
105479154|NCT00160667|363766008|FG002|Overall Study|Withdrawal by Subject|1|||
105479155|NCT00160667|363766006|FG000|Overall Study|Lack of Efficacy|0|||
105479156|NCT00160667|363766007|FG001|Overall Study|Lack of Efficacy|1|||
105479157|NCT00160667|363766008|FG002|Overall Study|Lack of Efficacy|0|||
105479158|NCT00160667|363766006|FG000|Overall Study|Protocol Violation|0|||
105479159|NCT00160667|363766007|FG001|Overall Study|Protocol Violation|1|||
105479160|NCT00160667|363766008|FG002|Overall Study|Protocol Violation|0|||
105479161|NCT00160667|363766006|FG000|Overall Study|Patient decision|0|||
105479162|NCT00160667|363766007|FG001|Overall Study|Patient decision|0|||
105479163|NCT00160667|363766008|FG002|Overall Study|Patient decision|1|||
105479164|NCT02342418|363766011|FG000|Overall Study|Adverse Event|0|||
105479165|NCT02342418|363766012|FG001|Overall Study|Adverse Event|1|||
105479166|NCT04255394|363766013|FG000|Overall Study|Death|35|||
105479167|NCT04255394|363766014|FG001|Overall Study|Death|25|||
105479168|NCT04255394|363766013|FG000|Overall Study|Device removed|2|||
105479169|NCT04255394|363766014|FG001|Overall Study|Device removed|10|||
105479170|NCT04255394|363766013|FG000|Overall Study|Withdrawal by Subject|9|||
105479171|NCT04255394|363766014|FG001|Overall Study|Withdrawal by Subject|8|||
105479172|NCT04255394|363766013|FG000|Overall Study|Screen Failure/Not treated|12|||
105479173|NCT04255394|363766014|FG001|Overall Study|Screen Failure/Not treated|8|||
105479174|NCT04255394|363766013|FG000|Overall Study|Lost to Follow-up|123|||
105479175|NCT04255394|363766014|FG001|Overall Study|Lost to Follow-up|265|||
105479176|NCT04255394|363766013|FG000|Overall Study|Adverse Event|1|||
105479177|NCT04255394|363766014|FG001|Overall Study|Adverse Event|3|||
105479178|NCT00363545|363766025|FG000|Overall Study|Serious Adverse Event|0|||
105479179|NCT00363545|363766026|FG001|Overall Study|Serious Adverse Event|1|||
105479180|NCT00363545|363766025|FG000|Overall Study|Withdrawal by Subject|12|||
105479181|NCT00363545|363766026|FG001|Overall Study|Withdrawal by Subject|15|||
105479182|NCT00363545|363766025|FG000|Overall Study|Migrated/moved from study area|3|||
105479183|NCT00363545|363766026|FG001|Overall Study|Migrated/moved from study area|6|||
105479184|NCT00363545|363766025|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
105479185|NCT00363545|363766026|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
105479186|NCT00363545|363766025|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
105479187|NCT00363545|363766026|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
105479188|NCT00363545|363766025|FG000|Overall Study|Others|1|||
105479189|NCT00363545|363766026|FG001|Overall Study|Others|0|||
105479190|NCT00336856|363767483|FG000|Overall Study|Withdrawal by Subject|3|||
105479191|NCT00336856|363767483|FG000|Overall Study|Found ineligible at time of analysis|1|||
105479192|NCT03320824|363767484|FG000|Overall Study|Withdrawal by Subject|8|||
105479193|NCT03320824|363767485|FG001|Overall Study|Withdrawal by Subject|1|||
105479194|NCT03320824|363767484|FG000|Overall Study|Lost to Follow-up|10|||
105479195|NCT03320824|363767485|FG001|Overall Study|Lost to Follow-up|1|||
105479196|NCT03320824|363767484|FG000|Overall Study|moved out of state|0|||
105479197|NCT03320824|363767485|FG001|Overall Study|moved out of state|1|||
105563748|NCT00118716|364061222|FG000|Overall Study|Non-compliance|1|||
105563749|NCT00118716|364061223|FG001|Overall Study|Non-compliance|3|||
105563750|NCT00118716|364061222|FG000|Overall Study|misrandomized|1|||
105563751|NCT00118716|364061223|FG001|Overall Study|misrandomized|1|||
105563752|NCT00118716|364061222|FG000|Overall Study|Expired drug use|1|||
105563753|NCT00118716|364061223|FG001|Overall Study|Expired drug use|2|||
105563754|NCT00118716|364061222|FG000|Overall Study|Investigator discretion|0|||
105563755|NCT00118716|364061223|FG001|Overall Study|Investigator discretion|1|||
105563756|NCT03002610|364061224|FG000|Overall Study|Withdrawal by Subject|6|||
105563757|NCT03002610|364061225|FG001|Overall Study|Withdrawal by Subject|25|||
105563758|NCT03002610|364061226|FG002|Overall Study|Withdrawal by Subject|13|||
105563759|NCT02436811|364061227|FG000|Overall Study|Lost to Follow-up|2|||
105563760|NCT02436811|364061228|FG001|Overall Study|Lost to Follow-up|9|||
105563761|NCT02436811|364061229|FG002|Overall Study|Lost to Follow-up|7|||
105563762|NCT01089374|364061234|FG000|Overall Study|Lost to Follow-up|3|||
105563763|NCT01089374|364061235|FG001|Overall Study|Lost to Follow-up|0|||
105563764|NCT01089374|364061234|FG000|Overall Study|Withdrawal by Subject|1|||
105563765|NCT01089374|364061235|FG001|Overall Study|Withdrawal by Subject|0|||
105563766|NCT01089374|364061234|FG000|Overall Study|Study closed early - low accrual|6|||
105563767|NCT01089374|364061235|FG001|Overall Study|Study closed early - low accrual|0|||
105794230|NCT03443973|364902191|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
105794231|NCT03443973|364902188|FG000|Double-blind Treatment Period|Physician Decision|5|||
105794232|NCT03443973|364902189|FG001|Double-blind Treatment Period|Physician Decision|6|||
105794233|NCT03443973|364902190|FG002|Double-blind Treatment Period|Physician Decision|0|||
105794234|NCT03443973|364902191|FG003|Double-blind Treatment Period|Physician Decision|0|||
105794235|NCT03443973|364902188|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
105794236|NCT03443973|364902189|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
105794237|NCT03443973|364902190|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
105794238|NCT03443973|364902191|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
105794239|NCT03443973|364902188|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
105563768|NCT02755597|364061236|FG000|Overall Study|Withdrew consent|27|||
105563769|NCT02755597|364061237|FG001|Overall Study|Withdrew consent|11|||
105563770|NCT02755597|364061236|FG000|Overall Study|Lost to Follow-up|1|||
105563771|NCT02755597|364061237|FG001|Overall Study|Lost to Follow-up|0|||
105794240|NCT03443973|364902189|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
105794241|NCT03443973|364902190|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105563772|NCT02755597|364061236|FG000|Overall Study|Death|78|||
105563773|NCT02755597|364061237|FG001|Overall Study|Death|36|||
105563774|NCT02755597|364061236|FG000|Overall Study|Study terminated by Sponsor|67|||
105794242|NCT03443973|364902191|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
105794243|NCT03443973|364902188|FG000|Open-label Extension Period|Reason Not Specified|0|||
105794244|NCT03443973|364902189|FG001|Open-label Extension Period|Reason Not Specified|0|||
105794245|NCT03443973|364902190|FG002|Open-label Extension Period|Reason Not Specified|3|||
105794246|NCT03443973|364902191|FG003|Open-label Extension Period|Reason Not Specified|0|||
105794247|NCT03443973|364902188|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
105794248|NCT03443973|364902189|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
105794249|NCT03443973|364902190|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
105794250|NCT03443973|364902191|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
105794251|NCT04651218|364902205|FG000|Overall Study|Withdrawal by Subject|0|||
105794252|NCT04651218|364902206|FG001|Overall Study|Withdrawal by Subject|2|||
105794253|NCT02476851|364902207|FG000|Overall Study|Protocol Violation|1|||
105794254|NCT02476851|364902208|FG001|Overall Study|Protocol Violation|1|||
105794255|NCT00647426|364902211|FG000|Overall Study|Withdrawal by Subject|2|||
105794256|NCT00883740|364902213|FG000|First Intervention|Lost to Follow-up|1|||
105794257|NCT00883740|364902214|FG001|First Intervention|Lost to Follow-up|0|||
105794258|NCT00883740|364902213|FG000|First Intervention|No longer willing to participate|2|||
105794259|NCT00883740|364902214|FG001|First Intervention|No longer willing to participate|0|||
105794260|NCT00883740|364902213|FG000|First Intervention|Protocol Violation|3|||
105794261|NCT00883740|364902214|FG001|First Intervention|Protocol Violation|6|||
105794262|NCT00883740|364902213|FG000|First Intervention|Adverse Event|1|||
105794263|NCT00883740|364902214|FG001|First Intervention|Adverse Event|2|||
105794264|NCT00883740|364902213|FG000|Second Intervention|Protocol Violation|1|||
105794265|NCT00883740|364902214|FG001|Second Intervention|Protocol Violation|0|||
105794266|NCT00883740|364902213|FG000|Second Intervention|No longer willing to participate|0|||
105794267|NCT00883740|364902214|FG001|Second Intervention|No longer willing to participate|1|||
105794268|NCT00568776|364902216|FG000|Overall Study|Adverse Event|8|||
105794269|NCT00568776|364902217|FG001|Overall Study|Adverse Event|8|||
105479198|NCT03320824|363767484|FG000|Overall Study|could not complete final visit|0|||
105479199|NCT03320824|363767485|FG001|Overall Study|could not complete final visit|1|||
105479200|NCT00955305|363767486|FG000|Overall Study|Disease progression|39|||
105479201|NCT00955305|363767487|FG001|Overall Study|Disease progression|41|||
105794270|NCT00568776|364902218|FG002|Overall Study|Adverse Event|10|||
105794271|NCT00568776|364902219|FG003|Overall Study|Adverse Event|8|||
105794272|NCT00568776|364902216|FG000|Overall Study|Death|0|||
105794273|NCT00568776|364902217|FG001|Overall Study|Death|1|||
105794274|NCT00568776|364902218|FG002|Overall Study|Death|4|||
105794275|NCT00568776|364902219|FG003|Overall Study|Death|3|||
105794276|NCT00568776|364902216|FG000|Overall Study|Physician Decision|0|||
105794277|NCT00568776|364902217|FG001|Overall Study|Physician Decision|2|||
105794278|NCT00568776|364902218|FG002|Overall Study|Physician Decision|0|||
105794279|NCT00568776|364902219|FG003|Overall Study|Physician Decision|0|||
105479202|NCT00955305|363767486|FG000|Overall Study|Adverse Event|22|||
105479203|NCT00955305|363767487|FG001|Overall Study|Adverse Event|22|||
105794280|NCT00568776|364902216|FG000|Overall Study|Lack of Efficacy|2|||
105794281|NCT00568776|364902217|FG001|Overall Study|Lack of Efficacy|2|||
105794282|NCT00568776|364902218|FG002|Overall Study|Lack of Efficacy|2|||
105794283|NCT00568776|364902219|FG003|Overall Study|Lack of Efficacy|4|||
105794284|NCT00568776|364902216|FG000|Overall Study|Lost to Follow-up|1|||
105794285|NCT00568776|364902217|FG001|Overall Study|Lost to Follow-up|1|||
105794286|NCT00568776|364902218|FG002|Overall Study|Lost to Follow-up|1|||
105794287|NCT00568776|364902219|FG003|Overall Study|Lost to Follow-up|1|||
105794288|NCT00568776|364902216|FG000|Overall Study|Protocol Violation|1|||
105794289|NCT00568776|364902217|FG001|Overall Study|Protocol Violation|0|||
105794290|NCT00568776|364902218|FG002|Overall Study|Protocol Violation|1|||
105794291|NCT00568776|364902219|FG003|Overall Study|Protocol Violation|1|||
105794292|NCT00568776|364902216|FG000|Overall Study|Withdrawal by Subject|13|||
105794293|NCT00568776|364902217|FG001|Overall Study|Withdrawal by Subject|15|||
105794294|NCT00568776|364902218|FG002|Overall Study|Withdrawal by Subject|13|||
105794295|NCT00568776|364902219|FG003|Overall Study|Withdrawal by Subject|7|||
105479204|NCT00955305|363767486|FG000|Overall Study|Death|2|||
105479205|NCT00955305|363767487|FG001|Overall Study|Death|1|||
105479206|NCT00955305|363767486|FG000|Overall Study|Withdrawal by Subject|5|||
105479207|NCT00955305|363767487|FG001|Overall Study|Withdrawal by Subject|4|||
105479208|NCT00955305|363767486|FG000|Overall Study|Alternative therapy|4|||
105479209|NCT00955305|363767487|FG001|Overall Study|Alternative therapy|0|||
105479210|NCT00955305|363767486|FG000|Overall Study|Other complicating disease|2|||
105479211|NCT00955305|363767487|FG001|Overall Study|Other complicating disease|4|||
105479212|NCT00955305|363767486|FG000|Overall Study|Physician Decision|1|||
105479213|NCT00955305|363767487|FG001|Overall Study|Physician Decision|0|||
105479214|NCT00955305|363767486|FG000|Overall Study|Continued presence of residual disease|0|||
105479215|NCT00955305|363767487|FG001|Overall Study|Continued presence of residual disease|1|||
105479216|NCT00955305|363767486|FG000|Overall Study|Functional decline|2|||
105479217|NCT00955305|363767487|FG001|Overall Study|Functional decline|0|||
105479218|NCT00955305|363767486|FG000|Overall Study|Maximum response achieved|0|||
105479219|NCT00955305|363767487|FG001|Overall Study|Maximum response achieved|1|||
105479220|NCT00955305|363767486|FG000|Overall Study|Lost to Follow-up|0|||
105479221|NCT00955305|363767487|FG001|Overall Study|Lost to Follow-up|1|||
105479222|NCT00955305|363767486|FG000|Overall Study|No off-treatment reason submitted|1|||
105479223|NCT00955305|363767487|FG001|Overall Study|No off-treatment reason submitted|0|||
105479224|NCT00955305|363767486|FG000|Overall Study|Never started protocol treatment|5|||
105479225|NCT00955305|363767487|FG001|Overall Study|Never started protocol treatment|5|||
105479226|NCT00955305|363767486|FG000|Overall Study|Ineligible|5|||
105479227|NCT00955305|363767487|FG001|Overall Study|Ineligible|7|||
105479228|NCT03472547|363767488|FG000|Overall Study|Withdrawal by Subject|30|||
105479229|NCT00369629|363767493|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
105479230|NCT00369629|363767494|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
105479231|NCT00369629|363767495|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
105479232|NCT00369629|363767496|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
105479233|NCT00369629|363767493|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
105479234|NCT00369629|363767494|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
105479235|NCT00369629|363767495|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
105479236|NCT00369629|363767496|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
105479237|NCT00369629|363767493|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
105479238|NCT00369629|363767494|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
105479239|NCT00369629|363767495|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
105479240|NCT00369629|363767496|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
105479241|NCT00369629|363767493|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
105479242|NCT00369629|363767494|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
105479243|NCT00369629|363767495|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
105479244|NCT00369629|363767496|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
105479245|NCT00369629|363767493|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
105479246|NCT00369629|363767494|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
105479247|NCT00369629|363767495|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
105479248|NCT00369629|363767496|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
105479249|NCT00369629|363767493|FG000|Completed 4 More Cycles|Progressive disease|2|||
105479250|NCT00369629|363767494|FG001|Completed 4 More Cycles|Progressive disease|1|||
105479251|NCT00369629|363767495|FG002|Completed 4 More Cycles|Progressive disease|2|||
105479252|NCT00369629|363767496|FG003|Completed 4 More Cycles|Progressive disease|0|||
105479253|NCT00369629|363767493|FG000|Follow up for 1 Year|Death|2|||
105479254|NCT00369629|363767494|FG001|Follow up for 1 Year|Death|1|||
105479255|NCT00369629|363767495|FG002|Follow up for 1 Year|Death|1|||
105479256|NCT00369629|363767496|FG003|Follow up for 1 Year|Death|0|||
105479257|NCT00369629|363767493|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
105479258|NCT00369629|363767494|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
105794296|NCT00568776|364902216|FG000|Overall Study|Loss of Caregiver|0|||
105794297|NCT00568776|364902217|FG001|Overall Study|Loss of Caregiver|2|||
105794298|NCT00568776|364902218|FG002|Overall Study|Loss of Caregiver|1|||
105479259|NCT00369629|363767495|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
105479260|NCT00369629|363767496|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
105479261|NCT00369629|363767493|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
105479262|NCT00369629|363767494|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
105479263|NCT00369629|363767495|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
105479264|NCT00369629|363767496|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
105479265|NCT01129583|363767497|FG000|Overall Study|Death|1|||
105479266|NCT01129583|363767498|FG001|Overall Study|Death|0|||
105479267|NCT01129583|363767497|FG000|Overall Study|Lost to Follow-up|1|||
105479268|NCT01129583|363767498|FG001|Overall Study|Lost to Follow-up|1|||
105479269|NCT01129583|363767497|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
105479270|NCT01129583|363767498|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
105479271|NCT01904773|363767499|FG000|Screen|Screen failure|3|||
105479272|NCT01904773|363767500|FG001|Screen|Screen failure|0|||
105479273|NCT01904773|363767501|FG002|Screen|Screen failure|0|||
105479274|NCT01904773|363767502|FG003|Screen|Screen failure|0|||
105479275|NCT01904773|363767503|FG004|Screen|Screen failure|0|||
105479276|NCT01904773|363767504|FG005|Screen|Screen failure|0|||
105479277|NCT01904773|363767505|FG006|Screen|Screen failure|0|||
105479278|NCT01904773|363767506|FG007|Screen|Screen failure|0|||
105479279|NCT01904773|363767507|FG008|Screen|Screen failure|0|||
105479280|NCT01904773|363767499|FG000|Screen|Withdrawal by Subject|1|||
105479281|NCT01904773|363767500|FG001|Screen|Withdrawal by Subject|0|||
105479282|NCT01904773|363767501|FG002|Screen|Withdrawal by Subject|0|||
105479283|NCT01904773|363767502|FG003|Screen|Withdrawal by Subject|0|||
105479284|NCT01904773|363767503|FG004|Screen|Withdrawal by Subject|0|||
105479285|NCT01904773|363767504|FG005|Screen|Withdrawal by Subject|0|||
105479286|NCT01904773|363767505|FG006|Screen|Withdrawal by Subject|0|||
105479287|NCT01904773|363767506|FG007|Screen|Withdrawal by Subject|0|||
105479288|NCT01904773|363767507|FG008|Screen|Withdrawal by Subject|0|||
105479289|NCT01904773|363767499|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
105479290|NCT01904773|363767500|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
105479291|NCT01904773|363767501|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
105479292|NCT01904773|363767502|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
105479293|NCT01904773|363767503|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
105479294|NCT01904773|363767504|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
105479295|NCT01904773|363767505|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
105479296|NCT01904773|363767506|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
105479297|NCT01904773|363767507|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
105479298|NCT01904773|363767499|FG000|First Intervention|Adverse Event|0|||
105479299|NCT01904773|363767500|FG001|First Intervention|Adverse Event|0|||
105479300|NCT01904773|363767501|FG002|First Intervention|Adverse Event|0|||
105479301|NCT01904773|363767502|FG003|First Intervention|Adverse Event|0|||
105479302|NCT01904773|363767503|FG004|First Intervention|Adverse Event|0|||
105479303|NCT01904773|363767504|FG005|First Intervention|Adverse Event|0|||
105479304|NCT01904773|363767505|FG006|First Intervention|Adverse Event|1|||
105479305|NCT01904773|363767506|FG007|First Intervention|Adverse Event|0|||
105479306|NCT01904773|363767507|FG008|First Intervention|Adverse Event|0|||
105479307|NCT01904773|363767499|FG000|Placebo Washout First Intervention|Condition worsened|0|||
105479308|NCT01904773|363767500|FG001|Placebo Washout First Intervention|Condition worsened|1|||
105479309|NCT01904773|363767501|FG002|Placebo Washout First Intervention|Condition worsened|0|||
105479310|NCT01904773|363767502|FG003|Placebo Washout First Intervention|Condition worsened|0|||
105479311|NCT01904773|363767503|FG004|Placebo Washout First Intervention|Condition worsened|0|||
105479312|NCT01904773|363767504|FG005|Placebo Washout First Intervention|Condition worsened|0|||
105479313|NCT01904773|363767505|FG006|Placebo Washout First Intervention|Condition worsened|0|||
105479314|NCT01904773|363767506|FG007|Placebo Washout First Intervention|Condition worsened|0|||
105479315|NCT01904773|363767507|FG008|Placebo Washout First Intervention|Condition worsened|0|||
105479316|NCT01904773|363767499|FG000|Fifth Intervention|Adverse Event|0|||
105479317|NCT01904773|363767500|FG001|Fifth Intervention|Adverse Event|0|||
105479318|NCT01904773|363767501|FG002|Fifth Intervention|Adverse Event|0|||
105479319|NCT01904773|363767502|FG003|Fifth Intervention|Adverse Event|0|||
105479320|NCT01904773|363767503|FG004|Fifth Intervention|Adverse Event|0|||
105479321|NCT01904773|363767504|FG005|Fifth Intervention|Adverse Event|0|||
105479322|NCT01904773|363767505|FG006|Fifth Intervention|Adverse Event|0|||
105479323|NCT01904773|363767506|FG007|Fifth Intervention|Adverse Event|1|||
105479324|NCT01904773|363767507|FG008|Fifth Intervention|Adverse Event|0|||
105479325|NCT01904773|363767499|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
105479326|NCT01904773|363767500|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
105479327|NCT01904773|363767501|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
105479328|NCT01904773|363767502|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
105479329|NCT01904773|363767503|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
105794299|NCT00568776|364902219|FG003|Overall Study|Loss of Caregiver|2|||
105479330|NCT01904773|363767504|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
105479331|NCT01904773|363767505|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
105479332|NCT01904773|363767506|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
105479333|NCT01904773|363767507|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
105479334|NCT02168387|363767527|FG000|Overall Study|Planned exubation|6|||
105479335|NCT02168387|363767528|FG001|Overall Study|Planned exubation|3|||
105479336|NCT02168387|363767527|FG000|Overall Study|Death|1|||
105479337|NCT02168387|363767528|FG001|Overall Study|Death|0|||
105479338|NCT03560518|363767531|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
105479339|NCT03560518|363767532|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
105479340|NCT03560518|363767533|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
105563775|NCT02755597|364061237|FG001|Overall Study|Study terminated by Sponsor|47|||
105563776|NCT02755597|364061236|FG000|Overall Study|Other, not specified|20|||
105479341|NCT03560518|363767531|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
105479342|NCT03560518|363767532|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
105479343|NCT03560518|363767533|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
105479344|NCT03560518|363767531|FG000|Double Blind Treatment Period|Protocol Violation|1|||
105479345|NCT03560518|363767532|FG001|Double Blind Treatment Period|Protocol Violation|2|||
105479346|NCT03560518|363767533|FG002|Double Blind Treatment Period|Protocol Violation|0|||
105479347|NCT03560518|363767531|FG000|Double Blind Treatment Period|Pregnancy|0|||
105479348|NCT03560518|363767532|FG001|Double Blind Treatment Period|Pregnancy|2|||
105479349|NCT03560518|363767533|FG002|Double Blind Treatment Period|Pregnancy|0|||
105479350|NCT03560518|363767531|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
105479351|NCT03560518|363767532|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
105479352|NCT03560518|363767533|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
105479353|NCT03560518|363767531|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
105479354|NCT03560518|363767532|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
105479355|NCT03560518|363767533|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
105479356|NCT03560518|363767531|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
105479357|NCT03560518|363767532|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
105479358|NCT03560518|363767533|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
105479359|NCT03560518|363767531|FG000|Double Blind Treatment Period|Adverse Event|0|||
105479360|NCT03560518|363767532|FG001|Double Blind Treatment Period|Adverse Event|3|||
105479361|NCT03560518|363767533|FG002|Double Blind Treatment Period|Adverse Event|1|||
105479362|NCT00913458|363767534|FG000|Phase 1|Non-Responder|54|||
105479363|NCT00913458|363767535|FG001|Phase 1|Non-Responder|0|||
105479364|NCT00913458|363767536|FG002|Phase 1|Non-Responder|0|||
105479365|NCT00913458|363767537|FG003|Phase 1|Non-Responder|0|||
105479366|NCT00913458|363767538|FG004|Phase 1|Non-Responder|0|||
105479367|NCT00913458|363767539|FG005|Phase 1|Non-Responder|0|||
105479368|NCT00913458|363767540|FG006|Phase 1|Non-Responder|0|||
105479369|NCT00913458|363767534|FG000|Phase 1|Subject Request|17|||
105479370|NCT00913458|363767535|FG001|Phase 1|Subject Request|0|||
105479371|NCT00913458|363767536|FG002|Phase 1|Subject Request|0|||
105479372|NCT00913458|363767537|FG003|Phase 1|Subject Request|0|||
105479373|NCT00913458|363767538|FG004|Phase 1|Subject Request|0|||
105479374|NCT00913458|363767539|FG005|Phase 1|Subject Request|0|||
105479375|NCT00913458|363767540|FG006|Phase 1|Subject Request|0|||
105479376|NCT00913458|363767534|FG000|Phase 1|Adverse Event|20|||
105479377|NCT00913458|363767535|FG001|Phase 1|Adverse Event|0|||
105479378|NCT00913458|363767536|FG002|Phase 1|Adverse Event|0|||
105479379|NCT00913458|363767537|FG003|Phase 1|Adverse Event|0|||
105479380|NCT00913458|363767538|FG004|Phase 1|Adverse Event|0|||
105479381|NCT00913458|363767539|FG005|Phase 1|Adverse Event|0|||
105479382|NCT00913458|363767540|FG006|Phase 1|Adverse Event|0|||
105479383|NCT00913458|363767534|FG000|Phase 1|Lost to Follow-up|2|||
105479384|NCT00913458|363767535|FG001|Phase 1|Lost to Follow-up|0|||
105479385|NCT00913458|363767536|FG002|Phase 1|Lost to Follow-up|0|||
105479386|NCT00913458|363767537|FG003|Phase 1|Lost to Follow-up|0|||
105479387|NCT00913458|363767538|FG004|Phase 1|Lost to Follow-up|0|||
105479388|NCT00913458|363767539|FG005|Phase 1|Lost to Follow-up|0|||
105479389|NCT00913458|363767540|FG006|Phase 1|Lost to Follow-up|0|||
105479390|NCT00913458|363767534|FG000|Phase 1|Protocol Violation|10|||
105479391|NCT00913458|363767535|FG001|Phase 1|Protocol Violation|0|||
105479392|NCT00913458|363767536|FG002|Phase 1|Protocol Violation|0|||
105563777|NCT02755597|364061237|FG001|Overall Study|Other, not specified|3|||
105479393|NCT00913458|363767537|FG003|Phase 1|Protocol Violation|0|||
105479394|NCT00913458|363767538|FG004|Phase 1|Protocol Violation|0|||
105479395|NCT00913458|363767539|FG005|Phase 1|Protocol Violation|0|||
105479396|NCT00913458|363767540|FG006|Phase 1|Protocol Violation|0|||
105479397|NCT00913458|363767534|FG000|Phase 1|Sponsor|2|||
105479398|NCT00913458|363767535|FG001|Phase 1|Sponsor|0|||
105479399|NCT00913458|363767536|FG002|Phase 1|Sponsor|0|||
105479400|NCT00913458|363767537|FG003|Phase 1|Sponsor|0|||
105479401|NCT00913458|363767538|FG004|Phase 1|Sponsor|0|||
105479402|NCT00913458|363767539|FG005|Phase 1|Sponsor|0|||
105479403|NCT00913458|363767540|FG006|Phase 1|Sponsor|0|||
105479404|NCT00913458|363767534|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
105563778|NCT02755597|364061236|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
105563779|NCT02755597|364061237|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
105563780|NCT01422408|364061246|FG000|Overall Study|Adverse Event|1|||
105563781|NCT01422408|364061246|FG000|Overall Study|Withdrawal by Subject|3|||
105563782|NCT00701038|364061250|FG000|Overall Study|study amended pilot group of patients|4|||
105563783|NCT00701038|364061251|FG001|Overall Study|study amended pilot group of patients|4|||
105563784|NCT03371940|364061255|FG000|Overall Study|Withdrawal by Subject|8|||
105563785|NCT03371940|364061256|FG001|Overall Study|Withdrawal by Subject|1|||
105563786|NCT03371940|364061257|FG002|Overall Study|Withdrawal by Subject|3|||
105563787|NCT03371940|364061258|FG003|Overall Study|Withdrawal by Subject|4|||
105563788|NCT05099926|364061264|FG000|Overall Study|Lost to Follow-up|1|||
105563789|NCT00504426|364061270|FG000|Overall Study|Adverse Event|0|||
105563790|NCT00504426|364061271|FG001|Overall Study|Adverse Event|0|||
105563791|NCT00504426|364061272|FG002|Overall Study|Adverse Event|2|||
105563792|NCT00504426|364061273|FG003|Overall Study|Adverse Event|0|||
105563793|NCT00504426|364061270|FG000|Overall Study|Protocol Violation|1|||
105563794|NCT00504426|364061271|FG001|Overall Study|Protocol Violation|1|||
105563795|NCT00504426|364061272|FG002|Overall Study|Protocol Violation|2|||
105563796|NCT00504426|364061273|FG003|Overall Study|Protocol Violation|0|||
105563797|NCT00504426|364061270|FG000|Overall Study|Withdrawal by Subject|2|||
105563798|NCT00504426|364061271|FG001|Overall Study|Withdrawal by Subject|0|||
105563799|NCT00504426|364061272|FG002|Overall Study|Withdrawal by Subject|0|||
105563800|NCT00504426|364061273|FG003|Overall Study|Withdrawal by Subject|0|||
105563801|NCT00168038|364061277|FG000|Overall Study|Adverse Event|1|||
105563802|NCT00168038|364061277|FG000|Overall Study|Therapy failure|1|||
105563803|NCT02703922|364061286|FG000|Overall Study|Death|5|||
105563804|NCT02703922|364061287|FG001|Overall Study|Death|8|||
105563805|NCT02703922|364061286|FG000|Overall Study|Lost to Follow-up|10|||
105563806|NCT02703922|364061287|FG001|Overall Study|Lost to Follow-up|10|||
105563807|NCT00394355|364061288|FG000|Overall Study|Adverse Event|10|||
105563808|NCT00394355|364061289|FG001|Overall Study|Adverse Event|6|||
105563809|NCT00394355|364061290|FG002|Overall Study|Adverse Event|7|||
105563810|NCT00394355|364061291|FG003|Overall Study|Adverse Event|8|||
105563811|NCT00394355|364061288|FG000|Overall Study|Did not meet protocol eligibility|1|||
105563812|NCT00394355|364061289|FG001|Overall Study|Did not meet protocol eligibility|5|||
105563813|NCT00394355|364061290|FG002|Overall Study|Did not meet protocol eligibility|4|||
105563814|NCT00394355|364061291|FG003|Overall Study|Did not meet protocol eligibility|2|||
105563815|NCT00394355|364061288|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
105563816|NCT00394355|364061289|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
105563817|NCT00394355|364061290|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
105563818|NCT00394355|364061291|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
105563819|NCT00394355|364061288|FG000|Overall Study|Subject withdrawal - related to drug|1|||
105563820|NCT00394355|364061289|FG001|Overall Study|Subject withdrawal - related to drug|0|||
105563821|NCT00394355|364061290|FG002|Overall Study|Subject withdrawal - related to drug|0|||
105563822|NCT00394355|364061291|FG003|Overall Study|Subject withdrawal - related to drug|0|||
105563823|NCT00394355|364061288|FG000|Overall Study|Lost to Follow-up|7|||
105563824|NCT00394355|364061289|FG001|Overall Study|Lost to Follow-up|5|||
105563825|NCT00394355|364061290|FG002|Overall Study|Lost to Follow-up|4|||
105563826|NCT00394355|364061291|FG003|Overall Study|Lost to Follow-up|3|||
105563827|NCT00394355|364061288|FG000|Overall Study|Noncompliance with protocol|4|||
105726468|NCT01431287|364655479|FG000|Overall Study|Non compliant with protocol|6|||
105726469|NCT01431287|364655480|FG001|Overall Study|Non compliant with protocol|6|||
105726470|NCT01431287|364655481|FG002|Overall Study|Non compliant with protocol|5|||
105726471|NCT01431287|364655482|FG003|Overall Study|Non compliant with protocol|6|||
105726472|NCT01431287|364655483|FG004|Overall Study|Non compliant with protocol|5|||
105726473|NCT01431287|364655479|FG000|Overall Study|Lost to Follow-up|0|||
105726474|NCT01431287|364655480|FG001|Overall Study|Lost to Follow-up|3|||
105726475|NCT01431287|364655481|FG002|Overall Study|Lost to Follow-up|2|||
105726476|NCT01431287|364655482|FG003|Overall Study|Lost to Follow-up|3|||
105563828|NCT00394355|364061289|FG001|Overall Study|Noncompliance with protocol|3|||
105563829|NCT00394355|364061290|FG002|Overall Study|Noncompliance with protocol|10|||
105563830|NCT00394355|364061291|FG003|Overall Study|Noncompliance with protocol|8|||
105563831|NCT00394355|364061288|FG000|Overall Study|Administrative|0|||
105563832|NCT00394355|364061289|FG001|Overall Study|Administrative|1|||
105563833|NCT00394355|364061290|FG002|Overall Study|Administrative|1|||
105563834|NCT00394355|364061291|FG003|Overall Study|Administrative|1|||
105563835|NCT00394355|364061288|FG000|Overall Study|Lack of Efficacy|0|||
105563836|NCT00394355|364061289|FG001|Overall Study|Lack of Efficacy|0|||
105563837|NCT00394355|364061290|FG002|Overall Study|Lack of Efficacy|2|||
105563838|NCT00394355|364061291|FG003|Overall Study|Lack of Efficacy|3|||
105726477|NCT01431287|364655483|FG004|Overall Study|Lost to Follow-up|1|||
105726478|NCT01431287|364655479|FG000|Overall Study|Consent withdrawn not due to AE|29|||
105726479|NCT01431287|364655480|FG001|Overall Study|Consent withdrawn not due to AE|30|||
105726480|NCT01431287|364655481|FG002|Overall Study|Consent withdrawn not due to AE|34|||
105726481|NCT01431287|364655482|FG003|Overall Study|Consent withdrawn not due to AE|19|||
105563839|NCT02612064|364061294|FG000|Overall Study|Withdrawal by Subject|1|||
105563840|NCT02612064|364061295|FG001|Overall Study|Withdrawal by Subject|1|||
105563841|NCT02612064|364061294|FG000|Overall Study|Other|0|||
105563842|NCT02612064|364061295|FG001|Overall Study|Other|2|||
105563843|NCT01648348|364061296|FG000|Overall Study|Cancel|1|||
105563844|NCT01648348|364061297|FG001|Overall Study|Cancel|0|||
105563845|NCT01648348|364061298|FG002|Overall Study|Cancel|0|||
105563846|NCT01648348|364061299|FG003|Overall Study|Cancel|0|||
105563847|NCT01648348|364061300|FG004|Overall Study|Cancel|3|||
105563848|NCT01648348|364061301|FG005|Overall Study|Cancel|6|||
105563849|NCT01648348|364061296|FG000|Overall Study|Replaced for MTD analysis|1|||
105563850|NCT01648348|364061297|FG001|Overall Study|Replaced for MTD analysis|0|||
105563851|NCT01648348|364061298|FG002|Overall Study|Replaced for MTD analysis|1|||
105563852|NCT01648348|364061299|FG003|Overall Study|Replaced for MTD analysis|0|||
105563853|NCT01648348|364061300|FG004|Overall Study|Replaced for MTD analysis|0|||
105563854|NCT01648348|364061301|FG005|Overall Study|Replaced for MTD analysis|0|||
105563855|NCT01669798|364061302|FG000|Overall Study|Physician Decision|5|||
105563856|NCT01120249|364061304|FG000|Overall Study|No protocol treatment received|21|||
105563857|NCT01120249|364061305|FG001|Overall Study|No protocol treatment received|15|||
105563858|NCT01120249|364061304|FG000|Overall Study|Disease recurrence|107|||
105563859|NCT01120249|364061305|FG001|Overall Study|Disease recurrence|57|||
105563860|NCT01120249|364061304|FG000|Overall Study|Death|1|||
105563861|NCT01120249|364061305|FG001|Overall Study|Death|0|||
105563862|NCT01120249|364061304|FG000|Overall Study|Adverse Event|40|||
105563863|NCT01120249|364061305|FG001|Overall Study|Adverse Event|276|||
105726482|NCT01431287|364655483|FG004|Overall Study|Consent withdrawn not due to AE|29|||
105726483|NCT01431287|364655479|FG000|Overall Study|not stated above|4|||
105726484|NCT01431287|364655480|FG001|Overall Study|not stated above|2|||
105726485|NCT01431287|364655481|FG002|Overall Study|not stated above|2|||
105726486|NCT01431287|364655482|FG003|Overall Study|not stated above|2|||
105726487|NCT01431287|364655483|FG004|Overall Study|not stated above|1|||
105726488|NCT03263806|364655484|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
105726489|NCT03263806|364655485|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
105726490|NCT03263806|364655484|FG000|Overall Study|Withdrawal by Subject|0|||
105726491|NCT03263806|364655485|FG001|Overall Study|Withdrawal by Subject|1|||
105726492|NCT03263806|364655484|FG000|Overall Study|Study Termination|5|||
105726493|NCT03263806|364655485|FG001|Overall Study|Study Termination|6|||
105726494|NCT00224016|364655486|FG000|Titration Period|Withdrawal by Subject|0|||
105726495|NCT00224016|364655487|FG001|Titration Period|Withdrawal by Subject|1|||
105726496|NCT00224016|364655486|FG000|Titration Period|Lost to Follow-up|1|||
105726497|NCT00224016|364655487|FG001|Titration Period|Lost to Follow-up|0|||
105726498|NCT00224016|364655486|FG000|Maintenance Period|Withdrawal by Subject|2|||
105726499|NCT00224016|364655487|FG001|Maintenance Period|Withdrawal by Subject|0|||
105726500|NCT00224016|364655486|FG000|Maintenance Period|Lost to Follow-up|0|||
105726501|NCT00224016|364655487|FG001|Maintenance Period|Lost to Follow-up|1|||
105726502|NCT01793792|364655491|FG000|Overall Study|Death|5|||
105726503|NCT01793792|364655491|FG000|Overall Study|Lost to Follow-up|5|||
105726504|NCT01793792|364655491|FG000|Overall Study|Withdrawal by Subject|1|||
105726505|NCT01793792|364655491|FG000|Overall Study|Device Not Implanted|1|||
105563864|NCT01120249|364061304|FG000|Overall Study|Participant refusal|34|||
105563865|NCT01120249|364061305|FG001|Overall Study|Participant refusal|42|||
105726506|NCT02626338|364655494|FG000|Overall Study|Lack of Efficacy|3|||
105726507|NCT02626338|364655495|FG001|Overall Study|Lack of Efficacy|2|||
105563866|NCT01120249|364061304|FG000|Overall Study|Other reasons, not protocol specified|29|||
105563867|NCT01120249|364061305|FG001|Overall Study|Other reasons, not protocol specified|22|||
105563868|NCT00717860|364061306|FG000|Overall Study|Clinical adverse experience|5|||
105563869|NCT00717860|364061307|FG001|Overall Study|Clinical adverse experience|9|||
105563870|NCT00717860|364061306|FG000|Overall Study|Laboratory adverse experience|2|||
105563871|NCT00717860|364061307|FG001|Overall Study|Laboratory adverse experience|2|||
105563872|NCT00717860|364061306|FG000|Overall Study|Lack of Efficacy|7|||
105563873|NCT00717860|364061307|FG001|Overall Study|Lack of Efficacy|13|||
105563874|NCT00717860|364061306|FG000|Overall Study|Discontinued for other reason|6|||
105563875|NCT00717860|364061307|FG001|Overall Study|Discontinued for other reason|1|||
105563876|NCT00717860|364061306|FG000|Overall Study|Withdrew consent|7|||
105563877|NCT00717860|364061307|FG001|Overall Study|Withdrew consent|3|||
105563878|NCT02453685|364061311|FG000|Overall Study|Adverse Event|0|||
105563879|NCT02453685|364061312|FG001|Overall Study|Adverse Event|1|||
105563880|NCT02453685|364061311|FG000|Overall Study|Protocol Violation|7|||
105563881|NCT02453685|364061312|FG001|Overall Study|Protocol Violation|4|||
105563882|NCT02453685|364061311|FG000|Overall Study|Lost to Follow-up|0|||
105563883|NCT02453685|364061312|FG001|Overall Study|Lost to Follow-up|1|||
105563884|NCT02453685|364061311|FG000|Overall Study|Withdrawal by Subject|8|||
105563885|NCT02453685|364061312|FG001|Overall Study|Withdrawal by Subject|4|||
105563886|NCT02453685|364061311|FG000|Overall Study|Unclassified|4|||
105563887|NCT02453685|364061312|FG001|Overall Study|Unclassified|2|||
105726508|NCT02626338|364655496|FG002|Overall Study|Lack of Efficacy|0|||
105563888|NCT02134587|364061313|FG000|Overall Study|Did not completed all meetings|30|||
105726509|NCT00826748|364655497|FG000|Overall Study|Withdrawal by Subject|0|||
105794300|NCT00568776|364902216|FG000|Overall Study|Sponsor Decision|2|||
105794301|NCT00568776|364902217|FG001|Overall Study|Sponsor Decision|2|||
105794302|NCT00568776|364902218|FG002|Overall Study|Sponsor Decision|41|||
105794303|NCT00568776|364902219|FG003|Overall Study|Sponsor Decision|42|||
105794304|NCT00568776|364902216|FG000|Overall Study|Miscellaeneous|3|||
105794305|NCT00568776|364902217|FG001|Overall Study|Miscellaeneous|3|||
105794306|NCT00568776|364902218|FG002|Overall Study|Miscellaeneous|1|||
105794307|NCT00568776|364902219|FG003|Overall Study|Miscellaeneous|4|||
105794308|NCT02742818|364902222|FG000|Overall Study|Adverse Event|0|||
105794309|NCT02742818|364902223|FG001|Overall Study|Adverse Event|1|||
105794310|NCT02742818|364902222|FG000|Overall Study|Protocol Violation|0|||
105794311|NCT02742818|364902223|FG001|Overall Study|Protocol Violation|1|||
105794312|NCT04701658|364902224|FG000|Overall Study|Lost to Follow-up|6|||
105794313|NCT02866695|364902227|FG000|Overall Study|Adverse Event|1|||
105794314|NCT02866695|364902227|FG000|Overall Study|Lost to Follow-up|1|||
105794315|NCT04101721|364902228|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
105794316|NCT04101721|364902229|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
105794317|NCT04101721|364902228|FG000|Overall Study|Death|0|||
105794318|NCT04101721|364902229|FG001|Overall Study|Death|1|||
105794319|NCT04101721|364902228|FG000|Overall Study|Lost to Follow-up|0|||
105794320|NCT04101721|364902229|FG001|Overall Study|Lost to Follow-up|3|||
105794321|NCT02564952|364902230|FG000|Overall Study|Adverse Event|6|||
105794322|NCT02564952|364902230|FG000|Overall Study|Lost to Follow-up|1|||
105794323|NCT02564952|364902230|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
105794324|NCT02564952|364902230|FG000|Overall Study|Withdrawal by Subject|1|||
105794325|NCT02564952|364902230|FG000|Overall Study|Low Efficacy|1|||
105794326|NCT02564952|364902230|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
105794327|NCT02007512|364902231|FG000|Double Blind Treatment Period|Adverse Event|4|||
105794328|NCT02007512|364902232|FG001|Double Blind Treatment Period|Adverse Event|2|||
105794329|NCT02007512|364902233|FG002|Double Blind Treatment Period|Adverse Event|6|||
105794330|NCT02007512|364902234|FG003|Double Blind Treatment Period|Adverse Event|2|||
105794331|NCT02007512|364902231|FG000|Double Blind Treatment Period|Death|1|||
105794332|NCT02007512|364902232|FG001|Double Blind Treatment Period|Death|0|||
105794333|NCT02007512|364902233|FG002|Double Blind Treatment Period|Death|0|||
105794334|NCT02007512|364902234|FG003|Double Blind Treatment Period|Death|0|||
105794335|NCT02007512|364902231|FG000|Double Blind Treatment Period|Disease progression|44|||
105794336|NCT02007512|364902232|FG001|Double Blind Treatment Period|Disease progression|49|||
105794337|NCT02007512|364902233|FG002|Double Blind Treatment Period|Disease progression|45|||
105794338|NCT02007512|364902234|FG003|Double Blind Treatment Period|Disease progression|51|||
105794339|NCT02007512|364902231|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
105794340|NCT02007512|364902232|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
105794341|NCT02007512|364902233|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
105794342|NCT02007512|364902234|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
105794343|NCT02007512|364902231|FG000|Double Blind Treatment Period|Protocol Violation|0|||
105794344|NCT02007512|364902232|FG001|Double Blind Treatment Period|Protocol Violation|0|||
105794345|NCT02007512|364902233|FG002|Double Blind Treatment Period|Protocol Violation|0|||
105794346|NCT02007512|364902234|FG003|Double Blind Treatment Period|Protocol Violation|1|||
105794347|NCT02007512|364902231|FG000|Double Blind Treatment Period|Other|0|||
105794348|NCT02007512|364902232|FG001|Double Blind Treatment Period|Other|0|||
105794349|NCT02007512|364902233|FG002|Double Blind Treatment Period|Other|1|||
105794350|NCT02007512|364902234|FG003|Double Blind Treatment Period|Other|2|||
105794351|NCT02007512|364902231|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
105794352|NCT02007512|364902232|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
105353242|NCT03046056|363298476|FG000|Overall Study|Investigator's Discretion|0|||
105353243|NCT03046056|363298477|FG001|Overall Study|Investigator's Discretion|1|||
105794353|NCT02007512|364902233|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
105794354|NCT02007512|364902234|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
105794355|NCT02007512|364902231|FG000|Open Label Treatment Period|Adverse Event|0|||
105794356|NCT02007512|364902232|FG001|Open Label Treatment Period|Adverse Event|1|||
105353244|NCT03046056|363298478|FG002|Overall Study|Investigator's Discretion|0|||
105353245|NCT03046056|363298476|FG000|Overall Study|Withdrew Consent|1|||
105794357|NCT02007512|364902233|FG002|Open Label Treatment Period|Adverse Event|0|||
105794358|NCT02007512|364902234|FG003|Open Label Treatment Period|Adverse Event|0|||
105794359|NCT02007512|364902231|FG000|Open Label Treatment Period|Other|0|||
105794360|NCT02007512|364902232|FG001|Open Label Treatment Period|Other|0|||
105794361|NCT02007512|364902233|FG002|Open Label Treatment Period|Other|0|||
105794362|NCT02007512|364902234|FG003|Open Label Treatment Period|Other|1|||
105794363|NCT02007512|364902231|FG000|Open Label Treatment Period|Disease progression|0|||
105794364|NCT02007512|364902232|FG001|Open Label Treatment Period|Disease progression|17|||
105794365|NCT02007512|364902233|FG002|Open Label Treatment Period|Disease progression|0|||
105794366|NCT02007512|364902234|FG003|Open Label Treatment Period|Disease progression|11|||
105794367|NCT02007512|364902231|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
105794368|NCT02007512|364902232|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
105794369|NCT02007512|364902233|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
105479405|NCT00913458|363767535|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
105479406|NCT00913458|363767536|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
105479407|NCT00913458|363767537|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
105479408|NCT00913458|363767538|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
105479409|NCT00913458|363767539|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
105479410|NCT00913458|363767540|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
105479411|NCT00913458|363767534|FG000|Phase 2|Non-Responder|0|||
105479412|NCT00913458|363767535|FG001|Phase 2|Non-Responder|5|||
105479413|NCT00913458|363767536|FG002|Phase 2|Non-Responder|7|||
105479414|NCT00913458|363767537|FG003|Phase 2|Non-Responder|12|||
105479415|NCT00913458|363767538|FG004|Phase 2|Non-Responder|0|||
105479416|NCT00913458|363767539|FG005|Phase 2|Non-Responder|0|||
105479417|NCT00913458|363767540|FG006|Phase 2|Non-Responder|0|||
105479418|NCT00913458|363767534|FG000|Phase 2|Subject Request|0|||
105479419|NCT00913458|363767535|FG001|Phase 2|Subject Request|0|||
105479420|NCT00913458|363767536|FG002|Phase 2|Subject Request|1|||
105479421|NCT00913458|363767537|FG003|Phase 2|Subject Request|2|||
105479422|NCT00913458|363767538|FG004|Phase 2|Subject Request|0|||
105479423|NCT00913458|363767539|FG005|Phase 2|Subject Request|0|||
105479424|NCT00913458|363767540|FG006|Phase 2|Subject Request|0|||
105479425|NCT00913458|363767534|FG000|Phase 2|Adverse Event|0|||
105479426|NCT00913458|363767535|FG001|Phase 2|Adverse Event|3|||
105479427|NCT00913458|363767536|FG002|Phase 2|Adverse Event|0|||
105479428|NCT00913458|363767537|FG003|Phase 2|Adverse Event|1|||
105479429|NCT00913458|363767538|FG004|Phase 2|Adverse Event|0|||
105479430|NCT00913458|363767539|FG005|Phase 2|Adverse Event|0|||
105479431|NCT00913458|363767540|FG006|Phase 2|Adverse Event|0|||
105479432|NCT00913458|363767534|FG000|Phase 2|Lost to Follow-up|0|||
105479433|NCT00913458|363767535|FG001|Phase 2|Lost to Follow-up|0|||
105479434|NCT00913458|363767536|FG002|Phase 2|Lost to Follow-up|0|||
105479435|NCT00913458|363767537|FG003|Phase 2|Lost to Follow-up|1|||
105479436|NCT00913458|363767538|FG004|Phase 2|Lost to Follow-up|0|||
105479437|NCT00913458|363767539|FG005|Phase 2|Lost to Follow-up|0|||
105479438|NCT00913458|363767540|FG006|Phase 2|Lost to Follow-up|0|||
105479439|NCT00913458|363767534|FG000|Phase 2|Protocol Violation|0|||
105479440|NCT00913458|363767535|FG001|Phase 2|Protocol Violation|2|||
105479441|NCT00913458|363767536|FG002|Phase 2|Protocol Violation|0|||
105479442|NCT00913458|363767537|FG003|Phase 2|Protocol Violation|0|||
105479443|NCT00913458|363767538|FG004|Phase 2|Protocol Violation|0|||
105479444|NCT00913458|363767539|FG005|Phase 2|Protocol Violation|0|||
105479445|NCT00913458|363767540|FG006|Phase 2|Protocol Violation|0|||
105479446|NCT00913458|363767534|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
105479447|NCT00913458|363767535|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
105479448|NCT00913458|363767536|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
105479449|NCT00913458|363767537|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
105479450|NCT00913458|363767538|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
105479451|NCT00913458|363767539|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
105479452|NCT00913458|363767540|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
105479453|NCT00913458|363767534|FG000|Phase 3|Adverse Event|0|||
105479454|NCT00913458|363767535|FG001|Phase 3|Adverse Event|0|||
105479455|NCT00913458|363767536|FG002|Phase 3|Adverse Event|0|||
105479456|NCT00913458|363767537|FG003|Phase 3|Adverse Event|0|||
105479457|NCT00913458|363767538|FG004|Phase 3|Adverse Event|5|||
105479458|NCT00913458|363767539|FG005|Phase 3|Adverse Event|4|||
105479459|NCT00913458|363767540|FG006|Phase 3|Adverse Event|1|||
105479460|NCT00913458|363767534|FG000|Phase 3|Lost to Follow-up|0|||
105479461|NCT00913458|363767535|FG001|Phase 3|Lost to Follow-up|0|||
105479462|NCT00913458|363767536|FG002|Phase 3|Lost to Follow-up|0|||
105479463|NCT00913458|363767537|FG003|Phase 3|Lost to Follow-up|0|||
105479464|NCT00913458|363767538|FG004|Phase 3|Lost to Follow-up|2|||
105479465|NCT00913458|363767539|FG005|Phase 3|Lost to Follow-up|0|||
105479466|NCT00913458|363767540|FG006|Phase 3|Lost to Follow-up|0|||
105479467|NCT00913458|363767534|FG000|Phase 3|Non-Responder|0|||
105479468|NCT00913458|363767535|FG001|Phase 3|Non-Responder|0|||
105479469|NCT00913458|363767536|FG002|Phase 3|Non-Responder|0|||
105479470|NCT00913458|363767537|FG003|Phase 3|Non-Responder|0|||
105479471|NCT00913458|363767538|FG004|Phase 3|Non-Responder|0|||
105479472|NCT00913458|363767539|FG005|Phase 3|Non-Responder|1|||
105479473|NCT00913458|363767540|FG006|Phase 3|Non-Responder|3|||
105479474|NCT00913458|363767534|FG000|Phase 3|Withdrawal by Subject|0|||
105479475|NCT00913458|363767535|FG001|Phase 3|Withdrawal by Subject|0|||
105726510|NCT00826748|364655498|FG001|Overall Study|Withdrawal by Subject|0|||
105479476|NCT00913458|363767536|FG002|Phase 3|Withdrawal by Subject|0|||
105726511|NCT00826748|364655499|FG002|Overall Study|Withdrawal by Subject|2|||
105726512|NCT00826748|364655497|FG000|Overall Study|Physician Decision|0|||
105726513|NCT00826748|364655498|FG001|Overall Study|Physician Decision|0|||
105726514|NCT00826748|364655499|FG002|Overall Study|Physician Decision|1|||
105726515|NCT00826748|364655497|FG000|Overall Study|Samples Did Not pass QC|0|||
105726516|NCT00826748|364655498|FG001|Overall Study|Samples Did Not pass QC|0|||
105726517|NCT00826748|364655499|FG002|Overall Study|Samples Did Not pass QC|1|||
105726518|NCT01901224|364655500|FG000|Overall Study|study was not funded and terminated|2|||
105726519|NCT01887912|364655502|FG000|Overall Study|Serious adverse event|400|||
105726520|NCT01887912|364655503|FG001|Overall Study|Serious adverse event|198|||
105726521|NCT01887912|364655502|FG000|Overall Study|Other Adverse Event|34|||
105726522|NCT01887912|364655503|FG001|Overall Study|Other Adverse Event|15|||
105726523|NCT01887912|364655502|FG000|Overall Study|Protocol Violation|67|||
105726524|NCT01887912|364655503|FG001|Overall Study|Protocol Violation|37|||
105726525|NCT01887912|364655502|FG000|Overall Study|Lost to Follow-up|163|||
105726526|NCT01887912|364655503|FG001|Overall Study|Lost to Follow-up|74|||
105726527|NCT01887912|364655502|FG000|Overall Study|Withdrawal by Subject|606|||
105726528|NCT01887912|364655503|FG001|Overall Study|Withdrawal by Subject|349|||
105726529|NCT01887912|364655502|FG000|Overall Study|Other|122|||
105726530|NCT01887912|364655503|FG001|Overall Study|Other|58|||
105726531|NCT04462536|364655505|FG000|Overall Study|Withdrawal by Subject|3|||
105726532|NCT04462536|364655506|FG001|Overall Study|Withdrawal by Subject|9|||
105726533|NCT04462536|364655505|FG000|Overall Study|Lost to Follow-up|2|||
105726534|NCT04462536|364655506|FG001|Overall Study|Lost to Follow-up|4|||
105726535|NCT02688647|364655511|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
105726536|NCT02688647|364655512|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
105726537|NCT02688647|364655511|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
105726538|NCT02688647|364655512|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
105726539|NCT02688647|364655511|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
105726540|NCT02688647|364655512|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
105726541|NCT02688647|364655511|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
105726542|NCT02688647|364655512|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
105726543|NCT02688647|364655511|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
105726544|NCT02688647|364655512|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
105726545|NCT02688647|364655511|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
105726546|NCT02688647|364655512|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
105726547|NCT02688647|364655511|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
105726548|NCT02688647|364655512|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
105726549|NCT00828464|364655513|FG000|Overall Study|Withdrawal by Subject|1|||
105726550|NCT02542267|364655514|FG000|Overall Study|Withdrawal by Subject|10|||
105726551|NCT02542267|364655514|FG000|Overall Study|Physician Decision|6|||
105726552|NCT02542267|364655514|FG000|Overall Study|Lost to Follow-up|4|||
105726553|NCT02542267|364655514|FG000|Overall Study|Death|13|||
105726554|NCT02542267|364655514|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
105726555|NCT02542267|364655514|FG000|Overall Study|Other|9|||
105726556|NCT02197377|364655515|FG000|Overall Study|Insertion Failure|0|||
105726557|NCT02197377|364655516|FG001|Overall Study|Insertion Failure|3|||
105726558|NCT01122927|364655517|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
105726559|NCT01122927|364655518|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
105726560|NCT01122927|364655517|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
105726561|NCT01122927|364655518|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
105726562|NCT01122927|364655517|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
105726563|NCT01122927|364655518|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
105726564|NCT01122927|364655517|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
105726565|NCT01122927|364655518|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
105726566|NCT01122927|364655517|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
105353246|NCT03046056|363298477|FG001|Overall Study|Withdrew Consent|0|||
105353247|NCT03046056|363298478|FG002|Overall Study|Withdrew Consent|0|||
105479477|NCT00913458|363767537|FG003|Phase 3|Withdrawal by Subject|0|||
105479478|NCT00913458|363767538|FG004|Phase 3|Withdrawal by Subject|1|||
105479479|NCT00913458|363767539|FG005|Phase 3|Withdrawal by Subject|2|||
105479480|NCT00913458|363767540|FG006|Phase 3|Withdrawal by Subject|0|||
105479481|NCT00913458|363767534|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
105479482|NCT00913458|363767535|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
105479483|NCT00913458|363767536|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
105726567|NCT01122927|364655518|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
105726568|NCT01122927|364655517|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
105726569|NCT01122927|364655518|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
105726570|NCT01122927|364655517|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
105726571|NCT01122927|364655518|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
105794370|NCT02007512|364902234|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
105794371|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
105794372|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
105794373|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
105794374|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
105794375|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
105794376|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
105794377|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
105794378|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
105794379|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
105794380|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
105794381|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
105794382|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
105794383|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
105794384|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
105794385|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
105794386|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
105794387|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
105794388|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
105794389|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
105794390|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
105794391|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
105794392|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
105794393|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
105794394|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
105794395|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
105794396|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
105794397|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
105794398|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
105794399|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
105794400|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
105794401|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
105794402|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
105794403|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
105794404|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
105794405|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
105794406|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
105794407|NCT03747939|364902235|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
105794408|NCT03747939|364902236|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
105794409|NCT03747939|364902237|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
105794410|NCT03747939|364902238|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
105794411|NCT03747939|364902235|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
105794412|NCT03747939|364902236|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
105794413|NCT03747939|364902237|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
105794414|NCT03747939|364902238|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
105794415|NCT03747939|364902235|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
105794416|NCT03747939|364902236|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
105794417|NCT03747939|364902237|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
105794418|NCT03747939|364902238|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
105794419|NCT03747939|364902235|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
105794420|NCT03747939|364902236|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
105794421|NCT03747939|364902237|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
105794422|NCT03747939|364902238|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
105794423|NCT03747939|364902235|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
105794424|NCT03747939|364902236|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
105794425|NCT03747939|364902237|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
105794426|NCT03747939|364902238|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
105794427|NCT00185731|364902241|FG000|Overall Study|Withdrawal by Subject|1|||
105794428|NCT00185731|364902241|FG000|Overall Study|Not Eligible|1|||
105794429|NCT02494583|364902244|FG000|Overall Study|Death|224|||
105479484|NCT00913458|363767537|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
105479485|NCT00913458|363767538|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
105479486|NCT00913458|363767539|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
105726572|NCT01122927|364655517|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
105563889|NCT00265889|364061314|FG000|Overall Study|Physician Decision|1|||
105563890|NCT00265889|364061314|FG000|Overall Study|Protocol Violation|1|||
105563891|NCT00265889|364061314|FG000|Overall Study|Insurance denied the request|3|||
105563892|NCT00453986|364061315|FG000|Overall Study|Lost to Follow-up|6|||
105563893|NCT00453986|364061316|FG001|Overall Study|Lost to Follow-up|5|||
105563894|NCT00453986|364061317|FG002|Overall Study|Lost to Follow-up|6|||
105563895|NCT00453986|364061318|FG003|Overall Study|Lost to Follow-up|2|||
105563896|NCT00453986|364061319|FG004|Overall Study|Lost to Follow-up|0|||
105563897|NCT02778100|364061323|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
105563898|NCT02778100|364061324|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
105563899|NCT00522626|364061327|FG000|Overall Study|Lost to Follow-up|7|||
105726573|NCT01122927|364655518|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
105726574|NCT01122927|364655517|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
105726575|NCT01122927|364655518|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
105726576|NCT01122927|364655517|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
105726577|NCT01122927|364655518|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
105726578|NCT01122927|364655517|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
105726579|NCT01122927|364655518|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
105726580|NCT01122927|364655517|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
105726581|NCT01122927|364655518|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
105726582|NCT00629083|364655519|FG000|Overall Study|Adverse Event|0|||
105726583|NCT00629083|364655520|FG001|Overall Study|Adverse Event|2|||
105726584|NCT00629083|364655519|FG000|Overall Study|Lack of Efficacy|3|||
105726585|NCT00629083|364655520|FG001|Overall Study|Lack of Efficacy|1|||
105726586|NCT00629083|364655519|FG000|Overall Study|Withdrawal by Subject|10|||
105726587|NCT00629083|364655520|FG001|Overall Study|Withdrawal by Subject|2|||
105353248|NCT00642954|363298479|FG000|Overall Study|Progressive Disease|3|||
105353249|NCT00642954|363298480|FG001|Overall Study|Progressive Disease|3|||
105563900|NCT02618616|364061330|FG000|Overall Study|Lack of Efficacy|4|||
105563901|NCT02618616|364061331|FG001|Overall Study|Lack of Efficacy|0|||
105563902|NCT02618616|364061330|FG000|Overall Study|Pregnancy|0|||
105563903|NCT02618616|364061331|FG001|Overall Study|Pregnancy|1|||
105563904|NCT02618616|364061330|FG000|Overall Study|Adverse Event|8|||
105563905|NCT02618616|364061331|FG001|Overall Study|Adverse Event|0|||
105563906|NCT02618616|364061330|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
105563907|NCT02618616|364061331|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
105563908|NCT02618616|364061330|FG000|Overall Study|Consent withdrawn by subject|8|||
105563909|NCT02618616|364061331|FG001|Overall Study|Consent withdrawn by subject|5|||
105563910|NCT02618616|364061330|FG000|Overall Study|Lost to Follow-up|0|||
105563911|NCT02618616|364061331|FG001|Overall Study|Lost to Follow-up|1|||
105563912|NCT01951638|364061332|FG000|Treatment Period|Protocol Violation|0|||
105563913|NCT01951638|364061333|FG001|Treatment Period|Protocol Violation|0|||
105563914|NCT01951638|364061334|FG002|Treatment Period|Protocol Violation|0|||
105563915|NCT01951638|364061335|FG003|Treatment Period|Protocol Violation|2|||
105563916|NCT01951638|364061336|FG004|Treatment Period|Protocol Violation|0|||
105563917|NCT01951638|364061332|FG000|Treatment Period|Protocol-driven decision point|1|||
105563918|NCT01951638|364061333|FG001|Treatment Period|Protocol-driven decision point|3|||
105563919|NCT01951638|364061334|FG002|Treatment Period|Protocol-driven decision point|0|||
105563920|NCT01951638|364061335|FG003|Treatment Period|Protocol-driven decision point|0|||
105563921|NCT01951638|364061336|FG004|Treatment Period|Protocol-driven decision point|0|||
105563922|NCT01951638|364061332|FG000|Treatment Period|Logistical difficulties|0|||
105563923|NCT01951638|364061333|FG001|Treatment Period|Logistical difficulties|1|||
105563924|NCT01951638|364061334|FG002|Treatment Period|Logistical difficulties|1|||
105563925|NCT01951638|364061335|FG003|Treatment Period|Logistical difficulties|0|||
105563926|NCT01951638|364061336|FG004|Treatment Period|Logistical difficulties|0|||
105563927|NCT01951638|364061332|FG000|Treatment Period|Withdrawal by Subject|9|||
105563928|NCT01951638|364061333|FG001|Treatment Period|Withdrawal by Subject|6|||
105563929|NCT01951638|364061334|FG002|Treatment Period|Withdrawal by Subject|4|||
105563930|NCT01951638|364061335|FG003|Treatment Period|Withdrawal by Subject|5|||
105563931|NCT01951638|364061336|FG004|Treatment Period|Withdrawal by Subject|4|||
105563932|NCT01951638|364061332|FG000|Treatment Period|Death|0|||
105563933|NCT01951638|364061333|FG001|Treatment Period|Death|0|||
105563934|NCT01951638|364061334|FG002|Treatment Period|Death|0|||
105563935|NCT01951638|364061335|FG003|Treatment Period|Death|3|||
105563936|NCT01951638|364061336|FG004|Treatment Period|Death|1|||
105563937|NCT01951638|364061332|FG000|Treatment Period|Adverse Event|3|||
105563938|NCT01951638|364061333|FG001|Treatment Period|Adverse Event|4|||
105563939|NCT01951638|364061334|FG002|Treatment Period|Adverse Event|8|||
105563940|NCT01951638|364061335|FG003|Treatment Period|Adverse Event|6|||
105563941|NCT01951638|364061336|FG004|Treatment Period|Adverse Event|5|||
105563942|NCT01951638|364061332|FG000|Follow-up Period|Protocol Violation|0|||
105726588|NCT00629083|364655519|FG000|Overall Study|Lost to Follow-up|12|||
105726589|NCT00629083|364655520|FG001|Overall Study|Lost to Follow-up|8|||
105726590|NCT00629083|364655519|FG000|Overall Study|Moved out of country/state|2|||
105479487|NCT00913458|363767540|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
105479488|NCT01155011|363767541|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
105479489|NCT01155011|363767542|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
105479490|NCT01155011|363767541|FG000|Baseline to 6 Months|investigator decision, moved|4|||
105479491|NCT01155011|363767542|FG001|Baseline to 6 Months|investigator decision, moved|5|||
105479492|NCT01155011|363767541|FG000|Baseline to 6 Months|Death|0|||
105479493|NCT01155011|363767542|FG001|Baseline to 6 Months|Death|1|||
105479494|NCT01155011|363767541|FG000|6 to 12 Months|Withdrawal by Subject|8|||
105479495|NCT01155011|363767542|FG001|6 to 12 Months|Withdrawal by Subject|5|||
105479496|NCT01155011|363767541|FG000|6 to 12 Months|Death|1|||
105479497|NCT01155011|363767542|FG001|6 to 12 Months|Death|5|||
105479498|NCT00869778|363767549|FG000|Overall Study|Adverse Event|2|||
105479499|NCT00869778|363767550|FG001|Overall Study|Adverse Event|0|||
105479500|NCT00869778|363767551|FG002|Overall Study|Adverse Event|0|||
105479501|NCT00869778|363767549|FG000|Overall Study|Withdrawal by Subject|3|||
105479502|NCT00869778|363767550|FG001|Overall Study|Withdrawal by Subject|4|||
105479503|NCT00869778|363767551|FG002|Overall Study|Withdrawal by Subject|5|||
105479504|NCT00869778|363767549|FG000|Overall Study|Pregnancy|1|||
105479505|NCT00869778|363767550|FG001|Overall Study|Pregnancy|0|||
105479506|NCT00869778|363767551|FG002|Overall Study|Pregnancy|0|||
105479507|NCT00869778|363767549|FG000|Overall Study|Protocol Violation|5|||
105479508|NCT00869778|363767550|FG001|Overall Study|Protocol Violation|3|||
105479509|NCT00869778|363767551|FG002|Overall Study|Protocol Violation|5|||
105479510|NCT00869778|363767549|FG000|Overall Study|Unblinding|1|||
105479511|NCT00869778|363767550|FG001|Overall Study|Unblinding|0|||
105479512|NCT00869778|363767551|FG002|Overall Study|Unblinding|0|||
105479513|NCT01403948|363767552|FG000|Overall Study|Progressive disease|0|||
105479514|NCT01403948|363767553|FG001|Overall Study|Progressive disease|2|||
105479515|NCT01403948|363767554|FG002|Overall Study|Progressive disease|2|||
105479516|NCT01403948|363767555|FG003|Overall Study|Progressive disease|4|||
105479517|NCT01403948|363767556|FG004|Overall Study|Progressive disease|2|||
105479518|NCT01403948|363767557|FG005|Overall Study|Progressive disease|6|||
105479519|NCT01403948|363767558|FG006|Overall Study|Progressive disease|2|||
105479520|NCT01403948|363767559|FG007|Overall Study|Progressive disease|4|||
105479521|NCT01403948|363767560|FG008|Overall Study|Progressive disease|5|||
105563943|NCT01951638|364061333|FG001|Follow-up Period|Protocol Violation|0|||
105563944|NCT01951638|364061334|FG002|Follow-up Period|Protocol Violation|0|||
105563945|NCT01951638|364061335|FG003|Follow-up Period|Protocol Violation|1|||
105563946|NCT01951638|364061336|FG004|Follow-up Period|Protocol Violation|0|||
105563947|NCT01951638|364061332|FG000|Follow-up Period|Logistical difficulties|0|||
105563948|NCT01951638|364061333|FG001|Follow-up Period|Logistical difficulties|2|||
105563949|NCT01951638|364061334|FG002|Follow-up Period|Logistical difficulties|0|||
105563950|NCT01951638|364061335|FG003|Follow-up Period|Logistical difficulties|0|||
105563951|NCT01951638|364061336|FG004|Follow-up Period|Logistical difficulties|1|||
105563952|NCT01951638|364061332|FG000|Follow-up Period|Withdrawal by Subject|1|||
105563953|NCT01951638|364061333|FG001|Follow-up Period|Withdrawal by Subject|5|||
105563954|NCT01951638|364061334|FG002|Follow-up Period|Withdrawal by Subject|2|||
105563955|NCT01951638|364061335|FG003|Follow-up Period|Withdrawal by Subject|1|||
105563956|NCT01951638|364061336|FG004|Follow-up Period|Withdrawal by Subject|2|||
105563957|NCT01951638|364061332|FG000|Follow-up Period|Lost to Follow-up|0|||
105563958|NCT01951638|364061333|FG001|Follow-up Period|Lost to Follow-up|1|||
105563959|NCT01951638|364061334|FG002|Follow-up Period|Lost to Follow-up|0|||
105563960|NCT01951638|364061335|FG003|Follow-up Period|Lost to Follow-up|1|||
105563961|NCT01951638|364061336|FG004|Follow-up Period|Lost to Follow-up|0|||
105563962|NCT01951638|364061332|FG000|Follow-up Period|Death|1|||
105563963|NCT01951638|364061333|FG001|Follow-up Period|Death|0|||
105563964|NCT01951638|364061334|FG002|Follow-up Period|Death|1|||
105563965|NCT01951638|364061335|FG003|Follow-up Period|Death|4|||
105563966|NCT01951638|364061336|FG004|Follow-up Period|Death|1|||
105479522|NCT01403948|363767561|FG009|Overall Study|Progressive disease|5|||
105479523|NCT01403948|363767552|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
105479524|NCT01403948|363767553|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
105479525|NCT01403948|363767554|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
105563967|NCT01951638|364061332|FG000|Follow-up Period|Adverse Event|0|||
105563968|NCT01951638|364061333|FG001|Follow-up Period|Adverse Event|1|||
105563969|NCT01951638|364061334|FG002|Follow-up Period|Adverse Event|2|||
105563970|NCT01951638|364061335|FG003|Follow-up Period|Adverse Event|1|||
105563971|NCT01951638|364061336|FG004|Follow-up Period|Adverse Event|1|||
105479526|NCT01403948|363767555|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
105479527|NCT01403948|363767556|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
105479528|NCT01403948|363767557|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
105479529|NCT01403948|363767558|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
105479530|NCT01403948|363767559|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
105563972|NCT00459342|364061339|FG000|Overall Study|Not eligible|1|||
105563973|NCT00696384|364061340|FG000|Open Label Phase|Adverse Event|27|||
105563974|NCT00696384|364061341|FG001|Open Label Phase|Adverse Event|0|||
105563975|NCT00696384|364061342|FG002|Open Label Phase|Adverse Event|0|||
105563976|NCT00696384|364061340|FG000|Open Label Phase|Protocol Violation|18|||
105563977|NCT00696384|364061341|FG001|Open Label Phase|Protocol Violation|0|||
105563978|NCT00696384|364061342|FG002|Open Label Phase|Protocol Violation|0|||
105563979|NCT00696384|364061340|FG000|Open Label Phase|Lost to Follow-up|24|||
105563980|NCT00696384|364061341|FG001|Open Label Phase|Lost to Follow-up|0|||
105563981|NCT00696384|364061342|FG002|Open Label Phase|Lost to Follow-up|0|||
105563982|NCT00696384|364061340|FG000|Open Label Phase|Withdrawal by Subject|37|||
105563983|NCT00696384|364061341|FG001|Open Label Phase|Withdrawal by Subject|0|||
105563984|NCT00696384|364061342|FG002|Open Label Phase|Withdrawal by Subject|0|||
105563985|NCT00696384|364061340|FG000|Open Label Phase|Other|6|||
105563986|NCT00696384|364061341|FG001|Open Label Phase|Other|0|||
105563987|NCT00696384|364061342|FG002|Open Label Phase|Other|0|||
105563988|NCT00696384|364061340|FG000|Open Label Phase|Lack of Efficacy|3|||
105563989|NCT00696384|364061341|FG001|Open Label Phase|Lack of Efficacy|0|||
105563990|NCT00696384|364061342|FG002|Open Label Phase|Lack of Efficacy|0|||
105563991|NCT00696384|364061340|FG000|Open Label Phase|Physician Decision|4|||
105563992|NCT00696384|364061341|FG001|Open Label Phase|Physician Decision|0|||
105563993|NCT00696384|364061342|FG002|Open Label Phase|Physician Decision|0|||
105563994|NCT00696384|364061340|FG000|Double Blind Phase|Adverse Event|0|||
105563995|NCT00696384|364061341|FG001|Double Blind Phase|Adverse Event|2|||
105563996|NCT00696384|364061342|FG002|Double Blind Phase|Adverse Event|2|||
105726591|NCT00629083|364655520|FG001|Overall Study|Moved out of country/state|1|||
105726592|NCT00629083|364655519|FG000|Overall Study|Refused to return for 12 month visit|1|||
105726593|NCT00629083|364655520|FG001|Overall Study|Refused to return for 12 month visit|0|||
105726594|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
105726595|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
105726596|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
105726597|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105726598|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105726599|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105726600|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105726601|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105726602|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105726603|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
105726604|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
105726605|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
105726606|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105726607|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105726608|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105726609|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105726610|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105726611|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105726612|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
105726613|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
105726614|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
105726615|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105726616|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105726617|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105726618|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105726619|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105726620|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105726621|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726622|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726623|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
105726624|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726625|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726626|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726627|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726628|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726629|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726630|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
105726631|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
105726632|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
105726633|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105726634|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105726635|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105726636|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105726637|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105794430|NCT02494583|364902245|FG001|Overall Study|Death|214|||
105794431|NCT02494583|364902246|FG002|Overall Study|Death|225|||
105794432|NCT02494583|364902244|FG000|Overall Study|Lost to Follow-up|1|||
105794433|NCT02494583|364902245|FG001|Overall Study|Lost to Follow-up|0|||
105794434|NCT02494583|364902246|FG002|Overall Study|Lost to Follow-up|0|||
105794435|NCT02494583|364902244|FG000|Overall Study|Protocol Violation|1|||
105794436|NCT02494583|364902245|FG001|Overall Study|Protocol Violation|2|||
105794437|NCT02494583|364902246|FG002|Overall Study|Protocol Violation|0|||
105794438|NCT02494583|364902244|FG000|Overall Study|Screen Failure|0|||
105794439|NCT02494583|364902245|FG001|Overall Study|Screen Failure|1|||
105794440|NCT02494583|364902246|FG002|Overall Study|Screen Failure|0|||
105794441|NCT02494583|364902244|FG000|Overall Study|Transferred to Extension Study|15|||
105794442|NCT02494583|364902245|FG001|Overall Study|Transferred to Extension Study|15|||
105794443|NCT02494583|364902246|FG002|Overall Study|Transferred to Extension Study|6|||
105794444|NCT02494583|364902244|FG000|Overall Study|Did Not Continue on Extension Study|8|||
105794445|NCT02494583|364902245|FG001|Overall Study|Did Not Continue on Extension Study|10|||
105794446|NCT02494583|364902246|FG002|Overall Study|Did Not Continue on Extension Study|4|||
105794447|NCT02494583|364902244|FG000|Overall Study|Withdrawal by Subject|7|||
105794448|NCT02494583|364902245|FG001|Overall Study|Withdrawal by Subject|15|||
105794449|NCT02494583|364902246|FG002|Overall Study|Withdrawal by Subject|15|||
105794450|NCT05144477|364902247|FG000|Overall Study|Withdrawal by Subject|1|||
105794451|NCT05144477|364902248|FG001|Overall Study|Withdrawal by Subject|1|||
105794452|NCT01339000|364902249|FG000|Overall Study|study closed due to lack of drug supply|1|||
105794453|NCT01339000|364902250|FG001|Overall Study|study closed due to lack of drug supply|0|||
105794454|NCT03506425|364902254|FG000|Overall Study|Adverse Event|1|||
105794455|NCT03506425|364902255|FG001|Overall Study|Adverse Event|3|||
105794456|NCT03506425|364902256|FG002|Overall Study|Adverse Event|0|||
105794457|NCT03506425|364902254|FG000|Overall Study|Death|1|||
105794458|NCT03506425|364902255|FG001|Overall Study|Death|0|||
105794459|NCT03506425|364902256|FG002|Overall Study|Death|0|||
105794460|NCT03506425|364902254|FG000|Overall Study|Withdrawal by Subject|0|||
105794461|NCT03506425|364902255|FG001|Overall Study|Withdrawal by Subject|0|||
105794462|NCT03506425|364902256|FG002|Overall Study|Withdrawal by Subject|1|||
105794463|NCT05349188|364902257|FG000|Overall Study|Withdrawal by Subject|1|||
105794464|NCT05349188|364902258|FG001|Overall Study|Withdrawal by Subject|0|||
105794465|NCT02643394|364902259|FG000|Overall Study|Protocol Violation|4|||
105794466|NCT02643394|364902260|FG001|Overall Study|Protocol Violation|5|||
105794467|NCT00096200|364902261|FG000|Overall Study|Adverse Event|0|||
105794468|NCT00096200|364902262|FG001|Overall Study|Adverse Event|4|||
105794469|NCT00096200|364902263|FG002|Overall Study|Adverse Event|0|||
105794470|NCT00096200|364902261|FG000|Overall Study|Withdrawal by Subject|1|||
105794471|NCT00096200|364902262|FG001|Overall Study|Withdrawal by Subject|2|||
105794472|NCT00096200|364902263|FG002|Overall Study|Withdrawal by Subject|0|||
105563997|NCT00696384|364061340|FG000|Double Blind Phase|Lost to Follow-up|0|||
105563998|NCT00696384|364061341|FG001|Double Blind Phase|Lost to Follow-up|2|||
105563999|NCT00696384|364061342|FG002|Double Blind Phase|Lost to Follow-up|1|||
105564000|NCT00696384|364061340|FG000|Double Blind Phase|Withdrawal by Subject|0|||
105564001|NCT00696384|364061341|FG001|Double Blind Phase|Withdrawal by Subject|4|||
105564002|NCT00696384|364061342|FG002|Double Blind Phase|Withdrawal by Subject|3|||
105564003|NCT00696384|364061340|FG000|Double Blind Phase|Lack of Efficacy|0|||
105564004|NCT00696384|364061341|FG001|Double Blind Phase|Lack of Efficacy|1|||
105564005|NCT00696384|364061342|FG002|Double Blind Phase|Lack of Efficacy|0|||
105564006|NCT00696384|364061340|FG000|Double Blind Phase|Physician Decision|0|||
105564007|NCT00696384|364061341|FG001|Double Blind Phase|Physician Decision|2|||
105564008|NCT00696384|364061342|FG002|Double Blind Phase|Physician Decision|0|||
105564009|NCT02027402|364061343|FG000|Overall Study|Withdrawal by Subject|4|||
105564010|NCT02027402|364061344|FG001|Overall Study|Withdrawal by Subject|1|||
105794473|NCT00096200|364902261|FG000|Overall Study|Ineligible pathology|0|||
105794474|NCT00096200|364902262|FG001|Overall Study|Ineligible pathology|1|||
105794475|NCT00096200|364902263|FG002|Overall Study|Ineligible pathology|0|||
105794476|NCT00478673|364902264|FG000|30-Days Post-Procedure|Death|2|||
105353250|NCT00642954|363298481|FG002|Overall Study|Progressive Disease|3|||
105794477|NCT00478673|364902264|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
105794478|NCT00478673|364902264|FG000|30-Days Post-Procedure|Missed Visit|7|||
105794479|NCT00478673|364902264|FG000|12-Months Post-Procedure|Death|23|||
105794480|NCT00478673|364902264|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
105794481|NCT00478673|364902264|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
105353251|NCT00642954|363298482|FG003|Overall Study|Progressive Disease|3|||
105353252|NCT00642954|363298483|FG004|Overall Study|Progressive Disease|9|||
105564011|NCT04179721|364061347|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
105564012|NCT04179721|364061348|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
105794482|NCT00478673|364902264|FG000|12-Months Post-Procedure|Missed Visit|25|||
105794483|NCT00478673|364902264|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
105564013|NCT04179721|364061347|FG000|Overall Study|Lost to Follow-up|0|||
105564014|NCT04179721|364061348|FG001|Overall Study|Lost to Follow-up|1|||
105564015|NCT02240108|364062921|FG000|Overall Study|Other than specified|8|||
105564016|NCT02240108|364062922|FG001|Overall Study|Other than specified|6|||
105564017|NCT02240108|364062921|FG000|Overall Study|Adverse Event|1|||
105564018|NCT02240108|364062922|FG001|Overall Study|Adverse Event|9|||
105564019|NCT02240108|364062921|FG000|Overall Study|Pregnancy|1|||
105564020|NCT02240108|364062922|FG001|Overall Study|Pregnancy|0|||
105564021|NCT02240108|364062921|FG000|Overall Study|Withdrawal by Subject|4|||
105564022|NCT02240108|364062922|FG001|Overall Study|Withdrawal by Subject|9|||
105564023|NCT02240108|364062921|FG000|Overall Study|StudyTerminated by Sponsor|0|||
105564024|NCT02240108|364062922|FG001|Overall Study|StudyTerminated by Sponsor|1|||
105564025|NCT00685945|364062923|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
105564026|NCT03183388|364062924|FG000|Overall Study|Lost to Follow-up|3|||
105564027|NCT03183388|364062925|FG001|Overall Study|Lost to Follow-up|5|||
105564028|NCT03183388|364062924|FG000|Overall Study|Physician Decision|1|||
105564029|NCT03183388|364062925|FG001|Overall Study|Physician Decision|4|||
105564030|NCT03183388|364062924|FG000|Overall Study|Withdrawal by Subject|4|||
105564031|NCT03183388|364062925|FG001|Overall Study|Withdrawal by Subject|1|||
105564032|NCT03183388|364062924|FG000|Overall Study|Moved|1|||
105564033|NCT03183388|364062925|FG001|Overall Study|Moved|0|||
105564034|NCT03183388|364062924|FG000|Overall Study|Met Exclusion Criteria|2|||
105564035|NCT03183388|364062925|FG001|Overall Study|Met Exclusion Criteria|2|||
105564036|NCT03183388|364062924|FG000|Overall Study|COVID Pandemic Related|2|||
105564037|NCT03183388|364062925|FG001|Overall Study|COVID Pandemic Related|4|||
105564038|NCT03938454|364062926|FG000|Overall Study|Protocol Violation|1|||
105564039|NCT03938454|364062926|FG000|Overall Study|Withdrawal by Subject|2|||
105564040|NCT03938454|364062926|FG000|Overall Study|Lost to Follow-up|3|||
105564041|NCT00847405|364062927|FG000|First Intervention|Adverse Event|0|||
105564042|NCT00847405|364062928|FG001|First Intervention|Adverse Event|1|||
105564043|NCT00847405|364062927|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
105564044|NCT00847405|364062928|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
105564045|NCT01203930|364062930|FG000|Overall Study|Disease Progression|0|||
105564046|NCT01203930|364062931|FG001|Overall Study|Disease Progression|4|||
105564047|NCT01203930|364062930|FG000|Overall Study|Death|3|||
105564048|NCT01203930|364062931|FG001|Overall Study|Death|1|||
105564049|NCT01203930|364062930|FG000|Overall Study|Withdrew Consent|1|||
105564050|NCT01203930|364062931|FG001|Overall Study|Withdrew Consent|10|||
105564051|NCT01203930|364062930|FG000|Overall Study|Investigator Request|0|||
105564052|NCT01203930|364062931|FG001|Overall Study|Investigator Request|8|||
105564053|NCT01203930|364062930|FG000|Overall Study|Study Terminated by Sponsor|0|||
105564054|NCT01203930|364062931|FG001|Overall Study|Study Terminated by Sponsor|12|||
105564055|NCT01203930|364062930|FG000|Overall Study|Poor tolerance of study drug|0|||
105564056|NCT01203930|364062931|FG001|Overall Study|Poor tolerance of study drug|1|||
105564057|NCT01203930|364062930|FG000|Overall Study|Adverse Event|17|||
105564058|NCT01203930|364062931|FG001|Overall Study|Adverse Event|5|||
105564059|NCT02178059|364062932|FG000|Washout|Physician Decision|1|||
105564060|NCT02178059|364062933|FG001|Washout|Physician Decision|0|||
105564061|NCT01787097|364062934|FG000|Overall Study|Withdrawal by Subject|1|||
105564062|NCT01787097|364062935|FG001|Overall Study|Withdrawal by Subject|0|||
105564063|NCT01787097|364062936|FG002|Overall Study|Withdrawal by Subject|0|||
105564064|NCT01787097|364062937|FG003|Overall Study|Withdrawal by Subject|0|||
105564065|NCT05178121|364062938|FG000|Overall Study|Other|4|||
105564066|NCT05178121|364062938|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
105564067|NCT00245102|364062939|FG000|Overall Study|Not Treated|1|||
105564068|NCT00245102|364062940|FG001|Overall Study|Not Treated|0|||
105564069|NCT00245102|364062941|FG002|Overall Study|Not Treated|1|||
105564070|NCT00245102|364062942|FG003|Overall Study|Not Treated|0|||
105564071|NCT00245102|364062943|FG004|Overall Study|Not Treated|0|||
105564072|NCT00245102|364062944|FG005|Overall Study|Not Treated|0|||
105564073|NCT00245102|364062939|FG000|Overall Study|Protocol Violation|1|||
105564074|NCT00245102|364062940|FG001|Overall Study|Protocol Violation|0|||
105564075|NCT00245102|364062941|FG002|Overall Study|Protocol Violation|0|||
105564076|NCT00245102|364062942|FG003|Overall Study|Protocol Violation|0|||
105726638|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105726639|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
105726640|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105726641|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105726642|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105726643|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105564077|NCT00245102|364062943|FG004|Overall Study|Protocol Violation|0|||
105726644|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105726645|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105726646|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105353253|NCT00642954|363298479|FG000|Overall Study|Withdrawal by Subject|0|||
105564078|NCT00245102|364062944|FG005|Overall Study|Protocol Violation|0|||
105564079|NCT00245102|364062939|FG000|Overall Study|Death|0|||
105564080|NCT00245102|364062940|FG001|Overall Study|Death|0|||
105564081|NCT00245102|364062941|FG002|Overall Study|Death|0|||
105564082|NCT00245102|364062942|FG003|Overall Study|Death|1|||
105564083|NCT00245102|364062943|FG004|Overall Study|Death|0|||
105726647|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105726648|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
105726649|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
105726650|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105726651|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105726652|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105726653|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105726654|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105726655|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105726656|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105726657|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
105726658|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
105726659|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
105726660|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
105726661|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
105726662|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
105726663|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
105726664|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
105726665|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
105726666|NCT01307423|364655521|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
105726667|NCT01307423|364655522|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
105726668|NCT01307423|364655523|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
105726669|NCT01307423|364655524|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
105726670|NCT01307423|364655525|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
105726671|NCT01307423|364655526|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
105726672|NCT01307423|364655527|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
105726673|NCT01307423|364655528|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
105726674|NCT01307423|364655529|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
105726675|NCT01307423|364655521|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
105726676|NCT01307423|364655522|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
105726677|NCT01307423|364655523|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
105726678|NCT01307423|364655524|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
105726679|NCT01307423|364655525|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
105726680|NCT01307423|364655526|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
105726681|NCT01307423|364655527|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
105726682|NCT01307423|364655528|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
105726683|NCT01307423|364655529|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
105726684|NCT01307423|364655521|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105726685|NCT01307423|364655522|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105726686|NCT01307423|364655523|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105726687|NCT01307423|364655524|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105726688|NCT01307423|364655525|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105564084|NCT00245102|364062944|FG005|Overall Study|Death|0|||
105564085|NCT00245102|364062939|FG000|Overall Study|Adverse Event|4|||
105564086|NCT00245102|364062940|FG001|Overall Study|Adverse Event|2|||
105564087|NCT00245102|364062941|FG002|Overall Study|Adverse Event|5|||
105564088|NCT00245102|364062942|FG003|Overall Study|Adverse Event|1|||
105564089|NCT00245102|364062943|FG004|Overall Study|Adverse Event|0|||
105564090|NCT00245102|364062944|FG005|Overall Study|Adverse Event|2|||
105564091|NCT00245102|364062939|FG000|Overall Study|Decline in performance|0|||
105564092|NCT00245102|364062940|FG001|Overall Study|Decline in performance|2|||
105564093|NCT00245102|364062941|FG002|Overall Study|Decline in performance|0|||
105564094|NCT00245102|364062942|FG003|Overall Study|Decline in performance|1|||
105564095|NCT00245102|364062943|FG004|Overall Study|Decline in performance|0|||
105564096|NCT00245102|364062944|FG005|Overall Study|Decline in performance|2|||
105564097|NCT00245102|364062939|FG000|Overall Study|Participant needed surgery|0|||
105564098|NCT00245102|364062940|FG001|Overall Study|Participant needed surgery|0|||
105564099|NCT00245102|364062941|FG002|Overall Study|Participant needed surgery|1|||
105564100|NCT00245102|364062942|FG003|Overall Study|Participant needed surgery|0|||
105564101|NCT00245102|364062943|FG004|Overall Study|Participant needed surgery|0|||
105564102|NCT00245102|364062944|FG005|Overall Study|Participant needed surgery|0|||
105564103|NCT00245102|364062939|FG000|Overall Study|Clinical progression|1|||
105564104|NCT00245102|364062940|FG001|Overall Study|Clinical progression|0|||
105564105|NCT00245102|364062941|FG002|Overall Study|Clinical progression|0|||
105564106|NCT00245102|364062942|FG003|Overall Study|Clinical progression|0|||
105564107|NCT00245102|364062943|FG004|Overall Study|Clinical progression|0|||
105564108|NCT00245102|364062944|FG005|Overall Study|Clinical progression|0|||
105564109|NCT02293395|364062945|FG000|Overall Study|Lost to Follow-up|1|||
105564110|NCT02293395|364062946|FG001|Overall Study|Lost to Follow-up|0|||
105726689|NCT01307423|364655526|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
105726690|NCT01307423|364655527|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105726691|NCT01307423|364655528|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105726692|NCT01307423|364655529|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105726693|NCT01307423|364655521|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
105726694|NCT01307423|364655522|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
105726695|NCT01307423|364655523|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
105726696|NCT01307423|364655524|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
105726697|NCT01307423|364655525|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
105564111|NCT02293395|364062945|FG000|Overall Study|Withdrawal by Subject|8|||
105564112|NCT02293395|364062946|FG001|Overall Study|Withdrawal by Subject|7|||
105564113|NCT01106430|364062949|FG000|Overall Study|Adverse Event|8|||
105564114|NCT01106430|364062950|FG001|Overall Study|Adverse Event|10|||
105564115|NCT01106430|364062949|FG000|Overall Study|Lack of Efficacy|2|||
105564116|NCT01106430|364062950|FG001|Overall Study|Lack of Efficacy|13|||
105564117|NCT01106430|364062949|FG000|Overall Study|Lost to Follow-up|5|||
105564118|NCT01106430|364062950|FG001|Overall Study|Lost to Follow-up|1|||
105564119|NCT01106430|364062949|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
105564120|NCT01106430|364062950|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
105564121|NCT01106430|364062949|FG000|Overall Study|Moved Out Of State|0|||
105564122|NCT01106430|364062950|FG001|Overall Study|Moved Out Of State|1|||
105564123|NCT01106430|364062949|FG000|Overall Study|Refused To Take Medication|0|||
105564124|NCT01106430|364062950|FG001|Overall Study|Refused To Take Medication|1|||
105564125|NCT01106430|364062949|FG000|Overall Study|Noncompliance|0|||
105564126|NCT01106430|364062950|FG001|Overall Study|Noncompliance|1|||
105564127|NCT01106430|364062949|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
105726698|NCT01307423|364655526|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
105726699|NCT01307423|364655527|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
105726700|NCT01307423|364655528|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
105726701|NCT01307423|364655529|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
105726702|NCT01307423|364655521|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726703|NCT01307423|364655522|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726704|NCT01307423|364655523|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726705|NCT01307423|364655524|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
105726706|NCT01307423|364655525|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726707|NCT01307423|364655526|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726708|NCT01307423|364655527|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726709|NCT01307423|364655528|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726710|NCT01307423|364655529|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726711|NCT01307423|364655521|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
105726712|NCT01307423|364655522|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
105726713|NCT01307423|364655523|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
105726714|NCT01307423|364655524|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
105726715|NCT01307423|364655525|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
105564128|NCT01106430|364062950|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
105564129|NCT01106430|364062949|FG000|Overall Study|Previous Use Of Marijuana|1|||
105564130|NCT01106430|364062950|FG001|Overall Study|Previous Use Of Marijuana|0|||
105564131|NCT01106430|364062949|FG000|Overall Study|Protocol Violation|7|||
105564132|NCT01106430|364062950|FG001|Overall Study|Protocol Violation|2|||
105564133|NCT01106430|364062949|FG000|Overall Study|Withdrawal by Subject|8|||
105564134|NCT01106430|364062950|FG001|Overall Study|Withdrawal by Subject|4|||
105564135|NCT00861614|364062953|FG000|Overall Study|Disease Progression|182|||
105564136|NCT00861614|364062954|FG001|Overall Study|Disease Progression|263|||
105564137|NCT00861614|364062953|FG000|Overall Study|Study Drug Toxicity|79|||
105564138|NCT00861614|364062954|FG001|Overall Study|Study Drug Toxicity|6|||
105564139|NCT00861614|364062953|FG000|Overall Study|Death|32|||
105564140|NCT00861614|364062954|FG001|Overall Study|Death|19|||
105564141|NCT00861614|364062953|FG000|Overall Study|Adverse Event|27|||
105564142|NCT00861614|364062954|FG001|Overall Study|Adverse Event|23|||
105564143|NCT00861614|364062953|FG000|Overall Study|Withdrawal by Subject|34|||
105564144|NCT00861614|364062954|FG001|Overall Study|Withdrawal by Subject|35|||
105564145|NCT00861614|364062953|FG000|Overall Study|Other|17|||
105564146|NCT00861614|364062954|FG001|Overall Study|Other|22|||
105564147|NCT00838682|364062955|FG000|Overall Study|Lost to Follow-up|21|||
105564148|NCT00838682|364062956|FG001|Overall Study|Lost to Follow-up|14|||
105564149|NCT00838682|364062955|FG000|Overall Study|detection of exclusion criteria|4|||
105564150|NCT00838682|364062956|FG001|Overall Study|detection of exclusion criteria|3|||
105564151|NCT00838682|364062955|FG000|Overall Study|Protocol Violation|0|||
105564152|NCT00838682|364062956|FG001|Overall Study|Protocol Violation|1|||
105564153|NCT00838682|364062955|FG000|Overall Study|Withdrawal by Subject|0|||
105564154|NCT00838682|364062956|FG001|Overall Study|Withdrawal by Subject|1|||
105564155|NCT03966053|364062957|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
105564156|NCT01807156|364062964|FG000|Overall Study|Physician Decision|1|||
105794484|NCT03728257|364902280|FG000|Overall Study|Death|3|||
105794485|NCT03728257|364902281|FG001|Overall Study|Death|0|||
105794486|NCT05789420|364902283|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
105794487|NCT05789420|364902283|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
105794488|NCT03151226|364902284|FG000|Overall Study|Withdrawal by Subject|2|||
105794489|NCT03151226|364902284|FG000|Overall Study|not wear device correctly|1|||
105794490|NCT00391118|364902285|FG000|Overall Study|Adverse Event|3|||
105564157|NCT00514943|364062965|FG000|Stage 1|Progressive disease|4|||
105564158|NCT00514943|364062966|FG001|Stage 1|Progressive disease|8|||
105564159|NCT00514943|364062965|FG000|Stage 1|Other Adverse Event|16|||
105564160|NCT00514943|364062966|FG001|Stage 1|Other Adverse Event|6|||
105564161|NCT00514943|364062965|FG000|Stage 1|Not treated|1|||
105564162|NCT00514943|364062966|FG001|Stage 1|Not treated|2|||
105726716|NCT01307423|364655526|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
105726717|NCT01307423|364655527|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
105726718|NCT01307423|364655528|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
105564163|NCT00514943|364062965|FG000|Stage 1|Patient refused to continue study meds|8|||
105726719|NCT01307423|364655529|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
105726720|NCT01307423|364655521|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726721|NCT01307423|364655522|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726722|NCT01307423|364655523|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726723|NCT01307423|364655524|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726724|NCT01307423|364655525|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726725|NCT01307423|364655526|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
105726726|NCT01307423|364655527|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726727|NCT01307423|364655528|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726728|NCT01307423|364655529|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726729|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105726730|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
105726731|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
105726732|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105726733|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105726734|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105726735|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105726736|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
105794491|NCT00391118|364902286|FG001|Overall Study|Adverse Event|10|||
105794492|NCT00391118|364902287|FG002|Overall Study|Adverse Event|7|||
105794493|NCT00391118|364902285|FG000|Overall Study|Lost to Follow-up|0|||
105794494|NCT00391118|364902286|FG001|Overall Study|Lost to Follow-up|2|||
105564164|NCT00514943|364062966|FG001|Stage 1|Patient refused to continue study meds|3|||
105564165|NCT00514943|364062965|FG000|Stage 1|Other than stated above|1|||
105564166|NCT00514943|364062966|FG001|Stage 1|Other than stated above|7|||
105564167|NCT00514943|364062965|FG000|Stage 2|Progressive disease|27|||
105564168|NCT00514943|364062966|FG001|Stage 2|Progressive disease|24|||
105564169|NCT00514943|364062965|FG000|Stage 2|Other Adverse Event|3|||
105564170|NCT00514943|364062966|FG001|Stage 2|Other Adverse Event|10|||
105564171|NCT00514943|364062965|FG000|Stage 2|Patient refused to continue study meds|2|||
105564172|NCT00514943|364062966|FG001|Stage 2|Patient refused to continue study meds|0|||
105564173|NCT00514943|364062965|FG000|Stage 2|Other than stated above|0|||
105564174|NCT00514943|364062966|FG001|Stage 2|Other than stated above|2|||
105564175|NCT02323646|364062968|FG000|Treatment Course 1|Adverse Event|1|||
105564176|NCT02323646|364062969|FG001|Treatment Course 1|Adverse Event|0|||
105564177|NCT02323646|364062970|FG002|Treatment Course 1|Adverse Event|1|||
105794495|NCT00391118|364902287|FG002|Overall Study|Lost to Follow-up|3|||
105794496|NCT00391118|364902285|FG000|Overall Study|Withdrawal by Subject|0|||
105794497|NCT00391118|364902286|FG001|Overall Study|Withdrawal by Subject|9|||
105794498|NCT00391118|364902287|FG002|Overall Study|Withdrawal by Subject|1|||
105794499|NCT00391118|364902285|FG000|Overall Study|Death|0|||
105794500|NCT00391118|364902286|FG001|Overall Study|Death|1|||
105794501|NCT00391118|364902287|FG002|Overall Study|Death|0|||
105794502|NCT00391118|364902285|FG000|Overall Study|Physician Decision|0|||
105564178|NCT02323646|364062968|FG000|Treatment Course 1|Heavy Bleeding|1|||
105564179|NCT02323646|364062969|FG001|Treatment Course 1|Heavy Bleeding|1|||
105564180|NCT02323646|364062970|FG002|Treatment Course 1|Heavy Bleeding|0|||
105564181|NCT02323646|364062968|FG000|Treatment Course 1|Lost to Follow-up|1|||
105564182|NCT02323646|364062969|FG001|Treatment Course 1|Lost to Follow-up|0|||
105564183|NCT02323646|364062970|FG002|Treatment Course 1|Lost to Follow-up|2|||
105564184|NCT02323646|364062968|FG000|Treatment Course 1|Withdrawal by Subject|0|||
105564185|NCT02323646|364062969|FG001|Treatment Course 1|Withdrawal by Subject|2|||
105564186|NCT02323646|364062970|FG002|Treatment Course 1|Withdrawal by Subject|0|||
105564187|NCT02323646|364062968|FG000|Treatment Course 2|Adverse Event|1|||
105564188|NCT02323646|364062969|FG001|Treatment Course 2|Adverse Event|0|||
105726737|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
105726738|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
105794503|NCT00391118|364902286|FG001|Overall Study|Physician Decision|3|||
105794504|NCT00391118|364902287|FG002|Overall Study|Physician Decision|0|||
105794505|NCT00391118|364902285|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
105794506|NCT00391118|364902286|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
105794507|NCT00391118|364902287|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
105794508|NCT00391118|364902285|FG000|Overall Study|Progressive Disease|7|||
105794509|NCT00391118|364902286|FG001|Overall Study|Progressive Disease|26|||
105794510|NCT00391118|364902287|FG002|Overall Study|Progressive Disease|43|||
105564189|NCT02323646|364062970|FG002|Treatment Course 2|Adverse Event|1|||
105564190|NCT02323646|364062968|FG000|Treatment Course 2|Lost to Follow-up|0|||
105794511|NCT00391118|364902285|FG000|Overall Study|Sponsor Decision|0|||
105794512|NCT00391118|364902286|FG001|Overall Study|Sponsor Decision|1|||
105794513|NCT00391118|364902287|FG002|Overall Study|Sponsor Decision|3|||
105794514|NCT00391118|364902285|FG000|Overall Study|Protocol Violation|1|||
105794515|NCT00391118|364902286|FG001|Overall Study|Protocol Violation|0|||
105794516|NCT00391118|364902287|FG002|Overall Study|Protocol Violation|0|||
105794517|NCT05473247|364902288|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
105794518|NCT02340078|364902291|FG000|Overall Study|Protocol Violation|1|||
105794519|NCT04278872|364902292|FG000|Overall Study|Adverse Event|1|||
105794520|NCT04278872|364902293|FG001|Overall Study|Adverse Event|0|||
105794521|NCT04278872|364902292|FG000|Overall Study|Protocol Violation|0|||
105794522|NCT04278872|364902293|FG001|Overall Study|Protocol Violation|1|||
105794523|NCT04278872|364902292|FG000|Overall Study|Study Termination|2|||
105794524|NCT04278872|364902293|FG001|Overall Study|Study Termination|0|||
105794525|NCT00953927|364903750|FG000|Overall Study|Lost to Follow-up|61|||
105794526|NCT00953927|364903751|FG001|Overall Study|Lost to Follow-up|65|||
105794527|NCT00953927|364903750|FG000|Overall Study|Withdrawal by Subject|36|||
105794528|NCT00953927|364903751|FG001|Overall Study|Withdrawal by Subject|25|||
105794529|NCT00953927|364903750|FG000|Overall Study|Death|7|||
105794530|NCT00953927|364903751|FG001|Overall Study|Death|4|||
105794531|NCT00953927|364903750|FG000|Overall Study|Other study discontinuation|1|||
105794532|NCT00953927|364903751|FG001|Overall Study|Other study discontinuation|1|||
105794533|NCT02953262|364903752|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
105794534|NCT02953262|364903753|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
105794535|NCT02953262|364903754|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
105794536|NCT02953262|364903755|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
105794537|NCT01856686|364903756|FG000|Overall Study|Lost to Follow-up|5|||
105794538|NCT01856686|364903757|FG001|Overall Study|Lost to Follow-up|11|||
105794539|NCT00602979|364903761|FG000|Overall Study|Lost to Follow-up|3|||
105794540|NCT00602979|364903762|FG001|Overall Study|Lost to Follow-up|2|||
105794541|NCT00602979|364903763|FG002|Overall Study|Lost to Follow-up|3|||
105794542|NCT00602979|364903764|FG003|Overall Study|Lost to Follow-up|2|||
105794543|NCT00602979|364903765|FG004|Overall Study|Lost to Follow-up|3|||
105794544|NCT00602979|364903761|FG000|Overall Study|Failed Intubation|0|||
105794545|NCT00602979|364903762|FG001|Overall Study|Failed Intubation|1|||
105794546|NCT00602979|364903763|FG002|Overall Study|Failed Intubation|0|||
105794547|NCT00602979|364903764|FG003|Overall Study|Failed Intubation|1|||
105794548|NCT00602979|364903765|FG004|Overall Study|Failed Intubation|0|||
105794549|NCT01052038|364903766|FG000|Overall Study|Lost to Follow-up|2|||
105794550|NCT01052038|364903767|FG001|Overall Study|Lost to Follow-up|3|||
105794551|NCT01052038|364903768|FG002|Overall Study|Lost to Follow-up|1|||
105794552|NCT01052038|364903766|FG000|Overall Study|Protocol Violation|2|||
105794553|NCT01052038|364903767|FG001|Overall Study|Protocol Violation|3|||
105794554|NCT01052038|364903768|FG002|Overall Study|Protocol Violation|3|||
105794555|NCT02499406|364903770|FG000|Overall Study|missed 3 treatment sessions|4|||
105794556|NCT01396161|364903776|FG000|Overall Study|Withdrawal by Subject|0|||
105794557|NCT01396161|364903777|FG001|Overall Study|Withdrawal by Subject|0|||
105794558|NCT01396161|364903778|FG002|Overall Study|Withdrawal by Subject|0|||
105794559|NCT01396161|364903779|FG003|Overall Study|Withdrawal by Subject|0|||
105794560|NCT01396161|364903780|FG004|Overall Study|Withdrawal by Subject|1|||
105564191|NCT02323646|364062969|FG001|Treatment Course 2|Lost to Follow-up|0|||
105564192|NCT02323646|364062970|FG002|Treatment Course 2|Lost to Follow-up|1|||
105564193|NCT02323646|364062968|FG000|Treatment Course 2|Non-compliance|0|||
105564194|NCT02323646|364062969|FG001|Treatment Course 2|Non-compliance|1|||
105564195|NCT02323646|364062970|FG002|Treatment Course 2|Non-compliance|1|||
105564196|NCT01783418|364062971|FG000|Overall Study|Withdrawal by Subject|1|||
105794561|NCT01396161|364903781|FG005|Overall Study|Withdrawal by Subject|0|||
105794562|NCT01396161|364903782|FG006|Overall Study|Withdrawal by Subject|0|||
105794563|NCT01396161|364903776|FG000|Overall Study|Other|0|||
105794564|NCT01396161|364903777|FG001|Overall Study|Other|0|||
105794565|NCT01396161|364903778|FG002|Overall Study|Other|0|||
105794566|NCT01396161|364903779|FG003|Overall Study|Other|0|||
105794567|NCT01396161|364903780|FG004|Overall Study|Other|0|||
105794568|NCT01396161|364903781|FG005|Overall Study|Other|0|||
105794569|NCT01396161|364903782|FG006|Overall Study|Other|1|||
105794570|NCT02962739|364903785|FG000|Overall Study|Withdrawal by Subject|0|||
105794571|NCT02962739|364903786|FG001|Overall Study|Withdrawal by Subject|1|||
105794572|NCT02962739|364903787|FG002|Overall Study|Withdrawal by Subject|0|||
105794573|NCT02962739|364903788|FG003|Overall Study|Withdrawal by Subject|0|||
105564197|NCT01783418|364062972|FG001|Overall Study|Withdrawal by Subject|0|||
105564198|NCT02459262|364062974|FG000|Overall Study|Withdrawal by Subject|0|||
105564199|NCT02459262|364062975|FG001|Overall Study|Withdrawal by Subject|0|||
105564200|NCT02459262|364062976|FG002|Overall Study|Withdrawal by Subject|0|||
105564201|NCT02459262|364062977|FG003|Overall Study|Withdrawal by Subject|0|||
105564202|NCT02459262|364062978|FG004|Overall Study|Withdrawal by Subject|0|||
105564203|NCT02459262|364062979|FG005|Overall Study|Withdrawal by Subject|0|||
105564204|NCT02459262|364062980|FG006|Overall Study|Withdrawal by Subject|0|||
105564205|NCT02459262|364062981|FG007|Overall Study|Withdrawal by Subject|0|||
105564206|NCT02459262|364062982|FG008|Overall Study|Withdrawal by Subject|0|||
105564207|NCT02459262|364062983|FG009|Overall Study|Withdrawal by Subject|1|||
105564208|NCT02459262|364062984|FG010|Overall Study|Withdrawal by Subject|0|||
105564209|NCT00840801|364062985|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
105564210|NCT00840801|364062986|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
105564211|NCT00840801|364062987|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
105564212|NCT00840801|364062985|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
105564213|NCT00840801|364062986|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
105564214|NCT00840801|364062987|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
105564215|NCT00840801|364062985|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
105726739|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
105726740|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
105726741|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
105726742|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
105726743|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
105726744|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
105564216|NCT00840801|364062986|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
105564217|NCT00840801|364062987|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
105564218|NCT00840801|364062985|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
105564219|NCT00840801|364062986|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
105564220|NCT00840801|364062987|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
105564221|NCT04539821|364062998|FG000|Overall Study|Withdrawal by Subject|2|||
105564222|NCT04539821|364062998|FG000|Overall Study|continued care with their physician|20|||
105564223|NCT04539821|364062998|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
105564224|NCT02641392|364062999|FG000|Overall Study|Lost to Follow-up|0|||
105564225|NCT02641392|364063000|FG001|Overall Study|Lost to Follow-up|0|||
105564226|NCT02641392|364063001|FG002|Overall Study|Lost to Follow-up|2|||
105564227|NCT02641392|364062999|FG000|Overall Study|Withdrawal by Subject|0|||
105564228|NCT02641392|364063000|FG001|Overall Study|Withdrawal by Subject|0|||
105564229|NCT02641392|364063001|FG002|Overall Study|Withdrawal by Subject|17|||
105564230|NCT02641392|364062999|FG000|Overall Study|Adverse Event|0|||
105564231|NCT02641392|364063000|FG001|Overall Study|Adverse Event|1|||
105564232|NCT02641392|364063001|FG002|Overall Study|Adverse Event|25|||
105564233|NCT02641392|364062999|FG000|Overall Study|Study Terminated by Sponsor|4|||
105564234|NCT02641392|364063000|FG001|Overall Study|Study Terminated by Sponsor|12|||
105564235|NCT02641392|364063001|FG002|Overall Study|Study Terminated by Sponsor|144|||
105564236|NCT02641392|364062999|FG000|Overall Study|Lack of Efficacy|0|||
105564237|NCT02641392|364063000|FG001|Overall Study|Lack of Efficacy|0|||
105564238|NCT02641392|364063001|FG002|Overall Study|Lack of Efficacy|101|||
105564239|NCT02641392|364062999|FG000|Overall Study|Miscellaneous|0|||
105564240|NCT02641392|364063000|FG001|Overall Study|Miscellaneous|0|||
105564241|NCT02641392|364063001|FG002|Overall Study|Miscellaneous|3|||
105564242|NCT02641392|364062999|FG000|Overall Study|Death|0|||
105564243|NCT02641392|364063000|FG001|Overall Study|Death|0|||
105564244|NCT02641392|364063001|FG002|Overall Study|Death|1|||
105564245|NCT02563002|364063002|FG000|Overall Study|Death|72|||
105564246|NCT02563002|364063003|FG001|Overall Study|Death|87|||
105564247|NCT02563002|364063002|FG000|Overall Study|Lost to Follow-up|5|||
105564248|NCT02563002|364063003|FG001|Overall Study|Lost to Follow-up|0|||
105564249|NCT02563002|364063002|FG000|Overall Study|Physician Decision|0|||
105564250|NCT02563002|364063003|FG001|Overall Study|Physician Decision|2|||
105564251|NCT02563002|364063002|FG000|Overall Study|Withdrawal by Subject|2|||
105564252|NCT02563002|364063003|FG001|Overall Study|Withdrawal by Subject|10|||
105564253|NCT02563002|364063002|FG000|Overall Study|Sponsor decision|74|||
105564254|NCT02563002|364063003|FG001|Overall Study|Sponsor decision|55|||
105564255|NCT01505387|364063006|FG000|Overall Study|Protocol Violation|1|||
105564256|NCT01505387|364063007|FG001|Overall Study|Protocol Violation|0|||
105564257|NCT01505387|364063006|FG000|Overall Study|Withdrawal by Subject|1|||
105564258|NCT01505387|364063007|FG001|Overall Study|Withdrawal by Subject|1|||
105564259|NCT01197508|364063010|FG000|Overall Study|Withdrawal by Subject|8|||
105564260|NCT01197508|364063011|FG001|Overall Study|Withdrawal by Subject|7|||
105564261|NCT01197508|364063012|FG002|Overall Study|Withdrawal by Subject|15|||
105564262|NCT01197508|364063013|FG003|Overall Study|Withdrawal by Subject|4|||
105564263|NCT01197508|364063010|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
105564264|NCT01197508|364063011|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
105794574|NCT02962739|364903789|FG004|Overall Study|Withdrawal by Subject|0|||
105794575|NCT02962739|364903790|FG005|Overall Study|Withdrawal by Subject|0|||
105794576|NCT02962739|364903785|FG000|Overall Study|Protocol Violation|0|||
105794577|NCT02962739|364903786|FG001|Overall Study|Protocol Violation|0|||
105794578|NCT02962739|364903787|FG002|Overall Study|Protocol Violation|1|||
105794579|NCT02962739|364903788|FG003|Overall Study|Protocol Violation|0|||
105794580|NCT02962739|364903789|FG004|Overall Study|Protocol Violation|1|||
105794581|NCT02962739|364903790|FG005|Overall Study|Protocol Violation|0|||
105794582|NCT00734617|364903791|FG000|Overall Study|Adverse Event|4|||
105794583|NCT00734617|364903792|FG001|Overall Study|Adverse Event|7|||
105794584|NCT00734617|364903791|FG000|Overall Study|Withdrawal by Subject|103|||
105794585|NCT00734617|364903792|FG001|Overall Study|Withdrawal by Subject|95|||
105794586|NCT00552617|364903793|FG000|Overall Study|Not Treated|0|||
105794587|NCT00552617|364903794|FG001|Overall Study|Not Treated|0|||
105794588|NCT00552617|364903795|FG002|Overall Study|Not Treated|1|||
105794589|NCT00552617|364903796|FG003|Overall Study|Not Treated|0|||
105794590|NCT00552617|364903797|FG004|Overall Study|Not Treated|0|||
105794591|NCT00552617|364903798|FG005|Overall Study|Not Treated|0|||
105794592|NCT00552617|364903799|FG006|Overall Study|Not Treated|0|||
105794593|NCT00552617|364903800|FG007|Overall Study|Not Treated|0|||
105794594|NCT00552617|364903801|FG008|Overall Study|Not Treated|0|||
105794595|NCT00552617|364903802|FG009|Overall Study|Not Treated|1|||
105794596|NCT00552617|364903793|FG000|Overall Study|Lost to Follow-up|0|||
105794597|NCT00552617|364903794|FG001|Overall Study|Lost to Follow-up|0|||
105794598|NCT00552617|364903795|FG002|Overall Study|Lost to Follow-up|0|||
105794599|NCT00552617|364903796|FG003|Overall Study|Lost to Follow-up|1|||
105794600|NCT00552617|364903797|FG004|Overall Study|Lost to Follow-up|0|||
105794601|NCT00552617|364903798|FG005|Overall Study|Lost to Follow-up|2|||
105794602|NCT00552617|364903799|FG006|Overall Study|Lost to Follow-up|0|||
105794603|NCT00552617|364903800|FG007|Overall Study|Lost to Follow-up|0|||
105794604|NCT00552617|364903801|FG008|Overall Study|Lost to Follow-up|2|||
105794605|NCT00552617|364903802|FG009|Overall Study|Lost to Follow-up|0|||
105794606|NCT01850108|364903803|FG000|Overall Study|Lost to Follow-up|4|||
105794607|NCT01850108|364903803|FG000|Overall Study|Not eligible|1|||
105794608|NCT01850108|364903803|FG000|Overall Study|Failed engraftment|2|||
105794609|NCT01850108|364903803|FG000|Overall Study|Physician Decision|1|||
105794610|NCT02072174|364903804|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
105794611|NCT02072174|364903805|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
105794612|NCT02072174|364903804|FG000|Overall Study|Protocol Violation|16|||
105794613|NCT02072174|364903805|FG001|Overall Study|Protocol Violation|23|||
105794614|NCT02072174|364903804|FG000|Overall Study|Physician Decision|0|||
105794615|NCT02072174|364903805|FG001|Overall Study|Physician Decision|1|||
105794616|NCT02072174|364903804|FG000|Overall Study|Non-compliance with protocol requirement|2|||
105794617|NCT02072174|364903805|FG001|Overall Study|Non-compliance with protocol requirement|0|||
105794618|NCT01787188|364903806|FG000|Overall Study|Adverse Event|2|||
105794619|NCT01787188|364903807|FG001|Overall Study|Adverse Event|4|||
105794620|NCT01787188|364903808|FG002|Overall Study|Adverse Event|6|||
105794621|NCT01787188|364903806|FG000|Overall Study|Lack of Efficacy|7|||
105794622|NCT01787188|364903807|FG001|Overall Study|Lack of Efficacy|3|||
105794623|NCT01787188|364903808|FG002|Overall Study|Lack of Efficacy|5|||
105794624|NCT01787188|364903806|FG000|Overall Study|Non-compliance with Study Drug|0|||
105794625|NCT01787188|364903807|FG001|Overall Study|Non-compliance with Study Drug|1|||
105794626|NCT01787188|364903808|FG002|Overall Study|Non-compliance with Study Drug|0|||
105794627|NCT01787188|364903806|FG000|Overall Study|Withdrawal by Subject|4|||
105794628|NCT01787188|364903807|FG001|Overall Study|Withdrawal by Subject|3|||
105794629|NCT01787188|364903808|FG002|Overall Study|Withdrawal by Subject|2|||
105794630|NCT01787188|364903806|FG000|Overall Study|Protocol Violation|3|||
105794631|NCT01787188|364903807|FG001|Overall Study|Protocol Violation|2|||
105794632|NCT01787188|364903808|FG002|Overall Study|Protocol Violation|3|||
105794633|NCT01787188|364903806|FG000|Overall Study|Lost to Follow-up|1|||
105794634|NCT01787188|364903807|FG001|Overall Study|Lost to Follow-up|2|||
105794635|NCT01787188|364903808|FG002|Overall Study|Lost to Follow-up|2|||
105794636|NCT01787188|364903806|FG000|Overall Study|Other, including patient moved|0|||
105794637|NCT01787188|364903807|FG001|Overall Study|Other, including patient moved|3|||
105794638|NCT01787188|364903808|FG002|Overall Study|Other, including patient moved|0|||
105794639|NCT05013749|364903813|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
105794640|NCT05013749|364903814|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
105794641|NCT05013749|364903813|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
105794642|NCT05013749|364903814|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
105794643|NCT01393626|364903817|FG000|Overall Study|Adverse Event|2|||
105794644|NCT01393626|364903818|FG001|Overall Study|Adverse Event|1|||
105794645|NCT01393626|364903819|FG002|Overall Study|Adverse Event|5|||
105794646|NCT01393626|364903820|FG003|Overall Study|Adverse Event|0|||
105794647|NCT01393626|364903817|FG000|Overall Study|Did not meet entrance criteria|1|||
105794648|NCT01393626|364903818|FG001|Overall Study|Did not meet entrance criteria|0|||
105794649|NCT01393626|364903819|FG002|Overall Study|Did not meet entrance criteria|0|||
105794650|NCT01393626|364903820|FG003|Overall Study|Did not meet entrance criteria|0|||
105564265|NCT01197508|364063012|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
105564266|NCT01197508|364063013|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
105564267|NCT01197508|364063010|FG000|Overall Study|Adverse Event|10|||
105794651|NCT01393626|364903817|FG000|Overall Study|Lack of Efficacy|6|||
105794652|NCT01393626|364903818|FG001|Overall Study|Lack of Efficacy|6|||
105794653|NCT01393626|364903819|FG002|Overall Study|Lack of Efficacy|4|||
105794654|NCT01393626|364903820|FG003|Overall Study|Lack of Efficacy|1|||
105794655|NCT01393626|364903817|FG000|Overall Study|Lost to Follow-up|1|||
105794656|NCT01393626|364903818|FG001|Overall Study|Lost to Follow-up|1|||
105794657|NCT01393626|364903819|FG002|Overall Study|Lost to Follow-up|1|||
105794658|NCT01393626|364903820|FG003|Overall Study|Lost to Follow-up|0|||
105794659|NCT01393626|364903817|FG000|Overall Study|Withdrawal by Subject|6|||
105794660|NCT01393626|364903818|FG001|Overall Study|Withdrawal by Subject|4|||
105794661|NCT01393626|364903819|FG002|Overall Study|Withdrawal by Subject|0|||
105794662|NCT01393626|364903820|FG003|Overall Study|Withdrawal by Subject|0|||
105794663|NCT01393626|364903817|FG000|Overall Study|Other|1|||
105794664|NCT01393626|364903818|FG001|Overall Study|Other|0|||
105794665|NCT01393626|364903819|FG002|Overall Study|Other|0|||
105794666|NCT01393626|364903820|FG003|Overall Study|Other|0|||
105794667|NCT01393626|364903817|FG000|Overall Study|Protocol Violation|1|||
105794668|NCT01393626|364903818|FG001|Overall Study|Protocol Violation|0|||
105794669|NCT01393626|364903819|FG002|Overall Study|Protocol Violation|2|||
105794670|NCT01393626|364903820|FG003|Overall Study|Protocol Violation|0|||
105794671|NCT02426125|364903821|FG000|Overall Study|Lost to Follow-up|14|||
105794672|NCT02426125|364903822|FG001|Overall Study|Lost to Follow-up|12|||
105794673|NCT02426125|364903821|FG000|Overall Study|Withdrawal by Subject|13|||
105794674|NCT02426125|364903822|FG001|Overall Study|Withdrawal by Subject|14|||
105794675|NCT02426125|364903821|FG000|Overall Study|Death|185|||
105794676|NCT02426125|364903822|FG001|Overall Study|Death|200|||
105794677|NCT02426125|364903821|FG000|Overall Study|Randomized, But Never Treated|5|||
105794678|NCT02426125|364903822|FG001|Overall Study|Randomized, But Never Treated|2|||
105794679|NCT02858076|364903823|FG000|Overall Study|Death|6|||
105794680|NCT02858076|364903824|FG001|Overall Study|Death|3|||
105564268|NCT01197508|364063011|FG001|Overall Study|Adverse Event|13|||
105564269|NCT01197508|364063012|FG002|Overall Study|Adverse Event|23|||
105564270|NCT01197508|364063013|FG003|Overall Study|Adverse Event|3|||
105564271|NCT01197508|364063010|FG000|Overall Study|Severe non-compliance to protocol|0|||
105794681|NCT02858076|364903823|FG000|Overall Study|Withdrawal by Subject|1|||
105794682|NCT02858076|364903824|FG001|Overall Study|Withdrawal by Subject|5|||
105794683|NCT02858076|364903823|FG000|Overall Study|Lost to Follow-up|2|||
105794684|NCT02858076|364903824|FG001|Overall Study|Lost to Follow-up|7|||
105564272|NCT01197508|364063011|FG001|Overall Study|Severe non-compliance to protocol|3|||
105564273|NCT01197508|364063012|FG002|Overall Study|Severe non-compliance to protocol|1|||
105564274|NCT01197508|364063013|FG003|Overall Study|Severe non-compliance to protocol|3|||
105564275|NCT01197508|364063010|FG000|Overall Study|Condition under investigation worsened|1|||
105564276|NCT01197508|364063011|FG001|Overall Study|Condition under investigation worsened|1|||
105564277|NCT01197508|364063012|FG002|Overall Study|Condition under investigation worsened|1|||
105794685|NCT02858076|364903823|FG000|Overall Study|Completed Out of Window|1|||
105794686|NCT02858076|364903824|FG001|Overall Study|Completed Out of Window|3|||
105794687|NCT00943384|364903827|FG000|Overall Study|Dispositioned prior to treatment|23|||
105794688|NCT00943384|364903827|FG000|Overall Study|Treated off protocol-protocol violation|5|||
105794689|NCT00943384|364903827|FG000|Overall Study|Lost to Follow-up|16|||
105794690|NCT00943384|364903827|FG000|Overall Study|Withdrawal by Subject|5|||
105794691|NCT03151707|364903828|FG000|Overall Study|Lost to Follow-up|6|||
105794692|NCT03332212|364903829|FG000|Overall Study|Not treated|0|||
105794693|NCT03332212|364903830|FG001|Overall Study|Not treated|1|||
105794694|NCT03332212|364903831|FG002|Overall Study|Not treated|0|||
105794695|NCT03332212|364903832|FG003|Overall Study|Not treated|0|||
105794696|NCT03332212|364903829|FG000|Overall Study|Adverse Event|0|||
105794697|NCT03332212|364903830|FG001|Overall Study|Adverse Event|0|||
105794698|NCT03332212|364903831|FG002|Overall Study|Adverse Event|0|||
105794699|NCT03332212|364903832|FG003|Overall Study|Adverse Event|1|||
105794700|NCT03332212|364903829|FG000|Overall Study|worsening of disease under study|1|||
105794701|NCT03332212|364903830|FG001|Overall Study|worsening of disease under study|1|||
105794702|NCT03332212|364903831|FG002|Overall Study|worsening of disease under study|0|||
105564278|NCT01197508|364063013|FG003|Overall Study|Condition under investigation worsened|1|||
105564279|NCT01197508|364063010|FG000|Overall Study|Lack of Efficacy|1|||
105564280|NCT01197508|364063011|FG001|Overall Study|Lack of Efficacy|2|||
105564281|NCT01197508|364063012|FG002|Overall Study|Lack of Efficacy|2|||
105794703|NCT03332212|364903832|FG003|Overall Study|worsening of disease under study|0|||
105794704|NCT02125734|364903833|FG000|Period 2|Adverse Event|0|||
105794705|NCT02125734|364903834|FG001|Period 2|Adverse Event|1|||
105794706|NCT01308762|364903835|FG000|Overall Study|Protocol Violation|0|||
105794707|NCT01308762|364903836|FG001|Overall Study|Protocol Violation|1|||
105794708|NCT01308762|364903837|FG002|Overall Study|Protocol Violation|0|||
105794709|NCT00605839|364903838|FG000|Overall Study|Protocol Violation|1|||
105794710|NCT00605839|364903839|FG001|Overall Study|Protocol Violation|0|||
105794711|NCT00605839|364903840|FG002|Overall Study|Protocol Violation|0|||
105564282|NCT01197508|364063013|FG003|Overall Study|Lack of Efficacy|1|||
105564283|NCT01197508|364063010|FG000|Overall Study|Study-specific withdrawal criteria|0|||
105564284|NCT01197508|364063011|FG001|Overall Study|Study-specific withdrawal criteria|0|||
105564285|NCT01197508|364063012|FG002|Overall Study|Study-specific withdrawal criteria|1|||
105564286|NCT01197508|364063013|FG003|Overall Study|Study-specific withdrawal criteria|2|||
105564287|NCT01197508|364063010|FG000|Overall Study|Lost to Follow-up|1|||
105564288|NCT01197508|364063011|FG001|Overall Study|Lost to Follow-up|1|||
105564289|NCT01197508|364063012|FG002|Overall Study|Lost to Follow-up|2|||
105564290|NCT01197508|364063013|FG003|Overall Study|Lost to Follow-up|0|||
105564291|NCT01197508|364063010|FG000|Overall Study|Other|2|||
105564292|NCT01197508|364063011|FG001|Overall Study|Other|3|||
105564293|NCT01197508|364063012|FG002|Overall Study|Other|2|||
105564294|NCT01197508|364063013|FG003|Overall Study|Other|2|||
105564295|NCT04067401|364063016|FG000|Overall Study|Withdrawal by Subject|7|||
105564296|NCT04067401|364063017|FG001|Overall Study|Withdrawal by Subject|0|||
105564297|NCT04067401|364063016|FG000|Overall Study|no data provided|1|||
105564298|NCT04067401|364063017|FG001|Overall Study|no data provided|0|||
105564299|NCT00595504|364063018|FG000|Overall Study|Withdrawal by Subject|1|||
105564300|NCT00595504|364063019|FG001|Overall Study|Withdrawal by Subject|3|||
105564301|NCT00595504|364063018|FG000|Overall Study|Physician Decision|1|||
105564302|NCT00595504|364063019|FG001|Overall Study|Physician Decision|0|||
105564303|NCT01477853|364063021|FG000|Phase A|Adverse Event|1|||
105564304|NCT01477853|364063022|FG001|Phase A|Adverse Event|2|||
105564305|NCT01477853|364063023|FG002|Phase A|Adverse Event|2|||
105564306|NCT01477853|364063021|FG000|Phase A|Lost to Follow-up|4|||
105564307|NCT01477853|364063022|FG001|Phase A|Lost to Follow-up|3|||
105564308|NCT01477853|364063023|FG002|Phase A|Lost to Follow-up|2|||
105564309|NCT01477853|364063021|FG000|Phase A|Physician Decision|1|||
105564310|NCT01477853|364063022|FG001|Phase A|Physician Decision|0|||
105564311|NCT01477853|364063023|FG002|Phase A|Physician Decision|1|||
105564312|NCT01477853|364063021|FG000|Phase A|Study terminated by sponsor|37|||
105564313|NCT01477853|364063022|FG001|Phase A|Study terminated by sponsor|40|||
105564314|NCT01477853|364063023|FG002|Phase A|Study terminated by sponsor|39|||
105564315|NCT01477853|364063021|FG000|Phase B|Lost to Follow-up|0|||
105564316|NCT01477853|364063022|FG001|Phase B|Lost to Follow-up|1|||
105564317|NCT01477853|364063023|FG002|Phase B|Lost to Follow-up|0|||
105564318|NCT01477853|364063021|FG000|Phase B|Study terminated by sponsor|12|||
105564319|NCT01477853|364063022|FG001|Phase B|Study terminated by sponsor|10|||
105564320|NCT01477853|364063023|FG002|Phase B|Study terminated by sponsor|11|||
105564321|NCT00948974|364063035|FG000|Overall Study|Lost to Follow-up|23|||
105794712|NCT02617446|364903841|FG000|Overall Study|Withdrawal by Subject|0|||
105794713|NCT02617446|364903842|FG001|Overall Study|Withdrawal by Subject|2|||
105794714|NCT02617446|364903843|FG002|Overall Study|Withdrawal by Subject|0|||
105794715|NCT02617446|364903841|FG000|Overall Study|Adverse Event|1|||
105794716|NCT02617446|364903842|FG001|Overall Study|Adverse Event|0|||
105794717|NCT02617446|364903843|FG002|Overall Study|Adverse Event|5|||
105794718|NCT02617446|364903841|FG000|Overall Study|Lost to Follow-up|3|||
105794719|NCT02617446|364903842|FG001|Overall Study|Lost to Follow-up|0|||
105794720|NCT02617446|364903843|FG002|Overall Study|Lost to Follow-up|0|||
105794721|NCT02617446|364903841|FG000|Overall Study|Death|0|||
105794722|NCT02617446|364903842|FG001|Overall Study|Death|0|||
105794723|NCT02617446|364903843|FG002|Overall Study|Death|2|||
105794724|NCT00981019|364903844|FG000|Overall Study|Did not respond|65|||
105794725|NCT00981019|364903844|FG000|Overall Study|Did not match target population|94|||
105794726|NCT00981019|364903844|FG000|Overall Study|Inadvertent exclusion|239|||
105794727|NCT00981019|364903844|FG000|Overall Study|Hit the survey after closure|79|||
105794728|NCT00358670|364903845|FG000|Overall Study|Adverse Event|26|||
105794729|NCT00358670|364903846|FG001|Overall Study|Adverse Event|29|||
105794730|NCT00358670|364903845|FG000|Overall Study|Lack of Efficacy|20|||
105794731|NCT00358670|364903846|FG001|Overall Study|Lack of Efficacy|23|||
105794732|NCT00358670|364903845|FG000|Overall Study|Protocol Violation|6|||
105794733|NCT00358670|364903846|FG001|Overall Study|Protocol Violation|9|||
105794734|NCT00358670|364903845|FG000|Overall Study|Lost to Follow-up|4|||
105564322|NCT00948974|364063036|FG001|Overall Study|Lost to Follow-up|20|||
105794735|NCT00358670|364903846|FG001|Overall Study|Lost to Follow-up|5|||
105564323|NCT01445652|364063044|FG000|Overall Study|Not comfortable in lenses|5|||
105564324|NCT01445652|364063045|FG001|Overall Study|Not comfortable in lenses|0|||
105564325|NCT01445652|364063044|FG000|Overall Study|Failed to attend scheduled visit|2|||
105564326|NCT01445652|364063045|FG001|Overall Study|Failed to attend scheduled visit|3|||
105564327|NCT01445652|364063044|FG000|Overall Study|Failed teach session|2|||
105564328|NCT01445652|364063045|FG001|Overall Study|Failed teach session|0|||
105564329|NCT01445652|364063044|FG000|Overall Study|Adverse Event|1|||
105794736|NCT00358670|364903845|FG000|Overall Study|Withdrawal by Subject|13|||
105794737|NCT00358670|364903846|FG001|Overall Study|Withdrawal by Subject|24|||
105794738|NCT00358670|364903845|FG000|Overall Study|Protocol Defined Clinical Event|0|||
105564330|NCT01445652|364063045|FG001|Overall Study|Adverse Event|0|||
105564331|NCT00855062|364063046|FG000|Step1|Early Study Closure|5|||
105564332|NCT00855062|364063047|FG001|Step1|Early Study Closure|7|||
105794739|NCT00358670|364903846|FG001|Overall Study|Protocol Defined Clinical Event|1|||
105794740|NCT00358670|364903845|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
105794741|NCT00358670|364903846|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
105794742|NCT00358670|364903845|FG000|Overall Study|Administrative|153|||
105794743|NCT00358670|364903846|FG001|Overall Study|Administrative|125|||
105794744|NCT00902278|364903847|FG000|Overall Study|Physician Decision|1|||
105794745|NCT00902278|364903848|FG001|Overall Study|Physician Decision|0|||
105794746|NCT00902278|364903849|FG002|Overall Study|Physician Decision|2|||
105794747|NCT00902278|364903850|FG003|Overall Study|Physician Decision|0|||
105794748|NCT00902278|364903851|FG004|Overall Study|Physician Decision|1|||
105794749|NCT00902278|364903847|FG000|Overall Study|Lost to Follow-up|3|||
105794750|NCT00902278|364903848|FG001|Overall Study|Lost to Follow-up|2|||
105794751|NCT00902278|364903849|FG002|Overall Study|Lost to Follow-up|3|||
105794752|NCT00902278|364903850|FG003|Overall Study|Lost to Follow-up|0|||
105794753|NCT00902278|364903851|FG004|Overall Study|Lost to Follow-up|1|||
105794754|NCT00960687|364903852|FG000|Washout Period of 7 Days|Adverse Event|3|||
105794755|NCT00960687|364903853|FG001|Washout Period of 7 Days|Adverse Event|2|||
105794756|NCT00960687|364903852|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
105794757|NCT00960687|364903853|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105794758|NCT02362646|364903854|FG000|Overall Study|Death|15|||
105794759|NCT02362646|364903855|FG001|Overall Study|Death|8|||
105564333|NCT00855062|364063046|FG000|Step1|Adverse Event|1|||
105564334|NCT00855062|364063047|FG001|Step1|Adverse Event|1|||
105564335|NCT00855062|364063046|FG000|Step1|Protocol Violation|1|||
105564336|NCT00855062|364063047|FG001|Step1|Protocol Violation|0|||
105564337|NCT00855062|364063046|FG000|Step1|Pregnancy|1|||
105564338|NCT00855062|364063047|FG001|Step1|Pregnancy|0|||
105564339|NCT00855062|364063046|FG000|Step1|Withdrawal by Subject|2|||
105564340|NCT00855062|364063047|FG001|Step1|Withdrawal by Subject|3|||
105564341|NCT00855062|364063046|FG000|Step2|Early Study Closure|6|||
105564342|NCT00855062|364063047|FG001|Step2|Early Study Closure|2|||
105564343|NCT00855062|364063046|FG000|Step2|Adverse Event|0|||
105564344|NCT00855062|364063047|FG001|Step2|Adverse Event|3|||
105564345|NCT00855062|364063046|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
105564346|NCT00855062|364063047|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
105564347|NCT00763958|364063056|FG000|Overall Study|did not meet final criteria|4|||
105564348|NCT00763958|364063057|FG001|Overall Study|did not meet final criteria|4|||
105564349|NCT00763958|364063056|FG000|Overall Study|Lost to Follow-up|10|||
105564350|NCT00763958|364063057|FG001|Overall Study|Lost to Follow-up|2|||
105564351|NCT00763958|364063056|FG000|Overall Study|Believed they were receiving placebo|0|||
105564352|NCT00763958|364063057|FG001|Overall Study|Believed they were receiving placebo|5|||
105564353|NCT00454571|364063059|FG000|Overall Study|Adverse Event|2|||
105564354|NCT00454571|364063060|FG001|Overall Study|Adverse Event|0|||
105564355|NCT00454571|364063059|FG000|Overall Study|Physician Decision|0|||
105564356|NCT00454571|364063060|FG001|Overall Study|Physician Decision|1|||
105564357|NCT00454571|364063059|FG000|Overall Study|Protocol Violation|1|||
105564358|NCT00454571|364063060|FG001|Overall Study|Protocol Violation|0|||
105564359|NCT00454571|364063059|FG000|Overall Study|Withdrawal by Subject|10|||
105564360|NCT00454571|364063060|FG001|Overall Study|Withdrawal by Subject|5|||
105564361|NCT03595332|364063061|FG000|Overall Study|Lost to Follow-up|16|||
105564362|NCT03595332|364063062|FG001|Overall Study|Lost to Follow-up|22|||
105564363|NCT03595332|364063061|FG000|Overall Study|Unable to retrieve ID from school|0|||
105564364|NCT03595332|364063062|FG001|Overall Study|Unable to retrieve ID from school|2|||
105564365|NCT02227875|364063063|FG000|Overall Study|Protocol Violation|10|||
105564366|NCT02227875|364063064|FG001|Overall Study|Protocol Violation|7|||
105564367|NCT02227875|364063063|FG000|Overall Study|Other|1|||
105794760|NCT02362646|364903854|FG000|Overall Study|Withdrawal by Subject|2|||
105794761|NCT02362646|364903855|FG001|Overall Study|Withdrawal by Subject|2|||
105794762|NCT02362646|364903854|FG000|Overall Study|received transplant|21|||
105564368|NCT02227875|364063064|FG001|Overall Study|Other|3|||
105794763|NCT02362646|364903855|FG001|Overall Study|received transplant|14|||
105794764|NCT00865306|364903856|FG000|Controlled Trial|Lost to Follow-up|1|||
105794765|NCT00865306|364903857|FG001|Controlled Trial|Lost to Follow-up|1|||
105564369|NCT02227875|364063063|FG000|Overall Study|Physician Decision|1|||
105564370|NCT02227875|364063064|FG001|Overall Study|Physician Decision|0|||
105564371|NCT02227875|364063063|FG000|Overall Study|Adverse Event|3|||
105564372|NCT02227875|364063064|FG001|Overall Study|Adverse Event|0|||
105564373|NCT02227875|364063063|FG000|Overall Study|Withdrawal by Subject|12|||
105564374|NCT02227875|364063064|FG001|Overall Study|Withdrawal by Subject|13|||
105564375|NCT02227875|364063063|FG000|Overall Study|Lost to Follow-up|10|||
105564376|NCT02227875|364063064|FG001|Overall Study|Lost to Follow-up|10|||
105564377|NCT04209725|364063065|FG000|Overall Study|Adverse Event|1|||
105794766|NCT00865306|364903856|FG000|Controlled Trial|Difficulty commuting|2|||
105564378|NCT02856113|364063066|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
105564379|NCT02856113|364063067|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
105794767|NCT00865306|364903857|FG001|Controlled Trial|Difficulty commuting|0|||
105794768|NCT00865306|364903856|FG000|Controlled Trial|Improved btw baseline and first session|1|||
105794769|NCT00865306|364903857|FG001|Controlled Trial|Improved btw baseline and first session|0|||
105794770|NCT00865306|364903856|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
105794771|NCT00865306|364903857|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
105794772|NCT00865306|364903856|FG000|Controlled Trial|Withdrawal by Subject|0|||
105794773|NCT00865306|364903857|FG001|Controlled Trial|Withdrawal by Subject|1|||
105794774|NCT05083559|364903860|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
105794775|NCT05083559|364903861|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
105794776|NCT05083559|364903860|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
105794777|NCT05083559|364903861|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
105794778|NCT05083559|364903860|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
105794779|NCT05083559|364903861|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
105794780|NCT02704130|364903864|FG000|Overall Study|Physician Decision|5|||
105794781|NCT02704130|364903865|FG001|Overall Study|Physician Decision|3|||
105794782|NCT02181842|364903866|FG000|Overall Study|Case Report Forms Uncollected|2|||
105794783|NCT01216319|364903867|FG000|Overall Study|Lost to Follow-up|2|||
105794784|NCT01216319|364903867|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
105794785|NCT02720094|364903868|FG000|Overall Study|Scheduled exit visit/end of study|2|||
105794786|NCT02720094|364903869|FG001|Overall Study|Scheduled exit visit/end of study|1|||
105794787|NCT02720094|364903868|FG000|Overall Study|Death|4|||
105794788|NCT02720094|364903869|FG001|Overall Study|Death|7|||
105794789|NCT02720094|364903868|FG000|Overall Study|Withdrawal by Subject|55|||
105794790|NCT02720094|364903869|FG001|Overall Study|Withdrawal by Subject|56|||
105794791|NCT02720094|364903868|FG000|Overall Study|Lost to Follow-up|2|||
105794792|NCT02720094|364903869|FG001|Overall Study|Lost to Follow-up|7|||
105794793|NCT02720094|364903868|FG000|Overall Study|Physician Decision|1|||
105794794|NCT02720094|364903869|FG001|Overall Study|Physician Decision|3|||
105794795|NCT02720094|364903868|FG000|Overall Study|Inappropriate enrollment|1|||
105794796|NCT02720094|364903869|FG001|Overall Study|Inappropriate enrollment|3|||
105794797|NCT02720094|364903868|FG000|Overall Study|Ongoing|2210|||
105794798|NCT02720094|364903869|FG001|Overall Study|Ongoing|2203|||
105794799|NCT02720094|364903868|FG000|Overall Study|Relocation|1|||
105794800|NCT02720094|364903869|FG001|Overall Study|Relocation|1|||
105794801|NCT05246111|364903870|FG000|Period 01|NOT ELIGIBLE IC5|1|||
105794802|NCT05246111|364903871|FG001|Period 01|NOT ELIGIBLE IC5|0|||
105794803|NCT02587325|364903872|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
105794804|NCT02587325|364903873|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
105794805|NCT02587325|364903874|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
105794806|NCT02587325|364903875|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
105794807|NCT02587325|364903876|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
105794808|NCT02587325|364903872|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
105794809|NCT02587325|364903873|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
105794810|NCT02587325|364903874|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
105794811|NCT02587325|364903875|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
105794812|NCT02587325|364903876|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
105794813|NCT02587325|364903872|FG000|32-Week Optional Extension Part|Adverse Event|0|||
105794814|NCT02587325|364903873|FG001|32-Week Optional Extension Part|Adverse Event|0|||
105794815|NCT02587325|364903874|FG002|32-Week Optional Extension Part|Adverse Event|1|||
105794816|NCT02587325|364903875|FG003|32-Week Optional Extension Part|Adverse Event|0|||
105794817|NCT02587325|364903876|FG004|32-Week Optional Extension Part|Adverse Event|0|||
105794818|NCT02587325|364903872|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
105794819|NCT02587325|364903873|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
105794820|NCT02587325|364903874|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
105794821|NCT02587325|364903875|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
105794822|NCT02587325|364903876|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
105794823|NCT01831596|364903877|FG000|Overall Study|Other|8|||
105794824|NCT01311505|364903878|FG000|First Intervention Period|Protocol Violation|0|||
105794825|NCT01311505|364903879|FG001|First Intervention Period|Protocol Violation|1|||
105794826|NCT02956005|364903883|FG000|Overall Study|Not eligible|1|||
105794827|NCT02956005|364903883|FG000|Overall Study|Withdrawal by Subject|3|||
105794828|NCT02956005|364903883|FG000|Overall Study|Physician Decision|12|||
105794829|NCT03022799|364903889|FG000|Overall Study|Adverse Event|0|||
105794830|NCT03022799|364903890|FG001|Overall Study|Adverse Event|0|||
105794831|NCT03022799|364903891|FG002|Overall Study|Adverse Event|0|||
105794832|NCT03022799|364903892|FG003|Overall Study|Adverse Event|0|||
105794833|NCT03022799|364903893|FG004|Overall Study|Adverse Event|0|||
105794834|NCT03022799|364903894|FG005|Overall Study|Adverse Event|0|||
105794835|NCT03022799|364903895|FG006|Overall Study|Adverse Event|0|||
105794836|NCT03022799|364903896|FG007|Overall Study|Adverse Event|0|||
105353254|NCT00642954|363298480|FG001|Overall Study|Withdrawal by Subject|0|||
105564380|NCT02856113|364063066|FG000|Overall Study|Significant Protocol Deviation|1|||
105794837|NCT03022799|364903897|FG008|Overall Study|Adverse Event|0|||
105794838|NCT03022799|364903898|FG009|Overall Study|Adverse Event|1|||
105794839|NCT03022799|364903899|FG010|Overall Study|Adverse Event|1|||
105794840|NCT03022799|364903900|FG011|Overall Study|Adverse Event|0|||
105794841|NCT03022799|364903901|FG012|Overall Study|Adverse Event|0|||
105794842|NCT04881448|364903902|FG000|Overall Study|Study cancelled by sponsor|220|||
105479531|NCT01403948|363767560|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
105726745|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
105726746|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
105726747|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105726748|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105726749|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
105726750|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105726751|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105479532|NCT01403948|363767561|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
105479533|NCT01403948|363767552|FG000|Overall Study|Lost to Follow-up|0|||
105479534|NCT01403948|363767553|FG001|Overall Study|Lost to Follow-up|0|||
105479535|NCT01403948|363767554|FG002|Overall Study|Lost to Follow-up|0|||
105479536|NCT01403948|363767555|FG003|Overall Study|Lost to Follow-up|0|||
105479537|NCT01403948|363767556|FG004|Overall Study|Lost to Follow-up|0|||
105479538|NCT01403948|363767557|FG005|Overall Study|Lost to Follow-up|0|||
105479539|NCT01403948|363767558|FG006|Overall Study|Lost to Follow-up|0|||
105479540|NCT01403948|363767559|FG007|Overall Study|Lost to Follow-up|0|||
105479541|NCT01403948|363767560|FG008|Overall Study|Lost to Follow-up|0|||
105479542|NCT01403948|363767561|FG009|Overall Study|Lost to Follow-up|1|||
105479543|NCT01403948|363767552|FG000|Overall Study|Refused cont. medication|0|||
105479544|NCT01403948|363767553|FG001|Overall Study|Refused cont. medication|0|||
105479545|NCT01403948|363767554|FG002|Overall Study|Refused cont. medication|0|||
105479546|NCT01403948|363767555|FG003|Overall Study|Refused cont. medication|0|||
105479547|NCT01403948|363767556|FG004|Overall Study|Refused cont. medication|1|||
105479548|NCT01403948|363767557|FG005|Overall Study|Refused cont. medication|0|||
105479549|NCT01403948|363767558|FG006|Overall Study|Refused cont. medication|0|||
105479550|NCT01403948|363767559|FG007|Overall Study|Refused cont. medication|0|||
105479551|NCT01403948|363767560|FG008|Overall Study|Refused cont. medication|0|||
105479552|NCT01403948|363767561|FG009|Overall Study|Refused cont. medication|1|||
105479553|NCT01403948|363767552|FG000|Overall Study|other than above|1|||
105479554|NCT01403948|363767553|FG001|Overall Study|other than above|2|||
105479555|NCT01403948|363767554|FG002|Overall Study|other than above|1|||
105479556|NCT01403948|363767555|FG003|Overall Study|other than above|0|||
105479557|NCT01403948|363767556|FG004|Overall Study|other than above|1|||
105479558|NCT01403948|363767557|FG005|Overall Study|other than above|1|||
105479559|NCT01403948|363767558|FG006|Overall Study|other than above|2|||
105479560|NCT01403948|363767559|FG007|Overall Study|other than above|0|||
105479561|NCT01403948|363767560|FG008|Overall Study|other than above|0|||
105479562|NCT01403948|363767561|FG009|Overall Study|other than above|0|||
105479563|NCT03726996|363767562|FG000|Overall Study|Parent's decision|2|||
105479564|NCT03726996|363767562|FG000|Overall Study|Study early termination|2|||
105479565|NCT00600119|363767563|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
105479566|NCT00600119|363767564|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
105479567|NCT00600119|363767565|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
105479568|NCT00600119|363767566|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
105479569|NCT00600119|363767567|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
105479570|NCT00600119|363767568|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
105479571|NCT00600119|363767563|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
105479572|NCT00600119|363767564|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
105479573|NCT00600119|363767565|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
105479574|NCT00600119|363767566|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
105479575|NCT00600119|363767567|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
105479576|NCT00600119|363767568|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
105479577|NCT00600119|363767563|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
105479578|NCT00600119|363767564|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
105479579|NCT00600119|363767565|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
105479580|NCT00600119|363767566|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
105479581|NCT00600119|363767567|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
105479582|NCT00600119|363767568|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
105479583|NCT00600119|363767563|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
105479584|NCT00600119|363767564|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
105479585|NCT00600119|363767565|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
105479586|NCT00600119|363767566|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
105479587|NCT00600119|363767567|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
105564381|NCT02856113|364063067|FG001|Overall Study|Significant Protocol Deviation|0|||
105564382|NCT02856113|364063066|FG000|Overall Study|Lost to Follow-up|3|||
105564383|NCT02856113|364063067|FG001|Overall Study|Lost to Follow-up|5|||
105564384|NCT02856113|364063066|FG000|Overall Study|Voluntary Withdrawal|3|||
105564385|NCT02856113|364063067|FG001|Overall Study|Voluntary Withdrawal|5|||
105564386|NCT02856113|364063066|FG000|Overall Study|Pregnancy|0|||
105564387|NCT02856113|364063067|FG001|Overall Study|Pregnancy|1|||
105564388|NCT02856113|364063066|FG000|Overall Study|Principal Investigator Discretion|2|||
105564389|NCT02856113|364063067|FG001|Overall Study|Principal Investigator Discretion|1|||
105564390|NCT02856113|364063066|FG000|Overall Study|Randomized but not Treated|1|||
105564391|NCT02856113|364063067|FG001|Overall Study|Randomized but not Treated|0|||
105564392|NCT02856113|364063066|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
105564393|NCT02856113|364063067|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
105564394|NCT02857426|364063068|FG000|Overall Study|Disease progression|34|||
105564395|NCT02857426|364063069|FG001|Overall Study|Disease progression|13|||
105564396|NCT02857426|364063068|FG000|Overall Study|Study drug toxicity|4|||
105564397|NCT02857426|364063069|FG001|Overall Study|Study drug toxicity|1|||
105564398|NCT02857426|364063068|FG000|Overall Study|Death|1|||
105564399|NCT02857426|364063069|FG001|Overall Study|Death|0|||
105564400|NCT02857426|364063068|FG000|Overall Study|Adverse event unrelated to study drug|6|||
105564401|NCT02857426|364063069|FG001|Overall Study|Adverse event unrelated to study drug|2|||
105564402|NCT02857426|364063068|FG000|Overall Study|Participant withdrew consent|1|||
105564403|NCT02857426|364063069|FG001|Overall Study|Participant withdrew consent|1|||
105564404|NCT02857426|364063068|FG000|Overall Study|Maximum clinical benefit|1|||
105564405|NCT02857426|364063069|FG001|Overall Study|Maximum clinical benefit|0|||
105564406|NCT02857426|364063068|FG000|Overall Study|Completed treatment|0|||
105564407|NCT02857426|364063069|FG001|Overall Study|Completed treatment|2|||
105564408|NCT04252742|364063072|FG000|Overall Study|Decision by sponsor|0|||
105564409|NCT04252742|364063073|FG001|Overall Study|Decision by sponsor|2|||
105726752|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105726753|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105726754|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105726755|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105726756|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105726757|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
105726758|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
105726759|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105726760|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105726761|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105726762|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105726763|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
105726764|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
105726765|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105726766|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
105726767|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105726768|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105726769|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105726770|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105726771|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105726772|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
105726773|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
105726774|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
105564410|NCT04252742|364063072|FG000|Overall Study|Withdrawal by Subject|15|||
105564411|NCT04252742|364063073|FG001|Overall Study|Withdrawal by Subject|9|||
105726775|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
105726776|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
105726777|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
105726778|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
105726779|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
105726780|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
105726781|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
105726782|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
105726783|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
105726784|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
105726785|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
105726786|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
105726787|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
105564412|NCT04252742|364063072|FG000|Overall Study|Lost to Follow-up|0|||
105564413|NCT04252742|364063073|FG001|Overall Study|Lost to Follow-up|1|||
105726788|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
105726789|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
105726790|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
105726791|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
105726792|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
105726793|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
105726794|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
105726795|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
105726796|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
105726797|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
105726798|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
105726799|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
105564414|NCT04899245|364063074|FG000|Overall Study|Withdrawal by Subject|3|||
105564415|NCT04899245|364063075|FG001|Overall Study|Withdrawal by Subject|5|||
105564416|NCT04899245|364063076|FG002|Overall Study|Withdrawal by Subject|2|||
105564417|NCT04899245|364063074|FG000|Overall Study|No longer eligible - Left staff position|0|||
105564418|NCT04899245|364063075|FG001|Overall Study|No longer eligible - Left staff position|0|||
105564419|NCT04899245|364063076|FG002|Overall Study|No longer eligible - Left staff position|1|||
105564420|NCT04899245|364063074|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
105564421|NCT04899245|364063075|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
105564422|NCT04899245|364063076|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
105564423|NCT04899245|364063074|FG000|Overall Study|No longer eligible - Moved away from area|2|||
105564424|NCT04899245|364063075|FG001|Overall Study|No longer eligible - Moved away from area|2|||
105564425|NCT04899245|364063076|FG002|Overall Study|No longer eligible - Moved away from area|0|||
105564426|NCT04987762|364063077|FG000|Overall Study|Study was Terminated by Sponsor|103|||
105564427|NCT03185481|364063080|FG000|Overall Study|Adverse Event|1|||
105564428|NCT03185481|364063080|FG000|Overall Study|Study Terminated by Sponsor|4|||
105564429|NCT02390531|364063084|FG000|Overall Study|Death|0|||
105564430|NCT02390531|364063085|FG001|Overall Study|Death|2|||
105564431|NCT02390531|364063086|FG002|Overall Study|Death|0|||
105564432|NCT02390531|364063087|FG003|Overall Study|Death|1|||
105564433|NCT02390531|364063088|FG004|Overall Study|Death|0|||
105564434|NCT02390531|364063089|FG005|Overall Study|Death|0|||
105564435|NCT02390531|364063090|FG006|Overall Study|Death|0|||
105564436|NCT02390531|364063091|FG007|Overall Study|Death|1|||
105564437|NCT02390531|364063084|FG000|Overall Study|Protocol Violation|0|||
105564438|NCT02390531|364063085|FG001|Overall Study|Protocol Violation|0|||
105564439|NCT02390531|364063086|FG002|Overall Study|Protocol Violation|0|||
105564440|NCT02390531|364063087|FG003|Overall Study|Protocol Violation|0|||
105564441|NCT02390531|364063088|FG004|Overall Study|Protocol Violation|1|||
105564442|NCT02390531|364063089|FG005|Overall Study|Protocol Violation|0|||
105564443|NCT02390531|364063090|FG006|Overall Study|Protocol Violation|2|||
105564444|NCT02390531|364063091|FG007|Overall Study|Protocol Violation|0|||
105564445|NCT00558064|364063093|FG000|Overall Study|Adverse Event|3|||
105564446|NCT00558064|364063094|FG001|Overall Study|Adverse Event|2|||
105564447|NCT00558064|364063093|FG000|Overall Study|Lack of Efficacy|0|||
105726800|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
105726801|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105726802|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
105726803|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
105726804|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105726805|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105726806|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105726807|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105794843|NCT04881448|364903902|FG000|Overall Study|Withdrawal by Subject|2|||
105564448|NCT00558064|364063094|FG001|Overall Study|Lack of Efficacy|1|||
105564449|NCT00558064|364063093|FG000|Overall Study|Protocol Violation|1|||
105564450|NCT00558064|364063094|FG001|Overall Study|Protocol Violation|0|||
105564451|NCT00558064|364063093|FG000|Overall Study|Lost to Follow-up|0|||
105564452|NCT00558064|364063094|FG001|Overall Study|Lost to Follow-up|1|||
105564453|NCT00558064|364063093|FG000|Overall Study|Withdrawal by Subject|0|||
105564454|NCT00558064|364063094|FG001|Overall Study|Withdrawal by Subject|1|||
105564455|NCT00558064|364063093|FG000|Overall Study|No visit within allowance period|1|||
105564456|NCT00558064|364063094|FG001|Overall Study|No visit within allowance period|0|||
105564457|NCT00982930|364063098|FG000|Overall Study|Adverse Event|1|||
105564458|NCT00982930|364063098|FG000|Overall Study|Withdrawal by Subject|1|||
105564459|NCT00982930|364063098|FG000|Overall Study|Administrative Problems|2|||
105564460|NCT00949884|364065189|FG000|Overall Study|Adverse Event|14|||
105564461|NCT00949884|364065190|FG001|Overall Study|Adverse Event|3|||
105564462|NCT00949884|364065191|FG002|Overall Study|Adverse Event|12|||
105564463|NCT00949884|364065189|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
105564464|NCT00949884|364065190|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
105564465|NCT00949884|364065191|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
105794844|NCT04881448|364903902|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
105564466|NCT00949884|364065189|FG000|Overall Study|Lost to Follow-up|7|||
105564467|NCT00949884|364065190|FG001|Overall Study|Lost to Follow-up|5|||
105564468|NCT00949884|364065191|FG002|Overall Study|Lost to Follow-up|5|||
105564469|NCT00949884|364065189|FG000|Overall Study|Physician Decision|5|||
105564470|NCT00949884|364065190|FG001|Overall Study|Physician Decision|0|||
105564471|NCT00949884|364065191|FG002|Overall Study|Physician Decision|6|||
105564472|NCT00949884|364065189|FG000|Overall Study|Treatment non-compliance|5|||
105564473|NCT00949884|364065190|FG001|Overall Study|Treatment non-compliance|0|||
105564474|NCT00949884|364065191|FG002|Overall Study|Treatment non-compliance|8|||
105564475|NCT00949884|364065189|FG000|Overall Study|Withdrawal by Subject|13|||
105564476|NCT00949884|364065190|FG001|Overall Study|Withdrawal by Subject|4|||
105564477|NCT00949884|364065191|FG002|Overall Study|Withdrawal by Subject|16|||
105564478|NCT00949884|364065189|FG000|Overall Study|Lack of Efficacy|4|||
105564479|NCT00949884|364065190|FG001|Overall Study|Lack of Efficacy|2|||
105564480|NCT00949884|364065191|FG002|Overall Study|Lack of Efficacy|7|||
105564481|NCT00949884|364065189|FG000|Overall Study|Study terminated by sponsor|0|||
105564482|NCT00949884|364065190|FG001|Overall Study|Study terminated by sponsor|0|||
105564483|NCT00949884|364065191|FG002|Overall Study|Study terminated by sponsor|1|||
105564484|NCT01953003|364065192|FG000|Overall Study|Not treated|0|||
105564485|NCT01953003|364065193|FG001|Overall Study|Not treated|1|||
105726808|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
105726809|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
105726810|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105726811|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
105726812|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
105726813|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105726814|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105726815|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105726816|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105726817|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
105726818|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
105726819|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105726820|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
105726821|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105726822|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105726823|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105726824|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105726825|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105726826|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
105726827|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105726828|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105726829|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
105726830|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105726831|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105726832|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105726833|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105726834|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105726835|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105794845|NCT03273257|364903903|FG000|Overall Study|Death|0|||
105794846|NCT03273257|364903904|FG001|Overall Study|Death|1|||
105564486|NCT01953003|364065192|FG000|Overall Study|Progressive disease|35|||
105564487|NCT01953003|364065193|FG001|Overall Study|Progressive disease|45|||
105564488|NCT01953003|364065192|FG000|Overall Study|Related Adverse events|7|||
105564489|NCT01953003|364065193|FG001|Overall Study|Related Adverse events|2|||
105564490|NCT01953003|364065192|FG000|Overall Study|Non-related adverse events|0|||
105564491|NCT01953003|364065193|FG001|Overall Study|Non-related adverse events|2|||
105564492|NCT01953003|364065192|FG000|Overall Study|Protocol Violation|0|||
105564493|NCT01953003|364065193|FG001|Overall Study|Protocol Violation|1|||
105564494|NCT01953003|364065192|FG000|Overall Study|Withdrawal by Subject|14|||
105564495|NCT01953003|364065193|FG001|Overall Study|Withdrawal by Subject|4|||
105564496|NCT04737109|364065194|FG000|Study Treatment|Disease Progression|5|||
105564497|NCT04737109|364065195|FG001|Study Treatment|Disease Progression|0|||
105564498|NCT04737109|364065196|FG002|Study Treatment|Disease Progression|0|||
105564499|NCT04737109|364065197|FG003|Study Treatment|Disease Progression|0|||
105564500|NCT04737109|364065194|FG000|Study Treatment|Death on study|1|||
105564501|NCT04737109|364065195|FG001|Study Treatment|Death on study|0|||
105564502|NCT04737109|364065196|FG002|Study Treatment|Death on study|0|||
105564503|NCT04737109|364065197|FG003|Study Treatment|Death on study|0|||
105564504|NCT01464021|364065202|FG000|Overall Study|Withdrawal by Subject|13|||
105564505|NCT01464021|364065202|FG000|Overall Study|Lost to Follow-up|1|||
105564506|NCT01464021|364065202|FG000|Overall Study|Lack of Efficacy|1|||
105564507|NCT01464021|364065202|FG000|Overall Study|various|11|||
105564508|NCT00949715|364065203|FG000|Overall Study|Physician Decision|1|||
105564509|NCT00949715|364065204|FG001|Overall Study|Physician Decision|0|||
105564510|NCT00949715|364065203|FG000|Overall Study|Lost to Follow-up|1|||
105564511|NCT00949715|364065204|FG001|Overall Study|Lost to Follow-up|0|||
105564512|NCT00949715|364065203|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
105564513|NCT00949715|364065204|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
105564514|NCT04858802|364065205|FG000|Overall Study|Lost to Follow-up|1|||
105564515|NCT04858802|364065206|FG001|Overall Study|Lost to Follow-up|1|||
105564516|NCT04858802|364065205|FG000|Overall Study|Withdrawal by Subject|1|||
105564517|NCT04858802|364065206|FG001|Overall Study|Withdrawal by Subject|1|||
105564518|NCT03391765|364065207|FG000|Overall Study|Adverse Event|2|||
105564519|NCT03391765|364065208|FG001|Overall Study|Adverse Event|0|||
105564520|NCT03391765|364065209|FG002|Overall Study|Adverse Event|0|||
105564521|NCT03391765|364065210|FG003|Overall Study|Adverse Event|2|||
105564522|NCT03391765|364065207|FG000|Overall Study|Withdrew consent|5|||
105564523|NCT03391765|364065208|FG001|Overall Study|Withdrew consent|7|||
105564524|NCT03391765|364065209|FG002|Overall Study|Withdrew consent|2|||
105564525|NCT03391765|364065210|FG003|Overall Study|Withdrew consent|5|||
105564526|NCT03391765|364065207|FG000|Overall Study|Other, not specified|44|||
105564527|NCT03391765|364065208|FG001|Overall Study|Other, not specified|38|||
105564528|NCT03391765|364065209|FG002|Overall Study|Other, not specified|21|||
105564529|NCT03391765|364065210|FG003|Overall Study|Other, not specified|16|||
105564530|NCT01352585|364065213|FG000|Overall Study|Adverse Event|2|||
105564531|NCT01352585|364065214|FG001|Overall Study|Adverse Event|1|||
105564532|NCT01352585|364065213|FG000|Overall Study|Lost to Follow-up|1|||
105564533|NCT01352585|364065214|FG001|Overall Study|Lost to Follow-up|0|||
105564534|NCT01352585|364065213|FG000|Overall Study|Other|5|||
105564535|NCT01352585|364065214|FG001|Overall Study|Other|2|||
105564536|NCT02832622|364065217|FG000|Overall Study|MPP not programmed|1259|||
105564537|NCT02832622|364065217|FG000|Overall Study|Withdrawal by Subject|123|||
105564538|NCT02832622|364065217|FG000|Overall Study|Death|119|||
105564539|NCT02832622|364065217|FG000|Overall Study|Unsuccessful CRT implant|93|||
105564540|NCT02832622|364065217|FG000|Overall Study|Lost to Follow-up|45|||
105564541|NCT02832622|364065217|FG000|Overall Study|Patient non-compliance|42|||
105564542|NCT02832622|364065217|FG000|Overall Study|Withdrawal by other reasons|25|||
105564543|NCT02832622|364065217|FG000|Overall Study|System explant|24|||
105564544|NCT02832622|364065217|FG000|Overall Study|Physician Decision|6|||
105564545|NCT02243280|364065218|FG000|Treated|Adverse Event|1|||
105564546|NCT02243280|364065219|FG001|Treated|Adverse Event|0|||
105564547|NCT02243280|364065220|FG002|Treated|Adverse Event|0|||
105564548|NCT02243280|364065221|FG003|Treated|Adverse Event|0|||
105564549|NCT02243280|364065222|FG004|Treated|Adverse Event|0|||
105564550|NCT02243280|364065223|FG005|Treated|Adverse Event|0|||
105564551|NCT02243280|364065224|FG006|Treated|Adverse Event|0|||
105564552|NCT02243280|364065225|FG007|Treated|Adverse Event|0|||
105564553|NCT02243280|364065226|FG008|Treated|Adverse Event|0|||
105564554|NCT02243280|364065227|FG009|Treated|Adverse Event|0|||
105564555|NCT02243280|364065228|FG010|Treated|Adverse Event|1|||
105564556|NCT02243280|364065218|FG000|Treated|Lost to Follow-up|0|||
105564557|NCT02243280|364065219|FG001|Treated|Lost to Follow-up|0|||
105564558|NCT02243280|364065220|FG002|Treated|Lost to Follow-up|0|||
105564559|NCT02243280|364065221|FG003|Treated|Lost to Follow-up|0|||
105564560|NCT02243280|364065222|FG004|Treated|Lost to Follow-up|0|||
105564561|NCT02243280|364065223|FG005|Treated|Lost to Follow-up|0|||
105564562|NCT02243280|364065224|FG006|Treated|Lost to Follow-up|0|||
105564563|NCT02243280|364065225|FG007|Treated|Lost to Follow-up|0|||
105564564|NCT02243280|364065226|FG008|Treated|Lost to Follow-up|1|||
105564565|NCT02243280|364065227|FG009|Treated|Lost to Follow-up|0|||
105564566|NCT02243280|364065228|FG010|Treated|Lost to Follow-up|2|||
105564567|NCT04098406|364065233|FG000|Overall Study|Adverse Event|2|||
105564568|NCT04098406|364065234|FG001|Overall Study|Adverse Event|1|||
105564569|NCT04098406|364065233|FG000|Overall Study|Withdrawal by Subject|1|||
105564570|NCT04098406|364065234|FG001|Overall Study|Withdrawal by Subject|0|||
105564571|NCT03928028|364065237|FG000|Overall Study|Physician Decision|9|||
105726836|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105726837|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105726838|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
105726839|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105726840|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105726841|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105564572|NCT03928028|364065238|FG001|Overall Study|Physician Decision|6|||
105564573|NCT03928028|364065239|FG002|Overall Study|Physician Decision|3|||
105564574|NCT03928028|364065237|FG000|Overall Study|Withdrawal by Subject|12|||
105726842|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105564575|NCT03928028|364065238|FG001|Overall Study|Withdrawal by Subject|3|||
105564576|NCT03928028|364065239|FG002|Overall Study|Withdrawal by Subject|3|||
105564577|NCT02710292|364065244|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
105564578|NCT02710292|364065245|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
105564579|NCT02710292|364065244|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
105479588|NCT00600119|363767568|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
105479589|NCT00600119|363767563|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
105479590|NCT00600119|363767564|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
105479591|NCT00600119|363767565|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
105479592|NCT00600119|363767566|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
105479593|NCT00600119|363767567|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
105479594|NCT00600119|363767568|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
105479595|NCT00600119|363767563|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
105479596|NCT00600119|363767564|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
105479597|NCT00600119|363767565|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
105479598|NCT00600119|363767566|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
105479599|NCT00600119|363767567|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
105479600|NCT00600119|363767568|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
105479601|NCT00600119|363767563|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
105479602|NCT00600119|363767564|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
105479603|NCT00600119|363767565|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105479604|NCT00600119|363767566|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
105479605|NCT00600119|363767567|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
105479606|NCT00600119|363767568|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
105479607|NCT00600119|363767563|FG000|Double-blind Treatment Period|Other|0|||
105479608|NCT00600119|363767564|FG001|Double-blind Treatment Period|Other|0|||
105479609|NCT00600119|363767565|FG002|Double-blind Treatment Period|Other|0|||
105479610|NCT00600119|363767566|FG003|Double-blind Treatment Period|Other|0|||
105479611|NCT00600119|363767567|FG004|Double-blind Treatment Period|Other|2|||
105479612|NCT00600119|363767568|FG005|Double-blind Treatment Period|Other|1|||
105479613|NCT00600119|363767563|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
105479614|NCT00600119|363767564|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
105479615|NCT00600119|363767565|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
105479616|NCT00600119|363767566|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
105479617|NCT00600119|363767567|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
105479618|NCT00600119|363767568|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
105479619|NCT00600119|363767563|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
105479620|NCT00600119|363767564|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
105479621|NCT00600119|363767565|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
105479622|NCT00600119|363767566|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
105479623|NCT00600119|363767567|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
105479624|NCT00600119|363767568|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
105479625|NCT00600119|363767563|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
105479626|NCT00600119|363767564|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
105479627|NCT00600119|363767565|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
105479628|NCT00600119|363767566|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
105479629|NCT00600119|363767567|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
105479630|NCT00600119|363767568|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
105479631|NCT00600119|363767563|FG000|Double-blind Treatment Period|Physician Decision|2|||
105479632|NCT00600119|363767564|FG001|Double-blind Treatment Period|Physician Decision|0|||
105479633|NCT00600119|363767565|FG002|Double-blind Treatment Period|Physician Decision|0|||
105479634|NCT00600119|363767566|FG003|Double-blind Treatment Period|Physician Decision|0|||
105479635|NCT00600119|363767567|FG004|Double-blind Treatment Period|Physician Decision|0|||
105479636|NCT00600119|363767568|FG005|Double-blind Treatment Period|Physician Decision|0|||
105479637|NCT00600119|363767563|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
105479638|NCT00600119|363767564|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
105479639|NCT00600119|363767565|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
105479640|NCT00600119|363767566|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
105479641|NCT00600119|363767567|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
105479642|NCT00600119|363767568|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
105479643|NCT00600119|363767563|FG000|Double-blind Treatment Period|Adverse Event|1|||
105479644|NCT00600119|363767564|FG001|Double-blind Treatment Period|Adverse Event|1|||
105479645|NCT00600119|363767565|FG002|Double-blind Treatment Period|Adverse Event|0|||
105479646|NCT00600119|363767566|FG003|Double-blind Treatment Period|Adverse Event|1|||
105479647|NCT00600119|363767567|FG004|Double-blind Treatment Period|Adverse Event|2|||
105479648|NCT00600119|363767568|FG005|Double-blind Treatment Period|Adverse Event|10|||
105479649|NCT00600119|363767563|FG000|Follow-up Period|Adverse Event|0|||
105479650|NCT00600119|363767564|FG001|Follow-up Period|Adverse Event|0|||
105479651|NCT00600119|363767565|FG002|Follow-up Period|Adverse Event|0|||
105479652|NCT00600119|363767566|FG003|Follow-up Period|Adverse Event|0|||
105479653|NCT00600119|363767567|FG004|Follow-up Period|Adverse Event|0|||
105479654|NCT00600119|363767568|FG005|Follow-up Period|Adverse Event|1|||
105564580|NCT02710292|364065245|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
105564581|NCT00800202|364065246|FG000|Overall Study|Adverse Event|7|||
105564582|NCT00800202|364065247|FG001|Overall Study|Adverse Event|6|||
105564583|NCT00800202|364065246|FG000|Overall Study|Death|1|||
105564584|NCT00800202|364065247|FG001|Overall Study|Death|0|||
105564585|NCT00800202|364065246|FG000|Overall Study|Other|5|||
105564586|NCT00800202|364065247|FG001|Overall Study|Other|0|||
105564587|NCT00800202|364065246|FG000|Overall Study|Disease Progression|54|||
105564588|NCT00800202|364065247|FG001|Overall Study|Disease Progression|18|||
105564589|NCT02127372|364065250|FG000|Overall Study|Withdrawal by Subject|1|||
105564590|NCT02127372|364065251|FG001|Overall Study|Withdrawal by Subject|0|||
105564591|NCT01392300|364065255|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
105564592|NCT01392300|364065256|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
105564593|NCT01392300|364065257|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
105564594|NCT01392300|364065255|FG000|Main Period (MP)|Withdrawal by Subject|5|||
105726843|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105726844|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105726845|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
105726846|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105726847|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
105564595|NCT01392300|364065256|FG001|Main Period (MP)|Withdrawal by Subject|1|||
105564596|NCT01392300|364065257|FG002|Main Period (MP)|Withdrawal by Subject|0|||
105564597|NCT01392300|364065255|FG000|Main Period (MP)|Lost to Follow-up|3|||
105564598|NCT01392300|364065256|FG001|Main Period (MP)|Lost to Follow-up|3|||
105564599|NCT01392300|364065257|FG002|Main Period (MP)|Lost to Follow-up|0|||
105564600|NCT01392300|364065255|FG000|Main Period (MP)|Non-compliance|1|||
105564601|NCT01392300|364065256|FG001|Main Period (MP)|Non-compliance|0|||
105564602|NCT01392300|364065257|FG002|Main Period (MP)|Non-compliance|0|||
105564603|NCT01392300|364065255|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
105564604|NCT01392300|364065256|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
105564605|NCT01392300|364065257|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
105564606|NCT01392300|364065255|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
105564607|NCT01392300|364065256|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
105564608|NCT01392300|364065257|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
105564609|NCT01392300|364065255|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
105564610|NCT01392300|364065256|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
105564611|NCT01392300|364065257|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
105564612|NCT01392300|364065255|FG000|Open Label Extension (OLEX) Period|Death|0|||
105564613|NCT01392300|364065256|FG001|Open Label Extension (OLEX) Period|Death|0|||
105564614|NCT01392300|364065257|FG002|Open Label Extension (OLEX) Period|Death|4|||
105564615|NCT01392300|364065255|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
105564616|NCT01392300|364065256|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
105564617|NCT01392300|364065257|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
105564618|NCT01392300|364065255|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
105564619|NCT01392300|364065256|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
105564620|NCT01392300|364065257|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
105564621|NCT01392300|364065255|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
105726848|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
105726849|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105726850|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105726851|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105726852|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105726853|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
105726854|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
105726855|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105726856|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105726857|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
105564622|NCT01392300|364065256|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
105564623|NCT01392300|364065257|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
105564624|NCT01493687|364065258|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
105564625|NCT01493687|364065259|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
105564626|NCT01493687|364065258|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
105794847|NCT03273257|364903903|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
105794848|NCT03273257|364903904|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
105794849|NCT03273257|364903903|FG000|Overall Study|Study terminated|3|||
105794850|NCT03273257|364903904|FG001|Overall Study|Study terminated|2|||
105794851|NCT01238172|364903906|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
105794852|NCT01238172|364903907|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
105794853|NCT01238172|364903906|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
105794854|NCT01238172|364903907|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
105794855|NCT00701558|364903909|FG000|Overall Study|Death|7|||
105794856|NCT00701558|364903909|FG000|Overall Study|Lost to Follow-up|8|||
105794857|NCT01784419|364905928|FG000|Overall Study|Adverse Event|3|||
105794858|NCT00366678|364905929|FG000|Infant Series|Withdrawal by Subject|8|||
105794859|NCT00366678|364905930|FG001|Infant Series|Withdrawal by Subject|6|||
105794860|NCT00366678|364905931|FG002|Infant Series|Withdrawal by Subject|0|||
105794861|NCT00366678|364905929|FG000|Infant Series|Protocol Violation|4|||
105794862|NCT00366678|364905930|FG001|Infant Series|Protocol Violation|3|||
105794863|NCT00366678|364905931|FG002|Infant Series|Protocol Violation|0|||
105794864|NCT00366678|364905929|FG000|Infant Series|Failed to return|1|||
105794865|NCT00366678|364905930|FG001|Infant Series|Failed to return|1|||
105794866|NCT00366678|364905931|FG002|Infant Series|Failed to return|0|||
105794867|NCT00366678|364905929|FG000|Infant Series|Adverse Event|1|||
105794868|NCT00366678|364905930|FG001|Infant Series|Adverse Event|0|||
105794869|NCT00366678|364905931|FG002|Infant Series|Adverse Event|0|||
105794870|NCT00366678|364905929|FG000|After Infant|Withdrawal by Subject|8|||
105794871|NCT00366678|364905930|FG001|After Infant|Withdrawal by Subject|4|||
105794872|NCT00366678|364905931|FG002|After Infant|Withdrawal by Subject|0|||
105794873|NCT00366678|364905929|FG000|After Infant|Lost to Follow-up|2|||
105794874|NCT00366678|364905930|FG001|After Infant|Lost to Follow-up|1|||
105794875|NCT00366678|364905931|FG002|After Infant|Lost to Follow-up|0|||
105794876|NCT00366678|364905929|FG000|After Infant|Failed to return|5|||
105794877|NCT00366678|364905930|FG001|After Infant|Failed to return|5|||
105794878|NCT00366678|364905931|FG002|After Infant|Failed to return|0|||
105794879|NCT00366678|364905929|FG000|After Infant|Adverse Event|1|||
105794880|NCT00366678|364905930|FG001|After Infant|Adverse Event|0|||
105794881|NCT00366678|364905931|FG002|After Infant|Adverse Event|0|||
105794882|NCT00366678|364905929|FG000|After Infant|Protocol Violation|1|||
105794883|NCT00366678|364905930|FG001|After Infant|Protocol Violation|0|||
105794884|NCT00366678|364905931|FG002|After Infant|Protocol Violation|0|||
105794885|NCT00366678|364905929|FG000|Toddler Dose|Protocol Violation|2|||
105794886|NCT00366678|364905930|FG001|Toddler Dose|Protocol Violation|1|||
105794887|NCT00366678|364905931|FG002|Toddler Dose|Protocol Violation|0|||
105794888|NCT00366678|364905929|FG000|Toddler Dose|Failed to return|1|||
105794889|NCT00366678|364905930|FG001|Toddler Dose|Failed to return|0|||
105794890|NCT00366678|364905931|FG002|Toddler Dose|Failed to return|0|||
105794891|NCT00366678|364905929|FG000|Toddler Dose|Withdrawal by Subject|1|||
105794892|NCT00366678|364905930|FG001|Toddler Dose|Withdrawal by Subject|0|||
105794893|NCT00366678|364905931|FG002|Toddler Dose|Withdrawal by Subject|0|||
105794894|NCT00366678|364905929|FG000|Toddler Dose|protocol deviation|1|||
105794895|NCT00366678|364905930|FG001|Toddler Dose|protocol deviation|0|||
105794896|NCT00366678|364905931|FG002|Toddler Dose|protocol deviation|0|||
105794897|NCT01777191|364905932|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
105794898|NCT01777191|364905933|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
105794899|NCT01777191|364905932|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
105794900|NCT01777191|364905933|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
105794901|NCT01777191|364905932|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
105794902|NCT01777191|364905933|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
105794903|NCT01777191|364905932|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
105794904|NCT01777191|364905933|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
105794905|NCT01777191|364905932|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
105794906|NCT01777191|364905933|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
105794907|NCT01777191|364905932|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
105794908|NCT01777191|364905933|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
105794909|NCT01777191|364905932|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
105794910|NCT01777191|364905933|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
105794911|NCT01777191|364905932|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
105794912|NCT01777191|364905933|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
105794913|NCT01777191|364905932|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
105794914|NCT01777191|364905933|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
105794915|NCT01777191|364905932|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
105794916|NCT01777191|364905933|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
105794917|NCT01777191|364905932|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
105564627|NCT01493687|364065259|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
105564628|NCT01493687|364065258|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
105564629|NCT01493687|364065259|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
105564630|NCT01493687|364065258|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
105564631|NCT01493687|364065259|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
105564632|NCT01493687|364065258|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
105564633|NCT01493687|364065259|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
105726858|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105564634|NCT01493687|364065258|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
105564635|NCT01493687|364065259|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
105564636|NCT01493687|364065258|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
105564637|NCT01493687|364065259|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
105564638|NCT01493687|364065258|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
105564639|NCT01493687|364065259|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
105564640|NCT01493687|364065258|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
105564641|NCT01493687|364065259|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
105564642|NCT01493687|364065258|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
105564643|NCT01493687|364065259|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
105564644|NCT01493687|364065258|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
105564645|NCT01493687|364065259|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
105564646|NCT01493687|364065258|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
105564647|NCT01493687|364065259|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
105564648|NCT01493687|364065258|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
105564649|NCT01493687|364065259|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
105564650|NCT01493687|364065258|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
105564651|NCT01493687|364065259|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
105564652|NCT01493687|364065258|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
105564653|NCT01493687|364065259|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
105564654|NCT02691182|364065266|FG000|Overall Study|Withdrawal by Subject|4|||
105564655|NCT02691182|364065267|FG001|Overall Study|Withdrawal by Subject|7|||
105564656|NCT02691182|364065268|FG002|Overall Study|Withdrawal by Subject|6|||
105564657|NCT02691182|364065269|FG003|Overall Study|Withdrawal by Subject|8|||
105564658|NCT02691182|364065266|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
105564659|NCT02691182|364065267|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
105564660|NCT02691182|364065268|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
105564661|NCT02691182|364065269|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
105564662|NCT02691182|364065266|FG000|Overall Study|Lost to Follow-up|8|||
105564663|NCT02691182|364065267|FG001|Overall Study|Lost to Follow-up|33|||
105564664|NCT02691182|364065268|FG002|Overall Study|Lost to Follow-up|19|||
105564665|NCT02691182|364065269|FG003|Overall Study|Lost to Follow-up|22|||
105564666|NCT02691182|364065266|FG000|Overall Study|Adverse Event|3|||
105564667|NCT02691182|364065267|FG001|Overall Study|Adverse Event|10|||
105564668|NCT02691182|364065268|FG002|Overall Study|Adverse Event|10|||
105564669|NCT02691182|364065269|FG003|Overall Study|Adverse Event|11|||
105564670|NCT02691182|364065266|FG000|Overall Study|Physician Decision|3|||
105564671|NCT02691182|364065267|FG001|Overall Study|Physician Decision|7|||
105564672|NCT02691182|364065268|FG002|Overall Study|Physician Decision|14|||
105564673|NCT02691182|364065269|FG003|Overall Study|Physician Decision|8|||
105564674|NCT02691182|364065266|FG000|Overall Study|Lack of Efficacy|0|||
105564675|NCT02691182|364065267|FG001|Overall Study|Lack of Efficacy|0|||
105564676|NCT02691182|364065268|FG002|Overall Study|Lack of Efficacy|0|||
105564677|NCT02691182|364065269|FG003|Overall Study|Lack of Efficacy|4|||
105564678|NCT02691182|364065266|FG000|Overall Study|Protocol Violation|2|||
105564679|NCT02691182|364065267|FG001|Overall Study|Protocol Violation|6|||
105564680|NCT02691182|364065268|FG002|Overall Study|Protocol Violation|6|||
105726859|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105726860|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105726861|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105726862|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105726863|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105726864|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726865|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726866|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726867|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726868|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726869|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726870|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726871|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
105726872|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726873|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105726874|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
105794918|NCT01777191|364905933|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
105794919|NCT00934622|364905935|FG000|Overall Study|Lost to Follow-up|7|||
105564681|NCT02691182|364065269|FG003|Overall Study|Protocol Violation|8|||
105564682|NCT02691182|364065266|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
105564683|NCT02691182|364065267|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
105564684|NCT02691182|364065268|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
105564685|NCT02691182|364065269|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
105564686|NCT02691182|364065266|FG000|Overall Study|Missing|0|||
105564687|NCT02691182|364065267|FG001|Overall Study|Missing|5|||
105564688|NCT02691182|364065268|FG002|Overall Study|Missing|1|||
105564689|NCT02691182|364065269|FG003|Overall Study|Missing|5|||
105564690|NCT00420199|364065270|FG000|Overall Study|Participant no longer met study criteria|1|||
105564691|NCT00420199|364065271|FG001|Overall Study|Participant no longer met study criteria|0|||
105564692|NCT00266825|364065273|FG000|Completed Follow-Up|Lost to Follow-up|14|||
105564693|NCT00266825|364065274|FG001|Completed Follow-Up|Lost to Follow-up|19|||
105564694|NCT00266825|364065273|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
105564695|NCT00266825|364065274|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
105564696|NCT01078155|364065275|FG000|Overall Study|Adverse Event|7|||
105564697|NCT01078155|364065275|FG000|Overall Study|Lack of Efficacy|16|||
105564698|NCT01078155|364065275|FG000|Overall Study|Participant's Decision|6|||
105564699|NCT01078155|364065275|FG000|Overall Study|Lost to Follow-up|15|||
105564700|NCT03286751|364065276|FG000|Washout Period 1|Withdrawal by Subject|0|||
105564701|NCT03286751|364065277|FG001|Washout Period 1|Withdrawal by Subject|0|||
105564702|NCT03286751|364065278|FG002|Washout Period 1|Withdrawal by Subject|0|||
105564703|NCT03286751|364065279|FG003|Washout Period 1|Withdrawal by Subject|0|||
105564704|NCT03286751|364065280|FG004|Washout Period 1|Withdrawal by Subject|1|||
105564705|NCT03286751|364065281|FG005|Washout Period 1|Withdrawal by Subject|0|||
105564706|NCT03286751|364065276|FG000|Washout Period 2|Personal Reasons|0|||
105564707|NCT03286751|364065277|FG001|Washout Period 2|Personal Reasons|1|||
105564708|NCT03286751|364065278|FG002|Washout Period 2|Personal Reasons|0|||
105564709|NCT03286751|364065279|FG003|Washout Period 2|Personal Reasons|0|||
105564710|NCT03286751|364065280|FG004|Washout Period 2|Personal Reasons|0|||
105564711|NCT03286751|364065281|FG005|Washout Period 2|Personal Reasons|0|||
105564712|NCT03286751|364065276|FG000|Washout Period 5|Adverse Event|0|||
105564713|NCT03286751|364065277|FG001|Washout Period 5|Adverse Event|0|||
105564714|NCT03286751|364065278|FG002|Washout Period 5|Adverse Event|0|||
105564715|NCT03286751|364065279|FG003|Washout Period 5|Adverse Event|0|||
105564716|NCT03286751|364065280|FG004|Washout Period 5|Adverse Event|1|||
105564717|NCT03286751|364065281|FG005|Washout Period 5|Adverse Event|0|||
105564718|NCT02799784|364065282|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
105564719|NCT02799784|364065283|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
105564720|NCT02799784|364065282|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
105564721|NCT02799784|364065283|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
105564722|NCT02799784|364065282|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
105564723|NCT02799784|364065283|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
105564724|NCT02799784|364065282|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
105564725|NCT02799784|364065283|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
105564726|NCT02799784|364065282|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
105564727|NCT02799784|364065283|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
105564728|NCT02799784|364065282|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
105564729|NCT02799784|364065283|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
105564730|NCT01621880|364065284|FG000|Overall Study|Adverse Event|5|||
105564731|NCT01621880|364065285|FG001|Overall Study|Adverse Event|1|||
105564732|NCT01621880|364065284|FG000|Overall Study|Withdrawal by Subject|5|||
105564733|NCT01621880|364065285|FG001|Overall Study|Withdrawal by Subject|4|||
105564734|NCT01127646|364065286|FG000|Overall Study|Entry Criteria Not Met|1|||
105564735|NCT01127646|364065287|FG001|Overall Study|Entry Criteria Not Met|0|||
105564736|NCT01127646|364065286|FG000|Overall Study|Protocol Violation|0|||
105564737|NCT01127646|364065287|FG001|Overall Study|Protocol Violation|1|||
105564738|NCT02313909|364065290|FG000|Overall Study|Consent withdrawn by participant|33|||
105564739|NCT02313909|364065291|FG001|Overall Study|Consent withdrawn by participant|33|||
105564740|NCT02313909|364065290|FG000|Overall Study|Lost to Follow-up|24|||
105564741|NCT02313909|364065291|FG001|Overall Study|Lost to Follow-up|17|||
105564742|NCT00638235|364065292|FG000|Overall Study|Lost to Follow-up|31|||
105564743|NCT00638235|364065293|FG001|Overall Study|Lost to Follow-up|3|||
105564744|NCT00638235|364065294|FG002|Overall Study|Lost to Follow-up|18|||
105564745|NCT00638235|364065295|FG003|Overall Study|Lost to Follow-up|10|||
105564746|NCT00638235|364065296|FG004|Overall Study|Lost to Follow-up|13|||
105564747|NCT00638235|364065297|FG005|Overall Study|Lost to Follow-up|26|||
105564748|NCT00638235|364065298|FG006|Overall Study|Lost to Follow-up|0|||
105564749|NCT00638235|364065299|FG007|Overall Study|Lost to Follow-up|1|||
105564750|NCT00638235|364065300|FG008|Overall Study|Lost to Follow-up|18|||
105564751|NCT02923739|364065301|FG000|Overall Study|Withdrawal by Subject|2|||
105564752|NCT02923739|364065302|FG001|Overall Study|Withdrawal by Subject|0|||
105564753|NCT02923739|364065303|FG002|Overall Study|Withdrawal by Subject|0|||
105564754|NCT02923739|364065304|FG003|Overall Study|Withdrawal by Subject|0|||
105564755|NCT02923739|364065301|FG000|Overall Study|Failed Screening|3|||
105564756|NCT02923739|364065302|FG001|Overall Study|Failed Screening|0|||
105564757|NCT02923739|364065303|FG002|Overall Study|Failed Screening|0|||
105564758|NCT02923739|364065304|FG003|Overall Study|Failed Screening|0|||
105564759|NCT03086330|364065305|FG000|Overall Study|Withdrawal by Subject|3|||
105564760|NCT03086330|364065306|FG001|Overall Study|Withdrawal by Subject|2|||
105564761|NCT03086330|364065305|FG000|Overall Study|Lost to Follow-up|1|||
105564762|NCT03086330|364065306|FG001|Overall Study|Lost to Follow-up|2|||
105726875|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
105726876|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105726877|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105726878|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105726879|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105726880|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105726881|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
105726882|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105726883|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
105726884|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
105726885|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105726886|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105726887|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105726888|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105726889|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105726890|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105726891|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105726892|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
105726893|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
105726894|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105726895|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105726896|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105726897|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105726898|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105726899|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
105726900|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105726901|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
105726902|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105726903|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105726904|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105726905|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105726906|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105726907|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105794920|NCT00934622|364905935|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
105794921|NCT01128153|364905942|FG000|Overall Study|Adverse Event|1|||
105564763|NCT01376323|364065307|FG000|Overall Study|Adverse Event|1|||
105794922|NCT01128153|364905943|FG001|Overall Study|Adverse Event|3|||
105564764|NCT01376323|364065308|FG001|Overall Study|Adverse Event|0|||
105564765|NCT01376323|364065309|FG002|Overall Study|Adverse Event|0|||
105564766|NCT01376323|364065310|FG003|Overall Study|Adverse Event|2|||
105794923|NCT01128153|364905942|FG000|Overall Study|Condition under investigation worsened|8|||
105794924|NCT01128153|364905943|FG001|Overall Study|Condition under investigation worsened|7|||
105794925|NCT01128153|364905942|FG000|Overall Study|Withdrawal by Subject|2|||
105794926|NCT01128153|364905943|FG001|Overall Study|Withdrawal by Subject|3|||
105794927|NCT01128153|364905942|FG000|Overall Study|Incorrect enrolment to study|2|||
105794928|NCT01128153|364905943|FG001|Overall Study|Incorrect enrolment to study|1|||
105794929|NCT01128153|364905942|FG000|Overall Study|Protocol Violation|2|||
105794930|NCT01128153|364905943|FG001|Overall Study|Protocol Violation|0|||
105794931|NCT01128153|364905942|FG000|Overall Study|Developed discontinuation criteria|1|||
105794932|NCT01128153|364905943|FG001|Overall Study|Developed discontinuation criteria|1|||
105794933|NCT02610842|364905958|FG000|Overall Study|Lost to Follow-up|5|||
105794934|NCT01988493|364905959|FG000|Overall Study|Randomized but not treated|0|||
105794935|NCT01988493|364905960|FG001|Overall Study|Randomized but not treated|0|||
105794936|NCT01988493|364905961|FG002|Overall Study|Randomized but not treated|0|||
105794937|NCT01988493|364905962|FG003|Overall Study|Randomized but not treated|0|||
105794938|NCT01988493|364905963|FG004|Overall Study|Randomized but not treated|1|||
105794939|NCT01766310|364905971|FG000|Overall Study|Lost to Follow-up|1|||
105794940|NCT01766310|364905972|FG001|Overall Study|Lost to Follow-up|3|||
105794941|NCT00481871|364905978|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
105794942|NCT00481871|364905979|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
105794943|NCT00481871|364905980|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
105794944|NCT00481871|364905981|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
105794945|NCT00481871|364905982|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
105794946|NCT01652872|364905986|FG000|Overall Study|Death|36|||
105794947|NCT01652872|364905987|FG001|Overall Study|Death|39|||
105794948|NCT01652872|364905986|FG000|Overall Study|Lost to Follow-up|28|||
105794949|NCT01652872|364905987|FG001|Overall Study|Lost to Follow-up|23|||
105794950|NCT01652872|364905986|FG000|Overall Study|Decision by sponsor|5|||
105794951|NCT01652872|364905987|FG001|Overall Study|Decision by sponsor|7|||
105794952|NCT01652872|364905986|FG000|Overall Study|Withdrawal by Subject|76|||
105794953|NCT01652872|364905987|FG001|Overall Study|Withdrawal by Subject|84|||
105794954|NCT04529096|364905988|FG000|Overall Study|Adverse Event|6|||
105794955|NCT04529096|364905989|FG001|Overall Study|Adverse Event|1|||
105794956|NCT04529096|364905988|FG000|Overall Study|Lack of Efficacy|1|||
105794957|NCT04529096|364905989|FG001|Overall Study|Lack of Efficacy|0|||
105794958|NCT04529096|364905988|FG000|Overall Study|Lost to Follow-up|1|||
105794959|NCT04529096|364905989|FG001|Overall Study|Lost to Follow-up|1|||
105794960|NCT04529096|364905988|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105794961|NCT04529096|364905989|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105794962|NCT04529096|364905988|FG000|Overall Study|Physician Decision|1|||
105794963|NCT04529096|364905989|FG001|Overall Study|Physician Decision|3|||
105794964|NCT04529096|364905988|FG000|Overall Study|Withdrawal by Subject|5|||
105794965|NCT04529096|364905989|FG001|Overall Study|Withdrawal by Subject|0|||
105794966|NCT00995488|364905990|FG000|Overall Study|Withdrawal by Subject|1|||
105794967|NCT01289990|364905994|FG000|Overall Study|Death|0|||
105794968|NCT01289990|364905995|FG001|Overall Study|Death|0|||
105794969|NCT01289990|364905996|FG002|Overall Study|Death|0|||
105794970|NCT01289990|364905997|FG003|Overall Study|Death|1|||
105794971|NCT01289990|364905998|FG004|Overall Study|Death|2|||
105794972|NCT01289990|364905999|FG005|Overall Study|Death|1|||
105794973|NCT01289990|364906000|FG006|Overall Study|Death|0|||
105794974|NCT01289990|364906001|FG007|Overall Study|Death|0|||
105794975|NCT01289990|364906002|FG008|Overall Study|Death|0|||
105794976|NCT01289990|364906003|FG009|Overall Study|Death|0|||
105794977|NCT01289990|364906004|FG010|Overall Study|Death|0|||
105794978|NCT01289990|364906005|FG011|Overall Study|Death|1|||
105794979|NCT01289990|364906006|FG012|Overall Study|Death|0|||
105794980|NCT01289990|364905994|FG000|Overall Study|Lost to Follow-up|3|||
105794981|NCT01289990|364905995|FG001|Overall Study|Lost to Follow-up|2|||
105794982|NCT01289990|364905996|FG002|Overall Study|Lost to Follow-up|5|||
105794983|NCT01289990|364905997|FG003|Overall Study|Lost to Follow-up|5|||
105794984|NCT01289990|364905998|FG004|Overall Study|Lost to Follow-up|3|||
105794985|NCT01289990|364905999|FG005|Overall Study|Lost to Follow-up|4|||
105794986|NCT01289990|364906000|FG006|Overall Study|Lost to Follow-up|2|||
105794987|NCT01289990|364906001|FG007|Overall Study|Lost to Follow-up|2|||
105794988|NCT01289990|364906002|FG008|Overall Study|Lost to Follow-up|1|||
105794989|NCT01289990|364906003|FG009|Overall Study|Lost to Follow-up|4|||
105794990|NCT01289990|364906004|FG010|Overall Study|Lost to Follow-up|2|||
105794991|NCT01289990|364906005|FG011|Overall Study|Lost to Follow-up|1|||
105794992|NCT01289990|364906006|FG012|Overall Study|Lost to Follow-up|2|||
105794993|NCT01289990|364905994|FG000|Overall Study|Withdrawal by Subject|15|||
105794994|NCT01289990|364905995|FG001|Overall Study|Withdrawal by Subject|14|||
105794995|NCT01289990|364905996|FG002|Overall Study|Withdrawal by Subject|12|||
105794996|NCT01289990|364905997|FG003|Overall Study|Withdrawal by Subject|13|||
105794997|NCT01289990|364905998|FG004|Overall Study|Withdrawal by Subject|8|||
105794998|NCT01289990|364905999|FG005|Overall Study|Withdrawal by Subject|7|||
105794999|NCT01289990|364906000|FG006|Overall Study|Withdrawal by Subject|13|||
105795000|NCT01289990|364906001|FG007|Overall Study|Withdrawal by Subject|9|||
105479655|NCT00600119|363767563|FG000|Follow-up Period|Other|1|||
105479656|NCT00600119|363767564|FG001|Follow-up Period|Other|0|||
105479657|NCT00600119|363767565|FG002|Follow-up Period|Other|0|||
105479658|NCT00600119|363767566|FG003|Follow-up Period|Other|0|||
105479659|NCT00600119|363767567|FG004|Follow-up Period|Other|0|||
105479660|NCT00600119|363767568|FG005|Follow-up Period|Other|0|||
105479661|NCT00729469|363767573|FG000|Overall Study|Adverse Event|14|||
105479662|NCT00729469|363767574|FG001|Overall Study|Adverse Event|25|||
105479663|NCT00729469|363767573|FG000|Overall Study|Lost to Follow-up|9|||
105479664|NCT00729469|363767574|FG001|Overall Study|Lost to Follow-up|9|||
105479665|NCT00729469|363767573|FG000|Overall Study|Protocol Violation|2|||
105479666|NCT00729469|363767574|FG001|Overall Study|Protocol Violation|1|||
105479667|NCT00729469|363767573|FG000|Overall Study|Withdrawal by Subject|19|||
105479668|NCT00729469|363767574|FG001|Overall Study|Withdrawal by Subject|8|||
105479669|NCT00729469|363767573|FG000|Overall Study|Other-Not mentioned|9|||
105479670|NCT00729469|363767574|FG001|Overall Study|Other-Not mentioned|4|||
105479671|NCT01566214|363767575|FG000|Overall Study|Lost to Follow-up|3|||
105479672|NCT01566214|363767576|FG001|Overall Study|Lost to Follow-up|0|||
105479673|NCT00561977|363767577|FG000|Overall Study|Withdrawal by Subject|0|||
105479674|NCT00561977|363767578|FG001|Overall Study|Withdrawal by Subject|2|||
105479675|NCT00561977|363767579|FG002|Overall Study|Withdrawal by Subject|1|||
105479676|NCT00561977|363767577|FG000|Overall Study|Pregnancy|0|||
105479677|NCT00561977|363767578|FG001|Overall Study|Pregnancy|1|||
105479678|NCT00561977|363767579|FG002|Overall Study|Pregnancy|1|||
105479679|NCT00393510|363767580|FG000|Overall Study|Physician Decision|3|||
105564767|NCT01376323|364065311|FG004|Overall Study|Adverse Event|0|||
105564768|NCT01376323|364065307|FG000|Overall Study|Lost to Follow-up|0|||
105564769|NCT01376323|364065308|FG001|Overall Study|Lost to Follow-up|0|||
105564770|NCT01376323|364065309|FG002|Overall Study|Lost to Follow-up|0|||
105564771|NCT01376323|364065310|FG003|Overall Study|Lost to Follow-up|2|||
105564772|NCT01376323|364065311|FG004|Overall Study|Lost to Follow-up|0|||
105564773|NCT01376323|364065307|FG000|Overall Study|Physician Decision|1|||
105564774|NCT01376323|364065308|FG001|Overall Study|Physician Decision|0|||
105564775|NCT01376323|364065309|FG002|Overall Study|Physician Decision|2|||
105564776|NCT01376323|364065310|FG003|Overall Study|Physician Decision|1|||
105564777|NCT01376323|364065311|FG004|Overall Study|Physician Decision|1|||
105564778|NCT01376323|364065307|FG000|Overall Study|Withdrawal by Subject|0|||
105564779|NCT01376323|364065308|FG001|Overall Study|Withdrawal by Subject|1|||
105564780|NCT01376323|364065309|FG002|Overall Study|Withdrawal by Subject|1|||
105564781|NCT01376323|364065310|FG003|Overall Study|Withdrawal by Subject|0|||
105564782|NCT01376323|364065311|FG004|Overall Study|Withdrawal by Subject|0|||
105564783|NCT01960725|364065312|FG000|Overall Study|Lost to Follow-up|4|||
105564784|NCT01960725|364065313|FG001|Overall Study|Lost to Follow-up|3|||
105564785|NCT01960725|364065312|FG000|Overall Study|Withdrawal by Subject|1|||
105564786|NCT01960725|364065313|FG001|Overall Study|Withdrawal by Subject|0|||
105564787|NCT01960725|364065312|FG000|Overall Study|unable to obtain blood sample|1|||
105564788|NCT01960725|364065313|FG001|Overall Study|unable to obtain blood sample|2|||
105564789|NCT00758459|364065315|FG000|Overall Study|Adverse Event|3|||
105564790|NCT00758459|364065316|FG001|Overall Study|Adverse Event|2|||
105564791|NCT00758459|364065315|FG000|Overall Study|Protocol Violation|0|||
105564792|NCT00758459|364065316|FG001|Overall Study|Protocol Violation|1|||
105564793|NCT00758459|364065315|FG000|Overall Study|Withdrawal by Subject|0|||
105564794|NCT00758459|364065316|FG001|Overall Study|Withdrawal by Subject|1|||
105564795|NCT04766086|364065318|FG000|Overall Study|Lost to Follow-up|3|||
105564796|NCT04766086|364065319|FG001|Overall Study|Lost to Follow-up|5|||
105564797|NCT04766086|364065320|FG002|Overall Study|Lost to Follow-up|3|||
105564798|NCT04766086|364065318|FG000|Overall Study|Withdrawal by Subject|1|||
105564799|NCT04766086|364065319|FG001|Overall Study|Withdrawal by Subject|1|||
105564800|NCT04766086|364065320|FG002|Overall Study|Withdrawal by Subject|2|||
105564801|NCT04766086|364065318|FG000|Overall Study|Other|0|||
105564802|NCT04766086|364065319|FG001|Overall Study|Other|0|||
105564803|NCT04766086|364065320|FG002|Overall Study|Other|1|||
105564804|NCT02496767|364065331|FG000|Open-label Lead-in Phase|Adverse Event|176|||
105564805|NCT02496767|364065332|FG001|Open-label Lead-in Phase|Adverse Event|0|||
105564806|NCT02496767|364065333|FG002|Open-label Lead-in Phase|Adverse Event|0|||
105564807|NCT02496767|364065334|FG003|Open-label Lead-in Phase|Adverse Event|0|||
105564808|NCT02496767|364065335|FG004|Open-label Lead-in Phase|Adverse Event|0|||
105564809|NCT02496767|364065336|FG005|Open-label Lead-in Phase|Adverse Event|0|||
105564810|NCT02496767|364065337|FG006|Open-label Lead-in Phase|Adverse Event|0|||
105564811|NCT02496767|364065338|FG007|Open-label Lead-in Phase|Adverse Event|0|||
105564812|NCT02496767|364065331|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
105564813|NCT02496767|364065332|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
105564814|NCT02496767|364065333|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
105564815|NCT02496767|364065334|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
105564816|NCT02496767|364065335|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
105564817|NCT02496767|364065336|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
105564818|NCT02496767|364065337|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
105564819|NCT02496767|364065338|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
105564820|NCT02496767|364065331|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
105564821|NCT02496767|364065332|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
105564822|NCT02496767|364065333|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
105564823|NCT02496767|364065334|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
105564824|NCT02496767|364065335|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
105564825|NCT02496767|364065336|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
105564826|NCT02496767|364065337|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
105564827|NCT02496767|364065338|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
105564828|NCT02496767|364065331|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
105564829|NCT02496767|364065332|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
105564830|NCT02496767|364065333|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
105564831|NCT02496767|364065334|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
105564832|NCT02496767|364065335|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
105564833|NCT02496767|364065336|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
105564834|NCT02496767|364065337|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
105564835|NCT02496767|364065338|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
105564836|NCT02496767|364065331|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
105564837|NCT02496767|364065332|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
105564838|NCT02496767|364065333|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
105564839|NCT02496767|364065334|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
105479680|NCT00393510|363767581|FG001|Overall Study|Physician Decision|9|||
105479681|NCT02112045|363767586|FG000|Overall Study|Withdrawal by Subject|1|||
105479682|NCT02112045|363767587|FG001|Overall Study|Withdrawal by Subject|0|||
105479683|NCT01960907|363767588|FG000|Overall Study|Death|4|||
105479684|NCT01960907|363767589|FG001|Overall Study|Death|3|||
105479685|NCT01960907|363767588|FG000|Overall Study|Withdrawal by Subject|32|||
105564840|NCT02496767|364065335|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
105564841|NCT02496767|364065336|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
105564842|NCT02496767|364065337|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
105564843|NCT02496767|364065338|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
105564844|NCT02496767|364065331|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
105564845|NCT02496767|364065332|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
105564846|NCT02496767|364065333|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
105564847|NCT02496767|364065334|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
105564848|NCT02496767|364065335|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
105564849|NCT02496767|364065336|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
105564850|NCT02496767|364065337|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
105564851|NCT02496767|364065338|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
105564852|NCT02496767|364065331|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
105564853|NCT02496767|364065332|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
105564854|NCT02496767|364065333|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
105564855|NCT02496767|364065334|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
105564856|NCT02496767|364065335|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
105564857|NCT02496767|364065336|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
105564858|NCT02496767|364065337|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
105353255|NCT00642954|363298481|FG002|Overall Study|Withdrawal by Subject|0|||
105353256|NCT00642954|363298482|FG003|Overall Study|Withdrawal by Subject|0|||
105353257|NCT00642954|363298483|FG004|Overall Study|Withdrawal by Subject|1|||
105353258|NCT00642954|363298479|FG000|Overall Study|Adverse Event|1|||
105353259|NCT00642954|363298480|FG001|Overall Study|Adverse Event|1|||
105353260|NCT00642954|363298481|FG002|Overall Study|Adverse Event|0|||
105353261|NCT00642954|363298482|FG003|Overall Study|Adverse Event|0|||
105353262|NCT00642954|363298483|FG004|Overall Study|Adverse Event|6|||
105353263|NCT00703326|363298485|FG000|Overall Study|Lost to Follow-up|47|||
105353264|NCT00703326|363298486|FG001|Overall Study|Lost to Follow-up|18|||
105479686|NCT01960907|363767589|FG001|Overall Study|Withdrawal by Subject|42|||
105479687|NCT00065429|363767590|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
105564859|NCT02496767|364065338|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
105564860|NCT02496767|364065331|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
105564861|NCT02496767|364065332|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
105564862|NCT02496767|364065333|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
105564863|NCT02496767|364065334|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
105564864|NCT02496767|364065335|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
105564865|NCT02496767|364065336|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
105564866|NCT02496767|364065337|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
105564867|NCT02496767|364065338|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
105564868|NCT02496767|364065331|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
105564869|NCT02496767|364065332|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
105479688|NCT00065429|363767591|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
105479689|NCT00065429|363767592|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
105479690|NCT00065429|363767593|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
105479691|NCT00065429|363767594|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
105564870|NCT02496767|364065333|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
105564871|NCT02496767|364065334|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
105564872|NCT02496767|364065335|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
105564873|NCT02496767|364065336|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
105564874|NCT02496767|364065337|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
105564875|NCT02496767|364065338|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
105564876|NCT02496767|364065331|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105564877|NCT02496767|364065332|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
105564878|NCT02496767|364065333|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105564879|NCT02496767|364065334|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
105564880|NCT02496767|364065335|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
105795001|NCT01289990|364906002|FG008|Overall Study|Withdrawal by Subject|12|||
105353265|NCT00703326|363298485|FG000|Overall Study|Withdrawal by Subject|54|||
105564881|NCT02496767|364065336|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105795002|NCT01289990|364906003|FG009|Overall Study|Withdrawal by Subject|13|||
105479692|NCT00065429|363767595|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
105479693|NCT00065429|363767596|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
105564882|NCT02496767|364065337|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105564883|NCT02496767|364065338|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105564884|NCT02496767|364065331|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
105564885|NCT02496767|364065332|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
105564886|NCT02496767|364065333|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
105564887|NCT02496767|364065334|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
105564888|NCT02496767|364065335|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
105564889|NCT02496767|364065336|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
105564890|NCT02496767|364065337|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
105564891|NCT02496767|364065338|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
105564892|NCT02496767|364065331|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
105564893|NCT02496767|364065332|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
105564894|NCT02496767|364065333|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
105564895|NCT02496767|364065334|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
105564896|NCT02496767|364065335|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
105564897|NCT02496767|364065336|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
105564898|NCT02496767|364065337|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
105564899|NCT02496767|364065338|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
105564900|NCT02496767|364065331|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
105564901|NCT02496767|364065332|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
105564902|NCT02496767|364065333|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
105564903|NCT02496767|364065334|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
105564904|NCT02496767|364065335|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
105564905|NCT02496767|364065336|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
105564906|NCT02496767|364065337|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
105564907|NCT02496767|364065338|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
105564908|NCT02496767|364065331|FG000|Double-blind, Withdrawal Phase|Death|0|||
105564909|NCT02496767|364065332|FG001|Double-blind, Withdrawal Phase|Death|0|||
105564910|NCT02496767|364065333|FG002|Double-blind, Withdrawal Phase|Death|0|||
105564911|NCT02496767|364065334|FG003|Double-blind, Withdrawal Phase|Death|0|||
105564912|NCT02496767|364065335|FG004|Double-blind, Withdrawal Phase|Death|0|||
105564913|NCT02496767|364065336|FG005|Double-blind, Withdrawal Phase|Death|0|||
105564914|NCT02496767|364065337|FG006|Double-blind, Withdrawal Phase|Death|1|||
105564915|NCT02496767|364065338|FG007|Double-blind, Withdrawal Phase|Death|2|||
105564916|NCT02496767|364065331|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
105564917|NCT02496767|364065332|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
105564918|NCT02496767|364065333|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
105564919|NCT02496767|364065334|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
105564920|NCT02496767|364065335|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
105564921|NCT02496767|364065336|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
105564922|NCT02496767|364065337|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
105564923|NCT02496767|364065338|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
105564924|NCT00166296|364065339|FG000|Overall Study|Withdrawal by Subject|1|||
105564925|NCT00166296|364065340|FG001|Overall Study|Withdrawal by Subject|3|||
105564926|NCT00166296|364065339|FG000|Overall Study|Adverse Event|2|||
105564927|NCT00166296|364065340|FG001|Overall Study|Adverse Event|4|||
105564928|NCT00166296|364065339|FG000|Overall Study|Lost to Follow-up|4|||
105564929|NCT00166296|364065340|FG001|Overall Study|Lost to Follow-up|2|||
105564930|NCT00724152|364065350|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
105564931|NCT00724152|364065351|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
105564932|NCT00724152|364065352|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
105564933|NCT00724152|364065350|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
105726908|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105726909|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105726910|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105726911|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
105726912|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105726913|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105726914|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105726915|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105726916|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
105726917|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
105726918|NCT00693706|364655530|FG000|Overall Study|Protocol Violation|0|||
105726919|NCT00693706|364655531|FG001|Overall Study|Protocol Violation|1|||
105726920|NCT02371629|364655535|FG000|Overall Study|Patient decision|14|||
105726921|NCT02371629|364655536|FG001|Overall Study|Patient decision|10|||
105726922|NCT02371629|364655535|FG000|Overall Study|Adverse Event|8|||
105726923|NCT02371629|364655536|FG001|Overall Study|Adverse Event|8|||
105726924|NCT02371629|364655535|FG000|Overall Study|Physician Decision|2|||
105795003|NCT01289990|364906004|FG010|Overall Study|Withdrawal by Subject|11|||
105726925|NCT02371629|364655536|FG001|Overall Study|Physician Decision|3|||
105726926|NCT02371629|364655535|FG000|Overall Study|Death|1|||
105726927|NCT02371629|364655536|FG001|Overall Study|Death|1|||
105726928|NCT02371629|364655535|FG000|Overall Study|Noncompliance with study treatment|1|||
105726929|NCT02371629|364655536|FG001|Overall Study|Noncompliance with study treatment|0|||
105726930|NCT02371629|364655535|FG000|Overall Study|Lack of Efficacy|0|||
105726931|NCT02371629|364655536|FG001|Overall Study|Lack of Efficacy|2|||
105726932|NCT02371629|364655535|FG000|Overall Study|Protocol deviation|0|||
105726933|NCT02371629|364655536|FG001|Overall Study|Protocol deviation|1|||
105726934|NCT03406962|364655537|FG000|Overall Study|Death|2|||
105726935|NCT03406962|364655537|FG000|Overall Study|Adverse Event|1|||
105726936|NCT03853694|364655538|FG000|Overall Study|Protocol Violation|3|||
105726937|NCT03853694|364655539|FG001|Overall Study|Protocol Violation|5|||
105726938|NCT03853694|364655540|FG002|Overall Study|Protocol Violation|3|||
105726939|NCT03853694|364655538|FG000|Overall Study|Delivered early|0|||
105726940|NCT03853694|364655539|FG001|Overall Study|Delivered early|1|||
105726941|NCT03853694|364655540|FG002|Overall Study|Delivered early|0|||
105726942|NCT03853694|364655538|FG000|Overall Study|not suitable to proceed|0|||
105726943|NCT03853694|364655539|FG001|Overall Study|not suitable to proceed|1|||
105726944|NCT03853694|364655540|FG002|Overall Study|not suitable to proceed|0|||
105726945|NCT03853694|364655538|FG000|Overall Study|difficult surgery|0|||
105726946|NCT03853694|364655539|FG001|Overall Study|difficult surgery|0|||
105726947|NCT03853694|364655540|FG002|Overall Study|difficult surgery|1|||
105726948|NCT03853694|364655538|FG000|Overall Study|Lost to Follow-up|0|||
105726949|NCT03853694|364655539|FG001|Overall Study|Lost to Follow-up|1|||
105726950|NCT03853694|364655540|FG002|Overall Study|Lost to Follow-up|0|||
105726951|NCT03853694|364655538|FG000|Overall Study|Withdrawal by Subject|0|||
105726952|NCT03853694|364655539|FG001|Overall Study|Withdrawal by Subject|1|||
105726953|NCT03853694|364655540|FG002|Overall Study|Withdrawal by Subject|0|||
105726954|NCT02499952|364655541|FG000|Overall Study|Lost to Follow-up|1|||
105726955|NCT02499952|364655541|FG000|Overall Study|Death|9|||
105726956|NCT05089708|364655542|FG000|Overall Study|Lost to Follow-up|9|||
105726957|NCT05089708|364655543|FG001|Overall Study|Lost to Follow-up|7|||
105726958|NCT05089708|364655542|FG000|Overall Study|Withdrawal by Subject|3|||
105726959|NCT05089708|364655543|FG001|Overall Study|Withdrawal by Subject|1|||
105726960|NCT05089708|364655542|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
105726961|NCT05089708|364655543|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
105726962|NCT05089708|364655542|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
105726963|NCT05089708|364655543|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
105726964|NCT00327444|364655544|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
105726965|NCT00327444|364655545|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
105726966|NCT00327444|364655544|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
105726967|NCT00327444|364655545|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
105726968|NCT00327444|364655544|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
105726969|NCT00327444|364655545|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
105726970|NCT00327444|364655544|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
105726971|NCT00327444|364655545|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
105726972|NCT00327444|364655544|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
105726973|NCT00327444|364655545|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
105726974|NCT00327444|364655544|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
105726975|NCT00327444|364655545|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
105726976|NCT00327444|364655544|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
105726977|NCT00327444|364655545|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
105726978|NCT00327444|364655544|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
105726979|NCT00327444|364655545|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
105726980|NCT03830281|364655546|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
105726981|NCT03830281|364655547|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
105726982|NCT03830281|364655546|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
105726983|NCT03830281|364655547|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
105726984|NCT03830281|364655546|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
105726985|NCT03830281|364655547|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
105726986|NCT03830281|364655546|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
105726987|NCT03830281|364655547|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
105726988|NCT03830281|364655546|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
105726989|NCT03830281|364655547|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
105726990|NCT03830281|364655546|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
105726991|NCT03830281|364655547|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
105726992|NCT03830281|364655546|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
105726993|NCT03830281|364655547|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
105726994|NCT03830281|364655546|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
105726995|NCT03830281|364655547|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
105726996|NCT03830281|364655546|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
105726997|NCT03830281|364655547|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
105726998|NCT00201851|364655548|FG000|Overall Study|Lost to Follow-up|2|||
105726999|NCT00201851|364655549|FG001|Overall Study|Lost to Follow-up|1|||
105727000|NCT00201851|364655550|FG002|Overall Study|Lost to Follow-up|0|||
105727001|NCT00201851|364655548|FG000|Overall Study|Ineligible post enrollment|6|||
105727002|NCT00201851|364655549|FG001|Overall Study|Ineligible post enrollment|1|||
105727003|NCT00201851|364655550|FG002|Overall Study|Ineligible post enrollment|1|||
105727004|NCT00144170|364655551|FG000|Overall Study|Adverse Event|84|||
105727005|NCT00144170|364655552|FG001|Overall Study|Adverse Event|41|||
105727006|NCT00144170|364655551|FG000|Overall Study|Protocol Violation|23|||
105727007|NCT00144170|364655552|FG001|Overall Study|Protocol Violation|16|||
105727008|NCT00144170|364655551|FG000|Overall Study|Lost to Follow-up|5|||
105727009|NCT00144170|364655552|FG001|Overall Study|Lost to Follow-up|10|||
105727010|NCT00144170|364655551|FG000|Overall Study|Withdrawal by Subject|29|||
105727011|NCT00144170|364655552|FG001|Overall Study|Withdrawal by Subject|13|||
105727012|NCT00144170|364655551|FG000|Overall Study|Other reason not defined above|211|||
105727013|NCT00144170|364655552|FG001|Overall Study|Other reason not defined above|316|||
105727014|NCT00702143|364655553|FG000|Overall Study|Lost to Follow-up|0|||
105727015|NCT00702143|364655554|FG001|Overall Study|Lost to Follow-up|0|||
105727016|NCT00702143|364655555|FG002|Overall Study|Lost to Follow-up|1|||
105727017|NCT04091217|364655556|FG000|Overall Study|Lost to Follow-up|2|||
105727018|NCT04826900|364655560|FG000|Overall Study|Family factor|1|||
105727019|NCT04826900|364655561|FG001|Overall Study|Family factor|1|||
105727020|NCT00818259|364655562|FG000|Part I|Withdrawal by Subject|1|||
105727021|NCT00818259|364655563|FG001|Part I|Withdrawal by Subject|0|||
105727022|NCT00818259|364655564|FG002|Part I|Withdrawal by Subject|0|||
105727023|NCT00818259|364655565|FG003|Part I|Withdrawal by Subject|0|||
105727024|NCT00818259|364655566|FG004|Part I|Withdrawal by Subject|0|||
105727025|NCT00818259|364655567|FG005|Part I|Withdrawal by Subject|0|||
105727026|NCT00818259|364655568|FG006|Part I|Withdrawal by Subject|0|||
105727027|NCT00818259|364655569|FG007|Part I|Withdrawal by Subject|0|||
105727028|NCT00818259|364655570|FG008|Part I|Withdrawal by Subject|0|||
105727029|NCT00818259|364655562|FG000|Part II|Physician Decision|0|||
105727030|NCT00818259|364655563|FG001|Part II|Physician Decision|0|||
105727031|NCT00818259|364655564|FG002|Part II|Physician Decision|1|||
105727032|NCT00818259|364655565|FG003|Part II|Physician Decision|0|||
105727033|NCT00818259|364655566|FG004|Part II|Physician Decision|0|||
105727034|NCT00818259|364655567|FG005|Part II|Physician Decision|0|||
105727035|NCT00818259|364655568|FG006|Part II|Physician Decision|0|||
105727036|NCT00818259|364655569|FG007|Part II|Physician Decision|0|||
105727037|NCT00818259|364655570|FG008|Part II|Physician Decision|0|||
105727038|NCT00818259|364655562|FG000|Part II|Lack of Efficacy|0|||
105727039|NCT00818259|364655563|FG001|Part II|Lack of Efficacy|0|||
105727040|NCT00818259|364655564|FG002|Part II|Lack of Efficacy|0|||
105727041|NCT00818259|364655565|FG003|Part II|Lack of Efficacy|1|||
105727042|NCT00818259|364655566|FG004|Part II|Lack of Efficacy|0|||
105727043|NCT00818259|364655567|FG005|Part II|Lack of Efficacy|0|||
105727044|NCT00818259|364655568|FG006|Part II|Lack of Efficacy|0|||
105727045|NCT00818259|364655569|FG007|Part II|Lack of Efficacy|0|||
105727046|NCT00818259|364655570|FG008|Part II|Lack of Efficacy|0|||
105727047|NCT00818259|364655562|FG000|Part II|Not Treated|0|||
105727048|NCT00818259|364655563|FG001|Part II|Not Treated|0|||
105727049|NCT00818259|364655564|FG002|Part II|Not Treated|0|||
105727050|NCT00818259|364655565|FG003|Part II|Not Treated|1|||
105727051|NCT00818259|364655566|FG004|Part II|Not Treated|0|||
105727052|NCT00818259|364655567|FG005|Part II|Not Treated|0|||
105727053|NCT00818259|364655568|FG006|Part II|Not Treated|0|||
105727054|NCT00818259|364655569|FG007|Part II|Not Treated|0|||
105727055|NCT00818259|364655570|FG008|Part II|Not Treated|0|||
105727056|NCT00818259|364655562|FG000|Part IV|Physician Decision|0|||
105727057|NCT00818259|364655563|FG001|Part IV|Physician Decision|0|||
105727058|NCT00818259|364655564|FG002|Part IV|Physician Decision|0|||
105727059|NCT00818259|364655565|FG003|Part IV|Physician Decision|0|||
105727060|NCT00818259|364655566|FG004|Part IV|Physician Decision|0|||
105727061|NCT00818259|364655567|FG005|Part IV|Physician Decision|1|||
105727062|NCT00818259|364655568|FG006|Part IV|Physician Decision|0|||
105727063|NCT00818259|364655569|FG007|Part IV|Physician Decision|0|||
105727064|NCT00818259|364655570|FG008|Part IV|Physician Decision|0|||
105727065|NCT00818259|364655562|FG000|Part V|Adverse Event|0|||
105727066|NCT00818259|364655563|FG001|Part V|Adverse Event|0|||
105727067|NCT00818259|364655564|FG002|Part V|Adverse Event|0|||
105727068|NCT00818259|364655565|FG003|Part V|Adverse Event|0|||
105727069|NCT00818259|364655566|FG004|Part V|Adverse Event|0|||
105727070|NCT00818259|364655567|FG005|Part V|Adverse Event|0|||
105727071|NCT00818259|364655568|FG006|Part V|Adverse Event|0|||
105727072|NCT00818259|364655569|FG007|Part V|Adverse Event|1|||
105727073|NCT00818259|364655570|FG008|Part V|Adverse Event|0|||
105727074|NCT02597062|364655572|FG000|Overall Study|Ineligible|1|||
105727075|NCT00741819|364655573|FG000|Overall Study|Adverse Event|3|||
105727076|NCT00741819|364655573|FG000|Overall Study|Withdrawal by Subject|3|||
105727077|NCT00741819|364655573|FG000|Overall Study|Death|1|||
105727078|NCT00741819|364655573|FG000|Overall Study|Disease progression|1|||
105727079|NCT02117687|364655574|FG000|Overall Study|Lost to Follow-up|0|||
105727080|NCT02117687|364655575|FG001|Overall Study|Lost to Follow-up|1|||
105479694|NCT00065429|363767590|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
105479695|NCT00065429|363767591|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
105479696|NCT00065429|363767592|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
105479697|NCT00065429|363767593|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
105479698|NCT00065429|363767594|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
105479699|NCT00065429|363767595|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
105479700|NCT00065429|363767596|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
105479701|NCT00065429|363767590|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
105727081|NCT02117687|364655574|FG000|Overall Study|Adverse Event|0|||
105727082|NCT02117687|364655575|FG001|Overall Study|Adverse Event|2|||
105727083|NCT02117687|364655574|FG000|Overall Study|Other Reasons|1|||
105727084|NCT02117687|364655575|FG001|Overall Study|Other Reasons|1|||
105727085|NCT01126580|364655578|FG000|Overall Study|Adverse Event|14|||
105727086|NCT01126580|364655579|FG001|Overall Study|Adverse Event|8|||
105727087|NCT01126580|364655580|FG002|Overall Study|Adverse Event|12|||
105727088|NCT01126580|364655578|FG000|Overall Study|Withdrawal by Subject|11|||
105727089|NCT01126580|364655579|FG001|Overall Study|Withdrawal by Subject|19|||
105727090|NCT01126580|364655580|FG002|Overall Study|Withdrawal by Subject|14|||
105727091|NCT01126580|364655578|FG000|Overall Study|Sponsor Decision|5|||
105727092|NCT01126580|364655579|FG001|Overall Study|Sponsor Decision|4|||
105727093|NCT01126580|364655580|FG002|Overall Study|Sponsor Decision|7|||
105727094|NCT01126580|364655578|FG000|Overall Study|Physician Decision|1|||
105727095|NCT01126580|364655579|FG001|Overall Study|Physician Decision|1|||
105727096|NCT01126580|364655580|FG002|Overall Study|Physician Decision|2|||
105727097|NCT01126580|364655578|FG000|Overall Study|Entry Criteria Not Met|1|||
105727098|NCT01126580|364655579|FG001|Overall Study|Entry Criteria Not Met|1|||
105727099|NCT01126580|364655580|FG002|Overall Study|Entry Criteria Not Met|2|||
105727100|NCT01126580|364655578|FG000|Overall Study|Lack of Efficacy|2|||
105727101|NCT01126580|364655579|FG001|Overall Study|Lack of Efficacy|3|||
105727102|NCT01126580|364655580|FG002|Overall Study|Lack of Efficacy|4|||
105727103|NCT01126580|364655578|FG000|Overall Study|Protocol Violation|0|||
105727104|NCT01126580|364655579|FG001|Overall Study|Protocol Violation|1|||
105727105|NCT01126580|364655580|FG002|Overall Study|Protocol Violation|2|||
105727106|NCT01126580|364655578|FG000|Overall Study|Lost to Follow-up|15|||
105727107|NCT01126580|364655579|FG001|Overall Study|Lost to Follow-up|13|||
105727108|NCT01126580|364655580|FG002|Overall Study|Lost to Follow-up|9|||
105727109|NCT01126580|364655578|FG000|Overall Study|Treatment Non-compliance|0|||
105727110|NCT01126580|364655579|FG001|Overall Study|Treatment Non-compliance|2|||
105727111|NCT01126580|364655580|FG002|Overall Study|Treatment Non-compliance|3|||
105727112|NCT01053429|364655592|FG000|Overall Study|Adverse Event|64|||
105727113|NCT01053429|364655592|FG000|Overall Study|Other|309|||
105727114|NCT01708057|364655593|FG000|Overall Study|Withdrawal due to study termination.|1|||
105727115|NCT01708057|364655594|FG001|Overall Study|Withdrawal due to study termination.|1|||
105727116|NCT01708057|364655595|FG002|Overall Study|Withdrawal due to study termination.|1|||
105727117|NCT02970929|364655597|FG000|Overall Study|Adverse Event|18|||
105727118|NCT02970929|364655597|FG000|Overall Study|Lack of Efficacy|8|||
105727119|NCT02970929|364655597|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
105727120|NCT02970929|364655597|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
105727121|NCT02970929|364655597|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
105727122|NCT02970929|364655597|FG000|Overall Study|LOST TO FOLLOWUP|6|||
105727123|NCT02970929|364655597|FG000|Overall Study|MOVED OUT OF STATE|1|||
105727124|NCT02970929|364655597|FG000|Overall Study|Withdrawal by Subject|16|||
105727125|NCT00628355|364655598|FG000|Overall Study|Withdrawal by Subject|1|||
105727126|NCT00628355|364655599|FG001|Overall Study|Withdrawal by Subject|1|||
105795004|NCT01289990|364906005|FG011|Overall Study|Withdrawal by Subject|13|||
105795005|NCT01289990|364906006|FG012|Overall Study|Withdrawal by Subject|16|||
105795006|NCT01289990|364905994|FG000|Overall Study|discontinued in preceding trial|18|||
105479702|NCT00065429|363767591|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
105479703|NCT00065429|363767592|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
105479704|NCT00065429|363767593|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
105727127|NCT00140855|364655600|FG000|Overall Study|Progressive disease|2|||
105727128|NCT03542682|364655605|FG000|Overall Study|COVID-19 Protocol|0|||
105727129|NCT03542682|364655606|FG001|Overall Study|COVID-19 Protocol|1|||
105727130|NCT00963807|364655608|FG000|Overall Study|Physician Decision|2|||
105727131|NCT00963807|364655608|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
105727132|NCT00963807|364655608|FG000|Overall Study|Disease progression|15|||
105795007|NCT01289990|364905995|FG001|Overall Study|discontinued in preceding trial|20|||
105727133|NCT03430310|364655609|FG000|Overall Study|Protocol Violation|2|||
105727134|NCT03430310|364655610|FG001|Overall Study|Protocol Violation|0|||
105727135|NCT03430310|364655609|FG000|Overall Study|Withdrawal by Subject|3|||
105727136|NCT03430310|364655610|FG001|Overall Study|Withdrawal by Subject|2|||
105727137|NCT03430310|364655609|FG000|Overall Study|COVID shutdown March 2020|0|||
105727138|NCT03430310|364655610|FG001|Overall Study|COVID shutdown March 2020|1|||
105795008|NCT01289990|364905996|FG002|Overall Study|discontinued in preceding trial|41|||
105795009|NCT01289990|364905997|FG003|Overall Study|discontinued in preceding trial|17|||
105795010|NCT01289990|364905998|FG004|Overall Study|discontinued in preceding trial|11|||
105795011|NCT01289990|364905999|FG005|Overall Study|discontinued in preceding trial|12|||
105795012|NCT01289990|364906000|FG006|Overall Study|discontinued in preceding trial|18|||
105795013|NCT01289990|364906001|FG007|Overall Study|discontinued in preceding trial|8|||
105795014|NCT01289990|364906002|FG008|Overall Study|discontinued in preceding trial|17|||
105479705|NCT00065429|363767594|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
105479706|NCT00065429|363767595|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
105479707|NCT00065429|363767596|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
105479708|NCT00065429|363767590|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
105479709|NCT00065429|363767591|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
105479710|NCT00065429|363767592|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
105479711|NCT00065429|363767593|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
105479712|NCT00065429|363767594|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
105479713|NCT00065429|363767595|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
105479714|NCT00065429|363767596|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
105479715|NCT00065429|363767590|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
105479716|NCT00065429|363767591|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
105479717|NCT00065429|363767592|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
105479718|NCT00065429|363767593|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
105479719|NCT00065429|363767594|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
105479720|NCT00065429|363767595|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
105479721|NCT00065429|363767596|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
105479722|NCT00065429|363767590|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
105479723|NCT00065429|363767591|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
105479724|NCT00065429|363767592|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
105479725|NCT00065429|363767593|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
105727139|NCT02234622|364655611|FG000|Overall Study|Withdrawal by Subject|16|||
105727140|NCT02234622|364655612|FG001|Overall Study|Withdrawal by Subject|22|||
105727141|NCT02234622|364655611|FG000|Overall Study|Lost to Follow-up|27|||
105727142|NCT02234622|364655612|FG001|Overall Study|Lost to Follow-up|14|||
105727143|NCT01446809|364655616|FG000|Overall Study|Adverse Event|0|||
105727144|NCT01446809|364655617|FG001|Overall Study|Adverse Event|0|||
105727145|NCT01446809|364655618|FG002|Overall Study|Adverse Event|1|||
105727146|NCT01446809|364655616|FG000|Overall Study|Failure to complete study procedures|0|||
105727147|NCT01446809|364655617|FG001|Overall Study|Failure to complete study procedures|0|||
105727148|NCT01446809|364655618|FG002|Overall Study|Failure to complete study procedures|1|||
105727149|NCT01331161|364655619|FG000|Overall Study|Physician Decision|1|||
105727150|NCT01331161|364655620|FG001|Overall Study|Physician Decision|0|||
105727151|NCT01331161|364655619|FG000|Overall Study|Lost to Follow-up|0|||
105727152|NCT01331161|364655620|FG001|Overall Study|Lost to Follow-up|1|||
105727153|NCT01331161|364655619|FG000|Overall Study|Pregnancy|0|||
105727154|NCT01331161|364655620|FG001|Overall Study|Pregnancy|1|||
105727155|NCT01097044|364655621|FG000|Overall Study|Withdrawal by Subject|4|||
105727156|NCT01097044|364655622|FG001|Overall Study|Withdrawal by Subject|4|||
105727157|NCT01097044|364655621|FG000|Overall Study|Lost to Follow-up|1|||
105727158|NCT01097044|364655622|FG001|Overall Study|Lost to Follow-up|0|||
105727159|NCT01097044|364655621|FG000|Overall Study|Withdrawal by Sponsor|0|||
105727160|NCT01097044|364655622|FG001|Overall Study|Withdrawal by Sponsor|1|||
105727161|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
105727162|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
105727163|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
105727164|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
105727165|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
105727166|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
105727167|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
105727168|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
105727169|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
105727170|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
105727171|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
105727172|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
105727173|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
105727174|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
105727175|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
105727176|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
105727177|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
105727178|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
105727179|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
105727180|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
105479726|NCT00065429|363767594|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
105479727|NCT00065429|363767595|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
105479728|NCT00065429|363767596|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
105727181|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
105727182|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
105727183|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
105727184|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
105727185|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
105727186|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
105727187|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
105727188|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
105727189|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
105727190|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
105727191|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
105727192|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
105727193|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
105727194|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
105727195|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
105727196|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
105727197|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
105727198|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
105727199|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
105727200|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
105727201|NCT00785577|364655623|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
105727202|NCT00785577|364655624|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
105727203|NCT00785577|364655625|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
105727204|NCT00785577|364655626|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
105727205|NCT00785577|364655627|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
105727206|NCT00785577|364655623|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
105727207|NCT00785577|364655624|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
105727208|NCT00785577|364655625|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
105727209|NCT00785577|364655626|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
105727210|NCT00785577|364655627|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
105727211|NCT02770807|364655630|FG000|Overall Study|Adverse Event|3|||
105727212|NCT02770807|364655631|FG001|Overall Study|Adverse Event|3|||
105727213|NCT02770807|364655632|FG002|Overall Study|Adverse Event|1|||
105727214|NCT02770807|364655630|FG000|Overall Study|Withdrawal by Subject|7|||
105727215|NCT02770807|364655631|FG001|Overall Study|Withdrawal by Subject|3|||
105727216|NCT02770807|364655632|FG002|Overall Study|Withdrawal by Subject|4|||
105727217|NCT02770807|364655630|FG000|Overall Study|Other|0|||
105727218|NCT02770807|364655631|FG001|Overall Study|Other|1|||
105727219|NCT02770807|364655632|FG002|Overall Study|Other|0|||
105727220|NCT02770807|364655630|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
105727221|NCT02770807|364655631|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
105727222|NCT02770807|364655632|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
105727223|NCT02770807|364655630|FG000|Overall Study|Physician Decision|0|||
105727224|NCT02770807|364655631|FG001|Overall Study|Physician Decision|0|||
105727225|NCT02770807|364655632|FG002|Overall Study|Physician Decision|1|||
105727226|NCT03277196|364655633|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
105727227|NCT03277196|364655633|FG000|Overall Study|Lost to Follow-up|3|||
105727228|NCT03277196|364655633|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
105727229|NCT03277196|364655633|FG000|Overall Study|Other|2|||
105727230|NCT02251743|364657242|FG000|Overall Study|Withdrawal by Subject|1|||
105727231|NCT02251743|364657243|FG001|Overall Study|Withdrawal by Subject|1|||
105727232|NCT00742781|364657244|FG000|Overall Study|Withdrawal by Subject|3|||
105727233|NCT02210780|364657245|FG000|Overall Study|Adverse Event|0|||
105727234|NCT02210780|364657246|FG001|Overall Study|Adverse Event|5|||
105727235|NCT02210780|364657245|FG000|Overall Study|Lost to Follow-up|2|||
105727236|NCT02210780|364657246|FG001|Overall Study|Lost to Follow-up|1|||
105727237|NCT02210780|364657245|FG000|Overall Study|Withdrawal by Subject|1|||
105727238|NCT02210780|364657246|FG001|Overall Study|Withdrawal by Subject|1|||
105727239|NCT02210780|364657245|FG000|Overall Study|Physician Decision|1|||
105727240|NCT02210780|364657246|FG001|Overall Study|Physician Decision|0|||
105727241|NCT02210780|364657245|FG000|Overall Study|Protocol Violation|1|||
105727242|NCT02210780|364657246|FG001|Overall Study|Protocol Violation|0|||
105727243|NCT02210780|364657245|FG000|Overall Study|Other than specified above|0|||
105727244|NCT02210780|364657246|FG001|Overall Study|Other than specified above|1|||
105727245|NCT02360098|364657247|FG000|Overall Study|Physician Decision|7|||
105727246|NCT02966314|364657248|FG000|Overall Study|Lost to Follow-up|1|||
105727247|NCT02966314|364657249|FG001|Overall Study|Lost to Follow-up|0|||
105727248|NCT00049127|364657250|FG000|Overall Study|Withdrawal by Subject|0|||
105727249|NCT00049127|364657251|FG001|Overall Study|Withdrawal by Subject|0|||
105727250|NCT00049127|364657252|FG002|Overall Study|Withdrawal by Subject|1|||
105727251|NCT00049127|364657253|FG003|Overall Study|Withdrawal by Subject|0|||
105727252|NCT00049127|364657254|FG004|Overall Study|Withdrawal by Subject|0|||
105727253|NCT05113940|364657259|FG000|Part A (18 Days)|Adverse Event|0|||
105795015|NCT01289990|364906003|FG009|Overall Study|discontinued in preceding trial|21|||
105795016|NCT01289990|364906004|FG010|Overall Study|discontinued in preceding trial|17|||
105795017|NCT01289990|364906005|FG011|Overall Study|discontinued in preceding trial|17|||
105795018|NCT01289990|364906006|FG012|Overall Study|discontinued in preceding trial|24|||
105795019|NCT01289990|364905994|FG000|Overall Study|did not continue in extension|41|||
105795020|NCT01289990|364905995|FG001|Overall Study|did not continue in extension|45|||
105795021|NCT01289990|364905996|FG002|Overall Study|did not continue in extension|51|||
105795022|NCT01289990|364905997|FG003|Overall Study|did not continue in extension|51|||
105795023|NCT01289990|364905998|FG004|Overall Study|did not continue in extension|48|||
105795024|NCT01289990|364905999|FG005|Overall Study|did not continue in extension|50|||
105795025|NCT01289990|364906000|FG006|Overall Study|did not continue in extension|54|||
105795026|NCT01289990|364906001|FG007|Overall Study|did not continue in extension|36|||
105795027|NCT01289990|364906002|FG008|Overall Study|did not continue in extension|44|||
105795028|NCT01289990|364906003|FG009|Overall Study|did not continue in extension|48|||
105795029|NCT01289990|364906004|FG010|Overall Study|did not continue in extension|45|||
105795030|NCT01289990|364906005|FG011|Overall Study|did not continue in extension|34|||
105795031|NCT01289990|364906006|FG012|Overall Study|did not continue in extension|56|||
105795032|NCT01289990|364905994|FG000|Overall Study|Not treated|0|||
105795033|NCT01289990|364905995|FG001|Overall Study|Not treated|0|||
105795034|NCT01289990|364905996|FG002|Overall Study|Not treated|0|||
105795035|NCT01289990|364905997|FG003|Overall Study|Not treated|0|||
105795036|NCT01289990|364905998|FG004|Overall Study|Not treated|0|||
105795037|NCT01289990|364905999|FG005|Overall Study|Not treated|0|||
105795038|NCT01289990|364906000|FG006|Overall Study|Not treated|1|||
105795039|NCT01289990|364906001|FG007|Overall Study|Not treated|0|||
105795040|NCT01289990|364906002|FG008|Overall Study|Not treated|1|||
105795041|NCT01289990|364906003|FG009|Overall Study|Not treated|0|||
105727254|NCT05113940|364657260|FG001|Part A (18 Days)|Adverse Event|0|||
105727255|NCT05113940|364657261|FG002|Part A (18 Days)|Adverse Event|1|||
105727256|NCT05113940|364657262|FG003|Part A (18 Days)|Adverse Event|1|||
105727257|NCT05113940|364657263|FG004|Part A (18 Days)|Adverse Event|1|||
105727258|NCT05113940|364657264|FG005|Part A (18 Days)|Adverse Event|0|||
105727259|NCT05113940|364657265|FG006|Part A (18 Days)|Adverse Event|0|||
105727260|NCT05113940|364657266|FG007|Part A (18 Days)|Adverse Event|0|||
105727261|NCT05113940|364657267|FG008|Part A (18 Days)|Adverse Event|0|||
105727262|NCT05113940|364657268|FG009|Part A (18 Days)|Adverse Event|0|||
105727263|NCT05113940|364657269|FG010|Part A (18 Days)|Adverse Event|0|||
105727264|NCT05113940|364657270|FG011|Part A (18 Days)|Adverse Event|2|||
105727265|NCT05113940|364657271|FG012|Part A (18 Days)|Adverse Event|0|||
105727266|NCT05113940|364657272|FG013|Part A (18 Days)|Adverse Event|0|||
105727267|NCT05113940|364657273|FG014|Part A (18 Days)|Adverse Event|0|||
105727268|NCT05113940|364657259|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727269|NCT05113940|364657260|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727270|NCT05113940|364657261|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727271|NCT05113940|364657262|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727272|NCT05113940|364657263|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727273|NCT05113940|364657264|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727274|NCT05113940|364657265|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727275|NCT05113940|364657266|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727276|NCT05113940|364657267|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727277|NCT05113940|364657268|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727278|NCT05113940|364657269|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727279|NCT05113940|364657270|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727280|NCT05113940|364657271|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727281|NCT05113940|364657272|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727282|NCT05113940|364657273|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
105727283|NCT04026568|364657274|FG000|Overall Study|study terminated|0|||
105727284|NCT04026568|364657275|FG001|Overall Study|study terminated|1|||
105727285|NCT02561156|364657276|FG000|Part 2|Adverse Event|0|||
105727286|NCT02561156|364657277|FG001|Part 2|Adverse Event|0|||
105795042|NCT01289990|364906004|FG010|Overall Study|Not treated|1|||
105795043|NCT01289990|364906005|FG011|Overall Study|Not treated|2|||
105795044|NCT01289990|364906006|FG012|Overall Study|Not treated|0|||
105795045|NCT00758706|364906007|FG000|Overall Study|Adverse Event|4|||
105795046|NCT00758706|364906008|FG001|Overall Study|Adverse Event|4|||
105727287|NCT02561156|364657278|FG002|Part 2|Adverse Event|0|||
105795047|NCT01039584|364906009|FG000|Overall Study|Withdrawal by Subject|4|||
105727288|NCT02561156|364657279|FG003|Part 2|Adverse Event|0|||
105727289|NCT02561156|364657280|FG004|Part 2|Adverse Event|0|||
105727290|NCT02561156|364657281|FG005|Part 2|Adverse Event|0|||
105727291|NCT02561156|364657282|FG006|Part 2|Adverse Event|0|||
105727292|NCT02561156|364657283|FG007|Part 2|Adverse Event|0|||
105727293|NCT02561156|364657284|FG008|Part 2|Adverse Event|0|||
105727294|NCT02561156|364657285|FG009|Part 2|Adverse Event|0|||
105727295|NCT02561156|364657286|FG010|Part 2|Adverse Event|0|||
105727296|NCT02561156|364657287|FG011|Part 2|Adverse Event|1|||
105727297|NCT02561156|364657288|FG012|Part 2|Adverse Event|0|||
105727298|NCT04927312|364657289|FG000|Overall Study|Adverse Event|1|||
105727299|NCT04927312|364657289|FG000|Overall Study|Death|1|||
105727300|NCT04927312|364657289|FG000|Overall Study|Withdrawal by Subject|1|||
105727301|NCT04927312|364657289|FG000|Overall Study|Other|1|||
105727302|NCT04919564|364657292|FG000|Overall Study|Lost to Follow-up|1|||
105727303|NCT04919564|364657293|FG001|Overall Study|Lost to Follow-up|0|||
105727304|NCT04919564|364657292|FG000|Overall Study|Physician Decision|1|||
105727305|NCT04919564|364657293|FG001|Overall Study|Physician Decision|1|||
105727306|NCT00929240|364657299|FG000|Initial Treatment Phase|Adverse Event|31|||
105727307|NCT00929240|364657300|FG001|Initial Treatment Phase|Adverse Event|0|||
105727308|NCT00929240|364657301|FG002|Initial Treatment Phase|Adverse Event|0|||
105727309|NCT00929240|364657299|FG000|Initial Treatment Phase|Disease progression|41|||
105727310|NCT00929240|364657300|FG001|Initial Treatment Phase|Disease progression|0|||
105727311|NCT00929240|364657301|FG002|Initial Treatment Phase|Disease progression|0|||
105727312|NCT00929240|364657299|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
105727313|NCT00929240|364657300|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
105727314|NCT00929240|364657301|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
105727315|NCT00929240|364657299|FG000|Initial Treatment Phase|Protocol Violation|5|||
105727316|NCT00929240|364657300|FG001|Initial Treatment Phase|Protocol Violation|0|||
105727317|NCT00929240|364657301|FG002|Initial Treatment Phase|Protocol Violation|0|||
105727318|NCT00929240|364657299|FG000|Initial Treatment Phase|Death|2|||
105727319|NCT00929240|364657300|FG001|Initial Treatment Phase|Death|0|||
105727320|NCT00929240|364657301|FG002|Initial Treatment Phase|Death|0|||
105727321|NCT00929240|364657299|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
105727322|NCT00929240|364657300|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
105727323|NCT00929240|364657301|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
105727324|NCT00929240|364657299|FG000|Initial Treatment Phase|Physician Decision|4|||
105727325|NCT00929240|364657300|FG001|Initial Treatment Phase|Physician Decision|0|||
105727326|NCT00929240|364657301|FG002|Initial Treatment Phase|Physician Decision|0|||
105727327|NCT00929240|364657299|FG000|Maintenance Phase|Disease progression|0|||
105727328|NCT00929240|364657300|FG001|Maintenance Phase|Disease progression|73|||
105727329|NCT00929240|364657301|FG002|Maintenance Phase|Disease progression|60|||
105727330|NCT00929240|364657299|FG000|Maintenance Phase|Adverse Event|0|||
105727331|NCT00929240|364657300|FG001|Maintenance Phase|Adverse Event|9|||
105727332|NCT00929240|364657301|FG002|Maintenance Phase|Adverse Event|12|||
105727333|NCT00929240|364657299|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105727334|NCT00929240|364657300|FG001|Maintenance Phase|Withdrawal by Subject|2|||
105727335|NCT00929240|364657301|FG002|Maintenance Phase|Withdrawal by Subject|6|||
105727336|NCT00929240|364657299|FG000|Maintenance Phase|Protocol Violation|0|||
105727337|NCT00929240|364657300|FG001|Maintenance Phase|Protocol Violation|1|||
105727338|NCT00929240|364657301|FG002|Maintenance Phase|Protocol Violation|0|||
105727339|NCT00929240|364657299|FG000|Maintenance Phase|Health authority/Study termination|0|||
105727340|NCT00929240|364657300|FG001|Maintenance Phase|Health authority/Study termination|1|||
105727341|NCT00929240|364657301|FG002|Maintenance Phase|Health authority/Study termination|2|||
105727342|NCT00929240|364657299|FG000|Maintenance Phase|Physician Decision|0|||
105727343|NCT00929240|364657300|FG001|Maintenance Phase|Physician Decision|2|||
105727344|NCT00929240|364657301|FG002|Maintenance Phase|Physician Decision|1|||
105727345|NCT00929240|364657299|FG000|Maintenance Phase|Change of treatment|0|||
105727346|NCT00929240|364657300|FG001|Maintenance Phase|Change of treatment|4|||
105727347|NCT00929240|364657301|FG002|Maintenance Phase|Change of treatment|0|||
105727348|NCT00929240|364657299|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
105727349|NCT00929240|364657300|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
105727350|NCT00929240|364657301|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
105727351|NCT00929240|364657299|FG000|Maintenance Phase|Participant not treated|0|||
105727352|NCT00929240|364657300|FG001|Maintenance Phase|Participant not treated|2|||
105727353|NCT00929240|364657301|FG002|Maintenance Phase|Participant not treated|0|||
105727354|NCT00684814|364657302|FG000|Washout Period of 7 Days|Adverse Event|1|||
105727355|NCT00684814|364657303|FG001|Washout Period of 7 Days|Adverse Event|2|||
105727356|NCT00684814|364657302|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
105727357|NCT00684814|364657303|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
105727358|NCT00684814|364657302|FG000|Second Intervention|Adverse Event|1|||
105727359|NCT00684814|364657303|FG001|Second Intervention|Adverse Event|0|||
105727360|NCT02886715|364657306|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105727361|NCT02886715|364657307|FG001|Overall Study|Non-Compliance With Study Drug|2|||
105727362|NCT02886715|364657308|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105727363|NCT02886715|364657306|FG000|Overall Study|Adverse Event|4|||
105727364|NCT02886715|364657307|FG001|Overall Study|Adverse Event|2|||
105727365|NCT02886715|364657308|FG002|Overall Study|Adverse Event|0|||
105727366|NCT02886715|364657306|FG000|Overall Study|Lack of Efficacy|0|||
105727367|NCT02886715|364657307|FG001|Overall Study|Lack of Efficacy|2|||
105727368|NCT02886715|364657308|FG002|Overall Study|Lack of Efficacy|1|||
105727369|NCT02886715|364657306|FG000|Overall Study|Lost to Follow-up|29|||
105727370|NCT02886715|364657307|FG001|Overall Study|Lost to Follow-up|26|||
105727371|NCT02886715|364657308|FG002|Overall Study|Lost to Follow-up|10|||
105727372|NCT02886715|364657306|FG000|Overall Study|Pregnancy|1|||
105727373|NCT02886715|364657307|FG001|Overall Study|Pregnancy|1|||
105727374|NCT02886715|364657308|FG002|Overall Study|Pregnancy|1|||
105727375|NCT02886715|364657306|FG000|Overall Study|Protocol Violation|3|||
105727376|NCT02886715|364657307|FG001|Overall Study|Protocol Violation|2|||
105727377|NCT02886715|364657308|FG002|Overall Study|Protocol Violation|1|||
105727378|NCT02886715|364657306|FG000|Overall Study|Withdrawal by Subject|20|||
105727379|NCT02886715|364657307|FG001|Overall Study|Withdrawal by Subject|18|||
105727380|NCT02886715|364657308|FG002|Overall Study|Withdrawal by Subject|5|||
105727381|NCT02886715|364657306|FG000|Overall Study|missing|7|||
105727382|NCT02886715|364657307|FG001|Overall Study|missing|2|||
105727383|NCT02886715|364657308|FG002|Overall Study|missing|2|||
105727384|NCT00768560|364657311|FG000|Intervention Set 1|Adverse Event|0|||
105727385|NCT00768560|364657312|FG001|Intervention Set 1|Adverse Event|1|||
105727386|NCT00768560|364657313|FG002|Intervention Set 1|Adverse Event|0|||
105727387|NCT00768560|364657314|FG003|Intervention Set 1|Adverse Event|0|||
105727388|NCT00768560|364657315|FG004|Intervention Set 1|Adverse Event|0|||
105727389|NCT00768560|364657316|FG005|Intervention Set 1|Adverse Event|0|||
105727390|NCT01128387|364657317|FG000|Overall Study|Physician Decision|0|||
105727391|NCT01128387|364657318|FG001|Overall Study|Physician Decision|1|||
105727392|NCT02286102|364657322|FG000|Overall Study|Screen Failure|1|||
105727393|NCT02286102|364657323|FG001|Overall Study|Screen Failure|1|||
105727394|NCT01440101|364657324|FG000|Overall Study|Adverse Event|2|||
105727395|NCT01440101|364657325|FG001|Overall Study|Adverse Event|0|||
105727396|NCT01440101|364657326|FG002|Overall Study|Adverse Event|0|||
105727397|NCT01440101|364657324|FG000|Overall Study|Withdrawal by Subject|0|||
105727398|NCT01440101|364657325|FG001|Overall Study|Withdrawal by Subject|3|||
105727399|NCT01440101|364657326|FG002|Overall Study|Withdrawal by Subject|1|||
105727400|NCT01440101|364657324|FG000|Overall Study|Other|0|||
105727401|NCT01440101|364657325|FG001|Overall Study|Other|1|||
105727402|NCT01440101|364657326|FG002|Overall Study|Other|0|||
105727403|NCT00805207|364657327|FG000|Overall Study|Protocol Violation|0|||
105727404|NCT00805207|364657328|FG001|Overall Study|Protocol Violation|0|||
105727405|NCT00805207|364657329|FG002|Overall Study|Protocol Violation|1|||
105727406|NCT00805207|364657330|FG003|Overall Study|Protocol Violation|0|||
105727407|NCT00805207|364657331|FG004|Overall Study|Protocol Violation|0|||
105727408|NCT00805207|364657332|FG005|Overall Study|Protocol Violation|0|||
105727409|NCT00805207|364657333|FG006|Overall Study|Protocol Violation|0|||
105727410|NCT00805207|364657334|FG007|Overall Study|Protocol Violation|0|||
105727411|NCT00805207|364657335|FG008|Overall Study|Protocol Violation|0|||
105727412|NCT00805207|364657327|FG000|Overall Study|Physician Decision|0|||
105727413|NCT00805207|364657328|FG001|Overall Study|Physician Decision|1|||
105727414|NCT00805207|364657329|FG002|Overall Study|Physician Decision|0|||
105727415|NCT00805207|364657330|FG003|Overall Study|Physician Decision|0|||
105727416|NCT00805207|364657331|FG004|Overall Study|Physician Decision|0|||
105727417|NCT00805207|364657332|FG005|Overall Study|Physician Decision|1|||
105727418|NCT00805207|364657333|FG006|Overall Study|Physician Decision|0|||
105727419|NCT00805207|364657334|FG007|Overall Study|Physician Decision|0|||
105727420|NCT00805207|364657335|FG008|Overall Study|Physician Decision|0|||
105727421|NCT00805207|364657327|FG000|Overall Study|Withdrawal by Subject|0|||
105727422|NCT00805207|364657328|FG001|Overall Study|Withdrawal by Subject|1|||
105727423|NCT00805207|364657329|FG002|Overall Study|Withdrawal by Subject|0|||
105727424|NCT00805207|364657330|FG003|Overall Study|Withdrawal by Subject|0|||
105727425|NCT00805207|364657331|FG004|Overall Study|Withdrawal by Subject|1|||
105727426|NCT00805207|364657332|FG005|Overall Study|Withdrawal by Subject|2|||
105727427|NCT00805207|364657333|FG006|Overall Study|Withdrawal by Subject|0|||
105727428|NCT00805207|364657334|FG007|Overall Study|Withdrawal by Subject|0|||
105727429|NCT00805207|364657335|FG008|Overall Study|Withdrawal by Subject|0|||
105727430|NCT00064701|364657336|FG000|One Year Post-transplant|Did not receive study drug|7|||
105727431|NCT00064701|364657337|FG001|One Year Post-transplant|Did not receive study drug|12|||
105353266|NCT00703326|363298486|FG001|Overall Study|Withdrawal by Subject|20|||
105353267|NCT00703326|363298485|FG000|Overall Study|Adverse Event|1|||
105353268|NCT00703326|363298486|FG001|Overall Study|Adverse Event|0|||
105727432|NCT00064701|364657338|FG002|One Year Post-transplant|Did not receive study drug|11|||
105727433|NCT00064701|364657336|FG000|One Year Post-transplant|Adverse Event|23|||
105727434|NCT00064701|364657337|FG001|One Year Post-transplant|Adverse Event|19|||
105727435|NCT00064701|364657338|FG002|One Year Post-transplant|Adverse Event|37|||
105727436|NCT00064701|364657336|FG000|One Year Post-transplant|Rejection|0|||
105727437|NCT00064701|364657337|FG001|One Year Post-transplant|Rejection|1|||
105727438|NCT00064701|364657338|FG002|One Year Post-transplant|Rejection|16|||
105727439|NCT00064701|364657336|FG000|One Year Post-transplant|Non-compliance|4|||
105727440|NCT00064701|364657337|FG001|One Year Post-transplant|Non-compliance|2|||
105727441|NCT00064701|364657338|FG002|One Year Post-transplant|Non-compliance|5|||
105727442|NCT00064701|364657336|FG000|One Year Post-transplant|Graft Failure|3|||
105727443|NCT00064701|364657337|FG001|One Year Post-transplant|Graft Failure|2|||
105727444|NCT00064701|364657338|FG002|One Year Post-transplant|Graft Failure|1|||
105727445|NCT00064701|364657336|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
105727446|NCT00064701|364657337|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
105727447|NCT00064701|364657338|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
105727448|NCT00064701|364657336|FG000|One Year Post-transplant|Lost to Follow-up|1|||
105727449|NCT00064701|364657337|FG001|One Year Post-transplant|Lost to Follow-up|0|||
105727450|NCT00064701|364657338|FG002|One Year Post-transplant|Lost to Follow-up|0|||
105727451|NCT00064701|364657336|FG000|One Year Post-transplant|Converted to rapamycin|1|||
105727452|NCT00064701|364657337|FG001|One Year Post-transplant|Converted to rapamycin|0|||
105727453|NCT00064701|364657338|FG002|One Year Post-transplant|Converted to rapamycin|0|||
105727454|NCT00064701|364657336|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
105727455|NCT00064701|364657337|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
105727456|NCT00064701|364657338|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
105727457|NCT00064701|364657336|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
105727458|NCT00064701|364657337|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
105727459|NCT00064701|364657338|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
105727460|NCT00064701|364657336|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
105727461|NCT00064701|364657337|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
105727462|NCT00064701|364657338|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
105727463|NCT00064701|364657336|FG000|One Year Post-transplant|Poor absorption|0|||
105727464|NCT00064701|364657337|FG001|One Year Post-transplant|Poor absorption|1|||
105727465|NCT00064701|364657338|FG002|One Year Post-transplant|Poor absorption|0|||
105727466|NCT00064701|364657336|FG000|One Year Post-transplant|Pancreas transplant|0|||
105727467|NCT00064701|364657337|FG001|One Year Post-transplant|Pancreas transplant|0|||
105727468|NCT00064701|364657338|FG002|One Year Post-transplant|Pancreas transplant|1|||
105727469|NCT00064701|364657336|FG000|Clinical Continuation Phase|Adverse Event|12|||
105727470|NCT00064701|364657337|FG001|Clinical Continuation Phase|Adverse Event|21|||
105727471|NCT00064701|364657338|FG002|Clinical Continuation Phase|Adverse Event|14|||
105727472|NCT00064701|364657336|FG000|Clinical Continuation Phase|Non-compliance|8|||
105727473|NCT00064701|364657337|FG001|Clinical Continuation Phase|Non-compliance|6|||
105727474|NCT00064701|364657338|FG002|Clinical Continuation Phase|Non-compliance|7|||
105727475|NCT00064701|364657336|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
105727476|NCT00064701|364657337|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
105727477|NCT00064701|364657338|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
105727478|NCT00064701|364657336|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
105727479|NCT00064701|364657337|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
105727480|NCT00064701|364657338|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
105727481|NCT00064701|364657336|FG000|Clinical Continuation Phase|Graft Failure|5|||
105727482|NCT00064701|364657337|FG001|Clinical Continuation Phase|Graft Failure|5|||
105727483|NCT00064701|364657338|FG002|Clinical Continuation Phase|Graft Failure|2|||
105727484|NCT00064701|364657336|FG000|Clinical Continuation Phase|Rejection|1|||
105727485|NCT00064701|364657337|FG001|Clinical Continuation Phase|Rejection|2|||
105727486|NCT00064701|364657338|FG002|Clinical Continuation Phase|Rejection|2|||
105727487|NCT00064701|364657336|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
105727488|NCT00064701|364657337|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
105727489|NCT00064701|364657338|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
105727490|NCT00064701|364657336|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
105727491|NCT00064701|364657337|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
105727492|NCT00064701|364657338|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
105727493|NCT00064701|364657336|FG000|Clinical Continuation Phase|Physician Decision|1|||
105727494|NCT00064701|364657337|FG001|Clinical Continuation Phase|Physician Decision|3|||
105727495|NCT00064701|364657338|FG002|Clinical Continuation Phase|Physician Decision|0|||
105727496|NCT00064701|364657336|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
105727497|NCT00064701|364657337|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
105727498|NCT00064701|364657338|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
105727499|NCT00064701|364657336|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
105727500|NCT00064701|364657337|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
105727501|NCT00064701|364657338|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
105727502|NCT00064701|364657336|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
105727503|NCT00064701|364657337|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
105727504|NCT00064701|364657338|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
105727505|NCT00064701|364657336|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
105727506|NCT00064701|364657337|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
105727507|NCT00064701|364657338|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
105727508|NCT00064701|364657336|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
105727509|NCT00064701|364657337|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
105727510|NCT00064701|364657338|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
105727511|NCT00064701|364657336|FG000|Clinical Continuation Phase|Patient opted out|0|||
105727512|NCT00064701|364657337|FG001|Clinical Continuation Phase|Patient opted out|0|||
105727513|NCT00064701|364657338|FG002|Clinical Continuation Phase|Patient opted out|1|||
105727514|NCT02469246|364657339|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
105727515|NCT02469246|364657340|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
105727516|NCT02469246|364657339|FG000|Double-Blind Phase|Adverse Event|12|||
105727517|NCT02469246|364657340|FG001|Double-Blind Phase|Adverse Event|9|||
105727518|NCT02469246|364657339|FG000|Double-Blind Phase|Death|2|||
105727519|NCT02469246|364657340|FG001|Double-Blind Phase|Death|0|||
105727520|NCT02469246|364657339|FG000|Double-Blind Phase|Lack of Efficacy|2|||
105727521|NCT02469246|364657340|FG001|Double-Blind Phase|Lack of Efficacy|1|||
105727522|NCT02469246|364657339|FG000|Double-Blind Phase|Investigator's Discretion|8|||
105727523|NCT02469246|364657340|FG001|Double-Blind Phase|Investigator's Discretion|8|||
105727524|NCT02469246|364657339|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
105727525|NCT02469246|364657340|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
105727526|NCT02469246|364657339|FG000|Double-Blind Phase|Protocol Violation|1|||
105727527|NCT02469246|364657340|FG001|Double-Blind Phase|Protocol Violation|1|||
105727528|NCT02469246|364657339|FG000|Double-Blind Phase|Withdrew Consent|25|||
105727529|NCT02469246|364657340|FG001|Double-Blind Phase|Withdrew Consent|25|||
105727530|NCT02469246|364657339|FG000|Double-Blind Phase|Lost to Follow-up|9|||
105727531|NCT02469246|364657340|FG001|Double-Blind Phase|Lost to Follow-up|5|||
105727532|NCT01491945|364657344|FG000|Overall Study|Death|30|||
105727533|NCT01491945|364657344|FG000|Overall Study|Withdrwan/LTF|16|||
105727534|NCT01491945|364657344|FG000|Overall Study|Conversion|4|||
105727535|NCT01491945|364657344|FG000|Overall Study|Missed Visit|1|||
105727536|NCT02201940|364657345|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
105727537|NCT02201940|364657346|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
105727538|NCT02201940|364657345|FG000|Overall Study|Lack of Efficacy|2|||
105727539|NCT02201940|364657346|FG001|Overall Study|Lack of Efficacy|113|||
105727540|NCT02201940|364657345|FG000|Overall Study|Lost to Follow-up|5|||
105727541|NCT02201940|364657346|FG001|Overall Study|Lost to Follow-up|0|||
105727542|NCT02201940|364657345|FG000|Overall Study|Withdrew Consent|2|||
105727543|NCT02201940|364657346|FG001|Overall Study|Withdrew Consent|1|||
105727544|NCT02201940|364657345|FG000|Overall Study|Investigator's Discretion|1|||
105727545|NCT02201940|364657346|FG001|Overall Study|Investigator's Discretion|1|||
105727546|NCT02201940|364657345|FG000|Overall Study|Death|1|||
105727547|NCT02201940|364657346|FG001|Overall Study|Death|0|||
105727548|NCT02201940|364657345|FG000|Overall Study|Adverse Event|0|||
105727549|NCT02201940|364657346|FG001|Overall Study|Adverse Event|1|||
105727550|NCT03466411|364657347|FG000|Overall Study|Lost to Follow-up|0|||
105727551|NCT03466411|364657348|FG001|Overall Study|Lost to Follow-up|1|||
105727552|NCT03466411|364657349|FG002|Overall Study|Lost to Follow-up|1|||
105727553|NCT03466411|364657350|FG003|Overall Study|Lost to Follow-up|0|||
105727554|NCT03466411|364657351|FG004|Overall Study|Lost to Follow-up|0|||
105727555|NCT03466411|364657352|FG005|Overall Study|Lost to Follow-up|0|||
105727556|NCT03466411|364657353|FG006|Overall Study|Lost to Follow-up|1|||
105727557|NCT03466411|364657354|FG007|Overall Study|Lost to Follow-up|1|||
105727558|NCT03466411|364657355|FG008|Overall Study|Lost to Follow-up|0|||
105727559|NCT03466411|364657356|FG009|Overall Study|Lost to Follow-up|1|||
105727560|NCT03466411|364657357|FG010|Overall Study|Lost to Follow-up|1|||
105727561|NCT03466411|364657358|FG011|Overall Study|Lost to Follow-up|1|||
105727562|NCT03466411|364657359|FG012|Overall Study|Lost to Follow-up|0|||
105727563|NCT03466411|364657347|FG000|Overall Study|Withdrawal by Subject|14|||
105727564|NCT03466411|364657348|FG001|Overall Study|Withdrawal by Subject|7|||
105727565|NCT03466411|364657349|FG002|Overall Study|Withdrawal by Subject|8|||
105727566|NCT03466411|364657350|FG003|Overall Study|Withdrawal by Subject|4|||
105727567|NCT03466411|364657351|FG004|Overall Study|Withdrawal by Subject|6|||
105727568|NCT03466411|364657352|FG005|Overall Study|Withdrawal by Subject|3|||
105353269|NCT01190189|363298487|FG000|Overall Study|Lost to Follow-up|4|||
105795048|NCT01039584|364906010|FG001|Overall Study|Withdrawal by Subject|2|||
105795049|NCT01039584|364906011|FG002|Overall Study|Withdrawal by Subject|1|||
105795050|NCT01039584|364906009|FG000|Overall Study|Protocol Violation|10|||
105795051|NCT01039584|364906010|FG001|Overall Study|Protocol Violation|4|||
105795052|NCT01039584|364906011|FG002|Overall Study|Protocol Violation|6|||
105795053|NCT01039584|364906009|FG000|Overall Study|Lost to Follow-up|5|||
105795054|NCT01039584|364906010|FG001|Overall Study|Lost to Follow-up|3|||
105795055|NCT01039584|364906011|FG002|Overall Study|Lost to Follow-up|4|||
105795056|NCT01039584|364906009|FG000|Overall Study|Negative Baseline culture for Candida|59|||
105795057|NCT01039584|364906010|FG001|Overall Study|Negative Baseline culture for Candida|59|||
105795058|NCT01039584|364906011|FG002|Overall Study|Negative Baseline culture for Candida|24|||
105795059|NCT01039584|364906009|FG000|Overall Study|Lack of Efficacy|7|||
105795060|NCT01039584|364906010|FG001|Overall Study|Lack of Efficacy|6|||
105795061|NCT01039584|364906011|FG002|Overall Study|Lack of Efficacy|10|||
105795062|NCT01039584|364906009|FG000|Overall Study|other|1|||
105795063|NCT01039584|364906010|FG001|Overall Study|other|3|||
105795064|NCT01039584|364906011|FG002|Overall Study|other|1|||
105727569|NCT03466411|364657353|FG006|Overall Study|Withdrawal by Subject|6|||
105727570|NCT03466411|364657354|FG007|Overall Study|Withdrawal by Subject|9|||
105727571|NCT03466411|364657355|FG008|Overall Study|Withdrawal by Subject|6|||
105727572|NCT03466411|364657356|FG009|Overall Study|Withdrawal by Subject|11|||
105727573|NCT03466411|364657357|FG010|Overall Study|Withdrawal by Subject|14|||
105727574|NCT03466411|364657358|FG011|Overall Study|Withdrawal by Subject|12|||
105727575|NCT03466411|364657359|FG012|Overall Study|Withdrawal by Subject|7|||
105727576|NCT03466411|364657347|FG000|Overall Study|Other|1|||
105727577|NCT03466411|364657348|FG001|Overall Study|Other|1|||
105727578|NCT03466411|364657349|FG002|Overall Study|Other|0|||
105727579|NCT03466411|364657350|FG003|Overall Study|Other|1|||
105727580|NCT03466411|364657351|FG004|Overall Study|Other|2|||
105727581|NCT03466411|364657352|FG005|Overall Study|Other|0|||
105727582|NCT03466411|364657353|FG006|Overall Study|Other|0|||
105727583|NCT03466411|364657354|FG007|Overall Study|Other|0|||
105727584|NCT03466411|364657355|FG008|Overall Study|Other|0|||
105727585|NCT03466411|364657356|FG009|Overall Study|Other|1|||
105727586|NCT03466411|364657357|FG010|Overall Study|Other|2|||
105727587|NCT03466411|364657358|FG011|Overall Study|Other|0|||
105727588|NCT03466411|364657359|FG012|Overall Study|Other|0|||
105727589|NCT03466411|364657347|FG000|Overall Study|Randomized but not Treated|0|||
105727590|NCT03466411|364657348|FG001|Overall Study|Randomized but not Treated|0|||
105727591|NCT03466411|364657349|FG002|Overall Study|Randomized but not Treated|0|||
105727592|NCT03466411|364657350|FG003|Overall Study|Randomized but not Treated|0|||
105727593|NCT03466411|364657351|FG004|Overall Study|Randomized but not Treated|0|||
105795065|NCT01039584|364906009|FG000|Overall Study|Pap smear with significant pathology|10|||
105727594|NCT03466411|364657352|FG005|Overall Study|Randomized but not Treated|0|||
105795066|NCT01039584|364906010|FG001|Overall Study|Pap smear with significant pathology|10|||
105795067|NCT01039584|364906011|FG002|Overall Study|Pap smear with significant pathology|3|||
105795068|NCT01039584|364906009|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
105795069|NCT01039584|364906010|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
105795070|NCT01039584|364906011|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
105795071|NCT00929864|364906014|FG000|Overall Study|Death|1|||
105795072|NCT00929864|364906015|FG001|Overall Study|Death|1|||
105795073|NCT00929864|364906014|FG000|Overall Study|Adverse Event|11|||
105795074|NCT00929864|364906015|FG001|Overall Study|Adverse Event|30|||
105795075|NCT00929864|364906014|FG000|Overall Study|Lack of Efficacy|19|||
105795076|NCT00929864|364906015|FG001|Overall Study|Lack of Efficacy|16|||
105795077|NCT00929864|364906014|FG000|Overall Study|Lost to Follow-up|7|||
105795078|NCT00929864|364906015|FG001|Overall Study|Lost to Follow-up|12|||
105795079|NCT00929864|364906014|FG000|Overall Study|Withdrawal by Subject|20|||
105795080|NCT00929864|364906015|FG001|Overall Study|Withdrawal by Subject|9|||
105795081|NCT00929864|364906014|FG000|Overall Study|No longer met criteria|2|||
105795082|NCT00929864|364906015|FG001|Overall Study|No longer met criteria|1|||
105795083|NCT00929864|364906014|FG000|Overall Study|Poor or non-compliance|3|||
105795084|NCT00929864|364906015|FG001|Overall Study|Poor or non-compliance|3|||
105795085|NCT00929864|364906014|FG000|Overall Study|Pregnancy|0|||
105795086|NCT00929864|364906015|FG001|Overall Study|Pregnancy|3|||
105795087|NCT00929864|364906014|FG000|Overall Study|Administrative reason by Sponsor|1|||
105795088|NCT00929864|364906015|FG001|Overall Study|Administrative reason by Sponsor|1|||
105795089|NCT00929864|364906014|FG000|Overall Study|Non-specified|2|||
105795090|NCT00929864|364906015|FG001|Overall Study|Non-specified|7|||
105795091|NCT01494649|364906016|FG000|Overall Study|Lost to Follow-up|0|||
105795092|NCT01494649|364906017|FG001|Overall Study|Lost to Follow-up|1|||
105795093|NCT01656967|364906020|FG000|Overall Study|faulty monitor|1|||
105795094|NCT01656967|364906021|FG001|Overall Study|faulty monitor|0|||
105795095|NCT01656967|364906020|FG000|Overall Study|unsuccessful ETT insertion|3|||
105795096|NCT01656967|364906021|FG001|Overall Study|unsuccessful ETT insertion|2|||
105795097|NCT01174368|364906022|FG000|Overall Study|Withdrawal by Subject|1|||
105795098|NCT03454672|364906023|FG000|Overall Study|Adverse Event|1|||
105795099|NCT03454672|364906024|FG001|Overall Study|Adverse Event|1|||
105795100|NCT03454672|364906023|FG000|Overall Study|Lost to Follow-up|1|||
105795101|NCT03454672|364906024|FG001|Overall Study|Lost to Follow-up|3|||
105795102|NCT03454672|364906023|FG000|Overall Study|painful|1|||
105795103|NCT03454672|364906024|FG001|Overall Study|painful|2|||
105795104|NCT03454672|364906023|FG000|Overall Study|Non-compliance|2|||
105795105|NCT03454672|364906024|FG001|Overall Study|Non-compliance|4|||
105795106|NCT03454672|364906023|FG000|Overall Study|personal reasons|3|||
105795107|NCT03454672|364906024|FG001|Overall Study|personal reasons|2|||
105795108|NCT03454672|364906023|FG000|Overall Study|Withdrawal by Subject|1|||
105795109|NCT03454672|364906024|FG001|Overall Study|Withdrawal by Subject|0|||
105795110|NCT05166512|364906025|FG000|Randomized|Lost to Follow-up|2|||
105795111|NCT05166512|364906026|FG001|Randomized|Lost to Follow-up|0|||
105795112|NCT05166512|364906025|FG000|Randomized|Withdrawal by Subject|1|||
105795113|NCT05166512|364906026|FG001|Randomized|Withdrawal by Subject|0|||
105795114|NCT05166512|364906025|FG000|Baseline Data Collection|Lost to Follow-up|0|||
105795115|NCT05166512|364906026|FG001|Baseline Data Collection|Lost to Follow-up|3|||
105795116|NCT05166512|364906025|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
105795117|NCT05166512|364906026|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
105795118|NCT05166512|364906025|FG000|Baseline Data Collection|Protocol Violation|2|||
105795119|NCT05166512|364906026|FG001|Baseline Data Collection|Protocol Violation|0|||
105795120|NCT05166512|364906025|FG000|4 Month Data Collection|Lost to Follow-up|1|||
105795121|NCT05166512|364906026|FG001|4 Month Data Collection|Lost to Follow-up|0|||
105795122|NCT05166512|364906025|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
105795123|NCT05166512|364906026|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
105795124|NCT05166512|364906025|FG000|12 Month Data Collection|Lost to Follow-up|3|||
105795125|NCT05166512|364906026|FG001|12 Month Data Collection|Lost to Follow-up|1|||
105795126|NCT05166512|364906025|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
105795127|NCT05166512|364906026|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
105795128|NCT03985293|364906027|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
105795129|NCT03985293|364906028|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
105795130|NCT03985293|364906029|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
105795131|NCT03985293|364906030|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
105795132|NCT03985293|364906031|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
105795133|NCT03985293|364906032|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
105795134|NCT03985293|364906027|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
105795135|NCT03985293|364906028|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
105795136|NCT03985293|364906029|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
105795137|NCT03985293|364906030|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
105795138|NCT03985293|364906031|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
105795139|NCT03985293|364906032|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
105795140|NCT03985293|364906027|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
105795141|NCT03985293|364906028|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
105795142|NCT03985293|364906029|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
105795143|NCT03985293|364906030|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
105795144|NCT03985293|364906031|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
105795145|NCT03985293|364906032|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
105795146|NCT03985293|364906027|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
105795147|NCT03985293|364906028|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
105727595|NCT03466411|364657353|FG006|Overall Study|Randomized but not Treated|1|||
105727596|NCT03466411|364657354|FG007|Overall Study|Randomized but not Treated|0|||
105727597|NCT03466411|364657355|FG008|Overall Study|Randomized but not Treated|0|||
105727598|NCT03466411|364657356|FG009|Overall Study|Randomized but not Treated|0|||
105727599|NCT03466411|364657357|FG010|Overall Study|Randomized but not Treated|0|||
105727600|NCT03466411|364657358|FG011|Overall Study|Randomized but not Treated|0|||
105727601|NCT03466411|364657359|FG012|Overall Study|Randomized but not Treated|0|||
105727602|NCT00074958|364657360|FG000|Overall Study|Adverse Event|1|||
105727603|NCT03770403|364657361|FG000|Overall Study|Adverse Event|8|||
105727604|NCT03770403|364657361|FG000|Overall Study|Death|5|||
105727605|NCT03770403|364657361|FG000|Overall Study|Physician Decision|1|||
105727606|NCT03770403|364657361|FG000|Overall Study|Sponsor decision|1|||
105727607|NCT03770403|364657361|FG000|Overall Study|Study terminated by Sponsor|1|||
105727608|NCT03770403|364657361|FG000|Overall Study|Withdrawal by Subject|13|||
105727609|NCT03770403|364657361|FG000|Overall Study|Other|88|||
105727610|NCT00552110|364657364|FG000|Overall Study|Serious or Life-Threatening AE|0|||
105727611|NCT00552110|364657365|FG001|Overall Study|Serious or Life-Threatening AE|0|||
105727612|NCT00552110|364657366|FG002|Overall Study|Serious or Life-Threatening AE|1|||
105727613|NCT00552110|364657367|FG003|Overall Study|Serious or Life-Threatening AE|0|||
105727614|NCT00552110|364657368|FG004|Overall Study|Serious or Life-Threatening AE|0|||
105727615|NCT00552110|364657364|FG000|Overall Study|Lack of Efficacy|1|||
105727616|NCT00552110|364657365|FG001|Overall Study|Lack of Efficacy|0|||
105727617|NCT00552110|364657366|FG002|Overall Study|Lack of Efficacy|0|||
105727618|NCT00552110|364657367|FG003|Overall Study|Lack of Efficacy|1|||
105727619|NCT00552110|364657368|FG004|Overall Study|Lack of Efficacy|4|||
105727620|NCT00552110|364657364|FG000|Overall Study|Withdrawal by Subject|0|||
105727621|NCT00552110|364657365|FG001|Overall Study|Withdrawal by Subject|2|||
105727622|NCT00552110|364657366|FG002|Overall Study|Withdrawal by Subject|0|||
105727623|NCT00552110|364657367|FG003|Overall Study|Withdrawal by Subject|3|||
105727624|NCT00552110|364657368|FG004|Overall Study|Withdrawal by Subject|2|||
105727625|NCT00552110|364657364|FG000|Overall Study|Lost to Follow-up|0|||
105727626|NCT00552110|364657365|FG001|Overall Study|Lost to Follow-up|0|||
105727627|NCT00552110|364657366|FG002|Overall Study|Lost to Follow-up|0|||
105727628|NCT00552110|364657367|FG003|Overall Study|Lost to Follow-up|1|||
105727629|NCT00552110|364657368|FG004|Overall Study|Lost to Follow-up|1|||
105727630|NCT00552110|364657364|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
105727631|NCT00552110|364657365|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
105727632|NCT00552110|364657366|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
105727633|NCT00552110|364657367|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
105727634|NCT00552110|364657368|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
105727635|NCT00552110|364657364|FG000|Overall Study|Withdrawn per Sponsor|0|||
105727636|NCT00552110|364657365|FG001|Overall Study|Withdrawn per Sponsor|1|||
105795148|NCT03985293|364906029|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
105727637|NCT00552110|364657366|FG002|Overall Study|Withdrawn per Sponsor|0|||
105727638|NCT00552110|364657367|FG003|Overall Study|Withdrawn per Sponsor|0|||
105727639|NCT00552110|364657368|FG004|Overall Study|Withdrawn per Sponsor|1|||
105727640|NCT00552110|364657364|FG000|Overall Study|Use of Prohibited Medication|1|||
105727641|NCT00552110|364657365|FG001|Overall Study|Use of Prohibited Medication|1|||
105795149|NCT03985293|364906030|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
105795150|NCT03985293|364906031|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
105795151|NCT03985293|364906032|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
105727642|NCT00552110|364657366|FG002|Overall Study|Use of Prohibited Medication|0|||
105727643|NCT00552110|364657367|FG003|Overall Study|Use of Prohibited Medication|0|||
105727644|NCT00552110|364657368|FG004|Overall Study|Use of Prohibited Medication|0|||
105727645|NCT00552110|364657364|FG000|Overall Study|Delay of Study due to Relabeling|0|||
105727646|NCT00552110|364657365|FG001|Overall Study|Delay of Study due to Relabeling|0|||
105727647|NCT00552110|364657366|FG002|Overall Study|Delay of Study due to Relabeling|0|||
105727648|NCT00552110|364657367|FG003|Overall Study|Delay of Study due to Relabeling|1|||
105727649|NCT00552110|364657368|FG004|Overall Study|Delay of Study due to Relabeling|0|||
105727650|NCT00552110|364657364|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
105727651|NCT00552110|364657365|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
105727652|NCT00552110|364657366|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
105727653|NCT00552110|364657367|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
105727654|NCT00552110|364657368|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
105727655|NCT00552110|364657364|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
105727656|NCT00552110|364657365|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
105727657|NCT00552110|364657366|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
105727658|NCT00552110|364657367|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
105727659|NCT00552110|364657368|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
105727660|NCT04325503|364657381|FG000|Overall Study|Withdrawal by Subject|1|||
105727661|NCT04325503|364657381|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
105727662|NCT01856114|364657383|FG000|Overall Study|Withdrawal by Subject|1|||
105727663|NCT01856114|364657384|FG001|Overall Study|Withdrawal by Subject|0|||
105727664|NCT01856114|364657383|FG000|Overall Study|Adverse Event|1|||
105727665|NCT01856114|364657384|FG001|Overall Study|Adverse Event|0|||
105727666|NCT01642212|364657385|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
105727667|NCT01642212|364657386|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
105727668|NCT01642212|364657387|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
105727669|NCT01642212|364657388|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
105727670|NCT01642212|364657389|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
105727671|NCT01642212|364657385|FG000|Double-blind Treatment|Other|0|||
105727672|NCT01642212|364657386|FG001|Double-blind Treatment|Other|2|||
105727673|NCT01642212|364657387|FG002|Double-blind Treatment|Other|1|||
105727674|NCT01642212|364657388|FG003|Double-blind Treatment|Other|0|||
105727675|NCT01642212|364657389|FG004|Double-blind Treatment|Other|0|||
105727676|NCT01642212|364657385|FG000|Double-blind Treatment|Non-compliance|0|||
105727677|NCT01642212|364657386|FG001|Double-blind Treatment|Non-compliance|1|||
105727678|NCT01642212|364657387|FG002|Double-blind Treatment|Non-compliance|0|||
105727679|NCT01642212|364657388|FG003|Double-blind Treatment|Non-compliance|0|||
105727680|NCT01642212|364657389|FG004|Double-blind Treatment|Non-compliance|0|||
105727681|NCT01642212|364657385|FG000|Double-blind Treatment|Adverse Event|0|||
105727682|NCT01642212|364657386|FG001|Double-blind Treatment|Adverse Event|0|||
105727683|NCT01642212|364657387|FG002|Double-blind Treatment|Adverse Event|1|||
105727684|NCT01642212|364657388|FG003|Double-blind Treatment|Adverse Event|0|||
105727685|NCT01642212|364657389|FG004|Double-blind Treatment|Adverse Event|0|||
105727686|NCT01642212|364657385|FG000|Open-label Extension|Adverse Event|0|||
105727687|NCT01642212|364657386|FG001|Open-label Extension|Adverse Event|0|||
105727688|NCT01642212|364657387|FG002|Open-label Extension|Adverse Event|0|||
105727689|NCT01642212|364657388|FG003|Open-label Extension|Adverse Event|3|||
105727690|NCT01642212|364657389|FG004|Open-label Extension|Adverse Event|0|||
105727691|NCT01642212|364657385|FG000|Open-label Extension|Sponsor Decision|0|||
105727692|NCT01642212|364657386|FG001|Open-label Extension|Sponsor Decision|0|||
105727693|NCT01642212|364657387|FG002|Open-label Extension|Sponsor Decision|0|||
105727694|NCT01642212|364657388|FG003|Open-label Extension|Sponsor Decision|7|||
105727695|NCT01642212|364657389|FG004|Open-label Extension|Sponsor Decision|4|||
105727696|NCT01642212|364657385|FG000|Open-label Extension|Consent Withdrawn|0|||
105727697|NCT01642212|364657386|FG001|Open-label Extension|Consent Withdrawn|0|||
105727698|NCT01642212|364657387|FG002|Open-label Extension|Consent Withdrawn|0|||
105727699|NCT01642212|364657388|FG003|Open-label Extension|Consent Withdrawn|0|||
105727700|NCT01642212|364657389|FG004|Open-label Extension|Consent Withdrawn|2|||
105727701|NCT01642212|364657385|FG000|Open-label Extension|Lost to Follow-up|0|||
105727702|NCT01642212|364657386|FG001|Open-label Extension|Lost to Follow-up|0|||
105727703|NCT01642212|364657387|FG002|Open-label Extension|Lost to Follow-up|0|||
105727704|NCT01642212|364657388|FG003|Open-label Extension|Lost to Follow-up|0|||
105727705|NCT01642212|364657389|FG004|Open-label Extension|Lost to Follow-up|1|||
105727706|NCT01642212|364657385|FG000|Open-label Extension|Other|0|||
105727707|NCT01642212|364657386|FG001|Open-label Extension|Other|0|||
105727708|NCT01642212|364657387|FG002|Open-label Extension|Other|0|||
105727709|NCT01642212|364657388|FG003|Open-label Extension|Other|0|||
105727710|NCT01642212|364657389|FG004|Open-label Extension|Other|1|||
105727711|NCT00613626|364657393|FG000|Overall Study|Ineligible|0|||
105727712|NCT00613626|364657394|FG001|Overall Study|Ineligible|1|||
105727713|NCT00613626|364657395|FG002|Overall Study|Ineligible|0|||
105727714|NCT00957853|364657396|FG000|Overall Study|Withdrawal by Subject|1|||
105727715|NCT00957853|364657397|FG001|Overall Study|Withdrawal by Subject|0|||
105727716|NCT00957853|364657398|FG002|Overall Study|Withdrawal by Subject|0|||
105727717|NCT00004980|364657399|FG000|Overall Study|Withdrawal by Subject|1|||
105727718|NCT00004980|364657400|FG001|Overall Study|Withdrawal by Subject|0|||
105727719|NCT00004980|364657399|FG000|Overall Study|memory difficulties|1|||
105727720|NCT00004980|364657400|FG001|Overall Study|memory difficulties|1|||
105727721|NCT00004980|364657399|FG000|Overall Study|Physician Decision|0|||
105727722|NCT00004980|364657400|FG001|Overall Study|Physician Decision|1|||
105727723|NCT01299025|364657401|FG000|Overall Study|Withdrawal by Subject|2|||
105727724|NCT01299025|364657402|FG001|Overall Study|Withdrawal by Subject|1|||
105727725|NCT01299025|364657401|FG000|Overall Study|Lost to Follow-up|1|||
105727726|NCT01299025|364657402|FG001|Overall Study|Lost to Follow-up|0|||
105727727|NCT03212261|364657403|FG000|Overall Study|Became ineligible d/t tech|2|||
105727728|NCT03212261|364657403|FG000|Overall Study|Tech Trouble- No first study visit|1|||
105727729|NCT03212261|364657403|FG000|Overall Study|Lost to Follow-up|7|||
105727730|NCT03212261|364657403|FG000|Overall Study|Family Emergency|1|||
105727731|NCT03212261|364657403|FG000|Overall Study|Too busy/ No time|5|||
105727732|NCT02722044|364657404|FG000|Overall Study|Adverse Event|2|||
105727733|NCT02722044|364657404|FG000|Overall Study|Physician Decision|1|||
105727734|NCT02722044|364657404|FG000|Overall Study|Withdrawal by Subject|1|||
105727735|NCT02722044|364657404|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
105727736|NCT04885257|364657405|FG000|Overall Study|Withdrawal by Subject|1|||
105727737|NCT04885257|364657406|FG001|Overall Study|Withdrawal by Subject|0|||
105727738|NCT00256295|364657407|FG000|Overall Study|Withdrawal by Subject|3|||
105727739|NCT00256295|364657407|FG000|Overall Study|Death|1|||
105727740|NCT01682044|364657408|FG000|Overall Study|Death|1|||
105727741|NCT01682044|364657408|FG000|Overall Study|Progression|3|||
105727742|NCT03945773|364659550|FG000|Overall Study|Consent Withdrawn|1|||
105727743|NCT03945773|364659551|FG001|Overall Study|Consent Withdrawn|1|||
105727744|NCT03945773|364659550|FG000|Overall Study|Lost to Follow-up|1|||
105727745|NCT03945773|364659551|FG001|Overall Study|Lost to Follow-up|0|||
105727746|NCT03945773|364659550|FG000|Overall Study|Death|46|||
105727747|NCT03945773|364659551|FG001|Overall Study|Death|22|||
105727748|NCT03945773|364659550|FG000|Overall Study|Physician Decision|1|||
105727749|NCT03945773|364659551|FG001|Overall Study|Physician Decision|0|||
105727750|NCT03945773|364659550|FG000|Overall Study|Other|1|||
105727751|NCT03945773|364659551|FG001|Overall Study|Other|0|||
105727752|NCT03945773|364659550|FG000|Overall Study|Ongoing at the time of DCO|4|||
105727753|NCT03945773|364659551|FG001|Overall Study|Ongoing at the time of DCO|3|||
105727754|NCT05630846|364659552|FG000|Overall Study|Death|1|||
105727755|NCT05630846|364659553|FG001|Overall Study|Death|0|||
105727756|NCT05630846|364659554|FG002|Overall Study|Death|0|||
105727757|NCT05630846|364659555|FG003|Overall Study|Death|0|||
105727758|NCT05630846|364659552|FG000|Overall Study|Withdrawal by Subject|3|||
105727759|NCT05630846|364659553|FG001|Overall Study|Withdrawal by Subject|3|||
105727760|NCT05630846|364659554|FG002|Overall Study|Withdrawal by Subject|4|||
105727761|NCT05630846|364659555|FG003|Overall Study|Withdrawal by Subject|1|||
105727762|NCT05630846|364659552|FG000|Overall Study|Lost to Follow-up|6|||
105727763|NCT05630846|364659553|FG001|Overall Study|Lost to Follow-up|5|||
105727764|NCT05630846|364659554|FG002|Overall Study|Lost to Follow-up|2|||
105727765|NCT05630846|364659555|FG003|Overall Study|Lost to Follow-up|5|||
105727766|NCT05630846|364659552|FG000|Overall Study|Other|1|||
105727767|NCT05630846|364659553|FG001|Overall Study|Other|0|||
105727768|NCT05630846|364659554|FG002|Overall Study|Other|0|||
105727769|NCT05630846|364659555|FG003|Overall Study|Other|0|||
105727770|NCT00960076|364659557|FG000|Overall Study|Adverse Event|1|||
105727771|NCT00960076|364659558|FG001|Overall Study|Adverse Event|7|||
105727772|NCT00960076|364659557|FG000|Overall Study|No longer met study criteria|1|||
105727773|NCT00960076|364659558|FG001|Overall Study|No longer met study criteria|5|||
105727774|NCT00960076|364659557|FG000|Overall Study|Withdrawal by Subject|1|||
105727775|NCT00960076|364659558|FG001|Overall Study|Withdrawal by Subject|2|||
105727776|NCT00960076|364659557|FG000|Overall Study|Lost to Follow-up|3|||
105727777|NCT00960076|364659558|FG001|Overall Study|Lost to Follow-up|3|||
105727778|NCT00960076|364659557|FG000|Overall Study|Severe non-compliance to protocol|1|||
105727779|NCT00960076|364659558|FG001|Overall Study|Severe non-compliance to protocol|2|||
105727780|NCT00960076|364659557|FG000|Overall Study|Hyperglycemia|1|||
105727781|NCT00960076|364659558|FG001|Overall Study|Hyperglycemia|5|||
105727782|NCT00960076|364659557|FG000|Overall Study|Did not attend the termination visit|0|||
105727783|NCT00960076|364659558|FG001|Overall Study|Did not attend the termination visit|1|||
105727784|NCT02224664|364659559|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
105727785|NCT02224664|364659560|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
105727786|NCT02224664|364659561|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
105727787|NCT02224664|364659562|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
105727788|NCT02224664|364659563|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
105727789|NCT02224664|364659559|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
105727790|NCT02224664|364659560|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
105727791|NCT02224664|364659561|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
105727792|NCT02224664|364659562|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
105727793|NCT02224664|364659563|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
105727794|NCT02224664|364659559|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
105727795|NCT02224664|364659560|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
105727796|NCT02224664|364659561|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
105727797|NCT02224664|364659562|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
105727798|NCT02224664|364659563|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
105727799|NCT01024244|364659577|FG000|Overall Study|Adverse Event|1|||
105727800|NCT01024244|364659578|FG001|Overall Study|Adverse Event|2|||
105727801|NCT01024244|364659579|FG002|Overall Study|Adverse Event|0|||
105727802|NCT01024244|364659580|FG003|Overall Study|Adverse Event|1|||
105727803|NCT01024244|364659581|FG004|Overall Study|Adverse Event|2|||
105727804|NCT01024244|364659577|FG000|Overall Study|Entry Criteria Not Met|0|||
105727805|NCT01024244|364659578|FG001|Overall Study|Entry Criteria Not Met|1|||
105564934|NCT00724152|364065351|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
105564935|NCT00724152|364065352|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
105564936|NCT01064297|364065353|FG000|Overall Study|Lost to Follow-up|791|||
105564937|NCT01064297|364065354|FG001|Overall Study|Lost to Follow-up|48|||
105564938|NCT01064297|364065355|FG002|Overall Study|Lost to Follow-up|133|||
105564939|NCT00031486|364065361|FG000|Overall Study|Adverse Event|1|||
105727806|NCT01024244|364659579|FG002|Overall Study|Entry Criteria Not Met|0|||
105727807|NCT01024244|364659580|FG003|Overall Study|Entry Criteria Not Met|0|||
105727808|NCT01024244|364659581|FG004|Overall Study|Entry Criteria Not Met|0|||
105727809|NCT01024244|364659577|FG000|Overall Study|Lack of Efficacy|1|||
105727810|NCT01024244|364659578|FG001|Overall Study|Lack of Efficacy|0|||
105727811|NCT01024244|364659579|FG002|Overall Study|Lack of Efficacy|0|||
105727812|NCT01024244|364659580|FG003|Overall Study|Lack of Efficacy|0|||
105727813|NCT01024244|364659581|FG004|Overall Study|Lack of Efficacy|0|||
105727814|NCT01024244|364659577|FG000|Overall Study|Protocol Violation|1|||
105727815|NCT01024244|364659578|FG001|Overall Study|Protocol Violation|0|||
105727816|NCT01024244|364659579|FG002|Overall Study|Protocol Violation|0|||
105727817|NCT01024244|364659580|FG003|Overall Study|Protocol Violation|0|||
105727818|NCT01024244|364659581|FG004|Overall Study|Protocol Violation|2|||
105727819|NCT01024244|364659577|FG000|Overall Study|Sponsor Decision|14|||
105727820|NCT01024244|364659578|FG001|Overall Study|Sponsor Decision|7|||
105727821|NCT01024244|364659579|FG002|Overall Study|Sponsor Decision|14|||
105727822|NCT01024244|364659580|FG003|Overall Study|Sponsor Decision|12|||
105727823|NCT01024244|364659581|FG004|Overall Study|Sponsor Decision|10|||
105727824|NCT01024244|364659577|FG000|Overall Study|Withdrawal by Subject|0|||
105727825|NCT01024244|364659578|FG001|Overall Study|Withdrawal by Subject|1|||
105727826|NCT01024244|364659579|FG002|Overall Study|Withdrawal by Subject|0|||
105727827|NCT01024244|364659580|FG003|Overall Study|Withdrawal by Subject|0|||
105727828|NCT01024244|364659581|FG004|Overall Study|Withdrawal by Subject|0|||
105727829|NCT00768222|364659582|FG000|Overall Study|Lost to Follow-up|1|||
105727830|NCT00768222|364659583|FG001|Overall Study|Lost to Follow-up|1|||
105727831|NCT00768222|364659582|FG000|Overall Study|Withdrawal by Subject|3|||
105727832|NCT00768222|364659583|FG001|Overall Study|Withdrawal by Subject|1|||
105727833|NCT00768222|364659582|FG000|Overall Study|Protocol Violation|0|||
105727834|NCT00768222|364659583|FG001|Overall Study|Protocol Violation|2|||
105727835|NCT00278629|364659590|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
105727836|NCT02698410|364659592|FG000|Overall Study|Adverse Event|2|||
105727837|NCT02698410|364659592|FG000|Overall Study|Withdrawal by Subject|1|||
105727838|NCT02698410|364659592|FG000|Overall Study|Other|1|||
105727839|NCT01896232|364659593|FG000|Overall Study|Death|6|||
105727840|NCT01896232|364659594|FG001|Overall Study|Death|10|||
105727841|NCT01896232|364659593|FG000|Overall Study|Withdrawal by Subject|32|||
105727842|NCT01896232|364659594|FG001|Overall Study|Withdrawal by Subject|31|||
105727843|NCT01896232|364659593|FG000|Overall Study|Sponsor Decision|2|||
105727844|NCT01896232|364659594|FG001|Overall Study|Sponsor Decision|0|||
105727845|NCT01896232|364659593|FG000|Overall Study|Lost to Follow-up|9|||
105727846|NCT01896232|364659594|FG001|Overall Study|Lost to Follow-up|12|||
105727847|NCT05224258|364659602|FG000|Overall Study|Withdrawal by Subject|1|||
105727848|NCT05224258|364659603|FG001|Overall Study|Withdrawal by Subject|1|||
105727849|NCT05224258|364659602|FG000|Overall Study|Physician Decision|1|||
105727850|NCT05224258|364659603|FG001|Overall Study|Physician Decision|1|||
105727851|NCT05224258|364659602|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105727852|NCT05224258|364659603|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105727853|NCT05224258|364659602|FG000|Overall Study|Study Product No Longer in Use|1|||
105727854|NCT05224258|364659603|FG001|Overall Study|Study Product No Longer in Use|0|||
105727855|NCT05224258|364659602|FG000|Overall Study|Adverse Event|0|||
105727856|NCT05224258|364659603|FG001|Overall Study|Adverse Event|1|||
105727857|NCT05224258|364659602|FG000|Overall Study|Protocol Deviation|0|||
105727858|NCT05224258|364659603|FG001|Overall Study|Protocol Deviation|1|||
105727859|NCT02665689|364659604|FG000|Overall Study|Adverse Event|1|||
105727860|NCT02665689|364659605|FG001|Overall Study|Adverse Event|0|||
105727861|NCT02665689|364659604|FG000|Overall Study|Trial termination|1|||
105727862|NCT02665689|364659605|FG001|Overall Study|Trial termination|1|||
105727863|NCT02665689|364659604|FG000|Overall Study|Lost to Follow-up|0|||
105727864|NCT02665689|364659605|FG001|Overall Study|Lost to Follow-up|1|||
105727865|NCT00541307|364659606|FG000|Overall Study|Death|5|||
105727866|NCT00541307|364659606|FG000|Overall Study|Physician Decision|3|||
105795152|NCT03985293|364906027|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
105795153|NCT03985293|364906028|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
105795154|NCT03985293|364906029|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
105795155|NCT03985293|364906030|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
105795156|NCT03985293|364906031|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
105795157|NCT03985293|364906032|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
105795158|NCT03985293|364906027|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
105795159|NCT03985293|364906028|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
105795160|NCT03985293|364906029|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
105795161|NCT03985293|364906030|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
105795162|NCT03985293|364906031|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
105795163|NCT03985293|364906032|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
105795164|NCT03985293|364906027|FG000|FOLLOW-UP|Lost to Follow-up|0|||
105795165|NCT03985293|364906028|FG001|FOLLOW-UP|Lost to Follow-up|0|||
105795166|NCT03985293|364906029|FG002|FOLLOW-UP|Lost to Follow-up|1|||
105795167|NCT03985293|364906030|FG003|FOLLOW-UP|Lost to Follow-up|0|||
105795168|NCT03985293|364906031|FG004|FOLLOW-UP|Lost to Follow-up|0|||
105795169|NCT03985293|364906032|FG005|FOLLOW-UP|Lost to Follow-up|0|||
105795170|NCT04449354|364906033|FG000|Overall Study|Withdrawal by Subject|1|||
105795171|NCT01220128|364906034|FG000|Overall Study|Progressive disease|0|||
105795172|NCT01220128|364906035|FG001|Overall Study|Progressive disease|0|||
105795173|NCT01220128|364906036|FG002|Overall Study|Progressive disease|2|||
105795174|NCT01220128|364906037|FG003|Overall Study|Progressive disease|0|||
105795175|NCT01220128|364906038|FG004|Overall Study|Progressive disease|0|||
105795176|NCT01220128|364906039|FG005|Overall Study|Progressive disease|0|||
105795177|NCT01220128|364906040|FG006|Overall Study|Progressive disease|0|||
105795178|NCT01220128|364906034|FG000|Overall Study|Sponsor study termination|0|||
105795179|NCT01220128|364906035|FG001|Overall Study|Sponsor study termination|1|||
105795180|NCT01220128|364906036|FG002|Overall Study|Sponsor study termination|0|||
105795181|NCT01220128|364906037|FG003|Overall Study|Sponsor study termination|0|||
105795182|NCT01220128|364906038|FG004|Overall Study|Sponsor study termination|0|||
105795183|NCT01220128|364906039|FG005|Overall Study|Sponsor study termination|0|||
105795184|NCT01220128|364906040|FG006|Overall Study|Sponsor study termination|1|||
105795185|NCT01220128|364906034|FG000|Overall Study|Adverse event, serious fatal|2|||
105795186|NCT01220128|364906035|FG001|Overall Study|Adverse event, serious fatal|0|||
105795187|NCT01220128|364906036|FG002|Overall Study|Adverse event, serious fatal|0|||
105795188|NCT01220128|364906037|FG003|Overall Study|Adverse event, serious fatal|0|||
105795189|NCT01220128|364906038|FG004|Overall Study|Adverse event, serious fatal|0|||
105795190|NCT01220128|364906039|FG005|Overall Study|Adverse event, serious fatal|0|||
105795191|NCT01220128|364906040|FG006|Overall Study|Adverse event, serious fatal|1|||
105795192|NCT01220128|364906034|FG000|Overall Study|Adverse event, non-fatal|1|||
105795193|NCT01220128|364906035|FG001|Overall Study|Adverse event, non-fatal|0|||
105795194|NCT01220128|364906036|FG002|Overall Study|Adverse event, non-fatal|0|||
105795195|NCT01220128|364906037|FG003|Overall Study|Adverse event, non-fatal|0|||
105795196|NCT01220128|364906038|FG004|Overall Study|Adverse event, non-fatal|0|||
105795197|NCT01220128|364906039|FG005|Overall Study|Adverse event, non-fatal|0|||
105795198|NCT01220128|364906040|FG006|Overall Study|Adverse event, non-fatal|3|||
105795199|NCT01220128|364906034|FG000|Overall Study|Other|0|||
105795200|NCT01220128|364906035|FG001|Overall Study|Other|0|||
105795201|NCT01220128|364906036|FG002|Overall Study|Other|1|||
105795202|NCT01220128|364906037|FG003|Overall Study|Other|0|||
105795203|NCT01220128|364906038|FG004|Overall Study|Other|0|||
105795204|NCT01220128|364906039|FG005|Overall Study|Other|0|||
105795205|NCT01220128|364906040|FG006|Overall Study|Other|0|||
105727867|NCT00541307|364659606|FG000|Overall Study|Withdrawal by Subject|6|||
105727868|NCT00541307|364659606|FG000|Overall Study|Lost to Follow-up|4|||
105727869|NCT00541307|364659606|FG000|Overall Study|Subject returned early (outside window)|1|||
105727870|NCT00541307|364659606|FG000|Overall Study|Surgical Bypass|5|||
105727871|NCT01154101|364659609|FG000|Overall Study|Adverse Event|0|||
105727872|NCT01154101|364659610|FG001|Overall Study|Adverse Event|2|||
105727873|NCT01154101|364659611|FG002|Overall Study|Adverse Event|1|||
105727874|NCT01154101|364659612|FG003|Overall Study|Adverse Event|1|||
105795206|NCT01220128|364906034|FG000|Overall Study|Consent withdrawn by subject|1|||
105795207|NCT01220128|364906035|FG001|Overall Study|Consent withdrawn by subject|0|||
105795208|NCT01220128|364906036|FG002|Overall Study|Consent withdrawn by subject|0|||
105795209|NCT01220128|364906037|FG003|Overall Study|Consent withdrawn by subject|0|||
105795210|NCT01220128|364906038|FG004|Overall Study|Consent withdrawn by subject|0|||
105795211|NCT01220128|364906039|FG005|Overall Study|Consent withdrawn by subject|0|||
105795212|NCT01220128|364906040|FG006|Overall Study|Consent withdrawn by subject|0|||
105795213|NCT02913261|364906047|FG000|Overall Study|Technical problems|0|||
105795214|NCT02913261|364906048|FG001|Overall Study|Technical problems|1|||
105795215|NCT02913261|364906047|FG000|Overall Study|Lack of Efficacy|32|||
105353270|NCT01190189|363298487|FG000|Overall Study|Withdrawal by Subject|1|||
105727875|NCT01154101|364659613|FG004|Overall Study|Adverse Event|0|||
105727876|NCT01154101|364659609|FG000|Overall Study|Lost to Follow-up|0|||
105727877|NCT01154101|364659610|FG001|Overall Study|Lost to Follow-up|1|||
105795216|NCT02913261|364906048|FG001|Overall Study|Lack of Efficacy|69|||
105795217|NCT02913261|364906047|FG000|Overall Study|Adverse Event|27|||
105795218|NCT02913261|364906048|FG001|Overall Study|Adverse Event|5|||
105795219|NCT02913261|364906047|FG000|Overall Study|Death|25|||
105795220|NCT02913261|364906048|FG001|Overall Study|Death|22|||
105795221|NCT02913261|364906047|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
105795222|NCT02913261|364906048|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
105795223|NCT02913261|364906047|FG000|Overall Study|Disease relapse|8|||
105795224|NCT02913261|364906048|FG001|Overall Study|Disease relapse|13|||
105795225|NCT02913261|364906047|FG000|Overall Study|Physician Decision|8|||
105795226|NCT02913261|364906048|FG001|Overall Study|Physician Decision|9|||
105795227|NCT02913261|364906047|FG000|Overall Study|Subject/guardian decision|4|||
105795228|NCT02913261|364906048|FG001|Overall Study|Subject/guardian decision|6|||
105795229|NCT02913261|364906047|FG000|Overall Study|Graft loss|2|||
105795230|NCT02913261|364906048|FG001|Overall Study|Graft loss|0|||
105795231|NCT00659581|364906049|FG000|Overall Study|Adverse Event|1006|||
105795232|NCT00659581|364906049|FG000|Overall Study|Lack of Efficacy|1183|||
105795233|NCT00659581|364906049|FG000|Overall Study|Other|6393|||
105727878|NCT01154101|364659611|FG002|Overall Study|Lost to Follow-up|0|||
105727879|NCT01154101|364659612|FG003|Overall Study|Lost to Follow-up|1|||
105727880|NCT01154101|364659613|FG004|Overall Study|Lost to Follow-up|0|||
105727881|NCT01154101|364659609|FG000|Overall Study|Withdrawal by Subject|0|||
105727882|NCT01154101|364659610|FG001|Overall Study|Withdrawal by Subject|1|||
105727883|NCT01154101|364659611|FG002|Overall Study|Withdrawal by Subject|2|||
105727884|NCT01154101|364659612|FG003|Overall Study|Withdrawal by Subject|0|||
105727885|NCT01154101|364659613|FG004|Overall Study|Withdrawal by Subject|1|||
105727886|NCT03895203|364659614|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
105727887|NCT03895203|364659615|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
105727888|NCT03895203|364659616|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
105727889|NCT03895203|364659617|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
105727890|NCT03895203|364659618|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
105727891|NCT03895203|364659619|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
105727892|NCT03895203|364659614|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
105727893|NCT03895203|364659615|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
105727894|NCT03895203|364659616|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
105727895|NCT03895203|364659617|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
105727896|NCT03895203|364659618|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
105727897|NCT03895203|364659619|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
105727898|NCT03895203|364659614|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
105727899|NCT03895203|364659615|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
105727900|NCT03895203|364659616|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
105727901|NCT03895203|364659617|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
105727902|NCT03895203|364659618|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
105727903|NCT03895203|364659619|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
105727904|NCT03895203|364659614|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
105727905|NCT03895203|364659615|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
105727906|NCT03895203|364659616|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
105727907|NCT03895203|364659617|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
105727908|NCT03895203|364659618|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
105727909|NCT03895203|364659619|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
105727910|NCT03895203|364659614|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
105727911|NCT03895203|364659615|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
105727912|NCT03895203|364659616|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
105727913|NCT03895203|364659617|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
105727914|NCT03895203|364659618|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
105727915|NCT03895203|364659619|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
105727916|NCT03895203|364659614|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
105727917|NCT03895203|364659615|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
105727918|NCT03895203|364659616|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
105727919|NCT03895203|364659617|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
105727920|NCT03895203|364659618|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
105727921|NCT03895203|364659619|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
105727922|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
105795234|NCT00000135|364906050|FG000|Overall Study|Death|27|||
105795235|NCT00000135|364906051|FG001|Overall Study|Death|14|||
105795236|NCT04355767|364906053|FG000|Overall Study|Withdrawal by Subject|2|||
105795237|NCT04355767|364906054|FG001|Overall Study|Withdrawal by Subject|2|||
105795238|NCT04355767|364906053|FG000|Overall Study|Death|5|||
105795239|NCT04355767|364906054|FG001|Overall Study|Death|1|||
105795240|NCT00532779|364906055|FG000|Overall Study|Adverse Event|122|||
105795241|NCT00532779|364906056|FG001|Overall Study|Adverse Event|112|||
105795242|NCT00532779|364906057|FG002|Overall Study|Adverse Event|56|||
105795243|NCT00532779|364906055|FG000|Overall Study|Lost to Follow-up|76|||
105795244|NCT00532779|364906056|FG001|Overall Study|Lost to Follow-up|65|||
105795245|NCT00532779|364906057|FG002|Overall Study|Lost to Follow-up|66|||
105795246|NCT00532779|364906055|FG000|Overall Study|Withdrawal by Subject|63|||
105795247|NCT00532779|364906056|FG001|Overall Study|Withdrawal by Subject|60|||
105795248|NCT00532779|364906057|FG002|Overall Study|Withdrawal by Subject|90|||
105795249|NCT00532779|364906055|FG000|Overall Study|Lack of Efficacy|12|||
105795250|NCT00532779|364906056|FG001|Overall Study|Lack of Efficacy|12|||
105795251|NCT00532779|364906057|FG002|Overall Study|Lack of Efficacy|40|||
105795252|NCT00532779|364906055|FG000|Overall Study|Protocol Violation|5|||
105795253|NCT00532779|364906056|FG001|Overall Study|Protocol Violation|9|||
105795254|NCT00532779|364906057|FG002|Overall Study|Protocol Violation|7|||
105795255|NCT00532779|364906055|FG000|Overall Study|Pregnancy|2|||
105795256|NCT00532779|364906056|FG001|Overall Study|Pregnancy|5|||
105795257|NCT00532779|364906057|FG002|Overall Study|Pregnancy|3|||
105795258|NCT00532779|364906055|FG000|Overall Study|Death|0|||
105795259|NCT00532779|364906056|FG001|Overall Study|Death|1|||
105795260|NCT00532779|364906057|FG002|Overall Study|Death|0|||
105795261|NCT00532779|364906055|FG000|Overall Study|Drug noncompliance, moved, other|14|||
105795262|NCT00532779|364906056|FG001|Overall Study|Drug noncompliance, moved, other|23|||
105795263|NCT00532779|364906057|FG002|Overall Study|Drug noncompliance, moved, other|29|||
105795264|NCT02662556|364906059|FG000|Overall Study|Adverse Event|4|||
105795265|NCT02662556|364906059|FG000|Overall Study|Lack of Efficacy|4|||
105795266|NCT02531698|364906066|FG000|Overall Study|Adverse Event|2|||
105795267|NCT02531698|364906067|FG001|Overall Study|Adverse Event|1|||
105795268|NCT02531698|364906066|FG000|Overall Study|Withdrawal by Subject|6|||
105795269|NCT02531698|364906067|FG001|Overall Study|Withdrawal by Subject|1|||
105795270|NCT02531698|364906066|FG000|Overall Study|Protocol Violation|2|||
105795271|NCT02531698|364906067|FG001|Overall Study|Protocol Violation|0|||
105795272|NCT02531698|364906066|FG000|Overall Study|Lost to Follow-up|1|||
105795273|NCT02531698|364906067|FG001|Overall Study|Lost to Follow-up|0|||
105795274|NCT01861717|364906068|FG000|Overall Study|Lost to Follow-up|1|||
105795275|NCT01861717|364906068|FG000|Overall Study|Withdrawal by Subject|1|||
105795276|NCT03033069|364906071|FG000|Overall Study|Adverse Event|6|||
105795277|NCT03033069|364906072|FG001|Overall Study|Adverse Event|7|||
105795278|NCT03033069|364906073|FG002|Overall Study|Adverse Event|4|||
105795279|NCT03033069|364906074|FG003|Overall Study|Adverse Event|6|||
105795280|NCT03033069|364906071|FG000|Overall Study|Lack of Efficacy|0|||
105795281|NCT03033069|364906072|FG001|Overall Study|Lack of Efficacy|0|||
105795282|NCT03033069|364906073|FG002|Overall Study|Lack of Efficacy|1|||
105795283|NCT03033069|364906074|FG003|Overall Study|Lack of Efficacy|0|||
105795284|NCT03033069|364906071|FG000|Overall Study|Lost to Follow-up|6|||
105795285|NCT03033069|364906072|FG001|Overall Study|Lost to Follow-up|5|||
105795286|NCT03033069|364906073|FG002|Overall Study|Lost to Follow-up|5|||
105795287|NCT03033069|364906074|FG003|Overall Study|Lost to Follow-up|6|||
105795288|NCT03033069|364906071|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105795289|NCT03033069|364906072|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105795290|NCT03033069|364906073|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105795291|NCT03033069|364906074|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105795292|NCT03033069|364906071|FG000|Overall Study|Protocol Deviation|0|||
105795293|NCT03033069|364906072|FG001|Overall Study|Protocol Deviation|1|||
105795294|NCT03033069|364906073|FG002|Overall Study|Protocol Deviation|0|||
105795295|NCT03033069|364906074|FG003|Overall Study|Protocol Deviation|0|||
105795296|NCT03033069|364906071|FG000|Overall Study|Withdrawal by Subject|10|||
105795297|NCT03033069|364906072|FG001|Overall Study|Withdrawal by Subject|10|||
105795298|NCT03033069|364906073|FG002|Overall Study|Withdrawal by Subject|11|||
105795299|NCT03033069|364906074|FG003|Overall Study|Withdrawal by Subject|6|||
105795300|NCT03033069|364906071|FG000|Overall Study|Withdrawal By Caregiver|1|||
105795301|NCT03033069|364906072|FG001|Overall Study|Withdrawal By Caregiver|0|||
105795302|NCT03033069|364906073|FG002|Overall Study|Withdrawal By Caregiver|0|||
105795303|NCT03033069|364906074|FG003|Overall Study|Withdrawal By Caregiver|0|||
105795304|NCT03033069|364906071|FG000|Overall Study|Reason not Specified|0|||
105795305|NCT03033069|364906072|FG001|Overall Study|Reason not Specified|1|||
105795306|NCT03033069|364906073|FG002|Overall Study|Reason not Specified|0|||
105795307|NCT03033069|364906074|FG003|Overall Study|Reason not Specified|1|||
105795308|NCT04639310|364906079|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
105795309|NCT04639310|364906080|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
105795310|NCT02038959|364907594|FG000|Overall Study|Withdrawal by Subject|6|||
105795311|NCT02038959|364907595|FG001|Overall Study|Withdrawal by Subject|8|||
105795312|NCT00424515|364907596|FG000|Overall Study|Progressive Disease|10|||
105795313|NCT00424515|364907597|FG001|Overall Study|Progressive Disease|11|||
105795314|NCT00424515|364907596|FG000|Overall Study|Adverse Event|0|||
105795315|NCT00424515|364907597|FG001|Overall Study|Adverse Event|1|||
105727923|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
105727924|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
105727925|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
105727926|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
105727927|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
105727928|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
105727929|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
105727930|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
105727931|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
105727932|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
105727933|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
105727934|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
105727935|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
105727936|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
105727937|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
105727938|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
105727939|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
105727940|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
105727941|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
105727942|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
105727943|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
105727944|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
105727945|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
105727946|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
105727947|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
105727948|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
105727949|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
105727950|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
105795316|NCT00424515|364907596|FG000|Overall Study|Intercurrent Illness|0|||
105795317|NCT00424515|364907597|FG001|Overall Study|Intercurrent Illness|1|||
105795318|NCT00424515|364907596|FG000|Overall Study|Withdrawal by Subject|1|||
105795319|NCT00424515|364907597|FG001|Overall Study|Withdrawal by Subject|0|||
105795320|NCT04071366|364907598|FG000|Part 1: Open-label (29 Days)|Death|4|||
105795321|NCT04071366|364907599|FG001|Part 1: Open-label (29 Days)|Death|2|||
105795322|NCT04071366|364907600|FG002|Part 1: Open-label (29 Days)|Death|8|||
105795323|NCT04071366|364907601|FG003|Part 1: Open-label (29 Days)|Death|0|||
105795324|NCT04071366|364907602|FG004|Part 1: Open-label (29 Days)|Death|0|||
105795325|NCT04071366|364907598|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
105795326|NCT04071366|364907599|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
105795327|NCT04071366|364907600|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
105795328|NCT04071366|364907601|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
105795329|NCT04071366|364907602|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
105795330|NCT04071366|364907598|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
105795331|NCT04071366|364907599|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
105795332|NCT04071366|364907600|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
105727951|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
105727952|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
105727953|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
105727954|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
105727955|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
105727956|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
105727957|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
105727958|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
105727959|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
105727960|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
105727961|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
105727962|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
105727963|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
105727964|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
105727965|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
105727966|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
105727967|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
105727968|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
105727969|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
105727970|NCT00733902|364659620|FG000|Overall Study|Death|0|||
105727971|NCT00733902|364659621|FG001|Overall Study|Death|0|||
105727972|NCT00733902|364659622|FG002|Overall Study|Death|0|||
105727973|NCT00733902|364659623|FG003|Overall Study|Death|1|||
105727974|NCT00733902|364659620|FG000|Overall Study|Adverse Event|3|||
105727975|NCT00733902|364659621|FG001|Overall Study|Adverse Event|4|||
105727976|NCT00733902|364659622|FG002|Overall Study|Adverse Event|7|||
105727977|NCT00733902|364659623|FG003|Overall Study|Adverse Event|11|||
105727978|NCT00733902|364659620|FG000|Overall Study|Lack of Efficacy|56|||
105727979|NCT00733902|364659621|FG001|Overall Study|Lack of Efficacy|21|||
105727980|NCT00733902|364659622|FG002|Overall Study|Lack of Efficacy|34|||
105727981|NCT00733902|364659623|FG003|Overall Study|Lack of Efficacy|23|||
105727982|NCT00733902|364659620|FG000|Overall Study|Protocol Violation|4|||
105727983|NCT00733902|364659621|FG001|Overall Study|Protocol Violation|6|||
105727984|NCT00733902|364659622|FG002|Overall Study|Protocol Violation|3|||
105727985|NCT00733902|364659623|FG003|Overall Study|Protocol Violation|3|||
105727986|NCT00733902|364659620|FG000|Overall Study|Withdrawal by Subject|10|||
105727987|NCT00733902|364659621|FG001|Overall Study|Withdrawal by Subject|5|||
105727988|NCT00733902|364659622|FG002|Overall Study|Withdrawal by Subject|4|||
105727989|NCT00733902|364659623|FG003|Overall Study|Withdrawal by Subject|16|||
105727990|NCT00733902|364659620|FG000|Overall Study|Entered extension study|89|||
105727991|NCT00733902|364659621|FG001|Overall Study|Entered extension study|124|||
105727992|NCT00733902|364659622|FG002|Overall Study|Entered extension study|111|||
105727993|NCT00733902|364659623|FG003|Overall Study|Entered extension study|109|||
105727994|NCT00733902|364659620|FG000|Overall Study|Randomized but not treated|2|||
105727995|NCT00733902|364659621|FG001|Overall Study|Randomized but not treated|2|||
105727996|NCT00733902|364659622|FG002|Overall Study|Randomized but not treated|2|||
105795333|NCT04071366|364907601|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
105795334|NCT04071366|364907602|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
105795335|NCT04071366|364907598|FG000|Part 2: Randomized (29 Days)|Death|0|||
105795336|NCT04071366|364907599|FG001|Part 2: Randomized (29 Days)|Death|0|||
105795337|NCT04071366|364907600|FG002|Part 2: Randomized (29 Days)|Death|0|||
105795338|NCT04071366|364907601|FG003|Part 2: Randomized (29 Days)|Death|2|||
105795339|NCT04071366|364907602|FG004|Part 2: Randomized (29 Days)|Death|2|||
105727997|NCT00733902|364659623|FG003|Overall Study|Randomized but not treated|1|||
105727998|NCT00886938|364659624|FG000|Overall Study|Adverse Event|1|||
105727999|NCT00886938|364659624|FG000|Overall Study|Withdrawal by Subject|1|||
105728000|NCT00391976|364659625|FG000|Overall Study|Adverse Event|0|||
105728001|NCT00391976|364659626|FG001|Overall Study|Adverse Event|0|||
105728002|NCT00391976|364659627|FG002|Overall Study|Adverse Event|1|||
105728003|NCT00391976|364659625|FG000|Overall Study|Withdrawal of consent|0|||
105728004|NCT00391976|364659626|FG001|Overall Study|Withdrawal of consent|1|||
105728005|NCT00391976|364659627|FG002|Overall Study|Withdrawal of consent|1|||
105728006|NCT00391976|364659625|FG000|Overall Study|Lost to Follow-up|1|||
105728007|NCT00391976|364659626|FG001|Overall Study|Lost to Follow-up|2|||
105728008|NCT00391976|364659627|FG002|Overall Study|Lost to Follow-up|0|||
105728009|NCT00391976|364659625|FG000|Overall Study|Inappropriate enrollment|1|||
105728010|NCT00391976|364659626|FG001|Overall Study|Inappropriate enrollment|1|||
105728011|NCT00391976|364659627|FG002|Overall Study|Inappropriate enrollment|0|||
105728012|NCT00391976|364659625|FG000|Overall Study|Protocol deviation/violation|4|||
105728013|NCT00391976|364659626|FG001|Overall Study|Protocol deviation/violation|2|||
105728014|NCT00391976|364659627|FG002|Overall Study|Protocol deviation/violation|1|||
105728015|NCT00391976|364659625|FG000|Overall Study|Recurrence/no eradication of infection|21|||
105728016|NCT00391976|364659626|FG001|Overall Study|Recurrence/no eradication of infection|19|||
105728017|NCT00391976|364659627|FG002|Overall Study|Recurrence/no eradication of infection|0|||
105728018|NCT00391976|364659625|FG000|Overall Study|Unable to classify|0|||
105728019|NCT00391976|364659626|FG001|Overall Study|Unable to classify|0|||
105795340|NCT04071366|364907598|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
105795341|NCT04071366|364907599|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
105795342|NCT04071366|364907600|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
105795343|NCT04071366|364907601|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
105795344|NCT04071366|364907602|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
105795345|NCT04071366|364907598|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
105795346|NCT04071366|364907599|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
105795347|NCT04071366|364907600|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
105795348|NCT04071366|364907601|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
105795349|NCT04071366|364907602|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
105795350|NCT04071366|364907598|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
105795351|NCT04071366|364907599|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
105795352|NCT04071366|364907600|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
105795353|NCT04071366|364907601|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
105795354|NCT04071366|364907602|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
105795355|NCT04071366|364907598|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
105795356|NCT04071366|364907599|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
105795357|NCT04071366|364907600|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
105795358|NCT04071366|364907601|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
105795359|NCT04071366|364907602|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
105795360|NCT04071366|364907598|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
105795361|NCT04071366|364907599|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
105795362|NCT04071366|364907600|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
105795363|NCT04071366|364907601|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
105795364|NCT04071366|364907602|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
105795365|NCT04071366|364907598|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
105795366|NCT04071366|364907599|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
105795367|NCT04071366|364907600|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
105795368|NCT04071366|364907601|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
105795369|NCT04071366|364907602|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
105795370|NCT02209454|364907607|FG000|Second Period|Adverse Event|1|||
105795371|NCT02209454|364907608|FG001|Second Period|Adverse Event|0|||
105795372|NCT02675426|364907609|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
105795373|NCT02675426|364907610|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
105795374|NCT02675426|364907611|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
105795375|NCT02675426|364907612|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
105795376|NCT02675426|364907609|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
105353271|NCT01190189|363298487|FG000|Overall Study|Migrated/moved from study area|1|||
105795377|NCT02675426|364907610|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
105795378|NCT02675426|364907611|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
105795379|NCT02675426|364907612|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
105795380|NCT02675426|364907609|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
105795381|NCT02675426|364907610|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
105795382|NCT02675426|364907611|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
105795383|NCT02675426|364907612|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
105795384|NCT02675426|364907609|FG000|Period 1: Week 1 to Week 12|Other|2|||
105728020|NCT00391976|364659627|FG002|Overall Study|Unable to classify|1|||
105728021|NCT00391976|364659625|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
105728022|NCT00391976|364659626|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
105728023|NCT00391976|364659627|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
105728024|NCT05127486|364659628|FG000|Overall Study|Adverse Event|2|||
105728025|NCT05127486|364659629|FG001|Overall Study|Adverse Event|4|||
105728026|NCT05127486|364659628|FG000|Overall Study|Lack of Efficacy|1|||
105728027|NCT05127486|364659629|FG001|Overall Study|Lack of Efficacy|0|||
105728028|NCT05127486|364659628|FG000|Overall Study|Pregnancy|0|||
105728029|NCT05127486|364659629|FG001|Overall Study|Pregnancy|1|||
105728030|NCT05127486|364659628|FG000|Overall Study|Physician Decision|4|||
105728031|NCT05127486|364659629|FG001|Overall Study|Physician Decision|1|||
105728032|NCT05127486|364659628|FG000|Overall Study|Withdrawal by Subject|14|||
105728033|NCT05127486|364659629|FG001|Overall Study|Withdrawal by Subject|13|||
105728034|NCT05127486|364659628|FG000|Overall Study|Lost to Follow-up|5|||
105728035|NCT05127486|364659629|FG001|Overall Study|Lost to Follow-up|8|||
105728036|NCT00363415|364659630|FG000|Overall Study|Progressive Disease|196|||
105728037|NCT00363415|364659631|FG001|Overall Study|Progressive Disease|107|||
105728038|NCT00363415|364659630|FG000|Overall Study|Sponsor Decision|67|||
105728039|NCT00363415|364659631|FG001|Overall Study|Sponsor Decision|31|||
105728040|NCT00363415|364659630|FG000|Overall Study|Death|32|||
105728041|NCT00363415|364659631|FG001|Overall Study|Death|29|||
105728042|NCT00363415|364659630|FG000|Overall Study|Adverse Event|24|||
105728043|NCT00363415|364659631|FG001|Overall Study|Adverse Event|15|||
105728044|NCT00363415|364659630|FG000|Overall Study|Physician Decision|18|||
105728045|NCT00363415|364659631|FG001|Overall Study|Physician Decision|35|||
105728046|NCT00363415|364659630|FG000|Overall Study|Entry Criteria Not Met|11|||
105728047|NCT00363415|364659631|FG001|Overall Study|Entry Criteria Not Met|10|||
105728048|NCT00363415|364659630|FG000|Overall Study|Withdrawal by Subject|9|||
105728049|NCT00363415|364659631|FG001|Overall Study|Withdrawal by Subject|15|||
105728050|NCT00363415|364659630|FG000|Overall Study|Lost to Follow-up|3|||
105728051|NCT00363415|364659631|FG001|Overall Study|Lost to Follow-up|3|||
105728052|NCT00363415|364659630|FG000|Overall Study|Protocol Violation|1|||
105728053|NCT00363415|364659631|FG001|Overall Study|Protocol Violation|4|||
105728054|NCT01242111|364659632|FG000|Overall Study|Adverse Event|1|||
105728055|NCT01242111|364659632|FG000|Overall Study|Withdrawal by Subject|1|||
105728056|NCT01242111|364659632|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
105728057|NCT00870688|364659633|FG000|Overall Study|Lost to Follow-up|2|||
105728058|NCT00870688|364659633|FG000|Overall Study|Death, Unrelated|1|||
105728059|NCT00870688|364659633|FG000|Overall Study|Granules in the Stools|1|||
105728060|NCT01021007|364659634|FG000|Overall Study|Lost to Follow-up|1|||
105728061|NCT01021007|364659635|FG001|Overall Study|Lost to Follow-up|1|||
105728062|NCT01021007|364659634|FG000|Overall Study|Adverse Event|1|||
105728063|NCT01021007|364659635|FG001|Overall Study|Adverse Event|3|||
105728064|NCT03801902|364659636|FG000|Overall Study|Did not receive protocol treatment.|1|||
105728065|NCT03801902|364659637|FG001|Overall Study|Did not receive protocol treatment.|0|||
105728066|NCT03801902|364659638|FG002|Overall Study|Did not receive protocol treatment.|0|||
105728067|NCT03801902|364659639|FG003|Overall Study|Did not receive protocol treatment.|0|||
105728068|NCT00001337|364659640|FG000|Overall Study|Switched to alternate treatment|2|||
105795385|NCT02675426|364907610|FG001|Period 1: Week 1 to Week 12|Other|1|||
105728069|NCT00001337|364659641|FG001|Overall Study|Switched to alternate treatment|2|||
105728070|NCT00001337|364659642|FG002|Overall Study|Switched to alternate treatment|0|||
105728071|NCT00001337|364659640|FG000|Overall Study|Refused further treatment|2|||
105728072|NCT00001337|364659641|FG001|Overall Study|Refused further treatment|1|||
105728073|NCT00001337|364659642|FG002|Overall Study|Refused further treatment|0|||
105728074|NCT00001337|364659640|FG000|Overall Study|Began other Tx|1|||
105728075|NCT00001337|364659641|FG001|Overall Study|Began other Tx|0|||
105728076|NCT00001337|364659642|FG002|Overall Study|Began other Tx|0|||
105728077|NCT00001337|364659640|FG000|Overall Study|Physician Decision|3|||
105728078|NCT00001337|364659641|FG001|Overall Study|Physician Decision|1|||
105795386|NCT02675426|364907611|FG002|Period 1: Week 1 to Week 12|Other|0|||
105795387|NCT02675426|364907612|FG003|Period 1: Week 1 to Week 12|Other|2|||
105795388|NCT02675426|364907609|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
105795389|NCT02675426|364907610|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
105795390|NCT02675426|364907611|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
105795391|NCT02675426|364907612|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
105795392|NCT02675426|364907609|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
105795393|NCT02675426|364907610|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
105795394|NCT02675426|364907611|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
105795395|NCT02675426|364907612|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
105795396|NCT02675426|364907609|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
105795397|NCT02675426|364907610|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
105795398|NCT02675426|364907611|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
105795399|NCT02675426|364907612|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
105795400|NCT02675426|364907609|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
105795401|NCT02675426|364907610|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
105795402|NCT02675426|364907611|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
105795403|NCT02675426|364907612|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
105795404|NCT02675426|364907609|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
105795405|NCT02675426|364907610|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
105795406|NCT02675426|364907611|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
105795407|NCT02675426|364907612|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
105795408|NCT02675426|364907609|FG000|Period 2: Week 12 to Week 260|Other|8|||
105795409|NCT02675426|364907610|FG001|Period 2: Week 12 to Week 260|Other|12|||
105795410|NCT02675426|364907611|FG002|Period 2: Week 12 to Week 260|Other|23|||
105795411|NCT02675426|364907612|FG003|Period 2: Week 12 to Week 260|Other|15|||
105795412|NCT02237118|364907617|FG000|Overall Study|Protocol Violation|0|||
105795413|NCT02237118|364907618|FG001|Overall Study|Protocol Violation|1|||
105795414|NCT02237118|364907617|FG000|Overall Study|consent withdrawn|1|||
105795415|NCT02237118|364907618|FG001|Overall Study|consent withdrawn|0|||
105795416|NCT04292171|364907621|FG000|Overall Study|Pharmacy error|2|||
105795417|NCT04292171|364907622|FG001|Overall Study|Pharmacy error|0|||
105795418|NCT04292171|364907621|FG000|Overall Study|Delivered prior to procedure|0|||
105795419|NCT04292171|364907622|FG001|Overall Study|Delivered prior to procedure|1|||
105795420|NCT02253654|364907623|FG000|Overall Study|Withdrawal by Subject|12|||
105795421|NCT02253654|364907624|FG001|Overall Study|Withdrawal by Subject|4|||
105795422|NCT02253654|364907623|FG000|Overall Study|Decision by Sponsor|1|||
105795423|NCT02253654|364907624|FG001|Overall Study|Decision by Sponsor|1|||
105795424|NCT02253654|364907623|FG000|Overall Study|Lost to Follow-up|2|||
105795425|NCT02253654|364907624|FG001|Overall Study|Lost to Follow-up|5|||
105795426|NCT02253654|364907623|FG000|Overall Study|Death|4|||
105795427|NCT02253654|364907624|FG001|Overall Study|Death|7|||
105795428|NCT02253654|364907623|FG000|Overall Study|Did Not Receive Study Treatment|4|||
105795429|NCT02253654|364907624|FG001|Overall Study|Did Not Receive Study Treatment|1|||
105795430|NCT04723173|364907625|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
105795431|NCT02996448|364907626|FG000|Overall Study|Study terminated due to adverse effects|3|||
105795432|NCT02703454|364907632|FG000|Overall Study|Not treated|1|||
105795433|NCT02703454|364907633|FG001|Overall Study|Not treated|3|||
105795434|NCT02703454|364907632|FG000|Overall Study|Withdrawal by Subject|4|||
105795435|NCT02703454|364907633|FG001|Overall Study|Withdrawal by Subject|3|||
105795436|NCT02703454|364907632|FG000|Overall Study|Lost to Follow-up|1|||
105795437|NCT02703454|364907633|FG001|Overall Study|Lost to Follow-up|2|||
105795438|NCT02703454|364907632|FG000|Overall Study|Study discontinuation|5|||
105795439|NCT02703454|364907633|FG001|Overall Study|Study discontinuation|8|||
105795440|NCT00791154|364907634|FG000|Overall Study|Noncompliance|0|||
105795441|NCT00791154|364907635|FG001|Overall Study|Noncompliance|1|||
105795442|NCT00791154|364907636|FG002|Overall Study|Noncompliance|0|||
105795443|NCT00791154|364907637|FG003|Overall Study|Noncompliance|0|||
105795444|NCT00791154|364907638|FG004|Overall Study|Noncompliance|1|||
105795445|NCT00791154|364907639|FG005|Overall Study|Noncompliance|1|||
105795446|NCT00791154|364907640|FG006|Overall Study|Noncompliance|1|||
105795447|NCT00791154|364907634|FG000|Overall Study|Adverse Event|0|||
105795448|NCT00791154|364907635|FG001|Overall Study|Adverse Event|0|||
105795449|NCT00791154|364907636|FG002|Overall Study|Adverse Event|0|||
105795450|NCT00791154|364907637|FG003|Overall Study|Adverse Event|0|||
105795451|NCT00791154|364907638|FG004|Overall Study|Adverse Event|2|||
105795452|NCT00791154|364907639|FG005|Overall Study|Adverse Event|0|||
105795453|NCT00791154|364907640|FG006|Overall Study|Adverse Event|1|||
105795454|NCT00791154|364907634|FG000|Overall Study|Full Consent withdrawn|1|||
105795455|NCT00791154|364907635|FG001|Overall Study|Full Consent withdrawn|3|||
105795456|NCT00791154|364907636|FG002|Overall Study|Full Consent withdrawn|0|||
105795457|NCT00791154|364907637|FG003|Overall Study|Full Consent withdrawn|0|||
105795458|NCT00791154|364907638|FG004|Overall Study|Full Consent withdrawn|1|||
105795459|NCT00791154|364907639|FG005|Overall Study|Full Consent withdrawn|3|||
105795460|NCT00791154|364907640|FG006|Overall Study|Full Consent withdrawn|1|||
105795461|NCT00791154|364907634|FG000|Overall Study|Lost to Follow-up|0|||
105795462|NCT00791154|364907635|FG001|Overall Study|Lost to Follow-up|0|||
105795463|NCT00791154|364907636|FG002|Overall Study|Lost to Follow-up|0|||
105795464|NCT00791154|364907637|FG003|Overall Study|Lost to Follow-up|1|||
105795465|NCT00791154|364907638|FG004|Overall Study|Lost to Follow-up|2|||
105795466|NCT00791154|364907639|FG005|Overall Study|Lost to Follow-up|0|||
105795467|NCT00791154|364907640|FG006|Overall Study|Lost to Follow-up|4|||
105795468|NCT00791154|364907634|FG000|Overall Study|Death|5|||
105795469|NCT00791154|364907635|FG001|Overall Study|Death|4|||
105795470|NCT00791154|364907636|FG002|Overall Study|Death|4|||
105795471|NCT00791154|364907637|FG003|Overall Study|Death|7|||
105795472|NCT00791154|364907638|FG004|Overall Study|Death|54|||
105795473|NCT00791154|364907639|FG005|Overall Study|Death|54|||
105795474|NCT00791154|364907640|FG006|Overall Study|Death|52|||
105795475|NCT00791154|364907634|FG000|Overall Study|Other event|0|||
105795476|NCT00791154|364907635|FG001|Overall Study|Other event|0|||
105795477|NCT00791154|364907636|FG002|Overall Study|Other event|2|||
105795478|NCT00791154|364907637|FG003|Overall Study|Other event|0|||
105795479|NCT00791154|364907638|FG004|Overall Study|Other event|2|||
105795480|NCT00791154|364907639|FG005|Overall Study|Other event|4|||
105795481|NCT00791154|364907640|FG006|Overall Study|Other event|2|||
105795482|NCT02284373|364907641|FG000|Overall Study|Withdrawal by Subject|0|||
105795483|NCT02284373|364907642|FG001|Overall Study|Withdrawal by Subject|1|||
105795484|NCT02284373|364907643|FG002|Overall Study|Withdrawal by Subject|0|||
105795485|NCT02284373|364907641|FG000|Overall Study|Other|0|||
105795486|NCT02284373|364907642|FG001|Overall Study|Other|1|||
105728079|NCT00001337|364659642|FG002|Overall Study|Physician Decision|0|||
105728080|NCT00001337|364659640|FG000|Overall Study|Doesn't have NHL|0|||
105728081|NCT00001337|364659641|FG001|Overall Study|Doesn't have NHL|1|||
105728082|NCT00001337|364659642|FG002|Overall Study|Doesn't have NHL|0|||
105728083|NCT00001337|364659640|FG000|Overall Study|Non protocol tx needed|3|||
105728084|NCT00001337|364659641|FG001|Overall Study|Non protocol tx needed|1|||
105728085|NCT00001337|364659642|FG002|Overall Study|Non protocol tx needed|0|||
105728086|NCT00001337|364659640|FG000|Overall Study|Protocol change|1|||
105728087|NCT00001337|364659641|FG001|Overall Study|Protocol change|0|||
105728088|NCT00001337|364659642|FG002|Overall Study|Protocol change|0|||
105728089|NCT00001337|364659640|FG000|Overall Study|2nd primary disease|0|||
105728090|NCT00001337|364659641|FG001|Overall Study|2nd primary disease|0|||
105728091|NCT00001337|364659642|FG002|Overall Study|2nd primary disease|1|||
105728092|NCT00001337|364659640|FG000|Overall Study|Death during follow up period|9|||
105728093|NCT00001337|364659641|FG001|Overall Study|Death during follow up period|4|||
105728094|NCT00001337|364659642|FG002|Overall Study|Death during follow up period|0|||
105728095|NCT00001337|364659640|FG000|Overall Study|Death on study|19|||
105728096|NCT00001337|364659641|FG001|Overall Study|Death on study|9|||
105728097|NCT00001337|364659642|FG002|Overall Study|Death on study|0|||
105728098|NCT00001337|364659640|FG000|Overall Study|Disease progression during follow-up period|3|||
105728099|NCT00001337|364659641|FG001|Overall Study|Disease progression during follow-up period|1|||
105728100|NCT00001337|364659642|FG002|Overall Study|Disease progression during follow-up period|0|||
105728101|NCT00001337|364659640|FG000|Overall Study|Disease progression on study|33|||
105728102|NCT00001337|364659641|FG001|Overall Study|Disease progression on study|41|||
105728103|NCT00001337|364659642|FG002|Overall Study|Disease progression on study|0|||
105728104|NCT00001337|364659640|FG000|Overall Study|Lost to further follow-up|10|||
105728105|NCT00001337|364659641|FG001|Overall Study|Lost to further follow-up|6|||
105728106|NCT00001337|364659642|FG002|Overall Study|Lost to further follow-up|0|||
105728107|NCT00001337|364659640|FG000|Overall Study|2nd malignancy|1|||
105728108|NCT00001337|364659641|FG001|Overall Study|2nd malignancy|0|||
105728109|NCT00001337|364659642|FG002|Overall Study|2nd malignancy|0|||
105728110|NCT00001337|364659640|FG000|Overall Study|Treatment for second lymphoma|0|||
105728111|NCT00001337|364659641|FG001|Overall Study|Treatment for second lymphoma|1|||
105795487|NCT02284373|364907643|FG002|Overall Study|Other|0|||
105728112|NCT00001337|364659642|FG002|Overall Study|Treatment for second lymphoma|0|||
105728113|NCT00001337|364659640|FG000|Overall Study|Transfer to transplant|0|||
105728114|NCT00001337|364659641|FG001|Overall Study|Transfer to transplant|1|||
105728115|NCT00001337|364659642|FG002|Overall Study|Transfer to transplant|0|||
105795488|NCT02284373|364907641|FG000|Overall Study|Lost to Follow-up|0|||
105795489|NCT02284373|364907642|FG001|Overall Study|Lost to Follow-up|1|||
105795490|NCT02284373|364907643|FG002|Overall Study|Lost to Follow-up|0|||
105795491|NCT01652573|364907644|FG000|Overall Study|Adverse Event|0|||
105795492|NCT01652573|364907645|FG001|Overall Study|Adverse Event|1|||
105795493|NCT00468312|364907648|FG000|Overall Study|Adverse Event|2|||
105795494|NCT00468312|364907649|FG001|Overall Study|Adverse Event|1|||
105795495|NCT00468312|364907648|FG000|Overall Study|Lack of Efficacy|0|||
105795496|NCT00468312|364907649|FG001|Overall Study|Lack of Efficacy|1|||
105795497|NCT00468312|364907648|FG000|Overall Study|Withdrawal by Subject|0|||
105795498|NCT00468312|364907649|FG001|Overall Study|Withdrawal by Subject|1|||
105795499|NCT00468312|364907648|FG000|Overall Study|Protocol Violation|2|||
105728116|NCT06161012|364659643|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
105728117|NCT06161012|364659644|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
105728118|NCT03619213|364659645|FG000|Overall Study|Lost to Follow-up|2|||
105728119|NCT03619213|364659646|FG001|Overall Study|Lost to Follow-up|1|||
105728120|NCT03619213|364659645|FG000|Overall Study|Withdrawal by Subject|8|||
105728121|NCT03619213|364659646|FG001|Overall Study|Withdrawal by Subject|10|||
105728122|NCT00442598|364659647|FG000|Overall Study|Adverse Event|1|||
105728123|NCT00442598|364659648|FG001|Overall Study|Adverse Event|0|||
105728124|NCT00442598|364659649|FG002|Overall Study|Adverse Event|0|||
105728125|NCT00442598|364659647|FG000|Overall Study|Tumor progression|3|||
105728126|NCT00442598|364659648|FG001|Overall Study|Tumor progression|4|||
105728127|NCT00442598|364659649|FG002|Overall Study|Tumor progression|0|||
105728128|NCT00442598|364659647|FG000|Overall Study|Clinical deterioration|1|||
105728129|NCT00442598|364659648|FG001|Overall Study|Clinical deterioration|2|||
105728130|NCT00442598|364659649|FG002|Overall Study|Clinical deterioration|0|||
105728131|NCT00442598|364659647|FG000|Overall Study|CA125 progression|0|||
105728132|NCT00442598|364659648|FG001|Overall Study|CA125 progression|1|||
105728133|NCT00442598|364659649|FG002|Overall Study|CA125 progression|0|||
105728134|NCT00442598|364659647|FG000|Overall Study|Reduced creatinine clearance|1|||
105728135|NCT00442598|364659648|FG001|Overall Study|Reduced creatinine clearance|0|||
105728136|NCT00442598|364659649|FG002|Overall Study|Reduced creatinine clearance|0|||
105728137|NCT00442598|364659647|FG000|Overall Study|Death|0|||
105728138|NCT00442598|364659648|FG001|Overall Study|Death|1|||
105728139|NCT00442598|364659649|FG002|Overall Study|Death|0|||
105728140|NCT01262898|364659650|FG000|Overall Study|Protocol Violation|1|||
105728141|NCT01262898|364659651|FG001|Overall Study|Protocol Violation|1|||
105728142|NCT01262898|364659652|FG002|Overall Study|Protocol Violation|0|||
105728143|NCT01262898|364659653|FG003|Overall Study|Protocol Violation|0|||
105728144|NCT01262898|364659650|FG000|Overall Study|Lost to Follow-up|1|||
105728145|NCT01262898|364659651|FG001|Overall Study|Lost to Follow-up|0|||
105728146|NCT01262898|364659652|FG002|Overall Study|Lost to Follow-up|0|||
105728147|NCT01262898|364659653|FG003|Overall Study|Lost to Follow-up|0|||
105728148|NCT01262898|364659650|FG000|Overall Study|Withdrawal by Subject|1|||
105728149|NCT01262898|364659651|FG001|Overall Study|Withdrawal by Subject|1|||
105728150|NCT01262898|364659652|FG002|Overall Study|Withdrawal by Subject|0|||
105728151|NCT01262898|364659653|FG003|Overall Study|Withdrawal by Subject|0|||
105728152|NCT02599402|364659654|FG000|Overall Study|Disease progression|153|||
105728153|NCT02599402|364659654|FG000|Overall Study|Study drug toxicity|201|||
105728154|NCT02599402|364659654|FG000|Overall Study|Death|26|||
105728155|NCT02599402|364659654|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
105728156|NCT02599402|364659654|FG000|Overall Study|Participant request to discontinue study treatment|13|||
105728157|NCT02599402|364659654|FG000|Overall Study|Participant withdrew consent|5|||
105728158|NCT02599402|364659654|FG000|Overall Study|Lost to Follow-up|1|||
105728159|NCT02599402|364659654|FG000|Overall Study|Maximum Clinical Benefit|7|||
105728160|NCT02599402|364659654|FG000|Overall Study|Poor/non-compliance|1|||
105728161|NCT02599402|364659654|FG000|Overall Study|Pregnancy|1|||
105728162|NCT02599402|364659654|FG000|Overall Study|Participant no longer met study criteria|7|||
105728163|NCT02599402|364659654|FG000|Overall Study|Other Reasons|95|||
105728164|NCT01974323|364659655|FG000|Overall Study|Other Reasons|25|||
105728165|NCT01974323|364659656|FG001|Overall Study|Other Reasons|28|||
105728166|NCT01974323|364659655|FG000|Overall Study|Protocol Violation|2|||
105728167|NCT01974323|364659656|FG001|Overall Study|Protocol Violation|2|||
105728168|NCT01974323|364659655|FG000|Overall Study|Personal Reasons|15|||
105728169|NCT01974323|364659656|FG001|Overall Study|Personal Reasons|19|||
105728170|NCT01974323|364659655|FG000|Overall Study|Lost to Follow-up|45|||
105728171|NCT01974323|364659656|FG001|Overall Study|Lost to Follow-up|40|||
105728172|NCT01974323|364659655|FG000|Overall Study|Pregnancy|2|||
105728173|NCT01974323|364659656|FG001|Overall Study|Pregnancy|1|||
105728174|NCT01974323|364659655|FG000|Overall Study|Lack of Efficacy|1|||
105728175|NCT01974323|364659656|FG001|Overall Study|Lack of Efficacy|1|||
105728176|NCT01974323|364659655|FG000|Overall Study|Adverse Event|2|||
105728177|NCT01974323|364659656|FG001|Overall Study|Adverse Event|2|||
105728178|NCT00461175|364659657|FG000|Overall Study|Protocol Violation|522|||
105728179|NCT00461175|364659658|FG001|Overall Study|Protocol Violation|365|||
105728180|NCT00809133|364659659|FG000|Overall Study|Progressive disease|2|||
105728181|NCT00809133|364659660|FG001|Overall Study|Progressive disease|5|||
105728182|NCT00809133|364659661|FG002|Overall Study|Progressive disease|5|||
105728183|NCT00809133|364659662|FG003|Overall Study|Progressive disease|3|||
105728184|NCT00809133|364659663|FG004|Overall Study|Progressive disease|4|||
105728185|NCT00809133|364659664|FG005|Overall Study|Progressive disease|1|||
105728186|NCT00809133|364659665|FG006|Overall Study|Progressive disease|3|||
105795500|NCT00468312|364907649|FG001|Overall Study|Protocol Violation|1|||
105795501|NCT00468312|364907648|FG000|Overall Study|Did not meet protocol eligibility|0|||
105795502|NCT00468312|364907649|FG001|Overall Study|Did not meet protocol eligibility|1|||
105795503|NCT00414011|364907650|FG000|Overall Study|Physician Decision|3|||
105795504|NCT00414011|364907650|FG000|Overall Study|Withdrawal by Subject|2|||
105795505|NCT00306852|364907656|FG000|Overall Study|Death|14|||
105795506|NCT00306852|364907657|FG001|Overall Study|Death|14|||
105795507|NCT00306852|364907656|FG000|Overall Study|Lost to Follow-up|15|||
105795508|NCT00306852|364907657|FG001|Overall Study|Lost to Follow-up|24|||
105795509|NCT00817778|364907658|FG000|Overall Study|Adverse Event|1|||
105795510|NCT00817778|364907659|FG001|Overall Study|Adverse Event|0|||
105795511|NCT00817778|364907658|FG000|Overall Study|Withdrawal by Subject|1|||
105795512|NCT00817778|364907659|FG001|Overall Study|Withdrawal by Subject|1|||
105795513|NCT00817778|364907658|FG000|Overall Study|Protocol Violation|0|||
105795514|NCT00817778|364907659|FG001|Overall Study|Protocol Violation|1|||
105795515|NCT00817778|364907658|FG000|Overall Study|Study-specific discontinuation criteria|0|||
105795516|NCT00817778|364907659|FG001|Overall Study|Study-specific discontinuation criteria|1|||
105795517|NCT00817778|364907658|FG000|Overall Study|Poor venous access|1|||
105795518|NCT00817778|364907659|FG001|Overall Study|Poor venous access|0|||
105795519|NCT03343054|364907660|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
105795520|NCT03343054|364907661|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
105795521|NCT03343054|364907662|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
105795522|NCT03343054|364907660|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
105795523|NCT03343054|364907661|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
105795524|NCT03343054|364907662|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
105795525|NCT03343054|364907660|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
105795526|NCT03343054|364907661|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
105795527|NCT03343054|364907662|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
105795528|NCT03343054|364907660|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
105795529|NCT03343054|364907661|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
105795530|NCT03343054|364907662|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
105795531|NCT01890109|364907663|FG000|Overall Study|Withdrawal by Subject|0|||
105795532|NCT01890109|364907664|FG001|Overall Study|Withdrawal by Subject|3|||
105795533|NCT01890109|364907663|FG000|Overall Study|Lost to Follow-up|1|||
105795534|NCT01890109|364907664|FG001|Overall Study|Lost to Follow-up|2|||
105795535|NCT01286207|364907665|FG000|Overall Study|Adverse Event|27|||
105795536|NCT01286207|364907666|FG001|Overall Study|Adverse Event|41|||
105795537|NCT01286207|364907667|FG002|Overall Study|Adverse Event|8|||
105795538|NCT01286207|364907665|FG000|Overall Study|Lost to Follow-up|49|||
105795539|NCT01286207|364907666|FG001|Overall Study|Lost to Follow-up|43|||
105795540|NCT01286207|364907667|FG002|Overall Study|Lost to Follow-up|20|||
105795541|NCT01286207|364907665|FG000|Overall Study|Withdrawal by Subject|93|||
105795542|NCT01286207|364907666|FG001|Overall Study|Withdrawal by Subject|79|||
105795543|NCT01286207|364907667|FG002|Overall Study|Withdrawal by Subject|41|||
105795544|NCT01286207|364907665|FG000|Overall Study|Lack of Response|92|||
105795545|NCT01286207|364907666|FG001|Overall Study|Lack of Response|38|||
105795546|NCT01286207|364907667|FG002|Overall Study|Lack of Response|8|||
105795547|NCT01286207|364907665|FG000|Overall Study|Other|37|||
105795548|NCT01286207|364907666|FG001|Overall Study|Other|47|||
105795549|NCT01286207|364907667|FG002|Overall Study|Other|13|||
105795550|NCT00981409|364907668|FG000|Overall Study|Adverse Event|4|||
105795551|NCT00981409|364907669|FG001|Overall Study|Adverse Event|0|||
105795552|NCT00981409|364907668|FG000|Overall Study|Protocol Violation|0|||
105795553|NCT00981409|364907669|FG001|Overall Study|Protocol Violation|1|||
105795554|NCT00981409|364907668|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
105795555|NCT00981409|364907669|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
105795556|NCT00078312|364907674|FG000|Overall Study|Adverse Event|43|||
105795557|NCT00078312|364907674|FG000|Overall Study|Lack of Efficacy|15|||
105795558|NCT00078312|364907674|FG000|Overall Study|Lost to Follow-up|41|||
105795559|NCT00078312|364907674|FG000|Overall Study|Physician Decision|9|||
105795560|NCT00078312|364907674|FG000|Overall Study|Protocol Violation|3|||
105795561|NCT00078312|364907674|FG000|Overall Study|Withdrawal by Subject|33|||
105479729|NCT00065429|363767590|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
105479730|NCT00065429|363767591|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
105795562|NCT00078312|364907674|FG000|Overall Study|Miscellaneous|33|||
105795563|NCT01296152|364907676|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
105795564|NCT00589693|364907677|FG000|Overall Study|randomized in error|12|||
105795565|NCT00589693|364907678|FG001|Overall Study|randomized in error|6|||
105795566|NCT00589693|364907677|FG000|Overall Study|Adverse Event|4|||
105795567|NCT00589693|364907678|FG001|Overall Study|Adverse Event|4|||
105795568|NCT00589693|364907677|FG000|Overall Study|Death|26|||
105795569|NCT00589693|364907678|FG001|Overall Study|Death|16|||
105795570|NCT00589693|364907677|FG000|Overall Study|Lack of Efficacy|0|||
105795571|NCT00589693|364907678|FG001|Overall Study|Lack of Efficacy|1|||
105795572|NCT00589693|364907677|FG000|Overall Study|Lost to Follow-up|1|||
105795573|NCT00589693|364907678|FG001|Overall Study|Lost to Follow-up|0|||
105795574|NCT00589693|364907677|FG000|Overall Study|Physician Decision|0|||
105795575|NCT00589693|364907678|FG001|Overall Study|Physician Decision|1|||
105795576|NCT00589693|364907677|FG000|Overall Study|Protocol Violation|1|||
105795577|NCT00589693|364907678|FG001|Overall Study|Protocol Violation|1|||
105795578|NCT00755937|364907679|FG000|Recruitment|Unknown if infliximab received|164|||
105795579|NCT00755937|364907679|FG000|Observational Follow-up|Lost to Follow-up|148|||
105795580|NCT00566631|364907680|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
105795581|NCT00566631|364907680|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
105795582|NCT00566631|364907680|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
105795583|NCT00566631|364907680|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
105795584|NCT00566631|364907680|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
105795585|NCT00566631|364907680|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
105795586|NCT00566631|364907680|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
105795587|NCT00566631|364907680|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
105795588|NCT00566631|364907680|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
105795589|NCT00566631|364907680|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
105795590|NCT00566631|364907680|FG000|Part 2: Extension Phase|Adverse Event|11|||
105795591|NCT00566631|364907680|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
105795592|NCT00566631|364907680|FG000|Part 2: Extension Phase|Death|1|||
105795593|NCT00566631|364907680|FG000|Part 2: Extension Phase|Other|5|||
105795594|NCT01346501|364907682|FG000|Overall Study|Initiated Other Biological Agents|3|||
105795595|NCT01346501|364907683|FG001|Overall Study|Initiated Other Biological Agents|1|||
105795596|NCT01346501|364907682|FG000|Overall Study|Other|8|||
105795597|NCT01346501|364907683|FG001|Overall Study|Other|12|||
105795598|NCT00756652|364907684|FG000|Original Phase|Withdrawal by Subject|864|||
105795599|NCT00756652|364907685|FG001|Original Phase|Withdrawal by Subject|23|||
105795600|NCT00756652|364907684|FG000|Original Phase|Lost to Follow-up|601|||
105795601|NCT00756652|364907685|FG001|Original Phase|Lost to Follow-up|0|||
105795602|NCT00756652|364907684|FG000|Original Phase|Other Discontinuation|797|||
105795603|NCT00756652|364907685|FG001|Original Phase|Other Discontinuation|5|||
105795604|NCT00756652|364907684|FG000|Original Phase|Participant Noncompliance|18622|||
105795605|NCT00756652|364907685|FG001|Original Phase|Participant Noncompliance|424|||
105795606|NCT00756652|364907684|FG000|Original Phase|Unknown Discontinuation Reason|2|||
105795607|NCT00756652|364907685|FG001|Original Phase|Unknown Discontinuation Reason|0|||
105795608|NCT00756652|364907684|FG000|Original Phase|Participants without data|3259|||
105795609|NCT00756652|364907685|FG001|Original Phase|Participants without data|466|||
105795610|NCT00756652|364907684|FG000|Original Phase|Death|168|||
105795611|NCT00756652|364907685|FG001|Original Phase|Death|1|||
105795612|NCT00756652|364907684|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
105795613|NCT00756652|364907685|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
105795614|NCT00756652|364907684|FG000|Re-Op Phase|Withdrawal by Subject|62|||
105795615|NCT00756652|364907685|FG001|Re-Op Phase|Withdrawal by Subject|0|||
105795616|NCT00756652|364907684|FG000|Re-Op Phase|Death|6|||
105795617|NCT00756652|364907685|FG001|Re-Op Phase|Death|0|||
105795618|NCT00756652|364907684|FG000|Re-Op Phase|Lost to Follow-up|340|||
105795619|NCT00756652|364907685|FG001|Re-Op Phase|Lost to Follow-up|0|||
105795620|NCT00756652|364907684|FG000|Re-Op Phase|Site Closed|2454|||
105795621|NCT00756652|364907685|FG001|Re-Op Phase|Site Closed|0|||
105795622|NCT00756652|364907684|FG000|Re-Op Phase|Withdrawn after explant|14|||
105795623|NCT00756652|364907685|FG001|Re-Op Phase|Withdrawn after explant|0|||
105795624|NCT04736576|364907686|FG000|Overall Study|Progressive disease|3|||
105795625|NCT04736576|364907687|FG001|Overall Study|Progressive disease|1|||
105795626|NCT04736576|364907686|FG000|Overall Study|Death|1|||
105795627|NCT04736576|364907687|FG001|Overall Study|Death|0|||
105795628|NCT01523301|364907690|FG000|Overall Study|Adverse Event|25|||
105795629|NCT01523301|364907691|FG001|Overall Study|Adverse Event|16|||
105795630|NCT01523301|364907690|FG000|Overall Study|Lack of Efficacy|0|||
105795631|NCT01523301|364907691|FG001|Overall Study|Lack of Efficacy|2|||
105795632|NCT01523301|364907690|FG000|Overall Study|Protocol Violation|3|||
105795633|NCT01523301|364907691|FG001|Overall Study|Protocol Violation|4|||
105795634|NCT01523301|364907690|FG000|Overall Study|Lost to Follow-up|1|||
105795635|NCT01523301|364907691|FG001|Overall Study|Lost to Follow-up|0|||
105795636|NCT01523301|364907690|FG000|Overall Study|Withdrawal by Subject|6|||
105795637|NCT01523301|364907691|FG001|Overall Study|Withdrawal by Subject|8|||
105353272|NCT00171158|363298488|FG000|Core Study|Death|27|||
105795638|NCT01523301|364907690|FG000|Overall Study|Other Reason|0|||
105795639|NCT01523301|364907691|FG001|Overall Study|Other Reason|2|||
105795640|NCT03273712|364907694|FG000|Overall Study|Death|5|||
105795641|NCT03273712|364907694|FG000|Overall Study|Adverse Event|1|||
105795642|NCT03273712|364907694|FG000|Overall Study|Disease Progression|1|||
105795643|NCT02268045|364907695|FG000|Overall Study|Death|4|||
105795644|NCT02268045|364907696|FG001|Overall Study|Death|4|||
105795645|NCT02268045|364907695|FG000|Overall Study|Disease Progression|2|||
105795646|NCT02268045|364907696|FG001|Overall Study|Disease Progression|1|||
105795647|NCT02268045|364907695|FG000|Overall Study|Adverse Event|7|||
105564940|NCT00031486|364065362|FG001|Overall Study|Adverse Event|0|||
105728187|NCT00809133|364659666|FG007|Overall Study|Progressive disease|3|||
105728188|NCT00809133|364659667|FG008|Overall Study|Progressive disease|3|||
105728189|NCT00809133|364659668|FG009|Overall Study|Progressive disease|9|||
105728190|NCT00809133|364659669|FG010|Overall Study|Progressive disease|5|||
105728191|NCT00809133|364659670|FG011|Overall Study|Progressive disease|7|||
105728192|NCT00809133|364659671|FG012|Overall Study|Progressive disease|5|||
105728193|NCT00809133|364659672|FG013|Overall Study|Progressive disease|4|||
105728194|NCT00809133|364659659|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728195|NCT00809133|364659660|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728196|NCT00809133|364659661|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728197|NCT00809133|364659662|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728198|NCT00809133|364659663|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728199|NCT00809133|364659664|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
105728200|NCT00809133|364659665|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
105728201|NCT00809133|364659666|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
105728202|NCT00809133|364659667|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728203|NCT00809133|364659668|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728204|NCT00809133|364659669|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728205|NCT00809133|364659670|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728206|NCT00809133|364659671|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728207|NCT00809133|364659672|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
105728208|NCT00809133|364659659|FG000|Overall Study|Other adverse event|1|||
105728209|NCT00809133|364659660|FG001|Overall Study|Other adverse event|1|||
105728210|NCT00809133|364659661|FG002|Overall Study|Other adverse event|1|||
105728211|NCT00809133|364659662|FG003|Overall Study|Other adverse event|0|||
105728212|NCT00809133|364659663|FG004|Overall Study|Other adverse event|0|||
105728213|NCT00809133|364659664|FG005|Overall Study|Other adverse event|3|||
105728214|NCT00809133|364659665|FG006|Overall Study|Other adverse event|2|||
105728215|NCT00809133|364659666|FG007|Overall Study|Other adverse event|4|||
105728216|NCT00809133|364659667|FG008|Overall Study|Other adverse event|0|||
105728217|NCT00809133|364659668|FG009|Overall Study|Other adverse event|0|||
105728218|NCT00809133|364659669|FG010|Overall Study|Other adverse event|1|||
105728219|NCT00809133|364659670|FG011|Overall Study|Other adverse event|1|||
105728220|NCT00809133|364659671|FG012|Overall Study|Other adverse event|0|||
105728221|NCT00809133|364659672|FG013|Overall Study|Other adverse event|1|||
105728222|NCT00809133|364659659|FG000|Overall Study|Lost to Follow-up|0|||
105728223|NCT00809133|364659660|FG001|Overall Study|Lost to Follow-up|0|||
105728224|NCT00809133|364659661|FG002|Overall Study|Lost to Follow-up|0|||
105728225|NCT00809133|364659662|FG003|Overall Study|Lost to Follow-up|0|||
105728226|NCT00809133|364659663|FG004|Overall Study|Lost to Follow-up|0|||
105795648|NCT02268045|364907696|FG001|Overall Study|Adverse Event|7|||
105795649|NCT02268045|364907695|FG000|Overall Study|Withdrawal by Subject|2|||
105795650|NCT02268045|364907696|FG001|Overall Study|Withdrawal by Subject|6|||
105795651|NCT02268045|364907695|FG000|Overall Study|Physician Decision|0|||
105795652|NCT02268045|364907696|FG001|Overall Study|Physician Decision|1|||
105795653|NCT02268045|364907695|FG000|Overall Study|Protocol Violation|1|||
105795654|NCT02268045|364907696|FG001|Overall Study|Protocol Violation|1|||
105795655|NCT00646282|364907697|FG000|Overall Study|Protocol terminated|4|||
105795656|NCT00646282|364907698|FG001|Overall Study|Protocol terminated|4|||
105795657|NCT00530088|364907704|FG000|Overall Study|Disease Progression|4|||
105795658|NCT00530088|364907704|FG000|Overall Study|Physician Decision|4|||
105795659|NCT00530088|364907704|FG000|Overall Study|Other Not Specified|2|||
105795660|NCT02058368|364907708|FG000|Overall Study|Adverse Event|15|||
105795661|NCT02058368|364907709|FG001|Overall Study|Adverse Event|20|||
105795662|NCT02058368|364907708|FG000|Overall Study|Lack of Efficacy|0|||
105795663|NCT02058368|364907709|FG001|Overall Study|Lack of Efficacy|1|||
105795664|NCT02058368|364907708|FG000|Overall Study|Protocol Violation|0|||
105795665|NCT02058368|364907709|FG001|Overall Study|Protocol Violation|4|||
105795666|NCT02058368|364907708|FG000|Overall Study|Lost to Follow-up|2|||
105795667|NCT02058368|364907709|FG001|Overall Study|Lost to Follow-up|0|||
105795668|NCT02058368|364907708|FG000|Overall Study|Physician Decision|2|||
105795669|NCT02058368|364907709|FG001|Overall Study|Physician Decision|3|||
105795670|NCT02058368|364907708|FG000|Overall Study|Withdrawal by Subject|22|||
105795671|NCT02058368|364907709|FG001|Overall Study|Withdrawal by Subject|26|||
105795672|NCT04529499|364907710|FG000|Overall Study|Withdrawal by Subject|9|||
105795673|NCT04529499|364907711|FG001|Overall Study|Withdrawal by Subject|11|||
105795674|NCT04529499|364907710|FG000|Overall Study|Physician Decision|1|||
105795675|NCT04529499|364907711|FG001|Overall Study|Physician Decision|2|||
105795676|NCT04529499|364907710|FG000|Overall Study|Adverse Event|4|||
105795677|NCT04529499|364907711|FG001|Overall Study|Adverse Event|4|||
105795678|NCT04529499|364907710|FG000|Overall Study|Death|14|||
105795679|NCT04529499|364907711|FG001|Overall Study|Death|11|||
105795680|NCT04529499|364907710|FG000|Overall Study|Lost to Follow-up|1|||
105795681|NCT04529499|364907711|FG001|Overall Study|Lost to Follow-up|1|||
105795682|NCT04529499|364907710|FG000|Overall Study|Others|7|||
105795683|NCT04529499|364907711|FG001|Overall Study|Others|11|||
105795684|NCT00683904|364907712|FG000|Dose Level 1|Disease progression|2|||
105795685|NCT00683904|364907713|FG001|Dose Level 1|Disease progression|0|||
105795686|NCT00683904|364907712|FG000|Dose Level 1|Adverse Event|1|||
105795687|NCT00683904|364907713|FG001|Dose Level 1|Adverse Event|0|||
105795688|NCT00683904|364907712|FG000|Dose Level 2|Adverse Event|0|||
105795689|NCT00683904|364907713|FG001|Dose Level 2|Adverse Event|2|||
105795690|NCT03672396|364907714|FG000|Overall Study|Withdrawal by Subject|4|||
105795691|NCT03672396|364907714|FG000|Overall Study|Physician Decision|1|||
105795692|NCT03672396|364907714|FG000|Overall Study|Adverse Event|1|||
105795693|NCT01211613|364909213|FG000|Overall Study|Lost to Follow-up|2|||
105795694|NCT01211613|364909214|FG001|Overall Study|Lost to Follow-up|2|||
105795695|NCT01211613|364909215|FG002|Overall Study|Lost to Follow-up|2|||
105795696|NCT01211613|364909213|FG000|Overall Study|Withdrawal by Subject|1|||
105795697|NCT01211613|364909214|FG001|Overall Study|Withdrawal by Subject|0|||
105795698|NCT01211613|364909215|FG002|Overall Study|Withdrawal by Subject|0|||
105795699|NCT01020773|364909216|FG000|Overall Study|Withdrawal by Subject|4|||
105795700|NCT01020773|364909217|FG001|Overall Study|Withdrawal by Subject|3|||
105795701|NCT01389024|364909218|FG000|Overall Study|Withdrawal by Subject|0|||
105795702|NCT01389024|364909219|FG001|Overall Study|Withdrawal by Subject|1|||
105795703|NCT01389024|364909218|FG000|Overall Study|Lost to Follow-up|1|||
105795704|NCT01389024|364909219|FG001|Overall Study|Lost to Follow-up|0|||
105795705|NCT03853213|364909222|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
105795706|NCT03853213|364909223|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
105795707|NCT03853213|364909222|FG000|Overall Study|Other (e.g., too busy)|0|||
105795708|NCT03853213|364909223|FG001|Overall Study|Other (e.g., too busy)|2|||
105795709|NCT03302299|364909224|FG000|Overall Study|Protocol Violation|1|||
105795710|NCT01458132|364909225|FG000|Overall Study|Other|15|||
105795711|NCT01458132|364909226|FG001|Overall Study|Other|3|||
105795712|NCT01964898|364909233|FG000|Overall Study|ineligible post-randomization|1|||
105795713|NCT01964898|364909234|FG001|Overall Study|ineligible post-randomization|1|||
105795714|NCT01964898|364909233|FG000|Overall Study|did not receive the allocated interventi|2|||
105479731|NCT00065429|363767592|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
105795715|NCT01964898|364909234|FG001|Overall Study|did not receive the allocated interventi|1|||
105795716|NCT01964898|364909233|FG000|Overall Study|Lost to Follow-up|3|||
105795717|NCT01964898|364909234|FG001|Overall Study|Lost to Follow-up|5|||
105795718|NCT01964898|364909233|FG000|Overall Study|Withdrawal by Subject|1|||
105795719|NCT01964898|364909234|FG001|Overall Study|Withdrawal by Subject|0|||
105795720|NCT00833976|364909236|FG000|Overall Study|Withdrawal by Subject|5|||
105795721|NCT00833976|364909236|FG000|Overall Study|Lost to Follow-up|4|||
105795722|NCT00833976|364909236|FG000|Overall Study|Did not meet eligibility criteria|41|||
105795723|NCT00833976|364909236|FG000|Overall Study|Physician Decision|1|||
105795724|NCT03911960|364909237|FG000|Overall Study|Lost to Follow-up|5|||
105795725|NCT03911960|364909238|FG001|Overall Study|Lost to Follow-up|3|||
105795726|NCT00391092|364909239|FG000|Overall Study|Death|78|||
105795727|NCT00391092|364909240|FG001|Overall Study|Death|81|||
105795728|NCT00391092|364909239|FG000|Overall Study|Lost to Follow-up|13|||
105795729|NCT00391092|364909240|FG001|Overall Study|Lost to Follow-up|18|||
105795730|NCT00391092|364909239|FG000|Overall Study|Alive on treatment|29|||
105728227|NCT00809133|364659664|FG005|Overall Study|Lost to Follow-up|1|||
105728228|NCT00809133|364659665|FG006|Overall Study|Lost to Follow-up|0|||
105728229|NCT00809133|364659666|FG007|Overall Study|Lost to Follow-up|0|||
105728230|NCT00809133|364659667|FG008|Overall Study|Lost to Follow-up|0|||
105728231|NCT00809133|364659668|FG009|Overall Study|Lost to Follow-up|0|||
105728232|NCT00809133|364659669|FG010|Overall Study|Lost to Follow-up|0|||
105728233|NCT00809133|364659670|FG011|Overall Study|Lost to Follow-up|0|||
105728234|NCT00809133|364659671|FG012|Overall Study|Lost to Follow-up|0|||
105728235|NCT00809133|364659672|FG013|Overall Study|Lost to Follow-up|0|||
105728236|NCT00809133|364659659|FG000|Overall Study|Consent withdrawn|0|||
105728237|NCT00809133|364659660|FG001|Overall Study|Consent withdrawn|0|||
105728238|NCT00809133|364659661|FG002|Overall Study|Consent withdrawn|0|||
105728239|NCT00809133|364659662|FG003|Overall Study|Consent withdrawn|0|||
105728240|NCT00809133|364659663|FG004|Overall Study|Consent withdrawn|1|||
105728241|NCT00809133|364659664|FG005|Overall Study|Consent withdrawn|0|||
105728242|NCT00809133|364659665|FG006|Overall Study|Consent withdrawn|0|||
105728243|NCT00809133|364659666|FG007|Overall Study|Consent withdrawn|0|||
105728244|NCT00809133|364659667|FG008|Overall Study|Consent withdrawn|0|||
105728245|NCT00809133|364659668|FG009|Overall Study|Consent withdrawn|0|||
105728246|NCT00809133|364659669|FG010|Overall Study|Consent withdrawn|0|||
105728247|NCT00809133|364659670|FG011|Overall Study|Consent withdrawn|0|||
105728248|NCT00809133|364659671|FG012|Overall Study|Consent withdrawn|0|||
105728249|NCT00809133|364659672|FG013|Overall Study|Consent withdrawn|0|||
105728250|NCT00809133|364659659|FG000|Overall Study|Other not mentioned above|0|||
105728251|NCT00809133|364659660|FG001|Overall Study|Other not mentioned above|1|||
105728252|NCT00809133|364659661|FG002|Overall Study|Other not mentioned above|0|||
105728253|NCT00809133|364659662|FG003|Overall Study|Other not mentioned above|0|||
105728254|NCT00809133|364659663|FG004|Overall Study|Other not mentioned above|0|||
105795731|NCT00391092|364909240|FG001|Overall Study|Alive on treatment|33|||
105795732|NCT00391092|364909239|FG000|Overall Study|Alive in follow-up|88|||
105795733|NCT00391092|364909240|FG001|Overall Study|Alive in follow-up|84|||
105795734|NCT00265239|364909241|FG000|Overall Study|Adverse Event|2|||
105795735|NCT00265239|364909242|FG001|Overall Study|Adverse Event|1|||
105795736|NCT02803138|364909245|FG000|Overall Study|Failure to return|38|||
105795737|NCT02803138|364909245|FG000|Overall Study|Insufficient virological response|2|||
105795738|NCT02803138|364909245|FG000|Overall Study|Withdrawn consent|1|||
105795739|NCT02803138|364909245|FG000|Overall Study|Death|1|||
105795740|NCT02803138|364909245|FG000|Overall Study|Other, not specified|28|||
105795741|NCT01678924|364909248|FG000|Overall Study|Adverse Event|1|||
105795742|NCT01678924|364909249|FG001|Overall Study|Adverse Event|1|||
105795743|NCT01678924|364909250|FG002|Overall Study|Adverse Event|0|||
105795744|NCT01678924|364909251|FG003|Overall Study|Adverse Event|1|||
105795745|NCT01678924|364909248|FG000|Overall Study|Lack of Efficacy|7|||
105795746|NCT01678924|364909249|FG001|Overall Study|Lack of Efficacy|2|||
105795747|NCT01678924|364909250|FG002|Overall Study|Lack of Efficacy|0|||
105795748|NCT01678924|364909251|FG003|Overall Study|Lack of Efficacy|5|||
105795749|NCT01678924|364909248|FG000|Overall Study|Lost to Follow-up|0|||
105795750|NCT01678924|364909249|FG001|Overall Study|Lost to Follow-up|4|||
105795751|NCT01678924|364909250|FG002|Overall Study|Lost to Follow-up|0|||
105795752|NCT01678924|364909251|FG003|Overall Study|Lost to Follow-up|2|||
105795753|NCT01678924|364909248|FG000|Overall Study|Personal Reasons|2|||
105795754|NCT01678924|364909249|FG001|Overall Study|Personal Reasons|2|||
105564941|NCT00031486|364065361|FG000|Overall Study|Lost to Follow-up|0|||
105564942|NCT00031486|364065362|FG001|Overall Study|Lost to Follow-up|1|||
105795755|NCT01678924|364909250|FG002|Overall Study|Personal Reasons|2|||
105795756|NCT01678924|364909251|FG003|Overall Study|Personal Reasons|7|||
105564943|NCT00031486|364065361|FG000|Overall Study|Withdrawal by Subject|3|||
105728255|NCT00809133|364659664|FG005|Overall Study|Other not mentioned above|1|||
105795757|NCT01678924|364909248|FG000|Overall Study|Withdrawal by Subject|0|||
105795758|NCT01678924|364909249|FG001|Overall Study|Withdrawal by Subject|3|||
105795759|NCT01678924|364909250|FG002|Overall Study|Withdrawal by Subject|0|||
105728256|NCT00809133|364659665|FG006|Overall Study|Other not mentioned above|0|||
105728257|NCT00809133|364659666|FG007|Overall Study|Other not mentioned above|0|||
105795760|NCT01678924|364909251|FG003|Overall Study|Withdrawal by Subject|2|||
105479732|NCT00065429|363767593|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
105479733|NCT00065429|363767594|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
105728258|NCT00809133|364659667|FG008|Overall Study|Other not mentioned above|0|||
105728259|NCT00809133|364659668|FG009|Overall Study|Other not mentioned above|0|||
105728260|NCT00809133|364659669|FG010|Overall Study|Other not mentioned above|0|||
105728261|NCT00809133|364659670|FG011|Overall Study|Other not mentioned above|0|||
105728262|NCT00809133|364659671|FG012|Overall Study|Other not mentioned above|0|||
105728263|NCT00809133|364659672|FG013|Overall Study|Other not mentioned above|0|||
105728264|NCT00833092|364659673|FG000|Overall Study|Withdrawal by Subject|2|||
105728265|NCT00833092|364659674|FG001|Overall Study|Withdrawal by Subject|3|||
105728266|NCT00833092|364659673|FG000|Overall Study|Protocol Violation|2|||
105728267|NCT00833092|364659674|FG001|Overall Study|Protocol Violation|1|||
105728268|NCT00833092|364659673|FG000|Overall Study|Diarrhea|0|||
105728269|NCT00833092|364659674|FG001|Overall Study|Diarrhea|2|||
105728270|NCT00833092|364659673|FG000|Overall Study|constipation|0|||
105728271|NCT00833092|364659674|FG001|Overall Study|constipation|1|||
105728272|NCT00619229|364659675|FG000|Overall Study|Withdrawal by Subject|1|||
105728273|NCT00619229|364659676|FG001|Overall Study|Withdrawal by Subject|1|||
105728274|NCT00619229|364659675|FG000|Overall Study|Lost to Follow-up|1|||
105728275|NCT00619229|364659676|FG001|Overall Study|Lost to Follow-up|0|||
105728276|NCT00619229|364659675|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
105728277|NCT00619229|364659676|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
105728278|NCT00619229|364659675|FG000|Overall Study|Investigator planned Cataract Operation|1|||
105728279|NCT00619229|364659676|FG001|Overall Study|Investigator planned Cataract Operation|0|||
105728280|NCT00087438|364659678|FG000|Overall Study|Ineligible / No protocol treatment|4|||
105728281|NCT00466505|364659679|FG000|Overall Study|disease progression|13|||
105728282|NCT00466505|364659679|FG000|Overall Study|Adverse Event|4|||
105728283|NCT00699192|364659680|FG000|Overall Study|Missing|1|||
105728284|NCT00699192|364659681|FG001|Overall Study|Missing|1|||
105728285|NCT00699192|364659682|FG002|Overall Study|Missing|1|||
105728286|NCT00699192|364659680|FG000|Overall Study|Adverse Event|9|||
105728287|NCT00699192|364659681|FG001|Overall Study|Adverse Event|4|||
105728288|NCT00699192|364659682|FG002|Overall Study|Adverse Event|3|||
105728289|NCT00699192|364659680|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105728290|NCT00699192|364659681|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105728291|NCT00699192|364659682|FG002|Overall Study|Abnormal test procedure result(s)|1|||
105728292|NCT00699192|364659680|FG000|Overall Study|Lack of Efficacy|0|||
105728293|NCT00699192|364659681|FG001|Overall Study|Lack of Efficacy|0|||
105728294|NCT00699192|364659682|FG002|Overall Study|Lack of Efficacy|1|||
105728295|NCT00699192|364659680|FG000|Overall Study|Withdrawal by Subject|3|||
105728296|NCT00699192|364659681|FG001|Overall Study|Withdrawal by Subject|2|||
105728297|NCT00699192|364659682|FG002|Overall Study|Withdrawal by Subject|4|||
105728298|NCT00699192|364659680|FG000|Overall Study|Administrative problems|1|||
105728299|NCT00699192|364659681|FG001|Overall Study|Administrative problems|3|||
105728300|NCT00699192|364659682|FG002|Overall Study|Administrative problems|1|||
105728301|NCT00699192|364659680|FG000|Overall Study|Protocol Violation|2|||
105728302|NCT00699192|364659681|FG001|Overall Study|Protocol Violation|2|||
105728303|NCT00699192|364659682|FG002|Overall Study|Protocol Violation|0|||
105728304|NCT01773473|364659683|FG000|Overall Study|Adverse Event|3|||
105728305|NCT01773473|364659684|FG001|Overall Study|Adverse Event|2|||
105728306|NCT01773473|364659683|FG000|Overall Study|Protocol Violation|0|||
105728307|NCT01773473|364659684|FG001|Overall Study|Protocol Violation|4|||
105728308|NCT01773473|364659683|FG000|Overall Study|Physician Decision|3|||
105728309|NCT01773473|364659684|FG001|Overall Study|Physician Decision|5|||
105728310|NCT01773473|364659683|FG000|Overall Study|Sponsor Decision|2|||
105728311|NCT01773473|364659684|FG001|Overall Study|Sponsor Decision|0|||
105728312|NCT01773473|364659683|FG000|Overall Study|Lack of Efficacy|0|||
105728313|NCT01773473|364659684|FG001|Overall Study|Lack of Efficacy|1|||
105728314|NCT01773473|364659683|FG000|Overall Study|Non-Compliance with study drug|1|||
105728315|NCT01773473|364659684|FG001|Overall Study|Non-Compliance with study drug|4|||
105728316|NCT01773473|364659683|FG000|Overall Study|Withdrawal by Subject|5|||
105728317|NCT01773473|364659684|FG001|Overall Study|Withdrawal by Subject|3|||
105795761|NCT01678924|364909248|FG000|Overall Study|Unable to attend scheduled visits|0|||
105728318|NCT01773473|364659683|FG000|Overall Study|Lost to Follow-up|2|||
105728319|NCT01773473|364659684|FG001|Overall Study|Lost to Follow-up|0|||
105728320|NCT01931865|364659685|FG000|Overall Study|Lost to Follow-up|2|||
105728321|NCT01931865|364659685|FG000|Overall Study|Withdrawal by Subject|2|||
105728322|NCT00283387|364659686|FG000|First Intervention|Subject non-compliant|1|||
105795762|NCT01678924|364909249|FG001|Overall Study|Unable to attend scheduled visits|0|||
105795763|NCT01678924|364909250|FG002|Overall Study|Unable to attend scheduled visits|0|||
105795764|NCT01678924|364909251|FG003|Overall Study|Unable to attend scheduled visits|1|||
105795765|NCT00021229|364909255|FG000|Overall Study|Adverse Event|10|||
105795766|NCT00021229|364909256|FG001|Overall Study|Adverse Event|5|||
105795767|NCT00021229|364909257|FG002|Overall Study|Adverse Event|2|||
105795768|NCT00021229|364909255|FG000|Overall Study|Death|0|||
105795769|NCT00021229|364909256|FG001|Overall Study|Death|1|||
105795770|NCT00021229|364909257|FG002|Overall Study|Death|0|||
105795771|NCT00021229|364909255|FG000|Overall Study|Withdrawal by Subject|7|||
105795772|NCT00021229|364909256|FG001|Overall Study|Withdrawal by Subject|7|||
105795773|NCT00021229|364909257|FG002|Overall Study|Withdrawal by Subject|1|||
105795774|NCT00021229|364909255|FG000|Overall Study|Progressive Disease|15|||
105795775|NCT00021229|364909256|FG001|Overall Study|Progressive Disease|19|||
105795776|NCT00021229|364909257|FG002|Overall Study|Progressive Disease|12|||
105795777|NCT00021229|364909255|FG000|Overall Study|Protocol Violation|1|||
105795778|NCT00021229|364909256|FG001|Overall Study|Protocol Violation|1|||
105795779|NCT00021229|364909257|FG002|Overall Study|Protocol Violation|0|||
105795780|NCT00021229|364909255|FG000|Overall Study|Physician Decision|0|||
105564944|NCT00031486|364065362|FG001|Overall Study|Withdrawal by Subject|2|||
105564945|NCT00031486|364065361|FG000|Overall Study|Death|0|||
105564946|NCT00031486|364065362|FG001|Overall Study|Death|3|||
105728323|NCT00283387|364659687|FG001|First Intervention|Subject non-compliant|1|||
105728324|NCT00283387|364659686|FG000|First Intervention|Withdrawal by Subject|0|||
105728325|NCT00283387|364659687|FG001|First Intervention|Withdrawal by Subject|1|||
105728326|NCT00222105|364659689|FG000|Overall Study|Removed due to wrong diagnosis|1|||
105728327|NCT00222105|364659689|FG000|Overall Study|Withdrawal by Subject|1|||
105728328|NCT00222105|364659689|FG000|Overall Study|Adverse Event|8|||
105728329|NCT00222105|364659689|FG000|Overall Study|Treatment delays|2|||
105728330|NCT00222105|364659689|FG000|Overall Study|Death|2|||
105728331|NCT00503399|364659690|FG000|Overall Study|Death|2|||
105728332|NCT00503399|364659691|FG001|Overall Study|Death|1|||
105728333|NCT00503399|364659690|FG000|Overall Study|Protocol Violation|1|||
105728334|NCT00503399|364659691|FG001|Overall Study|Protocol Violation|0|||
105728335|NCT00503399|364659690|FG000|Overall Study|Withdrawal by Subject|4|||
105728336|NCT00503399|364659691|FG001|Overall Study|Withdrawal by Subject|2|||
105728337|NCT00503399|364659690|FG000|Overall Study|Adverse Event|0|||
105728338|NCT00503399|364659691|FG001|Overall Study|Adverse Event|3|||
105728339|NCT00503399|364659690|FG000|Overall Study|Lost to Follow-up|0|||
105728340|NCT00503399|364659691|FG001|Overall Study|Lost to Follow-up|2|||
105728341|NCT01676961|364659692|FG000|Overall Study|Death|3|||
105728342|NCT01676961|364659692|FG000|Overall Study|Lost to Follow-up|1|||
105728343|NCT01676961|364659692|FG000|Overall Study|Withdrawal by Subject|1|||
105728344|NCT03812510|364659693|FG000|Overall Study|Lost to Follow-up|39|||
105728345|NCT03812510|364659693|FG000|Overall Study|Withdrawal by Subject|42|||
105728346|NCT03812510|364659693|FG000|Overall Study|Physician Decision|2|||
105728347|NCT03812510|364659693|FG000|Overall Study|Study Terminated by Sponsor|9|||
105728348|NCT03812510|364659693|FG000|Overall Study|Did Not Start Study Medication|55|||
105728349|NCT03812510|364659693|FG000|Overall Study|Adverse Event|5|||
105728350|NCT00195650|364659696|FG000|Overall Study|Adverse Event|194|||
105728351|NCT00195650|364659696|FG000|Overall Study|Lack of Efficacy|99|||
105728352|NCT00195650|364659696|FG000|Overall Study|Withdrawal by Subject|67|||
105728353|NCT00195650|364659696|FG000|Overall Study|Lost to Follow-up|44|||
105728354|NCT00195650|364659696|FG000|Overall Study|Death|23|||
105728355|NCT00195650|364659696|FG000|Overall Study|Protocol Violation|15|||
105728356|NCT00195650|364659696|FG000|Overall Study|Administrative reasons|83|||
105728357|NCT01120626|364659697|FG000|Overall Study|Withdrawal by Subject|1|||
105728358|NCT01120626|364659698|FG001|Overall Study|Withdrawal by Subject|0|||
105728359|NCT03427073|364659699|FG000|Overall Study|Disease Progression|1|||
105728360|NCT03427073|364659700|FG001|Overall Study|Disease Progression|1|||
105728361|NCT03427073|364659701|FG002|Overall Study|Disease Progression|1|||
105728362|NCT03427073|364659702|FG003|Overall Study|Disease Progression|3|||
105728363|NCT03427073|364659703|FG004|Overall Study|Disease Progression|3|||
105728364|NCT03427073|364659704|FG005|Overall Study|Disease Progression|4|||
105728365|NCT03427073|364659705|FG006|Overall Study|Disease Progression|2|||
105728366|NCT03427073|364659706|FG007|Overall Study|Disease Progression|3|||
105728367|NCT03427073|364659699|FG000|Overall Study|Physician Decision|0|||
105728368|NCT03427073|364659700|FG001|Overall Study|Physician Decision|0|||
105728369|NCT03427073|364659701|FG002|Overall Study|Physician Decision|0|||
105728370|NCT03427073|364659702|FG003|Overall Study|Physician Decision|0|||
105728371|NCT03427073|364659703|FG004|Overall Study|Physician Decision|0|||
105728372|NCT03427073|364659704|FG005|Overall Study|Physician Decision|0|||
105728373|NCT03427073|364659705|FG006|Overall Study|Physician Decision|1|||
105728374|NCT03427073|364659706|FG007|Overall Study|Physician Decision|1|||
105728375|NCT02635204|364659707|FG000|Overall Study|Adverse Event|1|||
105728376|NCT02635204|364659708|FG001|Overall Study|Adverse Event|0|||
105728377|NCT02635204|364659707|FG000|Overall Study|Lost to Follow-up|1|||
105728378|NCT02635204|364659708|FG001|Overall Study|Lost to Follow-up|1|||
105728379|NCT00858832|364659709|FG000|Overall Study|became ineligible: delivered vaginally|1|||
105728380|NCT00858832|364659710|FG001|Overall Study|became ineligible: delivered vaginally|0|||
105728381|NCT00858832|364659709|FG000|Overall Study|Adverse Event|0|||
105728382|NCT00858832|364659710|FG001|Overall Study|Adverse Event|1|||
105728383|NCT01244737|364659711|FG000|Overall Study|Physician Decision|2|||
105728384|NCT01244737|364659712|FG001|Overall Study|Physician Decision|18|||
105728385|NCT01244737|364659713|FG002|Overall Study|Physician Decision|5|||
105728386|NCT01244737|364659711|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
105728387|NCT01244737|364659712|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
105728388|NCT01244737|364659713|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
105728389|NCT01244737|364659711|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
105728390|NCT01244737|364659712|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
105728391|NCT01244737|364659713|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
105795781|NCT00021229|364909256|FG001|Overall Study|Physician Decision|0|||
105795782|NCT00021229|364909257|FG002|Overall Study|Physician Decision|1|||
105795783|NCT00021229|364909255|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
105795784|NCT00021229|364909256|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
105795785|NCT00021229|364909257|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
105728392|NCT01244737|364659711|FG000|Overall Study|MIB immunopathology results not available|3|||
105728393|NCT01244737|364659712|FG001|Overall Study|MIB immunopathology results not available|2|||
105728394|NCT01244737|364659713|FG002|Overall Study|MIB immunopathology results not available|0|||
105728395|NCT01244737|364659711|FG000|Overall Study|PET data failure|0|||
105728396|NCT01244737|364659712|FG001|Overall Study|PET data failure|1|||
105728397|NCT01244737|364659713|FG002|Overall Study|PET data failure|0|||
105728398|NCT01244737|364659711|FG000|Overall Study|Withdrawal by Subject|0|||
105728399|NCT01244737|364659712|FG001|Overall Study|Withdrawal by Subject|0|||
105728400|NCT01244737|364659713|FG002|Overall Study|Withdrawal by Subject|1|||
105728401|NCT00389207|364659716|FG000|Overall Study|Adverse Event|26|||
105728402|NCT00389207|364659717|FG001|Overall Study|Adverse Event|32|||
105728403|NCT00389207|364659718|FG002|Overall Study|Adverse Event|10|||
105728404|NCT00389207|364659716|FG000|Overall Study|Protocol Violation|3|||
105728405|NCT00389207|364659717|FG001|Overall Study|Protocol Violation|1|||
105728406|NCT00389207|364659718|FG002|Overall Study|Protocol Violation|4|||
105728407|NCT00389207|364659716|FG000|Overall Study|Lost to Follow-up|12|||
105728408|NCT00389207|364659717|FG001|Overall Study|Lost to Follow-up|9|||
105728409|NCT00389207|364659718|FG002|Overall Study|Lost to Follow-up|7|||
105728410|NCT00389207|364659716|FG000|Overall Study|Withdrawal by Subject|5|||
105728411|NCT00389207|364659717|FG001|Overall Study|Withdrawal by Subject|7|||
105728412|NCT00389207|364659718|FG002|Overall Study|Withdrawal by Subject|11|||
105728413|NCT00389207|364659716|FG000|Overall Study|Other|17|||
105728414|NCT00389207|364659717|FG001|Overall Study|Other|23|||
105728415|NCT00389207|364659718|FG002|Overall Study|Other|9|||
105728416|NCT05564052|364659720|FG000|Overall Study|Withdrawal by Subject|0|||
105728417|NCT05564052|364659721|FG001|Overall Study|Withdrawal by Subject|0|||
105728418|NCT05564052|364659722|FG002|Overall Study|Withdrawal by Subject|0|||
105728419|NCT05564052|364659723|FG003|Overall Study|Withdrawal by Subject|1|||
105728420|NCT05564052|364659720|FG000|Overall Study|Ongoing|8|||
105728421|NCT05564052|364659721|FG001|Overall Study|Ongoing|5|||
105728422|NCT05564052|364659722|FG002|Overall Study|Ongoing|4|||
105728423|NCT05564052|364659723|FG003|Overall Study|Ongoing|1|||
105728424|NCT05480514|364659726|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
105728425|NCT05480514|364659727|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
105728426|NCT05480514|364659726|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
105728427|NCT05480514|364659727|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
105728428|NCT05480514|364659726|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
105728429|NCT05480514|364659727|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
105728430|NCT05480514|364659726|FG000|Period 1|Covid-19 Related|1|||
105728431|NCT05480514|364659727|FG001|Period 1|Covid-19 Related|0|||
105728432|NCT05480514|364659726|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
105728433|NCT05480514|364659727|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
105728434|NCT03815175|364659728|FG000|Overall Study|Subject Lost to Follow-up|6|||
105728435|NCT03815175|364659728|FG000|Overall Study|Subject Withdrew Consent|48|||
105728436|NCT03815175|364659728|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
105728437|NCT03815175|364659728|FG000|Overall Study|Death|86|||
105728438|NCT03815175|364659728|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
105728439|NCT03815175|364659728|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
105728440|NCT03815175|364659728|FG000|Overall Study|Other Status Change Reason|1|||
105728441|NCT03815175|364659728|FG000|Overall Study|Missed Visit|12|||
105728442|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
105728443|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
105728444|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
105728445|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105728446|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105728447|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105728448|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105795786|NCT03284424|364909258|FG000|Overall Study|Death|70|||
105795787|NCT03284424|364909259|FG001|Overall Study|Death|24|||
105795788|NCT03284424|364909258|FG000|Overall Study|Lost to Follow-up|3|||
105728449|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
105728450|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
105728451|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
105728452|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
105795789|NCT03284424|364909259|FG001|Overall Study|Lost to Follow-up|1|||
105728453|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
105728454|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
105728455|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
105728456|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
105795790|NCT03284424|364909258|FG000|Overall Study|Physician Decision|1|||
105728457|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105728458|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
105728459|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105728460|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105728461|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105728462|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105728463|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
105728464|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105728465|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
105728466|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105728467|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105728468|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105728469|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105728470|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
105728471|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
105728472|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
105728473|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105728474|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105728475|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105728476|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105728477|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
105728478|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
105728479|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
105728480|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
105728481|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
105728482|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
105728483|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
105795791|NCT03284424|364909259|FG001|Overall Study|Physician Decision|2|||
105795792|NCT03284424|364909258|FG000|Overall Study|Withdrawal by Subject|4|||
105795793|NCT03284424|364909259|FG001|Overall Study|Withdrawal by Subject|5|||
105795794|NCT03284424|364909258|FG000|Overall Study|Sponsor's decision|27|||
105795795|NCT03284424|364909259|FG001|Overall Study|Sponsor's decision|22|||
105795796|NCT02016755|364909260|FG000|Overall Study|Major amputation of index limb|2|||
105795797|NCT02016755|364909260|FG000|Overall Study|Adverse Event|2|||
105795798|NCT02016755|364909260|FG000|Overall Study|Physician Decision|1|||
105795799|NCT02016755|364909260|FG000|Overall Study|Death|2|||
105795800|NCT01461369|364909261|FG000|Overall Study|Lack of Efficacy|2|||
105795801|NCT01461369|364909262|FG001|Overall Study|Lack of Efficacy|0|||
105795802|NCT01461369|364909263|FG002|Overall Study|Lack of Efficacy|6|||
105795803|NCT01461369|364909261|FG000|Overall Study|Lost to Follow-up|0|||
105795804|NCT01461369|364909262|FG001|Overall Study|Lost to Follow-up|0|||
105795805|NCT01461369|364909263|FG002|Overall Study|Lost to Follow-up|3|||
105795806|NCT01461369|364909261|FG000|Overall Study|Adverse Event|9|||
105795807|NCT01461369|364909262|FG001|Overall Study|Adverse Event|12|||
105795808|NCT01461369|364909263|FG002|Overall Study|Adverse Event|4|||
105795809|NCT01461369|364909261|FG000|Overall Study|Protocol Violation|1|||
105795810|NCT01461369|364909262|FG001|Overall Study|Protocol Violation|2|||
105795811|NCT01461369|364909263|FG002|Overall Study|Protocol Violation|2|||
105795812|NCT01461369|364909261|FG000|Overall Study|Withdrawal by Subject|1|||
105795813|NCT01461369|364909262|FG001|Overall Study|Withdrawal by Subject|3|||
105795814|NCT01461369|364909263|FG002|Overall Study|Withdrawal by Subject|2|||
105795815|NCT00765999|364909264|FG000|Overall Study|Adverse Event|203|||
105795816|NCT00765999|364909264|FG000|Overall Study|Insufficient Therapeutic Response|100|||
105795817|NCT00765999|364909264|FG000|Overall Study|Protocol Violation|95|||
105795818|NCT00765999|364909264|FG000|Overall Study|Consent Withdrawn|202|||
105795819|NCT00765999|364909264|FG000|Overall Study|Lost to Follow-up|131|||
105795820|NCT00765999|364909264|FG000|Overall Study|Study Terminated by Sponsor|2|||
105795821|NCT00765999|364909264|FG000|Overall Study|Other Miscellaneous Reasons|51|||
105795822|NCT02626182|364909272|FG000|Overall Study|Adverse Event|2|||
105795823|NCT02626182|364909273|FG001|Overall Study|Adverse Event|0|||
105795824|NCT03578276|364909274|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
105564947|NCT00031486|364065361|FG000|Overall Study|Non-compliant|0|||
105479734|NCT00065429|363767595|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
105479735|NCT00065429|363767596|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
105479736|NCT03554486|363767600|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
105479737|NCT03554486|363767601|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
105479738|NCT03554486|363767602|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
105479739|NCT03554486|363767600|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
105479740|NCT03554486|363767601|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
105479741|NCT03554486|363767602|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
105479742|NCT03554486|363767600|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
105728484|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
105728485|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
105728486|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
105728487|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
105728488|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
105728489|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
105479743|NCT03554486|363767601|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
105728490|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
105728491|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105728492|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
105728493|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
105728494|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105728495|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105728496|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105728497|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105728498|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
105728499|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
105728500|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
105728501|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
105728502|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
105728503|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
105728504|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
105728505|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
105728506|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
105728507|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
105728508|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
105728509|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
105728510|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
105728511|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
105728512|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105728513|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105728514|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105728515|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105728516|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105795825|NCT03578276|364909275|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
105795826|NCT03372369|364909276|FG000|Qualification Period|Withdrawal by Subject|16|||
105795827|NCT03372369|364909277|FG001|Qualification Period|Withdrawal by Subject|13|||
105479744|NCT03554486|363767602|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
105479745|NCT00441116|363767608|FG000|Overall Study|Adverse Event|1|||
105564948|NCT00031486|364065362|FG001|Overall Study|Non-compliant|4|||
105795828|NCT03372369|364909276|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
105479746|NCT00441116|363767609|FG001|Overall Study|Adverse Event|1|||
105479747|NCT00441116|363767608|FG000|Overall Study|Withdrawal by Subject|1|||
105564949|NCT00031486|364065361|FG000|Overall Study|Did not meet eligibility requirement|2|||
105564950|NCT00031486|364065362|FG001|Overall Study|Did not meet eligibility requirement|1|||
105564951|NCT00031486|364065361|FG000|Overall Study|Other|1|||
105728517|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
105728518|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
105728519|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
105728520|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
105728521|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
105728522|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
105728523|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
105728524|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
105728525|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
105728526|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
105728527|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
105728528|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
105728529|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
105728530|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
105728531|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
105728532|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
105728533|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
105728534|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
105728535|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
105728536|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
105728537|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
105728538|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
105728539|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
105728540|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
105728541|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
105728542|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
105728543|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
105728544|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
105728545|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
105728546|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
105728547|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
105728548|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
105728549|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
105728550|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
105728551|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
105728552|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
105728553|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
105728554|NCT03372941|364659741|FG000|Overall Study|Lost to Follow-up|2|||
105728555|NCT03372941|364659742|FG001|Overall Study|Lost to Follow-up|4|||
105728556|NCT01731002|364659743|FG000|Overall Study|Adverse Event|0|||
105728557|NCT01731002|364659744|FG001|Overall Study|Adverse Event|2|||
105728558|NCT01731002|364659745|FG002|Overall Study|Adverse Event|2|||
105728559|NCT01731002|364659743|FG000|Overall Study|Non-Compliant|0|||
105728560|NCT01731002|364659744|FG001|Overall Study|Non-Compliant|1|||
105728561|NCT01731002|364659745|FG002|Overall Study|Non-Compliant|0|||
105728562|NCT01731002|364659743|FG000|Overall Study|Lost to Follow-up|1|||
105728563|NCT01731002|364659744|FG001|Overall Study|Lost to Follow-up|0|||
105728564|NCT01731002|364659745|FG002|Overall Study|Lost to Follow-up|0|||
105728565|NCT01731002|364659743|FG000|Overall Study|Test Agent Discontinuation|0|||
105728566|NCT01731002|364659744|FG001|Overall Study|Test Agent Discontinuation|1|||
105728567|NCT01731002|364659745|FG002|Overall Study|Test Agent Discontinuation|0|||
105728568|NCT01731002|364659743|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
105728569|NCT01731002|364659744|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
105728570|NCT01731002|364659745|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
105728571|NCT01731002|364659743|FG000|Overall Study|Elevated IOP|1|||
105728572|NCT01731002|364659744|FG001|Overall Study|Elevated IOP|0|||
105728573|NCT01731002|364659745|FG002|Overall Study|Elevated IOP|0|||
105728574|NCT01731002|364659743|FG000|Overall Study|Inappropriate use of study medications|0|||
105728575|NCT01731002|364659744|FG001|Overall Study|Inappropriate use of study medications|0|||
105728576|NCT01731002|364659745|FG002|Overall Study|Inappropriate use of study medications|1|||
105728577|NCT02031679|364661110|FG000|Overall Study|Protocol Violation|0|||
105728578|NCT02031679|364661111|FG001|Overall Study|Protocol Violation|1|||
105728579|NCT02031679|364661110|FG000|Overall Study|Lack of Efficacy|0|||
105728580|NCT02031679|364661111|FG001|Overall Study|Lack of Efficacy|1|||
105728581|NCT03019549|364661112|FG000|Washout|DId not meet genotype criteria|11|||
105728582|NCT03019549|364661112|FG000|Period 2|Adverse Event|2|||
105728583|NCT03019549|364661112|FG000|Period 2|Physician Decision|2|||
105728584|NCT03019549|364661112|FG000|Period 2|Withdrawal by Subject|1|||
105728585|NCT04030195|364661113|FG000|Overall Study|Withdrawal by Subject|2|||
105728586|NCT04030195|364661114|FG001|Overall Study|Withdrawal by Subject|0|||
105728587|NCT04030195|364661115|FG002|Overall Study|Withdrawal by Subject|0|||
105728588|NCT02109029|364661116|FG000|Part B|Adverse Event|0|||
105728589|NCT02109029|364661117|FG001|Part B|Adverse Event|0|||
105728590|NCT02109029|364661118|FG002|Part B|Adverse Event|0|||
105728591|NCT02109029|364661119|FG003|Part B|Adverse Event|0|||
105728592|NCT02109029|364661120|FG004|Part B|Adverse Event|1|||
105728593|NCT02109029|364661121|FG005|Part B|Adverse Event|1|||
105728594|NCT01445171|364661122|FG000|Overall Study|Lost to Follow-up|11|||
105728595|NCT01445171|364661122|FG000|Overall Study|Withdrawal by Subject|16|||
105728596|NCT01445171|364661122|FG000|Overall Study|Death|51|||
105728597|NCT01445171|364661122|FG000|Overall Study|Subjects declined to return for followup|9|||
105728598|NCT01445171|364661122|FG000|Overall Study|Consented but did not receive device|8|||
105728599|NCT01609933|364661133|FG000|Overall Study|Adverse Event|1|||
105728600|NCT01609933|364661133|FG000|Overall Study|Withdrawal by Subject|3|||
105728601|NCT01252966|364661134|FG000|Overall Study|Lost to Follow-up|16|||
105728602|NCT01252966|364661135|FG001|Overall Study|Lost to Follow-up|10|||
105728603|NCT01252966|364661134|FG000|Overall Study|Withdrawal by Subject|7|||
105728604|NCT01252966|364661135|FG001|Overall Study|Withdrawal by Subject|3|||
105728605|NCT02017444|364661136|FG000|Overall Study|Physician Decision|1|||
105728606|NCT02017444|364661137|FG001|Overall Study|Physician Decision|0|||
105728607|NCT02017444|364661136|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
105728608|NCT02017444|364661137|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
105728609|NCT00886821|364661146|FG000|Stage 2|Adverse Event|0|||
105728610|NCT00886821|364661147|FG001|Stage 2|Adverse Event|0|||
105728611|NCT00886821|364661148|FG002|Stage 2|Adverse Event|0|||
105728612|NCT00886821|364661149|FG003|Stage 2|Adverse Event|0|||
105728613|NCT00886821|364661150|FG004|Stage 2|Adverse Event|0|||
105728614|NCT00886821|364661151|FG005|Stage 2|Adverse Event|0|||
105728615|NCT00886821|364661152|FG006|Stage 2|Adverse Event|0|||
105728616|NCT00886821|364661153|FG007|Stage 2|Adverse Event|0|||
105728617|NCT00886821|364661154|FG008|Stage 2|Adverse Event|0|||
105728618|NCT00886821|364661155|FG009|Stage 2|Adverse Event|0|||
105728619|NCT00886821|364661156|FG010|Stage 2|Adverse Event|0|||
105728620|NCT00886821|364661157|FG011|Stage 2|Adverse Event|1|||
105728621|NCT00886821|364661158|FG012|Stage 2|Adverse Event|3|||
105728622|NCT00886821|364661159|FG013|Stage 2|Adverse Event|0|||
105728623|NCT00886821|364661146|FG000|Stage 2|Lost to Follow-up|0|||
105728624|NCT00886821|364661147|FG001|Stage 2|Lost to Follow-up|0|||
105728625|NCT00886821|364661148|FG002|Stage 2|Lost to Follow-up|0|||
105728626|NCT00886821|364661149|FG003|Stage 2|Lost to Follow-up|0|||
105728627|NCT00886821|364661150|FG004|Stage 2|Lost to Follow-up|0|||
105728628|NCT00886821|364661151|FG005|Stage 2|Lost to Follow-up|0|||
105728629|NCT00886821|364661152|FG006|Stage 2|Lost to Follow-up|0|||
105728630|NCT00886821|364661153|FG007|Stage 2|Lost to Follow-up|0|||
105728631|NCT00886821|364661154|FG008|Stage 2|Lost to Follow-up|0|||
105728632|NCT00886821|364661155|FG009|Stage 2|Lost to Follow-up|0|||
105728633|NCT00886821|364661156|FG010|Stage 2|Lost to Follow-up|0|||
105728634|NCT00886821|364661157|FG011|Stage 2|Lost to Follow-up|0|||
105728635|NCT00886821|364661158|FG012|Stage 2|Lost to Follow-up|2|||
105728636|NCT00886821|364661159|FG013|Stage 2|Lost to Follow-up|1|||
105728637|NCT02660580|364661160|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
105728638|NCT02660580|364661161|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
105728639|NCT02660580|364661162|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
105728640|NCT02660580|364661163|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
105728641|NCT02660580|364661164|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
105728642|NCT02660580|364661160|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
105728643|NCT02660580|364661161|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
105728644|NCT02660580|364661162|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
105728645|NCT02660580|364661163|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
105728646|NCT02660580|364661164|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
105728647|NCT02660580|364661160|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
105728648|NCT02660580|364661161|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
105728649|NCT02660580|364661162|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
105728650|NCT02660580|364661163|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
105728651|NCT02660580|364661164|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
105728652|NCT02660580|364661160|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
105728653|NCT02660580|364661161|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
105728654|NCT02660580|364661162|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
105728655|NCT02660580|364661163|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
105728656|NCT02660580|364661164|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
105728657|NCT02660580|364661160|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
105728658|NCT02660580|364661161|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
105728659|NCT02660580|364661162|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
105728660|NCT02660580|364661163|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
105728661|NCT02660580|364661164|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
105728662|NCT02660580|364661160|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
105728663|NCT02660580|364661161|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
105728664|NCT02660580|364661162|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
105728665|NCT02660580|364661163|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
105728666|NCT02660580|364661164|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
105728667|NCT02660580|364661160|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
105728668|NCT02660580|364661161|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
105728669|NCT02660580|364661162|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
105728670|NCT02660580|364661163|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
105728671|NCT02660580|364661164|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
105728672|NCT02660580|364661160|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
105728673|NCT02660580|364661161|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
105728674|NCT02660580|364661162|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
105728675|NCT02660580|364661163|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
105728676|NCT02660580|364661164|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
105728677|NCT02660580|364661160|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
105728678|NCT02660580|364661161|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
105728679|NCT02660580|364661162|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
105728680|NCT02660580|364661163|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
105728681|NCT02660580|364661164|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
105728682|NCT02660580|364661160|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
105728683|NCT02660580|364661161|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
105728684|NCT02660580|364661162|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
105728685|NCT02660580|364661163|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
105728686|NCT02660580|364661164|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
105728687|NCT02660580|364661160|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
105728688|NCT02660580|364661161|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
105728689|NCT02660580|364661162|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
105728690|NCT02660580|364661163|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
105728691|NCT02660580|364661164|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
105728692|NCT02660580|364661160|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
105728693|NCT02660580|364661161|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
105728694|NCT02660580|364661162|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
105728695|NCT02660580|364661163|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
105728696|NCT02660580|364661164|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
105795829|NCT03372369|364909277|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
105728697|NCT02660580|364661160|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
105728698|NCT02660580|364661161|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
105728699|NCT02660580|364661162|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
105728700|NCT02660580|364661163|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
105728701|NCT02660580|364661164|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
105728702|NCT00377962|364661165|FG000|Core Study: 0-12 Months|Adverse Event|18|||
105728703|NCT00377962|364661166|FG001|Core Study: 0-12 Months|Adverse Event|2|||
105728704|NCT00377962|364661165|FG000|Core Study: 0-12 Months|Death|3|||
105728705|NCT00377962|364661166|FG001|Core Study: 0-12 Months|Death|0|||
105728706|NCT00377962|364661165|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
105728707|NCT00377962|364661166|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
105728708|NCT00377962|364661165|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
105728709|NCT00377962|364661166|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
105728710|NCT00377962|364661165|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
105728711|NCT00377962|364661166|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
105728712|NCT00377962|364661165|FG000|Extension Study: 12-24 Months|Death|1|||
105728713|NCT00377962|364661166|FG001|Extension Study: 12-24 Months|Death|1|||
105728714|NCT00377962|364661165|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
105728715|NCT00377962|364661166|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
105728716|NCT00377962|364661165|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
105728717|NCT00377962|364661166|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
105728718|NCT00377962|364661165|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
105728719|NCT00377962|364661166|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
105728720|NCT03368859|364661171|FG000|Overall Study|Withdrew Consent|5|||
105728721|NCT03368859|364661172|FG001|Overall Study|Withdrew Consent|4|||
105728722|NCT03368859|364661171|FG000|Overall Study|Death|12|||
105728723|NCT03368859|364661172|FG001|Overall Study|Death|6|||
105728724|NCT03368859|364661171|FG000|Overall Study|Study terminated by Sponsor|18|||
105728725|NCT03368859|364661172|FG001|Overall Study|Study terminated by Sponsor|23|||
105728726|NCT03368859|364661171|FG000|Overall Study|Other|1|||
105728727|NCT03368859|364661172|FG001|Overall Study|Other|1|||
105728728|NCT01713348|364661173|FG000|Overall Study|Withdrawal by Subject|3|||
105728729|NCT01713348|364661174|FG001|Overall Study|Withdrawal by Subject|2|||
105728730|NCT01713348|364661175|FG002|Overall Study|Withdrawal by Subject|2|||
105728731|NCT01713348|364661176|FG003|Overall Study|Withdrawal by Subject|0|||
105728732|NCT01713348|364661173|FG000|Overall Study|Lost to Follow-up|1|||
105728733|NCT01713348|364661174|FG001|Overall Study|Lost to Follow-up|0|||
105728734|NCT01713348|364661175|FG002|Overall Study|Lost to Follow-up|0|||
105728735|NCT01713348|364661176|FG003|Overall Study|Lost to Follow-up|0|||
105728736|NCT01324830|364661183|FG000|Overall Study|Progressive Disease|3|||
105728737|NCT01324830|364661184|FG001|Overall Study|Progressive Disease|2|||
105728738|NCT01324830|364661185|FG002|Overall Study|Progressive Disease|3|||
105728739|NCT01324830|364661186|FG003|Overall Study|Progressive Disease|3|||
105728740|NCT01324830|364661187|FG004|Overall Study|Progressive Disease|6|||
105728741|NCT01324830|364661188|FG005|Overall Study|Progressive Disease|6|||
105728742|NCT01324830|364661189|FG006|Overall Study|Progressive Disease|3|||
105728743|NCT01324830|364661190|FG007|Overall Study|Progressive Disease|3|||
105728744|NCT01324830|364661191|FG008|Overall Study|Progressive Disease|3|||
105728745|NCT01324830|364661192|FG009|Overall Study|Progressive Disease|6|||
105728746|NCT01324830|364661193|FG010|Overall Study|Progressive Disease|2|||
105728747|NCT01324830|364661194|FG011|Overall Study|Progressive Disease|1|||
105728748|NCT01324830|364661195|FG012|Overall Study|Progressive Disease|1|||
105728749|NCT01324830|364661196|FG013|Overall Study|Progressive Disease|1|||
105728750|NCT01324830|364661197|FG014|Overall Study|Progressive Disease|1|||
105728751|NCT01324830|364661198|FG015|Overall Study|Progressive Disease|3|||
105728752|NCT01324830|364661199|FG016|Overall Study|Progressive Disease|2|||
105728753|NCT01324830|364661200|FG017|Overall Study|Progressive Disease|3|||
105728754|NCT01324830|364661201|FG018|Overall Study|Progressive Disease|4|||
105728755|NCT01324830|364661183|FG000|Overall Study|Dose limiting toxicity|0|||
105728756|NCT01324830|364661184|FG001|Overall Study|Dose limiting toxicity|0|||
105728757|NCT01324830|364661185|FG002|Overall Study|Dose limiting toxicity|0|||
105728758|NCT01324830|364661186|FG003|Overall Study|Dose limiting toxicity|0|||
105728759|NCT01324830|364661187|FG004|Overall Study|Dose limiting toxicity|1|||
105728760|NCT01324830|364661188|FG005|Overall Study|Dose limiting toxicity|0|||
105564952|NCT00031486|364065362|FG001|Overall Study|Other|1|||
105795830|NCT03372369|364909276|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
105728761|NCT01324830|364661189|FG006|Overall Study|Dose limiting toxicity|0|||
105728762|NCT01324830|364661190|FG007|Overall Study|Dose limiting toxicity|0|||
105728763|NCT01324830|364661191|FG008|Overall Study|Dose limiting toxicity|0|||
105728764|NCT01324830|364661192|FG009|Overall Study|Dose limiting toxicity|0|||
105728765|NCT01324830|364661193|FG010|Overall Study|Dose limiting toxicity|0|||
105728766|NCT01324830|364661194|FG011|Overall Study|Dose limiting toxicity|0|||
105728767|NCT01324830|364661195|FG012|Overall Study|Dose limiting toxicity|0|||
105728768|NCT01324830|364661196|FG013|Overall Study|Dose limiting toxicity|0|||
105728769|NCT01324830|364661197|FG014|Overall Study|Dose limiting toxicity|0|||
105728770|NCT01324830|364661198|FG015|Overall Study|Dose limiting toxicity|0|||
105728771|NCT01324830|364661199|FG016|Overall Study|Dose limiting toxicity|1|||
105728772|NCT01324830|364661200|FG017|Overall Study|Dose limiting toxicity|1|||
105479748|NCT00441116|363767609|FG001|Overall Study|Withdrawal by Subject|0|||
105795831|NCT03372369|364909277|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
105795832|NCT02923115|364909280|FG000|Overall Study|Lost to Follow-up|0|||
105795833|NCT02923115|364909281|FG001|Overall Study|Lost to Follow-up|0|||
105795834|NCT02923115|364909282|FG002|Overall Study|Lost to Follow-up|0|||
105795835|NCT02923115|364909283|FG003|Overall Study|Lost to Follow-up|1|||
105795836|NCT02923115|364909284|FG004|Overall Study|Lost to Follow-up|0|||
105795837|NCT02923115|364909285|FG005|Overall Study|Lost to Follow-up|0|||
105795838|NCT02923115|364909280|FG000|Overall Study|Withdrawal by Subject|0|||
105795839|NCT02923115|364909281|FG001|Overall Study|Withdrawal by Subject|1|||
105795840|NCT02923115|364909282|FG002|Overall Study|Withdrawal by Subject|0|||
105795841|NCT02923115|364909283|FG003|Overall Study|Withdrawal by Subject|0|||
105795842|NCT02923115|364909284|FG004|Overall Study|Withdrawal by Subject|0|||
105795843|NCT02923115|364909285|FG005|Overall Study|Withdrawal by Subject|0|||
105795844|NCT02923115|364909280|FG000|Overall Study|Randomized, but not dosed|0|||
105795845|NCT02923115|364909281|FG001|Overall Study|Randomized, but not dosed|0|||
105795846|NCT02923115|364909282|FG002|Overall Study|Randomized, but not dosed|3|||
105795847|NCT02923115|364909283|FG003|Overall Study|Randomized, but not dosed|1|||
105795848|NCT02923115|364909284|FG004|Overall Study|Randomized, but not dosed|5|||
105795849|NCT02923115|364909285|FG005|Overall Study|Randomized, but not dosed|0|||
105795850|NCT03451331|364909292|FG000|Overall Study|Withdrawal by Subject|1|||
105795851|NCT03451331|364909293|FG001|Overall Study|Withdrawal by Subject|0|||
105795852|NCT03451331|364909292|FG000|Overall Study|Unable to start treatment.|1|||
105795853|NCT03451331|364909293|FG001|Overall Study|Unable to start treatment.|1|||
105795854|NCT00038467|364909294|FG000|Overall Study|Adverse Event|170|||
105479749|NCT00441116|363767608|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
105479750|NCT00441116|363767609|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
105353273|NCT00171158|363298488|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
105795855|NCT00038467|364909295|FG001|Overall Study|Adverse Event|145|||
105795856|NCT00038467|364909294|FG000|Overall Study|Withdrawal by Subject|150|||
105479751|NCT02925338|363767610|FG000|Overall Study|Death|0|||
105795857|NCT00038467|364909295|FG001|Overall Study|Withdrawal by Subject|107|||
105795858|NCT00038467|364909294|FG000|Overall Study|Protocol Violation|19|||
105795859|NCT00038467|364909295|FG001|Overall Study|Protocol Violation|22|||
105795860|NCT00038467|364909294|FG000|Overall Study|Death|22|||
105795861|NCT00038467|364909295|FG001|Overall Study|Death|16|||
105795862|NCT00038467|364909294|FG000|Overall Study|Lost to Follow-up|15|||
105795863|NCT00038467|364909295|FG001|Overall Study|Lost to Follow-up|10|||
105795864|NCT00038467|364909294|FG000|Overall Study|Recurrence|109|||
105795865|NCT00038467|364909295|FG001|Overall Study|Recurrence|179|||
105795866|NCT00038467|364909294|FG000|Overall Study|Randomized, but not treated|31|||
105795867|NCT00038467|364909295|FG001|Overall Study|Randomized, but not treated|35|||
105795868|NCT00038467|364909294|FG000|Overall Study|Other|26|||
105795869|NCT00038467|364909295|FG001|Overall Study|Other|28|||
105795870|NCT04330482|364909296|FG000|Overall Study|Lost to Follow-up|2|||
105795871|NCT04330482|364909297|FG001|Overall Study|Lost to Follow-up|1|||
105795872|NCT04330482|364909296|FG000|Overall Study|Withdrawal by Subject|0|||
105795873|NCT04330482|364909297|FG001|Overall Study|Withdrawal by Subject|3|||
105795874|NCT05180630|364909298|FG000|First Intervention|Physician Decision|0|||
105795875|NCT05180630|364909299|FG001|First Intervention|Physician Decision|0|||
105795876|NCT05180630|364909300|FG002|First Intervention|Physician Decision|3|||
105795877|NCT00944125|364909308|FG000|3 to 6 Months|Withdrawal by Subject|0|||
105795878|NCT00944125|364909309|FG001|3 to 6 Months|Withdrawal by Subject|2|||
105795879|NCT00944125|364909308|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
105795880|NCT00944125|364909309|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
105795881|NCT00446134|364909310|FG000|Overall Study|Adverse Event|7|||
105795882|NCT00446134|364909311|FG001|Overall Study|Adverse Event|17|||
105795883|NCT00446134|364909312|FG002|Overall Study|Adverse Event|13|||
105795884|NCT00446134|364909313|FG003|Overall Study|Adverse Event|18|||
105795885|NCT00446134|364909310|FG000|Overall Study|Lack of Efficacy|19|||
105795886|NCT00446134|364909311|FG001|Overall Study|Lack of Efficacy|19|||
105795887|NCT00446134|364909312|FG002|Overall Study|Lack of Efficacy|24|||
105795888|NCT00446134|364909313|FG003|Overall Study|Lack of Efficacy|19|||
105795889|NCT00446134|364909310|FG000|Overall Study|Protocol Violation|0|||
105795890|NCT00446134|364909311|FG001|Overall Study|Protocol Violation|2|||
105795891|NCT00446134|364909312|FG002|Overall Study|Protocol Violation|1|||
105795892|NCT00446134|364909313|FG003|Overall Study|Protocol Violation|0|||
105795893|NCT00446134|364909310|FG000|Overall Study|Lost to Follow-up|1|||
105795894|NCT00446134|364909311|FG001|Overall Study|Lost to Follow-up|3|||
105795895|NCT00446134|364909312|FG002|Overall Study|Lost to Follow-up|1|||
105795896|NCT00446134|364909313|FG003|Overall Study|Lost to Follow-up|1|||
105795897|NCT00446134|364909310|FG000|Overall Study|Withdrawal by Subject|3|||
105795898|NCT00446134|364909311|FG001|Overall Study|Withdrawal by Subject|3|||
105795899|NCT00446134|364909312|FG002|Overall Study|Withdrawal by Subject|1|||
105795900|NCT00446134|364909313|FG003|Overall Study|Withdrawal by Subject|3|||
105795901|NCT00446134|364909310|FG000|Overall Study|Physician Decision|0|||
105795902|NCT00446134|364909311|FG001|Overall Study|Physician Decision|0|||
105795903|NCT00446134|364909312|FG002|Overall Study|Physician Decision|0|||
105795904|NCT00446134|364909313|FG003|Overall Study|Physician Decision|2|||
105795905|NCT00446134|364909310|FG000|Overall Study|Adverse Event-Diarrhea|1|||
105795906|NCT00446134|364909311|FG001|Overall Study|Adverse Event-Diarrhea|1|||
105795907|NCT00446134|364909312|FG002|Overall Study|Adverse Event-Diarrhea|2|||
105795908|NCT00446134|364909313|FG003|Overall Study|Adverse Event-Diarrhea|0|||
105795909|NCT00446134|364909310|FG000|Overall Study|Reason Not Completed|3|||
105795910|NCT00446134|364909311|FG001|Overall Study|Reason Not Completed|0|||
105795911|NCT00446134|364909312|FG002|Overall Study|Reason Not Completed|1|||
105795912|NCT00446134|364909313|FG003|Overall Study|Reason Not Completed|2|||
105795913|NCT02524665|364909314|FG000|Overall Study|Lost to Follow-up|1|||
105795914|NCT01500434|364909315|FG000|Overall Study|Death|1|||
105795915|NCT01500434|364909315|FG000|Overall Study|Withdrawal by Subject|1|||
105795916|NCT01500434|364909315|FG000|Overall Study|Missed 12-month follow-up|5|||
105795917|NCT02602080|364909316|FG000|Overall Study|Protocol Violation|6|||
105795918|NCT02602080|364909317|FG001|Overall Study|Protocol Violation|1|||
105795919|NCT02602080|364909318|FG002|Overall Study|Protocol Violation|3|||
105795920|NCT01185639|364909325|FG000|Overall Study|Progressed and didn't receive therapy|2|||
105479752|NCT02925338|363767611|FG001|Overall Study|Death|2|||
105479753|NCT02925338|363767612|FG002|Overall Study|Death|1|||
105479754|NCT02925338|363767613|FG003|Overall Study|Death|0|||
105479755|NCT02925338|363767614|FG004|Overall Study|Death|0|||
105479756|NCT02925338|363767610|FG000|Overall Study|Lost to Follow-up|30|||
105795921|NCT02200614|364909326|FG000|Double Blind Treatment|Adverse Event|86|||
105795922|NCT02200614|364909327|FG001|Double Blind Treatment|Adverse Event|48|||
105795923|NCT02200614|364909326|FG000|Double Blind Treatment|Confirmed metastasis|120|||
105479757|NCT02925338|363767611|FG001|Overall Study|Lost to Follow-up|10|||
105479758|NCT02925338|363767612|FG002|Overall Study|Lost to Follow-up|1|||
105479759|NCT02925338|363767613|FG003|Overall Study|Lost to Follow-up|16|||
105795924|NCT02200614|364909327|FG001|Double Blind Treatment|Confirmed metastasis|140|||
105795925|NCT02200614|364909326|FG000|Double Blind Treatment|Judgment of the investigator|59|||
105728773|NCT01324830|364661201|FG018|Overall Study|Dose limiting toxicity|1|||
105728774|NCT01324830|364661183|FG000|Overall Study|Reason not mentioned above|0|||
105728775|NCT01324830|364661184|FG001|Overall Study|Reason not mentioned above|0|||
105728776|NCT01324830|364661185|FG002|Overall Study|Reason not mentioned above|0|||
105728777|NCT01324830|364661186|FG003|Overall Study|Reason not mentioned above|0|||
105728778|NCT01324830|364661187|FG004|Overall Study|Reason not mentioned above|0|||
105728779|NCT01324830|364661188|FG005|Overall Study|Reason not mentioned above|0|||
105728780|NCT01324830|364661189|FG006|Overall Study|Reason not mentioned above|0|||
105728781|NCT01324830|364661190|FG007|Overall Study|Reason not mentioned above|0|||
105728782|NCT01324830|364661191|FG008|Overall Study|Reason not mentioned above|0|||
105728783|NCT01324830|364661192|FG009|Overall Study|Reason not mentioned above|0|||
105728784|NCT01324830|364661193|FG010|Overall Study|Reason not mentioned above|0|||
105728785|NCT01324830|364661194|FG011|Overall Study|Reason not mentioned above|0|||
105728786|NCT01324830|364661195|FG012|Overall Study|Reason not mentioned above|0|||
105728787|NCT01324830|364661196|FG013|Overall Study|Reason not mentioned above|0|||
105728788|NCT01324830|364661197|FG014|Overall Study|Reason not mentioned above|0|||
105728789|NCT01324830|364661198|FG015|Overall Study|Reason not mentioned above|0|||
105728790|NCT01324830|364661199|FG016|Overall Study|Reason not mentioned above|0|||
105728791|NCT01324830|364661200|FG017|Overall Study|Reason not mentioned above|1|||
105728792|NCT01324830|364661201|FG018|Overall Study|Reason not mentioned above|0|||
105728793|NCT01324830|364661183|FG000|Overall Study|Adverse Event, serious fatal|0|||
105728794|NCT01324830|364661184|FG001|Overall Study|Adverse Event, serious fatal|1|||
105728795|NCT01324830|364661185|FG002|Overall Study|Adverse Event, serious fatal|0|||
105728796|NCT01324830|364661186|FG003|Overall Study|Adverse Event, serious fatal|0|||
105728797|NCT01324830|364661187|FG004|Overall Study|Adverse Event, serious fatal|0|||
105728798|NCT01324830|364661188|FG005|Overall Study|Adverse Event, serious fatal|0|||
105728799|NCT01324830|364661189|FG006|Overall Study|Adverse Event, serious fatal|0|||
105728800|NCT01324830|364661190|FG007|Overall Study|Adverse Event, serious fatal|0|||
105728801|NCT01324830|364661191|FG008|Overall Study|Adverse Event, serious fatal|0|||
105728802|NCT01324830|364661192|FG009|Overall Study|Adverse Event, serious fatal|0|||
105728803|NCT01324830|364661193|FG010|Overall Study|Adverse Event, serious fatal|0|||
105728804|NCT01324830|364661194|FG011|Overall Study|Adverse Event, serious fatal|0|||
105728805|NCT01324830|364661195|FG012|Overall Study|Adverse Event, serious fatal|0|||
105728806|NCT01324830|364661196|FG013|Overall Study|Adverse Event, serious fatal|0|||
105728807|NCT01324830|364661197|FG014|Overall Study|Adverse Event, serious fatal|0|||
105728808|NCT01324830|364661198|FG015|Overall Study|Adverse Event, serious fatal|0|||
105728809|NCT01324830|364661199|FG016|Overall Study|Adverse Event, serious fatal|0|||
105728810|NCT01324830|364661200|FG017|Overall Study|Adverse Event, serious fatal|0|||
105728811|NCT01324830|364661201|FG018|Overall Study|Adverse Event, serious fatal|0|||
105728812|NCT01324830|364661183|FG000|Overall Study|Adverse Event, non-fatal|0|||
105728813|NCT01324830|364661184|FG001|Overall Study|Adverse Event, non-fatal|0|||
105728814|NCT01324830|364661185|FG002|Overall Study|Adverse Event, non-fatal|0|||
105728815|NCT01324830|364661186|FG003|Overall Study|Adverse Event, non-fatal|0|||
105728816|NCT01324830|364661187|FG004|Overall Study|Adverse Event, non-fatal|0|||
105728817|NCT01324830|364661188|FG005|Overall Study|Adverse Event, non-fatal|0|||
105728818|NCT01324830|364661189|FG006|Overall Study|Adverse Event, non-fatal|0|||
105728819|NCT01324830|364661190|FG007|Overall Study|Adverse Event, non-fatal|0|||
105728820|NCT01324830|364661191|FG008|Overall Study|Adverse Event, non-fatal|2|||
105728821|NCT01324830|364661192|FG009|Overall Study|Adverse Event, non-fatal|0|||
105728822|NCT01324830|364661193|FG010|Overall Study|Adverse Event, non-fatal|1|||
105728823|NCT01324830|364661194|FG011|Overall Study|Adverse Event, non-fatal|0|||
105728824|NCT01324830|364661195|FG012|Overall Study|Adverse Event, non-fatal|0|||
105728825|NCT01324830|364661196|FG013|Overall Study|Adverse Event, non-fatal|0|||
105728826|NCT01324830|364661197|FG014|Overall Study|Adverse Event, non-fatal|0|||
105728827|NCT01324830|364661198|FG015|Overall Study|Adverse Event, non-fatal|0|||
105728828|NCT01324830|364661199|FG016|Overall Study|Adverse Event, non-fatal|0|||
105728829|NCT01324830|364661200|FG017|Overall Study|Adverse Event, non-fatal|1|||
105728830|NCT01324830|364661201|FG018|Overall Study|Adverse Event, non-fatal|0|||
105728831|NCT01324830|364661183|FG000|Overall Study|Withdrawal by Subject|0|||
105728832|NCT01324830|364661184|FG001|Overall Study|Withdrawal by Subject|0|||
105728833|NCT01324830|364661185|FG002|Overall Study|Withdrawal by Subject|0|||
105728834|NCT01324830|364661186|FG003|Overall Study|Withdrawal by Subject|0|||
105728835|NCT01324830|364661187|FG004|Overall Study|Withdrawal by Subject|0|||
105728836|NCT01324830|364661188|FG005|Overall Study|Withdrawal by Subject|1|||
105728837|NCT01324830|364661189|FG006|Overall Study|Withdrawal by Subject|0|||
105728838|NCT01324830|364661190|FG007|Overall Study|Withdrawal by Subject|0|||
105728839|NCT01324830|364661191|FG008|Overall Study|Withdrawal by Subject|0|||
105728840|NCT01324830|364661192|FG009|Overall Study|Withdrawal by Subject|0|||
105728841|NCT01324830|364661193|FG010|Overall Study|Withdrawal by Subject|1|||
105728842|NCT01324830|364661194|FG011|Overall Study|Withdrawal by Subject|0|||
105728843|NCT01324830|364661195|FG012|Overall Study|Withdrawal by Subject|0|||
105728844|NCT01324830|364661196|FG013|Overall Study|Withdrawal by Subject|0|||
105728845|NCT01324830|364661197|FG014|Overall Study|Withdrawal by Subject|0|||
105728846|NCT01324830|364661198|FG015|Overall Study|Withdrawal by Subject|0|||
105728847|NCT01324830|364661199|FG016|Overall Study|Withdrawal by Subject|0|||
105728848|NCT01324830|364661200|FG017|Overall Study|Withdrawal by Subject|0|||
105728849|NCT01324830|364661201|FG018|Overall Study|Withdrawal by Subject|1|||
105728850|NCT00942409|364661202|FG000|Overall Study|Lack of Efficacy|1|||
105728851|NCT00942409|364661202|FG000|Overall Study|study drug unavailable|2|||
105728852|NCT00097539|364661203|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
105728853|NCT00097539|364661204|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
105728854|NCT00097539|364661205|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
105728855|NCT00097539|364661206|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
105728856|NCT00097539|364661207|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
105728857|NCT00097539|364661208|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
105728858|NCT00097539|364661209|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
105728859|NCT00097539|364661203|FG000|Overall Study|Withdrawal by Subject|925|||
105728860|NCT00097539|364661204|FG001|Overall Study|Withdrawal by Subject|323|||
105728861|NCT00097539|364661205|FG002|Overall Study|Withdrawal by Subject|346|||
105728862|NCT00097539|364661206|FG003|Overall Study|Withdrawal by Subject|217|||
105728863|NCT00097539|364661207|FG004|Overall Study|Withdrawal by Subject|68|||
105728864|NCT00097539|364661208|FG005|Overall Study|Withdrawal by Subject|229|||
105728865|NCT00097539|364661209|FG006|Overall Study|Withdrawal by Subject|3|||
105728866|NCT00097539|364661203|FG000|Overall Study|Participant Non-compliant|2140|||
105728867|NCT00097539|364661204|FG001|Overall Study|Participant Non-compliant|567|||
105728868|NCT00097539|364661205|FG002|Overall Study|Participant Non-compliant|1067|||
105728869|NCT00097539|364661206|FG003|Overall Study|Participant Non-compliant|353|||
105728870|NCT00097539|364661207|FG004|Overall Study|Participant Non-compliant|136|||
105728871|NCT00097539|364661208|FG005|Overall Study|Participant Non-compliant|543|||
105728872|NCT00097539|364661209|FG006|Overall Study|Participant Non-compliant|18|||
105728873|NCT00097539|364661203|FG000|Overall Study|Lack of Efficacy|249|||
105728874|NCT00097539|364661204|FG001|Overall Study|Lack of Efficacy|122|||
105728875|NCT00097539|364661205|FG002|Overall Study|Lack of Efficacy|202|||
105728876|NCT00097539|364661206|FG003|Overall Study|Lack of Efficacy|105|||
105353274|NCT00171158|363298488|FG000|Core Study|Protocol Violation|4|||
105479760|NCT02925338|363767614|FG004|Overall Study|Lost to Follow-up|3|||
105479761|NCT02925338|363767610|FG000|Overall Study|Withdrawal by Subject|3|||
105479762|NCT02925338|363767611|FG001|Overall Study|Withdrawal by Subject|0|||
105479763|NCT02925338|363767612|FG002|Overall Study|Withdrawal by Subject|3|||
105479764|NCT02925338|363767613|FG003|Overall Study|Withdrawal by Subject|2|||
105479765|NCT02925338|363767614|FG004|Overall Study|Withdrawal by Subject|2|||
105479766|NCT02925338|363767610|FG000|Overall Study|Missing|38|||
105479767|NCT02925338|363767611|FG001|Overall Study|Missing|27|||
105479768|NCT02925338|363767612|FG002|Overall Study|Missing|0|||
105479769|NCT02925338|363767613|FG003|Overall Study|Missing|3|||
105479770|NCT02925338|363767614|FG004|Overall Study|Missing|2|||
105795926|NCT02200614|364909327|FG001|Double Blind Treatment|Judgment of the investigator|99|||
105564953|NCT01685138|364065363|FG000|Overall Study|Lost to Follow-up|1|||
105728877|NCT00097539|364661207|FG004|Overall Study|Lack of Efficacy|45|||
105728878|NCT00097539|364661208|FG005|Overall Study|Lack of Efficacy|228|||
105728879|NCT00097539|364661209|FG006|Overall Study|Lack of Efficacy|5|||
105728880|NCT00097539|364661203|FG000|Overall Study|Adverse Event|78|||
105728881|NCT00097539|364661204|FG001|Overall Study|Adverse Event|133|||
105728882|NCT00097539|364661205|FG002|Overall Study|Adverse Event|37|||
105728883|NCT00097539|364661206|FG003|Overall Study|Adverse Event|27|||
105728884|NCT00097539|364661207|FG004|Overall Study|Adverse Event|30|||
105728885|NCT00097539|364661208|FG005|Overall Study|Adverse Event|59|||
105728886|NCT00097539|364661209|FG006|Overall Study|Adverse Event|1|||
105728887|NCT00097539|364661203|FG000|Overall Study|Death|2|||
105728888|NCT00097539|364661204|FG001|Overall Study|Death|7|||
105728889|NCT00097539|364661205|FG002|Overall Study|Death|0|||
105728890|NCT00097539|364661206|FG003|Overall Study|Death|0|||
105728891|NCT00097539|364661207|FG004|Overall Study|Death|1|||
105728892|NCT00097539|364661208|FG005|Overall Study|Death|3|||
105728893|NCT00097539|364661209|FG006|Overall Study|Death|0|||
105728894|NCT00097539|364661203|FG000|Overall Study|Reasons Other Than Above|3602|||
105728895|NCT00097539|364661204|FG001|Overall Study|Reasons Other Than Above|1382|||
105728896|NCT00097539|364661205|FG002|Overall Study|Reasons Other Than Above|1757|||
105728897|NCT00097539|364661206|FG003|Overall Study|Reasons Other Than Above|692|||
105728898|NCT00097539|364661207|FG004|Overall Study|Reasons Other Than Above|361|||
105728899|NCT00097539|364661208|FG005|Overall Study|Reasons Other Than Above|1244|||
105728900|NCT00097539|364661209|FG006|Overall Study|Reasons Other Than Above|34|||
105728901|NCT00097539|364661203|FG000|Overall Study|Reason not Specified|111|||
105728902|NCT00097539|364661204|FG001|Overall Study|Reason not Specified|49|||
105728903|NCT00097539|364661205|FG002|Overall Study|Reason not Specified|53|||
105728904|NCT00097539|364661206|FG003|Overall Study|Reason not Specified|21|||
105728905|NCT00097539|364661207|FG004|Overall Study|Reason not Specified|11|||
105728906|NCT00097539|364661208|FG005|Overall Study|Reason not Specified|40|||
105728907|NCT00097539|364661209|FG006|Overall Study|Reason not Specified|2|||
105728908|NCT01241786|364661211|FG000|Overall Study|Lack of Efficacy|5|||
105728909|NCT02317510|364661215|FG000|Overall Study|Adverse Event|0|||
105728910|NCT02317510|364661216|FG001|Overall Study|Adverse Event|1|||
105728911|NCT00472303|364661217|FG000|Titration Phase|Adverse Event|22|||
105728912|NCT00472303|364661218|FG001|Titration Phase|Adverse Event|12|||
105728913|NCT00472303|364661219|FG002|Titration Phase|Adverse Event|0|||
105728914|NCT00472303|364661217|FG000|Titration Phase|Death|4|||
105728915|NCT00472303|364661218|FG001|Titration Phase|Death|2|||
105728916|NCT00472303|364661219|FG002|Titration Phase|Death|0|||
105728917|NCT00472303|364661217|FG000|Titration Phase|Lack of Efficacy|10|||
105728918|NCT00472303|364661218|FG001|Titration Phase|Lack of Efficacy|0|||
105728919|NCT00472303|364661219|FG002|Titration Phase|Lack of Efficacy|0|||
105728920|NCT00472303|364661217|FG000|Titration Phase|Withdrawal by Subject|16|||
105728921|NCT00472303|364661218|FG001|Titration Phase|Withdrawal by Subject|13|||
105728922|NCT00472303|364661219|FG002|Titration Phase|Withdrawal by Subject|0|||
105728923|NCT00472303|364661217|FG000|Titration Phase|Trial Medication non-compliant|4|||
105728924|NCT00472303|364661218|FG001|Titration Phase|Trial Medication non-compliant|1|||
105728925|NCT00472303|364661219|FG002|Titration Phase|Trial Medication non-compliant|0|||
105728926|NCT00472303|364661217|FG000|Titration Phase|Other|3|||
105728927|NCT00472303|364661218|FG001|Titration Phase|Other|1|||
105728928|NCT00472303|364661219|FG002|Titration Phase|Other|0|||
105728929|NCT00472303|364661217|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
105728930|NCT00472303|364661218|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
105728931|NCT00472303|364661219|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
105728932|NCT00472303|364661217|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
105728933|NCT00472303|364661218|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
105728934|NCT00472303|364661219|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
105728935|NCT00472303|364661217|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
105728936|NCT00472303|364661218|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
105728937|NCT00472303|364661219|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
105728938|NCT00472303|364661217|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
105728939|NCT00472303|364661218|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
105728940|NCT00472303|364661219|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
105728941|NCT00472303|364661217|FG000|Discontinuations After Titration Phase|Other|5|||
105728942|NCT00472303|364661218|FG001|Discontinuations After Titration Phase|Other|0|||
105728943|NCT00472303|364661219|FG002|Discontinuations After Titration Phase|Other|0|||
105728944|NCT00472303|364661217|FG000|Maintenance Phase|Adverse Event|5|||
105728945|NCT00472303|364661218|FG001|Maintenance Phase|Adverse Event|6|||
105728946|NCT00472303|364661219|FG002|Maintenance Phase|Adverse Event|6|||
105728947|NCT00472303|364661217|FG000|Maintenance Phase|Death|3|||
105728948|NCT00472303|364661218|FG001|Maintenance Phase|Death|0|||
105728949|NCT00472303|364661219|FG002|Maintenance Phase|Death|2|||
105728950|NCT00472303|364661217|FG000|Maintenance Phase|Lack of Efficacy|2|||
105728951|NCT00472303|364661218|FG001|Maintenance Phase|Lack of Efficacy|2|||
105728952|NCT00472303|364661219|FG002|Maintenance Phase|Lack of Efficacy|4|||
105795927|NCT02200614|364909326|FG000|Double Blind Treatment|Metastasis by local reading|1|||
105795928|NCT02200614|364909327|FG001|Double Blind Treatment|Metastasis by local reading|3|||
105795929|NCT02200614|364909326|FG000|Double Blind Treatment|Other reason|6|||
105795930|NCT02200614|364909327|FG001|Double Blind Treatment|Other reason|2|||
105795931|NCT02200614|364909326|FG000|Double Blind Treatment|Personal reason|77|||
105795932|NCT02200614|364909327|FG001|Double Blind Treatment|Personal reason|85|||
105795933|NCT02200614|364909326|FG000|Double Blind Treatment|Protocol deviation|14|||
105795934|NCT02200614|364909327|FG001|Double Blind Treatment|Protocol deviation|7|||
105795935|NCT02200614|364909326|FG000|Double Blind Treatment|Not treated|1|||
105795936|NCT02200614|364909327|FG001|Double Blind Treatment|Not treated|0|||
105795937|NCT02200614|364909326|FG000|Open Label|Adverse Event|41|||
105795938|NCT02200614|364909327|FG001|Open Label|Adverse Event|11|||
105795939|NCT02200614|364909326|FG000|Open Label|Confirmed metastasis|1|||
105795940|NCT02200614|364909327|FG001|Open Label|Confirmed metastasis|0|||
105795941|NCT02200614|364909326|FG000|Open Label|Judgment of the investigator|29|||
105795942|NCT02200614|364909327|FG001|Open Label|Judgment of the investigator|2|||
105795943|NCT02200614|364909326|FG000|Open Label|Metastasis by local reading|138|||
105795944|NCT02200614|364909327|FG001|Open Label|Metastasis by local reading|27|||
105795945|NCT02200614|364909326|FG000|Open Label|Other reason|22|||
105795946|NCT02200614|364909327|FG001|Open Label|Other reason|4|||
105795947|NCT02200614|364909326|FG000|Open Label|Personal reason|60|||
105795948|NCT02200614|364909327|FG001|Open Label|Personal reason|8|||
105795949|NCT02200614|364909326|FG000|Open Label|Protocol deviation|3|||
105795950|NCT02200614|364909327|FG001|Open Label|Protocol deviation|2|||
105795951|NCT02200614|364909326|FG000|Open Label|Missing|2|||
105795952|NCT02200614|364909327|FG001|Open Label|Missing|2|||
105795953|NCT01898884|364909328|FG000|Multiple Dose Period|Adverse Event|0|||
105795954|NCT01898884|364909329|FG001|Multiple Dose Period|Adverse Event|0|||
105795955|NCT01898884|364909330|FG002|Multiple Dose Period|Adverse Event|0|||
105795956|NCT01898884|364909331|FG003|Multiple Dose Period|Adverse Event|0|||
105795957|NCT01898884|364909332|FG004|Multiple Dose Period|Adverse Event|0|||
105795958|NCT01898884|364909333|FG005|Multiple Dose Period|Adverse Event|0|||
105795959|NCT01898884|364909334|FG006|Multiple Dose Period|Adverse Event|1|||
105795960|NCT01898884|364909335|FG007|Multiple Dose Period|Adverse Event|0|||
105795961|NCT01898884|364909336|FG008|Multiple Dose Period|Adverse Event|0|||
105795962|NCT01898884|364909328|FG000|Multiple Dose Period|Randomized Not Treated|0|||
105795963|NCT01898884|364909329|FG001|Multiple Dose Period|Randomized Not Treated|0|||
105795964|NCT01898884|364909330|FG002|Multiple Dose Period|Randomized Not Treated|0|||
105795965|NCT01898884|364909331|FG003|Multiple Dose Period|Randomized Not Treated|0|||
105795966|NCT01898884|364909332|FG004|Multiple Dose Period|Randomized Not Treated|0|||
105795967|NCT01898884|364909333|FG005|Multiple Dose Period|Randomized Not Treated|0|||
105795968|NCT01898884|364909334|FG006|Multiple Dose Period|Randomized Not Treated|0|||
105795969|NCT01898884|364909335|FG007|Multiple Dose Period|Randomized Not Treated|0|||
105795970|NCT01898884|364909336|FG008|Multiple Dose Period|Randomized Not Treated|1|||
105795971|NCT00759759|364909337|FG000|Overall Study|didn't return for period 2|1|||
105795972|NCT00759759|364909338|FG001|Overall Study|didn't return for period 2|0|||
105795973|NCT00759759|364909337|FG000|Overall Study|Didn't receive drug in period 2|1|||
105795974|NCT00759759|364909338|FG001|Overall Study|Didn't receive drug in period 2|0|||
105795975|NCT00759759|364909337|FG000|Overall Study|Withdrawal by Subject|2|||
105795976|NCT00759759|364909338|FG001|Overall Study|Withdrawal by Subject|1|||
105795977|NCT00434148|364909339|FG000|Overall Study|Adverse Event|18|||
105795978|NCT00434148|364909340|FG001|Overall Study|Adverse Event|18|||
105795979|NCT00434148|364909339|FG000|Overall Study|Lack of Efficacy|25|||
105795980|NCT00434148|364909340|FG001|Overall Study|Lack of Efficacy|28|||
105795981|NCT00434148|364909339|FG000|Overall Study|Withdrawal by Subject|15|||
105795982|NCT00434148|364909340|FG001|Overall Study|Withdrawal by Subject|15|||
105795983|NCT00434148|364909339|FG000|Overall Study|Protocol Violation|4|||
105795984|NCT00434148|364909340|FG001|Overall Study|Protocol Violation|0|||
105795985|NCT00434148|364909339|FG000|Overall Study|Administrative problems|6|||
105795986|NCT00434148|364909340|FG001|Overall Study|Administrative problems|10|||
105795987|NCT00434148|364909339|FG000|Overall Study|Lost to Follow-up|0|||
105795988|NCT00434148|364909340|FG001|Overall Study|Lost to Follow-up|1|||
105795989|NCT00434148|364909339|FG000|Overall Study|Condition no longer requires study drug|1|||
105795990|NCT00434148|364909340|FG001|Overall Study|Condition no longer requires study drug|0|||
105795991|NCT00434148|364909339|FG000|Overall Study|Abnormal test procedure result|0|||
105795992|NCT00434148|364909340|FG001|Overall Study|Abnormal test procedure result|1|||
105795993|NCT03185949|364909343|FG000|ITT Analysis|Withdrawal by Subject|4|||
105795994|NCT03185949|364909344|FG001|ITT Analysis|Withdrawal by Subject|3|||
105795995|NCT03185949|364909343|FG000|PP Analysis|Protocol Violation|2|||
105564954|NCT01685138|364065363|FG000|Overall Study|Protocol Violation|1|||
105795996|NCT03185949|364909344|FG001|PP Analysis|Protocol Violation|2|||
105479771|NCT02925338|363767610|FG000|Overall Study|Participant's Decision|11|||
105479772|NCT02925338|363767611|FG001|Overall Study|Participant's Decision|7|||
105479773|NCT02925338|363767612|FG002|Overall Study|Participant's Decision|3|||
105795997|NCT03185949|364909343|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
105795998|NCT03185949|364909344|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
105795999|NCT05458895|364909346|FG000|Overall Study|Withdrawal by Subject|8|||
105796000|NCT05458895|364909346|FG000|Overall Study|Lost to Follow-up|17|||
105796001|NCT05458895|364909346|FG000|Overall Study|Pregnancy|2|||
105796002|NCT05458895|364909346|FG000|Overall Study|Withdrawal by Study Team|1|||
105796003|NCT04318535|364911312|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
105796004|NCT04318535|364911313|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
105796005|NCT04318535|364911314|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
105796006|NCT02428231|364911315|FG000|Overall Study|Other|10|||
105796007|NCT02428231|364911316|FG001|Overall Study|Other|16|||
105796008|NCT02428231|364911315|FG000|Overall Study|Required Symptomatic Therapy|0|||
105796009|NCT02428231|364911316|FG001|Overall Study|Required Symptomatic Therapy|1|||
105796010|NCT02428231|364911315|FG000|Overall Study|Adverse Event|3|||
105479774|NCT02925338|363767613|FG003|Overall Study|Participant's Decision|8|||
105479775|NCT02925338|363767614|FG004|Overall Study|Participant's Decision|1|||
105479776|NCT02925338|363767610|FG000|Overall Study|Treatment Discontinuation|144|||
105796011|NCT02428231|364911316|FG001|Overall Study|Adverse Event|0|||
105796012|NCT01336608|364911317|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
105479777|NCT02925338|363767611|FG001|Overall Study|Treatment Discontinuation|65|||
105479778|NCT02925338|363767612|FG002|Overall Study|Treatment Discontinuation|56|||
105479779|NCT02925338|363767613|FG003|Overall Study|Treatment Discontinuation|131|||
105479780|NCT02925338|363767614|FG004|Overall Study|Treatment Discontinuation|22|||
105479781|NCT04268823|363767615|FG000|Overall Study|Adverse Event|1|||
105564955|NCT01685138|364065363|FG000|Overall Study|No longer requires treatment|1|||
105796013|NCT01336608|364911318|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105796014|NCT01336608|364911319|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105796015|NCT01336608|364911320|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105796016|NCT01336608|364911317|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
105479782|NCT04268823|363767616|FG001|Overall Study|Adverse Event|0|||
105479783|NCT04268823|363767615|FG000|Overall Study|Participant Decision|1|||
105479784|NCT04268823|363767616|FG001|Overall Study|Participant Decision|0|||
105479785|NCT01306929|363767619|FG000|Overall Study|Withdrawal by Subject|23|||
105479786|NCT01306929|363767619|FG000|Overall Study|Adverse Event|21|||
105479787|NCT01306929|363767619|FG000|Overall Study|Physician Decision|13|||
105479788|NCT01306929|363767619|FG000|Overall Study|Death|8|||
105479789|NCT01306929|363767619|FG000|Overall Study|Withdrawal by parent/guardian|5|||
105479790|NCT01306929|363767619|FG000|Overall Study|Protocol Violation|3|||
105479791|NCT01306929|363767619|FG000|Overall Study|Non-compliance with study drug|2|||
105728953|NCT00472303|364661217|FG000|Maintenance Phase|Withdrawal by Subject|6|||
105728954|NCT00472303|364661218|FG001|Maintenance Phase|Withdrawal by Subject|7|||
105728955|NCT00472303|364661219|FG002|Maintenance Phase|Withdrawal by Subject|3|||
105728956|NCT00472303|364661217|FG000|Maintenance Phase|Trial medication non-compliant|0|||
105728957|NCT00472303|364661218|FG001|Maintenance Phase|Trial medication non-compliant|0|||
105728958|NCT00472303|364661219|FG002|Maintenance Phase|Trial medication non-compliant|1|||
105728959|NCT00472303|364661217|FG000|Maintenance Phase|Resolution of pain|0|||
105728960|NCT00472303|364661218|FG001|Maintenance Phase|Resolution of pain|0|||
105728961|NCT00472303|364661219|FG002|Maintenance Phase|Resolution of pain|1|||
105728962|NCT00472303|364661217|FG000|Maintenance Phase|Other|1|||
105728963|NCT00472303|364661218|FG001|Maintenance Phase|Other|1|||
105728964|NCT00472303|364661219|FG002|Maintenance Phase|Other|0|||
105728965|NCT01238120|364661220|FG000|Overall Study|Withdrawal by Subject|4|||
105728966|NCT01238120|364661221|FG001|Overall Study|Withdrawal by Subject|1|||
105728967|NCT01238120|364661222|FG002|Overall Study|Withdrawal by Subject|2|||
105728968|NCT01238120|364661223|FG003|Overall Study|Withdrawal by Subject|5|||
105728969|NCT01238120|364661220|FG000|Overall Study|Lost to Follow-up|2|||
105728970|NCT01238120|364661221|FG001|Overall Study|Lost to Follow-up|0|||
105728971|NCT01238120|364661222|FG002|Overall Study|Lost to Follow-up|1|||
105728972|NCT01238120|364661223|FG003|Overall Study|Lost to Follow-up|1|||
105728973|NCT01238120|364661220|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
105728974|NCT01238120|364661221|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
105728975|NCT01238120|364661222|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
105728976|NCT01238120|364661223|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
105728977|NCT01535235|364661224|FG000|Overall Study|Adverse Event|1|||
105728978|NCT01535235|364661225|FG001|Overall Study|Adverse Event|0|||
105728979|NCT02835495|364661228|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
105728980|NCT02835495|364661229|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
105728981|NCT02835495|364661228|FG000|Overall Study|Declined in-person follow-up visit|4|||
105728982|NCT02835495|364661229|FG001|Overall Study|Declined in-person follow-up visit|2|||
105728983|NCT02318602|364661230|FG000|Overall Study|Adverse Event|0|||
105728984|NCT02318602|364661231|FG001|Overall Study|Adverse Event|1|||
105728985|NCT02318602|364661232|FG002|Overall Study|Adverse Event|1|||
105728986|NCT02318602|364661230|FG000|Overall Study|Withdrawal by Subject|0|||
105728987|NCT02318602|364661231|FG001|Overall Study|Withdrawal by Subject|3|||
105728988|NCT02318602|364661232|FG002|Overall Study|Withdrawal by Subject|0|||
105728989|NCT02318602|364661230|FG000|Overall Study|Death|1|||
105728990|NCT02318602|364661231|FG001|Overall Study|Death|0|||
105728991|NCT02318602|364661232|FG002|Overall Study|Death|0|||
105728992|NCT02318602|364661230|FG000|Overall Study|Guardian decision to withdraw|0|||
105728993|NCT02318602|364661231|FG001|Overall Study|Guardian decision to withdraw|0|||
105728994|NCT02318602|364661232|FG002|Overall Study|Guardian decision to withdraw|1|||
105728995|NCT01697345|364661236|FG000|Overall Study|Withdrawal by Subject|1|||
105728996|NCT01826214|364662710|FG000|Overall Study|Adverse Event|7|||
105728997|NCT01826214|364662711|FG001|Overall Study|Adverse Event|6|||
105728998|NCT01826214|364662710|FG000|Overall Study|Death|3|||
105728999|NCT01826214|364662711|FG001|Overall Study|Death|1|||
105729000|NCT01826214|364662710|FG000|Overall Study|Lost to Follow-up|1|||
105729001|NCT01826214|364662711|FG001|Overall Study|Lost to Follow-up|0|||
105729002|NCT01826214|364662710|FG000|Overall Study|Physician Decision|0|||
105729003|NCT01826214|364662711|FG001|Overall Study|Physician Decision|2|||
105729004|NCT01826214|364662710|FG000|Overall Study|Progressive disease|22|||
105729005|NCT01826214|364662711|FG001|Overall Study|Progressive disease|21|||
105729006|NCT01826214|364662710|FG000|Overall Study|Study terminated by Sponsor|0|||
105729007|NCT01826214|364662711|FG001|Overall Study|Study terminated by Sponsor|1|||
105729008|NCT01826214|364662710|FG000|Overall Study|Subject/guardian decision|2|||
105729009|NCT01826214|364662711|FG001|Overall Study|Subject/guardian decision|3|||
105729010|NCT03311126|364662712|FG000|Induction|Death|1|||
105729011|NCT03311126|364662712|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
105729012|NCT00469079|364662720|FG000|Overall Study|Lack of Efficacy|3|||
105729013|NCT00469079|364662721|FG001|Overall Study|Lack of Efficacy|8|||
105479792|NCT01306929|363767619|FG000|Overall Study|Lost to Follow-up|2|||
105479793|NCT01306929|363767619|FG000|Overall Study|Various|17|||
105479794|NCT01870076|363767621|FG000|Overall Study|Withdrawal by Subject|1|||
105729014|NCT00469079|364662722|FG002|Overall Study|Lack of Efficacy|5|||
105729015|NCT00469079|364662720|FG000|Overall Study|Adverse Event|1|||
105729016|NCT00469079|364662721|FG001|Overall Study|Adverse Event|3|||
105729017|NCT00469079|364662722|FG002|Overall Study|Adverse Event|2|||
105729018|NCT00469079|364662720|FG000|Overall Study|Lost to Follow-up|4|||
105729019|NCT00469079|364662721|FG001|Overall Study|Lost to Follow-up|8|||
105729020|NCT00469079|364662722|FG002|Overall Study|Lost to Follow-up|10|||
105729021|NCT00469079|364662720|FG000|Overall Study|Withdrawal by Subject|1|||
105729022|NCT00469079|364662721|FG001|Overall Study|Withdrawal by Subject|2|||
105729023|NCT00469079|364662722|FG002|Overall Study|Withdrawal by Subject|2|||
105729024|NCT00469079|364662720|FG000|Overall Study|Ineligible|0|||
105729025|NCT00469079|364662721|FG001|Overall Study|Ineligible|1|||
105729026|NCT00469079|364662722|FG002|Overall Study|Ineligible|0|||
105729027|NCT00942162|364662723|FG000|Overall Study|Death|45|||
105729028|NCT00942162|364662724|FG001|Overall Study|Death|35|||
105729029|NCT00942162|364662725|FG002|Overall Study|Death|0|||
105729030|NCT00942162|364662723|FG000|Overall Study|Withdrawal by Subject|7|||
105729031|NCT00942162|364662724|FG001|Overall Study|Withdrawal by Subject|2|||
105729032|NCT00942162|364662725|FG002|Overall Study|Withdrawal by Subject|0|||
105729033|NCT00942162|364662723|FG000|Overall Study|Lost to Follow-up|4|||
105729034|NCT00942162|364662724|FG001|Overall Study|Lost to Follow-up|0|||
105729035|NCT00942162|364662725|FG002|Overall Study|Lost to Follow-up|0|||
105729036|NCT00942162|364662723|FG000|Overall Study|Other|14|||
105729037|NCT00942162|364662724|FG001|Overall Study|Other|13|||
105729038|NCT00942162|364662725|FG002|Overall Study|Other|2|||
105729039|NCT03874234|364662729|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729040|NCT03874234|364662730|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729041|NCT03874234|364662731|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729042|NCT03874234|364662732|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
105729043|NCT03874234|364662733|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729044|NCT03874234|364662734|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729045|NCT03874234|364662735|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729046|NCT03874234|364662736|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729047|NCT03874234|364662737|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729048|NCT03874234|364662738|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729049|NCT03874234|364662739|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729050|NCT03874234|364662740|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729051|NCT03874234|364662741|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729052|NCT03874234|364662729|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
105729053|NCT03874234|364662730|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729054|NCT03874234|364662731|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729055|NCT03874234|364662732|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729056|NCT03874234|364662733|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729057|NCT03874234|364662734|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729058|NCT03874234|364662735|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729059|NCT03874234|364662736|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729060|NCT03874234|364662737|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729061|NCT03874234|364662738|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729062|NCT03874234|364662739|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729063|NCT03874234|364662740|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729064|NCT03874234|364662741|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729065|NCT03874234|364662729|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729066|NCT03874234|364662730|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729067|NCT03874234|364662731|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729068|NCT03874234|364662732|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
105729069|NCT03874234|364662733|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729070|NCT03874234|364662734|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729071|NCT03874234|364662735|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729072|NCT03874234|364662736|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729073|NCT03874234|364662737|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729074|NCT03874234|364662738|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729075|NCT03874234|364662739|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729076|NCT03874234|364662740|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729077|NCT03874234|364662741|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729078|NCT03874234|364662729|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729079|NCT03874234|364662730|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729080|NCT03874234|364662731|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729081|NCT03874234|364662732|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105479795|NCT01870076|363767622|FG001|Overall Study|Withdrawal by Subject|0|||
105479796|NCT01870076|363767623|FG002|Overall Study|Withdrawal by Subject|1|||
105479797|NCT01870076|363767624|FG003|Overall Study|Withdrawal by Subject|0|||
105479798|NCT03011892|363767625|FG000|Double Blind (DB) Period|Adverse Event|0|||
105479799|NCT03011892|363767626|FG001|Double Blind (DB) Period|Adverse Event|1|||
105479800|NCT03011892|363767627|FG002|Double Blind (DB) Period|Adverse Event|1|||
105479801|NCT03011892|363767628|FG003|Double Blind (DB) Period|Adverse Event|0|||
105479802|NCT03011892|363767629|FG004|Double Blind (DB) Period|Adverse Event|0|||
105479803|NCT03011892|363767630|FG005|Double Blind (DB) Period|Adverse Event|0|||
105479804|NCT03011892|363767631|FG006|Double Blind (DB) Period|Adverse Event|0|||
105479805|NCT03011892|363767632|FG007|Double Blind (DB) Period|Adverse Event|0|||
105479806|NCT03011892|363767633|FG008|Double Blind (DB) Period|Adverse Event|0|||
105479807|NCT03011892|363767634|FG009|Double Blind (DB) Period|Adverse Event|0|||
105479808|NCT03011892|363767635|FG010|Double Blind (DB) Period|Adverse Event|0|||
105479809|NCT03011892|363767636|FG011|Double Blind (DB) Period|Adverse Event|0|||
105479810|NCT03011892|363767625|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
105479811|NCT03011892|363767626|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
105479812|NCT03011892|363767627|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
105479813|NCT03011892|363767628|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
105479814|NCT03011892|363767629|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
105479815|NCT03011892|363767630|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
105479816|NCT03011892|363767631|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
105479817|NCT03011892|363767632|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
105479818|NCT03011892|363767633|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
105479819|NCT03011892|363767634|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
105479820|NCT03011892|363767635|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
105564956|NCT01685138|364065363|FG000|Overall Study|Subject/guardian decision|2|||
105729082|NCT03874234|364662733|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
105729083|NCT03874234|364662734|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729084|NCT03874234|364662735|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729085|NCT03874234|364662736|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729086|NCT03874234|364662737|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729087|NCT03874234|364662738|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729088|NCT03874234|364662739|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729089|NCT03874234|364662740|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729090|NCT03874234|364662741|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729091|NCT03874234|364662729|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729092|NCT03874234|364662730|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729093|NCT03874234|364662731|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729094|NCT03874234|364662732|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729095|NCT03874234|364662733|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729096|NCT03874234|364662734|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729097|NCT03874234|364662735|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729098|NCT03874234|364662736|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
105729099|NCT03874234|364662737|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729100|NCT03874234|364662738|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729101|NCT03874234|364662739|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729102|NCT03874234|364662740|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729103|NCT03874234|364662741|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729104|NCT03874234|364662729|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729105|NCT03874234|364662730|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729106|NCT03874234|364662731|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729107|NCT03874234|364662732|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729108|NCT03874234|364662733|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
105729109|NCT03874234|364662734|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
105729110|NCT03874234|364662735|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729111|NCT03874234|364662736|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729112|NCT03874234|364662737|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105479821|NCT03011892|363767636|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
105479822|NCT03011892|363767625|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
105479823|NCT03011892|363767626|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
105479824|NCT03011892|363767627|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
105479825|NCT03011892|363767628|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
105796017|NCT01336608|364911318|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105796018|NCT01336608|364911319|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105796019|NCT01336608|364911320|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105796020|NCT01336608|364911317|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
105796021|NCT01336608|364911318|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
105796022|NCT01336608|364911319|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
105796023|NCT01336608|364911320|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
105796024|NCT01336608|364911317|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
105796025|NCT01336608|364911318|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
105564957|NCT01685138|364065363|FG000|Overall Study|Physician Decision|6|||
105564958|NCT01685138|364065363|FG000|Overall Study|Death|10|||
105564959|NCT01685138|364065363|FG000|Overall Study|Adverse Event|18|||
105796026|NCT01336608|364911319|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
105796027|NCT01336608|364911320|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
105796028|NCT01336608|364911317|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
105796029|NCT01336608|364911318|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105796030|NCT01336608|364911319|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105796031|NCT01336608|364911320|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105796032|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
105796033|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
105796034|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
105796035|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
105796036|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
105796037|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
105796038|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
105796039|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
105796040|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
105796041|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
105796042|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
105796043|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
105796044|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
105796045|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
105796046|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
105796047|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
105796048|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
105796049|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
105353275|NCT00171158|363298488|FG000|Core Study|Administrative problems|1|||
105564960|NCT01685138|364065363|FG000|Overall Study|Progressive disease|53|||
105564961|NCT02068495|364065364|FG000|Overall Study|Case Report Forms Uncollected|60|||
105564962|NCT02068495|364065364|FG000|Overall Study|Protocol Deviation|49|||
105564963|NCT00689026|364065365|FG000|Overall Study|Withdrawal by Subject|13|||
105796050|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
105796051|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
105796052|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105796053|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
105796054|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105796055|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105796056|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
105796057|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
105796058|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
105796059|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
105796060|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
105796061|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
105796062|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
105796063|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
105796064|NCT03044431|364911321|FG000|Overall Study|Lost to Follow-up|59|||
105796065|NCT03456726|364911322|FG000|Overall Study|Disease Progression|6|||
105796066|NCT03456726|364911323|FG001|Overall Study|Disease Progression|1|||
105796067|NCT03456726|364911322|FG000|Overall Study|Adverse Event|4|||
105796068|NCT03456726|364911323|FG001|Overall Study|Adverse Event|2|||
105796069|NCT03456726|364911322|FG000|Overall Study|Withdrawal by Subject|1|||
105796070|NCT03456726|364911323|FG001|Overall Study|Withdrawal by Subject|0|||
105796071|NCT03456726|364911322|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
105796072|NCT03456726|364911323|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
105796073|NCT04470622|364911324|FG000|Overall Study|Withdrawal by Subject|0|||
105796074|NCT04470622|364911325|FG001|Overall Study|Withdrawal by Subject|1|||
105796075|NCT04470622|364911324|FG000|Overall Study|Screen Failure|0|||
105796076|NCT04470622|364911325|FG001|Overall Study|Screen Failure|1|||
105796077|NCT04470622|364911324|FG000|Overall Study|Death|0|||
105796078|NCT04470622|364911325|FG001|Overall Study|Death|1|||
105796079|NCT02437890|364911326|FG000|Overall Study|Non-compliance to study drug|0|||
105796080|NCT02437890|364911327|FG001|Overall Study|Non-compliance to study drug|1|||
105796081|NCT02437890|364911328|FG002|Overall Study|Non-compliance to study drug|0|||
105796082|NCT02437890|364911329|FG003|Overall Study|Non-compliance to study drug|0|||
105796083|NCT02437890|364911330|FG004|Overall Study|Non-compliance to study drug|1|||
105796084|NCT02437890|364911326|FG000|Overall Study|Sponsor's decision|1|||
105796085|NCT02437890|364911327|FG001|Overall Study|Sponsor's decision|1|||
105796086|NCT02437890|364911328|FG002|Overall Study|Sponsor's decision|4|||
105796087|NCT02437890|364911329|FG003|Overall Study|Sponsor's decision|0|||
105796088|NCT02437890|364911330|FG004|Overall Study|Sponsor's decision|2|||
105796089|NCT02437890|364911326|FG000|Overall Study|Physician Decision|0|||
105796090|NCT02437890|364911327|FG001|Overall Study|Physician Decision|0|||
105796091|NCT02437890|364911328|FG002|Overall Study|Physician Decision|0|||
105796092|NCT02437890|364911329|FG003|Overall Study|Physician Decision|1|||
105796093|NCT02437890|364911330|FG004|Overall Study|Physician Decision|0|||
105796094|NCT02437890|364911326|FG000|Overall Study|Unable to attend visit(s)|1|||
105796095|NCT02437890|364911327|FG001|Overall Study|Unable to attend visit(s)|0|||
105796096|NCT02437890|364911328|FG002|Overall Study|Unable to attend visit(s)|0|||
105796097|NCT02437890|364911329|FG003|Overall Study|Unable to attend visit(s)|0|||
105796098|NCT02437890|364911330|FG004|Overall Study|Unable to attend visit(s)|0|||
105729113|NCT03874234|364662738|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729114|NCT03874234|364662739|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729115|NCT03874234|364662740|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729116|NCT03874234|364662741|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729117|NCT03874234|364662729|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729118|NCT03874234|364662730|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729119|NCT03874234|364662731|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729120|NCT03874234|364662732|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105796099|NCT02437890|364911326|FG000|Overall Study|Lack of Efficacy|1|||
105796100|NCT02437890|364911327|FG001|Overall Study|Lack of Efficacy|3|||
105796101|NCT02437890|364911328|FG002|Overall Study|Lack of Efficacy|0|||
105796102|NCT02437890|364911329|FG003|Overall Study|Lack of Efficacy|3|||
105729121|NCT03874234|364662733|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729122|NCT03874234|364662734|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105796103|NCT02437890|364911330|FG004|Overall Study|Lack of Efficacy|1|||
105796104|NCT02437890|364911326|FG000|Overall Study|Adverse Event|4|||
105796105|NCT02437890|364911327|FG001|Overall Study|Adverse Event|9|||
105796106|NCT02437890|364911328|FG002|Overall Study|Adverse Event|5|||
105796107|NCT02437890|364911329|FG003|Overall Study|Adverse Event|11|||
105796108|NCT02437890|364911330|FG004|Overall Study|Adverse Event|7|||
105796109|NCT02437890|364911326|FG000|Overall Study|Withdrawal by Subject|1|||
105796110|NCT02437890|364911327|FG001|Overall Study|Withdrawal by Subject|2|||
105796111|NCT02437890|364911328|FG002|Overall Study|Withdrawal by Subject|6|||
105796112|NCT02437890|364911329|FG003|Overall Study|Withdrawal by Subject|5|||
105796113|NCT02437890|364911330|FG004|Overall Study|Withdrawal by Subject|5|||
105796114|NCT02437890|364911326|FG000|Overall Study|Death|0|||
105796115|NCT02437890|364911327|FG001|Overall Study|Death|0|||
105796116|NCT02437890|364911328|FG002|Overall Study|Death|0|||
105796117|NCT02437890|364911329|FG003|Overall Study|Death|2|||
105796118|NCT02437890|364911330|FG004|Overall Study|Death|0|||
105796119|NCT02328547|364911331|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
105796120|NCT02328547|364911332|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
105479826|NCT03011892|363767629|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
105729123|NCT03874234|364662735|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
105729124|NCT03874234|364662736|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729125|NCT03874234|364662737|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729126|NCT03874234|364662738|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729127|NCT03874234|364662739|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729128|NCT03874234|364662740|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729129|NCT03874234|364662741|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729130|NCT03874234|364662729|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729131|NCT03874234|364662730|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729132|NCT03874234|364662731|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729133|NCT03874234|364662732|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729134|NCT03874234|364662733|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
105729135|NCT03874234|364662734|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729136|NCT03874234|364662735|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729137|NCT03874234|364662736|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729138|NCT03874234|364662737|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729139|NCT03874234|364662738|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729140|NCT03874234|364662739|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729141|NCT03874234|364662740|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729142|NCT03874234|364662741|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729143|NCT02799381|364662749|FG000|Overall Study|Withdrew consent|3|||
105729144|NCT02799381|364662750|FG001|Overall Study|Withdrew consent|2|||
105729145|NCT02799381|364662749|FG000|Overall Study|Adverse Event|0|||
105729146|NCT02799381|364662750|FG001|Overall Study|Adverse Event|1|||
105729147|NCT02799381|364662749|FG000|Overall Study|Participant did not take any study drug|1|||
105729148|NCT02799381|364662750|FG001|Overall Study|Participant did not take any study drug|0|||
105729149|NCT00783289|364662751|FG000|Overall Study|Protocol Violation|0|||
105729150|NCT00783289|364662752|FG001|Overall Study|Protocol Violation|1|||
105729151|NCT00783289|364662753|FG002|Overall Study|Protocol Violation|0|||
105729152|NCT00783289|364662754|FG003|Overall Study|Protocol Violation|0|||
105729153|NCT03952130|364662756|FG000|Overall Study|Adverse Event|0|||
105729154|NCT03952130|364662757|FG001|Overall Study|Adverse Event|1|||
105729155|NCT03952130|364662756|FG000|Overall Study|Lost to Follow-up|1|||
105729156|NCT03952130|364662757|FG001|Overall Study|Lost to Follow-up|0|||
105729157|NCT03952130|364662756|FG000|Overall Study|Withdrawal by Subject|1|||
105729158|NCT03952130|364662757|FG001|Overall Study|Withdrawal by Subject|5|||
105729159|NCT00506389|364662758|FG000|In-treatment Period|Other|3|||
105729160|NCT00506389|364662759|FG001|In-treatment Period|Other|3|||
105729161|NCT00506389|364662760|FG002|In-treatment Period|Other|4|||
105729162|NCT00506389|364662758|FG000|In-treatment Period|Lost to Follow-up|0|||
105729163|NCT00506389|364662759|FG001|In-treatment Period|Lost to Follow-up|0|||
105729164|NCT00506389|364662760|FG002|In-treatment Period|Lost to Follow-up|1|||
105729165|NCT00506389|364662758|FG000|In-treatment Period|Lack of compliance|1|||
105729166|NCT00506389|364662759|FG001|In-treatment Period|Lack of compliance|0|||
105729167|NCT00506389|364662760|FG002|In-treatment Period|Lack of compliance|0|||
105729168|NCT00506389|364662758|FG000|In-treatment Period|Reasons not related to trial|4|||
105729169|NCT00506389|364662759|FG001|In-treatment Period|Reasons not related to trial|1|||
105729170|NCT00506389|364662760|FG002|In-treatment Period|Reasons not related to trial|0|||
105729171|NCT00506389|364662758|FG000|In-treatment Period|Withdrawal by Subject|3|||
105479827|NCT03011892|363767630|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
105479828|NCT03011892|363767631|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
105729172|NCT00506389|364662759|FG001|In-treatment Period|Withdrawal by Subject|3|||
105729173|NCT00506389|364662760|FG002|In-treatment Period|Withdrawal by Subject|4|||
105729174|NCT00506389|364662758|FG000|In-treatment Period|Lack of Efficacy|0|||
105729175|NCT00506389|364662759|FG001|In-treatment Period|Lack of Efficacy|2|||
105729176|NCT00506389|364662760|FG002|In-treatment Period|Lack of Efficacy|0|||
105729177|NCT00506389|364662758|FG000|In-treatment Period|Adverse Event|11|||
105729178|NCT00506389|364662759|FG001|In-treatment Period|Adverse Event|5|||
105729179|NCT00506389|364662760|FG002|In-treatment Period|Adverse Event|2|||
105796121|NCT02328547|364911331|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
105796122|NCT02328547|364911332|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
105729180|NCT00506389|364662758|FG000|In-treatment Period|Randomized but not treated|4|||
105729181|NCT00506389|364662759|FG001|In-treatment Period|Randomized but not treated|1|||
105729182|NCT00506389|364662760|FG002|In-treatment Period|Randomized but not treated|1|||
105729183|NCT00265941|364662763|FG000|Overall Study|Protocol Violation|22|||
105729184|NCT00265941|364662764|FG001|Overall Study|Protocol Violation|25|||
105729185|NCT00265941|364662763|FG000|Overall Study|Lost to Follow-up|1|||
105729186|NCT00265941|364662764|FG001|Overall Study|Lost to Follow-up|1|||
105729187|NCT01381094|364662765|FG000|Overall Study|Adverse Event|1|||
105729188|NCT01381094|364662766|FG001|Overall Study|Adverse Event|2|||
105729189|NCT01381094|364662767|FG002|Overall Study|Adverse Event|0|||
105729190|NCT01381094|364662768|FG003|Overall Study|Adverse Event|1|||
105729191|NCT01381094|364662769|FG004|Overall Study|Adverse Event|0|||
105729192|NCT01381094|364662765|FG000|Overall Study|Lost to Follow-up|0|||
105729193|NCT01381094|364662766|FG001|Overall Study|Lost to Follow-up|0|||
105729194|NCT01381094|364662767|FG002|Overall Study|Lost to Follow-up|0|||
105729195|NCT01381094|364662768|FG003|Overall Study|Lost to Follow-up|0|||
105729196|NCT01381094|364662769|FG004|Overall Study|Lost to Follow-up|1|||
105729197|NCT01381094|364662765|FG000|Overall Study|Withdrawal of informed consent|0|||
105729198|NCT01381094|364662766|FG001|Overall Study|Withdrawal of informed consent|1|||
105729199|NCT01381094|364662767|FG002|Overall Study|Withdrawal of informed consent|0|||
105729200|NCT01381094|364662768|FG003|Overall Study|Withdrawal of informed consent|0|||
105729201|NCT01381094|364662769|FG004|Overall Study|Withdrawal of informed consent|0|||
105729202|NCT01381094|364662765|FG000|Overall Study|Participant given Aranesp injection|1|||
105729203|NCT01381094|364662766|FG001|Overall Study|Participant given Aranesp injection|0|||
105729204|NCT01381094|364662767|FG002|Overall Study|Participant given Aranesp injection|0|||
105729205|NCT01381094|364662768|FG003|Overall Study|Participant given Aranesp injection|0|||
105729206|NCT01381094|364662769|FG004|Overall Study|Participant given Aranesp injection|0|||
105729207|NCT02900092|364662772|FG000|Overall Study|Adverse Event|1|||
105729208|NCT05408858|364662773|FG000|Overall Study|no longer met eligibility criteria|1|||
105729209|NCT00817414|364662776|FG000|Overall Study|Adverse Event|1|||
105729210|NCT00817414|364662777|FG001|Overall Study|Adverse Event|1|||
105729211|NCT00817414|364662778|FG002|Overall Study|Adverse Event|1|||
105729212|NCT00817414|364662779|FG003|Overall Study|Adverse Event|0|||
105796123|NCT02414854|364911333|FG000|Overall Study|Adverse Event|9|||
105729213|NCT00817414|364662780|FG004|Overall Study|Adverse Event|0|||
105729214|NCT00817414|364662776|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
105729215|NCT00817414|364662777|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
105729216|NCT00817414|364662778|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
105729217|NCT00817414|364662779|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
105729218|NCT00817414|364662780|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
105729219|NCT00817414|364662776|FG000|Overall Study|Withdrawal by Subject|1|||
105729220|NCT00817414|364662777|FG001|Overall Study|Withdrawal by Subject|1|||
105729221|NCT00817414|364662778|FG002|Overall Study|Withdrawal by Subject|0|||
105729222|NCT00817414|364662779|FG003|Overall Study|Withdrawal by Subject|0|||
105729223|NCT00817414|364662780|FG004|Overall Study|Withdrawal by Subject|0|||
105729224|NCT00817414|364662776|FG000|Overall Study|Lost to Follow-up|0|||
105729225|NCT00817414|364662777|FG001|Overall Study|Lost to Follow-up|0|||
105729226|NCT00817414|364662778|FG002|Overall Study|Lost to Follow-up|1|||
105729227|NCT00817414|364662779|FG003|Overall Study|Lost to Follow-up|1|||
105729228|NCT00817414|364662780|FG004|Overall Study|Lost to Follow-up|1|||
105729229|NCT00817414|364662776|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
105729230|NCT00817414|364662777|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
105729231|NCT00817414|364662778|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
105729232|NCT00817414|364662779|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
105729233|NCT00817414|364662780|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
105729234|NCT00817414|364662776|FG000|Overall Study|Protocol Violation|0|||
105729235|NCT00817414|364662777|FG001|Overall Study|Protocol Violation|0|||
105729236|NCT00817414|364662778|FG002|Overall Study|Protocol Violation|0|||
105729237|NCT00817414|364662779|FG003|Overall Study|Protocol Violation|0|||
105729238|NCT00817414|364662780|FG004|Overall Study|Protocol Violation|1|||
105729239|NCT02586805|364662784|FG000|Overall Study|Withdrawal by Subject|3|||
105729240|NCT02586805|364662785|FG001|Overall Study|Withdrawal by Subject|1|||
105729241|NCT02586805|364662786|FG002|Overall Study|Withdrawal by Subject|1|||
105729242|NCT02586805|364662787|FG003|Overall Study|Withdrawal by Subject|2|||
105729243|NCT02586805|364662784|FG000|Overall Study|Adverse Event|2|||
105729244|NCT02586805|364662785|FG001|Overall Study|Adverse Event|0|||
105729245|NCT02586805|364662786|FG002|Overall Study|Adverse Event|1|||
105729246|NCT02586805|364662787|FG003|Overall Study|Adverse Event|0|||
105729247|NCT02586805|364662784|FG000|Overall Study|Lost to Follow-up|0|||
105729248|NCT02586805|364662785|FG001|Overall Study|Lost to Follow-up|0|||
105729249|NCT02586805|364662786|FG002|Overall Study|Lost to Follow-up|1|||
105729250|NCT02586805|364662787|FG003|Overall Study|Lost to Follow-up|0|||
105729251|NCT02586805|364662784|FG000|Overall Study|Physician Decision|1|||
105729252|NCT02586805|364662785|FG001|Overall Study|Physician Decision|0|||
105729253|NCT02586805|364662786|FG002|Overall Study|Physician Decision|0|||
105729254|NCT02586805|364662787|FG003|Overall Study|Physician Decision|0|||
105729255|NCT02504541|364662795|FG000|Overall Study|Adverse Event|4|||
105729256|NCT02504541|364662795|FG000|Overall Study|Withdrawal by Subject|4|||
105729257|NCT02504541|364662795|FG000|Overall Study|Lost to Follow-up|1|||
105729258|NCT02504541|364662795|FG000|Overall Study|Met Stopping Criteria|1|||
105729259|NCT02504541|364662795|FG000|Overall Study|Protocol Violation|2|||
105729260|NCT02504541|364662795|FG000|Overall Study|Termination by Sponsor|1|||
105729261|NCT02504541|364662795|FG000|Overall Study|Other|2|||
105729262|NCT02504541|364662795|FG000|Overall Study|Multiple|5|||
105729263|NCT03182738|364662801|FG000|Overall Study|Lost to Follow-up|9|||
105729264|NCT03182738|364662802|FG001|Overall Study|Lost to Follow-up|3|||
105729265|NCT03182738|364662801|FG000|Overall Study|Pregnancy|0|||
105729266|NCT03182738|364662802|FG001|Overall Study|Pregnancy|1|||
105729267|NCT03182738|364662801|FG000|Overall Study|Withdrawal by Subject|0|||
105729268|NCT03182738|364662802|FG001|Overall Study|Withdrawal by Subject|1|||
105729269|NCT00356915|364662803|FG000|Overall Study|Non compliance|1|||
105729270|NCT00356915|364662804|FG001|Overall Study|Non compliance|2|||
105729271|NCT00356915|364662805|FG002|Overall Study|Non compliance|1|||
105729272|NCT00356915|364662803|FG000|Overall Study|Protocol Violation|2|||
105729273|NCT00356915|364662804|FG001|Overall Study|Protocol Violation|3|||
105729274|NCT00356915|364662805|FG002|Overall Study|Protocol Violation|2|||
105729275|NCT00356915|364662803|FG000|Overall Study|Withdrawal by Subject|14|||
105729276|NCT00356915|364662804|FG001|Overall Study|Withdrawal by Subject|14|||
105729277|NCT00356915|364662805|FG002|Overall Study|Withdrawal by Subject|10|||
105479829|NCT03011892|363767632|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
105479830|NCT03011892|363767633|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
105729278|NCT00356915|364662803|FG000|Overall Study|Lack of Efficacy|0|||
105729279|NCT00356915|364662804|FG001|Overall Study|Lack of Efficacy|0|||
105729280|NCT00356915|364662805|FG002|Overall Study|Lack of Efficacy|3|||
105479831|NCT03011892|363767634|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
105479832|NCT03011892|363767635|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
105729281|NCT00356915|364662803|FG000|Overall Study|Lost to Follow-up|27|||
105729282|NCT00356915|364662804|FG001|Overall Study|Lost to Follow-up|34|||
105729283|NCT00356915|364662805|FG002|Overall Study|Lost to Follow-up|14|||
105729284|NCT00356915|364662803|FG000|Overall Study|Administrative Decision|0|||
105729285|NCT00356915|364662804|FG001|Overall Study|Administrative Decision|0|||
105729286|NCT00356915|364662805|FG002|Overall Study|Administrative Decision|1|||
105729287|NCT00356915|364662803|FG000|Overall Study|Physician Decision|0|||
105729288|NCT00356915|364662804|FG001|Overall Study|Physician Decision|2|||
105729289|NCT00356915|364662805|FG002|Overall Study|Physician Decision|0|||
105729290|NCT00356915|364662803|FG000|Overall Study|Adverse Event|21|||
105729291|NCT00356915|364662804|FG001|Overall Study|Adverse Event|31|||
105729292|NCT00356915|364662805|FG002|Overall Study|Adverse Event|8|||
105796124|NCT02414854|364911334|FG001|Overall Study|Adverse Event|7|||
105796125|NCT02414854|364911335|FG002|Overall Study|Adverse Event|1|||
105796126|NCT02414854|364911336|FG003|Overall Study|Adverse Event|12|||
105796127|NCT02414854|364911333|FG000|Overall Study|Poor compliance to protocol|1|||
105796128|NCT02414854|364911334|FG001|Overall Study|Poor compliance to protocol|1|||
105796129|NCT02414854|364911335|FG002|Overall Study|Poor compliance to protocol|2|||
105796130|NCT02414854|364911336|FG003|Overall Study|Poor compliance to protocol|2|||
105796131|NCT02414854|364911333|FG000|Overall Study|Other than specified above|12|||
105796132|NCT02414854|364911334|FG001|Overall Study|Other than specified above|37|||
105796133|NCT02414854|364911335|FG002|Overall Study|Other than specified above|17|||
105796134|NCT02414854|364911336|FG003|Overall Study|Other than specified above|37|||
105796135|NCT02576054|364911337|FG000|Overall Study|Withdrawal by Subject|1|||
105796136|NCT00344305|364911341|FG000|Overall Study|Lost to Follow-up|2|||
105796137|NCT00344305|364911342|FG001|Overall Study|Lost to Follow-up|0|||
105796138|NCT00344305|364911341|FG000|Overall Study|Participant was not contacted in window|0|||
105796139|NCT00344305|364911342|FG001|Overall Study|Participant was not contacted in window|1|||
105796140|NCT01190098|364911343|FG000|Overall Study|Adverse Event|2|||
105796141|NCT01190098|364911344|FG001|Overall Study|Adverse Event|0|||
105796142|NCT01190098|364911343|FG000|Overall Study|Patient coomorbidity|0|||
105796143|NCT01190098|364911344|FG001|Overall Study|Patient coomorbidity|1|||
105796144|NCT01190098|364911343|FG000|Overall Study|Lack of transportation|1|||
105796145|NCT01190098|364911344|FG001|Overall Study|Lack of transportation|0|||
105796146|NCT01190098|364911343|FG000|Overall Study|Other|0|||
105796147|NCT01190098|364911344|FG001|Overall Study|Other|1|||
105796148|NCT02957682|364911345|FG000|Overall Study|Adverse Event|64|||
105796149|NCT02957682|364911346|FG001|Overall Study|Adverse Event|67|||
105796150|NCT02957682|364911345|FG000|Overall Study|Poor Compliance to Protocol|30|||
105796151|NCT02957682|364911346|FG001|Overall Study|Poor Compliance to Protocol|26|||
105796152|NCT02957682|364911345|FG000|Overall Study|Physician Decision|4|||
105796153|NCT02957682|364911346|FG001|Overall Study|Physician Decision|4|||
105796154|NCT02957682|364911345|FG000|Overall Study|Study Terminated by Sponsor|4|||
105796155|NCT02957682|364911346|FG001|Overall Study|Study Terminated by Sponsor|3|||
105796156|NCT02957682|364911345|FG000|Overall Study|Subject Moved|10|||
105796157|NCT02957682|364911346|FG001|Overall Study|Subject Moved|16|||
105796158|NCT02957682|364911345|FG000|Overall Study|Withdrawal by Subject|64|||
105796159|NCT02957682|364911346|FG001|Overall Study|Withdrawal by Subject|33|||
105796160|NCT02957682|364911345|FG000|Overall Study|Related to IMP Administration|3|||
105796161|NCT02957682|364911346|FG001|Overall Study|Related to IMP Administration|6|||
105796162|NCT02957682|364911345|FG000|Overall Study|Non-disclosed|16|||
105796163|NCT02957682|364911346|FG001|Overall Study|Non-disclosed|12|||
105796164|NCT02957682|364911345|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
105796165|NCT02957682|364911346|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
105796166|NCT00606801|364911348|FG000|Intervention|Protocol Violation|3|||
105796167|NCT00606801|364911349|FG001|Intervention|Protocol Violation|3|||
105796168|NCT02082262|364911350|FG000|Overall Study|Withdrawal by Subject|3|||
105796169|NCT02082262|364911350|FG000|Overall Study|Adverse Event|48|||
105796170|NCT00740480|364911353|FG000|Overall Study|Adverse Event|1|||
105796171|NCT00740480|364911353|FG000|Overall Study|Physician Decision|1|||
105796172|NCT01222715|364911358|FG000|Overall Study|Adverse Event|0|||
105796173|NCT01222715|364911359|FG001|Overall Study|Adverse Event|4|||
105796174|NCT01222715|364911358|FG000|Overall Study|Death|0|||
105796175|NCT01222715|364911359|FG001|Overall Study|Death|1|||
105796176|NCT01222715|364911358|FG000|Overall Study|Lack of Efficacy|22|||
105796177|NCT01222715|364911359|FG001|Overall Study|Lack of Efficacy|14|||
105796178|NCT01222715|364911358|FG000|Overall Study|Physician Decision|12|||
105796179|NCT01222715|364911359|FG001|Overall Study|Physician Decision|2|||
105796180|NCT01222715|364911358|FG000|Overall Study|Refusal of further protocol therapy|0|||
105796181|NCT01222715|364911359|FG001|Overall Study|Refusal of further protocol therapy|4|||
105796182|NCT01222715|364911358|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
105796183|NCT01222715|364911359|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
105796184|NCT01222715|364911358|FG000|Overall Study|Ineligible|0|||
105796185|NCT01222715|364911359|FG001|Overall Study|Ineligible|1|||
105796186|NCT01222715|364911358|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
105479833|NCT03011892|363767636|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
105796187|NCT01222715|364911359|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
105796188|NCT01508325|364911360|FG000|Overall Study|Withdrawal by Subject|8|||
105796189|NCT01508325|364911361|FG001|Overall Study|Withdrawal by Subject|9|||
105796190|NCT01508325|364911360|FG000|Overall Study|Protocol Violation|0|||
105796191|NCT01508325|364911361|FG001|Overall Study|Protocol Violation|3|||
105796192|NCT01508325|364911360|FG000|Overall Study|Physician Decision|2|||
105796193|NCT01508325|364911361|FG001|Overall Study|Physician Decision|1|||
105796194|NCT01508325|364911360|FG000|Overall Study|Adverse Event|1|||
105796195|NCT01508325|364911361|FG001|Overall Study|Adverse Event|0|||
105796196|NCT01508325|364911360|FG000|Overall Study|Lost to Follow-up|5|||
105796197|NCT01508325|364911361|FG001|Overall Study|Lost to Follow-up|6|||
105796198|NCT01508325|364911360|FG000|Overall Study|Other|2|||
105479834|NCT03011892|363767625|FG000|Double Blind (DB) Period|Other|1|||
105479835|NCT03011892|363767626|FG001|Double Blind (DB) Period|Other|1|||
105479836|NCT03011892|363767627|FG002|Double Blind (DB) Period|Other|1|||
105479837|NCT03011892|363767628|FG003|Double Blind (DB) Period|Other|0|||
105479838|NCT03011892|363767629|FG004|Double Blind (DB) Period|Other|1|||
105479839|NCT03011892|363767630|FG005|Double Blind (DB) Period|Other|0|||
105479840|NCT03011892|363767631|FG006|Double Blind (DB) Period|Other|0|||
105479841|NCT03011892|363767632|FG007|Double Blind (DB) Period|Other|0|||
105479842|NCT03011892|363767633|FG008|Double Blind (DB) Period|Other|0|||
105479843|NCT03011892|363767634|FG009|Double Blind (DB) Period|Other|0|||
105729293|NCT00356915|364662803|FG000|Overall Study|Miscellaneous reasons|11|||
105729294|NCT00356915|364662804|FG001|Overall Study|Miscellaneous reasons|8|||
105729295|NCT00356915|364662805|FG002|Overall Study|Miscellaneous reasons|3|||
105729296|NCT00509106|364662807|FG000|Overall Study|Adverse Event|3|||
105729297|NCT00509106|364662808|FG001|Overall Study|Adverse Event|2|||
105729298|NCT00509106|364662807|FG000|Overall Study|Noncompliance|0|||
105729299|NCT00509106|364662808|FG001|Overall Study|Noncompliance|1|||
105729300|NCT00509106|364662807|FG000|Overall Study|At the request of sponsor/investigator|1|||
105729301|NCT00509106|364662808|FG001|Overall Study|At the request of sponsor/investigator|2|||
105729302|NCT00509106|364662807|FG000|Overall Study|Withdrew consent|4|||
105729303|NCT00509106|364662808|FG001|Overall Study|Withdrew consent|8|||
105729304|NCT00509106|364662807|FG000|Overall Study|Lost to Follow-up|16|||
105729305|NCT00509106|364662808|FG001|Overall Study|Lost to Follow-up|10|||
105729306|NCT00509106|364662807|FG000|Overall Study|Other|1|||
105729307|NCT00509106|364662808|FG001|Overall Study|Other|0|||
105729308|NCT00509106|364662807|FG000|Overall Study|Death|6|||
105729309|NCT00509106|364662808|FG001|Overall Study|Death|6|||
105729310|NCT00488631|364662820|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
105729311|NCT00488631|364662821|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
105729312|NCT00488631|364662822|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
105729313|NCT00488631|364662823|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
105729314|NCT00488631|364662824|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
105729315|NCT00488631|364662825|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
105729316|NCT00488631|364662826|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
105729317|NCT00488631|364662827|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
105729318|NCT00488631|364662828|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
105729319|NCT00488631|364662829|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
105729320|NCT00488631|364662820|FG000|Double Blind Period (Week 0-54)|Death|0|||
105729321|NCT00488631|364662821|FG001|Double Blind Period (Week 0-54)|Death|0|||
105729322|NCT00488631|364662822|FG002|Double Blind Period (Week 0-54)|Death|0|||
105729323|NCT00488631|364662823|FG003|Double Blind Period (Week 0-54)|Death|0|||
105729324|NCT00488631|364662824|FG004|Double Blind Period (Week 0-54)|Death|0|||
105729325|NCT00488631|364662825|FG005|Double Blind Period (Week 0-54)|Death|1|||
105729326|NCT00488631|364662826|FG006|Double Blind Period (Week 0-54)|Death|0|||
105729327|NCT00488631|364662827|FG007|Double Blind Period (Week 0-54)|Death|0|||
105729328|NCT00488631|364662828|FG008|Double Blind Period (Week 0-54)|Death|0|||
105729329|NCT00488631|364662829|FG009|Double Blind Period (Week 0-54)|Death|0|||
105729330|NCT00488631|364662820|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
105729331|NCT00488631|364662821|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
105729332|NCT00488631|364662822|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
105729333|NCT00488631|364662823|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
105729334|NCT00488631|364662824|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
105729335|NCT00488631|364662825|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
105796199|NCT01508325|364911361|FG001|Overall Study|Other|2|||
105796200|NCT01392170|364911362|FG000|Overall Study|Withdrawal by Subject|1|||
105796201|NCT01392170|364911362|FG000|Overall Study|Ineligible|1|||
105796202|NCT01383954|364911364|FG000|Overall Study|Lack of Efficacy|2|||
105796203|NCT01383954|364911364|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
105796204|NCT01383954|364911364|FG000|Overall Study|Adverse Event|1|||
105796205|NCT01383954|364911364|FG000|Overall Study|Reason Not Specified|9|||
105796206|NCT00450177|364911365|FG000|Overall Study|Adverse Event|7|||
105479844|NCT03011892|363767635|FG010|Double Blind (DB) Period|Other|0|||
105479845|NCT03011892|363767636|FG011|Double Blind (DB) Period|Other|0|||
105729336|NCT00488631|364662826|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
105729337|NCT00488631|364662827|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
105729338|NCT00488631|364662828|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
105729339|NCT00488631|364662829|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
105729340|NCT00488631|364662820|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
105729341|NCT00488631|364662821|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
105796207|NCT00450177|364911366|FG001|Overall Study|Adverse Event|4|||
105796208|NCT00450177|364911365|FG000|Overall Study|Withdrawal by Subject|1|||
105479846|NCT03011892|363767625|FG000|Double Blind (DB) Period|Physician Decision|1|||
105479847|NCT03011892|363767626|FG001|Double Blind (DB) Period|Physician Decision|0|||
105479848|NCT03011892|363767627|FG002|Double Blind (DB) Period|Physician Decision|1|||
105729342|NCT00488631|364662822|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
105729343|NCT00488631|364662823|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
105729344|NCT00488631|364662824|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
105729345|NCT00488631|364662825|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
105729346|NCT00488631|364662826|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
105729347|NCT00488631|364662827|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
105729348|NCT00488631|364662828|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
105729349|NCT00488631|364662829|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
105729350|NCT00488631|364662820|FG000|Double Blind Period (Week 0-54)|Other|6|||
105729351|NCT00488631|364662821|FG001|Double Blind Period (Week 0-54)|Other|12|||
105729352|NCT00488631|364662822|FG002|Double Blind Period (Week 0-54)|Other|10|||
105729353|NCT00488631|364662823|FG003|Double Blind Period (Week 0-54)|Other|11|||
105729354|NCT00488631|364662824|FG004|Double Blind Period (Week 0-54)|Other|14|||
105729355|NCT00488631|364662825|FG005|Double Blind Period (Week 0-54)|Other|34|||
105729356|NCT00488631|364662826|FG006|Double Blind Period (Week 0-54)|Other|0|||
105729357|NCT00488631|364662827|FG007|Double Blind Period (Week 0-54)|Other|0|||
105729358|NCT00488631|364662828|FG008|Double Blind Period (Week 0-54)|Other|0|||
105729359|NCT00488631|364662829|FG009|Double Blind Period (Week 0-54)|Other|0|||
105729360|NCT00488631|364662820|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
105729361|NCT00488631|364662821|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
105729362|NCT00488631|364662822|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
105729363|NCT00488631|364662823|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
105729364|NCT00488631|364662824|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
105729365|NCT00488631|364662825|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
105729366|NCT00488631|364662826|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
105729367|NCT00488631|364662827|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
105729368|NCT00488631|364662828|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
105729369|NCT00488631|364662829|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
105729370|NCT00488631|364662820|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
105729371|NCT00488631|364662821|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
105729372|NCT00488631|364662822|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
105729373|NCT00488631|364662823|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
105729374|NCT00488631|364662824|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
105729375|NCT00488631|364662825|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
105729376|NCT00488631|364662826|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
105729377|NCT00488631|364662827|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
105729378|NCT00488631|364662828|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
105729379|NCT00488631|364662829|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
105729380|NCT00488631|364662820|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
105729381|NCT00488631|364662821|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
105729382|NCT00488631|364662822|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
105729383|NCT00488631|364662823|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
105729384|NCT00488631|364662824|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
105729385|NCT00488631|364662825|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
105729386|NCT00488631|364662826|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
105729387|NCT00488631|364662827|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
105729388|NCT00488631|364662828|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
105729389|NCT00488631|364662829|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
105729390|NCT00488631|364662820|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105729391|NCT00488631|364662821|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105729392|NCT00488631|364662822|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105729393|NCT00488631|364662823|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105729394|NCT00488631|364662824|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105729395|NCT00488631|364662825|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105729396|NCT00488631|364662826|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
105729397|NCT00488631|364662827|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105729398|NCT00488631|364662828|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
105729399|NCT00488631|364662829|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105479849|NCT03011892|363767628|FG003|Double Blind (DB) Period|Physician Decision|0|||
105479850|NCT03011892|363767629|FG004|Double Blind (DB) Period|Physician Decision|0|||
105796209|NCT00450177|364911366|FG001|Overall Study|Withdrawal by Subject|6|||
105796210|NCT00450177|364911365|FG000|Overall Study|Withdrawal by Primary Team|1|||
105796211|NCT00450177|364911366|FG001|Overall Study|Withdrawal by Primary Team|1|||
105796212|NCT04056299|364911375|FG000|Overall Study|Sponsor discontinued study|3|||
105796213|NCT04056299|364911376|FG001|Overall Study|Sponsor discontinued study|3|||
105796214|NCT01227954|364911377|FG000|Overall Study|Protocol Violation|6|||
105796215|NCT01227954|364911377|FG000|Overall Study|No protocol treatment|7|||
105796216|NCT01791127|364911380|FG000|Overall Study|Death|356|||
105796217|NCT01791127|364911380|FG000|Overall Study|Patient has withdrawn from study|293|||
105796218|NCT01791127|364911380|FG000|Overall Study|Lost to Follow-up|42|||
105796219|NCT01791127|364911380|FG000|Overall Study|All Siello leads are explanted|31|||
105796220|NCT01791127|364911380|FG000|Overall Study|Completion of 30 day safety registry|1|||
105796221|NCT01791127|364911380|FG000|Overall Study|Study terminated for EP Passion|749|||
105796222|NCT03333382|364911381|FG000|Overall Study|Lost to Follow-up|1|||
105796223|NCT03333382|364911382|FG001|Overall Study|Lost to Follow-up|0|||
105796224|NCT04247594|364911383|FG000|Overall Study|Withdrawal by Subject|4|||
105796225|NCT03231709|364911390|FG000|Treatment Period 1|Reason not Specified|0|||
105796226|NCT03231709|364911391|FG001|Treatment Period 1|Reason not Specified|1|||
105796227|NCT03231709|364911390|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
105796228|NCT03231709|364911391|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
105796229|NCT02419469|364911392|FG000|Overall Study|Withdrawal by Subject|1|||
105796230|NCT04991311|364911393|FG000|Overall Study|Adverse Event|1|||
105796231|NCT01238822|364911394|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
105796232|NCT00720304|364911399|FG000|Overall Study|Withdrawal by Subject|14|||
105796233|NCT00720304|364911400|FG001|Overall Study|Withdrawal by Subject|1|||
105796234|NCT00720304|364911399|FG000|Overall Study|Death|1|||
105796235|NCT00720304|364911400|FG001|Overall Study|Death|0|||
105796236|NCT00720304|364911399|FG000|Overall Study|Physician Decision|5|||
105796237|NCT00720304|364911400|FG001|Overall Study|Physician Decision|2|||
105796238|NCT00720304|364911399|FG000|Overall Study|Adverse Event|3|||
105796239|NCT00720304|364911400|FG001|Overall Study|Adverse Event|1|||
105796240|NCT00720304|364911399|FG000|Overall Study|Disease progression|6|||
105796241|NCT00720304|364911400|FG001|Overall Study|Disease progression|1|||
105796242|NCT00996918|364911403|FG000|Overall Study|Lack of Efficacy|1|||
105796243|NCT00996918|364911404|FG001|Overall Study|Lack of Efficacy|1|||
105796244|NCT00996918|364911405|FG002|Overall Study|Lack of Efficacy|2|||
105796245|NCT00996918|364911406|FG003|Overall Study|Lack of Efficacy|2|||
105796246|NCT00996918|364911407|FG004|Overall Study|Lack of Efficacy|0|||
105796247|NCT00996918|364911403|FG000|Overall Study|Adverse Event|2|||
105796248|NCT00996918|364911404|FG001|Overall Study|Adverse Event|5|||
105796249|NCT00996918|364911405|FG002|Overall Study|Adverse Event|2|||
105796250|NCT00996918|364911406|FG003|Overall Study|Adverse Event|6|||
105796251|NCT00996918|364911407|FG004|Overall Study|Adverse Event|0|||
105796252|NCT00996918|364911403|FG000|Overall Study|Withdrawal by Subject|1|||
105796253|NCT00996918|364911404|FG001|Overall Study|Withdrawal by Subject|4|||
105796254|NCT00996918|364911405|FG002|Overall Study|Withdrawal by Subject|3|||
105796255|NCT00996918|364911406|FG003|Overall Study|Withdrawal by Subject|3|||
105796256|NCT00996918|364911407|FG004|Overall Study|Withdrawal by Subject|2|||
105796257|NCT00996918|364911403|FG000|Overall Study|Physician Decision|1|||
105796258|NCT00996918|364911404|FG001|Overall Study|Physician Decision|0|||
105796259|NCT00996918|364911405|FG002|Overall Study|Physician Decision|0|||
105796260|NCT00996918|364911406|FG003|Overall Study|Physician Decision|0|||
105796261|NCT00996918|364911407|FG004|Overall Study|Physician Decision|0|||
105796262|NCT00996918|364911403|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
105796263|NCT00996918|364911404|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
105796264|NCT00996918|364911405|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
105479851|NCT03011892|363767630|FG005|Double Blind (DB) Period|Physician Decision|0|||
105479852|NCT03011892|363767631|FG006|Double Blind (DB) Period|Physician Decision|0|||
105479853|NCT03011892|363767632|FG007|Double Blind (DB) Period|Physician Decision|0|||
105796265|NCT00996918|364911406|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
105796266|NCT00996918|364911407|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
105796267|NCT00996918|364911403|FG000|Overall Study|Loss of Caregiver|0|||
105796268|NCT00996918|364911404|FG001|Overall Study|Loss of Caregiver|1|||
105796269|NCT00996918|364911405|FG002|Overall Study|Loss of Caregiver|0|||
105796270|NCT00996918|364911406|FG003|Overall Study|Loss of Caregiver|0|||
105796271|NCT00996918|364911407|FG004|Overall Study|Loss of Caregiver|0|||
105796272|NCT00996918|364911403|FG000|Overall Study|Other|3|||
105479854|NCT03011892|363767633|FG008|Double Blind (DB) Period|Physician Decision|0|||
105796273|NCT00996918|364911404|FG001|Overall Study|Other|1|||
105796274|NCT00996918|364911405|FG002|Overall Study|Other|0|||
105796275|NCT00996918|364911406|FG003|Overall Study|Other|0|||
105796276|NCT00996918|364911407|FG004|Overall Study|Other|0|||
105796277|NCT02487979|364911415|FG000|Overall Study|Physician Decision|2|||
105796278|NCT02487979|364911415|FG000|Overall Study|Withdrawal by Subject|2|||
105729400|NCT00488631|364662820|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
105729401|NCT00488631|364662821|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
105729402|NCT00488631|364662822|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
105729403|NCT00488631|364662823|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
105729404|NCT00488631|364662824|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
105729405|NCT00488631|364662825|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
105729406|NCT00488631|364662826|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
105729407|NCT00488631|364662827|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
105729408|NCT00488631|364662828|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
105729409|NCT00488631|364662829|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
105729410|NCT01873950|364662830|FG000|Period 5|Withdrawal by Subject|0|||
105729411|NCT01873950|364662831|FG001|Period 5|Withdrawal by Subject|0|||
105729412|NCT01873950|364662832|FG002|Period 5|Withdrawal by Subject|0|||
105729413|NCT01873950|364662833|FG003|Period 5|Withdrawal by Subject|1|||
105729414|NCT01873950|364662834|FG004|Period 5|Withdrawal by Subject|0|||
105729415|NCT01794780|364662836|FG000|Overall Study|Adverse Event|0|||
105729416|NCT01794780|364662837|FG001|Overall Study|Adverse Event|1|||
105729417|NCT01794780|364662838|FG002|Overall Study|Adverse Event|2|||
105729418|NCT01794780|364662839|FG003|Overall Study|Adverse Event|0|||
105729419|NCT01794780|364662840|FG004|Overall Study|Adverse Event|0|||
105729420|NCT01794780|364662841|FG005|Overall Study|Adverse Event|0|||
105729421|NCT01794780|364662842|FG006|Overall Study|Adverse Event|0|||
105729422|NCT01794780|364662843|FG007|Overall Study|Adverse Event|0|||
105729423|NCT01794780|364662836|FG000|Overall Study|Death|0|||
105729424|NCT01794780|364662837|FG001|Overall Study|Death|2|||
105729425|NCT01794780|364662838|FG002|Overall Study|Death|14|||
105729426|NCT01794780|364662839|FG003|Overall Study|Death|1|||
105729427|NCT01794780|364662840|FG004|Overall Study|Death|0|||
105729428|NCT01794780|364662841|FG005|Overall Study|Death|9|||
105729429|NCT01794780|364662842|FG006|Overall Study|Death|4|||
105729430|NCT01794780|364662843|FG007|Overall Study|Death|0|||
105729431|NCT01794780|364662836|FG000|Overall Study|Lost to Follow-up|10|||
105729432|NCT01794780|364662837|FG001|Overall Study|Lost to Follow-up|64|||
105729433|NCT01794780|364662838|FG002|Overall Study|Lost to Follow-up|165|||
105729434|NCT01794780|364662839|FG003|Overall Study|Lost to Follow-up|53|||
105729435|NCT01794780|364662840|FG004|Overall Study|Lost to Follow-up|2|||
105729436|NCT01794780|364662841|FG005|Overall Study|Lost to Follow-up|99|||
105729437|NCT01794780|364662842|FG006|Overall Study|Lost to Follow-up|30|||
105729438|NCT01794780|364662843|FG007|Overall Study|Lost to Follow-up|5|||
105729439|NCT01794780|364662836|FG000|Overall Study|Withdrew informed consent|7|||
105729440|NCT01794780|364662837|FG001|Overall Study|Withdrew informed consent|17|||
105729441|NCT01794780|364662838|FG002|Overall Study|Withdrew informed consent|36|||
105729442|NCT01794780|364662839|FG003|Overall Study|Withdrew informed consent|9|||
105729443|NCT01794780|364662840|FG004|Overall Study|Withdrew informed consent|0|||
105729444|NCT01794780|364662841|FG005|Overall Study|Withdrew informed consent|48|||
105729445|NCT01794780|364662842|FG006|Overall Study|Withdrew informed consent|4|||
105729446|NCT01794780|364662843|FG007|Overall Study|Withdrew informed consent|3|||
105729447|NCT01794780|364662836|FG000|Overall Study|Other|0|||
105729448|NCT01794780|364662837|FG001|Overall Study|Other|12|||
105729449|NCT01794780|364662838|FG002|Overall Study|Other|25|||
105729450|NCT01794780|364662839|FG003|Overall Study|Other|20|||
105729451|NCT01794780|364662840|FG004|Overall Study|Other|1|||
105729452|NCT01794780|364662841|FG005|Overall Study|Other|24|||
105729453|NCT01794780|364662842|FG006|Overall Study|Other|4|||
105729454|NCT01794780|364662843|FG007|Overall Study|Other|1|||
105729455|NCT00824421|364662844|FG000|Overall Study|Adverse Event|6|||
105729456|NCT00824421|364662845|FG001|Overall Study|Adverse Event|6|||
105729457|NCT00824421|364662846|FG002|Overall Study|Adverse Event|6|||
105729458|NCT00824421|364662844|FG000|Overall Study|Death|0|||
105729459|NCT00824421|364662845|FG001|Overall Study|Death|1|||
105729460|NCT00824421|364662846|FG002|Overall Study|Death|0|||
105729461|NCT00824421|364662844|FG000|Overall Study|Lack of Efficacy|5|||
105729462|NCT00824421|364662845|FG001|Overall Study|Lack of Efficacy|7|||
105729463|NCT00824421|364662846|FG002|Overall Study|Lack of Efficacy|4|||
105796279|NCT02487979|364911415|FG000|Overall Study|Progressive Disease|17|||
105729464|NCT00824421|364662844|FG000|Overall Study|Lost to Follow-up|2|||
105729465|NCT00824421|364662845|FG001|Overall Study|Lost to Follow-up|3|||
105729466|NCT00824421|364662846|FG002|Overall Study|Lost to Follow-up|0|||
105729467|NCT00824421|364662844|FG000|Overall Study|Pregnancy|1|||
105729468|NCT00824421|364662845|FG001|Overall Study|Pregnancy|0|||
105729469|NCT00824421|364662846|FG002|Overall Study|Pregnancy|1|||
105729470|NCT00824421|364662844|FG000|Overall Study|Withdrawal by Subject|2|||
105729471|NCT00824421|364662845|FG001|Overall Study|Withdrawal by Subject|3|||
105729472|NCT00824421|364662846|FG002|Overall Study|Withdrawal by Subject|3|||
105729473|NCT00824421|364662844|FG000|Overall Study|Randomized but not Treated|1|||
105729474|NCT00824421|364662845|FG001|Overall Study|Randomized but not Treated|1|||
105729475|NCT00824421|364662846|FG002|Overall Study|Randomized but not Treated|0|||
105796280|NCT04333199|364911418|FG000|Evaluated Patients|Lost to Follow-up|0|||
105729476|NCT00824421|364662844|FG000|Overall Study|Other|0|||
105796281|NCT04333199|364911419|FG001|Evaluated Patients|Lost to Follow-up|1|||
105796282|NCT04333199|364911420|FG002|Evaluated Patients|Lost to Follow-up|2|||
105796283|NCT00627458|364911421|FG000|Overall Study|Migrated from study area|1|||
105796284|NCT00627458|364911422|FG001|Overall Study|Migrated from study area|0|||
105796285|NCT00627458|364911423|FG002|Overall Study|Migrated from study area|1|||
105796286|NCT00627458|364911421|FG000|Overall Study|Withdrawal by Subject|2|||
105796287|NCT00627458|364911422|FG001|Overall Study|Withdrawal by Subject|6|||
105796288|NCT00627458|364911423|FG002|Overall Study|Withdrawal by Subject|5|||
105796289|NCT00627458|364911421|FG000|Overall Study|Lost to Follow-up|1|||
105796290|NCT00627458|364911422|FG001|Overall Study|Lost to Follow-up|1|||
105796291|NCT00627458|364911423|FG002|Overall Study|Lost to Follow-up|0|||
105796292|NCT00963599|364911427|FG000|Overall Study|Adverse Event|2|||
105796293|NCT00963599|364911428|FG001|Overall Study|Adverse Event|0|||
105796294|NCT00963599|364911429|FG002|Overall Study|Adverse Event|1|||
105796295|NCT00963599|364911430|FG003|Overall Study|Adverse Event|2|||
105796296|NCT00963599|364911427|FG000|Overall Study|Lack of Efficacy|0|||
105796297|NCT00963599|364911428|FG001|Overall Study|Lack of Efficacy|2|||
105796298|NCT00963599|364911429|FG002|Overall Study|Lack of Efficacy|1|||
105796299|NCT00963599|364911430|FG003|Overall Study|Lack of Efficacy|4|||
105796300|NCT00963599|364911427|FG000|Overall Study|Lost to Follow-up|0|||
105796301|NCT00963599|364911428|FG001|Overall Study|Lost to Follow-up|1|||
105796302|NCT00963599|364911429|FG002|Overall Study|Lost to Follow-up|1|||
105796303|NCT00963599|364911430|FG003|Overall Study|Lost to Follow-up|1|||
105796304|NCT00963599|364911427|FG000|Overall Study|Protocol Violation|2|||
105796305|NCT00963599|364911428|FG001|Overall Study|Protocol Violation|2|||
105796306|NCT00963599|364911429|FG002|Overall Study|Protocol Violation|3|||
105796307|NCT00963599|364911430|FG003|Overall Study|Protocol Violation|4|||
105796308|NCT00963599|364911427|FG000|Overall Study|Withdrawal by Subject|2|||
105796309|NCT00963599|364911428|FG001|Overall Study|Withdrawal by Subject|1|||
105796310|NCT00963599|364911429|FG002|Overall Study|Withdrawal by Subject|3|||
105796311|NCT00963599|364911430|FG003|Overall Study|Withdrawal by Subject|3|||
105796312|NCT03959137|364911431|FG000|Overall Study|Protocol Violation|6|||
105796313|NCT00190684|364911435|FG000|Overall Study|Adverse Event|86|||
105796314|NCT00190684|364911435|FG000|Overall Study|Satisfactory response|80|||
105796315|NCT00190684|364911435|FG000|Overall Study|Lack of efficacy|204|||
105796316|NCT00190684|364911435|FG000|Overall Study|Lost to Follow-up|232|||
105796317|NCT00190684|364911435|FG000|Overall Study|Patient moved|60|||
105796318|NCT00190684|364911435|FG000|Overall Study|Patient Decision|432|||
105796319|NCT00190684|364911435|FG000|Overall Study|Clinical relapse|67|||
105796320|NCT00190684|364911435|FG000|Overall Study|Sponsor's decision|17|||
105796321|NCT00190684|364911435|FG000|Overall Study|Physician Decision|84|||
105796322|NCT00190684|364911435|FG000|Overall Study|Protocol Violation|123|||
105796323|NCT00190684|364911435|FG000|Overall Study|Study Period III Completed|103|||
105796324|NCT00190684|364911435|FG000|Overall Study|Study Period V Completed|1|||
105796325|NCT01155284|364911436|FG000|Overall Study|Withdrawal by Subject|4|||
105796326|NCT01155284|364911437|FG001|Overall Study|Withdrawal by Subject|3|||
105796327|NCT01155284|364911436|FG000|Overall Study|Lost to Follow-up|1|||
105796328|NCT01155284|364911437|FG001|Overall Study|Lost to Follow-up|2|||
105796329|NCT01155284|364911436|FG000|Overall Study|Physician Decision|1|||
105796330|NCT01155284|364911437|FG001|Overall Study|Physician Decision|0|||
105796331|NCT01155284|364911436|FG000|Overall Study|Adverse Event|1|||
105796332|NCT01155284|364911437|FG001|Overall Study|Adverse Event|0|||
105796333|NCT00886782|364911438|FG000|Overall Study|Disease progression|3|||
105796334|NCT00886782|364911439|FG001|Overall Study|Disease progression|3|||
105796335|NCT00886782|364911440|FG002|Overall Study|Disease progression|3|||
105796336|NCT00886782|364911438|FG000|Overall Study|Study drug toxicity|0|||
105796337|NCT00886782|364911439|FG001|Overall Study|Study drug toxicity|0|||
105796338|NCT00886782|364911440|FG002|Overall Study|Study drug toxicity|1|||
105796339|NCT00886782|364911438|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
105796340|NCT00886782|364911439|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
105479855|NCT03011892|363767634|FG009|Double Blind (DB) Period|Physician Decision|0|||
105479856|NCT03011892|363767635|FG010|Double Blind (DB) Period|Physician Decision|0|||
105479857|NCT03011892|363767636|FG011|Double Blind (DB) Period|Physician Decision|0|||
105796341|NCT00886782|364911440|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
105479858|NCT03011892|363767625|FG000|Double Blind (DB) Period|Pregnancy|0|||
105796342|NCT01154673|364911441|FG000|Overall Study|Lost to Follow-up|1|||
105796343|NCT01154673|364911442|FG001|Overall Study|Lost to Follow-up|0|||
105796344|NCT01154673|364911441|FG000|Overall Study|moved out of province|1|||
105479859|NCT03011892|363767626|FG001|Double Blind (DB) Period|Pregnancy|0|||
105796345|NCT01154673|364911442|FG001|Overall Study|moved out of province|0|||
105796346|NCT03467971|364911443|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105796347|NCT03467971|364911444|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105796348|NCT01358708|364911445|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
105796349|NCT01358708|364911446|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105796350|NCT01358708|364911445|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
105796351|NCT01358708|364911446|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
105796352|NCT00051636|364911447|FG000|Period 1 - Core|Adverse Event|2|||
105796353|NCT00051636|364911448|FG001|Period 1 - Core|Adverse Event|2|||
105729477|NCT00824421|364662845|FG001|Overall Study|Other|1|||
105729478|NCT00824421|364662846|FG002|Overall Study|Other|0|||
105729479|NCT00927485|364662847|FG000|Overall Study|Adverse Event|4|||
105729480|NCT00927485|364662848|FG001|Overall Study|Adverse Event|2|||
105729481|NCT00927485|364662847|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
105729482|NCT00927485|364662848|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
105729483|NCT03293680|364662858|FG000|Overall Study|Death|1|||
105729484|NCT03293680|364662858|FG000|Overall Study|Did not meet inclusion criteria|8|||
105729485|NCT00636818|364662859|FG000|Overall Study|Adverse Event|1|||
105729486|NCT00636818|364662859|FG000|Overall Study|Lost to Follow-up|2|||
105729487|NCT00636818|364662859|FG000|Overall Study|Entry Criteria Exclusion|3|||
105729488|NCT00636818|364662859|FG000|Overall Study|Protocol Violation|1|||
105729489|NCT00636818|364662859|FG000|Overall Study|Withdrawal by Subject|4|||
105729490|NCT03228186|364662860|FG000|Overall Study|Patient never started treatment|1|||
105729491|NCT01023789|364662862|FG000|3 - Year Visit|Death|29|||
105729492|NCT01023789|364662862|FG000|3 - Year Visit|Withdrawal of consent|1|||
105729493|NCT01023789|364662862|FG000|3 - Year Visit|Lost to Follow-up|13|||
105729494|NCT03772327|364662863|FG000|Overall Study|Lost to Follow-up|3|||
105729495|NCT03772327|364662864|FG001|Overall Study|Lost to Follow-up|4|||
105729496|NCT03772327|364662863|FG000|Overall Study|Withdrawal by Subject|2|||
105729497|NCT03772327|364662864|FG001|Overall Study|Withdrawal by Subject|3|||
105729498|NCT00749203|364662865|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
105729499|NCT00749203|364662866|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
105729500|NCT00749203|364662865|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
105729501|NCT00749203|364662866|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
105729502|NCT00749203|364662865|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
105729503|NCT00749203|364662866|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
105729504|NCT00749203|364662865|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
105729505|NCT00749203|364662866|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
105729506|NCT00749203|364662865|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
105729507|NCT00749203|364662866|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
105729508|NCT00749203|364662865|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
105729509|NCT00749203|364662866|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
105729510|NCT04233424|364662868|FG000|Overall Study|Death|15|||
105729511|NCT04233424|364662869|FG001|Overall Study|Death|16|||
105729512|NCT04233424|364662868|FG000|Overall Study|Withdrawal by Subject|2|||
105729513|NCT04233424|364662869|FG001|Overall Study|Withdrawal by Subject|8|||
105729514|NCT04233424|364662868|FG000|Overall Study|Physician Decision|1|||
105729515|NCT04233424|364662869|FG001|Overall Study|Physician Decision|3|||
105729516|NCT04233424|364662868|FG000|Overall Study|Protocol Violation|3|||
105729517|NCT04233424|364662869|FG001|Overall Study|Protocol Violation|1|||
105729518|NCT04233424|364662868|FG000|Overall Study|Lost to Follow-up|1|||
105729519|NCT04233424|364662869|FG001|Overall Study|Lost to Follow-up|3|||
105729520|NCT04233424|364662868|FG000|Overall Study|subject refuse to visit site|2|||
105729521|NCT04233424|364662869|FG001|Overall Study|subject refuse to visit site|0|||
105729522|NCT01006356|364664130|FG000|Overall Study|Adverse Event|6|||
105729523|NCT01006356|364664130|FG000|Overall Study|Physician Decision|1|||
105729524|NCT01006356|364664130|FG000|Overall Study|Paticipants did not cooperate|6|||
105729525|NCT01006356|364664130|FG000|Overall Study|Withdrawal by Subject|1|||
105729526|NCT01006356|364664130|FG000|Overall Study|Choice by participants|2|||
105729527|NCT01006356|364664130|FG000|Overall Study|Protocol Violation|3|||
105729528|NCT01006356|364664130|FG000|Overall Study|Other|23|||
105729529|NCT01821963|364664131|FG000|Overall Study|Adverse Event|1|||
105729530|NCT00686205|364664134|FG000|Overall Study|Protocol Violation|127|||
105729531|NCT00686205|364664135|FG001|Overall Study|Protocol Violation|0|||
105729532|NCT00686205|364664134|FG000|Overall Study|Withdrawal by Subject|2|||
105729533|NCT00686205|364664135|FG001|Overall Study|Withdrawal by Subject|0|||
105729534|NCT00686205|364664134|FG000|Overall Study|Specimen handling procedure altered|5878|||
105729535|NCT00686205|364664135|FG001|Overall Study|Specimen handling procedure altered|0|||
105729536|NCT00686205|364664134|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
105729537|NCT00686205|364664135|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
105729538|NCT03095703|364664138|FG000|Overall Study|Withdrawal by Subject|1|||
105729539|NCT01503021|364664141|FG000|Overall Study|Adverse Event|7|||
105729540|NCT01503021|364664142|FG001|Overall Study|Adverse Event|6|||
105729541|NCT01503021|364664141|FG000|Overall Study|Death|0|||
105729542|NCT01503021|364664142|FG001|Overall Study|Death|2|||
105729543|NCT01503021|364664141|FG000|Overall Study|Lost to Follow-up|2|||
105729544|NCT01503021|364664142|FG001|Overall Study|Lost to Follow-up|0|||
105729545|NCT01503021|364664141|FG000|Overall Study|Physician Decision|3|||
105729546|NCT01503021|364664142|FG001|Overall Study|Physician Decision|0|||
105729547|NCT01503021|364664141|FG000|Overall Study|Protocol Violation|1|||
105729548|NCT01503021|364664142|FG001|Overall Study|Protocol Violation|3|||
105729549|NCT01503021|364664141|FG000|Overall Study|Withdrawal by Subject|9|||
105729550|NCT01503021|364664142|FG001|Overall Study|Withdrawal by Subject|8|||
105729551|NCT01503021|364664141|FG000|Overall Study|Moved, received transplant, etc.|5|||
105729552|NCT01503021|364664142|FG001|Overall Study|Moved, received transplant, etc.|7|||
105796354|NCT00051636|364911447|FG000|Period 1 - Core|Protocol Violation|1|||
105796355|NCT00051636|364911448|FG001|Period 1 - Core|Protocol Violation|0|||
105796356|NCT00051636|364911447|FG000|Period 1 - Core|Withdrawal by Subject|1|||
105796357|NCT00051636|364911448|FG001|Period 1 - Core|Withdrawal by Subject|2|||
105796358|NCT00051636|364911447|FG000|Period 1 - Core|Lost to Follow-up|0|||
105796359|NCT00051636|364911448|FG001|Period 1 - Core|Lost to Follow-up|2|||
105796360|NCT00051636|364911447|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
105796361|NCT00051636|364911448|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
105796362|NCT00051636|364911447|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
105796363|NCT00051636|364911448|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
105796364|NCT00051636|364911447|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
105796365|NCT00051636|364911448|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
105796366|NCT00051636|364911447|FG000|Period 2- Extended Observation Period|Death|4|||
105796367|NCT00051636|364911448|FG001|Period 2- Extended Observation Period|Death|5|||
105796368|NCT00051636|364911447|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
105796369|NCT00051636|364911448|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
105796370|NCT00975884|364911449|FG000|Overall Study|Adverse Event|1|||
105796371|NCT00975884|364911450|FG001|Overall Study|Adverse Event|0|||
105796372|NCT00975884|364911449|FG000|Overall Study|Lost to Follow-up|5|||
105796373|NCT00975884|364911450|FG001|Overall Study|Lost to Follow-up|3|||
105796374|NCT00975884|364911449|FG000|Overall Study|Withdrawal by Subject|9|||
105796375|NCT00975884|364911450|FG001|Overall Study|Withdrawal by Subject|9|||
105796376|NCT00975884|364911449|FG000|Overall Study|Other|1|||
105796377|NCT00975884|364911450|FG001|Overall Study|Other|3|||
105796378|NCT01901146|364912983|FG000|Neoadjuvant Phase|Death|1|||
105796379|NCT01901146|364912984|FG001|Neoadjuvant Phase|Death|2|||
105796380|NCT01901146|364912985|FG002|Neoadjuvant Phase|Death|0|||
105796381|NCT01901146|364912986|FG003|Neoadjuvant Phase|Death|0|||
105796382|NCT01901146|364912987|FG004|Neoadjuvant Phase|Death|0|||
105796383|NCT01901146|364912983|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
105796384|NCT01901146|364912984|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
105796385|NCT01901146|364912985|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
105796386|NCT01901146|364912986|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
105796387|NCT01901146|364912987|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
105796388|NCT01901146|364912983|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
105796389|NCT01901146|364912984|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
105796390|NCT01901146|364912985|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
105796391|NCT01901146|364912986|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
105796392|NCT01901146|364912987|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
105796393|NCT01901146|364912983|FG000|Neoadjuvant Phase|Physician Decision|1|||
105796394|NCT01901146|364912984|FG001|Neoadjuvant Phase|Physician Decision|2|||
105796395|NCT01901146|364912985|FG002|Neoadjuvant Phase|Physician Decision|0|||
105796396|NCT01901146|364912986|FG003|Neoadjuvant Phase|Physician Decision|0|||
105796397|NCT01901146|364912987|FG004|Neoadjuvant Phase|Physician Decision|0|||
105796398|NCT01901146|364912983|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
105796399|NCT01901146|364912984|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
105796400|NCT01901146|364912985|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
105796401|NCT01901146|364912986|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
105796402|NCT01901146|364912987|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
105796403|NCT01901146|364912983|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
105796404|NCT01901146|364912984|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
105796405|NCT01901146|364912985|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
105796406|NCT01901146|364912986|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
105796407|NCT01901146|364912987|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
105796408|NCT01901146|364912983|FG000|Adjuvant Phase|Other|0|||
105796409|NCT01901146|364912984|FG001|Adjuvant Phase|Other|0|||
105796410|NCT01901146|364912985|FG002|Adjuvant Phase|Other|1|||
105796411|NCT01901146|364912986|FG003|Adjuvant Phase|Other|0|||
105796412|NCT01901146|364912987|FG004|Adjuvant Phase|Other|0|||
105796413|NCT01901146|364912983|FG000|Adjuvant Phase|Death|0|||
105796414|NCT01901146|364912984|FG001|Adjuvant Phase|Death|0|||
105796415|NCT01901146|364912985|FG002|Adjuvant Phase|Death|0|||
105796416|NCT01901146|364912986|FG003|Adjuvant Phase|Death|0|||
105796417|NCT01901146|364912987|FG004|Adjuvant Phase|Death|3|||
105796418|NCT01901146|364912983|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
105796419|NCT01901146|364912984|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
105479860|NCT03011892|363767627|FG002|Double Blind (DB) Period|Pregnancy|0|||
105479861|NCT03011892|363767628|FG003|Double Blind (DB) Period|Pregnancy|0|||
105479862|NCT03011892|363767629|FG004|Double Blind (DB) Period|Pregnancy|1|||
105479863|NCT03011892|363767630|FG005|Double Blind (DB) Period|Pregnancy|0|||
105796420|NCT01901146|364912985|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
105796421|NCT01901146|364912986|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
105479864|NCT03011892|363767631|FG006|Double Blind (DB) Period|Pregnancy|0|||
105729553|NCT00504257|364664145|FG000|Overall Study|Withdrawal by Subject|2|||
105729554|NCT00504257|364664145|FG000|Overall Study|ineligible histology|2|||
105729555|NCT03584009|364664150|FG000|Overall Study|Death|25|||
105729556|NCT03584009|364664151|FG001|Overall Study|Death|18|||
105729557|NCT03584009|364664150|FG000|Overall Study|Lost to Follow-up|0|||
105729558|NCT03584009|364664151|FG001|Overall Study|Lost to Follow-up|1|||
105729559|NCT03584009|364664150|FG000|Overall Study|Physician Decision|1|||
105729560|NCT03584009|364664151|FG001|Overall Study|Physician Decision|1|||
105729561|NCT03584009|364664150|FG000|Overall Study|Study Terminated by Sponsor|22|||
105729562|NCT03584009|364664151|FG001|Overall Study|Study Terminated by Sponsor|30|||
105729563|NCT03584009|364664150|FG000|Overall Study|Withdrawal by Subject|3|||
105729564|NCT03584009|364664151|FG001|Overall Study|Withdrawal by Subject|2|||
105729565|NCT04112914|364664154|FG000|Overall Study|Lost to Follow-up|13|||
105729566|NCT04112914|364664155|FG001|Overall Study|Lost to Follow-up|9|||
105729567|NCT04112914|364664154|FG000|Overall Study|Withdrawal by Subject|1|||
105729568|NCT04112914|364664155|FG001|Overall Study|Withdrawal by Subject|0|||
105729569|NCT00117312|364664156|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
105729570|NCT00117312|364664157|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
105729571|NCT00117312|364664158|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
105729572|NCT00117312|364664159|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
105729573|NCT00117312|364664156|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
105729574|NCT00117312|364664157|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
105729575|NCT00117312|364664158|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
105729576|NCT00117312|364664159|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
105729577|NCT00117312|364664156|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
105729578|NCT00117312|364664157|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
105729579|NCT00117312|364664158|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
105729580|NCT00117312|364664159|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
105729581|NCT00117312|364664156|FG000|Overall Study|Other|0|||
105729582|NCT00117312|364664157|FG001|Overall Study|Other|1|||
105729583|NCT00117312|364664158|FG002|Overall Study|Other|3|||
105729584|NCT00117312|364664159|FG003|Overall Study|Other|1|||
105729585|NCT00117312|364664156|FG000|Overall Study|Patient choice|0|||
105729586|NCT00117312|364664157|FG001|Overall Study|Patient choice|0|||
105729587|NCT00117312|364664158|FG002|Overall Study|Patient choice|2|||
105729588|NCT00117312|364664159|FG003|Overall Study|Patient choice|1|||
105729589|NCT00117312|364664156|FG000|Overall Study|Adverse Event|0|||
105729590|NCT00117312|364664157|FG001|Overall Study|Adverse Event|2|||
105729591|NCT00117312|364664158|FG002|Overall Study|Adverse Event|0|||
105729592|NCT00117312|364664159|FG003|Overall Study|Adverse Event|0|||
105729593|NCT00117312|364664156|FG000|Overall Study|Protocol Violation|0|||
105729594|NCT00117312|364664157|FG001|Overall Study|Protocol Violation|1|||
105729595|NCT00117312|364664158|FG002|Overall Study|Protocol Violation|3|||
105729596|NCT00117312|364664159|FG003|Overall Study|Protocol Violation|0|||
105729597|NCT00117312|364664156|FG000|Overall Study|PSA decrease <=50%|0|||
105729598|NCT00117312|364664157|FG001|Overall Study|PSA decrease <=50%|2|||
105729599|NCT00117312|364664158|FG002|Overall Study|PSA decrease <=50%|2|||
105729600|NCT00117312|364664159|FG003|Overall Study|PSA decrease <=50%|4|||
105729601|NCT00117312|364664156|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
105729602|NCT00117312|364664157|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
105729603|NCT00117312|364664158|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
105729604|NCT00117312|364664159|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
105729605|NCT00117312|364664156|FG000|Overall Study|Hepatic abnormality|0|||
105729606|NCT00117312|364664157|FG001|Overall Study|Hepatic abnormality|1|||
105729607|NCT00117312|364664158|FG002|Overall Study|Hepatic abnormality|0|||
105729608|NCT00117312|364664159|FG003|Overall Study|Hepatic abnormality|1|||
105729609|NCT00117312|364664156|FG000|Overall Study|Withdrawal by Subject|0|||
105729610|NCT00117312|364664157|FG001|Overall Study|Withdrawal by Subject|2|||
105729611|NCT00117312|364664158|FG002|Overall Study|Withdrawal by Subject|0|||
105729612|NCT00117312|364664159|FG003|Overall Study|Withdrawal by Subject|0|||
105729613|NCT03486314|364664162|FG000|Part A|Adverse Event|1|||
105729614|NCT03486314|364664163|FG001|Part A|Adverse Event|0|||
105729615|NCT03486314|364664164|FG002|Part A|Adverse Event|0|||
105796422|NCT01901146|364912987|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
105796423|NCT01901146|364912983|FG000|Adjuvant Phase|Physician Decision|0|||
105796424|NCT01901146|364912984|FG001|Adjuvant Phase|Physician Decision|0|||
105796425|NCT01901146|364912985|FG002|Adjuvant Phase|Physician Decision|9|||
105796426|NCT01901146|364912986|FG003|Adjuvant Phase|Physician Decision|2|||
105796427|NCT01901146|364912987|FG004|Adjuvant Phase|Physician Decision|4|||
105796428|NCT01901146|364912983|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
105796429|NCT01901146|364912984|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
105796430|NCT01901146|364912985|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
105796431|NCT01901146|364912986|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
105796432|NCT01901146|364912987|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
105796433|NCT00297492|364912991|FG000|Set Quit Date|Lost to Follow-up|7|||
105796434|NCT00297492|364912992|FG001|Set Quit Date|Lost to Follow-up|13|||
105796435|NCT00297492|364912993|FG002|Set Quit Date|Lost to Follow-up|5|||
105796436|NCT00297492|364912991|FG000|6 Month Follow-up|Lost to Follow-up|63|||
105796437|NCT00297492|364912992|FG001|6 Month Follow-up|Lost to Follow-up|49|||
105796438|NCT00297492|364912993|FG002|6 Month Follow-up|Lost to Follow-up|27|||
105796439|NCT02156466|364912996|FG000|Overall Study|Adverse Event|0|||
105796440|NCT02156466|364912997|FG001|Overall Study|Adverse Event|0|||
105796441|NCT02156466|364912998|FG002|Overall Study|Adverse Event|1|||
105796442|NCT02156466|364912999|FG003|Overall Study|Adverse Event|1|||
105796443|NCT02156466|364913000|FG004|Overall Study|Adverse Event|0|||
105796444|NCT02156466|364912996|FG000|Overall Study|Quantiferon Positivity|0|||
105796445|NCT02156466|364912997|FG001|Overall Study|Quantiferon Positivity|0|||
105796446|NCT02156466|364912998|FG002|Overall Study|Quantiferon Positivity|0|||
105796447|NCT02156466|364912999|FG003|Overall Study|Quantiferon Positivity|1|||
105796448|NCT02156466|364913000|FG004|Overall Study|Quantiferon Positivity|0|||
105796449|NCT00399490|364913007|FG000|Overall Study|Adverse Event|19|||
105796450|NCT00399490|364913007|FG000|Overall Study|Lack of Efficacy|31|||
105796451|NCT00399490|364913007|FG000|Overall Study|Lost to Follow-up|5|||
105796452|NCT00399490|364913007|FG000|Overall Study|Withdrawal by Subject|18|||
105796453|NCT00399490|364913007|FG000|Overall Study|Other|25|||
105796454|NCT02162511|364913009|FG000|Overall Study|Lack of Efficacy|0|||
105796455|NCT02162511|364913010|FG001|Overall Study|Lack of Efficacy|0|||
105796456|NCT02162511|364913011|FG002|Overall Study|Lack of Efficacy|2|||
105796457|NCT01408576|364913012|FG000|Overall Study|Lack of Efficacy|17|||
105796458|NCT01408576|364913013|FG001|Overall Study|Lack of Efficacy|30|||
105796459|NCT01408576|364913014|FG002|Overall Study|Lack of Efficacy|48|||
105796460|NCT01408576|364913012|FG000|Overall Study|Protocol Violation|1|||
105796461|NCT01408576|364913013|FG001|Overall Study|Protocol Violation|2|||
105796462|NCT01408576|364913014|FG002|Overall Study|Protocol Violation|2|||
105796463|NCT01408576|364913012|FG000|Overall Study|Lost to Follow-up|10|||
105796464|NCT01408576|364913013|FG001|Overall Study|Lost to Follow-up|9|||
105796465|NCT01408576|364913014|FG002|Overall Study|Lost to Follow-up|17|||
105796466|NCT01408576|364913012|FG000|Overall Study|Withdrawal by Subject|34|||
105796467|NCT01408576|364913013|FG001|Overall Study|Withdrawal by Subject|60|||
105796468|NCT01408576|364913014|FG002|Overall Study|Withdrawal by Subject|66|||
105796469|NCT01408576|364913012|FG000|Overall Study|Sponsor terminated study|89|||
105796470|NCT01408576|364913013|FG001|Overall Study|Sponsor terminated study|333|||
105796471|NCT01408576|364913014|FG002|Overall Study|Sponsor terminated study|330|||
105796472|NCT01408576|364913012|FG000|Overall Study|AE, serious fatal|4|||
105796473|NCT01408576|364913013|FG001|Overall Study|AE, serious fatal|4|||
105796474|NCT01408576|364913014|FG002|Overall Study|AE, serious fatal|1|||
105796475|NCT01408576|364913012|FG000|Overall Study|SAE, non-fatal|11|||
105796476|NCT01408576|364913013|FG001|Overall Study|SAE, non-fatal|23|||
105796477|NCT01408576|364913014|FG002|Overall Study|SAE, non-fatal|14|||
105796478|NCT01408576|364913012|FG000|Overall Study|AE, non-serious non-fatal|12|||
105796479|NCT01408576|364913013|FG001|Overall Study|AE, non-serious non-fatal|19|||
105796480|NCT01408576|364913014|FG002|Overall Study|AE, non-serious non-fatal|11|||
105796481|NCT01408576|364913012|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
105796482|NCT01408576|364913013|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
105796483|NCT01408576|364913014|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
105796484|NCT01408576|364913012|FG000|Overall Study|AE, unknown type|0|||
105796485|NCT01408576|364913013|FG001|Overall Study|AE, unknown type|1|||
105796486|NCT01408576|364913014|FG002|Overall Study|AE, unknown type|0|||
105796487|NCT01408576|364913012|FG000|Overall Study|Other|10|||
105796488|NCT01408576|364913013|FG001|Overall Study|Other|16|||
105796489|NCT01408576|364913014|FG002|Overall Study|Other|18|||
105564964|NCT00689026|364065366|FG001|Overall Study|Withdrawal by Subject|6|||
105796490|NCT01399125|364913020|FG000|Overall Study|Adverse Event|32|||
105796491|NCT01399125|364913021|FG001|Overall Study|Adverse Event|30|||
105796492|NCT01399125|364913020|FG000|Overall Study|Abnormal Lab values|0|||
105796493|NCT01399125|364913021|FG001|Overall Study|Abnormal Lab values|1|||
105796494|NCT01399125|364913020|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105796495|NCT01399125|364913021|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
105796496|NCT01399125|364913020|FG000|Overall Study|Withdrawal by Subject|5|||
105796497|NCT01399125|364913021|FG001|Overall Study|Withdrawal by Subject|8|||
105796498|NCT01399125|364913020|FG000|Overall Study|Lost to Follow-up|2|||
105729616|NCT03486314|364664162|FG000|Part A|Symptomatic Deterioration|2|||
105729617|NCT03486314|364664163|FG001|Part A|Symptomatic Deterioration|0|||
105729618|NCT03486314|364664164|FG002|Part A|Symptomatic Deterioration|0|||
105729619|NCT01985321|364664165|FG000|Overall Study|Protocol Violation|4|||
105729620|NCT01985321|364664166|FG001|Overall Study|Protocol Violation|3|||
105729621|NCT01985321|364664165|FG000|Overall Study|Withdrawal by Subject|1|||
105729622|NCT01985321|364664166|FG001|Overall Study|Withdrawal by Subject|0|||
105729623|NCT01985321|364664165|FG000|Overall Study|Lost to Follow-up|5|||
105729624|NCT01985321|364664166|FG001|Overall Study|Lost to Follow-up|2|||
105729625|NCT01985321|364664165|FG000|Overall Study|Subject treated wrong type of sore|1|||
105729626|NCT01985321|364664166|FG001|Overall Study|Subject treated wrong type of sore|0|||
105729627|NCT04246047|364664172|FG000|Overall Study|Death|50|||
105729628|NCT04246047|364664173|FG001|Overall Study|Death|77|||
105353276|NCT00171158|363298488|FG000|Core Study|Adverse event, non-fatal|21|||
105353277|NCT00171158|363298488|FG000|Core Study|Consent withdrawn by subject|6|||
105729629|NCT04246047|364664172|FG000|Overall Study|Lost to Follow-up|1|||
105729630|NCT04246047|364664173|FG001|Overall Study|Lost to Follow-up|3|||
105729631|NCT04246047|364664172|FG000|Overall Study|Physician Decision|4|||
105729632|NCT04246047|364664173|FG001|Overall Study|Physician Decision|10|||
105729633|NCT04246047|364664172|FG000|Overall Study|Withdrawal by Subject|19|||
105729634|NCT04246047|364664173|FG001|Overall Study|Withdrawal by Subject|26|||
105729635|NCT04246047|364664172|FG000|Overall Study|Ongoing|169|||
105729636|NCT04246047|364664173|FG001|Overall Study|Ongoing|135|||
105729637|NCT02604264|364664177|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
105729638|NCT02604264|364664178|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
105729639|NCT03192904|364664179|FG000|Overall Study|Physician Decision|3|||
105729640|NCT03192904|364664180|FG001|Overall Study|Physician Decision|1|||
105729641|NCT03192904|364664179|FG000|Overall Study|Lost to Follow-up|0|||
105729642|NCT03192904|364664180|FG001|Overall Study|Lost to Follow-up|1|||
105729643|NCT05139030|364664181|FG000|Overall Study|Withdrawal by Subject|1|||
105729644|NCT05139030|364664182|FG001|Overall Study|Withdrawal by Subject|3|||
105729645|NCT05139030|364664181|FG000|Overall Study|Adverse Event|0|||
105729646|NCT05139030|364664182|FG001|Overall Study|Adverse Event|1|||
105729647|NCT05139030|364664181|FG000|Overall Study|Failure to meet continuation criteria|0|||
105729648|NCT05139030|364664182|FG001|Overall Study|Failure to meet continuation criteria|1|||
105729649|NCT04003610|364664183|FG000|Overall Study|Lost to Follow-up|0|||
105729650|NCT04003610|364664184|FG001|Overall Study|Lost to Follow-up|1|||
105729651|NCT04003610|364664185|FG002|Overall Study|Lost to Follow-up|0|||
105729652|NCT04003610|364664183|FG000|Overall Study|Death|0|||
105729653|NCT04003610|364664184|FG001|Overall Study|Death|0|||
105729654|NCT04003610|364664185|FG002|Overall Study|Death|3|||
105729655|NCT04003610|364664183|FG000|Overall Study|Study Terminated by Sponsor|0|||
105729656|NCT04003610|364664184|FG001|Overall Study|Study Terminated by Sponsor|0|||
105729657|NCT04003610|364664185|FG002|Overall Study|Study Terminated by Sponsor|3|||
105729658|NCT00424398|364664186|FG000|Overall Study|Withdrawal by Subject|2|||
105729659|NCT00424398|364664187|FG001|Overall Study|Withdrawal by Subject|1|||
105729660|NCT00424398|364664188|FG002|Overall Study|Withdrawal by Subject|0|||
105729661|NCT00424398|364664186|FG000|Overall Study|Subject met exclusion criteria|1|||
105729662|NCT00424398|364664187|FG001|Overall Study|Subject met exclusion criteria|0|||
105729663|NCT00424398|364664188|FG002|Overall Study|Subject met exclusion criteria|0|||
105729664|NCT01309737|364664189|FG000|Week 0 to 16|Death|1|||
105729665|NCT01309737|364664190|FG001|Week 0 to 16|Death|0|||
105729666|NCT01309737|364664191|FG002|Week 0 to 16|Death|1|||
105729667|NCT01309737|364664192|FG003|Week 0 to 16|Death|0|||
105729668|NCT01309737|364664193|FG004|Week 0 to 16|Death|0|||
105729669|NCT01309737|364664189|FG000|Week 0 to 16|Adverse Event|11|||
105729670|NCT01309737|364664190|FG001|Week 0 to 16|Adverse Event|10|||
105729671|NCT01309737|364664191|FG002|Week 0 to 16|Adverse Event|5|||
105729672|NCT01309737|364664192|FG003|Week 0 to 16|Adverse Event|0|||
105729673|NCT01309737|364664193|FG004|Week 0 to 16|Adverse Event|0|||
105353278|NCT00171158|363298488|FG000|Core Study|No longer required drug (BMT)|14|||
105729674|NCT01309737|364664189|FG000|Week 0 to 16|Lack of Efficacy|15|||
105729675|NCT01309737|364664190|FG001|Week 0 to 16|Lack of Efficacy|2|||
105729676|NCT01309737|364664191|FG002|Week 0 to 16|Lack of Efficacy|24|||
105729677|NCT01309737|364664192|FG003|Week 0 to 16|Lack of Efficacy|0|||
105729678|NCT01309737|364664193|FG004|Week 0 to 16|Lack of Efficacy|0|||
105729679|NCT01309737|364664189|FG000|Week 0 to 16|Lost to Follow-up|7|||
105729680|NCT01309737|364664190|FG001|Week 0 to 16|Lost to Follow-up|8|||
105729681|NCT01309737|364664191|FG002|Week 0 to 16|Lost to Follow-up|3|||
105729682|NCT01309737|364664192|FG003|Week 0 to 16|Lost to Follow-up|0|||
105729683|NCT01309737|364664193|FG004|Week 0 to 16|Lost to Follow-up|0|||
105729684|NCT01309737|364664189|FG000|Week 0 to 16|Withdrawal by Subject|7|||
105729685|NCT01309737|364664190|FG001|Week 0 to 16|Withdrawal by Subject|6|||
105729686|NCT01309737|364664191|FG002|Week 0 to 16|Withdrawal by Subject|7|||
105729687|NCT01309737|364664192|FG003|Week 0 to 16|Withdrawal by Subject|0|||
105729688|NCT01309737|364664193|FG004|Week 0 to 16|Withdrawal by Subject|0|||
105729689|NCT01309737|364664189|FG000|Week 0 to 16|Other|10|||
105729690|NCT01309737|364664190|FG001|Week 0 to 16|Other|14|||
105729691|NCT01309737|364664191|FG002|Week 0 to 16|Other|4|||
105796499|NCT01399125|364913021|FG001|Overall Study|Lost to Follow-up|3|||
105796500|NCT01399125|364913020|FG000|Overall Study|Administrative Problems|7|||
105796501|NCT01399125|364913021|FG001|Overall Study|Administrative Problems|11|||
105796502|NCT01399125|364913020|FG000|Overall Study|Death|0|||
105796503|NCT01399125|364913021|FG001|Overall Study|Death|1|||
105796504|NCT01399125|364913020|FG000|Overall Study|Protocol Deviation|5|||
105796505|NCT01399125|364913021|FG001|Overall Study|Protocol Deviation|2|||
105796506|NCT00337129|364913022|FG000|Overall Study|Adverse Event|4|||
105796507|NCT00337129|364913022|FG000|Overall Study|Withdrawal by Subject|1|||
105796508|NCT00337129|364913022|FG000|Overall Study|Lack of Efficacy|32|||
105796509|NCT00337129|364913022|FG000|Overall Study|Death|2|||
105796510|NCT00337129|364913022|FG000|Overall Study|not protocol specified|1|||
105796511|NCT00563524|364913025|FG000|Overall Study|Adverse Event|0|||
105796512|NCT00563524|364913026|FG001|Overall Study|Adverse Event|1|||
105796513|NCT00563524|364913027|FG002|Overall Study|Adverse Event|0|||
105729692|NCT01309737|364664192|FG003|Week 0 to 16|Other|0|||
105729693|NCT01309737|364664193|FG004|Week 0 to 16|Other|0|||
105729694|NCT01309737|364664189|FG000|Week 0 to 16|Randomized, but not treated|1|||
105729695|NCT01309737|364664190|FG001|Week 0 to 16|Randomized, but not treated|0|||
105729696|NCT01309737|364664191|FG002|Week 0 to 16|Randomized, but not treated|0|||
105729697|NCT01309737|364664192|FG003|Week 0 to 16|Randomized, but not treated|0|||
105729698|NCT01309737|364664193|FG004|Week 0 to 16|Randomized, but not treated|0|||
105729699|NCT01309737|364664189|FG000|Week 16 to 52|Death|0|||
105729700|NCT01309737|364664190|FG001|Week 16 to 52|Death|0|||
105729701|NCT01309737|364664191|FG002|Week 16 to 52|Death|0|||
105729702|NCT01309737|364664192|FG003|Week 16 to 52|Death|0|||
105729703|NCT01309737|364664193|FG004|Week 16 to 52|Death|1|||
105729704|NCT01309737|364664189|FG000|Week 16 to 52|Adverse Event|7|||
105729705|NCT01309737|364664190|FG001|Week 16 to 52|Adverse Event|7|||
105729706|NCT01309737|364664191|FG002|Week 16 to 52|Adverse Event|0|||
105729707|NCT01309737|364664192|FG003|Week 16 to 52|Adverse Event|6|||
105729708|NCT01309737|364664193|FG004|Week 16 to 52|Adverse Event|5|||
105729709|NCT01309737|364664189|FG000|Week 16 to 52|Lack of Efficacy|107|||
105729710|NCT01309737|364664190|FG001|Week 16 to 52|Lack of Efficacy|76|||
105729711|NCT01309737|364664191|FG002|Week 16 to 52|Lack of Efficacy|0|||
105729712|NCT01309737|364664192|FG003|Week 16 to 52|Lack of Efficacy|25|||
105729713|NCT01309737|364664193|FG004|Week 16 to 52|Lack of Efficacy|21|||
105729714|NCT01309737|364664189|FG000|Week 16 to 52|Lost to Follow-up|4|||
105729715|NCT01309737|364664190|FG001|Week 16 to 52|Lost to Follow-up|2|||
105729716|NCT01309737|364664191|FG002|Week 16 to 52|Lost to Follow-up|0|||
105729717|NCT01309737|364664192|FG003|Week 16 to 52|Lost to Follow-up|1|||
105729718|NCT01309737|364664193|FG004|Week 16 to 52|Lost to Follow-up|4|||
105729719|NCT01309737|364664189|FG000|Week 16 to 52|Withdrawal by Subject|5|||
105729720|NCT01309737|364664190|FG001|Week 16 to 52|Withdrawal by Subject|6|||
105729721|NCT01309737|364664191|FG002|Week 16 to 52|Withdrawal by Subject|0|||
105729722|NCT01309737|364664192|FG003|Week 16 to 52|Withdrawal by Subject|0|||
105729723|NCT01309737|364664193|FG004|Week 16 to 52|Withdrawal by Subject|2|||
105729724|NCT01309737|364664189|FG000|Week 16 to 52|Other|10|||
105729725|NCT01309737|364664190|FG001|Week 16 to 52|Other|12|||
105729726|NCT01309737|364664191|FG002|Week 16 to 52|Other|0|||
105729727|NCT01309737|364664192|FG003|Week 16 to 52|Other|2|||
105729728|NCT01309737|364664193|FG004|Week 16 to 52|Other|0|||
105729729|NCT02502864|364664194|FG000|Overall Study|Withdrawal by Subject|1|||
105729730|NCT02333227|364664196|FG000|Overall Study|Lost to Follow-up|137|||
105729731|NCT02333227|364664197|FG001|Overall Study|Lost to Follow-up|106|||
105729732|NCT02333227|364664196|FG000|Overall Study|Pregnancy Interrupted|42|||
105729733|NCT02333227|364664197|FG001|Overall Study|Pregnancy Interrupted|89|||
105729734|NCT02333227|364664196|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
105729735|NCT02333227|364664197|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
105729736|NCT00816036|364664198|FG000|Overall Study|Death|47|||
105729737|NCT00816036|364664199|FG001|Overall Study|Death|28|||
105729738|NCT00816036|364664198|FG000|Overall Study|Lost to Follow-up|75|||
105729739|NCT00816036|364664199|FG001|Overall Study|Lost to Follow-up|57|||
105729740|NCT00816036|364664198|FG000|Overall Study|Withdrawal by Subject|54|||
105729741|NCT00816036|364664199|FG001|Overall Study|Withdrawal by Subject|23|||
105796514|NCT00563524|364913028|FG003|Overall Study|Adverse Event|0|||
105564965|NCT02220894|364065367|FG000|Overall Study|Adverse Event|127|||
105729742|NCT01624194|364664200|FG000|Overall Study|Lost to Follow-up|1|||
105729743|NCT01624194|364664201|FG001|Overall Study|Lost to Follow-up|0|||
105729744|NCT01624194|364664200|FG000|Overall Study|Withdrawal by Subject|1|||
105729745|NCT01624194|364664201|FG001|Overall Study|Withdrawal by Subject|0|||
105729746|NCT01076179|364664202|FG000|Overall Study|Withdrawal by Subject|1|||
105796515|NCT00563524|364913029|FG004|Overall Study|Adverse Event|2|||
105796516|NCT00563524|364913030|FG005|Overall Study|Adverse Event|0|||
105729747|NCT03459040|364664203|FG000|Overall Study|Death|8|||
105729748|NCT03459040|364664203|FG000|Overall Study|Withdrawal by Subject|1|||
105729749|NCT03577990|364664206|FG000|Overall Study|Lost to Follow-up|4|||
105729750|NCT03577990|364664207|FG001|Overall Study|Lost to Follow-up|6|||
105729751|NCT03577990|364664206|FG000|Overall Study|Withdrawal by Subject|4|||
105729752|NCT03577990|364664207|FG001|Overall Study|Withdrawal by Subject|7|||
105729753|NCT02493751|364664208|FG000|Overall Study|Withdrawal by Subject|2|||
105729754|NCT02493751|364664209|FG001|Overall Study|Withdrawal by Subject|8|||
105729755|NCT02493751|364664208|FG000|Overall Study|Death|6|||
105729756|NCT02493751|364664209|FG001|Overall Study|Death|13|||
105729757|NCT02493751|364664208|FG000|Overall Study|Lost to Follow-up|2|||
105729758|NCT02493751|364664209|FG001|Overall Study|Lost to Follow-up|3|||
105729759|NCT02493751|364664208|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
105729760|NCT02493751|364664209|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
105729761|NCT03822468|364664210|FG000|Treatment Period|Progressive disease|98|||
105729762|NCT03822468|364664211|FG001|Treatment Period|Progressive disease|94|||
105729763|NCT03822468|364664210|FG000|Treatment Period|Adverse Event|21|||
105729764|NCT03822468|364664211|FG001|Treatment Period|Adverse Event|24|||
105729765|NCT03822468|364664210|FG000|Treatment Period|Withdrawal by Subject|9|||
105729766|NCT03822468|364664211|FG001|Treatment Period|Withdrawal by Subject|5|||
105729767|NCT03822468|364664210|FG000|Treatment Period|Physician Decision|9|||
105729768|NCT03822468|364664211|FG001|Treatment Period|Physician Decision|7|||
105729769|NCT03822468|364664210|FG000|Treatment Period|Protocol Violation|2|||
105729770|NCT03822468|364664211|FG001|Treatment Period|Protocol Violation|1|||
105729771|NCT03822468|364664210|FG000|Treatment Period|Death|2|||
105729772|NCT03822468|364664211|FG001|Treatment Period|Death|3|||
105729773|NCT03822468|364664210|FG000|Treatment Period|Lost to Follow-up|1|||
105729774|NCT03822468|364664211|FG001|Treatment Period|Lost to Follow-up|1|||
105729775|NCT03822468|364664210|FG000|Treatment Period|Sponsor decision|46|||
105729776|NCT03822468|364664211|FG001|Treatment Period|Sponsor decision|53|||
105729777|NCT03822468|364664210|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
105729778|NCT03822468|364664211|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
105729779|NCT03822468|364664210|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
105729780|NCT03822468|364664211|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
105729781|NCT03822468|364664210|FG000|Post-treatment Efficacy Follow-up|Death|1|||
105729782|NCT03822468|364664211|FG001|Post-treatment Efficacy Follow-up|Death|0|||
105729783|NCT03822468|364664210|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
105729784|NCT03822468|364664211|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
105729785|NCT03822468|364664210|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
105729786|NCT03822468|364664211|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
105729787|NCT03822468|364664210|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
105729788|NCT03822468|364664211|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
105729789|NCT03822468|364664210|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
105729790|NCT03822468|364664211|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
105729791|NCT05121103|364664212|FG000|Overall Study|Progressive disease|2|||
105729792|NCT05121103|364664213|FG001|Overall Study|Progressive disease|1|||
105729793|NCT05121103|364664214|FG002|Overall Study|Progressive disease|6|||
105729794|NCT05121103|364664212|FG000|Overall Study|Physician Decision|2|||
105729795|NCT05121103|364664213|FG001|Overall Study|Physician Decision|1|||
105729796|NCT05121103|364664214|FG002|Overall Study|Physician Decision|0|||
105729797|NCT05121103|364664212|FG000|Overall Study|Withdrawal by Subject|0|||
105729798|NCT05121103|364664213|FG001|Overall Study|Withdrawal by Subject|1|||
105729799|NCT05121103|364664214|FG002|Overall Study|Withdrawal by Subject|0|||
105729800|NCT03248128|364664215|FG000|Overall Study|Lost to Follow-up|1|||
105729801|NCT03248128|364664216|FG001|Overall Study|Lost to Follow-up|0|||
105796517|NCT00563524|364913025|FG000|Overall Study|Lost to Follow-up|1|||
105796518|NCT00563524|364913026|FG001|Overall Study|Lost to Follow-up|0|||
105796519|NCT00563524|364913027|FG002|Overall Study|Lost to Follow-up|0|||
105796520|NCT00563524|364913028|FG003|Overall Study|Lost to Follow-up|0|||
105796521|NCT00563524|364913029|FG004|Overall Study|Lost to Follow-up|0|||
105796522|NCT00563524|364913030|FG005|Overall Study|Lost to Follow-up|0|||
105796523|NCT00563524|364913025|FG000|Overall Study|Protocol Violation|0|||
105796524|NCT00563524|364913026|FG001|Overall Study|Protocol Violation|1|||
105796525|NCT00563524|364913027|FG002|Overall Study|Protocol Violation|0|||
105796526|NCT00563524|364913028|FG003|Overall Study|Protocol Violation|0|||
105796527|NCT00563524|364913029|FG004|Overall Study|Protocol Violation|0|||
105796528|NCT00563524|364913030|FG005|Overall Study|Protocol Violation|0|||
105796529|NCT00563524|364913025|FG000|Overall Study|Withdrawal by Subject|1|||
105796530|NCT00563524|364913026|FG001|Overall Study|Withdrawal by Subject|1|||
105796531|NCT00563524|364913027|FG002|Overall Study|Withdrawal by Subject|3|||
105796532|NCT00563524|364913028|FG003|Overall Study|Withdrawal by Subject|0|||
105796533|NCT00563524|364913029|FG004|Overall Study|Withdrawal by Subject|0|||
105796534|NCT00563524|364913030|FG005|Overall Study|Withdrawal by Subject|1|||
105796535|NCT02239601|364913033|FG000|Overall Study|Withdrawal by Subject|3|||
105796536|NCT02239601|364913034|FG001|Overall Study|Withdrawal by Subject|4|||
105796537|NCT02239601|364913033|FG000|Overall Study|Protocol Violation|4|||
105796538|NCT02239601|364913034|FG001|Overall Study|Protocol Violation|2|||
105796539|NCT04682639|364913035|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
105796540|NCT04682639|364913036|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
105796541|NCT04682639|364913037|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
105796542|NCT04682639|364913038|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
105796543|NCT04682639|364913039|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
105796544|NCT04682639|364913035|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
105796545|NCT04682639|364913036|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
105796546|NCT04682639|364913037|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
105796547|NCT04682639|364913038|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105796548|NCT04682639|364913039|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105796549|NCT04682639|364913035|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
105796550|NCT04682639|364913036|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105796551|NCT04682639|364913037|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105796552|NCT04682639|364913038|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105796553|NCT04682639|364913039|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105796554|NCT04682639|364913035|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
105796555|NCT04682639|364913036|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
105796556|NCT04682639|364913037|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
105796557|NCT04682639|364913038|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
105796558|NCT04682639|364913039|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
105796559|NCT04682639|364913035|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
105796560|NCT04682639|364913036|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
105796561|NCT04682639|364913037|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
105796562|NCT04682639|364913038|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
105796563|NCT04682639|364913039|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
105796564|NCT04682639|364913035|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
105796565|NCT04682639|364913036|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
105796566|NCT04682639|364913037|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
105796567|NCT04682639|364913038|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
105796568|NCT04682639|364913039|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
105796569|NCT04682639|364913035|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
105796570|NCT04682639|364913036|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
105796571|NCT04682639|364913037|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
105796572|NCT04682639|364913038|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
105796573|NCT04682639|364913039|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
105796574|NCT04682639|364913035|FG000|OLE Period (28 Weeks)|Other|1|||
105796575|NCT04682639|364913036|FG001|OLE Period (28 Weeks)|Other|2|||
105796576|NCT04682639|364913037|FG002|OLE Period (28 Weeks)|Other|0|||
105564966|NCT02220894|364065368|FG001|Overall Study|Adverse Event|74|||
105796577|NCT04682639|364913038|FG003|OLE Period (28 Weeks)|Other|0|||
105796578|NCT04682639|364913039|FG004|OLE Period (28 Weeks)|Other|1|||
105796579|NCT04682639|364913035|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
105796580|NCT04682639|364913036|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
105796581|NCT04682639|364913037|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
105796582|NCT04682639|364913038|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
105796583|NCT04682639|364913039|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
105796584|NCT04682639|364913035|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
105796585|NCT04682639|364913036|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
105796586|NCT04682639|364913037|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105796587|NCT04682639|364913038|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105796588|NCT04682639|364913039|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105796589|NCT04682639|364913035|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
105796590|NCT04682639|364913036|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
105796591|NCT04682639|364913037|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
105796592|NCT04682639|364913038|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
105796593|NCT04682639|364913039|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
105796594|NCT04682639|364913035|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
105796595|NCT04682639|364913036|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
105796596|NCT04682639|364913037|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
105796597|NCT04682639|364913038|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
105796598|NCT04682639|364913039|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
105796599|NCT00763269|364913040|FG000|Overall Study|Lost to Follow-up|12|||
105796600|NCT00763269|364913041|FG001|Overall Study|Lost to Follow-up|13|||
105796601|NCT03543046|364913044|FG000|Overall Study|Adverse Event|1|||
105796602|NCT03543046|364913045|FG001|Overall Study|Adverse Event|1|||
105796603|NCT03543046|364913044|FG000|Overall Study|Physician Decision|1|||
105796604|NCT03543046|364913045|FG001|Overall Study|Physician Decision|1|||
105796605|NCT03543046|364913044|FG000|Overall Study|Protocol Violation|1|||
105796606|NCT03543046|364913045|FG001|Overall Study|Protocol Violation|0|||
105796607|NCT03174925|364913050|FG000|Overall Study|Elastographic images not retrievable|2|||
105796608|NCT03174925|364913050|FG000|Overall Study|Elastography image not interpretable|1|||
105796609|NCT02019979|364913052|FG000|Overall Study|study terminated|14|||
105796610|NCT00572156|364913053|FG000|Overall Study|Adverse Event|3|||
105796611|NCT00572156|364913054|FG001|Overall Study|Adverse Event|1|||
105796612|NCT00572156|364913055|FG002|Overall Study|Adverse Event|5|||
105796613|NCT00572156|364913056|FG003|Overall Study|Adverse Event|1|||
105796614|NCT00572156|364913053|FG000|Overall Study|Lost to Follow-up|1|||
105796615|NCT00572156|364913054|FG001|Overall Study|Lost to Follow-up|1|||
105796616|NCT00572156|364913055|FG002|Overall Study|Lost to Follow-up|1|||
105796617|NCT00572156|364913056|FG003|Overall Study|Lost to Follow-up|0|||
105796618|NCT00572156|364913053|FG000|Overall Study|Protocol Violation|1|||
105796619|NCT00572156|364913054|FG001|Overall Study|Protocol Violation|2|||
105796620|NCT00572156|364913055|FG002|Overall Study|Protocol Violation|0|||
105796621|NCT00572156|364913056|FG003|Overall Study|Protocol Violation|2|||
105796622|NCT00572156|364913053|FG000|Overall Study|Patient/Parent Decision|1|||
105796623|NCT00572156|364913054|FG001|Overall Study|Patient/Parent Decision|6|||
105796624|NCT00572156|364913055|FG002|Overall Study|Patient/Parent Decision|4|||
105796625|NCT00572156|364913056|FG003|Overall Study|Patient/Parent Decision|3|||
105796626|NCT00572156|364913053|FG000|Overall Study|Sponsor Decision|20|||
105796627|NCT00572156|364913054|FG001|Overall Study|Sponsor Decision|16|||
105796628|NCT00572156|364913055|FG002|Overall Study|Sponsor Decision|17|||
105796629|NCT00572156|364913056|FG003|Overall Study|Sponsor Decision|19|||
105796630|NCT02261974|364913057|FG000|Overall Study|Withdrawal by Subject|3|||
105796631|NCT02261974|364913058|FG001|Overall Study|Withdrawal by Subject|2|||
105796632|NCT02261974|364913057|FG000|Overall Study|Pregnancy|0|||
105796633|NCT02261974|364913058|FG001|Overall Study|Pregnancy|1|||
105796634|NCT02261974|364913057|FG000|Overall Study|Missed treatment cut-off date|6|||
105796635|NCT02261974|364913058|FG001|Overall Study|Missed treatment cut-off date|3|||
105796636|NCT02261974|364913057|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
105796637|NCT02261974|364913058|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
105796638|NCT02261974|364913057|FG000|Overall Study|Lost to Follow-up|2|||
105796639|NCT02261974|364913058|FG001|Overall Study|Lost to Follow-up|0|||
105796640|NCT02261974|364913057|FG000|Overall Study|Adverse Event|1|||
105796641|NCT02261974|364913058|FG001|Overall Study|Adverse Event|0|||
105796642|NCT02030834|364913062|FG000|Overall Study|Death|4|||
105796643|NCT02030834|364913063|FG001|Overall Study|Death|0|||
105796644|NCT02030834|364913064|FG002|Overall Study|Death|0|||
105796645|NCT02030834|364913062|FG000|Overall Study|Manufacturing failure|2|||
105796646|NCT02030834|364913063|FG001|Overall Study|Manufacturing failure|0|||
105796647|NCT02030834|364913064|FG002|Overall Study|Manufacturing failure|1|||
105796648|NCT02030834|364913062|FG000|Overall Study|Disease progression|2|||
105796649|NCT02030834|364913063|FG001|Overall Study|Disease progression|0|||
105796650|NCT02030834|364913064|FG002|Overall Study|Disease progression|2|||
105796651|NCT02030834|364913062|FG000|Overall Study|Lost to Follow-up|1|||
105796652|NCT02030834|364913063|FG001|Overall Study|Lost to Follow-up|0|||
105796653|NCT02030834|364913064|FG002|Overall Study|Lost to Follow-up|0|||
105796654|NCT02030834|364913062|FG000|Overall Study|Withdrawal by Subject|1|||
105796655|NCT02030834|364913063|FG001|Overall Study|Withdrawal by Subject|0|||
105479865|NCT03011892|363767632|FG007|Double Blind (DB) Period|Pregnancy|0|||
105796656|NCT02030834|364913064|FG002|Overall Study|Withdrawal by Subject|0|||
105796657|NCT02030834|364913062|FG000|Overall Study|Lack of funding|1|||
105796658|NCT02030834|364913063|FG001|Overall Study|Lack of funding|0|||
105796659|NCT02030834|364913064|FG002|Overall Study|Lack of funding|0|||
105796660|NCT00103259|364913067|FG000|Overall Study|Death|3|||
105479866|NCT03011892|363767633|FG008|Double Blind (DB) Period|Pregnancy|0|||
105796661|NCT00103259|364913068|FG001|Overall Study|Death|2|||
105796662|NCT00103259|364913067|FG000|Overall Study|Withdrawal by Subject|2|||
105564967|NCT02220894|364065367|FG000|Overall Study|Death|418|||
105564968|NCT02220894|364065368|FG001|Overall Study|Death|508|||
105729802|NCT03248128|364664215|FG000|Overall Study|Withdrawal by Subject|16|||
105729803|NCT03248128|364664216|FG001|Overall Study|Withdrawal by Subject|14|||
105729804|NCT03248128|364664215|FG000|Overall Study|Site Closed|4|||
105729805|NCT03248128|364664216|FG001|Overall Study|Site Closed|3|||
105729806|NCT03248128|364664215|FG000|Overall Study|Randomized, but did not receive treatment|1|||
105729807|NCT03248128|364664216|FG001|Overall Study|Randomized, but did not receive treatment|3|||
105729808|NCT03878446|364664217|FG000|Overall Study|Withdrawn by parent or guardian|1|||
105729809|NCT03878446|364664218|FG001|Overall Study|Withdrawn by parent or guardian|0|||
105729810|NCT03878446|364664219|FG002|Overall Study|Withdrawn by parent or guardian|0|||
105729811|NCT03878446|364664220|FG003|Overall Study|Withdrawn by parent or guardian|0|||
105729812|NCT03878446|364664221|FG004|Overall Study|Withdrawn by parent or guardian|0|||
105729813|NCT04526665|364664222|FG000|Overall Study|Withdrawal by Subject|6|||
105729814|NCT04526665|364664223|FG001|Overall Study|Withdrawal by Subject|3|||
105729815|NCT04526665|364664222|FG000|Overall Study|Adverse Event|4|||
105729816|NCT04526665|364664223|FG001|Overall Study|Adverse Event|1|||
105729817|NCT04526665|364664222|FG000|Overall Study|Physician Decision|2|||
105729818|NCT04526665|364664223|FG001|Overall Study|Physician Decision|2|||
105729819|NCT04526665|364664222|FG000|Overall Study|Death|2|||
105729820|NCT04526665|364664223|FG001|Overall Study|Death|0|||
105729821|NCT04526665|364664222|FG000|Overall Study|Other|0|||
105729822|NCT04526665|364664223|FG001|Overall Study|Other|1|||
105564969|NCT02220894|364065367|FG000|Overall Study|Lost to Follow-up|0|||
105564970|NCT02220894|364065368|FG001|Overall Study|Lost to Follow-up|4|||
105729823|NCT00473694|364665758|FG000|Overall Study|Adverse Event|0|||
105564971|NCT02220894|364065367|FG000|Overall Study|Site Terminated by Sponsor|2|||
105729824|NCT00473694|364665759|FG001|Overall Study|Adverse Event|1|||
105729825|NCT00473694|364665760|FG002|Overall Study|Adverse Event|0|||
105729826|NCT00473694|364665761|FG003|Overall Study|Adverse Event|0|||
105729827|NCT00473694|364665758|FG000|Overall Study|Participants did not receive treatment|11|||
105729828|NCT00473694|364665759|FG001|Overall Study|Participants did not receive treatment|3|||
105729829|NCT00473694|364665760|FG002|Overall Study|Participants did not receive treatment|5|||
105729830|NCT00473694|364665761|FG003|Overall Study|Participants did not receive treatment|6|||
105729831|NCT00473694|364665758|FG000|Overall Study|Lost to Follow-up|0|||
105729832|NCT00473694|364665759|FG001|Overall Study|Lost to Follow-up|0|||
105729833|NCT00473694|364665760|FG002|Overall Study|Lost to Follow-up|0|||
105729834|NCT00473694|364665761|FG003|Overall Study|Lost to Follow-up|1|||
105729835|NCT02579603|364665767|FG000|Overall Study|Not treated|1|||
105729836|NCT02579603|364665768|FG001|Overall Study|Not treated|0|||
105729837|NCT02579603|364665767|FG000|Overall Study|Adverse Event|2|||
105729838|NCT02579603|364665768|FG001|Overall Study|Adverse Event|2|||
105729839|NCT02579603|364665767|FG000|Overall Study|Other than stated|1|||
105729840|NCT02579603|364665768|FG001|Overall Study|Other than stated|0|||
105729841|NCT02981472|364665769|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
105729842|NCT02981472|364665770|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
105729843|NCT02981472|364665769|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
105729844|NCT02981472|364665770|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105729845|NCT02981472|364665769|FG000|Treatment Period|Adverse Event|6|||
105729846|NCT02981472|364665770|FG001|Treatment Period|Adverse Event|1|||
105729847|NCT02981472|364665769|FG000|Treatment Period|Participant withdrew consent|1|||
105729848|NCT02981472|364665770|FG001|Treatment Period|Participant withdrew consent|0|||
105729849|NCT02981472|364665769|FG000|Treatment Period|Lost to Follow-up|0|||
105729850|NCT02981472|364665770|FG001|Treatment Period|Lost to Follow-up|1|||
105729851|NCT00621023|364665772|FG000|Overall Study|Death|5|||
105729852|NCT00621023|364665772|FG000|Overall Study|Follow up discontinued|1|||
105729853|NCT00613314|364665783|FG000|Overall Study|Adverse Event|5|||
105729854|NCT00613314|364665783|FG000|Overall Study|Protocol Violation|14|||
105729855|NCT00613314|364665783|FG000|Overall Study|Lost to Follow-up|46|||
105729856|NCT00613314|364665783|FG000|Overall Study|Other reason not defined above|90|||
105729857|NCT01531725|364665788|FG000|Overall Study|Protocol Violation|5|||
105729858|NCT03596164|364665797|FG000|Overall Study|Adverse Event|0|||
105729859|NCT03596164|364665798|FG001|Overall Study|Adverse Event|1|||
105729860|NCT03596164|364665797|FG000|Overall Study|Death|1|||
105729861|NCT03596164|364665798|FG001|Overall Study|Death|0|||
105729862|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
105729863|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
105729864|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
105729865|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
105729866|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
105729867|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
105729868|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
105729869|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
105729870|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
105729871|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
105796663|NCT00103259|364913068|FG001|Overall Study|Withdrawal by Subject|3|||
105796664|NCT00103259|364913067|FG000|Overall Study|alternative therapy|1|||
105796665|NCT00103259|364913068|FG001|Overall Study|alternative therapy|0|||
105796666|NCT00103259|364913067|FG000|Overall Study|other (reasons were not specified)|2|||
105796667|NCT00103259|364913068|FG001|Overall Study|other (reasons were not specified)|1|||
105796668|NCT00103259|364913067|FG000|Overall Study|ineligible/no protocol therapy|4|||
105796669|NCT00103259|364913068|FG001|Overall Study|ineligible/no protocol therapy|6|||
105796670|NCT03496207|364913085|FG000|Base Study|Adverse Event|0|||
105796671|NCT03496207|364913086|FG001|Base Study|Adverse Event|0|||
105796672|NCT03496207|364913087|FG002|Base Study|Adverse Event|1|||
105796673|NCT03496207|364913088|FG003|Base Study|Adverse Event|1|||
105796674|NCT03496207|364913089|FG004|Base Study|Adverse Event|4|||
105796675|NCT03496207|364913085|FG000|Base Study|Death|0|||
105796676|NCT03496207|364913086|FG001|Base Study|Death|0|||
105796677|NCT03496207|364913087|FG002|Base Study|Death|0|||
105796678|NCT03496207|364913088|FG003|Base Study|Death|0|||
105729872|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
105729873|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
105729874|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
105729875|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
105729876|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
105729877|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
105729878|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
105729879|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
105729880|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
105729881|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
105729882|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
105729883|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
105729884|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
105729885|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
105729886|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
105729887|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
105729888|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
105729889|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
105729890|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
105729891|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
105729892|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
105729893|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
105729894|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
105729895|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
105729896|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
105729897|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
105729898|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
105729899|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
105729900|NCT01073943|364665809|FG000|Overall Study|Withdrawal by Subject|8|||
105729901|NCT01073943|364665810|FG001|Overall Study|Withdrawal by Subject|2|||
105729902|NCT01073943|364665809|FG000|Overall Study|Protocol Violation|2|||
105729903|NCT01073943|364665810|FG001|Overall Study|Protocol Violation|1|||
105729904|NCT01073943|364665809|FG000|Overall Study|Adverse Event|1|||
105729905|NCT01073943|364665810|FG001|Overall Study|Adverse Event|1|||
105729906|NCT01073943|364665809|FG000|Overall Study|Lost to Follow-up|0|||
105729907|NCT01073943|364665810|FG001|Overall Study|Lost to Follow-up|2|||
105729908|NCT01073943|364665809|FG000|Overall Study|Power outage; colonoscopy not done|1|||
105729909|NCT01073943|364665810|FG001|Overall Study|Power outage; colonoscopy not done|0|||
105729910|NCT01073943|364665809|FG000|Overall Study|Subject forgot|0|||
105729911|NCT01073943|364665810|FG001|Overall Study|Subject forgot|1|||
105729912|NCT01073943|364665809|FG000|Overall Study|Unable to return for follow-up|0|||
105796679|NCT03496207|364913089|FG004|Base Study|Death|1|||
105796680|NCT03496207|364913085|FG000|Base Study|Withdrawal by Subject|0|||
105796681|NCT03496207|364913086|FG001|Base Study|Withdrawal by Subject|0|||
105729913|NCT01073943|364665810|FG001|Overall Study|Unable to return for follow-up|1|||
105729914|NCT01073943|364665809|FG000|Overall Study|Could not tolerate prep|1|||
105729915|NCT01073943|364665810|FG001|Overall Study|Could not tolerate prep|0|||
105729916|NCT01193335|364665812|FG000|After Infant Series|Lost to Follow-up|1|||
105796682|NCT03496207|364913087|FG002|Base Study|Withdrawal by Subject|1|||
105796683|NCT03496207|364913088|FG003|Base Study|Withdrawal by Subject|0|||
105796684|NCT03496207|364913089|FG004|Base Study|Withdrawal by Subject|1|||
105729917|NCT01193335|364665813|FG001|After Infant Series|Lost to Follow-up|2|||
105729918|NCT01193335|364665812|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
105729919|NCT01193335|364665813|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
105729920|NCT01193335|364665812|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
105729921|NCT01193335|364665813|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
105729922|NCT01193335|364665812|FG000|1-Year Follow-up|Lost to Follow-up|4|||
105729923|NCT01193335|364665813|FG001|1-Year Follow-up|Lost to Follow-up|0|||
105729924|NCT01193335|364665812|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
105729925|NCT01193335|364665813|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
105729926|NCT01193335|364665812|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
105729927|NCT01193335|364665813|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
105729928|NCT00730236|364665814|FG000|Overall Study|Adverse Event|4|||
105729929|NCT00730236|364665814|FG000|Overall Study|Withdrawal by Subject|1|||
105729930|NCT00730236|364665814|FG000|Overall Study|Non-compliance|1|||
105729931|NCT01772134|364665815|FG000|Overall Study|Adverse Event|6|||
105729932|NCT01772134|364665816|FG001|Overall Study|Adverse Event|5|||
105729933|NCT01772134|364665817|FG002|Overall Study|Adverse Event|10|||
105729934|NCT01772134|364665815|FG000|Overall Study|Withdrew Consent|3|||
105729935|NCT01772134|364665816|FG001|Overall Study|Withdrew Consent|1|||
105729936|NCT01772134|364665817|FG002|Overall Study|Withdrew Consent|5|||
105729937|NCT01772134|364665815|FG000|Overall Study|Lost to Follow-up|2|||
105729938|NCT01772134|364665816|FG001|Overall Study|Lost to Follow-up|0|||
105729939|NCT01772134|364665817|FG002|Overall Study|Lost to Follow-up|0|||
105729940|NCT01772134|364665815|FG000|Overall Study|Protocol Deviation|4|||
105729941|NCT01772134|364665816|FG001|Overall Study|Protocol Deviation|3|||
105729942|NCT01772134|364665817|FG002|Overall Study|Protocol Deviation|3|||
105729943|NCT01772134|364665815|FG000|Overall Study|Lack of Efficacy|11|||
105729944|NCT01772134|364665816|FG001|Overall Study|Lack of Efficacy|5|||
105729945|NCT01772134|364665817|FG002|Overall Study|Lack of Efficacy|3|||
105729946|NCT01772134|364665815|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
105729947|NCT01772134|364665816|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
105729948|NCT01772134|364665817|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
105729949|NCT01772134|364665815|FG000|Overall Study|Randomized Study Medication Not Received|2|||
105729950|NCT01772134|364665816|FG001|Overall Study|Randomized Study Medication Not Received|0|||
105729951|NCT01772134|364665817|FG002|Overall Study|Randomized Study Medication Not Received|1|||
105729952|NCT00594399|364665819|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
105729953|NCT00594399|364665820|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
105729954|NCT00594399|364665821|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
105729955|NCT00594399|364665819|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
105729956|NCT00594399|364665820|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
105729957|NCT00594399|364665821|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
105729958|NCT00594399|364665819|FG000|Initial 3 Month Counseling|Personal issues|2|||
105729959|NCT00594399|364665820|FG001|Initial 3 Month Counseling|Personal issues|0|||
105729960|NCT00594399|364665821|FG002|Initial 3 Month Counseling|Personal issues|0|||
105729961|NCT00594399|364665819|FG000|Initial 3 Month Counseling|Too busy|7|||
105729962|NCT00594399|364665820|FG001|Initial 3 Month Counseling|Too busy|1|||
105729963|NCT00594399|364665821|FG002|Initial 3 Month Counseling|Too busy|0|||
105729964|NCT00594399|364665819|FG000|Initial 3 Month Counseling|Pain|2|||
105729965|NCT00594399|364665820|FG001|Initial 3 Month Counseling|Pain|0|||
105729966|NCT00594399|364665821|FG002|Initial 3 Month Counseling|Pain|0|||
105729967|NCT00594399|364665819|FG000|Initial 3 Month Counseling|Moved|1|||
105729968|NCT00594399|364665820|FG001|Initial 3 Month Counseling|Moved|0|||
105729969|NCT00594399|364665821|FG002|Initial 3 Month Counseling|Moved|0|||
105729970|NCT00594399|364665819|FG000|Initial 3 Month Counseling|Family illness|1|||
105729971|NCT00594399|364665820|FG001|Initial 3 Month Counseling|Family illness|0|||
105729972|NCT00594399|364665821|FG002|Initial 3 Month Counseling|Family illness|0|||
105729973|NCT00594399|364665819|FG000|Rerandomization Arm 1 Only|Death|2|||
105729974|NCT00594399|364665820|FG001|Rerandomization Arm 1 Only|Death|1|||
105729975|NCT00594399|364665821|FG002|Rerandomization Arm 1 Only|Death|0|||
105729976|NCT00594399|364665819|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
105729977|NCT00594399|364665820|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
105729978|NCT00594399|364665821|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
105729979|NCT02388776|364665822|FG000|Overall Study|Death|1|||
105729980|NCT02388776|364665822|FG000|Overall Study|Lost to Follow-up|1|||
105729981|NCT03826914|364665823|FG000|Overall Study|Withdrawal by Subject|1|||
105729982|NCT03826914|364665824|FG001|Overall Study|Withdrawal by Subject|1|||
105729983|NCT02034123|364665831|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729984|NCT02034123|364665832|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729985|NCT02034123|364665833|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729986|NCT02034123|364665834|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729987|NCT02034123|364665835|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
105729988|NCT02034123|364665836|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729989|NCT02034123|364665837|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729990|NCT02034123|364665838|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
105796685|NCT03496207|364913085|FG000|Extension Period|Adverse Event|0|||
105796686|NCT03496207|364913086|FG001|Extension Period|Adverse Event|0|||
105796687|NCT03496207|364913087|FG002|Extension Period|Adverse Event|0|||
105796688|NCT03496207|364913088|FG003|Extension Period|Adverse Event|1|||
105796689|NCT03496207|364913089|FG004|Extension Period|Adverse Event|1|||
105796690|NCT03496207|364913085|FG000|Extension Period|Death|1|||
105796691|NCT03496207|364913086|FG001|Extension Period|Death|0|||
105796692|NCT03496207|364913087|FG002|Extension Period|Death|0|||
105729991|NCT02034123|364665839|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
105729992|NCT02034123|364665840|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729993|NCT02034123|364665841|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729994|NCT02034123|364665842|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729995|NCT02034123|364665843|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729996|NCT02034123|364665844|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729997|NCT02034123|364665845|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729998|NCT02034123|364665846|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729999|NCT02034123|364665847|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105730000|NCT02034123|364665848|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105730001|NCT02034123|364665831|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730002|NCT02034123|364665832|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730003|NCT02034123|364665833|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730004|NCT02034123|364665834|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
105730005|NCT02034123|364665835|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730006|NCT02034123|364665836|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730007|NCT02034123|364665837|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730008|NCT02034123|364665838|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730009|NCT02034123|364665839|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730010|NCT02034123|364665840|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730011|NCT02034123|364665841|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730012|NCT02034123|364665842|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730013|NCT02034123|364665843|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730014|NCT02034123|364665844|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730015|NCT02034123|364665845|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730016|NCT02034123|364665846|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730017|NCT02034123|364665847|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730018|NCT02034123|364665848|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730019|NCT02034123|364665831|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730020|NCT02034123|364665832|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730021|NCT02034123|364665833|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730022|NCT02034123|364665834|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730023|NCT02034123|364665835|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730024|NCT02034123|364665836|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730025|NCT02034123|364665837|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730026|NCT02034123|364665838|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730027|NCT02034123|364665839|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
105730028|NCT02034123|364665840|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730029|NCT02034123|364665841|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730030|NCT02034123|364665842|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730031|NCT02034123|364665843|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730032|NCT02034123|364665844|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730033|NCT02034123|364665845|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730034|NCT02034123|364665846|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730035|NCT02034123|364665847|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730036|NCT02034123|364665848|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730037|NCT02034123|364665831|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730038|NCT02034123|364665832|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730039|NCT02034123|364665833|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730040|NCT02034123|364665834|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
105730041|NCT02034123|364665835|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
105796693|NCT03496207|364913088|FG003|Extension Period|Death|1|||
105796694|NCT03496207|364913089|FG004|Extension Period|Death|2|||
105796695|NCT03496207|364913085|FG000|Extension Period|Withdrawal by Subject|1|||
105796696|NCT03496207|364913086|FG001|Extension Period|Withdrawal by Subject|0|||
105796697|NCT03496207|364913087|FG002|Extension Period|Withdrawal by Subject|0|||
105796698|NCT03496207|364913088|FG003|Extension Period|Withdrawal by Subject|1|||
105796699|NCT03496207|364913089|FG004|Extension Period|Withdrawal by Subject|1|||
105730042|NCT02034123|364665836|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730043|NCT02034123|364665837|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730044|NCT02034123|364665838|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730045|NCT02034123|364665839|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730046|NCT02034123|364665840|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730047|NCT02034123|364665841|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730048|NCT02034123|364665842|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730049|NCT02034123|364665843|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730050|NCT02034123|364665844|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730051|NCT02034123|364665845|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730052|NCT02034123|364665846|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730053|NCT02034123|364665847|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730054|NCT02034123|364665848|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730055|NCT02240706|364665849|FG000|Overall Study|Lack of Efficacy|2|||
105730056|NCT02240706|364665850|FG001|Overall Study|Lack of Efficacy|2|||
105730057|NCT02240706|364665851|FG002|Overall Study|Lack of Efficacy|2|||
105730058|NCT02240706|364665852|FG003|Overall Study|Lack of Efficacy|2|||
105730059|NCT02240706|364665853|FG004|Overall Study|Lack of Efficacy|5|||
105730060|NCT02240706|364665854|FG005|Overall Study|Lack of Efficacy|0|||
105730061|NCT02240706|364665855|FG006|Overall Study|Lack of Efficacy|0|||
105730062|NCT02240706|364665849|FG000|Overall Study|Adverse Event|1|||
105730063|NCT02240706|364665850|FG001|Overall Study|Adverse Event|0|||
105730064|NCT02240706|364665851|FG002|Overall Study|Adverse Event|1|||
105730065|NCT02240706|364665852|FG003|Overall Study|Adverse Event|0|||
105730066|NCT02240706|364665853|FG004|Overall Study|Adverse Event|2|||
105730067|NCT02240706|364665854|FG005|Overall Study|Adverse Event|0|||
105730068|NCT02240706|364665855|FG006|Overall Study|Adverse Event|0|||
105730069|NCT02240706|364665849|FG000|Overall Study|Progressive disease|0|||
105730070|NCT02240706|364665850|FG001|Overall Study|Progressive disease|0|||
105730071|NCT02240706|364665851|FG002|Overall Study|Progressive disease|0|||
105730072|NCT02240706|364665852|FG003|Overall Study|Progressive disease|0|||
105730073|NCT02240706|364665853|FG004|Overall Study|Progressive disease|1|||
105730074|NCT02240706|364665854|FG005|Overall Study|Progressive disease|0|||
105730075|NCT02240706|364665855|FG006|Overall Study|Progressive disease|0|||
105730076|NCT02240706|364665849|FG000|Overall Study|Dose limiting toxicity|0|||
105730077|NCT02240706|364665850|FG001|Overall Study|Dose limiting toxicity|0|||
105730078|NCT02240706|364665851|FG002|Overall Study|Dose limiting toxicity|0|||
105730079|NCT02240706|364665852|FG003|Overall Study|Dose limiting toxicity|0|||
105730080|NCT02240706|364665853|FG004|Overall Study|Dose limiting toxicity|1|||
105730081|NCT02240706|364665854|FG005|Overall Study|Dose limiting toxicity|0|||
105730082|NCT02240706|364665855|FG006|Overall Study|Dose limiting toxicity|0|||
105730083|NCT02240706|364665849|FG000|Overall Study|Refused to continue taking medication|0|||
105730084|NCT02240706|364665850|FG001|Overall Study|Refused to continue taking medication|1|||
105730085|NCT02240706|364665851|FG002|Overall Study|Refused to continue taking medication|3|||
105730086|NCT02240706|364665852|FG003|Overall Study|Refused to continue taking medication|1|||
105730087|NCT02240706|364665853|FG004|Overall Study|Refused to continue taking medication|2|||
105730088|NCT02240706|364665854|FG005|Overall Study|Refused to continue taking medication|0|||
105730089|NCT02240706|364665855|FG006|Overall Study|Refused to continue taking medication|0|||
105730090|NCT02240706|364665849|FG000|Overall Study|Insurance billing concerns|0|||
105730091|NCT02240706|364665850|FG001|Overall Study|Insurance billing concerns|0|||
105730092|NCT02240706|364665851|FG002|Overall Study|Insurance billing concerns|0|||
105730093|NCT02240706|364665852|FG003|Overall Study|Insurance billing concerns|1|||
105730094|NCT02240706|364665853|FG004|Overall Study|Insurance billing concerns|0|||
105730095|NCT02240706|364665854|FG005|Overall Study|Insurance billing concerns|0|||
105730096|NCT02240706|364665855|FG006|Overall Study|Insurance billing concerns|0|||
105730097|NCT05300087|364665860|FG000|Overall Study|Withdrawal by Subject|0|||
105730098|NCT05300087|364665861|FG001|Overall Study|Withdrawal by Subject|1|||
105730099|NCT04488822|364665862|FG000|Overall Study|Adverse Event|8|||
105730100|NCT04488822|364665862|FG000|Overall Study|Withdrawal by Subject|1|||
105730101|NCT01662999|364665863|FG000|Period 3|Withdrawal by Subject|0|||
105730102|NCT01662999|364665864|FG001|Period 3|Withdrawal by Subject|1|||
105730103|NCT01662999|364665865|FG002|Period 3|Withdrawal by Subject|0|||
105730104|NCT01662999|364665866|FG003|Period 3|Withdrawal by Subject|0|||
105730105|NCT01662999|364665867|FG004|Period 3|Withdrawal by Subject|0|||
105730106|NCT01662999|364665868|FG005|Period 3|Withdrawal by Subject|0|||
105730107|NCT02932267|364665874|FG000|Overall Study|Withdrawal by Subject|3|||
105730108|NCT02932267|364665874|FG000|Overall Study|Lost to Follow-up|4|||
105730109|NCT02932267|364665874|FG000|Overall Study|Pregnancy|1|||
105730110|NCT04725682|364665881|FG000|Overall Study|Withdrawal by Subject|7|||
105730111|NCT04725682|364665882|FG001|Overall Study|Withdrawal by Subject|5|||
105730112|NCT04725682|364665881|FG000|Overall Study|Failed to comply with the requirements|2|||
105730113|NCT04725682|364665882|FG001|Overall Study|Failed to comply with the requirements|1|||
105730114|NCT04725682|364665881|FG000|Overall Study|Adverse Event|1|||
105730115|NCT04725682|364665882|FG001|Overall Study|Adverse Event|1|||
105730116|NCT04725682|364665881|FG000|Overall Study|Death|0|||
105730117|NCT04725682|364665882|FG001|Overall Study|Death|1|||
105730118|NCT03598777|364665885|FG000|Overall Study|Study Terminated by Sponsor|3|||
105730119|NCT03598777|364665886|FG001|Overall Study|Study Terminated by Sponsor|0|||
105730120|NCT03598777|364665887|FG002|Overall Study|Study Terminated by Sponsor|0|||
105730121|NCT03598777|364665888|FG003|Overall Study|Study Terminated by Sponsor|0|||
105730122|NCT03598777|364665889|FG004|Overall Study|Study Terminated by Sponsor|15|||
105730123|NCT03598777|364665885|FG000|Overall Study|Withdrawal by Subject|1|||
105730124|NCT03598777|364665886|FG001|Overall Study|Withdrawal by Subject|1|||
105730125|NCT03598777|364665887|FG002|Overall Study|Withdrawal by Subject|0|||
105730126|NCT03598777|364665888|FG003|Overall Study|Withdrawal by Subject|0|||
105730127|NCT03598777|364665889|FG004|Overall Study|Withdrawal by Subject|0|||
105730128|NCT03598777|364665885|FG000|Overall Study|Adverse Event|1|||
105730129|NCT03598777|364665886|FG001|Overall Study|Adverse Event|0|||
105730130|NCT03598777|364665887|FG002|Overall Study|Adverse Event|0|||
105730131|NCT03598777|364665888|FG003|Overall Study|Adverse Event|0|||
105730132|NCT03598777|364665889|FG004|Overall Study|Adverse Event|0|||
105730133|NCT03598777|364665885|FG000|Overall Study|Lost to Follow-up|1|||
105730134|NCT03598777|364665886|FG001|Overall Study|Lost to Follow-up|0|||
105730135|NCT03598777|364665887|FG002|Overall Study|Lost to Follow-up|0|||
105730136|NCT03598777|364665888|FG003|Overall Study|Lost to Follow-up|0|||
105730137|NCT03598777|364665889|FG004|Overall Study|Lost to Follow-up|0|||
105730138|NCT04090164|364665890|FG000|Overall Study|incomplete data on file|245|||
105730139|NCT04090164|364665891|FG001|Overall Study|incomplete data on file|0|||
105730140|NCT01650805|364665892|FG000|Overall Study|Withdrawal by Subject|1|||
105730141|NCT01650805|364665893|FG001|Overall Study|Withdrawal by Subject|0|||
105730142|NCT01877655|364665896|FG000|Overall Study|Death|57|||
105730143|NCT01877655|364665897|FG001|Overall Study|Death|52|||
105730144|NCT01877655|364665896|FG000|Overall Study|Withdrawal by Subject|18|||
105730145|NCT01877655|364665897|FG001|Overall Study|Withdrawal by Subject|26|||
105730146|NCT01877655|364665896|FG000|Overall Study|Physician Decision|11|||
105730147|NCT01877655|364665897|FG001|Overall Study|Physician Decision|10|||
105730148|NCT01877655|364665896|FG000|Overall Study|Miscellaneous|4|||
105730149|NCT01877655|364665897|FG001|Overall Study|Miscellaneous|4|||
105730150|NCT01877655|364665896|FG000|Overall Study|Randomized but Never Received Drug|8|||
105730151|NCT01877655|364665897|FG001|Overall Study|Randomized but Never Received Drug|5|||
105730152|NCT01901328|364665898|FG000|Overall Study|Lost to Follow-up|1|||
105730153|NCT01901328|364665899|FG001|Overall Study|Lost to Follow-up|0|||
105730154|NCT01901328|364665898|FG000|Overall Study|Physician Decision|0|||
105730155|NCT01901328|364665899|FG001|Overall Study|Physician Decision|1|||
105730156|NCT01901328|364665898|FG000|Overall Study|Protocol Violation|1|||
105730157|NCT01901328|364665899|FG001|Overall Study|Protocol Violation|1|||
105730158|NCT01901328|364665898|FG000|Overall Study|Study Terminated by Sponsor|19|||
105730159|NCT01901328|364665899|FG001|Overall Study|Study Terminated by Sponsor|16|||
105730160|NCT01901328|364665898|FG000|Overall Study|Withdrawal by Subject|1|||
105730161|NCT01901328|364665899|FG001|Overall Study|Withdrawal by Subject|2|||
105730162|NCT01901328|364665898|FG000|Overall Study|Lack of Efficacy|0|||
105730163|NCT01901328|364665899|FG001|Overall Study|Lack of Efficacy|1|||
105730164|NCT03232073|364665903|FG000|Overall Study|Death|1|||
105730165|NCT03232073|364665904|FG001|Overall Study|Death|0|||
105730166|NCT03232073|364665903|FG000|Overall Study|Adverse Event|7|||
105730167|NCT03232073|364665904|FG001|Overall Study|Adverse Event|12|||
105730168|NCT03232073|364665903|FG000|Overall Study|Lost to Follow-up|6|||
105730169|NCT03232073|364665904|FG001|Overall Study|Lost to Follow-up|6|||
105730170|NCT03232073|364665903|FG000|Overall Study|Lack of Efficacy|10|||
105730171|NCT03232073|364665904|FG001|Overall Study|Lack of Efficacy|8|||
105730172|NCT03232073|364665903|FG000|Overall Study|Physician Decision|9|||
105730173|NCT03232073|364665904|FG001|Overall Study|Physician Decision|2|||
105730174|NCT03232073|364665903|FG000|Overall Study|Withdrawal by Subject|54|||
105730175|NCT03232073|364665904|FG001|Overall Study|Withdrawal by Subject|39|||
105730176|NCT03439345|364667563|FG000|Overall Study|Lost to Follow-up|0|||
105730177|NCT03439345|364667564|FG001|Overall Study|Lost to Follow-up|1|||
105730178|NCT03439345|364667563|FG000|Overall Study|Consent withdrawn|0|||
105730179|NCT03439345|364667564|FG001|Overall Study|Consent withdrawn|1|||
105730180|NCT02143414|364667565|FG000|Induction|Adverse Event|1|||
105730181|NCT02143414|364667566|FG001|Induction|Adverse Event|2|||
105730182|NCT02143414|364667565|FG000|Induction|Death|1|||
105730183|NCT02143414|364667566|FG001|Induction|Death|2|||
105730184|NCT02143414|364667565|FG000|Induction|Patient refusal|1|||
105730185|NCT02143414|364667566|FG001|Induction|Patient refusal|1|||
105730186|NCT02143414|364667565|FG000|Induction|Refractory|1|||
105730187|NCT02143414|364667566|FG001|Induction|Refractory|0|||
105730188|NCT02143414|364667565|FG000|Induction|Began alternative treatment|1|||
105730189|NCT02143414|364667566|FG001|Induction|Began alternative treatment|0|||
105730190|NCT02143414|364667565|FG000|Induction|Ineligible for postremission|5|||
105796700|NCT03496207|364913085|FG000|Extension Period|Elevated hemoglobin levels|0|||
105796701|NCT03496207|364913086|FG001|Extension Period|Elevated hemoglobin levels|0|||
105796702|NCT03496207|364913087|FG002|Extension Period|Elevated hemoglobin levels|0|||
105796703|NCT03496207|364913088|FG003|Extension Period|Elevated hemoglobin levels|0|||
105796704|NCT03496207|364913089|FG004|Extension Period|Elevated hemoglobin levels|1|||
105796705|NCT01169987|364913090|FG000|Overall Study|Withdrawal by Subject|3|||
105796706|NCT01169987|364913090|FG000|Overall Study|Lost to Follow-up|24|||
105796707|NCT01169987|364913090|FG000|Overall Study|Other|4|||
105796708|NCT01556490|364913099|FG000|Randomized Patients Summary|Protocol Violation|22|||
105796709|NCT01556490|364913100|FG001|Randomized Patients Summary|Protocol Violation|23|||
105796710|NCT01556490|364913099|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
105796711|NCT01556490|364913100|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
105796712|NCT02441179|364913102|FG000|Overall Study|Withdrawal by Subject|1|||
105796713|NCT02441179|364913103|FG001|Overall Study|Withdrawal by Subject|1|||
105796714|NCT03091400|364913104|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
105796715|NCT03091400|364913105|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
105796716|NCT00479765|364913108|FG000|Overall Study|study terminated|4|||
105796717|NCT03056001|364913109|FG000|Overall Study|Death|24|||
105796718|NCT04816877|364913112|FG000|Overall Study|Withdrawal by Subject|1|||
105796719|NCT04816877|364913113|FG001|Overall Study|Withdrawal by Subject|0|||
105796720|NCT00828516|364913114|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
105796721|NCT00378482|364913117|FG000|Overall Study|Lost to Follow-up|1|||
105796722|NCT00378482|364913117|FG000|Overall Study|Lack of Efficacy|8|||
105796723|NCT00378482|364913117|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
105796724|NCT00378482|364913117|FG000|Overall Study|Withdrawal by Subject|4|||
105796725|NCT00378482|364913117|FG000|Overall Study|Adverse Event|9|||
105796726|NCT05166421|364913120|FG000|Overall Study|Other|3|||
105796727|NCT05166421|364913121|FG001|Overall Study|Other|1|||
105796728|NCT05166421|364913122|FG002|Overall Study|Other|1|||
105796729|NCT05166421|364913120|FG000|Overall Study|Withdrawal by Subject|5|||
105796730|NCT05166421|364913121|FG001|Overall Study|Withdrawal by Subject|3|||
105796731|NCT05166421|364913122|FG002|Overall Study|Withdrawal by Subject|6|||
105796732|NCT05166421|364913120|FG000|Overall Study|Lost to Follow-up|4|||
105796733|NCT05166421|364913121|FG001|Overall Study|Lost to Follow-up|1|||
105796734|NCT05166421|364913122|FG002|Overall Study|Lost to Follow-up|7|||
105796735|NCT00080288|364914537|FG000|Overall Study|Adverse Event|7|||
105796736|NCT00080288|364914538|FG001|Overall Study|Adverse Event|4|||
105796737|NCT00080288|364914537|FG000|Overall Study|Lost to Follow-up|3|||
105796738|NCT00080288|364914538|FG001|Overall Study|Lost to Follow-up|5|||
105796739|NCT00080288|364914537|FG000|Overall Study|Physician Decision|6|||
105796740|NCT00080288|364914538|FG001|Overall Study|Physician Decision|2|||
105796741|NCT00080288|364914537|FG000|Overall Study|Withdrawal by Subject|3|||
105796742|NCT00080288|364914538|FG001|Overall Study|Withdrawal by Subject|16|||
105796743|NCT00080288|364914537|FG000|Overall Study|Miscellaneous|11|||
105796744|NCT00080288|364914538|FG001|Overall Study|Miscellaneous|11|||
105796745|NCT01614925|364914539|FG000|Overall Study|Withdrawal by Subject|1|||
105796746|NCT01614925|364914540|FG001|Overall Study|Withdrawal by Subject|0|||
105796747|NCT01614925|364914539|FG000|Overall Study|Protocol Violation|3|||
105796748|NCT01614925|364914540|FG001|Overall Study|Protocol Violation|2|||
105796749|NCT03349437|364914541|FG000|Screening|Screen Fail|4|||
105796750|NCT03349437|364914542|FG001|Screening|Screen Fail|0|||
105796751|NCT03349437|364914543|FG002|Screening|Screen Fail|0|||
105796752|NCT03349437|364914541|FG000|Screening|Withdrawn|1|||
105796753|NCT03349437|364914542|FG001|Screening|Withdrawn|0|||
105796754|NCT03349437|364914543|FG002|Screening|Withdrawn|0|||
105796755|NCT03591107|364914544|FG000|Overall Study|Same patient in both arms|1|||
105796756|NCT03591107|364914545|FG001|Overall Study|Same patient in both arms|1|||
105796757|NCT03591107|364914544|FG000|Overall Study|Sought care at other clinics|0|||
105564972|NCT02220894|364065368|FG001|Overall Study|Site Terminated by Sponsor|0|||
105564973|NCT02220894|364065367|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
105564974|NCT02220894|364065368|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
105730191|NCT02143414|364667566|FG001|Induction|Ineligible for postremission|1|||
105730192|NCT02143414|364667565|FG000|Post-remission|Adverse Event|0|||
105730193|NCT02143414|364667566|FG001|Post-remission|Adverse Event|2|||
105730194|NCT02143414|364667565|FG000|Post-remission|Disease progression/relapse|5|||
105730195|NCT02143414|364667566|FG001|Post-remission|Disease progression/relapse|0|||
105730196|NCT02143414|364667565|FG000|Maintenance|Adverse Event|4|||
105730197|NCT02143414|364667566|FG001|Maintenance|Adverse Event|6|||
105730198|NCT02143414|364667565|FG000|Maintenance|Disease progression/relapse|3|||
105730199|NCT02143414|364667566|FG001|Maintenance|Disease progression/relapse|2|||
105730200|NCT02143414|364667565|FG000|Maintenance|Patient refusal|2|||
105730201|NCT02143414|364667566|FG001|Maintenance|Patient refusal|1|||
105796758|NCT03591107|364914545|FG001|Overall Study|Sought care at other clinics|2|||
105796759|NCT03591107|364914544|FG000|Overall Study|Discharged from clinic|0|||
105796760|NCT03591107|364914545|FG001|Overall Study|Discharged from clinic|1|||
105730202|NCT02143414|364667565|FG000|Maintenance|Physician Decision|1|||
105796761|NCT03591107|364914544|FG000|Overall Study|Withdrawal by Subject|0|||
105796762|NCT03591107|364914545|FG001|Overall Study|Withdrawal by Subject|1|||
105796763|NCT02766088|364914548|FG000|Overall Study|Sponsor study termination|498|||
105796764|NCT02766088|364914548|FG000|Overall Study|Migrated/moved from the study area|1|||
105796765|NCT02766088|364914548|FG000|Overall Study|Lost to Follow-up|5|||
105796766|NCT02766088|364914548|FG000|Overall Study|Other|1|||
105796767|NCT02766088|364914548|FG000|Overall Study|Death|1|||
105796768|NCT01537549|364914549|FG000|Overall Study|Lost to Follow-up|1|||
105796769|NCT01537549|364914549|FG000|Overall Study|Withdrawal by Subject|2|||
105796770|NCT04388527|364914551|FG000|Overall Study|Death|14|||
105796771|NCT04388527|364914551|FG000|Overall Study|Withdrawal by Subject|2|||
105796772|NCT04388527|364914551|FG000|Overall Study|Lost to Follow-up|1|||
105796773|NCT00520494|364914554|FG000|Overall Study|Withdrawal by Subject|1|||
105796774|NCT03471182|364914555|FG000|Overall Study|Withdrawal by Subject|1|||
105796775|NCT03471182|364914556|FG001|Overall Study|Withdrawal by Subject|1|||
105796776|NCT03471182|364914557|FG002|Overall Study|Withdrawal by Subject|0|||
105796777|NCT03471182|364914555|FG000|Overall Study|Technical failure|2|||
105796778|NCT03471182|364914556|FG001|Overall Study|Technical failure|0|||
105796779|NCT03471182|364914557|FG002|Overall Study|Technical failure|0|||
105796780|NCT02773446|364914562|FG000|First Admission|Withdrawal by Subject|0|||
105796781|NCT02773446|364914563|FG001|First Admission|Withdrawal by Subject|0|||
105796782|NCT02773446|364914564|FG002|First Admission|Withdrawal by Subject|0|||
105796783|NCT02773446|364914565|FG003|First Admission|Withdrawal by Subject|1|||
105796784|NCT02773446|364914566|FG004|First Admission|Withdrawal by Subject|0|||
105796785|NCT02773446|364914567|FG005|First Admission|Withdrawal by Subject|0|||
105796786|NCT02773446|364914562|FG000|First Admission|Lost to Follow-up|1|||
105796787|NCT02773446|364914563|FG001|First Admission|Lost to Follow-up|0|||
105796788|NCT02773446|364914564|FG002|First Admission|Lost to Follow-up|0|||
105796789|NCT02773446|364914565|FG003|First Admission|Lost to Follow-up|0|||
105796790|NCT02773446|364914566|FG004|First Admission|Lost to Follow-up|0|||
105796791|NCT02773446|364914567|FG005|First Admission|Lost to Follow-up|0|||
105796792|NCT01682512|364914568|FG000|Overall Study|Adverse Event|6|||
105796793|NCT01682512|364914569|FG001|Overall Study|Adverse Event|5|||
105796794|NCT01682512|364914570|FG002|Overall Study|Adverse Event|2|||
105796795|NCT01682512|364914568|FG000|Overall Study|Withdrawal by Subject|2|||
105796796|NCT01682512|364914569|FG001|Overall Study|Withdrawal by Subject|6|||
105796797|NCT01682512|364914570|FG002|Overall Study|Withdrawal by Subject|3|||
105796798|NCT01682512|364914568|FG000|Overall Study|Physician Decision|0|||
105796799|NCT01682512|364914569|FG001|Overall Study|Physician Decision|2|||
105796800|NCT01682512|364914570|FG002|Overall Study|Physician Decision|0|||
105796801|NCT01682512|364914568|FG000|Overall Study|Study terminated by sponsor|46|||
105796802|NCT01682512|364914569|FG001|Overall Study|Study terminated by sponsor|43|||
105796803|NCT01682512|364914570|FG002|Overall Study|Study terminated by sponsor|0|||
105796804|NCT01682512|364914568|FG000|Overall Study|Lost to Follow-up|3|||
105796805|NCT01682512|364914569|FG001|Overall Study|Lost to Follow-up|0|||
105796806|NCT01682512|364914570|FG002|Overall Study|Lost to Follow-up|2|||
105796807|NCT01682512|364914568|FG000|Overall Study|Protocol Violation|2|||
105796808|NCT01682512|364914569|FG001|Overall Study|Protocol Violation|3|||
105796809|NCT01682512|364914570|FG002|Overall Study|Protocol Violation|2|||
105796810|NCT01682512|364914568|FG000|Overall Study|Primary lack of efficacy|10|||
105796811|NCT01682512|364914569|FG001|Overall Study|Primary lack of efficacy|7|||
105796812|NCT01682512|364914570|FG002|Overall Study|Primary lack of efficacy|7|||
105796813|NCT01682512|364914568|FG000|Overall Study|Secondary lack of efficacy|1|||
105796814|NCT01682512|364914569|FG001|Overall Study|Secondary lack of efficacy|1|||
105796815|NCT01682512|364914570|FG002|Overall Study|Secondary lack of efficacy|0|||
105796816|NCT01682512|364914568|FG000|Overall Study|Other than stated above|2|||
105796817|NCT01682512|364914569|FG001|Overall Study|Other than stated above|4|||
105796818|NCT01682512|364914570|FG002|Overall Study|Other than stated above|2|||
105796819|NCT01333475|364914571|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
105796820|NCT01333475|364914572|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
105796821|NCT01333475|364914571|FG000|Overall Study|Toxicity|1|||
105796822|NCT01333475|364914572|FG001|Overall Study|Toxicity|3|||
105796823|NCT01466673|364914573|FG000|Overall Study|Non-compliance with study treatment|2|||
105796824|NCT01466673|364914574|FG001|Overall Study|Non-compliance with study treatment|0|||
105796825|NCT01466673|364914573|FG000|Overall Study|Lost to Follow-up|3|||
105796826|NCT01466673|364914574|FG001|Overall Study|Lost to Follow-up|5|||
105796827|NCT01466673|364914573|FG000|Overall Study|Adverse Event|2|||
105796828|NCT01466673|364914574|FG001|Overall Study|Adverse Event|1|||
105796829|NCT00854607|364914575|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
105796830|NCT00965263|364914576|FG000|Overall Study|Physician Decision|2|||
105796831|NCT00965263|364914577|FG001|Overall Study|Physician Decision|0|||
105564975|NCT02220894|364065367|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105796832|NCT00965263|364914576|FG000|Overall Study|Family emergency|0|||
105796833|NCT00965263|364914577|FG001|Overall Study|Family emergency|1|||
105796834|NCT00965263|364914576|FG000|Overall Study|Protocol Violation|0|||
105796835|NCT00965263|364914577|FG001|Overall Study|Protocol Violation|2|||
105796836|NCT04476017|364914578|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
105796837|NCT04476017|364914579|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
105730203|NCT02143414|364667566|FG001|Maintenance|Physician Decision|0|||
105730204|NCT02143414|364667565|FG000|Maintenance|Death|0|||
105730205|NCT02143414|364667566|FG001|Maintenance|Death|1|||
105730206|NCT02143414|364667565|FG000|Maintenance|On protocol treatment|0|||
105730207|NCT02143414|364667566|FG001|Maintenance|On protocol treatment|6|||
105730208|NCT03528681|364667570|FG000|Open-Label Phase|Physician Decision|2|||
105730209|NCT03528681|364667571|FG001|Open-Label Phase|Physician Decision|0|||
105730210|NCT03528681|364667572|FG002|Open-Label Phase|Physician Decision|0|||
105730211|NCT03528681|364667573|FG003|Open-Label Phase|Physician Decision|0|||
105730212|NCT03528681|364667570|FG000|Open-Label Phase|Withdrawal by Subject|8|||
105730213|NCT03528681|364667571|FG001|Open-Label Phase|Withdrawal by Subject|0|||
105730214|NCT03528681|364667572|FG002|Open-Label Phase|Withdrawal by Subject|0|||
105730215|NCT03528681|364667573|FG003|Open-Label Phase|Withdrawal by Subject|0|||
105730216|NCT03528681|364667570|FG000|Open-Label Phase|(Not collected)|4|||
105730217|NCT03528681|364667571|FG001|Open-Label Phase|(Not collected)|0|||
105730218|NCT03528681|364667572|FG002|Open-Label Phase|(Not collected)|0|||
105730219|NCT03528681|364667573|FG003|Open-Label Phase|(Not collected)|0|||
105730220|NCT03528681|364667570|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
105730221|NCT03528681|364667571|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
105730222|NCT03528681|364667572|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
105730223|NCT03528681|364667573|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
105730224|NCT03528681|364667570|FG000|Randomized Treatment Phase|Physician Decision|0|||
105730225|NCT03528681|364667571|FG001|Randomized Treatment Phase|Physician Decision|5|||
105730226|NCT03528681|364667572|FG002|Randomized Treatment Phase|Physician Decision|1|||
105730227|NCT03528681|364667573|FG003|Randomized Treatment Phase|Physician Decision|2|||
105730228|NCT03528681|364667570|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
105730229|NCT03528681|364667571|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
105730230|NCT03528681|364667572|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
105730231|NCT03528681|364667573|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
105730232|NCT03528681|364667570|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
105730233|NCT03528681|364667571|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
105730234|NCT03528681|364667572|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
105730235|NCT03528681|364667573|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
105730236|NCT03528681|364667570|FG000|Randomized Treatment Phase|(Not collected)|0|||
105730237|NCT03528681|364667571|FG001|Randomized Treatment Phase|(Not collected)|4|||
105730238|NCT03528681|364667572|FG002|Randomized Treatment Phase|(Not collected)|6|||
105730239|NCT03528681|364667573|FG003|Randomized Treatment Phase|(Not collected)|5|||
105730240|NCT02243176|364667574|FG000|Overall Study|Other reason|1|||
105730241|NCT02243176|364667575|FG001|Overall Study|Other reason|2|||
105730242|NCT02243176|364667574|FG000|Overall Study|protocol specified withdrawal critera|1|||
105730243|NCT02243176|364667575|FG001|Overall Study|protocol specified withdrawal critera|3|||
105730244|NCT02243176|364667574|FG000|Overall Study|Protocol Violation|2|||
105730245|NCT02243176|364667575|FG001|Overall Study|Protocol Violation|1|||
105730246|NCT02243176|364667574|FG000|Overall Study|Withdrawal by Subject|8|||
105730247|NCT02243176|364667575|FG001|Overall Study|Withdrawal by Subject|7|||
105730248|NCT02243176|364667574|FG000|Overall Study|Adverse Event|2|||
105730249|NCT02243176|364667575|FG001|Overall Study|Adverse Event|2|||
105730250|NCT01056107|364667576|FG000|Overall Study|Withdrawal by Subject|0|||
105730251|NCT01056107|364667577|FG001|Overall Study|Withdrawal by Subject|1|||
105730252|NCT01056107|364667578|FG002|Overall Study|Withdrawal by Subject|3|||
105730253|NCT01056107|364667579|FG003|Overall Study|Withdrawal by Subject|0|||
105730254|NCT03404960|364667580|FG000|Overall Study|Adverse Event|0|||
105730255|NCT03404960|364667581|FG001|Overall Study|Adverse Event|2|||
105730256|NCT03404960|364667580|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
105730257|NCT03404960|364667581|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
105730258|NCT03404960|364667580|FG000|Overall Study|Bowel obstruction|0|||
105730259|NCT03404960|364667581|FG001|Overall Study|Bowel obstruction|1|||
105730260|NCT03404960|364667580|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
105730261|NCT03404960|364667581|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
105730262|NCT02629393|364667582|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
105730263|NCT02629393|364667582|FG000|Overall Study|Physician Decision|1|||
105730264|NCT00374556|364667585|FG000|Overall Study|Lost to Follow-up|1|||
105730265|NCT00374556|364667586|FG001|Overall Study|Lost to Follow-up|0|||
105730266|NCT00374556|364667585|FG000|Overall Study|Removed at baseline due to medical cond|0|||
105730267|NCT00374556|364667586|FG001|Overall Study|Removed at baseline due to medical cond|1|||
105730268|NCT03716726|364667587|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
105730269|NCT03716726|364667588|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
105730270|NCT03716726|364667587|FG000|12 Months Followup|Lost to Follow-up|10|||
105730271|NCT03716726|364667588|FG001|12 Months Followup|Lost to Follow-up|17|||
105730272|NCT01756157|364667591|FG000|First Intervention Period|Withdrawal by Subject|1|||
105730273|NCT01756157|364667592|FG001|First Intervention Period|Withdrawal by Subject|0|||
105730274|NCT01756157|364667591|FG000|First Intervention Period|Lost to Follow-up|0|||
105730275|NCT01756157|364667592|FG001|First Intervention Period|Lost to Follow-up|2|||
105730276|NCT04430348|364667593|FG000|Overall Study|Death|3|||
105730277|NCT04430348|364667594|FG001|Overall Study|Death|2|||
105730278|NCT04430348|364667595|FG002|Overall Study|Death|2|||
105730279|NCT04430348|364667596|FG003|Overall Study|Death|2|||
105730280|NCT04430348|364667597|FG004|Overall Study|Death|2|||
105730281|NCT04430348|364667598|FG005|Overall Study|Death|3|||
105730282|NCT04430348|364667593|FG000|Overall Study|Lost to Follow-up|0|||
105730283|NCT04430348|364667594|FG001|Overall Study|Lost to Follow-up|0|||
105730284|NCT04430348|364667595|FG002|Overall Study|Lost to Follow-up|0|||
105730285|NCT04430348|364667596|FG003|Overall Study|Lost to Follow-up|1|||
105730286|NCT04430348|364667597|FG004|Overall Study|Lost to Follow-up|0|||
105730287|NCT04430348|364667598|FG005|Overall Study|Lost to Follow-up|0|||
105730288|NCT04430348|364667593|FG000|Overall Study|Adverse Event|0|||
105730289|NCT04430348|364667594|FG001|Overall Study|Adverse Event|0|||
105730290|NCT04430348|364667595|FG002|Overall Study|Adverse Event|0|||
105730291|NCT04430348|364667596|FG003|Overall Study|Adverse Event|0|||
105730292|NCT04430348|364667597|FG004|Overall Study|Adverse Event|0|||
105730293|NCT04430348|364667598|FG005|Overall Study|Adverse Event|1|||
105730294|NCT04430348|364667593|FG000|Overall Study|Withdrawal by Subject|0|||
105730295|NCT04430348|364667594|FG001|Overall Study|Withdrawal by Subject|1|||
105730296|NCT04430348|364667595|FG002|Overall Study|Withdrawal by Subject|0|||
105730297|NCT04430348|364667596|FG003|Overall Study|Withdrawal by Subject|0|||
105730298|NCT04430348|364667597|FG004|Overall Study|Withdrawal by Subject|0|||
105730299|NCT04430348|364667598|FG005|Overall Study|Withdrawal by Subject|1|||
105730300|NCT04430348|364667593|FG000|Overall Study|Study Terminated by Sponsor|0|||
105730301|NCT04430348|364667594|FG001|Overall Study|Study Terminated by Sponsor|0|||
105730302|NCT04430348|364667595|FG002|Overall Study|Study Terminated by Sponsor|2|||
105730303|NCT04430348|364667596|FG003|Overall Study|Study Terminated by Sponsor|0|||
105730304|NCT04430348|364667597|FG004|Overall Study|Study Terminated by Sponsor|1|||
105730305|NCT04430348|364667598|FG005|Overall Study|Study Terminated by Sponsor|1|||
105730306|NCT04331899|364667608|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
105730307|NCT04331899|364667609|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
105730308|NCT00719810|364667612|FG000|Overall Study|Adverse Event|0|||
105730309|NCT00719810|364667613|FG001|Overall Study|Adverse Event|2|||
105730310|NCT00719810|364667614|FG002|Overall Study|Adverse Event|3|||
105730311|NCT00719810|364667612|FG000|Overall Study|Lost to Follow-up|2|||
105730312|NCT00719810|364667613|FG001|Overall Study|Lost to Follow-up|0|||
105730313|NCT00719810|364667614|FG002|Overall Study|Lost to Follow-up|3|||
105730314|NCT00719810|364667612|FG000|Overall Study|Physician Decision|0|||
105730315|NCT00719810|364667613|FG001|Overall Study|Physician Decision|1|||
105730316|NCT00719810|364667614|FG002|Overall Study|Physician Decision|0|||
105730317|NCT00719810|364667612|FG000|Overall Study|Withdrawal by Subject|1|||
105730318|NCT00719810|364667613|FG001|Overall Study|Withdrawal by Subject|1|||
105730319|NCT00719810|364667614|FG002|Overall Study|Withdrawal by Subject|2|||
105730320|NCT02024464|364667617|FG000|Overall Study|Discontinued|5|||
105730321|NCT02024464|364667618|FG001|Overall Study|Discontinued|4|||
105730322|NCT02024464|364667617|FG000|Overall Study|Missed Visits|1|||
105730323|NCT02024464|364667618|FG001|Overall Study|Missed Visits|0|||
105730324|NCT02024464|364667617|FG000|Overall Study|Lost to Follow-up|4|||
105730325|NCT02024464|364667618|FG001|Overall Study|Lost to Follow-up|7|||
105730326|NCT03976401|364667621|FG000|Overall Study|Adverse Event|2|||
105730327|NCT03976401|364667622|FG001|Overall Study|Adverse Event|0|||
105730328|NCT03976401|364667623|FG002|Overall Study|Adverse Event|4|||
105730329|NCT03976401|364667624|FG003|Overall Study|Adverse Event|1|||
105730330|NCT03976401|364667625|FG004|Overall Study|Adverse Event|1|||
105730331|NCT03976401|364667626|FG005|Overall Study|Adverse Event|0|||
105730332|NCT03976401|364667621|FG000|Overall Study|Withdrawal by Subject|0|||
105730333|NCT03976401|364667622|FG001|Overall Study|Withdrawal by Subject|1|||
105730334|NCT03976401|364667623|FG002|Overall Study|Withdrawal by Subject|0|||
105730335|NCT03976401|364667624|FG003|Overall Study|Withdrawal by Subject|0|||
105730336|NCT03976401|364667625|FG004|Overall Study|Withdrawal by Subject|0|||
105730337|NCT03976401|364667626|FG005|Overall Study|Withdrawal by Subject|1|||
105730338|NCT03976401|364667621|FG000|Overall Study|Physician Decision|0|||
105730339|NCT03976401|364667622|FG001|Overall Study|Physician Decision|0|||
105730340|NCT03976401|364667623|FG002|Overall Study|Physician Decision|1|||
105730341|NCT03976401|364667624|FG003|Overall Study|Physician Decision|0|||
105730342|NCT03976401|364667625|FG004|Overall Study|Physician Decision|0|||
105730343|NCT03976401|364667626|FG005|Overall Study|Physician Decision|0|||
105730344|NCT03976401|364667621|FG000|Overall Study|Lost to Follow-up|1|||
105730345|NCT03976401|364667622|FG001|Overall Study|Lost to Follow-up|2|||
105730346|NCT03976401|364667623|FG002|Overall Study|Lost to Follow-up|0|||
105730347|NCT03976401|364667624|FG003|Overall Study|Lost to Follow-up|0|||
105730348|NCT03976401|364667625|FG004|Overall Study|Lost to Follow-up|0|||
105730349|NCT03976401|364667626|FG005|Overall Study|Lost to Follow-up|0|||
105730350|NCT03976401|364667621|FG000|Overall Study|Protocol Violation|0|||
105730351|NCT03976401|364667622|FG001|Overall Study|Protocol Violation|1|||
105730352|NCT03976401|364667623|FG002|Overall Study|Protocol Violation|0|||
105730353|NCT03976401|364667624|FG003|Overall Study|Protocol Violation|0|||
105730354|NCT03976401|364667625|FG004|Overall Study|Protocol Violation|0|||
105730355|NCT03976401|364667626|FG005|Overall Study|Protocol Violation|0|||
105796838|NCT01612702|364914580|FG000|Overall Study|Protocol Violation|11|||
105796839|NCT01612702|364914581|FG001|Overall Study|Protocol Violation|11|||
105796840|NCT03070431|364914582|FG000|Overall Study|Withdrawal by Subject|2|||
105796841|NCT03070431|364914582|FG000|Overall Study|Lost to Follow-up|2|||
105796842|NCT03674827|364914583|FG000|Treatment Phase|Adverse Event|0|||
105796843|NCT03674827|364914584|FG001|Treatment Phase|Adverse Event|0|||
105796844|NCT03674827|364914585|FG002|Treatment Phase|Adverse Event|0|||
105796845|NCT03674827|364914586|FG003|Treatment Phase|Adverse Event|0|||
105796846|NCT03674827|364914587|FG004|Treatment Phase|Adverse Event|0|||
105796847|NCT03674827|364914588|FG005|Treatment Phase|Adverse Event|2|||
105796848|NCT03674827|364914583|FG000|Treatment Phase|Death|2|||
105796849|NCT03674827|364914584|FG001|Treatment Phase|Death|0|||
105796850|NCT03674827|364914585|FG002|Treatment Phase|Death|0|||
105796851|NCT03674827|364914586|FG003|Treatment Phase|Death|0|||
105796852|NCT03674827|364914587|FG004|Treatment Phase|Death|1|||
105796853|NCT03674827|364914588|FG005|Treatment Phase|Death|0|||
105796854|NCT03674827|364914583|FG000|Treatment Phase|Progressive Disease|0|||
105796855|NCT03674827|364914584|FG001|Treatment Phase|Progressive Disease|4|||
105796856|NCT03674827|364914585|FG002|Treatment Phase|Progressive Disease|3|||
105796857|NCT03674827|364914586|FG003|Treatment Phase|Progressive Disease|4|||
105796858|NCT03674827|364914587|FG004|Treatment Phase|Progressive Disease|4|||
105796859|NCT03674827|364914588|FG005|Treatment Phase|Progressive Disease|9|||
105796860|NCT03674827|364914583|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
105796861|NCT03674827|364914584|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
105796862|NCT03674827|364914585|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
105796863|NCT03674827|364914586|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
105796864|NCT03674827|364914587|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
105796865|NCT03674827|364914588|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
105796866|NCT03674827|364914583|FG000|Treatment Phase|Withdrawal by Subject|0|||
105796867|NCT03674827|364914584|FG001|Treatment Phase|Withdrawal by Subject|0|||
105796868|NCT03674827|364914585|FG002|Treatment Phase|Withdrawal by Subject|0|||
105796869|NCT03674827|364914586|FG003|Treatment Phase|Withdrawal by Subject|0|||
105796870|NCT03674827|364914587|FG004|Treatment Phase|Withdrawal by Subject|0|||
105730356|NCT03976401|364667621|FG000|Overall Study|Withdrew Consent|0|||
105730357|NCT03976401|364667622|FG001|Overall Study|Withdrew Consent|0|||
105730358|NCT03976401|364667623|FG002|Overall Study|Withdrew Consent|0|||
105730359|NCT03976401|364667624|FG003|Overall Study|Withdrew Consent|1|||
105730360|NCT03976401|364667625|FG004|Overall Study|Withdrew Consent|0|||
105730361|NCT03976401|364667626|FG005|Overall Study|Withdrew Consent|0|||
105730362|NCT01973283|364667633|FG000|Overall Study|Lost to Follow-up|4|||
105730363|NCT03941548|364667635|FG000|Overall Study|Adverse Event|0|||
105730364|NCT03941548|364667636|FG001|Overall Study|Adverse Event|1|||
105730365|NCT03941548|364667635|FG000|Overall Study|Lost to Follow-up|0|||
105730366|NCT03941548|364667636|FG001|Overall Study|Lost to Follow-up|1|||
105730367|NCT03941548|364667635|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
105730368|NCT03941548|364667636|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
105730369|NCT03717922|364667639|FG000|Overall Study|Lost to Follow-up|2|||
105730370|NCT03717922|364667640|FG001|Overall Study|Lost to Follow-up|2|||
105796871|NCT03674827|364914588|FG005|Treatment Phase|Withdrawal by Subject|1|||
105796872|NCT03674827|364914583|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
105796873|NCT03674827|364914584|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
105796874|NCT03674827|364914585|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
105796875|NCT03674827|364914586|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
105796876|NCT03674827|364914587|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
105796877|NCT03674827|364914588|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
105796878|NCT03674827|364914583|FG000|Treatment Phase|Other|0|||
105796879|NCT03674827|364914584|FG001|Treatment Phase|Other|1|||
105796880|NCT03674827|364914585|FG002|Treatment Phase|Other|0|||
105796881|NCT03674827|364914586|FG003|Treatment Phase|Other|0|||
105796882|NCT03674827|364914587|FG004|Treatment Phase|Other|0|||
105796883|NCT03674827|364914588|FG005|Treatment Phase|Other|1|||
105796884|NCT03674827|364914583|FG000|Long-Term Follow-up Phase|Death|2|||
105796885|NCT03674827|364914584|FG001|Long-Term Follow-up Phase|Death|4|||
105796886|NCT03674827|364914585|FG002|Long-Term Follow-up Phase|Death|2|||
105796887|NCT03674827|364914586|FG003|Long-Term Follow-up Phase|Death|3|||
105796888|NCT03674827|364914587|FG004|Long-Term Follow-up Phase|Death|2|||
105796889|NCT03674827|364914588|FG005|Long-Term Follow-up Phase|Death|6|||
105730371|NCT02015819|364667646|FG000|Overall Study|Rickham catheter was misaligned|0|||
105730372|NCT02015819|364667647|FG001|Overall Study|Rickham catheter was misaligned|0|||
105730373|NCT02015819|364667648|FG002|Overall Study|Rickham catheter was misaligned|0|||
105730374|NCT02015819|364667649|FG003|Overall Study|Rickham catheter was misaligned|1|||
105730375|NCT03230097|364667650|FG000|Overall Study|Adverse Event|2|||
105796890|NCT03674827|364914583|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
105796891|NCT03674827|364914584|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
105796892|NCT03674827|364914585|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
105796893|NCT03674827|364914586|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
105730376|NCT03230097|364667651|FG001|Overall Study|Adverse Event|1|||
105730377|NCT03230097|364667650|FG000|Overall Study|non-compliance|0|||
105730378|NCT03230097|364667651|FG001|Overall Study|non-compliance|1|||
105730379|NCT03230097|364667650|FG000|Overall Study|Lost to Follow-up|2|||
105730380|NCT03230097|364667651|FG001|Overall Study|Lost to Follow-up|4|||
105730381|NCT03230097|364667650|FG000|Overall Study|Withdrawal by Subject|7|||
105730382|NCT03230097|364667651|FG001|Overall Study|Withdrawal by Subject|3|||
105730383|NCT03230097|364667650|FG000|Overall Study|Trial termination|4|||
105730384|NCT03230097|364667651|FG001|Overall Study|Trial termination|5|||
105730385|NCT03230097|364667650|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
105730386|NCT03230097|364667651|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
105730387|NCT03230097|364667650|FG000|Overall Study|outcome event|0|||
105730388|NCT03230097|364667651|FG001|Overall Study|outcome event|1|||
105730389|NCT01697215|364667657|FG000|Overall Study|Physician Decision|5|||
105730390|NCT01697215|364667657|FG000|Overall Study|Malfunction|9|||
105730391|NCT01697215|364667657|FG000|Overall Study|CXR not available|9|||
105730392|NCT04899271|364667658|FG000|Overall Study|Lost to Follow-up|1|||
105730393|NCT04899271|364667659|FG001|Overall Study|Lost to Follow-up|0|||
105730394|NCT04899271|364667658|FG000|Overall Study|Subject request/consent withdrawal|2|||
105730395|NCT04899271|364667659|FG001|Overall Study|Subject request/consent withdrawal|0|||
105730396|NCT01929083|364667660|FG000|Intervention 1|Lost to Follow-up|2|||
105730397|NCT01929083|364667661|FG001|Intervention 1|Lost to Follow-up|0|||
105730398|NCT01929083|364667660|FG000|Intervention 1|Nonadherent to study medications|1|||
105730399|NCT01929083|364667661|FG001|Intervention 1|Nonadherent to study medications|0|||
105730400|NCT01929083|364667660|FG000|Intervention 2|Adverse Event|0|||
105730401|NCT01929083|364667661|FG001|Intervention 2|Adverse Event|1|||
105730402|NCT00900796|364667664|FG000|Phase 1|Lacked sufficient information|4|||
105730403|NCT00900796|364667664|FG000|Phase 1|Missing information at Week 16|7|||
105730404|NCT00900796|364667664|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
105730405|NCT00900796|364667664|FG000|Phase 2|Lost to Follow-up|5|||
105730406|NCT02945657|364667665|FG000|Overall Study|Adverse Event|1|||
105730407|NCT02945657|364667665|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
105730408|NCT01859403|364667675|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
105730409|NCT01859403|364667676|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
105730410|NCT01859403|364667675|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
105730411|NCT01859403|364667676|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
105730412|NCT01859403|364667675|FG000|Primary Endpoint Measure|Physician Decision|0|||
105730413|NCT01859403|364667676|FG001|Primary Endpoint Measure|Physician Decision|1|||
105730414|NCT01859403|364667675|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
105730415|NCT01859403|364667676|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
105730416|NCT00811252|364667681|FG000|Overall Study|Adverse Event|6|||
105730417|NCT00811252|364667682|FG001|Overall Study|Adverse Event|10|||
105730418|NCT00811252|364667683|FG002|Overall Study|Adverse Event|15|||
105730419|NCT00811252|364667681|FG000|Overall Study|Lack of Efficacy|7|||
105730420|NCT00811252|364667682|FG001|Overall Study|Lack of Efficacy|2|||
105730421|NCT00811252|364667683|FG002|Overall Study|Lack of Efficacy|0|||
105730422|NCT00811252|364667681|FG000|Overall Study|Protocol Violation|3|||
105730423|NCT00811252|364667682|FG001|Overall Study|Protocol Violation|3|||
105730424|NCT00811252|364667683|FG002|Overall Study|Protocol Violation|2|||
105730425|NCT00811252|364667681|FG000|Overall Study|Withdrawal of Consent|1|||
105730426|NCT00811252|364667682|FG001|Overall Study|Withdrawal of Consent|2|||
105730427|NCT00811252|364667683|FG002|Overall Study|Withdrawal of Consent|2|||
105730428|NCT00811252|364667681|FG000|Overall Study|Lost to Follow-up|0|||
105796894|NCT03674827|364914587|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
105796895|NCT03674827|364914588|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
105730429|NCT00811252|364667682|FG001|Overall Study|Lost to Follow-up|0|||
105730430|NCT00811252|364667683|FG002|Overall Study|Lost to Follow-up|2|||
105730431|NCT00811252|364667681|FG000|Overall Study|Administrative or Other Reasons|0|||
105730432|NCT00811252|364667682|FG001|Overall Study|Administrative or Other Reasons|3|||
105730433|NCT00811252|364667683|FG002|Overall Study|Administrative or Other Reasons|2|||
105730434|NCT00813748|364667684|FG000|Skin Test Substudy|Physician Decision|0|||
105730435|NCT00813748|364667685|FG001|Skin Test Substudy|Physician Decision|1|||
105730436|NCT00892437|364667686|FG000|Randomized Phase|Randomized but not treated|6|||
105730437|NCT00892437|364667687|FG001|Randomized Phase|Randomized but not treated|0|||
105730438|NCT00892437|364667686|FG000|Randomized Phase|Adverse Event|2|||
105796896|NCT03674827|364914583|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
105730439|NCT00892437|364667687|FG001|Randomized Phase|Adverse Event|2|||
105730440|NCT00892437|364667686|FG000|Randomized Phase|Lost to Follow-up|1|||
105730441|NCT00892437|364667687|FG001|Randomized Phase|Lost to Follow-up|3|||
105730442|NCT00892437|364667686|FG000|Randomized Phase|Investigator's Discretion|1|||
105730443|NCT00892437|364667687|FG001|Randomized Phase|Investigator's Discretion|0|||
105730444|NCT00892437|364667686|FG000|Randomized Phase|Withdrew Consent|1|||
105730445|NCT00892437|364667687|FG001|Randomized Phase|Withdrew Consent|0|||
105730446|NCT00892437|364667686|FG000|Open-Label Extension Phase|Adverse Event|4|||
105730447|NCT00892437|364667687|FG001|Open-Label Extension Phase|Adverse Event|2|||
105796897|NCT03674827|364914584|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
105796898|NCT03674827|364914585|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
105796899|NCT03674827|364914586|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
105796900|NCT03674827|364914587|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
105796901|NCT03674827|364914588|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
105796902|NCT02624518|364914589|FG000|Overall Study|Physician Decision|1|||
105796903|NCT00370396|364914590|FG000|Overall Study|Withdrawal by Subject|0|||
105796904|NCT00370396|364914591|FG001|Overall Study|Withdrawal by Subject|0|||
105796905|NCT00370396|364914592|FG002|Overall Study|Withdrawal by Subject|1|||
105730448|NCT00892437|364667686|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
105730449|NCT00892437|364667687|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
105730450|NCT00892437|364667686|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
105730451|NCT00892437|364667687|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
105730452|NCT00892437|364667686|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
105730453|NCT00892437|364667687|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
105730454|NCT00892437|364667686|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
105730455|NCT00892437|364667687|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
105730456|NCT02750410|364667688|FG000|Double-Blind Treatment Period|Adverse Event|2|||
105730457|NCT02750410|364667689|FG001|Double-Blind Treatment Period|Adverse Event|2|||
105730458|NCT02750410|364667688|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105730459|NCT02750410|364667689|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105730460|NCT02750410|364667688|FG000|Open-Label Extension Period|Adverse Event|5|||
105730461|NCT02750410|364667689|FG001|Open-Label Extension Period|Adverse Event|3|||
105730462|NCT02750410|364667688|FG000|Open-Label Extension Period|Protocol Violation|0|||
105730463|NCT02750410|364667689|FG001|Open-Label Extension Period|Protocol Violation|1|||
105730464|NCT02750410|364667688|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
105730465|NCT02750410|364667689|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
105730466|NCT02500550|364667697|FG000|Overall Study|Death|7|||
105730467|NCT00659438|364667698|FG000|Overall Study|Withdrawal by Subject|2|||
105730468|NCT00659438|364667699|FG001|Overall Study|Withdrawal by Subject|2|||
105730469|NCT00659438|364667698|FG000|Overall Study|Death|11|||
105730470|NCT00659438|364667699|FG001|Overall Study|Death|6|||
105730471|NCT00659438|364667698|FG000|Overall Study|Lost to Follow-up|1|||
105730472|NCT00659438|364667699|FG001|Overall Study|Lost to Follow-up|0|||
105730473|NCT00246259|364667700|FG000|Overall Study|Other|3|||
105730474|NCT00246259|364667701|FG001|Overall Study|Other|3|||
105730475|NCT00246259|364667700|FG000|Overall Study|Not stable by Week 18|2|||
105730476|NCT00246259|364667701|FG001|Overall Study|Not stable by Week 18|1|||
105730477|NCT00246259|364667700|FG000|Overall Study|Participant non-compliant|4|||
105730478|NCT00246259|364667701|FG001|Overall Study|Participant non-compliant|9|||
105730479|NCT00246259|364667700|FG000|Overall Study|Lack of Efficacy|2|||
105730480|NCT00246259|364667701|FG001|Overall Study|Lack of Efficacy|2|||
105730481|NCT00246259|364667700|FG000|Overall Study|Investigator withdrew participant|2|||
105730482|NCT00246259|364667701|FG001|Overall Study|Investigator withdrew participant|0|||
105730483|NCT00246259|364667700|FG000|Overall Study|Adverse Event|5|||
105730484|NCT00246259|364667701|FG001|Overall Study|Adverse Event|0|||
105730485|NCT00246259|364667700|FG000|Overall Study|Lost to Follow-up|3|||
105730486|NCT00246259|364667701|FG001|Overall Study|Lost to Follow-up|4|||
105730487|NCT00246259|364667700|FG000|Overall Study|Withdrawal by Subject|5|||
105730488|NCT00246259|364667701|FG001|Overall Study|Withdrawal by Subject|1|||
105730489|NCT00246259|364667700|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
105730490|NCT00246259|364667701|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
105730491|NCT03133767|364667708|FG000|Overall Study|Lost to Follow-up|38|||
105730492|NCT03133767|364667709|FG001|Overall Study|Lost to Follow-up|24|||
105730493|NCT03133767|364667708|FG000|Overall Study|Protocol Violation|0|||
105730494|NCT03133767|364667709|FG001|Overall Study|Protocol Violation|1|||
105730495|NCT03517436|364667710|FG000|Overall Study|Death|3|||
105730496|NCT03517436|364667710|FG000|Overall Study|Withdrawal by Subject|4|||
105730497|NCT03517436|364667710|FG000|Overall Study|Did not receive study valve.|1|||
105730498|NCT02698189|364667713|FG000|Overall Study|Physician Decision|3|||
105730499|NCT02698189|364667714|FG001|Overall Study|Physician Decision|0|||
105730500|NCT02698189|364667713|FG000|Overall Study|Progressive disease|0|||
105730501|NCT02698189|364667714|FG001|Overall Study|Progressive disease|5|||
105730502|NCT02698189|364667713|FG000|Overall Study|Study terminated by sponsor|0|||
105796906|NCT00370396|364914590|FG000|Overall Study|Lost to Follow-up|11|||
105353279|NCT00171158|363298488|FG000|Core Study|Abnormal Laboratory Values|2|||
105730503|NCT02698189|364667714|FG001|Overall Study|Study terminated by sponsor|1|||
105730504|NCT03301857|364667720|FG000|Overall Study|Death|0|||
105730505|NCT03301857|364667721|FG001|Overall Study|Death|2|||
105730506|NCT03301857|364667720|FG000|Overall Study|Lost to Follow-up|4|||
105730507|NCT03301857|364667721|FG001|Overall Study|Lost to Follow-up|2|||
105353280|NCT00171158|363298488|FG000|Core Study|Lost to Follow-up|1|||
105730508|NCT03301857|364667720|FG000|Overall Study|Decision by Sponsor|6|||
105730509|NCT03301857|364667721|FG001|Overall Study|Decision by Sponsor|0|||
105730510|NCT03301857|364667720|FG000|Overall Study|Withdrawal by Subject|12|||
105730511|NCT03301857|364667721|FG001|Overall Study|Withdrawal by Subject|4|||
105796907|NCT00370396|364914591|FG001|Overall Study|Lost to Follow-up|1|||
105796908|NCT00370396|364914592|FG002|Overall Study|Lost to Follow-up|0|||
105796909|NCT00061945|364914594|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
105796910|NCT00061945|364914595|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
105796911|NCT00061945|364914594|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
105796912|NCT00061945|364914595|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
105796913|NCT00061945|364914594|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
105796914|NCT00061945|364914595|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
105796915|NCT00061945|364914594|FG000|Course IV: Alemtuzumab|Early exits|6|||
105796916|NCT00061945|364914595|FG001|Course IV: Alemtuzumab|Early exits|15|||
105796917|NCT03611751|364914596|FG000|Pre-treatment|Randomized but not treated|1|||
105796918|NCT03611751|364914597|FG001|Pre-treatment|Randomized but not treated|1|||
105796919|NCT03611751|364914598|FG002|Pre-treatment|Randomized but not treated|0|||
105796920|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
105796921|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
105796922|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
105796923|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
105796924|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
105796925|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
105796926|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
105796927|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
105796928|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
105796929|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
105796930|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
105796931|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
105796932|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
105796933|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
105796934|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
105796935|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
105796936|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
105796937|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
105796938|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
105796939|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
105796940|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
105796941|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Death|0|||
105796942|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Death|0|||
105796943|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Death|1|||
105796944|NCT03611751|364914596|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
105796945|NCT03611751|364914597|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
105796946|NCT03611751|364914598|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
105796947|NCT03611751|364914596|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
105796948|NCT03611751|364914597|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
105796949|NCT03611751|364914598|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
105796950|NCT03611751|364914596|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
105796951|NCT03611751|364914597|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
105796952|NCT03611751|364914598|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
105796953|NCT03611751|364914596|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
105796954|NCT03611751|364914597|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
105796955|NCT03611751|364914598|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
105796956|NCT03611751|364914596|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
105796957|NCT03611751|364914597|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
105796958|NCT03611751|364914598|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
105796959|NCT03611751|364914596|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
105796960|NCT03611751|364914597|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
105796961|NCT03611751|364914598|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
105796962|NCT03611751|364914596|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
105796963|NCT03611751|364914597|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
105796964|NCT03611751|364914598|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
105796965|NCT03611751|364914596|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
105796966|NCT03611751|364914597|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
105796967|NCT03611751|364914598|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
105796968|NCT03611751|364914596|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
105796969|NCT03611751|364914597|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
105796970|NCT03611751|364914598|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
105796971|NCT03611751|364914596|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
105796972|NCT03611751|364914597|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
105796973|NCT03611751|364914598|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
105796974|NCT03611751|364914596|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
105796975|NCT03611751|364914597|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
105796976|NCT03611751|364914598|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
105796977|NCT03611751|364914596|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
105353281|NCT00171158|363298488|FG000|E2 Extension|Other|7|||
105796978|NCT03611751|364914597|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
105796979|NCT03611751|364914598|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
105796980|NCT03611751|364914596|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
105796981|NCT03611751|364914597|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
105796982|NCT03611751|364914598|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
105796983|NCT03611751|364914596|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
105796984|NCT03611751|364914597|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
105796985|NCT03611751|364914598|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
105796986|NCT01238211|364914599|FG000|Overall Study|Continues active treatment|31|||
105796987|NCT01238211|364914599|FG000|Overall Study|Adverse Event|7|||
105796988|NCT01238211|364914599|FG000|Overall Study|Death|4|||
105796989|NCT01238211|364914599|FG000|Overall Study|Relapse/Progression|2|||
105796990|NCT01238211|364914599|FG000|Overall Study|Withdrawal by Subject|7|||
105796991|NCT01238211|364914599|FG000|Overall Study|Non-protocol treatment|4|||
105796992|NCT01238211|364914599|FG000|Overall Study|Investigator/Patient Decision|3|||
105796993|NCT03707522|364914602|FG000|Overall Study|Lost to Follow-up|24|||
105796994|NCT03707522|364914603|FG001|Overall Study|Lost to Follow-up|27|||
105796995|NCT03707522|364914604|FG002|Overall Study|Lost to Follow-up|41|||
105796996|NCT03707522|364914605|FG003|Overall Study|Lost to Follow-up|36|||
105796997|NCT00725725|364914611|FG000|Overall Study|Adverse Event|1|||
105796998|NCT00725725|364914612|FG001|Overall Study|Adverse Event|3|||
105796999|NCT00725725|364914613|FG002|Overall Study|Adverse Event|2|||
105797000|NCT00725725|364914611|FG000|Overall Study|Lost to Follow-up|2|||
105797001|NCT00725725|364914612|FG001|Overall Study|Lost to Follow-up|0|||
105797002|NCT00725725|364914613|FG002|Overall Study|Lost to Follow-up|2|||
105797003|NCT00725725|364914611|FG000|Overall Study|Withdrawal by Subject|1|||
105797004|NCT00725725|364914612|FG001|Overall Study|Withdrawal by Subject|0|||
105797005|NCT00725725|364914613|FG002|Overall Study|Withdrawal by Subject|1|||
105797006|NCT00725725|364914611|FG000|Overall Study|Protocol Violation|0|||
105797007|NCT00725725|364914612|FG001|Overall Study|Protocol Violation|1|||
105797008|NCT00725725|364914613|FG002|Overall Study|Protocol Violation|0|||
105797009|NCT01619085|364914614|FG000|Overall Study|Adverse Event|231|||
105797010|NCT01619085|364914614|FG000|Overall Study|Protocol Violation|4|||
105797011|NCT01619085|364914614|FG000|Overall Study|Lost to Follow-up|3|||
105797012|NCT01619085|364914614|FG000|Overall Study|Withdrawal by Subject|45|||
105797013|NCT01619085|364914614|FG000|Overall Study|Other than specified|96|||
105797014|NCT01619085|364914614|FG000|Overall Study|Not treated|1|||
105797015|NCT01619085|364914614|FG000|Overall Study|Death|145|||
105797016|NCT03125915|364914615|FG000|1 Month Follow up|Lost to Follow-up|3|||
105797017|NCT03125915|364914616|FG001|1 Month Follow up|Lost to Follow-up|3|||
105797018|NCT03125915|364914617|FG002|1 Month Follow up|Lost to Follow-up|2|||
105797019|NCT03125915|364914618|FG003|1 Month Follow up|Lost to Follow-up|3|||
105797020|NCT03125915|364914615|FG000|3 Month Follow-up|Lost to Follow-up|6|||
105797021|NCT03125915|364914616|FG001|3 Month Follow-up|Lost to Follow-up|4|||
105797022|NCT03125915|364914617|FG002|3 Month Follow-up|Lost to Follow-up|4|||
105797023|NCT03125915|364914618|FG003|3 Month Follow-up|Lost to Follow-up|2|||
105797024|NCT03125915|364914615|FG000|6 Month Follow-up|Lost to Follow-up|7|||
105797025|NCT03125915|364914616|FG001|6 Month Follow-up|Lost to Follow-up|3|||
105797026|NCT03125915|364914617|FG002|6 Month Follow-up|Lost to Follow-up|6|||
105797027|NCT03125915|364914618|FG003|6 Month Follow-up|Lost to Follow-up|3|||
105797028|NCT00743119|364914619|FG000|Overall Study|unreliable|3|||
105797029|NCT00743119|364914619|FG000|Overall Study|Withdrawal by Subject|1|||
105797030|NCT03909971|364914620|FG000|Overall Study|Other Reasons Not Specified|0|||
105797031|NCT03909971|364914621|FG001|Overall Study|Other Reasons Not Specified|1|||
105797032|NCT03909971|364914620|FG000|Overall Study|Global Deterioration of Health Status|2|||
105797033|NCT03909971|364914621|FG001|Overall Study|Global Deterioration of Health Status|1|||
105797034|NCT03909971|364914620|FG000|Overall Study|Progressive Disease|6|||
105797035|NCT03909971|364914621|FG001|Overall Study|Progressive Disease|14|||
105797036|NCT03909971|364914620|FG000|Overall Study|Death|2|||
105797037|NCT03909971|364914621|FG001|Overall Study|Death|6|||
105797042|NCT02176642|364914625|FG000|Overall Study|Withdrawal by Subject|0|||
105479867|NCT03011892|363767634|FG009|Double Blind (DB) Period|Pregnancy|0|||
105797043|NCT02176642|364914626|FG001|Overall Study|Withdrawal by Subject|1|||
105797044|NCT00295620|364914628|FG000|Overall Study|Lost to Follow-up|9|||
105797045|NCT00295620|364914629|FG001|Overall Study|Lost to Follow-up|5|||
105797046|NCT00295620|364914628|FG000|Overall Study|Withdrawal by Subject|37|||
105353282|NCT05437640|363298489|FG000|Washout (1 Week)|Adverse Event|1|||
105479868|NCT03011892|363767635|FG010|Double Blind (DB) Period|Pregnancy|0|||
105797047|NCT00295620|364914629|FG001|Overall Study|Withdrawal by Subject|50|||
105797048|NCT00295620|364914628|FG000|Overall Study|Death|206|||
105797049|NCT00295620|364914629|FG001|Overall Study|Death|207|||
105797050|NCT00295620|364914628|FG000|Overall Study|Other reasons|10|||
105797051|NCT00295620|364914629|FG001|Overall Study|Other reasons|9|||
105730512|NCT00855439|364667722|FG000|Overall Study|Withdrawal by Subject|2|||
105730513|NCT00855439|364667723|FG001|Overall Study|Withdrawal by Subject|0|||
105730514|NCT00855439|364667722|FG000|Overall Study|Pregnancy|1|||
105730515|NCT00855439|364667723|FG001|Overall Study|Pregnancy|0|||
105730516|NCT01914679|364667726|FG000|Overall Study|Lack of Efficacy|1|||
105730517|NCT01914679|364667726|FG000|Overall Study|Sponsor terminated study|4|||
105730518|NCT01591330|364667732|FG000|Period 1|Adverse Event|1|||
105730519|NCT01591330|364667733|FG001|Period 1|Adverse Event|0|||
105730520|NCT01591330|364667734|FG002|Period 1|Adverse Event|0|||
105730521|NCT01591330|364667735|FG003|Period 1|Adverse Event|0|||
105730522|NCT01591330|364667732|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
105730523|NCT01591330|364667733|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
105730524|NCT01591330|364667734|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
105730525|NCT01591330|364667735|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
105730526|NCT01591330|364667732|FG000|Period 2|Adverse Event|1|||
105730527|NCT01591330|364667733|FG001|Period 2|Adverse Event|0|||
105730528|NCT01591330|364667734|FG002|Period 2|Adverse Event|0|||
105730529|NCT01591330|364667735|FG003|Period 2|Adverse Event|0|||
105730530|NCT00002850|364667738|FG000|Overall Study|Death|4|||
105730531|NCT00002850|364667739|FG001|Overall Study|Death|1|||
105730532|NCT00002850|364667740|FG002|Overall Study|Death|3|||
105730533|NCT00002850|364667738|FG000|Overall Study|Protocol Violation|1|||
105730534|NCT00002850|364667739|FG001|Overall Study|Protocol Violation|0|||
105730535|NCT00002850|364667740|FG002|Overall Study|Protocol Violation|1|||
105730536|NCT00002850|364667738|FG000|Overall Study|Withdrawal by Subject|0|||
105730537|NCT00002850|364667739|FG001|Overall Study|Withdrawal by Subject|1|||
105730538|NCT00002850|364667740|FG002|Overall Study|Withdrawal by Subject|0|||
105730539|NCT01450540|364667741|FG000|Overall Study|Withdrawal by Subject|19|||
105730540|NCT01450540|364667742|FG001|Overall Study|Withdrawal by Subject|13|||
105730541|NCT01450540|364667741|FG000|Overall Study|protocol deviation|3|||
105730542|NCT01450540|364667742|FG001|Overall Study|protocol deviation|23|||
105730543|NCT04800315|364667751|FG000|Randomization|Did not receive study treatment|1|||
105730544|NCT04800315|364667752|FG001|Randomization|Did not receive study treatment|0|||
105730545|NCT04800315|364667753|FG002|Randomization|Did not receive study treatment|0|||
105730546|NCT04800315|364667754|FG003|Randomization|Did not receive study treatment|0|||
105730547|NCT04800315|364667751|FG000|Treatment Period|Adverse Event|4|||
105730548|NCT04800315|364667752|FG001|Treatment Period|Adverse Event|2|||
105730549|NCT04800315|364667753|FG002|Treatment Period|Adverse Event|1|||
105730550|NCT04800315|364667754|FG003|Treatment Period|Adverse Event|2|||
105730551|NCT04800315|364667751|FG000|Treatment Period|Lack of Efficacy|1|||
105730552|NCT04800315|364667752|FG001|Treatment Period|Lack of Efficacy|0|||
105730553|NCT04800315|364667753|FG002|Treatment Period|Lack of Efficacy|0|||
105730554|NCT04800315|364667754|FG003|Treatment Period|Lack of Efficacy|3|||
105730555|NCT04800315|364667751|FG000|Treatment Period|Lost to Follow-up|0|||
105730556|NCT04800315|364667752|FG001|Treatment Period|Lost to Follow-up|1|||
105730557|NCT04800315|364667753|FG002|Treatment Period|Lost to Follow-up|2|||
105730558|NCT04800315|364667754|FG003|Treatment Period|Lost to Follow-up|2|||
105730559|NCT04800315|364667751|FG000|Treatment Period|Withdrawal by participant|0|||
105730560|NCT04800315|364667752|FG001|Treatment Period|Withdrawal by participant|0|||
105730561|NCT04800315|364667753|FG002|Treatment Period|Withdrawal by participant|0|||
105730562|NCT04800315|364667754|FG003|Treatment Period|Withdrawal by participant|4|||
105730563|NCT04800315|364667751|FG000|Treatment Period|Other Reasons|0|||
105730564|NCT04800315|364667752|FG001|Treatment Period|Other Reasons|2|||
105730565|NCT04800315|364667753|FG002|Treatment Period|Other Reasons|0|||
105730566|NCT04800315|364667754|FG003|Treatment Period|Other Reasons|1|||
105730567|NCT04909463|364669236|FG000|Overall Study|Withdrawal by Subject|0|||
105730568|NCT04909463|364669237|FG001|Overall Study|Withdrawal by Subject|1|||
105730569|NCT04909463|364669238|FG002|Overall Study|Withdrawal by Subject|0|||
105730570|NCT04909463|364669239|FG003|Overall Study|Withdrawal by Subject|0|||
105730571|NCT04909463|364669236|FG000|Overall Study|Lost to Follow-up|2|||
105730572|NCT04909463|364669237|FG001|Overall Study|Lost to Follow-up|1|||
105730573|NCT04909463|364669238|FG002|Overall Study|Lost to Follow-up|1|||
105730574|NCT04909463|364669239|FG003|Overall Study|Lost to Follow-up|0|||
105730575|NCT00853632|364669240|FG000|Overall Study|Death|88|||
105730576|NCT00853632|364669240|FG000|Overall Study|Withdrawal by Subject|45|||
105730577|NCT00853632|364669240|FG000|Overall Study|Lost to Follow-up|30|||
105730578|NCT00853632|364669240|FG000|Overall Study|Reoperation/Explant|17|||
105730579|NCT00853632|364669240|FG000|Overall Study|Exit with other reason|22|||
105730580|NCT02128490|364669246|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
105730581|NCT02128490|364669247|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
105730582|NCT02128490|364669248|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
105730583|NCT02128490|364669249|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
105730584|NCT02128490|364669250|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
105730585|NCT02128490|364669246|FG000|Overall Study|Major Protocol Deviation|1|||
105730586|NCT02128490|364669247|FG001|Overall Study|Major Protocol Deviation|2|||
105730587|NCT02128490|364669248|FG002|Overall Study|Major Protocol Deviation|0|||
105730588|NCT02128490|364669249|FG003|Overall Study|Major Protocol Deviation|2|||
105730589|NCT02128490|364669250|FG004|Overall Study|Major Protocol Deviation|2|||
105730590|NCT02128490|364669246|FG000|Overall Study|Lost to Follow-up|0|||
105730591|NCT02128490|364669247|FG001|Overall Study|Lost to Follow-up|0|||
105730592|NCT02128490|364669248|FG002|Overall Study|Lost to Follow-up|1|||
105730593|NCT02128490|364669249|FG003|Overall Study|Lost to Follow-up|1|||
105730594|NCT02128490|364669250|FG004|Overall Study|Lost to Follow-up|1|||
105730595|NCT02128490|364669246|FG000|Overall Study|Voluntary Withdrawal|3|||
105730596|NCT02128490|364669247|FG001|Overall Study|Voluntary Withdrawal|3|||
105730597|NCT02128490|364669248|FG002|Overall Study|Voluntary Withdrawal|1|||
105730598|NCT02128490|364669249|FG003|Overall Study|Voluntary Withdrawal|1|||
105730599|NCT02128490|364669250|FG004|Overall Study|Voluntary Withdrawal|2|||
105730600|NCT02128490|364669246|FG000|Overall Study|Lack of Efficacy|0|||
105730601|NCT02128490|364669247|FG001|Overall Study|Lack of Efficacy|1|||
105730602|NCT02128490|364669248|FG002|Overall Study|Lack of Efficacy|0|||
105730603|NCT02128490|364669249|FG003|Overall Study|Lack of Efficacy|0|||
105730604|NCT02128490|364669250|FG004|Overall Study|Lack of Efficacy|0|||
105730605|NCT02128490|364669246|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
105730606|NCT02128490|364669247|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
105730607|NCT02128490|364669248|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
105730608|NCT02128490|364669249|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
105730609|NCT02128490|364669250|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
105730610|NCT02128490|364669246|FG000|Overall Study|Other Miscellaneous Reasons|0|||
105730611|NCT02128490|364669247|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105730612|NCT02128490|364669248|FG002|Overall Study|Other Miscellaneous Reasons|2|||
105730613|NCT02128490|364669249|FG003|Overall Study|Other Miscellaneous Reasons|1|||
105730614|NCT02128490|364669250|FG004|Overall Study|Other Miscellaneous Reasons|1|||
105730615|NCT04024228|364669252|FG000|Overall Study|Adverse Event|1|||
105730616|NCT04024228|364669253|FG001|Overall Study|Adverse Event|0|||
105730617|NCT04024228|364669252|FG000|Overall Study|Protocol Deviation|0|||
105730618|NCT04024228|364669253|FG001|Overall Study|Protocol Deviation|2|||
105730619|NCT04024228|364669252|FG000|Overall Study|Withdrawal by Subject|3|||
105730620|NCT04024228|364669253|FG001|Overall Study|Withdrawal by Subject|4|||
105730621|NCT01614457|364669256|FG000|Overall Study|Non-Compliance|1|||
105730622|NCT01614457|364669257|FG001|Overall Study|Non-Compliance|0|||
105730623|NCT01614457|364669256|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
105730624|NCT01614457|364669257|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
105730625|NCT01584024|364669265|FG000|Overall Study|Lost to Follow-up|10|||
105730626|NCT01584024|364669265|FG000|Overall Study|Withdrawal by Subject|3|||
105730627|NCT01217606|364669266|FG000|Initial Treatment Phase|Other Reasons|0|||
105730628|NCT01217606|364669267|FG001|Initial Treatment Phase|Other Reasons|2|||
105730629|NCT01217606|364669266|FG000|Initial Treatment Phase|Protocol Violation|3|||
105730630|NCT01217606|364669267|FG001|Initial Treatment Phase|Protocol Violation|2|||
105730631|NCT01217606|364669266|FG000|Initial Treatment Phase|Personal Reasons|0|||
105730632|NCT01217606|364669267|FG001|Initial Treatment Phase|Personal Reasons|2|||
105730633|NCT01217606|364669266|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
105730634|NCT01217606|364669267|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
105730635|NCT01217606|364669266|FG000|Initial Treatment Phase|Adverse Event|10|||
105730636|NCT01217606|364669267|FG001|Initial Treatment Phase|Adverse Event|6|||
105730637|NCT01217606|364669266|FG000|9-Month Masked Extension|Adverse Event|3|||
105730638|NCT01217606|364669267|FG001|9-Month Masked Extension|Adverse Event|6|||
105730639|NCT01217606|364669266|FG000|9-Month Masked Extension|Other Reasons|4|||
105730640|NCT01217606|364669267|FG001|9-Month Masked Extension|Other Reasons|4|||
105730641|NCT01217606|364669266|FG000|9-Month Masked Extension|Personal Reasons|2|||
105730642|NCT01217606|364669267|FG001|9-Month Masked Extension|Personal Reasons|1|||
105730643|NCT01217606|364669266|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
105730644|NCT01217606|364669267|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
105730645|NCT01217606|364669266|FG000|9-Month Masked Extension|Pregnancy|1|||
105730646|NCT01217606|364669267|FG001|9-Month Masked Extension|Pregnancy|0|||
105730647|NCT01217606|364669266|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
105730648|NCT01217606|364669267|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
105730649|NCT02586207|364669271|FG000|Overall Study|Physician Decision|1|||
105730650|NCT02586207|364669271|FG000|Overall Study|Withdrawal by Subject|1|||
105730651|NCT02424539|364669272|FG000|Overall Study|Adverse Event|0|||
105730652|NCT02424539|364669273|FG001|Overall Study|Adverse Event|0|||
105730653|NCT02424539|364669274|FG002|Overall Study|Adverse Event|1|||
105730654|NCT02424539|364669272|FG000|Overall Study|Physician Decision|0|||
105730655|NCT02424539|364669273|FG001|Overall Study|Physician Decision|0|||
105730656|NCT02424539|364669274|FG002|Overall Study|Physician Decision|1|||
105730657|NCT02424539|364669272|FG000|Overall Study|Withdrawal by Subject|3|||
105730658|NCT02424539|364669273|FG001|Overall Study|Withdrawal by Subject|1|||
105730659|NCT02424539|364669274|FG002|Overall Study|Withdrawal by Subject|0|||
105730660|NCT02424539|364669272|FG000|Overall Study|Other: Reached stopping criteria|11|||
105730661|NCT02424539|364669273|FG001|Overall Study|Other: Reached stopping criteria|7|||
105730662|NCT02424539|364669274|FG002|Overall Study|Other: Reached stopping criteria|6|||
105730663|NCT04893265|364669277|FG000|Overall Study|Withdrawal by Subject|2|||
105730664|NCT04893265|364669278|FG001|Overall Study|Withdrawal by Subject|5|||
105730665|NCT04893265|364669277|FG000|Overall Study|Lost to Follow-up|0|||
105730666|NCT04893265|364669278|FG001|Overall Study|Lost to Follow-up|4|||
105730667|NCT00573131|364669280|FG000|Overall Study|Withdrawal by Subject|10|||
105730668|NCT00573131|364669281|FG001|Overall Study|Withdrawal by Subject|8|||
105730669|NCT03090191|364669284|FG000|Overall Study|Adverse Event|90|||
105730670|NCT03090191|364669285|FG001|Overall Study|Adverse Event|72|||
105730671|NCT03090191|364669284|FG000|Overall Study|Death|365|||
105730672|NCT03090191|364669285|FG001|Overall Study|Death|358|||
105730673|NCT03090191|364669284|FG000|Overall Study|Lost to Follow-up|382|||
105730674|NCT03090191|364669285|FG001|Overall Study|Lost to Follow-up|394|||
105730675|NCT03090191|364669284|FG000|Overall Study|Physician Decision|77|||
105730676|NCT03090191|364669285|FG001|Overall Study|Physician Decision|66|||
105730677|NCT03090191|364669284|FG000|Overall Study|Protocol Violation|43|||
105730678|NCT03090191|364669285|FG001|Overall Study|Protocol Violation|52|||
105730679|NCT03090191|364669284|FG000|Overall Study|Withdrawal by Subject|2160|||
105730680|NCT03090191|364669285|FG001|Overall Study|Withdrawal by Subject|2133|||
105730681|NCT03090191|364669284|FG000|Overall Study|Site terminated|7|||
105730682|NCT03090191|364669285|FG001|Overall Study|Site terminated|8|||
105730683|NCT03090191|364669284|FG000|Overall Study|Other|66|||
105730684|NCT03090191|364669285|FG001|Overall Study|Other|60|||
105730685|NCT03090191|364669284|FG000|Overall Study|Withdrawn before any study vaccination|43|||
105730686|NCT03090191|364669285|FG001|Overall Study|Withdrawn before any study vaccination|52|||
105730687|NCT00893789|364669287|FG000|Overall Study|Withdrawal by Subject|3|||
105730688|NCT00893789|364669288|FG001|Overall Study|Withdrawal by Subject|1|||
105730689|NCT00893789|364669289|FG002|Overall Study|Withdrawal by Subject|3|||
105730690|NCT00893789|364669290|FG003|Overall Study|Withdrawal by Subject|1|||
105730691|NCT00893789|364669287|FG000|Overall Study|Noncompliance With Study Drug|1|||
105730692|NCT00893789|364669288|FG001|Overall Study|Noncompliance With Study Drug|0|||
105730693|NCT00893789|364669289|FG002|Overall Study|Noncompliance With Study Drug|1|||
105730694|NCT00893789|364669290|FG003|Overall Study|Noncompliance With Study Drug|2|||
105730695|NCT00893789|364669287|FG000|Overall Study|Noncompliance With Study Procedures|1|||
105730696|NCT00893789|364669288|FG001|Overall Study|Noncompliance With Study Procedures|0|||
105730697|NCT00893789|364669289|FG002|Overall Study|Noncompliance With Study Procedures|0|||
105730698|NCT00893789|364669290|FG003|Overall Study|Noncompliance With Study Procedures|0|||
105730699|NCT00893789|364669287|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
105730700|NCT00893789|364669288|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
105730701|NCT00893789|364669289|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
105730702|NCT00893789|364669290|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
105730703|NCT00893789|364669287|FG000|Overall Study|Adverse Event|0|||
105730704|NCT00893789|364669288|FG001|Overall Study|Adverse Event|2|||
105730705|NCT00893789|364669289|FG002|Overall Study|Adverse Event|1|||
105730706|NCT00893789|364669290|FG003|Overall Study|Adverse Event|5|||
105730707|NCT00893789|364669287|FG000|Overall Study|Protocol Violation|0|||
105730708|NCT00893789|364669288|FG001|Overall Study|Protocol Violation|1|||
105730709|NCT00893789|364669289|FG002|Overall Study|Protocol Violation|1|||
105730710|NCT00893789|364669290|FG003|Overall Study|Protocol Violation|4|||
105730711|NCT00893789|364669287|FG000|Overall Study|Lost to Follow-up|0|||
105730712|NCT00893789|364669288|FG001|Overall Study|Lost to Follow-up|0|||
105730713|NCT00893789|364669289|FG002|Overall Study|Lost to Follow-up|0|||
105730714|NCT00893789|364669290|FG003|Overall Study|Lost to Follow-up|1|||
105730715|NCT04723537|364669295|FG000|Overall Study|Withdrawal by Subject|3|||
105730716|NCT04723537|364669296|FG001|Overall Study|Withdrawal by Subject|0|||
105730717|NCT04723537|364669297|FG002|Overall Study|Withdrawal by Subject|0|||
105730718|NCT04723537|364669295|FG000|Overall Study|Physician Decision|0|||
105730719|NCT04723537|364669296|FG001|Overall Study|Physician Decision|0|||
105730720|NCT04723537|364669297|FG002|Overall Study|Physician Decision|1|||
105730721|NCT04723537|364669295|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
105730722|NCT04723537|364669296|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
105730723|NCT04723537|364669297|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
105479869|NCT03011892|363767636|FG011|Double Blind (DB) Period|Pregnancy|0|||
105479870|NCT03011892|363767625|FG000|Double Blind (DB) Period|Protocol Violation|1|||
105479871|NCT03011892|363767626|FG001|Double Blind (DB) Period|Protocol Violation|0|||
105479872|NCT03011892|363767627|FG002|Double Blind (DB) Period|Protocol Violation|0|||
105479873|NCT03011892|363767628|FG003|Double Blind (DB) Period|Protocol Violation|0|||
105479874|NCT03011892|363767629|FG004|Double Blind (DB) Period|Protocol Violation|0|||
105479875|NCT03011892|363767630|FG005|Double Blind (DB) Period|Protocol Violation|0|||
105479876|NCT03011892|363767631|FG006|Double Blind (DB) Period|Protocol Violation|0|||
105479877|NCT03011892|363767632|FG007|Double Blind (DB) Period|Protocol Violation|0|||
105479878|NCT03011892|363767633|FG008|Double Blind (DB) Period|Protocol Violation|0|||
105479879|NCT03011892|363767634|FG009|Double Blind (DB) Period|Protocol Violation|0|||
105479880|NCT03011892|363767635|FG010|Double Blind (DB) Period|Protocol Violation|0|||
105479881|NCT03011892|363767636|FG011|Double Blind (DB) Period|Protocol Violation|0|||
105730724|NCT02432807|364669298|FG000|Overall Study|Adverse Event|0|||
105730725|NCT02432807|364669299|FG001|Overall Study|Adverse Event|2|||
105730726|NCT02432807|364669298|FG000|Overall Study|Lost to Follow-up|1|||
105479882|NCT03011892|363767625|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
105479883|NCT03011892|363767626|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
105479884|NCT03011892|363767627|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
105730727|NCT02432807|364669299|FG001|Overall Study|Lost to Follow-up|0|||
105730728|NCT02432807|364669298|FG000|Overall Study|Withdrawal by Subject|1|||
105730729|NCT02432807|364669299|FG001|Overall Study|Withdrawal by Subject|1|||
105730730|NCT02432807|364669298|FG000|Overall Study|Other|1|||
105730731|NCT02432807|364669299|FG001|Overall Study|Other|1|||
105730732|NCT04419506|364669300|FG000|Overall Study|Adverse Event|0|||
105730733|NCT04419506|364669301|FG001|Overall Study|Adverse Event|10|||
105730734|NCT04419506|364669302|FG002|Overall Study|Adverse Event|0|||
105730735|NCT04419506|364669303|FG003|Overall Study|Adverse Event|3|||
105730736|NCT04419506|364669300|FG000|Overall Study|Withdrawal by Subject|0|||
105730737|NCT04419506|364669301|FG001|Overall Study|Withdrawal by Subject|0|||
105730738|NCT04419506|364669302|FG002|Overall Study|Withdrawal by Subject|0|||
105730739|NCT04419506|364669303|FG003|Overall Study|Withdrawal by Subject|1|||
105730740|NCT04419506|364669300|FG000|Overall Study|poor-compliance|0|||
105730741|NCT04419506|364669301|FG001|Overall Study|poor-compliance|0|||
105730742|NCT04419506|364669302|FG002|Overall Study|poor-compliance|0|||
105730743|NCT04419506|364669303|FG003|Overall Study|poor-compliance|1|||
105730744|NCT02337829|364669304|FG000|Overall Study|Death|0|||
105730745|NCT02337829|364669305|FG001|Overall Study|Death|1|||
105730746|NCT02337829|364669306|FG002|Overall Study|Death|0|||
105730747|NCT02337829|364669307|FG003|Overall Study|Death|0|||
105730748|NCT02337829|364669304|FG000|Overall Study|Study terminated by sponsor|12|||
105730749|NCT02337829|364669305|FG001|Overall Study|Study terminated by sponsor|10|||
105730750|NCT02337829|364669306|FG002|Overall Study|Study terminated by sponsor|5|||
105730751|NCT02337829|364669307|FG003|Overall Study|Study terminated by sponsor|6|||
105730752|NCT02337829|364669304|FG000|Overall Study|discontinued for other reasons|6|||
105730753|NCT02337829|364669305|FG001|Overall Study|discontinued for other reasons|3|||
105730754|NCT02337829|364669306|FG002|Overall Study|discontinued for other reasons|1|||
105730755|NCT02337829|364669307|FG003|Overall Study|discontinued for other reasons|4|||
105730756|NCT01845025|364669308|FG000|Overall Study|Adverse Event|6|||
105730757|NCT01845025|364669309|FG001|Overall Study|Adverse Event|3|||
105730758|NCT01845025|364669308|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105730759|NCT01845025|364669309|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105730760|NCT01845025|364669308|FG000|Overall Study|Withdrawal by Subject|48|||
105730761|NCT01845025|364669309|FG001|Overall Study|Withdrawal by Subject|44|||
105730762|NCT01845025|364669308|FG000|Overall Study|Lost to Follow-up|13|||
105730763|NCT01845025|364669309|FG001|Overall Study|Lost to Follow-up|13|||
105730764|NCT01845025|364669308|FG000|Overall Study|Administrative problems|8|||
105730765|NCT01845025|364669309|FG001|Overall Study|Administrative problems|8|||
105730766|NCT01845025|364669308|FG000|Overall Study|Death|2|||
105730767|NCT01845025|364669309|FG001|Overall Study|Death|0|||
105730768|NCT01845025|364669308|FG000|Overall Study|Protocol deviation|3|||
105730769|NCT01845025|364669309|FG001|Overall Study|Protocol deviation|6|||
105730770|NCT01845025|364669308|FG000|Overall Study|Missing|1|||
105730771|NCT01845025|364669309|FG001|Overall Study|Missing|1|||
105730772|NCT01486264|364669312|FG000|Overall Study|Death|1|||
105730773|NCT01486264|364669313|FG001|Overall Study|Death|1|||
105730774|NCT01486264|364669312|FG000|Overall Study|Adverse Event|3|||
105730775|NCT01486264|364669313|FG001|Overall Study|Adverse Event|3|||
105730776|NCT01486264|364669312|FG000|Overall Study|Lack of Efficacy|6|||
105730777|NCT01486264|364669313|FG001|Overall Study|Lack of Efficacy|10|||
105730778|NCT01486264|364669312|FG000|Overall Study|Withdrawal by Subject|7|||
105730779|NCT01486264|364669313|FG001|Overall Study|Withdrawal by Subject|18|||
105730780|NCT01486264|364669312|FG000|Overall Study|Physician Decision|1|||
105730781|NCT01486264|364669313|FG001|Overall Study|Physician Decision|1|||
105730782|NCT01486264|364669312|FG000|Overall Study|Protocol Violation|3|||
105730783|NCT01486264|364669313|FG001|Overall Study|Protocol Violation|0|||
105730784|NCT01486264|364669312|FG000|Overall Study|Lost to Follow-up|3|||
105479885|NCT03011892|363767628|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
105730785|NCT01486264|364669313|FG001|Overall Study|Lost to Follow-up|2|||
105730786|NCT01486264|364669312|FG000|Overall Study|Other|5|||
105730787|NCT01486264|364669313|FG001|Overall Study|Other|11|||
105730788|NCT01486264|364669312|FG000|Overall Study|Not treated|0|||
105730789|NCT01486264|364669313|FG001|Overall Study|Not treated|1|||
105730790|NCT01829048|364669316|FG000|Overall Study|Withdrawal by Subject|0|||
105730791|NCT01829048|364669317|FG001|Overall Study|Withdrawal by Subject|0|||
105730792|NCT01829048|364669318|FG002|Overall Study|Withdrawal by Subject|0|||
105730793|NCT01829048|364669319|FG003|Overall Study|Withdrawal by Subject|2|||
105730794|NCT01829048|364669320|FG004|Overall Study|Withdrawal by Subject|0|||
105730795|NCT03185130|364669323|FG000|Overall Study|Withdrawal by Subject|0|||
105797052|NCT00295620|364914628|FG000|Overall Study|Discontinuation by sponsor|580|||
105797053|NCT00295620|364914629|FG001|Overall Study|Discontinuation by sponsor|593|||
105730796|NCT03185130|364669324|FG001|Overall Study|Withdrawal by Subject|2|||
105730797|NCT01486238|364669334|FG000|Overall Study|Death|0|||
105730798|NCT01486238|364669335|FG001|Overall Study|Death|2|||
105730799|NCT01486238|364669334|FG000|Overall Study|Withdrawal by Subject|2|||
105730800|NCT01486238|364669335|FG001|Overall Study|Withdrawal by Subject|1|||
105730801|NCT01486238|364669334|FG000|Overall Study|Lost to Follow-up|0|||
105730802|NCT01486238|364669335|FG001|Overall Study|Lost to Follow-up|3|||
105730803|NCT02120417|364669342|FG000|Overall Study|Death|5|||
105730804|NCT02120417|364669343|FG001|Overall Study|Death|1|||
105730805|NCT02120417|364669342|FG000|Overall Study|Adverse Event|3|||
105730806|NCT02120417|364669343|FG001|Overall Study|Adverse Event|9|||
105730807|NCT02120417|364669342|FG000|Overall Study|Participant decision|4|||
105730808|NCT02120417|364669343|FG001|Overall Study|Participant decision|4|||
105730809|NCT02120417|364669342|FG000|Overall Study|Disease progression|41|||
105730810|NCT02120417|364669343|FG001|Overall Study|Disease progression|45|||
105730811|NCT02120417|364669342|FG000|Overall Study|Noncompliance with study treatment|0|||
105730812|NCT02120417|364669343|FG001|Overall Study|Noncompliance with study treatment|2|||
105730813|NCT02120417|364669342|FG000|Overall Study|Physician Decision|2|||
105730814|NCT02120417|364669343|FG001|Overall Study|Physician Decision|3|||
105730815|NCT02120417|364669342|FG000|Overall Study|Other unspecified|5|||
105730816|NCT02120417|364669343|FG001|Overall Study|Other unspecified|4|||
105730817|NCT01733329|364669344|FG000|Overall Study|Protocol Violation|1|||
105730818|NCT01733329|364669345|FG001|Overall Study|Protocol Violation|1|||
105730819|NCT01733329|364669344|FG000|Overall Study|Uterine artery injury|1|||
105730820|NCT01733329|364669345|FG001|Overall Study|Uterine artery injury|0|||
105730821|NCT00542828|364669346|FG000|Overall Study|Physician Decision|1|||
105730822|NCT00542828|364669346|FG000|Overall Study|Need for Prohibited Treatment|3|||
105730823|NCT00542828|364669346|FG000|Overall Study|Study Prematurely Discontinued|7|||
105730824|NCT00542828|364669346|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
105730825|NCT05502289|364669349|FG000|Period 1|Out Of Window|1|||
105730826|NCT05502289|364669350|FG001|Period 1|Out Of Window|0|||
105730827|NCT03633331|364669358|FG000|Overall Study|Withdrawal by Subject|1|||
105730828|NCT00971321|364669359|FG000|Up to Month 7|Withdrawal by Subject|1|||
105730829|NCT00971321|364669360|FG001|Up to Month 7|Withdrawal by Subject|0|||
105730830|NCT00971321|364669359|FG000|Up to Month 7|Migrated/moved from study area|3|||
105730831|NCT00971321|364669360|FG001|Up to Month 7|Migrated/moved from study area|2|||
105730832|NCT00971321|364669359|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
105730833|NCT00971321|364669360|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
105730834|NCT00971321|364669359|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
105730835|NCT00971321|364669360|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
105730836|NCT00971321|364669359|FG000|Up to Month 11-12|Lost to Follow-up|1|||
105730837|NCT00971321|364669360|FG001|Up to Month 11-12|Lost to Follow-up|0|||
105730838|NCT01824602|364669361|FG000|Overall Study|Withdrawal by Subject|0|||
105730839|NCT01824602|364669362|FG001|Overall Study|Withdrawal by Subject|0|||
105730840|NCT01824602|364669363|FG002|Overall Study|Withdrawal by Subject|1|||
105730841|NCT01824602|364669364|FG003|Overall Study|Withdrawal by Subject|2|||
105730842|NCT01824602|364669361|FG000|Overall Study|Patient non-compliance|0|||
105730843|NCT01824602|364669362|FG001|Overall Study|Patient non-compliance|0|||
105730844|NCT01824602|364669363|FG002|Overall Study|Patient non-compliance|1|||
105730845|NCT01824602|364669364|FG003|Overall Study|Patient non-compliance|0|||
105730846|NCT01824602|364669361|FG000|Overall Study|Adverse Event|1|||
105730847|NCT01824602|364669362|FG001|Overall Study|Adverse Event|0|||
105730848|NCT01824602|364669363|FG002|Overall Study|Adverse Event|2|||
105730849|NCT01824602|364669364|FG003|Overall Study|Adverse Event|2|||
105730850|NCT01824602|364669361|FG000|Overall Study|Treatment failure|0|||
105730851|NCT01824602|364669362|FG001|Overall Study|Treatment failure|0|||
105730852|NCT01824602|364669363|FG002|Overall Study|Treatment failure|0|||
105730853|NCT01824602|364669364|FG003|Overall Study|Treatment failure|1|||
105730854|NCT02485717|364669367|FG000|Overall Study|Lost to Follow-up|6|||
105730855|NCT02485717|364669368|FG001|Overall Study|Lost to Follow-up|0|||
105730856|NCT02485717|364669369|FG002|Overall Study|Lost to Follow-up|0|||
105730857|NCT02485717|364669367|FG000|Overall Study|Withdrawal by Subject|0|||
105730858|NCT02485717|364669368|FG001|Overall Study|Withdrawal by Subject|0|||
105730859|NCT02485717|364669369|FG002|Overall Study|Withdrawal by Subject|1|||
105730860|NCT02485717|364669367|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
105730861|NCT02485717|364669368|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
105730862|NCT02485717|364669369|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
105730863|NCT02485717|364669367|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
105730864|NCT02485717|364669368|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
105730865|NCT02485717|364669369|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
105730866|NCT00761215|364669370|FG000|Overall Study|Randomized but didn't receive drug|1|||
105730867|NCT00761215|364669371|FG001|Overall Study|Randomized but didn't receive drug|1|||
105730868|NCT00761215|364669372|FG002|Overall Study|Randomized but didn't receive drug|2|||
105730869|NCT00761215|364669370|FG000|Overall Study|Lost to Follow-up|6|||
105730870|NCT00761215|364669371|FG001|Overall Study|Lost to Follow-up|3|||
105730871|NCT00761215|364669372|FG002|Overall Study|Lost to Follow-up|6|||
105730872|NCT00761215|364669370|FG000|Overall Study|Withdrawal by Subject|1|||
105730873|NCT00761215|364669371|FG001|Overall Study|Withdrawal by Subject|0|||
105730874|NCT00761215|364669372|FG002|Overall Study|Withdrawal by Subject|0|||
105730875|NCT00761215|364669370|FG000|Overall Study|Bacteremia|1|||
105730876|NCT00761215|364669371|FG001|Overall Study|Bacteremia|0|||
105730877|NCT00761215|364669372|FG002|Overall Study|Bacteremia|0|||
105730878|NCT00519532|364669373|FG000|Overall Study|Adverse Event|11|||
105730879|NCT00519532|364669373|FG000|Overall Study|Withdrawal by Subject|5|||
105730880|NCT00519532|364669373|FG000|Overall Study|Lost to Follow-up|2|||
105730881|NCT00667277|364669374|FG000|Overall Study|Withdrawal by Subject|2|||
105730882|NCT03138564|364669375|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
105730883|NCT03138564|364669376|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
105730884|NCT03138564|364669375|FG000|Overall Study|Lost to Follow-up|16|||
105730885|NCT03138564|364669376|FG001|Overall Study|Lost to Follow-up|2|||
105730886|NCT03138564|364669375|FG000|Overall Study|Withdrawal by Subject|48|||
105730887|NCT03138564|364669376|FG001|Overall Study|Withdrawal by Subject|4|||
105730888|NCT03138564|364669375|FG000|Overall Study|No longer met eligibility criteria|2|||
105730889|NCT03138564|364669376|FG001|Overall Study|No longer met eligibility criteria|0|||
105730890|NCT03138564|364669375|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
105730891|NCT03138564|364669376|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
105730892|NCT03138564|364669375|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
105730893|NCT03138564|364669376|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
105730894|NCT03138564|364669375|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
105730895|NCT03138564|364669376|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
105730896|NCT03138564|364669375|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
105730897|NCT03138564|364669376|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
105730898|NCT00814710|364669377|FG000|Overall Study|Adverse Event|1|||
105730899|NCT00814710|364669378|FG001|Overall Study|Adverse Event|0|||
105730900|NCT00814710|364669377|FG000|Overall Study|Lost to Follow-up|7|||
105730901|NCT00814710|364669378|FG001|Overall Study|Lost to Follow-up|3|||
105730902|NCT01450137|364669380|FG000|Up to Week 12|Adverse Event|2|||
105730903|NCT01450137|364669381|FG001|Up to Week 12|Adverse Event|1|||
105730904|NCT01450137|364669380|FG000|Up to Week 12|Withdrawal by Subject|0|||
105730905|NCT01450137|364669381|FG001|Up to Week 12|Withdrawal by Subject|2|||
105730906|NCT01450137|364669380|FG000|Week 12 to Study End|Death|0|||
105730907|NCT01450137|364669381|FG001|Week 12 to Study End|Death|1|||
105730908|NCT01450137|364669380|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
105730909|NCT01450137|364669381|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
105730910|NCT04458857|364669382|FG000|Overall Study|Adverse Event|0|||
105730911|NCT04458857|364669383|FG001|Overall Study|Adverse Event|1|||
105730912|NCT04458857|364669384|FG002|Overall Study|Adverse Event|0|||
105730913|NCT04458857|364669382|FG000|Overall Study|Withdrawal by Subject|2|||
105730914|NCT04458857|364669383|FG001|Overall Study|Withdrawal by Subject|0|||
105730915|NCT04458857|364669384|FG002|Overall Study|Withdrawal by Subject|0|||
105730916|NCT04458857|364669382|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105730917|NCT04458857|364669383|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105730918|NCT04458857|364669384|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105730919|NCT04458857|364669382|FG000|Overall Study|Non-compliance with study drug|0|||
105730920|NCT04458857|364669383|FG001|Overall Study|Non-compliance with study drug|1|||
105730921|NCT04458857|364669384|FG002|Overall Study|Non-compliance with study drug|0|||
105730922|NCT04458857|364669382|FG000|Overall Study|Lost to Follow-up|4|||
105730923|NCT04458857|364669383|FG001|Overall Study|Lost to Follow-up|1|||
105730924|NCT04458857|364669384|FG002|Overall Study|Lost to Follow-up|0|||
105730925|NCT03851510|364669385|FG000|Overall Study|Screen Fail|1|||
105730926|NCT03851510|364669385|FG000|Overall Study|Adverse Event|1|||
105730927|NCT03851510|364669385|FG000|Overall Study|Withdrawal by Subject|1|||
105730928|NCT03191786|364669386|FG000|Overall Study|Death|236|||
105730929|NCT03191786|364669387|FG001|Overall Study|Death|127|||
105730930|NCT03191786|364669386|FG000|Overall Study|Lost to Follow-up|9|||
105730931|NCT03191786|364669387|FG001|Overall Study|Lost to Follow-up|3|||
105730932|NCT03191786|364669386|FG000|Overall Study|Physician Decision|1|||
105730933|NCT03191786|364669387|FG001|Overall Study|Physician Decision|0|||
105730934|NCT03191786|364669386|FG000|Overall Study|Moved to Post Trial Access Program|30|||
105730935|NCT03191786|364669387|FG001|Overall Study|Moved to Post Trial Access Program|5|||
105730936|NCT03191786|364669386|FG000|Overall Study|Withdrawal by Subject|26|||
105730937|NCT03191786|364669387|FG001|Overall Study|Withdrawal by Subject|16|||
105730938|NCT03937986|364671526|FG000|Overall Study|COVID-19 Pandemic|1|||
105730939|NCT01981187|364671527|FG000|Overall Study|Participant/guardian decision|2|||
105730940|NCT01981187|364671527|FG000|Overall Study|Physician Decision|1|||
105730941|NCT01981187|364671527|FG000|Overall Study|Disease progression|2|||
105730942|NCT01981187|364671527|FG000|Overall Study|Adverse Event|7|||
105730943|NCT02413255|364671528|FG000|Overall Study|Voluntary Withdrawal|0|||
105730944|NCT02413255|364671529|FG001|Overall Study|Voluntary Withdrawal|0|||
105730945|NCT02413255|364671530|FG002|Overall Study|Voluntary Withdrawal|0|||
105730946|NCT02413255|364671531|FG003|Overall Study|Voluntary Withdrawal|0|||
105730947|NCT02413255|364671532|FG004|Overall Study|Voluntary Withdrawal|0|||
105730948|NCT02413255|364671533|FG005|Overall Study|Voluntary Withdrawal|0|||
105730949|NCT02413255|364671534|FG006|Overall Study|Voluntary Withdrawal|0|||
105730950|NCT02413255|364671535|FG007|Overall Study|Voluntary Withdrawal|0|||
105730951|NCT02413255|364671536|FG008|Overall Study|Voluntary Withdrawal|0|||
105730952|NCT02413255|364671537|FG009|Overall Study|Voluntary Withdrawal|0|||
105730953|NCT02413255|364671538|FG010|Overall Study|Voluntary Withdrawal|0|||
105730954|NCT02413255|364671539|FG011|Overall Study|Voluntary Withdrawal|0|||
105730955|NCT02413255|364671540|FG012|Overall Study|Voluntary Withdrawal|0|||
105730956|NCT02413255|364671541|FG013|Overall Study|Voluntary Withdrawal|0|||
105730957|NCT02413255|364671542|FG014|Overall Study|Voluntary Withdrawal|1|||
105730958|NCT02413255|364671543|FG015|Overall Study|Voluntary Withdrawal|0|||
105730959|NCT02413255|364671544|FG016|Overall Study|Voluntary Withdrawal|0|||
105730960|NCT02333331|364671545|FG000|Overall Study|Adverse Event|1|||
105730961|NCT02333331|364671546|FG001|Overall Study|Adverse Event|0|||
105730962|NCT02333331|364671547|FG002|Overall Study|Adverse Event|4|||
105730963|NCT02333331|364671548|FG003|Overall Study|Adverse Event|1|||
105730964|NCT02333331|364671545|FG000|Overall Study|Death|0|||
105730965|NCT02333331|364671546|FG001|Overall Study|Death|0|||
105730966|NCT02333331|364671547|FG002|Overall Study|Death|2|||
105730967|NCT02333331|364671548|FG003|Overall Study|Death|0|||
105730968|NCT02333331|364671545|FG000|Overall Study|Lost to Follow-up|0|||
105730969|NCT02333331|364671546|FG001|Overall Study|Lost to Follow-up|0|||
105730970|NCT02333331|364671547|FG002|Overall Study|Lost to Follow-up|1|||
105730971|NCT02333331|364671548|FG003|Overall Study|Lost to Follow-up|0|||
105730972|NCT02333331|364671545|FG000|Overall Study|Physician Decision|0|||
105730973|NCT02333331|364671546|FG001|Overall Study|Physician Decision|1|||
105730974|NCT02333331|364671547|FG002|Overall Study|Physician Decision|0|||
105730975|NCT02333331|364671548|FG003|Overall Study|Physician Decision|0|||
105730976|NCT02333331|364671545|FG000|Overall Study|Protocol Deviation|0|||
105730977|NCT02333331|364671546|FG001|Overall Study|Protocol Deviation|3|||
105730978|NCT02333331|364671547|FG002|Overall Study|Protocol Deviation|2|||
105730979|NCT02333331|364671548|FG003|Overall Study|Protocol Deviation|1|||
105730980|NCT02333331|364671545|FG000|Overall Study|Patient/Guardian Decision|1|||
105730981|NCT02333331|364671546|FG001|Overall Study|Patient/Guardian Decision|2|||
105730982|NCT02333331|364671547|FG002|Overall Study|Patient/Guardian Decision|9|||
105730983|NCT02333331|364671548|FG003|Overall Study|Patient/Guardian Decision|1|||
105730984|NCT05882890|364671549|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
105730985|NCT02158533|364671551|FG000|Stage 1|Adverse Event|6|||
105730986|NCT02158533|364671552|FG001|Stage 1|Adverse Event|4|||
105730987|NCT02158533|364671553|FG002|Stage 1|Adverse Event|7|||
105730988|NCT02158533|364671554|FG003|Stage 1|Adverse Event|0|||
105730989|NCT02158533|364671555|FG004|Stage 1|Adverse Event|0|||
105730990|NCT02158533|364671556|FG005|Stage 1|Adverse Event|0|||
105730991|NCT02158533|364671551|FG000|Stage 1|Withdrawal by Subject|3|||
105730992|NCT02158533|364671552|FG001|Stage 1|Withdrawal by Subject|2|||
105730993|NCT02158533|364671553|FG002|Stage 1|Withdrawal by Subject|1|||
105730994|NCT02158533|364671554|FG003|Stage 1|Withdrawal by Subject|0|||
105730995|NCT02158533|364671555|FG004|Stage 1|Withdrawal by Subject|0|||
105730996|NCT02158533|364671556|FG005|Stage 1|Withdrawal by Subject|0|||
105730997|NCT02158533|364671551|FG000|Stage 1|Lack of Efficacy|1|||
105730998|NCT02158533|364671552|FG001|Stage 1|Lack of Efficacy|0|||
105730999|NCT02158533|364671553|FG002|Stage 1|Lack of Efficacy|0|||
105731000|NCT02158533|364671554|FG003|Stage 1|Lack of Efficacy|0|||
105731001|NCT02158533|364671555|FG004|Stage 1|Lack of Efficacy|0|||
105731002|NCT02158533|364671556|FG005|Stage 1|Lack of Efficacy|0|||
105731003|NCT02158533|364671551|FG000|Stage 1|Lost to Follow-up|3|||
105731004|NCT02158533|364671552|FG001|Stage 1|Lost to Follow-up|1|||
105731005|NCT02158533|364671553|FG002|Stage 1|Lost to Follow-up|0|||
105731006|NCT02158533|364671554|FG003|Stage 1|Lost to Follow-up|0|||
105731007|NCT02158533|364671555|FG004|Stage 1|Lost to Follow-up|0|||
105731008|NCT02158533|364671556|FG005|Stage 1|Lost to Follow-up|0|||
105731009|NCT02158533|364671551|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
105731010|NCT02158533|364671552|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
105731011|NCT02158533|364671553|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
105731012|NCT02158533|364671554|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
105731013|NCT02158533|364671555|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
105731014|NCT02158533|364671556|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
105731015|NCT02158533|364671551|FG000|Stage 1|Non-compliance with study visits|1|||
105731016|NCT02158533|364671552|FG001|Stage 1|Non-compliance with study visits|0|||
105731017|NCT02158533|364671553|FG002|Stage 1|Non-compliance with study visits|0|||
105731018|NCT02158533|364671554|FG003|Stage 1|Non-compliance with study visits|0|||
105731019|NCT02158533|364671555|FG004|Stage 1|Non-compliance with study visits|0|||
105731020|NCT02158533|364671556|FG005|Stage 1|Non-compliance with study visits|0|||
105731021|NCT02158533|364671551|FG000|Stage 2|Adverse Event|0|||
105731022|NCT02158533|364671552|FG001|Stage 2|Adverse Event|0|||
105731023|NCT02158533|364671553|FG002|Stage 2|Adverse Event|0|||
105731024|NCT02158533|364671554|FG003|Stage 2|Adverse Event|0|||
105731025|NCT02158533|364671555|FG004|Stage 2|Adverse Event|0|||
105731026|NCT02158533|364671556|FG005|Stage 2|Adverse Event|1|||
105731027|NCT02158533|364671551|FG000|Stage 2|Lack of Efficacy|0|||
105731028|NCT02158533|364671552|FG001|Stage 2|Lack of Efficacy|0|||
105731029|NCT02158533|364671553|FG002|Stage 2|Lack of Efficacy|0|||
105731030|NCT02158533|364671554|FG003|Stage 2|Lack of Efficacy|0|||
105731031|NCT02158533|364671555|FG004|Stage 2|Lack of Efficacy|1|||
105731032|NCT02158533|364671556|FG005|Stage 2|Lack of Efficacy|0|||
105731033|NCT02158533|364671551|FG000|Stage 2|Lost to Follow-up|0|||
105731034|NCT02158533|364671552|FG001|Stage 2|Lost to Follow-up|0|||
105731035|NCT02158533|364671553|FG002|Stage 2|Lost to Follow-up|0|||
105731036|NCT02158533|364671554|FG003|Stage 2|Lost to Follow-up|1|||
105731037|NCT02158533|364671555|FG004|Stage 2|Lost to Follow-up|1|||
105731038|NCT02158533|364671556|FG005|Stage 2|Lost to Follow-up|2|||
105731039|NCT02158533|364671551|FG000|Stage 2|Withdrawal by Subject|0|||
105731040|NCT02158533|364671552|FG001|Stage 2|Withdrawal by Subject|0|||
105731041|NCT02158533|364671553|FG002|Stage 2|Withdrawal by Subject|0|||
105731042|NCT02158533|364671554|FG003|Stage 2|Withdrawal by Subject|0|||
105731043|NCT02158533|364671555|FG004|Stage 2|Withdrawal by Subject|1|||
105731044|NCT02158533|364671556|FG005|Stage 2|Withdrawal by Subject|2|||
105731045|NCT02158533|364671551|FG000|Stage 2|Physician Decision|0|||
105731046|NCT02158533|364671552|FG001|Stage 2|Physician Decision|0|||
105731047|NCT02158533|364671553|FG002|Stage 2|Physician Decision|0|||
105731048|NCT02158533|364671554|FG003|Stage 2|Physician Decision|0|||
105731049|NCT02158533|364671555|FG004|Stage 2|Physician Decision|1|||
105731050|NCT02158533|364671556|FG005|Stage 2|Physician Decision|0|||
105731051|NCT02158533|364671551|FG000|Stage 2|Pregnancy|0|||
105731052|NCT02158533|364671552|FG001|Stage 2|Pregnancy|0|||
105731053|NCT02158533|364671553|FG002|Stage 2|Pregnancy|0|||
105731054|NCT02158533|364671554|FG003|Stage 2|Pregnancy|1|||
105731055|NCT02158533|364671555|FG004|Stage 2|Pregnancy|0|||
105731056|NCT02158533|364671556|FG005|Stage 2|Pregnancy|0|||
105731057|NCT02158533|364671551|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
105731058|NCT02158533|364671552|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
105731059|NCT02158533|364671553|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
105731060|NCT02158533|364671554|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
105731061|NCT02158533|364671555|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
105731062|NCT02158533|364671556|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
105731063|NCT02158533|364671551|FG000|Stage 2|Non-adherence with study visits|0|||
105731064|NCT02158533|364671552|FG001|Stage 2|Non-adherence with study visits|0|||
105731065|NCT02158533|364671553|FG002|Stage 2|Non-adherence with study visits|0|||
105731066|NCT02158533|364671554|FG003|Stage 2|Non-adherence with study visits|0|||
105731067|NCT02158533|364671555|FG004|Stage 2|Non-adherence with study visits|0|||
105731068|NCT02158533|364671556|FG005|Stage 2|Non-adherence with study visits|1|||
105731069|NCT04329949|364671561|FG000|Overall Study|Death|36|||
105731070|NCT04329949|364671561|FG000|Overall Study|Withdrawal by Subject|4|||
105731071|NCT04329949|364671561|FG000|Overall Study|Termination of study by sponsor|3|||
105731072|NCT02037919|364671562|FG000|Overall Study|Lost to Follow-up|30|||
105731073|NCT02037919|364671563|FG001|Overall Study|Lost to Follow-up|45|||
105731074|NCT00345605|364671570|FG000|Arm 1|Adverse Event|0|||
105731075|NCT00345605|364671571|FG001|Arm 1|Adverse Event|1|||
105479886|NCT03011892|363767629|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
105479887|NCT03011892|363767630|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
105731076|NCT00345605|364671570|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
105731077|NCT00345605|364671571|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
105731078|NCT01335971|364671572|FG000|Overall Study|Withdrawal by Subject|1|||
105731079|NCT01335971|364671573|FG001|Overall Study|Withdrawal by Subject|0|||
105731080|NCT01335971|364671574|FG002|Overall Study|Withdrawal by Subject|0|||
105731081|NCT01335971|364671572|FG000|Overall Study|Did not complete bronchoscopy|1|||
105731082|NCT01335971|364671573|FG001|Overall Study|Did not complete bronchoscopy|1|||
105731083|NCT01335971|364671574|FG002|Overall Study|Did not complete bronchoscopy|1|||
105731084|NCT00384956|364671575|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
105731085|NCT00917384|364671583|FG000|Overall Study|Lost to Follow-up|4|||
105479888|NCT03011892|363767631|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
105479889|NCT03011892|363767632|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
105479890|NCT03011892|363767633|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
105479891|NCT03011892|363767634|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
105479892|NCT03011892|363767635|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
105479893|NCT03011892|363767636|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
105479894|NCT03011892|363767625|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
105479895|NCT03011892|363767626|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
105479896|NCT03011892|363767627|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
105479897|NCT03011892|363767628|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
105479898|NCT03011892|363767629|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
105479899|NCT03011892|363767630|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
105479900|NCT03011892|363767631|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
105479901|NCT03011892|363767632|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
105479902|NCT03011892|363767633|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
105479903|NCT03011892|363767634|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
105479904|NCT03011892|363767635|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
105479905|NCT03011892|363767636|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
105479906|NCT03011892|363767625|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
105479907|NCT03011892|363767626|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
105479908|NCT03011892|363767627|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
105479909|NCT03011892|363767628|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
105479910|NCT03011892|363767629|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
105479911|NCT03011892|363767630|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
105479912|NCT03011892|363767631|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
105479913|NCT03011892|363767632|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
105479914|NCT03011892|363767633|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
105479915|NCT03011892|363767634|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
105479916|NCT03011892|363767635|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
105479917|NCT03011892|363767636|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
105479918|NCT03011892|363767625|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
105731086|NCT00917384|364671584|FG001|Overall Study|Lost to Follow-up|2|||
105731087|NCT00917384|364671583|FG000|Overall Study|Withdrawal by Subject|10|||
105731088|NCT00917384|364671584|FG001|Overall Study|Withdrawal by Subject|2|||
105731089|NCT05299892|364671586|FG000|Overall Study|Withdrawal by Subject|2|||
105479919|NCT03011892|363767626|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
105731090|NCT03180736|364671587|FG000|Overall Study|Adverse Event|3|||
105731091|NCT03180736|364671588|FG001|Overall Study|Adverse Event|4|||
105731092|NCT03180736|364671587|FG000|Overall Study|Death|10|||
105731093|NCT03180736|364671588|FG001|Overall Study|Death|7|||
105731094|NCT03180736|364671587|FG000|Overall Study|Withdrawal by Subject|5|||
105731095|NCT03180736|364671588|FG001|Overall Study|Withdrawal by Subject|12|||
105731096|NCT03180736|364671587|FG000|Overall Study|Lost to Follow-up|1|||
105731097|NCT03180736|364671588|FG001|Overall Study|Lost to Follow-up|0|||
105731098|NCT03180736|364671587|FG000|Overall Study|Lack of Efficacy|66|||
105731099|NCT03180736|364671588|FG001|Overall Study|Lack of Efficacy|87|||
105731100|NCT03180736|364671587|FG000|Overall Study|Physician Decision|4|||
105731101|NCT03180736|364671588|FG001|Overall Study|Physician Decision|7|||
105731102|NCT03180736|364671587|FG000|Overall Study|randomized but not treated|2|||
105731103|NCT03180736|364671588|FG001|Overall Study|randomized but not treated|3|||
105731104|NCT03351244|364671592|FG000|Overall Study|Adverse Event|7|||
105731105|NCT03351244|364671593|FG001|Overall Study|Adverse Event|11|||
105731106|NCT03351244|364671594|FG002|Overall Study|Adverse Event|12|||
105731107|NCT03351244|364671592|FG000|Overall Study|Investigator's decision|0|||
105731108|NCT03351244|364671593|FG001|Overall Study|Investigator's decision|0|||
105731109|NCT03351244|364671594|FG002|Overall Study|Investigator's decision|2|||
105731110|NCT03351244|364671592|FG000|Overall Study|System error|0|||
105731111|NCT03351244|364671593|FG001|Overall Study|System error|0|||
105731112|NCT03351244|364671594|FG002|Overall Study|System error|2|||
105731113|NCT03351244|364671592|FG000|Overall Study|COVID-19 restrictions|3|||
105731114|NCT03351244|364671593|FG001|Overall Study|COVID-19 restrictions|0|||
105731115|NCT03351244|364671594|FG002|Overall Study|COVID-19 restrictions|1|||
105731116|NCT03351244|364671592|FG000|Overall Study|Non-compliance|2|||
105731117|NCT03351244|364671593|FG001|Overall Study|Non-compliance|5|||
105731118|NCT03351244|364671594|FG002|Overall Study|Non-compliance|0|||
105731119|NCT03351244|364671592|FG000|Overall Study|Withdrawal by Subject|11|||
105479920|NCT03011892|363767627|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
105731120|NCT03351244|364671593|FG001|Overall Study|Withdrawal by Subject|16|||
105731121|NCT03351244|364671594|FG002|Overall Study|Withdrawal by Subject|13|||
105731122|NCT03351244|364671592|FG000|Overall Study|Lost to Follow-up|2|||
105731123|NCT03351244|364671593|FG001|Overall Study|Lost to Follow-up|6|||
105731124|NCT03351244|364671594|FG002|Overall Study|Lost to Follow-up|4|||
105479921|NCT03011892|363767628|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
105731125|NCT03351244|364671592|FG000|Overall Study|Protocol Violation|2|||
105731126|NCT03351244|364671593|FG001|Overall Study|Protocol Violation|2|||
105479922|NCT03011892|363767629|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
105479923|NCT03011892|363767630|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
105479924|NCT03011892|363767631|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
105479925|NCT03011892|363767632|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
105479926|NCT03011892|363767633|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
105479927|NCT03011892|363767634|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
105479928|NCT03011892|363767635|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
105479929|NCT03011892|363767636|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
105479930|NCT03011892|363767625|FG000|Open Label (OL) Period|Reason not specified|0|||
105731127|NCT03351244|364671594|FG002|Overall Study|Protocol Violation|0|||
105731128|NCT03794986|364671595|FG000|Overall Study|0 Sessions Attended|34|||
105731129|NCT03794986|364671596|FG001|Overall Study|0 Sessions Attended|37|||
105731130|NCT03794986|364671595|FG000|Overall Study|Withdrawal by Subject|4|||
105731131|NCT03794986|364671596|FG001|Overall Study|Withdrawal by Subject|6|||
105731132|NCT03794986|364671595|FG000|Overall Study|Protocol Violation|1|||
105731133|NCT03794986|364671596|FG001|Overall Study|Protocol Violation|0|||
105731134|NCT00728416|364671598|FG000|Overall Study|Adverse Event|1|||
105731135|NCT00728416|364671599|FG001|Overall Study|Adverse Event|1|||
105731136|NCT00728416|364671598|FG000|Overall Study|Treatment Failure|0|||
105731137|NCT00728416|364671599|FG001|Overall Study|Treatment Failure|1|||
105731138|NCT00728416|364671598|FG000|Overall Study|Withdrawal by Subject|1|||
105731139|NCT00728416|364671599|FG001|Overall Study|Withdrawal by Subject|0|||
105731140|NCT04375878|364671602|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
105731141|NCT04375878|364671603|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
105731142|NCT04375878|364671604|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
105731143|NCT04375878|364671605|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
105731144|NCT04375878|364671606|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
105731145|NCT04375878|364671607|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
105731146|NCT04375878|364671602|FG000|Crossover First and Second Interventions|Adverse Event|0|||
105731147|NCT04375878|364671603|FG001|Crossover First and Second Interventions|Adverse Event|0|||
105731148|NCT04375878|364671604|FG002|Crossover First and Second Interventions|Adverse Event|1|||
105731149|NCT04375878|364671605|FG003|Crossover First and Second Interventions|Adverse Event|0|||
105731150|NCT04375878|364671606|FG004|Crossover First and Second Interventions|Adverse Event|0|||
105731151|NCT04375878|364671607|FG005|Crossover First and Second Interventions|Adverse Event|0|||
105731152|NCT04375878|364671602|FG000|Extension Phase|Withdrawal by Subject|0|||
105731153|NCT04375878|364671603|FG001|Extension Phase|Withdrawal by Subject|0|||
105731154|NCT04375878|364671604|FG002|Extension Phase|Withdrawal by Subject|0|||
105731155|NCT04375878|364671605|FG003|Extension Phase|Withdrawal by Subject|0|||
105731156|NCT04375878|364671606|FG004|Extension Phase|Withdrawal by Subject|1|||
105731157|NCT04375878|364671607|FG005|Extension Phase|Withdrawal by Subject|0|||
105731158|NCT01254344|364671608|FG000|Overall Study|Adverse Event|2|||
105731159|NCT01254344|364671609|FG001|Overall Study|Adverse Event|5|||
105731160|NCT01254344|364671608|FG000|Overall Study|Physician Decision|7|||
105731161|NCT01254344|364671609|FG001|Overall Study|Physician Decision|4|||
105731162|NCT01254344|364671608|FG000|Overall Study|Protocol Violation|1|||
105731163|NCT01254344|364671609|FG001|Overall Study|Protocol Violation|4|||
105731164|NCT01254344|364671608|FG000|Overall Study|Withdrawal by Subject|3|||
105731165|NCT01254344|364671609|FG001|Overall Study|Withdrawal by Subject|6|||
105731166|NCT03022461|364671610|FG000|Overall Study|Death|3|||
105731167|NCT00754390|364671611|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
105731168|NCT00754390|364671611|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
105731169|NCT00754390|364671611|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
105731170|NCT00754390|364671611|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
105731171|NCT01856673|364671614|FG000|Overall Study|Withdrawal by Subject|44|||
105731172|NCT01856673|364671615|FG001|Overall Study|Withdrawal by Subject|50|||
105731173|NCT01856673|364671616|FG002|Overall Study|Withdrawal by Subject|33|||
105731174|NCT01856673|364671614|FG000|Overall Study|Lost to Follow-up|31|||
105731175|NCT01856673|364671615|FG001|Overall Study|Lost to Follow-up|34|||
105731176|NCT01856673|364671616|FG002|Overall Study|Lost to Follow-up|0|||
105731177|NCT01856673|364671614|FG000|Overall Study|Unknown reasons|9|||
105731178|NCT01856673|364671615|FG001|Overall Study|Unknown reasons|0|||
105731179|NCT01856673|364671616|FG002|Overall Study|Unknown reasons|0|||
105479931|NCT03011892|363767626|FG001|Open Label (OL) Period|Reason not specified|0|||
105731180|NCT01856673|364671614|FG000|Overall Study|Psychologist decision|1|||
105731181|NCT01856673|364671615|FG001|Overall Study|Psychologist decision|0|||
105731182|NCT01856673|364671616|FG002|Overall Study|Psychologist decision|0|||
105731183|NCT01856673|364671614|FG000|Overall Study|Paperwork errors|8|||
105731184|NCT01856673|364671615|FG001|Overall Study|Paperwork errors|0|||
105731185|NCT01856673|364671616|FG002|Overall Study|Paperwork errors|0|||
105731186|NCT01856673|364671614|FG000|Overall Study|Death|1|||
105731187|NCT01856673|364671615|FG001|Overall Study|Death|1|||
105731188|NCT01856673|364671616|FG002|Overall Study|Death|0|||
105479932|NCT03011892|363767627|FG002|Open Label (OL) Period|Reason not specified|0|||
105479933|NCT03011892|363767628|FG003|Open Label (OL) Period|Reason not specified|0|||
105479934|NCT03011892|363767629|FG004|Open Label (OL) Period|Reason not specified|0|||
105479935|NCT03011892|363767630|FG005|Open Label (OL) Period|Reason not specified|0|||
105479936|NCT03011892|363767631|FG006|Open Label (OL) Period|Reason not specified|0|||
105479937|NCT03011892|363767632|FG007|Open Label (OL) Period|Reason not specified|1|||
105479938|NCT03011892|363767633|FG008|Open Label (OL) Period|Reason not specified|0|||
105479939|NCT03011892|363767634|FG009|Open Label (OL) Period|Reason not specified|0|||
105479940|NCT03011892|363767635|FG010|Open Label (OL) Period|Reason not specified|0|||
105479941|NCT03011892|363767636|FG011|Open Label (OL) Period|Reason not specified|0|||
105479942|NCT02282293|363767637|FG000|Overall Study|Lost to Follow-up|2|||
105479943|NCT02282293|363767638|FG001|Overall Study|Lost to Follow-up|2|||
105479944|NCT02282293|363767637|FG000|Overall Study|Unable to comply with study procedures|1|||
105479945|NCT02282293|363767638|FG001|Overall Study|Unable to comply with study procedures|0|||
105479946|NCT02282293|363767637|FG000|Overall Study|Moved out of study area|0|||
105479947|NCT02282293|363767638|FG001|Overall Study|Moved out of study area|1|||
105479948|NCT00821509|363767639|FG000|Overall Study|Withdrawal by Subject|12|||
105731189|NCT01856673|364671614|FG000|Overall Study|Protocol Violation|1|||
105731190|NCT01856673|364671615|FG001|Overall Study|Protocol Violation|0|||
105731191|NCT01856673|364671616|FG002|Overall Study|Protocol Violation|1|||
105731192|NCT01273818|364671617|FG000|Overall Study|Physician Decision|13|||
105731193|NCT01273818|364671618|FG001|Overall Study|Physician Decision|2|||
105731194|NCT01273818|364671619|FG002|Overall Study|Physician Decision|9|||
105731195|NCT02436239|364671624|FG000|Open-Lable Treatment Period|Adverse Event|12|||
105731196|NCT02436239|364671625|FG001|Open-Lable Treatment Period|Adverse Event|3|||
105731197|NCT02436239|364671626|FG002|Open-Lable Treatment Period|Adverse Event|4|||
105731198|NCT02436239|364671627|FG003|Open-Lable Treatment Period|Adverse Event|2|||
105731199|NCT02436239|364671624|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
105731200|NCT02436239|364671625|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
105731201|NCT02436239|364671626|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
105731202|NCT02436239|364671627|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
105731203|NCT02436239|364671624|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
105731204|NCT02436239|364671625|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
105731205|NCT02436239|364671626|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
105731206|NCT02436239|364671627|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
105731207|NCT02436239|364671624|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
105731208|NCT02436239|364671625|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
105731209|NCT02436239|364671626|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
105731210|NCT02436239|364671627|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
105731211|NCT02436239|364671624|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
105731212|NCT02436239|364671625|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
105731213|NCT02436239|364671626|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
105731214|NCT02436239|364671627|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
105731215|NCT02436239|364671624|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
105731216|NCT02436239|364671625|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
105731217|NCT02436239|364671626|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
105731218|NCT02436239|364671627|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
105731219|NCT02436239|364671624|FG000|Open-Lable Treatment Period|Other Reason|1|||
105731220|NCT02436239|364671625|FG001|Open-Lable Treatment Period|Other Reason|1|||
105731221|NCT02436239|364671626|FG002|Open-Lable Treatment Period|Other Reason|0|||
105731222|NCT02436239|364671627|FG003|Open-Lable Treatment Period|Other Reason|0|||
105731223|NCT02436239|364671624|FG000|Down-Taper Period|Withdrawal by Subject|4|||
105731224|NCT02436239|364671625|FG001|Down-Taper Period|Withdrawal by Subject|4|||
105731225|NCT02436239|364671626|FG002|Down-Taper Period|Withdrawal by Subject|1|||
105731226|NCT02436239|364671627|FG003|Down-Taper Period|Withdrawal by Subject|2|||
105731227|NCT00104871|364671631|FG000|Overall Study|Not evaluable|1|||
105731228|NCT01548638|364671632|FG000|Overall Study|Protocol Violation|3|||
105731229|NCT01548638|364671632|FG000|Overall Study|Withdrawal by Subject|1|||
105731230|NCT05593432|364671633|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
105731231|NCT05593432|364671634|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
105731232|NCT05593432|364671635|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
105731233|NCT05593432|364671636|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
105731234|NCT05593432|364671633|FG000|16-Week OLE Period|Lack of Efficacy|0|||
105479949|NCT00821509|363767640|FG001|Overall Study|Withdrawal by Subject|11|||
105479950|NCT00821509|363767641|FG002|Overall Study|Withdrawal by Subject|34|||
105479951|NCT04054947|363767642|FG000|Overall Study|Withdrawal by Subject|1|||
105479952|NCT04054947|363767643|FG001|Overall Study|Withdrawal by Subject|0|||
105479953|NCT04054947|363767642|FG000|Overall Study|Lost to Follow-up|2|||
105479954|NCT04054947|363767643|FG001|Overall Study|Lost to Follow-up|5|||
105564976|NCT02220894|364065368|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
105731235|NCT05593432|364671634|FG001|16-Week OLE Period|Lack of Efficacy|0|||
105731236|NCT05593432|364671635|FG002|16-Week OLE Period|Lack of Efficacy|0|||
105731237|NCT05593432|364671636|FG003|16-Week OLE Period|Lack of Efficacy|1|||
105479955|NCT04463069|363767644|FG000|Overall Study|Withdrawal by Subject|2|||
105479956|NCT04463069|363767645|FG001|Overall Study|Withdrawal by Subject|10|||
105479957|NCT04463069|363767644|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
105479958|NCT04463069|363767645|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
105479959|NCT01181986|363767646|FG000|Phase 1|Lost to Follow-up|0|||
105479960|NCT01181986|363767647|FG001|Phase 1|Lost to Follow-up|1|||
105479961|NCT01181986|363767648|FG002|Phase 1|Lost to Follow-up|1|||
105479962|NCT01181986|363767646|FG000|Phase 1|Adverse Event|0|||
105479963|NCT01181986|363767647|FG001|Phase 1|Adverse Event|0|||
105479964|NCT01181986|363767648|FG002|Phase 1|Adverse Event|1|||
105479965|NCT01181986|363767646|FG000|Phase 1|Protocol Violation|1|||
105479966|NCT01181986|363767647|FG001|Phase 1|Protocol Violation|0|||
105479967|NCT01181986|363767648|FG002|Phase 1|Protocol Violation|0|||
105479968|NCT01181986|363767646|FG000|Phase 2|Adverse Event|0|||
105479969|NCT01181986|363767647|FG001|Phase 2|Adverse Event|3|||
105479970|NCT01181986|363767648|FG002|Phase 2|Adverse Event|0|||
105479971|NCT01181986|363767646|FG000|Phase 2|Medical condition|0|||
105479972|NCT01181986|363767647|FG001|Phase 2|Medical condition|1|||
105479973|NCT01181986|363767648|FG002|Phase 2|Medical condition|0|||
105479974|NCT01159431|363767649|FG000|Overall Study|Adverse Event|1|||
105479975|NCT01159431|363767650|FG001|Overall Study|Adverse Event|2|||
105479976|NCT01159431|363767649|FG000|Overall Study|non-compliance|1|||
105479977|NCT01159431|363767650|FG001|Overall Study|non-compliance|1|||
105479978|NCT01159431|363767649|FG000|Overall Study|Lack of Efficacy|0|||
105479979|NCT01159431|363767650|FG001|Overall Study|Lack of Efficacy|3|||
105479980|NCT01981551|363767656|FG000|Overall Study|Refused further treatment|8|||
105479981|NCT01981551|363767656|FG000|Overall Study|Adverse Event|1|||
105479982|NCT00362180|363769014|FG000|Treated Period|Withdrawal by Subject|1|||
105479983|NCT00362180|363769015|FG001|Treated Period|Withdrawal by Subject|0|||
105479984|NCT00362180|363769016|FG002|Treated Period|Withdrawal by Subject|0|||
105479985|NCT00362180|363769017|FG003|Treated Period|Withdrawal by Subject|0|||
105479986|NCT00362180|363769018|FG004|Treated Period|Withdrawal by Subject|0|||
105479987|NCT00362180|363769019|FG005|Treated Period|Withdrawal by Subject|0|||
105479988|NCT00362180|363769020|FG006|Treated Period|Withdrawal by Subject|0|||
105479989|NCT00362180|363769021|FG007|Treated Period|Withdrawal by Subject|0|||
105479990|NCT00362180|363769022|FG008|Treated Period|Withdrawal by Subject|0|||
105479991|NCT00362180|363769014|FG000|Treated Period|Adverse Event|0|||
105479992|NCT00362180|363769015|FG001|Treated Period|Adverse Event|0|||
105479993|NCT00362180|363769016|FG002|Treated Period|Adverse Event|0|||
105479994|NCT00362180|363769017|FG003|Treated Period|Adverse Event|0|||
105479995|NCT00362180|363769018|FG004|Treated Period|Adverse Event|0|||
105479996|NCT00362180|363769019|FG005|Treated Period|Adverse Event|1|||
105479997|NCT00362180|363769020|FG006|Treated Period|Adverse Event|0|||
105479998|NCT00362180|363769021|FG007|Treated Period|Adverse Event|1|||
105479999|NCT00362180|363769022|FG008|Treated Period|Adverse Event|0|||
105480000|NCT02434471|363769023|FG000|Overall Study|Physician Decision|9|||
105480001|NCT00843778|363769024|FG000|Overall Study|Adverse Event|15|||
105480002|NCT00843778|363769024|FG000|Overall Study|Lack of Efficacy|14|||
105480003|NCT00843778|363769024|FG000|Overall Study|Loss of efficacy|2|||
105480004|NCT00843778|363769024|FG000|Overall Study|Withdrawal by Subject|4|||
105480005|NCT04839562|363769027|FG000|Overall Study|Withdrawal by Subject|0|||
105480006|NCT04839562|363769028|FG001|Overall Study|Withdrawal by Subject|1|||
105480007|NCT04839562|363769027|FG000|Overall Study|Physician Decision|0|||
105480008|NCT04839562|363769028|FG001|Overall Study|Physician Decision|1|||
105480009|NCT03338959|363769029|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
105480010|NCT03338959|363769029|FG000|Overall Study|Physician Decision|1|||
105480011|NCT02848729|363769030|FG000|Overall Study|Withdrawal by Subject|1|||
105731238|NCT05593432|364671633|FG000|16-Week OLE Period|Lost to Follow-up|0|||
105731239|NCT05593432|364671634|FG001|16-Week OLE Period|Lost to Follow-up|0|||
105731240|NCT05593432|364671635|FG002|16-Week OLE Period|Lost to Follow-up|1|||
105731241|NCT05593432|364671636|FG003|16-Week OLE Period|Lost to Follow-up|2|||
105731242|NCT05593432|364671633|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
105731243|NCT05593432|364671634|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
105731244|NCT05593432|364671635|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
105731245|NCT05593432|364671636|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
105480012|NCT02848729|363769031|FG001|Overall Study|Withdrawal by Subject|0|||
105480013|NCT02848729|363769030|FG000|Overall Study|Emesis|15|||
105480014|NCT02848729|363769031|FG001|Overall Study|Emesis|11|||
105480015|NCT01604278|363769033|FG000|Overall Study|Lack of Efficacy|0|||
105480016|NCT01604278|363769034|FG001|Overall Study|Lack of Efficacy|1|||
105480017|NCT01604278|363769033|FG000|Overall Study|Lost to Follow-up|1|||
105480018|NCT01604278|363769034|FG001|Overall Study|Lost to Follow-up|0|||
105480019|NCT01604278|363769033|FG000|Overall Study|Administrative problems|2|||
105480020|NCT01604278|363769034|FG001|Overall Study|Administrative problems|1|||
105731246|NCT03885284|364671637|FG000|Overall Study|Disease Progression|1|||
105731247|NCT03885284|364671638|FG001|Overall Study|Disease Progression|3|||
105480021|NCT01604278|363769033|FG000|Overall Study|Withdrawal by Subject|3|||
105480022|NCT01604278|363769034|FG001|Overall Study|Withdrawal by Subject|3|||
105480023|NCT01604278|363769033|FG000|Overall Study|Adverse Event|3|||
105480024|NCT01604278|363769034|FG001|Overall Study|Adverse Event|5|||
105480025|NCT01604278|363769033|FG000|Overall Study|Protocol Deviation|5|||
105480026|NCT01604278|363769034|FG001|Overall Study|Protocol Deviation|3|||
105480027|NCT02184455|363769035|FG000|Overall Study|Lost to Follow-up|1|||
105480028|NCT00003472|363769036|FG000|Overall Study|Not evaluable|3|||
105480029|NCT01659554|363769037|FG000|Overall Study|Study Termination|4|||
105480030|NCT03467152|363769040|FG000|Overall Study|Adverse Event|4|||
105480031|NCT03467152|363769041|FG001|Overall Study|Adverse Event|5|||
105480032|NCT03467152|363769042|FG002|Overall Study|Adverse Event|0|||
105480033|NCT03467152|363769040|FG000|Overall Study|Subject Choice|1|||
105480034|NCT03467152|363769041|FG001|Overall Study|Subject Choice|3|||
105480035|NCT03467152|363769042|FG002|Overall Study|Subject Choice|0|||
105480036|NCT03467152|363769040|FG000|Overall Study|Lost to Follow-up|1|||
105480037|NCT03467152|363769041|FG001|Overall Study|Lost to Follow-up|0|||
105480038|NCT03467152|363769042|FG002|Overall Study|Lost to Follow-up|0|||
105480039|NCT03467152|363769040|FG000|Overall Study|Withdrawal by Subject|4|||
105480040|NCT03467152|363769041|FG001|Overall Study|Withdrawal by Subject|2|||
105480041|NCT03467152|363769042|FG002|Overall Study|Withdrawal by Subject|0|||
105480042|NCT03467152|363769040|FG000|Overall Study|Others|3|||
105480043|NCT03467152|363769041|FG001|Overall Study|Others|0|||
105480044|NCT03467152|363769042|FG002|Overall Study|Others|0|||
105480045|NCT03467152|363769040|FG000|Overall Study|Not treated|3|||
105480046|NCT03467152|363769041|FG001|Overall Study|Not treated|1|||
105480047|NCT03467152|363769042|FG002|Overall Study|Not treated|6|||
105480048|NCT04250077|363769043|FG000|Overall Study|Withdrawal by Subject|0|||
105480049|NCT04250077|363769044|FG001|Overall Study|Withdrawal by Subject|1|||
105480050|NCT04250077|363769045|FG002|Overall Study|Withdrawal by Subject|0|||
105480051|NCT04250077|363769043|FG000|Overall Study|Lost to Follow-up|2|||
105480052|NCT04250077|363769044|FG001|Overall Study|Lost to Follow-up|3|||
105480053|NCT04250077|363769045|FG002|Overall Study|Lost to Follow-up|0|||
105480054|NCT01444092|363769048|FG000|Overall Study|Adverse Event|8|||
105480055|NCT01444092|363769048|FG000|Overall Study|Protocol Violation|1|||
105480056|NCT01444092|363769048|FG000|Overall Study|Withdrawal by Subject|1|||
105480057|NCT01444092|363769048|FG000|Overall Study|Other Eligibility criteria|7|||
105480058|NCT01328366|363769049|FG000|Overall Study|Death|1|||
105480059|NCT01328366|363769049|FG000|Overall Study|Withdrawal by Subject|2|||
105480060|NCT01328366|363769049|FG000|Overall Study|Lost to Follow-up|7|||
105480061|NCT03565367|363769050|FG000|Overall Study|No scan due to technical issues|4|||
105480062|NCT03565367|363769051|FG001|Overall Study|No scan due to technical issues|0|||
105480063|NCT03005873|363769052|FG000|Overall Study|Prohibited medication use post radnomization|1|||
105480064|NCT03005873|363769053|FG001|Overall Study|Prohibited medication use post radnomization|1|||
105480065|NCT03005873|363769054|FG002|Overall Study|Prohibited medication use post radnomization|1|||
105480066|NCT03005873|363769052|FG000|Overall Study|Withdrew consent|0|||
105480067|NCT03005873|363769053|FG001|Overall Study|Withdrew consent|1|||
105480068|NCT03005873|363769054|FG002|Overall Study|Withdrew consent|2|||
105480069|NCT03005873|363769052|FG000|Overall Study|Lost to Follow-up|0|||
105480070|NCT03005873|363769053|FG001|Overall Study|Lost to Follow-up|1|||
105480071|NCT03005873|363769054|FG002|Overall Study|Lost to Follow-up|0|||
105480072|NCT03005873|363769052|FG000|Overall Study|Ineligible post randomization|0|||
105480073|NCT03005873|363769053|FG001|Overall Study|Ineligible post randomization|0|||
105731248|NCT03885284|364671637|FG000|Overall Study|Physician Decision|0|||
105731249|NCT03885284|364671638|FG001|Overall Study|Physician Decision|1|||
105731250|NCT01926886|364671640|FG000|Overall Study|Administrative/other|1|||
105731251|NCT01926886|364671641|FG001|Overall Study|Administrative/other|0|||
105731252|NCT01926886|364671640|FG000|Overall Study|Adverse event/intercurrent illness|4|||
105731253|NCT01926886|364671641|FG001|Overall Study|Adverse event/intercurrent illness|0|||
105731254|NCT01926886|364671640|FG000|Overall Study|Disease progression/recurrence|4|||
105731255|NCT01926886|364671641|FG001|Overall Study|Disease progression/recurrence|0|||
105731256|NCT01926886|364671640|FG000|Overall Study|Withdrawal by Subject|15|||
105731257|NCT01926886|364671641|FG001|Overall Study|Withdrawal by Subject|0|||
105731258|NCT01926886|364671640|FG000|Overall Study|Failure to return|3|||
105731259|NCT01926886|364671641|FG001|Overall Study|Failure to return|0|||
105731260|NCT01926886|364671640|FG000|Overall Study|Recurrence of disease|1|||
105480074|NCT03005873|363769054|FG002|Overall Study|Ineligible post randomization|1|||
105480075|NCT04585009|363769063|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
105480076|NCT04585009|363769064|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
105480077|NCT04585009|363769065|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
105480078|NCT04585009|363769066|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
105564977|NCT02220894|364065367|FG000|Overall Study|Withdrawal by Subject|10|||
105564978|NCT02220894|364065368|FG001|Overall Study|Withdrawal by Subject|9|||
105564979|NCT03248375|364065369|FG000|Overall Study|Lost to Follow-up|5|||
105480079|NCT04585009|363769067|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
105480080|NCT04585009|363769068|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
105731261|NCT01926886|364671641|FG001|Overall Study|Recurrence of disease|0|||
105731262|NCT01926886|364671640|FG000|Overall Study|Progression of disease|2|||
105797054|NCT00295620|364914628|FG000|Overall Study|Protocol Violation|30|||
105797055|NCT00295620|364914629|FG001|Overall Study|Protocol Violation|32|||
105797056|NCT00217971|364914630|FG000|Overall Study|Adverse Event|1|||
105797057|NCT00217971|364914631|FG001|Overall Study|Adverse Event|1|||
105797058|NCT00217971|364914630|FG000|Overall Study|Lost to Follow-up|15|||
105797059|NCT00217971|364914631|FG001|Overall Study|Lost to Follow-up|19|||
105797060|NCT00217971|364914630|FG000|Overall Study|Physician Decision|0|||
105797061|NCT00217971|364914631|FG001|Overall Study|Physician Decision|1|||
105797062|NCT00217971|364914630|FG000|Overall Study|Withdrawal by Subject|7|||
105797063|NCT00217971|364914631|FG001|Overall Study|Withdrawal by Subject|12|||
105797064|NCT00217971|364914630|FG000|Overall Study|non compliant|1|||
105797065|NCT00217971|364914631|FG001|Overall Study|non compliant|0|||
105797066|NCT02989610|364914632|FG000|Overall Study|Withdrawal by Subject|20|||
105797067|NCT02989610|364914632|FG000|Overall Study|Departure of PI from Site|8|||
105797068|NCT02989610|364914632|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
105797069|NCT02989610|364914632|FG000|Overall Study|Lost to Follow-up|3|||
105797070|NCT02989610|364914632|FG000|Overall Study|Death|3|||
105797071|NCT02989610|364914632|FG000|Overall Study|System Explant|3|||
105797072|NCT02989610|364914632|FG000|Overall Study|Subject Non-Compliance|2|||
105797073|NCT02989610|364914632|FG000|Overall Study|System Revision|2|||
105797074|NCT02989610|364914632|FG000|Overall Study|PI Left, Study Closing|1|||
105797075|NCT02989610|364914632|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
105797076|NCT02989610|364914632|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
105797077|NCT00808015|364914637|FG000|Overall Study|Death|1|||
105797078|NCT00808015|364914637|FG000|Overall Study|Lack of Efficacy|58|||
105797079|NCT00808015|364914637|FG000|Overall Study|Lost to Follow-up|76|||
105797080|NCT00808015|364914637|FG000|Overall Study|Participants not willing to participate|158|||
105797081|NCT00808015|364914637|FG000|Overall Study|Adverse Event|22|||
105797082|NCT00808015|364914637|FG000|Overall Study|Other|25|||
105797083|NCT00808015|364914637|FG000|Overall Study|Enrolled but not treated|4|||
105797084|NCT04508621|364914638|FG000|Overall Study|Adverse Event|39|||
105797085|NCT04508621|364914639|FG001|Overall Study|Adverse Event|16|||
105797086|NCT04508621|364914638|FG000|Overall Study|Lack of Efficacy|2|||
105797087|NCT04508621|364914639|FG001|Overall Study|Lack of Efficacy|8|||
105797088|NCT04508621|364914638|FG000|Overall Study|Physician Decision|0|||
105797089|NCT04508621|364914639|FG001|Overall Study|Physician Decision|1|||
105797090|NCT04508621|364914638|FG000|Overall Study|Withdrawal by Subject|10|||
105797091|NCT04508621|364914639|FG001|Overall Study|Withdrawal by Subject|14|||
105797092|NCT04508621|364914638|FG000|Overall Study|Lost to Follow-up|12|||
105797093|NCT04508621|364914639|FG001|Overall Study|Lost to Follow-up|9|||
105797094|NCT04508621|364914638|FG000|Overall Study|COVID-19 related crisis|3|||
105797095|NCT04508621|364914639|FG001|Overall Study|COVID-19 related crisis|0|||
105797096|NCT04508621|364914638|FG000|Overall Study|Subject non-compliance|1|||
105797097|NCT04508621|364914639|FG001|Overall Study|Subject non-compliance|0|||
105797098|NCT00084617|364914653|FG000|Overall Study|Withdrawal by Subject|7|||
105797099|NCT00084617|364914653|FG000|Overall Study|Lack of Efficacy|1|||
105797100|NCT00084617|364914653|FG000|Overall Study|Protocol Violation|1|||
105797101|NCT00928135|364914654|FG000|Overall Study|Withdrawal by Subject|1|||
105797102|NCT00928135|364914655|FG001|Overall Study|Withdrawal by Subject|0|||
105797103|NCT01999322|364914656|FG000|Overall Study|Adverse Event|1|||
105797104|NCT01999322|364914657|FG001|Overall Study|Adverse Event|0|||
105797105|NCT03338673|364914660|FG000|Overall Study|Lost to Follow-up|1|||
105797106|NCT03338673|364914661|FG001|Overall Study|Lost to Follow-up|1|||
105797107|NCT00990093|364914665|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
105797108|NCT00990093|364914666|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
105797109|NCT00990093|364914665|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
105797110|NCT00990093|364914666|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
105797111|NCT00990093|364914665|FG000|Test Period 1 (1-14 Days)|Other|1|||
105797112|NCT00990093|364914666|FG001|Test Period 1 (1-14 Days)|Other|0|||
105797113|NCT00990093|364914665|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
105797114|NCT00990093|364914666|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
105797115|NCT00990093|364914665|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
105480081|NCT04585009|363769069|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
105480082|NCT04585009|363769070|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
105480083|NCT04585009|363769071|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
105480084|NCT04585009|363769072|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
105480085|NCT04585009|363769073|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
105480086|NCT04585009|363769074|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
105480087|NCT04585009|363769063|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
105797116|NCT00990093|364914666|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
105797117|NCT00990093|364914665|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
105797118|NCT00990093|364914666|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
105797119|NCT00990093|364914665|FG000|Test Period 2 (15-28 Days)|Other|0|||
105797120|NCT00990093|364914666|FG001|Test Period 2 (15-28 Days)|Other|1|||
105797121|NCT04556838|364914671|FG000|Overall Study|Withdrawal by Subject|3|||
105480088|NCT04585009|363769064|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
105480089|NCT04585009|363769065|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
105480090|NCT04585009|363769066|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
105480091|NCT04585009|363769067|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
105480092|NCT04585009|363769068|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
105480093|NCT04585009|363769069|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
105480094|NCT04585009|363769070|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
105480095|NCT04585009|363769071|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
105731263|NCT01926886|364671641|FG001|Overall Study|Progression of disease|0|||
105731264|NCT01926886|364671640|FG000|Overall Study|Death|1|||
105731265|NCT01926886|364671641|FG001|Overall Study|Death|0|||
105731266|NCT01926886|364671640|FG000|Overall Study|Did not cooperate|1|||
105731267|NCT01926886|364671641|FG001|Overall Study|Did not cooperate|0|||
105731268|NCT02609399|364671642|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
105731269|NCT02609399|364671643|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
105731270|NCT02609399|364671642|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
105731271|NCT02609399|364671643|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
105731272|NCT02609399|364671642|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
105731273|NCT02609399|364671643|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
105731274|NCT00995371|364671644|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
105731275|NCT00995371|364671645|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
105731276|NCT03875235|364671646|FG000|Overall Study|Ongoing study treatment|63|||
105731277|NCT03875235|364671647|FG001|Overall Study|Ongoing study treatment|20|||
105731278|NCT03875235|364671646|FG000|Overall Study|Off treatment|77|||
105731279|NCT03875235|364671647|FG001|Overall Study|Off treatment|91|||
105731280|NCT03875235|364671646|FG000|Overall Study|Withdrawal by Subject|3|||
105731281|NCT03875235|364671647|FG001|Overall Study|Withdrawal by Subject|10|||
105731282|NCT03875235|364671646|FG000|Overall Study|Death|198|||
105731283|NCT03875235|364671647|FG001|Overall Study|Death|223|||
105731284|NCT01687673|364671648|FG000|Overall Study|Physician Decision|1|||
105731285|NCT00618956|364671649|FG000|Overall Study|Adverse Event|10|||
105731286|NCT00618956|364671650|FG001|Overall Study|Adverse Event|34|||
105731287|NCT00618956|364671649|FG000|Overall Study|Lack of Efficacy|2|||
105731288|NCT00618956|364671650|FG001|Overall Study|Lack of Efficacy|1|||
105731289|NCT00618956|364671649|FG000|Overall Study|Withdrawal by Subject|5|||
105731290|NCT00618956|364671650|FG001|Overall Study|Withdrawal by Subject|7|||
105731291|NCT00618956|364671649|FG000|Overall Study|Lost to Follow-up|4|||
105731292|NCT00618956|364671650|FG001|Overall Study|Lost to Follow-up|5|||
105731293|NCT00618956|364671649|FG000|Overall Study|Protocol Violation|2|||
105731294|NCT00618956|364671650|FG001|Overall Study|Protocol Violation|2|||
105731295|NCT00618956|364671649|FG000|Overall Study|did not meet criteria, non-compliance|2|||
105731296|NCT00618956|364671650|FG001|Overall Study|did not meet criteria, non-compliance|1|||
105731297|NCT01151137|364671651|FG000|Overall Study|Death|15|||
105731298|NCT01151137|364671652|FG001|Overall Study|Death|27|||
105731299|NCT01151137|364671651|FG000|Overall Study|Lost to Follow-up|1|||
105731300|NCT01151137|364671652|FG001|Overall Study|Lost to Follow-up|1|||
105731301|NCT02452359|364671658|FG000|Overall Study|Adverse Event|1|||
105731302|NCT02452359|364671658|FG000|Overall Study|Lost to Follow-up|15|||
105731303|NCT02452359|364671658|FG000|Overall Study|Pregnancy|1|||
105731304|NCT02452359|364671658|FG000|Overall Study|Withdrawal by Subject|4|||
105731305|NCT00630032|364671665|FG000|Overall Study|Death|55|||
105731306|NCT00630032|364671666|FG001|Overall Study|Death|49|||
105731307|NCT00630032|364671665|FG000|Overall Study|Withdrawal by Subject|3|||
105731308|NCT00630032|364671666|FG001|Overall Study|Withdrawal by Subject|2|||
105731309|NCT00630032|364671665|FG000|Overall Study|Lost to Follow-up|18|||
105731310|NCT00630032|364671666|FG001|Overall Study|Lost to Follow-up|31|||
105731311|NCT00630032|364671665|FG000|Overall Study|Protocol Violation|1|||
105731312|NCT00630032|364671666|FG001|Overall Study|Protocol Violation|0|||
105731313|NCT00630032|364671665|FG000|Overall Study|Patient has moved|1|||
105480096|NCT04585009|363769072|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
105731314|NCT00630032|364671666|FG001|Overall Study|Patient has moved|1|||
105731315|NCT00630032|364671665|FG000|Overall Study|Disease progression|1|||
105731316|NCT00630032|364671666|FG001|Overall Study|Disease progression|1|||
105731317|NCT00630032|364671665|FG000|Overall Study|End of monitoring in US centers|11|||
105731318|NCT00630032|364671666|FG001|Overall Study|End of monitoring in US centers|11|||
105731319|NCT00538733|364671667|FG000|Overall Study|Adverse Event|8|||
105731320|NCT00538733|364671667|FG000|Overall Study|Death|1|||
105731321|NCT00538733|364671667|FG000|Overall Study|declined to participate|2|||
105731322|NCT00538733|364671667|FG000|Overall Study|still on therapy|1|||
105731323|NCT02975349|364671672|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105731324|NCT02975349|364671673|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105731325|NCT02975349|364671674|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105731326|NCT02975349|364671675|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
105731327|NCT02975349|364671676|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
105797122|NCT04556838|364914672|FG001|Overall Study|Withdrawal by Subject|1|||
105797123|NCT04556838|364914673|FG002|Overall Study|Withdrawal by Subject|2|||
105797124|NCT04556838|364914671|FG000|Overall Study|Adverse Event|0|||
105797125|NCT04556838|364914672|FG001|Overall Study|Adverse Event|1|||
105797126|NCT04556838|364914673|FG002|Overall Study|Adverse Event|1|||
105797127|NCT04556838|364914671|FG000|Overall Study|Lost to Follow-up|0|||
105797128|NCT04556838|364914672|FG001|Overall Study|Lost to Follow-up|0|||
105797129|NCT04556838|364914673|FG002|Overall Study|Lost to Follow-up|2|||
105797130|NCT04556838|364914671|FG000|Overall Study|Subject travel|0|||
105797131|NCT04556838|364914672|FG001|Overall Study|Subject travel|1|||
105797132|NCT04556838|364914673|FG002|Overall Study|Subject travel|0|||
105797133|NCT04556838|364914671|FG000|Overall Study|Physician Decision|1|||
105797134|NCT04556838|364914672|FG001|Overall Study|Physician Decision|0|||
105797135|NCT04556838|364914673|FG002|Overall Study|Physician Decision|0|||
105797136|NCT02367781|364914676|FG000|Overall Study|Withdrawal by Subject|20|||
105797137|NCT02367781|364914677|FG001|Overall Study|Withdrawal by Subject|13|||
105731328|NCT02975349|364671677|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105731329|NCT02975349|364671678|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105731330|NCT02975349|364671672|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105731331|NCT02975349|364671673|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105731332|NCT02975349|364671674|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105731333|NCT02975349|364671675|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105731334|NCT02975349|364671676|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105731335|NCT02975349|364671677|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105731336|NCT02975349|364671678|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105731337|NCT02975349|364671672|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
105731338|NCT02975349|364671673|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
105731339|NCT02975349|364671674|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
105731340|NCT02975349|364671675|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
105731341|NCT02975349|364671676|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
105731342|NCT02975349|364671677|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
105731343|NCT02975349|364671678|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
105731344|NCT02975349|364671672|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
105731345|NCT02975349|364671673|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
105731346|NCT02975349|364671674|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
105731347|NCT02975349|364671675|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
105731348|NCT02975349|364671676|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
105731349|NCT02975349|364671677|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
105731350|NCT02975349|364671678|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
105731351|NCT02975349|364671672|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
105731352|NCT02975349|364671673|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
105731353|NCT02975349|364671674|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
105731354|NCT02975349|364671675|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
105731355|NCT02975349|364671676|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
105731356|NCT02975349|364671677|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
105731357|NCT02975349|364671678|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
105731358|NCT02975349|364671672|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
105731359|NCT02975349|364671673|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
105731360|NCT02975349|364671674|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
105731361|NCT02975349|364671675|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
105731362|NCT02975349|364671676|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
105731363|NCT02975349|364671677|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
105731364|NCT02975349|364671678|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
105731365|NCT02975349|364671672|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
105731366|NCT02975349|364671673|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
105731367|NCT02975349|364671674|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
105731368|NCT02975349|364671675|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
105731369|NCT02975349|364671676|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
105731370|NCT02975349|364671677|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
105731371|NCT02975349|364671678|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
105731372|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
105797138|NCT02367781|364914676|FG000|Overall Study|Protocol Violation|0|||
105731373|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
105731374|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
105797139|NCT02367781|364914677|FG001|Overall Study|Protocol Violation|1|||
105797140|NCT02367781|364914676|FG000|Overall Study|Physician Decision|7|||
105797141|NCT02367781|364914677|FG001|Overall Study|Physician Decision|0|||
105480097|NCT04585009|363769073|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
105480098|NCT04585009|363769074|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
105797142|NCT02367781|364914676|FG000|Overall Study|Randomized in Error|5|||
105480099|NCT04585009|363769063|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
105480100|NCT04585009|363769064|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
105480101|NCT04585009|363769065|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
105480102|NCT04585009|363769066|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
105480103|NCT04585009|363769067|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
105480104|NCT04585009|363769068|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
105480105|NCT04585009|363769069|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
105480106|NCT04585009|363769070|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
105480107|NCT04585009|363769071|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
105480108|NCT04585009|363769072|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
105480109|NCT04585009|363769073|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
105480110|NCT04585009|363769074|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
105480111|NCT04585009|363769063|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
105731375|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
105731376|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
105731377|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
105731378|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
105731379|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
105731380|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
105731381|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
105731382|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
105731383|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
105731384|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
105731385|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
105731386|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
105731387|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
105731388|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
105731389|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
105731390|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
105731391|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
105731392|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
105731393|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
105731394|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
105731395|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
105731396|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
105731397|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
105731398|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
105731399|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
105731400|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
105731401|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
105731402|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
105731403|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
105731404|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
105731405|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
105731406|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
105731407|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
105731408|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
105731409|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
105731410|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
105731411|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
105731412|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
105731413|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
105731414|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
105731415|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
105731416|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
105731417|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
105731418|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
105731419|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
105731420|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
105731421|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
105731422|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
105731423|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
105480112|NCT04585009|363769064|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
105480113|NCT04585009|363769065|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
105480114|NCT04585009|363769066|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
105731424|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
105731425|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
105731426|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
105731427|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
105731428|NCT03091192|364671681|FG000|Overall Study|Study terminated by sponsor|21|||
105731429|NCT03091192|364671682|FG001|Overall Study|Study terminated by sponsor|14|||
105731430|NCT03091192|364671681|FG000|Overall Study|Death|9|||
105731431|NCT03091192|364671682|FG001|Overall Study|Death|13|||
105731432|NCT03091192|364671681|FG000|Overall Study|Withdrawal by Subject|2|||
105731433|NCT03091192|364671682|FG001|Overall Study|Withdrawal by Subject|0|||
105731434|NCT03091192|364671681|FG000|Overall Study|Lost to Follow-up|1|||
105731435|NCT03091192|364671682|FG001|Overall Study|Lost to Follow-up|0|||
105731436|NCT03497689|364671683|FG000|Overall Study|Adverse Event|2|||
105731437|NCT03497689|364671683|FG000|Overall Study|Death|1|||
105731438|NCT03497689|364671683|FG000|Overall Study|Physician Decision|1|||
105731439|NCT03497689|364671683|FG000|Overall Study|Withdrawal by Subject|1|||
105731440|NCT03497689|364671683|FG000|Overall Study|Protocol Violation|2|||
105731441|NCT04358458|364671684|FG000|Overall Study|Death|1|||
105731442|NCT04358458|364671685|FG001|Overall Study|Death|1|||
105731443|NCT04358458|364671686|FG002|Overall Study|Death|3|||
105731444|NCT04358458|364671687|FG003|Overall Study|Death|8|||
105731445|NCT04358458|364671688|FG004|Overall Study|Death|1|||
105731446|NCT04358458|364671689|FG005|Overall Study|Death|6|||
105731447|NCT04358458|364671690|FG006|Overall Study|Death|2|||
105731448|NCT04358458|364671691|FG007|Overall Study|Death|3|||
105731449|NCT04358458|364671684|FG000|Overall Study|Lost to Follow-up|0|||
105731450|NCT04358458|364671685|FG001|Overall Study|Lost to Follow-up|0|||
105731451|NCT04358458|364671686|FG002|Overall Study|Lost to Follow-up|0|||
105731452|NCT04358458|364671687|FG003|Overall Study|Lost to Follow-up|0|||
105731453|NCT04358458|364671688|FG004|Overall Study|Lost to Follow-up|0|||
105731454|NCT04358458|364671689|FG005|Overall Study|Lost to Follow-up|0|||
105731455|NCT04358458|364671690|FG006|Overall Study|Lost to Follow-up|0|||
105731456|NCT04358458|364671691|FG007|Overall Study|Lost to Follow-up|1|||
105731457|NCT04358458|364671684|FG000|Overall Study|Site is closing study participation|0|||
105731458|NCT04358458|364671685|FG001|Overall Study|Site is closing study participation|0|||
105731459|NCT04358458|364671686|FG002|Overall Study|Site is closing study participation|0|||
105731460|NCT04358458|364671687|FG003|Overall Study|Site is closing study participation|1|||
105731461|NCT04358458|364671688|FG004|Overall Study|Site is closing study participation|0|||
105731462|NCT04358458|364671689|FG005|Overall Study|Site is closing study participation|0|||
105731463|NCT04358458|364671690|FG006|Overall Study|Site is closing study participation|0|||
105731464|NCT04358458|364671691|FG007|Overall Study|Site is closing study participation|0|||
105731465|NCT04358458|364671684|FG000|Overall Study|Sponsor request|2|||
105731466|NCT04358458|364671685|FG001|Overall Study|Sponsor request|3|||
105731467|NCT04358458|364671686|FG002|Overall Study|Sponsor request|3|||
105731468|NCT04358458|364671687|FG003|Overall Study|Sponsor request|0|||
105731469|NCT04358458|364671688|FG004|Overall Study|Sponsor request|2|||
105731470|NCT04358458|364671689|FG005|Overall Study|Sponsor request|3|||
105731471|NCT04358458|364671690|FG006|Overall Study|Sponsor request|1|||
105731472|NCT04358458|364671691|FG007|Overall Study|Sponsor request|1|||
105731473|NCT04358458|364671684|FG000|Overall Study|Withdrawal by Subject|0|||
105731474|NCT04358458|364671685|FG001|Overall Study|Withdrawal by Subject|0|||
105731475|NCT04358458|364671686|FG002|Overall Study|Withdrawal by Subject|1|||
105731476|NCT04358458|364671687|FG003|Overall Study|Withdrawal by Subject|1|||
105731477|NCT04358458|364671688|FG004|Overall Study|Withdrawal by Subject|0|||
105731478|NCT04358458|364671689|FG005|Overall Study|Withdrawal by Subject|1|||
105731479|NCT04358458|364671690|FG006|Overall Study|Withdrawal by Subject|0|||
105731480|NCT04358458|364671691|FG007|Overall Study|Withdrawal by Subject|1|||
105731481|NCT05847881|364671692|FG000|Overall Study|Principal Investigator Decision|8|||
105731482|NCT05847881|364671692|FG000|Overall Study|Withdrawal by Subject|2|||
105731483|NCT05635838|364673707|FG000|16-Week DBVC Period|Adverse Event|2|||
105731484|NCT05635838|364673708|FG001|16-Week DBVC Period|Adverse Event|0|||
105731485|NCT05635838|364673709|FG002|16-Week DBVC Period|Adverse Event|0|||
105731486|NCT05635838|364673710|FG003|16-Week DBVC Period|Adverse Event|0|||
105731487|NCT05635838|364673707|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
105731488|NCT05635838|364673708|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
105731489|NCT05635838|364673709|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
105731490|NCT05635838|364673710|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
105731491|NCT05635838|364673707|FG000|16-Week DBVC Period|Physician Decision|0|||
105731492|NCT05635838|364673708|FG001|16-Week DBVC Period|Physician Decision|1|||
105731493|NCT05635838|364673709|FG002|16-Week DBVC Period|Physician Decision|0|||
105731494|NCT05635838|364673710|FG003|16-Week DBVC Period|Physician Decision|0|||
105731495|NCT05635838|364673707|FG000|16-Week DBVC Period|Protocol Violation|1|||
105731496|NCT05635838|364673708|FG001|16-Week DBVC Period|Protocol Violation|0|||
105480115|NCT04585009|363769067|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
105731497|NCT05635838|364673709|FG002|16-Week DBVC Period|Protocol Violation|0|||
105731498|NCT05635838|364673710|FG003|16-Week DBVC Period|Protocol Violation|0|||
105797143|NCT02367781|364914677|FG001|Overall Study|Randomized in Error|4|||
105797144|NCT02367781|364914676|FG000|Overall Study|Non-Compliance|1|||
105797145|NCT02367781|364914677|FG001|Overall Study|Non-Compliance|0|||
105797146|NCT02367781|364914676|FG000|Overall Study|Lost to Follow-up|1|||
105797147|NCT02367781|364914677|FG001|Overall Study|Lost to Follow-up|2|||
105797148|NCT02367781|364914676|FG000|Overall Study|Death|330|||
105797149|NCT02367781|364914677|FG001|Overall Study|Death|176|||
105797150|NCT02367781|364914676|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
105797151|NCT02367781|364914677|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
105797152|NCT02367781|364914676|FG000|Overall Study|Prolonged Hospitalization|1|||
105797153|NCT02367781|364914677|FG001|Overall Study|Prolonged Hospitalization|0|||
105797154|NCT02367781|364914676|FG000|Overall Study|Death Prior First Dose|1|||
105797155|NCT02367781|364914677|FG001|Overall Study|Death Prior First Dose|0|||
105797156|NCT02367781|364914676|FG000|Overall Study|Administrative-Change Facility|1|||
105797157|NCT02367781|364914677|FG001|Overall Study|Administrative-Change Facility|0|||
105797158|NCT02367781|364914676|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
105797159|NCT02367781|364914677|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
105797160|NCT02367781|364914676|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
105797161|NCT02367781|364914677|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
105797162|NCT02367781|364914676|FG000|Overall Study|Study Terminated by Sponsor|3|||
105797163|NCT02367781|364914677|FG001|Overall Study|Study Terminated by Sponsor|1|||
105797164|NCT02367781|364914676|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
105797165|NCT02367781|364914677|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
105797166|NCT02367781|364914676|FG000|Overall Study|Sponsor Decision|2|||
105797167|NCT02367781|364914677|FG001|Overall Study|Sponsor Decision|0|||
105797168|NCT02367781|364914676|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
105797169|NCT02367781|364914677|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
105797170|NCT02623426|364914678|FG000|Overall Study|Lost to Follow-up|0|||
105797171|NCT02623426|364914679|FG001|Overall Study|Lost to Follow-up|0|||
105797172|NCT02623426|364914680|FG002|Overall Study|Lost to Follow-up|1|||
105480116|NCT04585009|363769068|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
105797173|NCT02623426|364914678|FG000|Overall Study|Withdrawal by Subject|1|||
105797174|NCT02623426|364914679|FG001|Overall Study|Withdrawal by Subject|2|||
105797175|NCT02623426|364914680|FG002|Overall Study|Withdrawal by Subject|2|||
105797176|NCT02842086|364914681|FG000|Overall Study|Randomized but Never Treated|6|||
105797177|NCT02842086|364914682|FG001|Overall Study|Randomized but Never Treated|6|||
105797178|NCT02842086|364914681|FG000|Overall Study|Still in Double-Blind Phase|7|||
105797179|NCT02842086|364914682|FG001|Overall Study|Still in Double-Blind Phase|3|||
105797180|NCT02842086|364914681|FG000|Overall Study|Adverse Event|18|||
105797181|NCT02842086|364914682|FG001|Overall Study|Adverse Event|20|||
105797182|NCT02842086|364914681|FG000|Overall Study|Death|3|||
105797183|NCT02842086|364914682|FG001|Overall Study|Death|3|||
105797184|NCT02842086|364914681|FG000|Overall Study|Investigator's Discretion|9|||
105797185|NCT02842086|364914682|FG001|Overall Study|Investigator's Discretion|13|||
105797186|NCT02842086|364914681|FG000|Overall Study|Non-Compliance with Study Drug|9|||
105797187|NCT02842086|364914682|FG001|Overall Study|Non-Compliance with Study Drug|8|||
105797188|NCT02842086|364914681|FG000|Overall Study|Protocol Violation|8|||
105797189|NCT02842086|364914682|FG001|Overall Study|Protocol Violation|4|||
105797190|NCT02842086|364914681|FG000|Overall Study|Withdrew Consent|205|||
105797191|NCT02842086|364914682|FG001|Overall Study|Withdrew Consent|194|||
105797192|NCT02842086|364914681|FG000|Overall Study|Lost to Follow-up|274|||
105480117|NCT04585009|363769069|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
105480118|NCT04585009|363769070|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
105731499|NCT05635838|364673707|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
105731500|NCT05635838|364673708|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
105731501|NCT05635838|364673709|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
105731502|NCT05635838|364673710|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
105731503|NCT05635838|364673707|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
105731504|NCT05635838|364673708|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
105731505|NCT05635838|364673709|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
105731506|NCT05635838|364673710|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
105731507|NCT05635838|364673707|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
105731508|NCT05635838|364673708|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
105797193|NCT02842086|364914682|FG001|Overall Study|Lost to Follow-up|236|||
105797194|NCT02842086|364914681|FG000|Overall Study|HIV-1 Infection|5|||
105797195|NCT02842086|364914682|FG001|Overall Study|HIV-1 Infection|6|||
105797196|NCT03751124|364914683|FG000|Overall Study|Adverse Event|4|||
105797197|NCT03751124|364914684|FG001|Overall Study|Adverse Event|3|||
105797198|NCT03751124|364914683|FG000|Overall Study|Protocol Deviation|0|||
105797199|NCT03751124|364914684|FG001|Overall Study|Protocol Deviation|1|||
105731509|NCT05635838|364673709|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
105564980|NCT00542880|364065376|FG000|Period 1|Eligibility criteria not fulfilled|2|||
105731510|NCT05635838|364673710|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
105731511|NCT05635838|364673707|FG000|16-Week OLE Period|Adverse Event|0|||
105731512|NCT05635838|364673708|FG001|16-Week OLE Period|Adverse Event|0|||
105731513|NCT05635838|364673709|FG002|16-Week OLE Period|Adverse Event|0|||
105731514|NCT05635838|364673710|FG003|16-Week OLE Period|Adverse Event|2|||
105731515|NCT05635838|364673707|FG000|16-Week OLE Period|Lost to Follow-up|0|||
105731516|NCT05635838|364673708|FG001|16-Week OLE Period|Lost to Follow-up|0|||
105731517|NCT05635838|364673709|FG002|16-Week OLE Period|Lost to Follow-up|1|||
105731518|NCT05635838|364673710|FG003|16-Week OLE Period|Lost to Follow-up|3|||
105731519|NCT05635838|364673707|FG000|16-Week OLE Period|Physician Decision|0|||
105731520|NCT05635838|364673708|FG001|16-Week OLE Period|Physician Decision|0|||
105731521|NCT05635838|364673709|FG002|16-Week OLE Period|Physician Decision|0|||
105731522|NCT05635838|364673710|FG003|16-Week OLE Period|Physician Decision|1|||
105731523|NCT05635838|364673707|FG000|16-Week OLE Period|Protocol Violation|0|||
105731524|NCT05635838|364673708|FG001|16-Week OLE Period|Protocol Violation|0|||
105731525|NCT05635838|364673709|FG002|16-Week OLE Period|Protocol Violation|1|||
105731526|NCT05635838|364673710|FG003|16-Week OLE Period|Protocol Violation|1|||
105731527|NCT05635838|364673707|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
105731528|NCT05635838|364673708|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
105731529|NCT05635838|364673709|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
105731530|NCT05635838|364673710|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
105731531|NCT05635838|364673707|FG000|16-Week OLE Period|Pregnancy|0|||
105731532|NCT05635838|364673708|FG001|16-Week OLE Period|Pregnancy|0|||
105731533|NCT05635838|364673709|FG002|16-Week OLE Period|Pregnancy|1|||
105731534|NCT05635838|364673710|FG003|16-Week OLE Period|Pregnancy|0|||
105731535|NCT01672892|364673712|FG000|Overall Study|Protocol Violation|7|||
105731536|NCT01672892|364673713|FG001|Overall Study|Protocol Violation|3|||
105731537|NCT02342171|364673719|FG000|Overall Study|Death|4|||
105731538|NCT02342171|364673720|FG001|Overall Study|Death|87|||
105731539|NCT02342171|364673719|FG000|Overall Study|Received favipiravir|10|||
105731540|NCT02342171|364673720|FG001|Overall Study|Received favipiravir|0|||
105731541|NCT02342171|364673719|FG000|Overall Study|Missing cycle treshold value|1|||
105731542|NCT02342171|364673720|FG001|Overall Study|Missing cycle treshold value|0|||
105731543|NCT02342171|364673719|FG000|Overall Study|Unknown outcome|0|||
105731544|NCT02342171|364673720|FG001|Overall Study|Unknown outcome|1|||
105731545|NCT02342171|364673719|FG000|Overall Study|Missing age data|0|||
105731546|NCT02342171|364673720|FG001|Overall Study|Missing age data|1|||
105731547|NCT04426630|364673721|FG000|Overall Study|Death|4|||
105731548|NCT04426630|364673721|FG000|Overall Study|Lost to Follow-up|2|||
105731549|NCT02082184|364673725|FG000|Overall Study|Adverse Event|1|||
105731550|NCT02082184|364673726|FG001|Overall Study|Adverse Event|0|||
105731551|NCT02082184|364673725|FG000|Overall Study|Medical diagnosis|1|||
105731552|NCT02082184|364673726|FG001|Overall Study|Medical diagnosis|2|||
105797200|NCT03751124|364914683|FG000|Overall Study|Lost to Follow-up|6|||
105731553|NCT02082184|364673725|FG000|Overall Study|Device associated symptoms|5|||
105731554|NCT02082184|364673726|FG001|Overall Study|Device associated symptoms|0|||
105731555|NCT02082184|364673725|FG000|Overall Study|Withdrawal by Subject|3|||
105731556|NCT02082184|364673726|FG001|Overall Study|Withdrawal by Subject|2|||
105797201|NCT03751124|364914684|FG001|Overall Study|Lost to Follow-up|4|||
105564981|NCT00542880|364065377|FG001|Period 1|Eligibility criteria not fulfilled|6|||
105731557|NCT02082184|364673725|FG000|Overall Study|Protocol Violation|0|||
105731558|NCT02082184|364673726|FG001|Overall Study|Protocol Violation|6|||
105731559|NCT02082184|364673725|FG000|Overall Study|Lost to Follow-up|0|||
105731560|NCT02082184|364673726|FG001|Overall Study|Lost to Follow-up|2|||
105797202|NCT03751124|364914683|FG000|Overall Study|Withdrawal by Subject|6|||
105797203|NCT03751124|364914684|FG001|Overall Study|Withdrawal by Subject|8|||
105797204|NCT03751124|364914683|FG000|Overall Study|Lack of Efficacy|1|||
105797205|NCT03751124|364914684|FG001|Overall Study|Lack of Efficacy|1|||
105797206|NCT03751124|364914683|FG000|Overall Study|Pregnancy|0|||
105797207|NCT03751124|364914684|FG001|Overall Study|Pregnancy|1|||
105797208|NCT03751124|364914683|FG000|Overall Study|Other|9|||
105480119|NCT04585009|363769071|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
105480120|NCT04585009|363769072|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
105480121|NCT04585009|363769073|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
105480122|NCT04585009|363769074|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
105797209|NCT03751124|364914684|FG001|Overall Study|Other|9|||
105797210|NCT03751124|364914683|FG000|Overall Study|Participants who did not receive any study drug|0|||
105480123|NCT04585009|363769063|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
105480124|NCT04585009|363769064|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
105480125|NCT04585009|363769065|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
105480126|NCT04585009|363769066|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
105480127|NCT04585009|363769067|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
105480128|NCT04585009|363769068|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
105480129|NCT04585009|363769069|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
105480130|NCT04585009|363769070|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
105480131|NCT04585009|363769071|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
105480132|NCT04585009|363769072|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
105480133|NCT04585009|363769073|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
105480134|NCT04585009|363769074|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
105480135|NCT04585009|363769063|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
105480136|NCT04585009|363769064|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
105480137|NCT04585009|363769065|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
105480138|NCT04585009|363769066|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
105480139|NCT04585009|363769067|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
105480140|NCT04585009|363769068|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
105480141|NCT04585009|363769069|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
105480142|NCT04585009|363769070|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
105480143|NCT04585009|363769071|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
105480144|NCT04585009|363769072|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
105480145|NCT04585009|363769073|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
105480146|NCT04585009|363769074|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
105480147|NCT00097981|363769075|FG000|Overall Study|Adverse Event|31|||
105480148|NCT00097981|363769076|FG001|Overall Study|Adverse Event|44|||
105480149|NCT00097981|363769075|FG000|Overall Study|Withdrawal by Subject|10|||
105480150|NCT00097981|363769076|FG001|Overall Study|Withdrawal by Subject|8|||
105480151|NCT00097981|363769075|FG000|Overall Study|Protocol Violation|1|||
105480152|NCT00097981|363769076|FG001|Overall Study|Protocol Violation|1|||
105480153|NCT00097981|363769075|FG000|Overall Study|Death|2|||
105480154|NCT00097981|363769076|FG001|Overall Study|Death|4|||
105480155|NCT00097981|363769075|FG000|Overall Study|Physician Decision|7|||
105480156|NCT00097981|363769076|FG001|Overall Study|Physician Decision|1|||
105480157|NCT00097981|363769075|FG000|Overall Study|Disease Progression|8|||
105480158|NCT00097981|363769076|FG001|Overall Study|Disease Progression|2|||
105480159|NCT00097981|363769075|FG000|Overall Study|Transplant planned|28|||
105480160|NCT00097981|363769076|FG001|Overall Study|Transplant planned|27|||
105480161|NCT00097981|363769075|FG000|Overall Study|Other|19|||
105480162|NCT00097981|363769076|FG001|Overall Study|Other|13|||
105480163|NCT04140227|363769077|FG000|Overall Study|Withdrawal by Subject|26|||
105480164|NCT04140227|363769077|FG000|Overall Study|Lost to Follow-up|8|||
105480165|NCT04140227|363769077|FG000|Overall Study|Adverse Event|8|||
105480166|NCT04140227|363769077|FG000|Overall Study|Death|1|||
105480167|NCT04140227|363769077|FG000|Overall Study|Other|3|||
105480168|NCT04140227|363769077|FG000|Overall Study|Protocol Violation|2|||
105480169|NCT00528970|363769078|FG000|Overall Study|Adverse Event|6|||
105480170|NCT00528970|363769079|FG001|Overall Study|Adverse Event|8|||
105480171|NCT00528970|363769080|FG002|Overall Study|Adverse Event|5|||
105480172|NCT00528970|363769078|FG000|Overall Study|Lost to Follow-up|0|||
105480173|NCT00528970|363769079|FG001|Overall Study|Lost to Follow-up|0|||
105480174|NCT00528970|363769080|FG002|Overall Study|Lost to Follow-up|1|||
105480175|NCT00528970|363769078|FG000|Overall Study|Other than specified|2|||
105480176|NCT00528970|363769079|FG001|Overall Study|Other than specified|3|||
105480177|NCT00528970|363769080|FG002|Overall Study|Other than specified|3|||
105480178|NCT00528970|363769078|FG000|Overall Study|Protocol Violation|2|||
105480179|NCT00528970|363769079|FG001|Overall Study|Protocol Violation|1|||
105480180|NCT00528970|363769080|FG002|Overall Study|Protocol Violation|4|||
105480181|NCT00528970|363769078|FG000|Overall Study|Lack of Efficacy|0|||
105480182|NCT00528970|363769079|FG001|Overall Study|Lack of Efficacy|0|||
105480183|NCT00528970|363769080|FG002|Overall Study|Lack of Efficacy|1|||
105480184|NCT00528970|363769078|FG000|Overall Study|Withdrawal by Subject|4|||
105480185|NCT00528970|363769079|FG001|Overall Study|Withdrawal by Subject|3|||
105480186|NCT00528970|363769080|FG002|Overall Study|Withdrawal by Subject|5|||
105480187|NCT00528970|363769078|FG000|Overall Study|Randomized but not treated|0|||
105480188|NCT00528970|363769079|FG001|Overall Study|Randomized but not treated|0|||
105480189|NCT00528970|363769080|FG002|Overall Study|Randomized but not treated|1|||
105480190|NCT00538785|363769081|FG000|Overall Study|Death|9|||
105480191|NCT00538785|363769082|FG001|Overall Study|Death|10|||
105480192|NCT00538785|363769081|FG000|Overall Study|Withdrawal of consent|9|||
105480193|NCT00538785|363769082|FG001|Overall Study|Withdrawal of consent|7|||
105480194|NCT00538785|363769081|FG000|Overall Study|Lost to Follow-up|1|||
105480195|NCT00538785|363769082|FG001|Overall Study|Lost to Follow-up|0|||
105480196|NCT01009840|363769083|FG000|Overall Study|Lost to Follow-up|1|||
105480197|NCT01009840|363769083|FG000|Overall Study|Adverse Event|4|||
105480198|NCT01009840|363769083|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
105731561|NCT02082184|364673725|FG000|Overall Study|Subject non-compliance|0|||
105731562|NCT02082184|364673726|FG001|Overall Study|Subject non-compliance|1|||
105731563|NCT02559505|364673729|FG000|Overall Study|Lost to Follow-up|23|||
105731564|NCT02559505|364673730|FG001|Overall Study|Lost to Follow-up|20|||
105731565|NCT02559505|364673729|FG000|Overall Study|Withdrawal by Subject|4|||
105731566|NCT02559505|364673730|FG001|Overall Study|Withdrawal by Subject|2|||
105731567|NCT00698516|364673731|FG000|Overall Study|Study Termination|2|||
105731568|NCT00698516|364673731|FG000|Overall Study|Withdrawal by Subject|3|||
105731569|NCT02213926|364673732|FG000|Overall Study|Death|59|||
105731570|NCT02213926|364673732|FG000|Overall Study|Withdrawal by Subject|10|||
105731571|NCT02213926|364673732|FG000|Overall Study|study terminated by sponsor|51|||
105731572|NCT02213926|364673732|FG000|Overall Study|Lost to Follow-up|3|||
105731573|NCT02213926|364673732|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
105731574|NCT03715465|364673736|FG000|Overall Study|Withdrawal by Subject|1|||
105731575|NCT03715465|364673737|FG001|Overall Study|Withdrawal by Subject|2|||
105731576|NCT00756002|364673738|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
105731577|NCT00756002|364673739|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
105731578|NCT00756002|364673738|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105731579|NCT00756002|364673739|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
105731580|NCT00756002|364673738|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
105731581|NCT00756002|364673739|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
105731582|NCT00756002|364673738|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
105731583|NCT00756002|364673739|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
105731584|NCT00756002|364673738|FG000|Double-Blind Treatment Period|Other|2|||
105731585|NCT00756002|364673739|FG001|Double-Blind Treatment Period|Other|2|||
105731586|NCT01451515|364673742|FG000|Overall Study|Death|0|||
105731587|NCT01451515|364673743|FG001|Overall Study|Death|1|||
105731588|NCT01451515|364673744|FG002|Overall Study|Death|0|||
105731589|NCT01451515|364673742|FG000|Overall Study|Withdrawal by Subject|0|||
105731590|NCT01451515|364673743|FG001|Overall Study|Withdrawal by Subject|1|||
105731591|NCT01451515|364673744|FG002|Overall Study|Withdrawal by Subject|0|||
105731592|NCT01451515|364673742|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
105731593|NCT01451515|364673743|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
105731594|NCT01451515|364673744|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
105731595|NCT01451515|364673742|FG000|Overall Study|Relapse (except CNS)|1|||
105731596|NCT01451515|364673743|FG001|Overall Study|Relapse (except CNS)|1|||
105731597|NCT01451515|364673744|FG002|Overall Study|Relapse (except CNS)|0|||
105731598|NCT02397655|364673745|FG000|Overall Study|data not completed|1301|||
105731599|NCT00440401|364673748|FG000|Overall Study|Adverse Event|2|||
105731600|NCT00440401|364673749|FG001|Overall Study|Adverse Event|1|||
105731601|NCT00440401|364673748|FG000|Overall Study|Other|2|||
105731602|NCT00440401|364673749|FG001|Overall Study|Other|5|||
105731603|NCT01925703|364673750|FG000|Overall Study|Physician Decision|1|||
105731604|NCT01925703|364673750|FG000|Overall Study|Lost to Follow-up|2|||
105731605|NCT01925703|364673750|FG000|Overall Study|Discharge prior to full iron repletion|1|||
105731606|NCT00500071|364673754|FG000|Screening and Washout Phase|Protocol Violation|1|||
105731607|NCT00500071|364673754|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
105731608|NCT00500071|364673754|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
105731609|NCT00500071|364673754|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
105731610|NCT00500071|364673754|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
105731611|NCT00500071|364673754|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
105731612|NCT00500071|364673754|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
105731613|NCT00881205|364673755|FG000|Overall Study|Adverse Event|8|||
105731614|NCT00881205|364673756|FG001|Overall Study|Adverse Event|3|||
105731615|NCT00881205|364673755|FG000|Overall Study|Withdrawal by Subject|1|||
105731616|NCT00881205|364673756|FG001|Overall Study|Withdrawal by Subject|2|||
105731617|NCT00881205|364673755|FG000|Overall Study|Lost to Follow-up|0|||
105731618|NCT00881205|364673756|FG001|Overall Study|Lost to Follow-up|1|||
105731619|NCT00881205|364673755|FG000|Overall Study|Administrative problems|1|||
105731620|NCT00881205|364673756|FG001|Overall Study|Administrative problems|1|||
105731621|NCT00881205|364673755|FG000|Overall Study|Condition no longer requires drug|1|||
105731622|NCT00881205|364673756|FG001|Overall Study|Condition no longer requires drug|0|||
105731623|NCT02580058|364673757|FG000|Overall Study|Adverse Event|16|||
105731624|NCT02580058|364673758|FG001|Overall Study|Adverse Event|30|||
105797211|NCT03751124|364914684|FG001|Overall Study|Participants who did not receive any study drug|1|||
105353283|NCT05437640|363298490|FG001|Washout (1 Week)|Adverse Event|0|||
105731625|NCT02580058|364673759|FG002|Overall Study|Adverse Event|20|||
105731626|NCT02580058|364673757|FG000|Overall Study|Death|4|||
105731627|NCT02580058|364673758|FG001|Overall Study|Death|4|||
105731628|NCT02580058|364673759|FG002|Overall Study|Death|5|||
105731629|NCT02580058|364673757|FG000|Overall Study|Physician Decision|1|||
105731630|NCT02580058|364673758|FG001|Overall Study|Physician Decision|3|||
105731631|NCT02580058|364673759|FG002|Overall Study|Physician Decision|11|||
105731632|NCT02580058|364673757|FG000|Overall Study|Other|5|||
105731633|NCT02580058|364673758|FG001|Overall Study|Other|1|||
105480199|NCT01009840|363769083|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
105480200|NCT01009840|363769083|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
105480201|NCT04022733|363769084|FG000|Overall Study|conversion to open surgery|3|||
105480202|NCT04022733|363769085|FG001|Overall Study|conversion to open surgery|2|||
105480203|NCT04022733|363769084|FG000|Overall Study|bradycardia|0|||
105480204|NCT04022733|363769085|FG001|Overall Study|bradycardia|1|||
105480205|NCT03086967|363769088|FG000|Overall Study|Screen Failure|2|||
105480206|NCT03086967|363769089|FG001|Overall Study|Screen Failure|2|||
105480207|NCT03859973|363769096|FG000|Overall Study|Other reason than listed|3|||
105480208|NCT03859973|363769097|FG001|Overall Study|Other reason than listed|2|||
105480209|NCT03859973|363769096|FG000|Overall Study|COVID-19 related, not due to AE|3|||
105480210|NCT03859973|363769097|FG001|Overall Study|COVID-19 related, not due to AE|4|||
105480211|NCT03859973|363769096|FG000|Overall Study|Withdrawal by Subject|8|||
105480212|NCT03859973|363769097|FG001|Overall Study|Withdrawal by Subject|9|||
105480213|NCT03859973|363769096|FG000|Overall Study|Lost to Follow-up|2|||
105480214|NCT03859973|363769097|FG001|Overall Study|Lost to Follow-up|3|||
105480215|NCT03859973|363769096|FG000|Overall Study|Protocol Violation|1|||
105480216|NCT03859973|363769097|FG001|Overall Study|Protocol Violation|3|||
105731634|NCT02580058|364673759|FG002|Overall Study|Other|3|||
105731635|NCT02580058|364673757|FG000|Overall Study|Withdrawal by Subject|4|||
105731636|NCT02580058|364673758|FG001|Overall Study|Withdrawal by Subject|7|||
105731637|NCT02580058|364673759|FG002|Overall Study|Withdrawal by Subject|31|||
105731638|NCT02580058|364673757|FG000|Overall Study|Global Deterioration of Health Status|19|||
105731639|NCT02580058|364673758|FG001|Overall Study|Global Deterioration of Health Status|18|||
105731640|NCT02580058|364673759|FG002|Overall Study|Global Deterioration of Health Status|24|||
105731641|NCT02580058|364673757|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
105731642|NCT02580058|364673758|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
105731643|NCT02580058|364673759|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
105731644|NCT02580058|364673757|FG000|Overall Study|Progressive Disease|137|||
105731645|NCT02580058|364673758|FG001|Overall Study|Progressive Disease|125|||
105731646|NCT02580058|364673759|FG002|Overall Study|Progressive Disease|94|||
105731647|NCT02580058|364673757|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105731648|NCT02580058|364673758|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105731649|NCT02580058|364673759|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105731650|NCT05370157|364673760|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
105731651|NCT05370157|364673761|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
105731652|NCT05370157|364673760|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
105731653|NCT05370157|364673761|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
105731654|NCT00849212|364673762|FG000|Overall Study|Lack of Efficacy|1|||
105731655|NCT00849212|364673762|FG000|Overall Study|Withdrawal by Subject|3|||
105731656|NCT00849212|364673762|FG000|Overall Study|Adverse Event|2|||
105731657|NCT00849212|364673762|FG000|Overall Study|Miscellaneous|1|||
105731658|NCT01364467|364673763|FG000|Overall Study|Lost to Follow-up|1|||
105731659|NCT01364467|364673764|FG001|Overall Study|Lost to Follow-up|2|||
105731660|NCT01499576|364673765|FG000|Overall Study|Physician Decision|12|||
105731661|NCT01499576|364673765|FG000|Overall Study|Withdrawal by Subject|9|||
105731662|NCT00847613|364673772|FG000|Overall Study|Ongoing at cut-off date|250|||
105731663|NCT00847613|364673773|FG001|Overall Study|Ongoing at cut-off date|265|||
105731664|NCT00847613|364673774|FG002|Overall Study|Ongoing at cut-off date|64|||
105731665|NCT00847613|364673775|FG003|Overall Study|Ongoing at cut-off date|64|||
105731666|NCT00847613|364673772|FG000|Overall Study|Death|1|||
105731667|NCT00847613|364673773|FG001|Overall Study|Death|1|||
105731668|NCT00847613|364673774|FG002|Overall Study|Death|0|||
105731669|NCT00847613|364673775|FG003|Overall Study|Death|0|||
105731670|NCT00847613|364673772|FG000|Overall Study|Adverse Event|36|||
105480217|NCT03859973|363769096|FG000|Overall Study|Adverse Event|3|||
105480218|NCT03859973|363769097|FG001|Overall Study|Adverse Event|5|||
105480219|NCT02855541|363769100|FG000|Overall Study|Change in health status|2|||
105731671|NCT00847613|364673773|FG001|Overall Study|Adverse Event|26|||
105731672|NCT00847613|364673774|FG002|Overall Study|Adverse Event|5|||
105480220|NCT02855541|363769100|FG000|Overall Study|Withdrawal by Subject|2|||
105480221|NCT03085914|363769101|FG000|Overall Study|Death|6|||
105564982|NCT00542880|364065376|FG000|Period 1|Adverse Event|2|||
105480222|NCT03085914|363769102|FG001|Overall Study|Death|6|||
105480223|NCT03085914|363769103|FG002|Overall Study|Death|4|||
105564983|NCT00542880|364065377|FG001|Period 1|Adverse Event|2|||
105564984|NCT00542880|364065376|FG000|Period 1|Development of study-specific criteria|1|||
105731673|NCT00847613|364673775|FG003|Overall Study|Adverse Event|6|||
105731674|NCT00847613|364673772|FG000|Overall Study|Lack of Efficacy|7|||
105731675|NCT00847613|364673773|FG001|Overall Study|Lack of Efficacy|3|||
105731676|NCT00847613|364673774|FG002|Overall Study|Lack of Efficacy|3|||
105731677|NCT00847613|364673775|FG003|Overall Study|Lack of Efficacy|1|||
105731678|NCT00847613|364673772|FG000|Overall Study|Study terminated by Sponsor|1|||
105731679|NCT00847613|364673773|FG001|Overall Study|Study terminated by Sponsor|0|||
105731680|NCT00847613|364673774|FG002|Overall Study|Study terminated by Sponsor|2|||
105731681|NCT00847613|364673775|FG003|Overall Study|Study terminated by Sponsor|1|||
105480224|NCT03085914|363769104|FG003|Overall Study|Death|1|||
105480225|NCT03085914|363769105|FG004|Overall Study|Death|5|||
105480226|NCT03085914|363769106|FG005|Overall Study|Death|2|||
105480227|NCT03085914|363769107|FG006|Overall Study|Death|2|||
105480228|NCT03085914|363769101|FG000|Overall Study|Withdrawal by Subject|1|||
105480229|NCT03085914|363769102|FG001|Overall Study|Withdrawal by Subject|1|||
105480230|NCT03085914|363769103|FG002|Overall Study|Withdrawal by Subject|2|||
105480231|NCT03085914|363769104|FG003|Overall Study|Withdrawal by Subject|2|||
105480232|NCT03085914|363769105|FG004|Overall Study|Withdrawal by Subject|2|||
105480233|NCT03085914|363769106|FG005|Overall Study|Withdrawal by Subject|0|||
105480234|NCT03085914|363769107|FG006|Overall Study|Withdrawal by Subject|1|||
105480235|NCT03085914|363769101|FG000|Overall Study|Lost to Follow-up|0|||
105480236|NCT03085914|363769102|FG001|Overall Study|Lost to Follow-up|0|||
105480237|NCT03085914|363769103|FG002|Overall Study|Lost to Follow-up|1|||
105480238|NCT03085914|363769104|FG003|Overall Study|Lost to Follow-up|0|||
105480239|NCT03085914|363769105|FG004|Overall Study|Lost to Follow-up|0|||
105480240|NCT03085914|363769106|FG005|Overall Study|Lost to Follow-up|1|||
105480241|NCT03085914|363769107|FG006|Overall Study|Lost to Follow-up|1|||
105480242|NCT03085914|363769101|FG000|Overall Study|Reason was not specified,|2|||
105480243|NCT03085914|363769102|FG001|Overall Study|Reason was not specified,|2|||
105480244|NCT03085914|363769103|FG002|Overall Study|Reason was not specified,|2|||
105480245|NCT03085914|363769104|FG003|Overall Study|Reason was not specified,|3|||
105480246|NCT03085914|363769105|FG004|Overall Study|Reason was not specified,|3|||
105480247|NCT03085914|363769106|FG005|Overall Study|Reason was not specified,|3|||
105480248|NCT03085914|363769107|FG006|Overall Study|Reason was not specified,|6|||
105480249|NCT03085914|363769101|FG000|Overall Study|Progressive Disease|0|||
105480250|NCT03085914|363769102|FG001|Overall Study|Progressive Disease|0|||
105480251|NCT03085914|363769103|FG002|Overall Study|Progressive Disease|2|||
105480252|NCT03085914|363769104|FG003|Overall Study|Progressive Disease|2|||
105480253|NCT03085914|363769105|FG004|Overall Study|Progressive Disease|1|||
105480254|NCT03085914|363769106|FG005|Overall Study|Progressive Disease|1|||
105480255|NCT03085914|363769107|FG006|Overall Study|Progressive Disease|1|||
105480256|NCT03085914|363769101|FG000|Overall Study|Study Terminated by the Sponsor|0|||
105480257|NCT03085914|363769102|FG001|Overall Study|Study Terminated by the Sponsor|0|||
105480258|NCT03085914|363769103|FG002|Overall Study|Study Terminated by the Sponsor|0|||
105480259|NCT03085914|363769104|FG003|Overall Study|Study Terminated by the Sponsor|1|||
105480260|NCT03085914|363769105|FG004|Overall Study|Study Terminated by the Sponsor|2|||
105480261|NCT03085914|363769106|FG005|Overall Study|Study Terminated by the Sponsor|1|||
105480262|NCT03085914|363769107|FG006|Overall Study|Study Terminated by the Sponsor|0|||
105480263|NCT00422513|363769108|FG000|Overall Study|Lack of Efficacy|4|||
105480264|NCT00422513|363769109|FG001|Overall Study|Lack of Efficacy|5|||
105480265|NCT00422513|363769108|FG000|Overall Study|Protocol Violation|23|||
105480266|NCT00422513|363769109|FG001|Overall Study|Protocol Violation|7|||
105564985|NCT00542880|364065377|FG001|Period 1|Development of study-specific criteria|2|||
105731682|NCT00847613|364673772|FG000|Overall Study|Lost to Follow-up|5|||
105731683|NCT00847613|364673773|FG001|Overall Study|Lost to Follow-up|0|||
105731684|NCT00847613|364673774|FG002|Overall Study|Lost to Follow-up|0|||
105731685|NCT00847613|364673775|FG003|Overall Study|Lost to Follow-up|3|||
105731686|NCT00847613|364673772|FG000|Overall Study|Protocol Violation|6|||
105731687|NCT00847613|364673773|FG001|Overall Study|Protocol Violation|6|||
105731688|NCT00847613|364673774|FG002|Overall Study|Protocol Violation|3|||
105731689|NCT00847613|364673775|FG003|Overall Study|Protocol Violation|1|||
105731690|NCT00847613|364673772|FG000|Overall Study|Pregnancy|1|||
105731691|NCT00847613|364673773|FG001|Overall Study|Pregnancy|1|||
105731692|NCT00847613|364673774|FG002|Overall Study|Pregnancy|0|||
105731693|NCT00847613|364673775|FG003|Overall Study|Pregnancy|0|||
105731694|NCT00847613|364673772|FG000|Overall Study|Site closure|1|||
105731695|NCT00847613|364673773|FG001|Overall Study|Site closure|0|||
105731696|NCT00847613|364673774|FG002|Overall Study|Site closure|0|||
105731697|NCT00847613|364673775|FG003|Overall Study|Site closure|1|||
105731698|NCT00847613|364673772|FG000|Overall Study|Withdrawal by Subject|8|||
105731699|NCT00847613|364673773|FG001|Overall Study|Withdrawal by Subject|11|||
105731700|NCT00847613|364673774|FG002|Overall Study|Withdrawal by Subject|2|||
105480267|NCT00422513|363769108|FG000|Overall Study|Refused Treatment|4|||
105480268|NCT00422513|363769109|FG001|Overall Study|Refused Treatment|2|||
105480269|NCT00422513|363769108|FG000|Overall Study|Withdrawal by Subject|2|||
105480270|NCT00422513|363769109|FG001|Overall Study|Withdrawal by Subject|1|||
105480271|NCT00422513|363769108|FG000|Overall Study|early termination of the study|67|||
105480272|NCT00422513|363769109|FG001|Overall Study|early termination of the study|80|||
105480273|NCT00422513|363769108|FG000|Overall Study|Adverse Event|4|||
105480274|NCT00422513|363769109|FG001|Overall Study|Adverse Event|4|||
105731701|NCT00847613|364673775|FG003|Overall Study|Withdrawal by Subject|2|||
105731702|NCT00847613|364673772|FG000|Overall Study|Participant moved|4|||
105480275|NCT00422513|363769108|FG000|Overall Study|Death|3|||
105480276|NCT00422513|363769109|FG001|Overall Study|Death|7|||
105731703|NCT00847613|364673773|FG001|Overall Study|Participant moved|1|||
105731704|NCT00847613|364673774|FG002|Overall Study|Participant moved|0|||
105731705|NCT00847613|364673775|FG003|Overall Study|Participant moved|0|||
105731706|NCT00847613|364673772|FG000|Overall Study|Sponsor request|0|||
105731707|NCT00847613|364673773|FG001|Overall Study|Sponsor request|1|||
105731708|NCT00847613|364673774|FG002|Overall Study|Sponsor request|0|||
105731709|NCT00847613|364673775|FG003|Overall Study|Sponsor request|0|||
105731710|NCT00847613|364673772|FG000|Overall Study|Randomized, but not treated|0|||
105731711|NCT00847613|364673773|FG001|Overall Study|Randomized, but not treated|3|||
105731712|NCT00847613|364673774|FG002|Overall Study|Randomized, but not treated|0|||
105731713|NCT00847613|364673775|FG003|Overall Study|Randomized, but not treated|0|||
105731714|NCT00847613|364673772|FG000|Overall Study|Other|1|||
105731715|NCT00847613|364673773|FG001|Overall Study|Other|1|||
105731716|NCT00847613|364673774|FG002|Overall Study|Other|2|||
105731717|NCT00847613|364673775|FG003|Overall Study|Other|0|||
105731718|NCT01633060|364673776|FG000|Randomization Phase|Protocol deviation|1|||
105731719|NCT01633060|364673777|FG001|Randomization Phase|Protocol deviation|2|||
105731720|NCT01633060|364673776|FG000|Randomization Phase|Technical problem|0|||
105731721|NCT01633060|364673777|FG001|Randomization Phase|Technical problem|1|||
105731722|NCT01633060|364673776|FG000|Treatment Phase|Adverse Event|24|||
105731723|NCT01633060|364673777|FG001|Treatment Phase|Adverse Event|3|||
105731724|NCT01633060|364673776|FG000|Treatment Phase|Lost to Follow-up|1|||
105731725|NCT01633060|364673777|FG001|Treatment Phase|Lost to Follow-up|0|||
105731726|NCT01633060|364673776|FG000|Treatment Phase|Physician Decision|16|||
105731727|NCT01633060|364673777|FG001|Treatment Phase|Physician Decision|7|||
105731728|NCT01633060|364673776|FG000|Treatment Phase|Progressive Disease|210|||
105731729|NCT01633060|364673777|FG001|Treatment Phase|Progressive Disease|120|||
105731730|NCT01633060|364673776|FG000|Treatment Phase|Protocol Deviation|1|||
105731731|NCT01633060|364673777|FG001|Treatment Phase|Protocol Deviation|0|||
105731732|NCT01633060|364673776|FG000|Treatment Phase|Study Terminated by sponsor|7|||
105731733|NCT01633060|364673777|FG001|Treatment Phase|Study Terminated by sponsor|3|||
105731734|NCT01633060|364673776|FG000|Treatment Phase|Subject/guardian decision|25|||
105731735|NCT01633060|364673777|FG001|Treatment Phase|Subject/guardian decision|4|||
105731736|NCT01633060|364673776|FG000|Treatment Phase|Death|4|||
105731737|NCT01633060|364673777|FG001|Treatment Phase|Death|3|||
105731738|NCT01633060|364673776|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
105731739|NCT01633060|364673777|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105731740|NCT01633060|364673776|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
105731741|NCT01633060|364673777|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
105731742|NCT01633060|364673776|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
105731743|NCT01633060|364673777|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
105731744|NCT01633060|364673776|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
105731745|NCT01633060|364673777|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
105731746|NCT01633060|364673776|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
105731747|NCT01633060|364673777|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
105731748|NCT01633060|364673776|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
105731749|NCT01633060|364673777|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
105731750|NCT01982630|364673778|FG000|Overall Study|Adverse Event|2|||
105731751|NCT01982630|364673779|FG001|Overall Study|Adverse Event|0|||
105731752|NCT01982630|364673780|FG002|Overall Study|Adverse Event|1|||
105731753|NCT01982630|364673781|FG003|Overall Study|Adverse Event|0|||
105731754|NCT01982630|364673782|FG004|Overall Study|Adverse Event|1|||
105731755|NCT01982630|364673783|FG005|Overall Study|Adverse Event|2|||
105353284|NCT00904917|363298491|FG000|Overall Study|Lost to Follow-up|2|||
105797212|NCT00555399|364914693|FG000|Overall Study|Withdrawal by Subject|0|||
105731756|NCT01982630|364673784|FG006|Overall Study|Adverse Event|1|||
105731757|NCT01982630|364673785|FG007|Overall Study|Adverse Event|0|||
105731758|NCT01982630|364673778|FG000|Overall Study|Physician Decision|1|||
105731759|NCT01982630|364673779|FG001|Overall Study|Physician Decision|0|||
105731760|NCT01982630|364673780|FG002|Overall Study|Physician Decision|2|||
105731761|NCT01982630|364673781|FG003|Overall Study|Physician Decision|1|||
105731762|NCT01982630|364673782|FG004|Overall Study|Physician Decision|2|||
105731763|NCT01982630|364673783|FG005|Overall Study|Physician Decision|0|||
105731764|NCT01982630|364673784|FG006|Overall Study|Physician Decision|0|||
105797213|NCT00555399|364914694|FG001|Overall Study|Withdrawal by Subject|0|||
105797214|NCT00555399|364914695|FG002|Overall Study|Withdrawal by Subject|1|||
105797215|NCT00555399|364914696|FG003|Overall Study|Withdrawal by Subject|0|||
105797216|NCT00555399|364914697|FG004|Overall Study|Withdrawal by Subject|0|||
105797217|NCT00555399|364914698|FG005|Overall Study|Withdrawal by Subject|0|||
105797218|NCT00555399|364914699|FG006|Overall Study|Withdrawal by Subject|0|||
105797219|NCT00555399|364914700|FG007|Overall Study|Withdrawal by Subject|0|||
105797220|NCT00555399|364914701|FG008|Overall Study|Withdrawal by Subject|0|||
105797221|NCT00555399|364914702|FG009|Overall Study|Withdrawal by Subject|0|||
105797222|NCT00555399|364914703|FG010|Overall Study|Withdrawal by Subject|0|||
105797223|NCT00555399|364914704|FG011|Overall Study|Withdrawal by Subject|1|||
105797224|NCT00555399|364914693|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
105797225|NCT00555399|364914694|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
105797226|NCT00555399|364914695|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
105797227|NCT00555399|364914696|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
105797228|NCT00555399|364914697|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
105797229|NCT00555399|364914698|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
105797230|NCT00555399|364914699|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
105797231|NCT00555399|364914700|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
105797232|NCT00555399|364914701|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
105797233|NCT00555399|364914702|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
105797234|NCT00555399|364914703|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
105797235|NCT00555399|364914704|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
105797236|NCT00303316|364915895|FG000|Overall Study|Protocol Violation|1|||
105797237|NCT00303316|364915896|FG001|Overall Study|Protocol Violation|0|||
105797238|NCT00303316|364915895|FG000|Overall Study|Lost to Follow-up|0|||
105797239|NCT00303316|364915896|FG001|Overall Study|Lost to Follow-up|1|||
105797240|NCT00303316|364915895|FG000|Overall Study|Withdrawal by Subject|1|||
105797241|NCT00303316|364915896|FG001|Overall Study|Withdrawal by Subject|2|||
105797242|NCT01160198|364915900|FG000|Overall Study|Withdrawal by Subject|2|||
105797243|NCT01160198|364915901|FG001|Overall Study|Withdrawal by Subject|1|||
105797244|NCT01160198|364915902|FG002|Overall Study|Withdrawal by Subject|0|||
105797245|NCT01160198|364915900|FG000|Overall Study|Adverse Event|0|||
105797246|NCT01160198|364915901|FG001|Overall Study|Adverse Event|1|||
105797247|NCT01160198|364915902|FG002|Overall Study|Adverse Event|0|||
105797248|NCT01160198|364915900|FG000|Overall Study|Lost to Follow-up|0|||
105797249|NCT01160198|364915901|FG001|Overall Study|Lost to Follow-up|1|||
105797250|NCT01160198|364915902|FG002|Overall Study|Lost to Follow-up|0|||
105797251|NCT01160198|364915900|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
105797252|NCT01160198|364915901|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
105797253|NCT01160198|364915902|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
105797254|NCT02360397|364915905|FG000|Overall Study|Incomplete screening|3|||
105797255|NCT02360397|364915905|FG000|Overall Study|Adverse Event|1|||
105797256|NCT01637961|364915908|FG000|Overall Study|Ineligible: wrong primary|1|||
105797257|NCT01637961|364915908|FG000|Overall Study|Ineligible: inadequate pathology|1|||
105797258|NCT03555890|364915913|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105797259|NCT03555890|364915914|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105797260|NCT03555890|364915915|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105797261|NCT03555890|364915916|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
105797262|NCT00550420|364915922|FG000|Overall Study|Adverse Event|28|||
105797263|NCT00550420|364915922|FG000|Overall Study|Lost to Follow-up|8|||
105797264|NCT00550420|364915922|FG000|Overall Study|Protocol Violation|11|||
105797265|NCT00550420|364915922|FG000|Overall Study|Withdrawal by Subject|30|||
105797266|NCT00550420|364915922|FG000|Overall Study|Still in study at termination|206|||
105797267|NCT00550420|364915922|FG000|Overall Study|Missing|2|||
105564986|NCT00542880|364065376|FG000|Period 1|Withdrawal by Subject|1|||
105564987|NCT00542880|364065377|FG001|Period 1|Withdrawal by Subject|1|||
105564988|NCT00542880|364065376|FG000|Period 1|Protocol Violation|0|||
105797268|NCT00550420|364915922|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
105797269|NCT00550420|364915922|FG000|Overall Study|Investigators opinion|1|||
105797270|NCT00550420|364915922|FG000|Overall Study|Lack of curative effect|1|||
105797271|NCT00550420|364915922|FG000|Overall Study|Unethical stop of enrollment|2|||
105797272|NCT00550420|364915922|FG000|Overall Study|Caregiver's decision to withdraw|1|||
105797273|NCT00550420|364915922|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
105797274|NCT00550420|364915922|FG000|Overall Study|Exclusion criteria|1|||
105797275|NCT00550420|364915922|FG000|Overall Study|Prohibited medicine|1|||
105797276|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
105797277|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
105797278|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
105797279|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
105797280|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
105797281|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
105797282|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
105797283|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
105797284|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
105797285|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
105797286|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
105797287|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
105797288|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
105797289|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
105797290|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
105797291|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
105797292|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
105797293|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
105797294|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
105797295|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
105797296|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
105797297|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
105797298|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
105797299|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
105797300|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
105797301|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
105797302|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
105797303|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
105797304|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
105797305|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
105797306|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
105797307|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
105797308|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
105797309|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
105797310|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
105797311|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
105797312|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
105797313|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
105797314|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
105797315|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
105797316|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
105797317|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
105797318|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
105797319|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
105797320|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
105797321|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
105797322|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
105797323|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
105797324|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
105797325|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
105797326|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
105797327|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
105797328|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
105797329|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
105797330|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
105797331|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
105797332|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
105797333|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
105797334|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
105797335|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
105797336|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
105797337|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
105797338|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
105797339|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
105797340|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
105797341|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
105797342|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
105797343|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
105797344|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
105797345|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
105797346|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
105797347|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
105797348|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
105797349|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
105797350|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
105797351|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
105797352|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
105797353|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
105797354|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
105797355|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
105797356|NCT04440163|364915924|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
105797357|NCT04440163|364915925|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
105797358|NCT04440163|364915926|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
105797359|NCT04440163|364915927|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
105480277|NCT01478048|363769110|FG000|Overall Study|Disease Progression|52|||
105731765|NCT01982630|364673785|FG007|Overall Study|Physician Decision|0|||
105731766|NCT01982630|364673778|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
105731767|NCT01982630|364673779|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
105731768|NCT01982630|364673780|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
105731769|NCT01982630|364673781|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
105731770|NCT01982630|364673782|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
105731771|NCT01982630|364673783|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
105731772|NCT01982630|364673784|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
105731773|NCT01982630|364673785|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
105731774|NCT01982630|364673778|FG000|Overall Study|Withdrawal by Subject|0|||
105731775|NCT01982630|364673779|FG001|Overall Study|Withdrawal by Subject|0|||
105731776|NCT01982630|364673780|FG002|Overall Study|Withdrawal by Subject|0|||
105731777|NCT01982630|364673781|FG003|Overall Study|Withdrawal by Subject|0|||
105731778|NCT01982630|364673782|FG004|Overall Study|Withdrawal by Subject|0|||
105731779|NCT01982630|364673783|FG005|Overall Study|Withdrawal by Subject|1|||
105731780|NCT01982630|364673784|FG006|Overall Study|Withdrawal by Subject|0|||
105731781|NCT01982630|364673785|FG007|Overall Study|Withdrawal by Subject|0|||
105731782|NCT01009294|364673789|FG000|Overall Study|Study discontinued by Sponsor|6|||
105731783|NCT03233048|364673790|FG000|Overall Study|Withdrawal by Subject|1|||
105731784|NCT00561353|364673791|FG000|Overall Study|Subject reached a virologic endpoint|2|||
105731785|NCT00561353|364673792|FG001|Overall Study|Subject reached a virologic endpoint|1|||
105731786|NCT00561353|364673793|FG002|Overall Study|Subject reached a virologic endpoint|1|||
105731787|NCT00561353|364673794|FG003|Overall Study|Subject reached a virologic endpoint|4|||
105731788|NCT00561353|364673795|FG004|Overall Study|Subject reached a virologic endpoint|1|||
105731789|NCT00561353|364673796|FG005|Overall Study|Subject reached a virologic endpoint|3|||
105731790|NCT00561353|364673797|FG006|Overall Study|Subject reached a virologic endpoint|4|||
105731791|NCT00561353|364673798|FG007|Overall Study|Subject reached a virologic endpoint|4|||
105731792|NCT00561353|364673799|FG008|Overall Study|Subject reached a virologic endpoint|5|||
105731793|NCT00561353|364673800|FG009|Overall Study|Subject reached a virologic endpoint|0|||
105731794|NCT00561353|364673791|FG000|Overall Study|Subject ineligible to continue the trial|0|||
105731795|NCT00561353|364673792|FG001|Overall Study|Subject ineligible to continue the trial|0|||
105731796|NCT00561353|364673793|FG002|Overall Study|Subject ineligible to continue the trial|0|||
105731797|NCT00561353|364673794|FG003|Overall Study|Subject ineligible to continue the trial|0|||
105731798|NCT00561353|364673795|FG004|Overall Study|Subject ineligible to continue the trial|0|||
105731799|NCT00561353|364673796|FG005|Overall Study|Subject ineligible to continue the trial|1|||
105731800|NCT00561353|364673797|FG006|Overall Study|Subject ineligible to continue the trial|1|||
105731801|NCT00561353|364673798|FG007|Overall Study|Subject ineligible to continue the trial|0|||
105731802|NCT00561353|364673799|FG008|Overall Study|Subject ineligible to continue the trial|2|||
105731803|NCT00561353|364673800|FG009|Overall Study|Subject ineligible to continue the trial|1|||
105731804|NCT00561353|364673791|FG000|Overall Study|Other|1|||
105731805|NCT00561353|364673792|FG001|Overall Study|Other|0|||
105731806|NCT00561353|364673793|FG002|Overall Study|Other|1|||
105797360|NCT04440163|364915928|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
105797361|NCT04440163|364915929|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
105797362|NCT04440163|364915930|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
105731807|NCT00561353|364673794|FG003|Overall Study|Other|0|||
105731808|NCT00561353|364673795|FG004|Overall Study|Other|0|||
105731809|NCT00561353|364673796|FG005|Overall Study|Other|2|||
105731810|NCT00561353|364673797|FG006|Overall Study|Other|0|||
105731811|NCT00561353|364673798|FG007|Overall Study|Other|0|||
105731812|NCT00561353|364673799|FG008|Overall Study|Other|0|||
105731813|NCT00561353|364673800|FG009|Overall Study|Other|0|||
105731814|NCT00561353|364673791|FG000|Overall Study|Adverse Event|0|||
105731815|NCT00561353|364673792|FG001|Overall Study|Adverse Event|0|||
105731816|NCT00561353|364673793|FG002|Overall Study|Adverse Event|0|||
105731817|NCT00561353|364673794|FG003|Overall Study|Adverse Event|2|||
105731818|NCT00561353|364673795|FG004|Overall Study|Adverse Event|0|||
105731819|NCT00561353|364673796|FG005|Overall Study|Adverse Event|0|||
105731820|NCT00561353|364673797|FG006|Overall Study|Adverse Event|1|||
105731821|NCT00561353|364673798|FG007|Overall Study|Adverse Event|0|||
105731822|NCT00561353|364673799|FG008|Overall Study|Adverse Event|0|||
105731823|NCT00561353|364673800|FG009|Overall Study|Adverse Event|1|||
105731824|NCT00561353|364673791|FG000|Overall Study|Lost to Follow-up|2|||
105731825|NCT00561353|364673792|FG001|Overall Study|Lost to Follow-up|0|||
105731826|NCT00561353|364673793|FG002|Overall Study|Lost to Follow-up|1|||
105731827|NCT00561353|364673794|FG003|Overall Study|Lost to Follow-up|0|||
105731828|NCT00561353|364673795|FG004|Overall Study|Lost to Follow-up|0|||
105731829|NCT00561353|364673796|FG005|Overall Study|Lost to Follow-up|0|||
105731830|NCT00561353|364673797|FG006|Overall Study|Lost to Follow-up|0|||
105731831|NCT00561353|364673798|FG007|Overall Study|Lost to Follow-up|0|||
105731832|NCT00561353|364673799|FG008|Overall Study|Lost to Follow-up|0|||
105731833|NCT00561353|364673800|FG009|Overall Study|Lost to Follow-up|0|||
105731834|NCT00561353|364673791|FG000|Overall Study|Withdrawal by Subject|0|||
105731835|NCT00561353|364673792|FG001|Overall Study|Withdrawal by Subject|2|||
105731836|NCT00561353|364673793|FG002|Overall Study|Withdrawal by Subject|0|||
105731837|NCT00561353|364673794|FG003|Overall Study|Withdrawal by Subject|0|||
105731838|NCT00561353|364673795|FG004|Overall Study|Withdrawal by Subject|0|||
105731839|NCT00561353|364673796|FG005|Overall Study|Withdrawal by Subject|0|||
105731840|NCT00561353|364673797|FG006|Overall Study|Withdrawal by Subject|0|||
105731841|NCT00561353|364673798|FG007|Overall Study|Withdrawal by Subject|0|||
105731842|NCT00561353|364673799|FG008|Overall Study|Withdrawal by Subject|0|||
105731843|NCT00561353|364673800|FG009|Overall Study|Withdrawal by Subject|0|||
105731844|NCT00195351|364673801|FG000|Overall Study|Lost to Follow-up|9|||
105731845|NCT00195351|364673802|FG001|Overall Study|Lost to Follow-up|9|||
105731846|NCT00195351|364673801|FG000|Overall Study|Withdrawal by Subject|6|||
105731847|NCT00195351|364673802|FG001|Overall Study|Withdrawal by Subject|3|||
105731848|NCT00195351|364673801|FG000|Overall Study|Protocol Deviation|3|||
105731849|NCT00195351|364673802|FG001|Overall Study|Protocol Deviation|2|||
105731850|NCT00195351|364673801|FG000|Overall Study|Death|3|||
105731851|NCT00195351|364673802|FG001|Overall Study|Death|1|||
105731852|NCT00195351|364673801|FG000|Overall Study|Lack of Efficacy|0|||
105731853|NCT00195351|364673802|FG001|Overall Study|Lack of Efficacy|1|||
105731854|NCT02111369|364673803|FG000|Overall Study|Lost to Follow-up|2|||
105731855|NCT02111369|364673803|FG000|Overall Study|Withdrawal by Subject|1|||
105731856|NCT03240081|364673807|FG000|Overall Study|Withdrawal by Subject|0|||
105731857|NCT03240081|364673808|FG001|Overall Study|Withdrawal by Subject|2|||
105731858|NCT03240081|364673807|FG000|Overall Study|Lost to Follow-up|0|||
105731859|NCT03240081|364673808|FG001|Overall Study|Lost to Follow-up|1|||
105731860|NCT00820040|364673809|FG000|Overall Study|Death|1|||
105731861|NCT00820040|364673809|FG000|Overall Study|Sponsor terminated study|1|||
105731862|NCT00820040|364673809|FG000|Overall Study|Screen failure|1|||
105731863|NCT00883753|364673810|FG000|Overall Study|Adverse Event|37|||
105731864|NCT00883753|364673810|FG000|Overall Study|Death|2|||
105731865|NCT00883753|364673810|FG000|Overall Study|Insufficient therapeutic response|16|||
105731866|NCT00883753|364673810|FG000|Overall Study|Lost to Follow-up|4|||
105731867|NCT00883753|364673810|FG000|Overall Study|Violation of selection criteria at entry|7|||
105731868|NCT00883753|364673810|FG000|Overall Study|Protocol Violation|2|||
105731869|NCT00883753|364673810|FG000|Overall Study|Refused treatment|4|||
105731870|NCT00883753|364673810|FG000|Overall Study|Withdrew consent|10|||
105731871|NCT00883753|364673810|FG000|Overall Study|Investigator's decision|17|||
105731872|NCT00883753|364673810|FG000|Overall Study|Administrative/Other|8|||
105731873|NCT04332419|364673811|FG000|Overall Study|Withdrawal by Subject|1|||
105731874|NCT01480180|364673812|FG000|Main Phase|Withdrawal criteria|12|||
105731875|NCT01480180|364673813|FG001|Main Phase|Withdrawal criteria|1|||
105731876|NCT01480180|364673814|FG002|Main Phase|Withdrawal criteria|0|||
105731877|NCT01480180|364673815|FG003|Main Phase|Withdrawal criteria|0|||
105731878|NCT01480180|364673816|FG004|Main Phase|Withdrawal criteria|0|||
105731879|NCT01480180|364673817|FG005|Main Phase|Withdrawal criteria|0|||
105731880|NCT01480180|364673812|FG000|Main Phase|Lack of Efficacy|1|||
105731881|NCT01480180|364673813|FG001|Main Phase|Lack of Efficacy|0|||
105731882|NCT01480180|364673814|FG002|Main Phase|Lack of Efficacy|0|||
105731883|NCT01480180|364673815|FG003|Main Phase|Lack of Efficacy|0|||
105731884|NCT01480180|364673816|FG004|Main Phase|Lack of Efficacy|0|||
105731885|NCT01480180|364673817|FG005|Main Phase|Lack of Efficacy|0|||
105731886|NCT01480180|364673812|FG000|Main Phase|Non-compliance|3|||
105797363|NCT04440163|364915931|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
105797364|NCT04440163|364915924|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
105797365|NCT04440163|364915925|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
105797366|NCT04440163|364915926|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
105797367|NCT04440163|364915927|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
105797368|NCT04440163|364915928|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
105797369|NCT04440163|364915929|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
105797370|NCT04440163|364915930|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
105797371|NCT04440163|364915931|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
105797372|NCT02748616|364915932|FG000|Overall Study|Lost to Follow-up|1|||
105797373|NCT02748616|364915932|FG000|Overall Study|Withdrawal by Subject|2|||
105797374|NCT02748616|364915932|FG000|Overall Study|Physician Decision|2|||
105797375|NCT02748616|364915932|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
105797376|NCT00782275|364915933|FG000|Overall Study|Adverse Event|11|||
105797377|NCT00782275|364915933|FG000|Overall Study|Withdrawal by Subject|1|||
105797378|NCT00782275|364915933|FG000|Overall Study|Progressive Disease|21|||
105797379|NCT00782275|364915933|FG000|Overall Study|Physician Decision|4|||
105797380|NCT00782275|364915933|FG000|Overall Study|Not started treatment|1|||
105797381|NCT00782275|364915933|FG000|Overall Study|Other|3|||
105797382|NCT02018042|364915934|FG000|Overall Study|Withdrawal by Subject|1|||
105797383|NCT03876873|364915940|FG000|Overall Study|Physician Decision|0|||
105797384|NCT03876873|364915941|FG001|Overall Study|Physician Decision|1|||
105797385|NCT03402126|364915945|FG000|Overall Study|Lost to Follow-up|6|||
105797386|NCT03402126|364915945|FG000|Overall Study|Protocol Violation|10|||
105797387|NCT03402126|364915945|FG000|Overall Study|Sponsor request/Study termination|29|||
105797388|NCT03402126|364915945|FG000|Overall Study|Study product no longer in use|1|||
105797389|NCT03402126|364915945|FG000|Overall Study|Technical problems|1|||
105797390|NCT03402126|364915945|FG000|Overall Study|Withdrawal by Subject|6|||
105797391|NCT03402126|364915945|FG000|Overall Study|Physician Decision|2|||
105797392|NCT03402126|364915945|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
105797393|NCT03402126|364915945|FG000|Overall Study|Death|4|||
105797394|NCT02117479|364915948|FG000|Overall Study|Death|13|||
105797395|NCT02117479|364915949|FG001|Overall Study|Death|8|||
105797396|NCT02117479|364915948|FG000|Overall Study|Adverse Event|8|||
105797397|NCT02117479|364915949|FG001|Overall Study|Adverse Event|16|||
105797398|NCT02117479|364915948|FG000|Overall Study|Subject decision|8|||
105797399|NCT02117479|364915949|FG001|Overall Study|Subject decision|9|||
105797400|NCT02117479|364915948|FG000|Overall Study|Disease progression|104|||
105797401|NCT02117479|364915949|FG001|Overall Study|Disease progression|108|||
105797402|NCT02117479|364915948|FG000|Overall Study|Noncompliance with study treatment|1|||
105797403|NCT02117479|364915949|FG001|Overall Study|Noncompliance with study treatment|0|||
105797404|NCT02117479|364915948|FG000|Overall Study|Study terminated by the sponsor|4|||
105797405|NCT02117479|364915949|FG001|Overall Study|Study terminated by the sponsor|6|||
105797406|NCT02117479|364915948|FG000|Overall Study|Physician Decision|7|||
105797407|NCT02117479|364915949|FG001|Overall Study|Physician Decision|2|||
105797408|NCT02117479|364915948|FG000|Overall Study|Other unspecified|11|||
105797409|NCT02117479|364915949|FG001|Overall Study|Other unspecified|7|||
105797410|NCT00447694|364915952|FG000|Overall Study|Adverse Event|2|||
105797411|NCT00447694|364915952|FG000|Overall Study|Abnormal laboratory value|1|||
105797412|NCT00447694|364915952|FG000|Overall Study|Abnormal test procedure result|1|||
105797413|NCT00447694|364915952|FG000|Overall Study|Withdrawal by Subject|2|||
105797414|NCT00709735|364915953|FG000|Overall Study|Lost to Follow-up|1|||
105797415|NCT00709735|364915954|FG001|Overall Study|Lost to Follow-up|1|||
105797416|NCT00709735|364915953|FG000|Overall Study|Relapse into Opioid Abuse|0|||
105797417|NCT00709735|364915954|FG001|Overall Study|Relapse into Opioid Abuse|1|||
105797418|NCT00709735|364915953|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
105797419|NCT00709735|364915954|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
105797420|NCT04440007|364915955|FG000|Overall Study|Adverse Event|0|||
105797421|NCT04440007|364915956|FG001|Overall Study|Adverse Event|1|||
105797422|NCT04440007|364915955|FG000|Overall Study|Lost to Follow-up|1|||
105797423|NCT04440007|364915956|FG001|Overall Study|Lost to Follow-up|3|||
105797424|NCT04440007|364915955|FG000|Overall Study|Death|7|||
105797425|NCT04440007|364915956|FG001|Overall Study|Death|2|||
105797426|NCT04440007|364915955|FG000|Overall Study|Physician Decision|1|||
105797427|NCT04440007|364915956|FG001|Overall Study|Physician Decision|1|||
105797428|NCT04440007|364915955|FG000|Overall Study|Withdrawal by Subject|2|||
105797429|NCT04440007|364915956|FG001|Overall Study|Withdrawal by Subject|1|||
105797430|NCT04440007|364915955|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
105797431|NCT04440007|364915956|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
105797432|NCT04440007|364915955|FG000|Overall Study|Discontinued prior to dosing|0|||
105797433|NCT04440007|364915956|FG001|Overall Study|Discontinued prior to dosing|2|||
105797434|NCT02725671|364915957|FG000|Overall Study|Lost to Follow-up|1|||
105731887|NCT01480180|364673813|FG001|Main Phase|Non-compliance|0|||
105731888|NCT01480180|364673814|FG002|Main Phase|Non-compliance|0|||
105731889|NCT01480180|364673815|FG003|Main Phase|Non-compliance|0|||
105731890|NCT01480180|364673816|FG004|Main Phase|Non-compliance|0|||
105731891|NCT01480180|364673817|FG005|Main Phase|Non-compliance|0|||
105731892|NCT01480180|364673812|FG000|Main Phase|Unclassified|3|||
105731893|NCT01480180|364673813|FG001|Main Phase|Unclassified|0|||
105731894|NCT01480180|364673814|FG002|Main Phase|Unclassified|0|||
105731895|NCT01480180|364673815|FG003|Main Phase|Unclassified|0|||
105731896|NCT01480180|364673816|FG004|Main Phase|Unclassified|0|||
105731897|NCT01480180|364673817|FG005|Main Phase|Unclassified|0|||
105731898|NCT01480180|364673812|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
105731899|NCT01480180|364673813|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
105731900|NCT01480180|364673814|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
105731901|NCT01480180|364673815|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
105731902|NCT01480180|364673816|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
105731903|NCT01480180|364673817|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
105731904|NCT01480180|364673812|FG000|Extension Phase, Part 1|Unclassified|0|||
105731905|NCT01480180|364673813|FG001|Extension Phase, Part 1|Unclassified|0|||
105731906|NCT01480180|364673814|FG002|Extension Phase, Part 1|Unclassified|1|||
105731907|NCT01480180|364673815|FG003|Extension Phase, Part 1|Unclassified|0|||
105731908|NCT01480180|364673816|FG004|Extension Phase, Part 1|Unclassified|0|||
105731909|NCT01480180|364673817|FG005|Extension Phase, Part 1|Unclassified|0|||
105731910|NCT01480180|364673812|FG000|Extension Phase, Part 1|Adverse Event|0|||
105731911|NCT01480180|364673813|FG001|Extension Phase, Part 1|Adverse Event|0|||
105731912|NCT01480180|364673814|FG002|Extension Phase, Part 1|Adverse Event|4|||
105731913|NCT01480180|364673815|FG003|Extension Phase, Part 1|Adverse Event|1|||
105731914|NCT01480180|364673816|FG004|Extension Phase, Part 1|Adverse Event|0|||
105731915|NCT01480180|364673817|FG005|Extension Phase, Part 1|Adverse Event|0|||
105731916|NCT01480180|364673812|FG000|Extension Phase, Part 1|Change of treatment|0|||
105731917|NCT01480180|364673813|FG001|Extension Phase, Part 1|Change of treatment|0|||
105731918|NCT01480180|364673814|FG002|Extension Phase, Part 1|Change of treatment|0|||
105731919|NCT01480180|364673815|FG003|Extension Phase, Part 1|Change of treatment|9|||
105731920|NCT01480180|364673816|FG004|Extension Phase, Part 1|Change of treatment|0|||
105731921|NCT01480180|364673817|FG005|Extension Phase, Part 1|Change of treatment|0|||
105731922|NCT01480180|364673812|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
105731923|NCT01480180|364673813|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
105731924|NCT01480180|364673814|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
105731925|NCT01480180|364673815|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
105731926|NCT01480180|364673816|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
105731927|NCT01480180|364673817|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
105731928|NCT01480180|364673812|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
105731929|NCT01480180|364673813|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
105731930|NCT01480180|364673814|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
105731931|NCT01480180|364673815|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
105731932|NCT01480180|364673816|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
105731933|NCT01480180|364673817|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
105731934|NCT01480180|364673812|FG000|Extension Phase, Part 2|Unclassified|0|||
105731935|NCT01480180|364673813|FG001|Extension Phase, Part 2|Unclassified|0|||
105731936|NCT01480180|364673814|FG002|Extension Phase, Part 2|Unclassified|3|||
105731937|NCT01480180|364673815|FG003|Extension Phase, Part 2|Unclassified|1|||
105731938|NCT01480180|364673816|FG004|Extension Phase, Part 2|Unclassified|1|||
105731939|NCT01480180|364673817|FG005|Extension Phase, Part 2|Unclassified|0|||
105731940|NCT01259466|364673820|FG000|Overall Study|Withdrawal by Subject|1|||
105731941|NCT01259466|364673821|FG001|Overall Study|Withdrawal by Subject|9|||
105731942|NCT02296840|364673825|FG000|Overall Study|Adverse Event|1|||
105731943|NCT02296840|364673826|FG001|Overall Study|Adverse Event|1|||
105731944|NCT02296840|364673825|FG000|Overall Study|Protocol Violation|2|||
105353285|NCT00904917|363298492|FG001|Overall Study|Lost to Follow-up|2|||
105731945|NCT02296840|364673826|FG001|Overall Study|Protocol Violation|1|||
105731946|NCT02296840|364673825|FG000|Overall Study|Lost to Follow-up|6|||
105731947|NCT02296840|364673826|FG001|Overall Study|Lost to Follow-up|17|||
105731948|NCT02498821|364673829|FG000|Overall Study|Screen failure|3|||
105731949|NCT02498821|364673830|FG001|Overall Study|Screen failure|5|||
105731950|NCT00828451|364673831|FG000|Overall Study|Death|2|||
105731951|NCT00828451|364673831|FG000|Overall Study|Lack of intravenous line|7|||
105731952|NCT00828451|364673831|FG000|Overall Study|Withdrawal by Subject|1|||
105731953|NCT00828451|364673831|FG000|Overall Study|Deterioration in clinical status|1|||
105731954|NCT01716169|364673833|FG000|Overall Study|Adverse Event|1|||
105731955|NCT01716169|364673833|FG000|Overall Study|Lost to Follow-up|1|||
105731956|NCT01716169|364673833|FG000|Overall Study|Withdrawal by Subject|1|||
105731957|NCT01716169|364673833|FG000|Overall Study|inconsistent dressing application|1|||
105731958|NCT03443024|364673834|FG000|Overall Study|Adverse Event|2|||
105731959|NCT03443024|364673835|FG001|Overall Study|Adverse Event|4|||
105731960|NCT03443024|364673836|FG002|Overall Study|Adverse Event|3|||
105731961|NCT03443024|364673837|FG003|Overall Study|Adverse Event|1|||
105731962|NCT03443024|364673834|FG000|Overall Study|Lost to Follow-up|9|||
105480278|NCT01478048|363769111|FG001|Overall Study|Disease Progression|35|||
105480279|NCT01478048|363769110|FG000|Overall Study|study drug toxicity|11|||
105480280|NCT01478048|363769111|FG001|Overall Study|study drug toxicity|14|||
105480281|NCT01478048|363769110|FG000|Overall Study|Adverse Event|2|||
105480282|NCT01478048|363769111|FG001|Overall Study|Adverse Event|11|||
105731963|NCT03443024|364673835|FG001|Overall Study|Lost to Follow-up|9|||
105731964|NCT03443024|364673836|FG002|Overall Study|Lost to Follow-up|7|||
105731965|NCT03443024|364673837|FG003|Overall Study|Lost to Follow-up|5|||
105731966|NCT03443024|364673834|FG000|Overall Study|Withdrawal by Subject|8|||
105731967|NCT03443024|364673835|FG001|Overall Study|Withdrawal by Subject|15|||
105731968|NCT03443024|364673836|FG002|Overall Study|Withdrawal by Subject|9|||
105731969|NCT03443024|364673837|FG003|Overall Study|Withdrawal by Subject|23|||
105731970|NCT03443024|364673834|FG000|Overall Study|Physician Decision|1|||
105731971|NCT03443024|364673835|FG001|Overall Study|Physician Decision|2|||
105731972|NCT03443024|364673836|FG002|Overall Study|Physician Decision|0|||
105731973|NCT03443024|364673837|FG003|Overall Study|Physician Decision|1|||
105731974|NCT03443024|364673834|FG000|Overall Study|Sponsor Decision|1|||
105731975|NCT03443024|364673835|FG001|Overall Study|Sponsor Decision|1|||
105731976|NCT03443024|364673836|FG002|Overall Study|Sponsor Decision|0|||
105731977|NCT03443024|364673837|FG003|Overall Study|Sponsor Decision|0|||
105731978|NCT03443024|364673834|FG000|Overall Study|Protocol Deviation|0|||
105731979|NCT03443024|364673835|FG001|Overall Study|Protocol Deviation|0|||
105731980|NCT03443024|364673836|FG002|Overall Study|Protocol Deviation|0|||
105731981|NCT03443024|364673837|FG003|Overall Study|Protocol Deviation|2|||
105731982|NCT00624338|364673839|FG000|Overall Study|Adverse Event|14|||
105731983|NCT00624338|364673840|FG001|Overall Study|Adverse Event|14|||
105731984|NCT00624338|364673841|FG002|Overall Study|Adverse Event|18|||
105731985|NCT00624338|364673839|FG000|Overall Study|Lost to Follow-up|1|||
105731986|NCT00624338|364673840|FG001|Overall Study|Lost to Follow-up|0|||
105731987|NCT00624338|364673841|FG002|Overall Study|Lost to Follow-up|0|||
105731988|NCT00624338|364673839|FG000|Overall Study|Lack of Efficacy|11|||
105731989|NCT00624338|364673840|FG001|Overall Study|Lack of Efficacy|3|||
105731990|NCT00624338|364673841|FG002|Overall Study|Lack of Efficacy|14|||
105731991|NCT00624338|364673839|FG000|Overall Study|Protocol Violation|3|||
105731992|NCT00624338|364673840|FG001|Overall Study|Protocol Violation|3|||
105731993|NCT00624338|364673841|FG002|Overall Study|Protocol Violation|2|||
105731994|NCT00624338|364673839|FG000|Overall Study|Death|0|||
105731995|NCT00624338|364673840|FG001|Overall Study|Death|2|||
105731996|NCT00624338|364673841|FG002|Overall Study|Death|0|||
105731997|NCT00624338|364673839|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
105731998|NCT00624338|364673840|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
105731999|NCT00624338|364673841|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
105732000|NCT00624338|364673839|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
105732001|NCT00624338|364673840|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
105732002|NCT00624338|364673841|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
105732003|NCT00624338|364673839|FG000|Overall Study|Other|15|||
105732004|NCT00624338|364673840|FG001|Overall Study|Other|5|||
105732005|NCT00624338|364673841|FG002|Overall Study|Other|9|||
105732006|NCT00624338|364673839|FG000|Overall Study|Randomized but not treated|2|||
105732007|NCT00624338|364673840|FG001|Overall Study|Randomized but not treated|1|||
105732008|NCT00624338|364673841|FG002|Overall Study|Randomized but not treated|3|||
105732009|NCT01476787|364673849|FG000|Treatment|Progression|64|||
105732010|NCT01476787|364673850|FG001|Treatment|Progression|71|||
105732011|NCT01476787|364673849|FG000|Treatment|Toxicity|44|||
105732012|NCT01476787|364673850|FG001|Treatment|Toxicity|16|||
105732013|NCT01476787|364673849|FG000|Treatment|Death|0|||
105732014|NCT01476787|364673850|FG001|Treatment|Death|1|||
105732015|NCT01476787|364673849|FG000|Treatment|Withdrawal by Subject|3|||
105732016|NCT01476787|364673850|FG001|Treatment|Withdrawal by Subject|14|||
105732017|NCT01476787|364673849|FG000|Treatment|Major protocol violation|1|||
105732018|NCT01476787|364673850|FG001|Treatment|Major protocol violation|6|||
105480283|NCT01478048|363769110|FG000|Overall Study|subject request to discontinue treatment|3|||
105480284|NCT01478048|363769111|FG001|Overall Study|subject request to discontinue treatment|5|||
105732019|NCT01476787|364673849|FG000|Treatment|Other reasons|10|||
105732020|NCT01476787|364673850|FG001|Treatment|Other reasons|22|||
105732021|NCT01476787|364673849|FG000|Treatment|Concurrent illness|12|||
105480285|NCT01478048|363769110|FG000|Overall Study|Withdrawal by Subject|2|||
105564989|NCT00542880|364065377|FG001|Period 1|Protocol Violation|1|||
105732022|NCT01476787|364673850|FG001|Treatment|Concurrent illness|9|||
105732023|NCT01476787|364673849|FG000|Treatment|Insufficient response|15|||
105732024|NCT01476787|364673850|FG001|Treatment|Insufficient response|3|||
105732025|NCT01476787|364673849|FG000|Treatment|Voluntary treatment discontinuation|8|||
105732026|NCT01476787|364673850|FG001|Treatment|Voluntary treatment discontinuation|4|||
105732027|NCT02453841|364673859|FG000|Overall Study|Protocol Violation|1|||
105732028|NCT02453841|364673859|FG000|Overall Study|Unable to obtain blood samples|2|||
105732029|NCT02006576|364673860|FG000|Overall Study|Withdrawal by Subject|4|||
105732030|NCT02006576|364673861|FG001|Overall Study|Withdrawal by Subject|6|||
105732031|NCT02006576|364673862|FG002|Overall Study|Withdrawal by Subject|2|||
105732032|NCT02006576|364673860|FG000|Overall Study|Death|0|||
105797435|NCT00666718|364915958|FG000|Overall Study|Adverse Event|0|||
105797436|NCT00666718|364915959|FG001|Overall Study|Adverse Event|1|||
105797437|NCT00666718|364915958|FG000|Overall Study|Death|1|||
105797438|NCT00666718|364915959|FG001|Overall Study|Death|0|||
105797439|NCT00666718|364915958|FG000|Overall Study|Lost to Follow-up|1|||
105797440|NCT00666718|364915959|FG001|Overall Study|Lost to Follow-up|0|||
105797441|NCT00666718|364915958|FG000|Overall Study|Entry Criteria Not Met|2|||
105797442|NCT00666718|364915959|FG001|Overall Study|Entry Criteria Not Met|0|||
105797443|NCT00666718|364915958|FG000|Overall Study|Protocol Violation|1|||
105797444|NCT00666718|364915959|FG001|Overall Study|Protocol Violation|3|||
105797445|NCT00666718|364915958|FG000|Overall Study|Withdrawal by Subject|7|||
105797446|NCT00666718|364915959|FG001|Overall Study|Withdrawal by Subject|12|||
105797447|NCT00666718|364915958|FG000|Overall Study|Physician Decision|0|||
105797448|NCT00666718|364915959|FG001|Overall Study|Physician Decision|2|||
105797449|NCT00829439|364915966|FG000|Overall Study|Adverse Event|0|||
105797450|NCT00829439|364915967|FG001|Overall Study|Adverse Event|0|||
105797451|NCT00829439|364915968|FG002|Overall Study|Adverse Event|1|||
105797452|NCT00829439|364915969|FG003|Overall Study|Adverse Event|0|||
105797453|NCT00386100|364915970|FG000|Overall Study|Did not receive study medication|6|||
105797454|NCT00386100|364915971|FG001|Overall Study|Did not receive study medication|4|||
105797455|NCT00386100|364915970|FG000|Overall Study|Adverse Event|15|||
105797456|NCT00386100|364915971|FG001|Overall Study|Adverse Event|25|||
105797457|NCT00386100|364915970|FG000|Overall Study|Death|0|||
105797458|NCT00386100|364915971|FG001|Overall Study|Death|1|||
105797459|NCT00386100|364915970|FG000|Overall Study|Insufficient therapeutic effect|30|||
105797460|NCT00386100|364915971|FG001|Overall Study|Insufficient therapeutic effect|6|||
105797461|NCT00386100|364915970|FG000|Overall Study|Lost to Follow-up|29|||
105797462|NCT00386100|364915971|FG001|Overall Study|Lost to Follow-up|29|||
105797463|NCT00386100|364915970|FG000|Overall Study|Non-compliance|18|||
105797464|NCT00386100|364915971|FG001|Overall Study|Non-compliance|19|||
105797465|NCT00386100|364915970|FG000|Overall Study|Protocol Violation|5|||
105797466|NCT00386100|364915971|FG001|Overall Study|Protocol Violation|3|||
105797467|NCT00386100|364915970|FG000|Overall Study|Withdrawal by Subject|32|||
105797468|NCT00386100|364915971|FG001|Overall Study|Withdrawal by Subject|31|||
105797469|NCT00386100|364915970|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
105797470|NCT00386100|364915971|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
105797471|NCT00386100|364915970|FG000|Overall Study|BMD <2.5|1|||
105797472|NCT00386100|364915971|FG001|Overall Study|BMD <2.5|0|||
105797473|NCT00386100|364915970|FG000|Overall Study|Consecutive elevated Hba1C|1|||
105797474|NCT00386100|364915971|FG001|Overall Study|Consecutive elevated Hba1C|0|||
105797475|NCT00386100|364915970|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
105797476|NCT00386100|364915971|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
105797477|NCT00386100|364915970|FG000|Overall Study|Laboratory findings|1|||
105797478|NCT00386100|364915971|FG001|Overall Study|Laboratory findings|0|||
105797479|NCT00386100|364915970|FG000|Overall Study|Participant's concern due to CPK levels|1|||
105797480|NCT00386100|364915971|FG001|Overall Study|Participant's concern due to CPK levels|0|||
105797481|NCT00386100|364915970|FG000|Overall Study|Participant moving out of state|2|||
105797482|NCT00386100|364915971|FG001|Overall Study|Participant moving out of state|0|||
105797483|NCT00386100|364915970|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
105797484|NCT00386100|364915971|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
105797485|NCT00386100|364915970|FG000|Overall Study|Didn't meet entry criteria|1|||
105797486|NCT00386100|364915971|FG001|Overall Study|Didn't meet entry criteria|1|||
105797487|NCT00386100|364915970|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
105797488|NCT00386100|364915971|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
105797489|NCT00386100|364915970|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
105797490|NCT00386100|364915971|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
105797491|NCT00386100|364915970|FG000|Overall Study|Bad metabolic control & patient security|1|||
105797492|NCT00386100|364915971|FG001|Overall Study|Bad metabolic control & patient security|0|||
105797493|NCT00386100|364915970|FG000|Overall Study|Bone loss by DXA bone scan|1|||
105797494|NCT00386100|364915971|FG001|Overall Study|Bone loss by DXA bone scan|0|||
105797495|NCT00386100|364915970|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
105797496|NCT00386100|364915971|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
105797497|NCT00386100|364915970|FG000|Overall Study|7.6% bone loss|1|||
105797498|NCT00386100|364915971|FG001|Overall Study|7.6% bone loss|0|||
105797499|NCT00386100|364915970|FG000|Overall Study|Osteoporosis|0|||
105797500|NCT00386100|364915971|FG001|Overall Study|Osteoporosis|1|||
105797501|NCT00386100|364915970|FG000|Overall Study|Positive pregnancy test|1|||
105797502|NCT00386100|364915971|FG001|Overall Study|Positive pregnancy test|3|||
105480286|NCT01478048|363769111|FG001|Overall Study|Withdrawal by Subject|5|||
105797503|NCT00386100|364915970|FG000|Overall Study|Out of country for 5 months|1|||
105797504|NCT00386100|364915971|FG001|Overall Study|Out of country for 5 months|0|||
105797505|NCT00386100|364915970|FG000|Overall Study|Hb1Ac >8%|0|||
105797506|NCT00386100|364915971|FG001|Overall Study|Hb1Ac >8%|1|||
105797507|NCT00386100|364915970|FG000|Overall Study|Participant randomized in error|1|||
105797508|NCT00386100|364915971|FG001|Overall Study|Participant randomized in error|0|||
105797509|NCT02525562|364915972|FG000|Overall Study|Death|9|||
105732033|NCT02006576|364673861|FG001|Overall Study|Death|0|||
105732034|NCT02006576|364673862|FG002|Overall Study|Death|1|||
105732035|NCT02006576|364673860|FG000|Overall Study|Lost to Follow-up|1|||
105732036|NCT02006576|364673861|FG001|Overall Study|Lost to Follow-up|0|||
105732037|NCT02006576|364673862|FG002|Overall Study|Lost to Follow-up|1|||
105732038|NCT02006576|364673860|FG000|Overall Study|Screen Failure, too sick, other|13|||
105732039|NCT02006576|364673861|FG001|Overall Study|Screen Failure, too sick, other|1|||
105732040|NCT02006576|364673862|FG002|Overall Study|Screen Failure, too sick, other|13|||
105732041|NCT03567187|364673863|FG000|Overall Study|Lost to Follow-up|18|||
105732042|NCT04513158|364673864|FG000|Overall Study|Screen Failure|1|||
105732043|NCT01084252|364675951|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732044|NCT01084252|364675952|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732045|NCT01084252|364675953|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732046|NCT01084252|364675954|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732047|NCT01084252|364675955|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732048|NCT01084252|364675956|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732049|NCT01084252|364675957|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732050|NCT01084252|364675958|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732051|NCT01084252|364675959|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732052|NCT01084252|364675960|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732053|NCT01084252|364675961|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732054|NCT01084252|364675962|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732055|NCT01084252|364675963|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
105732056|NCT01084252|364675964|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732057|NCT04493619|364675965|FG000|Overall Study|Death|4|||
105732058|NCT04493619|364675966|FG001|Overall Study|Death|3|||
105732059|NCT04493619|364675967|FG002|Overall Study|Death|3|||
105732060|NCT04493619|364675968|FG003|Overall Study|Death|4|||
105732061|NCT04493619|364675965|FG000|Overall Study|Study discontinued early|10|||
105732062|NCT04493619|364675966|FG001|Overall Study|Study discontinued early|0|||
105732063|NCT04493619|364675967|FG002|Overall Study|Study discontinued early|4|||
105732064|NCT04493619|364675968|FG003|Overall Study|Study discontinued early|8|||
105732065|NCT04493619|364675965|FG000|Overall Study|Lost to Follow-up|0|||
105732066|NCT04493619|364675966|FG001|Overall Study|Lost to Follow-up|0|||
105732067|NCT04493619|364675967|FG002|Overall Study|Lost to Follow-up|0|||
105732068|NCT04493619|364675968|FG003|Overall Study|Lost to Follow-up|1|||
105732069|NCT00955110|364675972|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
105732070|NCT00955110|364675972|FG000|Treatment Phase|Adverse Event|2|||
105732071|NCT00955110|364675972|FG000|Treatment Phase|Administrative reasons|2|||
105732072|NCT00955110|364675972|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
105732073|NCT00955110|364675972|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
105732074|NCT03518840|364675975|FG000|Overall Study|Lost to Follow-up|6|||
105732075|NCT05165394|364675981|FG000|Overall Study|Withdrawal by Subject|5|||
105732076|NCT05165394|364675982|FG001|Overall Study|Withdrawal by Subject|1|||
105732077|NCT05165394|364675981|FG000|Overall Study|Lost to Follow-up|1|||
105732078|NCT05165394|364675982|FG001|Overall Study|Lost to Follow-up|2|||
105732079|NCT05165394|364675981|FG000|Overall Study|Other Than Specified|0|||
105732080|NCT05165394|364675982|FG001|Overall Study|Other Than Specified|1|||
105732081|NCT00875420|364675985|FG000|Overall Study|Adverse Event|0|||
105732082|NCT00875420|364675986|FG001|Overall Study|Adverse Event|1|||
105732083|NCT00875420|364675987|FG002|Overall Study|Adverse Event|1|||
105732084|NCT00875420|364675988|FG003|Overall Study|Adverse Event|0|||
105732085|NCT00875420|364675989|FG004|Overall Study|Adverse Event|0|||
105732086|NCT00875420|364675985|FG000|Overall Study|Inability to complete study procedures|1|||
105732087|NCT00875420|364675986|FG001|Overall Study|Inability to complete study procedures|0|||
105732088|NCT00875420|364675987|FG002|Overall Study|Inability to complete study procedures|1|||
105732089|NCT00875420|364675988|FG003|Overall Study|Inability to complete study procedures|1|||
105480287|NCT01478048|363769110|FG000|Overall Study|non-specified|6|||
105480288|NCT01478048|363769111|FG001|Overall Study|non-specified|4|||
105732090|NCT00875420|364675989|FG004|Overall Study|Inability to complete study procedures|1|||
105732091|NCT00875420|364675985|FG000|Overall Study|Lost to Follow-up|1|||
105732092|NCT00875420|364675986|FG001|Overall Study|Lost to Follow-up|0|||
105732093|NCT00875420|364675987|FG002|Overall Study|Lost to Follow-up|0|||
105732094|NCT00875420|364675988|FG003|Overall Study|Lost to Follow-up|0|||
105732095|NCT00875420|364675989|FG004|Overall Study|Lost to Follow-up|0|||
105732096|NCT00875420|364675985|FG000|Overall Study|Personal reason|0|||
105732097|NCT00875420|364675986|FG001|Overall Study|Personal reason|0|||
105732098|NCT00875420|364675987|FG002|Overall Study|Personal reason|0|||
105732099|NCT00875420|364675988|FG003|Overall Study|Personal reason|0|||
105732100|NCT00875420|364675989|FG004|Overall Study|Personal reason|1|||
105732101|NCT00875420|364675985|FG000|Overall Study|Prohibited medication|0|||
105732102|NCT00875420|364675986|FG001|Overall Study|Prohibited medication|0|||
105732103|NCT00875420|364675987|FG002|Overall Study|Prohibited medication|0|||
105732104|NCT00875420|364675988|FG003|Overall Study|Prohibited medication|1|||
105732105|NCT00875420|364675989|FG004|Overall Study|Prohibited medication|0|||
105732106|NCT00875420|364675985|FG000|Overall Study|Sponsor decision|0|||
105732107|NCT00875420|364675986|FG001|Overall Study|Sponsor decision|1|||
105732108|NCT00875420|364675987|FG002|Overall Study|Sponsor decision|0|||
105732109|NCT00875420|364675988|FG003|Overall Study|Sponsor decision|0|||
105732110|NCT00875420|364675989|FG004|Overall Study|Sponsor decision|0|||
105732111|NCT00875420|364675985|FG000|Overall Study|Withdrawal by Subject|0|||
105732112|NCT00875420|364675986|FG001|Overall Study|Withdrawal by Subject|0|||
105732113|NCT00875420|364675987|FG002|Overall Study|Withdrawal by Subject|1|||
105732114|NCT00875420|364675988|FG003|Overall Study|Withdrawal by Subject|0|||
105732115|NCT00875420|364675989|FG004|Overall Study|Withdrawal by Subject|0|||
105732116|NCT00001259|364675992|FG000|Study 2|Adverse Event|0|||
105732117|NCT00001259|364675993|FG001|Study 2|Adverse Event|0|||
105732118|NCT00001259|364675994|FG002|Study 2|Adverse Event|0|||
105732119|NCT00001259|364675995|FG003|Study 2|Adverse Event|0|||
105732120|NCT00001259|364675996|FG004|Study 2|Adverse Event|2|||
105732121|NCT00001259|364675997|FG005|Study 2|Adverse Event|0|||
105732122|NCT00001259|364675998|FG006|Study 2|Adverse Event|0|||
105732123|NCT03705494|364675999|FG000|Overall Study|Lost to Follow-up|2|||
105732124|NCT03705494|364676000|FG001|Overall Study|Lost to Follow-up|1|||
105732125|NCT03705494|364675999|FG000|Overall Study|Withdrawal by Subject|5|||
105732126|NCT03705494|364676000|FG001|Overall Study|Withdrawal by Subject|2|||
105732127|NCT03704051|364676006|FG000|Overall Study|Withdrawal by Subject|4|||
105732128|NCT03704051|364676007|FG001|Overall Study|Withdrawal by Subject|0|||
105732129|NCT01266148|364676008|FG000|Overall Study|Adverse Event|2|||
105732130|NCT01266148|364676009|FG001|Overall Study|Adverse Event|0|||
105732131|NCT01266148|364676008|FG000|Overall Study|Ongoing rejection|1|||
105732132|NCT01266148|364676009|FG001|Overall Study|Ongoing rejection|0|||
105732133|NCT01266148|364676008|FG000|Overall Study|2 2R rejections|1|||
105732134|NCT01266148|364676009|FG001|Overall Study|2 2R rejections|0|||
105732135|NCT01266148|364676008|FG000|Overall Study|Death|2|||
105732136|NCT01266148|364676009|FG001|Overall Study|Death|3|||
105732137|NCT01266148|364676008|FG000|Overall Study|missing mGFR value + AE|1|||
105732138|NCT01266148|364676009|FG001|Overall Study|missing mGFR value + AE|0|||
105732139|NCT00914628|364676010|FG000|Overall Study|Death|35|||
105732140|NCT00914628|364676011|FG001|Overall Study|Death|17|||
105732141|NCT00914628|364676010|FG000|Overall Study|Medical decision|4|||
105732142|NCT00914628|364676011|FG001|Overall Study|Medical decision|0|||
105732143|NCT00914628|364676010|FG000|Overall Study|Protocol Violation|1|||
105732144|NCT00914628|364676011|FG001|Overall Study|Protocol Violation|0|||
105732145|NCT00914628|364676010|FG000|Overall Study|Lack of Efficacy|1|||
105732146|NCT00914628|364676011|FG001|Overall Study|Lack of Efficacy|0|||
105732147|NCT00914628|364676010|FG000|Overall Study|non-randomized|1|||
105732148|NCT00914628|364676011|FG001|Overall Study|non-randomized|0|||
105732149|NCT00914628|364676010|FG000|Overall Study|Relapse|1|||
105732150|NCT00914628|364676011|FG001|Overall Study|Relapse|2|||
105732151|NCT00914628|364676010|FG000|Overall Study|Study terminated by Sponsor|14|||
105732152|NCT00914628|364676011|FG001|Overall Study|Study terminated by Sponsor|8|||
105732153|NCT00914628|364676010|FG000|Overall Study|Patients who did not receive a single dose|7|||
105732154|NCT00914628|364676011|FG001|Overall Study|Patients who did not receive a single dose|1|||
105732155|NCT01416181|364676016|FG000|Part 1|Other|10|||
105732156|NCT01416181|364676017|FG001|Part 1|Other|24|||
105732157|NCT01416181|364676016|FG000|Part 1|Death|0|||
105732158|NCT01416181|364676017|FG001|Part 1|Death|1|||
105732159|NCT01416181|364676016|FG000|Part 1|Investigator Decision|7|||
105732160|NCT01416181|364676017|FG001|Part 1|Investigator Decision|6|||
105732161|NCT01416181|364676016|FG000|Part 1|Withdrawal by Subject|74|||
105732162|NCT01416181|364676017|FG001|Part 1|Withdrawal by Subject|48|||
105732163|NCT01416181|364676016|FG000|Part 1|Lack of Efficacy|16|||
105732164|NCT01416181|364676017|FG001|Part 1|Lack of Efficacy|8|||
105732165|NCT01416181|364676016|FG000|Part 1|Lost to Follow-up|1|||
105732166|NCT01416181|364676017|FG001|Part 1|Lost to Follow-up|1|||
105732167|NCT01416181|364676016|FG000|Part 1|Adverse Event|15|||
105732168|NCT01416181|364676017|FG001|Part 1|Adverse Event|18|||
105732169|NCT01416181|364676016|FG000|Part 1|Ongoing in Follow-Up|14|||
105732170|NCT01416181|364676017|FG001|Part 1|Ongoing in Follow-Up|8|||
105732171|NCT01416181|364676016|FG000|Part 2|Adverse Event|11|||
105732172|NCT01416181|364676017|FG001|Part 2|Adverse Event|4|||
105732173|NCT01416181|364676016|FG000|Part 2|Other|234|||
105797510|NCT02525562|364915973|FG001|Overall Study|Death|0|||
105732174|NCT01416181|364676017|FG001|Part 2|Other|267|||
105732175|NCT01416181|364676016|FG000|Part 2|Investigator Decision|6|||
105732176|NCT01416181|364676017|FG001|Part 2|Investigator Decision|7|||
105732177|NCT01416181|364676016|FG000|Part 2|Withdrawal by Subject|14|||
105732178|NCT01416181|364676017|FG001|Part 2|Withdrawal by Subject|5|||
105732179|NCT01416181|364676016|FG000|Part 2|Lack of Efficacy|4|||
105732180|NCT01416181|364676017|FG001|Part 2|Lack of Efficacy|1|||
105732181|NCT01416181|364676016|FG000|Part 2|Lost to Follow-up|2|||
105732182|NCT01416181|364676017|FG001|Part 2|Lost to Follow-up|2|||
105732183|NCT01157169|364676020|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
105732184|NCT01157169|364676021|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
105732185|NCT01157169|364676020|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
105353286|NCT00904917|363298493|FG002|Overall Study|Lost to Follow-up|2|||
105564990|NCT00542880|364065376|FG000|Period 2|Adverse Event|5|||
105732186|NCT01157169|364676021|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
105732187|NCT02786537|364676022|FG000|As Randomized|Adverse Event|0|||
105732188|NCT02786537|364676023|FG001|As Randomized|Adverse Event|11|||
105732189|NCT02786537|364676024|FG002|As Randomized|Adverse Event|0|||
105732190|NCT02786537|364676025|FG003|As Randomized|Adverse Event|4|||
105732191|NCT02786537|364676026|FG004|As Randomized|Adverse Event|6|||
105732192|NCT02786537|364676027|FG005|As Randomized|Adverse Event|2|||
105732193|NCT02786537|364676022|FG000|As Randomized|Lack of Efficacy|0|||
105732194|NCT02786537|364676023|FG001|As Randomized|Lack of Efficacy|0|||
105732195|NCT02786537|364676024|FG002|As Randomized|Lack of Efficacy|0|||
105732196|NCT02786537|364676025|FG003|As Randomized|Lack of Efficacy|1|||
105732197|NCT02786537|364676026|FG004|As Randomized|Lack of Efficacy|0|||
105732198|NCT02786537|364676027|FG005|As Randomized|Lack of Efficacy|0|||
105732199|NCT02786537|364676022|FG000|As Randomized|Withdrawal by Subject|1|||
105732200|NCT02786537|364676023|FG001|As Randomized|Withdrawal by Subject|2|||
105732201|NCT02786537|364676024|FG002|As Randomized|Withdrawal by Subject|0|||
105732202|NCT02786537|364676025|FG003|As Randomized|Withdrawal by Subject|1|||
105732203|NCT02786537|364676026|FG004|As Randomized|Withdrawal by Subject|1|||
105732204|NCT02786537|364676027|FG005|As Randomized|Withdrawal by Subject|0|||
105732205|NCT02786537|364676022|FG000|As Randomized|Death|0|||
105732206|NCT02786537|364676023|FG001|As Randomized|Death|2|||
105732207|NCT02786537|364676024|FG002|As Randomized|Death|0|||
105732208|NCT02786537|364676025|FG003|As Randomized|Death|3|||
105732209|NCT02786537|364676026|FG004|As Randomized|Death|1|||
105732210|NCT02786537|364676027|FG005|As Randomized|Death|0|||
105732211|NCT02786537|364676022|FG000|As Randomized|Non-compliance with study drug|1|||
105732212|NCT02786537|364676023|FG001|As Randomized|Non-compliance with study drug|11|||
105732213|NCT02786537|364676024|FG002|As Randomized|Non-compliance with study drug|0|||
105732214|NCT02786537|364676025|FG003|As Randomized|Non-compliance with study drug|1|||
105732215|NCT02786537|364676026|FG004|As Randomized|Non-compliance with study drug|0|||
105732216|NCT02786537|364676027|FG005|As Randomized|Non-compliance with study drug|1|||
105732217|NCT02786537|364676022|FG000|As Randomized|Lost to treatment follow-up|4|||
105732218|NCT02786537|364676023|FG001|As Randomized|Lost to treatment follow-up|32|||
105732219|NCT02786537|364676024|FG002|As Randomized|Lost to treatment follow-up|0|||
105732220|NCT02786537|364676025|FG003|As Randomized|Lost to treatment follow-up|24|||
105732221|NCT02786537|364676026|FG004|As Randomized|Lost to treatment follow-up|4|||
105732222|NCT02786537|364676027|FG005|As Randomized|Lost to treatment follow-up|4|||
105732223|NCT02786537|364676022|FG000|As Randomized|Incarceration|0|||
105732224|NCT02786537|364676023|FG001|As Randomized|Incarceration|1|||
105732225|NCT02786537|364676024|FG002|As Randomized|Incarceration|0|||
105732226|NCT02786537|364676025|FG003|As Randomized|Incarceration|0|||
105732227|NCT02786537|364676026|FG004|As Randomized|Incarceration|0|||
105732228|NCT02786537|364676027|FG005|As Randomized|Incarceration|0|||
105732229|NCT02786537|364676022|FG000|As Randomized|Opiate Dependency Relapse|0|||
105732230|NCT02786537|364676023|FG001|As Randomized|Opiate Dependency Relapse|1|||
105732231|NCT02786537|364676024|FG002|As Randomized|Opiate Dependency Relapse|0|||
105732232|NCT02786537|364676025|FG003|As Randomized|Opiate Dependency Relapse|0|||
105732233|NCT02786537|364676026|FG004|As Randomized|Opiate Dependency Relapse|0|||
105732234|NCT02786537|364676027|FG005|As Randomized|Opiate Dependency Relapse|0|||
105732235|NCT02786537|364676022|FG000|As Randomized|HCV drugs stolen from pt|0|||
105732236|NCT02786537|364676023|FG001|As Randomized|HCV drugs stolen from pt|1|||
105732237|NCT02786537|364676024|FG002|As Randomized|HCV drugs stolen from pt|0|||
105732238|NCT02786537|364676025|FG003|As Randomized|HCV drugs stolen from pt|0|||
105732239|NCT02786537|364676026|FG004|As Randomized|HCV drugs stolen from pt|0|||
105732240|NCT02786537|364676027|FG005|As Randomized|HCV drugs stolen from pt|0|||
105732241|NCT02786537|364676022|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
105732242|NCT02786537|364676023|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
105732243|NCT02786537|364676024|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
105732244|NCT02786537|364676025|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
105732245|NCT02786537|364676026|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
105732246|NCT02786537|364676027|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
105732247|NCT02786537|364676022|FG000|As Randomized|Subject lost insurance|0|||
105732248|NCT02786537|364676023|FG001|As Randomized|Subject lost insurance|0|||
105732249|NCT02786537|364676024|FG002|As Randomized|Subject lost insurance|0|||
105732250|NCT02786537|364676025|FG003|As Randomized|Subject lost insurance|1|||
105732251|NCT02786537|364676026|FG004|As Randomized|Subject lost insurance|0|||
105732252|NCT02786537|364676027|FG005|As Randomized|Subject lost insurance|0|||
105732253|NCT02786537|364676022|FG000|As Treated|Adverse Event|0|||
105732254|NCT02786537|364676023|FG001|As Treated|Adverse Event|11|||
105732255|NCT02786537|364676024|FG002|As Treated|Adverse Event|0|||
105732256|NCT02786537|364676025|FG003|As Treated|Adverse Event|4|||
105732257|NCT02786537|364676026|FG004|As Treated|Adverse Event|6|||
105732258|NCT02786537|364676027|FG005|As Treated|Adverse Event|2|||
105732259|NCT02786537|364676022|FG000|As Treated|Death|0|||
105732260|NCT02786537|364676023|FG001|As Treated|Death|2|||
105480289|NCT01478048|363769110|FG000|Overall Study|poor/non-compliance|0|||
105480290|NCT01478048|363769111|FG001|Overall Study|poor/non-compliance|1|||
105480291|NCT01478048|363769110|FG000|Overall Study|no longer meets study criteria|1|||
105480292|NCT01478048|363769111|FG001|Overall Study|no longer meets study criteria|0|||
105480293|NCT00833417|363769114|FG000|Overall Study|Adverse Event|5|||
105480294|NCT00833417|363769115|FG001|Overall Study|Adverse Event|16|||
105732261|NCT02786537|364676024|FG002|As Treated|Death|0|||
105732262|NCT02786537|364676025|FG003|As Treated|Death|3|||
105732263|NCT02786537|364676026|FG004|As Treated|Death|1|||
105732264|NCT02786537|364676027|FG005|As Treated|Death|0|||
105732265|NCT02786537|364676022|FG000|As Treated|Lack of Efficacy|0|||
105732266|NCT02786537|364676023|FG001|As Treated|Lack of Efficacy|0|||
105732267|NCT02786537|364676024|FG002|As Treated|Lack of Efficacy|0|||
105732268|NCT02786537|364676025|FG003|As Treated|Lack of Efficacy|1|||
105732269|NCT02786537|364676026|FG004|As Treated|Lack of Efficacy|0|||
105732270|NCT02786537|364676027|FG005|As Treated|Lack of Efficacy|0|||
105732271|NCT02786537|364676022|FG000|As Treated|Lost to Follow-up|4|||
105732272|NCT02786537|364676023|FG001|As Treated|Lost to Follow-up|32|||
105732273|NCT02786537|364676024|FG002|As Treated|Lost to Follow-up|0|||
105732274|NCT02786537|364676025|FG003|As Treated|Lost to Follow-up|25|||
105732275|NCT02786537|364676026|FG004|As Treated|Lost to Follow-up|4|||
105732276|NCT02786537|364676027|FG005|As Treated|Lost to Follow-up|4|||
105732277|NCT02786537|364676022|FG000|As Treated|Non-compliance with study drug|1|||
105732278|NCT02786537|364676023|FG001|As Treated|Non-compliance with study drug|11|||
105732279|NCT02786537|364676024|FG002|As Treated|Non-compliance with study drug|0|||
105732280|NCT02786537|364676025|FG003|As Treated|Non-compliance with study drug|1|||
105732281|NCT02786537|364676026|FG004|As Treated|Non-compliance with study drug|0|||
105732282|NCT02786537|364676027|FG005|As Treated|Non-compliance with study drug|1|||
105732283|NCT02786537|364676022|FG000|As Treated|Lost insurance|0|||
105732284|NCT02786537|364676023|FG001|As Treated|Lost insurance|0|||
105732285|NCT02786537|364676024|FG002|As Treated|Lost insurance|0|||
105732286|NCT02786537|364676025|FG003|As Treated|Lost insurance|1|||
105732287|NCT02786537|364676026|FG004|As Treated|Lost insurance|0|||
105732288|NCT02786537|364676027|FG005|As Treated|Lost insurance|0|||
105732289|NCT02786537|364676022|FG000|As Treated|Withdrawal by Subject|1|||
105732290|NCT02786537|364676023|FG001|As Treated|Withdrawal by Subject|2|||
105732291|NCT02786537|364676024|FG002|As Treated|Withdrawal by Subject|0|||
105732292|NCT02786537|364676025|FG003|As Treated|Withdrawal by Subject|0|||
105732293|NCT02786537|364676026|FG004|As Treated|Withdrawal by Subject|1|||
105732294|NCT02786537|364676027|FG005|As Treated|Withdrawal by Subject|0|||
105732295|NCT02786537|364676022|FG000|As Treated|Incarceration|0|||
105732296|NCT02786537|364676023|FG001|As Treated|Incarceration|1|||
105732297|NCT02786537|364676024|FG002|As Treated|Incarceration|0|||
105732298|NCT02786537|364676025|FG003|As Treated|Incarceration|0|||
105732299|NCT02786537|364676026|FG004|As Treated|Incarceration|0|||
105732300|NCT02786537|364676027|FG005|As Treated|Incarceration|0|||
105732301|NCT02786537|364676022|FG000|As Treated|Opiate dependency relapse|0|||
105732302|NCT02786537|364676023|FG001|As Treated|Opiate dependency relapse|1|||
105732303|NCT02786537|364676024|FG002|As Treated|Opiate dependency relapse|0|||
105732304|NCT02786537|364676025|FG003|As Treated|Opiate dependency relapse|0|||
105732305|NCT02786537|364676026|FG004|As Treated|Opiate dependency relapse|0|||
105732306|NCT02786537|364676027|FG005|As Treated|Opiate dependency relapse|0|||
105732307|NCT02786537|364676022|FG000|As Treated|Drugs stolen from patient|0|||
105732308|NCT02786537|364676023|FG001|As Treated|Drugs stolen from patient|1|||
105732309|NCT02786537|364676024|FG002|As Treated|Drugs stolen from patient|0|||
105732310|NCT02786537|364676025|FG003|As Treated|Drugs stolen from patient|0|||
105732311|NCT02786537|364676026|FG004|As Treated|Drugs stolen from patient|0|||
105732312|NCT02786537|364676027|FG005|As Treated|Drugs stolen from patient|0|||
105732313|NCT02786537|364676022|FG000|As Treated|Advised to stop tx after loss of meds|0|||
105732314|NCT02786537|364676023|FG001|As Treated|Advised to stop tx after loss of meds|1|||
105732315|NCT02786537|364676024|FG002|As Treated|Advised to stop tx after loss of meds|0|||
105732316|NCT02786537|364676025|FG003|As Treated|Advised to stop tx after loss of meds|0|||
105732317|NCT02786537|364676026|FG004|As Treated|Advised to stop tx after loss of meds|0|||
105732318|NCT02786537|364676027|FG005|As Treated|Advised to stop tx after loss of meds|0|||
105732319|NCT03199911|364676030|FG000|Overall Study|Lost to Follow-up|5|||
105732320|NCT03199911|364676031|FG001|Overall Study|Lost to Follow-up|5|||
105732321|NCT03199911|364676030|FG000|Overall Study|Did not proceed with surgery|2|||
105732322|NCT03199911|364676031|FG001|Overall Study|Did not proceed with surgery|1|||
105732323|NCT05309668|364676033|FG000|Overall Study|Ongoing at data cut-off|14|||
105797511|NCT02525562|364915974|FG002|Overall Study|Death|0|||
105480295|NCT00833417|363769114|FG000|Overall Study|Death|1|||
105480296|NCT00833417|363769115|FG001|Overall Study|Death|3|||
105732324|NCT05309668|364676034|FG001|Overall Study|Ongoing at data cut-off|17|||
105732325|NCT05309668|364676035|FG002|Overall Study|Ongoing at data cut-off|4|||
105732326|NCT01059812|364676040|FG000|Overall Study|Adverse Event|9|||
105732327|NCT01059812|364676041|FG001|Overall Study|Adverse Event|5|||
105732328|NCT01059812|364676040|FG000|Overall Study|Lack of Efficacy|2|||
105732329|NCT01059812|364676041|FG001|Overall Study|Lack of Efficacy|2|||
105732330|NCT01059812|364676040|FG000|Overall Study|Protocol Violation|3|||
105732331|NCT01059812|364676041|FG001|Overall Study|Protocol Violation|1|||
105797512|NCT02525562|364915972|FG000|Overall Study|Lost to Follow-up|19|||
105797513|NCT02525562|364915973|FG001|Overall Study|Lost to Follow-up|0|||
105797514|NCT02525562|364915974|FG002|Overall Study|Lost to Follow-up|0|||
105797515|NCT02525562|364915972|FG000|Overall Study|Withdrawal by Subject|37|||
105797516|NCT02525562|364915973|FG001|Overall Study|Withdrawal by Subject|0|||
105797517|NCT02525562|364915974|FG002|Overall Study|Withdrawal by Subject|0|||
105797518|NCT02525562|364915972|FG000|Overall Study|Revision/Removal of Study Device|4|||
105797519|NCT02525562|364915973|FG001|Overall Study|Revision/Removal of Study Device|0|||
105797520|NCT02525562|364915974|FG002|Overall Study|Revision/Removal of Study Device|0|||
105797521|NCT02525562|364915972|FG000|Overall Study|Study Closed by Sponsor|154|||
105797522|NCT02525562|364915973|FG001|Overall Study|Study Closed by Sponsor|0|||
105797523|NCT02525562|364915974|FG002|Overall Study|Study Closed by Sponsor|0|||
105797524|NCT01706770|364915977|FG000|Overall Study|Lost to Follow-up|1|||
105797525|NCT01706770|364915978|FG001|Overall Study|Lost to Follow-up|0|||
105797526|NCT01706770|364915977|FG000|Overall Study|Physician Decision|1|||
105797527|NCT01706770|364915978|FG001|Overall Study|Physician Decision|0|||
105797528|NCT00123487|364915980|FG000|Randomized|Death prior to starting treatment|0|||
105797529|NCT00123487|364915981|FG001|Randomized|Death prior to starting treatment|1|||
105797530|NCT00123487|364915980|FG000|Randomized|SAE prior to starting treatment|1|||
105797531|NCT00123487|364915981|FG001|Randomized|SAE prior to starting treatment|0|||
105797532|NCT00123487|364915980|FG000|Treated With Study Drug|Adverse Event|23|||
105797533|NCT00123487|364915981|FG001|Treated With Study Drug|Adverse Event|22|||
105797534|NCT00123487|364915980|FG000|Treated With Study Drug|Disease Progression|141|||
105797535|NCT00123487|364915981|FG001|Treated With Study Drug|Disease Progression|122|||
105797536|NCT00123487|364915980|FG000|Treated With Study Drug|Physician Decision|8|||
105797537|NCT00123487|364915981|FG001|Treated With Study Drug|Physician Decision|9|||
105797538|NCT00123487|364915980|FG000|Treated With Study Drug|Other|59|||
105797539|NCT00123487|364915981|FG001|Treated With Study Drug|Other|58|||
105797540|NCT00123487|364915980|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
105797541|NCT00123487|364915981|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
105797542|NCT00123487|364915980|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
105797543|NCT00123487|364915981|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
105797544|NCT00123487|364915980|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
105797545|NCT00123487|364915981|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
105797546|NCT01749033|364915982|FG000|Overall Study|Did not receive allocated intervention|3|||
105797547|NCT01749033|364915983|FG001|Overall Study|Did not receive allocated intervention|3|||
105797548|NCT01749033|364915984|FG002|Overall Study|Did not receive allocated intervention|0|||
105797549|NCT01749033|364915982|FG000|Overall Study|Lost to Follow-up|0|||
105797550|NCT01749033|364915983|FG001|Overall Study|Lost to Follow-up|2|||
105797551|NCT01749033|364915984|FG002|Overall Study|Lost to Follow-up|1|||
105797552|NCT00068237|364915985|FG000|Overall Study|Ineligible|3|||
105797553|NCT00068237|364915985|FG000|Overall Study|No protocol treatment received|2|||
105797554|NCT04428502|364915986|FG000|Overall Study|Did not meet entrance criteria|14|||
105797555|NCT03125629|364915987|FG000|Overall Study|Withdrawal by Subject|2|||
105797556|NCT03125629|364915987|FG000|Overall Study|Equipment malfunction|1|||
105797557|NCT02574260|364915994|FG000|Overall Study|Disease Progression|1|||
105797558|NCT01066039|364915995|FG000|Overall Study|Adverse Event|6|||
105797559|NCT01066039|364915995|FG000|Overall Study|Withdrawal by Subject|17|||
105797560|NCT01066039|364915995|FG000|Overall Study|Protocol Violation|2|||
105797561|NCT01066039|364915995|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
105797562|NCT01066039|364915995|FG000|Overall Study|Investigator's Request|1|||
105797563|NCT01066039|364915995|FG000|Overall Study|Dropout due to Insulin Administration|1|||
105797564|NCT01066039|364915995|FG000|Overall Study|Additional Antihypertensive Required|4|||
105797565|NCT01066039|364915995|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
105797566|NCT01066039|364915995|FG000|Overall Study|Failure to Control Blood Pressure|1|||
105797567|NCT01066039|364915995|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
105797568|NCT00995930|364915996|FG000|Overall Study|Protocol deviation|2|||
105797569|NCT00995930|364915997|FG001|Overall Study|Protocol deviation|5|||
105797570|NCT00995930|364915996|FG000|Overall Study|Death|0|||
105797571|NCT00995930|364915997|FG001|Overall Study|Death|1|||
105797572|NCT00995930|364915996|FG000|Overall Study|Administrative problems|4|||
105797573|NCT00995930|364915997|FG001|Overall Study|Administrative problems|2|||
105797574|NCT00995930|364915996|FG000|Overall Study|Lost to Follow-up|1|||
105797575|NCT00995930|364915997|FG001|Overall Study|Lost to Follow-up|2|||
105797576|NCT00995930|364915996|FG000|Overall Study|Withdrawal by Subject|3|||
105797577|NCT00995930|364915997|FG001|Overall Study|Withdrawal by Subject|4|||
105797578|NCT00995930|364915996|FG000|Overall Study|Adverse Event|11|||
105797579|NCT00995930|364915997|FG001|Overall Study|Adverse Event|14|||
105797580|NCT05003167|364915998|FG000|Overall Study|Withdrawal by Subject|1|||
105797581|NCT03120520|364916005|FG000|Overall Study|Lost to Follow-up|1|||
105797582|NCT03120520|364916006|FG001|Overall Study|Lost to Follow-up|1|||
105480297|NCT00833417|363769114|FG000|Overall Study|Lost to Follow-up|1|||
105480298|NCT00833417|363769115|FG001|Overall Study|Lost to Follow-up|2|||
105480299|NCT00833417|363769114|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
105480300|NCT00833417|363769115|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
105480301|NCT00833417|363769114|FG000|Overall Study|Patient Decision to Withdraw|4|||
105480302|NCT00833417|363769115|FG001|Overall Study|Patient Decision to Withdraw|23|||
105480303|NCT00833417|363769114|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
105480304|NCT00833417|363769115|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
105480305|NCT00833417|363769114|FG000|Overall Study|Disease Progression|18|||
105480306|NCT00833417|363769115|FG001|Overall Study|Disease Progression|17|||
105480307|NCT00833417|363769114|FG000|Overall Study|Reason Not Specified|0|||
105480308|NCT00833417|363769115|FG001|Overall Study|Reason Not Specified|1|||
105480309|NCT03032380|363769116|FG000|Overall Study|Adverse Event|0|||
105480310|NCT03032380|363769117|FG001|Overall Study|Adverse Event|1|||
105480311|NCT03032380|363769116|FG000|Overall Study|Lack of Efficacy|1|||
105480312|NCT03032380|363769117|FG001|Overall Study|Lack of Efficacy|0|||
105480313|NCT03032380|363769116|FG000|Overall Study|Withdrawal by Subject|2|||
105480314|NCT03032380|363769117|FG001|Overall Study|Withdrawal by Subject|3|||
105480315|NCT03032380|363769116|FG000|Overall Study|Recovery|0|||
105480316|NCT03032380|363769117|FG001|Overall Study|Recovery|1|||
105480317|NCT03032380|363769116|FG000|Overall Study|Death|39|||
105480318|NCT03032380|363769117|FG001|Overall Study|Death|34|||
105480319|NCT03032380|363769116|FG000|Overall Study|Other - Miscellaneous|0|||
105480320|NCT03032380|363769117|FG001|Overall Study|Other - Miscellaneous|1|||
105480321|NCT04644315|363769118|FG000|Overall Study|Subject withdrawal of consent|1|||
105480322|NCT05315908|363769119|FG000|Overall Study|Lost to Follow-up|4477|||
105480323|NCT05315908|363769120|FG001|Overall Study|Lost to Follow-up|4606|||
105480324|NCT01561898|363769121|FG000|Overall Study|Withdrawal by Subject|0|||
105480325|NCT01561898|363769122|FG001|Overall Study|Withdrawal by Subject|8|||
105480326|NCT01561898|363769123|FG002|Overall Study|Withdrawal by Subject|12|||
105480327|NCT01561898|363769124|FG003|Overall Study|Withdrawal by Subject|5|||
105480328|NCT01561898|363769121|FG000|Overall Study|Lack of Efficacy|0|||
105480329|NCT01561898|363769122|FG001|Overall Study|Lack of Efficacy|8|||
105480330|NCT01561898|363769123|FG002|Overall Study|Lack of Efficacy|10|||
105480331|NCT01561898|363769124|FG003|Overall Study|Lack of Efficacy|5|||
105480332|NCT01561898|363769121|FG000|Overall Study|Worsening of complications|0|||
105480333|NCT01561898|363769122|FG001|Overall Study|Worsening of complications|1|||
105480334|NCT01561898|363769123|FG002|Overall Study|Worsening of complications|0|||
105480335|NCT01561898|363769124|FG003|Overall Study|Worsening of complications|0|||
105480336|NCT01561898|363769121|FG000|Overall Study|Lost to Follow-up|0|||
105480337|NCT01561898|363769122|FG001|Overall Study|Lost to Follow-up|0|||
105480338|NCT01561898|363769123|FG002|Overall Study|Lost to Follow-up|1|||
105564991|NCT00542880|364065377|FG001|Period 2|Adverse Event|7|||
105564992|NCT00542880|364065376|FG000|Period 2|Eligibility not fulfilled|0|||
105564993|NCT00542880|364065377|FG001|Period 2|Eligibility not fulfilled|1|||
105732332|NCT01059812|364676040|FG000|Overall Study|Withdrawal Criteria|9|||
105732333|NCT01059812|364676041|FG001|Overall Study|Withdrawal Criteria|4|||
105732334|NCT01059812|364676040|FG000|Overall Study|Unclassified|14|||
105732335|NCT01059812|364676041|FG001|Overall Study|Unclassified|4|||
105732336|NCT01389128|364676042|FG000|Overall Study|Fetal distress|1|||
105732337|NCT01389128|364676043|FG001|Overall Study|Fetal distress|0|||
105732338|NCT01389128|364676042|FG000|Overall Study|Cervix dilation stop|1|||
105732339|NCT01389128|364676043|FG001|Overall Study|Cervix dilation stop|2|||
105732340|NCT01389128|364676042|FG000|Overall Study|Rapid labor evolution|3|||
105732341|NCT01389128|364676043|FG001|Overall Study|Rapid labor evolution|2|||
105732342|NCT01389128|364676042|FG000|Overall Study|Intolerance to procedure|0|||
105732343|NCT01389128|364676043|FG001|Overall Study|Intolerance to procedure|2|||
105732344|NCT00149214|364676044|FG000|Overall Study|Adverse Event|12|||
105732345|NCT00149214|364676045|FG001|Overall Study|Adverse Event|9|||
105732346|NCT00149214|364676044|FG000|Overall Study|Withdrawal by Subject|4|||
105480339|NCT01561898|363769124|FG003|Overall Study|Lost to Follow-up|0|||
105480340|NCT01561898|363769121|FG000|Overall Study|Adverse Event|1|||
105480341|NCT01561898|363769122|FG001|Overall Study|Adverse Event|19|||
105480342|NCT01561898|363769123|FG002|Overall Study|Adverse Event|14|||
105480343|NCT01561898|363769124|FG003|Overall Study|Adverse Event|9|||
105480344|NCT01561898|363769121|FG000|Overall Study|Physician Decision|1|||
105480345|NCT01561898|363769122|FG001|Overall Study|Physician Decision|5|||
105480346|NCT01561898|363769123|FG002|Overall Study|Physician Decision|7|||
105480347|NCT01561898|363769124|FG003|Overall Study|Physician Decision|1|||
105480348|NCT01445548|363769125|FG000|Overall Study|Adverse Event|1|||
105480349|NCT01738646|363769126|FG000|Overall Study|Still Receiving Treatment|2|||
105480350|NCT00422084|363769127|FG000|Overall Study|Adverse Event|21|||
105480351|NCT00422084|363769128|FG001|Overall Study|Adverse Event|7|||
105480352|NCT00422084|363769127|FG000|Overall Study|Withdrawal by Subject|12|||
105732347|NCT00149214|364676045|FG001|Overall Study|Withdrawal by Subject|1|||
105732348|NCT00149214|364676044|FG000|Overall Study|Physician Decision|3|||
105732349|NCT00149214|364676045|FG001|Overall Study|Physician Decision|3|||
105732350|NCT00149214|364676044|FG000|Overall Study|Sponsor Decision|0|||
105732351|NCT00149214|364676045|FG001|Overall Study|Sponsor Decision|1|||
105732352|NCT00149214|364676044|FG000|Overall Study|Progressive Disease|7|||
105732353|NCT00149214|364676045|FG001|Overall Study|Progressive Disease|3|||
105732354|NCT01736683|364676047|FG000|Overall Study|Disease Relapse|0|||
105732355|NCT01736683|364676048|FG001|Overall Study|Disease Relapse|0|||
105732356|NCT01736683|364676049|FG002|Overall Study|Disease Relapse|2|||
105732357|NCT01736683|364676050|FG003|Overall Study|Disease Relapse|1|||
105732358|NCT01736683|364676051|FG004|Overall Study|Disease Relapse|0|||
105732359|NCT01736683|364676047|FG000|Overall Study|Adverse Event|0|||
105732360|NCT01736683|364676048|FG001|Overall Study|Adverse Event|2|||
105732361|NCT01736683|364676049|FG002|Overall Study|Adverse Event|2|||
105732362|NCT01736683|364676050|FG003|Overall Study|Adverse Event|3|||
105732363|NCT01736683|364676051|FG004|Overall Study|Adverse Event|2|||
105732364|NCT01736683|364676047|FG000|Overall Study|Withdrawal by Subject|0|||
105732365|NCT01736683|364676048|FG001|Overall Study|Withdrawal by Subject|0|||
105732366|NCT01736683|364676049|FG002|Overall Study|Withdrawal by Subject|3|||
105732367|NCT01736683|364676050|FG003|Overall Study|Withdrawal by Subject|1|||
105732368|NCT01736683|364676051|FG004|Overall Study|Withdrawal by Subject|1|||
105732369|NCT01736683|364676047|FG000|Overall Study|Lack of Therapeutic Effect|7|||
105732370|NCT01736683|364676048|FG001|Overall Study|Lack of Therapeutic Effect|4|||
105732371|NCT01736683|364676049|FG002|Overall Study|Lack of Therapeutic Effect|13|||
105732372|NCT01736683|364676050|FG003|Overall Study|Lack of Therapeutic Effect|20|||
105732373|NCT01736683|364676051|FG004|Overall Study|Lack of Therapeutic Effect|1|||
105732374|NCT01736683|364676047|FG000|Overall Study|Progressive Disease|0|||
105732375|NCT01736683|364676048|FG001|Overall Study|Progressive Disease|0|||
105732376|NCT01736683|364676049|FG002|Overall Study|Progressive Disease|0|||
105732377|NCT01736683|364676050|FG003|Overall Study|Progressive Disease|1|||
105732378|NCT01736683|364676051|FG004|Overall Study|Progressive Disease|0|||
105732379|NCT01736683|364676047|FG000|Overall Study|Other|0|||
105732380|NCT01736683|364676048|FG001|Overall Study|Other|0|||
105732381|NCT01736683|364676049|FG002|Overall Study|Other|1|||
105732382|NCT01736683|364676050|FG003|Overall Study|Other|9|||
105353287|NCT00904917|363298494|FG003|Overall Study|Lost to Follow-up|2|||
105732383|NCT01736683|364676051|FG004|Overall Study|Other|1|||
105732384|NCT01458340|364676054|FG000|Overall Study|Adverse Event|5|||
105732385|NCT01458340|364676055|FG001|Overall Study|Adverse Event|4|||
105732386|NCT01458340|364676056|FG002|Overall Study|Adverse Event|2|||
105732387|NCT01458340|364676054|FG000|Overall Study|Lost to Follow-up|3|||
105732388|NCT01458340|364676055|FG001|Overall Study|Lost to Follow-up|3|||
105797583|NCT03120520|364916007|FG002|Overall Study|Lost to Follow-up|1|||
105797584|NCT03120520|364916008|FG003|Overall Study|Lost to Follow-up|1|||
105797585|NCT03120520|364916005|FG000|Overall Study|Withdrawal by Subject|3|||
105797586|NCT03120520|364916006|FG001|Overall Study|Withdrawal by Subject|2|||
105797587|NCT03120520|364916007|FG002|Overall Study|Withdrawal by Subject|3|||
105797588|NCT03120520|364916008|FG003|Overall Study|Withdrawal by Subject|2|||
105797589|NCT03120520|364916005|FG000|Overall Study|Other|0|||
105797590|NCT03120520|364916006|FG001|Overall Study|Other|1|||
105797591|NCT03120520|364916007|FG002|Overall Study|Other|0|||
105797592|NCT03120520|364916008|FG003|Overall Study|Other|0|||
105797593|NCT04385199|364916009|FG000|Overall Study|Withdrawal by Subject|1|||
105797594|NCT04385199|364916010|FG001|Overall Study|Withdrawal by Subject|0|||
105797595|NCT00267020|364917519|FG000|Overall Study|Adverse Event|22|||
105797596|NCT00267020|364917520|FG001|Overall Study|Adverse Event|5|||
105797597|NCT00267020|364917519|FG000|Overall Study|Death|2|||
105797598|NCT00267020|364917520|FG001|Overall Study|Death|1|||
105797599|NCT00267020|364917519|FG000|Overall Study|Withdrawal by Subject|17|||
105797600|NCT00267020|364917520|FG001|Overall Study|Withdrawal by Subject|7|||
105797601|NCT00267020|364917519|FG000|Overall Study|Physician Decision|3|||
105797602|NCT00267020|364917520|FG001|Overall Study|Physician Decision|2|||
105797603|NCT00267020|364917519|FG000|Overall Study|Disease Progression|39|||
105797604|NCT00267020|364917520|FG001|Overall Study|Disease Progression|25|||
105797605|NCT00267020|364917519|FG000|Overall Study|Unrelated Complication|1|||
105797606|NCT00267020|364917520|FG001|Overall Study|Unrelated Complication|1|||
105797607|NCT00267020|364917519|FG000|Overall Study|Sponsor Request|1|||
105797608|NCT00267020|364917520|FG001|Overall Study|Sponsor Request|0|||
105797609|NCT00267020|364917519|FG000|Overall Study|Other|1|||
105797610|NCT00267020|364917520|FG001|Overall Study|Other|2|||
105797611|NCT00858234|364917521|FG000|Overall Study|Adverse Event|6|||
105797612|NCT00858234|364917521|FG000|Overall Study|Progressive disease|2|||
105797613|NCT00858234|364917521|FG000|Overall Study|Status unknown|1|||
105797614|NCT00640614|364917524|FG000|Overall Study|Lost to Follow-up|1|||
105797615|NCT00640614|364917525|FG001|Overall Study|Lost to Follow-up|0|||
105797616|NCT00529802|364917527|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
105797617|NCT00529802|364917527|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
105797618|NCT00529802|364917527|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
105732389|NCT01458340|364676056|FG002|Overall Study|Lost to Follow-up|10|||
105732390|NCT01458340|364676054|FG000|Overall Study|Miscellaneous|0|||
105732391|NCT01458340|364676055|FG001|Overall Study|Miscellaneous|1|||
105732392|NCT01458340|364676056|FG002|Overall Study|Miscellaneous|0|||
105732393|NCT01458340|364676054|FG000|Overall Study|Physician Decision|1|||
105732394|NCT01458340|364676055|FG001|Overall Study|Physician Decision|1|||
105732395|NCT01458340|364676056|FG002|Overall Study|Physician Decision|2|||
105732396|NCT01458340|364676054|FG000|Overall Study|Protocol Violation|6|||
105732397|NCT01458340|364676055|FG001|Overall Study|Protocol Violation|6|||
105732398|NCT01458340|364676056|FG002|Overall Study|Protocol Violation|5|||
105732399|NCT01458340|364676054|FG000|Overall Study|Withdrawal by Subject|12|||
105732400|NCT01458340|364676055|FG001|Overall Study|Withdrawal by Subject|6|||
105732401|NCT01458340|364676056|FG002|Overall Study|Withdrawal by Subject|4|||
105732402|NCT03056287|364676058|FG000|Overall Study|Withdrawal by Subject|0|||
105732403|NCT03056287|364676059|FG001|Overall Study|Withdrawal by Subject|1|||
105732404|NCT03056287|364676060|FG002|Overall Study|Withdrawal by Subject|0|||
105732405|NCT03056287|364676061|FG003|Overall Study|Withdrawal by Subject|0|||
105732406|NCT03056287|364676058|FG000|Overall Study|move out of area|0|||
105732407|NCT03056287|364676059|FG001|Overall Study|move out of area|0|||
105732408|NCT03056287|364676060|FG002|Overall Study|move out of area|1|||
105732409|NCT03056287|364676061|FG003|Overall Study|move out of area|1|||
105732410|NCT02442349|364676062|FG000|Overall Study|Death|95|||
105732411|NCT02442349|364676062|FG000|Overall Study|Withdrawal by Subject|27|||
105732412|NCT02442349|364676062|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
105732413|NCT02442349|364676062|FG000|Overall Study|Lost to Follow-up|1|||
105732414|NCT02286960|364676065|FG000|Overall Study|Lost to Follow-up|3|||
105732415|NCT02286960|364676066|FG001|Overall Study|Lost to Follow-up|3|||
105732416|NCT01165229|364676070|FG000|Overall Study|Serious Adverse Event|456|||
105732417|NCT01165229|364676071|FG001|Overall Study|Serious Adverse Event|487|||
105732418|NCT01165229|364676070|FG000|Overall Study|Non-Serious Adverse Event|47|||
105732419|NCT01165229|364676071|FG001|Overall Study|Non-Serious Adverse Event|15|||
105732420|NCT01165229|364676070|FG000|Overall Study|Protocol Violation|6|||
105732421|NCT01165229|364676071|FG001|Overall Study|Protocol Violation|8|||
105797619|NCT00529802|364917527|FG000|Evaluable for Primary Endpoint|Death|1|||
105797620|NCT00529802|364917527|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
105797621|NCT00529802|364917527|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
105797622|NCT00529802|364917527|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
105797623|NCT01858558|364917528|FG000|Overall Study|Death|1|||
105797624|NCT01858558|364917529|FG001|Overall Study|Death|1|||
105797625|NCT01858558|364917528|FG000|Overall Study|Lost to Follow-up|1|||
105797626|NCT01858558|364917529|FG001|Overall Study|Lost to Follow-up|0|||
105732422|NCT01165229|364676070|FG000|Overall Study|Withdrawal by Subject|387|||
105480353|NCT00422084|363769128|FG001|Overall Study|Withdrawal by Subject|9|||
105732423|NCT01165229|364676071|FG001|Overall Study|Withdrawal by Subject|396|||
105732424|NCT01165229|364676070|FG000|Overall Study|Migrated/moved from study area|51|||
105732425|NCT01165229|364676071|FG001|Overall Study|Migrated/moved from study area|46|||
105732426|NCT01165229|364676070|FG000|Overall Study|Lost to Follow-up|123|||
105732427|NCT01165229|364676071|FG001|Overall Study|Lost to Follow-up|133|||
105732428|NCT01165229|364676070|FG000|Overall Study|Suspected HZ Episode|2|||
105732429|NCT01165229|364676071|FG001|Overall Study|Suspected HZ Episode|2|||
105732430|NCT01165229|364676070|FG000|Overall Study|No reason from the subject|108|||
105732431|NCT01165229|364676071|FG001|Overall Study|No reason from the subject|102|||
105732432|NCT01165229|364676070|FG000|Overall Study|Unknown completion status|0|||
105732433|NCT01165229|364676071|FG001|Overall Study|Unknown completion status|1|||
105732434|NCT00474253|364676072|FG000|Overall Study|Withdrew consent|2|||
105732435|NCT00474253|364676073|FG001|Overall Study|Withdrew consent|0|||
105732436|NCT00474253|364676072|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
105732437|NCT00474253|364676073|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
105732438|NCT00474253|364676072|FG000|Overall Study|Lost to Follow-up|1|||
105732439|NCT00474253|364676073|FG001|Overall Study|Lost to Follow-up|0|||
105732440|NCT00474253|364676072|FG000|Overall Study|Discharged prior to study completion|0|||
105732441|NCT00474253|364676073|FG001|Overall Study|Discharged prior to study completion|1|||
105732442|NCT00550238|364676077|FG000|Overall Study|Adverse Event|88|||
105732443|NCT00550238|364676077|FG000|Overall Study|Death|34|||
105732444|NCT00550238|364676077|FG000|Overall Study|Disease progression|46|||
105732445|NCT00550238|364676077|FG000|Overall Study|Withdrawal by Subject|167|||
105732446|NCT00550238|364676077|FG000|Overall Study|Physician Decision|31|||
105732447|NCT00550238|364676077|FG000|Overall Study|Patient noncompliance|25|||
105732448|NCT00550238|364676077|FG000|Overall Study|Lost to Follow-up|13|||
105732449|NCT00550238|364676077|FG000|Overall Study|Sponsor decision|55|||
105732450|NCT05421754|364676078|FG000|Overall Study|Technical issue with sensor|1|||
105732451|NCT00465569|364676079|FG000|Overall Study|persistent eczema during dose escalation|1|||
105732452|NCT00465569|364676080|FG001|Overall Study|persistent eczema during dose escalation|0|||
105732453|NCT04334148|364676082|FG000|Overall Study|positive nasal swab at baseline|0|||
105732454|NCT04334148|364676083|FG001|Overall Study|positive nasal swab at baseline|1|||
105732455|NCT00095303|364676086|FG000|Main Study|Lost to Follow-up|91|||
105732456|NCT00095303|364676087|FG001|Main Study|Lost to Follow-up|87|||
105732457|NCT00095303|364676086|FG000|Follow Up Study|Lost to Follow-up|59|||
105732458|NCT00095303|364676087|FG001|Follow Up Study|Lost to Follow-up|58|||
105732459|NCT01634243|364676088|FG000|Overall Study|Adverse Event|5|||
105732460|NCT01634243|364676089|FG001|Overall Study|Adverse Event|5|||
105732461|NCT01634243|364676088|FG000|Overall Study|Lack of Efficacy|1|||
105732462|NCT01634243|364676089|FG001|Overall Study|Lack of Efficacy|0|||
105732463|NCT00467649|364676097|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
105732464|NCT00467649|364676098|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
105732465|NCT00467649|364676099|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
105732466|NCT00467649|364676100|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
105732467|NCT00467649|364676101|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
105732468|NCT00467649|364676102|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
105732469|NCT00467649|364676097|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
105732470|NCT00467649|364676098|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
105732471|NCT00467649|364676099|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
105732472|NCT00467649|364676100|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
105732473|NCT00467649|364676101|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
105732474|NCT00467649|364676102|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
105732475|NCT00467649|364676097|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
105732476|NCT00467649|364676098|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
105732477|NCT00467649|364676099|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
105732478|NCT00467649|364676100|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
105732479|NCT00467649|364676101|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
105732480|NCT00467649|364676102|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
105732481|NCT00467649|364676097|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
105480354|NCT00422084|363769127|FG000|Overall Study|Lost to Follow-up|14|||
105732482|NCT00467649|364676098|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
105732483|NCT00467649|364676099|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
105732484|NCT00467649|364676100|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
105732485|NCT00467649|364676101|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
105732486|NCT00467649|364676102|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
105732487|NCT00467649|364676097|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
105732488|NCT00467649|364676098|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
105732489|NCT00467649|364676099|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
105732490|NCT00467649|364676100|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
105480355|NCT00422084|363769128|FG001|Overall Study|Lost to Follow-up|9|||
105732491|NCT00467649|364676101|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
105797627|NCT01858558|364917528|FG000|Overall Study|Disease progression|3|||
105797628|NCT01858558|364917529|FG001|Overall Study|Disease progression|1|||
105797629|NCT01858558|364917528|FG000|Overall Study|Product contamination|2|||
105797630|NCT01858558|364917529|FG001|Overall Study|Product contamination|0|||
105797631|NCT01858558|364917528|FG000|Overall Study|Failed expansion of cell product|2|||
105797632|NCT01858558|364917529|FG001|Overall Study|Failed expansion of cell product|0|||
105797633|NCT01142466|364917530|FG000|Overall Study|Adverse Event|2|||
105797634|NCT01142466|364917531|FG001|Overall Study|Adverse Event|1|||
105797635|NCT01142466|364917530|FG000|Overall Study|Withdrawal by Subject|1|||
105797636|NCT01142466|364917531|FG001|Overall Study|Withdrawal by Subject|1|||
105797637|NCT00343642|364917532|FG000|Overall Study|Lost to Follow-up|0|||
105797638|NCT00343642|364917533|FG001|Overall Study|Lost to Follow-up|1|||
105797639|NCT00343642|364917534|FG002|Overall Study|Lost to Follow-up|0|||
105797640|NCT00343642|364917532|FG000|Overall Study|Pregnancy|1|||
105797641|NCT00343642|364917533|FG001|Overall Study|Pregnancy|0|||
105797642|NCT00343642|364917534|FG002|Overall Study|Pregnancy|2|||
105797643|NCT00343642|364917532|FG000|Overall Study|Withdrawal by Subject|2|||
105797644|NCT00343642|364917533|FG001|Overall Study|Withdrawal by Subject|3|||
105797645|NCT00343642|364917534|FG002|Overall Study|Withdrawal by Subject|4|||
105797646|NCT00343642|364917532|FG000|Overall Study|Adverse Event|0|||
105797647|NCT00343642|364917533|FG001|Overall Study|Adverse Event|0|||
105797648|NCT00343642|364917534|FG002|Overall Study|Adverse Event|1|||
105797649|NCT00343642|364917532|FG000|Overall Study|Flare up|6|||
105797650|NCT00343642|364917533|FG001|Overall Study|Flare up|4|||
105797651|NCT00343642|364917534|FG002|Overall Study|Flare up|0|||
105797652|NCT00700310|364917537|FG000|Overall Study|Adverse Event|6|||
105797653|NCT00700310|364917538|FG001|Overall Study|Adverse Event|10|||
105797654|NCT00700310|364917539|FG002|Overall Study|Adverse Event|5|||
105797655|NCT00700310|364917540|FG003|Overall Study|Adverse Event|11|||
105797656|NCT00700310|364917537|FG000|Overall Study|Lost to Follow-up|4|||
105797657|NCT00700310|364917538|FG001|Overall Study|Lost to Follow-up|1|||
105797658|NCT00700310|364917539|FG002|Overall Study|Lost to Follow-up|0|||
105797659|NCT00700310|364917540|FG003|Overall Study|Lost to Follow-up|1|||
105797660|NCT00700310|364917537|FG000|Overall Study|Withdrawal by Subject|8|||
105797661|NCT00700310|364917538|FG001|Overall Study|Withdrawal by Subject|9|||
105797662|NCT00700310|364917539|FG002|Overall Study|Withdrawal by Subject|8|||
105797663|NCT00700310|364917540|FG003|Overall Study|Withdrawal by Subject|8|||
105797664|NCT00700310|364917537|FG000|Overall Study|Lack of Efficacy|0|||
105797665|NCT00700310|364917538|FG001|Overall Study|Lack of Efficacy|3|||
105797666|NCT00700310|364917539|FG002|Overall Study|Lack of Efficacy|0|||
105797667|NCT00700310|364917540|FG003|Overall Study|Lack of Efficacy|1|||
105797668|NCT00700310|364917537|FG000|Overall Study|Administrative/Other|1|||
105797669|NCT00700310|364917538|FG001|Overall Study|Administrative/Other|3|||
105797670|NCT00700310|364917539|FG002|Overall Study|Administrative/Other|1|||
105797671|NCT00700310|364917540|FG003|Overall Study|Administrative/Other|3|||
105797672|NCT00700310|364917537|FG000|Overall Study|Randomized, Not Treated|2|||
105797673|NCT00700310|364917538|FG001|Overall Study|Randomized, Not Treated|0|||
105797674|NCT00700310|364917539|FG002|Overall Study|Randomized, Not Treated|2|||
105797675|NCT00700310|364917540|FG003|Overall Study|Randomized, Not Treated|2|||
105797676|NCT02598622|364917545|FG000|Overall Study|Withdrawal by Subject|3|||
105797677|NCT02598622|364917546|FG001|Overall Study|Withdrawal by Subject|0|||
105797678|NCT02598622|364917545|FG000|Overall Study|Physician Decision|3|||
105797679|NCT02598622|364917546|FG001|Overall Study|Physician Decision|0|||
105797680|NCT00681824|364917550|FG000|Overall Study|withdrawn by investigator|0|||
105797681|NCT00681824|364917551|FG001|Overall Study|withdrawn by investigator|0|||
105797682|NCT00681824|364917552|FG002|Overall Study|withdrawn by investigator|1|||
105797683|NCT00681824|364917550|FG000|Overall Study|scheduling conflict|1|||
105797684|NCT00681824|364917551|FG001|Overall Study|scheduling conflict|0|||
105797685|NCT00681824|364917552|FG002|Overall Study|scheduling conflict|0|||
105797686|NCT00681824|364917550|FG000|Overall Study|Death|0|||
105797687|NCT00681824|364917551|FG001|Overall Study|Death|1|||
105797688|NCT00681824|364917552|FG002|Overall Study|Death|0|||
105797689|NCT03724916|364917553|FG000|Overall Study|Withdrawal by Subject|0|||
105797690|NCT03724916|364917554|FG001|Overall Study|Withdrawal by Subject|1|||
105797691|NCT03724916|364917555|FG002|Overall Study|Withdrawal by Subject|1|||
105797692|NCT03724916|364917556|FG003|Overall Study|Withdrawal by Subject|2|||
105797693|NCT03724916|364917553|FG000|Overall Study|Randomized but not Treated|1|||
105797694|NCT03724916|364917554|FG001|Overall Study|Randomized but not Treated|0|||
105797695|NCT03724916|364917555|FG002|Overall Study|Randomized but not Treated|0|||
105797696|NCT03724916|364917556|FG003|Overall Study|Randomized but not Treated|0|||
105797697|NCT04575038|364917557|FG000|Overall Study|Withdrawal by Subject|1|||
105797698|NCT04575038|364917558|FG001|Overall Study|Withdrawal by Subject|1|||
105797699|NCT01586624|364917562|FG000|Overall Study|Adverse Event|3|||
105797700|NCT01586624|364917563|FG001|Overall Study|Adverse Event|0|||
105797701|NCT01586624|364917564|FG002|Overall Study|Adverse Event|2|||
105797702|NCT01586624|364917565|FG003|Overall Study|Adverse Event|1|||
105797703|NCT01586624|364917566|FG004|Overall Study|Adverse Event|3|||
105797704|NCT01586624|364917567|FG005|Overall Study|Adverse Event|3|||
105797705|NCT01586624|364917568|FG006|Overall Study|Adverse Event|2|||
105797706|NCT01586624|364917569|FG007|Overall Study|Adverse Event|3|||
105797707|NCT01586624|364917562|FG000|Overall Study|Physician Decision|0|||
105797708|NCT01586624|364917563|FG001|Overall Study|Physician Decision|1|||
105797709|NCT01586624|364917564|FG002|Overall Study|Physician Decision|1|||
105797710|NCT01586624|364917565|FG003|Overall Study|Physician Decision|0|||
105797711|NCT01586624|364917566|FG004|Overall Study|Physician Decision|2|||
105797712|NCT01586624|364917567|FG005|Overall Study|Physician Decision|0|||
105797713|NCT01586624|364917568|FG006|Overall Study|Physician Decision|1|||
105797714|NCT01586624|364917569|FG007|Overall Study|Physician Decision|1|||
105797715|NCT01586624|364917562|FG000|Overall Study|Withdrawal by Subject|0|||
105797716|NCT01586624|364917563|FG001|Overall Study|Withdrawal by Subject|0|||
105797717|NCT01586624|364917564|FG002|Overall Study|Withdrawal by Subject|0|||
105797718|NCT01586624|364917565|FG003|Overall Study|Withdrawal by Subject|1|||
105797719|NCT01586624|364917566|FG004|Overall Study|Withdrawal by Subject|0|||
105797720|NCT01586624|364917567|FG005|Overall Study|Withdrawal by Subject|0|||
105797721|NCT01586624|364917568|FG006|Overall Study|Withdrawal by Subject|0|||
105797722|NCT01586624|364917569|FG007|Overall Study|Withdrawal by Subject|0|||
105797723|NCT01586624|364917562|FG000|Overall Study|Evidence of disease progression|1|||
105797724|NCT01586624|364917563|FG001|Overall Study|Evidence of disease progression|3|||
105797725|NCT01586624|364917564|FG002|Overall Study|Evidence of disease progression|2|||
105797726|NCT01586624|364917565|FG003|Overall Study|Evidence of disease progression|5|||
105797727|NCT01586624|364917566|FG004|Overall Study|Evidence of disease progression|3|||
105797728|NCT01586624|364917567|FG005|Overall Study|Evidence of disease progression|5|||
105797729|NCT01586624|364917568|FG006|Overall Study|Evidence of disease progression|4|||
105797730|NCT01586624|364917569|FG007|Overall Study|Evidence of disease progression|6|||
105797731|NCT01586624|364917562|FG000|Overall Study|Screen failure (no treatment received)|0|||
105797732|NCT01586624|364917563|FG001|Overall Study|Screen failure (no treatment received)|0|||
105797733|NCT01586624|364917564|FG002|Overall Study|Screen failure (no treatment received)|0|||
105480356|NCT00422084|363769127|FG000|Overall Study|Protocol Violation|4|||
105480357|NCT00422084|363769128|FG001|Overall Study|Protocol Violation|1|||
105480358|NCT00422084|363769127|FG000|Overall Study|Lack of Efficacy|40|||
105480359|NCT00422084|363769128|FG001|Overall Study|Lack of Efficacy|42|||
105480360|NCT00422084|363769127|FG000|Overall Study|P. vivax infection|3|||
105480361|NCT00422084|363769128|FG001|Overall Study|P. vivax infection|6|||
105564994|NCT00542880|364065376|FG000|Period 2|Discontinuation criteria|2|||
105564995|NCT00542880|364065377|FG001|Period 2|Discontinuation criteria|0|||
105564996|NCT00542880|364065376|FG000|Period 2|Severe non-compliance|0|||
105797734|NCT01586624|364917565|FG003|Overall Study|Screen failure (no treatment received)|0|||
105797735|NCT01586624|364917566|FG004|Overall Study|Screen failure (no treatment received)|0|||
105480362|NCT00422084|363769127|FG000|Overall Study|Cyesis|1|||
105480363|NCT00422084|363769128|FG001|Overall Study|Cyesis|0|||
105480364|NCT00422084|363769127|FG000|Overall Study|Withdrawn from study accidentally|1|||
105480365|NCT00422084|363769128|FG001|Overall Study|Withdrawn from study accidentally|0|||
105480366|NCT00422084|363769127|FG000|Overall Study|Non-compliance|1|||
105480367|NCT00422084|363769128|FG001|Overall Study|Non-compliance|0|||
105480368|NCT00422084|363769127|FG000|Overall Study|Re-location|0|||
105480369|NCT00422084|363769128|FG001|Overall Study|Re-location|1|||
105480370|NCT00422084|363769127|FG000|Overall Study|Not defined|1|||
105480371|NCT00422084|363769128|FG001|Overall Study|Not defined|1|||
105480372|NCT03996369|363769130|FG000|Overall Study|Protocol deviation|1|||
105480373|NCT03996369|363769131|FG001|Overall Study|Protocol deviation|1|||
105480374|NCT03996369|363769130|FG000|Overall Study|Physician Decision|4|||
105480375|NCT03996369|363769131|FG001|Overall Study|Physician Decision|2|||
105480376|NCT03996369|363769130|FG000|Overall Study|Participant decision|0|||
105480377|NCT03996369|363769131|FG001|Overall Study|Participant decision|1|||
105797736|NCT01586624|364917567|FG005|Overall Study|Screen failure (no treatment received)|0|||
105797737|NCT01586624|364917568|FG006|Overall Study|Screen failure (no treatment received)|1|||
105797738|NCT01586624|364917569|FG007|Overall Study|Screen failure (no treatment received)|0|||
105797739|NCT01954082|364917579|FG000|Overall Study|Study Suspension|42|||
105797740|NCT01954082|364917580|FG001|Overall Study|Study Suspension|36|||
105797741|NCT01954082|364917579|FG000|Overall Study|Adverse Event|10|||
105797742|NCT01954082|364917580|FG001|Overall Study|Adverse Event|4|||
105797743|NCT01954082|364917579|FG000|Overall Study|Intolerance|0|||
105797744|NCT01954082|364917580|FG001|Overall Study|Intolerance|1|||
105797745|NCT01954082|364917579|FG000|Overall Study|Non-compliance|6|||
105797746|NCT01954082|364917580|FG001|Overall Study|Non-compliance|4|||
105797747|NCT01954082|364917579|FG000|Overall Study|Physician Decision|2|||
105797748|NCT01954082|364917580|FG001|Overall Study|Physician Decision|0|||
105797749|NCT01954082|364917579|FG000|Overall Study|Parent Decision|1|||
105480378|NCT03996369|363769130|FG000|Overall Study|Lack of Efficacy|4|||
105797750|NCT01954082|364917580|FG001|Overall Study|Parent Decision|0|||
105480379|NCT03996369|363769131|FG001|Overall Study|Lack of Efficacy|0|||
105480380|NCT03996369|363769130|FG000|Overall Study|Adverse Event|9|||
105480381|NCT03996369|363769131|FG001|Overall Study|Adverse Event|0|||
105480382|NCT03996369|363769130|FG000|Overall Study|Withdrawal by Subject|6|||
105480383|NCT03996369|363769131|FG001|Overall Study|Withdrawal by Subject|8|||
105564997|NCT00542880|364065377|FG001|Period 2|Severe non-compliance|1|||
105480384|NCT03996369|363769130|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
105480385|NCT03996369|363769131|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
105480386|NCT03996369|363769130|FG000|Overall Study|Lost to Follow-up|0|||
105480387|NCT03996369|363769131|FG001|Overall Study|Lost to Follow-up|1|||
105480388|NCT00653432|363769132|FG000|Overall Study|Adverse Event|4|||
105480389|NCT00653432|363769133|FG001|Overall Study|Adverse Event|1|||
105480390|NCT00653432|363769132|FG000|Overall Study|Withdrawal by Subject|4|||
105732492|NCT00467649|364676102|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
105732493|NCT00467649|364676097|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
105732494|NCT00467649|364676098|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
105732495|NCT00467649|364676099|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
105353288|NCT01690299|363298520|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
105353289|NCT01690299|363298521|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
105353290|NCT01690299|363298522|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
105480391|NCT00653432|363769133|FG001|Overall Study|Withdrawal by Subject|5|||
105564998|NCT00542880|364065376|FG000|Period 2|Other|0|||
105732496|NCT00467649|364676100|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
105732497|NCT00467649|364676101|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
105732498|NCT00467649|364676102|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
105732499|NCT00467649|364676097|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
105732500|NCT00467649|364676098|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
105732501|NCT00467649|364676099|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
105732502|NCT00467649|364676100|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
105732503|NCT00467649|364676101|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
105732504|NCT00467649|364676102|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
105732505|NCT00845429|364676103|FG000|Overall Study|Protocol Violation|5|||
105732506|NCT00845429|364676104|FG001|Overall Study|Protocol Violation|4|||
105732507|NCT00845429|364676105|FG002|Overall Study|Protocol Violation|7|||
105732508|NCT00845429|364676103|FG000|Overall Study|Lost to Follow-up|7|||
105732509|NCT00845429|364676104|FG001|Overall Study|Lost to Follow-up|9|||
105732510|NCT00845429|364676105|FG002|Overall Study|Lost to Follow-up|10|||
105732511|NCT00845429|364676103|FG000|Overall Study|Withdrawal by Subject|2|||
105732512|NCT00845429|364676104|FG001|Overall Study|Withdrawal by Subject|2|||
105732513|NCT00845429|364676105|FG002|Overall Study|Withdrawal by Subject|2|||
105732514|NCT00845429|364676103|FG000|Overall Study|Serious adverse event|0|||
105732515|NCT00845429|364676104|FG001|Overall Study|Serious adverse event|0|||
105732516|NCT00845429|364676105|FG002|Overall Study|Serious adverse event|1|||
105732517|NCT00986349|364676109|FG000|Overall Study|Unsuccessful implant procedure|3|||
105732518|NCT00986349|364676109|FG000|Overall Study|Adverse Event|2|||
105732519|NCT00986349|364676109|FG000|Overall Study|Physician Decision|1|||
105732520|NCT00986349|364676109|FG000|Overall Study|device migration|1|||
105732521|NCT00587223|364676110|FG000|Overall Study|Adverse Event|1|||
105732522|NCT02111811|364676113|FG000|Treatment Phase|Lost to Follow-up|22|||
105732523|NCT02111811|364676114|FG001|Treatment Phase|Lost to Follow-up|18|||
105732524|NCT02111811|364676113|FG000|Treatment Phase|Death|2|||
105732525|NCT02111811|364676114|FG001|Treatment Phase|Death|0|||
105732526|NCT02111811|364676113|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
105732527|NCT02111811|364676114|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
105732528|NCT02111811|364676113|FG000|Follow up Period (Aim 2)|Death|2|||
105732529|NCT02111811|364676114|FG001|Follow up Period (Aim 2)|Death|0|||
105732530|NCT05897853|364676120|FG000|Overall Study|Lost to Follow-up|2|||
105732531|NCT05897853|364676121|FG001|Overall Study|Lost to Follow-up|0|||
105732532|NCT05897853|364676120|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
105732533|NCT05897853|364676121|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
105732534|NCT02986373|364676122|FG000|Overall Study|Adverse Event|4|||
105732535|NCT02986373|364676122|FG000|Overall Study|Lost to Follow-up|1|||
105732536|NCT02986373|364676122|FG000|Overall Study|Withdrawal by Subject|10|||
105732537|NCT02986373|364676122|FG000|Overall Study|Other|24|||
105732538|NCT00753922|364676126|FG000|Overall Study|Lost to Follow-up|155|||
105732539|NCT00753922|364676127|FG001|Overall Study|Lost to Follow-up|24|||
105732540|NCT00753922|364676128|FG002|Overall Study|Lost to Follow-up|28|||
105732541|NCT00753922|364676129|FG003|Overall Study|Lost to Follow-up|5|||
105732542|NCT00753922|364676126|FG000|Overall Study|Withdrawal by Subject|9|||
105732543|NCT00753922|364676127|FG001|Overall Study|Withdrawal by Subject|11|||
105732544|NCT00753922|364676128|FG002|Overall Study|Withdrawal by Subject|4|||
105732545|NCT00753922|364676129|FG003|Overall Study|Withdrawal by Subject|2|||
105732546|NCT00753922|364676126|FG000|Overall Study|Patient Non-compliance|55|||
105732547|NCT00753922|364676127|FG001|Overall Study|Patient Non-compliance|22|||
105480392|NCT00653432|363769132|FG000|Overall Study|Lost to Follow-up|7|||
105480393|NCT00653432|363769133|FG001|Overall Study|Lost to Follow-up|6|||
105732548|NCT00753922|364676128|FG002|Overall Study|Patient Non-compliance|14|||
105732549|NCT00753922|364676129|FG003|Overall Study|Patient Non-compliance|11|||
105732550|NCT00753922|364676126|FG000|Overall Study|Patients Not Completing Visit|11|||
105732551|NCT00753922|364676127|FG001|Overall Study|Patients Not Completing Visit|0|||
105797751|NCT01954082|364917579|FG000|Overall Study|Withdrawal by Subject|0|||
105797752|NCT01954082|364917580|FG001|Overall Study|Withdrawal by Subject|1|||
105797753|NCT01954082|364917579|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
105797754|NCT01954082|364917580|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
105797755|NCT01954082|364917579|FG000|Overall Study|Redirection of Care|0|||
105797756|NCT01954082|364917580|FG001|Overall Study|Redirection of Care|2|||
105797757|NCT01954082|364917579|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
105797758|NCT01954082|364917580|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
105797759|NCT01954082|364917579|FG000|Overall Study|Comfort Care|0|||
105797760|NCT01954082|364917580|FG001|Overall Study|Comfort Care|1|||
105797761|NCT01954082|364917579|FG000|Overall Study|Infant Moved|0|||
105797762|NCT01954082|364917580|FG001|Overall Study|Infant Moved|1|||
105797763|NCT01954082|364917579|FG000|Overall Study|Randomized not Treated|4|||
105797764|NCT01954082|364917580|FG001|Overall Study|Randomized not Treated|2|||
105797765|NCT01875991|364917581|FG000|Overall Study|Withdrawal by Subject|6|||
105797766|NCT01875991|364917582|FG001|Overall Study|Withdrawal by Subject|6|||
105797767|NCT01875991|364917581|FG000|Overall Study|Sponsor Decision|1|||
105797768|NCT01875991|364917582|FG001|Overall Study|Sponsor Decision|0|||
105797769|NCT00923195|364917587|FG000|Overall Study|Death|0|||
105797770|NCT00923195|364917588|FG001|Overall Study|Death|1|||
105797771|NCT01106352|364917589|FG000|Overall Study|Subjects untreated|0|||
105797772|NCT01106352|364917590|FG001|Overall Study|Subjects untreated|0|||
105797773|NCT01106352|364917591|FG002|Overall Study|Subjects untreated|0|||
105797774|NCT01106352|364917592|FG003|Overall Study|Subjects untreated|3|||
105797775|NCT01106352|364917593|FG004|Overall Study|Subjects untreated|4|||
105797776|NCT01106352|364917589|FG000|Overall Study|Sponsor Decision|1|||
105797777|NCT01106352|364917590|FG001|Overall Study|Sponsor Decision|0|||
105797778|NCT01106352|364917591|FG002|Overall Study|Sponsor Decision|0|||
105797779|NCT01106352|364917592|FG003|Overall Study|Sponsor Decision|0|||
105797780|NCT01106352|364917593|FG004|Overall Study|Sponsor Decision|0|||
105797781|NCT01106352|364917589|FG000|Overall Study|Too ill to come in for the visit|0|||
105797782|NCT01106352|364917590|FG001|Overall Study|Too ill to come in for the visit|0|||
105797783|NCT01106352|364917591|FG002|Overall Study|Too ill to come in for the visit|1|||
105797784|NCT01106352|364917592|FG003|Overall Study|Too ill to come in for the visit|0|||
105797785|NCT01106352|364917593|FG004|Overall Study|Too ill to come in for the visit|0|||
105797786|NCT01106352|364917589|FG000|Overall Study|Lost to Follow-up|0|||
105797787|NCT01106352|364917590|FG001|Overall Study|Lost to Follow-up|0|||
105797788|NCT01106352|364917591|FG002|Overall Study|Lost to Follow-up|0|||
105797789|NCT01106352|364917592|FG003|Overall Study|Lost to Follow-up|0|||
105797790|NCT01106352|364917593|FG004|Overall Study|Lost to Follow-up|1|||
105797791|NCT01106352|364917589|FG000|Overall Study|Death|0|||
105797792|NCT01106352|364917590|FG001|Overall Study|Death|0|||
105797793|NCT01106352|364917591|FG002|Overall Study|Death|1|||
105797794|NCT01106352|364917592|FG003|Overall Study|Death|3|||
105797795|NCT01106352|364917593|FG004|Overall Study|Death|1|||
105797796|NCT01106352|364917589|FG000|Overall Study|Disease progression|0|||
105797797|NCT01106352|364917590|FG001|Overall Study|Disease progression|0|||
105480394|NCT00653432|363769132|FG000|Overall Study|Use/Need of Con Therapy|2|||
105480395|NCT00653432|363769133|FG001|Overall Study|Use/Need of Con Therapy|1|||
105732552|NCT00753922|364676128|FG002|Overall Study|Patients Not Completing Visit|1|||
105732553|NCT00753922|364676129|FG003|Overall Study|Patients Not Completing Visit|0|||
105732554|NCT00753922|364676126|FG000|Overall Study|Death|2|||
105732555|NCT00753922|364676127|FG001|Overall Study|Death|23|||
105732556|NCT00753922|364676128|FG002|Overall Study|Death|2|||
105732557|NCT00753922|364676129|FG003|Overall Study|Death|1|||
105732558|NCT00753922|364676126|FG000|Overall Study|Discontinuation Due to Explantation|14|||
105732559|NCT00753922|364676127|FG001|Overall Study|Discontinuation Due to Explantation|14|||
105732560|NCT00753922|364676128|FG002|Overall Study|Discontinuation Due to Explantation|14|||
105732561|NCT00753922|364676129|FG003|Overall Study|Discontinuation Due to Explantation|4|||
105732562|NCT00586690|364676138|FG000|Overall Study|Death|2|||
105732563|NCT00586690|364676139|FG001|Overall Study|Death|0|||
105732564|NCT00586690|364676138|FG000|Overall Study|Disease Progression|10|||
105797798|NCT01106352|364917591|FG002|Overall Study|Disease progression|0|||
105797799|NCT01106352|364917592|FG003|Overall Study|Disease progression|1|||
105797800|NCT01106352|364917593|FG004|Overall Study|Disease progression|0|||
105797801|NCT01106352|364917589|FG000|Overall Study|Withdrawal by Subject|0|||
105797802|NCT01106352|364917590|FG001|Overall Study|Withdrawal by Subject|0|||
105797803|NCT01106352|364917591|FG002|Overall Study|Withdrawal by Subject|0|||
105797804|NCT01106352|364917592|FG003|Overall Study|Withdrawal by Subject|3|||
105797805|NCT01106352|364917593|FG004|Overall Study|Withdrawal by Subject|2|||
105797806|NCT01106352|364917589|FG000|Overall Study|Went on hospice|0|||
105797807|NCT01106352|364917590|FG001|Overall Study|Went on hospice|0|||
105797808|NCT01106352|364917591|FG002|Overall Study|Went on hospice|0|||
105797809|NCT01106352|364917592|FG003|Overall Study|Went on hospice|1|||
105732565|NCT00586690|364676139|FG001|Overall Study|Disease Progression|0|||
105732566|NCT00586690|364676138|FG000|Overall Study|Adverse Event|1|||
105797810|NCT01106352|364917593|FG004|Overall Study|Went on hospice|0|||
105797811|NCT01106352|364917589|FG000|Overall Study|Subject entered hospice|0|||
105797812|NCT01106352|364917590|FG001|Overall Study|Subject entered hospice|0|||
105797813|NCT01106352|364917591|FG002|Overall Study|Subject entered hospice|0|||
105797814|NCT01106352|364917592|FG003|Overall Study|Subject entered hospice|1|||
105797815|NCT01106352|364917593|FG004|Overall Study|Subject entered hospice|0|||
105797816|NCT01106352|364917589|FG000|Overall Study|Home hospice since July 2013|0|||
105797817|NCT01106352|364917590|FG001|Overall Study|Home hospice since July 2013|0|||
105797818|NCT01106352|364917591|FG002|Overall Study|Home hospice since July 2013|0|||
105797819|NCT01106352|364917592|FG003|Overall Study|Home hospice since July 2013|1|||
105797820|NCT01106352|364917593|FG004|Overall Study|Home hospice since July 2013|0|||
105797821|NCT03547531|364917594|FG000|Overall Study|not coming in data collection : sick|2|||
105797822|NCT03547531|364917595|FG001|Overall Study|not coming in data collection : sick|2|||
105797823|NCT03547531|364917594|FG000|Overall Study|having family occasion|0|||
105797824|NCT03547531|364917595|FG001|Overall Study|having family occasion|2|||
105797825|NCT02444182|364917603|FG000|Overall Study|non-compliance|2|||
105797826|NCT02444182|364917604|FG001|Overall Study|non-compliance|1|||
105797827|NCT02444182|364917603|FG000|Overall Study|Lost to Follow-up|0|||
105797828|NCT02444182|364917604|FG001|Overall Study|Lost to Follow-up|4|||
105797829|NCT01959230|364917605|FG000|Overall Study|Failure to follow study procedures|0|||
105797830|NCT01959230|364917606|FG001|Overall Study|Failure to follow study procedures|1|||
105797831|NCT01959230|364917605|FG000|Overall Study|Administrative reasons|2|||
105797832|NCT01959230|364917606|FG001|Overall Study|Administrative reasons|0|||
105797833|NCT01959230|364917605|FG000|Overall Study|Withdrawal by Subject|2|||
105797834|NCT01959230|364917606|FG001|Overall Study|Withdrawal by Subject|0|||
105797835|NCT01453374|364917609|FG000|Overall Study|Adverse Event|7|||
105797836|NCT01453374|364917609|FG000|Overall Study|Lack of Efficacy|1|||
105797837|NCT01453374|364917609|FG000|Overall Study|Lost to Follow-up|3|||
105797838|NCT01453374|364917609|FG000|Overall Study|Withdrawal by Subject|5|||
105797839|NCT01453374|364917609|FG000|Overall Study|Incarcerated|2|||
105797840|NCT00810615|364917611|FG000|Overall Study|Withdrawal by Subject|1|||
105797841|NCT00810615|364917612|FG001|Overall Study|Withdrawal by Subject|1|||
105797842|NCT02567266|364917613|FG000|Overall Study|Withdrawal by Subject|10|||
105797843|NCT02567266|364917614|FG001|Overall Study|Withdrawal by Subject|7|||
105797844|NCT02567266|364917615|FG002|Overall Study|Withdrawal by Subject|6|||
105797845|NCT02567266|364917613|FG000|Overall Study|Lost to Follow-up|13|||
105797846|NCT02567266|364917614|FG001|Overall Study|Lost to Follow-up|8|||
105797847|NCT02567266|364917615|FG002|Overall Study|Lost to Follow-up|10|||
105797848|NCT02643966|364917616|FG000|First Screening Round|ineligible|1|||
105797849|NCT02643966|364917616|FG000|First Screening Round|excluded from analysis|2|||
105797850|NCT02643966|364917616|FG000|First Screening Round|Lost to Follow-up|56|||
105797851|NCT02643966|364917616|FG000|First Screening Round|Withdrawal by Subject|28|||
105797852|NCT02643966|364917616|FG000|First Screening Round|Death|1|||
105797853|NCT02643966|364917616|FG000|Between First and Second Screening|Lost to Follow-up|65|||
105797854|NCT02643966|364917616|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
105797855|NCT02643966|364917616|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
105797856|NCT02643966|364917616|FG000|Second Screening Round|Withdrawal by Subject|20|||
105797857|NCT02643966|364917616|FG000|Second Screening Round|Lost to Follow-up|57|||
105797858|NCT02643966|364917616|FG000|Second Screening Round|Physician Decision|2|||
105797859|NCT02643966|364917616|FG000|Second Screening Round|Death|4|||
105797860|NCT02643966|364917616|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
105797861|NCT02643966|364917616|FG000|Between Second and Third Screening|Death|1|||
105797862|NCT02643966|364917616|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
105797863|NCT02643966|364917616|FG000|Third Screening Round|PI excluded|2|||
105797864|NCT02643966|364917616|FG000|Third Screening Round|Lost to Follow-up|241|||
105797865|NCT01946282|364917617|FG000|Year 1|Did not return FIT kit|4186|||
105797866|NCT01946282|364917618|FG001|Year 1|Did not return FIT kit|608|||
105797867|NCT01946282|364917619|FG002|Year 1|Did not return FIT kit|654|||
105797868|NCT01946282|364917617|FG000|Year 2|Did not return FIT kit|803|||
105797869|NCT01946282|364917618|FG001|Year 2|Did not return FIT kit|131|||
105797870|NCT01946282|364917619|FG002|Year 2|Did not return FIT kit|115|||
105797871|NCT01946282|364917617|FG000|Year 3|Did not return FIT kit|288|||
105797872|NCT01946282|364917618|FG001|Year 3|Did not return FIT kit|43|||
105797873|NCT01946282|364917619|FG002|Year 3|Did not return FIT kit|30|||
105797874|NCT03636542|364917620|FG000|Overall Study|Lost to Follow-up|1|||
105797875|NCT03636542|364917621|FG001|Overall Study|Lost to Follow-up|1|||
105797876|NCT03636542|364917620|FG000|Overall Study|Physician Decision|0|||
105797877|NCT03636542|364917621|FG001|Overall Study|Physician Decision|1|||
105797878|NCT03636542|364917620|FG000|Overall Study|Withdrawal by Subject|1|||
105797879|NCT03636542|364917621|FG001|Overall Study|Withdrawal by Subject|0|||
105797880|NCT00411762|364917624|FG000|Overall Study|Withdrawal by Subject|5|||
105797881|NCT01364298|364917625|FG000|Overall Study|Adverse Event|3|||
105797882|NCT01364298|364917626|FG001|Overall Study|Adverse Event|4|||
105797883|NCT01364298|364917625|FG000|Overall Study|Lack of adherence to treatment|1|||
105797884|NCT01364298|364917626|FG001|Overall Study|Lack of adherence to treatment|3|||
105797885|NCT01364298|364917625|FG000|Overall Study|Lack of Efficacy|1|||
105480396|NCT00653432|363769132|FG000|Overall Study|Other - Reason Not Provided|5|||
105480397|NCT00653432|363769133|FG001|Overall Study|Other - Reason Not Provided|3|||
105732567|NCT00586690|364676139|FG001|Overall Study|Adverse Event|0|||
105732568|NCT00586690|364676138|FG000|Overall Study|Lack of Efficacy|2|||
105732569|NCT00586690|364676139|FG001|Overall Study|Lack of Efficacy|0|||
105732570|NCT00586690|364676138|FG000|Overall Study|Lab can't accommodate|1|||
105732571|NCT00586690|364676139|FG001|Overall Study|Lab can't accommodate|0|||
105732572|NCT02426086|364676142|FG000|Overall Study|Death|33|||
105732573|NCT02426086|364676143|FG001|Overall Study|Death|36|||
105732574|NCT02426086|364676142|FG000|Overall Study|Lost to Follow-up|2|||
105732575|NCT02426086|364676143|FG001|Overall Study|Lost to Follow-up|0|||
105732576|NCT02426086|364676142|FG000|Overall Study|Study Terminated by Sponsor|5|||
105732577|NCT02426086|364676143|FG001|Overall Study|Study Terminated by Sponsor|14|||
105732578|NCT02426086|364676142|FG000|Overall Study|Withdrawal by Subject|8|||
105732579|NCT02426086|364676143|FG001|Overall Study|Withdrawal by Subject|9|||
105732580|NCT00524303|364676144|FG000|Overall Study|Lost to Follow-up|6|||
105732581|NCT00524303|364676145|FG001|Overall Study|Lost to Follow-up|0|||
105732582|NCT00524303|364676146|FG002|Overall Study|Lost to Follow-up|3|||
105732583|NCT00524303|364676144|FG000|Overall Study|Protocol Violation|0|||
105732584|NCT00524303|364676145|FG001|Overall Study|Protocol Violation|1|||
105732585|NCT00524303|364676146|FG002|Overall Study|Protocol Violation|1|||
105732586|NCT00524303|364676144|FG000|Overall Study|Withdrawal by Subject|3|||
105732587|NCT00524303|364676145|FG001|Overall Study|Withdrawal by Subject|0|||
105732588|NCT00524303|364676146|FG002|Overall Study|Withdrawal by Subject|4|||
105732589|NCT00524303|364676144|FG000|Overall Study|Death|0|||
105732590|NCT00524303|364676145|FG001|Overall Study|Death|2|||
105732591|NCT00524303|364676146|FG002|Overall Study|Death|3|||
105732592|NCT00524303|364676144|FG000|Overall Study|Adverse Event|1|||
105732593|NCT00524303|364676145|FG001|Overall Study|Adverse Event|2|||
105732594|NCT00524303|364676146|FG002|Overall Study|Adverse Event|3|||
105732595|NCT00524303|364676144|FG000|Overall Study|Did not Complete Study Dosing|1|||
105732596|NCT00524303|364676145|FG001|Overall Study|Did not Complete Study Dosing|0|||
105732597|NCT00524303|364676146|FG002|Overall Study|Did not Complete Study Dosing|0|||
105732598|NCT00524303|364676144|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
105732599|NCT00524303|364676145|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
105732600|NCT00524303|364676146|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
105732601|NCT00524303|364676144|FG000|Overall Study|Disease Progression|0|||
105732602|NCT00524303|364676145|FG001|Overall Study|Disease Progression|4|||
105732603|NCT00524303|364676146|FG002|Overall Study|Disease Progression|1|||
105732604|NCT00524303|364676144|FG000|Overall Study|Disease Recurrence|0|||
105732605|NCT00524303|364676145|FG001|Overall Study|Disease Recurrence|1|||
105732606|NCT00524303|364676146|FG002|Overall Study|Disease Recurrence|0|||
105732607|NCT00524303|364676144|FG000|Overall Study|Sponsor Request|0|||
105732608|NCT00524303|364676145|FG001|Overall Study|Sponsor Request|0|||
105732609|NCT00524303|364676146|FG002|Overall Study|Sponsor Request|1|||
105732610|NCT00524303|364676144|FG000|Overall Study|Physician Decision|0|||
105732611|NCT00524303|364676145|FG001|Overall Study|Physician Decision|0|||
105732612|NCT00524303|364676146|FG002|Overall Study|Physician Decision|1|||
105732613|NCT00524303|364676144|FG000|Overall Study|Completed 5 years|0|||
105732614|NCT00524303|364676145|FG001|Overall Study|Completed 5 years|0|||
105732615|NCT00524303|364676146|FG002|Overall Study|Completed 5 years|1|||
105732616|NCT01739595|364676151|FG000|Overall Study|Adverse Event|3|||
105732617|NCT01739595|364676152|FG001|Overall Study|Adverse Event|0|||
105732618|NCT01739595|364676153|FG002|Overall Study|Adverse Event|0|||
105732619|NCT01739595|364676151|FG000|Overall Study|Lost to Follow-up|2|||
105732620|NCT01739595|364676152|FG001|Overall Study|Lost to Follow-up|0|||
105732621|NCT01739595|364676153|FG002|Overall Study|Lost to Follow-up|0|||
105732622|NCT01739595|364676151|FG000|Overall Study|Withdrawal by Subject|2|||
105732623|NCT01739595|364676152|FG001|Overall Study|Withdrawal by Subject|1|||
105732624|NCT01739595|364676153|FG002|Overall Study|Withdrawal by Subject|2|||
105732625|NCT01739595|364676151|FG000|Overall Study|Eligibility issue|3|||
105732626|NCT01739595|364676152|FG001|Overall Study|Eligibility issue|0|||
105732627|NCT01739595|364676153|FG002|Overall Study|Eligibility issue|0|||
105732628|NCT01739595|364676151|FG000|Overall Study|Protocol Violation|1|||
105480398|NCT01133990|363769134|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
105480399|NCT01133990|363769135|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
105732629|NCT01739595|364676152|FG001|Overall Study|Protocol Violation|0|||
105732630|NCT01739595|364676153|FG002|Overall Study|Protocol Violation|0|||
105797886|NCT01364298|364917626|FG001|Overall Study|Lack of Efficacy|0|||
105480400|NCT01133990|363769136|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
105732631|NCT01739595|364676151|FG000|Overall Study|Lab assessment|1|||
105732632|NCT01739595|364676152|FG001|Overall Study|Lab assessment|0|||
105732633|NCT01739595|364676153|FG002|Overall Study|Lab assessment|0|||
105732634|NCT01739595|364676151|FG000|Overall Study|Drug discrepancy|1|||
105732635|NCT01739595|364676152|FG001|Overall Study|Drug discrepancy|0|||
105732636|NCT01739595|364676153|FG002|Overall Study|Drug discrepancy|0|||
105732637|NCT03750838|364676162|FG000|Overall Study|Lost to Follow-up|10|||
105732638|NCT03750838|364676163|FG001|Overall Study|Lost to Follow-up|6|||
105732639|NCT00778999|364676165|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
105564999|NCT00542880|364065377|FG001|Period 2|Other|1|||
105565000|NCT00542880|364065376|FG000|Period 3|Adverse Event|0|||
105565001|NCT00542880|364065377|FG001|Period 3|Adverse Event|2|||
105732640|NCT00778999|364676166|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
105732641|NCT00778999|364676165|FG000|Overall Study|Did not receive recFSH|14|||
105732642|NCT00778999|364676166|FG001|Overall Study|Did not receive recFSH|20|||
105732643|NCT02032875|364676167|FG000|Treatment Period|Adverse Event|1|||
105732644|NCT02032875|364676168|FG001|Treatment Period|Adverse Event|0|||
105732645|NCT02032875|364676167|FG000|Treatment Period|Liver transplant, No extension needed|0|||
105732646|NCT02032875|364676168|FG001|Treatment Period|Liver transplant, No extension needed|1|||
105732647|NCT02032875|364676167|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
105732648|NCT02032875|364676168|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
105732649|NCT02032875|364676167|FG000|Follow-up Period|Death|0|||
105732650|NCT02032875|364676168|FG001|Follow-up Period|Death|1|||
105732651|NCT02032875|364676167|FG000|Follow-up Period|Virologic Relapse|3|||
105732652|NCT02032875|364676168|FG001|Follow-up Period|Virologic Relapse|10|||
105732653|NCT01853228|364677745|FG000|Phase 1|Lack of Efficacy|8|||
105732654|NCT01853228|364677746|FG001|Phase 1|Lack of Efficacy|0|||
105732655|NCT01853228|364677745|FG000|Phase 1|Other|1|||
105732656|NCT01853228|364677746|FG001|Phase 1|Other|0|||
105732657|NCT01853228|364677745|FG000|Phase 2|Physician Decision|0|||
105732658|NCT01853228|364677746|FG001|Phase 2|Physician Decision|1|||
105732659|NCT01853228|364677745|FG000|Phase 2|Proceed To Transplant|0|||
105732660|NCT01853228|364677746|FG001|Phase 2|Proceed To Transplant|3|||
105732661|NCT01853228|364677745|FG000|Phase 2|Lack of Efficacy|0|||
105732662|NCT01853228|364677746|FG001|Phase 2|Lack of Efficacy|4|||
105732663|NCT03167619|364677748|FG000|Overall Study|Death|11|||
105732664|NCT03167619|364677749|FG001|Overall Study|Death|8|||
105732665|NCT03167619|364677748|FG000|Overall Study|Withdrawal by Subject|1|||
105732666|NCT03167619|364677749|FG001|Overall Study|Withdrawal by Subject|2|||
105732667|NCT03167619|364677748|FG000|Overall Study|Physician Decision|0|||
105732668|NCT03167619|364677749|FG001|Overall Study|Physician Decision|1|||
105732669|NCT01348919|364677752|FG000|Overall Study|Adverse Event|3|||
105732670|NCT01348919|364677753|FG001|Overall Study|Adverse Event|1|||
105732671|NCT01348919|364677754|FG002|Overall Study|Adverse Event|0|||
105732672|NCT01348919|364677752|FG000|Overall Study|Withdrawal by Subject|0|||
105732673|NCT01348919|364677753|FG001|Overall Study|Withdrawal by Subject|1|||
105732674|NCT01348919|364677754|FG002|Overall Study|Withdrawal by Subject|0|||
105732675|NCT01348919|364677752|FG000|Overall Study|Disease progression|0|||
105732676|NCT01348919|364677753|FG001|Overall Study|Disease progression|1|||
105732677|NCT01348919|364677754|FG002|Overall Study|Disease progression|1|||
105732678|NCT01123889|364677755|FG000|Overall Study|Lost to Follow-up|3|||
105732679|NCT01123889|364677756|FG001|Overall Study|Lost to Follow-up|1|||
105732680|NCT02638012|364677761|FG000|Overall Study|Lost to Follow-up|1|||
105732681|NCT03846947|364677762|FG000|Overall Study|technical issues with imaging sequence|2|||
105732682|NCT00174941|364677764|FG000|Overall Study|Adverse Event|1|||
105732683|NCT00174941|364677765|FG001|Overall Study|Adverse Event|10|||
105732684|NCT00174941|364677766|FG002|Overall Study|Adverse Event|2|||
105732685|NCT00174941|364677767|FG003|Overall Study|Adverse Event|13|||
105732686|NCT00174941|364677764|FG000|Overall Study|Protocol Violation|0|||
105732687|NCT00174941|364677765|FG001|Overall Study|Protocol Violation|1|||
105732688|NCT00174941|364677766|FG002|Overall Study|Protocol Violation|0|||
105732689|NCT00174941|364677767|FG003|Overall Study|Protocol Violation|1|||
105732690|NCT00174941|364677764|FG000|Overall Study|Lost to Follow-up|0|||
105732691|NCT00174941|364677765|FG001|Overall Study|Lost to Follow-up|3|||
105732692|NCT00174941|364677766|FG002|Overall Study|Lost to Follow-up|2|||
105732693|NCT00174941|364677767|FG003|Overall Study|Lost to Follow-up|5|||
105732694|NCT00174941|364677764|FG000|Overall Study|Personal Reason(s)|0|||
105732695|NCT00174941|364677765|FG001|Overall Study|Personal Reason(s)|14|||
105732696|NCT00174941|364677766|FG002|Overall Study|Personal Reason(s)|8|||
105732697|NCT00174941|364677767|FG003|Overall Study|Personal Reason(s)|22|||
105732698|NCT00174941|364677764|FG000|Overall Study|Gout Flare|0|||
105732699|NCT00174941|364677765|FG001|Overall Study|Gout Flare|4|||
105732700|NCT00174941|364677766|FG002|Overall Study|Gout Flare|4|||
105732701|NCT00174941|364677767|FG003|Overall Study|Gout Flare|8|||
105732702|NCT00174941|364677764|FG000|Overall Study|Reason Not Specified|1|||
105732703|NCT00174941|364677765|FG001|Overall Study|Reason Not Specified|6|||
105732704|NCT00174941|364677766|FG002|Overall Study|Reason Not Specified|2|||
105797887|NCT01364298|364917625|FG000|Overall Study|Lost to Follow-up|5|||
105565002|NCT03308825|364066656|FG000|Overall Study|Lost to Follow-up|2|||
105732705|NCT00174941|364677767|FG003|Overall Study|Reason Not Specified|9|||
105565003|NCT03308825|364066657|FG001|Overall Study|Lost to Follow-up|2|||
105732706|NCT03126227|364677768|FG000|Overall Study|Adverse Event|43|||
105732707|NCT03126227|364677769|FG001|Overall Study|Adverse Event|4|||
105732708|NCT03126227|364677768|FG000|Overall Study|Death|0|||
105732709|NCT03126227|364677769|FG001|Overall Study|Death|1|||
105732710|NCT03126227|364677768|FG000|Overall Study|Lost to Follow-up|0|||
105732711|NCT03126227|364677769|FG001|Overall Study|Lost to Follow-up|1|||
105732712|NCT03126227|364677768|FG000|Overall Study|Physician Decision|2|||
105732713|NCT03126227|364677769|FG001|Overall Study|Physician Decision|0|||
105732714|NCT03126227|364677768|FG000|Overall Study|Protocol Violation|1|||
105732715|NCT03126227|364677769|FG001|Overall Study|Protocol Violation|0|||
105732716|NCT03126227|364677768|FG000|Overall Study|Withdrawal by Subject|19|||
105732717|NCT03126227|364677769|FG001|Overall Study|Withdrawal by Subject|3|||
105732718|NCT03126227|364677768|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
105732719|NCT03126227|364677769|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
105732720|NCT03126227|364677768|FG000|Overall Study|Lack of dosing compliance|2|||
105732721|NCT03126227|364677769|FG001|Overall Study|Lack of dosing compliance|0|||
105732722|NCT03126227|364677768|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
105732723|NCT03126227|364677769|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
105732724|NCT03126227|364677768|FG000|Overall Study|Scheduling conflict|1|||
105732725|NCT03126227|364677769|FG001|Overall Study|Scheduling conflict|0|||
105732726|NCT00947154|364677776|FG000|Overall Study|Lost to Follow-up|1|||
105732727|NCT01121406|364677781|FG000|Overall Study|Progressive disease RECIST|44|||
105732728|NCT01121406|364677782|FG001|Overall Study|Progressive disease RECIST|28|||
105732729|NCT01121406|364677781|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
105732730|NCT01121406|364677782|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
105732731|NCT01121406|364677781|FG000|Overall Study|Other AE|3|||
105732732|NCT01121406|364677782|FG001|Overall Study|Other AE|10|||
105732733|NCT01121406|364677781|FG000|Overall Study|Non-compliant with protocol|0|||
105732734|NCT01121406|364677782|FG001|Overall Study|Non-compliant with protocol|2|||
105732735|NCT01121406|364677781|FG000|Overall Study|Lost to Follow-up|0|||
105732736|NCT01121406|364677782|FG001|Overall Study|Lost to Follow-up|1|||
105732737|NCT01121406|364677781|FG000|Overall Study|Refused continuation of study med.|1|||
105732738|NCT01121406|364677782|FG001|Overall Study|Refused continuation of study med.|2|||
105732739|NCT01121406|364677781|FG000|Overall Study|Reason other than specified above|2|||
105732740|NCT01121406|364677782|FG001|Overall Study|Reason other than specified above|6|||
105732741|NCT01121406|364677781|FG000|Overall Study|Not treated|1|||
105732742|NCT01121406|364677782|FG001|Overall Study|Not treated|0|||
105732743|NCT00592683|364677790|FG000|Overall Study|Found ineligible|0|||
105732744|NCT00592683|364677791|FG001|Overall Study|Found ineligible|1|||
105732745|NCT00592683|364677790|FG000|Overall Study|Withdrawal by Subject|1|||
105732746|NCT00592683|364677791|FG001|Overall Study|Withdrawal by Subject|0|||
105732747|NCT00592683|364677790|FG000|Overall Study|Adverse Event|0|||
105732748|NCT00592683|364677791|FG001|Overall Study|Adverse Event|2|||
105732749|NCT00592683|364677790|FG000|Overall Study|Protocol Violation|1|||
105732750|NCT00592683|364677791|FG001|Overall Study|Protocol Violation|0|||
105732751|NCT00592683|364677790|FG000|Overall Study|Study drug expired|1|||
105732752|NCT00592683|364677791|FG001|Overall Study|Study drug expired|0|||
105732753|NCT00592683|364677790|FG000|Overall Study|Other|1|||
105732754|NCT00592683|364677791|FG001|Overall Study|Other|0|||
105732755|NCT00592683|364677790|FG000|Overall Study|Lost to Follow-up|0|||
105732756|NCT00592683|364677791|FG001|Overall Study|Lost to Follow-up|1|||
105732757|NCT05309083|364677792|FG000|Overall Study|Withdrawal by Subject|2|||
105732758|NCT00479466|364677794|FG000|Overall Study|Adverse Event|5|||
105732759|NCT00479466|364677795|FG001|Overall Study|Adverse Event|1|||
105732760|NCT00479466|364677796|FG002|Overall Study|Adverse Event|0|||
105732761|NCT00479466|364677797|FG003|Overall Study|Adverse Event|1|||
105732762|NCT00479466|364677798|FG004|Overall Study|Adverse Event|2|||
105732763|NCT00479466|364677799|FG005|Overall Study|Adverse Event|0|||
105732764|NCT00479466|364677794|FG000|Overall Study|Hyperglycemia|0|||
105732765|NCT00479466|364677795|FG001|Overall Study|Hyperglycemia|0|||
105732766|NCT00479466|364677796|FG002|Overall Study|Hyperglycemia|0|||
105732767|NCT00479466|364677797|FG003|Overall Study|Hyperglycemia|0|||
105732768|NCT00479466|364677798|FG004|Overall Study|Hyperglycemia|0|||
105732769|NCT00479466|364677799|FG005|Overall Study|Hyperglycemia|1|||
105732770|NCT00479466|364677794|FG000|Overall Study|Lack of Efficacy|2|||
105732771|NCT00479466|364677795|FG001|Overall Study|Lack of Efficacy|0|||
105732772|NCT00479466|364677796|FG002|Overall Study|Lack of Efficacy|1|||
105732773|NCT00479466|364677797|FG003|Overall Study|Lack of Efficacy|0|||
105732774|NCT00479466|364677798|FG004|Overall Study|Lack of Efficacy|0|||
105732775|NCT00479466|364677799|FG005|Overall Study|Lack of Efficacy|0|||
105732776|NCT00479466|364677794|FG000|Overall Study|Lost to Follow-up|0|||
105732777|NCT00479466|364677795|FG001|Overall Study|Lost to Follow-up|1|||
105732778|NCT00479466|364677796|FG002|Overall Study|Lost to Follow-up|1|||
105732779|NCT00479466|364677797|FG003|Overall Study|Lost to Follow-up|0|||
105732780|NCT00479466|364677798|FG004|Overall Study|Lost to Follow-up|2|||
105732781|NCT00479466|364677799|FG005|Overall Study|Lost to Follow-up|2|||
105732782|NCT00479466|364677794|FG000|Overall Study|Physician Decision|2|||
105732783|NCT00479466|364677795|FG001|Overall Study|Physician Decision|1|||
105732784|NCT00479466|364677796|FG002|Overall Study|Physician Decision|1|||
105732785|NCT00479466|364677797|FG003|Overall Study|Physician Decision|0|||
105732786|NCT00479466|364677798|FG004|Overall Study|Physician Decision|0|||
105732787|NCT00479466|364677799|FG005|Overall Study|Physician Decision|0|||
105732788|NCT00479466|364677794|FG000|Overall Study|Pregnancy|0|||
105732789|NCT00479466|364677795|FG001|Overall Study|Pregnancy|0|||
105732790|NCT00479466|364677796|FG002|Overall Study|Pregnancy|0|||
105732791|NCT00479466|364677797|FG003|Overall Study|Pregnancy|0|||
105732792|NCT00479466|364677798|FG004|Overall Study|Pregnancy|1|||
105353291|NCT01690299|363298523|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
105732793|NCT00479466|364677799|FG005|Overall Study|Pregnancy|0|||
105732794|NCT00479466|364677794|FG000|Overall Study|Protocol Violation|1|||
105732795|NCT00479466|364677795|FG001|Overall Study|Protocol Violation|0|||
105732796|NCT00479466|364677796|FG002|Overall Study|Protocol Violation|0|||
105732797|NCT00479466|364677797|FG003|Overall Study|Protocol Violation|0|||
105732798|NCT00479466|364677798|FG004|Overall Study|Protocol Violation|0|||
105732799|NCT00479466|364677799|FG005|Overall Study|Protocol Violation|0|||
105732800|NCT00479466|364677794|FG000|Overall Study|Withdrawal by Subject|3|||
105732801|NCT00479466|364677795|FG001|Overall Study|Withdrawal by Subject|5|||
105732802|NCT00479466|364677796|FG002|Overall Study|Withdrawal by Subject|0|||
105732803|NCT00479466|364677797|FG003|Overall Study|Withdrawal by Subject|2|||
105732804|NCT00479466|364677798|FG004|Overall Study|Withdrawal by Subject|3|||
105732805|NCT00479466|364677799|FG005|Overall Study|Withdrawal by Subject|1|||
105732806|NCT04283461|364677800|FG000|Overall Study|Enrolled in separate trial|0|||
105732807|NCT04283461|364677801|FG001|Overall Study|Enrolled in separate trial|0|||
105732808|NCT04283461|364677802|FG002|Overall Study|Enrolled in separate trial|8|||
105732809|NCT04283461|364677803|FG003|Overall Study|Enrolled in separate trial|13|||
105732810|NCT04283461|364677804|FG004|Overall Study|Enrolled in separate trial|12|||
105732811|NCT04283461|364677805|FG005|Overall Study|Enrolled in separate trial|0|||
105732812|NCT04283461|364677806|FG006|Overall Study|Enrolled in separate trial|0|||
105732813|NCT04283461|364677807|FG007|Overall Study|Enrolled in separate trial|8|||
105732814|NCT04283461|364677808|FG008|Overall Study|Enrolled in separate trial|0|||
105732815|NCT04283461|364677809|FG009|Overall Study|Enrolled in separate trial|0|||
105732816|NCT04283461|364677810|FG010|Overall Study|Enrolled in separate trial|0|||
105732817|NCT04283461|364677811|FG011|Overall Study|Enrolled in separate trial|7|||
105732818|NCT04283461|364677812|FG012|Overall Study|Enrolled in separate trial|0|||
105732819|NCT02299934|364677813|FG000|Overall Study|Termination of study|13|||
105732820|NCT04651777|364677814|FG000|Overall Study|Adverse Event|1|||
105732821|NCT04651777|364677814|FG000|Overall Study|Withdrawal by Subject|2|||
105732822|NCT00519623|364677815|FG000|Overall Study|Adverse Event|1|||
105732823|NCT00184054|364677816|FG000|Overall Study|Adverse Event|1|||
105732824|NCT04925570|364677817|FG000|Overall Study|Protocol Violation|24|||
105732825|NCT04925570|364677818|FG001|Overall Study|Protocol Violation|30|||
105732826|NCT04925570|364677817|FG000|Overall Study|Withdrawal by Subject|0|||
105732827|NCT04925570|364677818|FG001|Overall Study|Withdrawal by Subject|2|||
105732828|NCT00144300|364677821|FG000|Overall Study|Adverse Event|18|||
105732829|NCT00144300|364677822|FG001|Overall Study|Adverse Event|16|||
105732830|NCT00144300|364677821|FG000|Overall Study|Protocol Violation|1|||
105732831|NCT00144300|364677822|FG001|Overall Study|Protocol Violation|3|||
105732832|NCT00144300|364677821|FG000|Overall Study|Lost to Follow-up|3|||
105732833|NCT00144300|364677822|FG001|Overall Study|Lost to Follow-up|0|||
105732834|NCT00144300|364677821|FG000|Overall Study|Withdrawal by Subject|6|||
105732835|NCT00144300|364677822|FG001|Overall Study|Withdrawal by Subject|6|||
105732836|NCT00144300|364677821|FG000|Overall Study|Other reason (not specified)|1|||
105732837|NCT00144300|364677822|FG001|Overall Study|Other reason (not specified)|3|||
105732838|NCT03478683|364677825|FG000|Overall Study|Adverse Event|5|||
105732839|NCT03478683|364677826|FG001|Overall Study|Adverse Event|3|||
105732840|NCT03478683|364677825|FG000|Overall Study|Lost to Follow-up|0|||
105732841|NCT03478683|364677826|FG001|Overall Study|Lost to Follow-up|5|||
105732842|NCT03478683|364677825|FG000|Overall Study|Physician Decision|1|||
105732843|NCT03478683|364677826|FG001|Overall Study|Physician Decision|3|||
105732844|NCT03478683|364677825|FG000|Overall Study|Withdrawal by Subject|7|||
105732845|NCT03478683|364677826|FG001|Overall Study|Withdrawal by Subject|7|||
105732846|NCT01607892|364677829|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
105732847|NCT01607892|364677830|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
105732848|NCT01607892|364677831|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
105732849|NCT01607892|364677832|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
105732850|NCT01607892|364677833|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
105732851|NCT01607892|364677829|FG000|Overall Study|Death|4|||
105732852|NCT01607892|364677830|FG001|Overall Study|Death|2|||
105732853|NCT01607892|364677831|FG002|Overall Study|Death|8|||
105732854|NCT01607892|364677832|FG003|Overall Study|Death|10|||
105732855|NCT01607892|364677833|FG004|Overall Study|Death|3|||
105732856|NCT01607892|364677829|FG000|Overall Study|Investigator discretion|2|||
105732857|NCT01607892|364677830|FG001|Overall Study|Investigator discretion|4|||
105732858|NCT01607892|364677831|FG002|Overall Study|Investigator discretion|4|||
105732859|NCT01607892|364677832|FG003|Overall Study|Investigator discretion|8|||
105732860|NCT01607892|364677833|FG004|Overall Study|Investigator discretion|0|||
105732861|NCT01607892|364677829|FG000|Overall Study|Other treatments became available|1|||
105732862|NCT01607892|364677830|FG001|Overall Study|Other treatments became available|1|||
105732863|NCT01607892|364677831|FG002|Overall Study|Other treatments became available|0|||
105732864|NCT01607892|364677832|FG003|Overall Study|Other treatments became available|0|||
105732865|NCT01607892|364677833|FG004|Overall Study|Other treatments became available|2|||
105732866|NCT01607892|364677829|FG000|Overall Study|Intercurrent illness|1|||
105732867|NCT01607892|364677830|FG001|Overall Study|Intercurrent illness|0|||
105480401|NCT01133990|363769137|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
105480402|NCT01133990|363769138|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
105480403|NCT01133990|363769139|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
105480404|NCT01133990|363769134|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
105480405|NCT01133990|363769135|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
105480406|NCT01133990|363769136|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
105480407|NCT01133990|363769137|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
105480408|NCT01133990|363769138|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
105480409|NCT01133990|363769139|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
105480410|NCT01133990|363769134|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
105480411|NCT01133990|363769135|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
105480412|NCT01133990|363769136|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
105480413|NCT01133990|363769137|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
105480414|NCT01133990|363769138|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
105480415|NCT01133990|363769139|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
105480416|NCT01133990|363769134|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
105480417|NCT01133990|363769135|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
105480418|NCT01133990|363769136|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
105480419|NCT01133990|363769137|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
105480420|NCT01133990|363769138|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
105480421|NCT01133990|363769139|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
105480422|NCT00567255|363769140|FG000|Overall Study|Adverse Event|241|||
105732868|NCT01607892|364677831|FG002|Overall Study|Intercurrent illness|0|||
105480423|NCT00567255|363769141|FG001|Overall Study|Adverse Event|68|||
105480424|NCT00567255|363769140|FG000|Overall Study|Lost to Follow-up|77|||
105480425|NCT00567255|363769141|FG001|Overall Study|Lost to Follow-up|48|||
105480426|NCT00567255|363769140|FG000|Overall Study|Withdrawal by Subject|75|||
105732869|NCT01607892|364677832|FG003|Overall Study|Intercurrent illness|3|||
105732870|NCT01607892|364677833|FG004|Overall Study|Intercurrent illness|0|||
105732871|NCT01607892|364677829|FG000|Overall Study|Non-Compliance with study procedures|0|||
105732872|NCT01607892|364677830|FG001|Overall Study|Non-Compliance with study procedures|0|||
105732873|NCT01607892|364677831|FG002|Overall Study|Non-Compliance with study procedures|1|||
105732874|NCT01607892|364677832|FG003|Overall Study|Non-Compliance with study procedures|0|||
105732875|NCT01607892|364677833|FG004|Overall Study|Non-Compliance with study procedures|0|||
105732876|NCT01607892|364677829|FG000|Overall Study|Consent withdrawn by participant|9|||
105732877|NCT01607892|364677830|FG001|Overall Study|Consent withdrawn by participant|4|||
105732878|NCT01607892|364677831|FG002|Overall Study|Consent withdrawn by participant|24|||
105732879|NCT01607892|364677832|FG003|Overall Study|Consent withdrawn by participant|14|||
105732880|NCT01607892|364677833|FG004|Overall Study|Consent withdrawn by participant|4|||
105732881|NCT01607892|364677829|FG000|Overall Study|Disease progression|38|||
105732882|NCT01607892|364677830|FG001|Overall Study|Disease progression|13|||
105732883|NCT01607892|364677831|FG002|Overall Study|Disease progression|37|||
105732884|NCT01607892|364677832|FG003|Overall Study|Disease progression|57|||
105732885|NCT01607892|364677833|FG004|Overall Study|Disease progression|9|||
105732886|NCT01607892|364677829|FG000|Overall Study|Incidence or severity of Adverse events|3|||
105732887|NCT01607892|364677830|FG001|Overall Study|Incidence or severity of Adverse events|3|||
105732888|NCT01607892|364677831|FG002|Overall Study|Incidence or severity of Adverse events|7|||
105732889|NCT01607892|364677832|FG003|Overall Study|Incidence or severity of Adverse events|2|||
105732890|NCT01607892|364677833|FG004|Overall Study|Incidence or severity of Adverse events|6|||
105732891|NCT01887210|364677834|FG000|Overall Study|Withdrawal by Subject|1|||
105732892|NCT01887210|364677835|FG001|Overall Study|Withdrawal by Subject|3|||
105732893|NCT01887210|364677834|FG000|Overall Study|Lost to Follow-up|0|||
105732894|NCT01887210|364677835|FG001|Overall Study|Lost to Follow-up|1|||
105480427|NCT00567255|363769141|FG001|Overall Study|Withdrawal by Subject|56|||
105732895|NCT00840463|364677839|FG000|Overall Study|Adverse Event|1|||
105732896|NCT00840463|364677840|FG001|Overall Study|Adverse Event|0|||
105732897|NCT03414359|364677841|FG000|Overall Study|Lack of Efficacy|1|||
105732898|NCT03414359|364677842|FG001|Overall Study|Lack of Efficacy|1|||
105732899|NCT03414359|364677841|FG000|Overall Study|Protocol Violation|0|||
105732900|NCT03414359|364677842|FG001|Overall Study|Protocol Violation|1|||
105732901|NCT02273973|364677843|FG000|Overall Study|Adverse Event|4|||
105732902|NCT02273973|364677844|FG001|Overall Study|Adverse Event|0|||
105732903|NCT02273973|364677843|FG000|Overall Study|Withdrawal by Subject|2|||
105732904|NCT02273973|364677844|FG001|Overall Study|Withdrawal by Subject|3|||
105732905|NCT02273973|364677843|FG000|Overall Study|Death|1|||
105732906|NCT02273973|364677844|FG001|Overall Study|Death|0|||
105732907|NCT02273973|364677843|FG000|Overall Study|Non-compliance|1|||
105732908|NCT02273973|364677844|FG001|Overall Study|Non-compliance|0|||
105732909|NCT02273973|364677843|FG000|Overall Study|Protocol Violation|1|||
105732910|NCT02273973|364677844|FG001|Overall Study|Protocol Violation|0|||
105732911|NCT02273973|364677843|FG000|Overall Study|Progression of disease|0|||
105732912|NCT02273973|364677844|FG001|Overall Study|Progression of disease|2|||
105732913|NCT02273973|364677843|FG000|Overall Study|Lost to Follow-up|0|||
105732914|NCT02273973|364677844|FG001|Overall Study|Lost to Follow-up|1|||
105732915|NCT02273973|364677843|FG000|Overall Study|Physician Decision|0|||
105732916|NCT02273973|364677844|FG001|Overall Study|Physician Decision|1|||
105732917|NCT02273973|364677843|FG000|Overall Study|Reason not specified|0|||
105732918|NCT02273973|364677844|FG001|Overall Study|Reason not specified|1|||
105732919|NCT02704429|364677847|FG000|Part A: 24 Weeks|Adverse Event|3|||
105732920|NCT02704429|364677848|FG001|Part A: 24 Weeks|Adverse Event|0|||
105732921|NCT02704429|364677847|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
105732922|NCT02704429|364677848|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
105732923|NCT01287117|364677852|FG000|Overall Study|Adverse Event|2|||
105732924|NCT01287117|364677853|FG001|Overall Study|Adverse Event|1|||
105732925|NCT01287117|364677854|FG002|Overall Study|Adverse Event|1|||
105732926|NCT01287117|364677855|FG003|Overall Study|Adverse Event|1|||
105732927|NCT01287117|364677852|FG000|Overall Study|Lost to Follow-up|1|||
105732928|NCT01287117|364677853|FG001|Overall Study|Lost to Follow-up|1|||
105732929|NCT01287117|364677854|FG002|Overall Study|Lost to Follow-up|0|||
105732930|NCT01287117|364677855|FG003|Overall Study|Lost to Follow-up|0|||
105732931|NCT01287117|364677852|FG000|Overall Study|Physician Decision|0|||
105732932|NCT01287117|364677853|FG001|Overall Study|Physician Decision|1|||
105732933|NCT01287117|364677854|FG002|Overall Study|Physician Decision|1|||
105732934|NCT01287117|364677855|FG003|Overall Study|Physician Decision|1|||
105732935|NCT01287117|364677852|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
105732936|NCT01287117|364677853|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
105732937|NCT01287117|364677854|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
105732938|NCT01287117|364677855|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
105732939|NCT01287117|364677852|FG000|Overall Study|Disease Progression|10|||
105732940|NCT01287117|364677853|FG001|Overall Study|Disease Progression|5|||
105732941|NCT01287117|364677854|FG002|Overall Study|Disease Progression|6|||
105732942|NCT01287117|364677855|FG003|Overall Study|Disease Progression|5|||
105732943|NCT02032524|364677858|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
105732944|NCT02032524|364677859|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
105732945|NCT02032524|364677860|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
105732946|NCT02032524|364677861|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
105732947|NCT02032524|364677862|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
105732948|NCT02032524|364677863|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
105732949|NCT02032524|364677858|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
105732950|NCT02032524|364677859|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
105732951|NCT02032524|364677860|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
105732952|NCT02032524|364677861|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
105732953|NCT02032524|364677862|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
105732954|NCT02032524|364677863|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
105732955|NCT02032524|364677858|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
105732956|NCT02032524|364677859|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
105732957|NCT02032524|364677860|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
105732958|NCT02032524|364677861|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
105732959|NCT02032524|364677862|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
105732960|NCT02032524|364677863|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
105732961|NCT02032524|364677858|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
105732962|NCT02032524|364677859|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
105732963|NCT02032524|364677860|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
105732964|NCT02032524|364677861|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
105732965|NCT02032524|364677862|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
105732966|NCT02032524|364677863|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
105732967|NCT02032524|364677858|FG000|Period 2: LTS13769 Study|Other|0|||
105732968|NCT02032524|364677859|FG001|Period 2: LTS13769 Study|Other|0|||
105732969|NCT02032524|364677860|FG002|Period 2: LTS13769 Study|Other|0|||
105732970|NCT02032524|364677861|FG003|Period 2: LTS13769 Study|Other|0|||
105732971|NCT02032524|364677862|FG004|Period 2: LTS13769 Study|Other|0|||
105732972|NCT02032524|364677863|FG005|Period 2: LTS13769 Study|Other|1|||
105797888|NCT01364298|364917626|FG001|Overall Study|Lost to Follow-up|10|||
105797889|NCT01364298|364917625|FG000|Overall Study|Withdrawal by Subject|3|||
105797890|NCT01364298|364917626|FG001|Overall Study|Withdrawal by Subject|3|||
105797891|NCT01364298|364917625|FG000|Overall Study|Other|1|||
105797892|NCT01364298|364917626|FG001|Overall Study|Other|3|||
105797893|NCT00420849|364917627|FG000|Overall Study|Lack of Efficacy|154|||
105480428|NCT00567255|363769140|FG000|Overall Study|Lack of Efficacy|19|||
105480429|NCT00567255|363769141|FG001|Overall Study|Lack of Efficacy|33|||
105480430|NCT00567255|363769140|FG000|Overall Study|Protocol Violation|20|||
105480431|NCT00567255|363769141|FG001|Overall Study|Protocol Violation|8|||
105480432|NCT00567255|363769140|FG000|Overall Study|Pregnancy|6|||
105480433|NCT00567255|363769141|FG001|Overall Study|Pregnancy|0|||
105480434|NCT00567255|363769140|FG000|Overall Study|Drug noncompliance,moved,other|25|||
105480435|NCT00567255|363769141|FG001|Overall Study|Drug noncompliance,moved,other|15|||
105565004|NCT03308825|364066658|FG002|Overall Study|Lost to Follow-up|1|||
105732973|NCT00907738|364677871|FG000|Overall Study|Adverse Event|2|||
105732974|NCT00907738|364677872|FG001|Overall Study|Adverse Event|0|||
105732975|NCT00907738|364677873|FG002|Overall Study|Adverse Event|1|||
105732976|NCT00907738|364677874|FG003|Overall Study|Adverse Event|0|||
105732977|NCT00907738|364677875|FG004|Overall Study|Adverse Event|0|||
105732978|NCT00907738|364677871|FG000|Overall Study|not specified or withdrew consent|3|||
105732979|NCT00907738|364677872|FG001|Overall Study|not specified or withdrew consent|0|||
105732980|NCT00907738|364677873|FG002|Overall Study|not specified or withdrew consent|0|||
105732981|NCT00907738|364677874|FG003|Overall Study|not specified or withdrew consent|0|||
105732982|NCT00907738|364677875|FG004|Overall Study|not specified or withdrew consent|0|||
105732983|NCT00907738|364677871|FG000|Overall Study|Disease progression|8|||
105732984|NCT00907738|364677872|FG001|Overall Study|Disease progression|1|||
105732985|NCT00907738|364677873|FG002|Overall Study|Disease progression|6|||
105732986|NCT00907738|364677874|FG003|Overall Study|Disease progression|4|||
105732987|NCT00907738|364677875|FG004|Overall Study|Disease progression|2|||
105732988|NCT02031146|364679274|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
105732989|NCT02031146|364679275|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
105732990|NCT02031146|364679276|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
105732991|NCT02031146|364679277|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
105732992|NCT02031146|364679278|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
105732993|NCT02031146|364679279|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
105732994|NCT02031146|364679280|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
105732995|NCT01518699|364679281|FG000|Period 2|Protocol Violation|1|||
105732996|NCT01518699|364679282|FG001|Period 2|Protocol Violation|1|||
105732997|NCT01518699|364679283|FG002|Period 2|Protocol Violation|0|||
105732998|NCT01518699|364679284|FG003|Period 2|Protocol Violation|0|||
105732999|NCT01518699|364679285|FG004|Period 2|Protocol Violation|0|||
105733000|NCT01518699|364679286|FG005|Period 2|Protocol Violation|0|||
105733001|NCT01518699|364679281|FG000|Period 2|Lost to Follow-up|0|||
105733002|NCT01518699|364679282|FG001|Period 2|Lost to Follow-up|1|||
105733003|NCT01518699|364679283|FG002|Period 2|Lost to Follow-up|0|||
105733004|NCT01518699|364679284|FG003|Period 2|Lost to Follow-up|0|||
105733005|NCT01518699|364679285|FG004|Period 2|Lost to Follow-up|0|||
105733006|NCT01518699|364679286|FG005|Period 2|Lost to Follow-up|0|||
105733007|NCT01518699|364679281|FG000|Period 2|Adverse Event|1|||
105733008|NCT01518699|364679282|FG001|Period 2|Adverse Event|0|||
105733009|NCT01518699|364679283|FG002|Period 2|Adverse Event|0|||
105733010|NCT01518699|364679284|FG003|Period 2|Adverse Event|0|||
105733011|NCT01518699|364679285|FG004|Period 2|Adverse Event|0|||
105733012|NCT01518699|364679286|FG005|Period 2|Adverse Event|0|||
105733013|NCT00443560|364679288|FG000|Overall Study|No intrathecal dose|58|||
105733014|NCT00443560|364679289|FG001|Overall Study|No intrathecal dose|26|||
105733015|NCT00443560|364679288|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
105733016|NCT00443560|364679289|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
105733017|NCT01943539|364679290|FG000|Overall Study|Non-compliance with at-home intervention|4|||
105733018|NCT01943539|364679291|FG001|Overall Study|Non-compliance with at-home intervention|0|||
105733019|NCT01009463|364679294|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
105733020|NCT01009463|364679295|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105733021|NCT01009463|364679296|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105733022|NCT01009463|364679297|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105733023|NCT01009463|364679298|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105733024|NCT01009463|364679294|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
105733025|NCT01009463|364679295|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
105733026|NCT01009463|364679296|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
105733027|NCT01009463|364679297|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
105733028|NCT01009463|364679298|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
105797894|NCT00420849|364917627|FG000|Overall Study|Adverse Event|107|||
105797895|NCT00420849|364917627|FG000|Overall Study|Withdrawal by Subject|28|||
105480436|NCT04136444|363769147|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
105733029|NCT01009463|364679294|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
105733030|NCT01009463|364679295|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105733031|NCT01009463|364679296|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105733032|NCT01009463|364679297|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105733033|NCT01009463|364679298|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105733034|NCT01009463|364679294|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
105733035|NCT01009463|364679295|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
105733036|NCT01009463|364679296|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
105733037|NCT01009463|364679297|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
105733038|NCT01009463|364679298|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
105733039|NCT01009463|364679294|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
105733040|NCT01009463|364679295|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105733041|NCT01009463|364679296|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105733042|NCT01009463|364679297|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105733043|NCT01009463|364679298|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105733044|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
105733045|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
105733046|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
105733047|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
105733048|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
105733049|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
105733050|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
105733051|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
105733052|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
105733053|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
105733054|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
105733055|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
105733056|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
105733057|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
105733058|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
105733059|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
105733060|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
105733061|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
105733062|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
105733063|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
105733064|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
105733065|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
105733066|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
105733067|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
105733068|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
105733069|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
105733070|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
105733071|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
105733072|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
105733073|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
105733074|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105733075|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
105733076|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
105733077|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
105733078|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
105733079|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
105733080|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
105733081|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
105733082|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
105733083|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
105733084|NCT01966731|364679313|FG000|Overall Study|Death|2|||
105733085|NCT01966731|364679313|FG000|Overall Study|Lost to Follow-up|1|||
105733086|NCT01966731|364679313|FG000|Overall Study|Physician Decision|2|||
105733087|NCT01966731|364679313|FG000|Overall Study|Follow up is not complete|600|||
105733088|NCT01966731|364679313|FG000|Overall Study|Screening Failure|29|||
105733089|NCT01966731|364679313|FG000|Overall Study|Found to be ineligible|1|||
105733090|NCT02088034|364679314|FG000|Overall Study|Lost to Follow-up|1|||
105733091|NCT02088034|364679315|FG001|Overall Study|Lost to Follow-up|1|||
105733092|NCT02088034|364679316|FG002|Overall Study|Lost to Follow-up|0|||
105733093|NCT02088034|364679314|FG000|Overall Study|Pregnancy|2|||
105797896|NCT00420849|364917627|FG000|Overall Study|Death|18|||
105797897|NCT00420849|364917627|FG000|Overall Study|Other|14|||
105797898|NCT00420849|364917627|FG000|Overall Study|Transplant|8|||
105797899|NCT00420849|364917627|FG000|Overall Study|Protocol Violation|1|||
105797900|NCT00420849|364917627|FG000|Overall Study|Lost to Follow-up|1|||
105797901|NCT02139306|364917628|FG000|Overall Study|Withdrawal by Subject|4|||
105797902|NCT02139306|364917629|FG001|Overall Study|Withdrawal by Subject|6|||
105797903|NCT02139306|364917628|FG000|Overall Study|Adverse Event|3|||
105797904|NCT02139306|364917629|FG001|Overall Study|Adverse Event|4|||
105797905|NCT02139306|364917628|FG000|Overall Study|Physician Decision|0|||
105797906|NCT02139306|364917629|FG001|Overall Study|Physician Decision|1|||
105797907|NCT02139306|364917628|FG000|Overall Study|Other Unspecified|2|||
105797908|NCT02139306|364917629|FG001|Overall Study|Other Unspecified|3|||
105797909|NCT02139306|364917628|FG000|Overall Study|Protocol Violation|4|||
105797910|NCT02139306|364917629|FG001|Overall Study|Protocol Violation|0|||
105797911|NCT01021137|364917634|FG000|Overall Study|Lost to Follow-up|9|||
105797912|NCT01021137|364917635|FG001|Overall Study|Lost to Follow-up|4|||
105797913|NCT01021137|364917636|FG002|Overall Study|Lost to Follow-up|2|||
105797914|NCT01021137|364917637|FG003|Overall Study|Lost to Follow-up|6|||
105797915|NCT01021137|364917634|FG000|Overall Study|Withdrawal by Subject|1|||
105797916|NCT01021137|364917635|FG001|Overall Study|Withdrawal by Subject|0|||
105797917|NCT01021137|364917636|FG002|Overall Study|Withdrawal by Subject|0|||
105797918|NCT01021137|364917637|FG003|Overall Study|Withdrawal by Subject|3|||
105797919|NCT03439293|364917638|FG000|Overall Study|Death|22|||
105797920|NCT03439293|364917638|FG000|Overall Study|Withdrawal by Subject|8|||
105797921|NCT03439293|364917638|FG000|Overall Study|Lost to Follow-up|2|||
105797922|NCT03439293|364917638|FG000|Overall Study|Reason Not Specified|28|||
105797923|NCT03439293|364917638|FG000|Overall Study|Missing|1|||
105797924|NCT03499249|364917646|FG000|Overall Study|Physician Decision|1|||
105797925|NCT01374906|364917647|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105797926|NCT01374906|364917648|FG001|Overall Study|Abnormal laboratory value(s)|3|||
105797927|NCT01374906|364917647|FG000|Overall Study|Administrative problems|2|||
105797928|NCT01374906|364917648|FG001|Overall Study|Administrative problems|2|||
105797929|NCT01374906|364917647|FG000|Overall Study|Adverse Event|10|||
105797930|NCT01374906|364917648|FG001|Overall Study|Adverse Event|11|||
105797931|NCT01374906|364917647|FG000|Overall Study|Death|0|||
105797932|NCT01374906|364917648|FG001|Overall Study|Death|2|||
105797933|NCT01374906|364917647|FG000|Overall Study|Protocol Violation|2|||
105797934|NCT01374906|364917648|FG001|Overall Study|Protocol Violation|2|||
105797935|NCT01374906|364917647|FG000|Overall Study|Withdrawal by Subject|15|||
105797936|NCT01374906|364917648|FG001|Overall Study|Withdrawal by Subject|9|||
105797937|NCT01374906|364917647|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
105797938|NCT01374906|364917648|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
105797939|NCT00665626|364917654|FG000|Overall Study|Lack of Efficacy|8|||
105797940|NCT00665626|364917655|FG001|Overall Study|Lack of Efficacy|5|||
105797941|NCT00665626|364917654|FG000|Overall Study|Lost to Follow-up|0|||
105797942|NCT00665626|364917655|FG001|Overall Study|Lost to Follow-up|2|||
105797943|NCT00665626|364917654|FG000|Overall Study|Withdrawal by Subject|0|||
105797944|NCT00665626|364917655|FG001|Overall Study|Withdrawal by Subject|1|||
105797945|NCT00665626|364917654|FG000|Overall Study|Protocol Violation|0|||
105797946|NCT00665626|364917655|FG001|Overall Study|Protocol Violation|2|||
105797947|NCT00665626|364917654|FG000|Overall Study|Adverse Event|1|||
105797948|NCT00665626|364917655|FG001|Overall Study|Adverse Event|9|||
105797949|NCT00665626|364917654|FG000|Overall Study|Due to exclusion criteria|0|||
105797950|NCT00665626|364917655|FG001|Overall Study|Due to exclusion criteria|1|||
105797951|NCT00665626|364917654|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
105797952|NCT00665626|364917655|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
105797953|NCT00665626|364917654|FG000|Overall Study|Unably to comply with dosing regimen|0|||
105797954|NCT00665626|364917655|FG001|Overall Study|Unably to comply with dosing regimen|1|||
105797955|NCT00665626|364917654|FG000|Overall Study|Death|1|||
105797956|NCT00665626|364917655|FG001|Overall Study|Death|0|||
105797957|NCT00585039|364917656|FG000|Overall Study|medication spilled|2|||
105797958|NCT00585039|364917657|FG001|Overall Study|medication spilled|0|||
105797959|NCT04147611|364917658|FG000|Overall Study|Physician Decision|0|||
105797960|NCT04147611|364917659|FG001|Overall Study|Physician Decision|1|||
105480437|NCT04136444|363769148|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
105480438|NCT01565343|363769149|FG000|Overall Study|Administrative decision/technical issues|1|||
105480439|NCT01565343|363769150|FG001|Overall Study|Administrative decision/technical issues|0|||
105797961|NCT02046369|364917660|FG000|Overall Study|Adverse Event|3|||
105797962|NCT02046369|364917661|FG001|Overall Study|Adverse Event|3|||
105797963|NCT02046369|364917660|FG000|Overall Study|Lack of Efficacy|3|||
105797964|NCT02046369|364917661|FG001|Overall Study|Lack of Efficacy|3|||
105797965|NCT02046369|364917660|FG000|Overall Study|Lost to Follow-up|3|||
105797966|NCT02046369|364917661|FG001|Overall Study|Lost to Follow-up|3|||
105797967|NCT02046369|364917660|FG000|Overall Study|Protocol Violation|1|||
105797968|NCT02046369|364917661|FG001|Overall Study|Protocol Violation|2|||
105797969|NCT02046369|364917660|FG000|Overall Study|Withdrawal by Subject|3|||
105797970|NCT02046369|364917661|FG001|Overall Study|Withdrawal by Subject|6|||
105797971|NCT02046369|364917660|FG000|Overall Study|never received study drug|0|||
105797972|NCT02046369|364917661|FG001|Overall Study|never received study drug|1|||
105797973|NCT02046369|364917660|FG000|Overall Study|non compliance|1|||
105797974|NCT02046369|364917661|FG001|Overall Study|non compliance|0|||
105797975|NCT01529749|364917662|FG000|Overall Study|Lost to Follow-up|0|||
105797976|NCT01529749|364917663|FG001|Overall Study|Lost to Follow-up|1|||
105797977|NCT01529749|364917664|FG002|Overall Study|Lost to Follow-up|1|||
105797978|NCT01529749|364917665|FG003|Overall Study|Lost to Follow-up|0|||
105797979|NCT01529749|364917662|FG000|Overall Study|Physician Decision|0|||
105797980|NCT01529749|364917663|FG001|Overall Study|Physician Decision|0|||
105797981|NCT01529749|364917664|FG002|Overall Study|Physician Decision|0|||
105797982|NCT01529749|364917665|FG003|Overall Study|Physician Decision|1|||
105797983|NCT01529749|364917662|FG000|Overall Study|Withdrawal by Subject|0|||
105797984|NCT01529749|364917663|FG001|Overall Study|Withdrawal by Subject|1|||
105797985|NCT01529749|364917664|FG002|Overall Study|Withdrawal by Subject|1|||
105797986|NCT01529749|364917665|FG003|Overall Study|Withdrawal by Subject|0|||
105797987|NCT01529749|364917662|FG000|Overall Study|Protocol Violation|0|||
105797988|NCT01529749|364917663|FG001|Overall Study|Protocol Violation|0|||
105797989|NCT01529749|364917664|FG002|Overall Study|Protocol Violation|0|||
105797990|NCT01529749|364917665|FG003|Overall Study|Protocol Violation|1|||
105797991|NCT03724968|364919187|FG000|Overall Study|Insurance issues|0|||
105797992|NCT03724968|364919188|FG001|Overall Study|Insurance issues|1|||
105797993|NCT03724968|364919187|FG000|Overall Study|Study closed|0|||
105797994|NCT03724968|364919188|FG001|Overall Study|Study closed|1|||
105797995|NCT03053622|364919192|FG000|Overall Study|Lost to Follow-up|0|||
105797996|NCT03053622|364919193|FG001|Overall Study|Lost to Follow-up|0|||
105797997|NCT03053622|364919194|FG002|Overall Study|Lost to Follow-up|0|||
105797998|NCT03053622|364919195|FG003|Overall Study|Lost to Follow-up|1|||
105797999|NCT01422720|364919196|FG000|Overall Study|Adverse Event|16|||
105798000|NCT01422720|364919196|FG000|Overall Study|Lack of Efficacy|1|||
105798001|NCT01422720|364919196|FG000|Overall Study|Withdrawal by Subject|4|||
105798002|NCT01422720|364919196|FG000|Overall Study|Ineligibility|1|||
105798003|NCT01726335|364919197|FG000|Overall Study|Lost to Follow-up|2|||
105798004|NCT01726335|364919197|FG000|Overall Study|Withdrawal by Subject|15|||
105798005|NCT01726335|364919197|FG000|Overall Study|Adverse Event|4|||
105798006|NCT01726335|364919197|FG000|Overall Study|Lost to Follow-up|2|||
105798007|NCT01726335|364919197|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
105798008|NCT01074307|364919198|FG000|Overall Study|No primary endpoint evaluation|14|||
105798009|NCT01074307|364919199|FG001|Overall Study|No primary endpoint evaluation|6|||
105798010|NCT01074307|364919198|FG000|Overall Study|Exclusion criterion|0|||
105798011|NCT01074307|364919199|FG001|Overall Study|Exclusion criterion|1|||
105798012|NCT01074307|364919198|FG000|Overall Study|Protocol Violation|8|||
105798013|NCT01074307|364919199|FG001|Overall Study|Protocol Violation|5|||
105798014|NCT01796860|364919200|FG000|Overall Study|Withdrawal by Subject|3|||
105798015|NCT01084603|364919208|FG000|Baseline|Withdrawal by Subject|2|||
105798016|NCT01084603|364919208|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
105798017|NCT01084603|364919208|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
105798018|NCT01084603|364919208|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
105798019|NCT01084603|364919208|FG000|Washout Period 4|Adverse Event|1|||
105798020|NCT04335110|364919209|FG000|Overall Study|Withdrawal by Subject|1|||
105798021|NCT04335110|364919210|FG001|Overall Study|Withdrawal by Subject|1|||
105798022|NCT04335110|364919209|FG000|Overall Study|Death|0|||
105798023|NCT04335110|364919210|FG001|Overall Study|Death|1|||
105798024|NCT00350519|364919212|FG000|Overall Study|Death|0|||
105798025|NCT00350519|364919213|FG001|Overall Study|Death|1|||
105798026|NCT00350519|364919212|FG000|Overall Study|Physician Decision|0|||
105798027|NCT00350519|364919213|FG001|Overall Study|Physician Decision|1|||
105798028|NCT00350519|364919212|FG000|Overall Study|Protocol Violation|1|||
105798029|NCT00350519|364919213|FG001|Overall Study|Protocol Violation|2|||
105798030|NCT00350519|364919212|FG000|Overall Study|Withdrawal by Subject|3|||
105798031|NCT00350519|364919213|FG001|Overall Study|Withdrawal by Subject|2|||
105798032|NCT03101293|364919216|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
105798033|NCT03101293|364919217|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
105798034|NCT00068406|364919224|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
105798035|NCT00068406|364919224|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
105565005|NCT03308825|364066659|FG003|Overall Study|Lost to Follow-up|0|||
105798036|NCT02609178|364919228|FG000|First Crown|Withdrawal by Subject|0|||
105798037|NCT02609178|364919229|FG001|First Crown|Withdrawal by Subject|0|||
105798038|NCT02609178|364919230|FG002|First Crown|Withdrawal by Subject|1|||
105798039|NCT02609178|364919231|FG003|First Crown|Withdrawal by Subject|1|||
105798040|NCT02609178|364919232|FG004|First Crown|Withdrawal by Subject|0|||
105565006|NCT03308825|364066656|FG000|Overall Study|Protocol Violation|0|||
105798041|NCT02609178|364919233|FG005|First Crown|Withdrawal by Subject|0|||
105798042|NCT00331773|364919234|FG000|Overall Study|Withdrawal by Subject|6|||
105798043|NCT00331773|364919235|FG001|Overall Study|Withdrawal by Subject|4|||
105798044|NCT00331773|364919234|FG000|Overall Study|Protocol Violation|10|||
105565007|NCT03308825|364066657|FG001|Overall Study|Protocol Violation|2|||
105798045|NCT00331773|364919235|FG001|Overall Study|Protocol Violation|3|||
105798046|NCT00289731|364919236|FG000|Overall Study|Adverse Event|1|||
105798047|NCT00289731|364919237|FG001|Overall Study|Adverse Event|2|||
105798048|NCT00289731|364919238|FG002|Overall Study|Adverse Event|2|||
105798049|NCT00289731|364919236|FG000|Overall Study|Other|1|||
105798050|NCT00289731|364919237|FG001|Overall Study|Other|0|||
105798051|NCT00289731|364919238|FG002|Overall Study|Other|0|||
105798052|NCT04378010|364919239|FG000|Overall Study|Adverse Event|8|||
105798053|NCT04378010|364919240|FG001|Overall Study|Adverse Event|14|||
105798054|NCT04378010|364919241|FG002|Overall Study|Adverse Event|4|||
105798055|NCT04378010|364919239|FG000|Overall Study|Withdrawal by Subject|0|||
105798056|NCT04378010|364919240|FG001|Overall Study|Withdrawal by Subject|2|||
105798057|NCT04378010|364919241|FG002|Overall Study|Withdrawal by Subject|1|||
105798058|NCT04378010|364919239|FG000|Overall Study|Protocol Violation|2|||
105798059|NCT04378010|364919240|FG001|Overall Study|Protocol Violation|1|||
105798060|NCT04378010|364919241|FG002|Overall Study|Protocol Violation|4|||
105798061|NCT04378010|364919239|FG000|Overall Study|Study terminated by Sponsor|22|||
105798062|NCT04378010|364919240|FG001|Overall Study|Study terminated by Sponsor|16|||
105798063|NCT04378010|364919241|FG002|Overall Study|Study terminated by Sponsor|22|||
105798064|NCT04378010|364919239|FG000|Overall Study|Subject inability to complete study visit|0|||
105798065|NCT04378010|364919240|FG001|Overall Study|Subject inability to complete study visit|0|||
105798066|NCT04378010|364919241|FG002|Overall Study|Subject inability to complete study visit|1|||
105798067|NCT04378010|364919239|FG000|Overall Study|Subject never dosed|0|||
105798068|NCT04378010|364919240|FG001|Overall Study|Subject never dosed|1|||
105798069|NCT04378010|364919241|FG002|Overall Study|Subject never dosed|0|||
105798070|NCT02513459|364919242|FG000|Overall Study|Adverse Event|7|||
105798071|NCT02513459|364919242|FG000|Overall Study|Withdrew consent|5|||
105798072|NCT02513459|364919242|FG000|Overall Study|Loss of efficacy|2|||
105798073|NCT02513459|364919242|FG000|Overall Study|Pregnancy|2|||
105798074|NCT02513459|364919242|FG000|Overall Study|Subject decision|2|||
105798075|NCT02513459|364919242|FG000|Overall Study|Lack of response|1|||
105798076|NCT02513459|364919242|FG000|Overall Study|Reproductive plans|1|||
105798077|NCT02513459|364919242|FG000|Overall Study|Surgery planned-- not done|1|||
105798078|NCT00379587|364919243|FG000|Overall Study|Lost to Follow-up|2|||
105798079|NCT03237611|364919244|FG000|Overall Study|Withdrawal by Subject|1|||
105798080|NCT03237611|364919244|FG000|Overall Study|Ineligible|1|||
105798081|NCT01440595|364919249|FG000|Overall Study|Lost to Follow-up|0|||
105798082|NCT01440595|364919250|FG001|Overall Study|Lost to Follow-up|1|||
105798083|NCT01440595|364919251|FG002|Overall Study|Lost to Follow-up|0|||
105798084|NCT01440595|364919249|FG000|Overall Study|Study terminated by sponsor.|1|||
105798085|NCT01440595|364919250|FG001|Overall Study|Study terminated by sponsor.|2|||
105798086|NCT01440595|364919251|FG002|Overall Study|Study terminated by sponsor.|1|||
105798087|NCT01347879|364919252|FG000|Overall Study|Adverse Event|0|||
105798088|NCT01347879|364919253|FG001|Overall Study|Adverse Event|12|||
105798089|NCT01347879|364919252|FG000|Overall Study|Lost to Follow-up|2|||
105798090|NCT01347879|364919253|FG001|Overall Study|Lost to Follow-up|0|||
105798091|NCT01347879|364919252|FG000|Overall Study|Withdrawal by Subject|3|||
105798092|NCT01347879|364919253|FG001|Overall Study|Withdrawal by Subject|2|||
105798093|NCT01347879|364919252|FG000|Overall Study|Other|2|||
105798094|NCT01347879|364919253|FG001|Overall Study|Other|3|||
105798095|NCT01223196|364919254|FG000|Overall Study|Lost to Follow-up|2|||
105798096|NCT01223196|364919255|FG001|Overall Study|Lost to Follow-up|0|||
105798097|NCT01223196|364919254|FG000|Overall Study|Physician Decision|1|||
105798098|NCT01223196|364919255|FG001|Overall Study|Physician Decision|0|||
105798099|NCT01223196|364919254|FG000|Overall Study|Withdrawal by Subject|1|||
105798100|NCT01223196|364919255|FG001|Overall Study|Withdrawal by Subject|0|||
105798101|NCT02629133|364919256|FG000|Overall Study|Lost to Follow-up|3|||
105798102|NCT02629133|364919257|FG001|Overall Study|Lost to Follow-up|1|||
105798103|NCT02629133|364919256|FG000|Overall Study|Withdrawal by Subject|1|||
105798104|NCT02629133|364919257|FG001|Overall Study|Withdrawal by Subject|1|||
105798105|NCT02598193|364919258|FG000|Overall Study|Adverse Event|13|||
105798106|NCT02598193|364919258|FG000|Overall Study|Withdrawal by Subject|1|||
105798107|NCT02598193|364919258|FG000|Overall Study|Listed in active lung transplant list|1|||
105798108|NCT02598193|364919258|FG000|Overall Study|Does not want to take Nintedanib|1|||
105798109|NCT00837577|364919261|FG000|Double-blind Period|Clinical Adverse Event|1|||
105798110|NCT00837577|364919262|FG001|Double-blind Period|Clinical Adverse Event|0|||
105480440|NCT01565343|363769151|FG002|Overall Study|Administrative decision/technical issues|0|||
105798111|NCT00837577|364919261|FG000|Double-blind Period|Withdrawal by Subject|1|||
105798112|NCT00837577|364919262|FG001|Double-blind Period|Withdrawal by Subject|0|||
105798113|NCT00837577|364919261|FG000|Open-label Period|Clinical Adverse Event|2|||
105798114|NCT00837577|364919262|FG001|Open-label Period|Clinical Adverse Event|2|||
105798115|NCT00837577|364919261|FG000|Open-label Period|Laboratory Adverse Event|0|||
105798116|NCT00837577|364919262|FG001|Open-label Period|Laboratory Adverse Event|1|||
105798117|NCT00837577|364919261|FG000|Open-label Period|Lack of Efficacy|4|||
105798118|NCT00837577|364919262|FG001|Open-label Period|Lack of Efficacy|3|||
105798119|NCT00837577|364919261|FG000|Open-label Period|Withdrawal by Subject|1|||
105798120|NCT00837577|364919262|FG001|Open-label Period|Withdrawal by Subject|2|||
105798121|NCT00837577|364919261|FG000|Open-label Period|Other Reason|1|||
105798122|NCT00837577|364919262|FG001|Open-label Period|Other Reason|1|||
105798123|NCT00068445|364919270|FG000|Randomization|Cancel|1|||
105798124|NCT00068445|364919271|FG001|Randomization|Cancel|3|||
105733094|NCT02088034|364679315|FG001|Overall Study|Pregnancy|1|||
105733095|NCT02088034|364679316|FG002|Overall Study|Pregnancy|2|||
105733096|NCT01937312|364679318|FG000|Overall Study|Adverse Event|10|||
105733097|NCT01937312|364679319|FG001|Overall Study|Adverse Event|1|||
105733098|NCT01937312|364679318|FG000|Overall Study|Lack of Efficacy|0|||
105733099|NCT01937312|364679319|FG001|Overall Study|Lack of Efficacy|1|||
105733100|NCT01937312|364679318|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
105733101|NCT01937312|364679319|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
105733102|NCT03215277|364679321|FG000|Overall Study|Adverse Event|2|||
105733103|NCT03215277|364679322|FG001|Overall Study|Adverse Event|3|||
105733104|NCT03215277|364679321|FG000|Overall Study|Death|1|||
105733105|NCT03215277|364679322|FG001|Overall Study|Death|0|||
105733106|NCT03215277|364679321|FG000|Overall Study|Lost to Follow-up|0|||
105733107|NCT03215277|364679322|FG001|Overall Study|Lost to Follow-up|1|||
105733108|NCT03215277|364679321|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
105733109|NCT03215277|364679322|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
105733110|NCT00201201|364679328|FG000|Overall Study|Death|0|||
105733111|NCT00201201|364679329|FG001|Overall Study|Death|2|||
105733112|NCT00201201|364679328|FG000|Overall Study|Withdrawal by Subject|5|||
105733113|NCT00201201|364679329|FG001|Overall Study|Withdrawal by Subject|5|||
105733114|NCT00609609|364679337|FG000|Overall Study|Withdrawal by Subject|2|||
105733115|NCT00609609|364679338|FG001|Overall Study|Withdrawal by Subject|0|||
105733116|NCT00609609|364679337|FG000|Overall Study|Progression|4|||
105733117|NCT00609609|364679338|FG001|Overall Study|Progression|2|||
105733118|NCT00670111|364679340|FG000|Enrollment to One Month|Testing Failure|0|||
105733119|NCT00670111|364679341|FG001|Enrollment to One Month|Testing Failure|0|||
105565008|NCT03308825|364066658|FG002|Overall Study|Protocol Violation|0|||
105565009|NCT03308825|364066659|FG003|Overall Study|Protocol Violation|0|||
105565010|NCT00045708|364066660|FG000|Phase 1|early progressive disease|0|||
105733120|NCT00670111|364679342|FG002|Enrollment to One Month|Testing Failure|13|||
105733121|NCT00670111|364679340|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
105733122|NCT00670111|364679341|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
105733123|NCT00670111|364679342|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
105565011|NCT00045708|364066661|FG001|Phase 1|early progressive disease|1|||
105565012|NCT00045708|364066662|FG002|Phase 1|early progressive disease|0|||
105733124|NCT00670111|364679340|FG000|Enrollment to One Month|Physician Decision|1|||
105733125|NCT00670111|364679341|FG001|Enrollment to One Month|Physician Decision|0|||
105733126|NCT00670111|364679342|FG002|Enrollment to One Month|Physician Decision|0|||
105733127|NCT03000452|364679344|FG000|Treatment Period|Death|1|||
105733128|NCT03000452|364679344|FG000|Treatment Period|Progressive Disease (PD)|14|||
105733129|NCT03000452|364679344|FG000|Treatment Period|Physician Decision|1|||
105733130|NCT03000452|364679344|FG000|Treatment Period|Miscellaneous|2|||
105733131|NCT03000452|364679344|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
105733132|NCT03000452|364679344|FG000|Follow-Up Period|Death|3|||
105733133|NCT03000452|364679344|FG000|Follow-Up Period|Withdrawal by Subject|3|||
105733134|NCT00593112|364679345|FG000|Overall Study|Scan Anxiety|3|||
105733135|NCT00593112|364679346|FG001|Overall Study|Scan Anxiety|0|||
105733136|NCT00593112|364679345|FG000|Overall Study|Abnormal Scan|1|||
105733137|NCT00593112|364679346|FG001|Overall Study|Abnormal Scan|0|||
105733138|NCT00593112|364679345|FG000|Overall Study|Unreadable Scan|1|||
105733139|NCT00593112|364679346|FG001|Overall Study|Unreadable Scan|0|||
105733140|NCT00593112|364679345|FG000|Overall Study|Withdrawal by Subject|5|||
105733141|NCT00593112|364679346|FG001|Overall Study|Withdrawal by Subject|0|||
105733142|NCT00852930|364679347|FG000|Overall Study|Withdrawal by Subject|1|||
105733143|NCT00852930|364679348|FG001|Overall Study|Withdrawal by Subject|1|||
105733144|NCT00852930|364679349|FG002|Overall Study|Withdrawal by Subject|1|||
105733145|NCT00852930|364679347|FG000|Overall Study|Physician Decision|0|||
105733146|NCT00852930|364679348|FG001|Overall Study|Physician Decision|0|||
105733147|NCT00852930|364679349|FG002|Overall Study|Physician Decision|1|||
105733148|NCT01325493|364679350|FG000|Overall Study|Protocol Violation|0|||
105733149|NCT01325493|364679351|FG001|Overall Study|Protocol Violation|1|||
105733150|NCT01325493|364679350|FG000|Overall Study|loss of neuromonitoring signals|0|||
105733151|NCT01325493|364679351|FG001|Overall Study|loss of neuromonitoring signals|2|||
105733152|NCT01325493|364679350|FG000|Overall Study|Allergy|1|||
105733153|NCT01325493|364679351|FG001|Overall Study|Allergy|0|||
105733154|NCT00482001|364679352|FG000|Overall Study|Protocol Violation|1|||
105733155|NCT00482001|364679353|FG001|Overall Study|Protocol Violation|1|||
105733156|NCT04786210|364679354|FG000|Overall Study|Lost to Follow-up|2|||
105733157|NCT04786210|364679354|FG000|Overall Study|Withdrawal by Subject|4|||
105733158|NCT03700892|364679359|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
105733159|NCT03700892|364679360|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
105733160|NCT03700892|364679361|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
105733161|NCT04814823|364679362|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
105733162|NCT03396471|364679377|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
105733163|NCT03396471|364679377|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
105733164|NCT03396471|364679377|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
105733165|NCT03396471|364679377|FG000|Study Treatment - Up to 22 Months|Death|2|||
105733166|NCT03396471|364679377|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
105733167|NCT03396471|364679377|FG000|Follow up - Up to 2 Years|Death|9|||
105733168|NCT03396471|364679377|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
105733169|NCT03396471|364679377|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
105733170|NCT03396471|364679377|FG000|Follow up - Up to 2 Years|study terminated|1|||
105733171|NCT03396471|364679377|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
105733172|NCT03396471|364679377|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
105733173|NCT00923091|364679378|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
105733174|NCT00923091|364679379|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
105733175|NCT00923091|364679380|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
105733176|NCT00923091|364679381|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
105733177|NCT00923091|364679382|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
105733178|NCT00923091|364679383|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
105733179|NCT00923091|364679384|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
105733180|NCT00923091|364679385|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
105733181|NCT00923091|364679386|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
105733182|NCT00923091|364679387|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
105733183|NCT00923091|364679388|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
105733184|NCT00923091|364679389|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
105733185|NCT00923091|364679390|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
105733186|NCT00923091|364679378|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
105733187|NCT00923091|364679379|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
105733188|NCT00923091|364679380|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
105733189|NCT00923091|364679381|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
105733190|NCT00923091|364679382|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
105733191|NCT00923091|364679383|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
105733192|NCT00923091|364679384|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
105733193|NCT00923091|364679385|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
105733194|NCT00923091|364679386|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
105733195|NCT00923091|364679387|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
105733196|NCT00923091|364679388|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
105733197|NCT00923091|364679389|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
105733198|NCT00923091|364679390|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
105733199|NCT00923091|364679378|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
105733200|NCT00923091|364679379|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
105733201|NCT00923091|364679380|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
105733202|NCT00923091|364679381|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
105733203|NCT00923091|364679382|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
105733204|NCT00923091|364679383|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
105733205|NCT00923091|364679384|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
105733206|NCT00923091|364679385|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
105733207|NCT00923091|364679386|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
105733208|NCT00923091|364679387|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
105733209|NCT00923091|364679388|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
105733210|NCT00923091|364679389|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
105733211|NCT00923091|364679390|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
105733212|NCT00923091|364679378|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733213|NCT00923091|364679379|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733214|NCT00923091|364679380|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733215|NCT00923091|364679381|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733216|NCT00923091|364679382|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733217|NCT00923091|364679383|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
105733218|NCT00923091|364679384|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733219|NCT00923091|364679385|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733220|NCT00923091|364679386|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733221|NCT00923091|364679387|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733222|NCT00923091|364679388|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733223|NCT00923091|364679389|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733224|NCT00923091|364679390|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733225|NCT00923091|364679378|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733226|NCT00923091|364679379|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
105733227|NCT00923091|364679380|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733228|NCT00923091|364679381|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
105733229|NCT00923091|364679382|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733230|NCT00923091|364679383|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
105733231|NCT00923091|364679384|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733232|NCT00923091|364679385|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733233|NCT00923091|364679386|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733234|NCT00923091|364679387|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733235|NCT00923091|364679388|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733236|NCT00923091|364679389|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733237|NCT00923091|364679390|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733238|NCT00923091|364679378|FG000|Period III (Single-Blind)|Adverse Event|5|||
105733239|NCT00923091|364679379|FG001|Period III (Single-Blind)|Adverse Event|0|||
105733240|NCT00923091|364679380|FG002|Period III (Single-Blind)|Adverse Event|0|||
105733241|NCT00923091|364679381|FG003|Period III (Single-Blind)|Adverse Event|0|||
105733242|NCT00923091|364679382|FG004|Period III (Single-Blind)|Adverse Event|0|||
105733243|NCT00923091|364679383|FG005|Period III (Single-Blind)|Adverse Event|0|||
105733244|NCT00923091|364679384|FG006|Period III (Single-Blind)|Adverse Event|0|||
105733245|NCT00923091|364679385|FG007|Period III (Single-Blind)|Adverse Event|0|||
105733246|NCT00923091|364679386|FG008|Period III (Single-Blind)|Adverse Event|0|||
105733247|NCT00923091|364679387|FG009|Period III (Single-Blind)|Adverse Event|0|||
105733248|NCT00923091|364679388|FG010|Period III (Single-Blind)|Adverse Event|0|||
105733249|NCT00923091|364679389|FG011|Period III (Single-Blind)|Adverse Event|0|||
105733250|NCT00923091|364679390|FG012|Period III (Single-Blind)|Adverse Event|0|||
105733251|NCT00923091|364679378|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
105733252|NCT00923091|364679379|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733253|NCT00923091|364679380|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733254|NCT00923091|364679381|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733255|NCT00923091|364679382|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733256|NCT00923091|364679383|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733257|NCT00923091|364679384|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733258|NCT00923091|364679385|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733259|NCT00923091|364679386|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733260|NCT00923091|364679387|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733261|NCT00923091|364679388|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733262|NCT00923091|364679389|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733263|NCT00923091|364679390|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
105798125|NCT00068445|364919270|FG000|Randomization|Ineligible|1|||
105798126|NCT00068445|364919271|FG001|Randomization|Ineligible|1|||
105798127|NCT00068445|364919270|FG000|Treatment|Refused Further Treatment|13|||
105798128|NCT00068445|364919271|FG001|Treatment|Refused Further Treatment|10|||
105798129|NCT00068445|364919270|FG000|Treatment|Adverse Event|7|||
105798130|NCT00068445|364919271|FG001|Treatment|Adverse Event|1|||
105798131|NCT00068445|364919270|FG000|Treatment|Other (Specifics not available)|9|||
105798132|NCT00068445|364919271|FG001|Treatment|Other (Specifics not available)|5|||
105798133|NCT00423488|364919275|FG000|Overall Study|No evidence of study drug intake|2|||
105798134|NCT00423488|364919276|FG001|Overall Study|No evidence of study drug intake|1|||
105798135|NCT00423488|364919275|FG000|Overall Study|No post baseline data|3|||
105798136|NCT00423488|364919276|FG001|Overall Study|No post baseline data|0|||
105798137|NCT02164539|364919277|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
105798138|NCT02164539|364919278|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
105798139|NCT02164539|364919279|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
105798140|NCT02164539|364919280|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
105798141|NCT02164539|364919281|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
105798142|NCT02164539|364919282|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
105798143|NCT02164539|364919283|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
105798144|NCT02164539|364919277|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
105798145|NCT02164539|364919278|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
105798146|NCT02164539|364919279|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
105798147|NCT02164539|364919280|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
105798148|NCT02164539|364919281|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
105798149|NCT02164539|364919282|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
105798150|NCT02164539|364919283|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
105798151|NCT02164539|364919277|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
105798152|NCT02164539|364919278|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
105798153|NCT02164539|364919279|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
105798154|NCT02164539|364919280|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
105798155|NCT02164539|364919281|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
105798156|NCT02164539|364919282|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
105798157|NCT02164539|364919283|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
105798158|NCT02164539|364919277|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
105798159|NCT02164539|364919278|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
105798160|NCT02164539|364919279|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
105798161|NCT02164539|364919280|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
105798162|NCT02164539|364919281|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
105798163|NCT02164539|364919282|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
105798164|NCT02164539|364919283|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
105798165|NCT02164539|364919277|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
105798166|NCT02164539|364919278|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
105798167|NCT02164539|364919279|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
105798168|NCT02164539|364919280|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
105798169|NCT02164539|364919281|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
105798170|NCT02164539|364919282|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
105798171|NCT02164539|364919283|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
105798172|NCT02164539|364919277|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
105798173|NCT02164539|364919278|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
105798174|NCT02164539|364919279|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
105798175|NCT02164539|364919280|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
105798176|NCT02164539|364919281|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
105798177|NCT02164539|364919282|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
105798178|NCT02164539|364919283|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
105798179|NCT01255722|364919284|FG000|Overall Study|Adverse Event|0|||
105798180|NCT01255722|364919285|FG001|Overall Study|Adverse Event|1|||
105798181|NCT01255722|364919286|FG002|Overall Study|Adverse Event|1|||
105798182|NCT01255722|364919284|FG000|Overall Study|asymptomatic patient|1|||
105798183|NCT01255722|364919285|FG001|Overall Study|asymptomatic patient|0|||
105798184|NCT01255722|364919286|FG002|Overall Study|asymptomatic patient|0|||
105798185|NCT01255722|364919284|FG000|Overall Study|beta-blocker contraindicated|2|||
105798186|NCT01255722|364919285|FG001|Overall Study|beta-blocker contraindicated|0|||
105798187|NCT01255722|364919286|FG002|Overall Study|beta-blocker contraindicated|0|||
105798188|NCT03835975|364919289|FG000|Overall Study|Lost to Follow-up|1|||
105798189|NCT03835975|364919290|FG001|Overall Study|Lost to Follow-up|1|||
105798190|NCT03835975|364919291|FG002|Overall Study|Lost to Follow-up|0|||
105798191|NCT03835975|364919292|FG003|Overall Study|Lost to Follow-up|0|||
105798192|NCT03835975|364919293|FG004|Overall Study|Lost to Follow-up|0|||
105798193|NCT03835975|364919289|FG000|Overall Study|No longer met eligibility criteria|0|||
105798194|NCT03835975|364919290|FG001|Overall Study|No longer met eligibility criteria|1|||
105798195|NCT03835975|364919291|FG002|Overall Study|No longer met eligibility criteria|0|||
105798196|NCT03835975|364919292|FG003|Overall Study|No longer met eligibility criteria|0|||
105798197|NCT03835975|364919293|FG004|Overall Study|No longer met eligibility criteria|0|||
105798198|NCT03835975|364919289|FG000|Overall Study|Protocol Violation|1|||
105565013|NCT01090310|364066663|FG000|Core Study|Adverse Event|2|||
105733264|NCT00923091|364679378|FG000|Period III (Single-Blind)|Protocol Violation|3|||
105733265|NCT00923091|364679379|FG001|Period III (Single-Blind)|Protocol Violation|0|||
105733266|NCT00923091|364679380|FG002|Period III (Single-Blind)|Protocol Violation|0|||
105733267|NCT00923091|364679381|FG003|Period III (Single-Blind)|Protocol Violation|0|||
105733268|NCT00923091|364679382|FG004|Period III (Single-Blind)|Protocol Violation|0|||
105733269|NCT00923091|364679383|FG005|Period III (Single-Blind)|Protocol Violation|0|||
105733270|NCT00923091|364679384|FG006|Period III (Single-Blind)|Protocol Violation|0|||
105733271|NCT00923091|364679385|FG007|Period III (Single-Blind)|Protocol Violation|0|||
105733272|NCT00923091|364679386|FG008|Period III (Single-Blind)|Protocol Violation|0|||
105733273|NCT00923091|364679387|FG009|Period III (Single-Blind)|Protocol Violation|0|||
105733274|NCT00923091|364679388|FG010|Period III (Single-Blind)|Protocol Violation|0|||
105733275|NCT00923091|364679389|FG011|Period III (Single-Blind)|Protocol Violation|0|||
105733276|NCT00923091|364679390|FG012|Period III (Single-Blind)|Protocol Violation|0|||
105733277|NCT00923091|364679378|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
105733278|NCT00923091|364679379|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
105733279|NCT00923091|364679380|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
105733280|NCT00923091|364679381|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
105733281|NCT00923091|364679382|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
105733282|NCT00923091|364679383|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
105733283|NCT00923091|364679384|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
105733284|NCT00923091|364679385|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
105733285|NCT00923091|364679386|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
105733286|NCT00923091|364679387|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
105733287|NCT00923091|364679388|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
105733288|NCT00923091|364679389|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
105733289|NCT00923091|364679390|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
105733290|NCT00923091|364679378|FG000|Period IV (Double-Blind)|Adverse Event|2|||
105733291|NCT00923091|364679379|FG001|Period IV (Double-Blind)|Adverse Event|0|||
105733292|NCT00923091|364679380|FG002|Period IV (Double-Blind)|Adverse Event|0|||
105733293|NCT00923091|364679381|FG003|Period IV (Double-Blind)|Adverse Event|0|||
105733294|NCT00923091|364679382|FG004|Period IV (Double-Blind)|Adverse Event|0|||
105733295|NCT00923091|364679383|FG005|Period IV (Double-Blind)|Adverse Event|0|||
105733296|NCT00923091|364679384|FG006|Period IV (Double-Blind)|Adverse Event|0|||
105733297|NCT00923091|364679385|FG007|Period IV (Double-Blind)|Adverse Event|0|||
105733298|NCT00923091|364679386|FG008|Period IV (Double-Blind)|Adverse Event|0|||
105733299|NCT00923091|364679387|FG009|Period IV (Double-Blind)|Adverse Event|0|||
105733300|NCT00923091|364679388|FG010|Period IV (Double-Blind)|Adverse Event|0|||
105733301|NCT00923091|364679389|FG011|Period IV (Double-Blind)|Adverse Event|0|||
105733302|NCT00923091|364679390|FG012|Period IV (Double-Blind)|Adverse Event|0|||
105733303|NCT00923091|364679378|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733304|NCT00923091|364679379|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
105733305|NCT00923091|364679380|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733306|NCT00923091|364679381|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733307|NCT00923091|364679382|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733308|NCT00923091|364679383|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733309|NCT00923091|364679384|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733310|NCT00923091|364679385|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733311|NCT00923091|364679386|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733312|NCT00923091|364679387|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733313|NCT00923091|364679388|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733314|NCT00923091|364679389|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733315|NCT00923091|364679390|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733316|NCT00923091|364679378|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
105733317|NCT00923091|364679379|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
105733318|NCT00923091|364679380|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
105733319|NCT00923091|364679381|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
105733320|NCT00923091|364679382|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
105733321|NCT00923091|364679383|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
105733322|NCT00923091|364679384|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
105733323|NCT00923091|364679385|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
105733324|NCT00923091|364679386|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
105733325|NCT00923091|364679387|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
105733326|NCT00923091|364679388|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
105733327|NCT00923091|364679389|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
105733328|NCT00923091|364679390|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
105733329|NCT00923091|364679378|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733330|NCT00923091|364679379|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733331|NCT00923091|364679380|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733332|NCT00923091|364679381|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
105798199|NCT03835975|364919290|FG001|Overall Study|Protocol Violation|1|||
105480441|NCT01270802|363769152|FG000|Overall Study|Withdrawal by Subject|1|||
105480442|NCT01270802|363769153|FG001|Overall Study|Withdrawal by Subject|0|||
105733333|NCT00923091|364679382|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733334|NCT00923091|364679383|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733335|NCT00923091|364679384|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733336|NCT00923091|364679385|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733337|NCT00923091|364679386|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
105733338|NCT00923091|364679387|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733339|NCT00923091|364679388|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733340|NCT00923091|364679389|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733341|NCT00923091|364679390|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
105733342|NCT00923091|364679378|FG000|Period V (Double -Blind)|Protocol Violation|0|||
105733343|NCT00923091|364679379|FG001|Period V (Double -Blind)|Protocol Violation|0|||
105733344|NCT00923091|364679380|FG002|Period V (Double -Blind)|Protocol Violation|0|||
105733345|NCT00923091|364679381|FG003|Period V (Double -Blind)|Protocol Violation|0|||
105733346|NCT00923091|364679382|FG004|Period V (Double -Blind)|Protocol Violation|0|||
105733347|NCT00923091|364679383|FG005|Period V (Double -Blind)|Protocol Violation|0|||
105733348|NCT00923091|364679384|FG006|Period V (Double -Blind)|Protocol Violation|0|||
105733349|NCT00923091|364679385|FG007|Period V (Double -Blind)|Protocol Violation|0|||
105733350|NCT00923091|364679386|FG008|Period V (Double -Blind)|Protocol Violation|0|||
105733351|NCT00923091|364679387|FG009|Period V (Double -Blind)|Protocol Violation|0|||
105733352|NCT00923091|364679388|FG010|Period V (Double -Blind)|Protocol Violation|0|||
105733353|NCT00923091|364679389|FG011|Period V (Double -Blind)|Protocol Violation|0|||
105733354|NCT00923091|364679390|FG012|Period V (Double -Blind)|Protocol Violation|1|||
105733355|NCT00923091|364679378|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
105733356|NCT00923091|364679379|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
105733357|NCT00923091|364679380|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
105733358|NCT00923091|364679381|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
105733359|NCT00923091|364679382|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
105733360|NCT00923091|364679383|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
105733361|NCT00923091|364679384|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
105733362|NCT00923091|364679385|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
105733363|NCT00923091|364679386|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
105733364|NCT00923091|364679387|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
105733365|NCT00923091|364679388|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
105733366|NCT00923091|364679389|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
105733367|NCT00923091|364679390|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
105733368|NCT00923091|364679378|FG000|Period VI (Open-Label)|Adverse Event|17|||
105733369|NCT00923091|364679379|FG001|Period VI (Open-Label)|Adverse Event|0|||
105733370|NCT00923091|364679380|FG002|Period VI (Open-Label)|Adverse Event|4|||
105733371|NCT00923091|364679381|FG003|Period VI (Open-Label)|Adverse Event|1|||
105733372|NCT00923091|364679382|FG004|Period VI (Open-Label)|Adverse Event|1|||
105733373|NCT00923091|364679383|FG005|Period VI (Open-Label)|Adverse Event|0|||
105733374|NCT00923091|364679384|FG006|Period VI (Open-Label)|Adverse Event|0|||
105733375|NCT00923091|364679385|FG007|Period VI (Open-Label)|Adverse Event|0|||
105733376|NCT00923091|364679386|FG008|Period VI (Open-Label)|Adverse Event|0|||
105733377|NCT00923091|364679387|FG009|Period VI (Open-Label)|Adverse Event|0|||
105733378|NCT00923091|364679388|FG010|Period VI (Open-Label)|Adverse Event|0|||
105733379|NCT00923091|364679389|FG011|Period VI (Open-Label)|Adverse Event|0|||
105733380|NCT00923091|364679390|FG012|Period VI (Open-Label)|Adverse Event|0|||
105733381|NCT00923091|364679378|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
105733382|NCT00923091|364679379|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
105733383|NCT00923091|364679380|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
105733384|NCT00923091|364679381|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733385|NCT00923091|364679382|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
105733386|NCT00923091|364679383|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733387|NCT00923091|364679384|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733388|NCT00923091|364679385|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733389|NCT00923091|364679386|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733390|NCT00923091|364679387|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733391|NCT00923091|364679388|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733392|NCT00923091|364679389|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733393|NCT00923091|364679390|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733394|NCT00923091|364679378|FG000|Period VI (Open-Label)|Protocol Violation|6|||
105733395|NCT00923091|364679379|FG001|Period VI (Open-Label)|Protocol Violation|1|||
105733396|NCT00923091|364679380|FG002|Period VI (Open-Label)|Protocol Violation|3|||
105733397|NCT00923091|364679381|FG003|Period VI (Open-Label)|Protocol Violation|1|||
105733398|NCT00923091|364679382|FG004|Period VI (Open-Label)|Protocol Violation|4|||
105733399|NCT00923091|364679383|FG005|Period VI (Open-Label)|Protocol Violation|0|||
105733400|NCT00923091|364679384|FG006|Period VI (Open-Label)|Protocol Violation|0|||
105733401|NCT00923091|364679385|FG007|Period VI (Open-Label)|Protocol Violation|0|||
105733402|NCT00923091|364679386|FG008|Period VI (Open-Label)|Protocol Violation|0|||
105798200|NCT03835975|364919291|FG002|Overall Study|Protocol Violation|2|||
105798201|NCT03835975|364919292|FG003|Overall Study|Protocol Violation|0|||
105798202|NCT03835975|364919293|FG004|Overall Study|Protocol Violation|0|||
105798203|NCT03835975|364919289|FG000|Overall Study|Withdrawal by Subject|1|||
105798204|NCT03835975|364919290|FG001|Overall Study|Withdrawal by Subject|0|||
105798205|NCT03835975|364919291|FG002|Overall Study|Withdrawal by Subject|1|||
105798206|NCT03835975|364919292|FG003|Overall Study|Withdrawal by Subject|1|||
105798207|NCT03835975|364919293|FG004|Overall Study|Withdrawal by Subject|0|||
105798208|NCT03031431|364919294|FG000|Overall Study|Infant removed by maternal request|1|||
105798209|NCT01027884|364919299|FG000|Overall Study|Adverse Event|2|||
105798210|NCT01027884|364919300|FG001|Overall Study|Adverse Event|1|||
105798211|NCT01027884|364919299|FG000|Overall Study|Protocol Violation|1|||
105798212|NCT01027884|364919300|FG001|Overall Study|Protocol Violation|0|||
105798213|NCT01027884|364919299|FG000|Overall Study|Non-compliance|1|||
105798214|NCT01027884|364919300|FG001|Overall Study|Non-compliance|1|||
105798215|NCT01027884|364919299|FG000|Overall Study|Withdrawal by Subject|0|||
105798216|NCT01027884|364919300|FG001|Overall Study|Withdrawal by Subject|1|||
105798217|NCT01027884|364919299|FG000|Overall Study|Lost to Follow-up|0|||
105798218|NCT01027884|364919300|FG001|Overall Study|Lost to Follow-up|1|||
105798219|NCT01027884|364919299|FG000|Overall Study|Spinal fixation surgery|0|||
105798220|NCT01027884|364919300|FG001|Overall Study|Spinal fixation surgery|3|||
105798221|NCT01542736|364919301|FG000|Overall Study|Death|1|||
105798222|NCT00527397|364919302|FG000|Overall Study|Adverse Event|3|||
105798223|NCT00527397|364919302|FG000|Overall Study|Lack of Efficacy|1|||
105798224|NCT00527397|364919302|FG000|Overall Study|Protocol Violation|1|||
105798225|NCT00527397|364919302|FG000|Overall Study|Withdrawal by Subject|6|||
105798226|NCT00527397|364919302|FG000|Overall Study|Study terminated by sponsor|13|||
105798227|NCT01783483|364919303|FG000|Overall Study|Death|3|||
105798228|NCT01783483|364919304|FG001|Overall Study|Death|3|||
105798229|NCT01783483|364919303|FG000|Overall Study|Lost to Follow-up|14|||
105798230|NCT01783483|364919304|FG001|Overall Study|Lost to Follow-up|10|||
105798231|NCT01783483|364919303|FG000|Overall Study|Withdrawal by Subject|2|||
105798232|NCT01783483|364919304|FG001|Overall Study|Withdrawal by Subject|1|||
105798233|NCT01783483|364919303|FG000|Overall Study|Physician Decision|1|||
105798234|NCT01783483|364919304|FG001|Overall Study|Physician Decision|1|||
105798235|NCT01462695|364919305|FG000|Overall Study|Adverse Event|1|||
105798236|NCT01462695|364919306|FG001|Overall Study|Adverse Event|1|||
105798237|NCT01462695|364919305|FG000|Overall Study|Death|2|||
105798238|NCT01462695|364919306|FG001|Overall Study|Death|0|||
105798239|NCT01462695|364919305|FG000|Overall Study|Lack of Efficacy|6|||
105798240|NCT01462695|364919306|FG001|Overall Study|Lack of Efficacy|12|||
105798241|NCT01462695|364919305|FG000|Overall Study|Physician Decision|5|||
105798242|NCT01462695|364919306|FG001|Overall Study|Physician Decision|0|||
105798243|NCT01462695|364919305|FG000|Overall Study|Withdrawal by Subject|2|||
105798244|NCT01462695|364919306|FG001|Overall Study|Withdrawal by Subject|0|||
105798245|NCT01462695|364919305|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
105798246|NCT01462695|364919306|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
105798247|NCT02400905|364919307|FG000|Overall Study|Death|24|||
105798248|NCT02400905|364919307|FG000|Overall Study|Lost to Follow-up|18|||
105798249|NCT02400905|364919307|FG000|Overall Study|Withdrawal by Subject|16|||
105798250|NCT02400905|364919307|FG000|Overall Study|Physician Decision|4|||
105798251|NCT02400905|364919307|FG000|Overall Study|Other|1|||
105798252|NCT03276962|364919308|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
105798253|NCT03276962|364919309|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
105798254|NCT03276962|364919310|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
105798255|NCT03276962|364919311|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
105798256|NCT03276962|364919312|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
105798257|NCT03276962|364919308|FG000|Overall Study|Protocol Deviation|2|||
105798258|NCT03276962|364919309|FG001|Overall Study|Protocol Deviation|0|||
105798259|NCT03276962|364919310|FG002|Overall Study|Protocol Deviation|1|||
105798260|NCT03276962|364919311|FG003|Overall Study|Protocol Deviation|2|||
105480443|NCT01270802|363769152|FG000|Overall Study|Adverse Event|1|||
105480444|NCT01270802|363769153|FG001|Overall Study|Adverse Event|0|||
105798261|NCT03276962|364919312|FG004|Overall Study|Protocol Deviation|1|||
105798262|NCT03276962|364919308|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
105798263|NCT03276962|364919309|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
105798264|NCT03276962|364919310|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
105798265|NCT03276962|364919311|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
105798266|NCT03276962|364919312|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
105798267|NCT03276962|364919308|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
105798268|NCT03276962|364919309|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
105798269|NCT03276962|364919310|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
105798270|NCT03276962|364919311|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
105798271|NCT03276962|364919312|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
105798272|NCT03276962|364919308|FG000|Overall Study|Lost to Follow-up|10|||
105565014|NCT01090310|364066664|FG001|Core Study|Adverse Event|2|||
105565015|NCT01090310|364066665|FG002|Core Study|Adverse Event|1|||
105565016|NCT01090310|364066666|FG003|Core Study|Adverse Event|1|||
105733403|NCT00923091|364679387|FG009|Period VI (Open-Label)|Protocol Violation|0|||
105733404|NCT00923091|364679388|FG010|Period VI (Open-Label)|Protocol Violation|0|||
105733405|NCT00923091|364679389|FG011|Period VI (Open-Label)|Protocol Violation|0|||
105733406|NCT00923091|364679390|FG012|Period VI (Open-Label)|Protocol Violation|0|||
105733407|NCT00923091|364679378|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
105733408|NCT00923091|364679379|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
105733409|NCT00923091|364679380|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
105733410|NCT00923091|364679381|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
105733411|NCT00923091|364679382|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
105733412|NCT00923091|364679383|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
105733413|NCT00923091|364679384|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
105733414|NCT00923091|364679385|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
105733415|NCT00923091|364679386|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
105733416|NCT00923091|364679387|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
105733417|NCT00923091|364679388|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
105733418|NCT00923091|364679389|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
105733419|NCT00923091|364679390|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
105733420|NCT00923091|364679378|FG000|Period VI (Open-Label)|Other Reason|0|||
105733421|NCT00923091|364679379|FG001|Period VI (Open-Label)|Other Reason|0|||
105733422|NCT00923091|364679380|FG002|Period VI (Open-Label)|Other Reason|0|||
105733423|NCT00923091|364679381|FG003|Period VI (Open-Label)|Other Reason|1|||
105733424|NCT00923091|364679382|FG004|Period VI (Open-Label)|Other Reason|1|||
105733425|NCT00923091|364679383|FG005|Period VI (Open-Label)|Other Reason|0|||
105733426|NCT00923091|364679384|FG006|Period VI (Open-Label)|Other Reason|0|||
105733427|NCT00923091|364679385|FG007|Period VI (Open-Label)|Other Reason|0|||
105733428|NCT00923091|364679386|FG008|Period VI (Open-Label)|Other Reason|0|||
105733429|NCT00923091|364679387|FG009|Period VI (Open-Label)|Other Reason|0|||
105733430|NCT00923091|364679388|FG010|Period VI (Open-Label)|Other Reason|0|||
105733431|NCT00923091|364679389|FG011|Period VI (Open-Label)|Other Reason|0|||
105733432|NCT00923091|364679390|FG012|Period VI (Open-Label)|Other Reason|0|||
105733433|NCT01743027|364679398|FG000|Overall Study|Adverse Event|2|||
105733434|NCT01743027|364679399|FG001|Overall Study|Adverse Event|0|||
105733435|NCT01743027|364679400|FG002|Overall Study|Adverse Event|0|||
105733436|NCT01743027|364679401|FG003|Overall Study|Adverse Event|0|||
105733437|NCT01743027|364679398|FG000|Overall Study|Lost to Follow-up|0|||
105733438|NCT01743027|364679399|FG001|Overall Study|Lost to Follow-up|0|||
105733439|NCT01743027|364679400|FG002|Overall Study|Lost to Follow-up|2|||
105733440|NCT01743027|364679401|FG003|Overall Study|Lost to Follow-up|0|||
105733441|NCT01743027|364679398|FG000|Overall Study|Progressive Disease|1|||
105733442|NCT01743027|364679399|FG001|Overall Study|Progressive Disease|4|||
105733443|NCT01743027|364679400|FG002|Overall Study|Progressive Disease|3|||
105733444|NCT01743027|364679401|FG003|Overall Study|Progressive Disease|0|||
105733445|NCT01743027|364679398|FG000|Overall Study|Protocol Violation|1|||
105733446|NCT01743027|364679399|FG001|Overall Study|Protocol Violation|1|||
105733447|NCT01743027|364679400|FG002|Overall Study|Protocol Violation|1|||
105733448|NCT01743027|364679401|FG003|Overall Study|Protocol Violation|0|||
105733449|NCT01743027|364679398|FG000|Overall Study|Withdrawal by Subject|1|||
105353292|NCT01690299|363298524|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
105565017|NCT01090310|364066663|FG000|Core Study|Subject withdrew consent|0|||
105565018|NCT01090310|364066664|FG001|Core Study|Subject withdrew consent|3|||
105565019|NCT01090310|364066665|FG002|Core Study|Subject withdrew consent|1|||
105565020|NCT01090310|364066666|FG003|Core Study|Subject withdrew consent|1|||
105565021|NCT01090310|364066663|FG000|Core Study|Abnormal test procedure result|0|||
105565022|NCT01090310|364066664|FG001|Core Study|Abnormal test procedure result|0|||
105565023|NCT01090310|364066665|FG002|Core Study|Abnormal test procedure result|1|||
105565024|NCT01090310|364066666|FG003|Core Study|Abnormal test procedure result|0|||
105565025|NCT01090310|364066663|FG000|Core Study|Administrative reasons|5|||
105565026|NCT01090310|364066664|FG001|Core Study|Administrative reasons|6|||
105565027|NCT01090310|364066665|FG002|Core Study|Administrative reasons|4|||
105565028|NCT01090310|364066666|FG003|Core Study|Administrative reasons|4|||
105565029|NCT01090310|364066663|FG000|Core Study|Protocol deviation|1|||
105565030|NCT01090310|364066664|FG001|Core Study|Protocol deviation|0|||
105565031|NCT01090310|364066665|FG002|Core Study|Protocol deviation|0|||
105733450|NCT01743027|364679399|FG001|Overall Study|Withdrawal by Subject|0|||
105733451|NCT01743027|364679400|FG002|Overall Study|Withdrawal by Subject|3|||
105733452|NCT01743027|364679401|FG003|Overall Study|Withdrawal by Subject|1|||
105733453|NCT01088412|364679406|FG000|Overall Study|Adverse Event|38|||
105733454|NCT01088412|364679407|FG001|Overall Study|Adverse Event|0|||
105733455|NCT01088412|364679408|FG002|Overall Study|Adverse Event|0|||
105733456|NCT01088412|364679406|FG000|Overall Study|Death|42|||
105733457|NCT01088412|364679407|FG001|Overall Study|Death|6|||
105733458|NCT01088412|364679408|FG002|Overall Study|Death|0|||
105733459|NCT01088412|364679406|FG000|Overall Study|Other Reason per Case Report Form|2089|||
105733460|NCT01088412|364679407|FG001|Overall Study|Other Reason per Case Report Form|103|||
105733461|NCT01088412|364679408|FG002|Overall Study|Other Reason per Case Report Form|9|||
105733462|NCT01088412|364679406|FG000|Overall Study|Withdrawal by Subject|1761|||
105733463|NCT01088412|364679407|FG001|Overall Study|Withdrawal by Subject|25|||
105733464|NCT01088412|364679408|FG002|Overall Study|Withdrawal by Subject|1|||
105733465|NCT01088412|364679406|FG000|Overall Study|Received Another GH Product|79|||
105733466|NCT01088412|364679407|FG001|Overall Study|Received Another GH Product|0|||
105733467|NCT01088412|364679408|FG002|Overall Study|Received Another GH Product|0|||
105733468|NCT01088412|364679406|FG000|Overall Study|Participant Moved|601|||
105733469|NCT01088412|364679407|FG001|Overall Study|Participant Moved|21|||
105733470|NCT01088412|364679408|FG002|Overall Study|Participant Moved|2|||
105733471|NCT01088412|364679406|FG000|Overall Study|Physician Decision|1041|||
105733472|NCT01088412|364679407|FG001|Overall Study|Physician Decision|8|||
105733473|NCT01088412|364679408|FG002|Overall Study|Physician Decision|4|||
105733474|NCT01088412|364679406|FG000|Overall Study|Sponsor Decision|4467|||
105733475|NCT01088412|364679407|FG001|Overall Study|Sponsor Decision|79|||
105733476|NCT01088412|364679408|FG002|Overall Study|Sponsor Decision|23|||
105733477|NCT01088412|364679406|FG000|Overall Study|Third Party Required to Change Brand|487|||
105733478|NCT01088412|364679407|FG001|Overall Study|Third Party Required to Change Brand|0|||
105733479|NCT01088412|364679408|FG002|Overall Study|Third Party Required to Change Brand|0|||
105733480|NCT01088412|364679406|FG000|Overall Study|Lost to Follow-up|3052|||
105733481|NCT01088412|364679407|FG001|Overall Study|Lost to Follow-up|130|||
105733482|NCT01088412|364679408|FG002|Overall Study|Lost to Follow-up|11|||
105733483|NCT01088412|364679406|FG000|Overall Study|Study Summary Not Completed|4360|||
105733484|NCT01088412|364679407|FG001|Overall Study|Study Summary Not Completed|64|||
105733485|NCT01088412|364679408|FG002|Overall Study|Study Summary Not Completed|22|||
105733486|NCT02782715|364679409|FG000|Overall Study|Withdrawal by Subject|1|||
105733487|NCT00069121|364679410|FG000|Overall Study|Death|286|||
105733488|NCT00069121|364679411|FG001|Overall Study|Death|242|||
105733489|NCT00069121|364679410|FG000|Overall Study|Withdrawal by Subject|18|||
105733490|NCT00069121|364679411|FG001|Overall Study|Withdrawal by Subject|20|||
105733491|NCT00069121|364679410|FG000|Overall Study|Lost to Follow-up|63|||
105733492|NCT00069121|364679411|FG001|Overall Study|Lost to Follow-up|63|||
105733493|NCT02190591|364679412|FG000|Overall Study|Withdrawal by Subject|1|||
105733494|NCT02190591|364679413|FG001|Overall Study|Withdrawal by Subject|8|||
105733495|NCT02190591|364679412|FG000|Overall Study|Protocol Violation|1|||
105733496|NCT02190591|364679413|FG001|Overall Study|Protocol Violation|0|||
105733497|NCT02190591|364679412|FG000|Overall Study|did not use peanut ball as instructed|0|||
105733498|NCT02190591|364679413|FG001|Overall Study|did not use peanut ball as instructed|2|||
105733499|NCT02190591|364679412|FG000|Overall Study|face presentation so she was ineligible|0|||
105733500|NCT02190591|364679413|FG001|Overall Study|face presentation so she was ineligible|1|||
105733501|NCT00857246|364679414|FG000|Induction Regimen|Adverse Event|1|||
105733502|NCT00857246|364679414|FG000|Induction Regimen|disease-related complications|1|||
105733503|NCT00857246|364679414|FG000|Induction Regimen|Withdrawal by Subject|1|||
105733504|NCT00857246|364679414|FG000|Surgery (Curative)|disease progression|6|||
105733505|NCT00857246|364679414|FG000|ChemoRT|Withdrawal by Subject|1|||
105733506|NCT00857246|364679414|FG000|ChemoRT|Adverse Event|2|||
105733507|NCT00072189|364679415|FG000|Overall Study|Withdrawal by Subject|1|||
105733508|NCT01919411|364679416|FG000|Overall Study|Lost to Follow-up|2|||
105733509|NCT01919411|364679417|FG001|Overall Study|Lost to Follow-up|4|||
105733510|NCT01919411|364679416|FG000|Overall Study|Physician Decision|1|||
105733511|NCT01919411|364679417|FG001|Overall Study|Physician Decision|0|||
105733512|NCT01919411|364679416|FG000|Overall Study|Protocol Violation|2|||
105733513|NCT01919411|364679417|FG001|Overall Study|Protocol Violation|1|||
105733514|NCT01933672|364679418|FG000|Metformin Run-in Period|Adverse Event|1|||
105733515|NCT01933672|364679419|FG001|Metformin Run-in Period|Adverse Event|0|||
105733516|NCT01933672|364679420|FG002|Metformin Run-in Period|Adverse Event|0|||
105733517|NCT01933672|364679421|FG003|Metformin Run-in Period|Adverse Event|0|||
105733518|NCT01933672|364679422|FG004|Metformin Run-in Period|Adverse Event|0|||
105733519|NCT01933672|364679423|FG005|Metformin Run-in Period|Adverse Event|0|||
105733520|NCT01933672|364679424|FG006|Metformin Run-in Period|Adverse Event|0|||
105733521|NCT01933672|364679418|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
105733522|NCT01933672|364679419|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
105733523|NCT01933672|364679420|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
105733524|NCT01933672|364679421|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
105733525|NCT01933672|364679422|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
105733526|NCT01933672|364679423|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
105733527|NCT01933672|364679424|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
105733528|NCT01933672|364679418|FG000|Metformin Run-in Period|Other|5|||
105565032|NCT01090310|364066666|FG003|Core Study|Protocol deviation|1|||
105565033|NCT01090310|364066663|FG000|Extension Study|Aministrative problems|13|||
105733529|NCT01933672|364679419|FG001|Metformin Run-in Period|Other|0|||
105733530|NCT01933672|364679420|FG002|Metformin Run-in Period|Other|0|||
105733531|NCT01933672|364679421|FG003|Metformin Run-in Period|Other|0|||
105733532|NCT01933672|364679422|FG004|Metformin Run-in Period|Other|0|||
105733533|NCT01933672|364679423|FG005|Metformin Run-in Period|Other|0|||
105733534|NCT01933672|364679424|FG006|Metformin Run-in Period|Other|0|||
105733535|NCT01933672|364679418|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733536|NCT01933672|364679419|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733537|NCT01933672|364679420|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733538|NCT01933672|364679421|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733539|NCT01933672|364679422|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
105733540|NCT01933672|364679423|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733541|NCT01933672|364679424|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733542|NCT01933672|364679418|FG000|First Intervention Period (12-16 Days)|Other|0|||
105733543|NCT01933672|364679419|FG001|First Intervention Period (12-16 Days)|Other|0|||
105733544|NCT01933672|364679420|FG002|First Intervention Period (12-16 Days)|Other|1|||
105733545|NCT01933672|364679421|FG003|First Intervention Period (12-16 Days)|Other|0|||
105733546|NCT01933672|364679422|FG004|First Intervention Period (12-16 Days)|Other|0|||
105733547|NCT01933672|364679423|FG005|First Intervention Period (12-16 Days)|Other|1|||
105733548|NCT01933672|364679424|FG006|First Intervention Period (12-16 Days)|Other|0|||
105733549|NCT01933672|364679418|FG000|Second Intervention Period (12-16 Days)|Other|0|||
105733550|NCT01933672|364679419|FG001|Second Intervention Period (12-16 Days)|Other|1|||
105733551|NCT01933672|364679420|FG002|Second Intervention Period (12-16 Days)|Other|1|||
105733552|NCT01933672|364679421|FG003|Second Intervention Period (12-16 Days)|Other|0|||
105733553|NCT01933672|364679422|FG004|Second Intervention Period (12-16 Days)|Other|0|||
105733554|NCT01933672|364679423|FG005|Second Intervention Period (12-16 Days)|Other|0|||
105733555|NCT01933672|364679424|FG006|Second Intervention Period (12-16 Days)|Other|0|||
105733556|NCT01933672|364679418|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733557|NCT01933672|364679419|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733558|NCT01933672|364679420|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733559|NCT01933672|364679421|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
105733560|NCT01933672|364679422|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733561|NCT01933672|364679423|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733562|NCT01933672|364679424|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733563|NCT01933672|364679418|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
105733564|NCT01933672|364679419|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
105733565|NCT01933672|364679420|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
105733566|NCT01933672|364679421|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
105733567|NCT01933672|364679422|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
105733568|NCT01933672|364679423|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
105733569|NCT01933672|364679424|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
105733570|NCT00853905|364679425|FG000|Overall Study|Lost to Follow-up|1|||
105733571|NCT00853905|364679426|FG001|Overall Study|Lost to Follow-up|3|||
105733572|NCT00853905|364679425|FG000|Overall Study|Withdrawal by Subject|0|||
105733573|NCT00853905|364679426|FG001|Overall Study|Withdrawal by Subject|1|||
105733574|NCT00853905|364679425|FG000|Overall Study|never had surgery|1|||
105733575|NCT00853905|364679426|FG001|Overall Study|never had surgery|0|||
105733576|NCT00393458|364679432|FG000|Overall Study|Adverse Event|35|||
105733577|NCT00393458|364679433|FG001|Overall Study|Adverse Event|24|||
105733578|NCT00393458|364679434|FG002|Overall Study|Adverse Event|40|||
105733579|NCT00393458|364679435|FG003|Overall Study|Adverse Event|35|||
105733580|NCT00393458|364679432|FG000|Overall Study|Subject withdrew consent|27|||
105733581|NCT00393458|364679433|FG001|Overall Study|Subject withdrew consent|40|||
105733582|NCT00393458|364679434|FG002|Overall Study|Subject withdrew consent|33|||
105733583|NCT00393458|364679435|FG003|Overall Study|Subject withdrew consent|50|||
105733584|NCT00393458|364679432|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
105733585|NCT00393458|364679433|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
105733586|NCT00393458|364679434|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
105733587|NCT00393458|364679435|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
105733588|NCT00393458|364679432|FG000|Overall Study|Protocol deviation|11|||
105733589|NCT00393458|364679433|FG001|Overall Study|Protocol deviation|11|||
105733590|NCT00393458|364679434|FG002|Overall Study|Protocol deviation|11|||
105733591|NCT00393458|364679435|FG003|Overall Study|Protocol deviation|10|||
105733592|NCT00393458|364679432|FG000|Overall Study|Administrative problems|7|||
105733593|NCT00393458|364679433|FG001|Overall Study|Administrative problems|8|||
105733594|NCT00393458|364679434|FG002|Overall Study|Administrative problems|5|||
105733595|NCT00393458|364679435|FG003|Overall Study|Administrative problems|2|||
105733596|NCT00393458|364679432|FG000|Overall Study|Lost to Follow-up|5|||
105733597|NCT00393458|364679433|FG001|Overall Study|Lost to Follow-up|6|||
105733598|NCT00393458|364679434|FG002|Overall Study|Lost to Follow-up|5|||
105733599|NCT00393458|364679435|FG003|Overall Study|Lost to Follow-up|3|||
105733600|NCT00393458|364679432|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105733601|NCT00393458|364679433|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105733602|NCT00393458|364679434|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105733603|NCT00393458|364679435|FG003|Overall Study|Abnormal laboratory value(s)|0|||
105480445|NCT01270802|363769152|FG000|Overall Study|Lost to Follow-up|0|||
105480446|NCT01270802|363769153|FG001|Overall Study|Lost to Follow-up|1|||
105480447|NCT03077087|363769154|FG000|Overall Study|Physician Decision|2|||
105480448|NCT00217464|363769158|FG000|Overall Study|Progression|15|||
105480449|NCT00217464|363769158|FG000|Overall Study|Other|2|||
105480450|NCT00311584|363769163|FG000|Overall Study|Death|1|||
105480451|NCT00311584|363769164|FG001|Overall Study|Death|0|||
105480452|NCT00311584|363769163|FG000|Overall Study|Lack of Efficacy|12|||
105480453|NCT00311584|363769164|FG001|Overall Study|Lack of Efficacy|15|||
105480454|NCT00311584|363769163|FG000|Overall Study|Physician Decision|4|||
105480455|NCT00311584|363769164|FG001|Overall Study|Physician Decision|5|||
105480456|NCT00311584|363769163|FG000|Overall Study|Withdrawal by Subject|1|||
105480457|NCT00311584|363769164|FG001|Overall Study|Withdrawal by Subject|1|||
105798273|NCT03276962|364919309|FG001|Overall Study|Lost to Follow-up|10|||
105798274|NCT03276962|364919310|FG002|Overall Study|Lost to Follow-up|4|||
105798275|NCT03276962|364919311|FG003|Overall Study|Lost to Follow-up|6|||
105798276|NCT03276962|364919312|FG004|Overall Study|Lost to Follow-up|10|||
105798277|NCT03276962|364919308|FG000|Overall Study|Other|0|||
105798278|NCT03276962|364919309|FG001|Overall Study|Other|2|||
105798279|NCT03276962|364919310|FG002|Overall Study|Other|0|||
105798280|NCT03276962|364919311|FG003|Overall Study|Other|2|||
105798281|NCT03276962|364919312|FG004|Overall Study|Other|1|||
105798282|NCT02702271|364919313|FG000|Overall Study|Death|36|||
105798283|NCT02702271|364919314|FG001|Overall Study|Death|7|||
105798284|NCT02702271|364919313|FG000|Overall Study|Lost to Follow-up|12|||
105798285|NCT02702271|364919314|FG001|Overall Study|Lost to Follow-up|0|||
105798286|NCT02702271|364919313|FG000|Overall Study|Withdrawal by Subject|8|||
105798287|NCT02702271|364919314|FG001|Overall Study|Withdrawal by Subject|1|||
105798288|NCT02702271|364919313|FG000|Overall Study|Physician Decision|2|||
105798289|NCT02702271|364919314|FG001|Overall Study|Physician Decision|0|||
105798290|NCT02702271|364919313|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
105798291|NCT02702271|364919314|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
105798292|NCT02713243|364919315|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
105798293|NCT02713243|364919316|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
105798294|NCT02713243|364919315|FG000|Overall Study|Administrative problems|0|||
105798295|NCT02713243|364919316|FG001|Overall Study|Administrative problems|1|||
105798296|NCT02713243|364919315|FG000|Overall Study|Protocol deviation|0|||
105798297|NCT02713243|364919316|FG001|Overall Study|Protocol deviation|1|||
105798298|NCT04363736|364919317|FG000|Overall Study|Withdrawal by Subject|1|||
105798299|NCT04363736|364919318|FG001|Overall Study|Withdrawal by Subject|0|||
105798300|NCT04363736|364919317|FG000|Overall Study|Lost to Follow-up|10|||
105798301|NCT04363736|364919318|FG001|Overall Study|Lost to Follow-up|7|||
105798302|NCT04363736|364919317|FG000|Overall Study|Death|8|||
105798303|NCT04363736|364919318|FG001|Overall Study|Death|6|||
105798304|NCT03056352|364919319|FG000|Overall Study|Lost to Follow-up|1|||
105798305|NCT03797222|364919322|FG000|Overall Study|Withdrawal by Subject|1|||
105798306|NCT04071626|364919326|FG000|Overall Study|Withdrawal by Subject|1|||
105798307|NCT04071626|364919327|FG001|Overall Study|Withdrawal by Subject|1|||
105798308|NCT04071626|364919326|FG000|Overall Study|Protocol Violation|0|||
105798309|NCT04071626|364919327|FG001|Overall Study|Protocol Violation|1|||
105798310|NCT04523831|364919330|FG000|Overall Study|Lost to Follow-up|15|||
105798311|NCT04523831|364919331|FG001|Overall Study|Lost to Follow-up|17|||
105798312|NCT04523831|364919330|FG000|Overall Study|Death|0|||
105798313|NCT04523831|364919331|FG001|Overall Study|Death|3|||
105798314|NCT04523831|364919330|FG000|Overall Study|Adverse Event|2|||
105798315|NCT04523831|364919331|FG001|Overall Study|Adverse Event|0|||
105798316|NCT01458119|364919332|FG000|Overall Study|Physician Decision|4|||
105798317|NCT01458119|364919332|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
105798318|NCT01458119|364919332|FG000|Overall Study|Pregnancy|1|||
105798319|NCT01458119|364919332|FG000|Overall Study|Death|2|||
105798320|NCT01458119|364919332|FG000|Overall Study|Adverse Event|1|||
105798321|NCT01458119|364919332|FG000|Overall Study|Consent Withdrawn by Participant|8|||
105480458|NCT00311584|363769163|FG000|Overall Study|ineligible|2|||
105480459|NCT00311584|363769164|FG001|Overall Study|ineligible|2|||
105480460|NCT03073733|363769165|FG000|Overall Study|Lost to Follow-up|1|||
105480461|NCT03073733|363769166|FG001|Overall Study|Lost to Follow-up|0|||
105798322|NCT01458119|364919332|FG000|Overall Study|Non-compliance With Study Drug|3|||
105798323|NCT00435825|364919333|FG000|Overall Study|Abnormality of Laboratory Test|0|||
105480462|NCT03073733|363769167|FG002|Overall Study|Lost to Follow-up|0|||
105480463|NCT03073733|363769165|FG000|Overall Study|Physician Decision|0|||
105480464|NCT03073733|363769166|FG001|Overall Study|Physician Decision|1|||
105798324|NCT00435825|364919334|FG001|Overall Study|Abnormality of Laboratory Test|1|||
105798325|NCT00435825|364919335|FG002|Overall Study|Abnormality of Laboratory Test|0|||
105798326|NCT00435825|364919336|FG003|Overall Study|Abnormality of Laboratory Test|0|||
105798327|NCT00435825|364919333|FG000|Overall Study|Insufficient Therapeutic Response|3|||
105798328|NCT00435825|364919334|FG001|Overall Study|Insufficient Therapeutic Response|1|||
105798329|NCT00435825|364919335|FG002|Overall Study|Insufficient Therapeutic Response|0|||
105798330|NCT00435825|364919336|FG003|Overall Study|Insufficient Therapeutic Response|3|||
105798331|NCT00435825|364919333|FG000|Overall Study|Other Protocol Violation|1|||
105480465|NCT03073733|363769167|FG002|Overall Study|Physician Decision|0|||
105480466|NCT03073733|363769165|FG000|Overall Study|Withdrawal by Subject|0|||
105798332|NCT00435825|364919334|FG001|Overall Study|Other Protocol Violation|0|||
105798333|NCT00435825|364919335|FG002|Overall Study|Other Protocol Violation|0|||
105798334|NCT00435825|364919336|FG003|Overall Study|Other Protocol Violation|0|||
105798335|NCT00435825|364919333|FG000|Overall Study|Refused treatment|2|||
105798336|NCT00435825|364919334|FG001|Overall Study|Refused treatment|0|||
105798337|NCT00435825|364919335|FG002|Overall Study|Refused treatment|0|||
105798338|NCT00435825|364919336|FG003|Overall Study|Refused treatment|5|||
105798339|NCT00435825|364919333|FG000|Overall Study|Failure to return|5|||
105798340|NCT00435825|364919334|FG001|Overall Study|Failure to return|0|||
105798341|NCT00435825|364919335|FG002|Overall Study|Failure to return|4|||
105798342|NCT00435825|364919336|FG003|Overall Study|Failure to return|0|||
105798343|NCT00435825|364919333|FG000|Overall Study|Did not receive study drug|1|||
105798344|NCT00435825|364919334|FG001|Overall Study|Did not receive study drug|0|||
105798345|NCT00435825|364919335|FG002|Overall Study|Did not receive study drug|2|||
105798346|NCT00435825|364919336|FG003|Overall Study|Did not receive study drug|0|||
105798347|NCT00435825|364919333|FG000|Overall Study|Did not enter follow-up|0|||
105798348|NCT00435825|364919334|FG001|Overall Study|Did not enter follow-up|4|||
105798349|NCT00435825|364919335|FG002|Overall Study|Did not enter follow-up|1|||
105798350|NCT00435825|364919336|FG003|Overall Study|Did not enter follow-up|3|||
105798351|NCT00435825|364919333|FG000|Overall Study|Did not complete full follow-up period|6|||
105798352|NCT00435825|364919334|FG001|Overall Study|Did not complete full follow-up period|6|||
105798353|NCT00435825|364919335|FG002|Overall Study|Did not complete full follow-up period|4|||
105798354|NCT00435825|364919336|FG003|Overall Study|Did not complete full follow-up period|5|||
105798355|NCT00530439|364919337|FG000|Overall Study|GDM|9|||
105798356|NCT00530439|364919338|FG001|Overall Study|GDM|3|||
105798357|NCT00530439|364919337|FG000|Overall Study|Withdraw|18|||
105798358|NCT00530439|364919338|FG001|Overall Study|Withdraw|14|||
105798359|NCT00530439|364919337|FG000|Overall Study|Missed abortion|1|||
105798360|NCT00530439|364919338|FG001|Overall Study|Missed abortion|4|||
105798361|NCT00530439|364919337|FG000|Overall Study|Misclassification|2|||
105798362|NCT00530439|364919338|FG001|Overall Study|Misclassification|0|||
105798363|NCT00530439|364919337|FG000|Overall Study|Twin pregnancy|0|||
105798364|NCT00530439|364919338|FG001|Overall Study|Twin pregnancy|2|||
105798365|NCT00530439|364919337|FG000|Overall Study|Severe malformation/abortion|0|||
105798366|NCT00530439|364919338|FG001|Overall Study|Severe malformation/abortion|3|||
105798367|NCT00430638|364919339|FG000|Overall Study|Adverse Event|15|||
105798368|NCT00430638|364919340|FG001|Overall Study|Adverse Event|15|||
105798369|NCT00430638|364919339|FG000|Overall Study|Uncontrolled blood pressure|48|||
105565034|NCT01090310|364066664|FG001|Extension Study|Aministrative problems|15|||
105565035|NCT01090310|364066665|FG002|Extension Study|Aministrative problems|14|||
105565036|NCT01090310|364066666|FG003|Extension Study|Aministrative problems|18|||
105565037|NCT01090310|364066663|FG000|Extension Study|Adverse Event|0|||
105565038|NCT01090310|364066664|FG001|Extension Study|Adverse Event|0|||
105565039|NCT01090310|364066665|FG002|Extension Study|Adverse Event|0|||
105565040|NCT01090310|364066666|FG003|Extension Study|Adverse Event|1|||
105565041|NCT01090310|364066663|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
105565042|NCT01090310|364066664|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
105565043|NCT01090310|364066665|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
105565044|NCT01090310|364066666|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
105565045|NCT01090310|364066663|FG000|Extension Study|Subject withdrew consent|0|||
105565046|NCT01090310|364066664|FG001|Extension Study|Subject withdrew consent|1|||
105565047|NCT01090310|364066665|FG002|Extension Study|Subject withdrew consent|0|||
105565048|NCT01090310|364066666|FG003|Extension Study|Subject withdrew consent|0|||
105733604|NCT00393458|364679432|FG000|Overall Study|Death|1|||
105733605|NCT00393458|364679433|FG001|Overall Study|Death|1|||
105733606|NCT00393458|364679434|FG002|Overall Study|Death|5|||
105798370|NCT00430638|364919340|FG001|Overall Study|Uncontrolled blood pressure|13|||
105798371|NCT00430638|364919339|FG000|Overall Study|Lost to Follow-up|1|||
105798372|NCT00430638|364919340|FG001|Overall Study|Lost to Follow-up|7|||
105798373|NCT00430638|364919339|FG000|Overall Study|Protocol Violation|6|||
105733607|NCT00393458|364679435|FG003|Overall Study|Death|5|||
105733608|NCT00393458|364679432|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105733609|NCT00393458|364679433|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105798374|NCT00430638|364919340|FG001|Overall Study|Protocol Violation|4|||
105798375|NCT00430638|364919339|FG000|Overall Study|Withdrawal by Subject|4|||
105798376|NCT00430638|364919340|FG001|Overall Study|Withdrawal by Subject|6|||
105565049|NCT01364922|364066667|FG000|Open-label (OL) Period|Adverse Event|7|||
105565050|NCT01364922|364066668|FG001|Open-label (OL) Period|Adverse Event|0|||
105565051|NCT01364922|364066669|FG002|Open-label (OL) Period|Adverse Event|0|||
105733610|NCT00393458|364679434|FG002|Overall Study|Abnormal test procedure result(s)|1|||
105733611|NCT00393458|364679435|FG003|Overall Study|Abnormal test procedure result(s)|2|||
105733612|NCT00393458|364679432|FG000|Overall Study|Subject no longer requires study drug|0|||
105733613|NCT00393458|364679433|FG001|Overall Study|Subject no longer requires study drug|1|||
105733614|NCT00393458|364679434|FG002|Overall Study|Subject no longer requires study drug|0|||
105733615|NCT00393458|364679435|FG003|Overall Study|Subject no longer requires study drug|0|||
105798377|NCT00430638|364919339|FG000|Overall Study|Non-compliant|2|||
105733616|NCT02104180|364679436|FG000|Overall Study|Protocol Violation|1|||
105733617|NCT02104180|364679437|FG001|Overall Study|Protocol Violation|0|||
105733618|NCT01524289|364679438|FG000|Overall Study|Lost to Follow-up|0|||
105733619|NCT01524289|364679439|FG001|Overall Study|Lost to Follow-up|1|||
105733620|NCT01524289|364679438|FG000|Overall Study|Physician Decision|1|||
105733621|NCT01524289|364679439|FG001|Overall Study|Physician Decision|0|||
105733622|NCT01524289|364679438|FG000|Overall Study|Protocol Violation|5|||
105733623|NCT01524289|364679439|FG001|Overall Study|Protocol Violation|1|||
105733624|NCT01524289|364679438|FG000|Overall Study|Withdrawal by Subject|11|||
105733625|NCT01524289|364679439|FG001|Overall Study|Withdrawal by Subject|7|||
105733626|NCT01524289|364679438|FG000|Overall Study|Adverse Event|12|||
105733627|NCT01524289|364679439|FG001|Overall Study|Adverse Event|5|||
105733628|NCT01524289|364679438|FG000|Overall Study|Did not take study medication|1|||
105733629|NCT01524289|364679439|FG001|Overall Study|Did not take study medication|0|||
105733630|NCT00377299|364679444|FG000|Overall Study|Lost to Follow-up|14|||
105733631|NCT00377299|364679445|FG001|Overall Study|Lost to Follow-up|19|||
105733632|NCT00377299|364679444|FG000|Overall Study|Adverse Event|0|||
105733633|NCT00377299|364679445|FG001|Overall Study|Adverse Event|1|||
105733634|NCT00377299|364679444|FG000|Overall Study|Withdrawal by Subject|5|||
105733635|NCT00377299|364679445|FG001|Overall Study|Withdrawal by Subject|4|||
105733636|NCT00638846|364679448|FG000|Overall Study|Adverse Event|0|||
105733637|NCT00638846|364679449|FG001|Overall Study|Adverse Event|1|||
105733638|NCT00638846|364679448|FG000|Overall Study|Lost to Follow-up|3|||
105733639|NCT00638846|364679449|FG001|Overall Study|Lost to Follow-up|2|||
105733640|NCT00638846|364679448|FG000|Overall Study|lens issue|1|||
105733641|NCT00638846|364679449|FG001|Overall Study|lens issue|3|||
105733642|NCT00035815|364679450|FG000|Overall Study|Withdrawal by Subject|17|||
105733643|NCT00035815|364679451|FG001|Overall Study|Withdrawal by Subject|11|||
105733644|NCT04285723|364679454|FG000|Overall Study|Subject decision|1|||
105733645|NCT04285723|364679455|FG001|Overall Study|Subject decision|2|||
105733646|NCT04285723|364679454|FG000|Overall Study|Physician Decision|1|||
105733647|NCT04285723|364679455|FG001|Overall Study|Physician Decision|0|||
105733648|NCT04285723|364679454|FG000|Overall Study|No efficiency|1|||
105733649|NCT04285723|364679455|FG001|Overall Study|No efficiency|0|||
105733650|NCT02903511|364679456|FG000|Overall Study|Withdrawal by Subject|1|||
105733651|NCT02903511|364679457|FG001|Overall Study|Withdrawal by Subject|0|||
105733652|NCT02903511|364679456|FG000|Overall Study|Lost to Follow-up|3|||
105733653|NCT02903511|364679457|FG001|Overall Study|Lost to Follow-up|2|||
105733654|NCT02839746|364680999|FG000|Overall Study|Not met selection criteria|12|||
105733655|NCT02517515|364681000|FG000|Overall Study|Adverse Event|0|||
105733656|NCT02517515|364681001|FG001|Overall Study|Adverse Event|1|||
105733657|NCT02517515|364681000|FG000|Overall Study|Withdrew Consent|0|||
105733658|NCT02517515|364681001|FG001|Overall Study|Withdrew Consent|1|||
105733659|NCT02517515|364681000|FG000|Overall Study|Lost to Follow-up|1|||
105733660|NCT02517515|364681001|FG001|Overall Study|Lost to Follow-up|0|||
105733661|NCT02517515|364681000|FG000|Overall Study|Other|1|||
105733662|NCT02517515|364681001|FG001|Overall Study|Other|0|||
105733663|NCT00151411|364681002|FG000|Overall Study|Lost to Follow-up|15|||
105733664|NCT00151411|364681003|FG001|Overall Study|Lost to Follow-up|19|||
105733665|NCT00151411|364681002|FG000|Overall Study|Withdrawal by Subject|12|||
105733666|NCT00151411|364681003|FG001|Overall Study|Withdrawal by Subject|20|||
105733667|NCT00151411|364681002|FG000|Overall Study|Adverse Event|6|||
105733668|NCT00151411|364681003|FG001|Overall Study|Adverse Event|0|||
105733669|NCT00151411|364681002|FG000|Overall Study|Pregnancy|0|||
105733670|NCT00151411|364681003|FG001|Overall Study|Pregnancy|4|||
105733671|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
105733672|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
105733673|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
105733674|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
105733675|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
105733676|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
105733677|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
105733678|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
105733679|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
105733680|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
105733681|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
105733682|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
105733683|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
105733684|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
105733685|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
105733686|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
105733687|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
105733688|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
105733689|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
105733690|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
105733691|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
105733692|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
105733693|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
105733694|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
105733695|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
105733696|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
105733697|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
105733698|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
105733699|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
105733700|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
105733701|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
105733702|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
105733703|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
105733704|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
105733705|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
105733706|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
105733707|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
105733708|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
105733709|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
105733710|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
105733711|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
105733712|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
105733713|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
105733714|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
105733715|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
105733716|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
105733717|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
105733718|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
105733719|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
105733720|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
105733721|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
105733722|NCT00092547|364681008|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
105733723|NCT00092547|364681009|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
105733724|NCT00092547|364681010|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
105733725|NCT00092547|364681008|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
105733726|NCT00092547|364681009|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
105733727|NCT00092547|364681010|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
105733728|NCT00092547|364681008|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
105733729|NCT00092547|364681009|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
105733730|NCT00092547|364681010|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
105733731|NCT00092547|364681008|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
105733732|NCT00092547|364681009|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
105733733|NCT00092547|364681010|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
105733734|NCT00634543|364681012|FG000|Overall Study|Other|1|||
105733735|NCT00634543|364681013|FG001|Overall Study|Other|2|||
105733736|NCT00634543|364681012|FG000|Overall Study|Protocol Violation|3|||
105733737|NCT00634543|364681013|FG001|Overall Study|Protocol Violation|3|||
105733738|NCT00634543|364681012|FG000|Overall Study|Adverse Event|11|||
105733739|NCT00634543|364681013|FG001|Overall Study|Adverse Event|11|||
105733740|NCT00634543|364681012|FG000|Overall Study|Withdrawal by Subject|4|||
105733741|NCT00634543|364681013|FG001|Overall Study|Withdrawal by Subject|4|||
105733742|NCT00634543|364681012|FG000|Overall Study|Lost to Follow-up|0|||
105733743|NCT00634543|364681013|FG001|Overall Study|Lost to Follow-up|1|||
105733744|NCT02138110|364681016|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
105733745|NCT02138110|364681016|FG000|Overall Scaffold Implantation|Death|3|||
105733746|NCT02401256|364681017|FG000|Overall Study|Adverse Event|5|||
105733747|NCT02401256|364681017|FG000|Overall Study|Withdrawal by Subject|12|||
105733748|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
105733749|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
105733750|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
105733751|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
105733752|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
105733753|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
105733754|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
105565052|NCT01364922|364066667|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
105565053|NCT01364922|364066668|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
105565054|NCT01364922|364066669|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
105733755|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
105733756|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
105733757|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
105733758|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
105733759|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
105733760|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
105353293|NCT01690299|363298525|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
105353294|NCT01690299|363298520|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
105353295|NCT01690299|363298521|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105353296|NCT01690299|363298522|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105353297|NCT01690299|363298523|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105353298|NCT01690299|363298524|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105353299|NCT01690299|363298525|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105353300|NCT01690299|363298520|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
105353301|NCT01690299|363298521|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
105353302|NCT01690299|363298522|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105353303|NCT01690299|363298523|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105353304|NCT01690299|363298524|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105353305|NCT01690299|363298525|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105353306|NCT01690299|363298520|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
105353307|NCT01690299|363298521|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
105353308|NCT01690299|363298522|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
105353309|NCT01690299|363298523|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
105353310|NCT01690299|363298524|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
105353311|NCT01690299|363298525|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
105353312|NCT01690299|363298520|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
105353313|NCT01690299|363298521|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
105353314|NCT01690299|363298522|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
105353315|NCT01690299|363298523|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
105353316|NCT01690299|363298524|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
105353317|NCT01690299|363298525|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
105353318|NCT01690299|363298520|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
105353319|NCT01690299|363298521|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
105353320|NCT01690299|363298522|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
105353321|NCT01690299|363298523|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
105353322|NCT01690299|363298524|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
105353323|NCT01690299|363298525|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
105353324|NCT01690299|363298520|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
105353325|NCT01690299|363298521|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
105353326|NCT01690299|363298522|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
105353327|NCT01690299|363298523|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
105353328|NCT01690299|363298524|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
105353329|NCT01690299|363298525|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
105353330|NCT01690299|363298520|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
105353331|NCT01690299|363298521|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
105353332|NCT01690299|363298522|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
105353333|NCT01690299|363298523|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
105353334|NCT01690299|363298524|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
105353335|NCT01690299|363298525|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
105353336|NCT01690299|363298520|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
105353337|NCT01690299|363298521|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
105353338|NCT01690299|363298522|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
105353339|NCT01690299|363298523|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
105353340|NCT01690299|363298524|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
105353341|NCT01690299|363298525|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
105353342|NCT01690299|363298520|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
105353343|NCT01690299|363298521|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
105353344|NCT01690299|363298522|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
105353345|NCT01690299|363298523|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
105353346|NCT01690299|363298524|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
105353347|NCT01690299|363298525|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
105353348|NCT05161481|363298526|FG000|Overall Study|Withdrawal of consent|0|||
105733761|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
105798378|NCT00430638|364919340|FG001|Overall Study|Non-compliant|1|||
105798379|NCT00430638|364919339|FG000|Overall Study|Other|2|||
105798380|NCT00430638|364919340|FG001|Overall Study|Other|2|||
105798381|NCT01010230|364919341|FG000|Overall Study|Withdrawal by Subject|6|||
105798382|NCT01010230|364919342|FG001|Overall Study|Withdrawal by Subject|5|||
105798383|NCT01010230|364919341|FG000|Overall Study|Lost to Follow-up|4|||
105798384|NCT01010230|364919342|FG001|Overall Study|Lost to Follow-up|2|||
105798385|NCT01629693|364919345|FG000|Overall Study|Lost to Follow-up|2|||
105798386|NCT01629693|364919346|FG001|Overall Study|Lost to Follow-up|4|||
105798387|NCT01629693|364919345|FG000|Overall Study|Withdrawal by Subject|2|||
105798388|NCT01629693|364919346|FG001|Overall Study|Withdrawal by Subject|2|||
105798389|NCT01629693|364919345|FG000|Overall Study|Adverse Event|1|||
105798390|NCT01629693|364919346|FG001|Overall Study|Adverse Event|0|||
105798391|NCT01629693|364919345|FG000|Overall Study|Investigator decision|0|||
105798392|NCT01629693|364919346|FG001|Overall Study|Investigator decision|1|||
105798393|NCT01629693|364919345|FG000|Overall Study|Poor comfort of study lenses|0|||
105798394|NCT01629693|364919346|FG001|Overall Study|Poor comfort of study lenses|2|||
105798395|NCT01629693|364919345|FG000|Overall Study|Subject decision unrelated to AE|0|||
105798396|NCT01629693|364919346|FG001|Overall Study|Subject decision unrelated to AE|1|||
105798397|NCT01225991|364919349|FG000|Overall Study|Withdrawal by Subject|6|||
105798398|NCT00789828|364919350|FG000|Core Period (48 Weeks)|Administrative problems|0|||
105798399|NCT00789828|364919351|FG001|Core Period (48 Weeks)|Administrative problems|1|||
105798400|NCT00789828|364919350|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
105798401|NCT00789828|364919351|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
105798402|NCT00789828|364919350|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
105798403|NCT00789828|364919351|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
105798404|NCT00789828|364919350|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
105798405|NCT00789828|364919351|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
105798406|NCT00789828|364919350|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
105798407|NCT00789828|364919351|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
105798408|NCT00789828|364919350|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
105798409|NCT00789828|364919351|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
105798410|NCT00789828|364919350|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
105798411|NCT00789828|364919351|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
105798412|NCT00789828|364919350|FG000|Open-label Extension Period (4 Years)|Death|1|||
105798413|NCT00789828|364919351|FG001|Open-label Extension Period (4 Years)|Death|0|||
105798414|NCT00789828|364919350|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
105798415|NCT00789828|364919351|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
105798416|NCT00789828|364919350|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
105798417|NCT00789828|364919351|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
105798418|NCT05788237|364919352|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
105798419|NCT05788237|364919353|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
105798420|NCT05788237|364919354|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
105798421|NCT05788237|364919355|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
105798422|NCT05788237|364919352|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
105798423|NCT05788237|364919353|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
105798424|NCT05788237|364919354|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
105798425|NCT05788237|364919355|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
105798426|NCT05788237|364919352|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
105798427|NCT05788237|364919353|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
105798428|NCT05788237|364919354|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
105798429|NCT05788237|364919355|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
105798430|NCT05788237|364919352|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
105798431|NCT05788237|364919353|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
105798432|NCT05788237|364919354|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
105798433|NCT05788237|364919355|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
105798434|NCT05788237|364919352|FG000|SSA (Approximately 2 Months)|Death|0|||
105798435|NCT05788237|364919353|FG001|SSA (Approximately 2 Months)|Death|1|||
105798436|NCT05788237|364919354|FG002|SSA (Approximately 2 Months)|Death|0|||
105565055|NCT01364922|364066667|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
105565056|NCT01364922|364066668|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
105565057|NCT01364922|364066669|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
105565058|NCT01364922|364066667|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
105565059|NCT01364922|364066668|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
105565060|NCT01364922|364066669|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
105565061|NCT01364922|364066667|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
105565062|NCT01364922|364066668|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
105565063|NCT01364922|364066669|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
105565064|NCT01364922|364066667|FG000|Open-label (OL) Period|Other, Unspecified|1|||
105565065|NCT01364922|364066668|FG001|Open-label (OL) Period|Other, Unspecified|0|||
105565066|NCT01364922|364066669|FG002|Open-label (OL) Period|Other, Unspecified|0|||
105733762|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
105733763|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
105733764|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
105733765|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
105733766|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Death|0|||
105733767|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Death|1|||
105733768|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Death|0|||
105733769|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
105733770|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
105733771|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
105733772|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
105733773|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
105733774|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
105733775|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
105733776|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
105733777|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
105733778|NCT00430781|364681018|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
105733779|NCT00430781|364681019|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
105733780|NCT00430781|364681020|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
105733781|NCT00430781|364681018|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
105733782|NCT00430781|364681019|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
105733783|NCT00430781|364681020|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
105733784|NCT00430781|364681018|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
105733785|NCT00430781|364681019|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
105733786|NCT00430781|364681020|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
105733787|NCT00430781|364681018|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
105733788|NCT00430781|364681019|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
105733789|NCT00430781|364681020|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
105733790|NCT00430781|364681018|FG000|Final Analysis; 31 July 2008|Other|0|||
105733791|NCT00430781|364681019|FG001|Final Analysis; 31 July 2008|Other|1|||
105733792|NCT00430781|364681020|FG002|Final Analysis; 31 July 2008|Other|0|||
105733793|NCT00430781|364681018|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
105733794|NCT00430781|364681019|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
105733795|NCT00430781|364681020|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
105733796|NCT00430781|364681018|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
105733797|NCT00430781|364681019|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
105733798|NCT00430781|364681020|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
105733799|NCT00430781|364681018|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
105733800|NCT00430781|364681019|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
105733801|NCT00430781|364681020|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
105733802|NCT00430781|364681018|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
105733803|NCT00430781|364681019|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
105733804|NCT00430781|364681020|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
105733805|NCT00430781|364681018|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
105733806|NCT00430781|364681019|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
105733807|NCT00430781|364681020|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
105733808|NCT00430781|364681018|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
105733809|NCT00430781|364681019|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
105733810|NCT00430781|364681020|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
105733811|NCT00430781|364681018|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
105733812|NCT00430781|364681019|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
105733813|NCT00430781|364681020|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
105733814|NCT00882713|364681021|FG000|Overall Study|Adverse Event|2|||
105733815|NCT00882713|364681021|FG000|Overall Study|Death|3|||
105733816|NCT00882713|364681021|FG000|Overall Study|Administrative reasons|4|||
105733817|NCT00882713|364681021|FG000|Overall Study|refused treatment/withdrew consent|4|||
105733818|NCT00882713|364681021|FG000|Overall Study|Blood transfusion|2|||
105733819|NCT00882713|364681021|FG000|Overall Study|Insufficient therapeutic response|3|||
105733820|NCT00882713|364681021|FG000|Overall Study|Failure to return|2|||
105565067|NCT01364922|364066667|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
105565068|NCT01364922|364066668|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
105565069|NCT01364922|364066669|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
105733821|NCT00882713|364681021|FG000|Overall Study|Other - Reasons|2|||
105733822|NCT03515538|364681024|FG000|Overall Study|Lack of Efficacy|2|||
105733823|NCT03515538|364681025|FG001|Overall Study|Lack of Efficacy|0|||
105733824|NCT03515538|364681026|FG002|Overall Study|Lack of Efficacy|2|||
105733825|NCT03515538|364681027|FG003|Overall Study|Lack of Efficacy|0|||
105733826|NCT03515538|364681024|FG000|Overall Study|Death|0|||
105733827|NCT03515538|364681025|FG001|Overall Study|Death|0|||
105733828|NCT03515538|364681026|FG002|Overall Study|Death|1|||
105733829|NCT03515538|364681027|FG003|Overall Study|Death|0|||
105733830|NCT03515538|364681024|FG000|Overall Study|Protocol Violation|0|||
105733831|NCT03515538|364681025|FG001|Overall Study|Protocol Violation|0|||
105733832|NCT03515538|364681026|FG002|Overall Study|Protocol Violation|0|||
105733833|NCT03515538|364681027|FG003|Overall Study|Protocol Violation|1|||
105733834|NCT03515538|364681024|FG000|Overall Study|Screen failure (baseline dropout)|0|||
105733835|NCT03515538|364681025|FG001|Overall Study|Screen failure (baseline dropout)|1|||
105733836|NCT03515538|364681026|FG002|Overall Study|Screen failure (baseline dropout)|0|||
105733837|NCT03515538|364681027|FG003|Overall Study|Screen failure (baseline dropout)|0|||
105733838|NCT03515538|364681024|FG000|Overall Study|Withdrawal by Subject|2|||
105733839|NCT03515538|364681025|FG001|Overall Study|Withdrawal by Subject|2|||
105733840|NCT03515538|364681026|FG002|Overall Study|Withdrawal by Subject|1|||
105733841|NCT03515538|364681027|FG003|Overall Study|Withdrawal by Subject|3|||
105733842|NCT03515538|364681024|FG000|Overall Study|Physician Decision|1|||
105733843|NCT03515538|364681025|FG001|Overall Study|Physician Decision|0|||
105733844|NCT03515538|364681026|FG002|Overall Study|Physician Decision|0|||
105733845|NCT03515538|364681027|FG003|Overall Study|Physician Decision|1|||
105733846|NCT00098345|364681029|FG000|Overall Study|Adverse Event|7|||
105733847|NCT00098345|364681029|FG000|Overall Study|Withdrawal by Subject|2|||
105733848|NCT00098345|364681029|FG000|Overall Study|progression|4|||
105733849|NCT03707977|364681030|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
105733850|NCT03707977|364681031|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
105733851|NCT03707977|364681032|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
105733852|NCT03707977|364681030|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
105733853|NCT03707977|364681031|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
105733854|NCT03707977|364681032|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
105733855|NCT01380093|364681035|FG000|Naloxone Challenge Phase|Screen failures|21|||
105733856|NCT01380093|364681036|FG001|Naloxone Challenge Phase|Screen failures|0|||
105733857|NCT01380093|364681037|FG002|Naloxone Challenge Phase|Screen failures|0|||
105733858|NCT01380093|364681038|FG003|Naloxone Challenge Phase|Screen failures|0|||
105733859|NCT01380093|364681039|FG004|Naloxone Challenge Phase|Screen failures|0|||
105733860|NCT01380093|364681040|FG005|Naloxone Challenge Phase|Screen failures|0|||
105733861|NCT01380093|364681041|FG006|Naloxone Challenge Phase|Screen failures|0|||
105733862|NCT01380093|364681042|FG007|Naloxone Challenge Phase|Screen failures|0|||
105733863|NCT01380093|364681043|FG008|Naloxone Challenge Phase|Screen failures|0|||
105733864|NCT01380093|364681035|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733865|NCT01380093|364681036|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
105733866|NCT01380093|364681037|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733867|NCT01380093|364681038|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733868|NCT01380093|364681039|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733869|NCT01380093|364681040|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733870|NCT01380093|364681041|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733871|NCT01380093|364681042|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733872|NCT01380093|364681043|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733873|NCT01380093|364681035|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
105733874|NCT01380093|364681036|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
105733875|NCT01380093|364681037|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
105733876|NCT01380093|364681038|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
105733877|NCT01380093|364681039|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
105733878|NCT01380093|364681040|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
105733879|NCT01380093|364681041|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
105733880|NCT01380093|364681042|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
105733881|NCT01380093|364681043|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
105733882|NCT01380093|364681035|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733883|NCT01380093|364681036|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
105733884|NCT01380093|364681037|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733885|NCT01380093|364681038|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733886|NCT01380093|364681039|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733887|NCT01380093|364681040|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733888|NCT01380093|364681041|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733889|NCT01380093|364681042|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733890|NCT01380093|364681043|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733891|NCT01380093|364681035|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
105733892|NCT01380093|364681036|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
105733893|NCT01380093|364681037|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
105480467|NCT03073733|363769166|FG001|Overall Study|Withdrawal by Subject|0|||
105480468|NCT03073733|363769167|FG002|Overall Study|Withdrawal by Subject|1|||
105480469|NCT03658876|363771203|FG000|Overall Study|Protocol Violation|3|||
105480470|NCT03658876|363771204|FG001|Overall Study|Protocol Violation|2|||
105480471|NCT03658876|363771203|FG000|Overall Study|Withdrawal by Subject|2|||
105733894|NCT01380093|364681038|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
105733895|NCT01380093|364681039|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
105733896|NCT01380093|364681040|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
105733897|NCT01380093|364681041|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
105733898|NCT01380093|364681042|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
105733899|NCT01380093|364681043|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
105733900|NCT01380093|364681035|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
105733901|NCT01380093|364681036|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
105733902|NCT01380093|364681037|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
105733903|NCT01380093|364681038|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
105733904|NCT01380093|364681039|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
105733905|NCT01380093|364681040|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
105733906|NCT01380093|364681041|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
105733907|NCT01380093|364681042|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
105733908|NCT01380093|364681043|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
105733909|NCT01380093|364681035|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733910|NCT01380093|364681036|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733911|NCT01380093|364681037|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
105733912|NCT01380093|364681038|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733913|NCT01380093|364681039|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733914|NCT01380093|364681040|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733915|NCT01380093|364681041|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733916|NCT01380093|364681042|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733917|NCT01380093|364681043|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733918|NCT01380093|364681035|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733919|NCT01380093|364681036|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733920|NCT01380093|364681037|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
105733921|NCT01380093|364681038|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733922|NCT01380093|364681039|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733923|NCT01380093|364681040|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733924|NCT01380093|364681041|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733925|NCT01380093|364681042|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733926|NCT01380093|364681043|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733927|NCT01380093|364681035|FG000|Treatment Phase: Second Intervention|Other|0|||
105733928|NCT01380093|364681036|FG001|Treatment Phase: Second Intervention|Other|0|||
105733929|NCT01380093|364681037|FG002|Treatment Phase: Second Intervention|Other|0|||
105733930|NCT01380093|364681038|FG003|Treatment Phase: Second Intervention|Other|1|||
105733931|NCT01380093|364681039|FG004|Treatment Phase: Second Intervention|Other|0|||
105733932|NCT01380093|364681040|FG005|Treatment Phase: Second Intervention|Other|0|||
105733933|NCT01380093|364681041|FG006|Treatment Phase: Second Intervention|Other|0|||
105733934|NCT01380093|364681042|FG007|Treatment Phase: Second Intervention|Other|0|||
105733935|NCT01380093|364681043|FG008|Treatment Phase: Second Intervention|Other|0|||
105733936|NCT01380093|364681035|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
105733937|NCT01380093|364681036|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
105733938|NCT01380093|364681037|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
105733939|NCT01380093|364681038|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
105733940|NCT01380093|364681039|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
105733941|NCT01380093|364681040|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
105733942|NCT01380093|364681041|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
105733943|NCT01380093|364681042|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
105733944|NCT01380093|364681043|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
105733945|NCT01380093|364681035|FG000|Treatment Phase: Third Intervention|Other|0|||
105733946|NCT01380093|364681036|FG001|Treatment Phase: Third Intervention|Other|0|||
105733947|NCT01380093|364681037|FG002|Treatment Phase: Third Intervention|Other|0|||
105733948|NCT01380093|364681038|FG003|Treatment Phase: Third Intervention|Other|0|||
105733949|NCT01380093|364681039|FG004|Treatment Phase: Third Intervention|Other|0|||
105733950|NCT01380093|364681040|FG005|Treatment Phase: Third Intervention|Other|0|||
105733951|NCT01380093|364681041|FG006|Treatment Phase: Third Intervention|Other|0|||
105733952|NCT01380093|364681042|FG007|Treatment Phase: Third Intervention|Other|0|||
105733953|NCT01380093|364681043|FG008|Treatment Phase: Third Intervention|Other|1|||
105733954|NCT00308620|364681044|FG000|Overall Study|Death|1|||
105733955|NCT00308620|364681045|FG001|Overall Study|Death|1|||
105733956|NCT00308620|364681046|FG002|Overall Study|Death|0|||
105733957|NCT00308620|364681044|FG000|Overall Study|Lost to Follow-up|0|||
105733958|NCT00308620|364681045|FG001|Overall Study|Lost to Follow-up|0|||
105733959|NCT00308620|364681046|FG002|Overall Study|Lost to Follow-up|1|||
105733960|NCT03952650|364681047|FG000|Overall Study|TRAVEL|0|||
105733961|NCT03952650|364681048|FG001|Overall Study|TRAVEL|4|||
105733962|NCT03952650|364681049|FG002|Overall Study|TRAVEL|0|||
105733963|NCT03952650|364681050|FG003|Overall Study|TRAVEL|4|||
105480472|NCT03658876|363771204|FG001|Overall Study|Withdrawal by Subject|0|||
105480473|NCT03658876|363771203|FG000|Overall Study|Death|0|||
105733964|NCT03952650|364681051|FG004|Overall Study|TRAVEL|0|||
105733965|NCT03952650|364681052|FG005|Overall Study|TRAVEL|3|||
105733966|NCT03952650|364681053|FG006|Overall Study|TRAVEL|2|||
105733967|NCT03952650|364681047|FG000|Overall Study|Withdrawal by Subject|0|||
105733968|NCT03952650|364681048|FG001|Overall Study|Withdrawal by Subject|2|||
105733969|NCT03952650|364681049|FG002|Overall Study|Withdrawal by Subject|0|||
105733970|NCT03952650|364681050|FG003|Overall Study|Withdrawal by Subject|3|||
105733971|NCT03952650|364681051|FG004|Overall Study|Withdrawal by Subject|0|||
105733972|NCT03952650|364681052|FG005|Overall Study|Withdrawal by Subject|1|||
105733973|NCT03952650|364681053|FG006|Overall Study|Withdrawal by Subject|1|||
105733974|NCT03952650|364681047|FG000|Overall Study|Lost to Follow-up|0|||
105733975|NCT03952650|364681048|FG001|Overall Study|Lost to Follow-up|1|||
105733976|NCT03952650|364681049|FG002|Overall Study|Lost to Follow-up|0|||
105733977|NCT03952650|364681050|FG003|Overall Study|Lost to Follow-up|0|||
105733978|NCT03952650|364681051|FG004|Overall Study|Lost to Follow-up|0|||
105733979|NCT03952650|364681052|FG005|Overall Study|Lost to Follow-up|1|||
105733980|NCT03952650|364681053|FG006|Overall Study|Lost to Follow-up|1|||
105798437|NCT05788237|364919355|FG003|SSA (Approximately 2 Months)|Death|0|||
105733981|NCT03952650|364681047|FG000|Overall Study|Received wrong vaccine and travelled|0|||
105733982|NCT03952650|364681048|FG001|Overall Study|Received wrong vaccine and travelled|0|||
105733983|NCT03952650|364681049|FG002|Overall Study|Received wrong vaccine and travelled|0|||
105733984|NCT03952650|364681050|FG003|Overall Study|Received wrong vaccine and travelled|0|||
105480474|NCT03658876|363771204|FG001|Overall Study|Death|1|||
105480475|NCT03658876|363771203|FG000|Overall Study|Intercurrent illness|6|||
105480476|NCT03658876|363771204|FG001|Overall Study|Intercurrent illness|4|||
105480477|NCT03658876|363771203|FG000|Overall Study|Transplantation/other operation|1|||
105480478|NCT03658876|363771204|FG001|Overall Study|Transplantation/other operation|5|||
105480479|NCT03137069|363771205|FG000|Overall Study|Withdrawal by Subject|1|||
105480480|NCT03137069|363771206|FG001|Overall Study|Withdrawal by Subject|2|||
105480481|NCT03137069|363771207|FG002|Overall Study|Withdrawal by Subject|2|||
105480482|NCT03137069|363771208|FG003|Overall Study|Withdrawal by Subject|2|||
105480483|NCT03137069|363771209|FG004|Overall Study|Withdrawal by Subject|0|||
105480484|NCT03137069|363771210|FG005|Overall Study|Withdrawal by Subject|0|||
105480485|NCT03137069|363771205|FG000|Overall Study|Adverse Event|0|||
105480486|NCT03137069|363771206|FG001|Overall Study|Adverse Event|3|||
105480487|NCT03137069|363771207|FG002|Overall Study|Adverse Event|1|||
105480488|NCT03137069|363771208|FG003|Overall Study|Adverse Event|1|||
105480489|NCT03137069|363771209|FG004|Overall Study|Adverse Event|0|||
105733985|NCT03952650|364681051|FG004|Overall Study|Received wrong vaccine and travelled|0|||
105733986|NCT03952650|364681052|FG005|Overall Study|Received wrong vaccine and travelled|1|||
105733987|NCT03952650|364681053|FG006|Overall Study|Received wrong vaccine and travelled|0|||
105733988|NCT03952650|364681047|FG000|Overall Study|Unable to make study visit|0|||
105733989|NCT03952650|364681048|FG001|Overall Study|Unable to make study visit|0|||
105733990|NCT03952650|364681049|FG002|Overall Study|Unable to make study visit|0|||
105733991|NCT03952650|364681050|FG003|Overall Study|Unable to make study visit|0|||
105733992|NCT03952650|364681051|FG004|Overall Study|Unable to make study visit|0|||
105798438|NCT05788237|364919352|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
105798439|NCT05788237|364919353|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
105798440|NCT05788237|364919354|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
105798441|NCT05788237|364919355|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
105798442|NCT05788237|364919352|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
105798443|NCT05788237|364919353|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
105798444|NCT05788237|364919354|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
105798445|NCT05788237|364919355|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
105798446|NCT05788237|364919352|FG000|SSB (Approximately 1 Month)|Other|0|||
105798447|NCT05788237|364919353|FG001|SSB (Approximately 1 Month)|Other|0|||
105798448|NCT05788237|364919354|FG002|SSB (Approximately 1 Month)|Other|0|||
105480490|NCT03137069|363771210|FG005|Overall Study|Adverse Event|1|||
105733993|NCT03952650|364681052|FG005|Overall Study|Unable to make study visit|1|||
105733994|NCT03952650|364681053|FG006|Overall Study|Unable to make study visit|0|||
105480491|NCT03137069|363771205|FG000|Overall Study|Protocol Violation|0|||
105480492|NCT03137069|363771206|FG001|Overall Study|Protocol Violation|1|||
105733995|NCT03988751|364681062|FG000|Overall Study|Withdrawal by Subject|1|||
105733996|NCT03988751|364681063|FG001|Overall Study|Withdrawal by Subject|0|||
105733997|NCT03988751|364681062|FG000|Overall Study|Protocol Violation|0|||
105733998|NCT03988751|364681063|FG001|Overall Study|Protocol Violation|1|||
105733999|NCT00844883|364681064|FG000|Overall Study|Bridged to liver transplant|3|||
105734000|NCT00844883|364681064|FG000|Overall Study|Bridged to resection|1|||
105734001|NCT02623361|364681065|FG000|Overall Study|Protocol Violation|0|||
105734002|NCT02623361|364681066|FG001|Overall Study|Protocol Violation|1|||
105734003|NCT02623361|364681065|FG000|Overall Study|Withdrawal by Subject|0|||
105734004|NCT02623361|364681066|FG001|Overall Study|Withdrawal by Subject|1|||
105734005|NCT03043365|364681067|FG000|Weeks 0 to Week 8|Adverse Event|1|||
105734006|NCT03043365|364681068|FG001|Weeks 0 to Week 8|Adverse Event|3|||
105734007|NCT03043365|364681067|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
105734008|NCT03043365|364681068|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
105734009|NCT03043365|364681067|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
105734010|NCT03043365|364681068|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
105734011|NCT03065530|364681069|FG000|Overall Study|Lack of Efficacy|1|||
105734012|NCT03065530|364681070|FG001|Overall Study|Lack of Efficacy|1|||
105734013|NCT03065530|364681071|FG002|Overall Study|Lack of Efficacy|0|||
105734014|NCT03065530|364681072|FG003|Overall Study|Lack of Efficacy|1|||
105734015|NCT03065530|364681069|FG000|Overall Study|Protocol Violation|1|||
105734016|NCT03065530|364681070|FG001|Overall Study|Protocol Violation|0|||
105734017|NCT03065530|364681071|FG002|Overall Study|Protocol Violation|1|||
105734018|NCT03065530|364681072|FG003|Overall Study|Protocol Violation|1|||
105734019|NCT02498652|364681073|FG000|Overall Study|Protocol Violation|0|||
105734020|NCT02498652|364681074|FG001|Overall Study|Protocol Violation|1|||
105734021|NCT02723630|364681075|FG000|Intervention Period 1|Adverse Event|1|||
105734022|NCT02723630|364681076|FG001|Intervention Period 1|Adverse Event|0|||
105734023|NCT02723630|364681077|FG002|Intervention Period 1|Adverse Event|0|||
105734024|NCT02723630|364681078|FG003|Intervention Period 1|Adverse Event|0|||
105734025|NCT02723630|364681079|FG004|Intervention Period 1|Adverse Event|0|||
105734026|NCT02723630|364681080|FG005|Intervention Period 1|Adverse Event|0|||
105734027|NCT02723630|364681075|FG000|Intervention Period 3|consumption of restricted item|0|||
105734028|NCT02723630|364681076|FG001|Intervention Period 3|consumption of restricted item|1|||
105734029|NCT02723630|364681077|FG002|Intervention Period 3|consumption of restricted item|0|||
105734030|NCT02723630|364681078|FG003|Intervention Period 3|consumption of restricted item|0|||
105734031|NCT02723630|364681079|FG004|Intervention Period 3|consumption of restricted item|0|||
105734032|NCT02723630|364681080|FG005|Intervention Period 3|consumption of restricted item|0|||
105798449|NCT05788237|364919355|FG003|SSB (Approximately 1 Month)|Other|1|||
105798450|NCT02239692|364920879|FG000|Overall Study|Incomplete colonoscopy|1|||
105480493|NCT03137069|363771207|FG002|Overall Study|Protocol Violation|0|||
105480494|NCT03137069|363771208|FG003|Overall Study|Protocol Violation|1|||
105480495|NCT03137069|363771209|FG004|Overall Study|Protocol Violation|1|||
105480496|NCT03137069|363771210|FG005|Overall Study|Protocol Violation|1|||
105480497|NCT03137069|363771205|FG000|Overall Study|Physician Decision|0|||
105734033|NCT03455543|364681081|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
105734034|NCT03455543|364681082|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
105734035|NCT03455543|364681083|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
105734036|NCT03455543|364681081|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
105734037|NCT03455543|364681082|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
105734038|NCT03455543|364681083|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
105798451|NCT02239692|364920880|FG001|Overall Study|Incomplete colonoscopy|2|||
105798452|NCT02239692|364920879|FG000|Overall Study|Adverse Event|0|||
105798453|NCT02239692|364920880|FG001|Overall Study|Adverse Event|1|||
105798454|NCT02239692|364920879|FG000|Overall Study|Physician Decision|0|||
105798455|NCT02239692|364920880|FG001|Overall Study|Physician Decision|1|||
105798456|NCT02239692|364920879|FG000|Overall Study|Lost to Follow-up|1|||
105798457|NCT02239692|364920880|FG001|Overall Study|Lost to Follow-up|4|||
105798458|NCT02239692|364920879|FG000|Overall Study|Withdrawal by Subject|3|||
105798459|NCT02239692|364920880|FG001|Overall Study|Withdrawal by Subject|5|||
105798460|NCT02239692|364920879|FG000|Overall Study|Other reason|1|||
105798461|NCT02239692|364920880|FG001|Overall Study|Other reason|0|||
105798462|NCT00569231|364920885|FG000|Overall Study|Study unrelated surgery|1|||
105798463|NCT00569231|364920885|FG000|Overall Study|Airfare expense|2|||
105798464|NCT00569231|364920885|FG000|Overall Study|Withdrawal by Subject|1|||
105798465|NCT00569231|364920885|FG000|Overall Study|Car accident injury|1|||
105798466|NCT00569231|364920885|FG000|Overall Study|Non-compliance|2|||
105798467|NCT00305110|364920888|FG000|Overall Study|Missing data|29|||
105798468|NCT01467570|364920891|FG000|Overall Study|Lost to Follow-up|8|||
105798469|NCT01467570|364920892|FG001|Overall Study|Lost to Follow-up|9|||
105798470|NCT01835470|364920893|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
105798471|NCT01835470|364920893|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
105798472|NCT00304954|364920894|FG000|Overall Study|Withdrawal by Subject|0|||
105798473|NCT00304954|364920895|FG001|Overall Study|Withdrawal by Subject|0|||
105798474|NCT00304954|364920896|FG002|Overall Study|Withdrawal by Subject|1|||
105798475|NCT00304954|364920897|FG003|Overall Study|Withdrawal by Subject|0|||
105798476|NCT00304954|364920894|FG000|Overall Study|Adverse Event|1|||
105798477|NCT00304954|364920895|FG001|Overall Study|Adverse Event|0|||
105798478|NCT00304954|364920896|FG002|Overall Study|Adverse Event|0|||
105798479|NCT00304954|364920897|FG003|Overall Study|Adverse Event|0|||
105798480|NCT01440647|364920898|FG000|Overall Study|Death|2|||
105798481|NCT01440647|364920899|FG001|Overall Study|Death|3|||
105798482|NCT02595528|364920924|FG000|Overall Study|Withdrawal by Subject|1|||
105798483|NCT02595528|364920925|FG001|Overall Study|Withdrawal by Subject|2|||
105798484|NCT02595528|364920926|FG002|Overall Study|Withdrawal by Subject|1|||
105798485|NCT02595528|364920927|FG003|Overall Study|Withdrawal by Subject|3|||
105798486|NCT02595528|364920924|FG000|Overall Study|Lost to Follow-up|1|||
105798487|NCT02595528|364920925|FG001|Overall Study|Lost to Follow-up|1|||
105798488|NCT02595528|364920926|FG002|Overall Study|Lost to Follow-up|0|||
105798489|NCT02595528|364920927|FG003|Overall Study|Lost to Follow-up|1|||
105798490|NCT03862625|364920928|FG000|Overall Study|Lost to Follow-up|0|||
105798491|NCT03862625|364920929|FG001|Overall Study|Lost to Follow-up|1|||
105798492|NCT04023994|364920940|FG000|Overall Study|Lost to Follow-up|0|||
105798493|NCT04023994|364920941|FG001|Overall Study|Lost to Follow-up|1|||
105798494|NCT04023994|364920942|FG002|Overall Study|Lost to Follow-up|2|||
105798495|NCT04023994|364920943|FG003|Overall Study|Lost to Follow-up|0|||
105798496|NCT04023994|364920944|FG004|Overall Study|Lost to Follow-up|0|||
105798497|NCT04023994|364920945|FG005|Overall Study|Lost to Follow-up|0|||
105798498|NCT04023994|364920940|FG000|Overall Study|Withdrawal by Subject|0|||
105798499|NCT04023994|364920941|FG001|Overall Study|Withdrawal by Subject|0|||
105798500|NCT04023994|364920942|FG002|Overall Study|Withdrawal by Subject|0|||
105798501|NCT04023994|364920943|FG003|Overall Study|Withdrawal by Subject|1|||
105798502|NCT04023994|364920944|FG004|Overall Study|Withdrawal by Subject|0|||
105798503|NCT04023994|364920945|FG005|Overall Study|Withdrawal by Subject|0|||
105798504|NCT01377233|364920946|FG000|Open-label|Adverse Event|1|||
105798505|NCT01377233|364920947|FG001|Open-label|Adverse Event|0|||
105798506|NCT01377233|364920948|FG002|Open-label|Adverse Event|0|||
105798507|NCT01377233|364920949|FG003|Open-label|Adverse Event|0|||
105734039|NCT03455543|364681081|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
105734040|NCT03455543|364681082|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
105734041|NCT03455543|364681083|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
105734042|NCT03455543|364681081|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
105734043|NCT03455543|364681082|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
105734044|NCT03455543|364681083|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
105734045|NCT03455543|364681081|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
105798508|NCT01377233|364920950|FG004|Open-label|Adverse Event|0|||
105798509|NCT01377233|364920946|FG000|Open-label|Withdrawal by Subject|3|||
105798510|NCT01377233|364920947|FG001|Open-label|Withdrawal by Subject|0|||
105734046|NCT03455543|364681082|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
105734047|NCT03455543|364681083|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
105798511|NCT01377233|364920948|FG002|Open-label|Withdrawal by Subject|0|||
105798512|NCT01377233|364920949|FG003|Open-label|Withdrawal by Subject|0|||
105798513|NCT01377233|364920950|FG004|Open-label|Withdrawal by Subject|0|||
105798514|NCT01377233|364920946|FG000|Double-blind|Adverse Event|0|||
105798515|NCT01377233|364920947|FG001|Double-blind|Adverse Event|1|||
105798516|NCT01377233|364920948|FG002|Double-blind|Adverse Event|2|||
105798517|NCT01377233|364920949|FG003|Double-blind|Adverse Event|2|||
105798518|NCT01377233|364920950|FG004|Double-blind|Adverse Event|0|||
105798519|NCT01377233|364920946|FG000|Double-blind|Protocol Violation|0|||
105798520|NCT01377233|364920947|FG001|Double-blind|Protocol Violation|0|||
105798521|NCT01377233|364920948|FG002|Double-blind|Protocol Violation|0|||
105798522|NCT01377233|364920949|FG003|Double-blind|Protocol Violation|0|||
105798523|NCT01377233|364920950|FG004|Double-blind|Protocol Violation|1|||
105798524|NCT01377233|364920946|FG000|Double-blind|Withdrawal by Subject|0|||
105798525|NCT01377233|364920947|FG001|Double-blind|Withdrawal by Subject|0|||
105798526|NCT01377233|364920948|FG002|Double-blind|Withdrawal by Subject|0|||
105798527|NCT01377233|364920949|FG003|Double-blind|Withdrawal by Subject|1|||
105798528|NCT01377233|364920950|FG004|Double-blind|Withdrawal by Subject|0|||
105798529|NCT01377233|364920946|FG000|Double-blind|Administrative or other|0|||
105798530|NCT01377233|364920947|FG001|Double-blind|Administrative or other|0|||
105798531|NCT01377233|364920948|FG002|Double-blind|Administrative or other|0|||
105798532|NCT01377233|364920949|FG003|Double-blind|Administrative or other|1|||
105798533|NCT01377233|364920950|FG004|Double-blind|Administrative or other|1|||
105798534|NCT01785875|364920951|FG000|Overall Study|Withdrawal by Subject|41|||
105798535|NCT01785875|364920952|FG001|Overall Study|Withdrawal by Subject|34|||
105798536|NCT01785875|364920953|FG002|Overall Study|Withdrawal by Subject|36|||
105798537|NCT01785875|364920951|FG000|Overall Study|Lost to Follow-up|19|||
105798538|NCT01785875|364920952|FG001|Overall Study|Lost to Follow-up|22|||
105798539|NCT01785875|364920953|FG002|Overall Study|Lost to Follow-up|6|||
105798540|NCT01785875|364920951|FG000|Overall Study|Death|27|||
105798541|NCT01785875|364920952|FG001|Overall Study|Death|16|||
105798542|NCT01785875|364920953|FG002|Overall Study|Death|7|||
105798543|NCT01785875|364920951|FG000|Overall Study|Sponsor Decision|0|||
105798544|NCT01785875|364920952|FG001|Overall Study|Sponsor Decision|2|||
105798545|NCT01785875|364920953|FG002|Overall Study|Sponsor Decision|0|||
105798546|NCT01785875|364920951|FG000|Overall Study|Protocol Specified Criteria|207|||
105798547|NCT01785875|364920952|FG001|Overall Study|Protocol Specified Criteria|214|||
105798548|NCT01785875|364920953|FG002|Overall Study|Protocol Specified Criteria|55|||
105798549|NCT01785875|364920951|FG000|Overall Study|Missing|0|||
105798550|NCT01785875|364920952|FG001|Overall Study|Missing|1|||
105798551|NCT01785875|364920953|FG002|Overall Study|Missing|3|||
105798552|NCT01814761|364920956|FG000|Overall Study|Other Reasons|1|||
105798553|NCT01814761|364920957|FG001|Overall Study|Other Reasons|10|||
105798554|NCT01814761|364920956|FG000|Overall Study|Ocular Adverse Event|6|||
105798555|NCT01814761|364920957|FG001|Overall Study|Ocular Adverse Event|15|||
105798556|NCT01814761|364920956|FG000|Overall Study|Lost to Follow-up|1|||
105798557|NCT01814761|364920957|FG001|Overall Study|Lost to Follow-up|5|||
105798558|NCT03137082|364920958|FG000|Overall Study|Withdrawal by Subject|1|||
105798559|NCT03137082|364920959|FG001|Overall Study|Withdrawal by Subject|1|||
105798560|NCT03137082|364920958|FG000|Overall Study|Lost to Follow-up|1|||
105798561|NCT03137082|364920959|FG001|Overall Study|Lost to Follow-up|0|||
105798562|NCT00417027|364920960|FG000|Overall Study|Protocol Violation|0|||
105798563|NCT00417027|364920961|FG001|Overall Study|Protocol Violation|5|||
105798564|NCT00417027|364920962|FG002|Overall Study|Protocol Violation|5|||
105798565|NCT00707174|364920963|FG000|Overall Study|Adverse Event|1|||
105798566|NCT00707174|364920964|FG001|Overall Study|Adverse Event|6|||
105798567|NCT00707174|364920963|FG000|Overall Study|Withdrawal by Subject|4|||
105798568|NCT00707174|364920964|FG001|Overall Study|Withdrawal by Subject|1|||
105798569|NCT00467818|364920965|FG000|Overall Study|Adverse Event|1|||
105798570|NCT00467818|364920966|FG001|Overall Study|Adverse Event|0|||
105798571|NCT00467818|364920965|FG000|Overall Study|Lost to Follow-up|2|||
105798572|NCT00467818|364920966|FG001|Overall Study|Lost to Follow-up|2|||
105798573|NCT01017029|364920967|FG000|Overall Study|Lost to Follow-up|1|||
105798574|NCT01017029|364920968|FG001|Overall Study|Lost to Follow-up|0|||
105798575|NCT01017029|364920967|FG000|Overall Study|Administrative problem|0|||
105798576|NCT01017029|364920968|FG001|Overall Study|Administrative problem|1|||
105798577|NCT01017029|364920967|FG000|Overall Study|Death|3|||
105798578|NCT01017029|364920968|FG001|Overall Study|Death|1|||
105798579|NCT00618774|364920971|FG000|Overall Study|Adverse Event|5|||
105798580|NCT00618774|364920972|FG001|Overall Study|Adverse Event|3|||
105798581|NCT00618774|364920971|FG000|Overall Study|Withdrawal by Subject|1|||
105798582|NCT00618774|364920972|FG001|Overall Study|Withdrawal by Subject|0|||
105798583|NCT02753400|364920974|FG000|Overall Study|Adverse Event|3|||
105798584|NCT02753400|364920975|FG001|Overall Study|Adverse Event|0|||
105798585|NCT02753400|364920974|FG000|Overall Study|Withdrawal by Subject|2|||
105798586|NCT02753400|364920975|FG001|Overall Study|Withdrawal by Subject|1|||
105798587|NCT00447603|364920976|FG000|Screening|Withdrawal by Subject|1|||
105798588|NCT00447603|364920977|FG001|Screening|Withdrawal by Subject|0|||
105798589|NCT00447603|364920978|FG002|Screening|Withdrawal by Subject|0|||
105798590|NCT00447603|364920976|FG000|Screening|Protocol Violation|1|||
105798591|NCT00447603|364920977|FG001|Screening|Protocol Violation|0|||
105798592|NCT00447603|364920978|FG002|Screening|Protocol Violation|0|||
105798593|NCT00447603|364920976|FG000|Screening|Screen Failure|4|||
105798594|NCT00447603|364920977|FG001|Screening|Screen Failure|0|||
105798595|NCT00447603|364920978|FG002|Screening|Screen Failure|0|||
105798596|NCT00447603|364920976|FG000|Screening|Study Terminated by Sponsor|15|||
105798597|NCT00447603|364920977|FG001|Screening|Study Terminated by Sponsor|0|||
105798598|NCT00447603|364920978|FG002|Screening|Study Terminated by Sponsor|0|||
105798599|NCT00447603|364920976|FG000|Filter Period|Adverse Event|0|||
105734048|NCT03455543|364681081|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
105734049|NCT03455543|364681082|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
105734050|NCT03455543|364681083|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
105734051|NCT03455543|364681081|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
105734052|NCT03455543|364681082|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
105734053|NCT03455543|364681083|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
105734054|NCT03455543|364681081|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
105734055|NCT03455543|364681082|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
105734056|NCT03455543|364681083|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
105353349|NCT05161481|363298527|FG001|Overall Study|Withdrawal of consent|1|||
105353350|NCT05161481|363298528|FG002|Overall Study|Withdrawal of consent|1|||
105353351|NCT05161481|363298526|FG000|Overall Study|Study terminated by sponsor|3|||
105353352|NCT05161481|363298527|FG001|Overall Study|Study terminated by sponsor|3|||
105734057|NCT03455543|364681081|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
105734058|NCT03455543|364681082|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
105353353|NCT05161481|363298528|FG002|Overall Study|Study terminated by sponsor|2|||
105353354|NCT05161481|363298526|FG000|Overall Study|Adverse Event|3|||
105353355|NCT05161481|363298527|FG001|Overall Study|Adverse Event|0|||
105353356|NCT05161481|363298528|FG002|Overall Study|Adverse Event|6|||
105353357|NCT05161481|363298526|FG000|Overall Study|Randomised in error and was not treated|1|||
105353358|NCT05161481|363298527|FG001|Overall Study|Randomised in error and was not treated|0|||
105353359|NCT05161481|363298528|FG002|Overall Study|Randomised in error and was not treated|0|||
105353360|NCT05161481|363298526|FG000|Overall Study|Subject decision|0|||
105353361|NCT05161481|363298527|FG001|Overall Study|Subject decision|0|||
105353362|NCT05161481|363298528|FG002|Overall Study|Subject decision|1|||
105353363|NCT04401202|363298529|FG000|Overall Study|Lost to Follow-up|2|||
105353364|NCT04401202|363298530|FG001|Overall Study|Lost to Follow-up|2|||
105353365|NCT04401202|363298529|FG000|Overall Study|Adverse Event|0|||
105353366|NCT04401202|363298530|FG001|Overall Study|Adverse Event|1|||
105353367|NCT04401202|363298529|FG000|Overall Study|Hospitalized|4|||
105353368|NCT04401202|363298530|FG001|Overall Study|Hospitalized|1|||
105565070|NCT01364922|364066667|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
105734059|NCT03455543|364681083|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
105734060|NCT02873221|364681084|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
105734061|NCT02873221|364681085|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
105734062|NCT02873221|364681086|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
105734063|NCT02873221|364681084|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
105734064|NCT02873221|364681085|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
105734065|NCT02873221|364681086|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
105734066|NCT02873221|364681084|FG000|Treatment Period|Protocol Violation|2|||
105734067|NCT02873221|364681085|FG001|Treatment Period|Protocol Violation|5|||
105734068|NCT02873221|364681086|FG002|Treatment Period|Protocol Violation|8|||
105734069|NCT02873221|364681084|FG000|Treatment Period|Pregnancy|4|||
105734070|NCT02873221|364681085|FG001|Treatment Period|Pregnancy|6|||
105734071|NCT02873221|364681086|FG002|Treatment Period|Pregnancy|3|||
105734072|NCT02873221|364681084|FG000|Treatment Period|Lack of Qualifying Event|0|||
105734073|NCT02873221|364681085|FG001|Treatment Period|Lack of Qualifying Event|3|||
105734074|NCT02873221|364681086|FG002|Treatment Period|Lack of Qualifying Event|1|||
105734075|NCT02873221|364681084|FG000|Treatment Period|Withdrawal of Consent|52|||
105734076|NCT02873221|364681085|FG001|Treatment Period|Withdrawal of Consent|51|||
105734077|NCT02873221|364681086|FG002|Treatment Period|Withdrawal of Consent|41|||
105734078|NCT02873221|364681084|FG000|Treatment Period|Lack of Efficacy|0|||
105734079|NCT02873221|364681085|FG001|Treatment Period|Lack of Efficacy|17|||
105734080|NCT02873221|364681086|FG002|Treatment Period|Lack of Efficacy|12|||
105734081|NCT02873221|364681084|FG000|Treatment Period|Adverse Event|4|||
105734082|NCT02873221|364681085|FG001|Treatment Period|Adverse Event|9|||
105734083|NCT02873221|364681086|FG002|Treatment Period|Adverse Event|11|||
105734084|NCT02873221|364681084|FG000|Treatment Period|Lost to Follow-up|26|||
105734085|NCT02873221|364681085|FG001|Treatment Period|Lost to Follow-up|30|||
105734086|NCT02873221|364681086|FG002|Treatment Period|Lost to Follow-up|26|||
105353369|NCT00162097|363298534|FG000|Overall Study|Participant no longer met study criteria|0|||
105353370|NCT00162097|363298535|FG001|Overall Study|Participant no longer met study criteria|0|||
105353371|NCT00162097|363298536|FG002|Overall Study|Participant no longer met study criteria|0|||
105734087|NCT02873221|364681084|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
105734088|NCT02873221|364681085|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
105734089|NCT02873221|364681086|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
105734090|NCT02873221|364681084|FG000|Safety Follow-up Period|Protocol Violation|0|||
105734091|NCT02873221|364681085|FG001|Safety Follow-up Period|Protocol Violation|0|||
105734092|NCT02873221|364681086|FG002|Safety Follow-up Period|Protocol Violation|1|||
105734093|NCT02873221|364681084|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
105734094|NCT02873221|364681085|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
105734095|NCT02873221|364681086|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
105734096|NCT02873221|364681084|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
105734097|NCT02873221|364681085|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
105734098|NCT02873221|364681086|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
105734099|NCT00779038|364681087|FG000|Overall Study|Study Prematurely Terminated|13|||
105734100|NCT05372315|364681090|FG000|Overall Study|Withdrawal by Subject|1|||
105734101|NCT05372315|364681091|FG001|Overall Study|Withdrawal by Subject|0|||
105734102|NCT00537745|364681092|FG000|Overall Study|Did not meet eligibility criteria|2|||
105734103|NCT00537745|364681092|FG000|Overall Study|Withdrawal by Subject|2|||
105734104|NCT00537745|364681092|FG000|Overall Study|Subject unable to provide Interlock info|1|||
105734105|NCT01512368|364681093|FG000|Overall Study|Protocol Violation|3|||
105734106|NCT01508676|364681094|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
105734107|NCT01508676|364681095|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
105734108|NCT01508676|364681094|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
105734109|NCT01508676|364681095|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
105734110|NCT01508676|364681094|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
105734111|NCT01508676|364681095|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
105734112|NCT01508676|364681094|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
105734113|NCT01508676|364681095|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
105734114|NCT01508676|364681094|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
105734115|NCT01508676|364681095|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
105734116|NCT00922935|364681096|FG000|Overall Study|Protocol Violation|0|||
105734117|NCT00922935|364681097|FG001|Overall Study|Protocol Violation|3|||
105734118|NCT00922935|364681098|FG002|Overall Study|Protocol Violation|0|||
105734119|NCT00922935|364681096|FG000|Overall Study|Physician Decision|1|||
105734120|NCT00922935|364681097|FG001|Overall Study|Physician Decision|1|||
105734121|NCT00922935|364681098|FG002|Overall Study|Physician Decision|0|||
105734122|NCT00922935|364681096|FG000|Overall Study|Lost to Follow-up|0|||
105734123|NCT00922935|364681097|FG001|Overall Study|Lost to Follow-up|1|||
105734124|NCT00922935|364681098|FG002|Overall Study|Lost to Follow-up|0|||
105734125|NCT02532543|364681099|FG000|Overall Study|Lost to Follow-up|0|||
105734126|NCT02532543|364681100|FG001|Overall Study|Lost to Follow-up|0|||
105734127|NCT02532543|364681101|FG002|Overall Study|Lost to Follow-up|1|||
105734128|NCT02532543|364681102|FG003|Overall Study|Lost to Follow-up|0|||
105734129|NCT02614794|364681104|FG000|Overall Study|Death|258|||
105734130|NCT02614794|364681105|FG001|Overall Study|Death|151|||
105734131|NCT02614794|364681104|FG000|Overall Study|Study closure by Sponsor|119|||
105734132|NCT02614794|364681105|FG001|Overall Study|Study closure by Sponsor|45|||
105734133|NCT02614794|364681104|FG000|Overall Study|Withdrawal by Subject|24|||
105734134|NCT02614794|364681105|FG001|Overall Study|Withdrawal by Subject|5|||
105734135|NCT02614794|364681104|FG000|Overall Study|Lost to Follow-up|7|||
105734136|NCT02614794|364681105|FG001|Overall Study|Lost to Follow-up|0|||
105734137|NCT02614794|364681104|FG000|Overall Study|Physician Decision|1|||
105734138|NCT02614794|364681105|FG001|Overall Study|Physician Decision|1|||
105734139|NCT02614794|364681104|FG000|Overall Study|Hospital closure|1|||
105480498|NCT03137069|363771206|FG001|Overall Study|Physician Decision|0|||
105734140|NCT02614794|364681105|FG001|Overall Study|Hospital closure|0|||
105734141|NCT03237845|364681110|FG000|Overall Study|Adverse Event|0|||
105734142|NCT03237845|364681111|FG001|Overall Study|Adverse Event|1|||
105734143|NCT03237845|364681110|FG000|Overall Study|Lost to Follow-up|13|||
105734144|NCT03237845|364681111|FG001|Overall Study|Lost to Follow-up|10|||
105734145|NCT03237845|364681110|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
105734146|NCT03237845|364681111|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
105734147|NCT03237845|364681110|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
105734148|NCT03237845|364681111|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
105734149|NCT03237845|364681110|FG000|Overall Study|Physician Decision|1|||
105734150|NCT03237845|364681111|FG001|Overall Study|Physician Decision|2|||
105734151|NCT03237845|364681110|FG000|Overall Study|Pregnancy|1|||
105734152|NCT03237845|364681111|FG001|Overall Study|Pregnancy|0|||
105734153|NCT03237845|364681110|FG000|Overall Study|Protocol Deviation|0|||
105734154|NCT03237845|364681111|FG001|Overall Study|Protocol Deviation|1|||
105734155|NCT03237845|364681110|FG000|Overall Study|Technical Problems|8|||
105734156|NCT03237845|364681111|FG001|Overall Study|Technical Problems|1|||
105734157|NCT03237845|364681110|FG000|Overall Study|Withdrawal by Subject|3|||
105734158|NCT03237845|364681111|FG001|Overall Study|Withdrawal by Subject|3|||
105734159|NCT03237845|364681110|FG000|Overall Study|Other Reasons|4|||
105734160|NCT03237845|364681111|FG001|Overall Study|Other Reasons|0|||
105734161|NCT00258154|364681112|FG000|Overall Study|Adverse Event|1|||
105734162|NCT00258154|364681113|FG001|Overall Study|Adverse Event|0|||
105734163|NCT00258154|364681112|FG000|Overall Study|Lost to Follow-up|0|||
105734164|NCT00258154|364681113|FG001|Overall Study|Lost to Follow-up|1|||
105734165|NCT00258154|364681112|FG000|Overall Study|Protocol Violation|2|||
105734166|NCT00258154|364681113|FG001|Overall Study|Protocol Violation|1|||
105734167|NCT00258154|364681112|FG000|Overall Study|Withdrawal by Subject|3|||
105734168|NCT00258154|364681113|FG001|Overall Study|Withdrawal by Subject|4|||
105734169|NCT00258154|364681112|FG000|Overall Study|Patient Moved|3|||
105734170|NCT00258154|364681113|FG001|Overall Study|Patient Moved|1|||
105734171|NCT00414440|364681122|FG000|Core Period|Withdrawal by Subject|70|||
105734172|NCT00414440|364681123|FG001|Core Period|Withdrawal by Subject|32|||
105734173|NCT00414440|364681122|FG000|Extension Period|Lost to Follow-up|44|||
105734174|NCT00414440|364681123|FG001|Extension Period|Lost to Follow-up|52|||
105734175|NCT00414440|364681122|FG000|Extension Period|Did not consent to continue follow up|61|||
105734176|NCT00414440|364681123|FG001|Extension Period|Did not consent to continue follow up|54|||
105734177|NCT00414440|364681122|FG000|Extension Period|Other|1|||
105734178|NCT00414440|364681123|FG001|Extension Period|Other|1|||
105734179|NCT00414440|364681122|FG000|Extension Period|Administrative|16|||
105480499|NCT03137069|363771207|FG002|Overall Study|Physician Decision|0|||
105734180|NCT00414440|364681123|FG001|Extension Period|Administrative|16|||
105734181|NCT00414440|364681122|FG000|Extension Period|Death|1|||
105734182|NCT00414440|364681123|FG001|Extension Period|Death|2|||
105734183|NCT00414440|364681122|FG000|Extension Period|Withdrawal by Subject|9|||
105734184|NCT00414440|364681123|FG001|Extension Period|Withdrawal by Subject|7|||
105734185|NCT00414440|364681122|FG000|Extension Period|Not included in follow up period|18|||
105734186|NCT00414440|364681123|FG001|Extension Period|Not included in follow up period|8|||
105734187|NCT04222725|364681124|FG000|Overall Study|Adverse Event|0|||
105734188|NCT04222725|364681125|FG001|Overall Study|Adverse Event|1|||
105734189|NCT04222725|364681126|FG002|Overall Study|Adverse Event|0|||
105734190|NCT04222725|364681127|FG003|Overall Study|Adverse Event|0|||
105734191|NCT03368404|364681133|FG000|Overall Study|Adverse Event|2|||
105734192|NCT03368404|364681134|FG001|Overall Study|Adverse Event|1|||
105734193|NCT03368404|364681133|FG000|Overall Study|Withdrawal by Subject|1|||
105734194|NCT03368404|364681134|FG001|Overall Study|Withdrawal by Subject|1|||
105353372|NCT00162097|363298537|FG003|Overall Study|Participant no longer met study criteria|1|||
105353373|NCT01964716|363298544|FG000|Overall Study|Withdrawal by Subject|2|||
105353374|NCT01964716|363298545|FG001|Overall Study|Withdrawal by Subject|3|||
105353375|NCT01964716|363298544|FG000|Overall Study|Lost to Follow-up|1|||
105353376|NCT01964716|363298545|FG001|Overall Study|Lost to Follow-up|2|||
105353377|NCT01964716|363298544|FG000|Overall Study|No longer met eligibility criteria|1|||
105353378|NCT01964716|363298545|FG001|Overall Study|No longer met eligibility criteria|1|||
105353379|NCT01964716|363298544|FG000|Overall Study|Death|1|||
105353380|NCT01964716|363298545|FG001|Overall Study|Death|0|||
105353381|NCT03148067|363298546|FG000|Overall Study|Lost to Follow-up|3|||
105353382|NCT03148067|363298546|FG000|Overall Study|Death|1|||
105353383|NCT02559570|363298547|FG000|Overall Study|Adverse Event|0|||
105353384|NCT02559570|363298548|FG001|Overall Study|Adverse Event|2|||
105353385|NCT02559570|363298549|FG002|Overall Study|Adverse Event|0|||
105353386|NCT02559570|363298550|FG003|Overall Study|Adverse Event|1|||
105353387|NCT02559570|363298551|FG004|Overall Study|Adverse Event|0|||
105734195|NCT00964795|364681135|FG000|Overall Study|Withdrawal by Subject|79|||
105353388|NCT02559570|363298547|FG000|Overall Study|Withdrawal of Consent|0|||
105353389|NCT02559570|363298548|FG001|Overall Study|Withdrawal of Consent|0|||
105353390|NCT02559570|363298549|FG002|Overall Study|Withdrawal of Consent|1|||
105353391|NCT02559570|363298550|FG003|Overall Study|Withdrawal of Consent|2|||
105353392|NCT02559570|363298551|FG004|Overall Study|Withdrawal of Consent|1|||
105353393|NCT02559570|363298547|FG000|Overall Study|Lost to Follow-up|1|||
105353394|NCT02559570|363298548|FG001|Overall Study|Lost to Follow-up|0|||
105353395|NCT02559570|363298549|FG002|Overall Study|Lost to Follow-up|0|||
105353396|NCT02559570|363298550|FG003|Overall Study|Lost to Follow-up|0|||
105353397|NCT02559570|363298551|FG004|Overall Study|Lost to Follow-up|0|||
105353398|NCT02559570|363298547|FG000|Overall Study|Protocol Violation|1|||
105353399|NCT02559570|363298548|FG001|Overall Study|Protocol Violation|0|||
105353400|NCT02559570|363298549|FG002|Overall Study|Protocol Violation|0|||
105353401|NCT02559570|363298550|FG003|Overall Study|Protocol Violation|0|||
105353402|NCT02559570|363298551|FG004|Overall Study|Protocol Violation|1|||
105353403|NCT02559570|363298547|FG000|Overall Study|Other Miscellaneous Reasons|0|||
105353404|NCT02559570|363298548|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105353405|NCT02559570|363298549|FG002|Overall Study|Other Miscellaneous Reasons|1|||
105353406|NCT02559570|363298550|FG003|Overall Study|Other Miscellaneous Reasons|0|||
105353407|NCT02559570|363298551|FG004|Overall Study|Other Miscellaneous Reasons|0|||
105353408|NCT02819440|363298553|FG000|Overall Study|Adverse Event|3|||
105353409|NCT02819440|363298554|FG001|Overall Study|Adverse Event|1|||
105353410|NCT02819440|363298553|FG000|Overall Study|Lost to Follow-up|1|||
105353411|NCT02819440|363298554|FG001|Overall Study|Lost to Follow-up|3|||
105734196|NCT00964795|364681135|FG000|Overall Study|Adverse Event|12|||
105734197|NCT00964795|364681135|FG000|Overall Study|Death|14|||
105734198|NCT00964795|364681135|FG000|Overall Study|Lost to Follow-up|7|||
105734199|NCT00964795|364681135|FG000|Overall Study|Termination of Study by Sponsor|169|||
105734200|NCT00964795|364681135|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
105734201|NCT00964795|364681135|FG000|Overall Study|Other|23|||
105734202|NCT00231478|364681137|FG000|Overall Study|Protocol Violation|3|||
105734203|NCT00231478|364681138|FG001|Overall Study|Protocol Violation|2|||
105734204|NCT00231478|364681137|FG000|Overall Study|Refused Treatment|1|||
105734205|NCT00231478|364681138|FG001|Overall Study|Refused Treatment|1|||
105734206|NCT00231478|364681137|FG000|Overall Study|Withdrawal by Subject|1|||
105734207|NCT00231478|364681138|FG001|Overall Study|Withdrawal by Subject|0|||
105734208|NCT00231478|364681137|FG000|Overall Study|Adverse Event|0|||
105734209|NCT00231478|364681138|FG001|Overall Study|Adverse Event|1|||
105734210|NCT00231478|364681137|FG000|Overall Study|Administrative|3|||
105734211|NCT00231478|364681138|FG001|Overall Study|Administrative|2|||
105734212|NCT02114203|364682644|FG000|Overall Study|Adverse Event|0|||
105734213|NCT02114203|364682645|FG001|Overall Study|Adverse Event|1|||
105734214|NCT02114203|364682646|FG002|Overall Study|Adverse Event|0|||
105734215|NCT02114203|364682644|FG000|Overall Study|Withdrawal by Subject|0|||
105734216|NCT02114203|364682645|FG001|Overall Study|Withdrawal by Subject|1|||
105734217|NCT02114203|364682646|FG002|Overall Study|Withdrawal by Subject|0|||
105734218|NCT04329923|364682656|FG000|Overall Study|Withdrawal by Subject|1|||
105734219|NCT04329923|364682657|FG001|Overall Study|Withdrawal by Subject|4|||
105734220|NCT04329923|364682658|FG002|Overall Study|Withdrawal by Subject|1|||
105734221|NCT04329923|364682659|FG003|Overall Study|Withdrawal by Subject|1|||
105734222|NCT04329923|364682660|FG004|Overall Study|Withdrawal by Subject|1|||
105734223|NCT04329923|364682661|FG005|Overall Study|Withdrawal by Subject|1|||
105734224|NCT04329923|364682656|FG000|Overall Study|early termination of study|0|||
105353412|NCT02819440|363298553|FG000|Overall Study|Withdrawal by Subject|9|||
105353413|NCT02819440|363298554|FG001|Overall Study|Withdrawal by Subject|8|||
105353414|NCT00524680|363298560|FG000|Overall Study|progression|0|||
105353415|NCT00524680|363298561|FG001|Overall Study|progression|0|||
105353416|NCT00524680|363298562|FG002|Overall Study|progression|0|||
105734225|NCT04329923|364682657|FG001|Overall Study|early termination of study|0|||
105734226|NCT04329923|364682658|FG002|Overall Study|early termination of study|0|||
105734227|NCT04329923|364682659|FG003|Overall Study|early termination of study|0|||
105353417|NCT00524680|363298563|FG003|Overall Study|progression|1|||
105798600|NCT00447603|364920977|FG001|Filter Period|Adverse Event|0|||
105353418|NCT00524680|363298560|FG000|Overall Study|Adverse Event|2|||
105353419|NCT00524680|363298561|FG001|Overall Study|Adverse Event|0|||
105353420|NCT00524680|363298562|FG002|Overall Study|Adverse Event|0|||
105353421|NCT00524680|363298563|FG003|Overall Study|Adverse Event|1|||
105353422|NCT00524680|363298560|FG000|Overall Study|Other|0|||
105353423|NCT00524680|363298561|FG001|Overall Study|Other|1|||
105353424|NCT00524680|363298562|FG002|Overall Study|Other|2|||
105353425|NCT00524680|363298563|FG003|Overall Study|Other|3|||
105353426|NCT00524680|363298560|FG000|Overall Study|Withdrawal by Subject|1|||
105353427|NCT00524680|363298561|FG001|Overall Study|Withdrawal by Subject|0|||
105353428|NCT00524680|363298562|FG002|Overall Study|Withdrawal by Subject|1|||
105353429|NCT00524680|363298563|FG003|Overall Study|Withdrawal by Subject|1|||
105353430|NCT00002525|363298564|FG000|Overall Study|Adverse Event|36|||
105353431|NCT00002525|363298565|FG001|Overall Study|Adverse Event|0|||
105353432|NCT00002525|363298564|FG000|Overall Study|Death|5|||
105353433|NCT00002525|363298565|FG001|Overall Study|Death|0|||
105353434|NCT00002525|363298564|FG000|Overall Study|Withdrawal by Subject|11|||
105353435|NCT00002525|363298565|FG001|Overall Study|Withdrawal by Subject|0|||
105353436|NCT00002525|363298564|FG000|Overall Study|Start non-protocol therapy|1|||
105353437|NCT00002525|363298565|FG001|Overall Study|Start non-protocol therapy|0|||
105353438|NCT00002525|363298564|FG000|Overall Study|Other complicating disease|1|||
105353439|NCT00002525|363298565|FG001|Overall Study|Other complicating disease|0|||
105353440|NCT00002525|363298564|FG000|Overall Study|Duke's A, B1, D disease|92|||
105353441|NCT00002525|363298565|FG001|Overall Study|Duke's A, B1, D disease|0|||
105353442|NCT00002525|363298564|FG000|Overall Study|Error|6|||
105353443|NCT00002525|363298565|FG001|Overall Study|Error|0|||
105353444|NCT00002525|363298564|FG000|Overall Study|Other|26|||
105353445|NCT00002525|363298565|FG001|Overall Study|Other|0|||
105353446|NCT00002525|363298564|FG000|Overall Study|Never start protocol therapy|8|||
105353447|NCT00002525|363298565|FG001|Overall Study|Never start protocol therapy|0|||
105353448|NCT00435188|363298568|FG000|Overall Study|Death|1|||
105353449|NCT00435188|363298569|FG001|Overall Study|Death|6|||
105353450|NCT00435188|363298568|FG000|Overall Study|Withdrawal by Subject|16|||
105353451|NCT00435188|363298569|FG001|Overall Study|Withdrawal by Subject|11|||
105353452|NCT00435188|363298568|FG000|Overall Study|Lost to Follow-up|5|||
105353453|NCT00435188|363298569|FG001|Overall Study|Lost to Follow-up|6|||
105353454|NCT01146561|363298572|FG000|Overall Study|Withdrawal by Subject|1|||
105353455|NCT01146561|363298572|FG000|Overall Study|Lost to Follow-up|1|||
105353456|NCT03124537|363298573|FG000|Overall Study|Lost to Follow-up|3|||
105353457|NCT03124537|363298574|FG001|Overall Study|Lost to Follow-up|5|||
105353458|NCT03124537|363298573|FG000|Overall Study|App Crash, Incomplete Data|7|||
105353459|NCT03124537|363298574|FG001|Overall Study|App Crash, Incomplete Data|8|||
105353460|NCT03681184|363298575|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
105353461|NCT03681184|363298576|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
105353462|NCT00396383|363298579|FG000|Overall Study|Death|2|||
105353463|NCT00396383|363298579|FG000|Overall Study|Lost to Follow-up|1|||
105353464|NCT00048165|363298580|FG000|Completed 6 Months Study|Administration/Other|8|||
105353465|NCT00048165|363298581|FG001|Completed 6 Months Study|Administration/Other|8|||
105353466|NCT00048165|363298580|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
105353467|NCT00048165|363298581|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
105353468|NCT00048165|363298580|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
105353469|NCT00048165|363298581|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
105798601|NCT00447603|364920978|FG002|Filter Period|Adverse Event|1|||
105353470|NCT00048165|363298580|FG000|Completed 6 Months Study|Death|12|||
105353471|NCT00048165|363298581|FG001|Completed 6 Months Study|Death|6|||
105353472|NCT00048165|363298580|FG000|Completed 6 Months Study|Insufficient therapy|1|||
105353473|NCT00048165|363298581|FG001|Completed 6 Months Study|Insufficient therapy|4|||
105353474|NCT00048165|363298580|FG000|Completed 6 Months Study|Other violation|4|||
105353475|NCT00048165|363298581|FG001|Completed 6 Months Study|Other violation|6|||
105798602|NCT00447603|364920976|FG000|Filter Period|Screen Failure|0|||
105353476|NCT00048165|363298580|FG000|Completed 6 Months Study|Refused treatment|5|||
105353477|NCT00048165|363298581|FG001|Completed 6 Months Study|Refused treatment|5|||
105353478|NCT00048165|363298580|FG000|Completed 6 Months Study|Violation criteria|0|||
105353479|NCT00048165|363298581|FG001|Completed 6 Months Study|Violation criteria|2|||
105480500|NCT03137069|363771208|FG003|Overall Study|Physician Decision|1|||
105734228|NCT04329923|364682660|FG004|Overall Study|early termination of study|1|||
105734229|NCT04329923|364682661|FG005|Overall Study|early termination of study|2|||
105734230|NCT04329923|364682656|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
105734231|NCT04329923|364682657|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
105734232|NCT04329923|364682658|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
105734233|NCT04329923|364682659|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
105734234|NCT04329923|364682660|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
105734235|NCT04329923|364682661|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
105734236|NCT01272180|364682662|FG000|Overall Study|Adverse Event|0|||
105734237|NCT01272180|364682663|FG001|Overall Study|Adverse Event|0|||
105734238|NCT01272180|364682664|FG002|Overall Study|Adverse Event|1|||
105734239|NCT01272180|364682665|FG003|Overall Study|Adverse Event|0|||
105734240|NCT01272180|364682662|FG000|Overall Study|Withdrawal by Subject|2|||
105734241|NCT01272180|364682663|FG001|Overall Study|Withdrawal by Subject|6|||
105734242|NCT01272180|364682664|FG002|Overall Study|Withdrawal by Subject|3|||
105734243|NCT01272180|364682665|FG003|Overall Study|Withdrawal by Subject|2|||
105734244|NCT01272180|364682662|FG000|Overall Study|Lost to Follow-up|15|||
105734245|NCT01272180|364682663|FG001|Overall Study|Lost to Follow-up|14|||
105734246|NCT01272180|364682664|FG002|Overall Study|Lost to Follow-up|8|||
105734247|NCT01272180|364682665|FG003|Overall Study|Lost to Follow-up|10|||
105734248|NCT01272180|364682662|FG000|Overall Study|Inappropriate enrollment|0|||
105734249|NCT01272180|364682663|FG001|Overall Study|Inappropriate enrollment|0|||
105734250|NCT01272180|364682664|FG002|Overall Study|Inappropriate enrollment|1|||
105734251|NCT01272180|364682665|FG003|Overall Study|Inappropriate enrollment|1|||
105734252|NCT01272180|364682662|FG000|Overall Study|Protocol Violation|0|||
105734253|NCT01272180|364682663|FG001|Overall Study|Protocol Violation|1|||
105734254|NCT01272180|364682664|FG002|Overall Study|Protocol Violation|0|||
105734255|NCT01272180|364682665|FG003|Overall Study|Protocol Violation|1|||
105734256|NCT01126619|364682668|FG000|Overall Study|Not eligible for the study|2|||
105734257|NCT01126619|364682668|FG000|Overall Study|Investigator decision|4|||
105734258|NCT01126619|364682668|FG000|Overall Study|Serious adverse event|1|||
105734259|NCT01126619|364682668|FG000|Overall Study|Withdrawal by Subject|9|||
105734260|NCT01126619|364682668|FG000|Overall Study|Non-compliance|1|||
105734261|NCT02564120|364682669|FG000|Overall Study|Did not return release forms|160|||
105734262|NCT02564120|364682669|FG000|Overall Study|Death|58|||
105734263|NCT02564120|364682669|FG000|Overall Study|Withdrawal by Subject|204|||
105734264|NCT02564120|364682669|FG000|Overall Study|Other medical condition|24|||
105734265|NCT03842709|364682670|FG000|Overall Study|Withdrawal by Subject|3|||
105734266|NCT03842709|364682671|FG001|Overall Study|Withdrawal by Subject|3|||
105734267|NCT03842709|364682670|FG000|Overall Study|Lost to Follow-up|1|||
105734268|NCT03842709|364682671|FG001|Overall Study|Lost to Follow-up|0|||
105734269|NCT01025336|364682674|FG000|Overall Study|Protocol Violation|0|||
105734270|NCT01025336|364682675|FG001|Overall Study|Protocol Violation|0|||
105734271|NCT01025336|364682676|FG002|Overall Study|Protocol Violation|0|||
105734272|NCT01025336|364682677|FG003|Overall Study|Protocol Violation|2|||
105734273|NCT01025336|364682678|FG004|Overall Study|Protocol Violation|0|||
105734274|NCT01357239|364682681|FG000|Stratum: All Patients|Adverse Event|0|||
105734275|NCT01357239|364682682|FG001|Stratum: All Patients|Adverse Event|0|||
105734276|NCT01357239|364682683|FG002|Stratum: All Patients|Adverse Event|1|||
105734277|NCT01357239|364682684|FG003|Stratum: All Patients|Adverse Event|1|||
105734278|NCT01357239|364682681|FG000|Stratum: All Patients|Subject withdrew consent|0|||
105734279|NCT01357239|364682682|FG001|Stratum: All Patients|Subject withdrew consent|0|||
105734280|NCT01357239|364682683|FG002|Stratum: All Patients|Subject withdrew consent|1|||
105734281|NCT01357239|364682684|FG003|Stratum: All Patients|Subject withdrew consent|1|||
105734282|NCT01357239|364682681|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
105734283|NCT01357239|364682682|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
105734284|NCT01357239|364682683|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
105734285|NCT01357239|364682684|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
105734286|NCT01357239|364682681|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
105734287|NCT01357239|364682682|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
105734288|NCT01357239|364682683|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
105734289|NCT01357239|364682684|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
105734290|NCT01357239|364682681|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
105734291|NCT01357239|364682682|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
105734292|NCT01357239|364682683|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
105734293|NCT01357239|364682684|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
105353480|NCT00048165|363298580|FG000|Completed 6 Months Study|Did not receive study drug|6|||
105353481|NCT00048165|363298581|FG001|Completed 6 Months Study|Did not receive study drug|6|||
105353482|NCT00048165|363298580|FG000|Completed 12 Months Study|Administration/Other|0|||
105353483|NCT00048165|363298581|FG001|Completed 12 Months Study|Administration/Other|2|||
105480501|NCT03137069|363771209|FG004|Overall Study|Physician Decision|0|||
105480502|NCT03137069|363771210|FG005|Overall Study|Physician Decision|0|||
105480503|NCT03137069|363771205|FG000|Overall Study|Study Terminated by Sponsor|0|||
105480504|NCT03137069|363771206|FG001|Overall Study|Study Terminated by Sponsor|0|||
105480505|NCT03137069|363771207|FG002|Overall Study|Study Terminated by Sponsor|0|||
105480506|NCT03137069|363771208|FG003|Overall Study|Study Terminated by Sponsor|0|||
105480507|NCT03137069|363771209|FG004|Overall Study|Study Terminated by Sponsor|1|||
105353484|NCT00048165|363298580|FG000|Completed 12 Months Study|Death|2|||
105353485|NCT00048165|363298581|FG001|Completed 12 Months Study|Death|1|||
105353486|NCT00048165|363298580|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
105353487|NCT00048165|363298581|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
105353488|NCT01605825|363298590|FG000|Overall Study|Adverse Event|4|||
105353489|NCT01605825|363298591|FG001|Overall Study|Adverse Event|2|||
105353490|NCT01605825|363298590|FG000|Overall Study|Withdrawal by Subject|0|||
105353491|NCT01605825|363298591|FG001|Overall Study|Withdrawal by Subject|1|||
105353492|NCT01605825|363298590|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
105353493|NCT01605825|363298591|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
105353494|NCT01605825|363298590|FG000|Overall Study|Non-Compliance with Protocol|3|||
105353495|NCT01605825|363298591|FG001|Overall Study|Non-Compliance with Protocol|0|||
105353496|NCT03244618|363298601|FG000|Overall Study|Lost to Follow-up|3|||
105353497|NCT03244618|363298602|FG001|Overall Study|Lost to Follow-up|4|||
105353498|NCT03244618|363298601|FG000|Overall Study|Protocol Violation|4|||
105353499|NCT03244618|363298602|FG001|Overall Study|Protocol Violation|3|||
105353500|NCT03244618|363298601|FG000|Overall Study|Withdrawal by Subject|0|||
105353501|NCT03244618|363298602|FG001|Overall Study|Withdrawal by Subject|2|||
105353502|NCT02083653|363298603|FG000|Overall Study|Randomized but not Treated|0|||
105353503|NCT02083653|363298604|FG001|Overall Study|Randomized but not Treated|2|||
105353504|NCT02083653|363298605|FG002|Overall Study|Randomized but not Treated|7|||
105353505|NCT02083653|363298603|FG000|Overall Study|Adverse Event|12|||
105353506|NCT02083653|363298604|FG001|Overall Study|Adverse Event|5|||
105353507|NCT02083653|363298605|FG002|Overall Study|Adverse Event|4|||
105353508|NCT02083653|363298603|FG000|Overall Study|Lost to Follow-up|1|||
105353509|NCT02083653|363298604|FG001|Overall Study|Lost to Follow-up|0|||
105353510|NCT02083653|363298605|FG002|Overall Study|Lost to Follow-up|0|||
105353511|NCT02083653|363298603|FG000|Overall Study|Death|2|||
105353512|NCT02083653|363298604|FG001|Overall Study|Death|2|||
105353513|NCT02083653|363298605|FG002|Overall Study|Death|2|||
105480508|NCT03137069|363771210|FG005|Overall Study|Study Terminated by Sponsor|0|||
105480509|NCT03137069|363771205|FG000|Overall Study|Data Entry Error|0|||
105480510|NCT03137069|363771206|FG001|Overall Study|Data Entry Error|0|||
105480511|NCT03137069|363771207|FG002|Overall Study|Data Entry Error|0|||
105480512|NCT03137069|363771208|FG003|Overall Study|Data Entry Error|1|||
105480513|NCT03137069|363771209|FG004|Overall Study|Data Entry Error|0|||
105480514|NCT03137069|363771210|FG005|Overall Study|Data Entry Error|0|||
105480515|NCT01794338|363771212|FG000|Overall Study|Death|2|||
105480516|NCT01794338|363771213|FG001|Overall Study|Death|0|||
105480517|NCT01794338|363771212|FG000|Overall Study|Lost to Follow-up|6|||
105480518|NCT01794338|363771213|FG001|Overall Study|Lost to Follow-up|9|||
105734294|NCT00637728|364682685|FG000|Double-blind Phase|Adverse Event|1|||
105734295|NCT00637728|364682686|FG001|Double-blind Phase|Adverse Event|0|||
105734296|NCT00637728|364682687|FG002|Double-blind Phase|Adverse Event|0|||
105734297|NCT00637728|364682685|FG000|Double-blind Phase|Non-compliance|2|||
105734298|NCT00637728|364682686|FG001|Double-blind Phase|Non-compliance|0|||
105734299|NCT00637728|364682687|FG002|Double-blind Phase|Non-compliance|0|||
105734300|NCT00637728|364682685|FG000|Double-blind Phase|Study Discontinued|1|||
105734301|NCT00637728|364682686|FG001|Double-blind Phase|Study Discontinued|1|||
105798603|NCT00447603|364920977|FG001|Filter Period|Screen Failure|3|||
105798604|NCT00447603|364920978|FG002|Filter Period|Screen Failure|4|||
105353514|NCT02083653|363298603|FG000|Overall Study|Progressive Disease|65|||
105353515|NCT02083653|363298604|FG001|Overall Study|Progressive Disease|73|||
105480519|NCT02043899|363771214|FG000|Overall Study|Adverse Event|3|||
105480520|NCT02043899|363771214|FG000|Overall Study|Physician Decision|1|||
105480521|NCT02043899|363771214|FG000|Overall Study|Withdrawal by Subject|2|||
105480522|NCT02043899|363771214|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
105480523|NCT02043899|363771214|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
105480524|NCT02043899|363771214|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
105353516|NCT02083653|363298605|FG002|Overall Study|Progressive Disease|63|||
105353517|NCT02083653|363298603|FG000|Overall Study|Withdrawal by Subject|2|||
105353518|NCT02083653|363298604|FG001|Overall Study|Withdrawal by Subject|1|||
105353519|NCT02083653|363298605|FG002|Overall Study|Withdrawal by Subject|2|||
105734302|NCT00637728|364682687|FG002|Double-blind Phase|Study Discontinued|0|||
105734303|NCT02441803|364682688|FG000|Overall Study|Physician Decision|0|||
105798605|NCT00447603|364920976|FG000|Filter Period|Study terminated by Sponsor|0|||
105798606|NCT00447603|364920977|FG001|Filter Period|Study terminated by Sponsor|1|||
105798607|NCT00447603|364920978|FG002|Filter Period|Study terminated by Sponsor|10|||
105798608|NCT00736333|364920985|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
105798609|NCT00736333|364920985|FG000|Overall Study|Data Missing|2|||
105798610|NCT00736333|364920985|FG000|Overall Study|Tumor Progression|75|||
105798611|NCT00736333|364920985|FG000|Overall Study|Toxicity|6|||
105798612|NCT00736333|364920985|FG000|Overall Study|Withdrawal by Subject|10|||
105798613|NCT00736333|364920985|FG000|Overall Study|Death|7|||
105798614|NCT00736333|364920985|FG000|Overall Study|Other|4|||
105798615|NCT03944707|364920986|FG000|Overall Study|Adverse Event|0|||
105798616|NCT03944707|364920987|FG001|Overall Study|Adverse Event|2|||
105798617|NCT03944707|364920986|FG000|Overall Study|Study terminated by sponsor|12|||
105798618|NCT03944707|364920987|FG001|Overall Study|Study terminated by sponsor|7|||
105798619|NCT03944707|364920986|FG000|Overall Study|Subject decision|0|||
105798620|NCT03944707|364920987|FG001|Overall Study|Subject decision|1|||
105798621|NCT00751998|364920993|FG000|Overall Study|Lost to Follow-up|7|||
105798622|NCT00751998|364920993|FG000|Overall Study|Death|11|||
105798623|NCT00751998|364920993|FG000|Overall Study|Withdrawal by Subject|2|||
105798624|NCT03216954|364920995|FG000|Overall Study|Adverse Event|0|||
105353520|NCT02083653|363298603|FG000|Overall Study|Other Events|0|||
105353521|NCT02083653|363298604|FG001|Overall Study|Other Events|2|||
105353522|NCT02083653|363298605|FG002|Overall Study|Other Events|2|||
105353523|NCT02083653|363298603|FG000|Overall Study|Reason Missing|0|||
105353524|NCT02083653|363298604|FG001|Overall Study|Reason Missing|0|||
105353525|NCT02083653|363298605|FG002|Overall Study|Reason Missing|4|||
105353526|NCT00334295|363298606|FG000|Overall Study|Patients received fewer than 3 injection|5|||
105353527|NCT00893971|363298609|FG000|Overall Study|Physician Decision|3|||
105353528|NCT03816007|363298610|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
105353529|NCT03816007|363298611|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
105353530|NCT03816007|363298610|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
105353531|NCT03816007|363298611|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
105353532|NCT03816007|363298610|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
105353533|NCT03816007|363298611|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
105353534|NCT01573754|363298615|FG000|Overall Study|Noncompliance or remission not achieved|3|||
105353535|NCT01573754|363298616|FG001|Overall Study|Noncompliance or remission not achieved|15|||
105353536|NCT01237327|363298620|FG000|Overall Study|Protocol Violation: Core Study|1|||
105353537|NCT01237327|363298621|FG001|Overall Study|Protocol Violation: Core Study|0|||
105353538|NCT01237327|363298620|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
105353539|NCT01237327|363298621|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
105353540|NCT01237327|363298620|FG000|Overall Study|Progression of Disease: Core Study|18|||
105353541|NCT01237327|363298621|FG001|Overall Study|Progression of Disease: Core Study|22|||
105734304|NCT02441803|364682689|FG001|Overall Study|Physician Decision|2|||
105734305|NCT02441803|364682690|FG002|Overall Study|Physician Decision|2|||
105734306|NCT04983901|364682691|FG000|Overall Study|Death|1|||
105734307|NCT04983901|364682692|FG001|Overall Study|Death|4|||
105734308|NCT04983901|364682691|FG000|Overall Study|Lost to Follow-up|3|||
105734309|NCT04983901|364682692|FG001|Overall Study|Lost to Follow-up|0|||
105734310|NCT04983901|364682691|FG000|Overall Study|Protocol Violation|1|||
105734311|NCT04983901|364682692|FG001|Overall Study|Protocol Violation|0|||
105734312|NCT04983901|364682691|FG000|Overall Study|Withdrawal by Subject|1|||
105734313|NCT04983901|364682692|FG001|Overall Study|Withdrawal by Subject|2|||
105734314|NCT00949650|364682693|FG000|Overall Study|Progressive disease|188|||
105734315|NCT00949650|364682694|FG001|Overall Study|Progressive disease|19|||
105734316|NCT00949650|364682693|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
105734317|NCT00949650|364682694|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
105734318|NCT00949650|364682693|FG000|Overall Study|Other Adverse Event (AE)|28|||
105734319|NCT00949650|364682694|FG001|Overall Study|Other Adverse Event (AE)|17|||
105734320|NCT00949650|364682693|FG000|Overall Study|Protocol Violation|1|||
105734321|NCT00949650|364682694|FG001|Overall Study|Protocol Violation|4|||
105734322|NCT00949650|364682693|FG000|Overall Study|Refusal to continue medication|7|||
105734323|NCT00949650|364682694|FG001|Overall Study|Refusal to continue medication|11|||
105734324|NCT00949650|364682693|FG000|Overall Study|Not treated|1|||
105734325|NCT00949650|364682694|FG001|Overall Study|Not treated|4|||
105734326|NCT00949650|364682693|FG000|Overall Study|Other not specified above|5|||
105798625|NCT03216954|364920996|FG001|Overall Study|Adverse Event|0|||
105798626|NCT03216954|364920997|FG002|Overall Study|Adverse Event|1|||
105353542|NCT01237327|363298620|FG000|Overall Study|Progression of Disease: Extension Study|15|||
105353543|NCT01237327|363298621|FG001|Overall Study|Progression of Disease: Extension Study|13|||
105353544|NCT01237327|363298620|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
105734327|NCT00949650|364682694|FG001|Overall Study|Other not specified above|0|||
105734328|NCT01208181|364682700|FG000|Part 1|Withdrawal by Subject|11|||
105734329|NCT01208181|364682701|FG001|Part 1|Withdrawal by Subject|10|||
105734330|NCT01208181|364682702|FG002|Part 1|Withdrawal by Subject|0|||
105734331|NCT01208181|364682703|FG003|Part 1|Withdrawal by Subject|0|||
105798627|NCT03216954|364920998|FG003|Overall Study|Adverse Event|0|||
105798628|NCT03216954|364920999|FG004|Overall Study|Adverse Event|1|||
105798629|NCT03216954|364920995|FG000|Overall Study|Withdrawal by Subject|2|||
105798630|NCT03216954|364920996|FG001|Overall Study|Withdrawal by Subject|0|||
105798631|NCT03216954|364920997|FG002|Overall Study|Withdrawal by Subject|0|||
105798632|NCT03216954|364920998|FG003|Overall Study|Withdrawal by Subject|0|||
105798633|NCT03216954|364920999|FG004|Overall Study|Withdrawal by Subject|0|||
105798634|NCT03216954|364920995|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
105798635|NCT03216954|364920996|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
105798636|NCT03216954|364920997|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
105798637|NCT03216954|364920998|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
105798638|NCT03216954|364920999|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
105798639|NCT01610167|364921000|FG000|Overall Study|Scheduling conflict.|0|||
105798640|NCT01610167|364921001|FG001|Overall Study|Scheduling conflict.|0|||
105798641|NCT01610167|364921002|FG002|Overall Study|Scheduling conflict.|2|||
105798642|NCT01050673|364921005|FG000|Overall Study|Physician Decision|4|||
105798643|NCT01050673|364921006|FG001|Overall Study|Physician Decision|5|||
105798644|NCT02191579|364921012|FG000|Treatment 1|Multiple Reasons Specified|27|||
105798645|NCT02191579|364921013|FG001|Treatment 1|Multiple Reasons Specified|58|||
105798646|NCT02191579|364921012|FG000|Treatment 2|Multiple Reasons Specified|0|||
105798647|NCT02191579|364921013|FG001|Treatment 2|Multiple Reasons Specified|25|||
105798648|NCT00383019|364921017|FG000|Overall Study|Adverse Event|5|||
105798649|NCT00383019|364921018|FG001|Overall Study|Adverse Event|1|||
105353545|NCT01237327|363298621|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
105353546|NCT01237327|363298620|FG000|Overall Study|Withdrawal by Subject|1|||
105353547|NCT01237327|363298621|FG001|Overall Study|Withdrawal by Subject|3|||
105353548|NCT01237327|363298620|FG000|Overall Study|Lost to Follow-up|3|||
105353549|NCT01237327|363298621|FG001|Overall Study|Lost to Follow-up|0|||
105353550|NCT01344759|363301107|FG000|Overall Study|Patients failed to reach sedation level|0|||
105353551|NCT01344759|363301108|FG001|Overall Study|Patients failed to reach sedation level|2|||
105353552|NCT03214679|363301111|FG000|Overall Study|Lost to Follow-up|12|||
105353553|NCT03214679|363301112|FG001|Overall Study|Lost to Follow-up|14|||
105353554|NCT03214679|363301111|FG000|Overall Study|not eligible|2|||
105353555|NCT03214679|363301112|FG001|Overall Study|not eligible|0|||
105353556|NCT01754766|363301115|FG000|Overall Study|Personal reasons|1|||
105353557|NCT01754766|363301116|FG001|Overall Study|Personal reasons|1|||
105353558|NCT01754766|363301117|FG002|Overall Study|Personal reasons|0|||
105353559|NCT04676152|363301118|FG000|Overall Study|screen fail|9|||
105353560|NCT00660595|363301122|FG000|Overall Study|Lost to Follow-up|0|||
105353561|NCT00660595|363301123|FG001|Overall Study|Lost to Follow-up|1|||
105353562|NCT00660595|363301122|FG000|Overall Study|Did not consent to participate in study|12|||
105353563|NCT00660595|363301123|FG001|Overall Study|Did not consent to participate in study|8|||
105353564|NCT00660595|363301122|FG000|Overall Study|Participant left hospital|1|||
105353565|NCT00660595|363301123|FG001|Overall Study|Participant left hospital|0|||
105353566|NCT00660595|363301122|FG000|Overall Study|Non Specified reasons|5|||
105353567|NCT00660595|363301123|FG001|Overall Study|Non Specified reasons|0|||
105353568|NCT05205005|363301136|FG000|Overall Study|Withdrawal by Subject|1|||
105353569|NCT05205005|363301137|FG001|Overall Study|Withdrawal by Subject|0|||
105353570|NCT05205005|363301136|FG000|Overall Study|Adverse Event|1|||
105353571|NCT05205005|363301137|FG001|Overall Study|Adverse Event|0|||
105353572|NCT01148459|363301138|FG000|Overall Study|Serious Adverse Event|5|||
105353573|NCT01148459|363301139|FG001|Overall Study|Serious Adverse Event|4|||
105353574|NCT01148459|363301138|FG000|Overall Study|Withdrawal by Subject|1|||
105480525|NCT02043899|363771214|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
105353575|NCT01148459|363301139|FG001|Overall Study|Withdrawal by Subject|0|||
105353576|NCT01148459|363301138|FG000|Overall Study|Migrated/moved from study area|3|||
105353577|NCT01148459|363301139|FG001|Overall Study|Migrated/moved from study area|6|||
105798650|NCT00383019|364921017|FG000|Overall Study|Withdrawal by Subject|0|||
105798651|NCT00383019|364921018|FG001|Overall Study|Withdrawal by Subject|1|||
105798652|NCT03940586|364921019|FG000|Overall Study|Death|3|||
105798653|NCT03940586|364921020|FG001|Overall Study|Death|2|||
105798654|NCT03940586|364921021|FG002|Overall Study|Death|0|||
105798655|NCT03940586|364921019|FG000|Overall Study|Physician Decision|1|||
105798656|NCT03940586|364921020|FG001|Overall Study|Physician Decision|0|||
105798657|NCT03940586|364921021|FG002|Overall Study|Physician Decision|1|||
105798658|NCT03940586|364921019|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
105798659|NCT03940586|364921020|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
105798660|NCT03940586|364921021|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
105798661|NCT03940586|364921019|FG000|Overall Study|Not Treated|0|||
105798662|NCT03940586|364921020|FG001|Overall Study|Not Treated|2|||
105798663|NCT03940586|364921021|FG002|Overall Study|Not Treated|0|||
105798664|NCT02766400|364921022|FG000|Overall Study|Death|1|||
105798665|NCT02766400|364921023|FG001|Overall Study|Death|2|||
105798666|NCT02766400|364921022|FG000|Overall Study|Withdrawal by Subject|1|||
105798667|NCT02766400|364921023|FG001|Overall Study|Withdrawal by Subject|0|||
105798668|NCT01309828|364921029|FG000|Overall Study|Adverse Event|10|||
105798669|NCT01309828|364921030|FG001|Overall Study|Adverse Event|11|||
105798670|NCT01309828|364921029|FG000|Overall Study|Voluntary Withdrawal|5|||
105798671|NCT01309828|364921030|FG001|Overall Study|Voluntary Withdrawal|4|||
105798672|NCT01309828|364921029|FG000|Overall Study|Major Protocol Deviation|0|||
105798673|NCT01309828|364921030|FG001|Overall Study|Major Protocol Deviation|1|||
105798674|NCT01309828|364921029|FG000|Overall Study|Other|1|||
105798675|NCT01309828|364921030|FG001|Overall Study|Other|0|||
105798676|NCT02556632|364921031|FG000|Overall Study|Lost to Follow-up|1|||
105798677|NCT02556632|364921032|FG001|Overall Study|Lost to Follow-up|0|||
105798678|NCT02556632|364921033|FG002|Overall Study|Lost to Follow-up|0|||
105798679|NCT02556632|364921031|FG000|Overall Study|Disliked Intervention|1|||
105798680|NCT02556632|364921032|FG001|Overall Study|Disliked Intervention|1|||
105798681|NCT02556632|364921033|FG002|Overall Study|Disliked Intervention|1|||
105798682|NCT02556632|364921031|FG000|Overall Study|No Reason|1|||
105798683|NCT02556632|364921032|FG001|Overall Study|No Reason|0|||
105798684|NCT02556632|364921033|FG002|Overall Study|No Reason|1|||
105798685|NCT02556632|364921031|FG000|Overall Study|Personal Issues|0|||
105798686|NCT02556632|364921032|FG001|Overall Study|Personal Issues|1|||
105798687|NCT02556632|364921033|FG002|Overall Study|Personal Issues|1|||
105798688|NCT02556632|364921031|FG000|Overall Study|Changed Mind|0|||
105798689|NCT02556632|364921032|FG001|Overall Study|Changed Mind|1|||
105798690|NCT02556632|364921033|FG002|Overall Study|Changed Mind|0|||
105798691|NCT02556632|364921031|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
105798692|NCT02556632|364921032|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
105798693|NCT02556632|364921033|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
105798694|NCT02556632|364921031|FG000|Overall Study|Unrelated Adverse Event|1|||
105798695|NCT02556632|364921032|FG001|Overall Study|Unrelated Adverse Event|0|||
105798696|NCT02556632|364921033|FG002|Overall Study|Unrelated Adverse Event|3|||
105798697|NCT02556632|364921031|FG000|Overall Study|Related Adverse Event|0|||
105798698|NCT02556632|364921032|FG001|Overall Study|Related Adverse Event|1|||
105480526|NCT02043899|363771214|FG000|Overall Study|Treatment delayed|1|||
105734332|NCT01208181|364682704|FG004|Part 1|Withdrawal by Subject|0|||
105734333|NCT01208181|364682700|FG000|Part 1|Technical problem|5|||
105734334|NCT01208181|364682701|FG001|Part 1|Technical problem|0|||
105734335|NCT01208181|364682702|FG002|Part 1|Technical problem|0|||
105734336|NCT01208181|364682703|FG003|Part 1|Technical problem|0|||
105734337|NCT01208181|364682704|FG004|Part 1|Technical problem|0|||
105734338|NCT01208181|364682700|FG000|Part 1|Protocol Violation|10|||
105734339|NCT01208181|364682701|FG001|Part 1|Protocol Violation|5|||
105734340|NCT01208181|364682702|FG002|Part 1|Protocol Violation|0|||
105734341|NCT01208181|364682703|FG003|Part 1|Protocol Violation|0|||
105734342|NCT01208181|364682704|FG004|Part 1|Protocol Violation|0|||
105734343|NCT01208181|364682700|FG000|Part 1|Physician Decision|4|||
105734344|NCT01208181|364682701|FG001|Part 1|Physician Decision|0|||
105734345|NCT01208181|364682702|FG002|Part 1|Physician Decision|0|||
105734346|NCT01208181|364682703|FG003|Part 1|Physician Decision|0|||
105734347|NCT01208181|364682704|FG004|Part 1|Physician Decision|0|||
105734348|NCT01208181|364682700|FG000|Part 1|Non-compliance with study drug|1|||
105734349|NCT01208181|364682701|FG001|Part 1|Non-compliance with study drug|1|||
105734350|NCT01208181|364682702|FG002|Part 1|Non-compliance with study drug|0|||
105734351|NCT01208181|364682703|FG003|Part 1|Non-compliance with study drug|0|||
105734352|NCT01208181|364682704|FG004|Part 1|Non-compliance with study drug|0|||
105734353|NCT01208181|364682700|FG000|Part 1|Lost to Follow-up|5|||
105734354|NCT01208181|364682701|FG001|Part 1|Lost to Follow-up|3|||
105734355|NCT01208181|364682702|FG002|Part 1|Lost to Follow-up|0|||
105734356|NCT01208181|364682703|FG003|Part 1|Lost to Follow-up|0|||
105734357|NCT01208181|364682704|FG004|Part 1|Lost to Follow-up|1|||
105734358|NCT01208181|364682700|FG000|Part 1|Lack of Efficacy|37|||
105734359|NCT01208181|364682701|FG001|Part 1|Lack of Efficacy|12|||
105734360|NCT01208181|364682702|FG002|Part 1|Lack of Efficacy|0|||
105734361|NCT01208181|364682703|FG003|Part 1|Lack of Efficacy|0|||
105734362|NCT01208181|364682704|FG004|Part 1|Lack of Efficacy|17|||
105734363|NCT01208181|364682700|FG000|Part 1|Adverse Event|26|||
105734364|NCT01208181|364682701|FG001|Part 1|Adverse Event|24|||
105734365|NCT01208181|364682702|FG002|Part 1|Adverse Event|0|||
105734366|NCT01208181|364682703|FG003|Part 1|Adverse Event|0|||
105734367|NCT01208181|364682704|FG004|Part 1|Adverse Event|4|||
105734368|NCT01208181|364682700|FG000|Part 2|Adverse Event|0|||
105734369|NCT01208181|364682701|FG001|Part 2|Adverse Event|0|||
105734370|NCT01208181|364682702|FG002|Part 2|Adverse Event|6|||
105734371|NCT01208181|364682703|FG003|Part 2|Adverse Event|7|||
105734372|NCT01208181|364682704|FG004|Part 2|Adverse Event|0|||
105734373|NCT01208181|364682700|FG000|Part 2|Withdrawal by Subject|0|||
105734374|NCT01208181|364682701|FG001|Part 2|Withdrawal by Subject|0|||
105734375|NCT01208181|364682702|FG002|Part 2|Withdrawal by Subject|1|||
105734376|NCT01208181|364682703|FG003|Part 2|Withdrawal by Subject|1|||
105734377|NCT01208181|364682704|FG004|Part 2|Withdrawal by Subject|0|||
105734378|NCT01208181|364682700|FG000|Part 2|Protocol Violation|0|||
105734379|NCT01208181|364682701|FG001|Part 2|Protocol Violation|0|||
105734380|NCT01208181|364682702|FG002|Part 2|Protocol Violation|1|||
105734381|NCT01208181|364682703|FG003|Part 2|Protocol Violation|0|||
105734382|NCT01208181|364682704|FG004|Part 2|Protocol Violation|0|||
105734383|NCT01208181|364682700|FG000|Part 2|Physician Decision|0|||
105734384|NCT01208181|364682701|FG001|Part 2|Physician Decision|0|||
105734385|NCT01208181|364682702|FG002|Part 2|Physician Decision|1|||
105734386|NCT01208181|364682703|FG003|Part 2|Physician Decision|2|||
105734387|NCT01208181|364682704|FG004|Part 2|Physician Decision|0|||
105734388|NCT01208181|364682700|FG000|Part 2|Non-compliance with study drug|0|||
105734389|NCT01208181|364682701|FG001|Part 2|Non-compliance with study drug|0|||
105734390|NCT01208181|364682702|FG002|Part 2|Non-compliance with study drug|1|||
105734391|NCT01208181|364682703|FG003|Part 2|Non-compliance with study drug|1|||
105734392|NCT01208181|364682704|FG004|Part 2|Non-compliance with study drug|0|||
105734393|NCT01208181|364682700|FG000|Part 2|Lost to Follow-up|0|||
105734394|NCT01208181|364682701|FG001|Part 2|Lost to Follow-up|0|||
105734395|NCT01208181|364682702|FG002|Part 2|Lost to Follow-up|1|||
105734396|NCT01208181|364682703|FG003|Part 2|Lost to Follow-up|2|||
105734397|NCT01208181|364682704|FG004|Part 2|Lost to Follow-up|0|||
105734398|NCT01208181|364682700|FG000|Part 2|Lack of Efficacy|0|||
105734399|NCT01208181|364682701|FG001|Part 2|Lack of Efficacy|0|||
105734400|NCT01208181|364682702|FG002|Part 2|Lack of Efficacy|5|||
105734401|NCT01208181|364682703|FG003|Part 2|Lack of Efficacy|7|||
105734402|NCT01208181|364682704|FG004|Part 2|Lack of Efficacy|0|||
105734403|NCT00942708|364682705|FG000|Overall Study|Withdrawal by Subject|1|||
105734404|NCT01457339|364682706|FG000|Period 3 (100 mg)|Adverse Event|0|||
105734405|NCT01457339|364682707|FG001|Period 3 (100 mg)|Adverse Event|1|||
105734406|NCT01457339|364682706|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
105734407|NCT01457339|364682707|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
105734408|NCT01457339|364682706|FG000|Period 6 (250 mg)|Family Emergency|1|||
105734409|NCT01457339|364682707|FG001|Period 6 (250 mg)|Family Emergency|0|||
105734410|NCT01457339|364682706|FG000|Period 6 (250 mg)|Personal appointment|0|||
105734411|NCT01457339|364682707|FG001|Period 6 (250 mg)|Personal appointment|1|||
105734412|NCT00196937|364682711|FG000|Overall Study|Serious Adverse Event|1|||
105734413|NCT00196937|364682712|FG001|Overall Study|Serious Adverse Event|0|||
105353578|NCT01148459|363301138|FG000|Overall Study|Lost to Follow-up|2|||
105353579|NCT01148459|363301139|FG001|Overall Study|Lost to Follow-up|0|||
105353580|NCT01148459|363301138|FG000|Overall Study|Refusal|1|||
105353581|NCT01148459|363301139|FG001|Overall Study|Refusal|0|||
105353582|NCT01148459|363301138|FG000|Overall Study|Failure to comply with study procedures|0|||
105353583|NCT01148459|363301139|FG001|Overall Study|Failure to comply with study procedures|1|||
105353584|NCT02187029|363301140|FG000|Overall Study|Adverse Event|0|||
105353585|NCT02187029|363301141|FG001|Overall Study|Adverse Event|1|||
105353586|NCT02187029|363301142|FG002|Overall Study|Adverse Event|1|||
105353587|NCT02187029|363301143|FG003|Overall Study|Adverse Event|0|||
105353588|NCT02187029|363301140|FG000|Overall Study|Study Terminated by Sponsor|0|||
105353589|NCT02187029|363301141|FG001|Overall Study|Study Terminated by Sponsor|0|||
105353590|NCT02187029|363301142|FG002|Overall Study|Study Terminated by Sponsor|10|||
105353591|NCT02187029|363301143|FG003|Overall Study|Study Terminated by Sponsor|3|||
105353592|NCT02187029|363301140|FG000|Overall Study|Withdrawal by Subject|1|||
105353593|NCT02187029|363301141|FG001|Overall Study|Withdrawal by Subject|0|||
105353594|NCT02187029|363301142|FG002|Overall Study|Withdrawal by Subject|0|||
105353595|NCT02187029|363301143|FG003|Overall Study|Withdrawal by Subject|0|||
105353596|NCT01066663|363301149|FG000|Overall Study|Adverse Event|0|||
105353597|NCT01066663|363301150|FG001|Overall Study|Adverse Event|0|||
105353598|NCT01066663|363301151|FG002|Overall Study|Adverse Event|1|||
105353599|NCT02985021|363301152|FG000|Overall Study|Inability to comply with study procedures|1|||
105353600|NCT01491841|363301153|FG000|Overall Study|Screen Failure|10|||
105353601|NCT01491841|363301153|FG000|Overall Study|Withdrawal by Subject|1|||
105353602|NCT03539484|363301154|FG000|Overall Study|Death|1|||
105353603|NCT03539484|363301155|FG001|Overall Study|Death|0|||
105353604|NCT03539484|363301156|FG002|Overall Study|Death|0|||
105734414|NCT00196937|364682713|FG002|Overall Study|Serious Adverse Event|0|||
105734415|NCT00196937|364682711|FG000|Overall Study|Non-serious adverse event|1|||
105734416|NCT00196937|364682712|FG001|Overall Study|Non-serious adverse event|1|||
105734417|NCT00196937|364682713|FG002|Overall Study|Non-serious adverse event|1|||
105734418|NCT00196937|364682711|FG000|Overall Study|Withdrawal by Subject|0|||
105734419|NCT00196937|364682712|FG001|Overall Study|Withdrawal by Subject|0|||
105734420|NCT00196937|364682713|FG002|Overall Study|Withdrawal by Subject|2|||
105734421|NCT00196937|364682711|FG000|Overall Study|Lost to Follow-up|4|||
105734422|NCT00196937|364682712|FG001|Overall Study|Lost to Follow-up|3|||
105734423|NCT00196937|364682713|FG002|Overall Study|Lost to Follow-up|3|||
105734424|NCT00196937|364682711|FG000|Overall Study|Other|3|||
105734425|NCT00196937|364682712|FG001|Overall Study|Other|1|||
105734426|NCT00196937|364682713|FG002|Overall Study|Other|1|||
105734427|NCT01164501|364682714|FG000|Overall Study|Not treated|2|||
105734428|NCT01164501|364682715|FG001|Overall Study|Not treated|0|||
105734429|NCT01164501|364682716|FG002|Overall Study|Not treated|1|||
105734430|NCT01164501|364682714|FG000|Overall Study|Adverse Event|18|||
105734431|NCT01164501|364682715|FG001|Overall Study|Adverse Event|4|||
105734432|NCT01164501|364682716|FG002|Overall Study|Adverse Event|21|||
105734433|NCT01164501|364682714|FG000|Overall Study|Lack of Efficacy|0|||
105734434|NCT01164501|364682715|FG001|Overall Study|Lack of Efficacy|0|||
105734435|NCT01164501|364682716|FG002|Overall Study|Lack of Efficacy|1|||
105734436|NCT01164501|364682714|FG000|Overall Study|Non compliant with protocol|1|||
105734437|NCT01164501|364682715|FG001|Overall Study|Non compliant with protocol|1|||
105734438|NCT01164501|364682716|FG002|Overall Study|Non compliant with protocol|4|||
105734439|NCT01164501|364682714|FG000|Overall Study|Lost to Follow-up|3|||
105734440|NCT01164501|364682715|FG001|Overall Study|Lost to Follow-up|0|||
105734441|NCT01164501|364682716|FG002|Overall Study|Lost to Follow-up|3|||
105734442|NCT01164501|364682714|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
105734443|NCT01164501|364682715|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
105734444|NCT01164501|364682716|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
105353605|NCT03539484|363301157|FG003|Overall Study|Death|2|||
105353606|NCT03539484|363301158|FG004|Overall Study|Death|8|||
105353607|NCT03539484|363301159|FG005|Overall Study|Death|3|||
105353608|NCT03539484|363301160|FG006|Overall Study|Death|0|||
105353609|NCT03539484|363301154|FG000|Overall Study|Lost to Follow-up|0|||
105353610|NCT03539484|363301155|FG001|Overall Study|Lost to Follow-up|1|||
105353611|NCT03539484|363301156|FG002|Overall Study|Lost to Follow-up|0|||
105734445|NCT01164501|364682714|FG000|Overall Study|Other reason not defined above|9|||
105734446|NCT01164501|364682715|FG001|Overall Study|Other reason not defined above|1|||
105734447|NCT01164501|364682716|FG002|Overall Study|Other reason not defined above|4|||
105734448|NCT02522377|364682717|FG000|Overall Study|Withdrawal by Subject|1|||
105734449|NCT02522377|364682718|FG001|Overall Study|Withdrawal by Subject|0|||
105734450|NCT02522377|364682717|FG000|Overall Study|Remission Achieved|3|||
105734451|NCT02522377|364682718|FG001|Overall Study|Remission Achieved|0|||
105353612|NCT03539484|363301157|FG003|Overall Study|Lost to Follow-up|0|||
105353613|NCT03539484|363301158|FG004|Overall Study|Lost to Follow-up|1|||
105353614|NCT03539484|363301159|FG005|Overall Study|Lost to Follow-up|0|||
105353615|NCT03539484|363301160|FG006|Overall Study|Lost to Follow-up|0|||
105353616|NCT03539484|363301154|FG000|Overall Study|Withdrawal by Subject|0|||
105353617|NCT03539484|363301155|FG001|Overall Study|Withdrawal by Subject|0|||
105734452|NCT02515669|364682723|FG000|228 Week Open-Label Phase|Other|0|||
105798699|NCT02556632|364921033|FG002|Overall Study|Related Adverse Event|0|||
105798700|NCT02556632|364921031|FG000|Overall Study|Possibly Related Adverse Event|0|||
105798701|NCT02556632|364921032|FG001|Overall Study|Possibly Related Adverse Event|0|||
105798702|NCT02556632|364921033|FG002|Overall Study|Possibly Related Adverse Event|1|||
105798703|NCT02556632|364921031|FG000|Overall Study|Did Not Start RT|0|||
105798704|NCT02556632|364921032|FG001|Overall Study|Did Not Start RT|1|||
105798705|NCT02556632|364921033|FG002|Overall Study|Did Not Start RT|0|||
105798706|NCT02556632|364921031|FG000|Overall Study|Ineligible|0|||
105798707|NCT02556632|364921032|FG001|Overall Study|Ineligible|1|||
105798708|NCT02556632|364921033|FG002|Overall Study|Ineligible|0|||
105798709|NCT02556632|364921031|FG000|Overall Study|Disliked Study Procedures|0|||
105798710|NCT02556632|364921032|FG001|Overall Study|Disliked Study Procedures|0|||
105798711|NCT02556632|364921033|FG002|Overall Study|Disliked Study Procedures|1|||
105798712|NCT02556632|364921031|FG000|Overall Study|Treatment or Change Delay|0|||
105798713|NCT02556632|364921032|FG001|Overall Study|Treatment or Change Delay|0|||
105798714|NCT02556632|364921033|FG002|Overall Study|Treatment or Change Delay|1|||
105798715|NCT01625286|364921034|FG000|Overall Study|Adverse Event|0|||
105798716|NCT01625286|364921035|FG001|Overall Study|Adverse Event|0|||
105798717|NCT01625286|364921036|FG002|Overall Study|Adverse Event|0|||
105798718|NCT01625286|364921037|FG003|Overall Study|Adverse Event|0|||
105798719|NCT01625286|364921038|FG004|Overall Study|Adverse Event|1|||
105798720|NCT01625286|364921039|FG005|Overall Study|Adverse Event|2|||
105798721|NCT01625286|364921040|FG006|Overall Study|Adverse Event|1|||
105798722|NCT01625286|364921034|FG000|Overall Study|Death|0|||
105798723|NCT01625286|364921035|FG001|Overall Study|Death|0|||
105798724|NCT01625286|364921036|FG002|Overall Study|Death|1|||
105798725|NCT01625286|364921037|FG003|Overall Study|Death|1|||
105798726|NCT01625286|364921038|FG004|Overall Study|Death|0|||
105480527|NCT01954927|363771216|FG000|Overall Study|Withdrawal by Subject|3|||
105480528|NCT01954927|363771217|FG001|Overall Study|Withdrawal by Subject|1|||
105480529|NCT03387111|363771218|FG000|Overall Study|Progressive Disease|3|||
105480530|NCT03387111|363771218|FG000|Overall Study|Other|1|||
105480531|NCT01771809|363771224|FG000|Overall Study|Adverse Event|4|||
105480532|NCT01771809|363771225|FG001|Overall Study|Adverse Event|12|||
105480533|NCT01771809|363771224|FG000|Overall Study|Protocol Violation|0|||
105480534|NCT01771809|363771225|FG001|Overall Study|Protocol Violation|1|||
105480535|NCT01771809|363771224|FG000|Overall Study|Withdrawal by Subject|34|||
105480536|NCT01771809|363771225|FG001|Overall Study|Withdrawal by Subject|42|||
105480537|NCT01771809|363771224|FG000|Overall Study|Lost to Follow-up|1|||
105480538|NCT01771809|363771225|FG001|Overall Study|Lost to Follow-up|3|||
105734453|NCT02515669|364682724|FG001|228 Week Open-Label Phase|Other|0|||
105734454|NCT02515669|364682725|FG002|228 Week Open-Label Phase|Other|1|||
105734455|NCT02515669|364682726|FG003|228 Week Open-Label Phase|Other|4|||
105734456|NCT02515669|364682723|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
105734457|NCT02515669|364682724|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
105734458|NCT02515669|364682725|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
105734459|NCT02515669|364682726|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
105734460|NCT02515669|364682723|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
105734461|NCT02515669|364682724|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
105734462|NCT02515669|364682725|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
105734463|NCT02515669|364682726|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
105734464|NCT02515669|364682723|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
105734465|NCT02515669|364682724|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
105734466|NCT02515669|364682725|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
105734467|NCT02515669|364682726|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
105734468|NCT02515669|364682723|FG000|228 Week Open-Label Phase|Missing|0|||
105798727|NCT01625286|364921039|FG005|Overall Study|Death|11|||
105798728|NCT01625286|364921040|FG006|Overall Study|Death|16|||
105798729|NCT01625286|364921034|FG000|Overall Study|Withdrawal by Subject|0|||
105798730|NCT01625286|364921035|FG001|Overall Study|Withdrawal by Subject|1|||
105798731|NCT01625286|364921036|FG002|Overall Study|Withdrawal by Subject|0|||
105480539|NCT01771809|363771224|FG000|Overall Study|Other (Insufficient clinical response)|22|||
105734469|NCT02515669|364682724|FG001|228 Week Open-Label Phase|Missing|2|||
105734470|NCT02515669|364682725|FG002|228 Week Open-Label Phase|Missing|2|||
105734471|NCT02515669|364682726|FG003|228 Week Open-Label Phase|Missing|2|||
105734472|NCT01282814|364682727|FG000|First Intervention|Emesis During Dosing Interval|0|||
105734473|NCT01282814|364682728|FG001|First Intervention|Emesis During Dosing Interval|3|||
105734474|NCT01282814|364682727|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
105734475|NCT01282814|364682728|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
105734476|NCT01444391|364682729|FG000|Overall Study|Death|1|||
105734477|NCT01089725|364682730|FG000|Overall Study|Adverse Event|1|||
105734478|NCT01089725|364682731|FG001|Overall Study|Adverse Event|1|||
105734479|NCT01089725|364682732|FG002|Overall Study|Adverse Event|0|||
105734480|NCT01089725|364682733|FG003|Overall Study|Adverse Event|0|||
105734481|NCT01089725|364682734|FG004|Overall Study|Adverse Event|2|||
105734482|NCT01089725|364682730|FG000|Overall Study|Lack of Efficacy|4|||
105734483|NCT01089725|364682731|FG001|Overall Study|Lack of Efficacy|3|||
105734484|NCT01089725|364682732|FG002|Overall Study|Lack of Efficacy|1|||
105734485|NCT01089725|364682733|FG003|Overall Study|Lack of Efficacy|0|||
105734486|NCT01089725|364682734|FG004|Overall Study|Lack of Efficacy|4|||
105734487|NCT01089725|364682730|FG000|Overall Study|Lost to Follow-up|2|||
105734488|NCT01089725|364682731|FG001|Overall Study|Lost to Follow-up|2|||
105734489|NCT01089725|364682732|FG002|Overall Study|Lost to Follow-up|0|||
105734490|NCT01089725|364682733|FG003|Overall Study|Lost to Follow-up|3|||
105734491|NCT01089725|364682734|FG004|Overall Study|Lost to Follow-up|0|||
105734492|NCT01089725|364682730|FG000|Overall Study|Protocol Violation|0|||
105734493|NCT01089725|364682731|FG001|Overall Study|Protocol Violation|0|||
105734494|NCT01089725|364682732|FG002|Overall Study|Protocol Violation|1|||
105734495|NCT01089725|364682733|FG003|Overall Study|Protocol Violation|1|||
105734496|NCT01089725|364682734|FG004|Overall Study|Protocol Violation|0|||
105734497|NCT01089725|364682730|FG000|Overall Study|Withdrawal by Subject|5|||
105734498|NCT01089725|364682731|FG001|Overall Study|Withdrawal by Subject|5|||
105734499|NCT01089725|364682732|FG002|Overall Study|Withdrawal by Subject|4|||
105734500|NCT01089725|364682733|FG003|Overall Study|Withdrawal by Subject|5|||
105734501|NCT01089725|364682734|FG004|Overall Study|Withdrawal by Subject|4|||
105734502|NCT01089725|364682730|FG000|Overall Study|Study Terminated by Sponsor|51|||
105734503|NCT01089725|364682731|FG001|Overall Study|Study Terminated by Sponsor|56|||
105734504|NCT01089725|364682732|FG002|Overall Study|Study Terminated by Sponsor|53|||
105734505|NCT01089725|364682733|FG003|Overall Study|Study Terminated by Sponsor|68|||
105734506|NCT01089725|364682734|FG004|Overall Study|Study Terminated by Sponsor|68|||
105734507|NCT01089725|364682730|FG000|Overall Study|Randomized, but not treated|0|||
105353618|NCT03539484|363301156|FG002|Overall Study|Withdrawal by Subject|0|||
105353619|NCT03539484|363301157|FG003|Overall Study|Withdrawal by Subject|0|||
105353620|NCT03539484|363301158|FG004|Overall Study|Withdrawal by Subject|2|||
105353621|NCT03539484|363301159|FG005|Overall Study|Withdrawal by Subject|0|||
105353622|NCT03539484|363301160|FG006|Overall Study|Withdrawal by Subject|1|||
105353623|NCT03539484|363301154|FG000|Overall Study|Study Terminated by Sponsor|0|||
105353624|NCT03539484|363301155|FG001|Overall Study|Study Terminated by Sponsor|0|||
105353625|NCT03539484|363301156|FG002|Overall Study|Study Terminated by Sponsor|1|||
105353626|NCT03539484|363301157|FG003|Overall Study|Study Terminated by Sponsor|1|||
105353627|NCT03539484|363301158|FG004|Overall Study|Study Terminated by Sponsor|2|||
105353628|NCT03539484|363301159|FG005|Overall Study|Study Terminated by Sponsor|2|||
105353629|NCT03539484|363301160|FG006|Overall Study|Study Terminated by Sponsor|1|||
105353630|NCT04105842|363301161|FG000|Overall Study|Withdrawal by Subject|2|||
105353631|NCT02757625|363301164|FG000|Overall Study|Investigator's discretion|0|||
105353632|NCT02757625|363301165|FG001|Overall Study|Investigator's discretion|0|||
105353633|NCT02757625|363301166|FG002|Overall Study|Investigator's discretion|1|||
105353634|NCT02757625|363301167|FG003|Overall Study|Investigator's discretion|0|||
105353635|NCT02757625|363301164|FG000|Overall Study|Adverse Event|0|||
105353636|NCT02757625|363301165|FG001|Overall Study|Adverse Event|0|||
105353637|NCT02757625|363301166|FG002|Overall Study|Adverse Event|1|||
105353638|NCT02757625|363301167|FG003|Overall Study|Adverse Event|0|||
105353639|NCT02734862|363301168|FG000|Part A|Death|3|||
105353640|NCT02734862|363301169|FG001|Part A|Death|4|||
105353641|NCT02734862|363301170|FG002|Part A|Death|6|||
105353642|NCT02734862|363301168|FG000|Part A|Lost to Follow-up|2|||
105353643|NCT02734862|363301169|FG001|Part A|Lost to Follow-up|1|||
105353644|NCT02734862|363301170|FG002|Part A|Lost to Follow-up|1|||
105353645|NCT02734862|363301168|FG000|Part A|Withdrawal by Subject|1|||
105353646|NCT02734862|363301169|FG001|Part A|Withdrawal by Subject|1|||
105353647|NCT02734862|363301170|FG002|Part A|Withdrawal by Subject|2|||
105353648|NCT02734862|363301168|FG000|Part A|Physician Decision|2|||
105353649|NCT02734862|363301169|FG001|Part A|Physician Decision|0|||
105353650|NCT02734862|363301170|FG002|Part A|Physician Decision|1|||
105353651|NCT02734862|363301168|FG000|Part A|Adverse Event|2|||
105353652|NCT02734862|363301169|FG001|Part A|Adverse Event|0|||
105353653|NCT02734862|363301170|FG002|Part A|Adverse Event|1|||
105353654|NCT02734862|363301168|FG000|Part A|Noncompliance|1|||
105353655|NCT02734862|363301169|FG001|Part A|Noncompliance|1|||
105353656|NCT02734862|363301170|FG002|Part A|Noncompliance|0|||
105353657|NCT02734862|363301168|FG000|Part A|Other|1|||
105353658|NCT02734862|363301169|FG001|Part A|Other|1|||
105353659|NCT02734862|363301170|FG002|Part A|Other|3|||
105353660|NCT02734862|363301168|FG000|Part B|Death|8|||
105353661|NCT02734862|363301169|FG001|Part B|Death|3|||
105353662|NCT02734862|363301170|FG002|Part B|Death|5|||
105353663|NCT02734862|363301168|FG000|Part B|Lost to Follow-up|2|||
105353664|NCT02734862|363301169|FG001|Part B|Lost to Follow-up|2|||
105353665|NCT02734862|363301170|FG002|Part B|Lost to Follow-up|0|||
105353666|NCT02734862|363301168|FG000|Part B|Withdrawal by Subject|3|||
105353667|NCT02734862|363301169|FG001|Part B|Withdrawal by Subject|1|||
105353668|NCT02734862|363301170|FG002|Part B|Withdrawal by Subject|0|||
105353669|NCT02734862|363301168|FG000|Part B|Other|0|||
105353670|NCT02734862|363301169|FG001|Part B|Other|1|||
105353671|NCT02734862|363301170|FG002|Part B|Other|0|||
105353672|NCT04854057|363301171|FG000|Overall Study|Adverse Event|0|||
105353673|NCT04854057|363301172|FG001|Overall Study|Adverse Event|1|||
105353674|NCT03519919|363301173|FG000|Overall Study|Withdrawal by Subject|1|||
105353675|NCT03519919|363301173|FG000|Overall Study|Lack of Efficacy|1|||
105353676|NCT03519919|363301173|FG000|Overall Study|Screen Failure|1|||
105734508|NCT01089725|364682731|FG001|Overall Study|Randomized, but not treated|1|||
105734509|NCT01089725|364682732|FG002|Overall Study|Randomized, but not treated|2|||
105734510|NCT01089725|364682733|FG003|Overall Study|Randomized, but not treated|1|||
105734511|NCT01089725|364682734|FG004|Overall Study|Randomized, but not treated|2|||
105734512|NCT01089725|364682730|FG000|Overall Study|Other|3|||
105734513|NCT01089725|364682731|FG001|Overall Study|Other|0|||
105734514|NCT01089725|364682732|FG002|Overall Study|Other|0|||
105734515|NCT01089725|364682733|FG003|Overall Study|Other|1|||
105734516|NCT01089725|364682734|FG004|Overall Study|Other|0|||
105734517|NCT02725177|364682738|FG000|Overall Study|Physician Decision|4|||
105734518|NCT02725177|364682738|FG000|Overall Study|Adverse Event|1|||
105734519|NCT00793585|364682739|FG000|Overall Study|Adverse Event|1|||
105734520|NCT00793585|364682740|FG001|Overall Study|Adverse Event|1|||
105734521|NCT00793585|364682739|FG000|Overall Study|Protocol Violation|1|||
105734522|NCT00793585|364682740|FG001|Overall Study|Protocol Violation|2|||
105734523|NCT02332915|364682741|FG000|Overall Study|Moved out of region|3|||
105734524|NCT02332915|364682742|FG001|Overall Study|Moved out of region|0|||
105734525|NCT02332915|364682741|FG000|Overall Study|Unrelated illness|1|||
105734526|NCT02332915|364682742|FG001|Overall Study|Unrelated illness|1|||
105353677|NCT00645671|363301174|FG000|Overall Study|Protocol Violation|1|||
105353678|NCT00645671|363301175|FG001|Overall Study|Protocol Violation|0|||
105353679|NCT00645671|363301174|FG000|Overall Study|Withdrawal by Subject|0|||
105353680|NCT00645671|363301175|FG001|Overall Study|Withdrawal by Subject|4|||
105734527|NCT02332915|364682741|FG000|Overall Study|Travel distance prohibitive|0|||
105798732|NCT01625286|364921037|FG003|Overall Study|Withdrawal by Subject|1|||
105798733|NCT01625286|364921038|FG004|Overall Study|Withdrawal by Subject|0|||
105798734|NCT01625286|364921039|FG005|Overall Study|Withdrawal by Subject|0|||
105798735|NCT01625286|364921040|FG006|Overall Study|Withdrawal by Subject|1|||
105798736|NCT01625286|364921034|FG000|Overall Study|Any reason not specifically recorded|0|||
105798737|NCT01625286|364921035|FG001|Overall Study|Any reason not specifically recorded|0|||
105798738|NCT01625286|364921036|FG002|Overall Study|Any reason not specifically recorded|0|||
105798739|NCT01625286|364921037|FG003|Overall Study|Any reason not specifically recorded|0|||
105798740|NCT01625286|364921038|FG004|Overall Study|Any reason not specifically recorded|0|||
105798741|NCT01625286|364921039|FG005|Overall Study|Any reason not specifically recorded|1|||
105798742|NCT01625286|364921040|FG006|Overall Study|Any reason not specifically recorded|0|||
105798743|NCT01625286|364921034|FG000|Overall Study|Progressive disease|6|||
105798744|NCT01625286|364921035|FG001|Overall Study|Progressive disease|3|||
105798745|NCT01625286|364921036|FG002|Overall Study|Progressive disease|4|||
105798746|NCT01625286|364921037|FG003|Overall Study|Progressive disease|5|||
105798747|NCT01625286|364921038|FG004|Overall Study|Progressive disease|5|||
105798748|NCT01625286|364921039|FG005|Overall Study|Progressive disease|0|||
105798749|NCT01625286|364921040|FG006|Overall Study|Progressive disease|0|||
105798750|NCT01625286|364921034|FG000|Overall Study|Lost to Follow-up|0|||
105798751|NCT01625286|364921035|FG001|Overall Study|Lost to Follow-up|0|||
105798752|NCT01625286|364921036|FG002|Overall Study|Lost to Follow-up|0|||
105798753|NCT01625286|364921037|FG003|Overall Study|Lost to Follow-up|0|||
105798754|NCT01625286|364921038|FG004|Overall Study|Lost to Follow-up|0|||
105798755|NCT01625286|364921039|FG005|Overall Study|Lost to Follow-up|0|||
105798756|NCT01625286|364921040|FG006|Overall Study|Lost to Follow-up|1|||
105798757|NCT02475980|364921041|FG000|Overall Study|Lost to Follow-up|4|||
105798758|NCT02475980|364921041|FG000|Overall Study|Withdrawal by Subject|1|||
105798759|NCT04128696|364921042|FG000|Overall Study|Lost to Follow-up|3|||
105798760|NCT04128696|364921043|FG001|Overall Study|Lost to Follow-up|7|||
105798761|NCT04128696|364921042|FG000|Overall Study|Withdrawal by Subject|12|||
105798762|NCT04128696|364921043|FG001|Overall Study|Withdrawal by Subject|11|||
105798763|NCT04128696|364921042|FG000|Overall Study|Study Closed/Terminated|26|||
105798764|NCT04128696|364921043|FG001|Overall Study|Study Closed/Terminated|38|||
105798765|NCT04128696|364921042|FG000|Overall Study|Physician Decision|2|||
105798766|NCT04128696|364921043|FG001|Overall Study|Physician Decision|3|||
105798767|NCT01585831|364921046|FG000|Overall Study|Physician Decision|0|||
105798768|NCT01585831|364921047|FG001|Overall Study|Physician Decision|1|||
105798769|NCT01585831|364921046|FG000|Overall Study|Withdrawal by Subject|2|||
105798770|NCT01585831|364921047|FG001|Overall Study|Withdrawal by Subject|1|||
105798771|NCT02904200|364921048|FG000|Overall Study|Withdrawal by Subject|1|||
105798772|NCT02904200|364921049|FG001|Overall Study|Withdrawal by Subject|0|||
105798773|NCT01272193|364922577|FG000|Overall Study|Adverse Event|1|||
105798774|NCT01272193|364922578|FG001|Overall Study|Adverse Event|1|||
105798775|NCT01272193|364922577|FG000|Overall Study|Lack of Efficacy|0|||
105798776|NCT01272193|364922578|FG001|Overall Study|Lack of Efficacy|3|||
105798777|NCT01272193|364922577|FG000|Overall Study|Withdrawal Criteria|1|||
105798778|NCT01272193|364922578|FG001|Overall Study|Withdrawal Criteria|1|||
105353681|NCT00645671|363301174|FG000|Overall Study|Adverse Event|0|||
105353682|NCT00645671|363301175|FG001|Overall Study|Adverse Event|1|||
105353683|NCT00645671|363301174|FG000|Overall Study|Physician Decision|0|||
105353684|NCT00645671|363301175|FG001|Overall Study|Physician Decision|1|||
105353685|NCT00493311|363301177|FG000|Overall Study|Need for rescue medication|2|||
105353686|NCT00493311|363301178|FG001|Overall Study|Need for rescue medication|2|||
105353687|NCT02779075|363301179|FG000|Overall Study|Withdrawal by Subject|1|||
105353688|NCT02779075|363301180|FG001|Overall Study|Withdrawal by Subject|3|||
105353689|NCT02779075|363301179|FG000|Overall Study|IV lost during 2nd study|1|||
105353690|NCT02779075|363301180|FG001|Overall Study|IV lost during 2nd study|0|||
105798779|NCT01272193|364922577|FG000|Overall Study|Unclassified|8|||
105798780|NCT01272193|364922578|FG001|Overall Study|Unclassified|7|||
105798781|NCT00736099|364922583|FG000|Overall Study|Adverse Event|61|||
105798782|NCT00736099|364922584|FG001|Overall Study|Adverse Event|18|||
105798783|NCT00736099|364922583|FG000|Overall Study|Protocol Violation|10|||
105798784|NCT00736099|364922584|FG001|Overall Study|Protocol Violation|4|||
105798785|NCT00736099|364922583|FG000|Overall Study|Lost to Follow-up|12|||
105798786|NCT00736099|364922584|FG001|Overall Study|Lost to Follow-up|5|||
105353691|NCT04399889|363301187|FG000|Overall Study|Death|5|||
105353692|NCT04399889|363301188|FG001|Overall Study|Death|1|||
105353693|NCT04399889|363301189|FG002|Overall Study|Death|1|||
105798787|NCT00736099|364922583|FG000|Overall Study|Withdrawal by Subject|42|||
105798788|NCT00736099|364922584|FG001|Overall Study|Withdrawal by Subject|13|||
105798789|NCT00736099|364922583|FG000|Overall Study|Lack of Efficacy|15|||
105798790|NCT00736099|364922584|FG001|Overall Study|Lack of Efficacy|8|||
105798791|NCT00736099|364922583|FG000|Overall Study|Other reason|43|||
105798792|NCT00736099|364922584|FG001|Overall Study|Other reason|10|||
105798793|NCT01613131|364922587|FG000|Overall Study|Withdrawal by Subject|3|||
105353694|NCT00707980|363301190|FG000|Overall Study|Adverse Event|49|||
105353695|NCT00707980|363301190|FG000|Overall Study|Lack of Efficacy|35|||
105353696|NCT00707980|363301190|FG000|Overall Study|Non-Compliance with Study Drug|28|||
105798794|NCT01613131|364922588|FG001|Overall Study|Withdrawal by Subject|5|||
105798795|NCT02454972|364922589|FG000|Overall Study|Progressive disease|17|||
105353697|NCT00707980|363301190|FG000|Overall Study|Protocol Deviations|19|||
105798796|NCT02454972|364922590|FG001|Overall Study|Progressive disease|16|||
105798797|NCT02454972|364922591|FG002|Overall Study|Progressive disease|59|||
105798798|NCT02454972|364922592|FG003|Overall Study|Progressive disease|23|||
105798799|NCT02454972|364922593|FG004|Overall Study|Progressive disease|16|||
105798800|NCT02454972|364922594|FG005|Overall Study|Progressive disease|12|||
105798801|NCT02454972|364922595|FG006|Overall Study|Progressive disease|19|||
105798802|NCT02454972|364922596|FG007|Overall Study|Progressive disease|27|||
105798803|NCT02454972|364922597|FG008|Overall Study|Progressive disease|0|||
105798804|NCT02454972|364922589|FG000|Overall Study|Death|0|||
105798805|NCT02454972|364922590|FG001|Overall Study|Death|0|||
105798806|NCT02454972|364922591|FG002|Overall Study|Death|5|||
105798807|NCT02454972|364922592|FG003|Overall Study|Death|1|||
105798808|NCT02454972|364922593|FG004|Overall Study|Death|0|||
105798809|NCT02454972|364922594|FG005|Overall Study|Death|0|||
105798810|NCT02454972|364922595|FG006|Overall Study|Death|0|||
105798811|NCT02454972|364922596|FG007|Overall Study|Death|0|||
105798812|NCT02454972|364922597|FG008|Overall Study|Death|95|||
105798813|NCT02454972|364922589|FG000|Overall Study|Physician Decision|0|||
105798814|NCT02454972|364922590|FG001|Overall Study|Physician Decision|1|||
105798815|NCT02454972|364922591|FG002|Overall Study|Physician Decision|2|||
105798816|NCT02454972|364922592|FG003|Overall Study|Physician Decision|1|||
105798817|NCT02454972|364922593|FG004|Overall Study|Physician Decision|2|||
105798818|NCT02454972|364922594|FG005|Overall Study|Physician Decision|0|||
105798819|NCT02454972|364922595|FG006|Overall Study|Physician Decision|0|||
105798820|NCT02454972|364922596|FG007|Overall Study|Physician Decision|1|||
105798821|NCT02454972|364922597|FG008|Overall Study|Physician Decision|0|||
105798822|NCT02454972|364922589|FG000|Overall Study|Non treatment-related adverse event|2|||
105798823|NCT02454972|364922590|FG001|Overall Study|Non treatment-related adverse event|0|||
105798824|NCT02454972|364922591|FG002|Overall Study|Non treatment-related adverse event|1|||
105798825|NCT02454972|364922592|FG003|Overall Study|Non treatment-related adverse event|0|||
105798826|NCT02454972|364922593|FG004|Overall Study|Non treatment-related adverse event|0|||
105798827|NCT02454972|364922594|FG005|Overall Study|Non treatment-related adverse event|1|||
105798828|NCT02454972|364922595|FG006|Overall Study|Non treatment-related adverse event|0|||
105798829|NCT02454972|364922596|FG007|Overall Study|Non treatment-related adverse event|1|||
105798830|NCT02454972|364922597|FG008|Overall Study|Non treatment-related adverse event|0|||
105798831|NCT02454972|364922589|FG000|Overall Study|Treatment-related adverse events|0|||
105798832|NCT02454972|364922590|FG001|Overall Study|Treatment-related adverse events|1|||
105798833|NCT02454972|364922591|FG002|Overall Study|Treatment-related adverse events|1|||
105353698|NCT00707980|363301190|FG000|Overall Study|Withdrawal of Consent|81|||
105353699|NCT00707980|363301190|FG000|Overall Study|Lost to Follow-up|59|||
105353700|NCT00707980|363301190|FG000|Overall Study|Other|39|||
105353701|NCT02829047|363301194|FG000|Overall Study|Withdrawal by Subject|1|||
105353702|NCT01005901|363301196|FG000|Overall Study|Withdrawal by Subject|38|||
105353703|NCT01005901|363301197|FG001|Overall Study|Withdrawal by Subject|14|||
105353704|NCT01005901|363301196|FG000|Overall Study|Adverse Event|30|||
105353705|NCT01005901|363301197|FG001|Overall Study|Adverse Event|16|||
105353706|NCT01005901|363301196|FG000|Overall Study|Administrative problems|21|||
105353707|NCT01005901|363301197|FG001|Overall Study|Administrative problems|13|||
105353708|NCT01005901|363301196|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
105353709|NCT01005901|363301197|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
105353710|NCT01005901|363301196|FG000|Overall Study|Protocol Violation|4|||
105353711|NCT01005901|363301197|FG001|Overall Study|Protocol Violation|3|||
105353712|NCT01005901|363301196|FG000|Overall Study|Death|2|||
105353713|NCT01005901|363301197|FG001|Overall Study|Death|3|||
105798834|NCT02454972|364922592|FG003|Overall Study|Treatment-related adverse events|0|||
105798835|NCT02454972|364922593|FG004|Overall Study|Treatment-related adverse events|2|||
105798836|NCT02454972|364922594|FG005|Overall Study|Treatment-related adverse events|0|||
105798837|NCT02454972|364922595|FG006|Overall Study|Treatment-related adverse events|0|||
105798838|NCT02454972|364922596|FG007|Overall Study|Treatment-related adverse events|2|||
105798839|NCT02454972|364922597|FG008|Overall Study|Treatment-related adverse events|0|||
105798840|NCT02454972|364922589|FG000|Overall Study|Patient moves to compassionate use|0|||
105798841|NCT02454972|364922590|FG001|Overall Study|Patient moves to compassionate use|0|||
105798842|NCT02454972|364922591|FG002|Overall Study|Patient moves to compassionate use|0|||
105798843|NCT02454972|364922592|FG003|Overall Study|Patient moves to compassionate use|0|||
105353714|NCT01005901|363301196|FG000|Overall Study|Lost to Follow-up|1|||
105353715|NCT01005901|363301197|FG001|Overall Study|Lost to Follow-up|2|||
105353716|NCT01005901|363301196|FG000|Overall Study|Patient's inability to use the device|1|||
105798844|NCT02454972|364922593|FG004|Overall Study|Patient moves to compassionate use|0|||
105798845|NCT02454972|364922594|FG005|Overall Study|Patient moves to compassionate use|0|||
105798846|NCT02454972|364922595|FG006|Overall Study|Patient moves to compassionate use|2|||
105798847|NCT02454972|364922596|FG007|Overall Study|Patient moves to compassionate use|0|||
105353717|NCT01005901|363301197|FG001|Overall Study|Patient's inability to use the device|1|||
105353718|NCT01005901|363301196|FG000|Overall Study|No longer requires study drug|0|||
105734528|NCT02332915|364682742|FG001|Overall Study|Travel distance prohibitive|1|||
105734529|NCT02332915|364682741|FG000|Overall Study|did not meet inclusion criteria|2|||
105734530|NCT02332915|364682742|FG001|Overall Study|did not meet inclusion criteria|4|||
105734531|NCT01769404|364682743|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
105734532|NCT01769404|364682744|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
105734533|NCT01769404|364682743|FG000|Treatment Period 1|Withdrawal by Subject|3|||
105734534|NCT01769404|364682744|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105734535|NCT01769404|364682743|FG000|Treatment Period 1|Sponsor decision|1|||
105734536|NCT01769404|364682744|FG001|Treatment Period 1|Sponsor decision|0|||
105734537|NCT01769404|364682743|FG000|Treatment Period 2|Sponsor decision|7|||
105734538|NCT01769404|364682744|FG001|Treatment Period 2|Sponsor decision|0|||
105734539|NCT01821677|364682745|FG000|Overall Study|Adverse Event|4|||
105734540|NCT01821677|364682746|FG001|Overall Study|Adverse Event|6|||
105734541|NCT01821677|364682747|FG002|Overall Study|Adverse Event|5|||
105734542|NCT01821677|364682745|FG000|Overall Study|Physician Decision|1|||
105734543|NCT01821677|364682746|FG001|Overall Study|Physician Decision|4|||
105734544|NCT01821677|364682747|FG002|Overall Study|Physician Decision|1|||
105734545|NCT01821677|364682745|FG000|Overall Study|Non-compliance|0|||
105734546|NCT01821677|364682746|FG001|Overall Study|Non-compliance|1|||
105734547|NCT01821677|364682747|FG002|Overall Study|Non-compliance|2|||
105798848|NCT02454972|364922597|FG008|Overall Study|Patient moves to compassionate use|0|||
105734548|NCT01821677|364682745|FG000|Overall Study|Lost to Follow-up|2|||
105734549|NCT01821677|364682746|FG001|Overall Study|Lost to Follow-up|1|||
105734550|NCT01821677|364682747|FG002|Overall Study|Lost to Follow-up|3|||
105734551|NCT01821677|364682745|FG000|Overall Study|Protocol Violation|0|||
105734552|NCT01821677|364682746|FG001|Overall Study|Protocol Violation|0|||
105734553|NCT01821677|364682747|FG002|Overall Study|Protocol Violation|2|||
105734554|NCT01821677|364682745|FG000|Overall Study|Withdrawal by Subject|7|||
105734555|NCT01821677|364682746|FG001|Overall Study|Withdrawal by Subject|3|||
105734556|NCT01821677|364682747|FG002|Overall Study|Withdrawal by Subject|2|||
105734557|NCT01821677|364682745|FG000|Overall Study|Other|9|||
105734558|NCT01821677|364682746|FG001|Overall Study|Other|0|||
105734559|NCT01821677|364682747|FG002|Overall Study|Other|0|||
105734560|NCT00095121|364682751|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
105734561|NCT00095121|364682752|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
105734562|NCT00095121|364682751|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
105734563|NCT00095121|364682752|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
105734564|NCT02209597|364682755|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
105734565|NCT02209597|364682755|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
105734566|NCT02209597|364682755|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
105734567|NCT02209597|364682755|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
105734568|NCT03067311|364682759|FG000|Overall Study|Lost to Follow-up|1|||
105734569|NCT03067311|364682760|FG001|Overall Study|Lost to Follow-up|1|||
105734570|NCT03067311|364682759|FG000|Overall Study|Moved away|1|||
105734571|NCT03067311|364682760|FG001|Overall Study|Moved away|1|||
105734572|NCT01507246|364682761|FG000|Overall Study|Required different surgical procedures|2|||
105734573|NCT01507246|364682762|FG001|Overall Study|Required different surgical procedures|1|||
105734574|NCT00969618|364682766|FG000|Overall Study|Adverse Event|29|||
105734575|NCT00969618|364682766|FG000|Overall Study|Entry Criteria Not Met|3|||
105734576|NCT00969618|364682766|FG000|Overall Study|Lack of Efficacy|2|||
105734577|NCT00969618|364682766|FG000|Overall Study|Lost to Follow-up|7|||
105734578|NCT00969618|364682766|FG000|Overall Study|Physician Decision|1|||
105734579|NCT00969618|364682766|FG000|Overall Study|Protocol Violation|9|||
105734580|NCT00969618|364682766|FG000|Overall Study|Withdrawal by Subject|27|||
105734581|NCT05363293|364682769|FG000|Overall Study|Withdrawal by Subject|1|||
105734582|NCT05363293|364682770|FG001|Overall Study|Withdrawal by Subject|0|||
105734583|NCT05363293|364682771|FG002|Overall Study|Withdrawal by Subject|0|||
105734584|NCT05363293|364682772|FG003|Overall Study|Withdrawal by Subject|0|||
105734585|NCT05363293|364682773|FG004|Overall Study|Withdrawal by Subject|0|||
105734586|NCT05363293|364682774|FG005|Overall Study|Withdrawal by Subject|0|||
105734587|NCT05363293|364682775|FG006|Overall Study|Withdrawal by Subject|0|||
105734588|NCT05363293|364682776|FG007|Overall Study|Withdrawal by Subject|0|||
105353719|NCT01005901|363301197|FG001|Overall Study|No longer requires study drug|1|||
105353720|NCT04278924|363301201|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
105353721|NCT04278924|363301202|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
105353722|NCT04278924|363301203|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
105353723|NCT04278924|363301204|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
105353724|NCT04278924|363301205|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
105353725|NCT04278924|363301206|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
105353726|NCT04278924|363301207|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
105353727|NCT04278924|363301201|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
105353728|NCT04278924|363301202|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
105353729|NCT04278924|363301203|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
105353730|NCT04278924|363301204|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
105353731|NCT04278924|363301205|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
105353732|NCT04278924|363301206|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
105353733|NCT04278924|363301207|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
105353734|NCT06010732|363301208|FG000|Crossover Period 1|Protocol Violation|0|||
105353735|NCT06010732|363301209|FG001|Crossover Period 1|Protocol Violation|0|||
105353736|NCT06010732|363301210|FG002|Crossover Period 1|Protocol Violation|1|||
105353737|NCT06010732|363301211|FG003|Crossover Period 1|Protocol Violation|0|||
105353738|NCT06010732|363301212|FG004|Crossover Period 1|Protocol Violation|1|||
105353739|NCT06010732|363301213|FG005|Crossover Period 1|Protocol Violation|0|||
105353740|NCT06010732|363301208|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
105353741|NCT06010732|363301209|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
105353742|NCT06010732|363301210|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
105734589|NCT05363293|364682777|FG008|Overall Study|Withdrawal by Subject|0|||
105734590|NCT05363293|364682778|FG009|Overall Study|Withdrawal by Subject|0|||
105734591|NCT01318902|364682779|FG000|Overall Study|Symptomatic Deterioration|0|||
105734592|NCT01318902|364682780|FG001|Overall Study|Symptomatic Deterioration|1|||
105734593|NCT01318902|364682781|FG002|Overall Study|Symptomatic Deterioration|1|||
105734594|NCT01318902|364682782|FG003|Overall Study|Symptomatic Deterioration|2|||
105734595|NCT01318902|364682779|FG000|Overall Study|Withdrawal by Patient|0|||
105734596|NCT01318902|364682780|FG001|Overall Study|Withdrawal by Patient|1|||
105798849|NCT02454972|364922589|FG000|Overall Study|Withdrawal by Subject|0|||
105798850|NCT02454972|364922590|FG001|Overall Study|Withdrawal by Subject|1|||
105798851|NCT02454972|364922591|FG002|Overall Study|Withdrawal by Subject|5|||
105798852|NCT02454972|364922592|FG003|Overall Study|Withdrawal by Subject|2|||
105798853|NCT02454972|364922593|FG004|Overall Study|Withdrawal by Subject|3|||
105798854|NCT02454972|364922594|FG005|Overall Study|Withdrawal by Subject|2|||
105480540|NCT01771809|363771225|FG001|Overall Study|Other (Insufficient clinical response)|20|||
105480541|NCT01771809|363771224|FG000|Overall Study|Death|1|||
105480542|NCT01771809|363771225|FG001|Overall Study|Death|0|||
105480543|NCT01771809|363771224|FG000|Overall Study|Other (other)|9|||
105480544|NCT01771809|363771225|FG001|Overall Study|Other (other)|5|||
105480545|NCT01713933|363771230|FG000|Overall Study|Lost to Follow-up|2|||
105480546|NCT01713933|363771230|FG000|Overall Study|Withdrawal by Subject|3|||
105480547|NCT01713933|363771230|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
105480548|NCT02230527|363771234|FG000|Overall Study|Withdrawal by Subject|1|||
105480549|NCT02230527|363771235|FG001|Overall Study|Withdrawal by Subject|1|||
105480550|NCT02230527|363771234|FG000|Overall Study|Death|1|||
105480551|NCT02230527|363771235|FG001|Overall Study|Death|0|||
105798855|NCT02454972|364922595|FG006|Overall Study|Withdrawal by Subject|0|||
105798856|NCT02454972|364922596|FG007|Overall Study|Withdrawal by Subject|1|||
105798857|NCT02454972|364922597|FG008|Overall Study|Withdrawal by Subject|2|||
105798858|NCT02454972|364922589|FG000|Overall Study|Multiple delay/holds on treatment|0|||
105798859|NCT02454972|364922590|FG001|Overall Study|Multiple delay/holds on treatment|0|||
105798860|NCT02454972|364922591|FG002|Overall Study|Multiple delay/holds on treatment|0|||
105798861|NCT02454972|364922592|FG003|Overall Study|Multiple delay/holds on treatment|1|||
105798862|NCT02454972|364922593|FG004|Overall Study|Multiple delay/holds on treatment|0|||
105798863|NCT02454972|364922594|FG005|Overall Study|Multiple delay/holds on treatment|0|||
105798864|NCT02454972|364922595|FG006|Overall Study|Multiple delay/holds on treatment|0|||
105480552|NCT02230527|363771234|FG000|Overall Study|Lost to Follow-up|2|||
105480553|NCT02230527|363771235|FG001|Overall Study|Lost to Follow-up|1|||
105480554|NCT02230527|363771234|FG000|Overall Study|Other|1|||
105480555|NCT02230527|363771235|FG001|Overall Study|Other|0|||
105798865|NCT02454972|364922596|FG007|Overall Study|Multiple delay/holds on treatment|0|||
105798866|NCT02454972|364922597|FG008|Overall Study|Multiple delay/holds on treatment|0|||
105798867|NCT02454972|364922589|FG000|Overall Study|Never treated|0|||
105798868|NCT02454972|364922590|FG001|Overall Study|Never treated|0|||
105798869|NCT02454972|364922591|FG002|Overall Study|Never treated|3|||
105798870|NCT02454972|364922592|FG003|Overall Study|Never treated|1|||
105798871|NCT02454972|364922593|FG004|Overall Study|Never treated|1|||
105798872|NCT02454972|364922594|FG005|Overall Study|Never treated|0|||
105798873|NCT02454972|364922595|FG006|Overall Study|Never treated|0|||
105798874|NCT02454972|364922596|FG007|Overall Study|Never treated|0|||
105798875|NCT02454972|364922597|FG008|Overall Study|Never treated|5|||
105798876|NCT02454972|364922589|FG000|Overall Study|Lost to Follow-up|0|||
105798877|NCT02454972|364922590|FG001|Overall Study|Lost to Follow-up|0|||
105798878|NCT02454972|364922591|FG002|Overall Study|Lost to Follow-up|0|||
105798879|NCT02454972|364922592|FG003|Overall Study|Lost to Follow-up|0|||
105798880|NCT02454972|364922593|FG004|Overall Study|Lost to Follow-up|0|||
105798881|NCT02454972|364922594|FG005|Overall Study|Lost to Follow-up|0|||
105798882|NCT02454972|364922595|FG006|Overall Study|Lost to Follow-up|0|||
105798883|NCT02454972|364922596|FG007|Overall Study|Lost to Follow-up|0|||
105798884|NCT02454972|364922597|FG008|Overall Study|Lost to Follow-up|2|||
105798885|NCT02454972|364922589|FG000|Overall Study|Study termination|0|||
105798886|NCT02454972|364922590|FG001|Overall Study|Study termination|0|||
105798887|NCT02454972|364922591|FG002|Overall Study|Study termination|0|||
105798888|NCT02454972|364922592|FG003|Overall Study|Study termination|0|||
105798889|NCT02454972|364922593|FG004|Overall Study|Study termination|0|||
105480556|NCT02661178|363771236|FG000|Part 1|Protocol Violation|1|||
105480557|NCT02661178|363771237|FG001|Part 1|Protocol Violation|0|||
105798890|NCT02454972|364922594|FG005|Overall Study|Study termination|0|||
105798891|NCT02454972|364922595|FG006|Overall Study|Study termination|0|||
105798892|NCT02454972|364922596|FG007|Overall Study|Study termination|0|||
105480558|NCT02661178|363771238|FG002|Part 1|Protocol Violation|0|||
105480559|NCT02661178|363771239|FG003|Part 1|Protocol Violation|0|||
105480560|NCT02661178|363771240|FG004|Part 1|Protocol Violation|0|||
105480561|NCT02661178|363771241|FG005|Part 1|Protocol Violation|0|||
105480562|NCT02661178|363771242|FG006|Part 1|Protocol Violation|0|||
105480563|NCT02661178|363771243|FG007|Part 1|Protocol Violation|0|||
105480564|NCT02661178|363771244|FG008|Part 1|Protocol Violation|0|||
105480565|NCT02661178|363771245|FG009|Part 1|Protocol Violation|0|||
105480566|NCT02661178|363771246|FG010|Part 1|Protocol Violation|0|||
105480567|NCT02661178|363771247|FG011|Part 1|Protocol Violation|0|||
105480568|NCT02661178|363771248|FG012|Part 1|Protocol Violation|0|||
105480569|NCT02661178|363771249|FG013|Part 1|Protocol Violation|0|||
105480570|NCT02661178|363771250|FG014|Part 1|Protocol Violation|0|||
105480571|NCT04461600|363771252|FG000|Overall Study|Death|6|||
105480572|NCT04461600|363771253|FG001|Overall Study|Death|5|||
105480573|NCT04461600|363771252|FG000|Overall Study|Withdrawal by Subject|0|||
105480574|NCT04461600|363771253|FG001|Overall Study|Withdrawal by Subject|1|||
105480575|NCT01242813|363771254|FG000|Overall Study|Lost to Follow-up|2|||
105480576|NCT03135119|363771255|FG000|Overall Study|Lost to Follow-up|2|||
105480577|NCT03135119|363771256|FG001|Overall Study|Lost to Follow-up|0|||
105480578|NCT03135119|363771255|FG000|Overall Study|Physician Decision|1|||
105480579|NCT03135119|363771256|FG001|Overall Study|Physician Decision|1|||
105480580|NCT03135119|363771255|FG000|Overall Study|COVID-19 Shutdown|2|||
105480581|NCT03135119|363771256|FG001|Overall Study|COVID-19 Shutdown|2|||
105480582|NCT01369329|363771260|FG000|Overall Study|Withdrawal by Subject|8|||
105480583|NCT01369329|363771261|FG001|Overall Study|Withdrawal by Subject|6|||
105480584|NCT01369329|363771262|FG002|Overall Study|Withdrawal by Subject|10|||
105480585|NCT01369329|363771260|FG000|Overall Study|Lost to Follow-up|2|||
105480586|NCT01369329|363771261|FG001|Overall Study|Lost to Follow-up|2|||
105480587|NCT01369329|363771262|FG002|Overall Study|Lost to Follow-up|2|||
105734597|NCT01318902|364682781|FG002|Overall Study|Withdrawal by Patient|0|||
105734598|NCT01318902|364682782|FG003|Overall Study|Withdrawal by Patient|3|||
105734599|NCT01318902|364682779|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
105734600|NCT01318902|364682780|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
105734601|NCT01318902|364682781|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
105734602|NCT01318902|364682782|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
105734603|NCT01318902|364682779|FG000|Overall Study|Adverse Event|0|||
105734604|NCT01318902|364682780|FG001|Overall Study|Adverse Event|1|||
105734605|NCT01318902|364682781|FG002|Overall Study|Adverse Event|0|||
105734606|NCT01318902|364682782|FG003|Overall Study|Adverse Event|0|||
105734607|NCT01318902|364682779|FG000|Overall Study|Terminated by Sponsor|0|||
105734608|NCT01318902|364682780|FG001|Overall Study|Terminated by Sponsor|0|||
105734609|NCT01318902|364682781|FG002|Overall Study|Terminated by Sponsor|1|||
105734610|NCT01318902|364682782|FG003|Overall Study|Terminated by Sponsor|0|||
105734611|NCT02089737|364684275|FG000|Overall Study|Survey form not completed|5|||
105734612|NCT02089737|364684275|FG000|Overall Study|Not treated|1|||
105734613|NCT00744055|364684276|FG000|Overall Study|Withdrawal by Subject|6|||
105734614|NCT00744055|364684277|FG001|Overall Study|Withdrawal by Subject|9|||
105734615|NCT00744055|364684276|FG000|Overall Study|Lack of Efficacy|0|||
105734616|NCT00744055|364684277|FG001|Overall Study|Lack of Efficacy|1|||
105734617|NCT00744055|364684276|FG000|Overall Study|Physician Decision|0|||
105734618|NCT00744055|364684277|FG001|Overall Study|Physician Decision|2|||
105734619|NCT00744055|364684276|FG000|Overall Study|Protocol Violation|1|||
105734620|NCT00744055|364684277|FG001|Overall Study|Protocol Violation|1|||
105734621|NCT00744055|364684276|FG000|Overall Study|Lost to Follow-up|0|||
105734622|NCT00744055|364684277|FG001|Overall Study|Lost to Follow-up|1|||
105734623|NCT02767570|364684278|FG000|Overall Study|Lost to Follow-up|3|||
105734624|NCT02767570|364684279|FG001|Overall Study|Lost to Follow-up|0|||
105734625|NCT02767570|364684278|FG000|Overall Study|COVID shutdown|2|||
105734626|NCT02767570|364684279|FG001|Overall Study|COVID shutdown|5|||
105734627|NCT02767570|364684278|FG000|Overall Study|Increased pain|2|||
105734628|NCT02767570|364684279|FG001|Overall Study|Increased pain|0|||
105734629|NCT02767570|364684278|FG000|Overall Study|Withdrawal by Subject|1|||
105734630|NCT02767570|364684279|FG001|Overall Study|Withdrawal by Subject|3|||
105734631|NCT02767570|364684278|FG000|Overall Study|Unrelated medical issue|1|||
105734632|NCT02767570|364684279|FG001|Overall Study|Unrelated medical issue|1|||
105734633|NCT02767570|364684278|FG000|Overall Study|Received intra-articular injection|0|||
105734634|NCT02767570|364684279|FG001|Overall Study|Received intra-articular injection|1|||
105734635|NCT01712438|364684280|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
105798893|NCT02454972|364922597|FG008|Overall Study|Study termination|6|||
105734636|NCT01712438|364684280|FG000|Overall Study|Ongoing ITI treatment|6|||
105734637|NCT01712438|364684280|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
105734638|NCT01712438|364684280|FG000|Overall Study|Prematurely Discontinued|25|||
105734639|NCT01981122|364684281|FG000|Overall Study|Withdrawal by Subject|0|||
105734640|NCT01981122|364684282|FG001|Overall Study|Withdrawal by Subject|2|||
105734641|NCT01981122|364684281|FG000|Overall Study|Protocol Violation|0|||
105734642|NCT01981122|364684282|FG001|Overall Study|Protocol Violation|1|||
105734643|NCT01981122|364684281|FG000|Overall Study|Lost to Follow-up|0|||
105734644|NCT01981122|364684282|FG001|Overall Study|Lost to Follow-up|1|||
105480588|NCT01369329|363771260|FG000|Overall Study|Other|2|||
105480589|NCT01369329|363771261|FG001|Overall Study|Other|3|||
105480590|NCT01369329|363771262|FG002|Overall Study|Other|2|||
105480591|NCT01252667|363771263|FG000|Overall Study|Transplant aborted post-conditioning|0|||
105353743|NCT06010732|363301211|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
105353744|NCT06010732|363301212|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
105353745|NCT06010732|363301213|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
105353746|NCT06010732|363301208|FG000|Crossover Period 2|Adverse Event|0|||
105353747|NCT06010732|363301209|FG001|Crossover Period 2|Adverse Event|1|||
105353748|NCT06010732|363301210|FG002|Crossover Period 2|Adverse Event|0|||
105353749|NCT06010732|363301211|FG003|Crossover Period 2|Adverse Event|0|||
105353750|NCT06010732|363301212|FG004|Crossover Period 2|Adverse Event|0|||
105353751|NCT06010732|363301213|FG005|Crossover Period 2|Adverse Event|0|||
105353752|NCT06010732|363301208|FG000|Crossover Period 2|broken denture|0|||
105353753|NCT06010732|363301209|FG001|Crossover Period 2|broken denture|0|||
105353754|NCT06010732|363301210|FG002|Crossover Period 2|broken denture|1|||
105353755|NCT06010732|363301211|FG003|Crossover Period 2|broken denture|0|||
105353756|NCT06010732|363301212|FG004|Crossover Period 2|broken denture|0|||
105353757|NCT06010732|363301213|FG005|Crossover Period 2|broken denture|0|||
105353758|NCT01716520|363301215|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
105353759|NCT01716520|363301216|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
105353760|NCT01716520|363301217|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
105353761|NCT01716520|363301218|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
105353762|NCT01716520|363301219|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
105353763|NCT01716520|363301220|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
105353764|NCT01716520|363301215|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
105353765|NCT01716520|363301216|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
105353766|NCT01716520|363301217|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
105353767|NCT01716520|363301218|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
105353768|NCT01716520|363301219|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
105353769|NCT01716520|363301220|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
105353770|NCT01716520|363301215|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105353771|NCT01716520|363301216|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
105353772|NCT01716520|363301217|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105353773|NCT01716520|363301218|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105353774|NCT01716520|363301219|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105353775|NCT01716520|363301220|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105353776|NCT01716520|363301215|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
105353777|NCT01716520|363301216|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
105353778|NCT01716520|363301217|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
105353779|NCT01716520|363301218|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
105353780|NCT01716520|363301219|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
105353781|NCT01716520|363301220|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
105353782|NCT01716520|363301215|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105353783|NCT01716520|363301216|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105353784|NCT01716520|363301217|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105353785|NCT01716520|363301218|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105734645|NCT01981122|364684281|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
105734646|NCT01981122|364684282|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
105734647|NCT01981122|364684281|FG000|Overall Study|Death|14|||
105734648|NCT01981122|364684282|FG001|Overall Study|Death|15|||
105734649|NCT04328623|364684285|FG000|Overall Study|Protocol Violation|0|||
105734650|NCT04328623|364684286|FG001|Overall Study|Protocol Violation|1|||
105734651|NCT00849693|364684287|FG000|Acute Treatment Phase|Adverse Event|12|||
105734652|NCT00849693|364684288|FG001|Acute Treatment Phase|Adverse Event|7|||
105734653|NCT00849693|364684289|FG002|Acute Treatment Phase|Adverse Event|6|||
105734654|NCT00849693|364684290|FG003|Acute Treatment Phase|Adverse Event|4|||
105734655|NCT00849693|364684287|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
105734656|NCT00849693|364684288|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
105734657|NCT00849693|364684289|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
105734658|NCT00849693|364684290|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
105734659|NCT00849693|364684287|FG000|Acute Treatment Phase|Protocol Violation|1|||
105734660|NCT00849693|364684288|FG001|Acute Treatment Phase|Protocol Violation|5|||
105734661|NCT00849693|364684289|FG002|Acute Treatment Phase|Protocol Violation|2|||
105734662|NCT00849693|364684290|FG003|Acute Treatment Phase|Protocol Violation|6|||
105734663|NCT00849693|364684287|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
105734664|NCT00849693|364684288|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
105734665|NCT00849693|364684289|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
105734666|NCT00849693|364684290|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
105353786|NCT01716520|363301219|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105353787|NCT01716520|363301220|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
105353788|NCT01716520|363301215|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
105734667|NCT00849693|364684287|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
105734668|NCT00849693|364684288|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
105734669|NCT00849693|364684289|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
105798894|NCT00544557|364922598|FG000|Overall Study|Adverse Event|140|||
105734670|NCT00849693|364684290|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
105734671|NCT00849693|364684287|FG000|Acute Treatment Phase|Physician Decision|2|||
105734672|NCT00849693|364684288|FG001|Acute Treatment Phase|Physician Decision|1|||
105734673|NCT00849693|364684289|FG002|Acute Treatment Phase|Physician Decision|2|||
105734674|NCT00849693|364684290|FG003|Acute Treatment Phase|Physician Decision|1|||
105734675|NCT00849693|364684287|FG000|Acute Treatment Phase|Sponsor decision|0|||
105734676|NCT00849693|364684288|FG001|Acute Treatment Phase|Sponsor decision|0|||
105734677|NCT00849693|364684289|FG002|Acute Treatment Phase|Sponsor decision|1|||
105734678|NCT00849693|364684290|FG003|Acute Treatment Phase|Sponsor decision|0|||
105734679|NCT00849693|364684287|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
105734680|NCT00849693|364684288|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
105734681|NCT00849693|364684289|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
105734682|NCT00849693|364684290|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
105734683|NCT00849693|364684287|FG000|Extension Phase|Adverse Event|4|||
105734684|NCT00849693|364684288|FG001|Extension Phase|Adverse Event|6|||
105734685|NCT00849693|364684289|FG002|Extension Phase|Adverse Event|3|||
105734686|NCT00849693|364684290|FG003|Extension Phase|Adverse Event|7|||
105734687|NCT00849693|364684287|FG000|Extension Phase|Lost to Follow-up|7|||
105734688|NCT00849693|364684288|FG001|Extension Phase|Lost to Follow-up|5|||
105734689|NCT00849693|364684289|FG002|Extension Phase|Lost to Follow-up|6|||
105734690|NCT00849693|364684290|FG003|Extension Phase|Lost to Follow-up|6|||
105734691|NCT00849693|364684287|FG000|Extension Phase|Protocol Violation|0|||
105734692|NCT00849693|364684288|FG001|Extension Phase|Protocol Violation|3|||
105734693|NCT00849693|364684289|FG002|Extension Phase|Protocol Violation|2|||
105734694|NCT00849693|364684290|FG003|Extension Phase|Protocol Violation|3|||
105734695|NCT00849693|364684287|FG000|Extension Phase|Withdrawal by Subject|6|||
105734696|NCT00849693|364684288|FG001|Extension Phase|Withdrawal by Subject|9|||
105734697|NCT00849693|364684289|FG002|Extension Phase|Withdrawal by Subject|10|||
105734698|NCT00849693|364684290|FG003|Extension Phase|Withdrawal by Subject|15|||
105734699|NCT00849693|364684287|FG000|Extension Phase|Parent or caregiver decision|9|||
105734700|NCT00849693|364684288|FG001|Extension Phase|Parent or caregiver decision|4|||
105734701|NCT00849693|364684289|FG002|Extension Phase|Parent or caregiver decision|10|||
105734702|NCT00849693|364684290|FG003|Extension Phase|Parent or caregiver decision|5|||
105734703|NCT00849693|364684287|FG000|Extension Phase|Physician Decision|1|||
105734704|NCT00849693|364684288|FG001|Extension Phase|Physician Decision|1|||
105734705|NCT00849693|364684289|FG002|Extension Phase|Physician Decision|2|||
105734706|NCT00849693|364684290|FG003|Extension Phase|Physician Decision|0|||
105734707|NCT00849693|364684287|FG000|Extension Phase|Sponsor decision|1|||
105734708|NCT00849693|364684288|FG001|Extension Phase|Sponsor decision|0|||
105734709|NCT00849693|364684289|FG002|Extension Phase|Sponsor decision|0|||
105734710|NCT00849693|364684290|FG003|Extension Phase|Sponsor decision|1|||
105353789|NCT01716520|363301216|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
105353790|NCT01716520|363301217|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
105353791|NCT01716520|363301218|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
105353792|NCT01716520|363301219|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
105353793|NCT01716520|363301220|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
105353794|NCT01716520|363301215|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
105353795|NCT01716520|363301216|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
105353796|NCT01716520|363301217|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
105353797|NCT01716520|363301218|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
105353798|NCT01716520|363301219|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
105353799|NCT01716520|363301220|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
105353800|NCT01716520|363301215|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105353801|NCT01716520|363301216|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105353802|NCT01716520|363301217|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105353803|NCT01716520|363301218|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105734711|NCT00849693|364684287|FG000|Extension Phase|Lack of Efficacy|2|||
105734712|NCT00849693|364684288|FG001|Extension Phase|Lack of Efficacy|2|||
105734713|NCT00849693|364684289|FG002|Extension Phase|Lack of Efficacy|2|||
105734714|NCT00849693|364684290|FG003|Extension Phase|Lack of Efficacy|1|||
105734715|NCT02465034|364684291|FG000|Overall Study|Withdrawal by Subject|1|||
105798895|NCT00544557|364922598|FG000|Overall Study|Lack of Efficacy|196|||
105798896|NCT00544557|364922598|FG000|Overall Study|Other|98|||
105353804|NCT01716520|363301219|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
105353805|NCT01716520|363301220|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105734716|NCT02465034|364684292|FG001|Overall Study|Withdrawal by Subject|1|||
105734717|NCT02465034|364684291|FG000|Overall Study|Screen fail|2|||
105734718|NCT02465034|364684292|FG001|Overall Study|Screen fail|0|||
105734719|NCT02465034|364684291|FG000|Overall Study|Could not be scheduled for study visit|0|||
105353806|NCT01716520|363301215|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
105734720|NCT02465034|364684292|FG001|Overall Study|Could not be scheduled for study visit|5|||
105734721|NCT01334125|364684293|FG000|Overall Study|Lost to Follow-up|3|||
105734722|NCT01334125|364684294|FG001|Overall Study|Lost to Follow-up|3|||
105734723|NCT04220866|364684295|FG000|Overall Study|Death|4|||
105480592|NCT01252667|363771264|FG001|Overall Study|Transplant aborted post-conditioning|0|||
105480593|NCT01252667|363771265|FG002|Overall Study|Transplant aborted post-conditioning|0|||
105480594|NCT01252667|363771266|FG003|Overall Study|Transplant aborted post-conditioning|0|||
105480595|NCT01252667|363771267|FG004|Overall Study|Transplant aborted post-conditioning|0|||
105480596|NCT01252667|363771268|FG005|Overall Study|Transplant aborted post-conditioning|1|||
105480597|NCT03330002|363771269|FG000|Overall Study|Lost to Follow-up|15|||
105480598|NCT03330002|363771269|FG000|Overall Study|Death|7|||
105480599|NCT01836276|363771270|FG000|Overall Study|Lost to Follow-up|28|||
105480600|NCT01836276|363771271|FG001|Overall Study|Lost to Follow-up|51|||
105480601|NCT00331552|363771274|FG000|Period 3: Phase II|Neurological Symptoms|1|||
105480602|NCT00331552|363771275|FG001|Period 3: Phase II|Neurological Symptoms|0|||
105480603|NCT00331552|363771274|FG000|Period 3: Phase II|Severe Nausea|1|||
105480604|NCT00331552|363771275|FG001|Period 3: Phase II|Severe Nausea|0|||
105480605|NCT00704522|363771276|FG000|Overall Study|Lack of Efficacy|65|||
105480606|NCT00704522|363771277|FG001|Overall Study|Lack of Efficacy|17|||
105480607|NCT00704522|363771276|FG000|Overall Study|Failure to appear again at hospital|56|||
105480608|NCT00704522|363771277|FG001|Overall Study|Failure to appear again at hospital|10|||
105480609|NCT00704522|363771276|FG000|Overall Study|Withdrawal by Subject|17|||
105480610|NCT00704522|363771277|FG001|Overall Study|Withdrawal by Subject|8|||
105480611|NCT00704522|363771276|FG000|Overall Study|Adverse Event|9|||
105480612|NCT00704522|363771277|FG001|Overall Study|Adverse Event|1|||
105480613|NCT00704522|363771276|FG000|Overall Study|Undefined causes|9|||
105480614|NCT00704522|363771277|FG001|Overall Study|Undefined causes|7|||
105480615|NCT00704522|363771276|FG000|Overall Study|No information on therapy end|27|||
105480616|NCT00704522|363771277|FG001|Overall Study|No information on therapy end|2|||
105480617|NCT03232333|363771278|FG000|Overall Study|Infection or Osteomyelitis|9|||
105480618|NCT03232333|363771278|FG000|Overall Study|Lost to Follow-up|4|||
105480619|NCT03232333|363771278|FG000|Overall Study|Withdrawal by Subject|2|||
105480620|NCT00958438|363771282|FG000|Overall Study|Protocol Violation|3|||
105480621|NCT00958438|363771283|FG001|Overall Study|Protocol Violation|2|||
105734724|NCT04220866|364684296|FG001|Overall Study|Death|5|||
105734725|NCT04220866|364684295|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
105734726|NCT04220866|364684296|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
105734727|NCT04220866|364684295|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
105734728|NCT04220866|364684296|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
105734729|NCT04220866|364684295|FG000|Overall Study|Withdrawal by Subject|0|||
105734730|NCT04220866|364684296|FG001|Overall Study|Withdrawal by Subject|1|||
105734731|NCT01408537|364684299|FG000|Overall Study|Withdrawal by Subject|2|||
105734732|NCT01408537|364684299|FG000|Overall Study|Protocol Violation|3|||
105734733|NCT01408537|364684299|FG000|Overall Study|Lost to Follow-up|3|||
105734734|NCT02760602|364684300|FG000|Overall Study|Withdrawal by Subject|1|||
105734735|NCT02760602|364684301|FG001|Overall Study|Withdrawal by Subject|0|||
105734736|NCT02760602|364684300|FG000|Overall Study|Terminated by sponsor|12|||
105734737|NCT02760602|364684301|FG001|Overall Study|Terminated by sponsor|13|||
105734738|NCT00791128|364684302|FG000|Overall Study|Adverse Event|4|||
105734739|NCT00791128|364684302|FG000|Overall Study|Device migration|2|||
105734740|NCT00791128|364684302|FG000|Overall Study|non-compliance by subject|2|||
105734741|NCT00791128|364684302|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
105734742|NCT04655586|364684303|FG000|Overall Study|Physician Decision|1|||
105734743|NCT04655586|364684304|FG001|Overall Study|Physician Decision|3|||
105734744|NCT04655586|364684305|FG002|Overall Study|Physician Decision|4|||
105734745|NCT04655586|364684303|FG000|Overall Study|Withdrawal by Subject|1|||
105734746|NCT04655586|364684304|FG001|Overall Study|Withdrawal by Subject|3|||
105734747|NCT04655586|364684305|FG002|Overall Study|Withdrawal by Subject|1|||
105734748|NCT01260181|364684306|FG000|Overall Study|Decision of Investigator|1|||
105734749|NCT01588197|364684307|FG000|Overall Study|Lack of Efficacy|0|||
105734750|NCT01588197|364684308|FG001|Overall Study|Lack of Efficacy|1|||
105734751|NCT01588197|364684307|FG000|Overall Study|No MRI|1|||
105734752|NCT01588197|364684308|FG001|Overall Study|No MRI|0|||
105734753|NCT01938625|364684309|FG000|Overall Study|Withdrawal by Subject|0|||
105734754|NCT01938625|364684310|FG001|Overall Study|Withdrawal by Subject|1|||
105734755|NCT01938625|364684309|FG000|Overall Study|Adverse Event|0|||
105480622|NCT00958438|363771284|FG002|Overall Study|Protocol Violation|2|||
105480623|NCT00958438|363771282|FG000|Overall Study|Withdrawal by Subject|4|||
105480624|NCT00958438|363771283|FG001|Overall Study|Withdrawal by Subject|2|||
105480625|NCT00958438|363771284|FG002|Overall Study|Withdrawal by Subject|1|||
105734756|NCT01938625|364684310|FG001|Overall Study|Adverse Event|1|||
105734757|NCT00546351|364684313|FG000|Overall Study|Adverse Event|76|||
105734758|NCT00546351|364684313|FG000|Overall Study|Lack of Efficacy|15|||
105734759|NCT00546351|364684313|FG000|Overall Study|Withdrawal by Subject|109|||
105734760|NCT00546351|364684313|FG000|Overall Study|Lost to Follow-up|9|||
105480626|NCT00958438|363771282|FG000|Overall Study|Adverse Event|0|||
105480627|NCT00958438|363771283|FG001|Overall Study|Adverse Event|3|||
105480628|NCT00958438|363771284|FG002|Overall Study|Adverse Event|0|||
105480629|NCT00958438|363771282|FG000|Overall Study|Physician Decision|1|||
105734761|NCT00546351|364684313|FG000|Overall Study|Protocol Deviation|1|||
105798897|NCT00623623|364922602|FG000|Overall Study|Previous enrolment into this study|1|||
105798898|NCT00623623|364922603|FG001|Overall Study|Previous enrolment into this study|1|||
105798899|NCT01759381|364922604|FG000|Overall Study|Death|1|||
105798900|NCT01759381|364922605|FG001|Overall Study|Death|0|||
105798901|NCT01313728|364922606|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
105798902|NCT02983227|364922607|FG000|Overall Study|Adverse Event|21|||
105798903|NCT02983227|364922608|FG001|Overall Study|Adverse Event|3|||
105798904|NCT02983227|364922607|FG000|Overall Study|Death|3|||
105798905|NCT02983227|364922608|FG001|Overall Study|Death|0|||
105798906|NCT02983227|364922607|FG000|Overall Study|Lack of Efficacy|8|||
105798907|NCT02983227|364922608|FG001|Overall Study|Lack of Efficacy|1|||
105798908|NCT02983227|364922607|FG000|Overall Study|Lost to Follow-up|3|||
105798909|NCT02983227|364922608|FG001|Overall Study|Lost to Follow-up|0|||
105798910|NCT02983227|364922607|FG000|Overall Study|Multiple Reasons|2|||
105734762|NCT00546351|364684313|FG000|Overall Study|Unsatisfactory compliance|9|||
105734763|NCT00546351|364684313|FG000|Overall Study|Other reasons for premature termination|17|||
105734764|NCT04734873|364684314|FG000|Overall Study|Lost to Follow-up|1|||
105734765|NCT04734873|364684315|FG001|Overall Study|Lost to Follow-up|3|||
105734766|NCT04734873|364684316|FG002|Overall Study|Lost to Follow-up|2|||
105734767|NCT04734873|364684314|FG000|Overall Study|Randomized but not dosed|1|||
105734768|NCT04734873|364684315|FG001|Overall Study|Randomized but not dosed|0|||
105734769|NCT04734873|364684316|FG002|Overall Study|Randomized but not dosed|1|||
105734770|NCT02424149|364684317|FG000|Overall Study|surgery cancelled|2|||
105734771|NCT02424149|364684318|FG001|Overall Study|surgery cancelled|0|||
105734772|NCT02424149|364684317|FG000|Overall Study|Withdrawal by Subject|0|||
105734773|NCT02424149|364684318|FG001|Overall Study|Withdrawal by Subject|1|||
105734774|NCT00650585|364684328|FG000|Overall Study|Lost to Follow-up|505|||
105734775|NCT00650585|364684329|FG001|Overall Study|Lost to Follow-up|482|||
105734776|NCT00650585|364684328|FG000|Overall Study|No parental consent|935|||
105734777|NCT00650585|364684329|FG001|Overall Study|No parental consent|866|||
105734778|NCT00650585|364684328|FG000|Overall Study|Excluded/ruled ineligible|357|||
105734779|NCT00650585|364684329|FG001|Overall Study|Excluded/ruled ineligible|129|||
105734780|NCT01070303|364684330|FG000|Overall Study|Adverse Event|39|||
105734781|NCT01070303|364684330|FG000|Overall Study|Withdrawal by Subject|20|||
105734782|NCT01070303|364684330|FG000|Overall Study|Lost to Follow-up|9|||
105734783|NCT01070303|364684330|FG000|Overall Study|Protocol Violation|0|||
105734784|NCT01070303|364684330|FG000|Overall Study|Lack of Efficacy|2|||
105734785|NCT01070303|364684330|FG000|Overall Study|Administrative Reason|1|||
105734786|NCT01070303|364684330|FG000|Overall Study|Other|18|||
105734787|NCT02460822|364684333|FG000|Overall Study|Withdrawal by Subject|1|||
105734788|NCT03114969|364684338|FG000|Overall Study|Lost to Follow-up|0|||
105734789|NCT03114969|364684339|FG001|Overall Study|Lost to Follow-up|0|||
105734790|NCT03114969|364684340|FG002|Overall Study|Lost to Follow-up|3|||
105734791|NCT03114969|364684341|FG003|Overall Study|Lost to Follow-up|2|||
105734792|NCT03114969|364684342|FG004|Overall Study|Lost to Follow-up|0|||
105353807|NCT01716520|363301216|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
105734793|NCT03114969|364684343|FG005|Overall Study|Lost to Follow-up|0|||
105734794|NCT03114969|364684344|FG006|Overall Study|Lost to Follow-up|0|||
105734795|NCT03114969|364684345|FG007|Overall Study|Lost to Follow-up|0|||
105734796|NCT03114969|364684346|FG008|Overall Study|Lost to Follow-up|0|||
105798911|NCT02983227|364922608|FG001|Overall Study|Multiple Reasons|1|||
105798912|NCT02983227|364922607|FG000|Overall Study|Physician Decision|3|||
105734797|NCT03114969|364684338|FG000|Overall Study|Adverse Event|0|||
105734798|NCT03114969|364684339|FG001|Overall Study|Adverse Event|0|||
105734799|NCT03114969|364684340|FG002|Overall Study|Adverse Event|1|||
105734800|NCT03114969|364684341|FG003|Overall Study|Adverse Event|0|||
105798913|NCT02983227|364922608|FG001|Overall Study|Physician Decision|1|||
105798914|NCT02983227|364922607|FG000|Overall Study|Withdrawal by Subject|19|||
105798915|NCT02983227|364922608|FG001|Overall Study|Withdrawal by Subject|8|||
105798916|NCT02354976|364922610|FG000|Overall Study|Other - reason not specified|1|||
105798917|NCT02354976|364922611|FG001|Overall Study|Other - reason not specified|0|||
105798918|NCT02354976|364922612|FG002|Overall Study|Other - reason not specified|1|||
105798919|NCT02354976|364922610|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
105798920|NCT02354976|364922611|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
105798921|NCT02354976|364922612|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
105798922|NCT02354976|364922610|FG000|Overall Study|Adverse Event|1|||
105798923|NCT02354976|364922611|FG001|Overall Study|Adverse Event|0|||
105798924|NCT02354976|364922612|FG002|Overall Study|Adverse Event|2|||
105798925|NCT00986154|364922613|FG000|Overall Study|Death|136|||
105798926|NCT00986154|364922614|FG001|Overall Study|Death|127|||
105798927|NCT00986154|364922613|FG000|Overall Study|Lost to Follow-up|7|||
105798928|NCT00986154|364922614|FG001|Overall Study|Lost to Follow-up|4|||
105798929|NCT00986154|364922613|FG000|Overall Study|Withdrawal by Subject|32|||
105798930|NCT00986154|364922614|FG001|Overall Study|Withdrawal by Subject|33|||
105798931|NCT00986154|364922613|FG000|Overall Study|investigator/subject decide not continue|6|||
105798932|NCT00986154|364922614|FG001|Overall Study|investigator/subject decide not continue|3|||
105798933|NCT00986154|364922613|FG000|Overall Study|never received study drug|25|||
105798934|NCT00986154|364922614|FG001|Overall Study|never received study drug|27|||
105798935|NCT03726437|364922615|FG000|Overall Study|Lost to Follow-up|85|||
105798936|NCT03726437|364922616|FG001|Overall Study|Lost to Follow-up|76|||
105798937|NCT03118765|364922617|FG000|Overall Study|Withdrawal by Subject|0|||
105798938|NCT03118765|364922618|FG001|Overall Study|Withdrawal by Subject|0|||
105798939|NCT03118765|364922619|FG002|Overall Study|Withdrawal by Subject|1|||
105798940|NCT03118765|364922620|FG003|Overall Study|Withdrawal by Subject|0|||
105798941|NCT03118765|364922621|FG004|Overall Study|Withdrawal by Subject|0|||
105798942|NCT03118765|364922617|FG000|Overall Study|Adverse Event|1|||
105798943|NCT03118765|364922618|FG001|Overall Study|Adverse Event|1|||
105798944|NCT03118765|364922619|FG002|Overall Study|Adverse Event|1|||
105798945|NCT03118765|364922620|FG003|Overall Study|Adverse Event|1|||
105798946|NCT03118765|364922621|FG004|Overall Study|Adverse Event|1|||
105798947|NCT03118765|364922617|FG000|Overall Study|Non compliance with Study Procedures|0|||
105798948|NCT03118765|364922618|FG001|Overall Study|Non compliance with Study Procedures|0|||
105798949|NCT03118765|364922619|FG002|Overall Study|Non compliance with Study Procedures|0|||
105798950|NCT03118765|364922620|FG003|Overall Study|Non compliance with Study Procedures|1|||
105798951|NCT03118765|364922621|FG004|Overall Study|Non compliance with Study Procedures|0|||
105798952|NCT03118765|364922617|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
105798953|NCT03118765|364922618|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
105798954|NCT03118765|364922619|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
105798955|NCT03118765|364922620|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
105798956|NCT03118765|364922621|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
105798957|NCT03118765|364922617|FG000|Overall Study|COPD Exacerbation|1|||
105798958|NCT03118765|364922618|FG001|Overall Study|COPD Exacerbation|0|||
105798959|NCT03118765|364922619|FG002|Overall Study|COPD Exacerbation|0|||
105798960|NCT03118765|364922620|FG003|Overall Study|COPD Exacerbation|1|||
105798961|NCT03118765|364922621|FG004|Overall Study|COPD Exacerbation|0|||
105798962|NCT03118765|364922617|FG000|Overall Study|Lost to Follow-up|1|||
105798963|NCT03118765|364922618|FG001|Overall Study|Lost to Follow-up|0|||
105798964|NCT03118765|364922619|FG002|Overall Study|Lost to Follow-up|1|||
105798965|NCT03118765|364922620|FG003|Overall Study|Lost to Follow-up|0|||
105798966|NCT03118765|364922621|FG004|Overall Study|Lost to Follow-up|0|||
105480630|NCT00958438|363771283|FG001|Overall Study|Physician Decision|0|||
105734801|NCT03114969|364684342|FG004|Overall Study|Adverse Event|0|||
105798967|NCT03118765|364922617|FG000|Overall Study|Sponsor Decision|1|||
105798968|NCT03118765|364922618|FG001|Overall Study|Sponsor Decision|0|||
105734802|NCT03114969|364684343|FG005|Overall Study|Adverse Event|1|||
105734803|NCT03114969|364684344|FG006|Overall Study|Adverse Event|1|||
105734804|NCT03114969|364684345|FG007|Overall Study|Adverse Event|0|||
105734805|NCT03114969|364684346|FG008|Overall Study|Adverse Event|2|||
105734806|NCT04601272|364684347|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
105734807|NCT04601272|364684348|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
105734808|NCT04601272|364684349|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
105734809|NCT02168946|364684350|FG000|Overall Study|Adverse Event|8|||
105734810|NCT02168946|364684351|FG001|Overall Study|Adverse Event|5|||
105734811|NCT02168946|364684350|FG000|Overall Study|Lost to Follow-up|3|||
105734812|NCT02168946|364684351|FG001|Overall Study|Lost to Follow-up|0|||
105734813|NCT02168946|364684350|FG000|Overall Study|Subject unable to come back for visits|1|||
105734814|NCT02168946|364684351|FG001|Overall Study|Subject unable to come back for visits|0|||
105734815|NCT02075255|364684358|FG000|Overall Study|Study specific withdrawal criteria|0|||
105734816|NCT02075255|364684359|FG001|Overall Study|Study specific withdrawal criteria|1|||
105734817|NCT02075255|364684360|FG002|Overall Study|Study specific withdrawal criteria|1|||
105734818|NCT02075255|364684358|FG000|Overall Study|Withdrawal by Subject|4|||
105734819|NCT02075255|364684359|FG001|Overall Study|Withdrawal by Subject|1|||
105734820|NCT02075255|364684360|FG002|Overall Study|Withdrawal by Subject|0|||
105734821|NCT02075255|364684358|FG000|Overall Study|Lost to Follow-up|0|||
105734822|NCT02075255|364684359|FG001|Overall Study|Lost to Follow-up|0|||
105734823|NCT02075255|364684360|FG002|Overall Study|Lost to Follow-up|1|||
105734824|NCT02075255|364684358|FG000|Overall Study|Adverse Event|0|||
105734825|NCT02075255|364684359|FG001|Overall Study|Adverse Event|0|||
105734826|NCT02075255|364684360|FG002|Overall Study|Adverse Event|1|||
105734827|NCT02075255|364684358|FG000|Overall Study|Death|0|||
105734828|NCT02075255|364684359|FG001|Overall Study|Death|2|||
105734829|NCT02075255|364684360|FG002|Overall Study|Death|0|||
105734830|NCT03503773|364684361|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
105734831|NCT03503773|364684362|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
105734832|NCT03503773|364684361|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
105734833|NCT03503773|364684362|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
105734834|NCT03503773|364684361|FG000|Overall Study|Not completing the primary ABPM|3|||
105734835|NCT03503773|364684362|FG001|Overall Study|Not completing the primary ABPM|1|||
105734836|NCT03503773|364684361|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
105734837|NCT03503773|364684362|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
105734838|NCT00658333|364684365|FG000|Overall Study|Adverse Event|2|||
105734839|NCT00658333|364684366|FG001|Overall Study|Adverse Event|1|||
105734840|NCT00553787|364684368|FG000|Overall Study|Adverse Event|34|||
105734841|NCT00553787|364684369|FG001|Overall Study|Adverse Event|21|||
105734842|NCT00553787|364684370|FG002|Overall Study|Adverse Event|67|||
105734843|NCT00553787|364684368|FG000|Overall Study|Lost to Follow-up|132|||
105734844|NCT00553787|364684369|FG001|Overall Study|Lost to Follow-up|44|||
105734845|NCT00553787|364684370|FG002|Overall Study|Lost to Follow-up|78|||
105734846|NCT00553787|364684368|FG000|Overall Study|Withdrawal by Subject|151|||
105734847|NCT00553787|364684369|FG001|Overall Study|Withdrawal by Subject|40|||
105734848|NCT00553787|364684370|FG002|Overall Study|Withdrawal by Subject|83|||
105734849|NCT00553787|364684368|FG000|Overall Study|Lack of Efficacy|31|||
105734850|NCT00553787|364684369|FG001|Overall Study|Lack of Efficacy|1|||
105734851|NCT00553787|364684370|FG002|Overall Study|Lack of Efficacy|3|||
105734852|NCT00553787|364684368|FG000|Overall Study|Pregnancy|0|||
105734853|NCT00553787|364684369|FG001|Overall Study|Pregnancy|1|||
105734854|NCT00553787|364684370|FG002|Overall Study|Pregnancy|2|||
105734855|NCT00553787|364684368|FG000|Overall Study|non compliance|4|||
105734856|NCT00553787|364684369|FG001|Overall Study|non compliance|0|||
105734857|NCT00553787|364684370|FG002|Overall Study|non compliance|11|||
105734858|NCT00553787|364684368|FG000|Overall Study|Requirement for restricted medication|8|||
105734859|NCT00553787|364684369|FG001|Overall Study|Requirement for restricted medication|7|||
105734860|NCT00553787|364684370|FG002|Overall Study|Requirement for restricted medication|5|||
105734861|NCT00553787|364684368|FG000|Overall Study|Other|18|||
105734862|NCT00553787|364684369|FG001|Overall Study|Other|10|||
105734863|NCT00553787|364684370|FG002|Overall Study|Other|13|||
105565071|NCT01364922|364066668|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
105565072|NCT01364922|364066669|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
105565073|NCT01364922|364066667|FG000|Double-Blind (DB) Period|Adverse Event|0|||
105565074|NCT01364922|364066668|FG001|Double-Blind (DB) Period|Adverse Event|0|||
105565075|NCT01364922|364066669|FG002|Double-Blind (DB) Period|Adverse Event|1|||
105565076|NCT01364922|364066667|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
105565077|NCT01364922|364066668|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
105734864|NCT02285010|364684371|FG000|Overall Study|not abdominal hysterectomy|2|||
105734865|NCT02285010|364684372|FG001|Overall Study|not abdominal hysterectomy|0|||
105734866|NCT02285010|364684371|FG000|Overall Study|Not spinal anesthesia|3|||
105734867|NCT02285010|364684372|FG001|Overall Study|Not spinal anesthesia|1|||
105734868|NCT00003641|364684373|FG000|Overall Study|Withdrawal by Subject|0|||
105734869|NCT00003641|364684374|FG001|Overall Study|Withdrawal by Subject|100|||
105734870|NCT00003641|364684373|FG000|Overall Study|Adverse Event|0|||
105734871|NCT00003641|364684374|FG001|Overall Study|Adverse Event|38|||
105734872|NCT00003641|364684373|FG000|Overall Study|Disease progression|0|||
105734873|NCT00003641|364684374|FG001|Overall Study|Disease progression|2|||
105734874|NCT00003641|364684373|FG000|Overall Study|Unknown/missing|0|||
105734875|NCT00003641|364684374|FG001|Overall Study|Unknown/missing|22|||
105734876|NCT00003641|364684373|FG000|Overall Study|Should not receive interferon therapy|2|||
105734877|NCT00003641|364684374|FG001|Overall Study|Should not receive interferon therapy|0|||
105734878|NCT00003641|364684373|FG000|Overall Study|Never started interferon|567|||
105734879|NCT00003641|364684374|FG001|Overall Study|Never started interferon|12|||
105734880|NCT00514449|364684375|FG000|Overall Study|Withdrawal by Subject|1|||
105734881|NCT00514449|364684376|FG001|Overall Study|Withdrawal by Subject|2|||
105734882|NCT00514449|364684375|FG000|Overall Study|Protocol Violation|1|||
105734883|NCT00514449|364684376|FG001|Overall Study|Protocol Violation|2|||
105734884|NCT00514449|364684375|FG000|Overall Study|Lost to Follow-up|1|||
105734885|NCT00514449|364684376|FG001|Overall Study|Lost to Follow-up|0|||
105734886|NCT01426386|364684379|FG000|Overall Study|Adverse Event|0|||
105734887|NCT01426386|364684380|FG001|Overall Study|Adverse Event|1|||
105734888|NCT01426386|364684381|FG002|Overall Study|Adverse Event|0|||
105734889|NCT01426386|364684382|FG003|Overall Study|Adverse Event|0|||
105734890|NCT01426386|364684383|FG004|Overall Study|Adverse Event|0|||
105734891|NCT01426386|364684384|FG005|Overall Study|Adverse Event|0|||
105734892|NCT01426386|364684379|FG000|Overall Study|Did not attend scheduled visit|1|||
105734893|NCT01426386|364684380|FG001|Overall Study|Did not attend scheduled visit|4|||
105734894|NCT01426386|364684381|FG002|Overall Study|Did not attend scheduled visit|0|||
105734895|NCT01426386|364684382|FG003|Overall Study|Did not attend scheduled visit|0|||
105734896|NCT01426386|364684383|FG004|Overall Study|Did not attend scheduled visit|2|||
105734897|NCT01426386|364684384|FG005|Overall Study|Did not attend scheduled visit|1|||
105734898|NCT01426386|364684379|FG000|Overall Study|Poor response|2|||
105734899|NCT01426386|364684380|FG001|Overall Study|Poor response|1|||
105734900|NCT01426386|364684381|FG002|Overall Study|Poor response|2|||
105734901|NCT01426386|364684382|FG003|Overall Study|Poor response|0|||
105734902|NCT01426386|364684383|FG004|Overall Study|Poor response|1|||
105734903|NCT01426386|364684384|FG005|Overall Study|Poor response|0|||
105734904|NCT01426386|364684379|FG000|Overall Study|Personal reasons|0|||
105734905|NCT01426386|364684380|FG001|Overall Study|Personal reasons|0|||
105734906|NCT01426386|364684381|FG002|Overall Study|Personal reasons|0|||
105734907|NCT01426386|364684382|FG003|Overall Study|Personal reasons|0|||
105734908|NCT01426386|364684383|FG004|Overall Study|Personal reasons|1|||
105734909|NCT01426386|364684384|FG005|Overall Study|Personal reasons|0|||
105734910|NCT03694522|364684385|FG000|Overall Study|Withdrawal by Subject|8|||
105734911|NCT03694522|364684386|FG001|Overall Study|Withdrawal by Subject|10|||
105734912|NCT03694522|364684385|FG000|Overall Study|Physician Decision|53|||
105734913|NCT03694522|364684386|FG001|Overall Study|Physician Decision|54|||
105734914|NCT03694522|364684385|FG000|Overall Study|Other|1|||
105734915|NCT03694522|364684386|FG001|Overall Study|Other|1|||
105734916|NCT03694522|364684385|FG000|Overall Study|Lost to Follow-up|0|||
105734917|NCT03694522|364684386|FG001|Overall Study|Lost to Follow-up|1|||
105734918|NCT02983292|364684387|FG000|Overall Study|Participant unwell & cannot travel|2|||
105734919|NCT02983292|364684387|FG000|Overall Study|Lost to Follow-up|3|||
105734920|NCT02983292|364684387|FG000|Overall Study|Participant withdrew consent|2|||
105734921|NCT02983292|364684387|FG000|Overall Study|Revision|7|||
105734922|NCT02983292|364684387|FG000|Overall Study|Death|1|||
105734923|NCT02983292|364684387|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
105734924|NCT02983292|364684387|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
105734925|NCT02983292|364684387|FG000|Overall Study|Participant relocation|1|||
105734926|NCT01158950|364684389|FG000|1st Intervention (1 Day)|Physician Decision|1|||
105734927|NCT01158950|364684390|FG001|1st Intervention (1 Day)|Physician Decision|2|||
105734928|NCT05258058|364684402|FG000|Overall Study|Withdrawal by Subject|2|||
105734929|NCT04579393|364684407|FG000|Overall Study|Withdrawal by Subject|2|||
105734930|NCT04579393|364684408|FG001|Overall Study|Withdrawal by Subject|2|||
105734931|NCT04579393|364684407|FG000|Overall Study|Death|1|||
105480631|NCT00958438|363771284|FG002|Overall Study|Physician Decision|1|||
105480632|NCT00958438|363771282|FG000|Overall Study|Other than specified above|2|||
105480633|NCT00958438|363771283|FG001|Overall Study|Other than specified above|3|||
105480634|NCT00958438|363771284|FG002|Overall Study|Other than specified above|2|||
105480635|NCT00329849|363771286|FG000|Overall Study|Withdrawal by Subject|6|||
105480636|NCT00329849|363771287|FG001|Overall Study|Withdrawal by Subject|4|||
105480637|NCT02984943|363771290|FG000|Overall Study|Withdrawal by Subject|3|||
105480638|NCT02984943|363771290|FG000|Overall Study|Physician Decision|1|||
105565078|NCT01364922|364066669|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
105734932|NCT04579393|364684408|FG001|Overall Study|Death|3|||
105734933|NCT00847561|364684409|FG000|Overall Study|Withdrawal by Subject|4|||
105734934|NCT00847561|364684410|FG001|Overall Study|Withdrawal by Subject|3|||
105734935|NCT00847561|364684409|FG000|Overall Study|Unable to schedule|9|||
105734936|NCT00847561|364684410|FG001|Overall Study|Unable to schedule|1|||
105734937|NCT01333189|364684412|FG000|Overall Study|Time constraints|1|||
105734938|NCT01333189|364684413|FG001|Overall Study|Time constraints|0|||
105734939|NCT01333189|364684412|FG000|Overall Study|Adverse Event|1|||
105734940|NCT01333189|364684413|FG001|Overall Study|Adverse Event|0|||
105734941|NCT01333189|364684412|FG000|Overall Study|Transportation difficulties|0|||
105480639|NCT05277337|363771291|FG000|Overall Study|Lost to Follow-up|2|||
105734942|NCT01333189|364684413|FG001|Overall Study|Transportation difficulties|1|||
105480640|NCT05277337|363771292|FG001|Overall Study|Lost to Follow-up|0|||
105734943|NCT01333189|364684412|FG000|Overall Study|Moved from region|0|||
105734944|NCT01333189|364684413|FG001|Overall Study|Moved from region|1|||
105734945|NCT03022422|364684414|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
105734946|NCT03022422|364684415|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
105734947|NCT03022422|364684416|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
105734948|NCT03022422|364684417|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
105734949|NCT03022422|364684418|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
105734950|NCT03022422|364684419|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
105734951|NCT02403206|364684420|FG000|Overall Study|Lost to Follow-up|4|||
105798969|NCT03118765|364922619|FG002|Overall Study|Sponsor Decision|1|||
105798970|NCT03118765|364922620|FG003|Overall Study|Sponsor Decision|0|||
105798971|NCT03118765|364922621|FG004|Overall Study|Sponsor Decision|1|||
105798972|NCT00849524|364922622|FG000|Overall Study|Lack of Efficacy|3|||
105798973|NCT01507831|364922625|FG000|Overall Study|Randomized but not treated|0|||
105798974|NCT01507831|364922626|FG001|Overall Study|Randomized but not treated|3|||
105798975|NCT01507831|364922625|FG000|Overall Study|Adverse Event|48|||
105798976|NCT01507831|364922626|FG001|Overall Study|Adverse Event|113|||
105565079|NCT03237858|364066674|FG000|Overall Study|Death|19|||
105734952|NCT02403206|364684421|FG001|Overall Study|Lost to Follow-up|3|||
105734953|NCT02403206|364684420|FG000|Overall Study|Physician Decision|2|||
105734954|NCT02403206|364684421|FG001|Overall Study|Physician Decision|0|||
105734955|NCT02403206|364684420|FG000|Overall Study|Withdrawal by Subject|3|||
105798977|NCT01507831|364922625|FG000|Overall Study|Death|6|||
105798978|NCT01507831|364922626|FG001|Overall Study|Death|2|||
105798979|NCT01507831|364922625|FG000|Overall Study|Poor compliance to protocol|38|||
105734956|NCT02403206|364684421|FG001|Overall Study|Withdrawal by Subject|3|||
105798980|NCT01507831|364922626|FG001|Overall Study|Poor compliance to protocol|60|||
105798981|NCT01507831|364922625|FG000|Overall Study|Physician Decision|0|||
105798982|NCT01507831|364922626|FG001|Overall Study|Physician Decision|4|||
105798983|NCT01507831|364922625|FG000|Overall Study|Participant moved|5|||
105798984|NCT01507831|364922626|FG001|Overall Study|Participant moved|19|||
105798985|NCT01507831|364922625|FG000|Overall Study|Consent withdrawn by participant|34|||
105798986|NCT01507831|364922626|FG001|Overall Study|Consent withdrawn by participant|72|||
105798987|NCT01507831|364922625|FG000|Overall Study|Related to study drug administration|5|||
105798988|NCT01507831|364922626|FG001|Overall Study|Related to study drug administration|14|||
105798989|NCT01507831|364922625|FG000|Overall Study|Last visit outside protocol visit window|51|||
105798990|NCT01507831|364922626|FG001|Overall Study|Last visit outside protocol visit window|143|||
105798991|NCT01507831|364922625|FG000|Overall Study|Selection criteria finally not met|0|||
105798992|NCT01507831|364922626|FG001|Overall Study|Selection criteria finally not met|1|||
105798993|NCT01507831|364922625|FG000|Overall Study|Site closure|0|||
105798994|NCT01507831|364922626|FG001|Overall Study|Site closure|3|||
105798995|NCT01507831|364922625|FG000|Overall Study|Potential lost to follow-up|3|||
105798996|NCT01507831|364922626|FG001|Overall Study|Potential lost to follow-up|0|||
105798997|NCT01507831|364922625|FG000|Overall Study|Other|3|||
105798998|NCT01507831|364922626|FG001|Overall Study|Other|6|||
105798999|NCT06371079|364922629|FG000|Overall Study|Missing data|88|||
105799000|NCT06371079|364922630|FG001|Overall Study|Missing data|247|||
105799001|NCT01864525|364922633|FG000|Overall Study|Adverse Event|1|||
105799002|NCT01864525|364922634|FG001|Overall Study|Adverse Event|0|||
105799003|NCT03712228|364922637|FG000|Treatment Period 1|Lack of Efficacy|0|||
105799004|NCT03712228|364922638|FG001|Treatment Period 1|Lack of Efficacy|0|||
105480641|NCT05277337|363771291|FG000|Overall Study|Withdrawal by Subject|1|||
105734957|NCT02403206|364684420|FG000|Overall Study|Reason not given|2|||
105799005|NCT03712228|364922639|FG002|Treatment Period 1|Lack of Efficacy|0|||
105799006|NCT03712228|364922640|FG003|Treatment Period 1|Lack of Efficacy|0|||
105734958|NCT02403206|364684421|FG001|Overall Study|Reason not given|4|||
105799007|NCT03712228|364922641|FG004|Treatment Period 1|Lack of Efficacy|0|||
105799008|NCT03712228|364922642|FG005|Treatment Period 1|Lack of Efficacy|1|||
105799009|NCT03712228|364922637|FG000|Treatment Period 2|Pregnancy|0|||
105799010|NCT03712228|364922638|FG001|Treatment Period 2|Pregnancy|0|||
105799011|NCT03712228|364922639|FG002|Treatment Period 2|Pregnancy|0|||
105799012|NCT03712228|364922640|FG003|Treatment Period 2|Pregnancy|1|||
105799013|NCT03712228|364922641|FG004|Treatment Period 2|Pregnancy|0|||
105799014|NCT03712228|364922642|FG005|Treatment Period 2|Pregnancy|0|||
105799015|NCT03712228|364922637|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105799016|NCT03712228|364922638|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105799017|NCT03712228|364922639|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105799018|NCT03712228|364922640|FG003|Treatment Period 2|Withdrawal by Subject|1|||
105799019|NCT03712228|364922641|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105799020|NCT03712228|364922642|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105799021|NCT00363129|364922643|FG000|Overall Study|Withdrawal by Subject|11|||
105799022|NCT00363129|364922644|FG001|Overall Study|Withdrawal by Subject|18|||
105799023|NCT00363129|364922643|FG000|Overall Study|Adverse Event|8|||
105799024|NCT00363129|364922644|FG001|Overall Study|Adverse Event|3|||
105799025|NCT00363129|364922643|FG000|Overall Study|Alternate Treatment|2|||
105799026|NCT00363129|364922644|FG001|Overall Study|Alternate Treatment|4|||
105799027|NCT00363129|364922643|FG000|Overall Study|Other Medical Problems|2|||
105799028|NCT00363129|364922644|FG001|Overall Study|Other Medical Problems|4|||
105799029|NCT00363129|364922643|FG000|Overall Study|Death|0|||
105799030|NCT00363129|364922644|FG001|Overall Study|Death|1|||
105799031|NCT00363129|364922643|FG000|Overall Study|Other Reasons|6|||
105734959|NCT00957372|364684422|FG000|PART I|Lost to Follow-up|0|||
105734960|NCT00957372|364684423|FG001|PART I|Lost to Follow-up|0|||
105734961|NCT00957372|364684424|FG002|PART I|Lost to Follow-up|1|||
105734962|NCT00957372|364684425|FG003|PART I|Lost to Follow-up|0|||
105734963|NCT00957372|364684422|FG000|PART II|Withdrawal by Subject|0|||
105734964|NCT00957372|364684423|FG001|PART II|Withdrawal by Subject|0|||
105734965|NCT00957372|364684424|FG002|PART II|Withdrawal by Subject|0|||
105734966|NCT00957372|364684425|FG003|PART II|Withdrawal by Subject|8|||
105734967|NCT00957372|364684422|FG000|PART II|Physician Decision|0|||
105734968|NCT00957372|364684423|FG001|PART II|Physician Decision|0|||
105734969|NCT00957372|364684424|FG002|PART II|Physician Decision|0|||
105799032|NCT00363129|364922644|FG001|Overall Study|Other Reasons|3|||
105799033|NCT03296553|364922646|FG000|Overall Study|Withdrawal by Subject|1|||
105799034|NCT03296553|364922647|FG001|Overall Study|Withdrawal by Subject|1|||
105799035|NCT03296553|364922646|FG000|Overall Study|Death|1|||
105799036|NCT03296553|364922647|FG001|Overall Study|Death|0|||
105799037|NCT02295280|364922648|FG000|Overall Study|Adverse Event|0|||
105799038|NCT02295280|364922649|FG001|Overall Study|Adverse Event|1|||
105480642|NCT05277337|363771292|FG001|Overall Study|Withdrawal by Subject|0|||
105480643|NCT04905498|363771298|FG000|Overall Study|Lost to Follow-up|0|||
105734970|NCT00957372|364684425|FG003|PART II|Physician Decision|1|||
105734971|NCT00957372|364684422|FG000|PART II|Pregnancy|0|||
105734972|NCT00957372|364684423|FG001|PART II|Pregnancy|0|||
105734973|NCT00957372|364684424|FG002|PART II|Pregnancy|0|||
105799039|NCT00558519|364922650|FG000|Overall Study|Ph+|20|||
105353808|NCT01716520|363301217|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
105353809|NCT01716520|363301218|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
105353810|NCT01716520|363301219|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
105353811|NCT01716520|363301220|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
105353812|NCT01716520|363301215|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
105353813|NCT01716520|363301216|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
105353814|NCT01716520|363301217|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
105353815|NCT01716520|363301218|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
105353816|NCT01716520|363301219|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
105353817|NCT01716520|363301220|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
105353818|NCT01716520|363301215|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
105353819|NCT01716520|363301216|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
105353820|NCT01716520|363301217|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
105353821|NCT01716520|363301218|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
105353822|NCT01716520|363301219|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
105353823|NCT01716520|363301220|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
105353824|NCT01716520|363301215|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
105353825|NCT01716520|363301216|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
105353826|NCT01716520|363301217|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
105353827|NCT01716520|363301218|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
105353828|NCT01716520|363301219|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
105353829|NCT01716520|363301220|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
105353830|NCT01716520|363301215|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
105353831|NCT01716520|363301216|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
105353832|NCT01716520|363301217|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
105353833|NCT01716520|363301218|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
105353834|NCT01716520|363301219|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
105353835|NCT01716520|363301220|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
105353836|NCT01716520|363301215|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105353837|NCT01716520|363301216|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105353838|NCT01716520|363301217|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105353839|NCT01716520|363301218|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105353840|NCT01716520|363301219|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105353841|NCT01716520|363301220|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
105353842|NCT01716520|363301215|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105734974|NCT00957372|364684425|FG003|PART II|Pregnancy|1|||
105734975|NCT00957372|364684422|FG000|PART II|Not Know|0|||
105734976|NCT00957372|364684423|FG001|PART II|Not Know|0|||
105734977|NCT00957372|364684424|FG002|PART II|Not Know|0|||
105734978|NCT00957372|364684425|FG003|PART II|Not Know|20|||
105734979|NCT00957372|364684422|FG000|PART II|Adverse Event|0|||
105734980|NCT00957372|364684423|FG001|PART II|Adverse Event|0|||
105734981|NCT00957372|364684424|FG002|PART II|Adverse Event|0|||
105734982|NCT00957372|364684425|FG003|PART II|Adverse Event|10|||
105353843|NCT01716520|363301216|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105734983|NCT00957372|364684422|FG000|PART II|Patient non-compliance|0|||
105734984|NCT00957372|364684423|FG001|PART II|Patient non-compliance|0|||
105734985|NCT00957372|364684424|FG002|PART II|Patient non-compliance|0|||
105734986|NCT00957372|364684425|FG003|PART II|Patient non-compliance|4|||
105734987|NCT00408681|364684426|FG000|Overall Study|Lack of Efficacy|2|||
105734988|NCT00408681|364684426|FG000|Overall Study|Adverse Event|7|||
105734989|NCT01676116|364684430|FG000|Overall Study|Withdrawal criteria|2|||
105734990|NCT01676116|364684431|FG001|Overall Study|Withdrawal criteria|14|||
105734991|NCT01676116|364684430|FG000|Overall Study|Adverse Event|1|||
105734992|NCT01676116|364684431|FG001|Overall Study|Adverse Event|2|||
105734993|NCT01676116|364684430|FG000|Overall Study|Unclassified|4|||
105734994|NCT01676116|364684431|FG001|Overall Study|Unclassified|10|||
105734995|NCT01676116|364684430|FG000|Overall Study|Protocol Violation|9|||
105480644|NCT04905498|363771299|FG001|Overall Study|Lost to Follow-up|2|||
105480645|NCT04905498|363771298|FG000|Overall Study|COVID lockdown|1|||
105480646|NCT04905498|363771299|FG001|Overall Study|COVID lockdown|0|||
105480647|NCT02946931|363771300|FG000|Overall Study|Did not require collection of CRFs|588|||
105480648|NCT02946931|363771300|FG000|Overall Study|Other than listed|37|||
105480649|NCT02946931|363771300|FG000|Overall Study|Discharge from hospital|118|||
105480650|NCT02946931|363771300|FG000|Overall Study|Adverse Event|81|||
105480651|NCT02946931|363771300|FG000|Overall Study|CRFs not valid|1|||
105480652|NCT02946931|363771300|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
105480653|NCT03339297|363771301|FG000|Overall Study|Relapse of Hematologic Disease|1|||
105480654|NCT03339297|363771302|FG001|Overall Study|Relapse of Hematologic Disease|0|||
105480655|NCT03339297|363771301|FG000|Overall Study|Death|10|||
105480656|NCT03339297|363771302|FG001|Overall Study|Death|7|||
105480657|NCT03339297|363771301|FG000|Overall Study|Hepatic Candidosis|1|||
105480658|NCT03339297|363771302|FG001|Overall Study|Hepatic Candidosis|0|||
105480659|NCT03339297|363771301|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
105480660|NCT03339297|363771302|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
105480661|NCT03339297|363771301|FG000|Overall Study|Consent Withdrawn by Participant|3|||
105480662|NCT03339297|363771302|FG001|Overall Study|Consent Withdrawn by Participant|3|||
105480663|NCT03339297|363771301|FG000|Overall Study|Disease Relapse|2|||
105480664|NCT03339297|363771302|FG001|Overall Study|Disease Relapse|0|||
105480665|NCT03339297|363771301|FG000|Overall Study|Physician Decision|1|||
105480666|NCT03339297|363771302|FG001|Overall Study|Physician Decision|1|||
105480667|NCT03339297|363771301|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
105480668|NCT03339297|363771302|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
105480669|NCT03339297|363771301|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
105480670|NCT03339297|363771302|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
105480671|NCT03339297|363771301|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
105480672|NCT03339297|363771302|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
105734996|NCT01676116|364684431|FG001|Overall Study|Protocol Violation|3|||
105734997|NCT00893113|364686167|FG000|Overall Study|Lost to Follow-up|4|||
105734998|NCT00893113|364686168|FG001|Overall Study|Lost to Follow-up|8|||
105734999|NCT00893113|364686167|FG000|Overall Study|Early Termination|1|||
105735000|NCT00893113|364686168|FG001|Overall Study|Early Termination|1|||
105735001|NCT00893113|364686167|FG000|Overall Study|Withdrew Consent|8|||
105735002|NCT00893113|364686168|FG001|Overall Study|Withdrew Consent|7|||
105735003|NCT02495077|364686169|FG000|Overall Study|Adverse Event|0|||
105735004|NCT02495077|364686170|FG001|Overall Study|Adverse Event|1|||
105735005|NCT02495077|364686171|FG002|Overall Study|Adverse Event|1|||
105735006|NCT02495077|364686172|FG003|Overall Study|Adverse Event|0|||
105735007|NCT02495077|364686169|FG000|Overall Study|Death|3|||
105480673|NCT03339297|363771301|FG000|Overall Study|Adverse Event, Non-fatal|1|||
105735008|NCT02495077|364686170|FG001|Overall Study|Death|5|||
105735009|NCT02495077|364686171|FG002|Overall Study|Death|0|||
105353844|NCT01716520|363301217|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
105480674|NCT03339297|363771302|FG001|Overall Study|Adverse Event, Non-fatal|0|||
105480675|NCT03339297|363771301|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
105735010|NCT02495077|364686172|FG003|Overall Study|Death|0|||
105353845|NCT01716520|363301218|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105353846|NCT01716520|363301219|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105353847|NCT01716520|363301220|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105353848|NCT00902746|363301221|FG000|Overall Study|Protocol Violation|7|||
105353849|NCT00902746|363301221|FG000|Overall Study|Withdrawal by Subject|16|||
105353850|NCT00902746|363301221|FG000|Overall Study|Adverse Event|8|||
105353851|NCT00902746|363301221|FG000|Overall Study|Lost to Follow-up|3|||
105353852|NCT00902746|363301221|FG000|Overall Study|Physician Decision|2|||
105353853|NCT00359294|363301226|FG000|Overall Study|Progressive disease|1|||
105353854|NCT00359294|363301227|FG001|Overall Study|Progressive disease|1|||
105353855|NCT00359294|363301228|FG002|Overall Study|Progressive disease|2|||
105353856|NCT00359294|363301229|FG003|Overall Study|Progressive disease|3|||
105353857|NCT00359294|363301230|FG004|Overall Study|Progressive disease|2|||
105353858|NCT00359294|363301226|FG000|Overall Study|Withdrawal by Subject|0|||
105353859|NCT00359294|363301227|FG001|Overall Study|Withdrawal by Subject|0|||
105353860|NCT00359294|363301228|FG002|Overall Study|Withdrawal by Subject|0|||
105353861|NCT00359294|363301229|FG003|Overall Study|Withdrawal by Subject|0|||
105353862|NCT00359294|363301230|FG004|Overall Study|Withdrawal by Subject|1|||
105353863|NCT00359294|363301226|FG000|Overall Study|Not treated|0|||
105353864|NCT00359294|363301227|FG001|Overall Study|Not treated|0|||
105353865|NCT00359294|363301228|FG002|Overall Study|Not treated|0|||
105353866|NCT00359294|363301229|FG003|Overall Study|Not treated|1|||
105353867|NCT00359294|363301230|FG004|Overall Study|Not treated|0|||
105353868|NCT00359294|363301226|FG000|Overall Study|Physician Decision|0|||
105353869|NCT00359294|363301227|FG001|Overall Study|Physician Decision|0|||
105353870|NCT00359294|363301228|FG002|Overall Study|Physician Decision|1|||
105353871|NCT00359294|363301229|FG003|Overall Study|Physician Decision|0|||
105353872|NCT00359294|363301230|FG004|Overall Study|Physician Decision|0|||
105353873|NCT01280682|363301231|FG000|Overall Study|Lost to Follow-up|0|||
105353874|NCT01280682|363301232|FG001|Overall Study|Lost to Follow-up|6|||
105353875|NCT01280682|363301231|FG000|Overall Study|Withdrawal by Subject|0|||
105353876|NCT01280682|363301232|FG001|Overall Study|Withdrawal by Subject|7|||
105353877|NCT00849290|363301233|FG000|Overall Study|Adverse Event|3|||
105353878|NCT00849290|363301233|FG000|Overall Study|Death|14|||
105353879|NCT00849290|363301233|FG000|Overall Study|Withdrawal by Subject|11|||
105353880|NCT00849290|363301233|FG000|Overall Study|Lost to Follow-up|2|||
105353881|NCT00849290|363301233|FG000|Overall Study|Protocol Violation|5|||
105353882|NCT00849290|363301233|FG000|Overall Study|Disease Progression|20|||
105353883|NCT01464619|363301238|FG000|Overall Study|Lost to Follow-up|3|||
105353884|NCT01464619|363301239|FG001|Overall Study|Lost to Follow-up|4|||
105353885|NCT00080483|363301240|FG000|Overall Study|Lost to Follow-up|1|||
105353886|NCT00080483|363301241|FG001|Overall Study|Lost to Follow-up|1|||
105353887|NCT00080483|363301240|FG000|Overall Study|Physician Decision|1|||
105353888|NCT00080483|363301241|FG001|Overall Study|Physician Decision|1|||
105353889|NCT01119846|363301244|FG000|Overall Study|Adverse Event|1|||
105353890|NCT01119846|363301245|FG001|Overall Study|Adverse Event|0|||
105353891|NCT01119846|363301246|FG002|Overall Study|Adverse Event|6|||
105353892|NCT01119846|363301244|FG000|Overall Study|Physician Decision|1|||
105353893|NCT01119846|363301245|FG001|Overall Study|Physician Decision|0|||
105353894|NCT01119846|363301246|FG002|Overall Study|Physician Decision|0|||
105353895|NCT01119846|363301244|FG000|Overall Study|Protocol Violation|0|||
105353896|NCT01119846|363301245|FG001|Overall Study|Protocol Violation|0|||
105353897|NCT01119846|363301246|FG002|Overall Study|Protocol Violation|1|||
105353898|NCT01119846|363301244|FG000|Overall Study|Withdrawal by Subject|0|||
105353899|NCT01119846|363301245|FG001|Overall Study|Withdrawal by Subject|0|||
105353900|NCT01119846|363301246|FG002|Overall Study|Withdrawal by Subject|4|||
105353901|NCT02223364|363301260|FG000|Overall Study|Protocol Violation|3|||
105353902|NCT02223364|363301261|FG001|Overall Study|Protocol Violation|0|||
105353903|NCT02223364|363301262|FG002|Overall Study|Protocol Violation|3|||
105353904|NCT02223364|363301260|FG000|Overall Study|subject expired before surgery|1|||
105353905|NCT02223364|363301261|FG001|Overall Study|subject expired before surgery|0|||
105353906|NCT02223364|363301262|FG002|Overall Study|subject expired before surgery|0|||
105353907|NCT02223364|363301260|FG000|Overall Study|Physician Decision|1|||
105735011|NCT02495077|364686169|FG000|Overall Study|Lost to Follow-up|6|||
105735012|NCT02495077|364686170|FG001|Overall Study|Lost to Follow-up|4|||
105735013|NCT02495077|364686171|FG002|Overall Study|Lost to Follow-up|0|||
105735014|NCT02495077|364686172|FG003|Overall Study|Lost to Follow-up|0|||
105735015|NCT02495077|364686169|FG000|Overall Study|Physician Decision|2|||
105735016|NCT02495077|364686170|FG001|Overall Study|Physician Decision|1|||
105735017|NCT02495077|364686171|FG002|Overall Study|Physician Decision|4|||
105735018|NCT02495077|364686172|FG003|Overall Study|Physician Decision|0|||
105353908|NCT02223364|363301261|FG001|Overall Study|Physician Decision|0|||
105353909|NCT02223364|363301262|FG002|Overall Study|Physician Decision|0|||
105353910|NCT01841567|363301263|FG000|Overall Study|Adverse Event|3|||
105353911|NCT01366638|363301264|FG000|Overall Study|Withdrawal by Subject|0|||
105353912|NCT01366638|363301265|FG001|Overall Study|Withdrawal by Subject|0|||
105353913|NCT01366638|363301266|FG002|Overall Study|Withdrawal by Subject|6|||
105353914|NCT01366638|363301264|FG000|Overall Study|Other|1|||
105353915|NCT01366638|363301265|FG001|Overall Study|Other|0|||
105353916|NCT01366638|363301266|FG002|Overall Study|Other|0|||
105353917|NCT00636636|363301267|FG000|Overall Study|Other reason|4|||
105353918|NCT00636636|363301268|FG001|Overall Study|Other reason|6|||
105353919|NCT00636636|363301267|FG000|Overall Study|Adverse Event|19|||
105353920|NCT00636636|363301268|FG001|Overall Study|Adverse Event|8|||
105353921|NCT00636636|363301267|FG000|Overall Study|Lack of Efficacy|7|||
105353922|NCT00636636|363301268|FG001|Overall Study|Lack of Efficacy|12|||
105353923|NCT00636636|363301267|FG000|Overall Study|Protocol Violation|2|||
105353924|NCT00636636|363301268|FG001|Overall Study|Protocol Violation|2|||
105353925|NCT00636636|363301267|FG000|Overall Study|Lost to Follow-up|0|||
105353926|NCT00636636|363301268|FG001|Overall Study|Lost to Follow-up|1|||
105353927|NCT00636636|363301267|FG000|Overall Study|Death|0|||
105353928|NCT00636636|363301268|FG001|Overall Study|Death|1|||
105353929|NCT00636636|363301267|FG000|Overall Study|Withdrawal by Subject|4|||
105353930|NCT00636636|363301268|FG001|Overall Study|Withdrawal by Subject|9|||
105353931|NCT02483572|363301269|FG000|Overall Study|Withdrawal by Subject|1|||
105353932|NCT02483572|363301270|FG001|Overall Study|Withdrawal by Subject|0|||
105353933|NCT02483572|363301269|FG000|Overall Study|Lost to Follow-up|1|||
105353934|NCT02483572|363301270|FG001|Overall Study|Lost to Follow-up|0|||
105353935|NCT02483572|363301269|FG000|Overall Study|Physician Decision|0|||
105353936|NCT02483572|363301270|FG001|Overall Study|Physician Decision|1|||
105353937|NCT05052697|363301271|FG000|Substudy A|Lost to Follow-up|0|||
105353938|NCT05052697|363301272|FG001|Substudy A|Lost to Follow-up|0|||
105353939|NCT05052697|363301273|FG002|Substudy A|Lost to Follow-up|0|||
105353940|NCT05052697|363301274|FG003|Substudy A|Lost to Follow-up|0|||
105735019|NCT02495077|364686169|FG000|Overall Study|Protocol Violation|0|||
105735020|NCT02495077|364686170|FG001|Overall Study|Protocol Violation|1|||
105735021|NCT02495077|364686171|FG002|Overall Study|Protocol Violation|0|||
105735022|NCT02495077|364686172|FG003|Overall Study|Protocol Violation|0|||
105735023|NCT02495077|364686169|FG000|Overall Study|Screen Failure|0|||
105735024|NCT02495077|364686170|FG001|Overall Study|Screen Failure|0|||
105735025|NCT02495077|364686171|FG002|Overall Study|Screen Failure|0|||
105735026|NCT02495077|364686172|FG003|Overall Study|Screen Failure|48|||
105735027|NCT02495077|364686169|FG000|Overall Study|Withdrawal by Subject|7|||
105735028|NCT02495077|364686170|FG001|Overall Study|Withdrawal by Subject|7|||
105735029|NCT02495077|364686171|FG002|Overall Study|Withdrawal by Subject|7|||
105735030|NCT02495077|364686172|FG003|Overall Study|Withdrawal by Subject|0|||
105735031|NCT02495077|364686169|FG000|Overall Study|Covid-19 research restrictions|1|||
105735032|NCT02495077|364686170|FG001|Overall Study|Covid-19 research restrictions|0|||
105735033|NCT02495077|364686171|FG002|Overall Study|Covid-19 research restrictions|0|||
105735034|NCT02495077|364686172|FG003|Overall Study|Covid-19 research restrictions|0|||
105735035|NCT02495077|364686169|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
105735036|NCT02495077|364686170|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
105735037|NCT02495077|364686171|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
105735038|NCT02495077|364686172|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
105735039|NCT02495077|364686169|FG000|Overall Study|Incarcerated|0|||
105735040|NCT02495077|364686170|FG001|Overall Study|Incarcerated|1|||
105735041|NCT02495077|364686171|FG002|Overall Study|Incarcerated|0|||
105735042|NCT02495077|364686172|FG003|Overall Study|Incarcerated|0|||
105735043|NCT02495077|364686169|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
105353941|NCT05052697|363301275|FG004|Substudy A|Lost to Follow-up|0|||
105353942|NCT05052697|363301276|FG005|Substudy A|Lost to Follow-up|1|||
105353943|NCT05052697|363301277|FG006|Substudy A|Lost to Follow-up|0|||
105353944|NCT05052697|363301278|FG007|Substudy A|Lost to Follow-up|0|||
105353945|NCT05052697|363301279|FG008|Substudy A|Lost to Follow-up|0|||
105353946|NCT05052697|363301280|FG009|Substudy A|Lost to Follow-up|0|||
105735044|NCT02495077|364686170|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
105735045|NCT02495077|364686171|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
105799040|NCT00558519|364922650|FG000|Overall Study|Ineligible|1|||
105799041|NCT00558519|364922650|FG000|Overall Study|Insufficient data|1|||
105353947|NCT05052697|363301281|FG010|Substudy A|Lost to Follow-up|0|||
105353948|NCT05052697|363301282|FG011|Substudy A|Lost to Follow-up|0|||
105353949|NCT05052697|363301283|FG012|Substudy A|Lost to Follow-up|0|||
105799042|NCT00558519|364922650|FG000|Overall Study|Never received treatment|1|||
105799043|NCT00575328|364922651|FG000|Overall Study|Adverse Event|1|||
105799044|NCT00575328|364922652|FG001|Overall Study|Adverse Event|1|||
105480676|NCT03339297|363771302|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
105480677|NCT03339297|363771301|FG000|Overall Study|Patient Was Not Eligible|1|||
105480678|NCT03339297|363771302|FG001|Overall Study|Patient Was Not Eligible|0|||
105480679|NCT05498701|363771303|FG000|Period 3|Adverse Event|1|||
105480680|NCT05498701|363771304|FG001|Period 3|Adverse Event|0|||
105480681|NCT01328444|363771305|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
105799045|NCT00575328|364922651|FG000|Overall Study|Lost to Follow-up|2|||
105799046|NCT00575328|364922652|FG001|Overall Study|Lost to Follow-up|1|||
105799047|NCT02124746|364922653|FG000|Overall Study|Adverse Event|2|||
105799048|NCT02124746|364922654|FG001|Overall Study|Adverse Event|1|||
105799049|NCT02124746|364922655|FG002|Overall Study|Adverse Event|2|||
105799050|NCT02124746|364922653|FG000|Overall Study|Death|2|||
105799051|NCT02124746|364922654|FG001|Overall Study|Death|1|||
105799052|NCT02124746|364922655|FG002|Overall Study|Death|3|||
105799053|NCT02124746|364922653|FG000|Overall Study|Lack of Efficacy|3|||
105799054|NCT02124746|364922654|FG001|Overall Study|Lack of Efficacy|2|||
105799055|NCT02124746|364922655|FG002|Overall Study|Lack of Efficacy|2|||
105799056|NCT02124746|364922653|FG000|Overall Study|Physician Decision|6|||
105799057|NCT02124746|364922654|FG001|Overall Study|Physician Decision|4|||
105799058|NCT02124746|364922655|FG002|Overall Study|Physician Decision|5|||
105799059|NCT02124746|364922653|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105799060|NCT02124746|364922654|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105799061|NCT02124746|364922655|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105799062|NCT02124746|364922653|FG000|Overall Study|Withdrawal by Subject|3|||
105799063|NCT02124746|364922654|FG001|Overall Study|Withdrawal by Subject|3|||
105799064|NCT02124746|364922655|FG002|Overall Study|Withdrawal by Subject|0|||
105799065|NCT02124746|364922653|FG000|Overall Study|Study Terminated by Sponsor|0|||
105480682|NCT01328444|363771306|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
105480683|NCT01328444|363771307|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
105480684|NCT01328444|363771308|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
105480685|NCT01328444|363771309|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
105480686|NCT01328444|363771310|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
105480687|NCT01328444|363771305|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
105799066|NCT02124746|364922654|FG001|Overall Study|Study Terminated by Sponsor|0|||
105799067|NCT02124746|364922655|FG002|Overall Study|Study Terminated by Sponsor|6|||
105799068|NCT02124746|364922653|FG000|Overall Study|Disease Progression|3|||
105799069|NCT02124746|364922654|FG001|Overall Study|Disease Progression|6|||
105799070|NCT02124746|364922655|FG002|Overall Study|Disease Progression|4|||
105799071|NCT00065065|364922656|FG000|Overall Study|Adverse Event|3|||
105799072|NCT00065065|364922657|FG001|Overall Study|Adverse Event|2|||
105799073|NCT00065065|364922656|FG000|Overall Study|Withdrawal by Subject|1|||
105799074|NCT00065065|364922657|FG001|Overall Study|Withdrawal by Subject|5|||
105799075|NCT00065065|364922656|FG000|Overall Study|Lack of Efficacy|4|||
105799076|NCT00065065|364922657|FG001|Overall Study|Lack of Efficacy|11|||
105799077|NCT00065065|364922656|FG000|Overall Study|Other|2|||
105799078|NCT00065065|364922657|FG001|Overall Study|Other|2|||
105799079|NCT05478603|364922673|FG000|Overall Study|Withdrawal by Subject|0|||
105799080|NCT05478603|364922674|FG001|Overall Study|Withdrawal by Subject|1|||
105480688|NCT01328444|363771306|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
105480689|NCT01328444|363771307|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
105480690|NCT01328444|363771308|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
105480691|NCT01328444|363771309|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
105480692|NCT01328444|363771310|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
105799081|NCT05478603|364922675|FG002|Overall Study|Withdrawal by Subject|0|||
105799082|NCT05478603|364922676|FG003|Overall Study|Withdrawal by Subject|0|||
105480693|NCT01328444|363771305|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
105480694|NCT01328444|363771306|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
105480695|NCT01328444|363771307|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
105480696|NCT01328444|363771308|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
105480697|NCT01328444|363771309|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
105565080|NCT03237858|364066674|FG000|Overall Study|Withdrawal by Subject|37|||
105799083|NCT02472977|364922677|FG000|Overall Study|Disease progression|4|||
105799084|NCT02472977|364922678|FG001|Overall Study|Disease progression|25|||
105799085|NCT02472977|364922679|FG002|Overall Study|Disease progression|6|||
105799086|NCT02472977|364922677|FG000|Overall Study|Withdrawal by Subject|0|||
105799087|NCT02472977|364922678|FG001|Overall Study|Withdrawal by Subject|1|||
105480698|NCT01328444|363771310|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
105799088|NCT02472977|364922679|FG002|Overall Study|Withdrawal by Subject|0|||
105353950|NCT05052697|363301284|FG013|Substudy A|Lost to Follow-up|0|||
105480699|NCT01328444|363771305|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
105799089|NCT02472977|364922677|FG000|Overall Study|Study drug toxicity|2|||
105799090|NCT02472977|364922678|FG001|Overall Study|Study drug toxicity|0|||
105799091|NCT02472977|364922679|FG002|Overall Study|Study drug toxicity|2|||
105480700|NCT01328444|363771306|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
105480701|NCT01328444|363771307|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
105480702|NCT01328444|363771308|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
105480703|NCT01328444|363771309|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
105480704|NCT01328444|363771310|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
105480705|NCT01328444|363771305|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
105480706|NCT01328444|363771306|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105480707|NCT01328444|363771307|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105480708|NCT01328444|363771308|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
105480709|NCT01328444|363771309|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105480710|NCT01328444|363771310|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
105480711|NCT01328444|363771305|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
105480712|NCT01328444|363771306|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
105480713|NCT01328444|363771307|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
105480714|NCT01328444|363771308|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
105480715|NCT01328444|363771309|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
105480716|NCT01328444|363771310|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
105480717|NCT01328444|363771305|FG000|Washout Period (14 Days)|Adverse Event|1|||
105480718|NCT01328444|363771306|FG001|Washout Period (14 Days)|Adverse Event|1|||
105480719|NCT01328444|363771307|FG002|Washout Period (14 Days)|Adverse Event|0|||
105480720|NCT01328444|363771308|FG003|Washout Period (14 Days)|Adverse Event|1|||
105480721|NCT01328444|363771309|FG004|Washout Period (14 Days)|Adverse Event|1|||
105480722|NCT01328444|363771310|FG005|Washout Period (14 Days)|Adverse Event|2|||
105480723|NCT01328444|363771305|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
105480724|NCT01328444|363771306|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
105480725|NCT01328444|363771307|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
105735046|NCT02495077|364686172|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
105735047|NCT02495077|364686169|FG000|Overall Study|Timing of transplant and randomization|0|||
105735048|NCT02495077|364686170|FG001|Overall Study|Timing of transplant and randomization|0|||
105735049|NCT02495077|364686171|FG002|Overall Study|Timing of transplant and randomization|5|||
105735050|NCT02495077|364686172|FG003|Overall Study|Timing of transplant and randomization|0|||
105735051|NCT00128206|364686173|FG000|Overall Study|Lost to Follow-up|137|||
105735052|NCT00128206|364686174|FG001|Overall Study|Lost to Follow-up|118|||
105735053|NCT00128206|364686173|FG000|Overall Study|Adverse Event|0|||
105735054|NCT00128206|364686174|FG001|Overall Study|Adverse Event|2|||
105735055|NCT03270085|364686175|FG000|Overall Study|Withdrawal by Subject|1|||
105735056|NCT03270085|364686176|FG001|Overall Study|Withdrawal by Subject|0|||
105735057|NCT02400346|364686182|FG000|Overall Study|Adverse Event|24|||
105735058|NCT02400346|364686182|FG000|Overall Study|Lack of Efficacy|9|||
105735059|NCT02400346|364686182|FG000|Overall Study|Non-compliance with IMP|1|||
105735060|NCT02400346|364686182|FG000|Overall Study|Withdrawal by Subject|7|||
105735061|NCT02400346|364686182|FG000|Overall Study|Administrative or other reason(s)|2|||
105735062|NCT02400346|364686182|FG000|Overall Study|Lost to Follow-up|1|||
105735063|NCT01269125|364686185|FG000|Overall Study|Adverse Event|3|||
105735064|NCT01269125|364686186|FG001|Overall Study|Adverse Event|5|||
105735065|NCT01269125|364686187|FG002|Overall Study|Adverse Event|0|||
105735066|NCT01269125|364686185|FG000|Overall Study|Lost to Follow-up|4|||
105735067|NCT01269125|364686186|FG001|Overall Study|Lost to Follow-up|0|||
105735068|NCT01269125|364686187|FG002|Overall Study|Lost to Follow-up|0|||
105735069|NCT03635190|364686188|FG000|Overall Study|Lost to Follow-up|4|||
105735070|NCT03635190|364686188|FG000|Overall Study|Death|3|||
105735071|NCT03635190|364686188|FG000|Overall Study|Withdrawal by Subject|1|||
105735072|NCT03635190|364686188|FG000|Overall Study|Patient moved and did not return for follow up|1|||
105735073|NCT03692910|364686191|FG000|Overall Study|Lost to Follow-up|4|||
105735074|NCT03692910|364686192|FG001|Overall Study|Lost to Follow-up|0|||
105735075|NCT03692910|364686193|FG002|Overall Study|Lost to Follow-up|0|||
105735076|NCT03692910|364686191|FG000|Overall Study|Withdrawal by Subject|2|||
105735077|NCT03692910|364686192|FG001|Overall Study|Withdrawal by Subject|0|||
105735078|NCT03692910|364686193|FG002|Overall Study|Withdrawal by Subject|0|||
105735079|NCT01330381|364686194|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
105735080|NCT01330381|364686195|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
105799092|NCT02472977|364922677|FG000|Overall Study|Subject request to discontinue treatment|0|||
105799093|NCT02472977|364922678|FG001|Overall Study|Subject request to discontinue treatment|1|||
105799094|NCT02472977|364922679|FG002|Overall Study|Subject request to discontinue treatment|0|||
105480726|NCT01328444|363771308|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
105480727|NCT01328444|363771309|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
105480728|NCT01328444|363771310|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
105735081|NCT01330381|364686196|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
105735082|NCT01330381|364686194|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
105735083|NCT01330381|364686195|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
105735084|NCT01330381|364686196|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
105735085|NCT01330381|364686194|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
105353951|NCT05052697|363301285|FG014|Substudy A|Lost to Follow-up|0|||
105353952|NCT05052697|363301286|FG015|Substudy A|Lost to Follow-up|2|||
105353953|NCT05052697|363301287|FG016|Substudy A|Lost to Follow-up|0|||
105353954|NCT05052697|363301288|FG017|Substudy A|Lost to Follow-up|0|||
105353955|NCT05052697|363301289|FG018|Substudy A|Lost to Follow-up|0|||
105353956|NCT05052697|363301290|FG019|Substudy A|Lost to Follow-up|0|||
105353957|NCT05052697|363301291|FG020|Substudy A|Lost to Follow-up|0|||
105353958|NCT05052697|363301292|FG021|Substudy A|Lost to Follow-up|0|||
105353959|NCT05052697|363301293|FG022|Substudy A|Lost to Follow-up|0|||
105353960|NCT05052697|363301294|FG023|Substudy A|Lost to Follow-up|0|||
105353961|NCT05052697|363301295|FG024|Substudy A|Lost to Follow-up|0|||
105353962|NCT05052697|363301296|FG025|Substudy A|Lost to Follow-up|0|||
105353963|NCT05052697|363301297|FG026|Substudy A|Lost to Follow-up|0|||
105353964|NCT05052697|363301298|FG027|Substudy A|Lost to Follow-up|0|||
105353965|NCT05052697|363301299|FG028|Substudy A|Lost to Follow-up|0|||
105353966|NCT05052697|363301300|FG029|Substudy A|Lost to Follow-up|0|||
105353967|NCT05052697|363301301|FG030|Substudy A|Lost to Follow-up|0|||
105353968|NCT05052697|363301302|FG031|Substudy A|Lost to Follow-up|0|||
105353969|NCT05052697|363301303|FG032|Substudy A|Lost to Follow-up|0|||
105353970|NCT05052697|363301304|FG033|Substudy A|Lost to Follow-up|0|||
105353971|NCT05052697|363301271|FG000|Substudy A|No longer met eligibility criteria|0|||
105353972|NCT05052697|363301272|FG001|Substudy A|No longer met eligibility criteria|0|||
105353973|NCT05052697|363301273|FG002|Substudy A|No longer met eligibility criteria|0|||
105353974|NCT05052697|363301274|FG003|Substudy A|No longer met eligibility criteria|0|||
105353975|NCT05052697|363301275|FG004|Substudy A|No longer met eligibility criteria|0|||
105353976|NCT05052697|363301276|FG005|Substudy A|No longer met eligibility criteria|0|||
105353977|NCT05052697|363301277|FG006|Substudy A|No longer met eligibility criteria|0|||
105353978|NCT05052697|363301278|FG007|Substudy A|No longer met eligibility criteria|0|||
105353979|NCT05052697|363301279|FG008|Substudy A|No longer met eligibility criteria|0|||
105353980|NCT05052697|363301280|FG009|Substudy A|No longer met eligibility criteria|0|||
105353981|NCT05052697|363301281|FG010|Substudy A|No longer met eligibility criteria|0|||
105353982|NCT05052697|363301282|FG011|Substudy A|No longer met eligibility criteria|0|||
105353983|NCT05052697|363301283|FG012|Substudy A|No longer met eligibility criteria|0|||
105353984|NCT05052697|363301284|FG013|Substudy A|No longer met eligibility criteria|1|||
105353985|NCT05052697|363301285|FG014|Substudy A|No longer met eligibility criteria|0|||
105353986|NCT05052697|363301286|FG015|Substudy A|No longer met eligibility criteria|0|||
105735086|NCT01330381|364686195|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
105735087|NCT01330381|364686196|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
105735088|NCT01330381|364686194|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
105735089|NCT01330381|364686195|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
105735090|NCT01330381|364686196|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
105735091|NCT01330381|364686194|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
105735092|NCT01330381|364686195|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
105735093|NCT01330381|364686196|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
105735094|NCT01330381|364686194|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
105735095|NCT01330381|364686195|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
105735096|NCT01330381|364686196|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
105735097|NCT01330381|364686194|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
105735098|NCT01330381|364686195|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
105735099|NCT01330381|364686196|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
105735100|NCT01330381|364686194|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
105735101|NCT01330381|364686195|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
105735102|NCT01330381|364686196|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
105735103|NCT01330381|364686194|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
105735104|NCT01330381|364686195|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
105735105|NCT01330381|364686196|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
105735106|NCT01330381|364686194|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
105735107|NCT01330381|364686195|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
105735108|NCT01330381|364686196|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
105735109|NCT01362322|364686201|FG000|Overall Study|Withdrawal by Subject|3|||
105735110|NCT01362322|364686202|FG001|Overall Study|Withdrawal by Subject|1|||
105735111|NCT01362322|364686201|FG000|Overall Study|Lost to Follow-up|2|||
105735112|NCT01362322|364686202|FG001|Overall Study|Lost to Follow-up|6|||
105735113|NCT03060577|364686203|FG000|Overall Study|Withdrawal by Subject|25|||
105735114|NCT03060577|364686204|FG001|Overall Study|Withdrawal by Subject|5|||
105353987|NCT05052697|363301287|FG016|Substudy A|No longer met eligibility criteria|0|||
105353988|NCT05052697|363301288|FG017|Substudy A|No longer met eligibility criteria|0|||
105353989|NCT05052697|363301289|FG018|Substudy A|No longer met eligibility criteria|0|||
105353990|NCT05052697|363301290|FG019|Substudy A|No longer met eligibility criteria|0|||
105735115|NCT03060577|364686203|FG000|Overall Study|Physician Decision|4|||
105735116|NCT03060577|364686204|FG001|Overall Study|Physician Decision|3|||
105735117|NCT03060577|364686203|FG000|Overall Study|Lost to Follow-up|3|||
105735118|NCT03060577|364686204|FG001|Overall Study|Lost to Follow-up|0|||
105735119|NCT03060577|364686203|FG000|Overall Study|Death|7|||
105735120|NCT03060577|364686204|FG001|Overall Study|Death|1|||
105735121|NCT03060577|364686203|FG000|Overall Study|Adverse Event|9|||
105735122|NCT03060577|364686204|FG001|Overall Study|Adverse Event|1|||
105735123|NCT03060577|364686203|FG000|Overall Study|Inclusion/Exclusion|1|||
105735124|NCT03060577|364686204|FG001|Overall Study|Inclusion/Exclusion|0|||
105735125|NCT03060577|364686203|FG000|Overall Study|Other|8|||
105735126|NCT03060577|364686204|FG001|Overall Study|Other|2|||
105735127|NCT02413398|364686208|FG000|Overall Study|Lost to Follow-up|2|||
105735128|NCT02413398|364686209|FG001|Overall Study|Lost to Follow-up|4|||
105735129|NCT02413398|364686208|FG000|Overall Study|Withdrawal by Subject|1|||
105735130|NCT02413398|364686209|FG001|Overall Study|Withdrawal by Subject|1|||
105735131|NCT02413398|364686208|FG000|Overall Study|Other Eligibility criteria|1|||
105735132|NCT02413398|364686209|FG001|Overall Study|Other Eligibility criteria|2|||
105735133|NCT01494038|364686210|FG000|Overall Study|Protocol Violation|1|||
105735134|NCT01494038|364686211|FG001|Overall Study|Protocol Violation|1|||
105735135|NCT01494038|364686210|FG000|Overall Study|Lost to Follow-up|18|||
105735136|NCT01494038|364686211|FG001|Overall Study|Lost to Follow-up|20|||
105735137|NCT01494038|364686210|FG000|Overall Study|Withdrawal by Subject|44|||
105735138|NCT01494038|364686211|FG001|Overall Study|Withdrawal by Subject|34|||
105735139|NCT01494038|364686210|FG000|Overall Study|Not able to get to clinic|21|||
105735140|NCT01494038|364686211|FG001|Overall Study|Not able to get to clinic|15|||
105735141|NCT01494038|364686210|FG000|Overall Study|Not willing to adhere to reqs|2|||
105735142|NCT01494038|364686211|FG001|Overall Study|Not willing to adhere to reqs|9|||
105735143|NCT01494038|364686210|FG000|Overall Study|Death|2|||
105735144|NCT01494038|364686211|FG001|Overall Study|Death|4|||
105735145|NCT02874794|364686215|FG000|Overall Study|Physician Decision|3|||
105735146|NCT02874794|364686216|FG001|Overall Study|Physician Decision|2|||
105735147|NCT02874794|364686215|FG000|Overall Study|Withdrawal by Subject|2|||
105735148|NCT02874794|364686216|FG001|Overall Study|Withdrawal by Subject|8|||
105735149|NCT02874794|364686215|FG000|Overall Study|Death|2|||
105735150|NCT02874794|364686216|FG001|Overall Study|Death|1|||
105735151|NCT00537940|364686217|FG000|Overall Study|Adverse Event|20|||
105735152|NCT00537940|364686218|FG001|Overall Study|Adverse Event|19|||
105735153|NCT00537940|364686217|FG000|Overall Study|Lack of Efficacy|8|||
105735154|NCT00537940|364686218|FG001|Overall Study|Lack of Efficacy|16|||
105735155|NCT00537940|364686217|FG000|Overall Study|Lost to Follow-up|23|||
105735156|NCT00537940|364686218|FG001|Overall Study|Lost to Follow-up|29|||
105735157|NCT00537940|364686217|FG000|Overall Study|Withdrawal by Subject|113|||
105735158|NCT00537940|364686218|FG001|Overall Study|Withdrawal by Subject|95|||
105735159|NCT00537940|364686217|FG000|Overall Study|Protocol Violation|6|||
105735160|NCT00537940|364686218|FG001|Overall Study|Protocol Violation|4|||
105735161|NCT00537940|364686217|FG000|Overall Study|Pregnancy|1|||
105735162|NCT00537940|364686218|FG001|Overall Study|Pregnancy|1|||
105735163|NCT00537940|364686217|FG000|Overall Study|Study terminated by sponsor|2|||
105735164|NCT00537940|364686218|FG001|Overall Study|Study terminated by sponsor|3|||
105735165|NCT00537940|364686217|FG000|Overall Study|Other|10|||
105735166|NCT00537940|364686218|FG001|Overall Study|Other|12|||
105735167|NCT01539837|364686219|FG000|Overall Study|reduce neutrophil level|0|||
105735168|NCT01539837|364686220|FG001|Overall Study|reduce neutrophil level|1|||
105735169|NCT01539837|364686221|FG002|Overall Study|reduce neutrophil level|1|||
105735170|NCT01539837|364686219|FG000|Overall Study|bad compliance|0|||
105735171|NCT01539837|364686220|FG001|Overall Study|bad compliance|0|||
105735172|NCT01539837|364686221|FG002|Overall Study|bad compliance|1|||
105735173|NCT01062399|364686224|FG000|Overall Study|Protocol Violation|0|||
105735174|NCT01062399|364686225|FG001|Overall Study|Protocol Violation|1|||
105735175|NCT01062399|364686226|FG002|Overall Study|Protocol Violation|0|||
105735176|NCT01062399|364686227|FG003|Overall Study|Protocol Violation|6|||
105735177|NCT01062399|364686228|FG004|Overall Study|Protocol Violation|4|||
105735178|NCT00685178|364686237|FG000|Overall Study|Adverse Event|1|||
105735179|NCT00685178|364686238|FG001|Overall Study|Adverse Event|5|||
105735180|NCT00685178|364686239|FG002|Overall Study|Adverse Event|2|||
105735181|NCT00685178|364686240|FG003|Overall Study|Adverse Event|4|||
105735182|NCT00685178|364686237|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
105735183|NCT00685178|364686238|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
105735184|NCT00685178|364686239|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
105735185|NCT00685178|364686240|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
105735186|NCT00685178|364686237|FG000|Overall Study|voluntary study discharge|4|||
105735187|NCT00685178|364686238|FG001|Overall Study|voluntary study discharge|5|||
105735188|NCT00685178|364686239|FG002|Overall Study|voluntary study discharge|1|||
105799095|NCT04288115|364922681|FG000|Overall Study|Withdrawal by Subject|0|||
105735189|NCT00685178|364686240|FG003|Overall Study|voluntary study discharge|1|||
105799096|NCT04288115|364922682|FG001|Overall Study|Withdrawal by Subject|1|||
105799097|NCT04288115|364922681|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
105353991|NCT05052697|363301291|FG020|Substudy A|No longer met eligibility criteria|0|||
105353992|NCT05052697|363301292|FG021|Substudy A|No longer met eligibility criteria|0|||
105353993|NCT05052697|363301293|FG022|Substudy A|No longer met eligibility criteria|0|||
105353994|NCT05052697|363301294|FG023|Substudy A|No longer met eligibility criteria|0|||
105353995|NCT05052697|363301295|FG024|Substudy A|No longer met eligibility criteria|0|||
105353996|NCT05052697|363301296|FG025|Substudy A|No longer met eligibility criteria|0|||
105353997|NCT05052697|363301297|FG026|Substudy A|No longer met eligibility criteria|0|||
105353998|NCT05052697|363301298|FG027|Substudy A|No longer met eligibility criteria|0|||
105353999|NCT05052697|363301299|FG028|Substudy A|No longer met eligibility criteria|0|||
105354000|NCT05052697|363301300|FG029|Substudy A|No longer met eligibility criteria|0|||
105354001|NCT05052697|363301301|FG030|Substudy A|No longer met eligibility criteria|0|||
105354002|NCT05052697|363301302|FG031|Substudy A|No longer met eligibility criteria|0|||
105354003|NCT05052697|363301303|FG032|Substudy A|No longer met eligibility criteria|0|||
105354004|NCT05052697|363301304|FG033|Substudy A|No longer met eligibility criteria|0|||
105799098|NCT04288115|364922682|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
105799099|NCT00291330|364922683|FG000|Overall Study|Adverse Event|47|||
105354005|NCT05052697|363301271|FG000|Substudy A|Not vaccinated|0|||
105354006|NCT05052697|363301272|FG001|Substudy A|Not vaccinated|0|||
105354007|NCT05052697|363301273|FG002|Substudy A|Not vaccinated|0|||
105354008|NCT05052697|363301274|FG003|Substudy A|Not vaccinated|1|||
105354009|NCT05052697|363301275|FG004|Substudy A|Not vaccinated|0|||
105799100|NCT00291330|364922684|FG001|Overall Study|Adverse Event|40|||
105799101|NCT00291330|364922683|FG000|Overall Study|Protocol Violation|13|||
105799102|NCT00291330|364922684|FG001|Overall Study|Protocol Violation|20|||
105799103|NCT00291330|364922683|FG000|Overall Study|Lost to Follow-up|16|||
105799104|NCT00291330|364922684|FG001|Overall Study|Lost to Follow-up|11|||
105799105|NCT00291330|364922683|FG000|Overall Study|Withdrawal by Subject|22|||
105799106|NCT00291330|364922684|FG001|Overall Study|Withdrawal by Subject|25|||
105799107|NCT00291330|364922683|FG000|Overall Study|Other|3|||
105799108|NCT00291330|364922684|FG001|Overall Study|Other|1|||
105799109|NCT01829295|364922685|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
105799110|NCT01829295|364922686|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
105799111|NCT01829295|364922687|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
105799112|NCT01829295|364922688|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
105799113|NCT01829295|364922685|FG000|6-12 Months|Adverse Event|0|||
105799114|NCT01829295|364922686|FG001|6-12 Months|Adverse Event|0|||
105799115|NCT01829295|364922687|FG002|6-12 Months|Adverse Event|3|||
105799116|NCT01829295|364922688|FG003|6-12 Months|Adverse Event|2|||
105799117|NCT01829295|364922685|FG000|6-12 Months|Lost to Follow-up|2|||
105799118|NCT01829295|364922686|FG001|6-12 Months|Lost to Follow-up|0|||
105799119|NCT01829295|364922687|FG002|6-12 Months|Lost to Follow-up|0|||
105799120|NCT01829295|364922688|FG003|6-12 Months|Lost to Follow-up|0|||
105354010|NCT05052697|363301276|FG005|Substudy A|Not vaccinated|0|||
105354011|NCT05052697|363301277|FG006|Substudy A|Not vaccinated|0|||
105354012|NCT05052697|363301278|FG007|Substudy A|Not vaccinated|0|||
105354013|NCT05052697|363301279|FG008|Substudy A|Not vaccinated|1|||
105354014|NCT05052697|363301280|FG009|Substudy A|Not vaccinated|0|||
105354015|NCT05052697|363301281|FG010|Substudy A|Not vaccinated|0|||
105354016|NCT05052697|363301282|FG011|Substudy A|Not vaccinated|0|||
105354017|NCT05052697|363301283|FG012|Substudy A|Not vaccinated|0|||
105354018|NCT05052697|363301284|FG013|Substudy A|Not vaccinated|0|||
105354019|NCT05052697|363301285|FG014|Substudy A|Not vaccinated|0|||
105354020|NCT05052697|363301286|FG015|Substudy A|Not vaccinated|0|||
105354021|NCT05052697|363301287|FG016|Substudy A|Not vaccinated|0|||
105354022|NCT05052697|363301288|FG017|Substudy A|Not vaccinated|0|||
105354023|NCT05052697|363301289|FG018|Substudy A|Not vaccinated|0|||
105354024|NCT05052697|363301290|FG019|Substudy A|Not vaccinated|0|||
105354025|NCT05052697|363301291|FG020|Substudy A|Not vaccinated|0|||
105354026|NCT05052697|363301292|FG021|Substudy A|Not vaccinated|0|||
105354027|NCT05052697|363301293|FG022|Substudy A|Not vaccinated|0|||
105354028|NCT05052697|363301294|FG023|Substudy A|Not vaccinated|0|||
105354029|NCT05052697|363301295|FG024|Substudy A|Not vaccinated|0|||
105354030|NCT05052697|363301296|FG025|Substudy A|Not vaccinated|0|||
105480729|NCT01328444|363771305|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
105799121|NCT01829295|364922685|FG000|6-12 Months|Withdrawal by Subject|2|||
105799122|NCT01829295|364922686|FG001|6-12 Months|Withdrawal by Subject|2|||
105354031|NCT05052697|363301297|FG026|Substudy A|Not vaccinated|0|||
105354032|NCT05052697|363301298|FG027|Substudy A|Not vaccinated|0|||
105480730|NCT01328444|363771306|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
105799123|NCT01829295|364922687|FG002|6-12 Months|Withdrawal by Subject|0|||
105799124|NCT01829295|364922688|FG003|6-12 Months|Withdrawal by Subject|0|||
105354033|NCT05052697|363301299|FG028|Substudy A|Not vaccinated|0|||
105354034|NCT05052697|363301300|FG029|Substudy A|Not vaccinated|0|||
105354035|NCT05052697|363301301|FG030|Substudy A|Not vaccinated|0|||
105354036|NCT05052697|363301302|FG031|Substudy A|Not vaccinated|0|||
105354037|NCT05052697|363301303|FG032|Substudy A|Not vaccinated|0|||
105480731|NCT01328444|363771307|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
105480732|NCT01328444|363771308|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
105480733|NCT01328444|363771309|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
105735190|NCT00685178|364686237|FG000|Overall Study|incarcerated|1|||
105735191|NCT00685178|364686238|FG001|Overall Study|incarcerated|3|||
105735192|NCT00685178|364686239|FG002|Overall Study|incarcerated|7|||
105735193|NCT00685178|364686240|FG003|Overall Study|incarcerated|0|||
105735194|NCT00685178|364686237|FG000|Overall Study|administrative (disciplinary) discharge|0|||
105735195|NCT00685178|364686238|FG001|Overall Study|administrative (disciplinary) discharge|1|||
105735196|NCT00685178|364686239|FG002|Overall Study|administrative (disciplinary) discharge|0|||
105735197|NCT00685178|364686240|FG003|Overall Study|administrative (disciplinary) discharge|2|||
105735198|NCT00685178|364686237|FG000|Overall Study|Pregnancy|0|||
105735199|NCT00685178|364686238|FG001|Overall Study|Pregnancy|0|||
105735200|NCT00685178|364686239|FG002|Overall Study|Pregnancy|0|||
105735201|NCT00685178|364686240|FG003|Overall Study|Pregnancy|1|||
105735202|NCT04275310|364686242|FG000|Overall Study|Non-randomized due to running out of funding|4|||
105735203|NCT04275310|364686243|FG001|Overall Study|Non-randomized due to running out of funding|0|||
105735204|NCT03088605|364686244|FG000|Overall Study|Withdrawal by Subject|1|||
105735205|NCT03088605|364686245|FG001|Overall Study|Withdrawal by Subject|0|||
105735206|NCT01183858|364686252|FG000|Overall Study|Death not related to Progressive Disease|5|||
105735207|NCT01183858|364686253|FG001|Overall Study|Death not related to Progressive Disease|6|||
105735208|NCT01183858|364686252|FG000|Overall Study|Adverse Event|14|||
105735209|NCT01183858|364686253|FG001|Overall Study|Adverse Event|11|||
105735210|NCT01183858|364686252|FG000|Overall Study|Investigator's Decision|0|||
105735211|NCT01183858|364686253|FG001|Overall Study|Investigator's Decision|3|||
105735212|NCT01183858|364686252|FG000|Overall Study|Insufficient Therapeutic Response|2|||
105735213|NCT01183858|364686253|FG001|Overall Study|Insufficient Therapeutic Response|0|||
105735214|NCT01183858|364686252|FG000|Overall Study|Refused Treatment|1|||
105735215|NCT01183858|364686253|FG001|Overall Study|Refused Treatment|4|||
105735216|NCT01183858|364686252|FG000|Overall Study|Withdrew Consent|4|||
105735217|NCT01183858|364686253|FG001|Overall Study|Withdrew Consent|4|||
105735218|NCT01183858|364686252|FG000|Overall Study|Discontinued Smoking|3|||
105735219|NCT01183858|364686253|FG001|Overall Study|Discontinued Smoking|1|||
105735220|NCT01183858|364686252|FG000|Overall Study|Protocol Violation|1|||
105735221|NCT01183858|364686253|FG001|Overall Study|Protocol Violation|0|||
105735222|NCT01183858|364686252|FG000|Overall Study|Administrative/Other|6|||
105735223|NCT01183858|364686253|FG001|Overall Study|Administrative/Other|6|||
105735224|NCT01183858|364686252|FG000|Overall Study|Progressive Disease|112|||
105735225|NCT01183858|364686253|FG001|Overall Study|Progressive Disease|115|||
105735226|NCT01183858|364686252|FG000|Overall Study|Death related to Progressive Disease|4|||
105735227|NCT01183858|364686253|FG001|Overall Study|Death related to Progressive Disease|5|||
105735228|NCT01183858|364686252|FG000|Overall Study|Lost to Follow-up|1|||
105735229|NCT01183858|364686253|FG001|Overall Study|Lost to Follow-up|1|||
105735230|NCT02046564|364686254|FG000|Overall Study|Adverse Event|6|||
105735231|NCT02046564|364686255|FG001|Overall Study|Adverse Event|3|||
105735232|NCT02046564|364686254|FG000|Overall Study|Physician Decision|0|||
105735233|NCT02046564|364686255|FG001|Overall Study|Physician Decision|1|||
105735234|NCT02046564|364686254|FG000|Overall Study|Protocol Violation|3|||
105735235|NCT02046564|364686255|FG001|Overall Study|Protocol Violation|1|||
105735236|NCT02046564|364686254|FG000|Overall Study|Withdrawal by Subject|4|||
105735237|NCT02046564|364686255|FG001|Overall Study|Withdrawal by Subject|10|||
105735238|NCT02046564|364686254|FG000|Overall Study|Subject met withdrawal criteria|2|||
105735239|NCT02046564|364686255|FG001|Overall Study|Subject met withdrawal criteria|5|||
105735240|NCT02747043|364686256|FG000|Overall Study|Other|1|||
105735241|NCT02747043|364686257|FG001|Overall Study|Other|1|||
105735242|NCT02747043|364686256|FG000|Overall Study|Adverse Event|3|||
105735243|NCT02747043|364686257|FG001|Overall Study|Adverse Event|1|||
105735244|NCT02747043|364686256|FG000|Overall Study|Withdrawal by Subject|1|||
105735245|NCT02747043|364686257|FG001|Overall Study|Withdrawal by Subject|1|||
105735246|NCT02747043|364686256|FG000|Overall Study|Physician Decision|1|||
105735247|NCT02747043|364686257|FG001|Overall Study|Physician Decision|1|||
105735248|NCT02747043|364686256|FG000|Overall Study|Protocol Violation|0|||
105735249|NCT02747043|364686257|FG001|Overall Study|Protocol Violation|1|||
105735250|NCT02747043|364686256|FG000|Overall Study|Disease progression|4|||
105735251|NCT02747043|364686257|FG001|Overall Study|Disease progression|0|||
105735252|NCT01295905|364686260|FG000|Overall Study|Did not meet inclusion criteria|1|||
105354038|NCT05052697|363301304|FG033|Substudy A|Not vaccinated|0|||
105354039|NCT05052697|363301271|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354040|NCT05052697|363301272|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354041|NCT05052697|363301273|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354042|NCT05052697|363301274|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354043|NCT05052697|363301275|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354044|NCT05052697|363301276|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354045|NCT05052697|363301277|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354046|NCT05052697|363301278|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354047|NCT05052697|363301279|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354048|NCT05052697|363301280|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354049|NCT05052697|363301281|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354050|NCT05052697|363301282|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354051|NCT05052697|363301283|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105735253|NCT01295905|364686261|FG001|Overall Study|Did not meet inclusion criteria|0|||
105735254|NCT01295905|364686260|FG000|Overall Study|Met exclusion criteria|1|||
105735255|NCT01295905|364686261|FG001|Overall Study|Met exclusion criteria|0|||
105354052|NCT05052697|363301284|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354053|NCT05052697|363301285|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354054|NCT05052697|363301286|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354055|NCT05052697|363301287|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354056|NCT05052697|363301288|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105735256|NCT00641147|364686267|FG000|Completed 4 Months.|Physician Decision|1|||
105735257|NCT00641147|364686268|FG001|Completed 4 Months.|Physician Decision|0|||
105735258|NCT00641147|364686267|FG000|Completed 4 Months.|Adverse Event|1|||
105354057|NCT05052697|363301289|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
105354058|NCT05052697|363301290|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
105354059|NCT05052697|363301291|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354060|NCT05052697|363301292|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
105354061|NCT05052697|363301293|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
105354062|NCT05052697|363301294|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354063|NCT05052697|363301295|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354064|NCT05052697|363301296|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354065|NCT05052697|363301297|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354066|NCT05052697|363301298|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354067|NCT05052697|363301299|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354068|NCT05052697|363301300|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354069|NCT05052697|363301301|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354070|NCT05052697|363301302|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354071|NCT05052697|363301303|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105354072|NCT05052697|363301304|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105565081|NCT01782742|364066675|FG000|Double-blind Treatment Phase|Adverse Event|1|||
105565082|NCT01782742|364066676|FG001|Double-blind Treatment Phase|Adverse Event|0|||
105565083|NCT01529008|364066677|FG000|Bone Marrow Harvesting|Physician Decision|1|||
105735259|NCT00641147|364686268|FG001|Completed 4 Months.|Adverse Event|0|||
105735260|NCT00641147|364686267|FG000|Completed 8 Months.|Physician Decision|2|||
105735261|NCT00641147|364686268|FG001|Completed 8 Months.|Physician Decision|1|||
105735262|NCT00641147|364686267|FG000|Completed 8 Months.|non compliance|1|||
105735263|NCT00641147|364686268|FG001|Completed 8 Months.|non compliance|0|||
105735264|NCT00641147|364686267|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
105735265|NCT00641147|364686268|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
105735266|NCT00641147|364686267|FG000|Completed 12 Months.|Physician Decision|1|||
105735267|NCT00641147|364686268|FG001|Completed 12 Months.|Physician Decision|1|||
105735268|NCT00641147|364686267|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
105735269|NCT00641147|364686268|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
105735270|NCT00641147|364686267|FG000|Completed 16 Months.|Physician Decision|1|||
105735271|NCT00641147|364686268|FG001|Completed 16 Months.|Physician Decision|0|||
105735272|NCT00641147|364686267|FG000|Completed 16 Months.|Lost to Follow-up|1|||
105735273|NCT00641147|364686268|FG001|Completed 16 Months.|Lost to Follow-up|0|||
105735274|NCT02296125|364686271|FG000|Overall Study|Withdrawal by Subject|18|||
105735275|NCT02296125|364686272|FG001|Overall Study|Withdrawal by Subject|8|||
105735276|NCT02296125|364686273|FG002|Overall Study|Withdrawal by Subject|6|||
105735277|NCT02296125|364686274|FG003|Overall Study|Withdrawal by Subject|2|||
105735278|NCT02296125|364686271|FG000|Overall Study|Adverse Event|41|||
105735279|NCT02296125|364686272|FG001|Overall Study|Adverse Event|52|||
105735280|NCT02296125|364686273|FG002|Overall Study|Adverse Event|9|||
105735281|NCT02296125|364686274|FG003|Overall Study|Adverse Event|4|||
105735282|NCT02296125|364686271|FG000|Overall Study|Severe non-compliance to protocol|0|||
105735283|NCT02296125|364686272|FG001|Overall Study|Severe non-compliance to protocol|1|||
105735284|NCT02296125|364686273|FG002|Overall Study|Severe non-compliance to protocol|0|||
105799125|NCT03182686|364922689|FG000|Overall Study|Lost to Follow-up|2|||
105799126|NCT03182686|364922690|FG001|Overall Study|Lost to Follow-up|0|||
105799127|NCT03182686|364922689|FG000|Overall Study|Adverse Event|2|||
105799128|NCT03182686|364922690|FG001|Overall Study|Adverse Event|0|||
105799129|NCT03182686|364922689|FG000|Overall Study|Withdrawal by Subject|3|||
105799130|NCT03182686|364922690|FG001|Overall Study|Withdrawal by Subject|0|||
105799131|NCT00869089|364922691|FG000|Overall Study|Lost to Follow-up|1|||
105799132|NCT00869089|364922691|FG000|Overall Study|Withdrawal by Subject|1|||
105799133|NCT00869089|364922691|FG000|Overall Study|Screen Fail|1|||
105799134|NCT01154127|364922692|FG000|Period 1 (21 Days)|Adverse Event|3|||
105799135|NCT01154127|364922693|FG001|Period 1 (21 Days)|Adverse Event|4|||
105799136|NCT01154127|364922692|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
105799137|NCT01154127|364922693|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
105799138|NCT01154127|364922692|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
105799139|NCT01154127|364922693|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
105799140|NCT01154127|364922692|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
105799141|NCT01154127|364922693|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
105799142|NCT01154127|364922692|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
105799143|NCT01154127|364922693|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
105799144|NCT01697449|364922694|FG000|Overall Study|Disease progression|47|||
105799145|NCT01697449|364922694|FG000|Overall Study|Adverse Event|7|||
105799146|NCT01697449|364922694|FG000|Overall Study|Lost to Follow-up|5|||
105799147|NCT01697449|364922694|FG000|Overall Study|Withdrawal by Subject|2|||
105735285|NCT02296125|364686274|FG003|Overall Study|Severe non-compliance to protocol|0|||
105735286|NCT02296125|364686271|FG000|Overall Study|Condition under investigation worsened|153|||
105735287|NCT02296125|364686272|FG001|Overall Study|Condition under investigation worsened|199|||
105735288|NCT02296125|364686273|FG002|Overall Study|Condition under investigation worsened|39|||
105735289|NCT02296125|364686274|FG003|Overall Study|Condition under investigation worsened|56|||
105735290|NCT02296125|364686271|FG000|Overall Study|Any reason not specifically recorded|6|||
105735291|NCT02296125|364686272|FG001|Overall Study|Any reason not specifically recorded|4|||
105735292|NCT02296125|364686273|FG002|Overall Study|Any reason not specifically recorded|2|||
105735293|NCT02296125|364686274|FG003|Overall Study|Any reason not specifically recorded|0|||
105354073|NCT05052697|363301271|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354074|NCT05052697|363301272|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354075|NCT05052697|363301273|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354076|NCT05052697|363301274|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354077|NCT05052697|363301275|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354078|NCT05052697|363301276|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354079|NCT05052697|363301277|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
105480734|NCT01328444|363771310|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
105735294|NCT01844076|364686275|FG000|Overall Study|Adverse Event|1|||
105480735|NCT01328444|363771305|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
105480736|NCT01328444|363771306|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
105735295|NCT01844076|364686276|FG001|Overall Study|Adverse Event|0|||
105735296|NCT01844076|364686277|FG002|Overall Study|Adverse Event|0|||
105735297|NCT01844076|364686278|FG003|Overall Study|Adverse Event|0|||
105799148|NCT01697449|364922694|FG000|Overall Study|Physician Decision|1|||
105799149|NCT01697449|364922694|FG000|Overall Study|Death|2|||
105799150|NCT01697449|364922694|FG000|Overall Study|Other|1|||
105799151|NCT01697449|364922694|FG000|Overall Study|Missing|25|||
105735298|NCT01844076|364686275|FG000|Overall Study|Withdrawal by Subject|1|||
105735299|NCT01844076|364686276|FG001|Overall Study|Withdrawal by Subject|0|||
105735300|NCT01844076|364686277|FG002|Overall Study|Withdrawal by Subject|0|||
105735301|NCT01844076|364686278|FG003|Overall Study|Withdrawal by Subject|0|||
105735302|NCT00635102|364686281|FG000|Overall Study|Withdrawal by Subject|7|||
105735303|NCT00635102|364686282|FG001|Overall Study|Withdrawal by Subject|8|||
105735304|NCT00091793|364686283|FG000|Overall Study|Adverse Event|1|||
105735305|NCT00091793|364686284|FG001|Overall Study|Adverse Event|2|||
105735306|NCT00091793|364686283|FG000|Overall Study|Withdrawal by Subject|10|||
105735307|NCT00091793|364686284|FG001|Overall Study|Withdrawal by Subject|15|||
105735308|NCT00091793|364686283|FG000|Overall Study|Ineligibility determined|2|||
105735309|NCT00091793|364686284|FG001|Overall Study|Ineligibility determined|0|||
105735310|NCT00091793|364686283|FG000|Overall Study|Lost to Follow-up|7|||
105735311|NCT00091793|364686284|FG001|Overall Study|Lost to Follow-up|5|||
105735312|NCT00091793|364686283|FG000|Overall Study|Noncompliance|2|||
105735313|NCT00091793|364686284|FG001|Overall Study|Noncompliance|0|||
105735314|NCT00091793|364686283|FG000|Overall Study|Other|2|||
105735315|NCT00091793|364686284|FG001|Overall Study|Other|0|||
105735316|NCT00545818|364686287|FG000|Overall Study|Protocol Violation|1|||
105735317|NCT00545818|364686288|FG001|Overall Study|Protocol Violation|0|||
105735318|NCT00545818|364686287|FG000|Overall Study|Adverse Event|1|||
105735319|NCT00545818|364686288|FG001|Overall Study|Adverse Event|1|||
105735320|NCT00545818|364686287|FG000|Overall Study|Lost to Follow-up|1|||
105735321|NCT00545818|364686288|FG001|Overall Study|Lost to Follow-up|6|||
105735322|NCT01396525|364686292|FG000|Overall Study|Withdrawal by Subject|8|||
105735323|NCT01396525|364686292|FG000|Overall Study|Death|14|||
105735324|NCT01396525|364686292|FG000|Overall Study|Lost to Follow-up|4|||
105735325|NCT00104104|364686298|FG000|Overall Study|Adverse Event|8|||
105735326|NCT00104104|364686299|FG001|Overall Study|Adverse Event|8|||
105735327|NCT00104104|364686298|FG000|Overall Study|Abnormal laboratory value(s)|20|||
105735328|NCT00104104|364686299|FG001|Overall Study|Abnormal laboratory value(s)|14|||
105735329|NCT00104104|364686298|FG000|Overall Study|Lack of Efficacy|0|||
105735330|NCT00104104|364686299|FG001|Overall Study|Lack of Efficacy|3|||
105735331|NCT00104104|364686298|FG000|Overall Study|Condition no longer requires study drug|7|||
105735332|NCT00104104|364686299|FG001|Overall Study|Condition no longer requires study drug|4|||
105735333|NCT00104104|364686298|FG000|Overall Study|Protocol Violation|5|||
105735334|NCT00104104|364686299|FG001|Overall Study|Protocol Violation|2|||
105735335|NCT00104104|364686298|FG000|Overall Study|Withdrawal by Subject|11|||
105735336|NCT00104104|364686299|FG001|Overall Study|Withdrawal by Subject|15|||
105735337|NCT00104104|364686298|FG000|Overall Study|Lost to Follow-up|3|||
105735338|NCT00104104|364686299|FG001|Overall Study|Lost to Follow-up|7|||
105735339|NCT00104104|364686298|FG000|Overall Study|Administrative problems|12|||
105735340|NCT00104104|364686299|FG001|Overall Study|Administrative problems|13|||
105735341|NCT00104104|364686298|FG000|Overall Study|Death|9|||
105735342|NCT00104104|364686299|FG001|Overall Study|Death|6|||
105480737|NCT01328444|363771307|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
105480738|NCT01328444|363771308|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
105735343|NCT01787591|364686300|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
105735344|NCT01787591|364686301|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
105735345|NCT01787591|364686302|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
105735346|NCT01787591|364686303|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
105735347|NCT01707147|364686307|FG000|Overall Study|Administered Trajenta prior to contract|5|||
105735348|NCT01707147|364686307|FG000|Overall Study|Patients who have not taken Trajenta|1|||
105354080|NCT05052697|363301278|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354081|NCT05052697|363301279|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354082|NCT05052697|363301280|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354083|NCT05052697|363301281|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354084|NCT05052697|363301282|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354085|NCT05052697|363301283|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354086|NCT05052697|363301284|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354087|NCT05052697|363301285|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354088|NCT05052697|363301286|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354089|NCT05052697|363301287|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354090|NCT05052697|363301288|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
105354091|NCT05052697|363301289|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354092|NCT05052697|363301290|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
105480739|NCT01328444|363771309|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
105480740|NCT01328444|363771310|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
105480741|NCT01328444|363771305|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
105480742|NCT01328444|363771306|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
105480743|NCT01328444|363771307|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
105735349|NCT01707147|364686307|FG000|Overall Study|Follow-up failure|17|||
105735350|NCT01707147|364686307|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
105735351|NCT02489630|364686310|FG000|Overall Study|Oversedation|1|||
105735352|NCT02489630|364686311|FG001|Overall Study|Oversedation|1|||
105735353|NCT02489630|364686310|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
105735354|NCT02489630|364686311|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
105735355|NCT01326962|364686312|FG000|Overall Study|Adverse Event|1|||
105735356|NCT01326962|364686312|FG000|Overall Study|Withdrawal by Subject|1|||
105735357|NCT01326962|364686312|FG000|Overall Study|Lost to Follow-up|3|||
105735358|NCT01326962|364686312|FG000|Overall Study|Other|2|||
105735359|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Adverse Event|37|||
105735360|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Adverse Event|0|||
105735361|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Adverse Event|0|||
105735362|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Adverse Event|0|||
105735363|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Death|2|||
105735364|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Death|0|||
105735365|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Death|0|||
105735366|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Death|0|||
105735367|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
105735368|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
105735369|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
105735370|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
105735371|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
105735372|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
105735373|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
105735374|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
105735375|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
105735376|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
105735377|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
105735378|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
105735379|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
105735380|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
105735381|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
105735382|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
105735383|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Physician Decision|4|||
105735384|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Physician Decision|0|||
105735385|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Physician Decision|0|||
105735386|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Physician Decision|0|||
105735387|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Pregnancy|1|||
105735388|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Pregnancy|0|||
105735389|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Pregnancy|0|||
105735390|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Pregnancy|0|||
105735391|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
105735392|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
105735393|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
105735394|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
105735395|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
105735396|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
105735397|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
105735398|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
105735399|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Other|4|||
105735400|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Other|0|||
105735401|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Other|0|||
105735402|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Other|0|||
105735403|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
105735404|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
105735405|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
105735406|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
105735407|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
105735408|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
105735409|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
105735410|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
105735411|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
105735412|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
105735413|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
105735414|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
105735415|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
105735416|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
105735417|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
105735418|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
105735419|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
105735420|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
105735421|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
105735422|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
105735423|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
105735424|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
105735425|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
105735426|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
105735427|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
105735428|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
105735429|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
105735430|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
105735431|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
105735432|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
105735433|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
105735434|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
105735435|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
105354093|NCT05052697|363301291|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354094|NCT05052697|363301292|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354095|NCT05052697|363301293|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354096|NCT05052697|363301294|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354097|NCT05052697|363301295|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354098|NCT05052697|363301296|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354099|NCT05052697|363301297|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354100|NCT05052697|363301298|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354101|NCT05052697|363301299|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354102|NCT05052697|363301300|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354103|NCT05052697|363301301|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354104|NCT05052697|363301302|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354105|NCT05052697|363301303|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354106|NCT05052697|363301304|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
105354107|NCT05052697|363301271|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354108|NCT05052697|363301272|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354109|NCT05052697|363301273|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354110|NCT05052697|363301274|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354111|NCT05052697|363301275|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354112|NCT05052697|363301276|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354113|NCT05052697|363301277|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354114|NCT05052697|363301278|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354115|NCT05052697|363301279|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354116|NCT05052697|363301280|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354117|NCT05052697|363301281|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354118|NCT05052697|363301282|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354119|NCT05052697|363301283|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354120|NCT05052697|363301284|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354121|NCT05052697|363301285|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105480744|NCT01328444|363771308|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
105480745|NCT01328444|363771309|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
105735436|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
105354122|NCT05052697|363301286|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354123|NCT05052697|363301287|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105480746|NCT01328444|363771310|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
105354124|NCT05052697|363301288|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354125|NCT05052697|363301289|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354126|NCT05052697|363301290|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
105354127|NCT05052697|363301291|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354128|NCT05052697|363301292|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354129|NCT05052697|363301293|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354130|NCT05052697|363301294|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354131|NCT05052697|363301295|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354132|NCT05052697|363301296|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354133|NCT05052697|363301297|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354134|NCT05052697|363301298|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354135|NCT05052697|363301299|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354136|NCT05052697|363301300|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105480747|NCT01328444|363771305|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
105480748|NCT01328444|363771306|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
105480749|NCT01328444|363771307|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
105480750|NCT01328444|363771308|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
105480751|NCT01328444|363771309|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
105480752|NCT01328444|363771310|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
105735437|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
105480753|NCT01328444|363771305|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
105735438|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
105735439|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Other|0|||
105735440|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Other|0|||
105735441|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Other|0|||
105735442|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Other|1|||
105735443|NCT02369510|364686319|FG000|Overall Study|Spilled Medication|1|||
105735444|NCT02369510|364686320|FG001|Overall Study|Spilled Medication|2|||
105354137|NCT05052697|363301301|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354138|NCT05052697|363301302|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105735445|NCT02369510|364686321|FG002|Overall Study|Spilled Medication|1|||
105735446|NCT02369510|364686319|FG000|Overall Study|Epidural Activation|1|||
105735447|NCT02369510|364686320|FG001|Overall Study|Epidural Activation|1|||
105735448|NCT02369510|364686321|FG002|Overall Study|Epidural Activation|5|||
105735449|NCT03459846|364686324|FG000|Overall Study|Death|52|||
105735450|NCT03459846|364686325|FG001|Overall Study|Death|46|||
105735451|NCT03459846|364686324|FG000|Overall Study|Study terminated by sponsor|24|||
105735452|NCT03459846|364686325|FG001|Overall Study|Study terminated by sponsor|28|||
105735453|NCT03459846|364686324|FG000|Overall Study|Withdrawal by Subject|2|||
105735454|NCT03459846|364686325|FG001|Overall Study|Withdrawal by Subject|2|||
105735455|NCT01589094|364686328|FG000|Overall Study|Did not receive treatment|2|||
105735456|NCT01894516|364687672|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
105735457|NCT01894516|364687673|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
105735458|NCT01894516|364687674|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
105735459|NCT01894516|364687675|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
105735460|NCT01894516|364687672|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
105735461|NCT01894516|364687673|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105735462|NCT01894516|364687674|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105735463|NCT01894516|364687675|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105735464|NCT01894516|364687672|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
105735465|NCT01894516|364687673|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
105735466|NCT01894516|364687674|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
105735467|NCT01894516|364687675|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
105735468|NCT01894516|364687672|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
105735469|NCT01894516|364687673|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
105735470|NCT01894516|364687674|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
105735471|NCT01894516|364687675|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
105735472|NCT01894516|364687672|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
105735473|NCT01894516|364687673|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
105735474|NCT01894516|364687674|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
105735475|NCT01894516|364687675|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
105735476|NCT01894516|364687672|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
105735477|NCT01894516|364687673|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
105735478|NCT01894516|364687674|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
105735479|NCT01894516|364687675|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
105735480|NCT01894516|364687672|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
105735481|NCT01894516|364687673|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
105735482|NCT01894516|364687674|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
105735483|NCT01894516|364687675|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
105735484|NCT01894516|364687672|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
105735485|NCT01894516|364687673|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
105735486|NCT01894516|364687674|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
105735487|NCT01894516|364687675|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
105735488|NCT01582282|364687676|FG000|Overall Study|Adverse Event|1|||
105735489|NCT01582282|364687677|FG001|Overall Study|Adverse Event|1|||
105735490|NCT01582282|364687678|FG002|Overall Study|Adverse Event|0|||
105735491|NCT01582282|364687676|FG000|Overall Study|Lost to Follow-up|1|||
105735492|NCT01582282|364687677|FG001|Overall Study|Lost to Follow-up|0|||
105735493|NCT01582282|364687678|FG002|Overall Study|Lost to Follow-up|0|||
105735494|NCT01582282|364687676|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
105735495|NCT01582282|364687677|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
105735496|NCT01582282|364687678|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
105735497|NCT01486316|364687679|FG000|Overall Study|Device explanted with/without re-implant|3|||
105735498|NCT01486316|364687680|FG001|Overall Study|Device explanted with/without re-implant|2|||
105480754|NCT01328444|363771306|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
105735499|NCT01486316|364687681|FG002|Overall Study|Device explanted with/without re-implant|0|||
105735500|NCT01486316|364687682|FG003|Overall Study|Device explanted with/without re-implant|2|||
105735501|NCT01486316|364687679|FG000|Overall Study|Not meeting eligibility criteria|0|||
105735502|NCT01486316|364687680|FG001|Overall Study|Not meeting eligibility criteria|0|||
105735503|NCT01486316|364687681|FG002|Overall Study|Not meeting eligibility criteria|1|||
105735504|NCT01486316|364687682|FG003|Overall Study|Not meeting eligibility criteria|0|||
105735505|NCT01486316|364687679|FG000|Overall Study|Withdrawal by Subject|1|||
105735506|NCT01486316|364687680|FG001|Overall Study|Withdrawal by Subject|0|||
105735507|NCT01486316|364687681|FG002|Overall Study|Withdrawal by Subject|3|||
105735508|NCT01486316|364687682|FG003|Overall Study|Withdrawal by Subject|0|||
105735509|NCT01486316|364687679|FG000|Overall Study|Physician Decision|0|||
105735510|NCT01486316|364687680|FG001|Overall Study|Physician Decision|0|||
105735511|NCT01486316|364687681|FG002|Overall Study|Physician Decision|1|||
105735512|NCT01486316|364687682|FG003|Overall Study|Physician Decision|0|||
105735513|NCT01486316|364687679|FG000|Overall Study|Death|0|||
105735514|NCT01486316|364687680|FG001|Overall Study|Death|1|||
105735515|NCT01486316|364687681|FG002|Overall Study|Death|0|||
105735516|NCT01486316|364687682|FG003|Overall Study|Death|0|||
105735517|NCT03191396|364687685|FG000|Overall Study|Lost to Follow-up|0|||
105735518|NCT03191396|364687686|FG001|Overall Study|Lost to Follow-up|3|||
105735519|NCT03191396|364687685|FG000|Overall Study|Withdrawal by Subject|3|||
105735520|NCT03191396|364687686|FG001|Overall Study|Withdrawal by Subject|2|||
105735521|NCT02742649|364687687|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
105735522|NCT02742649|364687688|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
105735523|NCT02742649|364687689|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
105735524|NCT02742649|364687690|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
105735525|NCT02742649|364687691|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
105735526|NCT02742649|364687687|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105735527|NCT02742649|364687688|FG001|Double-Blind Treatment Period|Adverse Event|1|||
105735528|NCT02742649|364687689|FG002|Double-Blind Treatment Period|Adverse Event|0|||
105735529|NCT02742649|364687690|FG003|Double-Blind Treatment Period|Adverse Event|0|||
105735530|NCT02742649|364687691|FG004|Double-Blind Treatment Period|Adverse Event|0|||
105735531|NCT02742649|364687687|FG000|Open-Label Period|Lost to Follow-up|0|||
105735532|NCT02742649|364687688|FG001|Open-Label Period|Lost to Follow-up|0|||
105735533|NCT02742649|364687689|FG002|Open-Label Period|Lost to Follow-up|0|||
105735534|NCT02742649|364687690|FG003|Open-Label Period|Lost to Follow-up|0|||
105735535|NCT02742649|364687691|FG004|Open-Label Period|Lost to Follow-up|1|||
105735536|NCT01650779|364687701|FG000|Overall Study|Withdrawal by Subject|1|||
105735537|NCT00283712|364687708|FG000|Overall Study|Death|0|||
105735538|NCT00283712|364687709|FG001|Overall Study|Death|1|||
105735539|NCT00984659|364687710|FG000|2-week Run-in Period|Adverse Event|8|||
105735540|NCT00984659|364687711|FG001|2-week Run-in Period|Adverse Event|0|||
105735541|NCT00984659|364687712|FG002|2-week Run-in Period|Adverse Event|0|||
105735542|NCT00984659|364687713|FG003|2-week Run-in Period|Adverse Event|0|||
105735543|NCT00984659|364687710|FG000|2-week Run-in Period|Protocol Violation|5|||
105735544|NCT00984659|364687711|FG001|2-week Run-in Period|Protocol Violation|0|||
105735545|NCT00984659|364687712|FG002|2-week Run-in Period|Protocol Violation|0|||
105735546|NCT00984659|364687713|FG003|2-week Run-in Period|Protocol Violation|0|||
105735547|NCT00984659|364687710|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
105735548|NCT00984659|364687711|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
105480755|NCT01328444|363771307|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
105735549|NCT00984659|364687712|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
105735550|NCT00984659|364687713|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
105735551|NCT00984659|364687710|FG000|2-week Run-in Period|Lost to Follow-up|3|||
105735552|NCT00984659|364687711|FG001|2-week Run-in Period|Lost to Follow-up|0|||
105735553|NCT00984659|364687712|FG002|2-week Run-in Period|Lost to Follow-up|0|||
105735554|NCT00984659|364687713|FG003|2-week Run-in Period|Lost to Follow-up|0|||
105735555|NCT00984659|364687710|FG000|2-week Run-in Period|Physician Decision|10|||
105735556|NCT00984659|364687711|FG001|2-week Run-in Period|Physician Decision|0|||
105735557|NCT00984659|364687712|FG002|2-week Run-in Period|Physician Decision|0|||
105354139|NCT05052697|363301303|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354140|NCT05052697|363301304|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105354141|NCT05052697|363301271|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354142|NCT05052697|363301272|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354143|NCT05052697|363301273|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354144|NCT05052697|363301274|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354145|NCT05052697|363301275|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354146|NCT05052697|363301276|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354147|NCT05052697|363301277|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354148|NCT05052697|363301278|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354149|NCT05052697|363301279|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354150|NCT05052697|363301280|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354151|NCT05052697|363301281|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354152|NCT05052697|363301282|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354153|NCT05052697|363301283|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354154|NCT05052697|363301284|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354155|NCT05052697|363301285|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354156|NCT05052697|363301286|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354157|NCT05052697|363301287|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354158|NCT05052697|363301288|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
105354159|NCT05052697|363301289|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354160|NCT05052697|363301290|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105480756|NCT01328444|363771308|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
105480757|NCT01328444|363771309|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
105735558|NCT00984659|364687713|FG003|2-week Run-in Period|Physician Decision|0|||
105735559|NCT00984659|364687710|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
105735560|NCT00984659|364687711|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
105735561|NCT00984659|364687712|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
105735562|NCT00984659|364687713|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
105735563|NCT00984659|364687710|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
105735564|NCT00984659|364687711|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
105735565|NCT00984659|364687712|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
105735566|NCT00984659|364687713|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
105735567|NCT00984659|364687710|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
105735568|NCT00984659|364687711|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
105735569|NCT00984659|364687712|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
105735570|NCT00984659|364687713|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
105735571|NCT00984659|364687710|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
105735572|NCT00984659|364687711|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
105735573|NCT00984659|364687712|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
105735574|NCT00984659|364687713|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
105735575|NCT00984659|364687710|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
105735576|NCT00984659|364687711|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
105735577|NCT00984659|364687712|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
105735578|NCT00984659|364687713|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
105735579|NCT00984659|364687710|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
105735580|NCT00984659|364687711|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
105735581|NCT00984659|364687712|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
105735582|NCT00984659|364687713|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
105735583|NCT00984659|364687710|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
105735584|NCT00984659|364687711|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
105735585|NCT00984659|364687712|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
105735586|NCT00984659|364687713|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
105735587|NCT01342640|364687715|FG000|Overall Study|Adverse Event|3|||
105735588|NCT01342640|364687715|FG000|Overall Study|Protocol Violation|16|||
105735589|NCT01342640|364687715|FG000|Overall Study|Lost to Follow-up|21|||
105735590|NCT01342640|364687715|FG000|Overall Study|Other|1|||
105480758|NCT01328444|363771310|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
105480759|NCT01328444|363771305|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
105480760|NCT01328444|363771306|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
105735591|NCT00891657|364687716|FG000|Overall Study|Withdrawal by Subject|1|||
105735592|NCT00891657|364687717|FG001|Overall Study|Withdrawal by Subject|1|||
105735593|NCT03133481|364687718|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
105735594|NCT03133481|364687719|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
105735595|NCT01050062|364687720|FG000|Overall Study|Adverse Event|75|||
105735596|NCT01050062|364687721|FG001|Overall Study|Adverse Event|22|||
105354161|NCT05052697|363301291|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354162|NCT05052697|363301292|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105480761|NCT01328444|363771307|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
105480762|NCT01328444|363771308|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
105480763|NCT01328444|363771309|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
105480764|NCT01328444|363771310|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
105480765|NCT01328444|363771305|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105480766|NCT01328444|363771306|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105480767|NCT01328444|363771307|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105480768|NCT01328444|363771308|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105480769|NCT01328444|363771309|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
105480770|NCT01328444|363771310|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
105480771|NCT01989468|363771311|FG000|Overall Study|Adverse Event|10|||
105480772|NCT01989468|363771312|FG001|Overall Study|Adverse Event|15|||
105480773|NCT01989468|363771313|FG002|Overall Study|Adverse Event|4|||
105480774|NCT01989468|363771314|FG003|Overall Study|Adverse Event|5|||
105480775|NCT01989468|363771315|FG004|Overall Study|Adverse Event|4|||
105480776|NCT01989468|363771311|FG000|Overall Study|Lack of Efficacy|11|||
105480777|NCT01989468|363771312|FG001|Overall Study|Lack of Efficacy|11|||
105480778|NCT01989468|363771313|FG002|Overall Study|Lack of Efficacy|7|||
105480779|NCT01989468|363771314|FG003|Overall Study|Lack of Efficacy|4|||
105480780|NCT01989468|363771315|FG004|Overall Study|Lack of Efficacy|2|||
105480781|NCT01989468|363771311|FG000|Overall Study|Lost to Follow-up|5|||
105480782|NCT01989468|363771312|FG001|Overall Study|Lost to Follow-up|2|||
105480783|NCT01989468|363771313|FG002|Overall Study|Lost to Follow-up|0|||
105480784|NCT01989468|363771314|FG003|Overall Study|Lost to Follow-up|1|||
105480785|NCT01989468|363771315|FG004|Overall Study|Lost to Follow-up|1|||
105480786|NCT01989468|363771311|FG000|Overall Study|Physician Decision|4|||
105480787|NCT01989468|363771312|FG001|Overall Study|Physician Decision|1|||
105480788|NCT01989468|363771313|FG002|Overall Study|Physician Decision|0|||
105480789|NCT01989468|363771314|FG003|Overall Study|Physician Decision|1|||
105480790|NCT01989468|363771315|FG004|Overall Study|Physician Decision|0|||
105480791|NCT01989468|363771311|FG000|Overall Study|Pregnancy|0|||
105480792|NCT01989468|363771312|FG001|Overall Study|Pregnancy|1|||
105480793|NCT01989468|363771313|FG002|Overall Study|Pregnancy|0|||
105480794|NCT01989468|363771314|FG003|Overall Study|Pregnancy|0|||
105480795|NCT01989468|363771315|FG004|Overall Study|Pregnancy|0|||
105480796|NCT01989468|363771311|FG000|Overall Study|Technical Problems|3|||
105480797|NCT01989468|363771312|FG001|Overall Study|Technical Problems|1|||
105480798|NCT01989468|363771313|FG002|Overall Study|Technical Problems|3|||
105480799|NCT01989468|363771314|FG003|Overall Study|Technical Problems|1|||
105480800|NCT01989468|363771315|FG004|Overall Study|Technical Problems|0|||
105480801|NCT01989468|363771311|FG000|Overall Study|Subject Guardian Decision|11|||
105480802|NCT01989468|363771312|FG001|Overall Study|Subject Guardian Decision|6|||
105480803|NCT01989468|363771313|FG002|Overall Study|Subject Guardian Decision|4|||
105480804|NCT01989468|363771314|FG003|Overall Study|Subject Guardian Decision|4|||
105480805|NCT01989468|363771315|FG004|Overall Study|Subject Guardian Decision|1|||
105480806|NCT01989468|363771311|FG000|Overall Study|Death|3|||
105480807|NCT01989468|363771312|FG001|Overall Study|Death|0|||
105480808|NCT01989468|363771313|FG002|Overall Study|Death|1|||
105480809|NCT01989468|363771314|FG003|Overall Study|Death|0|||
105480810|NCT01989468|363771315|FG004|Overall Study|Death|0|||
105480811|NCT02486627|363771321|FG000|Overall Study|Death|1|||
105480812|NCT02486627|363771322|FG001|Overall Study|Death|0|||
105480813|NCT02486627|363771321|FG000|Overall Study|Other Unspecified|0|||
105735597|NCT01050062|364687720|FG000|Overall Study|Lost to Follow-up|83|||
105735598|NCT01050062|364687721|FG001|Overall Study|Lost to Follow-up|35|||
105735599|NCT01050062|364687720|FG000|Overall Study|Lack of Efficacy|22|||
105735600|NCT01050062|364687721|FG001|Overall Study|Lack of Efficacy|35|||
105735601|NCT01050062|364687720|FG000|Overall Study|Physician Decision|74|||
105735602|NCT01050062|364687721|FG001|Overall Study|Physician Decision|9|||
105735603|NCT01050062|364687720|FG000|Overall Study|Others|17|||
105735604|NCT01050062|364687721|FG001|Overall Study|Others|11|||
105735605|NCT03894540|364687726|FG000|Overall Study|Adverse Event|0|||
105735606|NCT03894540|364687727|FG001|Overall Study|Adverse Event|0|||
105480814|NCT02486627|363771322|FG001|Overall Study|Other Unspecified|2|||
105480815|NCT02486627|363771321|FG000|Overall Study|Consent Withdrawn by Participant|4|||
105480816|NCT02486627|363771322|FG001|Overall Study|Consent Withdrawn by Participant|3|||
105735607|NCT03894540|364687728|FG002|Overall Study|Adverse Event|0|||
105480817|NCT02486627|363771321|FG000|Overall Study|Significant Participant Noncompliance|1|||
105480818|NCT02486627|363771322|FG001|Overall Study|Significant Participant Noncompliance|1|||
105480819|NCT02486627|363771321|FG000|Overall Study|Lost to Follow-up|1|||
105480820|NCT02486627|363771322|FG001|Overall Study|Lost to Follow-up|3|||
105799152|NCT01169844|364922696|FG000|Overall Study|Adverse Event|0|||
105480821|NCT01509053|363771323|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
105480822|NCT01509053|363771323|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
105735608|NCT03894540|364687729|FG003|Overall Study|Adverse Event|0|||
105735609|NCT03894540|364687730|FG004|Overall Study|Adverse Event|1|||
105735610|NCT03894540|364687731|FG005|Overall Study|Adverse Event|0|||
105480823|NCT01509053|363771323|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
105480824|NCT01509053|363771323|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
105735611|NCT03894540|364687726|FG000|Overall Study|Withdrawal by Subject|0|||
105480825|NCT01509053|363771323|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
105480826|NCT01509053|363771323|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
105480827|NCT01738477|363771325|FG000|Overall Study|Lost to Follow-up|1|||
105480828|NCT01738477|363771326|FG001|Overall Study|Lost to Follow-up|4|||
105480829|NCT01915303|363771329|FG000|Core Phase|Adverse Event|7|||
105480830|NCT01915303|363771329|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
105480831|NCT01915303|363771329|FG000|Core Phase|Death|2|||
105480832|NCT01915303|363771329|FG000|Core Phase|Protocol Violation|2|||
105480833|NCT01915303|363771329|FG000|Core Phase|Abnormal lab value|1|||
105480834|NCT01915303|363771329|FG000|Core Phase|Withdrawal by Subject|1|||
105480835|NCT01915303|363771329|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
105480836|NCT01915303|363771329|FG000|Extension Phase|Withdrawal by Subject|4|||
105480837|NCT01915303|363771329|FG000|Extension Phase|Adverse Event|3|||
105480838|NCT01915303|363771329|FG000|Extension Phase|Death|1|||
105480839|NCT01915303|363771329|FG000|Extension Phase|Protocol Violation|1|||
105480840|NCT02509117|363771330|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
105480841|NCT02509117|363771331|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
105480842|NCT02509117|363771332|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
105480843|NCT02509117|363771333|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
105480844|NCT02509117|363771334|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
105480845|NCT02509117|363771335|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
105480846|NCT02509117|363771336|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
105480847|NCT02509117|363771337|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
105480848|NCT02509117|363771338|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
105480849|NCT02509117|363771339|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
105735612|NCT03894540|364687727|FG001|Overall Study|Withdrawal by Subject|0|||
105735613|NCT03894540|364687728|FG002|Overall Study|Withdrawal by Subject|0|||
105735614|NCT03894540|364687729|FG003|Overall Study|Withdrawal by Subject|0|||
105735615|NCT03894540|364687730|FG004|Overall Study|Withdrawal by Subject|1|||
105735616|NCT03894540|364687731|FG005|Overall Study|Withdrawal by Subject|0|||
105735617|NCT03894540|364687726|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
105735618|NCT03894540|364687727|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
105735619|NCT03894540|364687728|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
105735620|NCT03894540|364687729|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
105735621|NCT03894540|364687730|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
105735622|NCT03894540|364687731|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
105735623|NCT03894540|364687726|FG000|Overall Study|Progressive Disease Clinical|1|||
105735624|NCT03894540|364687727|FG001|Overall Study|Progressive Disease Clinical|1|||
105735625|NCT03894540|364687728|FG002|Overall Study|Progressive Disease Clinical|0|||
105735626|NCT03894540|364687729|FG003|Overall Study|Progressive Disease Clinical|1|||
105735627|NCT03894540|364687730|FG004|Overall Study|Progressive Disease Clinical|5|||
105735628|NCT03894540|364687731|FG005|Overall Study|Progressive Disease Clinical|1|||
105735629|NCT03894540|364687726|FG000|Overall Study|Study termination by sponsor|0|||
105735630|NCT03894540|364687727|FG001|Overall Study|Study termination by sponsor|0|||
105735631|NCT03894540|364687728|FG002|Overall Study|Study termination by sponsor|0|||
105735632|NCT03894540|364687729|FG003|Overall Study|Study termination by sponsor|0|||
105735633|NCT03894540|364687730|FG004|Overall Study|Study termination by sponsor|2|||
105735634|NCT03894540|364687731|FG005|Overall Study|Study termination by sponsor|0|||
105735635|NCT00537823|364687732|FG000|Overall Study|Adverse Event|2|||
105735636|NCT00537823|364687733|FG001|Overall Study|Adverse Event|0|||
105735637|NCT01184989|364687738|FG000|Overall Study|Adverse Event|11|||
105735638|NCT01184989|364687738|FG000|Overall Study|Withdrawal by Subject|1|||
105735639|NCT02927171|364687739|FG000|Overall Study|Lost to Follow-up|0|||
105735640|NCT02927171|364687740|FG001|Overall Study|Lost to Follow-up|1|||
105735641|NCT01570491|364687743|FG000|Overall Study|Lost to Follow-up|3|||
105735642|NCT01570491|364687744|FG001|Overall Study|Lost to Follow-up|1|||
105480850|NCT02509117|363771330|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
105480851|NCT02509117|363771331|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
105735643|NCT01570491|364687743|FG000|Overall Study|treatment: not given or discontinued|2|||
105735644|NCT01570491|364687744|FG001|Overall Study|treatment: not given or discontinued|0|||
105735645|NCT02240628|364687747|FG000|Overall Study|Physician Decision|6|||
105735646|NCT02240628|364687748|FG001|Overall Study|Physician Decision|5|||
105735647|NCT02717546|364687749|FG000|Overall Study|Lost to Follow-up|12|||
105480852|NCT02509117|363771332|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
105480853|NCT02509117|363771333|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
105735648|NCT00850499|364687751|FG000|Overall Study|Adverse Event|3|||
105735649|NCT00850499|364687752|FG001|Overall Study|Adverse Event|1|||
105735650|NCT00850499|364687751|FG000|Overall Study|Lack of Efficacy|0|||
105735651|NCT00850499|364687752|FG001|Overall Study|Lack of Efficacy|1|||
105735652|NCT04498910|364687753|FG000|Overall Study|Lost to Follow-up|0|||
105735653|NCT04498910|364687754|FG001|Overall Study|Lost to Follow-up|1|||
105735654|NCT04498910|364687753|FG000|Overall Study|Withdrawal by Subject|2|||
105735655|NCT04498910|364687754|FG001|Overall Study|Withdrawal by Subject|1|||
105735656|NCT04498910|364687753|FG000|Overall Study|Adverse Event|1|||
105735657|NCT04498910|364687754|FG001|Overall Study|Adverse Event|0|||
105735658|NCT01849848|364687755|FG000|Overall Study|Physician Decision|1|||
105735659|NCT01849848|364687755|FG000|Overall Study|Progression of the primary disease|3|||
105735660|NCT01873742|364687763|FG000|Overall Study|Lost to Follow-up|68|||
105735661|NCT01873742|364687764|FG001|Overall Study|Lost to Follow-up|76|||
105735662|NCT01478347|364687769|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
105735663|NCT01478347|364687769|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
105735664|NCT01478347|364687769|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
105735665|NCT02760407|364687770|FG000|Overall Study|Death|2|||
105735666|NCT02760407|364687771|FG001|Overall Study|Death|3|||
105735667|NCT02760407|364687772|FG002|Overall Study|Death|1|||
105735668|NCT02760407|364687773|FG003|Overall Study|Death|1|||
105735669|NCT02760407|364687770|FG000|Overall Study|Lost to Follow-up|1|||
105735670|NCT02760407|364687771|FG001|Overall Study|Lost to Follow-up|7|||
105735671|NCT02760407|364687772|FG002|Overall Study|Lost to Follow-up|4|||
105735672|NCT02760407|364687773|FG003|Overall Study|Lost to Follow-up|6|||
105735673|NCT02760407|364687770|FG000|Overall Study|Withdrawal by Subject|25|||
105735674|NCT02760407|364687771|FG001|Overall Study|Withdrawal by Subject|31|||
105735675|NCT02760407|364687772|FG002|Overall Study|Withdrawal by Subject|37|||
105735676|NCT02760407|364687773|FG003|Overall Study|Withdrawal by Subject|25|||
105735677|NCT02760407|364687770|FG000|Overall Study|Violation of Eligibility criteria|0|||
105735678|NCT02760407|364687771|FG001|Overall Study|Violation of Eligibility criteria|0|||
105735679|NCT02760407|364687772|FG002|Overall Study|Violation of Eligibility criteria|1|||
105735680|NCT02760407|364687773|FG003|Overall Study|Violation of Eligibility criteria|1|||
105735681|NCT02760407|364687770|FG000|Overall Study|Personal reasons|0|||
105735682|NCT02760407|364687771|FG001|Overall Study|Personal reasons|0|||
105735683|NCT02760407|364687772|FG002|Overall Study|Personal reasons|0|||
105735684|NCT02760407|364687773|FG003|Overall Study|Personal reasons|1|||
105735685|NCT02760407|364687770|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
105735686|NCT02760407|364687771|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
105735687|NCT02760407|364687772|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
105735688|NCT02760407|364687773|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
105735689|NCT02760407|364687770|FG000|Overall Study|Use of prohibited Medication|0|||
105735690|NCT02760407|364687771|FG001|Overall Study|Use of prohibited Medication|0|||
105735691|NCT02760407|364687772|FG002|Overall Study|Use of prohibited Medication|1|||
105735692|NCT02760407|364687773|FG003|Overall Study|Use of prohibited Medication|0|||
105735693|NCT02760407|364687770|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
105735694|NCT02760407|364687771|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
105735695|NCT02760407|364687772|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
105735696|NCT02760407|364687773|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
105735697|NCT02760407|364687770|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
105735698|NCT02760407|364687771|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
105735699|NCT02760407|364687772|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
105735700|NCT02760407|364687773|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
105735701|NCT02760407|364687770|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
105735702|NCT02760407|364687771|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
105735703|NCT02760407|364687772|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
105735704|NCT02760407|364687773|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
105735705|NCT02760407|364687770|FG000|Overall Study|Inadequately Enrolled|0|||
105735706|NCT02760407|364687771|FG001|Overall Study|Inadequately Enrolled|0|||
105735707|NCT02760407|364687772|FG002|Overall Study|Inadequately Enrolled|0|||
105735708|NCT02760407|364687773|FG003|Overall Study|Inadequately Enrolled|1|||
105735709|NCT02760407|364687770|FG000|Overall Study|Withdrawal By PI's Decision|0|||
105735710|NCT02760407|364687771|FG001|Overall Study|Withdrawal By PI's Decision|1|||
105735711|NCT02760407|364687772|FG002|Overall Study|Withdrawal By PI's Decision|0|||
105735712|NCT02760407|364687773|FG003|Overall Study|Withdrawal By PI's Decision|0|||
105799153|NCT01169844|364922697|FG001|Overall Study|Adverse Event|1|||
105799154|NCT01169844|364922696|FG000|Overall Study|Patient withdrew consent|4|||
105799155|NCT01169844|364922697|FG001|Overall Study|Patient withdrew consent|0|||
105799156|NCT01169844|364922696|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105735713|NCT02760407|364687770|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
105735714|NCT02760407|364687771|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
105735715|NCT02760407|364687772|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
105735716|NCT02760407|364687773|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
105735717|NCT02760407|364687770|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
105735718|NCT02760407|364687771|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
105735719|NCT02760407|364687772|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
105735720|NCT02760407|364687773|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
105735721|NCT02760407|364687770|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
105735722|NCT02760407|364687771|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
105735723|NCT02760407|364687772|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
105735724|NCT02760407|364687773|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
105735725|NCT02760407|364687770|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
105735726|NCT02760407|364687771|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
105735727|NCT02760407|364687772|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
105735728|NCT02760407|364687773|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
105735729|NCT02760407|364687770|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
105735730|NCT02760407|364687771|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
105735731|NCT02760407|364687772|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
105735732|NCT02760407|364687773|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
105735733|NCT02760407|364687770|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
105735734|NCT02760407|364687771|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
105735735|NCT02760407|364687772|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
105735736|NCT02760407|364687773|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
105735737|NCT02760407|364687770|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
105735738|NCT02760407|364687771|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
105735739|NCT02760407|364687772|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
105735740|NCT02760407|364687773|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
105735741|NCT02760407|364687770|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
105735742|NCT02760407|364687771|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
105735743|NCT02760407|364687772|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
105735744|NCT02760407|364687773|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
105735745|NCT02760407|364687770|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
105735746|NCT02760407|364687771|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
105480854|NCT02509117|363771334|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
105480855|NCT02509117|363771335|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
105480856|NCT02509117|363771336|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
105735747|NCT02760407|364687772|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
105735748|NCT02760407|364687773|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
105735749|NCT01645930|364687774|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
105735750|NCT01645930|364687774|FG000|Overall Study|Progressive Disease|12|||
105735751|NCT01645930|364687774|FG000|Overall Study|Adverse Event|4|||
105735752|NCT01645930|364687774|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
105735753|NCT01645930|364687774|FG000|Overall Study|Withdrawal by Participant|2|||
105735754|NCT01645930|364687774|FG000|Overall Study|Reason not Defined|1|||
105735755|NCT01748760|364687775|FG000|Overall Study|Withdrawal by Subject|1|||
105735756|NCT01748760|364687776|FG001|Overall Study|Withdrawal by Subject|1|||
105735757|NCT01748760|364687775|FG000|Overall Study|Lost to Follow-up|5|||
105735758|NCT01748760|364687776|FG001|Overall Study|Lost to Follow-up|1|||
105735759|NCT03245814|364687777|FG000|Overall Study|Lost to Follow-up|5|||
105735760|NCT03245814|364687778|FG001|Overall Study|Lost to Follow-up|8|||
105735761|NCT03245814|364687777|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
105735762|NCT03245814|364687778|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
105735763|NCT01096667|364687779|FG000|Overall Study|Lost to Follow-up|1|||
105735764|NCT01096667|364687780|FG001|Overall Study|Lost to Follow-up|1|||
105735765|NCT01096667|364687781|FG002|Overall Study|Lost to Follow-up|1|||
105735766|NCT01096667|364687782|FG003|Overall Study|Lost to Follow-up|0|||
105735767|NCT01096667|364687783|FG004|Overall Study|Lost to Follow-up|0|||
105735768|NCT01096667|364687779|FG000|Overall Study|Withdrawal by Subject|1|||
105735769|NCT01096667|364687780|FG001|Overall Study|Withdrawal by Subject|0|||
105735770|NCT01096667|364687781|FG002|Overall Study|Withdrawal by Subject|0|||
105735771|NCT01096667|364687782|FG003|Overall Study|Withdrawal by Subject|1|||
105735772|NCT01096667|364687783|FG004|Overall Study|Withdrawal by Subject|0|||
105735773|NCT01096667|364687779|FG000|Overall Study|Reason not available|0|||
105735774|NCT01096667|364687780|FG001|Overall Study|Reason not available|1|||
105735775|NCT01096667|364687781|FG002|Overall Study|Reason not available|1|||
105735776|NCT01096667|364687782|FG003|Overall Study|Reason not available|1|||
105735777|NCT01096667|364687783|FG004|Overall Study|Reason not available|0|||
105735778|NCT01096667|364687779|FG000|Overall Study|Protocol Violation|0|||
105735779|NCT01096667|364687780|FG001|Overall Study|Protocol Violation|0|||
105735780|NCT01096667|364687781|FG002|Overall Study|Protocol Violation|0|||
105735781|NCT01096667|364687782|FG003|Overall Study|Protocol Violation|1|||
105735782|NCT01096667|364687783|FG004|Overall Study|Protocol Violation|0|||
105735783|NCT01096667|364687779|FG000|Overall Study|Not treated|1|||
105735784|NCT01096667|364687780|FG001|Overall Study|Not treated|0|||
105735785|NCT01096667|364687781|FG002|Overall Study|Not treated|0|||
105735786|NCT01096667|364687782|FG003|Overall Study|Not treated|0|||
105735787|NCT01096667|364687783|FG004|Overall Study|Not treated|0|||
105735788|NCT00306891|364687784|FG000|Part A|Withdrawal by Subject|1|||
105735789|NCT00306891|364687785|FG001|Part A|Withdrawal by Subject|1|||
105480857|NCT02509117|363771337|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
105480858|NCT02509117|363771338|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
105735790|NCT00306891|364687786|FG002|Part A|Withdrawal by Subject|0|||
105735791|NCT00306891|364687787|FG003|Part A|Withdrawal by Subject|0|||
105735792|NCT00306891|364687784|FG000|Part A|Condition under investigation worsened|2|||
105735793|NCT00306891|364687785|FG001|Part A|Condition under investigation worsened|2|||
105735794|NCT00306891|364687786|FG002|Part A|Condition under investigation worsened|0|||
105735795|NCT00306891|364687787|FG003|Part A|Condition under investigation worsened|0|||
105735796|NCT00306891|364687784|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
105735797|NCT00306891|364687785|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
105735798|NCT00306891|364687786|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
105735799|NCT00306891|364687787|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
105735800|NCT00306891|364687784|FG000|Part A|Partial bowel obstruction|1|||
105735801|NCT00306891|364687785|FG001|Part A|Partial bowel obstruction|0|||
105735802|NCT00306891|364687786|FG002|Part A|Partial bowel obstruction|0|||
105735803|NCT00306891|364687787|FG003|Part A|Partial bowel obstruction|0|||
105735804|NCT00306891|364687784|FG000|Part A|Reaccumul. of ascites following drainage|0|||
105735805|NCT00306891|364687785|FG001|Part A|Reaccumul. of ascites following drainage|1|||
105735806|NCT00306891|364687786|FG002|Part A|Reaccumul. of ascites following drainage|0|||
105735807|NCT00306891|364687787|FG003|Part A|Reaccumul. of ascites following drainage|0|||
105735808|NCT00306891|364687784|FG000|Part A|Suspicion of second malignancy|0|||
105735809|NCT00306891|364687785|FG001|Part A|Suspicion of second malignancy|1|||
105735810|NCT00306891|364687786|FG002|Part A|Suspicion of second malignancy|0|||
105735811|NCT00306891|364687787|FG003|Part A|Suspicion of second malignancy|0|||
105735812|NCT00306891|364687784|FG000|Part A|QTC interval outwith elig. criteria|1|||
105735813|NCT00306891|364687785|FG001|Part A|QTC interval outwith elig. criteria|0|||
105735814|NCT00306891|364687786|FG002|Part A|QTC interval outwith elig. criteria|0|||
105735815|NCT00306891|364687787|FG003|Part A|QTC interval outwith elig. criteria|0|||
105735816|NCT00306891|364687784|FG000|Part B|Death|0|||
105735817|NCT00306891|364687785|FG001|Part B|Death|0|||
105735818|NCT00306891|364687786|FG002|Part B|Death|1|||
105735819|NCT00306891|364687787|FG003|Part B|Death|2|||
105735820|NCT00306891|364687784|FG000|Part B|Adverse Event|0|||
105735821|NCT00306891|364687785|FG001|Part B|Adverse Event|0|||
105735822|NCT00306891|364687786|FG002|Part B|Adverse Event|5|||
105735823|NCT00306891|364687787|FG003|Part B|Adverse Event|5|||
105735824|NCT00306891|364687784|FG000|Part B|Withdrawal by Subject|0|||
105735825|NCT00306891|364687785|FG001|Part B|Withdrawal by Subject|0|||
105735826|NCT00306891|364687786|FG002|Part B|Withdrawal by Subject|3|||
105735827|NCT00306891|364687787|FG003|Part B|Withdrawal by Subject|1|||
105735828|NCT00306891|364687784|FG000|Part B|Condition under investigation worsened|0|||
105735829|NCT00306891|364687785|FG001|Part B|Condition under investigation worsened|0|||
105735830|NCT00306891|364687786|FG002|Part B|Condition under investigation worsened|2|||
105735831|NCT00306891|364687787|FG003|Part B|Condition under investigation worsened|8|||
105735832|NCT00306891|364687784|FG000|Part B|Development of study specific disc crit.|0|||
105735833|NCT00306891|364687785|FG001|Part B|Development of study specific disc crit.|0|||
105735834|NCT00306891|364687786|FG002|Part B|Development of study specific disc crit.|0|||
105735835|NCT00306891|364687787|FG003|Part B|Development of study specific disc crit.|1|||
105735836|NCT00673673|364687788|FG000|Overall Study|Progressive disease|27|||
105735837|NCT00673673|364687788|FG000|Overall Study|Adverse Event|4|||
105735838|NCT00673673|364687788|FG000|Overall Study|Withdrawal by Subject|3|||
105735839|NCT00673673|364687788|FG000|Overall Study|Investigators' discretion|2|||
105735840|NCT02263365|364687789|FG000|Overall Study|Physician Decision|22|||
105735841|NCT02263365|364687790|FG001|Overall Study|Physician Decision|18|||
105735842|NCT04542291|364687794|FG000|Overall Study|Adverse Event|1|||
105735843|NCT04542291|364687794|FG000|Overall Study|Physician Decision|2|||
105735844|NCT04538950|364687795|FG000|Overall Study|Pulmonary Issues|2|||
105735845|NCT04538950|364687795|FG000|Overall Study|illness|2|||
105735846|NCT02795156|364687801|FG000|Overall Study|Progressive Disease|22|||
105735847|NCT02795156|364687802|FG001|Overall Study|Progressive Disease|7|||
105735848|NCT02795156|364687803|FG002|Overall Study|Progressive Disease|34|||
105735849|NCT02795156|364687804|FG003|Overall Study|Progressive Disease|7|||
105735850|NCT02795156|364687801|FG000|Overall Study|Adverse Event|13|||
105735851|NCT02795156|364687802|FG001|Overall Study|Adverse Event|2|||
105735852|NCT02795156|364687803|FG002|Overall Study|Adverse Event|3|||
105735853|NCT02795156|364687804|FG003|Overall Study|Adverse Event|2|||
105735854|NCT02795156|364687801|FG000|Overall Study|Death|1|||
105735855|NCT02795156|364687802|FG001|Overall Study|Death|1|||
105735856|NCT02795156|364687803|FG002|Overall Study|Death|1|||
105735857|NCT02795156|364687804|FG003|Overall Study|Death|0|||
105735858|NCT02795156|364687801|FG000|Overall Study|Physician Decision|1|||
105735859|NCT02795156|364687802|FG001|Overall Study|Physician Decision|0|||
105735860|NCT02795156|364687803|FG002|Overall Study|Physician Decision|1|||
105735861|NCT02795156|364687804|FG003|Overall Study|Physician Decision|0|||
105735862|NCT02795156|364687801|FG000|Overall Study|Withdrawal by Subject|2|||
105799157|NCT01169844|364922697|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105735863|NCT02795156|364687802|FG001|Overall Study|Withdrawal by Subject|0|||
105735864|NCT02795156|364687803|FG002|Overall Study|Withdrawal by Subject|3|||
105735865|NCT02795156|364687804|FG003|Overall Study|Withdrawal by Subject|0|||
105354163|NCT05052697|363301293|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354164|NCT05052697|363301294|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354165|NCT05052697|363301295|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354166|NCT05052697|363301296|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
105354167|NCT05052697|363301297|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354168|NCT05052697|363301298|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
105735866|NCT00469014|364687805|FG000|Initial Phase Randomization|Disease Progression|0|||
105735867|NCT00469014|364687806|FG001|Initial Phase Randomization|Disease Progression|1|||
105735868|NCT00469014|364687807|FG002|Initial Phase Randomization|Disease Progression|1|||
105735869|NCT00469014|364687808|FG003|Initial Phase Randomization|Disease Progression|0|||
105735870|NCT00469014|364687805|FG000|Initial Phase Randomization|No Response|1|||
105735871|NCT00469014|364687806|FG001|Initial Phase Randomization|No Response|0|||
105735872|NCT00469014|364687807|FG002|Initial Phase Randomization|No Response|0|||
105735873|NCT00469014|364687808|FG003|Initial Phase Randomization|No Response|1|||
105735874|NCT00469014|364687805|FG000|Adaptive Randomization|Not Evaluable|1|||
105735875|NCT00469014|364687806|FG001|Adaptive Randomization|Not Evaluable|0|||
105735876|NCT00469014|364687807|FG002|Adaptive Randomization|Not Evaluable|0|||
105735877|NCT00469014|364687808|FG003|Adaptive Randomization|Not Evaluable|1|||
105735878|NCT00469014|364687805|FG000|Adaptive Randomization|No Response|0|||
105735879|NCT00469014|364687806|FG001|Adaptive Randomization|No Response|1|||
105735880|NCT00469014|364687807|FG002|Adaptive Randomization|No Response|0|||
105735881|NCT00469014|364687808|FG003|Adaptive Randomization|No Response|0|||
105735882|NCT00469014|364687805|FG000|Adaptive Randomization|Death|0|||
105735883|NCT00469014|364687806|FG001|Adaptive Randomization|Death|0|||
105735884|NCT00469014|364687807|FG002|Adaptive Randomization|Death|1|||
105735885|NCT00469014|364687808|FG003|Adaptive Randomization|Death|0|||
105735886|NCT03825042|364689539|FG000|Overall Study|Adverse Event|1|||
105735887|NCT03825042|364689540|FG001|Overall Study|Adverse Event|0|||
105735888|NCT03825042|364689539|FG000|Overall Study|Withdrawal by Subject|1|||
105735889|NCT03825042|364689540|FG001|Overall Study|Withdrawal by Subject|0|||
105735890|NCT00417612|364689543|FG000|Overall Study|Errant diagnosis|0|||
105735891|NCT00417612|364689544|FG001|Overall Study|Errant diagnosis|1|||
105735892|NCT00417612|364689543|FG000|Overall Study|Adverse Event|2|||
105735893|NCT00417612|364689544|FG001|Overall Study|Adverse Event|0|||
105735894|NCT00417612|364689543|FG000|Overall Study|Protocol Violation|0|||
105735895|NCT00417612|364689544|FG001|Overall Study|Protocol Violation|2|||
105735896|NCT00417612|364689543|FG000|Overall Study|Lost to Follow-up|1|||
105735897|NCT00417612|364689544|FG001|Overall Study|Lost to Follow-up|0|||
105735898|NCT00663858|364689545|FG000|Overall Study|Adverse Event|9|||
105735899|NCT00663858|364689546|FG001|Overall Study|Adverse Event|1|||
105735900|NCT00663858|364689547|FG002|Overall Study|Adverse Event|6|||
105735901|NCT00663858|364689545|FG000|Overall Study|Lack of Efficacy|5|||
105735902|NCT00663858|364689546|FG001|Overall Study|Lack of Efficacy|1|||
105735903|NCT00663858|364689547|FG002|Overall Study|Lack of Efficacy|3|||
105735904|NCT00663858|364689545|FG000|Overall Study|Withdrawal by Subject|7|||
105735905|NCT00663858|364689546|FG001|Overall Study|Withdrawal by Subject|3|||
105735906|NCT00663858|364689547|FG002|Overall Study|Withdrawal by Subject|3|||
105735907|NCT00663858|364689545|FG000|Overall Study|Protocol Violation|5|||
105735908|NCT00663858|364689546|FG001|Overall Study|Protocol Violation|3|||
105735909|NCT00663858|364689547|FG002|Overall Study|Protocol Violation|4|||
105735910|NCT00663858|364689545|FG000|Overall Study|Other|8|||
105735911|NCT00663858|364689546|FG001|Overall Study|Other|2|||
105735912|NCT00663858|364689547|FG002|Overall Study|Other|4|||
105735913|NCT03216265|364689552|FG000|Overall Study|Adverse Event|2|||
105735914|NCT03216265|364689553|FG001|Overall Study|Adverse Event|0|||
105735915|NCT03216265|364689554|FG002|Overall Study|Adverse Event|2|||
105735916|NCT03216265|364689552|FG000|Overall Study|Lost to Follow-up|0|||
105735917|NCT03216265|364689553|FG001|Overall Study|Lost to Follow-up|1|||
105735918|NCT03216265|364689554|FG002|Overall Study|Lost to Follow-up|0|||
105735919|NCT03216265|364689552|FG000|Overall Study|Withdrawal by Subject|0|||
105735920|NCT03216265|364689553|FG001|Overall Study|Withdrawal by Subject|0|||
105735921|NCT03216265|364689554|FG002|Overall Study|Withdrawal by Subject|1|||
105735922|NCT01978912|364689557|FG000|Overall Study|Adverse Event|0|||
105799158|NCT05037409|364922698|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
105354169|NCT05052697|363301299|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105735923|NCT01978912|364689558|FG001|Overall Study|Adverse Event|1|||
105735924|NCT01978912|364689559|FG002|Overall Study|Adverse Event|0|||
105735925|NCT01978912|364689560|FG003|Overall Study|Adverse Event|0|||
105735926|NCT01978912|364689557|FG000|Overall Study|Lost to Follow-up|1|||
105735927|NCT01978912|364689558|FG001|Overall Study|Lost to Follow-up|1|||
105735928|NCT01978912|364689559|FG002|Overall Study|Lost to Follow-up|0|||
105735929|NCT01978912|364689560|FG003|Overall Study|Lost to Follow-up|1|||
105735930|NCT01978912|364689557|FG000|Overall Study|Withdrawal by Subject|1|||
105735931|NCT01978912|364689558|FG001|Overall Study|Withdrawal by Subject|0|||
105735932|NCT01978912|364689559|FG002|Overall Study|Withdrawal by Subject|2|||
105735933|NCT01978912|364689560|FG003|Overall Study|Withdrawal by Subject|2|||
105735934|NCT01978912|364689557|FG000|Overall Study|Lumbar Surgery|1|||
105799159|NCT05037409|364922699|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
105354170|NCT05052697|363301300|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354171|NCT05052697|363301301|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354172|NCT05052697|363301302|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354173|NCT05052697|363301303|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354174|NCT05052697|363301304|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105354175|NCT05052697|363301271|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354176|NCT05052697|363301272|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354177|NCT05052697|363301273|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354178|NCT05052697|363301274|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354179|NCT05052697|363301275|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354180|NCT05052697|363301276|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354181|NCT05052697|363301277|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354182|NCT05052697|363301278|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105735935|NCT01978912|364689558|FG001|Overall Study|Lumbar Surgery|0|||
105735936|NCT01978912|364689559|FG002|Overall Study|Lumbar Surgery|1|||
105735937|NCT01978912|364689560|FG003|Overall Study|Lumbar Surgery|0|||
105735938|NCT01978912|364689557|FG000|Overall Study|Intradiscal Steroid Injection|0|||
105735939|NCT01978912|364689558|FG001|Overall Study|Intradiscal Steroid Injection|1|||
105735940|NCT01978912|364689559|FG002|Overall Study|Intradiscal Steroid Injection|0|||
105735941|NCT01978912|364689560|FG003|Overall Study|Intradiscal Steroid Injection|0|||
105735942|NCT00224107|364689561|FG000|Overall Study|Adverse Event|20|||
105735943|NCT00224107|364689562|FG001|Overall Study|Adverse Event|6|||
105735944|NCT00224107|364689561|FG000|Overall Study|Protocol Violation|2|||
105735945|NCT00224107|364689562|FG001|Overall Study|Protocol Violation|3|||
105735946|NCT00224107|364689561|FG000|Overall Study|Withdrawal by Subject|1|||
105735947|NCT00224107|364689562|FG001|Overall Study|Withdrawal by Subject|4|||
105735948|NCT00224107|364689561|FG000|Overall Study|Lack of Efficacy|2|||
105735949|NCT00224107|364689562|FG001|Overall Study|Lack of Efficacy|0|||
105735950|NCT00224107|364689561|FG000|Overall Study|Lost to Follow-up|4|||
105735951|NCT00224107|364689562|FG001|Overall Study|Lost to Follow-up|0|||
105735952|NCT00224107|364689561|FG000|Overall Study|Physician Decision|1|||
105735953|NCT00224107|364689562|FG001|Overall Study|Physician Decision|0|||
105735954|NCT00224107|364689561|FG000|Overall Study|Other|1|||
105735955|NCT00224107|364689562|FG001|Overall Study|Other|1|||
105735956|NCT01371838|364689563|FG000|Overall Study|Withdrawal by Subject|27|||
105735957|NCT01371838|364689564|FG001|Overall Study|Withdrawal by Subject|33|||
105735958|NCT01371838|364689563|FG000|Overall Study|Lost to Follow-up|10|||
105735959|NCT01371838|364689564|FG001|Overall Study|Lost to Follow-up|20|||
105735960|NCT01371838|364689563|FG000|Overall Study|Death|3|||
105735961|NCT01371838|364689564|FG001|Overall Study|Death|4|||
105735962|NCT01371838|364689563|FG000|Overall Study|Protocol Violation|3|||
105735963|NCT01371838|364689564|FG001|Overall Study|Protocol Violation|0|||
105735964|NCT01371838|364689563|FG000|Overall Study|Investigator Decision|3|||
105735965|NCT01371838|364689564|FG001|Overall Study|Investigator Decision|8|||
105735966|NCT01371838|364689563|FG000|Overall Study|Last follow-up visit not conducted|2|||
105735967|NCT01371838|364689564|FG001|Overall Study|Last follow-up visit not conducted|0|||
105735968|NCT01371838|364689563|FG000|Overall Study|Lack of therapeutic response|0|||
105735969|NCT01371838|364689564|FG001|Overall Study|Lack of therapeutic response|1|||
105735970|NCT01371838|364689563|FG000|Overall Study|Surgery|1|||
105799160|NCT05037409|364922700|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
105735971|NCT01371838|364689564|FG001|Overall Study|Surgery|0|||
105735972|NCT00077623|364689565|FG000|Overall Study|Adverse Event|1|||
105735973|NCT00077623|364689566|FG001|Overall Study|Adverse Event|0|||
105799161|NCT01201356|364922704|FG000|Overall Study|Adverse Event|170|||
105799162|NCT01201356|364922704|FG000|Overall Study|Abnormal laboratory value(s)|51|||
105735974|NCT00077623|364689567|FG002|Overall Study|Adverse Event|1|||
105735975|NCT00077623|364689565|FG000|Overall Study|Withdrawal by Subject|2|||
105735976|NCT00077623|364689566|FG001|Overall Study|Withdrawal by Subject|10|||
105735977|NCT00077623|364689567|FG002|Overall Study|Withdrawal by Subject|1|||
105735978|NCT00077623|364689565|FG000|Overall Study|Other-Non safety reason|18|||
105735979|NCT00077623|364689566|FG001|Overall Study|Other-Non safety reason|15|||
105735980|NCT00077623|364689567|FG002|Overall Study|Other-Non safety reason|19|||
105735981|NCT00077623|364689565|FG000|Overall Study|Insufficient therapeutic response|2|||
105735982|NCT00077623|364689566|FG001|Overall Study|Insufficient therapeutic response|0|||
105735983|NCT00077623|364689567|FG002|Overall Study|Insufficient therapeutic response|0|||
105735984|NCT00077623|364689565|FG000|Overall Study|Death|12|||
105735985|NCT00077623|364689566|FG001|Overall Study|Death|18|||
105735986|NCT00077623|364689567|FG002|Overall Study|Death|11|||
105735987|NCT00077623|364689565|FG000|Overall Study|Failure to return|1|||
105735988|NCT00077623|364689566|FG001|Overall Study|Failure to return|0|||
105735989|NCT00077623|364689567|FG002|Overall Study|Failure to return|0|||
105735990|NCT00401973|364689574|FG000|Overall Study|Adverse Event|2|||
105735991|NCT00401973|364689575|FG001|Overall Study|Adverse Event|8|||
105735992|NCT00401973|364689576|FG002|Overall Study|Adverse Event|4|||
105735993|NCT00401973|364689574|FG000|Overall Study|Clinical Relapse|0|||
105735994|NCT00401973|364689575|FG001|Overall Study|Clinical Relapse|1|||
105735995|NCT00401973|364689576|FG002|Overall Study|Clinical Relapse|1|||
105735996|NCT00401973|364689574|FG000|Overall Study|Lack of Efficacy|0|||
105735997|NCT00401973|364689575|FG001|Overall Study|Lack of Efficacy|0|||
105735998|NCT00401973|364689576|FG002|Overall Study|Lack of Efficacy|3|||
105735999|NCT00401973|364689574|FG000|Overall Study|Lost to Follow-up|2|||
105736000|NCT00401973|364689575|FG001|Overall Study|Lost to Follow-up|2|||
105736001|NCT00401973|364689576|FG002|Overall Study|Lost to Follow-up|2|||
105736002|NCT00401973|364689574|FG000|Overall Study|Physician Decision|2|||
105736003|NCT00401973|364689575|FG001|Overall Study|Physician Decision|0|||
105736004|NCT00401973|364689576|FG002|Overall Study|Physician Decision|1|||
105736005|NCT00401973|364689574|FG000|Overall Study|Protocol Violation|1|||
105736006|NCT00401973|364689575|FG001|Overall Study|Protocol Violation|2|||
105736007|NCT00401973|364689576|FG002|Overall Study|Protocol Violation|3|||
105736008|NCT00401973|364689574|FG000|Overall Study|Sponsor Decision|0|||
105354183|NCT05052697|363301279|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105736009|NCT00401973|364689575|FG001|Overall Study|Sponsor Decision|1|||
105736010|NCT00401973|364689576|FG002|Overall Study|Sponsor Decision|0|||
105736011|NCT00401973|364689574|FG000|Overall Study|Withdrawal by Subject|4|||
105736012|NCT00401973|364689575|FG001|Overall Study|Withdrawal by Subject|12|||
105736013|NCT00401973|364689576|FG002|Overall Study|Withdrawal by Subject|9|||
105736014|NCT00641043|364689577|FG000|Overall Study|Adverse Event|6|||
105736015|NCT00641043|364689578|FG001|Overall Study|Adverse Event|4|||
105736016|NCT00641043|364689577|FG000|Overall Study|Protocol Violation|2|||
105736017|NCT00641043|364689578|FG001|Overall Study|Protocol Violation|3|||
105736018|NCT00641043|364689577|FG000|Overall Study|Lost to Follow-up|3|||
105736019|NCT00641043|364689578|FG001|Overall Study|Lost to Follow-up|2|||
105736020|NCT00641043|364689577|FG000|Overall Study|Withdrawal by Subject|4|||
105736021|NCT00641043|364689578|FG001|Overall Study|Withdrawal by Subject|4|||
105736022|NCT00641043|364689577|FG000|Overall Study|Other incl. lack of efficacy|4|||
105736023|NCT00641043|364689578|FG001|Overall Study|Other incl. lack of efficacy|2|||
105736024|NCT05523362|364689579|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
105736025|NCT05523362|364689579|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
105736026|NCT05523362|364689579|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
105736027|NCT05523362|364689579|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
105736028|NCT00474630|364689580|FG000|Overall Study|Adverse Event|98|||
105736029|NCT00474630|364689581|FG001|Overall Study|Adverse Event|26|||
105736030|NCT00474630|364689580|FG000|Overall Study|Lost to Follow-up|22|||
105736031|NCT00474630|364689581|FG001|Overall Study|Lost to Follow-up|15|||
105354184|NCT05052697|363301280|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354185|NCT05052697|363301281|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354186|NCT05052697|363301282|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354187|NCT05052697|363301283|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354188|NCT05052697|363301284|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354189|NCT05052697|363301285|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105480859|NCT02509117|363771339|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
105480860|NCT02509117|363771330|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
105480861|NCT02509117|363771331|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
105480862|NCT02509117|363771332|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
105736032|NCT00474630|364689580|FG000|Overall Study|Withdrawal by Subject|21|||
105736033|NCT00474630|364689581|FG001|Overall Study|Withdrawal by Subject|15|||
105736034|NCT00474630|364689580|FG000|Overall Study|Protocol Violation|3|||
105736035|NCT00474630|364689581|FG001|Overall Study|Protocol Violation|4|||
105736036|NCT00474630|364689580|FG000|Overall Study|Lack of Efficacy|5|||
105736037|NCT00474630|364689581|FG001|Overall Study|Lack of Efficacy|6|||
105736038|NCT00474630|364689580|FG000|Overall Study|Drug noncompliance, other|11|||
105736039|NCT00474630|364689581|FG001|Overall Study|Drug noncompliance, other|4|||
105736040|NCT04075604|364689582|FG000|Overall Study|Adverse Event|0|||
105736041|NCT04075604|364689583|FG001|Overall Study|Adverse Event|0|||
105736042|NCT04075604|364689584|FG002|Overall Study|Adverse Event|3|||
105736043|NCT04075604|364689582|FG000|Overall Study|Participant request to discontinue study treatment|0|||
105736044|NCT04075604|364689583|FG001|Overall Study|Participant request to discontinue study treatment|0|||
105736045|NCT04075604|364689584|FG002|Overall Study|Participant request to discontinue study treatment|1|||
105736046|NCT04075604|364689582|FG000|Overall Study|Participant withdrew consent|0|||
105736047|NCT04075604|364689583|FG001|Overall Study|Participant withdrew consent|0|||
105736048|NCT04075604|364689584|FG002|Overall Study|Participant withdrew consent|1|||
105736049|NCT04075604|364689582|FG000|Overall Study|Other reasons|1|||
105736050|NCT04075604|364689583|FG001|Overall Study|Other reasons|0|||
105736051|NCT04075604|364689584|FG002|Overall Study|Other reasons|0|||
105736052|NCT04075604|364689582|FG000|Overall Study|Disease progression|0|||
105736053|NCT04075604|364689583|FG001|Overall Study|Disease progression|1|||
105736054|NCT04075604|364689584|FG002|Overall Study|Disease progression|0|||
105736055|NCT04075604|364689582|FG000|Overall Study|Study drug toxicity|0|||
105736056|NCT04075604|364689583|FG001|Overall Study|Study drug toxicity|5|||
105736057|NCT04075604|364689584|FG002|Overall Study|Study drug toxicity|1|||
105736058|NCT02225223|364689588|FG000|Overall Study|Death|10|||
105736059|NCT02225223|364689589|FG001|Overall Study|Death|1|||
105736060|NCT02225223|364689588|FG000|Overall Study|Lost to Follow-up|5|||
105736061|NCT02225223|364689589|FG001|Overall Study|Lost to Follow-up|0|||
105736062|NCT02225223|364689588|FG000|Overall Study|Other|1|||
105736063|NCT02225223|364689589|FG001|Overall Study|Other|2|||
105736064|NCT02225223|364689588|FG000|Overall Study|Physician Decision|1|||
105736065|NCT02225223|364689589|FG001|Overall Study|Physician Decision|0|||
105736066|NCT02225223|364689588|FG000|Overall Study|Withdrawal by Subject|2|||
105736067|NCT02225223|364689589|FG001|Overall Study|Withdrawal by Subject|2|||
105736068|NCT03334214|364689593|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
105736069|NCT03334214|364689594|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
105736070|NCT03334214|364689593|FG000|Overall Study|Withdrawal by Subject|0|||
105736071|NCT03334214|364689594|FG001|Overall Study|Withdrawal by Subject|1|||
105736072|NCT03334214|364689593|FG000|Overall Study|Other|1|||
105736073|NCT03334214|364689594|FG001|Overall Study|Other|0|||
105736074|NCT03047213|364689595|FG000|Overall Study|Withdrawal by Subject|2|||
105736075|NCT03047213|364689596|FG001|Overall Study|Withdrawal by Subject|0|||
105736076|NCT03047213|364689595|FG000|Overall Study|Adverse Event|2|||
105736077|NCT03047213|364689596|FG001|Overall Study|Adverse Event|0|||
105736078|NCT04530825|364689599|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
105736079|NCT04530825|364689600|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
105736080|NCT04530825|364689601|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
105736081|NCT04530825|364689602|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
105736082|NCT04530825|364689599|FG000|Overall Study|Did not complete follow-up|3|||
105736083|NCT04530825|364689600|FG001|Overall Study|Did not complete follow-up|0|||
105736084|NCT04530825|364689601|FG002|Overall Study|Did not complete follow-up|0|||
105736085|NCT04530825|364689602|FG003|Overall Study|Did not complete follow-up|0|||
105736086|NCT04101422|364689604|FG000|Overall Study|Ineligible|1|||
105736087|NCT04101422|364689605|FG001|Overall Study|Ineligible|0|||
105736088|NCT04101422|364689606|FG002|Overall Study|Ineligible|9|||
105736089|NCT04101422|364689607|FG003|Overall Study|Ineligible|0|||
105736090|NCT04101422|364689604|FG000|Overall Study|Withdrawal by Subject|0|||
105736091|NCT04101422|364689605|FG001|Overall Study|Withdrawal by Subject|0|||
105736092|NCT04101422|364689606|FG002|Overall Study|Withdrawal by Subject|1|||
105736093|NCT04101422|364689607|FG003|Overall Study|Withdrawal by Subject|0|||
105736094|NCT04101422|364689604|FG000|Overall Study|Not attending to the stimuli|0|||
105736095|NCT04101422|364689605|FG001|Overall Study|Not attending to the stimuli|0|||
105736096|NCT04101422|364689606|FG002|Overall Study|Not attending to the stimuli|4|||
105799163|NCT01201356|364922704|FG000|Overall Study|Abnormal test procedure result(s)|3|||
105799164|NCT01201356|364922704|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
105799165|NCT01201356|364922704|FG000|Overall Study|Condition no longer requires study drug|12|||
105799166|NCT01201356|364922704|FG000|Overall Study|Withdrawal by Subject|144|||
105799167|NCT01201356|364922704|FG000|Overall Study|Lost to Follow-up|50|||
105354190|NCT05052697|363301286|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105799168|NCT01201356|364922704|FG000|Overall Study|administrative problems|74|||
105799169|NCT01201356|364922704|FG000|Overall Study|Death|16|||
105799170|NCT01201356|364922704|FG000|Overall Study|Protocol Violation|12|||
105799171|NCT04079842|364922705|FG000|Overall Study|Request of subject|2|||
105799172|NCT04079842|364922705|FG000|Overall Study|Unable to draw Arterial samples|1|||
105799173|NCT04444752|364922706|FG000|Overall Study|Adverse Event|1|||
105799174|NCT04444752|364922707|FG001|Overall Study|Adverse Event|0|||
105799175|NCT04444752|364922708|FG002|Overall Study|Adverse Event|0|||
105799176|NCT04444752|364922709|FG003|Overall Study|Adverse Event|2|||
105799177|NCT04444752|364922706|FG000|Overall Study|Lost to Follow-up|2|||
105354191|NCT05052697|363301287|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354192|NCT05052697|363301288|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354193|NCT05052697|363301289|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354194|NCT05052697|363301290|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354195|NCT05052697|363301291|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354196|NCT05052697|363301292|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354197|NCT05052697|363301293|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354198|NCT05052697|363301294|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354199|NCT05052697|363301295|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354200|NCT05052697|363301296|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354201|NCT05052697|363301297|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354202|NCT05052697|363301298|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354203|NCT05052697|363301299|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
105354204|NCT05052697|363301300|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354205|NCT05052697|363301301|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
105354206|NCT05052697|363301302|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
105354207|NCT05052697|363301303|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
105354208|NCT05052697|363301304|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105354209|NCT05052697|363301271|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105799178|NCT04444752|364922707|FG001|Overall Study|Lost to Follow-up|6|||
105799179|NCT04444752|364922708|FG002|Overall Study|Lost to Follow-up|2|||
105799180|NCT04444752|364922709|FG003|Overall Study|Lost to Follow-up|5|||
105799181|NCT04444752|364922706|FG000|Overall Study|Physician Decision|0|||
105354210|NCT05052697|363301272|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354211|NCT05052697|363301273|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354212|NCT05052697|363301274|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354213|NCT05052697|363301275|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105736097|NCT04101422|364689607|FG003|Overall Study|Not attending to the stimuli|0|||
105736098|NCT04101422|364689604|FG000|Overall Study|Did not download app|0|||
105736099|NCT04101422|364689605|FG001|Overall Study|Did not download app|0|||
105736100|NCT04101422|364689606|FG002|Overall Study|Did not download app|0|||
105736101|NCT04101422|364689607|FG003|Overall Study|Did not download app|17|||
105736102|NCT04101422|364689604|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
105736103|NCT04101422|364689605|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
105736104|NCT04101422|364689606|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
105736105|NCT04101422|364689607|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
105736106|NCT02640612|364689608|FG000|Overall Study|Adverse Event|6|||
105736107|NCT02640612|364689609|FG001|Overall Study|Adverse Event|7|||
105736108|NCT02640612|364689610|FG002|Overall Study|Adverse Event|2|||
105736109|NCT02640612|364689608|FG000|Overall Study|Death|1|||
105736110|NCT02640612|364689609|FG001|Overall Study|Death|0|||
105736111|NCT02640612|364689610|FG002|Overall Study|Death|0|||
105736112|NCT02640612|364689608|FG000|Overall Study|Withdrawal by Subject|10|||
105736113|NCT02640612|364689609|FG001|Overall Study|Withdrawal by Subject|3|||
105736114|NCT02640612|364689610|FG002|Overall Study|Withdrawal by Subject|3|||
105736115|NCT02640612|364689608|FG000|Overall Study|Lost to Follow-up|4|||
105736116|NCT02640612|364689609|FG001|Overall Study|Lost to Follow-up|1|||
105736117|NCT02640612|364689610|FG002|Overall Study|Lost to Follow-up|1|||
105736118|NCT02640612|364689608|FG000|Overall Study|Protocol Violation|0|||
105736119|NCT02640612|364689609|FG001|Overall Study|Protocol Violation|2|||
105736120|NCT02640612|364689610|FG002|Overall Study|Protocol Violation|0|||
105736121|NCT02640612|364689608|FG000|Overall Study|Lack of Efficacy|1|||
105736122|NCT02640612|364689609|FG001|Overall Study|Lack of Efficacy|1|||
105736123|NCT02640612|364689610|FG002|Overall Study|Lack of Efficacy|0|||
105736124|NCT01720667|364689611|FG000|Overall Study|Adverse Event|1|||
105736125|NCT01720667|364689612|FG001|Overall Study|Adverse Event|1|||
105736126|NCT01720667|364689611|FG000|Overall Study|Withdrawal by Subject|3|||
105736127|NCT01720667|364689612|FG001|Overall Study|Withdrawal by Subject|0|||
105736128|NCT04407507|364689613|FG000|Overall Study|Withdrawal by Subject|0|||
105736129|NCT04407507|364689614|FG001|Overall Study|Withdrawal by Subject|1|||
105736130|NCT00552305|364689615|FG000|Overall Study|Adverse Event|43|||
105736131|NCT00552305|364689615|FG000|Overall Study|Lack of Efficacy|120|||
105736132|NCT00552305|364689615|FG000|Overall Study|Lost to Follow-up|4|||
105736133|NCT00552305|364689615|FG000|Overall Study|Protocol Violation|3|||
105736134|NCT00552305|364689615|FG000|Overall Study|Withdrawal by Subject|44|||
105736135|NCT00552305|364689615|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
105736136|NCT00552305|364689615|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
105736137|NCT00552305|364689615|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
105736138|NCT00552305|364689615|FG000|Overall Study|Unsatisfactory compliance|11|||
105736139|NCT00552305|364689615|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
105736140|NCT00552305|364689615|FG000|Overall Study|AE/Other: prohibited drug required|1|||
105736141|NCT00552305|364689615|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
105736142|NCT00552305|364689615|FG000|Overall Study|Other: Site closed|4|||
105736143|NCT00552305|364689615|FG000|Overall Study|Other: Personal problems|1|||
105736144|NCT00552305|364689615|FG000|Overall Study|Other: Unable to attend visits|1|||
105736145|NCT00552305|364689615|FG000|Overall Study|Other: Subject underwent surgery|4|||
105736146|NCT00552305|364689615|FG000|Overall Study|Other: Subject became pregnant|1|||
105736147|NCT00552305|364689615|FG000|Overall Study|Other: Health problems, not drug related|1|||
105736148|NCT00552305|364689615|FG000|Overall Study|Other: Subject moved from area|2|||
105736149|NCT00552305|364689615|FG000|Overall Study|Other: Subject incarcerated|1|||
105736150|NCT00552305|364689615|FG000|Overall Study|Other: Subject went to rehab|1|||
105736151|NCT02117050|364689619|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
105736152|NCT03865407|364689620|FG000|Overall Study|Adverse Event|1|||
105736153|NCT03865407|364689621|FG001|Overall Study|Adverse Event|0|||
105736154|NCT03865407|364689620|FG000|Overall Study|Withdrawal by Subject|1|||
105736155|NCT03865407|364689621|FG001|Overall Study|Withdrawal by Subject|0|||
105736156|NCT03865407|364689620|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
105736157|NCT03865407|364689621|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
105354214|NCT05052697|363301276|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105736158|NCT01507545|364689627|FG000|Overall Study|Withdrawal by Subject|6|||
105736159|NCT01507545|364689628|FG001|Overall Study|Withdrawal by Subject|2|||
105736160|NCT01507545|364689627|FG000|Overall Study|Lost to Follow-up|1|||
105736161|NCT01507545|364689628|FG001|Overall Study|Lost to Follow-up|0|||
105736162|NCT01507545|364689627|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
105736163|NCT01507545|364689628|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
105736164|NCT01507545|364689627|FG000|Overall Study|Progressive disease|60|||
105736165|NCT01507545|364689628|FG001|Overall Study|Progressive disease|27|||
105480863|NCT02509117|363771333|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
105480864|NCT02509117|363771334|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
105480865|NCT02509117|363771335|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
105480866|NCT02509117|363771336|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
105480867|NCT02509117|363771337|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
105480868|NCT02509117|363771338|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
105480869|NCT02509117|363771339|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
105480870|NCT00832624|363771340|FG000|Overall Study|Study Terminated|10|||
105480871|NCT00636363|363771343|FG000|Overall Study|Conjunctivitis|0|||
105480872|NCT00636363|363771344|FG001|Overall Study|Conjunctivitis|0|||
105480873|NCT00636363|363771345|FG002|Overall Study|Conjunctivitis|1|||
105480874|NCT00636363|363771343|FG000|Overall Study|Adverse Event|0|||
105480875|NCT00636363|363771344|FG001|Overall Study|Adverse Event|0|||
105480876|NCT00636363|363771345|FG002|Overall Study|Adverse Event|1|||
105480877|NCT00636363|363771343|FG000|Overall Study|Positive slit lamp finding|0|||
105480878|NCT00636363|363771344|FG001|Overall Study|Positive slit lamp finding|2|||
105480879|NCT00636363|363771345|FG002|Overall Study|Positive slit lamp finding|1|||
105480880|NCT00636363|363771343|FG000|Overall Study|Study related symptoms/complaints|8|||
105480881|NCT00636363|363771344|FG001|Overall Study|Study related symptoms/complaints|7|||
105480882|NCT00636363|363771345|FG002|Overall Study|Study related symptoms/complaints|4|||
105480883|NCT00636363|363771343|FG000|Overall Study|Met ineligibility criteria|0|||
105480884|NCT00636363|363771344|FG001|Overall Study|Met ineligibility criteria|0|||
105480885|NCT00636363|363771345|FG002|Overall Study|Met ineligibility criteria|3|||
105480886|NCT00636363|363771343|FG000|Overall Study|Missed > 1 visit|0|||
105480887|NCT00636363|363771344|FG001|Overall Study|Missed > 1 visit|1|||
105480888|NCT00636363|363771345|FG002|Overall Study|Missed > 1 visit|3|||
105480889|NCT00636363|363771343|FG000|Overall Study|Lack of motivation|1|||
105480890|NCT00636363|363771344|FG001|Overall Study|Lack of motivation|0|||
105480891|NCT00636363|363771345|FG002|Overall Study|Lack of motivation|1|||
105480892|NCT00636363|363771343|FG000|Overall Study|Protocol Violation|0|||
105480893|NCT00636363|363771344|FG001|Overall Study|Protocol Violation|3|||
105480894|NCT00636363|363771345|FG002|Overall Study|Protocol Violation|0|||
105480895|NCT00636363|363771343|FG000|Overall Study|Lost to Follow-up|3|||
105480896|NCT00636363|363771344|FG001|Overall Study|Lost to Follow-up|4|||
105480897|NCT00636363|363771345|FG002|Overall Study|Lost to Follow-up|2|||
105480898|NCT00636363|363771343|FG000|Overall Study|Withdrawal by Subject|1|||
105480899|NCT00636363|363771344|FG001|Overall Study|Withdrawal by Subject|3|||
105736166|NCT01507545|364689627|FG000|Overall Study|Other|6|||
105736167|NCT01507545|364689628|FG001|Overall Study|Other|4|||
105736168|NCT00450866|364689629|FG000|Overall Study|Adverse Event|0|||
105736169|NCT00450866|364689630|FG001|Overall Study|Adverse Event|1|||
105736170|NCT00450866|364689629|FG000|Overall Study|Withdrawal by Subject|5|||
105736171|NCT00450866|364689630|FG001|Overall Study|Withdrawal by Subject|2|||
105736172|NCT00450866|364689629|FG000|Overall Study|Death|1|||
105736173|NCT00450866|364689630|FG001|Overall Study|Death|0|||
105736174|NCT00450866|364689629|FG000|Overall Study|Physician Decision|1|||
105736175|NCT00450866|364689630|FG001|Overall Study|Physician Decision|0|||
105736176|NCT00790296|364689632|FG000|Overall Study|Did not meet study eligibility criteria|1|||
105736177|NCT00790296|364689633|FG001|Overall Study|Did not meet study eligibility criteria|1|||
105736178|NCT00790296|364689632|FG000|Overall Study|Adverse Event|0|||
105736179|NCT00790296|364689633|FG001|Overall Study|Adverse Event|1|||
105736180|NCT01671488|364689634|FG000|Overall Study|Withdrawal by Subject|1|||
105736181|NCT01022853|364689635|FG000|Overall Study|Progressive disease|2|||
105736182|NCT01022853|364689636|FG001|Overall Study|Progressive disease|3|||
105736183|NCT01022853|364689637|FG002|Overall Study|Progressive disease|11|||
105736184|NCT01022853|364689638|FG003|Overall Study|Progressive disease|7|||
105736185|NCT01022853|364689639|FG004|Overall Study|Progressive disease|1|||
105480900|NCT00636363|363771345|FG002|Overall Study|Withdrawal by Subject|2|||
105480901|NCT00796991|363771352|FG000|Overall Study|Adverse Event|0|||
105480902|NCT00796991|363771353|FG001|Overall Study|Adverse Event|0|||
105480903|NCT00796991|363771354|FG002|Overall Study|Adverse Event|1|||
105480904|NCT00796991|363771352|FG000|Overall Study|Death|2|||
105480905|NCT00796991|363771353|FG001|Overall Study|Death|0|||
105736186|NCT01022853|364689635|FG000|Overall Study|Dose-limiting toxicity|0|||
105736187|NCT01022853|364689636|FG001|Overall Study|Dose-limiting toxicity|0|||
105736188|NCT01022853|364689637|FG002|Overall Study|Dose-limiting toxicity|0|||
105480906|NCT00796991|363771354|FG002|Overall Study|Death|0|||
105736189|NCT01022853|364689638|FG003|Overall Study|Dose-limiting toxicity|0|||
105354215|NCT05052697|363301277|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354216|NCT05052697|363301278|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354217|NCT05052697|363301279|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354218|NCT05052697|363301280|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354219|NCT05052697|363301281|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105736190|NCT01022853|364689639|FG004|Overall Study|Dose-limiting toxicity|1|||
105354220|NCT05052697|363301282|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354221|NCT05052697|363301283|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354222|NCT05052697|363301284|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105736191|NCT01022853|364689635|FG000|Overall Study|Withdrawal by Subject|0|||
105736192|NCT01022853|364689636|FG001|Overall Study|Withdrawal by Subject|1|||
105736193|NCT01022853|364689637|FG002|Overall Study|Withdrawal by Subject|1|||
105354223|NCT05052697|363301285|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354224|NCT05052697|363301286|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354225|NCT05052697|363301287|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354226|NCT05052697|363301288|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354227|NCT05052697|363301289|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354228|NCT05052697|363301290|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354229|NCT05052697|363301291|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354230|NCT05052697|363301292|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354231|NCT05052697|363301293|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354232|NCT05052697|363301294|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354233|NCT05052697|363301295|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354234|NCT05052697|363301296|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354235|NCT05052697|363301297|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354236|NCT05052697|363301298|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354237|NCT05052697|363301299|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
105736194|NCT01022853|364689638|FG003|Overall Study|Withdrawal by Subject|1|||
105736195|NCT01022853|364689639|FG004|Overall Study|Withdrawal by Subject|0|||
105736196|NCT01022853|364689635|FG000|Overall Study|Other not stated above|1|||
105736197|NCT01022853|364689636|FG001|Overall Study|Other not stated above|0|||
105736198|NCT01022853|364689637|FG002|Overall Study|Other not stated above|1|||
105736199|NCT01022853|364689638|FG003|Overall Study|Other not stated above|0|||
105736200|NCT01022853|364689639|FG004|Overall Study|Other not stated above|0|||
105736201|NCT01971476|364689640|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
105354238|NCT05052697|363301300|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
105736202|NCT01971476|364689641|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
105736203|NCT01971476|364689642|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
105736204|NCT01971476|364689640|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
105354239|NCT05052697|363301301|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
105480907|NCT00796991|363771352|FG000|Overall Study|Disease Progression|10|||
105736205|NCT01971476|364689641|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
105480908|NCT00796991|363771353|FG001|Overall Study|Disease Progression|9|||
105480909|NCT00796991|363771354|FG002|Overall Study|Disease Progression|7|||
105480910|NCT00796991|363771352|FG000|Overall Study|Study Drug Toxicity|3|||
105736206|NCT01971476|364689642|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
105736207|NCT01971476|364689640|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
105736208|NCT01971476|364689641|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
105736209|NCT01971476|364689642|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
105736210|NCT02675517|364689646|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
105736211|NCT02675517|364689646|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
105736212|NCT01751646|364689651|FG000|Overall Study|Lost to Follow-up|5|||
105736213|NCT01751646|364689652|FG001|Overall Study|Lost to Follow-up|1|||
105736214|NCT01751646|364689651|FG000|Overall Study|Withdrawal by Subject|0|||
105736215|NCT01751646|364689652|FG001|Overall Study|Withdrawal by Subject|4|||
105736216|NCT01751646|364689651|FG000|Overall Study|Starting hormone therapy|1|||
105736217|NCT01751646|364689652|FG001|Overall Study|Starting hormone therapy|0|||
105736218|NCT01751646|364689651|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
105736219|NCT01751646|364689652|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
105736220|NCT01751646|364689651|FG000|Overall Study|Inadvertent enrollment|1|||
105736221|NCT01751646|364689652|FG001|Overall Study|Inadvertent enrollment|1|||
105736222|NCT01751646|364689651|FG000|Overall Study|Moved out of the area|1|||
105736223|NCT01751646|364689652|FG001|Overall Study|Moved out of the area|5|||
105736224|NCT01751646|364689651|FG000|Overall Study|Inability to attend required visits|0|||
105736225|NCT01751646|364689652|FG001|Overall Study|Inability to attend required visits|1|||
105736226|NCT01751646|364689651|FG000|Overall Study|Off study due to multiple obligations|0|||
105736227|NCT01751646|364689652|FG001|Overall Study|Off study due to multiple obligations|1|||
105736228|NCT01751646|364689651|FG000|Overall Study|Fails to comply with study requirements|0|||
105736229|NCT01751646|364689652|FG001|Overall Study|Fails to comply with study requirements|1|||
105736230|NCT01751646|364689651|FG000|Overall Study|Childcare issues|1|||
105736231|NCT01751646|364689652|FG001|Overall Study|Childcare issues|1|||
105736232|NCT00945191|364689653|FG000|Overall Study|Did not achieve a complete response|18|||
105736233|NCT00945191|364689653|FG000|Overall Study|Participant relocated to another state|1|||
105736234|NCT00945191|364689653|FG000|Overall Study|Disease progression|3|||
105736235|NCT00945191|364689653|FG000|Overall Study|Serious adverse event or adverse event|1|||
105736236|NCT00945191|364689653|FG000|Overall Study|Investigator's discretion|1|||
105736237|NCT00206518|364689654|FG000|Overall Study|Lack of Efficacy|6|||
105736238|NCT00206518|364689655|FG001|Overall Study|Lack of Efficacy|4|||
105736239|NCT00206518|364689654|FG000|Overall Study|Adverse Event|2|||
105736240|NCT00206518|364689655|FG001|Overall Study|Adverse Event|1|||
105736241|NCT00206518|364689654|FG000|Overall Study|Physician Decision|1|||
105736242|NCT00206518|364689655|FG001|Overall Study|Physician Decision|0|||
105736243|NCT00206518|364689654|FG000|Overall Study|Protocol Violation|1|||
105736244|NCT00206518|364689655|FG001|Overall Study|Protocol Violation|1|||
105736245|NCT02335450|364689656|FG000|Overall Study|Pregnancy|1|||
105736246|NCT02973815|364689661|FG000|Post Intervention|Death|1|||
105736247|NCT02973815|364689662|FG001|Post Intervention|Death|0|||
105736248|NCT02973815|364689661|FG000|Post Intervention|Lost to Follow-up|7|||
105736249|NCT02973815|364689662|FG001|Post Intervention|Lost to Follow-up|24|||
105736250|NCT02973815|364689661|FG000|Follow-up|Lost to Follow-up|2|||
105736251|NCT02973815|364689662|FG001|Follow-up|Lost to Follow-up|0|||
105736252|NCT02613572|364689663|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
105736253|NCT02613572|364689664|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
105736254|NCT02613572|364689665|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
105736255|NCT02613572|364689663|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
105736256|NCT02613572|364689664|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
105736257|NCT02613572|364689665|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
105736258|NCT01004146|364689670|FG000|Overall Study|Withdrawal by Subject|4|||
105736259|NCT01004146|364689671|FG001|Overall Study|Withdrawal by Subject|5|||
105736260|NCT05253807|364689676|FG000|Overall Study|Death|1|||
105736261|NCT05253807|364689677|FG001|Overall Study|Death|4|||
105736262|NCT05253807|364689676|FG000|Overall Study|Withdrawal by Subject|1|||
105736263|NCT05253807|364689677|FG001|Overall Study|Withdrawal by Subject|0|||
105736264|NCT05253807|364689676|FG000|Overall Study|Study Terminated by Sponsor|1|||
105736265|NCT05253807|364689677|FG001|Overall Study|Study Terminated by Sponsor|1|||
105736266|NCT00447421|364689678|FG000|Overall Study|Lack of Efficacy|1|||
105736267|NCT00447421|364689678|FG000|Overall Study|Adverse Event|3|||
105736268|NCT00447421|364689678|FG000|Overall Study|Sponsor Decision|2|||
105736269|NCT02124798|364689680|FG000|Overall Study|Adverse Event|3|||
105736270|NCT02124798|364689680|FG000|Overall Study|Lost to Follow-up|1|||
105736271|NCT01797432|364689683|FG000|Overall Study|Lost to Follow-up|1|||
105736272|NCT01797432|364689683|FG000|Overall Study|Adverse Event|1|||
105736273|NCT01797432|364689683|FG000|Overall Study|Withdrawal by Subject|1|||
105736274|NCT01797432|364689683|FG000|Overall Study|lived too far from study site|1|||
105736275|NCT02792777|364689684|FG000|Overall Study|Withdrawal by Subject|2|||
105736276|NCT02792777|364689685|FG001|Overall Study|Withdrawal by Subject|0|||
105736277|NCT02792777|364689684|FG000|Overall Study|Recording malfunction|2|||
105736278|NCT02792777|364689685|FG001|Overall Study|Recording malfunction|0|||
105736279|NCT02792777|364689684|FG000|Overall Study|Later determined to be ineligible|2|||
105736280|NCT02792777|364689685|FG001|Overall Study|Later determined to be ineligible|0|||
105736281|NCT02792777|364689684|FG000|Overall Study|Participant interviewed twice|1|||
105736282|NCT02792777|364689685|FG001|Overall Study|Participant interviewed twice|0|||
105736283|NCT02053246|364689686|FG000|Overall Study|Withdrawal by Subject|3|||
105736284|NCT02053246|364689686|FG000|Overall Study|Physician Decision|1|||
105736285|NCT02707757|364689687|FG000|Overall Study|Protocol Violation|3|||
105736286|NCT02707757|364689688|FG001|Overall Study|Protocol Violation|2|||
105736287|NCT02707757|364689687|FG000|Overall Study|Withdrawal by Subject|2|||
105736288|NCT02707757|364689688|FG001|Overall Study|Withdrawal by Subject|0|||
105736289|NCT02707757|364689687|FG000|Overall Study|Death|0|||
105736290|NCT02707757|364689688|FG001|Overall Study|Death|1|||
105736291|NCT02707757|364689687|FG000|Overall Study|Adverse Event|6|||
105736292|NCT02707757|364689688|FG001|Overall Study|Adverse Event|4|||
105736293|NCT02707757|364689687|FG000|Overall Study|Renal transplant/elective operation|1|||
105736294|NCT02707757|364689688|FG001|Overall Study|Renal transplant/elective operation|5|||
105736295|NCT03429556|364689689|FG000|Overall Study|Lost to Follow-up|0|||
105736296|NCT03429556|364689690|FG001|Overall Study|Lost to Follow-up|1|||
105736297|NCT03429556|364689691|FG002|Overall Study|Lost to Follow-up|0|||
105736298|NCT03429556|364689692|FG003|Overall Study|Lost to Follow-up|0|||
105354240|NCT05052697|363301302|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
105480911|NCT00796991|363771353|FG001|Overall Study|Study Drug Toxicity|3|||
105736299|NCT02746679|364689705|FG000|Overall Study|Lost to Follow-up|4|||
105736300|NCT02746679|364689706|FG001|Overall Study|Lost to Follow-up|6|||
105480912|NCT00796991|363771354|FG002|Overall Study|Study Drug Toxicity|5|||
105736301|NCT01118143|364689707|FG000|Overall Study|Withdrawal by Subject|2|||
105736302|NCT01118143|364689708|FG001|Overall Study|Withdrawal by Subject|5|||
105736303|NCT03268746|364691065|FG000|Overall Study|Withdrawal by Subject|1|||
105736304|NCT01629667|364691066|FG000|Overall Study|Lost to Follow-up|0|||
105736305|NCT01629667|364691067|FG001|Overall Study|Lost to Follow-up|1|||
105736306|NCT01629667|364691068|FG002|Overall Study|Lost to Follow-up|1|||
105799182|NCT04444752|364922707|FG001|Overall Study|Physician Decision|0|||
105480913|NCT00796991|363771352|FG000|Overall Study|Withdrawal by Subject|0|||
105480914|NCT00796991|363771353|FG001|Overall Study|Withdrawal by Subject|0|||
105480915|NCT00796991|363771354|FG002|Overall Study|Withdrawal by Subject|1|||
105480916|NCT00029146|363771356|FG000|Overall Study|Lost to Follow-up|2|||
105480917|NCT00029146|363771357|FG001|Overall Study|Lost to Follow-up|1|||
105480918|NCT01546623|363771358|FG000|Overall Study|Adverse Event|2|||
105480919|NCT01546623|363771359|FG001|Overall Study|Adverse Event|3|||
105480920|NCT01546623|363771358|FG000|Overall Study|Major Protocol Deviation|1|||
105480921|NCT01546623|363771359|FG001|Overall Study|Major Protocol Deviation|1|||
105480922|NCT01546623|363771358|FG000|Overall Study|High Prostate specific antigen|2|||
105480923|NCT01546623|363771359|FG001|Overall Study|High Prostate specific antigen|1|||
105480924|NCT01546623|363771358|FG000|Overall Study|Did Not Receive Study Drug|1|||
105480925|NCT01546623|363771359|FG001|Overall Study|Did Not Receive Study Drug|1|||
105480926|NCT03567343|363771361|FG000|Overall Study|Lost to Follow-up|2|||
105480927|NCT03567343|363771362|FG001|Overall Study|Lost to Follow-up|1|||
105480928|NCT03567343|363771361|FG000|Overall Study|No longer eligible|2|||
105480929|NCT03567343|363771362|FG001|Overall Study|No longer eligible|1|||
105480930|NCT03567343|363771361|FG000|Overall Study|Adverse Event|1|||
105480931|NCT03567343|363771362|FG001|Overall Study|Adverse Event|0|||
105480932|NCT03567343|363771361|FG000|Overall Study|Protocol Violation|1|||
105480933|NCT03567343|363771362|FG001|Overall Study|Protocol Violation|1|||
105480934|NCT03148691|363771363|FG000|Overall Study|Protocol Violation|1|||
105480935|NCT03148691|363771364|FG001|Overall Study|Protocol Violation|2|||
105480936|NCT03148691|363771365|FG002|Overall Study|Protocol Violation|7|||
105480937|NCT03148691|363771363|FG000|Overall Study|Lost to Follow-up|0|||
105480938|NCT03148691|363771364|FG001|Overall Study|Lost to Follow-up|0|||
105480939|NCT03148691|363771365|FG002|Overall Study|Lost to Follow-up|1|||
105480940|NCT03148691|363771363|FG000|Overall Study|Other|1|||
105480941|NCT03148691|363771364|FG001|Overall Study|Other|0|||
105480942|NCT03148691|363771365|FG002|Overall Study|Other|0|||
105480943|NCT03148691|363771363|FG000|Overall Study|Withdrawal by Subject|1|||
105480944|NCT03148691|363771364|FG001|Overall Study|Withdrawal by Subject|0|||
105480945|NCT03148691|363771365|FG002|Overall Study|Withdrawal by Subject|0|||
105480946|NCT00834080|363771366|FG000|Overall Study|Adverse Event|7|||
105480947|NCT00834080|363771366|FG000|Overall Study|Lost to Follow-up|7|||
105480948|NCT00834080|363771366|FG000|Overall Study|Withdrawal by Subject|5|||
105480949|NCT00834080|363771366|FG000|Overall Study|Other - Pregnancy|1|||
105480950|NCT00834080|363771366|FG000|Overall Study|Other - False positive tests of the UDS|1|||
105480951|NCT00834080|363771366|FG000|Overall Study|Physician Decision|1|||
105480952|NCT00834080|363771366|FG000|Overall Study|Subject Relocated|1|||
105480953|NCT00321646|363771367|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
105480954|NCT00321646|363771367|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
105480955|NCT00321646|363771367|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
105480956|NCT00392379|363771368|FG000|Overall Study|Withdrawal by Subject|17|||
105480957|NCT00392379|363771369|FG001|Overall Study|Withdrawal by Subject|28|||
105480958|NCT00392379|363771368|FG000|Overall Study|Lost to Follow-up|4|||
105480959|NCT00392379|363771369|FG001|Overall Study|Lost to Follow-up|9|||
105480960|NCT00392379|363771368|FG000|Overall Study|Adverse Event|1|||
105480961|NCT00392379|363771369|FG001|Overall Study|Adverse Event|1|||
105480962|NCT02365233|363771374|FG000|Overall Study|IRB withheld the data|1|||
105480963|NCT02365233|363771375|FG001|Overall Study|IRB withheld the data|2|||
105480964|NCT02365233|363771376|FG002|Overall Study|IRB withheld the data|2|||
105480965|NCT04604132|363771377|FG000|Overall Study|Adverse Event|2|||
105480966|NCT04604132|363771378|FG001|Overall Study|Adverse Event|0|||
105480967|NCT04604132|363771379|FG002|Overall Study|Adverse Event|0|||
105736307|NCT01629667|364691066|FG000|Overall Study|Withdrawal by Subject|31|||
105736308|NCT01629667|364691067|FG001|Overall Study|Withdrawal by Subject|20|||
105736309|NCT01629667|364691068|FG002|Overall Study|Withdrawal by Subject|28|||
105736310|NCT01629667|364691066|FG000|Overall Study|Death|1|||
105736311|NCT01629667|364691067|FG001|Overall Study|Death|5|||
105736312|NCT01629667|364691068|FG002|Overall Study|Death|3|||
105736313|NCT01629667|364691066|FG000|Overall Study|Randomized, not treated|2|||
105736314|NCT01629667|364691067|FG001|Overall Study|Randomized, not treated|1|||
105736315|NCT01629667|364691068|FG002|Overall Study|Randomized, not treated|0|||
105480968|NCT04604132|363771380|FG003|Overall Study|Adverse Event|1|||
105480969|NCT04604132|363771381|FG004|Overall Study|Adverse Event|2|||
105480970|NCT04604132|363771377|FG000|Overall Study|Study terminated by sponsor|0|||
105480971|NCT04604132|363771378|FG001|Overall Study|Study terminated by sponsor|0|||
105736316|NCT01629667|364691066|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
105736317|NCT01629667|364691067|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
105480972|NCT04604132|363771379|FG002|Overall Study|Study terminated by sponsor|0|||
105480973|NCT04604132|363771380|FG003|Overall Study|Study terminated by sponsor|0|||
105480974|NCT04604132|363771381|FG004|Overall Study|Study terminated by sponsor|1|||
105480975|NCT04604132|363771377|FG000|Overall Study|Progressive disease: Clinical progression|0|||
105480976|NCT04604132|363771378|FG001|Overall Study|Progressive disease: Clinical progression|0|||
105480977|NCT04604132|363771379|FG002|Overall Study|Progressive disease: Clinical progression|1|||
105480978|NCT04604132|363771380|FG003|Overall Study|Progressive disease: Clinical progression|0|||
105480979|NCT04604132|363771381|FG004|Overall Study|Progressive disease: Clinical progression|0|||
105480980|NCT04604132|363771377|FG000|Overall Study|Progressive disease: Radiological progression|8|||
105480981|NCT04604132|363771378|FG001|Overall Study|Progressive disease: Radiological progression|7|||
105480982|NCT04604132|363771379|FG002|Overall Study|Progressive disease: Radiological progression|10|||
105480983|NCT04604132|363771380|FG003|Overall Study|Progressive disease: Radiological progression|4|||
105480984|NCT04604132|363771381|FG004|Overall Study|Progressive disease: Radiological progression|3|||
105480985|NCT04604132|363771377|FG000|Overall Study|Death|3|||
105736318|NCT01629667|364691068|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
105736319|NCT01629667|364691066|FG000|Overall Study|Requiring lung transplant|2|||
105736320|NCT01629667|364691067|FG001|Overall Study|Requiring lung transplant|1|||
105736321|NCT01629667|364691068|FG002|Overall Study|Requiring lung transplant|3|||
105736322|NCT01629667|364691066|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
105736323|NCT01629667|364691067|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
105736324|NCT01629667|364691068|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
105736325|NCT01629667|364691066|FG000|Overall Study|Started other medicine|1|||
105736326|NCT01629667|364691067|FG001|Overall Study|Started other medicine|0|||
105736327|NCT01629667|364691068|FG002|Overall Study|Started other medicine|1|||
105736328|NCT01629667|364691066|FG000|Overall Study|Site error in safety follow-up|0|||
105736329|NCT01629667|364691067|FG001|Overall Study|Site error in safety follow-up|0|||
105736330|NCT01629667|364691068|FG002|Overall Study|Site error in safety follow-up|1|||
105736331|NCT01629667|364691066|FG000|Overall Study|Enrolled in another clinical study|0|||
105736332|NCT01629667|364691067|FG001|Overall Study|Enrolled in another clinical study|1|||
105736333|NCT01629667|364691068|FG002|Overall Study|Enrolled in another clinical study|0|||
105736334|NCT01629667|364691066|FG000|Overall Study|Code break|1|||
105480986|NCT04604132|363771378|FG001|Overall Study|Death|1|||
105480987|NCT04604132|363771379|FG002|Overall Study|Death|2|||
105480988|NCT04604132|363771380|FG003|Overall Study|Death|1|||
105480989|NCT04604132|363771381|FG004|Overall Study|Death|0|||
105480990|NCT00995566|363771382|FG000|Overall Study|Adverse Event|2|||
105480991|NCT00995566|363771382|FG000|Overall Study|Early study termination|52|||
105736335|NCT01629667|364691067|FG001|Overall Study|Code break|0|||
105480992|NCT00510653|363771383|FG000|Overall Study|Withdrawal by Subject|8|||
105736336|NCT01629667|364691068|FG002|Overall Study|Code break|0|||
105736337|NCT01319929|364691070|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
105736338|NCT01319929|364691071|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
105736339|NCT01319929|364691070|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
105736340|NCT01319929|364691071|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
105736341|NCT01319929|364691070|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
105736342|NCT01319929|364691071|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
105736343|NCT01319929|364691070|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
105354241|NCT05052697|363301303|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
105354242|NCT05052697|363301304|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105354243|NCT05052697|363301271|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354244|NCT05052697|363301272|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354245|NCT05052697|363301273|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354246|NCT05052697|363301274|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354247|NCT05052697|363301275|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354248|NCT05052697|363301276|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354249|NCT05052697|363301277|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354250|NCT05052697|363301278|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354251|NCT05052697|363301279|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354252|NCT05052697|363301280|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354253|NCT05052697|363301281|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354254|NCT05052697|363301282|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354255|NCT05052697|363301283|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354256|NCT05052697|363301284|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354257|NCT05052697|363301285|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354258|NCT05052697|363301286|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354259|NCT05052697|363301287|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354260|NCT05052697|363301288|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354261|NCT05052697|363301289|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354262|NCT05052697|363301290|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354263|NCT05052697|363301291|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354264|NCT05052697|363301292|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354265|NCT05052697|363301293|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354266|NCT05052697|363301294|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354267|NCT05052697|363301295|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354268|NCT05052697|363301296|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354269|NCT05052697|363301297|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354270|NCT05052697|363301298|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354271|NCT05052697|363301299|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354272|NCT05052697|363301300|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354273|NCT05052697|363301301|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354274|NCT05052697|363301302|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354275|NCT05052697|363301303|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
105354276|NCT05052697|363301304|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105354277|NCT05052697|363301271|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354278|NCT05052697|363301272|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354279|NCT05052697|363301273|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354280|NCT05052697|363301274|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354281|NCT05052697|363301275|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354282|NCT05052697|363301276|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354283|NCT05052697|363301277|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354284|NCT05052697|363301278|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354285|NCT05052697|363301279|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354286|NCT05052697|363301280|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354287|NCT05052697|363301281|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354288|NCT05052697|363301282|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354289|NCT05052697|363301283|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354290|NCT05052697|363301284|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354291|NCT05052697|363301285|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354292|NCT05052697|363301286|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354293|NCT05052697|363301287|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354294|NCT05052697|363301288|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354295|NCT05052697|363301289|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354296|NCT05052697|363301290|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354297|NCT05052697|363301291|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354298|NCT05052697|363301292|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105736344|NCT01319929|364691071|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
105736345|NCT01319929|364691070|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
105480993|NCT00510653|363771383|FG000|Overall Study|Monetary|3|||
105799183|NCT04444752|364922708|FG002|Overall Study|Physician Decision|0|||
105354299|NCT05052697|363301293|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354300|NCT05052697|363301294|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354301|NCT05052697|363301295|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354302|NCT05052697|363301296|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354303|NCT05052697|363301297|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354304|NCT05052697|363301298|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354305|NCT05052697|363301299|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
105354306|NCT05052697|363301300|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
105354307|NCT05052697|363301301|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
105354308|NCT05052697|363301302|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354309|NCT05052697|363301303|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354310|NCT05052697|363301304|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105354311|NCT00528372|363301308|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
105354312|NCT00528372|363301309|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105354313|NCT00528372|363301310|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105354314|NCT00528372|363301311|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105354315|NCT00528372|363301312|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105354316|NCT00528372|363301313|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105354317|NCT00528372|363301314|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105354318|NCT00528372|363301315|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105354319|NCT00528372|363301316|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105354320|NCT00528372|363301308|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
105354321|NCT00528372|363301309|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
105354322|NCT00528372|363301310|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
105354323|NCT00528372|363301311|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
105354324|NCT00528372|363301312|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
105354325|NCT00528372|363301313|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
105354326|NCT00528372|363301314|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
105354327|NCT00528372|363301315|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
105354328|NCT00528372|363301316|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
105354329|NCT00528372|363301308|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
105354330|NCT00528372|363301309|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
105354331|NCT00528372|363301310|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
105354332|NCT00528372|363301311|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
105354333|NCT00528372|363301312|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
105354334|NCT00528372|363301313|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
105354335|NCT00528372|363301314|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
105354336|NCT00528372|363301315|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
105354337|NCT00528372|363301316|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
105354338|NCT00528372|363301308|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
105354339|NCT00528372|363301309|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
105354340|NCT00528372|363301310|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
105354341|NCT00528372|363301311|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
105354342|NCT00528372|363301312|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
105354343|NCT00528372|363301313|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
105354344|NCT00528372|363301314|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
105354345|NCT00528372|363301315|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
105354346|NCT00528372|363301316|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
105354347|NCT00528372|363301308|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
105354348|NCT00528372|363301309|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
105354349|NCT00528372|363301310|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
105354350|NCT00528372|363301311|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
105354351|NCT00528372|363301312|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
105354352|NCT00528372|363301313|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
105354353|NCT00528372|363301314|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
105354354|NCT00528372|363301315|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
105354355|NCT00528372|363301316|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
105354356|NCT00528372|363301308|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
105354357|NCT00528372|363301309|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
105354358|NCT00528372|363301310|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
105354359|NCT00528372|363301311|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
105354360|NCT00528372|363301312|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
105480994|NCT01924429|363771385|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
105480995|NCT01924429|363771386|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
105480996|NCT03720652|363771389|FG000|Overall Study|Withdrawal by Subject|2|||
105480997|NCT03720652|363771390|FG001|Overall Study|Withdrawal by Subject|7|||
105354361|NCT00528372|363301313|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
105354362|NCT00528372|363301314|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
105354363|NCT00528372|363301315|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
105354364|NCT00528372|363301316|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
105354365|NCT00528372|363301308|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
105354366|NCT00528372|363301309|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
105354367|NCT00528372|363301310|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
105354368|NCT00528372|363301311|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
105354369|NCT00528372|363301312|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
105354370|NCT00528372|363301313|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
105354371|NCT00528372|363301314|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
105480998|NCT03720652|363771389|FG000|Overall Study|Lost to Follow-up|0|||
105480999|NCT03720652|363771390|FG001|Overall Study|Lost to Follow-up|4|||
105481000|NCT01454778|363771392|FG000|Overall Study|Lost to Follow-up|2|||
105481001|NCT01454778|363771392|FG000|Overall Study|Death|1|||
105481002|NCT00835731|363771393|FG000|Overall Study|Withdrawal by Subject|1|||
105481003|NCT00835731|363771394|FG001|Overall Study|Withdrawal by Subject|0|||
105481004|NCT00835731|363771393|FG000|Overall Study|Physician Decision|1|||
105481005|NCT00835731|363771394|FG001|Overall Study|Physician Decision|1|||
105481006|NCT00348881|363771395|FG000|Overall Study|Lost to Follow-up|12|||
105481007|NCT00348881|363771396|FG001|Overall Study|Lost to Follow-up|6|||
105481008|NCT00348881|363771395|FG000|Overall Study|Withdrawal by Subject|3|||
105481009|NCT00348881|363771396|FG001|Overall Study|Withdrawal by Subject|4|||
105481010|NCT00348881|363771395|FG000|Overall Study|Adverse Event|2|||
105481011|NCT00348881|363771396|FG001|Overall Study|Adverse Event|0|||
105481012|NCT00348881|363771395|FG000|Overall Study|Serious Adverse Event|0|||
105481013|NCT00348881|363771396|FG001|Overall Study|Serious Adverse Event|2|||
105481014|NCT00534599|363771397|FG000|Overall Study|Adverse Event|25|||
105481015|NCT00534599|363771398|FG001|Overall Study|Adverse Event|4|||
105481016|NCT00534599|363771397|FG000|Overall Study|Incorrect enrollment|2|||
105481017|NCT00534599|363771398|FG001|Overall Study|Incorrect enrollment|1|||
105481018|NCT00534599|363771397|FG000|Overall Study|Mis-randomization|2|||
105481019|NCT00534599|363771398|FG001|Overall Study|Mis-randomization|2|||
105481020|NCT00534599|363771397|FG000|Overall Study|Developed study-specific d/c criteria|5|||
105481021|NCT00534599|363771398|FG001|Overall Study|Developed study-specific d/c criteria|0|||
105481022|NCT00534599|363771397|FG000|Overall Study|Lack of Efficacy|0|||
105481023|NCT00534599|363771398|FG001|Overall Study|Lack of Efficacy|1|||
105481024|NCT00534599|363771397|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
105481025|NCT00534599|363771398|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
105481026|NCT00534599|363771397|FG000|Overall Study|Protocol Violation|1|||
105481027|NCT00534599|363771398|FG001|Overall Study|Protocol Violation|3|||
105481028|NCT00534599|363771397|FG000|Overall Study|Lost to Follow-up|11|||
105481029|NCT00534599|363771398|FG001|Overall Study|Lost to Follow-up|14|||
105481030|NCT00534599|363771397|FG000|Overall Study|Withdrawal by Subject|4|||
105481031|NCT00534599|363771398|FG001|Overall Study|Withdrawal by Subject|6|||
105481032|NCT00534599|363771397|FG000|Overall Study|Other|7|||
105481033|NCT00534599|363771398|FG001|Overall Study|Other|0|||
105481034|NCT00535288|363773450|FG000|Overall Study|Adverse Event|20|||
105481035|NCT00535288|363773451|FG001|Overall Study|Adverse Event|19|||
105481036|NCT00535288|363773452|FG002|Overall Study|Adverse Event|25|||
105481037|NCT00535288|363773453|FG003|Overall Study|Adverse Event|20|||
105481038|NCT00535288|363773454|FG004|Overall Study|Adverse Event|30|||
105799184|NCT04444752|364922709|FG003|Overall Study|Physician Decision|2|||
105481039|NCT00535288|363773450|FG000|Overall Study|Lost to Follow-up|0|||
105481040|NCT00535288|363773451|FG001|Overall Study|Lost to Follow-up|3|||
105481041|NCT00535288|363773452|FG002|Overall Study|Lost to Follow-up|0|||
105481042|NCT00535288|363773453|FG003|Overall Study|Lost to Follow-up|0|||
105481043|NCT00535288|363773454|FG004|Overall Study|Lost to Follow-up|0|||
105481044|NCT00535288|363773450|FG000|Overall Study|Lack of Efficacy|26|||
105481045|NCT00535288|363773451|FG001|Overall Study|Lack of Efficacy|3|||
105481046|NCT00535288|363773452|FG002|Overall Study|Lack of Efficacy|4|||
105481047|NCT00535288|363773453|FG003|Overall Study|Lack of Efficacy|4|||
105481048|NCT00535288|363773454|FG004|Overall Study|Lack of Efficacy|7|||
105481049|NCT00535288|363773450|FG000|Overall Study|Unwilling to cooperate|6|||
105799185|NCT04444752|364922706|FG000|Overall Study|Pregnancy|0|||
105481050|NCT00535288|363773451|FG001|Overall Study|Unwilling to cooperate|6|||
105481051|NCT00535288|363773452|FG002|Overall Study|Unwilling to cooperate|3|||
105481052|NCT00535288|363773453|FG003|Overall Study|Unwilling to cooperate|3|||
105481053|NCT00535288|363773454|FG004|Overall Study|Unwilling to cooperate|4|||
105481054|NCT00535288|363773450|FG000|Overall Study|Other|2|||
105481055|NCT00535288|363773451|FG001|Overall Study|Other|1|||
105481056|NCT00535288|363773452|FG002|Overall Study|Other|1|||
105481057|NCT00535288|363773453|FG003|Overall Study|Other|2|||
105481058|NCT00535288|363773454|FG004|Overall Study|Other|1|||
105481059|NCT00830869|363773457|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
105799186|NCT04444752|364922707|FG001|Overall Study|Pregnancy|0|||
105736346|NCT01319929|364691071|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
105354372|NCT00528372|363301315|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
105354373|NCT00528372|363301316|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
105354374|NCT00528372|363301308|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
105354375|NCT00528372|363301309|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
105354376|NCT00528372|363301310|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
105354377|NCT00528372|363301311|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
105354378|NCT00528372|363301312|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
105354379|NCT00528372|363301313|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
105354380|NCT00528372|363301314|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
105354381|NCT00528372|363301315|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
105354382|NCT00528372|363301316|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
105354383|NCT00528372|363301308|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
105354384|NCT00528372|363301309|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
105354385|NCT00528372|363301310|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
105354386|NCT00528372|363301311|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
105354387|NCT00528372|363301312|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
105354388|NCT00528372|363301313|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
105354389|NCT00528372|363301314|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
105354390|NCT00528372|363301315|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
105354391|NCT00528372|363301316|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
105354392|NCT00528372|363301308|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
105354393|NCT00528372|363301309|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
105354394|NCT00528372|363301310|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
105354395|NCT00528372|363301311|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
105354396|NCT00528372|363301312|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
105354397|NCT00528372|363301313|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
105354398|NCT00528372|363301314|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
105354399|NCT00528372|363301315|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
105354400|NCT00528372|363301316|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
105354401|NCT00528372|363301308|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
105354402|NCT00528372|363301309|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
105354403|NCT00528372|363301310|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
105354404|NCT00528372|363301311|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
105354405|NCT00528372|363301312|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
105354406|NCT00528372|363301313|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
105354407|NCT00528372|363301314|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
105354408|NCT00528372|363301315|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
105354409|NCT00528372|363301316|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
105354410|NCT00528372|363301308|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
105354411|NCT00528372|363301309|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
105736347|NCT01749735|364691072|FG000|Overall Study|Withdrawal by Subject|1|||
105736348|NCT01749735|364691073|FG001|Overall Study|Withdrawal by Subject|0|||
105736349|NCT01645280|364691074|FG000|Overall Study|Death|0|||
105736350|NCT01645280|364691075|FG001|Overall Study|Death|1|||
105736351|NCT01645280|364691076|FG002|Overall Study|Death|0|||
105736352|NCT01645280|364691077|FG003|Overall Study|Death|0|||
105736353|NCT01645280|364691078|FG004|Overall Study|Death|0|||
105736354|NCT01645280|364691074|FG000|Overall Study|Withdrawal by Subject|4|||
105736355|NCT01645280|364691075|FG001|Overall Study|Withdrawal by Subject|0|||
105736356|NCT01645280|364691076|FG002|Overall Study|Withdrawal by Subject|2|||
105736357|NCT01645280|364691077|FG003|Overall Study|Withdrawal by Subject|4|||
105736358|NCT01645280|364691078|FG004|Overall Study|Withdrawal by Subject|5|||
105736359|NCT01645280|364691074|FG000|Overall Study|Lost to Follow-up|0|||
105736360|NCT01645280|364691075|FG001|Overall Study|Lost to Follow-up|0|||
105736361|NCT01645280|364691076|FG002|Overall Study|Lost to Follow-up|0|||
105736362|NCT01645280|364691077|FG003|Overall Study|Lost to Follow-up|2|||
105736363|NCT01645280|364691078|FG004|Overall Study|Lost to Follow-up|1|||
105736364|NCT01645280|364691074|FG000|Overall Study|Other|1|||
105736365|NCT01645280|364691075|FG001|Overall Study|Other|1|||
105354412|NCT00528372|363301310|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
105354413|NCT00528372|363301311|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
105354414|NCT00528372|363301312|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
105736366|NCT01645280|364691076|FG002|Overall Study|Other|2|||
105736367|NCT01645280|364691077|FG003|Overall Study|Other|0|||
105736368|NCT01645280|364691078|FG004|Overall Study|Other|0|||
105736369|NCT01645280|364691074|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
105736370|NCT01645280|364691075|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
105736371|NCT01645280|364691076|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
105799187|NCT04444752|364922708|FG002|Overall Study|Pregnancy|0|||
105799188|NCT04444752|364922709|FG003|Overall Study|Pregnancy|1|||
105799189|NCT04444752|364922706|FG000|Overall Study|Withdrawal by Subject|6|||
105799190|NCT04444752|364922707|FG001|Overall Study|Withdrawal by Subject|5|||
105799191|NCT04444752|364922708|FG002|Overall Study|Withdrawal by Subject|3|||
105799192|NCT04444752|364922709|FG003|Overall Study|Withdrawal by Subject|4|||
105799193|NCT04444752|364922706|FG000|Overall Study|Protocol Violation|1|||
105799194|NCT04444752|364922707|FG001|Overall Study|Protocol Violation|1|||
105799195|NCT04444752|364922708|FG002|Overall Study|Protocol Violation|0|||
105799196|NCT04444752|364922709|FG003|Overall Study|Protocol Violation|0|||
105799197|NCT04444752|364922706|FG000|Overall Study|Patient moving out of town|1|||
105799198|NCT04444752|364922707|FG001|Overall Study|Patient moving out of town|0|||
105799199|NCT04444752|364922708|FG002|Overall Study|Patient moving out of town|0|||
105799200|NCT04444752|364922709|FG003|Overall Study|Patient moving out of town|1|||
105799201|NCT04444752|364922706|FG000|Overall Study|Lack of Efficacy|0|||
105354415|NCT00528372|363301313|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
105799202|NCT04444752|364922707|FG001|Overall Study|Lack of Efficacy|0|||
105799203|NCT04444752|364922708|FG002|Overall Study|Lack of Efficacy|0|||
105799204|NCT04444752|364922709|FG003|Overall Study|Lack of Efficacy|1|||
105799205|NCT04444752|364922706|FG000|Overall Study|Death|0|||
105799206|NCT04444752|364922707|FG001|Overall Study|Death|0|||
105354416|NCT00528372|363301314|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
105799207|NCT04444752|364922708|FG002|Overall Study|Death|1|||
105799208|NCT04444752|364922709|FG003|Overall Study|Death|0|||
105799209|NCT00579254|364922710|FG000|Overall Study|Lost to Follow-up|39|||
105354417|NCT00528372|363301315|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
105354418|NCT00528372|363301316|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
105354419|NCT00528372|363301308|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
105354420|NCT00528372|363301309|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
105354421|NCT00528372|363301310|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
105354422|NCT00528372|363301311|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
105354423|NCT00528372|363301312|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
105354424|NCT00528372|363301313|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
105354425|NCT00528372|363301314|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
105354426|NCT00528372|363301315|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
105354427|NCT00528372|363301316|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
105354428|NCT00528372|363301308|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
105354429|NCT00528372|363301309|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
105354430|NCT00528372|363301310|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
105354431|NCT00528372|363301311|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
105354432|NCT00528372|363301312|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
105354433|NCT00528372|363301313|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
105354434|NCT00528372|363301314|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
105354435|NCT00528372|363301315|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
105354436|NCT00528372|363301316|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
105354437|NCT00528372|363301308|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
105354438|NCT00528372|363301309|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
105354439|NCT00528372|363301310|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
105354440|NCT00528372|363301311|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
105354441|NCT00528372|363301312|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
105354442|NCT00528372|363301313|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
105354443|NCT00528372|363301314|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
105354444|NCT00528372|363301315|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
105354445|NCT00528372|363301316|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
105354446|NCT02226120|363301319|FG000|Overall Study|Adverse Event|60|||
105354447|NCT02226120|363301319|FG000|Overall Study|Death|172|||
105354448|NCT02226120|363301319|FG000|Overall Study|Study terminated by sponsor|1|||
105354449|NCT02226120|363301319|FG000|Overall Study|Technical problems|4|||
105354450|NCT02226120|363301319|FG000|Overall Study|Lost to Follow-up|13|||
105354451|NCT02226120|363301319|FG000|Overall Study|Physician Decision|21|||
105354452|NCT02226120|363301319|FG000|Overall Study|Withdrawal by parent/guardian|36|||
105354453|NCT02226120|363301319|FG000|Overall Study|Non-compliance with study drug|10|||
105354454|NCT02226120|363301319|FG000|Overall Study|Protocol deviation|1|||
105354455|NCT02226120|363301319|FG000|Overall Study|missing treatment disposition pages|2|||
105354456|NCT01153009|363303274|FG000|Overall Study|Adverse Event|4|||
105354457|NCT01153009|363303275|FG001|Overall Study|Adverse Event|14|||
105354458|NCT01153009|363303276|FG002|Overall Study|Adverse Event|14|||
105481060|NCT00830869|363773458|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
105481061|NCT00830869|363773459|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
105481062|NCT00830869|363773460|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
105481063|NCT00830869|363773461|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
105799210|NCT00579254|364922710|FG000|Overall Study|Discontinued when study terminated|73|||
105354459|NCT01153009|363303277|FG003|Overall Study|Adverse Event|10|||
105354460|NCT01153009|363303274|FG000|Overall Study|Lack of Efficacy|9|||
105354461|NCT01153009|363303275|FG001|Overall Study|Lack of Efficacy|0|||
105354462|NCT01153009|363303276|FG002|Overall Study|Lack of Efficacy|2|||
105481064|NCT00830869|363773462|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
105481065|NCT00830869|363773463|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
105481066|NCT00830869|363773464|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
105481067|NCT00830869|363773465|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
105481068|NCT00830869|363773466|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
105481069|NCT00830869|363773467|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
105481070|NCT00830869|363773468|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
105481071|NCT00830869|363773457|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
105481072|NCT00830869|363773458|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
105481073|NCT00830869|363773459|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
105481074|NCT00830869|363773460|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
105481075|NCT00830869|363773461|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
105481076|NCT00830869|363773462|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
105481077|NCT00830869|363773463|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
105481078|NCT00830869|363773464|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
105481079|NCT00830869|363773465|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
105481080|NCT00830869|363773466|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
105481081|NCT00830869|363773467|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
105481082|NCT00830869|363773468|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
105481083|NCT00830869|363773457|FG000|Period 1: Part 1|Adverse Event|0|||
105481084|NCT00830869|363773458|FG001|Period 1: Part 1|Adverse Event|0|||
105481085|NCT00830869|363773459|FG002|Period 1: Part 1|Adverse Event|0|||
105481086|NCT00830869|363773460|FG003|Period 1: Part 1|Adverse Event|0|||
105481087|NCT00830869|363773461|FG004|Period 1: Part 1|Adverse Event|0|||
105481088|NCT00830869|363773462|FG005|Period 1: Part 1|Adverse Event|1|||
105481089|NCT00830869|363773463|FG006|Period 1: Part 1|Adverse Event|1|||
105481090|NCT00830869|363773464|FG007|Period 1: Part 1|Adverse Event|0|||
105481091|NCT00830869|363773465|FG008|Period 1: Part 1|Adverse Event|0|||
105481092|NCT00830869|363773466|FG009|Period 1: Part 1|Adverse Event|0|||
105481093|NCT00830869|363773467|FG010|Period 1: Part 1|Adverse Event|0|||
105481094|NCT00830869|363773468|FG011|Period 1: Part 1|Adverse Event|0|||
105481095|NCT00830869|363773457|FG000|Period 1: Part 1|Progressive disease|1|||
105481096|NCT00830869|363773458|FG001|Period 1: Part 1|Progressive disease|0|||
105481097|NCT00830869|363773459|FG002|Period 1: Part 1|Progressive disease|1|||
105481098|NCT00830869|363773460|FG003|Period 1: Part 1|Progressive disease|6|||
105481099|NCT00830869|363773461|FG004|Period 1: Part 1|Progressive disease|4|||
105481100|NCT00830869|363773462|FG005|Period 1: Part 1|Progressive disease|4|||
105481101|NCT00830869|363773463|FG006|Period 1: Part 1|Progressive disease|1|||
105481102|NCT00830869|363773464|FG007|Period 1: Part 1|Progressive disease|0|||
105481103|NCT00830869|363773465|FG008|Period 1: Part 1|Progressive disease|0|||
105481104|NCT00830869|363773466|FG009|Period 1: Part 1|Progressive disease|0|||
105481105|NCT00830869|363773467|FG010|Period 1: Part 1|Progressive disease|0|||
105481106|NCT00830869|363773468|FG011|Period 1: Part 1|Progressive disease|0|||
105481107|NCT00830869|363773457|FG000|Period 2: Part 2|Protocol Violation|0|||
105481108|NCT00830869|363773458|FG001|Period 2: Part 2|Protocol Violation|0|||
105481109|NCT00830869|363773459|FG002|Period 2: Part 2|Protocol Violation|0|||
105481110|NCT00830869|363773460|FG003|Period 2: Part 2|Protocol Violation|0|||
105481111|NCT00830869|363773461|FG004|Period 2: Part 2|Protocol Violation|0|||
105481112|NCT00830869|363773462|FG005|Period 2: Part 2|Protocol Violation|0|||
105481113|NCT00830869|363773463|FG006|Period 2: Part 2|Protocol Violation|0|||
105481114|NCT00830869|363773464|FG007|Period 2: Part 2|Protocol Violation|1|||
105481115|NCT00830869|363773465|FG008|Period 2: Part 2|Protocol Violation|0|||
105481116|NCT00830869|363773466|FG009|Period 2: Part 2|Protocol Violation|1|||
105481117|NCT00830869|363773467|FG010|Period 2: Part 2|Protocol Violation|0|||
105481118|NCT00830869|363773468|FG011|Period 2: Part 2|Protocol Violation|0|||
105481119|NCT00830869|363773457|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
105481120|NCT00830869|363773458|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
105736372|NCT01645280|364691077|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
105736373|NCT01645280|364691078|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
105736374|NCT00234104|364691079|FG000|Overall Study|Adverse Event|4|||
105736375|NCT00234104|364691080|FG001|Overall Study|Adverse Event|0|||
105736376|NCT00234104|364691081|FG002|Overall Study|Adverse Event|3|||
105736377|NCT00234104|364691082|FG003|Overall Study|Adverse Event|5|||
105736378|NCT00234104|364691079|FG000|Overall Study|Protocol Violation|0|||
105736379|NCT00234104|364691080|FG001|Overall Study|Protocol Violation|0|||
105481121|NCT00830869|363773459|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
105481122|NCT00830869|363773460|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
105481123|NCT00830869|363773461|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
105481124|NCT00830869|363773462|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
105481125|NCT00830869|363773463|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
105481126|NCT00830869|363773464|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
105481127|NCT00830869|363773465|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
105481128|NCT00830869|363773466|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
105481129|NCT00830869|363773467|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
105565084|NCT01529008|364066678|FG001|Bone Marrow Harvesting|Physician Decision|1|||
105736380|NCT00234104|364691081|FG002|Overall Study|Protocol Violation|0|||
105736381|NCT00234104|364691082|FG003|Overall Study|Protocol Violation|1|||
105736382|NCT00234104|364691079|FG000|Overall Study|Physician Decision|0|||
105736383|NCT00234104|364691080|FG001|Overall Study|Physician Decision|1|||
105736384|NCT00234104|364691081|FG002|Overall Study|Physician Decision|2|||
105736385|NCT00234104|364691082|FG003|Overall Study|Physician Decision|2|||
105736386|NCT00546819|364691085|FG000|Overall Study|Adverse Event|2|||
105736387|NCT00546819|364691086|FG001|Overall Study|Adverse Event|3|||
105736388|NCT00546819|364691085|FG000|Overall Study|Lost to Follow-up|2|||
105736389|NCT00546819|364691086|FG001|Overall Study|Lost to Follow-up|1|||
105736390|NCT00546819|364691085|FG000|Overall Study|Withdrawal by Subject|4|||
105736391|NCT00546819|364691086|FG001|Overall Study|Withdrawal by Subject|2|||
105736392|NCT00858702|364691089|FG000|Overall Study|Lack of Efficacy|1|||
105736393|NCT00858702|364691090|FG001|Overall Study|Lack of Efficacy|0|||
105736394|NCT00858702|364691089|FG000|Overall Study|Protocol Violation|1|||
105736395|NCT00858702|364691090|FG001|Overall Study|Protocol Violation|1|||
105736396|NCT00858702|364691089|FG000|Overall Study|Other|2|||
105736397|NCT00858702|364691090|FG001|Overall Study|Other|1|||
105354463|NCT01153009|363303277|FG003|Overall Study|Lack of Efficacy|1|||
105354464|NCT01153009|363303274|FG000|Overall Study|Noncompliance with Study Medication|1|||
105354465|NCT01153009|363303275|FG001|Overall Study|Noncompliance with Study Medication|3|||
105799211|NCT01606137|364922711|FG000|Overall Study|Adverse Event|85|||
105354466|NCT01153009|363303276|FG002|Overall Study|Noncompliance with Study Medication|4|||
105354467|NCT01153009|363303277|FG003|Overall Study|Noncompliance with Study Medication|1|||
105354468|NCT01153009|363303274|FG000|Overall Study|Protocol Deviations|4|||
105354469|NCT01153009|363303275|FG001|Overall Study|Protocol Deviations|3|||
105354470|NCT01153009|363303276|FG002|Overall Study|Protocol Deviations|3|||
105354471|NCT01153009|363303277|FG003|Overall Study|Protocol Deviations|2|||
105354472|NCT01153009|363303274|FG000|Overall Study|Withdrawal of Consent|5|||
105354473|NCT01153009|363303275|FG001|Overall Study|Withdrawal of Consent|5|||
105354474|NCT01153009|363303276|FG002|Overall Study|Withdrawal of Consent|4|||
105354475|NCT01153009|363303277|FG003|Overall Study|Withdrawal of Consent|6|||
105354476|NCT01153009|363303274|FG000|Overall Study|Lost to Follow-up|8|||
105354477|NCT01153009|363303275|FG001|Overall Study|Lost to Follow-up|8|||
105354478|NCT01153009|363303276|FG002|Overall Study|Lost to Follow-up|11|||
105354479|NCT01153009|363303277|FG003|Overall Study|Lost to Follow-up|15|||
105354480|NCT01153009|363303274|FG000|Overall Study|Other|1|||
105354481|NCT01153009|363303275|FG001|Overall Study|Other|1|||
105354482|NCT01153009|363303276|FG002|Overall Study|Other|3|||
105354483|NCT01153009|363303277|FG003|Overall Study|Other|2|||
105354484|NCT00385827|363303278|FG000|Part 1|Adverse Event|1|||
105354485|NCT00385827|363303279|FG001|Part 1|Adverse Event|0|||
105354486|NCT00385827|363303280|FG002|Part 1|Adverse Event|0|||
105354487|NCT00385827|363303278|FG000|Part 1|Death|2|||
105354488|NCT00385827|363303279|FG001|Part 1|Death|0|||
105354489|NCT00385827|363303280|FG002|Part 1|Death|0|||
105354490|NCT00385827|363303278|FG000|Part 1|Lack of Efficacy|5|||
105354491|NCT00385827|363303279|FG001|Part 1|Lack of Efficacy|0|||
105354492|NCT00385827|363303280|FG002|Part 1|Lack of Efficacy|0|||
105354493|NCT00385827|363303278|FG000|Part 1|Other|1|||
105354494|NCT00385827|363303279|FG001|Part 1|Other|0|||
105354495|NCT00385827|363303280|FG002|Part 1|Other|0|||
105354496|NCT00385827|363303278|FG000|Part 2|Adverse Event|0|||
105354497|NCT00385827|363303279|FG001|Part 2|Adverse Event|6|||
105354498|NCT00385827|363303280|FG002|Part 2|Adverse Event|10|||
105354499|NCT00385827|363303278|FG000|Part 2|Death|0|||
105354500|NCT00385827|363303279|FG001|Part 2|Death|0|||
105354501|NCT00385827|363303280|FG002|Part 2|Death|2|||
105354502|NCT00385827|363303278|FG000|Part 2|Lack of Efficacy|0|||
105354503|NCT00385827|363303279|FG001|Part 2|Lack of Efficacy|14|||
105354504|NCT00385827|363303280|FG002|Part 2|Lack of Efficacy|13|||
105354505|NCT00385827|363303278|FG000|Part 2|Randomized but not treated|0|||
105354506|NCT00385827|363303279|FG001|Part 2|Randomized but not treated|2|||
105354507|NCT00385827|363303280|FG002|Part 2|Randomized but not treated|2|||
105354508|NCT00385827|363303278|FG000|Part 2|Other|0|||
105354509|NCT00385827|363303279|FG001|Part 2|Other|11|||
105354510|NCT00385827|363303280|FG002|Part 2|Other|21|||
105354511|NCT02442206|363303289|FG000|Period 1|Adverse Event|1|||
105354512|NCT02442206|363303290|FG001|Period 1|Adverse Event|1|||
105481130|NCT00830869|363773468|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
105481131|NCT00830869|363773457|FG000|Period 2: Part 2|Adverse Event|0|||
105736398|NCT00858702|364691089|FG000|Overall Study|Withdrawal by Subject|1|||
105736399|NCT00858702|364691090|FG001|Overall Study|Withdrawal by Subject|0|||
105481132|NCT00830869|363773458|FG001|Period 2: Part 2|Adverse Event|0|||
105736400|NCT02859415|364691093|FG000|Overall Study|Physician Decision|1|||
105736401|NCT02859415|364691094|FG001|Overall Study|Physician Decision|0|||
105354513|NCT02442206|363303289|FG000|Period 1|withdrew consent|0|||
105354514|NCT02442206|363303290|FG001|Period 1|withdrew consent|1|||
105736402|NCT02859415|364691093|FG000|Overall Study|Off treatment due to cardiac event|0|||
105354515|NCT02442206|363303289|FG000|Period 1|COPD exacerbation|0|||
105354516|NCT02442206|363303290|FG001|Period 1|COPD exacerbation|1|||
105354517|NCT02442206|363303289|FG000|Period 2|Adverse Event|1|||
105354518|NCT02442206|363303290|FG001|Period 2|Adverse Event|0|||
105354519|NCT00734656|363303291|FG000|Lab Session 1|Withdrawal by Subject|2|||
105354520|NCT00734656|363303292|FG001|Lab Session 1|Withdrawal by Subject|0|||
105736403|NCT02859415|364691094|FG001|Overall Study|Off treatment due to cardiac event|1|||
105736404|NCT01174784|364691095|FG000|Overall Study|Screen fails|4|||
105736405|NCT03671369|364691100|FG000|Overall Study|Other|1|||
105736406|NCT03671369|364691100|FG000|Overall Study|Withdrawal by Subject|289|||
105736407|NCT03671369|364691100|FG000|Overall Study|Not willing to be vaccinated|1|||
105736408|NCT02732912|364691101|FG000|Overall Study|Discharged before night|2|||
105736409|NCT02732912|364691102|FG001|Overall Study|Discharged before night|6|||
105736410|NCT02732912|364691101|FG000|Overall Study|Incomplete completion of questionnaire|2|||
105736411|NCT02732912|364691102|FG001|Overall Study|Incomplete completion of questionnaire|3|||
105736412|NCT02732912|364691101|FG000|Overall Study|No outcome; discharged or refused|6|||
105736413|NCT02732912|364691102|FG001|Overall Study|No outcome; discharged or refused|9|||
105736414|NCT01214434|364691104|FG000|Overall Study|Withdrawal by Subject|1|||
105736415|NCT01214434|364691105|FG001|Overall Study|Withdrawal by Subject|0|||
105736416|NCT01214434|364691104|FG000|Overall Study|Lost to Follow-up|2|||
105736417|NCT01214434|364691105|FG001|Overall Study|Lost to Follow-up|2|||
105736418|NCT01214434|364691104|FG000|Overall Study|Site error|1|||
105736419|NCT01214434|364691105|FG001|Overall Study|Site error|0|||
105736420|NCT03792750|364691106|FG000|Overall Study|Death|3|||
105736421|NCT00793104|364691107|FG000|Overall Study|Lost to Follow-up|1|||
105736422|NCT02619253|364691108|FG000|Overall Study|Adverse Event|0|||
105736423|NCT02619253|364691109|FG001|Overall Study|Adverse Event|0|||
105736424|NCT02619253|364691110|FG002|Overall Study|Adverse Event|1|||
105736425|NCT02619253|364691111|FG003|Overall Study|Adverse Event|1|||
105736426|NCT02619253|364691112|FG004|Overall Study|Adverse Event|3|||
105736427|NCT02619253|364691108|FG000|Overall Study|Alternative Therapy|0|||
105736428|NCT02619253|364691109|FG001|Overall Study|Alternative Therapy|0|||
105736429|NCT02619253|364691110|FG002|Overall Study|Alternative Therapy|1|||
105736430|NCT02619253|364691111|FG003|Overall Study|Alternative Therapy|0|||
105736431|NCT02619253|364691112|FG004|Overall Study|Alternative Therapy|0|||
105736432|NCT02619253|364691108|FG000|Overall Study|Death|0|||
105736433|NCT02619253|364691109|FG001|Overall Study|Death|0|||
105736434|NCT02619253|364691110|FG002|Overall Study|Death|0|||
105736435|NCT02619253|364691111|FG003|Overall Study|Death|1|||
105736436|NCT02619253|364691112|FG004|Overall Study|Death|0|||
105354521|NCT00734656|363303293|FG002|Lab Session 1|Withdrawal by Subject|0|||
105736437|NCT02619253|364691108|FG000|Overall Study|Disease Progression|4|||
105736438|NCT02619253|364691109|FG001|Overall Study|Disease Progression|2|||
105736439|NCT02619253|364691110|FG002|Overall Study|Disease Progression|8|||
105736440|NCT02619253|364691111|FG003|Overall Study|Disease Progression|9|||
105736441|NCT02619253|364691112|FG004|Overall Study|Disease Progression|10|||
105736442|NCT02619253|364691108|FG000|Overall Study|Needed a disqualifying therapy|0|||
105736443|NCT02619253|364691109|FG001|Overall Study|Needed a disqualifying therapy|0|||
105736444|NCT02619253|364691110|FG002|Overall Study|Needed a disqualifying therapy|1|||
105736445|NCT02619253|364691111|FG003|Overall Study|Needed a disqualifying therapy|0|||
105736446|NCT02619253|364691112|FG004|Overall Study|Needed a disqualifying therapy|0|||
105736447|NCT02619253|364691108|FG000|Overall Study|Transferred to hospice|0|||
105736448|NCT02619253|364691109|FG001|Overall Study|Transferred to hospice|0|||
105736449|NCT02619253|364691110|FG002|Overall Study|Transferred to hospice|1|||
105736450|NCT02619253|364691111|FG003|Overall Study|Transferred to hospice|0|||
105736451|NCT02619253|364691112|FG004|Overall Study|Transferred to hospice|0|||
105736452|NCT02619253|364691108|FG000|Overall Study|Physician Decision|0|||
105736453|NCT02619253|364691109|FG001|Overall Study|Physician Decision|1|||
105736454|NCT02619253|364691110|FG002|Overall Study|Physician Decision|2|||
105736455|NCT02619253|364691111|FG003|Overall Study|Physician Decision|3|||
105736456|NCT02619253|364691112|FG004|Overall Study|Physician Decision|0|||
105736457|NCT02619253|364691108|FG000|Overall Study|Withdrawal by Subject|0|||
105736458|NCT02619253|364691109|FG001|Overall Study|Withdrawal by Subject|1|||
105736459|NCT02619253|364691110|FG002|Overall Study|Withdrawal by Subject|0|||
105736460|NCT02619253|364691111|FG003|Overall Study|Withdrawal by Subject|0|||
105736461|NCT02619253|364691112|FG004|Overall Study|Withdrawal by Subject|2|||
105736462|NCT00970294|364691114|FG000|Overall Study|Physician Decision|4|||
105736463|NCT00970294|364691114|FG000|Overall Study|Withdrawal by Subject|1|||
105736464|NCT01056523|364691115|FG000|Overall Study|Death|1|||
105736465|NCT01056523|364691116|FG001|Overall Study|Death|0|||
105736466|NCT01056523|364691117|FG002|Overall Study|Death|2|||
105736467|NCT01056523|364691118|FG003|Overall Study|Death|3|||
105354522|NCT00734656|363303294|FG003|Lab Session 1|Withdrawal by Subject|0|||
105354523|NCT00734656|363303291|FG000|Washout 1|Withdrawal by Subject|1|||
105354524|NCT00734656|363303292|FG001|Washout 1|Withdrawal by Subject|5|||
105354525|NCT00734656|363303293|FG002|Washout 1|Withdrawal by Subject|2|||
105354526|NCT00734656|363303294|FG003|Washout 1|Withdrawal by Subject|3|||
105354527|NCT00734656|363303291|FG000|Lab Session 2|Withdrawal by Subject|1|||
105736468|NCT01056523|364691119|FG004|Overall Study|Death|0|||
105736469|NCT01056523|364691120|FG005|Overall Study|Death|0|||
105736470|NCT01056523|364691121|FG006|Overall Study|Death|1|||
105736471|NCT00487279|364691122|FG000|Overall Study|Death|1|||
105736472|NCT00487279|364691123|FG001|Overall Study|Death|0|||
105354528|NCT00734656|363303292|FG001|Lab Session 2|Withdrawal by Subject|0|||
105354529|NCT00734656|363303293|FG002|Lab Session 2|Withdrawal by Subject|0|||
105354530|NCT00734656|363303294|FG003|Lab Session 2|Withdrawal by Subject|1|||
105354531|NCT00734656|363303291|FG000|Washout 2|Withdrawal by Subject|1|||
105354532|NCT00734656|363303292|FG001|Washout 2|Withdrawal by Subject|1|||
105354533|NCT00734656|363303293|FG002|Washout 2|Withdrawal by Subject|1|||
105354534|NCT00734656|363303294|FG003|Washout 2|Withdrawal by Subject|0|||
105354535|NCT00734656|363303291|FG000|Washout 3|Withdrawal by Subject|1|||
105736473|NCT00487279|364691122|FG000|Overall Study|Withdrawal by Subject|0|||
105736474|NCT00487279|364691123|FG001|Overall Study|Withdrawal by Subject|2|||
105736475|NCT00501852|364691124|FG000|Overall Study|Adverse Event|3|||
105736476|NCT00501852|364691124|FG000|Overall Study|Withdrawal by Subject|2|||
105736477|NCT01171521|364691125|FG000|Overall Study|Lost to Follow-up|5|||
105736478|NCT01171521|364691125|FG000|Overall Study|screen failure|1|||
105736479|NCT01416610|364691126|FG000|Overall Study|Adverse Event|4|||
105736480|NCT01416610|364691126|FG000|Overall Study|Adverse Event -Patient decision|3|||
105736481|NCT01416610|364691126|FG000|Overall Study|Lack of Efficacy|4|||
105736482|NCT01416610|364691126|FG000|Overall Study|No reason given|5|||
105736483|NCT01416610|364691126|FG000|Overall Study|Withdrawal by Subject|13|||
105736484|NCT01416610|364691126|FG000|Overall Study|Lost to Follow-up|7|||
105736485|NCT01416610|364691126|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
105736486|NCT01927562|364691128|FG000|Overall Study|Lost to Follow-up|30|||
105736487|NCT01927562|364691128|FG000|Overall Study|Withdrawal by Subject|3|||
105736488|NCT01927562|364691128|FG000|Overall Study|Physician Decision|5|||
105736489|NCT00642616|364691133|FG000|Overall Study|Adverse Event|2|||
105736490|NCT00642616|364691134|FG001|Overall Study|Adverse Event|0|||
105736491|NCT00642616|364691135|FG002|Overall Study|Adverse Event|1|||
105736492|NCT00642616|364691136|FG003|Overall Study|Adverse Event|0|||
105736493|NCT00642616|364691133|FG000|Overall Study|Study Terminated by Sponsor|7|||
105736494|NCT00642616|364691134|FG001|Overall Study|Study Terminated by Sponsor|6|||
105736495|NCT00642616|364691135|FG002|Overall Study|Study Terminated by Sponsor|4|||
105354536|NCT00734656|363303292|FG001|Washout 3|Withdrawal by Subject|0|||
105354537|NCT00734656|363303293|FG002|Washout 3|Withdrawal by Subject|0|||
105736496|NCT00642616|364691136|FG003|Overall Study|Study Terminated by Sponsor|5|||
105736497|NCT00642616|364691133|FG000|Overall Study|Withdrawal by Subject|0|||
105354538|NCT00734656|363303294|FG003|Washout 3|Withdrawal by Subject|1|||
105354539|NCT00734656|363303291|FG000|Lab Session 4|Withdrawal by Subject|0|||
105354540|NCT00734656|363303292|FG001|Lab Session 4|Withdrawal by Subject|0|||
105354541|NCT00734656|363303293|FG002|Lab Session 4|Withdrawal by Subject|0|||
105354542|NCT00734656|363303294|FG003|Lab Session 4|Withdrawal by Subject|1|||
105354543|NCT03915626|363303295|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
105354544|NCT02362425|363303296|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
105354545|NCT02362425|363303297|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
105354546|NCT02362425|363303298|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
105354547|NCT02362425|363303299|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
105354548|NCT02362425|363303296|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
105354549|NCT02362425|363303297|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
105354550|NCT02362425|363303298|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
105354551|NCT02362425|363303299|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
105354552|NCT02362425|363303296|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
105354553|NCT02362425|363303297|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
105354554|NCT02362425|363303298|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
105354555|NCT02362425|363303299|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
105354556|NCT02362425|363303296|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
105354557|NCT02362425|363303297|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
105354558|NCT02362425|363303298|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
105354559|NCT02362425|363303299|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
105354560|NCT02362425|363303296|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
105354561|NCT02362425|363303297|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
105354562|NCT02362425|363303298|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
105354563|NCT02362425|363303299|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
105354564|NCT02362425|363303296|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
105354565|NCT02362425|363303297|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
105354566|NCT02362425|363303298|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
105354567|NCT02362425|363303299|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
105354568|NCT02362425|363303296|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
105354569|NCT02362425|363303297|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
105354570|NCT02362425|363303298|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
105354571|NCT02362425|363303299|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
105354572|NCT02362425|363303296|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
105354573|NCT02362425|363303297|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
105354574|NCT02362425|363303298|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
105354575|NCT02362425|363303299|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
105354576|NCT01031004|363303312|FG000|Overall Study|Protocol Violation|0|||
105354577|NCT01031004|363303313|FG001|Overall Study|Protocol Violation|1|||
105354578|NCT01031004|363303312|FG000|Overall Study|Lost to Follow-up|1|||
105354579|NCT01031004|363303313|FG001|Overall Study|Lost to Follow-up|0|||
105354580|NCT02634801|363303314|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
105354581|NCT02634801|363303315|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
105354582|NCT02634801|363303316|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
105354583|NCT02634801|363303314|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
105354584|NCT02634801|363303315|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
105354585|NCT02634801|363303316|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
105354586|NCT02634801|363303314|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
105354587|NCT02634801|363303315|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
105354588|NCT02634801|363303316|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
105354589|NCT02634801|363303314|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
105354590|NCT02634801|363303315|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
105354591|NCT02634801|363303316|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
105354592|NCT02634801|363303314|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
105354593|NCT02634801|363303315|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
105354594|NCT02634801|363303316|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
105354595|NCT02634801|363303314|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
105354596|NCT02634801|363303315|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
105354597|NCT02634801|363303316|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
105354598|NCT02634801|363303314|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
105354599|NCT02634801|363303315|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
105354600|NCT02634801|363303316|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
105354601|NCT02634801|363303314|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
105354602|NCT02634801|363303315|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
105354603|NCT02634801|363303316|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
105354604|NCT02634801|363303314|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
105354605|NCT02634801|363303315|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
105736498|NCT00642616|364691134|FG001|Overall Study|Withdrawal by Subject|1|||
105736499|NCT00642616|364691135|FG002|Overall Study|Withdrawal by Subject|1|||
105736500|NCT00642616|364691136|FG003|Overall Study|Withdrawal by Subject|1|||
105736501|NCT00642616|364691133|FG000|Overall Study|Protocol Violation|0|||
105736502|NCT00642616|364691134|FG001|Overall Study|Protocol Violation|0|||
105736503|NCT00642616|364691135|FG002|Overall Study|Protocol Violation|2|||
105736504|NCT00642616|364691136|FG003|Overall Study|Protocol Violation|0|||
105736505|NCT00642616|364691133|FG000|Overall Study|Physician Decision|0|||
105736506|NCT00642616|364691134|FG001|Overall Study|Physician Decision|0|||
105736507|NCT00642616|364691135|FG002|Overall Study|Physician Decision|1|||
105736508|NCT00642616|364691136|FG003|Overall Study|Physician Decision|1|||
105736509|NCT00492921|364691137|FG000|Overall Study|Death|1|||
105736510|NCT00492921|364691138|FG001|Overall Study|Death|0|||
105736511|NCT00492921|364691139|FG002|Overall Study|Death|1|||
105354606|NCT02634801|363303316|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
105354607|NCT02634801|363303314|FG000|Follow-up Period|Lost to Follow-up|3|||
105354608|NCT02634801|363303315|FG001|Follow-up Period|Lost to Follow-up|1|||
105354609|NCT02634801|363303316|FG002|Follow-up Period|Lost to Follow-up|2|||
105354610|NCT02634801|363303314|FG000|Follow-up Period|Physician Decision|0|||
105354611|NCT02634801|363303315|FG001|Follow-up Period|Physician Decision|0|||
105354612|NCT02634801|363303316|FG002|Follow-up Period|Physician Decision|1|||
105354613|NCT02634801|363303314|FG000|Follow-up Period|Withdrawal by Subject|1|||
105354614|NCT02634801|363303315|FG001|Follow-up Period|Withdrawal by Subject|2|||
105354615|NCT02634801|363303316|FG002|Follow-up Period|Withdrawal by Subject|5|||
105354616|NCT02634801|363303314|FG000|Follow-up Period|Adverse Event|1|||
105354617|NCT02634801|363303315|FG001|Follow-up Period|Adverse Event|5|||
105354618|NCT02634801|363303316|FG002|Follow-up Period|Adverse Event|0|||
105354619|NCT02626000|363303325|FG000|Overall Study|Decision by Sponsor|1|||
105354620|NCT02626000|363303325|FG000|Overall Study|Death|29|||
105354621|NCT00662311|363303326|FG000|Overall Study|Respiratory Infection|1|||
105354622|NCT00662311|363303327|FG001|Overall Study|Respiratory Infection|0|||
105354623|NCT00662311|363303328|FG002|Overall Study|Respiratory Infection|0|||
105354624|NCT01467271|363303329|FG000|Overall Study|Death|84|||
105354625|NCT01467271|363303329|FG000|Overall Study|Lost to Follow-up|83|||
105354626|NCT01467271|363303329|FG000|Overall Study|Retraction of patient's consent|21|||
105354627|NCT01467271|363303329|FG000|Overall Study|Other reason|14|||
105354628|NCT03300050|363303330|FG000|Overall Study|Lost to Follow-up|2|||
105354629|NCT03300050|363303331|FG001|Overall Study|Lost to Follow-up|1|||
105354630|NCT03300050|363303332|FG002|Overall Study|Lost to Follow-up|0|||
105354631|NCT03300050|363303333|FG003|Overall Study|Lost to Follow-up|0|||
105354632|NCT03300050|363303334|FG004|Overall Study|Lost to Follow-up|1|||
105354633|NCT03300050|363303330|FG000|Overall Study|Withdrawal by Subject|1|||
105354634|NCT03300050|363303331|FG001|Overall Study|Withdrawal by Subject|1|||
105354635|NCT03300050|363303332|FG002|Overall Study|Withdrawal by Subject|1|||
105354636|NCT03300050|363303333|FG003|Overall Study|Withdrawal by Subject|0|||
105354637|NCT03300050|363303334|FG004|Overall Study|Withdrawal by Subject|0|||
105354638|NCT03300050|363303330|FG000|Overall Study|Death|0|||
105354639|NCT03300050|363303331|FG001|Overall Study|Death|0|||
105354640|NCT03300050|363303332|FG002|Overall Study|Death|1|||
105354641|NCT03300050|363303333|FG003|Overall Study|Death|0|||
105354642|NCT03300050|363303334|FG004|Overall Study|Death|0|||
105354643|NCT03300050|363303330|FG000|Overall Study|Not Eligible at Randomization|0|||
105354644|NCT03300050|363303331|FG001|Overall Study|Not Eligible at Randomization|0|||
105354645|NCT03300050|363303332|FG002|Overall Study|Not Eligible at Randomization|1|||
105354646|NCT03300050|363303333|FG003|Overall Study|Not Eligible at Randomization|1|||
105354647|NCT03300050|363303334|FG004|Overall Study|Not Eligible at Randomization|0|||
105354648|NCT03084302|363303335|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
105354649|NCT03084302|363303335|FG000|Overall Study|No valid objective monitor data|6|||
105354650|NCT01411319|363303336|FG000|Overall Study|Lost to Follow-up|1|||
105354651|NCT01214668|363303337|FG000|Overall Study|Adverse Event|0|||
105354652|NCT01214668|363303338|FG001|Overall Study|Adverse Event|1|||
105354653|NCT01214668|363303339|FG002|Overall Study|Adverse Event|0|||
105354654|NCT01214668|363303340|FG003|Overall Study|Adverse Event|2|||
105354655|NCT01214668|363303341|FG004|Overall Study|Adverse Event|1|||
105354656|NCT01214668|363303342|FG005|Overall Study|Adverse Event|1|||
105354657|NCT01214668|363303337|FG000|Overall Study|Death|0|||
105354658|NCT01214668|363303338|FG001|Overall Study|Death|0|||
105354659|NCT01214668|363303339|FG002|Overall Study|Death|1|||
105354660|NCT01214668|363303340|FG003|Overall Study|Death|0|||
105736512|NCT00399802|364691140|FG000|Overall Study|Adverse Event|0|||
105354661|NCT01214668|363303341|FG004|Overall Study|Death|0|||
105736513|NCT00399802|364691141|FG001|Overall Study|Adverse Event|2|||
105736514|NCT00399802|364691140|FG000|Overall Study|Participant discontinued by mistake|0|||
105354662|NCT01214668|363303342|FG005|Overall Study|Death|0|||
105354663|NCT01214668|363303337|FG000|Overall Study|Progressive Disease|4|||
105354664|NCT01214668|363303338|FG001|Overall Study|Progressive Disease|2|||
105354665|NCT01214668|363303339|FG002|Overall Study|Progressive Disease|5|||
105354666|NCT01214668|363303340|FG003|Overall Study|Progressive Disease|4|||
105736515|NCT00399802|364691141|FG001|Overall Study|Participant discontinued by mistake|1|||
105799212|NCT01606137|364922711|FG000|Overall Study|Withdrawal by Subject|74|||
105799213|NCT01606137|364922711|FG000|Overall Study|Lack of Efficacy|56|||
105799214|NCT01606137|364922711|FG000|Overall Study|Lost to Follow-up|15|||
105799215|NCT01606137|364922711|FG000|Overall Study|Protocol Violation|1|||
105799216|NCT01606137|364922711|FG000|Overall Study|Patient non-compliance|9|||
105799217|NCT01606137|364922711|FG000|Overall Study|Death|1|||
105799218|NCT01606137|364922711|FG000|Overall Study|Decreased/no pain|4|||
105565085|NCT01529008|364066677|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
105565086|NCT01529008|364066678|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
105565087|NCT01529008|364066677|FG000|Treatment|Adverse Event|6|||
105565088|NCT01529008|364066678|FG001|Treatment|Adverse Event|0|||
105565089|NCT01529008|364066677|FG000|Treatment|Other|3|||
105565090|NCT01529008|364066678|FG001|Treatment|Other|1|||
105799219|NCT01606137|364922711|FG000|Overall Study|Issues with driving|4|||
105799220|NCT01606137|364922711|FG000|Overall Study|multiple sclerosis less stable|1|||
105799221|NCT01606137|364922711|FG000|Overall Study|Increased bilirubin|1|||
105799222|NCT01606137|364922711|FG000|Overall Study|Spray causes nausea|1|||
105799223|NCT01606137|364922711|FG000|Overall Study|Not enough improvement|4|||
105799224|NCT01606137|364922711|FG000|Overall Study|Wanted to try another treatment|1|||
105799225|NCT01606137|364922711|FG000|Overall Study|Patient leaving country|1|||
105799226|NCT01606137|364922711|FG000|Overall Study|Personal reasons|1|||
105799227|NCT01606137|364922711|FG000|Overall Study|Unable to tolerate study med. taste|1|||
105799228|NCT01606137|364922711|FG000|Overall Study|Patient moving|1|||
105799229|NCT01606137|364922711|FG000|Overall Study|Unable to collect consistent data|1|||
105799230|NCT02094937|364922712|FG000|8 Weeks in Period 1|Adverse Event|9|||
105799231|NCT02094937|364922713|FG001|8 Weeks in Period 1|Adverse Event|0|||
105799232|NCT02094937|364922714|FG002|8 Weeks in Period 1|Adverse Event|0|||
105799233|NCT02094937|364922715|FG003|8 Weeks in Period 1|Adverse Event|0|||
105799234|NCT02094937|364922712|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
105799235|NCT02094937|364922713|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
105799236|NCT02094937|364922714|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
105799237|NCT02094937|364922715|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
105799238|NCT02094937|364922712|FG000|8 Weeks in Period 1|Protocol Violation|2|||
105799239|NCT02094937|364922713|FG001|8 Weeks in Period 1|Protocol Violation|0|||
105799240|NCT02094937|364922714|FG002|8 Weeks in Period 1|Protocol Violation|0|||
105799241|NCT02094937|364922715|FG003|8 Weeks in Period 1|Protocol Violation|0|||
105799242|NCT02094937|364922712|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
105799243|NCT02094937|364922713|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
105799244|NCT02094937|364922714|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
105799245|NCT02094937|364922715|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
105799246|NCT02094937|364922712|FG000|8 Weeks in Period 1|Physician Decision|1|||
105799247|NCT02094937|364922713|FG001|8 Weeks in Period 1|Physician Decision|0|||
105799248|NCT02094937|364922714|FG002|8 Weeks in Period 1|Physician Decision|0|||
105799249|NCT02094937|364922715|FG003|8 Weeks in Period 1|Physician Decision|0|||
105799250|NCT02094937|364922712|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
105799251|NCT02094937|364922713|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
105799252|NCT02094937|364922714|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
105799253|NCT02094937|364922715|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
105799254|NCT02094937|364922712|FG000|12 Weeks in Period 2|Adverse Event|0|||
105799255|NCT02094937|364922713|FG001|12 Weeks in Period 2|Adverse Event|2|||
105799256|NCT02094937|364922714|FG002|12 Weeks in Period 2|Adverse Event|4|||
105799257|NCT02094937|364922715|FG003|12 Weeks in Period 2|Adverse Event|1|||
105799258|NCT02094937|364922712|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
105799259|NCT02094937|364922713|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
105799260|NCT02094937|364922714|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
105799261|NCT02094937|364922715|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
105799262|NCT02094937|364922712|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
105799263|NCT02094937|364922713|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
105799264|NCT02094937|364922714|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
105799265|NCT02094937|364922715|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
105799266|NCT02094937|364922712|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
105799267|NCT02094937|364922713|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
105799268|NCT02094937|364922714|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
105799269|NCT02094937|364922715|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
105799270|NCT02094937|364922712|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
105799271|NCT02094937|364922713|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
105354667|NCT01214668|363303341|FG004|Overall Study|Progressive Disease|4|||
105354668|NCT01214668|363303342|FG005|Overall Study|Progressive Disease|5|||
105354669|NCT01214668|363303337|FG000|Overall Study|Withdrawal by Subject|0|||
105354670|NCT01214668|363303338|FG001|Overall Study|Withdrawal by Subject|0|||
105354671|NCT01214668|363303339|FG002|Overall Study|Withdrawal by Subject|0|||
105354672|NCT01214668|363303340|FG003|Overall Study|Withdrawal by Subject|0|||
105354673|NCT01214668|363303341|FG004|Overall Study|Withdrawal by Subject|1|||
105354674|NCT01214668|363303342|FG005|Overall Study|Withdrawal by Subject|0|||
105354675|NCT01964989|363303343|FG000|Overall Study|Protocol Violation|3|||
105354676|NCT01964989|363303344|FG001|Overall Study|Protocol Violation|4|||
105354677|NCT01964989|363303343|FG000|Overall Study|Administrative Reason|103|||
105354678|NCT01964989|363303344|FG001|Overall Study|Administrative Reason|95|||
105354679|NCT01964989|363303343|FG000|Overall Study|Adverse Event|0|||
105354680|NCT01964989|363303344|FG001|Overall Study|Adverse Event|1|||
105354681|NCT01964989|363303343|FG000|Overall Study|Death|1|||
105354682|NCT01964989|363303344|FG001|Overall Study|Death|3|||
105354683|NCT01964989|363303343|FG000|Overall Study|Withdrawal by Subject|156|||
105354684|NCT01964989|363303344|FG001|Overall Study|Withdrawal by Subject|160|||
105354685|NCT01964989|363303343|FG000|Overall Study|Lost to Follow-up|254|||
105354686|NCT01964989|363303344|FG001|Overall Study|Lost to Follow-up|232|||
105354687|NCT01964989|363303343|FG000|Overall Study|Other|267|||
105354688|NCT01964989|363303344|FG001|Overall Study|Other|252|||
105354689|NCT00184002|363303345|FG000|Overall Study|Adverse Event|9|||
105736516|NCT00542815|364691142|FG000|Overall Study|Adverse Event|19|||
105736517|NCT00542815|364691143|FG001|Overall Study|Adverse Event|6|||
105736518|NCT00542815|364691144|FG002|Overall Study|Adverse Event|9|||
105736519|NCT00542815|364691142|FG000|Overall Study|Death|10|||
105736520|NCT00542815|364691143|FG001|Overall Study|Death|7|||
105736521|NCT00542815|364691144|FG002|Overall Study|Death|3|||
105736522|NCT00542815|364691142|FG000|Overall Study|Lack of Efficacy|9|||
105736523|NCT00542815|364691143|FG001|Overall Study|Lack of Efficacy|2|||
105736524|NCT00542815|364691144|FG002|Overall Study|Lack of Efficacy|0|||
105736525|NCT00542815|364691142|FG000|Overall Study|Physician Decision|2|||
105736526|NCT00542815|364691143|FG001|Overall Study|Physician Decision|1|||
105736527|NCT00542815|364691144|FG002|Overall Study|Physician Decision|0|||
105736528|NCT00542815|364691142|FG000|Overall Study|Protocol Violation|1|||
105736529|NCT00542815|364691143|FG001|Overall Study|Protocol Violation|1|||
105736530|NCT00542815|364691144|FG002|Overall Study|Protocol Violation|2|||
105736531|NCT00542815|364691142|FG000|Overall Study|Withdrawal by Subject|41|||
105736532|NCT00542815|364691143|FG001|Overall Study|Withdrawal by Subject|5|||
105736533|NCT00542815|364691144|FG002|Overall Study|Withdrawal by Subject|8|||
105736534|NCT00542815|364691142|FG000|Overall Study|Other reasons|24|||
105736535|NCT00542815|364691143|FG001|Overall Study|Other reasons|10|||
105736536|NCT00542815|364691144|FG002|Overall Study|Other reasons|10|||
105736537|NCT00652093|364691145|FG000|Overall Study|Withdrawal by Subject|0|||
105736538|NCT00652093|364691146|FG001|Overall Study|Withdrawal by Subject|0|||
105736539|NCT00652093|364691147|FG002|Overall Study|Withdrawal by Subject|1|||
105736540|NCT00652093|364691148|FG003|Overall Study|Withdrawal by Subject|0|||
105736541|NCT00652093|364691149|FG004|Overall Study|Withdrawal by Subject|1|||
105736542|NCT00652093|364691150|FG005|Overall Study|Withdrawal by Subject|0|||
105736543|NCT00652093|364691145|FG000|Overall Study|Physician Decision|0|||
105736544|NCT00652093|364691146|FG001|Overall Study|Physician Decision|0|||
105736545|NCT00652093|364691147|FG002|Overall Study|Physician Decision|0|||
105736546|NCT00652093|364691148|FG003|Overall Study|Physician Decision|0|||
105736547|NCT00652093|364691149|FG004|Overall Study|Physician Decision|1|||
105736548|NCT00652093|364691150|FG005|Overall Study|Physician Decision|0|||
105736549|NCT00734929|364691151|FG000|Overall Study|Lost to Follow-up|1|||
105736550|NCT00734929|364691152|FG001|Overall Study|Lost to Follow-up|2|||
105736551|NCT00734929|364691151|FG000|Overall Study|No intervention/ screen fail|5|||
105736552|NCT00734929|364691152|FG001|Overall Study|No intervention/ screen fail|3|||
105736553|NCT03176966|364691156|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
105736554|NCT03176966|364691157|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
105736555|NCT03176966|364691156|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
105736556|NCT03176966|364691157|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
105736557|NCT03176966|364691156|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
105736558|NCT03176966|364691157|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
105354690|NCT00184002|363303345|FG000|Overall Study|Death|3|||
105481133|NCT00830869|363773459|FG002|Period 2: Part 2|Adverse Event|0|||
105481134|NCT00830869|363773460|FG003|Period 2: Part 2|Adverse Event|0|||
105736559|NCT03176966|364691156|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
105736560|NCT03176966|364691157|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
105736561|NCT03176966|364691156|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
105354691|NCT00184002|363303345|FG000|Overall Study|Physician Decision|1|||
105354692|NCT00184002|363303345|FG000|Overall Study|Withdrawal by Subject|4|||
105354693|NCT02499263|363303346|FG000|Overall Study|Lost to Follow-up|9|||
105354694|NCT02499263|363303346|FG000|Overall Study|Participant's withdrawal of consent|4|||
105354695|NCT02499263|363303346|FG000|Overall Study|Lack of Efficacy|22|||
105481135|NCT00830869|363773461|FG004|Period 2: Part 2|Adverse Event|0|||
105736562|NCT03176966|364691157|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
105736563|NCT03176966|364691156|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
105736564|NCT03176966|364691157|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
105736565|NCT03176966|364691156|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
105736566|NCT03176966|364691157|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
105736567|NCT01520922|364691158|FG000|Treatment Phase|Physician Decision|2|||
105736568|NCT01520922|364691159|FG001|Treatment Phase|Physician Decision|1|||
105736569|NCT01520922|364691158|FG000|Treatment Phase|Progression|0|||
105736570|NCT01520922|364691159|FG001|Treatment Phase|Progression|2|||
105736571|NCT01520922|364691158|FG000|Treatment Phase|Adverse Event|3|||
105481136|NCT00830869|363773462|FG005|Period 2: Part 2|Adverse Event|0|||
105481137|NCT00830869|363773463|FG006|Period 2: Part 2|Adverse Event|0|||
105481138|NCT00830869|363773464|FG007|Period 2: Part 2|Adverse Event|4|||
105481139|NCT00830869|363773465|FG008|Period 2: Part 2|Adverse Event|3|||
105481140|NCT00830869|363773466|FG009|Period 2: Part 2|Adverse Event|2|||
105481141|NCT00830869|363773467|FG010|Period 2: Part 2|Adverse Event|2|||
105481142|NCT00830869|363773468|FG011|Period 2: Part 2|Adverse Event|0|||
105481143|NCT00830869|363773457|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
105481144|NCT00830869|363773458|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
105481145|NCT00830869|363773459|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
105481146|NCT00830869|363773460|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
105481147|NCT00830869|363773461|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
105481148|NCT00830869|363773462|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
105481149|NCT00830869|363773463|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
105481150|NCT00830869|363773464|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
105481151|NCT00830869|363773465|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
105481152|NCT00830869|363773466|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
105481153|NCT00830869|363773467|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
105481154|NCT00830869|363773468|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
105481155|NCT00830869|363773457|FG000|Period 2: Part 2|Progressive disease|0|||
105481156|NCT00830869|363773458|FG001|Period 2: Part 2|Progressive disease|0|||
105481157|NCT00830869|363773459|FG002|Period 2: Part 2|Progressive disease|0|||
105481158|NCT00830869|363773460|FG003|Period 2: Part 2|Progressive disease|0|||
105481159|NCT00830869|363773461|FG004|Period 2: Part 2|Progressive disease|0|||
105481160|NCT00830869|363773462|FG005|Period 2: Part 2|Progressive disease|0|||
105481161|NCT00830869|363773463|FG006|Period 2: Part 2|Progressive disease|0|||
105481162|NCT00830869|363773464|FG007|Period 2: Part 2|Progressive disease|14|||
105481163|NCT00830869|363773465|FG008|Period 2: Part 2|Progressive disease|11|||
105354696|NCT02499263|363303346|FG000|Overall Study|investigator's judgment|12|||
105354697|NCT02499263|363303346|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
105354698|NCT02499263|363303346|FG000|Overall Study|Participant's decision|3|||
105481164|NCT00830869|363773466|FG009|Period 2: Part 2|Progressive disease|12|||
105736572|NCT01520922|364691159|FG001|Treatment Phase|Adverse Event|5|||
105736573|NCT01520922|364691158|FG000|Follow up|Lost to Follow-up|0|||
105354699|NCT02499263|363303346|FG000|Overall Study|Pregnancy|1|||
105354700|NCT02496039|363303350|FG000|Overall Study|Adverse Event|3|||
105354701|NCT02496039|363303350|FG000|Overall Study|Protocol Violation|1|||
105354702|NCT04472494|363303351|FG000|Pre-treatment|Other reasons|2|||
105354703|NCT04472494|363303352|FG001|Pre-treatment|Other reasons|0|||
105354704|NCT04472494|363303351|FG000|Treatment|Death|5|||
105354705|NCT04472494|363303352|FG001|Treatment|Death|2|||
105354706|NCT04472494|363303351|FG000|Treatment|Hospital discharge|1|||
105354707|NCT04472494|363303352|FG001|Treatment|Hospital discharge|1|||
105354708|NCT01972464|363303353|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
105354709|NCT01972464|363303354|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
105354710|NCT01972464|363303353|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
105354711|NCT01972464|363303354|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
105354712|NCT01972464|363303353|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
105354713|NCT01972464|363303354|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
105354714|NCT01972464|363303353|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
105354715|NCT01972464|363303354|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
105354716|NCT01979523|363303357|FG000|Overall Study|Withdrawal by Subject|1|||
105354717|NCT01979523|363303358|FG001|Overall Study|Withdrawal by Subject|0|||
105354718|NCT03959527|363303359|FG000|Overall Study|Withdrawal by Subject|8|||
105354719|NCT03959527|363303360|FG001|Overall Study|Withdrawal by Subject|3|||
105354720|NCT03959527|363303359|FG000|Overall Study|Lost to Follow-up|31|||
105354721|NCT03959527|363303360|FG001|Overall Study|Lost to Follow-up|15|||
105354722|NCT03959527|363303359|FG000|Overall Study|Did not meet eligibility criteria|1|||
105354723|NCT03959527|363303360|FG001|Overall Study|Did not meet eligibility criteria|1|||
105354724|NCT03959527|363303359|FG000|Overall Study|Protocol Violation|10|||
105481165|NCT00830869|363773467|FG010|Period 2: Part 2|Progressive disease|8|||
105481166|NCT00830869|363773468|FG011|Period 2: Part 2|Progressive disease|15|||
105736574|NCT01520922|364691159|FG001|Follow up|Lost to Follow-up|1|||
105736575|NCT01520922|364691158|FG000|Survival Follow-up|Withdrawal by Subject|1|||
105736576|NCT01520922|364691159|FG001|Survival Follow-up|Withdrawal by Subject|0|||
105354725|NCT03959527|363303360|FG001|Overall Study|Protocol Violation|5|||
105354726|NCT02937636|363303361|FG000|Overall Study|Other (Not specified)|3|||
105354727|NCT02937636|363303362|FG001|Overall Study|Other (Not specified)|2|||
105354728|NCT03585712|363303363|FG000|Treatment Period 1|Protocol Violation|1|||
105354729|NCT03585712|363303364|FG001|Treatment Period 1|Protocol Violation|0|||
105354730|NCT03585712|363303365|FG002|Treatment Period 1|Protocol Violation|0|||
105481167|NCT00830869|363773457|FG000|Period 2: Part 2|Other|0|||
105481168|NCT00830869|363773458|FG001|Period 2: Part 2|Other|0|||
105481169|NCT00830869|363773459|FG002|Period 2: Part 2|Other|0|||
105481170|NCT00830869|363773460|FG003|Period 2: Part 2|Other|0|||
105481171|NCT00830869|363773461|FG004|Period 2: Part 2|Other|0|||
105481172|NCT00830869|363773462|FG005|Period 2: Part 2|Other|0|||
105481173|NCT00830869|363773463|FG006|Period 2: Part 2|Other|0|||
105481174|NCT00830869|363773464|FG007|Period 2: Part 2|Other|0|||
105481175|NCT00830869|363773465|FG008|Period 2: Part 2|Other|0|||
105481176|NCT00830869|363773466|FG009|Period 2: Part 2|Other|1|||
105481177|NCT00830869|363773467|FG010|Period 2: Part 2|Other|0|||
105481178|NCT00830869|363773468|FG011|Period 2: Part 2|Other|0|||
105481179|NCT00877773|363773469|FG000|Overall Study|Disease Progression|44|||
105481180|NCT02446171|363773476|FG000|Overall Study|Withdrawal by Subject|0|||
105481181|NCT02446171|363773477|FG001|Overall Study|Withdrawal by Subject|0|||
105481182|NCT02446171|363773478|FG002|Overall Study|Withdrawal by Subject|2|||
105481183|NCT02446171|363773479|FG003|Overall Study|Withdrawal by Subject|0|||
105481184|NCT03745820|363773480|FG000|Overall Study|Adverse Event|0|||
105481185|NCT03745820|363773481|FG001|Overall Study|Adverse Event|3|||
105481186|NCT03745820|363773482|FG002|Overall Study|Adverse Event|2|||
105481187|NCT03745820|363773480|FG000|Overall Study|Non-Compliance with Study Drug|4|||
105481188|NCT03745820|363773481|FG001|Overall Study|Non-Compliance with Study Drug|3|||
105736577|NCT03090737|364691174|FG000|Overall Study|Other reasons|1|||
105736578|NCT03090737|364691174|FG000|Overall Study|Completed treatment as per protocol|17|||
105736579|NCT03090737|364691174|FG000|Overall Study|Maximum clinical benefit|2|||
105736580|NCT03090737|364691174|FG000|Overall Study|Adverse event unrelated to study drug|7|||
105354731|NCT03585712|363303363|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
105354732|NCT03585712|363303364|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
105354733|NCT03585712|363303365|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
105354734|NCT03585712|363303363|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
105354735|NCT03585712|363303364|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
105354736|NCT03585712|363303365|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
105354737|NCT03585712|363303363|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
105354738|NCT03585712|363303364|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
105354739|NCT03585712|363303365|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
105354740|NCT01658904|363303370|FG000|Overall Study|Principal Investigator discretion|2|||
105354741|NCT01658904|363303371|FG001|Overall Study|Principal Investigator discretion|0|||
105354742|NCT01658904|363303372|FG002|Overall Study|Principal Investigator discretion|0|||
105354743|NCT03762681|363303375|FG000|Part 1|Withdrawal by Subject|0|||
105354744|NCT03762681|363303376|FG001|Part 1|Withdrawal by Subject|0|||
105354745|NCT03762681|363303377|FG002|Part 1|Withdrawal by Subject|0|||
105354746|NCT03762681|363303378|FG003|Part 1|Withdrawal by Subject|1|||
105354747|NCT03762681|363303379|FG004|Part 1|Withdrawal by Subject|0|||
105354748|NCT03762681|363303380|FG005|Part 1|Withdrawal by Subject|0|||
105354749|NCT03762681|363303381|FG006|Part 1|Withdrawal by Subject|0|||
105354750|NCT03762681|363303382|FG007|Part 1|Withdrawal by Subject|0|||
105354751|NCT03762681|363303375|FG000|Part 2a|Pandemic Travel Restrictions|0|||
105354752|NCT03762681|363303376|FG001|Part 2a|Pandemic Travel Restrictions|0|||
105354753|NCT03762681|363303377|FG002|Part 2a|Pandemic Travel Restrictions|0|||
105354754|NCT03762681|363303378|FG003|Part 2a|Pandemic Travel Restrictions|0|||
105354755|NCT03762681|363303379|FG004|Part 2a|Pandemic Travel Restrictions|0|||
105354756|NCT03762681|363303380|FG005|Part 2a|Pandemic Travel Restrictions|0|||
105354757|NCT03762681|363303381|FG006|Part 2a|Pandemic Travel Restrictions|0|||
105354758|NCT03762681|363303382|FG007|Part 2a|Pandemic Travel Restrictions|1|||
105354759|NCT02137226|363303383|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
105354760|NCT02137226|363303384|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
105354761|NCT02137226|363303385|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
105354762|NCT02137226|363303386|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
105354763|NCT02137226|363303387|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
105354764|NCT02137226|363303383|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
105354765|NCT02137226|363303384|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
105354766|NCT02137226|363303385|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
105354767|NCT02137226|363303386|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
105354768|NCT02137226|363303387|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
105354769|NCT02137226|363303383|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
105481189|NCT03745820|363773482|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105481190|NCT03745820|363773480|FG000|Overall Study|Withdrawal by Subject|4|||
105736581|NCT03090737|364691174|FG000|Overall Study|Study drug toxicity|4|||
105736582|NCT03090737|364691174|FG000|Overall Study|Disease progression|98|||
105736583|NCT00227877|364691175|FG000|Pre-visit Assessment|Technical difficulties|7|||
105354770|NCT02137226|363303384|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
105354771|NCT02137226|363303385|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
105354772|NCT02137226|363303386|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
105481191|NCT03745820|363773481|FG001|Overall Study|Withdrawal by Subject|4|||
105481192|NCT03745820|363773482|FG002|Overall Study|Withdrawal by Subject|4|||
105481193|NCT03745820|363773480|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
105481194|NCT03745820|363773481|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
105481195|NCT03745820|363773482|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
105736584|NCT00227877|364691176|FG001|Pre-visit Assessment|Technical difficulties|3|||
105736585|NCT00227877|364691177|FG002|Pre-visit Assessment|Technical difficulties|0|||
105736586|NCT00227877|364691178|FG003|Pre-visit Assessment|Technical difficulties|0|||
105736587|NCT00227877|364691175|FG000|Post-visit Checklist|Lost to Follow-up|24|||
105736588|NCT00227877|364691176|FG001|Post-visit Checklist|Lost to Follow-up|13|||
105736589|NCT00227877|364691177|FG002|Post-visit Checklist|Lost to Follow-up|1|||
105736590|NCT00227877|364691178|FG003|Post-visit Checklist|Lost to Follow-up|0|||
105736591|NCT00227877|364691175|FG000|3-months Follow-up|Completed late|135|||
105736592|NCT00227877|364691176|FG001|3-months Follow-up|Completed late|128|||
105736593|NCT00227877|364691177|FG002|3-months Follow-up|Completed late|34|||
105736594|NCT00227877|364691178|FG003|3-months Follow-up|Completed late|8|||
105736595|NCT00227877|364691175|FG000|3-months Follow-up|Lost to Follow-up|178|||
105736596|NCT00227877|364691176|FG001|3-months Follow-up|Lost to Follow-up|139|||
105736597|NCT00227877|364691177|FG002|3-months Follow-up|Lost to Follow-up|18|||
105736598|NCT00227877|364691178|FG003|3-months Follow-up|Lost to Follow-up|13|||
105736599|NCT00227877|364691175|FG000|12-months Follow-up|Completed late|78|||
105736600|NCT00227877|364691176|FG001|12-months Follow-up|Completed late|74|||
105736601|NCT00227877|364691177|FG002|12-months Follow-up|Completed late|1|||
105736602|NCT00227877|364691178|FG003|12-months Follow-up|Completed late|0|||
105736603|NCT00227877|364691175|FG000|12-months Follow-up|Lost to Follow-up|232|||
105736604|NCT00227877|364691176|FG001|12-months Follow-up|Lost to Follow-up|189|||
105736605|NCT00227877|364691177|FG002|12-months Follow-up|Lost to Follow-up|30|||
105736606|NCT00227877|364691178|FG003|12-months Follow-up|Lost to Follow-up|26|||
105736607|NCT02269319|364691180|FG000|Overall Study|Lost to Follow-up|4|||
105736608|NCT02269319|364691181|FG001|Overall Study|Lost to Follow-up|3|||
105736609|NCT02269319|364691180|FG000|Overall Study|Adverse Event|0|||
105736610|NCT02269319|364691181|FG001|Overall Study|Adverse Event|1|||
105736611|NCT02269319|364691180|FG000|Overall Study|Instructions not followed|1|||
105736612|NCT02269319|364691181|FG001|Overall Study|Instructions not followed|0|||
105736613|NCT04430582|364691183|FG000|Overall Study|Found to meet exclusionary criteria|1|||
105736614|NCT04430582|364691184|FG001|Overall Study|Found to meet exclusionary criteria|0|||
105736615|NCT04430582|364691183|FG000|Overall Study|Withdrawal by Subject|0|||
105736616|NCT04430582|364691184|FG001|Overall Study|Withdrawal by Subject|1|||
105736617|NCT02522481|364691185|FG000|Overall Study|discontinued|1|||
105736618|NCT02522481|364691185|FG000|Overall Study|Not dosed|2|||
105736619|NCT00404768|364691186|FG000|Part A and B|Withdrawn due to labor progression|1|||
105736620|NCT00404768|364691187|FG001|Part A and B|Withdrawn due to labor progression|0|||
105736621|NCT00404768|364691188|FG002|Part A and B|Withdrawn due to labor progression|0|||
105736622|NCT00404768|364691189|FG003|Part A and B|Withdrawn due to labor progression|0|||
105736623|NCT00404768|364691186|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
105736624|NCT00404768|364691187|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
105736625|NCT00404768|364691188|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
105736626|NCT00404768|364691189|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
105736627|NCT00404768|364691186|FG000|Part C|Adverse Event|0|||
105736628|NCT00404768|364691187|FG001|Part C|Adverse Event|0|||
105736629|NCT00404768|364691188|FG002|Part C|Adverse Event|0|||
105736630|NCT00404768|364691189|FG003|Part C|Adverse Event|3|||
105736631|NCT00404768|364691186|FG000|Part C|Lost to Follow-up|0|||
105736632|NCT00404768|364691187|FG001|Part C|Lost to Follow-up|0|||
105736633|NCT00404768|364691188|FG002|Part C|Lost to Follow-up|3|||
105736634|NCT00404768|364691189|FG003|Part C|Lost to Follow-up|1|||
105736635|NCT00404768|364691186|FG000|Part C|Withdrawal by Subject|0|||
105736636|NCT00404768|364691187|FG001|Part C|Withdrawal by Subject|0|||
105736637|NCT00404768|364691188|FG002|Part C|Withdrawal by Subject|2|||
105736638|NCT00404768|364691189|FG003|Part C|Withdrawal by Subject|1|||
105736639|NCT00404768|364691186|FG000|Part C|Early withdrawal from study medication|0|||
105481196|NCT03745820|363773480|FG000|Overall Study|Lost to Follow-up|2|||
105481197|NCT03745820|363773481|FG001|Overall Study|Lost to Follow-up|0|||
105481198|NCT03745820|363773482|FG002|Overall Study|Lost to Follow-up|3|||
105481199|NCT03745820|363773480|FG000|Overall Study|Reason not Specified|2|||
105481200|NCT03745820|363773481|FG001|Overall Study|Reason not Specified|4|||
105481201|NCT03745820|363773482|FG002|Overall Study|Reason not Specified|1|||
105481202|NCT01347580|363773485|FG000|Overall Study|Withdrawal by Subject|13|||
105481203|NCT01347580|363773486|FG001|Overall Study|Withdrawal by Subject|23|||
105481204|NCT01347580|363773485|FG000|Overall Study|Death|30|||
105481205|NCT01347580|363773486|FG001|Overall Study|Death|19|||
105481206|NCT01347580|363773485|FG000|Overall Study|Protocol Violation|10|||
105481207|NCT01347580|363773486|FG001|Overall Study|Protocol Violation|7|||
105481208|NCT01347580|363773485|FG000|Overall Study|Lost to Follow-up|3|||
105481209|NCT01347580|363773486|FG001|Overall Study|Lost to Follow-up|1|||
105481210|NCT01347580|363773485|FG000|Overall Study|Had other reason|9|||
105481211|NCT01347580|363773486|FG001|Overall Study|Had other reason|6|||
105481212|NCT00883688|363773487|FG000|Overall Study|Ineligible|2|||
105481213|NCT01122264|363773488|FG000|Overall Study|Adverse Event|6|||
105481214|NCT01122264|363773489|FG001|Overall Study|Adverse Event|5|||
105481215|NCT01122264|363773490|FG002|Overall Study|Adverse Event|7|||
105481216|NCT01122264|363773488|FG000|Overall Study|Death|1|||
105481217|NCT01122264|363773489|FG001|Overall Study|Death|0|||
105736640|NCT00404768|364691187|FG001|Part C|Early withdrawal from study medication|0|||
105736641|NCT00404768|364691188|FG002|Part C|Early withdrawal from study medication|1|||
105736642|NCT00404768|364691189|FG003|Part C|Early withdrawal from study medication|0|||
105736643|NCT00404768|364691186|FG000|Part C|Participant did not respond to therapy|0|||
105736644|NCT00404768|364691187|FG001|Part C|Participant did not respond to therapy|0|||
105736645|NCT00404768|364691188|FG002|Part C|Participant did not respond to therapy|1|||
105736646|NCT00404768|364691189|FG003|Part C|Participant did not respond to therapy|1|||
105736647|NCT00404768|364691186|FG000|Part C|Physician withdrew the study medication|0|||
105736648|NCT00404768|364691187|FG001|Part C|Physician withdrew the study medication|0|||
105736649|NCT00404768|364691188|FG002|Part C|Physician withdrew the study medication|1|||
105736650|NCT00404768|364691189|FG003|Part C|Physician withdrew the study medication|0|||
105736651|NCT00404768|364691186|FG000|Part C|Participant delivered baby|0|||
105736652|NCT00404768|364691187|FG001|Part C|Participant delivered baby|0|||
105736653|NCT00404768|364691188|FG002|Part C|Participant delivered baby|0|||
105736654|NCT00404768|364691189|FG003|Part C|Participant delivered baby|1|||
105736655|NCT00404768|364691186|FG000|Part C|Unsatisfactory uterine response to IP|0|||
105736656|NCT00404768|364691187|FG001|Part C|Unsatisfactory uterine response to IP|0|||
105736657|NCT00404768|364691188|FG002|Part C|Unsatisfactory uterine response to IP|0|||
105736658|NCT00404768|364691189|FG003|Part C|Unsatisfactory uterine response to IP|1|||
105736659|NCT00404768|364691186|FG000|Part C|Active labor|0|||
105736660|NCT00404768|364691187|FG001|Part C|Active labor|0|||
105736661|NCT00404768|364691188|FG002|Part C|Active labor|0|||
105736662|NCT00404768|364691189|FG003|Part C|Active labor|1|||
105736663|NCT00404768|364691186|FG000|Part C|Lack of Efficacy|0|||
105736664|NCT00404768|364691187|FG001|Part C|Lack of Efficacy|0|||
105736665|NCT00404768|364691188|FG002|Part C|Lack of Efficacy|0|||
105481218|NCT01122264|363773490|FG002|Overall Study|Death|0|||
105481219|NCT01122264|363773488|FG000|Overall Study|Lost to Follow-up|5|||
105481220|NCT01122264|363773489|FG001|Overall Study|Lost to Follow-up|9|||
105481221|NCT01122264|363773490|FG002|Overall Study|Lost to Follow-up|13|||
105481222|NCT01122264|363773488|FG000|Overall Study|Entry Criteria Not Met|1|||
105481223|NCT01122264|363773489|FG001|Overall Study|Entry Criteria Not Met|0|||
105481224|NCT01122264|363773490|FG002|Overall Study|Entry Criteria Not Met|0|||
105481225|NCT01122264|363773488|FG000|Overall Study|Protocol Violation|7|||
105799272|NCT02094937|364922714|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
105799273|NCT02094937|364922715|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
105354773|NCT02137226|363303387|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
105354774|NCT02137226|363303383|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
105354775|NCT02137226|363303384|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
105354776|NCT02137226|363303385|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
105354777|NCT02137226|363303386|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
105354778|NCT02137226|363303387|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
105354779|NCT02137226|363303383|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
105354780|NCT02137226|363303384|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
105354781|NCT02137226|363303385|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
105354782|NCT02137226|363303386|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
105354783|NCT02137226|363303387|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
105354784|NCT02137226|363303383|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
105354785|NCT02137226|363303384|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
105354786|NCT02137226|363303385|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
105354787|NCT02137226|363303386|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
105354788|NCT02137226|363303387|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
105354789|NCT02137226|363303383|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
105354790|NCT02137226|363303384|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
105354791|NCT02137226|363303385|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
105354792|NCT02137226|363303386|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
105354793|NCT02137226|363303387|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
105354794|NCT02137226|363303383|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
105354795|NCT02137226|363303384|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
105354796|NCT02137226|363303385|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
105354797|NCT02137226|363303386|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
105354798|NCT02137226|363303387|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
105354799|NCT02137226|363303383|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
105354800|NCT02137226|363303384|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
105354801|NCT02137226|363303385|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
105354802|NCT02137226|363303386|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
105354803|NCT02137226|363303387|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
105354804|NCT02137226|363303383|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
105354805|NCT02137226|363303384|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
105354806|NCT02137226|363303385|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
105354807|NCT02137226|363303386|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
105354808|NCT02137226|363303387|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
105354809|NCT02137226|363303383|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
105354810|NCT02137226|363303384|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
105354811|NCT02137226|363303385|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
105354812|NCT02137226|363303386|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
105354813|NCT02137226|363303387|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
105354814|NCT02137226|363303383|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
105354815|NCT02137226|363303384|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
105354816|NCT02137226|363303385|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
105354817|NCT02137226|363303386|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
105354818|NCT02137226|363303387|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
105354819|NCT01398358|363303388|FG000|Overall Study|Lost to Follow-up|11|||
105354820|NCT01398358|363303389|FG001|Overall Study|Lost to Follow-up|21|||
105354821|NCT01398358|363303390|FG002|Overall Study|Lost to Follow-up|18|||
105354822|NCT01398358|363303388|FG000|Overall Study|Withdrawal by Subject|3|||
105354823|NCT01398358|363303389|FG001|Overall Study|Withdrawal by Subject|2|||
105354824|NCT01398358|363303390|FG002|Overall Study|Withdrawal by Subject|2|||
105354825|NCT01398358|363303388|FG000|Overall Study|no longer eligible|1|||
105354826|NCT01398358|363303389|FG001|Overall Study|no longer eligible|0|||
105354827|NCT01398358|363303390|FG002|Overall Study|no longer eligible|1|||
105354828|NCT01607346|363303394|FG000|Overall Study|Adverse Event|3|||
105354829|NCT03383692|363303399|FG000|Overall Study|Progressive disease as per RECIST|3|||
105354830|NCT03383692|363303400|FG001|Overall Study|Progressive disease as per RECIST|3|||
105354831|NCT03383692|363303399|FG000|Overall Study|Clinical progression|0|||
105354832|NCT03383692|363303400|FG001|Overall Study|Clinical progression|1|||
105354833|NCT03383692|363303399|FG000|Overall Study|Adverse Event|3|||
105354834|NCT03383692|363303400|FG001|Overall Study|Adverse Event|0|||
105354835|NCT03268005|363303401|FG000|Overall Study|Death|2|||
105354836|NCT03268005|363303402|FG001|Overall Study|Death|1|||
105354837|NCT03268005|363303401|FG000|Overall Study|Lost to Follow-up|2|||
105354838|NCT03268005|363303402|FG001|Overall Study|Lost to Follow-up|2|||
105354839|NCT03268005|363303401|FG000|Overall Study|Withdrawal by Subject|11|||
105799274|NCT01133392|364922716|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
105799275|NCT01133392|364922717|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
105481226|NCT01122264|363773489|FG001|Overall Study|Protocol Violation|7|||
105481227|NCT01122264|363773490|FG002|Overall Study|Protocol Violation|9|||
105481228|NCT01122264|363773488|FG000|Overall Study|Withdrawal by Subject|6|||
105481229|NCT01122264|363773489|FG001|Overall Study|Withdrawal by Subject|6|||
105481230|NCT01122264|363773490|FG002|Overall Study|Withdrawal by Subject|16|||
105481231|NCT01122264|363773488|FG000|Overall Study|Physician Decision|3|||
105481232|NCT01122264|363773489|FG001|Overall Study|Physician Decision|1|||
105481233|NCT01122264|363773490|FG002|Overall Study|Physician Decision|1|||
105481234|NCT01122264|363773488|FG000|Overall Study|Lack of Efficacy|3|||
105481235|NCT01122264|363773489|FG001|Overall Study|Lack of Efficacy|1|||
105481236|NCT01122264|363773490|FG002|Overall Study|Lack of Efficacy|1|||
105481237|NCT01002820|363773501|FG000|Overall Study|Adverse Event|1|||
105481238|NCT01002820|363773501|FG000|Overall Study|Withdrawal by Subject|2|||
105481239|NCT01002820|363773501|FG000|Overall Study|Lack of Efficacy|1|||
105481240|NCT01673347|363773503|FG000|Overall Study|failure of allograft|7|||
105481241|NCT02500056|363773508|FG000|Overall Study|Lost to Follow-up|3|||
105481242|NCT02500056|363773509|FG001|Overall Study|Lost to Follow-up|7|||
105481243|NCT02500056|363773508|FG000|Overall Study|Recurrence|1|||
105481244|NCT02500056|363773509|FG001|Overall Study|Recurrence|0|||
105481245|NCT02500056|363773508|FG000|Overall Study|Death|3|||
105481246|NCT02500056|363773509|FG001|Overall Study|Death|1|||
105481247|NCT00864916|363773510|FG000|Overall Study|Lost to Follow-up|4|||
105481248|NCT00864916|363773511|FG001|Overall Study|Lost to Follow-up|4|||
105481249|NCT00864916|363773510|FG000|Overall Study|Protocol Violation|1|||
105481250|NCT00864916|363773511|FG001|Overall Study|Protocol Violation|0|||
105481251|NCT00864916|363773510|FG000|Overall Study|Withdrawal by Subject|1|||
105481252|NCT00864916|363773511|FG001|Overall Study|Withdrawal by Subject|0|||
105481253|NCT00329901|363773512|FG000|Overall Study|Withdrawal by Subject|4|||
105481254|NCT00329901|363773513|FG001|Overall Study|Withdrawal by Subject|3|||
105481255|NCT00329901|363773514|FG002|Overall Study|Withdrawal by Subject|2|||
105481256|NCT00329901|363773512|FG000|Overall Study|Lost to Follow-up|2|||
105481257|NCT00329901|363773513|FG001|Overall Study|Lost to Follow-up|0|||
105481258|NCT00329901|363773514|FG002|Overall Study|Lost to Follow-up|1|||
105481259|NCT00329901|363773512|FG000|Overall Study|Protocol Violation|1|||
105481260|NCT00329901|363773513|FG001|Overall Study|Protocol Violation|0|||
105481261|NCT00329901|363773514|FG002|Overall Study|Protocol Violation|1|||
105481262|NCT00329901|363773512|FG000|Overall Study|Unable to classify|2|||
105481263|NCT00329901|363773513|FG001|Overall Study|Unable to classify|2|||
105481264|NCT00329901|363773514|FG002|Overall Study|Unable to classify|0|||
105481265|NCT01105065|363773515|FG000|Overall Study|Adverse Event|5|||
105481266|NCT01105065|363773515|FG000|Overall Study|Technical Problems|1|||
105481267|NCT03774823|363773516|FG000|Overall Study|Withdrawal by Subject|1|||
105481268|NCT03774823|363773517|FG001|Overall Study|Withdrawal by Subject|1|||
105481269|NCT01253811|363773518|FG000|Overall Study|Withdrawal criteria|1|||
105481270|NCT02788279|363773519|FG000|Overall Study|Death|62|||
105481271|NCT02788279|363773520|FG001|Overall Study|Death|136|||
105481272|NCT02788279|363773521|FG002|Overall Study|Death|72|||
105481273|NCT02788279|363773519|FG000|Overall Study|Withdrawal by Subject|10|||
105736666|NCT00404768|364691189|FG003|Part C|Lack of Efficacy|2|||
105736667|NCT00404768|364691186|FG000|Part C|Treatment failure|0|||
105736668|NCT00404768|364691187|FG001|Part C|Treatment failure|0|||
105736669|NCT00404768|364691188|FG002|Part C|Treatment failure|0|||
105736670|NCT00404768|364691189|FG003|Part C|Treatment failure|1|||
105736671|NCT00404768|364691186|FG000|Part C|Investigator discretion|0|||
105736672|NCT00404768|364691187|FG001|Part C|Investigator discretion|0|||
105736673|NCT00404768|364691188|FG002|Part C|Investigator discretion|0|||
105481274|NCT02788279|363773520|FG001|Overall Study|Withdrawal by Subject|15|||
105481275|NCT02788279|363773521|FG002|Overall Study|Withdrawal by Subject|5|||
105481276|NCT02788279|363773519|FG000|Overall Study|Lost to Follow-up|0|||
105481277|NCT02788279|363773520|FG001|Overall Study|Lost to Follow-up|3|||
105481278|NCT02788279|363773521|FG002|Overall Study|Lost to Follow-up|2|||
105565091|NCT01529008|364066677|FG000|Efficacy Analysis|Protocol Violation|2|||
105736674|NCT00404768|364691189|FG003|Part C|Investigator discretion|1|||
105736675|NCT00404768|364691186|FG000|Part C|Researcher suspended study medication|0|||
105481279|NCT02788279|363773519|FG000|Overall Study|Sponsor decision|18|||
105481280|NCT02788279|363773520|FG001|Overall Study|Sponsor decision|29|||
105481281|NCT02788279|363773521|FG002|Overall Study|Sponsor decision|11|||
105736676|NCT00404768|364691187|FG001|Part C|Researcher suspended study medication|0|||
105736677|NCT00404768|364691188|FG002|Part C|Researcher suspended study medication|0|||
105736678|NCT00404768|364691189|FG003|Part C|Researcher suspended study medication|1|||
105736679|NCT04773041|364691192|FG000|Overall Study|Unable to data match|1|||
105736680|NCT04773041|364691193|FG001|Overall Study|Unable to data match|0|||
105565092|NCT01529008|364066678|FG001|Efficacy Analysis|Protocol Violation|0|||
105565093|NCT01529008|364066677|FG000|Efficacy Analysis|Physician Decision|0|||
105565094|NCT01529008|364066678|FG001|Efficacy Analysis|Physician Decision|1|||
105565095|NCT01529008|364066677|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
105565096|NCT01529008|364066678|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
105565097|NCT00944658|364066682|FG000|Treatment 12 Weeks|Adverse Event|0|||
105565098|NCT00944658|364066683|FG001|Treatment 12 Weeks|Adverse Event|2|||
105565099|NCT01255592|364066684|FG000|Overall Study|Adverse Event|5|||
105565100|NCT01255592|364066685|FG001|Overall Study|Adverse Event|0|||
105565101|NCT01255592|364066684|FG000|Overall Study|Withdrawal by Subject|1|||
105565102|NCT01255592|364066685|FG001|Overall Study|Withdrawal by Subject|0|||
105565103|NCT01255592|364066684|FG000|Overall Study|Other|0|||
105565104|NCT01255592|364066685|FG001|Overall Study|Other|1|||
105565105|NCT02035332|364066686|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
105565106|NCT00998400|364066687|FG000|Overall Study|Lack of interest/motivation|1|||
105565107|NCT00998400|364066688|FG001|Overall Study|Lack of interest/motivation|2|||
105565108|NCT00998400|364066687|FG000|Overall Study|Logistical problems|1|||
105565109|NCT00998400|364066688|FG001|Overall Study|Logistical problems|0|||
105565110|NCT02364180|364066691|FG000|Overall Study|Screen Fail|1|||
105565111|NCT00521144|364066692|FG000|Overall Study|Not Treated|0|||
105565112|NCT00521144|364066693|FG001|Overall Study|Not Treated|0|||
105565113|NCT00521144|364066694|FG002|Overall Study|Not Treated|0|||
105565114|NCT00521144|364066695|FG003|Overall Study|Not Treated|1|||
105565115|NCT00521144|364066696|FG004|Overall Study|Not Treated|0|||
105565116|NCT00521144|364066692|FG000|Overall Study|Adverse Event|0|||
105565117|NCT00521144|364066693|FG001|Overall Study|Adverse Event|1|||
105565118|NCT00521144|364066694|FG002|Overall Study|Adverse Event|0|||
105565119|NCT00521144|364066695|FG003|Overall Study|Adverse Event|0|||
105565120|NCT00521144|364066696|FG004|Overall Study|Adverse Event|1|||
105565121|NCT00521144|364066692|FG000|Overall Study|Progressive Disease|4|||
105565122|NCT00521144|364066693|FG001|Overall Study|Progressive Disease|2|||
105565123|NCT00521144|364066694|FG002|Overall Study|Progressive Disease|2|||
105565124|NCT00521144|364066695|FG003|Overall Study|Progressive Disease|0|||
105565125|NCT00521144|364066696|FG004|Overall Study|Progressive Disease|6|||
105565126|NCT01370525|364066697|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
105565127|NCT01370525|364066698|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
105565128|NCT01370525|364066697|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
105565129|NCT01370525|364066698|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105565130|NCT01370525|364066697|FG000|Overall Study|Adverse Event|0|||
105565131|NCT01370525|364066698|FG001|Overall Study|Adverse Event|1|||
105565132|NCT01370525|364066697|FG000|Overall Study|Protocol Violation|2|||
105565133|NCT01370525|364066698|FG001|Overall Study|Protocol Violation|1|||
105565134|NCT01370525|364066697|FG000|Overall Study|Lost to follow up|2|||
105565135|NCT01370525|364066698|FG001|Overall Study|Lost to follow up|6|||
105565136|NCT00710606|364066699|FG000|Overall Study|Adverse Event|0|||
105565137|NCT00710606|364066700|FG001|Overall Study|Adverse Event|2|||
105565138|NCT05131165|364066701|FG000|Overall Study|Death|1|||
105565139|NCT05131165|364066702|FG001|Overall Study|Death|1|||
105565140|NCT05131165|364066703|FG002|Overall Study|Death|0|||
105565141|NCT05131165|364066701|FG000|Overall Study|Lost to Follow-up|2|||
105565142|NCT05131165|364066702|FG001|Overall Study|Lost to Follow-up|2|||
105565143|NCT05131165|364066703|FG002|Overall Study|Lost to Follow-up|5|||
105736681|NCT04773041|364691194|FG002|Overall Study|Unable to data match|0|||
105736682|NCT02112448|364691198|FG000|Overall Study|lab values precluding use of ketorolac|2|||
105565144|NCT05131165|364066701|FG000|Overall Study|Transferred out of clinic|1|||
105565145|NCT05131165|364066702|FG001|Overall Study|Transferred out of clinic|0|||
105565146|NCT05131165|364066703|FG002|Overall Study|Transferred out of clinic|3|||
105565147|NCT05131165|364066701|FG000|Overall Study|Dropped out|1|||
105565148|NCT05131165|364066702|FG001|Overall Study|Dropped out|2|||
105565149|NCT05131165|364066703|FG002|Overall Study|Dropped out|0|||
105565150|NCT01964326|364066704|FG000|Overall Study|Adverse Event|48|||
105565151|NCT01964326|364066704|FG000|Overall Study|Death|2|||
105565152|NCT01964326|364066704|FG000|Overall Study|Protocol Violation|4|||
105565153|NCT01964326|364066704|FG000|Overall Study|Lost to Follow-up|88|||
105565154|NCT01964326|364066704|FG000|Overall Study|Withdrawal by Subject|87|||
105565155|NCT01964326|364066704|FG000|Overall Study|Pregnancy|1|||
105736683|NCT02112448|364691199|FG001|Overall Study|lab values precluding use of ketorolac|2|||
105736684|NCT02112448|364691198|FG000|Overall Study|Protocol Violation|1|||
105481282|NCT00322621|363773524|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
105481283|NCT00322621|363773525|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
105481284|NCT00322621|363773526|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
105481285|NCT00322621|363773524|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
105481286|NCT00322621|363773525|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
105481287|NCT00322621|363773526|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
105481288|NCT00322621|363773524|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
105481289|NCT00322621|363773525|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
105481290|NCT00322621|363773526|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
105481291|NCT00322621|363773524|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
105481292|NCT00322621|363773525|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
105481293|NCT00322621|363773526|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
105481294|NCT00322621|363773524|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
105481295|NCT00322621|363773525|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
105481296|NCT00322621|363773526|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
105481297|NCT00322621|363773524|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
105481298|NCT00322621|363773525|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
105481299|NCT00322621|363773526|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
105481300|NCT00322621|363773524|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
105481301|NCT00322621|363773525|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
105481302|NCT00322621|363773526|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
105481303|NCT00322621|363773524|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
105481304|NCT00322621|363773525|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
105481305|NCT00322621|363773526|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
105481306|NCT00322621|363773524|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
105481307|NCT00322621|363773525|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
105481308|NCT00322621|363773526|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
105481309|NCT00322621|363773524|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
105481310|NCT00322621|363773525|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
105736685|NCT02112448|364691199|FG001|Overall Study|Protocol Violation|2|||
105736686|NCT02112448|364691198|FG000|Overall Study|Physician Decision|4|||
105736687|NCT02112448|364691199|FG001|Overall Study|Physician Decision|6|||
105736688|NCT02112448|364691198|FG000|Overall Study|required heparin so could not use ketoro|1|||
105736689|NCT02112448|364691199|FG001|Overall Study|required heparin so could not use ketoro|0|||
105736690|NCT05243550|364693250|FG000|Overall Study|Ongoing in the Study|171|||
105736691|NCT05243550|364693250|FG000|Overall Study|Withdrawal by Subject|10|||
105736692|NCT05243550|364693250|FG000|Overall Study|Lost to Follow-up|7|||
105736693|NCT05243550|364693250|FG000|Overall Study|Adverse Event|3|||
105736694|NCT05243550|364693250|FG000|Overall Study|Noncompliance|1|||
105736695|NCT05243550|364693250|FG000|Overall Study|Physician Decision|1|||
105736696|NCT05243550|364693250|FG000|Overall Study|Other Reason|4|||
105736697|NCT01543490|364693266|FG000|Overall Study|Adverse Event|4|||
105736698|NCT01543490|364693267|FG001|Overall Study|Adverse Event|0|||
105736699|NCT01543490|364693266|FG000|Overall Study|Physician Decision|1|||
105736700|NCT01543490|364693267|FG001|Overall Study|Physician Decision|0|||
105736701|NCT01543490|364693266|FG000|Overall Study|Lack of Efficacy|3|||
105736702|NCT01543490|364693267|FG001|Overall Study|Lack of Efficacy|3|||
105736703|NCT01543490|364693266|FG000|Overall Study|Lost to Follow-up|5|||
105736704|NCT01543490|364693267|FG001|Overall Study|Lost to Follow-up|0|||
105736705|NCT01543490|364693266|FG000|Overall Study|Withdrawal by Subject|2|||
105736706|NCT01543490|364693267|FG001|Overall Study|Withdrawal by Subject|0|||
105736707|NCT01543490|364693266|FG000|Overall Study|Other-Various Administrative Reasons|1|||
105736708|NCT01543490|364693267|FG001|Overall Study|Other-Various Administrative Reasons|2|||
105736709|NCT01597622|364693268|FG000|Overall Study|Adverse Event|7|||
105736710|NCT01597622|364693268|FG000|Overall Study|Lack of Efficacy|3|||
105736711|NCT01597622|364693268|FG000|Overall Study|Protocol Violation|1|||
105736712|NCT01597622|364693268|FG000|Overall Study|Lost to Follow-up|1|||
105736713|NCT01597622|364693268|FG000|Overall Study|Investigator Discretion|5|||
105736714|NCT01597622|364693268|FG000|Overall Study|Withdrawal by Subject|20|||
105481311|NCT00322621|363773526|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
105481312|NCT00322621|363773524|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
105736715|NCT01597622|364693268|FG000|Overall Study|Death|1|||
105736716|NCT01040832|364693270|FG000|Overall Study|Adverse Event|4|||
105736717|NCT01040832|364693271|FG001|Overall Study|Adverse Event|5|||
105736718|NCT01040832|364693270|FG000|Overall Study|Death|4|||
105736719|NCT01040832|364693271|FG001|Overall Study|Death|6|||
105736720|NCT01040832|364693270|FG000|Overall Study|Withdrawal by Subject|2|||
105736721|NCT01040832|364693271|FG001|Overall Study|Withdrawal by Subject|3|||
105736722|NCT01040832|364693270|FG000|Overall Study|Progressive disease|32|||
105736723|NCT01040832|364693271|FG001|Overall Study|Progressive disease|17|||
105736724|NCT01040832|364693270|FG000|Overall Study|Symptomatic deterioration|2|||
105736725|NCT01040832|364693271|FG001|Overall Study|Symptomatic deterioration|5|||
105736726|NCT01040832|364693270|FG000|Overall Study|Other|2|||
105736727|NCT01040832|364693271|FG001|Overall Study|Other|1|||
105736728|NCT01300286|364693272|FG000|Overall Study|did not get dosed|1|||
105736729|NCT02601001|364693275|FG000|Dosing Period 2|Adverse Event|0|||
105736730|NCT02601001|364693276|FG001|Dosing Period 2|Adverse Event|0|||
105736731|NCT02601001|364693277|FG002|Dosing Period 2|Adverse Event|0|||
105736732|NCT02601001|364693278|FG003|Dosing Period 2|Adverse Event|0|||
105736733|NCT02601001|364693279|FG004|Dosing Period 2|Adverse Event|0|||
105736734|NCT02601001|364693280|FG005|Dosing Period 2|Adverse Event|0|||
105736735|NCT02601001|364693281|FG006|Dosing Period 2|Adverse Event|1|||
105736736|NCT01277289|364693284|FG000|Overall Study|fragile vein|1|||
105736737|NCT01277289|364693285|FG001|Overall Study|fragile vein|0|||
105736738|NCT01277289|364693284|FG000|Overall Study|Physician Decision|1|||
105736739|NCT01277289|364693285|FG001|Overall Study|Physician Decision|0|||
105736740|NCT01277289|364693284|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
105736741|NCT01277289|364693285|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
105736742|NCT01277289|364693284|FG000|Overall Study|Protocol Violation|1|||
105736743|NCT01277289|364693285|FG001|Overall Study|Protocol Violation|1|||
105736744|NCT01277289|364693284|FG000|Overall Study|Adverse Event|2|||
105736745|NCT01277289|364693285|FG001|Overall Study|Adverse Event|1|||
105736746|NCT01277289|364693284|FG000|Overall Study|consent withdrawn|1|||
105736747|NCT01277289|364693285|FG001|Overall Study|consent withdrawn|1|||
105736748|NCT01277289|364693284|FG000|Overall Study|premature closure of the study|4|||
105736749|NCT01277289|364693285|FG001|Overall Study|premature closure of the study|2|||
105736750|NCT01013883|364693286|FG000|Overall Study|Lost to Follow-up|2|||
105736751|NCT01013883|364693287|FG001|Overall Study|Lost to Follow-up|2|||
105736752|NCT02584634|364693289|FG000|Overall Study|Adverse Event|3|||
105736753|NCT02584634|364693290|FG001|Overall Study|Adverse Event|5|||
105736754|NCT02584634|364693289|FG000|Overall Study|Death|0|||
105736755|NCT02584634|364693290|FG001|Overall Study|Death|1|||
105799276|NCT01133392|364922716|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
105799277|NCT01133392|364922717|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
105354840|NCT03268005|363303402|FG001|Overall Study|Withdrawal by Subject|11|||
105354841|NCT03628716|363303403|FG000|Overall Study|Adverse Event|1|||
105354842|NCT03628716|363303404|FG001|Overall Study|Adverse Event|1|||
105354843|NCT03628716|363303403|FG000|Overall Study|Death|1|||
105354844|NCT03628716|363303404|FG001|Overall Study|Death|0|||
105354845|NCT03628716|363303403|FG000|Overall Study|Lack of Efficacy|15|||
105354846|NCT03628716|363303404|FG001|Overall Study|Lack of Efficacy|20|||
105354847|NCT03628716|363303403|FG000|Overall Study|Withdrawal by Subject|1|||
105354848|NCT03628716|363303404|FG001|Overall Study|Withdrawal by Subject|2|||
105354849|NCT03628716|363303403|FG000|Overall Study|Study Terminated by Sponsor|1|||
105354850|NCT03628716|363303404|FG001|Overall Study|Study Terminated by Sponsor|0|||
105354851|NCT00492232|363303405|FG000|Placebo Run-in|Adverse Event|0|||
105354852|NCT00492232|363303406|FG001|Placebo Run-in|Adverse Event|2|||
105354853|NCT00492232|363303405|FG000|Placebo Run-in|Protocol Violation|0|||
105354854|NCT00492232|363303406|FG001|Placebo Run-in|Protocol Violation|3|||
105354855|NCT00492232|363303405|FG000|Placebo Run-in|Lost to Follow-up|0|||
105354856|NCT00492232|363303406|FG001|Placebo Run-in|Lost to Follow-up|3|||
105354857|NCT00492232|363303405|FG000|Placebo Run-in|Withdrawal by Subject|0|||
105354858|NCT00492232|363303406|FG001|Placebo Run-in|Withdrawal by Subject|8|||
105354859|NCT00492232|363303405|FG000|Placebo Run-in|Pregnancy|0|||
105354860|NCT00492232|363303406|FG001|Placebo Run-in|Pregnancy|1|||
105354861|NCT00492232|363303405|FG000|Placebo Run-in|Entrance criteria not met|0|||
105354862|NCT00492232|363303406|FG001|Placebo Run-in|Entrance criteria not met|45|||
105354863|NCT00492232|363303405|FG000|Placebo Run-in|Other|0|||
105354864|NCT00492232|363303406|FG001|Placebo Run-in|Other|6|||
105354865|NCT00492232|363303405|FG000|Placebo Run-in|Missing|0|||
105354866|NCT00492232|363303406|FG001|Placebo Run-in|Missing|2|||
105736756|NCT02584634|364693289|FG000|Overall Study|Lost to Follow-up|0|||
105736757|NCT02584634|364693290|FG001|Overall Study|Lost to Follow-up|1|||
105736758|NCT02584634|364693289|FG000|Overall Study|Physician Decision|1|||
105736759|NCT02584634|364693290|FG001|Overall Study|Physician Decision|2|||
105736760|NCT02584634|364693289|FG000|Overall Study|Progressive disease|7|||
105799278|NCT01759537|364922718|FG000|Overall Study|Death|1|||
105354867|NCT00492232|363303405|FG000|Double-Blind Treatment|Adverse Event|1|||
105354868|NCT00492232|363303406|FG001|Double-Blind Treatment|Adverse Event|2|||
105354869|NCT00492232|363303405|FG000|Double-Blind Treatment|Protocol Violation|3|||
105354870|NCT00492232|363303406|FG001|Double-Blind Treatment|Protocol Violation|7|||
105354871|NCT00492232|363303405|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
105354872|NCT00492232|363303406|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
105736761|NCT02584634|364693290|FG001|Overall Study|Progressive disease|15|||
105736762|NCT02584634|364693289|FG000|Overall Study|Withdrawal by Subject|1|||
105736763|NCT02584634|364693290|FG001|Overall Study|Withdrawal by Subject|1|||
105736764|NCT02584634|364693289|FG000|Overall Study|Other|0|||
105799279|NCT01759537|364922719|FG001|Overall Study|Death|1|||
105354873|NCT00492232|363303405|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
105736765|NCT02584634|364693290|FG001|Overall Study|Other|6|||
105736766|NCT03666143|364693292|FG000|Overall Study|Death|158|||
105481313|NCT00322621|363773525|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
105481314|NCT00322621|363773526|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
105481315|NCT02047318|363773527|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
105481316|NCT02047318|363773527|FG000|Core Study Period|Adverse Event|1|||
105481317|NCT02047318|363773527|FG000|Core Study Period|Withdrawal by caregiver|3|||
105481318|NCT02047318|363773527|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
105481319|NCT01038869|363773530|FG000|Overall Study|Withdrawal by Subject|1|||
105481320|NCT01038869|363773530|FG000|Overall Study|Lost to Follow-up|6|||
105481321|NCT00466687|363773532|FG000|Overall Study|Adverse Event|1|||
105736767|NCT03666143|364693292|FG000|Overall Study|Sponsor Decision|31|||
105736768|NCT03666143|364693292|FG000|Overall Study|Withdrawal by Subject|11|||
105736769|NCT03666143|364693292|FG000|Overall Study|Lost to Follow-up|5|||
105736770|NCT03666143|364693292|FG000|Overall Study|Physician Decision|1|||
105736771|NCT03666143|364693292|FG000|Overall Study|Rolled into extension study|9|||
105736772|NCT03666143|364693292|FG000|Overall Study|Progressive Disease|1|||
105736773|NCT01103349|364693293|FG000|Overall Study|Adverse Event|8|||
105736774|NCT01103349|364693294|FG001|Overall Study|Adverse Event|5|||
105354874|NCT00492232|363303406|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
105354875|NCT00492232|363303405|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
105354876|NCT00492232|363303406|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
105354877|NCT00492232|363303405|FG000|Double-Blind Treatment|Other|6|||
105354878|NCT00492232|363303406|FG001|Double-Blind Treatment|Other|5|||
105354879|NCT00492232|363303405|FG000|Double-Blind Treatment|Randomized not treated|1|||
105354880|NCT00492232|363303406|FG001|Double-Blind Treatment|Randomized not treated|0|||
105354881|NCT00492232|363303405|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
105354882|NCT00492232|363303406|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
105354883|NCT00845676|363303407|FG000|Overall Study|Virologic breakthrough at week 20|1|||
105354884|NCT00845676|363303407|FG000|Overall Study|Adverse Event|1|||
105354885|NCT00524173|363303408|FG000|Overall Study|Lost to Follow-up|0|||
105354886|NCT00524173|363303409|FG001|Overall Study|Lost to Follow-up|1|||
105354887|NCT00524173|363303408|FG000|Overall Study|Death|1|||
105354888|NCT00524173|363303409|FG001|Overall Study|Death|0|||
105354889|NCT00524173|363303408|FG000|Overall Study|Had not reached endpoint at study close|4|||
105354890|NCT00524173|363303409|FG001|Overall Study|Had not reached endpoint at study close|1|||
105354891|NCT02070978|363303410|FG000|Overall Study|Adverse Event|6|||
105354892|NCT02070978|363303411|FG001|Overall Study|Adverse Event|2|||
105354893|NCT02070978|363303412|FG002|Overall Study|Adverse Event|0|||
105354894|NCT02070978|363303410|FG000|Overall Study|Lost to Follow-up|1|||
105354895|NCT02070978|363303411|FG001|Overall Study|Lost to Follow-up|3|||
105354896|NCT02070978|363303412|FG002|Overall Study|Lost to Follow-up|4|||
105354897|NCT02070978|363303410|FG000|Overall Study|Withdrawal by Subject|3|||
105354898|NCT02070978|363303411|FG001|Overall Study|Withdrawal by Subject|5|||
105354899|NCT02070978|363303412|FG002|Overall Study|Withdrawal by Subject|3|||
105354900|NCT02070978|363303410|FG000|Overall Study|Protocol Violation|1|||
105354901|NCT02070978|363303411|FG001|Overall Study|Protocol Violation|0|||
105354902|NCT02070978|363303412|FG002|Overall Study|Protocol Violation|3|||
105354903|NCT02070978|363303410|FG000|Overall Study|Lack of Efficacy|0|||
105354904|NCT02070978|363303411|FG001|Overall Study|Lack of Efficacy|1|||
105354905|NCT02070978|363303412|FG002|Overall Study|Lack of Efficacy|0|||
105354906|NCT02070978|363303410|FG000|Overall Study|Death|0|||
105354907|NCT02070978|363303411|FG001|Overall Study|Death|0|||
105354908|NCT02070978|363303412|FG002|Overall Study|Death|2|||
105354909|NCT02070978|363303410|FG000|Overall Study|Un-specified|3|||
105354910|NCT02070978|363303411|FG001|Overall Study|Un-specified|2|||
105354911|NCT02070978|363303412|FG002|Overall Study|Un-specified|2|||
105354912|NCT02070978|363303410|FG000|Overall Study|Terminated by Sponsor|33|||
105354913|NCT02070978|363303411|FG001|Overall Study|Terminated by Sponsor|40|||
105354914|NCT02070978|363303412|FG002|Overall Study|Terminated by Sponsor|39|||
105354915|NCT03951753|363303413|FG000|Overall Study|Adverse Event|1|||
105354916|NCT03951753|363303414|FG001|Overall Study|Adverse Event|0|||
105354917|NCT03951753|363303415|FG002|Overall Study|Adverse Event|3|||
105481322|NCT00466687|363773532|FG000|Overall Study|Other complicating illness|3|||
105565156|NCT01964326|364066704|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
105736775|NCT01103349|364693295|FG002|Overall Study|Adverse Event|3|||
105736776|NCT01103349|364693293|FG000|Overall Study|Consent withdrawn|1|||
105736777|NCT01103349|364693294|FG001|Overall Study|Consent withdrawn|0|||
105736778|NCT01103349|364693295|FG002|Overall Study|Consent withdrawn|0|||
105736779|NCT01103349|364693293|FG000|Overall Study|Incorrectly included in the trial|1|||
105736780|NCT01103349|364693294|FG001|Overall Study|Incorrectly included in the trial|0|||
105736781|NCT01103349|364693295|FG002|Overall Study|Incorrectly included in the trial|0|||
105736782|NCT01103349|364693293|FG000|Overall Study|Withdrawal by Subject|1|||
105736783|NCT01103349|364693294|FG001|Overall Study|Withdrawal by Subject|1|||
105736784|NCT01103349|364693295|FG002|Overall Study|Withdrawal by Subject|0|||
105354918|NCT03951753|363303413|FG000|Overall Study|Withdrawal by Subject|3|||
105354919|NCT03951753|363303414|FG001|Overall Study|Withdrawal by Subject|1|||
105354920|NCT03951753|363303415|FG002|Overall Study|Withdrawal by Subject|0|||
105354921|NCT03951753|363303413|FG000|Overall Study|Lost to Follow-up|0|||
105354922|NCT03951753|363303414|FG001|Overall Study|Lost to Follow-up|0|||
105354923|NCT03951753|363303415|FG002|Overall Study|Lost to Follow-up|1|||
105354924|NCT03536663|363304408|FG000|Endexo|Protocol Violation|1|||
105354925|NCT00762034|363304411|FG000|Induction Period|Protocol Violation|1|||
105736785|NCT01103349|364693293|FG000|Overall Study|did not want to take trial medication|0|||
105736786|NCT01103349|364693294|FG001|Overall Study|did not want to take trial medication|1|||
105736787|NCT01103349|364693295|FG002|Overall Study|did not want to take trial medication|0|||
105736788|NCT01103349|364693293|FG000|Overall Study|forgot to take medication|0|||
105736789|NCT01103349|364693294|FG001|Overall Study|forgot to take medication|0|||
105736790|NCT01103349|364693295|FG002|Overall Study|forgot to take medication|1|||
105736791|NCT00090285|364693296|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
105736792|NCT00090285|364693297|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
105736793|NCT00090285|364693298|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
105736794|NCT00090285|364693299|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
105736795|NCT00090285|364693300|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
105736796|NCT00090285|364693301|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
105736797|NCT00090285|364693296|FG000|Base Study Vaccination Period|Adverse Event|2|||
105736798|NCT00090285|364693297|FG001|Base Study Vaccination Period|Adverse Event|4|||
105736799|NCT00090285|364693298|FG002|Base Study Vaccination Period|Adverse Event|0|||
105736800|NCT00090285|364693299|FG003|Base Study Vaccination Period|Adverse Event|0|||
105736801|NCT00090285|364693300|FG004|Base Study Vaccination Period|Adverse Event|0|||
105736802|NCT00090285|364693301|FG005|Base Study Vaccination Period|Adverse Event|0|||
105799280|NCT01759537|364922718|FG000|Overall Study|Pregnancy|1|||
105799281|NCT01759537|364922719|FG001|Overall Study|Pregnancy|1|||
105565157|NCT01964326|364066704|FG000|Overall Study|Physician Decision|55|||
105736803|NCT00090285|364693296|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
105736804|NCT00090285|364693297|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
105736805|NCT00090285|364693298|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
105736806|NCT00090285|364693299|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
105736807|NCT00090285|364693300|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
105736808|NCT00090285|364693301|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
105736809|NCT00090285|364693296|FG000|Base Study Vaccination Period|Protocol Violation|2|||
105736810|NCT00090285|364693297|FG001|Base Study Vaccination Period|Protocol Violation|3|||
105736811|NCT00090285|364693298|FG002|Base Study Vaccination Period|Protocol Violation|0|||
105736812|NCT00090285|364693299|FG003|Base Study Vaccination Period|Protocol Violation|0|||
105736813|NCT00090285|364693300|FG004|Base Study Vaccination Period|Protocol Violation|0|||
105736814|NCT00090285|364693301|FG005|Base Study Vaccination Period|Protocol Violation|0|||
105736815|NCT00090285|364693296|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
105736816|NCT00090285|364693297|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
105736817|NCT00090285|364693298|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
105736818|NCT00090285|364693299|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
105736819|NCT00090285|364693300|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
105736820|NCT00090285|364693301|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
105736821|NCT00090285|364693296|FG000|Base Study Vaccination Period|Uncooperative|2|||
105736822|NCT00090285|364693297|FG001|Base Study Vaccination Period|Uncooperative|2|||
105736823|NCT00090285|364693298|FG002|Base Study Vaccination Period|Uncooperative|0|||
105736824|NCT00090285|364693299|FG003|Base Study Vaccination Period|Uncooperative|0|||
105736825|NCT00090285|364693300|FG004|Base Study Vaccination Period|Uncooperative|0|||
105736826|NCT00090285|364693301|FG005|Base Study Vaccination Period|Uncooperative|0|||
105736827|NCT00090285|364693296|FG000|Base Study Vaccination Period|Moved|20|||
105736828|NCT00090285|364693297|FG001|Base Study Vaccination Period|Moved|21|||
105736829|NCT00090285|364693298|FG002|Base Study Vaccination Period|Moved|0|||
105736830|NCT00090285|364693299|FG003|Base Study Vaccination Period|Moved|0|||
105736831|NCT00090285|364693300|FG004|Base Study Vaccination Period|Moved|0|||
105736832|NCT00090285|364693301|FG005|Base Study Vaccination Period|Moved|0|||
105736833|NCT00090285|364693296|FG000|Base Study Vaccination Period|Site Terminated|1|||
105736834|NCT00090285|364693297|FG001|Base Study Vaccination Period|Site Terminated|0|||
105736835|NCT00090285|364693298|FG002|Base Study Vaccination Period|Site Terminated|0|||
105736836|NCT00090285|364693299|FG003|Base Study Vaccination Period|Site Terminated|0|||
105736837|NCT00090285|364693300|FG004|Base Study Vaccination Period|Site Terminated|0|||
105736838|NCT00090285|364693301|FG005|Base Study Vaccination Period|Site Terminated|0|||
105736839|NCT00090285|364693296|FG000|Base Study Vaccination Period|Other|2|||
105736840|NCT00090285|364693297|FG001|Base Study Vaccination Period|Other|2|||
105354926|NCT00762034|363304412|FG001|Induction Period|Protocol Violation|2|||
105354927|NCT00762034|363304411|FG000|Induction Period|Entry Criterion Not Met|12|||
105354928|NCT00762034|363304412|FG001|Induction Period|Entry Criterion Not Met|11|||
105354929|NCT00762034|363304411|FG000|Induction Period|Adverse Event|27|||
105354930|NCT00762034|363304412|FG001|Induction Period|Adverse Event|38|||
105354931|NCT00762034|363304411|FG000|Induction Period|Lost to Follow-up|1|||
105354932|NCT00762034|363304412|FG001|Induction Period|Lost to Follow-up|1|||
105354933|NCT00762034|363304411|FG000|Induction Period|Progressive Disease|73|||
105354934|NCT00762034|363304412|FG001|Induction Period|Progressive Disease|55|||
105354935|NCT00762034|363304411|FG000|Induction Period|Physician Decision|21|||
105481323|NCT00466687|363773532|FG000|Overall Study|Withdrawal by Subject|1|||
105481324|NCT00466687|363773532|FG000|Overall Study|Disease progression|29|||
105481325|NCT04740905|363773533|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
105481326|NCT04740905|363773534|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
105481327|NCT04740905|363773533|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
105481328|NCT04740905|363773534|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
105481329|NCT04740905|363773533|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
105481330|NCT04740905|363773534|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
105481331|NCT04740905|363773533|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
105481332|NCT04740905|363773534|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
105481333|NCT04740905|363773533|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
105481334|NCT04740905|363773534|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
105481335|NCT04740905|363773533|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
105481336|NCT04740905|363773534|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
105481337|NCT04740905|363773533|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
105481338|NCT04740905|363773534|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
105481339|NCT04740905|363773533|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
105481340|NCT04740905|363773534|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
105481341|NCT04740905|363773533|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
105481342|NCT04740905|363773534|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
105736841|NCT00090285|364693298|FG002|Base Study Vaccination Period|Other|0|||
105354936|NCT00762034|363304412|FG001|Induction Period|Physician Decision|20|||
105354937|NCT00762034|363304411|FG000|Induction Period|Withdrawal by Subject|15|||
105354938|NCT00762034|363304412|FG001|Induction Period|Withdrawal by Subject|19|||
105354939|NCT00762034|363304411|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
105354940|NCT00762034|363304412|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
105354941|NCT00762034|363304411|FG000|Induction Period|Deaths Due to Study Disease|9|||
105354942|NCT00762034|363304412|FG001|Induction Period|Deaths Due to Study Disease|9|||
105354943|NCT00762034|363304411|FG000|Maintenance Period|Protocol Violation|1|||
105354944|NCT00762034|363304412|FG001|Maintenance Period|Protocol Violation|3|||
105354945|NCT00762034|363304411|FG000|Maintenance Period|Entry Criterion Not Met|0|||
105354946|NCT00762034|363304412|FG001|Maintenance Period|Entry Criterion Not Met|2|||
105354947|NCT00762034|363304411|FG000|Maintenance Period|Adverse Event|42|||
105354948|NCT00762034|363304412|FG001|Maintenance Period|Adverse Event|26|||
105354949|NCT00762034|363304411|FG000|Maintenance Period|Progressive Disease|186|||
105354950|NCT00762034|363304412|FG001|Maintenance Period|Progressive Disease|224|||
105354951|NCT00762034|363304411|FG000|Maintenance Period|Physician Decision|25|||
105354952|NCT00762034|363304412|FG001|Maintenance Period|Physician Decision|20|||
105354953|NCT00762034|363304411|FG000|Maintenance Period|Withdrawal by Subject|34|||
105354954|NCT00762034|363304412|FG001|Maintenance Period|Withdrawal by Subject|14|||
105354955|NCT00762034|363304411|FG000|Maintenance Period|Death not due to study disease|2|||
105354956|NCT00762034|363304412|FG001|Maintenance Period|Death not due to study disease|5|||
105354957|NCT00762034|363304411|FG000|Maintenance Period|Death due to study disease|3|||
105354958|NCT00762034|363304412|FG001|Maintenance Period|Death due to study disease|3|||
105354959|NCT00762034|363304411|FG000|Maintenance Period|Other|1|||
105354960|NCT00762034|363304412|FG001|Maintenance Period|Other|1|||
105354961|NCT00314808|363304417|FG000|Overall Study|Disease Progression without AE|4|||
105354962|NCT00314808|363304417|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
105354963|NCT02688764|363304418|FG000|Overall Study|Adverse Event|3|||
105354964|NCT02688764|363304419|FG001|Overall Study|Adverse Event|3|||
105354965|NCT02688764|363304418|FG000|Overall Study|AE/Kidney transplant|1|||
105354966|NCT02688764|363304419|FG001|Overall Study|AE/Kidney transplant|0|||
105354967|NCT02688764|363304418|FG000|Overall Study|AE/Lack of efficacy|1|||
105354968|NCT02688764|363304419|FG001|Overall Study|AE/Lack of efficacy|0|||
105354969|NCT02688764|363304418|FG000|Overall Study|AE/Non-compl.|1|||
105354970|NCT02688764|363304419|FG001|Overall Study|AE/Non-compl.|0|||
105354971|NCT02688764|363304418|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
105354972|NCT02688764|363304419|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
105354973|NCT02688764|363304418|FG000|Overall Study|AE/Other|0|||
105354974|NCT02688764|363304419|FG001|Overall Study|AE/Other|1|||
105354975|NCT02688764|363304418|FG000|Overall Study|AE/Physician decision|1|||
105354976|NCT02688764|363304419|FG001|Overall Study|AE/Physician decision|0|||
105354977|NCT02688764|363304418|FG000|Overall Study|AE/Withd. parent|3|||
105354978|NCT02688764|363304419|FG001|Overall Study|AE/Withd. parent|0|||
105799282|NCT01759537|364922718|FG000|Overall Study|Lost to Follow-up|9|||
105799283|NCT01759537|364922719|FG001|Overall Study|Lost to Follow-up|9|||
105354979|NCT02688764|363304418|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
105354980|NCT02688764|363304419|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
105354981|NCT02688764|363304418|FG000|Overall Study|AE/Withd. subject|1|||
105354982|NCT02688764|363304419|FG001|Overall Study|AE/Withd. subject|0|||
105354983|NCT02688764|363304418|FG000|Overall Study|Kidney transplant|10|||
105354984|NCT02688764|363304419|FG001|Overall Study|Kidney transplant|4|||
105354985|NCT02688764|363304418|FG000|Overall Study|Lack of Efficacy|3|||
105354986|NCT02688764|363304419|FG001|Overall Study|Lack of Efficacy|2|||
105354987|NCT02688764|363304418|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
105354988|NCT02688764|363304419|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
105354989|NCT02688764|363304418|FG000|Overall Study|Non-compliance with study drug|4|||
105354990|NCT02688764|363304419|FG001|Overall Study|Non-compliance with study drug|0|||
105354991|NCT02688764|363304418|FG000|Overall Study|Non-compl./Physician decision|2|||
105354992|NCT02688764|363304419|FG001|Overall Study|Non-compl./Physician decision|0|||
105354993|NCT02688764|363304418|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
105354994|NCT02688764|363304419|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
105354995|NCT02688764|363304418|FG000|Overall Study|Non-compl./Withd. subject|0|||
105354996|NCT02688764|363304419|FG001|Overall Study|Non-compl./Withd. subject|2|||
105354997|NCT02688764|363304418|FG000|Overall Study|Phosphorus level outside safe range|0|||
105354998|NCT02688764|363304419|FG001|Overall Study|Phosphorus level outside safe range|1|||
105481343|NCT04740905|363773533|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
105481344|NCT04740905|363773534|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
105481345|NCT04740905|363773533|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
105481346|NCT04740905|363773534|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
105481347|NCT04740905|363773533|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
105481348|NCT04740905|363773534|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
105481349|NCT04740905|363773533|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
105481350|NCT04740905|363773534|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
105736842|NCT00090285|364693299|FG003|Base Study Vaccination Period|Other|0|||
105736843|NCT00090285|364693300|FG004|Base Study Vaccination Period|Other|0|||
105736844|NCT00090285|364693301|FG005|Base Study Vaccination Period|Other|0|||
105736845|NCT00090285|364693296|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
105736846|NCT00090285|364693297|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
105736847|NCT00090285|364693298|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
105736848|NCT00090285|364693299|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
105736849|NCT00090285|364693300|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
105736850|NCT00090285|364693301|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
105736851|NCT00090285|364693296|FG000|Base Study Vaccination Period|HIV positive|1|||
105736852|NCT00090285|364693297|FG001|Base Study Vaccination Period|HIV positive|1|||
105736853|NCT00090285|364693298|FG002|Base Study Vaccination Period|HIV positive|0|||
105736854|NCT00090285|364693299|FG003|Base Study Vaccination Period|HIV positive|0|||
105736855|NCT00090285|364693300|FG004|Base Study Vaccination Period|HIV positive|0|||
105736856|NCT00090285|364693301|FG005|Base Study Vaccination Period|HIV positive|0|||
105736857|NCT00090285|364693296|FG000|Base Study Follow-up Period|Adverse Event|3|||
105736858|NCT00090285|364693297|FG001|Base Study Follow-up Period|Adverse Event|10|||
105736859|NCT00090285|364693298|FG002|Base Study Follow-up Period|Adverse Event|0|||
105736860|NCT00090285|364693299|FG003|Base Study Follow-up Period|Adverse Event|0|||
105736861|NCT00090285|364693300|FG004|Base Study Follow-up Period|Adverse Event|0|||
105736862|NCT00090285|364693301|FG005|Base Study Follow-up Period|Adverse Event|0|||
105736863|NCT00090285|364693296|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
105736864|NCT00090285|364693297|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
105736865|NCT00090285|364693298|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
105736866|NCT00090285|364693299|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
105736867|NCT00090285|364693300|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
105736868|NCT00090285|364693301|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
105736869|NCT00090285|364693296|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
105736870|NCT00090285|364693297|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
105736871|NCT00090285|364693298|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
105736872|NCT00090285|364693299|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
105736873|NCT00090285|364693300|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
105736874|NCT00090285|364693301|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
105736875|NCT00090285|364693296|FG000|Base Study Follow-up Period|Moved|41|||
105736876|NCT00090285|364693297|FG001|Base Study Follow-up Period|Moved|36|||
105736877|NCT00090285|364693298|FG002|Base Study Follow-up Period|Moved|0|||
105736878|NCT00090285|364693299|FG003|Base Study Follow-up Period|Moved|0|||
105736879|NCT00090285|364693300|FG004|Base Study Follow-up Period|Moved|0|||
105736880|NCT00090285|364693301|FG005|Base Study Follow-up Period|Moved|0|||
105736881|NCT00090285|364693296|FG000|Base Study Follow-up Period|Other|2|||
105736882|NCT00090285|364693297|FG001|Base Study Follow-up Period|Other|0|||
105736883|NCT00090285|364693298|FG002|Base Study Follow-up Period|Other|0|||
105736884|NCT00090285|364693299|FG003|Base Study Follow-up Period|Other|0|||
105799284|NCT01759537|364922718|FG000|Overall Study|Accident involving jaw fracture|1|||
105736885|NCT00090285|364693300|FG004|Base Study Follow-up Period|Other|0|||
105736886|NCT00090285|364693301|FG005|Base Study Follow-up Period|Other|0|||
105736887|NCT00090285|364693296|FG000|Base Study Follow-up Period|Protocol Violation|1|||
105354999|NCT02688764|363304418|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
105355000|NCT02688764|363304419|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
105355001|NCT02688764|363304418|FG000|Overall Study|Study drug taste/Withd. parent|1|||
105355002|NCT02688764|363304419|FG001|Overall Study|Study drug taste/Withd. parent|0|||
105355003|NCT02688764|363304418|FG000|Overall Study|Subject moving out|2|||
105355004|NCT02688764|363304419|FG001|Overall Study|Subject moving out|0|||
105355005|NCT02688764|363304418|FG000|Overall Study|Subject taken off dialysis|1|||
105355006|NCT02688764|363304419|FG001|Overall Study|Subject taken off dialysis|0|||
105355007|NCT02688764|363304418|FG000|Overall Study|Withdrawal by parent|3|||
105355008|NCT02688764|363304419|FG001|Overall Study|Withdrawal by parent|0|||
105355009|NCT00885378|363304420|FG000|Overall Study|Lack of Efficacy|2|||
105355010|NCT00885378|363304421|FG001|Overall Study|Lack of Efficacy|2|||
105355011|NCT00885378|363304420|FG000|Overall Study|Withdrawal by Subject|1|||
105355012|NCT00885378|363304421|FG001|Overall Study|Withdrawal by Subject|2|||
105355013|NCT00885378|363304420|FG000|Overall Study|Lost to Follow-up|1|||
105355014|NCT00885378|363304421|FG001|Overall Study|Lost to Follow-up|2|||
105355015|NCT00885378|363304420|FG000|Overall Study|Poor/Noncompliance|2|||
105355016|NCT00885378|363304421|FG001|Overall Study|Poor/Noncompliance|2|||
105355017|NCT00885378|363304420|FG000|Overall Study|Protocol Violation|2|||
105355018|NCT00885378|363304421|FG001|Overall Study|Protocol Violation|0|||
105481351|NCT04740905|363773533|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
105481352|NCT04740905|363773534|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
105736888|NCT00090285|364693297|FG001|Base Study Follow-up Period|Protocol Violation|0|||
105736889|NCT00090285|364693298|FG002|Base Study Follow-up Period|Protocol Violation|0|||
105736890|NCT00090285|364693299|FG003|Base Study Follow-up Period|Protocol Violation|0|||
105736891|NCT00090285|364693300|FG004|Base Study Follow-up Period|Protocol Violation|0|||
105736892|NCT00090285|364693301|FG005|Base Study Follow-up Period|Protocol Violation|0|||
105736893|NCT00090285|364693296|FG000|Base Study Follow-up Period|Uncooperative|3|||
105736894|NCT00090285|364693297|FG001|Base Study Follow-up Period|Uncooperative|4|||
105736895|NCT00090285|364693298|FG002|Base Study Follow-up Period|Uncooperative|0|||
105736896|NCT00090285|364693299|FG003|Base Study Follow-up Period|Uncooperative|0|||
105736897|NCT00090285|364693300|FG004|Base Study Follow-up Period|Uncooperative|0|||
105736898|NCT00090285|364693301|FG005|Base Study Follow-up Period|Uncooperative|0|||
105736899|NCT00090285|364693296|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
105736900|NCT00090285|364693297|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
105736901|NCT00090285|364693298|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
105736902|NCT00090285|364693299|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
105736903|NCT00090285|364693300|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
105736904|NCT00090285|364693301|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
105736905|NCT00090285|364693296|FG000|Extension 1|Adverse Event|0|||
105736906|NCT00090285|364693297|FG001|Extension 1|Adverse Event|0|||
105736907|NCT00090285|364693298|FG002|Extension 1|Adverse Event|2|||
105736908|NCT00090285|364693299|FG003|Extension 1|Adverse Event|0|||
105736909|NCT00090285|364693300|FG004|Extension 1|Adverse Event|0|||
105736910|NCT00090285|364693301|FG005|Extension 1|Adverse Event|0|||
105736911|NCT00090285|364693296|FG000|Extension 1|Lost to Follow-up|0|||
105736912|NCT00090285|364693297|FG001|Extension 1|Lost to Follow-up|0|||
105736913|NCT00090285|364693298|FG002|Extension 1|Lost to Follow-up|35|||
105736914|NCT00090285|364693299|FG003|Extension 1|Lost to Follow-up|0|||
105736915|NCT00090285|364693300|FG004|Extension 1|Lost to Follow-up|0|||
105736916|NCT00090285|364693301|FG005|Extension 1|Lost to Follow-up|0|||
105736917|NCT00090285|364693296|FG000|Extension 1|Withdrawal by Subject|0|||
105736918|NCT00090285|364693297|FG001|Extension 1|Withdrawal by Subject|0|||
105736919|NCT00090285|364693298|FG002|Extension 1|Withdrawal by Subject|13|||
105736920|NCT00090285|364693299|FG003|Extension 1|Withdrawal by Subject|1|||
105736921|NCT00090285|364693300|FG004|Extension 1|Withdrawal by Subject|0|||
105736922|NCT00090285|364693301|FG005|Extension 1|Withdrawal by Subject|0|||
105736923|NCT00090285|364693296|FG000|Extension 1|Other|0|||
105736924|NCT00090285|364693297|FG001|Extension 1|Other|0|||
105736925|NCT00090285|364693298|FG002|Extension 1|Other|4|||
105736926|NCT00090285|364693299|FG003|Extension 1|Other|0|||
105736927|NCT00090285|364693300|FG004|Extension 1|Other|0|||
105736928|NCT00090285|364693301|FG005|Extension 1|Other|0|||
105736929|NCT00090285|364693296|FG000|Extension 1|Moved|0|||
105736930|NCT00090285|364693297|FG001|Extension 1|Moved|0|||
105355019|NCT01909973|363304422|FG000|Overall Study|Lost to Follow-up|1|||
105355020|NCT01909973|363304423|FG001|Overall Study|Lost to Follow-up|0|||
105355021|NCT06360588|363304429|FG000|Overall Study|Adverse Event|3|||
105481353|NCT00770146|363773541|FG000|Treatment Period|Withdrawal by Subject|6|||
105355022|NCT06360588|363304429|FG000|Overall Study|Death|2|||
105355023|NCT06360588|363304429|FG000|Overall Study|Disease Progression|14|||
105736931|NCT00090285|364693298|FG002|Extension 1|Moved|3|||
105736932|NCT00090285|364693299|FG003|Extension 1|Moved|0|||
105736933|NCT00090285|364693300|FG004|Extension 1|Moved|0|||
105736934|NCT00090285|364693301|FG005|Extension 1|Moved|0|||
105736935|NCT00090285|364693296|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
105736936|NCT00090285|364693297|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
105736937|NCT00090285|364693298|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
105736938|NCT00090285|364693299|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
105736939|NCT00090285|364693300|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
105736940|NCT00090285|364693301|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
105736941|NCT00090285|364693296|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105736942|NCT00090285|364693297|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105736943|NCT00090285|364693298|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105736944|NCT00090285|364693299|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105736945|NCT00090285|364693300|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
105736946|NCT00090285|364693301|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
105736947|NCT00090285|364693296|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105736948|NCT00090285|364693297|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105736949|NCT00090285|364693298|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105736950|NCT00090285|364693299|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105736951|NCT00090285|364693300|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
105736952|NCT00090285|364693301|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
105736953|NCT00090285|364693296|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
105736954|NCT00090285|364693297|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
105736955|NCT00090285|364693298|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
105736956|NCT00090285|364693299|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
105736957|NCT00090285|364693300|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
105736958|NCT00090285|364693301|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
105736959|NCT01936649|364693306|FG000|Overall Study|Withdrawal by Subject|4|||
105355024|NCT06360588|363304429|FG000|Overall Study|Withdrawal by Subject|1|||
105736960|NCT01936649|364693306|FG000|Overall Study|Physician Decision|2|||
105355025|NCT06360588|363304429|FG000|Overall Study|Lack of Efficacy|1|||
105355026|NCT06360588|363304429|FG000|Overall Study|Ineligible|1|||
105355027|NCT00807612|363304430|FG000|Overall Study|Death|8|||
105355028|NCT00807612|363304430|FG000|Overall Study|Study early termination|5|||
105355029|NCT00807612|363304430|FG000|Overall Study|Withdrawal by Subject|1|||
105355030|NCT02476916|363304431|FG000|Core Period|Adverse Event|2|||
105355031|NCT02476916|363304432|FG001|Core Period|Adverse Event|2|||
105355032|NCT02476916|363304431|FG000|Core Period|Investigator decision|1|||
105355033|NCT02476916|363304432|FG001|Core Period|Investigator decision|1|||
105355034|NCT02476916|363304431|FG000|Core Period|Withdrawal by Subject|3|||
105355035|NCT02476916|363304432|FG001|Core Period|Withdrawal by Subject|0|||
105355036|NCT02476916|363304431|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
105355037|NCT02476916|363304432|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
105355038|NCT02476916|363304431|FG000|Extension Period|On Treatment|12|||
105355039|NCT02476916|363304432|FG001|Extension Period|On Treatment|17|||
105355040|NCT01939223|363304434|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
105355041|NCT01939223|363304435|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
105355042|NCT01939223|363304434|FG000|Overall Study|Disease recurrence (radiological)|1|||
105355043|NCT01939223|363304435|FG001|Overall Study|Disease recurrence (radiological)|3|||
105355044|NCT01939223|363304434|FG000|Overall Study|Study stopped by Sponsor|5|||
105355045|NCT01939223|363304435|FG001|Overall Study|Study stopped by Sponsor|7|||
105355046|NCT01939223|363304434|FG000|Overall Study|Withdrawal by Subject|6|||
105355047|NCT01939223|363304435|FG001|Overall Study|Withdrawal by Subject|0|||
105355048|NCT04865419|363304436|FG000|Overall Study|Other|1|||
105355049|NCT04865419|363304437|FG001|Overall Study|Other|2|||
105355050|NCT04865419|363304438|FG002|Overall Study|Other|2|||
105736961|NCT01936649|364693306|FG000|Overall Study|Protocol Violation|2|||
105355051|NCT04865419|363304439|FG003|Overall Study|Other|1|||
105355052|NCT04865419|363304440|FG004|Overall Study|Other|3|||
105481354|NCT00770146|363773542|FG001|Treatment Period|Withdrawal by Subject|13|||
105481355|NCT00770146|363773541|FG000|Treatment Period|Adverse Event|2|||
105481356|NCT00770146|363773542|FG001|Treatment Period|Adverse Event|26|||
105736962|NCT01936649|364693306|FG000|Overall Study|Other than specified above|5|||
105736963|NCT00328198|364693309|FG000|Treatment|Adverse Event|21|||
105736964|NCT00328198|364693309|FG000|Treatment|Death|1|||
105736965|NCT00328198|364693309|FG000|Treatment|Physician Decision|5|||
105736966|NCT00328198|364693309|FG000|Treatment|Withdrawal by Subject|5|||
105736967|NCT00328198|364693309|FG000|Treatment|Evidence of disease progression|2|||
105736968|NCT00328198|364693309|FG000|Treatment|Non-compliance|1|||
105736969|NCT00328198|364693309|FG000|Treatment|Confirmed complete response, MRD -|3|||
105736970|NCT00328198|364693309|FG000|Follow-up|Lost to Follow-up|4|||
105736971|NCT00328198|364693309|FG000|Follow-up|Death|31|||
105736972|NCT02385123|364693310|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
105736973|NCT03472534|364693311|FG000|Overall Study|Withdrawal by Subject|9|||
105736974|NCT03472534|364693311|FG000|Overall Study|Adverse Event|2|||
105736975|NCT00909090|364693315|FG000|Overall Study|Lost to Follow-up|17|||
105736976|NCT00909090|364693316|FG001|Overall Study|Lost to Follow-up|17|||
105736977|NCT00859898|364693317|FG000|Overall Study|Lack of Efficacy|0|||
105736978|NCT00859898|364693318|FG001|Overall Study|Lack of Efficacy|1|||
105355053|NCT04865419|363304441|FG005|Overall Study|Other|0|||
105355054|NCT04865419|363304442|FG006|Overall Study|Other|0|||
105355055|NCT04865419|363304443|FG007|Overall Study|Other|1|||
105736979|NCT00859898|364693319|FG002|Overall Study|Lack of Efficacy|1|||
105736980|NCT00859898|364693317|FG000|Overall Study|Adverse Event|4|||
105736981|NCT00859898|364693318|FG001|Overall Study|Adverse Event|9|||
105736982|NCT00859898|364693319|FG002|Overall Study|Adverse Event|8|||
105355056|NCT04865419|363304444|FG008|Overall Study|Other|0|||
105355057|NCT04865419|363304445|FG009|Overall Study|Other|0|||
105355058|NCT04865419|363304446|FG010|Overall Study|Other|0|||
105355059|NCT04865419|363304436|FG000|Overall Study|Withdrawal by Subject|0|||
105355060|NCT04865419|363304437|FG001|Overall Study|Withdrawal by Subject|1|||
105355061|NCT04865419|363304438|FG002|Overall Study|Withdrawal by Subject|1|||
105355062|NCT04865419|363304439|FG003|Overall Study|Withdrawal by Subject|0|||
105355063|NCT04865419|363304440|FG004|Overall Study|Withdrawal by Subject|0|||
105355064|NCT04865419|363304441|FG005|Overall Study|Withdrawal by Subject|0|||
105355065|NCT04865419|363304442|FG006|Overall Study|Withdrawal by Subject|0|||
105355066|NCT04865419|363304443|FG007|Overall Study|Withdrawal by Subject|1|||
105355067|NCT04865419|363304444|FG008|Overall Study|Withdrawal by Subject|2|||
105355068|NCT04865419|363304445|FG009|Overall Study|Withdrawal by Subject|1|||
105355069|NCT04865419|363304446|FG010|Overall Study|Withdrawal by Subject|0|||
105355070|NCT04865419|363304436|FG000|Overall Study|Study terminated by Sponsor|0|||
105355071|NCT04865419|363304437|FG001|Overall Study|Study terminated by Sponsor|0|||
105355072|NCT04865419|363304438|FG002|Overall Study|Study terminated by Sponsor|0|||
105355073|NCT04865419|363304439|FG003|Overall Study|Study terminated by Sponsor|2|||
105355074|NCT04865419|363304440|FG004|Overall Study|Study terminated by Sponsor|2|||
105355075|NCT04865419|363304441|FG005|Overall Study|Study terminated by Sponsor|0|||
105355076|NCT04865419|363304442|FG006|Overall Study|Study terminated by Sponsor|0|||
105355077|NCT04865419|363304443|FG007|Overall Study|Study terminated by Sponsor|0|||
105355078|NCT04865419|363304444|FG008|Overall Study|Study terminated by Sponsor|0|||
105355079|NCT04865419|363304445|FG009|Overall Study|Study terminated by Sponsor|0|||
105355080|NCT04865419|363304446|FG010|Overall Study|Study terminated by Sponsor|1|||
105355081|NCT04865419|363304436|FG000|Overall Study|Death|3|||
105355082|NCT04865419|363304437|FG001|Overall Study|Death|1|||
105355083|NCT04865419|363304438|FG002|Overall Study|Death|4|||
105355084|NCT04865419|363304439|FG003|Overall Study|Death|2|||
105355085|NCT04865419|363304440|FG004|Overall Study|Death|5|||
105355086|NCT04865419|363304441|FG005|Overall Study|Death|2|||
105355087|NCT04865419|363304442|FG006|Overall Study|Death|1|||
105355088|NCT04865419|363304443|FG007|Overall Study|Death|1|||
105355089|NCT04865419|363304444|FG008|Overall Study|Death|2|||
105355090|NCT04865419|363304445|FG009|Overall Study|Death|2|||
105355091|NCT04865419|363304446|FG010|Overall Study|Death|1|||
105355092|NCT04865419|363304436|FG000|Overall Study|Lost to Follow-up|0|||
105355093|NCT04865419|363304437|FG001|Overall Study|Lost to Follow-up|0|||
105355094|NCT04865419|363304438|FG002|Overall Study|Lost to Follow-up|0|||
105355095|NCT04865419|363304439|FG003|Overall Study|Lost to Follow-up|0|||
105355096|NCT04865419|363304440|FG004|Overall Study|Lost to Follow-up|0|||
105355097|NCT04865419|363304441|FG005|Overall Study|Lost to Follow-up|0|||
105355098|NCT04865419|363304442|FG006|Overall Study|Lost to Follow-up|0|||
105355099|NCT04865419|363304443|FG007|Overall Study|Lost to Follow-up|0|||
105355100|NCT04865419|363304444|FG008|Overall Study|Lost to Follow-up|0|||
105355101|NCT04865419|363304445|FG009|Overall Study|Lost to Follow-up|1|||
105355102|NCT04865419|363304446|FG010|Overall Study|Lost to Follow-up|0|||
105355103|NCT00099632|363304458|FG000|Overall Study|Lost to Follow-up|1|||
105355104|NCT00099632|363304459|FG001|Overall Study|Lost to Follow-up|0|||
105355105|NCT00099632|363304460|FG002|Overall Study|Lost to Follow-up|3|||
105355106|NCT00099632|363304461|FG003|Overall Study|Lost to Follow-up|1|||
105355107|NCT00099632|363304462|FG004|Overall Study|Lost to Follow-up|1|||
105355108|NCT00099632|363304463|FG005|Overall Study|Lost to Follow-up|0|||
105355109|NCT00099632|363304458|FG000|Overall Study|Withdrawal by Subject|0|||
105355110|NCT00099632|363304459|FG001|Overall Study|Withdrawal by Subject|1|||
105355111|NCT00099632|363304460|FG002|Overall Study|Withdrawal by Subject|0|||
105355112|NCT00099632|363304461|FG003|Overall Study|Withdrawal by Subject|0|||
105355113|NCT00099632|363304462|FG004|Overall Study|Withdrawal by Subject|0|||
105355114|NCT00099632|363304463|FG005|Overall Study|Withdrawal by Subject|1|||
105355115|NCT00099632|363304458|FG000|Overall Study|Protocol Violation|0|||
105355116|NCT00099632|363304459|FG001|Overall Study|Protocol Violation|0|||
105355117|NCT00099632|363304460|FG002|Overall Study|Protocol Violation|0|||
105355118|NCT00099632|363304461|FG003|Overall Study|Protocol Violation|0|||
105355119|NCT00099632|363304462|FG004|Overall Study|Protocol Violation|0|||
105355120|NCT00099632|363304463|FG005|Overall Study|Protocol Violation|1|||
105355121|NCT00423813|363304464|FG000|Overall Study|Adverse Event|11|||
105355122|NCT00423813|363304465|FG001|Overall Study|Adverse Event|30|||
105481357|NCT00770146|363773541|FG000|Treatment Period|Other|1|||
105355123|NCT00423813|363304466|FG002|Overall Study|Adverse Event|40|||
105355124|NCT00423813|363304464|FG000|Overall Study|Withdrawal by Subject|6|||
105355125|NCT00423813|363304465|FG001|Overall Study|Withdrawal by Subject|8|||
105355126|NCT00423813|363304466|FG002|Overall Study|Withdrawal by Subject|5|||
105355127|NCT00423813|363304464|FG000|Overall Study|Lost to Follow-up|5|||
105355128|NCT00423813|363304465|FG001|Overall Study|Lost to Follow-up|4|||
105355129|NCT00423813|363304466|FG002|Overall Study|Lost to Follow-up|4|||
105355130|NCT00423813|363304464|FG000|Overall Study|Lack of Efficacy|23|||
105355131|NCT00423813|363304465|FG001|Overall Study|Lack of Efficacy|18|||
105355132|NCT00423813|363304466|FG002|Overall Study|Lack of Efficacy|19|||
105355133|NCT00423813|363304464|FG000|Overall Study|Physician Decision|2|||
105355134|NCT00423813|363304465|FG001|Overall Study|Physician Decision|0|||
105355135|NCT00423813|363304466|FG002|Overall Study|Physician Decision|0|||
105355136|NCT00423813|363304464|FG000|Overall Study|Sponsor Decision|0|||
105355137|NCT00423813|363304465|FG001|Overall Study|Sponsor Decision|1|||
105481358|NCT00770146|363773542|FG001|Treatment Period|Other|5|||
105799285|NCT01759537|364922719|FG001|Overall Study|Accident involving jaw fracture|1|||
105799286|NCT01759537|364922718|FG000|Overall Study|Subcrestal implant too coronal|1|||
105799287|NCT01759537|364922719|FG001|Overall Study|Subcrestal implant too coronal|1|||
105799288|NCT00420290|364922720|FG000|Overall Study|Adverse Event|3|||
105799289|NCT00420290|364922721|FG001|Overall Study|Adverse Event|1|||
105799290|NCT00420290|364922720|FG000|Overall Study|Withdrawal by Subject|0|||
105799291|NCT00420290|364922721|FG001|Overall Study|Withdrawal by Subject|2|||
105799292|NCT00420290|364922720|FG000|Overall Study|did not meet inclusion/exclusion|1|||
105799293|NCT00420290|364922721|FG001|Overall Study|did not meet inclusion/exclusion|1|||
105799294|NCT01963676|364924507|FG000|Overall Study|Withdrawal by Subject|1|||
105799295|NCT01963676|364924508|FG001|Overall Study|Withdrawal by Subject|0|||
105799296|NCT01246973|364924513|FG000|Overall Study|Other|38|||
105799297|NCT01246973|364924514|FG001|Overall Study|Other|25|||
105799298|NCT01246973|364924513|FG000|Overall Study|Adverse Event|16|||
105799299|NCT01246973|364924514|FG001|Overall Study|Adverse Event|9|||
105799300|NCT01246973|364924513|FG000|Overall Study|Withdrawal by Subject|7|||
105799301|NCT01246973|364924514|FG001|Overall Study|Withdrawal by Subject|13|||
105799302|NCT02496221|364924517|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
105799303|NCT02496221|364924518|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
105799304|NCT02496221|364924517|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
105799305|NCT02496221|364924518|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
105799306|NCT02496221|364924517|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
105799307|NCT02496221|364924518|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
105799308|NCT02464059|364924519|FG000|Overall Study|Lost to Follow-up|6|||
105799309|NCT00802529|364924523|FG000|Overall Study|Lost to Follow-up|0|||
105799310|NCT00802529|364924524|FG001|Overall Study|Lost to Follow-up|1|||
105799311|NCT01902134|364924525|FG000|Overall Study|Adverse Event|3|||
105799312|NCT01902134|364924526|FG001|Overall Study|Adverse Event|1|||
105799313|NCT01902134|364924527|FG002|Overall Study|Adverse Event|2|||
105799314|NCT01902134|364924528|FG003|Overall Study|Adverse Event|1|||
105355138|NCT00423813|363304466|FG002|Overall Study|Sponsor Decision|0|||
105355139|NCT00423813|363304464|FG000|Overall Study|Protocol Violation|9|||
105355140|NCT00423813|363304465|FG001|Overall Study|Protocol Violation|4|||
105355141|NCT00423813|363304466|FG002|Overall Study|Protocol Violation|4|||
105355142|NCT00423813|363304464|FG000|Overall Study|Pregnancy|0|||
105355143|NCT00423813|363304465|FG001|Overall Study|Pregnancy|0|||
105355144|NCT00423813|363304466|FG002|Overall Study|Pregnancy|1|||
105355145|NCT00423813|363304464|FG000|Overall Study|Subject started night shift work|1|||
105355146|NCT00423813|363304465|FG001|Overall Study|Subject started night shift work|0|||
105355147|NCT00423813|363304466|FG002|Overall Study|Subject started night shift work|0|||
105355148|NCT00423813|363304464|FG000|Overall Study|Will start exclusionary medications|0|||
105355149|NCT00423813|363304465|FG001|Overall Study|Will start exclusionary medications|1|||
105355150|NCT00423813|363304466|FG002|Overall Study|Will start exclusionary medications|0|||
105355151|NCT00423813|363304464|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
105355152|NCT00423813|363304465|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
105355153|NCT00423813|363304466|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
105355154|NCT02347072|363304472|FG000|Overall Study|Adverse Event|2|||
105355155|NCT02347072|363304472|FG000|Overall Study|Withdrawal by Subject|6|||
105355156|NCT02347072|363304472|FG000|Overall Study|Physician Decision|1|||
105355157|NCT02347072|363304472|FG000|Overall Study|Lost to Follow-up|2|||
105355158|NCT02347072|363304472|FG000|Overall Study|Protocol Violation|1|||
105355159|NCT02347072|363304472|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
105355160|NCT01808222|363304478|FG000|Overall Study|mpMR scan was not performed|1|||
105355161|NCT00282152|363304483|FG000|Overall Study|Withdrawal by Subject|1|||
105355162|NCT00282152|363304484|FG001|Overall Study|Withdrawal by Subject|0|||
105355163|NCT04318132|363304485|FG000|Overall Study|Protocol Violation|0|||
105355164|NCT04318132|363304486|FG001|Overall Study|Protocol Violation|0|||
105355165|NCT04318132|363304487|FG002|Overall Study|Protocol Violation|3|||
105355166|NCT04318132|363304488|FG003|Overall Study|Protocol Violation|0|||
105355167|NCT00585325|363304489|FG000|Overall Study|Withdrawal by Subject|1|||
105355168|NCT00585325|363304490|FG001|Overall Study|Withdrawal by Subject|1|||
105355169|NCT03301831|363304491|FG000|Overall Study|Lost to Follow-up|5|||
105355170|NCT03301831|363304492|FG001|Overall Study|Lost to Follow-up|3|||
105355171|NCT03301831|363304491|FG000|Overall Study|Protocol Violation|4|||
105355172|NCT03301831|363304492|FG001|Overall Study|Protocol Violation|0|||
105355173|NCT03301831|363304491|FG000|Overall Study|Withdrawal by Subject|11|||
105355174|NCT03301831|363304492|FG001|Overall Study|Withdrawal by Subject|0|||
105355175|NCT04424914|363304494|FG000|Overall Study|Other|0|||
105355176|NCT04424914|363304495|FG001|Overall Study|Other|0|||
105355177|NCT04424914|363304496|FG002|Overall Study|Other|28|||
105355178|NCT04424914|363304494|FG000|Overall Study|Withdrawal by Subject|3|||
105355179|NCT04424914|363304495|FG001|Overall Study|Withdrawal by Subject|0|||
105355180|NCT04424914|363304496|FG002|Overall Study|Withdrawal by Subject|0|||
105799315|NCT01902134|364924529|FG004|Overall Study|Adverse Event|1|||
105799316|NCT01902134|364924530|FG005|Overall Study|Adverse Event|3|||
105799317|NCT01902134|364924525|FG000|Overall Study|Lack of Efficacy|0|||
105799318|NCT01902134|364924526|FG001|Overall Study|Lack of Efficacy|0|||
105799319|NCT01902134|364924527|FG002|Overall Study|Lack of Efficacy|2|||
105799320|NCT01902134|364924528|FG003|Overall Study|Lack of Efficacy|0|||
105799321|NCT01902134|364924529|FG004|Overall Study|Lack of Efficacy|0|||
105799322|NCT01902134|364924530|FG005|Overall Study|Lack of Efficacy|1|||
105799323|NCT01902134|364924525|FG000|Overall Study|Physician Decision|0|||
105799324|NCT01902134|364924526|FG001|Overall Study|Physician Decision|1|||
105799325|NCT01902134|364924527|FG002|Overall Study|Physician Decision|0|||
105799326|NCT01902134|364924528|FG003|Overall Study|Physician Decision|0|||
105799327|NCT01902134|364924529|FG004|Overall Study|Physician Decision|0|||
105799328|NCT01902134|364924530|FG005|Overall Study|Physician Decision|0|||
105799329|NCT01902134|364924525|FG000|Overall Study|Protocol Violation|0|||
105799330|NCT01902134|364924526|FG001|Overall Study|Protocol Violation|0|||
105799331|NCT01902134|364924527|FG002|Overall Study|Protocol Violation|0|||
105799332|NCT01902134|364924528|FG003|Overall Study|Protocol Violation|0|||
105799333|NCT01902134|364924529|FG004|Overall Study|Protocol Violation|0|||
105799334|NCT01902134|364924530|FG005|Overall Study|Protocol Violation|1|||
105799335|NCT01902134|364924525|FG000|Overall Study|Withdrawal by Subject|4|||
105799336|NCT01902134|364924526|FG001|Overall Study|Withdrawal by Subject|8|||
105799337|NCT01902134|364924527|FG002|Overall Study|Withdrawal by Subject|9|||
105799338|NCT01902134|364924528|FG003|Overall Study|Withdrawal by Subject|1|||
105799339|NCT01902134|364924529|FG004|Overall Study|Withdrawal by Subject|5|||
105565158|NCT01964326|364066704|FG000|Overall Study|Investigator Discretion|1|||
105565159|NCT01964326|364066704|FG000|Overall Study|Other|9|||
105565160|NCT01964326|364066704|FG000|Overall Study|Did not meet eligibility criteria|1|||
105799340|NCT01902134|364924530|FG005|Overall Study|Withdrawal by Subject|4|||
105799341|NCT01902134|364924525|FG000|Overall Study|no compliance|1|||
105799342|NCT01902134|364924526|FG001|Overall Study|no compliance|0|||
105799343|NCT01902134|364924527|FG002|Overall Study|no compliance|0|||
105799344|NCT01902134|364924528|FG003|Overall Study|no compliance|0|||
105799345|NCT01902134|364924529|FG004|Overall Study|no compliance|0|||
105799346|NCT01902134|364924530|FG005|Overall Study|no compliance|0|||
105799347|NCT01902134|364924525|FG000|Overall Study|Other|0|||
105799348|NCT01902134|364924526|FG001|Overall Study|Other|1|||
105799349|NCT01902134|364924527|FG002|Overall Study|Other|2|||
105799350|NCT01902134|364924528|FG003|Overall Study|Other|0|||
105799351|NCT01902134|364924529|FG004|Overall Study|Other|1|||
105799352|NCT01902134|364924530|FG005|Overall Study|Other|0|||
105799353|NCT00678379|364924531|FG000|Overall Study|Injection performed after tonsillectomy|2|||
105799354|NCT00678379|364924532|FG001|Overall Study|Injection performed after tonsillectomy|0|||
105355181|NCT04424914|363304494|FG000|Overall Study|Study terminated by sponsor|23|||
105355182|NCT04424914|363304495|FG001|Overall Study|Study terminated by sponsor|7|||
105355183|NCT04424914|363304496|FG002|Overall Study|Study terminated by sponsor|0|||
105355184|NCT04424914|363304494|FG000|Overall Study|Lost to Follow-up|0|||
105355185|NCT04424914|363304495|FG001|Overall Study|Lost to Follow-up|0|||
105355186|NCT04424914|363304496|FG002|Overall Study|Lost to Follow-up|1|||
105355187|NCT04424914|363304494|FG000|Overall Study|Death|3|||
105355188|NCT04424914|363304495|FG001|Overall Study|Death|1|||
105355189|NCT04424914|363304496|FG002|Overall Study|Death|0|||
105355190|NCT01778751|363304500|FG000|Overall Study|Lost to Follow-up|1|||
105355191|NCT01778751|363304501|FG001|Overall Study|Lost to Follow-up|0|||
105355192|NCT01778751|363304500|FG000|Overall Study|Withdrawal by Subject|0|||
105355193|NCT01778751|363304501|FG001|Overall Study|Withdrawal by Subject|2|||
105355194|NCT01778751|363304500|FG000|Overall Study|Transfered care|1|||
105355195|NCT01778751|363304501|FG001|Overall Study|Transfered care|0|||
105355196|NCT00792116|363304510|FG000|Overall Study|Lost to Follow-up|0|||
105355197|NCT00792116|363304511|FG001|Overall Study|Lost to Follow-up|1|||
105355198|NCT00792116|363304510|FG000|Overall Study|Discontnued intervention|1|||
105355199|NCT00792116|363304511|FG001|Overall Study|Discontnued intervention|0|||
105355200|NCT01216332|363304512|FG000|Overall Study|Withdrawal by Subject|4|||
105355201|NCT01216332|363304513|FG001|Overall Study|Withdrawal by Subject|0|||
105355202|NCT02655016|363304514|FG000|Overall Study|Disease progression|6|||
105355203|NCT02655016|363304515|FG001|Overall Study|Disease progression|4|||
105355204|NCT02655016|363304514|FG000|Overall Study|Site closed|0|||
105355205|NCT02655016|363304515|FG001|Overall Study|Site closed|1|||
105355206|NCT02655016|363304514|FG000|Overall Study|Death|30|||
105355207|NCT02655016|363304515|FG001|Overall Study|Death|48|||
105355208|NCT02655016|363304514|FG000|Overall Study|Lost to Follow-up|1|||
105355209|NCT02655016|363304515|FG001|Overall Study|Lost to Follow-up|1|||
105355210|NCT02655016|363304514|FG000|Overall Study|Withdrawal by Subject|18|||
105355211|NCT02655016|363304515|FG001|Overall Study|Withdrawal by Subject|36|||
105355212|NCT00829829|363304516|FG000|Overall Study|Protocol Violation|0|||
105355213|NCT00829829|363304517|FG001|Overall Study|Protocol Violation|3|||
105355214|NCT00829829|363304518|FG002|Overall Study|Protocol Violation|0|||
105355215|NCT00829829|363304516|FG000|Overall Study|Adverse Event|4|||
105355216|NCT00829829|363304517|FG001|Overall Study|Adverse Event|4|||
105355217|NCT00829829|363304518|FG002|Overall Study|Adverse Event|3|||
105355218|NCT00829829|363304516|FG000|Overall Study|Withdrawal by Subject|8|||
105355219|NCT00829829|363304517|FG001|Overall Study|Withdrawal by Subject|4|||
105355220|NCT00829829|363304518|FG002|Overall Study|Withdrawal by Subject|2|||
105355221|NCT00829829|363304516|FG000|Overall Study|Decision by the Sponsor|1|||
105355222|NCT00829829|363304517|FG001|Overall Study|Decision by the Sponsor|0|||
105355223|NCT00829829|363304518|FG002|Overall Study|Decision by the Sponsor|2|||
105355224|NCT00829829|363304516|FG000|Overall Study|Lost to Follow-up|7|||
105355225|NCT00829829|363304517|FG001|Overall Study|Lost to Follow-up|3|||
105355226|NCT00829829|363304518|FG002|Overall Study|Lost to Follow-up|3|||
105355227|NCT00829829|363304516|FG000|Overall Study|Other than specified above|2|||
105355228|NCT00829829|363304517|FG001|Overall Study|Other than specified above|2|||
105355229|NCT00829829|363304518|FG002|Overall Study|Other than specified above|1|||
105355230|NCT00481767|363304521|FG000|Overall Study|Withdrawal by Subject|16|||
105355231|NCT00481767|363304522|FG001|Overall Study|Withdrawal by Subject|11|||
105355232|NCT00481767|363304521|FG000|Overall Study|Lost to Follow-up|16|||
105355233|NCT00481767|363304522|FG001|Overall Study|Lost to Follow-up|10|||
105355234|NCT04549545|363306051|FG000|Initial Period|Withdrawal by Subject|4|||
105355235|NCT04549545|363306052|FG001|Initial Period|Withdrawal by Subject|0|||
105355236|NCT04549545|363306051|FG000|Initial Period|Additional ENT Procedure|3|||
105355237|NCT04549545|363306052|FG001|Initial Period|Additional ENT Procedure|0|||
105355238|NCT04549545|363306051|FG000|Initial Period|Lost to Follow-up|3|||
105355239|NCT04549545|363306052|FG001|Initial Period|Lost to Follow-up|1|||
105355240|NCT04549545|363306051|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
105355241|NCT04549545|363306052|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
105355242|NCT04549545|363306051|FG000|Crossover Period|Additional ENT Procedure|0|||
105355243|NCT04549545|363306052|FG001|Crossover Period|Additional ENT Procedure|6|||
105355244|NCT04549545|363306051|FG000|Crossover Period|Lost to Follow-up|0|||
105355245|NCT04549545|363306052|FG001|Crossover Period|Lost to Follow-up|1|||
105799355|NCT00678379|364924533|FG002|Overall Study|Injection performed after tonsillectomy|1|||
105799356|NCT00678379|364924531|FG000|Overall Study|Incomplete Data|4|||
105799357|NCT00678379|364924532|FG001|Overall Study|Incomplete Data|3|||
105355246|NCT04549545|363306051|FG000|Crossover Period|Withdrawal by Subject|0|||
105355247|NCT04549545|363306052|FG001|Crossover Period|Withdrawal by Subject|4|||
105355248|NCT00802672|363306055|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
105355249|NCT00802672|363306056|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
105355250|NCT00802672|363306057|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
105355251|NCT00802672|363306055|FG000|Overall Study|Adverse Event|1|||
105355252|NCT00802672|363306056|FG001|Overall Study|Adverse Event|1|||
105481359|NCT00770146|363773541|FG000|Treatment Period|Protocol non-compliance|0|||
105481360|NCT00770146|363773542|FG001|Treatment Period|Protocol non-compliance|1|||
105481361|NCT00770146|363773541|FG000|Follow-up Period|Withdrawal by Subject|7|||
105355253|NCT00802672|363306057|FG002|Overall Study|Adverse Event|1|||
105355254|NCT00802672|363306055|FG000|Overall Study|Protocol Violation|2|||
105355255|NCT00802672|363306056|FG001|Overall Study|Protocol Violation|1|||
105355256|NCT00802672|363306057|FG002|Overall Study|Protocol Violation|1|||
105355257|NCT00802672|363306055|FG000|Overall Study|Lost to Follow-up|5|||
105355258|NCT00802672|363306056|FG001|Overall Study|Lost to Follow-up|5|||
105355259|NCT00802672|363306057|FG002|Overall Study|Lost to Follow-up|3|||
105355260|NCT00802672|363306055|FG000|Overall Study|Withdrawal by Subject|1|||
105355261|NCT00802672|363306056|FG001|Overall Study|Withdrawal by Subject|1|||
105355262|NCT00802672|363306057|FG002|Overall Study|Withdrawal by Subject|2|||
105481362|NCT00770146|363773542|FG001|Follow-up Period|Withdrawal by Subject|13|||
105736983|NCT00859898|364693317|FG000|Overall Study|Withdrawal by Subject|11|||
105736984|NCT00859898|364693318|FG001|Overall Study|Withdrawal by Subject|8|||
105736985|NCT00859898|364693319|FG002|Overall Study|Withdrawal by Subject|11|||
105736986|NCT00859898|364693317|FG000|Overall Study|Death|0|||
105355263|NCT00802672|363306055|FG000|Overall Study|other|3|||
105355264|NCT00802672|363306056|FG001|Overall Study|other|1|||
105481363|NCT00770146|363773541|FG000|Follow-up Period|Adverse Event|0|||
105355265|NCT00802672|363306057|FG002|Overall Study|other|2|||
105355266|NCT01616758|363306059|FG000|Overall Study|Adverse Event|1|||
105355267|NCT01616758|363306059|FG000|Overall Study|Withdrawal by Subject|2|||
105355268|NCT01616758|363306059|FG000|Overall Study|Disease progression|18|||
105355269|NCT01616758|363306059|FG000|Overall Study|Study termination by Sponsor|1|||
105355270|NCT04076319|363306060|FG000|Overall Study|Withdrawal by Subject|2|||
105355271|NCT04076319|363306061|FG001|Overall Study|Withdrawal by Subject|0|||
105355272|NCT04076319|363306060|FG000|Overall Study|Death|1|||
105355273|NCT04076319|363306061|FG001|Overall Study|Death|0|||
105355274|NCT03782571|363306062|FG000|Period 1|Withdrawal by Subject|1|||
105355275|NCT03782571|363306063|FG001|Period 1|Withdrawal by Subject|0|||
105355276|NCT03782571|363306064|FG002|Period 1|Withdrawal by Subject|0|||
105355277|NCT03782571|363306065|FG003|Period 1|Withdrawal by Subject|0|||
105355278|NCT03782571|363306062|FG000|Period 3|Subject Unable to Attend V5|1|||
105355279|NCT03782571|363306063|FG001|Period 3|Subject Unable to Attend V5|0|||
105355280|NCT03782571|363306064|FG002|Period 3|Subject Unable to Attend V5|0|||
105355281|NCT03782571|363306065|FG003|Period 3|Subject Unable to Attend V5|0|||
105736987|NCT00859898|364693318|FG001|Overall Study|Death|0|||
105736988|NCT00859898|364693319|FG002|Overall Study|Death|1|||
105736989|NCT00859898|364693317|FG000|Overall Study|Lost to Follow-up|10|||
105736990|NCT00859898|364693318|FG001|Overall Study|Lost to Follow-up|11|||
105736991|NCT00859898|364693319|FG002|Overall Study|Lost to Follow-up|5|||
105736992|NCT00859898|364693317|FG000|Overall Study|poor/non-compliance|2|||
105736993|NCT00859898|364693318|FG001|Overall Study|poor/non-compliance|0|||
105736994|NCT00859898|364693319|FG002|Overall Study|poor/non-compliance|0|||
105799358|NCT00678379|364924533|FG002|Overall Study|Incomplete Data|3|||
105799359|NCT02290028|364924536|FG000|Overall Study|Death|217|||
105799360|NCT02290028|364924536|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
105799361|NCT02290028|364924536|FG000|Overall Study|No longer under care of study physician|76|||
105799362|NCT02290028|364924536|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
105799363|NCT02290028|364924536|FG000|Overall Study|Withdrawal by Subject|52|||
105799364|NCT02290028|364924536|FG000|Overall Study|Study site closure|44|||
105799365|NCT02290028|364924536|FG000|Overall Study|Lost to Follow-up|34|||
105799366|NCT02290028|364924536|FG000|Overall Study|Miscellaneous|10|||
105799367|NCT02290028|364924536|FG000|Overall Study|Transition to EP PASSION|1295|||
105799368|NCT02290028|364924536|FG000|Overall Study|Planned study completion at 12 months|257|||
105799369|NCT03202511|364924537|FG000|Overall Study|Withdrawal by Subject|1|||
105799370|NCT03202511|364924538|FG001|Overall Study|Withdrawal by Subject|0|||
105799371|NCT04126733|364924554|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
105799372|NCT04126733|364924554|FG000|Treatment Period|Adverse Event|8|||
105799373|NCT04126733|364924554|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
105799374|NCT04126733|364924554|FG000|Treatment Period|Physician Decision|5|||
105799375|NCT04126733|364924554|FG000|Treatment Period|Death|1|||
105799376|NCT04126733|364924554|FG000|Treatment Period|Other Reasons|2|||
105799377|NCT04126733|364924554|FG000|Active Follow-up Period|Death|13|||
105799378|NCT04126733|364924554|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
105799379|NCT04126733|364924554|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
105799380|NCT04126733|364924554|FG000|Active Follow-up Period|Other Reasons|1|||
105799381|NCT04126733|364924554|FG000|Long-term Follow-up Period|Death|22|||
105799382|NCT04126733|364924554|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
105799383|NCT04126733|364924554|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
105799384|NCT02622074|364924555|FG000|Overall Study|Death|4|||
105799385|NCT02622074|364924556|FG001|Overall Study|Death|0|||
105799386|NCT02622074|364924557|FG002|Overall Study|Death|0|||
105799387|NCT02622074|364924558|FG003|Overall Study|Death|1|||
105799388|NCT02622074|364924559|FG004|Overall Study|Death|1|||
105799389|NCT02622074|364924560|FG005|Overall Study|Death|0|||
105799390|NCT02622074|364924555|FG000|Overall Study|Withdrawal by Subject|0|||
105799391|NCT02622074|364924556|FG001|Overall Study|Withdrawal by Subject|1|||
105799392|NCT02622074|364924557|FG002|Overall Study|Withdrawal by Subject|0|||
105799393|NCT02622074|364924558|FG003|Overall Study|Withdrawal by Subject|0|||
105799394|NCT02622074|364924559|FG004|Overall Study|Withdrawal by Subject|0|||
105799395|NCT02622074|364924560|FG005|Overall Study|Withdrawal by Subject|0|||
105799396|NCT02981602|364924561|FG000|Overall Study|Adverse Event|0|||
105799397|NCT02981602|364924562|FG001|Overall Study|Adverse Event|0|||
105799398|NCT02981602|364924563|FG002|Overall Study|Adverse Event|0|||
105799399|NCT02981602|364924564|FG003|Overall Study|Adverse Event|1|||
105799400|NCT02981602|364924565|FG004|Overall Study|Adverse Event|0|||
105799401|NCT02410837|364924566|FG000|Overall Study|Death|387|||
105799402|NCT02410837|364924566|FG000|Overall Study|Lost to Follow-up|50|||
105799403|NCT02410837|364924566|FG000|Overall Study|Withdrawal by Subject|44|||
105799404|NCT02410837|364924566|FG000|Overall Study|Physician Decision|6|||
105799405|NCT02410837|364924566|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
105799406|NCT01896700|364924567|FG000|Overall Study|Adverse Event|4|||
105799407|NCT01896700|364924568|FG001|Overall Study|Adverse Event|5|||
105799408|NCT01896700|364924567|FG000|Overall Study|Withdrawal by Subject|0|||
105799409|NCT01896700|364924568|FG001|Overall Study|Withdrawal by Subject|1|||
105799410|NCT00267007|364924570|FG000|Overall Study|Withdrawal by Subject|6|||
105799411|NCT00267007|364924571|FG001|Overall Study|Withdrawal by Subject|0|||
105799412|NCT00267007|364924570|FG000|Overall Study|Lost to Follow-up|1|||
105799413|NCT00267007|364924571|FG001|Overall Study|Lost to Follow-up|0|||
105799414|NCT00267007|364924570|FG000|Overall Study|Non-compliance|0|||
105799415|NCT00267007|364924571|FG001|Overall Study|Non-compliance|1|||
105799416|NCT00267007|364924570|FG000|Overall Study|Adverse Event|1|||
105799417|NCT00267007|364924571|FG001|Overall Study|Adverse Event|0|||
105799418|NCT01493531|364924576|FG000|Overall Study|Adverse Event|4|||
105799419|NCT01493531|364924577|FG001|Overall Study|Adverse Event|12|||
105799420|NCT01493531|364924578|FG002|Overall Study|Adverse Event|9|||
105799421|NCT01493531|364924576|FG000|Overall Study|Gout flare|3|||
105799422|NCT01493531|364924577|FG001|Overall Study|Gout flare|0|||
105799423|NCT01493531|364924578|FG002|Overall Study|Gout flare|2|||
105481364|NCT00770146|363773542|FG001|Follow-up Period|Adverse Event|2|||
105481365|NCT00770146|363773541|FG000|Follow-up Period|Other|4|||
105799424|NCT01493531|364924576|FG000|Overall Study|Protocol Violation|8|||
105799425|NCT01493531|364924577|FG001|Overall Study|Protocol Violation|15|||
105799426|NCT01493531|364924578|FG002|Overall Study|Protocol Violation|12|||
105799427|NCT01493531|364924576|FG000|Overall Study|Sponsor terminated study|5|||
105799428|NCT01493531|364924577|FG001|Overall Study|Sponsor terminated study|2|||
105799429|NCT01493531|364924578|FG002|Overall Study|Sponsor terminated study|3|||
105799430|NCT01493531|364924576|FG000|Overall Study|Lost to Follow-up|5|||
105736995|NCT00859898|364693317|FG000|Overall Study|No longer meets criteria|0|||
105736996|NCT00859898|364693318|FG001|Overall Study|No longer meets criteria|1|||
105736997|NCT00859898|364693319|FG002|Overall Study|No longer meets criteria|0|||
105736998|NCT00859898|364693317|FG000|Overall Study|non-specified|1|||
105736999|NCT00859898|364693318|FG001|Overall Study|non-specified|1|||
105737000|NCT00859898|364693319|FG002|Overall Study|non-specified|1|||
105737001|NCT04045613|364693321|FG000|Overall Study|Adverse Event|2|||
105737002|NCT04045613|364693322|FG001|Overall Study|Adverse Event|2|||
105737003|NCT04045613|364693323|FG002|Overall Study|Adverse Event|1|||
105737004|NCT04045613|364693324|FG003|Overall Study|Adverse Event|1|||
105737005|NCT04045613|364693325|FG004|Overall Study|Adverse Event|0|||
105737006|NCT04045613|364693326|FG005|Overall Study|Adverse Event|0|||
105737007|NCT04045613|364693327|FG006|Overall Study|Adverse Event|1|||
105737008|NCT04045613|364693321|FG000|Overall Study|Withdrawal by Subject|0|||
105737009|NCT04045613|364693322|FG001|Overall Study|Withdrawal by Subject|5|||
105737010|NCT04045613|364693323|FG002|Overall Study|Withdrawal by Subject|0|||
105737011|NCT04045613|364693324|FG003|Overall Study|Withdrawal by Subject|0|||
105737012|NCT04045613|364693325|FG004|Overall Study|Withdrawal by Subject|0|||
105737013|NCT04045613|364693326|FG005|Overall Study|Withdrawal by Subject|1|||
105737014|NCT04045613|364693327|FG006|Overall Study|Withdrawal by Subject|0|||
105737015|NCT04045613|364693321|FG000|Overall Study|Physician Decision|2|||
105737016|NCT04045613|364693322|FG001|Overall Study|Physician Decision|0|||
105737017|NCT04045613|364693323|FG002|Overall Study|Physician Decision|0|||
105737018|NCT04045613|364693324|FG003|Overall Study|Physician Decision|0|||
105737019|NCT04045613|364693325|FG004|Overall Study|Physician Decision|1|||
105737020|NCT04045613|364693326|FG005|Overall Study|Physician Decision|0|||
105737021|NCT04045613|364693327|FG006|Overall Study|Physician Decision|0|||
105737022|NCT04045613|364693321|FG000|Overall Study|Death|3|||
105737023|NCT04045613|364693322|FG001|Overall Study|Death|0|||
105737024|NCT04045613|364693323|FG002|Overall Study|Death|0|||
105737025|NCT04045613|364693324|FG003|Overall Study|Death|0|||
105737026|NCT04045613|364693325|FG004|Overall Study|Death|0|||
105737027|NCT04045613|364693326|FG005|Overall Study|Death|0|||
105737028|NCT04045613|364693327|FG006|Overall Study|Death|1|||
105737029|NCT04045613|364693321|FG000|Overall Study|Other reasons|0|||
105737030|NCT04045613|364693322|FG001|Overall Study|Other reasons|1|||
105737031|NCT04045613|364693323|FG002|Overall Study|Other reasons|0|||
105737032|NCT04045613|364693324|FG003|Overall Study|Other reasons|0|||
105737033|NCT04045613|364693325|FG004|Overall Study|Other reasons|0|||
105737034|NCT04045613|364693326|FG005|Overall Study|Other reasons|0|||
105737035|NCT04045613|364693327|FG006|Overall Study|Other reasons|1|||
105737036|NCT04045613|364693321|FG000|Overall Study|Progressive disease: Clinical progression|1|||
105737037|NCT04045613|364693322|FG001|Overall Study|Progressive disease: Clinical progression|0|||
105737038|NCT04045613|364693323|FG002|Overall Study|Progressive disease: Clinical progression|3|||
105737039|NCT04045613|364693324|FG003|Overall Study|Progressive disease: Clinical progression|1|||
105481366|NCT00770146|363773542|FG001|Follow-up Period|Other|5|||
105481367|NCT02158364|363773543|FG000|Overall Study|Case report forms uncollected|10|||
105481368|NCT02158364|363773543|FG000|Overall Study|Protocol Deviation|50|||
105737040|NCT04045613|364693325|FG004|Overall Study|Progressive disease: Clinical progression|1|||
105737041|NCT04045613|364693326|FG005|Overall Study|Progressive disease: Clinical progression|3|||
105737042|NCT04045613|364693327|FG006|Overall Study|Progressive disease: Clinical progression|3|||
105737043|NCT04045613|364693321|FG000|Overall Study|Progressive disease: Radiological progression|24|||
105737044|NCT04045613|364693322|FG001|Overall Study|Progressive disease: Radiological progression|6|||
105737045|NCT04045613|364693323|FG002|Overall Study|Progressive disease: Radiological progression|8|||
105481369|NCT02412488|363773544|FG000|Overall Study|Lost to Follow-up|10|||
105481370|NCT02412488|363773544|FG000|Overall Study|Withdrawal by Subject|5|||
105737046|NCT04045613|364693324|FG003|Overall Study|Progressive disease: Radiological progression|0|||
105737047|NCT04045613|364693325|FG004|Overall Study|Progressive disease: Radiological progression|6|||
105737048|NCT04045613|364693326|FG005|Overall Study|Progressive disease: Radiological progression|6|||
105799431|NCT01493531|364924577|FG001|Overall Study|Lost to Follow-up|7|||
105481371|NCT02412488|363773544|FG000|Overall Study|Physician Decision|1|||
105737049|NCT04045613|364693327|FG006|Overall Study|Progressive disease: Radiological progression|11|||
105737050|NCT00491530|364693328|FG000|Overall Study|Adverse Event|6|||
105737051|NCT00491530|364693329|FG001|Overall Study|Adverse Event|1|||
105737052|NCT00491530|364693330|FG002|Overall Study|Adverse Event|2|||
105737053|NCT00491530|364693328|FG000|Overall Study|Withdrawal by Subject|3|||
105737054|NCT00491530|364693329|FG001|Overall Study|Withdrawal by Subject|0|||
105737055|NCT00491530|364693330|FG002|Overall Study|Withdrawal by Subject|0|||
105737056|NCT00491530|364693328|FG000|Overall Study|Lost to Follow-up|3|||
105737057|NCT00491530|364693329|FG001|Overall Study|Lost to Follow-up|2|||
105737058|NCT00491530|364693330|FG002|Overall Study|Lost to Follow-up|2|||
105737059|NCT00491530|364693328|FG000|Overall Study|Lack of Efficacy|0|||
105737060|NCT00491530|364693329|FG001|Overall Study|Lack of Efficacy|1|||
105355282|NCT03782571|363306062|FG000|Period 3|Adverse Event|1|||
105355283|NCT03782571|363306063|FG001|Period 3|Adverse Event|0|||
105355284|NCT03782571|363306064|FG002|Period 3|Adverse Event|0|||
105355285|NCT03782571|363306065|FG003|Period 3|Adverse Event|0|||
105355286|NCT02793947|363306072|FG000|Overall Study|Death|1|||
105355287|NCT02793947|363306073|FG001|Overall Study|Death|0|||
105355288|NCT02793947|363306072|FG000|Overall Study|Physician Decision|1|||
105355289|NCT02793947|363306073|FG001|Overall Study|Physician Decision|5|||
105737061|NCT00491530|364693330|FG002|Overall Study|Lack of Efficacy|0|||
105737062|NCT00491530|364693328|FG000|Overall Study|Investigator Discretion|0|||
105737063|NCT00491530|364693329|FG001|Overall Study|Investigator Discretion|1|||
105737064|NCT00491530|364693330|FG002|Overall Study|Investigator Discretion|0|||
105737065|NCT00491530|364693328|FG000|Overall Study|Patient Request|0|||
105737066|NCT00491530|364693329|FG001|Overall Study|Patient Request|1|||
105737067|NCT00491530|364693330|FG002|Overall Study|Patient Request|0|||
105737068|NCT00491530|364693328|FG000|Overall Study|Use of Prohibited Medication|0|||
105737069|NCT00491530|364693329|FG001|Overall Study|Use of Prohibited Medication|0|||
105737070|NCT00491530|364693330|FG002|Overall Study|Use of Prohibited Medication|1|||
105737071|NCT02612077|364693336|FG000|Overall Study|Adverse Event|3|||
105737072|NCT02612077|364693336|FG000|Overall Study|Withdrawal by Subject|9|||
105737073|NCT02612077|364693336|FG000|Overall Study|Protocol Violation|28|||
105737074|NCT02612077|364693336|FG000|Overall Study|Lost to Follow-up|20|||
105737075|NCT02612077|364693336|FG000|Overall Study|Death|377|||
105737076|NCT02612077|364693336|FG000|Overall Study|Moved or Changed Medical Team|23|||
105737077|NCT02612077|364693336|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
105737078|NCT02612077|364693336|FG000|Overall Study|Disease Progression|3|||
105737079|NCT02612077|364693336|FG000|Overall Study|Unknown reason|2|||
105737080|NCT01753518|364693337|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
105737081|NCT01753518|364693338|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
105737082|NCT01753518|364693337|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
105737083|NCT01753518|364693338|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
105737084|NCT01753518|364693337|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
105737085|NCT01753518|364693338|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
105737086|NCT01753518|364693337|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
105737087|NCT01753518|364693338|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
105737088|NCT00425438|364693342|FG000|Overall Study|Termination by Sponsor|25|||
105737089|NCT00425438|364693343|FG001|Overall Study|Termination by Sponsor|27|||
105737090|NCT02902809|364693344|FG000|Overall Study|Discontinuation of asthma program|28|||
105737091|NCT00532259|364693345|FG000|Overall Study|Withdrawal by Subject|2|||
105355290|NCT03746405|363306076|FG000|Overall Study|Withdrawal by Subject|3|||
105355291|NCT03746405|363306077|FG001|Overall Study|Withdrawal by Subject|0|||
105737092|NCT00532259|364693345|FG000|Overall Study|Adverse Event|1|||
105737093|NCT00532259|364693345|FG000|Overall Study|Death|1|||
105737094|NCT00532259|364693345|FG000|Overall Study|Lack of Efficacy|21|||
105737095|NCT00532259|364693345|FG000|Overall Study|Lost to Follow-up|3|||
105737096|NCT00532259|364693345|FG000|Overall Study|Physician Decision|3|||
105737097|NCT00532259|364693345|FG000|Overall Study|Protocol Violation|1|||
105737098|NCT01188798|364693348|FG000|Overall Study|Death|0|||
105737099|NCT01188798|364693349|FG001|Overall Study|Death|1|||
105737100|NCT01188798|364693348|FG000|Overall Study|Required additional transplant|1|||
105737101|NCT01188798|364693349|FG001|Overall Study|Required additional transplant|1|||
105737102|NCT01188798|364693348|FG000|Overall Study|Protocol closure|1|||
105737103|NCT01188798|364693349|FG001|Overall Study|Protocol closure|1|||
105737104|NCT02795767|364693350|FG000|Overall Study|Received Commercial Emicizumab|1|||
105737105|NCT02795767|364693351|FG001|Overall Study|Received Commercial Emicizumab|0|||
105737106|NCT02795767|364693352|FG002|Overall Study|Received Commercial Emicizumab|0|||
105737107|NCT03662334|364693353|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
105737108|NCT03662334|364693354|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
105737109|NCT03494725|364693359|FG000|Overall Study|Withdrawal by Subject|0|||
105737110|NCT03494725|364693360|FG001|Overall Study|Withdrawal by Subject|2|||
105737111|NCT03494725|364693359|FG000|Overall Study|Antibiotic use|1|||
105737112|NCT03494725|364693360|FG001|Overall Study|Antibiotic use|0|||
105737113|NCT00301067|364693363|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
105737114|NCT00301067|364693364|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
105737115|NCT00301067|364693365|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
105737116|NCT00301067|364693366|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
105737117|NCT00301067|364693363|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
105737118|NCT00301067|364693364|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
105737119|NCT00301067|364693365|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
105737120|NCT00301067|364693366|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
105737121|NCT00301067|364693363|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
105737122|NCT00301067|364693364|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
105737123|NCT00301067|364693365|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
105737124|NCT00301067|364693366|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
105737125|NCT00301067|364693363|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
105737126|NCT00301067|364693364|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
105737127|NCT00301067|364693365|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
105737128|NCT00301067|364693366|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
105737129|NCT00301067|364693363|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
105737130|NCT00301067|364693364|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
105737131|NCT00301067|364693365|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
105737132|NCT00301067|364693366|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
105737133|NCT00301067|364693363|FG000|Follow up Until Death|Alive at last data cut point|1|||
105737134|NCT00301067|364693364|FG001|Follow up Until Death|Alive at last data cut point|0|||
105737135|NCT00301067|364693365|FG002|Follow up Until Death|Alive at last data cut point|0|||
105737136|NCT00301067|364693366|FG003|Follow up Until Death|Alive at last data cut point|1|||
105737137|NCT03303339|364693367|FG000|Overall Study|Death|2|||
105737138|NCT03303339|364693368|FG001|Overall Study|Death|2|||
105737139|NCT03303339|364693369|FG002|Overall Study|Death|2|||
105737140|NCT03303339|364693370|FG003|Overall Study|Death|1|||
105737141|NCT03303339|364693371|FG004|Overall Study|Death|4|||
105737142|NCT03303339|364693372|FG005|Overall Study|Death|2|||
105737143|NCT03303339|364693373|FG006|Overall Study|Death|2|||
105737144|NCT03303339|364693374|FG007|Overall Study|Death|2|||
105737145|NCT03303339|364693375|FG008|Overall Study|Death|3|||
105799432|NCT01493531|364924578|FG002|Overall Study|Lost to Follow-up|11|||
105799433|NCT01493531|364924576|FG000|Overall Study|Withdrawal by Subject|16|||
105565161|NCT01995539|364066705|FG000|Overall Study|Screening Failure|1|||
105565162|NCT01995539|364066705|FG000|Overall Study|Withdrawal by Investigator|15|||
105565163|NCT01995539|364066705|FG000|Overall Study|Withdrawal by Subject|11|||
105565164|NCT01995539|364066705|FG000|Overall Study|Lost to Follow-up|5|||
105737146|NCT03303339|364693376|FG009|Overall Study|Death|3|||
105737147|NCT03303339|364693377|FG010|Overall Study|Death|4|||
105737148|NCT03303339|364693378|FG011|Overall Study|Death|24|||
105737149|NCT03303339|364693367|FG000|Overall Study|Study Terminated by Sponsor|0|||
105737150|NCT03303339|364693368|FG001|Overall Study|Study Terminated by Sponsor|0|||
105737151|NCT03303339|364693369|FG002|Overall Study|Study Terminated by Sponsor|0|||
105737152|NCT03303339|364693370|FG003|Overall Study|Study Terminated by Sponsor|0|||
105737153|NCT03303339|364693371|FG004|Overall Study|Study Terminated by Sponsor|0|||
105737154|NCT03303339|364693372|FG005|Overall Study|Study Terminated by Sponsor|0|||
105737155|NCT03303339|364693373|FG006|Overall Study|Study Terminated by Sponsor|0|||
105737156|NCT03303339|364693374|FG007|Overall Study|Study Terminated by Sponsor|0|||
105737157|NCT03303339|364693375|FG008|Overall Study|Study Terminated by Sponsor|1|||
105737158|NCT03303339|364693376|FG009|Overall Study|Study Terminated by Sponsor|0|||
105737159|NCT03303339|364693377|FG010|Overall Study|Study Terminated by Sponsor|1|||
105737160|NCT03303339|364693378|FG011|Overall Study|Study Terminated by Sponsor|1|||
105737161|NCT03303339|364693367|FG000|Overall Study|Withdrawal by Subject|1|||
105737162|NCT03303339|364693368|FG001|Overall Study|Withdrawal by Subject|0|||
105737163|NCT03303339|364693369|FG002|Overall Study|Withdrawal by Subject|0|||
105737164|NCT03303339|364693370|FG003|Overall Study|Withdrawal by Subject|0|||
105737165|NCT03303339|364693371|FG004|Overall Study|Withdrawal by Subject|0|||
105737166|NCT03303339|364693372|FG005|Overall Study|Withdrawal by Subject|1|||
105737167|NCT03303339|364693373|FG006|Overall Study|Withdrawal by Subject|1|||
105737168|NCT03303339|364693374|FG007|Overall Study|Withdrawal by Subject|0|||
105737169|NCT03303339|364693375|FG008|Overall Study|Withdrawal by Subject|0|||
105737170|NCT03303339|364693376|FG009|Overall Study|Withdrawal by Subject|0|||
105737171|NCT03303339|364693377|FG010|Overall Study|Withdrawal by Subject|0|||
105737172|NCT03303339|364693378|FG011|Overall Study|Withdrawal by Subject|2|||
105737173|NCT03303339|364693367|FG000|Overall Study|Physician Decision|0|||
105737174|NCT03303339|364693368|FG001|Overall Study|Physician Decision|0|||
105737175|NCT03303339|364693369|FG002|Overall Study|Physician Decision|0|||
105737176|NCT03303339|364693370|FG003|Overall Study|Physician Decision|0|||
105737177|NCT03303339|364693371|FG004|Overall Study|Physician Decision|1|||
105737178|NCT03303339|364693372|FG005|Overall Study|Physician Decision|0|||
105737179|NCT03303339|364693373|FG006|Overall Study|Physician Decision|0|||
105737180|NCT03303339|364693374|FG007|Overall Study|Physician Decision|0|||
105737181|NCT03303339|364693375|FG008|Overall Study|Physician Decision|0|||
105737182|NCT03303339|364693376|FG009|Overall Study|Physician Decision|0|||
105737183|NCT03303339|364693377|FG010|Overall Study|Physician Decision|0|||
105737184|NCT03303339|364693378|FG011|Overall Study|Physician Decision|0|||
105737185|NCT03303339|364693367|FG000|Overall Study|Safety/Non-compliance|0|||
105737186|NCT03303339|364693368|FG001|Overall Study|Safety/Non-compliance|0|||
105737187|NCT03303339|364693369|FG002|Overall Study|Safety/Non-compliance|0|||
105737188|NCT03303339|364693370|FG003|Overall Study|Safety/Non-compliance|0|||
105737189|NCT03303339|364693371|FG004|Overall Study|Safety/Non-compliance|0|||
105737190|NCT03303339|364693372|FG005|Overall Study|Safety/Non-compliance|0|||
105737191|NCT03303339|364693373|FG006|Overall Study|Safety/Non-compliance|0|||
105737192|NCT03303339|364693374|FG007|Overall Study|Safety/Non-compliance|0|||
105737193|NCT03303339|364693375|FG008|Overall Study|Safety/Non-compliance|0|||
105737194|NCT03303339|364693376|FG009|Overall Study|Safety/Non-compliance|0|||
105737195|NCT03303339|364693377|FG010|Overall Study|Safety/Non-compliance|0|||
105737196|NCT03303339|364693378|FG011|Overall Study|Safety/Non-compliance|1|||
105355292|NCT03746405|363306076|FG000|Overall Study|technical difficulties|0|||
105355293|NCT03746405|363306077|FG001|Overall Study|technical difficulties|2|||
105355294|NCT02178358|363306083|FG000|Overall Study|Withdrawal by Subject|0|||
105355295|NCT02178358|363306084|FG001|Overall Study|Withdrawal by Subject|2|||
105355296|NCT02178358|363306085|FG002|Overall Study|Withdrawal by Subject|2|||
105355297|NCT02178358|363306083|FG000|Overall Study|Lost to Follow-up|1|||
105355298|NCT02178358|363306084|FG001|Overall Study|Lost to Follow-up|0|||
105355299|NCT02178358|363306085|FG002|Overall Study|Lost to Follow-up|0|||
105355300|NCT01301079|363306089|FG000|Overall Study|Lost to Follow-up|2|||
105355301|NCT01301079|363306090|FG001|Overall Study|Lost to Follow-up|2|||
105355302|NCT02087670|363306091|FG000|Overall Study|Withdrawal by Subject|3|||
105355303|NCT02087670|363306092|FG001|Overall Study|Withdrawal by Subject|2|||
105355304|NCT01639703|363306093|FG000|Overall Study|Withdrawal by Subject|5|||
105355305|NCT01639703|363306093|FG000|Overall Study|Other reason|7|||
105355306|NCT00264290|363306094|FG000|Intervention (8 Weeks)|Adverse Event|1|||
105355307|NCT00264290|363306095|FG001|Intervention (8 Weeks)|Adverse Event|0|||
105355308|NCT01308463|363306097|FG000|Overall Study|Study Discontinued|23|||
105355309|NCT01308463|363306097|FG000|Overall Study|Death|4|||
105355310|NCT01308463|363306097|FG000|Overall Study|Revision|2|||
105355311|NCT02784288|363306098|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
105355312|NCT02095197|363306099|FG000|Overall Study|Lost to Follow-up|0|||
105355313|NCT02095197|363306100|FG001|Overall Study|Lost to Follow-up|3|||
105355314|NCT03374488|363306101|FG000|Overall Study|Death|13|||
105355315|NCT03374488|363306102|FG001|Overall Study|Death|13|||
105355316|NCT03374488|363306101|FG000|Overall Study|Withdrawal by Subject|3|||
105355317|NCT03374488|363306102|FG001|Overall Study|Withdrawal by Subject|1|||
105355318|NCT03374488|363306101|FG000|Overall Study|Physician Decision|3|||
105355319|NCT03374488|363306102|FG001|Overall Study|Physician Decision|0|||
105355320|NCT01951573|363306103|FG000|Washout Period|Adverse Event|0|||
105737197|NCT00149825|364693379|FG000|Overall Study|Intolerance to medication side effects|1|||
105737198|NCT00149825|364693380|FG001|Overall Study|Intolerance to medication side effects|2|||
105737199|NCT00149825|364693379|FG000|Overall Study|Time commitments|2|||
105737200|NCT00149825|364693380|FG001|Overall Study|Time commitments|1|||
105737201|NCT00149825|364693379|FG000|Overall Study|Not liking insomnia therapy|1|||
105737202|NCT00149825|364693380|FG001|Overall Study|Not liking insomnia therapy|0|||
105737203|NCT00149825|364693379|FG000|Overall Study|Other|1|||
105355321|NCT01951573|363306104|FG001|Washout Period|Adverse Event|1|||
105355322|NCT02072941|363306105|FG000|Overall Study|Withdrawal by Subject|29|||
105355323|NCT02072941|363306106|FG001|Overall Study|Withdrawal by Subject|21|||
105737204|NCT00149825|364693380|FG001|Overall Study|Other|0|||
105737205|NCT01359982|364693381|FG000|Overall Study|Adverse Event|2|||
105737206|NCT01359982|364693382|FG001|Overall Study|Adverse Event|0|||
105737207|NCT01359982|364693383|FG002|Overall Study|Adverse Event|0|||
105355324|NCT02072941|363306105|FG000|Overall Study|Lost to Follow-up|4|||
105355325|NCT02072941|363306106|FG001|Overall Study|Lost to Follow-up|4|||
105355326|NCT02072941|363306105|FG000|Overall Study|Death|3|||
105737208|NCT01359982|364693384|FG003|Overall Study|Adverse Event|1|||
105355327|NCT02072941|363306106|FG001|Overall Study|Death|2|||
105737209|NCT01359982|364693385|FG004|Overall Study|Adverse Event|0|||
105737210|NCT01359982|364693386|FG005|Overall Study|Adverse Event|0|||
105737211|NCT01359982|364693381|FG000|Overall Study|Death|1|||
105737212|NCT01359982|364693382|FG001|Overall Study|Death|0|||
105737213|NCT01359982|364693383|FG002|Overall Study|Death|0|||
105355328|NCT02072941|363306105|FG000|Overall Study|Removed by Study Staff|2|||
105737214|NCT01359982|364693384|FG003|Overall Study|Death|0|||
105355329|NCT02072941|363306106|FG001|Overall Study|Removed by Study Staff|2|||
105355330|NCT00460239|363306107|FG000|Overall Study|Physician Decision|0|||
105355331|NCT00460239|363306108|FG001|Overall Study|Physician Decision|1|||
105355332|NCT00460239|363306109|FG002|Overall Study|Physician Decision|0|||
105355333|NCT00460239|363306110|FG003|Overall Study|Physician Decision|0|||
105355334|NCT00460239|363306111|FG004|Overall Study|Physician Decision|0|||
105355335|NCT00460239|363306112|FG005|Overall Study|Physician Decision|2|||
105355336|NCT00460239|363306113|FG006|Overall Study|Physician Decision|0|||
105355337|NCT00460239|363306114|FG007|Overall Study|Physician Decision|0|||
105355338|NCT00460239|363306115|FG008|Overall Study|Physician Decision|0|||
105355339|NCT00460239|363306107|FG000|Overall Study|Withdrawal by Subject|0|||
105355340|NCT00460239|363306108|FG001|Overall Study|Withdrawal by Subject|0|||
105355341|NCT00460239|363306109|FG002|Overall Study|Withdrawal by Subject|0|||
105355342|NCT00460239|363306110|FG003|Overall Study|Withdrawal by Subject|0|||
105355343|NCT00460239|363306111|FG004|Overall Study|Withdrawal by Subject|0|||
105355344|NCT00460239|363306112|FG005|Overall Study|Withdrawal by Subject|1|||
105355345|NCT00460239|363306113|FG006|Overall Study|Withdrawal by Subject|0|||
105355346|NCT00460239|363306114|FG007|Overall Study|Withdrawal by Subject|0|||
105355347|NCT00460239|363306115|FG008|Overall Study|Withdrawal by Subject|0|||
105355348|NCT02020889|363306136|FG000|Overall Study|Adverse Event|0|||
105355349|NCT02020889|363306137|FG001|Overall Study|Adverse Event|1|||
105355350|NCT02020889|363306136|FG000|Overall Study|Lack of Efficacy|1|||
105355351|NCT02020889|363306137|FG001|Overall Study|Lack of Efficacy|0|||
105355352|NCT02020889|363306136|FG000|Overall Study|Lost to Follow-up|1|||
105355353|NCT02020889|363306137|FG001|Overall Study|Lost to Follow-up|0|||
105355354|NCT02020889|363306136|FG000|Overall Study|Physician Decision|2|||
105355355|NCT02020889|363306137|FG001|Overall Study|Physician Decision|0|||
105355356|NCT02020889|363306136|FG000|Overall Study|Withdrawal by Subject|3|||
105355357|NCT02020889|363306137|FG001|Overall Study|Withdrawal by Subject|2|||
105355358|NCT00760487|363306138|FG000|Overall Study|Unilateral implantation|3|||
105355359|NCT04217317|363306140|FG000|Overall Study|Lack of Efficacy|4|||
105355360|NCT04217317|363306140|FG000|Overall Study|Physician Decision|1|||
105355361|NCT04313400|363306141|FG000|Overall Study|Withdrawal by Subject|0|||
105355362|NCT04313400|363306142|FG001|Overall Study|Withdrawal by Subject|0|||
105355363|NCT04313400|363306143|FG002|Overall Study|Withdrawal by Subject|0|||
105355364|NCT04313400|363306144|FG003|Overall Study|Withdrawal by Subject|0|||
105355365|NCT04313400|363306145|FG004|Overall Study|Withdrawal by Subject|0|||
105355366|NCT04313400|363306146|FG005|Overall Study|Withdrawal by Subject|4|||
105355367|NCT04313400|363306147|FG006|Overall Study|Withdrawal by Subject|1|||
105355368|NCT04313400|363306141|FG000|Overall Study|Adverse Event|0|||
105355369|NCT04313400|363306142|FG001|Overall Study|Adverse Event|0|||
105355370|NCT04313400|363306143|FG002|Overall Study|Adverse Event|0|||
105355371|NCT04313400|363306144|FG003|Overall Study|Adverse Event|0|||
105737215|NCT01359982|364693385|FG004|Overall Study|Death|0|||
105737216|NCT01359982|364693386|FG005|Overall Study|Death|0|||
105737217|NCT00465738|364693398|FG000|Overall Study|Lost to Follow-up|2|||
105737218|NCT00465738|364693399|FG001|Overall Study|Lost to Follow-up|0|||
105737219|NCT00465738|364693398|FG000|Overall Study|Adverse Event|0|||
105737220|NCT00465738|364693399|FG001|Overall Study|Adverse Event|1|||
105737221|NCT00465738|364693398|FG000|Overall Study|Withdrawal by Subject|2|||
105737222|NCT00465738|364693399|FG001|Overall Study|Withdrawal by Subject|0|||
105355372|NCT04313400|363306145|FG004|Overall Study|Adverse Event|0|||
105355373|NCT04313400|363306146|FG005|Overall Study|Adverse Event|1|||
105355374|NCT04313400|363306147|FG006|Overall Study|Adverse Event|0|||
105355375|NCT04313400|363306141|FG000|Overall Study|Lost to Follow-up|0|||
105799434|NCT01493531|364924577|FG001|Overall Study|Withdrawal by Subject|13|||
105799435|NCT01493531|364924578|FG002|Overall Study|Withdrawal by Subject|11|||
105799436|NCT01493531|364924576|FG000|Overall Study|Death|0|||
105799437|NCT01493531|364924577|FG001|Overall Study|Death|1|||
105799438|NCT01493531|364924578|FG002|Overall Study|Death|0|||
105355376|NCT04313400|363306142|FG001|Overall Study|Lost to Follow-up|0|||
105355377|NCT04313400|363306143|FG002|Overall Study|Lost to Follow-up|0|||
105355378|NCT04313400|363306144|FG003|Overall Study|Lost to Follow-up|0|||
105355379|NCT04313400|363306145|FG004|Overall Study|Lost to Follow-up|0|||
105355380|NCT04313400|363306146|FG005|Overall Study|Lost to Follow-up|1|||
105355381|NCT04313400|363306147|FG006|Overall Study|Lost to Follow-up|0|||
105355382|NCT03146741|363306150|FG000|Overall Study|Txp with non-HCV+ heart|4|||
105355383|NCT03146741|363306150|FG000|Overall Study|Listeted for MOT|2|||
105355384|NCT03146741|363306150|FG000|Overall Study|Physician Decision|2|||
105355385|NCT03146741|363306150|FG000|Overall Study|Awaiting txp|2|||
105355386|NCT00551525|363306151|FG000|Overall Study|Protocol Violation|5|||
105355387|NCT00303472|363306152|FG000|Treatment Period|Adverse Event|0|||
105355388|NCT00303472|363306153|FG001|Treatment Period|Adverse Event|0|||
105355389|NCT00303472|363306154|FG002|Treatment Period|Adverse Event|0|||
105355390|NCT00303472|363306155|FG003|Treatment Period|Adverse Event|0|||
105355391|NCT00303472|363306156|FG004|Treatment Period|Adverse Event|1|||
105355392|NCT00303472|363306157|FG005|Treatment Period|Adverse Event|0|||
105355393|NCT00303472|363306158|FG006|Treatment Period|Adverse Event|0|||
105355394|NCT00303472|363306152|FG000|Treatment Period|Death|0|||
105355395|NCT00303472|363306153|FG001|Treatment Period|Death|0|||
105355396|NCT00303472|363306154|FG002|Treatment Period|Death|0|||
105355397|NCT00303472|363306155|FG003|Treatment Period|Death|1|||
105355398|NCT00303472|363306156|FG004|Treatment Period|Death|0|||
105355399|NCT00303472|363306157|FG005|Treatment Period|Death|0|||
105355400|NCT00303472|363306158|FG006|Treatment Period|Death|1|||
105355401|NCT00303472|363306152|FG000|Treatment Period|Withdrawal by Subject|0|||
105355402|NCT00303472|363306153|FG001|Treatment Period|Withdrawal by Subject|0|||
105799439|NCT01825876|364924581|FG000|Period 2|Withdrawal by Subject|0|||
105799440|NCT01825876|364924582|FG001|Period 2|Withdrawal by Subject|1|||
105355403|NCT00303472|363306154|FG002|Treatment Period|Withdrawal by Subject|0|||
105481372|NCT02412488|363773544|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
105481373|NCT02412488|363773544|FG000|Overall Study|Reveal LINQ explant|1|||
105481374|NCT01073462|363773545|FG000|Overall Study|Death|14|||
105737223|NCT00465738|364693398|FG000|Overall Study|Other|2|||
105737224|NCT00465738|364693399|FG001|Overall Study|Other|5|||
105737225|NCT01618656|364693404|FG000|Overall Study|Withdrawal by Subject|7|||
105737226|NCT01618656|364693405|FG001|Overall Study|Withdrawal by Subject|3|||
105737227|NCT01618656|364693404|FG000|Overall Study|Physician Decision|1|||
105737228|NCT01618656|364693405|FG001|Overall Study|Physician Decision|1|||
105737229|NCT01276847|364693406|FG000|Overall Study|Withdrawal by Subject|1|||
105737230|NCT01276847|364693407|FG001|Overall Study|Withdrawal by Subject|0|||
105737231|NCT01276847|364693408|FG002|Overall Study|Withdrawal by Subject|0|||
105737232|NCT01696877|364693409|FG000|Overall Study|Adverse Event|0|||
105737233|NCT01696877|364693410|FG001|Overall Study|Adverse Event|1|||
105737234|NCT01863758|364693411|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
105737235|NCT01863758|364693411|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
105737236|NCT02961764|364693412|FG000|Overall Study|Protocol Violation|0|||
105737237|NCT02961764|364693413|FG001|Overall Study|Protocol Violation|1|||
105737238|NCT02961764|364693412|FG000|Overall Study|Death|2|||
105737239|NCT02961764|364693413|FG001|Overall Study|Death|0|||
105737240|NCT02961764|364693412|FG000|Overall Study|Lost to Follow-up|35|||
105737241|NCT02961764|364693413|FG001|Overall Study|Lost to Follow-up|24|||
105737242|NCT02961764|364693412|FG000|Overall Study|Withdrawal by Subject|2|||
105737243|NCT02961764|364693413|FG001|Overall Study|Withdrawal by Subject|0|||
105737244|NCT00751881|364693414|FG000|Core Treatment Period|Not treated|1|||
105737245|NCT00751881|364693415|FG001|Core Treatment Period|Not treated|1|||
105737246|NCT00751881|364693416|FG002|Core Treatment Period|Not treated|2|||
105737247|NCT00751881|364693414|FG000|Core Treatment Period|Adverse Event|26|||
105737248|NCT00751881|364693415|FG001|Core Treatment Period|Adverse Event|54|||
105737249|NCT00751881|364693416|FG002|Core Treatment Period|Adverse Event|58|||
105737250|NCT00751881|364693414|FG000|Core Treatment Period|Lack of Efficacy|37|||
105737251|NCT00751881|364693415|FG001|Core Treatment Period|Lack of Efficacy|30|||
105737252|NCT00751881|364693416|FG002|Core Treatment Period|Lack of Efficacy|20|||
105737253|NCT00751881|364693414|FG000|Core Treatment Period|Poor compliance to protocol|15|||
105737254|NCT00751881|364693415|FG001|Core Treatment Period|Poor compliance to protocol|3|||
105799441|NCT01205529|364924583|FG000|Overall Study|Procedure Cancelled|4|||
105355404|NCT00303472|363306155|FG003|Treatment Period|Withdrawal by Subject|1|||
105355405|NCT00303472|363306156|FG004|Treatment Period|Withdrawal by Subject|0|||
105355406|NCT00303472|363306157|FG005|Treatment Period|Withdrawal by Subject|1|||
105355407|NCT00303472|363306158|FG006|Treatment Period|Withdrawal by Subject|0|||
105355408|NCT00303472|363306152|FG000|Treatment Period|Other|0|||
105355409|NCT00303472|363306153|FG001|Treatment Period|Other|0|||
105355410|NCT00303472|363306154|FG002|Treatment Period|Other|0|||
105355411|NCT00303472|363306155|FG003|Treatment Period|Other|0|||
105355412|NCT00303472|363306156|FG004|Treatment Period|Other|1|||
105481375|NCT01073462|363773545|FG000|Overall Study|Kidney transplant|10|||
105481376|NCT01073462|363773545|FG000|Overall Study|Low parathyroid hormone levels|8|||
105481377|NCT01073462|363773545|FG000|Overall Study|Serious adverse event|2|||
105481378|NCT01073462|363773545|FG000|Overall Study|Lost to Follow-up|7|||
105481379|NCT00773838|363773549|FG000|Overall Study|Adverse Event|29|||
105481380|NCT00773838|363773549|FG000|Overall Study|Lost to Follow-up|1|||
105481381|NCT00773838|363773549|FG000|Overall Study|Physician Decision|8|||
105481382|NCT00773838|363773549|FG000|Overall Study|Progressive Disease|82|||
105481383|NCT00773838|363773549|FG000|Overall Study|Protocol Violation|2|||
105481384|NCT00773838|363773549|FG000|Overall Study|Withdrawal by Subject|21|||
105481385|NCT02694757|363773555|FG000|Overall Study|Lack of Efficacy|3|||
105481386|NCT00890045|363773561|FG000|Overall Study|Death|0|||
105481387|NCT00890045|363773562|FG001|Overall Study|Death|1|||
105481388|NCT00890045|363773561|FG000|Overall Study|Did not receive HeRO Graft|0|||
105481389|NCT00890045|363773562|FG001|Overall Study|Did not receive HeRO Graft|2|||
105481390|NCT00890045|363773561|FG000|Overall Study|Lost to Follow-up|5|||
105481391|NCT00890045|363773562|FG001|Overall Study|Lost to Follow-up|7|||
105481392|NCT00384111|363773565|FG000|Overall Study|Disease Progression|3|||
105481393|NCT00384111|363773565|FG000|Overall Study|Adverse Event|1|||
105481394|NCT00384111|363773565|FG000|Overall Study|Investigator Decision|3|||
105481395|NCT00384111|363773565|FG000|Overall Study|Study Terminated by the Sponsor|19|||
105481396|NCT00906971|363773566|FG000|Overall Study|Withdrawal by Subject|8|||
105481397|NCT00906971|363773567|FG001|Overall Study|Withdrawal by Subject|2|||
105481398|NCT00906971|363773566|FG000|Overall Study|Lost to Follow-up|0|||
105481399|NCT00906971|363773567|FG001|Overall Study|Lost to Follow-up|1|||
105481400|NCT00545129|363773568|FG000|Overall Study|Lack of Efficacy|2|||
105481401|NCT00545129|363773569|FG001|Overall Study|Lack of Efficacy|5|||
105481402|NCT00545129|363773568|FG000|Overall Study|Death|2|||
105481403|NCT00545129|363773569|FG001|Overall Study|Death|1|||
105481404|NCT00545129|363773568|FG000|Overall Study|Adverse Event|1|||
105481405|NCT00545129|363773569|FG001|Overall Study|Adverse Event|1|||
105481406|NCT00545129|363773568|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
105481407|NCT00545129|363773569|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
105481408|NCT00545129|363773568|FG000|Overall Study|Other|3|||
105481409|NCT00545129|363773569|FG001|Overall Study|Other|3|||
105737255|NCT00751881|364693416|FG002|Core Treatment Period|Poor compliance to protocol|4|||
105737256|NCT00751881|364693414|FG000|Core Treatment Period|Lost to Follow-up|6|||
105737257|NCT00751881|364693415|FG001|Core Treatment Period|Lost to Follow-up|4|||
105737258|NCT00751881|364693416|FG002|Core Treatment Period|Lost to Follow-up|3|||
105737259|NCT00751881|364693414|FG000|Core Treatment Period|Other: protocol deviation|3|||
105737260|NCT00751881|364693415|FG001|Core Treatment Period|Other: protocol deviation|3|||
105737261|NCT00751881|364693416|FG002|Core Treatment Period|Other: protocol deviation|7|||
105737262|NCT00751881|364693414|FG000|Core Treatment Period|Other: wish to parent|5|||
105737263|NCT00751881|364693415|FG001|Core Treatment Period|Other: wish to parent|7|||
105737264|NCT00751881|364693416|FG002|Core Treatment Period|Other: wish to parent|4|||
105737265|NCT00751881|364693414|FG000|Core Treatment Period|Other: personal/family constraints|6|||
105737266|NCT00751881|364693415|FG001|Core Treatment Period|Other: personal/family constraints|7|||
105737267|NCT00751881|364693416|FG002|Core Treatment Period|Other: personal/family constraints|10|||
105737268|NCT00751881|364693414|FG000|Core Treatment Period|Other: MS treatment change|6|||
105737269|NCT00751881|364693415|FG001|Core Treatment Period|Other: MS treatment change|4|||
105737270|NCT00751881|364693416|FG002|Core Treatment Period|Other: MS treatment change|4|||
105737271|NCT00751881|364693414|FG000|Core Treatment Period|Other: tolerability complaints|2|||
105737272|NCT00751881|364693415|FG001|Core Treatment Period|Other: tolerability complaints|0|||
105737273|NCT00751881|364693416|FG002|Core Treatment Period|Other: tolerability complaints|0|||
105737274|NCT00751881|364693414|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
105737275|NCT00751881|364693415|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
105737276|NCT00751881|364693416|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
105737277|NCT00751881|364693414|FG000|Extension Study Period|Adverse Event|18|||
105737278|NCT00751881|364693415|FG001|Extension Study Period|Adverse Event|20|||
105737279|NCT00751881|364693416|FG002|Extension Study Period|Adverse Event|21|||
105737280|NCT00751881|364693414|FG000|Extension Study Period|Lack of Efficacy|14|||
105737281|NCT00751881|364693415|FG001|Extension Study Period|Lack of Efficacy|10|||
105737282|NCT00751881|364693416|FG002|Extension Study Period|Lack of Efficacy|20|||
105737283|NCT00751881|364693414|FG000|Extension Study Period|Lost to Follow-up|4|||
105481410|NCT03678870|363773570|FG000|Overall Study|prescribed non- protocol medications|10|||
105481411|NCT03678870|363773571|FG001|Overall Study|prescribed non- protocol medications|6|||
105481412|NCT03678870|363773570|FG000|Overall Study|Lost to Follow-up|3|||
105481413|NCT03678870|363773571|FG001|Overall Study|Lost to Follow-up|2|||
105481414|NCT03612856|363773572|FG000|Pre-dose Period|Physician Decision|0|||
105481415|NCT03612856|363773573|FG001|Pre-dose Period|Physician Decision|1|||
105481416|NCT03612856|363773574|FG002|Pre-dose Period|Physician Decision|1|||
105481417|NCT03612856|363773572|FG000|Pre-dose Period|Withdrawal by Subject|0|||
105737284|NCT00751881|364693415|FG001|Extension Study Period|Lost to Follow-up|9|||
105355413|NCT00303472|363306157|FG005|Treatment Period|Other|0|||
105355414|NCT00303472|363306158|FG006|Treatment Period|Other|1|||
105355415|NCT00303472|363306152|FG000|Treatment Period|Disease Progression (to AML)|0|||
105355416|NCT00303472|363306153|FG001|Treatment Period|Disease Progression (to AML)|0|||
105355417|NCT00303472|363306154|FG002|Treatment Period|Disease Progression (to AML)|0|||
105355418|NCT00303472|363306155|FG003|Treatment Period|Disease Progression (to AML)|0|||
105355419|NCT00303472|363306156|FG004|Treatment Period|Disease Progression (to AML)|1|||
105355420|NCT00303472|363306157|FG005|Treatment Period|Disease Progression (to AML)|0|||
105355421|NCT00303472|363306158|FG006|Treatment Period|Disease Progression (to AML)|0|||
105355422|NCT00303472|363306152|FG000|Treatment Extension (Optional)|Adverse Event|1|||
105355423|NCT00303472|363306153|FG001|Treatment Extension (Optional)|Adverse Event|0|||
105355424|NCT00303472|363306154|FG002|Treatment Extension (Optional)|Adverse Event|1|||
105355425|NCT00303472|363306155|FG003|Treatment Extension (Optional)|Adverse Event|0|||
105355426|NCT00303472|363306156|FG004|Treatment Extension (Optional)|Adverse Event|0|||
105355427|NCT00303472|363306157|FG005|Treatment Extension (Optional)|Adverse Event|0|||
105355428|NCT00303472|363306158|FG006|Treatment Extension (Optional)|Adverse Event|0|||
105355429|NCT00303472|363306152|FG000|Treatment Extension (Optional)|Death|2|||
105355430|NCT00303472|363306153|FG001|Treatment Extension (Optional)|Death|0|||
105355431|NCT00303472|363306154|FG002|Treatment Extension (Optional)|Death|1|||
105355432|NCT00303472|363306155|FG003|Treatment Extension (Optional)|Death|0|||
105355433|NCT00303472|363306156|FG004|Treatment Extension (Optional)|Death|0|||
105355434|NCT00303472|363306157|FG005|Treatment Extension (Optional)|Death|0|||
105355435|NCT00303472|363306158|FG006|Treatment Extension (Optional)|Death|0|||
105355436|NCT00303472|363306152|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
105355437|NCT00303472|363306153|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
105355438|NCT00303472|363306154|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
105355439|NCT00303472|363306155|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
105355440|NCT00303472|363306156|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
105355441|NCT00303472|363306157|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
105355442|NCT00303472|363306158|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
105355443|NCT00303472|363306152|FG000|Treatment Extension (Optional)|Physician Decision|0|||
105355444|NCT00303472|363306153|FG001|Treatment Extension (Optional)|Physician Decision|4|||
105355445|NCT00303472|363306154|FG002|Treatment Extension (Optional)|Physician Decision|2|||
105355446|NCT00303472|363306155|FG003|Treatment Extension (Optional)|Physician Decision|3|||
105355447|NCT00303472|363306156|FG004|Treatment Extension (Optional)|Physician Decision|2|||
105355448|NCT00303472|363306157|FG005|Treatment Extension (Optional)|Physician Decision|0|||
105355449|NCT00303472|363306158|FG006|Treatment Extension (Optional)|Physician Decision|0|||
105355450|NCT00303472|363306152|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
105355451|NCT00303472|363306153|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
105355452|NCT00303472|363306154|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
105355453|NCT00303472|363306155|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
105355454|NCT00303472|363306156|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
105355455|NCT00303472|363306157|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
105355456|NCT00303472|363306158|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
105355457|NCT00303472|363306152|FG000|Treatment Extension (Optional)|Other|0|||
105355458|NCT00303472|363306153|FG001|Treatment Extension (Optional)|Other|2|||
105355459|NCT00303472|363306154|FG002|Treatment Extension (Optional)|Other|4|||
105355460|NCT00303472|363306155|FG003|Treatment Extension (Optional)|Other|2|||
105355461|NCT00303472|363306156|FG004|Treatment Extension (Optional)|Other|1|||
105355462|NCT00303472|363306157|FG005|Treatment Extension (Optional)|Other|0|||
105355463|NCT00303472|363306158|FG006|Treatment Extension (Optional)|Other|0|||
105355464|NCT00303472|363306152|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
105355465|NCT00303472|363306153|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
105355466|NCT00303472|363306154|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
105355467|NCT00303472|363306155|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
105355468|NCT00303472|363306156|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
105355469|NCT00303472|363306157|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
105355470|NCT00303472|363306158|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
105355471|NCT00110357|363306162|FG000|Overall Study|Deterioration without progression|2|||
105355472|NCT00110357|363306163|FG001|Overall Study|Deterioration without progression|0|||
105355473|NCT00110357|363306162|FG000|Overall Study|Disease progression/relapse|20|||
105355474|NCT00110357|363306163|FG001|Overall Study|Disease progression/relapse|15|||
105355475|NCT00110357|363306162|FG000|Overall Study|Study Closure|1|||
105355476|NCT00110357|363306163|FG001|Overall Study|Study Closure|0|||
105355477|NCT00110357|363306162|FG000|Overall Study|Study Drug Toxicity|1|||
105355478|NCT00110357|363306163|FG001|Overall Study|Study Drug Toxicity|3|||
105355479|NCT00110357|363306162|FG000|Overall Study|Withdrawal by Subject|3|||
105355480|NCT00110357|363306163|FG001|Overall Study|Withdrawal by Subject|1|||
105355481|NCT03853291|363306164|FG000|Overall Study|Lost to Follow-up|1|||
105355482|NCT03853291|363306165|FG001|Overall Study|Lost to Follow-up|2|||
105355483|NCT03853291|363306166|FG002|Overall Study|Lost to Follow-up|0|||
105737285|NCT00751881|364693416|FG002|Extension Study Period|Lost to Follow-up|6|||
105737286|NCT00751881|364693414|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
105737287|NCT00751881|364693415|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
105737288|NCT00751881|364693416|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
105737289|NCT00751881|364693414|FG000|Extension Study Period|Other than specified above|26|||
105737290|NCT00751881|364693415|FG001|Extension Study Period|Other than specified above|30|||
105737291|NCT00751881|364693416|FG002|Extension Study Period|Other than specified above|18|||
105737292|NCT01422304|364693419|FG000|Overall Study|Adverse Event|0|||
105737293|NCT01422304|364693420|FG001|Overall Study|Adverse Event|1|||
105737294|NCT01422304|364693419|FG000|Overall Study|Lost to Follow-up|14|||
105737295|NCT01422304|364693420|FG001|Overall Study|Lost to Follow-up|20|||
105737296|NCT01422304|364693419|FG000|Overall Study|Never Entered Follow-up|2|||
105737297|NCT01422304|364693420|FG001|Overall Study|Never Entered Follow-up|1|||
105737298|NCT01422304|364693419|FG000|Overall Study|Protocol Violation|1|||
105737299|NCT01422304|364693420|FG001|Overall Study|Protocol Violation|0|||
105737300|NCT01422304|364693419|FG000|Overall Study|Withdrawal by Subject|4|||
105737301|NCT01422304|364693420|FG001|Overall Study|Withdrawal by Subject|2|||
105737302|NCT01422304|364693419|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
105737303|NCT01422304|364693420|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
105737304|NCT01422304|364693419|FG000|Overall Study|Not Treated|3|||
105737305|NCT01422304|364693420|FG001|Overall Study|Not Treated|11|||
105737306|NCT04770155|364693421|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
105737307|NCT04770155|364693422|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
105737308|NCT04770155|364693423|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
105355484|NCT03853291|363306167|FG003|Overall Study|Lost to Follow-up|0|||
105355485|NCT03853291|363306168|FG004|Overall Study|Lost to Follow-up|0|||
105355486|NCT03853291|363306169|FG005|Overall Study|Lost to Follow-up|0|||
105355487|NCT03853291|363306164|FG000|Overall Study|Determined to be ineligible|1|||
105355488|NCT03853291|363306165|FG001|Overall Study|Determined to be ineligible|1|||
105355489|NCT03853291|363306166|FG002|Overall Study|Determined to be ineligible|0|||
105355490|NCT03853291|363306167|FG003|Overall Study|Determined to be ineligible|0|||
105355491|NCT03853291|363306168|FG004|Overall Study|Determined to be ineligible|0|||
105355492|NCT03853291|363306169|FG005|Overall Study|Determined to be ineligible|0|||
105355493|NCT03882957|363306170|FG000|Overall Study|Did not complete all three arms|1|||
105355494|NCT01670045|363306182|FG000|Overall Study|Withdrawal by Subject|3|||
105355495|NCT01670045|363306182|FG000|Overall Study|Adverse Event|1|||
105355496|NCT01670045|363306182|FG000|Overall Study|Death|1|||
105355497|NCT01670045|363306182|FG000|Overall Study|Lost to Follow-up|11|||
105355498|NCT02383355|363306185|FG000|Overall Study|Adverse Event|2|||
105737309|NCT04770155|364693424|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
105355499|NCT02383355|363306186|FG001|Overall Study|Adverse Event|0|||
105355500|NCT02588664|363306190|FG000|Overall Study|Death|56|||
105355501|NCT02588664|363306191|FG001|Overall Study|Death|55|||
105355502|NCT02588664|363306190|FG000|Overall Study|Lost to Follow-up|1305|||
105355503|NCT02588664|363306191|FG001|Overall Study|Lost to Follow-up|990|||
105737310|NCT04770155|364693425|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
105737311|NCT04770155|364693426|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
105737312|NCT04770155|364693427|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
105737313|NCT04770155|364693428|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
105737314|NCT03321929|364693433|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
105737315|NCT00866294|364693434|FG000|Overall Study|Adverse Event|12|||
105737316|NCT00866294|364693435|FG001|Overall Study|Adverse Event|13|||
105737317|NCT00866294|364693436|FG002|Overall Study|Adverse Event|9|||
105737318|NCT00866294|364693434|FG000|Overall Study|Lack of Efficacy|7|||
105737319|NCT00866294|364693435|FG001|Overall Study|Lack of Efficacy|1|||
105737320|NCT00866294|364693436|FG002|Overall Study|Lack of Efficacy|0|||
105737321|NCT00866294|364693434|FG000|Overall Study|Protocol Violation|2|||
105737322|NCT00866294|364693435|FG001|Overall Study|Protocol Violation|0|||
105737323|NCT00866294|364693436|FG002|Overall Study|Protocol Violation|0|||
105737324|NCT00866294|364693434|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
105737325|NCT00866294|364693435|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105737326|NCT00866294|364693436|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105737327|NCT00866294|364693434|FG000|Overall Study|Lost to Follow-up|1|||
105737328|NCT00866294|364693435|FG001|Overall Study|Lost to Follow-up|3|||
105737329|NCT00866294|364693436|FG002|Overall Study|Lost to Follow-up|0|||
105737330|NCT00866294|364693434|FG000|Overall Study|Physician Decision|6|||
105737331|NCT00866294|364693435|FG001|Overall Study|Physician Decision|2|||
105737332|NCT00866294|364693436|FG002|Overall Study|Physician Decision|1|||
105355504|NCT01098162|363306192|FG000|Overall Study|Adverse Event|37|||
105355505|NCT01098162|363306192|FG000|Overall Study|Lack of Efficacy|4|||
105355506|NCT01098162|363306192|FG000|Overall Study|Wish of Patient|7|||
105737333|NCT02119104|364693437|FG000|Overall Study|Protocol Violation|16|||
105737334|NCT01632878|364693438|FG000|Screening|Physician Decision|268|||
105737335|NCT01632878|364693438|FG000|Treatment|Lost to Follow-up|41|||
105737336|NCT01632878|364693438|FG000|Treatment|Withdrawal by Subject|36|||
105737337|NCT01632878|364693438|FG000|Treatment|Physician Decision|34|||
105737338|NCT01632878|364693438|FG000|Treatment|missing information|4|||
105737339|NCT01632878|364693438|FG000|Treatment|no information on study completion|43|||
105737340|NCT00515463|364693443|FG000|Overall Study|Physician Decision|4|||
105737341|NCT00515463|364693444|FG001|Overall Study|Physician Decision|2|||
105737342|NCT00515463|364693443|FG000|Overall Study|Adverse Event|1|||
105737343|NCT00515463|364693444|FG001|Overall Study|Adverse Event|2|||
105737344|NCT00515463|364693443|FG000|Overall Study|Withdrawal by Subject|3|||
105737345|NCT00515463|364693444|FG001|Overall Study|Withdrawal by Subject|4|||
105737346|NCT00515463|364693443|FG000|Overall Study|Lost to Follow-up|6|||
105737347|NCT00515463|364693444|FG001|Overall Study|Lost to Follow-up|5|||
105737348|NCT00515463|364693443|FG000|Overall Study|Other|0|||
105737349|NCT00515463|364693444|FG001|Overall Study|Other|1|||
105737350|NCT00081289|364693445|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
105737351|NCT00081289|364693446|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
105737352|NCT00081289|364693445|FG000|Overall Study|Ineligible / no protocol treatment|3|||
105737353|NCT00081289|364693446|FG001|Overall Study|Ineligible / no protocol treatment|4|||
105737354|NCT02190435|364693447|FG000|Overall Study|First 12 patients were lead-ins|12|||
105737355|NCT02190435|364693448|FG001|Overall Study|First 12 patients were lead-ins|0|||
105737356|NCT02190435|364693447|FG000|Overall Study|3 consented screen fails|3|||
105737357|NCT02190435|364693448|FG001|Overall Study|3 consented screen fails|0|||
105737358|NCT03575468|364693449|FG000|Overall Study|Withdrawal by Subject|3|||
105737359|NCT03575468|364693450|FG001|Overall Study|Withdrawal by Subject|0|||
105737360|NCT03575468|364693449|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
105737361|NCT03575468|364693450|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
105737362|NCT03575468|364693449|FG000|Overall Study|Lost to Follow-up|13|||
105737363|NCT03575468|364693450|FG001|Overall Study|Lost to Follow-up|17|||
105737364|NCT03069690|364694676|FG000|Pregnancy Intervention|Pregnancy loss|9|||
105737365|NCT03069690|364694677|FG001|Pregnancy Intervention|Pregnancy loss|4|||
105737366|NCT03069690|364694678|FG002|Pregnancy Intervention|Pregnancy loss|0|||
105737367|NCT03069690|364694679|FG003|Pregnancy Intervention|Pregnancy loss|0|||
105737368|NCT03069690|364694680|FG004|Pregnancy Intervention|Pregnancy loss|0|||
105737369|NCT03069690|364694681|FG005|Pregnancy Intervention|Pregnancy loss|0|||
105737370|NCT03069690|364694676|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
105737371|NCT03069690|364694677|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
105737372|NCT03069690|364694678|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
105737373|NCT03069690|364694679|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
105737374|NCT03069690|364694680|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
105737375|NCT03069690|364694681|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
105737376|NCT03069690|364694676|FG000|Postpartum Intervention|Lost to Follow-up|0|||
105737377|NCT03069690|364694677|FG001|Postpartum Intervention|Lost to Follow-up|0|||
105737378|NCT03069690|364694678|FG002|Postpartum Intervention|Lost to Follow-up|5|||
105737379|NCT03069690|364694679|FG003|Postpartum Intervention|Lost to Follow-up|5|||
105737380|NCT03069690|364694680|FG004|Postpartum Intervention|Lost to Follow-up|2|||
105737381|NCT03069690|364694681|FG005|Postpartum Intervention|Lost to Follow-up|4|||
105737382|NCT01372878|364694684|FG000|Overall Study|Withdrawal by Subject|63|||
105737383|NCT01372878|364694684|FG000|Overall Study|Protocol Violation|17|||
105737384|NCT01372878|364694684|FG000|Overall Study|incomplete study procedure|104|||
105737385|NCT00718861|364694688|FG000|Overall Study|Withdrawal by Subject|15|||
105737386|NCT00718861|364694689|FG001|Overall Study|Withdrawal by Subject|10|||
105737387|NCT00718861|364694688|FG000|Overall Study|Adverse Event|2|||
105737388|NCT00718861|364694689|FG001|Overall Study|Adverse Event|1|||
105737389|NCT00718861|364694688|FG000|Overall Study|Lost to Follow-up|2|||
105737390|NCT00718861|364694689|FG001|Overall Study|Lost to Follow-up|1|||
105737391|NCT00718861|364694688|FG000|Overall Study|Administrative Problems|1|||
105737392|NCT00718861|364694689|FG001|Overall Study|Administrative Problems|1|||
105737393|NCT00718861|364694688|FG000|Overall Study|Death|1|||
105737394|NCT00718861|364694689|FG001|Overall Study|Death|5|||
105737395|NCT01221233|364694690|FG000|Overall Study|Withdrawal by Subject|3|||
105737396|NCT01221233|364694691|FG001|Overall Study|Withdrawal by Subject|1|||
105737397|NCT02345434|364694692|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
105737398|NCT02345434|364694693|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
105737399|NCT01505491|364694694|FG000|Overall Study|Other reason not listed|1|||
105737400|NCT01505491|364694695|FG001|Overall Study|Other reason not listed|0|||
105737401|NCT01505491|364694696|FG002|Overall Study|Other reason not listed|0|||
105481418|NCT03612856|363773573|FG001|Pre-dose Period|Withdrawal by Subject|1|||
105481419|NCT03612856|363773574|FG002|Pre-dose Period|Withdrawal by Subject|0|||
105481420|NCT00169442|363773575|FG000|Overall Study|Withdrawal by Subject|0|||
105481421|NCT00169442|363773576|FG001|Overall Study|Withdrawal by Subject|0|||
105481422|NCT00169442|363773577|FG002|Overall Study|Withdrawal by Subject|1|||
105481423|NCT00169442|363773578|FG003|Overall Study|Withdrawal by Subject|0|||
105481424|NCT00169442|363773579|FG004|Overall Study|Withdrawal by Subject|0|||
105481425|NCT00169442|363773580|FG005|Overall Study|Withdrawal by Subject|0|||
105481426|NCT00169442|363773575|FG000|Overall Study|Migrated/moved from study area|0|||
105481427|NCT00169442|363773576|FG001|Overall Study|Migrated/moved from study area|0|||
105481428|NCT00169442|363773577|FG002|Overall Study|Migrated/moved from study area|0|||
105481429|NCT00169442|363773578|FG003|Overall Study|Migrated/moved from study area|0|||
105481430|NCT00169442|363773579|FG004|Overall Study|Migrated/moved from study area|0|||
105481431|NCT00169442|363773580|FG005|Overall Study|Migrated/moved from study area|2|||
105481432|NCT00169442|363773575|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
105737402|NCT01505491|364694694|FG000|Overall Study|Withdrawal by Subject|1|||
105737403|NCT01505491|364694695|FG001|Overall Study|Withdrawal by Subject|1|||
105737404|NCT01505491|364694696|FG002|Overall Study|Withdrawal by Subject|4|||
105737405|NCT01505491|364694694|FG000|Overall Study|Lost to Follow-up|0|||
105737406|NCT01505491|364694695|FG001|Overall Study|Lost to Follow-up|0|||
105737407|NCT01505491|364694696|FG002|Overall Study|Lost to Follow-up|1|||
105737408|NCT02926573|364694697|FG000|Overall Study|Nausea|1|||
105737409|NCT02926573|364694698|FG001|Overall Study|Nausea|0|||
105737410|NCT02926573|364694697|FG000|Overall Study|Remain intubated|2|||
105737411|NCT02926573|364694698|FG001|Overall Study|Remain intubated|2|||
105737412|NCT02926573|364694697|FG000|Overall Study|Change in surgery plan|3|||
105737413|NCT02926573|364694698|FG001|Overall Study|Change in surgery plan|1|||
105737414|NCT02926573|364694697|FG000|Overall Study|Change to outpatient status|5|||
105737415|NCT02926573|364694698|FG001|Overall Study|Change to outpatient status|1|||
105737416|NCT02926573|364694697|FG000|Overall Study|Withdrawal by Subject|0|||
105737417|NCT02926573|364694698|FG001|Overall Study|Withdrawal by Subject|2|||
105737418|NCT02926573|364694697|FG000|Overall Study|Return to operating room|0|||
105737419|NCT02926573|364694698|FG001|Overall Study|Return to operating room|2|||
105737420|NCT02926573|364694697|FG000|Overall Study|Delirium|0|||
105737421|NCT02926573|364694698|FG001|Overall Study|Delirium|1|||
105737422|NCT02052960|364694699|FG000|Overall Study|Adverse Event|19|||
105737423|NCT02052960|364694700|FG001|Overall Study|Adverse Event|17|||
105737424|NCT02052960|364694699|FG000|Overall Study|Protocol Violation|4|||
105737425|NCT02052960|364694700|FG001|Overall Study|Protocol Violation|3|||
105737426|NCT02052960|364694699|FG000|Overall Study|Withdrawal by Subject|6|||
105737427|NCT02052960|364694700|FG001|Overall Study|Withdrawal by Subject|11|||
105737428|NCT02052960|364694699|FG000|Overall Study|Other|25|||
105737429|NCT02052960|364694700|FG001|Overall Study|Other|15|||
105737430|NCT01302041|364694703|FG000|Overall Study|Death|5|||
105737431|NCT01302041|364694703|FG000|Overall Study|Withdrawal by Subject|4|||
105737432|NCT01302041|364694703|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
105737433|NCT01302041|364694703|FG000|Overall Study|Other-Miscellaneous Reason|2|||
105737434|NCT03849560|364694704|FG000|Overall Study|Withdrawal by Subject|1|||
105737435|NCT03849560|364694705|FG001|Overall Study|Withdrawal by Subject|0|||
105737436|NCT03849560|364694706|FG002|Overall Study|Withdrawal by Subject|0|||
105737437|NCT04382651|364694707|FG000|Overall Study|Death|26|||
105737438|NCT04382651|364694708|FG001|Overall Study|Death|23|||
105737439|NCT04382651|364694707|FG000|Overall Study|Lost to Follow-up|3|||
105737440|NCT04382651|364694708|FG001|Overall Study|Lost to Follow-up|4|||
105737441|NCT04382651|364694707|FG000|Overall Study|Withdrawal by Subject|2|||
105737442|NCT04382651|364694708|FG001|Overall Study|Withdrawal by Subject|0|||
105737443|NCT04382651|364694707|FG000|Overall Study|Physician Decision|0|||
105737444|NCT04382651|364694708|FG001|Overall Study|Physician Decision|1|||
105737445|NCT02416908|364694713|FG000|Dose Escalation Phase|Adverse Event|0|||
105737446|NCT02416908|364694714|FG001|Dose Escalation Phase|Adverse Event|0|||
105737447|NCT02416908|364694715|FG002|Dose Escalation Phase|Adverse Event|3|||
105737448|NCT02416908|364694716|FG003|Dose Escalation Phase|Adverse Event|0|||
105737449|NCT02416908|364694713|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
105481433|NCT00169442|363773576|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
105481434|NCT00169442|363773577|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
105481435|NCT00169442|363773578|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
105481436|NCT00169442|363773579|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
105481437|NCT00169442|363773580|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
105737450|NCT02416908|364694714|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
105737451|NCT02416908|364694715|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
105737452|NCT02416908|364694716|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
105737453|NCT00611130|364694721|FG000|Overall Study|Lost to Follow-up|25|||
105737454|NCT00611130|364694722|FG001|Overall Study|Lost to Follow-up|29|||
105737455|NCT00611130|364694721|FG000|Overall Study|Protocol noncompliance|7|||
105737456|NCT00611130|364694722|FG001|Overall Study|Protocol noncompliance|6|||
105737457|NCT00611130|364694721|FG000|Overall Study|Withdrawal by Subject|6|||
105481438|NCT00169442|363773575|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
105481439|NCT00169442|363773576|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
105481440|NCT00169442|363773577|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
105481441|NCT00169442|363773578|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
105481442|NCT00169442|363773579|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
105481443|NCT00169442|363773580|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
105481444|NCT01426789|363773581|FG000|Part 1|Protocol deviation|0|||
105481445|NCT01426789|363773582|FG001|Part 1|Protocol deviation|1|||
105481446|NCT01426789|363773583|FG002|Part 1|Protocol deviation|0|||
105481447|NCT01426789|363773584|FG003|Part 1|Protocol deviation|0|||
105481448|NCT01426789|363773585|FG004|Part 1|Protocol deviation|0|||
105481449|NCT01426789|363773586|FG005|Part 1|Protocol deviation|0|||
105481450|NCT01426789|363773581|FG000|Part 1|Lost to Follow-up|1|||
105481451|NCT01426789|363773582|FG001|Part 1|Lost to Follow-up|2|||
105481452|NCT01426789|363773583|FG002|Part 1|Lost to Follow-up|0|||
105481453|NCT01426789|363773584|FG003|Part 1|Lost to Follow-up|0|||
105737458|NCT00611130|364694722|FG001|Overall Study|Withdrawal by Subject|5|||
105737459|NCT00611130|364694721|FG000|Overall Study|Other|5|||
105737460|NCT00611130|364694722|FG001|Overall Study|Other|4|||
105737461|NCT00611130|364694721|FG000|Overall Study|Incarceration|3|||
105737462|NCT00611130|364694722|FG001|Overall Study|Incarceration|2|||
105737463|NCT00611130|364694721|FG000|Overall Study|Administrative|1|||
105355507|NCT01098162|363306192|FG000|Overall Study|Lost to Follow-up|9|||
105355508|NCT01098162|363306192|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
105355509|NCT01098162|363306192|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
105355510|NCT01098162|363306192|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
105355511|NCT01098162|363306192|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
105355512|NCT01098162|363306192|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
105355513|NCT01098162|363306192|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
105355514|NCT01098162|363306192|FG000|Overall Study|Other Reason|1|||
105355515|NCT01098162|363306192|FG000|Overall Study|Reason Unknown|26|||
105355516|NCT01941537|363306195|FG000|Overall Study|Lack of Efficacy|1|||
105355517|NCT01941537|363306196|FG001|Overall Study|Lack of Efficacy|2|||
105481454|NCT01426789|363773585|FG004|Part 1|Lost to Follow-up|0|||
105355518|NCT01941537|363306195|FG000|Overall Study|Lost to Follow-up|1|||
105737464|NCT00611130|364694722|FG001|Overall Study|Administrative|1|||
105737465|NCT00611130|364694721|FG000|Overall Study|Adverse Event|1|||
105355519|NCT01941537|363306196|FG001|Overall Study|Lost to Follow-up|0|||
105481455|NCT01426789|363773586|FG005|Part 1|Lost to Follow-up|0|||
105481456|NCT01426789|363773581|FG000|Part 1|Lack of Efficacy|2|||
105737466|NCT00611130|364694722|FG001|Overall Study|Adverse Event|0|||
105737467|NCT00611130|364694721|FG000|Overall Study|Death|1|||
105737468|NCT00611130|364694722|FG001|Overall Study|Death|0|||
105737469|NCT00700752|364694723|FG000|First Intervention|Withdrawal by Subject|0|||
105737470|NCT00700752|364694724|FG001|First Intervention|Withdrawal by Subject|2|||
105737471|NCT01302769|364694725|FG000|Overall Study|Lost to Follow-up|1|||
105737472|NCT01302769|364694726|FG001|Overall Study|Lost to Follow-up|1|||
105737473|NCT01097330|364694730|FG000|Overall Study|Study terminated early|7|||
105737474|NCT01097330|364694731|FG001|Overall Study|Study terminated early|5|||
105737475|NCT02853331|364694737|FG000|Overall Study|Death|59|||
105737476|NCT02853331|364694738|FG001|Overall Study|Death|95|||
105737477|NCT02853331|364694737|FG000|Overall Study|Withdrawal by Subject|5|||
105737478|NCT02853331|364694738|FG001|Overall Study|Withdrawal by Subject|9|||
105737479|NCT02853331|364694737|FG000|Overall Study|Ongoing in study|368|||
105737480|NCT02853331|364694738|FG001|Overall Study|Ongoing in study|325|||
105737481|NCT04156646|364694739|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
105737482|NCT04156646|364694740|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
105737483|NCT00510692|364694746|FG000|Overall Study|Adverse Event|1|||
105737484|NCT00510692|364694747|FG001|Overall Study|Adverse Event|3|||
105737485|NCT00510692|364694746|FG000|Overall Study|Withdrawal by Subject|1|||
105737486|NCT00510692|364694747|FG001|Overall Study|Withdrawal by Subject|0|||
105737487|NCT01845077|364694748|FG000|Washout Period|Lost to Follow-up|0|||
105737488|NCT01845077|364694749|FG001|Washout Period|Lost to Follow-up|1|||
105737489|NCT01845077|364694750|FG002|Washout Period|Lost to Follow-up|0|||
105737490|NCT01845077|364694751|FG003|Washout Period|Lost to Follow-up|1|||
105737491|NCT01845077|364694752|FG004|Washout Period|Lost to Follow-up|0|||
105737492|NCT01845077|364694753|FG005|Washout Period|Lost to Follow-up|1|||
105737493|NCT01845077|364694748|FG000|Washout Period|Adverse Event|1|||
105737494|NCT01845077|364694749|FG001|Washout Period|Adverse Event|0|||
105737495|NCT01845077|364694750|FG002|Washout Period|Adverse Event|0|||
105737496|NCT01845077|364694751|FG003|Washout Period|Adverse Event|0|||
105737497|NCT01845077|364694752|FG004|Washout Period|Adverse Event|0|||
105737498|NCT01845077|364694753|FG005|Washout Period|Adverse Event|0|||
105737499|NCT01845077|364694748|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
105737500|NCT01845077|364694749|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
105737501|NCT01845077|364694750|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
105737502|NCT01845077|364694751|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
105737503|NCT01845077|364694752|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
105737504|NCT01845077|364694753|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
105737505|NCT01845077|364694748|FG000|Washout Period|Protocol Violation|0|||
105737506|NCT01845077|364694749|FG001|Washout Period|Protocol Violation|0|||
105737507|NCT01845077|364694750|FG002|Washout Period|Protocol Violation|0|||
105737508|NCT01845077|364694751|FG003|Washout Period|Protocol Violation|1|||
105737509|NCT01845077|364694752|FG004|Washout Period|Protocol Violation|1|||
105737510|NCT01845077|364694753|FG005|Washout Period|Protocol Violation|0|||
105737511|NCT01001494|364694762|FG000|Overall Study|Adverse Event|8|||
105737512|NCT01001494|364694763|FG001|Overall Study|Adverse Event|4|||
105737513|NCT01001494|364694764|FG002|Overall Study|Adverse Event|6|||
105737514|NCT01001494|364694762|FG000|Overall Study|Protocol Violation|0|||
105737515|NCT01001494|364694763|FG001|Overall Study|Protocol Violation|1|||
105737516|NCT01001494|364694764|FG002|Overall Study|Protocol Violation|1|||
105737517|NCT01001494|364694762|FG000|Overall Study|Lost to Follow-up|2|||
105737518|NCT01001494|364694763|FG001|Overall Study|Lost to Follow-up|0|||
105737519|NCT01001494|364694764|FG002|Overall Study|Lost to Follow-up|1|||
105737520|NCT01001494|364694762|FG000|Overall Study|Withdrawal by Subject|9|||
105737521|NCT01001494|364694763|FG001|Overall Study|Withdrawal by Subject|7|||
105737522|NCT01001494|364694764|FG002|Overall Study|Withdrawal by Subject|17|||
105737523|NCT01001494|364694762|FG000|Overall Study|COPD exacerbation|3|||
105737524|NCT01001494|364694763|FG001|Overall Study|COPD exacerbation|4|||
105737525|NCT01001494|364694764|FG002|Overall Study|COPD exacerbation|5|||
105737526|NCT01001494|364694762|FG000|Overall Study|Lack of Efficacy|2|||
105737527|NCT01001494|364694763|FG001|Overall Study|Lack of Efficacy|0|||
105799442|NCT01205529|364924583|FG000|Overall Study|Withdrawal by Subject|2|||
105799443|NCT01205529|364924583|FG000|Overall Study|Physician Decision|4|||
105737528|NCT01001494|364694764|FG002|Overall Study|Lack of Efficacy|8|||
105737529|NCT01001494|364694762|FG000|Overall Study|Other|0|||
105737530|NCT01001494|364694763|FG001|Overall Study|Other|1|||
105737531|NCT01001494|364694764|FG002|Overall Study|Other|3|||
105737532|NCT02519231|364694765|FG000|Overall Study|Lost to Follow-up|2|||
105737533|NCT02519231|364694766|FG001|Overall Study|Lost to Follow-up|5|||
105799444|NCT01205529|364924583|FG000|Overall Study|Unstable post op|15|||
105737534|NCT02519231|364694765|FG000|Overall Study|Withdrawal by Subject|0|||
105737535|NCT02519231|364694766|FG001|Overall Study|Withdrawal by Subject|1|||
105737536|NCT00815308|364694768|FG000|Overall Study|Adverse Event|4|||
105737537|NCT00815308|364694768|FG000|Overall Study|Withdrawal by Subject|0|||
105737538|NCT00815308|364694768|FG000|Overall Study|Protocol Violation|6|||
105737539|NCT01137435|364694769|FG000|Overall Study|Lost to Follow-up|24|||
105737540|NCT01137435|364694769|FG000|Overall Study|Off label usage|4|||
105737541|NCT01765764|364694776|FG000|Treatment Period|Adverse Event|1|||
105799445|NCT01205529|364924583|FG000|Overall Study|No longer met criteria|30|||
105355520|NCT01941537|363306195|FG000|Overall Study|Pregnancy|1|||
105355521|NCT01941537|363306196|FG001|Overall Study|Pregnancy|0|||
105355522|NCT01941537|363306195|FG000|Overall Study|Adverse Event|1|||
105355523|NCT01941537|363306196|FG001|Overall Study|Adverse Event|0|||
105355524|NCT01941537|363306195|FG000|Overall Study|Withdrawal by Subject|0|||
105355525|NCT01941537|363306196|FG001|Overall Study|Withdrawal by Subject|1|||
105355526|NCT03034135|363306198|FG000|Overall Study|Withdrawal by Subject|2|||
105355527|NCT02557516|363306199|FG000|Overall Study|Adverse Event|1|||
105355528|NCT02557516|363306200|FG001|Overall Study|Adverse Event|0|||
105355529|NCT02557516|363306201|FG002|Overall Study|Adverse Event|2|||
105355530|NCT02557516|363306202|FG003|Overall Study|Adverse Event|1|||
105355531|NCT02557516|363306199|FG000|Overall Study|Disease progression|0|||
105355532|NCT02557516|363306200|FG001|Overall Study|Disease progression|2|||
105355533|NCT02557516|363306201|FG002|Overall Study|Disease progression|0|||
105355534|NCT02557516|363306202|FG003|Overall Study|Disease progression|0|||
105355535|NCT02557516|363306199|FG000|Overall Study|Physician Decision|0|||
105355536|NCT02557516|363306200|FG001|Overall Study|Physician Decision|2|||
105355537|NCT02557516|363306201|FG002|Overall Study|Physician Decision|0|||
105355538|NCT02557516|363306202|FG003|Overall Study|Physician Decision|0|||
105481457|NCT01426789|363773582|FG001|Part 1|Lack of Efficacy|1|||
105481458|NCT01426789|363773583|FG002|Part 1|Lack of Efficacy|0|||
105481459|NCT01426789|363773584|FG003|Part 1|Lack of Efficacy|0|||
105481460|NCT01426789|363773585|FG004|Part 1|Lack of Efficacy|0|||
105481461|NCT01426789|363773586|FG005|Part 1|Lack of Efficacy|0|||
105481462|NCT01426789|363773581|FG000|Part 1|Adverse Event|3|||
105481463|NCT01426789|363773582|FG001|Part 1|Adverse Event|0|||
105481464|NCT01426789|363773583|FG002|Part 1|Adverse Event|0|||
105481465|NCT01426789|363773584|FG003|Part 1|Adverse Event|0|||
105481466|NCT01426789|363773585|FG004|Part 1|Adverse Event|0|||
105481467|NCT01426789|363773586|FG005|Part 1|Adverse Event|0|||
105481468|NCT01426789|363773581|FG000|Part 2|Protocol deviation|0|||
105481469|NCT01426789|363773582|FG001|Part 2|Protocol deviation|0|||
105481470|NCT01426789|363773583|FG002|Part 2|Protocol deviation|1|||
105481471|NCT01426789|363773584|FG003|Part 2|Protocol deviation|0|||
105481472|NCT01426789|363773585|FG004|Part 2|Protocol deviation|0|||
105481473|NCT01426789|363773586|FG005|Part 2|Protocol deviation|0|||
105481474|NCT01426789|363773581|FG000|Part 2|Death|0|||
105481475|NCT01426789|363773582|FG001|Part 2|Death|0|||
105481476|NCT01426789|363773583|FG002|Part 2|Death|1|||
105481477|NCT01426789|363773584|FG003|Part 2|Death|0|||
105481478|NCT01426789|363773585|FG004|Part 2|Death|1|||
105481479|NCT01426789|363773586|FG005|Part 2|Death|0|||
105481480|NCT01426789|363773581|FG000|Part 2|Administrative problems|0|||
105481481|NCT01426789|363773582|FG001|Part 2|Administrative problems|0|||
105481482|NCT01426789|363773583|FG002|Part 2|Administrative problems|2|||
105481483|NCT01426789|363773584|FG003|Part 2|Administrative problems|0|||
105481484|NCT01426789|363773585|FG004|Part 2|Administrative problems|1|||
105481485|NCT01426789|363773586|FG005|Part 2|Administrative problems|0|||
105481486|NCT01426789|363773581|FG000|Part 2|Lost to Follow-up|0|||
105481487|NCT01426789|363773582|FG001|Part 2|Lost to Follow-up|0|||
105481488|NCT01426789|363773583|FG002|Part 2|Lost to Follow-up|4|||
105481489|NCT01426789|363773584|FG003|Part 2|Lost to Follow-up|0|||
105481490|NCT01426789|363773585|FG004|Part 2|Lost to Follow-up|1|||
105481491|NCT01426789|363773586|FG005|Part 2|Lost to Follow-up|0|||
105481492|NCT01426789|363773581|FG000|Part 2|Withdrawal by Subject|0|||
105481493|NCT01426789|363773582|FG001|Part 2|Withdrawal by Subject|0|||
105481494|NCT01426789|363773583|FG002|Part 2|Withdrawal by Subject|0|||
105481495|NCT01426789|363773584|FG003|Part 2|Withdrawal by Subject|1|||
105481496|NCT01426789|363773585|FG004|Part 2|Withdrawal by Subject|2|||
105481497|NCT01426789|363773586|FG005|Part 2|Withdrawal by Subject|0|||
105481498|NCT01426789|363773581|FG000|Part 2|Lack of Efficacy|0|||
105481499|NCT01426789|363773582|FG001|Part 2|Lack of Efficacy|0|||
105481500|NCT01426789|363773583|FG002|Part 2|Lack of Efficacy|5|||
105481501|NCT01426789|363773584|FG003|Part 2|Lack of Efficacy|0|||
105481502|NCT01426789|363773585|FG004|Part 2|Lack of Efficacy|2|||
105481503|NCT01426789|363773586|FG005|Part 2|Lack of Efficacy|0|||
105481504|NCT01426789|363773581|FG000|Part 2|Adverse Event|0|||
105481505|NCT01426789|363773582|FG001|Part 2|Adverse Event|0|||
105481506|NCT01426789|363773583|FG002|Part 2|Adverse Event|2|||
105481507|NCT01426789|363773584|FG003|Part 2|Adverse Event|0|||
105481508|NCT01426789|363773585|FG004|Part 2|Adverse Event|1|||
105481509|NCT01426789|363773586|FG005|Part 2|Adverse Event|0|||
105481510|NCT01227629|363773588|FG000|Overall Study|Adverse Event|2|||
105481511|NCT01227629|363773589|FG001|Overall Study|Adverse Event|2|||
105481512|NCT01227629|363773590|FG002|Overall Study|Adverse Event|1|||
105481513|NCT01227629|363773591|FG003|Overall Study|Adverse Event|6|||
105481514|NCT01227629|363773592|FG004|Overall Study|Adverse Event|1|||
105481515|NCT01227629|363773593|FG005|Overall Study|Adverse Event|1|||
105481516|NCT01227629|363773594|FG006|Overall Study|Adverse Event|6|||
105481517|NCT01227629|363773595|FG007|Overall Study|Adverse Event|6|||
105481518|NCT01227629|363773596|FG008|Overall Study|Adverse Event|4|||
105481519|NCT01227629|363773597|FG009|Overall Study|Adverse Event|0|||
105481520|NCT01227629|363773588|FG000|Overall Study|Protocol Violation|0|||
105481521|NCT01227629|363773589|FG001|Overall Study|Protocol Violation|0|||
105481522|NCT01227629|363773590|FG002|Overall Study|Protocol Violation|0|||
105737542|NCT01765764|364694777|FG001|Treatment Period|Adverse Event|2|||
105481523|NCT01227629|363773591|FG003|Overall Study|Protocol Violation|1|||
105481524|NCT01227629|363773592|FG004|Overall Study|Protocol Violation|0|||
105481525|NCT01227629|363773593|FG005|Overall Study|Protocol Violation|0|||
105481526|NCT01227629|363773594|FG006|Overall Study|Protocol Violation|0|||
105481527|NCT01227629|363773595|FG007|Overall Study|Protocol Violation|0|||
105737543|NCT01765764|364694778|FG002|Treatment Period|Adverse Event|1|||
105481528|NCT01227629|363773596|FG008|Overall Study|Protocol Violation|0|||
105481529|NCT01227629|363773597|FG009|Overall Study|Protocol Violation|0|||
105481530|NCT01227629|363773588|FG000|Overall Study|Lost to Follow-up|0|||
105481531|NCT01227629|363773589|FG001|Overall Study|Lost to Follow-up|0|||
105481532|NCT01227629|363773590|FG002|Overall Study|Lost to Follow-up|0|||
105481533|NCT01227629|363773591|FG003|Overall Study|Lost to Follow-up|0|||
105481534|NCT01227629|363773592|FG004|Overall Study|Lost to Follow-up|1|||
105481535|NCT01227629|363773593|FG005|Overall Study|Lost to Follow-up|0|||
105481536|NCT01227629|363773594|FG006|Overall Study|Lost to Follow-up|0|||
105481537|NCT01227629|363773595|FG007|Overall Study|Lost to Follow-up|0|||
105481538|NCT01227629|363773596|FG008|Overall Study|Lost to Follow-up|0|||
105481539|NCT01227629|363773597|FG009|Overall Study|Lost to Follow-up|0|||
105737544|NCT01765764|364694776|FG000|Treatment Period|Lost to Follow-up|0|||
105737545|NCT01765764|364694777|FG001|Treatment Period|Lost to Follow-up|3|||
105737546|NCT01765764|364694778|FG002|Treatment Period|Lost to Follow-up|2|||
105737547|NCT01765764|364694776|FG000|Treatment Period|Personal Reasons|1|||
105737548|NCT01765764|364694777|FG001|Treatment Period|Personal Reasons|2|||
105737549|NCT01765764|364694778|FG002|Treatment Period|Personal Reasons|1|||
105737550|NCT01765764|364694776|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
105737551|NCT01765764|364694777|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
105737552|NCT01765764|364694778|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
105737553|NCT00916721|364694779|FG000|Overall Study|Lost to Follow-up|0|||
105737554|NCT00916721|364694780|FG001|Overall Study|Lost to Follow-up|1|||
105737555|NCT00916721|364694779|FG000|Overall Study|Adverse Event|6|||
105737556|NCT00916721|364694780|FG001|Overall Study|Adverse Event|3|||
105737557|NCT00916721|364694779|FG000|Overall Study|Withdrawal by Subject|2|||
105737558|NCT00916721|364694780|FG001|Overall Study|Withdrawal by Subject|2|||
105737559|NCT00916721|364694779|FG000|Overall Study|Protocol Violation|2|||
105737560|NCT00916721|364694780|FG001|Overall Study|Protocol Violation|4|||
105737561|NCT00839098|364694783|FG000|Overall Study|Withdrawal by Subject|2|||
105737562|NCT00839098|364694784|FG001|Overall Study|Withdrawal by Subject|1|||
105737563|NCT00839098|364694785|FG002|Overall Study|Withdrawal by Subject|7|||
105737564|NCT00365976|364694788|FG000|Overall Study|Withdrawal by Subject|1|||
105737565|NCT00365976|364694789|FG001|Overall Study|Withdrawal by Subject|5|||
105737566|NCT00336492|364694790|FG000|Overall Study|Adverse Event|4|||
105737567|NCT00336492|364694791|FG001|Overall Study|Adverse Event|3|||
105737568|NCT00336492|364694792|FG002|Overall Study|Adverse Event|6|||
105737569|NCT00336492|364694790|FG000|Overall Study|Lack of Efficacy|6|||
105737570|NCT00336492|364694791|FG001|Overall Study|Lack of Efficacy|1|||
105737571|NCT00336492|364694792|FG002|Overall Study|Lack of Efficacy|4|||
105737572|NCT00336492|364694790|FG000|Overall Study|Other|5|||
105737573|NCT00336492|364694791|FG001|Overall Study|Other|0|||
105737574|NCT00336492|364694792|FG002|Overall Study|Other|1|||
105737575|NCT01781026|364694795|FG000|Overall Study|Lack of Efficacy|2|||
105737576|NCT03123939|364694799|FG000|Overall Study|Lack of Efficacy|6|||
105737577|NCT03123939|364694799|FG000|Overall Study|Death|5|||
105737578|NCT03123939|364694799|FG000|Overall Study|Physician Decision|2|||
105737579|NCT03123939|364694799|FG000|Overall Study|Subject/guardian decision|2|||
105737580|NCT03123939|364694799|FG000|Overall Study|Lost to Follow-up|1|||
105737581|NCT03123939|364694799|FG000|Overall Study|New therapy for study indication|1|||
105737582|NCT03123939|364694799|FG000|Overall Study|Protocol deviation|1|||
105737583|NCT03123939|364694799|FG000|Overall Study|Progressive disease|18|||
105737584|NCT03123939|364694799|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
105737585|NCT03123939|364694799|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
105737586|NCT01991977|364696700|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
105737587|NCT01991977|364696700|FG000|Overall Study|Withdrew after start of treatment|5|||
105737588|NCT02699515|364696707|FG000|Overall Study|Death|3|||
105737589|NCT02699515|364696708|FG001|Overall Study|Death|3|||
105737590|NCT02699515|364696709|FG002|Overall Study|Death|3|||
105737591|NCT02699515|364696710|FG003|Overall Study|Death|23|||
105737592|NCT02699515|364696711|FG004|Overall Study|Death|22|||
105737593|NCT02699515|364696712|FG005|Overall Study|Death|23|||
105737594|NCT02699515|364696713|FG006|Overall Study|Death|3|||
105737595|NCT02699515|364696714|FG007|Overall Study|Death|5|||
105355539|NCT02557516|363306199|FG000|Overall Study|Sponsor decision|0|||
105355540|NCT02557516|363306200|FG001|Overall Study|Sponsor decision|1|||
105737596|NCT02699515|364696707|FG000|Overall Study|Withdrawal by Subject|0|||
105737597|NCT02699515|364696708|FG001|Overall Study|Withdrawal by Subject|0|||
105737598|NCT02699515|364696709|FG002|Overall Study|Withdrawal by Subject|3|||
105737599|NCT02699515|364696710|FG003|Overall Study|Withdrawal by Subject|1|||
105737600|NCT02699515|364696711|FG004|Overall Study|Withdrawal by Subject|5|||
105737601|NCT02699515|364696712|FG005|Overall Study|Withdrawal by Subject|3|||
105737602|NCT02699515|364696713|FG006|Overall Study|Withdrawal by Subject|0|||
105737603|NCT02699515|364696714|FG007|Overall Study|Withdrawal by Subject|1|||
105737604|NCT02699515|364696707|FG000|Overall Study|Other|1|||
105737605|NCT02699515|364696708|FG001|Overall Study|Other|0|||
105737606|NCT02699515|364696709|FG002|Overall Study|Other|1|||
105737607|NCT02699515|364696710|FG003|Overall Study|Other|6|||
105737608|NCT02699515|364696711|FG004|Overall Study|Other|4|||
105737609|NCT02699515|364696712|FG005|Overall Study|Other|3|||
105481540|NCT01227629|363773588|FG000|Overall Study|Withdrawal by Subject|0|||
105481541|NCT01227629|363773589|FG001|Overall Study|Withdrawal by Subject|0|||
105481542|NCT01227629|363773590|FG002|Overall Study|Withdrawal by Subject|0|||
105481543|NCT01227629|363773591|FG003|Overall Study|Withdrawal by Subject|0|||
105481544|NCT01227629|363773592|FG004|Overall Study|Withdrawal by Subject|0|||
105481545|NCT01227629|363773593|FG005|Overall Study|Withdrawal by Subject|0|||
105481546|NCT01227629|363773594|FG006|Overall Study|Withdrawal by Subject|2|||
105737610|NCT02699515|364696713|FG006|Overall Study|Other|0|||
105355541|NCT02557516|363306201|FG002|Overall Study|Sponsor decision|2|||
105355542|NCT02557516|363306202|FG003|Overall Study|Sponsor decision|8|||
105355543|NCT05645432|363306203|FG000|Overall Study|Withdrawal by Subject|1|||
105355544|NCT01243177|363306204|FG000|Overall Study|Lack of Efficacy|47|||
105355545|NCT01243177|363306205|FG001|Overall Study|Lack of Efficacy|31|||
105355546|NCT01243177|363306204|FG000|Overall Study|Protocol Violation|11|||
105355547|NCT01243177|363306205|FG001|Overall Study|Protocol Violation|10|||
105355548|NCT01243177|363306204|FG000|Overall Study|Lost to Follow-up|15|||
105355549|NCT01243177|363306205|FG001|Overall Study|Lost to Follow-up|18|||
105355550|NCT01243177|363306204|FG000|Overall Study|Withdrawal by Subject|46|||
105481547|NCT01227629|363773595|FG007|Overall Study|Withdrawal by Subject|0|||
105481548|NCT01227629|363773596|FG008|Overall Study|Withdrawal by Subject|0|||
105737611|NCT02699515|364696714|FG007|Overall Study|Other|0|||
105737612|NCT00375934|364696717|FG000|Overall Study|Adverse Event|1|||
105737613|NCT00375934|364696718|FG001|Overall Study|Adverse Event|1|||
105737614|NCT00375934|364696717|FG000|Overall Study|Withdrawal by Subject|2|||
105737615|NCT00375934|364696718|FG001|Overall Study|Withdrawal by Subject|2|||
105737616|NCT00375934|364696717|FG000|Overall Study|Lack of Efficacy|0|||
105737617|NCT00375934|364696718|FG001|Overall Study|Lack of Efficacy|2|||
105737618|NCT00375934|364696717|FG000|Overall Study|Physician Decision|0|||
105737619|NCT00375934|364696718|FG001|Overall Study|Physician Decision|1|||
105737620|NCT02452970|364696719|FG000|Overall Study|Adverse Event|1|||
105737621|NCT03953898|364696720|FG000|Overall Study|Lack of Efficacy|8|||
105737622|NCT03953898|364696720|FG000|Overall Study|Death|3|||
105355551|NCT01243177|363306205|FG001|Overall Study|Withdrawal by Subject|38|||
105737623|NCT03953898|364696720|FG000|Overall Study|Withdrawal by Subject|2|||
105355552|NCT01243177|363306204|FG000|Overall Study|AE, serious fatal|0|||
105355553|NCT01243177|363306205|FG001|Overall Study|AE, serious fatal|1|||
105355554|NCT01243177|363306204|FG000|Overall Study|SAE, non-fatal|7|||
105481549|NCT01227629|363773597|FG009|Overall Study|Withdrawal by Subject|1|||
105737624|NCT03953898|364696720|FG000|Overall Study|Adverse Event|1|||
105355555|NCT01243177|363306205|FG001|Overall Study|SAE, non-fatal|9|||
105737625|NCT04359823|364696721|FG000|Overall Study|Lost to Follow-up|0|||
105737626|NCT04359823|364696722|FG001|Overall Study|Lost to Follow-up|1|||
105737627|NCT04359823|364696721|FG000|Overall Study|Withdrawal by Subject|0|||
105355556|NCT01243177|363306204|FG000|Overall Study|AE, non-serious non-fatal|40|||
105355557|NCT01243177|363306205|FG001|Overall Study|AE, non-serious non-fatal|58|||
105355558|NCT01243177|363306204|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
105355559|NCT01243177|363306205|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
105355560|NCT01243177|363306204|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
105355561|NCT01243177|363306205|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
105355562|NCT01243177|363306204|FG000|Overall Study|Other Reason|11|||
105355563|NCT01243177|363306205|FG001|Overall Study|Other Reason|12|||
105355564|NCT01317004|363307657|FG000|Overall Study|Withdrawal by Subject|1|||
105355565|NCT01317004|363307658|FG001|Overall Study|Withdrawal by Subject|4|||
105355566|NCT01317004|363307657|FG000|Overall Study|Protocol Violation|0|||
105355567|NCT01317004|363307658|FG001|Overall Study|Protocol Violation|2|||
105355568|NCT01317004|363307657|FG000|Overall Study|Adverse Event|3|||
105355569|NCT01317004|363307658|FG001|Overall Study|Adverse Event|3|||
105355570|NCT01859949|363307660|FG000|Overall Study|Family Matters|0|||
105355571|NCT01859949|363307661|FG001|Overall Study|Family Matters|1|||
105355572|NCT01859949|363307660|FG000|Overall Study|Physician Decision|2|||
105355573|NCT01859949|363307661|FG001|Overall Study|Physician Decision|4|||
105355574|NCT01859949|363307660|FG000|Overall Study|Withdrawal by Subject|11|||
105355575|NCT01859949|363307661|FG001|Overall Study|Withdrawal by Subject|10|||
105355576|NCT01859949|363307660|FG000|Overall Study|Protocol Violation|1|||
105355577|NCT01859949|363307661|FG001|Overall Study|Protocol Violation|1|||
105355578|NCT01859949|363307660|FG000|Overall Study|Adverse Event|0|||
105355579|NCT01859949|363307661|FG001|Overall Study|Adverse Event|1|||
105355580|NCT01890759|363307662|FG000|Overall Study|Protocol Violation|0|||
105355581|NCT01890759|363307663|FG001|Overall Study|Protocol Violation|2|||
105355582|NCT01890759|363307662|FG000|Overall Study|Lost to Follow-up|0|||
105355583|NCT01890759|363307663|FG001|Overall Study|Lost to Follow-up|2|||
105355584|NCT01890759|363307662|FG000|Overall Study|Withdrawal by Subject|2|||
105355585|NCT01890759|363307663|FG001|Overall Study|Withdrawal by Subject|8|||
105355586|NCT00398216|363307664|FG000|Overall Study|Adverse Event|4|||
105355587|NCT00398216|363307665|FG001|Overall Study|Adverse Event|2|||
105355588|NCT00398216|363307666|FG002|Overall Study|Adverse Event|5|||
105355589|NCT00398216|363307667|FG003|Overall Study|Adverse Event|7|||
105355590|NCT00398216|363307668|FG004|Overall Study|Adverse Event|2|||
105355591|NCT00398216|363307664|FG000|Overall Study|Protocol Violation|2|||
105355592|NCT00398216|363307665|FG001|Overall Study|Protocol Violation|4|||
105355593|NCT00398216|363307666|FG002|Overall Study|Protocol Violation|5|||
105355594|NCT00398216|363307667|FG003|Overall Study|Protocol Violation|7|||
105355595|NCT00398216|363307668|FG004|Overall Study|Protocol Violation|5|||
105355596|NCT00398216|363307664|FG000|Overall Study|Lost to Follow-up|1|||
105355597|NCT00398216|363307665|FG001|Overall Study|Lost to Follow-up|6|||
105355598|NCT00398216|363307666|FG002|Overall Study|Lost to Follow-up|4|||
105355599|NCT00398216|363307667|FG003|Overall Study|Lost to Follow-up|4|||
105355600|NCT00398216|363307668|FG004|Overall Study|Lost to Follow-up|1|||
105355601|NCT00398216|363307664|FG000|Overall Study|Death|0|||
105355602|NCT00398216|363307665|FG001|Overall Study|Death|3|||
105355603|NCT00398216|363307666|FG002|Overall Study|Death|0|||
105355604|NCT00398216|363307667|FG003|Overall Study|Death|0|||
105355605|NCT00398216|363307668|FG004|Overall Study|Death|0|||
105355606|NCT00398216|363307664|FG000|Overall Study|Withdrawal by Subject|1|||
105737628|NCT04359823|364696722|FG001|Overall Study|Withdrawal by Subject|1|||
105737629|NCT02531035|364696723|FG000|Overall Study|Death|0|||
105355607|NCT00398216|363307665|FG001|Overall Study|Withdrawal by Subject|0|||
105355608|NCT00398216|363307666|FG002|Overall Study|Withdrawal by Subject|3|||
105355609|NCT00398216|363307667|FG003|Overall Study|Withdrawal by Subject|1|||
105355610|NCT00398216|363307668|FG004|Overall Study|Withdrawal by Subject|2|||
105355611|NCT00398216|363307664|FG000|Overall Study|administrative reasons|3|||
105481550|NCT01227629|363773588|FG000|Overall Study|Other|0|||
105355612|NCT00398216|363307665|FG001|Overall Study|administrative reasons|4|||
105355613|NCT00398216|363307666|FG002|Overall Study|administrative reasons|4|||
105355614|NCT00398216|363307667|FG003|Overall Study|administrative reasons|3|||
105355615|NCT00398216|363307668|FG004|Overall Study|administrative reasons|3|||
105355616|NCT00398216|363307664|FG000|Overall Study|entrance criteria|0|||
105355617|NCT00398216|363307665|FG001|Overall Study|entrance criteria|0|||
105355618|NCT00398216|363307666|FG002|Overall Study|entrance criteria|0|||
105355619|NCT00398216|363307667|FG003|Overall Study|entrance criteria|0|||
105355620|NCT00398216|363307668|FG004|Overall Study|entrance criteria|2|||
105355621|NCT00410072|363307671|FG000|Day 1 to Week 48|Adverse Event|1|||
105355622|NCT00410072|363307672|FG001|Day 1 to Week 48|Adverse Event|2|||
105355623|NCT00410072|363307671|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
105355624|NCT00410072|363307672|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
105355625|NCT00410072|363307671|FG000|Day 1 to Week 48|Other|0|||
105355626|NCT00410072|363307672|FG001|Day 1 to Week 48|Other|1|||
105481551|NCT01227629|363773589|FG001|Overall Study|Other|0|||
105481552|NCT01227629|363773590|FG002|Overall Study|Other|0|||
105737630|NCT02531035|364696724|FG001|Overall Study|Death|1|||
105737631|NCT02531035|364696723|FG000|Overall Study|Protocol Violation|1|||
105737632|NCT02531035|364696724|FG001|Overall Study|Protocol Violation|1|||
105737633|NCT02531035|364696723|FG000|Overall Study|Noncompliance with study drug|8|||
105737634|NCT02531035|364696724|FG001|Overall Study|Noncompliance with study drug|3|||
105737635|NCT02531035|364696723|FG000|Overall Study|Physician Decision|1|||
105737636|NCT02531035|364696724|FG001|Overall Study|Physician Decision|0|||
105737637|NCT02531035|364696723|FG000|Overall Study|Adverse Event|16|||
105737638|NCT02531035|364696724|FG001|Overall Study|Adverse Event|45|||
105737639|NCT02531035|364696723|FG000|Overall Study|Other|3|||
105737640|NCT02531035|364696724|FG001|Overall Study|Other|2|||
105737641|NCT02531035|364696723|FG000|Overall Study|Withdrawal by Subject|42|||
105737642|NCT02531035|364696724|FG001|Overall Study|Withdrawal by Subject|32|||
105737643|NCT02531035|364696723|FG000|Overall Study|Lost to Follow-up|8|||
105737644|NCT02531035|364696724|FG001|Overall Study|Lost to Follow-up|10|||
105737645|NCT02531035|364696723|FG000|Overall Study|Randomized, not treated|2|||
105737646|NCT02531035|364696724|FG001|Overall Study|Randomized, not treated|1|||
105737647|NCT04168645|364696729|FG000|Overall Study|Lost to Follow-up|23|||
105737648|NCT04168645|364696730|FG001|Overall Study|Lost to Follow-up|28|||
105737649|NCT04168645|364696731|FG002|Overall Study|Lost to Follow-up|15|||
105737650|NCT04168645|364696732|FG003|Overall Study|Lost to Follow-up|12|||
105737651|NCT04168645|364696729|FG000|Overall Study|Death|1|||
105737652|NCT04168645|364696730|FG001|Overall Study|Death|1|||
105737653|NCT04168645|364696731|FG002|Overall Study|Death|0|||
105737654|NCT04168645|364696732|FG003|Overall Study|Death|0|||
105737655|NCT04168645|364696729|FG000|Overall Study|Withdrawal by Subject|5|||
105737656|NCT04168645|364696730|FG001|Overall Study|Withdrawal by Subject|2|||
105737657|NCT04168645|364696731|FG002|Overall Study|Withdrawal by Subject|2|||
105737658|NCT04168645|364696732|FG003|Overall Study|Withdrawal by Subject|2|||
105737659|NCT04168645|364696729|FG000|Overall Study|Administrative Withdrawal|3|||
105737660|NCT04168645|364696730|FG001|Overall Study|Administrative Withdrawal|1|||
105737661|NCT04168645|364696731|FG002|Overall Study|Administrative Withdrawal|1|||
105737662|NCT04168645|364696732|FG003|Overall Study|Administrative Withdrawal|3|||
105737663|NCT03032068|364696743|FG000|Overall Study|Adverse Event|1|||
105737664|NCT03132805|364696746|FG000|Overall Study|Lost to Follow-up|142|||
105355627|NCT00410072|363307671|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
105355628|NCT00410072|363307672|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
105355629|NCT00410072|363307671|FG000|Day 1 to Week 48|Pregnancy|0|||
105481553|NCT01227629|363773591|FG003|Overall Study|Other|1|||
105737665|NCT03132805|364696747|FG001|Overall Study|Lost to Follow-up|141|||
105737666|NCT03132805|364696748|FG002|Overall Study|Lost to Follow-up|113|||
105737667|NCT00710034|364696749|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
105737668|NCT00710034|364696750|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
105355630|NCT00410072|363307672|FG001|Day 1 to Week 48|Pregnancy|2|||
105355631|NCT00410072|363307671|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
105481554|NCT01227629|363773592|FG004|Overall Study|Other|0|||
105481555|NCT01227629|363773593|FG005|Overall Study|Other|0|||
105355632|NCT00410072|363307672|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
105355633|NCT00410072|363307671|FG000|After Week 48 to Week 96|Adverse Event|1|||
105355634|NCT00410072|363307672|FG001|After Week 48 to Week 96|Adverse Event|2|||
105355635|NCT00410072|363307671|FG000|After Week 48 to Week 96|Death|0|||
105355636|NCT00410072|363307672|FG001|After Week 48 to Week 96|Death|1|||
105355637|NCT00410072|363307671|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
105355638|NCT00410072|363307672|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
105355639|NCT00410072|363307671|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
105355640|NCT00410072|363307672|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
105355641|NCT00410072|363307671|FG000|After Week 48 to Week 96|Other|2|||
105355642|NCT00410072|363307672|FG001|After Week 48 to Week 96|Other|0|||
105355643|NCT00410072|363307671|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
105355644|NCT00410072|363307672|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
105355645|NCT00410072|363307671|FG000|After Week 48 to Week 96|Pregnancy|0|||
105355646|NCT00410072|363307672|FG001|After Week 48 to Week 96|Pregnancy|2|||
105355647|NCT00410072|363307671|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
105355648|NCT00410072|363307672|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
105355649|NCT01048944|363307673|FG000|Overall Study|Protocol Violation|8|||
105355650|NCT01048944|363307674|FG001|Overall Study|Protocol Violation|10|||
105355651|NCT01048944|363307675|FG002|Overall Study|Protocol Violation|10|||
105355652|NCT01048944|363307676|FG003|Overall Study|Protocol Violation|2|||
105737669|NCT00710034|364696749|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
105737670|NCT00710034|364696750|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
105737671|NCT00710034|364696749|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
105737672|NCT00710034|364696750|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
105737673|NCT00710034|364696749|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
105737674|NCT00710034|364696750|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
105737675|NCT00710034|364696749|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
105737676|NCT00710034|364696750|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
105737677|NCT00710034|364696749|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
105737678|NCT00710034|364696750|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
105737679|NCT00710034|364696749|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
105737680|NCT00710034|364696750|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
105737681|NCT00710034|364696749|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
105737682|NCT00710034|364696750|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
105737683|NCT00710034|364696749|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
105737684|NCT00710034|364696750|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
105737685|NCT00710034|364696749|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
105737686|NCT00710034|364696750|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
105737687|NCT00710034|364696749|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
105737688|NCT00710034|364696750|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
105737689|NCT03918642|364696751|FG000|Overall Study|Lost to Follow-up|12|||
105737690|NCT03918642|364696752|FG001|Overall Study|Lost to Follow-up|10|||
105737691|NCT01283581|364696753|FG000|Overall Study|Lost to Follow-up|8|||
105737692|NCT01283581|364696754|FG001|Overall Study|Lost to Follow-up|6|||
105737693|NCT01283581|364696755|FG002|Overall Study|Lost to Follow-up|8|||
105737694|NCT01283581|364696753|FG000|Overall Study|Withdrawal by Subject|2|||
105737695|NCT01283581|364696754|FG001|Overall Study|Withdrawal by Subject|5|||
105737696|NCT01283581|364696755|FG002|Overall Study|Withdrawal by Subject|2|||
105737697|NCT01283581|364696753|FG000|Overall Study|Adverse Event|1|||
105737698|NCT01283581|364696754|FG001|Overall Study|Adverse Event|1|||
105737699|NCT01283581|364696755|FG002|Overall Study|Adverse Event|4|||
105737700|NCT01283581|364696753|FG000|Overall Study|Physician Decision|0|||
105737701|NCT01283581|364696754|FG001|Overall Study|Physician Decision|1|||
105737702|NCT01283581|364696755|FG002|Overall Study|Physician Decision|2|||
105737703|NCT01283581|364696753|FG000|Overall Study|Protocol Violation|0|||
105737704|NCT01283581|364696754|FG001|Overall Study|Protocol Violation|1|||
105737705|NCT01283581|364696755|FG002|Overall Study|Protocol Violation|2|||
105737706|NCT01283581|364696753|FG000|Overall Study|Noncompliance|1|||
105799446|NCT01325532|364924590|FG000|Overall Study|Withdrawal by Subject|2|||
105799447|NCT01325532|364924591|FG001|Overall Study|Withdrawal by Subject|0|||
105355653|NCT00376532|363307677|FG000|Overall Study|Lack sufficient blood sample|6|||
105355654|NCT00376532|363307678|FG001|Overall Study|Lack sufficient blood sample|6|||
105355655|NCT02207400|363307679|FG000|Overall Study|Adverse Event|1|||
105355656|NCT02207400|363307680|FG001|Overall Study|Adverse Event|1|||
105355657|NCT02207400|363307679|FG000|Overall Study|Lost to Follow-up|6|||
105799448|NCT03012815|364924592|FG000|Overall Study|Lost to Follow-up|1|||
105355658|NCT02207400|363307680|FG001|Overall Study|Lost to Follow-up|7|||
105355659|NCT02207400|363307679|FG000|Overall Study|Protocol Violation|1|||
105737707|NCT01283581|364696754|FG001|Overall Study|Noncompliance|0|||
105737708|NCT01283581|364696755|FG002|Overall Study|Noncompliance|0|||
105799449|NCT03012815|364924593|FG001|Overall Study|Lost to Follow-up|0|||
105799450|NCT03012815|364924592|FG000|Overall Study|Physician Decision|3|||
105355660|NCT02207400|363307680|FG001|Overall Study|Protocol Violation|1|||
105355661|NCT02207400|363307679|FG000|Overall Study|Withdrawal by Subject|8|||
105355662|NCT02207400|363307680|FG001|Overall Study|Withdrawal by Subject|4|||
105355663|NCT02207400|363307679|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
105355664|NCT02207400|363307680|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
105355665|NCT02849704|363307684|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
105355666|NCT02849704|363307685|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
105355667|NCT02849704|363307684|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
105355668|NCT02849704|363307685|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
105355669|NCT02849704|363307684|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
105355670|NCT02849704|363307685|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
105355671|NCT01471444|363307686|FG000|Overall Study|Physician Decision|3|||
105355672|NCT01471444|363307687|FG001|Overall Study|Physician Decision|2|||
105355673|NCT01471444|363307686|FG000|Overall Study|Withdrawal by Subject|0|||
105355674|NCT01471444|363307687|FG001|Overall Study|Withdrawal by Subject|1|||
105355675|NCT03251482|363307688|FG000|Overall Study|Withdrawal by Subject|0|||
105355676|NCT03251482|363307689|FG001|Overall Study|Withdrawal by Subject|1|||
105355677|NCT03251482|363307690|FG002|Overall Study|Withdrawal by Subject|0|||
105355678|NCT03251482|363307691|FG003|Overall Study|Withdrawal by Subject|0|||
105355679|NCT03251482|363307692|FG004|Overall Study|Withdrawal by Subject|0|||
105355680|NCT02107313|363307699|FG000|Overall Study|One participant did not do the FED cohor|0|||
105481556|NCT01227629|363773594|FG006|Overall Study|Other|0|||
105737709|NCT01283581|364696753|FG000|Overall Study|Investigator unblinded|0|||
105737710|NCT01283581|364696754|FG001|Overall Study|Investigator unblinded|0|||
105737711|NCT01283581|364696755|FG002|Overall Study|Investigator unblinded|1|||
105737712|NCT01283581|364696753|FG000|Overall Study|"Early termination"|0|||
105737713|NCT01283581|364696754|FG001|Overall Study|"Early termination"|0|||
105737714|NCT01283581|364696755|FG002|Overall Study|"Early termination"|1|||
105737715|NCT00486226|364696756|FG000|Overall Study|Death|3|||
105737716|NCT00486226|364696756|FG000|Overall Study|Adverse Event|1|||
105737717|NCT00486226|364696756|FG000|Overall Study|Withdrawal by Subject|1|||
105737718|NCT00486226|364696756|FG000|Overall Study|Lost to Follow-up|8|||
105737719|NCT01259492|364696762|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
105737720|NCT01259492|364696763|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
105737721|NCT01259492|364696764|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
105737722|NCT01259492|364696765|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
105737723|NCT01259492|364696762|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
105737724|NCT01259492|364696763|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
105737725|NCT01259492|364696764|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
105737726|NCT01259492|364696765|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
105737727|NCT01259492|364696762|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
105737728|NCT01259492|364696763|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
105737729|NCT01259492|364696764|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
105737730|NCT01259492|364696765|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
105737731|NCT01259492|364696762|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
105737732|NCT01259492|364696763|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
105737733|NCT01259492|364696764|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
105737734|NCT01259492|364696765|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
105737735|NCT01259492|364696762|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
105355681|NCT02107313|363307700|FG001|Overall Study|One participant did not do the FED cohor|1|||
105355682|NCT03026283|363307701|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
105355683|NCT03026283|363307702|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
105737736|NCT01259492|364696763|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
105737737|NCT01259492|364696764|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
105737738|NCT01259492|364696765|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
105737739|NCT01259492|364696762|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
105737740|NCT01259492|364696763|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
105737741|NCT01259492|364696764|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
105737742|NCT01259492|364696765|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
105481557|NCT01227629|363773595|FG007|Overall Study|Other|0|||
105481558|NCT01227629|363773596|FG008|Overall Study|Other|2|||
105481559|NCT01227629|363773597|FG009|Overall Study|Other|1|||
105481560|NCT01258998|363775124|FG000|Overall Study|Ineligible|1|||
105481561|NCT02276027|363775125|FG000|Overall Study|Death|1|||
105481562|NCT02276027|363775126|FG001|Overall Study|Death|0|||
105481563|NCT02276027|363775127|FG002|Overall Study|Death|0|||
105481564|NCT02276027|363775128|FG003|Overall Study|Death|2|||
105481565|NCT02276027|363775125|FG000|Overall Study|Physician Decision|0|||
105481566|NCT02276027|363775126|FG001|Overall Study|Physician Decision|0|||
105481567|NCT02276027|363775127|FG002|Overall Study|Physician Decision|0|||
105481568|NCT02276027|363775128|FG003|Overall Study|Physician Decision|1|||
105481569|NCT02276027|363775125|FG000|Overall Study|Progressive disease|1|||
105481570|NCT02276027|363775126|FG001|Overall Study|Progressive disease|13|||
105481571|NCT02276027|363775127|FG002|Overall Study|Progressive disease|12|||
105481572|NCT02276027|363775128|FG003|Overall Study|Progressive disease|14|||
105481573|NCT02276027|363775125|FG000|Overall Study|Subject/guardian decision|0|||
105481574|NCT02276027|363775126|FG001|Overall Study|Subject/guardian decision|1|||
105481575|NCT02276027|363775127|FG002|Overall Study|Subject/guardian decision|0|||
105481576|NCT02276027|363775128|FG003|Overall Study|Subject/guardian decision|3|||
105481577|NCT02276027|363775125|FG000|Overall Study|Adverse Event|0|||
105481578|NCT02276027|363775126|FG001|Overall Study|Adverse Event|2|||
105481579|NCT02276027|363775127|FG002|Overall Study|Adverse Event|8|||
105737743|NCT01259492|364696762|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
105737744|NCT01259492|364696763|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
105737745|NCT01259492|364696764|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
105737746|NCT01259492|364696765|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
105737747|NCT01259492|364696762|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
105737748|NCT01259492|364696763|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
105737749|NCT01259492|364696764|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
105737750|NCT01259492|364696765|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
105737751|NCT01259492|364696762|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
105737752|NCT01259492|364696763|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
105737753|NCT01259492|364696764|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
105737754|NCT01259492|364696765|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
105737755|NCT01259492|364696762|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
105737756|NCT01259492|364696763|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
105737757|NCT01259492|364696764|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
105737758|NCT01259492|364696765|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
105737759|NCT01259492|364696762|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
105737760|NCT01259492|364696763|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
105737761|NCT01259492|364696764|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
105737762|NCT01259492|364696765|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
105737763|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
105737764|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
105737765|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
105737766|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
105737767|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
105737768|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
105737769|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
105737770|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
105737771|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
105737772|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
105737773|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
105737774|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
105737775|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
105737776|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
105737777|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
105737778|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
105481580|NCT02276027|363775128|FG003|Overall Study|Adverse Event|2|||
105481581|NCT00895011|363775133|FG000|Overall Study|Withdrawal by Subject|14|||
105481582|NCT00895011|363775134|FG001|Overall Study|Withdrawal by Subject|7|||
105481583|NCT00895011|363775135|FG002|Overall Study|Withdrawal by Subject|2|||
105481584|NCT00895011|363775133|FG000|Overall Study|Lost to Follow-up|5|||
105481585|NCT00895011|363775134|FG001|Overall Study|Lost to Follow-up|4|||
105481586|NCT00895011|363775135|FG002|Overall Study|Lost to Follow-up|1|||
105481587|NCT00895011|363775133|FG000|Overall Study|Protocol Violation|3|||
105481588|NCT00895011|363775134|FG001|Overall Study|Protocol Violation|1|||
105481589|NCT00895011|363775135|FG002|Overall Study|Protocol Violation|3|||
105799451|NCT03012815|364924593|FG001|Overall Study|Physician Decision|2|||
105799452|NCT03012815|364924592|FG000|Overall Study|Adverse Event|1|||
105799453|NCT03012815|364924593|FG001|Overall Study|Adverse Event|0|||
105799454|NCT01252238|364924594|FG000|Overall Study|Sponsor terminated study|4|||
105799455|NCT01252238|364924595|FG001|Overall Study|Sponsor terminated study|4|||
105799456|NCT01252238|364924596|FG002|Overall Study|Sponsor terminated study|4|||
105799457|NCT01814137|364924597|FG000|Overall Study|Adverse Event|0|||
105799458|NCT01814137|364924598|FG001|Overall Study|Adverse Event|1|||
105799459|NCT01814137|364924597|FG000|Overall Study|Withdrawal by Subject|2|||
105799460|NCT01814137|364924598|FG001|Overall Study|Withdrawal by Subject|2|||
105799461|NCT01814137|364924597|FG000|Overall Study|Physician Decision|1|||
105799462|NCT01814137|364924598|FG001|Overall Study|Physician Decision|1|||
105799463|NCT01814137|364924597|FG000|Overall Study|Unclassified|2|||
105799464|NCT01814137|364924598|FG001|Overall Study|Unclassified|1|||
105799465|NCT01271933|364924606|FG000|Single-Blind Phase|Lack of Efficacy|37|||
105799466|NCT01271933|364924607|FG001|Single-Blind Phase|Lack of Efficacy|0|||
105799467|NCT01271933|364924608|FG002|Single-Blind Phase|Lack of Efficacy|0|||
105799468|NCT01271933|364924606|FG000|Single-Blind Phase|Lost to Follow-up|10|||
105799469|NCT01271933|364924607|FG001|Single-Blind Phase|Lost to Follow-up|0|||
105799470|NCT01271933|364924608|FG002|Single-Blind Phase|Lost to Follow-up|0|||
105799471|NCT01271933|364924606|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
105799472|NCT01271933|364924607|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
105799473|NCT01271933|364924608|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
105799474|NCT01271933|364924606|FG000|Single-Blind Phase|Protocol Violation|3|||
105799475|NCT01271933|364924607|FG001|Single-Blind Phase|Protocol Violation|0|||
105799476|NCT01271933|364924608|FG002|Single-Blind Phase|Protocol Violation|0|||
105355684|NCT03026283|363307703|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
105355685|NCT03026283|363307704|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
105799477|NCT01271933|364924606|FG000|Single-Blind Phase|Adverse Event|52|||
105737779|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
105737780|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
105799478|NCT01271933|364924607|FG001|Single-Blind Phase|Adverse Event|0|||
105355686|NCT03026283|363307705|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
105355687|NCT03026283|363307706|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
105355688|NCT03026283|363307707|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
105355689|NCT03026283|363307708|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
105355690|NCT03026283|363307701|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
105355691|NCT03026283|363307702|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
105355692|NCT03026283|363307703|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
105355693|NCT03026283|363307704|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
105355694|NCT03026283|363307705|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
105355695|NCT03026283|363307706|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
105355696|NCT03026283|363307707|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
105355697|NCT03026283|363307708|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
105355698|NCT03026283|363307701|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
105355699|NCT03026283|363307702|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
105355700|NCT03026283|363307703|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
105355701|NCT03026283|363307704|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
105355702|NCT03026283|363307705|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
105355703|NCT03026283|363307706|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
105355704|NCT03026283|363307707|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
105355705|NCT03026283|363307708|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
105355706|NCT03026283|363307701|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
105355707|NCT03026283|363307702|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
105355708|NCT03026283|363307703|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
105355709|NCT03026283|363307704|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
105355710|NCT03026283|363307705|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
105355711|NCT03026283|363307706|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
105355712|NCT03026283|363307707|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
105355713|NCT03026283|363307708|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
105355714|NCT03026283|363307701|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
105355715|NCT03026283|363307702|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
105355716|NCT03026283|363307703|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
105355717|NCT03026283|363307704|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
105355718|NCT03026283|363307705|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
105355719|NCT03026283|363307706|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
105355720|NCT03026283|363307707|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
105355721|NCT03026283|363307708|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
105355722|NCT03026283|363307701|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
105355723|NCT03026283|363307702|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
105355724|NCT03026283|363307703|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
105355725|NCT03026283|363307704|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
105355726|NCT03026283|363307705|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
105355727|NCT03026283|363307706|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
105355728|NCT03026283|363307707|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
105481590|NCT00895011|363775133|FG000|Overall Study|Adverse Event|1|||
105481591|NCT00895011|363775134|FG001|Overall Study|Adverse Event|2|||
105481592|NCT00895011|363775135|FG002|Overall Study|Adverse Event|2|||
105799479|NCT01271933|364924608|FG002|Single-Blind Phase|Adverse Event|0|||
105799480|NCT01271933|364924606|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
105799481|NCT01271933|364924607|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
105799482|NCT01271933|364924608|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
105799483|NCT01271933|364924606|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
105799484|NCT01271933|364924607|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
105799485|NCT01271933|364924608|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
105799486|NCT01271933|364924606|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
105799487|NCT01271933|364924607|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
105799488|NCT01271933|364924608|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
105799489|NCT01271933|364924606|FG000|Double-Blind Phase|Randomized but not treated|0|||
105799490|NCT01271933|364924607|FG001|Double-Blind Phase|Randomized but not treated|0|||
105799491|NCT01271933|364924608|FG002|Double-Blind Phase|Randomized but not treated|1|||
105799492|NCT01271933|364924606|FG000|Double-Blind Phase|Lack of Efficacy|0|||
105799493|NCT01271933|364924607|FG001|Double-Blind Phase|Lack of Efficacy|6|||
105799494|NCT01271933|364924608|FG002|Double-Blind Phase|Lack of Efficacy|9|||
105799495|NCT01271933|364924606|FG000|Double-Blind Phase|Lost to Follow-up|0|||
105799496|NCT01271933|364924607|FG001|Double-Blind Phase|Lost to Follow-up|1|||
105799497|NCT01271933|364924608|FG002|Double-Blind Phase|Lost to Follow-up|1|||
105799498|NCT01271933|364924606|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
105799499|NCT01271933|364924607|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
105799500|NCT01271933|364924608|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
105799501|NCT01271933|364924606|FG000|Double-Blind Phase|Adverse Event|0|||
105799502|NCT01271933|364924607|FG001|Double-Blind Phase|Adverse Event|3|||
105799503|NCT01271933|364924608|FG002|Double-Blind Phase|Adverse Event|0|||
105799504|NCT01271933|364924606|FG000|Double-Blind Phase|Participant request-personal reason|0|||
105799505|NCT01271933|364924607|FG001|Double-Blind Phase|Participant request-personal reason|1|||
105355729|NCT03026283|363307708|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
105355730|NCT03026283|363307701|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
105355731|NCT03026283|363307702|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
105355732|NCT03026283|363307703|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
105355733|NCT03026283|363307704|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
105355734|NCT03026283|363307705|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
105355735|NCT03026283|363307706|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
105355736|NCT03026283|363307707|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
105355737|NCT03026283|363307708|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
105355738|NCT03026283|363307701|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
105355739|NCT03026283|363307702|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
105355740|NCT03026283|363307703|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
105355741|NCT03026283|363307704|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
105355742|NCT03026283|363307705|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
105355743|NCT03026283|363307706|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
105799506|NCT01271933|364924608|FG002|Double-Blind Phase|Participant request-personal reason|0|||
105799507|NCT01256398|364924609|FG000|Overall Study|Withdrawal by Subject|1|||
105799508|NCT04380701|364924614|FG000|Overall Study|Pregnancy|0|||
105799509|NCT04380701|364924615|FG001|Overall Study|Pregnancy|0|||
105799510|NCT04380701|364924616|FG002|Overall Study|Pregnancy|0|||
105799511|NCT04380701|364924617|FG003|Overall Study|Pregnancy|0|||
105799512|NCT04380701|364924618|FG004|Overall Study|Pregnancy|0|||
105799513|NCT04380701|364924619|FG005|Overall Study|Pregnancy|0|||
105799514|NCT04380701|364924620|FG006|Overall Study|Pregnancy|0|||
105799515|NCT04380701|364924621|FG007|Overall Study|Pregnancy|0|||
105799516|NCT04380701|364924622|FG008|Overall Study|Pregnancy|0|||
105799517|NCT04380701|364924623|FG009|Overall Study|Pregnancy|0|||
105799518|NCT04380701|364924624|FG010|Overall Study|Pregnancy|0|||
105799519|NCT04380701|364924625|FG011|Overall Study|Pregnancy|0|||
105799520|NCT04380701|364924626|FG012|Overall Study|Pregnancy|0|||
105799521|NCT04380701|364924627|FG013|Overall Study|Pregnancy|0|||
105799522|NCT04380701|364924628|FG014|Overall Study|Pregnancy|0|||
105799523|NCT04380701|364924629|FG015|Overall Study|Pregnancy|0|||
105799524|NCT04380701|364924630|FG016|Overall Study|Pregnancy|0|||
105799525|NCT04380701|364924631|FG017|Overall Study|Pregnancy|0|||
105355744|NCT03026283|363307707|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
105355745|NCT03026283|363307708|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
105355746|NCT03026283|363307701|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
105355747|NCT03026283|363307702|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
105355748|NCT03026283|363307703|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
105799526|NCT04380701|364924632|FG018|Overall Study|Pregnancy|0|||
105799527|NCT04380701|364924633|FG019|Overall Study|Pregnancy|0|||
105799528|NCT04380701|364924634|FG020|Overall Study|Pregnancy|0|||
105799529|NCT04380701|364924635|FG021|Overall Study|Pregnancy|0|||
105799530|NCT04380701|364924636|FG022|Overall Study|Pregnancy|0|||
105799531|NCT04380701|364924637|FG023|Overall Study|Pregnancy|0|||
105481593|NCT00895011|363775133|FG000|Overall Study|schedule conflict|1|||
105481594|NCT00895011|363775134|FG001|Overall Study|schedule conflict|0|||
105481595|NCT00895011|363775135|FG002|Overall Study|schedule conflict|0|||
105481596|NCT01430754|363775136|FG000|Run-In Phase|Circadian Period Ineligible|24|||
105481597|NCT01430754|363775137|FG001|Run-In Phase|Circadian Period Ineligible|0|||
105481598|NCT01430754|363775136|FG000|Run-In Phase|Protocol Violation|6|||
105481599|NCT01430754|363775137|FG001|Run-In Phase|Protocol Violation|0|||
105481600|NCT01430754|363775136|FG000|Run-In Phase|Adverse Event|2|||
105481601|NCT01430754|363775137|FG001|Run-In Phase|Adverse Event|0|||
105481602|NCT01430754|363775136|FG000|Run-In Phase|Other|2|||
105481603|NCT01430754|363775137|FG001|Run-In Phase|Other|0|||
105481604|NCT01430754|363775136|FG000|Run-In Phase|Withdrawal by Subject|2|||
105481605|NCT01430754|363775137|FG001|Run-In Phase|Withdrawal by Subject|0|||
105481606|NCT01430754|363775136|FG000|Run-In Phase|Lost to Follow-up|1|||
105481607|NCT01430754|363775137|FG001|Run-In Phase|Lost to Follow-up|0|||
105481608|NCT01343823|363775138|FG000|Overall Study|Study Terminated|1|||
105481609|NCT01343823|363775139|FG001|Overall Study|Study Terminated|0|||
105481610|NCT01343823|363775140|FG002|Overall Study|Study Terminated|0|||
105481611|NCT01343823|363775141|FG003|Overall Study|Study Terminated|1|||
105481612|NCT01343823|363775138|FG000|Overall Study|Withdrawal by Subject|1|||
105481613|NCT01343823|363775139|FG001|Overall Study|Withdrawal by Subject|0|||
105481614|NCT01343823|363775140|FG002|Overall Study|Withdrawal by Subject|0|||
105481615|NCT01343823|363775141|FG003|Overall Study|Withdrawal by Subject|0|||
105481616|NCT02577887|363775144|FG000|Overall Study|Death|93|||
105481617|NCT02577887|363775144|FG000|Overall Study|Protocol Violation|125|||
105481618|NCT02577887|363775144|FG000|Overall Study|Withdrawal by Subject|80|||
105481619|NCT01958489|363775145|FG000|Period 2|Adverse Event|0|||
105481620|NCT01958489|363775146|FG001|Period 2|Adverse Event|1|||
105481621|NCT00917644|363775147|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
105481622|NCT00917644|363775148|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
105481623|NCT00917644|363775147|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
105481624|NCT00917644|363775148|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
105481625|NCT00917644|363775147|FG000|Period 2: Second Intervention|family emergency|1|||
105481626|NCT00917644|363775148|FG001|Period 2: Second Intervention|family emergency|0|||
105481627|NCT02338232|363775149|FG000|Overall Study|Screen Failure|3|||
105481628|NCT02338232|363775149|FG000|Overall Study|Withdrawal by Subject|6|||
105481629|NCT02338232|363775149|FG000|Overall Study|Adverse Event|2|||
105481630|NCT00713310|363775150|FG000|Overall Study|Adverse Event|5|||
105481631|NCT00713310|363775151|FG001|Overall Study|Adverse Event|2|||
105481632|NCT00713310|363775150|FG000|Overall Study|Lack of Efficacy|0|||
105481633|NCT00713310|363775151|FG001|Overall Study|Lack of Efficacy|2|||
105481634|NCT00713310|363775150|FG000|Overall Study|Withdrawal by Subject|0|||
105481635|NCT00713310|363775151|FG001|Overall Study|Withdrawal by Subject|2|||
105481636|NCT01215916|363775152|FG000|Overall Study|Progressive Disease|0|||
105481637|NCT01215916|363775153|FG001|Overall Study|Progressive Disease|2|||
105481638|NCT01215916|363775154|FG002|Overall Study|Progressive Disease|1|||
105481639|NCT01215916|363775155|FG003|Overall Study|Progressive Disease|2|||
105481640|NCT01215916|363775156|FG004|Overall Study|Progressive Disease|5|||
105481641|NCT01215916|363775157|FG005|Overall Study|Progressive Disease|4|||
105481642|NCT01215916|363775158|FG006|Overall Study|Progressive Disease|5|||
105481643|NCT01215916|363775159|FG007|Overall Study|Progressive Disease|3|||
105481644|NCT01215916|363775160|FG008|Overall Study|Progressive Disease|1|||
105481645|NCT01215916|363775152|FG000|Overall Study|Adverse Event|1|||
105481646|NCT01215916|363775153|FG001|Overall Study|Adverse Event|1|||
105481647|NCT01215916|363775154|FG002|Overall Study|Adverse Event|0|||
105481648|NCT01215916|363775155|FG003|Overall Study|Adverse Event|1|||
105481649|NCT01215916|363775156|FG004|Overall Study|Adverse Event|0|||
105481650|NCT01215916|363775157|FG005|Overall Study|Adverse Event|0|||
105481651|NCT01215916|363775158|FG006|Overall Study|Adverse Event|3|||
105481652|NCT01215916|363775159|FG007|Overall Study|Adverse Event|0|||
105481653|NCT01215916|363775160|FG008|Overall Study|Adverse Event|0|||
105481654|NCT01215916|363775152|FG000|Overall Study|Withdrawal by Subject|0|||
105481655|NCT01215916|363775153|FG001|Overall Study|Withdrawal by Subject|1|||
105481656|NCT01215916|363775154|FG002|Overall Study|Withdrawal by Subject|1|||
105481657|NCT01215916|363775155|FG003|Overall Study|Withdrawal by Subject|2|||
105481658|NCT01215916|363775156|FG004|Overall Study|Withdrawal by Subject|0|||
105481659|NCT01215916|363775157|FG005|Overall Study|Withdrawal by Subject|0|||
105481660|NCT01215916|363775158|FG006|Overall Study|Withdrawal by Subject|1|||
105481661|NCT01215916|363775159|FG007|Overall Study|Withdrawal by Subject|0|||
105481662|NCT01215916|363775160|FG008|Overall Study|Withdrawal by Subject|0|||
105481663|NCT01215916|363775152|FG000|Overall Study|Death|0|||
105481664|NCT01215916|363775153|FG001|Overall Study|Death|1|||
105481665|NCT01215916|363775154|FG002|Overall Study|Death|0|||
105481666|NCT01215916|363775155|FG003|Overall Study|Death|0|||
105481667|NCT01215916|363775156|FG004|Overall Study|Death|1|||
105481668|NCT01215916|363775157|FG005|Overall Study|Death|0|||
105481669|NCT01215916|363775158|FG006|Overall Study|Death|0|||
105481670|NCT01215916|363775159|FG007|Overall Study|Death|0|||
105481671|NCT01215916|363775160|FG008|Overall Study|Death|1|||
105737781|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
105737782|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
105737783|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
105737784|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
105799532|NCT04380701|364924638|FG024|Overall Study|Pregnancy|0|||
105799533|NCT04380701|364924639|FG025|Overall Study|Pregnancy|0|||
105799534|NCT04380701|364924640|FG026|Overall Study|Pregnancy|0|||
105799535|NCT04380701|364924641|FG027|Overall Study|Pregnancy|0|||
105799536|NCT04380701|364924642|FG028|Overall Study|Pregnancy|0|||
105799537|NCT04380701|364924643|FG029|Overall Study|Pregnancy|0|||
105799538|NCT04380701|364924644|FG030|Overall Study|Pregnancy|0|||
105799539|NCT04380701|364924645|FG031|Overall Study|Pregnancy|0|||
105799540|NCT04380701|364924646|FG032|Overall Study|Pregnancy|1|||
105799541|NCT04380701|364924647|FG033|Overall Study|Pregnancy|0|||
105799542|NCT04380701|364924614|FG000|Overall Study|Lost to Follow-up|0|||
105799543|NCT04380701|364924615|FG001|Overall Study|Lost to Follow-up|0|||
105481672|NCT01215916|363775152|FG000|Overall Study|Physician Decision|0|||
105481673|NCT01215916|363775153|FG001|Overall Study|Physician Decision|0|||
105481674|NCT01215916|363775154|FG002|Overall Study|Physician Decision|1|||
105481675|NCT01215916|363775155|FG003|Overall Study|Physician Decision|1|||
105481676|NCT01215916|363775156|FG004|Overall Study|Physician Decision|0|||
105481677|NCT01215916|363775157|FG005|Overall Study|Physician Decision|0|||
105481678|NCT01215916|363775158|FG006|Overall Study|Physician Decision|0|||
105481679|NCT01215916|363775159|FG007|Overall Study|Physician Decision|0|||
105481680|NCT01215916|363775160|FG008|Overall Study|Physician Decision|0|||
105481681|NCT01087736|363775163|FG000|Overall Study|Lost to Follow-up|1|||
105481682|NCT01087736|363775164|FG001|Overall Study|Lost to Follow-up|0|||
105481683|NCT01087736|363775163|FG000|Overall Study|Death|0|||
105481684|NCT01087736|363775164|FG001|Overall Study|Death|1|||
105481685|NCT01087736|363775163|FG000|Overall Study|Withdrawal by Subject|0|||
105481686|NCT01087736|363775164|FG001|Overall Study|Withdrawal by Subject|1|||
105481687|NCT01101308|363775167|FG000|Period 1|Adverse Event|2|||
105481688|NCT01101308|363775168|FG001|Period 1|Adverse Event|1|||
105481689|NCT01101308|363775167|FG000|Period 1|Positive for cotinine|1|||
105481690|NCT01101308|363775168|FG001|Period 1|Positive for cotinine|0|||
105481691|NCT01579812|363775169|FG000|Overall Study|Ineligible after treatment start|40|||
105481692|NCT01579812|363775169|FG000|Overall Study|Patient choice|3|||
105481693|NCT01579812|363775169|FG000|Overall Study|Noncompliance|3|||
105481694|NCT01579812|363775169|FG000|Overall Study|Withdrawal by Subject|6|||
105481695|NCT02282345|363775171|FG000|Overall Study|Progression|0|||
105481696|NCT02282345|363775172|FG001|Overall Study|Progression|1|||
105481697|NCT01185301|363775174|FG000|Overall Study|Adverse Event|3|||
105481698|NCT01185301|363775175|FG001|Overall Study|Adverse Event|0|||
105481699|NCT01185301|363775176|FG002|Overall Study|Adverse Event|2|||
105481700|NCT01185301|363775177|FG003|Overall Study|Adverse Event|3|||
105481701|NCT01185301|363775174|FG000|Overall Study|Withdrawal by Subject|7|||
105481702|NCT01185301|363775175|FG001|Overall Study|Withdrawal by Subject|5|||
105481703|NCT01185301|363775176|FG002|Overall Study|Withdrawal by Subject|2|||
105481704|NCT01185301|363775177|FG003|Overall Study|Withdrawal by Subject|3|||
105481705|NCT01185301|363775174|FG000|Overall Study|Lost to Follow-up|2|||
105481706|NCT01185301|363775175|FG001|Overall Study|Lost to Follow-up|0|||
105481707|NCT01185301|363775176|FG002|Overall Study|Lost to Follow-up|0|||
105481708|NCT01185301|363775177|FG003|Overall Study|Lost to Follow-up|1|||
105737785|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
105737786|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
105737787|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
105737788|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
105737789|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
105737790|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
105737791|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
105737792|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
105737793|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
105737794|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
105737795|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
105737796|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
105737797|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
105737798|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
105737799|NCT01988012|364696778|FG000|Overall Study|Adverse Event|5|||
105737800|NCT01988012|364696778|FG000|Overall Study|Insufficient Therapeutic Response|3|||
105737801|NCT01988012|364696778|FG000|Overall Study|Patient Withdrawal of Consent|4|||
105737802|NCT01988012|364696778|FG000|Overall Study|Lost to Follow-up|1|||
105737803|NCT01988012|364696778|FG000|Overall Study|Physician Decision|1|||
105737804|NCT01988012|364696778|FG000|Overall Study|Protocol Violation|1|||
105481709|NCT01185301|363775174|FG000|Overall Study|Other Reason|3|||
105481710|NCT01185301|363775175|FG001|Overall Study|Other Reason|2|||
105481711|NCT01185301|363775176|FG002|Overall Study|Other Reason|2|||
105481712|NCT01185301|363775177|FG003|Overall Study|Other Reason|2|||
105737805|NCT01058369|364696779|FG000|Overall Study|Adverse Event|1|||
105737806|NCT01058369|364696779|FG000|Overall Study|Early termination study|1|||
105737807|NCT00089843|364696780|FG000|Overall Study|Withdrawal by Subject|1|||
105737808|NCT00089843|364696781|FG001|Overall Study|Withdrawal by Subject|4|||
105799544|NCT04380701|364924616|FG002|Overall Study|Lost to Follow-up|0|||
105481713|NCT02683746|363775178|FG000|Overall Study|Adverse Event|3|||
105481714|NCT02683746|363775179|FG001|Overall Study|Adverse Event|2|||
105481715|NCT02683746|363775178|FG000|Overall Study|Lost to Follow-up|5|||
105481716|NCT02683746|363775179|FG001|Overall Study|Lost to Follow-up|6|||
105481717|NCT02683746|363775178|FG000|Overall Study|Withdrawal by Subject|6|||
105481718|NCT02683746|363775179|FG001|Overall Study|Withdrawal by Subject|5|||
105481719|NCT02683746|363775178|FG000|Overall Study|Physician Decision|2|||
105481720|NCT02683746|363775179|FG001|Overall Study|Physician Decision|1|||
105481721|NCT01743001|363775180|FG000|Overall Study|Physician Decision|1|||
105481722|NCT01743001|363775181|FG001|Overall Study|Physician Decision|0|||
105355749|NCT03026283|363307704|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
105355750|NCT03026283|363307705|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
105355751|NCT03026283|363307706|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
105355752|NCT03026283|363307707|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
105355753|NCT03026283|363307708|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
105355754|NCT01054222|363307713|FG000|Overall Study|Lack of Efficacy|1|||
105355755|NCT01054222|363307713|FG000|Overall Study|Lost to Follow-up|4|||
105355756|NCT01054222|363307713|FG000|Overall Study|Withdrawal by Subject|6|||
105355757|NCT03504189|363307714|FG000|Overall Study|Withdrawal by Subject|1|||
105355758|NCT03504189|363307714|FG000|Overall Study|Screening Failure|1|||
105355759|NCT03504189|363307714|FG000|Overall Study|Device Failure|2|||
105355760|NCT04336475|363307715|FG000|Overall Study|pain|1|||
105355761|NCT04336475|363307716|FG001|Overall Study|pain|0|||
105355762|NCT04336475|363307715|FG000|Overall Study|upper respiratory infection|1|||
105355763|NCT04336475|363307716|FG001|Overall Study|upper respiratory infection|0|||
105355764|NCT04336475|363307715|FG000|Overall Study|Lost to Follow-up|0|||
105355765|NCT04336475|363307716|FG001|Overall Study|Lost to Follow-up|2|||
105355766|NCT00199849|363307721|FG000|Overall Study|Unrelated illness or complication|0|||
105355767|NCT00199849|363307722|FG001|Overall Study|Unrelated illness or complication|1|||
105355768|NCT00199849|363307723|FG002|Overall Study|Unrelated illness or complication|0|||
105355769|NCT00199849|363307721|FG000|Overall Study|Progressive disease requiring intervention|0|||
105355770|NCT00199849|363307722|FG001|Overall Study|Progressive disease requiring intervention|0|||
105355771|NCT00199849|363307723|FG002|Overall Study|Progressive disease requiring intervention|1|||
105355772|NCT00199849|363307721|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
105355773|NCT00199849|363307722|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
105355774|NCT00199849|363307723|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
105737809|NCT00089843|364696782|FG002|Overall Study|Withdrawal by Subject|5|||
105737810|NCT00089843|364696783|FG003|Overall Study|Withdrawal by Subject|6|||
105737811|NCT00089843|364696780|FG000|Overall Study|Physician Decision|1|||
105737812|NCT00089843|364696781|FG001|Overall Study|Physician Decision|0|||
105737813|NCT00089843|364696782|FG002|Overall Study|Physician Decision|0|||
105737814|NCT00089843|364696783|FG003|Overall Study|Physician Decision|1|||
105737815|NCT04003155|364696784|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
105737816|NCT04003155|364696785|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
105737817|NCT04003155|364696786|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
105737818|NCT04003155|364696787|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
105737819|NCT04003155|364696788|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
105737820|NCT04003155|364696784|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
105737821|NCT04003155|364696785|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
105737822|NCT04003155|364696786|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
105737823|NCT04003155|364696787|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
105737824|NCT04003155|364696788|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
105737825|NCT04003155|364696784|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
105737826|NCT04003155|364696785|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
105737827|NCT04003155|364696786|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
105355775|NCT01465230|363307725|FG000|Overall Study|Withdrawal by Subject|2|||
105355776|NCT02542397|363307726|FG000|Overall Study|Death|2|||
105355777|NCT02542397|363307726|FG000|Overall Study|Physician Decision|6|||
105355778|NCT02542397|363307726|FG000|Overall Study|Withdrawal by Subject|6|||
105355779|NCT02542397|363307726|FG000|Overall Study|Lost to Follow-up|2|||
105799545|NCT04380701|364924617|FG003|Overall Study|Lost to Follow-up|0|||
105799546|NCT04380701|364924618|FG004|Overall Study|Lost to Follow-up|0|||
105799547|NCT04380701|364924619|FG005|Overall Study|Lost to Follow-up|0|||
105799548|NCT04380701|364924620|FG006|Overall Study|Lost to Follow-up|0|||
105799549|NCT04380701|364924621|FG007|Overall Study|Lost to Follow-up|0|||
105355780|NCT02532257|363307727|FG000|Overall Study|Adverse Event|2|||
105355781|NCT02532257|363307727|FG000|Overall Study|Physician Decision|4|||
105799550|NCT04380701|364924622|FG008|Overall Study|Lost to Follow-up|0|||
105799551|NCT04380701|364924623|FG009|Overall Study|Lost to Follow-up|0|||
105799552|NCT04380701|364924624|FG010|Overall Study|Lost to Follow-up|0|||
105799553|NCT04380701|364924625|FG011|Overall Study|Lost to Follow-up|0|||
105799554|NCT04380701|364924626|FG012|Overall Study|Lost to Follow-up|0|||
105799555|NCT04380701|364924627|FG013|Overall Study|Lost to Follow-up|0|||
105799556|NCT04380701|364924628|FG014|Overall Study|Lost to Follow-up|0|||
105799557|NCT04380701|364924629|FG015|Overall Study|Lost to Follow-up|0|||
105799558|NCT04380701|364924630|FG016|Overall Study|Lost to Follow-up|0|||
105799559|NCT04380701|364924631|FG017|Overall Study|Lost to Follow-up|0|||
105799560|NCT04380701|364924632|FG018|Overall Study|Lost to Follow-up|0|||
105799561|NCT04380701|364924633|FG019|Overall Study|Lost to Follow-up|0|||
105799562|NCT04380701|364924634|FG020|Overall Study|Lost to Follow-up|1|||
105799563|NCT04380701|364924635|FG021|Overall Study|Lost to Follow-up|0|||
105799564|NCT04380701|364924636|FG022|Overall Study|Lost to Follow-up|0|||
105799565|NCT04380701|364924637|FG023|Overall Study|Lost to Follow-up|1|||
105799566|NCT04380701|364924638|FG024|Overall Study|Lost to Follow-up|0|||
105799567|NCT04380701|364924639|FG025|Overall Study|Lost to Follow-up|0|||
105799568|NCT04380701|364924640|FG026|Overall Study|Lost to Follow-up|0|||
105799569|NCT04380701|364924641|FG027|Overall Study|Lost to Follow-up|0|||
105799570|NCT04380701|364924642|FG028|Overall Study|Lost to Follow-up|0|||
105799571|NCT04380701|364924643|FG029|Overall Study|Lost to Follow-up|1|||
105799572|NCT04380701|364924644|FG030|Overall Study|Lost to Follow-up|0|||
105799573|NCT04380701|364924645|FG031|Overall Study|Lost to Follow-up|0|||
105799574|NCT04380701|364924646|FG032|Overall Study|Lost to Follow-up|0|||
105799575|NCT04380701|364924647|FG033|Overall Study|Lost to Follow-up|1|||
105355782|NCT02532257|363307727|FG000|Overall Study|Withdrawal by Subject|3|||
105355783|NCT02532257|363307727|FG000|Overall Study|Progressive Disease|10|||
105355784|NCT02933528|363307728|FG000|Overall Study|Lost to Follow-up|2|||
105355785|NCT00571103|363307731|FG000|Overall Study|Withdrawal by Subject|1|||
105355786|NCT00571103|363307731|FG000|Overall Study|Lost to Follow-up|1|||
105355787|NCT02131233|363307732|FG000|Overall Study|Not Treated|2|||
105355788|NCT02131233|363307733|FG001|Overall Study|Not Treated|3|||
105355789|NCT02131233|363307732|FG000|Overall Study|Adverse Event|7|||
105355790|NCT02131233|363307733|FG001|Overall Study|Adverse Event|6|||
105355791|NCT02131233|363307732|FG000|Overall Study|Death|0|||
105355792|NCT02131233|363307733|FG001|Overall Study|Death|1|||
105355793|NCT02131233|363307732|FG000|Overall Study|Lack of Efficacy|6|||
105355794|NCT02131233|363307733|FG001|Overall Study|Lack of Efficacy|3|||
105355795|NCT02131233|363307732|FG000|Overall Study|Lost to Follow-up|14|||
105355796|NCT02131233|363307733|FG001|Overall Study|Lost to Follow-up|13|||
105355797|NCT02131233|363307732|FG000|Overall Study|Non-Compliance With Study Drug|8|||
105355798|NCT02131233|363307733|FG001|Overall Study|Non-Compliance With Study Drug|5|||
105355799|NCT02131233|363307732|FG000|Overall Study|Physician Decision|7|||
105355800|NCT02131233|363307733|FG001|Overall Study|Physician Decision|0|||
105355801|NCT02131233|363307732|FG000|Overall Study|Pregnancy|4|||
105355802|NCT02131233|363307733|FG001|Overall Study|Pregnancy|0|||
105355803|NCT02131233|363307732|FG000|Overall Study|Withdrawal by Subject|18|||
105355804|NCT02131233|363307733|FG001|Overall Study|Withdrawal by Subject|11|||
105355805|NCT00790556|363307734|FG000|Treatment Period 1|Physician Decision|1|||
105355806|NCT00790556|363307735|FG001|Treatment Period 1|Physician Decision|0|||
105355807|NCT00790556|363307734|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105355808|NCT00790556|363307735|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105799576|NCT04380701|364924614|FG000|Overall Study|Private reason(s)|0|||
105799577|NCT04380701|364924615|FG001|Overall Study|Private reason(s)|0|||
105799578|NCT04380701|364924616|FG002|Overall Study|Private reason(s)|0|||
105799579|NCT04380701|364924617|FG003|Overall Study|Private reason(s)|0|||
105799580|NCT04380701|364924618|FG004|Overall Study|Private reason(s)|0|||
105799581|NCT04380701|364924619|FG005|Overall Study|Private reason(s)|0|||
105799582|NCT04380701|364924620|FG006|Overall Study|Private reason(s)|1|||
105799583|NCT04380701|364924621|FG007|Overall Study|Private reason(s)|0|||
105355809|NCT00435461|363307738|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
105355810|NCT00435461|363307739|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
105355811|NCT00435461|363307740|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
105355812|NCT00435461|363307738|FG000|Overall Study|Protocol Violation|6|||
105355813|NCT00435461|363307739|FG001|Overall Study|Protocol Violation|9|||
105355814|NCT00435461|363307740|FG002|Overall Study|Protocol Violation|10|||
105355815|NCT00435461|363307738|FG000|Overall Study|Participant randomized(inadequate score)|1|||
105355816|NCT00435461|363307739|FG001|Overall Study|Participant randomized(inadequate score)|0|||
105799584|NCT04380701|364924622|FG008|Overall Study|Private reason(s)|1|||
105799585|NCT04380701|364924623|FG009|Overall Study|Private reason(s)|1|||
105799586|NCT04380701|364924624|FG010|Overall Study|Private reason(s)|0|||
105799587|NCT04380701|364924625|FG011|Overall Study|Private reason(s)|0|||
105799588|NCT04380701|364924626|FG012|Overall Study|Private reason(s)|0|||
105799589|NCT04380701|364924627|FG013|Overall Study|Private reason(s)|0|||
105799590|NCT04380701|364924628|FG014|Overall Study|Private reason(s)|0|||
105799591|NCT04380701|364924629|FG015|Overall Study|Private reason(s)|0|||
105799592|NCT04380701|364924630|FG016|Overall Study|Private reason(s)|0|||
105799593|NCT04380701|364924631|FG017|Overall Study|Private reason(s)|0|||
105799594|NCT04380701|364924632|FG018|Overall Study|Private reason(s)|0|||
105799595|NCT04380701|364924633|FG019|Overall Study|Private reason(s)|0|||
105799596|NCT04380701|364924634|FG020|Overall Study|Private reason(s)|0|||
105799597|NCT04380701|364924635|FG021|Overall Study|Private reason(s)|0|||
105799598|NCT04380701|364924636|FG022|Overall Study|Private reason(s)|0|||
105799599|NCT04380701|364924637|FG023|Overall Study|Private reason(s)|1|||
105799600|NCT04380701|364924638|FG024|Overall Study|Private reason(s)|0|||
105799601|NCT04380701|364924639|FG025|Overall Study|Private reason(s)|0|||
105355817|NCT00435461|363307740|FG002|Overall Study|Participant randomized(inadequate score)|0|||
105355818|NCT00435461|363307738|FG000|Overall Study|Compliance less than 80 percent|1|||
105355819|NCT00435461|363307739|FG001|Overall Study|Compliance less than 80 percent|0|||
105355820|NCT00435461|363307740|FG002|Overall Study|Compliance less than 80 percent|0|||
105355821|NCT00435461|363307738|FG000|Overall Study|In error, two study medications switched|1|||
105355822|NCT00435461|363307739|FG001|Overall Study|In error, two study medications switched|0|||
105355823|NCT00435461|363307740|FG002|Overall Study|In error, two study medications switched|0|||
105355824|NCT00435461|363307738|FG000|Overall Study|Lack of Efficacy|2|||
105355825|NCT00435461|363307739|FG001|Overall Study|Lack of Efficacy|1|||
105355826|NCT00435461|363307740|FG002|Overall Study|Lack of Efficacy|0|||
105355827|NCT00435461|363307738|FG000|Overall Study|Withdrawal by Subject|1|||
105355828|NCT00435461|363307739|FG001|Overall Study|Withdrawal by Subject|0|||
105355829|NCT00435461|363307740|FG002|Overall Study|Withdrawal by Subject|2|||
105355830|NCT00435461|363307738|FG000|Overall Study|Randomized in error|1|||
105355831|NCT00435461|363307739|FG001|Overall Study|Randomized in error|0|||
105355832|NCT00435461|363307740|FG002|Overall Study|Randomized in error|0|||
105355833|NCT00435461|363307738|FG000|Overall Study|Participant could not tolerate symptoms|0|||
105355834|NCT00435461|363307739|FG001|Overall Study|Participant could not tolerate symptoms|0|||
105355835|NCT00435461|363307740|FG002|Overall Study|Participant could not tolerate symptoms|1|||
105355836|NCT00435461|363307738|FG000|Overall Study|Participant could not swallow capsule|0|||
105355837|NCT00435461|363307739|FG001|Overall Study|Participant could not swallow capsule|0|||
105355838|NCT00435461|363307740|FG002|Overall Study|Participant could not swallow capsule|1|||
105355839|NCT00435461|363307738|FG000|Overall Study|Pregnancy|2|||
105355840|NCT00435461|363307739|FG001|Overall Study|Pregnancy|0|||
105355841|NCT00435461|363307740|FG002|Overall Study|Pregnancy|0|||
105355842|NCT00435461|363307738|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
105355843|NCT00435461|363307739|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
105355844|NCT00435461|363307740|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
105355845|NCT00435461|363307738|FG000|Overall Study|Participant ended study one day early|1|||
105355846|NCT00435461|363307739|FG001|Overall Study|Participant ended study one day early|0|||
105355847|NCT00435461|363307740|FG002|Overall Study|Participant ended study one day early|0|||
105355848|NCT00435461|363307738|FG000|Overall Study|Noncompliance with study requirements|1|||
105355849|NCT00435461|363307739|FG001|Overall Study|Noncompliance with study requirements|1|||
105355850|NCT00435461|363307740|FG002|Overall Study|Noncompliance with study requirements|1|||
105481723|NCT01743001|363775180|FG000|Overall Study|Pregnancy|1|||
105481724|NCT01743001|363775181|FG001|Overall Study|Pregnancy|0|||
105481725|NCT01743001|363775180|FG000|Overall Study|Death|1|||
105481726|NCT01743001|363775181|FG001|Overall Study|Death|0|||
105481727|NCT04987944|363775186|FG000|Overall Study|Adverse Event|0|||
105799602|NCT04380701|364924640|FG026|Overall Study|Private reason(s)|0|||
105799603|NCT04380701|364924641|FG027|Overall Study|Private reason(s)|0|||
105799604|NCT04380701|364924642|FG028|Overall Study|Private reason(s)|0|||
105799605|NCT04380701|364924643|FG029|Overall Study|Private reason(s)|1|||
105799606|NCT04380701|364924644|FG030|Overall Study|Private reason(s)|0|||
105799607|NCT04380701|364924645|FG031|Overall Study|Private reason(s)|0|||
105799608|NCT04380701|364924646|FG032|Overall Study|Private reason(s)|0|||
105799609|NCT04380701|364924647|FG033|Overall Study|Private reason(s)|0|||
105799610|NCT04380701|364924614|FG000|Overall Study|Withdrawal by Subject|0|||
105799611|NCT04380701|364924615|FG001|Overall Study|Withdrawal by Subject|0|||
105355851|NCT00435461|363307738|FG000|Overall Study|Adverse Event|1|||
105355852|NCT00435461|363307739|FG001|Overall Study|Adverse Event|2|||
105355853|NCT00435461|363307740|FG002|Overall Study|Adverse Event|6|||
105355854|NCT00435461|363307738|FG000|Overall Study|Non-Compliance of diary|2|||
105355855|NCT00435461|363307739|FG001|Overall Study|Non-Compliance of diary|0|||
105355856|NCT00435461|363307740|FG002|Overall Study|Non-Compliance of diary|1|||
105355857|NCT00435461|363307738|FG000|Overall Study|Lost to Follow-up|1|||
105355858|NCT00435461|363307739|FG001|Overall Study|Lost to Follow-up|1|||
105799612|NCT04380701|364924616|FG002|Overall Study|Withdrawal by Subject|0|||
105799613|NCT04380701|364924617|FG003|Overall Study|Withdrawal by Subject|0|||
105355859|NCT00435461|363307740|FG002|Overall Study|Lost to Follow-up|2|||
105355860|NCT01348100|363307741|FG000|Overall Study|Subject Withdrew Consent|0|||
105355861|NCT01348100|363307742|FG001|Overall Study|Subject Withdrew Consent|0|||
105737828|NCT04003155|364696787|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
105737829|NCT04003155|364696788|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
105737830|NCT04003155|364696784|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
105737831|NCT04003155|364696785|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
105737832|NCT04003155|364696786|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
105737833|NCT04003155|364696787|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
105481728|NCT04987944|363775187|FG001|Overall Study|Adverse Event|1|||
105481729|NCT04987944|363775186|FG000|Overall Study|Withdrawal by Subject|0|||
105481730|NCT04987944|363775187|FG001|Overall Study|Withdrawal by Subject|1|||
105481731|NCT00711516|363775189|FG000|Overall Study|Adverse Event|1|||
105481732|NCT00711516|363775190|FG001|Overall Study|Adverse Event|1|||
105481733|NCT00711516|363775189|FG000|Overall Study|Withdrawal by Subject|0|||
105481734|NCT00711516|363775190|FG001|Overall Study|Withdrawal by Subject|1|||
105481735|NCT00711516|363775189|FG000|Overall Study|Protocol Violation|0|||
105481736|NCT00711516|363775190|FG001|Overall Study|Protocol Violation|1|||
105481737|NCT03316911|363775193|FG000|Overall Study|Lost to Follow-up|33|||
105481738|NCT03316911|363775194|FG001|Overall Study|Lost to Follow-up|29|||
105481739|NCT02586506|363775201|FG000|Overall Study|Protocol Violation|6|||
105481740|NCT02586506|363775201|FG000|Overall Study|Lost to Follow-up|1|||
105481741|NCT02586506|363775201|FG000|Overall Study|Other Reason|2|||
105481742|NCT03051620|363775202|FG000|Overall Study|Lost to Follow-up|6|||
105481743|NCT03051620|363775202|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
105481744|NCT03499964|363775203|FG000|Overall Study|Lack of Efficacy|6|||
105481745|NCT03499964|363775204|FG001|Overall Study|Lack of Efficacy|26|||
105481746|NCT03499964|363775203|FG000|Overall Study|Adverse Event|1|||
105481747|NCT03499964|363775204|FG001|Overall Study|Adverse Event|0|||
105481748|NCT03499964|363775203|FG000|Overall Study|Death|1|||
105481749|NCT03499964|363775204|FG001|Overall Study|Death|0|||
105481750|NCT03499964|363775203|FG000|Overall Study|Withdrawal by Subject|2|||
105481751|NCT03499964|363775204|FG001|Overall Study|Withdrawal by Subject|1|||
105481752|NCT03499964|363775203|FG000|Overall Study|Lost to Follow-up|1|||
105481753|NCT03499964|363775204|FG001|Overall Study|Lost to Follow-up|0|||
105481754|NCT00548184|363775216|FG000|Overall Study|Adverse Event|3|||
105481755|NCT00548184|363775216|FG000|Overall Study|took other drug|1|||
105481756|NCT00548184|363775216|FG000|Overall Study|Found Her2 negative|1|||
105481757|NCT00313781|363775217|FG000|Before Crossover|Death|22|||
105481758|NCT00313781|363775218|FG001|Before Crossover|Death|8|||
105481759|NCT00313781|363775219|FG002|Before Crossover|Death|0|||
105481760|NCT00313781|363775217|FG000|Before Crossover|Lost to Follow-up|0|||
105481761|NCT00313781|363775218|FG001|Before Crossover|Lost to Follow-up|3|||
105481762|NCT00313781|363775219|FG002|Before Crossover|Lost to Follow-up|0|||
105481763|NCT00313781|363775217|FG000|Before Crossover|Withdrawal by Subject|3|||
105481764|NCT00313781|363775218|FG001|Before Crossover|Withdrawal by Subject|1|||
105481765|NCT00313781|363775219|FG002|Before Crossover|Withdrawal by Subject|0|||
105481766|NCT00313781|363775217|FG000|Before Crossover|Other|45|||
105481767|NCT00313781|363775218|FG001|Before Crossover|Other|30|||
105481768|NCT00313781|363775219|FG002|Before Crossover|Other|0|||
105481769|NCT00313781|363775217|FG000|Before Crossover|Crossover|0|||
105481770|NCT00313781|363775218|FG001|Before Crossover|Crossover|37|||
105481771|NCT00313781|363775219|FG002|Before Crossover|Crossover|0|||
105481772|NCT00313781|363775217|FG000|Before Crossover|Randomized, not treated|5|||
105481773|NCT00313781|363775218|FG001|Before Crossover|Randomized, not treated|0|||
105481774|NCT00313781|363775219|FG002|Before Crossover|Randomized, not treated|0|||
105481775|NCT00313781|363775217|FG000|After Crossover|Death|0|||
105481776|NCT00313781|363775218|FG001|After Crossover|Death|0|||
105481777|NCT00313781|363775219|FG002|After Crossover|Death|6|||
105481778|NCT00313781|363775217|FG000|After Crossover|Withdrawal by Subject|0|||
105481779|NCT00313781|363775218|FG001|After Crossover|Withdrawal by Subject|0|||
105481780|NCT00313781|363775219|FG002|After Crossover|Withdrawal by Subject|3|||
105481781|NCT00313781|363775217|FG000|After Crossover|Other|0|||
105481782|NCT00313781|363775218|FG001|After Crossover|Other|0|||
105481783|NCT00313781|363775219|FG002|After Crossover|Other|18|||
105481784|NCT01903252|363775220|FG000|Double-Blind Induction|Adverse Event|20|||
105481785|NCT01903252|363775221|FG001|Double-Blind Induction|Adverse Event|18|||
105481786|NCT01903252|363775222|FG002|Double-Blind Induction|Adverse Event|0|||
105481787|NCT01903252|363775223|FG003|Double-Blind Induction|Adverse Event|0|||
105481788|NCT01903252|363775224|FG004|Double-Blind Induction|Adverse Event|0|||
105481789|NCT01903252|363775225|FG005|Double-Blind Induction|Adverse Event|0|||
105481790|NCT01903252|363775220|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
105481791|NCT01903252|363775221|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
105481792|NCT01903252|363775222|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
105481793|NCT01903252|363775223|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
105481794|NCT01903252|363775224|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
105481795|NCT01903252|363775225|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
105737834|NCT04003155|364696788|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
105737835|NCT04003155|364696784|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
105737836|NCT04003155|364696785|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
105737837|NCT04003155|364696786|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
105481796|NCT01903252|363775220|FG000|Double-Blind Induction|Physician Decision|2|||
105481797|NCT01903252|363775221|FG001|Double-Blind Induction|Physician Decision|3|||
105481798|NCT01903252|363775222|FG002|Double-Blind Induction|Physician Decision|0|||
105481799|NCT01903252|363775223|FG003|Double-Blind Induction|Physician Decision|0|||
105481800|NCT01903252|363775224|FG004|Double-Blind Induction|Physician Decision|0|||
105481801|NCT01903252|363775225|FG005|Double-Blind Induction|Physician Decision|0|||
105481802|NCT01903252|363775220|FG000|Double-Blind Induction|non-compliance,|7|||
105481803|NCT01903252|363775221|FG001|Double-Blind Induction|non-compliance,|7|||
105481804|NCT01903252|363775222|FG002|Double-Blind Induction|non-compliance,|0|||
105481805|NCT01903252|363775223|FG003|Double-Blind Induction|non-compliance,|0|||
105481806|NCT01903252|363775224|FG004|Double-Blind Induction|non-compliance,|0|||
105481807|NCT01903252|363775225|FG005|Double-Blind Induction|non-compliance,|0|||
105481808|NCT01903252|363775220|FG000|Extended Induction, Open-Label|Adverse Event|0|||
105481809|NCT01903252|363775221|FG001|Extended Induction, Open-Label|Adverse Event|0|||
105481810|NCT01903252|363775222|FG002|Extended Induction, Open-Label|Adverse Event|17|||
105481811|NCT01903252|363775223|FG003|Extended Induction, Open-Label|Adverse Event|0|||
105481812|NCT01903252|363775224|FG004|Extended Induction, Open-Label|Adverse Event|0|||
105481813|NCT01903252|363775225|FG005|Extended Induction, Open-Label|Adverse Event|0|||
105481814|NCT01903252|363775220|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
105481815|NCT01903252|363775221|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
105481816|NCT01903252|363775222|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
105481817|NCT01903252|363775223|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
105481818|NCT01903252|363775224|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
105481819|NCT01903252|363775225|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
105481820|NCT01903252|363775220|FG000|Extended Induction, Open-Label|Physician Decision|0|||
105481821|NCT01903252|363775221|FG001|Extended Induction, Open-Label|Physician Decision|0|||
105481822|NCT01903252|363775222|FG002|Extended Induction, Open-Label|Physician Decision|1|||
105481823|NCT01903252|363775223|FG003|Extended Induction, Open-Label|Physician Decision|0|||
105481824|NCT01903252|363775224|FG004|Extended Induction, Open-Label|Physician Decision|0|||
105481825|NCT01903252|363775225|FG005|Extended Induction, Open-Label|Physician Decision|0|||
105481826|NCT01903252|363775220|FG000|Maintenance, Open-Label|Adverse Event|0|||
105481827|NCT01903252|363775221|FG001|Maintenance, Open-Label|Adverse Event|0|||
105481828|NCT01903252|363775222|FG002|Maintenance, Open-Label|Adverse Event|0|||
105481829|NCT01903252|363775223|FG003|Maintenance, Open-Label|Adverse Event|3|||
105481830|NCT01903252|363775224|FG004|Maintenance, Open-Label|Adverse Event|9|||
105481831|NCT01903252|363775225|FG005|Maintenance, Open-Label|Adverse Event|14|||
105481832|NCT01903252|363775220|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
105481833|NCT01903252|363775221|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
105481834|NCT01903252|363775222|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
105481835|NCT01903252|363775223|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
105481836|NCT01903252|363775224|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
105481837|NCT01903252|363775225|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
105481838|NCT01903252|363775220|FG000|Maintenance, Open-Label|Other|0|||
105481839|NCT01903252|363775221|FG001|Maintenance, Open-Label|Other|0|||
105481840|NCT01903252|363775222|FG002|Maintenance, Open-Label|Other|0|||
105481841|NCT01903252|363775223|FG003|Maintenance, Open-Label|Other|2|||
105481842|NCT01903252|363775224|FG004|Maintenance, Open-Label|Other|6|||
105481843|NCT01903252|363775225|FG005|Maintenance, Open-Label|Other|2|||
105481844|NCT01642732|363775228|FG000|Overall Study|Withdrawal by Subject|1|||
105481845|NCT02395302|363775233|FG000|Overall Study|Screen Failure|3|||
105481846|NCT02395302|363775233|FG000|Overall Study|Run In Failure|7|||
105481847|NCT02395302|363775233|FG000|Overall Study|Withdrawal by Subject|2|||
105481848|NCT02395302|363775233|FG000|Overall Study|Physician Decision|2|||
105481849|NCT01087788|363775234|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
105481850|NCT01087788|363775235|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
105481851|NCT01087788|363775236|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
105481852|NCT01087788|363775234|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
105481853|NCT01087788|363775235|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
105481854|NCT01087788|363775236|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
105481855|NCT01087788|363775234|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
105737838|NCT04003155|364696787|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
105737839|NCT04003155|364696788|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
105481856|NCT01087788|363775235|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
105481857|NCT01087788|363775236|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
105481858|NCT01087788|363775234|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
105481859|NCT01087788|363775235|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
105481860|NCT01087788|363775236|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
105481861|NCT01087788|363775234|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
105737840|NCT04003155|364696784|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
105737841|NCT04003155|364696785|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
105737842|NCT04003155|364696786|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
105737843|NCT04003155|364696787|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
105737844|NCT04003155|364696788|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
105737845|NCT04003155|364696784|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
105737846|NCT04003155|364696785|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
105737847|NCT04003155|364696786|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
105737848|NCT04003155|364696787|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
105737849|NCT04003155|364696788|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
105737850|NCT04003155|364696784|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
105737851|NCT04003155|364696785|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
105737852|NCT04003155|364696786|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
105737853|NCT04003155|364696787|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
105737854|NCT04003155|364696788|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
105737855|NCT04003155|364696784|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
105737856|NCT04003155|364696785|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
105737857|NCT04003155|364696786|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
105737858|NCT04003155|364696787|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
105737859|NCT04003155|364696788|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
105799614|NCT04380701|364924618|FG004|Overall Study|Withdrawal by Subject|0|||
105799615|NCT04380701|364924619|FG005|Overall Study|Withdrawal by Subject|0|||
105799616|NCT04380701|364924620|FG006|Overall Study|Withdrawal by Subject|1|||
105799617|NCT04380701|364924621|FG007|Overall Study|Withdrawal by Subject|1|||
105481862|NCT01087788|363775235|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
105481863|NCT01087788|363775236|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
105481864|NCT01087788|363775234|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
105481865|NCT01087788|363775235|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
105481866|NCT01087788|363775236|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
105481867|NCT01087788|363775234|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
105481868|NCT01087788|363775235|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
105481869|NCT01087788|363775236|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
105481870|NCT01087788|363775234|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
105481871|NCT01087788|363775235|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
105481872|NCT01087788|363775236|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
105481873|NCT01087788|363775234|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
105481874|NCT01087788|363775235|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
105481875|NCT01087788|363775236|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
105481876|NCT01087788|363775234|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
105481877|NCT01087788|363775235|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
105481878|NCT01087788|363775236|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
105481879|NCT01087788|363775234|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
105481880|NCT01087788|363775235|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
105481881|NCT01087788|363775236|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
105481882|NCT01087788|363775234|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
105481883|NCT01087788|363775235|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
105481884|NCT01087788|363775236|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
105481885|NCT01087788|363775234|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
105481886|NCT01087788|363775235|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
105481887|NCT01087788|363775236|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
105481888|NCT01087788|363775234|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
105481889|NCT01087788|363775235|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
105481890|NCT01087788|363775236|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
105481891|NCT01087788|363775234|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
105481892|NCT01087788|363775235|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
105481893|NCT01087788|363775236|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
105481894|NCT01087788|363775234|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
105481895|NCT01087788|363775235|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
105481896|NCT01087788|363775236|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
105481897|NCT01087788|363775234|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
105481898|NCT01087788|363775235|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
105481899|NCT01087788|363775236|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
105737860|NCT03042611|364696789|FG000|Core Phase|Withdrawal by Subject|13|||
105737861|NCT03042611|364696790|FG001|Core Phase|Withdrawal by Subject|4|||
105737862|NCT03042611|364696791|FG002|Core Phase|Withdrawal by Subject|0|||
105799618|NCT04380701|364924622|FG008|Overall Study|Withdrawal by Subject|0|||
105481900|NCT01087788|363775234|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
105565165|NCT01995539|364066705|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
105565166|NCT00261495|364066712|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
105565167|NCT00261495|364066713|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
105565168|NCT00261495|364066712|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
105565169|NCT00261495|364066713|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
105565170|NCT00261495|364066712|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
105565171|NCT00261495|364066713|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
105565172|NCT00261495|364066712|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
105565173|NCT00261495|364066713|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
105565174|NCT00261495|364066712|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
105565175|NCT00261495|364066713|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
105565176|NCT00261495|364066712|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
105565177|NCT00261495|364066713|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
105565178|NCT00261495|364066712|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
105565179|NCT00261495|364066713|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
105565180|NCT00261495|364066712|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
105565181|NCT00261495|364066713|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
105565182|NCT00261495|364066712|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
105565183|NCT00261495|364066713|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
105565184|NCT00261495|364066712|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
105565185|NCT00261495|364066713|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
105565186|NCT00261495|364066712|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
105565187|NCT00261495|364066713|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
105565188|NCT00261495|364066712|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
105565189|NCT00261495|364066713|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
105565190|NCT00261495|364066712|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
105565191|NCT00261495|364066713|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
105565192|NCT00261495|364066712|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
105565193|NCT00261495|364066713|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
105565194|NCT00261495|364066712|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
105565195|NCT00261495|364066713|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
105565196|NCT00261495|364066712|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
105565197|NCT00261495|364066713|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
105565198|NCT00261495|364066712|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
105565199|NCT00261495|364066713|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
105565200|NCT00261495|364066712|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
105565201|NCT00261495|364066713|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
105565202|NCT00261495|364066712|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
105565203|NCT00261495|364066713|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
105565204|NCT00261495|364066712|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
105565205|NCT00261495|364066713|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
105565206|NCT00261495|364066712|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
105565207|NCT00261495|364066713|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105565208|NCT02066402|364066714|FG000|Overall Study|Adverse Event|1|||
105565209|NCT02066402|364066715|FG001|Overall Study|Adverse Event|2|||
105565210|NCT02066402|364066714|FG000|Overall Study|Lost to Follow-up|11|||
105565211|NCT02066402|364066715|FG001|Overall Study|Lost to Follow-up|8|||
105565212|NCT02066402|364066714|FG000|Overall Study|Withdrawal by Subject|14|||
105565213|NCT02066402|364066715|FG001|Overall Study|Withdrawal by Subject|11|||
105565214|NCT02066402|364066714|FG000|Overall Study|Progressive disease-clinical progression|0|||
105565215|NCT02066402|364066715|FG001|Overall Study|Progressive disease-clinical progression|1|||
105565216|NCT02066402|364066714|FG000|Overall Study|Protocol driven decision point|0|||
105565217|NCT02066402|364066715|FG001|Overall Study|Protocol driven decision point|1|||
105737863|NCT03042611|364696792|FG003|Core Phase|Withdrawal by Subject|0|||
105565218|NCT03243422|364066716|FG000|Overall Study|Death|20|||
105565219|NCT03243422|364066717|FG001|Overall Study|Death|21|||
105565220|NCT03243422|364066716|FG000|Overall Study|Lost to Follow-up|9|||
105565221|NCT03243422|364066717|FG001|Overall Study|Lost to Follow-up|21|||
105565222|NCT03243422|364066716|FG000|Overall Study|Withdrawal by Subject|22|||
105565223|NCT03243422|364066717|FG001|Overall Study|Withdrawal by Subject|8|||
105565224|NCT01424930|364066719|FG000|Overall Study|Adverse Event|0|||
105565225|NCT01424930|364066720|FG001|Overall Study|Adverse Event|1|||
105565226|NCT01424930|364066719|FG000|Overall Study|Death|1|||
105565227|NCT01424930|364066720|FG001|Overall Study|Death|0|||
105737864|NCT03042611|364696789|FG000|Core Phase|Death|232|||
105565228|NCT01424930|364066719|FG000|Overall Study|Progressive Disease|3|||
105565229|NCT01424930|364066720|FG001|Overall Study|Progressive Disease|6|||
105737865|NCT03042611|364696790|FG001|Core Phase|Death|110|||
105565230|NCT01424930|364066719|FG000|Overall Study|Screen Failure|0|||
105565231|NCT01424930|364066720|FG001|Overall Study|Screen Failure|1|||
105565232|NCT01424930|364066719|FG000|Overall Study|Reason not specified|0|||
105737866|NCT03042611|364696791|FG002|Core Phase|Death|0|||
105737867|NCT03042611|364696792|FG003|Core Phase|Death|0|||
105481901|NCT01087788|363775235|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
105481902|NCT01087788|363775236|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
105481903|NCT01087788|363775234|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
105481904|NCT01087788|363775235|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
105481905|NCT01087788|363775236|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
105481906|NCT01087788|363775234|FG000|24-weeks Dose-blind Period|Patient moved|0|||
105481907|NCT01087788|363775235|FG001|24-weeks Dose-blind Period|Patient moved|0|||
105481908|NCT01087788|363775236|FG002|24-weeks Dose-blind Period|Patient moved|1|||
105481909|NCT01087788|363775234|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
105481910|NCT01087788|363775235|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
105481911|NCT01087788|363775236|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
105481912|NCT01087788|363775234|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
105481913|NCT01087788|363775235|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
105481914|NCT01087788|363775236|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
105481915|NCT01087788|363775234|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
105481916|NCT01087788|363775235|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
105481917|NCT01087788|363775236|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
105481918|NCT01087788|363775234|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
105481919|NCT01087788|363775235|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
105481920|NCT01087788|363775236|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
105481921|NCT01087788|363775234|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
105481922|NCT01087788|363775235|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
105481923|NCT01087788|363775236|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
105481924|NCT01087788|363775234|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
105481925|NCT01087788|363775235|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
105481926|NCT01087788|363775236|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
105481927|NCT01087788|363775234|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
105481928|NCT01087788|363775235|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
105481929|NCT01087788|363775236|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
105737868|NCT03042611|364696789|FG000|Core Phase|Lost to Follow-up|4|||
105737869|NCT03042611|364696790|FG001|Core Phase|Lost to Follow-up|7|||
105737870|NCT03042611|364696791|FG002|Core Phase|Lost to Follow-up|0|||
105737871|NCT03042611|364696792|FG003|Core Phase|Lost to Follow-up|0|||
105737872|NCT03042611|364696789|FG000|Core Phase|Physician Decision|7|||
105737873|NCT03042611|364696790|FG001|Core Phase|Physician Decision|2|||
105737874|NCT03042611|364696791|FG002|Core Phase|Physician Decision|0|||
105737875|NCT03042611|364696792|FG003|Core Phase|Physician Decision|0|||
105737876|NCT03042611|364696789|FG000|Core Phase|Study Closed|0|||
105737877|NCT03042611|364696790|FG001|Core Phase|Study Closed|1|||
105737878|NCT03042611|364696791|FG002|Core Phase|Study Closed|0|||
105737879|NCT03042611|364696792|FG003|Core Phase|Study Closed|0|||
105737880|NCT03042611|364696789|FG000|Extension Phase|Death|0|||
105737881|NCT03042611|364696790|FG001|Extension Phase|Death|0|||
105737882|NCT03042611|364696791|FG002|Extension Phase|Death|34|||
105737883|NCT03042611|364696792|FG003|Extension Phase|Death|16|||
105737884|NCT03042611|364696789|FG000|Extension Phase|Lost to Follow-up|0|||
105737885|NCT03042611|364696790|FG001|Extension Phase|Lost to Follow-up|0|||
105737886|NCT03042611|364696791|FG002|Extension Phase|Lost to Follow-up|1|||
105737887|NCT03042611|364696792|FG003|Extension Phase|Lost to Follow-up|1|||
105737888|NCT03042611|364696789|FG000|Extension Phase|Study Closed|0|||
105737889|NCT03042611|364696790|FG001|Extension Phase|Study Closed|0|||
105737890|NCT03042611|364696791|FG002|Extension Phase|Study Closed|17|||
105737891|NCT03042611|364696792|FG003|Extension Phase|Study Closed|11|||
105737892|NCT02421120|364696793|FG000|Overall Study|Adverse Event|1|||
105737893|NCT02345161|364696796|FG000|Overall Study|Withdrawal by Subject|25|||
105737894|NCT02345161|364696797|FG001|Overall Study|Withdrawal by Subject|33|||
105737895|NCT02345161|364696796|FG000|Overall Study|Adverse Event|16|||
105737896|NCT02345161|364696797|FG001|Overall Study|Adverse Event|19|||
105737897|NCT02345161|364696796|FG000|Overall Study|Physician Decision|4|||
105737898|NCT02345161|364696797|FG001|Overall Study|Physician Decision|4|||
105737899|NCT02345161|364696796|FG000|Overall Study|Lost to Follow-up|0|||
105737900|NCT02345161|364696797|FG001|Overall Study|Lost to Follow-up|1|||
105737901|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
105737902|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
105737903|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
105737904|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
105737905|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
105737906|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
105737907|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
105737908|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
105737909|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
105737910|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
105799619|NCT04380701|364924623|FG009|Overall Study|Withdrawal by Subject|0|||
105799620|NCT04380701|364924624|FG010|Overall Study|Withdrawal by Subject|0|||
105799621|NCT04380701|364924625|FG011|Overall Study|Withdrawal by Subject|1|||
105799622|NCT04380701|364924626|FG012|Overall Study|Withdrawal by Subject|0|||
105799623|NCT04380701|364924627|FG013|Overall Study|Withdrawal by Subject|1|||
105799624|NCT04380701|364924628|FG014|Overall Study|Withdrawal by Subject|0|||
105799625|NCT04380701|364924629|FG015|Overall Study|Withdrawal by Subject|0|||
105799626|NCT04380701|364924630|FG016|Overall Study|Withdrawal by Subject|1|||
105799627|NCT04380701|364924631|FG017|Overall Study|Withdrawal by Subject|0|||
105799628|NCT04380701|364924632|FG018|Overall Study|Withdrawal by Subject|0|||
105799629|NCT04380701|364924633|FG019|Overall Study|Withdrawal by Subject|0|||
105799630|NCT04380701|364924634|FG020|Overall Study|Withdrawal by Subject|0|||
105799631|NCT04380701|364924635|FG021|Overall Study|Withdrawal by Subject|0|||
105799632|NCT04380701|364924636|FG022|Overall Study|Withdrawal by Subject|2|||
105799633|NCT04380701|364924637|FG023|Overall Study|Withdrawal by Subject|2|||
105799634|NCT04380701|364924638|FG024|Overall Study|Withdrawal by Subject|1|||
105799635|NCT04380701|364924639|FG025|Overall Study|Withdrawal by Subject|1|||
105799636|NCT04380701|364924640|FG026|Overall Study|Withdrawal by Subject|0|||
105799637|NCT04380701|364924641|FG027|Overall Study|Withdrawal by Subject|0|||
105481930|NCT01087788|363775234|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
105799638|NCT04380701|364924642|FG028|Overall Study|Withdrawal by Subject|0|||
105799639|NCT04380701|364924643|FG029|Overall Study|Withdrawal by Subject|0|||
105799640|NCT04380701|364924644|FG030|Overall Study|Withdrawal by Subject|0|||
105799641|NCT04380701|364924645|FG031|Overall Study|Withdrawal by Subject|0|||
105799642|NCT04380701|364924646|FG032|Overall Study|Withdrawal by Subject|0|||
105799643|NCT04380701|364924647|FG033|Overall Study|Withdrawal by Subject|0|||
105481931|NCT01087788|363775235|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
105481932|NCT01087788|363775236|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
105481933|NCT01087788|363775234|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
105737911|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
105737912|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
105737913|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
105737914|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
105737915|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
105737916|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
105737917|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
105737918|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
105737919|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
105737920|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
105737921|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
105481934|NCT01087788|363775235|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
105565233|NCT01424930|364066720|FG001|Overall Study|Reason not specified|6|||
105565234|NCT03420781|364066725|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
105355862|NCT01348100|363307743|FG002|Overall Study|Subject Withdrew Consent|2|||
105355863|NCT01348100|363307744|FG003|Overall Study|Subject Withdrew Consent|0|||
105355864|NCT01348100|363307745|FG004|Overall Study|Subject Withdrew Consent|1|||
105355865|NCT01348100|363307746|FG005|Overall Study|Subject Withdrew Consent|0|||
105355866|NCT01348100|363307747|FG006|Overall Study|Subject Withdrew Consent|1|||
105355867|NCT01348100|363307741|FG000|Overall Study|Protocol Deviation|0|||
105355868|NCT01348100|363307742|FG001|Overall Study|Protocol Deviation|0|||
105355869|NCT01348100|363307743|FG002|Overall Study|Protocol Deviation|0|||
105355870|NCT01348100|363307744|FG003|Overall Study|Protocol Deviation|1|||
105355871|NCT01348100|363307745|FG004|Overall Study|Protocol Deviation|0|||
105355872|NCT01348100|363307746|FG005|Overall Study|Protocol Deviation|0|||
105355873|NCT01348100|363307747|FG006|Overall Study|Protocol Deviation|0|||
105355874|NCT01348100|363307741|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105355875|NCT01348100|363307742|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105355876|NCT01348100|363307743|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105355877|NCT01348100|363307744|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105355878|NCT01348100|363307745|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105355879|NCT01348100|363307746|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
105355880|NCT01348100|363307747|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105355881|NCT01348100|363307741|FG000|Overall Study|Lost to Follow-up|0|||
105355882|NCT01348100|363307742|FG001|Overall Study|Lost to Follow-up|0|||
105355883|NCT01348100|363307743|FG002|Overall Study|Lost to Follow-up|0|||
105355884|NCT01348100|363307744|FG003|Overall Study|Lost to Follow-up|0|||
105355885|NCT01348100|363307745|FG004|Overall Study|Lost to Follow-up|0|||
105355886|NCT01348100|363307746|FG005|Overall Study|Lost to Follow-up|0|||
105355887|NCT01348100|363307747|FG006|Overall Study|Lost to Follow-up|1|||
105355888|NCT01348100|363307741|FG000|Overall Study|Administrative Problems|0|||
105355889|NCT01348100|363307742|FG001|Overall Study|Administrative Problems|0|||
105355890|NCT01348100|363307743|FG002|Overall Study|Administrative Problems|0|||
105355891|NCT01348100|363307744|FG003|Overall Study|Administrative Problems|0|||
105355892|NCT01348100|363307745|FG004|Overall Study|Administrative Problems|0|||
105355893|NCT01348100|363307746|FG005|Overall Study|Administrative Problems|1|||
105355894|NCT01348100|363307747|FG006|Overall Study|Administrative Problems|1|||
105355895|NCT01134393|363307750|FG000|Overall Study|Adverse Event|18|||
105355896|NCT01134393|363307750|FG000|Overall Study|Lack of Efficacy|2|||
105355897|NCT01134393|363307750|FG000|Overall Study|Protocol Violation|12|||
105355898|NCT01134393|363307750|FG000|Overall Study|Lost to Follow-up|3|||
105355899|NCT01134393|363307750|FG000|Overall Study|Withdrawal by Subject|11|||
105355900|NCT01134393|363307750|FG000|Overall Study|Other|6|||
105355901|NCT04074330|363307754|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
105355902|NCT04074330|363307755|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
105355903|NCT04074330|363307756|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
105355904|NCT04074330|363307757|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
105355905|NCT04074330|363307758|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
105355906|NCT04074330|363307759|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
105355907|NCT04074330|363307760|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
105355908|NCT04074330|363307761|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
105355909|NCT04074330|363307762|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
105355910|NCT04074330|363307763|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
105355911|NCT04074330|363307754|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
105355912|NCT04074330|363307755|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
105355913|NCT04074330|363307756|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
105355914|NCT04074330|363307757|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
105355915|NCT04074330|363307758|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
105355916|NCT04074330|363307759|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
105355917|NCT04074330|363307760|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
105355918|NCT04074330|363307761|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
105355919|NCT04074330|363307762|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
105355920|NCT04074330|363307763|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
105355921|NCT04074330|363307754|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105355922|NCT04074330|363307755|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105355923|NCT04074330|363307756|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
105355924|NCT04074330|363307757|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105355925|NCT04074330|363307758|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105355926|NCT04074330|363307759|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105355927|NCT04074330|363307760|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105355928|NCT04074330|363307761|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105355929|NCT04074330|363307762|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105355930|NCT04074330|363307763|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105737922|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
105355931|NCT04074330|363307754|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105355932|NCT04074330|363307755|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105355933|NCT04074330|363307756|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105355934|NCT04074330|363307757|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105355935|NCT04074330|363307758|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105355936|NCT04074330|363307759|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
105355937|NCT04074330|363307760|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105355938|NCT04074330|363307761|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
105355939|NCT04074330|363307762|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105355940|NCT04074330|363307763|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105355941|NCT04074330|363307754|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
105355942|NCT04074330|363307755|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
105355943|NCT04074330|363307756|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
105355944|NCT04074330|363307757|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
105355945|NCT04074330|363307758|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
105355946|NCT04074330|363307759|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
105355947|NCT04074330|363307760|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
105355948|NCT04074330|363307761|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
105355949|NCT04074330|363307762|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
105355950|NCT04074330|363307763|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
105355951|NCT04074330|363307754|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
105355952|NCT04074330|363307755|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
105355953|NCT04074330|363307756|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
105481935|NCT01087788|363775236|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
105481936|NCT01087788|363775234|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
105481937|NCT01087788|363775235|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
105481938|NCT01087788|363775236|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
105481939|NCT01087788|363775234|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
105481940|NCT01087788|363775235|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
105481941|NCT01087788|363775236|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
105481942|NCT01087788|363775234|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
105481943|NCT01087788|363775235|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
105481944|NCT01087788|363775236|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
105481945|NCT01087788|363775234|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
105481946|NCT01087788|363775235|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
105481947|NCT01087788|363775236|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
105481948|NCT03400956|363775237|FG000|Treatment Period 1|Adverse Event|0|||
105481949|NCT03400956|363775238|FG001|Treatment Period 1|Adverse Event|1|||
105481950|NCT03400956|363775239|FG002|Treatment Period 1|Adverse Event|0|||
105481951|NCT03400956|363775237|FG000|Treatment Period 1|Lost to Follow-up|0|||
105481952|NCT03400956|363775238|FG001|Treatment Period 1|Lost to Follow-up|0|||
105481953|NCT03400956|363775239|FG002|Treatment Period 1|Lost to Follow-up|1|||
105481954|NCT03400956|363775237|FG000|Treatment Period 1|Protocol Violation|0|||
105481955|NCT03400956|363775238|FG001|Treatment Period 1|Protocol Violation|2|||
105481956|NCT03400956|363775239|FG002|Treatment Period 1|Protocol Violation|0|||
105481957|NCT03400956|363775237|FG000|Treatment Period 1|Study terminated by sponsor|3|||
105481958|NCT03400956|363775238|FG001|Treatment Period 1|Study terminated by sponsor|1|||
105481959|NCT03400956|363775239|FG002|Treatment Period 1|Study terminated by sponsor|1|||
105481960|NCT03400956|363775237|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105481961|NCT03400956|363775238|FG001|Treatment Period 1|Withdrawal by Subject|2|||
105481962|NCT03400956|363775239|FG002|Treatment Period 1|Withdrawal by Subject|4|||
105481963|NCT03400956|363775237|FG000|Treatment Period 1|Other|1|||
105481964|NCT03400956|363775238|FG001|Treatment Period 1|Other|2|||
105481965|NCT03400956|363775239|FG002|Treatment Period 1|Other|3|||
105481966|NCT03400956|363775237|FG000|Post-treatment Period 1|Adverse Event|0|||
105481967|NCT03400956|363775238|FG001|Post-treatment Period 1|Adverse Event|0|||
105481968|NCT03400956|363775239|FG002|Post-treatment Period 1|Adverse Event|1|||
105481969|NCT03400956|363775237|FG000|Post-treatment Period 1|Physician Decision|2|||
105481970|NCT03400956|363775238|FG001|Post-treatment Period 1|Physician Decision|3|||
105481971|NCT03400956|363775239|FG002|Post-treatment Period 1|Physician Decision|0|||
105481972|NCT03400956|363775237|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
105481973|NCT03400956|363775238|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
105737923|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
105481974|NCT03400956|363775239|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
105481975|NCT03400956|363775237|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
105481976|NCT03400956|363775238|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
105737924|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
105481977|NCT03400956|363775239|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
105481978|NCT03400956|363775237|FG000|Post-treatment Period 1|Other|4|||
105481979|NCT03400956|363775238|FG001|Post-treatment Period 1|Other|3|||
105481980|NCT03400956|363775239|FG002|Post-treatment Period 1|Other|4|||
105481981|NCT03400956|363775237|FG000|Treatment Period 2|Adverse Event|2|||
105481982|NCT03400956|363775238|FG001|Treatment Period 2|Adverse Event|1|||
105481983|NCT03400956|363775239|FG002|Treatment Period 2|Adverse Event|1|||
105481984|NCT03400956|363775237|FG000|Treatment Period 2|Lost to Follow-up|1|||
105481985|NCT03400956|363775238|FG001|Treatment Period 2|Lost to Follow-up|1|||
105481986|NCT03400956|363775239|FG002|Treatment Period 2|Lost to Follow-up|0|||
105481987|NCT03400956|363775237|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105481988|NCT03400956|363775238|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105481989|NCT03400956|363775239|FG002|Treatment Period 2|Withdrawal by Subject|3|||
105481990|NCT03400956|363775237|FG000|Treatment Period 2|Other|1|||
105481991|NCT03400956|363775238|FG001|Treatment Period 2|Other|1|||
105481992|NCT03400956|363775239|FG002|Treatment Period 2|Other|0|||
105481993|NCT03400956|363775237|FG000|Follow-up Period|Withdrawal by Subject|0|||
105481994|NCT03400956|363775238|FG001|Follow-up Period|Withdrawal by Subject|0|||
105481995|NCT03400956|363775239|FG002|Follow-up Period|Withdrawal by Subject|1|||
105481996|NCT03400956|363775237|FG000|Follow-up Period|Other|0|||
105481997|NCT03400956|363775238|FG001|Follow-up Period|Other|0|||
105481998|NCT03400956|363775239|FG002|Follow-up Period|Other|1|||
105481999|NCT00534313|363775240|FG000|Short-term Period|Adverse Event|1|||
105482000|NCT00534313|363775241|FG001|Short-term Period|Adverse Event|2|||
105482001|NCT00534313|363775242|FG002|Short-term Period|Adverse Event|1|||
105482002|NCT00534313|363775243|FG003|Short-term Period|Adverse Event|3|||
105482003|NCT00534313|363775240|FG000|Short-term Period|Lack of Efficacy|3|||
105482004|NCT00534313|363775241|FG001|Short-term Period|Lack of Efficacy|4|||
105482005|NCT00534313|363775242|FG002|Short-term Period|Lack of Efficacy|0|||
105482006|NCT00534313|363775243|FG003|Short-term Period|Lack of Efficacy|3|||
105482007|NCT00534313|363775240|FG000|Short-term Period|Participant not meeting study criteria|0|||
105482008|NCT00534313|363775241|FG001|Short-term Period|Participant not meeting study criteria|0|||
105482009|NCT00534313|363775242|FG002|Short-term Period|Participant not meeting study criteria|0|||
105482010|NCT00534313|363775243|FG003|Short-term Period|Participant not meeting study criteria|1|||
105482011|NCT00534313|363775240|FG000|Short-term Period|Participant withdrew consent|2|||
105482012|NCT00534313|363775241|FG001|Short-term Period|Participant withdrew consent|0|||
105482013|NCT00534313|363775242|FG002|Short-term Period|Participant withdrew consent|0|||
105482014|NCT00534313|363775243|FG003|Short-term Period|Participant withdrew consent|2|||
105482015|NCT00534313|363775240|FG000|Short-term Period|Pregnancy|0|||
105482016|NCT00534313|363775241|FG001|Short-term Period|Pregnancy|0|||
105482017|NCT00534313|363775242|FG002|Short-term Period|Pregnancy|1|||
105482018|NCT00534313|363775243|FG003|Short-term Period|Pregnancy|0|||
105482019|NCT00534313|363775240|FG000|Long-term Period|Adverse Event|2|||
105482020|NCT00534313|363775241|FG001|Long-term Period|Adverse Event|1|||
105482021|NCT00534313|363775242|FG002|Long-term Period|Adverse Event|0|||
105482022|NCT00534313|363775243|FG003|Long-term Period|Adverse Event|1|||
105482023|NCT00534313|363775240|FG000|Long-term Period|Lack of Efficacy|14|||
105482024|NCT00534313|363775241|FG001|Long-term Period|Lack of Efficacy|10|||
105482025|NCT00534313|363775242|FG002|Long-term Period|Lack of Efficacy|14|||
105737925|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
105737926|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
105737927|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
105737928|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
105737929|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
105737930|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
105737931|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
105799644|NCT04380701|364924614|FG000|Overall Study|Adverse Event|0|||
105482026|NCT00534313|363775243|FG003|Long-term Period|Lack of Efficacy|12|||
105737932|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
105737933|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
105799645|NCT04380701|364924615|FG001|Overall Study|Adverse Event|0|||
105799646|NCT04380701|364924616|FG002|Overall Study|Adverse Event|0|||
105799647|NCT04380701|364924617|FG003|Overall Study|Adverse Event|0|||
105482027|NCT00534313|363775240|FG000|Long-term Period|Lost to Follow-up|1|||
105482028|NCT00534313|363775241|FG001|Long-term Period|Lost to Follow-up|2|||
105482029|NCT00534313|363775242|FG002|Long-term Period|Lost to Follow-up|0|||
105482030|NCT00534313|363775243|FG003|Long-term Period|Lost to Follow-up|0|||
105482031|NCT00534313|363775240|FG000|Long-term Period|Withdrawal by Subject|2|||
105482032|NCT00534313|363775241|FG001|Long-term Period|Withdrawal by Subject|2|||
105799648|NCT04380701|364924618|FG004|Overall Study|Adverse Event|0|||
105482033|NCT00534313|363775242|FG002|Long-term Period|Withdrawal by Subject|0|||
105482034|NCT00534313|363775243|FG003|Long-term Period|Withdrawal by Subject|0|||
105482035|NCT00534313|363775240|FG000|Long-term Period|No longer meets study criteria|0|||
105482036|NCT00534313|363775241|FG001|Long-term Period|No longer meets study criteria|1|||
105799649|NCT04380701|364924619|FG005|Overall Study|Adverse Event|1|||
105482037|NCT00534313|363775242|FG002|Long-term Period|No longer meets study criteria|0|||
105737934|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
105737935|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
105737936|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
105737937|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
105737938|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
105737939|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
105737940|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
105737941|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
105737942|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
105737943|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
105737944|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
105737945|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
105737946|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
105737947|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
105737948|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
105737949|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
105737950|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
105737951|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
105737952|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
105737953|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
105737954|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
105737955|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
105737956|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
105737957|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
105737958|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
105737959|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
105737960|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
105737961|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
105737962|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
105737963|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
105737964|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
105737965|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
105737966|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
105737967|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
105737968|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
105737969|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
105737970|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
105737971|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
105737972|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
105737973|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
105737974|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
105799650|NCT04380701|364924620|FG006|Overall Study|Adverse Event|0|||
105355954|NCT04074330|363307757|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
105355955|NCT04074330|363307758|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
105355956|NCT04074330|363307759|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
105482038|NCT00534313|363775243|FG003|Long-term Period|No longer meets study criteria|0|||
105482039|NCT00534313|363775240|FG000|Long-term Period|Poor compliance/noncompliance|0|||
105482040|NCT00534313|363775241|FG001|Long-term Period|Poor compliance/noncompliance|1|||
105482041|NCT00534313|363775242|FG002|Long-term Period|Poor compliance/noncompliance|1|||
105482042|NCT00534313|363775243|FG003|Long-term Period|Poor compliance/noncompliance|0|||
105482043|NCT00534313|363775240|FG000|Long-term Period|Administrative reason by sponsor|17|||
105482044|NCT00534313|363775241|FG001|Long-term Period|Administrative reason by sponsor|15|||
105482045|NCT00534313|363775242|FG002|Long-term Period|Administrative reason by sponsor|26|||
105482046|NCT00534313|363775243|FG003|Long-term Period|Administrative reason by sponsor|18|||
105482047|NCT00534313|363775240|FG000|Long-term Period|Other|1|||
105482048|NCT00534313|363775241|FG001|Long-term Period|Other|2|||
105482049|NCT00534313|363775242|FG002|Long-term Period|Other|2|||
105482050|NCT00534313|363775243|FG003|Long-term Period|Other|2|||
105737975|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
105737976|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
105482051|NCT03007888|363775244|FG000|First Intervention (14 Days)|Adverse Event|1|||
105482052|NCT03007888|363775245|FG001|First Intervention (14 Days)|Adverse Event|0|||
105482053|NCT01806662|363775246|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
105482054|NCT01806662|363775247|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
105482055|NCT01806662|363775246|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
105482056|NCT01806662|363775247|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
105482057|NCT01806662|363775246|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
105482058|NCT01806662|363775247|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
105482059|NCT01806662|363775246|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
105482060|NCT01806662|363775247|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
105482061|NCT00043550|363775248|FG000|Overall Study|Withdrawal by Subject|22|||
105482062|NCT00043550|363775249|FG001|Overall Study|Withdrawal by Subject|12|||
105482063|NCT00043550|363775250|FG002|Overall Study|Withdrawal by Subject|20|||
105482064|NCT01917656|363775259|FG000|Overall Study|Adverse Event|11|||
105482065|NCT01917656|363775260|FG001|Overall Study|Adverse Event|0|||
105482066|NCT01917656|363775259|FG000|Overall Study|Withdrawal criteria|8|||
105482067|NCT01917656|363775260|FG001|Overall Study|Withdrawal criteria|14|||
105482068|NCT01917656|363775259|FG000|Overall Study|Unclassified|0|||
105482069|NCT01917656|363775260|FG001|Overall Study|Unclassified|3|||
105482070|NCT01917656|363775259|FG000|Overall Study|Withdrawal by Subject|4|||
105482071|NCT01917656|363775260|FG001|Overall Study|Withdrawal by Subject|3|||
105482072|NCT01917656|363775259|FG000|Overall Study|Lost to Follow-up|3|||
105482073|NCT01917656|363775260|FG001|Overall Study|Lost to Follow-up|4|||
105482074|NCT02081859|363775261|FG000|Overall Study|No fertilization|2|||
105482075|NCT02081859|363775262|FG001|Overall Study|No fertilization|2|||
105482076|NCT02081859|363775261|FG000|Overall Study|No sperm|1|||
105482077|NCT02081859|363775262|FG001|Overall Study|No sperm|0|||
105482078|NCT02081859|363775261|FG000|Overall Study|Unanticipated freeze all cycle|2|||
105737977|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
105737978|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
105737979|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
105737980|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
105737981|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
105799651|NCT04380701|364924621|FG007|Overall Study|Adverse Event|0|||
105482079|NCT02081859|363775262|FG001|Overall Study|Unanticipated freeze all cycle|6|||
105482080|NCT02081859|363775261|FG000|Overall Study|< 4 embryos|27|||
105482081|NCT02081859|363775262|FG001|Overall Study|< 4 embryos|23|||
105737982|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
105737983|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
105737984|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
105737985|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
105737986|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
105737987|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
105737988|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
105737989|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
105737990|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
105737991|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
105737992|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
105737993|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
105737994|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
105737995|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
105737996|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
105737997|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
105737998|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
105737999|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
105738000|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
105738001|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
105738002|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
105738003|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
105738004|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
105738005|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
105738006|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
105738007|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
105738008|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
105738009|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
105738010|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
105738011|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
105738012|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
105738013|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
105738014|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
105738015|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
105738016|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
105738017|NCT00915005|364696807|FG000|Overall Study|Withdrawal by Subject|4|||
105738018|NCT00915005|364696808|FG001|Overall Study|Withdrawal by Subject|4|||
105738019|NCT00915005|364696807|FG000|Overall Study|Patient preferred protons therapy|6|||
105738020|NCT00915005|364696808|FG001|Overall Study|Patient preferred protons therapy|0|||
105738021|NCT00915005|364696807|FG000|Overall Study|Insurance denial|3|||
105738022|NCT00915005|364696808|FG001|Overall Study|Insurance denial|15|||
105738023|NCT00907478|364696811|FG000|Overall Study|Ineligibility determined|0|||
105738024|NCT00907478|364696812|FG001|Overall Study|Ineligibility determined|0|||
105738025|NCT00907478|364696813|FG002|Overall Study|Ineligibility determined|1|||
105738026|NCT00907478|364696811|FG000|Overall Study|Noncompliance|0|||
105738027|NCT00907478|364696812|FG001|Overall Study|Noncompliance|0|||
105738028|NCT00907478|364696813|FG002|Overall Study|Noncompliance|1|||
105799652|NCT04380701|364924622|FG008|Overall Study|Adverse Event|0|||
105799653|NCT04380701|364924623|FG009|Overall Study|Adverse Event|0|||
105799654|NCT04380701|364924624|FG010|Overall Study|Adverse Event|0|||
105799655|NCT04380701|364924625|FG011|Overall Study|Adverse Event|0|||
105799656|NCT04380701|364924626|FG012|Overall Study|Adverse Event|0|||
105799657|NCT04380701|364924627|FG013|Overall Study|Adverse Event|0|||
105799658|NCT04380701|364924628|FG014|Overall Study|Adverse Event|0|||
105799659|NCT04380701|364924629|FG015|Overall Study|Adverse Event|1|||
105799660|NCT04380701|364924630|FG016|Overall Study|Adverse Event|0|||
105799661|NCT04380701|364924631|FG017|Overall Study|Adverse Event|0|||
105799662|NCT04380701|364924632|FG018|Overall Study|Adverse Event|0|||
105799663|NCT04380701|364924633|FG019|Overall Study|Adverse Event|1|||
105799664|NCT04380701|364924634|FG020|Overall Study|Adverse Event|0|||
105799665|NCT04380701|364924635|FG021|Overall Study|Adverse Event|0|||
105799666|NCT04380701|364924636|FG022|Overall Study|Adverse Event|0|||
105799667|NCT04380701|364924637|FG023|Overall Study|Adverse Event|0|||
105799668|NCT04380701|364924638|FG024|Overall Study|Adverse Event|0|||
105799669|NCT04380701|364924639|FG025|Overall Study|Adverse Event|0|||
105799670|NCT04380701|364924640|FG026|Overall Study|Adverse Event|0|||
105799671|NCT04380701|364924641|FG027|Overall Study|Adverse Event|0|||
105799672|NCT04380701|364924642|FG028|Overall Study|Adverse Event|0|||
105799673|NCT04380701|364924643|FG029|Overall Study|Adverse Event|0|||
105799674|NCT04380701|364924644|FG030|Overall Study|Adverse Event|0|||
105799675|NCT04380701|364924645|FG031|Overall Study|Adverse Event|0|||
105799676|NCT04380701|364924646|FG032|Overall Study|Adverse Event|0|||
105799677|NCT04380701|364924647|FG033|Overall Study|Adverse Event|0|||
105799678|NCT04380701|364924614|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
105799679|NCT04380701|364924615|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
105799680|NCT04380701|364924616|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
105799681|NCT04380701|364924617|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
105799682|NCT04380701|364924618|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
105799683|NCT04380701|364924619|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
105799684|NCT04380701|364924620|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
105799685|NCT04380701|364924621|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
105799686|NCT04380701|364924622|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
105799687|NCT04380701|364924623|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
105799688|NCT04380701|364924624|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
105799689|NCT04380701|364924625|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
105799690|NCT04380701|364924626|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
105799691|NCT04380701|364924627|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
105799692|NCT04380701|364924628|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
105799693|NCT04380701|364924629|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
105799694|NCT04380701|364924630|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
105799695|NCT04380701|364924631|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
105799696|NCT04380701|364924632|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
105738029|NCT00907478|364696811|FG000|Overall Study|Adverse Event|3|||
105738030|NCT00907478|364696812|FG001|Overall Study|Adverse Event|1|||
105738031|NCT00907478|364696813|FG002|Overall Study|Adverse Event|2|||
105738032|NCT00907478|364696811|FG000|Overall Study|Withdrawal by Subject|8|||
105738033|NCT00907478|364696812|FG001|Overall Study|Withdrawal by Subject|9|||
105738034|NCT00907478|364696813|FG002|Overall Study|Withdrawal by Subject|6|||
105738035|NCT00907478|364696811|FG000|Overall Study|Requirement for alternative therapy|1|||
105738036|NCT00907478|364696812|FG001|Overall Study|Requirement for alternative therapy|2|||
105738037|NCT00907478|364696813|FG002|Overall Study|Requirement for alternative therapy|3|||
105738038|NCT00907478|364696811|FG000|Overall Study|Physician Decision|2|||
105738039|NCT00907478|364696812|FG001|Overall Study|Physician Decision|0|||
105799697|NCT04380701|364924633|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
105799698|NCT04380701|364924634|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
105799699|NCT04380701|364924635|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
105799700|NCT04380701|364924636|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
105799701|NCT04380701|364924637|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
105738040|NCT00907478|364696813|FG002|Overall Study|Physician Decision|3|||
105738041|NCT00907478|364696811|FG000|Overall Study|Death|4|||
105738042|NCT00907478|364696812|FG001|Overall Study|Death|2|||
105738043|NCT00907478|364696813|FG002|Overall Study|Death|1|||
105738044|NCT00907478|364696811|FG000|Overall Study|Protocol-specified criteria|5|||
105738045|NCT00907478|364696812|FG001|Overall Study|Protocol-specified criteria|2|||
105738046|NCT00907478|364696813|FG002|Overall Study|Protocol-specified criteria|3|||
105738047|NCT00907478|364696811|FG000|Overall Study|Pregnancy|0|||
105738048|NCT00907478|364696812|FG001|Overall Study|Pregnancy|1|||
105738049|NCT00907478|364696813|FG002|Overall Study|Pregnancy|1|||
105738050|NCT00907478|364696811|FG000|Overall Study|Lost to Follow-up|1|||
105738051|NCT00907478|364696812|FG001|Overall Study|Lost to Follow-up|0|||
105738052|NCT00907478|364696813|FG002|Overall Study|Lost to Follow-up|0|||
105738053|NCT00907478|364696811|FG000|Overall Study|Other|3|||
105738054|NCT00907478|364696812|FG001|Overall Study|Other|0|||
105738055|NCT00907478|364696813|FG002|Overall Study|Other|1|||
105738056|NCT02639182|364696818|FG000|Overall Study|Disease Progression|50|||
105738057|NCT02639182|364696819|FG001|Overall Study|Disease Progression|49|||
105738058|NCT02639182|364696818|FG000|Overall Study|Adverse Event|7|||
105738059|NCT02639182|364696819|FG001|Overall Study|Adverse Event|5|||
105738060|NCT02639182|364696818|FG000|Overall Study|Physician Decision|3|||
105738061|NCT02639182|364696819|FG001|Overall Study|Physician Decision|3|||
105738062|NCT02639182|364696818|FG000|Overall Study|Withdrew Consent|5|||
105738063|NCT02639182|364696819|FG001|Overall Study|Withdrew Consent|4|||
105738064|NCT02639182|364696818|FG000|Overall Study|Lost to Follow-up|0|||
105738065|NCT02639182|364696819|FG001|Overall Study|Lost to Follow-up|1|||
105738066|NCT02639182|364696818|FG000|Overall Study|Study Closure|1|||
105738067|NCT02639182|364696819|FG001|Overall Study|Study Closure|2|||
105738068|NCT02639182|364696818|FG000|Overall Study|Sponsor Ended Study|0|||
105738069|NCT02639182|364696819|FG001|Overall Study|Sponsor Ended Study|1|||
105738070|NCT02639182|364696818|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
105738071|NCT02639182|364696819|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
105738072|NCT02546856|364696822|FG000|4 Months Evaluation|Death|2|||
105355957|NCT04074330|363307760|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
105355958|NCT04074330|363307761|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
105355959|NCT04074330|363307762|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
105355960|NCT04074330|363307763|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
105355961|NCT04074330|363307754|FG000|Dose Expansion (up to 42 Months)|Death|0|||
105355962|NCT04074330|363307755|FG001|Dose Expansion (up to 42 Months)|Death|0|||
105355963|NCT04074330|363307756|FG002|Dose Expansion (up to 42 Months)|Death|0|||
105355964|NCT04074330|363307757|FG003|Dose Expansion (up to 42 Months)|Death|0|||
105355965|NCT04074330|363307758|FG004|Dose Expansion (up to 42 Months)|Death|0|||
105355966|NCT04074330|363307759|FG005|Dose Expansion (up to 42 Months)|Death|0|||
105355967|NCT04074330|363307760|FG006|Dose Expansion (up to 42 Months)|Death|0|||
105355968|NCT04074330|363307761|FG007|Dose Expansion (up to 42 Months)|Death|0|||
105355969|NCT04074330|363307762|FG008|Dose Expansion (up to 42 Months)|Death|1|||
105355970|NCT04074330|363307763|FG009|Dose Expansion (up to 42 Months)|Death|0|||
105355971|NCT04074330|363307754|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105355972|NCT04074330|363307755|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105355973|NCT04074330|363307756|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105355974|NCT04074330|363307757|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105355975|NCT04074330|363307758|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105355976|NCT04074330|363307759|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105355977|NCT04074330|363307760|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105355978|NCT04074330|363307761|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105355979|NCT04074330|363307762|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
105355980|NCT04074330|363307763|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
105355981|NCT00184093|363307764|FG000|Overall Study|Adverse Event|3|||
105355982|NCT00184093|363307764|FG000|Overall Study|Lost to Follow-up|3|||
105355983|NCT00184093|363307764|FG000|Overall Study|Physician Decision|1|||
105482082|NCT02081859|363775261|FG000|Overall Study|Other reasons|2|||
105482083|NCT02081859|363775262|FG001|Overall Study|Other reasons|0|||
105482084|NCT02285062|363775263|FG000|Pre-Treatment Period|Protocol Violation|0|||
105482085|NCT02285062|363775264|FG001|Pre-Treatment Period|Protocol Violation|2|||
105738073|NCT02546856|364696823|FG001|4 Months Evaluation|Death|3|||
105738074|NCT02546856|364696822|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
105738075|NCT02546856|364696823|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
105738076|NCT02546856|364696822|FG000|4 Months Evaluation|Lost to Follow-up|3|||
105738077|NCT02546856|364696823|FG001|4 Months Evaluation|Lost to Follow-up|3|||
105738078|NCT02546856|364696822|FG000|4 Months Evaluation|Physician Decision|3|||
105738079|NCT02546856|364696823|FG001|4 Months Evaluation|Physician Decision|0|||
105355984|NCT00184093|363307764|FG000|Overall Study|Withdrawal by Subject|2|||
105355985|NCT05095311|363307765|FG000|Overall Study|Lost to Follow-up|7|||
105355986|NCT05095311|363307766|FG001|Overall Study|Lost to Follow-up|0|||
105738080|NCT02546856|364696822|FG000|4 Months Evaluation|Working or living abroad|5|||
105738081|NCT02546856|364696823|FG001|4 Months Evaluation|Working or living abroad|1|||
105355987|NCT05095311|363307767|FG002|Overall Study|Lost to Follow-up|0|||
105355988|NCT01429298|363307771|FG000|Overall Study|Protocol Violation|4|||
105355989|NCT01429298|363307772|FG001|Overall Study|Protocol Violation|6|||
105355990|NCT01603407|363307773|FG000|Overall Study|Adverse Event|1|||
105355991|NCT01603407|363307774|FG001|Overall Study|Adverse Event|1|||
105355992|NCT01603407|363307775|FG002|Overall Study|Adverse Event|1|||
105355993|NCT01603407|363307773|FG000|Overall Study|Protocol Violation|2|||
105355994|NCT01603407|363307774|FG001|Overall Study|Protocol Violation|2|||
105355995|NCT01603407|363307775|FG002|Overall Study|Protocol Violation|0|||
105355996|NCT01603407|363307773|FG000|Overall Study|Withdrawal by Subject|8|||
105355997|NCT01603407|363307774|FG001|Overall Study|Withdrawal by Subject|5|||
105355998|NCT01603407|363307775|FG002|Overall Study|Withdrawal by Subject|7|||
105355999|NCT01603407|363307773|FG000|Overall Study|Lost to Follow-up|0|||
105356000|NCT01603407|363307774|FG001|Overall Study|Lost to Follow-up|3|||
105356001|NCT01603407|363307775|FG002|Overall Study|Lost to Follow-up|2|||
105356002|NCT02903420|363307776|FG000|Overall Study|Death|3|||
105356003|NCT00625183|363307777|FG000|Overall Study|Disease Progression|1|||
105356004|NCT02500719|363307779|FG000|Overall Study|Lost to Follow-up|2|||
105356005|NCT02500719|363307780|FG001|Overall Study|Lost to Follow-up|3|||
105356006|NCT02500719|363307779|FG000|Overall Study|Trauma history|1|||
105356007|NCT02500719|363307780|FG001|Overall Study|Trauma history|0|||
105356008|NCT02500719|363307779|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
105356009|NCT02500719|363307780|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
105356010|NCT02500719|363307779|FG000|Overall Study|Did not meet criteria for PTSD|0|||
105356011|NCT02500719|363307780|FG001|Overall Study|Did not meet criteria for PTSD|1|||
105356012|NCT02500719|363307779|FG000|Overall Study|Claustrophobia|0|||
105356013|NCT02500719|363307780|FG001|Overall Study|Claustrophobia|1|||
105356014|NCT02500719|363307779|FG000|Overall Study|History of head trauma|0|||
105356015|NCT02500719|363307780|FG001|Overall Study|History of head trauma|1|||
105356016|NCT02787083|363307781|FG000|Overall Study|Adverse Event|1|||
105356017|NCT02787083|363307782|FG001|Overall Study|Adverse Event|0|||
105356018|NCT02787083|363307781|FG000|Overall Study|Withdrawal by Subject|2|||
105356019|NCT02787083|363307782|FG001|Overall Study|Withdrawal by Subject|2|||
105356020|NCT02710084|363307785|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
105356021|NCT02710084|363307786|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
105356022|NCT05305989|363307787|FG000|Overall Study|Other|3|||
105356023|NCT05305989|363307788|FG001|Overall Study|Other|2|||
105356024|NCT05305989|363307789|FG002|Overall Study|Other|0|||
105356025|NCT05305989|363307787|FG000|Overall Study|Sponsor decision|2|||
105356026|NCT05305989|363307788|FG001|Overall Study|Sponsor decision|1|||
105356027|NCT05305989|363307789|FG002|Overall Study|Sponsor decision|0|||
105356028|NCT05305989|363307787|FG000|Overall Study|Protocol Violation|0|||
105356029|NCT05305989|363307788|FG001|Overall Study|Protocol Violation|1|||
105356030|NCT05305989|363307789|FG002|Overall Study|Protocol Violation|0|||
105356031|NCT05305989|363307787|FG000|Overall Study|Investigator decision|1|||
105356032|NCT05305989|363307788|FG001|Overall Study|Investigator decision|2|||
105356033|NCT05305989|363307789|FG002|Overall Study|Investigator decision|0|||
105356034|NCT05305989|363307787|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
105356035|NCT05305989|363307788|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
105356036|NCT05305989|363307789|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
105356037|NCT05305989|363307787|FG000|Overall Study|Adverse Event|1|||
105356038|NCT05305989|363307788|FG001|Overall Study|Adverse Event|1|||
105356039|NCT05305989|363307789|FG002|Overall Study|Adverse Event|0|||
105356040|NCT05305989|363307787|FG000|Overall Study|Enrolled but never dosed|3|||
105356041|NCT05305989|363307788|FG001|Overall Study|Enrolled but never dosed|2|||
105356042|NCT05305989|363307789|FG002|Overall Study|Enrolled but never dosed|1|||
105356043|NCT03162328|363307790|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
105356044|NCT03162328|363307791|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
105356045|NCT03162328|363307792|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
105356046|NCT03162328|363307790|FG000|Screening Period|Withdrawal by Subject|1|||
105356047|NCT03162328|363307791|FG001|Screening Period|Withdrawal by Subject|0|||
105356048|NCT03162328|363307792|FG002|Screening Period|Withdrawal by Subject|0|||
105356049|NCT03162328|363307790|FG000|Study Period|Withdrawal by Subject|0|||
105356050|NCT03162328|363307791|FG001|Study Period|Withdrawal by Subject|0|||
105356051|NCT03162328|363307792|FG002|Study Period|Withdrawal by Subject|1|||
105738082|NCT02546856|364696822|FG000|4 Months Evaluation|reasons not due to titration|4|||
105356052|NCT02453256|363307794|FG000|Double Blind Period|Death|1|||
105356053|NCT02453256|363307795|FG001|Double Blind Period|Death|1|||
105356054|NCT02453256|363307794|FG000|Double Blind Period|Adverse Event|3|||
105356055|NCT02453256|363307795|FG001|Double Blind Period|Adverse Event|2|||
105356056|NCT02453256|363307794|FG000|Double Blind Period|Withdrawal by Subject|9|||
105356057|NCT02453256|363307795|FG001|Double Blind Period|Withdrawal by Subject|5|||
105356058|NCT02453256|363307794|FG000|Double Blind Period|Other|0|||
105356059|NCT02453256|363307795|FG001|Double Blind Period|Other|1|||
105356060|NCT02453256|363307794|FG000|Open Label Period|Adverse Event|1|||
105356061|NCT02453256|363307795|FG001|Open Label Period|Adverse Event|3|||
105565235|NCT03420781|364066726|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
105565236|NCT03420781|364066727|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
105738083|NCT02546856|364696823|FG001|4 Months Evaluation|reasons not due to titration|1|||
105738084|NCT02546856|364696822|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
105738085|NCT02546856|364696823|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
105738086|NCT02546856|364696822|FG000|6 Months Evaluation|Death|1|||
105738087|NCT02546856|364696823|FG001|6 Months Evaluation|Death|1|||
105738088|NCT02546856|364696822|FG000|6 Months Evaluation|Lost to Follow-up|1|||
105738089|NCT02546856|364696823|FG001|6 Months Evaluation|Lost to Follow-up|1|||
105738090|NCT02546856|364696822|FG000|6 Months Evaluation|Working or living abroad|6|||
105738091|NCT02546856|364696823|FG001|6 Months Evaluation|Working or living abroad|4|||
105738092|NCT02546856|364696822|FG000|6 Months Evaluation|reasons not due to titration|0|||
105738093|NCT02546856|364696823|FG001|6 Months Evaluation|reasons not due to titration|1|||
105738094|NCT00611455|364696826|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
105738095|NCT00611455|364696827|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
105738096|NCT00611455|364696828|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105738097|NCT00611455|364696826|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
105738098|NCT00611455|364696827|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
105738099|NCT00611455|364696828|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
105738100|NCT00611455|364696826|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
105738101|NCT00611455|364696827|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
105738102|NCT00611455|364696828|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105738103|NCT00611455|364696826|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
105738104|NCT00611455|364696827|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
105738105|NCT00611455|364696828|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105738106|NCT00611455|364696826|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
105738107|NCT00611455|364696827|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
105738108|NCT00611455|364696828|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
105738109|NCT00611455|364696826|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
105738110|NCT00611455|364696827|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
105738111|NCT00611455|364696828|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
105738112|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
105738113|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
105738114|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
105738115|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
105565237|NCT03420781|364066728|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
105482086|NCT02285062|363775263|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
105482087|NCT02285062|363775264|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
105482088|NCT02015221|363775265|FG000|Overall Study|Withdrawal by Subject|8|||
105482089|NCT02015221|363775266|FG001|Overall Study|Withdrawal by Subject|6|||
105482090|NCT02015221|363775265|FG000|Overall Study|Lost to Follow-up|1|||
105482091|NCT02015221|363775266|FG001|Overall Study|Lost to Follow-up|0|||
105482092|NCT00492063|363775267|FG000|Overall Study|Death|0|||
105482093|NCT00492063|363775268|FG001|Overall Study|Death|0|||
105482094|NCT00492063|363775269|FG002|Overall Study|Death|1|||
105738116|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
105738117|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
105738118|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
105738119|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
105482095|NCT00492063|363775270|FG003|Overall Study|Death|2|||
105482096|NCT00492063|363775267|FG000|Overall Study|Withdrawal by Subject|4|||
105482097|NCT00492063|363775268|FG001|Overall Study|Withdrawal by Subject|3|||
105482098|NCT00492063|363775269|FG002|Overall Study|Withdrawal by Subject|5|||
105482099|NCT00492063|363775270|FG003|Overall Study|Withdrawal by Subject|4|||
105482100|NCT00492063|363775267|FG000|Overall Study|Lost to Follow-up|6|||
105482101|NCT00492063|363775268|FG001|Overall Study|Lost to Follow-up|11|||
105482102|NCT00492063|363775269|FG002|Overall Study|Lost to Follow-up|5|||
105482103|NCT00492063|363775270|FG003|Overall Study|Lost to Follow-up|3|||
105482104|NCT00492063|363775267|FG000|Overall Study|Protocol Violation|0|||
105482105|NCT00492063|363775268|FG001|Overall Study|Protocol Violation|0|||
105482106|NCT00492063|363775269|FG002|Overall Study|Protocol Violation|0|||
105482107|NCT00492063|363775270|FG003|Overall Study|Protocol Violation|1|||
105482108|NCT03709576|363775277|FG000|Overall Study|progression prior to enrollment|1|||
105482109|NCT03044574|363775280|FG000|Overall Study|Lost to Follow-up|37|||
105482110|NCT03044574|363775281|FG001|Overall Study|Lost to Follow-up|45|||
105482111|NCT01947855|363775284|FG000|Overall Study|Withdrawal by Subject|1|||
105482112|NCT01947855|363775285|FG001|Overall Study|Withdrawal by Subject|0|||
105482113|NCT01947855|363775286|FG002|Overall Study|Withdrawal by Subject|0|||
105356062|NCT02453256|363307794|FG000|Open Label Period|Death|0|||
105356063|NCT02453256|363307795|FG001|Open Label Period|Death|1|||
105356064|NCT02453256|363307794|FG000|Open Label Period|Lost to Follow-up|1|||
105356065|NCT02453256|363307795|FG001|Open Label Period|Lost to Follow-up|0|||
105356066|NCT02453256|363307794|FG000|Open Label Period|Other|0|||
105356067|NCT02453256|363307795|FG001|Open Label Period|Other|2|||
105356068|NCT02453256|363307794|FG000|Open Label Period|Withdrawal by Subject|5|||
105356069|NCT02453256|363307795|FG001|Open Label Period|Withdrawal by Subject|1|||
105356070|NCT01124292|363307796|FG000|Overall Study|Lost to Follow-up|2|||
105356071|NCT01124292|363307797|FG001|Overall Study|Lost to Follow-up|4|||
105356072|NCT01124292|363307798|FG002|Overall Study|Lost to Follow-up|3|||
105356073|NCT01124292|363307796|FG000|Overall Study|Physician Decision|0|||
105356074|NCT01124292|363307797|FG001|Overall Study|Physician Decision|3|||
105482114|NCT00710762|363775287|FG000|Overall Study|Progressive disease|27|||
105482115|NCT00710762|363775288|FG001|Overall Study|Progressive disease|30|||
105482116|NCT00710762|363775287|FG000|Overall Study|Adverse Event other disease worsening|2|||
105482117|NCT00710762|363775288|FG001|Overall Study|Adverse Event other disease worsening|1|||
105565238|NCT03420781|364066729|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
105738120|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
105738121|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
105738122|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
105738123|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
105738124|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
105738125|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
105738126|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
105738127|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
105738128|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
105738129|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
105356075|NCT01124292|363307798|FG002|Overall Study|Physician Decision|2|||
105356076|NCT01124292|363307796|FG000|Overall Study|Withdrawal by Subject|0|||
105356077|NCT01124292|363307797|FG001|Overall Study|Withdrawal by Subject|6|||
105356078|NCT01124292|363307798|FG002|Overall Study|Withdrawal by Subject|2|||
105356079|NCT01124292|363307796|FG000|Overall Study|medical issue unrelated to the study|0|||
105482118|NCT00710762|363775287|FG000|Overall Study|Other Adverse Event|7|||
105565239|NCT03420781|364066725|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
105738130|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
105738131|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
105356080|NCT01124292|363307797|FG001|Overall Study|medical issue unrelated to the study|0|||
105356081|NCT01124292|363307798|FG002|Overall Study|medical issue unrelated to the study|2|||
105356082|NCT01124292|363307796|FG000|Overall Study|piercing track closed|0|||
105482119|NCT00710762|363775288|FG001|Overall Study|Other Adverse Event|7|||
105482120|NCT00710762|363775287|FG000|Overall Study|Lost to Follow-up|1|||
105482121|NCT00710762|363775288|FG001|Overall Study|Lost to Follow-up|0|||
105356083|NCT01124292|363307797|FG001|Overall Study|piercing track closed|2|||
105356084|NCT01124292|363307798|FG002|Overall Study|piercing track closed|1|||
105356085|NCT03396822|363309575|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
105356086|NCT03396822|363309575|FG000|Overall Study|Physician Decision|1|||
105356087|NCT04985942|363309576|FG000|Overall Study|Adverse Event|14|||
105356088|NCT04985942|363309577|FG001|Overall Study|Adverse Event|2|||
105356089|NCT04985942|363309576|FG000|Overall Study|Lack of Efficacy|0|||
105356090|NCT04985942|363309577|FG001|Overall Study|Lack of Efficacy|3|||
105356091|NCT04985942|363309576|FG000|Overall Study|Lost to Follow-up|1|||
105356092|NCT04985942|363309577|FG001|Overall Study|Lost to Follow-up|1|||
105356093|NCT04985942|363309576|FG000|Overall Study|Protocol Violation|1|||
105356094|NCT04985942|363309577|FG001|Overall Study|Protocol Violation|1|||
105356095|NCT04985942|363309576|FG000|Overall Study|Withdrawal by Subject|5|||
105356096|NCT04985942|363309577|FG001|Overall Study|Withdrawal by Subject|4|||
105356097|NCT03638466|363309580|FG000|Overall Study|Early Termination|0|||
105356098|NCT03638466|363309581|FG001|Overall Study|Early Termination|1|||
105356099|NCT00497146|363309582|FG000|Treatment Period|Adverse Event|6|||
105356100|NCT00497146|363309583|FG001|Treatment Period|Adverse Event|2|||
105356101|NCT00497146|363309582|FG000|Treatment Period|Withdrawal by Subject|5|||
105356102|NCT00497146|363309583|FG001|Treatment Period|Withdrawal by Subject|9|||
105356103|NCT00497146|363309582|FG000|Treatment Period|Lost to Follow-up|1|||
105356104|NCT00497146|363309583|FG001|Treatment Period|Lost to Follow-up|3|||
105356105|NCT00497146|363309582|FG000|Treatment Period|Required dialysis|4|||
105356106|NCT00497146|363309583|FG001|Treatment Period|Required dialysis|1|||
105356107|NCT00497146|363309582|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
105356108|NCT00497146|363309583|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
105356109|NCT00497146|363309582|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
105356110|NCT00497146|363309583|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
105356111|NCT00497146|363309582|FG000|Treatment Period|Other Reason|2|||
105356112|NCT00497146|363309583|FG001|Treatment Period|Other Reason|3|||
105356113|NCT00497146|363309582|FG000|Long-term Follow-up Period|Adverse Event|2|||
105356114|NCT00497146|363309583|FG001|Long-term Follow-up Period|Adverse Event|2|||
105356115|NCT00497146|363309582|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
105356116|NCT00497146|363309583|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
105356117|NCT00497146|363309582|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
105356118|NCT00497146|363309583|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
105356119|NCT00497146|363309582|FG000|Long-term Follow-up Period|Other|0|||
105356120|NCT00497146|363309583|FG001|Long-term Follow-up Period|Other|1|||
105356121|NCT02447328|363309586|FG000|Overall Study|Withdrawal by Subject|1|||
105356122|NCT02113007|363309587|FG000|Overall Study|Progressive disease|2|||
105356123|NCT04750278|363309589|FG000|Overall Study|Death|9|||
105356124|NCT04750278|363309590|FG001|Overall Study|Death|10|||
105356125|NCT04750278|363309591|FG002|Overall Study|Death|10|||
105565240|NCT03420781|364066726|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
105738132|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
105738133|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
105738134|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
105738135|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
105738136|NCT00611455|364696826|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
105738137|NCT00611455|364696827|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
105738138|NCT00611455|364696828|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
105738139|NCT00611455|364696826|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
105738140|NCT00611455|364696827|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
105738141|NCT00611455|364696828|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
105738142|NCT00611455|364696826|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
105738143|NCT00611455|364696827|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
105738144|NCT00611455|364696828|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
105738145|NCT00611455|364696826|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
105738146|NCT00611455|364696827|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
105738147|NCT00611455|364696828|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
105738148|NCT00611455|364696826|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
105738149|NCT00611455|364696827|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
105738150|NCT00611455|364696828|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
105738151|NCT00611455|364696826|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
105356126|NCT04750278|363309589|FG000|Overall Study|Withdrawal by Subject|4|||
105356127|NCT04750278|363309590|FG001|Overall Study|Withdrawal by Subject|1|||
105356128|NCT04750278|363309591|FG002|Overall Study|Withdrawal by Subject|2|||
105356129|NCT04750278|363309589|FG000|Overall Study|Lost to Follow-up|1|||
105356130|NCT04750278|363309590|FG001|Overall Study|Lost to Follow-up|1|||
105356131|NCT04750278|363309591|FG002|Overall Study|Lost to Follow-up|1|||
105356132|NCT04750278|363309589|FG000|Overall Study|Pregnancy|1|||
105356133|NCT04750278|363309590|FG001|Overall Study|Pregnancy|0|||
105482122|NCT00710762|363775287|FG000|Overall Study|Reason other than listed above|2|||
105482123|NCT00710762|363775288|FG001|Overall Study|Reason other than listed above|2|||
105482124|NCT00621621|363775292|FG000|Overall Study|Subjects were exited at EP study|30|||
105482125|NCT00621621|363775293|FG001|Overall Study|Subjects were exited at EP study|0|||
105482126|NCT00807573|363775296|FG000|Overall Study|Withdrawal by Subject|1|||
105482127|NCT00807573|363775296|FG000|Overall Study|Adverse Event|1|||
105482128|NCT01037088|363775297|FG000|Overall Study|Withdrawal by Subject|3|||
105482129|NCT04236141|363776901|FG000|Overall Study|Death|18|||
105482130|NCT04236141|363776902|FG001|Overall Study|Death|10|||
105482131|NCT04236141|363776901|FG000|Overall Study|Withdrawal by Participant|1|||
105482132|NCT04236141|363776902|FG001|Overall Study|Withdrawal by Participant|0|||
105482133|NCT04236141|363776901|FG000|Overall Study|Reason not Specified|1|||
105482134|NCT04236141|363776902|FG001|Overall Study|Reason not Specified|0|||
105482135|NCT04236141|363776901|FG000|Overall Study|Study terminated by Sponsor|8|||
105482136|NCT04236141|363776902|FG001|Overall Study|Study terminated by Sponsor|4|||
105482137|NCT01925131|363776907|FG000|Overall Study|Death|0|||
105482138|NCT01925131|363776908|FG001|Overall Study|Death|0|||
105482139|NCT01925131|363776909|FG002|Overall Study|Death|1|||
105482140|NCT01925131|363776910|FG003|Overall Study|Death|0|||
105482141|NCT01925131|363776911|FG004|Overall Study|Death|0|||
105482142|NCT01925131|363776912|FG005|Overall Study|Death|0|||
105482143|NCT01925131|363776907|FG000|Overall Study|Progression/Relapse|1|||
105482144|NCT01925131|363776908|FG001|Overall Study|Progression/Relapse|1|||
105482145|NCT01925131|363776909|FG002|Overall Study|Progression/Relapse|4|||
105482146|NCT01925131|363776910|FG003|Overall Study|Progression/Relapse|0|||
105482147|NCT01925131|363776911|FG004|Overall Study|Progression/Relapse|0|||
105482148|NCT01925131|363776912|FG005|Overall Study|Progression/Relapse|1|||
105482149|NCT01925131|363776907|FG000|Overall Study|Patient Refusal|1|||
105482150|NCT01925131|363776908|FG001|Overall Study|Patient Refusal|0|||
105482151|NCT01925131|363776909|FG002|Overall Study|Patient Refusal|0|||
105482152|NCT01925131|363776910|FG003|Overall Study|Patient Refusal|0|||
105482153|NCT01925131|363776911|FG004|Overall Study|Patient Refusal|0|||
105482154|NCT01925131|363776912|FG005|Overall Study|Patient Refusal|0|||
105482155|NCT01925131|363776907|FG000|Overall Study|Adverse Event|0|||
105482156|NCT01925131|363776908|FG001|Overall Study|Adverse Event|0|||
105482157|NCT01925131|363776909|FG002|Overall Study|Adverse Event|2|||
105482158|NCT01925131|363776910|FG003|Overall Study|Adverse Event|0|||
105482159|NCT01925131|363776911|FG004|Overall Study|Adverse Event|1|||
105482160|NCT01925131|363776912|FG005|Overall Study|Adverse Event|3|||
105482161|NCT01925131|363776907|FG000|Overall Study|Other - Not Protocol Specified|3|||
105482162|NCT01925131|363776908|FG001|Overall Study|Other - Not Protocol Specified|1|||
105482163|NCT01925131|363776909|FG002|Overall Study|Other - Not Protocol Specified|2|||
105482164|NCT01925131|363776910|FG003|Overall Study|Other - Not Protocol Specified|5|||
105482165|NCT01925131|363776911|FG004|Overall Study|Other - Not Protocol Specified|10|||
105482166|NCT01925131|363776912|FG005|Overall Study|Other - Not Protocol Specified|6|||
105482167|NCT01948193|363776914|FG000|Overall Study|Serious event|2|||
105482168|NCT01948193|363776914|FG000|Overall Study|Lost to Follow-up|7|||
105738152|NCT00611455|364696827|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
105738153|NCT00611455|364696828|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
105738154|NCT00611455|364696826|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
105738155|NCT00611455|364696827|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
105738156|NCT00611455|364696828|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
105738157|NCT01797783|364696829|FG000|Overall Study|Adverse Event|1|||
105482169|NCT03860935|363776915|FG000|Overall Study|Withdrawal of Consent|15|||
105482170|NCT03860935|363776916|FG001|Overall Study|Withdrawal of Consent|6|||
105482171|NCT03860935|363776915|FG000|Overall Study|Death|75|||
105738158|NCT01797783|364696830|FG001|Overall Study|Adverse Event|1|||
105738159|NCT01797783|364696829|FG000|Overall Study|Withdrawal by Subject|1|||
105738160|NCT01797783|364696830|FG001|Overall Study|Withdrawal by Subject|0|||
105738161|NCT00138151|364696831|FG000|Overall Study|Withdrawal by Subject|3|||
105738162|NCT00138151|364696831|FG000|Overall Study|Physician Decision|1|||
105482172|NCT03860935|363776916|FG001|Overall Study|Death|51|||
105482173|NCT00775203|363776920|FG000|Overall Study|Adverse Event|25|||
105482174|NCT00775203|363776921|FG001|Overall Study|Adverse Event|6|||
105482175|NCT00775203|363776920|FG000|Overall Study|Lack of Efficacy|8|||
105565241|NCT03420781|364066727|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
105738163|NCT04983940|364696837|FG000|Overall Study|Lost to Follow-up|14|||
105738164|NCT04983940|364696837|FG000|Overall Study|Lack of Efficacy|2|||
105738165|NCT01734993|364696838|FG000|Overall Study|Adverse Event|1|||
105482176|NCT00775203|363776921|FG001|Overall Study|Lack of Efficacy|9|||
105482177|NCT00775203|363776920|FG000|Overall Study|Withdrawal by Subject|11|||
105482178|NCT00775203|363776921|FG001|Overall Study|Withdrawal by Subject|9|||
105482179|NCT00775203|363776920|FG000|Overall Study|Lost to Follow-up|11|||
105482180|NCT00775203|363776921|FG001|Overall Study|Lost to Follow-up|15|||
105482181|NCT00775203|363776920|FG000|Overall Study|Administrative reason|2|||
105482182|NCT00775203|363776921|FG001|Overall Study|Administrative reason|0|||
105738166|NCT01734993|364696838|FG000|Overall Study|Lack of Efficacy|1|||
105356134|NCT04750278|363309591|FG002|Overall Study|Pregnancy|0|||
105356135|NCT04750278|363309589|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
105356136|NCT04750278|363309590|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
105356137|NCT04750278|363309591|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
105356138|NCT04750278|363309589|FG000|Overall Study|Non-compliance|0|||
105356139|NCT04750278|363309590|FG001|Overall Study|Non-compliance|0|||
105356140|NCT04750278|363309591|FG002|Overall Study|Non-compliance|1|||
105356141|NCT04750278|363309589|FG000|Overall Study|Transfer to Outside Facility|0|||
105356142|NCT04750278|363309590|FG001|Overall Study|Transfer to Outside Facility|2|||
105356143|NCT04750278|363309591|FG002|Overall Study|Transfer to Outside Facility|1|||
105356144|NCT04750278|363309589|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
105356145|NCT04750278|363309590|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
105356146|NCT04750278|363309591|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
105356147|NCT04750278|363309589|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
105356148|NCT04750278|363309590|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
105356149|NCT04750278|363309591|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
105356150|NCT02579382|363309592|FG000|Main Study Phase|Lost to Follow-up|0|||
105356151|NCT02579382|363309593|FG001|Main Study Phase|Lost to Follow-up|0|||
105356152|NCT02579382|363309594|FG002|Main Study Phase|Lost to Follow-up|2|||
105356153|NCT02579382|363309595|FG003|Main Study Phase|Lost to Follow-up|0|||
105356154|NCT02579382|363309592|FG000|Main Study Phase|Withdrew Consent|0|||
105356155|NCT02579382|363309593|FG001|Main Study Phase|Withdrew Consent|0|||
105356156|NCT02579382|363309594|FG002|Main Study Phase|Withdrew Consent|0|||
105356157|NCT02579382|363309595|FG003|Main Study Phase|Withdrew Consent|2|||
105356158|NCT02579382|363309592|FG000|Main Study Phase|Lack of Efficacy|0|||
105356159|NCT02579382|363309593|FG001|Main Study Phase|Lack of Efficacy|0|||
105356160|NCT02579382|363309594|FG002|Main Study Phase|Lack of Efficacy|0|||
105356161|NCT02579382|363309595|FG003|Main Study Phase|Lack of Efficacy|1|||
105356162|NCT02579382|363309592|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
105356163|NCT02579382|363309593|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
105356164|NCT02579382|363309594|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
105356165|NCT02579382|363309595|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
105356166|NCT02579382|363309592|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
105356167|NCT02579382|363309593|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
105356168|NCT02579382|363309594|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
105356169|NCT02579382|363309595|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
105356170|NCT02579382|363309592|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
105356171|NCT02579382|363309593|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
105356172|NCT02579382|363309594|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
105356173|NCT02579382|363309595|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
105356174|NCT02579382|363309592|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
105356175|NCT02579382|363309593|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
105356176|NCT02579382|363309594|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
105356177|NCT02579382|363309595|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
105356178|NCT02579382|363309592|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
105356179|NCT02579382|363309593|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
105356180|NCT02579382|363309594|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
105356181|NCT02579382|363309595|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
105356182|NCT02579382|363309592|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
105356183|NCT02579382|363309593|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
105356184|NCT02579382|363309594|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
105356185|NCT02579382|363309595|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
105356186|NCT00759655|363309615|FG000|Overall Study|Termination of the study by sponsor|1|||
105356187|NCT01310127|363309618|FG000|Overall Study|Protocol Violation|1|||
105356188|NCT01310127|363309619|FG001|Overall Study|Protocol Violation|1|||
105356189|NCT01310127|363309618|FG000|Overall Study|advanced psc cataract outlier|1|||
105356190|NCT01310127|363309619|FG001|Overall Study|advanced psc cataract outlier|0|||
105356191|NCT00412932|363309620|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
105356192|NCT00412932|363309620|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
105356193|NCT00412932|363309620|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
105356194|NCT00412932|363309620|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
105356195|NCT00412932|363309620|FG000|Olmesartan (Olm) 20 mg|Other|1|||
105356196|NCT00412932|363309620|FG000|Olmesartan 40 mg|Adverse Event|4|||
105356197|NCT00412932|363309620|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
105482183|NCT00775203|363776920|FG000|Overall Study|Noncompliance|4|||
105482184|NCT00775203|363776921|FG001|Overall Study|Noncompliance|2|||
105482185|NCT00775203|363776920|FG000|Overall Study|Protocol Violation|0|||
105482186|NCT00775203|363776921|FG001|Overall Study|Protocol Violation|1|||
105738167|NCT03461289|364696839|FG000|Overall Study|Death|1|||
105738168|NCT04799782|364696840|FG000|Washout|Physician Decision|2|||
105738169|NCT04799782|364696841|FG001|Washout|Physician Decision|0|||
105738170|NCT04799782|364696840|FG000|Washout|Withdrawal by Subject|0|||
105738171|NCT04799782|364696841|FG001|Washout|Withdrawal by Subject|2|||
105738172|NCT04799782|364696840|FG000|Washout|Lost to Follow-up|0|||
105738173|NCT04799782|364696841|FG001|Washout|Lost to Follow-up|1|||
105738174|NCT01903434|364696842|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
105738175|NCT01903434|364696843|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
105738176|NCT01903434|364696842|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
105799702|NCT04380701|364924638|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
105356198|NCT00412932|363309620|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
105356199|NCT00412932|363309620|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
105356200|NCT00412932|363309620|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
105356201|NCT00412932|363309620|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
105356202|NCT00412932|363309620|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
105356203|NCT02171429|363309625|FG000|Overall Study|Other|0|||
105356204|NCT02171429|363309626|FG001|Overall Study|Other|1|||
105356205|NCT02171429|363309627|FG002|Overall Study|Other|1|||
105356206|NCT02171429|363309625|FG000|Overall Study|Non-Compliance|0|||
105356207|NCT02171429|363309626|FG001|Overall Study|Non-Compliance|0|||
105356208|NCT02171429|363309627|FG002|Overall Study|Non-Compliance|1|||
105356209|NCT02171429|363309625|FG000|Overall Study|Physician Decision|0|||
105356210|NCT02171429|363309626|FG001|Overall Study|Physician Decision|0|||
105356211|NCT02171429|363309627|FG002|Overall Study|Physician Decision|1|||
105356212|NCT02171429|363309625|FG000|Overall Study|Withdrawal by Subject|1|||
105356213|NCT02171429|363309626|FG001|Overall Study|Withdrawal by Subject|1|||
105356214|NCT02171429|363309627|FG002|Overall Study|Withdrawal by Subject|1|||
105356215|NCT02171429|363309625|FG000|Overall Study|Lost to Follow-up|0|||
105356216|NCT02171429|363309626|FG001|Overall Study|Lost to Follow-up|1|||
105356217|NCT02171429|363309627|FG002|Overall Study|Lost to Follow-up|0|||
105356218|NCT02171429|363309625|FG000|Overall Study|Death|0|||
105356219|NCT02171429|363309626|FG001|Overall Study|Death|0|||
105356220|NCT02171429|363309627|FG002|Overall Study|Death|1|||
105356221|NCT00424593|363309628|FG000|Acute Double-Blind Period|Adverse Event|16|||
105356222|NCT00424593|363309629|FG001|Acute Double-Blind Period|Adverse Event|7|||
105356223|NCT00424593|363309628|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
105356224|NCT00424593|363309629|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
105356225|NCT00424593|363309628|FG000|Acute Double-Blind Period|Protocol Violation|2|||
105356226|NCT00424593|363309629|FG001|Acute Double-Blind Period|Protocol Violation|2|||
105356227|NCT00424593|363309628|FG000|Acute Double-Blind Period|Physician Decision|1|||
105356228|NCT00424593|363309629|FG001|Acute Double-Blind Period|Physician Decision|2|||
105356229|NCT00424593|363309628|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
105356230|NCT00424593|363309629|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
105356231|NCT00424593|363309628|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
105356232|NCT00424593|363309629|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
105356233|NCT00424593|363309628|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
105356234|NCT00424593|363309629|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
105356235|NCT00424593|363309628|FG000|Dose-Blind Extension Period|Adverse Event|18|||
105356236|NCT00424593|363309629|FG001|Dose-Blind Extension Period|Adverse Event|0|||
105356237|NCT00424593|363309628|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
105356238|NCT00424593|363309629|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
105356239|NCT00424593|363309628|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
105356240|NCT00424593|363309629|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
105356241|NCT00424593|363309628|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
105356242|NCT00424593|363309629|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
105356243|NCT00424593|363309628|FG000|Dose-Blind Extension Period|Physician Decision|3|||
105356244|NCT00424593|363309629|FG001|Dose-Blind Extension Period|Physician Decision|0|||
105356245|NCT01763203|363309630|FG000|Overall Study|Death|4|||
105356246|NCT01763203|363309631|FG001|Overall Study|Death|7|||
105356247|NCT01763203|363309630|FG000|Overall Study|Lost to Follow-up|12|||
105356248|NCT01763203|363309631|FG001|Overall Study|Lost to Follow-up|12|||
105356249|NCT01763203|363309630|FG000|Overall Study|Withdrawal by Subject|8|||
105356250|NCT01763203|363309631|FG001|Overall Study|Withdrawal by Subject|12|||
105356251|NCT01763203|363309630|FG000|Overall Study|Moved out of study region|7|||
105738177|NCT01903434|364696843|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
105356252|NCT01763203|363309631|FG001|Overall Study|Moved out of study region|10|||
105356253|NCT01763203|363309630|FG000|Overall Study|Physician Decision|2|||
105356254|NCT01763203|363309631|FG001|Overall Study|Physician Decision|1|||
105356255|NCT02187861|363309632|FG000|Overall Study|Adverse Event|2|||
105356256|NCT02187861|363309633|FG001|Overall Study|Adverse Event|1|||
105356257|NCT02187861|363309634|FG002|Overall Study|Adverse Event|2|||
105356258|NCT02187861|363309635|FG003|Overall Study|Adverse Event|1|||
105356259|NCT02187861|363309632|FG000|Overall Study|Death|0|||
105738178|NCT00530712|364696844|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
105738179|NCT00530712|364696844|FG000|30 Day Follow-up Visit|Missed Visit|5|||
105482187|NCT00775203|363776920|FG000|Overall Study|Entered other study|1|||
105482188|NCT00775203|363776921|FG001|Overall Study|Entered other study|0|||
105482189|NCT00775203|363776920|FG000|Overall Study|Physician Decision|0|||
105482190|NCT00775203|363776921|FG001|Overall Study|Physician Decision|1|||
105565242|NCT03420781|364066728|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
105565243|NCT03420781|364066729|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
105565244|NCT03420781|364066725|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
105565245|NCT03420781|364066726|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
105482191|NCT00701662|363776922|FG000|Overall Study|Lack of Efficacy|1|||
105482192|NCT00635024|363776925|FG000|Overall Study|Adverse Event|1|||
105482193|NCT02279407|363776926|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
105482194|NCT02279407|363776927|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
105482195|NCT02279407|363776928|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
105482196|NCT02279407|363776929|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
105482197|NCT02279407|363776926|FG000|Overall Study|Withdrawal by Subject|1|||
105482198|NCT02279407|363776927|FG001|Overall Study|Withdrawal by Subject|0|||
105482199|NCT02279407|363776928|FG002|Overall Study|Withdrawal by Subject|1|||
105482200|NCT02279407|363776929|FG003|Overall Study|Withdrawal by Subject|1|||
105482201|NCT02279407|363776926|FG000|Overall Study|Adverse Event|1|||
105482202|NCT02279407|363776927|FG001|Overall Study|Adverse Event|1|||
105482203|NCT02279407|363776928|FG002|Overall Study|Adverse Event|2|||
105482204|NCT02279407|363776929|FG003|Overall Study|Adverse Event|0|||
105482205|NCT05028361|363776931|FG000|Overall Study|Withdrawal by Subject|1|||
105482206|NCT05028361|363776932|FG001|Overall Study|Withdrawal by Subject|0|||
105482207|NCT02122783|363776940|FG000|Overall Study|Adverse Event|0|||
105482208|NCT02122783|363776941|FG001|Overall Study|Adverse Event|1|||
105482209|NCT02239120|363776943|FG000|Overall Study|Death|56|||
105482210|NCT02239120|363776944|FG001|Overall Study|Death|58|||
105482211|NCT02239120|363776943|FG000|Overall Study|Lost to Follow-up|19|||
105482212|NCT02239120|363776944|FG001|Overall Study|Lost to Follow-up|14|||
105482213|NCT02213133|363776945|FG000|Overall Study|Participant discontinued study therapy|2|||
105482214|NCT02213133|363776946|FG001|Overall Study|Participant discontinued study therapy|0|||
105482215|NCT02213133|363776947|FG002|Overall Study|Participant discontinued study therapy|0|||
105482216|NCT02213133|363776945|FG000|Overall Study|Participant withdrew informed consent|2|||
105482217|NCT02213133|363776946|FG001|Overall Study|Participant withdrew informed consent|1|||
105482218|NCT02213133|363776947|FG002|Overall Study|Participant withdrew informed consent|2|||
105482219|NCT02213133|363776945|FG000|Overall Study|Disease progression|11|||
105482220|NCT02213133|363776946|FG001|Overall Study|Disease progression|2|||
105482221|NCT02213133|363776947|FG002|Overall Study|Disease progression|0|||
105482222|NCT02213133|363776945|FG000|Overall Study|Adverse Event (AE)|1|||
105482223|NCT02213133|363776946|FG001|Overall Study|Adverse Event (AE)|0|||
105482224|NCT02213133|363776947|FG002|Overall Study|Adverse Event (AE)|0|||
105482225|NCT02213133|363776945|FG000|Overall Study|Death|16|||
105482226|NCT02213133|363776946|FG001|Overall Study|Death|2|||
105482227|NCT02213133|363776947|FG002|Overall Study|Death|1|||
105482228|NCT02213133|363776945|FG000|Overall Study|Other|5|||
105482229|NCT02213133|363776946|FG001|Overall Study|Other|0|||
105482230|NCT02213133|363776947|FG002|Overall Study|Other|0|||
105482231|NCT01224782|363776958|FG000|Overall Study|Lost to Follow-up|177|||
105482232|NCT01224782|363776958|FG000|Overall Study|Withdrawal by Subject|16|||
105482233|NCT01224782|363776958|FG000|Overall Study|Death|14|||
105482234|NCT01224782|363776958|FG000|Overall Study|Improvement|13|||
105482235|NCT01224782|363776958|FG000|Overall Study|Adverse Event|12|||
105482236|NCT01224782|363776958|FG000|Overall Study|Adverse Reaction|11|||
105482237|NCT01224782|363776958|FG000|Overall Study|Noncompliance|10|||
105482238|NCT01224782|363776958|FG000|Overall Study|Other|4|||
105482239|NCT01224782|363776958|FG000|Overall Study|Start of Dialysis|3|||
105482240|NCT01224782|363776958|FG000|Overall Study|Change of Treatment|1|||
105482241|NCT01224782|363776958|FG000|Overall Study|Financial Reasons|1|||
105482242|NCT01224782|363776958|FG000|Overall Study|Deterioration|1|||
105482243|NCT01224782|363776958|FG000|Overall Study|Transplantation|1|||
105482244|NCT00977080|363776959|FG000|Overall Study|Adverse Event|2|||
105565246|NCT03420781|364066727|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
105565247|NCT03420781|364066728|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
105565248|NCT03420781|364066729|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
105565249|NCT03420781|364066725|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
105565250|NCT03420781|364066726|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
105482245|NCT00977080|363776960|FG001|Overall Study|Adverse Event|7|||
105482246|NCT00977080|363776961|FG002|Overall Study|Adverse Event|7|||
105565251|NCT03420781|364066727|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
105565252|NCT03420781|364066728|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
105482247|NCT00977080|363776962|FG003|Overall Study|Adverse Event|7|||
105482248|NCT00977080|363776959|FG000|Overall Study|Withdrawal by Subject|1|||
105565253|NCT03420781|364066729|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
105482249|NCT00977080|363776960|FG001|Overall Study|Withdrawal by Subject|5|||
105482250|NCT00977080|363776961|FG002|Overall Study|Withdrawal by Subject|1|||
105482251|NCT00977080|363776962|FG003|Overall Study|Withdrawal by Subject|5|||
105356260|NCT02187861|363309633|FG001|Overall Study|Death|3|||
105356261|NCT02187861|363309634|FG002|Overall Study|Death|1|||
105356262|NCT02187861|363309635|FG003|Overall Study|Death|2|||
105356263|NCT02187861|363309632|FG000|Overall Study|Physician Decision|0|||
105356264|NCT02187861|363309633|FG001|Overall Study|Physician Decision|1|||
105356265|NCT02187861|363309634|FG002|Overall Study|Physician Decision|0|||
105356266|NCT02187861|363309635|FG003|Overall Study|Physician Decision|3|||
105356267|NCT02187861|363309632|FG000|Overall Study|Progressive Disease|4|||
105356268|NCT02187861|363309633|FG001|Overall Study|Progressive Disease|42|||
105356269|NCT02187861|363309634|FG002|Overall Study|Progressive Disease|19|||
105356270|NCT02187861|363309635|FG003|Overall Study|Progressive Disease|22|||
105356271|NCT02187861|363309632|FG000|Overall Study|Withdrawal by Subject|0|||
105356272|NCT02187861|363309633|FG001|Overall Study|Withdrawal by Subject|0|||
105356273|NCT02187861|363309634|FG002|Overall Study|Withdrawal by Subject|3|||
105356274|NCT02187861|363309635|FG003|Overall Study|Withdrawal by Subject|3|||
105356275|NCT02187861|363309632|FG000|Overall Study|Other|0|||
105356276|NCT02187861|363309633|FG001|Overall Study|Other|1|||
105356277|NCT02187861|363309634|FG002|Overall Study|Other|7|||
105356278|NCT02187861|363309635|FG003|Overall Study|Other|1|||
105356279|NCT00741598|363309636|FG000|Overall Study|Lost to Follow-up|3|||
105356280|NCT00741598|363309637|FG001|Overall Study|Lost to Follow-up|4|||
105356281|NCT00741598|363309636|FG000|Overall Study|Lack of Efficacy|1|||
105356282|NCT00741598|363309637|FG001|Overall Study|Lack of Efficacy|2|||
105356283|NCT00741598|363309636|FG000|Overall Study|Physician Decision|1|||
105356284|NCT00741598|363309637|FG001|Overall Study|Physician Decision|1|||
105356285|NCT00741598|363309636|FG000|Overall Study|Pregnancy|1|||
105356286|NCT00741598|363309637|FG001|Overall Study|Pregnancy|0|||
105356287|NCT00741598|363309636|FG000|Overall Study|Withdrawal by Subject|3|||
105356288|NCT00741598|363309637|FG001|Overall Study|Withdrawal by Subject|2|||
105356289|NCT00313586|363309638|FG000|Overall Study|Disease progression|14|||
105356290|NCT00313586|363309639|FG001|Overall Study|Disease progression|19|||
105356291|NCT00313586|363309640|FG002|Overall Study|Disease progression|10|||
105356292|NCT00313586|363309641|FG003|Overall Study|Disease progression|3|||
105356293|NCT00313586|363309638|FG000|Overall Study|Adverse Event|12|||
105356294|NCT00313586|363309639|FG001|Overall Study|Adverse Event|18|||
105356295|NCT00313586|363309640|FG002|Overall Study|Adverse Event|3|||
105356296|NCT00313586|363309641|FG003|Overall Study|Adverse Event|10|||
105356297|NCT00313586|363309638|FG000|Overall Study|Death|11|||
105356298|NCT00313586|363309639|FG001|Overall Study|Death|8|||
105356299|NCT00313586|363309640|FG002|Overall Study|Death|1|||
105356300|NCT00313586|363309641|FG003|Overall Study|Death|7|||
105356301|NCT00313586|363309638|FG000|Overall Study|Withdrawal by Subject|13|||
105356302|NCT00313586|363309639|FG001|Overall Study|Withdrawal by Subject|6|||
105356303|NCT00313586|363309640|FG002|Overall Study|Withdrawal by Subject|6|||
105356304|NCT00313586|363309641|FG003|Overall Study|Withdrawal by Subject|2|||
105356305|NCT00313586|363309638|FG000|Overall Study|Alternative therapy|3|||
105356306|NCT00313586|363309639|FG001|Overall Study|Alternative therapy|6|||
105356307|NCT00313586|363309640|FG002|Overall Study|Alternative therapy|2|||
105356308|NCT00313586|363309641|FG003|Overall Study|Alternative therapy|0|||
105356309|NCT00313586|363309638|FG000|Overall Study|Other complicating disease|2|||
105356310|NCT00313586|363309639|FG001|Overall Study|Other complicating disease|2|||
105356311|NCT00313586|363309640|FG002|Overall Study|Other complicating disease|0|||
105356312|NCT00313586|363309641|FG003|Overall Study|Other complicating disease|0|||
105356313|NCT00313586|363309638|FG000|Overall Study|Did not achieve HI-major/better response|10|||
105356314|NCT00313586|363309639|FG001|Overall Study|Did not achieve HI-major/better response|7|||
105482252|NCT00977080|363776959|FG000|Overall Study|Protocol Violation|7|||
105482253|NCT00977080|363776960|FG001|Overall Study|Protocol Violation|3|||
105482254|NCT00977080|363776961|FG002|Overall Study|Protocol Violation|4|||
105482255|NCT00977080|363776962|FG003|Overall Study|Protocol Violation|3|||
105482256|NCT00977080|363776959|FG000|Overall Study|Noncompliance|0|||
105482257|NCT00977080|363776960|FG001|Overall Study|Noncompliance|2|||
105482258|NCT00977080|363776961|FG002|Overall Study|Noncompliance|1|||
105482259|NCT00977080|363776962|FG003|Overall Study|Noncompliance|0|||
105482260|NCT00977080|363776959|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
105482261|NCT00977080|363776960|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
105482262|NCT00977080|363776961|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
105482263|NCT00977080|363776962|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
105482264|NCT00977080|363776959|FG000|Overall Study|Required kidney transplantation|1|||
105482265|NCT00977080|363776960|FG001|Overall Study|Required kidney transplantation|3|||
105482266|NCT00977080|363776961|FG002|Overall Study|Required kidney transplantation|3|||
105356315|NCT00313586|363309640|FG002|Overall Study|Did not achieve HI-major/better response|2|||
105356316|NCT00313586|363309641|FG003|Overall Study|Did not achieve HI-major/better response|1|||
105482267|NCT00977080|363776962|FG003|Overall Study|Required kidney transplantation|1|||
105482268|NCT00977080|363776959|FG000|Overall Study|Travel for family reasons|1|||
105482269|NCT00977080|363776960|FG001|Overall Study|Travel for family reasons|0|||
105482270|NCT00977080|363776961|FG002|Overall Study|Travel for family reasons|0|||
105356317|NCT00313586|363309638|FG000|Overall Study|Physician Decision|2|||
105356318|NCT00313586|363309639|FG001|Overall Study|Physician Decision|1|||
105356319|NCT00313586|363309640|FG002|Overall Study|Physician Decision|0|||
105799703|NCT04380701|364924639|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
105799704|NCT04380701|364924640|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
105799705|NCT04380701|364924641|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
105799706|NCT04380701|364924642|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
105799707|NCT04380701|364924643|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
105482271|NCT00977080|363776962|FG003|Overall Study|Travel for family reasons|0|||
105482272|NCT00502203|363776964|FG000|Overall Study|Inevaluable|1|||
105356320|NCT00313586|363309641|FG003|Overall Study|Physician Decision|0|||
105482273|NCT00732940|363776967|FG000|Overall Study|Withdrawal by Subject|1|||
105482274|NCT00732940|363776968|FG001|Overall Study|Withdrawal by Subject|2|||
105799708|NCT04380701|364924644|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
105799709|NCT04380701|364924645|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
105799710|NCT04380701|364924646|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
105799711|NCT04380701|364924647|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
105799712|NCT04380701|364924614|FG000|Overall Study|Physician Decision|0|||
105799713|NCT04380701|364924615|FG001|Overall Study|Physician Decision|0|||
105799714|NCT04380701|364924616|FG002|Overall Study|Physician Decision|0|||
105799715|NCT04380701|364924617|FG003|Overall Study|Physician Decision|0|||
105799716|NCT04380701|364924618|FG004|Overall Study|Physician Decision|0|||
105799717|NCT04380701|364924619|FG005|Overall Study|Physician Decision|0|||
105799718|NCT04380701|364924620|FG006|Overall Study|Physician Decision|0|||
105799719|NCT04380701|364924621|FG007|Overall Study|Physician Decision|0|||
105799720|NCT04380701|364924622|FG008|Overall Study|Physician Decision|0|||
105799721|NCT04380701|364924623|FG009|Overall Study|Physician Decision|0|||
105799722|NCT04380701|364924624|FG010|Overall Study|Physician Decision|0|||
105799723|NCT04380701|364924625|FG011|Overall Study|Physician Decision|0|||
105799724|NCT04380701|364924626|FG012|Overall Study|Physician Decision|0|||
105799725|NCT04380701|364924627|FG013|Overall Study|Physician Decision|0|||
105738180|NCT00530712|364696844|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
105738181|NCT00530712|364696844|FG000|6 Month Follow-up Visit|Missed Visit|3|||
105738182|NCT00530712|364696844|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
105738183|NCT00530712|364696844|FG000|6 Month Follow-up Visit|Death|2|||
105738184|NCT00530712|364696844|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
105738185|NCT00530712|364696844|FG000|12 Month Follow-up Visit|Missed Visit|3|||
105738186|NCT00530712|364696844|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
105799726|NCT04380701|364924628|FG014|Overall Study|Physician Decision|0|||
105799727|NCT04380701|364924629|FG015|Overall Study|Physician Decision|0|||
105799728|NCT04380701|364924630|FG016|Overall Study|Physician Decision|0|||
105799729|NCT04380701|364924631|FG017|Overall Study|Physician Decision|0|||
105799730|NCT04380701|364924632|FG018|Overall Study|Physician Decision|0|||
105799731|NCT04380701|364924633|FG019|Overall Study|Physician Decision|0|||
105482275|NCT00732940|363776967|FG000|Overall Study|Adverse Event|0|||
105482276|NCT00732940|363776968|FG001|Overall Study|Adverse Event|1|||
105799732|NCT04380701|364924634|FG020|Overall Study|Physician Decision|0|||
105799733|NCT04380701|364924635|FG021|Overall Study|Physician Decision|0|||
105356321|NCT00313586|363309638|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
105482277|NCT00732940|363776967|FG000|Overall Study|Lost to Follow-up|1|||
105482278|NCT00732940|363776968|FG001|Overall Study|Lost to Follow-up|0|||
105482279|NCT02431260|363776969|FG000|Overall Study|Subject Decision|0|||
105482280|NCT02431260|363776970|FG001|Overall Study|Subject Decision|1|||
105482281|NCT02431260|363776971|FG002|Overall Study|Subject Decision|1|||
105482282|NCT02431260|363776972|FG003|Overall Study|Subject Decision|0|||
105482283|NCT02431260|363776973|FG004|Overall Study|Subject Decision|0|||
105738187|NCT00530712|364696844|FG000|12 Month Follow-up Visit|Death|9|||
105799734|NCT04380701|364924636|FG022|Overall Study|Physician Decision|0|||
105799735|NCT04380701|364924637|FG023|Overall Study|Physician Decision|0|||
105799736|NCT04380701|364924638|FG024|Overall Study|Physician Decision|2|||
105799737|NCT04380701|364924639|FG025|Overall Study|Physician Decision|0|||
105799738|NCT04380701|364924640|FG026|Overall Study|Physician Decision|0|||
105482284|NCT02431260|363776974|FG005|Overall Study|Subject Decision|0|||
105799739|NCT04380701|364924641|FG027|Overall Study|Physician Decision|0|||
105482285|NCT02431260|363776975|FG006|Overall Study|Subject Decision|0|||
105799740|NCT04380701|364924642|FG028|Overall Study|Physician Decision|0|||
105738188|NCT02749370|364696845|FG000|Overall Study|Withdrawal by Subject|11|||
105738189|NCT02749370|364696845|FG000|Overall Study|Lost to Follow-up|3|||
105738190|NCT01519427|364696846|FG000|Overall Study|disease progression|2|||
105738191|NCT02260193|364696863|FG000|Overall Study|Lack of Efficacy|0|||
105738192|NCT02260193|364696864|FG001|Overall Study|Lack of Efficacy|1|||
105738193|NCT02260193|364696865|FG002|Overall Study|Lack of Efficacy|6|||
105738194|NCT02260193|364696863|FG000|Overall Study|Adverse Event|3|||
105738195|NCT02260193|364696864|FG001|Overall Study|Adverse Event|4|||
105738196|NCT02260193|364696865|FG002|Overall Study|Adverse Event|1|||
105738197|NCT02260193|364696863|FG000|Overall Study|Protocol Violation|0|||
105738198|NCT02260193|364696864|FG001|Overall Study|Protocol Violation|4|||
105738199|NCT02260193|364696865|FG002|Overall Study|Protocol Violation|0|||
105738200|NCT02260193|364696863|FG000|Overall Study|Withdrawal by Subject|3|||
105738201|NCT02260193|364696864|FG001|Overall Study|Withdrawal by Subject|0|||
105738202|NCT02260193|364696865|FG002|Overall Study|Withdrawal by Subject|2|||
105738203|NCT02260193|364696863|FG000|Overall Study|Kidney Transplantation|0|||
105738204|NCT02260193|364696864|FG001|Overall Study|Kidney Transplantation|0|||
105738205|NCT02260193|364696865|FG002|Overall Study|Kidney Transplantation|1|||
105356322|NCT00313586|363309639|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
105738206|NCT01108809|364696866|FG000|Overall Study|Adverse Event|3|||
105738207|NCT01108809|364696866|FG000|Overall Study|Lost to Follow-up|1|||
105738208|NCT01200511|364696868|FG000|Overall Study|Lost to Follow-up|3|||
105738209|NCT01200511|364696868|FG000|Overall Study|Withdrawal by Subject|1|||
105738210|NCT01200511|364696868|FG000|Overall Study|Adverse Event|1|||
105738211|NCT02504892|364696869|FG000|Overall Study|Adverse event-pneumonitis|2|||
105738212|NCT01415440|364696870|FG000|Overall Study|Lost to Follow-up|0|||
105738213|NCT01415440|364696871|FG001|Overall Study|Lost to Follow-up|1|||
105738214|NCT01415440|364696872|FG002|Overall Study|Lost to Follow-up|2|||
105738215|NCT01415440|364696870|FG000|Overall Study|Physician Decision|3|||
105738216|NCT01415440|364696871|FG001|Overall Study|Physician Decision|0|||
105356323|NCT00313586|363309640|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
105356324|NCT00313586|363309641|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
105356325|NCT00313586|363309638|FG000|Overall Study|Lost insurance|0|||
105356326|NCT00313586|363309639|FG001|Overall Study|Lost insurance|1|||
105356327|NCT00313586|363309640|FG002|Overall Study|Lost insurance|0|||
105356328|NCT00313586|363309641|FG003|Overall Study|Lost insurance|0|||
105738217|NCT01415440|364696872|FG002|Overall Study|Physician Decision|0|||
105738218|NCT01415440|364696870|FG000|Overall Study|Withdrawal by Subject|1|||
105738219|NCT01415440|364696871|FG001|Overall Study|Withdrawal by Subject|0|||
105738220|NCT01415440|364696872|FG002|Overall Study|Withdrawal by Subject|0|||
105738221|NCT04083222|364696875|FG000|Overall Study|Voluntary Withdrawal|0|||
105356329|NCT00313586|363309638|FG000|Overall Study|Moved|0|||
105356330|NCT00313586|363309639|FG001|Overall Study|Moved|1|||
105356331|NCT00313586|363309640|FG002|Overall Study|Moved|0|||
105356332|NCT00313586|363309641|FG003|Overall Study|Moved|0|||
105356333|NCT00313586|363309638|FG000|Overall Study|Death before starting treatment|1|||
105738222|NCT04083222|364696876|FG001|Overall Study|Voluntary Withdrawal|1|||
105738223|NCT04083222|364696875|FG000|Overall Study|Reason not Specified|0|||
105738224|NCT04083222|364696876|FG001|Overall Study|Reason not Specified|1|||
105799741|NCT04380701|364924643|FG029|Overall Study|Physician Decision|0|||
105356334|NCT00313586|363309639|FG001|Overall Study|Death before starting treatment|0|||
105356335|NCT00313586|363309640|FG002|Overall Study|Death before starting treatment|0|||
105356336|NCT00313586|363309641|FG003|Overall Study|Death before starting treatment|0|||
105738225|NCT03103750|364696877|FG000|Overall Study|Adverse Event|1|||
105738226|NCT03103750|364696878|FG001|Overall Study|Adverse Event|0|||
105799742|NCT04380701|364924644|FG030|Overall Study|Physician Decision|0|||
105799743|NCT04380701|364924645|FG031|Overall Study|Physician Decision|0|||
105356337|NCT01042392|363309642|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
105738227|NCT03103750|364696877|FG000|Overall Study|Lost to Follow-up|1|||
105738228|NCT03103750|364696878|FG001|Overall Study|Lost to Follow-up|0|||
105738229|NCT03103750|364696877|FG000|Overall Study|PET Equipment Related|2|||
105356338|NCT01042392|363309643|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
105356339|NCT01042392|363309644|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
105356340|NCT01042392|363309645|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
105356341|NCT01042392|363309642|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
105356342|NCT01042392|363309643|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
105356343|NCT01042392|363309644|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
105356344|NCT01042392|363309645|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
105356345|NCT01042392|363309642|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
105356346|NCT01042392|363309643|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
105356347|NCT01042392|363309644|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
105356348|NCT01042392|363309645|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
105356349|NCT01042392|363309642|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
105356350|NCT01042392|363309643|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
105356351|NCT01042392|363309644|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
105356352|NCT01042392|363309645|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
105356353|NCT01042392|363309642|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
105356354|NCT01042392|363309643|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
105356355|NCT01042392|363309644|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
105356356|NCT01042392|363309645|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
105356357|NCT01042392|363309642|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
105356358|NCT01042392|363309643|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
105356359|NCT01042392|363309644|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
105356360|NCT01042392|363309645|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
105356361|NCT01042392|363309642|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
105356362|NCT01042392|363309643|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
105356363|NCT01042392|363309644|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
105356364|NCT01042392|363309645|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
105356365|NCT01042392|363309642|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
105356366|NCT01042392|363309643|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
105356367|NCT01042392|363309644|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
105356368|NCT01042392|363309645|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
105356369|NCT01042392|363309642|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
105356370|NCT01042392|363309643|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
105356371|NCT01042392|363309644|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
105356372|NCT01042392|363309645|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
105356373|NCT05114564|363309646|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
105356374|NCT05114564|363309647|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
105356375|NCT05114564|363309646|FG000|First Intervention|Adverse Event|0|||
105356376|NCT05114564|363309647|FG001|First Intervention|Adverse Event|1|||
105356377|NCT03474107|363309648|FG000|Overall Study|Adverse Event|42|||
105356378|NCT03474107|363309649|FG001|Overall Study|Adverse Event|46|||
105738230|NCT03103750|364696878|FG001|Overall Study|PET Equipment Related|2|||
105738231|NCT03607682|364696879|FG000|Overall Study|Withdrawal by Subject|1|||
105738232|NCT03607682|364696879|FG000|Overall Study|Disease progression|1|||
105738233|NCT00376688|364696880|FG000|Overall Study|Adverse Event|3|||
105738234|NCT00376688|364696880|FG000|Overall Study|Death|1|||
105738235|NCT01770353|364696881|FG000|Overall Study|Progressive disease|2|||
105738236|NCT01770353|364696882|FG001|Overall Study|Progressive disease|1|||
105738237|NCT01770353|364696881|FG000|Overall Study|Adverse Event|0|||
105738238|NCT01770353|364696882|FG001|Overall Study|Adverse Event|1|||
105738239|NCT01770353|364696881|FG000|Overall Study|Protocol Violation|1|||
105738240|NCT01770353|364696882|FG001|Overall Study|Protocol Violation|0|||
105799744|NCT04380701|364924646|FG032|Overall Study|Physician Decision|0|||
105482286|NCT02431260|363776976|FG007|Overall Study|Subject Decision|0|||
105799745|NCT04380701|364924647|FG033|Overall Study|Physician Decision|0|||
105799746|NCT04380701|364924614|FG000|Overall Study|Death|0|||
105799747|NCT04380701|364924615|FG001|Overall Study|Death|0|||
105482287|NCT02431260|363776977|FG008|Overall Study|Subject Decision|1|||
105482288|NCT02431260|363776978|FG009|Overall Study|Subject Decision|1|||
105482289|NCT02431260|363776979|FG010|Overall Study|Subject Decision|0|||
105482290|NCT02431260|363776980|FG011|Overall Study|Subject Decision|1|||
105482291|NCT02431260|363776981|FG012|Overall Study|Subject Decision|0|||
105482292|NCT02431260|363776982|FG013|Overall Study|Subject Decision|0|||
105482293|NCT02431260|363776969|FG000|Overall Study|Death|4|||
105482294|NCT02431260|363776970|FG001|Overall Study|Death|4|||
105482295|NCT02431260|363776971|FG002|Overall Study|Death|3|||
105482296|NCT02431260|363776972|FG003|Overall Study|Death|4|||
105482297|NCT02431260|363776973|FG004|Overall Study|Death|2|||
105482298|NCT02431260|363776974|FG005|Overall Study|Death|2|||
105482299|NCT02431260|363776975|FG006|Overall Study|Death|3|||
105482300|NCT02431260|363776976|FG007|Overall Study|Death|1|||
105482301|NCT02431260|363776977|FG008|Overall Study|Death|6|||
105482302|NCT02431260|363776978|FG009|Overall Study|Death|6|||
105482303|NCT02431260|363776979|FG010|Overall Study|Death|3|||
105482304|NCT02431260|363776980|FG011|Overall Study|Death|2|||
105482305|NCT02431260|363776981|FG012|Overall Study|Death|5|||
105482306|NCT02431260|363776982|FG013|Overall Study|Death|1|||
105482307|NCT02431260|363776969|FG000|Overall Study|Lost to Follow-up|0|||
105482308|NCT02431260|363776970|FG001|Overall Study|Lost to Follow-up|0|||
105482309|NCT02431260|363776971|FG002|Overall Study|Lost to Follow-up|0|||
105482310|NCT02431260|363776972|FG003|Overall Study|Lost to Follow-up|0|||
105482311|NCT02431260|363776973|FG004|Overall Study|Lost to Follow-up|0|||
105482312|NCT02431260|363776974|FG005|Overall Study|Lost to Follow-up|1|||
105482313|NCT02431260|363776975|FG006|Overall Study|Lost to Follow-up|0|||
105482314|NCT02431260|363776976|FG007|Overall Study|Lost to Follow-up|0|||
105482315|NCT02431260|363776977|FG008|Overall Study|Lost to Follow-up|0|||
105482316|NCT02431260|363776978|FG009|Overall Study|Lost to Follow-up|0|||
105482317|NCT02431260|363776979|FG010|Overall Study|Lost to Follow-up|0|||
105482318|NCT02431260|363776980|FG011|Overall Study|Lost to Follow-up|0|||
105482319|NCT02431260|363776981|FG012|Overall Study|Lost to Follow-up|0|||
105482320|NCT02431260|363776982|FG013|Overall Study|Lost to Follow-up|0|||
105482321|NCT02431260|363776969|FG000|Overall Study|Study Terminated by the Sponsor|0|||
105482322|NCT02431260|363776970|FG001|Overall Study|Study Terminated by the Sponsor|0|||
105482323|NCT02431260|363776971|FG002|Overall Study|Study Terminated by the Sponsor|2|||
105482324|NCT02431260|363776972|FG003|Overall Study|Study Terminated by the Sponsor|1|||
105482325|NCT02431260|363776973|FG004|Overall Study|Study Terminated by the Sponsor|1|||
105482326|NCT02431260|363776974|FG005|Overall Study|Study Terminated by the Sponsor|0|||
105482327|NCT02431260|363776975|FG006|Overall Study|Study Terminated by the Sponsor|1|||
105482328|NCT02431260|363776976|FG007|Overall Study|Study Terminated by the Sponsor|2|||
105482329|NCT02431260|363776977|FG008|Overall Study|Study Terminated by the Sponsor|1|||
105482330|NCT02431260|363776978|FG009|Overall Study|Study Terminated by the Sponsor|1|||
105482331|NCT02431260|363776979|FG010|Overall Study|Study Terminated by the Sponsor|1|||
105482332|NCT02431260|363776980|FG011|Overall Study|Study Terminated by the Sponsor|0|||
105482333|NCT02431260|363776981|FG012|Overall Study|Study Terminated by the Sponsor|4|||
105482334|NCT02431260|363776982|FG013|Overall Study|Study Terminated by the Sponsor|0|||
105482335|NCT02431260|363776969|FG000|Overall Study|Physician Decision|0|||
105482336|NCT02431260|363776970|FG001|Overall Study|Physician Decision|0|||
105799748|NCT04380701|364924616|FG002|Overall Study|Death|0|||
105482337|NCT02431260|363776971|FG002|Overall Study|Physician Decision|0|||
105482338|NCT02431260|363776972|FG003|Overall Study|Physician Decision|0|||
105482339|NCT02431260|363776973|FG004|Overall Study|Physician Decision|0|||
105482340|NCT02431260|363776974|FG005|Overall Study|Physician Decision|1|||
105482341|NCT02431260|363776975|FG006|Overall Study|Physician Decision|0|||
105482342|NCT02431260|363776976|FG007|Overall Study|Physician Decision|0|||
105482343|NCT02431260|363776977|FG008|Overall Study|Physician Decision|0|||
105482344|NCT02431260|363776978|FG009|Overall Study|Physician Decision|0|||
105482345|NCT02431260|363776979|FG010|Overall Study|Physician Decision|0|||
105482346|NCT02431260|363776980|FG011|Overall Study|Physician Decision|0|||
105482347|NCT02431260|363776981|FG012|Overall Study|Physician Decision|0|||
105565254|NCT03420781|364066725|FG000|Treatment Period (40 Weeks)|Death|2|||
105482348|NCT02431260|363776982|FG013|Overall Study|Physician Decision|0|||
105482349|NCT02431260|363776969|FG000|Overall Study|Other Unspecified|0|||
105482350|NCT02431260|363776970|FG001|Overall Study|Other Unspecified|0|||
105482351|NCT02431260|363776971|FG002|Overall Study|Other Unspecified|0|||
105482352|NCT02431260|363776972|FG003|Overall Study|Other Unspecified|0|||
105799749|NCT04380701|364924617|FG003|Overall Study|Death|0|||
105482353|NCT02431260|363776973|FG004|Overall Study|Other Unspecified|0|||
105356379|NCT03474107|363309648|FG000|Overall Study|Death|2|||
105356380|NCT03474107|363309649|FG001|Overall Study|Death|2|||
105356381|NCT03474107|363309648|FG000|Overall Study|Lost to Follow-up|0|||
105356382|NCT03474107|363309649|FG001|Overall Study|Lost to Follow-up|1|||
105356383|NCT03474107|363309648|FG000|Overall Study|Progressive Disease|177|||
105356384|NCT03474107|363309649|FG001|Overall Study|Progressive Disease|180|||
105356385|NCT03474107|363309648|FG000|Overall Study|Protocol Violation|1|||
105356386|NCT03474107|363309649|FG001|Overall Study|Protocol Violation|1|||
105356387|NCT03474107|363309648|FG000|Overall Study|Withdrawal by Subject|15|||
105356388|NCT03474107|363309649|FG001|Overall Study|Withdrawal by Subject|27|||
105356389|NCT03474107|363309648|FG000|Overall Study|Physician Decision|7|||
105356390|NCT03474107|363309649|FG001|Overall Study|Physician Decision|22|||
105356391|NCT03474107|363309648|FG000|Overall Study|Miscellaneous|1|||
105356392|NCT03474107|363309649|FG001|Overall Study|Miscellaneous|6|||
105356393|NCT02768792|363309655|FG000|Overall Study|Adverse Event|1|||
105356394|NCT03224624|363309659|FG000|Overall Study|Lost to Follow-up|9|||
105356395|NCT03224624|363309660|FG001|Overall Study|Lost to Follow-up|4|||
105356396|NCT03224624|363309659|FG000|Overall Study|Death|1|||
105356397|NCT03224624|363309660|FG001|Overall Study|Death|0|||
105356398|NCT01884545|363309663|FG000|Overall Study|Lost to Follow-up|6|||
105356399|NCT01884545|363309664|FG001|Overall Study|Lost to Follow-up|4|||
105356400|NCT01884545|363309665|FG002|Overall Study|Lost to Follow-up|9|||
105356401|NCT01884545|363309666|FG003|Overall Study|Lost to Follow-up|4|||
105356402|NCT01884545|363309663|FG000|Overall Study|Patient withdrawn|7|||
105356403|NCT01884545|363309664|FG001|Overall Study|Patient withdrawn|12|||
105356404|NCT01884545|363309665|FG002|Overall Study|Patient withdrawn|5|||
105356405|NCT01884545|363309666|FG003|Overall Study|Patient withdrawn|5|||
105356406|NCT01884545|363309663|FG000|Overall Study|Non-adherence|0|||
105356407|NCT01884545|363309664|FG001|Overall Study|Non-adherence|2|||
105356408|NCT01884545|363309665|FG002|Overall Study|Non-adherence|0|||
105356409|NCT01884545|363309666|FG003|Overall Study|Non-adherence|0|||
105356410|NCT01424241|363309667|FG000|Overall Study|Withdrawal by Subject|1|||
105356411|NCT01424241|363309667|FG000|Overall Study|Time constraints|2|||
105356412|NCT02521792|363309676|FG000|Overall Study|Study Terminated|6|||
105356413|NCT02609984|363309677|FG000|Overall Study|Death|29|||
105356414|NCT02609984|363309678|FG001|Overall Study|Death|26|||
105356415|NCT02609984|363309677|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
105356416|NCT02609984|363309678|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
105356417|NCT02609984|363309677|FG000|Overall Study|Lost to Follow-up|1|||
105356418|NCT02609984|363309678|FG001|Overall Study|Lost to Follow-up|2|||
105356419|NCT02609984|363309677|FG000|Overall Study|Withdrawal by Subject|0|||
105356420|NCT02609984|363309678|FG001|Overall Study|Withdrawal by Subject|1|||
105356421|NCT02609984|363309677|FG000|Overall Study|Disease Progression|2|||
105356422|NCT02609984|363309678|FG001|Overall Study|Disease Progression|0|||
105356423|NCT00398047|363309679|FG000|Overall Study|all patient progressed before completion|3|||
105356424|NCT02306850|363309680|FG000|Overall Study|Lack of Efficacy|2|||
105356425|NCT01188668|363309681|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
105356426|NCT01188668|363309681|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
105356427|NCT01188668|363309681|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
105356428|NCT05259917|363309682|FG000|Overall Study|Protocol Violation|0|||
105356429|NCT05259917|363309683|FG001|Overall Study|Protocol Violation|0|||
105356430|NCT05259917|363309684|FG002|Overall Study|Protocol Violation|1|||
105356431|NCT05259917|363309685|FG003|Overall Study|Protocol Violation|0|||
105356432|NCT05259917|363309686|FG004|Overall Study|Protocol Violation|0|||
105356433|NCT05259917|363309687|FG005|Overall Study|Protocol Violation|0|||
105356434|NCT05259917|363309682|FG000|Overall Study|Lost to Follow-up|0|||
105356435|NCT05259917|363309683|FG001|Overall Study|Lost to Follow-up|0|||
105356436|NCT05259917|363309684|FG002|Overall Study|Lost to Follow-up|1|||
105482354|NCT02431260|363776974|FG005|Overall Study|Other Unspecified|0|||
105482355|NCT02431260|363776975|FG006|Overall Study|Other Unspecified|0|||
105356437|NCT05259917|363309685|FG003|Overall Study|Lost to Follow-up|0|||
105482356|NCT02431260|363776976|FG007|Overall Study|Other Unspecified|0|||
105356438|NCT05259917|363309686|FG004|Overall Study|Lost to Follow-up|0|||
105356439|NCT05259917|363309687|FG005|Overall Study|Lost to Follow-up|1|||
105356440|NCT05259917|363309682|FG000|Overall Study|Physician Decision|0|||
105356441|NCT05259917|363309683|FG001|Overall Study|Physician Decision|1|||
105356442|NCT05259917|363309684|FG002|Overall Study|Physician Decision|0|||
105356443|NCT05259917|363309685|FG003|Overall Study|Physician Decision|0|||
105356444|NCT05259917|363309686|FG004|Overall Study|Physician Decision|0|||
105356445|NCT05259917|363309687|FG005|Overall Study|Physician Decision|0|||
105356446|NCT05259917|363309682|FG000|Overall Study|Withdrawal by Subject|0|||
105356447|NCT05259917|363309683|FG001|Overall Study|Withdrawal by Subject|1|||
105356448|NCT05259917|363309684|FG002|Overall Study|Withdrawal by Subject|0|||
105356449|NCT05259917|363309685|FG003|Overall Study|Withdrawal by Subject|0|||
105356450|NCT05259917|363309686|FG004|Overall Study|Withdrawal by Subject|1|||
105356451|NCT05259917|363309687|FG005|Overall Study|Withdrawal by Subject|1|||
105356452|NCT05259917|363309682|FG000|Overall Study|Trial Termination by Sponsor|7|||
105482357|NCT02431260|363776977|FG008|Overall Study|Other Unspecified|0|||
105482358|NCT02431260|363776978|FG009|Overall Study|Other Unspecified|0|||
105482359|NCT02431260|363776979|FG010|Overall Study|Other Unspecified|0|||
105482360|NCT02431260|363776980|FG011|Overall Study|Other Unspecified|1|||
105482361|NCT02431260|363776981|FG012|Overall Study|Other Unspecified|1|||
105482362|NCT02431260|363776982|FG013|Overall Study|Other Unspecified|0|||
105482363|NCT00308581|363776984|FG000|Induction Phase|Adverse Event|0|||
105482364|NCT00308581|363776985|FG001|Induction Phase|Adverse Event|0|||
105482365|NCT00308581|363776986|FG002|Induction Phase|Adverse Event|37|||
105482366|NCT00308581|363776984|FG000|Induction Phase|Lack of Efficacy|0|||
105482367|NCT00308581|363776985|FG001|Induction Phase|Lack of Efficacy|0|||
105482368|NCT00308581|363776986|FG002|Induction Phase|Lack of Efficacy|121|||
105482369|NCT00308581|363776984|FG000|Induction Phase|Withdrawal by Subject|0|||
105482370|NCT00308581|363776985|FG001|Induction Phase|Withdrawal by Subject|0|||
105482371|NCT00308581|363776986|FG002|Induction Phase|Withdrawal by Subject|5|||
105482372|NCT00308581|363776984|FG000|Induction Phase|Unknown reason|0|||
105482373|NCT00308581|363776985|FG001|Induction Phase|Unknown reason|0|||
105482374|NCT00308581|363776986|FG002|Induction Phase|Unknown reason|3|||
105482375|NCT00308581|363776984|FG000|Randomized Maintenance Phase|Adverse Event|10|||
105482376|NCT00308581|363776985|FG001|Randomized Maintenance Phase|Adverse Event|17|||
105565255|NCT03420781|364066726|FG001|Treatment Period (40 Weeks)|Death|2|||
105565256|NCT03420781|364066727|FG002|Treatment Period (40 Weeks)|Death|0|||
105738241|NCT01770353|364696881|FG000|Overall Study|Physician Decision|0|||
105738242|NCT01770353|364696882|FG001|Overall Study|Physician Decision|3|||
105738243|NCT01770353|364696881|FG000|Overall Study|Clinical deterioration|3|||
105738244|NCT01770353|364696882|FG001|Overall Study|Clinical deterioration|6|||
105738245|NCT01770353|364696881|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
105738246|NCT01770353|364696882|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
105738247|NCT05270694|364698191|FG000|Overall Study|Death|1|||
105738248|NCT05270694|364698191|FG000|Overall Study|Medical issues impacted ability to participate|2|||
105738249|NCT05270694|364698191|FG000|Overall Study|Lost to Follow-up|3|||
105738250|NCT05270694|364698191|FG000|Overall Study|Withdrawal by Subject|3|||
105738251|NCT00408421|364698209|FG000|Treatment Initial Randomization|Adverse Event|5|||
105738252|NCT00408421|364698210|FG001|Treatment Initial Randomization|Adverse Event|9|||
105738253|NCT00408421|364698211|FG002|Treatment Initial Randomization|Adverse Event|0|||
105738254|NCT00408421|364698209|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
105738255|NCT00408421|364698210|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
105738256|NCT00408421|364698211|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
105565257|NCT03420781|364066728|FG003|Treatment Period (40 Weeks)|Death|0|||
105482377|NCT00308581|363776986|FG002|Randomized Maintenance Phase|Adverse Event|0|||
105482378|NCT00308581|363776984|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
105482379|NCT00308581|363776985|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
105738257|NCT00408421|364698209|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
105738258|NCT00408421|364698210|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
105738259|NCT00408421|364698211|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
105482380|NCT00308581|363776986|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
105738260|NCT00408421|364698209|FG000|Treatment Initial Randomization|Physician Decision|1|||
105738261|NCT00408421|364698210|FG001|Treatment Initial Randomization|Physician Decision|0|||
105738262|NCT00408421|364698211|FG002|Treatment Initial Randomization|Physician Decision|0|||
105738263|NCT00408421|364698209|FG000|Treatment Initial Randomization|Protocol Violation|0|||
105738264|NCT00408421|364698210|FG001|Treatment Initial Randomization|Protocol Violation|1|||
105738265|NCT00408421|364698211|FG002|Treatment Initial Randomization|Protocol Violation|0|||
105738266|NCT00408421|364698209|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
105738267|NCT00408421|364698210|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
105738268|NCT00408421|364698211|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
105738269|NCT00408421|364698209|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
105738270|NCT00408421|364698210|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
105738271|NCT00408421|364698211|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
105738272|NCT00408421|364698209|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
105738273|NCT00408421|364698210|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
105356453|NCT05259917|363309683|FG001|Overall Study|Trial Termination by Sponsor|2|||
105356454|NCT05259917|363309684|FG002|Overall Study|Trial Termination by Sponsor|3|||
105356455|NCT05259917|363309685|FG003|Overall Study|Trial Termination by Sponsor|5|||
105356456|NCT05259917|363309686|FG004|Overall Study|Trial Termination by Sponsor|11|||
105356457|NCT05259917|363309687|FG005|Overall Study|Trial Termination by Sponsor|4|||
105356458|NCT05259917|363309682|FG000|Overall Study|Other|1|||
105356459|NCT05259917|363309683|FG001|Overall Study|Other|0|||
105356460|NCT05259917|363309684|FG002|Overall Study|Other|2|||
105356461|NCT05259917|363309685|FG003|Overall Study|Other|0|||
105356462|NCT05259917|363309686|FG004|Overall Study|Other|0|||
105356463|NCT05259917|363309687|FG005|Overall Study|Other|0|||
105356464|NCT01210222|363309690|FG000|Overall Study|Ineligible|2|||
105356465|NCT01210222|363309690|FG000|Overall Study|Never treated|1|||
105356466|NCT02081001|363309691|FG000|Overall Study|Adverse Event|0|||
105356467|NCT02081001|363309692|FG001|Overall Study|Adverse Event|0|||
105356468|NCT02081001|363309693|FG002|Overall Study|Adverse Event|0|||
105356469|NCT02081001|363309694|FG003|Overall Study|Adverse Event|0|||
105356470|NCT02081001|363309695|FG004|Overall Study|Adverse Event|1|||
105356471|NCT02081001|363309696|FG005|Overall Study|Adverse Event|0|||
105356472|NCT02081001|363309697|FG006|Overall Study|Adverse Event|0|||
105356473|NCT02081001|363309698|FG007|Overall Study|Adverse Event|0|||
105356474|NCT02081001|363309699|FG008|Overall Study|Adverse Event|0|||
105356475|NCT02081001|363309700|FG009|Overall Study|Adverse Event|0|||
105356476|NCT02081001|363309701|FG010|Overall Study|Adverse Event|0|||
105356477|NCT02081001|363309702|FG011|Overall Study|Adverse Event|0|||
105356478|NCT03382418|363309714|FG000|Overall Study|Withdrawal by Subject|1|||
105356479|NCT03382418|363309715|FG001|Overall Study|Withdrawal by Subject|0|||
105356480|NCT03382418|363309716|FG002|Overall Study|Withdrawal by Subject|0|||
105356481|NCT03382418|363309714|FG000|Overall Study|Lost to Follow-up|2|||
105356482|NCT03382418|363309715|FG001|Overall Study|Lost to Follow-up|3|||
105356483|NCT03382418|363309716|FG002|Overall Study|Lost to Follow-up|0|||
105356484|NCT00770913|363309717|FG000|Overall Study|Adverse Event|1|||
105356485|NCT00770913|363309718|FG001|Overall Study|Adverse Event|3|||
105356486|NCT00770913|363309719|FG002|Overall Study|Adverse Event|6|||
105356487|NCT00770913|363309717|FG000|Overall Study|Refusal to continue participation|6|||
105356488|NCT00770913|363309718|FG001|Overall Study|Refusal to continue participation|4|||
105356489|NCT00770913|363309719|FG002|Overall Study|Refusal to continue participation|5|||
105356490|NCT00770913|363309717|FG000|Overall Study|Physician Decision|0|||
105356491|NCT00770913|363309718|FG001|Overall Study|Physician Decision|1|||
105356492|NCT00770913|363309719|FG002|Overall Study|Physician Decision|1|||
105356493|NCT00770913|363309717|FG000|Overall Study|Protocol Violation|3|||
105356494|NCT00770913|363309718|FG001|Overall Study|Protocol Violation|0|||
105356495|NCT00770913|363309719|FG002|Overall Study|Protocol Violation|1|||
105356496|NCT00770913|363309717|FG000|Overall Study|Incorrect drug was allocated|1|||
105356497|NCT00770913|363309718|FG001|Overall Study|Incorrect drug was allocated|0|||
105356498|NCT00770913|363309719|FG002|Overall Study|Incorrect drug was allocated|0|||
105738274|NCT00408421|364698211|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
105738275|NCT00408421|364698209|FG000|Treatment Re-Randomization|Adverse Event|2|||
105356499|NCT04633226|363309720|FG000|Overall Study|Withdrawal by parent/guardian|4|||
105356500|NCT04633226|363309720|FG000|Overall Study|Randomized by mistake without study treatment|1|||
105482381|NCT00308581|363776984|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
105482382|NCT00308581|363776985|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
105738276|NCT00408421|364698210|FG001|Treatment Re-Randomization|Adverse Event|2|||
105356501|NCT01151345|363309724|FG000|First Intervention Period|Protocol Violation|0|||
105356502|NCT01151345|363309725|FG001|First Intervention Period|Protocol Violation|1|||
105356503|NCT04186221|363309728|FG000|Overall Study|Death|1|||
105356504|NCT00985686|363309731|FG000|Overall Study|Lost to Follow-up|1|||
105356505|NCT00985686|363309732|FG001|Overall Study|Lost to Follow-up|1|||
105482383|NCT00308581|363776986|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
105356506|NCT00985686|363309733|FG002|Overall Study|Lost to Follow-up|0|||
105356507|NCT00985686|363309734|FG003|Overall Study|Lost to Follow-up|2|||
105799750|NCT04380701|364924618|FG004|Overall Study|Death|0|||
105799751|NCT04380701|364924619|FG005|Overall Study|Death|0|||
105738277|NCT00408421|364698211|FG002|Treatment Re-Randomization|Adverse Event|4|||
105738278|NCT00408421|364698209|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
105738279|NCT00408421|364698210|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
105738280|NCT00408421|364698211|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
105738281|NCT00408421|364698209|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
105738282|NCT00408421|364698210|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
105738283|NCT00408421|364698211|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
105738284|NCT00408421|364698209|FG000|Treatment Re-Randomization|Physician Decision|1|||
105738285|NCT00408421|364698210|FG001|Treatment Re-Randomization|Physician Decision|3|||
105738286|NCT00408421|364698211|FG002|Treatment Re-Randomization|Physician Decision|0|||
105738287|NCT00408421|364698209|FG000|Treatment Re-Randomization|Protocol Violation|1|||
105738288|NCT00408421|364698210|FG001|Treatment Re-Randomization|Protocol Violation|1|||
105738289|NCT00408421|364698211|FG002|Treatment Re-Randomization|Protocol Violation|0|||
105738290|NCT00408421|364698209|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
105738291|NCT00408421|364698210|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
105738292|NCT00408421|364698211|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
105738293|NCT03314519|364698216|FG000|Overall Study|Protocol Violation|3|||
105738294|NCT03314519|364698217|FG001|Overall Study|Protocol Violation|2|||
105738295|NCT01912872|364698218|FG000|Overall Study|Lost to Follow-up|2|||
105738296|NCT01912872|364698219|FG001|Overall Study|Lost to Follow-up|3|||
105738297|NCT01912872|364698220|FG002|Overall Study|Lost to Follow-up|5|||
105738298|NCT01912872|364698221|FG003|Overall Study|Lost to Follow-up|5|||
105738299|NCT01912872|364698218|FG000|Overall Study|Other unspecified|3|||
105738300|NCT01912872|364698219|FG001|Overall Study|Other unspecified|1|||
105738301|NCT01912872|364698220|FG002|Overall Study|Other unspecified|3|||
105738302|NCT01912872|364698221|FG003|Overall Study|Other unspecified|0|||
105738303|NCT01912872|364698218|FG000|Overall Study|Informed consent withdrawn|0|||
105799752|NCT04380701|364924620|FG006|Overall Study|Death|0|||
105738304|NCT01912872|364698219|FG001|Overall Study|Informed consent withdrawn|0|||
105738305|NCT01912872|364698220|FG002|Overall Study|Informed consent withdrawn|1|||
105738306|NCT01912872|364698221|FG003|Overall Study|Informed consent withdrawn|1|||
105799753|NCT04380701|364924621|FG007|Overall Study|Death|0|||
105799754|NCT04380701|364924622|FG008|Overall Study|Death|0|||
105799755|NCT04380701|364924623|FG009|Overall Study|Death|0|||
105799756|NCT04380701|364924624|FG010|Overall Study|Death|0|||
105482384|NCT00308581|363776984|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
105482385|NCT00308581|363776985|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
105738307|NCT01912872|364698218|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
105799757|NCT04380701|364924625|FG011|Overall Study|Death|0|||
105799758|NCT04380701|364924626|FG012|Overall Study|Death|0|||
105738308|NCT01912872|364698219|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
105356508|NCT03134911|363309735|FG000|Overall Study|Screen failure|31|||
105356509|NCT03134911|363309735|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
105356510|NCT02282163|363309742|FG000|Overall Study|Protocol Violation|1|||
105356511|NCT02182830|363309747|FG000|Overall Study|Not Treated|1|||
105356512|NCT02182830|363309748|FG001|Overall Study|Not Treated|1|||
105356513|NCT02182830|363309747|FG000|Overall Study|Trial stopped, reason missing|3|||
105356514|NCT02182830|363309748|FG001|Overall Study|Trial stopped, reason missing|3|||
105356515|NCT02182830|363309747|FG000|Overall Study|Consent withdrawn|8|||
105356516|NCT02182830|363309748|FG001|Overall Study|Consent withdrawn|8|||
105356517|NCT02182830|363309747|FG000|Overall Study|Lost to Follow-up|3|||
105356518|NCT02182830|363309748|FG001|Overall Study|Lost to Follow-up|3|||
105356519|NCT04227405|363311521|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
105356520|NCT04227405|363311522|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
105356521|NCT04227405|363311521|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
105356522|NCT04227405|363311522|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
105356523|NCT04227405|363311521|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
105356524|NCT04227405|363311522|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
105356525|NCT01128400|363311523|FG000|Overall Study|Lost to Follow-up|1|||
105356526|NCT01128400|363311524|FG001|Overall Study|Lost to Follow-up|0|||
105356527|NCT01128400|363311525|FG002|Overall Study|Lost to Follow-up|1|||
105356528|NCT01128400|363311523|FG000|Overall Study|Screening failure|1|||
105356529|NCT01128400|363311524|FG001|Overall Study|Screening failure|0|||
105356530|NCT01128400|363311525|FG002|Overall Study|Screening failure|0|||
105356531|NCT01128400|363311523|FG000|Overall Study|were not invited to participate on taste|0|||
105356532|NCT01128400|363311524|FG001|Overall Study|were not invited to participate on taste|0|||
105356533|NCT01128400|363311525|FG002|Overall Study|were not invited to participate on taste|15|||
105356534|NCT01128400|363311523|FG000|Overall Study|Excluded due to sinus problems|0|||
105356535|NCT01128400|363311524|FG001|Overall Study|Excluded due to sinus problems|1|||
105356536|NCT01128400|363311525|FG002|Overall Study|Excluded due to sinus problems|0|||
105356537|NCT04304508|363311526|FG000|Overall Study|Subject Decision|29|||
105356538|NCT04304508|363311527|FG001|Overall Study|Subject Decision|39|||
105356539|NCT04304508|363311528|FG002|Overall Study|Subject Decision|37|||
105356540|NCT04304508|363311529|FG003|Overall Study|Subject Decision|48|||
105356541|NCT04304508|363311526|FG000|Overall Study|Death|6|||
105356542|NCT04304508|363311527|FG001|Overall Study|Death|1|||
105356543|NCT04304508|363311528|FG002|Overall Study|Death|8|||
105356544|NCT04304508|363311529|FG003|Overall Study|Death|5|||
105356545|NCT04304508|363311526|FG000|Overall Study|Non-compliance With Study Drug|3|||
105356546|NCT04304508|363311527|FG001|Overall Study|Non-compliance With Study Drug|1|||
105356547|NCT04304508|363311528|FG002|Overall Study|Non-compliance With Study Drug|2|||
105356548|NCT04304508|363311529|FG003|Overall Study|Non-compliance With Study Drug|0|||
105356549|NCT04304508|363311526|FG000|Overall Study|Switching To Other Therapy|1|||
105356550|NCT04304508|363311527|FG001|Overall Study|Switching To Other Therapy|1|||
105356551|NCT04304508|363311528|FG002|Overall Study|Switching To Other Therapy|1|||
105356552|NCT04304508|363311529|FG003|Overall Study|Switching To Other Therapy|2|||
105356553|NCT04304508|363311526|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
105356554|NCT04304508|363311527|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
105356555|NCT04304508|363311528|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
105356556|NCT04304508|363311529|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
105356557|NCT04304508|363311526|FG000|Overall Study|Withdrawal by Subject|7|||
105356558|NCT04304508|363311527|FG001|Overall Study|Withdrawal by Subject|5|||
105356559|NCT04304508|363311528|FG002|Overall Study|Withdrawal by Subject|11|||
105356560|NCT04304508|363311529|FG003|Overall Study|Withdrawal by Subject|6|||
105356561|NCT04304508|363311526|FG000|Overall Study|Logistical Difficulties|2|||
105356562|NCT04304508|363311527|FG001|Overall Study|Logistical Difficulties|2|||
105356563|NCT04304508|363311528|FG002|Overall Study|Logistical Difficulties|3|||
105356564|NCT04304508|363311529|FG003|Overall Study|Logistical Difficulties|2|||
105356565|NCT04304508|363311526|FG000|Overall Study|Missing Information|1|||
105356566|NCT04304508|363311527|FG001|Overall Study|Missing Information|2|||
105356567|NCT04304508|363311528|FG002|Overall Study|Missing Information|1|||
105356568|NCT04304508|363311529|FG003|Overall Study|Missing Information|3|||
105356569|NCT04304508|363311526|FG000|Overall Study|Other|7|||
105356570|NCT04304508|363311527|FG001|Overall Study|Other|6|||
105356571|NCT04304508|363311528|FG002|Overall Study|Other|5|||
105356572|NCT04304508|363311529|FG003|Overall Study|Other|4|||
105356573|NCT04304508|363311526|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
105356574|NCT04304508|363311527|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
105356575|NCT04304508|363311528|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
105356576|NCT04304508|363311529|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
105356577|NCT04304508|363311526|FG000|Overall Study|Physician Decision|3|||
105356578|NCT04304508|363311527|FG001|Overall Study|Physician Decision|4|||
105482386|NCT00308581|363776986|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
105356579|NCT04304508|363311528|FG002|Overall Study|Physician Decision|9|||
105565258|NCT03420781|364066729|FG004|Treatment Period (40 Weeks)|Death|0|||
105738309|NCT01912872|364698220|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
105738310|NCT01912872|364698221|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
105738311|NCT01912872|364698218|FG000|Overall Study|Protocol Violation|0|||
105738312|NCT01912872|364698219|FG001|Overall Study|Protocol Violation|0|||
105738313|NCT01912872|364698220|FG002|Overall Study|Protocol Violation|1|||
105738314|NCT01912872|364698221|FG003|Overall Study|Protocol Violation|0|||
105738315|NCT01912872|364698218|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105738316|NCT01912872|364698219|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105738317|NCT01912872|364698220|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105738318|NCT01912872|364698221|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
105738319|NCT01912872|364698218|FG000|Overall Study|Withdrawal of study medication|0|||
105738320|NCT01912872|364698219|FG001|Overall Study|Withdrawal of study medication|0|||
105738321|NCT01912872|364698220|FG002|Overall Study|Withdrawal of study medication|0|||
105738322|NCT01912872|364698221|FG003|Overall Study|Withdrawal of study medication|2|||
105738323|NCT01912872|364698218|FG000|Overall Study|Missing|0|||
105738324|NCT01912872|364698219|FG001|Overall Study|Missing|0|||
105738325|NCT01912872|364698220|FG002|Overall Study|Missing|0|||
105738326|NCT01912872|364698221|FG003|Overall Study|Missing|1|||
105738327|NCT02940886|364698222|FG000|Overall Study|Adverse Event|7|||
105738328|NCT02940886|364698223|FG001|Overall Study|Adverse Event|3|||
105738329|NCT02940886|364698222|FG000|Overall Study|Protocol Violation|0|||
105738330|NCT02940886|364698223|FG001|Overall Study|Protocol Violation|2|||
105738331|NCT02940886|364698222|FG000|Overall Study|Withdrawal by Subject|28|||
105738332|NCT02940886|364698223|FG001|Overall Study|Withdrawal by Subject|20|||
105738333|NCT02940886|364698222|FG000|Overall Study|Death|1|||
105738334|NCT02940886|364698223|FG001|Overall Study|Death|0|||
105738335|NCT02940886|364698222|FG000|Overall Study|Lack of Efficacy|1|||
105738336|NCT02940886|364698223|FG001|Overall Study|Lack of Efficacy|0|||
105738337|NCT02940886|364698222|FG000|Overall Study|Lost to Follow-up|49|||
105738338|NCT02940886|364698223|FG001|Overall Study|Lost to Follow-up|21|||
105738339|NCT02940886|364698222|FG000|Overall Study|Physician Decision|9|||
105738340|NCT02940886|364698223|FG001|Overall Study|Physician Decision|4|||
105738341|NCT02940886|364698222|FG000|Overall Study|Sponsor decision|0|||
105738342|NCT02940886|364698223|FG001|Overall Study|Sponsor decision|1|||
105738343|NCT02940886|364698222|FG000|Overall Study|No treatment|7|||
105738344|NCT02940886|364698223|FG001|Overall Study|No treatment|2|||
105738345|NCT02940886|364698222|FG000|Overall Study|Enrolment error|0|||
105738346|NCT02940886|364698223|FG001|Overall Study|Enrolment error|1|||
105738347|NCT01306058|364698224|FG000|Overall Study|Death|1|||
105738348|NCT01306058|364698224|FG000|Overall Study|Enrolled but did not get treatment|1|||
105738349|NCT01666444|364698225|FG000|Overall Study|Did not initiate treatment|2|||
105738350|NCT01666444|364698226|FG001|Overall Study|Did not initiate treatment|1|||
105738351|NCT03074162|364698227|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
105738352|NCT03074162|364698228|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
105738353|NCT03074162|364698229|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
105738354|NCT03074162|364698230|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
105738355|NCT03074162|364698231|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
105738356|NCT03074162|364698232|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
105738357|NCT03074162|364698227|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
105738358|NCT03074162|364698228|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
105738359|NCT03074162|364698229|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
105738360|NCT03074162|364698230|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
105738361|NCT03074162|364698231|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
105738362|NCT03074162|364698232|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
105738363|NCT03074162|364698227|FG000|Period 3|Withdrawal by Subject|1|||
105738364|NCT03074162|364698228|FG001|Period 3|Withdrawal by Subject|0|||
105738365|NCT03074162|364698229|FG002|Period 3|Withdrawal by Subject|0|||
105738366|NCT03074162|364698230|FG003|Period 3|Withdrawal by Subject|0|||
105738367|NCT03074162|364698231|FG004|Period 3|Withdrawal by Subject|1|||
105356580|NCT04304508|363311529|FG003|Overall Study|Physician Decision|7|||
105356581|NCT04304508|363311526|FG000|Overall Study|Study drug never administered|10|||
105356582|NCT04304508|363311527|FG001|Overall Study|Study drug never administered|4|||
105356583|NCT04304508|363311528|FG002|Overall Study|Study drug never administered|4|||
105356584|NCT04304508|363311529|FG003|Overall Study|Study drug never administered|4|||
105356585|NCT04304508|363311526|FG000|Overall Study|Adverse Event|49|||
105356586|NCT04304508|363311527|FG001|Overall Study|Adverse Event|50|||
105356587|NCT04304508|363311528|FG002|Overall Study|Adverse Event|51|||
105356588|NCT04304508|363311529|FG003|Overall Study|Adverse Event|56|||
105356589|NCT04304508|363311526|FG000|Overall Study|Lost to Follow-up|1|||
105356590|NCT04304508|363311527|FG001|Overall Study|Lost to Follow-up|5|||
105356591|NCT04304508|363311528|FG002|Overall Study|Lost to Follow-up|2|||
105356592|NCT04304508|363311529|FG003|Overall Study|Lost to Follow-up|3|||
105356593|NCT01775787|363311536|FG000|First 7-10 Days|Adverse Event|0|||
105356594|NCT01775787|363311537|FG001|First 7-10 Days|Adverse Event|1|||
105356595|NCT01775787|363311536|FG000|First 7-10 Days|family emergency|0|||
105356596|NCT01775787|363311537|FG001|First 7-10 Days|family emergency|1|||
105356597|NCT01775787|363311536|FG000|First 7-10 Days|time commitment|0|||
105356598|NCT01775787|363311537|FG001|First 7-10 Days|time commitment|2|||
105356599|NCT01775787|363311536|FG000|First 7-10 Days|concerns with using IV|1|||
105356600|NCT01775787|363311537|FG001|First 7-10 Days|concerns with using IV|2|||
105356601|NCT01775787|363311536|FG000|Second 7-10 Days|time commitment|0|||
105356602|NCT01775787|363311537|FG001|Second 7-10 Days|time commitment|1|||
105356603|NCT01775787|363311536|FG000|Second 7-10 Days|concerns with using IV|0|||
105356604|NCT01775787|363311537|FG001|Second 7-10 Days|concerns with using IV|1|||
105356605|NCT01299896|363311538|FG000|Overall Study|Withdrawal by Subject|1|||
105356606|NCT01299896|363311539|FG001|Overall Study|Withdrawal by Subject|7|||
105356607|NCT01299896|363311538|FG000|Overall Study|Lost to Follow-up|0|||
105356608|NCT01299896|363311539|FG001|Overall Study|Lost to Follow-up|11|||
105356609|NCT03252145|363311540|FG000|Overall Study|Withdrawal by Subject|1|||
105356610|NCT03252145|363311541|FG001|Overall Study|Withdrawal by Subject|0|||
105356611|NCT03252145|363311540|FG000|Overall Study|Complicating Disease|1|||
105356612|NCT03252145|363311541|FG001|Overall Study|Complicating Disease|2|||
105356613|NCT02849171|363311550|FG000|Overall Study|Withdrawal by Subject|1|||
105356614|NCT02849171|363311550|FG000|Overall Study|Not treated|1|||
105356615|NCT02090283|363311552|FG000|Overall Study|Withdrawal by Subject|6|||
105356616|NCT02090283|363311553|FG001|Overall Study|Withdrawal by Subject|6|||
105356617|NCT02090283|363311554|FG002|Overall Study|Withdrawal by Subject|6|||
105356618|NCT02090283|363311552|FG000|Overall Study|Sponsor Terminated Study|6|||
105356619|NCT02090283|363311553|FG001|Overall Study|Sponsor Terminated Study|6|||
105356620|NCT02090283|363311554|FG002|Overall Study|Sponsor Terminated Study|1|||
105356621|NCT02090283|363311552|FG000|Overall Study|Lost to Follow-up|2|||
105356622|NCT02090283|363311553|FG001|Overall Study|Lost to Follow-up|2|||
105356623|NCT02090283|363311554|FG002|Overall Study|Lost to Follow-up|3|||
105356624|NCT02090283|363311552|FG000|Overall Study|Adverse Event|1|||
105356625|NCT02090283|363311553|FG001|Overall Study|Adverse Event|1|||
105356626|NCT02090283|363311554|FG002|Overall Study|Adverse Event|0|||
105356627|NCT02090283|363311552|FG000|Overall Study|Protocol Violation|2|||
105356628|NCT02090283|363311553|FG001|Overall Study|Protocol Violation|0|||
105356629|NCT02090283|363311554|FG002|Overall Study|Protocol Violation|0|||
105356630|NCT02372383|363311560|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
105356631|NCT02372383|363311561|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
105356632|NCT02372383|363311562|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
105356633|NCT00667563|363311563|FG000|Overall Study|Protocol Violation|24|||
105356634|NCT02075008|363311564|FG000|Overall Study|Technical problems|1|||
105356635|NCT02075008|363311564|FG000|Overall Study|Pregnancy|1|||
105356636|NCT02075008|363311564|FG000|Overall Study|Physician Decision|1|||
105356637|NCT02075008|363311564|FG000|Overall Study|Lost to Follow-up|1|||
105356638|NCT02075008|363311564|FG000|Overall Study|Lack of Efficacy|1|||
105356639|NCT02075008|363311564|FG000|Overall Study|Death|1|||
105356640|NCT02075008|363311564|FG000|Overall Study|Adverse Event|5|||
105356641|NCT02075008|363311564|FG000|Overall Study|Withdrawal by Subject|6|||
105356642|NCT02075008|363311564|FG000|Overall Study|Study terminated by Sponsor|159|||
105356643|NCT02465437|363311565|FG000|Overall Study|Physician Decision|0|||
105738368|NCT03074162|364698232|FG005|Period 3|Withdrawal by Subject|0|||
105738369|NCT00950690|364698235|FG000|Overall Study|Death|4|||
105738370|NCT00950690|364698235|FG000|Overall Study|Adverse Event|15|||
105738371|NCT00950690|364698235|FG000|Overall Study|Lack of Efficacy|22|||
105738372|NCT00950690|364698235|FG000|Overall Study|Lost to Follow-up|40|||
105356644|NCT02465437|363311566|FG001|Overall Study|Physician Decision|0|||
105356645|NCT02465437|363311567|FG002|Overall Study|Physician Decision|1|||
105356646|NCT02465437|363311568|FG003|Overall Study|Physician Decision|0|||
105356647|NCT02465437|363311565|FG000|Overall Study|Withdrawal by Subject|1|||
105356648|NCT02465437|363311566|FG001|Overall Study|Withdrawal by Subject|0|||
105356649|NCT02465437|363311567|FG002|Overall Study|Withdrawal by Subject|0|||
105356650|NCT02465437|363311568|FG003|Overall Study|Withdrawal by Subject|1|||
105356651|NCT02465437|363311565|FG000|Overall Study|Adverse Event|0|||
105356652|NCT02465437|363311566|FG001|Overall Study|Adverse Event|1|||
105356653|NCT02465437|363311567|FG002|Overall Study|Adverse Event|0|||
105356654|NCT02465437|363311568|FG003|Overall Study|Adverse Event|0|||
105356655|NCT03117361|363311571|FG000|Overall Study|Progressive disease|5|||
105356656|NCT03117361|363311571|FG000|Overall Study|Death|1|||
105356657|NCT03117361|363311571|FG000|Overall Study|Physician Decision|2|||
105356658|NCT03117361|363311571|FG000|Overall Study|On study treatment at the end of study|1|||
105356659|NCT03117361|363311571|FG000|Overall Study|Treatment-related adverse event|1|||
105356660|NCT00943592|363311574|FG000|Overall Study|Death|3|||
105356661|NCT01152996|363311575|FG000|Overall Study|Withdrawal by Subject|142|||
105356662|NCT01152996|363311575|FG000|Overall Study|Adverse Event|115|||
105356663|NCT01152996|363311575|FG000|Overall Study|Lost to Follow-up|112|||
105356664|NCT01152996|363311575|FG000|Overall Study|Lack of Efficacy|68|||
105356665|NCT01152996|363311575|FG000|Overall Study|Noncompliance|41|||
105356666|NCT01152996|363311575|FG000|Overall Study|Other|36|||
105356667|NCT01152996|363311575|FG000|Overall Study|Protocol Violation|22|||
105356668|NCT01152996|363311575|FG000|Overall Study|Elevated liver enzymes|1|||
105356669|NCT03465709|363311585|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
105356670|NCT03465709|363311585|FG000|Overall Study|Withdrawal by Subject|3|||
105356671|NCT00272844|363311586|FG000|Overall Study|Withdrawal by Subject|5|||
105356672|NCT02959918|363311591|FG000|Overall Study|Adverse Event|1|||
105356673|NCT02959918|363311592|FG001|Overall Study|Adverse Event|1|||
105356674|NCT02959918|363311593|FG002|Overall Study|Adverse Event|2|||
105356675|NCT02959918|363311594|FG003|Overall Study|Adverse Event|0|||
105356676|NCT02959918|363311595|FG004|Overall Study|Adverse Event|0|||
105356677|NCT02959918|363311596|FG005|Overall Study|Adverse Event|2|||
105356678|NCT02959918|363311597|FG006|Overall Study|Adverse Event|2|||
105356679|NCT02959918|363311598|FG007|Overall Study|Adverse Event|1|||
105356680|NCT02959918|363311599|FG008|Overall Study|Adverse Event|2|||
105356681|NCT02959918|363311600|FG009|Overall Study|Adverse Event|1|||
105356682|NCT02959918|363311601|FG010|Overall Study|Adverse Event|1|||
105356683|NCT02959918|363311602|FG011|Overall Study|Adverse Event|3|||
105356684|NCT02959918|363311603|FG012|Overall Study|Adverse Event|2|||
105356685|NCT02959918|363311604|FG013|Overall Study|Adverse Event|4|||
105356686|NCT02959918|363311591|FG000|Overall Study|Lost to Follow-up|0|||
105356687|NCT02959918|363311592|FG001|Overall Study|Lost to Follow-up|0|||
105356688|NCT02959918|363311593|FG002|Overall Study|Lost to Follow-up|0|||
105356689|NCT02959918|363311594|FG003|Overall Study|Lost to Follow-up|0|||
105356690|NCT02959918|363311595|FG004|Overall Study|Lost to Follow-up|0|||
105356691|NCT02959918|363311596|FG005|Overall Study|Lost to Follow-up|0|||
105356692|NCT02959918|363311597|FG006|Overall Study|Lost to Follow-up|0|||
105356693|NCT02959918|363311598|FG007|Overall Study|Lost to Follow-up|0|||
105356694|NCT02959918|363311599|FG008|Overall Study|Lost to Follow-up|0|||
105356695|NCT02959918|363311600|FG009|Overall Study|Lost to Follow-up|1|||
105356696|NCT02959918|363311601|FG010|Overall Study|Lost to Follow-up|0|||
105356697|NCT02959918|363311602|FG011|Overall Study|Lost to Follow-up|0|||
105356698|NCT02959918|363311603|FG012|Overall Study|Lost to Follow-up|1|||
105356699|NCT02959918|363311604|FG013|Overall Study|Lost to Follow-up|0|||
105356700|NCT02959918|363311591|FG000|Overall Study|Withdrawal by Subject|0|||
105356701|NCT02959918|363311592|FG001|Overall Study|Withdrawal by Subject|0|||
105356702|NCT02959918|363311593|FG002|Overall Study|Withdrawal by Subject|1|||
105356703|NCT02959918|363311594|FG003|Overall Study|Withdrawal by Subject|2|||
105356704|NCT02959918|363311595|FG004|Overall Study|Withdrawal by Subject|0|||
105356705|NCT02959918|363311596|FG005|Overall Study|Withdrawal by Subject|0|||
105356706|NCT02959918|363311597|FG006|Overall Study|Withdrawal by Subject|1|||
105356707|NCT02959918|363311598|FG007|Overall Study|Withdrawal by Subject|0|||
105356708|NCT02959918|363311599|FG008|Overall Study|Withdrawal by Subject|1|||
105356709|NCT02959918|363311600|FG009|Overall Study|Withdrawal by Subject|1|||
105356710|NCT02959918|363311601|FG010|Overall Study|Withdrawal by Subject|2|||
105356711|NCT02959918|363311602|FG011|Overall Study|Withdrawal by Subject|3|||
105356712|NCT02959918|363311603|FG012|Overall Study|Withdrawal by Subject|1|||
105356713|NCT02959918|363311604|FG013|Overall Study|Withdrawal by Subject|1|||
105356714|NCT02959918|363311591|FG000|Overall Study|Protocol Violation|0|||
105356715|NCT02959918|363311592|FG001|Overall Study|Protocol Violation|0|||
105356716|NCT02959918|363311593|FG002|Overall Study|Protocol Violation|1|||
105356717|NCT02959918|363311594|FG003|Overall Study|Protocol Violation|0|||
105356718|NCT02959918|363311595|FG004|Overall Study|Protocol Violation|0|||
105356719|NCT02959918|363311596|FG005|Overall Study|Protocol Violation|1|||
105356720|NCT02959918|363311597|FG006|Overall Study|Protocol Violation|0|||
105356721|NCT02959918|363311598|FG007|Overall Study|Protocol Violation|0|||
105356722|NCT02959918|363311599|FG008|Overall Study|Protocol Violation|2|||
105356723|NCT02959918|363311600|FG009|Overall Study|Protocol Violation|1|||
105356724|NCT02959918|363311601|FG010|Overall Study|Protocol Violation|0|||
105356725|NCT02959918|363311602|FG011|Overall Study|Protocol Violation|1|||
105356726|NCT02959918|363311603|FG012|Overall Study|Protocol Violation|1|||
105356727|NCT02959918|363311604|FG013|Overall Study|Protocol Violation|0|||
105356728|NCT02959918|363311591|FG000|Overall Study|Stopping Rule Met|1|||
105356729|NCT02959918|363311592|FG001|Overall Study|Stopping Rule Met|0|||
105356730|NCT02959918|363311593|FG002|Overall Study|Stopping Rule Met|3|||
105356731|NCT02959918|363311594|FG003|Overall Study|Stopping Rule Met|4|||
105356732|NCT02959918|363311595|FG004|Overall Study|Stopping Rule Met|5|||
105356733|NCT02959918|363311596|FG005|Overall Study|Stopping Rule Met|3|||
105356734|NCT02959918|363311597|FG006|Overall Study|Stopping Rule Met|2|||
105356735|NCT02959918|363311598|FG007|Overall Study|Stopping Rule Met|4|||
105356736|NCT02959918|363311599|FG008|Overall Study|Stopping Rule Met|1|||
105356737|NCT02959918|363311600|FG009|Overall Study|Stopping Rule Met|1|||
105356738|NCT02959918|363311601|FG010|Overall Study|Stopping Rule Met|3|||
105356739|NCT02959918|363311602|FG011|Overall Study|Stopping Rule Met|5|||
105356740|NCT02959918|363311603|FG012|Overall Study|Stopping Rule Met|2|||
105356741|NCT02959918|363311604|FG013|Overall Study|Stopping Rule Met|1|||
105356742|NCT02959918|363311591|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
105356743|NCT02959918|363311592|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
105356744|NCT02959918|363311593|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
105356745|NCT02959918|363311594|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
105356746|NCT02959918|363311595|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105356747|NCT02959918|363311596|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105356748|NCT02959918|363311597|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105356749|NCT02959918|363311598|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105356750|NCT02959918|363311599|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105356751|NCT02959918|363311600|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105356752|NCT02959918|363311601|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105356753|NCT02959918|363311602|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105565259|NCT03420781|364066725|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
105738373|NCT00950690|364698235|FG000|Overall Study|Other|163|||
105356754|NCT02959918|363311603|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105356755|NCT02959918|363311604|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105738374|NCT01713036|364698240|FG000|Overall Study|Death|1|||
105356756|NCT02959918|363311591|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105356757|NCT02959918|363311592|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105356758|NCT02959918|363311593|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105738375|NCT00592358|364698241|FG000|Overall Study|Withdrawal by Subject|2|||
105356759|NCT02959918|363311594|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105356760|NCT02959918|363311595|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105356761|NCT02959918|363311596|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105356762|NCT02959918|363311597|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105738376|NCT00592358|364698241|FG000|Overall Study|Adverse Event|1|||
105738377|NCT00592358|364698241|FG000|Overall Study|Lack of Efficacy|2|||
105738378|NCT00592358|364698241|FG000|Overall Study|Inability to swallow pills|1|||
105738379|NCT02778867|364698242|FG000|Phase 1|Withdrawal by Subject|2|||
105738380|NCT02778867|364698243|FG001|Phase 1|Withdrawal by Subject|3|||
105738381|NCT02778867|364698244|FG002|Phase 1|Withdrawal by Subject|0|||
105738382|NCT02778867|364698245|FG003|Phase 1|Withdrawal by Subject|0|||
105738383|NCT02778867|364698242|FG000|Phase 2|Withdrawal by Subject|0|||
105738384|NCT02778867|364698243|FG001|Phase 2|Withdrawal by Subject|0|||
105738385|NCT02778867|364698244|FG002|Phase 2|Withdrawal by Subject|1|||
105738386|NCT02778867|364698245|FG003|Phase 2|Withdrawal by Subject|0|||
105738387|NCT02778867|364698242|FG000|Phase 2|Physician Decision|0|||
105738388|NCT02778867|364698243|FG001|Phase 2|Physician Decision|0|||
105738389|NCT02778867|364698244|FG002|Phase 2|Physician Decision|0|||
105738390|NCT02778867|364698245|FG003|Phase 2|Physician Decision|1|||
105738391|NCT02778867|364698242|FG000|Phase 2|Adverse Event|0|||
105738392|NCT02778867|364698243|FG001|Phase 2|Adverse Event|0|||
105738393|NCT02778867|364698244|FG002|Phase 2|Adverse Event|0|||
105738394|NCT02778867|364698245|FG003|Phase 2|Adverse Event|1|||
105738395|NCT00084682|364698246|FG000|Overall Study|Withdrawal by Subject|1|||
105738396|NCT01166659|364698247|FG000|Overall Study|Subject Decision|8|||
105738397|NCT01166659|364698247|FG000|Overall Study|Investigator Decision|2|||
105738398|NCT01166659|364698247|FG000|Overall Study|Death|1|||
105738399|NCT01166659|364698247|FG000|Overall Study|Lost to Follow-up|1|||
105738400|NCT01166659|364698247|FG000|Overall Study|Study Closed at Site|1|||
105738401|NCT04760314|364698248|FG000|Induction Period|Withdrawal by Subject|0|||
105738402|NCT04760314|364698249|FG001|Induction Period|Withdrawal by Subject|1|||
105738403|NCT04760314|364698250|FG002|Induction Period|Withdrawal by Subject|1|||
105738404|NCT04760314|364698251|FG003|Induction Period|Withdrawal by Subject|0|||
105738405|NCT04760314|364698252|FG004|Induction Period|Withdrawal by Subject|0|||
105738406|NCT04760314|364698253|FG005|Induction Period|Withdrawal by Subject|0|||
105738407|NCT04760314|364698254|FG006|Induction Period|Withdrawal by Subject|0|||
105738408|NCT04760314|364698255|FG007|Induction Period|Withdrawal by Subject|0|||
105738409|NCT04760314|364698256|FG008|Induction Period|Withdrawal by Subject|0|||
105738410|NCT04760314|364698257|FG009|Induction Period|Withdrawal by Subject|0|||
105738411|NCT04760314|364698258|FG010|Induction Period|Withdrawal by Subject|0|||
105738412|NCT04760314|364698248|FG000|Induction Period|Adverse Event|0|||
105738413|NCT04760314|364698249|FG001|Induction Period|Adverse Event|0|||
105738414|NCT04760314|364698250|FG002|Induction Period|Adverse Event|2|||
105738415|NCT04760314|364698251|FG003|Induction Period|Adverse Event|0|||
105738416|NCT04760314|364698252|FG004|Induction Period|Adverse Event|0|||
105738417|NCT04760314|364698253|FG005|Induction Period|Adverse Event|0|||
105738418|NCT04760314|364698254|FG006|Induction Period|Adverse Event|0|||
105738419|NCT04760314|364698255|FG007|Induction Period|Adverse Event|0|||
105738420|NCT04760314|364698256|FG008|Induction Period|Adverse Event|0|||
105738421|NCT04760314|364698257|FG009|Induction Period|Adverse Event|0|||
105738422|NCT04760314|364698258|FG010|Induction Period|Adverse Event|0|||
105738423|NCT04760314|364698248|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
105738424|NCT04760314|364698249|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
105738425|NCT04760314|364698250|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
105738426|NCT04760314|364698251|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
105738427|NCT04760314|364698252|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
105738428|NCT04760314|364698253|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
105738429|NCT04760314|364698254|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
105738430|NCT04760314|364698255|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
105738431|NCT04760314|364698256|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
105799759|NCT04380701|364924627|FG013|Overall Study|Death|0|||
105799760|NCT04380701|364924628|FG014|Overall Study|Death|0|||
105738432|NCT04760314|364698257|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
105738433|NCT04760314|364698258|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
105738434|NCT04760314|364698248|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
105738435|NCT04760314|364698249|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
105738436|NCT04760314|364698250|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
105799761|NCT04380701|364924629|FG015|Overall Study|Death|0|||
105738437|NCT04760314|364698251|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
105738438|NCT04760314|364698252|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
105738439|NCT04760314|364698253|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
105738440|NCT04760314|364698254|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
105738441|NCT04760314|364698255|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
105738442|NCT04760314|364698256|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
105738443|NCT04760314|364698257|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
105738444|NCT04760314|364698258|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
105356763|NCT02959918|363311598|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
105356764|NCT02959918|363311599|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105356765|NCT02959918|363311600|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105356766|NCT02959918|363311601|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105356767|NCT02959918|363311602|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105356768|NCT02959918|363311603|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105356769|NCT02959918|363311604|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105356770|NCT02959918|363311591|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105356771|NCT02959918|363311592|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105356772|NCT02959918|363311593|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105356773|NCT02959918|363311594|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105738445|NCT04760314|364698248|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738446|NCT04760314|364698249|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738447|NCT04760314|364698250|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738448|NCT04760314|364698251|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738449|NCT04760314|364698252|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
105738450|NCT04760314|364698253|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738451|NCT04760314|364698254|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738452|NCT04760314|364698255|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738453|NCT04760314|364698256|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738454|NCT04760314|364698257|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738455|NCT04760314|364698258|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738456|NCT04760314|364698248|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
105738457|NCT04760314|364698249|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
105738458|NCT04760314|364698250|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
105738459|NCT04760314|364698251|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
105738460|NCT04760314|364698252|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
105738461|NCT04760314|364698253|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
105738462|NCT04760314|364698254|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
105738463|NCT04760314|364698255|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
105738464|NCT04760314|364698256|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
105738465|NCT04760314|364698257|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
105738466|NCT04760314|364698258|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
105738467|NCT04760314|364698248|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738468|NCT04760314|364698249|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738469|NCT04760314|364698250|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738470|NCT04760314|364698251|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738471|NCT04760314|364698252|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738472|NCT04760314|364698253|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738473|NCT04760314|364698254|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738474|NCT04760314|364698255|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
105738475|NCT04760314|364698256|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738476|NCT04760314|364698257|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
105738477|NCT04760314|364698258|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
105356774|NCT02959918|363311595|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105356775|NCT02959918|363311596|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105356776|NCT02959918|363311597|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105356777|NCT02959918|363311598|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105738478|NCT04760314|364698248|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738479|NCT04760314|364698249|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738480|NCT04760314|364698250|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738481|NCT04760314|364698251|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738482|NCT04760314|364698252|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738483|NCT04760314|364698253|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738484|NCT04760314|364698254|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738485|NCT04760314|364698255|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
105738486|NCT04760314|364698256|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
105738487|NCT04760314|364698257|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
105738488|NCT04760314|364698258|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738489|NCT04760314|364698248|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105356778|NCT02959918|363311599|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
105738490|NCT04760314|364698249|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105799762|NCT04380701|364924630|FG016|Overall Study|Death|0|||
105799763|NCT04380701|364924631|FG017|Overall Study|Death|0|||
105356779|NCT02959918|363311600|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105565260|NCT03420781|364066726|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
105356780|NCT02959918|363311601|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105356781|NCT02959918|363311602|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105356782|NCT02959918|363311603|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105356783|NCT02959918|363311604|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105356784|NCT02959918|363311591|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105356785|NCT02959918|363311592|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105356786|NCT02959918|363311593|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105356787|NCT02959918|363311594|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105356788|NCT02959918|363311595|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105356789|NCT02959918|363311596|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105356790|NCT02959918|363311597|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105356791|NCT02959918|363311598|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105356792|NCT02959918|363311599|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105356793|NCT02959918|363311600|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
105356794|NCT02959918|363311601|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105356795|NCT02959918|363311602|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105356796|NCT02959918|363311603|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105356797|NCT02959918|363311604|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105356798|NCT00837967|363311605|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
105356799|NCT00837967|363311606|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
105356800|NCT02782377|363311609|FG000|Overall Study|Physician Decision|5|||
105356801|NCT03883477|363311613|FG000|Overall Study|Death|1|||
105356802|NCT03883477|363311614|FG001|Overall Study|Death|0|||
105356803|NCT03883477|363311613|FG000|Overall Study|Protocol Violation|0|||
105356804|NCT03883477|363311614|FG001|Overall Study|Protocol Violation|1|||
105356805|NCT01904032|363311615|FG000|Overall Study|Adverse Event|3|||
105356806|NCT01904032|363311616|FG001|Overall Study|Adverse Event|1|||
105356807|NCT01904032|363311615|FG000|Overall Study|Lost to Follow-up|4|||
105356808|NCT01904032|363311616|FG001|Overall Study|Lost to Follow-up|2|||
105356809|NCT00003896|363311621|FG000|Overall Study|Adverse Event|16|||
105356810|NCT00003896|363311621|FG000|Overall Study|Withdrawal by Subject|1|||
105356811|NCT00003896|363311621|FG000|Overall Study|Lack of Efficacy|1|||
105356812|NCT00003896|363311621|FG000|Overall Study|Death|3|||
105356813|NCT00003896|363311621|FG000|Overall Study|not protocol specified|3|||
105356814|NCT00003896|363311621|FG000|Overall Study|ineligible|5|||
105356815|NCT01087203|363311622|FG000|Overall Study|Lost to Follow-up|2|||
105356816|NCT01087203|363311623|FG001|Overall Study|Lost to Follow-up|0|||
105356817|NCT01087203|363311622|FG000|Overall Study|Withdrawal by Subject|2|||
105356818|NCT01087203|363311623|FG001|Overall Study|Withdrawal by Subject|6|||
105356819|NCT01087203|363311622|FG000|Overall Study|Lack of Efficacy|1|||
105356820|NCT01087203|363311623|FG001|Overall Study|Lack of Efficacy|2|||
105356821|NCT01087203|363311622|FG000|Overall Study|Study terminated by sponsor|27|||
105356822|NCT01087203|363311623|FG001|Overall Study|Study terminated by sponsor|27|||
105356823|NCT05279131|363311635|FG000|Overall Study|Lost to Follow-up|1|||
105356824|NCT05279131|363311635|FG000|Overall Study|Death|1|||
105356825|NCT05279131|363311635|FG000|Overall Study|Physician Decision|1|||
105356826|NCT01868165|363311640|FG000|Overall Study|Withdrawal by Subject|36|||
105356827|NCT01868165|363311640|FG000|Overall Study|Physician Decision|2|||
105356828|NCT01868165|363311640|FG000|Overall Study|Lost to Follow-up|3|||
105356829|NCT01868165|363311640|FG000|Overall Study|Death|4|||
105356830|NCT03092791|363311641|FG000|Overall Study|Lost to Follow-up|0|||
105356831|NCT03092791|363311642|FG001|Overall Study|Lost to Follow-up|0|||
105356832|NCT03092791|363311643|FG002|Overall Study|Lost to Follow-up|0|||
105356833|NCT03092791|363311644|FG003|Overall Study|Lost to Follow-up|0|||
105356834|NCT03092791|363311645|FG004|Overall Study|Lost to Follow-up|0|||
105356835|NCT03092791|363311646|FG005|Overall Study|Lost to Follow-up|0|||
105356836|NCT03092791|363311647|FG006|Overall Study|Lost to Follow-up|1|||
105356837|NCT03092791|363311648|FG007|Overall Study|Lost to Follow-up|0|||
105356838|NCT03092791|363311641|FG000|Overall Study|Withdrawal of Consent|0|||
105482387|NCT00308581|363776984|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
105482388|NCT00308581|363776985|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
105482389|NCT00308581|363776986|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
105482390|NCT00308581|363776984|FG000|Randomized Maintenance Phase|Unknown reason|3|||
105356839|NCT03092791|363311642|FG001|Overall Study|Withdrawal of Consent|0|||
105356840|NCT03092791|363311643|FG002|Overall Study|Withdrawal of Consent|0|||
105356841|NCT03092791|363311644|FG003|Overall Study|Withdrawal of Consent|0|||
105356842|NCT03092791|363311645|FG004|Overall Study|Withdrawal of Consent|4|||
105356843|NCT03092791|363311646|FG005|Overall Study|Withdrawal of Consent|12|||
105356844|NCT03092791|363311647|FG006|Overall Study|Withdrawal of Consent|6|||
105482391|NCT00308581|363776985|FG001|Randomized Maintenance Phase|Unknown reason|0|||
105482392|NCT00308581|363776986|FG002|Randomized Maintenance Phase|Unknown reason|0|||
105482393|NCT00899353|363776987|FG000|Overall Study|Adverse Event|2|||
105356845|NCT03092791|363311648|FG007|Overall Study|Withdrawal of Consent|4|||
105356846|NCT03092791|363311641|FG000|Overall Study|Study Termination|0|||
105356847|NCT03092791|363311642|FG001|Overall Study|Study Termination|0|||
105356848|NCT03092791|363311643|FG002|Overall Study|Study Termination|0|||
105356849|NCT03092791|363311644|FG003|Overall Study|Study Termination|0|||
105356850|NCT03092791|363311645|FG004|Overall Study|Study Termination|55|||
105356851|NCT03092791|363311646|FG005|Overall Study|Study Termination|46|||
105356852|NCT03092791|363311647|FG006|Overall Study|Study Termination|53|||
105356853|NCT03092791|363311648|FG007|Overall Study|Study Termination|55|||
105356854|NCT03092791|363311641|FG000|Overall Study|Death|0|||
105356855|NCT03092791|363311642|FG001|Overall Study|Death|0|||
105356856|NCT03092791|363311643|FG002|Overall Study|Death|0|||
105356857|NCT03092791|363311644|FG003|Overall Study|Death|0|||
105356858|NCT03092791|363311645|FG004|Overall Study|Death|0|||
105356859|NCT03092791|363311646|FG005|Overall Study|Death|1|||
105356860|NCT03092791|363311647|FG006|Overall Study|Death|0|||
105356861|NCT03092791|363311648|FG007|Overall Study|Death|1|||
105356862|NCT03092791|363311641|FG000|Overall Study|Reason Not Specified|0|||
105356863|NCT03092791|363311642|FG001|Overall Study|Reason Not Specified|0|||
105356864|NCT03092791|363311643|FG002|Overall Study|Reason Not Specified|0|||
105356865|NCT03092791|363311644|FG003|Overall Study|Reason Not Specified|0|||
105356866|NCT03092791|363311645|FG004|Overall Study|Reason Not Specified|1|||
105356867|NCT03092791|363311646|FG005|Overall Study|Reason Not Specified|1|||
105356868|NCT03092791|363311647|FG006|Overall Study|Reason Not Specified|0|||
105356869|NCT03092791|363311648|FG007|Overall Study|Reason Not Specified|0|||
105356870|NCT01990768|363311649|FG000|Intervention Started|Found to be ineligible|14|||
105356871|NCT01990768|363311650|FG001|Intervention Started|Found to be ineligible|13|||
105356872|NCT01990768|363311651|FG002|Intervention Started|Found to be ineligible|11|||
105356873|NCT01990768|363311649|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
105356874|NCT01990768|363311650|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
105356875|NCT01990768|363311651|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
105356876|NCT01990768|363311649|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
105356877|NCT01990768|363311650|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
105356878|NCT01990768|363311651|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
105356879|NCT01990768|363311649|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
105356880|NCT01990768|363311650|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
105356881|NCT01990768|363311651|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
105356882|NCT01990768|363311649|FG000|Intervention Started|Patient care priority|1|||
105356883|NCT01990768|363311650|FG001|Intervention Started|Patient care priority|2|||
105356884|NCT01990768|363311651|FG002|Intervention Started|Patient care priority|3|||
105356885|NCT01990768|363311649|FG000|Intervention Started|IV lost|2|||
105356886|NCT01990768|363311650|FG001|Intervention Started|IV lost|2|||
105356887|NCT01990768|363311651|FG002|Intervention Started|IV lost|2|||
105356888|NCT01990768|363311649|FG000|Intervention Started|Required CPR|1|||
105356889|NCT01990768|363311650|FG001|Intervention Started|Required CPR|1|||
105356890|NCT01990768|363311651|FG002|Intervention Started|Required CPR|0|||
105356891|NCT01990768|363311649|FG000|Intervention Started|Seizure or hx of seizure|0|||
105356892|NCT01990768|363311650|FG001|Intervention Started|Seizure or hx of seizure|0|||
105356893|NCT01990768|363311651|FG002|Intervention Started|Seizure or hx of seizure|2|||
105356894|NCT01990768|363311649|FG000|Intervention Started|Discovered to be pregnant|0|||
105356895|NCT01990768|363311650|FG001|Intervention Started|Discovered to be pregnant|1|||
105356896|NCT01990768|363311651|FG002|Intervention Started|Discovered to be pregnant|0|||
105356897|NCT01990768|363311649|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
105356898|NCT01990768|363311650|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
105356899|NCT01990768|363311651|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
105356900|NCT01990768|363311649|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
105356901|NCT01990768|363311650|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
105356902|NCT01990768|363311651|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
105356903|NCT01990768|363311649|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
105738491|NCT04760314|364698250|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738492|NCT04760314|364698251|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738493|NCT04760314|364698252|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738494|NCT04760314|364698253|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738495|NCT04760314|364698254|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738496|NCT04760314|364698255|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
105356904|NCT01990768|363311650|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
105356905|NCT01990768|363311651|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
105356906|NCT01990768|363311649|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
105356907|NCT01990768|363311650|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
105356908|NCT01990768|363311651|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
105356909|NCT01990768|363311649|FG000|Prehospital Study Drug Infusion|Death|3|||
105356910|NCT01990768|363311650|FG001|Prehospital Study Drug Infusion|Death|1|||
105482394|NCT00899353|363776987|FG000|Overall Study|Lost to Follow-up|1|||
105482395|NCT00899353|363776987|FG000|Overall Study|Withdrawal by Subject|2|||
105482396|NCT00436501|363776993|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
105482397|NCT00436501|363776994|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
105482398|NCT00436501|363776993|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
105738497|NCT04760314|364698256|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738498|NCT04760314|364698257|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738499|NCT04760314|364698258|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738500|NCT04760314|364698248|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738501|NCT04760314|364698249|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738502|NCT04760314|364698250|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738503|NCT04760314|364698251|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738504|NCT04760314|364698252|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738505|NCT04760314|364698253|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738506|NCT04760314|364698254|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738507|NCT04760314|364698255|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738508|NCT04760314|364698256|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
105738509|NCT04760314|364698257|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
105738510|NCT04760314|364698258|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738511|NCT03504774|364698265|FG000|Overall Study|Adverse Event|2|||
105738512|NCT03504774|364698266|FG001|Overall Study|Adverse Event|0|||
105738513|NCT03504774|364698265|FG000|Overall Study|Lost to Follow-up|0|||
105738514|NCT03504774|364698266|FG001|Overall Study|Lost to Follow-up|1|||
105738515|NCT03504774|364698265|FG000|Overall Study|Protocol Violation|11|||
105738516|NCT03504774|364698266|FG001|Overall Study|Protocol Violation|3|||
105738517|NCT03504774|364698265|FG000|Overall Study|failed wk 52 DBPCFC|1|||
105738518|NCT03504774|364698266|FG001|Overall Study|failed wk 52 DBPCFC|0|||
105738519|NCT03238248|364698268|FG000|Overall Study|Death|5|||
105738520|NCT03238248|364698268|FG000|Overall Study|Withdrawal by Subject|7|||
105738521|NCT03238248|364698268|FG000|Overall Study|Participant proceeding to transplant|10|||
105738522|NCT03238248|364698268|FG000|Overall Study|Lack of Efficacy|4|||
105738523|NCT03238248|364698268|FG000|Overall Study|Physician Decision|3|||
105738524|NCT03238248|364698268|FG000|Overall Study|Transitioning to another study|1|||
105738525|NCT03238248|364698268|FG000|Overall Study|No longer benefiting|1|||
105738526|NCT03238248|364698268|FG000|Overall Study|Other complicating disease|1|||
105738527|NCT03238248|364698268|FG000|Overall Study|Adverse Event|5|||
105738528|NCT03238248|364698268|FG000|Overall Study|Disease progression|26|||
105738529|NCT03238248|364698268|FG000|Overall Study|N/A participant is still on treatment|1|||
105738530|NCT03238248|364698268|FG000|Overall Study|Decline in condition|1|||
105738531|NCT03238248|364698268|FG000|Overall Study|Alternative therapy|2|||
105738532|NCT00305006|364698273|FG000|Overall Study|Withdrawal by Subject|1|||
105738533|NCT00305006|364698274|FG001|Overall Study|Withdrawal by Subject|0|||
105738534|NCT00305006|364698273|FG000|Overall Study|Failure to complete pretest|0|||
105738535|NCT00305006|364698274|FG001|Overall Study|Failure to complete pretest|1|||
105738536|NCT00631488|364698275|FG000|Overall Study|Adverse Event|1|||
105738537|NCT00631488|364698276|FG001|Overall Study|Adverse Event|0|||
105738538|NCT00631488|364698277|FG002|Overall Study|Adverse Event|0|||
105738539|NCT00631488|364698275|FG000|Overall Study|Lost to Follow-up|2|||
105738540|NCT00631488|364698276|FG001|Overall Study|Lost to Follow-up|2|||
105738541|NCT00631488|364698277|FG002|Overall Study|Lost to Follow-up|0|||
105738542|NCT00631488|364698275|FG000|Overall Study|Physician Decision|1|||
105482399|NCT00436501|363776994|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
105738543|NCT00631488|364698276|FG001|Overall Study|Physician Decision|0|||
105738544|NCT00631488|364698277|FG002|Overall Study|Physician Decision|1|||
105738545|NCT00631488|364698275|FG000|Overall Study|Protocol Violation|0|||
105738546|NCT00631488|364698276|FG001|Overall Study|Protocol Violation|0|||
105738547|NCT00631488|364698277|FG002|Overall Study|Protocol Violation|1|||
105356911|NCT01990768|363311651|FG002|Prehospital Study Drug Infusion|Death|1|||
105356912|NCT01990768|363311649|FG000|Prehospital Study Drug Infusion|Discharged|2|||
105356913|NCT01990768|363311650|FG001|Prehospital Study Drug Infusion|Discharged|1|||
105738548|NCT03648476|364698278|FG000|Overall Study|Withdrawal by Subject|2|||
105738549|NCT03648476|364698279|FG001|Overall Study|Withdrawal by Subject|1|||
105738550|NCT02606045|364698280|FG000|Overall Study|Study closed before treament could begin|1|||
105738551|NCT02606045|364698281|FG001|Overall Study|Study closed before treament could begin|2|||
105738552|NCT00723840|364698292|FG000|Overall Study|Lost to Follow-up|2|||
105738553|NCT00723840|364698292|FG000|Overall Study|Failure to return|18|||
105738554|NCT00723840|364698292|FG000|Overall Study|Withdrawal by Subject|55|||
105738555|NCT00723840|364698292|FG000|Overall Study|Serious Adverse Events|3|||
105738556|NCT00723840|364698292|FG000|Overall Study|Other Medical Event|2|||
105738557|NCT00723840|364698292|FG000|Overall Study|Unspecified reason|2|||
105738558|NCT00570739|364698293|FG000|Overall Study|Adverse Event|8|||
105356914|NCT01990768|363311651|FG002|Prehospital Study Drug Infusion|Discharged|0|||
105356915|NCT01990768|363311649|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
105356916|NCT01990768|363311650|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
105356917|NCT01990768|363311651|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
105356918|NCT01990768|363311649|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
105356919|NCT01990768|363311650|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
105356920|NCT01990768|363311651|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
105356921|NCT01990768|363311649|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
105356922|NCT01990768|363311650|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
105356923|NCT01990768|363311651|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
105356924|NCT01990768|363311649|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
105356925|NCT01990768|363311650|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
105356926|NCT01990768|363311651|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
105356927|NCT01990768|363311649|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
105356928|NCT01990768|363311650|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
105356929|NCT01990768|363311651|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
105356930|NCT01990768|363311649|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
105356931|NCT01990768|363311650|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
105356932|NCT01990768|363311651|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
105356933|NCT01990768|363311649|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
105356934|NCT01990768|363311650|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
105356935|NCT01990768|363311651|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
105356936|NCT01990768|363311649|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
105356937|NCT01990768|363311650|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
105356938|NCT01990768|363311651|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
105356939|NCT01990768|363311649|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
105356940|NCT01990768|363311650|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
105356941|NCT01990768|363311651|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
105356942|NCT01990768|363311649|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
105738559|NCT00570739|364698294|FG001|Overall Study|Adverse Event|6|||
105738560|NCT00570739|364698295|FG002|Overall Study|Adverse Event|2|||
105482400|NCT00495040|363776996|FG000|Overall Study|Withdrawal by Subject|3|||
105482401|NCT01700439|363776997|FG000|Overall Study|Lost to Follow-up|47|||
105482402|NCT01700439|363776997|FG000|Overall Study|Withdrawal by Subject|183|||
105482403|NCT01700439|363776997|FG000|Overall Study|Death|186|||
105482404|NCT01892384|363776998|FG000|Overall Study|Withdrawal by Subject|1|||
105482405|NCT01892384|363776999|FG001|Overall Study|Withdrawal by Subject|1|||
105482406|NCT01892384|363777000|FG002|Overall Study|Withdrawal by Subject|0|||
105482407|NCT01892384|363777001|FG003|Overall Study|Withdrawal by Subject|0|||
105482408|NCT02518464|363777002|FG000|Overall Study|Adverse Event|2|||
105482409|NCT01829243|363777009|FG000|First Intervention|Screen Failure|4|||
105482410|NCT01829243|363777010|FG001|First Intervention|Screen Failure|2|||
105482411|NCT00608569|363777014|FG000|Overall Study|Death|4|||
105482412|NCT00608569|363777015|FG001|Overall Study|Death|3|||
105482413|NCT00608569|363777014|FG000|Overall Study|Lost to Follow-up|4|||
105482414|NCT00608569|363777015|FG001|Overall Study|Lost to Follow-up|5|||
105482415|NCT00608569|363777014|FG000|Overall Study|Withdrawal by Subject|1|||
105482416|NCT00608569|363777015|FG001|Overall Study|Withdrawal by Subject|0|||
105482417|NCT00608569|363777014|FG000|Overall Study|Adverse Event|1|||
105482418|NCT00608569|363777015|FG001|Overall Study|Adverse Event|0|||
105482419|NCT00608569|363777014|FG000|Overall Study|Unable to adhere with study requirements|0|||
105482420|NCT00608569|363777015|FG001|Overall Study|Unable to adhere with study requirements|1|||
105482421|NCT02312687|363777029|FG000|Overall Study|Other, Not Specified|1|||
105482422|NCT00278915|363777031|FG000|Overall Study|Disease progression|1|||
105482423|NCT03353740|363777034|FG000|Overall Study|Images for these participants not viable|52|||
105482424|NCT03473548|363777035|FG000|Overall Study|Did not attempt HST testing|3|||
105482425|NCT03473548|363777036|FG001|Overall Study|Did not attempt HST testing|0|||
105482426|NCT02207946|363777040|FG000|Overall Study|Lost to Follow-up|1|||
105482427|NCT02207946|363777041|FG001|Overall Study|Lost to Follow-up|0|||
105482428|NCT02207946|363777040|FG000|Overall Study|Adverse Event|0|||
105482429|NCT02207946|363777041|FG001|Overall Study|Adverse Event|1|||
105482430|NCT02545543|363777042|FG000|Overall Study|Lost to Follow-up|67|||
105482431|NCT02545543|363777043|FG001|Overall Study|Lost to Follow-up|25|||
105482432|NCT02545543|363777042|FG000|Overall Study|Physician Decision|3|||
105482433|NCT02545543|363777043|FG001|Overall Study|Physician Decision|0|||
105482434|NCT02545543|363777042|FG000|Overall Study|Withdrawal by Subject|9|||
105738561|NCT00570739|364698296|FG003|Overall Study|Adverse Event|2|||
105738562|NCT00570739|364698293|FG000|Overall Study|Lost to Follow-up|4|||
105738563|NCT00570739|364698294|FG001|Overall Study|Lost to Follow-up|5|||
105738564|NCT00570739|364698295|FG002|Overall Study|Lost to Follow-up|4|||
105738565|NCT00570739|364698296|FG003|Overall Study|Lost to Follow-up|1|||
105738566|NCT00570739|364698293|FG000|Overall Study|Physician Decision|1|||
105738567|NCT00570739|364698294|FG001|Overall Study|Physician Decision|1|||
105738568|NCT00570739|364698295|FG002|Overall Study|Physician Decision|0|||
105738569|NCT00570739|364698296|FG003|Overall Study|Physician Decision|0|||
105738570|NCT00570739|364698293|FG000|Overall Study|Withdrawal by Subject|7|||
105738571|NCT00570739|364698294|FG001|Overall Study|Withdrawal by Subject|7|||
105738572|NCT00570739|364698295|FG002|Overall Study|Withdrawal by Subject|3|||
105738573|NCT00570739|364698296|FG003|Overall Study|Withdrawal by Subject|5|||
105738574|NCT00570739|364698293|FG000|Overall Study|Required restricted medication|0|||
105738575|NCT00570739|364698294|FG001|Overall Study|Required restricted medication|0|||
105738576|NCT00570739|364698295|FG002|Overall Study|Required restricted medication|1|||
105738577|NCT00570739|364698296|FG003|Overall Study|Required restricted medication|0|||
105738578|NCT00570739|364698293|FG000|Overall Study|Met discontinuation criteria|1|||
105738579|NCT00570739|364698294|FG001|Overall Study|Met discontinuation criteria|0|||
105738580|NCT00570739|364698295|FG002|Overall Study|Met discontinuation criteria|1|||
105738581|NCT00570739|364698296|FG003|Overall Study|Met discontinuation criteria|1|||
105738582|NCT00570739|364698293|FG000|Overall Study|Other|0|||
105738583|NCT00570739|364698294|FG001|Overall Study|Other|2|||
105799764|NCT04380701|364924632|FG018|Overall Study|Death|0|||
105799765|NCT04380701|364924633|FG019|Overall Study|Death|0|||
105799766|NCT04380701|364924634|FG020|Overall Study|Death|0|||
105482435|NCT02545543|363777043|FG001|Overall Study|Withdrawal by Subject|8|||
105482436|NCT02545543|363777042|FG000|Overall Study|Noncomplaince|1|||
105482437|NCT02545543|363777043|FG001|Overall Study|Noncomplaince|0|||
105482438|NCT02545543|363777042|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
105482439|NCT02545543|363777043|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
105482440|NCT01155167|363777044|FG000|Overall Study|Insufficient ultrasound data|2|||
105482441|NCT01155167|363777045|FG001|Overall Study|Insufficient ultrasound data|0|||
105738584|NCT00570739|364698295|FG002|Overall Study|Other|5|||
105738585|NCT00570739|364698296|FG003|Overall Study|Other|3|||
105482442|NCT01155167|363777044|FG000|Overall Study|Access site changed to femoral artery|1|||
105482443|NCT01155167|363777045|FG001|Overall Study|Access site changed to femoral artery|0|||
105738586|NCT01242020|364698299|FG000|Overall Study|Withdrawal by Subject|2|||
105799767|NCT04380701|364924635|FG021|Overall Study|Death|0|||
105738587|NCT01242020|364698300|FG001|Overall Study|Withdrawal by Subject|0|||
105738588|NCT01242020|364698299|FG000|Overall Study|Failed screening|1|||
105738589|NCT01242020|364698300|FG001|Overall Study|Failed screening|0|||
105738590|NCT02179398|364698305|FG000|Overall Study|Lack of obligatory data|3|||
105738591|NCT02179398|364698306|FG001|Overall Study|Lack of obligatory data|3|||
105738592|NCT02179398|364698305|FG000|Overall Study|Lost to Follow-up|0|||
105738593|NCT02179398|364698306|FG001|Overall Study|Lost to Follow-up|1|||
105738594|NCT00772967|364698307|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
105738595|NCT00772967|364698308|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
105738596|NCT00772967|364698309|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
105738597|NCT00772967|364698310|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
105738598|NCT00772967|364698311|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
105738599|NCT00772967|364698312|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
105738600|NCT00772967|364698307|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
105738601|NCT00772967|364698308|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
105738602|NCT00772967|364698309|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
105738603|NCT00772967|364698310|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
105738604|NCT00772967|364698311|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
105738605|NCT00772967|364698312|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
105738606|NCT00772967|364698307|FG000|Crossover Treatment 3|Adverse Event|0|||
105738607|NCT00772967|364698308|FG001|Crossover Treatment 3|Adverse Event|0|||
105738608|NCT00772967|364698309|FG002|Crossover Treatment 3|Adverse Event|0|||
105738609|NCT00772967|364698310|FG003|Crossover Treatment 3|Adverse Event|0|||
105738610|NCT00772967|364698311|FG004|Crossover Treatment 3|Adverse Event|1|||
105738611|NCT00772967|364698312|FG005|Crossover Treatment 3|Adverse Event|0|||
105738612|NCT01595646|364698313|FG000|Overall Study|Withdrawal by Subject|1|||
105738613|NCT01595646|364698314|FG001|Overall Study|Withdrawal by Subject|0|||
105738614|NCT01595646|364698315|FG002|Overall Study|Withdrawal by Subject|0|||
105738615|NCT01161524|364698320|FG000|Core Study (23 Weeks)|Adverse Event|3|||
105738616|NCT01161524|364698321|FG001|Core Study (23 Weeks)|Adverse Event|0|||
105738617|NCT01161524|364698322|FG002|Core Study (23 Weeks)|Adverse Event|0|||
105738618|NCT01161524|364698320|FG000|Core Study (23 Weeks)|Other|1|||
105738619|NCT01161524|364698321|FG001|Core Study (23 Weeks)|Other|0|||
105738620|NCT01161524|364698322|FG002|Core Study (23 Weeks)|Other|0|||
105738621|NCT01161524|364698320|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
105738622|NCT01161524|364698321|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
105738623|NCT01161524|364698322|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
105738624|NCT01161524|364698320|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
105738625|NCT01161524|364698321|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
105738626|NCT01161524|364698322|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
105738627|NCT01161524|364698320|FG000|Core Study (23 Weeks)|Subject Choice|3|||
105738628|NCT01161524|364698321|FG001|Core Study (23 Weeks)|Subject Choice|2|||
105738629|NCT01161524|364698322|FG002|Core Study (23 Weeks)|Subject Choice|0|||
105738630|NCT01161524|364698320|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
105738631|NCT01161524|364698321|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
105738632|NCT01161524|364698322|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
105738633|NCT01161524|364698320|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
105738634|NCT01161524|364698321|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
105738635|NCT01161524|364698322|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
105738636|NCT01161524|364698320|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
105738637|NCT01161524|364698321|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
105738638|NCT01161524|364698322|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
105738639|NCT01161524|364698320|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
105738640|NCT01161524|364698321|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
105738641|NCT01161524|364698322|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
105738642|NCT01161524|364698320|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
105738643|NCT01161524|364698321|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
105738644|NCT01161524|364698322|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
105738645|NCT01041573|364698331|FG000|Overall Study|Withdrawal by Subject|2|||
105738646|NCT01041573|364698332|FG001|Overall Study|Withdrawal by Subject|5|||
105738647|NCT01041573|364698333|FG002|Overall Study|Withdrawal by Subject|2|||
105738648|NCT01041573|364698334|FG003|Overall Study|Withdrawal by Subject|0|||
105799768|NCT04380701|364924636|FG022|Overall Study|Death|0|||
105356943|NCT01990768|363311650|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
105738649|NCT01041573|364698331|FG000|Overall Study|Death|1|||
105738650|NCT01041573|364698332|FG001|Overall Study|Death|0|||
105738651|NCT01041573|364698333|FG002|Overall Study|Death|0|||
105738652|NCT01041573|364698334|FG003|Overall Study|Death|0|||
105738653|NCT01041573|364698331|FG000|Overall Study|Lost to Follow-up|0|||
105738654|NCT01041573|364698332|FG001|Overall Study|Lost to Follow-up|1|||
105738655|NCT01041573|364698333|FG002|Overall Study|Lost to Follow-up|2|||
105738656|NCT01041573|364698334|FG003|Overall Study|Lost to Follow-up|1|||
105738657|NCT01041573|364698331|FG000|Overall Study|Adverse Event|0|||
105738658|NCT01041573|364698332|FG001|Overall Study|Adverse Event|2|||
105738659|NCT01041573|364698333|FG002|Overall Study|Adverse Event|0|||
105738660|NCT01041573|364698334|FG003|Overall Study|Adverse Event|0|||
105738661|NCT01041573|364698331|FG000|Overall Study|relocation|1|||
105738662|NCT01041573|364698332|FG001|Overall Study|relocation|4|||
105738663|NCT01041573|364698333|FG002|Overall Study|relocation|3|||
105738664|NCT01041573|364698334|FG003|Overall Study|relocation|1|||
105738665|NCT01041573|364698331|FG000|Overall Study|further blood extraction|0|||
105738666|NCT01041573|364698332|FG001|Overall Study|further blood extraction|1|||
105738667|NCT01041573|364698333|FG002|Overall Study|further blood extraction|0|||
105738668|NCT01041573|364698334|FG003|Overall Study|further blood extraction|0|||
105738669|NCT01041573|364698331|FG000|Overall Study|positive to anti-HCV|1|||
105738670|NCT01041573|364698332|FG001|Overall Study|positive to anti-HCV|0|||
105738671|NCT01041573|364698333|FG002|Overall Study|positive to anti-HCV|0|||
105738672|NCT01041573|364698334|FG003|Overall Study|positive to anti-HCV|0|||
105738673|NCT02955186|364698335|FG000|Overall Study|Withdrawal by Subject|6|||
105738674|NCT02955186|364698336|FG001|Overall Study|Withdrawal by Subject|2|||
105738675|NCT02955186|364698335|FG000|Overall Study|Protocol Violation|1|||
105738676|NCT02955186|364698336|FG001|Overall Study|Protocol Violation|0|||
105738677|NCT01899144|364698337|FG000|Treatment Period 2|Other|1|||
105738678|NCT01899144|364698337|FG000|Treatment Period 3|Other|2|||
105738679|NCT01899144|364698337|FG000|Treatment Period 5|Other|1|||
105738680|NCT00231062|364698338|FG000|Overall Study|Physician Decision|6|||
105738681|NCT00864227|364698339|FG000|Overall Study|Withdrawal by Subject|1|||
105738682|NCT00864227|364698339|FG000|Overall Study|Disease Relapse/Progression|3|||
105738683|NCT00616239|364698340|FG000|Overall Study|Withdrawal by Subject|2|||
105738684|NCT02606877|364698341|FG000|Overall Study|Adverse Event|3|||
105738685|NCT02606877|364698342|FG001|Overall Study|Adverse Event|0|||
105738686|NCT02606877|364698341|FG000|Overall Study|Non-compliance with protocol|0|||
105738687|NCT02606877|364698342|FG001|Overall Study|Non-compliance with protocol|1|||
105738688|NCT02606877|364698341|FG000|Overall Study|Other than listed above|1|||
105738689|NCT02606877|364698342|FG001|Overall Study|Other than listed above|0|||
105738690|NCT04952389|364698346|FG000|Overall Study|Withdrawal by Subject|8|||
105738691|NCT04952389|364698347|FG001|Overall Study|Withdrawal by Subject|4|||
105738692|NCT02815397|364698350|FG000|Overall Study|Physician Decision|2|||
105738693|NCT04998851|364699870|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
105738694|NCT04998851|364699871|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
105738695|NCT04998851|364699870|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|2|||
105738696|NCT04998851|364699871|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
105738697|NCT04998851|364699870|FG000|Vaccination Period (11 Months)|Reason Not Specified|0|||
105738698|NCT04998851|364699871|FG001|Vaccination Period (11 Months)|Reason Not Specified|1|||
105738699|NCT04998851|364699870|FG000|Vaccination Period (11 Months)|Ongoing in the study|4|||
105738700|NCT04998851|364699871|FG001|Vaccination Period (11 Months)|Ongoing in the study|4|||
105738701|NCT00931892|364699872|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
105738702|NCT00931892|364699873|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
105738703|NCT00390780|364699874|FG000|Overall Study|Not completed|10|||
105738704|NCT00390780|364699875|FG001|Overall Study|Not completed|4|||
105356944|NCT01990768|363311651|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
105738705|NCT00390780|364699874|FG000|Overall Study|Protocol Violation|6|||
105738706|NCT00390780|364699875|FG001|Overall Study|Protocol Violation|4|||
105738707|NCT00390780|364699874|FG000|Overall Study|Lost to Follow-up|3|||
105738708|NCT00390780|364699875|FG001|Overall Study|Lost to Follow-up|6|||
105738709|NCT00390780|364699874|FG000|Overall Study|Adverse Event|2|||
105738710|NCT00390780|364699875|FG001|Overall Study|Adverse Event|3|||
105738711|NCT00390780|364699874|FG000|Overall Study|Death|1|||
105738712|NCT00390780|364699875|FG001|Overall Study|Death|3|||
105738713|NCT00390780|364699874|FG000|Overall Study|Withdrawal by Subject|1|||
105738714|NCT00390780|364699875|FG001|Overall Study|Withdrawal by Subject|2|||
105356945|NCT01990768|363311649|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
105738715|NCT00390780|364699874|FG000|Overall Study|Inclusion criteria not satisfied|0|||
105738716|NCT00390780|364699875|FG001|Overall Study|Inclusion criteria not satisfied|2|||
105738717|NCT00390780|364699874|FG000|Overall Study|Lost to follow up and other reasons|0|||
105738718|NCT00390780|364699875|FG001|Overall Study|Lost to follow up and other reasons|1|||
105738719|NCT00390780|364699874|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
105738720|NCT00390780|364699875|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
105799769|NCT04380701|364924637|FG023|Overall Study|Death|0|||
105799770|NCT04380701|364924638|FG024|Overall Study|Death|1|||
105799771|NCT04380701|364924639|FG025|Overall Study|Death|0|||
105799772|NCT04380701|364924640|FG026|Overall Study|Death|0|||
105799773|NCT04380701|364924641|FG027|Overall Study|Death|0|||
105799774|NCT04380701|364924642|FG028|Overall Study|Death|0|||
105799775|NCT04380701|364924643|FG029|Overall Study|Death|0|||
105799776|NCT04380701|364924644|FG030|Overall Study|Death|0|||
105799777|NCT04380701|364924645|FG031|Overall Study|Death|0|||
105799778|NCT04380701|364924646|FG032|Overall Study|Death|0|||
105799779|NCT04380701|364924647|FG033|Overall Study|Death|0|||
105799780|NCT04380701|364924614|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799781|NCT04380701|364924615|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799782|NCT04380701|364924616|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799783|NCT04380701|364924617|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799784|NCT04380701|364924618|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799785|NCT04380701|364924619|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799786|NCT04380701|364924620|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799787|NCT04380701|364924621|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799788|NCT04380701|364924622|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799789|NCT04380701|364924623|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799790|NCT04380701|364924624|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799791|NCT04380701|364924625|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799792|NCT04380701|364924626|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799793|NCT04380701|364924627|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799794|NCT04380701|364924628|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799795|NCT04380701|364924629|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799796|NCT04380701|364924630|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799797|NCT04380701|364924631|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799798|NCT04380701|364924632|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799799|NCT04380701|364924633|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799800|NCT04380701|364924634|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799801|NCT04380701|364924635|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
105799802|NCT04380701|364924636|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
105799803|NCT04380701|364924637|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
105356946|NCT01990768|363311650|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
105356947|NCT01990768|363311651|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
105356948|NCT01990768|363311649|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
105356949|NCT01990768|363311650|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
105356950|NCT01990768|363311651|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
105356951|NCT01990768|363311649|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
105356952|NCT01990768|363311650|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
105356953|NCT01990768|363311651|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
105356954|NCT01990768|363311649|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
105356955|NCT01990768|363311650|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
105356956|NCT01990768|363311651|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
105356957|NCT01990768|363311649|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
105356958|NCT01990768|363311650|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
105356959|NCT01990768|363311651|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
105356960|NCT01990768|363311649|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
105356961|NCT01990768|363311650|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
105356962|NCT01990768|363311651|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
105356963|NCT01990768|363311649|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
105356964|NCT01990768|363311650|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
105356965|NCT01990768|363311651|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
105356966|NCT01990768|363311649|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
105356967|NCT01990768|363311650|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
105356968|NCT01990768|363311651|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
105356969|NCT01990768|363311649|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
105356970|NCT01990768|363311650|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
105356971|NCT01990768|363311651|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
105356972|NCT01990768|363311649|FG000|6-Month Follow-up|No contact information|5|||
105356973|NCT01990768|363311650|FG001|6-Month Follow-up|No contact information|6|||
105356974|NCT01990768|363311651|FG002|6-Month Follow-up|No contact information|5|||
105356975|NCT01990768|363311649|FG000|6-Month Follow-up|Homeless|4|||
105356976|NCT01990768|363311650|FG001|6-Month Follow-up|Homeless|3|||
105356977|NCT01990768|363311651|FG002|6-Month Follow-up|Homeless|6|||
105356978|NCT01990768|363311649|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
105356979|NCT01990768|363311650|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
105356980|NCT01990768|363311651|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
105356981|NCT01990768|363311649|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
105356982|NCT01990768|363311650|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
105356983|NCT01990768|363311651|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
105356984|NCT01990768|363311649|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
105356985|NCT01990768|363311650|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
105356986|NCT01990768|363311651|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
105356987|NCT00154375|363311652|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
105356988|NCT00154375|363311653|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
105356989|NCT00154375|363311652|FG000|Overall Study|Adverse Event|18|||
105356990|NCT00154375|363311653|FG001|Overall Study|Adverse Event|20|||
105356991|NCT00154375|363311652|FG000|Overall Study|Withdrawal by Subject|14|||
105356992|NCT00154375|363311653|FG001|Overall Study|Withdrawal by Subject|10|||
105356993|NCT00154375|363311652|FG000|Overall Study|Death|5|||
105356994|NCT00154375|363311653|FG001|Overall Study|Death|13|||
105356995|NCT00154375|363311652|FG000|Overall Study|Study drug no longer required|5|||
105356996|NCT00154375|363311653|FG001|Overall Study|Study drug no longer required|3|||
105356997|NCT00154375|363311652|FG000|Overall Study|Lost to Follow-up|2|||
105356998|NCT00154375|363311653|FG001|Overall Study|Lost to Follow-up|1|||
105356999|NCT00154375|363311652|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105357000|NCT00154375|363311653|FG001|Overall Study|Abnormal laboratory value(s)|2|||
105357001|NCT00154375|363311652|FG000|Overall Study|Protocol Violation|0|||
105357002|NCT00154375|363311653|FG001|Overall Study|Protocol Violation|1|||
105357003|NCT00154375|363311652|FG000|Overall Study|Suspected progression of disease|44|||
105357004|NCT00154375|363311653|FG001|Overall Study|Suspected progression of disease|30|||
105357005|NCT02348008|363311654|FG000|Overall Study|Adverse Event|2|||
105357006|NCT02348008|363311655|FG001|Overall Study|Adverse Event|3|||
105738721|NCT00390780|364699874|FG000|Overall Study|SAE, death|0|||
105357007|NCT02348008|363311656|FG002|Overall Study|Adverse Event|3|||
105357008|NCT02348008|363311654|FG000|Overall Study|Disease Progression|1|||
105357009|NCT02348008|363311655|FG001|Overall Study|Disease Progression|5|||
105357010|NCT02348008|363311656|FG002|Overall Study|Disease Progression|16|||
105482444|NCT00167778|363777046|FG000|Overall Study|Withdrawal by Subject|1|||
105482445|NCT02654717|363777047|FG000|Overall Study|Adverse Event|2|||
105738722|NCT00390780|364699875|FG001|Overall Study|SAE, death|1|||
105357011|NCT02348008|363311654|FG000|Overall Study|Withdrawal by Subject|0|||
105357012|NCT02348008|363311655|FG001|Overall Study|Withdrawal by Subject|1|||
105738723|NCT01070550|364699880|FG000|Overall Study|Adverse Event|43|||
105738724|NCT01070550|364699881|FG001|Overall Study|Adverse Event|1|||
105738725|NCT01070550|364699882|FG002|Overall Study|Adverse Event|3|||
105738726|NCT01070550|364699883|FG003|Overall Study|Adverse Event|0|||
105738727|NCT01070550|364699884|FG004|Overall Study|Adverse Event|0|||
105482446|NCT02654717|363777048|FG001|Overall Study|Adverse Event|2|||
105738728|NCT01070550|364699885|FG005|Overall Study|Adverse Event|0|||
105738729|NCT01070550|364699880|FG000|Overall Study|Death|20|||
105738730|NCT01070550|364699881|FG001|Overall Study|Death|4|||
105738731|NCT01070550|364699882|FG002|Overall Study|Death|3|||
105738732|NCT01070550|364699883|FG003|Overall Study|Death|0|||
105738733|NCT01070550|364699884|FG004|Overall Study|Death|0|||
105738734|NCT01070550|364699885|FG005|Overall Study|Death|0|||
105738735|NCT01070550|364699880|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
105738736|NCT01070550|364699881|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
105738737|NCT01070550|364699882|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
105738738|NCT01070550|364699883|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
105738739|NCT01070550|364699884|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
105738740|NCT01070550|364699885|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
105738741|NCT01070550|364699880|FG000|Overall Study|Early termination|3|||
105738742|NCT01070550|364699881|FG001|Overall Study|Early termination|0|||
105738743|NCT01070550|364699882|FG002|Overall Study|Early termination|0|||
105738744|NCT01070550|364699883|FG003|Overall Study|Early termination|0|||
105738745|NCT01070550|364699884|FG004|Overall Study|Early termination|0|||
105738746|NCT01070550|364699885|FG005|Overall Study|Early termination|0|||
105738747|NCT01070550|364699880|FG000|Overall Study|Failed to return|450|||
105738748|NCT01070550|364699881|FG001|Overall Study|Failed to return|33|||
105738749|NCT01070550|364699882|FG002|Overall Study|Failed to return|144|||
105738750|NCT01070550|364699883|FG003|Overall Study|Failed to return|40|||
105357013|NCT02348008|363311656|FG002|Overall Study|Withdrawal by Subject|0|||
105357014|NCT02348008|363311654|FG000|Overall Study|Symptomatic Deterioration|0|||
105357015|NCT02348008|363311655|FG001|Overall Study|Symptomatic Deterioration|1|||
105357016|NCT02348008|363311656|FG002|Overall Study|Symptomatic Deterioration|0|||
105357017|NCT01588405|363311660|FG000|Overall Study|Adverse Event|1|||
105357018|NCT01588405|363311660|FG000|Overall Study|Clinical Worsening|1|||
105357019|NCT05219968|363311664|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
105357020|NCT05219968|363311665|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
105357021|NCT05219968|363311666|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
105357022|NCT05219968|363311667|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
105357023|NCT05219968|363311668|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
105357024|NCT05219968|363311664|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
105357025|NCT05219968|363311665|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
105357026|NCT05219968|363311666|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
105357027|NCT05219968|363311667|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
105357028|NCT05219968|363311668|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
105357029|NCT05219968|363311664|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
105357030|NCT05219968|363311665|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
105357031|NCT05219968|363311666|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
105357032|NCT05219968|363311667|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
105357033|NCT05219968|363311668|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
105357034|NCT05219968|363311664|FG000|Week 24 Treatment Period|Adverse Event|3|||
105357035|NCT05219968|363311665|FG001|Week 24 Treatment Period|Adverse Event|0|||
105357036|NCT05219968|363311666|FG002|Week 24 Treatment Period|Adverse Event|0|||
105357037|NCT05219968|363311667|FG003|Week 24 Treatment Period|Adverse Event|0|||
105357038|NCT05219968|363311668|FG004|Week 24 Treatment Period|Adverse Event|0|||
105357039|NCT05219968|363311664|FG000|Week 24 Treatment Period|Physician Decision|0|||
105357040|NCT05219968|363311665|FG001|Week 24 Treatment Period|Physician Decision|1|||
105357041|NCT05219968|363311666|FG002|Week 24 Treatment Period|Physician Decision|0|||
105357042|NCT05219968|363311667|FG003|Week 24 Treatment Period|Physician Decision|0|||
105357043|NCT05219968|363311668|FG004|Week 24 Treatment Period|Physician Decision|0|||
105357044|NCT05219968|363311664|FG000|Week 24 Treatment Period|Other, not specified|3|||
105357045|NCT05219968|363311665|FG001|Week 24 Treatment Period|Other, not specified|0|||
105357046|NCT05219968|363311666|FG002|Week 24 Treatment Period|Other, not specified|0|||
105357047|NCT05219968|363311667|FG003|Week 24 Treatment Period|Other, not specified|0|||
105357048|NCT05219968|363311668|FG004|Week 24 Treatment Period|Other, not specified|0|||
105357049|NCT05219968|363311664|FG000|Safety Extension Period|Treatment administration failure|0|||
105357050|NCT05219968|363311665|FG001|Safety Extension Period|Treatment administration failure|0|||
105357051|NCT05219968|363311666|FG002|Safety Extension Period|Treatment administration failure|0|||
105357052|NCT05219968|363311667|FG003|Safety Extension Period|Treatment administration failure|1|||
105357053|NCT05219968|363311668|FG004|Safety Extension Period|Treatment administration failure|4|||
105357054|NCT05219968|363311664|FG000|Safety Extension Period|Bilateral dislodgement|0|||
105357055|NCT05219968|363311665|FG001|Safety Extension Period|Bilateral dislodgement|0|||
105357056|NCT05219968|363311666|FG002|Safety Extension Period|Bilateral dislodgement|4|||
105357057|NCT05219968|363311667|FG003|Safety Extension Period|Bilateral dislodgement|0|||
105357058|NCT05219968|363311668|FG004|Safety Extension Period|Bilateral dislodgement|1|||
105357059|NCT05219968|363311664|FG000|Safety Extension Period|Withdrawal by Subject|0|||
105357060|NCT05219968|363311665|FG001|Safety Extension Period|Withdrawal by Subject|0|||
105357061|NCT05219968|363311666|FG002|Safety Extension Period|Withdrawal by Subject|2|||
105357062|NCT05219968|363311667|FG003|Safety Extension Period|Withdrawal by Subject|0|||
105357063|NCT05219968|363311668|FG004|Safety Extension Period|Withdrawal by Subject|4|||
105357064|NCT05219968|363311664|FG000|Safety Extension Period|Adverse Event|0|||
105357065|NCT05219968|363311665|FG001|Safety Extension Period|Adverse Event|0|||
105357066|NCT05219968|363311666|FG002|Safety Extension Period|Adverse Event|2|||
105357067|NCT05219968|363311667|FG003|Safety Extension Period|Adverse Event|1|||
105357068|NCT05219968|363311668|FG004|Safety Extension Period|Adverse Event|1|||
105357069|NCT05219968|363311664|FG000|Safety Extension Period|Lost to Follow-up|0|||
105357070|NCT05219968|363311665|FG001|Safety Extension Period|Lost to Follow-up|0|||
105357071|NCT05219968|363311666|FG002|Safety Extension Period|Lost to Follow-up|0|||
105357072|NCT05219968|363311667|FG003|Safety Extension Period|Lost to Follow-up|1|||
105357073|NCT05219968|363311668|FG004|Safety Extension Period|Lost to Follow-up|0|||
105357074|NCT03373461|363311669|FG000|Part 2|Adverse Event|0|||
105357075|NCT03373461|363311670|FG001|Part 2|Adverse Event|1|||
105357076|NCT03373461|363311671|FG002|Part 2|Adverse Event|0|||
105482447|NCT02654717|363777047|FG000|Overall Study|Protocol Violation|1|||
105482448|NCT02654717|363777048|FG001|Overall Study|Protocol Violation|2|||
105482449|NCT02654717|363777047|FG000|Overall Study|Withdrawal by Subject|0|||
105482450|NCT02654717|363777048|FG001|Overall Study|Withdrawal by Subject|1|||
105482451|NCT02654717|363777047|FG000|Overall Study|Non-permitted medication|3|||
105482452|NCT02654717|363777048|FG001|Overall Study|Non-permitted medication|0|||
105482453|NCT02880956|363777053|FG000|Overall Study|Adverse Event|3|||
105738751|NCT01070550|364699884|FG004|Overall Study|Failed to return|1|||
105738752|NCT01070550|364699885|FG005|Overall Study|Failed to return|2|||
105738753|NCT01070550|364699880|FG000|Overall Study|Incomplete treatment|2|||
105738754|NCT01070550|364699881|FG001|Overall Study|Incomplete treatment|0|||
105738755|NCT01070550|364699882|FG002|Overall Study|Incomplete treatment|0|||
105738756|NCT01070550|364699883|FG003|Overall Study|Incomplete treatment|0|||
105738757|NCT01070550|364699884|FG004|Overall Study|Incomplete treatment|0|||
105738758|NCT01070550|364699885|FG005|Overall Study|Incomplete treatment|0|||
105738759|NCT01070550|364699880|FG000|Overall Study|Lab test not done|22|||
105738760|NCT01070550|364699881|FG001|Overall Study|Lab test not done|3|||
105738761|NCT01070550|364699882|FG002|Overall Study|Lab test not done|4|||
105738762|NCT01070550|364699883|FG003|Overall Study|Lab test not done|1|||
105738763|NCT01070550|364699884|FG004|Overall Study|Lab test not done|0|||
105738764|NCT01070550|364699885|FG005|Overall Study|Lab test not done|1|||
105738765|NCT01070550|364699880|FG000|Overall Study|Lack of Efficacy|65|||
105738766|NCT01070550|364699881|FG001|Overall Study|Lack of Efficacy|1|||
105738767|NCT01070550|364699882|FG002|Overall Study|Lack of Efficacy|5|||
105738768|NCT01070550|364699883|FG003|Overall Study|Lack of Efficacy|5|||
105738769|NCT01070550|364699884|FG004|Overall Study|Lack of Efficacy|0|||
105738770|NCT01070550|364699885|FG005|Overall Study|Lack of Efficacy|1|||
105738771|NCT01070550|364699880|FG000|Overall Study|Miscellaneous|12|||
105738772|NCT01070550|364699881|FG001|Overall Study|Miscellaneous|2|||
105738773|NCT01070550|364699882|FG002|Overall Study|Miscellaneous|3|||
105738774|NCT01070550|364699883|FG003|Overall Study|Miscellaneous|1|||
105738775|NCT01070550|364699884|FG004|Overall Study|Miscellaneous|0|||
105738776|NCT01070550|364699885|FG005|Overall Study|Miscellaneous|0|||
105738777|NCT01070550|364699880|FG000|Overall Study|New treatment started|3|||
105738778|NCT01070550|364699881|FG001|Overall Study|New treatment started|1|||
105738779|NCT01070550|364699882|FG002|Overall Study|New treatment started|0|||
105357077|NCT03373461|363311672|FG003|Part 2|Adverse Event|0|||
105357078|NCT03373461|363311673|FG004|Part 2|Adverse Event|1|||
105357079|NCT03300180|363311674|FG000|Baseline|Withdrawal by Subject|4|||
105357080|NCT03300180|363311675|FG001|Baseline|Withdrawal by Subject|6|||
105482454|NCT02880956|363777054|FG001|Overall Study|Adverse Event|6|||
105482455|NCT02880956|363777055|FG002|Overall Study|Adverse Event|5|||
105482456|NCT02880956|363777056|FG003|Overall Study|Adverse Event|4|||
105738780|NCT01070550|364699883|FG003|Overall Study|New treatment started|2|||
105357081|NCT03300180|363311676|FG002|Baseline|Withdrawal by Subject|4|||
105357082|NCT03300180|363311674|FG000|6 Month Outcome|Withdrawal by Subject|12|||
105357083|NCT03300180|363311675|FG001|6 Month Outcome|Withdrawal by Subject|12|||
105357084|NCT03300180|363311676|FG002|6 Month Outcome|Withdrawal by Subject|19|||
105357085|NCT03300180|363311674|FG000|6 Month Outcome|Death|2|||
105357086|NCT03300180|363311675|FG001|6 Month Outcome|Death|4|||
105357087|NCT03300180|363311676|FG002|6 Month Outcome|Death|3|||
105357088|NCT03300180|363311674|FG000|6 Month Outcome|Missed Assessment|43|||
105357089|NCT03300180|363311675|FG001|6 Month Outcome|Missed Assessment|52|||
105357090|NCT03300180|363311676|FG002|6 Month Outcome|Missed Assessment|46|||
105357091|NCT03300180|363311674|FG000|12 Month Outcome|Withdrawal by Subject|3|||
105357092|NCT03300180|363311675|FG001|12 Month Outcome|Withdrawal by Subject|6|||
105357093|NCT03300180|363311676|FG002|12 Month Outcome|Withdrawal by Subject|6|||
105357094|NCT03300180|363311674|FG000|12 Month Outcome|Death|9|||
105357095|NCT03300180|363311675|FG001|12 Month Outcome|Death|6|||
105357096|NCT03300180|363311676|FG002|12 Month Outcome|Death|6|||
105357097|NCT03300180|363311674|FG000|12 Month Outcome|Missed Assessment|62|||
105357098|NCT03300180|363311675|FG001|12 Month Outcome|Missed Assessment|59|||
105357099|NCT03300180|363311676|FG002|12 Month Outcome|Missed Assessment|58|||
105357100|NCT03300180|363311674|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
105357101|NCT03300180|363311675|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
105357102|NCT03300180|363311676|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
105357103|NCT03300180|363311674|FG000|18 Month Outcome Assessment|Death|8|||
105357104|NCT03300180|363311675|FG001|18 Month Outcome Assessment|Death|5|||
105357105|NCT03300180|363311676|FG002|18 Month Outcome Assessment|Death|5|||
105357106|NCT03300180|363311674|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
105357107|NCT03300180|363311675|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
105357108|NCT03300180|363311676|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
105482457|NCT02880956|363777053|FG000|Overall Study|Withdrawal by Subject|9|||
105738781|NCT01070550|364699884|FG004|Overall Study|New treatment started|0|||
105738782|NCT01070550|364699885|FG005|Overall Study|New treatment started|0|||
105738783|NCT01070550|364699880|FG000|Overall Study|Non-responders|493|||
105738784|NCT01070550|364699881|FG001|Overall Study|Non-responders|4|||
105738785|NCT01070550|364699882|FG002|Overall Study|Non-responders|21|||
105738786|NCT01070550|364699883|FG003|Overall Study|Non-responders|20|||
105738787|NCT01070550|364699884|FG004|Overall Study|Non-responders|0|||
105738788|NCT01070550|364699885|FG005|Overall Study|Non-responders|2|||
105738789|NCT01070550|364699880|FG000|Overall Study|Not categorized|33|||
105738790|NCT01070550|364699881|FG001|Overall Study|Not categorized|2|||
105738791|NCT01070550|364699882|FG002|Overall Study|Not categorized|6|||
105738792|NCT01070550|364699883|FG003|Overall Study|Not categorized|1|||
105738793|NCT01070550|364699884|FG004|Overall Study|Not categorized|0|||
105738794|NCT01070550|364699885|FG005|Overall Study|Not categorized|1|||
105738795|NCT01070550|364699880|FG000|Overall Study|Protocol Violation|15|||
105738796|NCT01070550|364699881|FG001|Overall Study|Protocol Violation|1|||
105738797|NCT01070550|364699882|FG002|Overall Study|Protocol Violation|1|||
105738798|NCT01070550|364699883|FG003|Overall Study|Protocol Violation|1|||
105738799|NCT01070550|364699884|FG004|Overall Study|Protocol Violation|0|||
105738800|NCT01070550|364699885|FG005|Overall Study|Protocol Violation|0|||
105799804|NCT04380701|364924638|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
105482458|NCT02880956|363777054|FG001|Overall Study|Withdrawal by Subject|4|||
105482459|NCT02880956|363777055|FG002|Overall Study|Withdrawal by Subject|6|||
105482460|NCT02880956|363777056|FG003|Overall Study|Withdrawal by Subject|11|||
105482461|NCT02880956|363777053|FG000|Overall Study|Lost to Follow-up|0|||
105482462|NCT02880956|363777054|FG001|Overall Study|Lost to Follow-up|1|||
105738801|NCT01070550|364699880|FG000|Overall Study|Relapse|44|||
105482463|NCT02880956|363777055|FG002|Overall Study|Lost to Follow-up|0|||
105738802|NCT01070550|364699881|FG001|Overall Study|Relapse|5|||
105738803|NCT01070550|364699882|FG002|Overall Study|Relapse|14|||
105799805|NCT04380701|364924639|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105357109|NCT03300180|363311674|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
105357110|NCT03300180|363311675|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
105357111|NCT03300180|363311676|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
105738804|NCT01070550|364699883|FG003|Overall Study|Relapse|4|||
105738805|NCT01070550|364699884|FG004|Overall Study|Relapse|0|||
105357112|NCT03300180|363311674|FG000|24 Month Outcome Assessment|Death|13|||
105357113|NCT03300180|363311675|FG001|24 Month Outcome Assessment|Death|13|||
105357114|NCT03300180|363311676|FG002|24 Month Outcome Assessment|Death|3|||
105482464|NCT02880956|363777056|FG003|Overall Study|Lost to Follow-up|0|||
105738806|NCT01070550|364699885|FG005|Overall Study|Relapse|0|||
105738807|NCT01070550|364699880|FG000|Overall Study|Result not available|3|||
105738808|NCT01070550|364699881|FG001|Overall Study|Result not available|1|||
105738809|NCT01070550|364699882|FG002|Overall Study|Result not available|3|||
105738810|NCT01070550|364699883|FG003|Overall Study|Result not available|0|||
105738811|NCT01070550|364699884|FG004|Overall Study|Result not available|0|||
105738812|NCT01070550|364699885|FG005|Overall Study|Result not available|0|||
105738813|NCT01070550|364699880|FG000|Overall Study|Screen failure|1|||
105738814|NCT01070550|364699881|FG001|Overall Study|Screen failure|0|||
105738815|NCT01070550|364699882|FG002|Overall Study|Screen failure|0|||
105738816|NCT01070550|364699883|FG003|Overall Study|Screen failure|0|||
105738817|NCT01070550|364699884|FG004|Overall Study|Screen failure|0|||
105357115|NCT03300180|363311674|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
105357116|NCT03300180|363311675|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
105357117|NCT03300180|363311676|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
105357118|NCT04587336|363311679|FG000|Overall Study|Lost to Follow-up|1|||
105357119|NCT04587336|363311680|FG001|Overall Study|Lost to Follow-up|0|||
105357120|NCT00401193|363314085|FG000|Overall Study|Adverse Event|1|||
105357121|NCT00401193|363314086|FG001|Overall Study|Adverse Event|3|||
105357122|NCT00401193|363314087|FG002|Overall Study|Adverse Event|1|||
105357123|NCT00401193|363314085|FG000|Overall Study|Protocol Violation|3|||
105357124|NCT00401193|363314086|FG001|Overall Study|Protocol Violation|1|||
105357125|NCT00401193|363314087|FG002|Overall Study|Protocol Violation|1|||
105357126|NCT00401193|363314085|FG000|Overall Study|Lost to Follow-up|6|||
105357127|NCT00401193|363314086|FG001|Overall Study|Lost to Follow-up|5|||
105357128|NCT00401193|363314087|FG002|Overall Study|Lost to Follow-up|1|||
105357129|NCT00401193|363314085|FG000|Overall Study|Withdrawal by Subject|2|||
105357130|NCT00401193|363314086|FG001|Overall Study|Withdrawal by Subject|0|||
105357131|NCT00401193|363314087|FG002|Overall Study|Withdrawal by Subject|1|||
105357132|NCT00401193|363314085|FG000|Overall Study|Other Event|3|||
105357133|NCT00401193|363314086|FG001|Overall Study|Other Event|2|||
105357134|NCT00401193|363314087|FG002|Overall Study|Other Event|2|||
105357135|NCT01133704|363314089|FG000|Overall Study|Death|44|||
105357136|NCT01133704|363314090|FG001|Overall Study|Death|26|||
105357137|NCT01133704|363314089|FG000|Overall Study|Patient refused to continue|4|||
105357138|NCT01133704|363314090|FG001|Overall Study|Patient refused to continue|0|||
105357139|NCT01133704|363314089|FG000|Overall Study|Study Closure|1|||
105357140|NCT01133704|363314090|FG001|Overall Study|Study Closure|0|||
105357141|NCT02757352|363314093|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
105357142|NCT02757352|363314094|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105357143|NCT02757352|363314095|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
105357144|NCT02757352|363314096|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105357145|NCT02757352|363314097|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105357146|NCT02757352|363314098|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105357147|NCT02757352|363314099|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105357148|NCT02757352|363314100|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105357149|NCT02757352|363314101|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105357150|NCT02757352|363314102|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105357151|NCT02757352|363314093|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105357152|NCT02757352|363314094|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105357153|NCT02757352|363314095|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
105357154|NCT02757352|363314096|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105357155|NCT02757352|363314097|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105357156|NCT02757352|363314098|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105357157|NCT02757352|363314099|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105357158|NCT02757352|363314100|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105357159|NCT02757352|363314101|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105357160|NCT02757352|363314102|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105357161|NCT02757352|363314093|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
105482465|NCT02880956|363777053|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
105357162|NCT02757352|363314094|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
105357163|NCT02757352|363314095|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
105357164|NCT02757352|363314096|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
105482466|NCT02880956|363777054|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
105482467|NCT02880956|363777055|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
105482468|NCT02880956|363777056|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
105482469|NCT02880956|363777053|FG000|Overall Study|Other, Not Specified|4|||
105482470|NCT02880956|363777054|FG001|Overall Study|Other, Not Specified|2|||
105482471|NCT02880956|363777055|FG002|Overall Study|Other, Not Specified|0|||
105482472|NCT02880956|363777056|FG003|Overall Study|Other, Not Specified|3|||
105738818|NCT01070550|364699885|FG005|Overall Study|Screen failure|0|||
105738819|NCT01070550|364699880|FG000|Overall Study|Sponsor decision|1|||
105738820|NCT01070550|364699881|FG001|Overall Study|Sponsor decision|0|||
105738821|NCT01070550|364699882|FG002|Overall Study|Sponsor decision|0|||
105738822|NCT01070550|364699883|FG003|Overall Study|Sponsor decision|0|||
105738823|NCT01070550|364699884|FG004|Overall Study|Sponsor decision|0|||
105738824|NCT01070550|364699885|FG005|Overall Study|Sponsor decision|0|||
105738825|NCT01070550|364699880|FG000|Overall Study|Treatment duration shortened|1|||
105738826|NCT01070550|364699881|FG001|Overall Study|Treatment duration shortened|0|||
105738827|NCT01070550|364699882|FG002|Overall Study|Treatment duration shortened|0|||
105738828|NCT01070550|364699883|FG003|Overall Study|Treatment duration shortened|0|||
105738829|NCT01070550|364699884|FG004|Overall Study|Treatment duration shortened|0|||
105738830|NCT01070550|364699885|FG005|Overall Study|Treatment duration shortened|0|||
105738831|NCT01070550|364699880|FG000|Overall Study|Treatment interrupted|7|||
105738832|NCT01070550|364699881|FG001|Overall Study|Treatment interrupted|0|||
105738833|NCT01070550|364699882|FG002|Overall Study|Treatment interrupted|1|||
105738834|NCT01070550|364699883|FG003|Overall Study|Treatment interrupted|1|||
105738835|NCT01070550|364699884|FG004|Overall Study|Treatment interrupted|0|||
105738836|NCT01070550|364699885|FG005|Overall Study|Treatment interrupted|0|||
105738837|NCT01070550|364699880|FG000|Overall Study|Treatment not started|14|||
105738838|NCT01070550|364699881|FG001|Overall Study|Treatment not started|2|||
105738839|NCT01070550|364699882|FG002|Overall Study|Treatment not started|4|||
105738840|NCT01070550|364699883|FG003|Overall Study|Treatment not started|0|||
105738841|NCT01070550|364699884|FG004|Overall Study|Treatment not started|0|||
105738842|NCT01070550|364699885|FG005|Overall Study|Treatment not started|0|||
105738843|NCT01070550|364699880|FG000|Overall Study|Treatment restarted|0|||
105738844|NCT01070550|364699881|FG001|Overall Study|Treatment restarted|1|||
105738845|NCT01070550|364699882|FG002|Overall Study|Treatment restarted|0|||
105738846|NCT01070550|364699883|FG003|Overall Study|Treatment restarted|0|||
105738847|NCT01070550|364699884|FG004|Overall Study|Treatment restarted|0|||
105738848|NCT01070550|364699885|FG005|Overall Study|Treatment restarted|0|||
105738849|NCT01070550|364699880|FG000|Overall Study|Treatment stopped|3|||
105738850|NCT01070550|364699881|FG001|Overall Study|Treatment stopped|0|||
105738851|NCT01070550|364699882|FG002|Overall Study|Treatment stopped|0|||
105738852|NCT01070550|364699883|FG003|Overall Study|Treatment stopped|0|||
105738853|NCT01070550|364699884|FG004|Overall Study|Treatment stopped|0|||
105738854|NCT01070550|364699885|FG005|Overall Study|Treatment stopped|0|||
105738855|NCT01070550|364699880|FG000|Overall Study|Treatment unavailable|1|||
105738856|NCT01070550|364699881|FG001|Overall Study|Treatment unavailable|0|||
105738857|NCT01070550|364699882|FG002|Overall Study|Treatment unavailable|0|||
105799806|NCT04380701|364924640|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105482473|NCT01395784|363777057|FG000|Overall Study|Lost to Follow-up|7|||
105482474|NCT01395784|363777057|FG000|Overall Study|Withdrawal by Subject|3|||
105738858|NCT01070550|364699883|FG003|Overall Study|Treatment unavailable|0|||
105738859|NCT01070550|364699884|FG004|Overall Study|Treatment unavailable|0|||
105738860|NCT01070550|364699885|FG005|Overall Study|Treatment unavailable|0|||
105738861|NCT01070550|364699880|FG000|Overall Study|Treatment was stopped early|7|||
105738862|NCT01070550|364699881|FG001|Overall Study|Treatment was stopped early|0|||
105738863|NCT01070550|364699882|FG002|Overall Study|Treatment was stopped early|0|||
105738864|NCT01070550|364699883|FG003|Overall Study|Treatment was stopped early|0|||
105738865|NCT01070550|364699884|FG004|Overall Study|Treatment was stopped early|0|||
105738866|NCT01070550|364699885|FG005|Overall Study|Treatment was stopped early|0|||
105738867|NCT01070550|364699880|FG000|Overall Study|Other|5|||
105738868|NCT01070550|364699881|FG001|Overall Study|Other|0|||
105738869|NCT01070550|364699882|FG002|Overall Study|Other|0|||
105738870|NCT01070550|364699883|FG003|Overall Study|Other|1|||
105738871|NCT01070550|364699884|FG004|Overall Study|Other|0|||
105738872|NCT01070550|364699885|FG005|Overall Study|Other|0|||
105738873|NCT01070550|364699880|FG000|Overall Study|Withdrawal by Subject|35|||
105738874|NCT01070550|364699881|FG001|Overall Study|Withdrawal by Subject|0|||
105738875|NCT01070550|364699882|FG002|Overall Study|Withdrawal by Subject|3|||
105738876|NCT01070550|364699883|FG003|Overall Study|Withdrawal by Subject|0|||
105738877|NCT01070550|364699884|FG004|Overall Study|Withdrawal by Subject|0|||
105738878|NCT01070550|364699885|FG005|Overall Study|Withdrawal by Subject|0|||
105738879|NCT02869867|364699888|FG000|Overall Study|Protocol Violation|1|||
105738880|NCT02869867|364699889|FG001|Overall Study|Protocol Violation|0|||
105738881|NCT02869867|364699888|FG000|Overall Study|Lost to Follow-up|5|||
105738882|NCT02869867|364699889|FG001|Overall Study|Lost to Follow-up|5|||
105738883|NCT03554005|364699892|FG000|Overall Study|Not in participant's best interest|0|||
105738884|NCT03554005|364699893|FG001|Overall Study|Not in participant's best interest|0|||
105738885|NCT03554005|364699894|FG002|Overall Study|Not in participant's best interest|0|||
105738886|NCT03554005|364699895|FG003|Overall Study|Not in participant's best interest|0|||
105738887|NCT03554005|364699896|FG004|Overall Study|Not in participant's best interest|0|||
105738888|NCT03554005|364699897|FG005|Overall Study|Not in participant's best interest|1|||
105738889|NCT03554005|364699892|FG000|Overall Study|Disease Progression|1|||
105738890|NCT03554005|364699893|FG001|Overall Study|Disease Progression|1|||
105738891|NCT03554005|364699894|FG002|Overall Study|Disease Progression|1|||
105738892|NCT03554005|364699895|FG003|Overall Study|Disease Progression|1|||
105738893|NCT03554005|364699896|FG004|Overall Study|Disease Progression|5|||
105738894|NCT03554005|364699897|FG005|Overall Study|Disease Progression|6|||
105738895|NCT03554005|364699892|FG000|Overall Study|Adverse Event|0|||
105738896|NCT03554005|364699893|FG001|Overall Study|Adverse Event|0|||
105738897|NCT03554005|364699894|FG002|Overall Study|Adverse Event|0|||
105738898|NCT03554005|364699895|FG003|Overall Study|Adverse Event|0|||
105738899|NCT03554005|364699896|FG004|Overall Study|Adverse Event|0|||
105738900|NCT03554005|364699897|FG005|Overall Study|Adverse Event|3|||
105738901|NCT03554005|364699892|FG000|Overall Study|Physician Decision|0|||
105738902|NCT03554005|364699893|FG001|Overall Study|Physician Decision|0|||
105738903|NCT03554005|364699894|FG002|Overall Study|Physician Decision|0|||
105738904|NCT03554005|364699895|FG003|Overall Study|Physician Decision|0|||
105738905|NCT03554005|364699896|FG004|Overall Study|Physician Decision|1|||
105738906|NCT03554005|364699897|FG005|Overall Study|Physician Decision|0|||
105738907|NCT03554005|364699892|FG000|Overall Study|Other|0|||
105738908|NCT03554005|364699893|FG001|Overall Study|Other|0|||
105738909|NCT03554005|364699894|FG002|Overall Study|Other|0|||
105738910|NCT03554005|364699895|FG003|Overall Study|Other|0|||
105738911|NCT03554005|364699896|FG004|Overall Study|Other|0|||
105738912|NCT03554005|364699897|FG005|Overall Study|Other|1|||
105738913|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
105738914|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
105738915|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
105738916|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105738917|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105738918|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105738919|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105738920|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105738921|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
105738922|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
105738923|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
105738924|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105738925|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105738926|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105738927|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105738928|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105738929|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
105738930|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
105738931|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
105738932|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105738933|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105738934|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105738935|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105738936|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105738937|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
105738938|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
105738939|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105738940|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105738941|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105799807|NCT04380701|364924641|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799808|NCT04380701|364924642|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799809|NCT04380701|364924643|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799810|NCT04380701|364924644|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105357165|NCT02757352|363314097|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
105799811|NCT04380701|364924645|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799812|NCT04380701|364924646|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799813|NCT04380701|364924647|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799814|NCT03550794|364924648|FG000|Overall Study|No longer met inclusion criteria|1|||
105799815|NCT03550794|364924649|FG001|Overall Study|No longer met inclusion criteria|2|||
105799816|NCT03550794|364924648|FG000|Overall Study|Goals of care changed|1|||
105799817|NCT03550794|364924649|FG001|Overall Study|Goals of care changed|0|||
105799818|NCT03550794|364924648|FG000|Overall Study|Withdrawal by Subject|2|||
105799819|NCT03550794|364924649|FG001|Overall Study|Withdrawal by Subject|0|||
105799820|NCT03550794|364924648|FG000|Overall Study|Death|0|||
105738942|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105799821|NCT03550794|364924649|FG001|Overall Study|Death|1|||
105799822|NCT00449930|364924650|FG000|Overall Study|Adverse Event|9|||
105799823|NCT00449930|364924651|FG001|Overall Study|Adverse Event|19|||
105799824|NCT00449930|364924650|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
105799825|NCT00449930|364924651|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
105799826|NCT00449930|364924650|FG000|Overall Study|Lack of Efficacy|10|||
105799827|NCT00449930|364924651|FG001|Overall Study|Lack of Efficacy|1|||
105799828|NCT00449930|364924650|FG000|Overall Study|Lost to Follow-up|9|||
105799829|NCT00449930|364924651|FG001|Overall Study|Lost to Follow-up|14|||
105799830|NCT00449930|364924650|FG000|Overall Study|Physician Decision|1|||
105799831|NCT00449930|364924651|FG001|Overall Study|Physician Decision|2|||
105799832|NCT00449930|364924650|FG000|Overall Study|Protocol Violation|14|||
105799833|NCT00449930|364924651|FG001|Overall Study|Protocol Violation|15|||
105799834|NCT00449930|364924650|FG000|Overall Study|Withdrawal by Subject|16|||
105799835|NCT00449930|364924651|FG001|Overall Study|Withdrawal by Subject|23|||
105357166|NCT02757352|363314098|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
105357167|NCT02757352|363314099|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
105357168|NCT02757352|363314100|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
105738943|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105738944|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105738945|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
105738946|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
105738947|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
105738948|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105738949|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105738950|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105738951|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105738952|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105738953|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
105799836|NCT00449930|364924650|FG000|Overall Study|Glycemic discontinuation criteria|1|||
105799837|NCT00449930|364924651|FG001|Overall Study|Glycemic discontinuation criteria|1|||
105799838|NCT01890785|364924652|FG000|Third Intervention|Withdrawal by Subject|0|||
105357169|NCT02757352|363314101|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
105799839|NCT01890785|364924653|FG001|Third Intervention|Withdrawal by Subject|1|||
105799840|NCT01890785|364924654|FG002|Third Intervention|Withdrawal by Subject|0|||
105357170|NCT02757352|363314102|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
105357171|NCT02757352|363314093|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105799841|NCT01890785|364924655|FG003|Third Intervention|Withdrawal by Subject|0|||
105799842|NCT01890785|364924656|FG004|Third Intervention|Withdrawal by Subject|0|||
105799843|NCT01890785|364924657|FG005|Third Intervention|Withdrawal by Subject|0|||
105357172|NCT02757352|363314094|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
105357173|NCT02757352|363314095|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105357174|NCT02757352|363314096|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105357175|NCT02757352|363314097|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105357176|NCT02757352|363314098|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105357177|NCT02757352|363314099|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105357178|NCT02757352|363314100|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105357179|NCT02757352|363314101|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105357180|NCT02757352|363314102|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105357181|NCT02757352|363314093|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105482475|NCT01395784|363777057|FG000|Overall Study|Physician Decision|5|||
105482476|NCT02055365|363778880|FG000|Overall Study|Prematurely Withdrawn|1|||
105738954|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
105738955|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
105738956|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
105738957|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
105738958|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
105738959|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
105738960|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
105738961|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
105738962|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
105738963|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105738964|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105738965|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105738966|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105738967|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105738968|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105738969|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105738970|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105738971|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
105738972|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105738973|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105738974|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105738975|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105738976|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105738977|NCT01097616|364699902|FG000|Optional DB EXT Phase|Adverse Event|0|||
105738978|NCT01097616|364699903|FG001|Optional DB EXT Phase|Adverse Event|7|||
105738979|NCT01097616|364699904|FG002|Optional DB EXT Phase|Adverse Event|2|||
105738980|NCT01097616|364699905|FG003|Optional DB EXT Phase|Adverse Event|0|||
105738981|NCT01097616|364699906|FG004|Optional DB EXT Phase|Adverse Event|0|||
105738982|NCT01097616|364699907|FG005|Optional DB EXT Phase|Adverse Event|0|||
105738983|NCT01097616|364699908|FG006|Optional DB EXT Phase|Adverse Event|0|||
105738984|NCT01097616|364699909|FG007|Optional DB EXT Phase|Adverse Event|0|||
105738985|NCT01097616|364699902|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
105738986|NCT01097616|364699903|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
105738987|NCT01097616|364699904|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
105738988|NCT01097616|364699905|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
105738989|NCT01097616|364699906|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
105738990|NCT01097616|364699907|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
105738991|NCT01097616|364699908|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
105738992|NCT01097616|364699909|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
105738993|NCT01097616|364699902|FG000|Optional DB EXT Phase|Protocol Violation|0|||
105738994|NCT01097616|364699903|FG001|Optional DB EXT Phase|Protocol Violation|2|||
105738995|NCT01097616|364699904|FG002|Optional DB EXT Phase|Protocol Violation|3|||
105738996|NCT01097616|364699905|FG003|Optional DB EXT Phase|Protocol Violation|0|||
105738997|NCT01097616|364699906|FG004|Optional DB EXT Phase|Protocol Violation|0|||
105738998|NCT01097616|364699907|FG005|Optional DB EXT Phase|Protocol Violation|0|||
105738999|NCT01097616|364699908|FG006|Optional DB EXT Phase|Protocol Violation|0|||
105739000|NCT01097616|364699909|FG007|Optional DB EXT Phase|Protocol Violation|0|||
105739001|NCT01097616|364699902|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
105739002|NCT01097616|364699903|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
105739003|NCT01097616|364699904|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
105739004|NCT01097616|364699905|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
105739005|NCT01097616|364699906|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
105739006|NCT01097616|364699907|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
105739007|NCT01097616|364699908|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
105739008|NCT01097616|364699909|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
105739009|NCT01097616|364699902|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
105739010|NCT01097616|364699903|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
105739011|NCT01097616|364699904|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
105357182|NCT02757352|363314094|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
105799844|NCT03001011|364924658|FG000|Overall Study|Adverse Event|9|||
105799845|NCT03001011|364924659|FG001|Overall Study|Adverse Event|3|||
105799846|NCT03001011|364924658|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
105799847|NCT03001011|364924659|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
105799848|NCT03001011|364924658|FG000|Overall Study|Other than specified above|3|||
105799849|NCT03001011|364924659|FG001|Overall Study|Other than specified above|8|||
105799850|NCT02875067|364924660|FG000|Overall Study|Withdrawal by Subject|1|||
105799851|NCT02875067|364924660|FG000|Overall Study|Withdrawal by Termination of Study|5|||
105799852|NCT02862535|364924661|FG000|Overall Study|Death|7|||
105799853|NCT02862535|364924662|FG001|Overall Study|Death|3|||
105357183|NCT02757352|363314095|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105357184|NCT02757352|363314096|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105357185|NCT02757352|363314097|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105357186|NCT02757352|363314098|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105357187|NCT02757352|363314099|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105357188|NCT02757352|363314100|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105357189|NCT02757352|363314101|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105799854|NCT02862535|364924663|FG002|Overall Study|Death|2|||
105799855|NCT02862535|364924664|FG003|Overall Study|Death|5|||
105799856|NCT02862535|364924661|FG000|Overall Study|Study Terminated by Sponsor|1|||
105799857|NCT02862535|364924662|FG001|Overall Study|Study Terminated by Sponsor|3|||
105799858|NCT02862535|364924663|FG002|Overall Study|Study Terminated by Sponsor|8|||
105799859|NCT02862535|364924664|FG003|Overall Study|Study Terminated by Sponsor|5|||
105357190|NCT02757352|363314102|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105357191|NCT02757352|363314093|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
105482477|NCT04966910|363778883|FG000|Baseline|Participant did not complete measure|0|||
105482478|NCT04966910|363778884|FG001|Baseline|Participant did not complete measure|0|||
105799860|NCT02862535|364924661|FG000|Overall Study|Enrolled, not Treated|1|||
105799861|NCT02862535|364924662|FG001|Overall Study|Enrolled, not Treated|0|||
105799862|NCT02862535|364924663|FG002|Overall Study|Enrolled, not Treated|0|||
105357192|NCT02757352|363314094|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
105739012|NCT01097616|364699905|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
105739013|NCT01097616|364699906|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
105739014|NCT01097616|364699907|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
105739015|NCT01097616|364699908|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
105739016|NCT01097616|364699909|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
105739017|NCT01097616|364699902|FG000|Optional DB EXT Phase|Physician Decision|1|||
105739018|NCT01097616|364699903|FG001|Optional DB EXT Phase|Physician Decision|0|||
105739019|NCT01097616|364699904|FG002|Optional DB EXT Phase|Physician Decision|0|||
105739020|NCT01097616|364699905|FG003|Optional DB EXT Phase|Physician Decision|0|||
105739021|NCT01097616|364699906|FG004|Optional DB EXT Phase|Physician Decision|0|||
105739022|NCT01097616|364699907|FG005|Optional DB EXT Phase|Physician Decision|0|||
105739023|NCT01097616|364699908|FG006|Optional DB EXT Phase|Physician Decision|0|||
105739024|NCT01097616|364699909|FG007|Optional DB EXT Phase|Physician Decision|0|||
105739025|NCT01097616|364699902|FG000|DB RO Phase|Adverse Event|0|||
105739026|NCT01097616|364699903|FG001|DB RO Phase|Adverse Event|0|||
105739027|NCT01097616|364699904|FG002|DB RO Phase|Adverse Event|0|||
105739028|NCT01097616|364699905|FG003|DB RO Phase|Adverse Event|0|||
105739029|NCT01097616|364699906|FG004|DB RO Phase|Adverse Event|0|||
105739030|NCT01097616|364699907|FG005|DB RO Phase|Adverse Event|0|||
105739031|NCT01097616|364699908|FG006|DB RO Phase|Adverse Event|1|||
105739032|NCT01097616|364699909|FG007|DB RO Phase|Adverse Event|0|||
105739033|NCT01097616|364699902|FG000|DB RO Phase|Withdrawal by Subject|0|||
105739034|NCT01097616|364699903|FG001|DB RO Phase|Withdrawal by Subject|0|||
105739035|NCT01097616|364699904|FG002|DB RO Phase|Withdrawal by Subject|0|||
105739036|NCT01097616|364699905|FG003|DB RO Phase|Withdrawal by Subject|0|||
105739037|NCT01097616|364699906|FG004|DB RO Phase|Withdrawal by Subject|0|||
105739038|NCT01097616|364699907|FG005|DB RO Phase|Withdrawal by Subject|1|||
105739039|NCT01097616|364699908|FG006|DB RO Phase|Withdrawal by Subject|0|||
105739040|NCT01097616|364699909|FG007|DB RO Phase|Withdrawal by Subject|0|||
105739041|NCT01097616|364699902|FG000|DB RO Phase|Lost to Follow-up|0|||
105739042|NCT01097616|364699903|FG001|DB RO Phase|Lost to Follow-up|0|||
105739043|NCT01097616|364699904|FG002|DB RO Phase|Lost to Follow-up|0|||
105739044|NCT01097616|364699905|FG003|DB RO Phase|Lost to Follow-up|1|||
105739045|NCT01097616|364699906|FG004|DB RO Phase|Lost to Follow-up|1|||
105357193|NCT02757352|363314095|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
105357194|NCT02757352|363314096|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105357195|NCT02757352|363314097|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105357196|NCT02757352|363314098|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105357197|NCT02757352|363314099|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105357198|NCT02757352|363314100|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105357199|NCT02757352|363314101|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105357200|NCT02757352|363314102|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105357201|NCT02757352|363314093|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
105357202|NCT02757352|363314094|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
105357203|NCT02757352|363314095|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
105357204|NCT02757352|363314096|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
105357205|NCT02757352|363314097|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
105357206|NCT02757352|363314098|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
105357207|NCT02757352|363314099|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
105357208|NCT02757352|363314100|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
105357209|NCT02757352|363314101|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
105357210|NCT02757352|363314102|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
105357211|NCT02757352|363314093|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105357212|NCT02757352|363314094|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105357213|NCT02757352|363314095|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105357214|NCT02757352|363314096|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
105482479|NCT04966910|363778885|FG002|Baseline|Participant did not complete measure|1|||
105739046|NCT01097616|364699907|FG005|DB RO Phase|Lost to Follow-up|0|||
105482480|NCT04966910|363778886|FG003|Baseline|Participant did not complete measure|0|||
105482481|NCT04966910|363778883|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
105739047|NCT01097616|364699908|FG006|DB RO Phase|Lost to Follow-up|0|||
105739048|NCT01097616|364699909|FG007|DB RO Phase|Lost to Follow-up|1|||
105739049|NCT01097616|364699902|FG000|DB RO Phase|Not Treated in RO|0|||
105739050|NCT01097616|364699903|FG001|DB RO Phase|Not Treated in RO|0|||
105739051|NCT01097616|364699904|FG002|DB RO Phase|Not Treated in RO|0|||
105739052|NCT01097616|364699905|FG003|DB RO Phase|Not Treated in RO|0|||
105739053|NCT01097616|364699906|FG004|DB RO Phase|Not Treated in RO|0|||
105739054|NCT01097616|364699907|FG005|DB RO Phase|Not Treated in RO|1|||
105739055|NCT01097616|364699908|FG006|DB RO Phase|Not Treated in RO|0|||
105739056|NCT01097616|364699909|FG007|DB RO Phase|Not Treated in RO|0|||
105739057|NCT01996319|364699910|FG000|Overall Study|Protocol Violation|1|||
105739058|NCT01996319|364699911|FG001|Overall Study|Protocol Violation|0|||
105739059|NCT01996319|364699910|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
105739060|NCT01996319|364699911|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
105739061|NCT01996319|364699910|FG000|Overall Study|Adverse Event|2|||
105739062|NCT01996319|364699911|FG001|Overall Study|Adverse Event|2|||
105739063|NCT00130208|364699912|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
105739064|NCT00130208|364699913|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
105739065|NCT00130208|364699912|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
105739066|NCT00130208|364699913|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
105739067|NCT00130208|364699912|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
105739068|NCT00130208|364699913|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
105739069|NCT00130208|364699912|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
105739070|NCT00130208|364699913|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
105739071|NCT00130208|364699912|FG000|Maintenance Period (26 Weeks)|Other|1|||
105739072|NCT00130208|364699913|FG001|Maintenance Period (26 Weeks)|Other|1|||
105739073|NCT00130208|364699912|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
105739074|NCT00130208|364699913|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
105739075|NCT00130208|364699912|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
105739076|NCT00130208|364699913|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
105739077|NCT00130208|364699912|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
105739078|NCT00130208|364699913|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
105739079|NCT00130208|364699912|FG000|Washout Period (8 Weeks)|Other|1|||
105739080|NCT00130208|364699913|FG001|Washout Period (8 Weeks)|Other|1|||
105739081|NCT00771030|364699918|FG000|Overall Study|Adverse Event|0|||
105739082|NCT00771030|364699919|FG001|Overall Study|Adverse Event|1|||
105739083|NCT00771030|364699920|FG002|Overall Study|Adverse Event|0|||
105739084|NCT00771030|364699921|FG003|Overall Study|Adverse Event|0|||
105739085|NCT00771030|364699922|FG004|Overall Study|Adverse Event|0|||
105739086|NCT00771030|364699923|FG005|Overall Study|Adverse Event|0|||
105739087|NCT00771030|364699924|FG006|Overall Study|Adverse Event|0|||
105739088|NCT01839188|364699925|FG000|Overall Study|Withdrawal by Subject|1|||
105739089|NCT01327339|364699928|FG000|Overall Study|Protocol Violation|8|||
105739090|NCT00871858|364699929|FG000|Overall Study|Protocol Violation|3|||
105739091|NCT00871858|364699930|FG001|Overall Study|Protocol Violation|4|||
105739092|NCT00871858|364699929|FG000|Overall Study|Adverse Event|1|||
105739093|NCT00871858|364699930|FG001|Overall Study|Adverse Event|1|||
105739094|NCT00871858|364699929|FG000|Overall Study|Withdrawal by Subject|1|||
105739095|NCT00871858|364699930|FG001|Overall Study|Withdrawal by Subject|1|||
105739096|NCT00871858|364699929|FG000|Overall Study|Lost to Follow-up|0|||
105739097|NCT00871858|364699930|FG001|Overall Study|Lost to Follow-up|1|||
105739098|NCT03964415|364699936|FG000|Overall Study|Sponsor's decision|1563|||
105739099|NCT03964415|364699937|FG001|Overall Study|Sponsor's decision|1528|||
105739100|NCT03964415|364699936|FG000|Overall Study|Lost to Follow-up|139|||
105739101|NCT03964415|364699937|FG001|Overall Study|Lost to Follow-up|146|||
105739102|NCT03964415|364699936|FG000|Overall Study|Withdrawal by Subject|68|||
105739103|NCT03964415|364699937|FG001|Overall Study|Withdrawal by Subject|72|||
105739104|NCT03964415|364699936|FG000|Overall Study|Physician Decision|34|||
105739105|NCT03964415|364699937|FG001|Overall Study|Physician Decision|48|||
105739106|NCT03964415|364699936|FG000|Overall Study|Adverse Event|3|||
105739107|NCT03964415|364699937|FG001|Overall Study|Adverse Event|0|||
105739108|NCT03964415|364699936|FG000|Overall Study|Death|4|||
105739109|NCT03964415|364699937|FG001|Overall Study|Death|6|||
105739110|NCT03964415|364699936|FG000|Overall Study|Protocol Violation|1|||
105739111|NCT03964415|364699937|FG001|Overall Study|Protocol Violation|4|||
105739112|NCT03964415|364699936|FG000|Overall Study|Other|35|||
105739113|NCT03964415|364699937|FG001|Overall Study|Other|38|||
105739114|NCT03964415|364699936|FG000|Overall Study|Randomized but not treated|6|||
105739115|NCT03964415|364699937|FG001|Overall Study|Randomized but not treated|7|||
105739116|NCT01024465|364699938|FG000|Overall Study|Adverse Event|2|||
105739117|NCT01024465|364699938|FG000|Overall Study|Physician Decision|1|||
105739118|NCT03078608|364699940|FG000|Overall Study|Death|1|||
105739119|NCT03078608|364699941|FG001|Overall Study|Death|2|||
105739120|NCT03078608|364699942|FG002|Overall Study|Death|0|||
105739121|NCT03078608|364699943|FG003|Overall Study|Death|0|||
105739122|NCT03078608|364699940|FG000|Overall Study|Withdrawal by Subject|8|||
105739123|NCT03078608|364699941|FG001|Overall Study|Withdrawal by Subject|1|||
105739124|NCT03078608|364699942|FG002|Overall Study|Withdrawal by Subject|0|||
105739125|NCT03078608|364699943|FG003|Overall Study|Withdrawal by Subject|0|||
105739126|NCT03078608|364699940|FG000|Overall Study|Lost to Follow-up|5|||
105739127|NCT03078608|364699941|FG001|Overall Study|Lost to Follow-up|8|||
105739128|NCT03078608|364699942|FG002|Overall Study|Lost to Follow-up|4|||
105739129|NCT03078608|364699943|FG003|Overall Study|Lost to Follow-up|1|||
105739130|NCT01455428|364699944|FG000|Overall Study|Protocol Violation|2|||
105739131|NCT01455428|364699945|FG001|Overall Study|Protocol Violation|1|||
105739132|NCT01455428|364699944|FG000|Overall Study|Adverse Event|6|||
105739133|NCT01455428|364699945|FG001|Overall Study|Adverse Event|2|||
105739134|NCT01455428|364699944|FG000|Overall Study|Lost to Follow-up|1|||
105739135|NCT01455428|364699945|FG001|Overall Study|Lost to Follow-up|1|||
105739136|NCT01455428|364699944|FG000|Overall Study|Withdrawal by Subject|2|||
105739137|NCT01455428|364699945|FG001|Overall Study|Withdrawal by Subject|5|||
105739138|NCT01455428|364699944|FG000|Overall Study|Did not meet entrance criteria|0|||
105739139|NCT01455428|364699945|FG001|Overall Study|Did not meet entrance criteria|2|||
105739140|NCT01455428|364699944|FG000|Overall Study|Insufficient clinical response|0|||
105739141|NCT01455428|364699945|FG001|Overall Study|Insufficient clinical response|2|||
105739142|NCT01455428|364699944|FG000|Overall Study|Did not receive treatment|1|||
105739143|NCT01455428|364699945|FG001|Overall Study|Did not receive treatment|1|||
105739144|NCT01455428|364699944|FG000|Overall Study|Other|2|||
105739145|NCT01455428|364699945|FG001|Overall Study|Other|4|||
105739146|NCT00312377|364699956|FG000|Overall Study|Death|403|||
105739147|NCT00312377|364699957|FG001|Overall Study|Death|418|||
105739148|NCT00312377|364699956|FG000|Overall Study|Withdrawal by Subject|23|||
105739149|NCT00312377|364699957|FG001|Overall Study|Withdrawal by Subject|30|||
105739150|NCT00312377|364699956|FG000|Overall Study|Lost to Follow-up|9|||
105739151|NCT00312377|364699957|FG001|Overall Study|Lost to Follow-up|12|||
105739152|NCT00312377|364699956|FG000|Overall Study|Non-compliance|0|||
105739153|NCT00312377|364699957|FG001|Overall Study|Non-compliance|2|||
105739154|NCT00312377|364699956|FG000|Overall Study|Randomised but never received treatment|6|||
105739155|NCT00312377|364699957|FG001|Overall Study|Randomised but never received treatment|6|||
105739156|NCT00312377|364699956|FG000|Overall Study|Discontinue treatment survival follow up|202|||
105739157|NCT00312377|364699957|FG001|Overall Study|Discontinue treatment survival follow up|200|||
105739158|NCT00312377|364699956|FG000|Overall Study|Site ended participation in study|1|||
105739159|NCT00312377|364699957|FG001|Overall Study|Site ended participation in study|0|||
105739160|NCT00872898|364699958|FG000|Part Two - Double Blind|Adverse Event|4|||
105739161|NCT00872898|364699959|FG001|Part Two - Double Blind|Adverse Event|3|||
105739162|NCT00872898|364699958|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
105739163|NCT00872898|364699959|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
105739164|NCT00872898|364699958|FG000|Part Two - Double Blind|Protocol Violation|1|||
105739165|NCT00872898|364699959|FG001|Part Two - Double Blind|Protocol Violation|0|||
105739166|NCT00872898|364699958|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
105739167|NCT00872898|364699959|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
105739168|NCT00872898|364699958|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
105739169|NCT00872898|364699959|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
105739170|NCT00872898|364699958|FG000|Part Two - Double Blind|Other reasons|2|||
105739171|NCT00872898|364699959|FG001|Part Two - Double Blind|Other reasons|0|||
105739172|NCT00455858|364699960|FG000|Overall Study|Lost to Follow-up|2|||
105739173|NCT00455858|364699960|FG000|Overall Study|Protocol Violation|1|||
105739174|NCT00455858|364699960|FG000|Overall Study|Lack of Efficacy|1|||
105739175|NCT00455858|364699960|FG000|Overall Study|Well controlled FPG without insulin|1|||
105739176|NCT00455858|364699960|FG000|Overall Study|Withdrawal|1|||
105482482|NCT04966910|363778884|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
105482483|NCT04966910|363778885|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
105482484|NCT04966910|363778886|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
105739177|NCT03290300|364699964|FG000|Overall Study|Lost to Follow-up|3|||
105739178|NCT04172831|364699965|FG000|Overall Study|Adverse Event|21|||
105739179|NCT04172831|364699966|FG001|Overall Study|Adverse Event|9|||
105739180|NCT04172831|364699965|FG000|Overall Study|Lack of Efficacy|2|||
105739181|NCT04172831|364699966|FG001|Overall Study|Lack of Efficacy|8|||
105739182|NCT04172831|364699965|FG000|Overall Study|Physician Decision|0|||
105739183|NCT04172831|364699966|FG001|Overall Study|Physician Decision|1|||
105739184|NCT04172831|364699965|FG000|Overall Study|Withdrawal by Subject|12|||
105739185|NCT04172831|364699966|FG001|Overall Study|Withdrawal by Subject|11|||
105482485|NCT04966910|363778883|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
105482486|NCT04966910|363778884|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
105482487|NCT04966910|363778885|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
105482488|NCT04966910|363778886|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
105739186|NCT04172831|364699965|FG000|Overall Study|Lost to Follow-up|4|||
105739187|NCT04172831|364699966|FG001|Overall Study|Lost to Follow-up|9|||
105739188|NCT04172831|364699965|FG000|Overall Study|COVID-19 related crisis|3|||
105739189|NCT04172831|364699966|FG001|Overall Study|COVID-19 related crisis|3|||
105739190|NCT04172831|364699965|FG000|Overall Study|Subject non-compliance|1|||
105739191|NCT04172831|364699966|FG001|Overall Study|Subject non-compliance|1|||
105739192|NCT04172831|364699965|FG000|Overall Study|Family emergency|1|||
105739193|NCT04172831|364699966|FG001|Overall Study|Family emergency|0|||
105739194|NCT01558089|364699971|FG000|Overall Study|Adverse Event|1|||
105739195|NCT01558089|364699971|FG000|Overall Study|Lack of Efficacy|1|||
105739196|NCT01558089|364699971|FG000|Overall Study|Lost to Follow-up|5|||
105739197|NCT01558089|364699971|FG000|Overall Study|Withdrawal by Subject|6|||
105739198|NCT02050048|364699972|FG000|Overall Study|Lost to Follow-up|0|||
105739199|NCT02050048|364699973|FG001|Overall Study|Lost to Follow-up|1|||
105739200|NCT02050048|364699972|FG000|Overall Study|Death|1|||
105739201|NCT02050048|364699973|FG001|Overall Study|Death|0|||
105739202|NCT02050048|364699972|FG000|Overall Study|Ineligible after ERCP|4|||
105739203|NCT02050048|364699973|FG001|Overall Study|Ineligible after ERCP|1|||
105739204|NCT01469052|364699976|FG000|Overall Study|Adverse Event|2|||
105739205|NCT01469052|364699977|FG001|Overall Study|Adverse Event|3|||
105739206|NCT01469052|364699978|FG002|Overall Study|Adverse Event|0|||
105739207|NCT01469052|364699979|FG003|Overall Study|Adverse Event|2|||
105739208|NCT01469052|364699980|FG004|Overall Study|Adverse Event|0|||
105739209|NCT01469052|364699981|FG005|Overall Study|Adverse Event|1|||
105739210|NCT01469052|364699976|FG000|Overall Study|Progressive disease|3|||
105739211|NCT01469052|364699977|FG001|Overall Study|Progressive disease|0|||
105739212|NCT01469052|364699978|FG002|Overall Study|Progressive disease|5|||
105739213|NCT01469052|364699979|FG003|Overall Study|Progressive disease|3|||
105739214|NCT01469052|364699980|FG004|Overall Study|Progressive disease|7|||
105739215|NCT01469052|364699981|FG005|Overall Study|Progressive disease|2|||
105799863|NCT02862535|364924664|FG003|Overall Study|Enrolled, not Treated|1|||
105799864|NCT00964223|364924665|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
105357215|NCT02757352|363314097|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105357216|NCT02757352|363314098|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
105357217|NCT02757352|363314099|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105357218|NCT02757352|363314100|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105357219|NCT02757352|363314101|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105357220|NCT02757352|363314102|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105357221|NCT02757352|363314093|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105357222|NCT02757352|363314094|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105357223|NCT02757352|363314095|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105357224|NCT02757352|363314096|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
105357225|NCT02757352|363314097|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
105357226|NCT02757352|363314098|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
105357227|NCT02757352|363314099|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105357228|NCT02757352|363314100|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105357229|NCT02757352|363314101|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105357230|NCT02757352|363314102|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105357231|NCT02757352|363314093|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105357232|NCT02757352|363314094|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105357233|NCT02757352|363314095|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105357234|NCT02757352|363314096|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105357235|NCT02757352|363314097|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
105357236|NCT02757352|363314098|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105357237|NCT02757352|363314099|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105357238|NCT02757352|363314100|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105357239|NCT02757352|363314101|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105357240|NCT02757352|363314102|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105357241|NCT02757352|363314093|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105482489|NCT04966910|363778883|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
105739216|NCT01469052|364699976|FG000|Overall Study|Lack of Efficacy|0|||
105739217|NCT01469052|364699977|FG001|Overall Study|Lack of Efficacy|0|||
105739218|NCT01469052|364699978|FG002|Overall Study|Lack of Efficacy|0|||
105739219|NCT01469052|364699979|FG003|Overall Study|Lack of Efficacy|0|||
105739220|NCT01469052|364699980|FG004|Overall Study|Lack of Efficacy|0|||
105739221|NCT01469052|364699981|FG005|Overall Study|Lack of Efficacy|2|||
105739222|NCT01469052|364699976|FG000|Overall Study|Moved to rollover protocol|1|||
105739223|NCT01469052|364699977|FG001|Overall Study|Moved to rollover protocol|0|||
105739224|NCT01469052|364699978|FG002|Overall Study|Moved to rollover protocol|1|||
105482490|NCT04966910|363778884|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
105482491|NCT04966910|363778885|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
105482492|NCT04966910|363778886|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
105482493|NCT03811093|363778887|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
105482494|NCT03811093|363778888|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
105482495|NCT03811093|363778887|FG000|Overall Study|Unable to measure body fat percentage|2|||
105482496|NCT03811093|363778888|FG001|Overall Study|Unable to measure body fat percentage|0|||
105482497|NCT01350544|363778889|FG000|Overall Study|Administrative Withdrawal|0|||
105482498|NCT01350544|363778890|FG001|Overall Study|Administrative Withdrawal|1|||
105482499|NCT01350544|363778889|FG000|Overall Study|Death|1|||
105482500|NCT01350544|363778890|FG001|Overall Study|Death|2|||
105482501|NCT01350544|363778889|FG000|Overall Study|Moved out of LA County|2|||
105482502|NCT01350544|363778890|FG001|Overall Study|Moved out of LA County|2|||
105482503|NCT01350544|363778889|FG000|Overall Study|Medical Issues|1|||
105482504|NCT01350544|363778890|FG001|Overall Study|Medical Issues|1|||
105482505|NCT01350544|363778889|FG000|Overall Study|Withdrawal by Subject|0|||
105482506|NCT01350544|363778890|FG001|Overall Study|Withdrawal by Subject|1|||
105482507|NCT01350544|363778889|FG000|Overall Study|Incarceration|1|||
105482508|NCT01350544|363778890|FG001|Overall Study|Incarceration|0|||
105482509|NCT01350544|363778889|FG000|Overall Study|Lost to Follow-up|18|||
105482510|NCT01350544|363778890|FG001|Overall Study|Lost to Follow-up|15|||
105482511|NCT04456673|363778900|FG000|Overall Study|Adverse Event|7|||
105482512|NCT04456673|363778901|FG001|Overall Study|Adverse Event|14|||
105482513|NCT04456673|363778900|FG000|Overall Study|Poor compliance to protocol|1|||
105482514|NCT04456673|363778901|FG001|Overall Study|Poor compliance to protocol|0|||
105482515|NCT04456673|363778900|FG000|Overall Study|Withdrawal by Subject|31|||
105482516|NCT04456673|363778901|FG001|Overall Study|Withdrawal by Subject|23|||
105482517|NCT04456673|363778900|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
105482518|NCT04456673|363778901|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
105482519|NCT00779259|363778902|FG000|Quinine Alone|Adverse Event|2|||
105482520|NCT04575597|363778903|FG000|Overall Study|Death|0|||
105482521|NCT04575597|363778904|FG001|Overall Study|Death|0|||
105482522|NCT04575597|363778905|FG002|Overall Study|Death|0|||
105482523|NCT04575597|363778906|FG003|Overall Study|Death|1|||
105482524|NCT04575597|363778907|FG004|Overall Study|Death|3|||
105482525|NCT04575597|363778908|FG005|Overall Study|Death|14|||
105482526|NCT04575597|363778903|FG000|Overall Study|Lost to Follow-up|2|||
105482527|NCT04575597|363778904|FG001|Overall Study|Lost to Follow-up|1|||
105482528|NCT04575597|363778905|FG002|Overall Study|Lost to Follow-up|1|||
105482529|NCT04575597|363778906|FG003|Overall Study|Lost to Follow-up|2|||
105482530|NCT04575597|363778907|FG004|Overall Study|Lost to Follow-up|10|||
105482531|NCT04575597|363778908|FG005|Overall Study|Lost to Follow-up|8|||
105482532|NCT04575597|363778903|FG000|Overall Study|Withdrawal by Subject|2|||
105482533|NCT04575597|363778904|FG001|Overall Study|Withdrawal by Subject|2|||
105482534|NCT04575597|363778905|FG002|Overall Study|Withdrawal by Subject|4|||
105482535|NCT04575597|363778906|FG003|Overall Study|Withdrawal by Subject|2|||
105482536|NCT04575597|363778907|FG004|Overall Study|Withdrawal by Subject|25|||
105482537|NCT04575597|363778908|FG005|Overall Study|Withdrawal by Subject|28|||
105482538|NCT04575597|363778903|FG000|Overall Study|Not Recorded|0|||
105482539|NCT04575597|363778904|FG001|Overall Study|Not Recorded|0|||
105482540|NCT04575597|363778905|FG002|Overall Study|Not Recorded|0|||
105482541|NCT04575597|363778906|FG003|Overall Study|Not Recorded|0|||
105482542|NCT04575597|363778907|FG004|Overall Study|Not Recorded|0|||
105482543|NCT04575597|363778908|FG005|Overall Study|Not Recorded|2|||
105482544|NCT04575597|363778903|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105482545|NCT04575597|363778904|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105482546|NCT04575597|363778905|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105739225|NCT01469052|364699979|FG003|Overall Study|Moved to rollover protocol|0|||
105739226|NCT01469052|364699980|FG004|Overall Study|Moved to rollover protocol|0|||
105739227|NCT01469052|364699981|FG005|Overall Study|Moved to rollover protocol|1|||
105739228|NCT01469052|364699976|FG000|Overall Study|Other|0|||
105482547|NCT04575597|363778906|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105482548|NCT04575597|363778907|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
105482549|NCT04575597|363778908|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
105482550|NCT02095132|363778912|FG000|Overall Study|Adverse Event|0|||
105482551|NCT02095132|363778913|FG001|Overall Study|Adverse Event|0|||
105482552|NCT02095132|363778914|FG002|Overall Study|Adverse Event|0|||
105482553|NCT02095132|363778915|FG003|Overall Study|Adverse Event|0|||
105482554|NCT02095132|363778916|FG004|Overall Study|Adverse Event|1|||
105482555|NCT02095132|363778917|FG005|Overall Study|Adverse Event|0|||
105482556|NCT02095132|363778918|FG006|Overall Study|Adverse Event|1|||
105482557|NCT02095132|363778919|FG007|Overall Study|Adverse Event|0|||
105482558|NCT02095132|363778920|FG008|Overall Study|Adverse Event|0|||
105739229|NCT01469052|364699977|FG001|Overall Study|Other|1|||
105739230|NCT01469052|364699978|FG002|Overall Study|Other|0|||
105482559|NCT02095132|363778912|FG000|Overall Study|Death|0|||
105482560|NCT02095132|363778913|FG001|Overall Study|Death|0|||
105482561|NCT02095132|363778914|FG002|Overall Study|Death|0|||
105482562|NCT02095132|363778915|FG003|Overall Study|Death|0|||
105482563|NCT02095132|363778916|FG004|Overall Study|Death|0|||
105482564|NCT02095132|363778917|FG005|Overall Study|Death|0|||
105482565|NCT02095132|363778918|FG006|Overall Study|Death|1|||
105482566|NCT02095132|363778919|FG007|Overall Study|Death|0|||
105482567|NCT02095132|363778920|FG008|Overall Study|Death|0|||
105482568|NCT02095132|363778912|FG000|Overall Study|Lack of Efficacy|3|||
105482569|NCT02095132|363778913|FG001|Overall Study|Lack of Efficacy|5|||
105482570|NCT02095132|363778914|FG002|Overall Study|Lack of Efficacy|2|||
105482571|NCT02095132|363778915|FG003|Overall Study|Lack of Efficacy|8|||
105482572|NCT02095132|363778916|FG004|Overall Study|Lack of Efficacy|3|||
105482573|NCT02095132|363778917|FG005|Overall Study|Lack of Efficacy|6|||
105482574|NCT02095132|363778918|FG006|Overall Study|Lack of Efficacy|10|||
105482575|NCT02095132|363778919|FG007|Overall Study|Lack of Efficacy|9|||
105482576|NCT02095132|363778920|FG008|Overall Study|Lack of Efficacy|8|||
105482577|NCT02095132|363778912|FG000|Overall Study|Physician Decision|1|||
105565261|NCT03420781|364066727|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
105565262|NCT03420781|364066728|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
105739231|NCT01469052|364699979|FG003|Overall Study|Other|0|||
105739232|NCT01469052|364699980|FG004|Overall Study|Other|1|||
105739233|NCT01469052|364699981|FG005|Overall Study|Other|0|||
105739234|NCT01597193|364699982|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
105739235|NCT01597193|364699983|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
105739236|NCT01597193|364699984|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
105739237|NCT01597193|364699985|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
105739238|NCT01597193|364699986|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
105739239|NCT01597193|364699987|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
105739240|NCT01597193|364699988|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
105739241|NCT01597193|364699982|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
105739242|NCT01597193|364699983|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
105739243|NCT01597193|364699984|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
105739244|NCT01597193|364699985|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
105739245|NCT01597193|364699986|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
105739246|NCT01597193|364699987|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
105739247|NCT01597193|364699988|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
105739248|NCT01597193|364699982|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
105739249|NCT01597193|364699983|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
105739250|NCT01597193|364699984|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
105739251|NCT01597193|364699985|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
105739252|NCT01597193|364699986|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
105739253|NCT01597193|364699987|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
105739254|NCT01597193|364699988|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
105739255|NCT01597193|364699982|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
105739256|NCT01597193|364699983|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
105739257|NCT01597193|364699984|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
105739258|NCT01597193|364699985|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
105739259|NCT01597193|364699986|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
105739260|NCT01597193|364699987|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
105799865|NCT02278952|364924666|FG000|Overall Study|Insufficient Sample|6|||
105799866|NCT04304950|364924669|FG000|Overall Study|Lost to Follow-up|1|||
105799867|NCT04304950|364924670|FG001|Overall Study|Lost to Follow-up|1|||
105799868|NCT02418910|364924671|FG000|Overall Study|Lost to Follow-up|3|||
105357242|NCT02757352|363314094|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105357243|NCT02757352|363314095|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105357244|NCT02757352|363314096|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105357245|NCT02757352|363314097|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105357246|NCT02757352|363314098|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
105357247|NCT02757352|363314099|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105357248|NCT02757352|363314100|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105357249|NCT02757352|363314101|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105482578|NCT02095132|363778913|FG001|Overall Study|Physician Decision|0|||
105482579|NCT02095132|363778914|FG002|Overall Study|Physician Decision|0|||
105482580|NCT02095132|363778915|FG003|Overall Study|Physician Decision|0|||
105482581|NCT02095132|363778916|FG004|Overall Study|Physician Decision|0|||
105482582|NCT02095132|363778917|FG005|Overall Study|Physician Decision|0|||
105482583|NCT02095132|363778918|FG006|Overall Study|Physician Decision|1|||
105482584|NCT02095132|363778919|FG007|Overall Study|Physician Decision|0|||
105482585|NCT02095132|363778920|FG008|Overall Study|Physician Decision|2|||
105739261|NCT01597193|364699988|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
105739262|NCT01597193|364699982|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
105739263|NCT01597193|364699983|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
105357250|NCT02757352|363314102|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105357251|NCT02757352|363314093|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105357252|NCT02757352|363314094|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105357253|NCT02757352|363314095|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105357254|NCT02757352|363314096|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
105357255|NCT02757352|363314097|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
105357256|NCT02757352|363314098|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
105357257|NCT02757352|363314099|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105357258|NCT02757352|363314100|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105482586|NCT02095132|363778912|FG000|Overall Study|Withdrawal by Subject|0|||
105482587|NCT02095132|363778913|FG001|Overall Study|Withdrawal by Subject|0|||
105739264|NCT01597193|364699984|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
105739265|NCT01597193|364699985|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
105739266|NCT01597193|364699986|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
105739267|NCT01597193|364699987|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
105739268|NCT01597193|364699988|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
105739269|NCT02508701|364699990|FG000|Overall Study|Lost to Follow-up|9|||
105739270|NCT02508701|364699991|FG001|Overall Study|Lost to Follow-up|5|||
105739271|NCT02508701|364699992|FG002|Overall Study|Lost to Follow-up|5|||
105739272|NCT02508701|364699993|FG003|Overall Study|Lost to Follow-up|3|||
105739273|NCT03648996|364699995|FG000|Overall Study|Withdrawal by Subject|0|||
105739274|NCT03648996|364699996|FG001|Overall Study|Withdrawal by Subject|2|||
105739275|NCT03648996|364699997|FG002|Overall Study|Withdrawal by Subject|2|||
105739276|NCT03648996|364699995|FG000|Overall Study|Physician Decision|2|||
105739277|NCT03648996|364699996|FG001|Overall Study|Physician Decision|0|||
105739278|NCT03648996|364699997|FG002|Overall Study|Physician Decision|0|||
105739279|NCT01259297|364700002|FG000|Double Blind Randomized Period|Death|1|||
105739280|NCT01259297|364700003|FG001|Double Blind Randomized Period|Death|1|||
105739281|NCT01259297|364700004|FG002|Double Blind Randomized Period|Death|1|||
105739282|NCT01259297|364700005|FG003|Double Blind Randomized Period|Death|2|||
105739283|NCT01259297|364700006|FG004|Double Blind Randomized Period|Death|1|||
105739284|NCT01259297|364700007|FG005|Double Blind Randomized Period|Death|5|||
105739285|NCT01259297|364700008|FG006|Double Blind Randomized Period|Death|2|||
105739286|NCT01259297|364700009|FG007|Double Blind Randomized Period|Death|1|||
105739287|NCT01259297|364700002|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
105739288|NCT01259297|364700003|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
105739289|NCT01259297|364700004|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
105739290|NCT01259297|364700005|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
105739291|NCT01259297|364700006|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
105739292|NCT01259297|364700007|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
105739293|NCT01259297|364700008|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
105739294|NCT01259297|364700009|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
105739295|NCT01259297|364700002|FG000|Double Blind Randomized Period|Other reasons|0|||
105739296|NCT01259297|364700003|FG001|Double Blind Randomized Period|Other reasons|1|||
105739297|NCT01259297|364700004|FG002|Double Blind Randomized Period|Other reasons|0|||
105739298|NCT01259297|364700005|FG003|Double Blind Randomized Period|Other reasons|0|||
105739299|NCT01259297|364700006|FG004|Double Blind Randomized Period|Other reasons|1|||
105739300|NCT01259297|364700007|FG005|Double Blind Randomized Period|Other reasons|2|||
105739301|NCT01259297|364700008|FG006|Double Blind Randomized Period|Other reasons|3|||
105739302|NCT01259297|364700009|FG007|Double Blind Randomized Period|Other reasons|1|||
105799869|NCT02418910|364924671|FG000|Overall Study|Withdrawal by Subject|4|||
105357259|NCT02757352|363314101|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105739303|NCT03242759|364700010|FG000|Overall Study|Adverse Event|5|||
105799870|NCT00345683|364924672|FG000|Overall Study|Lost to Follow-up|19|||
105482588|NCT02095132|363778914|FG002|Overall Study|Withdrawal by Subject|2|||
105739304|NCT03242759|364700011|FG001|Overall Study|Adverse Event|1|||
105799871|NCT00345683|364924673|FG001|Overall Study|Lost to Follow-up|7|||
105799872|NCT00345683|364924672|FG000|Overall Study|Other|6|||
105799873|NCT00345683|364924673|FG001|Overall Study|Other|2|||
105799874|NCT03634488|364924674|FG000|Overall Study|Death|1|||
105799875|NCT03634488|364924675|FG001|Overall Study|Death|0|||
105799876|NCT03634488|364924676|FG002|Overall Study|Death|0|||
105799877|NCT03634488|364924674|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
105799878|NCT03634488|364924675|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
105799879|NCT03634488|364924676|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
105799880|NCT00729365|364924677|FG000|Overall Study|Physician Decision|33|||
105799881|NCT00729365|364924678|FG001|Overall Study|Physician Decision|6|||
105799882|NCT00729365|364924679|FG002|Overall Study|Physician Decision|7|||
105799883|NCT00811070|364924680|FG000|Overall Study|Death|0|||
105799884|NCT00811070|364924681|FG001|Overall Study|Death|0|||
105799885|NCT00811070|364924682|FG002|Overall Study|Death|0|||
105799886|NCT00811070|364924683|FG003|Overall Study|Death|2|||
105799887|NCT00811070|364924684|FG004|Overall Study|Death|5|||
105799888|NCT00811070|364924685|FG005|Overall Study|Death|0|||
105799889|NCT00811070|364924680|FG000|Overall Study|Other|1|||
105799890|NCT00811070|364924681|FG001|Overall Study|Other|0|||
105799891|NCT00811070|364924682|FG002|Overall Study|Other|0|||
105799892|NCT00811070|364924683|FG003|Overall Study|Other|0|||
105799893|NCT00811070|364924684|FG004|Overall Study|Other|0|||
105799894|NCT00811070|364924685|FG005|Overall Study|Other|0|||
105799895|NCT00811070|364924680|FG000|Overall Study|Withdrawal by Subject|0|||
105799896|NCT00811070|364924681|FG001|Overall Study|Withdrawal by Subject|1|||
105799897|NCT00811070|364924682|FG002|Overall Study|Withdrawal by Subject|0|||
105799898|NCT00811070|364924683|FG003|Overall Study|Withdrawal by Subject|0|||
105799899|NCT00811070|364924684|FG004|Overall Study|Withdrawal by Subject|0|||
105799900|NCT00811070|364924685|FG005|Overall Study|Withdrawal by Subject|0|||
105799901|NCT00811070|364924680|FG000|Overall Study|Physician Decision|0|||
105799902|NCT00811070|364924681|FG001|Overall Study|Physician Decision|0|||
105799903|NCT00811070|364924682|FG002|Overall Study|Physician Decision|0|||
105799904|NCT00811070|364924683|FG003|Overall Study|Physician Decision|0|||
105799905|NCT00811070|364924684|FG004|Overall Study|Physician Decision|0|||
105799906|NCT00811070|364924685|FG005|Overall Study|Physician Decision|1|||
105799907|NCT01298596|364924687|FG000|Overall Study|Withdrawal by Subject|1|||
105799908|NCT01298596|364924688|FG001|Overall Study|Withdrawal by Subject|1|||
105799909|NCT01298596|364924687|FG000|Overall Study|Death|5|||
105799910|NCT01298596|364924688|FG001|Overall Study|Death|3|||
105799911|NCT01298596|364924687|FG000|Overall Study|Lost to Follow-up|6|||
105799912|NCT01298596|364924688|FG001|Overall Study|Lost to Follow-up|14|||
105799913|NCT01298596|364924687|FG000|Overall Study|Referred for further management|16|||
105799914|NCT01298596|364924688|FG001|Overall Study|Referred for further management|15|||
105799915|NCT01123980|364924691|FG000|Overall Study|Adverse Event|1|||
105799916|NCT01123980|364924692|FG001|Overall Study|Adverse Event|1|||
105799917|NCT01123980|364924691|FG000|Overall Study|Lack of Efficacy|1|||
105799918|NCT01123980|364924692|FG001|Overall Study|Lack of Efficacy|0|||
105799919|NCT01123980|364924691|FG000|Overall Study|Physician Decision|0|||
105799920|NCT01123980|364924692|FG001|Overall Study|Physician Decision|1|||
105799921|NCT01123980|364924691|FG000|Overall Study|Lost to Follow-up|0|||
105799922|NCT01123980|364924692|FG001|Overall Study|Lost to Follow-up|6|||
105799923|NCT01123980|364924691|FG000|Overall Study|Protocol Violation|6|||
105799924|NCT01123980|364924692|FG001|Overall Study|Protocol Violation|6|||
105799925|NCT01123980|364924691|FG000|Overall Study|Withdrawal by Subject|5|||
105799926|NCT01123980|364924692|FG001|Overall Study|Withdrawal by Subject|3|||
105799927|NCT01123980|364924691|FG000|Overall Study|Unclassified|6|||
105799928|NCT01123980|364924692|FG001|Overall Study|Unclassified|7|||
105799929|NCT04578548|364924693|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
105799930|NCT04578548|364924694|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
105799931|NCT04578548|364924693|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
105799932|NCT04578548|364924694|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
105799933|NCT04578548|364924693|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
105799934|NCT04578548|364924694|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
105799935|NCT04578548|364924693|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
105799936|NCT04578548|364924694|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
105799937|NCT04578548|364924693|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
105799938|NCT04578548|364924694|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
105799939|NCT04578548|364924693|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
105799940|NCT04578548|364924694|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
105799941|NCT00628745|364924695|FG000|Overall Study|Withdrawal by Subject|63|||
105799942|NCT00628745|364924696|FG001|Overall Study|Withdrawal by Subject|3|||
105799943|NCT00628745|364924697|FG002|Overall Study|Withdrawal by Subject|9|||
105799944|NCT00628745|364924698|FG003|Overall Study|Withdrawal by Subject|2|||
105799945|NCT00628745|364924699|FG004|Overall Study|Withdrawal by Subject|69|||
105482589|NCT02095132|363778915|FG003|Overall Study|Withdrawal by Subject|2|||
105482590|NCT02095132|363778916|FG004|Overall Study|Withdrawal by Subject|3|||
105482591|NCT02095132|363778917|FG005|Overall Study|Withdrawal by Subject|0|||
105482592|NCT02095132|363778918|FG006|Overall Study|Withdrawal by Subject|5|||
105482593|NCT02095132|363778919|FG007|Overall Study|Withdrawal by Subject|0|||
105482594|NCT02095132|363778920|FG008|Overall Study|Withdrawal by Subject|0|||
105482595|NCT02108262|363778923|FG000|Overall Study|Non-compliance|0|||
105482596|NCT02108262|363778924|FG001|Overall Study|Non-compliance|2|||
105482597|NCT02108262|363778925|FG002|Overall Study|Non-compliance|1|||
105739305|NCT03242759|364700010|FG000|Overall Study|Withdrawal by Subject|4|||
105739306|NCT03242759|364700011|FG001|Overall Study|Withdrawal by Subject|3|||
105739307|NCT03242759|364700010|FG000|Overall Study|Lost to Follow-up|3|||
105739308|NCT03242759|364700011|FG001|Overall Study|Lost to Follow-up|1|||
105739309|NCT03242759|364700010|FG000|Overall Study|Administrative problems|1|||
105739310|NCT03242759|364700011|FG001|Overall Study|Administrative problems|1|||
105739311|NCT03242759|364700010|FG000|Overall Study|Death|22|||
105739312|NCT03242759|364700011|FG001|Overall Study|Death|0|||
105739313|NCT03242759|364700010|FG000|Overall Study|Change visit schedule|0|||
105739314|NCT03242759|364700011|FG001|Overall Study|Change visit schedule|1|||
105739315|NCT00651118|364700012|FG000|Overall Study|Adverse Event|4|||
105739316|NCT00651118|364700013|FG001|Overall Study|Adverse Event|0|||
105739317|NCT00651118|364700014|FG002|Overall Study|Adverse Event|1|||
105739318|NCT00651118|364700015|FG003|Overall Study|Adverse Event|1|||
105739319|NCT00651118|364700012|FG000|Overall Study|Protocol Violation|2|||
105739320|NCT00651118|364700013|FG001|Overall Study|Protocol Violation|2|||
105739321|NCT00651118|364700014|FG002|Overall Study|Protocol Violation|6|||
105739322|NCT00651118|364700015|FG003|Overall Study|Protocol Violation|2|||
105739323|NCT00651118|364700012|FG000|Overall Study|Lost to Follow-up|2|||
105739324|NCT00651118|364700013|FG001|Overall Study|Lost to Follow-up|0|||
105739325|NCT00651118|364700014|FG002|Overall Study|Lost to Follow-up|1|||
105739326|NCT00651118|364700015|FG003|Overall Study|Lost to Follow-up|2|||
105739327|NCT00651118|364700012|FG000|Overall Study|administrative|1|||
105739328|NCT00651118|364700013|FG001|Overall Study|administrative|4|||
105739329|NCT00651118|364700014|FG002|Overall Study|administrative|2|||
105739330|NCT00651118|364700015|FG003|Overall Study|administrative|1|||
105739331|NCT00651118|364700012|FG000|Overall Study|Withdrawal by Subject|0|||
105739332|NCT00651118|364700013|FG001|Overall Study|Withdrawal by Subject|1|||
105739333|NCT00651118|364700014|FG002|Overall Study|Withdrawal by Subject|1|||
105739334|NCT00651118|364700015|FG003|Overall Study|Withdrawal by Subject|1|||
105739335|NCT00935220|364700017|FG000|Overall Study|Adverse Event|1|||
105739336|NCT00935220|364700017|FG000|Overall Study|Other reason (not specified)|1|||
105739337|NCT01000064|364700018|FG000|Overall Study|Withdrawal by Subject|1|||
105739338|NCT01000064|364700019|FG001|Overall Study|Withdrawal by Subject|1|||
105739339|NCT02518620|364700020|FG000|Overall Study|Adverse Event|23|||
105739340|NCT02518620|364700021|FG001|Overall Study|Adverse Event|11|||
105739341|NCT02518620|364700020|FG000|Overall Study|Lack of Efficacy|2|||
105739342|NCT02518620|364700021|FG001|Overall Study|Lack of Efficacy|0|||
105739343|NCT02518620|364700020|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105739344|NCT02518620|364700021|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105739345|NCT02518620|364700020|FG000|Overall Study|Physician Decision|1|||
105739346|NCT02518620|364700021|FG001|Overall Study|Physician Decision|1|||
105739347|NCT02518620|364700020|FG000|Overall Study|Sponsor's Decision|0|||
105739348|NCT02518620|364700021|FG001|Overall Study|Sponsor's Decision|3|||
105739349|NCT02518620|364700020|FG000|Overall Study|Lost to Follow-up|1|||
105482598|NCT02108262|363778926|FG003|Overall Study|Non-compliance|1|||
105482599|NCT02108262|363778923|FG000|Overall Study|Randomized by error/screen failure|0|||
105739350|NCT02518620|364700021|FG001|Overall Study|Lost to Follow-up|1|||
105739351|NCT02518620|364700020|FG000|Overall Study|Withdrawal by Subject|17|||
105739352|NCT02518620|364700021|FG001|Overall Study|Withdrawal by Subject|9|||
105739353|NCT02518620|364700020|FG000|Overall Study|Death|1|||
105739354|NCT02518620|364700021|FG001|Overall Study|Death|0|||
105739355|NCT02518620|364700020|FG000|Overall Study|Pregnancy Wish|3|||
105739356|NCT02518620|364700021|FG001|Overall Study|Pregnancy Wish|0|||
105739357|NCT02518620|364700020|FG000|Overall Study|Pregnancy|1|||
105739358|NCT02518620|364700021|FG001|Overall Study|Pregnancy|0|||
105739359|NCT02518620|364700020|FG000|Overall Study|Relocation|2|||
105739360|NCT02518620|364700021|FG001|Overall Study|Relocation|1|||
105739361|NCT03141307|364700022|FG000|In-Hospital|Withdrawal by Subject|0|||
105739362|NCT03141307|364700023|FG001|In-Hospital|Withdrawal by Subject|2|||
105739363|NCT03141307|364700022|FG000|In-Hospital|Protocol Violation|4|||
105739364|NCT03141307|364700023|FG001|In-Hospital|Protocol Violation|0|||
105739365|NCT03141307|364700022|FG000|Follow-Up|Lost to Follow-up|97|||
105739366|NCT03141307|364700023|FG001|Follow-Up|Lost to Follow-up|54|||
105739367|NCT02658656|364700024|FG000|Screening|Failed eligibility criteria|0|||
105739368|NCT02658656|364700025|FG001|Screening|Failed eligibility criteria|0|||
105739369|NCT02658656|364700026|FG002|Screening|Failed eligibility criteria|263|||
105739370|NCT02658656|364700024|FG000|Randomization|Withdrawal by Subject|8|||
105739371|NCT02658656|364700025|FG001|Randomization|Withdrawal by Subject|7|||
105739372|NCT02658656|364700026|FG002|Randomization|Withdrawal by Subject|0|||
105739373|NCT02658656|364700024|FG000|Randomization|Lost to Follow-up|1|||
105739374|NCT02658656|364700025|FG001|Randomization|Lost to Follow-up|3|||
105739375|NCT02658656|364700026|FG002|Randomization|Lost to Follow-up|0|||
105739376|NCT02658656|364700024|FG000|Randomization|Adverse Event|4|||
105739377|NCT02658656|364700025|FG001|Randomization|Adverse Event|0|||
105739378|NCT02658656|364700026|FG002|Randomization|Adverse Event|0|||
105739379|NCT02658656|364700024|FG000|Randomization|Administrative Termination|3|||
105739380|NCT02658656|364700025|FG001|Randomization|Administrative Termination|1|||
105739381|NCT02658656|364700026|FG002|Randomization|Administrative Termination|0|||
105739382|NCT02658656|364700024|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
105739383|NCT02658656|364700025|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
105739384|NCT02658656|364700026|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
105739385|NCT02658656|364700024|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
105739386|NCT02658656|364700025|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
105739387|NCT02658656|364700026|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
105739388|NCT02658656|364700024|FG000|Randomization|Not eligible for Randomization|1|||
105739389|NCT02658656|364700025|FG001|Randomization|Not eligible for Randomization|0|||
105739390|NCT02658656|364700026|FG002|Randomization|Not eligible for Randomization|0|||
105739391|NCT02658656|364700024|FG000|Randomization|Protocol Violation|1|||
105739392|NCT02658656|364700025|FG001|Randomization|Protocol Violation|0|||
105739393|NCT02658656|364700026|FG002|Randomization|Protocol Violation|0|||
105739394|NCT05094154|364701509|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
105739395|NCT05094154|364701510|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
105739396|NCT05094154|364701509|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
105739397|NCT05094154|364701510|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
105739398|NCT01937130|364701511|FG000|Overall Study|Withdrawal by Subject|0|||
105739399|NCT01937130|364701512|FG001|Overall Study|Withdrawal by Subject|0|||
105739400|NCT01937130|364701513|FG002|Overall Study|Withdrawal by Subject|0|||
105739401|NCT01937130|364701514|FG003|Overall Study|Withdrawal by Subject|1|||
105739402|NCT01937130|364701511|FG000|Overall Study|Adverse Event|0|||
105739403|NCT01937130|364701512|FG001|Overall Study|Adverse Event|1|||
105739404|NCT01937130|364701513|FG002|Overall Study|Adverse Event|0|||
105739405|NCT01937130|364701514|FG003|Overall Study|Adverse Event|1|||
105739406|NCT01937130|364701511|FG000|Overall Study|Death|1|||
105739407|NCT01937130|364701512|FG001|Overall Study|Death|1|||
105739408|NCT01937130|364701513|FG002|Overall Study|Death|1|||
105739409|NCT01937130|364701514|FG003|Overall Study|Death|0|||
105739410|NCT01937130|364701511|FG000|Overall Study|Lost to Follow-up|2|||
105739411|NCT01937130|364701512|FG001|Overall Study|Lost to Follow-up|0|||
105739412|NCT01937130|364701513|FG002|Overall Study|Lost to Follow-up|2|||
105739413|NCT01937130|364701514|FG003|Overall Study|Lost to Follow-up|0|||
105739414|NCT01937130|364701511|FG000|Overall Study|Physician Decision|0|||
105739415|NCT01937130|364701512|FG001|Overall Study|Physician Decision|1|||
105739416|NCT01937130|364701513|FG002|Overall Study|Physician Decision|0|||
105739417|NCT01937130|364701514|FG003|Overall Study|Physician Decision|0|||
105739418|NCT01937130|364701511|FG000|Overall Study|Patients unable to swallow|0|||
105739419|NCT01937130|364701512|FG001|Overall Study|Patients unable to swallow|1|||
105739420|NCT01937130|364701513|FG002|Overall Study|Patients unable to swallow|0|||
105739421|NCT01937130|364701514|FG003|Overall Study|Patients unable to swallow|0|||
105739422|NCT01937130|364701511|FG000|Overall Study|Patient lost to FU due to death|2|||
105739423|NCT01937130|364701512|FG001|Overall Study|Patient lost to FU due to death|0|||
105739424|NCT01937130|364701513|FG002|Overall Study|Patient lost to FU due to death|0|||
105739425|NCT01937130|364701514|FG003|Overall Study|Patient lost to FU due to death|0|||
105739426|NCT02100657|364701515|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
105739427|NCT02100657|364701516|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
105739428|NCT02100657|364701517|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
105739429|NCT02100657|364701515|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
105739430|NCT02100657|364701516|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
105739431|NCT02100657|364701517|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
105739432|NCT02100657|364701515|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
105739433|NCT02100657|364701516|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
105739434|NCT02100657|364701517|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
105739435|NCT02100657|364701515|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
105739436|NCT02100657|364701516|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
105739437|NCT02100657|364701517|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
105739438|NCT02100657|364701515|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
105739439|NCT02100657|364701516|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
105739440|NCT02100657|364701517|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
105739441|NCT02100657|364701515|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
105739442|NCT02100657|364701516|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
105739443|NCT02100657|364701517|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
105739444|NCT02100657|364701515|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
105739445|NCT02100657|364701516|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
105739446|NCT02100657|364701517|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
105739447|NCT02100657|364701515|FG000|Cohort 3: Dose Level 3|Death|0|||
105739448|NCT02100657|364701516|FG001|Cohort 3: Dose Level 3|Death|0|||
105739449|NCT02100657|364701517|FG002|Cohort 3: Dose Level 3|Death|1|||
105739450|NCT02100657|364701515|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
105739451|NCT02100657|364701516|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
105739452|NCT02100657|364701517|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
105739453|NCT02100657|364701515|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
105739454|NCT02100657|364701516|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
105739455|NCT02100657|364701517|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
105739456|NCT02100657|364701515|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
105739457|NCT02100657|364701516|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
105739458|NCT02100657|364701517|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
105739459|NCT02100657|364701515|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
105739460|NCT02100657|364701516|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
105739461|NCT02100657|364701517|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
105739462|NCT02100657|364701515|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
105739463|NCT02100657|364701516|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
105739464|NCT02100657|364701517|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
105739465|NCT01850563|364701518|FG000|Overall Study|Not eligible|3|||
105739466|NCT01850563|364701519|FG001|Overall Study|Not eligible|0|||
105739467|NCT01790438|364701520|FG000|Overall Study|Adverse Event|3|||
105739468|NCT01790438|364701521|FG001|Overall Study|Adverse Event|2|||
105739469|NCT01790438|364701520|FG000|Overall Study|Death|4|||
105739470|NCT01790438|364701521|FG001|Overall Study|Death|0|||
105739471|NCT01790438|364701520|FG000|Overall Study|Lost to Follow-up|5|||
105739472|NCT01790438|364701521|FG001|Overall Study|Lost to Follow-up|2|||
105739473|NCT01790438|364701520|FG000|Overall Study|Withdrawal by Subject|13|||
105739474|NCT01790438|364701521|FG001|Overall Study|Withdrawal by Subject|2|||
105739475|NCT01790438|364701520|FG000|Overall Study|Physician Decision|3|||
105739476|NCT01790438|364701521|FG001|Overall Study|Physician Decision|1|||
105739477|NCT01790438|364701520|FG000|Overall Study|Sponsor Decision|0|||
105739478|NCT01790438|364701521|FG001|Overall Study|Sponsor Decision|3|||
105739479|NCT01790438|364701520|FG000|Overall Study|Protocol Required Discontinuation|7|||
105739480|NCT01790438|364701521|FG001|Overall Study|Protocol Required Discontinuation|1|||
105739481|NCT02311478|364701533|FG000|Overall Study|Withdrawal by Subject|1|||
105739482|NCT02311478|364701533|FG000|Overall Study|Lost to Follow-up|5|||
105739483|NCT02311478|364701533|FG000|Overall Study|Failed IUD Insertion|1|||
105739484|NCT03242928|364701534|FG000|Overall Study|Adverse Event|2|||
105739485|NCT03242928|364701535|FG001|Overall Study|Adverse Event|1|||
105739486|NCT03242928|364701534|FG000|Overall Study|Lost to Follow-up|2|||
105739487|NCT03242928|364701535|FG001|Overall Study|Lost to Follow-up|0|||
105739488|NCT03242928|364701534|FG000|Overall Study|Physician Decision|0|||
105739489|NCT03242928|364701535|FG001|Overall Study|Physician Decision|1|||
105739490|NCT03242928|364701534|FG000|Overall Study|Withdrawal by Subject|5|||
105739491|NCT03242928|364701535|FG001|Overall Study|Withdrawal by Subject|3|||
105739492|NCT00960440|364701536|FG000|Overall Study|Death|0|||
105739493|NCT00960440|364701537|FG001|Overall Study|Death|0|||
105739494|NCT00960440|364701538|FG002|Overall Study|Death|0|||
105565263|NCT03420781|364066729|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
105565264|NCT03420781|364066725|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
105739495|NCT00960440|364701539|FG003|Overall Study|Death|1|||
105739496|NCT00960440|364701536|FG000|Overall Study|Adverse Event|12|||
105739497|NCT00960440|364701537|FG001|Overall Study|Adverse Event|12|||
105739498|NCT00960440|364701538|FG002|Overall Study|Adverse Event|4|||
105739499|NCT00960440|364701539|FG003|Overall Study|Adverse Event|4|||
105739500|NCT00960440|364701536|FG000|Overall Study|Lack of Efficacy|2|||
105739501|NCT00960440|364701537|FG001|Overall Study|Lack of Efficacy|5|||
105739502|NCT00960440|364701538|FG002|Overall Study|Lack of Efficacy|3|||
105739503|NCT00960440|364701539|FG003|Overall Study|Lack of Efficacy|8|||
105739504|NCT00960440|364701536|FG000|Overall Study|Protocol Violation|2|||
105739505|NCT00960440|364701537|FG001|Overall Study|Protocol Violation|8|||
105739506|NCT00960440|364701538|FG002|Overall Study|Protocol Violation|3|||
105739507|NCT00960440|364701539|FG003|Overall Study|Protocol Violation|4|||
105739508|NCT00960440|364701536|FG000|Overall Study|Withdrawal by Subject|9|||
105739509|NCT00960440|364701537|FG001|Overall Study|Withdrawal by Subject|5|||
105739510|NCT00960440|364701538|FG002|Overall Study|Withdrawal by Subject|2|||
105739511|NCT00960440|364701539|FG003|Overall Study|Withdrawal by Subject|1|||
105739512|NCT00960440|364701536|FG000|Overall Study|Other|1|||
105739513|NCT00960440|364701537|FG001|Overall Study|Other|1|||
105739514|NCT00960440|364701538|FG002|Overall Study|Other|1|||
105739515|NCT00960440|364701539|FG003|Overall Study|Other|0|||
105739516|NCT02241512|364701544|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
105739517|NCT02241512|364701545|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
105739518|NCT00536731|364701546|FG000|Overall Study|Adverse Event|3|||
105739519|NCT00536731|364701547|FG001|Overall Study|Adverse Event|2|||
105739520|NCT00536731|364701548|FG002|Overall Study|Adverse Event|3|||
105739521|NCT00536731|364701546|FG000|Overall Study|Withdrawal by Subject|0|||
105739522|NCT00536731|364701547|FG001|Overall Study|Withdrawal by Subject|2|||
105739523|NCT00536731|364701548|FG002|Overall Study|Withdrawal by Subject|0|||
105739524|NCT00536731|364701546|FG000|Overall Study|Intake of prohibited conc. medication|0|||
105739525|NCT00536731|364701547|FG001|Overall Study|Intake of prohibited conc. medication|0|||
105739526|NCT00536731|364701548|FG002|Overall Study|Intake of prohibited conc. medication|1|||
105739527|NCT00536731|364701546|FG000|Overall Study|Safety reasons|0|||
105739528|NCT00536731|364701547|FG001|Overall Study|Safety reasons|0|||
105739529|NCT00536731|364701548|FG002|Overall Study|Safety reasons|1|||
105739530|NCT00536731|364701546|FG000|Overall Study|Other|1|||
105739531|NCT00536731|364701547|FG001|Overall Study|Other|1|||
105739532|NCT00536731|364701548|FG002|Overall Study|Other|0|||
105739533|NCT03567291|364701549|FG000|Period I|Adverse Event|14|||
105739534|NCT03567291|364701550|FG001|Period I|Adverse Event|0|||
105739535|NCT03567291|364701551|FG002|Period I|Adverse Event|0|||
105739536|NCT03567291|364701552|FG003|Period I|Adverse Event|0|||
105739537|NCT03567291|364701549|FG000|Period I|Protocol Violation|1|||
105739538|NCT03567291|364701550|FG001|Period I|Protocol Violation|0|||
105739539|NCT03567291|364701551|FG002|Period I|Protocol Violation|0|||
105739540|NCT03567291|364701552|FG003|Period I|Protocol Violation|0|||
105739541|NCT03567291|364701549|FG000|Period I|Withdrawal by Subject|23|||
105739542|NCT03567291|364701550|FG001|Period I|Withdrawal by Subject|0|||
105739543|NCT03567291|364701551|FG002|Period I|Withdrawal by Subject|0|||
105739544|NCT03567291|364701552|FG003|Period I|Withdrawal by Subject|0|||
105739545|NCT03567291|364701549|FG000|Period I|Lost to Follow-up|2|||
105739546|NCT03567291|364701550|FG001|Period I|Lost to Follow-up|0|||
105739547|NCT03567291|364701551|FG002|Period I|Lost to Follow-up|0|||
105739548|NCT03567291|364701552|FG003|Period I|Lost to Follow-up|0|||
105739549|NCT03567291|364701549|FG000|Period I|Terminated by sponsor|44|||
105739550|NCT03567291|364701550|FG001|Period I|Terminated by sponsor|0|||
105739551|NCT03567291|364701551|FG002|Period I|Terminated by sponsor|0|||
105739552|NCT03567291|364701552|FG003|Period I|Terminated by sponsor|0|||
105739553|NCT03567291|364701549|FG000|Period I|Missing or unknown|7|||
105739554|NCT03567291|364701550|FG001|Period I|Missing or unknown|0|||
105739555|NCT03567291|364701551|FG002|Period I|Missing or unknown|0|||
105739556|NCT03567291|364701552|FG003|Period I|Missing or unknown|0|||
105739557|NCT03567291|364701549|FG000|Period II|Adverse Event|0|||
105739558|NCT03567291|364701550|FG001|Period II|Adverse Event|1|||
105739559|NCT03567291|364701551|FG002|Period II|Adverse Event|0|||
105739560|NCT03567291|364701552|FG003|Period II|Adverse Event|0|||
105739561|NCT03567291|364701549|FG000|Period II|Missing or unknown|0|||
105739562|NCT03567291|364701550|FG001|Period II|Missing or unknown|2|||
105739563|NCT03567291|364701551|FG002|Period II|Missing or unknown|1|||
105739564|NCT03567291|364701552|FG003|Period II|Missing or unknown|0|||
105739565|NCT03567291|364701549|FG000|Period III|Adverse Event|0|||
105739566|NCT03567291|364701550|FG001|Period III|Adverse Event|0|||
105739567|NCT03567291|364701551|FG002|Period III|Adverse Event|0|||
105739568|NCT03567291|364701552|FG003|Period III|Adverse Event|4|||
105739569|NCT03567291|364701549|FG000|Period III|Withdrawal by Subject|0|||
105739570|NCT03567291|364701550|FG001|Period III|Withdrawal by Subject|0|||
105739571|NCT03567291|364701551|FG002|Period III|Withdrawal by Subject|0|||
105739572|NCT03567291|364701552|FG003|Period III|Withdrawal by Subject|4|||
105482600|NCT02108262|363778924|FG001|Overall Study|Randomized by error/screen failure|0|||
105739573|NCT03567291|364701549|FG000|Period III|Lost to Follow-up|0|||
105739574|NCT03567291|364701550|FG001|Period III|Lost to Follow-up|0|||
105739575|NCT03567291|364701551|FG002|Period III|Lost to Follow-up|0|||
105739576|NCT03567291|364701552|FG003|Period III|Lost to Follow-up|1|||
105739577|NCT03567291|364701549|FG000|Period III|Terminated by sponsor|0|||
105739578|NCT03567291|364701550|FG001|Period III|Terminated by sponsor|0|||
105739579|NCT03567291|364701551|FG002|Period III|Terminated by sponsor|0|||
105739580|NCT03567291|364701552|FG003|Period III|Terminated by sponsor|68|||
105739581|NCT03567291|364701549|FG000|Period III|Missing or unknown|0|||
105739582|NCT03567291|364701550|FG001|Period III|Missing or unknown|0|||
105739583|NCT03567291|364701551|FG002|Period III|Missing or unknown|0|||
105739584|NCT03567291|364701552|FG003|Period III|Missing or unknown|8|||
105739585|NCT00637273|364701553|FG000|Overall Study|Adverse Event|11|||
105739586|NCT00637273|364701554|FG001|Overall Study|Adverse Event|5|||
105739587|NCT00637273|364701555|FG002|Overall Study|Adverse Event|7|||
105565265|NCT03420781|364066726|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
105565266|NCT03420781|364066727|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
105739588|NCT00637273|364701553|FG000|Overall Study|Lost to Follow-up|8|||
105739589|NCT00637273|364701554|FG001|Overall Study|Lost to Follow-up|9|||
105739590|NCT00637273|364701555|FG002|Overall Study|Lost to Follow-up|13|||
105739591|NCT00637273|364701553|FG000|Overall Study|Protocol Violation|2|||
105739592|NCT00637273|364701554|FG001|Overall Study|Protocol Violation|4|||
105739593|NCT00637273|364701555|FG002|Overall Study|Protocol Violation|1|||
105739594|NCT00637273|364701553|FG000|Overall Study|Withdrawal of Consent|18|||
105739595|NCT00637273|364701554|FG001|Overall Study|Withdrawal of Consent|6|||
105739596|NCT00637273|364701555|FG002|Overall Study|Withdrawal of Consent|18|||
105739597|NCT00637273|364701553|FG000|Overall Study|Investigator Decision|1|||
105739598|NCT00637273|364701554|FG001|Overall Study|Investigator Decision|3|||
105739599|NCT00637273|364701555|FG002|Overall Study|Investigator Decision|1|||
105739600|NCT00637273|364701553|FG000|Overall Study|Administrative|2|||
105739601|NCT00637273|364701554|FG001|Overall Study|Administrative|0|||
105739602|NCT00637273|364701555|FG002|Overall Study|Administrative|0|||
105739603|NCT00637273|364701553|FG000|Overall Study|Loss of Glucose Control|1|||
105739604|NCT00637273|364701554|FG001|Overall Study|Loss of Glucose Control|1|||
105739605|NCT00637273|364701555|FG002|Overall Study|Loss of Glucose Control|1|||
105739606|NCT00589472|364701556|FG000|Overall Study|Adverse Event|1|||
105739607|NCT05232097|364701557|FG000|Overall Study|Physician Decision|1|||
105739608|NCT01651052|364701558|FG000|Overall Study|Death|21|||
105739609|NCT01651052|364701558|FG000|Overall Study|Explant|1|||
105739610|NCT01651052|364701558|FG000|Overall Study|Withdrawal by Subject|1|||
105739611|NCT01651052|364701558|FG000|Overall Study|Lost to Follow-up|3|||
105739612|NCT01172288|364701561|FG000|Overall Study|Adverse Event|1|||
105739613|NCT01172288|364701562|FG001|Overall Study|Adverse Event|0|||
105739614|NCT01172288|364701561|FG000|Overall Study|Protocol Violation|0|||
105739615|NCT01172288|364701562|FG001|Overall Study|Protocol Violation|1|||
105739616|NCT02062151|364701567|FG000|Overall Study|screen failure|1|||
105739617|NCT00257192|364701568|FG000|Overall Study|Adverse Event|21|||
105739618|NCT00257192|364701569|FG001|Overall Study|Adverse Event|10|||
105739619|NCT00257192|364701568|FG000|Overall Study|Laboratory abnormality|1|||
105739620|NCT00257192|364701569|FG001|Overall Study|Laboratory abnormality|1|||
105739621|NCT00257192|364701568|FG000|Overall Study|Lost to Follow-up|3|||
105739622|NCT00257192|364701569|FG001|Overall Study|Lost to Follow-up|3|||
105739623|NCT00257192|364701568|FG000|Overall Study|Insufficient clinical response|18|||
105739624|NCT00257192|364701569|FG001|Overall Study|Insufficient clinical response|18|||
105739625|NCT00257192|364701568|FG000|Overall Study|Withdrawal by Subject|14|||
105739626|NCT00257192|364701569|FG001|Overall Study|Withdrawal by Subject|2|||
105739627|NCT00257192|364701568|FG000|Overall Study|Randomized but not treated|0|||
105739628|NCT00257192|364701569|FG001|Overall Study|Randomized but not treated|1|||
105739629|NCT00257192|364701568|FG000|Overall Study|Study terminated by sponsor|1|||
105739630|NCT00257192|364701569|FG001|Overall Study|Study terminated by sponsor|0|||
105739631|NCT00257192|364701568|FG000|Overall Study|Miscellaneous|0|||
105739632|NCT00257192|364701569|FG001|Overall Study|Miscellaneous|4|||
105739633|NCT02086565|364701570|FG000|Overall Study|Lost to Follow-up|9|||
105739634|NCT02086565|364701571|FG001|Overall Study|Lost to Follow-up|7|||
105739635|NCT02086565|364701570|FG000|Overall Study|Withdrawal by Subject|2|||
105739636|NCT02086565|364701571|FG001|Overall Study|Withdrawal by Subject|1|||
105739637|NCT02086565|364701570|FG000|Overall Study|Death|3|||
105739638|NCT02086565|364701571|FG001|Overall Study|Death|2|||
105739639|NCT02086565|364701570|FG000|Overall Study|withdrawn by research team|2|||
105739640|NCT02086565|364701571|FG001|Overall Study|withdrawn by research team|2|||
105739641|NCT00751101|364701572|FG000|Overall Study|Withdrawal by Subject|1|||
105739642|NCT00751101|364701573|FG001|Overall Study|Withdrawal by Subject|0|||
105739643|NCT00751101|364701572|FG000|Overall Study|No HFS / Never Started Patch/|0|||
105739644|NCT00751101|364701573|FG001|Overall Study|No HFS / Never Started Patch/|4|||
105739645|NCT00751101|364701572|FG000|Overall Study|Never began capecitabine|1|||
105739646|NCT00751101|364701573|FG001|Overall Study|Never began capecitabine|0|||
105739647|NCT00751101|364701572|FG000|Overall Study|Physician Decision|0|||
105739648|NCT00751101|364701573|FG001|Overall Study|Physician Decision|1|||
105565267|NCT03420781|364066728|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
105739649|NCT00739297|364701574|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
105739650|NCT00739297|364701575|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
105739651|NCT00739297|364701576|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
105739652|NCT00739297|364701577|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
105739653|NCT00739297|364701578|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
105739654|NCT00739297|364701579|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
105739655|NCT00739297|364701580|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
105739656|NCT00739297|364701574|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
105739657|NCT00739297|364701575|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
105739658|NCT00739297|364701576|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
105739659|NCT00739297|364701577|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
105739660|NCT00739297|364701578|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
105739661|NCT00739297|364701579|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
105739662|NCT00739297|364701580|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
105739663|NCT00394914|364701581|FG000|Treatment Period|Adverse Event|0|||
105739664|NCT00394914|364701582|FG001|Treatment Period|Adverse Event|3|||
105739665|NCT00394914|364701583|FG002|Treatment Period|Adverse Event|1|||
105739666|NCT00394914|364701581|FG000|Treatment Period|Lost to Follow-up|0|||
105739667|NCT00394914|364701582|FG001|Treatment Period|Lost to Follow-up|1|||
105739668|NCT00394914|364701583|FG002|Treatment Period|Lost to Follow-up|0|||
105739669|NCT00394914|364701581|FG000|Treatment Period|Withdrawal by Subject|0|||
105739670|NCT00394914|364701582|FG001|Treatment Period|Withdrawal by Subject|2|||
105739671|NCT00394914|364701583|FG002|Treatment Period|Withdrawal by Subject|2|||
105739672|NCT00394914|364701581|FG000|Treatment Period|Noncompliance with protocol|0|||
105739673|NCT00394914|364701582|FG001|Treatment Period|Noncompliance with protocol|3|||
105739674|NCT00394914|364701583|FG002|Treatment Period|Noncompliance with protocol|2|||
105739675|NCT00394914|364701581|FG000|Treatment Period|Did not meet protocol eligibility|0|||
105739676|NCT00394914|364701582|FG001|Treatment Period|Did not meet protocol eligibility|1|||
105799946|NCT00628745|364924695|FG000|Overall Study|Does not meet inclusion criteria|0|||
105739677|NCT00394914|364701583|FG002|Treatment Period|Did not meet protocol eligibility|1|||
105739678|NCT00844428|364701585|FG000|Screening Period|Screen Failure|3|||
105739679|NCT00844428|364701585|FG000|Extension Treatment Period|Death|1|||
105739680|NCT00844428|364701585|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
105739681|NCT02749721|364701586|FG000|Screening|Withdrawal by Subject|1|||
105739682|NCT02749721|364701586|FG000|Screening|Lost to Follow-up|2|||
105739683|NCT02749721|364701586|FG000|Screening|Protocol Violation|3|||
105739684|NCT02749721|364701586|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
105739685|NCT02749721|364701586|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
105739686|NCT00863928|364701587|FG000|Overall Study|Protocol Violation|26|||
105739687|NCT00863928|364701588|FG001|Overall Study|Protocol Violation|0|||
105739688|NCT00863928|364701587|FG000|Overall Study|Withdrawal by Subject|3|||
105739689|NCT00863928|364701588|FG001|Overall Study|Withdrawal by Subject|0|||
105739690|NCT00863928|364701587|FG000|Overall Study|surgery cancellation|4|||
105739691|NCT00863928|364701588|FG001|Overall Study|surgery cancellation|0|||
105739692|NCT00863928|364701587|FG000|Overall Study|medication allergy|3|||
105739693|NCT00863928|364701588|FG001|Overall Study|medication allergy|0|||
105739694|NCT00803244|364701589|FG000|Overall Study|Adverse Event|1|||
105739695|NCT00803244|364701590|FG001|Overall Study|Adverse Event|2|||
105739696|NCT00803244|364701589|FG000|Overall Study|Withdrawal by Subject|2|||
105739697|NCT00803244|364701590|FG001|Overall Study|Withdrawal by Subject|3|||
105739698|NCT00803244|364701589|FG000|Overall Study|Any other reason not above-mentioned|4|||
105739699|NCT00803244|364701590|FG001|Overall Study|Any other reason not above-mentioned|10|||
105739700|NCT02873715|364701591|FG000|Overall Study|Lost to Follow-up|84|||
105739701|NCT02873715|364701592|FG001|Overall Study|Lost to Follow-up|94|||
105739702|NCT02873715|364701591|FG000|Overall Study|Withdrawal by Subject|7|||
105739703|NCT02873715|364701592|FG001|Overall Study|Withdrawal by Subject|26|||
105739704|NCT02021812|364701593|FG000|Overall Study|Death|8|||
105739705|NCT02021812|364701593|FG000|Overall Study|Withdrawal by Subject|3|||
105739706|NCT02021812|364701593|FG000|Overall Study|Lost to Follow-up|2|||
105739707|NCT02021812|364701593|FG000|Overall Study|Refuse to return, COVD 19|2|||
105739708|NCT03241173|364701594|FG000|Overall Study|Death|3|||
105739709|NCT03241173|364701595|FG001|Overall Study|Death|2|||
105739710|NCT03241173|364701596|FG002|Overall Study|Death|4|||
105739711|NCT03241173|364701597|FG003|Overall Study|Death|4|||
105739712|NCT03241173|364701598|FG004|Overall Study|Death|2|||
105739713|NCT03241173|364701599|FG005|Overall Study|Death|2|||
105739714|NCT03241173|364701600|FG006|Overall Study|Death|3|||
105739715|NCT03241173|364701601|FG007|Overall Study|Death|1|||
105739716|NCT03241173|364701602|FG008|Overall Study|Death|0|||
105739717|NCT03241173|364701603|FG009|Overall Study|Death|5|||
105739718|NCT03241173|364701604|FG010|Overall Study|Death|4|||
105739719|NCT03241173|364701605|FG011|Overall Study|Death|3|||
105799947|NCT00628745|364924696|FG001|Overall Study|Does not meet inclusion criteria|12|||
105739720|NCT03241173|364701606|FG012|Overall Study|Death|0|||
105739721|NCT03241173|364701607|FG013|Overall Study|Death|0|||
105739722|NCT03241173|364701608|FG014|Overall Study|Death|0|||
105739723|NCT03241173|364701594|FG000|Overall Study|Withdrawal by Subject|0|||
105739724|NCT03241173|364701595|FG001|Overall Study|Withdrawal by Subject|0|||
105739725|NCT03241173|364701596|FG002|Overall Study|Withdrawal by Subject|1|||
105799948|NCT00628745|364924697|FG002|Overall Study|Does not meet inclusion criteria|0|||
105799949|NCT00628745|364924698|FG003|Overall Study|Does not meet inclusion criteria|0|||
105799950|NCT00628745|364924699|FG004|Overall Study|Does not meet inclusion criteria|18|||
105799951|NCT00628745|364924695|FG000|Overall Study|Participation in an interventional clinical trial|81|||
105799952|NCT00628745|364924696|FG001|Overall Study|Participation in an interventional clinical trial|4|||
105799953|NCT00628745|364924697|FG002|Overall Study|Participation in an interventional clinical trial|7|||
105799954|NCT00628745|364924698|FG003|Overall Study|Participation in an interventional clinical trial|0|||
105799955|NCT00628745|364924699|FG004|Overall Study|Participation in an interventional clinical trial|63|||
105799956|NCT00628745|364924695|FG000|Overall Study|Physician Decision|8|||
105799957|NCT00628745|364924696|FG001|Overall Study|Physician Decision|4|||
105799958|NCT00628745|364924697|FG002|Overall Study|Physician Decision|3|||
105799959|NCT00628745|364924698|FG003|Overall Study|Physician Decision|0|||
105799960|NCT00628745|364924699|FG004|Overall Study|Physician Decision|30|||
105799961|NCT00628745|364924695|FG000|Overall Study|Lost to Follow-up|109|||
105799962|NCT00628745|364924696|FG001|Overall Study|Lost to Follow-up|7|||
105799963|NCT00628745|364924697|FG002|Overall Study|Lost to Follow-up|7|||
105799964|NCT00628745|364924698|FG003|Overall Study|Lost to Follow-up|0|||
105799965|NCT00628745|364924699|FG004|Overall Study|Lost to Follow-up|498|||
105799966|NCT00628745|364924695|FG000|Overall Study|Death|197|||
105799967|NCT00628745|364924696|FG001|Overall Study|Death|81|||
105799968|NCT00628745|364924697|FG002|Overall Study|Death|12|||
105799969|NCT00628745|364924698|FG003|Overall Study|Death|4|||
105799970|NCT00628745|364924699|FG004|Overall Study|Death|939|||
105799971|NCT00628745|364924695|FG000|Overall Study|Participant transferred to another THAOS site|6|||
105799972|NCT00628745|364924696|FG001|Overall Study|Participant transferred to another THAOS site|0|||
105799973|NCT00628745|364924697|FG002|Overall Study|Participant transferred to another THAOS site|0|||
105799974|NCT00628745|364924698|FG003|Overall Study|Participant transferred to another THAOS site|0|||
105799975|NCT00628745|364924699|FG004|Overall Study|Participant transferred to another THAOS site|7|||
105799976|NCT00628745|364924695|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
105799977|NCT00628745|364924696|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
105799978|NCT00628745|364924697|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
105799979|NCT00628745|364924698|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
105799980|NCT00628745|364924699|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
105799981|NCT00628745|364924695|FG000|Overall Study|Site closure|152|||
105799982|NCT00628745|364924696|FG001|Overall Study|Site closure|146|||
105799983|NCT00628745|364924697|FG002|Overall Study|Site closure|6|||
105799984|NCT00628745|364924698|FG003|Overall Study|Site closure|8|||
105799985|NCT00628745|364924699|FG004|Overall Study|Site closure|691|||
105799986|NCT00628745|364924695|FG000|Overall Study|Duplicate participant|0|||
105799987|NCT00628745|364924696|FG001|Overall Study|Duplicate participant|0|||
105799988|NCT00628745|364924697|FG002|Overall Study|Duplicate participant|0|||
105799989|NCT00628745|364924698|FG003|Overall Study|Duplicate participant|0|||
105799990|NCT00628745|364924699|FG004|Overall Study|Duplicate participant|1|||
105799991|NCT00628745|364924695|FG000|Overall Study|Missing|4|||
105799992|NCT00628745|364924696|FG001|Overall Study|Missing|3|||
105799993|NCT00628745|364924697|FG002|Overall Study|Missing|0|||
105799994|NCT00628745|364924698|FG003|Overall Study|Missing|0|||
105799995|NCT00628745|364924699|FG004|Overall Study|Missing|10|||
105799996|NCT00628745|364924695|FG000|Overall Study|Othe reasons|987|||
105799997|NCT00628745|364924696|FG001|Overall Study|Othe reasons|373|||
105799998|NCT00628745|364924697|FG002|Overall Study|Othe reasons|105|||
105799999|NCT00628745|364924698|FG003|Overall Study|Othe reasons|1|||
105800000|NCT00628745|364924699|FG004|Overall Study|Othe reasons|1772|||
105800001|NCT00874757|364924700|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
105800002|NCT00766506|364926326|FG000|Overall Study|Use rescue medication after 3 hours|3|||
105800003|NCT00766506|364926327|FG001|Overall Study|Use rescue medication after 3 hours|0|||
105800004|NCT00766506|364926326|FG000|Overall Study|Other|2|||
105800005|NCT00766506|364926327|FG001|Overall Study|Other|2|||
105800006|NCT00860574|364926328|FG000|Overall Study|Death|2|||
105800007|NCT00860574|364926328|FG000|Overall Study|Relapse|1|||
105800008|NCT01246986|364926329|FG000|Overall Study|Lost to Follow-up|0|||
105800009|NCT01246986|364926330|FG001|Overall Study|Lost to Follow-up|1|||
105800010|NCT01246986|364926331|FG002|Overall Study|Lost to Follow-up|3|||
105800011|NCT01246986|364926332|FG003|Overall Study|Lost to Follow-up|0|||
105800012|NCT01246986|364926333|FG004|Overall Study|Lost to Follow-up|0|||
105800013|NCT01246986|364926334|FG005|Overall Study|Lost to Follow-up|1|||
105800014|NCT01246986|364926335|FG006|Overall Study|Lost to Follow-up|0|||
105800015|NCT01246986|364926329|FG000|Overall Study|Withdrawal by Subject|3|||
105800016|NCT01246986|364926330|FG001|Overall Study|Withdrawal by Subject|4|||
105800017|NCT01246986|364926331|FG002|Overall Study|Withdrawal by Subject|3|||
105800018|NCT01246986|364926332|FG003|Overall Study|Withdrawal by Subject|0|||
105800019|NCT01246986|364926333|FG004|Overall Study|Withdrawal by Subject|4|||
105800020|NCT01246986|364926334|FG005|Overall Study|Withdrawal by Subject|0|||
105800021|NCT01246986|364926335|FG006|Overall Study|Withdrawal by Subject|0|||
105357260|NCT02757352|363314102|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105357261|NCT02757352|363314093|FG000|Follow-Up Period|Adverse Event|0|||
105357262|NCT02757352|363314094|FG001|Follow-Up Period|Adverse Event|0|||
105357263|NCT02757352|363314095|FG002|Follow-Up Period|Adverse Event|0|||
105357264|NCT02757352|363314096|FG003|Follow-Up Period|Adverse Event|0|||
105357265|NCT02757352|363314097|FG004|Follow-Up Period|Adverse Event|0|||
105357266|NCT02757352|363314098|FG005|Follow-Up Period|Adverse Event|0|||
105357267|NCT02757352|363314099|FG006|Follow-Up Period|Adverse Event|1|||
105357268|NCT02757352|363314100|FG007|Follow-Up Period|Adverse Event|0|||
105357269|NCT02757352|363314101|FG008|Follow-Up Period|Adverse Event|2|||
105357270|NCT02757352|363314102|FG009|Follow-Up Period|Adverse Event|0|||
105357271|NCT02757352|363314093|FG000|Follow-Up Period|Lost to Follow-up|0|||
105357272|NCT02757352|363314094|FG001|Follow-Up Period|Lost to Follow-up|0|||
105357273|NCT02757352|363314095|FG002|Follow-Up Period|Lost to Follow-up|0|||
105357274|NCT02757352|363314096|FG003|Follow-Up Period|Lost to Follow-up|0|||
105357275|NCT02757352|363314097|FG004|Follow-Up Period|Lost to Follow-up|0|||
105357276|NCT02757352|363314098|FG005|Follow-Up Period|Lost to Follow-up|0|||
105357277|NCT02757352|363314099|FG006|Follow-Up Period|Lost to Follow-up|0|||
105357278|NCT02757352|363314100|FG007|Follow-Up Period|Lost to Follow-up|0|||
105357279|NCT02757352|363314101|FG008|Follow-Up Period|Lost to Follow-up|1|||
105357280|NCT02757352|363314102|FG009|Follow-Up Period|Lost to Follow-up|0|||
105357281|NCT02757352|363314093|FG000|Follow-Up Period|Lack of Efficacy|0|||
105357282|NCT02757352|363314094|FG001|Follow-Up Period|Lack of Efficacy|0|||
105357283|NCT02757352|363314095|FG002|Follow-Up Period|Lack of Efficacy|0|||
105357284|NCT02757352|363314096|FG003|Follow-Up Period|Lack of Efficacy|0|||
105357285|NCT02757352|363314097|FG004|Follow-Up Period|Lack of Efficacy|0|||
105357286|NCT02757352|363314098|FG005|Follow-Up Period|Lack of Efficacy|0|||
105357287|NCT02757352|363314099|FG006|Follow-Up Period|Lack of Efficacy|0|||
105357288|NCT02757352|363314100|FG007|Follow-Up Period|Lack of Efficacy|0|||
105357289|NCT02757352|363314101|FG008|Follow-Up Period|Lack of Efficacy|1|||
105357290|NCT02757352|363314102|FG009|Follow-Up Period|Lack of Efficacy|1|||
105357291|NCT02757352|363314093|FG000|Follow-Up Period|Withdrawal by Subject|0|||
105357292|NCT02757352|363314094|FG001|Follow-Up Period|Withdrawal by Subject|0|||
105357293|NCT02757352|363314095|FG002|Follow-Up Period|Withdrawal by Subject|0|||
105357294|NCT02757352|363314096|FG003|Follow-Up Period|Withdrawal by Subject|0|||
105357295|NCT02757352|363314097|FG004|Follow-Up Period|Withdrawal by Subject|0|||
105357296|NCT02757352|363314098|FG005|Follow-Up Period|Withdrawal by Subject|0|||
105357297|NCT02757352|363314099|FG006|Follow-Up Period|Withdrawal by Subject|0|||
105357298|NCT02757352|363314100|FG007|Follow-Up Period|Withdrawal by Subject|1|||
105357299|NCT02757352|363314101|FG008|Follow-Up Period|Withdrawal by Subject|6|||
105357300|NCT02757352|363314102|FG009|Follow-Up Period|Withdrawal by Subject|2|||
105357301|NCT02576977|363314103|FG000|Overall Study|Adverse Event|13|||
105357302|NCT02576977|363314104|FG001|Overall Study|Adverse Event|2|||
105357303|NCT02576977|363314103|FG000|Overall Study|Death|73|||
105357304|NCT02576977|363314104|FG001|Overall Study|Death|60|||
105357305|NCT02576977|363314103|FG000|Overall Study|Screen failure|1|||
105357306|NCT02576977|363314104|FG001|Overall Study|Screen failure|0|||
105357307|NCT02576977|363314103|FG000|Overall Study|Study Terminated at Selected Sites|27|||
105357308|NCT02576977|363314104|FG001|Overall Study|Study Terminated at Selected Sites|50|||
105357309|NCT02576977|363314103|FG000|Overall Study|Withdrawal by Subject|11|||
105357310|NCT02576977|363314104|FG001|Overall Study|Withdrawal by Subject|11|||
105357311|NCT02576977|363314103|FG000|Overall Study|Final Disposition Unknown|0|||
105357312|NCT02576977|363314104|FG001|Overall Study|Final Disposition Unknown|1|||
105357313|NCT02576977|363314103|FG000|Overall Study|Lost to Follow-up|1|||
105739726|NCT03241173|364701597|FG003|Overall Study|Withdrawal by Subject|0|||
105739727|NCT03241173|364701598|FG004|Overall Study|Withdrawal by Subject|0|||
105739728|NCT03241173|364701599|FG005|Overall Study|Withdrawal by Subject|1|||
105739729|NCT03241173|364701600|FG006|Overall Study|Withdrawal by Subject|0|||
105739730|NCT03241173|364701601|FG007|Overall Study|Withdrawal by Subject|0|||
105739731|NCT03241173|364701602|FG008|Overall Study|Withdrawal by Subject|0|||
105739732|NCT03241173|364701603|FG009|Overall Study|Withdrawal by Subject|0|||
105739733|NCT03241173|364701604|FG010|Overall Study|Withdrawal by Subject|0|||
105357314|NCT02576977|363314104|FG001|Overall Study|Lost to Follow-up|0|||
105357315|NCT02576977|363314103|FG000|Overall Study|Progressive Disease|0|||
105357316|NCT02576977|363314104|FG001|Overall Study|Progressive Disease|1|||
105357317|NCT04441788|363314105|FG000|Overall Study|Voluntary Withdrawl|0|||
105357318|NCT04441788|363314106|FG001|Overall Study|Voluntary Withdrawl|1|||
105357319|NCT04441788|363314107|FG002|Overall Study|Voluntary Withdrawl|0|||
105357320|NCT04441788|363314105|FG000|Overall Study|Ineligibility|1|||
105357321|NCT04441788|363314106|FG001|Overall Study|Ineligibility|0|||
105357322|NCT04441788|363314107|FG002|Overall Study|Ineligibility|0|||
105739734|NCT03241173|364701605|FG011|Overall Study|Withdrawal by Subject|0|||
105357323|NCT04441788|363314105|FG000|Overall Study|Adverse Event|0|||
105482601|NCT02108262|363778925|FG002|Overall Study|Randomized by error/screen failure|1|||
105482602|NCT02108262|363778926|FG003|Overall Study|Randomized by error/screen failure|0|||
105357324|NCT04441788|363314106|FG001|Overall Study|Adverse Event|0|||
105357325|NCT04441788|363314107|FG002|Overall Study|Adverse Event|4|||
105357326|NCT04441788|363314105|FG000|Overall Study|Study Terminated by Sponsor|16|||
105482603|NCT02108262|363778923|FG000|Overall Study|Distance to center|0|||
105482604|NCT02108262|363778924|FG001|Overall Study|Distance to center|1|||
105482605|NCT02108262|363778925|FG002|Overall Study|Distance to center|1|||
105482606|NCT02108262|363778926|FG003|Overall Study|Distance to center|0|||
105482607|NCT02108262|363778923|FG000|Overall Study|Adverse Event|0|||
105482608|NCT02108262|363778924|FG001|Overall Study|Adverse Event|11|||
105482609|NCT02108262|363778925|FG002|Overall Study|Adverse Event|6|||
105482610|NCT02108262|363778926|FG003|Overall Study|Adverse Event|12|||
105482611|NCT02108262|363778923|FG000|Overall Study|Death|0|||
105482612|NCT02108262|363778924|FG001|Overall Study|Death|2|||
105482613|NCT02108262|363778925|FG002|Overall Study|Death|2|||
105482614|NCT02108262|363778926|FG003|Overall Study|Death|1|||
105482615|NCT02108262|363778923|FG000|Overall Study|Lost to Follow-up|0|||
105482616|NCT02108262|363778924|FG001|Overall Study|Lost to Follow-up|0|||
105482617|NCT02108262|363778925|FG002|Overall Study|Lost to Follow-up|1|||
105482618|NCT02108262|363778926|FG003|Overall Study|Lost to Follow-up|0|||
105482619|NCT02108262|363778923|FG000|Overall Study|Physician Decision|0|||
105482620|NCT02108262|363778924|FG001|Overall Study|Physician Decision|0|||
105482621|NCT02108262|363778925|FG002|Overall Study|Physician Decision|2|||
105482622|NCT02108262|363778926|FG003|Overall Study|Physician Decision|0|||
105482623|NCT02108262|363778923|FG000|Overall Study|Withdrawal by Subject|0|||
105482624|NCT02108262|363778924|FG001|Overall Study|Withdrawal by Subject|7|||
105482625|NCT02108262|363778925|FG002|Overall Study|Withdrawal by Subject|3|||
105482626|NCT02108262|363778926|FG003|Overall Study|Withdrawal by Subject|4|||
105482627|NCT02108262|363778923|FG000|Overall Study|Due to key hepatic values|0|||
105482628|NCT02108262|363778924|FG001|Overall Study|Due to key hepatic values|1|||
105482629|NCT02108262|363778925|FG002|Overall Study|Due to key hepatic values|0|||
105482630|NCT02108262|363778926|FG003|Overall Study|Due to key hepatic values|0|||
105482631|NCT02108262|363778923|FG000|Overall Study|Unable to contact patient|0|||
105482632|NCT02108262|363778924|FG001|Overall Study|Unable to contact patient|3|||
105482633|NCT02108262|363778925|FG002|Overall Study|Unable to contact patient|1|||
105482634|NCT02108262|363778926|FG003|Overall Study|Unable to contact patient|2|||
105482635|NCT02108262|363778923|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
105482636|NCT02108262|363778924|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
105482637|NCT02108262|363778925|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
105482638|NCT02108262|363778926|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
105482639|NCT02108262|363778923|FG000|Overall Study|Patient did not want another infusion|0|||
105482640|NCT02108262|363778924|FG001|Overall Study|Patient did not want another infusion|3|||
105482641|NCT02108262|363778925|FG002|Overall Study|Patient did not want another infusion|3|||
105482642|NCT02108262|363778926|FG003|Overall Study|Patient did not want another infusion|2|||
105482643|NCT02108262|363778923|FG000|Overall Study|Vacation|0|||
105482644|NCT02108262|363778924|FG001|Overall Study|Vacation|1|||
105482645|NCT02108262|363778925|FG002|Overall Study|Vacation|0|||
105482646|NCT02108262|363778926|FG003|Overall Study|Vacation|0|||
105482647|NCT02108262|363778923|FG000|Overall Study|Patient decision|0|||
105482648|NCT02108262|363778924|FG001|Overall Study|Patient decision|7|||
105482649|NCT02108262|363778925|FG002|Overall Study|Patient decision|9|||
105482650|NCT02108262|363778926|FG003|Overall Study|Patient decision|14|||
105482651|NCT02108262|363778923|FG000|Overall Study|Missed IV due to pharmacy error|0|||
105482652|NCT02108262|363778924|FG001|Overall Study|Missed IV due to pharmacy error|0|||
105482653|NCT02108262|363778925|FG002|Overall Study|Missed IV due to pharmacy error|1|||
105482654|NCT02108262|363778926|FG003|Overall Study|Missed IV due to pharmacy error|0|||
105482655|NCT02536404|363778935|FG000|Overall Study|Adverse Event|5|||
105482656|NCT02536404|363778936|FG001|Overall Study|Adverse Event|0|||
105482657|NCT02536404|363778935|FG000|Overall Study|Withdrawal by Subject|4|||
105482658|NCT02536404|363778936|FG001|Overall Study|Withdrawal by Subject|1|||
105482659|NCT02536404|363778935|FG000|Overall Study|Physician Decision|10|||
105739735|NCT03241173|364701606|FG012|Overall Study|Withdrawal by Subject|0|||
105739736|NCT03241173|364701607|FG013|Overall Study|Withdrawal by Subject|0|||
105739737|NCT03241173|364701608|FG014|Overall Study|Withdrawal by Subject|0|||
105739738|NCT03241173|364701594|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
105739739|NCT03241173|364701595|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
105739740|NCT03241173|364701596|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
105739741|NCT03241173|364701597|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
105739742|NCT03241173|364701598|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
105739743|NCT03241173|364701599|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
105739744|NCT03241173|364701600|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
105739745|NCT03241173|364701601|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
105739746|NCT03241173|364701602|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
105739747|NCT03241173|364701603|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
105760785|NCT03627494|364776199|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
105357327|NCT04441788|363314106|FG001|Overall Study|Study Terminated by Sponsor|16|||
105357328|NCT04441788|363314107|FG002|Overall Study|Study Terminated by Sponsor|12|||
105357329|NCT02315664|363314108|FG000|Overall Study|Lost to Follow-up|1|||
105357330|NCT02315664|363314109|FG001|Overall Study|Lost to Follow-up|1|||
105357331|NCT02315664|363314108|FG000|Overall Study|Withdrawal by Subject|0|||
105357332|NCT02315664|363314109|FG001|Overall Study|Withdrawal by Subject|3|||
105357333|NCT00824655|363314110|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
105357334|NCT00824655|363314111|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
105357335|NCT00824655|363314110|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
105357336|NCT00824655|363314111|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
105357337|NCT00215644|363314119|FG000|Overall Study|Disease Progression|28|||
105357338|NCT00215644|363314120|FG001|Overall Study|Disease Progression|10|||
105357339|NCT00215644|363314119|FG000|Overall Study|Adverse Event|2|||
105357340|NCT00215644|363314120|FG001|Overall Study|Adverse Event|9|||
105357341|NCT00215644|363314119|FG000|Overall Study|Death|1|||
105357342|NCT00215644|363314120|FG001|Overall Study|Death|2|||
105357343|NCT00215644|363314119|FG000|Overall Study|Withdrawal by Subject|1|||
105357344|NCT00215644|363314120|FG001|Overall Study|Withdrawal by Subject|0|||
105357345|NCT00215644|363314119|FG000|Overall Study|Other|3|||
105357346|NCT00215644|363314120|FG001|Overall Study|Other|15|||
105357347|NCT00215644|363314119|FG000|Overall Study|Randomized but Not Treated|1|||
105357348|NCT00215644|363314120|FG001|Overall Study|Randomized but Not Treated|0|||
105357349|NCT04727528|363314121|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
105357350|NCT04727528|363314122|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
105357351|NCT04727528|363314121|FG000|Open-label Period|Randomized who did not receive treatment|1|||
105357352|NCT04727528|363314122|FG001|Open-label Period|Randomized who did not receive treatment|0|||
105357353|NCT04727528|363314121|FG000|Double-blind Treatment Phase|Adverse Event|0|||
105357354|NCT04727528|363314122|FG001|Double-blind Treatment Phase|Adverse Event|1|||
105357355|NCT04727528|363314121|FG000|Double-blind Treatment Phase|Death|0|||
105357356|NCT04727528|363314122|FG001|Double-blind Treatment Phase|Death|1|||
105357357|NCT04727528|363314121|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
105357358|NCT04727528|363314122|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
105357359|NCT04727528|363314121|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
105357360|NCT04727528|363314122|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
105357361|NCT04727528|363314121|FG000|Double-blind Treatment Phase|Physician Decision|0|||
105357362|NCT04727528|363314122|FG001|Double-blind Treatment Phase|Physician Decision|1|||
105357363|NCT04727528|363314121|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
105357364|NCT04727528|363314122|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105357365|NCT01763827|363314124|FG000|Overall Study|Withdrawal by Subject|1|||
105357366|NCT01763827|363314125|FG001|Overall Study|Withdrawal by Subject|0|||
105357367|NCT01763827|363314126|FG002|Overall Study|Withdrawal by Subject|0|||
105357368|NCT01763827|363314127|FG003|Overall Study|Withdrawal by Subject|0|||
105357369|NCT01763827|363314128|FG004|Overall Study|Withdrawal by Subject|2|||
105357370|NCT01763827|363314129|FG005|Overall Study|Withdrawal by Subject|0|||
105357371|NCT01763827|363314124|FG000|Overall Study|Decision by sponsor|2|||
105357372|NCT01763827|363314125|FG001|Overall Study|Decision by sponsor|0|||
105357373|NCT01763827|363314126|FG002|Overall Study|Decision by sponsor|3|||
105357374|NCT01763827|363314127|FG003|Overall Study|Decision by sponsor|0|||
105357375|NCT01763827|363314128|FG004|Overall Study|Decision by sponsor|2|||
105357376|NCT01763827|363314129|FG005|Overall Study|Decision by sponsor|1|||
105357377|NCT01763827|363314124|FG000|Overall Study|Lost to Follow-up|0|||
105357378|NCT01763827|363314125|FG001|Overall Study|Lost to Follow-up|1|||
105357379|NCT01763827|363314126|FG002|Overall Study|Lost to Follow-up|1|||
105565268|NCT03420781|364066729|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
105565269|NCT03420781|364066725|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
105357380|NCT01763827|363314127|FG003|Overall Study|Lost to Follow-up|1|||
105357381|NCT01763827|363314128|FG004|Overall Study|Lost to Follow-up|2|||
105357382|NCT01763827|363314129|FG005|Overall Study|Lost to Follow-up|1|||
105357383|NCT02906579|363314130|FG000|Overall Study|Adverse Event|1|||
105357384|NCT02906579|363314130|FG000|Overall Study|Physician Decision|1|||
105357385|NCT02213380|363314133|FG000|Underwent Randomization|Withdrawal by Subject|2|||
105357386|NCT02213380|363314134|FG001|Underwent Randomization|Withdrawal by Subject|0|||
105357387|NCT02213380|363314133|FG000|Underwent Randomization|Not treated|3|||
105357388|NCT02213380|363314134|FG001|Underwent Randomization|Not treated|3|||
105357389|NCT02213380|363314133|FG000|Per-protocol Analysis|Protocol Violation|32|||
105357390|NCT02213380|363314134|FG001|Per-protocol Analysis|Protocol Violation|36|||
105357391|NCT00905632|363314136|FG000|Overall Study|Adverse Event|0|||
105357392|NCT00905632|363314137|FG001|Overall Study|Adverse Event|0|||
105357393|NCT00905632|363314138|FG002|Overall Study|Adverse Event|0|||
105357394|NCT00905632|363314139|FG003|Overall Study|Adverse Event|0|||
105357395|NCT00905632|363314140|FG004|Overall Study|Adverse Event|0|||
105357396|NCT00905632|363314141|FG005|Overall Study|Adverse Event|1|||
105357397|NCT00905632|363314142|FG006|Overall Study|Adverse Event|4|||
105357398|NCT03479008|363314143|FG000|Overall Study|Withdrawal by Subject|3|||
105357399|NCT01516736|363314151|FG000|Overall Study|Withdrawal by Subject|10|||
105357400|NCT01516736|363314152|FG001|Overall Study|Withdrawal by Subject|4|||
105357401|NCT01516736|363314151|FG000|Overall Study|Adverse Event|4|||
105357402|NCT01516736|363314152|FG001|Overall Study|Adverse Event|5|||
105357403|NCT01516736|363314151|FG000|Overall Study|Death|3|||
105357404|NCT01516736|363314152|FG001|Overall Study|Death|1|||
105357405|NCT01516736|363314151|FG000|Overall Study|Physician Decision|2|||
105357406|NCT01516736|363314152|FG001|Overall Study|Physician Decision|1|||
105357407|NCT01516736|363314151|FG000|Overall Study|Lack of Efficacy|1|||
105357408|NCT01516736|363314152|FG001|Overall Study|Lack of Efficacy|0|||
105357409|NCT01516736|363314151|FG000|Overall Study|Protocol Violation|0|||
105357410|NCT01516736|363314152|FG001|Overall Study|Protocol Violation|1|||
105357411|NCT01516736|363314151|FG000|Overall Study|Other (not specified)|0|||
105357412|NCT01516736|363314152|FG001|Overall Study|Other (not specified)|1|||
105357413|NCT01490840|363314153|FG000|Phase 1|Lost to Follow-up|1|||
105357414|NCT01490840|363314154|FG001|Phase 1|Lost to Follow-up|0|||
105357415|NCT01490840|363314153|FG000|Phase 1|Adverse Event|2|||
105357416|NCT01490840|363314154|FG001|Phase 1|Adverse Event|1|||
105357417|NCT01490840|363314153|FG000|Phase 1|Withdrawal by Subject|6|||
105357418|NCT01490840|363314154|FG001|Phase 1|Withdrawal by Subject|5|||
105739748|NCT03241173|364701604|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
105739749|NCT03241173|364701605|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
105739750|NCT03241173|364701606|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
105739751|NCT03241173|364701607|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
105739752|NCT03241173|364701608|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
105739753|NCT03241173|364701594|FG000|Overall Study|Lost to Follow-up|0|||
105739754|NCT03241173|364701595|FG001|Overall Study|Lost to Follow-up|0|||
105739755|NCT03241173|364701596|FG002|Overall Study|Lost to Follow-up|0|||
105739756|NCT03241173|364701597|FG003|Overall Study|Lost to Follow-up|0|||
105739757|NCT03241173|364701598|FG004|Overall Study|Lost to Follow-up|1|||
105739758|NCT03241173|364701599|FG005|Overall Study|Lost to Follow-up|0|||
105739759|NCT03241173|364701600|FG006|Overall Study|Lost to Follow-up|0|||
105739760|NCT03241173|364701601|FG007|Overall Study|Lost to Follow-up|0|||
105739761|NCT03241173|364701602|FG008|Overall Study|Lost to Follow-up|0|||
105739762|NCT03241173|364701603|FG009|Overall Study|Lost to Follow-up|1|||
105739763|NCT03241173|364701604|FG010|Overall Study|Lost to Follow-up|0|||
105739764|NCT03241173|364701605|FG011|Overall Study|Lost to Follow-up|0|||
105739765|NCT03241173|364701606|FG012|Overall Study|Lost to Follow-up|0|||
105739766|NCT03241173|364701607|FG013|Overall Study|Lost to Follow-up|0|||
105739767|NCT03241173|364701608|FG014|Overall Study|Lost to Follow-up|0|||
105739768|NCT01651260|364701612|FG000|Overall Study|unable to apply product|3|||
105739769|NCT03894904|364701621|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
105739770|NCT03894904|364701622|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
105739771|NCT03894904|364701621|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
105739772|NCT03894904|364701622|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
105739773|NCT03117049|364701623|FG000|Overall Study|Continued the follow-up period|109|||
105739774|NCT03117049|364701624|FG001|Overall Study|Continued the follow-up period|129|||
105739775|NCT03117049|364701623|FG000|Overall Study|Died|82|||
105739776|NCT03117049|364701624|FG001|Overall Study|Died|93|||
105739777|NCT03117049|364701623|FG000|Overall Study|Consent withdrawal|7|||
105357419|NCT01490840|363314153|FG000|Phase 1|Visit 6a omitted|1|||
105357420|NCT01490840|363314154|FG001|Phase 1|Visit 6a omitted|0|||
105357421|NCT01490840|363314153|FG000|Phase 2|Withdrawal by Subject|4|||
105357422|NCT01490840|363314154|FG001|Phase 2|Withdrawal by Subject|3|||
105357423|NCT01490840|363314153|FG000|Phase 2|Permanent interruption of fingolimod|0|||
105357424|NCT01490840|363314154|FG001|Phase 2|Permanent interruption of fingolimod|1|||
105357425|NCT01490840|363314153|FG000|Phase 2|Lost to Follow-up|1|||
105357426|NCT01490840|363314154|FG001|Phase 2|Lost to Follow-up|1|||
105357427|NCT01490840|363314153|FG000|Phase 2|Adverse Event|1|||
105357428|NCT01490840|363314154|FG001|Phase 2|Adverse Event|1|||
105357429|NCT02781818|363314158|FG000|Overall Study|Lost to Follow-up|4|||
105357430|NCT02781818|363314159|FG001|Overall Study|Lost to Follow-up|2|||
105357431|NCT02781818|363314160|FG002|Overall Study|Lost to Follow-up|1|||
105357432|NCT00524771|363314161|FG000|Overall Study|Protocol Violation|220|||
105357433|NCT00524771|363314162|FG001|Overall Study|Protocol Violation|585|||
105357434|NCT02492165|363314163|FG000|Overall Study|Withdrawal by Subject|0|||
105357435|NCT02492165|363314164|FG001|Overall Study|Withdrawal by Subject|1|||
105357436|NCT02492165|363314165|FG002|Overall Study|Withdrawal by Subject|0|||
105357437|NCT02492165|363314166|FG003|Overall Study|Withdrawal by Subject|0|||
105357438|NCT01025284|363314170|FG000|Overall Study|Investigator Decision|0|||
105357439|NCT01025284|363314171|FG001|Overall Study|Investigator Decision|1|||
105357440|NCT01025284|363314172|FG002|Overall Study|Investigator Decision|0|||
105357441|NCT01025284|363314170|FG000|Overall Study|Withdrawal by Subject|0|||
105357442|NCT01025284|363314171|FG001|Overall Study|Withdrawal by Subject|1|||
105357443|NCT01025284|363314172|FG002|Overall Study|Withdrawal by Subject|0|||
105357444|NCT02753816|363314173|FG000|Overall Study|Protocol Violation|0|||
105357445|NCT02753816|363314174|FG001|Overall Study|Protocol Violation|1|||
105357446|NCT02753816|363314175|FG002|Overall Study|Protocol Violation|0|||
105357447|NCT00905567|363314176|FG000|Washout|Withdrawal by Subject|0|||
105357448|NCT00905567|363314177|FG001|Washout|Withdrawal by Subject|1|||
105357449|NCT01957579|363314179|FG000|Overall Study|Withdrawal of concent|0|||
105357450|NCT01957579|363314180|FG001|Overall Study|Withdrawal of concent|1|||
105357451|NCT01957579|363314181|FG002|Overall Study|Withdrawal of concent|0|||
105357452|NCT01957579|363314182|FG003|Overall Study|Withdrawal of concent|0|||
105357453|NCT01957579|363314179|FG000|Overall Study|Death|0|||
105357454|NCT01957579|363314180|FG001|Overall Study|Death|0|||
105357455|NCT01957579|363314181|FG002|Overall Study|Death|2|||
105357456|NCT01957579|363314182|FG003|Overall Study|Death|0|||
105357457|NCT01639144|363314183|FG000|Overall Study|Withdrawal by Subject|4|||
105357458|NCT01639144|363314184|FG001|Overall Study|Withdrawal by Subject|2|||
105357459|NCT01639144|363314183|FG000|Overall Study|Physician Decision|2|||
105357460|NCT01639144|363314184|FG001|Overall Study|Physician Decision|0|||
105357461|NCT01639144|363314183|FG000|Overall Study|Met postoperative exclusion criteria|4|||
105357462|NCT01639144|363314184|FG001|Overall Study|Met postoperative exclusion criteria|3|||
105357463|NCT01738919|363314185|FG000|Overall Study|Lost to Follow-up|1|||
105357464|NCT01738919|363314186|FG001|Overall Study|Lost to Follow-up|0|||
105357465|NCT01738919|363314185|FG000|Overall Study|Immigrated|0|||
105357466|NCT01738919|363314186|FG001|Overall Study|Immigrated|1|||
105357467|NCT01738919|363314185|FG000|Overall Study|Withdrawal by Subject|0|||
105357468|NCT01738919|363314186|FG001|Overall Study|Withdrawal by Subject|1|||
105357469|NCT01738919|363314185|FG000|Overall Study|Not treated in accordance to guidelines|0|||
105357470|NCT01738919|363314186|FG001|Overall Study|Not treated in accordance to guidelines|1|||
105357471|NCT02750332|363314189|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105357472|NCT02750332|363314190|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105357473|NCT01473940|363314194|FG000|Induction Therapy|Death|0|||
105357474|NCT01473940|363314195|FG001|Induction Therapy|Death|0|||
105357475|NCT01473940|363314196|FG002|Induction Therapy|Death|1|||
105357476|NCT01473940|363314197|FG003|Induction Therapy|Death|1|||
105357477|NCT01473940|363314194|FG000|Induction Therapy|Progressive Disease|0|||
105357478|NCT01473940|363314195|FG001|Induction Therapy|Progressive Disease|1|||
105357479|NCT01473940|363314196|FG002|Induction Therapy|Progressive Disease|1|||
105357480|NCT01473940|363314197|FG003|Induction Therapy|Progressive Disease|0|||
105357481|NCT01473940|363314194|FG000|Maintenance Therapy|Progressive Disease|1|||
105357482|NCT01473940|363314195|FG001|Maintenance Therapy|Progressive Disease|2|||
105357483|NCT01473940|363314196|FG002|Maintenance Therapy|Progressive Disease|1|||
105739778|NCT03117049|364701624|FG001|Overall Study|Consent withdrawal|6|||
105739779|NCT03117049|364701623|FG000|Overall Study|Missing contact|3|||
105739780|NCT03117049|364701624|FG001|Overall Study|Missing contact|3|||
105739781|NCT01345786|364701625|FG000|Overall Study|Adverse Event|0|||
105739782|NCT01345786|364701626|FG001|Overall Study|Adverse Event|1|||
105739783|NCT01345786|364701627|FG002|Overall Study|Adverse Event|3|||
105357484|NCT01473940|363314197|FG003|Maintenance Therapy|Progressive Disease|4|||
105357485|NCT00547248|363314198|FG000|Overall Study|Protocol Violation|0|||
105357486|NCT00547248|363314199|FG001|Overall Study|Protocol Violation|0|||
105357487|NCT00547248|363314200|FG002|Overall Study|Protocol Violation|1|||
105357488|NCT00547248|363314201|FG003|Overall Study|Protocol Violation|1|||
105357489|NCT00547248|363314198|FG000|Overall Study|Migrated/moved from study area|0|||
105357490|NCT00547248|363314199|FG001|Overall Study|Migrated/moved from study area|0|||
105357491|NCT00547248|363314200|FG002|Overall Study|Migrated/moved from study area|2|||
105739784|NCT01345786|364701628|FG003|Overall Study|Adverse Event|1|||
105357492|NCT00547248|363314201|FG003|Overall Study|Migrated/moved from study area|0|||
105357493|NCT00547248|363314198|FG000|Overall Study|Withdrawal by Subject|0|||
105357494|NCT00547248|363314199|FG001|Overall Study|Withdrawal by Subject|0|||
105482660|NCT02536404|363778936|FG001|Overall Study|Physician Decision|0|||
105357495|NCT00547248|363314200|FG002|Overall Study|Withdrawal by Subject|7|||
105357496|NCT00547248|363314201|FG003|Overall Study|Withdrawal by Subject|1|||
105357497|NCT00534248|363314202|FG000|Overall Study|Adverse Event|19|||
105357498|NCT00534248|363314203|FG001|Overall Study|Adverse Event|29|||
105357499|NCT00534248|363314202|FG000|Overall Study|Lost to Follow-up|353|||
105357500|NCT00534248|363314203|FG001|Overall Study|Lost to Follow-up|375|||
105357501|NCT00534248|363314202|FG000|Overall Study|Other protocol specified criteria|13|||
105357502|NCT00534248|363314203|FG001|Overall Study|Other protocol specified criteria|3|||
105357503|NCT00534248|363314202|FG000|Overall Study|Physician Decision|10|||
105357504|NCT00534248|363314203|FG001|Overall Study|Physician Decision|7|||
105357505|NCT00534248|363314202|FG000|Overall Study|Protocol Violation|3|||
105357506|NCT00534248|363314203|FG001|Overall Study|Protocol Violation|4|||
105357507|NCT00534248|363314202|FG000|Overall Study|Withdrawal by Subject|263|||
105357508|NCT00534248|363314203|FG001|Overall Study|Withdrawal by Subject|255|||
105357509|NCT02259400|363314206|FG000|Overall Study|Death|0|||
105357510|NCT02259400|363314207|FG001|Overall Study|Death|2|||
105357511|NCT00697593|363314211|FG000|Overall Study|Adverse Event|3|||
105357512|NCT00697593|363314211|FG000|Overall Study|Protocol Violation|1|||
105357513|NCT00697593|363314211|FG000|Overall Study|Lack of Efficacy|3|||
105357514|NCT00697593|363314211|FG000|Overall Study|Suspension of the study by sponsor|12|||
105357515|NCT03498313|363314212|FG000|Experimental Period 1|Adverse Event|1|||
105357516|NCT03498313|363314213|FG001|Experimental Period 1|Adverse Event|0|||
105357517|NCT03498313|363314214|FG002|Experimental Period 1|Adverse Event|0|||
105357518|NCT03498313|363314215|FG003|Experimental Period 1|Adverse Event|1|||
105357519|NCT03498313|363314216|FG004|Experimental Period 1|Adverse Event|0|||
105357520|NCT03498313|363314217|FG005|Experimental Period 1|Adverse Event|0|||
105357521|NCT03498313|363314212|FG000|Experimental Period 1|Withdrawal by Subject|0|||
105357522|NCT03498313|363314213|FG001|Experimental Period 1|Withdrawal by Subject|1|||
105357523|NCT03498313|363314214|FG002|Experimental Period 1|Withdrawal by Subject|0|||
105357524|NCT03498313|363314215|FG003|Experimental Period 1|Withdrawal by Subject|0|||
105357525|NCT03498313|363314216|FG004|Experimental Period 1|Withdrawal by Subject|0|||
105357526|NCT03498313|363314217|FG005|Experimental Period 1|Withdrawal by Subject|0|||
105357527|NCT03498313|363314212|FG000|Washout Period 1|Anovulation|1|||
105357528|NCT03498313|363314213|FG001|Washout Period 1|Anovulation|0|||
105357529|NCT03498313|363314214|FG002|Washout Period 1|Anovulation|0|||
105357530|NCT03498313|363314215|FG003|Washout Period 1|Anovulation|0|||
105357531|NCT03498313|363314216|FG004|Washout Period 1|Anovulation|0|||
105357532|NCT03498313|363314217|FG005|Washout Period 1|Anovulation|0|||
105357533|NCT03498313|363314212|FG000|Washout Period 1|Withdrawal by Subject|0|||
105357534|NCT03498313|363314213|FG001|Washout Period 1|Withdrawal by Subject|3|||
105357535|NCT03498313|363314214|FG002|Washout Period 1|Withdrawal by Subject|0|||
105357536|NCT03498313|363314215|FG003|Washout Period 1|Withdrawal by Subject|1|||
105357537|NCT03498313|363314216|FG004|Washout Period 1|Withdrawal by Subject|0|||
105357538|NCT03498313|363314217|FG005|Washout Period 1|Withdrawal by Subject|1|||
105357539|NCT03498313|363314212|FG000|Experimental Period 2|Adverse Event|0|||
105357540|NCT03498313|363314213|FG001|Experimental Period 2|Adverse Event|0|||
105357541|NCT03498313|363314214|FG002|Experimental Period 2|Adverse Event|0|||
105357542|NCT03498313|363314215|FG003|Experimental Period 2|Adverse Event|0|||
105357543|NCT03498313|363314216|FG004|Experimental Period 2|Adverse Event|1|||
105357544|NCT03498313|363314217|FG005|Experimental Period 2|Adverse Event|2|||
105357545|NCT03498313|363314212|FG000|Washout Period 2|Physician Decision|1|||
105357546|NCT03498313|363314213|FG001|Washout Period 2|Physician Decision|0|||
105357547|NCT03498313|363314214|FG002|Washout Period 2|Physician Decision|0|||
105357548|NCT03498313|363314215|FG003|Washout Period 2|Physician Decision|1|||
105357549|NCT03498313|363314216|FG004|Washout Period 2|Physician Decision|0|||
105357550|NCT03498313|363314217|FG005|Washout Period 2|Physician Decision|1|||
105357551|NCT03498313|363314212|FG000|Washout Period 2|Withdrawal by Subject|3|||
105739785|NCT01345786|364701625|FG000|Overall Study|Subject withdrew consent|2|||
105739786|NCT01345786|364701626|FG001|Overall Study|Subject withdrew consent|2|||
105739787|NCT01345786|364701627|FG002|Overall Study|Subject withdrew consent|1|||
105739788|NCT01345786|364701628|FG003|Overall Study|Subject withdrew consent|0|||
105357552|NCT03498313|363314213|FG001|Washout Period 2|Withdrawal by Subject|2|||
105357553|NCT03498313|363314214|FG002|Washout Period 2|Withdrawal by Subject|0|||
105357554|NCT03498313|363314215|FG003|Washout Period 2|Withdrawal by Subject|0|||
105357555|NCT03498313|363314216|FG004|Washout Period 2|Withdrawal by Subject|2|||
105357556|NCT03498313|363314217|FG005|Washout Period 2|Withdrawal by Subject|0|||
105357557|NCT03498313|363314212|FG000|Washout Period 2|Anovulation|0|||
105739789|NCT01345786|364701625|FG000|Overall Study|Noncompliance with protocol|1|||
105739790|NCT01345786|364701626|FG001|Overall Study|Noncompliance with protocol|0|||
105739791|NCT01345786|364701627|FG002|Overall Study|Noncompliance with protocol|1|||
105739792|NCT01345786|364701628|FG003|Overall Study|Noncompliance with protocol|0|||
105739793|NCT01345786|364701625|FG000|Overall Study|Administrative|3|||
105739794|NCT01345786|364701626|FG001|Overall Study|Administrative|5|||
105739795|NCT01345786|364701627|FG002|Overall Study|Administrative|0|||
105739796|NCT01345786|364701628|FG003|Overall Study|Administrative|0|||
105739797|NCT01345786|364701625|FG000|Overall Study|Lost to Follow-up|0|||
105739798|NCT01345786|364701626|FG001|Overall Study|Lost to Follow-up|0|||
105739799|NCT01345786|364701627|FG002|Overall Study|Lost to Follow-up|0|||
105739800|NCT01345786|364701628|FG003|Overall Study|Lost to Follow-up|2|||
105739801|NCT02399475|364701629|FG000|Overall Study|Physician Decision|1|||
105739802|NCT02399475|364701630|FG001|Overall Study|Physician Decision|0|||
105739803|NCT02807454|364701631|FG000|Overall Study|Adverse Event|1|||
105739804|NCT02807454|364701632|FG001|Overall Study|Adverse Event|0|||
105739805|NCT02807454|364701631|FG000|Overall Study|Withdrawal by Subject|0|||
105739806|NCT02807454|364701632|FG001|Overall Study|Withdrawal by Subject|1|||
105739807|NCT02807454|364701631|FG000|Overall Study|Progressive Disease|30|||
105739808|NCT02807454|364701632|FG001|Overall Study|Progressive Disease|3|||
105739809|NCT02807454|364701631|FG000|Overall Study|Other Reasons|1|||
105739810|NCT02807454|364701632|FG001|Overall Study|Other Reasons|1|||
105739811|NCT01780389|364701633|FG000|Overall Study|Adverse Event|1|||
105739812|NCT01518192|364701634|FG000|Overall Study|Lost to Follow-up|29|||
105739813|NCT01518192|364701635|FG001|Overall Study|Lost to Follow-up|26|||
105739814|NCT01518192|364701636|FG002|Overall Study|Lost to Follow-up|35|||
105739815|NCT00085540|364701637|FG000|Overall Study|Withdrawal by Subject|0|||
105739816|NCT00085540|364701638|FG001|Overall Study|Withdrawal by Subject|1|||
105739817|NCT00085540|364701637|FG000|Overall Study|Protocol Violation|0|||
105739818|NCT00085540|364701638|FG001|Overall Study|Protocol Violation|1|||
105739819|NCT00426751|364701641|FG000|Overall Study|Adverse Event|8|||
105739820|NCT00426751|364701642|FG001|Overall Study|Adverse Event|1|||
105739821|NCT00426751|364701641|FG000|Overall Study|Lost to Follow-up|7|||
105739822|NCT00426751|364701642|FG001|Overall Study|Lost to Follow-up|6|||
105739823|NCT00426751|364701641|FG000|Overall Study|Consent Withdrawn|0|||
105739824|NCT00426751|364701642|FG001|Overall Study|Consent Withdrawn|1|||
105739825|NCT00426751|364701641|FG000|Overall Study|Other Reasons|7|||
105739826|NCT00426751|364701642|FG001|Overall Study|Other Reasons|12|||
105482661|NCT02536404|363778935|FG000|Overall Study|Sponsor decision|1|||
105482662|NCT02536404|363778936|FG001|Overall Study|Sponsor decision|0|||
105482663|NCT00816023|363778942|FG000|Overall Study|Lost to Follow-up|1|||
105482664|NCT00816023|363778943|FG001|Overall Study|Lost to Follow-up|1|||
105482665|NCT00816023|363778944|FG002|Overall Study|Lost to Follow-up|0|||
105482666|NCT00816023|363778945|FG003|Overall Study|Lost to Follow-up|0|||
105482667|NCT00816023|363778942|FG000|Overall Study|Withdrawal by Subject|1|||
105482668|NCT00816023|363778943|FG001|Overall Study|Withdrawal by Subject|0|||
105482669|NCT00816023|363778944|FG002|Overall Study|Withdrawal by Subject|0|||
105482670|NCT00816023|363778945|FG003|Overall Study|Withdrawal by Subject|0|||
105482671|NCT00816023|363778942|FG000|Overall Study|Physician Decision|0|||
105482672|NCT00816023|363778943|FG001|Overall Study|Physician Decision|0|||
105482673|NCT00816023|363778944|FG002|Overall Study|Physician Decision|1|||
105482674|NCT00816023|363778945|FG003|Overall Study|Physician Decision|0|||
105482675|NCT00816023|363778942|FG000|Overall Study|assessments complete prior to window|1|||
105482676|NCT00816023|363778943|FG001|Overall Study|assessments complete prior to window|1|||
105482677|NCT00816023|363778944|FG002|Overall Study|assessments complete prior to window|2|||
105482678|NCT00816023|363778945|FG003|Overall Study|assessments complete prior to window|1|||
105482679|NCT00816023|363778942|FG000|Overall Study|Randomized Not Treated|6|||
105482680|NCT00816023|363778943|FG001|Overall Study|Randomized Not Treated|4|||
105482681|NCT00816023|363778944|FG002|Overall Study|Randomized Not Treated|6|||
105482682|NCT00816023|363778945|FG003|Overall Study|Randomized Not Treated|11|||
105482683|NCT01009281|363778946|FG000|Overall Study|Administrative problems|7|||
105482684|NCT01525901|363778947|FG000|Period 2: 12 Weeks|Adverse Event|0|||
105482685|NCT01525901|363778948|FG001|Period 2: 12 Weeks|Adverse Event|1|||
105482686|NCT01525901|363778949|FG002|Period 2: 12 Weeks|Adverse Event|0|||
105482687|NCT01525901|363778950|FG003|Period 2: 12 Weeks|Adverse Event|0|||
105482688|NCT04449029|363778951|FG000|Overall Study|Adverse Event|0|||
105482689|NCT04449029|363778952|FG001|Overall Study|Adverse Event|1|||
105482690|NCT04449029|363778953|FG002|Overall Study|Adverse Event|1|||
105482691|NCT04449029|363778954|FG003|Overall Study|Adverse Event|0|||
105482692|NCT04449029|363778955|FG004|Overall Study|Adverse Event|1|||
105482693|NCT04449029|363778956|FG005|Overall Study|Adverse Event|0|||
105482694|NCT04449029|363778957|FG006|Overall Study|Adverse Event|1|||
105482695|NCT04449029|363778958|FG007|Overall Study|Adverse Event|0|||
105482696|NCT04449029|363778951|FG000|Overall Study|Lost to Follow-up|0|||
105482697|NCT04449029|363778952|FG001|Overall Study|Lost to Follow-up|1|||
105482698|NCT04449029|363778953|FG002|Overall Study|Lost to Follow-up|0|||
105482699|NCT04449029|363778954|FG003|Overall Study|Lost to Follow-up|0|||
105482700|NCT04449029|363778955|FG004|Overall Study|Lost to Follow-up|0|||
105482701|NCT04449029|363778956|FG005|Overall Study|Lost to Follow-up|0|||
105482702|NCT04449029|363778957|FG006|Overall Study|Lost to Follow-up|0|||
105482703|NCT04449029|363778958|FG007|Overall Study|Lost to Follow-up|0|||
105482704|NCT04449029|363778951|FG000|Overall Study|Protocol Violation|0|||
105482705|NCT04449029|363778952|FG001|Overall Study|Protocol Violation|1|||
105739827|NCT00576693|364701647|FG000|Overall Study|Lost to Follow-up|7|||
105739828|NCT00576693|364701648|FG001|Overall Study|Lost to Follow-up|11|||
105739829|NCT00576693|364701647|FG000|Overall Study|Withdrawal by Subject|3|||
105739830|NCT00576693|364701648|FG001|Overall Study|Withdrawal by Subject|13|||
105739831|NCT02574312|364701651|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
105739832|NCT02574312|364701652|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
105739833|NCT01522651|364701653|FG000|Overall Study|Adverse Event|3|||
105739834|NCT01522651|364701654|FG001|Overall Study|Adverse Event|4|||
105482706|NCT04449029|363778953|FG002|Overall Study|Protocol Violation|0|||
105482707|NCT04449029|363778954|FG003|Overall Study|Protocol Violation|0|||
105482708|NCT04449029|363778955|FG004|Overall Study|Protocol Violation|0|||
105482709|NCT04449029|363778956|FG005|Overall Study|Protocol Violation|0|||
105482710|NCT04449029|363778957|FG006|Overall Study|Protocol Violation|0|||
105482711|NCT04449029|363778958|FG007|Overall Study|Protocol Violation|0|||
105482712|NCT04449029|363778951|FG000|Overall Study|Physician Decision|0|||
105482713|NCT04449029|363778952|FG001|Overall Study|Physician Decision|0|||
105357558|NCT03498313|363314213|FG001|Washout Period 2|Anovulation|0|||
105357559|NCT03498313|363314214|FG002|Washout Period 2|Anovulation|0|||
105357560|NCT03498313|363314215|FG003|Washout Period 2|Anovulation|0|||
105357561|NCT03498313|363314216|FG004|Washout Period 2|Anovulation|0|||
105357562|NCT03498313|363314217|FG005|Washout Period 2|Anovulation|1|||
105357563|NCT02964338|363314218|FG000|Overall Study|Sponsor terminated study for futility|12|||
105357564|NCT02964338|363314219|FG001|Overall Study|Sponsor terminated study for futility|15|||
105357565|NCT02964338|363314220|FG002|Overall Study|Sponsor terminated study for futility|14|||
105357566|NCT02964338|363314218|FG000|Overall Study|Lack of Efficacy|0|||
105357567|NCT02964338|363314219|FG001|Overall Study|Lack of Efficacy|3|||
105357568|NCT02964338|363314220|FG002|Overall Study|Lack of Efficacy|0|||
105357569|NCT02964338|363314218|FG000|Overall Study|Lost to Follow-up|1|||
105357570|NCT02964338|363314219|FG001|Overall Study|Lost to Follow-up|0|||
105357571|NCT02964338|363314220|FG002|Overall Study|Lost to Follow-up|3|||
105357572|NCT02964338|363314218|FG000|Overall Study|Protocol Violation|0|||
105357573|NCT02964338|363314219|FG001|Overall Study|Protocol Violation|1|||
105357574|NCT02964338|363314220|FG002|Overall Study|Protocol Violation|0|||
105357575|NCT02964338|363314218|FG000|Overall Study|Withdrawal by Subject|1|||
105357576|NCT02964338|363314219|FG001|Overall Study|Withdrawal by Subject|3|||
105357577|NCT02964338|363314220|FG002|Overall Study|Withdrawal by Subject|1|||
105357578|NCT02964338|363314218|FG000|Overall Study|Adverse Event|2|||
105357579|NCT02964338|363314219|FG001|Overall Study|Adverse Event|1|||
105357580|NCT02964338|363314220|FG002|Overall Study|Adverse Event|1|||
105357581|NCT02964338|363314218|FG000|Overall Study|Non-compliant with e-diary|0|||
105357582|NCT02964338|363314219|FG001|Overall Study|Non-compliant with e-diary|1|||
105357583|NCT02964338|363314220|FG002|Overall Study|Non-compliant with e-diary|0|||
105357584|NCT02964338|363314218|FG000|Overall Study|Did not meet criteria|1|||
105357585|NCT02964338|363314219|FG001|Overall Study|Did not meet criteria|0|||
105357586|NCT02964338|363314220|FG002|Overall Study|Did not meet criteria|0|||
105357587|NCT00929994|363314226|FG000|Overall Study|Withdrawal by Subject|1|||
105357588|NCT00929994|363314226|FG000|Overall Study|medical issue unrelated to intervention|4|||
105357589|NCT00929994|363314226|FG000|Overall Study|employment|1|||
105357590|NCT00587795|363314228|FG000|Overall Study|Withdrawal by Subject|1|||
105357591|NCT00587795|363314229|FG001|Overall Study|Withdrawal by Subject|0|||
105357592|NCT01001520|363314230|FG000|Medication Period 1|Withdrawal by Subject|2|||
105357593|NCT01001520|363314231|FG001|Medication Period 1|Withdrawal by Subject|2|||
105357594|NCT01001520|363314230|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
105357595|NCT01001520|363314231|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
105357596|NCT01001520|363314230|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
105357597|NCT01001520|363314231|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
105357598|NCT01001520|363314230|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
105357599|NCT01001520|363314231|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
105357600|NCT01001520|363314230|FG000|Washout Period|Withdrawal by Subject|2|||
105357601|NCT01001520|363314231|FG001|Washout Period|Withdrawal by Subject|1|||
105357602|NCT01001520|363314230|FG000|Medication Period 2|Withdrawal by Subject|0|||
105357603|NCT01001520|363314231|FG001|Medication Period 2|Withdrawal by Subject|3|||
105357604|NCT00141518|363314232|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
105357605|NCT00141518|363314233|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
105357606|NCT00141518|363314234|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
105357607|NCT00141518|363314232|FG000|Overall Study|Adverse Event|7|||
105357608|NCT00141518|363314233|FG001|Overall Study|Adverse Event|5|||
105357609|NCT00141518|363314234|FG002|Overall Study|Adverse Event|2|||
105357610|NCT00141518|363314232|FG000|Overall Study|Withdrawal by Subject|2|||
105357611|NCT00141518|363314233|FG001|Overall Study|Withdrawal by Subject|0|||
105357612|NCT00141518|363314234|FG002|Overall Study|Withdrawal by Subject|2|||
105357613|NCT00141518|363314232|FG000|Overall Study|Protocol Violation|1|||
105357614|NCT00141518|363314233|FG001|Overall Study|Protocol Violation|1|||
105357615|NCT00141518|363314234|FG002|Overall Study|Protocol Violation|2|||
105357616|NCT00141518|363314232|FG000|Overall Study|Lack of Efficacy|5|||
105357617|NCT00141518|363314233|FG001|Overall Study|Lack of Efficacy|0|||
105357618|NCT00141518|363314234|FG002|Overall Study|Lack of Efficacy|0|||
105357619|NCT01806168|363314235|FG000|Overall Study|Adverse Event|1|||
105357620|NCT01806168|363314236|FG001|Overall Study|Adverse Event|0|||
105357621|NCT01806168|363314237|FG002|Overall Study|Adverse Event|0|||
105357622|NCT01806168|363314235|FG000|Overall Study|Withdrawal by Subject|0|||
105357623|NCT01806168|363314236|FG001|Overall Study|Withdrawal by Subject|1|||
105357624|NCT01806168|363314237|FG002|Overall Study|Withdrawal by Subject|2|||
105357625|NCT01806168|363314235|FG000|Overall Study|Protocol Violation|0|||
105357626|NCT01806168|363314236|FG001|Overall Study|Protocol Violation|0|||
105357627|NCT01806168|363314237|FG002|Overall Study|Protocol Violation|1|||
105357628|NCT04819438|363314238|FG000|Overall Study|Withdrawal by Subject|1|||
105482714|NCT04449029|363778953|FG002|Overall Study|Physician Decision|0|||
105482715|NCT04449029|363778954|FG003|Overall Study|Physician Decision|0|||
105357629|NCT04819438|363314239|FG001|Overall Study|Withdrawal by Subject|0|||
105357630|NCT04819438|363314238|FG000|Overall Study|Adverse Event|0|||
105357631|NCT04819438|363314239|FG001|Overall Study|Adverse Event|1|||
105357632|NCT04819438|363314238|FG000|Overall Study|Protocol Violation|0|||
105357633|NCT04819438|363314239|FG001|Overall Study|Protocol Violation|1|||
105357634|NCT02028507|363314240|FG000|Overall Study|Progressive Disease|122|||
105357635|NCT02028507|363314241|FG001|Overall Study|Progressive Disease|90|||
105357636|NCT02028507|363314242|FG002|Overall Study|Progressive Disease|102|||
105357637|NCT02028507|363314243|FG003|Overall Study|Progressive Disease|89|||
105357638|NCT02028507|363314240|FG000|Overall Study|Adverse Event|8|||
105357639|NCT02028507|363314241|FG001|Overall Study|Adverse Event|25|||
105357640|NCT02028507|363314242|FG002|Overall Study|Adverse Event|3|||
105357641|NCT02028507|363314243|FG003|Overall Study|Adverse Event|16|||
105357642|NCT02028507|363314240|FG000|Overall Study|Withdrawal by Subject|6|||
105357643|NCT02028507|363314241|FG001|Overall Study|Withdrawal by Subject|8|||
105357644|NCT02028507|363314242|FG002|Overall Study|Withdrawal by Subject|5|||
105357645|NCT02028507|363314243|FG003|Overall Study|Withdrawal by Subject|9|||
105357646|NCT02028507|363314240|FG000|Overall Study|Protocol Violation|2|||
105357647|NCT02028507|363314241|FG001|Overall Study|Protocol Violation|4|||
105357648|NCT02028507|363314242|FG002|Overall Study|Protocol Violation|1|||
105357649|NCT02028507|363314243|FG003|Overall Study|Protocol Violation|3|||
105357650|NCT02028507|363314240|FG000|Overall Study|Physician Decision|0|||
105357651|NCT02028507|363314241|FG001|Overall Study|Physician Decision|4|||
105357652|NCT02028507|363314242|FG002|Overall Study|Physician Decision|0|||
105357653|NCT02028507|363314243|FG003|Overall Study|Physician Decision|0|||
105357654|NCT02028507|363314240|FG000|Overall Study|Death|1|||
105357655|NCT02028507|363314241|FG001|Overall Study|Death|0|||
105357656|NCT02028507|363314242|FG002|Overall Study|Death|1|||
105357657|NCT02028507|363314243|FG003|Overall Study|Death|3|||
105357658|NCT02028507|363314240|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
105357659|NCT02028507|363314241|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
105357660|NCT02028507|363314242|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
105357661|NCT02028507|363314243|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
105357662|NCT02028507|363314240|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
105357663|NCT02028507|363314241|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
105357664|NCT02028507|363314242|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
105357665|NCT02028507|363314243|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
105357666|NCT02028507|363314240|FG000|Overall Study|Randomized But Not Treated|3|||
105357667|NCT02028507|363314241|FG001|Overall Study|Randomized But Not Treated|6|||
105357668|NCT02028507|363314242|FG002|Overall Study|Randomized But Not Treated|0|||
105357669|NCT02028507|363314243|FG003|Overall Study|Randomized But Not Treated|4|||
105357670|NCT02028507|363314240|FG000|Overall Study|Enzyme defect|0|||
105357671|NCT02028507|363314241|FG001|Overall Study|Enzyme defect|0|||
105357672|NCT02028507|363314242|FG002|Overall Study|Enzyme defect|0|||
105357673|NCT02028507|363314243|FG003|Overall Study|Enzyme defect|1|||
105357674|NCT02028507|363314240|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
105357675|NCT02028507|363314241|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
105357676|NCT02028507|363314242|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
105357677|NCT02028507|363314243|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
105357678|NCT02028507|363314240|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
105357679|NCT02028507|363314241|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
105357680|NCT02028507|363314242|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
105357681|NCT02028507|363314243|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
105357682|NCT05980013|363314244|FG000|Overall Study|Withdrawal by Subject|0|||
105357683|NCT05980013|363314245|FG001|Overall Study|Withdrawal by Subject|1|||
105357684|NCT05980013|363314244|FG000|Overall Study|Device Error|0|||
105357685|NCT05980013|363314245|FG001|Overall Study|Device Error|1|||
105357686|NCT04202965|363314248|FG000|Overall Study|Adverse Event|3|||
105357687|NCT04202965|363314248|FG000|Overall Study|Did not meet inclusion criteria|1|||
105357688|NCT01556932|363314249|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
105357689|NCT01556932|363314250|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
105357690|NCT03066778|363314251|FG000|Overall Study|Death|195|||
105357691|NCT03066778|363314252|FG001|Overall Study|Death|205|||
105739835|NCT01522651|364701655|FG002|Overall Study|Adverse Event|4|||
105739836|NCT01522651|364701656|FG003|Overall Study|Adverse Event|5|||
105739837|NCT01522651|364701657|FG004|Overall Study|Adverse Event|4|||
105739838|NCT01522651|364701653|FG000|Overall Study|Cardioversion|1|||
105739839|NCT01522651|364701654|FG001|Overall Study|Cardioversion|0|||
105739840|NCT01522651|364701655|FG002|Overall Study|Cardioversion|0|||
105357692|NCT03066778|363314251|FG000|Overall Study|Withdrawal by Subject|5|||
105357693|NCT03066778|363314252|FG001|Overall Study|Withdrawal by Subject|7|||
105357694|NCT02328937|363314253|FG000|Period 1|Lost to Follow-up|0|||
105357695|NCT02328937|363314254|FG001|Period 1|Lost to Follow-up|0|||
105357696|NCT02328937|363314255|FG002|Period 1|Lost to Follow-up|0|||
105357697|NCT02328937|363314256|FG003|Period 1|Lost to Follow-up|1|||
105357698|NCT02328937|363314257|FG004|Period 1|Lost to Follow-up|0|||
105357699|NCT02328937|363314258|FG005|Period 1|Lost to Follow-up|0|||
105357700|NCT02328937|363314253|FG000|Period 2|Adverse Event|0|||
105357701|NCT02328937|363314254|FG001|Period 2|Adverse Event|0|||
105357702|NCT02328937|363314255|FG002|Period 2|Adverse Event|1|||
105739841|NCT01522651|364701656|FG003|Overall Study|Cardioversion|0|||
105739842|NCT01522651|364701657|FG004|Overall Study|Cardioversion|0|||
105739843|NCT01522651|364701653|FG000|Overall Study|Device Malfunction|0|||
105739844|NCT01522651|364701654|FG001|Overall Study|Device Malfunction|1|||
105739845|NCT01522651|364701655|FG002|Overall Study|Device Malfunction|0|||
105739846|NCT01522651|364701656|FG003|Overall Study|Device Malfunction|0|||
105739847|NCT01522651|364701657|FG004|Overall Study|Device Malfunction|0|||
105739848|NCT01522651|364701653|FG000|Overall Study|Investigator's Discretion|0|||
105739849|NCT01522651|364701654|FG001|Overall Study|Investigator's Discretion|1|||
105739850|NCT01522651|364701655|FG002|Overall Study|Investigator's Discretion|0|||
105739851|NCT01522651|364701656|FG003|Overall Study|Investigator's Discretion|0|||
105739852|NCT01522651|364701657|FG004|Overall Study|Investigator's Discretion|0|||
105739853|NCT01522651|364701653|FG000|Overall Study|Protocol Violation|3|||
105739854|NCT01522651|364701654|FG001|Overall Study|Protocol Violation|0|||
105739855|NCT01522651|364701655|FG002|Overall Study|Protocol Violation|0|||
105739856|NCT01522651|364701656|FG003|Overall Study|Protocol Violation|0|||
105739857|NCT01522651|364701657|FG004|Overall Study|Protocol Violation|0|||
105739858|NCT01522651|364701653|FG000|Overall Study|Reason Not Specified|0|||
105800022|NCT01335399|364926337|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
105565270|NCT03420781|364066726|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
105739859|NCT01522651|364701654|FG001|Overall Study|Reason Not Specified|0|||
105739860|NCT01522651|364701655|FG002|Overall Study|Reason Not Specified|0|||
105739861|NCT01522651|364701656|FG003|Overall Study|Reason Not Specified|1|||
105739862|NCT01522651|364701657|FG004|Overall Study|Reason Not Specified|0|||
105800023|NCT01335399|364926338|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
105739863|NCT01522651|364701653|FG000|Overall Study|Participant Non-Compliance|1|||
105739864|NCT01522651|364701654|FG001|Overall Study|Participant Non-Compliance|0|||
105565271|NCT03420781|364066727|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
105739865|NCT01522651|364701655|FG002|Overall Study|Participant Non-Compliance|0|||
105482716|NCT04449029|363778955|FG004|Overall Study|Physician Decision|0|||
105482717|NCT04449029|363778956|FG005|Overall Study|Physician Decision|1|||
105482718|NCT04449029|363778957|FG006|Overall Study|Physician Decision|0|||
105482719|NCT04449029|363778958|FG007|Overall Study|Physician Decision|0|||
105482720|NCT04449029|363778951|FG000|Overall Study|Withdrawal by Subject|3|||
105482721|NCT04449029|363778952|FG001|Overall Study|Withdrawal by Subject|0|||
105482722|NCT04449029|363778953|FG002|Overall Study|Withdrawal by Subject|1|||
105482723|NCT04449029|363778954|FG003|Overall Study|Withdrawal by Subject|1|||
105482724|NCT04449029|363778955|FG004|Overall Study|Withdrawal by Subject|5|||
105482725|NCT04449029|363778956|FG005|Overall Study|Withdrawal by Subject|1|||
105482726|NCT04449029|363778957|FG006|Overall Study|Withdrawal by Subject|4|||
105482727|NCT04449029|363778958|FG007|Overall Study|Withdrawal by Subject|0|||
105482728|NCT01203852|363778965|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
105482729|NCT01203852|363778965|FG000|Washout 2 Weeks|Physician Decision|46|||
105357703|NCT02328937|363314256|FG003|Period 2|Adverse Event|0|||
105482730|NCT01238588|363778968|FG000|Overall Study|Withdrawal by Subject|1|||
105482731|NCT01238588|363778968|FG000|Overall Study|Physician Decision|2|||
105482732|NCT01587898|363778974|FG000|Overall Study|Adverse Event|1|||
105482733|NCT01587898|363778975|FG001|Overall Study|Adverse Event|1|||
105482734|NCT01587898|363778976|FG002|Overall Study|Adverse Event|0|||
105482735|NCT01587898|363778977|FG003|Overall Study|Adverse Event|0|||
105482736|NCT01587898|363778974|FG000|Overall Study|Protocol Violation|0|||
105482737|NCT01587898|363778975|FG001|Overall Study|Protocol Violation|2|||
105482738|NCT01587898|363778976|FG002|Overall Study|Protocol Violation|1|||
105482739|NCT01587898|363778977|FG003|Overall Study|Protocol Violation|1|||
105482740|NCT01587898|363778974|FG000|Overall Study|Lost to Follow-up|0|||
105482741|NCT01587898|363778975|FG001|Overall Study|Lost to Follow-up|0|||
105482742|NCT01587898|363778976|FG002|Overall Study|Lost to Follow-up|0|||
105482743|NCT01587898|363778977|FG003|Overall Study|Lost to Follow-up|1|||
105482744|NCT01587898|363778974|FG000|Overall Study|Withdrawal by Subject|2|||
105357704|NCT02328937|363314257|FG004|Period 2|Adverse Event|0|||
105357705|NCT02328937|363314258|FG005|Period 2|Adverse Event|0|||
105357706|NCT02091414|363314259|FG000|Overall Study|Withdrawal by Subject|2|||
105357707|NCT02091414|363314259|FG000|Overall Study|Death|2|||
105357708|NCT03665077|363314262|FG000|Overall Study|Lost to Follow-up|2|||
105357709|NCT03665077|363314262|FG000|Overall Study|Physician Decision|2|||
105357710|NCT00791700|363314265|FG000|Overall Study|Insufficient clinical response|1|||
105357711|NCT00791700|363314266|FG001|Overall Study|Insufficient clinical response|4|||
105357712|NCT00791700|363314267|FG002|Overall Study|Insufficient clinical response|1|||
105357713|NCT00791700|363314268|FG003|Overall Study|Insufficient clinical response|8|||
105357714|NCT00791700|363314265|FG000|Overall Study|No longer willing to participate|1|||
105357715|NCT00791700|363314266|FG001|Overall Study|No longer willing to participate|1|||
105357716|NCT00791700|363314267|FG002|Overall Study|No longer willing to participate|0|||
105357717|NCT00791700|363314268|FG003|Overall Study|No longer willing to participate|8|||
105357718|NCT00791700|363314265|FG000|Overall Study|Non-compliance with study treatment|0|||
105357719|NCT00791700|363314266|FG001|Overall Study|Non-compliance with study treatment|2|||
105357720|NCT00791700|363314267|FG002|Overall Study|Non-compliance with study treatment|0|||
105357721|NCT00791700|363314268|FG003|Overall Study|Non-compliance with study treatment|4|||
105357722|NCT00791700|363314265|FG000|Overall Study|Withdrawn due to pregnancy|0|||
105357723|NCT00791700|363314266|FG001|Overall Study|Withdrawn due to pregnancy|0|||
105357724|NCT00791700|363314267|FG002|Overall Study|Withdrawn due to pregnancy|0|||
105357725|NCT00791700|363314268|FG003|Overall Study|Withdrawn due to pregnancy|1|||
105357726|NCT00791700|363314265|FG000|Overall Study|Other|0|||
105357727|NCT00791700|363314266|FG001|Overall Study|Other|1|||
105357728|NCT00791700|363314267|FG002|Overall Study|Other|0|||
105357729|NCT00791700|363314268|FG003|Overall Study|Other|1|||
105357730|NCT00791700|363314265|FG000|Overall Study|Death|0|||
105357731|NCT00791700|363314266|FG001|Overall Study|Death|0|||
105357732|NCT00791700|363314267|FG002|Overall Study|Death|0|||
105357733|NCT00791700|363314268|FG003|Overall Study|Death|1|||
105482745|NCT01587898|363778975|FG001|Overall Study|Withdrawal by Subject|1|||
105482746|NCT01587898|363778976|FG002|Overall Study|Withdrawal by Subject|0|||
105482747|NCT01587898|363778977|FG003|Overall Study|Withdrawal by Subject|0|||
105482748|NCT01587898|363778974|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
105482749|NCT01587898|363778975|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
105482750|NCT01587898|363778976|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
105482751|NCT01587898|363778977|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
105482752|NCT01433250|363778980|FG000|Overall Study|Protocol Violation|0|||
105482753|NCT01433250|363778981|FG001|Overall Study|Protocol Violation|1|||
105357734|NCT00791700|363314265|FG000|Overall Study|Lost to Follow-up|4|||
105357735|NCT00791700|363314266|FG001|Overall Study|Lost to Follow-up|3|||
105482754|NCT01433250|363778980|FG000|Overall Study|Withdrawal by Subject|3|||
105482755|NCT01433250|363778981|FG001|Overall Study|Withdrawal by Subject|2|||
105482756|NCT01239732|363778988|FG000|Overall Study|Termination of study per protocol|667|||
105482757|NCT01239732|363778988|FG000|Overall Study|Death|226|||
105482758|NCT01239732|363778988|FG000|Overall Study|Withdrawal by Subject|87|||
105482759|NCT01239732|363778988|FG000|Overall Study|Adverse Event|6|||
105482760|NCT01239732|363778988|FG000|Overall Study|Protocol Violation|3|||
105739866|NCT01522651|364701656|FG003|Overall Study|Participant Non-Compliance|0|||
105739867|NCT01522651|364701657|FG004|Overall Study|Participant Non-Compliance|0|||
105739868|NCT01522651|364701653|FG000|Overall Study|Withdrew Consent|1|||
105739869|NCT01522651|364701654|FG001|Overall Study|Withdrew Consent|1|||
105739870|NCT01522651|364701655|FG002|Overall Study|Withdrew Consent|0|||
105739871|NCT01522651|364701656|FG003|Overall Study|Withdrew Consent|1|||
105739872|NCT01522651|364701657|FG004|Overall Study|Withdrew Consent|1|||
105739873|NCT01522651|364701653|FG000|Overall Study|Randomized but Never Treated|0|||
105739874|NCT01522651|364701654|FG001|Overall Study|Randomized but Never Treated|1|||
105739875|NCT01522651|364701655|FG002|Overall Study|Randomized but Never Treated|0|||
105739876|NCT01522651|364701656|FG003|Overall Study|Randomized but Never Treated|1|||
105739877|NCT01522651|364701657|FG004|Overall Study|Randomized but Never Treated|1|||
105739878|NCT01993329|364703419|FG000|Period 2|Adverse Event|0|||
105739879|NCT01993329|364703420|FG001|Period 2|Adverse Event|0|||
105739880|NCT01993329|364703421|FG002|Period 2|Adverse Event|0|||
105739881|NCT01993329|364703422|FG003|Period 2|Adverse Event|0|||
105739882|NCT01993329|364703423|FG004|Period 2|Adverse Event|0|||
105739883|NCT01993329|364703424|FG005|Period 2|Adverse Event|1|||
105357736|NCT00791700|363314267|FG002|Overall Study|Lost to Follow-up|4|||
105357737|NCT00791700|363314268|FG003|Overall Study|Lost to Follow-up|6|||
105739884|NCT01993329|364703419|FG000|Wash-out|Personal reasons|0|||
105739885|NCT01993329|364703420|FG001|Wash-out|Personal reasons|1|||
105739886|NCT01993329|364703421|FG002|Wash-out|Personal reasons|0|||
105739887|NCT01993329|364703422|FG003|Wash-out|Personal reasons|0|||
105357738|NCT00791700|363314265|FG000|Overall Study|Adverse Event|0|||
105357739|NCT00791700|363314266|FG001|Overall Study|Adverse Event|0|||
105357740|NCT00791700|363314267|FG002|Overall Study|Adverse Event|1|||
105357741|NCT00791700|363314268|FG003|Overall Study|Adverse Event|1|||
105357742|NCT03231306|363314269|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
105357743|NCT03231306|363314269|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
105357744|NCT03231306|363314269|FG000|Overall Study|Treatment delay > 21 days|2|||
105357745|NCT03231306|363314269|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
105357746|NCT03231306|363314269|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
105357747|NCT03231306|363314269|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
105357748|NCT03231306|363314269|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
105357749|NCT03231306|363314269|FG000|Overall Study|More than 1 Reason|2|||
105357750|NCT00237692|363314270|FG000|Overall Study|Lost to Follow-up|9|||
105357751|NCT00237692|363314271|FG001|Overall Study|Lost to Follow-up|3|||
105357752|NCT00237692|363314272|FG002|Overall Study|Lost to Follow-up|5|||
105357753|NCT00237692|363314273|FG003|Overall Study|Lost to Follow-up|3|||
105357754|NCT00237692|363314270|FG000|Overall Study|Death|1|||
105357755|NCT00237692|363314271|FG001|Overall Study|Death|2|||
105357756|NCT00237692|363314272|FG002|Overall Study|Death|2|||
105357757|NCT00237692|363314273|FG003|Overall Study|Death|3|||
105357758|NCT00237692|363314270|FG000|Overall Study|Excluded - did not meet criteria|4|||
105357759|NCT00237692|363314271|FG001|Overall Study|Excluded - did not meet criteria|3|||
105357760|NCT00237692|363314272|FG002|Overall Study|Excluded - did not meet criteria|5|||
105357761|NCT00237692|363314273|FG003|Overall Study|Excluded - did not meet criteria|9|||
105357762|NCT00237692|363314270|FG000|Overall Study|Withdrawal by Subject|4|||
105357763|NCT00237692|363314271|FG001|Overall Study|Withdrawal by Subject|6|||
105357764|NCT00237692|363314272|FG002|Overall Study|Withdrawal by Subject|10|||
105357765|NCT00237692|363314273|FG003|Overall Study|Withdrawal by Subject|4|||
105357766|NCT05446142|363314277|FG000|Period 2|Adverse Event|1|||
105357767|NCT05446142|363314278|FG001|Period 2|Adverse Event|0|||
105357768|NCT05446142|363314279|FG002|Period 2|Adverse Event|0|||
105357769|NCT05446142|363314280|FG003|Period 2|Adverse Event|0|||
105357770|NCT05446142|363314281|FG004|Period 2|Adverse Event|0|||
105739888|NCT01993329|364703423|FG004|Wash-out|Personal reasons|0|||
105739889|NCT01993329|364703424|FG005|Wash-out|Personal reasons|0|||
105739890|NCT02207530|364703425|FG000|Overall Study|Worsening condition under investigation|78|||
105739891|NCT02207530|364703425|FG000|Overall Study|Patient decision to stop study treatment|5|||
105739892|NCT02207530|364703425|FG000|Overall Study|Adverse Event|8|||
105739893|NCT02795988|364703426|FG000|Phase 1b|Withdrawal by Subject|0|||
105739894|NCT02795988|364703427|FG001|Phase 1b|Withdrawal by Subject|1|||
105739895|NCT02795988|364703428|FG002|Phase 1b|Withdrawal by Subject|0|||
105739896|NCT02795988|364703429|FG003|Phase 1b|Withdrawal by Subject|0|||
105739897|NCT02795988|364703430|FG004|Phase 1b|Withdrawal by Subject|0|||
105739898|NCT02795988|364703431|FG005|Phase 1b|Withdrawal by Subject|0|||
105739899|NCT02795988|364703432|FG006|Phase 1b|Withdrawal by Subject|0|||
105739900|NCT02795988|364703426|FG000|Phase 1b|Death|1|||
105739901|NCT02795988|364703427|FG001|Phase 1b|Death|2|||
105565272|NCT03420781|364066728|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
105739902|NCT02795988|364703428|FG002|Phase 1b|Death|1|||
105357771|NCT05446142|363314282|FG005|Period 2|Adverse Event|0|||
105357772|NCT02098395|363314283|FG000|Overall Study|Protocol Violation|2|||
105739903|NCT02795988|364703429|FG003|Phase 1b|Death|0|||
105739904|NCT02795988|364703430|FG004|Phase 1b|Death|0|||
105739905|NCT02795988|364703431|FG005|Phase 1b|Death|0|||
105357773|NCT02098395|363314284|FG001|Overall Study|Protocol Violation|2|||
105357774|NCT02098395|363314285|FG002|Overall Study|Protocol Violation|0|||
105357775|NCT02098395|363314286|FG003|Overall Study|Protocol Violation|7|||
105357776|NCT02098395|363314283|FG000|Overall Study|Withdrawal by Subject|10|||
105357777|NCT02098395|363314284|FG001|Overall Study|Withdrawal by Subject|10|||
105357778|NCT02098395|363314285|FG002|Overall Study|Withdrawal by Subject|5|||
105357779|NCT02098395|363314286|FG003|Overall Study|Withdrawal by Subject|13|||
105739906|NCT02795988|364703432|FG006|Phase 1b|Death|0|||
105739907|NCT02795988|364703426|FG000|Phase 1b|Physician Decision|0|||
105739908|NCT02795988|364703427|FG001|Phase 1b|Physician Decision|0|||
105739909|NCT02795988|364703428|FG002|Phase 1b|Physician Decision|1|||
105739910|NCT02795988|364703429|FG003|Phase 1b|Physician Decision|0|||
105739911|NCT02795988|364703430|FG004|Phase 1b|Physician Decision|0|||
105739912|NCT02795988|364703431|FG005|Phase 1b|Physician Decision|0|||
105739913|NCT02795988|364703432|FG006|Phase 1b|Physician Decision|0|||
105739914|NCT02795988|364703426|FG000|Phase 1b|Progressive Disease|2|||
105739915|NCT02795988|364703427|FG001|Phase 1b|Progressive Disease|2|||
105739916|NCT02795988|364703428|FG002|Phase 1b|Progressive Disease|0|||
105739917|NCT02795988|364703429|FG003|Phase 1b|Progressive Disease|0|||
105739918|NCT02795988|364703430|FG004|Phase 1b|Progressive Disease|0|||
105739919|NCT02795988|364703431|FG005|Phase 1b|Progressive Disease|0|||
105739920|NCT02795988|364703432|FG006|Phase 1b|Progressive Disease|0|||
105739921|NCT02795988|364703426|FG000|Phase 2|Withdrawal by Subject|0|||
105739922|NCT02795988|364703427|FG001|Phase 2|Withdrawal by Subject|0|||
105739923|NCT02795988|364703428|FG002|Phase 2|Withdrawal by Subject|0|||
105739924|NCT02795988|364703429|FG003|Phase 2|Withdrawal by Subject|1|||
105739925|NCT02795988|364703430|FG004|Phase 2|Withdrawal by Subject|0|||
105739926|NCT02795988|364703431|FG005|Phase 2|Withdrawal by Subject|0|||
105739927|NCT02795988|364703432|FG006|Phase 2|Withdrawal by Subject|0|||
105739928|NCT02795988|364703426|FG000|Phase 2|Death|0|||
105739929|NCT02795988|364703427|FG001|Phase 2|Death|0|||
105739930|NCT02795988|364703428|FG002|Phase 2|Death|0|||
105739931|NCT02795988|364703429|FG003|Phase 2|Death|17|||
105739932|NCT02795988|364703430|FG004|Phase 2|Death|17|||
105739933|NCT02795988|364703431|FG005|Phase 2|Death|0|||
105739934|NCT02795988|364703432|FG006|Phase 2|Death|0|||
105739935|NCT02795988|364703426|FG000|Phase 2|Other|0|||
105739936|NCT02795988|364703427|FG001|Phase 2|Other|0|||
105739937|NCT02795988|364703428|FG002|Phase 2|Other|0|||
105739938|NCT02795988|364703429|FG003|Phase 2|Other|1|||
105357780|NCT02098395|363314283|FG000|Overall Study|Adverse Event|12|||
105357781|NCT02098395|363314284|FG001|Overall Study|Adverse Event|19|||
105357782|NCT02098395|363314285|FG002|Overall Study|Adverse Event|34|||
105739939|NCT02795988|364703430|FG004|Phase 2|Other|0|||
105357783|NCT02098395|363314286|FG003|Overall Study|Adverse Event|2|||
105357784|NCT02098395|363314283|FG000|Overall Study|Lost to Follow-up|2|||
105357785|NCT02098395|363314284|FG001|Overall Study|Lost to Follow-up|1|||
105739940|NCT02795988|364703431|FG005|Phase 2|Other|0|||
105739941|NCT02795988|364703432|FG006|Phase 2|Other|0|||
105739942|NCT02795988|364703426|FG000|Phase 2 Extension|Death|0|||
105739943|NCT02795988|364703427|FG001|Phase 2 Extension|Death|0|||
105739944|NCT02795988|364703428|FG002|Phase 2 Extension|Death|0|||
105739945|NCT02795988|364703429|FG003|Phase 2 Extension|Death|0|||
105357786|NCT02098395|363314285|FG002|Overall Study|Lost to Follow-up|0|||
105357787|NCT02098395|363314286|FG003|Overall Study|Lost to Follow-up|3|||
105357788|NCT02098395|363314283|FG000|Overall Study|Unclassified|0|||
105357789|NCT02098395|363314284|FG001|Overall Study|Unclassified|0|||
105357790|NCT02098395|363314285|FG002|Overall Study|Unclassified|3|||
105357791|NCT02098395|363314286|FG003|Overall Study|Unclassified|2|||
105357792|NCT01386944|363314291|FG000|Overall Study|Adverse Event|26|||
105357793|NCT01386944|363314291|FG000|Overall Study|Lack of Efficacy|14|||
105357794|NCT01386944|363314291|FG000|Overall Study|Lost to Follow-up|8|||
105357795|NCT01386944|363314291|FG000|Overall Study|Unspecified reason|8|||
105357796|NCT00531947|363314292|FG000|Overall Study|Adverse Event|5|||
105357797|NCT00531947|363314293|FG001|Overall Study|Adverse Event|10|||
105357798|NCT00531947|363314292|FG000|Overall Study|Lost to Follow-up|12|||
105357799|NCT00531947|363314293|FG001|Overall Study|Lost to Follow-up|9|||
105357800|NCT00531947|363314292|FG000|Overall Study|Withdrawal by Subject|14|||
105357801|NCT00531947|363314293|FG001|Overall Study|Withdrawal by Subject|19|||
105357802|NCT00531947|363314292|FG000|Overall Study|Protocol Violation|2|||
105357803|NCT00531947|363314293|FG001|Overall Study|Protocol Violation|1|||
105357804|NCT00531947|363314292|FG000|Overall Study|Non-Compliance|4|||
105357805|NCT00531947|363314293|FG001|Overall Study|Non-Compliance|7|||
105357806|NCT00531947|363314292|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
105357807|NCT00531947|363314293|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
105357808|NCT06597084|363314294|FG000|Overall Study|Withdrawal by Subject|4|||
105357809|NCT06597084|363314295|FG001|Overall Study|Withdrawal by Subject|9|||
105357810|NCT06597084|363314294|FG000|Overall Study|Consent was not given by the patient until V2|0|||
105357811|NCT06597084|363314295|FG001|Overall Study|Consent was not given by the patient until V2|3|||
105357812|NCT06597084|363314294|FG000|Overall Study|Physician Decision|1|||
105357813|NCT06597084|363314295|FG001|Overall Study|Physician Decision|0|||
105357814|NCT06597084|363314294|FG000|Overall Study|Adverse Event|3|||
105357815|NCT06597084|363314295|FG001|Overall Study|Adverse Event|2|||
105357816|NCT06597084|363314294|FG000|Overall Study|Death|4|||
105357817|NCT06597084|363314295|FG001|Overall Study|Death|0|||
105357818|NCT06597084|363314294|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
105357819|NCT06597084|363314295|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
105357820|NCT06597084|363314294|FG000|Overall Study|Lost to Follow-up|4|||
105357821|NCT06597084|363314295|FG001|Overall Study|Lost to Follow-up|2|||
105357822|NCT06597084|363314294|FG000|Overall Study|Other. Not specified|1|||
105357823|NCT06597084|363314295|FG001|Overall Study|Other. Not specified|0|||
105357824|NCT02155309|363315612|FG000|Overall Study|Protocol Violation|0|||
105357825|NCT02155309|363315613|FG001|Overall Study|Protocol Violation|0|||
105357826|NCT02155309|363315614|FG002|Overall Study|Protocol Violation|1|||
105357827|NCT03091738|363315618|FG000|Overall Study|Adverse Event|1|||
105357828|NCT03091738|363315618|FG000|Overall Study|Lost to Follow-up|1|||
105357829|NCT02030119|363315623|FG000|Overall Study|Withdrawal by Subject|3|||
105357830|NCT02030119|363315624|FG001|Overall Study|Withdrawal by Subject|1|||
105357831|NCT02030119|363315625|FG002|Overall Study|Withdrawal by Subject|5|||
105357832|NCT02030119|363315626|FG003|Overall Study|Withdrawal by Subject|3|||
105357833|NCT02030119|363315623|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
105357834|NCT02030119|363315624|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
105357835|NCT02030119|363315625|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
105357836|NCT02030119|363315626|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
105357837|NCT02485483|363315632|FG000|Overall Study|Depression at baseline|15|||
105357838|NCT02485483|363315633|FG001|Overall Study|Depression at baseline|0|||
105357839|NCT02485483|363315632|FG000|Overall Study|Discontinued after baseline|39|||
105357840|NCT02485483|363315633|FG001|Overall Study|Discontinued after baseline|0|||
105357841|NCT01724177|363315636|FG000|Overall Study|Adverse Event|8|||
105357842|NCT01724177|363315636|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
105357843|NCT01724177|363315636|FG000|Overall Study|Nervous participant|1|||
105357844|NCT01724177|363315636|FG000|Overall Study|Serious Adverse Event Related|1|||
105357845|NCT00206427|363315640|FG000|Overall Study|Adverse Event|2|||
105357846|NCT01704755|363315644|FG000|Overall Study|Adverse Event|4|||
105357847|NCT01704755|363315645|FG001|Overall Study|Adverse Event|1|||
105357848|NCT01704755|363315644|FG000|Overall Study|Lost to Follow-up|3|||
105357849|NCT01704755|363315645|FG001|Overall Study|Lost to Follow-up|4|||
105357850|NCT01704755|363315644|FG000|Overall Study|Withdrew consent|1|||
105357851|NCT01704755|363315645|FG001|Overall Study|Withdrew consent|1|||
105357852|NCT01704755|363315644|FG000|Overall Study|Other (not specified)|3|||
105357853|NCT01704755|363315645|FG001|Overall Study|Other (not specified)|1|||
105357854|NCT01704755|363315644|FG000|Overall Study|Withdrew consent and personal issues|1|||
105357855|NCT01704755|363315645|FG001|Overall Study|Withdrew consent and personal issues|0|||
105357856|NCT01535443|363315654|FG000|Overall Study|Physician Decision|3|||
105357857|NCT04892446|363315656|FG000|Overall Study|Death|4|||
105357858|NCT04892446|363315657|FG001|Overall Study|Death|4|||
105357859|NCT04892446|363315658|FG002|Overall Study|Death|0|||
105357860|NCT04892446|363315656|FG000|Overall Study|Withdrew consent|3|||
105357861|NCT04892446|363315657|FG001|Overall Study|Withdrew consent|0|||
105357862|NCT04892446|363315658|FG002|Overall Study|Withdrew consent|1|||
105357863|NCT04892446|363315656|FG000|Overall Study|Investigator's discretion|1|||
105357864|NCT04892446|363315657|FG001|Overall Study|Investigator's discretion|1|||
105357865|NCT04892446|363315658|FG002|Overall Study|Investigator's discretion|0|||
105357866|NCT04892446|363315656|FG000|Overall Study|Study terminated by sponsor|0|||
105357867|NCT04892446|363315657|FG001|Overall Study|Study terminated by sponsor|0|||
105357868|NCT04892446|363315658|FG002|Overall Study|Study terminated by sponsor|2|||
105357869|NCT02869893|363315659|FG000|Overall Study|participant aversion to IV|5|||
105357870|NCT02869893|363315659|FG000|Overall Study|participant fear of MRI scanner|2|||
105357871|NCT01563913|363315660|FG000|Overall Study|Physician Decision|1|||
105357872|NCT01563913|363315661|FG001|Overall Study|Physician Decision|0|||
105357873|NCT01563913|363315660|FG000|Overall Study|Spouse Passed Away|1|||
105357874|NCT01563913|363315661|FG001|Overall Study|Spouse Passed Away|0|||
105357875|NCT00705341|363315662|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
105357876|NCT00705341|363315663|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
105357877|NCT00705341|363315664|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
105357878|NCT00705341|363315665|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
105357879|NCT00705341|363315662|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
105357880|NCT00705341|363315663|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
105357881|NCT00705341|363315664|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
105357882|NCT00705341|363315665|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
105357883|NCT00158262|363315668|FG000|Overall Study|Lost to Follow-up|1|||
105357884|NCT00158262|363315669|FG001|Overall Study|Lost to Follow-up|1|||
105357885|NCT00436826|363315674|FG000|Double Blind Period (DBP)|Adverse Event|2|||
105357886|NCT00436826|363315675|FG001|Double Blind Period (DBP)|Adverse Event|0|||
105357887|NCT00436826|363315676|FG002|Double Blind Period (DBP)|Adverse Event|0|||
105357888|NCT00436826|363315677|FG003|Double Blind Period (DBP)|Adverse Event|0|||
105357889|NCT00436826|363315678|FG004|Double Blind Period (DBP)|Adverse Event|0|||
105357890|NCT00436826|363315679|FG005|Double Blind Period (DBP)|Adverse Event|0|||
105357891|NCT00436826|363315674|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
105357892|NCT00436826|363315675|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
105357893|NCT00436826|363315676|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
105357894|NCT00436826|363315677|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
105357895|NCT00436826|363315678|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
105357896|NCT00436826|363315679|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
105357897|NCT00436826|363315674|FG000|Double Blind Period (DBP)|Other|10|||
105357898|NCT00436826|363315675|FG001|Double Blind Period (DBP)|Other|11|||
105357899|NCT00436826|363315676|FG002|Double Blind Period (DBP)|Other|0|||
105357900|NCT00436826|363315677|FG003|Double Blind Period (DBP)|Other|0|||
105357901|NCT00436826|363315678|FG004|Double Blind Period (DBP)|Other|0|||
105357902|NCT00436826|363315679|FG005|Double Blind Period (DBP)|Other|0|||
105357903|NCT00436826|363315674|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
105357904|NCT00436826|363315675|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
105357905|NCT00436826|363315676|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
105357906|NCT00436826|363315677|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
105357907|NCT00436826|363315678|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
105357908|NCT00436826|363315679|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
105357909|NCT00436826|363315674|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
105357910|NCT00436826|363315675|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
105357911|NCT00436826|363315676|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
105357912|NCT00436826|363315677|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
105357913|NCT00436826|363315678|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
105357914|NCT00436826|363315679|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
105357915|NCT00436826|363315674|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
105357916|NCT00436826|363315675|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
105357917|NCT00436826|363315676|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
105357918|NCT00436826|363315677|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
105357919|NCT00436826|363315678|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
105357920|NCT00436826|363315679|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
105357921|NCT00784719|363315682|FG000|Overall Study|Adverse Event|0|||
105357922|NCT00784719|363315683|FG001|Overall Study|Adverse Event|2|||
105357923|NCT00784719|363315684|FG002|Overall Study|Adverse Event|0|||
105482761|NCT01239732|363778988|FG000|Overall Study|Participant non compliance|5|||
105482762|NCT01239732|363778988|FG000|Overall Study|Study termination by sponsor|2|||
105482763|NCT01239732|363778988|FG000|Overall Study|Investigator's decision|4|||
105357924|NCT00784719|363315685|FG003|Overall Study|Adverse Event|0|||
105357925|NCT00784719|363315686|FG004|Overall Study|Adverse Event|1|||
105357926|NCT00784719|363315687|FG005|Overall Study|Adverse Event|1|||
105357927|NCT00784719|363315688|FG006|Overall Study|Adverse Event|1|||
105357928|NCT00784719|363315682|FG000|Overall Study|Lost to Follow-up|0|||
105357929|NCT00784719|363315683|FG001|Overall Study|Lost to Follow-up|0|||
105357930|NCT00784719|363315684|FG002|Overall Study|Lost to Follow-up|0|||
105739946|NCT02795988|364703430|FG004|Phase 2 Extension|Death|0|||
105739947|NCT02795988|364703431|FG005|Phase 2 Extension|Death|5|||
105739948|NCT02795988|364703432|FG006|Phase 2 Extension|Death|6|||
105739949|NCT02795988|364703426|FG000|Phase 2 Extension|Other reasons|0|||
105739950|NCT02795988|364703427|FG001|Phase 2 Extension|Other reasons|0|||
105739951|NCT02795988|364703428|FG002|Phase 2 Extension|Other reasons|0|||
105357931|NCT00784719|363315685|FG003|Overall Study|Lost to Follow-up|0|||
105357932|NCT00784719|363315686|FG004|Overall Study|Lost to Follow-up|1|||
105357933|NCT00784719|363315687|FG005|Overall Study|Lost to Follow-up|1|||
105357934|NCT00784719|363315688|FG006|Overall Study|Lost to Follow-up|0|||
105357935|NCT00784719|363315682|FG000|Overall Study|Other|2|||
105357936|NCT00784719|363315683|FG001|Overall Study|Other|1|||
105357937|NCT00784719|363315684|FG002|Overall Study|Other|1|||
105357938|NCT00784719|363315685|FG003|Overall Study|Other|0|||
105357939|NCT00784719|363315686|FG004|Overall Study|Other|2|||
105357940|NCT00784719|363315687|FG005|Overall Study|Other|1|||
105357941|NCT00784719|363315688|FG006|Overall Study|Other|3|||
105357942|NCT00784719|363315682|FG000|Overall Study|Withdrawal by Subject|1|||
105357943|NCT00784719|363315683|FG001|Overall Study|Withdrawal by Subject|0|||
105357944|NCT00784719|363315684|FG002|Overall Study|Withdrawal by Subject|0|||
105357945|NCT00784719|363315685|FG003|Overall Study|Withdrawal by Subject|0|||
105357946|NCT00784719|363315686|FG004|Overall Study|Withdrawal by Subject|2|||
105357947|NCT00784719|363315687|FG005|Overall Study|Withdrawal by Subject|0|||
105357948|NCT00784719|363315688|FG006|Overall Study|Withdrawal by Subject|1|||
105357949|NCT02497404|363315689|FG000|Overall Study|Adverse Event|1|||
105357950|NCT04978337|363315692|FG000|Overall Study|Withdrawal by Subject|0|||
105357951|NCT04978337|363315693|FG001|Overall Study|Withdrawal by Subject|1|||
105357952|NCT02588092|363315697|FG000|Overall Study|Death|4|||
105357953|NCT02588092|363315698|FG001|Overall Study|Death|3|||
105357954|NCT02588092|363315699|FG002|Overall Study|Death|3|||
105357955|NCT02588092|363315700|FG003|Overall Study|Death|3|||
105357956|NCT02588092|363315701|FG004|Overall Study|Death|2|||
105357957|NCT02588092|363315702|FG005|Overall Study|Death|2|||
105357958|NCT02588092|363315703|FG006|Overall Study|Death|2|||
105357959|NCT02588092|363315704|FG007|Overall Study|Death|1|||
105357960|NCT02588092|363315705|FG008|Overall Study|Death|5|||
105357961|NCT02588092|363315706|FG009|Overall Study|Death|2|||
105357962|NCT02588092|363315697|FG000|Overall Study|Withdrawal by Subject|0|||
105739952|NCT02795988|364703429|FG003|Phase 2 Extension|Other reasons|0|||
105739953|NCT02795988|364703430|FG004|Phase 2 Extension|Other reasons|0|||
105739954|NCT02795988|364703431|FG005|Phase 2 Extension|Other reasons|2|||
105739955|NCT02795988|364703432|FG006|Phase 2 Extension|Other reasons|1|||
105739956|NCT02341014|364703433|FG000|Overall Study|Adverse Event|0|||
105739957|NCT02341014|364703434|FG001|Overall Study|Adverse Event|1|||
105739958|NCT02341014|364703435|FG002|Overall Study|Adverse Event|0|||
105739959|NCT02341014|364703436|FG003|Overall Study|Adverse Event|0|||
105739960|NCT02341014|364703437|FG004|Overall Study|Adverse Event|2|||
105739961|NCT00273858|364703444|FG000|Overall Study|Not completed 24 month observation time|334|||
105739962|NCT00273858|364703444|FG000|Overall Study|Lost to Follow-up|101|||
105739963|NCT00273858|364703444|FG000|Overall Study|Withdrawal by Subject|21|||
105739964|NCT00273858|364703444|FG000|Overall Study|Adverse Event|81|||
105739965|NCT01585961|364703445|FG000|Overall Study|Death|6|||
105739966|NCT01585961|364703445|FG000|Overall Study|Physician Decision|1|||
105739967|NCT01585961|364703445|FG000|Overall Study|Decision to use non-study catheter|1|||
105739968|NCT01585961|364703445|FG000|Overall Study|Withdrawal by Subject|1|||
105739969|NCT01585961|364703445|FG000|Overall Study|Lost to Follow-up|23|||
105739970|NCT01585961|364703445|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
105739971|NCT00109733|364703446|FG000|Overall Study|Protocol Violation|0|||
105739972|NCT00109733|364703447|FG001|Overall Study|Protocol Violation|1|||
105739973|NCT00109733|364703446|FG000|Overall Study|Stopped taking study drug|1|||
105739974|NCT00109733|364703447|FG001|Overall Study|Stopped taking study drug|1|||
105357963|NCT02588092|363315698|FG001|Overall Study|Withdrawal by Subject|0|||
105357964|NCT02588092|363315699|FG002|Overall Study|Withdrawal by Subject|0|||
105357965|NCT02588092|363315700|FG003|Overall Study|Withdrawal by Subject|0|||
105739975|NCT00109733|364703446|FG000|Overall Study|Non-compliant|0|||
105739976|NCT00109733|364703447|FG001|Overall Study|Non-compliant|1|||
105739977|NCT00109733|364703446|FG000|Overall Study|Could not commit time for study|1|||
105739978|NCT00109733|364703447|FG001|Overall Study|Could not commit time for study|1|||
105357966|NCT02588092|363315701|FG004|Overall Study|Withdrawal by Subject|0|||
105357967|NCT02588092|363315702|FG005|Overall Study|Withdrawal by Subject|1|||
105357968|NCT02588092|363315703|FG006|Overall Study|Withdrawal by Subject|1|||
105357969|NCT02588092|363315704|FG007|Overall Study|Withdrawal by Subject|2|||
105357970|NCT02588092|363315705|FG008|Overall Study|Withdrawal by Subject|0|||
105357971|NCT02588092|363315706|FG009|Overall Study|Withdrawal by Subject|0|||
105739979|NCT01671085|364703455|FG000|Overall Study|Withdrawal by Subject|1|||
105739980|NCT01671085|364703456|FG001|Overall Study|Withdrawal by Subject|0|||
105739981|NCT00553059|364703457|FG000|Overall Study|Deemed ineligible|1|||
105739982|NCT00553059|364703458|FG001|Overall Study|Deemed ineligible|1|||
105739983|NCT00553059|364703457|FG000|Overall Study|Drug supply not available|0|||
105739984|NCT00553059|364703458|FG001|Overall Study|Drug supply not available|1|||
105739985|NCT06094296|364703459|FG000|Overall Study|Progressive Disease|1|||
105739986|NCT06094296|364703460|FG001|Overall Study|Progressive Disease|0|||
105739987|NCT06094296|364703461|FG002|Overall Study|Progressive Disease|0|||
105739988|NCT06094296|364703462|FG003|Overall Study|Progressive Disease|0|||
105739989|NCT00986258|364703463|FG000|Observation Period|Not eligible to be dosed|11|||
105739990|NCT00986258|364703463|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
105739991|NCT00986258|364703463|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
105739992|NCT00986258|364703463|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
105739993|NCT00986258|364703463|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
105739994|NCT00986258|364703463|FG000|Titration and Optimal Dose Period|Other|1|||
105739995|NCT00986258|364703463|FG000|Maintenance Period|Adverse Event|5|||
105739996|NCT00986258|364703463|FG000|Maintenance Period|Lack of Efficacy|2|||
105357972|NCT02588092|363315697|FG000|Overall Study|Started Another Treatment|0|||
105357973|NCT02588092|363315698|FG001|Overall Study|Started Another Treatment|0|||
105357974|NCT02588092|363315699|FG002|Overall Study|Started Another Treatment|0|||
105357975|NCT02588092|363315700|FG003|Overall Study|Started Another Treatment|0|||
105357976|NCT02588092|363315701|FG004|Overall Study|Started Another Treatment|1|||
105357977|NCT02588092|363315702|FG005|Overall Study|Started Another Treatment|0|||
105357978|NCT02588092|363315703|FG006|Overall Study|Started Another Treatment|0|||
105357979|NCT02588092|363315704|FG007|Overall Study|Started Another Treatment|1|||
105357980|NCT02588092|363315705|FG008|Overall Study|Started Another Treatment|0|||
105357981|NCT02588092|363315706|FG009|Overall Study|Started Another Treatment|0|||
105357982|NCT02588092|363315697|FG000|Overall Study|Sponsor Decision|0|||
105357983|NCT02588092|363315698|FG001|Overall Study|Sponsor Decision|0|||
105357984|NCT02588092|363315699|FG002|Overall Study|Sponsor Decision|0|||
105357985|NCT02588092|363315700|FG003|Overall Study|Sponsor Decision|0|||
105357986|NCT02588092|363315701|FG004|Overall Study|Sponsor Decision|0|||
105357987|NCT02588092|363315702|FG005|Overall Study|Sponsor Decision|0|||
105357988|NCT02588092|363315703|FG006|Overall Study|Sponsor Decision|0|||
105357989|NCT02588092|363315704|FG007|Overall Study|Sponsor Decision|0|||
105357990|NCT02588092|363315705|FG008|Overall Study|Sponsor Decision|1|||
105357991|NCT02588092|363315706|FG009|Overall Study|Sponsor Decision|1|||
105357992|NCT01118663|363315718|FG000|Overall Study|Adverse Event|2|||
105357993|NCT01118663|363315719|FG001|Overall Study|Adverse Event|1|||
105357994|NCT01118663|363315718|FG000|Overall Study|Withdrawal by Subject|0|||
105357995|NCT01118663|363315719|FG001|Overall Study|Withdrawal by Subject|1|||
105357996|NCT03046953|363315720|FG000|Overall Study|Relapse/progressive disease|21|||
105357997|NCT03046953|363315720|FG000|Overall Study|Death|2|||
105357998|NCT03046953|363315720|FG000|Overall Study|Withdrawal by Subject|3|||
105357999|NCT01189461|363315721|FG000|Overall Study|Lack of Efficacy|13|||
105358000|NCT01189461|363315721|FG000|Overall Study|Lost to Follow-up|1|||
105358001|NCT01189461|363315721|FG000|Overall Study|Withdrawal by Subject|6|||
105358002|NCT01189461|363315721|FG000|Overall Study|Protocol Violation|1|||
105358003|NCT01189461|363315721|FG000|Overall Study|Adverse Event|2|||
105358004|NCT01189461|363315721|FG000|Overall Study|Did not meet entrance criteria|3|||
105358005|NCT01189461|363315721|FG000|Overall Study|Other|8|||
105358006|NCT00420628|363315722|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
105358007|NCT00420628|363315723|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
105358008|NCT00420628|363315722|FG000|Overall Study|Lost to Follow-up|3|||
105358009|NCT00420628|363315723|FG001|Overall Study|Lost to Follow-up|2|||
105358010|NCT00420628|363315722|FG000|Overall Study|Adverse Event|1|||
105358011|NCT00420628|363315723|FG001|Overall Study|Adverse Event|0|||
105358012|NCT01903993|363315726|FG000|Overall Study|Death|118|||
105358013|NCT01903993|363315727|FG001|Overall Study|Death|121|||
105358014|NCT01903993|363315726|FG000|Overall Study|Withdrawal by Subject|15|||
105358015|NCT01903993|363315727|FG001|Overall Study|Withdrawal by Subject|4|||
105358016|NCT01903993|363315726|FG000|Overall Study|Lost to Follow-up|2|||
105358017|NCT01903993|363315727|FG001|Overall Study|Lost to Follow-up|3|||
105358018|NCT01903993|363315726|FG000|Overall Study|Study Terminated by Sponsor|8|||
105739997|NCT00986258|364703463|FG000|Maintenance Period|Withdrawal by Subject|2|||
105739998|NCT03332667|364703464|FG000|Overall Study|Adverse Event|0|||
105739999|NCT03332667|364703465|FG001|Overall Study|Adverse Event|0|||
105740000|NCT03332667|364703466|FG002|Overall Study|Adverse Event|2|||
105358019|NCT01903993|363315727|FG001|Overall Study|Study Terminated by Sponsor|14|||
105358020|NCT01903993|363315726|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
105358021|NCT01903993|363315727|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
105358022|NCT02385110|363315731|FG000|Overall Study|Early Death|1|||
105358023|NCT02385110|363315732|FG001|Overall Study|Early Death|0|||
105358024|NCT01066871|363315737|FG000|Overall Study|Lost to Follow-up|0|||
105740001|NCT03332667|364703467|FG003|Overall Study|Adverse Event|1|||
105740002|NCT03332667|364703464|FG000|Overall Study|Withdrawal by Subject|2|||
105740003|NCT03332667|364703465|FG001|Overall Study|Withdrawal by Subject|1|||
105740004|NCT03332667|364703466|FG002|Overall Study|Withdrawal by Subject|5|||
105740005|NCT03332667|364703467|FG003|Overall Study|Withdrawal by Subject|1|||
105358025|NCT01066871|363315738|FG001|Overall Study|Lost to Follow-up|2|||
105358026|NCT01066871|363315739|FG002|Overall Study|Lost to Follow-up|2|||
105358027|NCT01066871|363315740|FG003|Overall Study|Lost to Follow-up|0|||
105740006|NCT03332667|364703464|FG000|Overall Study|Disease Progression or Relapse|2|||
105800024|NCT01335399|364926337|FG000|Pre-treatment Period|Participant request to discontinue|0|||
105740007|NCT03332667|364703465|FG001|Overall Study|Disease Progression or Relapse|1|||
105740008|NCT03332667|364703466|FG002|Overall Study|Disease Progression or Relapse|3|||
105740009|NCT03332667|364703467|FG003|Overall Study|Disease Progression or Relapse|0|||
105740010|NCT03332667|364703464|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
105740011|NCT03332667|364703465|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
105740012|NCT03332667|364703466|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
105740013|NCT03332667|364703467|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
105740014|NCT03332667|364703464|FG000|Overall Study|No Treatment Received|0|||
105740015|NCT03332667|364703465|FG001|Overall Study|No Treatment Received|0|||
105740016|NCT03332667|364703466|FG002|Overall Study|No Treatment Received|1|||
105740017|NCT03332667|364703467|FG003|Overall Study|No Treatment Received|0|||
105740018|NCT00117338|364703468|FG000|Overall Study|Adverse Event|0|||
105740019|NCT00117338|364703469|FG001|Overall Study|Adverse Event|1|||
105740020|NCT00117338|364703468|FG000|Overall Study|Protocol Violation|3|||
105740021|NCT00117338|364703469|FG001|Overall Study|Protocol Violation|2|||
105740022|NCT00117338|364703468|FG000|Overall Study|Withdrawal by Subject|1|||
105740023|NCT00117338|364703469|FG001|Overall Study|Withdrawal by Subject|0|||
105740024|NCT00117338|364703468|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
105740025|NCT00117338|364703469|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
105740026|NCT00117338|364703468|FG000|Overall Study|Lack of Efficacy|0|||
105740027|NCT00117338|364703469|FG001|Overall Study|Lack of Efficacy|1|||
105740028|NCT02616029|364703471|FG000|Overall Study|Adverse Event|1|||
105740029|NCT02616029|364703472|FG001|Overall Study|Adverse Event|0|||
105740030|NCT02616029|364703471|FG000|Overall Study|Death|0|||
105740031|NCT02616029|364703472|FG001|Overall Study|Death|1|||
105740032|NCT02616029|364703471|FG000|Overall Study|Protocol Violation|1|||
105740033|NCT02616029|364703472|FG001|Overall Study|Protocol Violation|0|||
105740034|NCT02616029|364703471|FG000|Overall Study|Withdrew Consent|1|||
105740035|NCT02616029|364703472|FG001|Overall Study|Withdrew Consent|0|||
105740036|NCT02616029|364703471|FG000|Overall Study|Enrolled and Never Treated|1|||
105740037|NCT02616029|364703472|FG001|Overall Study|Enrolled and Never Treated|1|||
105740038|NCT04429503|364703473|FG000|Overall Study|Non-compliance with protocol by the subject|2|||
105740039|NCT04429503|364703474|FG001|Overall Study|Non-compliance with protocol by the subject|1|||
105740040|NCT04429503|364703475|FG002|Overall Study|Non-compliance with protocol by the subject|0|||
105740041|NCT04429503|364703473|FG000|Overall Study|Adverse Event|1|||
105740042|NCT04429503|364703474|FG001|Overall Study|Adverse Event|9|||
105740043|NCT04429503|364703475|FG002|Overall Study|Adverse Event|2|||
105740044|NCT04429503|364703473|FG000|Overall Study|Decision by the investigator/sponsor|2|||
105740045|NCT04429503|364703474|FG001|Overall Study|Decision by the investigator/sponsor|9|||
105740046|NCT04429503|364703475|FG002|Overall Study|Decision by the investigator/sponsor|3|||
105740047|NCT04429503|364703473|FG000|Overall Study|Withdrawal by Subject|9|||
105740048|NCT04429503|364703474|FG001|Overall Study|Withdrawal by Subject|17|||
105740049|NCT04429503|364703475|FG002|Overall Study|Withdrawal by Subject|8|||
105740050|NCT04429503|364703473|FG000|Overall Study|Lost to Follow-up|5|||
105740051|NCT04429503|364703474|FG001|Overall Study|Lost to Follow-up|19|||
105482764|NCT01239732|363778988|FG000|Overall Study|Treatment failure|2|||
105482765|NCT01239732|363778988|FG000|Overall Study|Other|19|||
105482766|NCT02730793|363778990|FG000|Overall Study|Physician Decision|0|||
105482767|NCT02730793|363778991|FG001|Overall Study|Physician Decision|1|||
105482768|NCT02730793|363778990|FG000|Overall Study|Withdrawal by Subject|0|||
105740052|NCT04429503|364703475|FG002|Overall Study|Lost to Follow-up|7|||
105740053|NCT04429503|364703473|FG000|Overall Study|Death|9|||
105740054|NCT04429503|364703474|FG001|Overall Study|Death|18|||
105740055|NCT04429503|364703475|FG002|Overall Study|Death|5|||
105740056|NCT01703819|364703476|FG000|Overall Study|Adverse Event|0|||
105740057|NCT01703819|364703477|FG001|Overall Study|Adverse Event|1|||
105740058|NCT01703819|364703476|FG000|Overall Study|Withdrawal by Subject|0|||
105740059|NCT01703819|364703477|FG001|Overall Study|Withdrawal by Subject|1|||
105740060|NCT02145156|364703479|FG000|Overall Study|No match to vaccination records|60|||
105740061|NCT02145156|364703480|FG001|Overall Study|No match to vaccination records|52|||
105358028|NCT01066871|363315737|FG000|Overall Study|Protocol Violation|1|||
105358029|NCT01066871|363315738|FG001|Overall Study|Protocol Violation|0|||
105358030|NCT01066871|363315739|FG002|Overall Study|Protocol Violation|3|||
105358031|NCT01066871|363315740|FG003|Overall Study|Protocol Violation|2|||
105358032|NCT01066871|363315737|FG000|Overall Study|Lack of Efficacy|0|||
105358033|NCT01066871|363315738|FG001|Overall Study|Lack of Efficacy|0|||
105358034|NCT01066871|363315739|FG002|Overall Study|Lack of Efficacy|0|||
105358035|NCT01066871|363315740|FG003|Overall Study|Lack of Efficacy|1|||
105358036|NCT01066871|363315737|FG000|Overall Study|Withdrawal by Subject|3|||
105358037|NCT01066871|363315738|FG001|Overall Study|Withdrawal by Subject|1|||
105740062|NCT02145156|364703481|FG002|Overall Study|No match to vaccination records|41|||
105740063|NCT02202031|364703484|FG000|Overall Study|Lost to Follow-up|1|||
105740064|NCT02202031|364703485|FG001|Overall Study|Lost to Follow-up|0|||
105740065|NCT02202031|364703484|FG000|Overall Study|Too Busy|1|||
105740066|NCT02202031|364703485|FG001|Overall Study|Too Busy|3|||
105358038|NCT01066871|363315739|FG002|Overall Study|Withdrawal by Subject|0|||
105358039|NCT01066871|363315740|FG003|Overall Study|Withdrawal by Subject|0|||
105358040|NCT01066871|363315737|FG000|Overall Study|Other|0|||
105358041|NCT01066871|363315738|FG001|Overall Study|Other|2|||
105358042|NCT01066871|363315739|FG002|Overall Study|Other|1|||
105358043|NCT01066871|363315740|FG003|Overall Study|Other|2|||
105358044|NCT02029274|363315741|FG000|Overall Study|Adverse Event|1|||
105358045|NCT02029274|363315742|FG001|Overall Study|Adverse Event|0|||
105358046|NCT02029274|363315743|FG002|Overall Study|Adverse Event|2|||
105358047|NCT02029274|363315744|FG003|Overall Study|Adverse Event|2|||
105358048|NCT02823470|363317018|FG000|Overall Study|Adverse Event|1|||
105358049|NCT02823470|363317019|FG001|Overall Study|Adverse Event|0|||
105358050|NCT02823470|363317018|FG000|Overall Study|Study terminated by sponsor|8|||
105358051|NCT02823470|363317019|FG001|Overall Study|Study terminated by sponsor|15|||
105358052|NCT02748057|363317023|FG000|Overall Study|Adverse Event|1|||
105358053|NCT02748057|363317024|FG001|Overall Study|Adverse Event|0|||
105358054|NCT02748057|363317023|FG000|Overall Study|Physician Decision|0|||
105358055|NCT02748057|363317024|FG001|Overall Study|Physician Decision|1|||
105358056|NCT02748057|363317023|FG000|Overall Study|Protocol Violation|2|||
105358057|NCT02748057|363317024|FG001|Overall Study|Protocol Violation|1|||
105358058|NCT02748057|363317023|FG000|Overall Study|Participant Moved|1|||
105358059|NCT02748057|363317024|FG001|Overall Study|Participant Moved|0|||
105358060|NCT02748057|363317023|FG000|Overall Study|Withdrawal by Subject|1|||
105358061|NCT02748057|363317024|FG001|Overall Study|Withdrawal by Subject|0|||
105358062|NCT00391872|363317027|FG000|Overall Study|Protocol Violation|7|||
105358063|NCT00391872|363317028|FG001|Overall Study|Protocol Violation|2|||
105358064|NCT00391872|363317027|FG000|Overall Study|Withdrawal by Subject|296|||
105358065|NCT00391872|363317028|FG001|Overall Study|Withdrawal by Subject|249|||
105358066|NCT00391872|363317027|FG000|Overall Study|Reason unknown|2|||
105358067|NCT00391872|363317028|FG001|Overall Study|Reason unknown|4|||
105358068|NCT00391872|363317027|FG000|Overall Study|Lost to Follow-up|2|||
105358069|NCT00391872|363317028|FG001|Overall Study|Lost to Follow-up|0|||
105358070|NCT01239394|363317029|FG000|Overall Study|Adverse Event|1|||
105358071|NCT00758498|363317031|FG000|Overall Study|Adverse Event|2|||
105358072|NCT00758498|363317032|FG001|Overall Study|Adverse Event|2|||
105358073|NCT00758498|363317033|FG002|Overall Study|Adverse Event|3|||
105358074|NCT00758498|363317031|FG000|Overall Study|Subject legally detained out of state|1|||
105358075|NCT00758498|363317032|FG001|Overall Study|Subject legally detained out of state|0|||
105358076|NCT00758498|363317033|FG002|Overall Study|Subject legally detained out of state|0|||
105358077|NCT00758498|363317031|FG000|Overall Study|Withdrawal by Subject|0|||
105358078|NCT00758498|363317032|FG001|Overall Study|Withdrawal by Subject|0|||
105358079|NCT00758498|363317033|FG002|Overall Study|Withdrawal by Subject|1|||
105358080|NCT00758498|363317031|FG000|Overall Study|Noncompliance to study procedures|0|||
105358081|NCT00758498|363317032|FG001|Overall Study|Noncompliance to study procedures|0|||
105358082|NCT00758498|363317033|FG002|Overall Study|Noncompliance to study procedures|1|||
105358083|NCT02630563|363317034|FG000|Overall Study|Administrative|1|||
105358084|NCT02239640|363317035|FG000|Overall Study|Withdrawal by Subject|3|||
105358085|NCT02239640|363317035|FG000|Overall Study|Lost to Follow-up|72|||
105358086|NCT02239640|363317035|FG000|Overall Study|Death|142|||
105358087|NCT02061813|363317036|FG000|Overall Study|Withdrawal by Subject|1|||
105358088|NCT02061813|363317036|FG000|Overall Study|Protocol Violation|2|||
105358089|NCT05359952|363317040|FG000|Overall Study|Lost to Follow-up|1|||
105358090|NCT05359952|363317041|FG001|Overall Study|Lost to Follow-up|0|||
105358091|NCT02258659|363317042|FG000|Overall Study|Withdrawal by Subject|1|||
105358092|NCT01882803|363317044|FG000|Overall Study|Disease Progression|1|||
105358093|NCT01882803|363317044|FG000|Overall Study|Withdrawal by Subject|9|||
105358094|NCT01882803|363317044|FG000|Overall Study|Death|68|||
105358095|NCT01882803|363317044|FG000|Overall Study|Physician Decision|3|||
105358096|NCT01882803|363317044|FG000|Overall Study|Lost to Follow-up|3|||
105358097|NCT01882803|363317044|FG000|Overall Study|Follow-up Completed|39|||
105358098|NCT01882803|363317044|FG000|Overall Study|Study Terminated by the Sponsor|6|||
105565273|NCT03420781|364066729|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
105740067|NCT02202031|364703484|FG000|Overall Study|Illness/Medical Reason|0|||
105358099|NCT01768559|363317045|FG000|Overall Study|Randomized but not treated|0|||
105358100|NCT01768559|363317046|FG001|Overall Study|Randomized but not treated|0|||
105358101|NCT01768559|363317047|FG002|Overall Study|Randomized but not treated|1|||
105358102|NCT01768559|363317045|FG000|Overall Study|Adverse Event|15|||
105740068|NCT02202031|364703485|FG001|Overall Study|Illness/Medical Reason|2|||
105358103|NCT01768559|363317046|FG001|Overall Study|Adverse Event|2|||
105358104|NCT01768559|363317047|FG002|Overall Study|Adverse Event|5|||
105358105|NCT01768559|363317045|FG000|Overall Study|Lack of Efficacy|6|||
105358106|NCT01768559|363317046|FG001|Overall Study|Lack of Efficacy|4|||
105358107|NCT01768559|363317047|FG002|Overall Study|Lack of Efficacy|0|||
105740069|NCT02202031|364703484|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
105740070|NCT02202031|364703485|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
105740071|NCT02698423|364703488|FG000|Overall Study|Lost to Follow-up|19|||
105740072|NCT02698423|364703489|FG001|Overall Study|Lost to Follow-up|24|||
105740073|NCT03634072|364703490|FG000|Overall Study|Early termination of overall study|1|||
105740074|NCT03634072|364703491|FG001|Overall Study|Early termination of overall study|0|||
105740075|NCT01952015|364703493|FG000|Induction|Protocol Violation|1|||
105740076|NCT01952015|364703493|FG000|Maintenance|Adverse Event|2|||
105740077|NCT01952015|364703493|FG000|Treatment Period 3|Physician Decision|9|||
105740078|NCT02239094|364703494|FG000|Overall Study|Withdrawal by Subject|1|||
105740079|NCT02239094|364703494|FG000|Overall Study|Remitted before started|1|||
105740080|NCT03184701|364703495|FG000|Overall Study|Death|3|||
105482769|NCT02730793|363778991|FG001|Overall Study|Withdrawal by Subject|1|||
105482770|NCT01284491|363778992|FG000|Overall Study|Study termination|13|||
105482771|NCT04658940|363778994|FG000|Overall Study|Withdrawal by Subject|1|||
105482772|NCT00483756|363779006|FG000|Overall Study|Death|2|||
105482773|NCT00483756|363779007|FG001|Overall Study|Death|0|||
105482774|NCT00483756|363779008|FG002|Overall Study|Death|1|||
105482775|NCT00483756|363779006|FG000|Overall Study|Adverse Event|19|||
105482776|NCT00483756|363779007|FG001|Overall Study|Adverse Event|38|||
105482777|NCT00483756|363779008|FG002|Overall Study|Adverse Event|40|||
105482778|NCT00483756|363779006|FG000|Overall Study|Lack of Efficacy|1|||
105482779|NCT00483756|363779007|FG001|Overall Study|Lack of Efficacy|0|||
105482780|NCT00483756|363779008|FG002|Overall Study|Lack of Efficacy|0|||
105482781|NCT00483756|363779006|FG000|Overall Study|Lost to Follow-up|3|||
105482782|NCT00483756|363779007|FG001|Overall Study|Lost to Follow-up|1|||
105482783|NCT00483756|363779008|FG002|Overall Study|Lost to Follow-up|0|||
105482784|NCT00483756|363779006|FG000|Overall Study|Withdrawal by Subject|5|||
105482785|NCT00483756|363779007|FG001|Overall Study|Withdrawal by Subject|3|||
105482786|NCT00483756|363779008|FG002|Overall Study|Withdrawal by Subject|4|||
105358108|NCT01768559|363317045|FG000|Overall Study|Poor compliance to protocol|0|||
105358109|NCT01768559|363317046|FG001|Overall Study|Poor compliance to protocol|3|||
105358110|NCT01768559|363317047|FG002|Overall Study|Poor compliance to protocol|2|||
105358111|NCT01768559|363317045|FG000|Overall Study|Other than specified|9|||
105358112|NCT01768559|363317046|FG001|Overall Study|Other than specified|8|||
105358113|NCT01768559|363317047|FG002|Overall Study|Other than specified|5|||
105358114|NCT01421641|363317050|FG000|Overall Study|Protocol Violation|2|||
105358115|NCT01421641|363317051|FG001|Overall Study|Protocol Violation|2|||
105358116|NCT04676724|363317053|FG000|Overall Study|Adverse Event|2|||
105358117|NCT04676724|363317054|FG001|Overall Study|Adverse Event|0|||
105358118|NCT04676724|363317053|FG000|Overall Study|Lost to Follow-up|1|||
105358119|NCT04676724|363317054|FG001|Overall Study|Lost to Follow-up|0|||
105358120|NCT04676724|363317053|FG000|Overall Study|Physician Decision|0|||
105358121|NCT04676724|363317054|FG001|Overall Study|Physician Decision|1|||
105358122|NCT04676724|363317053|FG000|Overall Study|Withdrawal by Subject|3|||
105358123|NCT04676724|363317054|FG001|Overall Study|Withdrawal by Subject|2|||
105358124|NCT04501952|363317059|FG000|Overall Study|Adverse Event|0|||
105358125|NCT04501952|363317060|FG001|Overall Study|Adverse Event|3|||
105358126|NCT04501952|363317059|FG000|Overall Study|Investigator's Discretion|0|||
105358127|NCT04501952|363317060|FG001|Overall Study|Investigator's Discretion|1|||
105358128|NCT04501952|363317059|FG000|Overall Study|Protocol Violation|1|||
105358129|NCT04501952|363317060|FG001|Overall Study|Protocol Violation|1|||
105358130|NCT04501952|363317059|FG000|Overall Study|Withdrew Consent|5|||
105358131|NCT04501952|363317060|FG001|Overall Study|Withdrew Consent|4|||
105358132|NCT04501952|363317059|FG000|Overall Study|Lost to Follow-up|7|||
105358133|NCT04501952|363317060|FG001|Overall Study|Lost to Follow-up|2|||
105358134|NCT04501952|363317059|FG000|Overall Study|Randomized and Never Treated|13|||
105358135|NCT04501952|363317060|FG001|Overall Study|Randomized and Never Treated|9|||
105358136|NCT03061188|363317061|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
105358137|NCT03061188|363317062|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
105358138|NCT03061188|363317063|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
105358139|NCT03061188|363317064|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
105358140|NCT03061188|363317061|FG000|On Follow-up for 3 Years|Death|0|||
105358141|NCT03061188|363317062|FG001|On Follow-up for 3 Years|Death|3|||
105358142|NCT03061188|363317063|FG002|On Follow-up for 3 Years|Death|5|||
105358143|NCT03061188|363317064|FG003|On Follow-up for 3 Years|Death|4|||
105358144|NCT03061188|363317061|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
105358145|NCT03061188|363317062|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
105358146|NCT03061188|363317063|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
105358147|NCT03061188|363317064|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
105358148|NCT02080364|363317069|FG000|Baseline Period|Protocol Violation|2|||
105358149|NCT02080364|363317070|FG001|Baseline Period|Protocol Violation|1|||
105358150|NCT02080364|363317071|FG002|Baseline Period|Protocol Violation|0|||
105358151|NCT02080364|363317072|FG003|Baseline Period|Protocol Violation|0|||
105358152|NCT02080364|363317069|FG000|Baseline Period|Other|0|||
105358153|NCT02080364|363317070|FG001|Baseline Period|Other|1|||
105358154|NCT02080364|363317071|FG002|Baseline Period|Other|1|||
105358155|NCT02080364|363317072|FG003|Baseline Period|Other|0|||
105358156|NCT02080364|363317069|FG000|Treatment Period|Adverse Event|10|||
105358157|NCT02080364|363317070|FG001|Treatment Period|Adverse Event|15|||
105358158|NCT02080364|363317071|FG002|Treatment Period|Adverse Event|11|||
105358159|NCT02080364|363317072|FG003|Treatment Period|Adverse Event|14|||
105482787|NCT00483756|363779006|FG000|Overall Study|Other|2|||
105482788|NCT00483756|363779007|FG001|Overall Study|Other|4|||
105482789|NCT00483756|363779008|FG002|Overall Study|Other|3|||
105358160|NCT02080364|363317069|FG000|Treatment Period|Lost to Follow-up|2|||
105358161|NCT02080364|363317070|FG001|Treatment Period|Lost to Follow-up|3|||
105358162|NCT02080364|363317071|FG002|Treatment Period|Lost to Follow-up|5|||
105358163|NCT02080364|363317072|FG003|Treatment Period|Lost to Follow-up|0|||
105482790|NCT00483756|363779006|FG000|Overall Study|Randomized, Not Treated|1|||
105740081|NCT03184701|364703495|FG000|Overall Study|Physician Decision|3|||
105740082|NCT03184701|364703495|FG000|Overall Study|Withdrawal by Subject|6|||
105740083|NCT03184701|364703495|FG000|Overall Study|Lost to Follow-up|5|||
105740084|NCT00590681|364703496|FG000|Overall Study|Withdrawal by Subject|7|||
105740085|NCT00590681|364703496|FG000|Overall Study|Adverse Event|8|||
105740086|NCT00590681|364703496|FG000|Overall Study|Death|3|||
105740087|NCT00590681|364703496|FG000|Overall Study|Lost to Follow-up|1|||
105740088|NCT00590681|364703496|FG000|Overall Study|disease progression|1|||
105740089|NCT02229864|364703505|FG000|Overall Study|Death|2|||
105740090|NCT02229864|364703505|FG000|Overall Study|Lost to Follow-up|1|||
105740091|NCT02084134|364703510|FG000|Overall Study|Protocol Violation|4|||
105740092|NCT02084134|364703511|FG001|Overall Study|Protocol Violation|2|||
105740093|NCT02084134|364703510|FG000|Overall Study|Death|0|||
105740094|NCT02084134|364703511|FG001|Overall Study|Death|1|||
105740095|NCT01165203|364703518|FG000|Active Phase|Serious Adverse Event|1|||
105740096|NCT01165203|364703519|FG001|Active Phase|Serious Adverse Event|0|||
105740097|NCT01165203|364703518|FG000|Active Phase|Withdrawal by Subject|2|||
105482791|NCT00483756|363779007|FG001|Overall Study|Randomized, Not Treated|4|||
105482792|NCT00483756|363779008|FG002|Overall Study|Randomized, Not Treated|4|||
105482793|NCT01120067|363779015|FG000|Overall Study|Lost to Follow-up|3|||
105482794|NCT01120067|363779016|FG001|Overall Study|Lost to Follow-up|1|||
105482795|NCT01120067|363779015|FG000|Overall Study|fail to engage >3 sessions|2|||
105482796|NCT01120067|363779016|FG001|Overall Study|fail to engage >3 sessions|0|||
105482797|NCT00053898|363779017|FG000|Overall Study|No follow-up data from any source|9|||
105740098|NCT01165203|364703519|FG001|Active Phase|Withdrawal by Subject|1|||
105740099|NCT01165203|364703518|FG000|Active Phase|Migrated/moved from study area|0|||
105740100|NCT01165203|364703519|FG001|Active Phase|Migrated/moved from study area|1|||
105740101|NCT01165203|364703518|FG000|Active Phase|Lost to Follow-up|2|||
105740102|NCT01165203|364703519|FG001|Active Phase|Lost to Follow-up|0|||
105740103|NCT01165203|364703518|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
105482798|NCT00053898|363779018|FG001|Overall Study|No follow-up data from any source|12|||
105482799|NCT00053898|363779017|FG000|Overall Study|Follow-up from telephone contact only|5|||
105482800|NCT00053898|363779018|FG001|Overall Study|Follow-up from telephone contact only|1|||
105482801|NCT01606878|363779019|FG000|Overall Study|Adverse Event|1|||
105482802|NCT01606878|363779020|FG001|Overall Study|Adverse Event|1|||
105482803|NCT01606878|363779021|FG002|Overall Study|Adverse Event|0|||
105482804|NCT01606878|363779022|FG003|Overall Study|Adverse Event|0|||
105482805|NCT01606878|363779023|FG004|Overall Study|Adverse Event|0|||
105482806|NCT01606878|363779024|FG005|Overall Study|Adverse Event|0|||
105482807|NCT01606878|363779025|FG006|Overall Study|Adverse Event|1|||
105482808|NCT01606878|363779026|FG007|Overall Study|Adverse Event|0|||
105482809|NCT01606878|363779027|FG008|Overall Study|Adverse Event|1|||
105740104|NCT01165203|364703519|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
105740105|NCT01165203|364703518|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
105740106|NCT01165203|364703519|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
105740107|NCT01165203|364703518|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
105740108|NCT01165203|364703519|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
105740109|NCT01165203|364703518|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
105740110|NCT01165203|364703519|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
105740111|NCT01165203|364703518|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
105740112|NCT01165203|364703519|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
105482810|NCT01606878|363779028|FG009|Overall Study|Adverse Event|3|||
105482811|NCT01606878|363779029|FG010|Overall Study|Adverse Event|0|||
105482812|NCT01606878|363779019|FG000|Overall Study|Lack of Efficacy|1|||
105482813|NCT01606878|363779020|FG001|Overall Study|Lack of Efficacy|1|||
105482814|NCT01606878|363779021|FG002|Overall Study|Lack of Efficacy|1|||
105482815|NCT01606878|363779022|FG003|Overall Study|Lack of Efficacy|2|||
105482816|NCT01606878|363779023|FG004|Overall Study|Lack of Efficacy|1|||
105482817|NCT01606878|363779024|FG005|Overall Study|Lack of Efficacy|2|||
105482818|NCT01606878|363779025|FG006|Overall Study|Lack of Efficacy|1|||
105740113|NCT01963117|364703531|FG000|Overall Study|Death|1|||
105740114|NCT01070784|364703533|FG000|Overall Study|Withdrawal by Subject|6|||
105740115|NCT01070784|364703534|FG001|Overall Study|Withdrawal by Subject|9|||
105740116|NCT01070784|364703533|FG000|Overall Study|Adverse Event|14|||
105740117|NCT01070784|364703534|FG001|Overall Study|Adverse Event|9|||
105740118|NCT00798967|364703535|FG000|Overall Study|Adverse Event|2|||
105740119|NCT00798967|364703536|FG001|Overall Study|Adverse Event|3|||
105740120|NCT00798967|364703535|FG000|Overall Study|Withdrawal by Subject|0|||
105740121|NCT00798967|364703536|FG001|Overall Study|Withdrawal by Subject|1|||
105740122|NCT00798967|364703535|FG000|Overall Study|Physician Decision|1|||
105740123|NCT00798967|364703536|FG001|Overall Study|Physician Decision|0|||
105740124|NCT00798967|364703535|FG000|Overall Study|Randomized in error by site|1|||
105740125|NCT00798967|364703536|FG001|Overall Study|Randomized in error by site|0|||
105740126|NCT01605396|364703537|FG000|Overall Study|Adverse Event|5|||
105740127|NCT01605396|364703538|FG001|Overall Study|Adverse Event|3|||
105740128|NCT01605396|364703537|FG000|Overall Study|Lost to Follow-up|1|||
105740129|NCT01605396|364703538|FG001|Overall Study|Lost to Follow-up|0|||
105740130|NCT01605396|364703537|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105740131|NCT01605396|364703538|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105740132|NCT01605396|364703537|FG000|Overall Study|Physician Decision|2|||
105740133|NCT01605396|364703538|FG001|Overall Study|Physician Decision|2|||
105740134|NCT01605396|364703537|FG000|Overall Study|Progressive Disease|23|||
105740135|NCT01605396|364703538|FG001|Overall Study|Progressive Disease|27|||
105740136|NCT01605396|364703537|FG000|Overall Study|Withdrawal by Subject|4|||
105740137|NCT01605396|364703538|FG001|Overall Study|Withdrawal by Subject|2|||
105740138|NCT01605396|364703537|FG000|Overall Study|Transfer Off Study|4|||
105740139|NCT01605396|364703538|FG001|Overall Study|Transfer Off Study|5|||
105740140|NCT01323673|364703539|FG000|Overall Study|Adverse Event|0|||
105740141|NCT01323673|364703540|FG001|Overall Study|Adverse Event|1|||
105740142|NCT01323673|364703539|FG000|Overall Study|Lost to Follow-up|0|||
105740143|NCT01323673|364703540|FG001|Overall Study|Lost to Follow-up|1|||
105740144|NCT01323673|364703539|FG000|Overall Study|Protocol Violation|1|||
105740145|NCT01323673|364703540|FG001|Overall Study|Protocol Violation|0|||
105740146|NCT01323673|364703539|FG000|Overall Study|Withdrawal by Subject|2|||
105740147|NCT01323673|364703540|FG001|Overall Study|Withdrawal by Subject|3|||
105740148|NCT04598165|364703541|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
105740149|NCT04598165|364703542|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
105740150|NCT04598165|364703541|FG000|Completed 6-week Follow-up|Death|2|||
105482819|NCT01606878|363779026|FG007|Overall Study|Lack of Efficacy|2|||
105740151|NCT04598165|364703542|FG001|Completed 6-week Follow-up|Death|1|||
105740152|NCT04598165|364703541|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
105740153|NCT04598165|364703542|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
105740154|NCT04598165|364703541|FG000|Completed 6-week Follow-up|Ineligible|4|||
105740155|NCT04598165|364703542|FG001|Completed 6-week Follow-up|Ineligible|3|||
105740156|NCT04598165|364703541|FG000|Completed 6-week Follow-up|Partner refusal|0|||
105740157|NCT04598165|364703542|FG001|Completed 6-week Follow-up|Partner refusal|1|||
105740158|NCT04598165|364703541|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
105740159|NCT04598165|364703542|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
105740160|NCT00783705|364703543|FG000|Overall Study|Adverse Event|2|||
105740161|NCT00783705|364703544|FG001|Overall Study|Adverse Event|0|||
105740162|NCT00783705|364703543|FG000|Overall Study|Withdrawal by Subject|3|||
105740163|NCT00783705|364703544|FG001|Overall Study|Withdrawal by Subject|2|||
105740164|NCT00783705|364703543|FG000|Overall Study|Lost to Follow-up|1|||
105740165|NCT00783705|364703544|FG001|Overall Study|Lost to Follow-up|3|||
105740166|NCT00633139|364703548|FG000|Overall Study|Non compliance|0|||
105740167|NCT00633139|364703549|FG001|Overall Study|Non compliance|0|||
105740168|NCT00633139|364703550|FG002|Overall Study|Non compliance|1|||
105740169|NCT00633139|364703548|FG000|Overall Study|Withdrawal by Subject|0|||
105740170|NCT00633139|364703549|FG001|Overall Study|Withdrawal by Subject|1|||
105740171|NCT00633139|364703550|FG002|Overall Study|Withdrawal by Subject|0|||
105740172|NCT02160977|364703551|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
105740173|NCT02160977|364703552|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
105740174|NCT02160977|364703551|FG000|Three Months After Surgery|Lost to Follow-up|0|||
105740175|NCT02160977|364703552|FG001|Three Months After Surgery|Lost to Follow-up|2|||
105740176|NCT02160977|364703551|FG000|Six Months After Surgery|Lost to Follow-up|2|||
105740177|NCT02160977|364703552|FG001|Six Months After Surgery|Lost to Follow-up|1|||
105740178|NCT04238663|364703555|FG000|Overall Study|Lost to Follow-up|0|||
105740179|NCT04238663|364703556|FG001|Overall Study|Lost to Follow-up|1|||
105740180|NCT04238663|364703557|FG002|Overall Study|Lost to Follow-up|0|||
105482820|NCT01606878|363779027|FG008|Overall Study|Lack of Efficacy|2|||
105740181|NCT02566525|364703558|FG000|Overall Study|Protocol Violation|3|||
105740182|NCT02566525|364703559|FG001|Overall Study|Protocol Violation|5|||
105740183|NCT00337467|364703562|FG000|Overall Study|Adverse Event|3|||
105740184|NCT00337467|364703562|FG000|Overall Study|Subject Withdrew Consent|2|||
105740185|NCT00337467|364703562|FG000|Overall Study|Pregnancy|1|||
105740186|NCT00337467|364703562|FG000|Overall Study|Lost to Follow-up|2|||
105358164|NCT02080364|363317069|FG000|Treatment Period|Protocol Violation|5|||
105358165|NCT02080364|363317070|FG001|Treatment Period|Protocol Violation|3|||
105358166|NCT02080364|363317071|FG002|Treatment Period|Protocol Violation|5|||
105358167|NCT02080364|363317072|FG003|Treatment Period|Protocol Violation|1|||
105358168|NCT02080364|363317069|FG000|Treatment Period|Withdrawal by Subject|16|||
105358169|NCT02080364|363317070|FG001|Treatment Period|Withdrawal by Subject|16|||
105358170|NCT02080364|363317071|FG002|Treatment Period|Withdrawal by Subject|15|||
105358171|NCT02080364|363317072|FG003|Treatment Period|Withdrawal by Subject|10|||
105482821|NCT01606878|363779028|FG009|Overall Study|Lack of Efficacy|0|||
105482822|NCT01606878|363779029|FG010|Overall Study|Lack of Efficacy|1|||
105358172|NCT02080364|363317069|FG000|Treatment Period|Study Terminated by Sponsor|0|||
105358173|NCT02080364|363317070|FG001|Treatment Period|Study Terminated by Sponsor|0|||
105482823|NCT01606878|363779019|FG000|Overall Study|Physician Decision|1|||
105358174|NCT02080364|363317071|FG002|Treatment Period|Study Terminated by Sponsor|180|||
105482824|NCT01606878|363779020|FG001|Overall Study|Physician Decision|0|||
105482825|NCT01606878|363779021|FG002|Overall Study|Physician Decision|2|||
105482826|NCT01606878|363779022|FG003|Overall Study|Physician Decision|1|||
105482827|NCT01606878|363779023|FG004|Overall Study|Physician Decision|1|||
105482828|NCT01606878|363779024|FG005|Overall Study|Physician Decision|1|||
105482829|NCT01606878|363779025|FG006|Overall Study|Physician Decision|2|||
105482830|NCT01606878|363779026|FG007|Overall Study|Physician Decision|0|||
105482831|NCT01606878|363779027|FG008|Overall Study|Physician Decision|1|||
105482832|NCT01606878|363779028|FG009|Overall Study|Physician Decision|0|||
105358175|NCT02080364|363317072|FG003|Treatment Period|Study Terminated by Sponsor|183|||
105358176|NCT02080364|363317069|FG000|Treatment Period|Other|14|||
105482833|NCT01606878|363779029|FG010|Overall Study|Physician Decision|0|||
105482834|NCT01606878|363779019|FG000|Overall Study|Withdrawal by Subject|3|||
105740187|NCT00337467|364703562|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
105740188|NCT01663740|364703564|FG000|Overall Study|Lost to Follow-up|1|||
105740189|NCT01663740|364703565|FG001|Overall Study|Lost to Follow-up|4|||
105740190|NCT01663740|364703564|FG000|Overall Study|Other|9|||
105740191|NCT01663740|364703565|FG001|Overall Study|Other|2|||
105740192|NCT01663740|364703564|FG000|Overall Study|Inclusion/Exclusion not met|1|||
105740193|NCT01663740|364703565|FG001|Overall Study|Inclusion/Exclusion not met|0|||
105740194|NCT01663740|364703564|FG000|Overall Study|Death|0|||
105740195|NCT01663740|364703565|FG001|Overall Study|Death|1|||
105740196|NCT01663740|364703564|FG000|Overall Study|Withdrawal by Subject|2|||
105740197|NCT01663740|364703565|FG001|Overall Study|Withdrawal by Subject|1|||
105740198|NCT01663740|364703564|FG000|Overall Study|No end of study status|3|||
105740199|NCT01663740|364703565|FG001|Overall Study|No end of study status|0|||
105740200|NCT02429427|364703566|FG000|Overall Study|Adverse Event|220|||
105740201|NCT02429427|364703567|FG001|Overall Study|Adverse Event|92|||
105740202|NCT02429427|364703566|FG000|Overall Study|Protocol Violation|10|||
105740203|NCT02429427|364703567|FG001|Overall Study|Protocol Violation|6|||
105740204|NCT02429427|364703566|FG000|Overall Study|Lost to Follow-up|15|||
105740205|NCT02429427|364703567|FG001|Overall Study|Lost to Follow-up|6|||
105740206|NCT02429427|364703566|FG000|Overall Study|Withdrawal by Subject|64|||
105740207|NCT02429427|364703567|FG001|Overall Study|Withdrawal by Subject|34|||
105740208|NCT02429427|364703566|FG000|Overall Study|Other|62|||
105740209|NCT02429427|364703567|FG001|Overall Study|Other|41|||
105740210|NCT02125331|364704995|FG000|Overall Study|Protocol Violation|1|||
105740211|NCT02125331|364704996|FG001|Overall Study|Protocol Violation|0|||
105740212|NCT02125331|364704995|FG000|Overall Study|technical problem|2|||
105740213|NCT02125331|364704996|FG001|Overall Study|technical problem|0|||
105740214|NCT02125331|364704995|FG000|Overall Study|screen failure|2|||
105740215|NCT02125331|364704996|FG001|Overall Study|screen failure|0|||
105740216|NCT00165646|364704997|FG000|Overall Study|Adverse Event|1|||
105740217|NCT00165646|364704998|FG001|Overall Study|Adverse Event|1|||
105740218|NCT00165646|364704999|FG002|Overall Study|Adverse Event|1|||
105358177|NCT02080364|363317070|FG001|Treatment Period|Other|12|||
105482835|NCT01606878|363779020|FG001|Overall Study|Withdrawal by Subject|2|||
105482836|NCT01606878|363779021|FG002|Overall Study|Withdrawal by Subject|2|||
105482837|NCT01606878|363779022|FG003|Overall Study|Withdrawal by Subject|0|||
105482838|NCT01606878|363779023|FG004|Overall Study|Withdrawal by Subject|1|||
105482839|NCT01606878|363779024|FG005|Overall Study|Withdrawal by Subject|1|||
105482840|NCT01606878|363779025|FG006|Overall Study|Withdrawal by Subject|2|||
105482841|NCT01606878|363779026|FG007|Overall Study|Withdrawal by Subject|1|||
105482842|NCT01606878|363779027|FG008|Overall Study|Withdrawal by Subject|2|||
105565274|NCT03420781|364066725|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
105740219|NCT00165646|364704997|FG000|Overall Study|Lack of Efficacy|1|||
105740220|NCT00165646|364704998|FG001|Overall Study|Lack of Efficacy|2|||
105740221|NCT00165646|364704999|FG002|Overall Study|Lack of Efficacy|0|||
105740222|NCT00165646|364704997|FG000|Overall Study|Withdrawal by Subject|0|||
105740223|NCT00165646|364704998|FG001|Overall Study|Withdrawal by Subject|2|||
105740224|NCT00165646|364704999|FG002|Overall Study|Withdrawal by Subject|1|||
105482843|NCT01606878|363779028|FG009|Overall Study|Withdrawal by Subject|0|||
105740225|NCT00165646|364704997|FG000|Overall Study|Physician Decision|2|||
105740226|NCT00165646|364704998|FG001|Overall Study|Physician Decision|0|||
105358178|NCT02080364|363317071|FG002|Treatment Period|Other|21|||
105358179|NCT02080364|363317072|FG003|Treatment Period|Other|16|||
105358180|NCT00685360|363317073|FG000|Overall Study|Lost to Follow-up|0|||
105358181|NCT00685360|363317074|FG001|Overall Study|Lost to Follow-up|1|||
105358182|NCT00685360|363317075|FG002|Overall Study|Lost to Follow-up|2|||
105358183|NCT00685360|363317073|FG000|Overall Study|Adverse Event|4|||
105358184|NCT00685360|363317074|FG001|Overall Study|Adverse Event|6|||
105358185|NCT00685360|363317075|FG002|Overall Study|Adverse Event|4|||
105358186|NCT00685360|363317073|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
105358187|NCT00685360|363317074|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
105358188|NCT00685360|363317075|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
105358189|NCT00685360|363317073|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
105358190|NCT00685360|363317074|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
105358191|NCT00685360|363317075|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
105358192|NCT00685360|363317073|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
105358193|NCT00685360|363317074|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
105358194|NCT00685360|363317075|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
105358195|NCT00685360|363317073|FG000|Overall Study|Protocol Deviation|0|||
105358196|NCT00685360|363317074|FG001|Overall Study|Protocol Deviation|1|||
105358197|NCT00685360|363317075|FG002|Overall Study|Protocol Deviation|1|||
105358198|NCT01843803|363317076|FG000|Overall Study|not a Veteran, did not see provider|1|||
105358199|NCT01843803|363317077|FG001|Overall Study|not a Veteran, did not see provider|3|||
105358200|NCT01408901|363317078|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
105358201|NCT01408901|363317079|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
105358202|NCT01408901|363317080|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
105358203|NCT01408901|363317081|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
105358204|NCT01408901|363317078|FG000|6-Week Follow-Up|Death|1|||
105358205|NCT01408901|363317079|FG001|6-Week Follow-Up|Death|0|||
105358206|NCT01408901|363317080|FG002|6-Week Follow-Up|Death|0|||
105358207|NCT01408901|363317081|FG003|6-Week Follow-Up|Death|0|||
105358208|NCT01408901|363317078|FG000|6-Week Follow-Up|Cancelled visit|0|||
105358209|NCT01408901|363317079|FG001|6-Week Follow-Up|Cancelled visit|1|||
105358210|NCT01408901|363317080|FG002|6-Week Follow-Up|Cancelled visit|0|||
105358211|NCT01408901|363317081|FG003|6-Week Follow-Up|Cancelled visit|2|||
105358212|NCT01408901|363317078|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
105358213|NCT01408901|363317079|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
105358214|NCT01408901|363317080|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
105358215|NCT01408901|363317081|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
105358216|NCT01408901|363317078|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
105482844|NCT01606878|363779029|FG010|Overall Study|Withdrawal by Subject|2|||
105740227|NCT00165646|364704999|FG002|Overall Study|Physician Decision|2|||
105740228|NCT00165646|364704997|FG000|Overall Study|Protocol Violation|1|||
105740229|NCT00165646|364704998|FG001|Overall Study|Protocol Violation|0|||
105740230|NCT00165646|364704999|FG002|Overall Study|Protocol Violation|0|||
105740231|NCT02090114|364705000|FG000|Overall Study|Withdrawal by Subject|3|||
105740232|NCT02090114|364705001|FG001|Overall Study|Withdrawal by Subject|6|||
105740233|NCT02090114|364705002|FG002|Overall Study|Withdrawal by Subject|2|||
105740234|NCT02090114|364705003|FG003|Overall Study|Withdrawal by Subject|1|||
105740235|NCT02090114|364705000|FG000|Overall Study|Physician Decision|5|||
105740236|NCT02090114|364705001|FG001|Overall Study|Physician Decision|0|||
105740237|NCT02090114|364705002|FG002|Overall Study|Physician Decision|1|||
105740238|NCT02090114|364705003|FG003|Overall Study|Physician Decision|1|||
105740239|NCT02090114|364705000|FG000|Overall Study|Adverse Event|1|||
105740240|NCT02090114|364705001|FG001|Overall Study|Adverse Event|2|||
105740241|NCT02090114|364705002|FG002|Overall Study|Adverse Event|2|||
105740242|NCT02090114|364705003|FG003|Overall Study|Adverse Event|0|||
105740243|NCT02090114|364705000|FG000|Overall Study|Progressive Disease|20|||
105740244|NCT02090114|364705001|FG001|Overall Study|Progressive Disease|21|||
105740245|NCT02090114|364705002|FG002|Overall Study|Progressive Disease|23|||
105740246|NCT02090114|364705003|FG003|Overall Study|Progressive Disease|6|||
105358217|NCT01408901|363317079|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
105358218|NCT01408901|363317080|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
105482845|NCT03865316|363780764|FG000|Overall Study|Procedure Cancelled|4|||
105482846|NCT03865316|363780764|FG000|Overall Study|Equipment failure|4|||
105482847|NCT00576420|363780766|FG000|Overall Study|Death|0|||
105740247|NCT02090114|364705000|FG000|Overall Study|Death|1|||
105740248|NCT02090114|364705001|FG001|Overall Study|Death|0|||
105740249|NCT02090114|364705002|FG002|Overall Study|Death|1|||
105740250|NCT02090114|364705003|FG003|Overall Study|Death|0|||
105358219|NCT01408901|363317081|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
105358220|NCT01408901|363317078|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
105740251|NCT00500149|364705004|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
105358221|NCT01408901|363317079|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
105740252|NCT00500149|364705005|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
105740253|NCT00500149|364705004|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
105740254|NCT00500149|364705005|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
105740255|NCT00500149|364705004|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
105740256|NCT00500149|364705005|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
105740257|NCT00500149|364705004|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
105740258|NCT00500149|364705005|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
105358222|NCT01408901|363317080|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
105358223|NCT01408901|363317081|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
105358224|NCT01408901|363317078|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
105358225|NCT01408901|363317079|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
105358226|NCT01408901|363317080|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
105358227|NCT01408901|363317081|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
105358228|NCT01408901|363317078|FG000|26-Week Follow-Up|Death|0|||
105358229|NCT01408901|363317079|FG001|26-Week Follow-Up|Death|1|||
105358230|NCT01408901|363317080|FG002|26-Week Follow-Up|Death|0|||
105358231|NCT01408901|363317081|FG003|26-Week Follow-Up|Death|0|||
105740259|NCT00500149|364705004|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
105740260|NCT00500149|364705005|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
105358232|NCT00547157|363317082|FG000|Overall Study|Other|1|||
105740261|NCT00500149|364705004|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
105740262|NCT00500149|364705005|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
105740263|NCT00500149|364705004|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
105740264|NCT00500149|364705005|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
105740265|NCT01158534|364705006|FG000|Overall Study|Withdrawal by Subject|1|||
105740266|NCT01158534|364705006|FG000|Overall Study|Death|1|||
105740267|NCT01158534|364705006|FG000|Overall Study|Other|1|||
105740268|NCT00521339|364705007|FG000|Treatment Phase|Adverse Event|2|||
105740269|NCT00521339|364705008|FG001|Treatment Phase|Adverse Event|0|||
105740270|NCT00521339|364705009|FG002|Treatment Phase|Adverse Event|0|||
105740271|NCT00521339|364705007|FG000|Treatment Phase|Intolerability to study drug|2|||
105740272|NCT00521339|364705008|FG001|Treatment Phase|Intolerability to study drug|0|||
105740273|NCT00521339|364705009|FG002|Treatment Phase|Intolerability to study drug|0|||
105740274|NCT00521339|364705007|FG000|Treatment Phase|Lack of Efficacy|3|||
105740275|NCT00521339|364705008|FG001|Treatment Phase|Lack of Efficacy|0|||
105740276|NCT00521339|364705009|FG002|Treatment Phase|Lack of Efficacy|0|||
105740277|NCT00521339|364705007|FG000|Treatment Phase|Withdrawal by Subject|3|||
105740278|NCT00521339|364705008|FG001|Treatment Phase|Withdrawal by Subject|0|||
105740279|NCT00521339|364705009|FG002|Treatment Phase|Withdrawal by Subject|0|||
105740280|NCT00521339|364705007|FG000|Treatment Phase|Lost to Follow-up|1|||
105358233|NCT00547157|363317083|FG001|Overall Study|Other|0|||
105358234|NCT00547157|363317082|FG000|Overall Study|Death|38|||
105358235|NCT00547157|363317083|FG001|Overall Study|Death|18|||
105358236|NCT00547157|363317082|FG000|Overall Study|Withdrawal by Subject|3|||
105358237|NCT00547157|363317083|FG001|Overall Study|Withdrawal by Subject|1|||
105358238|NCT00547157|363317082|FG000|Overall Study|Administrative decision|3|||
105358239|NCT00547157|363317083|FG001|Overall Study|Administrative decision|2|||
105482848|NCT00576420|363780767|FG001|Overall Study|Death|0|||
105482849|NCT00576420|363780768|FG002|Overall Study|Death|1|||
105482850|NCT02616146|363780769|FG000|Overall Study|Adverse Event|64|||
105482851|NCT02616146|363780770|FG001|Overall Study|Adverse Event|24|||
105740281|NCT00521339|364705008|FG001|Treatment Phase|Lost to Follow-up|0|||
105740282|NCT00521339|364705009|FG002|Treatment Phase|Lost to Follow-up|0|||
105740283|NCT00521339|364705007|FG000|Treatment Phase|Protocol Violation|1|||
105740284|NCT00521339|364705008|FG001|Treatment Phase|Protocol Violation|0|||
105740285|NCT00521339|364705009|FG002|Treatment Phase|Protocol Violation|0|||
105740286|NCT00521339|364705007|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
105740287|NCT00521339|364705008|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
105740288|NCT00521339|364705009|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
105740289|NCT00521339|364705007|FG000|Treatment Extension Phase|Death|0|||
105740290|NCT00521339|364705008|FG001|Treatment Extension Phase|Death|0|||
105740291|NCT00521339|364705009|FG002|Treatment Extension Phase|Death|1|||
105740292|NCT02115815|364705010|FG000|Overall Study|Withdrawal by Subject|2|||
105740293|NCT02115815|364705011|FG001|Overall Study|Withdrawal by Subject|0|||
105740294|NCT02115815|364705012|FG002|Overall Study|Withdrawal by Subject|0|||
105740295|NCT02115815|364705013|FG003|Overall Study|Withdrawal by Subject|0|||
105740296|NCT02115815|364705014|FG004|Overall Study|Withdrawal by Subject|0|||
105740297|NCT02115815|364705015|FG005|Overall Study|Withdrawal by Subject|0|||
105740298|NCT02115815|364705016|FG006|Overall Study|Withdrawal by Subject|0|||
105740299|NCT02115815|364705010|FG000|Overall Study|Not enough drug to dose participant|0|||
105740300|NCT02115815|364705011|FG001|Overall Study|Not enough drug to dose participant|0|||
105740301|NCT02115815|364705012|FG002|Overall Study|Not enough drug to dose participant|0|||
105740302|NCT02115815|364705013|FG003|Overall Study|Not enough drug to dose participant|0|||
105740303|NCT02115815|364705014|FG004|Overall Study|Not enough drug to dose participant|0|||
105740304|NCT02115815|364705015|FG005|Overall Study|Not enough drug to dose participant|1|||
105358240|NCT00547157|363317082|FG000|Overall Study|Lost to Follow-up|4|||
105482852|NCT02616146|363780769|FG000|Overall Study|Lost to Follow-up|23|||
105358241|NCT00547157|363317083|FG001|Overall Study|Lost to Follow-up|2|||
105358245|NCT04208412|363317087|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
105358246|NCT04208412|363317088|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
105358247|NCT04208412|363317087|FG000|Overall Study|Withdrawal by Subject|1|||
105358248|NCT04208412|363317088|FG001|Overall Study|Withdrawal by Subject|0|||
105358249|NCT04208412|363317087|FG000|Overall Study|Lost to Follow-up|0|||
105358250|NCT04208412|363317088|FG001|Overall Study|Lost to Follow-up|1|||
105358251|NCT01030718|363317089|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
105358252|NCT01030718|363317090|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
105358253|NCT01030718|363317091|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
105358254|NCT01030718|363317089|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
105740305|NCT02115815|364705016|FG006|Overall Study|Not enough drug to dose participant|0|||
105740306|NCT02115815|364705010|FG000|Overall Study|Missed appointment, randomized in error|0|||
105740307|NCT02115815|364705011|FG001|Overall Study|Missed appointment, randomized in error|0|||
105740308|NCT02115815|364705012|FG002|Overall Study|Missed appointment, randomized in error|0|||
105740309|NCT02115815|364705013|FG003|Overall Study|Missed appointment, randomized in error|0|||
105740310|NCT02115815|364705014|FG004|Overall Study|Missed appointment, randomized in error|0|||
105740311|NCT02115815|364705015|FG005|Overall Study|Missed appointment, randomized in error|1|||
105740312|NCT02115815|364705016|FG006|Overall Study|Missed appointment, randomized in error|0|||
105740313|NCT01958671|364705017|FG000|Overall Study|Adverse Event|1|||
105740314|NCT01958671|364705018|FG001|Overall Study|Adverse Event|1|||
105740315|NCT01958671|364705019|FG002|Overall Study|Adverse Event|5|||
105740316|NCT01958671|364705017|FG000|Overall Study|Death|1|||
105740317|NCT01958671|364705018|FG001|Overall Study|Death|0|||
105740318|NCT01958671|364705019|FG002|Overall Study|Death|0|||
105740319|NCT01958671|364705017|FG000|Overall Study|Excluded medication|0|||
105740320|NCT01958671|364705018|FG001|Overall Study|Excluded medication|0|||
105740321|NCT01958671|364705019|FG002|Overall Study|Excluded medication|1|||
105740322|NCT01958671|364705017|FG000|Overall Study|Hyperglycemia|0|||
105740323|NCT01958671|364705018|FG001|Overall Study|Hyperglycemia|0|||
105740324|NCT01958671|364705019|FG002|Overall Study|Hyperglycemia|2|||
105740325|NCT01958671|364705017|FG000|Overall Study|Lost to Follow-up|7|||
105740326|NCT01958671|364705018|FG001|Overall Study|Lost to Follow-up|11|||
105740327|NCT01958671|364705019|FG002|Overall Study|Lost to Follow-up|7|||
105358255|NCT01030718|363317090|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
105740328|NCT01958671|364705017|FG000|Overall Study|Non-compliance with study drug|1|||
105740329|NCT01958671|364705018|FG001|Overall Study|Non-compliance with study drug|1|||
105740330|NCT01958671|364705019|FG002|Overall Study|Non-compliance with study drug|1|||
105740331|NCT01958671|364705017|FG000|Overall Study|Pregnancy|0|||
105740332|NCT01958671|364705018|FG001|Overall Study|Pregnancy|0|||
105740333|NCT01958671|364705019|FG002|Overall Study|Pregnancy|1|||
105740334|NCT01958671|364705017|FG000|Overall Study|Protocol Violation|0|||
105740335|NCT01958671|364705018|FG001|Overall Study|Protocol Violation|1|||
105740336|NCT01958671|364705019|FG002|Overall Study|Protocol Violation|0|||
105740337|NCT01958671|364705017|FG000|Overall Study|Study site terminated by sponsor|1|||
105740338|NCT01958671|364705018|FG001|Overall Study|Study site terminated by sponsor|0|||
105740339|NCT01958671|364705019|FG002|Overall Study|Study site terminated by sponsor|1|||
105740340|NCT01958671|364705017|FG000|Overall Study|Participant moved|0|||
105740341|NCT01958671|364705018|FG001|Overall Study|Participant moved|0|||
105740342|NCT01958671|364705019|FG002|Overall Study|Participant moved|1|||
105740343|NCT01958671|364705017|FG000|Overall Study|Withdrawal by Subject|8|||
105740344|NCT01958671|364705018|FG001|Overall Study|Withdrawal by Subject|10|||
105740345|NCT01958671|364705019|FG002|Overall Study|Withdrawal by Subject|13|||
105740346|NCT01675531|364705022|FG000|Overall Study|Adverse Event|9|||
105740347|NCT01675531|364705022|FG000|Overall Study|Withdrawal by Subject|7|||
105740348|NCT01675531|364705022|FG000|Overall Study|Lack of Efficacy|1|||
105740349|NCT01675531|364705022|FG000|Overall Study|Protocol Violation|8|||
105740350|NCT04705597|364705023|FG000|Overall Study|Death|16|||
105740351|NCT04705597|364705024|FG001|Overall Study|Death|9|||
105740352|NCT04705597|364705023|FG000|Overall Study|Lost to Follow-up|1|||
105740353|NCT04705597|364705024|FG001|Overall Study|Lost to Follow-up|0|||
105740354|NCT04705597|364705023|FG000|Overall Study|Withdrawal by Subject|1|||
105740355|NCT04705597|364705024|FG001|Overall Study|Withdrawal by Subject|2|||
105740356|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
105740357|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
105740358|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
105740359|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
105740360|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
105740361|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
105740362|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
105740363|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
105740364|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
105740365|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
105740366|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
105740367|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
105740368|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
105740369|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
105740370|NCT02232516|364705028|FG000|Survival Follow-up|Death|15|||
105740371|NCT02232516|364705028|FG000|Survival Follow-up|Withdrawal by Subject|3|||
105740372|NCT02232516|364705028|FG000|Survival Follow-up|Lost to Follow-up|1|||
105740373|NCT02232516|364705028|FG000|Survival Follow-up|Still in follow-up|5|||
105740374|NCT01258348|364705030|FG000|Overall Study|Adverse Event|1|||
105740375|NCT01258348|364705031|FG001|Overall Study|Adverse Event|1|||
105740376|NCT01258348|364705032|FG002|Overall Study|Adverse Event|3|||
105740377|NCT01258348|364705033|FG003|Overall Study|Adverse Event|2|||
105740378|NCT01258348|364705034|FG004|Overall Study|Adverse Event|4|||
105740379|NCT01258348|364705030|FG000|Overall Study|Progressive Disease|0|||
105740380|NCT01258348|364705031|FG001|Overall Study|Progressive Disease|3|||
105740381|NCT01258348|364705032|FG002|Overall Study|Progressive Disease|0|||
105740382|NCT01258348|364705033|FG003|Overall Study|Progressive Disease|2|||
105740383|NCT01258348|364705034|FG004|Overall Study|Progressive Disease|2|||
105740384|NCT01258348|364705030|FG000|Overall Study|Physician Decision|0|||
105740385|NCT01258348|364705031|FG001|Overall Study|Physician Decision|0|||
105740386|NCT01258348|364705032|FG002|Overall Study|Physician Decision|0|||
105740387|NCT01258348|364705033|FG003|Overall Study|Physician Decision|2|||
105740388|NCT01258348|364705034|FG004|Overall Study|Physician Decision|0|||
105740389|NCT01258348|364705030|FG000|Overall Study|Withdrawal by Subject|0|||
105740390|NCT01258348|364705031|FG001|Overall Study|Withdrawal by Subject|1|||
105740391|NCT01258348|364705032|FG002|Overall Study|Withdrawal by Subject|0|||
105740392|NCT01258348|364705033|FG003|Overall Study|Withdrawal by Subject|0|||
105740393|NCT01258348|364705034|FG004|Overall Study|Withdrawal by Subject|0|||
105740394|NCT02855411|364705035|FG000|Overall Study|Study terminated by sponsor|21|||
105740395|NCT02855411|364705035|FG000|Overall Study|Does not meet entrance criteria|14|||
105740396|NCT00907881|364705036|FG000|Overall Study|Lost to Follow-up|59|||
105740397|NCT00907881|364705036|FG000|Overall Study|Noncompliance|5|||
105740398|NCT00907881|364705036|FG000|Overall Study|Withdrawal by Subject|5|||
105740399|NCT00907881|364705036|FG000|Overall Study|Protocol Violation|1|||
105740400|NCT00907881|364705036|FG000|Overall Study|Missing discontinuation information|15|||
105740401|NCT02561000|364705037|FG000|Overall Study|Withdrawal by Subject|2|||
105740402|NCT02561000|364705038|FG001|Overall Study|Withdrawal by Subject|3|||
105740403|NCT02561000|364705039|FG002|Overall Study|Withdrawal by Subject|0|||
105740404|NCT02561000|364705037|FG000|Overall Study|Adverse Event|0|||
105740405|NCT02561000|364705038|FG001|Overall Study|Adverse Event|1|||
105740406|NCT02561000|364705039|FG002|Overall Study|Adverse Event|0|||
105740407|NCT01809262|364705040|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740408|NCT01809262|364705041|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740409|NCT01809262|364705042|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740410|NCT01809262|364705043|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
105358256|NCT01030718|363317091|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
105358257|NCT01030718|363317089|FG000|Studies CA180-031 and -036 Combined|Death|0|||
105358258|NCT01030718|363317090|FG001|Studies CA180-031 and -036 Combined|Death|1|||
105358259|NCT01030718|363317091|FG002|Studies CA180-031 and -036 Combined|Death|0|||
105358260|NCT01030718|363317089|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
105358261|NCT01030718|363317090|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
105358262|NCT01030718|363317091|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
105358263|NCT01030718|363317089|FG000|Study CA180-036 Only|insufficient effect|1|||
105358264|NCT01030718|363317090|FG001|Study CA180-036 Only|insufficient effect|1|||
105358265|NCT01030718|363317091|FG002|Study CA180-036 Only|insufficient effect|5|||
105358266|NCT01030718|363317089|FG000|Study CA180-036 Only|Adverse Event|2|||
105358267|NCT01030718|363317090|FG001|Study CA180-036 Only|Adverse Event|3|||
105358268|NCT01030718|363317091|FG002|Study CA180-036 Only|Adverse Event|0|||
105358269|NCT01030718|363317089|FG000|Study CA180-036 Only|Death|0|||
105740411|NCT01809262|364705044|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
105740412|NCT01809262|364705045|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740413|NCT01809262|364705046|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740414|NCT01809262|364705047|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740415|NCT01809262|364705048|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740416|NCT01809262|364705049|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740417|NCT01809262|364705040|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740418|NCT01809262|364705041|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
105740419|NCT01809262|364705042|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740420|NCT01809262|364705043|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740421|NCT01809262|364705044|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740422|NCT01809262|364705045|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740423|NCT01809262|364705046|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740424|NCT01809262|364705047|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740425|NCT01809262|364705048|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740426|NCT01809262|364705049|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740427|NCT04230486|364705063|FG000|Overall Study|Screen Failure|1|||
105740428|NCT03215264|364705064|FG000|Dose Level 2|Adverse Event|0|||
105740429|NCT03215264|364705065|FG001|Dose Level 2|Adverse Event|1|||
105740430|NCT03215264|364705066|FG002|Dose Level 2|Adverse Event|0|||
105740431|NCT03215264|364705064|FG000|Dose Level 3|Withdrawal by Subject|0|||
105740432|NCT03215264|364705065|FG001|Dose Level 3|Withdrawal by Subject|0|||
105740433|NCT03215264|364705066|FG002|Dose Level 3|Withdrawal by Subject|1|||
105740434|NCT02064439|364705067|FG000|Overall Study|Adverse Event|51|||
105740435|NCT02064439|364705068|FG001|Overall Study|Adverse Event|47|||
105740436|NCT02064439|364705069|FG002|Overall Study|Adverse Event|46|||
105740437|NCT02064439|364705067|FG000|Overall Study|Death|0|||
105740438|NCT02064439|364705068|FG001|Overall Study|Death|2|||
105740439|NCT02064439|364705069|FG002|Overall Study|Death|3|||
105740440|NCT02064439|364705067|FG000|Overall Study|Withdrawal by Subject|29|||
105740441|NCT02064439|364705068|FG001|Overall Study|Withdrawal by Subject|18|||
105740442|NCT02064439|364705069|FG002|Overall Study|Withdrawal by Subject|26|||
105740443|NCT02064439|364705067|FG000|Overall Study|Protocol Violation|3|||
105740444|NCT02064439|364705068|FG001|Overall Study|Protocol Violation|5|||
105740445|NCT02064439|364705069|FG002|Overall Study|Protocol Violation|3|||
105740446|NCT02064439|364705067|FG000|Overall Study|Lost to Follow-up|1|||
105740447|NCT02064439|364705068|FG001|Overall Study|Lost to Follow-up|3|||
105740448|NCT02064439|364705069|FG002|Overall Study|Lost to Follow-up|4|||
105740449|NCT02064439|364705067|FG000|Overall Study|Non-compliance with study medication|21|||
105740450|NCT02064439|364705068|FG001|Overall Study|Non-compliance with study medication|19|||
105740451|NCT02064439|364705069|FG002|Overall Study|Non-compliance with study medication|23|||
105740452|NCT02064439|364705067|FG000|Overall Study|Physician Decision|0|||
105740453|NCT02064439|364705068|FG001|Overall Study|Physician Decision|1|||
105740454|NCT02064439|364705069|FG002|Overall Study|Physician Decision|1|||
105740455|NCT02064439|364705067|FG000|Overall Study|Logistical difficulties|6|||
105740456|NCT02064439|364705068|FG001|Overall Study|Logistical difficulties|5|||
105740457|NCT02064439|364705069|FG002|Overall Study|Logistical difficulties|2|||
105740458|NCT02064439|364705067|FG000|Overall Study|Efficacy outcome reached|18|||
105358270|NCT01030718|363317090|FG001|Study CA180-036 Only|Death|1|||
105740459|NCT02064439|364705068|FG001|Overall Study|Efficacy outcome reached|16|||
105740460|NCT02064439|364705069|FG002|Overall Study|Efficacy outcome reached|57|||
105740461|NCT02064439|364705067|FG000|Overall Study|Safety outcome reached|12|||
105740462|NCT02064439|364705068|FG001|Overall Study|Safety outcome reached|20|||
105740463|NCT02064439|364705069|FG002|Overall Study|Safety outcome reached|10|||
105740464|NCT02064439|364705067|FG000|Overall Study|Other|2|||
105740465|NCT02064439|364705068|FG001|Overall Study|Other|2|||
105740466|NCT02064439|364705069|FG002|Overall Study|Other|7|||
105740467|NCT02234583|364705072|FG000|Overall Study|Adverse Event|172|||
105740468|NCT02234583|364705073|FG001|Overall Study|Adverse Event|156|||
105740469|NCT02234583|364705072|FG000|Overall Study|Withdrawal by Subject|109|||
105358271|NCT01030718|363317091|FG002|Study CA180-036 Only|Death|0|||
105358272|NCT01030718|363317089|FG000|Study CA180-036 Only|Other Reasons|0|||
105740470|NCT02234583|364705073|FG001|Overall Study|Withdrawal by Subject|157|||
105740471|NCT02234583|364705072|FG000|Overall Study|Lost to Follow-up|0|||
105740472|NCT02234583|364705073|FG001|Overall Study|Lost to Follow-up|1|||
105740473|NCT02234583|364705072|FG000|Overall Study|Lack of Efficacy|58|||
105740474|NCT02234583|364705073|FG001|Overall Study|Lack of Efficacy|103|||
105740475|NCT02234583|364705072|FG000|Overall Study|Protocol Violation|35|||
105740476|NCT02234583|364705073|FG001|Overall Study|Protocol Violation|42|||
105740477|NCT02234583|364705072|FG000|Overall Study|Other|39|||
105740478|NCT02234583|364705073|FG001|Overall Study|Other|97|||
105740479|NCT01740440|364705074|FG000|Overall Study|Lost to Follow-up|3|||
105740480|NCT01849250|364705075|FG000|Overall Study|Withdrawal by Subject|1|||
105740481|NCT01849250|364705076|FG001|Overall Study|Withdrawal by Subject|0|||
105740482|NCT01849250|364705075|FG000|Overall Study|Not Evaluable|5|||
105740483|NCT01849250|364705076|FG001|Overall Study|Not Evaluable|3|||
105740484|NCT01849250|364705075|FG000|Overall Study|Screen Failure|1|||
105740485|NCT01849250|364705076|FG001|Overall Study|Screen Failure|0|||
105740486|NCT00367640|364705077|FG000|Overall Study|Adverse Event|3|||
105740487|NCT00367640|364705078|FG001|Overall Study|Adverse Event|6|||
105740488|NCT00367640|364705079|FG002|Overall Study|Adverse Event|8|||
105740489|NCT00367640|364705080|FG003|Overall Study|Adverse Event|0|||
105740490|NCT00367640|364705077|FG000|Overall Study|Withdrawal by Subject|8|||
105740491|NCT00367640|364705078|FG001|Overall Study|Withdrawal by Subject|11|||
105740492|NCT00367640|364705079|FG002|Overall Study|Withdrawal by Subject|8|||
105740493|NCT00367640|364705080|FG003|Overall Study|Withdrawal by Subject|6|||
105740494|NCT00367640|364705077|FG000|Overall Study|Any other reason not above-mentioned|7|||
105740495|NCT00367640|364705078|FG001|Overall Study|Any other reason not above-mentioned|5|||
105740496|NCT00367640|364705079|FG002|Overall Study|Any other reason not above-mentioned|3|||
105740497|NCT00367640|364705080|FG003|Overall Study|Any other reason not above-mentioned|4|||
105740498|NCT04504032|364705082|FG000|Overall Study|Adverse Event|1|||
105740499|NCT04504032|364705083|FG001|Overall Study|Adverse Event|2|||
105740500|NCT04504032|364705082|FG000|Overall Study|Lost to Follow-up|6|||
105740501|NCT04504032|364705083|FG001|Overall Study|Lost to Follow-up|9|||
105740502|NCT04504032|364705082|FG000|Overall Study|Protocol Violation|2|||
105740503|NCT04504032|364705083|FG001|Overall Study|Protocol Violation|0|||
105740504|NCT04504032|364705082|FG000|Overall Study|Study terminated by sponsor|1|||
105740505|NCT04504032|364705083|FG001|Overall Study|Study terminated by sponsor|2|||
105740506|NCT04504032|364705082|FG000|Overall Study|Withdrawal by Subject|9|||
105740507|NCT04504032|364705083|FG001|Overall Study|Withdrawal by Subject|11|||
105740508|NCT04504032|364705082|FG000|Overall Study|Disease progression prior to dosing|15|||
105740509|NCT04504032|364705083|FG001|Overall Study|Disease progression prior to dosing|3|||
105740510|NCT04504032|364705082|FG000|Overall Study|Drug supply issues|1|||
105740511|NCT04504032|364705083|FG001|Overall Study|Drug supply issues|1|||
105740512|NCT04504032|364705082|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
105740513|NCT04504032|364705083|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
105740514|NCT02805907|364705084|FG000|Overall Study|Lost to Follow-up|3|||
105740515|NCT02805907|364705085|FG001|Overall Study|Lost to Follow-up|3|||
105740516|NCT01264965|364705086|FG000|Overall Study|Withdrawal by Subject|10|||
105740517|NCT00940342|364705088|FG000|Overall Study|Adverse Event|0|||
105740518|NCT00940342|364705089|FG001|Overall Study|Adverse Event|2|||
105740519|NCT00940342|364705090|FG002|Overall Study|Adverse Event|1|||
105740520|NCT02214186|364705093|FG000|Overall Study|Lost to Follow-up|1|||
105740521|NCT02214186|364705094|FG001|Overall Study|Lost to Follow-up|1|||
105740522|NCT02214186|364705093|FG000|Overall Study|Protocol Violation|1|||
105740523|NCT02214186|364705094|FG001|Overall Study|Protocol Violation|1|||
105740524|NCT02142894|364705095|FG000|Overall Study|Protocol Violation|8|||
105740525|NCT02116972|364705108|FG000|Overall Study|Adverse Event|4|||
105740526|NCT02116972|364705109|FG001|Overall Study|Adverse Event|4|||
105740527|NCT02116972|364705110|FG002|Overall Study|Adverse Event|1|||
105740528|NCT02116972|364705108|FG000|Overall Study|Withdrawal by Subject|1|||
105740529|NCT02116972|364705109|FG001|Overall Study|Withdrawal by Subject|1|||
105740530|NCT02116972|364705110|FG002|Overall Study|Withdrawal by Subject|5|||
105740531|NCT02116972|364705108|FG000|Overall Study|Protocol Violation|1|||
105740532|NCT02116972|364705109|FG001|Overall Study|Protocol Violation|0|||
105740533|NCT02116972|364705110|FG002|Overall Study|Protocol Violation|1|||
105740534|NCT02116972|364705108|FG000|Overall Study|Lost to Follow-up|4|||
105740535|NCT02116972|364705109|FG001|Overall Study|Lost to Follow-up|3|||
105740536|NCT02116972|364705110|FG002|Overall Study|Lost to Follow-up|1|||
105740537|NCT02116972|364705108|FG000|Overall Study|Lack of Efficacy|6|||
105740538|NCT02116972|364705109|FG001|Overall Study|Lack of Efficacy|6|||
105740539|NCT02116972|364705110|FG002|Overall Study|Lack of Efficacy|5|||
105740540|NCT02116972|364705108|FG000|Overall Study|scheduling conflicts and relocation|3|||
105740541|NCT02116972|364705109|FG001|Overall Study|scheduling conflicts and relocation|3|||
105740542|NCT02116972|364705110|FG002|Overall Study|scheduling conflicts and relocation|6|||
105740543|NCT00784784|364705111|FG000|Overall Study|Withdrawal by Subject|2|||
105358273|NCT01030718|363317090|FG001|Study CA180-036 Only|Other Reasons|2|||
105740544|NCT00784784|364705112|FG001|Overall Study|Withdrawal by Subject|2|||
105740545|NCT01400971|364705113|FG000|Overall Study|Death|82|||
105740546|NCT01400971|364705113|FG000|Overall Study|Lost to Follow-up|196|||
105740547|NCT01400971|364705113|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
105740548|NCT01400971|364705113|FG000|Overall Study|Physician Decision|57|||
105740549|NCT01400971|364705113|FG000|Overall Study|Withdrawal by Subject|158|||
105740550|NCT01400971|364705113|FG000|Overall Study|Other|422|||
105740551|NCT01905397|364705114|FG000|Overall Study|Death|0|||
105740552|NCT01905397|364705115|FG001|Overall Study|Death|1|||
105740553|NCT01905397|364705114|FG000|Overall Study|Withdrawal by Subject|2|||
105740554|NCT01905397|364705115|FG001|Overall Study|Withdrawal by Subject|0|||
105740555|NCT01905397|364705114|FG000|Overall Study|Surgery canceled/aborted|9|||
105740556|NCT01905397|364705115|FG001|Overall Study|Surgery canceled/aborted|5|||
105740557|NCT01905397|364705114|FG000|Overall Study|Incision < 7 cm|2|||
105740558|NCT01905397|364705115|FG001|Overall Study|Incision < 7 cm|0|||
105740559|NCT01905397|364705114|FG000|Overall Study|Wrong treatment|1|||
105740560|NCT01905397|364705115|FG001|Overall Study|Wrong treatment|1|||
105740561|NCT01905397|364705114|FG000|Overall Study|Device not applied|3|||
105740562|NCT01905397|364705115|FG001|Overall Study|Device not applied|0|||
105740563|NCT01905397|364705114|FG000|Overall Study|Dressing not applied in operating room|1|||
105740564|NCT01905397|364705115|FG001|Overall Study|Dressing not applied in operating room|0|||
105740565|NCT01905397|364705114|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
105740566|NCT01905397|364705115|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
105740567|NCT01035255|364705119|FG000|Overall Study|Death|724|||
105740568|NCT01035255|364705120|FG001|Overall Study|Death|844|||
105740569|NCT01035255|364705119|FG000|Overall Study|Lost to Follow-up|2|||
105740570|NCT01035255|364705120|FG001|Overall Study|Lost to Follow-up|5|||
105740571|NCT01035255|364705119|FG000|Overall Study|patient's request|15|||
105740572|NCT01035255|364705120|FG001|Overall Study|patient's request|13|||
105740573|NCT01921270|364705121|FG000|Overall Study|Withdrawal by Subject|1|||
105740574|NCT00789477|364705122|FG000|Overall Study|Withdrawal by Subject|2|||
105740575|NCT00789477|364705123|FG001|Overall Study|Withdrawal by Subject|1|||
105740576|NCT00789477|364705124|FG002|Overall Study|Withdrawal by Subject|3|||
105740577|NCT00789477|364705125|FG003|Overall Study|Withdrawal by Subject|2|||
105740578|NCT00789477|364705126|FG004|Overall Study|Withdrawal by Subject|3|||
105740579|NCT00789477|364705122|FG000|Overall Study|Protocol Violation|1|||
105740580|NCT00789477|364705123|FG001|Overall Study|Protocol Violation|0|||
105740581|NCT00789477|364705124|FG002|Overall Study|Protocol Violation|0|||
105740582|NCT00789477|364705125|FG003|Overall Study|Protocol Violation|1|||
105740583|NCT00789477|364705126|FG004|Overall Study|Protocol Violation|0|||
105740584|NCT00789477|364705122|FG000|Overall Study|Adverse Event|3|||
105740585|NCT00789477|364705123|FG001|Overall Study|Adverse Event|3|||
105740586|NCT00789477|364705124|FG002|Overall Study|Adverse Event|1|||
105740587|NCT00789477|364705125|FG003|Overall Study|Adverse Event|0|||
105740588|NCT00789477|364705126|FG004|Overall Study|Adverse Event|0|||
105740589|NCT00789477|364705122|FG000|Overall Study|Death|1|||
105740590|NCT00789477|364705123|FG001|Overall Study|Death|1|||
105740591|NCT00789477|364705124|FG002|Overall Study|Death|2|||
105740592|NCT00789477|364705125|FG003|Overall Study|Death|2|||
105740593|NCT00789477|364705126|FG004|Overall Study|Death|0|||
105740594|NCT00789477|364705122|FG000|Overall Study|Lost to Follow-up|0|||
105740595|NCT00789477|364705123|FG001|Overall Study|Lost to Follow-up|1|||
105740596|NCT00789477|364705124|FG002|Overall Study|Lost to Follow-up|4|||
105740597|NCT00789477|364705125|FG003|Overall Study|Lost to Follow-up|2|||
105740598|NCT00789477|364705126|FG004|Overall Study|Lost to Follow-up|4|||
105740599|NCT00789477|364705122|FG000|Overall Study|Lack of Efficacy|2|||
105740600|NCT00789477|364705123|FG001|Overall Study|Lack of Efficacy|0|||
105740601|NCT00789477|364705124|FG002|Overall Study|Lack of Efficacy|0|||
105740602|NCT00789477|364705125|FG003|Overall Study|Lack of Efficacy|0|||
105740603|NCT00789477|364705126|FG004|Overall Study|Lack of Efficacy|0|||
105740604|NCT00789477|364705122|FG000|Overall Study|Other|2|||
105740605|NCT00789477|364705123|FG001|Overall Study|Other|0|||
105740606|NCT00789477|364705124|FG002|Overall Study|Other|1|||
105740607|NCT00789477|364705125|FG003|Overall Study|Other|3|||
105740608|NCT00789477|364705126|FG004|Overall Study|Other|0|||
105740609|NCT02137772|364705127|FG000|Overall Study|Adverse Event|6|||
105740610|NCT02137772|364705128|FG001|Overall Study|Adverse Event|3|||
105740611|NCT02137772|364705127|FG000|Overall Study|Death|71|||
105740612|NCT02137772|364705128|FG001|Overall Study|Death|44|||
105740613|NCT02137772|364705127|FG000|Overall Study|Lost to Follow-up|8|||
105740614|NCT02137772|364705128|FG001|Overall Study|Lost to Follow-up|4|||
105740615|NCT02137772|364705127|FG000|Overall Study|Physician Decision|15|||
105740616|NCT02137772|364705128|FG001|Overall Study|Physician Decision|5|||
105740617|NCT02137772|364705127|FG000|Overall Study|Withdrawal by Subject|28|||
105740618|NCT02137772|364705128|FG001|Overall Study|Withdrawal by Subject|17|||
105740619|NCT02137772|364705127|FG000|Overall Study|Non-compliance with study drug|1|||
105740620|NCT02137772|364705128|FG001|Overall Study|Non-compliance with study drug|0|||
105740621|NCT02137772|364705127|FG000|Overall Study|Not treated|3|||
105740622|NCT02137772|364705128|FG001|Overall Study|Not treated|2|||
105740623|NCT02092389|364705129|FG000|Overall Study|Adverse Event|1|||
105740624|NCT02092389|364705129|FG000|Overall Study|Other|5|||
105740625|NCT01844700|364705130|FG000|Overall Study|Lack of Efficacy|1|||
105740626|NCT01844700|364705131|FG001|Overall Study|Lack of Efficacy|0|||
105740627|NCT01844700|364705130|FG000|Overall Study|refused medication switch|1|||
105740628|NCT01844700|364705131|FG001|Overall Study|refused medication switch|0|||
105740629|NCT01844700|364705130|FG000|Overall Study|Withdrawal by Subject|1|||
105740630|NCT01844700|364705131|FG001|Overall Study|Withdrawal by Subject|0|||
105740631|NCT01844700|364705130|FG000|Overall Study|stopped taking meds|0|||
105740632|NCT01844700|364705131|FG001|Overall Study|stopped taking meds|1|||
105740633|NCT02375698|364705132|FG000|Overall Study|Withdrawal by Subject|0|||
105740634|NCT02375698|364705133|FG001|Overall Study|Withdrawal by Subject|2|||
105740635|NCT02375698|364705132|FG000|Overall Study|Physician Decision|2|||
105740636|NCT02375698|364705133|FG001|Overall Study|Physician Decision|0|||
105740637|NCT01052012|364705137|FG000|Overall Study|Not treated|2|||
105740638|NCT01052012|364705138|FG001|Overall Study|Not treated|5|||
105740639|NCT01052012|364705139|FG002|Overall Study|Not treated|0|||
105740640|NCT01052012|364705140|FG003|Overall Study|Not treated|0|||
105740641|NCT01052012|364705141|FG004|Overall Study|Not treated|11|||
105740642|NCT01052012|364705142|FG005|Overall Study|Not treated|8|||
105740643|NCT01052012|364705137|FG000|Overall Study|Adverse Event|1|||
105740644|NCT01052012|364705138|FG001|Overall Study|Adverse Event|0|||
105740645|NCT01052012|364705139|FG002|Overall Study|Adverse Event|0|||
105740646|NCT01052012|364705140|FG003|Overall Study|Adverse Event|1|||
105740647|NCT01052012|364705141|FG004|Overall Study|Adverse Event|0|||
105740648|NCT01052012|364705142|FG005|Overall Study|Adverse Event|0|||
105740649|NCT01052012|364705137|FG000|Overall Study|Lost to Follow-up|0|||
105740650|NCT01052012|364705138|FG001|Overall Study|Lost to Follow-up|0|||
105740651|NCT01052012|364705139|FG002|Overall Study|Lost to Follow-up|0|||
105740652|NCT01052012|364705140|FG003|Overall Study|Lost to Follow-up|0|||
105740653|NCT01052012|364705141|FG004|Overall Study|Lost to Follow-up|1|||
105740654|NCT01052012|364705142|FG005|Overall Study|Lost to Follow-up|0|||
105740655|NCT01052012|364705137|FG000|Overall Study|Withdrawal by Subject|1|||
105740656|NCT01052012|364705138|FG001|Overall Study|Withdrawal by Subject|1|||
105740657|NCT01052012|364705139|FG002|Overall Study|Withdrawal by Subject|0|||
105740658|NCT01052012|364705140|FG003|Overall Study|Withdrawal by Subject|0|||
105740659|NCT01052012|364705141|FG004|Overall Study|Withdrawal by Subject|3|||
105740660|NCT01052012|364705142|FG005|Overall Study|Withdrawal by Subject|1|||
105740661|NCT01052012|364705137|FG000|Overall Study|Physician Decision|0|||
105740662|NCT01052012|364705138|FG001|Overall Study|Physician Decision|0|||
105740663|NCT01052012|364705139|FG002|Overall Study|Physician Decision|0|||
105358274|NCT01030718|363317091|FG002|Study CA180-036 Only|Other Reasons|0|||
105358275|NCT03131687|363317092|FG000|Overall Study|Adverse Event|0|||
105358276|NCT03131687|363317093|FG001|Overall Study|Adverse Event|1|||
105358277|NCT03131687|363317094|FG002|Overall Study|Adverse Event|0|||
105358278|NCT03131687|363317095|FG003|Overall Study|Adverse Event|1|||
105358279|NCT03131687|363317096|FG004|Overall Study|Adverse Event|2|||
105740664|NCT01052012|364705140|FG003|Overall Study|Physician Decision|0|||
105740665|NCT01052012|364705141|FG004|Overall Study|Physician Decision|0|||
105740666|NCT01052012|364705142|FG005|Overall Study|Physician Decision|1|||
105740667|NCT01052012|364705137|FG000|Overall Study|Other|0|||
105740668|NCT01052012|364705138|FG001|Overall Study|Other|0|||
105740669|NCT01052012|364705139|FG002|Overall Study|Other|0|||
105740670|NCT01052012|364705140|FG003|Overall Study|Other|0|||
105740671|NCT01052012|364705141|FG004|Overall Study|Other|1|||
105740672|NCT01052012|364705142|FG005|Overall Study|Other|0|||
105740673|NCT00564629|364705145|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
105740674|NCT00564629|364705146|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
105740675|NCT03280550|364705150|FG000|Overall Study|Withdrawal by Subject|2|||
105740676|NCT03280550|364705151|FG001|Overall Study|Withdrawal by Subject|2|||
105740677|NCT03280550|364705150|FG000|Overall Study|Physician Decision|0|||
105740678|NCT03280550|364705151|FG001|Overall Study|Physician Decision|1|||
105740679|NCT02144220|364705153|FG000|Overall Study|technology incompatibility|9|||
105740680|NCT02144220|364705153|FG000|Overall Study|Lack of Efficacy|4|||
105740681|NCT02144220|364705153|FG000|Overall Study|Physician Decision|3|||
105740682|NCT02144220|364705153|FG000|Overall Study|Withdrawal by Subject|2|||
105740683|NCT02144220|364705153|FG000|Overall Study|Protocol Violation|1|||
105740684|NCT01096446|364706914|FG000|Overall Study|Death|1|||
105740685|NCT01096446|364706915|FG001|Overall Study|Death|0|||
105740686|NCT01096446|364706914|FG000|Overall Study|Protocol Violation|2|||
105740687|NCT01096446|364706915|FG001|Overall Study|Protocol Violation|0|||
105740688|NCT01240811|364706916|FG000|Overall Study|Physician Decision|0|||
105740689|NCT01240811|364706917|FG001|Overall Study|Physician Decision|1|||
105740690|NCT01240811|364706918|FG002|Overall Study|Physician Decision|0|||
105740691|NCT01240811|364706916|FG000|Overall Study|Withdrawal by Subject|0|||
105740692|NCT01240811|364706917|FG001|Overall Study|Withdrawal by Subject|0|||
105740693|NCT01240811|364706918|FG002|Overall Study|Withdrawal by Subject|1|||
105740694|NCT02410902|364706921|FG000|Overall Study|Adverse Event|2|||
105740695|NCT02410902|364706922|FG001|Overall Study|Adverse Event|3|||
105740696|NCT02410902|364706921|FG000|Overall Study|Lost to Follow-up|4|||
105740697|NCT02410902|364706922|FG001|Overall Study|Lost to Follow-up|1|||
105740698|NCT02410902|364706921|FG000|Overall Study|Protocol Violation|1|||
105740699|NCT02410902|364706922|FG001|Overall Study|Protocol Violation|4|||
105740700|NCT02410902|364706921|FG000|Overall Study|Withdrawal by Subject|6|||
105740701|NCT02410902|364706922|FG001|Overall Study|Withdrawal by Subject|8|||
105740702|NCT02410902|364706921|FG000|Overall Study|Non-Compliance|8|||
105740703|NCT02410902|364706922|FG001|Overall Study|Non-Compliance|2|||
105740704|NCT01746732|364706923|FG000|Lead-In Period|Withdrawal by Subject|1|||
105740705|NCT01746732|364706924|FG001|Lead-In Period|Withdrawal by Subject|0|||
105740706|NCT01746732|364706925|FG002|Lead-In Period|Withdrawal by Subject|0|||
105740707|NCT01746732|364706923|FG000|Period 1|Physician Decision|0|||
105740708|NCT01746732|364706924|FG001|Period 1|Physician Decision|1|||
105740709|NCT01746732|364706925|FG002|Period 1|Physician Decision|0|||
105740710|NCT01746732|364706923|FG000|Period 2|Withdrawal by Subject|0|||
105740711|NCT01746732|364706924|FG001|Period 2|Withdrawal by Subject|0|||
105740712|NCT01746732|364706925|FG002|Period 2|Withdrawal by Subject|2|||
105740713|NCT01746732|364706923|FG000|Period 2|Adverse Event|0|||
105740714|NCT01746732|364706924|FG001|Period 2|Adverse Event|0|||
105740715|NCT01746732|364706925|FG002|Period 2|Adverse Event|1|||
105740716|NCT01746732|364706923|FG000|Period 2|Lost to Follow-up|0|||
105740717|NCT01746732|364706924|FG001|Period 2|Lost to Follow-up|0|||
105358280|NCT03131687|363317097|FG005|Overall Study|Adverse Event|2|||
105482853|NCT02616146|363780770|FG001|Overall Study|Lost to Follow-up|13|||
105482854|NCT02616146|363780769|FG000|Overall Study|Non-compliance with study protocol|2|||
105482855|NCT02616146|363780770|FG001|Overall Study|Non-compliance with study protocol|0|||
105482856|NCT02616146|363780769|FG000|Overall Study|Non-compliance with study drug|4|||
105740718|NCT01746732|364706925|FG002|Period 2|Lost to Follow-up|1|||
105740719|NCT02817555|364706926|FG000|Overall Study|Death|1|||
105740720|NCT02817555|364706927|FG001|Overall Study|Death|3|||
105740721|NCT02817555|364706926|FG000|Overall Study|moved away|1|||
105358281|NCT03131687|363317092|FG000|Overall Study|Death|1|||
105358282|NCT03131687|363317093|FG001|Overall Study|Death|0|||
105358283|NCT03131687|363317094|FG002|Overall Study|Death|0|||
105740722|NCT02817555|364706927|FG001|Overall Study|moved away|0|||
105740723|NCT02817555|364706926|FG000|Overall Study|transplant|1|||
105740724|NCT02817555|364706927|FG001|Overall Study|transplant|1|||
105740725|NCT02817555|364706926|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
105740726|NCT02817555|364706927|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
105740727|NCT01432262|364706928|FG000|Overall Study|Withdrawal by Subject|2|||
105740728|NCT01432262|364706929|FG001|Overall Study|Withdrawal by Subject|1|||
105740729|NCT04657016|364706930|FG000|Overall Study|Adverse Event|2|||
105740730|NCT04657016|364706931|FG001|Overall Study|Adverse Event|4|||
105740731|NCT04657016|364706930|FG000|Overall Study|Death|1|||
105740732|NCT04657016|364706931|FG001|Overall Study|Death|1|||
105740733|NCT04657016|364706930|FG000|Overall Study|Lost to Follow-up|24|||
105740734|NCT04657016|364706931|FG001|Overall Study|Lost to Follow-up|12|||
105740735|NCT04657016|364706930|FG000|Overall Study|Physician Decision|1|||
105740736|NCT04657016|364706931|FG001|Overall Study|Physician Decision|2|||
105740737|NCT04657016|364706930|FG000|Overall Study|Pregnancy|2|||
105740738|NCT04657016|364706931|FG001|Overall Study|Pregnancy|2|||
105740739|NCT04657016|364706930|FG000|Overall Study|Protocol Deviation|1|||
105740740|NCT04657016|364706931|FG001|Overall Study|Protocol Deviation|0|||
105740741|NCT04657016|364706930|FG000|Overall Study|Withdrawal by Subject|28|||
105740742|NCT04657016|364706931|FG001|Overall Study|Withdrawal by Subject|14|||
105740743|NCT04657016|364706930|FG000|Overall Study|Other - as reported by the investigator|6|||
105740744|NCT04657016|364706931|FG001|Overall Study|Other - as reported by the investigator|0|||
105740745|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
105740746|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
105740747|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
105740748|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
105740749|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Death|8|||
105740750|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Death|3|||
105740751|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
105740752|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
105740753|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
105740754|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
105740755|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
105740756|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
105740757|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
105740758|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
105740759|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
105740760|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
105740761|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
105740762|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
105740763|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
105740764|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
105740765|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
105740766|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
105740767|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
105740768|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
105740769|NCT00494871|364706932|FG000|Follow-up (FU) Period|Adverse Event|1|||
105740770|NCT00494871|364706933|FG001|Follow-up (FU) Period|Adverse Event|1|||
105740771|NCT00494871|364706932|FG000|Follow-up (FU) Period|Death|13|||
105740772|NCT00494871|364706933|FG001|Follow-up (FU) Period|Death|12|||
105740773|NCT00494871|364706932|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
105740774|NCT00494871|364706933|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
105740775|NCT00494871|364706932|FG000|Follow-up (FU) Period|Physician Decision|0|||
105740776|NCT00494871|364706933|FG001|Follow-up (FU) Period|Physician Decision|1|||
105740777|NCT00494871|364706932|FG000|Follow-up (FU) Period|Protocol Violation|1|||
105740778|NCT00494871|364706933|FG001|Follow-up (FU) Period|Protocol Violation|0|||
105740779|NCT00494871|364706932|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
105740780|NCT00494871|364706933|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
105740781|NCT00494871|364706932|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
105358284|NCT03131687|363317095|FG003|Overall Study|Death|0|||
105740782|NCT00494871|364706933|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
105740783|NCT02078713|364706936|FG000|Overall Study|Lost to Follow-up|49|||
105740784|NCT02078713|364706937|FG001|Overall Study|Lost to Follow-up|55|||
105740785|NCT02078713|364706938|FG002|Overall Study|Lost to Follow-up|0|||
105740786|NCT02078713|364706939|FG003|Overall Study|Lost to Follow-up|0|||
105358285|NCT03131687|363317096|FG004|Overall Study|Death|0|||
105740787|NCT02078713|364706936|FG000|Overall Study|Pregnant at baseline|3|||
105740788|NCT02078713|364706937|FG001|Overall Study|Pregnant at baseline|5|||
105740789|NCT02078713|364706938|FG002|Overall Study|Pregnant at baseline|0|||
105740790|NCT02078713|364706939|FG003|Overall Study|Pregnant at baseline|0|||
105740791|NCT02078713|364706936|FG000|Overall Study|Enrolled twice|0|||
105740792|NCT02078713|364706937|FG001|Overall Study|Enrolled twice|1|||
105740793|NCT02078713|364706938|FG002|Overall Study|Enrolled twice|0|||
105740794|NCT02078713|364706939|FG003|Overall Study|Enrolled twice|0|||
105740795|NCT01104558|364706944|FG000|Overall Study|Protocol Violation|6|||
105740796|NCT01104558|364706944|FG000|Overall Study|Missing of primary efficacy assessment|10|||
105740797|NCT01104558|364706944|FG000|Overall Study|Missing of genetic analysis results|1|||
105740798|NCT04543955|364706945|FG000|Overall Study|Company cancelled study|1|||
105740799|NCT04543955|364706946|FG001|Overall Study|Company cancelled study|0|||
105740800|NCT00696657|364706947|FG000|Overall Study|Protocol Violation|0|||
105740801|NCT00696657|364706948|FG001|Overall Study|Protocol Violation|0|||
105740802|NCT00696657|364706949|FG002|Overall Study|Protocol Violation|0|||
105740803|NCT00696657|364706950|FG003|Overall Study|Protocol Violation|0|||
105740804|NCT00696657|364706951|FG004|Overall Study|Protocol Violation|0|||
105740805|NCT00696657|364706952|FG005|Overall Study|Protocol Violation|1|||
105740806|NCT00696657|364706953|FG006|Overall Study|Protocol Violation|0|||
105740807|NCT00696657|364706954|FG007|Overall Study|Protocol Violation|0|||
105740808|NCT00696657|364706955|FG008|Overall Study|Protocol Violation|1|||
105740809|NCT00696657|364706947|FG000|Overall Study|Lack of Efficacy|0|||
105740810|NCT00696657|364706948|FG001|Overall Study|Lack of Efficacy|1|||
105740811|NCT00696657|364706949|FG002|Overall Study|Lack of Efficacy|0|||
105740812|NCT00696657|364706950|FG003|Overall Study|Lack of Efficacy|0|||
105740813|NCT00696657|364706951|FG004|Overall Study|Lack of Efficacy|0|||
105740814|NCT00696657|364706952|FG005|Overall Study|Lack of Efficacy|0|||
105740815|NCT00696657|364706953|FG006|Overall Study|Lack of Efficacy|0|||
105740816|NCT00696657|364706954|FG007|Overall Study|Lack of Efficacy|0|||
105740817|NCT00696657|364706955|FG008|Overall Study|Lack of Efficacy|0|||
105740818|NCT00696657|364706947|FG000|Overall Study|Withdrawal criteria|1|||
105740819|NCT00696657|364706948|FG001|Overall Study|Withdrawal criteria|3|||
105740820|NCT00696657|364706949|FG002|Overall Study|Withdrawal criteria|2|||
105740821|NCT00696657|364706950|FG003|Overall Study|Withdrawal criteria|2|||
105740822|NCT00696657|364706951|FG004|Overall Study|Withdrawal criteria|0|||
105482857|NCT02616146|363780770|FG001|Overall Study|Non-compliance with study drug|2|||
105482858|NCT02616146|363780769|FG000|Overall Study|Pregnancy|2|||
105740823|NCT00696657|364706952|FG005|Overall Study|Withdrawal criteria|0|||
105740824|NCT00696657|364706953|FG006|Overall Study|Withdrawal criteria|1|||
105740825|NCT00696657|364706954|FG007|Overall Study|Withdrawal criteria|1|||
105740826|NCT00696657|364706955|FG008|Overall Study|Withdrawal criteria|2|||
105740827|NCT00696657|364706947|FG000|Overall Study|Unclassified|0|||
105740828|NCT00696657|364706948|FG001|Overall Study|Unclassified|1|||
105740829|NCT00696657|364706949|FG002|Overall Study|Unclassified|3|||
105740830|NCT00696657|364706950|FG003|Overall Study|Unclassified|2|||
105358286|NCT03131687|363317097|FG005|Overall Study|Death|0|||
105358287|NCT03131687|363317092|FG000|Overall Study|Withdrawal by Subject|3|||
105358288|NCT03131687|363317093|FG001|Overall Study|Withdrawal by Subject|3|||
105358289|NCT03131687|363317094|FG002|Overall Study|Withdrawal by Subject|3|||
105358290|NCT03131687|363317095|FG003|Overall Study|Withdrawal by Subject|1|||
105358291|NCT03131687|363317096|FG004|Overall Study|Withdrawal by Subject|2|||
105358292|NCT03131687|363317097|FG005|Overall Study|Withdrawal by Subject|1|||
105358293|NCT03131687|363317092|FG000|Overall Study|Lost to Follow-up|1|||
105358294|NCT03131687|363317093|FG001|Overall Study|Lost to Follow-up|4|||
105358295|NCT03131687|363317094|FG002|Overall Study|Lost to Follow-up|0|||
105358296|NCT03131687|363317095|FG003|Overall Study|Lost to Follow-up|1|||
105358297|NCT03131687|363317096|FG004|Overall Study|Lost to Follow-up|4|||
105358298|NCT03131687|363317097|FG005|Overall Study|Lost to Follow-up|2|||
105358299|NCT03131687|363317092|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
105358300|NCT03131687|363317093|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
105358301|NCT03131687|363317094|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
105358302|NCT03131687|363317095|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
105482859|NCT02616146|363780770|FG001|Overall Study|Pregnancy|2|||
105740831|NCT00696657|364706951|FG004|Overall Study|Unclassified|4|||
105740832|NCT00696657|364706952|FG005|Overall Study|Unclassified|2|||
105740833|NCT00696657|364706953|FG006|Overall Study|Unclassified|0|||
105740834|NCT00696657|364706954|FG007|Overall Study|Unclassified|0|||
105740835|NCT00696657|364706955|FG008|Overall Study|Unclassified|1|||
105740836|NCT00696657|364706947|FG000|Overall Study|Adverse Event|0|||
105740837|NCT00696657|364706948|FG001|Overall Study|Adverse Event|0|||
105740838|NCT00696657|364706949|FG002|Overall Study|Adverse Event|3|||
105740839|NCT00696657|364706950|FG003|Overall Study|Adverse Event|7|||
105740840|NCT00696657|364706951|FG004|Overall Study|Adverse Event|6|||
105740841|NCT00696657|364706952|FG005|Overall Study|Adverse Event|9|||
105740842|NCT00696657|364706953|FG006|Overall Study|Adverse Event|14|||
105740843|NCT00696657|364706954|FG007|Overall Study|Adverse Event|2|||
105740844|NCT00696657|364706955|FG008|Overall Study|Adverse Event|5|||
105740845|NCT03653507|364706958|FG000|Overall Study|Miscellaneous|26|||
105740846|NCT03653507|364706959|FG001|Overall Study|Miscellaneous|16|||
105740847|NCT03653507|364706958|FG000|Overall Study|Withdrawal by Subject|35|||
105740848|NCT03653507|364706959|FG001|Overall Study|Withdrawal by Subject|23|||
105740849|NCT03653507|364706958|FG000|Overall Study|Protocol Deviation|2|||
105740850|NCT03653507|364706959|FG001|Overall Study|Protocol Deviation|1|||
105740851|NCT03653507|364706958|FG000|Overall Study|Progressive disease|102|||
105740852|NCT03653507|364706959|FG001|Overall Study|Progressive disease|157|||
105740853|NCT03653507|364706958|FG000|Overall Study|Lost to Follow-up|1|||
105740854|NCT03653507|364706959|FG001|Overall Study|Lost to Follow-up|1|||
105740855|NCT03653507|364706958|FG000|Overall Study|Death|24|||
105740856|NCT03653507|364706959|FG001|Overall Study|Death|22|||
105740857|NCT03653507|364706958|FG000|Overall Study|Adverse Event|34|||
105740858|NCT03653507|364706959|FG001|Overall Study|Adverse Event|15|||
105740859|NCT02433210|364706960|FG000|Overall Study|Physician Decision|1|||
105740860|NCT02433210|364706961|FG001|Overall Study|Physician Decision|0|||
105740861|NCT02433210|364706962|FG002|Overall Study|Physician Decision|0|||
105740862|NCT01356602|364706963|FG000|Overall Study|Protocol Deviation|0|||
105358303|NCT03131687|363317096|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
105740863|NCT01356602|364706964|FG001|Overall Study|Protocol Deviation|1|||
105740864|NCT01356602|364706965|FG002|Overall Study|Protocol Deviation|1|||
105740865|NCT01356602|364706963|FG000|Overall Study|Administrative Problems|1|||
105740866|NCT01356602|364706964|FG001|Overall Study|Administrative Problems|4|||
105358304|NCT03131687|363317097|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
105358305|NCT03131687|363317092|FG000|Overall Study|Principle Investigator Decision|0|||
105358306|NCT03131687|363317093|FG001|Overall Study|Principle Investigator Decision|1|||
105740867|NCT01356602|364706965|FG002|Overall Study|Administrative Problems|5|||
105740868|NCT01356602|364706963|FG000|Overall Study|Lost to Follow-up|4|||
105740869|NCT01356602|364706964|FG001|Overall Study|Lost to Follow-up|5|||
105358307|NCT03131687|363317094|FG002|Overall Study|Principle Investigator Decision|0|||
105800025|NCT01335399|364926338|FG001|Pre-treatment Period|Participant request to discontinue|1|||
105800026|NCT01335399|364926337|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
105800027|NCT01335399|364926338|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
105800028|NCT01335399|364926337|FG000|Pre-treatment Period|Consent withdrawal|3|||
105800029|NCT01335399|364926338|FG001|Pre-treatment Period|Consent withdrawal|0|||
105800030|NCT01335399|364926337|FG000|Treatment Period|Disease progression|117|||
105800031|NCT01335399|364926338|FG001|Treatment Period|Disease progression|145|||
105800032|NCT01335399|364926337|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
105800033|NCT01335399|364926338|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
105800034|NCT01335399|364926337|FG000|Treatment Period|Study drug toxicity|52|||
105800035|NCT01335399|364926338|FG001|Treatment Period|Study drug toxicity|64|||
105800036|NCT01335399|364926337|FG000|Treatment Period|Participant request to discontinue|30|||
105800037|NCT01335399|364926338|FG001|Treatment Period|Participant request to discontinue|22|||
105800038|NCT01335399|364926337|FG000|Treatment Period|Other reasons|30|||
105800039|NCT01335399|364926338|FG001|Treatment Period|Other reasons|30|||
105800040|NCT01335399|364926337|FG000|Treatment Period|Consent withdrawal|10|||
105800041|NCT01335399|364926338|FG001|Treatment Period|Consent withdrawal|7|||
105358308|NCT03131687|363317095|FG003|Overall Study|Principle Investigator Decision|0|||
105565275|NCT03420781|364066726|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
105358309|NCT03131687|363317096|FG004|Overall Study|Principle Investigator Decision|0|||
105800042|NCT01335399|364926337|FG000|Treatment Period|Death|7|||
105800043|NCT01335399|364926338|FG001|Treatment Period|Death|6|||
105800044|NCT01335399|364926337|FG000|Treatment Period|Poor/Non-compliance|3|||
105482860|NCT02616146|363780769|FG000|Overall Study|Pregnancy wish|3|||
105482861|NCT02616146|363780770|FG001|Overall Study|Pregnancy wish|0|||
105482862|NCT02616146|363780769|FG000|Overall Study|Protocol Violation|6|||
105482863|NCT02616146|363780770|FG001|Overall Study|Protocol Violation|3|||
105482864|NCT02616146|363780769|FG000|Overall Study|Study terminated by sponsor|1372|||
105482865|NCT02616146|363780770|FG001|Overall Study|Study terminated by sponsor|432|||
105482866|NCT02616146|363780769|FG000|Overall Study|Participant moved|4|||
105482867|NCT02616146|363780770|FG001|Overall Study|Participant moved|3|||
105482868|NCT02616146|363780769|FG000|Overall Study|Withdrawal by Subject|30|||
105482869|NCT02616146|363780770|FG001|Overall Study|Withdrawal by Subject|24|||
105482870|NCT02616146|363780769|FG000|Overall Study|Physician Decision|2|||
105482871|NCT02616146|363780770|FG001|Overall Study|Physician Decision|1|||
105482872|NCT01221272|363780771|FG000|Period 1|Adverse Event|2|||
105482873|NCT01221272|363780772|FG001|Period 1|Adverse Event|0|||
105482874|NCT01221272|363780771|FG000|Period 1|Consent Withdrawal|0|||
105482875|NCT01221272|363780772|FG001|Period 1|Consent Withdrawal|1|||
105482876|NCT01221272|363780771|FG000|Period 1|Significant Dosing Noncompliance|0|||
105482877|NCT01221272|363780772|FG001|Period 1|Significant Dosing Noncompliance|1|||
105482878|NCT01221272|363780771|FG000|Period 2|Adverse Event|0|||
105482879|NCT01221272|363780772|FG001|Period 2|Adverse Event|2|||
105565276|NCT03420781|364066727|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
105565277|NCT03420781|364066728|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
105482882|NCT01143389|363780776|FG000|Overall Study|Lost to Follow-up|26|||
105565278|NCT03420781|364066729|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
105740870|NCT01356602|364706965|FG002|Overall Study|Lost to Follow-up|6|||
105740871|NCT01356602|364706963|FG000|Overall Study|Withdrawal by Subject|4|||
105740872|NCT01356602|364706964|FG001|Overall Study|Withdrawal by Subject|3|||
105740873|NCT01356602|364706965|FG002|Overall Study|Withdrawal by Subject|7|||
105740874|NCT01356602|364706963|FG000|Overall Study|Lack of Efficacy|0|||
105740875|NCT01356602|364706964|FG001|Overall Study|Lack of Efficacy|1|||
105740876|NCT01356602|364706965|FG002|Overall Study|Lack of Efficacy|4|||
105740877|NCT01356602|364706963|FG000|Overall Study|Adverse Event|0|||
105740878|NCT01356602|364706964|FG001|Overall Study|Adverse Event|1|||
105740879|NCT01356602|364706965|FG002|Overall Study|Adverse Event|1|||
105740880|NCT01115569|364706968|FG000|Conversion/Titration Phase|Adverse Event|59|||
105482883|NCT01143389|363780777|FG001|Overall Study|Lost to Follow-up|25|||
105565279|NCT03420781|364066725|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
105565280|NCT03420781|364066726|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
105565281|NCT03420781|364066727|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
105565282|NCT03420781|364066728|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
105565283|NCT03420781|364066729|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
105565284|NCT03420781|364066725|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
105565285|NCT03420781|364066726|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
105565286|NCT03420781|364066727|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
105565287|NCT03420781|364066728|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
105565288|NCT03420781|364066729|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
105565289|NCT03420781|364066725|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
105565290|NCT03420781|364066726|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
105565291|NCT03420781|364066727|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
105565292|NCT03420781|364066728|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
105565293|NCT03420781|364066729|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
105740881|NCT01115569|364706969|FG001|Conversion/Titration Phase|Adverse Event|0|||
105740882|NCT01115569|364706968|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
105740883|NCT01115569|364706969|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
105740884|NCT01115569|364706968|FG000|Conversion/Titration Phase|Physician Decision|5|||
105740885|NCT01115569|364706969|FG001|Conversion/Titration Phase|Physician Decision|0|||
105740886|NCT01115569|364706968|FG000|Conversion/Titration Phase|Protocol Violation|68|||
105358310|NCT03131687|363317097|FG005|Overall Study|Principle Investigator Decision|0|||
105482884|NCT03224598|363780778|FG000|Overall Study|Lost to Follow-up|0|||
105482885|NCT03224598|363780779|FG001|Overall Study|Lost to Follow-up|2|||
105482886|NCT03224598|363780780|FG002|Overall Study|Lost to Follow-up|0|||
105482887|NCT03224598|363780778|FG000|Overall Study|Other|0|||
105482888|NCT03224598|363780779|FG001|Overall Study|Other|1|||
105482889|NCT03224598|363780780|FG002|Overall Study|Other|0|||
105565294|NCT03420781|364066725|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
105565295|NCT03420781|364066726|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
105740887|NCT01115569|364706969|FG001|Conversion/Titration Phase|Protocol Violation|0|||
105740888|NCT01115569|364706968|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
105740889|NCT01115569|364706969|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
105740890|NCT01115569|364706968|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
105740891|NCT01115569|364706969|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
105482890|NCT00814333|363780781|FG000|Enrollment|Lost to Follow-up|1|||
105482891|NCT00814333|363780782|FG001|Enrollment|Lost to Follow-up|0|||
105358311|NCT03131687|363317092|FG000|Overall Study|Inadvertent Enrollment|0|||
105358312|NCT03131687|363317093|FG001|Overall Study|Inadvertent Enrollment|0|||
105358313|NCT03131687|363317094|FG002|Overall Study|Inadvertent Enrollment|0|||
105358314|NCT03131687|363317095|FG003|Overall Study|Inadvertent Enrollment|1|||
105358315|NCT03131687|363317096|FG004|Overall Study|Inadvertent Enrollment|0|||
105358316|NCT03131687|363317097|FG005|Overall Study|Inadvertent Enrollment|0|||
105358317|NCT00869128|363317099|FG000|Overall Study|lack of Compliance|6|||
105358318|NCT00869128|363317100|FG001|Overall Study|lack of Compliance|6|||
105358319|NCT03360019|363317103|FG000|Overall Study|Withdrawal by Subject|2|||
105358320|NCT03360019|363317104|FG001|Overall Study|Withdrawal by Subject|0|||
105358321|NCT03360019|363317105|FG002|Overall Study|Withdrawal by Subject|0|||
105358322|NCT03360019|363317103|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
105358323|NCT03360019|363317104|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
105358324|NCT03360019|363317105|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
105358325|NCT01462110|363317106|FG000|Overall Study|Adverse Event|1|||
105358326|NCT01462110|363317107|FG001|Overall Study|Adverse Event|0|||
105358327|NCT00656175|363317109|FG000|Overall Study|Adverse Event|1|||
105358328|NCT00656175|363317110|FG001|Overall Study|Adverse Event|0|||
105358329|NCT00656175|363317109|FG000|Overall Study|Transportation issues|0|||
105358330|NCT00656175|363317110|FG001|Overall Study|Transportation issues|1|||
105358331|NCT03999749|363317115|FG000|Overall Study|Toxicity|16|||
105358332|NCT03999749|363317115|FG000|Overall Study|Withdrawal by Subject|3|||
105358333|NCT03999749|363317115|FG000|Overall Study|Disease progression|26|||
105358334|NCT03999749|363317115|FG000|Overall Study|Physician Decision|4|||
105358335|NCT03999749|363317115|FG000|Overall Study|Death|5|||
105358336|NCT03999749|363317115|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
105358337|NCT00980655|363317116|FG000|Overall Study|Adverse Event|13|||
105358338|NCT00980655|363317117|FG001|Overall Study|Adverse Event|31|||
105358339|NCT00980655|363317116|FG000|Overall Study|Death|0|||
105482892|NCT01974765|363780783|FG000|Overall Study|Withdrawal by Subject|1|||
105482893|NCT01974765|363780783|FG000|Overall Study|Death|1|||
105740892|NCT01115569|364706968|FG000|Maintenance Phase|Adverse Event|0|||
105740893|NCT01115569|364706969|FG001|Maintenance Phase|Adverse Event|43|||
105740894|NCT01115569|364706968|FG000|Maintenance Phase|Lost to Follow-up|0|||
105740895|NCT01115569|364706969|FG001|Maintenance Phase|Lost to Follow-up|8|||
105740896|NCT01115569|364706968|FG000|Maintenance Phase|Physician Decision|0|||
105740897|NCT01115569|364706969|FG001|Maintenance Phase|Physician Decision|3|||
105740898|NCT01115569|364706968|FG000|Maintenance Phase|Protocol Violation|0|||
105740899|NCT01115569|364706969|FG001|Maintenance Phase|Protocol Violation|9|||
105740900|NCT01115569|364706968|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105740901|NCT01115569|364706969|FG001|Maintenance Phase|Withdrawal by Subject|27|||
105740902|NCT01115569|364706968|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
105740903|NCT01115569|364706969|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
105740904|NCT01115569|364706968|FG000|Maintenance Phase|Administrative|0|||
105740905|NCT01115569|364706969|FG001|Maintenance Phase|Administrative|1|||
105740906|NCT01614769|364706970|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
105740907|NCT01614769|364706971|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
105740908|NCT01614769|364706972|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
105740909|NCT01614769|364706973|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
105740910|NCT01614769|364706974|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
105740911|NCT01614769|364706975|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
105740912|NCT01614769|364706970|FG000|Period 1|Protocol Violation|0|||
105740913|NCT01614769|364706971|FG001|Period 1|Protocol Violation|0|||
105740914|NCT01614769|364706972|FG002|Period 1|Protocol Violation|0|||
105740915|NCT01614769|364706973|FG003|Period 1|Protocol Violation|1|||
105740916|NCT01614769|364706974|FG004|Period 1|Protocol Violation|0|||
105740917|NCT01614769|364706975|FG005|Period 1|Protocol Violation|0|||
105740918|NCT01614769|364706970|FG000|Period 1|Withdrawal by Subject|1|||
105740919|NCT01614769|364706971|FG001|Period 1|Withdrawal by Subject|0|||
105740920|NCT01614769|364706972|FG002|Period 1|Withdrawal by Subject|0|||
105740921|NCT01614769|364706973|FG003|Period 1|Withdrawal by Subject|0|||
105800045|NCT01335399|364926338|FG001|Treatment Period|Poor/Non-compliance|4|||
105358340|NCT00980655|363317117|FG001|Overall Study|Death|7|||
105358341|NCT00980655|363317116|FG000|Overall Study|Protocol Violation|2|||
105740922|NCT01614769|364706974|FG004|Period 1|Withdrawal by Subject|0|||
105358342|NCT00980655|363317117|FG001|Overall Study|Protocol Violation|7|||
105358343|NCT00980655|363317116|FG000|Overall Study|Withdrawal by Subject|0|||
105358344|NCT00980655|363317117|FG001|Overall Study|Withdrawal by Subject|4|||
105358345|NCT00980655|363317116|FG000|Overall Study|Lost to Follow-up|0|||
105358346|NCT00980655|363317117|FG001|Overall Study|Lost to Follow-up|1|||
105358347|NCT00980655|363317116|FG000|Overall Study|Parent/legal guardian request|1|||
105740923|NCT01614769|364706975|FG005|Period 1|Withdrawal by Subject|0|||
105740924|NCT01614769|364706970|FG000|Period 3|Withdrawal by Subject|0|||
105740925|NCT01614769|364706971|FG001|Period 3|Withdrawal by Subject|0|||
105740926|NCT01614769|364706972|FG002|Period 3|Withdrawal by Subject|1|||
105740927|NCT01614769|364706973|FG003|Period 3|Withdrawal by Subject|0|||
105740928|NCT01614769|364706974|FG004|Period 3|Withdrawal by Subject|0|||
105358348|NCT00980655|363317117|FG001|Overall Study|Parent/legal guardian request|0|||
105358349|NCT00980655|363317116|FG000|Overall Study|Other|0|||
105358350|NCT00980655|363317117|FG001|Overall Study|Other|1|||
105358351|NCT04162795|363317118|FG000|Overall Study|Other|16|||
105358352|NCT04162795|363317118|FG000|Overall Study|Screen failures|10|||
105358353|NCT04265261|363317121|FG000|Overall Study|Adverse Event|2|||
105358354|NCT04265261|363317122|FG001|Overall Study|Adverse Event|0|||
105358355|NCT04265261|363317123|FG002|Overall Study|Adverse Event|0|||
105358356|NCT04265261|363317121|FG000|Overall Study|Death|1|||
105358357|NCT04265261|363317122|FG001|Overall Study|Death|0|||
105358358|NCT04265261|363317123|FG002|Overall Study|Death|0|||
105358359|NCT04265261|363317121|FG000|Overall Study|Lost to Follow-up|4|||
105358360|NCT04265261|363317122|FG001|Overall Study|Lost to Follow-up|1|||
105358361|NCT04265261|363317123|FG002|Overall Study|Lost to Follow-up|3|||
105358362|NCT04265261|363317121|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105358363|NCT04265261|363317122|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105358364|NCT04265261|363317123|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105358365|NCT04265261|363317121|FG000|Overall Study|Physician Decision|0|||
105358366|NCT04265261|363317122|FG001|Overall Study|Physician Decision|0|||
105358367|NCT04265261|363317123|FG002|Overall Study|Physician Decision|1|||
105358368|NCT04265261|363317121|FG000|Overall Study|Protocol Deviation|0|||
105358369|NCT04265261|363317122|FG001|Overall Study|Protocol Deviation|2|||
105358370|NCT04265261|363317123|FG002|Overall Study|Protocol Deviation|0|||
105358371|NCT04265261|363317121|FG000|Overall Study|Withdrawal by Subject|2|||
105740929|NCT01614769|364706975|FG005|Period 3|Withdrawal by Subject|0|||
105740930|NCT01228071|364706976|FG000|Overall Study|Protocol Violation|1|||
105740931|NCT01228071|364706976|FG000|Overall Study|Withdrawal by Subject|1|||
105358372|NCT04265261|363317122|FG001|Overall Study|Withdrawal by Subject|1|||
105358373|NCT04265261|363317123|FG002|Overall Study|Withdrawal by Subject|4|||
105358374|NCT03877224|363317124|FG000|Overall Study|Death|3|||
105358375|NCT03877224|363317125|FG001|Overall Study|Death|2|||
105740932|NCT02948777|364706986|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
105740933|NCT02750813|364706987|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
105740934|NCT02750813|364706988|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
105740935|NCT02750813|364706987|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
105740936|NCT02750813|364706988|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
105740937|NCT02043301|364706989|FG000|Overall Study|Discontinued|0|||
105740938|NCT02043301|364706990|FG001|Overall Study|Discontinued|1|||
105740939|NCT02043301|364706991|FG002|Overall Study|Discontinued|0|||
105740940|NCT03097328|364706992|FG000|Overall Study|Still on Therapy|2|||
105740941|NCT03097328|364706992|FG000|Overall Study|Progressive Disease|29|||
105740942|NCT03097328|364706992|FG000|Overall Study|Adverse Event|4|||
105740943|NCT03097328|364706992|FG000|Overall Study|Withdrawal by Subject|1|||
105740944|NCT03097328|364706992|FG000|Overall Study|Physician Decision|1|||
105740945|NCT03097328|364706992|FG000|Overall Study|Patient Decision|1|||
105740946|NCT03097328|364706992|FG000|Overall Study|Ineligible for Study Drug|1|||
105740947|NCT00883558|364706993|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
105740948|NCT00883558|364706994|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
105740949|NCT00883558|364706995|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
105740950|NCT00883558|364706993|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
105740951|NCT00883558|364706994|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
105740952|NCT00883558|364706995|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
105740953|NCT00883558|364706993|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
105740954|NCT00883558|364706994|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
105740955|NCT00883558|364706995|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
105740956|NCT00883558|364706993|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
105740957|NCT00883558|364706994|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
105740958|NCT00883558|364706995|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
105740959|NCT00883558|364706993|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
105740960|NCT00883558|364706994|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
105358376|NCT03877224|363317124|FG000|Overall Study|Withdrawal by Subject|1|||
105358377|NCT03877224|363317125|FG001|Overall Study|Withdrawal by Subject|6|||
105358378|NCT03877224|363317124|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
105358379|NCT03877224|363317125|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
105358380|NCT00447902|363317126|FG000|Overall Study|Adverse Event|0|||
105358381|NCT00447902|363317127|FG001|Overall Study|Adverse Event|3|||
105358382|NCT00447902|363317126|FG000|Overall Study|Protocol Violation|1|||
105358383|NCT00447902|363317127|FG001|Overall Study|Protocol Violation|0|||
105358384|NCT00447902|363317126|FG000|Overall Study|Withdrawal by Subject|0|||
105740961|NCT00883558|364706995|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
105740962|NCT02436577|364706996|FG000|Overall Study|Protocol Deviation|0|||
105740963|NCT02436577|364706997|FG001|Overall Study|Protocol Deviation|1|||
105740964|NCT02436577|364706998|FG002|Overall Study|Protocol Deviation|0|||
105358385|NCT00447902|363317127|FG001|Overall Study|Withdrawal by Subject|1|||
105800046|NCT01335399|364926337|FG000|Treatment Period|Lost to Follow-up|2|||
105800047|NCT01335399|364926338|FG001|Treatment Period|Lost to Follow-up|2|||
105800048|NCT01335399|364926337|FG000|Treatment Period|Maximum clinical benefit|1|||
105800049|NCT01335399|364926338|FG001|Treatment Period|Maximum clinical benefit|1|||
105800050|NCT01335399|364926337|FG000|Treatment Period|No longer meet study criteria|1|||
105800051|NCT01335399|364926338|FG001|Treatment Period|No longer meet study criteria|1|||
105800052|NCT01335399|364926337|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
105800053|NCT01335399|364926338|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
105800054|NCT03262233|364926339|FG000|Overall Study|Withdrawal by Subject|12|||
105800055|NCT03262233|364926340|FG001|Overall Study|Withdrawal by Subject|8|||
105800056|NCT03262233|364926341|FG002|Overall Study|Withdrawal by Subject|21|||
105800057|NCT03262233|364926342|FG003|Overall Study|Withdrawal by Subject|13|||
105800058|NCT03262233|364926339|FG000|Overall Study|Declined due to shock|1|||
105800059|NCT03262233|364926340|FG001|Overall Study|Declined due to shock|2|||
105800060|NCT03262233|364926341|FG002|Overall Study|Declined due to shock|2|||
105800061|NCT03262233|364926342|FG003|Overall Study|Declined due to shock|3|||
105800062|NCT03262233|364926339|FG000|Overall Study|Protocol Violation|5|||
105800063|NCT03262233|364926340|FG001|Overall Study|Protocol Violation|10|||
105800064|NCT03262233|364926341|FG002|Overall Study|Protocol Violation|2|||
105800065|NCT03262233|364926342|FG003|Overall Study|Protocol Violation|13|||
105800066|NCT03262233|364926339|FG000|Overall Study|data collection artifact|0|||
105800067|NCT03262233|364926340|FG001|Overall Study|data collection artifact|1|||
105800068|NCT03262233|364926341|FG002|Overall Study|data collection artifact|0|||
105800069|NCT03262233|364926342|FG003|Overall Study|data collection artifact|0|||
105800070|NCT01120600|364926343|FG000|Overall Study|Adverse Event|7|||
105800071|NCT01120600|364926344|FG001|Overall Study|Adverse Event|7|||
105800072|NCT01120600|364926343|FG000|Overall Study|Excessive Bone Loss|0|||
105800073|NCT01120600|364926344|FG001|Overall Study|Excessive Bone Loss|4|||
105800074|NCT01120600|364926343|FG000|Overall Study|Lost to Follow-up|1|||
105800075|NCT01120600|364926344|FG001|Overall Study|Lost to Follow-up|3|||
105800076|NCT01120600|364926343|FG000|Overall Study|Physician Decision|1|||
105800077|NCT01120600|364926344|FG001|Overall Study|Physician Decision|3|||
105800078|NCT01120600|364926343|FG000|Overall Study|Protocol Violation|0|||
105800079|NCT01120600|364926344|FG001|Overall Study|Protocol Violation|4|||
105800080|NCT01120600|364926343|FG000|Overall Study|Withdrawal by Subject|10|||
105800081|NCT01120600|364926344|FG001|Overall Study|Withdrawal by Subject|11|||
105800082|NCT01011907|364926345|FG000|Overall Study|Withdrawal by Subject|13|||
105800083|NCT01011907|364926346|FG001|Overall Study|Withdrawal by Subject|11|||
105800084|NCT01011907|364926345|FG000|Overall Study|Adverse Event|1|||
105800085|NCT01011907|364926346|FG001|Overall Study|Adverse Event|4|||
105800086|NCT01406873|364926349|FG000|Overall Study|Withdrawal by Subject|1|||
105800087|NCT01406873|364926350|FG001|Overall Study|Withdrawal by Subject|1|||
105800088|NCT03990389|364926351|FG000|Overall Study|Lost to Follow-up|3|||
105358386|NCT00447902|363317126|FG000|Overall Study|included patients who discontinued|1|||
105358387|NCT00447902|363317127|FG001|Overall Study|included patients who discontinued|1|||
105800089|NCT03990389|364926352|FG001|Overall Study|Lost to Follow-up|0|||
105800090|NCT00207714|364926353|FG000|Overall Study|Adverse Event|6|||
105800091|NCT00207714|364926354|FG001|Overall Study|Adverse Event|2|||
105800092|NCT00207714|364926355|FG002|Overall Study|Adverse Event|4|||
105800093|NCT00207714|364926356|FG003|Overall Study|Adverse Event|3|||
105800094|NCT00207714|364926357|FG004|Overall Study|Adverse Event|1|||
105800095|NCT00207714|364926353|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
105358388|NCT00447902|363317126|FG000|Overall Study|Lack of Efficacy|2|||
105358389|NCT00447902|363317127|FG001|Overall Study|Lack of Efficacy|1|||
105358390|NCT02526160|363318923|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
105358391|NCT02526160|363318924|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
105358392|NCT02526160|363318923|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
105358393|NCT02526160|363318924|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
105358394|NCT02526160|363318923|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
105358395|NCT02526160|363318924|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
105482894|NCT01974765|363780783|FG000|Overall Study|Adverse Event|2|||
105800096|NCT00207714|364926354|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105800097|NCT00207714|364926355|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
105800098|NCT00207714|364926356|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
105800099|NCT00207714|364926357|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
105482895|NCT02519855|363780786|FG000|Overall Study|Adverse Event|0|||
105482896|NCT02519855|363780787|FG001|Overall Study|Adverse Event|1|||
105800100|NCT00207714|364926353|FG000|Overall Study|Other|3|||
105800101|NCT00207714|364926354|FG001|Overall Study|Other|2|||
105800102|NCT00207714|364926355|FG002|Overall Study|Other|5|||
105800103|NCT00207714|364926356|FG003|Overall Study|Other|1|||
105800104|NCT00207714|364926357|FG004|Overall Study|Other|0|||
105800105|NCT03627195|364926358|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
105800106|NCT03627195|364926359|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
105800107|NCT03627195|364926360|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
105800108|NCT03627195|364926361|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
105740965|NCT02436577|364706999|FG003|Overall Study|Protocol Deviation|0|||
105740966|NCT02436577|364707000|FG004|Overall Study|Protocol Deviation|0|||
105740967|NCT02436577|364707001|FG005|Overall Study|Protocol Deviation|0|||
105740968|NCT01675011|364707005|FG000|Overall Study|Trial terminated by Sponsor|3|||
105740969|NCT01675011|364707006|FG001|Overall Study|Trial terminated by Sponsor|1|||
105740970|NCT01252134|364707007|FG000|Period 1, 8 Hours|Personal Reasons|0|||
105740971|NCT01252134|364707008|FG001|Period 1, 8 Hours|Personal Reasons|1|||
105740972|NCT01252134|364707009|FG002|Period 1, 8 Hours|Personal Reasons|1|||
105740973|NCT01252134|364707010|FG003|Period 1, 8 Hours|Personal Reasons|0|||
105740974|NCT01252134|364707011|FG004|Period 1, 8 Hours|Personal Reasons|0|||
105740975|NCT01252134|364707012|FG005|Period 1, 8 Hours|Personal Reasons|0|||
105740976|NCT01703286|364707023|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
105740977|NCT01703286|364707024|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
105740978|NCT01703286|364707025|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
105740979|NCT01703286|364707026|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
105740980|NCT01703286|364707027|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
105740981|NCT01703286|364707028|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
105740982|NCT01703286|364707023|FG000|Period 2 Including Washout|Adverse Event|0|||
105740983|NCT01703286|364707024|FG001|Period 2 Including Washout|Adverse Event|0|||
105740984|NCT01703286|364707025|FG002|Period 2 Including Washout|Adverse Event|0|||
105740985|NCT01703286|364707026|FG003|Period 2 Including Washout|Adverse Event|1|||
105740986|NCT01703286|364707027|FG004|Period 2 Including Washout|Adverse Event|0|||
105740987|NCT01703286|364707028|FG005|Period 2 Including Washout|Adverse Event|0|||
105740988|NCT02531373|364707029|FG000|Overall Study|Lack of Efficacy|0|||
105740989|NCT02531373|364707030|FG001|Overall Study|Lack of Efficacy|0|||
105740990|NCT02531373|364707031|FG002|Overall Study|Lack of Efficacy|0|||
105740991|NCT02531373|364707032|FG003|Overall Study|Lack of Efficacy|0|||
105740992|NCT02531373|364707033|FG004|Overall Study|Lack of Efficacy|3|||
105740993|NCT02531373|364707034|FG005|Overall Study|Lack of Efficacy|2|||
105740994|NCT02531373|364707035|FG006|Overall Study|Lack of Efficacy|4|||
105740995|NCT02531373|364707036|FG007|Overall Study|Lack of Efficacy|8|||
105740996|NCT02531373|364707037|FG008|Overall Study|Lack of Efficacy|5|||
105740997|NCT02531373|364707029|FG000|Overall Study|Lost to Follow-up|0|||
105740998|NCT02531373|364707030|FG001|Overall Study|Lost to Follow-up|0|||
105740999|NCT02531373|364707031|FG002|Overall Study|Lost to Follow-up|0|||
105741000|NCT02531373|364707032|FG003|Overall Study|Lost to Follow-up|0|||
105741001|NCT02531373|364707033|FG004|Overall Study|Lost to Follow-up|0|||
105741002|NCT02531373|364707034|FG005|Overall Study|Lost to Follow-up|2|||
105741003|NCT02531373|364707035|FG006|Overall Study|Lost to Follow-up|2|||
105741004|NCT02531373|364707036|FG007|Overall Study|Lost to Follow-up|0|||
105741005|NCT02531373|364707037|FG008|Overall Study|Lost to Follow-up|0|||
105741006|NCT02531373|364707029|FG000|Overall Study|Physician Decision|0|||
105741007|NCT02531373|364707030|FG001|Overall Study|Physician Decision|0|||
105741008|NCT02531373|364707031|FG002|Overall Study|Physician Decision|0|||
105741009|NCT02531373|364707032|FG003|Overall Study|Physician Decision|0|||
105741010|NCT02531373|364707033|FG004|Overall Study|Physician Decision|2|||
105741011|NCT02531373|364707034|FG005|Overall Study|Physician Decision|1|||
105741012|NCT02531373|364707035|FG006|Overall Study|Physician Decision|0|||
105741013|NCT02531373|364707036|FG007|Overall Study|Physician Decision|0|||
105482897|NCT02519855|363780786|FG000|Overall Study|Lost to Follow-up|3|||
105482898|NCT02519855|363780787|FG001|Overall Study|Lost to Follow-up|3|||
105482899|NCT03621475|363780788|FG000|Overall Study|No longer required restraints at initiation|0|||
105741014|NCT02531373|364707037|FG008|Overall Study|Physician Decision|0|||
105741015|NCT02531373|364707029|FG000|Overall Study|Protocol Violation|0|||
105741016|NCT02531373|364707030|FG001|Overall Study|Protocol Violation|0|||
105741017|NCT02531373|364707031|FG002|Overall Study|Protocol Violation|0|||
105741018|NCT02531373|364707032|FG003|Overall Study|Protocol Violation|0|||
105741019|NCT02531373|364707033|FG004|Overall Study|Protocol Violation|0|||
105741020|NCT02531373|364707034|FG005|Overall Study|Protocol Violation|1|||
105741021|NCT02531373|364707035|FG006|Overall Study|Protocol Violation|1|||
105741022|NCT02531373|364707036|FG007|Overall Study|Protocol Violation|0|||
105741023|NCT02531373|364707037|FG008|Overall Study|Protocol Violation|1|||
105741024|NCT02531373|364707029|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105741025|NCT02531373|364707030|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105741026|NCT02531373|364707031|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105741027|NCT02531373|364707032|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
105358396|NCT02526160|363318923|FG000|Open-Label Treatment Extension Period I|Death|0|||
105358397|NCT02526160|363318924|FG001|Open-Label Treatment Extension Period I|Death|1|||
105358398|NCT02526160|363318923|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
105358399|NCT02526160|363318924|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
105358400|NCT02526160|363318923|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
105358401|NCT02526160|363318924|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
105358402|NCT02526160|363318923|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
105358403|NCT02526160|363318924|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
105358404|NCT02526160|363318923|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
105358405|NCT02526160|363318924|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
105358406|NCT01962948|363318925|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
105358407|NCT01962948|363318926|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
105358408|NCT01962948|363318927|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
105358409|NCT01962948|363318928|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
105358410|NCT03630705|363318929|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
105358411|NCT03630705|363318930|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
105358412|NCT03630705|363318931|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
105358413|NCT03630705|363318932|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
105358414|NCT03630705|363318929|FG000|Overall Study|Lost to Follow-up|1|||
105358415|NCT03630705|363318930|FG001|Overall Study|Lost to Follow-up|2|||
105358416|NCT03630705|363318931|FG002|Overall Study|Lost to Follow-up|0|||
105358417|NCT03630705|363318932|FG003|Overall Study|Lost to Follow-up|0|||
105358418|NCT03654729|363318935|FG000|Overall Study|Death|9|||
105358419|NCT03654729|363318936|FG001|Overall Study|Death|9|||
105565296|NCT03420781|364066727|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
105565297|NCT03420781|364066728|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
105741028|NCT02531373|364707033|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
105741029|NCT02531373|364707034|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
105741030|NCT02531373|364707035|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
105741031|NCT02531373|364707036|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
105741032|NCT02531373|364707037|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
105741033|NCT02531373|364707029|FG000|Overall Study|Withdrawal by Subject|0|||
105741034|NCT02531373|364707030|FG001|Overall Study|Withdrawal by Subject|0|||
105741035|NCT02531373|364707031|FG002|Overall Study|Withdrawal by Subject|0|||
105741036|NCT02531373|364707032|FG003|Overall Study|Withdrawal by Subject|0|||
105741037|NCT02531373|364707033|FG004|Overall Study|Withdrawal by Subject|3|||
105741038|NCT02531373|364707034|FG005|Overall Study|Withdrawal by Subject|0|||
105741039|NCT02531373|364707035|FG006|Overall Study|Withdrawal by Subject|0|||
105741040|NCT02531373|364707036|FG007|Overall Study|Withdrawal by Subject|0|||
105741041|NCT02531373|364707037|FG008|Overall Study|Withdrawal by Subject|0|||
105741042|NCT01035606|364707043|FG000|Overall Study|change in health, job demands,family|3|||
105741043|NCT01035606|364707044|FG001|Overall Study|change in health, job demands,family|3|||
105741044|NCT01035606|364707045|FG002|Overall Study|change in health, job demands,family|4|||
105741045|NCT00592501|364707046|FG000|Overall Study|Withdrawal by Subject|1|||
105741046|NCT00592501|364707046|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
105741047|NCT03880227|364707054|FG000|First Visit|Withdrawal by Subject|1|||
105741048|NCT03880227|364707055|FG001|First Visit|Withdrawal by Subject|0|||
105741049|NCT03880227|364707056|FG002|First Visit|Withdrawal by Subject|0|||
105741050|NCT03880227|364707057|FG003|First Visit|Withdrawal by Subject|0|||
105741051|NCT03880227|364707054|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
105741052|NCT03880227|364707055|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
105741053|NCT03880227|364707056|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
105741054|NCT03880227|364707057|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
105741055|NCT03880227|364707054|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
105741056|NCT03880227|364707055|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
105741057|NCT03880227|364707056|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
105741058|NCT03880227|364707057|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
105741059|NCT03880227|364707054|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
105741060|NCT03880227|364707055|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
105741061|NCT03880227|364707056|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
105741062|NCT03880227|364707057|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
105800109|NCT03627195|364926362|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
105800110|NCT03627195|364926363|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
105741063|NCT00504166|364707058|FG000|Overall Study|Adverse Event|1|||
105741064|NCT00504166|364707059|FG001|Overall Study|Adverse Event|4|||
105741065|NCT00504166|364707058|FG000|Overall Study|Withdrawal by Subject|3|||
105800111|NCT00833547|364926364|FG000|Overall Study|Withdrawal by Subject|2|||
105800112|NCT00833547|364926365|FG001|Overall Study|Withdrawal by Subject|2|||
105358420|NCT03654729|363318937|FG002|Overall Study|Death|16|||
105358421|NCT03654729|363318935|FG000|Overall Study|Withdrawal by Subject|8|||
105358422|NCT03654729|363318936|FG001|Overall Study|Withdrawal by Subject|6|||
105358423|NCT03654729|363318937|FG002|Overall Study|Withdrawal by Subject|4|||
105358424|NCT03654729|363318935|FG000|Overall Study|Study terminated by Sponsor|3|||
105358425|NCT03654729|363318936|FG001|Overall Study|Study terminated by Sponsor|5|||
105358426|NCT03654729|363318937|FG002|Overall Study|Study terminated by Sponsor|4|||
105358427|NCT03654729|363318935|FG000|Overall Study|Not reported|2|||
105358428|NCT03654729|363318936|FG001|Overall Study|Not reported|4|||
105358429|NCT03654729|363318937|FG002|Overall Study|Not reported|5|||
105358430|NCT03654729|363318935|FG000|Overall Study|Progressive disease|3|||
105358431|NCT03654729|363318936|FG001|Overall Study|Progressive disease|0|||
105358432|NCT03654729|363318937|FG002|Overall Study|Progressive disease|0|||
105358433|NCT03654729|363318935|FG000|Overall Study|Lost to Follow-up|2|||
105358434|NCT03654729|363318936|FG001|Overall Study|Lost to Follow-up|0|||
105358435|NCT03654729|363318937|FG002|Overall Study|Lost to Follow-up|0|||
105565298|NCT03420781|364066729|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
105565299|NCT01281202|364066730|FG000|Overall Study|Adverse Event|2|||
105741066|NCT00504166|364707059|FG001|Overall Study|Withdrawal by Subject|6|||
105741067|NCT00504166|364707058|FG000|Overall Study|Physician Decision|1|||
105741068|NCT00504166|364707059|FG001|Overall Study|Physician Decision|1|||
105741069|NCT00504166|364707058|FG000|Overall Study|Lost to Follow-up|1|||
105741070|NCT00504166|364707059|FG001|Overall Study|Lost to Follow-up|3|||
105741071|NCT02650284|364707060|FG000|Overall Study|Lost to Follow-up|3|||
105741072|NCT02650284|364707061|FG001|Overall Study|Lost to Follow-up|3|||
105741073|NCT02650284|364707060|FG000|Overall Study|Consent incorrectly taken|0|||
105741074|NCT02650284|364707061|FG001|Overall Study|Consent incorrectly taken|1|||
105741075|NCT01929044|364707066|FG000|Overall Study|Adverse Event|1|||
105741076|NCT01929044|364707067|FG001|Overall Study|Adverse Event|0|||
105741077|NCT01929044|364707066|FG000|Overall Study|Protocol Violation|9|||
105741078|NCT01929044|364707067|FG001|Overall Study|Protocol Violation|14|||
105741079|NCT01929044|364707066|FG000|Overall Study|Not Treated|1|||
105741080|NCT01929044|364707067|FG001|Overall Study|Not Treated|3|||
105741081|NCT02488759|364707073|FG000|Overall Study|Disease progression|73|||
105741082|NCT02488759|364707074|FG001|Overall Study|Disease progression|111|||
105741083|NCT02488759|364707075|FG002|Overall Study|Disease progression|62|||
105741084|NCT02488759|364707076|FG003|Overall Study|Disease progression|7|||
105741085|NCT02488759|364707077|FG004|Overall Study|Disease progression|4|||
105741086|NCT02488759|364707078|FG005|Overall Study|Disease progression|2|||
105741087|NCT02488759|364707073|FG000|Overall Study|Study drug toxicity|11|||
105741088|NCT02488759|364707074|FG001|Overall Study|Study drug toxicity|33|||
105741089|NCT02488759|364707075|FG002|Overall Study|Study drug toxicity|31|||
105741090|NCT02488759|364707076|FG003|Overall Study|Study drug toxicity|0|||
105741091|NCT02488759|364707077|FG004|Overall Study|Study drug toxicity|0|||
105741092|NCT02488759|364707078|FG005|Overall Study|Study drug toxicity|2|||
105741093|NCT02488759|364707073|FG000|Overall Study|Adverse event unrelated to study drug|9|||
105741094|NCT02488759|364707074|FG001|Overall Study|Adverse event unrelated to study drug|11|||
105741095|NCT02488759|364707075|FG002|Overall Study|Adverse event unrelated to study drug|7|||
105741096|NCT02488759|364707076|FG003|Overall Study|Adverse event unrelated to study drug|0|||
105741097|NCT02488759|364707077|FG004|Overall Study|Adverse event unrelated to study drug|1|||
105741098|NCT02488759|364707078|FG005|Overall Study|Adverse event unrelated to study drug|0|||
105741099|NCT02488759|364707073|FG000|Overall Study|Participant request to discontinue study treatment|6|||
105741100|NCT02488759|364707074|FG001|Overall Study|Participant request to discontinue study treatment|8|||
105741101|NCT02488759|364707075|FG002|Overall Study|Participant request to discontinue study treatment|4|||
105741102|NCT02488759|364707076|FG003|Overall Study|Participant request to discontinue study treatment|0|||
105741103|NCT02488759|364707077|FG004|Overall Study|Participant request to discontinue study treatment|0|||
105741104|NCT02488759|364707078|FG005|Overall Study|Participant request to discontinue study treatment|0|||
105741105|NCT02488759|364707073|FG000|Overall Study|Withdrawal by Subject|4|||
105741106|NCT02488759|364707074|FG001|Overall Study|Withdrawal by Subject|0|||
105741107|NCT02488759|364707075|FG002|Overall Study|Withdrawal by Subject|3|||
105741108|NCT02488759|364707076|FG003|Overall Study|Withdrawal by Subject|0|||
105741109|NCT02488759|364707077|FG004|Overall Study|Withdrawal by Subject|0|||
105741110|NCT02488759|364707078|FG005|Overall Study|Withdrawal by Subject|2|||
105741111|NCT02488759|364707073|FG000|Overall Study|Lost to Follow-up|0|||
105741112|NCT02488759|364707074|FG001|Overall Study|Lost to Follow-up|0|||
105741113|NCT02488759|364707075|FG002|Overall Study|Lost to Follow-up|2|||
105741114|NCT02488759|364707076|FG003|Overall Study|Lost to Follow-up|0|||
105741115|NCT02488759|364707077|FG004|Overall Study|Lost to Follow-up|0|||
105358436|NCT03654729|363318935|FG000|Overall Study|Physician Decision|2|||
105358437|NCT03654729|363318936|FG001|Overall Study|Physician Decision|0|||
105741116|NCT02488759|364707078|FG005|Overall Study|Lost to Follow-up|0|||
105741117|NCT02488759|364707073|FG000|Overall Study|Maximum clinical benefit|3|||
105358438|NCT03654729|363318937|FG002|Overall Study|Physician Decision|0|||
105358439|NCT03654729|363318935|FG000|Overall Study|Protocol Violation|1|||
105358440|NCT03654729|363318936|FG001|Overall Study|Protocol Violation|1|||
105741118|NCT02488759|364707074|FG001|Overall Study|Maximum clinical benefit|0|||
105358441|NCT03654729|363318937|FG002|Overall Study|Protocol Violation|0|||
105358442|NCT03654729|363318935|FG000|Overall Study|Non-compliance with study drug|0|||
105358443|NCT03654729|363318936|FG001|Overall Study|Non-compliance with study drug|1|||
105358444|NCT03654729|363318937|FG002|Overall Study|Non-compliance with study drug|0|||
105358445|NCT03654729|363318935|FG000|Overall Study|Site terminated by Sponsor|1|||
105358446|NCT03654729|363318936|FG001|Overall Study|Site terminated by Sponsor|0|||
105358447|NCT03654729|363318937|FG002|Overall Study|Site terminated by Sponsor|0|||
105358448|NCT04530838|363318938|FG000|Overall Study|Other|2|||
105358449|NCT04530838|363318939|FG001|Overall Study|Other|1|||
105358450|NCT04530838|363318940|FG002|Overall Study|Other|0|||
105358451|NCT04530838|363318938|FG000|Overall Study|Physician Decision|0|||
105358452|NCT04530838|363318939|FG001|Overall Study|Physician Decision|0|||
105358453|NCT04530838|363318940|FG002|Overall Study|Physician Decision|1|||
105358454|NCT04530838|363318938|FG000|Overall Study|Death|0|||
105358455|NCT04530838|363318939|FG001|Overall Study|Death|0|||
105358456|NCT04530838|363318940|FG002|Overall Study|Death|1|||
105741119|NCT02488759|364707075|FG002|Overall Study|Maximum clinical benefit|1|||
105741120|NCT02488759|364707076|FG003|Overall Study|Maximum clinical benefit|0|||
105741121|NCT02488759|364707077|FG004|Overall Study|Maximum clinical benefit|0|||
105741122|NCT02488759|364707078|FG005|Overall Study|Maximum clinical benefit|0|||
105741123|NCT02488759|364707073|FG000|Overall Study|Other reasons|7|||
105741124|NCT02488759|364707074|FG001|Overall Study|Other reasons|32|||
105741125|NCT02488759|364707075|FG002|Overall Study|Other reasons|23|||
105741126|NCT02488759|364707076|FG003|Overall Study|Other reasons|1|||
105741127|NCT02488759|364707077|FG004|Overall Study|Other reasons|1|||
105741128|NCT02488759|364707078|FG005|Overall Study|Other reasons|1|||
105741129|NCT04267562|364708249|FG000|Assessed for Eligibility|Screen Failure|64|||
105741130|NCT04267562|364708249|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
105741131|NCT04267562|364708249|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
105741132|NCT04267562|364708249|FG000|Assessed for Eligibility|Site closure|6|||
105741133|NCT04267562|364708249|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
105741134|NCT04267562|364708249|FG000|Assessed for Eligibility|Physician Decision|1|||
105741135|NCT04267562|364708249|FG000|Month 24|Elective hysterectomy|1|||
105741136|NCT04267562|364708249|FG000|Month 24|Lost to Follow-up|1|||
105741137|NCT04267562|364708249|FG000|Month 36|Elective hysterectomy|2|||
105741138|NCT04267562|364708249|FG000|Month 36|Lost to Follow-up|3|||
105741139|NCT00620321|364708250|FG000|Overall Study|Adverse Event|1|||
105741140|NCT00620321|364708251|FG001|Overall Study|Adverse Event|1|||
105741141|NCT00620321|364708250|FG000|Overall Study|Death|1|||
105741142|NCT00620321|364708251|FG001|Overall Study|Death|1|||
105741143|NCT00620321|364708250|FG000|Overall Study|Physician Decision|0|||
105741144|NCT00620321|364708251|FG001|Overall Study|Physician Decision|7|||
105741145|NCT00620321|364708250|FG000|Overall Study|Progressive Disease|5|||
105741146|NCT00620321|364708251|FG001|Overall Study|Progressive Disease|5|||
105741147|NCT00620321|364708250|FG000|Overall Study|Sponsor Decision|0|||
105741148|NCT00620321|364708251|FG001|Overall Study|Sponsor Decision|1|||
105741149|NCT00620321|364708250|FG000|Overall Study|Withdrawal by Subject|1|||
105741150|NCT00620321|364708251|FG001|Overall Study|Withdrawal by Subject|1|||
105741151|NCT00747617|364708253|FG000|Overall Study|Lost to Follow-up|3|||
105741152|NCT00747617|364708254|FG001|Overall Study|Lost to Follow-up|1|||
105741153|NCT01043185|364708255|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
105741154|NCT01043185|364708256|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
105741155|NCT01043185|364708257|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
105741156|NCT01043185|364708258|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
105741157|NCT01043185|364708259|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
105741158|NCT01043185|364708260|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
105358457|NCT04530838|363318938|FG000|Overall Study|Adverse Event|0|||
105358458|NCT04530838|363318939|FG001|Overall Study|Adverse Event|1|||
105358459|NCT04530838|363318940|FG002|Overall Study|Adverse Event|0|||
105741159|NCT01043185|364708261|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
105741160|NCT01043185|364708262|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
105741161|NCT01043185|364708263|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
105741162|NCT01043185|364708264|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
105358460|NCT04530838|363318938|FG000|Overall Study|No longer meets eligibility criteria|1|||
105741163|NCT00137436|364708265|FG000|Overall Study|Adverse Event|13|||
105741164|NCT00137436|364708265|FG000|Overall Study|Death|2|||
105741165|NCT00137436|364708265|FG000|Overall Study|Lack of Efficacy|17|||
105741166|NCT00137436|364708265|FG000|Overall Study|Withdrawal by Subject|6|||
105741167|NCT00137436|364708265|FG000|Overall Study|Other|5|||
105741168|NCT03009539|364708266|FG000|Overall Study|Lost to Follow-up|132|||
105741169|NCT03009539|364708267|FG001|Overall Study|Lost to Follow-up|113|||
105358461|NCT04530838|363318939|FG001|Overall Study|No longer meets eligibility criteria|0|||
105358462|NCT04530838|363318940|FG002|Overall Study|No longer meets eligibility criteria|2|||
105358463|NCT04530838|363318938|FG000|Overall Study|Withdrawal by parent/guardian|5|||
105741170|NCT03009539|364708268|FG002|Overall Study|Lost to Follow-up|132|||
105741171|NCT03009539|364708269|FG003|Overall Study|Lost to Follow-up|113|||
105741172|NCT03151148|364708270|FG000|Overall Study|Lost to Follow-up|1|||
105482900|NCT03621475|363780789|FG001|Overall Study|No longer required restraints at initiation|1|||
105482901|NCT00003830|363780803|FG000|Overall Study|No follow up data|3|||
105482902|NCT00003830|363780804|FG001|Overall Study|No follow up data|0|||
105482903|NCT00003830|363780803|FG000|Overall Study|Sentinel node positive patients|829|||
105482904|NCT00003830|363780804|FG001|Overall Study|Sentinel node positive patients|793|||
105482905|NCT01095094|363780810|FG000|Overall Study|Withdrawal by Subject|1|||
105482906|NCT01095094|363780810|FG000|Overall Study|Death|1|||
105482907|NCT01095094|363780810|FG000|Overall Study|Physician Decision|1|||
105482908|NCT05347147|363780811|FG000|Overall Study|Lost to Follow-up|0|||
105482909|NCT05347147|363780812|FG001|Overall Study|Lost to Follow-up|1|||
105482910|NCT05347147|363780811|FG000|Overall Study|Sponsor request|3|||
105482911|NCT05347147|363780812|FG001|Overall Study|Sponsor request|3|||
105482912|NCT05347147|363780811|FG000|Overall Study|Study termination|2|||
105482913|NCT05347147|363780812|FG001|Overall Study|Study termination|1|||
105482914|NCT03188042|363780813|FG000|Overall Study|Withdrawal by Subject|1|||
105482915|NCT03188042|363780814|FG001|Overall Study|Withdrawal by Subject|1|||
105482916|NCT00923364|363780820|FG000|Overall Study|Death|3|||
105482917|NCT00923364|363780821|FG001|Overall Study|Death|0|||
105482918|NCT00923364|363780820|FG000|Overall Study|Did not go to transplant|1|||
105482919|NCT00923364|363780821|FG001|Overall Study|Did not go to transplant|0|||
105482920|NCT01752036|363780822|FG000|Overall Study|Death|2|||
105482921|NCT01011478|363780823|FG000|Overall Study|No follow up data|12|||
105482922|NCT01011478|363780824|FG001|Overall Study|No follow up data|7|||
105482923|NCT02142387|363780826|FG000|Overall Study|<19 years old|49|||
105482924|NCT02142387|363780827|FG001|Overall Study|<19 years old|326|||
105482925|NCT02142387|363780826|FG000|Overall Study|non-cardiac etiology|504|||
105482926|NCT02142387|363780827|FG001|Overall Study|non-cardiac etiology|3431|||
105482927|NCT02142387|363780826|FG000|Overall Study|CPR not performed|74|||
105482928|NCT02142387|363780827|FG001|Overall Study|CPR not performed|473|||
105482929|NCT02142387|363780826|FG000|Overall Study|witnessed by paramedic|139|||
105482930|NCT02142387|363780827|FG001|Overall Study|witnessed by paramedic|917|||
105482931|NCT02142387|363780826|FG000|Overall Study|incomplete data|1|||
105482932|NCT02142387|363780827|FG001|Overall Study|incomplete data|9|||
105482933|NCT02142387|363780826|FG000|Overall Study|occurred not at home|298|||
105482934|NCT02142387|363780827|FG001|Overall Study|occurred not at home|2474|||
105482935|NCT03459690|363780831|FG000|Overall Study|Lost to Follow-up|0|||
105482936|NCT03459690|363780832|FG001|Overall Study|Lost to Follow-up|1|||
105482937|NCT03459690|363780831|FG000|Overall Study|Withdrawal by Subject|1|||
105482938|NCT03459690|363780832|FG001|Overall Study|Withdrawal by Subject|1|||
105482939|NCT02815280|363780833|FG000|Double-Blind Phase|Adverse Event|1|||
105482940|NCT02815280|363780834|FG001|Double-Blind Phase|Adverse Event|1|||
105482941|NCT02815280|363780833|FG000|Double-Blind Phase|Lost to Follow-up|10|||
105482942|NCT02815280|363780834|FG001|Double-Blind Phase|Lost to Follow-up|9|||
105482943|NCT02815280|363780833|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
105741173|NCT03151148|364708271|FG001|Overall Study|Lost to Follow-up|0|||
105741174|NCT03151148|364708270|FG000|Overall Study|Withdrawal by Subject|1|||
105741175|NCT03151148|364708271|FG001|Overall Study|Withdrawal by Subject|0|||
105741176|NCT00701727|364708272|FG000|First Treatment Period|Adverse Event|0|||
105741177|NCT00701727|364708273|FG001|First Treatment Period|Adverse Event|0|||
105741178|NCT00701727|364708272|FG000|First Treatment Period|Withdrawal by Subject|1|||
105741179|NCT00701727|364708273|FG001|First Treatment Period|Withdrawal by Subject|0|||
105741180|NCT00701727|364708272|FG000|First Treatment Period|sponsor decision|0|||
105741181|NCT00701727|364708273|FG001|First Treatment Period|sponsor decision|1|||
105741182|NCT00701727|364708272|FG000|First Treatment Period|Lost to Follow-up|0|||
105741183|NCT00701727|364708273|FG001|First Treatment Period|Lost to Follow-up|1|||
105741184|NCT00701727|364708272|FG000|Second Treatment Period|Withdrawal by Subject|2|||
105741185|NCT00701727|364708273|FG001|Second Treatment Period|Withdrawal by Subject|0|||
105741186|NCT00912015|364708275|FG000|Overall Study|Lack of Efficacy|1|||
105741187|NCT00912015|364708276|FG001|Overall Study|Lack of Efficacy|0|||
105741188|NCT00912015|364708277|FG002|Overall Study|Lack of Efficacy|0|||
105741189|NCT00912015|364708278|FG003|Overall Study|Lack of Efficacy|0|||
105741190|NCT00912015|364708275|FG000|Overall Study|Withdrawal by Subject|8|||
105741191|NCT00912015|364708276|FG001|Overall Study|Withdrawal by Subject|8|||
105741192|NCT00912015|364708277|FG002|Overall Study|Withdrawal by Subject|3|||
105741193|NCT00912015|364708278|FG003|Overall Study|Withdrawal by Subject|0|||
105741194|NCT00912015|364708275|FG000|Overall Study|Protocol Violation|1|||
105741195|NCT00912015|364708276|FG001|Overall Study|Protocol Violation|0|||
105741196|NCT00912015|364708277|FG002|Overall Study|Protocol Violation|0|||
105482944|NCT02815280|363780834|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
105482945|NCT02815280|363780833|FG000|Double-Blind Phase|Protocol Violation|2|||
105482946|NCT02815280|363780834|FG001|Double-Blind Phase|Protocol Violation|2|||
105482947|NCT02815280|363780833|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
105741197|NCT00912015|364708278|FG003|Overall Study|Protocol Violation|1|||
105741198|NCT00912015|364708275|FG000|Overall Study|Adverse Event|6|||
105741199|NCT00912015|364708276|FG001|Overall Study|Adverse Event|0|||
105741200|NCT00912015|364708277|FG002|Overall Study|Adverse Event|0|||
105484984|NCT01895361|363787031|FG000|Overall Study|Withdrawal by Subject|7|||
105741201|NCT00912015|364708278|FG003|Overall Study|Adverse Event|1|||
105741202|NCT02834403|364708281|FG000|Overall Study|Physician Decision|2|||
105741203|NCT02834403|364708282|FG001|Overall Study|Physician Decision|1|||
105741204|NCT02834403|364708283|FG002|Overall Study|Physician Decision|2|||
105741205|NCT02834403|364708284|FG003|Overall Study|Physician Decision|1|||
105741206|NCT02834403|364708285|FG004|Overall Study|Physician Decision|1|||
105741207|NCT02834403|364708286|FG005|Overall Study|Physician Decision|2|||
105741208|NCT02834403|364708287|FG006|Overall Study|Physician Decision|12|||
105741209|NCT02834403|364708281|FG000|Overall Study|Adverse Event|0|||
105741210|NCT02834403|364708282|FG001|Overall Study|Adverse Event|0|||
105741211|NCT02834403|364708283|FG002|Overall Study|Adverse Event|0|||
105741212|NCT02834403|364708284|FG003|Overall Study|Adverse Event|0|||
105741213|NCT02834403|364708285|FG004|Overall Study|Adverse Event|1|||
105741214|NCT02834403|364708286|FG005|Overall Study|Adverse Event|1|||
105741215|NCT02834403|364708287|FG006|Overall Study|Adverse Event|3|||
105741216|NCT02834403|364708281|FG000|Overall Study|Withdrawal by Subject|0|||
105741217|NCT02834403|364708282|FG001|Overall Study|Withdrawal by Subject|1|||
105741218|NCT02834403|364708283|FG002|Overall Study|Withdrawal by Subject|0|||
105741219|NCT02834403|364708284|FG003|Overall Study|Withdrawal by Subject|0|||
105741220|NCT02834403|364708285|FG004|Overall Study|Withdrawal by Subject|1|||
105741221|NCT02834403|364708286|FG005|Overall Study|Withdrawal by Subject|0|||
105741222|NCT02834403|364708287|FG006|Overall Study|Withdrawal by Subject|0|||
105741223|NCT02834403|364708281|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
105741224|NCT02834403|364708282|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
105741225|NCT02834403|364708283|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
105741226|NCT02834403|364708284|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
105741227|NCT02834403|364708285|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
105741228|NCT02834403|364708286|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
105741229|NCT02834403|364708287|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
105741230|NCT04426825|364708293|FG000|Overall Study|Death|17|||
105741231|NCT04426825|364708293|FG000|Overall Study|Lost to Follow-up|1|||
105741232|NCT04426825|364708293|FG000|Overall Study|Study terminated by sponsor|5|||
105741233|NCT01597557|364708294|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
105741234|NCT01597557|364708295|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
105741235|NCT01028651|364708299|FG000|Overall Study|Death|2|||
105741236|NCT01028651|364708299|FG000|Overall Study|Adverse Event|1|||
105741237|NCT01533935|364708300|FG000|Overall Study|Adverse Event|5|||
105741238|NCT01533935|364708301|FG001|Overall Study|Adverse Event|7|||
105741239|NCT01533935|364708302|FG002|Overall Study|Adverse Event|1|||
105741240|NCT01533935|364708303|FG003|Overall Study|Adverse Event|5|||
105741241|NCT01533935|364708304|FG004|Overall Study|Adverse Event|3|||
105741242|NCT01533935|364708300|FG000|Overall Study|Protocol Violation|0|||
105741243|NCT01533935|364708301|FG001|Overall Study|Protocol Violation|2|||
105741244|NCT01533935|364708302|FG002|Overall Study|Protocol Violation|0|||
105741245|NCT01533935|364708303|FG003|Overall Study|Protocol Violation|0|||
105741246|NCT01533935|364708304|FG004|Overall Study|Protocol Violation|0|||
105741247|NCT01533935|364708300|FG000|Overall Study|Lost to Follow-up|0|||
105741248|NCT01533935|364708301|FG001|Overall Study|Lost to Follow-up|0|||
105741249|NCT01533935|364708302|FG002|Overall Study|Lost to Follow-up|1|||
105741250|NCT01533935|364708303|FG003|Overall Study|Lost to Follow-up|0|||
105741251|NCT01533935|364708304|FG004|Overall Study|Lost to Follow-up|0|||
105741252|NCT01533935|364708300|FG000|Overall Study|Withdrawal by Subject|0|||
105741253|NCT01533935|364708301|FG001|Overall Study|Withdrawal by Subject|4|||
105741254|NCT01533935|364708302|FG002|Overall Study|Withdrawal by Subject|5|||
105741255|NCT01533935|364708303|FG003|Overall Study|Withdrawal by Subject|2|||
105741256|NCT01533935|364708304|FG004|Overall Study|Withdrawal by Subject|4|||
105741257|NCT01533935|364708300|FG000|Overall Study|Other reason not defined above|1|||
105741258|NCT01533935|364708301|FG001|Overall Study|Other reason not defined above|0|||
105741259|NCT01533935|364708302|FG002|Overall Study|Other reason not defined above|1|||
105565300|NCT01281202|364066731|FG001|Overall Study|Adverse Event|0|||
105565301|NCT01281202|364066730|FG000|Overall Study|Withdrawal by Subject|2|||
105741260|NCT01533935|364708303|FG003|Overall Study|Other reason not defined above|0|||
105741261|NCT01533935|364708304|FG004|Overall Study|Other reason not defined above|1|||
105741262|NCT03196505|364708306|FG000|Overall Study|Physician Decision|26|||
105741263|NCT03196505|364708307|FG001|Overall Study|Physician Decision|26|||
105741264|NCT01293032|364708308|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
105741265|NCT01293032|364708309|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
105741266|NCT01293032|364708310|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
105741267|NCT01293032|364708311|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
105741268|NCT01293032|364708308|FG000|Treatment|Adverse Event|0|||
105741269|NCT01293032|364708309|FG001|Treatment|Adverse Event|0|||
105741270|NCT01293032|364708310|FG002|Treatment|Adverse Event|1|||
105565302|NCT01281202|364066731|FG001|Overall Study|Withdrawal by Subject|2|||
105741271|NCT01293032|364708311|FG003|Treatment|Adverse Event|1|||
105741272|NCT01293032|364708308|FG000|Treatment|Withdrawal by Subject|2|||
105741273|NCT01293032|364708309|FG001|Treatment|Withdrawal by Subject|4|||
105741274|NCT01293032|364708310|FG002|Treatment|Withdrawal by Subject|0|||
105741275|NCT01293032|364708311|FG003|Treatment|Withdrawal by Subject|0|||
105741276|NCT01293032|364708308|FG000|Treatment|Disease Progression, relapse|0|||
105741277|NCT01293032|364708309|FG001|Treatment|Disease Progression, relapse|1|||
105741278|NCT01293032|364708310|FG002|Treatment|Disease Progression, relapse|0|||
105741279|NCT01293032|364708311|FG003|Treatment|Disease Progression, relapse|0|||
105741280|NCT01063751|364708312|FG000|Overall Study|Censored from analyses|42|||
105741281|NCT01063751|364708312|FG000|Overall Study|Withdrawal by Subject|34|||
105741282|NCT01063751|364708312|FG000|Overall Study|Lost to Follow-up|30|||
105741283|NCT01063751|364708312|FG000|Overall Study|Death|13|||
105741284|NCT01063751|364708312|FG000|Overall Study|Sponsored Terminated Study|60|||
105741285|NCT01063751|364708312|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
105741286|NCT01063751|364708312|FG000|Overall Study|Investigator site closed|10|||
105741287|NCT01063751|364708312|FG000|Overall Study|Revision|6|||
105741288|NCT01063751|364708312|FG000|Overall Study|Physician Decision|4|||
105741289|NCT02985450|364708321|FG000|Overall Study|Lost to Follow-up|7|||
105741290|NCT00431847|364708322|FG000|Overall Study|completion of less than two study visits|6|||
105741291|NCT00431847|364708323|FG001|Overall Study|completion of less than two study visits|3|||
105741292|NCT00431847|364708324|FG002|Overall Study|completion of less than two study visits|4|||
105741293|NCT00431847|364708325|FG003|Overall Study|completion of less than two study visits|14|||
105741294|NCT00431847|364708326|FG004|Overall Study|completion of less than two study visits|0|||
105741295|NCT00431847|364708322|FG000|Overall Study|Protocol Violation|0|||
105741296|NCT00431847|364708323|FG001|Overall Study|Protocol Violation|0|||
105741297|NCT00431847|364708324|FG002|Overall Study|Protocol Violation|0|||
105741298|NCT00431847|364708325|FG003|Overall Study|Protocol Violation|0|||
105741299|NCT00431847|364708326|FG004|Overall Study|Protocol Violation|1|||
105741300|NCT00339183|364708327|FG000|Overall Study|Adverse Event|5|||
105741301|NCT00339183|364708328|FG001|Overall Study|Adverse Event|3|||
105741302|NCT00339183|364708327|FG000|Overall Study|Withdrawal by Subject|16|||
105741303|NCT00339183|364708328|FG001|Overall Study|Withdrawal by Subject|19|||
105741304|NCT00339183|364708327|FG000|Overall Study|Physician Decision|2|||
105741305|NCT00339183|364708328|FG001|Overall Study|Physician Decision|4|||
105741306|NCT00339183|364708327|FG000|Overall Study|Lost to Follow-up|17|||
105741307|NCT00339183|364708328|FG001|Overall Study|Lost to Follow-up|17|||
105741308|NCT00339183|364708327|FG000|Overall Study|Protocol-specified criteria|12|||
105741309|NCT00339183|364708328|FG001|Overall Study|Protocol-specified criteria|8|||
105741310|NCT00339183|364708327|FG000|Overall Study|Missing reason|3|||
105741311|NCT00339183|364708328|FG001|Overall Study|Missing reason|1|||
105741312|NCT00339183|364708327|FG000|Overall Study|Other|46|||
105741313|NCT00339183|364708328|FG001|Overall Study|Other|40|||
105741314|NCT00339183|364708327|FG000|Overall Study|Ongoing|20|||
105741315|NCT00339183|364708328|FG001|Overall Study|Ongoing|13|||
105741316|NCT00446446|364708329|FG000|Overall Study|Death|10|||
105741317|NCT00446446|364708329|FG000|Overall Study|Withdrawal by Subject|6|||
105741318|NCT00446446|364708329|FG000|Overall Study|Other|4|||
105741319|NCT00446446|364708329|FG000|Overall Study|Disease Progession|2|||
105741320|NCT00446446|364708329|FG000|Overall Study|Adverse Event|1|||
105741321|NCT00446446|364708329|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
105741322|NCT02691247|364708335|FG000|Overall Study|Withdrawal by Subject|1|||
105741323|NCT02691247|364708336|FG001|Overall Study|Withdrawal by Subject|2|||
105741324|NCT02691247|364708337|FG002|Overall Study|Withdrawal by Subject|2|||
105741325|NCT02691247|364708335|FG000|Overall Study|Lost to Follow-up|2|||
105741326|NCT02691247|364708336|FG001|Overall Study|Lost to Follow-up|0|||
105741327|NCT02691247|364708337|FG002|Overall Study|Lost to Follow-up|1|||
105741328|NCT02399813|364708338|FG000|Overall Study|Progressive Disease-Radiographic|2|||
105741329|NCT02399813|364708338|FG000|Overall Study|Death|20|||
105741330|NCT02399813|364708338|FG000|Overall Study|Withdrawal by Subject|3|||
105741331|NCT02399813|364708338|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
105358464|NCT04530838|363318939|FG001|Overall Study|Withdrawal by parent/guardian|2|||
105358465|NCT04530838|363318940|FG002|Overall Study|Withdrawal by parent/guardian|2|||
105358466|NCT01919164|363318948|FG000|Overall Study|Adverse Event|6|||
105358467|NCT01919164|363318949|FG001|Overall Study|Adverse Event|4|||
105741332|NCT02399813|364708338|FG000|Overall Study|Lost to Follow-up|2|||
105741333|NCT02399813|364708338|FG000|Overall Study|Other than specified|5|||
105741334|NCT02224846|364708339|FG000|Period 1 (Month 3)|Adverse Event|2|||
105741335|NCT02224846|364708340|FG001|Period 1 (Month 3)|Adverse Event|1|||
105741336|NCT02224846|364708339|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
105741337|NCT02224846|364708340|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
105741338|NCT02224846|364708339|FG000|Period 1 (Month 3)|Protocol Violation|4|||
105741339|NCT02224846|364708340|FG001|Period 1 (Month 3)|Protocol Violation|8|||
105741340|NCT02224846|364708339|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
105741341|NCT02224846|364708340|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
105741342|NCT02224846|364708339|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
105741343|NCT02224846|364708340|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
105741344|NCT02224846|364708339|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
105741345|NCT02224846|364708340|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
105741346|NCT02224846|364708339|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
105358468|NCT01919164|363318950|FG002|Overall Study|Adverse Event|9|||
105358469|NCT01919164|363318951|FG003|Overall Study|Adverse Event|3|||
105358470|NCT01919164|363318952|FG004|Overall Study|Adverse Event|2|||
105358471|NCT01919164|363318948|FG000|Overall Study|Lost to Follow-up|2|||
105358472|NCT01919164|363318949|FG001|Overall Study|Lost to Follow-up|2|||
105358473|NCT01919164|363318950|FG002|Overall Study|Lost to Follow-up|2|||
105358474|NCT01919164|363318951|FG003|Overall Study|Lost to Follow-up|0|||
105741347|NCT02224846|364708340|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
105741348|NCT02224846|364708339|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
105741349|NCT02224846|364708340|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
105741350|NCT02224846|364708339|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
105741351|NCT02224846|364708340|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
105741352|NCT02224846|364708339|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
105741353|NCT02224846|364708340|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
105741354|NCT02224846|364708339|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
105741355|NCT02224846|364708340|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
105741356|NCT02224846|364708339|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
105741357|NCT02224846|364708340|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
105741358|NCT02224846|364708339|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
105741359|NCT02224846|364708340|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
105741360|NCT02224846|364708339|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
105741361|NCT02224846|364708340|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
105741362|NCT02224846|364708339|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
105741363|NCT02224846|364708340|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
105741364|NCT02224846|364708339|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
105741365|NCT02224846|364708340|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
105741366|NCT02224846|364708339|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
105741367|NCT02224846|364708340|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
105741368|NCT05372575|364708345|FG000|Overall Study|Protocol Violation|7|||
105741369|NCT05372575|364708346|FG001|Overall Study|Protocol Violation|16|||
105741370|NCT00053846|364708347|FG000|Overall Study|Changed mind|8|||
105741371|NCT00053846|364708348|FG001|Overall Study|Changed mind|13|||
105741372|NCT00053846|364708347|FG000|Overall Study|Became too ill|8|||
105741373|NCT00053846|364708348|FG001|Overall Study|Became too ill|7|||
105741374|NCT00053846|364708347|FG000|Overall Study|Expired|5|||
105741375|NCT00053846|364708348|FG001|Overall Study|Expired|0|||
105741376|NCT00053846|364708347|FG000|Overall Study|Became ineligible|3|||
105741377|NCT00053846|364708348|FG001|Overall Study|Became ineligible|1|||
105741378|NCT00053846|364708347|FG000|Overall Study|Did not return data|1|||
105741379|NCT00053846|364708348|FG001|Overall Study|Did not return data|2|||
105741380|NCT00053846|364708347|FG000|Overall Study|Quit due to side effects|1|||
105741381|NCT00053846|364708348|FG001|Overall Study|Quit due to side effects|3|||
105741382|NCT00053846|364708347|FG000|Overall Study|Pills too large|0|||
105741383|NCT00053846|364708348|FG001|Overall Study|Pills too large|1|||
105741384|NCT00064662|364708350|FG000|Overall Study|Death|1|||
105741385|NCT00064662|364708351|FG001|Overall Study|Death|1|||
105741386|NCT00064662|364708350|FG000|Overall Study|Lost to Follow-up|57|||
105741387|NCT00064662|364708351|FG001|Overall Study|Lost to Follow-up|44|||
105741388|NCT00064662|364708350|FG000|Overall Study|Withdrawal by Subject|14|||
105741389|NCT00064662|364708351|FG001|Overall Study|Withdrawal by Subject|14|||
105741390|NCT00064662|364708350|FG000|Overall Study|Administratively withdrawn|2|||
105741391|NCT00064662|364708351|FG001|Overall Study|Administratively withdrawn|2|||
105741392|NCT00933335|364708352|FG000|Overall Study|Lost to Follow-up|1|||
105741393|NCT00933335|364708353|FG001|Overall Study|Lost to Follow-up|3|||
105741394|NCT00933335|364708352|FG000|Overall Study|Withdrawal by Subject|0|||
105741395|NCT00933335|364708353|FG001|Overall Study|Withdrawal by Subject|1|||
105741396|NCT00933335|364708352|FG000|Overall Study|Progressive Disease|0|||
105741397|NCT00933335|364708353|FG001|Overall Study|Progressive Disease|11|||
105741398|NCT00933335|364708352|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
105358475|NCT01919164|363318952|FG004|Overall Study|Lost to Follow-up|4|||
105741399|NCT00933335|364708353|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
105358476|NCT01919164|363318948|FG000|Overall Study|Death|1|||
105358477|NCT01919164|363318949|FG001|Overall Study|Death|0|||
105565303|NCT01281202|364066730|FG000|Overall Study|Protocol Violation|11|||
105741400|NCT00933335|364708352|FG000|Overall Study|Co-morbid Illness|1|||
105741401|NCT00933335|364708353|FG001|Overall Study|Co-morbid Illness|0|||
105741402|NCT03196297|364708354|FG000|Main Period|Withdrawal by Subject|4|||
105741403|NCT03196297|364708354|FG000|Extension Period|Withdrawal by Subject|1|||
105741404|NCT03196297|364708354|FG000|Extension Period|Lack of Efficacy|2|||
105741405|NCT04333433|364708357|FG000|Overall Study|Withdrawal by Subject|6|||
105741406|NCT04333433|364708358|FG001|Overall Study|Withdrawal by Subject|3|||
105741407|NCT04333433|364708357|FG000|Overall Study|Death|3|||
105358478|NCT01919164|363318950|FG002|Overall Study|Death|0|||
105358479|NCT01919164|363318951|FG003|Overall Study|Death|0|||
105358480|NCT01919164|363318952|FG004|Overall Study|Death|0|||
105741408|NCT04333433|364708358|FG001|Overall Study|Death|0|||
105741409|NCT04333433|364708357|FG000|Overall Study|Lost to Follow-up|6|||
105741410|NCT04333433|364708358|FG001|Overall Study|Lost to Follow-up|1|||
105741411|NCT04333433|364708357|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
105741412|NCT04333433|364708358|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
105741413|NCT02275026|364708359|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
105741414|NCT02275026|364708359|FG000|Overall Study|Withdrawal by Subject|4|||
105741415|NCT02275026|364708359|FG000|Overall Study|Ineligible due to medical history|13|||
105741416|NCT02275026|364708359|FG000|Overall Study|MRI malfunction precluded testing|1|||
105741417|NCT02275026|364708359|FG000|Overall Study|Ineligible after MRI findings|1|||
105741418|NCT02275026|364708359|FG000|Overall Study|Lost to Follow-up|2|||
105741419|NCT02275026|364708359|FG000|Overall Study|Scanner failure|1|||
105741420|NCT05468086|364708360|FG000|Overall Study|Withdrawal by Subject|3|||
105741421|NCT05468086|364708360|FG000|Overall Study|Subject was found ineligible after consent|1|||
105741422|NCT00374907|364708361|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
105741423|NCT00374907|364708362|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
105741424|NCT00374907|364708361|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
105741425|NCT00374907|364708362|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
105741426|NCT00374907|364708361|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
105741427|NCT00374907|364708362|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
105741428|NCT00374907|364708361|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
105741429|NCT00374907|364708362|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
105741430|NCT00374907|364708361|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
105741431|NCT00374907|364708362|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
105741432|NCT02582749|364708363|FG000|Overall Study|Study terminated by funder|5|||
105741433|NCT02582749|364708364|FG001|Overall Study|Study terminated by funder|10|||
105741434|NCT02582749|364708363|FG000|Overall Study|Withdrawal by Subject|0|||
105741435|NCT02582749|364708364|FG001|Overall Study|Withdrawal by Subject|1|||
105741436|NCT04229446|364708366|FG000|Overall Study|Death|12|||
105741437|NCT04229446|364708367|FG001|Overall Study|Death|10|||
105741438|NCT04229446|364708366|FG000|Overall Study|Lost to Follow-up|5|||
105741439|NCT04229446|364708367|FG001|Overall Study|Lost to Follow-up|8|||
105741440|NCT01413178|364708368|FG000|Overall Study|Toxicity|1|||
105741441|NCT01413178|364708369|FG001|Overall Study|Toxicity|0|||
105741442|NCT01413178|364708368|FG000|Overall Study|Ineligible|0|||
105741443|NCT01413178|364708369|FG001|Overall Study|Ineligible|2|||
105741444|NCT01721408|364708370|FG000|Overall Study|Adverse Event|6|||
105741445|NCT01721408|364708371|FG001|Overall Study|Adverse Event|1|||
105741446|NCT01721408|364708370|FG000|Overall Study|Death|1|||
105741447|NCT01721408|364708371|FG001|Overall Study|Death|0|||
105741448|NCT01721408|364708370|FG000|Overall Study|Insufficient clinical response|15|||
105741449|NCT01721408|364708371|FG001|Overall Study|Insufficient clinical response|6|||
105741450|NCT01721408|364708370|FG000|Overall Study|No longer willing to participate study|9|||
105741451|NCT01721408|364708371|FG001|Overall Study|No longer willing to participate study|10|||
105741452|NCT01721408|364708370|FG000|Overall Study|Protocol Violation|0|||
105741453|NCT01721408|364708371|FG001|Overall Study|Protocol Violation|2|||
105741454|NCT01721408|364708370|FG000|Overall Study|Other|3|||
105741455|NCT01721408|364708371|FG001|Overall Study|Other|3|||
105741456|NCT01721408|364708370|FG000|Overall Study|Lost to Follow-up|1|||
105741457|NCT01721408|364708371|FG001|Overall Study|Lost to Follow-up|2|||
105741458|NCT01721408|364708370|FG000|Overall Study|Does not meet entrance criteria|1|||
105741459|NCT01721408|364708371|FG001|Overall Study|Does not meet entrance criteria|0|||
105741460|NCT01678807|364708372|FG000|Overall Study|Adverse Event|4|||
105741461|NCT01678807|364708373|FG001|Overall Study|Adverse Event|4|||
105741462|NCT01678807|364708374|FG002|Overall Study|Adverse Event|0|||
105741463|NCT01678807|364708372|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
105741464|NCT01678807|364708373|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
105741465|NCT01678807|364708374|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
105741466|NCT00370149|364708375|FG000|Overall Study|Physician Decision|16|||
105358481|NCT01919164|363318948|FG000|Overall Study|Protocol Violation|6|||
105358482|NCT01919164|363318949|FG001|Overall Study|Protocol Violation|0|||
105800113|NCT00686790|364926369|FG000|Overall Study|Adverse Event|2|||
105800114|NCT00686790|364926369|FG000|Overall Study|Withdrawal by Subject|1|||
105800115|NCT00686790|364926369|FG000|Overall Study|Death|1|||
105800116|NCT00686790|364926369|FG000|Overall Study|Lost to Follow-up|12|||
105800117|NCT01690520|364926372|FG000|Overall Study|Death|25|||
105800118|NCT01690520|364926373|FG001|Overall Study|Death|21|||
105800119|NCT01690520|364926372|FG000|Overall Study|Lost to Follow-up|2|||
105800120|NCT01690520|364926373|FG001|Overall Study|Lost to Follow-up|3|||
105800121|NCT01690520|364926372|FG000|Overall Study|Withdrawal by Subject|2|||
105800122|NCT01690520|364926373|FG001|Overall Study|Withdrawal by Subject|0|||
105800123|NCT01690520|364926372|FG000|Overall Study|Relapse|0|||
105800124|NCT01690520|364926373|FG001|Overall Study|Relapse|1|||
105800125|NCT01690520|364926372|FG000|Overall Study|Other|0|||
105800126|NCT01690520|364926373|FG001|Overall Study|Other|1|||
105800127|NCT01690520|364926372|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
105800128|NCT01690520|364926373|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
105358483|NCT01919164|363318950|FG002|Overall Study|Protocol Violation|3|||
105358484|NCT01919164|363318951|FG003|Overall Study|Protocol Violation|2|||
105358485|NCT01919164|363318952|FG004|Overall Study|Protocol Violation|2|||
105358486|NCT01919164|363318948|FG000|Overall Study|Disease progression|2|||
105358487|NCT01919164|363318949|FG001|Overall Study|Disease progression|2|||
105358488|NCT01919164|363318950|FG002|Overall Study|Disease progression|1|||
105358489|NCT01919164|363318951|FG003|Overall Study|Disease progression|2|||
105358490|NCT01919164|363318952|FG004|Overall Study|Disease progression|1|||
105358491|NCT01919164|363318948|FG000|Overall Study|Withdrew consent|13|||
105358492|NCT01919164|363318949|FG001|Overall Study|Withdrew consent|13|||
105358493|NCT01919164|363318950|FG002|Overall Study|Withdrew consent|14|||
105358494|NCT01919164|363318951|FG003|Overall Study|Withdrew consent|14|||
105358495|NCT01919164|363318952|FG004|Overall Study|Withdrew consent|9|||
105358496|NCT01919164|363318948|FG000|Overall Study|Other Un-specified|13|||
105358497|NCT01919164|363318949|FG001|Overall Study|Other Un-specified|9|||
105358498|NCT01919164|363318950|FG002|Overall Study|Other Un-specified|8|||
105358499|NCT01919164|363318951|FG003|Overall Study|Other Un-specified|7|||
105358500|NCT01919164|363318952|FG004|Overall Study|Other Un-specified|15|||
105358501|NCT03272347|363318954|FG000|Overall Study|Death|0|||
105358502|NCT03272347|363318955|FG001|Overall Study|Death|0|||
105358503|NCT03272347|363318956|FG002|Overall Study|Death|0|||
105358504|NCT03272347|363318957|FG003|Overall Study|Death|1|||
105358505|NCT03272347|363318954|FG000|Overall Study|Lost to Follow-up|1|||
105358506|NCT03272347|363318955|FG001|Overall Study|Lost to Follow-up|3|||
105358507|NCT03272347|363318956|FG002|Overall Study|Lost to Follow-up|5|||
105358508|NCT03272347|363318957|FG003|Overall Study|Lost to Follow-up|1|||
105358509|NCT03272347|363318954|FG000|Overall Study|Physician Decision|4|||
105358510|NCT03272347|363318955|FG001|Overall Study|Physician Decision|2|||
105358511|NCT03272347|363318956|FG002|Overall Study|Physician Decision|5|||
105358512|NCT03272347|363318957|FG003|Overall Study|Physician Decision|4|||
105358513|NCT03272347|363318954|FG000|Overall Study|Screen Failure|1|||
105358514|NCT03272347|363318955|FG001|Overall Study|Screen Failure|0|||
105358515|NCT03272347|363318956|FG002|Overall Study|Screen Failure|0|||
105358516|NCT03272347|363318957|FG003|Overall Study|Screen Failure|0|||
105358517|NCT03272347|363318954|FG000|Overall Study|Withdrawal by Subject|5|||
105358518|NCT03272347|363318955|FG001|Overall Study|Withdrawal by Subject|1|||
105358519|NCT03272347|363318956|FG002|Overall Study|Withdrawal by Subject|2|||
105358520|NCT03272347|363318957|FG003|Overall Study|Withdrawal by Subject|1|||
105358521|NCT03859648|363318958|FG000|Overall Study|Lost to Follow-up|1|||
105358522|NCT03859648|363318958|FG000|Overall Study|Adverse Event|1|||
105358523|NCT01677182|363318959|FG000|Overall Study|Adverse Event|2|||
105358524|NCT01677182|363318960|FG001|Overall Study|Adverse Event|1|||
105800129|NCT00096382|364926374|FG000|Overall Study|Not treated|1|||
105800130|NCT00096382|364926375|FG001|Overall Study|Not treated|0|||
105358525|NCT01677182|363318961|FG002|Overall Study|Adverse Event|8|||
105358526|NCT01677182|363318959|FG000|Overall Study|Protocol Violation|5|||
105358527|NCT01677182|363318960|FG001|Overall Study|Protocol Violation|1|||
105358528|NCT01677182|363318961|FG002|Overall Study|Protocol Violation|4|||
105358529|NCT01677182|363318959|FG000|Overall Study|Lost to Follow-up|4|||
105800131|NCT00096382|364926374|FG000|Overall Study|Death during treatment|1|||
105800132|NCT00096382|364926375|FG001|Overall Study|Death during treatment|0|||
105800133|NCT00948025|364926377|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
105800134|NCT00948025|364926378|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
105800135|NCT00948025|364926377|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
105800136|NCT00948025|364926378|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
105358530|NCT01677182|363318960|FG001|Overall Study|Lost to Follow-up|0|||
105358531|NCT01677182|363318961|FG002|Overall Study|Lost to Follow-up|3|||
105358532|NCT01677182|363318959|FG000|Overall Study|Withdrawal by Subject|7|||
105358533|NCT01677182|363318960|FG001|Overall Study|Withdrawal by Subject|12|||
105358534|NCT01677182|363318961|FG002|Overall Study|Withdrawal by Subject|10|||
105358535|NCT01677182|363318959|FG000|Overall Study|Study termination|12|||
105358536|NCT01677182|363318960|FG001|Overall Study|Study termination|9|||
105358537|NCT01677182|363318961|FG002|Overall Study|Study termination|11|||
105358538|NCT01677182|363318959|FG000|Overall Study|Lack of Efficacy|3|||
105358539|NCT01677182|363318960|FG001|Overall Study|Lack of Efficacy|0|||
105358540|NCT01677182|363318961|FG002|Overall Study|Lack of Efficacy|1|||
105358541|NCT01677182|363318959|FG000|Overall Study|Other reasons|1|||
105358542|NCT01677182|363318960|FG001|Overall Study|Other reasons|5|||
105741467|NCT00370149|364708376|FG001|Overall Study|Physician Decision|16|||
105741468|NCT00370149|364708375|FG000|Overall Study|Protocol Violation|1|||
105741469|NCT00370149|364708376|FG001|Overall Study|Protocol Violation|0|||
105741470|NCT00370149|364708375|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
105741471|NCT00370149|364708376|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
105741472|NCT00370149|364708375|FG000|Overall Study|Pre-existing infection|0|||
105741473|NCT00370149|364708376|FG001|Overall Study|Pre-existing infection|1|||
105741474|NCT00370149|364708375|FG000|Overall Study|Antibiotic coated dressing placed|0|||
105741475|NCT00370149|364708376|FG001|Overall Study|Antibiotic coated dressing placed|1|||
105741476|NCT02322892|364709689|FG000|Overall Study|Surgery cancelled|1|||
105741477|NCT02322892|364709690|FG001|Overall Study|Surgery cancelled|2|||
105741478|NCT02322892|364709689|FG000|Overall Study|Met exclusion criteria|0|||
105741479|NCT02322892|364709690|FG001|Overall Study|Met exclusion criteria|1|||
105741480|NCT02322892|364709689|FG000|Overall Study|Protocol Violation|1|||
105741481|NCT02322892|364709690|FG001|Overall Study|Protocol Violation|0|||
105741482|NCT01755195|364709691|FG000|Overall Study|Participant noncompliance|2|||
105741483|NCT01755195|364709691|FG000|Overall Study|Switched to alternative treatment|4|||
105741484|NCT01755195|364709691|FG000|Overall Study|Withdrawal by Subject|1|||
105741485|NCT01755195|364709691|FG000|Overall Study|Participant refused to start treatment|1|||
105741486|NCT01755195|364709691|FG000|Overall Study|Participant has been consented for another trial|1|||
105741487|NCT01755195|364709691|FG000|Overall Study|Refused further treatment|3|||
105741488|NCT01755195|364709691|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
105741489|NCT01989546|364709692|FG000|Overall Study|Clinical Progression|1|||
105741490|NCT01989546|364709692|FG000|Overall Study|Disease progression on study|8|||
105741491|NCT03123354|364709693|FG000|Overall Study|Physician Decision|6|||
105741492|NCT02340819|364709694|FG000|Overall Study|Adverse Event|1|||
105741493|NCT02340819|364709694|FG000|Overall Study|Withdrawal by Subject|2|||
105741494|NCT02340819|364709694|FG000|Overall Study|Discontinued with other reason|1|||
105741495|NCT04907539|364709699|FG000|Overall Study|Consent withdrawn|1|||
105741496|NCT04907539|364709700|FG001|Overall Study|Consent withdrawn|0|||
105741497|NCT04907539|364709699|FG000|Overall Study|Death|14|||
105741498|NCT04907539|364709700|FG001|Overall Study|Death|3|||
105741499|NCT01441440|364709701|FG000|Overall Study|Death|1|||
105741500|NCT01441440|364709702|FG001|Overall Study|Death|0|||
105741501|NCT01441440|364709703|FG002|Overall Study|Death|1|||
105741502|NCT01441440|364709701|FG000|Overall Study|Adverse Event|2|||
105741503|NCT01441440|364709702|FG001|Overall Study|Adverse Event|9|||
105741504|NCT01441440|364709703|FG002|Overall Study|Adverse Event|9|||
105741505|NCT01441440|364709701|FG000|Overall Study|Lost to Follow-up|0|||
105741506|NCT01441440|364709702|FG001|Overall Study|Lost to Follow-up|2|||
105741507|NCT01441440|364709703|FG002|Overall Study|Lost to Follow-up|1|||
105741508|NCT01441440|364709701|FG000|Overall Study|Withdrawal by Subject|11|||
105741509|NCT01441440|364709702|FG001|Overall Study|Withdrawal by Subject|9|||
105741510|NCT01441440|364709703|FG002|Overall Study|Withdrawal by Subject|9|||
105741511|NCT01441440|364709701|FG000|Overall Study|Pregnancy|1|||
105741512|NCT01441440|364709702|FG001|Overall Study|Pregnancy|0|||
105741513|NCT01441440|364709703|FG002|Overall Study|Pregnancy|0|||
105741514|NCT01441440|364709701|FG000|Overall Study|Lack of Efficacy|1|||
105741515|NCT01441440|364709702|FG001|Overall Study|Lack of Efficacy|0|||
105741516|NCT01441440|364709703|FG002|Overall Study|Lack of Efficacy|1|||
105741517|NCT01441440|364709701|FG000|Overall Study|Moving|0|||
105741518|NCT01441440|364709702|FG001|Overall Study|Moving|1|||
105741519|NCT01441440|364709703|FG002|Overall Study|Moving|1|||
105741520|NCT01441440|364709701|FG000|Overall Study|Work-related matter|0|||
105741521|NCT01441440|364709702|FG001|Overall Study|Work-related matter|1|||
105741522|NCT01441440|364709703|FG002|Overall Study|Work-related matter|0|||
105741523|NCT01441440|364709701|FG000|Overall Study|Difficllty in keeping the schedule|1|||
105741524|NCT01441440|364709702|FG001|Overall Study|Difficllty in keeping the schedule|1|||
105741525|NCT01441440|364709703|FG002|Overall Study|Difficllty in keeping the schedule|0|||
105741526|NCT03276936|364709709|FG000|Overall Study|Adverse Event|4|||
105741527|NCT03276936|364709710|FG001|Overall Study|Adverse Event|2|||
105741528|NCT03276936|364709709|FG000|Overall Study|Lost to Follow-up|16|||
105741529|NCT03276936|364709710|FG001|Overall Study|Lost to Follow-up|13|||
105741530|NCT03276936|364709709|FG000|Overall Study|Withdrawal by Subject|30|||
105741531|NCT03276936|364709710|FG001|Overall Study|Withdrawal by Subject|20|||
105741532|NCT03276936|364709709|FG000|Overall Study|Not mentioned|6|||
105741533|NCT03276936|364709710|FG001|Overall Study|Not mentioned|3|||
105741534|NCT01798134|364709711|FG000|Overall Study|Lost to Follow-up|1|||
105741535|NCT01798134|364709711|FG000|Overall Study|Withdrawal by Subject|3|||
105358543|NCT01677182|363318961|FG002|Overall Study|Other reasons|2|||
105358544|NCT02489448|363318962|FG000|Overall Study|Death|3|||
105741536|NCT01798134|364709711|FG000|Overall Study|Death|2|||
105741537|NCT01798134|364709711|FG000|Overall Study|Adverse Event|3|||
105741538|NCT01798134|364709711|FG000|Overall Study|Physician Decision|3|||
105741539|NCT01798134|364709711|FG000|Overall Study|Liver transplant/surgery|4|||
105741540|NCT02653976|364709712|FG000|Overall Study|Withdrawal by Subject|5|||
105358545|NCT02489448|363318962|FG000|Overall Study|Withdrawal by Subject|2|||
105358546|NCT01990573|363318963|FG000|Overall Study|Physician Decision|0|||
105358547|NCT01990573|363318964|FG001|Overall Study|Physician Decision|0|||
105358548|NCT01990573|363318965|FG002|Overall Study|Physician Decision|1|||
105358549|NCT01971567|363318966|FG000|Overall Study|Withdrawal by Subject|3|||
105358550|NCT01971567|363318967|FG001|Overall Study|Withdrawal by Subject|2|||
105358551|NCT01971567|363318966|FG000|Overall Study|Lost to Follow-up|1|||
105358552|NCT01971567|363318967|FG001|Overall Study|Lost to Follow-up|0|||
105358553|NCT01826981|363318968|FG000|Overall Study|Lack of Efficacy|0|||
105358554|NCT01826981|363318969|FG001|Overall Study|Lack of Efficacy|1|||
105358555|NCT01826981|363318970|FG002|Overall Study|Lack of Efficacy|0|||
105358556|NCT01826981|363318971|FG003|Overall Study|Lack of Efficacy|0|||
105358557|NCT01826981|363318972|FG004|Overall Study|Lack of Efficacy|5|||
105358558|NCT01826981|363318973|FG005|Overall Study|Lack of Efficacy|0|||
105741541|NCT02653976|364709712|FG000|Overall Study|Death|4|||
105741542|NCT02023164|364709713|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
105741543|NCT02023164|364709714|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
105741544|NCT02042404|364709715|FG000|Overall Study|Death|1|||
105741545|NCT02042404|364709716|FG001|Overall Study|Death|0|||
105741546|NCT02042404|364709715|FG000|Overall Study|Unrelated Adverse Event|3|||
105741547|NCT02042404|364709716|FG001|Overall Study|Unrelated Adverse Event|0|||
105741548|NCT02042404|364709715|FG000|Overall Study|Inability to meet time requirements|1|||
105741549|NCT02042404|364709716|FG001|Overall Study|Inability to meet time requirements|0|||
105741550|NCT00726323|364709717|FG000|Overall Study|Withdrawal by Subject|3|||
105741551|NCT00726323|364709718|FG001|Overall Study|Withdrawal by Subject|1|||
105741552|NCT00726323|364709717|FG000|Overall Study|Physician Decision|1|||
105741553|NCT00726323|364709718|FG001|Overall Study|Physician Decision|0|||
105741554|NCT00726323|364709717|FG000|Overall Study|Progressive disease|23|||
105741555|NCT00726323|364709718|FG001|Overall Study|Progressive disease|16|||
105741556|NCT00726323|364709717|FG000|Overall Study|Clinical progression|0|||
105741557|NCT00726323|364709718|FG001|Overall Study|Clinical progression|3|||
105741558|NCT00726323|364709717|FG000|Overall Study|Adverse Event|9|||
105741559|NCT00726323|364709718|FG001|Overall Study|Adverse Event|9|||
105741560|NCT00726323|364709717|FG000|Overall Study|Death|1|||
105741561|NCT00726323|364709718|FG001|Overall Study|Death|0|||
105741562|NCT00726323|364709717|FG000|Overall Study|Participant wished to discontinue|0|||
105741563|NCT00726323|364709718|FG001|Overall Study|Participant wished to discontinue|1|||
105741564|NCT00726323|364709717|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
105741565|NCT00726323|364709718|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
105741566|NCT03010423|364709719|FG000|Overall Study|Study termination|8|||
105741567|NCT03430245|364709723|FG000|Overall Study|Withdrawal by Subject|6|||
105741568|NCT03430245|364709723|FG000|Overall Study|Lost to Follow-up|1|||
105741569|NCT01234402|364709724|FG000|Overall Study|Lost to Follow-up|0|||
105741570|NCT01234402|364709725|FG001|Overall Study|Lost to Follow-up|1|||
105741571|NCT01234402|364709726|FG002|Overall Study|Lost to Follow-up|3|||
105741572|NCT01234402|364709724|FG000|Overall Study|Withdrawal by Subject|1|||
105741573|NCT01234402|364709725|FG001|Overall Study|Withdrawal by Subject|3|||
105741574|NCT01234402|364709726|FG002|Overall Study|Withdrawal by Subject|4|||
105741575|NCT01234402|364709724|FG000|Overall Study|Never treated: Death|0|||
105741576|NCT01234402|364709725|FG001|Overall Study|Never treated: Death|0|||
105741577|NCT01234402|364709726|FG002|Overall Study|Never treated: Death|1|||
105741578|NCT01234402|364709724|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
105741579|NCT01234402|364709725|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
105741580|NCT01234402|364709726|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
105741581|NCT01234402|364709724|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
105741582|NCT01234402|364709725|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
105741583|NCT01234402|364709726|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
105741584|NCT04742907|364709727|FG000|Overall Study|Adverse Event|1|||
105741585|NCT04742907|364709728|FG001|Overall Study|Adverse Event|0|||
105741586|NCT04742907|364709729|FG002|Overall Study|Adverse Event|1|||
105741587|NCT04742907|364709727|FG000|Overall Study|Lost to Follow-up|3|||
105741588|NCT04742907|364709728|FG001|Overall Study|Lost to Follow-up|3|||
105741589|NCT04742907|364709729|FG002|Overall Study|Lost to Follow-up|2|||
105741590|NCT04742907|364709727|FG000|Overall Study|Physician Decision|0|||
105741591|NCT04742907|364709728|FG001|Overall Study|Physician Decision|1|||
105741592|NCT04742907|364709729|FG002|Overall Study|Physician Decision|0|||
105741593|NCT04742907|364709727|FG000|Overall Study|Protocol Violation|1|||
105741594|NCT04742907|364709728|FG001|Overall Study|Protocol Violation|1|||
105741595|NCT04742907|364709729|FG002|Overall Study|Protocol Violation|1|||
105741596|NCT04742907|364709727|FG000|Overall Study|Withdrawal by Subject|5|||
105358559|NCT01826981|363318974|FG006|Overall Study|Lack of Efficacy|0|||
105358560|NCT01826981|363318975|FG007|Overall Study|Lack of Efficacy|8|||
105358561|NCT01826981|363318976|FG008|Overall Study|Lack of Efficacy|7|||
105358562|NCT01826981|363318977|FG009|Overall Study|Lack of Efficacy|0|||
105358563|NCT01826981|363318978|FG010|Overall Study|Lack of Efficacy|1|||
105358564|NCT01826981|363318979|FG011|Overall Study|Lack of Efficacy|0|||
105741597|NCT04742907|364709728|FG001|Overall Study|Withdrawal by Subject|6|||
105358565|NCT01826981|363318980|FG012|Overall Study|Lack of Efficacy|0|||
105358566|NCT01826981|363318981|FG013|Overall Study|Lack of Efficacy|3|||
105358567|NCT01826981|363318982|FG014|Overall Study|Lack of Efficacy|0|||
105358568|NCT01826981|363318968|FG000|Overall Study|Lost to Follow-up|0|||
105358569|NCT01826981|363318969|FG001|Overall Study|Lost to Follow-up|0|||
105358570|NCT01826981|363318970|FG002|Overall Study|Lost to Follow-up|0|||
105358571|NCT01826981|363318971|FG003|Overall Study|Lost to Follow-up|0|||
105358572|NCT01826981|363318972|FG004|Overall Study|Lost to Follow-up|1|||
105358573|NCT01826981|363318973|FG005|Overall Study|Lost to Follow-up|1|||
105358574|NCT01826981|363318974|FG006|Overall Study|Lost to Follow-up|0|||
105358575|NCT01826981|363318975|FG007|Overall Study|Lost to Follow-up|1|||
105358576|NCT01826981|363318976|FG008|Overall Study|Lost to Follow-up|0|||
105358577|NCT01826981|363318977|FG009|Overall Study|Lost to Follow-up|1|||
105358578|NCT01826981|363318978|FG010|Overall Study|Lost to Follow-up|1|||
105358579|NCT01826981|363318979|FG011|Overall Study|Lost to Follow-up|1|||
105358580|NCT01826981|363318980|FG012|Overall Study|Lost to Follow-up|1|||
105358581|NCT01826981|363318981|FG013|Overall Study|Lost to Follow-up|0|||
105358582|NCT01826981|363318982|FG014|Overall Study|Lost to Follow-up|0|||
105358583|NCT01826981|363318968|FG000|Overall Study|Withdrew Consent|0|||
105358584|NCT01826981|363318969|FG001|Overall Study|Withdrew Consent|0|||
105358585|NCT01826981|363318970|FG002|Overall Study|Withdrew Consent|0|||
105741598|NCT04742907|364709729|FG002|Overall Study|Withdrawal by Subject|4|||
105741599|NCT04742907|364709727|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
105741600|NCT04742907|364709728|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
105741601|NCT04742907|364709729|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
105741602|NCT04742907|364709727|FG000|Overall Study|Did Not Receive the Study Drug|2|||
105741603|NCT04742907|364709728|FG001|Overall Study|Did Not Receive the Study Drug|4|||
105741604|NCT04742907|364709729|FG002|Overall Study|Did Not Receive the Study Drug|4|||
105741605|NCT02280291|364709730|FG000|Overall Study|Lost to Follow-up|2|||
105741606|NCT02280291|364709731|FG001|Overall Study|Lost to Follow-up|1|||
105741607|NCT02280291|364709732|FG002|Overall Study|Lost to Follow-up|3|||
105741608|NCT02280291|364709733|FG003|Overall Study|Lost to Follow-up|8|||
105741609|NCT02280291|364709730|FG000|Overall Study|Protocol Violation|1|||
105741610|NCT02280291|364709731|FG001|Overall Study|Protocol Violation|0|||
105741611|NCT02280291|364709732|FG002|Overall Study|Protocol Violation|0|||
105741612|NCT02280291|364709733|FG003|Overall Study|Protocol Violation|0|||
105741613|NCT02280291|364709730|FG000|Overall Study|Other|1|||
105741614|NCT02280291|364709731|FG001|Overall Study|Other|1|||
105741615|NCT02280291|364709732|FG002|Overall Study|Other|0|||
105741616|NCT02280291|364709733|FG003|Overall Study|Other|0|||
105741617|NCT04964063|364709735|FG000|Overall Study|Adverse Event|4|||
105741618|NCT04964063|364709735|FG000|Overall Study|Lost to Follow-up|47|||
105741619|NCT04964063|364709735|FG000|Overall Study|Withdrawal by Subject|5|||
105741620|NCT04964063|364709735|FG000|Overall Study|Baseline Tasks Expired|41|||
105741621|NCT04964063|364709735|FG000|Overall Study|Participant withdrawn in error|1|||
105741622|NCT02284906|364709736|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
105741623|NCT02284906|364709737|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
105741624|NCT02284906|364709738|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
105741625|NCT02284906|364709736|FG000|Overall Study|Major Protocol Deviation|0|||
105741626|NCT02284906|364709737|FG001|Overall Study|Major Protocol Deviation|1|||
105741627|NCT02284906|364709738|FG002|Overall Study|Major Protocol Deviation|0|||
105741628|NCT02284906|364709736|FG000|Overall Study|Voluntary Withdrawal|2|||
105741629|NCT02284906|364709737|FG001|Overall Study|Voluntary Withdrawal|4|||
105741630|NCT02284906|364709738|FG002|Overall Study|Voluntary Withdrawal|5|||
105741631|NCT02284906|364709736|FG000|Overall Study|Study Termination|0|||
105741632|NCT02284906|364709737|FG001|Overall Study|Study Termination|11|||
105741633|NCT02284906|364709738|FG002|Overall Study|Study Termination|14|||
105741634|NCT02284906|364709736|FG000|Overall Study|Reason not Specified|1|||
105741635|NCT02284906|364709737|FG001|Overall Study|Reason not Specified|1|||
105741636|NCT02284906|364709738|FG002|Overall Study|Reason not Specified|0|||
105741637|NCT02433288|364709740|FG000|Overall Study|Severe non-compliance to protocol|13|||
105741638|NCT02433288|364709741|FG001|Overall Study|Severe non-compliance to protocol|7|||
105741639|NCT02433288|364709740|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
105741640|NCT02433288|364709741|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
105741641|NCT02433288|364709740|FG000|Overall Study|Withdrawal by Subject|101|||
105800137|NCT00948025|364926377|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
105800138|NCT00948025|364926378|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
105358586|NCT01826981|363318971|FG003|Overall Study|Withdrew Consent|0|||
105358587|NCT01826981|363318972|FG004|Overall Study|Withdrew Consent|0|||
105358588|NCT01826981|363318973|FG005|Overall Study|Withdrew Consent|0|||
105358589|NCT01826981|363318974|FG006|Overall Study|Withdrew Consent|1|||
105565304|NCT01281202|364066731|FG001|Overall Study|Protocol Violation|10|||
105358590|NCT01826981|363318975|FG007|Overall Study|Withdrew Consent|1|||
105358591|NCT01826981|363318976|FG008|Overall Study|Withdrew Consent|0|||
105741642|NCT02433288|364709741|FG001|Overall Study|Withdrawal by Subject|99|||
105741643|NCT02433288|364709740|FG000|Overall Study|Lost to Follow-up|2|||
105741644|NCT02433288|364709741|FG001|Overall Study|Lost to Follow-up|14|||
105482948|NCT02815280|363780834|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
105741645|NCT02433288|364709740|FG000|Overall Study|Death|0|||
105741646|NCT02433288|364709741|FG001|Overall Study|Death|3|||
105741647|NCT01120093|364709744|FG000|Treatment Period 1|Adverse Event|0|||
105741648|NCT01120093|364709745|FG001|Treatment Period 1|Adverse Event|0|||
105741649|NCT01120093|364709746|FG002|Treatment Period 1|Adverse Event|1|||
105741650|NCT01120093|364709747|FG003|Treatment Period 1|Adverse Event|0|||
105741651|NCT01120093|364709748|FG004|Treatment Period 1|Adverse Event|1|||
105741652|NCT01120093|364709744|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105741653|NCT01120093|364709745|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105741654|NCT01120093|364709746|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105741655|NCT01120093|364709747|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105741656|NCT01120093|364709748|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105741657|NCT01120093|364709744|FG000|Treatment Period 2|Adverse Event|0|||
105741658|NCT01120093|364709745|FG001|Treatment Period 2|Adverse Event|0|||
105741659|NCT01120093|364709746|FG002|Treatment Period 2|Adverse Event|0|||
105741660|NCT01120093|364709747|FG003|Treatment Period 2|Adverse Event|1|||
105741661|NCT01120093|364709748|FG004|Treatment Period 2|Adverse Event|0|||
105741662|NCT01120093|364709744|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105741663|NCT01120093|364709745|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105741664|NCT01120093|364709746|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105741665|NCT01120093|364709747|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105741666|NCT01120093|364709748|FG004|Treatment Period 2|Withdrawal by Subject|1|||
105741667|NCT01120093|364709744|FG000|Treatment Period 3|Lack of Efficacy|0|||
105741668|NCT01120093|364709745|FG001|Treatment Period 3|Lack of Efficacy|0|||
105741669|NCT01120093|364709746|FG002|Treatment Period 3|Lack of Efficacy|0|||
105741670|NCT01120093|364709747|FG003|Treatment Period 3|Lack of Efficacy|1|||
105741671|NCT01120093|364709748|FG004|Treatment Period 3|Lack of Efficacy|0|||
105741672|NCT01120093|364709744|FG000|Treatment Period 3|Adverse Event|0|||
105741673|NCT01120093|364709745|FG001|Treatment Period 3|Adverse Event|0|||
105741674|NCT01120093|364709746|FG002|Treatment Period 3|Adverse Event|0|||
105741675|NCT01120093|364709747|FG003|Treatment Period 3|Adverse Event|0|||
105741676|NCT01120093|364709748|FG004|Treatment Period 3|Adverse Event|1|||
105741677|NCT01120093|364709744|FG000|Treatment Period 3|Withdrawal by Subject|0|||
105741678|NCT01120093|364709745|FG001|Treatment Period 3|Withdrawal by Subject|0|||
105741679|NCT01120093|364709746|FG002|Treatment Period 3|Withdrawal by Subject|1|||
105741680|NCT01120093|364709747|FG003|Treatment Period 3|Withdrawal by Subject|0|||
105741681|NCT01120093|364709748|FG004|Treatment Period 3|Withdrawal by Subject|0|||
105741682|NCT01120093|364709744|FG000|Treatment Period 4|Adverse Event|1|||
105741683|NCT01120093|364709745|FG001|Treatment Period 4|Adverse Event|0|||
105741684|NCT01120093|364709746|FG002|Treatment Period 4|Adverse Event|0|||
105741685|NCT01120093|364709747|FG003|Treatment Period 4|Adverse Event|0|||
105741686|NCT01120093|364709748|FG004|Treatment Period 4|Adverse Event|0|||
105741687|NCT01120093|364709744|FG000|Treatment Period 5|Adverse Event|0|||
105741688|NCT01120093|364709745|FG001|Treatment Period 5|Adverse Event|1|||
105741689|NCT01120093|364709746|FG002|Treatment Period 5|Adverse Event|0|||
105741690|NCT01120093|364709747|FG003|Treatment Period 5|Adverse Event|1|||
105741691|NCT01120093|364709748|FG004|Treatment Period 5|Adverse Event|0|||
105741692|NCT00850759|364709749|FG000|Overall Study|Lost to Follow-up|7|||
105741693|NCT00850759|364709750|FG001|Overall Study|Lost to Follow-up|5|||
105741694|NCT00850759|364709751|FG002|Overall Study|Lost to Follow-up|5|||
105741695|NCT00850759|364709752|FG003|Overall Study|Lost to Follow-up|3|||
105741696|NCT01005719|364709753|FG000|Period 1|Adverse Event|0|||
105741697|NCT01005719|364709754|FG001|Period 1|Adverse Event|0|||
105741698|NCT01005719|364709755|FG002|Period 1|Adverse Event|0|||
105482949|NCT02815280|363780833|FG000|Open-Label Phase|Adverse Event|2|||
105482950|NCT02815280|363780834|FG001|Open-Label Phase|Adverse Event|3|||
105741699|NCT01005719|364709756|FG003|Period 1|Adverse Event|1|||
105741700|NCT01005719|364709757|FG004|Period 1|Adverse Event|0|||
105741701|NCT01005719|364709758|FG005|Period 1|Adverse Event|0|||
105800139|NCT04006847|364926379|FG000|Overall Study|Product issue|1|||
105482951|NCT02815280|363780833|FG000|Open-Label Phase|Lost to Follow-up|18|||
105482952|NCT02815280|363780834|FG001|Open-Label Phase|Lost to Follow-up|9|||
105482953|NCT02815280|363780833|FG000|Open-Label Phase|Withdrawal by Subject|33|||
105741702|NCT01005719|364709753|FG000|Period 1|Delay in completing study procedures|0|||
105741703|NCT01005719|364709754|FG001|Period 1|Delay in completing study procedures|0|||
105741704|NCT01005719|364709755|FG002|Period 1|Delay in completing study procedures|0|||
105741705|NCT01005719|364709756|FG003|Period 1|Delay in completing study procedures|0|||
105741706|NCT01005719|364709757|FG004|Period 1|Delay in completing study procedures|0|||
105741707|NCT01005719|364709758|FG005|Period 1|Delay in completing study procedures|1|||
105741708|NCT01005719|364709753|FG000|Period 2|Adverse Event|0|||
105741709|NCT01005719|364709754|FG001|Period 2|Adverse Event|0|||
105741710|NCT01005719|364709755|FG002|Period 2|Adverse Event|0|||
105741711|NCT01005719|364709756|FG003|Period 2|Adverse Event|0|||
105741712|NCT01005719|364709757|FG004|Period 2|Adverse Event|1|||
105741713|NCT01005719|364709758|FG005|Period 2|Adverse Event|1|||
105741714|NCT02389816|364709759|FG000|Overall Study|Randomized but Not Treated|1|||
105741715|NCT02389816|364709760|FG001|Overall Study|Randomized but Not Treated|0|||
105741716|NCT02389816|364709761|FG002|Overall Study|Randomized but Not Treated|0|||
105741717|NCT02389816|364709759|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
105741718|NCT02389816|364709760|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
105741719|NCT02389816|364709761|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
105741720|NCT02389816|364709759|FG000|Overall Study|Major Protocol Deviation|1|||
105741721|NCT02389816|364709760|FG001|Overall Study|Major Protocol Deviation|0|||
105741722|NCT02389816|364709761|FG002|Overall Study|Major Protocol Deviation|0|||
105741723|NCT02389816|364709759|FG000|Overall Study|Lost to Follow-up|1|||
105741724|NCT02389816|364709760|FG001|Overall Study|Lost to Follow-up|0|||
105741725|NCT02389816|364709761|FG002|Overall Study|Lost to Follow-up|0|||
105741726|NCT02389816|364709759|FG000|Overall Study|Withdrawal of Consent|6|||
105741727|NCT02389816|364709760|FG001|Overall Study|Withdrawal of Consent|4|||
105741728|NCT02389816|364709761|FG002|Overall Study|Withdrawal of Consent|4|||
105741729|NCT02389816|364709759|FG000|Overall Study|Lack of Efficacy|1|||
105741730|NCT02389816|364709760|FG001|Overall Study|Lack of Efficacy|0|||
105741731|NCT02389816|364709761|FG002|Overall Study|Lack of Efficacy|0|||
105741732|NCT02389816|364709759|FG000|Overall Study|Non Compliance with Study Drug|1|||
105741733|NCT02389816|364709760|FG001|Overall Study|Non Compliance with Study Drug|1|||
105741734|NCT02389816|364709761|FG002|Overall Study|Non Compliance with Study Drug|1|||
105741735|NCT02389816|364709759|FG000|Overall Study|Reason not Specified|0|||
105741736|NCT02389816|364709760|FG001|Overall Study|Reason not Specified|2|||
105741737|NCT02389816|364709761|FG002|Overall Study|Reason not Specified|0|||
105741738|NCT03649321|364709762|FG000|Overall Study|Withdrawal by Subject|1|||
105741739|NCT03649321|364709763|FG001|Overall Study|Withdrawal by Subject|0|||
105741740|NCT03649321|364709762|FG000|Overall Study|Death|1|||
105800140|NCT01270841|364926383|FG000|Overall Study|Adverse Event|0|||
105800141|NCT01270841|364926384|FG001|Overall Study|Adverse Event|1|||
105800142|NCT01270841|364926385|FG002|Overall Study|Adverse Event|0|||
105358592|NCT01826981|363318977|FG009|Overall Study|Withdrew Consent|0|||
105358593|NCT01826981|363318978|FG010|Overall Study|Withdrew Consent|0|||
105358594|NCT01826981|363318979|FG011|Overall Study|Withdrew Consent|1|||
105358595|NCT01826981|363318980|FG012|Overall Study|Withdrew Consent|0|||
105358596|NCT01826981|363318981|FG013|Overall Study|Withdrew Consent|1|||
105358597|NCT01826981|363318982|FG014|Overall Study|Withdrew Consent|0|||
105358598|NCT01826981|363318968|FG000|Overall Study|Adverse Event|0|||
105358599|NCT01826981|363318969|FG001|Overall Study|Adverse Event|0|||
105358600|NCT01826981|363318970|FG002|Overall Study|Adverse Event|0|||
105358601|NCT01826981|363318971|FG003|Overall Study|Adverse Event|0|||
105358602|NCT01826981|363318972|FG004|Overall Study|Adverse Event|1|||
105358603|NCT01826981|363318973|FG005|Overall Study|Adverse Event|0|||
105358604|NCT01826981|363318974|FG006|Overall Study|Adverse Event|0|||
105358605|NCT01826981|363318975|FG007|Overall Study|Adverse Event|0|||
105358606|NCT01826981|363318976|FG008|Overall Study|Adverse Event|0|||
105358607|NCT01826981|363318977|FG009|Overall Study|Adverse Event|0|||
105358608|NCT01826981|363318978|FG010|Overall Study|Adverse Event|0|||
105358609|NCT01826981|363318979|FG011|Overall Study|Adverse Event|0|||
105358610|NCT01826981|363318980|FG012|Overall Study|Adverse Event|0|||
105358611|NCT01826981|363318981|FG013|Overall Study|Adverse Event|0|||
105358612|NCT01826981|363318982|FG014|Overall Study|Adverse Event|0|||
105358613|NCT01826981|363318968|FG000|Overall Study|Upper G-I Haemorrhage|0|||
105358614|NCT01826981|363318969|FG001|Overall Study|Upper G-I Haemorrhage|0|||
105358615|NCT01826981|363318970|FG002|Overall Study|Upper G-I Haemorrhage|0|||
105358616|NCT01826981|363318971|FG003|Overall Study|Upper G-I Haemorrhage|0|||
105358617|NCT01826981|363318972|FG004|Overall Study|Upper G-I Haemorrhage|0|||
105358618|NCT01826981|363318973|FG005|Overall Study|Upper G-I Haemorrhage|0|||
105358619|NCT01826981|363318974|FG006|Overall Study|Upper G-I Haemorrhage|0|||
105358620|NCT01826981|363318975|FG007|Overall Study|Upper G-I Haemorrhage|0|||
105358621|NCT01826981|363318976|FG008|Overall Study|Upper G-I Haemorrhage|0|||
105741741|NCT03649321|364709763|FG001|Overall Study|Death|0|||
105741742|NCT03408873|364709767|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
105741743|NCT03408873|364709767|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
105800143|NCT01270841|364926386|FG003|Overall Study|Adverse Event|3|||
105358622|NCT01826981|363318977|FG009|Overall Study|Upper G-I Haemorrhage|0|||
105358623|NCT01826981|363318978|FG010|Overall Study|Upper G-I Haemorrhage|0|||
105358624|NCT01826981|363318979|FG011|Overall Study|Upper G-I Haemorrhage|0|||
105358625|NCT01826981|363318980|FG012|Overall Study|Upper G-I Haemorrhage|0|||
105358626|NCT01826981|363318981|FG013|Overall Study|Upper G-I Haemorrhage|1|||
105358627|NCT01826981|363318982|FG014|Overall Study|Upper G-I Haemorrhage|0|||
105358628|NCT01826981|363318968|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
105358629|NCT01826981|363318969|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
105741744|NCT03408873|364709767|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
105741745|NCT03408873|364709767|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
105741746|NCT03408873|364709767|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
105741747|NCT03408873|364709767|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
105741748|NCT01594476|364709768|FG000|Overall Study|Protocol Violation|1|||
105741749|NCT01594476|364709769|FG001|Overall Study|Protocol Violation|3|||
105741750|NCT00406315|364709772|FG000|Overall Study|Death|1|||
105358630|NCT01826981|363318970|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
105358631|NCT01826981|363318971|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
105358632|NCT01826981|363318972|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
105358633|NCT01826981|363318973|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
105741751|NCT00406315|364709772|FG000|Overall Study|Adverse Event|39|||
105741752|NCT00406315|364709772|FG000|Overall Study|Laboratory Abnormality|4|||
105741753|NCT00406315|364709772|FG000|Overall Study|Lack of Efficacy|13|||
105741754|NCT00406315|364709772|FG000|Overall Study|Other|33|||
105741755|NCT00406315|364709772|FG000|Overall Study|Lost to Follow-up|21|||
105741756|NCT00406315|364709772|FG000|Overall Study|Withdrawal by Subject|30|||
105741757|NCT01312428|364709773|FG000|Overall Study|Study Termination|3|||
105741758|NCT01312428|364709774|FG001|Overall Study|Study Termination|4|||
105741759|NCT01106534|364709775|FG000|Overall Study|Withdrawal by Subject|18|||
105741760|NCT01106534|364709775|FG000|Overall Study|Lost to Follow-up|2|||
105741761|NCT01106534|364709775|FG000|Overall Study|Death|16|||
105741762|NCT01106534|364709775|FG000|Overall Study|Physician Decision|1|||
105741763|NCT00532883|364709778|FG000|Overall Study|Adverse Event|1|||
105741764|NCT00532883|364709779|FG001|Overall Study|Adverse Event|0|||
105741765|NCT00532883|364709780|FG002|Overall Study|Adverse Event|0|||
105741766|NCT00532883|364709781|FG003|Overall Study|Adverse Event|1|||
105741767|NCT00532883|364709778|FG000|Overall Study|Lost to Follow-up|1|||
105741768|NCT00532883|364709779|FG001|Overall Study|Lost to Follow-up|1|||
105741769|NCT00532883|364709780|FG002|Overall Study|Lost to Follow-up|1|||
105741770|NCT00532883|364709781|FG003|Overall Study|Lost to Follow-up|0|||
105741771|NCT00532883|364709778|FG000|Overall Study|Withdrawal by Subject|0|||
105741772|NCT00532883|364709779|FG001|Overall Study|Withdrawal by Subject|1|||
105741773|NCT00532883|364709780|FG002|Overall Study|Withdrawal by Subject|1|||
105741774|NCT00532883|364709781|FG003|Overall Study|Withdrawal by Subject|0|||
105741775|NCT00532883|364709778|FG000|Overall Study|Subject was Nonadherent|0|||
105741776|NCT00532883|364709779|FG001|Overall Study|Subject was Nonadherent|1|||
105741777|NCT00532883|364709780|FG002|Overall Study|Subject was Nonadherent|1|||
105741778|NCT00532883|364709781|FG003|Overall Study|Subject was Nonadherent|0|||
105741779|NCT00532883|364709778|FG000|Overall Study|Early Study Termination|4|||
105741780|NCT00532883|364709779|FG001|Overall Study|Early Study Termination|4|||
105741781|NCT00532883|364709780|FG002|Overall Study|Early Study Termination|1|||
105741782|NCT00532883|364709781|FG003|Overall Study|Early Study Termination|4|||
105358634|NCT01826981|363318974|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
105358635|NCT01826981|363318975|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
105358636|NCT01826981|363318976|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
105741783|NCT03799718|364709782|FG000|Overall Study|Adverse Event|2|||
105741784|NCT02184143|364709785|FG000|Overall Study|Withdrawal by Subject|4|||
105741785|NCT02184143|364709786|FG001|Overall Study|Withdrawal by Subject|4|||
105358637|NCT01826981|363318977|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
105741786|NCT02184143|364709785|FG000|Overall Study|Lost to Follow-up|5|||
105741787|NCT02184143|364709786|FG001|Overall Study|Lost to Follow-up|3|||
105741788|NCT02184143|364709785|FG000|Overall Study|Death|1|||
105741789|NCT02184143|364709786|FG001|Overall Study|Death|0|||
105741790|NCT00321984|364709790|FG000|Overall Study|Adverse Event|9|||
105741791|NCT00321984|364709791|FG001|Overall Study|Adverse Event|6|||
105741792|NCT00321984|364709792|FG002|Overall Study|Adverse Event|8|||
105741793|NCT00321984|364709790|FG000|Overall Study|Protocol Violation|0|||
105741794|NCT00321984|364709791|FG001|Overall Study|Protocol Violation|1|||
105741795|NCT00321984|364709792|FG002|Overall Study|Protocol Violation|1|||
105741796|NCT00321984|364709790|FG000|Overall Study|Lost to Follow-up|2|||
105741797|NCT00321984|364709791|FG001|Overall Study|Lost to Follow-up|4|||
105741798|NCT00321984|364709792|FG002|Overall Study|Lost to Follow-up|2|||
105741799|NCT00321984|364709790|FG000|Overall Study|Withdrawal by Subject|8|||
105741800|NCT00321984|364709791|FG001|Overall Study|Withdrawal by Subject|6|||
105741801|NCT00321984|364709792|FG002|Overall Study|Withdrawal by Subject|5|||
105741802|NCT00321984|364709790|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
105741803|NCT00321984|364709791|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
105741804|NCT00321984|364709792|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
105741805|NCT00321984|364709790|FG000|Overall Study|Lack of Efficacy|3|||
105741806|NCT00321984|364709791|FG001|Overall Study|Lack of Efficacy|1|||
105741807|NCT00321984|364709792|FG002|Overall Study|Lack of Efficacy|3|||
105741808|NCT00321984|364709790|FG000|Overall Study|Noncompliant|0|||
105741809|NCT00321984|364709791|FG001|Overall Study|Noncompliant|0|||
105741810|NCT00321984|364709792|FG002|Overall Study|Noncompliant|2|||
105741811|NCT00321984|364709790|FG000|Overall Study|Pregnancy|0|||
105741812|NCT00321984|364709791|FG001|Overall Study|Pregnancy|1|||
105741813|NCT00321984|364709792|FG002|Overall Study|Pregnancy|0|||
105741814|NCT00321984|364709790|FG000|Overall Study|Per Subject Request|1|||
105741815|NCT00321984|364709791|FG001|Overall Study|Per Subject Request|0|||
105741816|NCT00321984|364709792|FG002|Overall Study|Per Subject Request|0|||
105741817|NCT00321984|364709790|FG000|Overall Study|Per Investigator Request|1|||
105482954|NCT02815280|363780834|FG001|Open-Label Phase|Withdrawal by Subject|18|||
105482955|NCT02815280|363780833|FG000|Open-Label Phase|Protocol Violation|3|||
105741818|NCT00321984|364709791|FG001|Overall Study|Per Investigator Request|0|||
105741819|NCT00321984|364709792|FG002|Overall Study|Per Investigator Request|0|||
105741820|NCT00321984|364709790|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
105741821|NCT00321984|364709791|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
105741822|NCT00321984|364709792|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
105741823|NCT01525849|364709796|FG000|Overall Study|Lost to Follow-up|3|||
105358638|NCT01826981|363318978|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
105358639|NCT01826981|363318979|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
105358640|NCT01826981|363318980|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
105358641|NCT01826981|363318981|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
105358642|NCT01826981|363318982|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
105358643|NCT02821416|363318990|FG000|Overall Study|Adverse Event|0|||
105358644|NCT02821416|363318991|FG001|Overall Study|Adverse Event|1|||
105358645|NCT02821416|363318990|FG000|Overall Study|Withdrawal by Subject|2|||
105358646|NCT02821416|363318991|FG001|Overall Study|Withdrawal by Subject|0|||
105358647|NCT02821416|363318990|FG000|Overall Study|Lost to Follow-up|1|||
105358648|NCT02821416|363318991|FG001|Overall Study|Lost to Follow-up|0|||
105358649|NCT00610168|363318996|FG000|Overall Study|Withdrawal by Subject|2|||
105358650|NCT00610168|363318997|FG001|Overall Study|Withdrawal by Subject|0|||
105358651|NCT00169104|363318998|FG000|Overall Study|Withdrawal by Subject|2|||
105358652|NCT00169104|363318999|FG001|Overall Study|Withdrawal by Subject|0|||
105358653|NCT00169104|363318998|FG000|Overall Study|Protocol Violation|0|||
105358654|NCT00169104|363318999|FG001|Overall Study|Protocol Violation|1|||
105358655|NCT00169104|363318998|FG000|Overall Study|Physician Decision|0|||
105358656|NCT00169104|363318999|FG001|Overall Study|Physician Decision|1|||
105358657|NCT01540981|363319001|FG000|Overall Study|Withdrawal by Subject|1|||
105358658|NCT01540981|363319002|FG001|Overall Study|Withdrawal by Subject|0|||
105358659|NCT00809094|363319004|FG000|Overall Study|Lost to Follow-up|0|||
105358660|NCT00809094|363319005|FG001|Overall Study|Lost to Follow-up|1|||
105358661|NCT00397189|363319006|FG000|3 Weeks Period|Lost to Follow-up|5|||
105358662|NCT00397189|363319007|FG001|3 Weeks Period|Lost to Follow-up|4|||
105358663|NCT00397189|363319006|FG000|3 Weeks Period|Adverse Event|3|||
105358664|NCT00397189|363319007|FG001|3 Weeks Period|Adverse Event|2|||
105358665|NCT00397189|363319006|FG000|3 Weeks Period|Withdrawal by Subject|13|||
105358666|NCT00397189|363319007|FG001|3 Weeks Period|Withdrawal by Subject|9|||
105358667|NCT00397189|363319006|FG000|3 Weeks Period|Physician Decision|0|||
105482956|NCT02815280|363780834|FG001|Open-Label Phase|Protocol Violation|0|||
105482957|NCT02815280|363780833|FG000|Open-Label Phase|Administrative|26|||
105482958|NCT02815280|363780834|FG001|Open-Label Phase|Administrative|12|||
105741824|NCT01525849|364709797|FG001|Overall Study|Lost to Follow-up|2|||
105741825|NCT01525849|364709796|FG000|Overall Study|Withdrawal by Subject|1|||
105358668|NCT00397189|363319007|FG001|3 Weeks Period|Physician Decision|2|||
105358669|NCT00397189|363319006|FG000|3 Weeks Period|Protocol Violation|0|||
105358670|NCT00397189|363319007|FG001|3 Weeks Period|Protocol Violation|3|||
105358671|NCT00397189|363319006|FG000|3 Weeks Period|Other|0|||
105358672|NCT00397189|363319007|FG001|3 Weeks Period|Other|2|||
105358673|NCT01029262|363319012|FG000|Overall Study|Adverse Event|9|||
105484985|NCT01895361|363787032|FG001|Overall Study|Withdrawal by Subject|6|||
105358674|NCT01029262|363319013|FG001|Overall Study|Adverse Event|52|||
105800144|NCT01270841|364926383|FG000|Overall Study|Withdrawal by Subject|3|||
105800145|NCT01270841|364926384|FG001|Overall Study|Withdrawal by Subject|2|||
105800146|NCT01270841|364926385|FG002|Overall Study|Withdrawal by Subject|3|||
105800147|NCT01270841|364926386|FG003|Overall Study|Withdrawal by Subject|3|||
105800148|NCT01270841|364926383|FG000|Overall Study|Lost to Follow-up|3|||
105800149|NCT01270841|364926384|FG001|Overall Study|Lost to Follow-up|1|||
105800150|NCT01270841|364926385|FG002|Overall Study|Lost to Follow-up|4|||
105800151|NCT01270841|364926386|FG003|Overall Study|Lost to Follow-up|2|||
105800152|NCT01270841|364926383|FG000|Overall Study|Physician Decision|0|||
105800153|NCT01270841|364926384|FG001|Overall Study|Physician Decision|1|||
105800154|NCT01270841|364926385|FG002|Overall Study|Physician Decision|0|||
105358675|NCT01029262|363319012|FG000|Overall Study|Lack of therapeutic effect|57|||
105358676|NCT01029262|363319013|FG001|Overall Study|Lack of therapeutic effect|76|||
105358677|NCT01029262|363319012|FG000|Overall Study|Withdrawal by Subject|10|||
105358678|NCT01029262|363319013|FG001|Overall Study|Withdrawal by Subject|17|||
105358679|NCT01029262|363319012|FG000|Overall Study|Protocol Violation|2|||
105358680|NCT01029262|363319013|FG001|Overall Study|Protocol Violation|3|||
105358681|NCT01029262|363319012|FG000|Overall Study|Miscellaneous|1|||
105358682|NCT01029262|363319013|FG001|Overall Study|Miscellaneous|9|||
105358683|NCT01029262|363319012|FG000|Overall Study|Death|0|||
105358684|NCT01029262|363319013|FG001|Overall Study|Death|3|||
105800155|NCT01270841|364926386|FG003|Overall Study|Physician Decision|0|||
105800156|NCT01270841|364926383|FG000|Overall Study|Did not qualify|6|||
105358685|NCT03904420|363319016|FG000|Overall Study|Study terminated|2|||
105358686|NCT03904420|363319017|FG001|Overall Study|Study terminated|2|||
105565305|NCT01281202|364066730|FG000|Overall Study|Administrative|2|||
105800157|NCT01270841|364926384|FG001|Overall Study|Did not qualify|3|||
105358687|NCT01468454|363319022|FG000|Overall Study|Did not have surgery after PET|9|||
105358688|NCT02438280|363319023|FG000|Overall Study|Physician Decision|1|||
105358689|NCT02438280|363319024|FG001|Overall Study|Physician Decision|0|||
105800158|NCT01270841|364926385|FG002|Overall Study|Did not qualify|4|||
105482959|NCT02815280|363780833|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
105482960|NCT02815280|363780834|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
105482961|NCT01107379|363780837|FG000|Overall Study|Withdrawal by Subject|18|||
105482962|NCT01107379|363780837|FG000|Overall Study|Lost to Follow-up|3|||
105482963|NCT00924170|363780838|FG000|Overall Study|Refused further treatment|0|||
105482964|NCT00924170|363780839|FG001|Overall Study|Refused further treatment|1|||
105482965|NCT00924170|363780838|FG000|Overall Study|Physician Decision|0|||
105741826|NCT01525849|364709797|FG001|Overall Study|Withdrawal by Subject|9|||
105741827|NCT01525849|364709796|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
105741828|NCT01525849|364709797|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
105741829|NCT01525849|364709796|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
105741830|NCT01525849|364709797|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
105741831|NCT01469013|364709803|FG000|Part A (Treatment Period)|Adverse Event|1|||
105741832|NCT01469013|364709804|FG001|Part A (Treatment Period)|Adverse Event|0|||
105741833|NCT01469013|364709805|FG002|Part A (Treatment Period)|Adverse Event|0|||
105741834|NCT01469013|364709806|FG003|Part A (Treatment Period)|Adverse Event|0|||
105741835|NCT01469013|364709807|FG004|Part A (Treatment Period)|Adverse Event|1|||
105741836|NCT01469013|364709808|FG005|Part A (Treatment Period)|Adverse Event|0|||
105741837|NCT01469013|364709809|FG006|Part A (Treatment Period)|Adverse Event|0|||
105741838|NCT01469013|364709810|FG007|Part A (Treatment Period)|Adverse Event|0|||
105741839|NCT01469013|364709811|FG008|Part A (Treatment Period)|Adverse Event|0|||
105741840|NCT01469013|364709812|FG009|Part A (Treatment Period)|Adverse Event|0|||
105741841|NCT01469013|364709813|FG010|Part A (Treatment Period)|Adverse Event|0|||
105741842|NCT01469013|364709814|FG011|Part A (Treatment Period)|Adverse Event|0|||
105741843|NCT01469013|364709815|FG012|Part A (Treatment Period)|Adverse Event|0|||
105741844|NCT01469013|364709803|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741845|NCT01469013|364709804|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741846|NCT01469013|364709805|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
105741847|NCT01469013|364709806|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741848|NCT01469013|364709807|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741849|NCT01469013|364709808|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741850|NCT01469013|364709809|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741851|NCT01469013|364709810|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741852|NCT01469013|364709811|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741853|NCT01469013|364709812|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741854|NCT01469013|364709813|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741855|NCT01469013|364709814|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741856|NCT01469013|364709815|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741857|NCT01469013|364709803|FG000|Part B (Extension Period)|Adverse Event|0|||
105741858|NCT01469013|364709804|FG001|Part B (Extension Period)|Adverse Event|0|||
105741859|NCT01469013|364709805|FG002|Part B (Extension Period)|Adverse Event|0|||
105741860|NCT01469013|364709806|FG003|Part B (Extension Period)|Adverse Event|0|||
105741861|NCT01469013|364709807|FG004|Part B (Extension Period)|Adverse Event|0|||
105741862|NCT01469013|364709808|FG005|Part B (Extension Period)|Adverse Event|2|||
105741863|NCT01469013|364709809|FG006|Part B (Extension Period)|Adverse Event|5|||
105741864|NCT01469013|364709810|FG007|Part B (Extension Period)|Adverse Event|5|||
105741865|NCT01469013|364709811|FG008|Part B (Extension Period)|Adverse Event|3|||
105741866|NCT01469013|364709812|FG009|Part B (Extension Period)|Adverse Event|3|||
105741867|NCT01469013|364709813|FG010|Part B (Extension Period)|Adverse Event|1|||
105741868|NCT01469013|364709814|FG011|Part B (Extension Period)|Adverse Event|6|||
105741869|NCT01469013|364709815|FG012|Part B (Extension Period)|Adverse Event|3|||
105741870|NCT01469013|364709803|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
105741871|NCT01469013|364709804|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
105741872|NCT01469013|364709805|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
105741873|NCT01469013|364709806|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
105741874|NCT01469013|364709807|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
105741875|NCT01469013|364709808|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
105741876|NCT01469013|364709809|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
105741877|NCT01469013|364709810|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
105741878|NCT01469013|364709811|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
105741879|NCT01469013|364709812|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
105741880|NCT01469013|364709813|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
105741881|NCT01469013|364709814|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
105741882|NCT01469013|364709815|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
105741883|NCT00793819|364709816|FG000|Overall Study|Adverse Event|8|||
105741884|NCT00793819|364709817|FG001|Overall Study|Adverse Event|4|||
105741885|NCT00793819|364709816|FG000|Overall Study|Lack of Efficacy|1|||
105741886|NCT00793819|364709817|FG001|Overall Study|Lack of Efficacy|1|||
105741887|NCT00793819|364709816|FG000|Overall Study|Withdrawal by Subject|4|||
105741888|NCT00793819|364709817|FG001|Overall Study|Withdrawal by Subject|3|||
105741889|NCT00793819|364709816|FG000|Overall Study|Lost to Follow-up|1|||
105482966|NCT00924170|363780839|FG001|Overall Study|Physician Decision|1|||
105741890|NCT00793819|364709817|FG001|Overall Study|Lost to Follow-up|1|||
105741891|NCT00002663|364709818|FG000|Overall Study|Death|4|||
105741892|NCT00002663|364709819|FG001|Overall Study|Death|1|||
105741893|NCT00002663|364709820|FG002|Overall Study|Death|1|||
105741894|NCT00002663|364709821|FG003|Overall Study|Death|0|||
105741895|NCT00002663|364709822|FG004|Overall Study|Death|0|||
105741896|NCT00002663|364709823|FG005|Overall Study|Death|13|||
105741897|NCT00002663|364709824|FG006|Overall Study|Death|0|||
105741898|NCT00002663|364709825|FG007|Overall Study|Death|1|||
105741899|NCT00002663|364709826|FG008|Overall Study|Death|1|||
105741900|NCT00002663|364709827|FG009|Overall Study|Death|1|||
105741901|NCT00002663|364709818|FG000|Overall Study|Lost to Follow-up|3|||
105741902|NCT00002663|364709819|FG001|Overall Study|Lost to Follow-up|0|||
105741903|NCT00002663|364709820|FG002|Overall Study|Lost to Follow-up|0|||
105741904|NCT00002663|364709821|FG003|Overall Study|Lost to Follow-up|1|||
105741905|NCT00002663|364709822|FG004|Overall Study|Lost to Follow-up|0|||
105741906|NCT00002663|364709823|FG005|Overall Study|Lost to Follow-up|1|||
105741907|NCT00002663|364709824|FG006|Overall Study|Lost to Follow-up|0|||
105741908|NCT00002663|364709825|FG007|Overall Study|Lost to Follow-up|0|||
105741909|NCT00002663|364709826|FG008|Overall Study|Lost to Follow-up|0|||
105741910|NCT00002663|364709827|FG009|Overall Study|Lost to Follow-up|0|||
105741911|NCT00002663|364709818|FG000|Overall Study|Other|0|||
105741912|NCT00002663|364709819|FG001|Overall Study|Other|1|||
105741913|NCT00002663|364709820|FG002|Overall Study|Other|0|||
105741914|NCT00002663|364709821|FG003|Overall Study|Other|0|||
105741915|NCT00002663|364709822|FG004|Overall Study|Other|0|||
105741916|NCT00002663|364709823|FG005|Overall Study|Other|1|||
105741917|NCT00002663|364709824|FG006|Overall Study|Other|1|||
105741918|NCT00002663|364709825|FG007|Overall Study|Other|0|||
105741919|NCT00002663|364709826|FG008|Overall Study|Other|0|||
105741920|NCT00002663|364709827|FG009|Overall Study|Other|0|||
105741921|NCT00002663|364709818|FG000|Overall Study|Physician Decision|0|||
105741922|NCT00002663|364709819|FG001|Overall Study|Physician Decision|0|||
105741923|NCT00002663|364709820|FG002|Overall Study|Physician Decision|0|||
105741924|NCT00002663|364709821|FG003|Overall Study|Physician Decision|0|||
105741925|NCT00002663|364709822|FG004|Overall Study|Physician Decision|1|||
105741926|NCT00002663|364709823|FG005|Overall Study|Physician Decision|0|||
105741927|NCT00002663|364709824|FG006|Overall Study|Physician Decision|0|||
105741928|NCT00002663|364709825|FG007|Overall Study|Physician Decision|0|||
105741929|NCT00002663|364709826|FG008|Overall Study|Physician Decision|1|||
105741930|NCT00002663|364709827|FG009|Overall Study|Physician Decision|1|||
105741931|NCT00002663|364709818|FG000|Overall Study|Adverse Event|0|||
105741932|NCT00002663|364709819|FG001|Overall Study|Adverse Event|0|||
105741933|NCT00002663|364709820|FG002|Overall Study|Adverse Event|0|||
105741934|NCT00002663|364709821|FG003|Overall Study|Adverse Event|1|||
105741935|NCT00002663|364709822|FG004|Overall Study|Adverse Event|0|||
105741936|NCT00002663|364709823|FG005|Overall Study|Adverse Event|0|||
105741937|NCT00002663|364709824|FG006|Overall Study|Adverse Event|0|||
105741938|NCT00002663|364709825|FG007|Overall Study|Adverse Event|1|||
105741939|NCT00002663|364709826|FG008|Overall Study|Adverse Event|0|||
105741940|NCT00002663|364709827|FG009|Overall Study|Adverse Event|0|||
105741941|NCT02868216|364709831|FG000|Overall Study|Death|0|||
105741942|NCT02868216|364709832|FG001|Overall Study|Death|1|||
105741943|NCT02868216|364709831|FG000|Overall Study|coronary artery bypass|1|||
105741944|NCT02868216|364709832|FG001|Overall Study|coronary artery bypass|0|||
105741945|NCT02868216|364709831|FG000|Overall Study|Withdrawal by Subject|7|||
105741946|NCT02868216|364709832|FG001|Overall Study|Withdrawal by Subject|5|||
105800159|NCT01270841|364926386|FG003|Overall Study|Did not qualify|5|||
105800160|NCT01270841|364926383|FG000|Overall Study|Protocol Violation|1|||
105800161|NCT01270841|364926384|FG001|Overall Study|Protocol Violation|5|||
105741947|NCT03161678|364709835|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
105741948|NCT03161678|364709836|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
105741949|NCT03161678|364709837|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
105741950|NCT03161678|364709838|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
105741951|NCT03161678|364709839|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
105741952|NCT03161678|364709840|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
105741953|NCT03161678|364709835|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
105741954|NCT03161678|364709836|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
105741955|NCT03161678|364709837|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
105741956|NCT03161678|364709838|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
105741957|NCT03161678|364709839|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
105741958|NCT03161678|364709840|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
105741959|NCT03161678|364709835|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
105741960|NCT03161678|364709836|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
105741961|NCT03161678|364709837|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
105741962|NCT03161678|364709838|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
105741963|NCT03161678|364709839|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
105741964|NCT03161678|364709840|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
105741965|NCT03161678|364709835|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
105741966|NCT03161678|364709836|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
105741967|NCT03161678|364709837|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
105741968|NCT03161678|364709838|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
105741969|NCT03161678|364709839|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
105741970|NCT03161678|364709840|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
105741971|NCT03609359|364709841|FG000|Overall Study|Progression of primary disease (PD)|25|||
105741972|NCT03609359|364709841|FG000|Overall Study|Patient's refusal|1|||
105741973|NCT03609359|364709841|FG000|Overall Study|Physician Decision|1|||
105741974|NCT03609359|364709841|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
105741975|NCT01757704|364709842|FG000|Overall Study|Protocol Violation|1|||
105741976|NCT01757704|364709843|FG001|Overall Study|Protocol Violation|3|||
105741977|NCT01879618|364709844|FG000|Overall Study|Does not meet entrance criteria|1|||
105741978|NCT01879618|364709844|FG000|Overall Study|Withdrawal by Subject|1|||
105741979|NCT01879618|364709844|FG000|Overall Study|Surgery;changed schedule; not available|8|||
105741980|NCT01879618|364709844|FG000|Overall Study|Protocol Violation|6|||
105741981|NCT01879618|364709844|FG000|Overall Study|Adverse Event|5|||
105741982|NCT02552355|364709845|FG000|Overall Study|Adverse Event|0|||
105741983|NCT02552355|364709846|FG001|Overall Study|Adverse Event|2|||
105741984|NCT02552355|364709847|FG002|Overall Study|Adverse Event|2|||
105741985|NCT02552355|364709848|FG003|Overall Study|Adverse Event|0|||
105741986|NCT02552355|364709845|FG000|Overall Study|Withdrawal by Subject|0|||
105741987|NCT02552355|364709846|FG001|Overall Study|Withdrawal by Subject|0|||
105741988|NCT02552355|364709847|FG002|Overall Study|Withdrawal by Subject|0|||
105741989|NCT02552355|364709848|FG003|Overall Study|Withdrawal by Subject|1|||
105741990|NCT00443430|364709849|FG000|Overall Study|Lack of Efficacy|3|||
105741991|NCT00443430|364709850|FG001|Overall Study|Lack of Efficacy|3|||
105741992|NCT00443430|364709849|FG000|Overall Study|Adverse Event|1|||
105741993|NCT00443430|364709850|FG001|Overall Study|Adverse Event|1|||
105741994|NCT04743635|364709851|FG000|Overall Study|Lost to Follow-up|2|||
105741995|NCT04743635|364709852|FG001|Overall Study|Lost to Follow-up|0|||
105741996|NCT03141086|364709855|FG000|Overall Study|Study Terminated By Sponsor|1|||
105741997|NCT03141086|364709856|FG001|Overall Study|Study Terminated By Sponsor|1|||
105741998|NCT03141086|364709855|FG000|Overall Study|Withdrawal by Subject|0|||
105741999|NCT03141086|364709856|FG001|Overall Study|Withdrawal by Subject|1|||
105742000|NCT03141086|364709855|FG000|Overall Study|Protocol Violation|0|||
105742001|NCT03141086|364709856|FG001|Overall Study|Protocol Violation|1|||
105742002|NCT03141086|364709855|FG000|Overall Study|Adverse Event|0|||
105742003|NCT03141086|364709856|FG001|Overall Study|Adverse Event|2|||
105742004|NCT04439838|364711049|FG000|Overall Study|Withdrawal by Subject|0|||
105742005|NCT04439838|364711050|FG001|Overall Study|Withdrawal by Subject|0|||
105742006|NCT04439838|364711051|FG002|Overall Study|Withdrawal by Subject|0|||
105742007|NCT04439838|364711052|FG003|Overall Study|Withdrawal by Subject|0|||
105742008|NCT04439838|364711053|FG004|Overall Study|Withdrawal by Subject|0|||
105742009|NCT04439838|364711054|FG005|Overall Study|Withdrawal by Subject|0|||
105742010|NCT04439838|364711055|FG006|Overall Study|Withdrawal by Subject|0|||
105742011|NCT04439838|364711056|FG007|Overall Study|Withdrawal by Subject|0|||
105742012|NCT04439838|364711057|FG008|Overall Study|Withdrawal by Subject|1|||
105742013|NCT04494633|364711058|FG000|Overall Study|Lost to Follow-up|5|||
105742014|NCT04494633|364711059|FG001|Overall Study|Lost to Follow-up|3|||
105742015|NCT04494633|364711058|FG000|Overall Study|Protocol Violation|1|||
105742016|NCT04494633|364711059|FG001|Overall Study|Protocol Violation|1|||
105482967|NCT00924170|363780838|FG000|Overall Study|Progressive disease|3|||
105742017|NCT04467164|364711063|FG000|Washout (1 Week)|Lost to Follow-up|2|||
105742018|NCT04467164|364711064|FG001|Washout (1 Week)|Lost to Follow-up|0|||
105742019|NCT01254604|364711065|FG000|Overall Study|Lost to Follow-up|1|||
105742020|NCT01254604|364711066|FG001|Overall Study|Lost to Follow-up|1|||
105742021|NCT01254604|364711065|FG000|Overall Study|Protocol Violation|2|||
105742022|NCT01254604|364711066|FG001|Overall Study|Protocol Violation|2|||
105742023|NCT01254604|364711065|FG000|Overall Study|Withdrawal by Subject|2|||
105742024|NCT01254604|364711066|FG001|Overall Study|Withdrawal by Subject|4|||
105742025|NCT01254604|364711065|FG000|Overall Study|Adverse Event|3|||
105742026|NCT01254604|364711066|FG001|Overall Study|Adverse Event|2|||
105742027|NCT01701583|364711067|FG000|Overall Study|Withdrawal by Subject|2|||
105742028|NCT01701583|364711068|FG001|Overall Study|Withdrawal by Subject|0|||
105742029|NCT00943319|364711069|FG000|Overall Study|Death|1|||
105742030|NCT03650452|364711073|FG000|Overall Study|Physician Decision|1|||
105742031|NCT03650452|364711074|FG001|Overall Study|Physician Decision|0|||
105742032|NCT03650452|364711073|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
105742033|NCT03650452|364711074|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
105742034|NCT03650452|364711073|FG000|Overall Study|Adverse Event|3|||
105742035|NCT03650452|364711074|FG001|Overall Study|Adverse Event|4|||
105742036|NCT03650452|364711073|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
105742037|NCT03650452|364711074|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
105742038|NCT02273050|364711075|FG000|Overall Study|Adverse Event|4|||
105742039|NCT02273050|364711076|FG001|Overall Study|Adverse Event|3|||
105742040|NCT02273050|364711077|FG002|Overall Study|Adverse Event|3|||
105742041|NCT02273050|364711075|FG000|Overall Study|Death|0|||
105742042|NCT02273050|364711076|FG001|Overall Study|Death|0|||
105742043|NCT02273050|364711077|FG002|Overall Study|Death|1|||
105742044|NCT02273050|364711075|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
105742045|NCT02273050|364711076|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
105742046|NCT02273050|364711077|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
105742047|NCT02273050|364711075|FG000|Overall Study|Lack of Efficacy|0|||
105742048|NCT02273050|364711076|FG001|Overall Study|Lack of Efficacy|1|||
105742049|NCT02273050|364711077|FG002|Overall Study|Lack of Efficacy|1|||
105742050|NCT02273050|364711075|FG000|Overall Study|Withdrawal by Subject|17|||
105742051|NCT02273050|364711076|FG001|Overall Study|Withdrawal by Subject|14|||
105742052|NCT02273050|364711077|FG002|Overall Study|Withdrawal by Subject|16|||
105742053|NCT02273050|364711075|FG000|Overall Study|Lost to Follow-up|0|||
105742054|NCT02273050|364711076|FG001|Overall Study|Lost to Follow-up|2|||
105742055|NCT02273050|364711077|FG002|Overall Study|Lost to Follow-up|3|||
105742056|NCT02273050|364711075|FG000|Overall Study|Protocol Violation|3|||
105742057|NCT02273050|364711076|FG001|Overall Study|Protocol Violation|1|||
105742058|NCT02273050|364711077|FG002|Overall Study|Protocol Violation|4|||
105742059|NCT01795898|364711078|FG000|Overall Study|Adverse Event|27|||
105742060|NCT01795898|364711078|FG000|Overall Study|Lost to Follow-up|20|||
105742061|NCT01795898|364711078|FG000|Overall Study|Withdrawal of consent|6|||
105742062|NCT01795898|364711078|FG000|Overall Study|Diagnosed with metastasis|1|||
105742063|NCT01795898|364711078|FG000|Overall Study|No pain|1|||
105742064|NCT01795898|364711078|FG000|Overall Study|Death|1|||
105742065|NCT01795898|364711078|FG000|Overall Study|Withdrew consent & had adverse events|3|||
105742066|NCT01795898|364711078|FG000|Overall Study|Physician Decision|1|||
105742067|NCT03628417|364711079|FG000|Overall Study|Death|1|||
105742068|NCT03628417|364711080|FG001|Overall Study|Death|1|||
105742069|NCT00769704|364711081|FG000|Overall Study|Lost to Follow-up|3|||
105742070|NCT00769704|364711082|FG001|Overall Study|Lost to Follow-up|2|||
105742071|NCT00769704|364711081|FG000|Overall Study|Death|95|||
105742072|NCT00769704|364711082|FG001|Overall Study|Death|190|||
105742073|NCT00769704|364711081|FG000|Overall Study|Withdrawal by Subject|12|||
105742074|NCT00769704|364711082|FG001|Overall Study|Withdrawal by Subject|5|||
105742075|NCT00769704|364711081|FG000|Overall Study|Other|1|||
105742076|NCT00769704|364711082|FG001|Overall Study|Other|2|||
105742077|NCT04346628|364711083|FG000|Overall Study|Lost to Follow-up|4|||
105742078|NCT04346628|364711084|FG001|Overall Study|Lost to Follow-up|4|||
105742079|NCT04346628|364711083|FG000|Overall Study|Withdrew (had personal reasons)|2|||
105358690|NCT02260817|363319025|FG000|Overall Study|Lost to Follow-up|0|||
105358691|NCT02260817|363319026|FG001|Overall Study|Lost to Follow-up|14|||
105358692|NCT02260817|363319025|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
105358693|NCT02260817|363319026|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
105358694|NCT02260817|363319025|FG000|Overall Study|Observation, no biopsy|0|||
105358695|NCT02260817|363319026|FG001|Overall Study|Observation, no biopsy|1|||
105358696|NCT02260817|363319025|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
105358697|NCT02260817|363319026|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
105358698|NCT02260817|363319025|FG000|Overall Study|Protocol Violation|0|||
105742080|NCT04346628|364711084|FG001|Overall Study|Withdrew (had personal reasons)|5|||
105742081|NCT04346628|364711083|FG000|Overall Study|Withdrew (medication intolerant)|0|||
105742082|NCT04346628|364711084|FG001|Overall Study|Withdrew (medication intolerant)|3|||
105742083|NCT04346628|364711083|FG000|Overall Study|Withdrew (declined intervention)|0|||
105742084|NCT04346628|364711084|FG001|Overall Study|Withdrew (declined intervention)|1|||
105742085|NCT03350750|364711085|FG000|Overall Study|Death|1|||
105742086|NCT03350750|364711086|FG001|Overall Study|Death|1|||
105742087|NCT02417233|364711089|FG000|Overall Study|Death|4|||
105742088|NCT02417233|364711090|FG001|Overall Study|Death|10|||
105742089|NCT02417233|364711091|FG002|Overall Study|Death|14|||
105800162|NCT01270841|364926385|FG002|Overall Study|Protocol Violation|0|||
105800163|NCT01270841|364926386|FG003|Overall Study|Protocol Violation|0|||
105800164|NCT01270841|364926383|FG000|Overall Study|Enrolled in error|0|||
105800165|NCT01270841|364926384|FG001|Overall Study|Enrolled in error|1|||
105800166|NCT01270841|364926385|FG002|Overall Study|Enrolled in error|0|||
105800167|NCT01270841|364926386|FG003|Overall Study|Enrolled in error|0|||
105800168|NCT01326702|364926387|FG000|Overall Study|Other|1|||
105800169|NCT01326702|364926388|FG001|Overall Study|Other|0|||
105800170|NCT01326702|364926389|FG002|Overall Study|Other|0|||
105800171|NCT01326702|364926390|FG003|Overall Study|Other|0|||
105800172|NCT01326702|364926391|FG004|Overall Study|Other|0|||
105800173|NCT01326702|364926392|FG005|Overall Study|Other|1|||
105800174|NCT01326702|364926393|FG006|Overall Study|Other|0|||
105800175|NCT01326702|364926387|FG000|Overall Study|progressive disease|1|||
105800176|NCT01326702|364926388|FG001|Overall Study|progressive disease|1|||
105800177|NCT01326702|364926389|FG002|Overall Study|progressive disease|3|||
105800178|NCT01326702|364926390|FG003|Overall Study|progressive disease|1|||
105800179|NCT01326702|364926391|FG004|Overall Study|progressive disease|3|||
105800180|NCT01326702|364926392|FG005|Overall Study|progressive disease|2|||
105800181|NCT01326702|364926393|FG006|Overall Study|progressive disease|3|||
105800182|NCT01326702|364926387|FG000|Overall Study|Death|0|||
105800183|NCT01326702|364926388|FG001|Overall Study|Death|1|||
105800184|NCT01326702|364926389|FG002|Overall Study|Death|0|||
105800185|NCT01326702|364926390|FG003|Overall Study|Death|0|||
105800186|NCT01326702|364926391|FG004|Overall Study|Death|0|||
105800187|NCT01326702|364926392|FG005|Overall Study|Death|0|||
105800188|NCT01326702|364926393|FG006|Overall Study|Death|0|||
105800189|NCT01326702|364926387|FG000|Overall Study|Adverse Event|0|||
105800190|NCT01326702|364926388|FG001|Overall Study|Adverse Event|0|||
105800191|NCT01326702|364926389|FG002|Overall Study|Adverse Event|1|||
105800192|NCT01326702|364926390|FG003|Overall Study|Adverse Event|1|||
105800193|NCT01326702|364926391|FG004|Overall Study|Adverse Event|0|||
105800194|NCT01326702|364926392|FG005|Overall Study|Adverse Event|3|||
105800195|NCT01326702|364926393|FG006|Overall Study|Adverse Event|1|||
105800196|NCT01326702|364926387|FG000|Overall Study|Withdrawal by Subject|0|||
105800197|NCT01326702|364926388|FG001|Overall Study|Withdrawal by Subject|0|||
105482968|NCT00924170|363780839|FG001|Overall Study|Progressive disease|6|||
105482969|NCT00924170|363780838|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
105800198|NCT01326702|364926389|FG002|Overall Study|Withdrawal by Subject|1|||
105800199|NCT01326702|364926390|FG003|Overall Study|Withdrawal by Subject|0|||
105800200|NCT01326702|364926391|FG004|Overall Study|Withdrawal by Subject|1|||
105800201|NCT01326702|364926392|FG005|Overall Study|Withdrawal by Subject|1|||
105800202|NCT01326702|364926393|FG006|Overall Study|Withdrawal by Subject|3|||
105800203|NCT01326702|364926387|FG000|Overall Study|Not Treated|0|||
105800204|NCT01326702|364926388|FG001|Overall Study|Not Treated|0|||
105800205|NCT01326702|364926389|FG002|Overall Study|Not Treated|0|||
105800206|NCT01326702|364926390|FG003|Overall Study|Not Treated|1|||
105800207|NCT01326702|364926391|FG004|Overall Study|Not Treated|0|||
105800208|NCT01326702|364926392|FG005|Overall Study|Not Treated|1|||
105800209|NCT01326702|364926393|FG006|Overall Study|Not Treated|0|||
105800210|NCT02402933|364926395|FG000|Overall Study|Withdrawal by Subject|4|||
105800211|NCT02402933|364926395|FG000|Overall Study|Discontinued; Site Termination|10|||
105800212|NCT00265083|364926401|FG000|Overall Study|Adverse Event|5|||
105800213|NCT00265083|364926402|FG001|Overall Study|Adverse Event|13|||
105800214|NCT00265083|364926403|FG002|Overall Study|Adverse Event|15|||
105482970|NCT00924170|363780839|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
105482971|NCT00924170|363780838|FG000|Overall Study|Death|1|||
105482972|NCT00924170|363780839|FG001|Overall Study|Death|0|||
105482973|NCT05027971|363780842|FG000|Overall Study|Physician Decision|7|||
105482974|NCT05027971|363780843|FG001|Overall Study|Physician Decision|3|||
105482975|NCT05027971|363780842|FG000|Overall Study|Lost to Follow-up|1|||
105482976|NCT05027971|363780843|FG001|Overall Study|Lost to Follow-up|1|||
105482977|NCT05027971|363780842|FG000|Overall Study|Withdrawal by Subject|0|||
105482978|NCT05027971|363780843|FG001|Overall Study|Withdrawal by Subject|2|||
105482979|NCT05027971|363780842|FG000|Overall Study|Non-study fiber used.|0|||
105482980|NCT05027971|363780843|FG001|Overall Study|Non-study fiber used.|1|||
105800215|NCT00265083|364926401|FG000|Overall Study|Lost to Follow-up|3|||
105800216|NCT00265083|364926402|FG001|Overall Study|Lost to Follow-up|4|||
105800217|NCT00265083|364926403|FG002|Overall Study|Lost to Follow-up|4|||
105800218|NCT00265083|364926401|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
105800219|NCT00265083|364926402|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
105800220|NCT00265083|364926403|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
105800221|NCT00265083|364926401|FG000|Overall Study|Other|1|||
105800222|NCT00265083|364926402|FG001|Overall Study|Other|12|||
105800223|NCT00265083|364926403|FG002|Overall Study|Other|9|||
105482981|NCT05027971|363780842|FG000|Overall Study|Protocol Violation|0|||
105482982|NCT05027971|363780843|FG001|Overall Study|Protocol Violation|2|||
105800224|NCT00534092|364926409|FG000|Overall Study|Lost to Follow-up|1|||
105800225|NCT00534092|364926410|FG001|Overall Study|Lost to Follow-up|0|||
105482983|NCT02025556|363780844|FG000|Overall Study|Adverse Event|0|||
105800226|NCT00534092|364926409|FG000|Overall Study|personal reasons/family concerns|1|||
105742090|NCT02417233|364711089|FG000|Overall Study|Lost to Follow-up|27|||
105742091|NCT02417233|364711090|FG001|Overall Study|Lost to Follow-up|39|||
105742092|NCT02417233|364711091|FG002|Overall Study|Lost to Follow-up|34|||
105742093|NCT02417233|364711089|FG000|Overall Study|Protocol Violation|2|||
105742094|NCT02417233|364711090|FG001|Overall Study|Protocol Violation|0|||
105742095|NCT02417233|364711091|FG002|Overall Study|Protocol Violation|2|||
105742096|NCT02417233|364711089|FG000|Overall Study|Withdrawal by Subject|2|||
105742097|NCT02417233|364711090|FG001|Overall Study|Withdrawal by Subject|1|||
105742098|NCT02417233|364711091|FG002|Overall Study|Withdrawal by Subject|8|||
105742099|NCT02417233|364711089|FG000|Overall Study|Relocation out of study area|1|||
105742100|NCT02417233|364711090|FG001|Overall Study|Relocation out of study area|0|||
105742101|NCT02417233|364711091|FG002|Overall Study|Relocation out of study area|1|||
105742102|NCT02417233|364711089|FG000|Overall Study|Mentally unstable|0|||
105742103|NCT02417233|364711090|FG001|Overall Study|Mentally unstable|1|||
105742104|NCT02417233|364711091|FG002|Overall Study|Mentally unstable|0|||
105742105|NCT01096550|364711097|FG000|Overall Study|discontinued site|10|||
105742106|NCT01096550|364711098|FG001|Overall Study|discontinued site|11|||
105742107|NCT01096550|364711097|FG000|Overall Study|non-regular treatment track at clinic|1|||
105742108|NCT01096550|364711098|FG001|Overall Study|non-regular treatment track at clinic|1|||
105742109|NCT01096550|364711097|FG000|Overall Study|clinic readmission|1|||
105742110|NCT01096550|364711098|FG001|Overall Study|clinic readmission|1|||
105742111|NCT01096550|364711097|FG000|Overall Study|Withdrawal by Subject|0|||
105742112|NCT01096550|364711098|FG001|Overall Study|Withdrawal by Subject|1|||
105742113|NCT01096550|364711097|FG000|Overall Study|non-African American participant|13|||
105742114|NCT01096550|364711098|FG001|Overall Study|non-African American participant|6|||
105742115|NCT01096550|364711097|FG000|Overall Study|Lost to Follow-up|12|||
105742116|NCT01096550|364711098|FG001|Overall Study|Lost to Follow-up|9|||
105742117|NCT03510663|364711101|FG000|Overall Study|Withdrawal by Subject|0|||
105742118|NCT03510663|364711102|FG001|Overall Study|Withdrawal by Subject|1|||
105742119|NCT03510663|364711103|FG002|Overall Study|Withdrawal by Subject|0|||
105742120|NCT03510663|364711104|FG003|Overall Study|Withdrawal by Subject|0|||
105742121|NCT03510663|364711105|FG004|Overall Study|Withdrawal by Subject|0|||
105742122|NCT03510663|364711106|FG005|Overall Study|Withdrawal by Subject|0|||
105742123|NCT03510663|364711107|FG006|Overall Study|Withdrawal by Subject|0|||
105742124|NCT03510663|364711108|FG007|Overall Study|Withdrawal by Subject|0|||
105742125|NCT02026271|364711111|FG000|Overall Study|Adverse Event|2|||
105742126|NCT02026271|364711112|FG001|Overall Study|Adverse Event|3|||
105742127|NCT02026271|364711113|FG002|Overall Study|Adverse Event|2|||
105742128|NCT02026271|364711114|FG003|Overall Study|Adverse Event|3|||
105742129|NCT02026271|364711115|FG004|Overall Study|Adverse Event|0|||
105742130|NCT02026271|364711111|FG000|Overall Study|Withdrawal by Subject|0|||
105742131|NCT02026271|364711112|FG001|Overall Study|Withdrawal by Subject|0|||
105742132|NCT02026271|364711113|FG002|Overall Study|Withdrawal by Subject|0|||
105742133|NCT02026271|364711114|FG003|Overall Study|Withdrawal by Subject|0|||
105742134|NCT02026271|364711115|FG004|Overall Study|Withdrawal by Subject|1|||
105742135|NCT01095250|364711116|FG000|Overall Study|administrative reasons|8|||
105742136|NCT01095250|364711117|FG001|Overall Study|administrative reasons|10|||
105742137|NCT01095250|364711118|FG002|Overall Study|administrative reasons|7|||
105742138|NCT01095250|364711119|FG003|Overall Study|administrative reasons|5|||
105742139|NCT01095250|364711116|FG000|Overall Study|Withdrawal by Subject|0|||
105742140|NCT01095250|364711117|FG001|Overall Study|Withdrawal by Subject|0|||
105742141|NCT01095250|364711118|FG002|Overall Study|Withdrawal by Subject|1|||
105742142|NCT01095250|364711119|FG003|Overall Study|Withdrawal by Subject|0|||
105742143|NCT01915849|364711120|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
105742144|NCT01915849|364711121|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
105742145|NCT01915849|364711122|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
105742146|NCT01915849|364711123|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
105742147|NCT01915849|364711120|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
105742148|NCT01915849|364711121|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
105742149|NCT01915849|364711122|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
105742150|NCT01915849|364711123|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
105742151|NCT00001262|364711126|FG000|Overall Study|Death|10|||
105742152|NCT00001262|364711127|FG001|Overall Study|Death|11|||
105742153|NCT00001262|364711128|FG002|Overall Study|Death|0|||
105742154|NCT00001262|364711126|FG000|Overall Study|Withdrawal by Subject|0|||
105742155|NCT00001262|364711127|FG001|Overall Study|Withdrawal by Subject|3|||
105742156|NCT00001262|364711128|FG002|Overall Study|Withdrawal by Subject|0|||
105742157|NCT00878072|364711129|FG000|Overall Study|Withdrew consent|2|||
105742158|NCT01954121|364711136|FG000|Overall Study|Lack of Efficacy|94|||
105742159|NCT01954121|364711137|FG001|Overall Study|Lack of Efficacy|41|||
105742160|NCT01954121|364711136|FG000|Overall Study|Protocol Violation|0|||
105742161|NCT01954121|364711137|FG001|Overall Study|Protocol Violation|2|||
105742162|NCT01954121|364711136|FG000|Overall Study|Lost to Follow-up|5|||
105358699|NCT02260817|363319026|FG001|Overall Study|Protocol Violation|14|||
105358700|NCT04435808|363319027|FG000|Overall Study|Study stopped by DSMB|0|||
105742163|NCT01954121|364711137|FG001|Overall Study|Lost to Follow-up|6|||
105742164|NCT01954121|364711136|FG000|Overall Study|Withdrawal by Subject|18|||
105742165|NCT01954121|364711137|FG001|Overall Study|Withdrawal by Subject|12|||
105742166|NCT01954121|364711136|FG000|Overall Study|Pregnancy|1|||
105742167|NCT01954121|364711137|FG001|Overall Study|Pregnancy|1|||
105742168|NCT01954121|364711136|FG000|Overall Study|AE, serious fatal|1|||
105742169|NCT01954121|364711137|FG001|Overall Study|AE, serious fatal|0|||
105742170|NCT01954121|364711136|FG000|Overall Study|AE, non-serious non-fatal|5|||
105742171|NCT01954121|364711137|FG001|Overall Study|AE, non-serious non-fatal|22|||
105742172|NCT01954121|364711136|FG000|Overall Study|SAE, non-fatal|1|||
105742173|NCT01954121|364711137|FG001|Overall Study|SAE, non-fatal|4|||
105742174|NCT01954121|364711136|FG000|Overall Study|Non-compliant with study procedures|1|||
105742175|NCT01954121|364711137|FG001|Overall Study|Non-compliant with study procedures|0|||
105742176|NCT01954121|364711136|FG000|Overall Study|Non-compliant patient|1|||
105742177|NCT01954121|364711137|FG001|Overall Study|Non-compliant patient|1|||
105742178|NCT01954121|364711136|FG000|Overall Study|Subject did not follow instructions|0|||
105742179|NCT01954121|364711137|FG001|Overall Study|Subject did not follow instructions|2|||
105742180|NCT03382899|364711141|FG000|Overall Study|Ineligibility Determined|0|||
105742181|NCT03382899|364711142|FG001|Overall Study|Ineligibility Determined|1|||
105742182|NCT03382899|364711141|FG000|Overall Study|Lost to Follow-up|0|||
105742183|NCT03382899|364711142|FG001|Overall Study|Lost to Follow-up|1|||
105742184|NCT03382899|364711141|FG000|Overall Study|Sponsor's decision|31|||
105742185|NCT03382899|364711142|FG001|Overall Study|Sponsor's decision|28|||
105742186|NCT03382899|364711141|FG000|Overall Study|Withdrawal by Subject|0|||
105742187|NCT03382899|364711142|FG001|Overall Study|Withdrawal by Subject|5|||
105742188|NCT02588248|364711143|FG000|Overall Study|Physician Decision|4|||
105742189|NCT02588248|364711144|FG001|Overall Study|Physician Decision|3|||
105742190|NCT00872170|364711148|FG000|Overall Study|Adverse Event|1|||
105742191|NCT00872170|364711149|FG001|Overall Study|Adverse Event|0|||
105742192|NCT00804193|364711150|FG000|Overall Study|Lack of baseline fungus|32|||
105742193|NCT00804193|364711151|FG001|Overall Study|Lack of baseline fungus|31|||
105742194|NCT00804193|364711152|FG002|Overall Study|Lack of baseline fungus|19|||
105742195|NCT00804193|364711150|FG000|Overall Study|Adverse Event|0|||
105742196|NCT00804193|364711151|FG001|Overall Study|Adverse Event|0|||
105742197|NCT00804193|364711152|FG002|Overall Study|Adverse Event|2|||
105742198|NCT00804193|364711150|FG000|Overall Study|Lack of Efficacy|1|||
105742199|NCT00804193|364711151|FG001|Overall Study|Lack of Efficacy|1|||
105565306|NCT01281202|364066731|FG001|Overall Study|Administrative|8|||
105742200|NCT00804193|364711152|FG002|Overall Study|Lack of Efficacy|3|||
105742201|NCT00804193|364711150|FG000|Overall Study|Protocol Violation|0|||
105742202|NCT00804193|364711151|FG001|Overall Study|Protocol Violation|8|||
105742203|NCT00804193|364711152|FG002|Overall Study|Protocol Violation|2|||
105742204|NCT00804193|364711150|FG000|Overall Study|Lost to Follow-up|3|||
105742205|NCT00804193|364711151|FG001|Overall Study|Lost to Follow-up|3|||
105742206|NCT00804193|364711152|FG002|Overall Study|Lost to Follow-up|4|||
105742207|NCT00804193|364711150|FG000|Overall Study|Withdrawal by Subject|3|||
105742208|NCT00804193|364711151|FG001|Overall Study|Withdrawal by Subject|1|||
105742209|NCT00804193|364711152|FG002|Overall Study|Withdrawal by Subject|2|||
105742210|NCT00527111|364711153|FG000|Overall Study|Adverse Event|14|||
105742211|NCT00527111|364711154|FG001|Overall Study|Adverse Event|13|||
105742212|NCT00527111|364711153|FG000|Overall Study|Death|0|||
105742213|NCT00527111|364711154|FG001|Overall Study|Death|1|||
105742214|NCT00527111|364711153|FG000|Overall Study|Investigator Request|2|||
105742215|NCT00527111|364711154|FG001|Overall Study|Investigator Request|1|||
105742216|NCT00527111|364711153|FG000|Overall Study|Patient Request|2|||
105742217|NCT00527111|364711154|FG001|Overall Study|Patient Request|5|||
105742218|NCT00527111|364711153|FG000|Overall Study|Other|2|||
105742219|NCT00527111|364711154|FG001|Overall Study|Other|2|||
105742220|NCT00705224|364711155|FG000|Overall Study|Adverse Event|1|||
105742221|NCT00705224|364711155|FG000|Overall Study|Lack of Efficacy|2|||
105742222|NCT00705224|364711155|FG000|Overall Study|Withdrawal by Subject|3|||
105742223|NCT00705224|364711155|FG000|Overall Study|Lost to Follow-up|5|||
105742224|NCT03283163|364711156|FG000|Overall Study|Lost to Follow-up|1|||
105742225|NCT03283163|364711156|FG000|Overall Study|other life commitments|6|||
105742226|NCT03283163|364711156|FG000|Overall Study|COVID-19 institution wide halting|1|||
105742227|NCT03283163|364711156|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
105742228|NCT03283163|364711156|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
105742229|NCT00237796|364711159|FG000|Overall Study|Baseline and one other ILSS required|10|||
105742230|NCT00237796|364711160|FG001|Overall Study|Baseline and one other ILSS required|5|||
105742231|NCT01193348|364711164|FG000|Screening Period|Screen Failure|5|||
105742232|NCT01193348|364711164|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
105742233|NCT01193348|364711164|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
105742234|NCT01193348|364711164|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
105742235|NCT01193348|364711164|FG000|Extension Treatment Period|Physician Decision|1|||
105742236|NCT01193348|364711164|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
105742237|NCT04070378|364711165|FG000|Overall Study|Withdrawal by Subject|2|||
105742238|NCT04070378|364711165|FG000|Overall Study|Screen Failure|6|||
105742239|NCT04070378|364711165|FG000|Overall Study|Physician Decision|1|||
105742240|NCT04070378|364711165|FG000|Overall Study|Adverse Event|1|||
105742241|NCT03596177|364711167|FG000|Single Blind Period|Withdrawal by Subject|1|||
105742242|NCT03596177|364711168|FG001|Single Blind Period|Withdrawal by Subject|1|||
105742243|NCT03596177|364711167|FG000|Single Blind Period|Other|1|||
105742244|NCT03596177|364711168|FG001|Single Blind Period|Other|0|||
105742245|NCT03596177|364711167|FG000|Double Blind Period|Withdrawal by Subject|0|||
105742246|NCT03596177|364711168|FG001|Double Blind Period|Withdrawal by Subject|1|||
105358701|NCT04435808|363319028|FG001|Overall Study|Study stopped by DSMB|1|||
105742247|NCT03596177|364711167|FG000|Double Blind Period|Other|0|||
105742248|NCT03596177|364711168|FG001|Double Blind Period|Other|4|||
105742249|NCT03596177|364711167|FG000|Double Blind Period|Death during safety follow-up|0|||
105742250|NCT03596177|364711168|FG001|Double Blind Period|Death during safety follow-up|1|||
105742251|NCT00968253|364711169|FG000|Overall Study|Death|0|||
105742252|NCT00968253|364711170|FG001|Overall Study|Death|0|||
105742253|NCT00968253|364711171|FG002|Overall Study|Death|2|||
105742254|NCT00968253|364711169|FG000|Overall Study|Withdrawal by Subject|0|||
105800227|NCT00534092|364926410|FG001|Overall Study|personal reasons/family concerns|0|||
105800228|NCT02323295|364926414|FG000|Overall Study|Adverse Event|0|||
105800229|NCT02323295|364926415|FG001|Overall Study|Adverse Event|1|||
105800230|NCT02323295|364926414|FG000|Overall Study|Withdrawal by Subject|0|||
105800231|NCT02323295|364926415|FG001|Overall Study|Withdrawal by Subject|1|||
105800232|NCT02323295|364926414|FG000|Overall Study|Patient did not have surgery as planned.|0|||
105800233|NCT02323295|364926415|FG001|Overall Study|Patient did not have surgery as planned.|1|||
105800234|NCT00830063|364926416|FG000|Overall Study|Adverse Event|7|||
105800235|NCT00830063|364926417|FG001|Overall Study|Adverse Event|13|||
105800236|NCT00830063|364926418|FG002|Overall Study|Adverse Event|16|||
105358702|NCT02620787|363319029|FG000|Overall Study|Adverse Event|1|||
105358703|NCT02620787|363319030|FG001|Overall Study|Adverse Event|0|||
105358704|NCT02620787|363319029|FG000|Overall Study|Eligibility Criteria Not Met|1|||
105358705|NCT02620787|363319030|FG001|Overall Study|Eligibility Criteria Not Met|0|||
105358706|NCT03299101|363319031|FG000|Overall Study|Lost to Follow-up|1|||
105358707|NCT03299101|363319031|FG000|Overall Study|Withdrawal by Subject|5|||
105358708|NCT03299101|363319031|FG000|Overall Study|Surgery was changed|3|||
105358709|NCT03299101|363319031|FG000|Overall Study|Not enough time to complete prehab|1|||
105358710|NCT03060291|363319034|FG000|3-month Follow-up|Declined to respond|8|||
105358711|NCT03060291|363319035|FG001|3-month Follow-up|Declined to respond|10|||
105358712|NCT03060291|363319036|FG002|3-month Follow-up|Declined to respond|2|||
105358713|NCT03060291|363319034|FG000|6-month Follow-up|Declined to respond|7|||
105358714|NCT03060291|363319035|FG001|6-month Follow-up|Declined to respond|13|||
105358715|NCT03060291|363319036|FG002|6-month Follow-up|Declined to respond|4|||
105358716|NCT03060291|363319034|FG000|12-month Follow-up|Declined to respond|7|||
105358717|NCT03060291|363319035|FG001|12-month Follow-up|Declined to respond|16|||
105358718|NCT03060291|363319036|FG002|12-month Follow-up|Declined to respond|6|||
105358719|NCT01720524|363319039|FG000|Part A|Insufficient Clinical Response|2|||
105358720|NCT01720524|363319040|FG001|Part A|Insufficient Clinical Response|4|||
105358721|NCT01720524|363319039|FG000|Part A|Adverse Event|2|||
105358722|NCT01720524|363319040|FG001|Part A|Adverse Event|2|||
105358723|NCT01720524|363319039|FG000|Part A|Death|2|||
105358724|NCT01720524|363319040|FG001|Part A|Death|1|||
105358725|NCT01720524|363319039|FG000|Part A|Lost to Follow-up|0|||
105358726|NCT01720524|363319040|FG001|Part A|Lost to Follow-up|1|||
105358727|NCT01720524|363319039|FG000|Part A|Missed 28 day follow-up visit|1|||
105358728|NCT01720524|363319040|FG001|Part A|Missed 28 day follow-up visit|1|||
105358729|NCT01720524|363319039|FG000|Part A|Withdrawal by Subject|0|||
105358730|NCT01720524|363319040|FG001|Part A|Withdrawal by Subject|1|||
105358731|NCT01720524|363319039|FG000|Part A|Other|0|||
105358732|NCT01720524|363319040|FG001|Part A|Other|1|||
105358733|NCT01720524|363319039|FG000|Part A|Lost to Follow-up|0|||
105358734|NCT01720524|363319040|FG001|Part A|Lost to Follow-up|1|||
105358735|NCT01720524|363319039|FG000|Part B|No longer willing to participate in study|1|||
105358736|NCT01720524|363319040|FG001|Part B|No longer willing to participate in study|4|||
105358737|NCT01720524|363319039|FG000|Part B|Other|2|||
105358738|NCT01720524|363319040|FG001|Part B|Other|0|||
105358739|NCT01720524|363319039|FG000|Part B|Lost to Follow-up|2|||
105358740|NCT01720524|363319040|FG001|Part B|Lost to Follow-up|3|||
105358741|NCT01720524|363319039|FG000|Part B|Death|0|||
105358742|NCT01720524|363319040|FG001|Part B|Death|2|||
105358743|NCT00527826|363319041|FG000|Overall Study|Adverse Event|10|||
105358744|NCT00527826|363319042|FG001|Overall Study|Adverse Event|10|||
105358745|NCT00527826|363319041|FG000|Overall Study|Lost to Follow-up|3|||
105358746|NCT00527826|363319042|FG001|Overall Study|Lost to Follow-up|2|||
105358747|NCT00527826|363319041|FG000|Overall Study|Withdrawal by Subject|5|||
105358748|NCT00527826|363319042|FG001|Overall Study|Withdrawal by Subject|8|||
105358749|NCT00527826|363319041|FG000|Overall Study|Inclusion Criteria Not Met|3|||
105358750|NCT00527826|363319042|FG001|Overall Study|Inclusion Criteria Not Met|3|||
105358751|NCT00527826|363319041|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
105358752|NCT00527826|363319042|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
105358753|NCT00527826|363319041|FG000|Overall Study|Additional Intake of Viani forte|0|||
105358754|NCT00527826|363319042|FG001|Overall Study|Additional Intake of Viani forte|1|||
105358755|NCT00527826|363319041|FG000|Overall Study|Participant moved away|0|||
105358756|NCT00527826|363319042|FG001|Overall Study|Participant moved away|1|||
105565307|NCT01281202|364066730|FG000|Overall Study|Lost to Follow-up|11|||
105358757|NCT02105285|363319043|FG000|Overall Study|Adverse Event|1|||
105565308|NCT01281202|364066731|FG001|Overall Study|Lost to Follow-up|13|||
105565309|NCT01281202|364066730|FG000|Overall Study|Incarceration|0|||
105358758|NCT02105285|363319044|FG001|Overall Study|Adverse Event|1|||
105358759|NCT02105285|363319045|FG002|Overall Study|Adverse Event|0|||
105358760|NCT02105285|363319043|FG000|Overall Study|Protocol Violation|0|||
105358761|NCT02105285|363319044|FG001|Overall Study|Protocol Violation|1|||
105358762|NCT02105285|363319045|FG002|Overall Study|Protocol Violation|0|||
105358763|NCT02105285|363319043|FG000|Overall Study|Withdrawal by Subject|1|||
105358764|NCT02105285|363319044|FG001|Overall Study|Withdrawal by Subject|0|||
105800237|NCT00830063|364926419|FG003|Overall Study|Adverse Event|13|||
105800238|NCT00830063|364926416|FG000|Overall Study|Death|1|||
105358765|NCT02105285|363319045|FG002|Overall Study|Withdrawal by Subject|0|||
105482984|NCT02025556|363780845|FG001|Overall Study|Adverse Event|4|||
105482985|NCT02025556|363780846|FG002|Overall Study|Adverse Event|2|||
105482986|NCT02025556|363780844|FG000|Overall Study|Lack of Efficacy|2|||
105482987|NCT02025556|363780845|FG001|Overall Study|Lack of Efficacy|1|||
105482988|NCT02025556|363780846|FG002|Overall Study|Lack of Efficacy|0|||
105482989|NCT02025556|363780844|FG000|Overall Study|Protocol Violation|2|||
105482990|NCT02025556|363780845|FG001|Overall Study|Protocol Violation|1|||
105482991|NCT02025556|363780846|FG002|Overall Study|Protocol Violation|0|||
105482992|NCT02025556|363780844|FG000|Overall Study|Withdrawal by Subject|0|||
105482993|NCT02025556|363780845|FG001|Overall Study|Withdrawal by Subject|3|||
105482994|NCT02025556|363780846|FG002|Overall Study|Withdrawal by Subject|6|||
105482995|NCT02025556|363780844|FG000|Overall Study|Lost to Follow-up|2|||
105482996|NCT02025556|363780845|FG001|Overall Study|Lost to Follow-up|4|||
105482997|NCT02025556|363780846|FG002|Overall Study|Lost to Follow-up|0|||
105482998|NCT02025556|363780844|FG000|Overall Study|Reason not reported|0|||
105482999|NCT02025556|363780845|FG001|Overall Study|Reason not reported|0|||
105483000|NCT02025556|363780846|FG002|Overall Study|Reason not reported|1|||
105483001|NCT05395091|363780847|FG000|Baseline to Month 12|Adverse Event|7|||
105483002|NCT05395091|363780848|FG001|Baseline to Month 12|Adverse Event|2|||
105483003|NCT05395091|363780849|FG002|Baseline to Month 12|Adverse Event|0|||
105483004|NCT05395091|363780847|FG000|Baseline to Month 12|Death|3|||
105483005|NCT05395091|363780848|FG001|Baseline to Month 12|Death|1|||
105483006|NCT05395091|363780849|FG002|Baseline to Month 12|Death|0|||
105483007|NCT05395091|363780847|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
105483008|NCT05395091|363780848|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
105483009|NCT05395091|363780849|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
105483010|NCT05395091|363780847|FG000|Baseline to Month 12|Protocol Violation|2|||
105483011|NCT05395091|363780848|FG001|Baseline to Month 12|Protocol Violation|3|||
105483012|NCT05395091|363780849|FG002|Baseline to Month 12|Protocol Violation|0|||
105483013|NCT05395091|363780847|FG000|Baseline to Month 12|Physician Decision|1|||
105483014|NCT05395091|363780848|FG001|Baseline to Month 12|Physician Decision|0|||
105483015|NCT05395091|363780849|FG002|Baseline to Month 12|Physician Decision|0|||
105483016|NCT05395091|363780847|FG000|Month 12 to Month 18|Death|1|||
105483017|NCT05395091|363780848|FG001|Month 12 to Month 18|Death|0|||
105483018|NCT05395091|363780849|FG002|Month 12 to Month 18|Death|0|||
105483019|NCT05395091|363780847|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
105483020|NCT05395091|363780848|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
105483021|NCT05395091|363780849|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
105483022|NCT05395091|363780847|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
105483023|NCT05395091|363780848|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
105483024|NCT05395091|363780849|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
105483025|NCT05395091|363780847|FG000|Month 12 to Month 18|Other reasons|0|||
105742255|NCT00968253|364711170|FG001|Overall Study|Withdrawal by Subject|0|||
105742256|NCT00968253|364711171|FG002|Overall Study|Withdrawal by Subject|1|||
105742257|NCT00968253|364711169|FG000|Overall Study|Disease Progression|0|||
105742258|NCT00968253|364711170|FG001|Overall Study|Disease Progression|3|||
105742259|NCT00968253|364711171|FG002|Overall Study|Disease Progression|3|||
105742260|NCT00968253|364711169|FG000|Overall Study|Adverse Event|0|||
105742261|NCT00968253|364711170|FG001|Overall Study|Adverse Event|0|||
105742262|NCT00968253|364711171|FG002|Overall Study|Adverse Event|1|||
105742263|NCT03259334|364711172|FG000|Overall Study|Adverse Event|3|||
105742264|NCT03259334|364711173|FG001|Overall Study|Adverse Event|8|||
105742265|NCT03259334|364711174|FG002|Overall Study|Adverse Event|5|||
105742266|NCT03259334|364711172|FG000|Overall Study|Withdrawal by Subject|4|||
105742267|NCT03259334|364711173|FG001|Overall Study|Withdrawal by Subject|2|||
105742268|NCT03259334|364711174|FG002|Overall Study|Withdrawal by Subject|4|||
105742269|NCT03259334|364711172|FG000|Overall Study|Physician Decision|1|||
105483026|NCT05395091|363780848|FG001|Month 12 to Month 18|Other reasons|0|||
105483027|NCT05395091|363780849|FG002|Month 12 to Month 18|Other reasons|1|||
105483028|NCT00899392|363780850|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
105483029|NCT00899392|363780851|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
105483030|NCT02437110|363780852|FG000|Screening|Lost to Follow-up|3|||
105483031|NCT02437110|363780852|FG000|Screening|Physician Decision|1|||
105483032|NCT02437110|363780852|FG000|ART|Adverse Event|3|||
105483033|NCT02437110|363780852|FG000|ART|Protocol Violation|3|||
105483034|NCT02437110|363780852|FG000|ART|Withdrawal by Subject|4|||
105483035|NCT02437110|363780852|FG000|ART|Lost to follow-up prior to start of intervention|1|||
105742270|NCT03259334|364711173|FG001|Overall Study|Physician Decision|0|||
105742271|NCT03259334|364711174|FG002|Overall Study|Physician Decision|0|||
105742272|NCT03259334|364711172|FG000|Overall Study|Lost to Follow-up|0|||
105742273|NCT03259334|364711173|FG001|Overall Study|Lost to Follow-up|2|||
105742274|NCT03259334|364711174|FG002|Overall Study|Lost to Follow-up|1|||
105483036|NCT02437110|363780852|FG000|ART|Physician decision prior to start of intervention|2|||
105483037|NCT02437110|363780852|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
105483038|NCT02437110|363780852|FG000|Post-ART|Lost to Follow-up|3|||
105483039|NCT02437110|363780852|FG000|Post-ART|Protocol Violation|4|||
105742275|NCT03259334|364711172|FG000|Overall Study|Protocol Deviation|0|||
105742276|NCT03259334|364711173|FG001|Overall Study|Protocol Deviation|3|||
105742277|NCT03259334|364711174|FG002|Overall Study|Protocol Deviation|2|||
105742278|NCT03259334|364711172|FG000|Overall Study|Lack of Efficacy|2|||
105742279|NCT03259334|364711173|FG001|Overall Study|Lack of Efficacy|0|||
105742280|NCT03259334|364711174|FG002|Overall Study|Lack of Efficacy|1|||
105742281|NCT03259334|364711172|FG000|Overall Study|Randomized but never treated|0|||
105742282|NCT03259334|364711173|FG001|Overall Study|Randomized but never treated|2|||
105742283|NCT03259334|364711174|FG002|Overall Study|Randomized but never treated|0|||
105742284|NCT01921257|364711175|FG000|Overall Study|Adverse Event|1|||
105742285|NCT01921257|364711175|FG000|Overall Study|Protocol Violation|1|||
105742286|NCT01921257|364711175|FG000|Overall Study|Withdrawal by Subject|1|||
105742287|NCT02149836|364711178|FG000|Overall Study|Withdrawal by Subject|1|||
105742288|NCT04594239|364711181|FG000|Overall Study|Withdrawal by Subject|3|||
105742289|NCT04594239|364711182|FG001|Overall Study|Withdrawal by Subject|4|||
105742290|NCT04594239|364711183|FG002|Overall Study|Withdrawal by Subject|2|||
105742291|NCT04594239|364711184|FG003|Overall Study|Withdrawal by Subject|4|||
105742292|NCT04594239|364711181|FG000|Overall Study|Lost to Follow-up|8|||
105742293|NCT04594239|364711182|FG001|Overall Study|Lost to Follow-up|5|||
105742294|NCT04594239|364711183|FG002|Overall Study|Lost to Follow-up|4|||
105742295|NCT04594239|364711184|FG003|Overall Study|Lost to Follow-up|6|||
105742296|NCT04594239|364711181|FG000|Overall Study|Subject relocated|0|||
105742297|NCT04594239|364711182|FG001|Overall Study|Subject relocated|0|||
105742298|NCT04594239|364711183|FG002|Overall Study|Subject relocated|0|||
105742299|NCT04594239|364711184|FG003|Overall Study|Subject relocated|1|||
105742300|NCT03229759|364711189|FG000|Overall Study|Screen Failure|30|||
105565310|NCT01281202|364066731|FG001|Overall Study|Incarceration|3|||
105565311|NCT02889133|364066735|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
105565312|NCT02889133|364066736|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
105565313|NCT02889133|364066735|FG000|Completed Primary Outcome|Manufacturing error|3|||
105565314|NCT02889133|364066736|FG001|Completed Primary Outcome|Manufacturing error|8|||
105565315|NCT02889133|364066735|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
105565316|NCT02889133|364066736|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
105565317|NCT02889133|364066735|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
105565318|NCT02889133|364066736|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
105742301|NCT05128162|364711190|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
105742302|NCT05128162|364711190|FG000|Overall Study|Physician Decision|1|||
105742303|NCT00719732|364711191|FG000|Overall Study|Lost to Follow-up|20|||
105742304|NCT00719732|364711191|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
105742305|NCT00719732|364711191|FG000|Overall Study|Illness not associated with device|1|||
105742306|NCT00436215|364711192|FG000|Overall Study|Refused further treatment|3|||
105742307|NCT00436215|364711192|FG000|Overall Study|Small bowel obstruction|1|||
105742308|NCT00309777|364711197|FG000|Overall Study|Adverse Event|13|||
105742309|NCT00309777|364711198|FG001|Overall Study|Adverse Event|2|||
105742310|NCT00309777|364711199|FG002|Overall Study|Adverse Event|8|||
105742311|NCT00309777|364711200|FG003|Overall Study|Adverse Event|1|||
105565319|NCT02889133|364066735|FG000|Completed Primary Outcome|Protocol Violation|1|||
105742312|NCT00309777|364711197|FG000|Overall Study|Protocol Violation|4|||
105742313|NCT00309777|364711198|FG001|Overall Study|Protocol Violation|1|||
105742314|NCT00309777|364711199|FG002|Overall Study|Protocol Violation|3|||
105742315|NCT00309777|364711200|FG003|Overall Study|Protocol Violation|1|||
105742316|NCT00309777|364711197|FG000|Overall Study|Withdrawal by Subject|6|||
105742317|NCT00309777|364711198|FG001|Overall Study|Withdrawal by Subject|5|||
105742318|NCT00309777|364711199|FG002|Overall Study|Withdrawal by Subject|7|||
105742319|NCT00309777|364711200|FG003|Overall Study|Withdrawal by Subject|2|||
105742320|NCT00309777|364711197|FG000|Overall Study|Lost to Follow-up|0|||
105742321|NCT00309777|364711198|FG001|Overall Study|Lost to Follow-up|0|||
105742322|NCT00309777|364711199|FG002|Overall Study|Lost to Follow-up|1|||
105742323|NCT00309777|364711200|FG003|Overall Study|Lost to Follow-up|0|||
105742324|NCT00309777|364711197|FG000|Overall Study|Death|0|||
105742325|NCT00309777|364711198|FG001|Overall Study|Death|1|||
105742326|NCT00309777|364711199|FG002|Overall Study|Death|0|||
105742327|NCT00309777|364711200|FG003|Overall Study|Death|0|||
105742328|NCT03625986|364712697|FG000|Randomization Period|Lost to Follow-up|7|||
105742329|NCT03625986|364712698|FG001|Randomization Period|Lost to Follow-up|12|||
105742330|NCT03625986|364712697|FG000|Randomization Period|Withdrawal by Subject|10|||
105742331|NCT03625986|364712698|FG001|Randomization Period|Withdrawal by Subject|6|||
105742332|NCT01605071|364712699|FG000|Overall Study|Withdrawal by Subject|3|||
105742333|NCT01605071|364712700|FG001|Overall Study|Withdrawal by Subject|2|||
105742334|NCT00392171|364712701|FG000|Overall Study|Did not meet inclusion criteria|4|||
105742335|NCT00392171|364712701|FG000|Overall Study|Disease progression|101|||
105742336|NCT01931462|364712702|FG000|Overall Study|Withdrawal by Subject|1|||
105742337|NCT02361762|364712703|FG000|Overall Study|Withdrawal by Subject|0|||
105742338|NCT02361762|364712704|FG001|Overall Study|Withdrawal by Subject|1|||
105742339|NCT02361762|364712703|FG000|Overall Study|Lost to Follow-up|0|||
105742340|NCT02361762|364712704|FG001|Overall Study|Lost to Follow-up|1|||
105742341|NCT00059215|364712706|FG000|Overall Study|Adverse Event|5|||
105742342|NCT00059215|364712707|FG001|Overall Study|Adverse Event|5|||
105742343|NCT00059215|364712708|FG002|Overall Study|Adverse Event|9|||
105742344|NCT00059215|364712709|FG003|Overall Study|Adverse Event|9|||
105742345|NCT00059215|364712706|FG000|Overall Study|Death|0|||
105742346|NCT00059215|364712707|FG001|Overall Study|Death|0|||
105742347|NCT00059215|364712708|FG002|Overall Study|Death|3|||
105742348|NCT00059215|364712709|FG003|Overall Study|Death|0|||
105742349|NCT00059215|364712706|FG000|Overall Study|Lost to Follow-up|1|||
105742350|NCT00059215|364712707|FG001|Overall Study|Lost to Follow-up|2|||
105742351|NCT00059215|364712708|FG002|Overall Study|Lost to Follow-up|0|||
105742352|NCT00059215|364712709|FG003|Overall Study|Lost to Follow-up|0|||
105742353|NCT00059215|364712706|FG000|Overall Study|Withdrawal by Subject|4|||
105742354|NCT00059215|364712707|FG001|Overall Study|Withdrawal by Subject|4|||
105742355|NCT00059215|364712708|FG002|Overall Study|Withdrawal by Subject|1|||
105742356|NCT00059215|364712709|FG003|Overall Study|Withdrawal by Subject|3|||
105742357|NCT00059215|364712706|FG000|Overall Study|Protocol Violation|1|||
105742358|NCT00059215|364712707|FG001|Overall Study|Protocol Violation|0|||
105742359|NCT00059215|364712708|FG002|Overall Study|Protocol Violation|1|||
105742360|NCT00059215|364712709|FG003|Overall Study|Protocol Violation|0|||
105742361|NCT00059215|364712706|FG000|Overall Study|Protocol entry criteria not met|1|||
105742362|NCT00059215|364712707|FG001|Overall Study|Protocol entry criteria not met|1|||
105742363|NCT00059215|364712708|FG002|Overall Study|Protocol entry criteria not met|0|||
105742364|NCT00059215|364712709|FG003|Overall Study|Protocol entry criteria not met|2|||
105742365|NCT00059215|364712706|FG000|Overall Study|Physician Decision|1|||
105742366|NCT00059215|364712707|FG001|Overall Study|Physician Decision|2|||
105742367|NCT00059215|364712708|FG002|Overall Study|Physician Decision|1|||
105358766|NCT01502033|363319048|FG000|Overall Study|1 participant had scalp discomfort|1|||
105483040|NCT02437110|363780852|FG000|Post-ART|Withdrawal by Subject|3|||
105742368|NCT00059215|364712709|FG003|Overall Study|Physician Decision|1|||
105742369|NCT00502307|364712712|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
105742370|NCT00502307|364712713|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
105800239|NCT00830063|364926417|FG001|Overall Study|Death|0|||
105483041|NCT01431638|363780856|FG000|Overall Study|Adverse Event|1|||
105742371|NCT00502307|364712714|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
105742372|NCT00502307|364712712|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
105742373|NCT00502307|364712713|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
105742374|NCT00502307|364712714|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
105742375|NCT00502307|364712712|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
105742376|NCT00502307|364712713|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
105742377|NCT00502307|364712714|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
105742378|NCT00502307|364712712|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
105742379|NCT00502307|364712713|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
105742380|NCT00502307|364712714|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
105742381|NCT00502307|364712712|FG000|Maintenance Period|Progressive disease|80|||
105742382|NCT00502307|364712713|FG001|Maintenance Period|Progressive disease|0|||
105742383|NCT00502307|364712714|FG002|Maintenance Period|Progressive disease|0|||
105742384|NCT00502307|364712712|FG000|Maintenance Period|Discontinued due to other reasons|68|||
105742385|NCT00502307|364712713|FG001|Maintenance Period|Discontinued due to other reasons|0|||
105742386|NCT00502307|364712714|FG002|Maintenance Period|Discontinued due to other reasons|0|||
105742387|NCT00414310|364712715|FG000|Overall Study|Not treated|1|||
105742388|NCT00414310|364712716|FG001|Overall Study|Not treated|0|||
105742389|NCT03041116|364712717|FG000|Double-blind|Death|0|||
105742390|NCT03041116|364712718|FG001|Double-blind|Death|2|||
105742391|NCT03041116|364712717|FG000|Double-blind|Withdrawal by Subject|0|||
105742392|NCT03041116|364712718|FG001|Double-blind|Withdrawal by Subject|4|||
105742393|NCT03041116|364712717|FG000|Open-label|Death|1|||
105742394|NCT03041116|364712718|FG001|Open-label|Death|0|||
105742395|NCT03041116|364712717|FG000|Open-label|Termination of the study by Sponsor|39|||
105742396|NCT03041116|364712718|FG001|Open-label|Termination of the study by Sponsor|37|||
105742397|NCT03041116|364712717|FG000|Open-label|Withdrawal by Subject|1|||
105742398|NCT03041116|364712718|FG001|Open-label|Withdrawal by Subject|0|||
105742399|NCT00833248|364712719|FG000|Overall Study|Adverse Event|3|||
105742400|NCT00833248|364712720|FG001|Overall Study|Adverse Event|0|||
105742401|NCT00833248|364712719|FG000|Overall Study|Protocol Violation|1|||
105742402|NCT00833248|364712720|FG001|Overall Study|Protocol Violation|2|||
105742403|NCT00833248|364712719|FG000|Overall Study|Withdrawal by Subject|0|||
105742404|NCT00833248|364712720|FG001|Overall Study|Withdrawal by Subject|1|||
105742405|NCT01781429|364712722|FG000|Overall Study|Death|0|||
105742406|NCT01781429|364712723|FG001|Overall Study|Death|0|||
105742407|NCT01781429|364712724|FG002|Overall Study|Death|0|||
105742408|NCT01781429|364712725|FG003|Overall Study|Death|0|||
105742409|NCT01781429|364712726|FG004|Overall Study|Death|0|||
105742410|NCT01781429|364712727|FG005|Overall Study|Death|0|||
105742411|NCT01781429|364712728|FG006|Overall Study|Death|0|||
105742412|NCT01781429|364712729|FG007|Overall Study|Death|0|||
105742413|NCT01781429|364712730|FG008|Overall Study|Death|0|||
105742414|NCT01781429|364712731|FG009|Overall Study|Death|1|||
105742415|NCT01781429|364712732|FG010|Overall Study|Death|0|||
105742416|NCT01781429|364712733|FG011|Overall Study|Death|0|||
105742417|NCT01781429|364712734|FG012|Overall Study|Death|1|||
105742418|NCT01781429|364712735|FG013|Overall Study|Death|0|||
105742419|NCT01781429|364712736|FG014|Overall Study|Death|1|||
105742420|NCT01781429|364712737|FG015|Overall Study|Death|0|||
105742421|NCT01781429|364712722|FG000|Overall Study|Withdrawal by Subject|0|||
105742422|NCT01781429|364712723|FG001|Overall Study|Withdrawal by Subject|0|||
105742423|NCT01781429|364712724|FG002|Overall Study|Withdrawal by Subject|0|||
105742424|NCT01781429|364712725|FG003|Overall Study|Withdrawal by Subject|0|||
105742425|NCT01781429|364712726|FG004|Overall Study|Withdrawal by Subject|0|||
105742426|NCT01781429|364712727|FG005|Overall Study|Withdrawal by Subject|0|||
105742427|NCT01781429|364712728|FG006|Overall Study|Withdrawal by Subject|0|||
105742428|NCT01781429|364712729|FG007|Overall Study|Withdrawal by Subject|0|||
105742429|NCT01781429|364712730|FG008|Overall Study|Withdrawal by Subject|1|||
105742430|NCT01781429|364712731|FG009|Overall Study|Withdrawal by Subject|3|||
105742431|NCT01781429|364712732|FG010|Overall Study|Withdrawal by Subject|1|||
105742432|NCT01781429|364712733|FG011|Overall Study|Withdrawal by Subject|1|||
105742433|NCT01781429|364712734|FG012|Overall Study|Withdrawal by Subject|5|||
105742434|NCT01781429|364712735|FG013|Overall Study|Withdrawal by Subject|2|||
105483042|NCT01431638|363780857|FG001|Overall Study|Adverse Event|3|||
105483043|NCT01431638|363780858|FG002|Overall Study|Adverse Event|1|||
105483044|NCT01431638|363780856|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105742435|NCT01781429|364712736|FG014|Overall Study|Withdrawal by Subject|3|||
105742436|NCT01781429|364712737|FG015|Overall Study|Withdrawal by Subject|0|||
105742437|NCT01781429|364712722|FG000|Overall Study|Disease Progression|1|||
105742438|NCT01781429|364712723|FG001|Overall Study|Disease Progression|0|||
105742439|NCT01781429|364712724|FG002|Overall Study|Disease Progression|1|||
105742440|NCT01781429|364712725|FG003|Overall Study|Disease Progression|1|||
105742441|NCT01781429|364712726|FG004|Overall Study|Disease Progression|1|||
105742442|NCT01781429|364712727|FG005|Overall Study|Disease Progression|4|||
105742443|NCT01781429|364712728|FG006|Overall Study|Disease Progression|7|||
105742444|NCT01781429|364712729|FG007|Overall Study|Disease Progression|4|||
105742445|NCT01781429|364712730|FG008|Overall Study|Disease Progression|6|||
105742446|NCT01781429|364712731|FG009|Overall Study|Disease Progression|15|||
105742447|NCT01781429|364712732|FG010|Overall Study|Disease Progression|15|||
105742448|NCT01781429|364712733|FG011|Overall Study|Disease Progression|15|||
105742449|NCT01781429|364712734|FG012|Overall Study|Disease Progression|15|||
105742450|NCT01781429|364712735|FG013|Overall Study|Disease Progression|4|||
105742451|NCT01781429|364712736|FG014|Overall Study|Disease Progression|11|||
105358767|NCT01502033|363319048|FG000|Overall Study|1 participant had worsening depression|1|||
105358768|NCT01502033|363319048|FG000|Overall Study|1 participant went back to school|1|||
105358769|NCT01808261|363319049|FG000|Overall Study|Physician Decision|0|||
105358770|NCT01808261|363319050|FG001|Overall Study|Physician Decision|2|||
105358771|NCT01808261|363319049|FG000|Overall Study|Study Closed/Terminated|25|||
105358772|NCT01808261|363319050|FG001|Overall Study|Study Closed/Terminated|23|||
105358773|NCT01808261|363319049|FG000|Overall Study|Adverse event, non-fatal|2|||
105358774|NCT01808261|363319050|FG001|Overall Study|Adverse event, non-fatal|0|||
105358775|NCT01808261|363319049|FG000|Overall Study|Consent withdrawn by subject|6|||
105358776|NCT01808261|363319050|FG001|Overall Study|Consent withdrawn by subject|7|||
105358777|NCT01808261|363319049|FG000|Overall Study|Lost to Follow-up|3|||
105358778|NCT01808261|363319050|FG001|Overall Study|Lost to Follow-up|1|||
105358779|NCT02585713|363319052|FG000|Overall Study|Withdrew prior to treatment|2|||
105358780|NCT02585713|363319053|FG001|Overall Study|Withdrew prior to treatment|7|||
105358781|NCT02585713|363319052|FG000|Overall Study|Other|3|||
105358782|NCT02585713|363319053|FG001|Overall Study|Other|1|||
105358783|NCT03173456|363319054|FG000|Baseline|Medication dispensing system malfunction'|0|||
105358784|NCT03173456|363319055|FG001|Baseline|Medication dispensing system malfunction'|1|||
105358785|NCT03173456|363319056|FG002|Baseline|Medication dispensing system malfunction'|0|||
105358786|NCT03173456|363319057|FG003|Baseline|Medication dispensing system malfunction'|0|||
105358787|NCT03173456|363319058|FG004|Baseline|Medication dispensing system malfunction'|2|||
105358788|NCT03173456|363319054|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
105358789|NCT03173456|363319055|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
105358790|NCT03173456|363319056|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
105358791|NCT03173456|363319057|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
105358792|NCT03173456|363319058|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
105358793|NCT01733121|363319059|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
105358794|NCT01733121|363319060|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
105358795|NCT01733121|363319059|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
105358796|NCT01733121|363319060|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
105358797|NCT01733121|363319059|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
105358798|NCT01733121|363319060|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
105358799|NCT01733121|363319059|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
105358800|NCT01733121|363319060|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
105358801|NCT02504320|363319067|FG000|Treatment Period 1|Positive Drug Screen|0|||
105358802|NCT02504320|363319068|FG001|Treatment Period 1|Positive Drug Screen|0|||
105358803|NCT02504320|363319069|FG002|Treatment Period 1|Positive Drug Screen|1|||
105358804|NCT02504320|363319070|FG003|Treatment Period 1|Positive Drug Screen|0|||
105358805|NCT02504320|363319067|FG000|Treatment Period 2|Positive Drug Screen|0|||
105358806|NCT02504320|363319068|FG001|Treatment Period 2|Positive Drug Screen|1|||
105358807|NCT02504320|363319069|FG002|Treatment Period 2|Positive Drug Screen|0|||
105358808|NCT02504320|363319070|FG003|Treatment Period 2|Positive Drug Screen|0|||
105358809|NCT02504320|363319067|FG000|Treatment Period 3|Positive Drug Screen|0|||
105483045|NCT01431638|363780857|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105358810|NCT02504320|363319068|FG001|Treatment Period 3|Positive Drug Screen|0|||
105358811|NCT02504320|363319069|FG002|Treatment Period 3|Positive Drug Screen|0|||
105358812|NCT02504320|363319070|FG003|Treatment Period 3|Positive Drug Screen|1|||
105358813|NCT02504320|363319067|FG000|Treatment Period 3|Adverse Event|0|||
105358814|NCT02504320|363319068|FG001|Treatment Period 3|Adverse Event|0|||
105358815|NCT02504320|363319069|FG002|Treatment Period 3|Adverse Event|1|||
105358816|NCT02504320|363319070|FG003|Treatment Period 3|Adverse Event|0|||
105483046|NCT01431638|363780858|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
105483047|NCT01431638|363780856|FG000|Overall Study|Participants condition no longer requires study drug|0|||
105358817|NCT01436227|363319078|FG000|Overall Study|Adverse Event|7|||
105358818|NCT01436227|363319078|FG000|Overall Study|Death|1|||
105742452|NCT01781429|364712737|FG015|Overall Study|Disease Progression|0|||
105742453|NCT01781429|364712722|FG000|Overall Study|Unacceptable Toxicity|0|||
105742454|NCT01781429|364712723|FG001|Overall Study|Unacceptable Toxicity|0|||
105742455|NCT01781429|364712724|FG002|Overall Study|Unacceptable Toxicity|0|||
105742456|NCT01781429|364712725|FG003|Overall Study|Unacceptable Toxicity|0|||
105742457|NCT01781429|364712726|FG004|Overall Study|Unacceptable Toxicity|0|||
105742458|NCT01781429|364712727|FG005|Overall Study|Unacceptable Toxicity|0|||
105742459|NCT01781429|364712728|FG006|Overall Study|Unacceptable Toxicity|0|||
105742460|NCT01781429|364712729|FG007|Overall Study|Unacceptable Toxicity|0|||
105742461|NCT01781429|364712730|FG008|Overall Study|Unacceptable Toxicity|0|||
105742462|NCT01781429|364712731|FG009|Overall Study|Unacceptable Toxicity|0|||
105742463|NCT01781429|364712732|FG010|Overall Study|Unacceptable Toxicity|0|||
105742464|NCT01781429|364712733|FG011|Overall Study|Unacceptable Toxicity|2|||
105742465|NCT01781429|364712734|FG012|Overall Study|Unacceptable Toxicity|0|||
105742466|NCT01781429|364712735|FG013|Overall Study|Unacceptable Toxicity|0|||
105742467|NCT01781429|364712736|FG014|Overall Study|Unacceptable Toxicity|0|||
105742468|NCT01781429|364712737|FG015|Overall Study|Unacceptable Toxicity|0|||
105742469|NCT01781429|364712722|FG000|Overall Study|Patient Condition Changed|0|||
105742470|NCT01781429|364712723|FG001|Overall Study|Patient Condition Changed|0|||
105742471|NCT01781429|364712724|FG002|Overall Study|Patient Condition Changed|0|||
105742472|NCT01781429|364712725|FG003|Overall Study|Patient Condition Changed|0|||
105742473|NCT01781429|364712726|FG004|Overall Study|Patient Condition Changed|0|||
105742474|NCT01781429|364712727|FG005|Overall Study|Patient Condition Changed|0|||
105742475|NCT01781429|364712728|FG006|Overall Study|Patient Condition Changed|0|||
105742476|NCT01781429|364712729|FG007|Overall Study|Patient Condition Changed|0|||
105742477|NCT01781429|364712730|FG008|Overall Study|Patient Condition Changed|0|||
105742478|NCT01781429|364712731|FG009|Overall Study|Patient Condition Changed|4|||
105742479|NCT01781429|364712732|FG010|Overall Study|Patient Condition Changed|0|||
105742480|NCT01781429|364712733|FG011|Overall Study|Patient Condition Changed|1|||
105742481|NCT01781429|364712734|FG012|Overall Study|Patient Condition Changed|0|||
105742482|NCT01781429|364712735|FG013|Overall Study|Patient Condition Changed|1|||
105742483|NCT01781429|364712736|FG014|Overall Study|Patient Condition Changed|0|||
105742484|NCT01781429|364712737|FG015|Overall Study|Patient Condition Changed|0|||
105742485|NCT01781429|364712722|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
105742486|NCT01781429|364712723|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
105742487|NCT01781429|364712724|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
105742488|NCT01781429|364712725|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
105742489|NCT01781429|364712726|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
105742490|NCT01781429|364712727|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
105742491|NCT01781429|364712728|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
105742492|NCT01781429|364712729|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
105742493|NCT01781429|364712730|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
105742494|NCT01781429|364712731|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
105742495|NCT01781429|364712732|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
105742496|NCT01781429|364712733|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
105742497|NCT01781429|364712734|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
105742498|NCT01781429|364712735|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
105742499|NCT01781429|364712736|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
105742500|NCT01781429|364712737|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
105742501|NCT01781429|364712722|FG000|Overall Study|Enrolled, but not treated|0|||
105742502|NCT01781429|364712723|FG001|Overall Study|Enrolled, but not treated|0|||
105742503|NCT01781429|364712724|FG002|Overall Study|Enrolled, but not treated|0|||
105742504|NCT01781429|364712725|FG003|Overall Study|Enrolled, but not treated|0|||
105742505|NCT01781429|364712726|FG004|Overall Study|Enrolled, but not treated|0|||
105742506|NCT01781429|364712727|FG005|Overall Study|Enrolled, but not treated|0|||
105742507|NCT01781429|364712728|FG006|Overall Study|Enrolled, but not treated|0|||
105742508|NCT01781429|364712729|FG007|Overall Study|Enrolled, but not treated|0|||
105742509|NCT01781429|364712730|FG008|Overall Study|Enrolled, but not treated|0|||
105742510|NCT01781429|364712731|FG009|Overall Study|Enrolled, but not treated|0|||
105742511|NCT01781429|364712732|FG010|Overall Study|Enrolled, but not treated|1|||
105742512|NCT01781429|364712733|FG011|Overall Study|Enrolled, but not treated|0|||
105742513|NCT01781429|364712734|FG012|Overall Study|Enrolled, but not treated|0|||
105800240|NCT00830063|364926418|FG002|Overall Study|Death|0|||
105800241|NCT00830063|364926419|FG003|Overall Study|Death|0|||
105742514|NCT01781429|364712735|FG013|Overall Study|Enrolled, but not treated|0|||
105742515|NCT01781429|364712736|FG014|Overall Study|Enrolled, but not treated|0|||
105742516|NCT01781429|364712737|FG015|Overall Study|Enrolled, but not treated|0|||
105742517|NCT02678741|364712738|FG000|Overall Study|Death|4|||
105742518|NCT02678741|364712738|FG000|Overall Study|Withdrawal by Subject|1|||
105742519|NCT02678741|364712738|FG000|Overall Study|ineligible|3|||
105742520|NCT02678741|364712738|FG000|Overall Study|Not RECIST Measurable|2|||
105742521|NCT02678741|364712738|FG000|Overall Study|Lack of Efficacy|10|||
105742522|NCT01725152|364712739|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
105742523|NCT01725152|364712740|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
105742524|NCT01725152|364712739|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
105742525|NCT01725152|364712740|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
105742526|NCT01725152|364712739|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
105742527|NCT01725152|364712740|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
105742528|NCT01725152|364712739|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
105742529|NCT01725152|364712740|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
105742530|NCT03539458|364712744|FG000|Overall Study|Death|1|||
105742531|NCT01202227|364712751|FG000|Overall Study|Adverse Event|16|||
105742532|NCT01202227|364712751|FG000|Overall Study|Withdrawal by Subject|2|||
105742533|NCT01202227|364712751|FG000|Overall Study|Lack of Efficacy|1|||
105742534|NCT00365716|364712754|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
105742535|NCT00365716|364712755|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
105742536|NCT00365716|364712756|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
105742537|NCT00365716|364712757|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
105742538|NCT00365716|364712758|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
105742539|NCT00365716|364712759|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
105742540|NCT00365716|364712760|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
105742541|NCT00365716|364712754|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
105742542|NCT00365716|364712755|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
105742543|NCT00365716|364712756|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
105742544|NCT00365716|364712757|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
105742545|NCT00365716|364712758|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
105742546|NCT00365716|364712759|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
105742547|NCT00365716|364712760|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
105742548|NCT00365716|364712754|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
105742549|NCT00365716|364712755|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
105742550|NCT00365716|364712756|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
105742551|NCT00365716|364712757|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
105742552|NCT00365716|364712758|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
105742553|NCT00365716|364712759|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
105742554|NCT00365716|364712760|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
105742555|NCT00365716|364712754|FG000|Base Study (Day 1 to Month 7)|Other|0|||
105742556|NCT00365716|364712755|FG001|Base Study (Day 1 to Month 7)|Other|1|||
105742557|NCT00365716|364712756|FG002|Base Study (Day 1 to Month 7)|Other|0|||
105742558|NCT00365716|364712757|FG003|Base Study (Day 1 to Month 7)|Other|0|||
105742559|NCT00365716|364712758|FG004|Base Study (Day 1 to Month 7)|Other|0|||
105742560|NCT00365716|364712759|FG005|Base Study (Day 1 to Month 7)|Other|0|||
105742561|NCT00365716|364712760|FG006|Base Study (Day 1 to Month 7)|Other|0|||
105742562|NCT00365716|364712754|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
105742563|NCT00365716|364712755|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
105742564|NCT00365716|364712756|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
105742565|NCT00365716|364712757|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
105742566|NCT00365716|364712758|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
105742567|NCT00365716|364712759|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
105742568|NCT00365716|364712760|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
105742569|NCT00365716|364712754|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
105742570|NCT00365716|364712755|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
105742571|NCT00365716|364712756|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
105742572|NCT00365716|364712757|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
105742573|NCT00365716|364712758|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
105742574|NCT00365716|364712759|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
105742575|NCT00365716|364712760|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
105742576|NCT00365716|364712754|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
105742577|NCT00365716|364712755|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
105742578|NCT00365716|364712756|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
105742579|NCT00365716|364712757|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
105742580|NCT00365716|364712758|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
105742581|NCT00365716|364712759|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
105742582|NCT00365716|364712760|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
105742583|NCT00365716|364712754|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
105742584|NCT00365716|364712755|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
105742585|NCT00365716|364712756|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
105742586|NCT00365716|364712757|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
105742587|NCT00365716|364712758|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
105565320|NCT02889133|364066736|FG001|Completed Primary Outcome|Protocol Violation|0|||
105742588|NCT00365716|364712759|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
105742589|NCT00365716|364712760|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
105742590|NCT00365716|364712754|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
105742591|NCT00365716|364712755|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
105742592|NCT00365716|364712756|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
105742593|NCT00365716|364712757|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
105742594|NCT00365716|364712758|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
105742595|NCT00365716|364712759|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
105742596|NCT00365716|364712760|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
105742597|NCT00365716|364712754|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
105742598|NCT00365716|364712755|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
105742599|NCT00365716|364712756|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
105742600|NCT00365716|364712757|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
105742601|NCT00365716|364712758|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
105742602|NCT00365716|364712759|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
105742603|NCT00365716|364712760|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
105742604|NCT00365716|364712754|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
105742605|NCT00365716|364712755|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
105742606|NCT00365716|364712756|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
105742607|NCT00365716|364712757|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
105742608|NCT00365716|364712758|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
105742609|NCT00365716|364712759|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
105742610|NCT00365716|364712760|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
105742611|NCT00365716|364712754|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
105742612|NCT00365716|364712755|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
105742613|NCT00365716|364712756|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
105742614|NCT00365716|364712757|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
105742615|NCT00365716|364712758|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
105742616|NCT00365716|364712759|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
105742617|NCT00365716|364712760|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
105742618|NCT00365716|364712754|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
105742619|NCT00365716|364712755|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
105742620|NCT00365716|364712756|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
105742621|NCT00365716|364712757|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
105742622|NCT00365716|364712758|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
105742623|NCT00365716|364712759|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
105742624|NCT00365716|364712760|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
105742625|NCT00365716|364712754|FG000|Extension 1|Lost to Follow-up|0|||
105742626|NCT00365716|364712755|FG001|Extension 1|Lost to Follow-up|0|||
105742627|NCT00365716|364712756|FG002|Extension 1|Lost to Follow-up|0|||
105742628|NCT00365716|364712757|FG003|Extension 1|Lost to Follow-up|0|||
105742629|NCT00365716|364712758|FG004|Extension 1|Lost to Follow-up|0|||
105742630|NCT00365716|364712759|FG005|Extension 1|Lost to Follow-up|1|||
105742631|NCT00365716|364712760|FG006|Extension 1|Lost to Follow-up|0|||
105742632|NCT00365716|364712754|FG000|Extension 1|Other|0|||
105742633|NCT00365716|364712755|FG001|Extension 1|Other|0|||
105742634|NCT00365716|364712756|FG002|Extension 1|Other|0|||
105742635|NCT00365716|364712757|FG003|Extension 1|Other|0|||
105742636|NCT00365716|364712758|FG004|Extension 1|Other|0|||
105358819|NCT01436227|363319078|FG000|Overall Study|Lack of Efficacy|1|||
105742637|NCT00365716|364712759|FG005|Extension 1|Other|9|||
105742638|NCT00365716|364712760|FG006|Extension 1|Other|0|||
105742639|NCT00365716|364712754|FG000|Extension 1|Moved|0|||
105742640|NCT00365716|364712755|FG001|Extension 1|Moved|0|||
105742641|NCT00365716|364712756|FG002|Extension 1|Moved|0|||
105742642|NCT00365716|364712757|FG003|Extension 1|Moved|0|||
105358820|NCT01436227|363319078|FG000|Overall Study|Lost to Follow-up|3|||
105742643|NCT00365716|364712758|FG004|Extension 1|Moved|0|||
105742644|NCT00365716|364712759|FG005|Extension 1|Moved|4|||
105742645|NCT00365716|364712760|FG006|Extension 1|Moved|0|||
105358821|NCT01436227|363319078|FG000|Overall Study|Physician Decision|1|||
105358822|NCT01436227|363319078|FG000|Overall Study|Withdrawal by Subject|7|||
105358823|NCT01436227|363319078|FG000|Overall Study|Disease progression, relapse|6|||
105358824|NCT04004260|363319079|FG000|Overall Study|Withdrawal by Subject|7|||
105358825|NCT04004260|363319080|FG001|Overall Study|Withdrawal by Subject|3|||
105358826|NCT04004260|363319079|FG000|Overall Study|Lost to Follow-up|22|||
105358827|NCT04004260|363319080|FG001|Overall Study|Lost to Follow-up|12|||
105358828|NCT04004260|363319079|FG000|Overall Study|Did not engage in intervention|13|||
105358829|NCT04004260|363319080|FG001|Overall Study|Did not engage in intervention|17|||
105358830|NCT03414229|363319081|FG000|Overall Study|Adverse Event|1|||
105358831|NCT03414229|363319082|FG001|Overall Study|Adverse Event|0|||
105358832|NCT03414229|363319083|FG002|Overall Study|Adverse Event|2|||
105358833|NCT03414229|363319084|FG003|Overall Study|Adverse Event|1|||
105358834|NCT03414229|363319081|FG000|Overall Study|Lack of Efficacy|7|||
105358835|NCT03414229|363319082|FG001|Overall Study|Lack of Efficacy|4|||
105358836|NCT03414229|363319083|FG002|Overall Study|Lack of Efficacy|1|||
105358837|NCT03414229|363319084|FG003|Overall Study|Lack of Efficacy|9|||
105358838|NCT03414229|363319081|FG000|Overall Study|Change in therapy|1|||
105358839|NCT03414229|363319082|FG001|Overall Study|Change in therapy|0|||
105358840|NCT03414229|363319083|FG002|Overall Study|Change in therapy|0|||
105358841|NCT03414229|363319084|FG003|Overall Study|Change in therapy|0|||
105358842|NCT03414229|363319081|FG000|Overall Study|Pregnancy|0|||
105358843|NCT03414229|363319082|FG001|Overall Study|Pregnancy|0|||
105358844|NCT03414229|363319083|FG002|Overall Study|Pregnancy|1|||
105358845|NCT03414229|363319084|FG003|Overall Study|Pregnancy|0|||
105358846|NCT03414229|363319081|FG000|Overall Study|Withdrawal by Subject|0|||
105483048|NCT01431638|363780857|FG001|Overall Study|Participants condition no longer requires study drug|1|||
105742646|NCT00365716|364712754|FG000|Extension 1|Withdrawal by Subject|0|||
105742647|NCT00365716|364712755|FG001|Extension 1|Withdrawal by Subject|0|||
105742648|NCT00365716|364712756|FG002|Extension 1|Withdrawal by Subject|0|||
105742649|NCT00365716|364712757|FG003|Extension 1|Withdrawal by Subject|0|||
105742650|NCT00365716|364712758|FG004|Extension 1|Withdrawal by Subject|0|||
105742651|NCT00365716|364712759|FG005|Extension 1|Withdrawal by Subject|3|||
105742652|NCT00365716|364712760|FG006|Extension 1|Withdrawal by Subject|0|||
105742653|NCT00365716|364712754|FG000|Extension 1|Pregnancy|0|||
105742654|NCT00365716|364712755|FG001|Extension 1|Pregnancy|0|||
105742655|NCT00365716|364712756|FG002|Extension 1|Pregnancy|0|||
105742656|NCT00365716|364712757|FG003|Extension 1|Pregnancy|0|||
105742657|NCT00365716|364712758|FG004|Extension 1|Pregnancy|0|||
105742658|NCT00365716|364712759|FG005|Extension 1|Pregnancy|4|||
105742659|NCT00365716|364712760|FG006|Extension 1|Pregnancy|0|||
105742660|NCT00365716|364712754|FG000|Extension 1|Protocol Violation|0|||
105742661|NCT00365716|364712755|FG001|Extension 1|Protocol Violation|0|||
105742662|NCT00365716|364712756|FG002|Extension 1|Protocol Violation|0|||
105742663|NCT00365716|364712757|FG003|Extension 1|Protocol Violation|0|||
105742664|NCT00365716|364712758|FG004|Extension 1|Protocol Violation|0|||
105742665|NCT00365716|364712759|FG005|Extension 1|Protocol Violation|1|||
105742666|NCT00365716|364712760|FG006|Extension 1|Protocol Violation|0|||
105742667|NCT00365716|364712754|FG000|Extension 2|Lost to Follow-up|0|||
105742668|NCT00365716|364712755|FG001|Extension 2|Lost to Follow-up|0|||
105742669|NCT00365716|364712756|FG002|Extension 2|Lost to Follow-up|0|||
105742670|NCT00365716|364712757|FG003|Extension 2|Lost to Follow-up|0|||
105742671|NCT00365716|364712758|FG004|Extension 2|Lost to Follow-up|0|||
105742672|NCT00365716|364712759|FG005|Extension 2|Lost to Follow-up|0|||
105742673|NCT00365716|364712760|FG006|Extension 2|Lost to Follow-up|2|||
105742674|NCT00365716|364712754|FG000|Extension 2|Other|0|||
105742675|NCT00365716|364712755|FG001|Extension 2|Other|0|||
105742676|NCT00365716|364712756|FG002|Extension 2|Other|0|||
105742677|NCT00365716|364712757|FG003|Extension 2|Other|0|||
105742678|NCT00365716|364712758|FG004|Extension 2|Other|0|||
105742679|NCT00365716|364712759|FG005|Extension 2|Other|0|||
105742680|NCT00365716|364712760|FG006|Extension 2|Other|3|||
105742681|NCT00365716|364712754|FG000|Extension 2|Withdrawal by Subject|0|||
105358847|NCT03414229|363319082|FG001|Overall Study|Withdrawal by Subject|1|||
105358848|NCT03414229|363319083|FG002|Overall Study|Withdrawal by Subject|1|||
105483049|NCT01431638|363780858|FG002|Overall Study|Participants condition no longer requires study drug|0|||
105358849|NCT03414229|363319084|FG003|Overall Study|Withdrawal by Subject|0|||
105358850|NCT04533438|363319085|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
105358851|NCT04533438|363319086|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
105358852|NCT02797678|363319113|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
105358853|NCT02797678|363319114|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
105742682|NCT00365716|364712755|FG001|Extension 2|Withdrawal by Subject|0|||
105742683|NCT00365716|364712756|FG002|Extension 2|Withdrawal by Subject|0|||
105742684|NCT00365716|364712757|FG003|Extension 2|Withdrawal by Subject|0|||
105742685|NCT00365716|364712758|FG004|Extension 2|Withdrawal by Subject|0|||
105742686|NCT00365716|364712759|FG005|Extension 2|Withdrawal by Subject|0|||
105742687|NCT00365716|364712760|FG006|Extension 2|Withdrawal by Subject|5|||
105742688|NCT00913978|364712761|FG000|Overall Study|Surgeon choice|1|||
105742689|NCT00913978|364712762|FG001|Overall Study|Surgeon choice|3|||
105742690|NCT00316303|364712763|FG000|Overall Study|Lost to Follow-up|11|||
105483050|NCT01431638|363780856|FG000|Overall Study|Participant withdrew consent|14|||
105742691|NCT00316303|364712764|FG001|Overall Study|Lost to Follow-up|16|||
105742692|NCT01753076|364712767|FG000|Overall Study|Adverse Event|17|||
105742693|NCT01753076|364712768|FG001|Overall Study|Adverse Event|18|||
105742694|NCT01753076|364712767|FG000|Overall Study|Lack of Efficacy|3|||
105742695|NCT01753076|364712768|FG001|Overall Study|Lack of Efficacy|1|||
105742696|NCT01753076|364712767|FG000|Overall Study|Lost to Follow-up|2|||
105742697|NCT01753076|364712768|FG001|Overall Study|Lost to Follow-up|1|||
105742698|NCT01753076|364712767|FG000|Overall Study|Physician Decision|4|||
105742699|NCT01753076|364712768|FG001|Overall Study|Physician Decision|2|||
105742700|NCT01753076|364712767|FG000|Overall Study|Withdrawal by Subject|14|||
105742701|NCT01753076|364712768|FG001|Overall Study|Withdrawal by Subject|24|||
105742702|NCT01753076|364712767|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
105742703|NCT01753076|364712768|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
105742704|NCT02575079|364712769|FG000|Overall Study|Death|3|||
105742705|NCT02575079|364712770|FG001|Overall Study|Death|0|||
105742706|NCT02575079|364712769|FG000|Overall Study|Withdrawal by Subject|3|||
105742707|NCT02575079|364712770|FG001|Overall Study|Withdrawal by Subject|0|||
105742708|NCT02918266|364712771|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
105742709|NCT02918266|364712772|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742710|NCT02918266|364712773|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742711|NCT02918266|364712774|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742712|NCT02918266|364712775|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742713|NCT02918266|364712776|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742714|NCT02918266|364712777|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
105742715|NCT02918266|364712778|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742716|NCT02918266|364712779|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
105742717|NCT02918266|364712780|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742718|NCT02918266|364712781|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742719|NCT00471536|364712782|FG000|Overall Study|Withdrawal by Subject|1|||
105742720|NCT01259856|364712789|FG000|Overall Study|Adverse Event|12|||
105742721|NCT01259856|364712790|FG001|Overall Study|Adverse Event|9|||
105742722|NCT01259856|364712789|FG000|Overall Study|Death|0|||
105742723|NCT01259856|364712790|FG001|Overall Study|Death|1|||
105742724|NCT01259856|364712789|FG000|Overall Study|Lack of Efficacy|3|||
105742725|NCT01259856|364712790|FG001|Overall Study|Lack of Efficacy|1|||
105742726|NCT01259856|364712789|FG000|Overall Study|Lost to Follow-up|1|||
105742727|NCT01259856|364712790|FG001|Overall Study|Lost to Follow-up|1|||
105742728|NCT01259856|364712789|FG000|Overall Study|Physician Decision|2|||
105742729|NCT01259856|364712790|FG001|Overall Study|Physician Decision|1|||
105742730|NCT01259856|364712789|FG000|Overall Study|Withdrawal by Subject|9|||
105742731|NCT01259856|364712790|FG001|Overall Study|Withdrawal by Subject|10|||
105742732|NCT01259856|364712789|FG000|Overall Study|Treatment never started|0|||
105742733|NCT01259856|364712790|FG001|Overall Study|Treatment never started|6|||
105742734|NCT01259856|364712789|FG000|Overall Study|Study closure by sponsor|40|||
105742735|NCT01259856|364712790|FG001|Overall Study|Study closure by sponsor|41|||
105742736|NCT01259856|364712789|FG000|Overall Study|Patient developed other disease|0|||
105742737|NCT01259856|364712790|FG001|Overall Study|Patient developed other disease|1|||
105742738|NCT01259856|364712789|FG000|Overall Study|Transfer to another study|0|||
105742739|NCT01259856|364712790|FG001|Overall Study|Transfer to another study|1|||
105742740|NCT01259856|364712789|FG000|Overall Study|Unknown/missing|2|||
105742741|NCT01259856|364712790|FG001|Overall Study|Unknown/missing|2|||
105742742|NCT01860534|364712793|FG000|ROP #1|Needed treatment for ROP|0|||
105742743|NCT01860534|364712794|FG001|ROP #1|Needed treatment for ROP|1|||
105742744|NCT01860534|364712793|FG000|ROP #2|discharged prior to ROP #2|1|||
105742745|NCT01860534|364712794|FG001|ROP #2|discharged prior to ROP #2|0|||
105742746|NCT00788775|364712795|FG000|Overall Study|Progressive Disease|8|||
105742747|NCT00788775|364712796|FG001|Overall Study|Progressive Disease|6|||
105742748|NCT00788775|364712795|FG000|Overall Study|Withdrawal by Subject|0|||
105742749|NCT00788775|364712796|FG001|Overall Study|Withdrawal by Subject|2|||
105742750|NCT00788775|364712795|FG000|Overall Study|Patient Non-Compliance|1|||
105742751|NCT00788775|364712796|FG001|Overall Study|Patient Non-Compliance|0|||
105742752|NCT00788775|364712795|FG000|Overall Study|Patient's measurable disease resected.|1|||
105742753|NCT00788775|364712796|FG001|Overall Study|Patient's measurable disease resected.|0|||
105742754|NCT00578864|364712797|FG000|Overall Study|Death|1|||
105742755|NCT00578864|364712798|FG001|Overall Study|Death|0|||
105742756|NCT01702363|364712799|FG000|Overall Study|Adverse Event|14|||
105742757|NCT01702363|364712799|FG000|Overall Study|Lack of Efficacy|4|||
105742758|NCT01702363|364712799|FG000|Overall Study|Withdrawal by Subject|2|||
105742759|NCT00905307|364712800|FG000|Overall Study|Switched to Open Label Rescue|7|||
105742760|NCT00905307|364712801|FG001|Overall Study|Switched to Open Label Rescue|17|||
105742761|NCT00905307|364712802|FG002|Overall Study|Switched to Open Label Rescue|11|||
105742762|NCT00905307|364712803|FG003|Overall Study|Switched to Open Label Rescue|11|||
105742763|NCT00905307|364712804|FG004|Overall Study|Switched to Open Label Rescue|4|||
105742764|NCT00905307|364712805|FG005|Overall Study|Switched to Open Label Rescue|15|||
105742765|NCT00905307|364712800|FG000|Overall Study|Lost to Follow-up|0|||
105742766|NCT00905307|364712801|FG001|Overall Study|Lost to Follow-up|0|||
105742767|NCT00905307|364712802|FG002|Overall Study|Lost to Follow-up|0|||
105742768|NCT00905307|364712803|FG003|Overall Study|Lost to Follow-up|0|||
105742769|NCT00905307|364712804|FG004|Overall Study|Lost to Follow-up|1|||
105742770|NCT00905307|364712805|FG005|Overall Study|Lost to Follow-up|1|||
105742771|NCT00905307|364712800|FG000|Overall Study|Adverse Event|3|||
105742772|NCT00905307|364712801|FG001|Overall Study|Adverse Event|4|||
105742773|NCT00905307|364712802|FG002|Overall Study|Adverse Event|5|||
105742774|NCT00905307|364712803|FG003|Overall Study|Adverse Event|11|||
105742775|NCT00905307|364712804|FG004|Overall Study|Adverse Event|3|||
105742776|NCT00905307|364712805|FG005|Overall Study|Adverse Event|5|||
105742777|NCT00905307|364712800|FG000|Overall Study|Withdrawal by Subject|5|||
105358854|NCT02797678|363319115|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
105742778|NCT00905307|364712801|FG001|Overall Study|Withdrawal by Subject|13|||
105742779|NCT00905307|364712802|FG002|Overall Study|Withdrawal by Subject|15|||
105742780|NCT00905307|364712803|FG003|Overall Study|Withdrawal by Subject|11|||
105742781|NCT00905307|364712804|FG004|Overall Study|Withdrawal by Subject|4|||
105742782|NCT00905307|364712805|FG005|Overall Study|Withdrawal by Subject|13|||
105742783|NCT00905307|364712800|FG000|Overall Study|Protocol Violation|1|||
105742784|NCT00905307|364712801|FG001|Overall Study|Protocol Violation|0|||
105742785|NCT00905307|364712802|FG002|Overall Study|Protocol Violation|1|||
105742786|NCT00905307|364712803|FG003|Overall Study|Protocol Violation|0|||
105742787|NCT00905307|364712804|FG004|Overall Study|Protocol Violation|0|||
105742788|NCT00905307|364712805|FG005|Overall Study|Protocol Violation|0|||
105742789|NCT00905307|364712800|FG000|Overall Study|Lack of Efficacy|6|||
105742790|NCT00905307|364712801|FG001|Overall Study|Lack of Efficacy|3|||
105742791|NCT00905307|364712802|FG002|Overall Study|Lack of Efficacy|5|||
105742792|NCT00905307|364712803|FG003|Overall Study|Lack of Efficacy|4|||
105358855|NCT02797678|363319116|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
105358856|NCT02797678|363319113|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
105358857|NCT02797678|363319114|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
105358858|NCT02797678|363319115|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
105358859|NCT02797678|363319116|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
105358860|NCT02797678|363319113|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
105358861|NCT02797678|363319114|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
105358862|NCT02797678|363319115|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
105358863|NCT02797678|363319116|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
105358864|NCT04039204|363319121|FG000|Overall Study|Withdrawal by Subject|0|||
105358865|NCT04039204|363319122|FG001|Overall Study|Withdrawal by Subject|2|||
105358866|NCT03538691|363319123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
105358867|NCT03538691|363319124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
105358868|NCT03538691|363319125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
105358869|NCT03538691|363319126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
105358870|NCT03538691|363319123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
105358871|NCT03538691|363319124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
105742793|NCT00905307|364712804|FG004|Overall Study|Lack of Efficacy|4|||
105742794|NCT00905307|364712805|FG005|Overall Study|Lack of Efficacy|8|||
105742795|NCT01201798|364712809|FG000|Overall Study|Adverse Event|2|||
105742796|NCT01201798|364712810|FG001|Overall Study|Adverse Event|0|||
105742797|NCT01201798|364712809|FG000|Overall Study|Lost to Follow-up|3|||
105742798|NCT01201798|364712810|FG001|Overall Study|Lost to Follow-up|5|||
105742799|NCT01201798|364712809|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
105358872|NCT03538691|363319125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
105358873|NCT03538691|363319126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
105358874|NCT03538691|363319123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
105358875|NCT03538691|363319124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
105358876|NCT03538691|363319125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
105358877|NCT03538691|363319126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
105358878|NCT03538691|363319123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
105358879|NCT03538691|363319124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
105358880|NCT03538691|363319125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
105358881|NCT03538691|363319126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
105358882|NCT03538691|363319123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
105358883|NCT03538691|363319124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
105358884|NCT03538691|363319125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
105358885|NCT03538691|363319126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
105358886|NCT03538691|363319123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
105358887|NCT03538691|363319124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
105358888|NCT03538691|363319125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
105358889|NCT03538691|363319126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
105358890|NCT03538691|363319123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
105358891|NCT03538691|363319124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
105358892|NCT03538691|363319125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
105358893|NCT03538691|363319126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
105742800|NCT01201798|364712810|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
105742801|NCT01201798|364712809|FG000|Overall Study|Noncompliance|1|||
105742802|NCT01201798|364712810|FG001|Overall Study|Noncompliance|0|||
105742803|NCT01201798|364712809|FG000|Overall Study|Protocol Violation|1|||
105742804|NCT01201798|364712810|FG001|Overall Study|Protocol Violation|1|||
105742805|NCT01201798|364712809|FG000|Overall Study|Treatment Failure|1|||
105742806|NCT01201798|364712810|FG001|Overall Study|Treatment Failure|8|||
105742807|NCT00525148|364712811|FG000|Overall Study|Other Adverse Event|3|||
105742808|NCT00525148|364712812|FG001|Overall Study|Other Adverse Event|5|||
105742809|NCT00525148|364712813|FG002|Overall Study|Other Adverse Event|1|||
105742810|NCT00525148|364712814|FG003|Overall Study|Other Adverse Event|8|||
105742811|NCT00525148|364712811|FG000|Overall Study|Progressive disease|18|||
105742812|NCT00525148|364712812|FG001|Overall Study|Progressive disease|30|||
105742813|NCT00525148|364712813|FG002|Overall Study|Progressive disease|6|||
105742814|NCT00525148|364712814|FG003|Overall Study|Progressive disease|49|||
105742815|NCT00525148|364712811|FG000|Overall Study|Refused continuation of study medication|0|||
105742816|NCT00525148|364712812|FG001|Overall Study|Refused continuation of study medication|2|||
105742817|NCT00525148|364712813|FG002|Overall Study|Refused continuation of study medication|0|||
105742818|NCT00525148|364712814|FG003|Overall Study|Refused continuation of study medication|1|||
105742819|NCT00525148|364712811|FG000|Overall Study|Other than stated|2|||
105742820|NCT00525148|364712812|FG001|Overall Study|Other than stated|1|||
105742821|NCT00525148|364712813|FG002|Overall Study|Other than stated|0|||
105742822|NCT00525148|364712814|FG003|Overall Study|Other than stated|3|||
105483051|NCT01431638|363780857|FG001|Overall Study|Participant withdrew consent|5|||
105742823|NCT01603641|364712815|FG000|Overall Study|Did not Receive Treatment|3|||
105742824|NCT01603641|364712815|FG000|Overall Study|Adverse Event|1|||
105742825|NCT01603641|364712815|FG000|Overall Study|Lack of Efficacy|1|||
105742826|NCT01603641|364712815|FG000|Overall Study|Lost to Follow-up|6|||
105742827|NCT01603641|364712815|FG000|Overall Study|Personal Reasons|18|||
105742828|NCT01603641|364712815|FG000|Overall Study|Other Miscellaneous Reasons|6|||
105742829|NCT00114972|364712822|FG000|Overall Study|Withdrawal by Subject|40|||
105742830|NCT00114972|364712823|FG001|Overall Study|Withdrawal by Subject|7|||
105742831|NCT00114972|364712822|FG000|Overall Study|Lost to Follow-up|8|||
105742832|NCT00114972|364712823|FG001|Overall Study|Lost to Follow-up|5|||
105742833|NCT00830037|364712824|FG000|Overall Study|Withdrawal by Subject|2|||
105742834|NCT00830037|364712825|FG001|Overall Study|Withdrawal by Subject|3|||
105742835|NCT00830037|364712824|FG000|Overall Study|Lost to Follow-up|1|||
105742836|NCT00830037|364712825|FG001|Overall Study|Lost to Follow-up|2|||
105742837|NCT00830037|364712824|FG000|Overall Study|Active when terminated by DSMB|15|||
105742838|NCT00830037|364712825|FG001|Overall Study|Active when terminated by DSMB|14|||
105742839|NCT00752609|364712826|FG000|Overall Study|Adverse Event|2|||
105742840|NCT00752609|364712827|FG001|Overall Study|Adverse Event|2|||
105742841|NCT00752609|364712826|FG000|Overall Study|Withdrawal by Subject|3|||
105742842|NCT00752609|364712827|FG001|Overall Study|Withdrawal by Subject|0|||
105742843|NCT00752609|364712826|FG000|Overall Study|Physician Decision|1|||
105742844|NCT00752609|364712827|FG001|Overall Study|Physician Decision|0|||
105742845|NCT00752609|364712826|FG000|Overall Study|Death|1|||
105742846|NCT00752609|364712827|FG001|Overall Study|Death|0|||
105742847|NCT00752609|364712826|FG000|Overall Study|Met exclusion criteria|1|||
105742848|NCT00752609|364712827|FG001|Overall Study|Met exclusion criteria|0|||
105742849|NCT00752609|364712826|FG000|Overall Study|Received Aranesp in error|1|||
105742850|NCT00752609|364712827|FG001|Overall Study|Received Aranesp in error|0|||
105742851|NCT00938327|364712830|FG000|Overall Study|Adverse Event|2|||
105742852|NCT00938327|364712830|FG000|Overall Study|Protocol Violation|1|||
105742853|NCT00938327|364712830|FG000|Overall Study|Withdrawal by Subject|4|||
105742854|NCT00938327|364712830|FG000|Overall Study|Lost to Follow-up|37|||
105742855|NCT00938327|364712830|FG000|Overall Study|2nd dose received outside of the study|7|||
105742856|NCT00938327|364712830|FG000|Overall Study|Vaccine not received as out of stock|9|||
105742857|NCT01379534|364712831|FG000|Treatment Phase|Withdrawal by Subject|2|||
105742858|NCT01379534|364712832|FG001|Treatment Phase|Withdrawal by Subject|2|||
105742859|NCT01379534|364712831|FG000|Treatment Phase|Progressive disease|13|||
105742860|NCT01379534|364712832|FG001|Treatment Phase|Progressive disease|22|||
105742861|NCT01379534|364712831|FG000|Treatment Phase|Adverse Event|7|||
105358894|NCT03538691|363319123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
105483052|NCT01431638|363780858|FG002|Overall Study|Participant withdrew consent|8|||
105742862|NCT01379534|364712832|FG001|Treatment Phase|Adverse Event|7|||
105742863|NCT01379534|364712831|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
105742864|NCT01379534|364712832|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
105800242|NCT00830063|364926416|FG000|Overall Study|Lost to Follow-up|0|||
105742865|NCT01379534|364712831|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
105742866|NCT01379534|364712832|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
105742867|NCT01379534|364712831|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
105742868|NCT01379534|364712832|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
105742869|NCT01379534|364712831|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
105742870|NCT01379534|364712832|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
105742871|NCT02680847|364712833|FG000|Overall Study|Other|2|||
105742872|NCT02680847|364712834|FG001|Overall Study|Other|0|||
105742873|NCT02680847|364712835|FG002|Overall Study|Other|0|||
105742874|NCT02680847|364712833|FG000|Overall Study|No longer met eligibility criteria|2|||
105742875|NCT02680847|364712834|FG001|Overall Study|No longer met eligibility criteria|2|||
105742876|NCT02680847|364712835|FG002|Overall Study|No longer met eligibility criteria|0|||
105742877|NCT02680847|364712833|FG000|Overall Study|Unwilling to participate in study|1|||
105742878|NCT02680847|364712834|FG001|Overall Study|Unwilling to participate in study|1|||
105742879|NCT02680847|364712835|FG002|Overall Study|Unwilling to participate in study|0|||
105742880|NCT02680847|364712833|FG000|Overall Study|Lack of Efficacy|0|||
105742881|NCT02680847|364712834|FG001|Overall Study|Lack of Efficacy|0|||
105742882|NCT02680847|364712835|FG002|Overall Study|Lack of Efficacy|2|||
105742883|NCT02680847|364712833|FG000|Overall Study|Adverse Event|0|||
105742884|NCT02680847|364712834|FG001|Overall Study|Adverse Event|0|||
105742885|NCT02680847|364712835|FG002|Overall Study|Adverse Event|1|||
105742886|NCT00829166|364712836|FG000|Overall Study|Death|305|||
105742887|NCT00829166|364712837|FG001|Overall Study|Death|333|||
105742888|NCT00829166|364712836|FG000|Overall Study|Lost to Follow-up|5|||
105742889|NCT00829166|364712837|FG001|Overall Study|Lost to Follow-up|4|||
105742890|NCT00829166|364712836|FG000|Overall Study|Physician's Decision|4|||
105742891|NCT00829166|364712837|FG001|Overall Study|Physician's Decision|3|||
105742892|NCT00829166|364712836|FG000|Overall Study|Subject's Decision|41|||
105742893|NCT00829166|364712837|FG001|Overall Study|Subject's Decision|55|||
105742894|NCT00829166|364712836|FG000|Overall Study|Sponsor's Decision|137|||
105742895|NCT00829166|364712837|FG001|Overall Study|Sponsor's Decision|98|||
105742896|NCT00829166|364712836|FG000|Overall Study|Reason Not Specified|3|||
105742897|NCT00829166|364712837|FG001|Overall Study|Reason Not Specified|3|||
105742898|NCT02538666|364712838|FG000|Pre-Treatment|Disease progression|1|||
105742899|NCT02538666|364712839|FG001|Pre-Treatment|Disease progression|0|||
105742900|NCT02538666|364712840|FG002|Pre-Treatment|Disease progression|0|||
105742901|NCT02538666|364712838|FG000|Pre-Treatment|no longer meets study criteria|1|||
105742902|NCT02538666|364712839|FG001|Pre-Treatment|no longer meets study criteria|0|||
105742903|NCT02538666|364712840|FG002|Pre-Treatment|no longer meets study criteria|0|||
105742904|NCT02538666|364712838|FG000|Pre-Treatment|Withdrew Consent|0|||
105742905|NCT02538666|364712839|FG001|Pre-Treatment|Withdrew Consent|1|||
105742906|NCT02538666|364712840|FG002|Pre-Treatment|Withdrew Consent|1|||
105742907|NCT02538666|364712838|FG000|Treatment|Disease progression|270|||
105742908|NCT02538666|364712839|FG001|Treatment|Disease progression|227|||
105742909|NCT02538666|364712840|FG002|Treatment|Disease progression|165|||
105742910|NCT02538666|364712838|FG000|Treatment|Study drug toxicity|1|||
105742911|NCT02538666|364712839|FG001|Treatment|Study drug toxicity|29|||
105742912|NCT02538666|364712840|FG002|Treatment|Study drug toxicity|92|||
105742913|NCT02538666|364712838|FG000|Treatment|Death|0|||
105742914|NCT02538666|364712839|FG001|Treatment|Death|2|||
105742915|NCT02538666|364712840|FG002|Treatment|Death|3|||
105742916|NCT02538666|364712838|FG000|Treatment|Adverse event unrelated to study drug|8|||
105742917|NCT02538666|364712839|FG001|Treatment|Adverse event unrelated to study drug|10|||
105742918|NCT02538666|364712840|FG002|Treatment|Adverse event unrelated to study drug|15|||
105742919|NCT02538666|364712838|FG000|Treatment|Participant request to discontinue study treatment|3|||
105742920|NCT02538666|364712839|FG001|Treatment|Participant request to discontinue study treatment|6|||
105742921|NCT02538666|364712840|FG002|Treatment|Participant request to discontinue study treatment|11|||
105742922|NCT02538666|364712838|FG000|Treatment|Participant withdrew consent|2|||
105742923|NCT02538666|364712839|FG001|Treatment|Participant withdrew consent|5|||
105742924|NCT02538666|364712840|FG002|Treatment|Participant withdrew consent|3|||
105742925|NCT02538666|364712838|FG000|Treatment|Lost to Follow-up|0|||
105742926|NCT02538666|364712839|FG001|Treatment|Lost to Follow-up|1|||
105742927|NCT02538666|364712840|FG002|Treatment|Lost to Follow-up|1|||
105742928|NCT02538666|364712838|FG000|Treatment|Maximum clinical benefit|4|||
105742929|NCT02538666|364712839|FG001|Treatment|Maximum clinical benefit|3|||
105742930|NCT02538666|364712840|FG002|Treatment|Maximum clinical benefit|4|||
105742931|NCT02538666|364712838|FG000|Treatment|Poor/non-compliance|0|||
105800243|NCT00830063|364926417|FG001|Overall Study|Lost to Follow-up|0|||
105742932|NCT02538666|364712839|FG001|Treatment|Poor/non-compliance|1|||
105742933|NCT02538666|364712840|FG002|Treatment|Poor/non-compliance|0|||
105742934|NCT02538666|364712838|FG000|Treatment|Participant no longer meets study criteria|0|||
105742935|NCT02538666|364712839|FG001|Treatment|Participant no longer meets study criteria|2|||
105742936|NCT02538666|364712840|FG002|Treatment|Participant no longer meets study criteria|0|||
105358895|NCT03538691|363319124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
105358896|NCT03538691|363319125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
105358897|NCT03538691|363319126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
105358898|NCT03538691|363319123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
105358899|NCT03538691|363319124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
105358900|NCT03538691|363319125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
105358901|NCT03538691|363319126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
105358902|NCT03538691|363319123|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
105358903|NCT03538691|363319124|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
105358904|NCT03538691|363319125|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
105358905|NCT03538691|363319126|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
105358906|NCT03538691|363319123|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
105358907|NCT03538691|363319124|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
105358908|NCT03538691|363319125|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
105358909|NCT03538691|363319126|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
105358910|NCT03538691|363319123|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
105358911|NCT03538691|363319124|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
105358912|NCT03538691|363319125|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
105358913|NCT03538691|363319126|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
105358914|NCT03538691|363319123|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
105742937|NCT02538666|364712838|FG000|Treatment|Administrative reason by sponsor|0|||
105742938|NCT02538666|364712839|FG001|Treatment|Administrative reason by sponsor|0|||
105742939|NCT02538666|364712840|FG002|Treatment|Administrative reason by sponsor|1|||
105742940|NCT02538666|364712838|FG000|Treatment|Other reasons|8|||
105742941|NCT02538666|364712839|FG001|Treatment|Other reasons|15|||
105742942|NCT02538666|364712840|FG002|Treatment|Other reasons|5|||
105742943|NCT02538666|364712838|FG000|Treatment|Not reported|2|||
105742944|NCT02538666|364712839|FG001|Treatment|Not reported|2|||
105742945|NCT02538666|364712840|FG002|Treatment|Not reported|2|||
105742946|NCT03345836|364712843|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
105742947|NCT03345836|364712844|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
105742948|NCT03345836|364712845|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
105742949|NCT03345836|364712846|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
105742950|NCT03345836|364712847|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
105742951|NCT03345836|364712848|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
105742952|NCT03345836|364712843|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
105742953|NCT03345836|364712844|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
105742954|NCT03345836|364712845|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
105742955|NCT03345836|364712846|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
105742956|NCT03345836|364712847|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
105742957|NCT03345836|364712848|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
105742958|NCT03345836|364712843|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
105742959|NCT03345836|364712844|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
105742960|NCT03345836|364712845|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
105742961|NCT03345836|364712846|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
105742962|NCT03345836|364712847|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
105742963|NCT03345836|364712848|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
105742964|NCT03345836|364712843|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
105742965|NCT03345836|364712844|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
105742966|NCT03345836|364712845|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
105742967|NCT03345836|364712846|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
105742968|NCT03345836|364712847|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
105742969|NCT03345836|364712848|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
105742970|NCT03345836|364712843|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
105742971|NCT03345836|364712844|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
105483053|NCT01431638|363780856|FG000|Overall Study|Lost to Follow-up|7|||
105483054|NCT01431638|363780857|FG001|Overall Study|Lost to Follow-up|9|||
105483055|NCT01431638|363780858|FG002|Overall Study|Lost to Follow-up|7|||
105742972|NCT03345836|364712845|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
105742973|NCT03345836|364712846|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
105742974|NCT03345836|364712847|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
105742975|NCT03345836|364712848|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
105742976|NCT03345836|364712843|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
105742977|NCT03345836|364712844|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
105800244|NCT00830063|364926418|FG002|Overall Study|Lost to Follow-up|3|||
105358915|NCT03538691|363319124|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
105358916|NCT03538691|363319125|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
105358917|NCT03538691|363319126|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
105742978|NCT03345836|364712845|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
105742979|NCT03345836|364712846|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
105742980|NCT03345836|364712847|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
105742981|NCT03345836|364712848|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
105742982|NCT03345836|364712843|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
105742983|NCT03345836|364712844|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
105742984|NCT03345836|364712845|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
105742985|NCT03345836|364712846|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
105742986|NCT03345836|364712847|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
105742987|NCT03345836|364712848|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
105742988|NCT03345836|364712843|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
105742989|NCT03345836|364712844|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
105742990|NCT03345836|364712845|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
105742991|NCT03345836|364712846|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
105742992|NCT03345836|364712847|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
105742993|NCT03345836|364712848|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
105742994|NCT03345836|364712843|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
105742995|NCT03345836|364712844|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
105742996|NCT03345836|364712845|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
105742997|NCT03345836|364712846|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
105742998|NCT03345836|364712847|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
105742999|NCT03345836|364712848|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
105743000|NCT03345836|364712843|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
105743001|NCT03345836|364712844|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
105743002|NCT03345836|364712845|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
105743003|NCT03345836|364712846|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
105743004|NCT03345836|364712847|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
105743005|NCT03345836|364712848|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
105743006|NCT03345836|364712843|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
105743007|NCT03345836|364712844|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
105743008|NCT03345836|364712845|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
105743009|NCT03345836|364712846|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
105743010|NCT03345836|364712847|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
105743011|NCT03345836|364712848|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
105743012|NCT01544595|364712849|FG000|Status at Week 68|Adverse Event|3|||
105743013|NCT01544595|364712850|FG001|Status at Week 68|Adverse Event|2|||
105743014|NCT01544595|364712851|FG002|Status at Week 68|Adverse Event|1|||
105743015|NCT01544595|364712852|FG003|Status at Week 68|Adverse Event|0|||
105743016|NCT01544595|364712853|FG004|Status at Week 68|Adverse Event|0|||
105743017|NCT01544595|364712854|FG005|Status at Week 68|Adverse Event|0|||
105743018|NCT01544595|364712849|FG000|Status at Week 68|Lack of Efficacy|1|||
105743019|NCT01544595|364712850|FG001|Status at Week 68|Lack of Efficacy|0|||
105743020|NCT01544595|364712851|FG002|Status at Week 68|Lack of Efficacy|0|||
105743021|NCT01544595|364712852|FG003|Status at Week 68|Lack of Efficacy|0|||
105743022|NCT01544595|364712853|FG004|Status at Week 68|Lack of Efficacy|0|||
105743023|NCT01544595|364712854|FG005|Status at Week 68|Lack of Efficacy|0|||
105743024|NCT01544595|364712849|FG000|Status at Week 68|Lost to Follow-up|1|||
105743025|NCT01544595|364712850|FG001|Status at Week 68|Lost to Follow-up|1|||
105743026|NCT01544595|364712851|FG002|Status at Week 68|Lost to Follow-up|0|||
105743027|NCT01544595|364712852|FG003|Status at Week 68|Lost to Follow-up|0|||
105743028|NCT01544595|364712853|FG004|Status at Week 68|Lost to Follow-up|0|||
105743029|NCT01544595|364712854|FG005|Status at Week 68|Lost to Follow-up|0|||
105743030|NCT01544595|364712849|FG000|Status at Week 68|Non-compliance with study treatment|1|||
105743031|NCT01544595|364712850|FG001|Status at Week 68|Non-compliance with study treatment|0|||
105743032|NCT01544595|364712851|FG002|Status at Week 68|Non-compliance with study treatment|0|||
105358918|NCT03538691|363319123|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
105358919|NCT03538691|363319124|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
105358920|NCT03538691|363319125|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
105358921|NCT03538691|363319126|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
105565321|NCT02889133|364066735|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
105565322|NCT02889133|364066736|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
105743033|NCT01544595|364712852|FG003|Status at Week 68|Non-compliance with study treatment|1|||
105743034|NCT01544595|364712853|FG004|Status at Week 68|Non-compliance with study treatment|0|||
105358922|NCT03538691|363319123|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
105358923|NCT03538691|363319124|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
105358924|NCT03538691|363319125|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
105358925|NCT03538691|363319126|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
105358926|NCT03538691|363319123|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
105358927|NCT03538691|363319124|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
105358928|NCT03538691|363319125|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
105358929|NCT03538691|363319126|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
105358930|NCT03538691|363319123|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
105358931|NCT03538691|363319124|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
105358932|NCT03538691|363319125|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
105358933|NCT03538691|363319126|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
105358934|NCT03538691|363319123|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
105358935|NCT03538691|363319124|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
105565323|NCT02889133|364066735|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
105743035|NCT01544595|364712854|FG005|Status at Week 68|Non-compliance with study treatment|0|||
105743036|NCT01544595|364712849|FG000|Status at Week 68|Protocol Violation|2|||
105743037|NCT01544595|364712850|FG001|Status at Week 68|Protocol Violation|0|||
105743038|NCT01544595|364712851|FG002|Status at Week 68|Protocol Violation|1|||
105743039|NCT01544595|364712852|FG003|Status at Week 68|Protocol Violation|1|||
105743040|NCT01544595|364712853|FG004|Status at Week 68|Protocol Violation|0|||
105743041|NCT01544595|364712854|FG005|Status at Week 68|Protocol Violation|0|||
105743042|NCT01544595|364712849|FG000|Status at Week 68|Technical problems|1|||
105743043|NCT01544595|364712850|FG001|Status at Week 68|Technical problems|0|||
105743044|NCT01544595|364712851|FG002|Status at Week 68|Technical problems|0|||
105743045|NCT01544595|364712852|FG003|Status at Week 68|Technical problems|1|||
105743046|NCT01544595|364712853|FG004|Status at Week 68|Technical problems|0|||
105743047|NCT01544595|364712854|FG005|Status at Week 68|Technical problems|0|||
105743048|NCT01544595|364712849|FG000|Status at Week 68|Withdrawal by Subject|0|||
105743049|NCT01544595|364712850|FG001|Status at Week 68|Withdrawal by Subject|1|||
105743050|NCT01544595|364712851|FG002|Status at Week 68|Withdrawal by Subject|1|||
105743051|NCT01544595|364712852|FG003|Status at Week 68|Withdrawal by Subject|2|||
105743052|NCT01544595|364712853|FG004|Status at Week 68|Withdrawal by Subject|0|||
105743053|NCT01544595|364712854|FG005|Status at Week 68|Withdrawal by Subject|0|||
105743054|NCT01544595|364712849|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
105743055|NCT01544595|364712850|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
105743056|NCT01544595|364712851|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
105743057|NCT01544595|364712852|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
105743058|NCT01544595|364712853|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
105743059|NCT01544595|364712854|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
105743060|NCT01544595|364712849|FG000|Status at Week 156|Withdrawal by Subject|9|||
105743061|NCT01544595|364712850|FG001|Status at Week 156|Withdrawal by Subject|10|||
105743062|NCT01544595|364712851|FG002|Status at Week 156|Withdrawal by Subject|4|||
105743063|NCT01544595|364712852|FG003|Status at Week 156|Withdrawal by Subject|9|||
105743064|NCT01544595|364712853|FG004|Status at Week 156|Withdrawal by Subject|20|||
105743065|NCT01544595|364712854|FG005|Status at Week 156|Withdrawal by Subject|6|||
105743066|NCT01544595|364712849|FG000|Status at Week 156|Adverse Event|9|||
105743067|NCT01544595|364712850|FG001|Status at Week 156|Adverse Event|11|||
105743068|NCT01544595|364712851|FG002|Status at Week 156|Adverse Event|1|||
105743069|NCT01544595|364712852|FG003|Status at Week 156|Adverse Event|3|||
105743070|NCT01544595|364712853|FG004|Status at Week 156|Adverse Event|4|||
105743071|NCT01544595|364712854|FG005|Status at Week 156|Adverse Event|2|||
105743072|NCT01544595|364712849|FG000|Status at Week 156|Lost to Follow-up|4|||
105743073|NCT01544595|364712850|FG001|Status at Week 156|Lost to Follow-up|4|||
105743074|NCT01544595|364712851|FG002|Status at Week 156|Lost to Follow-up|0|||
105743075|NCT01544595|364712852|FG003|Status at Week 156|Lost to Follow-up|1|||
105743076|NCT01544595|364712853|FG004|Status at Week 156|Lost to Follow-up|4|||
105743077|NCT01544595|364712854|FG005|Status at Week 156|Lost to Follow-up|1|||
105743078|NCT01544595|364712849|FG000|Status at Week 156|Non-compliance with study treatement|0|||
105743079|NCT01544595|364712850|FG001|Status at Week 156|Non-compliance with study treatement|1|||
105743080|NCT01544595|364712851|FG002|Status at Week 156|Non-compliance with study treatement|0|||
105743081|NCT01544595|364712852|FG003|Status at Week 156|Non-compliance with study treatement|1|||
105743082|NCT01544595|364712853|FG004|Status at Week 156|Non-compliance with study treatement|0|||
105743083|NCT01544595|364712854|FG005|Status at Week 156|Non-compliance with study treatement|1|||
105743084|NCT01544595|364712849|FG000|Status at Week 156|Physician Decision|0|||
105743085|NCT01544595|364712850|FG001|Status at Week 156|Physician Decision|3|||
105743086|NCT01544595|364712851|FG002|Status at Week 156|Physician Decision|1|||
105743087|NCT01544595|364712852|FG003|Status at Week 156|Physician Decision|0|||
105743088|NCT01544595|364712853|FG004|Status at Week 156|Physician Decision|0|||
105743089|NCT01544595|364712854|FG005|Status at Week 156|Physician Decision|0|||
105743090|NCT01544595|364712849|FG000|Status at Week 156|Pregnancy|2|||
105743091|NCT01544595|364712850|FG001|Status at Week 156|Pregnancy|3|||
105358936|NCT03538691|363319125|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
105743092|NCT01544595|364712851|FG002|Status at Week 156|Pregnancy|0|||
105743093|NCT01544595|364712852|FG003|Status at Week 156|Pregnancy|0|||
105743094|NCT01544595|364712853|FG004|Status at Week 156|Pregnancy|0|||
105743095|NCT01544595|364712854|FG005|Status at Week 156|Pregnancy|0|||
105743096|NCT01544595|364712849|FG000|Status at Week 156|Protocol Violation|3|||
105743097|NCT01544595|364712850|FG001|Status at Week 156|Protocol Violation|1|||
105743098|NCT01544595|364712851|FG002|Status at Week 156|Protocol Violation|2|||
105743099|NCT01544595|364712852|FG003|Status at Week 156|Protocol Violation|2|||
105743100|NCT01544595|364712853|FG004|Status at Week 156|Protocol Violation|0|||
105743101|NCT01544595|364712854|FG005|Status at Week 156|Protocol Violation|0|||
105743102|NCT01544595|364712849|FG000|Status at Week 156|Technical problems|3|||
105743103|NCT01544595|364712850|FG001|Status at Week 156|Technical problems|1|||
105743104|NCT01544595|364712851|FG002|Status at Week 156|Technical problems|0|||
105743105|NCT01544595|364712852|FG003|Status at Week 156|Technical problems|1|||
105743106|NCT01544595|364712853|FG004|Status at Week 156|Technical problems|0|||
105743107|NCT01544595|364712854|FG005|Status at Week 156|Technical problems|0|||
105743108|NCT01544595|364712849|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
105743109|NCT01544595|364712850|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
105743110|NCT01544595|364712851|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
105743111|NCT01544595|364712852|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
105743112|NCT01544595|364712853|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
105743113|NCT01544595|364712854|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
105743114|NCT01544595|364712849|FG000|Status at Week 156|Lack of Efficacy|1|||
105743115|NCT01544595|364712850|FG001|Status at Week 156|Lack of Efficacy|0|||
105743116|NCT01544595|364712851|FG002|Status at Week 156|Lack of Efficacy|1|||
105743117|NCT01544595|364712852|FG003|Status at Week 156|Lack of Efficacy|4|||
105743118|NCT01544595|364712853|FG004|Status at Week 156|Lack of Efficacy|10|||
105743119|NCT01544595|364712854|FG005|Status at Week 156|Lack of Efficacy|5|||
105743120|NCT01465178|364712858|FG000|Overall Study|Withdrawal by Subject|1|||
105743121|NCT01465178|364712859|FG001|Overall Study|Withdrawal by Subject|0|||
105743122|NCT04072146|364712864|FG000|Overall Study|Adverse Event|0|||
105743123|NCT04072146|364712865|FG001|Overall Study|Adverse Event|1|||
105743124|NCT01987986|364712866|FG000|Overall Study|Lost to Follow-up|1|||
105743125|NCT01987986|364712867|FG001|Overall Study|Lost to Follow-up|0|||
105743126|NCT01987986|364712868|FG002|Overall Study|Lost to Follow-up|0|||
105743127|NCT01987986|364712869|FG003|Overall Study|Lost to Follow-up|0|||
105743128|NCT01987986|364712866|FG000|Overall Study|Adverse Event|1|||
105743129|NCT01987986|364712867|FG001|Overall Study|Adverse Event|0|||
105743130|NCT01987986|364712868|FG002|Overall Study|Adverse Event|2|||
105743131|NCT01987986|364712869|FG003|Overall Study|Adverse Event|0|||
105743132|NCT01617434|364712870|FG000|Overall Study|Adverse Event|12|||
105743133|NCT01617434|364712871|FG001|Overall Study|Adverse Event|3|||
105743134|NCT01617434|364712870|FG000|Overall Study|Protocol Violation|8|||
105743135|NCT01617434|364712871|FG001|Overall Study|Protocol Violation|7|||
105743136|NCT01617434|364712870|FG000|Overall Study|Withdrawal Criteria|12|||
105743137|NCT01617434|364712871|FG001|Overall Study|Withdrawal Criteria|37|||
105743138|NCT01617434|364712870|FG000|Overall Study|Unclassified|3|||
105743139|NCT01617434|364712871|FG001|Overall Study|Unclassified|4|||
105483056|NCT01431638|363780856|FG000|Overall Study|Administrative problems|1|||
105483057|NCT01431638|363780857|FG001|Overall Study|Administrative problems|4|||
105800245|NCT00830063|364926419|FG003|Overall Study|Lost to Follow-up|1|||
105483058|NCT01431638|363780858|FG002|Overall Study|Administrative problems|6|||
105483059|NCT01431638|363780856|FG000|Overall Study|Death|1|||
105483060|NCT01431638|363780857|FG001|Overall Study|Death|0|||
105483061|NCT01431638|363780858|FG002|Overall Study|Death|0|||
105483062|NCT01431638|363780856|FG000|Overall Study|Protocol deviation|1|||
105483063|NCT01431638|363780857|FG001|Overall Study|Protocol deviation|1|||
105483064|NCT01431638|363780858|FG002|Overall Study|Protocol deviation|4|||
105565324|NCT02889133|364066736|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
105743140|NCT01431144|364714859|FG000|Overall Study|Implant mobility and removal|2|||
105743141|NCT01431144|364714860|FG001|Overall Study|Implant mobility and removal|0|||
105743142|NCT02279524|364714861|FG000|Overall Study|Withdrawal by Subject|3|||
105743143|NCT02279524|364714862|FG001|Overall Study|Withdrawal by Subject|6|||
105743144|NCT02279524|364714863|FG002|Overall Study|Withdrawal by Subject|3|||
105743145|NCT02279524|364714861|FG000|Overall Study|Adverse Event|4|||
105743146|NCT02279524|364714862|FG001|Overall Study|Adverse Event|3|||
105743147|NCT02279524|364714863|FG002|Overall Study|Adverse Event|2|||
105743148|NCT02279524|364714861|FG000|Overall Study|Lost to Follow-up|1|||
105743149|NCT02279524|364714862|FG001|Overall Study|Lost to Follow-up|1|||
105743150|NCT02279524|364714863|FG002|Overall Study|Lost to Follow-up|0|||
105743151|NCT02279524|364714861|FG000|Overall Study|Disallowed medication|1|||
105743152|NCT02279524|364714862|FG001|Overall Study|Disallowed medication|1|||
105743153|NCT02279524|364714863|FG002|Overall Study|Disallowed medication|2|||
105743154|NCT02279524|364714861|FG000|Overall Study|Bariatric surgery|1|||
105743155|NCT02279524|364714862|FG001|Overall Study|Bariatric surgery|0|||
105743156|NCT02279524|364714863|FG002|Overall Study|Bariatric surgery|0|||
105743157|NCT00074412|364714864|FG000|Overall Study|Death|30|||
105743158|NCT00074412|364714865|FG001|Overall Study|Death|26|||
105743159|NCT00074412|364714864|FG000|Overall Study|Lost to Follow-up|52|||
105743160|NCT00074412|364714865|FG001|Overall Study|Lost to Follow-up|58|||
105743161|NCT03509207|364714866|FG000|Overall Study|Death|2|||
105743162|NCT00418834|364714869|FG000|Overall Study|Adverse Event|16|||
105743163|NCT00418834|364714870|FG001|Overall Study|Adverse Event|9|||
105743164|NCT00418834|364714869|FG000|Overall Study|Lost to Follow-up|0|||
105743165|NCT00418834|364714870|FG001|Overall Study|Lost to Follow-up|1|||
105743166|NCT00418834|364714869|FG000|Overall Study|Protocol Violation|4|||
105743167|NCT00418834|364714870|FG001|Overall Study|Protocol Violation|3|||
105743168|NCT00418834|364714869|FG000|Overall Study|Withdrawal by Subject|3|||
105743169|NCT00418834|364714870|FG001|Overall Study|Withdrawal by Subject|7|||
105743170|NCT01953328|364714871|FG000|Overall Study|Withdrawal by Subject|0|||
105743171|NCT01953328|364714872|FG001|Overall Study|Withdrawal by Subject|0|||
105743172|NCT01953328|364714873|FG002|Overall Study|Withdrawal by Subject|0|||
105743173|NCT01953328|364714874|FG003|Overall Study|Withdrawal by Subject|0|||
105743174|NCT01953328|364714875|FG004|Overall Study|Withdrawal by Subject|1|||
105743175|NCT01953328|364714876|FG005|Overall Study|Withdrawal by Subject|0|||
105743176|NCT01953328|364714877|FG006|Overall Study|Withdrawal by Subject|0|||
105743177|NCT01953328|364714878|FG007|Overall Study|Withdrawal by Subject|0|||
105743178|NCT01953328|364714871|FG000|Overall Study|Lost to Follow-up|0|||
105743179|NCT01953328|364714872|FG001|Overall Study|Lost to Follow-up|0|||
105743180|NCT01953328|364714873|FG002|Overall Study|Lost to Follow-up|0|||
105743181|NCT01953328|364714874|FG003|Overall Study|Lost to Follow-up|0|||
105743182|NCT01953328|364714875|FG004|Overall Study|Lost to Follow-up|1|||
105743183|NCT01953328|364714876|FG005|Overall Study|Lost to Follow-up|0|||
105743184|NCT01953328|364714877|FG006|Overall Study|Lost to Follow-up|0|||
105743185|NCT01953328|364714878|FG007|Overall Study|Lost to Follow-up|0|||
105743186|NCT00492856|364714882|FG000|Induction|Adverse Event|2|||
105743187|NCT00492856|364714883|FG001|Induction|Adverse Event|0|||
105743188|NCT00492856|364714884|FG002|Induction|Adverse Event|0|||
105743189|NCT00492856|364714885|FG003|Induction|Adverse Event|0|||
105743190|NCT00492856|364714882|FG000|Induction|Withdrawal by Subject|1|||
105743191|NCT00492856|364714883|FG001|Induction|Withdrawal by Subject|0|||
105743192|NCT00492856|364714884|FG002|Induction|Withdrawal by Subject|0|||
105743193|NCT00492856|364714885|FG003|Induction|Withdrawal by Subject|0|||
105743194|NCT00492856|364714882|FG000|Induction|Death|3|||
105743195|NCT00492856|364714883|FG001|Induction|Death|0|||
105743196|NCT00492856|364714884|FG002|Induction|Death|0|||
105743197|NCT00492856|364714885|FG003|Induction|Death|0|||
105743198|NCT00492856|364714882|FG000|Consolidation|Adverse Event|6|||
105743199|NCT00492856|364714883|FG001|Consolidation|Adverse Event|0|||
105743200|NCT00492856|364714884|FG002|Consolidation|Adverse Event|0|||
105743201|NCT00492856|364714885|FG003|Consolidation|Adverse Event|0|||
105743202|NCT00492856|364714882|FG000|Consolidation|Not protocol specified|2|||
105743203|NCT00492856|364714883|FG001|Consolidation|Not protocol specified|0|||
105483065|NCT01431638|363780856|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
105483066|NCT01431638|363780857|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
105483067|NCT01431638|363780858|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
105743204|NCT00492856|364714884|FG002|Consolidation|Not protocol specified|0|||
105800246|NCT00830063|364926416|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
105743205|NCT00492856|364714885|FG003|Consolidation|Not protocol specified|0|||
105743206|NCT00492856|364714882|FG000|Consolidation|Lost to Follow-up|1|||
105743207|NCT00492856|364714883|FG001|Consolidation|Lost to Follow-up|0|||
105743208|NCT00492856|364714884|FG002|Consolidation|Lost to Follow-up|0|||
105743209|NCT00492856|364714885|FG003|Consolidation|Lost to Follow-up|0|||
105743210|NCT00492856|364714882|FG000|Post-consolidation|Adverse Event|0|||
105743211|NCT00492856|364714883|FG001|Post-consolidation|Adverse Event|4|||
105743212|NCT00492856|364714884|FG002|Post-consolidation|Adverse Event|0|||
105743213|NCT00492856|364714885|FG003|Post-consolidation|Adverse Event|1|||
105743214|NCT00492856|364714882|FG000|Post-consolidation|Withdrawal by Subject|0|||
105743215|NCT00492856|364714883|FG001|Post-consolidation|Withdrawal by Subject|4|||
105743216|NCT00492856|364714884|FG002|Post-consolidation|Withdrawal by Subject|0|||
105743217|NCT00492856|364714885|FG003|Post-consolidation|Withdrawal by Subject|0|||
105743218|NCT00492856|364714882|FG000|Post-consolidation|Death|0|||
105743219|NCT00492856|364714883|FG001|Post-consolidation|Death|1|||
105743220|NCT00492856|364714884|FG002|Post-consolidation|Death|0|||
105743221|NCT00492856|364714885|FG003|Post-consolidation|Death|0|||
105743222|NCT00492856|364714882|FG000|Post-consolidation|Not protocol specified|0|||
105743223|NCT00492856|364714883|FG001|Post-consolidation|Not protocol specified|1|||
105743224|NCT00492856|364714884|FG002|Post-consolidation|Not protocol specified|0|||
105743225|NCT00492856|364714885|FG003|Post-consolidation|Not protocol specified|0|||
105743226|NCT00492856|364714882|FG000|Post-consolidation|Lost to Follow-up|0|||
105743227|NCT00492856|364714883|FG001|Post-consolidation|Lost to Follow-up|2|||
105743228|NCT00492856|364714884|FG002|Post-consolidation|Lost to Follow-up|0|||
105743229|NCT00492856|364714885|FG003|Post-consolidation|Lost to Follow-up|0|||
105743230|NCT00492856|364714882|FG000|Post-consolidation|Observation Arm|0|||
105743231|NCT00492856|364714883|FG001|Post-consolidation|Observation Arm|0|||
105743232|NCT00492856|364714884|FG002|Post-consolidation|Observation Arm|27|||
105743233|NCT00492856|364714885|FG003|Post-consolidation|Observation Arm|0|||
105743234|NCT01520324|364714886|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
105743235|NCT02626819|364714887|FG000|Overall Study|Lost to Follow-up|3|||
105743236|NCT02626819|364714888|FG001|Overall Study|Lost to Follow-up|2|||
105743237|NCT02626819|364714887|FG000|Overall Study|Withdrawal by Subject|1|||
105743238|NCT02626819|364714888|FG001|Overall Study|Withdrawal by Subject|0|||
105743239|NCT02626819|364714887|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
105743240|NCT02626819|364714888|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
105743241|NCT02819310|364714889|FG000|Overall Study|Withdrawal by Subject|37|||
105743242|NCT02819310|364714889|FG000|Overall Study|Lost to Follow-up|16|||
105743243|NCT02819310|364714889|FG000|Overall Study|Adverse Event|13|||
105743244|NCT02819310|364714889|FG000|Overall Study|Lack of Efficacy|5|||
105743245|NCT02819310|364714889|FG000|Overall Study|Physician Decision|8|||
105743246|NCT02819310|364714889|FG000|Overall Study|Protocol Violation|30|||
105743247|NCT03488472|364714890|FG000|Overall Study|disease progression additional mets|1|||
105743248|NCT00028002|364714895|FG000|Overall Study|Withdrawal by Subject|3|||
105743249|NCT00028002|364714895|FG000|Overall Study|Ineligible|8|||
105743250|NCT01793051|364714896|FG000|Overall Study|Withdrawal by Subject|6|||
105743251|NCT01793051|364714897|FG001|Overall Study|Withdrawal by Subject|4|||
105743252|NCT01793051|364714896|FG000|Overall Study|Adverse Event|0|||
105743253|NCT01793051|364714897|FG001|Overall Study|Adverse Event|2|||
105743254|NCT01793051|364714896|FG000|Overall Study|Too ill to continue|1|||
105743255|NCT01793051|364714897|FG001|Overall Study|Too ill to continue|0|||
105743256|NCT01793051|364714896|FG000|Overall Study|Switched chemo|1|||
105743257|NCT01793051|364714897|FG001|Overall Study|Switched chemo|1|||
105743258|NCT01793051|364714896|FG000|Overall Study|Lack of compliance|1|||
105743259|NCT01793051|364714897|FG001|Overall Study|Lack of compliance|0|||
105743260|NCT01793051|364714896|FG000|Overall Study|Requested to be removed from the study|1|||
105743261|NCT01793051|364714897|FG001|Overall Study|Requested to be removed from the study|1|||
105743262|NCT01881620|364714898|FG000|Overall Study|Protocol Violation|4|||
105743263|NCT01808118|364714899|FG000|Period 1|Adverse Event|15|||
105743264|NCT01808118|364714900|FG001|Period 1|Adverse Event|0|||
105743265|NCT01808118|364714901|FG002|Period 1|Adverse Event|0|||
105743266|NCT01808118|364714899|FG000|Period 1|Withdrew consent|24|||
105743267|NCT01808118|364714900|FG001|Period 1|Withdrew consent|0|||
105743268|NCT01808118|364714901|FG002|Period 1|Withdrew consent|0|||
105743269|NCT01808118|364714899|FG000|Period 1|Lost to Follow-up|9|||
105743270|NCT01808118|364714900|FG001|Period 1|Lost to Follow-up|0|||
105800247|NCT00830063|364926417|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
105800248|NCT00830063|364926418|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
105800249|NCT00830063|364926419|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
105743271|NCT01808118|364714901|FG002|Period 1|Lost to Follow-up|0|||
105743272|NCT01808118|364714899|FG000|Period 1|Did not meet criteria for remission|303|||
105743273|NCT01808118|364714900|FG001|Period 1|Did not meet criteria for remission|0|||
105743274|NCT01808118|364714901|FG002|Period 1|Did not meet criteria for remission|0|||
105743275|NCT01808118|364714899|FG000|Period 1|Enrolled in error|7|||
105800250|NCT00830063|364926416|FG000|Overall Study|Lack of Efficacy|51|||
105743276|NCT01808118|364714900|FG001|Period 1|Enrolled in error|0|||
105743277|NCT01808118|364714901|FG002|Period 1|Enrolled in error|0|||
105743278|NCT01808118|364714899|FG000|Period 1|Did not meet inclusion criteria|3|||
105743279|NCT01808118|364714900|FG001|Period 1|Did not meet inclusion criteria|0|||
105743280|NCT01808118|364714901|FG002|Period 1|Did not meet inclusion criteria|0|||
105743281|NCT01808118|364714899|FG000|Period 1|Non-conformance with inclusion criteria|3|||
105743282|NCT01808118|364714900|FG001|Period 1|Non-conformance with inclusion criteria|0|||
105743283|NCT01808118|364714901|FG002|Period 1|Non-conformance with inclusion criteria|0|||
105743284|NCT01808118|364714899|FG000|Period 1|Investigator decision: site closure|2|||
105743285|NCT01808118|364714900|FG001|Period 1|Investigator decision: site closure|0|||
105358937|NCT03538691|363319126|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
105358938|NCT03538691|363319123|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
105743286|NCT01808118|364714901|FG002|Period 1|Investigator decision: site closure|0|||
105358939|NCT03538691|363319124|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
105358940|NCT03538691|363319125|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
105360900|NCT01051557|363328103|FG000|Overall Study|Withdrawal by Subject|0|||
105743287|NCT01808118|364714899|FG000|Period 1|Non-compliance per sponsor|1|||
105743288|NCT01808118|364714900|FG001|Period 1|Non-compliance per sponsor|0|||
105743289|NCT01808118|364714901|FG002|Period 1|Non-compliance per sponsor|0|||
105743290|NCT01808118|364714899|FG000|Period 1|Lack of Efficacy|1|||
105743291|NCT01808118|364714900|FG001|Period 1|Lack of Efficacy|0|||
105743292|NCT01808118|364714901|FG002|Period 1|Lack of Efficacy|0|||
105743293|NCT01808118|364714899|FG000|Period 2|Adverse Event|0|||
105743294|NCT01808118|364714900|FG001|Period 2|Adverse Event|4|||
105743295|NCT01808118|364714901|FG002|Period 2|Adverse Event|0|||
105743296|NCT01808118|364714899|FG000|Period 2|Withdrew consent|0|||
105743297|NCT01808118|364714900|FG001|Period 2|Withdrew consent|7|||
105743298|NCT01808118|364714901|FG002|Period 2|Withdrew consent|6|||
105743299|NCT01808118|364714899|FG000|Period 2|Lost to Follow-up|0|||
105743300|NCT01808118|364714900|FG001|Period 2|Lost to Follow-up|0|||
105743301|NCT01808118|364714901|FG002|Period 2|Lost to Follow-up|2|||
105743302|NCT01808118|364714899|FG000|Period 2|Investigator no longer conducting trials|0|||
105743303|NCT01808118|364714900|FG001|Period 2|Investigator no longer conducting trials|1|||
105743304|NCT01808118|364714901|FG002|Period 2|Investigator no longer conducting trials|0|||
105743305|NCT01808118|364714899|FG000|Period 2|Switched to other therapy|0|||
105743306|NCT01808118|364714900|FG001|Period 2|Switched to other therapy|1|||
105743307|NCT01808118|364714901|FG002|Period 2|Switched to other therapy|0|||
105743308|NCT01998581|364714903|FG000|Overall Study|Refused repeat treatment|20|||
105743309|NCT01998581|364714904|FG001|Overall Study|Refused repeat treatment|4|||
105743310|NCT01998581|364714903|FG000|Overall Study|Protocol Violation|1|||
105743311|NCT01998581|364714904|FG001|Overall Study|Protocol Violation|0|||
105743312|NCT01998581|364714903|FG000|Overall Study|Withdrawal by Subject|8|||
105743313|NCT01998581|364714904|FG001|Overall Study|Withdrawal by Subject|1|||
105743314|NCT01998581|364714903|FG000|Overall Study|Lost to Follow-up|12|||
105743315|NCT01998581|364714904|FG001|Overall Study|Lost to Follow-up|4|||
105743316|NCT01998581|364714903|FG000|Overall Study|Adverse Event|1|||
105743317|NCT01998581|364714904|FG001|Overall Study|Adverse Event|1|||
105743318|NCT01998581|364714903|FG000|Overall Study|Other reasons|3|||
105743319|NCT01998581|364714904|FG001|Overall Study|Other reasons|2|||
105743320|NCT01998581|364714903|FG000|Overall Study|Randomized but withdrew before treatment|1|||
105743321|NCT01998581|364714904|FG001|Overall Study|Randomized but withdrew before treatment|0|||
105743322|NCT02245568|364714905|FG000|Overall Study|Study terminated by Sponsor|346|||
105743323|NCT02245568|364714905|FG000|Overall Study|Adverse Event|144|||
105743324|NCT02245568|364714905|FG000|Overall Study|Lack of Efficacy|98|||
105743325|NCT02245568|364714905|FG000|Overall Study|Withdrawal by Caregiver|85|||
105743326|NCT02245568|364714905|FG000|Overall Study|Withdrawal by Subject|77|||
105743327|NCT02245568|364714905|FG000|Overall Study|Withdrawal by Legal Representative|31|||
105743328|NCT02245568|364714905|FG000|Overall Study|Missing (Site closure)|16|||
105743329|NCT02245568|364714905|FG000|Overall Study|Physician Decision|14|||
105743330|NCT02245568|364714905|FG000|Overall Study|Non-compliance with study drug|11|||
105743331|NCT02245568|364714905|FG000|Overall Study|Death|9|||
105743332|NCT02245568|364714905|FG000|Overall Study|Blue staining|6|||
105743333|NCT02245568|364714905|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
105743334|NCT02245568|364714905|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
105743335|NCT02245568|364714905|FG000|Overall Study|Lost to Follow-up|5|||
105743336|NCT02044159|364714907|FG000|Overall Study|Consent declined (deferred consent)|2|||
105743337|NCT02044159|364714908|FG001|Overall Study|Consent declined (deferred consent)|4|||
105743338|NCT02044159|364714907|FG000|Overall Study|No longer eligible, drug not given|1|||
105743339|NCT02044159|364714908|FG001|Overall Study|No longer eligible, drug not given|0|||
105743340|NCT02044159|364714907|FG000|Overall Study|Nurse declined to give study drug|1|||
105743341|NCT02044159|364714908|FG001|Overall Study|Nurse declined to give study drug|0|||
105743342|NCT00903032|364714909|FG000|Overall Study|Withdrawal by Subject|5|||
105743343|NCT00903032|364714910|FG001|Overall Study|Withdrawal by Subject|3|||
105743344|NCT00903032|364714909|FG000|Overall Study|Lost to Follow-up|2|||
105743345|NCT00903032|364714910|FG001|Overall Study|Lost to Follow-up|2|||
105743346|NCT01111539|364714911|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
105800251|NCT00830063|364926417|FG001|Overall Study|Lack of Efficacy|23|||
105743347|NCT01111539|364714912|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105743348|NCT01111539|364714913|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105743349|NCT01111539|364714914|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105743350|NCT01111539|364714915|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105743351|NCT01111539|364714911|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
105743352|NCT01111539|364714912|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105743353|NCT01111539|364714913|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105743354|NCT01111539|364714914|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105743355|NCT01111539|364714915|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105743356|NCT01111539|364714911|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
105743357|NCT01111539|364714912|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105743358|NCT01111539|364714913|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105743359|NCT01111539|364714914|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105743360|NCT01111539|364714915|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105743361|NCT01111539|364714911|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
105743362|NCT01111539|364714912|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
105743363|NCT01111539|364714913|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
105743364|NCT01111539|364714914|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
105743365|NCT01111539|364714915|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
105743366|NCT01111539|364714911|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
105743367|NCT01111539|364714912|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
105743368|NCT01111539|364714913|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
105743369|NCT01111539|364714914|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
105743370|NCT01111539|364714915|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
105743371|NCT01111539|364714911|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
105743372|NCT01111539|364714912|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
105358941|NCT03538691|363319126|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
105358942|NCT03538691|363319123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
105358943|NCT03538691|363319124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
105358944|NCT03538691|363319125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
105358945|NCT03538691|363319126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
105358946|NCT03538691|363319123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
105358947|NCT03538691|363319124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
105358948|NCT03538691|363319125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
105358949|NCT03538691|363319126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
105358950|NCT03538691|363319123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
105358951|NCT03538691|363319124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
105358952|NCT03538691|363319125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
105358953|NCT03538691|363319126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
105358954|NCT03538691|363319123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
105358955|NCT03538691|363319124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
105358956|NCT03538691|363319125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
105358957|NCT03538691|363319126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
105358958|NCT03538691|363319123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
105483068|NCT01261780|363780859|FG000|Overall Study|Withdrawal by Subject|1|||
105483069|NCT01261780|363780860|FG001|Overall Study|Withdrawal by Subject|0|||
105483070|NCT01261780|363780859|FG000|Overall Study|Event not related to subject|1|||
105483071|NCT01261780|363780860|FG001|Overall Study|Event not related to subject|2|||
105483072|NCT01227824|363780864|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
105483073|NCT01227824|363780865|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
105483074|NCT01227824|363780866|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
105743373|NCT01111539|364714913|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
105743374|NCT01111539|364714914|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
105483075|NCT01227824|363780864|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
105483076|NCT01227824|363780865|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
105483077|NCT01227824|363780866|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
105483078|NCT01227824|363780864|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
105483079|NCT01227824|363780865|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
105483080|NCT01227824|363780866|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
105483081|NCT01227824|363780864|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
105743375|NCT01111539|364714915|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
105743376|NCT01111539|364714911|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
105743377|NCT01111539|364714912|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
105743378|NCT01111539|364714913|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
105743379|NCT01111539|364714914|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
105800252|NCT00830063|364926418|FG002|Overall Study|Lack of Efficacy|25|||
105800253|NCT00830063|364926419|FG003|Overall Study|Lack of Efficacy|32|||
105800254|NCT00830063|364926416|FG000|Overall Study|Other|5|||
105800255|NCT00830063|364926417|FG001|Overall Study|Other|5|||
105800256|NCT00830063|364926418|FG002|Overall Study|Other|8|||
105800257|NCT00830063|364926419|FG003|Overall Study|Other|6|||
105743380|NCT01111539|364714915|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
105743381|NCT01111539|364714911|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
105800258|NCT00830063|364926416|FG000|Overall Study|Withdrawal by Subject|16|||
105800259|NCT00830063|364926417|FG001|Overall Study|Withdrawal by Subject|10|||
105800260|NCT00830063|364926418|FG002|Overall Study|Withdrawal by Subject|16|||
105800261|NCT00830063|364926419|FG003|Overall Study|Withdrawal by Subject|13|||
105800262|NCT00830063|364926416|FG000|Overall Study|Protocol Violation|1|||
105800263|NCT00830063|364926417|FG001|Overall Study|Protocol Violation|0|||
105743382|NCT01111539|364714912|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
105743383|NCT01111539|364714913|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
105743384|NCT01111539|364714914|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
105743385|NCT01111539|364714915|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
105743386|NCT01111539|364714911|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105743387|NCT01111539|364714912|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105743388|NCT01111539|364714913|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
105743389|NCT01111539|364714914|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105743390|NCT01111539|364714915|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
105743391|NCT01111539|364714911|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
105800264|NCT00830063|364926418|FG002|Overall Study|Protocol Violation|3|||
105800265|NCT00830063|364926419|FG003|Overall Study|Protocol Violation|2|||
105800266|NCT00830063|364926416|FG000|Overall Study|Randomized But Not Treated|0|||
105800267|NCT00830063|364926417|FG001|Overall Study|Randomized But Not Treated|2|||
105800268|NCT00830063|364926418|FG002|Overall Study|Randomized But Not Treated|0|||
105800269|NCT00830063|364926419|FG003|Overall Study|Randomized But Not Treated|2|||
105743392|NCT01111539|364714912|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
105743393|NCT01111539|364714913|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
105743394|NCT01111539|364714914|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
105743395|NCT01111539|364714915|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
105743396|NCT01111539|364714911|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
105743397|NCT01111539|364714912|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
105800270|NCT00787566|364926420|FG000|Overall Study|AE related to chemotherapy|0|||
105800271|NCT00787566|364926421|FG001|Overall Study|AE related to chemotherapy|1|||
105800272|NCT00787566|364926422|FG002|Overall Study|AE related to chemotherapy|0|||
105800273|NCT02140164|364926423|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
105800274|NCT00686374|364926428|FG000|Overall Study|Lack of Efficacy|10|||
105800275|NCT00686374|364926428|FG000|Overall Study|Adverse Event|8|||
105800276|NCT00686374|364926428|FG000|Overall Study|Withdrew consent|5|||
105800277|NCT00686374|364926428|FG000|Overall Study|Lost to Follow-up|1|||
105800278|NCT00686374|364926428|FG000|Overall Study|Missing reason|33|||
105800279|NCT00686374|364926428|FG000|Overall Study|Other, not specified|4|||
105800280|NCT02853929|364926429|FG000|Overall Study|Lost to Follow-up|3|||
105800281|NCT02853929|364926430|FG001|Overall Study|Lost to Follow-up|0|||
105800282|NCT02853929|364926429|FG000|Overall Study|Withdrawal by Subject|1|||
105358959|NCT03538691|363319124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
105358960|NCT03538691|363319125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
105358961|NCT03538691|363319126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
105358962|NCT03538691|363319123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
105358963|NCT03538691|363319124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
105358964|NCT03538691|363319125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
105358965|NCT03538691|363319126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
105358966|NCT03538691|363319123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
105358967|NCT03538691|363319124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
105358968|NCT03538691|363319125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
105358969|NCT03538691|363319126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
105358970|NCT03538691|363319123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
105358971|NCT03538691|363319124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
105358972|NCT03538691|363319125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
105358973|NCT03538691|363319126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
105358974|NCT03538691|363319123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
105358975|NCT03538691|363319124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
105358976|NCT03538691|363319125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
105358977|NCT03538691|363319126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
105358978|NCT00255164|363319127|FG000|Overall Study|Adverse Event|10|||
105358979|NCT00255164|363319128|FG001|Overall Study|Adverse Event|6|||
105358980|NCT00255164|363319129|FG002|Overall Study|Adverse Event|9|||
105358981|NCT00255164|363319127|FG000|Overall Study|Lost to Follow-up|4|||
105358982|NCT00255164|363319128|FG001|Overall Study|Lost to Follow-up|3|||
105358983|NCT00255164|363319129|FG002|Overall Study|Lost to Follow-up|4|||
105743398|NCT01111539|364714913|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
105743399|NCT01111539|364714914|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
105743400|NCT01111539|364714915|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
105743401|NCT01111539|364714911|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
105743402|NCT01111539|364714912|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
105743403|NCT01111539|364714913|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
105743404|NCT01111539|364714914|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
105565325|NCT02889133|364066735|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
105565326|NCT02889133|364066736|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
105565327|NCT02889133|364066735|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
105565328|NCT02889133|364066736|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
105800283|NCT02853929|364926430|FG001|Overall Study|Withdrawal by Subject|0|||
105800284|NCT02853929|364926429|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
105800285|NCT02853929|364926430|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
105800286|NCT02770716|364926431|FG000|Overall Study|Death|101|||
105800287|NCT02770716|364926432|FG001|Overall Study|Death|45|||
105800288|NCT02770716|364926431|FG000|Overall Study|Withdrawal by Subject|4|||
105800289|NCT02770716|364926432|FG001|Overall Study|Withdrawal by Subject|2|||
105800290|NCT02770716|364926431|FG000|Overall Study|Lost to Follow-up|1|||
105800291|NCT02770716|364926432|FG001|Overall Study|Lost to Follow-up|0|||
105743405|NCT01111539|364714915|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
105743406|NCT01111539|364714911|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
105743407|NCT01111539|364714912|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
105743408|NCT01111539|364714913|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
105743409|NCT01111539|364714914|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
105743410|NCT01111539|364714915|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
105743411|NCT01111539|364714911|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105743412|NCT01111539|364714912|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105800292|NCT02770716|364926431|FG000|Overall Study|Various reasons|6|||
105800293|NCT02770716|364926432|FG001|Overall Study|Various reasons|2|||
105800294|NCT03568500|364926433|FG000|Overall Study|Lost to Follow-up|1|||
105800295|NCT03568500|364926434|FG001|Overall Study|Lost to Follow-up|1|||
105800296|NCT03568500|364926435|FG002|Overall Study|Lost to Follow-up|2|||
105800297|NCT03568500|364926433|FG000|Overall Study|Adverse Event|1|||
105358984|NCT00255164|363319127|FG000|Overall Study|Withdrawal by Subject|18|||
105565329|NCT02889133|364066735|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
105565330|NCT02889133|364066736|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
105565331|NCT02277990|364066737|FG000|Overall Study|Death|170|||
105565332|NCT02277990|364066738|FG001|Overall Study|Death|188|||
105565333|NCT02277990|364066737|FG000|Overall Study|Withdrawal by Subject|64|||
105565334|NCT02277990|364066738|FG001|Overall Study|Withdrawal by Subject|53|||
105800298|NCT03568500|364926434|FG001|Overall Study|Adverse Event|1|||
105800299|NCT03568500|364926435|FG002|Overall Study|Adverse Event|2|||
105800300|NCT03568500|364926433|FG000|Overall Study|Physician Decision|1|||
105800301|NCT03568500|364926434|FG001|Overall Study|Physician Decision|0|||
105800302|NCT03568500|364926435|FG002|Overall Study|Physician Decision|0|||
105800303|NCT03568500|364926433|FG000|Overall Study|Withdrawal by Subject|4|||
105800304|NCT03568500|364926434|FG001|Overall Study|Withdrawal by Subject|2|||
105800305|NCT03568500|364926435|FG002|Overall Study|Withdrawal by Subject|0|||
105800306|NCT03568500|364926433|FG000|Overall Study|Technical Problems|2|||
105800307|NCT03568500|364926434|FG001|Overall Study|Technical Problems|1|||
105800308|NCT03568500|364926435|FG002|Overall Study|Technical Problems|0|||
105800309|NCT03568500|364926433|FG000|Overall Study|Participant Noncompliance|1|||
105800310|NCT03568500|364926434|FG001|Overall Study|Participant Noncompliance|1|||
105800311|NCT03568500|364926435|FG002|Overall Study|Participant Noncompliance|0|||
105800312|NCT00827359|364926447|FG000|Overall Study|Progressive Diseas|19|||
105800313|NCT00827359|364926447|FG000|Overall Study|Unacceptable Toxicity|5|||
105800314|NCT00827359|364926447|FG000|Overall Study|Ineligible|1|||
105800315|NCT02059187|364926448|FG000|Overall Study|Adverse Event|0|||
105800316|NCT02059187|364926449|FG001|Overall Study|Adverse Event|3|||
105800317|NCT02059187|364926448|FG000|Overall Study|Death|1|||
105800318|NCT02059187|364926449|FG001|Overall Study|Death|1|||
105800319|NCT02059187|364926448|FG000|Overall Study|Lost to Follow-up|9|||
105800320|NCT02059187|364926449|FG001|Overall Study|Lost to Follow-up|8|||
105800321|NCT02059187|364926448|FG000|Overall Study|Non-compliance with study drug|1|||
105800322|NCT02059187|364926449|FG001|Overall Study|Non-compliance with study drug|0|||
105800323|NCT02059187|364926448|FG000|Overall Study|Physician Decision|1|||
105800324|NCT02059187|364926449|FG001|Overall Study|Physician Decision|2|||
105800325|NCT02059187|364926448|FG000|Overall Study|Protocol Violation|1|||
105800326|NCT02059187|364926449|FG001|Overall Study|Protocol Violation|0|||
105800327|NCT02059187|364926448|FG000|Overall Study|Withdrawal by Subject|12|||
105800328|NCT02059187|364926449|FG001|Overall Study|Withdrawal by Subject|8|||
105800329|NCT01889862|364926450|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
105800330|NCT01889862|364926451|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
105800331|NCT01889862|364926452|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
105800332|NCT01889862|364926453|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
105800333|NCT01889862|364926454|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
105800334|NCT01889862|364926450|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
105800335|NCT01889862|364926451|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
105800336|NCT01889862|364926452|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
105800337|NCT01889862|364926453|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
105800338|NCT01889862|364926454|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
105800339|NCT01889862|364926450|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
105800340|NCT01889862|364926451|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
105800341|NCT01889862|364926452|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
105800342|NCT01889862|364926453|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
105800343|NCT01889862|364926454|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
105800344|NCT01889862|364926450|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
105800345|NCT01889862|364926451|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
105800346|NCT01889862|364926452|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
105800347|NCT01889862|364926453|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
105800348|NCT01889862|364926454|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
105565335|NCT02277990|364066737|FG000|Overall Study|Physician Decision|40|||
105800349|NCT01889862|364926450|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
105800350|NCT01889862|364926451|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
105800351|NCT01889862|364926452|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
105800352|NCT01889862|364926453|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
105800353|NCT01889862|364926454|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
105800354|NCT01889862|364926450|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
105800355|NCT01889862|364926451|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
105800356|NCT01889862|364926452|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
105358985|NCT00255164|363319128|FG001|Overall Study|Withdrawal by Subject|17|||
105358986|NCT00255164|363319129|FG002|Overall Study|Withdrawal by Subject|8|||
105358987|NCT00255164|363319127|FG000|Overall Study|Noncompliance|0|||
105358988|NCT00255164|363319128|FG001|Overall Study|Noncompliance|1|||
105358989|NCT00255164|363319129|FG002|Overall Study|Noncompliance|2|||
105358990|NCT00255164|363319127|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
105358991|NCT00255164|363319128|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
105358992|NCT00255164|363319129|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
105358993|NCT00255164|363319127|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
105358994|NCT00255164|363319128|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
105358995|NCT00255164|363319129|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
105358996|NCT00255164|363319127|FG000|Overall Study|Possible Barrett's Esophagus|1|||
105358997|NCT00255164|363319128|FG001|Overall Study|Possible Barrett's Esophagus|3|||
105358998|NCT00255164|363319129|FG002|Overall Study|Possible Barrett's Esophagus|8|||
105358999|NCT00255164|363319127|FG000|Overall Study|Esophageal Stricture|0|||
105565336|NCT02277990|364066738|FG001|Overall Study|Physician Decision|34|||
105565337|NCT02277990|364066737|FG000|Overall Study|Lost to Follow-up|66|||
105565338|NCT02277990|364066738|FG001|Overall Study|Lost to Follow-up|69|||
105565339|NCT02277990|364066737|FG000|Overall Study|Had other reason|26|||
105565340|NCT02277990|364066738|FG001|Overall Study|Had other reason|32|||
105565341|NCT00386022|364066750|FG000|Plus Estrogen|Lost to Follow-up|2|||
105565342|NCT00386022|364066751|FG001|Plus Estrogen|Lost to Follow-up|0|||
105565343|NCT00386022|364066750|FG000|Plus Estrogen|Adverse Event|0|||
105565344|NCT00386022|364066751|FG001|Plus Estrogen|Adverse Event|1|||
105565345|NCT03848403|364066754|FG000|Period 2 (Day 8)|Adverse Event|1|||
105565346|NCT03848403|364066755|FG001|Period 2 (Day 8)|Adverse Event|2|||
105565347|NCT03848403|364066756|FG002|Period 2 (Day 8)|Adverse Event|2|||
105565348|NCT03848403|364066754|FG000|Period 2 (Day 8)|Physician Decision|0|||
105565349|NCT03848403|364066755|FG001|Period 2 (Day 8)|Physician Decision|1|||
105565350|NCT03848403|364066756|FG002|Period 2 (Day 8)|Physician Decision|0|||
105565351|NCT03848403|364066754|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
105565352|NCT03848403|364066755|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
105565353|NCT03848403|364066756|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
105565354|NCT02124265|364066759|FG000|Overall Study|Adverse Event|1|||
105565355|NCT04241094|364066760|FG000|Overall Study|Dropped out of treatment|4|||
105565356|NCT04241094|364066760|FG000|Overall Study|Ineligible after clinical assessment|2|||
105483082|NCT01227824|363780865|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
105483083|NCT01227824|363780866|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
105483084|NCT01227824|363780864|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
105483085|NCT01227824|363780865|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
105483086|NCT01227824|363780866|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
105483087|NCT01227824|363780864|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
105483088|NCT01227824|363780865|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
105483089|NCT01227824|363780866|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
105483090|NCT01227824|363780864|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
105483091|NCT01227824|363780865|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
105483092|NCT01227824|363780866|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
105483093|NCT01227824|363780864|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
105483094|NCT01227824|363780865|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
105483095|NCT01227824|363780866|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
105483096|NCT01227824|363780864|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
105483097|NCT01227824|363780865|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
105359000|NCT00255164|363319128|FG001|Overall Study|Esophageal Stricture|0|||
105359001|NCT00255164|363319129|FG002|Overall Study|Esophageal Stricture|1|||
105359002|NCT00255164|363319127|FG000|Overall Study|Therapeutic Failure|11|||
105483098|NCT01227824|363780866|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
105565357|NCT04241094|364066760|FG000|Overall Study|Lost to Follow-up|2|||
105565358|NCT04058353|364066762|FG000|Overall Study|Adverse Event|2|||
105565359|NCT04058353|364066763|FG001|Overall Study|Adverse Event|1|||
105565360|NCT04058353|364066762|FG000|Overall Study|Physician Decision|1|||
105359003|NCT00255164|363319128|FG001|Overall Study|Therapeutic Failure|2|||
105359004|NCT00255164|363319129|FG002|Overall Study|Therapeutic Failure|3|||
105359005|NCT00565604|363319131|FG000|Overall Study|Failure to treat|2|||
105483099|NCT01227824|363780864|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
105483100|NCT01227824|363780865|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
105483101|NCT01227824|363780866|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
105483102|NCT01227824|363780864|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
105483103|NCT01227824|363780865|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
105483104|NCT01227824|363780866|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
105483105|NCT01227824|363780864|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
105483106|NCT01227824|363780865|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
105483107|NCT01227824|363780866|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
105483108|NCT01227824|363780864|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
105483109|NCT01227824|363780865|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
105483110|NCT01227824|363780866|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
105483111|NCT01227824|363780864|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
105483112|NCT01227824|363780865|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
105743413|NCT01111539|364714913|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105743414|NCT01111539|364714914|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105743415|NCT01111539|364714915|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
105743416|NCT01984346|364714916|FG000|Overall Study|Physician Decision|4|||
105743417|NCT01984346|364714917|FG001|Overall Study|Physician Decision|2|||
105743418|NCT01984346|364714916|FG000|Overall Study|Withdrawal by Subject|2|||
105743419|NCT01984346|364714917|FG001|Overall Study|Withdrawal by Subject|2|||
105743420|NCT01984346|364714916|FG000|Overall Study|Enrollment Closed|8|||
105743421|NCT01984346|364714917|FG001|Overall Study|Enrollment Closed|1|||
105743422|NCT01984346|364714916|FG000|Overall Study|Insurance Coverage|1|||
105743423|NCT01984346|364714917|FG001|Overall Study|Insurance Coverage|0|||
105743424|NCT01984346|364714916|FG000|Overall Study|Intra-operative Exclusion|2|||
105743425|NCT01984346|364714917|FG001|Overall Study|Intra-operative Exclusion|0|||
105743426|NCT01876732|364714922|FG000|Overall Study|MMA was not over 800mg/dL|75|||
105743427|NCT00372190|364714923|FG000|Overall Study|Lost to Follow-up|3|||
105743428|NCT00372190|364714924|FG001|Overall Study|Lost to Follow-up|1|||
105743429|NCT05058664|364714929|FG000|Overall Study|No follow-up data provided|4|||
105743430|NCT05058664|364714930|FG001|Overall Study|No follow-up data provided|0|||
105743431|NCT05058664|364714931|FG002|Overall Study|No follow-up data provided|2|||
105743432|NCT05058664|364714929|FG000|Overall Study|Withdrawal by Subject|0|||
105743433|NCT05058664|364714930|FG001|Overall Study|Withdrawal by Subject|0|||
105743434|NCT05058664|364714931|FG002|Overall Study|Withdrawal by Subject|1|||
105743435|NCT01617681|364714932|FG000|Period 1 Double Blind|Adverse Event|2|||
105743436|NCT01617681|364714933|FG001|Period 1 Double Blind|Adverse Event|0|||
105743437|NCT01617681|364714934|FG002|Period 1 Double Blind|Adverse Event|0|||
105743438|NCT01617681|364714935|FG003|Period 1 Double Blind|Adverse Event|2|||
105743439|NCT01617681|364714936|FG004|Period 1 Double Blind|Adverse Event|0|||
105743440|NCT01617681|364714932|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
105743441|NCT01617681|364714933|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
105743442|NCT01617681|364714934|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
105743443|NCT01617681|364714935|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
105743444|NCT01617681|364714936|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
105743445|NCT01617681|364714932|FG000|Period 2 Open Label|Adverse Event|0|||
105743446|NCT01617681|364714933|FG001|Period 2 Open Label|Adverse Event|0|||
105743447|NCT01617681|364714934|FG002|Period 2 Open Label|Adverse Event|0|||
105743448|NCT01617681|364714935|FG003|Period 2 Open Label|Adverse Event|0|||
105743449|NCT01617681|364714936|FG004|Period 2 Open Label|Adverse Event|3|||
105743450|NCT01617681|364714932|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
105743451|NCT01617681|364714933|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
105743452|NCT01617681|364714934|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
105743453|NCT01617681|364714935|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
105743454|NCT01617681|364714936|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
105743455|NCT05131451|364714937|FG000|Overall Study|Protocol Violation|1|||
105743456|NCT05131451|364714938|FG001|Overall Study|Protocol Violation|0|||
105743457|NCT00972244|364714939|FG000|Overall Study|Incorrect Enrolment|1|||
105743458|NCT00972244|364714940|FG001|Overall Study|Incorrect Enrolment|0|||
105743459|NCT00972244|364714941|FG002|Overall Study|Incorrect Enrolment|0|||
105743460|NCT00972244|364714942|FG003|Overall Study|Incorrect Enrolment|0|||
105483113|NCT01227824|363780866|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
105743461|NCT00972244|364714943|FG004|Overall Study|Incorrect Enrolment|0|||
105743462|NCT00972244|364714939|FG000|Overall Study|Adverse Event|0|||
105743463|NCT00972244|364714940|FG001|Overall Study|Adverse Event|1|||
105743464|NCT00972244|364714941|FG002|Overall Study|Adverse Event|1|||
105743465|NCT00972244|364714942|FG003|Overall Study|Adverse Event|0|||
105743466|NCT00972244|364714943|FG004|Overall Study|Adverse Event|0|||
105743467|NCT00972244|364714939|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
105743468|NCT00972244|364714940|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
105743469|NCT00972244|364714941|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
105800357|NCT01889862|364926453|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
105800358|NCT01889862|364926454|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
105800359|NCT01889862|364926450|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
105800360|NCT01889862|364926451|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
105800361|NCT01889862|364926452|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
105800362|NCT01889862|364926453|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
105800363|NCT01889862|364926454|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
105800364|NCT01889862|364926450|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
105800365|NCT01889862|364926451|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
105800366|NCT01889862|364926452|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
105800367|NCT01889862|364926453|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
105800368|NCT01889862|364926454|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
105359006|NCT00565604|363319131|FG000|Overall Study|Lost to Follow-up|2|||
105359007|NCT04378569|363320866|FG000|Overall Study|Adverse Event|0|||
105359008|NCT04378569|363320867|FG001|Overall Study|Adverse Event|0|||
105359009|NCT04378569|363320868|FG002|Overall Study|Adverse Event|2|||
105359010|NCT04378569|363320869|FG003|Overall Study|Adverse Event|0|||
105359011|NCT04378569|363320870|FG004|Overall Study|Adverse Event|3|||
105359012|NCT04378569|363320871|FG005|Overall Study|Adverse Event|3|||
105359013|NCT04378569|363320866|FG000|Overall Study|Lost to Follow-up|0|||
105359014|NCT04378569|363320867|FG001|Overall Study|Lost to Follow-up|3|||
105359015|NCT04378569|363320868|FG002|Overall Study|Lost to Follow-up|1|||
105359016|NCT04378569|363320869|FG003|Overall Study|Lost to Follow-up|0|||
105359017|NCT04378569|363320870|FG004|Overall Study|Lost to Follow-up|1|||
105359018|NCT04378569|363320871|FG005|Overall Study|Lost to Follow-up|1|||
105359019|NCT04378569|363320866|FG000|Overall Study|Protocol Violation|0|||
105359020|NCT04378569|363320867|FG001|Overall Study|Protocol Violation|0|||
105359021|NCT04378569|363320868|FG002|Overall Study|Protocol Violation|0|||
105359022|NCT04378569|363320869|FG003|Overall Study|Protocol Violation|0|||
105359023|NCT04378569|363320870|FG004|Overall Study|Protocol Violation|0|||
105359024|NCT04378569|363320871|FG005|Overall Study|Protocol Violation|1|||
105359025|NCT04378569|363320866|FG000|Overall Study|Withdrawal by Subject|0|||
105359026|NCT04378569|363320867|FG001|Overall Study|Withdrawal by Subject|6|||
105359027|NCT04378569|363320868|FG002|Overall Study|Withdrawal by Subject|7|||
105359028|NCT04378569|363320869|FG003|Overall Study|Withdrawal by Subject|4|||
105359029|NCT04378569|363320870|FG004|Overall Study|Withdrawal by Subject|5|||
105359030|NCT04378569|363320871|FG005|Overall Study|Withdrawal by Subject|4|||
105359031|NCT04378569|363320866|FG000|Overall Study|Lack of response|0|||
105359032|NCT04378569|363320867|FG001|Overall Study|Lack of response|0|||
105359033|NCT04378569|363320868|FG002|Overall Study|Lack of response|1|||
105359034|NCT04378569|363320869|FG003|Overall Study|Lack of response|0|||
105743470|NCT00972244|364714942|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
105743471|NCT00972244|364714943|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
105743472|NCT00972244|364714939|FG000|Overall Study|Withdrawal by Subject|1|||
105743473|NCT00972244|364714940|FG001|Overall Study|Withdrawal by Subject|2|||
105743474|NCT00972244|364714941|FG002|Overall Study|Withdrawal by Subject|1|||
105743475|NCT00972244|364714942|FG003|Overall Study|Withdrawal by Subject|0|||
105743476|NCT00972244|364714943|FG004|Overall Study|Withdrawal by Subject|1|||
105743477|NCT00972244|364714939|FG000|Overall Study|Safety|0|||
105743478|NCT00972244|364714940|FG001|Overall Study|Safety|0|||
105743479|NCT00972244|364714941|FG002|Overall Study|Safety|0|||
105743480|NCT00972244|364714942|FG003|Overall Study|Safety|0|||
105743481|NCT00972244|364714943|FG004|Overall Study|Safety|1|||
105743482|NCT00972244|364714939|FG000|Overall Study|Death|1|||
105743483|NCT00972244|364714940|FG001|Overall Study|Death|0|||
105743484|NCT00972244|364714941|FG002|Overall Study|Death|0|||
105743485|NCT00972244|364714942|FG003|Overall Study|Death|0|||
105743486|NCT00972244|364714943|FG004|Overall Study|Death|0|||
105743487|NCT00972244|364714939|FG000|Overall Study|Various|0|||
105743488|NCT00972244|364714940|FG001|Overall Study|Various|0|||
105743489|NCT00972244|364714941|FG002|Overall Study|Various|0|||
105743490|NCT00972244|364714942|FG003|Overall Study|Various|0|||
105359035|NCT04378569|363320870|FG004|Overall Study|Lack of response|1|||
105359036|NCT04378569|363320871|FG005|Overall Study|Lack of response|1|||
105359037|NCT01844817|363320872|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
105359038|NCT01844817|363320873|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
105359039|NCT01844817|363320872|FG000|Treatment|Progressive Disease|27|||
105359040|NCT01844817|363320873|FG001|Treatment|Progressive Disease|36|||
105359041|NCT01844817|363320872|FG000|Treatment|Adverse Event|17|||
105743491|NCT00972244|364714943|FG004|Overall Study|Various|2|||
105359042|NCT01844817|363320873|FG001|Treatment|Adverse Event|9|||
105359043|NCT01844817|363320872|FG000|Treatment|Withdrawal by Subject|10|||
105743492|NCT01856595|364714950|FG000|Overall Study|Withdrawal by Subject|0|||
105743493|NCT01856595|364714951|FG001|Overall Study|Withdrawal by Subject|1|||
105743494|NCT01856595|364714952|FG002|Overall Study|Withdrawal by Subject|0|||
105743495|NCT01856595|364714953|FG003|Overall Study|Withdrawal by Subject|0|||
105743496|NCT01856595|364714954|FG004|Overall Study|Withdrawal by Subject|0|||
105743497|NCT01856595|364714955|FG005|Overall Study|Withdrawal by Subject|0|||
105743498|NCT01856595|364714956|FG006|Overall Study|Withdrawal by Subject|1|||
105743499|NCT01856595|364714957|FG007|Overall Study|Withdrawal by Subject|0|||
105743500|NCT01856595|364714958|FG008|Overall Study|Withdrawal by Subject|0|||
105743501|NCT01763905|364714966|FG000|Overall Study|Withdrawal by Subject|1|||
105743502|NCT01763905|364714967|FG001|Overall Study|Withdrawal by Subject|1|||
105743503|NCT01763905|364714968|FG002|Overall Study|Withdrawal by Subject|0|||
105743504|NCT01763905|364714969|FG003|Overall Study|Withdrawal by Subject|1|||
105743505|NCT01763905|364714966|FG000|Overall Study|Decision by sponsor|5|||
105743506|NCT01763905|364714967|FG001|Overall Study|Decision by sponsor|0|||
105743507|NCT01763905|364714968|FG002|Overall Study|Decision by sponsor|8|||
105743508|NCT01763905|364714969|FG003|Overall Study|Decision by sponsor|0|||
105743509|NCT01763905|364714966|FG000|Overall Study|Lost to Follow-up|0|||
105743510|NCT01763905|364714967|FG001|Overall Study|Lost to Follow-up|0|||
105743511|NCT01763905|364714968|FG002|Overall Study|Lost to Follow-up|1|||
105743512|NCT01763905|364714969|FG003|Overall Study|Lost to Follow-up|0|||
105743513|NCT01327651|364714971|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
105743514|NCT01327651|364714972|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
105743515|NCT01327651|364714973|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
105743516|NCT01327651|364714974|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
105743517|NCT01327651|364714975|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
105743518|NCT01327651|364714976|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
105743519|NCT01327651|364714977|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
105743520|NCT01327651|364714978|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
105743521|NCT01327651|364714979|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
105743522|NCT01327651|364714971|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
105743523|NCT01327651|364714972|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743524|NCT01327651|364714973|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743525|NCT01327651|364714974|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743526|NCT01327651|364714975|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743527|NCT01327651|364714976|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743528|NCT01327651|364714977|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743529|NCT01327651|364714978|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743530|NCT01327651|364714979|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743531|NCT01327651|364714971|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
105743532|NCT01327651|364714972|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
105743533|NCT01327651|364714973|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
105743534|NCT01327651|364714974|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
105743535|NCT01327651|364714975|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
105743536|NCT01327651|364714976|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
105743537|NCT01327651|364714977|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
105743538|NCT01327651|364714978|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
105743539|NCT01327651|364714979|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
105743540|NCT01327651|364714971|FG000|Post Study Follow-up|Lost to Follow-up|0|||
105743541|NCT01327651|364714972|FG001|Post Study Follow-up|Lost to Follow-up|1|||
105743542|NCT01327651|364714973|FG002|Post Study Follow-up|Lost to Follow-up|1|||
105743543|NCT01327651|364714974|FG003|Post Study Follow-up|Lost to Follow-up|0|||
105743544|NCT01327651|364714975|FG004|Post Study Follow-up|Lost to Follow-up|0|||
105743545|NCT01327651|364714976|FG005|Post Study Follow-up|Lost to Follow-up|0|||
105743546|NCT01327651|364714977|FG006|Post Study Follow-up|Lost to Follow-up|4|||
105743547|NCT01327651|364714978|FG007|Post Study Follow-up|Lost to Follow-up|1|||
105743548|NCT01327651|364714979|FG008|Post Study Follow-up|Lost to Follow-up|2|||
105743549|NCT00995345|364714982|FG000|Overall Study|Withdrawal by Subject|4|||
105743550|NCT00995345|364714983|FG001|Overall Study|Withdrawal by Subject|2|||
105743551|NCT00995345|364714984|FG002|Overall Study|Withdrawal by Subject|1|||
105743552|NCT00995345|364714985|FG003|Overall Study|Withdrawal by Subject|3|||
105743553|NCT00995345|364714986|FG004|Overall Study|Withdrawal by Subject|1|||
105743554|NCT00995345|364714982|FG000|Overall Study|Adverse Event|3|||
105743555|NCT00995345|364714983|FG001|Overall Study|Adverse Event|1|||
105743556|NCT00995345|364714984|FG002|Overall Study|Adverse Event|2|||
105743557|NCT00995345|364714985|FG003|Overall Study|Adverse Event|0|||
105743558|NCT00995345|364714986|FG004|Overall Study|Adverse Event|1|||
105743559|NCT00995345|364714982|FG000|Overall Study|Lost to Follow-up|2|||
105483114|NCT01227824|363780864|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
105743560|NCT00995345|364714983|FG001|Overall Study|Lost to Follow-up|2|||
105743561|NCT00995345|364714984|FG002|Overall Study|Lost to Follow-up|2|||
105743562|NCT00995345|364714985|FG003|Overall Study|Lost to Follow-up|1|||
105743563|NCT00995345|364714986|FG004|Overall Study|Lost to Follow-up|0|||
105743564|NCT00995345|364714982|FG000|Overall Study|all other reasons combined|2|||
105359044|NCT01844817|363320873|FG001|Treatment|Withdrawal by Subject|6|||
105359045|NCT01844817|363320872|FG000|Treatment|Death|10|||
105359046|NCT01844817|363320873|FG001|Treatment|Death|8|||
105359047|NCT01844817|363320872|FG000|Treatment|Lost to Follow-up|0|||
105359048|NCT01844817|363320873|FG001|Treatment|Lost to Follow-up|1|||
105359049|NCT01844817|363320872|FG000|Treatment|Other|0|||
105743565|NCT00995345|364714983|FG001|Overall Study|all other reasons combined|2|||
105743566|NCT00995345|364714984|FG002|Overall Study|all other reasons combined|2|||
105743567|NCT00995345|364714985|FG003|Overall Study|all other reasons combined|1|||
105743568|NCT00995345|364714986|FG004|Overall Study|all other reasons combined|3|||
105743569|NCT01425190|364714989|FG000|Overall Study|Full dose not consumed.|1|||
105743570|NCT01425190|364714990|FG001|Overall Study|Full dose not consumed.|0|||
105743571|NCT01425190|364714991|FG002|Overall Study|Full dose not consumed.|0|||
105743572|NCT04285346|364714992|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
105743573|NCT04285346|364714993|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
105743574|NCT04285346|364714992|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
105743575|NCT04285346|364714993|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105743576|NCT04285346|364714992|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
105743577|NCT04285346|364714993|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
105743578|NCT01975272|364714996|FG000|Overall Study|Excluded after protocol amendment|1|||
105743579|NCT01975272|364714997|FG001|Overall Study|Excluded after protocol amendment|1|||
105743580|NCT01975272|364714998|FG002|Overall Study|Excluded after protocol amendment|2|||
105743581|NCT00610935|364714999|FG000|Overall Study|Lost to Follow-up|0|||
105743582|NCT00610935|364715000|FG001|Overall Study|Lost to Follow-up|1|||
105743583|NCT00610935|364714999|FG000|Overall Study|Withdrawal by Subject|0|||
105743584|NCT00610935|364715000|FG001|Overall Study|Withdrawal by Subject|2|||
105743585|NCT00610935|364714999|FG000|Overall Study|Sponsor Discontinuation|1|||
105743586|NCT00610935|364715000|FG001|Overall Study|Sponsor Discontinuation|0|||
105743587|NCT01519245|364715001|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
105743588|NCT01519245|364715002|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
105743589|NCT00740779|364715003|FG000|Overall Study|Adverse Event|4|||
105743590|NCT00740779|364715004|FG001|Overall Study|Adverse Event|6|||
105743591|NCT00740779|364715005|FG002|Overall Study|Adverse Event|3|||
105743592|NCT00740779|364715003|FG000|Overall Study|Protocol Violation|1|||
105743593|NCT00740779|364715004|FG001|Overall Study|Protocol Violation|1|||
105743594|NCT00740779|364715005|FG002|Overall Study|Protocol Violation|1|||
105743595|NCT00740779|364715003|FG000|Overall Study|Lack of Efficacy|0|||
105743596|NCT00740779|364715004|FG001|Overall Study|Lack of Efficacy|0|||
105743597|NCT00740779|364715005|FG002|Overall Study|Lack of Efficacy|2|||
105743598|NCT00740779|364715003|FG000|Overall Study|Withdrawal by Subject|2|||
105743599|NCT00740779|364715004|FG001|Overall Study|Withdrawal by Subject|4|||
105743600|NCT00740779|364715005|FG002|Overall Study|Withdrawal by Subject|2|||
105743601|NCT00740779|364715003|FG000|Overall Study|Lost to Follow-up|2|||
105743602|NCT00740779|364715004|FG001|Overall Study|Lost to Follow-up|3|||
105743603|NCT00740779|364715005|FG002|Overall Study|Lost to Follow-up|5|||
105743604|NCT00850460|364715006|FG000|Overall Study|Lost to Follow-up|4|||
105743605|NCT00850460|364715007|FG001|Overall Study|Lost to Follow-up|4|||
105743606|NCT02203838|364715010|FG000|Overall Study|Lack of Efficacy|7|||
105743607|NCT02203838|364715011|FG001|Overall Study|Lack of Efficacy|0|||
105743608|NCT02203838|364715012|FG002|Overall Study|Lack of Efficacy|1|||
105743609|NCT02203838|364715013|FG003|Overall Study|Lack of Efficacy|1|||
105743610|NCT02203838|364715010|FG000|Overall Study|Adverse Event|46|||
105743611|NCT02203838|364715011|FG001|Overall Study|Adverse Event|6|||
105743612|NCT02203838|364715012|FG002|Overall Study|Adverse Event|3|||
105743613|NCT02203838|364715013|FG003|Overall Study|Adverse Event|2|||
105743614|NCT02203838|364715010|FG000|Overall Study|Lost to Follow-up|39|||
105743615|NCT02203838|364715011|FG001|Overall Study|Lost to Follow-up|3|||
105743616|NCT02203838|364715012|FG002|Overall Study|Lost to Follow-up|2|||
105743617|NCT02203838|364715013|FG003|Overall Study|Lost to Follow-up|1|||
105743618|NCT02203838|364715010|FG000|Overall Study|Protocol Violation|7|||
105359050|NCT01844817|363320873|FG001|Treatment|Other|3|||
105359051|NCT00588146|363320877|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
105800369|NCT01889862|364926450|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
105800370|NCT01889862|364926451|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
105800371|NCT01889862|364926452|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
105359052|NCT00588146|363320878|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
105743619|NCT02203838|364715011|FG001|Overall Study|Protocol Violation|3|||
105743620|NCT02203838|364715012|FG002|Overall Study|Protocol Violation|0|||
105743621|NCT02203838|364715013|FG003|Overall Study|Protocol Violation|0|||
105743622|NCT02203838|364715010|FG000|Overall Study|Withdrawal by Subject|83|||
105743623|NCT02203838|364715011|FG001|Overall Study|Withdrawal by Subject|10|||
105743624|NCT02203838|364715012|FG002|Overall Study|Withdrawal by Subject|8|||
105743625|NCT02203838|364715013|FG003|Overall Study|Withdrawal by Subject|11|||
105743626|NCT02203838|364715010|FG000|Overall Study|Physician Decision|27|||
105359053|NCT02501161|363320883|FG000|Overall Study|Adverse Event|2|||
105359054|NCT02501161|363320884|FG001|Overall Study|Adverse Event|6|||
105359055|NCT02501161|363320883|FG000|Overall Study|Lost to Follow-up|7|||
105743627|NCT02203838|364715011|FG001|Overall Study|Physician Decision|0|||
105359056|NCT02501161|363320884|FG001|Overall Study|Lost to Follow-up|4|||
105743628|NCT02203838|364715012|FG002|Overall Study|Physician Decision|2|||
105743629|NCT02203838|364715013|FG003|Overall Study|Physician Decision|3|||
105743630|NCT02203838|364715010|FG000|Overall Study|Other|1|||
105743631|NCT02203838|364715011|FG001|Overall Study|Other|0|||
105743632|NCT02203838|364715012|FG002|Overall Study|Other|0|||
105743633|NCT02203838|364715013|FG003|Overall Study|Other|0|||
105743634|NCT04590937|364715014|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
105743635|NCT01635933|364715015|FG000|Overall Study|Adverse Event|1|||
105743636|NCT01635933|364715016|FG001|Overall Study|Adverse Event|0|||
105743637|NCT01635933|364715015|FG000|Overall Study|Lost to Follow-up|0|||
105743638|NCT01635933|364715016|FG001|Overall Study|Lost to Follow-up|5|||
105743639|NCT01635933|364715015|FG000|Overall Study|Subject decision|1|||
105743640|NCT01635933|364715016|FG001|Overall Study|Subject decision|1|||
105743641|NCT01635933|364715015|FG000|Overall Study|Noncompliance|0|||
105743642|NCT01635933|364715016|FG001|Overall Study|Noncompliance|1|||
105743643|NCT01635933|364715015|FG000|Overall Study|No longer had transportation|0|||
105743644|NCT01635933|364715016|FG001|Overall Study|No longer had transportation|1|||
105743645|NCT01555463|364715021|FG000|Treatment|Adverse Event|6|||
105743646|NCT01555463|364715022|FG001|Treatment|Adverse Event|12|||
105743647|NCT01555463|364715021|FG000|Treatment|Withdrawal by Subject|24|||
105743648|NCT01555463|364715022|FG001|Treatment|Withdrawal by Subject|36|||
105743649|NCT01555463|364715021|FG000|Treatment|Lost to Follow-up|28|||
105743650|NCT01555463|364715022|FG001|Treatment|Lost to Follow-up|23|||
105743651|NCT01555463|364715021|FG000|Treatment|Protocol Violation|4|||
105743652|NCT01555463|364715022|FG001|Treatment|Protocol Violation|5|||
105743653|NCT01555463|364715021|FG000|Treatment|Other reason|2|||
105743654|NCT01555463|364715022|FG001|Treatment|Other reason|3|||
105743655|NCT01555463|364715021|FG000|Follow up|Adverse Event|2|||
105743656|NCT01555463|364715022|FG001|Follow up|Adverse Event|5|||
105743657|NCT01555463|364715021|FG000|Follow up|Death|0|||
105743658|NCT01555463|364715022|FG001|Follow up|Death|1|||
105743659|NCT01555463|364715021|FG000|Follow up|Withdrawal by Subject|22|||
105743660|NCT01555463|364715022|FG001|Follow up|Withdrawal by Subject|22|||
105743661|NCT01555463|364715021|FG000|Follow up|Lost to Follow-up|9|||
105743662|NCT01555463|364715022|FG001|Follow up|Lost to Follow-up|10|||
105743663|NCT01555463|364715021|FG000|Follow up|Protocol Violation|2|||
105743664|NCT01555463|364715022|FG001|Follow up|Protocol Violation|4|||
105743665|NCT01555463|364715021|FG000|Follow up|Other reason|3|||
105743666|NCT01555463|364715022|FG001|Follow up|Other reason|3|||
105743667|NCT00320385|364715024|FG000|Overall Study|Lost to Follow-up|7|||
105743668|NCT00320385|364715025|FG001|Overall Study|Lost to Follow-up|10|||
105743669|NCT00320385|364715024|FG000|Overall Study|Withdrawal by Subject|6|||
105743670|NCT00320385|364715025|FG001|Overall Study|Withdrawal by Subject|7|||
105743671|NCT00320385|364715024|FG000|Overall Study|Sponsor Terminated Study|2|||
105743672|NCT00320385|364715025|FG001|Overall Study|Sponsor Terminated Study|1|||
105743673|NCT00320385|364715024|FG000|Overall Study|Investigator Decision|0|||
105743674|NCT00320385|364715025|FG001|Overall Study|Investigator Decision|1|||
105743675|NCT00320385|364715024|FG000|Overall Study|Death|1|||
105743676|NCT00320385|364715025|FG001|Overall Study|Death|2|||
105743677|NCT00320385|364715024|FG000|Overall Study|Serious Adverse Event|1|||
105743678|NCT00320385|364715025|FG001|Overall Study|Serious Adverse Event|0|||
105743679|NCT00320385|364715024|FG000|Overall Study|Withdrew Consent|1|||
105743680|NCT00320385|364715025|FG001|Overall Study|Withdrew Consent|0|||
105743681|NCT00320385|364715024|FG000|Overall Study|Adverse Event|0|||
105743682|NCT00320385|364715025|FG001|Overall Study|Adverse Event|1|||
105743683|NCT04370028|364715026|FG000|Overall Study|Withdrawal by Subject|695|||
105743684|NCT04370028|364715026|FG000|Overall Study|Protocol Violation|9|||
105743685|NCT04370028|364715026|FG000|Overall Study|Adverse Event|3|||
105743686|NCT00222729|364715027|FG000|Overall Study|Adverse Event|3|||
105743687|NCT02213198|364715032|FG000|Baseline|No show for intake|7|||
105743688|NCT02213198|364715033|FG001|Baseline|No show for intake|9|||
105743689|NCT02213198|364715032|FG000|Baseline|Withdrawal by Subject|34|||
105743690|NCT02213198|364715033|FG001|Baseline|Withdrawal by Subject|11|||
105743691|NCT02213198|364715032|FG000|Baseline|transferred out of clinic|7|||
105743692|NCT02213198|364715033|FG001|Baseline|transferred out of clinic|9|||
105743693|NCT02213198|364715032|FG000|Baseline|Lost to Follow-up|40|||
105743694|NCT02213198|364715033|FG001|Baseline|Lost to Follow-up|21|||
105743695|NCT02213198|364715032|FG000|Baseline|incarcerated,violent|0|||
105743696|NCT02213198|364715033|FG001|Baseline|incarcerated,violent|1|||
105743697|NCT02213198|364715032|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
105743698|NCT02213198|364715033|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
105743699|NCT02213198|364715032|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
105743700|NCT02213198|364715033|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
105743701|NCT02213198|364715032|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
105743702|NCT02213198|364715033|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
105743703|NCT02213198|364715032|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
105743704|NCT02213198|364715033|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
105743705|NCT02213198|364715032|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
105743706|NCT02213198|364715033|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
105743707|NCT02213198|364715032|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
105743708|NCT02213198|364715033|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
105743709|NCT03135028|364715034|FG000|Overall Study|Death|6|||
105743710|NCT03135028|364715034|FG000|Overall Study|Study Terminated by Sponsor|2|||
105743711|NCT03135028|364715034|FG000|Overall Study|Withdrew Consent|1|||
105743712|NCT02379923|364715038|FG000|Overall Study|Death|5|||
105743713|NCT03844633|364715039|FG000|1 Week FU|Lost to Follow-up|0|||
105743714|NCT03844633|364715040|FG001|1 Week FU|Lost to Follow-up|1|||
105743715|NCT03844633|364715041|FG002|1 Week FU|Lost to Follow-up|4|||
105743716|NCT03844633|364715039|FG000|12-month Follow-up|Lost to Follow-up|7|||
105743717|NCT03844633|364715040|FG001|12-month Follow-up|Lost to Follow-up|5|||
105743718|NCT03844633|364715041|FG002|12-month Follow-up|Lost to Follow-up|8|||
105743719|NCT05896761|364715042|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
105743720|NCT05896761|364715043|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
105743721|NCT05896761|364715042|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
105743722|NCT05896761|364715043|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
105743723|NCT03552549|364715044|FG000|Overall Study|Disease progression|25|||
105743724|NCT03552549|364715045|FG001|Overall Study|Disease progression|17|||
105743725|NCT03552549|364715044|FG000|Overall Study|Adverse event in first 12 months|12|||
105743726|NCT03552549|364715045|FG001|Overall Study|Adverse event in first 12 months|8|||
105743727|NCT03552549|364715044|FG000|Overall Study|Withdrawal by Subject|7|||
105743728|NCT03552549|364715045|FG001|Overall Study|Withdrawal by Subject|7|||
105743729|NCT03552549|364715044|FG000|Overall Study|Unknown (no reason provided)|4|||
105743730|NCT03552549|364715045|FG001|Overall Study|Unknown (no reason provided)|2|||
105743731|NCT03552549|364715044|FG000|Overall Study|Not in participant's best interest|2|||
105743732|NCT03552549|364715045|FG001|Overall Study|Not in participant's best interest|1|||
105743733|NCT03552549|364715044|FG000|Overall Study|Did not complete study treatment|2|||
105743734|NCT03552549|364715045|FG001|Overall Study|Did not complete study treatment|3|||
105743735|NCT03552549|364715044|FG000|Overall Study|Did not meet eligibility criteria|1|||
105743736|NCT03552549|364715045|FG001|Overall Study|Did not meet eligibility criteria|0|||
105743737|NCT03552549|364715044|FG000|Overall Study|Administrative|0|||
105743738|NCT03552549|364715045|FG001|Overall Study|Administrative|14|||
105743739|NCT03288779|364715046|FG000|Overall Study|Withdrawal by Subject|3|||
105743740|NCT01355068|364715047|FG000|First Intervention Period|Adverse Event|0|||
105743741|NCT01355068|364715048|FG001|First Intervention Period|Adverse Event|1|||
105743742|NCT01355068|364715047|FG000|First Intervention Period|Withdrawal by Subject|0|||
105743743|NCT01355068|364715048|FG001|First Intervention Period|Withdrawal by Subject|1|||
105743744|NCT00524745|364715049|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
105743745|NCT00524745|364715050|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
105743746|NCT00524745|364715051|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
105743747|NCT00524745|364715052|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
105743748|NCT00540449|364715053|FG000|Overall Study|Adverse Event|12|||
105743749|NCT00540449|364715054|FG001|Overall Study|Adverse Event|32|||
105743750|NCT00540449|364715053|FG000|Overall Study|Sponsor's Decision|1|||
105743751|NCT00540449|364715054|FG001|Overall Study|Sponsor's Decision|1|||
105743752|NCT00540449|364715053|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
105743753|NCT00540449|364715054|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
105743754|NCT00540449|364715053|FG000|Overall Study|Lost to Follow-up|19|||
105743755|NCT00540449|364715054|FG001|Overall Study|Lost to Follow-up|17|||
105743756|NCT00540449|364715053|FG000|Overall Study|Subject Non-Compliant|7|||
105743757|NCT00540449|364715054|FG001|Overall Study|Subject Non-Compliant|5|||
105743758|NCT00540449|364715053|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
105743759|NCT00540449|364715054|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
105743760|NCT00540449|364715053|FG000|Overall Study|Withdrawal by Subject|10|||
105743761|NCT00540449|364715054|FG001|Overall Study|Withdrawal by Subject|10|||
105743762|NCT00540449|364715053|FG000|Overall Study|Other|1|||
105743763|NCT00540449|364715054|FG001|Overall Study|Other|4|||
105743764|NCT00601523|364715055|FG000|Overall Study|Adverse Event|42|||
105743765|NCT00601523|364715056|FG001|Overall Study|Adverse Event|14|||
105743766|NCT00601523|364715055|FG000|Overall Study|Lack of Efficacy|3|||
105743767|NCT00601523|364715056|FG001|Overall Study|Lack of Efficacy|0|||
105743768|NCT00601523|364715055|FG000|Overall Study|Protocol Violation|5|||
105743769|NCT00601523|364715056|FG001|Overall Study|Protocol Violation|1|||
105743770|NCT00601523|364715055|FG000|Overall Study|Lost to Follow-up|0|||
105743771|NCT00601523|364715056|FG001|Overall Study|Lost to Follow-up|1|||
105743772|NCT00601523|364715055|FG000|Overall Study|Withdrawal by Subject|18|||
105743773|NCT00601523|364715056|FG001|Overall Study|Withdrawal by Subject|9|||
105743774|NCT00601523|364715055|FG000|Overall Study|Other|9|||
105743775|NCT00601523|364715056|FG001|Overall Study|Other|1|||
105743776|NCT03643432|364715057|FG000|Overall Study|Lost to Follow-up|1|||
105743777|NCT03643432|364715058|FG001|Overall Study|Lost to Follow-up|0|||
105359057|NCT02501161|363320883|FG000|Overall Study|Withdrawal by Subject|10|||
105359058|NCT02501161|363320884|FG001|Overall Study|Withdrawal by Subject|15|||
105359059|NCT02501161|363320883|FG000|Overall Study|Other|3|||
105359060|NCT02501161|363320884|FG001|Overall Study|Other|0|||
105359061|NCT00667992|363320887|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
105359062|NCT00667992|363320888|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
105359063|NCT00667992|363320887|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
105359064|NCT00667992|363320888|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
105359065|NCT00667992|363320887|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
105359066|NCT00667992|363320888|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
105359067|NCT00667992|363320887|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
105359068|NCT00667992|363320888|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
105359069|NCT00667992|363320887|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
105359070|NCT00667992|363320888|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
105359071|NCT00667992|363320887|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
105359072|NCT00667992|363320888|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
105743778|NCT00953043|364716786|FG000|Overall Study|Withdrawal by Subject|4|||
105743779|NCT00953043|364716787|FG001|Overall Study|Withdrawal by Subject|0|||
105743780|NCT00953043|364716786|FG000|Overall Study|Physician Decision|0|||
105743781|NCT00953043|364716787|FG001|Overall Study|Physician Decision|2|||
105743782|NCT01251276|364716791|FG000|Overall Study|Protocol Violation|1|||
105743783|NCT01251276|364716792|FG001|Overall Study|Protocol Violation|0|||
105743784|NCT01251276|364716791|FG000|Overall Study|Lost to Follow-up|0|||
105743785|NCT01251276|364716792|FG001|Overall Study|Lost to Follow-up|1|||
105743786|NCT01345123|364716793|FG000|Overall Study|participants no longer with health plan|79|||
105743787|NCT01345123|364716794|FG001|Overall Study|participants no longer with health plan|85|||
105743788|NCT01345123|364716795|FG002|Overall Study|participants no longer with health plan|88|||
105743789|NCT03703375|364716796|FG000|Randomization Period|Withdrawal by Subject|0|||
105743790|NCT03703375|364716797|FG001|Randomization Period|Withdrawal by Subject|0|||
105743791|NCT03703375|364716798|FG002|Randomization Period|Withdrawal by Subject|0|||
105743792|NCT03703375|364716799|FG003|Randomization Period|Withdrawal by Subject|1|||
105743793|NCT03703375|364716796|FG000|Randomization Period|Completed safety run-in treatment|7|||
105743794|NCT03703375|364716797|FG001|Randomization Period|Completed safety run-in treatment|0|||
105743795|NCT03703375|364716798|FG002|Randomization Period|Completed safety run-in treatment|0|||
105743796|NCT03703375|364716799|FG003|Randomization Period|Completed safety run-in treatment|0|||
105743797|NCT03703375|364716796|FG000|Treatment Period|Other Reasons|0|||
105743798|NCT03703375|364716797|FG001|Treatment Period|Other Reasons|1|||
105743799|NCT03703375|364716798|FG002|Treatment Period|Other Reasons|0|||
105743800|NCT03703375|364716799|FG003|Treatment Period|Other Reasons|3|||
105743801|NCT03703375|364716796|FG000|Treatment Period|Consent Withdrawal|0|||
105743802|NCT03703375|364716797|FG001|Treatment Period|Consent Withdrawal|0|||
105743803|NCT03703375|364716798|FG002|Treatment Period|Consent Withdrawal|0|||
105743804|NCT03703375|364716799|FG003|Treatment Period|Consent Withdrawal|1|||
105743805|NCT03703375|364716796|FG000|Treatment Period|Death|1|||
105743806|NCT03703375|364716797|FG001|Treatment Period|Death|0|||
105743807|NCT03703375|364716798|FG002|Treatment Period|Death|1|||
105743808|NCT03703375|364716799|FG003|Treatment Period|Death|2|||
105743809|NCT03703375|364716796|FG000|Treatment Period|Toxicity of Study Treatment|2|||
105743810|NCT03703375|364716797|FG001|Treatment Period|Toxicity of Study Treatment|0|||
105743811|NCT03703375|364716798|FG002|Treatment Period|Toxicity of Study Treatment|4|||
105743812|NCT03703375|364716799|FG003|Treatment Period|Toxicity of Study Treatment|1|||
105743813|NCT03703375|364716796|FG000|Treatment Period|Progression|32|||
105743814|NCT03703375|364716797|FG001|Treatment Period|Progression|1|||
105743815|NCT03703375|364716798|FG002|Treatment Period|Progression|7|||
105743816|NCT03703375|364716799|FG003|Treatment Period|Progression|11|||
105743817|NCT03703375|364716796|FG000|Treatment Period|Completed treatment|7|||
105743818|NCT03703375|364716797|FG001|Treatment Period|Completed treatment|2|||
105743819|NCT03703375|364716798|FG002|Treatment Period|Completed treatment|0|||
105743820|NCT03703375|364716799|FG003|Treatment Period|Completed treatment|0|||
105743821|NCT00625365|364716801|FG000|Overall Study|Withdrawal by Subject|1|||
105743822|NCT00625365|364716801|FG000|Overall Study|No IV access|5|||
105743823|NCT00625365|364716801|FG000|Overall Study|VSD|1|||
105359073|NCT00667992|363320887|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
105800372|NCT01889862|364926453|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
105800373|NCT01889862|364926454|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
105359074|NCT00667992|363320888|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
105483115|NCT01227824|363780865|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
105565361|NCT04058353|364066763|FG001|Overall Study|Physician Decision|0|||
105743824|NCT00366548|364716802|FG000|Infant Series|Adverse Event|1|||
105743825|NCT00366548|364716803|FG001|Infant Series|Adverse Event|3|||
105743826|NCT00366548|364716802|FG000|Infant Series|Protocol Violation|0|||
105743827|NCT00366548|364716803|FG001|Infant Series|Protocol Violation|1|||
105743828|NCT00366548|364716802|FG000|Infant Series|Withdrawal by Subject|3|||
105743829|NCT00366548|364716803|FG001|Infant Series|Withdrawal by Subject|1|||
105359075|NCT00667992|363320887|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
105359076|NCT00667992|363320888|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
105359077|NCT00667992|363320887|FG000|Wash-out|Not within one doubling dilution|4|||
105359078|NCT00667992|363320888|FG001|Wash-out|Not within one doubling dilution|3|||
105359079|NCT00667992|363320887|FG000|Wash-out|Failure to wash-out|2|||
105359080|NCT00667992|363320888|FG001|Wash-out|Failure to wash-out|2|||
105359081|NCT00667992|363320887|FG000|Wash-out|Withdrawal by Subject|1|||
105359082|NCT00667992|363320888|FG001|Wash-out|Withdrawal by Subject|0|||
105743830|NCT00366548|364716802|FG000|After Infant Series|Withdrawal by Subject|3|||
105743831|NCT00366548|364716803|FG001|After Infant Series|Withdrawal by Subject|1|||
105743832|NCT00366548|364716802|FG000|After Infant Series|Adverse Event|2|||
105743833|NCT00366548|364716803|FG001|After Infant Series|Adverse Event|0|||
105743834|NCT00366548|364716802|FG000|After Infant Series|Lost to Follow-up|1|||
105743835|NCT00366548|364716803|FG001|After Infant Series|Lost to Follow-up|0|||
105743836|NCT02849990|364716804|FG000|Overall Study|Adverse Event|1|||
105743837|NCT02849990|364716804|FG000|Overall Study|Withdrawal by Subject|1|||
105743838|NCT01051986|364716805|FG000|Overall Study|Death|1|||
105743839|NCT01051986|364716806|FG001|Overall Study|Death|0|||
105743840|NCT01051986|364716805|FG000|Overall Study|Withdrawal by Subject|2|||
105743841|NCT01051986|364716806|FG001|Overall Study|Withdrawal by Subject|1|||
105743842|NCT01051986|364716805|FG000|Overall Study|Protocol Violation|2|||
105743843|NCT01051986|364716806|FG001|Overall Study|Protocol Violation|3|||
105743844|NCT00623467|364716807|FG000|Overall Study|Lost to Follow-up|1|||
105743845|NCT00623467|364716807|FG000|Overall Study|Protocol Violation|4|||
105743846|NCT00623467|364716807|FG000|Overall Study|Withdrawal by Subject|2|||
105743847|NCT02179515|364716808|FG000|Overall Study|switched to alternative treatment|0|||
105743848|NCT02179515|364716809|FG001|Overall Study|switched to alternative treatment|1|||
105743849|NCT02179515|364716810|FG002|Overall Study|switched to alternative treatment|1|||
105743850|NCT02179515|364716808|FG000|Overall Study|Death|0|||
105743851|NCT02179515|364716809|FG001|Overall Study|Death|1|||
105743852|NCT02179515|364716810|FG002|Overall Study|Death|1|||
105743853|NCT02179515|364716808|FG000|Overall Study|refused further treatment|0|||
105743854|NCT02179515|364716809|FG001|Overall Study|refused further treatment|3|||
105743855|NCT02179515|364716810|FG002|Overall Study|refused further treatment|4|||
105743856|NCT02179515|364716808|FG000|Overall Study|Disease progression on study|2|||
105743857|NCT02179515|364716809|FG001|Overall Study|Disease progression on study|11|||
105743858|NCT02179515|364716810|FG002|Overall Study|Disease progression on study|8|||
105743859|NCT00411788|364716812|FG000|Overall Study|Protocol Violation|1|||
105743860|NCT00411788|364716812|FG000|Overall Study|Adverse Event|1|||
105743861|NCT00879814|364716813|FG000|Overall Study|Adverse Event|0|||
105743862|NCT00879814|364716814|FG001|Overall Study|Adverse Event|1|||
105743863|NCT00879814|364716815|FG002|Overall Study|Adverse Event|0|||
105743864|NCT00879814|364716816|FG003|Overall Study|Adverse Event|0|||
105743865|NCT00879814|364716813|FG000|Overall Study|Lost to Follow-up|1|||
105743866|NCT00879814|364716814|FG001|Overall Study|Lost to Follow-up|0|||
105743867|NCT00879814|364716815|FG002|Overall Study|Lost to Follow-up|0|||
105743868|NCT00879814|364716816|FG003|Overall Study|Lost to Follow-up|2|||
105743869|NCT00879814|364716813|FG000|Overall Study|Participant Failed to Return|0|||
105743870|NCT00879814|364716814|FG001|Overall Study|Participant Failed to Return|0|||
105743871|NCT00879814|364716815|FG002|Overall Study|Participant Failed to Return|0|||
105743872|NCT00879814|364716816|FG003|Overall Study|Participant Failed to Return|1|||
105743873|NCT00879814|364716813|FG000|Overall Study|Withdrawal by Subject|3|||
105359083|NCT00667992|363320887|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
105359084|NCT00667992|363320888|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
105359085|NCT00667992|363320887|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
105359086|NCT00667992|363320888|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
105359087|NCT03335813|363320889|FG000|Overall Study|Withdrawal by Subject|1|||
105359088|NCT02861664|363320892|FG000|Overall Study|Withdrawal of Consent|0|||
105359089|NCT02861664|363320893|FG001|Overall Study|Withdrawal of Consent|1|||
105359090|NCT01223404|363320895|FG000|First Intervention (1 Day)|Adverse Event|0|||
105743874|NCT00879814|364716814|FG001|Overall Study|Withdrawal by Subject|1|||
105743875|NCT00879814|364716815|FG002|Overall Study|Withdrawal by Subject|1|||
105743876|NCT00879814|364716816|FG003|Overall Study|Withdrawal by Subject|2|||
105743877|NCT00879814|364716813|FG000|Overall Study|Physician Decision|0|||
105743878|NCT00879814|364716814|FG001|Overall Study|Physician Decision|0|||
105743879|NCT00879814|364716815|FG002|Overall Study|Physician Decision|1|||
105743880|NCT00879814|364716816|FG003|Overall Study|Physician Decision|0|||
105743881|NCT00879814|364716813|FG000|Overall Study|Other|0|||
105743882|NCT00879814|364716814|FG001|Overall Study|Other|0|||
105743883|NCT00879814|364716815|FG002|Overall Study|Other|1|||
105743884|NCT00879814|364716816|FG003|Overall Study|Other|0|||
105359091|NCT01223404|363320896|FG001|First Intervention (1 Day)|Adverse Event|0|||
105359092|NCT01223404|363320897|FG002|First Intervention (1 Day)|Adverse Event|0|||
105743885|NCT01554956|364716819|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
105800374|NCT01889862|364926450|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
105800375|NCT01889862|364926451|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
105743886|NCT01554956|364716820|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
105743887|NCT01554956|364716821|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
105743888|NCT01554956|364716819|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
105743889|NCT01554956|364716820|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
105743890|NCT01554956|364716821|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
105743891|NCT01554956|364716819|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
105743892|NCT01554956|364716820|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
105743893|NCT01554956|364716821|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
105743894|NCT01428063|364716822|FG000|Overall Study|Lack of Efficacy|8|||
105743895|NCT01428063|364716823|FG001|Overall Study|Lack of Efficacy|4|||
105743896|NCT01428063|364716824|FG002|Overall Study|Lack of Efficacy|1|||
105743897|NCT01428063|364716822|FG000|Overall Study|Adverse Event|2|||
105743898|NCT01428063|364716823|FG001|Overall Study|Adverse Event|3|||
105743899|NCT01428063|364716824|FG002|Overall Study|Adverse Event|0|||
105743900|NCT01428063|364716822|FG000|Overall Study|Lost to Follow-up|0|||
105743901|NCT01428063|364716823|FG001|Overall Study|Lost to Follow-up|2|||
105743902|NCT01428063|364716824|FG002|Overall Study|Lost to Follow-up|0|||
105743903|NCT01428063|364716822|FG000|Overall Study|No longer meets study criteria|0|||
105743904|NCT01428063|364716823|FG001|Overall Study|No longer meets study criteria|1|||
105743905|NCT01428063|364716824|FG002|Overall Study|No longer meets study criteria|0|||
105743906|NCT00069095|364716825|FG000|Primary Treatment Phase|Ongoing|0|||
105743907|NCT00069095|364716826|FG001|Primary Treatment Phase|Ongoing|0|||
105743908|NCT00069095|364716827|FG002|Primary Treatment Phase|Ongoing|5|||
105743909|NCT00069095|364716828|FG003|Primary Treatment Phase|Ongoing|7|||
105743910|NCT00069095|364716829|FG004|Primary Treatment Phase|Ongoing|7|||
105743911|NCT00069095|364716830|FG005|Primary Treatment Phase|Ongoing|4|||
105743912|NCT00069095|364716825|FG000|Primary Treatment Phase|Admin/Other|29|||
105743913|NCT00069095|364716826|FG001|Primary Treatment Phase|Admin/Other|38|||
105743914|NCT00069095|364716827|FG002|Primary Treatment Phase|Admin/Other|31|||
105743915|NCT00069095|364716828|FG003|Primary Treatment Phase|Admin/Other|45|||
105743916|NCT00069095|364716829|FG004|Primary Treatment Phase|Admin/Other|48|||
105743917|NCT00069095|364716830|FG005|Primary Treatment Phase|Admin/Other|42|||
105743918|NCT00069095|364716825|FG000|Primary Treatment Phase|Adverse Event|99|||
105743919|NCT00069095|364716826|FG001|Primary Treatment Phase|Adverse Event|92|||
105743920|NCT00069095|364716827|FG002|Primary Treatment Phase|Adverse Event|71|||
105743921|NCT00069095|364716828|FG003|Primary Treatment Phase|Adverse Event|72|||
105743922|NCT00069095|364716829|FG004|Primary Treatment Phase|Adverse Event|109|||
105743923|NCT00069095|364716830|FG005|Primary Treatment Phase|Adverse Event|101|||
105743924|NCT00069095|364716825|FG000|Primary Treatment Phase|Death|14|||
105743925|NCT00069095|364716826|FG001|Primary Treatment Phase|Death|8|||
105743926|NCT00069095|364716827|FG002|Primary Treatment Phase|Death|2|||
105743927|NCT00069095|364716828|FG003|Primary Treatment Phase|Death|5|||
105743928|NCT00069095|364716829|FG004|Primary Treatment Phase|Death|8|||
105743929|NCT00069095|364716830|FG005|Primary Treatment Phase|Death|8|||
105743930|NCT00069095|364716825|FG000|Primary Treatment Phase|Failure to return|5|||
105743931|NCT00069095|364716826|FG001|Primary Treatment Phase|Failure to return|5|||
105743932|NCT00069095|364716827|FG002|Primary Treatment Phase|Failure to return|0|||
105743933|NCT00069095|364716828|FG003|Primary Treatment Phase|Failure to return|0|||
105743934|NCT00069095|364716829|FG004|Primary Treatment Phase|Failure to return|0|||
105743935|NCT00069095|364716830|FG005|Primary Treatment Phase|Failure to return|2|||
105743936|NCT00069095|364716825|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
105743937|NCT00069095|364716826|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
105743938|NCT00069095|364716827|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
105743939|NCT00069095|364716828|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
105743940|NCT00069095|364716829|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
105743941|NCT00069095|364716830|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
105743942|NCT00069095|364716825|FG000|Primary Treatment Phase|Refused treatment|15|||
105743943|NCT00069095|364716826|FG001|Primary Treatment Phase|Refused treatment|26|||
105743944|NCT00069095|364716827|FG002|Primary Treatment Phase|Refused treatment|17|||
105743945|NCT00069095|364716828|FG003|Primary Treatment Phase|Refused treatment|31|||
105743946|NCT00069095|364716829|FG004|Primary Treatment Phase|Refused treatment|24|||
105743947|NCT00069095|364716830|FG005|Primary Treatment Phase|Refused treatment|27|||
105800376|NCT01889862|364926452|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
105743948|NCT00069095|364716825|FG000|Primary Treatment Phase|Withdrew|2|||
105743949|NCT00069095|364716826|FG001|Primary Treatment Phase|Withdrew|3|||
105743950|NCT00069095|364716827|FG002|Primary Treatment Phase|Withdrew|8|||
105743951|NCT00069095|364716828|FG003|Primary Treatment Phase|Withdrew|2|||
105743952|NCT00069095|364716829|FG004|Primary Treatment Phase|Withdrew|4|||
105743953|NCT00069095|364716830|FG005|Primary Treatment Phase|Withdrew|9|||
105743954|NCT00069095|364716825|FG000|Primary Treatment Phase|Other Violation|0|||
105743955|NCT00069095|364716826|FG001|Primary Treatment Phase|Other Violation|1|||
105743956|NCT00069095|364716827|FG002|Primary Treatment Phase|Other Violation|1|||
105743957|NCT00069095|364716828|FG003|Primary Treatment Phase|Other Violation|1|||
105743958|NCT00069095|364716829|FG004|Primary Treatment Phase|Other Violation|0|||
105743959|NCT00069095|364716830|FG005|Primary Treatment Phase|Other Violation|1|||
105743960|NCT00069095|364716825|FG000|Primary Treatment Phase|Violation criteria|0|||
105743961|NCT00069095|364716826|FG001|Primary Treatment Phase|Violation criteria|2|||
105743962|NCT00069095|364716827|FG002|Primary Treatment Phase|Violation criteria|4|||
105743963|NCT00069095|364716828|FG003|Primary Treatment Phase|Violation criteria|3|||
105743964|NCT00069095|364716829|FG004|Primary Treatment Phase|Violation criteria|1|||
105743965|NCT00069095|364716830|FG005|Primary Treatment Phase|Violation criteria|5|||
105743966|NCT00069095|364716825|FG000|Post-study Treatment Phase|Missing reason|1|||
105743967|NCT00069095|364716826|FG001|Post-study Treatment Phase|Missing reason|3|||
105743968|NCT00069095|364716827|FG002|Post-study Treatment Phase|Missing reason|12|||
105743969|NCT00069095|364716828|FG003|Post-study Treatment Phase|Missing reason|8|||
105743970|NCT00069095|364716829|FG004|Post-study Treatment Phase|Missing reason|18|||
105743971|NCT00069095|364716830|FG005|Post-study Treatment Phase|Missing reason|17|||
105743972|NCT00069095|364716825|FG000|Post-study Treatment Phase|Adverse Event|2|||
105743973|NCT00069095|364716826|FG001|Post-study Treatment Phase|Adverse Event|3|||
105743974|NCT00069095|364716827|FG002|Post-study Treatment Phase|Adverse Event|1|||
105743975|NCT00069095|364716828|FG003|Post-study Treatment Phase|Adverse Event|0|||
105743976|NCT00069095|364716829|FG004|Post-study Treatment Phase|Adverse Event|5|||
105743977|NCT00069095|364716830|FG005|Post-study Treatment Phase|Adverse Event|1|||
105743978|NCT00069095|364716825|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
105743979|NCT00069095|364716826|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
105743980|NCT00069095|364716827|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
105743981|NCT00069095|364716828|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
105743982|NCT00069095|364716829|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
105743983|NCT00069095|364716830|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
105743984|NCT00069095|364716825|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
105743985|NCT00069095|364716826|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
105743986|NCT00069095|364716827|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
105743987|NCT00069095|364716828|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
105743988|NCT00069095|364716829|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
105743989|NCT00069095|364716830|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
105743990|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
105743991|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
105743992|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
105743993|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
105743994|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
105743995|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
105743996|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant had complete response|1|||
105743997|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant had complete response|1|||
105743998|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant had complete response|0|||
105743999|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant had complete response|0|||
105744000|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant had complete response|0|||
105744001|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant had complete response|0|||
105744002|NCT00069095|364716825|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
105744003|NCT00069095|364716826|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
105744004|NCT00069095|364716827|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
105744005|NCT00069095|364716828|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
105744006|NCT00069095|364716829|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
105744007|NCT00069095|364716830|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
105744008|NCT00069095|364716825|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
105744009|NCT00069095|364716826|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
105744010|NCT00069095|364716827|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
105744011|NCT00069095|364716828|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
105744012|NCT00069095|364716829|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
105359093|NCT01223404|363320898|FG003|First Intervention (1 Day)|Adverse Event|1|||
105744013|NCT00069095|364716830|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
105744014|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
105744015|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
105744016|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
105744017|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
105744018|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
105744019|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
105744020|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
105744021|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
105744022|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
105744023|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
105744024|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
105744025|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
105744026|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
105744027|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
105744028|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
105744029|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
105744030|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
105744031|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
105744032|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
105744033|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
105744034|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
105744035|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
105744036|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
105744037|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
105744038|NCT00069095|364716825|FG000|Post-study Treatment Phase|Surgery|0|||
105744039|NCT00069095|364716826|FG001|Post-study Treatment Phase|Surgery|0|||
105744040|NCT00069095|364716827|FG002|Post-study Treatment Phase|Surgery|0|||
105744041|NCT00069095|364716828|FG003|Post-study Treatment Phase|Surgery|1|||
105744042|NCT00069095|364716829|FG004|Post-study Treatment Phase|Surgery|1|||
105744043|NCT00069095|364716830|FG005|Post-study Treatment Phase|Surgery|0|||
105744044|NCT00069095|364716825|FG000|Post-study Treatment Phase|Death|0|||
105744045|NCT00069095|364716826|FG001|Post-study Treatment Phase|Death|0|||
105744046|NCT00069095|364716827|FG002|Post-study Treatment Phase|Death|0|||
105744047|NCT00069095|364716828|FG003|Post-study Treatment Phase|Death|0|||
105744048|NCT00069095|364716829|FG004|Post-study Treatment Phase|Death|1|||
105744049|NCT00069095|364716830|FG005|Post-study Treatment Phase|Death|0|||
105744050|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
105744051|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
105744052|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
105744053|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
105744054|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
105744055|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
105744056|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
105744057|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
105744058|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
105744059|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
105744060|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
105744061|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
105744062|NCT00069095|364716825|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
105744063|NCT00069095|364716826|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
105744064|NCT00069095|364716827|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
105744065|NCT00069095|364716828|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
105744066|NCT00069095|364716829|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
105744067|NCT00069095|364716830|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
105744068|NCT00069095|364716825|FG000|Post-study Treatment Phase|Investigator decision|0|||
105800377|NCT01889862|364926453|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
105800378|NCT01889862|364926454|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
105800379|NCT00971204|364926455|FG000|Overall Study|Did not meet all criteria-not treated|14|||
105800380|NCT00971204|364926455|FG000|Overall Study|Lost to Follow-up|10|||
105800381|NCT00879970|364926459|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
105359094|NCT01223404|363320899|FG004|First Intervention (1 Day)|Adverse Event|0|||
105744069|NCT00069095|364716826|FG001|Post-study Treatment Phase|Investigator decision|0|||
105744070|NCT00069095|364716827|FG002|Post-study Treatment Phase|Investigator decision|0|||
105744071|NCT00069095|364716828|FG003|Post-study Treatment Phase|Investigator decision|0|||
105744072|NCT00069095|364716829|FG004|Post-study Treatment Phase|Investigator decision|0|||
105744073|NCT00069095|364716830|FG005|Post-study Treatment Phase|Investigator decision|1|||
105744074|NCT00069095|364716825|FG000|Follow-up Phase|Death|174|||
105359095|NCT01223404|363320900|FG005|First Intervention (1 Day)|Adverse Event|0|||
105359096|NCT01223404|363320895|FG000|Second Intervention (1 Day)|Adverse Event|1|||
105359097|NCT01223404|363320896|FG001|Second Intervention (1 Day)|Adverse Event|0|||
105744075|NCT00069095|364716826|FG001|Follow-up Phase|Death|206|||
105744076|NCT00069095|364716827|FG002|Follow-up Phase|Death|120|||
105744077|NCT00069095|364716828|FG003|Follow-up Phase|Death|112|||
105744078|NCT00069095|364716829|FG004|Follow-up Phase|Death|92|||
105744079|NCT00069095|364716830|FG005|Follow-up Phase|Death|101|||
105744080|NCT00506077|364716831|FG000|Treatment Period 1|Adverse Event|2|||
105744081|NCT00506077|364716832|FG001|Treatment Period 1|Adverse Event|1|||
105744082|NCT00506077|364716831|FG000|Treatment Period 1|Lost to Follow-up|0|||
105744083|NCT00506077|364716832|FG001|Treatment Period 1|Lost to Follow-up|2|||
105744084|NCT00506077|364716831|FG000|Treatment Period 1|Withdrawal by Subject|2|||
105744085|NCT00506077|364716832|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105744086|NCT00506077|364716831|FG000|Treatment Period 2|Adverse Event|0|||
105744087|NCT00506077|364716832|FG001|Treatment Period 2|Adverse Event|1|||
105565362|NCT04058353|364066762|FG000|Overall Study|Other|1|||
105744088|NCT00506077|364716831|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105744089|NCT00506077|364716832|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105744090|NCT00532948|364716835|FG000|Overall Study|Protocol Violation|1|||
105744091|NCT00532948|364716836|FG001|Overall Study|Protocol Violation|0|||
105744092|NCT00532948|364716837|FG002|Overall Study|Protocol Violation|0|||
105744093|NCT00532948|364716835|FG000|Overall Study|Death|3|||
105744094|NCT00532948|364716836|FG001|Overall Study|Death|3|||
105744095|NCT00532948|364716837|FG002|Overall Study|Death|4|||
105744096|NCT00532948|364716835|FG000|Overall Study|Violation of selection criteria at entry|0|||
105744097|NCT00532948|364716836|FG001|Overall Study|Violation of selection criteria at entry|1|||
105744098|NCT00532948|364716837|FG002|Overall Study|Violation of selection criteria at entry|0|||
105744099|NCT00532948|364716835|FG000|Overall Study|Failure to return|0|||
105744100|NCT00532948|364716836|FG001|Overall Study|Failure to return|1|||
105744101|NCT00532948|364716837|FG002|Overall Study|Failure to return|0|||
105744102|NCT01087528|364716843|FG000|Overall Study|Withdrawal by Subject|1|||
105744103|NCT01087528|364716843|FG000|Overall Study|Incomplete CE procedure|6|||
105744104|NCT03116399|364716848|FG000|Overall Study|Death|8|||
105744105|NCT03116399|364716849|FG001|Overall Study|Death|3|||
105744106|NCT03116399|364716848|FG000|Overall Study|Lost to Follow-up|7|||
105744107|NCT03116399|364716849|FG001|Overall Study|Lost to Follow-up|11|||
105744108|NCT03116399|364716848|FG000|Overall Study|Investigator Decision|1|||
105744109|NCT03116399|364716849|FG001|Overall Study|Investigator Decision|1|||
105744110|NCT03116399|364716848|FG000|Overall Study|Withdrawal by Subject|24|||
105744111|NCT03116399|364716849|FG001|Overall Study|Withdrawal by Subject|9|||
105744112|NCT00069576|364716852|FG000|Original Trial|Lost to Follow-up|25|||
105744113|NCT00069576|364716853|FG001|Original Trial|Lost to Follow-up|33|||
105744114|NCT00069576|364716852|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
105744115|NCT00069576|364716853|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
105744116|NCT02496585|364716854|FG000|Overall Study|Death|3|||
105744117|NCT02496585|364716855|FG001|Overall Study|Death|0|||
105744118|NCT02496585|364716854|FG000|Overall Study|Lost to Follow-up|2|||
105744119|NCT02496585|364716855|FG001|Overall Study|Lost to Follow-up|0|||
105744120|NCT02496585|364716854|FG000|Overall Study|Withdrawal by Subject|1|||
105744121|NCT02496585|364716855|FG001|Overall Study|Withdrawal by Subject|2|||
105744122|NCT02496585|364716854|FG000|Overall Study|Progression of Malignancy|4|||
105744123|NCT02496585|364716855|FG001|Overall Study|Progression of Malignancy|1|||
105359098|NCT01223404|363320897|FG002|Second Intervention (1 Day)|Adverse Event|0|||
105359099|NCT01223404|363320898|FG003|Second Intervention (1 Day)|Adverse Event|0|||
105359100|NCT01223404|363320899|FG004|Second Intervention (1 Day)|Adverse Event|0|||
105359101|NCT01223404|363320900|FG005|Second Intervention (1 Day)|Adverse Event|0|||
105359102|NCT01223404|363320895|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
105359103|NCT01223404|363320896|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
105359104|NCT01223404|363320897|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
105359105|NCT01223404|363320898|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
105359106|NCT01223404|363320899|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
105359107|NCT01223404|363320900|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
105359108|NCT00707057|363320901|FG000|Overall Study|Withdrawal by Subject|8|||
105565363|NCT04058353|364066763|FG001|Overall Study|Other|0|||
105744124|NCT02702193|364716856|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
105744125|NCT02702193|364716857|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
105744126|NCT02702193|364716856|FG000|4 Month Follow up|Withdrawal by Subject|1|||
105744127|NCT02702193|364716857|FG001|4 Month Follow up|Withdrawal by Subject|0|||
105744128|NCT02702193|364716856|FG000|4 Month Follow up|Lost to Follow-up|17|||
105744129|NCT02702193|364716857|FG001|4 Month Follow up|Lost to Follow-up|18|||
105744130|NCT02702193|364716856|FG000|8 Month Follow up|Withdrawal by Subject|1|||
105744131|NCT02702193|364716857|FG001|8 Month Follow up|Withdrawal by Subject|0|||
105800382|NCT00879970|364926460|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
105800383|NCT00879970|364926461|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
105800384|NCT00879970|364926462|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
105800385|NCT00879970|364926463|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
105800386|NCT00879970|364926459|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
105800387|NCT00879970|364926460|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
105800388|NCT00879970|364926461|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
105800389|NCT00879970|364926462|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
105800390|NCT00879970|364926463|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
105800391|NCT00879970|364926459|FG000|Period 1 TZD Randomization|Death|2|||
105800392|NCT00879970|364926460|FG001|Period 1 TZD Randomization|Death|1|||
105800393|NCT00879970|364926461|FG002|Period 1 TZD Randomization|Death|0|||
105800394|NCT00879970|364926462|FG003|Period 1 TZD Randomization|Death|0|||
105800395|NCT00879970|364926463|FG004|Period 1 TZD Randomization|Death|0|||
105800396|NCT00879970|364926459|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
105800397|NCT00879970|364926460|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
105800398|NCT00879970|364926461|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
105800399|NCT00879970|364926462|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
105800400|NCT00879970|364926463|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
105800401|NCT00879970|364926459|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
105800402|NCT00879970|364926460|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
105800403|NCT00879970|364926461|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
105800404|NCT00879970|364926462|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
105800405|NCT00879970|364926463|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
105800406|NCT00879970|364926459|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
105800407|NCT00879970|364926460|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
105800408|NCT00879970|364926461|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
105800409|NCT00879970|364926462|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
105800410|NCT00879970|364926463|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
105800411|NCT00879970|364926459|FG000|Period 2 Vitamin D Randomization|Death|0|||
105800412|NCT00879970|364926460|FG001|Period 2 Vitamin D Randomization|Death|0|||
105800413|NCT00879970|364926461|FG002|Period 2 Vitamin D Randomization|Death|0|||
105359109|NCT00707057|363320902|FG001|Overall Study|Withdrawal by Subject|3|||
105359110|NCT00707057|363320901|FG000|Overall Study|Dosed incorrectly|0|||
105359111|NCT00707057|363320902|FG001|Overall Study|Dosed incorrectly|1|||
105359112|NCT00632125|363320903|FG000|Overall Study|Death|82|||
105359113|NCT00632125|363320903|FG000|Overall Study|Withdrawal by Subject|44|||
105359114|NCT00632125|363320903|FG000|Overall Study|Adverse Event|36|||
105359115|NCT00632125|363320903|FG000|Overall Study|Renal transplantation|17|||
105359116|NCT00632125|363320903|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
105359117|NCT00632125|363320903|FG000|Overall Study|Non-compliance|8|||
105359118|NCT00632125|363320903|FG000|Overall Study|Development of uncontrolled hypertension|5|||
105359119|NCT00632125|363320903|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
105359120|NCT02384538|363320910|FG000|Overall Study|Adverse Event|1|||
105359121|NCT02384538|363320911|FG001|Overall Study|Adverse Event|4|||
105359122|NCT02384538|363320910|FG000|Overall Study|Lack of Efficacy|4|||
105359123|NCT02384538|363320911|FG001|Overall Study|Lack of Efficacy|4|||
105359124|NCT02384538|363320910|FG000|Overall Study|Withdrew Consent|0|||
105359125|NCT02384538|363320911|FG001|Overall Study|Withdrew Consent|4|||
105359126|NCT02384538|363320910|FG000|Overall Study|Other|1|||
105359127|NCT02384538|363320911|FG001|Overall Study|Other|3|||
105359128|NCT04446429|363320912|FG000|Overall Study|Lost to Follow-up|6|||
105359129|NCT04446429|363320913|FG001|Overall Study|Lost to Follow-up|0|||
105359130|NCT02256917|363320914|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
105359131|NCT02256917|363320914|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
105359132|NCT02256917|363320914|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
105359133|NCT02256917|363320914|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
105359134|NCT02256917|363320914|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
105359135|NCT04152083|363320915|FG000|Overall Study|Lost to Follow-up|2|||
105359136|NCT04152083|363320916|FG001|Overall Study|Lost to Follow-up|1|||
105359137|NCT04152083|363320915|FG000|Overall Study|Adverse Event|1|||
105359138|NCT04152083|363320916|FG001|Overall Study|Adverse Event|0|||
105359139|NCT04152083|363320915|FG000|Overall Study|Randomized but not treated|3|||
105359140|NCT04152083|363320916|FG001|Overall Study|Randomized but not treated|2|||
105359141|NCT03076996|363320919|FG000|Overall Study|Withdrawal by Subject|2|||
105359142|NCT03076996|363320919|FG000|Overall Study|Lost to Follow-up|3|||
105359143|NCT03076996|363320919|FG000|Overall Study|Literacy precluded participation|1|||
105359144|NCT00540644|363320923|FG000|Overall Study|Adverse Event|3|||
105359145|NCT00540644|363320924|FG001|Overall Study|Adverse Event|1|||
105359146|NCT00540644|363320923|FG000|Overall Study|Disease Progression|3|||
105359147|NCT00540644|363320924|FG001|Overall Study|Disease Progression|1|||
105483116|NCT01227824|363780866|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
105744132|NCT02702193|364716856|FG000|8 Month Follow up|Lost to Follow-up|14|||
105744133|NCT02702193|364716857|FG001|8 Month Follow up|Lost to Follow-up|18|||
105744134|NCT02702193|364716856|FG000|12 Month Follow up|Withdrawal by Subject|1|||
105744135|NCT02702193|364716857|FG001|12 Month Follow up|Withdrawal by Subject|0|||
105744136|NCT02702193|364716856|FG000|12 Month Follow up|Lost to Follow-up|16|||
105744137|NCT02702193|364716857|FG001|12 Month Follow up|Lost to Follow-up|18|||
105744138|NCT00358917|364716858|FG000|Overall Study|Adverse Event|14|||
105744139|NCT00358917|364716859|FG001|Overall Study|Adverse Event|21|||
105744140|NCT00358917|364716858|FG000|Overall Study|Withdrawal by Subject|5|||
105744141|NCT00358917|364716859|FG001|Overall Study|Withdrawal by Subject|7|||
105744142|NCT00358917|364716858|FG000|Overall Study|Lost to Follow-up|20|||
105744143|NCT00358917|364716859|FG001|Overall Study|Lost to Follow-up|17|||
105744144|NCT00358917|364716858|FG000|Overall Study|Noncompliance|12|||
105744145|NCT00358917|364716859|FG001|Overall Study|Noncompliance|11|||
105744146|NCT00358917|364716858|FG000|Overall Study|Death|2|||
105744147|NCT00358917|364716859|FG001|Overall Study|Death|3|||
105744148|NCT00358917|364716858|FG000|Overall Study|Virologic failure|11|||
105744149|NCT00358917|364716859|FG001|Overall Study|Virologic failure|8|||
105744150|NCT00358917|364716858|FG000|Overall Study|Unable to Continue Participation|2|||
105744151|NCT00358917|364716859|FG001|Overall Study|Unable to Continue Participation|2|||
105744152|NCT05091060|364716868|FG000|Overall Study|Lost to Follow-up|1|||
105744153|NCT01798706|364716869|FG000|Overall Study|Adverse Event|15|||
105744154|NCT01798706|364716870|FG001|Overall Study|Adverse Event|10|||
105744155|NCT01798706|364716869|FG000|Overall Study|Lack of Efficacy|0|||
105744156|NCT01798706|364716870|FG001|Overall Study|Lack of Efficacy|2|||
105744157|NCT01798706|364716869|FG000|Overall Study|Poor compliance to protocol|1|||
105744158|NCT01798706|364716870|FG001|Overall Study|Poor compliance to protocol|0|||
105744159|NCT01798706|364716869|FG000|Overall Study|Other than specified above|5|||
105744160|NCT01798706|364716870|FG001|Overall Study|Other than specified above|9|||
105744161|NCT00496873|364716871|FG000|Overall Study|Ineligible|2|||
105744162|NCT00496873|364716871|FG000|Overall Study|Death|2|||
105744163|NCT00496873|364716871|FG000|Overall Study|Withdrawal by Subject|3|||
105744164|NCT02775864|364716872|FG000|Overall Study|Data ended end of 2010|1764|||
105744165|NCT02775864|364716873|FG001|Overall Study|Data ended end of 2010|2880|||
105744166|NCT02775864|364716874|FG002|Overall Study|Data ended end of 2010|1140|||
105744167|NCT02775864|364716875|FG003|Overall Study|Data ended end of 2010|1194|||
105744168|NCT02775864|364716872|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
105744169|NCT02775864|364716873|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
105744170|NCT02775864|364716874|FG002|Overall Study|Medicaid eligibility discontinued|720|||
105744171|NCT02775864|364716875|FG003|Overall Study|Medicaid eligibility discontinued|890|||
105744172|NCT03238235|364716876|FG000|Overall Study|Adverse Event|2|||
105744173|NCT03238235|364716877|FG001|Overall Study|Adverse Event|0|||
105744174|NCT03238235|364716876|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
105744175|NCT03238235|364716877|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
105744176|NCT01318083|364716878|FG000|Overall Study|Adverse Event|4|||
105744177|NCT01318083|364716879|FG001|Overall Study|Adverse Event|1|||
105744178|NCT01318083|364716880|FG002|Overall Study|Adverse Event|2|||
105744179|NCT01318083|364716878|FG000|Overall Study|Withdrawal by Subject|1|||
105744180|NCT01318083|364716879|FG001|Overall Study|Withdrawal by Subject|0|||
105744181|NCT01318083|364716880|FG002|Overall Study|Withdrawal by Subject|2|||
105744182|NCT01318083|364716878|FG000|Overall Study|Lack of Efficacy|0|||
105744183|NCT01318083|364716879|FG001|Overall Study|Lack of Efficacy|0|||
105744184|NCT01318083|364716880|FG002|Overall Study|Lack of Efficacy|1|||
105744185|NCT01318083|364716878|FG000|Overall Study|Treatment Complications|1|||
105744186|NCT01318083|364716879|FG001|Overall Study|Treatment Complications|0|||
105744187|NCT01318083|364716880|FG002|Overall Study|Treatment Complications|0|||
105744188|NCT01318083|364716878|FG000|Overall Study|Lack of Study Medication Compliance|0|||
105744189|NCT01318083|364716879|FG001|Overall Study|Lack of Study Medication Compliance|1|||
105744190|NCT01318083|364716880|FG002|Overall Study|Lack of Study Medication Compliance|0|||
105744191|NCT02028338|364716881|FG000|Overall Study|Withdrawal by Subject|3|||
105744192|NCT02028338|364716882|FG001|Overall Study|Withdrawal by Subject|1|||
105744193|NCT02028338|364716881|FG000|Overall Study|Unable to contact participant|1|||
105744194|NCT02028338|364716882|FG001|Overall Study|Unable to contact participant|0|||
105744195|NCT00256867|364716890|FG000|Overall Study|Adverse Event|0|||
105744196|NCT00256867|364716891|FG001|Overall Study|Adverse Event|1|||
105744197|NCT00256867|364716892|FG002|Overall Study|Adverse Event|1|||
105744198|NCT00256867|364716893|FG003|Overall Study|Adverse Event|1|||
105744199|NCT00256867|364716894|FG004|Overall Study|Adverse Event|2|||
105744200|NCT00256867|364716895|FG005|Overall Study|Adverse Event|2|||
105744201|NCT00256867|364716896|FG006|Overall Study|Adverse Event|1|||
105744202|NCT00256867|364716897|FG007|Overall Study|Adverse Event|4|||
105744203|NCT00256867|364716890|FG000|Overall Study|Lost to Follow-up|2|||
105744204|NCT00256867|364716891|FG001|Overall Study|Lost to Follow-up|2|||
105744205|NCT00256867|364716892|FG002|Overall Study|Lost to Follow-up|2|||
105744206|NCT00256867|364716893|FG003|Overall Study|Lost to Follow-up|3|||
105744207|NCT00256867|364716894|FG004|Overall Study|Lost to Follow-up|2|||
105744208|NCT00256867|364716895|FG005|Overall Study|Lost to Follow-up|0|||
105744209|NCT00256867|364716896|FG006|Overall Study|Lost to Follow-up|1|||
105744210|NCT00256867|364716897|FG007|Overall Study|Lost to Follow-up|2|||
105744211|NCT00256867|364716890|FG000|Overall Study|Protocol Violation|0|||
105744212|NCT00256867|364716891|FG001|Overall Study|Protocol Violation|0|||
105744213|NCT00256867|364716892|FG002|Overall Study|Protocol Violation|0|||
105744214|NCT00256867|364716893|FG003|Overall Study|Protocol Violation|1|||
105744215|NCT00256867|364716894|FG004|Overall Study|Protocol Violation|0|||
105744216|NCT00256867|364716895|FG005|Overall Study|Protocol Violation|1|||
105744217|NCT00256867|364716896|FG006|Overall Study|Protocol Violation|0|||
105744218|NCT00256867|364716897|FG007|Overall Study|Protocol Violation|1|||
105744219|NCT00256867|364716890|FG000|Overall Study|Withdrawal by Subject|0|||
105744220|NCT00256867|364716891|FG001|Overall Study|Withdrawal by Subject|0|||
105744221|NCT00256867|364716892|FG002|Overall Study|Withdrawal by Subject|1|||
105744222|NCT00256867|364716893|FG003|Overall Study|Withdrawal by Subject|1|||
105744223|NCT00256867|364716894|FG004|Overall Study|Withdrawal by Subject|2|||
105744224|NCT00256867|364716895|FG005|Overall Study|Withdrawal by Subject|2|||
105744225|NCT00256867|364716896|FG006|Overall Study|Withdrawal by Subject|3|||
105744226|NCT00256867|364716897|FG007|Overall Study|Withdrawal by Subject|2|||
105744227|NCT00256867|364716890|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
105744228|NCT00256867|364716891|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
105744229|NCT00256867|364716892|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
105744230|NCT00256867|364716893|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
105744231|NCT00256867|364716894|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
105744232|NCT00256867|364716895|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
105744233|NCT00256867|364716896|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
105744234|NCT00256867|364716897|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
105744235|NCT00256867|364716890|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
105744236|NCT00256867|364716891|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
105744237|NCT00256867|364716892|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
105744238|NCT00256867|364716893|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
105744239|NCT00256867|364716894|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
105744240|NCT00256867|364716895|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
105744241|NCT00256867|364716896|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
105744242|NCT00256867|364716897|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
105744243|NCT00256867|364716890|FG000|Overall Study|Investigator's Decision|0|||
105744244|NCT00256867|364716891|FG001|Overall Study|Investigator's Decision|0|||
105744245|NCT00256867|364716892|FG002|Overall Study|Investigator's Decision|0|||
105744246|NCT00256867|364716893|FG003|Overall Study|Investigator's Decision|0|||
105744247|NCT00256867|364716894|FG004|Overall Study|Investigator's Decision|1|||
105744248|NCT00256867|364716895|FG005|Overall Study|Investigator's Decision|0|||
105744249|NCT00256867|364716896|FG006|Overall Study|Investigator's Decision|0|||
105744250|NCT00256867|364716897|FG007|Overall Study|Investigator's Decision|0|||
105744251|NCT00256867|364716890|FG000|Overall Study|Non-compliance with study medication|0|||
105744252|NCT00256867|364716891|FG001|Overall Study|Non-compliance with study medication|0|||
105744253|NCT00256867|364716892|FG002|Overall Study|Non-compliance with study medication|0|||
105744254|NCT00256867|364716893|FG003|Overall Study|Non-compliance with study medication|0|||
105744255|NCT00256867|364716894|FG004|Overall Study|Non-compliance with study medication|0|||
105744256|NCT00256867|364716895|FG005|Overall Study|Non-compliance with study medication|0|||
105744257|NCT00256867|364716896|FG006|Overall Study|Non-compliance with study medication|0|||
105744258|NCT00256867|364716897|FG007|Overall Study|Non-compliance with study medication|1|||
105744259|NCT00256867|364716890|FG000|Overall Study|Participant travelled Overseas|0|||
105744260|NCT00256867|364716891|FG001|Overall Study|Participant travelled Overseas|1|||
105744261|NCT00256867|364716892|FG002|Overall Study|Participant travelled Overseas|0|||
105744262|NCT00256867|364716893|FG003|Overall Study|Participant travelled Overseas|0|||
105744263|NCT00256867|364716894|FG004|Overall Study|Participant travelled Overseas|0|||
105744264|NCT00256867|364716895|FG005|Overall Study|Participant travelled Overseas|0|||
105744265|NCT00256867|364716896|FG006|Overall Study|Participant travelled Overseas|0|||
105744266|NCT00256867|364716897|FG007|Overall Study|Participant travelled Overseas|0|||
105744267|NCT00256867|364716890|FG000|Overall Study|Participant out of assessment window|0|||
105744268|NCT00256867|364716891|FG001|Overall Study|Participant out of assessment window|0|||
105744269|NCT00256867|364716892|FG002|Overall Study|Participant out of assessment window|1|||
105744270|NCT00256867|364716893|FG003|Overall Study|Participant out of assessment window|0|||
105744271|NCT00256867|364716894|FG004|Overall Study|Participant out of assessment window|0|||
105744272|NCT00256867|364716895|FG005|Overall Study|Participant out of assessment window|0|||
105744273|NCT00256867|364716896|FG006|Overall Study|Participant out of assessment window|0|||
105744274|NCT00256867|364716897|FG007|Overall Study|Participant out of assessment window|0|||
105800414|NCT00879970|364926462|FG003|Period 2 Vitamin D Randomization|Death|2|||
105744275|NCT00256867|364716890|FG000|Overall Study|Withdrawal by participant|0|||
105744276|NCT00256867|364716891|FG001|Overall Study|Withdrawal by participant|0|||
105800415|NCT00879970|364926463|FG004|Period 2 Vitamin D Randomization|Death|0|||
105744277|NCT00256867|364716892|FG002|Overall Study|Withdrawal by participant|0|||
105744278|NCT00256867|364716893|FG003|Overall Study|Withdrawal by participant|0|||
105744279|NCT00256867|364716894|FG004|Overall Study|Withdrawal by participant|0|||
105744280|NCT00256867|364716895|FG005|Overall Study|Withdrawal by participant|1|||
105744281|NCT00256867|364716896|FG006|Overall Study|Withdrawal by participant|0|||
105744282|NCT00256867|364716897|FG007|Overall Study|Withdrawal by participant|0|||
105744283|NCT03827473|364716901|FG000|Overall Study|Withdrawal by Subject|1|||
105744284|NCT03827473|364716902|FG001|Overall Study|Withdrawal by Subject|0|||
105744285|NCT03342469|364716903|FG000|Overall Study|Withdrawal by Subject|0|||
105744286|NCT03342469|364716904|FG001|Overall Study|Withdrawal by Subject|1|||
105744287|NCT03342469|364716905|FG002|Overall Study|Withdrawal by Subject|0|||
105744288|NCT03342469|364716906|FG003|Overall Study|Withdrawal by Subject|0|||
105744289|NCT00243230|364716907|FG000|Double-Blind Period|Adverse Event|0|||
105744290|NCT00243230|364716908|FG001|Double-Blind Period|Adverse Event|2|||
105744291|NCT00243230|364716909|FG002|Double-Blind Period|Adverse Event|2|||
105744292|NCT00243230|364716910|FG003|Double-Blind Period|Adverse Event|0|||
105744293|NCT00243230|364716907|FG000|Double-Blind Period|Withdrawal by Subject|1|||
105744294|NCT00243230|364716908|FG001|Double-Blind Period|Withdrawal by Subject|0|||
105744295|NCT00243230|364716909|FG002|Double-Blind Period|Withdrawal by Subject|0|||
105744296|NCT00243230|364716910|FG003|Double-Blind Period|Withdrawal by Subject|0|||
105744297|NCT00243230|364716907|FG000|Double-Blind Period|Protocol Violation|0|||
105744298|NCT00243230|364716908|FG001|Double-Blind Period|Protocol Violation|0|||
105744299|NCT00243230|364716909|FG002|Double-Blind Period|Protocol Violation|1|||
105744300|NCT00243230|364716910|FG003|Double-Blind Period|Protocol Violation|0|||
105744301|NCT00243230|364716907|FG000|Double-Blind Period|Randomized but Not Treated|0|||
105744302|NCT00243230|364716908|FG001|Double-Blind Period|Randomized but Not Treated|0|||
105744303|NCT00243230|364716909|FG002|Double-Blind Period|Randomized but Not Treated|2|||
105744304|NCT00243230|364716910|FG003|Double-Blind Period|Randomized but Not Treated|0|||
105744305|NCT00243230|364716907|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
105744306|NCT00243230|364716908|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
105744307|NCT00243230|364716909|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
105744308|NCT00243230|364716910|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
105744309|NCT00243230|364716907|FG000|Open Label Period|Adverse Event|0|||
105744310|NCT00243230|364716908|FG001|Open Label Period|Adverse Event|0|||
105744311|NCT00243230|364716909|FG002|Open Label Period|Adverse Event|0|||
105744312|NCT00243230|364716910|FG003|Open Label Period|Adverse Event|2|||
105744313|NCT00243230|364716907|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
105744314|NCT00243230|364716908|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
105744315|NCT00243230|364716909|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
105744316|NCT00243230|364716910|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
105744317|NCT00243230|364716907|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
105744318|NCT00243230|364716908|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
105744319|NCT00243230|364716909|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
105744320|NCT00243230|364716910|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
105744321|NCT00243230|364716907|FG000|Open Label Period|Lost to Follow-up|0|||
105744322|NCT00243230|364716908|FG001|Open Label Period|Lost to Follow-up|0|||
105744323|NCT00243230|364716909|FG002|Open Label Period|Lost to Follow-up|0|||
105744324|NCT00243230|364716910|FG003|Open Label Period|Lost to Follow-up|2|||
105744325|NCT00243230|364716907|FG000|Open Label Period|Withdrawal by Subject|0|||
105744326|NCT00243230|364716908|FG001|Open Label Period|Withdrawal by Subject|0|||
105744327|NCT00243230|364716909|FG002|Open Label Period|Withdrawal by Subject|0|||
105744328|NCT00243230|364716910|FG003|Open Label Period|Withdrawal by Subject|2|||
105744329|NCT00243230|364716907|FG000|Open Label Period|Protocol Violation|0|||
105744330|NCT00243230|364716908|FG001|Open Label Period|Protocol Violation|0|||
105744331|NCT00243230|364716909|FG002|Open Label Period|Protocol Violation|0|||
105744332|NCT00243230|364716910|FG003|Open Label Period|Protocol Violation|2|||
105744333|NCT00243230|364716907|FG000|Open Label Period|Administrative Reason|0|||
105744334|NCT00243230|364716908|FG001|Open Label Period|Administrative Reason|0|||
105744335|NCT00243230|364716909|FG002|Open Label Period|Administrative Reason|0|||
105744336|NCT00243230|364716910|FG003|Open Label Period|Administrative Reason|63|||
105744337|NCT04160468|364716914|FG000|Overall Study|Lost to Follow-up|19|||
105744338|NCT04160468|364716915|FG001|Overall Study|Lost to Follow-up|4|||
105744339|NCT04160468|364716914|FG000|Overall Study|Randomized but not dosed|6|||
105744340|NCT04160468|364716915|FG001|Overall Study|Randomized but not dosed|0|||
105744341|NCT04160468|364716914|FG000|Overall Study|Withdrawal by Subject|4|||
105744342|NCT04160468|364716915|FG001|Overall Study|Withdrawal by Subject|1|||
105744343|NCT04160468|364716914|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
105744344|NCT04160468|364716915|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
105744345|NCT04160468|364716914|FG000|Overall Study|Participant incarcerated|1|||
105744346|NCT04160468|364716915|FG001|Overall Study|Participant incarcerated|0|||
105744347|NCT01912768|364716916|FG000|Overall Study|Adverse Event|2|||
105744348|NCT01912768|364716917|FG001|Overall Study|Adverse Event|0|||
105744349|NCT01912768|364716916|FG000|Overall Study|Lost to Follow-up|2|||
105483117|NCT03836001|363780867|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
105744350|NCT01912768|364716917|FG001|Overall Study|Lost to Follow-up|1|||
105744351|NCT01912768|364716916|FG000|Overall Study|Withdrawal by Subject|5|||
105744352|NCT01912768|364716917|FG001|Overall Study|Withdrawal by Subject|3|||
105744353|NCT01912768|364716916|FG000|Overall Study|Randomized in error|1|||
105744354|NCT01912768|364716917|FG001|Overall Study|Randomized in error|0|||
105744355|NCT01402284|364716918|FG000|Overall Study|Withdrawal consent|2|||
105744356|NCT01402284|364716918|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
105744357|NCT01402284|364716918|FG000|Overall Study|Physician Decision|1|||
105744358|NCT01402284|364716918|FG000|Overall Study|Disease progression on study|10|||
105744359|NCT01199263|364716919|FG000|Overall Study|Ineligible|0|||
105744360|NCT01199263|364716920|FG001|Overall Study|Ineligible|2|||
105744361|NCT01199263|364716919|FG000|Overall Study|Never Treated|6|||
105744362|NCT01199263|364716920|FG001|Overall Study|Never Treated|0|||
105744363|NCT00540436|364716921|FG000|First 12-Week Treatment Period|Adverse Event|1|||
105744364|NCT00540436|364716921|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
105744365|NCT00540436|364716921|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
105744366|NCT00540436|364716921|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
105744367|NCT03255291|364716922|FG000|Overall Study|Determined to be ineligible|10|||
105744368|NCT03255291|364716923|FG001|Overall Study|Determined to be ineligible|12|||
105744369|NCT03255291|364716924|FG002|Overall Study|Determined to be ineligible|6|||
105744370|NCT03255291|364716925|FG003|Overall Study|Determined to be ineligible|6|||
105744371|NCT03255291|364716926|FG004|Overall Study|Determined to be ineligible|5|||
105744372|NCT03255291|364716927|FG005|Overall Study|Determined to be ineligible|10|||
105744373|NCT03255291|364716922|FG000|Overall Study|Baseline data collection issues|3|||
105744374|NCT03255291|364716923|FG001|Overall Study|Baseline data collection issues|0|||
105744375|NCT03255291|364716924|FG002|Overall Study|Baseline data collection issues|0|||
105744376|NCT03255291|364716925|FG003|Overall Study|Baseline data collection issues|0|||
105744377|NCT03255291|364716926|FG004|Overall Study|Baseline data collection issues|2|||
105744378|NCT03255291|364716927|FG005|Overall Study|Baseline data collection issues|0|||
105744379|NCT03987620|364716928|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
105744380|NCT03987620|364716929|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
105744381|NCT03987620|364716928|FG000|Overall Study|Adverse Event|3|||
105744382|NCT03987620|364716929|FG001|Overall Study|Adverse Event|0|||
105744383|NCT03987620|364716928|FG000|Overall Study|Lost to Follow-up|1|||
105744384|NCT03987620|364716929|FG001|Overall Study|Lost to Follow-up|2|||
105744385|NCT03987620|364716928|FG000|Overall Study|Physician Decision|0|||
105744386|NCT03987620|364716929|FG001|Overall Study|Physician Decision|1|||
105744387|NCT03987620|364716928|FG000|Overall Study|Pregnancy|1|||
105744388|NCT03987620|364716929|FG001|Overall Study|Pregnancy|0|||
105744389|NCT03987620|364716928|FG000|Overall Study|Withdrawal by Subject|7|||
105744390|NCT03987620|364716929|FG001|Overall Study|Withdrawal by Subject|1|||
105744391|NCT03987620|364716928|FG000|Overall Study|Other|2|||
105744392|NCT03987620|364716929|FG001|Overall Study|Other|5|||
105744393|NCT01204658|364716930|FG000|Primary Phase|Adverse Event|0|||
105744394|NCT01204658|364716931|FG001|Primary Phase|Adverse Event|0|||
105483118|NCT03836001|363780868|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
105744395|NCT01204658|364716932|FG002|Primary Phase|Adverse Event|1|||
105744396|NCT01204658|364716933|FG003|Primary Phase|Adverse Event|0|||
105744397|NCT04937816|364716934|FG000|Overall Study|Study drug stopped, reason missing|5|||
105800416|NCT00863057|364926464|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
105800417|NCT00863057|364926465|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
105800418|NCT00863057|364926466|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
105800419|NCT00863057|364926467|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
105800420|NCT00863057|364926464|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
105800421|NCT00863057|364926465|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
105800422|NCT00863057|364926466|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
105800423|NCT00863057|364926467|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
105800424|NCT00863057|364926464|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
105800425|NCT00863057|364926465|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
105800426|NCT00863057|364926466|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
105800427|NCT00863057|364926467|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
105800428|NCT00863057|364926464|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
105800429|NCT00863057|364926465|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
105800430|NCT00863057|364926466|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
105800431|NCT00863057|364926467|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
105800432|NCT01789281|364926472|FG000|Overall Study|Disease progression|15|||
105800433|NCT01789281|364926473|FG001|Overall Study|Disease progression|4|||
105800434|NCT01789281|364926472|FG000|Overall Study|Adverse Event|5|||
105800435|NCT01789281|364926473|FG001|Overall Study|Adverse Event|5|||
105800436|NCT01789281|364926472|FG000|Overall Study|Withdrawal by Subject|1|||
105800437|NCT01789281|364926473|FG001|Overall Study|Withdrawal by Subject|0|||
105800438|NCT01789281|364926472|FG000|Overall Study|Lost to Follow-up|1|||
105800439|NCT01789281|364926473|FG001|Overall Study|Lost to Follow-up|0|||
105800440|NCT01789281|364926472|FG000|Overall Study|Administrative problems|0|||
105800441|NCT01789281|364926473|FG001|Overall Study|Administrative problems|1|||
105800442|NCT00106028|364926474|FG000|Overall Study|Adverse Event|3|||
105800443|NCT00106028|364926475|FG001|Overall Study|Adverse Event|2|||
105800444|NCT00106028|364926474|FG000|Overall Study|Protocol Violation|1|||
105800445|NCT00106028|364926475|FG001|Overall Study|Protocol Violation|1|||
105800446|NCT00106028|364926474|FG000|Overall Study|Withdrawal by Subject|2|||
105800447|NCT00106028|364926475|FG001|Overall Study|Withdrawal by Subject|8|||
105800448|NCT00106028|364926474|FG000|Overall Study|Lost to Follow-up|0|||
105800449|NCT00106028|364926475|FG001|Overall Study|Lost to Follow-up|1|||
105800450|NCT00814658|364926476|FG000|Overall Study|Lost to Follow-up|0|||
105800451|NCT00814658|364926477|FG001|Overall Study|Lost to Follow-up|1|||
105800452|NCT00814658|364926476|FG000|Overall Study|Physician Decision|1|||
105800453|NCT00814658|364926477|FG001|Overall Study|Physician Decision|0|||
105800454|NCT00814658|364926476|FG000|Overall Study|Adverse Event|3|||
105800455|NCT00814658|364926477|FG001|Overall Study|Adverse Event|3|||
105800456|NCT00738920|364926484|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
105800457|NCT00738920|364926485|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
105800458|NCT00738920|364926486|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
105359148|NCT00540644|363320923|FG000|Overall Study|Physician Decision|0|||
105744398|NCT04937816|364716935|FG001|Overall Study|Study drug stopped, reason missing|3|||
105744399|NCT04937816|364716936|FG002|Overall Study|Study drug stopped, reason missing|4|||
105744400|NCT04937816|364716937|FG003|Overall Study|Study drug stopped, reason missing|6|||
105744401|NCT04937816|364716938|FG004|Overall Study|Study drug stopped, reason missing|1|||
105744402|NCT04937816|364716939|FG005|Overall Study|Study drug stopped, reason missing|0|||
105744403|NCT04937816|364716940|FG006|Overall Study|Study drug stopped, reason missing|0|||
105744404|NCT04937816|364716934|FG000|Overall Study|Other than stated below|173|||
105744405|NCT04937816|364716935|FG001|Overall Study|Other than stated below|143|||
105744406|NCT04937816|364716936|FG002|Overall Study|Other than stated below|125|||
105744407|NCT04937816|364716937|FG003|Overall Study|Other than stated below|44|||
105744408|NCT04937816|364716938|FG004|Overall Study|Other than stated below|45|||
105744409|NCT04937816|364716939|FG005|Overall Study|Other than stated below|28|||
105359149|NCT00540644|363320924|FG001|Overall Study|Physician Decision|5|||
105744410|NCT04937816|364716940|FG006|Overall Study|Other than stated below|31|||
105744411|NCT04937816|364716934|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
105744412|NCT04937816|364716935|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
105744413|NCT04937816|364716936|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
105744414|NCT04937816|364716937|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
105800459|NCT00738920|364926484|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
105800460|NCT00738920|364926485|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
105800461|NCT00738920|364926486|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
105800462|NCT00738920|364926484|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
105800463|NCT00738920|364926485|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
105800464|NCT00738920|364926486|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
105800465|NCT00738920|364926484|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
105800466|NCT00738920|364926485|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
105483119|NCT03836001|363780869|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
105800467|NCT00738920|364926486|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
105800468|NCT00738920|364926484|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
105359150|NCT00540644|363320923|FG000|Overall Study|Withdrawal by Subject|2|||
105359151|NCT00540644|363320924|FG001|Overall Study|Withdrawal by Subject|2|||
105359152|NCT00540644|363320923|FG000|Overall Study|Noncomplilance|1|||
105359153|NCT00540644|363320924|FG001|Overall Study|Noncomplilance|0|||
105359154|NCT03280056|363320927|FG000|Overall Study|Withdrawal by Subject|12|||
105359155|NCT03280056|363320928|FG001|Overall Study|Withdrawal by Subject|14|||
105359156|NCT03280056|363320927|FG000|Overall Study|Death|9|||
105359157|NCT03280056|363320928|FG001|Overall Study|Death|2|||
105359158|NCT03280056|363320927|FG000|Overall Study|Adverse Event|1|||
105359159|NCT03280056|363320928|FG001|Overall Study|Adverse Event|3|||
105359160|NCT03280056|363320927|FG000|Overall Study|Lost to Follow-up|1|||
105359161|NCT03280056|363320928|FG001|Overall Study|Lost to Follow-up|1|||
105359162|NCT03280056|363320927|FG000|Overall Study|Physician Decision|0|||
105359163|NCT03280056|363320928|FG001|Overall Study|Physician Decision|1|||
105359164|NCT03280056|363320927|FG000|Overall Study|Early Discontinuation|1|||
105359165|NCT03280056|363320928|FG001|Overall Study|Early Discontinuation|0|||
105359166|NCT02144077|363320929|FG000|Overall Study|Withdrawal by Subject|3|||
105359167|NCT02144077|363320930|FG001|Overall Study|Withdrawal by Subject|3|||
105359168|NCT02144077|363320929|FG000|Overall Study|Adverse Event|2|||
105359169|NCT02144077|363320930|FG001|Overall Study|Adverse Event|3|||
105359170|NCT02144077|363320929|FG000|Overall Study|Lost to Follow-up|2|||
105359171|NCT02144077|363320930|FG001|Overall Study|Lost to Follow-up|2|||
105359172|NCT02144077|363320929|FG000|Overall Study|Protocol Violation|1|||
105359173|NCT02144077|363320930|FG001|Overall Study|Protocol Violation|2|||
105359174|NCT02144077|363320929|FG000|Overall Study|Death|0|||
105359175|NCT02144077|363320930|FG001|Overall Study|Death|1|||
105359176|NCT02144077|363320929|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
105359177|NCT02144077|363320930|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
105359178|NCT00613821|363320931|FG000|Overall Study|Withdrawal by Subject|1|||
105359179|NCT00613821|363320932|FG001|Overall Study|Withdrawal by Subject|0|||
105359180|NCT00613821|363320931|FG000|Overall Study|Physician Decision|1|||
105359181|NCT00613821|363320932|FG001|Overall Study|Physician Decision|1|||
105359182|NCT05464420|363320936|FG000|Overall Study|Death|0|||
105359183|NCT05464420|363320937|FG001|Overall Study|Death|0|||
105359184|NCT05464420|363320938|FG002|Overall Study|Death|0|||
105359185|NCT05464420|363320939|FG003|Overall Study|Death|1|||
105359186|NCT05464420|363320936|FG000|Overall Study|Lost to Follow-up|16|||
105359187|NCT05464420|363320937|FG001|Overall Study|Lost to Follow-up|11|||
105483120|NCT03836001|363780867|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
105483121|NCT03836001|363780868|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
105744415|NCT04937816|364716938|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
105744416|NCT04937816|364716939|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
105744417|NCT04937816|364716940|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
105744418|NCT04937816|364716934|FG000|Overall Study|Lost to Follow-up|15|||
105744419|NCT04937816|364716935|FG001|Overall Study|Lost to Follow-up|9|||
105744420|NCT04937816|364716936|FG002|Overall Study|Lost to Follow-up|6|||
105744421|NCT04937816|364716937|FG003|Overall Study|Lost to Follow-up|6|||
105744422|NCT04937816|364716938|FG004|Overall Study|Lost to Follow-up|16|||
105744423|NCT04937816|364716939|FG005|Overall Study|Lost to Follow-up|11|||
105744424|NCT04937816|364716940|FG006|Overall Study|Lost to Follow-up|17|||
105744425|NCT04937816|364716934|FG000|Overall Study|Protocol Violation|15|||
105744426|NCT04937816|364716935|FG001|Overall Study|Protocol Violation|15|||
105744427|NCT04937816|364716936|FG002|Overall Study|Protocol Violation|12|||
105744428|NCT04937816|364716937|FG003|Overall Study|Protocol Violation|30|||
105744429|NCT04937816|364716938|FG004|Overall Study|Protocol Violation|24|||
105744430|NCT04937816|364716939|FG005|Overall Study|Protocol Violation|5|||
105744431|NCT04937816|364716940|FG006|Overall Study|Protocol Violation|5|||
105744432|NCT04937816|364716934|FG000|Overall Study|Adverse Event|303|||
105744433|NCT04937816|364716935|FG001|Overall Study|Adverse Event|267|||
105744434|NCT04937816|364716936|FG002|Overall Study|Adverse Event|273|||
105744435|NCT04937816|364716937|FG003|Overall Study|Adverse Event|553|||
105744436|NCT04937816|364716938|FG004|Overall Study|Adverse Event|575|||
105744437|NCT04937816|364716939|FG005|Overall Study|Adverse Event|343|||
105744438|NCT04937816|364716940|FG006|Overall Study|Adverse Event|337|||
105744439|NCT04937816|364716934|FG000|Overall Study|Not treated|4|||
105744440|NCT04937816|364716935|FG001|Overall Study|Not treated|2|||
105744441|NCT04937816|364716936|FG002|Overall Study|Not treated|2|||
105744442|NCT04937816|364716937|FG003|Overall Study|Not treated|2|||
105744443|NCT04937816|364716938|FG004|Overall Study|Not treated|1|||
105359188|NCT05464420|363320938|FG002|Overall Study|Lost to Follow-up|11|||
105359189|NCT05464420|363320939|FG003|Overall Study|Lost to Follow-up|11|||
105359190|NCT05464420|363320936|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
105359191|NCT05464420|363320937|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
105359192|NCT05464420|363320938|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
105359193|NCT05464420|363320939|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
105359194|NCT05464420|363320936|FG000|Overall Study|Withdrawal by Subject|4|||
105359195|NCT05464420|363320937|FG001|Overall Study|Withdrawal by Subject|8|||
105359196|NCT05464420|363320938|FG002|Overall Study|Withdrawal by Subject|3|||
105744444|NCT04937816|364716939|FG005|Overall Study|Not treated|4|||
105359197|NCT05464420|363320939|FG003|Overall Study|Withdrawal by Subject|1|||
105359198|NCT05464420|363320936|FG000|Overall Study|Protocol Violation|0|||
105359199|NCT05464420|363320937|FG001|Overall Study|Protocol Violation|0|||
105359200|NCT05464420|363320938|FG002|Overall Study|Protocol Violation|1|||
105359201|NCT05464420|363320939|FG003|Overall Study|Protocol Violation|1|||
105359202|NCT05464420|363320936|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
105359203|NCT05464420|363320937|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
105359204|NCT05464420|363320938|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
105359205|NCT05464420|363320939|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
105359206|NCT02360280|363320940|FG000|Overall Study|Withdrawal by Subject|2|||
105359207|NCT02360280|363320941|FG001|Overall Study|Withdrawal by Subject|0|||
105359208|NCT02360280|363320940|FG000|Overall Study|Adverse Event|0|||
105359209|NCT02360280|363320941|FG001|Overall Study|Adverse Event|1|||
105359210|NCT02360280|363320940|FG000|Overall Study|Lost to Follow-up|1|||
105359211|NCT02360280|363320941|FG001|Overall Study|Lost to Follow-up|0|||
105359212|NCT01383018|363320949|FG000|Overall Study|Adverse Event|14|||
105359213|NCT01383018|363320949|FG000|Overall Study|Death|10|||
105359214|NCT01383018|363320949|FG000|Overall Study|Lost to Follow-up|5|||
105359215|NCT01383018|363320949|FG000|Overall Study|Physician Decision|5|||
105359216|NCT01383018|363320949|FG000|Overall Study|Withdrawal by Subject|9|||
105744445|NCT04937816|364716940|FG006|Overall Study|Not treated|0|||
105744446|NCT02364947|364719177|FG000|Overall Study|Withdrawal by Subject|10|||
105744447|NCT02364947|364719178|FG001|Overall Study|Withdrawal by Subject|8|||
105744448|NCT02364947|364719179|FG002|Overall Study|Withdrawal by Subject|9|||
105744449|NCT02364947|364719177|FG000|Overall Study|Adverse Event|45|||
105744450|NCT02364947|364719178|FG001|Overall Study|Adverse Event|33|||
105744451|NCT02364947|364719179|FG002|Overall Study|Adverse Event|11|||
105744452|NCT02364947|364719177|FG000|Overall Study|Protocol Violation|1|||
105744453|NCT02364947|364719178|FG001|Overall Study|Protocol Violation|1|||
105744454|NCT02364947|364719179|FG002|Overall Study|Protocol Violation|1|||
105744455|NCT02364947|364719177|FG000|Overall Study|Physician Decision|3|||
105744456|NCT02364947|364719178|FG001|Overall Study|Physician Decision|2|||
105744457|NCT02364947|364719179|FG002|Overall Study|Physician Decision|5|||
105744458|NCT02364947|364719177|FG000|Overall Study|Death|0|||
105744459|NCT02364947|364719178|FG001|Overall Study|Death|1|||
105744460|NCT02364947|364719179|FG002|Overall Study|Death|0|||
105744461|NCT05525975|364719180|FG000|Overall Study|Surgery cancellation|4|||
105744462|NCT05525975|364719181|FG001|Overall Study|Surgery cancellation|5|||
105744463|NCT05525975|364719180|FG000|Overall Study|didn't fill prescription|1|||
105744464|NCT05525975|364719181|FG001|Overall Study|didn't fill prescription|0|||
105744465|NCT05525975|364719180|FG000|Overall Study|Withdrawal by Subject|0|||
105744466|NCT05525975|364719181|FG001|Overall Study|Withdrawal by Subject|3|||
105744467|NCT00615290|364719182|FG000|Overall Study|Adverse Event|2|||
105744468|NCT00615290|364719182|FG000|Overall Study|Lost to Follow-up|3|||
105744469|NCT00615290|364719182|FG000|Overall Study|Withdrawal by Subject|1|||
105744470|NCT00615290|364719182|FG000|Overall Study|Other|2|||
105744471|NCT00441441|364719186|FG000|Overall Study|Adverse Event|2|||
105744472|NCT00441441|364719187|FG001|Overall Study|Adverse Event|1|||
105744473|NCT00441441|364719186|FG000|Overall Study|Protocol Violation|4|||
105744474|NCT00441441|364719187|FG001|Overall Study|Protocol Violation|6|||
105744475|NCT00441441|364719186|FG000|Overall Study|Exacerbation of asthma|1|||
105744476|NCT00441441|364719187|FG001|Overall Study|Exacerbation of asthma|2|||
105744477|NCT00441441|364719186|FG000|Overall Study|Withdrawal by Subject|1|||
105744478|NCT00441441|364719187|FG001|Overall Study|Withdrawal by Subject|2|||
105744479|NCT00441441|364719186|FG000|Overall Study|Other|3|||
105744480|NCT00441441|364719187|FG001|Overall Study|Other|3|||
105744481|NCT00262080|364719188|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
105744482|NCT00262080|364719189|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
105744483|NCT00262080|364719190|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
105744484|NCT00262080|364719188|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
105744485|NCT00262080|364719189|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
105744486|NCT00262080|364719190|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
105744487|NCT00262080|364719188|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
105744488|NCT00262080|364719189|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
105744489|NCT00262080|364719190|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
105800469|NCT00738920|364926485|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
105800470|NCT00738920|364926486|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
105359217|NCT01383018|363320949|FG000|Overall Study|Subject not implanted|76|||
105359218|NCT01383018|363320949|FG000|Overall Study|Missed Visit|247|||
105359219|NCT01383018|363320949|FG000|Overall Study|Site closed early-not compliance related|7|||
105359220|NCT01383018|363320949|FG000|Overall Study|Patient moved away from site|1|||
105744490|NCT00262080|364719188|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
105744491|NCT00262080|364719189|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
105744492|NCT00262080|364719190|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
105359221|NCT01383018|363320949|FG000|Overall Study|Subject Incarcerated|1|||
105359222|NCT01051817|363320951|FG000|Overall Study|Adverse Event|0|||
105800471|NCT00738920|364926484|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
105800472|NCT00738920|364926485|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
105800473|NCT00738920|364926486|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
105800474|NCT00738920|364926484|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
105800475|NCT00738920|364926485|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
105744493|NCT00262080|364719188|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
105800476|NCT00738920|364926486|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
105800477|NCT00738920|364926484|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
105800478|NCT00738920|364926485|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
105800479|NCT00738920|364926486|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
105800480|NCT00738920|364926484|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
105800481|NCT00738920|364926485|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
105800482|NCT00738920|364926486|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
105800483|NCT00738920|364926484|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
105800484|NCT00738920|364926485|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
105800485|NCT00738920|364926486|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
105800486|NCT02133352|364926487|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
105800487|NCT03016078|364926488|FG000|Overall Study|Protocol Violation|1|||
105800488|NCT03016078|364926488|FG000|Overall Study|Protocol Violation|1|||
105800489|NCT02378506|364926489|FG000|Overall Study|Lack of Efficacy|3|||
105800490|NCT02378506|364926489|FG000|Overall Study|Withdrawal by Subject|4|||
105800491|NCT02378506|364926489|FG000|Overall Study|Protocol Violation|2|||
105800492|NCT02378506|364926489|FG000|Overall Study|Death|1|||
105800493|NCT02378506|364926489|FG000|Overall Study|Adverse Event|14|||
105800494|NCT02378506|364926489|FG000|Overall Study|Randomized But Not Treated|1|||
105800495|NCT02557672|364926490|FG000|Overall Study|Withdrawal by Subject|4|||
105800496|NCT02557672|364926491|FG001|Overall Study|Withdrawal by Subject|2|||
105800497|NCT01355523|364928467|FG000|Overall Study|Withdrawal by Subject|1|||
105800498|NCT01355523|364928468|FG001|Overall Study|Withdrawal by Subject|4|||
105800499|NCT01355523|364928467|FG000|Overall Study|Lost to Follow-up|0|||
105800500|NCT01355523|364928468|FG001|Overall Study|Lost to Follow-up|2|||
105800501|NCT01355523|364928467|FG000|Overall Study|Protocol Violation|0|||
105800502|NCT01355523|364928468|FG001|Overall Study|Protocol Violation|2|||
105800503|NCT01355523|364928467|FG000|Overall Study|Adverse Event|0|||
105800504|NCT01355523|364928468|FG001|Overall Study|Adverse Event|2|||
105800505|NCT00566098|364928472|FG000|Collection of MILs|Withdrawal by Subject|1|||
105800506|NCT00566098|364928472|FG000|Collection of MILs|Relapsed|1|||
105800507|NCT00566098|364928472|FG000|Generation of MILs Product|Relapsed|1|||
105800508|NCT00566098|364928472|FG000|Administration of ASCT+MILs|Death|10|||
105800509|NCT00566098|364928472|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
105800510|NCT03836729|364928473|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
105800511|NCT02544633|364928476|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
105800512|NCT02544633|364928477|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
105800513|NCT02544633|364928478|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
105800514|NCT02544633|364928479|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
105744494|NCT00262080|364719189|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
105744495|NCT00262080|364719190|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
105800515|NCT02544633|364928476|FG000|Treatment Period|Adverse Event|7|||
105800516|NCT02544633|364928477|FG001|Treatment Period|Adverse Event|4|||
105800517|NCT02544633|364928478|FG002|Treatment Period|Adverse Event|0|||
105800518|NCT02544633|364928479|FG003|Treatment Period|Adverse Event|5|||
105744496|NCT00262080|364719188|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
105744497|NCT00262080|364719189|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
105744498|NCT00262080|364719190|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
105744499|NCT02273752|364719191|FG000|Overall Study|Trial was terminated early|2|||
105744500|NCT03580382|364719192|FG000|Overall Study|Early Termination of Study|0|||
105744501|NCT03580382|364719193|FG001|Overall Study|Early Termination of Study|3|||
105744502|NCT02808312|364719194|FG000|Overall Study|Enrolled but Never Treated|0|||
105744503|NCT02808312|364719195|FG001|Overall Study|Enrolled but Never Treated|0|||
105800519|NCT02544633|364928476|FG000|Treatment Period|Lack of Efficacy|17|||
105800520|NCT02544633|364928477|FG001|Treatment Period|Lack of Efficacy|11|||
105359223|NCT01051817|363320952|FG001|Overall Study|Adverse Event|2|||
105359224|NCT01051817|363320951|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
105800521|NCT02544633|364928478|FG002|Treatment Period|Lack of Efficacy|5|||
105800522|NCT02544633|364928479|FG003|Treatment Period|Lack of Efficacy|5|||
105800523|NCT02544633|364928476|FG000|Treatment Period|Global Deterioration of Health|3|||
105359225|NCT01051817|363320952|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
105800524|NCT02544633|364928477|FG001|Treatment Period|Global Deterioration of Health|3|||
105800525|NCT02544633|364928478|FG002|Treatment Period|Global Deterioration of Health|0|||
105800526|NCT02544633|364928479|FG003|Treatment Period|Global Deterioration of Health|1|||
105800527|NCT02544633|364928476|FG000|Treatment Period|Withdrawal by Subject|1|||
105800528|NCT02544633|364928477|FG001|Treatment Period|Withdrawal by Subject|0|||
105359226|NCT01051817|363320951|FG000|Overall Study|Withdrawal by Subject|3|||
105359227|NCT01051817|363320952|FG001|Overall Study|Withdrawal by Subject|5|||
105359228|NCT01051817|363320951|FG000|Overall Study|Protocol Violation|0|||
105359229|NCT01051817|363320952|FG001|Overall Study|Protocol Violation|1|||
105359230|NCT00320788|363320953|FG000|Overall Study|Adverse Event|0|||
105359231|NCT00320788|363320954|FG001|Overall Study|Adverse Event|0|||
105359232|NCT00320788|363320955|FG002|Overall Study|Adverse Event|0|||
105359233|NCT00320788|363320956|FG003|Overall Study|Adverse Event|1|||
105359234|NCT00320788|363320957|FG004|Overall Study|Adverse Event|0|||
105359235|NCT00320788|363320953|FG000|Overall Study|Death|0|||
105359236|NCT00320788|363320954|FG001|Overall Study|Death|0|||
105359237|NCT00320788|363320955|FG002|Overall Study|Death|1|||
105359238|NCT00320788|363320956|FG003|Overall Study|Death|0|||
105359239|NCT00320788|363320957|FG004|Overall Study|Death|1|||
105359240|NCT00320788|363320953|FG000|Overall Study|Lost to Follow-up|0|||
105359241|NCT00320788|363320954|FG001|Overall Study|Lost to Follow-up|2|||
105359242|NCT00320788|363320955|FG002|Overall Study|Lost to Follow-up|1|||
105359243|NCT00320788|363320956|FG003|Overall Study|Lost to Follow-up|0|||
105359244|NCT00320788|363320957|FG004|Overall Study|Lost to Follow-up|0|||
105359245|NCT00320788|363320953|FG000|Overall Study|Decision by the Sponsor|1|||
105359246|NCT00320788|363320954|FG001|Overall Study|Decision by the Sponsor|1|||
105359247|NCT00320788|363320955|FG002|Overall Study|Decision by the Sponsor|0|||
105359248|NCT00320788|363320956|FG003|Overall Study|Decision by the Sponsor|0|||
105359249|NCT00320788|363320957|FG004|Overall Study|Decision by the Sponsor|1|||
105359250|NCT00320788|363320953|FG000|Overall Study|Other|1|||
105359251|NCT00320788|363320954|FG001|Overall Study|Other|2|||
105359252|NCT00320788|363320955|FG002|Overall Study|Other|1|||
105359253|NCT00320788|363320956|FG003|Overall Study|Other|1|||
105359254|NCT00320788|363320957|FG004|Overall Study|Other|1|||
105744504|NCT02808312|364719196|FG002|Overall Study|Enrolled but Never Treated|1|||
105744505|NCT02808312|364719197|FG003|Overall Study|Enrolled but Never Treated|0|||
105744506|NCT02808312|364719198|FG004|Overall Study|Enrolled but Never Treated|0|||
105744507|NCT01826422|364719204|FG000|Overall Study|Withdrawal by Subject|1|||
105744508|NCT01826422|364719205|FG001|Overall Study|Withdrawal by Subject|3|||
105744509|NCT04009096|364719206|FG000|Overall Study|Withdrawal by Subject|0|||
105744510|NCT04009096|364719207|FG001|Overall Study|Withdrawal by Subject|7|||
105744511|NCT04009096|364719208|FG002|Overall Study|Withdrawal by Subject|0|||
105744512|NCT04009096|364719206|FG000|Overall Study|Physician Decision|0|||
105744513|NCT04009096|364719207|FG001|Overall Study|Physician Decision|1|||
105744514|NCT04009096|364719208|FG002|Overall Study|Physician Decision|0|||
105744515|NCT05151471|364719209|FG000|Overall Study|Adverse Event|21|||
105744516|NCT05151471|364719210|FG001|Overall Study|Adverse Event|16|||
105744517|NCT05151471|364719209|FG000|Overall Study|Death|1|||
105744518|NCT05151471|364719210|FG001|Overall Study|Death|0|||
105744519|NCT05151471|364719209|FG000|Overall Study|Lost to Follow-up|0|||
105744520|NCT05151471|364719210|FG001|Overall Study|Lost to Follow-up|1|||
105744521|NCT05151471|364719209|FG000|Overall Study|Withdrawal by Subject|7|||
105744522|NCT05151471|364719210|FG001|Overall Study|Withdrawal by Subject|9|||
105744523|NCT05151471|364719209|FG000|Overall Study|Study terminated by sponsor|49|||
105744524|NCT05151471|364719210|FG001|Overall Study|Study terminated by sponsor|47|||
105744525|NCT05151471|364719209|FG000|Overall Study|Other|2|||
105744526|NCT05151471|364719210|FG001|Overall Study|Other|1|||
105744527|NCT04263142|364719211|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
105744528|NCT04263142|364719212|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
105744529|NCT04263142|364719213|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
105744530|NCT04263142|364719214|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
105744531|NCT04263142|364719215|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
105744532|NCT04263142|364719211|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
105744533|NCT04263142|364719212|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
105744534|NCT04263142|364719213|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
105744535|NCT04263142|364719214|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
105744536|NCT04263142|364719215|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
105744537|NCT00718419|364719216|FG000|Overall Study|Adverse Event|2|||
105744538|NCT00718419|364719217|FG001|Overall Study|Adverse Event|1|||
105744539|NCT00718419|364719216|FG000|Overall Study|Physician Decision|1|||
105744540|NCT00718419|364719217|FG001|Overall Study|Physician Decision|6|||
105744541|NCT00718419|364719216|FG000|Overall Study|Sponsor decision|0|||
105359255|NCT00320788|363320953|FG000|Overall Study|Physician Decision|1|||
105359256|NCT00320788|363320954|FG001|Overall Study|Physician Decision|1|||
105359257|NCT00320788|363320955|FG002|Overall Study|Physician Decision|0|||
105359258|NCT00320788|363320956|FG003|Overall Study|Physician Decision|0|||
105359259|NCT00320788|363320957|FG004|Overall Study|Physician Decision|0|||
105359260|NCT00320788|363320953|FG000|Overall Study|Protocol Violation|0|||
105359261|NCT00320788|363320954|FG001|Overall Study|Protocol Violation|0|||
105565364|NCT04512066|364066765|FG000|Double-blind Treatment Period|Adverse Event|6|||
105744542|NCT00718419|364719217|FG001|Overall Study|Sponsor decision|1|||
105359262|NCT00320788|363320955|FG002|Overall Study|Protocol Violation|0|||
105359263|NCT00320788|363320956|FG003|Overall Study|Protocol Violation|0|||
105359264|NCT00320788|363320957|FG004|Overall Study|Protocol Violation|1|||
105359265|NCT00320788|363320953|FG000|Overall Study|Withdrawal by Subject|3|||
105359266|NCT00320788|363320954|FG001|Overall Study|Withdrawal by Subject|0|||
105359267|NCT00320788|363320955|FG002|Overall Study|Withdrawal by Subject|0|||
105359268|NCT00320788|363320956|FG003|Overall Study|Withdrawal by Subject|3|||
105359269|NCT00320788|363320957|FG004|Overall Study|Withdrawal by Subject|1|||
105359270|NCT00627926|363320958|FG000|Overall Study|Adverse Event|26|||
105359271|NCT00627926|363320959|FG001|Overall Study|Adverse Event|37|||
105359272|NCT00627926|363320960|FG002|Overall Study|Adverse Event|36|||
105744543|NCT00718419|364719216|FG000|Overall Study|Withdrawal by Subject|0|||
105744544|NCT00718419|364719217|FG001|Overall Study|Withdrawal by Subject|5|||
105744545|NCT00718419|364719216|FG000|Overall Study|Progressive Disease|7|||
105744546|NCT00718419|364719217|FG001|Overall Study|Progressive Disease|25|||
105744547|NCT00718419|364719216|FG000|Overall Study|Death Due to Progressive Disease|2|||
105744548|NCT00718419|364719217|FG001|Overall Study|Death Due to Progressive Disease|0|||
105744549|NCT00718419|364719216|FG000|Overall Study|Death Due to Study Drug Related|0|||
105744550|NCT00718419|364719217|FG001|Overall Study|Death Due to Study Drug Related|1|||
105744551|NCT00718419|364719216|FG000|Overall Study|Death Due to Adverse Events|1|||
105744552|NCT00718419|364719217|FG001|Overall Study|Death Due to Adverse Events|0|||
105744553|NCT01623531|364719220|FG000|Overall Study|Death|1|||
105744554|NCT01623531|364719221|FG001|Overall Study|Death|0|||
105744555|NCT01623531|364719220|FG000|Overall Study|Protocol Violation|2|||
105744556|NCT01623531|364719221|FG001|Overall Study|Protocol Violation|1|||
105744557|NCT01623531|364719220|FG000|Overall Study|Missing data at primary outcome time poi|1|||
105744558|NCT01623531|364719221|FG001|Overall Study|Missing data at primary outcome time poi|1|||
105744559|NCT01429792|364719222|FG000|Overall Study|Other Reasons|67|||
105744560|NCT01429792|364719222|FG000|Overall Study|Unknown Disposition|94|||
105744561|NCT01429792|364719222|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
105744562|NCT01429792|364719222|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
105744563|NCT01429792|364719222|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
105744564|NCT01429792|364719222|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
105744565|NCT01429792|364719222|FG000|Overall Study|Withdrawal by Subject|70|||
105744566|NCT01429792|364719222|FG000|Overall Study|Lost to Follow-up|88|||
105744567|NCT00450372|364719224|FG000|Overall Study|Physician Decision|1|||
105744568|NCT00520676|364719226|FG000|Overall Study|Death|84|||
105744569|NCT00520676|364719227|FG001|Overall Study|Death|81|||
105744570|NCT00520676|364719226|FG000|Overall Study|Lost to Follow-up|6|||
105744571|NCT00520676|364719227|FG001|Overall Study|Lost to Follow-up|10|||
105744572|NCT00520676|364719226|FG000|Overall Study|Physician Decision|4|||
105744573|NCT00520676|364719227|FG001|Overall Study|Physician Decision|1|||
105359273|NCT00627926|363320958|FG000|Overall Study|Death|1|||
105359274|NCT00627926|363320959|FG001|Overall Study|Death|0|||
105359275|NCT00627926|363320960|FG002|Overall Study|Death|0|||
105483122|NCT03836001|363780869|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
105483123|NCT03836001|363780867|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
105483124|NCT03836001|363780868|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
105483125|NCT03836001|363780869|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
105483126|NCT03836001|363780867|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
105483127|NCT03836001|363780868|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
105483128|NCT03836001|363780869|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
105483129|NCT01381562|363780870|FG000|Overall Study|Adverse Event|0|||
105483130|NCT01381562|363780871|FG001|Overall Study|Adverse Event|1|||
105483131|NCT01381562|363780872|FG002|Overall Study|Adverse Event|0|||
105483132|NCT01894568|363780886|FG000|Overall Study|Adverse Event|2|||
105483133|NCT01894568|363780887|FG001|Overall Study|Adverse Event|3|||
105483134|NCT01894568|363780886|FG000|Overall Study|Protocol required discontinuation|2|||
105483135|NCT01894568|363780887|FG001|Overall Study|Protocol required discontinuation|1|||
105483136|NCT01894568|363780886|FG000|Overall Study|Withdrawal by Subject|5|||
105483137|NCT01894568|363780887|FG001|Overall Study|Withdrawal by Subject|5|||
105744574|NCT00520676|364719226|FG000|Overall Study|Withdrawal by Subject|7|||
105744575|NCT00520676|364719227|FG001|Overall Study|Withdrawal by Subject|11|||
105744576|NCT03484923|364719230|FG000|Overall Study|Adverse Event|3|||
105744577|NCT03484923|364719231|FG001|Overall Study|Adverse Event|3|||
105744578|NCT03484923|364719232|FG002|Overall Study|Adverse Event|5|||
105744579|NCT03484923|364719233|FG003|Overall Study|Adverse Event|11|||
105744580|NCT03484923|364719234|FG004|Overall Study|Adverse Event|1|||
105744581|NCT03484923|364719230|FG000|Overall Study|Death|2|||
105744582|NCT03484923|364719231|FG001|Overall Study|Death|2|||
105744583|NCT03484923|364719232|FG002|Overall Study|Death|3|||
105744584|NCT03484923|364719233|FG003|Overall Study|Death|0|||
105744585|NCT03484923|364719234|FG004|Overall Study|Death|1|||
105744586|NCT03484923|364719230|FG000|Overall Study|Physician Decision|6|||
105359276|NCT00627926|363320958|FG000|Overall Study|Lost to Follow-up|4|||
105359277|NCT00627926|363320959|FG001|Overall Study|Lost to Follow-up|3|||
105483138|NCT01894568|363780886|FG000|Overall Study|Physician Decision|1|||
105483139|NCT01894568|363780887|FG001|Overall Study|Physician Decision|0|||
105359278|NCT00627926|363320960|FG002|Overall Study|Lost to Follow-up|4|||
105483140|NCT01894568|363780886|FG000|Overall Study|Lost to Follow-up|0|||
105744587|NCT03484923|364719231|FG001|Overall Study|Physician Decision|7|||
105744588|NCT03484923|364719232|FG002|Overall Study|Physician Decision|6|||
105744589|NCT03484923|364719233|FG003|Overall Study|Physician Decision|3|||
105744590|NCT03484923|364719234|FG004|Overall Study|Physician Decision|2|||
105744591|NCT03484923|364719230|FG000|Overall Study|Progressive disease|33|||
105744592|NCT03484923|364719231|FG001|Overall Study|Progressive disease|28|||
105744593|NCT03484923|364719232|FG002|Overall Study|Progressive disease|26|||
105744594|NCT03484923|364719233|FG003|Overall Study|Progressive disease|30|||
105744595|NCT03484923|364719234|FG004|Overall Study|Progressive disease|16|||
105744596|NCT03484923|364719230|FG000|Overall Study|Subject Decision|1|||
105744597|NCT03484923|364719231|FG001|Overall Study|Subject Decision|3|||
105744598|NCT03484923|364719232|FG002|Overall Study|Subject Decision|3|||
105744599|NCT03484923|364719233|FG003|Overall Study|Subject Decision|0|||
105744600|NCT03484923|364719234|FG004|Overall Study|Subject Decision|1|||
105744601|NCT03439748|364719236|FG000|Overall Study|Withdrawal by Subject|11|||
105744602|NCT03439748|364719237|FG001|Overall Study|Withdrawal by Subject|17|||
105744603|NCT03165721|364719242|FG000|Overall Study|Refused further treatment|3|||
105744604|NCT03165721|364719243|FG001|Overall Study|Refused further treatment|0|||
105744605|NCT03165721|364719244|FG002|Overall Study|Refused further treatment|0|||
105744606|NCT03165721|364719242|FG000|Overall Study|Physician Decision|1|||
105744607|NCT03165721|364719243|FG001|Overall Study|Physician Decision|0|||
105744608|NCT03165721|364719244|FG002|Overall Study|Physician Decision|0|||
105744609|NCT01863849|364719245|FG000|Overall Study|Lost to Follow-up|1|||
105744610|NCT01863849|364719246|FG001|Overall Study|Lost to Follow-up|0|||
105744611|NCT01718509|364719249|FG000|Overall Study|Lost to Follow-up|18|||
105744612|NCT01718509|364719250|FG001|Overall Study|Lost to Follow-up|15|||
105744613|NCT01718509|364719249|FG000|Overall Study|Withdrawal by Subject|7|||
105744614|NCT01718509|364719250|FG001|Overall Study|Withdrawal by Subject|13|||
105744615|NCT01718509|364719249|FG000|Overall Study|Adverse Event|5|||
105744616|NCT01718509|364719250|FG001|Overall Study|Adverse Event|7|||
105744617|NCT01718509|364719249|FG000|Overall Study|Other|13|||
105744618|NCT01718509|364719250|FG001|Overall Study|Other|11|||
105744619|NCT01718509|364719249|FG000|Overall Study|Protocol Violation|4|||
105744620|NCT01718509|364719250|FG001|Overall Study|Protocol Violation|2|||
105744621|NCT01718509|364719249|FG000|Overall Study|Lack of Efficacy|1|||
105744622|NCT01718509|364719250|FG001|Overall Study|Lack of Efficacy|0|||
105744623|NCT03456713|364719252|FG000|Overall Study|Lost to Follow-up|1|||
105744624|NCT03456713|364719253|FG001|Overall Study|Lost to Follow-up|0|||
105744625|NCT03456713|364719254|FG002|Overall Study|Lost to Follow-up|0|||
105744626|NCT03456713|364719255|FG003|Overall Study|Lost to Follow-up|0|||
105744627|NCT01263691|364719256|FG000|Overall Study|Lost to Follow-up|1|||
105744628|NCT01263691|364719257|FG001|Overall Study|Lost to Follow-up|0|||
105744629|NCT01263691|364719258|FG002|Overall Study|Lost to Follow-up|1|||
105744630|NCT01263691|364719259|FG003|Overall Study|Lost to Follow-up|1|||
105744631|NCT01263691|364719260|FG004|Overall Study|Lost to Follow-up|0|||
105359279|NCT00627926|363320958|FG000|Overall Study|Withdrawal by Subject|2|||
105359280|NCT00627926|363320959|FG001|Overall Study|Withdrawal by Subject|1|||
105359281|NCT00627926|363320960|FG002|Overall Study|Withdrawal by Subject|0|||
105359282|NCT00627926|363320958|FG000|Overall Study|Lack of Efficacy|118|||
105359283|NCT00627926|363320959|FG001|Overall Study|Lack of Efficacy|40|||
105744632|NCT01263691|364719261|FG005|Overall Study|Lost to Follow-up|0|||
105744633|NCT01263691|364719256|FG000|Overall Study|Withdrawal by Subject|1|||
105744634|NCT01263691|364719257|FG001|Overall Study|Withdrawal by Subject|0|||
105744635|NCT01263691|364719258|FG002|Overall Study|Withdrawal by Subject|0|||
105744636|NCT01263691|364719259|FG003|Overall Study|Withdrawal by Subject|0|||
105744637|NCT01263691|364719260|FG004|Overall Study|Withdrawal by Subject|0|||
105744638|NCT01263691|364719261|FG005|Overall Study|Withdrawal by Subject|0|||
105744639|NCT01263691|364719256|FG000|Overall Study|Adverse Event|1|||
105744640|NCT01263691|364719257|FG001|Overall Study|Adverse Event|0|||
105744641|NCT01263691|364719258|FG002|Overall Study|Adverse Event|0|||
105744642|NCT01263691|364719259|FG003|Overall Study|Adverse Event|0|||
105744643|NCT01263691|364719260|FG004|Overall Study|Adverse Event|0|||
105744644|NCT01263691|364719261|FG005|Overall Study|Adverse Event|0|||
105744645|NCT01728584|364719265|FG000|Overall Study|Adverse Event|1|||
105744646|NCT01728584|364719266|FG001|Overall Study|Adverse Event|0|||
105744647|NCT01728584|364719267|FG002|Overall Study|Adverse Event|0|||
105744648|NCT01728584|364719268|FG003|Overall Study|Adverse Event|0|||
105744649|NCT01728584|364719265|FG000|Overall Study|Physician Decision|4|||
105744650|NCT01728584|364719266|FG001|Overall Study|Physician Decision|0|||
105744651|NCT01728584|364719267|FG002|Overall Study|Physician Decision|1|||
105744652|NCT01728584|364719268|FG003|Overall Study|Physician Decision|0|||
105744653|NCT01728584|364719265|FG000|Overall Study|Withdrawal by Subject|1|||
105744654|NCT01728584|364719266|FG001|Overall Study|Withdrawal by Subject|0|||
105744655|NCT01728584|364719267|FG002|Overall Study|Withdrawal by Subject|0|||
105744656|NCT01728584|364719268|FG003|Overall Study|Withdrawal by Subject|0|||
105744657|NCT01728584|364719265|FG000|Overall Study|Screen failure|1|||
105744658|NCT01728584|364719266|FG001|Overall Study|Screen failure|0|||
105744659|NCT01728584|364719267|FG002|Overall Study|Screen failure|0|||
105744660|NCT01728584|364719268|FG003|Overall Study|Screen failure|0|||
105744661|NCT01728584|364719265|FG000|Overall Study|Other reason (not specified)|1|||
105744662|NCT01728584|364719266|FG001|Overall Study|Other reason (not specified)|0|||
105744663|NCT01728584|364719267|FG002|Overall Study|Other reason (not specified)|0|||
105744664|NCT01728584|364719268|FG003|Overall Study|Other reason (not specified)|1|||
105744665|NCT02935634|364719269|FG000|Randomization|Participant withdrew consent|0|||
105744666|NCT02935634|364719270|FG001|Randomization|Participant withdrew consent|1|||
105744667|NCT02935634|364719271|FG002|Randomization|Participant withdrew consent|0|||
105744668|NCT02935634|364719272|FG003|Randomization|Participant withdrew consent|0|||
105744669|NCT02935634|364719273|FG004|Randomization|Participant withdrew consent|0|||
105744670|NCT02935634|364719274|FG005|Randomization|Participant withdrew consent|0|||
105744671|NCT02935634|364719269|FG000|Randomization|Death|2|||
105744672|NCT02935634|364719270|FG001|Randomization|Death|1|||
105744673|NCT02935634|364719271|FG002|Randomization|Death|1|||
105744674|NCT02935634|364719272|FG003|Randomization|Death|0|||
105744675|NCT02935634|364719273|FG004|Randomization|Death|0|||
105744676|NCT02935634|364719274|FG005|Randomization|Death|0|||
105744677|NCT02935634|364719269|FG000|Randomization|Other reasons|0|||
105744678|NCT02935634|364719270|FG001|Randomization|Other reasons|2|||
105744679|NCT02935634|364719271|FG002|Randomization|Other reasons|2|||
105744680|NCT02935634|364719272|FG003|Randomization|Other reasons|0|||
105744681|NCT02935634|364719273|FG004|Randomization|Other reasons|0|||
105744682|NCT02935634|364719274|FG005|Randomization|Other reasons|0|||
105744683|NCT02935634|364719269|FG000|Treatment: Track 1|Disease progression|15|||
105744684|NCT02935634|364719270|FG001|Treatment: Track 1|Disease progression|17|||
105744685|NCT02935634|364719271|FG002|Treatment: Track 1|Disease progression|28|||
105744686|NCT02935634|364719272|FG003|Treatment: Track 1|Disease progression|4|||
105359284|NCT00627926|363320960|FG002|Overall Study|Lack of Efficacy|38|||
105359285|NCT00627926|363320958|FG000|Overall Study|Noncompliance/unspecified|8|||
105359286|NCT00627926|363320959|FG001|Overall Study|Noncompliance/unspecified|23|||
105744687|NCT02935634|364719273|FG004|Treatment: Track 1|Disease progression|6|||
105744688|NCT02935634|364719274|FG005|Treatment: Track 1|Disease progression|2|||
105744689|NCT02935634|364719269|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
105744690|NCT02935634|364719270|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
105565365|NCT04512066|364066766|FG001|Double-blind Treatment Period|Adverse Event|4|||
105744691|NCT02935634|364719271|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
105744692|NCT02935634|364719272|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
105744693|NCT02935634|364719273|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
105359287|NCT00627926|363320960|FG002|Overall Study|Noncompliance/unspecified|17|||
105359288|NCT02401035|363320965|FG000|Overall Study|Withdrawal by Subject|1|||
105744694|NCT02935634|364719274|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
105744695|NCT02935634|364719269|FG000|Treatment: Track 1|Lost to Follow-up|1|||
105744696|NCT02935634|364719270|FG001|Treatment: Track 1|Lost to Follow-up|0|||
105744697|NCT02935634|364719271|FG002|Treatment: Track 1|Lost to Follow-up|0|||
105744698|NCT02935634|364719272|FG003|Treatment: Track 1|Lost to Follow-up|0|||
105744699|NCT02935634|364719273|FG004|Treatment: Track 1|Lost to Follow-up|0|||
105744700|NCT02935634|364719274|FG005|Treatment: Track 1|Lost to Follow-up|0|||
105744701|NCT02935634|364719269|FG000|Treatment: Track 1|Study drug toxicity|2|||
105744702|NCT02935634|364719270|FG001|Treatment: Track 1|Study drug toxicity|1|||
105744703|NCT02935634|364719271|FG002|Treatment: Track 1|Study drug toxicity|3|||
105744704|NCT02935634|364719272|FG003|Treatment: Track 1|Study drug toxicity|0|||
105744705|NCT02935634|364719273|FG004|Treatment: Track 1|Study drug toxicity|0|||
105744706|NCT02935634|364719274|FG005|Treatment: Track 1|Study drug toxicity|1|||
105744707|NCT02935634|364719269|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
105483141|NCT01894568|363780887|FG001|Overall Study|Lost to Follow-up|1|||
105483142|NCT02119676|363780888|FG000|Overall Study|Adverse Event|9|||
105744708|NCT02935634|364719270|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
105744709|NCT02935634|364719271|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
105744710|NCT02935634|364719272|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
105744711|NCT02935634|364719273|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
105744712|NCT02935634|364719274|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
105744713|NCT02935634|364719269|FG000|Treatment: Track 1|Participant withdrew consent|2|||
105744714|NCT02935634|364719270|FG001|Treatment: Track 1|Participant withdrew consent|0|||
105744715|NCT02935634|364719271|FG002|Treatment: Track 1|Participant withdrew consent|1|||
105744716|NCT02935634|364719272|FG003|Treatment: Track 1|Participant withdrew consent|0|||
105744717|NCT02935634|364719273|FG004|Treatment: Track 1|Participant withdrew consent|1|||
105744718|NCT02935634|364719274|FG005|Treatment: Track 1|Participant withdrew consent|0|||
105744719|NCT02935634|364719269|FG000|Treatment: Track 1|Other reasons|0|||
105744720|NCT02935634|364719270|FG001|Treatment: Track 1|Other reasons|0|||
105744721|NCT02935634|364719271|FG002|Treatment: Track 1|Other reasons|2|||
105744722|NCT02935634|364719272|FG003|Treatment: Track 1|Other reasons|0|||
105744723|NCT02935634|364719273|FG004|Treatment: Track 1|Other reasons|0|||
105744724|NCT02935634|364719274|FG005|Treatment: Track 1|Other reasons|0|||
105744725|NCT02935634|364719269|FG000|Treatment: Track 2|Disease progression|13|||
105744726|NCT02935634|364719270|FG001|Treatment: Track 2|Disease progression|26|||
105744727|NCT02935634|364719271|FG002|Treatment: Track 2|Disease progression|20|||
105744728|NCT02935634|364719272|FG003|Treatment: Track 2|Disease progression|5|||
105744729|NCT02935634|364719273|FG004|Treatment: Track 2|Disease progression|1|||
105744730|NCT02935634|364719274|FG005|Treatment: Track 2|Disease progression|4|||
105744731|NCT02935634|364719269|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
105744732|NCT02935634|364719270|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
105744733|NCT02935634|364719271|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
105744734|NCT02935634|364719272|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
105744735|NCT02935634|364719273|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
105744736|NCT02935634|364719274|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
105744737|NCT02935634|364719269|FG000|Treatment: Track 2|Study drug toxicity|7|||
105744738|NCT02935634|364719270|FG001|Treatment: Track 2|Study drug toxicity|3|||
105744739|NCT02935634|364719271|FG002|Treatment: Track 2|Study drug toxicity|0|||
105744740|NCT02935634|364719272|FG003|Treatment: Track 2|Study drug toxicity|0|||
105744741|NCT02935634|364719273|FG004|Treatment: Track 2|Study drug toxicity|0|||
105744742|NCT02935634|364719274|FG005|Treatment: Track 2|Study drug toxicity|0|||
105744743|NCT02935634|364719269|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
105744744|NCT02935634|364719270|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
105744745|NCT02935634|364719271|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
105744746|NCT02935634|364719272|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
105744747|NCT02935634|364719273|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
105744748|NCT02935634|364719274|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
105744749|NCT02935634|364719269|FG000|Treatment: Track 2|Participant withdrew consent|0|||
105744750|NCT02935634|364719270|FG001|Treatment: Track 2|Participant withdrew consent|1|||
105483143|NCT02119676|363780889|FG001|Overall Study|Adverse Event|17|||
105483144|NCT02119676|363780890|FG002|Overall Study|Adverse Event|10|||
105800529|NCT02544633|364928478|FG002|Treatment Period|Withdrawal by Subject|0|||
105800530|NCT02544633|364928479|FG003|Treatment Period|Withdrawal by Subject|0|||
105800531|NCT02544633|364928476|FG000|Treatment Period|Lost to Follow-up|0|||
105800532|NCT02544633|364928477|FG001|Treatment Period|Lost to Follow-up|1|||
105800533|NCT02544633|364928478|FG002|Treatment Period|Lost to Follow-up|0|||
105800534|NCT02544633|364928479|FG003|Treatment Period|Lost to Follow-up|0|||
105800535|NCT02544633|364928476|FG000|Treatment Period|Death|0|||
105800536|NCT02544633|364928477|FG001|Treatment Period|Death|0|||
105359289|NCT02401035|363320966|FG001|Overall Study|Withdrawal by Subject|0|||
105744751|NCT02935634|364719271|FG002|Treatment: Track 2|Participant withdrew consent|1|||
105744752|NCT02935634|364719272|FG003|Treatment: Track 2|Participant withdrew consent|0|||
105744753|NCT02935634|364719273|FG004|Treatment: Track 2|Participant withdrew consent|1|||
105744754|NCT02935634|364719274|FG005|Treatment: Track 2|Participant withdrew consent|0|||
105744755|NCT01727713|364719291|FG000|Overall Study|Lost to Follow-up|5|||
105744756|NCT01727713|364719291|FG000|Overall Study|Adverse Event|10|||
105744757|NCT01727713|364719291|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
105744758|NCT01727713|364719291|FG000|Overall Study|Withdrawal by Subject|13|||
105744759|NCT01727713|364719291|FG000|Overall Study|Protocol Deviation|2|||
105744760|NCT02651194|364719292|FG000|Overall Study|Lost to Follow-up|3|||
105744761|NCT02651194|364719292|FG000|Overall Study|Other|2|||
105744762|NCT01253044|364719296|FG000|Overall Study|Lost to Follow-up|38|||
105744763|NCT01253044|364719297|FG001|Overall Study|Lost to Follow-up|29|||
105744764|NCT03885726|364719298|FG000|Overall Study|Staffing issues/lost interest|1|||
105744765|NCT03885726|364719298|FG000|Overall Study|Early discharge from hospital|3|||
105744766|NCT02065869|364719301|FG000|Overall Study|Death|7|||
105744767|NCT02065869|364719301|FG000|Overall Study|Disease relapse|16|||
105744768|NCT02065869|364719301|FG000|Overall Study|Lost to Follow-up|4|||
105744769|NCT02065869|364719301|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
105744770|NCT02065869|364719301|FG000|Overall Study|Withdrawal by Subject|1|||
105744771|NCT02761993|364719304|FG000|Overall Study|Adverse Event|0|||
105744772|NCT02761993|364719305|FG001|Overall Study|Adverse Event|2|||
105744773|NCT02761993|364719306|FG002|Overall Study|Adverse Event|0|||
105744774|NCT02761993|364719304|FG000|Overall Study|Lost to Follow-up|1|||
105744775|NCT02761993|364719305|FG001|Overall Study|Lost to Follow-up|3|||
105744776|NCT02761993|364719306|FG002|Overall Study|Lost to Follow-up|2|||
105744777|NCT02761993|364719304|FG000|Overall Study|Withdrawal by Subject|1|||
105744778|NCT02761993|364719305|FG001|Overall Study|Withdrawal by Subject|1|||
105744779|NCT02761993|364719306|FG002|Overall Study|Withdrawal by Subject|2|||
105744780|NCT01842620|364719307|FG000|Period 1|Withdrawal by Subject|1|||
105744781|NCT01842620|364719308|FG001|Period 1|Withdrawal by Subject|0|||
105744782|NCT02739594|364719309|FG000|Overall Study|Undesired Event|3|||
105744783|NCT02739594|364719310|FG001|Overall Study|Undesired Event|4|||
105744784|NCT02739594|364719309|FG000|Overall Study|Violation of Eligibility Criteria|1|||
105744785|NCT02739594|364719310|FG001|Overall Study|Violation of Eligibility Criteria|2|||
105744786|NCT02739594|364719309|FG000|Overall Study|Protocol Violation|5|||
105744787|NCT02739594|364719310|FG001|Overall Study|Protocol Violation|6|||
105744788|NCT02739594|364719309|FG000|Overall Study|Death|4|||
105744789|NCT02739594|364719310|FG001|Overall Study|Death|2|||
105744790|NCT02739594|364719309|FG000|Overall Study|Renal Insufficiency|4|||
105744791|NCT02739594|364719310|FG001|Overall Study|Renal Insufficiency|6|||
105744792|NCT02739594|364719309|FG000|Overall Study|Administrative Reasons|1|||
105744793|NCT02739594|364719310|FG001|Overall Study|Administrative Reasons|3|||
105800537|NCT02544633|364928478|FG002|Treatment Period|Death|1|||
105359290|NCT02998996|363320967|FG000|Overall Study|Lost to Follow-up|0|||
105359291|NCT02998996|363320968|FG001|Overall Study|Lost to Follow-up|0|||
105359292|NCT02998996|363320969|FG002|Overall Study|Lost to Follow-up|1|||
105359293|NCT02998996|363320970|FG003|Overall Study|Lost to Follow-up|0|||
105359294|NCT02998996|363320971|FG004|Overall Study|Lost to Follow-up|0|||
105359295|NCT02998996|363320972|FG005|Overall Study|Lost to Follow-up|0|||
105359296|NCT02998996|363320967|FG000|Overall Study|Pregnancy|0|||
105359297|NCT02998996|363320968|FG001|Overall Study|Pregnancy|1|||
105359298|NCT02998996|363320969|FG002|Overall Study|Pregnancy|0|||
105359299|NCT02998996|363320970|FG003|Overall Study|Pregnancy|0|||
105744794|NCT02739594|364719309|FG000|Overall Study|Withdrawal by Subject|1|||
105744795|NCT02739594|364719310|FG001|Overall Study|Withdrawal by Subject|1|||
105744796|NCT02739594|364719309|FG000|Overall Study|Lost to Follow-up|0|||
105744797|NCT02739594|364719310|FG001|Overall Study|Lost to Follow-up|1|||
105744798|NCT02739594|364719309|FG000|Overall Study|Elevated Serum Creatinine|0|||
105744799|NCT02739594|364719310|FG001|Overall Study|Elevated Serum Creatinine|1|||
105800538|NCT02544633|364928479|FG003|Treatment Period|Death|0|||
105359300|NCT02998996|363320971|FG004|Overall Study|Pregnancy|0|||
105359301|NCT02998996|363320972|FG005|Overall Study|Pregnancy|0|||
105744800|NCT02739594|364719309|FG000|Overall Study|Other|6|||
105744801|NCT02739594|364719310|FG001|Overall Study|Other|2|||
105744802|NCT00952289|364719316|FG000|All Participants|Death|9|||
105744803|NCT00952289|364719317|FG001|All Participants|Death|9|||
105744804|NCT00952289|364719316|FG000|All Participants|Adverse Event|8|||
105800539|NCT02544633|364928476|FG000|Treatment Period|Non-compliance|0|||
105359302|NCT02998996|363320967|FG000|Overall Study|Family reasons|0|||
105359303|NCT02998996|363320968|FG001|Overall Study|Family reasons|0|||
105359304|NCT02998996|363320969|FG002|Overall Study|Family reasons|0|||
105359305|NCT02998996|363320970|FG003|Overall Study|Family reasons|0|||
105359306|NCT02998996|363320971|FG004|Overall Study|Family reasons|1|||
105359307|NCT02998996|363320972|FG005|Overall Study|Family reasons|0|||
105359308|NCT02716584|363320973|FG000|Overall Study|Lost to Follow-up|8|||
105359309|NCT02716584|363320974|FG001|Overall Study|Lost to Follow-up|5|||
105359310|NCT02149264|363320975|FG000|Overall Study|Withdrawal by Subject|9|||
105483145|NCT02119676|363780891|FG003|Overall Study|Adverse Event|10|||
105744805|NCT00952289|364719317|FG001|All Participants|Adverse Event|8|||
105359311|NCT02149264|363320975|FG000|Overall Study|Adverse Event|7|||
105359312|NCT02149264|363320975|FG000|Overall Study|Physician Decision|3|||
105359313|NCT02149264|363320975|FG000|Overall Study|Protocol Violation|1|||
105359314|NCT00972283|363320976|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
105359315|NCT00972283|363320977|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
105359316|NCT00972283|363320976|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
105359317|NCT00972283|363320977|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
105359318|NCT00972283|363320976|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
105359319|NCT00972283|363320977|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
105359320|NCT00972283|363320976|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
105359321|NCT00972283|363320977|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
105359322|NCT00972283|363320976|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
105359323|NCT00972283|363320977|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
105359324|NCT00972283|363320976|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
105359325|NCT00972283|363320977|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
105359326|NCT00972283|363320976|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
105359327|NCT00972283|363320977|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
105359328|NCT00972283|363320976|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
105359329|NCT00972283|363320977|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
105359330|NCT00972283|363320976|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
105483146|NCT02119676|363780888|FG000|Overall Study|Disease progression|53|||
105483147|NCT02119676|363780889|FG001|Overall Study|Disease progression|55|||
105483148|NCT02119676|363780890|FG002|Overall Study|Disease progression|68|||
105483149|NCT02119676|363780891|FG003|Overall Study|Disease progression|73|||
105744806|NCT00952289|364719316|FG000|All Participants|Disease progression|3|||
105744807|NCT00952289|364719317|FG001|All Participants|Disease progression|12|||
105744808|NCT00952289|364719316|FG000|All Participants|Withdrawal by Subject|1|||
105744809|NCT00952289|364719317|FG001|All Participants|Withdrawal by Subject|10|||
105744810|NCT00952289|364719316|FG000|All Participants|Data lost during site relocation|0|||
105744811|NCT00952289|364719317|FG001|All Participants|Data lost during site relocation|1|||
105744812|NCT00952289|364719316|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
105744813|NCT00952289|364719317|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
105744814|NCT00952289|364719316|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
105744815|NCT00952289|364719317|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
105744816|NCT00952289|364719316|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
105744817|NCT00952289|364719317|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
105744818|NCT00952289|364719316|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
105359331|NCT00972283|363320977|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
105359332|NCT00972283|363320976|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
105359333|NCT00972283|363320977|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
105359334|NCT02686164|363320978|FG000|Overall Study|Adverse Event|1|||
105359335|NCT02686164|363320978|FG000|Overall Study|Withdrawal of consent|1|||
105483150|NCT02119676|363780888|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
105744819|NCT00952289|364719317|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
105744820|NCT00952289|364719316|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
105744821|NCT00952289|364719317|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
105744822|NCT00875017|364719318|FG000|First Intervention|Withdrawal by Subject|1|||
105744823|NCT00875017|364719319|FG001|First Intervention|Withdrawal by Subject|0|||
105744824|NCT00875017|364719320|FG002|First Intervention|Withdrawal by Subject|1|||
105744825|NCT00875017|364719321|FG003|First Intervention|Withdrawal by Subject|0|||
105744826|NCT00875017|364719322|FG004|First Intervention|Withdrawal by Subject|0|||
105744827|NCT00875017|364719323|FG005|First Intervention|Withdrawal by Subject|0|||
105744828|NCT00875017|364719318|FG000|First Intervention|Adverse Event|0|||
105744829|NCT00875017|364719319|FG001|First Intervention|Adverse Event|0|||
105744830|NCT00875017|364719320|FG002|First Intervention|Adverse Event|0|||
105744831|NCT00875017|364719321|FG003|First Intervention|Adverse Event|1|||
105744832|NCT00875017|364719322|FG004|First Intervention|Adverse Event|0|||
105744833|NCT00875017|364719323|FG005|First Intervention|Adverse Event|0|||
105744834|NCT00875017|364719318|FG000|First Intervention|Problems collecting rectal effluent|1|||
105744835|NCT00875017|364719319|FG001|First Intervention|Problems collecting rectal effluent|0|||
105744836|NCT00875017|364719320|FG002|First Intervention|Problems collecting rectal effluent|0|||
105744837|NCT00875017|364719321|FG003|First Intervention|Problems collecting rectal effluent|0|||
105744838|NCT00875017|364719322|FG004|First Intervention|Problems collecting rectal effluent|0|||
105744839|NCT00875017|364719323|FG005|First Intervention|Problems collecting rectal effluent|0|||
105744840|NCT00875017|364719318|FG000|First Intervention|Intolerance to nasogastric tube|0|||
105744841|NCT00875017|364719319|FG001|First Intervention|Intolerance to nasogastric tube|0|||
105744842|NCT00875017|364719320|FG002|First Intervention|Intolerance to nasogastric tube|0|||
105744843|NCT00875017|364719321|FG003|First Intervention|Intolerance to nasogastric tube|0|||
105744844|NCT00875017|364719322|FG004|First Intervention|Intolerance to nasogastric tube|1|||
105744845|NCT00875017|364719323|FG005|First Intervention|Intolerance to nasogastric tube|0|||
105359336|NCT02686164|363320978|FG000|Overall Study|Clinical progression|1|||
105359337|NCT00805129|363320982|FG000|Overall Study|Not treated|1|||
105359338|NCT02824627|363320985|FG000|Overall Study|Adverse Event|1|||
105744846|NCT00875017|364719318|FG000|Washout|Problem collecting rectal effluent|0|||
105744847|NCT00875017|364719319|FG001|Washout|Problem collecting rectal effluent|0|||
105744848|NCT00875017|364719320|FG002|Washout|Problem collecting rectal effluent|1|||
105744849|NCT00875017|364719321|FG003|Washout|Problem collecting rectal effluent|0|||
105744850|NCT00875017|364719322|FG004|Washout|Problem collecting rectal effluent|0|||
105744851|NCT00875017|364719323|FG005|Washout|Problem collecting rectal effluent|0|||
105744852|NCT00875017|364719318|FG000|Second Intervention|Adverse Event|0|||
105744853|NCT00875017|364719319|FG001|Second Intervention|Adverse Event|0|||
105744854|NCT00875017|364719320|FG002|Second Intervention|Adverse Event|0|||
105744855|NCT00875017|364719321|FG003|Second Intervention|Adverse Event|1|||
105744856|NCT00875017|364719322|FG004|Second Intervention|Adverse Event|0|||
105744857|NCT00875017|364719323|FG005|Second Intervention|Adverse Event|0|||
105744858|NCT00875017|364719318|FG000|Washout|Problems collecting rectal effluent|0|||
105744859|NCT00875017|364719319|FG001|Washout|Problems collecting rectal effluent|1|||
105744860|NCT00875017|364719320|FG002|Washout|Problems collecting rectal effluent|0|||
105744861|NCT00875017|364719321|FG003|Washout|Problems collecting rectal effluent|0|||
105744862|NCT00875017|364719322|FG004|Washout|Problems collecting rectal effluent|0|||
105744863|NCT00875017|364719323|FG005|Washout|Problems collecting rectal effluent|0|||
105744864|NCT00875017|364719318|FG000|Third Intervention|Adverse Event|0|||
105744865|NCT00875017|364719319|FG001|Third Intervention|Adverse Event|1|||
105744866|NCT00875017|364719320|FG002|Third Intervention|Adverse Event|1|||
105744867|NCT00875017|364719321|FG003|Third Intervention|Adverse Event|0|||
105744868|NCT00875017|364719322|FG004|Third Intervention|Adverse Event|0|||
105744869|NCT00875017|364719323|FG005|Third Intervention|Adverse Event|0|||
105744870|NCT00875017|364719318|FG000|Washout|Withdrawal by Subject|0|||
105744871|NCT00875017|364719319|FG001|Washout|Withdrawal by Subject|0|||
105744872|NCT00875017|364719320|FG002|Washout|Withdrawal by Subject|0|||
105744873|NCT00875017|364719321|FG003|Washout|Withdrawal by Subject|0|||
105744874|NCT00875017|364719322|FG004|Washout|Withdrawal by Subject|1|||
105744875|NCT00875017|364719323|FG005|Washout|Withdrawal by Subject|0|||
105744876|NCT00875017|364719318|FG000|Fourth Intervention|Inability to comply with fasting|0|||
105744877|NCT00875017|364719319|FG001|Fourth Intervention|Inability to comply with fasting|0|||
105744878|NCT00875017|364719320|FG002|Fourth Intervention|Inability to comply with fasting|0|||
105744879|NCT00875017|364719321|FG003|Fourth Intervention|Inability to comply with fasting|0|||
105744880|NCT00875017|364719322|FG004|Fourth Intervention|Inability to comply with fasting|0|||
105744881|NCT00875017|364719323|FG005|Fourth Intervention|Inability to comply with fasting|1|||
105744882|NCT02689219|364719324|FG000|Overall Study|Death|1|||
105744883|NCT02689219|364719325|FG001|Overall Study|Death|1|||
105744884|NCT02689219|364719324|FG000|Overall Study|Disease Progression|10|||
105744885|NCT02689219|364719325|FG001|Overall Study|Disease Progression|6|||
105744886|NCT01477892|364719326|FG000|Overall Study|Withdrawal by Subject|0|||
105744887|NCT01477892|364719327|FG001|Overall Study|Withdrawal by Subject|2|||
105744888|NCT03375112|364719331|FG000|Overall Study|Withdrawal by Subject|3|||
105744889|NCT03375112|364719332|FG001|Overall Study|Withdrawal by Subject|0|||
105744890|NCT05515601|364719336|FG000|Overall Study|Withdrawal by Subject|1|||
105744891|NCT05515601|364719337|FG001|Overall Study|Withdrawal by Subject|3|||
105744892|NCT05515601|364719338|FG002|Overall Study|Withdrawal by Subject|2|||
105744893|NCT05515601|364719339|FG003|Overall Study|Withdrawal by Subject|1|||
105744894|NCT05515601|364719340|FG004|Overall Study|Withdrawal by Subject|1|||
105744895|NCT05515601|364719341|FG005|Overall Study|Withdrawal by Subject|1|||
105744896|NCT05515601|364719336|FG000|Overall Study|Lost to Follow-up|0|||
105744897|NCT05515601|364719337|FG001|Overall Study|Lost to Follow-up|0|||
105744898|NCT05515601|364719338|FG002|Overall Study|Lost to Follow-up|0|||
105744899|NCT05515601|364719339|FG003|Overall Study|Lost to Follow-up|0|||
105744900|NCT05515601|364719340|FG004|Overall Study|Lost to Follow-up|1|||
105744901|NCT05515601|364719341|FG005|Overall Study|Lost to Follow-up|0|||
105744902|NCT00777491|364719342|FG000|Overall Study|Protocol Violation|0|||
105744903|NCT00777491|364719343|FG001|Overall Study|Protocol Violation|2|||
105744904|NCT00777491|364719342|FG000|Overall Study|Did not receive any protocol treatment|2|||
105744905|NCT00777491|364719343|FG001|Overall Study|Did not receive any protocol treatment|0|||
105744906|NCT00364845|364719346|FG000|Overall Study|Adverse Event|1|||
105744907|NCT00364845|364719347|FG001|Overall Study|Adverse Event|0|||
105744908|NCT00364845|364719346|FG000|Overall Study|Withdrawal by Subject|2|||
105744909|NCT00364845|364719347|FG001|Overall Study|Withdrawal by Subject|1|||
105744910|NCT00364845|364719346|FG000|Overall Study|Physician Decision|8|||
105744911|NCT00364845|364719347|FG001|Overall Study|Physician Decision|8|||
105744912|NCT00364845|364719346|FG000|Overall Study|Lost to Follow-up|0|||
105359339|NCT02824627|363320986|FG001|Overall Study|Adverse Event|2|||
105744913|NCT00364845|364719347|FG001|Overall Study|Lost to Follow-up|1|||
105744914|NCT00364845|364719346|FG000|Overall Study|Death|0|||
105744915|NCT00364845|364719347|FG001|Overall Study|Death|1|||
105744916|NCT01187901|364719348|FG000|Overall Study|Protocol Violation|1|||
105744917|NCT01187901|364719349|FG001|Overall Study|Protocol Violation|0|||
105744918|NCT01187901|364719348|FG000|Overall Study|Lost to Follow-up|1|||
105744919|NCT01187901|364719349|FG001|Overall Study|Lost to Follow-up|2|||
105744920|NCT01187901|364719348|FG000|Overall Study|Unrelated Health Reasons|1|||
105359340|NCT02824627|363320985|FG000|Overall Study|Lost to Follow-up|2|||
105744921|NCT01187901|364719349|FG001|Overall Study|Unrelated Health Reasons|2|||
105744922|NCT01187901|364719348|FG000|Overall Study|Suspected Allergic Reaction|1|||
105744923|NCT01187901|364719349|FG001|Overall Study|Suspected Allergic Reaction|1|||
105744924|NCT01187901|364719348|FG000|Overall Study|Adverse Event|3|||
105744925|NCT01187901|364719349|FG001|Overall Study|Adverse Event|0|||
105359341|NCT02824627|363320986|FG001|Overall Study|Lost to Follow-up|1|||
105744926|NCT01187901|364719348|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
105744927|NCT01187901|364719349|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
105744928|NCT01187901|364719348|FG000|Overall Study|Pregnancy|0|||
105744929|NCT01187901|364719349|FG001|Overall Study|Pregnancy|2|||
105744930|NCT00524316|364719352|FG000|Overall Study|Withdrawal by Subject|2|||
105744931|NCT00524316|364719352|FG000|Overall Study|Adverse Event|7|||
105744932|NCT00524316|364719352|FG000|Overall Study|Disease Progression|7|||
105744933|NCT02426658|364719353|FG000|Overall Study|Withdrawal by Subject|1|||
105744934|NCT02426658|364719353|FG000|Overall Study|Patient expired before treatment|2|||
105744935|NCT02928406|364719356|FG000|Overall Study|Death|780|||
105744936|NCT02928406|364719356|FG000|Overall Study|Progressive disease|3|||
105744937|NCT02928406|364719356|FG000|Overall Study|Lost to Follow-up|49|||
105744938|NCT02928406|364719356|FG000|Overall Study|Non-compliance|2|||
105744939|NCT02928406|364719356|FG000|Overall Study|Withdrawal by Subject|40|||
105744940|NCT02928406|364719356|FG000|Overall Study|Study terminated by sponsor|57|||
105744941|NCT02928406|364719356|FG000|Overall Study|Physician Decision|1|||
105744942|NCT02928406|364719356|FG000|Overall Study|Various reasons|72|||
105744943|NCT00786838|364719357|FG000|Overall Study|Physician Decision|4|||
105744944|NCT00786838|364719357|FG000|Overall Study|Death|4|||
105744945|NCT00786838|364719357|FG000|Overall Study|Adverse Event|6|||
105744946|NCT00786838|364719357|FG000|Overall Study|Progressive disease|31|||
105744947|NCT00786838|364719357|FG000|Overall Study|Withdrawal by Subject|4|||
105744948|NCT02065622|364719358|FG000|Induction Study|Adverse Event|13|||
105744949|NCT02065622|364719359|FG001|Induction Study|Adverse Event|19|||
105744950|NCT02065622|364719360|FG002|Induction Study|Adverse Event|0|||
105744951|NCT02065622|364719361|FG003|Induction Study|Adverse Event|0|||
105744952|NCT02065622|364719362|FG004|Induction Study|Adverse Event|0|||
105744953|NCT02065622|364719358|FG000|Induction Study|Withdrawal by Subject|3|||
105744954|NCT02065622|364719359|FG001|Induction Study|Withdrawal by Subject|5|||
105744955|NCT02065622|364719360|FG002|Induction Study|Withdrawal by Subject|0|||
105744956|NCT02065622|364719361|FG003|Induction Study|Withdrawal by Subject|0|||
105744957|NCT02065622|364719362|FG004|Induction Study|Withdrawal by Subject|0|||
105744958|NCT02065622|364719358|FG000|Induction Study|Lost to Follow-up|1|||
105744959|NCT02065622|364719359|FG001|Induction Study|Lost to Follow-up|0|||
105744960|NCT02065622|364719360|FG002|Induction Study|Lost to Follow-up|0|||
105744961|NCT02065622|364719361|FG003|Induction Study|Lost to Follow-up|0|||
105744962|NCT02065622|364719362|FG004|Induction Study|Lost to Follow-up|0|||
105744963|NCT02065622|364719358|FG000|Induction Study|Lack of Efficacy|22|||
105744964|NCT02065622|364719359|FG001|Induction Study|Lack of Efficacy|27|||
105744965|NCT02065622|364719360|FG002|Induction Study|Lack of Efficacy|0|||
105744966|NCT02065622|364719361|FG003|Induction Study|Lack of Efficacy|0|||
105744967|NCT02065622|364719362|FG004|Induction Study|Lack of Efficacy|0|||
105744968|NCT02065622|364719358|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
105744969|NCT02065622|364719359|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
105744970|NCT02065622|364719360|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
105744971|NCT02065622|364719361|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
105744972|NCT02065622|364719362|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
105744973|NCT02065622|364719358|FG000|Induction Study|Subject Noncompliance|1|||
105744974|NCT02065622|364719359|FG001|Induction Study|Subject Noncompliance|1|||
105744975|NCT02065622|364719360|FG002|Induction Study|Subject Noncompliance|0|||
105744976|NCT02065622|364719361|FG003|Induction Study|Subject Noncompliance|0|||
105744977|NCT02065622|364719362|FG004|Induction Study|Subject Noncompliance|0|||
105744978|NCT02065622|364719358|FG000|Induction Study|Other, Not Specified|3|||
105744979|NCT02065622|364719359|FG001|Induction Study|Other, Not Specified|2|||
105744980|NCT02065622|364719360|FG002|Induction Study|Other, Not Specified|0|||
105744981|NCT02065622|364719361|FG003|Induction Study|Other, Not Specified|0|||
105744982|NCT02065622|364719362|FG004|Induction Study|Other, Not Specified|0|||
105744983|NCT02065622|364719358|FG000|Maintenance Study|Adverse Event|0|||
105744984|NCT02065622|364719359|FG001|Maintenance Study|Adverse Event|0|||
105744985|NCT02065622|364719360|FG002|Maintenance Study|Adverse Event|25|||
105744986|NCT02065622|364719361|FG003|Maintenance Study|Adverse Event|22|||
105744987|NCT02065622|364719362|FG004|Maintenance Study|Adverse Event|11|||
105744988|NCT02065622|364719358|FG000|Maintenance Study|Withdrawal by Subject|0|||
105744989|NCT02065622|364719359|FG001|Maintenance Study|Withdrawal by Subject|0|||
105744990|NCT02065622|364719360|FG002|Maintenance Study|Withdrawal by Subject|11|||
105359342|NCT01938846|363320987|FG000|Overall Study|Progressive disease|26|||
105744991|NCT02065622|364719361|FG003|Maintenance Study|Withdrawal by Subject|5|||
105744992|NCT02065622|364719362|FG004|Maintenance Study|Withdrawal by Subject|7|||
105744993|NCT02065622|364719358|FG000|Maintenance Study|Lost to Follow-up|0|||
105744994|NCT02065622|364719359|FG001|Maintenance Study|Lost to Follow-up|0|||
105744995|NCT02065622|364719360|FG002|Maintenance Study|Lost to Follow-up|4|||
105744996|NCT02065622|364719361|FG003|Maintenance Study|Lost to Follow-up|1|||
105744997|NCT02065622|364719362|FG004|Maintenance Study|Lost to Follow-up|1|||
105744998|NCT02065622|364719358|FG000|Maintenance Study|Lack of Efficacy|0|||
105744999|NCT02065622|364719359|FG001|Maintenance Study|Lack of Efficacy|0|||
105745000|NCT02065622|364719360|FG002|Maintenance Study|Lack of Efficacy|70|||
105745001|NCT02065622|364719361|FG003|Maintenance Study|Lack of Efficacy|55|||
105745002|NCT02065622|364719362|FG004|Maintenance Study|Lack of Efficacy|19|||
105745003|NCT02065622|364719358|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
105745004|NCT02065622|364719359|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
105745005|NCT02065622|364719360|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
105745006|NCT02065622|364719361|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
105745007|NCT02065622|364719362|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
105745008|NCT02065622|364719358|FG000|Maintenance Study|Subject Non-Compliance|0|||
105745009|NCT02065622|364719359|FG001|Maintenance Study|Subject Non-Compliance|0|||
105745010|NCT02065622|364719360|FG002|Maintenance Study|Subject Non-Compliance|1|||
105745011|NCT02065622|364719361|FG003|Maintenance Study|Subject Non-Compliance|3|||
105745012|NCT02065622|364719362|FG004|Maintenance Study|Subject Non-Compliance|2|||
105745013|NCT02065622|364719358|FG000|Maintenance Study|Other, Not Specified|0|||
105745014|NCT02065622|364719359|FG001|Maintenance Study|Other, Not Specified|0|||
105745015|NCT02065622|364719360|FG002|Maintenance Study|Other, Not Specified|6|||
105745016|NCT02065622|364719361|FG003|Maintenance Study|Other, Not Specified|14|||
105745017|NCT02065622|364719362|FG004|Maintenance Study|Other, Not Specified|2|||
105745018|NCT02065622|364719358|FG000|Maintenance Study|Unknown Reason|0|||
105745019|NCT02065622|364719359|FG001|Maintenance Study|Unknown Reason|0|||
105745020|NCT02065622|364719360|FG002|Maintenance Study|Unknown Reason|0|||
105745021|NCT02065622|364719361|FG003|Maintenance Study|Unknown Reason|1|||
105745022|NCT02065622|364719362|FG004|Maintenance Study|Unknown Reason|0|||
105745023|NCT00091390|364719363|FG000|Overall Study|Protocol Violation|1|||
105745024|NCT00091390|364719363|FG000|Overall Study|No protocol treatment|3|||
105745025|NCT04920084|364721049|FG000|Overall Study|Adverse Event|1|||
105745026|NCT04920084|364721049|FG000|Overall Study|Lost to Follow-up|2|||
105745027|NCT04920084|364721049|FG000|Overall Study|Withdrawal by Subject|2|||
105745028|NCT04191967|364721050|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
105745029|NCT04191967|364721050|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
105745030|NCT00523341|364721060|FG000|Overall Study|Withdrawal by Subject|399|||
105745031|NCT00523341|364721061|FG001|Overall Study|Withdrawal by Subject|427|||
105745032|NCT00523341|364721060|FG000|Overall Study|Other|181|||
105745033|NCT00523341|364721061|FG001|Overall Study|Other|198|||
105745034|NCT00523341|364721060|FG000|Overall Study|Adverse Event|122|||
105745035|NCT00523341|364721061|FG001|Overall Study|Adverse Event|155|||
105745036|NCT00523341|364721060|FG000|Overall Study|Death|101|||
105745037|NCT00523341|364721061|FG001|Overall Study|Death|110|||
105745038|NCT00523341|364721060|FG000|Overall Study|Lost to Follow-up|73|||
105745039|NCT00523341|364721061|FG001|Overall Study|Lost to Follow-up|61|||
105745040|NCT00523341|364721060|FG000|Overall Study|Non-compliance|20|||
105745041|NCT00523341|364721061|FG001|Overall Study|Non-compliance|13|||
105745042|NCT00523341|364721060|FG000|Overall Study|Physician Decision|14|||
105745043|NCT00523341|364721061|FG001|Overall Study|Physician Decision|13|||
105745044|NCT00523341|364721060|FG000|Overall Study|Requirement for Alternative Therapy|4|||
105745045|NCT00523341|364721061|FG001|Overall Study|Requirement for Alternative Therapy|14|||
105745046|NCT00523341|364721060|FG000|Overall Study|Protocol Deviation|6|||
105745047|NCT00523341|364721061|FG001|Overall Study|Protocol Deviation|5|||
105745048|NCT00523341|364721060|FG000|Overall Study|Ineligibility Determined|3|||
105745049|NCT00523341|364721061|FG001|Overall Study|Ineligibility Determined|4|||
105745050|NCT00523341|364721060|FG000|Overall Study|Disease Progression|1|||
105745051|NCT00523341|364721061|FG001|Overall Study|Disease Progression|0|||
105745052|NCT00051558|364721064|FG000|Overall Study|Adverse Event|30|||
105745053|NCT00051558|364721065|FG001|Overall Study|Adverse Event|18|||
105745054|NCT00051558|364721064|FG000|Overall Study|Withdrawal by Subject|29|||
105745055|NCT00051558|364721065|FG001|Overall Study|Withdrawal by Subject|42|||
105745056|NCT00051558|364721064|FG000|Overall Study|Death|9|||
105745057|NCT00051558|364721065|FG001|Overall Study|Death|15|||
105745058|NCT00051558|364721064|FG000|Overall Study|Lost to Follow-up|4|||
105745059|NCT00051558|364721065|FG001|Overall Study|Lost to Follow-up|13|||
105745060|NCT00051558|364721064|FG000|Overall Study|Protocol Violation|3|||
105745061|NCT00051558|364721065|FG001|Overall Study|Protocol Violation|4|||
105745062|NCT00051558|364721064|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
105800540|NCT02544633|364928477|FG001|Treatment Period|Non-compliance|0|||
105745063|NCT00051558|364721065|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
105745064|NCT00051558|364721064|FG000|Overall Study|Sponsor Decision|6|||
105745065|NCT00051558|364721065|FG001|Overall Study|Sponsor Decision|1|||
105745066|NCT00051558|364721064|FG000|Overall Study|Other|2|||
105745067|NCT00051558|364721065|FG001|Overall Study|Other|1|||
105745068|NCT00051558|364721064|FG000|Overall Study|Significant Lab Value|2|||
105745069|NCT00051558|364721065|FG001|Overall Study|Significant Lab Value|0|||
105745070|NCT00051558|364721064|FG000|Overall Study|Physician Decision|5|||
105745071|NCT00051558|364721065|FG001|Overall Study|Physician Decision|0|||
105800541|NCT02544633|364928478|FG002|Treatment Period|Non-compliance|1|||
105745072|NCT00716417|364721069|FG000|Overall Study|Adverse Event|0|||
105745073|NCT00716417|364721070|FG001|Overall Study|Adverse Event|0|||
105745074|NCT00716417|364721071|FG002|Overall Study|Adverse Event|2|||
105745075|NCT00716417|364721072|FG003|Overall Study|Adverse Event|1|||
105745076|NCT00716417|364721073|FG004|Overall Study|Adverse Event|0|||
105745077|NCT00716417|364721074|FG005|Overall Study|Adverse Event|0|||
105745078|NCT00716417|364721075|FG006|Overall Study|Adverse Event|3|||
105745079|NCT00716417|364721076|FG007|Overall Study|Adverse Event|1|||
105745080|NCT00716417|364721077|FG008|Overall Study|Adverse Event|0|||
105745081|NCT00716417|364721078|FG009|Overall Study|Adverse Event|3|||
105745082|NCT00716417|364721069|FG000|Overall Study|Withdrawal by Subject|0|||
105745083|NCT00716417|364721070|FG001|Overall Study|Withdrawal by Subject|1|||
105745084|NCT00716417|364721071|FG002|Overall Study|Withdrawal by Subject|0|||
105745085|NCT00716417|364721072|FG003|Overall Study|Withdrawal by Subject|2|||
105745086|NCT00716417|364721073|FG004|Overall Study|Withdrawal by Subject|0|||
105745087|NCT00716417|364721074|FG005|Overall Study|Withdrawal by Subject|0|||
105745088|NCT00716417|364721075|FG006|Overall Study|Withdrawal by Subject|1|||
105745089|NCT00716417|364721076|FG007|Overall Study|Withdrawal by Subject|0|||
105745090|NCT00716417|364721077|FG008|Overall Study|Withdrawal by Subject|0|||
105745091|NCT00716417|364721078|FG009|Overall Study|Withdrawal by Subject|0|||
105745092|NCT00716417|364721069|FG000|Overall Study|Progressive disease|3|||
105745093|NCT00716417|364721070|FG001|Overall Study|Progressive disease|5|||
105745094|NCT00716417|364721071|FG002|Overall Study|Progressive disease|3|||
105745095|NCT00716417|364721072|FG003|Overall Study|Progressive disease|8|||
105745096|NCT00716417|364721073|FG004|Overall Study|Progressive disease|0|||
105745097|NCT00716417|364721074|FG005|Overall Study|Progressive disease|3|||
105745098|NCT00716417|364721075|FG006|Overall Study|Progressive disease|3|||
105745099|NCT00716417|364721076|FG007|Overall Study|Progressive disease|1|||
105745100|NCT00716417|364721077|FG008|Overall Study|Progressive disease|5|||
105745101|NCT00716417|364721078|FG009|Overall Study|Progressive disease|0|||
105745102|NCT00716417|364721069|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
105745103|NCT00716417|364721070|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
105745104|NCT00716417|364721071|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
105745105|NCT00716417|364721072|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
105745106|NCT00716417|364721073|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
105745107|NCT00716417|364721074|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
105745108|NCT00716417|364721075|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
105745109|NCT00716417|364721076|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
105745110|NCT00716417|364721077|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
105745111|NCT00716417|364721078|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
105745112|NCT00716417|364721069|FG000|Overall Study|On patient request due to toxicities|0|||
105745113|NCT00716417|364721070|FG001|Overall Study|On patient request due to toxicities|0|||
105745114|NCT00716417|364721071|FG002|Overall Study|On patient request due to toxicities|0|||
105745115|NCT00716417|364721072|FG003|Overall Study|On patient request due to toxicities|0|||
105745116|NCT00716417|364721073|FG004|Overall Study|On patient request due to toxicities|0|||
105745117|NCT00716417|364721074|FG005|Overall Study|On patient request due to toxicities|0|||
105745118|NCT00716417|364721075|FG006|Overall Study|On patient request due to toxicities|0|||
105745119|NCT00716417|364721076|FG007|Overall Study|On patient request due to toxicities|1|||
105745120|NCT00716417|364721077|FG008|Overall Study|On patient request due to toxicities|0|||
105745121|NCT00716417|364721078|FG009|Overall Study|On patient request due to toxicities|0|||
105745122|NCT01830543|364721083|FG000|Overall Study|Subject Decision|19|||
105745123|NCT01830543|364721084|FG001|Overall Study|Subject Decision|21|||
105745124|NCT01830543|364721085|FG002|Overall Study|Subject Decision|57|||
105745125|NCT01830543|364721083|FG000|Overall Study|Adverse Event|91|||
105745126|NCT01830543|364721084|FG001|Overall Study|Adverse Event|77|||
105745127|NCT01830543|364721085|FG002|Overall Study|Adverse Event|76|||
105745128|NCT01830543|364721083|FG000|Overall Study|Death|20|||
105745129|NCT01830543|364721084|FG001|Overall Study|Death|22|||
105745130|NCT01830543|364721085|FG002|Overall Study|Death|22|||
105745131|NCT01830543|364721083|FG000|Overall Study|Protocol Violation|3|||
105745132|NCT01830543|364721084|FG001|Overall Study|Protocol Violation|7|||
105745133|NCT01830543|364721085|FG002|Overall Study|Protocol Violation|7|||
105745134|NCT01830543|364721083|FG000|Overall Study|Physician Decision|11|||
105745135|NCT01830543|364721084|FG001|Overall Study|Physician Decision|5|||
105745136|NCT01830543|364721085|FG002|Overall Study|Physician Decision|12|||
105359343|NCT01938846|363320988|FG001|Overall Study|Progressive disease|18|||
105745137|NCT01830543|364721083|FG000|Overall Study|Withdrawal by consent|3|||
105745138|NCT01830543|364721084|FG001|Overall Study|Withdrawal by consent|3|||
105745139|NCT01830543|364721085|FG002|Overall Study|Withdrawal by consent|3|||
105745140|NCT01830543|364721083|FG000|Overall Study|Other|12|||
105359344|NCT01938846|363320989|FG002|Overall Study|Progressive disease|16|||
105359345|NCT01938846|363320987|FG000|Overall Study|Adverse Event|8|||
105745141|NCT01830543|364721084|FG001|Overall Study|Other|17|||
105745142|NCT01830543|364721085|FG002|Overall Study|Other|37|||
105745143|NCT04281030|364721087|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
105745144|NCT04281030|364721088|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
105800542|NCT02544633|364928479|FG003|Treatment Period|Non-compliance|0|||
105745145|NCT04281030|364721087|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
105745146|NCT04281030|364721088|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
105745147|NCT05619172|364721091|FG000|Safety Cohort 1|Death|7|||
105745148|NCT05619172|364721092|FG001|Safety Cohort 1|Death|0|||
105745149|NCT05619172|364721091|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
105745150|NCT05619172|364721092|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
105745151|NCT05619172|364721091|FG000|Safety Cohort 2|Death|0|||
105745152|NCT05619172|364721092|FG001|Safety Cohort 2|Death|1|||
105800543|NCT02544633|364928476|FG000|Treatment Period|Clinical Disease Progression|0|||
105800544|NCT02544633|364928477|FG001|Treatment Period|Clinical Disease Progression|0|||
105800545|NCT02544633|364928478|FG002|Treatment Period|Clinical Disease Progression|0|||
105800546|NCT02544633|364928479|FG003|Treatment Period|Clinical Disease Progression|1|||
105800547|NCT02544633|364928476|FG000|Survival Follow-up Period|Death|12|||
105800548|NCT02544633|364928477|FG001|Survival Follow-up Period|Death|14|||
105800549|NCT02544633|364928478|FG002|Survival Follow-up Period|Death|3|||
105800550|NCT02544633|364928479|FG003|Survival Follow-up Period|Death|9|||
105800551|NCT02544633|364928476|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
105800552|NCT02544633|364928477|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
105800553|NCT02544633|364928478|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
105800554|NCT02544633|364928479|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
105800555|NCT02544633|364928476|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
105800556|NCT02544633|364928477|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
105800557|NCT02544633|364928478|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
105800558|NCT02544633|364928479|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
105800559|NCT02544633|364928476|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
105800560|NCT02544633|364928477|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
105800561|NCT02544633|364928478|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
105800562|NCT02544633|364928479|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
105800578|NCT00775983|364928487|FG000|Overall Study|Protocol Violation|1|||
105800579|NCT00775983|364928488|FG001|Overall Study|Protocol Violation|2|||
105800580|NCT03763331|364928489|FG000|Overall Study|Lost to Follow-up|1|||
105800581|NCT03763331|364928490|FG001|Overall Study|Lost to Follow-up|0|||
105800582|NCT03763331|364928489|FG000|Overall Study|Withdrawal by Subject|1|||
105800583|NCT03763331|364928490|FG001|Overall Study|Withdrawal by Subject|0|||
105800584|NCT03763331|364928489|FG000|Overall Study|Non-compliance|0|||
105800585|NCT03763331|364928490|FG001|Overall Study|Non-compliance|3|||
105745153|NCT05619172|364721091|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
105745154|NCT05619172|364721092|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
105800586|NCT01155063|364928491|FG000|Overall Study|Adverse Event|1|||
105359346|NCT01938846|363320988|FG001|Overall Study|Adverse Event|4|||
105359347|NCT01938846|363320989|FG002|Overall Study|Adverse Event|3|||
105800587|NCT01155063|364928491|FG000|Overall Study|Withdrawal by Subject|1|||
105800588|NCT01155063|364928491|FG000|Overall Study|Study terminated by sponsor|87|||
105745155|NCT04184622|364721093|FG000|Primary Treatment Period|Adverse Event|6|||
105745156|NCT04184622|364721094|FG001|Primary Treatment Period|Adverse Event|4|||
105745157|NCT04184622|364721095|FG002|Primary Treatment Period|Adverse Event|8|||
105800589|NCT00936884|364928492|FG000|Double-blind|Withdrawal by Subject|6|||
105800590|NCT00936884|364928493|FG001|Double-blind|Withdrawal by Subject|4|||
105800591|NCT00936884|364928494|FG002|Double-blind|Withdrawal by Subject|0|||
105359348|NCT01938846|363320987|FG000|Overall Study|Withdrawal by Subject|2|||
105745158|NCT04184622|364721096|FG003|Primary Treatment Period|Adverse Event|6|||
105745159|NCT04184622|364721093|FG000|Primary Treatment Period|Death|4|||
105745160|NCT04184622|364721094|FG001|Primary Treatment Period|Death|4|||
105745161|NCT04184622|364721095|FG002|Primary Treatment Period|Death|2|||
105745162|NCT04184622|364721096|FG003|Primary Treatment Period|Death|1|||
105745163|NCT04184622|364721093|FG000|Primary Treatment Period|Lost to Follow-up|41|||
105745164|NCT04184622|364721094|FG001|Primary Treatment Period|Lost to Follow-up|17|||
105745165|NCT04184622|364721095|FG002|Primary Treatment Period|Lost to Follow-up|15|||
105745166|NCT04184622|364721096|FG003|Primary Treatment Period|Lost to Follow-up|13|||
105745167|NCT04184622|364721093|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
105745168|NCT04184622|364721094|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
105745169|NCT04184622|364721095|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
105745170|NCT04184622|364721096|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
105745171|NCT04184622|364721093|FG000|Primary Treatment Period|Physician Decision|0|||
105745172|NCT04184622|364721094|FG001|Primary Treatment Period|Physician Decision|0|||
105745173|NCT04184622|364721095|FG002|Primary Treatment Period|Physician Decision|3|||
105745174|NCT04184622|364721096|FG003|Primary Treatment Period|Physician Decision|1|||
105745175|NCT04184622|364721093|FG000|Primary Treatment Period|Pregnancy|4|||
105745176|NCT04184622|364721094|FG001|Primary Treatment Period|Pregnancy|3|||
105745177|NCT04184622|364721095|FG002|Primary Treatment Period|Pregnancy|4|||
105745178|NCT04184622|364721096|FG003|Primary Treatment Period|Pregnancy|1|||
105745179|NCT04184622|364721093|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
105745180|NCT04184622|364721094|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
105745181|NCT04184622|364721095|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
105745182|NCT04184622|364721096|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
105745183|NCT04184622|364721093|FG000|Additional Treatment Period|Adverse Event|1|||
105745184|NCT04184622|364721094|FG001|Additional Treatment Period|Adverse Event|2|||
105745185|NCT04184622|364721095|FG002|Additional Treatment Period|Adverse Event|1|||
105745186|NCT04184622|364721096|FG003|Additional Treatment Period|Adverse Event|0|||
105745187|NCT04184622|364721093|FG000|Additional Treatment Period|Death|0|||
105745188|NCT04184622|364721094|FG001|Additional Treatment Period|Death|0|||
105745189|NCT04184622|364721095|FG002|Additional Treatment Period|Death|1|||
105745190|NCT04184622|364721096|FG003|Additional Treatment Period|Death|1|||
105745191|NCT04184622|364721093|FG000|Additional Treatment Period|Lost to Follow-up|6|||
105745192|NCT04184622|364721094|FG001|Additional Treatment Period|Lost to Follow-up|4|||
105745193|NCT04184622|364721095|FG002|Additional Treatment Period|Lost to Follow-up|8|||
105745194|NCT04184622|364721096|FG003|Additional Treatment Period|Lost to Follow-up|6|||
105745195|NCT04184622|364721093|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
105745196|NCT04184622|364721094|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
105745197|NCT04184622|364721095|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
105745198|NCT04184622|364721096|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
105745199|NCT04184622|364721093|FG000|Additional Treatment Period|Physician Decision|0|||
105745200|NCT04184622|364721094|FG001|Additional Treatment Period|Physician Decision|0|||
105745201|NCT04184622|364721095|FG002|Additional Treatment Period|Physician Decision|1|||
105745202|NCT04184622|364721096|FG003|Additional Treatment Period|Physician Decision|0|||
105745203|NCT04184622|364721093|FG000|Additional Treatment Period|Pregnancy|0|||
105745204|NCT04184622|364721094|FG001|Additional Treatment Period|Pregnancy|0|||
105745205|NCT04184622|364721095|FG002|Additional Treatment Period|Pregnancy|0|||
105745206|NCT04184622|364721096|FG003|Additional Treatment Period|Pregnancy|1|||
105745207|NCT04184622|364721093|FG000|Additional Treatment Period|Protocol deviation|0|||
105745208|NCT04184622|364721094|FG001|Additional Treatment Period|Protocol deviation|0|||
105745209|NCT04184622|364721095|FG002|Additional Treatment Period|Protocol deviation|1|||
105745210|NCT04184622|364721096|FG003|Additional Treatment Period|Protocol deviation|0|||
105745211|NCT04184622|364721093|FG000|Additional Treatment Period|Site closed|1|||
105745212|NCT04184622|364721094|FG001|Additional Treatment Period|Site closed|0|||
105745213|NCT04184622|364721095|FG002|Additional Treatment Period|Site closed|1|||
105745214|NCT04184622|364721096|FG003|Additional Treatment Period|Site closed|0|||
105745215|NCT04184622|364721093|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
105745216|NCT04184622|364721094|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
105359349|NCT01938846|363320988|FG001|Overall Study|Withdrawal by Subject|2|||
105745217|NCT04184622|364721095|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
105745218|NCT04184622|364721096|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
105745219|NCT04184622|364721093|FG000|Safety Follow-up Period|Adverse Event|6|||
105745220|NCT04184622|364721094|FG001|Safety Follow-up Period|Adverse Event|8|||
105745221|NCT04184622|364721095|FG002|Safety Follow-up Period|Adverse Event|9|||
105745222|NCT04184622|364721096|FG003|Safety Follow-up Period|Adverse Event|16|||
105745223|NCT04184622|364721093|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
105745224|NCT04184622|364721094|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
105745225|NCT04184622|364721095|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
105745226|NCT04184622|364721096|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
105800592|NCT00936884|364928492|FG000|Double-blind|Death|2|||
105800593|NCT00936884|364928493|FG001|Double-blind|Death|1|||
105800594|NCT00936884|364928494|FG002|Double-blind|Death|0|||
105800595|NCT00936884|364928492|FG000|Double-blind|Lack of Efficacy|1|||
105800596|NCT00936884|364928493|FG001|Double-blind|Lack of Efficacy|1|||
105800597|NCT00936884|364928494|FG002|Double-blind|Lack of Efficacy|0|||
105800598|NCT00936884|364928492|FG000|Double-blind|Adverse Event|1|||
105800599|NCT00936884|364928493|FG001|Double-blind|Adverse Event|0|||
105800600|NCT00936884|364928494|FG002|Double-blind|Adverse Event|0|||
105800601|NCT00936884|364928492|FG000|Double-blind|Physician Decision|1|||
105800602|NCT00936884|364928493|FG001|Double-blind|Physician Decision|0|||
105800603|NCT00936884|364928494|FG002|Double-blind|Physician Decision|0|||
105800604|NCT00936884|364928492|FG000|Double-blind|No post baseline diary entry|1|||
105800605|NCT00936884|364928493|FG001|Double-blind|No post baseline diary entry|0|||
105800606|NCT00936884|364928494|FG002|Double-blind|No post baseline diary entry|0|||
105800607|NCT00936884|364928492|FG000|Double-blind|Did not receive study drug|0|||
105800608|NCT00936884|364928493|FG001|Double-blind|Did not receive study drug|1|||
105800609|NCT00936884|364928494|FG002|Double-blind|Did not receive study drug|0|||
105800610|NCT01312779|364928495|FG000|Overall Study|Withdrawal by Subject|2|||
105800611|NCT01312779|364928495|FG000|Overall Study|Death|3|||
105800612|NCT01312779|364928495|FG000|Overall Study|Not Implanted with Device|27|||
105800613|NCT04741503|364928496|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
105800614|NCT04741503|364928497|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
105800615|NCT04741503|364928498|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
105800616|NCT04741503|364928496|FG000|Initial Enrollment|Overquotas removed|0|||
105800617|NCT04741503|364928497|FG001|Initial Enrollment|Overquotas removed|0|||
105800618|NCT04741503|364928498|FG002|Initial Enrollment|Overquotas removed|186|||
105800619|NCT04741503|364928496|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
105800620|NCT04741503|364928497|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
105800621|NCT04741503|364928498|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
105800622|NCT01314703|364928499|FG000|Overall Study|screen failure and closed enrollment|8|||
105800623|NCT00597584|364928500|FG000|Overall Study|Adverse Event|4|||
105800624|NCT00597584|364928501|FG001|Overall Study|Adverse Event|2|||
105800625|NCT00597584|364928500|FG000|Overall Study|Death|53|||
105800626|NCT00597584|364928501|FG001|Overall Study|Death|30|||
105800627|NCT00597584|364928500|FG000|Overall Study|Lack of Efficacy|1|||
105800628|NCT00597584|364928501|FG001|Overall Study|Lack of Efficacy|0|||
105800629|NCT00597584|364928500|FG000|Overall Study|Lost to Follow-up|2|||
105800630|NCT00597584|364928501|FG001|Overall Study|Lost to Follow-up|4|||
105800631|NCT00597584|364928500|FG000|Overall Study|Physician Decision|3|||
105800632|NCT00597584|364928501|FG001|Overall Study|Physician Decision|0|||
105800633|NCT00597584|364928500|FG000|Overall Study|Pregnancy|2|||
105800634|NCT00597584|364928501|FG001|Overall Study|Pregnancy|0|||
105800635|NCT00597584|364928500|FG000|Overall Study|Withdrawal by Subject|44|||
105800636|NCT00597584|364928501|FG001|Overall Study|Withdrawal by Subject|12|||
105800637|NCT00597584|364928500|FG000|Overall Study|Discontinued Dialysis|0|||
105800638|NCT00597584|364928501|FG001|Overall Study|Discontinued Dialysis|1|||
105800639|NCT00597584|364928500|FG000|Overall Study|Lost ability to consent|1|||
105800640|NCT00597584|364928501|FG001|Overall Study|Lost ability to consent|1|||
105745227|NCT04184622|364721093|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
105745228|NCT04184622|364721094|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
105745229|NCT04184622|364721095|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
105745230|NCT04184622|364721096|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
105745231|NCT04184622|364721093|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
105745232|NCT04184622|364721094|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
105745233|NCT04184622|364721095|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
105745234|NCT04184622|364721096|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
105745235|NCT04184622|364721093|FG000|Safety Follow-up Period|Physician Decision|1|||
105745236|NCT04184622|364721094|FG001|Safety Follow-up Period|Physician Decision|0|||
105745237|NCT04184622|364721095|FG002|Safety Follow-up Period|Physician Decision|0|||
105745238|NCT04184622|364721096|FG003|Safety Follow-up Period|Physician Decision|1|||
105745239|NCT04184622|364721093|FG000|Safety Follow-up Period|Pregnancy|1|||
105800641|NCT00597584|364928500|FG000|Overall Study|Never dosed|1|||
105800642|NCT00597584|364928501|FG001|Overall Study|Never dosed|0|||
105800643|NCT00597584|364928500|FG000|Overall Study|Relocation|8|||
105800644|NCT00597584|364928501|FG001|Overall Study|Relocation|6|||
105800645|NCT00597584|364928500|FG000|Overall Study|Renal transplant|9|||
105800646|NCT00597584|364928501|FG001|Overall Study|Renal transplant|7|||
105800647|NCT01859390|364928502|FG000|Overall Study|Insufficient Sputum Collected|1|||
105800648|NCT01859390|364928503|FG001|Overall Study|Insufficient Sputum Collected|3|||
105800649|NCT01859390|364928502|FG000|Overall Study|Sample Missing Collection Date|0|||
105745240|NCT04184622|364721094|FG001|Safety Follow-up Period|Pregnancy|3|||
105745241|NCT04184622|364721095|FG002|Safety Follow-up Period|Pregnancy|0|||
105800650|NCT01859390|364928503|FG001|Overall Study|Sample Missing Collection Date|1|||
105745242|NCT04184622|364721096|FG003|Safety Follow-up Period|Pregnancy|6|||
105745243|NCT04184622|364721093|FG000|Safety Follow-up Period|Protocol deviation|1|||
105745244|NCT04184622|364721094|FG001|Safety Follow-up Period|Protocol deviation|0|||
105745245|NCT04184622|364721095|FG002|Safety Follow-up Period|Protocol deviation|0|||
105745246|NCT04184622|364721096|FG003|Safety Follow-up Period|Protocol deviation|0|||
105745247|NCT04184622|364721093|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
105745248|NCT04184622|364721094|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
105745249|NCT04184622|364721095|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
105745250|NCT04184622|364721096|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
105745251|NCT01219959|364721107|FG000|Overall Study|Adverse Event|6|||
105745252|NCT01219959|364721108|FG001|Overall Study|Adverse Event|14|||
105745253|NCT01219959|364721107|FG000|Overall Study|Physician Decision|0|||
105745254|NCT01219959|364721108|FG001|Overall Study|Physician Decision|4|||
105745255|NCT01219959|364721107|FG000|Overall Study|Withdrawal by Subject|0|||
105745256|NCT01219959|364721108|FG001|Overall Study|Withdrawal by Subject|2|||
105745257|NCT01219959|364721107|FG000|Overall Study|Renal Transplantation|0|||
105745258|NCT01219959|364721108|FG001|Overall Study|Renal Transplantation|3|||
105745259|NCT01219959|364721107|FG000|Overall Study|Other|1|||
105745260|NCT01219959|364721108|FG001|Overall Study|Other|0|||
105745261|NCT05906732|364721109|FG000|Overall Study|Withdrawal by Subject|1|||
105745262|NCT05906732|364721110|FG001|Overall Study|Withdrawal by Subject|0|||
105745263|NCT05906732|364721111|FG002|Overall Study|Withdrawal by Subject|0|||
105745264|NCT05906732|364721112|FG003|Overall Study|Withdrawal by Subject|0|||
105745265|NCT05906732|364721109|FG000|Overall Study|Physician Decision|2|||
105745266|NCT05906732|364721110|FG001|Overall Study|Physician Decision|4|||
105745267|NCT05906732|364721111|FG002|Overall Study|Physician Decision|0|||
105745268|NCT05906732|364721112|FG003|Overall Study|Physician Decision|0|||
105745269|NCT05628181|364721113|FG000|Overall Study|Death|2|||
105745270|NCT05628181|364721114|FG001|Overall Study|Death|4|||
105745271|NCT05628181|364721115|FG002|Overall Study|Death|0|||
105745272|NCT01358877|364721117|FG000|Overall Study|Death|80|||
105745273|NCT01358877|364721118|FG001|Overall Study|Death|89|||
105745274|NCT01358877|364721117|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
105745275|NCT01358877|364721118|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
105745276|NCT01358877|364721117|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
105745277|NCT01358877|364721118|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
105745278|NCT01358877|364721117|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
105745279|NCT01358877|364721118|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
105745280|NCT01358877|364721117|FG000|Overall Study|Other|142|||
105745281|NCT01358877|364721118|FG001|Overall Study|Other|129|||
105745282|NCT03656926|364721119|FG000|Overall Study|Adverse Event|5|||
105745283|NCT03656926|364721120|FG001|Overall Study|Adverse Event|4|||
105745284|NCT03656926|364721119|FG000|Overall Study|Withdrawal by Subject|7|||
105745285|NCT03656926|364721120|FG001|Overall Study|Withdrawal by Subject|2|||
105745286|NCT03656926|364721119|FG000|Overall Study|Screen fail after randomization|1|||
105745287|NCT03656926|364721120|FG001|Overall Study|Screen fail after randomization|0|||
105745288|NCT03656926|364721119|FG000|Overall Study|PI decision due to patient condition|1|||
105745289|NCT03656926|364721120|FG001|Overall Study|PI decision due to patient condition|0|||
105745290|NCT03656926|364721119|FG000|Overall Study|Patient unresponsiveness|1|||
105745291|NCT03656926|364721120|FG001|Overall Study|Patient unresponsiveness|0|||
105745292|NCT06150573|364721121|FG000|Overall Study|Did not meet study criteria|1|||
105745293|NCT06150573|364721122|FG001|Overall Study|Did not meet study criteria|0|||
105745294|NCT06150573|364721121|FG000|Overall Study|Adverse Event|1|||
105745295|NCT06150573|364721122|FG001|Overall Study|Adverse Event|0|||
105745296|NCT06150573|364721121|FG000|Overall Study|Lost to Follow-up|0|||
105745297|NCT06150573|364721122|FG001|Overall Study|Lost to Follow-up|1|||
105745298|NCT06150573|364721121|FG000|Overall Study|Protocol Violation|0|||
105745299|NCT06150573|364721122|FG001|Overall Study|Protocol Violation|1|||
105745300|NCT06150573|364721121|FG000|Overall Study|Withdrawal by Subject|2|||
105745301|NCT06150573|364721122|FG001|Overall Study|Withdrawal by Subject|0|||
105745302|NCT01698905|364721123|FG000|Overall Study|Adverse Event|4|||
105745303|NCT01698905|364721123|FG000|Overall Study|Physician Decision|2|||
105745304|NCT01698905|364721123|FG000|Overall Study|Pregnancy|1|||
105745305|NCT01698905|364721123|FG000|Overall Study|Protocol Violation|1|||
105745306|NCT01698905|364721123|FG000|Overall Study|Subject/guardian decision|2|||
105745307|NCT01698905|364721123|FG000|Overall Study|Death|1|||
105745308|NCT05610176|364721124|FG000|Overall Study|Death|6|||
105745309|NCT04948333|364721125|FG000|Overall Study|Adverse Event|6|||
105745310|NCT04948333|364721126|FG001|Overall Study|Adverse Event|4|||
105745311|NCT04948333|364721127|FG002|Overall Study|Adverse Event|0|||
105745312|NCT04948333|364721128|FG003|Overall Study|Adverse Event|2|||
105745313|NCT04948333|364721125|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
105745314|NCT04948333|364721126|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
105745315|NCT04948333|364721127|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105745316|NCT04948333|364721128|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105745317|NCT04948333|364721125|FG000|Overall Study|Progressive Disease|1|||
105745318|NCT04948333|364721126|FG001|Overall Study|Progressive Disease|5|||
105745319|NCT04948333|364721127|FG002|Overall Study|Progressive Disease|0|||
105745320|NCT04948333|364721128|FG003|Overall Study|Progressive Disease|0|||
105745321|NCT04948333|364721125|FG000|Overall Study|Physician Decision|2|||
105745322|NCT04948333|364721126|FG001|Overall Study|Physician Decision|2|||
105745323|NCT04948333|364721127|FG002|Overall Study|Physician Decision|0|||
105745324|NCT04948333|364721128|FG003|Overall Study|Physician Decision|0|||
105745325|NCT04948333|364721125|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
105745326|NCT04948333|364721126|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
105745327|NCT04948333|364721127|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
105745328|NCT04948333|364721128|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
105745329|NCT04948333|364721125|FG000|Overall Study|Withdrawal by Subject|2|||
105745330|NCT04948333|364721126|FG001|Overall Study|Withdrawal by Subject|0|||
105745331|NCT04948333|364721127|FG002|Overall Study|Withdrawal by Subject|0|||
105745332|NCT04948333|364721128|FG003|Overall Study|Withdrawal by Subject|1|||
105745333|NCT04948333|364721125|FG000|Overall Study|Protocol Violation|0|||
105745334|NCT04948333|364721126|FG001|Overall Study|Protocol Violation|1|||
105745335|NCT04948333|364721127|FG002|Overall Study|Protocol Violation|0|||
105745336|NCT04948333|364721128|FG003|Overall Study|Protocol Violation|0|||
105745337|NCT04948333|364721125|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
105745338|NCT04948333|364721126|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
105745339|NCT04948333|364721127|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
105745340|NCT04948333|364721128|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
105745341|NCT03607838|364721129|FG000|Overall Study|Lack of Efficacy|14|||
105745342|NCT03607838|364721130|FG001|Overall Study|Lack of Efficacy|20|||
105745343|NCT03607838|364721129|FG000|Overall Study|Withdrawal by Subject|13|||
105745344|NCT03607838|364721130|FG001|Overall Study|Withdrawal by Subject|8|||
105745345|NCT03607838|364721129|FG000|Overall Study|Lost to Follow-up|6|||
105745346|NCT03607838|364721130|FG001|Overall Study|Lost to Follow-up|11|||
105745347|NCT03607838|364721129|FG000|Overall Study|Adverse Event|2|||
105745348|NCT03607838|364721130|FG001|Overall Study|Adverse Event|2|||
105745349|NCT03607838|364721129|FG000|Overall Study|Physician Decision|2|||
105745350|NCT03607838|364721130|FG001|Overall Study|Physician Decision|0|||
105745351|NCT03607838|364721129|FG000|Overall Study|Failure to meet randomization criteria|1|||
105745352|NCT03607838|364721130|FG001|Overall Study|Failure to meet randomization criteria|2|||
105745353|NCT03607838|364721129|FG000|Overall Study|Pregnancy|1|||
105745354|NCT03607838|364721130|FG001|Overall Study|Pregnancy|0|||
105745355|NCT03607838|364721129|FG000|Overall Study|Protocol Violation|1|||
105745356|NCT03607838|364721130|FG001|Overall Study|Protocol Violation|0|||
105745357|NCT03607838|364721129|FG000|Overall Study|Due to work|1|||
105745358|NCT03607838|364721130|FG001|Overall Study|Due to work|0|||
105745359|NCT03607838|364721129|FG000|Overall Study|Litigation|0|||
105745360|NCT03607838|364721130|FG001|Overall Study|Litigation|1|||
105745361|NCT03607838|364721129|FG000|Overall Study|Temperature excursion for study drug|0|||
105745362|NCT03607838|364721130|FG001|Overall Study|Temperature excursion for study drug|1|||
105745363|NCT03607838|364721129|FG000|Overall Study|Change of mind|0|||
105745364|NCT03607838|364721130|FG001|Overall Study|Change of mind|1|||
105745365|NCT03249792|364721131|FG000|Arms 1, 2, and 4|Death|1|||
105745366|NCT03249792|364721132|FG001|Arms 1, 2, and 4|Death|1|||
105745367|NCT03249792|364721133|FG002|Arms 1, 2, and 4|Death|0|||
105745368|NCT03249792|364721134|FG003|Arms 1, 2, and 4|Death|2|||
105745369|NCT03249792|364721135|FG004|Arms 1, 2, and 4|Death|3|||
105745370|NCT03249792|364721136|FG005|Arms 1, 2, and 4|Death|2|||
105745371|NCT03249792|364721137|FG006|Arms 1, 2, and 4|Death|2|||
105745372|NCT03249792|364721138|FG007|Arms 1, 2, and 4|Death|4|||
105745373|NCT03249792|364721139|FG008|Arms 1, 2, and 4|Death|2|||
105745374|NCT03249792|364721140|FG009|Arms 1, 2, and 4|Death|1|||
105745375|NCT03249792|364721141|FG010|Arms 1, 2, and 4|Death|7|||
105745376|NCT03249792|364721142|FG011|Arms 1, 2, and 4|Death|7|||
105745377|NCT03249792|364721143|FG012|Arms 1, 2, and 4|Death|12|||
105745378|NCT03249792|364721144|FG013|Arms 1, 2, and 4|Death|7|||
105745379|NCT03249792|364721145|FG014|Arms 1, 2, and 4|Death|0|||
105745380|NCT03249792|364721146|FG015|Arms 1, 2, and 4|Death|4|||
105745381|NCT03249792|364721147|FG016|Arms 1, 2, and 4|Death|4|||
105745382|NCT03249792|364721148|FG017|Arms 1, 2, and 4|Death|12|||
105745383|NCT03249792|364721149|FG018|Arms 1, 2, and 4|Death|6|||
105745384|NCT03249792|364721150|FG019|Arms 1, 2, and 4|Death|4|||
105745385|NCT03249792|364721151|FG020|Arms 1, 2, and 4|Death|2|||
105745386|NCT03249792|364721152|FG021|Arms 1, 2, and 4|Death|3|||
105745387|NCT03249792|364721153|FG022|Arms 1, 2, and 4|Death|1|||
105745388|NCT03249792|364721154|FG023|Arms 1, 2, and 4|Death|1|||
105745389|NCT03249792|364721155|FG024|Arms 1, 2, and 4|Death|4|||
105745390|NCT03249792|364721156|FG025|Arms 1, 2, and 4|Death|0|||
105745391|NCT03249792|364721157|FG026|Arms 1, 2, and 4|Death|0|||
105745392|NCT03249792|364721158|FG027|Arms 1, 2, and 4|Death|0|||
105745393|NCT03249792|364721159|FG028|Arms 1, 2, and 4|Death|0|||
105745394|NCT03249792|364721160|FG029|Arms 1, 2, and 4|Death|0|||
105745395|NCT03249792|364721161|FG030|Arms 1, 2, and 4|Death|0|||
105745396|NCT03249792|364721162|FG031|Arms 1, 2, and 4|Death|0|||
105745397|NCT03249792|364721163|FG032|Arms 1, 2, and 4|Death|0|||
105800651|NCT01859390|364928502|FG000|Overall Study|Tube Cracked|0|||
105800652|NCT01859390|364928503|FG001|Overall Study|Tube Cracked|2|||
105800653|NCT01859390|364928502|FG000|Overall Study|Shipment Error|0|||
105800654|NCT01859390|364928503|FG001|Overall Study|Shipment Error|1|||
105800655|NCT01020305|364928511|FG000|Overall Study|Adverse Event|2|||
105800656|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
105800657|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
105800658|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
105800659|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
105800660|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
105800661|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
105800662|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
105800663|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
105800664|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
105800665|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
105800666|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
105800667|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
105800668|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
105800669|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
105800670|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
105800671|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
105800672|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
105800673|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
105800674|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
105800675|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
105800676|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
105800677|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
105800678|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
105800679|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
105800680|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
105800681|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
105800682|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
105800683|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
105800684|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
105800685|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
105359350|NCT01938846|363320989|FG002|Overall Study|Withdrawal by Subject|1|||
105359351|NCT01938846|363320987|FG000|Overall Study|Other than listed|5|||
105359352|NCT01938846|363320988|FG001|Overall Study|Other than listed|1|||
105359353|NCT01938846|363320989|FG002|Overall Study|Other than listed|4|||
105359354|NCT02499120|363320995|FG000|Overall Study|Death|52|||
105359355|NCT02499120|363320996|FG001|Overall Study|Death|43|||
105359356|NCT02499120|363320995|FG000|Overall Study|Lost to Follow-up|1|||
105359357|NCT02499120|363320996|FG001|Overall Study|Lost to Follow-up|2|||
105359358|NCT02499120|363320995|FG000|Overall Study|Participant refused further follow-up|1|||
105359359|NCT02499120|363320996|FG001|Overall Study|Participant refused further follow-up|0|||
105359360|NCT02499120|363320995|FG000|Overall Study|Withdrawal by Subject|2|||
105359361|NCT02499120|363320996|FG001|Overall Study|Withdrawal by Subject|5|||
105359362|NCT02499120|363320995|FG000|Overall Study|Other|9|||
105745398|NCT03249792|364721131|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745399|NCT03249792|364721132|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745400|NCT03249792|364721133|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
105745401|NCT03249792|364721134|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745402|NCT03249792|364721135|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745403|NCT03249792|364721136|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
105745404|NCT03249792|364721137|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
105745405|NCT03249792|364721138|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745406|NCT03249792|364721139|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
105745407|NCT03249792|364721140|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
105745408|NCT03249792|364721141|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
105745409|NCT03249792|364721142|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
105745410|NCT03249792|364721143|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
105745411|NCT03249792|364721144|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
105745412|NCT03249792|364721145|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105800686|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
105745413|NCT03249792|364721146|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745414|NCT03249792|364721147|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
105359363|NCT02499120|363320996|FG001|Overall Study|Other|10|||
105745415|NCT03249792|364721148|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105800687|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
105359364|NCT02324361|363320999|FG000|Overall Study|Lost to Follow-up|5|||
105359365|NCT02324361|363321000|FG001|Overall Study|Lost to Follow-up|2|||
105745416|NCT03249792|364721149|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
105745417|NCT03249792|364721150|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745418|NCT03249792|364721151|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745419|NCT03249792|364721152|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745420|NCT03249792|364721153|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
105359366|NCT00964028|363321006|FG000|Overall Study|Withdrawal by Subject|0|||
105359367|NCT00964028|363321007|FG001|Overall Study|Withdrawal by Subject|1|||
105359368|NCT03472521|363321008|FG000|Overall Study|Lost to Follow-up|3|||
105359369|NCT03472521|363321009|FG001|Overall Study|Lost to Follow-up|2|||
105359370|NCT03472521|363321008|FG000|Overall Study|Discontinued intervention|3|||
105359371|NCT03472521|363321009|FG001|Overall Study|Discontinued intervention|1|||
105359372|NCT04235504|363321011|FG000|Study Phase|Withdrawal by Subject|5|||
105359373|NCT04235504|363321012|FG001|Study Phase|Withdrawal by Subject|2|||
105359374|NCT04235504|363321013|FG002|Study Phase|Withdrawal by Subject|0|||
105359375|NCT04235504|363321014|FG003|Study Phase|Withdrawal by Subject|0|||
105359376|NCT04235504|363321011|FG000|Continuation Phase|Withdrawal by Subject|0|||
105745421|NCT03249792|364721154|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
105745422|NCT03249792|364721155|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745423|NCT03249792|364721156|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745424|NCT03249792|364721157|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745425|NCT03249792|364721158|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745426|NCT03249792|364721159|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745427|NCT03249792|364721160|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745428|NCT03249792|364721161|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745429|NCT03249792|364721162|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745430|NCT03249792|364721163|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745431|NCT03249792|364721131|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
105745432|NCT03249792|364721132|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
105745433|NCT03249792|364721133|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
105745434|NCT03249792|364721134|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
105745435|NCT03249792|364721135|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
105745436|NCT03249792|364721136|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
105745437|NCT03249792|364721137|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
105745438|NCT03249792|364721138|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
105745439|NCT03249792|364721139|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
105745440|NCT03249792|364721140|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
105745441|NCT03249792|364721141|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
105745442|NCT03249792|364721142|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
105745443|NCT03249792|364721143|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
105745444|NCT03249792|364721144|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
105745445|NCT03249792|364721145|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
105745446|NCT03249792|364721146|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
105745447|NCT03249792|364721147|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
105745448|NCT03249792|364721148|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
105745449|NCT03249792|364721149|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
105745450|NCT03249792|364721150|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
105745451|NCT03249792|364721151|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
105745452|NCT03249792|364721152|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
105359377|NCT04235504|363321012|FG001|Continuation Phase|Withdrawal by Subject|4|||
105359378|NCT04235504|363321013|FG002|Continuation Phase|Withdrawal by Subject|0|||
105359379|NCT04235504|363321014|FG003|Continuation Phase|Withdrawal by Subject|0|||
105359380|NCT04235504|363321011|FG000|Continuation Phase|Adverse Event|0|||
105359381|NCT04235504|363321012|FG001|Continuation Phase|Adverse Event|1|||
105359382|NCT04235504|363321013|FG002|Continuation Phase|Adverse Event|0|||
105359383|NCT04235504|363321014|FG003|Continuation Phase|Adverse Event|0|||
105359384|NCT04235504|363321011|FG000|Continuation Phase|Physician Decision|1|||
105359385|NCT04235504|363321012|FG001|Continuation Phase|Physician Decision|2|||
105359386|NCT04235504|363321013|FG002|Continuation Phase|Physician Decision|1|||
105359387|NCT04235504|363321014|FG003|Continuation Phase|Physician Decision|0|||
105359388|NCT01931397|363321022|FG000|Overall Study|Physician Decision|2|||
105359389|NCT01931397|363321022|FG000|Overall Study|Withdrawal by Subject|8|||
105483151|NCT02119676|363780889|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
105483152|NCT02119676|363780890|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
105745453|NCT03249792|364721153|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
105359390|NCT01931397|363321022|FG000|Overall Study|moved out of state|1|||
105359391|NCT01223937|363321023|FG000|Overall Study|Withdrawal by Subject|3|||
105745454|NCT03249792|364721154|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
105745455|NCT03249792|364721155|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
105745456|NCT03249792|364721156|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
105745457|NCT03249792|364721157|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
105745458|NCT03249792|364721158|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
105359392|NCT01223937|363321024|FG001|Overall Study|Withdrawal by Subject|2|||
105359393|NCT01223937|363321023|FG000|Overall Study|Lost to Follow-up|1|||
105359394|NCT01223937|363321024|FG001|Overall Study|Lost to Follow-up|4|||
105359395|NCT01223937|363321023|FG000|Overall Study|Adverse Event|1|||
105745459|NCT03249792|364721159|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
105745460|NCT03249792|364721160|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
105745461|NCT03249792|364721161|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
105359396|NCT01223937|363321024|FG001|Overall Study|Adverse Event|4|||
105359397|NCT01223937|363321023|FG000|Overall Study|Protocol Violation|8|||
105359398|NCT01223937|363321024|FG001|Overall Study|Protocol Violation|7|||
105359399|NCT01223937|363321023|FG000|Overall Study|Other|4|||
105359400|NCT01223937|363321024|FG001|Overall Study|Other|1|||
105359401|NCT00765817|363321026|FG000|Overall Study|Adverse Event|13|||
105359402|NCT00765817|363321027|FG001|Overall Study|Adverse Event|1|||
105745462|NCT03249792|364721162|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
105745463|NCT03249792|364721163|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
105745464|NCT03249792|364721131|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745465|NCT03249792|364721132|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745466|NCT03249792|364721133|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745467|NCT03249792|364721134|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745468|NCT03249792|364721135|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745469|NCT03249792|364721136|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745470|NCT03249792|364721137|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745471|NCT03249792|364721138|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745472|NCT03249792|364721139|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
105745473|NCT03249792|364721140|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745474|NCT03249792|364721141|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
105359403|NCT00765817|363321026|FG000|Overall Study|Death|0|||
105359404|NCT00765817|363321027|FG001|Overall Study|Death|1|||
105745475|NCT03249792|364721142|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745476|NCT03249792|364721143|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745477|NCT03249792|364721144|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745478|NCT03249792|364721145|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745479|NCT03249792|364721146|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745480|NCT03249792|364721147|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
105745481|NCT03249792|364721148|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
105745482|NCT03249792|364721149|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
105800688|NCT01872689|364928521|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
105800689|NCT01872689|364928522|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
105359405|NCT00765817|363321026|FG000|Overall Study|Entry criteria not met|2|||
105359406|NCT00765817|363321027|FG001|Overall Study|Entry criteria not met|2|||
105359407|NCT00765817|363321026|FG000|Overall Study|Loss of glucose control|0|||
105359408|NCT00765817|363321027|FG001|Overall Study|Loss of glucose control|2|||
105359409|NCT00765817|363321026|FG000|Overall Study|Lost to Follow-up|1|||
105359410|NCT00765817|363321027|FG001|Overall Study|Lost to Follow-up|3|||
105359411|NCT00765817|363321026|FG000|Overall Study|Physician Decision|2|||
105745483|NCT03249792|364721150|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
105745484|NCT03249792|364721151|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745485|NCT03249792|364721152|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745486|NCT03249792|364721153|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745487|NCT03249792|364721154|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
105800690|NCT01872689|364928523|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
105359412|NCT00765817|363321027|FG001|Overall Study|Physician Decision|1|||
105359413|NCT00765817|363321026|FG000|Overall Study|Protocol Violation|1|||
105359414|NCT00765817|363321027|FG001|Overall Study|Protocol Violation|1|||
105359415|NCT00765817|363321026|FG000|Overall Study|Subject decision|7|||
105359416|NCT00765817|363321027|FG001|Overall Study|Subject decision|11|||
105359417|NCT02308228|363321028|FG000|Overall Study|Adverse Event|3|||
105359418|NCT02308228|363321029|FG001|Overall Study|Adverse Event|4|||
105359419|NCT02308228|363321028|FG000|Overall Study|Withdrawal by Subject|5|||
105359420|NCT02308228|363321029|FG001|Overall Study|Withdrawal by Subject|3|||
105359421|NCT02532283|363321030|FG000|Overall Study|Adverse Event|0|||
105359422|NCT02532283|363321031|FG001|Overall Study|Adverse Event|1|||
105359423|NCT02532283|363321030|FG000|Overall Study|Death|1|||
105359424|NCT02532283|363321031|FG001|Overall Study|Death|0|||
105800691|NCT01872689|364928524|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
105800692|NCT01872689|364928521|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
105800693|NCT01872689|364928522|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
105800694|NCT01872689|364928523|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
105800695|NCT01872689|364928524|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
105800696|NCT01872689|364928521|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
105800697|NCT01872689|364928522|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
105800698|NCT01872689|364928523|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
105800699|NCT01872689|364928524|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
105800700|NCT01872689|364928521|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
105800701|NCT01872689|364928522|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
105800702|NCT01872689|364928523|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
105800703|NCT01872689|364928524|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
105800704|NCT01872689|364928521|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
105800705|NCT01872689|364928522|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
105800706|NCT01872689|364928523|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
105800707|NCT01872689|364928524|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
105800708|NCT01872689|364928521|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
105800709|NCT01872689|364928522|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
105800710|NCT01872689|364928523|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
105800711|NCT01872689|364928524|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
105800712|NCT03989115|364928525|FG000|Overall Study|Withdrawal by Subject|2|||
105800713|NCT03989115|364928526|FG001|Overall Study|Withdrawal by Subject|1|||
105800714|NCT03989115|364928527|FG002|Overall Study|Withdrawal by Subject|3|||
105800715|NCT03989115|364928528|FG003|Overall Study|Withdrawal by Subject|0|||
105800716|NCT03989115|364928529|FG004|Overall Study|Withdrawal by Subject|17|||
105800717|NCT03989115|364928530|FG005|Overall Study|Withdrawal by Subject|1|||
105800718|NCT03989115|364928531|FG006|Overall Study|Withdrawal by Subject|0|||
105800719|NCT03989115|364928532|FG007|Overall Study|Withdrawal by Subject|0|||
105800720|NCT03989115|364928525|FG000|Overall Study|Sponsor decision to terminate the study|1|||
105800721|NCT03989115|364928526|FG001|Overall Study|Sponsor decision to terminate the study|1|||
105800722|NCT03989115|364928527|FG002|Overall Study|Sponsor decision to terminate the study|0|||
105800723|NCT03989115|364928528|FG003|Overall Study|Sponsor decision to terminate the study|1|||
105800724|NCT03989115|364928529|FG004|Overall Study|Sponsor decision to terminate the study|11|||
105800725|NCT03989115|364928530|FG005|Overall Study|Sponsor decision to terminate the study|0|||
105800726|NCT03989115|364928531|FG006|Overall Study|Sponsor decision to terminate the study|2|||
105800727|NCT03989115|364928532|FG007|Overall Study|Sponsor decision to terminate the study|1|||
105800728|NCT03989115|364928525|FG000|Overall Study|Lost to Follow-up|2|||
105800729|NCT03989115|364928526|FG001|Overall Study|Lost to Follow-up|0|||
105800730|NCT03989115|364928527|FG002|Overall Study|Lost to Follow-up|0|||
105800731|NCT03989115|364928528|FG003|Overall Study|Lost to Follow-up|0|||
105800732|NCT03989115|364928529|FG004|Overall Study|Lost to Follow-up|1|||
105359425|NCT02532283|363321030|FG000|Overall Study|Lost to Follow-up|0|||
105359426|NCT02532283|363321031|FG001|Overall Study|Lost to Follow-up|1|||
105359427|NCT02532283|363321030|FG000|Overall Study|Withdrawal by Subject|8|||
105359428|NCT02532283|363321031|FG001|Overall Study|Withdrawal by Subject|3|||
105359429|NCT00803712|363322250|FG000|Overall Study|Noncompliance|3|||
105359430|NCT00803712|363322251|FG001|Overall Study|Noncompliance|0|||
105359431|NCT00803712|363322250|FG000|Overall Study|Adverse Event|5|||
105359432|NCT00803712|363322251|FG001|Overall Study|Adverse Event|0|||
105359433|NCT00803712|363322250|FG000|Overall Study|Death|8|||
105359434|NCT00803712|363322251|FG001|Overall Study|Death|7|||
105359435|NCT00803712|363322250|FG000|Overall Study|Lost to Follow-up|3|||
105359436|NCT00803712|363322251|FG001|Overall Study|Lost to Follow-up|1|||
105359437|NCT00803712|363322250|FG000|Overall Study|Withdrawal by Subject|2|||
105359438|NCT00803712|363322251|FG001|Overall Study|Withdrawal by Subject|4|||
105359439|NCT00803712|363322250|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
105359440|NCT00803712|363322251|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
105359441|NCT00803712|363322250|FG000|Overall Study|Protocol criteria (other)|0|||
105359442|NCT00803712|363322251|FG001|Overall Study|Protocol criteria (other)|2|||
105359443|NCT00803712|363322250|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
105359444|NCT00803712|363322251|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
105359445|NCT00803712|363322250|FG000|Overall Study|Administrative decision|2|||
105359446|NCT00803712|363322251|FG001|Overall Study|Administrative decision|3|||
105359447|NCT00803712|363322250|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
105359448|NCT00803712|363322251|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
105359449|NCT00463801|363322265|FG000|Overall Study|Protocol Violation|1|||
105359450|NCT00463801|363322265|FG000|Overall Study|Lack of Efficacy|2|||
105359451|NCT00463801|363322265|FG000|Overall Study|Adverse Event|4|||
105359452|NCT00463801|363322265|FG000|Overall Study|Lost to Follow-up|5|||
105359453|NCT00463801|363322265|FG000|Overall Study|No longer require therapy|1|||
105359454|NCT01073163|363322266|FG000|Overall Study|Adverse Event|1|||
105359455|NCT01073163|363322266|FG000|Overall Study|Disease Progression|1|||
105359456|NCT01073163|363322266|FG000|Overall Study|Early termination|1|||
105359457|NCT00703677|363322267|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
105359458|NCT00940888|363322268|FG000|Overall Study|Unsuccessful Implant|4|||
105359459|NCT00940888|363322268|FG000|Overall Study|Death|461|||
105359460|NCT00940888|363322268|FG000|Overall Study|Withdrawn - Non-Death|364|||
105359461|NCT00940888|363322268|FG000|Overall Study|Lost to Follow-up|6|||
105359462|NCT01409915|363322277|FG000|Overall Study|Adverse Event|0|||
105745488|NCT03249792|364721155|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745489|NCT03249792|364721156|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745490|NCT03249792|364721157|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745491|NCT03249792|364721158|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745492|NCT03249792|364721159|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745493|NCT03249792|364721160|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745494|NCT03249792|364721161|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745495|NCT03249792|364721162|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745496|NCT03249792|364721163|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745497|NCT03249792|364721131|FG000|Switch Over Period|Withdrawal by Subject|0|||
105745498|NCT03249792|364721132|FG001|Switch Over Period|Withdrawal by Subject|0|||
105745499|NCT03249792|364721133|FG002|Switch Over Period|Withdrawal by Subject|0|||
105745500|NCT03249792|364721134|FG003|Switch Over Period|Withdrawal by Subject|0|||
105745501|NCT03249792|364721135|FG004|Switch Over Period|Withdrawal by Subject|0|||
105745502|NCT03249792|364721136|FG005|Switch Over Period|Withdrawal by Subject|0|||
105745503|NCT03249792|364721137|FG006|Switch Over Period|Withdrawal by Subject|0|||
105745504|NCT03249792|364721138|FG007|Switch Over Period|Withdrawal by Subject|0|||
105745505|NCT03249792|364721139|FG008|Switch Over Period|Withdrawal by Subject|0|||
105745506|NCT03249792|364721140|FG009|Switch Over Period|Withdrawal by Subject|0|||
105745507|NCT03249792|364721141|FG010|Switch Over Period|Withdrawal by Subject|0|||
105745508|NCT03249792|364721142|FG011|Switch Over Period|Withdrawal by Subject|0|||
105745509|NCT03249792|364721143|FG012|Switch Over Period|Withdrawal by Subject|0|||
105745510|NCT03249792|364721144|FG013|Switch Over Period|Withdrawal by Subject|0|||
105745511|NCT03249792|364721145|FG014|Switch Over Period|Withdrawal by Subject|0|||
105745512|NCT03249792|364721146|FG015|Switch Over Period|Withdrawal by Subject|0|||
105745513|NCT03249792|364721147|FG016|Switch Over Period|Withdrawal by Subject|0|||
105745514|NCT03249792|364721148|FG017|Switch Over Period|Withdrawal by Subject|0|||
105745515|NCT03249792|364721149|FG018|Switch Over Period|Withdrawal by Subject|0|||
105745516|NCT03249792|364721150|FG019|Switch Over Period|Withdrawal by Subject|0|||
105745517|NCT03249792|364721151|FG020|Switch Over Period|Withdrawal by Subject|0|||
105745518|NCT03249792|364721152|FG021|Switch Over Period|Withdrawal by Subject|0|||
105745519|NCT03249792|364721153|FG022|Switch Over Period|Withdrawal by Subject|0|||
105745520|NCT03249792|364721154|FG023|Switch Over Period|Withdrawal by Subject|0|||
105745521|NCT03249792|364721155|FG024|Switch Over Period|Withdrawal by Subject|0|||
105745522|NCT03249792|364721156|FG025|Switch Over Period|Withdrawal by Subject|0|||
105359463|NCT01409915|363322278|FG001|Overall Study|Adverse Event|2|||
105359464|NCT01409915|363322277|FG000|Overall Study|Withdrawal by Subject|0|||
105359465|NCT01409915|363322278|FG001|Overall Study|Withdrawal by Subject|1|||
105359466|NCT01409915|363322277|FG000|Overall Study|Protocol Violation|1|||
105745523|NCT03249792|364721157|FG026|Switch Over Period|Withdrawal by Subject|0|||
105745524|NCT03249792|364721158|FG027|Switch Over Period|Withdrawal by Subject|0|||
105745525|NCT03249792|364721159|FG028|Switch Over Period|Withdrawal by Subject|0|||
105745526|NCT03249792|364721160|FG029|Switch Over Period|Withdrawal by Subject|0|||
105745527|NCT03249792|364721161|FG030|Switch Over Period|Withdrawal by Subject|0|||
105359467|NCT01409915|363322278|FG001|Overall Study|Protocol Violation|0|||
105745528|NCT03249792|364721162|FG031|Switch Over Period|Withdrawal by Subject|1|||
105745529|NCT03249792|364721163|FG032|Switch Over Period|Withdrawal by Subject|0|||
105745530|NCT03249792|364721131|FG000|Switch Over Period|Progressive Disease|0|||
105745531|NCT03249792|364721132|FG001|Switch Over Period|Progressive Disease|0|||
105745532|NCT03249792|364721133|FG002|Switch Over Period|Progressive Disease|0|||
105745533|NCT03249792|364721134|FG003|Switch Over Period|Progressive Disease|0|||
105745534|NCT03249792|364721135|FG004|Switch Over Period|Progressive Disease|0|||
105745535|NCT03249792|364721136|FG005|Switch Over Period|Progressive Disease|0|||
105745536|NCT03249792|364721137|FG006|Switch Over Period|Progressive Disease|0|||
105745537|NCT03249792|364721138|FG007|Switch Over Period|Progressive Disease|0|||
105745538|NCT03249792|364721139|FG008|Switch Over Period|Progressive Disease|0|||
105745539|NCT03249792|364721140|FG009|Switch Over Period|Progressive Disease|0|||
105745540|NCT03249792|364721141|FG010|Switch Over Period|Progressive Disease|0|||
105745541|NCT03249792|364721142|FG011|Switch Over Period|Progressive Disease|0|||
105745542|NCT03249792|364721143|FG012|Switch Over Period|Progressive Disease|0|||
105745543|NCT03249792|364721144|FG013|Switch Over Period|Progressive Disease|0|||
105745544|NCT03249792|364721145|FG014|Switch Over Period|Progressive Disease|0|||
105745545|NCT03249792|364721146|FG015|Switch Over Period|Progressive Disease|0|||
105745546|NCT03249792|364721147|FG016|Switch Over Period|Progressive Disease|0|||
105745547|NCT03249792|364721148|FG017|Switch Over Period|Progressive Disease|0|||
105745548|NCT03249792|364721149|FG018|Switch Over Period|Progressive Disease|0|||
105745549|NCT03249792|364721150|FG019|Switch Over Period|Progressive Disease|0|||
105745550|NCT03249792|364721151|FG020|Switch Over Period|Progressive Disease|0|||
105745551|NCT03249792|364721152|FG021|Switch Over Period|Progressive Disease|0|||
105745552|NCT03249792|364721153|FG022|Switch Over Period|Progressive Disease|0|||
105745553|NCT03249792|364721154|FG023|Switch Over Period|Progressive Disease|0|||
105745554|NCT03249792|364721155|FG024|Switch Over Period|Progressive Disease|0|||
105745555|NCT03249792|364721156|FG025|Switch Over Period|Progressive Disease|0|||
105745556|NCT03249792|364721157|FG026|Switch Over Period|Progressive Disease|1|||
105745557|NCT03249792|364721158|FG027|Switch Over Period|Progressive Disease|0|||
105745558|NCT03249792|364721159|FG028|Switch Over Period|Progressive Disease|1|||
105745559|NCT03249792|364721160|FG029|Switch Over Period|Progressive Disease|2|||
105745560|NCT03249792|364721161|FG030|Switch Over Period|Progressive Disease|1|||
105745561|NCT03249792|364721162|FG031|Switch Over Period|Progressive Disease|0|||
105745562|NCT03249792|364721163|FG032|Switch Over Period|Progressive Disease|1|||
105745563|NCT03249792|364721131|FG000|Switch Over Period|Adverse Event|0|||
105745564|NCT03249792|364721132|FG001|Switch Over Period|Adverse Event|0|||
105745565|NCT03249792|364721133|FG002|Switch Over Period|Adverse Event|0|||
105745566|NCT03249792|364721134|FG003|Switch Over Period|Adverse Event|0|||
105745567|NCT03249792|364721135|FG004|Switch Over Period|Adverse Event|0|||
105745568|NCT03249792|364721136|FG005|Switch Over Period|Adverse Event|0|||
105745569|NCT03249792|364721137|FG006|Switch Over Period|Adverse Event|0|||
105745570|NCT03249792|364721138|FG007|Switch Over Period|Adverse Event|0|||
105745571|NCT03249792|364721139|FG008|Switch Over Period|Adverse Event|0|||
105745572|NCT03249792|364721140|FG009|Switch Over Period|Adverse Event|0|||
105745573|NCT03249792|364721141|FG010|Switch Over Period|Adverse Event|0|||
105745574|NCT03249792|364721142|FG011|Switch Over Period|Adverse Event|0|||
105745575|NCT03249792|364721143|FG012|Switch Over Period|Adverse Event|0|||
105745576|NCT03249792|364721144|FG013|Switch Over Period|Adverse Event|0|||
105745577|NCT03249792|364721145|FG014|Switch Over Period|Adverse Event|0|||
105745578|NCT03249792|364721146|FG015|Switch Over Period|Adverse Event|0|||
105745579|NCT03249792|364721147|FG016|Switch Over Period|Adverse Event|0|||
105745580|NCT03249792|364721148|FG017|Switch Over Period|Adverse Event|0|||
105745581|NCT03249792|364721149|FG018|Switch Over Period|Adverse Event|0|||
105745582|NCT03249792|364721150|FG019|Switch Over Period|Adverse Event|0|||
105745583|NCT03249792|364721151|FG020|Switch Over Period|Adverse Event|0|||
105745584|NCT03249792|364721152|FG021|Switch Over Period|Adverse Event|0|||
105745585|NCT03249792|364721153|FG022|Switch Over Period|Adverse Event|0|||
105745586|NCT03249792|364721154|FG023|Switch Over Period|Adverse Event|0|||
105745587|NCT03249792|364721155|FG024|Switch Over Period|Adverse Event|0|||
105745588|NCT03249792|364721156|FG025|Switch Over Period|Adverse Event|1|||
105745589|NCT03249792|364721157|FG026|Switch Over Period|Adverse Event|0|||
105745590|NCT03249792|364721158|FG027|Switch Over Period|Adverse Event|1|||
105745591|NCT03249792|364721159|FG028|Switch Over Period|Adverse Event|0|||
105745592|NCT03249792|364721160|FG029|Switch Over Period|Adverse Event|0|||
105745593|NCT03249792|364721161|FG030|Switch Over Period|Adverse Event|0|||
105359468|NCT01302418|363322285|FG000|Overall Study|Protocol Violation|9|||
105565366|NCT04512066|364066767|FG002|Double-blind Treatment Period|Adverse Event|5|||
105565367|NCT04512066|364066768|FG003|Double-blind Treatment Period|Adverse Event|1|||
105745594|NCT03249792|364721162|FG031|Switch Over Period|Adverse Event|0|||
105745595|NCT03249792|364721163|FG032|Switch Over Period|Adverse Event|0|||
105745596|NCT03745313|364721164|FG000|At 30 Days Follow-up|Death|2|||
105745597|NCT03745313|364721164|FG000|At 6 Months Follow-up|Death|1|||
105745598|NCT03745313|364721164|FG000|At 6 Months Follow-up|Missed Visit|1|||
105745599|NCT03745313|364721164|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
105745600|NCT03745313|364721164|FG000|At 1 Year Follow-up|Death|2|||
105745601|NCT03745313|364721164|FG000|At 1 Year Follow-up|Missed Visit|2|||
105745602|NCT03745313|364721164|FG000|At 2 Year Follow-up|Missed Visit|1|||
105483153|NCT02119676|363780891|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
105745603|NCT04171037|364721165|FG000|Overall Study|Lost to Follow-up|1|||
105745604|NCT04171037|364721166|FG001|Overall Study|Lost to Follow-up|0|||
105745605|NCT04171037|364721165|FG000|Overall Study|Physician Decision|3|||
105745606|NCT04171037|364721166|FG001|Overall Study|Physician Decision|3|||
105745607|NCT01864018|364721169|FG000|Overall Study|Ineligible|3|||
105745608|NCT01864018|364721170|FG001|Overall Study|Ineligible|1|||
105745609|NCT05122650|364721173|FG000|Overall Study|Adverse Event|4|||
105745610|NCT05122650|364721174|FG001|Overall Study|Adverse Event|16|||
105745611|NCT05122650|364721175|FG002|Overall Study|Adverse Event|11|||
105745612|NCT05122650|364721176|FG003|Overall Study|Adverse Event|12|||
105745613|NCT05122650|364721173|FG000|Overall Study|Lack of Efficacy|0|||
105745614|NCT05122650|364721174|FG001|Overall Study|Lack of Efficacy|1|||
105745615|NCT05122650|364721175|FG002|Overall Study|Lack of Efficacy|1|||
105745616|NCT05122650|364721176|FG003|Overall Study|Lack of Efficacy|2|||
105745617|NCT05122650|364721173|FG000|Overall Study|Lost to Follow-up|1|||
105745618|NCT05122650|364721174|FG001|Overall Study|Lost to Follow-up|1|||
105745619|NCT05122650|364721175|FG002|Overall Study|Lost to Follow-up|3|||
105745620|NCT05122650|364721176|FG003|Overall Study|Lost to Follow-up|0|||
105745621|NCT05122650|364721173|FG000|Overall Study|Non-compliance with study intervention|0|||
105745622|NCT05122650|364721174|FG001|Overall Study|Non-compliance with study intervention|0|||
105745623|NCT05122650|364721175|FG002|Overall Study|Non-compliance with study intervention|0|||
105745624|NCT05122650|364721176|FG003|Overall Study|Non-compliance with study intervention|2|||
105745625|NCT05122650|364721173|FG000|Overall Study|Protocol Violation|0|||
105745626|NCT05122650|364721174|FG001|Overall Study|Protocol Violation|1|||
105745627|NCT05122650|364721175|FG002|Overall Study|Protocol Violation|0|||
105745628|NCT05122650|364721176|FG003|Overall Study|Protocol Violation|1|||
105745629|NCT05122650|364721173|FG000|Overall Study|Randomized by mistake|0|||
105745630|NCT05122650|364721174|FG001|Overall Study|Randomized by mistake|0|||
105745631|NCT05122650|364721175|FG002|Overall Study|Randomized by mistake|3|||
105745632|NCT05122650|364721176|FG003|Overall Study|Randomized by mistake|2|||
105745633|NCT05122650|364721173|FG000|Overall Study|Sponsor request|0|||
105745634|NCT05122650|364721174|FG001|Overall Study|Sponsor request|1|||
105745635|NCT05122650|364721175|FG002|Overall Study|Sponsor request|1|||
105745636|NCT05122650|364721176|FG003|Overall Study|Sponsor request|2|||
105745637|NCT05122650|364721173|FG000|Overall Study|Withdrawal by Subject|3|||
105745638|NCT05122650|364721174|FG001|Overall Study|Withdrawal by Subject|7|||
105745639|NCT05122650|364721175|FG002|Overall Study|Withdrawal by Subject|4|||
105745640|NCT05122650|364721176|FG003|Overall Study|Withdrawal by Subject|8|||
105745641|NCT05122650|364721173|FG000|Overall Study|Other|5|||
105745642|NCT05122650|364721174|FG001|Overall Study|Other|0|||
105745643|NCT05122650|364721175|FG002|Overall Study|Other|0|||
105745644|NCT05122650|364721176|FG003|Overall Study|Other|0|||
105745645|NCT00488033|364721181|FG000|Overall Study|Withdrawal by Subject|1|||
105483154|NCT02119676|363780888|FG000|Overall Study|Physician Decision|4|||
105483155|NCT02119676|363780889|FG001|Overall Study|Physician Decision|2|||
105483156|NCT02119676|363780890|FG002|Overall Study|Physician Decision|3|||
105483157|NCT02119676|363780891|FG003|Overall Study|Physician Decision|2|||
105745646|NCT00488033|364721182|FG001|Overall Study|Withdrawal by Subject|0|||
105745647|NCT00992446|364721184|FG000|Overall Study|Disease Progression|1|||
105745648|NCT00992446|364721184|FG000|Overall Study|Withdrawal by Subject|2|||
105745649|NCT00992446|364721184|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
105745650|NCT04891770|364721617|FG000|Overall Study|Withdrew consent|1|||
105745651|NCT04891770|364721618|FG001|Overall Study|Withdrew consent|3|||
105745652|NCT04891770|364721619|FG002|Overall Study|Withdrew consent|0|||
105745653|NCT04891770|364721617|FG000|Overall Study|Enrolled but never treated|0|||
105745654|NCT04891770|364721618|FG001|Overall Study|Enrolled but never treated|0|||
105745655|NCT04891770|364721619|FG002|Overall Study|Enrolled but never treated|1|||
105745656|NCT04891770|364721617|FG000|Overall Study|Investigator's discretion|0|||
105745657|NCT04891770|364721618|FG001|Overall Study|Investigator's discretion|1|||
105745658|NCT04891770|364721619|FG002|Overall Study|Investigator's discretion|0|||
105745659|NCT06239610|364721620|FG000|Overall Study|no usable migration data for minimum of one day|11|||
105745660|NCT02678780|364721631|FG000|Overall Study|Adverse Event|11|||
105745661|NCT02678780|364721632|FG001|Overall Study|Adverse Event|14|||
105745662|NCT02678780|364721631|FG000|Overall Study|Withdrawal by Subject|2|||
105745663|NCT02678780|364721632|FG001|Overall Study|Withdrawal by Subject|1|||
105745664|NCT02678780|364721631|FG000|Overall Study|Sponsor discontinuation|7|||
105745665|NCT02678780|364721632|FG001|Overall Study|Sponsor discontinuation|4|||
105745666|NCT02678780|364721631|FG000|Overall Study|Death|1|||
105745667|NCT02678780|364721632|FG001|Overall Study|Death|1|||
105745668|NCT02678780|364721631|FG000|Overall Study|Other|6|||
105745669|NCT02678780|364721632|FG001|Overall Study|Other|8|||
105745670|NCT03675737|364721636|FG000|Overall Study|Death|593|||
105745671|NCT03675737|364721637|FG001|Overall Study|Death|660|||
105745672|NCT03675737|364721636|FG000|Overall Study|Lost to Follow-up|1|||
105745673|NCT03675737|364721637|FG001|Overall Study|Lost to Follow-up|5|||
105745674|NCT03675737|364721636|FG000|Overall Study|Physician Decision|1|||
105745675|NCT03675737|364721637|FG001|Overall Study|Physician Decision|0|||
105745676|NCT03675737|364721636|FG000|Overall Study|Withdrawal by Subject|14|||
105745677|NCT03675737|364721637|FG001|Overall Study|Withdrawal by Subject|12|||
105745678|NCT03675737|364721636|FG000|Overall Study|Ongoing in Study|181|||
105745679|NCT03675737|364721637|FG001|Overall Study|Ongoing in Study|112|||
105745680|NCT05315297|364721638|FG000|Overall Study|Lost to Follow-up|6|||
105745681|NCT05315297|364721639|FG001|Overall Study|Lost to Follow-up|4|||
105483158|NCT02119676|363780888|FG000|Overall Study|Death|9|||
105745682|NCT05315297|364721638|FG000|Overall Study|Withdrawal by Subject|0|||
105745683|NCT05315297|364721639|FG001|Overall Study|Withdrawal by Subject|1|||
105745684|NCT03050359|364722950|FG000|Overall Study|Randomized But Not Treated|2|||
105800733|NCT03989115|364928530|FG005|Overall Study|Lost to Follow-up|0|||
105800734|NCT03989115|364928531|FG006|Overall Study|Lost to Follow-up|0|||
105800735|NCT03989115|364928532|FG007|Overall Study|Lost to Follow-up|0|||
105800736|NCT03989115|364928525|FG000|Overall Study|Death|2|||
105800737|NCT03989115|364928526|FG001|Overall Study|Death|2|||
105800738|NCT03989115|364928527|FG002|Overall Study|Death|9|||
105800739|NCT03989115|364928528|FG003|Overall Study|Death|6|||
105800740|NCT03989115|364928529|FG004|Overall Study|Death|31|||
105800741|NCT03989115|364928530|FG005|Overall Study|Death|6|||
105800742|NCT03989115|364928531|FG006|Overall Study|Death|2|||
105800743|NCT03989115|364928532|FG007|Overall Study|Death|3|||
105800744|NCT03989115|364928525|FG000|Overall Study|Other|1|||
105800745|NCT03989115|364928526|FG001|Overall Study|Other|2|||
105800746|NCT03989115|364928527|FG002|Overall Study|Other|0|||
105800747|NCT03989115|364928528|FG003|Overall Study|Other|0|||
105800748|NCT03989115|364928529|FG004|Overall Study|Other|5|||
105800749|NCT03989115|364928530|FG005|Overall Study|Other|0|||
105800750|NCT03989115|364928531|FG006|Overall Study|Other|0|||
105800751|NCT03989115|364928532|FG007|Overall Study|Other|0|||
105800752|NCT00326885|364928533|FG000|Overall Study|Adverse Event|1|||
105800753|NCT00326885|364928533|FG000|Overall Study|Withdrawal by Subject|3|||
105800754|NCT00326885|364928533|FG000|Overall Study|Physician Decision|1|||
105800755|NCT00326885|364928533|FG000|Overall Study|Hospice withdrew consent|2|||
105800756|NCT01706198|364928534|FG000|Overall Study|Adverse Event|12|||
105800757|NCT01706198|364928535|FG001|Overall Study|Adverse Event|15|||
105800758|NCT01706198|364928534|FG000|Overall Study|Protocol Violation|7|||
105800759|NCT01706198|364928535|FG001|Overall Study|Protocol Violation|5|||
105800760|NCT01706198|364928534|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
105800761|NCT01706198|364928535|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
105800762|NCT01706198|364928534|FG000|Overall Study|Lost to Follow-up|97|||
105800763|NCT01706198|364928535|FG001|Overall Study|Lost to Follow-up|93|||
105800764|NCT01706198|364928534|FG000|Overall Study|Physician Decision|23|||
105800765|NCT01706198|364928535|FG001|Overall Study|Physician Decision|37|||
105800766|NCT01706198|364928534|FG000|Overall Study|Withdrawal by Subject|23|||
105800767|NCT01706198|364928535|FG001|Overall Study|Withdrawal by Subject|31|||
105800768|NCT02499354|364928536|FG000|Overall Study|Withdrawal by Subject|1|||
105800769|NCT02499354|364928537|FG001|Overall Study|Withdrawal by Subject|0|||
105800770|NCT04356573|364928538|FG000|Overall Study|Didn't Qualify|1|||
105800771|NCT04356573|364928539|FG001|Overall Study|Didn't Qualify|0|||
105800772|NCT02424565|364928540|FG000|Period 1 (D0)|Protocol Violation|0|||
105800773|NCT02424565|364928541|FG001|Period 1 (D0)|Protocol Violation|1|||
105800774|NCT01415921|364928543|FG000|Overall Study|Adverse Event|0|||
105800775|NCT01415921|364928544|FG001|Overall Study|Adverse Event|1|||
105800776|NCT01415921|364928543|FG000|Overall Study|Physician Decision|1|||
105800777|NCT01415921|364928544|FG001|Overall Study|Physician Decision|1|||
105800778|NCT01415921|364928543|FG000|Overall Study|Withdrawal by Subject|0|||
105800779|NCT01415921|364928544|FG001|Overall Study|Withdrawal by Subject|1|||
105800780|NCT01415921|364928543|FG000|Overall Study|Other|2|||
105800781|NCT01415921|364928544|FG001|Overall Study|Other|0|||
105800782|NCT02143947|364928547|FG000|Overall Study|Lost to Follow-up|4|||
105800783|NCT02143947|364928548|FG001|Overall Study|Lost to Follow-up|2|||
105800784|NCT01244815|364928549|FG000|Overall Study|Not Treated|0|||
105800785|NCT01244815|364928550|FG001|Overall Study|Not Treated|1|||
105800786|NCT01244815|364928551|FG002|Overall Study|Not Treated|0|||
105800787|NCT01244815|364928552|FG003|Overall Study|Not Treated|0|||
105359469|NCT01302418|363322285|FG000|Overall Study|Non-evaluable|9|||
105359470|NCT02937740|363322286|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
105359471|NCT02937740|363322287|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
105359472|NCT02937740|363322286|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
105359473|NCT02937740|363322287|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
105483159|NCT02119676|363780889|FG001|Overall Study|Death|3|||
105483160|NCT02119676|363780890|FG002|Overall Study|Death|2|||
105800788|NCT01244815|364928549|FG000|Overall Study|Adverse Event|4|||
105800789|NCT01244815|364928550|FG001|Overall Study|Adverse Event|7|||
105800790|NCT01244815|364928551|FG002|Overall Study|Adverse Event|5|||
105800791|NCT01244815|364928552|FG003|Overall Study|Adverse Event|5|||
105800792|NCT01244815|364928549|FG000|Overall Study|Treatment Failure|0|||
105800793|NCT01244815|364928550|FG001|Overall Study|Treatment Failure|0|||
105800794|NCT01244815|364928551|FG002|Overall Study|Treatment Failure|0|||
105800795|NCT01244815|364928552|FG003|Overall Study|Treatment Failure|1|||
105800796|NCT01244815|364928549|FG000|Overall Study|Lost to Follow-up|3|||
105359474|NCT02937740|363322286|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
105800797|NCT01244815|364928550|FG001|Overall Study|Lost to Follow-up|2|||
105800798|NCT01244815|364928551|FG002|Overall Study|Lost to Follow-up|3|||
105800799|NCT01244815|364928552|FG003|Overall Study|Lost to Follow-up|2|||
105359475|NCT02937740|363322287|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
105359476|NCT02937740|363322286|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
105800800|NCT01244815|364928549|FG000|Overall Study|Withdrawal by Subject|0|||
105800801|NCT01244815|364928550|FG001|Overall Study|Withdrawal by Subject|2|||
105800802|NCT01244815|364928551|FG002|Overall Study|Withdrawal by Subject|0|||
105800803|NCT01244815|364928552|FG003|Overall Study|Withdrawal by Subject|3|||
105745685|NCT03050359|364722951|FG001|Overall Study|Randomized But Not Treated|0|||
105745686|NCT03050359|364722950|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
105745687|NCT03050359|364722951|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
105745688|NCT03050359|364722950|FG000|Overall Study|Significant Protocol Deviation|2|||
105745689|NCT03050359|364722951|FG001|Overall Study|Significant Protocol Deviation|3|||
105745690|NCT03050359|364722950|FG000|Overall Study|Lost to Follow-up|2|||
105745691|NCT03050359|364722951|FG001|Overall Study|Lost to Follow-up|1|||
105745692|NCT03050359|364722950|FG000|Overall Study|Voluntary Withdrawal|4|||
105745693|NCT03050359|364722951|FG001|Overall Study|Voluntary Withdrawal|6|||
105745694|NCT03050359|364722950|FG000|Overall Study|Pregnancy|1|||
105745695|NCT03050359|364722951|FG001|Overall Study|Pregnancy|0|||
105745696|NCT03050359|364722950|FG000|Overall Study|Reason Not Specified|1|||
105745697|NCT03050359|364722951|FG001|Overall Study|Reason Not Specified|0|||
105745698|NCT02614287|364722954|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
105745699|NCT02614287|364722955|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
105745700|NCT02614287|364722954|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
105745701|NCT02614287|364722955|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
105745702|NCT02614287|364722954|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
105745703|NCT02614287|364722955|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
105745704|NCT02614287|364722954|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
105745705|NCT02614287|364722955|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
105745706|NCT02614287|364722954|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
105745707|NCT02614287|364722955|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
105745708|NCT02614287|364722954|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
105745709|NCT02614287|364722955|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
105745710|NCT02614287|364722954|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
105745711|NCT02614287|364722955|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
105745712|NCT02614287|364722954|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
105745713|NCT02614287|364722955|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
105745714|NCT00683475|364722957|FG000|Overall Study|Withdrawal by Subject|1|||
105745715|NCT00683475|364722958|FG001|Overall Study|Withdrawal by Subject|0|||
105745716|NCT00683475|364722957|FG000|Overall Study|Never Treated: Adverse Event|2|||
105745717|NCT00683475|364722958|FG001|Overall Study|Never Treated: Adverse Event|3|||
105745718|NCT00683475|364722957|FG000|Overall Study|Never Treated: Progressive Disease|1|||
105745719|NCT00683475|364722958|FG001|Overall Study|Never Treated: Progressive Disease|0|||
105745720|NCT02922634|364722959|FG000|Overall Study|Withdrawal by Subject|5|||
105745721|NCT02922634|364722959|FG000|Overall Study|Did not have their surgery|5|||
105745722|NCT00352755|364722960|FG000|Overall Study|Physician Decision|1|||
105745723|NCT00352755|364722960|FG000|Overall Study|Adverse Event|1|||
105745724|NCT00423085|364722961|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
105745725|NCT00423085|364722962|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
105745726|NCT00423085|364722963|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
105745727|NCT00423085|364722964|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
105745728|NCT00423085|364722961|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
105745729|NCT00423085|364722962|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
105745730|NCT00423085|364722963|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
105800804|NCT01244815|364928549|FG000|Overall Study|Protocol Violation|7|||
105483161|NCT02119676|363780891|FG003|Overall Study|Death|1|||
105800805|NCT01244815|364928550|FG001|Overall Study|Protocol Violation|4|||
105745731|NCT00423085|364722964|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
105745732|NCT00423085|364722961|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
105745733|NCT00423085|364722962|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
105745734|NCT00423085|364722963|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
105745735|NCT00423085|364722964|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
105745736|NCT00423085|364722961|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
105745737|NCT00423085|364722962|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
105745738|NCT00423085|364722963|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
105745739|NCT00423085|364722964|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
105745740|NCT00423085|364722961|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
105745741|NCT00423085|364722962|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
105745742|NCT00423085|364722963|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
105359477|NCT02937740|363322287|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
105359478|NCT02937740|363322286|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
105359479|NCT02937740|363322287|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
105359480|NCT02937740|363322286|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
105359481|NCT02937740|363322287|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
105359482|NCT00621257|363322290|FG000|Overall Study|Lost to Follow-up|4|||
105359483|NCT00621257|363322291|FG001|Overall Study|Lost to Follow-up|0|||
105359484|NCT00621257|363322292|FG002|Overall Study|Lost to Follow-up|2|||
105359485|NCT00621257|363322293|FG003|Overall Study|Lost to Follow-up|4|||
105359486|NCT00621257|363322294|FG004|Overall Study|Lost to Follow-up|7|||
105359487|NCT00621257|363322290|FG000|Overall Study|Adverse Event|0|||
105745743|NCT00423085|364722964|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
105745744|NCT00423085|364722961|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
105745745|NCT00423085|364722962|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
105745746|NCT00423085|364722963|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
105745747|NCT00423085|364722964|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
105745748|NCT00423085|364722961|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
105745749|NCT00423085|364722962|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
105745750|NCT00423085|364722963|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
105745751|NCT00423085|364722964|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
105745752|NCT00423085|364722961|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
105745753|NCT00423085|364722962|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
105745754|NCT00423085|364722963|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
105745755|NCT00423085|364722964|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
105745756|NCT00423085|364722961|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
105745757|NCT00423085|364722962|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
105745758|NCT00423085|364722963|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
105745759|NCT00423085|364722964|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
105745760|NCT00423085|364722961|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
105745761|NCT00423085|364722962|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
105745762|NCT00423085|364722963|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
105800806|NCT01244815|364928551|FG002|Overall Study|Protocol Violation|3|||
105359488|NCT00621257|363322291|FG001|Overall Study|Adverse Event|1|||
105359489|NCT00621257|363322292|FG002|Overall Study|Adverse Event|1|||
105359490|NCT00621257|363322293|FG003|Overall Study|Adverse Event|0|||
105359491|NCT00621257|363322294|FG004|Overall Study|Adverse Event|0|||
105359492|NCT00621257|363322290|FG000|Overall Study|Physician Decision|0|||
105359493|NCT00621257|363322291|FG001|Overall Study|Physician Decision|2|||
105359494|NCT00621257|363322292|FG002|Overall Study|Physician Decision|0|||
105359495|NCT00621257|363322293|FG003|Overall Study|Physician Decision|1|||
105359496|NCT00621257|363322294|FG004|Overall Study|Physician Decision|1|||
105359497|NCT00621257|363322290|FG000|Overall Study|Withdrawal by Subject|0|||
105359498|NCT00621257|363322291|FG001|Overall Study|Withdrawal by Subject|0|||
105359499|NCT00621257|363322292|FG002|Overall Study|Withdrawal by Subject|0|||
105359500|NCT00621257|363322293|FG003|Overall Study|Withdrawal by Subject|1|||
105359501|NCT00621257|363322294|FG004|Overall Study|Withdrawal by Subject|1|||
105359502|NCT00357877|363322302|FG000|Overall Study|Death|2|||
105359503|NCT00357877|363322303|FG001|Overall Study|Death|1|||
105483162|NCT02119676|363780888|FG000|Overall Study|Noncompliance|0|||
105483163|NCT02119676|363780889|FG001|Overall Study|Noncompliance|1|||
105483164|NCT02119676|363780890|FG002|Overall Study|Noncompliance|0|||
105483165|NCT02119676|363780891|FG003|Overall Study|Noncompliance|0|||
105483166|NCT02119676|363780888|FG000|Overall Study|Lost to Follow-up|0|||
105359504|NCT00357877|363322302|FG000|Overall Study|Lost to Follow-up|20|||
105359505|NCT00357877|363322303|FG001|Overall Study|Lost to Follow-up|23|||
105359506|NCT00357877|363322302|FG000|Overall Study|Withdrawal by Subject|3|||
105359507|NCT00357877|363322303|FG001|Overall Study|Withdrawal by Subject|3|||
105359508|NCT00357877|363322302|FG000|Overall Study|Administrative withdrawal|1|||
105483167|NCT02119676|363780889|FG001|Overall Study|Lost to Follow-up|0|||
105483168|NCT02119676|363780890|FG002|Overall Study|Lost to Follow-up|1|||
105483169|NCT02119676|363780891|FG003|Overall Study|Lost to Follow-up|0|||
105483170|NCT02119676|363780888|FG000|Overall Study|Protocol deviation|0|||
105483171|NCT02119676|363780889|FG001|Overall Study|Protocol deviation|0|||
105483172|NCT02119676|363780890|FG002|Overall Study|Protocol deviation|1|||
105745763|NCT00423085|364722964|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
105745764|NCT00423085|364722961|FG000|52-Week Open-Label Extension Phase|Death|0|||
105745765|NCT00423085|364722962|FG001|52-Week Open-Label Extension Phase|Death|0|||
105745766|NCT00423085|364722963|FG002|52-Week Open-Label Extension Phase|Death|0|||
105745767|NCT00423085|364722964|FG003|52-Week Open-Label Extension Phase|Death|2|||
105745768|NCT03331666|364722965|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
105745769|NCT03331666|364722966|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
105745770|NCT02939937|364722967|FG000|Overall Study|Adverse Event|5|||
105745771|NCT02939937|364722968|FG001|Overall Study|Adverse Event|0|||
105745772|NCT02939937|364722967|FG000|Overall Study|Lost to Follow-up|1|||
105745773|NCT02939937|364722968|FG001|Overall Study|Lost to Follow-up|3|||
105745774|NCT01361009|364722972|FG000|Overall Study|Protocol Violation|116|||
105745775|NCT03100942|364722976|FG000|Randomized Treatment Period|Withdrew Consent|4|||
105745776|NCT03100942|364722977|FG001|Randomized Treatment Period|Withdrew Consent|5|||
105745777|NCT03100942|364722978|FG002|Randomized Treatment Period|Withdrew Consent|3|||
105745778|NCT03100942|364722979|FG003|Randomized Treatment Period|Withdrew Consent|3|||
105745779|NCT03100942|364722980|FG004|Randomized Treatment Period|Withdrew Consent|0|||
105745780|NCT03100942|364722981|FG005|Randomized Treatment Period|Withdrew Consent|0|||
105745781|NCT03100942|364722982|FG006|Randomized Treatment Period|Withdrew Consent|0|||
105745782|NCT03100942|364722976|FG000|Randomized Treatment Period|Adverse Event|5|||
105745783|NCT03100942|364722977|FG001|Randomized Treatment Period|Adverse Event|2|||
105745784|NCT03100942|364722978|FG002|Randomized Treatment Period|Adverse Event|1|||
105745785|NCT03100942|364722979|FG003|Randomized Treatment Period|Adverse Event|0|||
105745786|NCT03100942|364722980|FG004|Randomized Treatment Period|Adverse Event|0|||
105745787|NCT03100942|364722981|FG005|Randomized Treatment Period|Adverse Event|0|||
105745788|NCT03100942|364722982|FG006|Randomized Treatment Period|Adverse Event|0|||
105745789|NCT03100942|364722976|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
105745790|NCT03100942|364722977|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
105745791|NCT03100942|364722978|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
105745792|NCT03100942|364722979|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
105745793|NCT03100942|364722980|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
105745794|NCT03100942|364722981|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
105745795|NCT03100942|364722982|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
105745796|NCT03100942|364722976|FG000|Randomized Treatment Period|Protocol Violation|0|||
105745797|NCT03100942|364722977|FG001|Randomized Treatment Period|Protocol Violation|1|||
105745798|NCT03100942|364722978|FG002|Randomized Treatment Period|Protocol Violation|1|||
105745799|NCT03100942|364722979|FG003|Randomized Treatment Period|Protocol Violation|1|||
105745800|NCT03100942|364722980|FG004|Randomized Treatment Period|Protocol Violation|0|||
105745801|NCT03100942|364722981|FG005|Randomized Treatment Period|Protocol Violation|0|||
105745802|NCT03100942|364722982|FG006|Randomized Treatment Period|Protocol Violation|0|||
105745803|NCT03100942|364722976|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
105745804|NCT03100942|364722977|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
105745805|NCT03100942|364722978|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
105745806|NCT03100942|364722979|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
105745807|NCT03100942|364722980|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
105745808|NCT03100942|364722981|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
105745809|NCT03100942|364722982|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
105745810|NCT03100942|364722976|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
105745811|NCT03100942|364722977|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
105745812|NCT03100942|364722978|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
105800807|NCT01244815|364928552|FG003|Overall Study|Protocol Violation|1|||
105800808|NCT01244815|364928549|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
105800809|NCT01244815|364928550|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
105800810|NCT01244815|364928551|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
105800811|NCT01244815|364928552|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
105800812|NCT01808209|364928555|FG000|Overall Study|Lost to Follow-up|0|||
105800813|NCT01808209|364928556|FG001|Overall Study|Lost to Follow-up|1|||
105800814|NCT00910858|364928557|FG000|Pharmacokinetic Phase|Adverse Event|1|||
105800815|NCT00910858|364928558|FG001|Pharmacokinetic Phase|Adverse Event|0|||
105800816|NCT00910858|364928559|FG002|Pharmacokinetic Phase|Adverse Event|0|||
105800817|NCT00910858|364928557|FG000|Monotherapy Phase|Adverse Event|3|||
105800818|NCT00910858|364928558|FG001|Monotherapy Phase|Adverse Event|2|||
105800819|NCT00910858|364928559|FG002|Monotherapy Phase|Adverse Event|0|||
105800820|NCT00910858|364928557|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
105800821|NCT00910858|364928558|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
105800822|NCT00910858|364928559|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
105800823|NCT00910858|364928557|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
105800824|NCT00910858|364928558|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
105800825|NCT00910858|364928559|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
105800826|NCT00910858|364928557|FG000|Monotherapy Phase|Protocol Violation|1|||
105800827|NCT00910858|364928558|FG001|Monotherapy Phase|Protocol Violation|0|||
105800828|NCT00910858|364928559|FG002|Monotherapy Phase|Protocol Violation|0|||
105800829|NCT00910858|364928557|FG000|Monotherapy Phase|Other|3|||
105800830|NCT00910858|364928558|FG001|Monotherapy Phase|Other|4|||
105800831|NCT00910858|364928559|FG002|Monotherapy Phase|Other|2|||
105800832|NCT00910858|364928557|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
105800833|NCT00910858|364928558|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
105800834|NCT00910858|364928559|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
105800835|NCT00910858|364928557|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
105800836|NCT00910858|364928558|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
105800837|NCT00910858|364928559|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
105800838|NCT00910858|364928557|FG000|Combined Treatment Phase|Protocol Violation|1|||
105800839|NCT00910858|364928558|FG001|Combined Treatment Phase|Protocol Violation|0|||
105800840|NCT00910858|364928559|FG002|Combined Treatment Phase|Protocol Violation|0|||
105800841|NCT00910858|364928557|FG000|Combined Treatment Phase|Other|0|||
105800842|NCT00910858|364928558|FG001|Combined Treatment Phase|Other|2|||
105800843|NCT00910858|364928559|FG002|Combined Treatment Phase|Other|1|||
105800844|NCT00697112|364928560|FG000|Overall Study|Adverse Event|8|||
105800845|NCT00697112|364928560|FG000|Overall Study|Lost to Follow-up|1|||
105800846|NCT00697112|364928560|FG000|Overall Study|Did not meet inclusion criteria|1|||
105800847|NCT02041494|364928561|FG000|Overall Study|Death|1|||
105800848|NCT02041494|364928562|FG001|Overall Study|Death|3|||
105800849|NCT02041494|364928561|FG000|Overall Study|Lost to Follow-up|2|||
105800850|NCT02041494|364928562|FG001|Overall Study|Lost to Follow-up|6|||
105800851|NCT02041494|364928561|FG000|Overall Study|study terminated|16|||
105800852|NCT02041494|364928562|FG001|Overall Study|study terminated|11|||
105800853|NCT03066440|364928563|FG000|Overall Study|Physician Decision|1|||
105800854|NCT03066440|364928564|FG001|Overall Study|Physician Decision|1|||
105800855|NCT03066440|364928563|FG000|Overall Study|Protocol Violation|0|||
105800856|NCT03066440|364928564|FG001|Overall Study|Protocol Violation|2|||
105800857|NCT01965535|364928566|FG000|Overall Study|Lack of Efficacy|2|||
105800858|NCT01965535|364928567|FG001|Overall Study|Lack of Efficacy|1|||
105800859|NCT01418352|364928568|FG000|Overall Study|Lost to Follow-up|2|||
105800860|NCT01418352|364928569|FG001|Overall Study|Lost to Follow-up|0|||
105800861|NCT01418352|364928570|FG002|Overall Study|Lost to Follow-up|0|||
105800862|NCT01418352|364928571|FG003|Overall Study|Lost to Follow-up|0|||
105800863|NCT01418352|364928568|FG000|Overall Study|Adverse Event|0|||
105800864|NCT01418352|364928569|FG001|Overall Study|Adverse Event|1|||
105800865|NCT01418352|364928570|FG002|Overall Study|Adverse Event|0|||
105359509|NCT00357877|363322303|FG001|Overall Study|Administrative withdrawal|1|||
105359510|NCT00357877|363322302|FG000|Overall Study|Other|0|||
105359511|NCT00357877|363322303|FG001|Overall Study|Other|2|||
105359512|NCT01247350|363322306|FG000|Overall Study|Adverse Event|0|||
105359513|NCT01247350|363322307|FG001|Overall Study|Adverse Event|0|||
105359514|NCT01247350|363322308|FG002|Overall Study|Adverse Event|1|||
105483173|NCT02119676|363780891|FG003|Overall Study|Protocol deviation|0|||
105800866|NCT01418352|364928571|FG003|Overall Study|Adverse Event|0|||
105800867|NCT01418352|364928568|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
105800868|NCT01418352|364928569|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
105800869|NCT01418352|364928570|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
105800870|NCT01418352|364928571|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
105359515|NCT01247350|363322309|FG003|Overall Study|Adverse Event|0|||
105800871|NCT01418352|364928568|FG000|Overall Study|Subject Withdrew Consent|0|||
105800872|NCT01418352|364928569|FG001|Overall Study|Subject Withdrew Consent|1|||
105800873|NCT01418352|364928570|FG002|Overall Study|Subject Withdrew Consent|2|||
105359516|NCT01247350|363322310|FG004|Overall Study|Adverse Event|0|||
105359517|NCT01247350|363322306|FG000|Overall Study|Withdrawal by Subject|0|||
105800874|NCT01418352|364928571|FG003|Overall Study|Subject Withdrew Consent|1|||
105800875|NCT01418352|364928568|FG000|Overall Study|Protocol Deviation|0|||
105800876|NCT01418352|364928569|FG001|Overall Study|Protocol Deviation|0|||
105800877|NCT01418352|364928570|FG002|Overall Study|Protocol Deviation|1|||
105800878|NCT01418352|364928571|FG003|Overall Study|Protocol Deviation|0|||
105800879|NCT01418352|364928568|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
105800880|NCT01418352|364928569|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
105800881|NCT01418352|364928570|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
105800882|NCT01418352|364928571|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
105745813|NCT03100942|364722979|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
105745814|NCT03100942|364722980|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
105745815|NCT03100942|364722981|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
105745816|NCT03100942|364722982|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
105745817|NCT03100942|364722976|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
105745818|NCT03100942|364722977|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
105745819|NCT03100942|364722978|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
105745820|NCT03100942|364722979|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
105745821|NCT03100942|364722980|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
105745822|NCT03100942|364722981|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
105745823|NCT03100942|364722982|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
105745824|NCT04402008|364722986|FG000|Overall Study|Adverse Event|0|||
105745825|NCT04402008|364722987|FG001|Overall Study|Adverse Event|0|||
105745826|NCT04402008|364722988|FG002|Overall Study|Adverse Event|0|||
105745827|NCT04402008|364722989|FG003|Overall Study|Adverse Event|1|||
105745828|NCT04402008|364722990|FG004|Overall Study|Adverse Event|0|||
105745829|NCT04402008|364722991|FG005|Overall Study|Adverse Event|0|||
105745830|NCT04402008|364722992|FG006|Overall Study|Adverse Event|0|||
105745831|NCT04402008|364722986|FG000|Overall Study|Disease Progression|3|||
105745832|NCT04402008|364722987|FG001|Overall Study|Disease Progression|2|||
105745833|NCT04402008|364722988|FG002|Overall Study|Disease Progression|3|||
105745834|NCT04402008|364722989|FG003|Overall Study|Disease Progression|3|||
105745835|NCT04402008|364722990|FG004|Overall Study|Disease Progression|4|||
105745836|NCT04402008|364722991|FG005|Overall Study|Disease Progression|3|||
105800883|NCT03670537|364928572|FG000|Overall Study|Protocol Violation|1|||
105800884|NCT03751020|364928573|FG000|Overall Study|Withdrawal by Subject|2|||
105800885|NCT03751020|364928574|FG001|Overall Study|Withdrawal by Subject|0|||
105483174|NCT02119676|363780888|FG000|Overall Study|Other, unspecified|2|||
105745837|NCT04402008|364722992|FG006|Overall Study|Disease Progression|10|||
105745838|NCT04402008|364722986|FG000|Overall Study|Withdrawal by Subject|0|||
105745839|NCT04402008|364722987|FG001|Overall Study|Withdrawal by Subject|1|||
105745840|NCT04402008|364722988|FG002|Overall Study|Withdrawal by Subject|0|||
105745841|NCT04402008|364722989|FG003|Overall Study|Withdrawal by Subject|0|||
105800886|NCT03751020|364928575|FG002|Overall Study|Withdrawal by Subject|0|||
105800887|NCT03751020|364928573|FG000|Overall Study|Lost to Follow-up|7|||
105800888|NCT03751020|364928574|FG001|Overall Study|Lost to Follow-up|4|||
105800889|NCT03751020|364928575|FG002|Overall Study|Lost to Follow-up|10|||
105800890|NCT00033631|364928576|FG000|Overall Study|Protocol Violation|14|||
105800891|NCT00033631|364928577|FG001|Overall Study|Protocol Violation|11|||
105800892|NCT00033631|364928576|FG000|Overall Study|Withdrawal by Subject|4|||
105800893|NCT00033631|364928577|FG001|Overall Study|Withdrawal by Subject|4|||
105800894|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
105800895|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
105800896|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
105800897|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
105800898|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
105800899|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
105800900|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
105800901|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
105800902|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
105800903|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
105800904|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
105800905|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
105800906|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
105800907|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
105800908|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
105800909|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
105800910|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
105800911|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
105800912|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
105800913|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
105800914|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
105800915|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
105800916|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
105800917|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
105800918|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
105800919|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
105800920|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
105800921|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
105800922|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
105800923|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
105800924|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
105800925|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
105800926|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
105800927|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
105800928|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
105800929|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
105800930|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
105800931|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
105800932|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
105800933|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
105800934|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
105800935|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
105800936|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
105800937|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
105800938|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
105800939|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
105800940|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
105800941|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
105800942|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
105800943|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
105800944|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
105800945|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
105800946|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
105359518|NCT01247350|363322307|FG001|Overall Study|Withdrawal by Subject|0|||
105359519|NCT01247350|363322308|FG002|Overall Study|Withdrawal by Subject|0|||
105359520|NCT01247350|363322309|FG003|Overall Study|Withdrawal by Subject|1|||
105359521|NCT01247350|363322310|FG004|Overall Study|Withdrawal by Subject|0|||
105359522|NCT01247350|363322306|FG000|Overall Study|Entry criteria not met|0|||
105359523|NCT01247350|363322307|FG001|Overall Study|Entry criteria not met|0|||
105745842|NCT04402008|364722990|FG004|Overall Study|Withdrawal by Subject|1|||
105745843|NCT04402008|364722991|FG005|Overall Study|Withdrawal by Subject|0|||
105745844|NCT04402008|364722992|FG006|Overall Study|Withdrawal by Subject|0|||
105745845|NCT04402008|364722986|FG000|Overall Study|Sponsor Decision|0|||
105745846|NCT04402008|364722987|FG001|Overall Study|Sponsor Decision|0|||
105745847|NCT04402008|364722988|FG002|Overall Study|Sponsor Decision|0|||
105745848|NCT04402008|364722989|FG003|Overall Study|Sponsor Decision|0|||
105745849|NCT04402008|364722990|FG004|Overall Study|Sponsor Decision|0|||
105745850|NCT04402008|364722991|FG005|Overall Study|Sponsor Decision|0|||
105745851|NCT04402008|364722992|FG006|Overall Study|Sponsor Decision|3|||
105745852|NCT04402008|364722986|FG000|Overall Study|Death|0|||
105745853|NCT04402008|364722987|FG001|Overall Study|Death|0|||
105745854|NCT04402008|364722988|FG002|Overall Study|Death|0|||
105745855|NCT04402008|364722989|FG003|Overall Study|Death|0|||
105745856|NCT04402008|364722990|FG004|Overall Study|Death|1|||
105745857|NCT04402008|364722991|FG005|Overall Study|Death|0|||
105745858|NCT04402008|364722992|FG006|Overall Study|Death|2|||
105745859|NCT04402008|364722986|FG000|Overall Study|Other|0|||
105745860|NCT04402008|364722987|FG001|Overall Study|Other|0|||
105745861|NCT04402008|364722988|FG002|Overall Study|Other|0|||
105745862|NCT04402008|364722989|FG003|Overall Study|Other|0|||
105745863|NCT04402008|364722990|FG004|Overall Study|Other|0|||
105745864|NCT04402008|364722991|FG005|Overall Study|Other|0|||
105745865|NCT04402008|364722992|FG006|Overall Study|Other|5|||
105745866|NCT01401010|364722997|FG000|Overall Study|Could not interpret assay results|1|||
105745867|NCT01401010|364722998|FG001|Overall Study|Could not interpret assay results|0|||
105745868|NCT01912729|364722999|FG000|Overall Study|Withdrawal by Subject|0|||
105745869|NCT01912729|364723000|FG001|Overall Study|Withdrawal by Subject|1|||
105745870|NCT01952834|364723001|FG000|Overall Study|Adverse Event|1|||
105745871|NCT04360187|364723008|FG000|Double-Blind Treatment|Adverse Event|9|||
105745872|NCT04360187|364723009|FG001|Double-Blind Treatment|Adverse Event|11|||
105745873|NCT04360187|364723008|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
105745874|NCT04360187|364723009|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
105745875|NCT04360187|364723008|FG000|Double-Blind Treatment|Physician Decision|1|||
105745876|NCT04360187|364723009|FG001|Double-Blind Treatment|Physician Decision|0|||
105745877|NCT04360187|364723008|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
105745878|NCT04360187|364723009|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
105745879|NCT04360187|364723008|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
105745880|NCT04360187|364723009|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
105745881|NCT04360187|364723008|FG000|Follow-Up|Lost to Follow-up|1|||
105745882|NCT04360187|364723009|FG001|Follow-Up|Lost to Follow-up|0|||
105745883|NCT00988559|364723015|FG000|Overall Study|Withdrawal by Subject|1|||
105745884|NCT00988559|364723016|FG001|Overall Study|Withdrawal by Subject|1|||
105745885|NCT00988559|364723017|FG002|Overall Study|Withdrawal by Subject|0|||
105745886|NCT00988559|364723018|FG003|Overall Study|Withdrawal by Subject|1|||
105745887|NCT00988559|364723015|FG000|Overall Study|Pregnancy|0|||
105745888|NCT00988559|364723016|FG001|Overall Study|Pregnancy|1|||
105745889|NCT00988559|364723017|FG002|Overall Study|Pregnancy|1|||
105745890|NCT00988559|364723018|FG003|Overall Study|Pregnancy|0|||
105359524|NCT01247350|363322308|FG002|Overall Study|Entry criteria not met|0|||
105359525|NCT01247350|363322309|FG003|Overall Study|Entry criteria not met|0|||
105359526|NCT01247350|363322310|FG004|Overall Study|Entry criteria not met|1|||
105359527|NCT01266824|363322311|FG000|Overall Study|Study terminated prior to completion|2|||
105359528|NCT01266824|363322312|FG001|Overall Study|Study terminated prior to completion|3|||
105359529|NCT02302846|363322313|FG000|Overall Study|Withdrawal by Subject|1|||
105359530|NCT00232557|363322314|FG000|Overall Study|Lost to Follow-up|3|||
105359531|NCT00232557|363322315|FG001|Overall Study|Lost to Follow-up|5|||
105359532|NCT01059773|363322316|FG000|Overall Study|Adverse Event|2|||
105359533|NCT01059773|363322317|FG001|Overall Study|Adverse Event|2|||
105359534|NCT01059773|363322316|FG000|Overall Study|Withdrawal by Subject|1|||
105359535|NCT01059773|363322317|FG001|Overall Study|Withdrawal by Subject|5|||
105359536|NCT01059773|363322316|FG000|Overall Study|Lost to Follow-up|1|||
105359537|NCT01059773|363322317|FG001|Overall Study|Lost to Follow-up|1|||
105359538|NCT01059773|363322316|FG000|Overall Study|Pregnancy|1|||
105359539|NCT01059773|363322317|FG001|Overall Study|Pregnancy|1|||
105359540|NCT01059773|363322316|FG000|Overall Study|Protocol Violation|6|||
105359541|NCT01059773|363322317|FG001|Overall Study|Protocol Violation|2|||
105359542|NCT01059773|363322316|FG000|Overall Study|Physician Decision|5|||
105359543|NCT01059773|363322317|FG001|Overall Study|Physician Decision|4|||
105359544|NCT01059773|363322316|FG000|Overall Study|Lack of Efficacy|3|||
105359545|NCT01059773|363322317|FG001|Overall Study|Lack of Efficacy|3|||
105359546|NCT01059773|363322316|FG000|Overall Study|Death|0|||
105359547|NCT01059773|363322317|FG001|Overall Study|Death|1|||
105359548|NCT01059773|363322316|FG000|Overall Study|Malignancy including squamous cell skin|0|||
105359549|NCT01059773|363322317|FG001|Overall Study|Malignancy including squamous cell skin|1|||
105359550|NCT01059773|363322316|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
105359551|NCT01059773|363322317|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
105359552|NCT01059773|363322316|FG000|Overall Study|Other|1|||
105745891|NCT00988559|364723015|FG000|Overall Study|Lost to Follow-up|0|||
105745892|NCT00988559|364723016|FG001|Overall Study|Lost to Follow-up|0|||
105745893|NCT00988559|364723017|FG002|Overall Study|Lost to Follow-up|1|||
105745894|NCT00988559|364723018|FG003|Overall Study|Lost to Follow-up|0|||
105745895|NCT03007953|364723019|FG000|Overall Study|Withdrawal by Subject|5|||
105745896|NCT03007953|364723020|FG001|Overall Study|Withdrawal by Subject|2|||
105745897|NCT03007953|364723019|FG000|Overall Study|Death|5|||
105745898|NCT03007953|364723020|FG001|Overall Study|Death|7|||
105745899|NCT03007953|364723019|FG000|Overall Study|Lost to Follow-up|3|||
105745900|NCT03007953|364723020|FG001|Overall Study|Lost to Follow-up|2|||
105745901|NCT03007953|364723019|FG000|Overall Study|Enrolled in Hospice|3|||
105745902|NCT03007953|364723020|FG001|Overall Study|Enrolled in Hospice|2|||
105745903|NCT00515008|364723021|FG000|Overall Study|Lost to Follow-up|1|||
105745904|NCT00515008|364723022|FG001|Overall Study|Lost to Follow-up|0|||
105745905|NCT00515008|364723021|FG000|Overall Study|Declined|0|||
105745906|NCT00515008|364723022|FG001|Overall Study|Declined|3|||
105745907|NCT00515008|364723021|FG000|Overall Study|Left the Boston Area|1|||
105745908|NCT00515008|364723022|FG001|Overall Study|Left the Boston Area|1|||
105745909|NCT00515008|364723021|FG000|Overall Study|Scheduling conflict|1|||
105745910|NCT00515008|364723022|FG001|Overall Study|Scheduling conflict|0|||
105745911|NCT00748540|364723023|FG000|Overall Study|Physician Decision|1|||
105745912|NCT01930799|364723027|FG000|Overall Study|Withdrawal by Subject|3|||
105745913|NCT01930799|364723027|FG000|Overall Study|Lost to Follow-up|5|||
105745914|NCT02402218|364723028|FG000|Overall Study|Did not pickup study medication|12|||
105745915|NCT02402218|364723029|FG001|Overall Study|Did not pickup study medication|9|||
105745916|NCT02402218|364723030|FG002|Overall Study|Did not pickup study medication|13|||
105745917|NCT02402218|364723028|FG000|Overall Study|Lack of Efficacy|0|||
105745918|NCT02402218|364723029|FG001|Overall Study|Lack of Efficacy|1|||
105745919|NCT02402218|364723030|FG002|Overall Study|Lack of Efficacy|1|||
105745920|NCT02402218|364723028|FG000|Overall Study|Death|1|||
105745921|NCT02402218|364723029|FG001|Overall Study|Death|0|||
105745922|NCT02402218|364723030|FG002|Overall Study|Death|0|||
105745923|NCT02402218|364723028|FG000|Overall Study|Reinfection|0|||
105745924|NCT02402218|364723029|FG001|Overall Study|Reinfection|0|||
105359553|NCT01059773|363322317|FG001|Overall Study|Other|3|||
105359554|NCT00872521|363322318|FG000|Completed PAD Induction|Patient choice|0|||
105745925|NCT02402218|364723030|FG002|Overall Study|Reinfection|1|||
105745926|NCT02402218|364723028|FG000|Overall Study|Adverse Event|0|||
105745927|NCT02402218|364723029|FG001|Overall Study|Adverse Event|2|||
105745928|NCT02402218|364723030|FG002|Overall Study|Adverse Event|1|||
105745929|NCT02402218|364723028|FG000|Overall Study|Withdrawal by Subject|1|||
105745930|NCT02402218|364723029|FG001|Overall Study|Withdrawal by Subject|1|||
105359555|NCT00872521|363322319|FG001|Completed PAD Induction|Patient choice|1|||
105359556|NCT00872521|363322320|FG002|Completed PAD Induction|Patient choice|0|||
105359557|NCT00872521|363322318|FG000|Completed PAD Induction|Disease progression|0|||
105359558|NCT00872521|363322319|FG001|Completed PAD Induction|Disease progression|2|||
105359559|NCT00872521|363322320|FG002|Completed PAD Induction|Disease progression|0|||
105359560|NCT00872521|363322318|FG000|Completed PAD Induction|Adverse Event|4|||
105359561|NCT00872521|363322319|FG001|Completed PAD Induction|Adverse Event|0|||
105359562|NCT00872521|363322320|FG002|Completed PAD Induction|Adverse Event|0|||
105359563|NCT00872521|363322318|FG000|Completed PAD Induction|Death|1|||
105359564|NCT00872521|363322319|FG001|Completed PAD Induction|Death|1|||
105359565|NCT00872521|363322320|FG002|Completed PAD Induction|Death|0|||
105359566|NCT00872521|363322318|FG000|Primary Endpoint Analysis|Other|1|||
105359567|NCT00872521|363322319|FG001|Primary Endpoint Analysis|Other|2|||
105359568|NCT00872521|363322320|FG002|Primary Endpoint Analysis|Other|0|||
105359569|NCT00872521|363322318|FG000|Primary Endpoint Analysis|Patient choice|0|||
105359570|NCT00872521|363322319|FG001|Primary Endpoint Analysis|Patient choice|1|||
105359571|NCT00872521|363322320|FG002|Primary Endpoint Analysis|Patient choice|0|||
105359572|NCT00872521|363322318|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
105359573|NCT00872521|363322319|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
105359574|NCT00872521|363322320|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
105359575|NCT00872521|363322318|FG000|Primary Endpoint Analysis|Patient response missing|0|||
105359576|NCT00872521|363322319|FG001|Primary Endpoint Analysis|Patient response missing|0|||
105359577|NCT00872521|363322320|FG002|Primary Endpoint Analysis|Patient response missing|1|||
105359578|NCT00872521|363322318|FG000|Completed 3-month Follow up|Other|0|||
105359579|NCT00872521|363322319|FG001|Completed 3-month Follow up|Other|2|||
105359580|NCT00872521|363322320|FG002|Completed 3-month Follow up|Other|0|||
105359581|NCT00872521|363322318|FG000|Completed 3-month Follow up|Physician Decision|0|||
105359582|NCT00872521|363322319|FG001|Completed 3-month Follow up|Physician Decision|1|||
105359583|NCT00872521|363322320|FG002|Completed 3-month Follow up|Physician Decision|0|||
105359584|NCT00872521|363322318|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
105359585|NCT00872521|363322319|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
105359586|NCT00872521|363322320|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
105745931|NCT02402218|364723030|FG002|Overall Study|Withdrawal by Subject|1|||
105483175|NCT02119676|363780889|FG001|Overall Study|Other, unspecified|1|||
105483176|NCT02119676|363780890|FG002|Overall Study|Other, unspecified|3|||
105483177|NCT02119676|363780891|FG003|Overall Study|Other, unspecified|4|||
105483178|NCT02119676|363780888|FG000|Overall Study|Did not receive study med|2|||
105745932|NCT04436822|364723031|FG000|Overall Study|Physician Decision|2|||
105745933|NCT04436822|364723032|FG001|Overall Study|Physician Decision|0|||
105745934|NCT04436822|364723031|FG000|Overall Study|Sponsor request|1|||
105745935|NCT04436822|364723032|FG001|Overall Study|Sponsor request|0|||
105745936|NCT04436822|364723031|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105745937|NCT04436822|364723032|FG001|Overall Study|Withdrawal by parent/guardian|3|||
105745938|NCT04436822|364723031|FG000|Overall Study|Unsuccessful procedure|0|||
105745939|NCT04436822|364723032|FG001|Overall Study|Unsuccessful procedure|1|||
105745940|NCT04436822|364723031|FG000|Overall Study|Withdrawal due to Covid-19|8|||
105745941|NCT04436822|364723032|FG001|Overall Study|Withdrawal due to Covid-19|1|||
105745942|NCT04436822|364723031|FG000|Overall Study|Withdrawal by Subject|1|||
105745943|NCT04436822|364723032|FG001|Overall Study|Withdrawal by Subject|0|||
105745944|NCT04436822|364723031|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
105745945|NCT04436822|364723032|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
105745946|NCT02371759|364723035|FG000|Overall Study|Protocol Violation|3|||
105745947|NCT02371759|364723036|FG001|Overall Study|Protocol Violation|1|||
105745948|NCT02371759|364723037|FG002|Overall Study|Protocol Violation|1|||
105745949|NCT02371759|364723038|FG003|Overall Study|Protocol Violation|0|||
105745950|NCT02371759|364723039|FG004|Overall Study|Protocol Violation|3|||
105745951|NCT02371759|364723040|FG005|Overall Study|Protocol Violation|1|||
105745952|NCT02371759|364723041|FG006|Overall Study|Protocol Violation|0|||
105745953|NCT02371759|364723042|FG007|Overall Study|Protocol Violation|3|||
105745954|NCT02371759|364723035|FG000|Overall Study|Withdrawal by Subject|0|||
105745955|NCT02371759|364723036|FG001|Overall Study|Withdrawal by Subject|0|||
105745956|NCT02371759|364723037|FG002|Overall Study|Withdrawal by Subject|0|||
105745957|NCT02371759|364723038|FG003|Overall Study|Withdrawal by Subject|0|||
105745958|NCT02371759|364723039|FG004|Overall Study|Withdrawal by Subject|0|||
105745959|NCT02371759|364723040|FG005|Overall Study|Withdrawal by Subject|0|||
105745960|NCT02371759|364723041|FG006|Overall Study|Withdrawal by Subject|0|||
105745961|NCT02371759|364723042|FG007|Overall Study|Withdrawal by Subject|1|||
105745962|NCT01423617|364723048|FG000|Overall Study|Lost to Follow-up|0|||
105745963|NCT01423617|364723049|FG001|Overall Study|Lost to Follow-up|1|||
105745964|NCT01515306|364723050|FG000|Overall Study|Adverse Event|3|||
105745965|NCT01515306|364723051|FG001|Overall Study|Adverse Event|2|||
105745966|NCT01515306|364723050|FG000|Overall Study|Progressive Disease|19|||
105745967|NCT01515306|364723051|FG001|Overall Study|Progressive Disease|9|||
105745968|NCT01515306|364723050|FG000|Overall Study|Withdrawal by Subject|1|||
105359587|NCT03410992|363322322|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105359588|NCT03410992|363322323|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
105483179|NCT02119676|363780889|FG001|Overall Study|Did not receive study med|2|||
105745969|NCT01515306|364723051|FG001|Overall Study|Withdrawal by Subject|2|||
105745970|NCT01515306|364723050|FG000|Overall Study|Physician Decision|1|||
105745971|NCT01515306|364723051|FG001|Overall Study|Physician Decision|1|||
105745972|NCT00369668|364723055|FG000|Overall Study|Lack of Efficacy|4|||
105745973|NCT00369668|364723056|FG001|Overall Study|Lack of Efficacy|5|||
105745974|NCT00369668|364723057|FG002|Overall Study|Lack of Efficacy|7|||
105745975|NCT03201198|364723065|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
105745976|NCT03201198|364723066|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
105745977|NCT03201198|364723065|FG000|Overall Study|Withdrawal by Subject|2|||
105745978|NCT03201198|364723066|FG001|Overall Study|Withdrawal by Subject|3|||
105745979|NCT03855137|364723068|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
105745980|NCT03855137|364723069|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
105745981|NCT03855137|364723070|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
105745982|NCT03855137|364723068|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
105745983|NCT03855137|364723069|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
105745984|NCT03855137|364723070|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
105745985|NCT03855137|364723068|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
105745986|NCT03855137|364723069|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
105745987|NCT03855137|364723070|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
105745988|NCT03855137|364723068|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
105745989|NCT03855137|364723069|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
105745990|NCT03855137|364723070|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
105745991|NCT03855137|364723068|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
105745992|NCT03855137|364723069|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
105745993|NCT03855137|364723070|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
105745994|NCT03855137|364723068|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
105745995|NCT03855137|364723069|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
105745996|NCT03855137|364723070|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
105745997|NCT03855137|364723068|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
105745998|NCT03855137|364723069|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
105745999|NCT03855137|364723070|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
105746000|NCT03855137|364723068|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
105746001|NCT03855137|364723069|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
105746002|NCT03855137|364723070|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
105746003|NCT03855137|364723068|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
105746004|NCT03855137|364723069|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
105746005|NCT03855137|364723070|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
105746006|NCT03855137|364723068|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
105746007|NCT03855137|364723069|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
105746008|NCT03855137|364723070|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
105746009|NCT01745393|364723071|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
105746010|NCT01745393|364723072|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
105746011|NCT01745393|364723071|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
105746012|NCT01745393|364723072|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
105746013|NCT01745393|364723071|FG000|12-month Follow-up|Lost to Follow-up|6|||
105746014|NCT01745393|364723072|FG001|12-month Follow-up|Lost to Follow-up|5|||
105746015|NCT02427477|364723077|FG000|Period 1|Adverse Event|1|||
105746016|NCT02427477|364723078|FG001|Period 1|Adverse Event|0|||
105746017|NCT00471445|364723079|FG000|Overall Study|Withdrawal by Subject|1|||
105746018|NCT00471445|364723080|FG001|Overall Study|Withdrawal by Subject|1|||
105746019|NCT00471445|364723079|FG000|Overall Study|Ineligible|1|||
105746020|NCT00471445|364723080|FG001|Overall Study|Ineligible|0|||
105746021|NCT00471445|364723079|FG000|Overall Study|Protocol Violation|0|||
105746022|NCT00471445|364723080|FG001|Overall Study|Protocol Violation|1|||
105746023|NCT03591146|364723084|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
105746024|NCT03591146|364723085|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
105746025|NCT03591146|364723086|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
105746026|NCT03591146|364723087|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
105746027|NCT03591146|364723088|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
105746028|NCT03591146|364723084|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
105746029|NCT03591146|364723085|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
105746030|NCT03591146|364723086|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
105746031|NCT03591146|364723087|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
105746032|NCT03591146|364723088|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
105746033|NCT03591146|364723084|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
105746034|NCT03591146|364723085|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
105746035|NCT03591146|364723086|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
105746036|NCT03591146|364723087|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
105746037|NCT03591146|364723088|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
105746038|NCT03591146|364723084|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
105746039|NCT03591146|364723085|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
105746040|NCT03591146|364723086|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
105746041|NCT03591146|364723087|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
105746042|NCT03591146|364723088|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
105746043|NCT04737031|364723091|FG000|Overall Study|Patients who did not have a treatment visit|0|||
105746044|NCT04737031|364723092|FG001|Overall Study|Patients who did not have a treatment visit|31|||
105746045|NCT04737031|364723093|FG002|Overall Study|Patients who did not have a treatment visit|93|||
105746046|NCT04737031|364723094|FG003|Overall Study|Patients who did not have a treatment visit|227|||
105746047|NCT04369430|364723095|FG000|Overall Study|Adverse Event|2|||
105746048|NCT04369430|364723096|FG001|Overall Study|Adverse Event|3|||
105746049|NCT04369430|364723095|FG000|Overall Study|Death|1|||
105746050|NCT04369430|364723096|FG001|Overall Study|Death|0|||
105746051|NCT04369430|364723095|FG000|Overall Study|Withdrawal by Subject|4|||
105746052|NCT04369430|364723096|FG001|Overall Study|Withdrawal by Subject|3|||
105746053|NCT04369430|364723095|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
105746054|NCT04369430|364723096|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
105746055|NCT04369430|364723095|FG000|Overall Study|Lost to Follow-up|0|||
105746056|NCT04369430|364723096|FG001|Overall Study|Lost to Follow-up|1|||
105746057|NCT02435277|364723099|FG000|Overall Study|Adverse Event|1|||
105746058|NCT02435277|364723100|FG001|Overall Study|Adverse Event|1|||
105746059|NCT02435277|364723101|FG002|Overall Study|Adverse Event|0|||
105746060|NCT02435277|364723102|FG003|Overall Study|Adverse Event|0|||
105746061|NCT02435277|364723099|FG000|Overall Study|Withdrawal by Subject|1|||
105746062|NCT02435277|364723100|FG001|Overall Study|Withdrawal by Subject|0|||
105746063|NCT02435277|364723101|FG002|Overall Study|Withdrawal by Subject|0|||
105746064|NCT02435277|364723102|FG003|Overall Study|Withdrawal by Subject|0|||
105746065|NCT01067508|364723103|FG000|Overall Study|Physician Decision|0|||
105746066|NCT01067508|364723104|FG001|Overall Study|Physician Decision|1|||
105746067|NCT01067508|364723103|FG000|Overall Study|Withdrawal by Subject|0|||
105746068|NCT01067508|364723104|FG001|Overall Study|Withdrawal by Subject|1|||
105746069|NCT00444626|364723107|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
105746070|NCT00444626|364723107|FG000|Initial Treatment Period|Adverse Event|1|||
105746071|NCT00444626|364723107|FG000|Initial Treatment Period|Lost to Follow-up|9|||
105746072|NCT04715230|364723110|FG000|Overall Study|Withdrawal by Subject|1|||
105746073|NCT04715230|364723111|FG001|Overall Study|Withdrawal by Subject|0|||
105746074|NCT04715230|364723112|FG002|Overall Study|Withdrawal by Subject|0|||
105746075|NCT04715230|364723110|FG000|Overall Study|Lost to Follow-up|0|||
105746076|NCT04715230|364723111|FG001|Overall Study|Lost to Follow-up|5|||
105746077|NCT04715230|364723112|FG002|Overall Study|Lost to Follow-up|1|||
105746078|NCT03352414|364723113|FG000|Overall Study|Ineligible by operative criteria|12|||
105746079|NCT03352414|364723114|FG001|Overall Study|Ineligible by operative criteria|10|||
105746080|NCT03453151|364723115|FG000|Overall Study|Withdrawal by Subject|1|||
105746081|NCT03453151|364723115|FG000|Overall Study|Physician Decision|3|||
105746082|NCT00142519|364723116|FG000|Overall Study|Not Treated|7|||
105746083|NCT00142519|364723117|FG001|Overall Study|Not Treated|9|||
105746084|NCT00142519|364723116|FG000|Overall Study|Protocol Violation|1|||
105746085|NCT00142519|364723117|FG001|Overall Study|Protocol Violation|0|||
105746086|NCT00142519|364723116|FG000|Overall Study|Withdrawal by Subject|10|||
105746087|NCT00142519|364723117|FG001|Overall Study|Withdrawal by Subject|7|||
105746088|NCT01687413|364723118|FG000|Overall Study|Withdrawal by Subject|0|||
105746089|NCT01687413|364723119|FG001|Overall Study|Withdrawal by Subject|2|||
105746090|NCT01687413|364723118|FG000|Overall Study|Not eligible|0|||
105746091|NCT01687413|364723119|FG001|Overall Study|Not eligible|2|||
105746092|NCT01687413|364723118|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
105746093|NCT01687413|364723119|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
105746094|NCT01767194|364723120|FG000|Overall Study|Adverse Event|1|||
105746095|NCT01767194|364723121|FG001|Overall Study|Adverse Event|1|||
105746096|NCT01767194|364723120|FG000|Overall Study|Death|0|||
105746097|NCT01767194|364723121|FG001|Overall Study|Death|1|||
105746098|NCT01767194|364723120|FG000|Overall Study|Lack of Efficacy|12|||
105746099|NCT01767194|364723121|FG001|Overall Study|Lack of Efficacy|11|||
105746100|NCT01767194|364723120|FG000|Overall Study|Physician Decision|2|||
105746101|NCT01767194|364723121|FG001|Overall Study|Physician Decision|23|||
105746102|NCT01767194|364723120|FG000|Overall Study|Withdrawal by Subject|0|||
105746103|NCT01767194|364723121|FG001|Overall Study|Withdrawal by Subject|1|||
105746104|NCT01767194|364723120|FG000|Overall Study|Ineligible|1|||
105746105|NCT01767194|364723121|FG001|Overall Study|Ineligible|1|||
105746106|NCT01767194|364723120|FG000|Overall Study|Refusal by patient/parent|2|||
105746107|NCT01767194|364723121|FG001|Overall Study|Refusal by patient/parent|4|||
105746108|NCT01767194|364723120|FG000|Overall Study|Criteria not met on time for next cycle|0|||
105746109|NCT01767194|364723121|FG001|Overall Study|Criteria not met on time for next cycle|1|||
105746110|NCT04973228|364723122|FG000|Overall Study|Adverse Event|2|||
105746111|NCT04973228|364723123|FG001|Overall Study|Adverse Event|3|||
105746112|NCT04973228|364723122|FG000|Overall Study|Lack of Efficacy|1|||
105746113|NCT04973228|364723123|FG001|Overall Study|Lack of Efficacy|3|||
105746114|NCT04973228|364723122|FG000|Overall Study|Lost to Follow-up|12|||
105746115|NCT04973228|364723123|FG001|Overall Study|Lost to Follow-up|4|||
105746116|NCT04973228|364723122|FG000|Overall Study|Withdrawal by Subject|11|||
105746117|NCT04973228|364723123|FG001|Overall Study|Withdrawal by Subject|4|||
105746118|NCT04973228|364723122|FG000|Overall Study|Did not tolerate application|1|||
105746119|NCT04973228|364723123|FG001|Overall Study|Did not tolerate application|0|||
105746120|NCT04973228|364723122|FG000|Overall Study|Wanted to early terminate and use own product|0|||
105746121|NCT04973228|364723123|FG001|Overall Study|Wanted to early terminate and use own product|1|||
105746122|NCT04973228|364723122|FG000|Overall Study|Missed visits due to new work schedule|1|||
105746123|NCT04973228|364723123|FG001|Overall Study|Missed visits due to new work schedule|0|||
105746124|NCT02349789|364725122|FG000|Overall Study|Withdrawal by Subject|2|||
105746125|NCT00786032|364725125|FG000|Overall Study|Death|4|||
105746126|NCT00786032|364725125|FG000|Overall Study|Withdrawal by Subject|14|||
105746127|NCT00786032|364725125|FG000|Overall Study|Did not complete in the timeframe|6|||
105746128|NCT02723604|364725126|FG000|Overall Study|ineligible|1|||
105746129|NCT02723604|364725126|FG000|Overall Study|never received treatment|1|||
105746130|NCT02457182|364725127|FG000|Overall Study|Lost to Follow-up|1|||
105746131|NCT02457182|364725128|FG001|Overall Study|Lost to Follow-up|0|||
105746132|NCT00311181|364725132|FG000|Overall Study|Final DFTs were not obtained|96|||
105746133|NCT02397694|364725133|FG000|Double-Blinded Phase|Adverse Event|1|||
105746134|NCT02397694|364725134|FG001|Double-Blinded Phase|Adverse Event|0|||
105746135|NCT02397694|364725133|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
105746136|NCT02397694|364725134|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
105746137|NCT02397694|364725133|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
105746138|NCT02397694|364725134|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
105746139|NCT02397694|364725133|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
105746140|NCT02397694|364725134|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
105746141|NCT02397694|364725133|FG000|Open Label Extension Phase|Protocol Violation|1|||
105746142|NCT02397694|364725134|FG001|Open Label Extension Phase|Protocol Violation|0|||
105746143|NCT02397694|364725133|FG000|Open Label Extension Phase|Withdrew Consent|3|||
105746144|NCT02397694|364725134|FG001|Open Label Extension Phase|Withdrew Consent|1|||
105746145|NCT02397694|364725133|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
105746146|NCT02397694|364725134|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
105746147|NCT03497429|364725136|FG000|Overall Study|Progressive disease|3|||
105746148|NCT03497429|364725137|FG001|Overall Study|Progressive disease|4|||
105746149|NCT03497429|364725136|FG000|Overall Study|Adverse Event|0|||
105746150|NCT03497429|364725137|FG001|Overall Study|Adverse Event|2|||
105746151|NCT03987919|364725138|FG000|Overall Study|Adverse Event|1|||
105746152|NCT03987919|364725139|FG001|Overall Study|Adverse Event|4|||
105746153|NCT03987919|364725140|FG002|Overall Study|Adverse Event|1|||
105746154|NCT03987919|364725141|FG003|Overall Study|Adverse Event|3|||
105746155|NCT03987919|364725138|FG000|Overall Study|Death|4|||
105746156|NCT03987919|364725139|FG001|Overall Study|Death|4|||
105746157|NCT03987919|364725140|FG002|Overall Study|Death|4|||
105746158|NCT03987919|364725141|FG003|Overall Study|Death|1|||
105746159|NCT03987919|364725138|FG000|Overall Study|Lost to Follow-up|5|||
105746160|NCT03987919|364725139|FG001|Overall Study|Lost to Follow-up|6|||
105746161|NCT03987919|364725140|FG002|Overall Study|Lost to Follow-up|8|||
105746162|NCT03987919|364725141|FG003|Overall Study|Lost to Follow-up|12|||
105746163|NCT03987919|364725138|FG000|Overall Study|Physician Decision|0|||
105746164|NCT03987919|364725139|FG001|Overall Study|Physician Decision|2|||
105483180|NCT02119676|363780890|FG002|Overall Study|Did not receive study med|4|||
105483181|NCT02119676|363780891|FG003|Overall Study|Did not receive study med|5|||
105746165|NCT03987919|364725140|FG002|Overall Study|Physician Decision|0|||
105746166|NCT03987919|364725141|FG003|Overall Study|Physician Decision|4|||
105746167|NCT03987919|364725138|FG000|Overall Study|Pregnancy|1|||
105746168|NCT03987919|364725139|FG001|Overall Study|Pregnancy|0|||
105746169|NCT03987919|364725140|FG002|Overall Study|Pregnancy|1|||
105746170|NCT03987919|364725141|FG003|Overall Study|Pregnancy|1|||
105746171|NCT03987919|364725138|FG000|Overall Study|Protocol Violation|0|||
105746172|NCT03987919|364725139|FG001|Overall Study|Protocol Violation|1|||
105746173|NCT03987919|364725140|FG002|Overall Study|Protocol Violation|0|||
105746174|NCT03987919|364725141|FG003|Overall Study|Protocol Violation|0|||
105746175|NCT03987919|364725138|FG000|Overall Study|Site terminated by Sponsor|0|||
105359589|NCT03410992|363322324|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105359590|NCT03410992|363322325|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105359591|NCT03410992|363322326|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105359592|NCT03410992|363322327|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105359593|NCT03410992|363322328|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105359594|NCT03410992|363322329|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105359595|NCT03410992|363322330|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105359596|NCT03410992|363322331|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105359597|NCT03410992|363322332|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105359598|NCT03410992|363322322|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
105359599|NCT03410992|363322323|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
105483182|NCT01514370|363780893|FG000|Overall Study|Protocol Violation|2|||
105483183|NCT01514370|363780894|FG001|Overall Study|Protocol Violation|3|||
105483184|NCT01514370|363780893|FG000|Overall Study|Lost to Follow-up|0|||
105483185|NCT01514370|363780894|FG001|Overall Study|Lost to Follow-up|2|||
105483186|NCT01514370|363780893|FG000|Overall Study|Withdrawal by Subject|2|||
105483187|NCT01514370|363780894|FG001|Overall Study|Withdrawal by Subject|1|||
105483188|NCT01514370|363780893|FG000|Overall Study|Adverse Event|1|||
105483189|NCT01514370|363780894|FG001|Overall Study|Adverse Event|3|||
105483190|NCT01514370|363780893|FG000|Overall Study|Other|6|||
105483191|NCT01514370|363780894|FG001|Overall Study|Other|7|||
105483192|NCT01089361|363780895|FG000|Overall Study|Death|1|||
105483193|NCT01089361|363780896|FG001|Overall Study|Death|0|||
105483194|NCT01551420|363780897|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
105483195|NCT01551420|363780898|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
105483196|NCT01551420|363780897|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
105483197|NCT01551420|363780898|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
105483198|NCT01551420|363780897|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
105483199|NCT01551420|363780898|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
105483200|NCT01551420|363780897|FG000|Screened for Part B Eligibility|Declined participation|8|||
105483201|NCT01551420|363780898|FG001|Screened for Part B Eligibility|Declined participation|1|||
105483202|NCT01551420|363780897|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
105483203|NCT01551420|363780898|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
105483204|NCT01551420|363780897|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
105483205|NCT01551420|363780898|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
105483206|NCT01551420|363780897|FG000|Home Use (Part B)|Withdrawal by staff|0|||
105483207|NCT01551420|363780898|FG001|Home Use (Part B)|Withdrawal by staff|1|||
105483208|NCT02520089|363780899|FG000|Overall Study|Lost to Follow-up|3|||
105746176|NCT03987919|364725139|FG001|Overall Study|Site terminated by Sponsor|0|||
105746177|NCT03987919|364725140|FG002|Overall Study|Site terminated by Sponsor|0|||
105746178|NCT03987919|364725141|FG003|Overall Study|Site terminated by Sponsor|1|||
105746179|NCT03987919|364725138|FG000|Overall Study|Withdrawal by Subject|7|||
105746180|NCT03987919|364725139|FG001|Overall Study|Withdrawal by Subject|7|||
105746181|NCT03987919|364725140|FG002|Overall Study|Withdrawal by Subject|8|||
105746182|NCT03987919|364725141|FG003|Overall Study|Withdrawal by Subject|4|||
105746183|NCT03987919|364725138|FG000|Overall Study|Other - as reported by the investigator|1|||
105746184|NCT03987919|364725139|FG001|Overall Study|Other - as reported by the investigator|3|||
105746185|NCT03987919|364725140|FG002|Overall Study|Other - as reported by the investigator|2|||
105746186|NCT03987919|364725141|FG003|Overall Study|Other - as reported by the investigator|0|||
105746187|NCT03725202|364725142|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
105746188|NCT03725202|364725143|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
105746189|NCT03725202|364725144|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
105746190|NCT03725202|364725145|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
105746191|NCT03725202|364725146|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
105746192|NCT03725202|364725147|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
105746193|NCT03725202|364725148|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
105359600|NCT03410992|363322324|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105359601|NCT03410992|363322325|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105483209|NCT02520089|363780900|FG001|Overall Study|Lost to Follow-up|4|||
105483210|NCT02216812|363780903|FG000|Overall Study|Lost to Follow-up|10|||
105483211|NCT02216812|363780904|FG001|Overall Study|Lost to Follow-up|5|||
105746194|NCT03725202|364725149|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
105746195|NCT03725202|364725142|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
105746196|NCT03725202|364725143|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
105746197|NCT03725202|364725144|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
105483212|NCT00129311|363780906|FG000|Overall Study|Withdrawal by Subject|12|||
105483213|NCT00129311|363780907|FG001|Overall Study|Withdrawal by Subject|19|||
105483214|NCT02232880|363780908|FG000|Overall Study|study stopped prior to randomization|1|||
105746198|NCT03725202|364725145|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
105746199|NCT03725202|364725146|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
105746200|NCT03725202|364725147|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
105746201|NCT03725202|364725148|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
105483215|NCT00686998|363780913|FG000|Overall Study|Adverse Event|3|||
105746202|NCT03725202|364725149|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
105746203|NCT03725202|364725142|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
105746204|NCT03725202|364725143|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
105746205|NCT03725202|364725144|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
105746206|NCT03725202|364725145|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
105746207|NCT03725202|364725146|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
105746208|NCT03725202|364725147|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
105746209|NCT03725202|364725148|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
105746210|NCT03725202|364725149|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
105746211|NCT03725202|364725142|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
105746212|NCT03725202|364725143|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
105746213|NCT03725202|364725144|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
105746214|NCT03725202|364725145|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
105746215|NCT03725202|364725146|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
105746216|NCT03725202|364725147|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
105746217|NCT03725202|364725148|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
105746218|NCT03725202|364725149|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
105746219|NCT03725202|364725142|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
105746220|NCT03725202|364725143|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
105746221|NCT03725202|364725144|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
105746222|NCT03725202|364725145|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
105746223|NCT03725202|364725146|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
105746224|NCT03725202|364725147|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
105746225|NCT03725202|364725148|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
105746226|NCT03725202|364725149|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
105746227|NCT03725202|364725142|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
105746228|NCT03725202|364725143|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
105746229|NCT03725202|364725144|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
105746230|NCT03725202|364725145|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
105746231|NCT03725202|364725146|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
105746232|NCT03725202|364725147|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
105746233|NCT03725202|364725148|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
105746234|NCT03725202|364725149|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
105746235|NCT03725202|364725142|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
105746236|NCT03725202|364725143|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
105746237|NCT03725202|364725144|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
105746238|NCT03725202|364725145|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
105746239|NCT03725202|364725146|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
105746240|NCT03725202|364725147|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
105746241|NCT03725202|364725148|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
105746242|NCT03725202|364725149|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
105746243|NCT03725202|364725142|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
105746244|NCT03725202|364725143|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
105746245|NCT03725202|364725144|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
105746246|NCT03725202|364725145|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
105746247|NCT03725202|364725146|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
105746248|NCT03725202|364725147|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
105746249|NCT03725202|364725148|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
105746250|NCT03725202|364725149|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
105746251|NCT03725202|364725142|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
105746252|NCT03725202|364725143|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
105746253|NCT03725202|364725144|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
105746254|NCT03725202|364725145|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
105746255|NCT03725202|364725146|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
105746256|NCT03725202|364725147|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
105746257|NCT03725202|364725148|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
105746258|NCT03725202|364725149|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
105746259|NCT03725202|364725142|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
105746260|NCT03725202|364725143|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
105746261|NCT03725202|364725144|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
105800947|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
105483216|NCT00686998|363780914|FG001|Overall Study|Adverse Event|2|||
105483217|NCT00686998|363780915|FG002|Overall Study|Adverse Event|1|||
105483218|NCT00686998|363780913|FG000|Overall Study|Withdrawal by Subject|2|||
105359602|NCT03410992|363322326|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105359603|NCT03410992|363322327|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105359604|NCT03410992|363322328|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105359605|NCT03410992|363322329|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105359606|NCT03410992|363322330|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105359607|NCT03410992|363322331|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105359608|NCT03410992|363322332|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105359609|NCT03410992|363322322|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
105359610|NCT03410992|363322323|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
105359611|NCT03410992|363322324|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105359612|NCT03410992|363322325|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105359613|NCT03410992|363322326|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105359614|NCT03410992|363322327|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105359615|NCT03410992|363322328|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105359616|NCT03410992|363322329|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105359617|NCT03410992|363322330|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105359618|NCT03410992|363322331|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105359619|NCT03410992|363322332|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105359620|NCT03410992|363322322|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
105359621|NCT03410992|363322323|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105359622|NCT03410992|363322324|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105359623|NCT03410992|363322325|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105746262|NCT03725202|364725145|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
105746263|NCT03725202|364725146|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
105746264|NCT03725202|364725147|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
105746265|NCT03725202|364725148|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
105746266|NCT03725202|364725149|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
105746267|NCT03725202|364725142|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
105746268|NCT03725202|364725143|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
105746269|NCT03725202|364725144|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
105746270|NCT03725202|364725145|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
105746271|NCT03725202|364725146|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
105746272|NCT03725202|364725147|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
105746273|NCT03725202|364725148|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
105746274|NCT03725202|364725149|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
105746275|NCT03725202|364725142|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
105746276|NCT03725202|364725143|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
105746277|NCT03725202|364725144|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
105746278|NCT03725202|364725145|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
105746279|NCT03725202|364725146|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
105746280|NCT03725202|364725147|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
105746281|NCT03725202|364725148|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
105746282|NCT03725202|364725149|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
105746283|NCT01328249|364725150|FG000|Overall Study|Adverse Event|3|||
105746284|NCT01328249|364725151|FG001|Overall Study|Adverse Event|0|||
105746285|NCT01328249|364725150|FG000|Overall Study|Disease progression|1|||
105746286|NCT01328249|364725151|FG001|Overall Study|Disease progression|0|||
105746287|NCT01328249|364725150|FG000|Overall Study|Withdrawal by Subject|1|||
105746288|NCT01328249|364725151|FG001|Overall Study|Withdrawal by Subject|1|||
105746289|NCT01328249|364725150|FG000|Overall Study|Moved before end of treatment visit|1|||
105746290|NCT01328249|364725151|FG001|Overall Study|Moved before end of treatment visit|0|||
105746291|NCT01328249|364725150|FG000|Overall Study|Subject choice|1|||
105746292|NCT01328249|364725151|FG001|Overall Study|Subject choice|1|||
105746293|NCT01328249|364725150|FG000|Overall Study|Protocol Violation|0|||
105746294|NCT01328249|364725151|FG001|Overall Study|Protocol Violation|1|||
105746295|NCT01215734|364725152|FG000|Overall Study|Death|0|||
105746296|NCT01215734|364725153|FG001|Overall Study|Death|1|||
105746297|NCT02330549|364725158|FG000|Overall Study|Adverse Event|1|||
105746298|NCT02330549|364725159|FG001|Overall Study|Adverse Event|0|||
105746299|NCT02330549|364725158|FG000|Overall Study|Subject withdrew consent|2|||
105746300|NCT02330549|364725159|FG001|Overall Study|Subject withdrew consent|1|||
105359624|NCT03410992|363322326|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105359625|NCT03410992|363322327|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105359626|NCT03410992|363322328|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105359627|NCT03410992|363322329|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105746301|NCT02330549|364725158|FG000|Overall Study|Failure to meet randomization criteria|1|||
105746302|NCT02330549|364725159|FG001|Overall Study|Failure to meet randomization criteria|0|||
105746303|NCT00495495|364725163|FG000|Overall Study|Protocol Violation|99|||
105746304|NCT00745368|364725164|FG000|Overall Study|Unable to provide sample|3|||
105746305|NCT02163993|364725168|FG000|Treatment Period|Adverse Event|0|||
105746306|NCT02163993|364725169|FG001|Treatment Period|Adverse Event|1|||
105746307|NCT02163993|364725170|FG002|Treatment Period|Adverse Event|0|||
105746308|NCT02163993|364725171|FG003|Treatment Period|Adverse Event|0|||
105746309|NCT02163993|364725172|FG004|Treatment Period|Adverse Event|1|||
105746310|NCT02163993|364725168|FG000|Treatment Period|Lost to Follow-up|2|||
105746311|NCT02163993|364725169|FG001|Treatment Period|Lost to Follow-up|3|||
105746312|NCT02163993|364725170|FG002|Treatment Period|Lost to Follow-up|1|||
105746313|NCT02163993|364725171|FG003|Treatment Period|Lost to Follow-up|3|||
105746314|NCT02163993|364725172|FG004|Treatment Period|Lost to Follow-up|1|||
105746315|NCT02163993|364725168|FG000|Treatment Period|Physician Decision|1|||
105746316|NCT02163993|364725169|FG001|Treatment Period|Physician Decision|0|||
105746317|NCT02163993|364725170|FG002|Treatment Period|Physician Decision|0|||
105746318|NCT02163993|364725171|FG003|Treatment Period|Physician Decision|0|||
105746319|NCT02163993|364725172|FG004|Treatment Period|Physician Decision|0|||
105746320|NCT02163993|364725168|FG000|Treatment Period|Protocol Violation|2|||
105746321|NCT02163993|364725169|FG001|Treatment Period|Protocol Violation|1|||
105746322|NCT02163993|364725170|FG002|Treatment Period|Protocol Violation|0|||
105746323|NCT02163993|364725171|FG003|Treatment Period|Protocol Violation|1|||
105746324|NCT02163993|364725172|FG004|Treatment Period|Protocol Violation|2|||
105746325|NCT02163993|364725168|FG000|Treatment Period|Withdrawal by Subject|6|||
105746326|NCT02163993|364725169|FG001|Treatment Period|Withdrawal by Subject|4|||
105746327|NCT02163993|364725170|FG002|Treatment Period|Withdrawal by Subject|1|||
105746328|NCT02163993|364725171|FG003|Treatment Period|Withdrawal by Subject|4|||
105746329|NCT02163993|364725172|FG004|Treatment Period|Withdrawal by Subject|1|||
105746330|NCT02163993|364725168|FG000|Treatment Period|Not treated|1|||
105746331|NCT02163993|364725169|FG001|Treatment Period|Not treated|0|||
105746332|NCT02163993|364725170|FG002|Treatment Period|Not treated|0|||
105746333|NCT02163993|364725171|FG003|Treatment Period|Not treated|1|||
105746334|NCT02163993|364725172|FG004|Treatment Period|Not treated|2|||
105746335|NCT02163993|364725168|FG000|Post-treatment Period|Adverse Event|0|||
105746336|NCT02163993|364725169|FG001|Post-treatment Period|Adverse Event|0|||
105746337|NCT02163993|364725170|FG002|Post-treatment Period|Adverse Event|1|||
105359628|NCT03410992|363322330|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105746338|NCT02163993|364725171|FG003|Post-treatment Period|Adverse Event|0|||
105746339|NCT02163993|364725172|FG004|Post-treatment Period|Adverse Event|0|||
105746340|NCT02163993|364725168|FG000|Post-treatment Period|Lost to Follow-up|2|||
105746341|NCT02163993|364725169|FG001|Post-treatment Period|Lost to Follow-up|2|||
105746342|NCT02163993|364725170|FG002|Post-treatment Period|Lost to Follow-up|3|||
105746343|NCT02163993|364725171|FG003|Post-treatment Period|Lost to Follow-up|1|||
105746344|NCT02163993|364725172|FG004|Post-treatment Period|Lost to Follow-up|0|||
105746345|NCT02163993|364725168|FG000|Post-treatment Period|Protocol Violation|0|||
105746346|NCT02163993|364725169|FG001|Post-treatment Period|Protocol Violation|0|||
105746347|NCT02163993|364725170|FG002|Post-treatment Period|Protocol Violation|0|||
105746348|NCT02163993|364725171|FG003|Post-treatment Period|Protocol Violation|0|||
105746349|NCT02163993|364725172|FG004|Post-treatment Period|Protocol Violation|1|||
105746350|NCT02163993|364725168|FG000|Post-treatment Period|Withdrawal by Subject|2|||
105746351|NCT02163993|364725169|FG001|Post-treatment Period|Withdrawal by Subject|4|||
105746352|NCT02163993|364725170|FG002|Post-treatment Period|Withdrawal by Subject|0|||
105746353|NCT02163993|364725171|FG003|Post-treatment Period|Withdrawal by Subject|1|||
105746354|NCT02163993|364725172|FG004|Post-treatment Period|Withdrawal by Subject|2|||
105746355|NCT00853489|364725173|FG000|Overall Study|Lost to Follow-up|5|||
105746356|NCT00853489|364725174|FG001|Overall Study|Lost to Follow-up|2|||
105746357|NCT00434512|364725175|FG000|Overall Study|Migrated/moved from study area|0|||
105746358|NCT00434512|364725176|FG001|Overall Study|Migrated/moved from study area|0|||
105746359|NCT00434512|364725177|FG002|Overall Study|Migrated/moved from study area|0|||
105746360|NCT00434512|364725178|FG003|Overall Study|Migrated/moved from study area|1|||
105746361|NCT00434512|364725179|FG004|Overall Study|Migrated/moved from study area|1|||
105746362|NCT00434512|364725180|FG005|Overall Study|Migrated/moved from study area|1|||
105746363|NCT00434512|364725175|FG000|Overall Study|Other|0|||
105746364|NCT00434512|364725176|FG001|Overall Study|Other|1|||
105746365|NCT00434512|364725177|FG002|Overall Study|Other|0|||
105746366|NCT00434512|364725178|FG003|Overall Study|Other|0|||
105746367|NCT00434512|364725179|FG004|Overall Study|Other|0|||
105746368|NCT00434512|364725180|FG005|Overall Study|Other|0|||
105746369|NCT02006667|364725181|FG000|Overall Study|Adverse Event|3|||
105746370|NCT02006667|364725181|FG000|Overall Study|Death|2|||
105746371|NCT02006667|364725181|FG000|Overall Study|Withdrawal by Subject|1|||
105746372|NCT00782418|364725184|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
105746373|NCT00782418|364725185|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
105746374|NCT00782418|364725186|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
105746375|NCT00782418|364725187|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
105746376|NCT00782418|364725188|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
105746377|NCT00782418|364725189|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
105746378|NCT00782418|364725190|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
105746379|NCT00782418|364725184|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
105746380|NCT00782418|364725185|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
105746381|NCT00782418|364725186|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
105746382|NCT00782418|364725187|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
105746383|NCT00782418|364725188|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
105483219|NCT00686998|363780914|FG001|Overall Study|Withdrawal by Subject|1|||
105483220|NCT00686998|363780915|FG002|Overall Study|Withdrawal by Subject|2|||
105483221|NCT00686998|363780913|FG000|Overall Study|Lack of Efficacy|7|||
105483222|NCT00686998|363780914|FG001|Overall Study|Lack of Efficacy|5|||
105746384|NCT00782418|364725189|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
105483223|NCT00686998|363780915|FG002|Overall Study|Lack of Efficacy|0|||
105483224|NCT00686998|363780913|FG000|Overall Study|Other|0|||
105359629|NCT03410992|363322331|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105359630|NCT03410992|363322332|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105359631|NCT03410992|363322322|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
105359632|NCT03410992|363322323|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
105359633|NCT03410992|363322324|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105359634|NCT03410992|363322325|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105359635|NCT03410992|363322326|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105359636|NCT03410992|363322327|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105359637|NCT03410992|363322328|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105359638|NCT03410992|363322329|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105359639|NCT03410992|363322330|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105359640|NCT03410992|363322331|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105359641|NCT03410992|363322332|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105359642|NCT03410992|363322322|FG000|Week 16 Assessment|Incorrect escapers|0|||
105359643|NCT03410992|363322323|FG001|Week 16 Assessment|Incorrect escapers|6|||
105359644|NCT03410992|363322324|FG002|Week 16 Assessment|Incorrect escapers|0|||
105359645|NCT03410992|363322325|FG003|Week 16 Assessment|Incorrect escapers|0|||
105359646|NCT03410992|363322326|FG004|Week 16 Assessment|Incorrect escapers|0|||
105359647|NCT03410992|363322327|FG005|Week 16 Assessment|Incorrect escapers|0|||
105359648|NCT03410992|363322328|FG006|Week 16 Assessment|Incorrect escapers|0|||
105359649|NCT03410992|363322329|FG007|Week 16 Assessment|Incorrect escapers|0|||
105359650|NCT03410992|363322330|FG008|Week 16 Assessment|Incorrect escapers|0|||
105359651|NCT03410992|363322331|FG009|Week 16 Assessment|Incorrect escapers|0|||
105359652|NCT03410992|363322332|FG010|Week 16 Assessment|Incorrect escapers|0|||
105359653|NCT03410992|363322322|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105359654|NCT03410992|363322323|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105359655|NCT03410992|363322324|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105359656|NCT03410992|363322325|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
105359657|NCT03410992|363322326|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
105359658|NCT03410992|363322327|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105359659|NCT03410992|363322328|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105746385|NCT00782418|364725190|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
105746386|NCT03298412|364725191|FG000|Run-in Period|Other, Not Specified|1|||
105746387|NCT03298412|364725191|FG000|Run-in Period|Disease Progression|1|||
105746388|NCT03298412|364725191|FG000|Run-in Period|Ineligibility Determined|1|||
105746389|NCT03298412|364725191|FG000|Run-in Period|Decision by Sponsor|6|||
105746390|NCT01104584|364725194|FG000|Overall Study|Study drug never administered|21|||
105746391|NCT01104584|364725194|FG000|Overall Study|Study prematurely discontinued|2|||
105746392|NCT02345252|364725207|FG000|Double-Blind Phase|Adverse Event|2|||
105746393|NCT02345252|364725208|FG001|Double-Blind Phase|Adverse Event|3|||
105746394|NCT02345252|364725207|FG000|Double-Blind Phase|Death|1|||
105746395|NCT02345252|364725208|FG001|Double-Blind Phase|Death|2|||
105746396|NCT02345252|364725207|FG000|Double-Blind Phase|Lack of Efficacy|1|||
105746397|NCT02345252|364725208|FG001|Double-Blind Phase|Lack of Efficacy|0|||
105746398|NCT02345252|364725207|FG000|Double-Blind Phase|Investigator's Discretion|4|||
105746399|NCT02345252|364725208|FG001|Double-Blind Phase|Investigator's Discretion|6|||
105746400|NCT02345252|364725207|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
105746401|NCT02345252|364725208|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
105746402|NCT02345252|364725207|FG000|Double-Blind Phase|Protocol Violation|2|||
105746403|NCT02345252|364725208|FG001|Double-Blind Phase|Protocol Violation|1|||
105746404|NCT02345252|364725207|FG000|Double-Blind Phase|Withdrew Consent|21|||
105746405|NCT02345252|364725208|FG001|Double-Blind Phase|Withdrew Consent|23|||
105746406|NCT02345252|364725207|FG000|Double-Blind Phase|Lost to Follow-up|8|||
105746407|NCT02345252|364725208|FG001|Double-Blind Phase|Lost to Follow-up|10|||
105746408|NCT02345252|364725207|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
105746409|NCT02345252|364725208|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
105746410|NCT00436566|364725209|FG000|Overall Study|Withdrawal by Subject|2|||
105746411|NCT00436566|364725209|FG000|Overall Study|Protocol Violation|1|||
105746412|NCT01934894|364725210|FG000|Overall Study|Adverse Event|1|||
105746413|NCT01934894|364725211|FG001|Overall Study|Adverse Event|2|||
105746414|NCT01934894|364725210|FG000|Overall Study|Death|2|||
105746415|NCT01934894|364725211|FG001|Overall Study|Death|0|||
105746416|NCT01934894|364725210|FG000|Overall Study|Withdrawal by Subject|0|||
105746417|NCT01934894|364725211|FG001|Overall Study|Withdrawal by Subject|1|||
105746418|NCT01934894|364725210|FG000|Overall Study|Progressive Disease|3|||
105746419|NCT01934894|364725211|FG001|Overall Study|Progressive Disease|2|||
105746420|NCT01689207|364725212|FG000|Overall Study|Adverse Event|0|||
105746421|NCT01689207|364725213|FG001|Overall Study|Adverse Event|1|||
105746422|NCT01689207|364725214|FG002|Overall Study|Adverse Event|0|||
105746423|NCT01689207|364725215|FG003|Overall Study|Adverse Event|0|||
105746424|NCT01689207|364725216|FG004|Overall Study|Adverse Event|2|||
105746425|NCT01689207|364725217|FG005|Overall Study|Adverse Event|1|||
105746426|NCT01689207|364725218|FG006|Overall Study|Adverse Event|0|||
105746427|NCT01689207|364725219|FG007|Overall Study|Adverse Event|0|||
105359660|NCT03410992|363322329|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105359661|NCT03410992|363322330|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105359662|NCT03410992|363322331|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105359663|NCT03410992|363322332|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105359664|NCT03410992|363322322|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
105359665|NCT03410992|363322323|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
105359666|NCT03410992|363322324|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
105359667|NCT03410992|363322325|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
105359668|NCT03410992|363322326|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
105359669|NCT03410992|363322327|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
105359670|NCT03410992|363322328|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
105359671|NCT03410992|363322329|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
105359672|NCT03410992|363322330|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
105359673|NCT03410992|363322331|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
105483225|NCT00686998|363780914|FG001|Overall Study|Other|0|||
105483226|NCT00686998|363780915|FG002|Overall Study|Other|1|||
105483227|NCT00686998|363780913|FG000|Overall Study|Safety Reasons|1|||
105483228|NCT00686998|363780914|FG001|Overall Study|Safety Reasons|0|||
105483229|NCT00686998|363780915|FG002|Overall Study|Safety Reasons|0|||
105483230|NCT02829944|363780916|FG000|Overall Study|Physician Decision|0|||
105483231|NCT02829944|363780917|FG001|Overall Study|Physician Decision|1|||
105483232|NCT02829944|363780916|FG000|Overall Study|Screen Failure|2|||
105483233|NCT02829944|363780917|FG001|Overall Study|Screen Failure|2|||
105483234|NCT02829944|363780916|FG000|Overall Study|Inadequate Neuraxial Block|1|||
105800948|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
105800949|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
105800950|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
105800951|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
105800952|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
105800953|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
105483235|NCT02829944|363780917|FG001|Overall Study|Inadequate Neuraxial Block|1|||
105800954|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
105800955|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
105800956|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
105800957|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
105800958|NCT04130919|364928587|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
105800959|NCT04130919|364928588|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
105800960|NCT04130919|364928589|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
105800961|NCT04130919|364928590|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
105800962|NCT04130919|364928591|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
105800963|NCT04130919|364928592|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
105800964|NCT04130919|364928587|FG000|Blinded Treatment Phase|Adverse Event|0|||
105800965|NCT04130919|364928588|FG001|Blinded Treatment Phase|Adverse Event|0|||
105800966|NCT04130919|364928589|FG002|Blinded Treatment Phase|Adverse Event|1|||
105800967|NCT04130919|364928590|FG003|Blinded Treatment Phase|Adverse Event|0|||
105800968|NCT04130919|364928591|FG004|Blinded Treatment Phase|Adverse Event|0|||
105800969|NCT04130919|364928592|FG005|Blinded Treatment Phase|Adverse Event|0|||
105800970|NCT04130919|364928587|FG000|Blinded Treatment Phase|Disease worsening|0|||
105483236|NCT02829944|363780916|FG000|Overall Study|Withdrawal by Subject|2|||
105483237|NCT02829944|363780917|FG001|Overall Study|Withdrawal by Subject|1|||
105483238|NCT02829944|363780916|FG000|Overall Study|Catheter Displacement|1|||
105483239|NCT02829944|363780917|FG001|Overall Study|Catheter Displacement|0|||
105800971|NCT04130919|364928588|FG001|Blinded Treatment Phase|Disease worsening|0|||
105800972|NCT04130919|364928589|FG002|Blinded Treatment Phase|Disease worsening|1|||
105359674|NCT03410992|363322332|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
105483240|NCT02829944|363780916|FG000|Overall Study|Catheter broke|0|||
105483241|NCT02829944|363780917|FG001|Overall Study|Catheter broke|1|||
105483242|NCT02829944|363780916|FG000|Overall Study|Staff unavailable|0|||
105483243|NCT02829944|363780917|FG001|Overall Study|Staff unavailable|1|||
105483244|NCT00853970|363780919|FG000|Overall Study|Withdrawal by Subject|2|||
105800973|NCT04130919|364928590|FG003|Blinded Treatment Phase|Disease worsening|0|||
105800974|NCT04130919|364928591|FG004|Blinded Treatment Phase|Disease worsening|0|||
105800975|NCT04130919|364928592|FG005|Blinded Treatment Phase|Disease worsening|0|||
105483245|NCT00853970|363780920|FG001|Overall Study|Withdrawal by Subject|1|||
105483246|NCT00853970|363780919|FG000|Overall Study|Cancelled surgery|4|||
105483247|NCT00853970|363780920|FG001|Overall Study|Cancelled surgery|2|||
105800976|NCT04130919|364928587|FG000|Blinded Treatment Phase|Investigator's decision|0|||
105800977|NCT04130919|364928588|FG001|Blinded Treatment Phase|Investigator's decision|1|||
105483248|NCT00002931|363782642|FG000|Overall Study|rapidly progressing disease during|2|||
105483249|NCT02907892|363782648|FG000|Overall Study|Lost to Follow-up|27|||
105483250|NCT02907892|363782649|FG001|Overall Study|Lost to Follow-up|40|||
105359675|NCT03410992|363322322|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105359676|NCT03410992|363322323|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105359677|NCT03410992|363322324|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105359678|NCT03410992|363322325|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105359679|NCT03410992|363322326|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105359680|NCT03410992|363322327|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
105359681|NCT03410992|363322328|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105359682|NCT03410992|363322329|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105359683|NCT03410992|363322330|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105746428|NCT01689207|364725220|FG008|Overall Study|Adverse Event|1|||
105746429|NCT01689207|364725221|FG009|Overall Study|Adverse Event|0|||
105746430|NCT01689207|364725222|FG010|Overall Study|Adverse Event|0|||
105746431|NCT00303108|364725225|FG000|Overall Study|Adverse Event|5|||
105746432|NCT00303108|364725226|FG001|Overall Study|Adverse Event|6|||
105746433|NCT00303108|364725227|FG002|Overall Study|Adverse Event|7|||
105746434|NCT00303108|364725225|FG000|Overall Study|Patient Request|4|||
105746435|NCT00303108|364725226|FG001|Overall Study|Patient Request|2|||
105746436|NCT00303108|364725227|FG002|Overall Study|Patient Request|8|||
105746437|NCT00303108|364725225|FG000|Overall Study|Failed Entry|1|||
105746438|NCT00303108|364725226|FG001|Overall Study|Failed Entry|0|||
105746439|NCT00303108|364725227|FG002|Overall Study|Failed Entry|1|||
105746440|NCT00303108|364725225|FG000|Overall Study|ineligible|2|||
105746441|NCT00303108|364725226|FG001|Overall Study|ineligible|1|||
105746442|NCT00303108|364725227|FG002|Overall Study|ineligible|0|||
105746443|NCT01655823|364725230|FG000|Overall Study|Lost to Follow-up|0|||
105746444|NCT01655823|364725231|FG001|Overall Study|Lost to Follow-up|1|||
105746445|NCT01655823|364725232|FG002|Overall Study|Lost to Follow-up|0|||
105746446|NCT01655823|364725233|FG003|Overall Study|Lost to Follow-up|0|||
105746447|NCT01655823|364725234|FG004|Overall Study|Lost to Follow-up|1|||
105746448|NCT01655823|364725230|FG000|Overall Study|Withdrawal by Subject|0|||
105746449|NCT01655823|364725231|FG001|Overall Study|Withdrawal by Subject|1|||
105746450|NCT01655823|364725232|FG002|Overall Study|Withdrawal by Subject|0|||
105746451|NCT01655823|364725233|FG003|Overall Study|Withdrawal by Subject|1|||
105746452|NCT01655823|364725234|FG004|Overall Study|Withdrawal by Subject|0|||
105746453|NCT00894413|364725235|FG000|Overall Study|Physician Decision|0|||
105746454|NCT00894413|364725236|FG001|Overall Study|Physician Decision|2|||
105746455|NCT00894413|364725235|FG000|Overall Study|Adverse Event|0|||
105746456|NCT00894413|364725236|FG001|Overall Study|Adverse Event|2|||
105746457|NCT00894413|364725235|FG000|Overall Study|Withdrawal by Subject|0|||
105746458|NCT00894413|364725236|FG001|Overall Study|Withdrawal by Subject|4|||
105746459|NCT03126539|364725244|FG000|Overall Study|Lost to Follow-up|1|||
105746460|NCT03126539|364725245|FG001|Overall Study|Lost to Follow-up|1|||
105746461|NCT03126539|364725246|FG002|Overall Study|Lost to Follow-up|1|||
105746462|NCT03126539|364725247|FG003|Overall Study|Lost to Follow-up|0|||
105746463|NCT03126539|364725248|FG004|Overall Study|Lost to Follow-up|0|||
105746464|NCT02632110|364725249|FG000|Overall Study|Withdrawal by Subject|1|||
105746465|NCT02632110|364725250|FG001|Overall Study|Withdrawal by Subject|1|||
105746466|NCT02632110|364725251|FG002|Overall Study|Withdrawal by Subject|0|||
105746467|NCT02632110|364725252|FG003|Overall Study|Withdrawal by Subject|0|||
105746468|NCT02632110|364725253|FG004|Overall Study|Withdrawal by Subject|1|||
105746469|NCT02632110|364725254|FG005|Overall Study|Withdrawal by Subject|1|||
105746470|NCT02632110|364725255|FG006|Overall Study|Withdrawal by Subject|3|||
105746471|NCT02632110|364725256|FG007|Overall Study|Withdrawal by Subject|3|||
105746472|NCT02632110|364725257|FG008|Overall Study|Withdrawal by Subject|1|||
105746473|NCT02632110|364725258|FG009|Overall Study|Withdrawal by Subject|1|||
105746474|NCT00008138|364725259|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
105746475|NCT00008138|364725259|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
105746476|NCT00008138|364725259|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
105746477|NCT00008138|364725259|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
105746478|NCT00008138|364725259|FG000|Interval Debulking|Withdrawal by Subject|2|||
105746479|NCT00008138|364725259|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
105746480|NCT00008138|364725259|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
105746481|NCT00008138|364725259|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
105746482|NCT00516269|364725260|FG000|Overall Study|Adverse Event|2|||
105746483|NCT00516269|364725261|FG001|Overall Study|Adverse Event|1|||
105746484|NCT00516269|364725260|FG000|Overall Study|Lost to Follow-up|0|||
105746485|NCT00516269|364725261|FG001|Overall Study|Lost to Follow-up|1|||
105746486|NCT00516269|364725260|FG000|Overall Study|Protocol Violation|0|||
105746487|NCT00516269|364725261|FG001|Overall Study|Protocol Violation|1|||
105746488|NCT03213626|364725262|FG000|Overall Study|Adverse Event|1|||
105746489|NCT03213626|364725262|FG000|Overall Study|Progressive Disease|6|||
105746490|NCT00905021|364725263|FG000|Overall Study|Adverse Event|2|||
105746491|NCT02635737|364725264|FG000|Overall Study|Protocol Violation|1|||
105800978|NCT04130919|364928589|FG002|Blinded Treatment Phase|Investigator's decision|0|||
105800979|NCT04130919|364928590|FG003|Blinded Treatment Phase|Investigator's decision|0|||
105800980|NCT04130919|364928591|FG004|Blinded Treatment Phase|Investigator's decision|0|||
105800981|NCT04130919|364928592|FG005|Blinded Treatment Phase|Investigator's decision|0|||
105800982|NCT04130919|364928587|FG000|Blinded Treatment Phase|Withdrew consent|1|||
105800983|NCT04130919|364928588|FG001|Blinded Treatment Phase|Withdrew consent|0|||
105800984|NCT04130919|364928589|FG002|Blinded Treatment Phase|Withdrew consent|0|||
105800985|NCT04130919|364928590|FG003|Blinded Treatment Phase|Withdrew consent|0|||
105800986|NCT04130919|364928591|FG004|Blinded Treatment Phase|Withdrew consent|0|||
105800987|NCT04130919|364928592|FG005|Blinded Treatment Phase|Withdrew consent|0|||
105800988|NCT04130919|364928587|FG000|Open-label Treatment Phase|Withdrew consent|0|||
105800989|NCT04130919|364928588|FG001|Open-label Treatment Phase|Withdrew consent|0|||
105800990|NCT04130919|364928589|FG002|Open-label Treatment Phase|Withdrew consent|0|||
105800991|NCT04130919|364928590|FG003|Open-label Treatment Phase|Withdrew consent|1|||
105800992|NCT04130919|364928591|FG004|Open-label Treatment Phase|Withdrew consent|1|||
105800993|NCT04130919|364928592|FG005|Open-label Treatment Phase|Withdrew consent|1|||
105800994|NCT04130919|364928587|FG000|Open-label Treatment Phase|Disease worsening|0|||
105800995|NCT04130919|364928588|FG001|Open-label Treatment Phase|Disease worsening|0|||
105800996|NCT04130919|364928589|FG002|Open-label Treatment Phase|Disease worsening|0|||
105800997|NCT04130919|364928590|FG003|Open-label Treatment Phase|Disease worsening|1|||
105800998|NCT04130919|364928591|FG004|Open-label Treatment Phase|Disease worsening|0|||
105800999|NCT04130919|364928592|FG005|Open-label Treatment Phase|Disease worsening|1|||
105801000|NCT04130919|364928587|FG000|Open-label Treatment Phase|Investigator's decision|0|||
105801001|NCT04130919|364928588|FG001|Open-label Treatment Phase|Investigator's decision|0|||
105801002|NCT04130919|364928589|FG002|Open-label Treatment Phase|Investigator's decision|0|||
105801003|NCT04130919|364928590|FG003|Open-label Treatment Phase|Investigator's decision|1|||
105801004|NCT04130919|364928591|FG004|Open-label Treatment Phase|Investigator's decision|0|||
105801005|NCT04130919|364928592|FG005|Open-label Treatment Phase|Investigator's decision|0|||
105801006|NCT04130919|364928587|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
105801007|NCT04130919|364928588|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
105801008|NCT04130919|364928589|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
105801009|NCT04130919|364928590|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
105801010|NCT04130919|364928591|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
105801011|NCT04130919|364928592|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
105801012|NCT04130919|364928587|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
105801013|NCT04130919|364928588|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
105801014|NCT04130919|364928589|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
105801015|NCT04130919|364928590|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
105801016|NCT04130919|364928591|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
105801017|NCT04130919|364928592|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
105746492|NCT01511419|364725265|FG000|Dose 2|Physician Decision|1|||
105746493|NCT01511419|364725266|FG001|Dose 2|Physician Decision|0|||
105746494|NCT04570657|364725267|FG000|Overall Study|Adverse Event|0|||
105746495|NCT04570657|364725268|FG001|Overall Study|Adverse Event|0|||
105746496|NCT04570657|364725269|FG002|Overall Study|Adverse Event|1|||
105746497|NCT04570657|364725267|FG000|Overall Study|Lost to Follow-up|0|||
105746498|NCT04570657|364725268|FG001|Overall Study|Lost to Follow-up|0|||
105746499|NCT04570657|364725269|FG002|Overall Study|Lost to Follow-up|1|||
105746500|NCT04570657|364725267|FG000|Overall Study|Physician Decision|0|||
105746501|NCT04570657|364725268|FG001|Overall Study|Physician Decision|1|||
105746502|NCT04570657|364725269|FG002|Overall Study|Physician Decision|0|||
105746503|NCT04570657|364725267|FG000|Overall Study|Withdrawal by Subject|1|||
105746504|NCT04570657|364725268|FG001|Overall Study|Withdrawal by Subject|2|||
105746505|NCT04570657|364725269|FG002|Overall Study|Withdrawal by Subject|2|||
105746506|NCT01752842|364725276|FG000|Overall Study|Adverse Event|3|||
105746507|NCT01752842|364725277|FG001|Overall Study|Adverse Event|0|||
105746508|NCT01752842|364725276|FG000|Overall Study|Withdrawal by Subject|0|||
105746509|NCT01752842|364725277|FG001|Overall Study|Withdrawal by Subject|2|||
105746510|NCT00488618|364725278|FG000|Overall Study|Adverse Event|13|||
105746511|NCT00488618|364725279|FG001|Overall Study|Adverse Event|17|||
105746512|NCT00488618|364725278|FG000|Overall Study|Insufficient Therapeutic Response|18|||
105746513|NCT00488618|364725279|FG001|Overall Study|Insufficient Therapeutic Response|11|||
105746514|NCT00488618|364725278|FG000|Overall Study|Protocol Violation|0|||
105746515|NCT00488618|364725279|FG001|Overall Study|Protocol Violation|2|||
105746516|NCT00488618|364725278|FG000|Overall Study|Withdrawal of Consent|15|||
105746517|NCT00488618|364725279|FG001|Overall Study|Withdrawal of Consent|13|||
105746518|NCT00488618|364725278|FG000|Overall Study|Lost to Follow-up|1|||
105746519|NCT00488618|364725279|FG001|Overall Study|Lost to Follow-up|0|||
105746520|NCT00506948|364726867|FG000|Overall Study|Death|4|||
105746521|NCT00506948|364726867|FG000|Overall Study|Adverse Event|5|||
105746522|NCT00506948|364726867|FG000|Overall Study|Physician Decision|1|||
105746523|NCT03364335|364726868|FG000|Overall Study|Adverse Event|3|||
105746524|NCT03364335|364726869|FG001|Overall Study|Adverse Event|4|||
105746525|NCT03364335|364726870|FG002|Overall Study|Adverse Event|1|||
105746526|NCT03364335|364726871|FG003|Overall Study|Adverse Event|2|||
105746527|NCT03364335|364726872|FG004|Overall Study|Adverse Event|0|||
105746528|NCT03364335|364726868|FG000|Overall Study|Lost to Follow-up|7|||
105746529|NCT03364335|364726869|FG001|Overall Study|Lost to Follow-up|7|||
105746530|NCT03364335|364726870|FG002|Overall Study|Lost to Follow-up|10|||
105746531|NCT03364335|364726871|FG003|Overall Study|Lost to Follow-up|11|||
105746532|NCT03364335|364726872|FG004|Overall Study|Lost to Follow-up|11|||
105746533|NCT01194804|364726873|FG000|Overall Study|Withdrawal by Subject|1|||
105746534|NCT01303380|364726874|FG000|Overall Study|Lack of compliance to study procedures|1|||
105746535|NCT02326467|364726877|FG000|Overall Study|Withdrawal by Subject|1|||
105746536|NCT02709083|364726886|FG000|Overall Study|Original PI left institution|7|||
105746537|NCT00111475|364726887|FG000|Overall Study|Lost to Follow-up|0|||
105746538|NCT00111475|364726888|FG001|Overall Study|Lost to Follow-up|0|||
105746539|NCT00111475|364726889|FG002|Overall Study|Lost to Follow-up|0|||
105746540|NCT00111475|364726890|FG003|Overall Study|Lost to Follow-up|0|||
105746541|NCT00111475|364726891|FG004|Overall Study|Lost to Follow-up|0|||
105746542|NCT00111475|364726892|FG005|Overall Study|Lost to Follow-up|1|||
105746543|NCT00111475|364726893|FG006|Overall Study|Lost to Follow-up|0|||
105746544|NCT00111475|364726894|FG007|Overall Study|Lost to Follow-up|0|||
105746545|NCT00111475|364726895|FG008|Overall Study|Lost to Follow-up|0|||
105746546|NCT00111475|364726896|FG009|Overall Study|Lost to Follow-up|0|||
105746547|NCT01026389|364726897|FG000|Overall Study|Withdrawal by Subject|1|||
105746548|NCT01026389|364726898|FG001|Overall Study|Withdrawal by Subject|3|||
105746549|NCT01026389|364726897|FG000|Overall Study|change of treatment, patient moved|4|||
105746550|NCT01026389|364726898|FG001|Overall Study|change of treatment, patient moved|2|||
105746551|NCT00836277|364726899|FG000|Overall Study|Not evaluable for response|6|||
105746552|NCT01457118|364726912|FG000|Overall Study|Adverse Event|1|||
105746553|NCT01457118|364726913|FG001|Overall Study|Adverse Event|0|||
105746554|NCT01457118|364726914|FG002|Overall Study|Adverse Event|0|||
105746555|NCT01457118|364726915|FG003|Overall Study|Adverse Event|1|||
105746556|NCT01457118|364726912|FG000|Overall Study|Clinical Progression|0|||
105746557|NCT01457118|364726913|FG001|Overall Study|Clinical Progression|1|||
105746558|NCT01457118|364726914|FG002|Overall Study|Clinical Progression|0|||
105746559|NCT01457118|364726915|FG003|Overall Study|Clinical Progression|1|||
105746560|NCT01457118|364726912|FG000|Overall Study|Physician Decision|2|||
105746561|NCT01457118|364726913|FG001|Overall Study|Physician Decision|0|||
105746562|NCT01457118|364726914|FG002|Overall Study|Physician Decision|0|||
105746563|NCT01457118|364726915|FG003|Overall Study|Physician Decision|0|||
105746564|NCT01457118|364726912|FG000|Overall Study|Progressive Disease by RECIST|12|||
105746565|NCT01457118|364726913|FG001|Overall Study|Progressive Disease by RECIST|3|||
105746566|NCT01457118|364726914|FG002|Overall Study|Progressive Disease by RECIST|1|||
105746567|NCT01457118|364726915|FG003|Overall Study|Progressive Disease by RECIST|0|||
105746568|NCT01457118|364726912|FG000|Overall Study|Withdrawal by Subject|5|||
105746569|NCT01457118|364726913|FG001|Overall Study|Withdrawal by Subject|0|||
105746570|NCT01457118|364726914|FG002|Overall Study|Withdrawal by Subject|0|||
105746571|NCT01457118|364726915|FG003|Overall Study|Withdrawal by Subject|0|||
105746572|NCT02324842|364726916|FG000|Overall Study|Lost to Follow-up|1|||
105565368|NCT04512066|364066769|FG004|Double-blind Treatment Period|Adverse Event|0|||
105746573|NCT02324842|364726917|FG001|Overall Study|Lost to Follow-up|1|||
105746574|NCT02324842|364726918|FG002|Overall Study|Lost to Follow-up|2|||
105746575|NCT00115349|364726919|FG000|Overall Study|Study closed due to low enrollment.|11|||
105746576|NCT00115349|364726920|FG001|Overall Study|Study closed due to low enrollment.|9|||
105746577|NCT05142332|364726921|FG000|Overall Study|Withdrawal by Subject|0|||
105746578|NCT05142332|364726922|FG001|Overall Study|Withdrawal by Subject|1|||
105746579|NCT05142332|364726923|FG002|Overall Study|Withdrawal by Subject|2|||
105746580|NCT05142332|364726924|FG003|Overall Study|Withdrawal by Subject|0|||
105746581|NCT05142332|364726925|FG004|Overall Study|Withdrawal by Subject|0|||
105746582|NCT05142332|364726926|FG005|Overall Study|Withdrawal by Subject|2|||
105746583|NCT05142332|364726927|FG006|Overall Study|Withdrawal by Subject|6|||
105746584|NCT05142332|364726921|FG000|Overall Study|Left ED|3|||
105746585|NCT05142332|364726922|FG001|Overall Study|Left ED|0|||
105746586|NCT05142332|364726923|FG002|Overall Study|Left ED|4|||
105746587|NCT05142332|364726924|FG003|Overall Study|Left ED|6|||
105746588|NCT05142332|364726925|FG004|Overall Study|Left ED|1|||
105746589|NCT05142332|364726926|FG005|Overall Study|Left ED|2|||
105746590|NCT05142332|364726927|FG006|Overall Study|Left ED|6|||
105746591|NCT05142332|364726921|FG000|Overall Study|Physician Decision|0|||
105746592|NCT05142332|364726922|FG001|Overall Study|Physician Decision|0|||
105746593|NCT05142332|364726923|FG002|Overall Study|Physician Decision|2|||
105746594|NCT05142332|364726924|FG003|Overall Study|Physician Decision|1|||
105746595|NCT05142332|364726925|FG004|Overall Study|Physician Decision|0|||
105746596|NCT05142332|364726926|FG005|Overall Study|Physician Decision|0|||
105746597|NCT05142332|364726927|FG006|Overall Study|Physician Decision|3|||
105746598|NCT05142332|364726921|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
105746599|NCT05142332|364726922|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
105746600|NCT05142332|364726923|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
105746601|NCT05142332|364726924|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
105746602|NCT05142332|364726925|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
105746603|NCT05142332|364726926|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
105746604|NCT05142332|364726927|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
105746605|NCT02116660|364726928|FG000|Overall Study|Deteriorating renal function|0|||
105746606|NCT02116660|364726929|FG001|Overall Study|Deteriorating renal function|1|||
105746607|NCT02116660|364726928|FG000|Overall Study|Adverse Event|1|||
105746608|NCT02116660|364726929|FG001|Overall Study|Adverse Event|1|||
105746609|NCT02116660|364726928|FG000|Overall Study|Withdrawal by Subject|0|||
105746610|NCT02116660|364726929|FG001|Overall Study|Withdrawal by Subject|2|||
105746611|NCT02116660|364726928|FG000|Overall Study|Organization reason|1|||
105746612|NCT02116660|364726929|FG001|Overall Study|Organization reason|0|||
105746613|NCT02750800|364726930|FG000|Overall Study|Adverse Event|18|||
105746614|NCT02750800|364726930|FG000|Overall Study|Lost to Follow-up|12|||
105746615|NCT02750800|364726930|FG000|Overall Study|Investigator decision|53|||
105746616|NCT02750800|364726930|FG000|Overall Study|Patient request|12|||
105746617|NCT02750800|364726930|FG000|Overall Study|Other, not specified|3|||
105746618|NCT00643487|364726937|FG000|Overall Study|Technical difficulty|3|||
105746619|NCT00390416|364726938|FG000|Overall Study|Withdrawal by Subject|1|||
105746620|NCT00390416|364726938|FG000|Overall Study|Not treated|3|||
105746621|NCT05631548|364726939|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
105746622|NCT05631548|364726940|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
105746623|NCT00630812|364726941|FG000|Randomisation to First Dose|Adverse Event|1|||
105746624|NCT00630812|364726942|FG001|Randomisation to First Dose|Adverse Event|1|||
105746625|NCT00630812|364726941|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
105746626|NCT00630812|364726942|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
105746627|NCT00630812|364726941|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
105746628|NCT00630812|364726942|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
105801018|NCT00845026|364928595|FG000|Study Period III|Adverse Event|23|||
105801019|NCT00845026|364928596|FG001|Study Period III|Adverse Event|19|||
105565369|NCT04512066|364066770|FG005|Double-blind Treatment Period|Adverse Event|0|||
105746629|NCT00630812|364726941|FG000|Randomisation to First Dose|Protocol Violation|4|||
105746630|NCT00630812|364726942|FG001|Randomisation to First Dose|Protocol Violation|1|||
105746631|NCT00630812|364726941|FG000|Double Blind Treatment Period|Adverse Event|13|||
105746632|NCT00630812|364726942|FG001|Double Blind Treatment Period|Adverse Event|5|||
105746633|NCT00630812|364726941|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
105801020|NCT00845026|364928595|FG000|Study Period III|Perceived lack of efficacy|27|||
105801021|NCT00845026|364928596|FG001|Study Period III|Perceived lack of efficacy|15|||
105801022|NCT00845026|364928595|FG000|Study Period III|Withdrawal by Subject|19|||
105801023|NCT00845026|364928596|FG001|Study Period III|Withdrawal by Subject|15|||
105801024|NCT00845026|364928595|FG000|Study Period III|Entry Criteria not met|8|||
105801025|NCT00845026|364928596|FG001|Study Period III|Entry Criteria not met|11|||
105801026|NCT00845026|364928595|FG000|Study Period III|Lost to Follow-up|4|||
105801027|NCT00845026|364928596|FG001|Study Period III|Lost to Follow-up|5|||
105801028|NCT00845026|364928595|FG000|Study Period III|Protocol Violation|8|||
105801029|NCT00845026|364928596|FG001|Study Period III|Protocol Violation|1|||
105801030|NCT00845026|364928595|FG000|Study Period III|Scheduled conflict|3|||
105801031|NCT00845026|364928596|FG001|Study Period III|Scheduled conflict|1|||
105801032|NCT00845026|364928595|FG000|Study Period III|Subject is moving or has moved|2|||
105801033|NCT00845026|364928596|FG001|Study Period III|Subject is moving or has moved|4|||
105801034|NCT00845026|364928595|FG000|Study Period III|Transportation issues|1|||
105801035|NCT00845026|364928596|FG001|Study Period III|Transportation issues|1|||
105801036|NCT00845026|364928595|FG000|Study Period IV|Adverse Event|4|||
105801037|NCT00845026|364928596|FG001|Study Period IV|Adverse Event|0|||
105801038|NCT00845026|364928595|FG000|Study Period IV|Perceived lack of efficacy|2|||
105801039|NCT00845026|364928596|FG001|Study Period IV|Perceived lack of efficacy|1|||
105801040|NCT00845026|364928595|FG000|Study Period IV|Protocol Violation|3|||
105801041|NCT00845026|364928596|FG001|Study Period IV|Protocol Violation|1|||
105801042|NCT00845026|364928595|FG000|Study Period IV|Lost to Follow-up|1|||
105801043|NCT00845026|364928596|FG001|Study Period IV|Lost to Follow-up|0|||
105801044|NCT00845026|364928595|FG000|Study Period IV|Withdrawal by Subject|4|||
105801045|NCT00845026|364928596|FG001|Study Period IV|Withdrawal by Subject|1|||
105801046|NCT00845026|364928595|FG000|Study Period IV|Entry Criteria Not Met|1|||
105801047|NCT00845026|364928596|FG001|Study Period IV|Entry Criteria Not Met|0|||
105801048|NCT00845026|364928595|FG000|Study Period IV|Subject is moving or has moved|0|||
105801049|NCT00845026|364928596|FG001|Study Period IV|Subject is moving or has moved|1|||
105801050|NCT00845026|364928595|FG000|Study Period IV|Scheduling conflict|1|||
105801051|NCT00845026|364928596|FG001|Study Period IV|Scheduling conflict|0|||
105801052|NCT02065791|364928597|FG000|Overall Study|Closed Site|1|||
105801053|NCT02065791|364928598|FG001|Overall Study|Closed Site|1|||
105801054|NCT02065791|364928597|FG000|Overall Study|Withdrawal by Subject|11|||
105801055|NCT02065791|364928598|FG001|Overall Study|Withdrawal by Subject|5|||
105801056|NCT02065791|364928597|FG000|Overall Study|Lost to Follow-up|13|||
105801057|NCT02065791|364928598|FG001|Overall Study|Lost to Follow-up|9|||
105801058|NCT00272961|364928599|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
105801059|NCT00272961|364928600|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
105801060|NCT00272961|364928601|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
105801061|NCT00272961|364928602|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
105801062|NCT00272961|364928603|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
105801063|NCT00272961|364928599|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
105801064|NCT00272961|364928600|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
105801065|NCT00272961|364928601|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
105746634|NCT00630812|364726942|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
105746635|NCT00630812|364726941|FG000|Double Blind Treatment Period|Physician Decision|2|||
105746636|NCT00630812|364726942|FG001|Double Blind Treatment Period|Physician Decision|1|||
105746637|NCT00630812|364726941|FG000|Double Blind Treatment Period|Protocol Violation|1|||
105746638|NCT00630812|364726942|FG001|Double Blind Treatment Period|Protocol Violation|0|||
105746639|NCT00630812|364726941|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
105746640|NCT00630812|364726942|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
105746641|NCT00630812|364726941|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
105746642|NCT00630812|364726942|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
105746643|NCT00630812|364726941|FG000|Double Blind Treatment Period|Non-compliance|0|||
105746644|NCT00630812|364726942|FG001|Double Blind Treatment Period|Non-compliance|1|||
105746645|NCT01248130|364726943|FG000|Overall Study|Protocol Violation|1|||
105746646|NCT01248130|364726944|FG001|Overall Study|Protocol Violation|0|||
105801066|NCT00272961|364928602|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
105801067|NCT00272961|364928603|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
105801068|NCT00272961|364928599|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
105801069|NCT00272961|364928600|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
105801070|NCT00272961|364928601|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
105801071|NCT00272961|364928602|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
105746647|NCT01248130|364726943|FG000|Overall Study|Ineligible|1|||
105746648|NCT01248130|364726944|FG001|Overall Study|Ineligible|0|||
105801072|NCT00272961|364928603|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
105801073|NCT00272961|364928599|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
105801074|NCT00272961|364928600|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
105801075|NCT00272961|364928601|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
105801076|NCT00272961|364928602|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
105801077|NCT00272961|364928603|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
105801078|NCT00272961|364928599|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
105801079|NCT00272961|364928600|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
105801080|NCT00272961|364928601|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
105801081|NCT00272961|364928602|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
105801082|NCT00272961|364928603|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
105801083|NCT00272961|364928599|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
105801084|NCT00272961|364928600|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
105801085|NCT00272961|364928601|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
105801086|NCT00272961|364928602|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
105801087|NCT00272961|364928603|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
105801088|NCT00272961|364928599|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
105801089|NCT00272961|364928600|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
105801090|NCT00272961|364928601|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
105801091|NCT00272961|364928602|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
105801092|NCT00272961|364928603|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
105801093|NCT00272961|364928599|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
105801094|NCT00272961|364928600|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
105801095|NCT00272961|364928601|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
105801096|NCT00272961|364928602|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
105801097|NCT00272961|364928603|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
105801098|NCT02746705|364928606|FG000|Overall Study|Physician Decision|1|||
105801099|NCT02746705|364928607|FG001|Overall Study|Physician Decision|1|||
105801100|NCT02746705|364928606|FG000|Overall Study|Lost to Follow-up|1|||
105801101|NCT02746705|364928607|FG001|Overall Study|Lost to Follow-up|0|||
105801102|NCT02746705|364928606|FG000|Overall Study|outlier scores deemed not valid|0|||
105801103|NCT02746705|364928607|FG001|Overall Study|outlier scores deemed not valid|1|||
105483251|NCT04531462|363782652|FG000|Overall Study|Withdrawal by Subject|3|||
105801104|NCT01964105|364928608|FG000|Overall Study|Lost to Follow-up|2|||
105801105|NCT01964105|364928609|FG001|Overall Study|Lost to Follow-up|13|||
105801106|NCT01964105|364928610|FG002|Overall Study|Lost to Follow-up|0|||
105801107|NCT01571635|364928612|FG000|Overall Study|Adverse Event|3|||
105801108|NCT01571635|364928613|FG001|Overall Study|Adverse Event|0|||
105746649|NCT01911845|364726945|FG000|Overall Study|Adverse Event|2|||
105746650|NCT01911845|364726945|FG000|Overall Study|Lost to Follow-up|1|||
105746651|NCT01911845|364726945|FG000|Overall Study|Other (not specified)|3|||
105746652|NCT01980706|364726946|FG000|Overall Study|Withdrawal by Subject|9|||
105746653|NCT01980706|364726947|FG001|Overall Study|Withdrawal by Subject|6|||
105746654|NCT01980706|364726948|FG002|Overall Study|Withdrawal by Subject|2|||
105746655|NCT01980706|364726946|FG000|Overall Study|Adverse Event|1|||
105746656|NCT01980706|364726947|FG001|Overall Study|Adverse Event|2|||
105483252|NCT04531462|363782653|FG001|Overall Study|Withdrawal by Subject|1|||
105483253|NCT04531462|363782652|FG000|Overall Study|Adverse Event|3|||
105483254|NCT04531462|363782653|FG001|Overall Study|Adverse Event|3|||
105483255|NCT02292784|363782656|FG000|Overall Study|Lost to Follow-up|1|||
105746657|NCT01980706|364726948|FG002|Overall Study|Adverse Event|5|||
105746658|NCT01980706|364726946|FG000|Overall Study|Lost to Follow-up|3|||
105746659|NCT01980706|364726947|FG001|Overall Study|Lost to Follow-up|4|||
105746660|NCT01980706|364726948|FG002|Overall Study|Lost to Follow-up|3|||
105746661|NCT01980706|364726946|FG000|Overall Study|miscellaneous|4|||
105746662|NCT01980706|364726947|FG001|Overall Study|miscellaneous|5|||
105746663|NCT01980706|364726948|FG002|Overall Study|miscellaneous|3|||
105746664|NCT01163253|364726949|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
105746665|NCT01163253|364726950|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
105483256|NCT02292784|363782657|FG001|Overall Study|Lost to Follow-up|17|||
105483257|NCT02292784|363782658|FG002|Overall Study|Lost to Follow-up|18|||
105483258|NCT02292784|363782656|FG000|Overall Study|Withdrawal by Subject|0|||
105483259|NCT02292784|363782657|FG001|Overall Study|Withdrawal by Subject|3|||
105483260|NCT02292784|363782658|FG002|Overall Study|Withdrawal by Subject|3|||
105483261|NCT00348933|363782659|FG000|Overall Study|Withdrawal by Subject|10|||
105483262|NCT00348933|363782659|FG000|Overall Study|Lost to Follow-up|6|||
105746666|NCT01163253|364726949|FG000|Overall Study|Study Terminated by Sponsor|978|||
105746667|NCT01163253|364726950|FG001|Overall Study|Study Terminated by Sponsor|349|||
105746668|NCT01163253|364726949|FG000|Overall Study|Protocol Violation|43|||
105746669|NCT01163253|364726950|FG001|Overall Study|Protocol Violation|12|||
105746670|NCT01163253|364726949|FG000|Overall Study|Withdrawal by Subject|199|||
105746671|NCT01163253|364726950|FG001|Overall Study|Withdrawal by Subject|50|||
105746672|NCT01163253|364726949|FG000|Overall Study|Medication Error|1|||
105746673|NCT01163253|364726950|FG001|Overall Study|Medication Error|0|||
105746674|NCT01163253|364726949|FG000|Overall Study|Lost to Follow-up|125|||
105746675|NCT01163253|364726950|FG001|Overall Study|Lost to Follow-up|23|||
105746676|NCT01163253|364726949|FG000|Overall Study|Insufficient Clinical Response|423|||
105746677|NCT01163253|364726950|FG001|Overall Study|Insufficient Clinical Response|29|||
105746678|NCT01163253|364726949|FG000|Overall Study|Adverse Event|300|||
105746679|NCT01163253|364726950|FG001|Overall Study|Adverse Event|78|||
105746680|NCT01163253|364726949|FG000|Overall Study|Death|17|||
105746681|NCT01163253|364726950|FG001|Overall Study|Death|5|||
105746682|NCT01163253|364726949|FG000|Overall Study|Ongoing|13|||
105746683|NCT01163253|364726950|FG001|Overall Study|Ongoing|4|||
105746684|NCT01163253|364726949|FG000|Overall Study|Other Unspecified|170|||
105746685|NCT01163253|364726950|FG001|Overall Study|Other Unspecified|34|||
105746686|NCT05118386|364726956|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
105746687|NCT05118386|364726957|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
105746688|NCT05118386|364726958|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
105746689|NCT05118386|364726959|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
105746690|NCT05118386|364726960|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
105746691|NCT05118386|364726961|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
105746692|NCT05118386|364726956|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
105746693|NCT05118386|364726957|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
105746694|NCT05118386|364726958|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
105746695|NCT05118386|364726959|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
105746696|NCT05118386|364726960|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
105746697|NCT05118386|364726961|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
105746698|NCT02683525|364726962|FG000|Overall Study|Lost to Follow-up|1|||
105746699|NCT02683525|364726962|FG000|Overall Study|Physician Decision|1|||
105746700|NCT02683525|364726962|FG000|Overall Study|Disease Progression|6|||
105746701|NCT01468909|364726972|FG000|Overall Study|Never Treated|2|||
105746702|NCT01468909|364726973|FG001|Overall Study|Never Treated|2|||
105746703|NCT01005732|364726979|FG000|Overall Study|Lost to Follow-up|10|||
105746704|NCT01005732|364726979|FG000|Overall Study|Death|1|||
105746705|NCT00937768|364726980|FG000|Overall Study|Refused Further Treatment|3|||
105483263|NCT00348933|363782659|FG000|Overall Study|Protocol Violation|2|||
105483264|NCT00348933|363782659|FG000|Overall Study|Adverse Event|7|||
105746706|NCT00937768|364726981|FG001|Overall Study|Refused Further Treatment|2|||
105746707|NCT00937768|364726980|FG000|Overall Study|Disease Progression|1|||
105746708|NCT00937768|364726981|FG001|Overall Study|Disease Progression|1|||
105746709|NCT00937768|364726980|FG000|Overall Study|Alternate Treatment|0|||
105746710|NCT00937768|364726981|FG001|Overall Study|Alternate Treatment|1|||
105746711|NCT00937768|364726980|FG000|Overall Study|No Further Funding|4|||
105483265|NCT01264081|363782660|FG000|Participants Screened|Screening failures|30|||
105483266|NCT01264081|363782660|FG000|Started Treatment|Withdrawal by Subject|1|||
105483267|NCT01264081|363782660|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
105483268|NCT01489111|363782661|FG000|Overall Study|Withdrawal criterion|1|||
105483269|NCT02716896|363782662|FG000|Overall Study|Physician Decision|0|||
105483270|NCT02716896|363782663|FG001|Overall Study|Physician Decision|1|||
105483271|NCT02054481|363782665|FG000|Overall Study|Adverse Event|1|||
105483272|NCT02054481|363782666|FG001|Overall Study|Adverse Event|1|||
105483273|NCT02054481|363782667|FG002|Overall Study|Adverse Event|0|||
105483274|NCT02054481|363782668|FG003|Overall Study|Adverse Event|1|||
105483275|NCT02054481|363782665|FG000|Overall Study|Lost to Follow-up|1|||
105483276|NCT02054481|363782666|FG001|Overall Study|Lost to Follow-up|0|||
105483277|NCT02054481|363782667|FG002|Overall Study|Lost to Follow-up|0|||
105483278|NCT02054481|363782668|FG003|Overall Study|Lost to Follow-up|0|||
105483279|NCT02054481|363782665|FG000|Overall Study|Other reason|2|||
105483280|NCT02054481|363782666|FG001|Overall Study|Other reason|1|||
105483281|NCT02054481|363782667|FG002|Overall Study|Other reason|2|||
105746712|NCT00937768|364726981|FG001|Overall Study|No Further Funding|4|||
105746713|NCT02998554|364726988|FG000|Overall Study|Adverse Event|8|||
105746714|NCT02998554|364726989|FG001|Overall Study|Adverse Event|3|||
105746715|NCT02998554|364726988|FG000|Overall Study|Protocol deviation|1|||
105746716|NCT02998554|364726989|FG001|Overall Study|Protocol deviation|0|||
105746717|NCT02998554|364726988|FG000|Overall Study|Withdrawal by Subject|2|||
105746718|NCT02998554|364726989|FG001|Overall Study|Withdrawal by Subject|6|||
105746719|NCT02998554|364726988|FG000|Overall Study|Lost to Follow-up|0|||
105746720|NCT02998554|364726989|FG001|Overall Study|Lost to Follow-up|1|||
105746721|NCT02998554|364726988|FG000|Overall Study|Lack of Efficacy|0|||
105746722|NCT02998554|364726989|FG001|Overall Study|Lack of Efficacy|1|||
105746723|NCT01079962|364726994|FG000|Overall Study|Adverse Event|2|||
105746724|NCT01079962|364726995|FG001|Overall Study|Adverse Event|2|||
105746725|NCT01079962|364726994|FG000|Overall Study|Withdrawal by Subject|5|||
105746726|NCT01079962|364726995|FG001|Overall Study|Withdrawal by Subject|7|||
105746727|NCT01079962|364726994|FG000|Overall Study|Protocol Violation|2|||
105746728|NCT01079962|364726995|FG001|Overall Study|Protocol Violation|2|||
105746729|NCT01079962|364726994|FG000|Overall Study|No blood pressure (BP) control|3|||
105746730|NCT01079962|364726995|FG001|Overall Study|No blood pressure (BP) control|0|||
105746731|NCT01079962|364726994|FG000|Overall Study|Inclusion/exclusion criteria|1|||
105746732|NCT01079962|364726995|FG001|Overall Study|Inclusion/exclusion criteria|3|||
105746733|NCT01079962|364726994|FG000|Overall Study|Participant not returning for next visit|1|||
105746734|NCT01079962|364726995|FG001|Overall Study|Participant not returning for next visit|0|||
105746735|NCT01079962|364726994|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
105746736|NCT01079962|364726995|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
105746737|NCT01331239|364726996|FG000|Part II: Core Study|Adverse Event|0|||
105746738|NCT01331239|364726997|FG001|Part II: Core Study|Adverse Event|3|||
105746739|NCT01331239|364726998|FG002|Part II: Core Study|Adverse Event|0|||
105746740|NCT01331239|364726996|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
105746741|NCT01331239|364726997|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
105746742|NCT01331239|364726998|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
105746743|NCT01331239|364726996|FG000|Part II: Core Study|Withdrawal by Subject|0|||
105746744|NCT01331239|364726997|FG001|Part II: Core Study|Withdrawal by Subject|2|||
105746745|NCT01331239|364726998|FG002|Part II: Core Study|Withdrawal by Subject|0|||
105746746|NCT01331239|364726996|FG000|Part II: Core Study|Administrative problems|0|||
105746747|NCT01331239|364726997|FG001|Part II: Core Study|Administrative problems|1|||
105746748|NCT01331239|364726998|FG002|Part II: Core Study|Administrative problems|0|||
105746749|NCT01072539|364726999|FG000|Overall Study|Treated prior to the Site Initiation|1|||
105746750|NCT01072539|364726999|FG000|Overall Study|Protocol Violation|2|||
105746751|NCT00946530|364727000|FG000|Overall Study|Withdrawal by Subject|0|||
105746752|NCT00946530|364727001|FG001|Overall Study|Withdrawal by Subject|3|||
105746753|NCT00946530|364727002|FG002|Overall Study|Withdrawal by Subject|0|||
105746754|NCT00946530|364727003|FG003|Overall Study|Withdrawal by Subject|3|||
105746755|NCT00946530|364727000|FG000|Overall Study|Physician Decision|1|||
105746756|NCT00946530|364727001|FG001|Overall Study|Physician Decision|1|||
105483282|NCT02054481|363782668|FG003|Overall Study|Other reason|0|||
105483283|NCT02320903|363782669|FG000|Overall Study|Withdrawal by Subject|0|||
105746757|NCT00946530|364727002|FG002|Overall Study|Physician Decision|1|||
105746758|NCT00946530|364727003|FG003|Overall Study|Physician Decision|1|||
105746759|NCT01008995|364727006|FG000|Controlled Period|Adverse Event|1|||
105746760|NCT01008995|364727007|FG001|Controlled Period|Adverse Event|2|||
105746761|NCT01008995|364727008|FG002|Controlled Period|Adverse Event|0|||
105746762|NCT01008995|364727009|FG003|Controlled Period|Adverse Event|0|||
105483284|NCT02320903|363782670|FG001|Overall Study|Withdrawal by Subject|9|||
105483285|NCT02320903|363782671|FG002|Overall Study|Withdrawal by Subject|9|||
105483286|NCT02320903|363782669|FG000|Overall Study|Exited therapy; no longer eligible|8|||
105483287|NCT02320903|363782670|FG001|Overall Study|Exited therapy; no longer eligible|2|||
105483288|NCT02320903|363782671|FG002|Overall Study|Exited therapy; no longer eligible|2|||
105483289|NCT02320903|363782669|FG000|Overall Study|Lost to Follow-up|0|||
105746763|NCT01008995|364727006|FG000|Controlled Period|Other|2|||
105746764|NCT01008995|364727007|FG001|Controlled Period|Other|1|||
105746765|NCT01008995|364727008|FG002|Controlled Period|Other|0|||
105746766|NCT01008995|364727009|FG003|Controlled Period|Other|0|||
105746767|NCT01008995|364727006|FG000|After Controlled Period|Adverse Event|0|||
105746768|NCT01008995|364727007|FG001|After Controlled Period|Adverse Event|0|||
105746769|NCT01008995|364727008|FG002|After Controlled Period|Adverse Event|1|||
105746770|NCT01008995|364727009|FG003|After Controlled Period|Adverse Event|1|||
105746771|NCT01008995|364727006|FG000|After Controlled Period|Other|0|||
105746772|NCT01008995|364727007|FG001|After Controlled Period|Other|0|||
105746773|NCT01008995|364727008|FG002|After Controlled Period|Other|1|||
105746774|NCT01008995|364727009|FG003|After Controlled Period|Other|0|||
105746775|NCT00115804|364727010|FG000|Overall Study|Adverse Event|2|||
105746776|NCT03422133|364727013|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
105483290|NCT02320903|363782670|FG001|Overall Study|Lost to Follow-up|5|||
105483291|NCT02320903|363782671|FG002|Overall Study|Lost to Follow-up|5|||
105746777|NCT03422133|364727014|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
105746778|NCT00755846|364729097|FG000|Overall Study|Adverse Event|0|||
105746779|NCT00755846|364729098|FG001|Overall Study|Adverse Event|0|||
105746780|NCT00755846|364729099|FG002|Overall Study|Adverse Event|0|||
105746781|NCT00755846|364729100|FG003|Overall Study|Adverse Event|1|||
105746782|NCT00755846|364729101|FG004|Overall Study|Adverse Event|3|||
105746783|NCT00755846|364729102|FG005|Overall Study|Adverse Event|2|||
105746784|NCT00755846|364729097|FG000|Overall Study|Protocol Violation|1|||
105746785|NCT00755846|364729098|FG001|Overall Study|Protocol Violation|1|||
105746786|NCT00755846|364729099|FG002|Overall Study|Protocol Violation|1|||
105746787|NCT00755846|364729100|FG003|Overall Study|Protocol Violation|1|||
105746788|NCT00755846|364729101|FG004|Overall Study|Protocol Violation|1|||
105746789|NCT00755846|364729102|FG005|Overall Study|Protocol Violation|1|||
105746790|NCT00755846|364729097|FG000|Overall Study|Lost to Follow-up|0|||
105746791|NCT00755846|364729098|FG001|Overall Study|Lost to Follow-up|2|||
105746792|NCT00755846|364729099|FG002|Overall Study|Lost to Follow-up|1|||
105746793|NCT00755846|364729100|FG003|Overall Study|Lost to Follow-up|0|||
105746794|NCT00755846|364729101|FG004|Overall Study|Lost to Follow-up|4|||
105746795|NCT00755846|364729102|FG005|Overall Study|Lost to Follow-up|2|||
105746796|NCT00755846|364729097|FG000|Overall Study|Withdrawal by Subject|2|||
105746797|NCT00755846|364729098|FG001|Overall Study|Withdrawal by Subject|3|||
105746798|NCT00755846|364729099|FG002|Overall Study|Withdrawal by Subject|5|||
105746799|NCT00755846|364729100|FG003|Overall Study|Withdrawal by Subject|2|||
105746800|NCT00755846|364729101|FG004|Overall Study|Withdrawal by Subject|0|||
105746801|NCT00755846|364729102|FG005|Overall Study|Withdrawal by Subject|1|||
105746802|NCT00755846|364729097|FG000|Overall Study|Hyperglycemic Rescue|21|||
105483292|NCT00730028|363782673|FG000|Overall Study|Adverse Event|23|||
105483293|NCT00730028|363782674|FG001|Overall Study|Adverse Event|26|||
105483294|NCT00730028|363782675|FG002|Overall Study|Adverse Event|16|||
105483295|NCT00730028|363782676|FG003|Overall Study|Adverse Event|20|||
105483296|NCT00730028|363782677|FG004|Overall Study|Adverse Event|43|||
105483297|NCT00730028|363782673|FG000|Overall Study|Lost to Follow-up|13|||
105483298|NCT00730028|363782674|FG001|Overall Study|Lost to Follow-up|26|||
105483299|NCT00730028|363782675|FG002|Overall Study|Lost to Follow-up|22|||
105483300|NCT00730028|363782676|FG003|Overall Study|Lost to Follow-up|26|||
105483301|NCT00730028|363782677|FG004|Overall Study|Lost to Follow-up|25|||
105483302|NCT00730028|363782673|FG000|Overall Study|Protocol Violation|6|||
105483303|NCT00730028|363782674|FG001|Overall Study|Protocol Violation|1|||
105483304|NCT00730028|363782675|FG002|Overall Study|Protocol Violation|1|||
105483305|NCT00730028|363782676|FG003|Overall Study|Protocol Violation|2|||
105483306|NCT00730028|363782677|FG004|Overall Study|Protocol Violation|0|||
105746803|NCT00755846|364729098|FG001|Overall Study|Hyperglycemic Rescue|7|||
105746804|NCT00755846|364729099|FG002|Overall Study|Hyperglycemic Rescue|5|||
105746805|NCT00755846|364729100|FG003|Overall Study|Hyperglycemic Rescue|8|||
105746806|NCT00755846|364729101|FG004|Overall Study|Hyperglycemic Rescue|8|||
105746807|NCT00755846|364729102|FG005|Overall Study|Hyperglycemic Rescue|7|||
105746808|NCT00755846|364729097|FG000|Overall Study|Physician Decision|1|||
105746809|NCT00755846|364729098|FG001|Overall Study|Physician Decision|3|||
105746810|NCT00755846|364729099|FG002|Overall Study|Physician Decision|0|||
105746811|NCT00755846|364729100|FG003|Overall Study|Physician Decision|1|||
105483307|NCT00730028|363782673|FG000|Overall Study|Withdrawal by Subject|9|||
105483308|NCT00730028|363782674|FG001|Overall Study|Withdrawal by Subject|5|||
105483309|NCT00730028|363782675|FG002|Overall Study|Withdrawal by Subject|4|||
105483310|NCT00730028|363782676|FG003|Overall Study|Withdrawal by Subject|5|||
105746812|NCT00755846|364729101|FG004|Overall Study|Physician Decision|0|||
105746813|NCT00755846|364729102|FG005|Overall Study|Physician Decision|1|||
105746814|NCT00755846|364729097|FG000|Overall Study|Administrative Error|0|||
105746815|NCT00755846|364729098|FG001|Overall Study|Administrative Error|1|||
105746816|NCT00755846|364729099|FG002|Overall Study|Administrative Error|0|||
105746817|NCT00755846|364729100|FG003|Overall Study|Administrative Error|0|||
105746818|NCT00755846|364729101|FG004|Overall Study|Administrative Error|0|||
105746819|NCT00755846|364729102|FG005|Overall Study|Administrative Error|0|||
105359684|NCT03410992|363322331|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105359685|NCT03410992|363322332|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105359686|NCT03410992|363322322|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105359687|NCT03410992|363322323|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105359688|NCT03410992|363322324|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105359689|NCT03410992|363322325|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
105360901|NCT01051557|363328104|FG001|Overall Study|Withdrawal by Subject|0|||
105746820|NCT00755846|364729097|FG000|Overall Study|Participant Non-compliance|0|||
105746821|NCT00755846|364729098|FG001|Overall Study|Participant Non-compliance|0|||
105746822|NCT00755846|364729099|FG002|Overall Study|Participant Non-compliance|0|||
105746823|NCT00755846|364729100|FG003|Overall Study|Participant Non-compliance|0|||
105746824|NCT00755846|364729101|FG004|Overall Study|Participant Non-compliance|1|||
105746825|NCT00755846|364729102|FG005|Overall Study|Participant Non-compliance|0|||
105746826|NCT02669862|364729103|FG000|Overall Study|Lost to Follow-up|0|||
105746827|NCT02669862|364729104|FG001|Overall Study|Lost to Follow-up|2|||
105746828|NCT02669862|364729105|FG002|Overall Study|Lost to Follow-up|1|||
105746829|NCT02669862|364729103|FG000|Overall Study|Withdrawal by Subject|2|||
105746830|NCT02669862|364729104|FG001|Overall Study|Withdrawal by Subject|2|||
105746831|NCT02669862|364729105|FG002|Overall Study|Withdrawal by Subject|3|||
105746832|NCT02669862|364729103|FG000|Overall Study|moved|0|||
105746833|NCT02669862|364729104|FG001|Overall Study|moved|1|||
105746834|NCT02669862|364729105|FG002|Overall Study|moved|0|||
105746835|NCT02669862|364729103|FG000|Overall Study|Protocol Violation|0|||
105746836|NCT02669862|364729104|FG001|Overall Study|Protocol Violation|0|||
105746837|NCT02669862|364729105|FG002|Overall Study|Protocol Violation|1|||
105746838|NCT00288860|364729106|FG000|Overall Study|Did not complete intake|4|||
105746839|NCT00288860|364729107|FG001|Overall Study|Did not complete intake|8|||
105746840|NCT00288860|364729106|FG000|Overall Study|Death|4|||
105746841|NCT00288860|364729107|FG001|Overall Study|Death|3|||
105746842|NCT00288860|364729106|FG000|Overall Study|Withdrawal by Subject|20|||
105746843|NCT00288860|364729107|FG001|Overall Study|Withdrawal by Subject|15|||
105746844|NCT00288860|364729106|FG000|Overall Study|Lost to Follow-up|74|||
105746845|NCT00288860|364729107|FG001|Overall Study|Lost to Follow-up|71|||
105746846|NCT00882999|364729108|FG000|Overall Study|Adverse Event|0|||
105746847|NCT00882999|364729109|FG001|Overall Study|Adverse Event|0|||
105746848|NCT00882999|364729110|FG002|Overall Study|Adverse Event|0|||
105746849|NCT00882999|364729111|FG003|Overall Study|Adverse Event|0|||
105746850|NCT00882999|364729112|FG004|Overall Study|Adverse Event|1|||
105746851|NCT00882999|364729113|FG005|Overall Study|Adverse Event|0|||
105746852|NCT00882999|364729114|FG006|Overall Study|Adverse Event|0|||
105359690|NCT03410992|363322326|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
105359691|NCT03410992|363322327|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
105359692|NCT03410992|363322328|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105746853|NCT00882999|364729108|FG000|Overall Study|Death|0|||
105746854|NCT00882999|364729109|FG001|Overall Study|Death|1|||
105746855|NCT00882999|364729110|FG002|Overall Study|Death|0|||
105746856|NCT00882999|364729111|FG003|Overall Study|Death|0|||
105746857|NCT00882999|364729112|FG004|Overall Study|Death|0|||
105746858|NCT00882999|364729113|FG005|Overall Study|Death|0|||
105746859|NCT00882999|364729114|FG006|Overall Study|Death|0|||
105746860|NCT00882999|364729108|FG000|Overall Study|Withdrawal by Subject|7|||
105746861|NCT00882999|364729109|FG001|Overall Study|Withdrawal by Subject|6|||
105746862|NCT00882999|364729110|FG002|Overall Study|Withdrawal by Subject|3|||
105746863|NCT00882999|364729111|FG003|Overall Study|Withdrawal by Subject|3|||
105746864|NCT00882999|364729112|FG004|Overall Study|Withdrawal by Subject|6|||
105746865|NCT00882999|364729113|FG005|Overall Study|Withdrawal by Subject|5|||
105746866|NCT00882999|364729114|FG006|Overall Study|Withdrawal by Subject|5|||
105746867|NCT00882999|364729108|FG000|Overall Study|Lost to Follow-up|0|||
105746868|NCT00882999|364729109|FG001|Overall Study|Lost to Follow-up|1|||
105746869|NCT00882999|364729110|FG002|Overall Study|Lost to Follow-up|1|||
105746870|NCT00882999|364729111|FG003|Overall Study|Lost to Follow-up|2|||
105746871|NCT00882999|364729112|FG004|Overall Study|Lost to Follow-up|1|||
105746872|NCT00882999|364729113|FG005|Overall Study|Lost to Follow-up|1|||
105746873|NCT00882999|364729114|FG006|Overall Study|Lost to Follow-up|2|||
105746874|NCT00882999|364729108|FG000|Overall Study|Physician Decision|1|||
105746875|NCT00882999|364729109|FG001|Overall Study|Physician Decision|0|||
105746876|NCT00882999|364729110|FG002|Overall Study|Physician Decision|0|||
105746877|NCT00882999|364729111|FG003|Overall Study|Physician Decision|0|||
105746878|NCT00882999|364729112|FG004|Overall Study|Physician Decision|0|||
105746879|NCT00882999|364729113|FG005|Overall Study|Physician Decision|1|||
105746880|NCT00882999|364729114|FG006|Overall Study|Physician Decision|1|||
105746881|NCT02586233|364729115|FG000|Overall Study|Randomized but did not receive treatment|0|||
105746882|NCT02586233|364729116|FG001|Overall Study|Randomized but did not receive treatment|1|||
105746883|NCT02586233|364729117|FG002|Overall Study|Randomized but did not receive treatment|0|||
105746884|NCT02586233|364729118|FG003|Overall Study|Randomized but did not receive treatment|0|||
105746885|NCT02586233|364729119|FG004|Overall Study|Randomized but did not receive treatment|0|||
105746886|NCT02586233|364729120|FG005|Overall Study|Randomized but did not receive treatment|2|||
105746887|NCT02586233|364729121|FG006|Overall Study|Randomized but did not receive treatment|2|||
105746888|NCT02586233|364729115|FG000|Overall Study|Death|0|||
105746889|NCT02586233|364729116|FG001|Overall Study|Death|1|||
105746890|NCT02586233|364729117|FG002|Overall Study|Death|0|||
105746891|NCT02586233|364729118|FG003|Overall Study|Death|0|||
105746892|NCT02586233|364729119|FG004|Overall Study|Death|2|||
105746893|NCT02586233|364729120|FG005|Overall Study|Death|0|||
105746894|NCT02586233|364729121|FG006|Overall Study|Death|0|||
105359693|NCT03410992|363322329|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105746895|NCT01894477|364729124|FG000|Overall Study|Protocol Violation|0|||
105359694|NCT03410992|363322330|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105746896|NCT01894477|364729125|FG001|Overall Study|Protocol Violation|1|||
105746897|NCT01894477|364729124|FG000|Overall Study|protocol changed due SC changed to cord|0|||
105746898|NCT01894477|364729125|FG001|Overall Study|protocol changed due SC changed to cord|1|||
105746899|NCT01757405|364729126|FG000|Overall Study|Lost to Follow-up|1|||
105746900|NCT01757405|364729127|FG001|Overall Study|Lost to Follow-up|1|||
105746901|NCT01757405|364729126|FG000|Overall Study|Withdrawal by Subject|0|||
105746902|NCT01757405|364729127|FG001|Overall Study|Withdrawal by Subject|1|||
105746903|NCT00238303|364729128|FG000|Overall Study|Withdrawal by Subject|11|||
105801109|NCT01571635|364928614|FG002|Overall Study|Adverse Event|2|||
105801110|NCT01571635|364928615|FG003|Overall Study|Adverse Event|3|||
105801111|NCT01571635|364928616|FG004|Overall Study|Adverse Event|5|||
105801112|NCT01571635|364928612|FG000|Overall Study|Other reasons|2|||
105801113|NCT01571635|364928613|FG001|Overall Study|Other reasons|1|||
105801114|NCT01571635|364928614|FG002|Overall Study|Other reasons|2|||
105801115|NCT01571635|364928615|FG003|Overall Study|Other reasons|2|||
105801116|NCT01571635|364928616|FG004|Overall Study|Other reasons|1|||
105801117|NCT01571635|364928612|FG000|Overall Study|Study terminated by sponsor|0|||
105801118|NCT01571635|364928613|FG001|Overall Study|Study terminated by sponsor|4|||
105801119|NCT01571635|364928614|FG002|Overall Study|Study terminated by sponsor|1|||
105801120|NCT01571635|364928615|FG003|Overall Study|Study terminated by sponsor|3|||
105801121|NCT01571635|364928616|FG004|Overall Study|Study terminated by sponsor|1|||
105801122|NCT01571635|364928612|FG000|Overall Study|Withdrew consent|1|||
105801123|NCT01571635|364928613|FG001|Overall Study|Withdrew consent|1|||
105801124|NCT01571635|364928614|FG002|Overall Study|Withdrew consent|2|||
105801125|NCT01571635|364928615|FG003|Overall Study|Withdrew consent|3|||
105801126|NCT01571635|364928616|FG004|Overall Study|Withdrew consent|0|||
105801127|NCT01571635|364928612|FG000|Overall Study|Lack of Efficacy|0|||
105801128|NCT01571635|364928613|FG001|Overall Study|Lack of Efficacy|2|||
105801129|NCT01571635|364928614|FG002|Overall Study|Lack of Efficacy|0|||
105801130|NCT01571635|364928615|FG003|Overall Study|Lack of Efficacy|1|||
105801131|NCT01571635|364928616|FG004|Overall Study|Lack of Efficacy|2|||
105801132|NCT02868281|364928617|FG000|Overall Study|Adverse Event|2|||
105801133|NCT02868281|364928618|FG001|Overall Study|Adverse Event|2|||
105801134|NCT02868281|364928617|FG000|Overall Study|Protocol Violation|13|||
105801135|NCT02868281|364928618|FG001|Overall Study|Protocol Violation|10|||
105801136|NCT02868281|364928617|FG000|Overall Study|Lost to Follow-up|3|||
105801137|NCT02868281|364928618|FG001|Overall Study|Lost to Follow-up|6|||
105801138|NCT02868281|364928617|FG000|Overall Study|Withdrawal by Subject|11|||
105801139|NCT02868281|364928618|FG001|Overall Study|Withdrawal by Subject|15|||
105801140|NCT02868281|364928617|FG000|Overall Study|Physician Decision|2|||
105801141|NCT02868281|364928618|FG001|Overall Study|Physician Decision|0|||
105801142|NCT02868281|364928617|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
105801143|NCT02868281|364928618|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
105801144|NCT02868281|364928617|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
105801145|NCT02868281|364928618|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
105801146|NCT02868281|364928617|FG000|Overall Study|Long journey/moving away|1|||
105801147|NCT02868281|364928618|FG001|Overall Study|Long journey/moving away|1|||
105801148|NCT00124449|364928619|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
105801149|NCT00124449|364928620|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
105801150|NCT00124449|364928619|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
105801151|NCT00124449|364928620|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
105801152|NCT00124449|364928619|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
105801153|NCT00124449|364928620|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
105801154|NCT00124449|364928619|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
105801155|NCT00124449|364928620|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801156|NCT00124449|364928619|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
105746904|NCT00238303|364729129|FG001|Overall Study|Withdrawal by Subject|1|||
105746905|NCT00238303|364729130|FG002|Overall Study|Withdrawal by Subject|2|||
105746906|NCT00238303|364729128|FG000|Overall Study|Death|1|||
105746907|NCT00238303|364729129|FG001|Overall Study|Death|0|||
105746908|NCT00238303|364729130|FG002|Overall Study|Death|1|||
105746909|NCT00238303|364729128|FG000|Overall Study|Other Medical Problems|2|||
105746910|NCT00238303|364729129|FG001|Overall Study|Other Medical Problems|0|||
105746911|NCT00238303|364729130|FG002|Overall Study|Other Medical Problems|2|||
105746912|NCT00238303|364729128|FG000|Overall Study|Poor tolerance of study treatment|1|||
105746913|NCT00238303|364729129|FG001|Overall Study|Poor tolerance of study treatment|0|||
105746914|NCT00238303|364729130|FG002|Overall Study|Poor tolerance of study treatment|1|||
105746915|NCT00238303|364729128|FG000|Overall Study|Adverse Event|0|||
105746916|NCT00238303|364729129|FG001|Overall Study|Adverse Event|1|||
105801157|NCT00124449|364928620|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
105801158|NCT00124449|364928619|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
105801159|NCT00124449|364928620|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
105801160|NCT00124449|364928619|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
105801161|NCT00124449|364928620|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
105801162|NCT00124449|364928619|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
105801163|NCT00124449|364928620|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
105801164|NCT00124449|364928619|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
105801165|NCT00124449|364928620|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
105746917|NCT00238303|364729130|FG002|Overall Study|Adverse Event|3|||
105746918|NCT02561299|364729131|FG000|Overall Study|Death|2|||
105746919|NCT02561299|364729132|FG001|Overall Study|Death|4|||
105746920|NCT02561299|364729131|FG000|Overall Study|Lost to Follow-up|1|||
105746921|NCT02561299|364729132|FG001|Overall Study|Lost to Follow-up|0|||
105746922|NCT02561299|364729131|FG000|Overall Study|Withdrawal by Subject|2|||
105746923|NCT02561299|364729132|FG001|Overall Study|Withdrawal by Subject|2|||
105746924|NCT01592409|364729133|FG000|Overall Study|Withdrawal by Subject|0|||
105746925|NCT01592409|364729134|FG001|Overall Study|Withdrawal by Subject|1|||
105746926|NCT02052778|364729137|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
105746927|NCT02052778|364729138|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
105746928|NCT02052778|364729139|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
105746929|NCT02052778|364729140|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
105746930|NCT02052778|364729141|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
105746931|NCT02052778|364729142|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
105746932|NCT02052778|364729143|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746933|NCT02052778|364729144|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
105746934|NCT02052778|364729145|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
105746935|NCT02052778|364729146|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
105746936|NCT02052778|364729147|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
105746937|NCT02052778|364729148|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
105746938|NCT02052778|364729149|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
105746939|NCT02052778|364729150|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
105746940|NCT02052778|364729151|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746941|NCT02052778|364729152|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746942|NCT02052778|364729153|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746943|NCT02052778|364729154|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746944|NCT02052778|364729155|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746945|NCT02052778|364729156|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746946|NCT02052778|364729157|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746947|NCT02052778|364729158|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746948|NCT02052778|364729159|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746949|NCT02052778|364729137|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
105746950|NCT02052778|364729138|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
105746951|NCT02052778|364729139|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
105746952|NCT02052778|364729140|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
105746953|NCT02052778|364729141|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
105746954|NCT02052778|364729142|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
105746955|NCT02052778|364729143|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
105746956|NCT02052778|364729144|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
105746957|NCT02052778|364729145|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
105746958|NCT02052778|364729146|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746959|NCT02052778|364729147|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746960|NCT02052778|364729148|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
105746961|NCT02052778|364729149|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
105746962|NCT02052778|364729150|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
105746963|NCT02052778|364729151|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746964|NCT02052778|364729152|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746965|NCT02052778|364729153|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746966|NCT02052778|364729154|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746967|NCT02052778|364729155|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746968|NCT02052778|364729156|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746969|NCT02052778|364729157|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746970|NCT02052778|364729158|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746971|NCT02052778|364729159|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746972|NCT02052778|364729137|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746973|NCT02052778|364729138|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746974|NCT02052778|364729139|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746975|NCT02052778|364729140|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746976|NCT02052778|364729141|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746977|NCT02052778|364729142|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746978|NCT02052778|364729143|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746979|NCT02052778|364729144|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746980|NCT02052778|364729145|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746981|NCT02052778|364729146|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746982|NCT02052778|364729147|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746983|NCT02052778|364729148|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746984|NCT02052778|364729149|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746985|NCT02052778|364729150|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
105746986|NCT02052778|364729151|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746987|NCT02052778|364729152|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746988|NCT02052778|364729153|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746989|NCT02052778|364729154|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746990|NCT02052778|364729155|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746991|NCT02052778|364729156|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746992|NCT02052778|364729157|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746993|NCT02052778|364729158|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746994|NCT02052778|364729159|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746995|NCT02052778|364729137|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
105746996|NCT02052778|364729138|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
105746997|NCT02052778|364729139|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
105746998|NCT02052778|364729140|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
105746999|NCT02052778|364729141|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
105747000|NCT02052778|364729142|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
105747001|NCT02052778|364729143|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
105747002|NCT02052778|364729144|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
105747003|NCT02052778|364729145|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
105747004|NCT02052778|364729146|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
105747005|NCT02052778|364729147|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
105747006|NCT02052778|364729148|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
105747007|NCT02052778|364729149|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
105747008|NCT02052778|364729150|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
105747009|NCT02052778|364729151|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
105747010|NCT02052778|364729152|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
105747011|NCT02052778|364729153|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
105747012|NCT02052778|364729154|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
105747013|NCT02052778|364729155|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
105747014|NCT02052778|364729156|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
105747015|NCT02052778|364729157|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
105747016|NCT02052778|364729158|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
105747017|NCT02052778|364729159|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
105747018|NCT02052778|364729137|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747019|NCT02052778|364729138|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747020|NCT02052778|364729139|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747021|NCT02052778|364729140|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747022|NCT02052778|364729141|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747023|NCT02052778|364729142|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747024|NCT02052778|364729143|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747025|NCT02052778|364729144|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747026|NCT02052778|364729145|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
105747027|NCT02052778|364729146|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747028|NCT02052778|364729147|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747029|NCT02052778|364729148|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747030|NCT02052778|364729149|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747031|NCT02052778|364729150|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
105747032|NCT02052778|364729151|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747033|NCT02052778|364729152|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747034|NCT02052778|364729153|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747035|NCT02052778|364729154|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747036|NCT02052778|364729155|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747037|NCT02052778|364729156|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747038|NCT02052778|364729157|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747039|NCT02052778|364729158|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747040|NCT02052778|364729159|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105483311|NCT00730028|363782677|FG004|Overall Study|Withdrawal by Subject|9|||
105483312|NCT00730028|363782673|FG000|Overall Study|Physician Decision|3|||
105483313|NCT00730028|363782674|FG001|Overall Study|Physician Decision|3|||
105801166|NCT00124449|364928619|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
105801167|NCT00124449|364928620|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
105801168|NCT00124449|364928619|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
105801169|NCT00124449|364928620|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
105801170|NCT00124449|364928619|FG000|18-Month Untreated Observation Period|Relocated|1|||
105801171|NCT00124449|364928620|FG001|18-Month Untreated Observation Period|Relocated|0|||
105801172|NCT00529568|364928621|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
105801173|NCT00529568|364928622|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
105801174|NCT00529568|364928623|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
105801175|NCT00529568|364928621|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
105801176|NCT00529568|364928622|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
105801177|NCT00529568|364928623|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
105801178|NCT00529568|364928621|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
105801179|NCT00529568|364928622|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
105801180|NCT00529568|364928623|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
105801181|NCT00529568|364928621|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
105801182|NCT00529568|364928622|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
105801183|NCT00529568|364928623|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
105801184|NCT00529568|364928621|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
105801185|NCT00529568|364928622|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
105801186|NCT00529568|364928623|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
105801187|NCT00529568|364928621|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
105801188|NCT00529568|364928622|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
105801189|NCT00529568|364928623|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
105801190|NCT00529568|364928621|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
105801191|NCT00529568|364928622|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
105801192|NCT00529568|364928623|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
105801193|NCT00529568|364928621|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
105801194|NCT00529568|364928622|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
105801195|NCT00529568|364928623|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
105801196|NCT00529568|364928621|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
105801197|NCT00529568|364928622|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
105801198|NCT00529568|364928623|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
105801199|NCT00529568|364928621|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
105801200|NCT00529568|364928622|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
105801201|NCT00529568|364928623|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
105801202|NCT00529568|364928621|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
105801203|NCT00529568|364928622|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
105801204|NCT00529568|364928623|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
105801205|NCT00931385|364928624|FG000|Overall Study|Adverse Event|2|||
105801206|NCT00931385|364928625|FG001|Overall Study|Adverse Event|1|||
105801207|NCT00931385|364928626|FG002|Overall Study|Adverse Event|0|||
105801208|NCT00931385|364928627|FG003|Overall Study|Adverse Event|3|||
105801209|NCT00931385|364928624|FG000|Overall Study|Protocol Violation|0|||
105801210|NCT00931385|364928625|FG001|Overall Study|Protocol Violation|0|||
105801211|NCT00931385|364928626|FG002|Overall Study|Protocol Violation|1|||
105801212|NCT00931385|364928627|FG003|Overall Study|Protocol Violation|0|||
105801213|NCT00931385|364928624|FG000|Overall Study|Withdrawal by Subject|0|||
105801214|NCT00931385|364928625|FG001|Overall Study|Withdrawal by Subject|1|||
105483314|NCT00730028|363782675|FG002|Overall Study|Physician Decision|2|||
105483315|NCT00730028|363782676|FG003|Overall Study|Physician Decision|3|||
105483316|NCT00730028|363782677|FG004|Overall Study|Physician Decision|2|||
105483317|NCT00730028|363782673|FG000|Overall Study|Treatment Failure|5|||
105483318|NCT00730028|363782674|FG001|Overall Study|Treatment Failure|5|||
105801215|NCT00931385|364928626|FG002|Overall Study|Withdrawal by Subject|0|||
105483319|NCT00730028|363782675|FG002|Overall Study|Treatment Failure|0|||
105747041|NCT02052778|364729137|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747042|NCT02052778|364729138|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747043|NCT02052778|364729139|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747044|NCT02052778|364729140|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747045|NCT02052778|364729141|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747046|NCT02052778|364729142|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
105747047|NCT02052778|364729143|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747048|NCT02052778|364729144|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747049|NCT02052778|364729145|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747050|NCT02052778|364729146|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747051|NCT02052778|364729147|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747052|NCT02052778|364729148|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747053|NCT02052778|364729149|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
105747054|NCT02052778|364729150|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747055|NCT02052778|364729151|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747056|NCT02052778|364729152|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747057|NCT02052778|364729153|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747058|NCT02052778|364729154|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747059|NCT02052778|364729155|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747060|NCT02052778|364729156|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747061|NCT02052778|364729157|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747062|NCT02052778|364729158|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747063|NCT02052778|364729159|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747064|NCT02052778|364729137|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747065|NCT02052778|364729138|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747066|NCT02052778|364729139|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747067|NCT02052778|364729140|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747068|NCT02052778|364729141|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747069|NCT02052778|364729142|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747070|NCT02052778|364729143|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747071|NCT02052778|364729144|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747072|NCT02052778|364729145|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747073|NCT02052778|364729146|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747074|NCT02052778|364729147|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747075|NCT02052778|364729148|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747076|NCT02052778|364729149|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747077|NCT02052778|364729150|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747078|NCT02052778|364729151|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
105747079|NCT02052778|364729152|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
105747080|NCT02052778|364729153|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
105747081|NCT02052778|364729154|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
105747082|NCT02052778|364729155|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
105747083|NCT02052778|364729156|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
105747084|NCT02052778|364729157|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
105747085|NCT02052778|364729158|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
105747086|NCT02052778|364729159|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747087|NCT02052778|364729137|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747088|NCT02052778|364729138|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747089|NCT02052778|364729139|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747090|NCT02052778|364729140|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747091|NCT02052778|364729141|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747092|NCT02052778|364729142|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747093|NCT02052778|364729143|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747094|NCT02052778|364729144|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747095|NCT02052778|364729145|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747096|NCT02052778|364729146|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747097|NCT02052778|364729147|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747098|NCT02052778|364729148|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747099|NCT02052778|364729149|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747100|NCT02052778|364729150|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105760786|NCT03627494|364776200|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
105359695|NCT03410992|363322331|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105359696|NCT03410992|363322332|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105565370|NCT04512066|364066765|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
105747101|NCT02052778|364729151|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
105747102|NCT02052778|364729152|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
105747103|NCT02052778|364729153|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747104|NCT02052778|364729154|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
105747105|NCT02052778|364729155|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
105747106|NCT02052778|364729156|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
105747107|NCT02052778|364729157|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
105747108|NCT02052778|364729158|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
105747109|NCT02052778|364729159|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747110|NCT02052778|364729137|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747111|NCT02052778|364729138|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747112|NCT02052778|364729139|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747113|NCT02052778|364729140|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747114|NCT02052778|364729141|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747115|NCT02052778|364729142|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747116|NCT02052778|364729143|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747117|NCT02052778|364729144|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747118|NCT02052778|364729145|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747119|NCT02052778|364729146|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747120|NCT02052778|364729147|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747121|NCT02052778|364729148|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747122|NCT02052778|364729149|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747123|NCT02052778|364729150|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747124|NCT02052778|364729151|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
105565371|NCT04512066|364066766|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
105747125|NCT02052778|364729152|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
105747126|NCT02052778|364729153|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
105747127|NCT02052778|364729154|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747128|NCT02052778|364729155|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
105747129|NCT02052778|364729156|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
105747130|NCT02052778|364729157|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747131|NCT02052778|364729158|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747132|NCT02052778|364729159|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747133|NCT02052778|364729137|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747134|NCT02052778|364729138|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747135|NCT02052778|364729139|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747136|NCT02052778|364729140|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747137|NCT02052778|364729141|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747138|NCT02052778|364729142|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747139|NCT02052778|364729143|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747140|NCT02052778|364729144|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747141|NCT02052778|364729145|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747142|NCT02052778|364729146|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747143|NCT02052778|364729147|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747144|NCT02052778|364729148|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747145|NCT02052778|364729149|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747146|NCT02052778|364729150|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747147|NCT02052778|364729151|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
105747148|NCT02052778|364729152|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
105747149|NCT02052778|364729153|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747150|NCT02052778|364729154|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747151|NCT02052778|364729155|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747152|NCT02052778|364729156|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747153|NCT02052778|364729157|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747154|NCT02052778|364729158|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747155|NCT02052778|364729159|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747156|NCT02052778|364729137|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747157|NCT02052778|364729138|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747158|NCT02052778|364729139|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747159|NCT02052778|364729140|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105359697|NCT03410992|363322322|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
105747160|NCT02052778|364729141|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747161|NCT02052778|364729142|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105359698|NCT03410992|363322323|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
105359699|NCT03410992|363322324|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
105483320|NCT00730028|363782676|FG003|Overall Study|Treatment Failure|0|||
105483321|NCT00730028|363782677|FG004|Overall Study|Treatment Failure|1|||
105483322|NCT00730028|363782673|FG000|Overall Study|Randomization Error|1|||
105483323|NCT00730028|363782674|FG001|Overall Study|Randomization Error|0|||
105483324|NCT00730028|363782675|FG002|Overall Study|Randomization Error|0|||
105483325|NCT00730028|363782676|FG003|Overall Study|Randomization Error|0|||
105483326|NCT00730028|363782677|FG004|Overall Study|Randomization Error|2|||
105483327|NCT01931670|363782680|FG000|Treatment Period|Exclusionary Medication Received|1|||
105483328|NCT01931670|363782681|FG001|Treatment Period|Exclusionary Medication Received|1|||
105483329|NCT01931670|363782682|FG002|Treatment Period|Exclusionary Medication Received|1|||
105747162|NCT02052778|364729143|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747163|NCT02052778|364729144|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747164|NCT02052778|364729145|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747165|NCT02052778|364729146|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747166|NCT02052778|364729147|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747167|NCT02052778|364729148|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747168|NCT02052778|364729149|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747169|NCT02052778|364729150|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747170|NCT02052778|364729151|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
105747171|NCT02052778|364729152|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
105747172|NCT02052778|364729153|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747173|NCT02052778|364729154|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747174|NCT02052778|364729155|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747175|NCT02052778|364729156|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
105747176|NCT02052778|364729157|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747177|NCT02052778|364729158|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747178|NCT02052778|364729159|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747179|NCT02052778|364729137|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
105747180|NCT02052778|364729138|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
105747181|NCT02052778|364729139|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
105747182|NCT02052778|364729140|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
105747183|NCT02052778|364729141|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
105747184|NCT02052778|364729142|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
105747185|NCT02052778|364729143|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
105747186|NCT02052778|364729144|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
105747187|NCT02052778|364729145|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
105747188|NCT02052778|364729146|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
105747189|NCT02052778|364729147|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
105747190|NCT02052778|364729148|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
105747191|NCT02052778|364729149|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
105747192|NCT02052778|364729150|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
105747193|NCT02052778|364729151|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
105747194|NCT02052778|364729152|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
105747195|NCT02052778|364729153|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
105747196|NCT02052778|364729154|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
105747197|NCT02052778|364729155|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
105747198|NCT02052778|364729156|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
105747199|NCT02052778|364729157|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
105747200|NCT02052778|364729158|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
105747201|NCT02052778|364729159|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
105747202|NCT02052778|364729137|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747203|NCT02052778|364729138|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747204|NCT02052778|364729139|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747205|NCT02052778|364729140|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747206|NCT02052778|364729141|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747207|NCT02052778|364729142|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747208|NCT02052778|364729143|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747209|NCT02052778|364729144|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747210|NCT02052778|364729145|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747211|NCT02052778|364729146|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747212|NCT02052778|364729147|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747213|NCT02052778|364729148|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105483330|NCT01931670|363782680|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
105483331|NCT01931670|363782681|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
105483332|NCT01931670|363782682|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
105483333|NCT01931670|363782680|FG000|Treatment Period|Subject Noncompliant|4|||
105747214|NCT02052778|364729149|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747215|NCT02052778|364729150|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747216|NCT02052778|364729151|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
105747217|NCT02052778|364729152|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
105747218|NCT02052778|364729153|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
105747219|NCT02052778|364729154|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747220|NCT02052778|364729155|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
105747221|NCT02052778|364729156|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747222|NCT02052778|364729157|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747223|NCT02052778|364729158|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747224|NCT02052778|364729159|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747225|NCT02052778|364729137|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747226|NCT02052778|364729138|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747227|NCT02052778|364729139|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747228|NCT02052778|364729140|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747229|NCT02052778|364729141|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747230|NCT02052778|364729142|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747231|NCT02052778|364729143|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747232|NCT02052778|364729144|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747233|NCT02052778|364729145|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747234|NCT02052778|364729146|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747235|NCT02052778|364729147|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747236|NCT02052778|364729148|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747237|NCT02052778|364729149|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747238|NCT02052778|364729150|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747239|NCT02052778|364729151|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747240|NCT02052778|364729152|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747241|NCT02052778|364729153|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747242|NCT02052778|364729154|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747243|NCT02052778|364729155|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747244|NCT02052778|364729156|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747245|NCT02052778|364729157|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747246|NCT02052778|364729158|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747247|NCT02052778|364729159|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
105747248|NCT02052778|364729137|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747249|NCT02052778|364729138|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747250|NCT02052778|364729139|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747251|NCT02052778|364729140|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747252|NCT02052778|364729141|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747253|NCT02052778|364729142|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747254|NCT02052778|364729143|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747255|NCT02052778|364729144|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747256|NCT02052778|364729145|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747257|NCT02052778|364729146|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747258|NCT02052778|364729147|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747259|NCT02052778|364729148|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747260|NCT02052778|364729149|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747261|NCT02052778|364729150|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747262|NCT02052778|364729151|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747263|NCT02052778|364729152|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747264|NCT02052778|364729153|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747265|NCT02052778|364729154|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747266|NCT02052778|364729155|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747267|NCT02052778|364729156|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747268|NCT02052778|364729157|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747269|NCT02052778|364729158|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747270|NCT02052778|364729159|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
105747271|NCT02052778|364729137|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747272|NCT02052778|364729138|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747273|NCT02052778|364729139|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747274|NCT02052778|364729140|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747275|NCT02052778|364729141|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747276|NCT02052778|364729142|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747277|NCT02052778|364729143|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747278|NCT02052778|364729144|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747279|NCT02052778|364729145|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747280|NCT02052778|364729146|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747281|NCT02052778|364729147|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747282|NCT02052778|364729148|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747283|NCT02052778|364729149|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747284|NCT02052778|364729150|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747285|NCT02052778|364729151|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747286|NCT02052778|364729152|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747287|NCT02052778|364729153|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747288|NCT02052778|364729154|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747289|NCT02052778|364729155|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747290|NCT02052778|364729156|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747291|NCT02052778|364729157|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747292|NCT02052778|364729158|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747293|NCT02052778|364729159|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
105747294|NCT02052778|364729137|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747295|NCT02052778|364729138|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747296|NCT02052778|364729139|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747297|NCT02052778|364729140|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747298|NCT02052778|364729141|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747299|NCT02052778|364729142|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747300|NCT02052778|364729143|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747301|NCT02052778|364729144|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747302|NCT02052778|364729145|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747303|NCT02052778|364729146|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747304|NCT02052778|364729147|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747305|NCT02052778|364729148|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747306|NCT02052778|364729149|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747307|NCT02052778|364729150|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747308|NCT02052778|364729151|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747309|NCT02052778|364729152|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747310|NCT02052778|364729153|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747311|NCT02052778|364729154|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747312|NCT02052778|364729155|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747313|NCT02052778|364729156|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747314|NCT02052778|364729157|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747315|NCT02052778|364729158|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747316|NCT02052778|364729159|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
105747317|NCT02052778|364729137|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747318|NCT02052778|364729138|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747319|NCT02052778|364729139|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747320|NCT02052778|364729140|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747321|NCT02052778|364729141|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747322|NCT02052778|364729142|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747323|NCT02052778|364729143|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747324|NCT02052778|364729144|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105483334|NCT01931670|363782681|FG001|Treatment Period|Subject Noncompliant|9|||
105483335|NCT01931670|363782682|FG002|Treatment Period|Subject Noncompliant|5|||
105483336|NCT01931670|363782680|FG000|Treatment Period|Adverse Event|19|||
105483337|NCT01931670|363782681|FG001|Treatment Period|Adverse Event|8|||
105483338|NCT01931670|363782682|FG002|Treatment Period|Adverse Event|21|||
105483339|NCT01931670|363782680|FG000|Treatment Period|Lack of Efficacy|11|||
105483340|NCT01931670|363782681|FG001|Treatment Period|Lack of Efficacy|2|||
105483341|NCT01931670|363782682|FG002|Treatment Period|Lack of Efficacy|2|||
105483342|NCT01931670|363782680|FG000|Treatment Period|Pregnancy|7|||
105483343|NCT01931670|363782681|FG001|Treatment Period|Pregnancy|2|||
105483344|NCT01931670|363782682|FG002|Treatment Period|Pregnancy|0|||
105483345|NCT01931670|363782680|FG000|Treatment Period|Other|8|||
105483346|NCT01931670|363782681|FG001|Treatment Period|Other|7|||
105483347|NCT01931670|363782682|FG002|Treatment Period|Other|2|||
105483348|NCT01931670|363782680|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
105747325|NCT02052778|364729145|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747326|NCT02052778|364729146|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747327|NCT02052778|364729147|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747328|NCT02052778|364729148|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747329|NCT02052778|364729149|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747330|NCT02052778|364729150|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747331|NCT02052778|364729151|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747332|NCT02052778|364729152|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747333|NCT02052778|364729153|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747334|NCT02052778|364729154|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747335|NCT02052778|364729155|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747336|NCT02052778|364729156|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747337|NCT02052778|364729157|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747338|NCT02052778|364729158|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747339|NCT02052778|364729159|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
105747340|NCT02052778|364729137|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
105747341|NCT02052778|364729138|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
105747342|NCT02052778|364729139|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
105747343|NCT02052778|364729140|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
105747344|NCT02052778|364729141|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
105747345|NCT02052778|364729142|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
105747346|NCT02052778|364729143|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
105747347|NCT02052778|364729144|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
105747348|NCT02052778|364729145|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
105747349|NCT02052778|364729146|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
105747350|NCT02052778|364729147|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
105747351|NCT02052778|364729148|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
105747352|NCT02052778|364729149|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
105747353|NCT02052778|364729150|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
105747354|NCT02052778|364729151|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
105747355|NCT02052778|364729152|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
105747356|NCT02052778|364729153|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
105747357|NCT02052778|364729154|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
105747358|NCT02052778|364729155|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
105747359|NCT02052778|364729156|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
105747360|NCT02052778|364729157|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
105747361|NCT02052778|364729158|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
105747362|NCT02052778|364729159|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
105747363|NCT02052778|364729137|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747364|NCT02052778|364729138|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747365|NCT02052778|364729139|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747366|NCT02052778|364729140|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747367|NCT02052778|364729141|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747368|NCT02052778|364729142|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747369|NCT02052778|364729143|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747370|NCT02052778|364729144|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747371|NCT02052778|364729145|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747372|NCT02052778|364729146|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747373|NCT02052778|364729147|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747374|NCT02052778|364729148|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747375|NCT02052778|364729149|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747376|NCT02052778|364729150|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
105483349|NCT01931670|363782681|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
105483350|NCT01931670|363782682|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
105483351|NCT01931670|363782680|FG000|Treatment Period|Lost to Follow-up|19|||
105483352|NCT01931670|363782681|FG001|Treatment Period|Lost to Follow-up|5|||
105483353|NCT01931670|363782682|FG002|Treatment Period|Lost to Follow-up|7|||
105483354|NCT01931670|363782680|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
105483355|NCT01931670|363782681|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
105483356|NCT01931670|363782682|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
105747377|NCT02052778|364729151|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747378|NCT02052778|364729152|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747379|NCT02052778|364729153|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747380|NCT02052778|364729154|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747381|NCT02052778|364729155|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747382|NCT02052778|364729156|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747383|NCT02052778|364729157|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747384|NCT02052778|364729158|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747385|NCT02052778|364729159|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
105747386|NCT01994226|364729162|FG000|Overall Study|Protocol Violation|13|||
105747387|NCT01994226|364729163|FG001|Overall Study|Protocol Violation|10|||
105747388|NCT01994226|364729162|FG000|Overall Study|Early Cessation of treatment|6|||
105747389|NCT01994226|364729163|FG001|Overall Study|Early Cessation of treatment|11|||
105747390|NCT01576016|364729168|FG000|Lead Safety|Death|132|||
105747391|NCT01576016|364729169|FG001|Lead Safety|Death|0|||
105747392|NCT01576016|364729168|FG000|Lead Safety|Withdrawal by Subject|81|||
105747393|NCT01576016|364729169|FG001|Lead Safety|Withdrawal by Subject|0|||
105747394|NCT01576016|364729168|FG000|Lead Safety|System Explanted without Replacement|24|||
105747395|NCT01576016|364729169|FG001|Lead Safety|System Explanted without Replacement|0|||
105747396|NCT01576016|364729168|FG000|Lead Safety|Physician Decision|14|||
105747397|NCT01576016|364729169|FG001|Lead Safety|Physician Decision|0|||
105747398|NCT01576016|364729168|FG000|Lead Safety|Lost to Follow-up|13|||
105747399|NCT01576016|364729169|FG001|Lead Safety|Lost to Follow-up|0|||
105747400|NCT01576016|364729168|FG000|Lead Safety|Unsuccessful implant|2|||
105747401|NCT01576016|364729169|FG001|Lead Safety|Unsuccessful implant|0|||
105747402|NCT01576016|364729168|FG000|Lead Safety|Sponsor request|1|||
105747403|NCT01576016|364729169|FG001|Lead Safety|Sponsor request|0|||
105747404|NCT01576016|364729168|FG000|Lead Safety|Device replaced with CRT-D|1|||
105747405|NCT01576016|364729169|FG001|Lead Safety|Device replaced with CRT-D|0|||
105747406|NCT01576016|364729168|FG000|Lead Safety|Patient on Palliative Care|1|||
105747407|NCT01576016|364729169|FG001|Lead Safety|Patient on Palliative Care|0|||
105747408|NCT01576016|364729168|FG000|Lead Safety|Patient noncompliance|1|||
105747409|NCT01576016|364729169|FG001|Lead Safety|Patient noncompliance|0|||
105747410|NCT01576016|364729168|FG000|Lead Safety|Too far from study site|1|||
105747411|NCT01576016|364729169|FG001|Lead Safety|Too far from study site|0|||
105747412|NCT01576016|364729168|FG000|Lead Safety|System deactivated|1|||
105747413|NCT01576016|364729169|FG001|Lead Safety|System deactivated|0|||
105747414|NCT01576016|364729168|FG000|Lead Safety|Patient no longer followed by study PI|1|||
105747415|NCT01576016|364729169|FG001|Lead Safety|Patient no longer followed by study PI|0|||
105747416|NCT01576016|364729168|FG000|MRI Safety|Withdrawal by Subject|0|||
105747417|NCT01576016|364729169|FG001|MRI Safety|Withdrawal by Subject|10|||
105747418|NCT01576016|364729168|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
105747419|NCT01576016|364729169|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
105747420|NCT01576016|364729168|FG000|MRI Safety|Has not yet completed MRI scan|0|||
105747421|NCT01576016|364729169|FG001|MRI Safety|Has not yet completed MRI scan|56|||
105747422|NCT01576016|364729168|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
105747423|NCT01576016|364729169|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
105747424|NCT02411201|364729170|FG000|Overall Study|Adverse Event|2|||
105747425|NCT02411201|364729170|FG000|Overall Study|Withdrawal by Subject|2|||
105747426|NCT02411201|364729170|FG000|Overall Study|Age group completed|2|||
105747427|NCT01260467|364729171|FG000|Overall Study|Withdrawal by Subject|2|||
105747428|NCT02488551|364729172|FG000|Overall Study|Lost to Follow-up|4|||
105747429|NCT02488551|364729173|FG001|Overall Study|Lost to Follow-up|7|||
105747430|NCT02488551|364729174|FG002|Overall Study|Lost to Follow-up|0|||
105747431|NCT02488551|364729175|FG003|Overall Study|Lost to Follow-up|0|||
105747432|NCT02488551|364729172|FG000|Overall Study|Military Deployment|1|||
105747433|NCT02488551|364729173|FG001|Overall Study|Military Deployment|1|||
105747434|NCT02488551|364729174|FG002|Overall Study|Military Deployment|0|||
105747435|NCT02488551|364729175|FG003|Overall Study|Military Deployment|0|||
105747436|NCT00798694|364729176|FG000|Overall Study|Lost to Follow-up|1|||
105747437|NCT00798694|364729177|FG001|Overall Study|Lost to Follow-up|1|||
105747438|NCT00798694|364729176|FG000|Overall Study|Physician Decision|1|||
105801216|NCT00931385|364928627|FG003|Overall Study|Withdrawal by Subject|1|||
105483357|NCT01931670|363782680|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
105483358|NCT01931670|363782681|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
105483359|NCT01931670|363782682|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
105747439|NCT00798694|364729177|FG001|Overall Study|Physician Decision|0|||
105747440|NCT01409031|364729180|FG000|Overall Study|transferred to other hosp|1|||
105747441|NCT01409031|364729181|FG001|Overall Study|transferred to other hosp|0|||
105747442|NCT04507867|364729193|FG000|Overall Study|Death|7|||
105747443|NCT04507867|364729194|FG001|Overall Study|Death|1|||
105747444|NCT01188564|364729197|FG000|Double-blind Phase|randomized not treated|1|||
105747445|NCT01188564|364729198|FG001|Double-blind Phase|randomized not treated|0|||
105747446|NCT01094730|364729199|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
105747447|NCT01094730|364729200|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
105747448|NCT01094730|364729199|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
105747449|NCT01094730|364729200|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
105747450|NCT01094730|364729199|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
105747451|NCT01094730|364729200|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
105747452|NCT01094730|364729199|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
105747453|NCT01094730|364729200|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
105747454|NCT01094730|364729199|FG000|Period 2 (14 Days)|Protocol Violation|2|||
105747455|NCT01094730|364729200|FG001|Period 2 (14 Days)|Protocol Violation|0|||
105747456|NCT01094730|364729199|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
105747457|NCT01094730|364729200|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
105747458|NCT01094730|364729199|FG000|Period 2 (14 Days)|Adverse Event|0|||
105747459|NCT01094730|364729200|FG001|Period 2 (14 Days)|Adverse Event|1|||
105747460|NCT01094730|364729199|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
105747461|NCT01094730|364729200|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
105747462|NCT00779324|364729201|FG000|Overall Study|Lost to Follow-up|2|||
105747463|NCT00779324|364729202|FG001|Overall Study|Lost to Follow-up|1|||
105747464|NCT00779324|364729201|FG000|Overall Study|Withdrawal by Subject|4|||
105747465|NCT00779324|364729202|FG001|Overall Study|Withdrawal by Subject|2|||
105747466|NCT00779324|364729201|FG000|Overall Study|Missed visit|1|||
105747467|NCT00779324|364729202|FG001|Overall Study|Missed visit|1|||
105747468|NCT01217190|364729203|FG000|Second Dosing|Withdrawal by Subject|0|||
105747469|NCT01217190|364729204|FG001|Second Dosing|Withdrawal by Subject|2|||
105747470|NCT00543569|364729205|FG000|Overall Study|Death|2|||
105747471|NCT00543569|364729206|FG001|Overall Study|Death|2|||
105747472|NCT00543569|364729207|FG002|Overall Study|Death|3|||
105747473|NCT00543569|364729208|FG003|Overall Study|Death|1|||
105747474|NCT00543569|364729205|FG000|Overall Study|Lost to Follow-up|0|||
105747475|NCT00543569|364729206|FG001|Overall Study|Lost to Follow-up|0|||
105747476|NCT00543569|364729207|FG002|Overall Study|Lost to Follow-up|1|||
105747477|NCT00543569|364729208|FG003|Overall Study|Lost to Follow-up|1|||
105747478|NCT00543569|364729205|FG000|Overall Study|Miscellaneous Reasons|7|||
105747479|NCT00543569|364729206|FG001|Overall Study|Miscellaneous Reasons|3|||
105747480|NCT00543569|364729207|FG002|Overall Study|Miscellaneous Reasons|11|||
105747481|NCT00543569|364729208|FG003|Overall Study|Miscellaneous Reasons|4|||
105747482|NCT00543569|364729205|FG000|Overall Study|Randomized but never received study drug|3|||
105747483|NCT00543569|364729206|FG001|Overall Study|Randomized but never received study drug|3|||
105747484|NCT00543569|364729207|FG002|Overall Study|Randomized but never received study drug|5|||
105747485|NCT00543569|364729208|FG003|Overall Study|Randomized but never received study drug|3|||
105483360|NCT01931670|363782680|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
105483361|NCT01931670|363782681|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
105483362|NCT01931670|363782682|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
105747486|NCT00195260|364729212|FG000|Part 1: Dose Escalation|Adverse Event|0|||
105747487|NCT00195260|364729213|FG001|Part 1: Dose Escalation|Adverse Event|1|||
105747488|NCT00195260|364729214|FG002|Part 1: Dose Escalation|Adverse Event|0|||
105747489|NCT00195260|364729215|FG003|Part 1: Dose Escalation|Adverse Event|1|||
105747490|NCT00195260|364729216|FG004|Part 1: Dose Escalation|Adverse Event|1|||
105747491|NCT00195260|364729217|FG005|Part 1: Dose Escalation|Adverse Event|0|||
105747492|NCT00195260|364729218|FG006|Part 1: Dose Escalation|Adverse Event|3|||
105747493|NCT00195260|364729219|FG007|Part 1: Dose Escalation|Adverse Event|0|||
105747494|NCT00195260|364729220|FG008|Part 1: Dose Escalation|Adverse Event|0|||
105747495|NCT00195260|364729221|FG009|Part 1: Dose Escalation|Adverse Event|0|||
105747496|NCT00195260|364729222|FG010|Part 1: Dose Escalation|Adverse Event|0|||
105747497|NCT00195260|364729212|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747498|NCT00195260|364729213|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747499|NCT00195260|364729214|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747500|NCT00195260|364729215|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747501|NCT00195260|364729216|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
105747502|NCT00195260|364729217|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747503|NCT00195260|364729218|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747504|NCT00195260|364729219|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
105747505|NCT00195260|364729220|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105801217|NCT00931385|364928624|FG000|Overall Study|Lost to Follow-up|0|||
105747506|NCT00195260|364729221|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747507|NCT00195260|364729222|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747508|NCT00195260|364729212|FG000|Part 1: Dose Escalation|Death|0|||
105747509|NCT00195260|364729213|FG001|Part 1: Dose Escalation|Death|0|||
105747510|NCT00195260|364729214|FG002|Part 1: Dose Escalation|Death|0|||
105747511|NCT00195260|364729215|FG003|Part 1: Dose Escalation|Death|0|||
105747512|NCT00195260|364729216|FG004|Part 1: Dose Escalation|Death|0|||
105747513|NCT00195260|364729217|FG005|Part 1: Dose Escalation|Death|0|||
105747514|NCT00195260|364729218|FG006|Part 1: Dose Escalation|Death|0|||
105747515|NCT00195260|364729219|FG007|Part 1: Dose Escalation|Death|1|||
105747516|NCT00195260|364729220|FG008|Part 1: Dose Escalation|Death|0|||
105747517|NCT00195260|364729221|FG009|Part 1: Dose Escalation|Death|0|||
105747518|NCT00195260|364729222|FG010|Part 1: Dose Escalation|Death|0|||
105747519|NCT00195260|364729212|FG000|Part 1: Dose Escalation|Disease Progression|3|||
105747520|NCT00195260|364729213|FG001|Part 1: Dose Escalation|Disease Progression|2|||
105747521|NCT00195260|364729214|FG002|Part 1: Dose Escalation|Disease Progression|5|||
105747522|NCT00195260|364729215|FG003|Part 1: Dose Escalation|Disease Progression|6|||
105747523|NCT00195260|364729216|FG004|Part 1: Dose Escalation|Disease Progression|4|||
105747524|NCT00195260|364729217|FG005|Part 1: Dose Escalation|Disease Progression|6|||
105747525|NCT00195260|364729218|FG006|Part 1: Dose Escalation|Disease Progression|7|||
105747526|NCT00195260|364729219|FG007|Part 1: Dose Escalation|Disease Progression|4|||
105747527|NCT00195260|364729220|FG008|Part 1: Dose Escalation|Disease Progression|0|||
105747528|NCT00195260|364729221|FG009|Part 1: Dose Escalation|Disease Progression|0|||
105747529|NCT00195260|364729222|FG010|Part 1: Dose Escalation|Disease Progression|0|||
105747530|NCT00195260|364729212|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
105747531|NCT00195260|364729213|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
105747532|NCT00195260|364729214|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
105747533|NCT00195260|364729215|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
105747534|NCT00195260|364729216|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
105747535|NCT00195260|364729217|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
105747536|NCT00195260|364729218|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
105747537|NCT00195260|364729219|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
105747538|NCT00195260|364729220|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
105747539|NCT00195260|364729221|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
105747540|NCT00195260|364729222|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
105747541|NCT00195260|364729212|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747542|NCT00195260|364729213|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747543|NCT00195260|364729214|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747544|NCT00195260|364729215|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747545|NCT00195260|364729216|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747546|NCT00195260|364729217|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747547|NCT00195260|364729218|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747548|NCT00195260|364729219|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747549|NCT00195260|364729220|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
105747550|NCT00195260|364729221|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
105747551|NCT00195260|364729222|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
105747552|NCT00195260|364729212|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747553|NCT00195260|364729213|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747554|NCT00195260|364729214|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747555|NCT00195260|364729215|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747556|NCT00195260|364729216|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747557|NCT00195260|364729217|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747558|NCT00195260|364729218|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747559|NCT00195260|364729219|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747560|NCT00195260|364729220|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
105747561|NCT00195260|364729221|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
105747562|NCT00195260|364729222|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
105747563|NCT00195260|364729212|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105483363|NCT01931670|363782680|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
105483364|NCT01931670|363782681|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
105747564|NCT00195260|364729213|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105747565|NCT00195260|364729214|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105801218|NCT00931385|364928625|FG001|Overall Study|Lost to Follow-up|0|||
105801219|NCT00931385|364928626|FG002|Overall Study|Lost to Follow-up|0|||
105801220|NCT00931385|364928627|FG003|Overall Study|Lost to Follow-up|1|||
105801221|NCT02230085|364928628|FG000|Overall Study|Physician Decision|1|||
105801222|NCT02230085|364928628|FG000|Overall Study|Withdrawal by Subject|3|||
105801223|NCT00580983|364928632|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
105801224|NCT02173301|364928633|FG000|Overall Study|Adverse Event|7|||
105801225|NCT02173301|364928634|FG001|Overall Study|Adverse Event|8|||
105801226|NCT02173301|364928635|FG002|Overall Study|Adverse Event|13|||
105801227|NCT02173301|364928636|FG003|Overall Study|Adverse Event|5|||
105801228|NCT02173301|364928633|FG000|Overall Study|Withdrawal by Subject|8|||
105801229|NCT02173301|364928634|FG001|Overall Study|Withdrawal by Subject|10|||
105801230|NCT02173301|364928635|FG002|Overall Study|Withdrawal by Subject|4|||
105801231|NCT02173301|364928636|FG003|Overall Study|Withdrawal by Subject|8|||
105801232|NCT02173301|364928633|FG000|Overall Study|Lost to Follow-up|4|||
105801233|NCT02173301|364928634|FG001|Overall Study|Lost to Follow-up|4|||
105801234|NCT02173301|364928635|FG002|Overall Study|Lost to Follow-up|2|||
105801235|NCT02173301|364928636|FG003|Overall Study|Lost to Follow-up|2|||
105801236|NCT02173301|364928633|FG000|Overall Study|Protocol Violation|0|||
105801237|NCT02173301|364928634|FG001|Overall Study|Protocol Violation|1|||
105801238|NCT02173301|364928635|FG002|Overall Study|Protocol Violation|0|||
105801239|NCT02173301|364928636|FG003|Overall Study|Protocol Violation|0|||
105801240|NCT02173301|364928633|FG000|Overall Study|Physician Decision|0|||
105801241|NCT02173301|364928634|FG001|Overall Study|Physician Decision|0|||
105801242|NCT02173301|364928635|FG002|Overall Study|Physician Decision|1|||
105801243|NCT02173301|364928636|FG003|Overall Study|Physician Decision|0|||
105801244|NCT02173301|364928633|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
105801245|NCT02173301|364928634|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
105801246|NCT02173301|364928635|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
105801247|NCT02173301|364928636|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
105801248|NCT01025193|364928637|FG000|Overall Study|Protocol Violation|1|||
105801249|NCT01025193|364928637|FG000|Overall Study|Adverse Event|3|||
105801250|NCT01098240|364928638|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
105801251|NCT01098240|364928639|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
105801252|NCT01098240|364928640|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
105801253|NCT01098240|364928638|FG000|Open-Label Phase|Protocol Violation|4|||
105801254|NCT01098240|364928639|FG001|Open-Label Phase|Protocol Violation|0|||
105801255|NCT01098240|364928640|FG002|Open-Label Phase|Protocol Violation|0|||
105801256|NCT01098240|364928638|FG000|Open-Label Phase|Lost to Follow-up|13|||
105801257|NCT01098240|364928639|FG001|Open-Label Phase|Lost to Follow-up|0|||
105801258|NCT01098240|364928640|FG002|Open-Label Phase|Lost to Follow-up|0|||
105801259|NCT01098240|364928638|FG000|Open-Label Phase|Other|19|||
105801260|NCT01098240|364928639|FG001|Open-Label Phase|Other|0|||
105801261|NCT01098240|364928640|FG002|Open-Label Phase|Other|0|||
105801262|NCT01098240|364928638|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
105801263|NCT01098240|364928639|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
105801264|NCT01098240|364928640|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
105801265|NCT01098240|364928638|FG000|Open-Label Phase|Pregnancy|1|||
105801266|NCT01098240|364928639|FG001|Open-Label Phase|Pregnancy|0|||
105801267|NCT01098240|364928640|FG002|Open-Label Phase|Pregnancy|0|||
105801268|NCT01098240|364928638|FG000|Open-Label Phase|Withdrawal by Subject|9|||
105801269|NCT01098240|364928639|FG001|Open-Label Phase|Withdrawal by Subject|0|||
105801270|NCT01098240|364928640|FG002|Open-Label Phase|Withdrawal by Subject|0|||
105359700|NCT03410992|363322325|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
105801271|NCT01098240|364928638|FG000|Open-Label Phase|Adverse Event|12|||
105801272|NCT01098240|364928639|FG001|Open-Label Phase|Adverse Event|0|||
105801273|NCT01098240|364928640|FG002|Open-Label Phase|Adverse Event|0|||
105801274|NCT01098240|364928638|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
105801275|NCT01098240|364928639|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
105801276|NCT01098240|364928640|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
105801277|NCT01098240|364928638|FG000|Double-Blind Phase|Protocol Violation|0|||
105801278|NCT01098240|364928639|FG001|Double-Blind Phase|Protocol Violation|2|||
105483365|NCT01931670|363782682|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
105483366|NCT01931670|363782680|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
105483367|NCT01931670|363782681|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
105747566|NCT00195260|364729215|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105747567|NCT00195260|364729216|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105747568|NCT00195260|364729217|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105747569|NCT00195260|364729218|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105747570|NCT00195260|364729219|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105747571|NCT00195260|364729220|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
105747572|NCT00195260|364729221|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
105747573|NCT00195260|364729222|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
105747574|NCT00195260|364729212|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747575|NCT00195260|364729213|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747576|NCT00195260|364729214|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747577|NCT00195260|364729215|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747578|NCT00195260|364729216|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747579|NCT00195260|364729217|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747580|NCT00195260|364729218|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747581|NCT00195260|364729219|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747582|NCT00195260|364729220|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
105747583|NCT00195260|364729221|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
105747584|NCT00195260|364729222|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
105747585|NCT04544709|364729223|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
105747586|NCT02993224|364729224|FG000|Core Phase - Period 1|Adverse Event|4|||
105747587|NCT02993224|364729224|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
105747588|NCT02993224|364729224|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
105747589|NCT02993224|364729224|FG000|Core Phase- Period 2|Adverse Event|1|||
105747590|NCT02993224|364729224|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
105747591|NCT02993224|364729224|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
105747592|NCT02993224|364729224|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
105747593|NCT02993224|364729224|FG000|Extension Phase|Adverse Event|3|||
105747594|NCT02993224|364729224|FG000|Extension Phase|Withdrawal by Subject|3|||
105747595|NCT02993224|364729224|FG000|Extension Phase|Lost to Follow-up|2|||
105747596|NCT02993224|364729224|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
105747597|NCT01814800|364729225|FG000|Overall Study|Adverse Event|2|||
105747598|NCT01814800|364729225|FG000|Overall Study|Pregnancy|1|||
105747599|NCT01814800|364729225|FG000|Overall Study|Sponsor decision|1|||
105747600|NCT01814800|364729225|FG000|Overall Study|Subject relocation|1|||
105747601|NCT03136185|364729226|FG000|Overall Study|Adverse Event|0|||
105747602|NCT03136185|364729227|FG001|Overall Study|Adverse Event|1|||
105747603|NCT03136185|364729228|FG002|Overall Study|Adverse Event|3|||
105747604|NCT03136185|364729229|FG003|Overall Study|Adverse Event|1|||
105747605|NCT03136185|364729230|FG004|Overall Study|Adverse Event|2|||
105747606|NCT03136185|364729231|FG005|Overall Study|Adverse Event|2|||
105747607|NCT03136185|364729232|FG006|Overall Study|Adverse Event|5|||
105747608|NCT03136185|364729233|FG007|Overall Study|Adverse Event|1|||
105747609|NCT03136185|364729234|FG008|Overall Study|Adverse Event|1|||
105747610|NCT03136185|364729226|FG000|Overall Study|Death|0|||
105747611|NCT03136185|364729227|FG001|Overall Study|Death|0|||
105747612|NCT03136185|364729228|FG002|Overall Study|Death|0|||
105747613|NCT03136185|364729229|FG003|Overall Study|Death|1|||
105747614|NCT03136185|364729230|FG004|Overall Study|Death|1|||
105747615|NCT03136185|364729231|FG005|Overall Study|Death|0|||
105747616|NCT03136185|364729232|FG006|Overall Study|Death|1|||
105747617|NCT03136185|364729233|FG007|Overall Study|Death|0|||
105747618|NCT03136185|364729234|FG008|Overall Study|Death|0|||
105747619|NCT03136185|364729226|FG000|Overall Study|Physician Decision|3|||
105747620|NCT03136185|364729227|FG001|Overall Study|Physician Decision|1|||
105747621|NCT03136185|364729228|FG002|Overall Study|Physician Decision|1|||
105747622|NCT03136185|364729229|FG003|Overall Study|Physician Decision|2|||
105747623|NCT03136185|364729230|FG004|Overall Study|Physician Decision|1|||
105747624|NCT03136185|364729231|FG005|Overall Study|Physician Decision|2|||
105747625|NCT03136185|364729232|FG006|Overall Study|Physician Decision|1|||
105747626|NCT03136185|364729233|FG007|Overall Study|Physician Decision|0|||
105747627|NCT03136185|364729234|FG008|Overall Study|Physician Decision|1|||
105747628|NCT03136185|364729226|FG000|Overall Study|Protocol Defined Disease Progression|0|||
105747629|NCT03136185|364729227|FG001|Overall Study|Protocol Defined Disease Progression|0|||
105747630|NCT03136185|364729228|FG002|Overall Study|Protocol Defined Disease Progression|1|||
105747631|NCT03136185|364729229|FG003|Overall Study|Protocol Defined Disease Progression|0|||
105747632|NCT03136185|364729230|FG004|Overall Study|Protocol Defined Disease Progression|0|||
105747633|NCT03136185|364729231|FG005|Overall Study|Protocol Defined Disease Progression|1|||
105747634|NCT03136185|364729232|FG006|Overall Study|Protocol Defined Disease Progression|0|||
105801279|NCT01098240|364928640|FG002|Double-Blind Phase|Protocol Violation|4|||
105747635|NCT03136185|364729233|FG007|Overall Study|Protocol Defined Disease Progression|1|||
105747636|NCT03136185|364729234|FG008|Overall Study|Protocol Defined Disease Progression|1|||
105747637|NCT03136185|364729226|FG000|Overall Study|Withdrawal by Subject|1|||
105747638|NCT03136185|364729227|FG001|Overall Study|Withdrawal by Subject|0|||
105747639|NCT03136185|364729228|FG002|Overall Study|Withdrawal by Subject|1|||
105747640|NCT03136185|364729229|FG003|Overall Study|Withdrawal by Subject|1|||
105747641|NCT03136185|364729230|FG004|Overall Study|Withdrawal by Subject|1|||
105747642|NCT03136185|364729231|FG005|Overall Study|Withdrawal by Subject|1|||
105747643|NCT03136185|364729232|FG006|Overall Study|Withdrawal by Subject|2|||
105747644|NCT03136185|364729233|FG007|Overall Study|Withdrawal by Subject|3|||
105747645|NCT03136185|364729234|FG008|Overall Study|Withdrawal by Subject|3|||
105747646|NCT03136185|364729226|FG000|Overall Study|Not Reported|4|||
105747647|NCT03136185|364729227|FG001|Overall Study|Not Reported|1|||
105747648|NCT03136185|364729228|FG002|Overall Study|Not Reported|0|||
105747649|NCT03136185|364729229|FG003|Overall Study|Not Reported|1|||
105747650|NCT03136185|364729230|FG004|Overall Study|Not Reported|0|||
105747651|NCT03136185|364729231|FG005|Overall Study|Not Reported|2|||
105747652|NCT03136185|364729232|FG006|Overall Study|Not Reported|1|||
105747653|NCT03136185|364729233|FG007|Overall Study|Not Reported|1|||
105747654|NCT03136185|364729234|FG008|Overall Study|Not Reported|0|||
105747655|NCT02491073|364729236|FG000|Overall Study|screen failure|1|||
105747656|NCT02491073|364729237|FG001|Overall Study|screen failure|0|||
105747657|NCT03738566|364729238|FG000|Initial Study Phase|Withdrawal by Subject|1|||
105747658|NCT03738566|364729239|FG001|Initial Study Phase|Withdrawal by Subject|1|||
105747659|NCT03738566|364729240|FG002|Initial Study Phase|Withdrawal by Subject|2|||
105747660|NCT03738566|364729241|FG003|Initial Study Phase|Withdrawal by Subject|0|||
105747661|NCT03738566|364729238|FG000|Initial Study Phase|Death|0|||
105747662|NCT03738566|364729239|FG001|Initial Study Phase|Death|1|||
105747663|NCT03738566|364729240|FG002|Initial Study Phase|Death|0|||
105747664|NCT03738566|364729241|FG003|Initial Study Phase|Death|0|||
105747665|NCT03738566|364729238|FG000|Initial Study Phase|Treatment failure|5|||
105747666|NCT03738566|364729239|FG001|Initial Study Phase|Treatment failure|0|||
105747667|NCT03738566|364729240|FG002|Initial Study Phase|Treatment failure|0|||
105747668|NCT03738566|364729241|FG003|Initial Study Phase|Treatment failure|0|||
105747669|NCT03738566|364729238|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
105747670|NCT03738566|364729239|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
105747671|NCT03738566|364729240|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
105747672|NCT03738566|364729241|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
105747673|NCT00634244|364729242|FG000|Overall Study|Never started treatment|0|||
105747674|NCT00634244|364729243|FG001|Overall Study|Never started treatment|1|||
105747675|NCT00634244|364729244|FG002|Overall Study|Never started treatment|0|||
105747676|NCT00634244|364729242|FG000|Overall Study|Death|1|||
105747677|NCT00634244|364729243|FG001|Overall Study|Death|6|||
105747678|NCT00634244|364729244|FG002|Overall Study|Death|0|||
105747679|NCT00634244|364729242|FG000|Overall Study|Adverse Event|0|||
105747680|NCT00634244|364729243|FG001|Overall Study|Adverse Event|2|||
105747681|NCT00634244|364729244|FG002|Overall Study|Adverse Event|0|||
105747682|NCT00634244|364729242|FG000|Overall Study|Withdrawal by Subject|0|||
105747683|NCT00634244|364729243|FG001|Overall Study|Withdrawal by Subject|1|||
105747684|NCT00634244|364729244|FG002|Overall Study|Withdrawal by Subject|0|||
105747685|NCT00634244|364729242|FG000|Overall Study|Physician Decision|0|||
105747686|NCT00634244|364729243|FG001|Overall Study|Physician Decision|1|||
105747687|NCT00634244|364729244|FG002|Overall Study|Physician Decision|0|||
105747688|NCT00634244|364729242|FG000|Overall Study|Disease progression/relapse|0|||
105747689|NCT00634244|364729243|FG001|Overall Study|Disease progression/relapse|1|||
105747690|NCT00634244|364729244|FG002|Overall Study|Disease progression/relapse|0|||
105747691|NCT00634244|364729242|FG000|Overall Study|Other complicating disease|0|||
105747692|NCT00634244|364729243|FG001|Overall Study|Other complicating disease|1|||
105747693|NCT00634244|364729244|FG002|Overall Study|Other complicating disease|0|||
105747694|NCT01683071|364729245|FG000|Part 1|Lack of Efficacy|1|||
105747695|NCT01683071|364729246|FG001|Part 1|Lack of Efficacy|0|||
105747696|NCT01683071|364729247|FG002|Part 1|Lack of Efficacy|0|||
105747697|NCT01683071|364729248|FG003|Part 1|Lack of Efficacy|3|||
105747698|NCT01683071|364729249|FG004|Part 1|Lack of Efficacy|0|||
105747699|NCT01683071|364729250|FG005|Part 1|Lack of Efficacy|0|||
105747700|NCT01683071|364729245|FG000|Part 1|Withdrawal by Subject|1|||
105747701|NCT01683071|364729246|FG001|Part 1|Withdrawal by Subject|2|||
105747702|NCT01683071|364729247|FG002|Part 1|Withdrawal by Subject|2|||
105747703|NCT01683071|364729248|FG003|Part 1|Withdrawal by Subject|1|||
105747704|NCT01683071|364729249|FG004|Part 1|Withdrawal by Subject|0|||
105747705|NCT01683071|364729250|FG005|Part 1|Withdrawal by Subject|0|||
105747706|NCT01683071|364729245|FG000|Part 1|Surgery Cancelled|1|||
105747707|NCT01683071|364729246|FG001|Part 1|Surgery Cancelled|0|||
105747708|NCT01683071|364729247|FG002|Part 1|Surgery Cancelled|0|||
105747709|NCT01683071|364729248|FG003|Part 1|Surgery Cancelled|0|||
105747710|NCT01683071|364729249|FG004|Part 1|Surgery Cancelled|0|||
105801280|NCT01098240|364928638|FG000|Double-Blind Phase|Lost to Follow-up|0|||
105801281|NCT01098240|364928639|FG001|Double-Blind Phase|Lost to Follow-up|2|||
105801282|NCT01098240|364928640|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105801283|NCT01098240|364928638|FG000|Double-Blind Phase|Other|0|||
105801284|NCT01098240|364928639|FG001|Double-Blind Phase|Other|2|||
105801285|NCT01098240|364928640|FG002|Double-Blind Phase|Other|2|||
105801286|NCT01098240|364928638|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
105801287|NCT01098240|364928639|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
105801288|NCT01098240|364928640|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
105801289|NCT01098240|364928638|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
105801290|NCT01098240|364928639|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
105801291|NCT01098240|364928640|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
105801292|NCT01098240|364928638|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
105801293|NCT01098240|364928639|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
105801294|NCT01098240|364928640|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
105801295|NCT01098240|364928638|FG000|Double-Blind Phase|Adverse Event|0|||
105801296|NCT01098240|364928639|FG001|Double-Blind Phase|Adverse Event|3|||
105801297|NCT01098240|364928640|FG002|Double-Blind Phase|Adverse Event|3|||
105801298|NCT01715415|364928644|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
105801299|NCT01715415|364928645|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
105801300|NCT01715415|364928644|FG000|Double-blind Treatment|Adverse Event|3|||
105801301|NCT01715415|364928645|FG001|Double-blind Treatment|Adverse Event|0|||
105801302|NCT01715415|364928644|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
105801303|NCT01715415|364928645|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
105801304|NCT01715415|364928644|FG000|Double-blind Treatment|Other|1|||
105801305|NCT01715415|364928645|FG001|Double-blind Treatment|Other|0|||
105801306|NCT01715415|364928644|FG000|Open-label Treatment|Adverse Event|0|||
105801307|NCT01715415|364928645|FG001|Open-label Treatment|Adverse Event|1|||
105801308|NCT01715415|364928644|FG000|Open-label Treatment|Subject Noncompliant|0|||
105801309|NCT01715415|364928645|FG001|Open-label Treatment|Subject Noncompliant|1|||
105801310|NCT01015612|364928646|FG000|Overall Study|Death|113|||
105801311|NCT01015612|364928646|FG000|Overall Study|Withdrawal by Subject|40|||
105801312|NCT04136626|364928647|FG000|Treatment Phase|Withdrawal by Subject|1|||
105801313|NCT04136626|364928648|FG001|Treatment Phase|Withdrawal by Subject|9|||
105801314|NCT04136626|364928647|FG000|Treatment Phase|Adverse Event|1|||
105801315|NCT04136626|364928648|FG001|Treatment Phase|Adverse Event|0|||
105801316|NCT04136626|364928647|FG000|Treatment Phase|Lost to Follow-up|1|||
105801317|NCT04136626|364928648|FG001|Treatment Phase|Lost to Follow-up|5|||
105801318|NCT04136626|364928647|FG000|12-month Follow-up|Lost to Follow-up|8|||
105801319|NCT04136626|364928648|FG001|12-month Follow-up|Lost to Follow-up|7|||
105801320|NCT01416142|364930533|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
105801321|NCT01416142|364930534|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
105801322|NCT01416142|364930535|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
105801323|NCT01165242|364930537|FG000|Overall Study|Unreachable Subjects|1|||
105801324|NCT01165242|364930538|FG001|Overall Study|Unreachable Subjects|0|||
105801325|NCT01165242|364930539|FG002|Overall Study|Unreachable Subjects|0|||
105801326|NCT01165242|364930537|FG000|Overall Study|Incarcerated Subjects|0|||
105801327|NCT01165242|364930538|FG001|Overall Study|Incarcerated Subjects|1|||
105801328|NCT01165242|364930539|FG002|Overall Study|Incarcerated Subjects|0|||
105801329|NCT01165242|364930537|FG000|Overall Study|Visit 2 Declined by Subject|0|||
105801330|NCT01165242|364930538|FG001|Overall Study|Visit 2 Declined by Subject|0|||
105801331|NCT01165242|364930539|FG002|Overall Study|Visit 2 Declined by Subject|1|||
105801332|NCT01165242|364930537|FG000|Overall Study|Withdrawal by Subject|0|||
105801333|NCT01165242|364930538|FG001|Overall Study|Withdrawal by Subject|2|||
105801334|NCT01165242|364930539|FG002|Overall Study|Withdrawal by Subject|2|||
105801335|NCT01165242|364930537|FG000|Overall Study|Extended Holiday|0|||
105801336|NCT01165242|364930538|FG001|Overall Study|Extended Holiday|0|||
105801337|NCT01165242|364930539|FG002|Overall Study|Extended Holiday|1|||
105801338|NCT01165242|364930537|FG000|Overall Study|Lost to Follow-up|9|||
105801339|NCT01165242|364930538|FG001|Overall Study|Lost to Follow-up|7|||
105801340|NCT01165242|364930539|FG002|Overall Study|Lost to Follow-up|10|||
105801341|NCT03770000|364930540|FG000|Overall Study|Premature discontinuation due to PD|0|||
105801342|NCT03770000|364930541|FG001|Overall Study|Premature discontinuation due to PD|0|||
105801343|NCT03770000|364930542|FG002|Overall Study|Premature discontinuation due to PD|1|||
105359701|NCT03410992|363322326|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
105801344|NCT03770000|364930543|FG003|Overall Study|Premature discontinuation due to PD|3|||
105801345|NCT03770000|364930544|FG004|Overall Study|Premature discontinuation due to PD|2|||
105801346|NCT03877237|364930545|FG000|Overall Study|Adverse Event|1|||
105801347|NCT03877237|364930546|FG001|Overall Study|Adverse Event|2|||
105801348|NCT03877237|364930545|FG000|Overall Study|Death|3|||
105801349|NCT03877237|364930546|FG001|Overall Study|Death|2|||
105801350|NCT03877237|364930545|FG000|Overall Study|Physician Decision|1|||
105801351|NCT03877237|364930546|FG001|Overall Study|Physician Decision|0|||
105801352|NCT03877237|364930545|FG000|Overall Study|Withdrawal by Subject|0|||
105359702|NCT03410992|363322327|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
105801353|NCT03877237|364930546|FG001|Overall Study|Withdrawal by Subject|2|||
105747711|NCT01683071|364729250|FG005|Part 1|Surgery Cancelled|0|||
105747712|NCT01683071|364729245|FG000|Part 1|Did not receive study drug|1|||
105747713|NCT01683071|364729246|FG001|Part 1|Did not receive study drug|0|||
105747714|NCT01683071|364729247|FG002|Part 1|Did not receive study drug|0|||
105747715|NCT01683071|364729248|FG003|Part 1|Did not receive study drug|1|||
105747716|NCT01683071|364729249|FG004|Part 1|Did not receive study drug|0|||
105747717|NCT01683071|364729250|FG005|Part 1|Did not receive study drug|0|||
105747718|NCT01683071|364729245|FG000|Part 1|Early termination; met exclusion criteria|0|||
105747719|NCT01683071|364729246|FG001|Part 1|Early termination; met exclusion criteria|2|||
105747720|NCT01683071|364729247|FG002|Part 1|Early termination; met exclusion criteria|1|||
105747721|NCT01683071|364729248|FG003|Part 1|Early termination; met exclusion criteria|0|||
105747722|NCT01683071|364729249|FG004|Part 1|Early termination; met exclusion criteria|0|||
105747723|NCT01683071|364729250|FG005|Part 1|Early termination; met exclusion criteria|0|||
105747724|NCT01683071|364729245|FG000|Part 2|Lack of Efficacy|0|||
105747725|NCT01683071|364729246|FG001|Part 2|Lack of Efficacy|0|||
105747726|NCT01683071|364729247|FG002|Part 2|Lack of Efficacy|0|||
105747727|NCT01683071|364729248|FG003|Part 2|Lack of Efficacy|0|||
105747728|NCT01683071|364729249|FG004|Part 2|Lack of Efficacy|3|||
105747729|NCT01683071|364729250|FG005|Part 2|Lack of Efficacy|4|||
105747730|NCT01683071|364729245|FG000|Part 2|Lost to Follow-up|0|||
105747731|NCT01683071|364729246|FG001|Part 2|Lost to Follow-up|0|||
105747732|NCT01683071|364729247|FG002|Part 2|Lost to Follow-up|0|||
105747733|NCT01683071|364729248|FG003|Part 2|Lost to Follow-up|0|||
105747734|NCT01683071|364729249|FG004|Part 2|Lost to Follow-up|2|||
105747735|NCT01683071|364729250|FG005|Part 2|Lost to Follow-up|0|||
105747736|NCT01683071|364729245|FG000|Part 2|Withdrawal by Subject|0|||
105747737|NCT01683071|364729246|FG001|Part 2|Withdrawal by Subject|0|||
105747738|NCT01683071|364729247|FG002|Part 2|Withdrawal by Subject|0|||
105747739|NCT01683071|364729248|FG003|Part 2|Withdrawal by Subject|0|||
105747740|NCT01683071|364729249|FG004|Part 2|Withdrawal by Subject|3|||
105747741|NCT01683071|364729250|FG005|Part 2|Withdrawal by Subject|3|||
105747742|NCT01683071|364729245|FG000|Part 2|Surgery cancelled|0|||
105747743|NCT01683071|364729246|FG001|Part 2|Surgery cancelled|0|||
105747744|NCT01683071|364729247|FG002|Part 2|Surgery cancelled|0|||
105747745|NCT01683071|364729248|FG003|Part 2|Surgery cancelled|0|||
105747746|NCT01683071|364729249|FG004|Part 2|Surgery cancelled|4|||
105747747|NCT01683071|364729250|FG005|Part 2|Surgery cancelled|2|||
105747748|NCT01683071|364729245|FG000|Part 2|Did not receive study drug|0|||
105747749|NCT01683071|364729246|FG001|Part 2|Did not receive study drug|0|||
105747750|NCT01683071|364729247|FG002|Part 2|Did not receive study drug|0|||
105747751|NCT01683071|364729248|FG003|Part 2|Did not receive study drug|0|||
105747752|NCT01683071|364729249|FG004|Part 2|Did not receive study drug|2|||
105747753|NCT01683071|364729250|FG005|Part 2|Did not receive study drug|1|||
105747754|NCT01683071|364729245|FG000|Part 2|Met exclusion criterion|0|||
105747755|NCT01683071|364729246|FG001|Part 2|Met exclusion criterion|0|||
105747756|NCT01683071|364729247|FG002|Part 2|Met exclusion criterion|0|||
105747757|NCT01683071|364729248|FG003|Part 2|Met exclusion criterion|0|||
105747758|NCT01683071|364729249|FG004|Part 2|Met exclusion criterion|1|||
105747759|NCT01683071|364729250|FG005|Part 2|Met exclusion criterion|1|||
105747760|NCT01683071|364729245|FG000|Part 2|Protocol deviation|0|||
105747761|NCT01683071|364729246|FG001|Part 2|Protocol deviation|0|||
105747762|NCT01683071|364729247|FG002|Part 2|Protocol deviation|0|||
105747763|NCT01683071|364729248|FG003|Part 2|Protocol deviation|0|||
105747764|NCT01683071|364729249|FG004|Part 2|Protocol deviation|1|||
105747765|NCT01683071|364729250|FG005|Part 2|Protocol deviation|2|||
105747766|NCT01683071|364729245|FG000|Part 2|Withdrawal by investigator decision|0|||
105747767|NCT01683071|364729246|FG001|Part 2|Withdrawal by investigator decision|0|||
105747768|NCT01683071|364729247|FG002|Part 2|Withdrawal by investigator decision|0|||
105747769|NCT01683071|364729248|FG003|Part 2|Withdrawal by investigator decision|0|||
105747770|NCT01683071|364729249|FG004|Part 2|Withdrawal by investigator decision|1|||
105747771|NCT01683071|364729250|FG005|Part 2|Withdrawal by investigator decision|2|||
105747772|NCT00406640|364729258|FG000|Acute Phase|Adverse Event|18|||
105359703|NCT03410992|363322328|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
105359704|NCT03410992|363322329|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
105747773|NCT00406640|364729259|FG001|Acute Phase|Adverse Event|13|||
105747774|NCT00406640|364729258|FG000|Acute Phase|Failed to Return|5|||
105747775|NCT00406640|364729259|FG001|Acute Phase|Failed to Return|1|||
105747776|NCT00406640|364729258|FG000|Acute Phase|Physician Decision|0|||
105747777|NCT00406640|364729259|FG001|Acute Phase|Physician Decision|1|||
105747778|NCT00406640|364729258|FG000|Acute Phase|Lost to Follow-up|7|||
105747779|NCT00406640|364729259|FG001|Acute Phase|Lost to Follow-up|4|||
105747780|NCT00406640|364729258|FG000|Acute Phase|Protocol deviation|4|||
105747781|NCT00406640|364729259|FG001|Acute Phase|Protocol deviation|10|||
105747782|NCT00406640|364729258|FG000|Acute Phase|Protocol Violation|3|||
105747783|NCT00406640|364729259|FG001|Acute Phase|Protocol Violation|2|||
105747784|NCT00406640|364729258|FG000|Acute Phase|Withdrawal by Subject|11|||
105747785|NCT00406640|364729259|FG001|Acute Phase|Withdrawal by Subject|9|||
105747786|NCT00406640|364729258|FG000|Acute Phase|Lack of Efficacy|3|||
105747787|NCT00406640|364729259|FG001|Acute Phase|Lack of Efficacy|3|||
105747788|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
105747789|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
105359705|NCT03410992|363322330|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
105359706|NCT03410992|363322331|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
105359707|NCT03410992|363322332|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
105359708|NCT03410992|363322322|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105359709|NCT03410992|363322323|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105359710|NCT03410992|363322324|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105747790|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Death|1|||
105747791|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Death|0|||
105747792|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
105747793|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
105747794|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
105747795|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
105747796|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
105747797|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
105747798|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|non-compliance|7|||
105747799|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|non-compliance|5|||
105747800|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
105747801|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
105747802|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
105747803|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
105747804|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
105747805|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
105747806|NCT00406640|364729258|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
105747807|NCT00406640|364729259|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
105747808|NCT00406640|364729258|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
105747809|NCT00406640|364729259|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
105747810|NCT00406640|364729258|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
105747811|NCT00406640|364729259|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
105747812|NCT00406640|364729258|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
105747813|NCT00406640|364729259|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
105747814|NCT00406640|364729258|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
105747815|NCT00406640|364729259|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
105747816|NCT00406640|364729258|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
105747817|NCT00406640|364729259|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
105747818|NCT00406640|364729258|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
105747819|NCT00406640|364729259|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
105747820|NCT05301322|364729267|FG000|Overall Study|Adverse Event|7|||
105747821|NCT05301322|364729268|FG001|Overall Study|Adverse Event|3|||
105747822|NCT05301322|364729267|FG000|Overall Study|Death|0|||
105747823|NCT05301322|364729268|FG001|Overall Study|Death|1|||
105747824|NCT05301322|364729267|FG000|Overall Study|Lost to Follow-up|2|||
105747825|NCT05301322|364729268|FG001|Overall Study|Lost to Follow-up|1|||
105747826|NCT05301322|364729267|FG000|Overall Study|Protocol Violation|3|||
105747827|NCT05301322|364729268|FG001|Overall Study|Protocol Violation|1|||
105747828|NCT05301322|364729267|FG000|Overall Study|Withdrawal by Subject|3|||
105747829|NCT05301322|364729268|FG001|Overall Study|Withdrawal by Subject|0|||
105747830|NCT05301322|364729267|FG000|Overall Study|Other|4|||
105747831|NCT05301322|364729268|FG001|Overall Study|Other|0|||
105747832|NCT01968187|364729272|FG000|Overall Study|Adverse Event|0|||
105747833|NCT01968187|364729273|FG001|Overall Study|Adverse Event|1|||
105747834|NCT01968187|364729272|FG000|Overall Study|Randomized but not treated|1|||
105747835|NCT01968187|364729273|FG001|Overall Study|Randomized but not treated|0|||
105747836|NCT03829332|364729276|FG000|Overall Study|Death|225|||
105747837|NCT03829332|364729277|FG001|Overall Study|Death|230|||
105747838|NCT03829332|364729276|FG000|Overall Study|Lost to Follow-up|1|||
105747839|NCT03829332|364729277|FG001|Overall Study|Lost to Follow-up|3|||
105747840|NCT03829332|364729276|FG000|Overall Study|Physician Decision|1|||
105747841|NCT03829332|364729277|FG001|Overall Study|Physician Decision|0|||
105747842|NCT03829332|364729276|FG000|Overall Study|Sponsor Decision|71|||
105747843|NCT03829332|364729277|FG001|Overall Study|Sponsor Decision|72|||
105747844|NCT03829332|364729276|FG000|Overall Study|Withdrawal by Subject|11|||
105747845|NCT03829332|364729277|FG001|Overall Study|Withdrawal by Subject|9|||
105747846|NCT00430521|364729278|FG000|Overall Study|Adverse Event|0|||
105747847|NCT00430521|364729279|FG001|Overall Study|Adverse Event|0|||
105747848|NCT00430521|364729280|FG002|Overall Study|Adverse Event|0|||
105747849|NCT00430521|364729281|FG003|Overall Study|Adverse Event|0|||
105747850|NCT00430521|364729282|FG004|Overall Study|Adverse Event|0|||
105747851|NCT00430521|364729283|FG005|Overall Study|Adverse Event|2|||
105747852|NCT00430521|364729284|FG006|Overall Study|Adverse Event|1|||
105747853|NCT00430521|364729285|FG007|Overall Study|Adverse Event|0|||
105747854|NCT00430521|364729278|FG000|Overall Study|Lost to Follow-up|7|||
105747855|NCT00430521|364729279|FG001|Overall Study|Lost to Follow-up|8|||
105747856|NCT00430521|364729280|FG002|Overall Study|Lost to Follow-up|3|||
105747857|NCT00430521|364729281|FG003|Overall Study|Lost to Follow-up|5|||
105747858|NCT00430521|364729282|FG004|Overall Study|Lost to Follow-up|5|||
105747859|NCT00430521|364729283|FG005|Overall Study|Lost to Follow-up|2|||
105747860|NCT00430521|364729284|FG006|Overall Study|Lost to Follow-up|8|||
105747861|NCT00430521|364729285|FG007|Overall Study|Lost to Follow-up|10|||
105747862|NCT00430521|364729278|FG000|Overall Study|Pregnancy|0|||
105747863|NCT00430521|364729279|FG001|Overall Study|Pregnancy|0|||
105747864|NCT00430521|364729280|FG002|Overall Study|Pregnancy|0|||
105747865|NCT00430521|364729281|FG003|Overall Study|Pregnancy|0|||
105747866|NCT00430521|364729282|FG004|Overall Study|Pregnancy|0|||
105747867|NCT00430521|364729283|FG005|Overall Study|Pregnancy|0|||
105747868|NCT00430521|364729284|FG006|Overall Study|Pregnancy|1|||
105747869|NCT00430521|364729285|FG007|Overall Study|Pregnancy|0|||
105747870|NCT00430521|364729278|FG000|Overall Study|Vaccine Expired|0|||
105747871|NCT00430521|364729279|FG001|Overall Study|Vaccine Expired|0|||
105747872|NCT00430521|364729280|FG002|Overall Study|Vaccine Expired|0|||
105747873|NCT00430521|364729281|FG003|Overall Study|Vaccine Expired|0|||
105747874|NCT00430521|364729282|FG004|Overall Study|Vaccine Expired|0|||
105747875|NCT00430521|364729283|FG005|Overall Study|Vaccine Expired|1|||
105747876|NCT00430521|364729284|FG006|Overall Study|Vaccine Expired|0|||
105747877|NCT00430521|364729285|FG007|Overall Study|Vaccine Expired|0|||
105747878|NCT00430521|364729278|FG000|Overall Study|Protocol Violation|1|||
105747879|NCT00430521|364729279|FG001|Overall Study|Protocol Violation|0|||
105747880|NCT00430521|364729280|FG002|Overall Study|Protocol Violation|0|||
105747881|NCT00430521|364729281|FG003|Overall Study|Protocol Violation|0|||
105747882|NCT00430521|364729282|FG004|Overall Study|Protocol Violation|0|||
105747883|NCT00430521|364729283|FG005|Overall Study|Protocol Violation|0|||
105747884|NCT00430521|364729284|FG006|Overall Study|Protocol Violation|0|||
105747885|NCT00430521|364729285|FG007|Overall Study|Protocol Violation|0|||
105747886|NCT00430521|364729278|FG000|Overall Study|Withdrawal by Subject|3|||
105747887|NCT00430521|364729279|FG001|Overall Study|Withdrawal by Subject|1|||
105747888|NCT00430521|364729280|FG002|Overall Study|Withdrawal by Subject|0|||
105747889|NCT00430521|364729281|FG003|Overall Study|Withdrawal by Subject|3|||
105747890|NCT00430521|364729282|FG004|Overall Study|Withdrawal by Subject|0|||
105747891|NCT00430521|364729283|FG005|Overall Study|Withdrawal by Subject|0|||
105747892|NCT00430521|364729284|FG006|Overall Study|Withdrawal by Subject|0|||
105747893|NCT00430521|364729285|FG007|Overall Study|Withdrawal by Subject|2|||
105747894|NCT04095286|364729286|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747895|NCT04095286|364729287|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
105747896|NCT04095286|364729288|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747897|NCT04095286|364729289|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747898|NCT04095286|364729290|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747899|NCT04095286|364729291|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747900|NCT04095286|364729286|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
105747901|NCT04095286|364729287|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
105747902|NCT04095286|364729288|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
105747903|NCT04095286|364729289|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
105747904|NCT04095286|364729290|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
105747905|NCT04095286|364729291|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
105747906|NCT04095286|364729286|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
105747907|NCT04095286|364729287|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
105747908|NCT04095286|364729288|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
105747909|NCT04095286|364729289|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
105801354|NCT02236754|364930547|FG000|Overall Study|Withdrawal by Subject|1|||
105747910|NCT04095286|364729290|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
105801355|NCT02236754|364930548|FG001|Overall Study|Withdrawal by Subject|0|||
105801356|NCT02082912|364930549|FG000|Overall Study|Physician Decision|0|||
105801357|NCT02082912|364930550|FG001|Overall Study|Physician Decision|1|||
105801358|NCT01835132|364930551|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
105801359|NCT00856778|364930552|FG000|Overall Study|Adverse Event|7|||
105483368|NCT01931670|363782682|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
105483369|NCT01931670|363782680|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
105483370|NCT01931670|363782681|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
105747911|NCT04095286|364729291|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
105801360|NCT00856778|364930552|FG000|Overall Study|Withdrawal by Subject|10|||
105801361|NCT00856778|364930552|FG000|Overall Study|Study deviation|2|||
105801362|NCT00856778|364930552|FG000|Overall Study|Lost to Follow-up|5|||
105747912|NCT04095286|364729286|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747913|NCT04095286|364729287|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747914|NCT04095286|364729288|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
105747915|NCT04095286|364729289|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747916|NCT04095286|364729290|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747917|NCT04095286|364729291|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747918|NCT04095286|364729286|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
105747919|NCT04095286|364729287|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
105747920|NCT04095286|364729288|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
105747921|NCT04095286|364729289|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
105747922|NCT04095286|364729290|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
105747923|NCT04095286|364729291|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
105747924|NCT03003403|364729292|FG000|Overall Study|Ineligible|8|||
105747925|NCT03003403|364729293|FG001|Overall Study|Ineligible|7|||
105747926|NCT03003403|364729292|FG000|Overall Study|Withdrawal by Subject|3|||
105747927|NCT03003403|364729293|FG001|Overall Study|Withdrawal by Subject|1|||
105760787|NCT03627494|364776201|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760788|NCT03627494|364776202|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760789|NCT03627494|364776203|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760790|NCT03627494|364776204|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760791|NCT03627494|364776205|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760792|NCT03627494|364776206|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760793|NCT03627494|364776207|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760794|NCT03627494|364776208|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760795|NCT03627494|364776197|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760796|NCT03627494|364776198|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760797|NCT03627494|364776199|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760798|NCT03627494|364776200|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760799|NCT03627494|364776201|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760800|NCT03627494|364776202|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760801|NCT03627494|364776203|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760802|NCT03627494|364776204|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760803|NCT03627494|364776205|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
105760804|NCT03627494|364776206|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760805|NCT03627494|364776207|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760806|NCT03627494|364776208|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760807|NCT03627494|364776197|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760808|NCT03627494|364776198|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760809|NCT03627494|364776199|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760810|NCT03627494|364776200|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760811|NCT03627494|364776201|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760812|NCT03627494|364776202|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760813|NCT03627494|364776203|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760814|NCT03627494|364776204|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760815|NCT03627494|364776205|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760816|NCT03627494|364776206|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760817|NCT03627494|364776207|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
105760818|NCT03627494|364776208|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
105760819|NCT00191386|364778025|FG000|Overall Study|Adverse Event|16|||
105760820|NCT00191386|364778025|FG000|Overall Study|Lost to Follow-up|1|||
105760821|NCT00191386|364778025|FG000|Overall Study|Entry Criteria Exclusion|3|||
105760822|NCT00191386|364778025|FG000|Overall Study|Protocol Violation|18|||
105760823|NCT00191386|364778025|FG000|Overall Study|Withdrawal by Subject|96|||
105760824|NCT00191386|364778025|FG000|Overall Study|Physician Decision|11|||
105760825|NCT00191386|364778025|FG000|Overall Study|Lack of Efficacy|15|||
105760826|NCT02009930|364778029|FG000|Overall Study|withdrawn|5|||
105760827|NCT02707601|364778030|FG000|Overall Study|Death|0|||
105760828|NCT02707601|364778031|FG001|Overall Study|Death|1|||
105760829|NCT02707601|364778030|FG000|Overall Study|Lack of Efficacy|0|||
105760830|NCT02707601|364778031|FG001|Overall Study|Lack of Efficacy|1|||
105760831|NCT02707601|364778030|FG000|Overall Study|Investigator's Discretion|1|||
105760832|NCT02707601|364778031|FG001|Overall Study|Investigator's Discretion|0|||
105760833|NCT02707601|364778030|FG000|Overall Study|Withdrew Consent|0|||
105760834|NCT02707601|364778031|FG001|Overall Study|Withdrew Consent|1|||
105760835|NCT02707601|364778030|FG000|Overall Study|Lost to Follow-up|1|||
105760836|NCT02707601|364778031|FG001|Overall Study|Lost to Follow-up|1|||
105760837|NCT02707601|364778030|FG000|Overall Study|Participants Randomized but Not Treated|2|||
105760838|NCT02707601|364778031|FG001|Overall Study|Participants Randomized but Not Treated|0|||
105760839|NCT01444898|364778032|FG000|Overall Study|Withdrawal by Subject|1|||
105760840|NCT00493467|364778035|FG000|Overall Study|Death|1|||
105760841|NCT01831804|364778036|FG000|Overall Study|Adverse Event|0|||
105565372|NCT04512066|364066767|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
105565373|NCT04512066|364066768|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
105565374|NCT04512066|364066769|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
105565375|NCT04512066|364066770|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
105565376|NCT04512066|364066765|FG000|Double-blind Treatment Period|Physician Decision|1|||
105565377|NCT04512066|364066766|FG001|Double-blind Treatment Period|Physician Decision|0|||
105565378|NCT04512066|364066767|FG002|Double-blind Treatment Period|Physician Decision|1|||
105565379|NCT04512066|364066768|FG003|Double-blind Treatment Period|Physician Decision|0|||
105565380|NCT04512066|364066769|FG004|Double-blind Treatment Period|Physician Decision|0|||
105565381|NCT04512066|364066770|FG005|Double-blind Treatment Period|Physician Decision|0|||
105565382|NCT04512066|364066765|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
105565383|NCT04512066|364066766|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
105565384|NCT04512066|364066767|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
105565385|NCT04512066|364066768|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
105565386|NCT04512066|364066769|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
105565387|NCT04512066|364066770|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
105565388|NCT04512066|364066765|FG000|Extension Period|Adverse Event|0|||
105565389|NCT04512066|364066766|FG001|Extension Period|Adverse Event|1|||
105565390|NCT04512066|364066767|FG002|Extension Period|Adverse Event|4|||
105565391|NCT04512066|364066768|FG003|Extension Period|Adverse Event|3|||
105565392|NCT04512066|364066769|FG004|Extension Period|Adverse Event|1|||
105565393|NCT04512066|364066770|FG005|Extension Period|Adverse Event|3|||
105565394|NCT04512066|364066765|FG000|Extension Period|Death|0|||
105565395|NCT04512066|364066766|FG001|Extension Period|Death|0|||
105565396|NCT04512066|364066767|FG002|Extension Period|Death|0|||
105565397|NCT04512066|364066768|FG003|Extension Period|Death|0|||
105565398|NCT04512066|364066769|FG004|Extension Period|Death|0|||
105565399|NCT04512066|364066770|FG005|Extension Period|Death|1|||
105565400|NCT04512066|364066765|FG000|Extension Period|Lack of Efficacy|0|||
105565401|NCT04512066|364066766|FG001|Extension Period|Lack of Efficacy|4|||
105747928|NCT02294318|364731028|FG000|Overall Study|Worsening of drinking|3|||
105747929|NCT02294318|364731029|FG001|Overall Study|Worsening of drinking|0|||
105747930|NCT02294318|364731028|FG000|Overall Study|Not exposed to intervention|0|||
105747931|NCT02294318|364731029|FG001|Overall Study|Not exposed to intervention|2|||
105747932|NCT01694420|364731031|FG000|Overall Study|Lost to Follow-up|3|||
105747933|NCT03621943|364731032|FG000|First Randomized Intervention|Lost to Follow-up|51|||
105747934|NCT03621943|364731033|FG001|First Randomized Intervention|Lost to Follow-up|54|||
105747935|NCT03621943|364731032|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
105747936|NCT03621943|364731033|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
105747937|NCT03621943|364731032|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
105747938|NCT03621943|364731033|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
105747939|NCT03621943|364731032|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
105747940|NCT03621943|364731033|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
105747941|NCT00315705|364731034|FG000|Phase 1|Refused further treatment|1|||
105747942|NCT00315705|364731034|FG000|Phase 1|Failure to achieve response|8|||
105747943|NCT00315705|364731034|FG000|Phase 1|Disease relapse|4|||
105747944|NCT00315705|364731034|FG000|Phase 1|Scheduled for transplant|9|||
105747945|NCT00315705|364731034|FG000|Phase 1|Death|3|||
105747946|NCT00315705|364731034|FG000|Phase 2|Physician Decision|4|||
105747947|NCT00315705|364731034|FG000|Phase 2|Adverse Event|1|||
105747948|NCT00315705|364731034|FG000|Phase 2|Failure to achieve response|3|||
105747949|NCT00315705|364731034|FG000|Phase 2|Disease relapse|1|||
105747950|NCT00315705|364731034|FG000|Phase 2|Scheduled for transplant|8|||
105747951|NCT00315705|364731034|FG000|Phase 2|Other|1|||
105747952|NCT00315705|364731034|FG000|Phase 2|Death|7|||
105747953|NCT00748553|364731035|FG000|Overall Study|Adverse Event|0|||
105747954|NCT00748553|364731036|FG001|Overall Study|Adverse Event|1|||
105747955|NCT00748553|364731035|FG000|Overall Study|disease progression|2|||
105747956|NCT00748553|364731036|FG001|Overall Study|disease progression|0|||
105747957|NCT00748553|364731035|FG000|Overall Study|noncompliance|1|||
105747958|NCT00748553|364731036|FG001|Overall Study|noncompliance|0|||
105747959|NCT00948818|364731037|FG000|Overall Study|Adverse Event|10|||
105747960|NCT00948818|364731038|FG001|Overall Study|Adverse Event|32|||
105747961|NCT00948818|364731037|FG000|Overall Study|Protocol Violation|9|||
105747962|NCT00948818|364731038|FG001|Overall Study|Protocol Violation|10|||
105747963|NCT00948818|364731037|FG000|Overall Study|Withdrawal by Subject|25|||
105747964|NCT00948818|364731038|FG001|Overall Study|Withdrawal by Subject|25|||
105747965|NCT00948818|364731037|FG000|Overall Study|Lost to Follow-up|10|||
105747966|NCT00948818|364731038|FG001|Overall Study|Lost to Follow-up|17|||
105747967|NCT00948818|364731037|FG000|Overall Study|Lack of Efficacy|4|||
105565402|NCT04512066|364066767|FG002|Extension Period|Lack of Efficacy|4|||
105565403|NCT04512066|364066768|FG003|Extension Period|Lack of Efficacy|1|||
105747968|NCT00948818|364731038|FG001|Overall Study|Lack of Efficacy|5|||
105747969|NCT00948818|364731037|FG000|Overall Study|Other Reason|4|||
105747970|NCT00948818|364731038|FG001|Overall Study|Other Reason|5|||
105801363|NCT01681771|364930553|FG000|Overall Study|Lost to Follow-up|4|||
105747971|NCT01716533|364731039|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
105801364|NCT01681771|364930554|FG001|Overall Study|Lost to Follow-up|2|||
105801365|NCT03208933|364930555|FG000|Overall Study|Death|3|||
105801366|NCT03208933|364930555|FG000|Overall Study|Withdrawal by Subject|3|||
105801367|NCT03208933|364930555|FG000|Overall Study|Adverse Event|1|||
105801368|NCT03208933|364930555|FG000|Overall Study|Lost to Follow-up|2|||
105801369|NCT03208933|364930555|FG000|Overall Study|Physician Decision|3|||
105801370|NCT03208933|364930555|FG000|Overall Study|Protocol Violation|1|||
105801371|NCT02024698|364930558|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
105801372|NCT02024698|364930559|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
105801373|NCT00525031|364930561|FG000|Overall Study|Disease Progression|1|||
105801374|NCT00525031|364930562|FG001|Overall Study|Disease Progression|1|||
105801375|NCT00881959|364930563|FG000|Overall Study|Lost to Follow-up|2|||
105801376|NCT00881959|364930564|FG001|Overall Study|Lost to Follow-up|4|||
105801377|NCT02791659|364930565|FG000|Overall Study|Protocol Violation|0|||
105801378|NCT02791659|364930566|FG001|Overall Study|Protocol Violation|1|||
105801379|NCT01456052|364930567|FG000|Overall Study|Adverse Event|1|||
105801380|NCT01456052|364930568|FG001|Overall Study|Adverse Event|1|||
105801381|NCT01456052|364930569|FG002|Overall Study|Adverse Event|2|||
105801382|NCT01456052|364930567|FG000|Overall Study|Consent withdrawn|0|||
105801383|NCT01456052|364930568|FG001|Overall Study|Consent withdrawn|2|||
105801384|NCT01456052|364930569|FG002|Overall Study|Consent withdrawn|1|||
105801385|NCT01456052|364930567|FG000|Overall Study|Protocol Violation|0|||
105801386|NCT01456052|364930568|FG001|Overall Study|Protocol Violation|1|||
105801387|NCT01456052|364930569|FG002|Overall Study|Protocol Violation|0|||
105801388|NCT01456052|364930567|FG000|Overall Study|Physician Decision|1|||
105801389|NCT01456052|364930568|FG001|Overall Study|Physician Decision|0|||
105801390|NCT01456052|364930569|FG002|Overall Study|Physician Decision|1|||
105801391|NCT01456052|364930567|FG000|Overall Study|Treatment Failure|0|||
105801392|NCT01456052|364930568|FG001|Overall Study|Treatment Failure|1|||
105801393|NCT01456052|364930569|FG002|Overall Study|Treatment Failure|1|||
105801394|NCT01625845|364930572|FG000|Overall Study|Adverse Event|1|||
105801395|NCT01625845|364930573|FG001|Overall Study|Adverse Event|2|||
105801396|NCT01625845|364930572|FG000|Overall Study|Lost to Follow-up|2|||
105801397|NCT01625845|364930573|FG001|Overall Study|Lost to Follow-up|1|||
105801398|NCT01625845|364930572|FG000|Overall Study|Withdrawal by Subject|2|||
105801399|NCT01625845|364930573|FG001|Overall Study|Withdrawal by Subject|0|||
105801400|NCT01070966|364930575|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
105801401|NCT01070966|364930575|FG000|Participants for Safety Evaluation|Off-label use|9|||
105801402|NCT01070966|364930575|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
105801403|NCT01070966|364930575|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
105801404|NCT01070966|364930575|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
105801405|NCT01070966|364930575|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
105801406|NCT01070966|364930575|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
105801407|NCT01070966|364930575|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
105747972|NCT01716533|364731040|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
105747973|NCT01716533|364731041|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
105747974|NCT01716533|364731042|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
105747975|NCT01716533|364731039|FG000|Overall Study|Withdrawal by Subject|0|||
105747976|NCT01716533|364731040|FG001|Overall Study|Withdrawal by Subject|0|||
105747977|NCT01716533|364731041|FG002|Overall Study|Withdrawal by Subject|0|||
105747978|NCT01716533|364731042|FG003|Overall Study|Withdrawal by Subject|5|||
105747979|NCT01716533|364731039|FG000|Overall Study|Death|0|||
105747980|NCT01716533|364731040|FG001|Overall Study|Death|0|||
105801408|NCT02762565|364930576|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
105801409|NCT01113710|364930577|FG000|Overall Study|Adverse Event|64|||
105801410|NCT01113710|364930577|FG000|Overall Study|Lack of Efficacy|41|||
105801411|NCT01113710|364930577|FG000|Overall Study|No Information Available|40|||
105801412|NCT01113710|364930577|FG000|Overall Study|Withdrawal by Subject|28|||
105801413|NCT01113710|364930577|FG000|Overall Study|Lost to Follow-up|20|||
105801414|NCT01113710|364930577|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
105801415|NCT01113710|364930577|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
105801416|NCT01113710|364930577|FG000|Overall Study|Lack of Patient's Compliance|8|||
105801417|NCT01113710|364930577|FG000|Overall Study|Other|7|||
105801418|NCT01113710|364930577|FG000|Overall Study|Adverse Event/Other|5|||
105801419|NCT01113710|364930577|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
105801420|NCT01113710|364930577|FG000|Overall Study|Lack of Efficacy/Other|4|||
105359711|NCT03410992|363322325|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105565404|NCT04512066|364066769|FG004|Extension Period|Lack of Efficacy|3|||
105747981|NCT01716533|364731041|FG002|Overall Study|Death|0|||
105747982|NCT01716533|364731042|FG003|Overall Study|Death|2|||
105747983|NCT01716533|364731039|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
105801421|NCT01113710|364930577|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
105801422|NCT01113710|364930577|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
105801423|NCT01113710|364930577|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
105801424|NCT01113710|364930577|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
105747984|NCT01716533|364731040|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
105747985|NCT01716533|364731041|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
105747986|NCT01716533|364731042|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
105747987|NCT01670656|364731046|FG000|Overall Study|Non-compliance with study drug|0|||
105747988|NCT01670656|364731047|FG001|Overall Study|Non-compliance with study drug|0|||
105747989|NCT01670656|364731048|FG002|Overall Study|Non-compliance with study drug|3|||
105747990|NCT01670656|364731049|FG003|Overall Study|Non-compliance with study drug|0|||
105747991|NCT01670656|364731050|FG004|Overall Study|Non-compliance with study drug|1|||
105747992|NCT01670656|364731046|FG000|Overall Study|Pregnancy|0|||
105747993|NCT01670656|364731047|FG001|Overall Study|Pregnancy|0|||
105747994|NCT01670656|364731048|FG002|Overall Study|Pregnancy|0|||
105747995|NCT01670656|364731049|FG003|Overall Study|Pregnancy|0|||
105747996|NCT01670656|364731050|FG004|Overall Study|Pregnancy|1|||
105747997|NCT01670656|364731046|FG000|Overall Study|Withdrawal by Subject|1|||
105747998|NCT01670656|364731047|FG001|Overall Study|Withdrawal by Subject|1|||
105747999|NCT01670656|364731048|FG002|Overall Study|Withdrawal by Subject|0|||
105748000|NCT01670656|364731049|FG003|Overall Study|Withdrawal by Subject|0|||
105748001|NCT01670656|364731050|FG004|Overall Study|Withdrawal by Subject|0|||
105748002|NCT01670656|364731046|FG000|Overall Study|Non-compliance with protocol|0|||
105748003|NCT01670656|364731047|FG001|Overall Study|Non-compliance with protocol|3|||
105748004|NCT01670656|364731048|FG002|Overall Study|Non-compliance with protocol|1|||
105748005|NCT01670656|364731049|FG003|Overall Study|Non-compliance with protocol|1|||
105748006|NCT01670656|364731050|FG004|Overall Study|Non-compliance with protocol|2|||
105748007|NCT01670656|364731046|FG000|Overall Study|Adverse Event|2|||
105748008|NCT01670656|364731047|FG001|Overall Study|Adverse Event|2|||
105748009|NCT01670656|364731048|FG002|Overall Study|Adverse Event|2|||
105748010|NCT01670656|364731049|FG003|Overall Study|Adverse Event|3|||
105748011|NCT01670656|364731050|FG004|Overall Study|Adverse Event|3|||
105748012|NCT01670656|364731046|FG000|Overall Study|Subject withdrew consent|0|||
105748013|NCT01670656|364731047|FG001|Overall Study|Subject withdrew consent|1|||
105748014|NCT01670656|364731048|FG002|Overall Study|Subject withdrew consent|2|||
105748015|NCT01670656|364731049|FG003|Overall Study|Subject withdrew consent|1|||
105748016|NCT01670656|364731050|FG004|Overall Study|Subject withdrew consent|1|||
105748017|NCT01670656|364731046|FG000|Overall Study|Lost to Follow-up|0|||
105748018|NCT01670656|364731047|FG001|Overall Study|Lost to Follow-up|0|||
105748019|NCT01670656|364731048|FG002|Overall Study|Lost to Follow-up|0|||
105748020|NCT01670656|364731049|FG003|Overall Study|Lost to Follow-up|0|||
105748021|NCT01670656|364731050|FG004|Overall Study|Lost to Follow-up|3|||
105748022|NCT01670656|364731046|FG000|Overall Study|Subject moved|0|||
105748023|NCT01670656|364731047|FG001|Overall Study|Subject moved|0|||
105748024|NCT01670656|364731048|FG002|Overall Study|Subject moved|0|||
105748025|NCT01670656|364731049|FG003|Overall Study|Subject moved|1|||
105748026|NCT01670656|364731050|FG004|Overall Study|Subject moved|0|||
105748027|NCT00165841|364731051|FG000|Overall Study|Adverse Event|2|||
105748028|NCT00165841|364731052|FG001|Overall Study|Adverse Event|3|||
105748029|NCT00165841|364731051|FG000|Overall Study|Lack of Efficacy|6|||
105748030|NCT00165841|364731052|FG001|Overall Study|Lack of Efficacy|33|||
105748031|NCT00165841|364731051|FG000|Overall Study|Lost to Follow-up|4|||
105748032|NCT00165841|364731052|FG001|Overall Study|Lost to Follow-up|4|||
105748033|NCT00165841|364731051|FG000|Overall Study|Withdrawal by Subject|7|||
105748034|NCT00165841|364731052|FG001|Overall Study|Withdrawal by Subject|8|||
105748035|NCT00165841|364731051|FG000|Overall Study|Physician Decision|1|||
105748036|NCT00165841|364731052|FG001|Overall Study|Physician Decision|0|||
105748037|NCT00165841|364731051|FG000|Overall Study|Protocol Violation|6|||
105748038|NCT00165841|364731052|FG001|Overall Study|Protocol Violation|8|||
105748039|NCT00165841|364731051|FG000|Overall Study|Other|3|||
105748040|NCT00165841|364731052|FG001|Overall Study|Other|5|||
105748041|NCT00165841|364731051|FG000|Overall Study|Medication Noncompliance|1|||
105748042|NCT00165841|364731052|FG001|Overall Study|Medication Noncompliance|1|||
105748043|NCT00789958|364731053|FG000|Overall Study|Adverse Event|3|||
105748044|NCT00789958|364731053|FG000|Overall Study|Withdrawal by Subject|4|||
105748045|NCT00789958|364731053|FG000|Overall Study|Progression|3|||
105748046|NCT00789958|364731053|FG000|Overall Study|not protocol specified|1|||
105801425|NCT01113710|364930577|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
105801426|NCT01113710|364930577|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
105748047|NCT00789958|364731053|FG000|Overall Study|Not eligible/not analyzable|26|||
105748048|NCT00254293|364731054|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
105748049|NCT00254293|364731055|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
105748050|NCT00254293|364731056|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
105748051|NCT00254293|364731057|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
105748052|NCT00254293|364731058|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
105748053|NCT00254293|364731059|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
105748054|NCT00254293|364731060|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
105748055|NCT00254293|364731054|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
105748056|NCT00254293|364731055|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
105748057|NCT00254293|364731056|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
105748058|NCT00254293|364731057|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
105748059|NCT00254293|364731058|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
105748060|NCT00254293|364731059|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
105748061|NCT00254293|364731060|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
105748062|NCT00254293|364731054|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
105748063|NCT00254293|364731055|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
105748064|NCT00254293|364731056|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
105748065|NCT00254293|364731057|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
105748066|NCT00254293|364731058|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
105748067|NCT00254293|364731059|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
105748068|NCT00254293|364731060|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
105748069|NCT00254293|364731054|FG000|LTE Open Label Variable SC Dosing|Death|0|||
105748070|NCT00254293|364731055|FG001|LTE Open Label Variable SC Dosing|Death|0|||
105748071|NCT00254293|364731056|FG002|LTE Open Label Variable SC Dosing|Death|1|||
105748072|NCT00254293|364731057|FG003|LTE Open Label Variable SC Dosing|Death|0|||
105748073|NCT00254293|364731058|FG004|LTE Open Label Variable SC Dosing|Death|0|||
105748074|NCT00254293|364731059|FG005|LTE Open Label Variable SC Dosing|Death|0|||
105748075|NCT00254293|364731060|FG006|LTE Open Label Variable SC Dosing|Death|0|||
105748076|NCT00254293|364731054|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
105748077|NCT00254293|364731055|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
105748078|NCT00254293|364731056|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
105748079|NCT00254293|364731057|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
105748080|NCT00254293|364731058|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
105748081|NCT00254293|364731059|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
105748082|NCT00254293|364731060|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
105748083|NCT00254293|364731054|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
105748084|NCT00254293|364731055|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
105748085|NCT00254293|364731056|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
105748086|NCT00254293|364731057|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
105748087|NCT00254293|364731058|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
105748088|NCT00254293|364731059|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
105748089|NCT00254293|364731060|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
105748090|NCT00254293|364731054|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
105748091|NCT00254293|364731055|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
105748092|NCT00254293|364731056|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
105748093|NCT00254293|364731057|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
105748094|NCT00254293|364731058|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
105748095|NCT00254293|364731059|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
105748096|NCT00254293|364731060|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
105748097|NCT00254293|364731054|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
105748098|NCT00254293|364731055|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
105748099|NCT00254293|364731056|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
105801427|NCT01113710|364930577|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
105748100|NCT00254293|364731057|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
105748101|NCT00254293|364731058|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
105748102|NCT00254293|364731059|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
105748103|NCT00254293|364731060|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
105748104|NCT00254293|364731054|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
105748105|NCT00254293|364731055|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
105748106|NCT00254293|364731056|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
105748107|NCT00254293|364731057|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
105748108|NCT00254293|364731058|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
105748109|NCT00254293|364731059|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
105748110|NCT00254293|364731060|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
105748111|NCT00254293|364731054|FG000|LTE Open Label Variable SC Dosing|Other|0|||
105748112|NCT00254293|364731055|FG001|LTE Open Label Variable SC Dosing|Other|0|||
105748113|NCT00254293|364731056|FG002|LTE Open Label Variable SC Dosing|Other|2|||
105748114|NCT00254293|364731057|FG003|LTE Open Label Variable SC Dosing|Other|0|||
105748115|NCT00254293|364731058|FG004|LTE Open Label Variable SC Dosing|Other|0|||
105748116|NCT00254293|364731059|FG005|LTE Open Label Variable SC Dosing|Other|0|||
105748117|NCT00254293|364731060|FG006|LTE Open Label Variable SC Dosing|Other|0|||
105748118|NCT00254293|364731054|FG000|LTE Open Label Fixed Dosing|Death|0|||
105748119|NCT00254293|364731055|FG001|LTE Open Label Fixed Dosing|Death|0|||
105748120|NCT00254293|364731056|FG002|LTE Open Label Fixed Dosing|Death|0|||
105748121|NCT00254293|364731057|FG003|LTE Open Label Fixed Dosing|Death|0|||
105748122|NCT00254293|364731058|FG004|LTE Open Label Fixed Dosing|Death|0|||
105748123|NCT00254293|364731059|FG005|LTE Open Label Fixed Dosing|Death|0|||
105748124|NCT00254293|364731060|FG006|LTE Open Label Fixed Dosing|Death|3|||
105748125|NCT00254293|364731054|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
105748126|NCT00254293|364731055|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
105748127|NCT00254293|364731056|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
105748128|NCT00254293|364731057|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
105748129|NCT00254293|364731058|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
105748130|NCT00254293|364731059|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
105748131|NCT00254293|364731060|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
105748132|NCT00254293|364731054|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
105748133|NCT00254293|364731055|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
105748134|NCT00254293|364731056|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
105748135|NCT00254293|364731057|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
105748136|NCT00254293|364731058|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
105748137|NCT00254293|364731059|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
105748138|NCT00254293|364731060|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
105748139|NCT00254293|364731054|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
105748140|NCT00254293|364731055|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
105748141|NCT00254293|364731056|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
105748142|NCT00254293|364731057|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
105748143|NCT00254293|364731058|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
105748144|NCT00254293|364731059|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
105748145|NCT00254293|364731060|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
105748146|NCT00254293|364731054|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
105748147|NCT00254293|364731055|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
105748148|NCT00254293|364731056|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
105748149|NCT00254293|364731057|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
105748150|NCT00254293|364731058|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
105748151|NCT00254293|364731059|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
105748152|NCT00254293|364731060|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
105748153|NCT00254293|364731054|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
105748154|NCT00254293|364731055|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
105748155|NCT00254293|364731056|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
105748156|NCT00254293|364731057|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
105748157|NCT00254293|364731058|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
105748158|NCT00254293|364731059|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
105748159|NCT00254293|364731060|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
105748160|NCT00254293|364731054|FG000|LTE Open Label Fixed Dosing|Other|0|||
105748161|NCT00254293|364731055|FG001|LTE Open Label Fixed Dosing|Other|0|||
105748162|NCT00254293|364731056|FG002|LTE Open Label Fixed Dosing|Other|0|||
105748163|NCT00254293|364731057|FG003|LTE Open Label Fixed Dosing|Other|0|||
105748164|NCT00254293|364731058|FG004|LTE Open Label Fixed Dosing|Other|0|||
105748165|NCT00254293|364731059|FG005|LTE Open Label Fixed Dosing|Other|0|||
105748166|NCT00254293|364731060|FG006|LTE Open Label Fixed Dosing|Other|1|||
105748167|NCT01575197|364731061|FG000|Overall Study|Migration out of study area|1|||
105748168|NCT01575197|364731062|FG001|Overall Study|Migration out of study area|5|||
105748169|NCT01575197|364731063|FG002|Overall Study|Migration out of study area|4|||
105748170|NCT01575197|364731061|FG000|Overall Study|SAE|0|||
105748171|NCT01575197|364731062|FG001|Overall Study|SAE|1|||
105748172|NCT01575197|364731063|FG002|Overall Study|SAE|0|||
105748173|NCT01575197|364731061|FG000|Overall Study|Lost to Follow-up|0|||
105748174|NCT01575197|364731062|FG001|Overall Study|Lost to Follow-up|1|||
105748175|NCT01575197|364731063|FG002|Overall Study|Lost to Follow-up|0|||
105748176|NCT01575197|364731061|FG000|Overall Study|Withdrawal by Subject|0|||
105760842|NCT01831804|364778037|FG001|Overall Study|Adverse Event|0|||
105748177|NCT01575197|364731062|FG001|Overall Study|Withdrawal by Subject|1|||
105748178|NCT01575197|364731063|FG002|Overall Study|Withdrawal by Subject|1|||
105748179|NCT01575197|364731061|FG000|Overall Study|Protocol Violation|2|||
105748180|NCT01575197|364731062|FG001|Overall Study|Protocol Violation|1|||
105748181|NCT01575197|364731063|FG002|Overall Study|Protocol Violation|1|||
105748182|NCT03137121|364731064|FG000|Overall Study|Withdrawal by Subject|0|||
105748183|NCT03137121|364731065|FG001|Overall Study|Withdrawal by Subject|1|||
105748184|NCT03196193|364731066|FG000|Overall Study|Adverse Event|1|||
105748185|NCT03196193|364731067|FG001|Overall Study|Adverse Event|0|||
105748186|NCT03196193|364731066|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
105748187|NCT03196193|364731067|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
105748188|NCT01995136|364731070|FG000|Overall Study|Change in residence|1|||
105748189|NCT04410198|364731071|FG000|Overall Study|Death|10|||
105748190|NCT04410198|364731071|FG000|Overall Study|Withdrawal by Subject|7|||
105748191|NCT04410198|364731071|FG000|Overall Study|Transferred/Relocation|4|||
105748192|NCT04410198|364731071|FG000|Overall Study|Kidney Transplant|9|||
105748193|NCT04410198|364731071|FG000|Overall Study|Adverse Event|4|||
105748194|NCT04410198|364731071|FG000|Overall Study|Physician Decision|2|||
105748195|NCT04410198|364731071|FG000|Overall Study|Other than specified|1|||
105748196|NCT01354353|364731078|FG000|Overall Study|Adverse Event|1|||
105748197|NCT01354353|364731079|FG001|Overall Study|Adverse Event|0|||
105748198|NCT01354353|364731080|FG002|Overall Study|Adverse Event|0|||
105748199|NCT01354353|364731081|FG003|Overall Study|Adverse Event|4|||
105748200|NCT01354353|364731082|FG004|Overall Study|Adverse Event|0|||
105748201|NCT01354353|364731083|FG005|Overall Study|Adverse Event|5|||
105748202|NCT01354353|364731078|FG000|Overall Study|Entry Criteria Not Met|0|||
105748203|NCT01354353|364731079|FG001|Overall Study|Entry Criteria Not Met|0|||
105748204|NCT01354353|364731080|FG002|Overall Study|Entry Criteria Not Met|0|||
105748205|NCT01354353|364731081|FG003|Overall Study|Entry Criteria Not Met|1|||
105748206|NCT01354353|364731082|FG004|Overall Study|Entry Criteria Not Met|1|||
105748207|NCT01354353|364731083|FG005|Overall Study|Entry Criteria Not Met|0|||
105748208|NCT01354353|364731078|FG000|Overall Study|Physician Decision|0|||
105748209|NCT01354353|364731079|FG001|Overall Study|Physician Decision|1|||
105748210|NCT01354353|364731080|FG002|Overall Study|Physician Decision|1|||
105748211|NCT01354353|364731081|FG003|Overall Study|Physician Decision|0|||
105748212|NCT01354353|364731082|FG004|Overall Study|Physician Decision|0|||
105748213|NCT01354353|364731083|FG005|Overall Study|Physician Decision|0|||
105748214|NCT01354353|364731078|FG000|Overall Study|Withdrawal by Subject|2|||
105748215|NCT01354353|364731079|FG001|Overall Study|Withdrawal by Subject|0|||
105748216|NCT01354353|364731080|FG002|Overall Study|Withdrawal by Subject|1|||
105748217|NCT01354353|364731081|FG003|Overall Study|Withdrawal by Subject|0|||
105748218|NCT01354353|364731082|FG004|Overall Study|Withdrawal by Subject|0|||
105748219|NCT01354353|364731083|FG005|Overall Study|Withdrawal by Subject|1|||
105748220|NCT03583372|364731084|FG000|Overall Study|Withdrawal by Subject|6|||
105748221|NCT03583372|364731085|FG001|Overall Study|Withdrawal by Subject|11|||
105748222|NCT03583372|364731086|FG002|Overall Study|Withdrawal by Subject|7|||
105748223|NCT03583372|364731087|FG003|Overall Study|Withdrawal by Subject|8|||
105748224|NCT03583372|364731084|FG000|Overall Study|Lost to Follow-up|4|||
105748225|NCT03583372|364731085|FG001|Overall Study|Lost to Follow-up|6|||
105748226|NCT03583372|364731086|FG002|Overall Study|Lost to Follow-up|3|||
105748227|NCT03583372|364731087|FG003|Overall Study|Lost to Follow-up|2|||
105748228|NCT03583372|364731084|FG000|Overall Study|Adverse Event|1|||
105748229|NCT03583372|364731085|FG001|Overall Study|Adverse Event|3|||
105748230|NCT03583372|364731086|FG002|Overall Study|Adverse Event|4|||
105748231|NCT03583372|364731087|FG003|Overall Study|Adverse Event|4|||
105748232|NCT03583372|364731084|FG000|Overall Study|Physician Decision|0|||
105748233|NCT03583372|364731085|FG001|Overall Study|Physician Decision|1|||
105748234|NCT03583372|364731086|FG002|Overall Study|Physician Decision|1|||
105748235|NCT03583372|364731087|FG003|Overall Study|Physician Decision|1|||
105748236|NCT03583372|364731084|FG000|Overall Study|Lack of Efficacy|0|||
105748237|NCT03583372|364731085|FG001|Overall Study|Lack of Efficacy|1|||
105748238|NCT03583372|364731086|FG002|Overall Study|Lack of Efficacy|0|||
105748239|NCT03583372|364731087|FG003|Overall Study|Lack of Efficacy|1|||
105748240|NCT03583372|364731084|FG000|Overall Study|Death|1|||
105748241|NCT03583372|364731085|FG001|Overall Study|Death|0|||
105748242|NCT03583372|364731086|FG002|Overall Study|Death|0|||
105748243|NCT03583372|364731087|FG003|Overall Study|Death|0|||
105748244|NCT03583372|364731084|FG000|Overall Study|Protocol Violation|0|||
105748245|NCT03583372|364731085|FG001|Overall Study|Protocol Violation|1|||
105801428|NCT01113710|364930577|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
105748246|NCT03583372|364731086|FG002|Overall Study|Protocol Violation|0|||
105748247|NCT03583372|364731087|FG003|Overall Study|Protocol Violation|0|||
105748248|NCT03583372|364731084|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
105748249|NCT03583372|364731085|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
105748250|NCT03583372|364731086|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
105748251|NCT03583372|364731087|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
105748252|NCT03583372|364731084|FG000|Overall Study|Did Not Receive Study Drug|0|||
105748253|NCT03583372|364731085|FG001|Overall Study|Did Not Receive Study Drug|1|||
105801429|NCT01113710|364930577|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
105801430|NCT01113710|364930577|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
105801431|NCT01113710|364930577|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
105801432|NCT01113710|364930577|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
105801433|NCT01113710|364930577|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
105801434|NCT01078623|364930578|FG000|Treatment Period 1|Adverse Event|1|||
105801435|NCT01078623|364930579|FG001|Treatment Period 1|Adverse Event|1|||
105801436|NCT01078623|364930580|FG002|Treatment Period 1|Adverse Event|1|||
105801437|NCT01078623|364930581|FG003|Treatment Period 1|Adverse Event|0|||
105801438|NCT01078623|364930582|FG004|Treatment Period 1|Adverse Event|0|||
105801439|NCT01078623|364930583|FG005|Treatment Period 1|Adverse Event|0|||
105801440|NCT01078623|364930584|FG006|Treatment Period 1|Adverse Event|1|||
105801441|NCT01078623|364930585|FG007|Treatment Period 1|Adverse Event|0|||
105801442|NCT01078623|364930586|FG008|Treatment Period 1|Adverse Event|1|||
105801443|NCT01078623|364930587|FG009|Treatment Period 1|Adverse Event|1|||
105801444|NCT01078623|364930588|FG010|Treatment Period 1|Adverse Event|0|||
105801445|NCT01078623|364930589|FG011|Treatment Period 1|Adverse Event|0|||
105801446|NCT01078623|364930590|FG012|Treatment Period 1|Adverse Event|0|||
105801447|NCT01078623|364930591|FG013|Treatment Period 1|Adverse Event|0|||
105801448|NCT01078623|364930592|FG014|Treatment Period 1|Adverse Event|0|||
105801449|NCT01078623|364930593|FG015|Treatment Period 1|Adverse Event|0|||
105801450|NCT01078623|364930594|FG016|Treatment Period 1|Adverse Event|0|||
105801451|NCT01078623|364930595|FG017|Treatment Period 1|Adverse Event|0|||
105801452|NCT01078623|364930596|FG018|Treatment Period 1|Adverse Event|0|||
105801453|NCT01078623|364930597|FG019|Treatment Period 1|Adverse Event|0|||
105801454|NCT01078623|364930578|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105801455|NCT01078623|364930579|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105801456|NCT01078623|364930580|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105801457|NCT01078623|364930581|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105801458|NCT01078623|364930582|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105801459|NCT01078623|364930583|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105801460|NCT01078623|364930584|FG006|Treatment Period 1|Withdrawal by Subject|0|||
105801461|NCT01078623|364930585|FG007|Treatment Period 1|Withdrawal by Subject|1|||
105801462|NCT01078623|364930586|FG008|Treatment Period 1|Withdrawal by Subject|0|||
105801463|NCT01078623|364930587|FG009|Treatment Period 1|Withdrawal by Subject|0|||
105801464|NCT01078623|364930588|FG010|Treatment Period 1|Withdrawal by Subject|1|||
105801465|NCT01078623|364930589|FG011|Treatment Period 1|Withdrawal by Subject|0|||
105801466|NCT01078623|364930590|FG012|Treatment Period 1|Withdrawal by Subject|0|||
105801467|NCT01078623|364930591|FG013|Treatment Period 1|Withdrawal by Subject|0|||
105801468|NCT01078623|364930592|FG014|Treatment Period 1|Withdrawal by Subject|0|||
105801469|NCT01078623|364930593|FG015|Treatment Period 1|Withdrawal by Subject|0|||
105801470|NCT01078623|364930594|FG016|Treatment Period 1|Withdrawal by Subject|0|||
105801471|NCT01078623|364930595|FG017|Treatment Period 1|Withdrawal by Subject|0|||
105801472|NCT01078623|364930596|FG018|Treatment Period 1|Withdrawal by Subject|0|||
105801473|NCT01078623|364930597|FG019|Treatment Period 1|Withdrawal by Subject|0|||
105801474|NCT01078623|364930578|FG000|Treatment Period 1|Protocol Violation|0|||
105801475|NCT01078623|364930579|FG001|Treatment Period 1|Protocol Violation|0|||
105801476|NCT01078623|364930580|FG002|Treatment Period 1|Protocol Violation|0|||
105801477|NCT01078623|364930581|FG003|Treatment Period 1|Protocol Violation|0|||
105801478|NCT01078623|364930582|FG004|Treatment Period 1|Protocol Violation|0|||
105801479|NCT01078623|364930583|FG005|Treatment Period 1|Protocol Violation|1|||
105801480|NCT01078623|364930584|FG006|Treatment Period 1|Protocol Violation|0|||
105801481|NCT01078623|364930585|FG007|Treatment Period 1|Protocol Violation|0|||
105801482|NCT01078623|364930586|FG008|Treatment Period 1|Protocol Violation|0|||
105801483|NCT01078623|364930587|FG009|Treatment Period 1|Protocol Violation|0|||
105801484|NCT01078623|364930588|FG010|Treatment Period 1|Protocol Violation|0|||
105801485|NCT01078623|364930589|FG011|Treatment Period 1|Protocol Violation|0|||
105801486|NCT01078623|364930590|FG012|Treatment Period 1|Protocol Violation|0|||
105801487|NCT01078623|364930591|FG013|Treatment Period 1|Protocol Violation|0|||
105801488|NCT01078623|364930592|FG014|Treatment Period 1|Protocol Violation|0|||
105483371|NCT01931670|363782682|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
105483372|NCT00976508|363782683|FG000|Overall Study|Death|7|||
105483373|NCT00976508|363782684|FG001|Overall Study|Death|1|||
105483374|NCT00976508|363782683|FG000|Overall Study|Lost to Follow-up|1|||
105483375|NCT00976508|363782684|FG001|Overall Study|Lost to Follow-up|0|||
105483376|NCT00976508|363782683|FG000|Overall Study|Withdrawal by Subject|1|||
105801489|NCT01078623|364930593|FG015|Treatment Period 1|Protocol Violation|0|||
105801490|NCT01078623|364930594|FG016|Treatment Period 1|Protocol Violation|0|||
105801491|NCT01078623|364930595|FG017|Treatment Period 1|Protocol Violation|0|||
105801492|NCT01078623|364930596|FG018|Treatment Period 1|Protocol Violation|0|||
105801493|NCT01078623|364930597|FG019|Treatment Period 1|Protocol Violation|0|||
105801494|NCT01078623|364930578|FG000|Treatment Period 2|Adverse Event|0|||
105801495|NCT01078623|364930579|FG001|Treatment Period 2|Adverse Event|0|||
105565405|NCT04512066|364066770|FG005|Extension Period|Lack of Efficacy|3|||
105801496|NCT01078623|364930580|FG002|Treatment Period 2|Adverse Event|0|||
105801497|NCT01078623|364930581|FG003|Treatment Period 2|Adverse Event|0|||
105748254|NCT03583372|364731086|FG002|Overall Study|Did Not Receive Study Drug|0|||
105748255|NCT03583372|364731087|FG003|Overall Study|Did Not Receive Study Drug|0|||
105748256|NCT03583372|364731084|FG000|Overall Study|Captured as Other in the Database|1|||
105748257|NCT03583372|364731085|FG001|Overall Study|Captured as Other in the Database|2|||
105748258|NCT03583372|364731086|FG002|Overall Study|Captured as Other in the Database|4|||
105748259|NCT03583372|364731087|FG003|Overall Study|Captured as Other in the Database|1|||
105748260|NCT02796391|364731088|FG000|Overall Study|Lost to Follow-up|2|||
105748261|NCT02796391|364731089|FG001|Overall Study|Lost to Follow-up|2|||
105748262|NCT02796391|364731090|FG002|Overall Study|Lost to Follow-up|13|||
105748263|NCT02796391|364731091|FG003|Overall Study|Lost to Follow-up|8|||
105748264|NCT02796391|364731092|FG004|Overall Study|Lost to Follow-up|14|||
105748265|NCT02796391|364731093|FG005|Overall Study|Lost to Follow-up|13|||
105748266|NCT02796391|364731088|FG000|Overall Study|COVID|0|||
105748267|NCT02796391|364731089|FG001|Overall Study|COVID|0|||
105748268|NCT02796391|364731090|FG002|Overall Study|COVID|5|||
105748269|NCT02796391|364731091|FG003|Overall Study|COVID|5|||
105748270|NCT02796391|364731092|FG004|Overall Study|COVID|2|||
105748271|NCT02796391|364731093|FG005|Overall Study|COVID|4|||
105748272|NCT02796391|364731088|FG000|Overall Study|Participant did not like study cigarettes|0|||
105748273|NCT02796391|364731089|FG001|Overall Study|Participant did not like study cigarettes|0|||
105748274|NCT02796391|364731090|FG002|Overall Study|Participant did not like study cigarettes|3|||
105748275|NCT02796391|364731091|FG003|Overall Study|Participant did not like study cigarettes|0|||
105748276|NCT02796391|364731092|FG004|Overall Study|Participant did not like study cigarettes|0|||
105748277|NCT02796391|364731093|FG005|Overall Study|Participant did not like study cigarettes|0|||
105748278|NCT02796391|364731088|FG000|Overall Study|Withdrawal by Subject|1|||
105748279|NCT02796391|364731089|FG001|Overall Study|Withdrawal by Subject|1|||
105748280|NCT02796391|364731090|FG002|Overall Study|Withdrawal by Subject|4|||
105748281|NCT02796391|364731091|FG003|Overall Study|Withdrawal by Subject|3|||
105748282|NCT02796391|364731092|FG004|Overall Study|Withdrawal by Subject|4|||
105748283|NCT02796391|364731093|FG005|Overall Study|Withdrawal by Subject|3|||
105748284|NCT02796391|364731088|FG000|Overall Study|Adverse Event|0|||
105748285|NCT02796391|364731089|FG001|Overall Study|Adverse Event|0|||
105748286|NCT02796391|364731090|FG002|Overall Study|Adverse Event|0|||
105748287|NCT02796391|364731091|FG003|Overall Study|Adverse Event|1|||
105748288|NCT02796391|364731092|FG004|Overall Study|Adverse Event|0|||
105748289|NCT02796391|364731093|FG005|Overall Study|Adverse Event|0|||
105748290|NCT02796391|364731088|FG000|Overall Study|Protocol Violation|0|||
105748291|NCT02796391|364731089|FG001|Overall Study|Protocol Violation|0|||
105748292|NCT02796391|364731090|FG002|Overall Study|Protocol Violation|0|||
105748293|NCT02796391|364731091|FG003|Overall Study|Protocol Violation|1|||
105748294|NCT02796391|364731092|FG004|Overall Study|Protocol Violation|0|||
105748295|NCT02796391|364731093|FG005|Overall Study|Protocol Violation|0|||
105748296|NCT02681055|364731096|FG000|Weeks 5-12|Adverse Event|1|||
105748297|NCT02695524|364731097|FG000|Overall Study|Lost to Follow-up|3|||
105748298|NCT02695524|364731098|FG001|Overall Study|Lost to Follow-up|2|||
105748299|NCT02695524|364731097|FG000|Overall Study|Death|0|||
105748300|NCT02695524|364731098|FG001|Overall Study|Death|1|||
105748301|NCT00377611|364731101|FG000|Overall Study|Adverse Event|2|||
105748302|NCT00377611|364731102|FG001|Overall Study|Adverse Event|9|||
105748303|NCT00377611|364731101|FG000|Overall Study|Protocol Violation|2|||
105748304|NCT00377611|364731102|FG001|Overall Study|Protocol Violation|0|||
105748305|NCT00377611|364731101|FG000|Overall Study|Withdrawal by Subject|0|||
105748306|NCT00377611|364731102|FG001|Overall Study|Withdrawal by Subject|5|||
105748307|NCT00377611|364731101|FG000|Overall Study|Lost to Follow-up|18|||
105748308|NCT00377611|364731102|FG001|Overall Study|Lost to Follow-up|16|||
105748309|NCT00377611|364731101|FG000|Overall Study|Other|0|||
105748310|NCT00377611|364731102|FG001|Overall Study|Other|3|||
105748311|NCT00831441|364731103|FG000|Randomized|Death|82|||
105748312|NCT00831441|364731104|FG001|Randomized|Death|81|||
105748313|NCT00831441|364731103|FG000|Randomized|Adverse Event|248|||
105748314|NCT00831441|364731104|FG001|Randomized|Adverse Event|321|||
105748315|NCT00831441|364731103|FG000|Randomized|Emergency procedure|2|||
105748316|NCT00831441|364731104|FG001|Randomized|Emergency procedure|2|||
105748317|NCT00831441|364731103|FG000|Randomized|Elective procedure|26|||
105748318|NCT00831441|364731104|FG001|Randomized|Elective procedure|25|||
105748319|NCT00831441|364731103|FG000|Randomized|Physician Decision|26|||
105748320|NCT00831441|364731104|FG001|Randomized|Physician Decision|35|||
105748321|NCT00831441|364731103|FG000|Randomized|No longer met criteria|13|||
105748322|NCT00831441|364731104|FG001|Randomized|No longer met criteria|19|||
105748323|NCT00831441|364731103|FG000|Randomized|Withdrawal by Subject|178|||
105748324|NCT00831441|364731104|FG001|Randomized|Withdrawal by Subject|212|||
105748325|NCT00831441|364731103|FG000|Randomized|Lost to Follow-up|26|||
105748326|NCT00831441|364731104|FG001|Randomized|Lost to Follow-up|35|||
105748327|NCT00831441|364731103|FG000|Randomized|Administrative reason by sponsor|2780|||
105748328|NCT00831441|364731104|FG001|Randomized|Administrative reason by sponsor|2671|||
105748329|NCT00831441|364731103|FG000|Randomized|poor/non-compliance|30|||
105748330|NCT00831441|364731104|FG001|Randomized|poor/non-compliance|38|||
105748331|NCT00831441|364731103|FG000|Randomized|non-specified|276|||
105748332|NCT00831441|364731104|FG001|Randomized|non-specified|266|||
105760843|NCT01831804|364778038|FG002|Overall Study|Adverse Event|0|||
105748333|NCT00831441|364731103|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
105748334|NCT00831441|364731104|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
105748335|NCT00831441|364731103|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
105748336|NCT00831441|364731104|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
105748337|NCT00831441|364731103|FG000|Follow Up (30 Days)|Death|63|||
105748338|NCT00831441|364731104|FG001|Follow Up (30 Days)|Death|86|||
105748339|NCT00831441|364731103|FG000|Follow Up (30 Days)|non-specified|16|||
105748340|NCT00831441|364731104|FG001|Follow Up (30 Days)|non-specified|26|||
105748341|NCT00831441|364731103|FG000|Follow Up (30 Days)|missing end of study status|0|||
105748342|NCT00831441|364731104|FG001|Follow Up (30 Days)|missing end of study status|1|||
105748343|NCT05674344|364731105|FG000|Overall Study|Screen Fail|21|||
105748344|NCT05674344|364731105|FG000|Overall Study|Incomplete study procedures|3|||
105748345|NCT00111917|364731106|FG000|Overall Study|Withdrawal by Subject|1|||
105748346|NCT00111917|364731107|FG001|Overall Study|Withdrawal by Subject|1|||
105748347|NCT00798655|364731111|FG000|Overall Study|Did not receive at least one dose of pan|2|||
105748348|NCT00960934|364731112|FG000|Overall Study|Adverse Event|2|||
105748349|NCT00960934|364731113|FG001|Overall Study|Adverse Event|3|||
105748350|NCT00960934|364731114|FG002|Overall Study|Adverse Event|3|||
105748351|NCT00960934|364731115|FG003|Overall Study|Adverse Event|2|||
105748352|NCT00960934|364731116|FG004|Overall Study|Adverse Event|4|||
105748353|NCT00960934|364731117|FG005|Overall Study|Adverse Event|3|||
105748354|NCT00960934|364731112|FG000|Overall Study|Lack of Efficacy|1|||
105748355|NCT00960934|364731113|FG001|Overall Study|Lack of Efficacy|0|||
105748356|NCT00960934|364731114|FG002|Overall Study|Lack of Efficacy|0|||
105748357|NCT00960934|364731115|FG003|Overall Study|Lack of Efficacy|0|||
105748358|NCT00960934|364731116|FG004|Overall Study|Lack of Efficacy|0|||
105748359|NCT00960934|364731117|FG005|Overall Study|Lack of Efficacy|0|||
105748360|NCT00960934|364731112|FG000|Overall Study|Lost to Follow-up|0|||
105748361|NCT00960934|364731113|FG001|Overall Study|Lost to Follow-up|1|||
105748362|NCT00960934|364731114|FG002|Overall Study|Lost to Follow-up|0|||
105748363|NCT00960934|364731115|FG003|Overall Study|Lost to Follow-up|0|||
105748364|NCT00960934|364731116|FG004|Overall Study|Lost to Follow-up|0|||
105748365|NCT00960934|364731117|FG005|Overall Study|Lost to Follow-up|0|||
105748366|NCT00960934|364731112|FG000|Overall Study|Other|2|||
105748367|NCT00960934|364731113|FG001|Overall Study|Other|1|||
105748368|NCT00960934|364731114|FG002|Overall Study|Other|5|||
105748369|NCT00960934|364731115|FG003|Overall Study|Other|4|||
105748370|NCT00960934|364731116|FG004|Overall Study|Other|2|||
105748371|NCT00960934|364731117|FG005|Overall Study|Other|2|||
105748372|NCT00960934|364731112|FG000|Overall Study|Physician Decision|0|||
105748373|NCT00960934|364731113|FG001|Overall Study|Physician Decision|1|||
105748374|NCT00960934|364731114|FG002|Overall Study|Physician Decision|0|||
105748375|NCT00960934|364731115|FG003|Overall Study|Physician Decision|0|||
105748376|NCT00960934|364731116|FG004|Overall Study|Physician Decision|0|||
105748377|NCT00960934|364731117|FG005|Overall Study|Physician Decision|0|||
105748378|NCT00960934|364731112|FG000|Overall Study|Progressive Disease|1|||
105748379|NCT00960934|364731113|FG001|Overall Study|Progressive Disease|1|||
105748380|NCT00960934|364731114|FG002|Overall Study|Progressive Disease|0|||
105748381|NCT00960934|364731115|FG003|Overall Study|Progressive Disease|0|||
105748382|NCT00960934|364731116|FG004|Overall Study|Progressive Disease|1|||
105748383|NCT00960934|364731117|FG005|Overall Study|Progressive Disease|1|||
105748384|NCT00960934|364731112|FG000|Overall Study|Protocol Violation|3|||
105748385|NCT00960934|364731113|FG001|Overall Study|Protocol Violation|4|||
105748386|NCT00960934|364731114|FG002|Overall Study|Protocol Violation|0|||
105748387|NCT00960934|364731115|FG003|Overall Study|Protocol Violation|3|||
105748388|NCT00960934|364731116|FG004|Overall Study|Protocol Violation|3|||
105748389|NCT00960934|364731117|FG005|Overall Study|Protocol Violation|2|||
105748390|NCT00960934|364731112|FG000|Overall Study|Withdrawal by Subject|5|||
105748391|NCT00960934|364731113|FG001|Overall Study|Withdrawal by Subject|6|||
105748392|NCT00960934|364731114|FG002|Overall Study|Withdrawal by Subject|4|||
105748393|NCT00960934|364731115|FG003|Overall Study|Withdrawal by Subject|5|||
105748394|NCT00960934|364731116|FG004|Overall Study|Withdrawal by Subject|5|||
105748395|NCT00960934|364731117|FG005|Overall Study|Withdrawal by Subject|7|||
105748396|NCT00960934|364731112|FG000|Overall Study|Study Terminated by Sponsor|50|||
105748397|NCT00960934|364731113|FG001|Overall Study|Study Terminated by Sponsor|46|||
105748398|NCT00960934|364731114|FG002|Overall Study|Study Terminated by Sponsor|52|||
105748399|NCT00960934|364731115|FG003|Overall Study|Study Terminated by Sponsor|50|||
105748400|NCT00960934|364731116|FG004|Overall Study|Study Terminated by Sponsor|49|||
105748401|NCT00960934|364731117|FG005|Overall Study|Study Terminated by Sponsor|49|||
105748402|NCT01640925|364731120|FG000|Overall Study|Withdrawal by Subject|1|||
105748403|NCT01640925|364731121|FG001|Overall Study|Withdrawal by Subject|0|||
105748404|NCT01640925|364731120|FG000|Overall Study|Previously enrolled in this trial|13|||
105748405|NCT01640925|364731121|FG001|Overall Study|Previously enrolled in this trial|11|||
105748406|NCT01030458|364731132|FG000|Overall Study|Lost to Follow-up|9|||
105748407|NCT01030458|364731133|FG001|Overall Study|Lost to Follow-up|10|||
105748408|NCT01030458|364731132|FG000|Overall Study|Withdrawal by Subject|2|||
105748409|NCT01030458|364731133|FG001|Overall Study|Withdrawal by Subject|3|||
105748410|NCT01030458|364731132|FG000|Overall Study|Logistical reasons|9|||
105748411|NCT01030458|364731133|FG001|Overall Study|Logistical reasons|5|||
105801498|NCT01078623|364930582|FG004|Treatment Period 2|Adverse Event|0|||
105801499|NCT01078623|364930583|FG005|Treatment Period 2|Adverse Event|0|||
105801500|NCT01078623|364930584|FG006|Treatment Period 2|Adverse Event|1|||
105801501|NCT01078623|364930585|FG007|Treatment Period 2|Adverse Event|0|||
105801502|NCT01078623|364930586|FG008|Treatment Period 2|Adverse Event|0|||
105801503|NCT01078623|364930587|FG009|Treatment Period 2|Adverse Event|0|||
105801504|NCT01078623|364930588|FG010|Treatment Period 2|Adverse Event|0|||
105801505|NCT01078623|364930589|FG011|Treatment Period 2|Adverse Event|0|||
105801506|NCT01078623|364930590|FG012|Treatment Period 2|Adverse Event|0|||
105801507|NCT01078623|364930591|FG013|Treatment Period 2|Adverse Event|0|||
105748412|NCT01030458|364731132|FG000|Overall Study|Moved or changed job|6|||
105748413|NCT01030458|364731133|FG001|Overall Study|Moved or changed job|13|||
105748414|NCT01030458|364731132|FG000|Overall Study|Side effect of medication|1|||
105748415|NCT01030458|364731133|FG001|Overall Study|Side effect of medication|1|||
105748416|NCT02338492|364731134|FG000|Overall Study|Death|32|||
105748417|NCT02338492|364731134|FG000|Overall Study|Adverse Event|3|||
105748418|NCT02338492|364731134|FG000|Overall Study|Lost to Follow-up|4|||
105748419|NCT02338492|364731134|FG000|Overall Study|Reason not captured above|6|||
105748420|NCT02492997|364731140|FG000|Overall Study|Withdrawal by Subject|1|||
105748421|NCT02492997|364731141|FG001|Overall Study|Withdrawal by Subject|0|||
105748422|NCT02492997|364731140|FG000|Overall Study|Gained Weight|1|||
105748423|NCT02492997|364731141|FG001|Overall Study|Gained Weight|0|||
105748424|NCT02492997|364731140|FG000|Overall Study|Lost to Follow-up|0|||
105748425|NCT02492997|364731141|FG001|Overall Study|Lost to Follow-up|1|||
105748426|NCT01842308|364731146|FG000|Overall Study|Withdrawal by Subject|0|||
105748427|NCT01842308|364731147|FG001|Overall Study|Withdrawal by Subject|0|||
105748428|NCT01842308|364731148|FG002|Overall Study|Withdrawal by Subject|0|||
105748429|NCT01842308|364731149|FG003|Overall Study|Withdrawal by Subject|0|||
105748430|NCT01842308|364731150|FG004|Overall Study|Withdrawal by Subject|1|||
105748431|NCT03888391|364731151|FG000|Overall Study|Lost to Follow-up|15|||
105748432|NCT02130427|364731157|FG000|Overall Study|Imaging results not interpretable|30|||
105748433|NCT01100307|364731166|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
105748434|NCT01100307|364731167|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
105748435|NCT01100307|364731166|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
105748436|NCT01100307|364731167|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
105748437|NCT01100307|364731166|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
105748438|NCT01100307|364731167|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
105748439|NCT01100307|364731166|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
105748440|NCT01100307|364731167|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
105748441|NCT01100307|364731166|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
105748442|NCT01100307|364731167|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
105748443|NCT01100307|364731166|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
105748444|NCT01100307|364731167|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
105748445|NCT01496430|364731168|FG000|Overall Study|Adverse Event|0|||
105748446|NCT01496430|364731169|FG001|Overall Study|Adverse Event|0|||
105748447|NCT01496430|364731170|FG002|Overall Study|Adverse Event|1|||
105748448|NCT01496430|364731168|FG000|Overall Study|Major Protocol Deviation|0|||
105748449|NCT01496430|364731169|FG001|Overall Study|Major Protocol Deviation|0|||
105748450|NCT01496430|364731170|FG002|Overall Study|Major Protocol Deviation|1|||
105748451|NCT01496430|364731168|FG000|Overall Study|Lost to Follow-up|2|||
105748452|NCT01496430|364731169|FG001|Overall Study|Lost to Follow-up|3|||
105748453|NCT01496430|364731170|FG002|Overall Study|Lost to Follow-up|1|||
105748454|NCT01496430|364731168|FG000|Overall Study|Voluntary Withdrawal|2|||
105748455|NCT01496430|364731169|FG001|Overall Study|Voluntary Withdrawal|1|||
105748456|NCT01496430|364731170|FG002|Overall Study|Voluntary Withdrawal|6|||
105748457|NCT01496430|364731168|FG000|Overall Study|Principal Investigator Discretion|0|||
105801508|NCT01078623|364930592|FG014|Treatment Period 2|Adverse Event|0|||
105748458|NCT01496430|364731169|FG001|Overall Study|Principal Investigator Discretion|1|||
105748459|NCT01496430|364731170|FG002|Overall Study|Principal Investigator Discretion|1|||
105748460|NCT01496430|364731168|FG000|Overall Study|Other|2|||
105748461|NCT01496430|364731169|FG001|Overall Study|Other|0|||
105748462|NCT01496430|364731170|FG002|Overall Study|Other|0|||
105748463|NCT04056455|364731171|FG000|Overall Study|Adverse Event|1|||
105748464|NCT04056455|364731172|FG001|Overall Study|Adverse Event|0|||
105748465|NCT01474746|364731176|FG000|Overall Study|Lost to Follow-up|1|||
105748466|NCT01474746|364731177|FG001|Overall Study|Lost to Follow-up|1|||
105748467|NCT01474746|364731176|FG000|Overall Study|Withdrawal by Subject|2|||
105748468|NCT01474746|364731177|FG001|Overall Study|Withdrawal by Subject|1|||
105748469|NCT01766336|364731178|FG000|Overall Study|Adverse Event|11|||
105748470|NCT01766336|364731179|FG001|Overall Study|Adverse Event|8|||
105748471|NCT01766336|364731178|FG000|Overall Study|Death|4|||
105801509|NCT01078623|364930593|FG015|Treatment Period 2|Adverse Event|0|||
105748472|NCT01766336|364731179|FG001|Overall Study|Death|3|||
105801510|NCT01078623|364930594|FG016|Treatment Period 2|Adverse Event|0|||
105801511|NCT01078623|364930595|FG017|Treatment Period 2|Adverse Event|0|||
105748473|NCT01766336|364731178|FG000|Overall Study|Lost to Follow-up|1|||
105748474|NCT01766336|364731179|FG001|Overall Study|Lost to Follow-up|3|||
105748475|NCT01766336|364731178|FG000|Overall Study|Physician Decision|4|||
105748476|NCT01766336|364731179|FG001|Overall Study|Physician Decision|2|||
105748477|NCT01766336|364731178|FG000|Overall Study|Protocol Violation|0|||
105748478|NCT01766336|364731179|FG001|Overall Study|Protocol Violation|1|||
105748479|NCT01766336|364731178|FG000|Overall Study|Sponsor Decision|52|||
105748480|NCT01766336|364731179|FG001|Overall Study|Sponsor Decision|43|||
105748481|NCT01766336|364731178|FG000|Overall Study|Withdrawal by Subject|18|||
105748482|NCT01766336|364731179|FG001|Overall Study|Withdrawal by Subject|15|||
105748483|NCT03807739|364731180|FG000|Overall Study|Adverse Event|1|||
105748484|NCT03807739|364731181|FG001|Overall Study|Adverse Event|0|||
105748485|NCT03807739|364731182|FG002|Overall Study|Adverse Event|0|||
105748486|NCT03807739|364731183|FG003|Overall Study|Adverse Event|0|||
105748487|NCT03807739|364731180|FG000|Overall Study|Withdrawal by Subject|1|||
105748488|NCT03807739|364731181|FG001|Overall Study|Withdrawal by Subject|0|||
105748489|NCT03807739|364731182|FG002|Overall Study|Withdrawal by Subject|0|||
105748490|NCT03807739|364731183|FG003|Overall Study|Withdrawal by Subject|0|||
105748491|NCT03599141|364731187|FG000|Overall Study|Lost to Follow-up|3|||
105748492|NCT03599141|364731188|FG001|Overall Study|Lost to Follow-up|1|||
105748493|NCT00807846|364731189|FG000|Overall Study|Adverse Event|5|||
105748494|NCT00807846|364731190|FG001|Overall Study|Adverse Event|0|||
105748495|NCT00807846|364731189|FG000|Overall Study|Lack of Efficacy|2|||
105748496|NCT00807846|364731190|FG001|Overall Study|Lack of Efficacy|0|||
105748497|NCT00807846|364731189|FG000|Overall Study|Protocol Violation|2|||
105748498|NCT00807846|364731190|FG001|Overall Study|Protocol Violation|1|||
105748499|NCT00807846|364731189|FG000|Overall Study|Withdrawal by Subject|2|||
105748500|NCT00807846|364731190|FG001|Overall Study|Withdrawal by Subject|1|||
105748501|NCT00807846|364731189|FG000|Overall Study|Other|1|||
105748502|NCT00807846|364731190|FG001|Overall Study|Other|2|||
105748503|NCT01081873|364731191|FG000|Overall Study|Death|86|||
105748504|NCT01081873|364731191|FG000|Overall Study|Withdrawal by Subject|10|||
105748505|NCT01081873|364731191|FG000|Overall Study|Lost to Follow-up|142|||
105748506|NCT01081873|364731191|FG000|Overall Study|Progression of prostate cancer|13|||
105748507|NCT01081873|364731191|FG000|Overall Study|Other|47|||
105748508|NCT01165021|364731192|FG000|Overall Study|Death|1|||
105748509|NCT03977727|364731193|FG000|Second Treatment|Lost to Follow-up|0|||
105748510|NCT03977727|364731194|FG001|Second Treatment|Lost to Follow-up|3|||
105748511|NCT01419665|364731195|FG000|Combination Treatment|Adverse Event|7|||
105748512|NCT01419665|364731196|FG001|Combination Treatment|Adverse Event|10|||
105748513|NCT01419665|364731195|FG000|Combination Treatment|Physician Decision|5|||
105748514|NCT01419665|364731196|FG001|Combination Treatment|Physician Decision|8|||
105748515|NCT01419665|364731195|FG000|Combination Treatment|Protocol Violation|6|||
105748516|NCT01419665|364731196|FG001|Combination Treatment|Protocol Violation|2|||
105748517|NCT01419665|364731195|FG000|Combination Treatment|disease progression|10|||
105748518|NCT01419665|364731196|FG001|Combination Treatment|disease progression|9|||
105748519|NCT01419665|364731195|FG000|Combination Treatment|Death|5|||
105748520|NCT01419665|364731196|FG001|Combination Treatment|Death|7|||
105748521|NCT01419665|364731195|FG000|Combination Treatment|administrative problems|0|||
105748522|NCT01419665|364731196|FG001|Combination Treatment|administrative problems|1|||
105748523|NCT01419665|364731195|FG000|Combination Treatment|Withdrawal by Subject|5|||
105748524|NCT01419665|364731196|FG001|Combination Treatment|Withdrawal by Subject|4|||
105748525|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
105748526|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
105748527|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
105748528|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
105748529|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
105748530|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
105748531|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
105748532|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
105748533|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
105748534|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
105748535|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
105748536|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
105748537|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|Death|1|||
105748538|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|Death|2|||
105748539|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
105748540|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
105748541|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
105748542|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
105748543|NCT01419665|364731195|FG000|Open Label Phase|Death|1|||
105748544|NCT01419665|364731196|FG001|Open Label Phase|Death|0|||
105760844|NCT01831804|364778039|FG003|Overall Study|Adverse Event|0|||
105483377|NCT00976508|363782684|FG001|Overall Study|Withdrawal by Subject|0|||
105748545|NCT01419665|364731195|FG000|Open Label Phase|disease progression|0|||
105748546|NCT01419665|364731196|FG001|Open Label Phase|disease progression|1|||
105748547|NCT02596711|364731197|FG000|Overall Study|Lost to Follow-up|1|||
105748548|NCT02596711|364731198|FG001|Overall Study|Lost to Follow-up|2|||
105748549|NCT02596711|364731199|FG002|Overall Study|Lost to Follow-up|3|||
105748550|NCT05108805|364731202|FG000|Overall Study|T-cell expansion was not successful.|5|||
105748551|NCT04752189|364731203|FG000|Overall Study|Withdrawal by Subject|0|||
105748552|NCT04752189|364731204|FG001|Overall Study|Withdrawal by Subject|150|||
105748553|NCT04752189|364731203|FG000|Overall Study|Lost to Follow-up|261|||
105748554|NCT04752189|364731204|FG001|Overall Study|Lost to Follow-up|126|||
105748555|NCT02020031|364732499|FG000|Overall Study|Physician Decision|1|||
105748556|NCT02020031|364732500|FG001|Overall Study|Physician Decision|1|||
105748557|NCT02625324|364732504|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
105748558|NCT02625324|364732504|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
105748559|NCT02625324|364732504|FG000|6-Month Follow-up Subject Accountability|Death|5|||
105748560|NCT02625324|364732504|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
105748561|NCT02625324|364732504|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
105748562|NCT02625324|364732504|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
105748563|NCT02625324|364732504|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
105748564|NCT02625324|364732504|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
105748565|NCT02625324|364732504|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
105748566|NCT02625324|364732504|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
105748567|NCT02625324|364732504|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
105748568|NCT02625324|364732504|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
105748569|NCT02625324|364732504|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
105748570|NCT02625324|364732504|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
105748571|NCT02625324|364732504|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
105748572|NCT02625324|364732504|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
105748573|NCT02625324|364732504|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
105748574|NCT02702518|364732505|FG000|Overall Study|Lost to Follow-up|3|||
105748575|NCT02702518|364732506|FG001|Overall Study|Lost to Follow-up|4|||
105748576|NCT01000727|364732509|FG000|Overall Study|Lost to Follow-up|41|||
105748577|NCT01000727|364732510|FG001|Overall Study|Lost to Follow-up|43|||
105748578|NCT01000727|364732509|FG000|Overall Study|Withdrawal by Subject|111|||
105748579|NCT01000727|364732510|FG001|Overall Study|Withdrawal by Subject|109|||
105748580|NCT01000727|364732509|FG000|Overall Study|Study closed/terminated|23|||
105748581|NCT01000727|364732510|FG001|Overall Study|Study closed/terminated|24|||
105748582|NCT03303092|364732514|FG000|Overall Study|Adverse Event|1|||
105748583|NCT03303092|364732515|FG001|Overall Study|Adverse Event|0|||
105748584|NCT03303092|364732516|FG002|Overall Study|Adverse Event|1|||
105748585|NCT03303092|364732514|FG000|Overall Study|Protocol Violation|1|||
105748586|NCT03303092|364732515|FG001|Overall Study|Protocol Violation|5|||
105748587|NCT03303092|364732516|FG002|Overall Study|Protocol Violation|1|||
105748588|NCT03303092|364732514|FG000|Overall Study|Withdrawal by Subject|1|||
105748589|NCT03303092|364732515|FG001|Overall Study|Withdrawal by Subject|1|||
105748590|NCT03303092|364732516|FG002|Overall Study|Withdrawal by Subject|3|||
105748591|NCT03544268|364732518|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
105748592|NCT03544268|364732519|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
105748593|NCT01697267|364732520|FG000|Overall Study|Death|3|||
105748594|NCT01697267|364732521|FG001|Overall Study|Death|1|||
105748595|NCT01697267|364732520|FG000|Overall Study|Withdrawal by Subject|5|||
105748596|NCT01697267|364732521|FG001|Overall Study|Withdrawal by Subject|5|||
105748597|NCT01697267|364732520|FG000|Overall Study|Adverse Event|2|||
105748598|NCT01697267|364732521|FG001|Overall Study|Adverse Event|1|||
105748599|NCT01697267|364732520|FG000|Overall Study|Lost to Follow-up|2|||
105748600|NCT01697267|364732521|FG001|Overall Study|Lost to Follow-up|4|||
105748601|NCT01697267|364732520|FG000|Overall Study|Physician Decision|2|||
105748602|NCT01697267|364732521|FG001|Overall Study|Physician Decision|4|||
105748603|NCT00568958|364732526|FG000|Allocation|Withdrawal by Subject|7|||
105748604|NCT00568958|364732527|FG001|Allocation|Withdrawal by Subject|3|||
105748605|NCT00568958|364732526|FG000|Allocation|Physician Decision|2|||
105748606|NCT00568958|364732527|FG001|Allocation|Physician Decision|0|||
105748607|NCT00568958|364732526|FG000|Follow-Up|Withdrawal by Subject|6|||
105748608|NCT00568958|364732527|FG001|Follow-Up|Withdrawal by Subject|6|||
105748609|NCT00568958|364732526|FG000|Follow-Up|Physician Decision|1|||
105748610|NCT00568958|364732527|FG001|Follow-Up|Physician Decision|1|||
105748611|NCT00568958|364732526|FG000|Follow-Up|Family Emergency|1|||
105748612|NCT00568958|364732527|FG001|Follow-Up|Family Emergency|0|||
105748613|NCT00568958|364732526|FG000|Follow-Up|Adverse Event|1|||
105748614|NCT00568958|364732527|FG001|Follow-Up|Adverse Event|0|||
105748615|NCT00756886|364732534|FG000|Overall Study|Lost to Follow-up|1|||
105748616|NCT00756886|364732535|FG001|Overall Study|Lost to Follow-up|0|||
105748617|NCT00756886|364732534|FG000|Overall Study|Adverse Event|0|||
105748618|NCT00756886|364732535|FG001|Overall Study|Adverse Event|3|||
105748619|NCT00756886|364732534|FG000|Overall Study|Lack of Efficacy|1|||
105748620|NCT00756886|364732535|FG001|Overall Study|Lack of Efficacy|0|||
105748621|NCT00756886|364732534|FG000|Overall Study|Ineligible|9|||
105748622|NCT00756886|364732535|FG001|Overall Study|Ineligible|4|||
105748623|NCT04348656|364732536|FG000|Overall Study|Withdrawal by Subject|2|||
105748624|NCT04348656|364732537|FG001|Overall Study|Withdrawal by Subject|0|||
105748625|NCT04348656|364732536|FG000|Overall Study|Lost to Follow-up|11|||
105748626|NCT04348656|364732537|FG001|Overall Study|Lost to Follow-up|6|||
105748627|NCT01395368|364732538|FG000|Overall Study|Physician Decision|14|||
105748628|NCT01395368|364732538|FG000|Overall Study|Withdrawal by Subject|2|||
105748629|NCT03072719|364732542|FG000|Overall Study|Adverse Event|1|||
105748630|NCT03072719|364732543|FG001|Overall Study|Adverse Event|1|||
105748631|NCT02387372|364732546|FG000|Overall Study|Not Treated|1|||
105748632|NCT02387372|364732547|FG001|Overall Study|Not Treated|0|||
105748633|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
105748634|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
105748635|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
105748636|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
105748637|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
105748638|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
105748639|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
105748640|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
105748641|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
105748642|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
105748643|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
105748644|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
105748645|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
105748646|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
105748647|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
105748648|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
105748649|NCT00848549|364732549|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
105748650|NCT00848549|364732550|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
105748651|NCT00848549|364732549|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
105748652|NCT00848549|364732550|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
105748653|NCT00848549|364732549|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
105748654|NCT00848549|364732550|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
105748655|NCT00848549|364732549|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
105801512|NCT01078623|364930596|FG018|Treatment Period 2|Adverse Event|1|||
105801513|NCT01078623|364930597|FG019|Treatment Period 2|Adverse Event|0|||
105801514|NCT01078623|364930578|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105801515|NCT01078623|364930579|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105801516|NCT01078623|364930580|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105801517|NCT01078623|364930581|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105801518|NCT01078623|364930582|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105801519|NCT01078623|364930583|FG005|Treatment Period 2|Withdrawal by Subject|1|||
105801520|NCT01078623|364930584|FG006|Treatment Period 2|Withdrawal by Subject|0|||
105801521|NCT01078623|364930585|FG007|Treatment Period 2|Withdrawal by Subject|0|||
105801522|NCT01078623|364930586|FG008|Treatment Period 2|Withdrawal by Subject|0|||
105801523|NCT01078623|364930587|FG009|Treatment Period 2|Withdrawal by Subject|0|||
105801524|NCT01078623|364930588|FG010|Treatment Period 2|Withdrawal by Subject|0|||
105801525|NCT01078623|364930589|FG011|Treatment Period 2|Withdrawal by Subject|0|||
105801526|NCT01078623|364930590|FG012|Treatment Period 2|Withdrawal by Subject|0|||
105801527|NCT01078623|364930591|FG013|Treatment Period 2|Withdrawal by Subject|0|||
105801528|NCT01078623|364930592|FG014|Treatment Period 2|Withdrawal by Subject|0|||
105801529|NCT01078623|364930593|FG015|Treatment Period 2|Withdrawal by Subject|0|||
105359712|NCT03410992|363322326|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105359713|NCT03410992|363322327|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105359714|NCT03410992|363322328|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105801530|NCT01078623|364930594|FG016|Treatment Period 2|Withdrawal by Subject|0|||
105359715|NCT03410992|363322329|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105748656|NCT00848549|364732550|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
105748657|NCT00848549|364732549|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
105748658|NCT00848549|364732550|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
105748659|NCT00848549|364732549|FG000|E2090-E044-314 (Extension Study)|Other|5|||
105801531|NCT01078623|364930595|FG017|Treatment Period 2|Withdrawal by Subject|0|||
105359716|NCT03410992|363322330|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
105359717|NCT03410992|363322331|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105748660|NCT00848549|364732550|FG001|E2090-E044-314 (Extension Study)|Other|6|||
105748661|NCT02546674|364732562|FG000|Overall Study|Adverse Event|19|||
105748662|NCT02546674|364732562|FG000|Overall Study|Death|1|||
105801532|NCT01078623|364930596|FG018|Treatment Period 2|Withdrawal by Subject|0|||
105748663|NCT02546674|364732562|FG000|Overall Study|Lost to Follow-up|1|||
105748664|NCT02546674|364732562|FG000|Overall Study|Physician Decision|13|||
105748665|NCT02546674|364732562|FG000|Overall Study|Pregnancy|1|||
105748666|NCT02546674|364732562|FG000|Overall Study|Progressive Disease|2|||
105748667|NCT02546674|364732562|FG000|Overall Study|Protocol Deviation|2|||
105748668|NCT02546674|364732562|FG000|Overall Study|Subject/Guardian Decision|6|||
105748669|NCT02546674|364732562|FG000|Overall Study|Withdrawal of Informed Consent|3|||
105748670|NCT02864940|364732564|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
105748671|NCT02864940|364732565|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
105748672|NCT02175771|364732566|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
105748673|NCT02175771|364732567|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748674|NCT02175771|364732568|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748675|NCT02175771|364732569|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748676|NCT02175771|364732570|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748677|NCT02175771|364732571|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748678|NCT02175771|364732572|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748679|NCT02175771|364732573|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748680|NCT02175771|364732574|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748681|NCT02175771|364732566|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
105748682|NCT02175771|364732567|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748683|NCT02175771|364732568|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748684|NCT02175771|364732569|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748685|NCT02175771|364732570|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748686|NCT02175771|364732571|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748687|NCT02175771|364732572|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748688|NCT02175771|364732573|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748689|NCT02175771|364732574|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748690|NCT02175771|364732566|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
105748691|NCT02175771|364732567|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748692|NCT02175771|364732568|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748693|NCT02175771|364732569|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748694|NCT02175771|364732570|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748695|NCT02175771|364732571|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748696|NCT02175771|364732572|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748697|NCT02175771|364732573|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748698|NCT02175771|364732574|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748699|NCT02175771|364732566|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
105748700|NCT02175771|364732567|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748701|NCT02175771|364732568|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748702|NCT02175771|364732569|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748703|NCT02175771|364732570|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748704|NCT02175771|364732571|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748705|NCT02175771|364732572|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748706|NCT02175771|364732573|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748707|NCT02175771|364732574|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748708|NCT02175771|364732566|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
105748709|NCT02175771|364732567|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748710|NCT02175771|364732568|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748711|NCT02175771|364732569|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748712|NCT02175771|364732570|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748713|NCT02175771|364732571|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748714|NCT02175771|364732572|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748715|NCT02175771|364732573|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748716|NCT02175771|364732574|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748717|NCT02175771|364732566|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
105748718|NCT02175771|364732567|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105748719|NCT02175771|364732568|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105748720|NCT02175771|364732569|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105748721|NCT02175771|364732570|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105748722|NCT02175771|364732571|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105359718|NCT03410992|363322332|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105359719|NCT02982863|363322333|FG000|Overall Study|Not eligible patients|809|||
105359720|NCT02982863|363322334|FG001|Overall Study|Not eligible patients|4261|||
105748723|NCT02175771|364732572|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105748724|NCT02175771|364732573|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105748725|NCT02175771|364732574|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105748726|NCT02175771|364732566|FG000|Run-In Period (Pre-assignment)|Other|8|||
105748727|NCT02175771|364732567|FG001|Run-In Period (Pre-assignment)|Other|0|||
105748728|NCT02175771|364732568|FG002|Run-In Period (Pre-assignment)|Other|0|||
105748729|NCT02175771|364732569|FG003|Run-In Period (Pre-assignment)|Other|0|||
105801533|NCT01078623|364930597|FG019|Treatment Period 2|Withdrawal by Subject|0|||
105801534|NCT01078623|364930578|FG000|Treatment Period 3|Adverse Event|0|||
105801535|NCT01078623|364930579|FG001|Treatment Period 3|Adverse Event|0|||
105801536|NCT01078623|364930580|FG002|Treatment Period 3|Adverse Event|0|||
105801537|NCT01078623|364930581|FG003|Treatment Period 3|Adverse Event|0|||
105801538|NCT01078623|364930582|FG004|Treatment Period 3|Adverse Event|1|||
105801539|NCT01078623|364930583|FG005|Treatment Period 3|Adverse Event|0|||
105801540|NCT01078623|364930584|FG006|Treatment Period 3|Adverse Event|0|||
105801541|NCT01078623|364930585|FG007|Treatment Period 3|Adverse Event|0|||
105748730|NCT02175771|364732570|FG004|Run-In Period (Pre-assignment)|Other|0|||
105748731|NCT02175771|364732571|FG005|Run-In Period (Pre-assignment)|Other|0|||
105748732|NCT02175771|364732572|FG006|Run-In Period (Pre-assignment)|Other|0|||
105748733|NCT02175771|364732573|FG007|Run-In Period (Pre-assignment)|Other|0|||
105748734|NCT02175771|364732574|FG008|Run-In Period (Pre-assignment)|Other|0|||
105748735|NCT02175771|364732566|FG000|Treatment Period|Adverse Event|0|||
105748736|NCT02175771|364732567|FG001|Treatment Period|Adverse Event|2|||
105748737|NCT02175771|364732568|FG002|Treatment Period|Adverse Event|1|||
105748738|NCT02175771|364732569|FG003|Treatment Period|Adverse Event|1|||
105748739|NCT02175771|364732570|FG004|Treatment Period|Adverse Event|1|||
105801542|NCT01078623|364930586|FG008|Treatment Period 3|Adverse Event|0|||
105801543|NCT01078623|364930587|FG009|Treatment Period 3|Adverse Event|0|||
105801544|NCT01078623|364930588|FG010|Treatment Period 3|Adverse Event|0|||
105801545|NCT01078623|364930589|FG011|Treatment Period 3|Adverse Event|0|||
105801546|NCT01078623|364930590|FG012|Treatment Period 3|Adverse Event|0|||
105801547|NCT01078623|364930591|FG013|Treatment Period 3|Adverse Event|1|||
105801548|NCT01078623|364930592|FG014|Treatment Period 3|Adverse Event|0|||
105801549|NCT01078623|364930593|FG015|Treatment Period 3|Adverse Event|0|||
105801550|NCT01078623|364930594|FG016|Treatment Period 3|Adverse Event|0|||
105801551|NCT01078623|364930595|FG017|Treatment Period 3|Adverse Event|0|||
105801552|NCT01078623|364930596|FG018|Treatment Period 3|Adverse Event|0|||
105801553|NCT01078623|364930597|FG019|Treatment Period 3|Adverse Event|0|||
105801554|NCT01078623|364930578|FG000|Treatment Period 4|Adverse Event|0|||
105801555|NCT01078623|364930579|FG001|Treatment Period 4|Adverse Event|0|||
105801556|NCT01078623|364930580|FG002|Treatment Period 4|Adverse Event|1|||
105801557|NCT01078623|364930581|FG003|Treatment Period 4|Adverse Event|0|||
105801558|NCT01078623|364930582|FG004|Treatment Period 4|Adverse Event|0|||
105801559|NCT01078623|364930583|FG005|Treatment Period 4|Adverse Event|0|||
105801560|NCT01078623|364930584|FG006|Treatment Period 4|Adverse Event|0|||
105801561|NCT01078623|364930585|FG007|Treatment Period 4|Adverse Event|0|||
105801562|NCT01078623|364930586|FG008|Treatment Period 4|Adverse Event|0|||
105801563|NCT01078623|364930587|FG009|Treatment Period 4|Adverse Event|0|||
105801564|NCT01078623|364930588|FG010|Treatment Period 4|Adverse Event|0|||
105801565|NCT01078623|364930589|FG011|Treatment Period 4|Adverse Event|0|||
105801566|NCT01078623|364930590|FG012|Treatment Period 4|Adverse Event|0|||
105801567|NCT01078623|364930591|FG013|Treatment Period 4|Adverse Event|0|||
105801568|NCT01078623|364930592|FG014|Treatment Period 4|Adverse Event|0|||
105483378|NCT00976508|363782683|FG000|Overall Study|Disease Progression|4|||
105748740|NCT02175771|364732571|FG005|Treatment Period|Adverse Event|3|||
105801569|NCT01078623|364930593|FG015|Treatment Period 4|Adverse Event|0|||
105801570|NCT01078623|364930594|FG016|Treatment Period 4|Adverse Event|0|||
105801571|NCT01078623|364930595|FG017|Treatment Period 4|Adverse Event|0|||
105801572|NCT01078623|364930596|FG018|Treatment Period 4|Adverse Event|0|||
105801573|NCT01078623|364930597|FG019|Treatment Period 4|Adverse Event|0|||
105483379|NCT00976508|363782684|FG001|Overall Study|Disease Progression|4|||
105748741|NCT02175771|364732572|FG006|Treatment Period|Adverse Event|2|||
105748742|NCT02175771|364732573|FG007|Treatment Period|Adverse Event|0|||
105801574|NCT01078623|364930578|FG000|Treatment Period 4|Withdrawal by Subject|0|||
105483380|NCT00976508|363782683|FG000|Overall Study|Subject Enrolled in Hospice|1|||
105748743|NCT02175771|364732574|FG008|Treatment Period|Adverse Event|1|||
105748744|NCT02175771|364732566|FG000|Treatment Period|Withdrawal by Subject|0|||
105748745|NCT02175771|364732567|FG001|Treatment Period|Withdrawal by Subject|9|||
105748746|NCT02175771|364732568|FG002|Treatment Period|Withdrawal by Subject|3|||
105801575|NCT01078623|364930579|FG001|Treatment Period 4|Withdrawal by Subject|0|||
105801576|NCT01078623|364930580|FG002|Treatment Period 4|Withdrawal by Subject|0|||
105801577|NCT01078623|364930581|FG003|Treatment Period 4|Withdrawal by Subject|0|||
105801578|NCT01078623|364930582|FG004|Treatment Period 4|Withdrawal by Subject|0|||
105801579|NCT01078623|364930583|FG005|Treatment Period 4|Withdrawal by Subject|0|||
105801580|NCT01078623|364930584|FG006|Treatment Period 4|Withdrawal by Subject|0|||
105801581|NCT01078623|364930585|FG007|Treatment Period 4|Withdrawal by Subject|0|||
105748747|NCT02175771|364732569|FG003|Treatment Period|Withdrawal by Subject|6|||
105748748|NCT02175771|364732570|FG004|Treatment Period|Withdrawal by Subject|2|||
105748749|NCT02175771|364732571|FG005|Treatment Period|Withdrawal by Subject|4|||
105748750|NCT02175771|364732572|FG006|Treatment Period|Withdrawal by Subject|2|||
105748751|NCT02175771|364732573|FG007|Treatment Period|Withdrawal by Subject|9|||
105748752|NCT02175771|364732574|FG008|Treatment Period|Withdrawal by Subject|2|||
105748753|NCT02175771|364732566|FG000|Treatment Period|Noncompliance|0|||
105748754|NCT02175771|364732567|FG001|Treatment Period|Noncompliance|1|||
105748755|NCT02175771|364732568|FG002|Treatment Period|Noncompliance|2|||
105748756|NCT02175771|364732569|FG003|Treatment Period|Noncompliance|0|||
105748757|NCT02175771|364732570|FG004|Treatment Period|Noncompliance|0|||
105748758|NCT02175771|364732571|FG005|Treatment Period|Noncompliance|0|||
105748759|NCT02175771|364732572|FG006|Treatment Period|Noncompliance|0|||
105748760|NCT02175771|364732573|FG007|Treatment Period|Noncompliance|0|||
105748761|NCT02175771|364732574|FG008|Treatment Period|Noncompliance|1|||
105748762|NCT02175771|364732566|FG000|Treatment Period|Protocol Violation|0|||
105748763|NCT02175771|364732567|FG001|Treatment Period|Protocol Violation|0|||
105748764|NCT02175771|364732568|FG002|Treatment Period|Protocol Violation|0|||
105748765|NCT02175771|364732569|FG003|Treatment Period|Protocol Violation|0|||
105748766|NCT02175771|364732570|FG004|Treatment Period|Protocol Violation|0|||
105748767|NCT02175771|364732571|FG005|Treatment Period|Protocol Violation|0|||
105748768|NCT02175771|364732572|FG006|Treatment Period|Protocol Violation|0|||
105748769|NCT02175771|364732573|FG007|Treatment Period|Protocol Violation|1|||
105748770|NCT02175771|364732574|FG008|Treatment Period|Protocol Violation|0|||
105748771|NCT02175771|364732566|FG000|Treatment Period|Disease progression|0|||
105748772|NCT02175771|364732567|FG001|Treatment Period|Disease progression|0|||
105748773|NCT02175771|364732568|FG002|Treatment Period|Disease progression|0|||
105748774|NCT02175771|364732569|FG003|Treatment Period|Disease progression|0|||
105748775|NCT02175771|364732570|FG004|Treatment Period|Disease progression|0|||
105748776|NCT02175771|364732571|FG005|Treatment Period|Disease progression|0|||
105748777|NCT02175771|364732572|FG006|Treatment Period|Disease progression|0|||
105748778|NCT02175771|364732573|FG007|Treatment Period|Disease progression|2|||
105748779|NCT02175771|364732574|FG008|Treatment Period|Disease progression|0|||
105748780|NCT02175771|364732566|FG000|Treatment Period|Lost to Follow-up|0|||
105748781|NCT02175771|364732567|FG001|Treatment Period|Lost to Follow-up|3|||
105748782|NCT02175771|364732568|FG002|Treatment Period|Lost to Follow-up|1|||
105748783|NCT02175771|364732569|FG003|Treatment Period|Lost to Follow-up|3|||
105748784|NCT02175771|364732570|FG004|Treatment Period|Lost to Follow-up|1|||
105748785|NCT02175771|364732571|FG005|Treatment Period|Lost to Follow-up|2|||
105748786|NCT02175771|364732572|FG006|Treatment Period|Lost to Follow-up|1|||
105748787|NCT02175771|364732573|FG007|Treatment Period|Lost to Follow-up|2|||
105748788|NCT02175771|364732574|FG008|Treatment Period|Lost to Follow-up|2|||
105748789|NCT02175771|364732566|FG000|Treatment Period|Lack of Efficacy|0|||
105748790|NCT02175771|364732567|FG001|Treatment Period|Lack of Efficacy|0|||
105748791|NCT02175771|364732568|FG002|Treatment Period|Lack of Efficacy|0|||
105748792|NCT02175771|364732569|FG003|Treatment Period|Lack of Efficacy|0|||
105748793|NCT02175771|364732570|FG004|Treatment Period|Lack of Efficacy|0|||
105748794|NCT02175771|364732571|FG005|Treatment Period|Lack of Efficacy|1|||
105748795|NCT02175771|364732572|FG006|Treatment Period|Lack of Efficacy|0|||
105748796|NCT02175771|364732573|FG007|Treatment Period|Lack of Efficacy|1|||
105748797|NCT02175771|364732574|FG008|Treatment Period|Lack of Efficacy|0|||
105748798|NCT02175771|364732566|FG000|Treatment Period|Other|0|||
105748799|NCT02175771|364732567|FG001|Treatment Period|Other|1|||
105748800|NCT02175771|364732568|FG002|Treatment Period|Other|0|||
105748801|NCT02175771|364732569|FG003|Treatment Period|Other|3|||
105748802|NCT02175771|364732570|FG004|Treatment Period|Other|1|||
105748803|NCT02175771|364732571|FG005|Treatment Period|Other|0|||
105748804|NCT02175771|364732572|FG006|Treatment Period|Other|0|||
105748805|NCT02175771|364732573|FG007|Treatment Period|Other|2|||
105748806|NCT02175771|364732574|FG008|Treatment Period|Other|0|||
105748807|NCT03364673|364732575|FG000|Overall Study|Withdrawal by Subject|2|||
105748808|NCT03364673|364732575|FG000|Overall Study|Injury unrelated to study|3|||
105748809|NCT02232087|364732576|FG000|Overall Study|Withdrawal by Subject|2|||
105748810|NCT02232087|364732577|FG001|Overall Study|Withdrawal by Subject|0|||
105748811|NCT02232087|364732578|FG002|Overall Study|Withdrawal by Subject|0|||
105748812|NCT02232087|364732579|FG003|Overall Study|Withdrawal by Subject|0|||
105748813|NCT02232087|364732580|FG004|Overall Study|Withdrawal by Subject|0|||
105748814|NCT02232087|364732581|FG005|Overall Study|Withdrawal by Subject|1|||
105748815|NCT02232087|364732576|FG000|Overall Study|poor inhalation technique|0|||
105748816|NCT02232087|364732577|FG001|Overall Study|poor inhalation technique|1|||
105748817|NCT02232087|364732578|FG002|Overall Study|poor inhalation technique|0|||
105748818|NCT02232087|364732579|FG003|Overall Study|poor inhalation technique|0|||
105748819|NCT02232087|364732580|FG004|Overall Study|poor inhalation technique|0|||
105748820|NCT02232087|364732581|FG005|Overall Study|poor inhalation technique|2|||
105748821|NCT02232087|364732576|FG000|Overall Study|protocol stop criteria|0|||
105748822|NCT02232087|364732577|FG001|Overall Study|protocol stop criteria|1|||
105359721|NCT02982863|363322335|FG002|Overall Study|Not eligible patients|1852|||
105748823|NCT02232087|364732578|FG002|Overall Study|protocol stop criteria|0|||
105748824|NCT02232087|364732579|FG003|Overall Study|protocol stop criteria|1|||
105748825|NCT02232087|364732580|FG004|Overall Study|protocol stop criteria|0|||
105748826|NCT02232087|364732581|FG005|Overall Study|protocol stop criteria|0|||
105748827|NCT02232087|364732576|FG000|Overall Study|Adverse Event|0|||
105748828|NCT02232087|364732577|FG001|Overall Study|Adverse Event|0|||
105748829|NCT02232087|364732578|FG002|Overall Study|Adverse Event|0|||
105748830|NCT02232087|364732579|FG003|Overall Study|Adverse Event|0|||
105748831|NCT02232087|364732580|FG004|Overall Study|Adverse Event|1|||
105748832|NCT02232087|364732581|FG005|Overall Study|Adverse Event|0|||
105748833|NCT02504268|364732583|FG000|Overall Study|Adverse Event|18|||
105748834|NCT02504268|364732584|FG001|Overall Study|Adverse Event|8|||
105748835|NCT02504268|364732585|FG002|Overall Study|Adverse Event|14|||
105748836|NCT02504268|364732586|FG003|Overall Study|Adverse Event|0|||
105748837|NCT02504268|364732587|FG004|Overall Study|Adverse Event|0|||
105748838|NCT02504268|364732588|FG005|Overall Study|Adverse Event|0|||
105748839|NCT02504268|364732589|FG006|Overall Study|Adverse Event|0|||
105748840|NCT02504268|364732590|FG007|Overall Study|Adverse Event|0|||
105748841|NCT02504268|364732591|FG008|Overall Study|Adverse Event|0|||
105748842|NCT02504268|364732583|FG000|Overall Study|Withdrawal of Consent|11|||
105748843|NCT02504268|364732584|FG001|Overall Study|Withdrawal of Consent|10|||
105748844|NCT02504268|364732585|FG002|Overall Study|Withdrawal of Consent|3|||
105748845|NCT02504268|364732586|FG003|Overall Study|Withdrawal of Consent|0|||
105748846|NCT02504268|364732587|FG004|Overall Study|Withdrawal of Consent|0|||
105748847|NCT02504268|364732588|FG005|Overall Study|Withdrawal of Consent|0|||
105748848|NCT02504268|364732589|FG006|Overall Study|Withdrawal of Consent|0|||
105748849|NCT02504268|364732590|FG007|Overall Study|Withdrawal of Consent|0|||
105748850|NCT02504268|364732591|FG008|Overall Study|Withdrawal of Consent|0|||
105748851|NCT02504268|364732583|FG000|Overall Study|Pregnancy|2|||
105748852|NCT02504268|364732584|FG001|Overall Study|Pregnancy|0|||
105748853|NCT02504268|364732585|FG002|Overall Study|Pregnancy|0|||
105748854|NCT02504268|364732586|FG003|Overall Study|Pregnancy|0|||
105748855|NCT02504268|364732587|FG004|Overall Study|Pregnancy|0|||
105748856|NCT02504268|364732588|FG005|Overall Study|Pregnancy|0|||
105748857|NCT02504268|364732589|FG006|Overall Study|Pregnancy|0|||
105748858|NCT02504268|364732590|FG007|Overall Study|Pregnancy|0|||
105748859|NCT02504268|364732591|FG008|Overall Study|Pregnancy|0|||
105748860|NCT02504268|364732583|FG000|Overall Study|Lost to Follow-up|3|||
105748861|NCT02504268|364732584|FG001|Overall Study|Lost to Follow-up|6|||
105748862|NCT02504268|364732585|FG002|Overall Study|Lost to Follow-up|4|||
105748863|NCT02504268|364732586|FG003|Overall Study|Lost to Follow-up|0|||
105359722|NCT02982863|363322336|FG003|Overall Study|Not eligible patients|1400|||
105359723|NCT02982863|363322337|FG004|Overall Study|Not eligible patients|492|||
105359724|NCT02457195|363322338|FG000|Overall Study|Adverse Event|3|||
105565406|NCT04512066|364066765|FG000|Extension Period|Lost to Follow-up|0|||
105748864|NCT02504268|364732587|FG004|Overall Study|Lost to Follow-up|0|||
105748865|NCT02504268|364732588|FG005|Overall Study|Lost to Follow-up|0|||
105748866|NCT02504268|364732589|FG006|Overall Study|Lost to Follow-up|0|||
105748867|NCT02504268|364732590|FG007|Overall Study|Lost to Follow-up|0|||
105748868|NCT02504268|364732591|FG008|Overall Study|Lost to Follow-up|0|||
105748869|NCT02504268|364732583|FG000|Overall Study|Death|1|||
105748870|NCT02504268|364732584|FG001|Overall Study|Death|1|||
105748871|NCT02504268|364732585|FG002|Overall Study|Death|0|||
105748872|NCT02504268|364732586|FG003|Overall Study|Death|0|||
105748873|NCT02504268|364732587|FG004|Overall Study|Death|0|||
105748874|NCT02504268|364732588|FG005|Overall Study|Death|0|||
105748875|NCT02504268|364732589|FG006|Overall Study|Death|0|||
105748876|NCT02504268|364732590|FG007|Overall Study|Death|0|||
105748877|NCT02504268|364732591|FG008|Overall Study|Death|0|||
105748878|NCT02504268|364732583|FG000|Overall Study|Subject Request to Discontinue|11|||
105565407|NCT04512066|364066766|FG001|Extension Period|Lost to Follow-up|1|||
105748879|NCT02504268|364732584|FG001|Overall Study|Subject Request to Discontinue|3|||
105748880|NCT02504268|364732585|FG002|Overall Study|Subject Request to Discontinue|6|||
105748881|NCT02504268|364732586|FG003|Overall Study|Subject Request to Discontinue|0|||
105748882|NCT02504268|364732587|FG004|Overall Study|Subject Request to Discontinue|0|||
105748883|NCT02504268|364732588|FG005|Overall Study|Subject Request to Discontinue|0|||
105748884|NCT02504268|364732589|FG006|Overall Study|Subject Request to Discontinue|0|||
105748885|NCT02504268|364732590|FG007|Overall Study|Subject Request to Discontinue|0|||
105748886|NCT02504268|364732591|FG008|Overall Study|Subject Request to Discontinue|0|||
105748887|NCT02504268|364732583|FG000|Overall Study|No Longer Meets Study Criteria|2|||
105748888|NCT02504268|364732584|FG001|Overall Study|No Longer Meets Study Criteria|3|||
105748889|NCT02504268|364732585|FG002|Overall Study|No Longer Meets Study Criteria|0|||
105748890|NCT02504268|364732586|FG003|Overall Study|No Longer Meets Study Criteria|0|||
105748891|NCT02504268|364732587|FG004|Overall Study|No Longer Meets Study Criteria|0|||
105748892|NCT02504268|364732588|FG005|Overall Study|No Longer Meets Study Criteria|0|||
105748893|NCT02504268|364732589|FG006|Overall Study|No Longer Meets Study Criteria|0|||
105748894|NCT02504268|364732590|FG007|Overall Study|No Longer Meets Study Criteria|0|||
105748895|NCT02504268|364732591|FG008|Overall Study|No Longer Meets Study Criteria|0|||
105748896|NCT02504268|364732583|FG000|Overall Study|Lack of Efficacy|11|||
105748897|NCT02504268|364732584|FG001|Overall Study|Lack of Efficacy|35|||
105748898|NCT02504268|364732585|FG002|Overall Study|Lack of Efficacy|9|||
105748899|NCT02504268|364732586|FG003|Overall Study|Lack of Efficacy|0|||
105748900|NCT02504268|364732587|FG004|Overall Study|Lack of Efficacy|0|||
105748901|NCT02504268|364732588|FG005|Overall Study|Lack of Efficacy|0|||
105748902|NCT02504268|364732589|FG006|Overall Study|Lack of Efficacy|0|||
105748903|NCT02504268|364732590|FG007|Overall Study|Lack of Efficacy|0|||
105748904|NCT02504268|364732591|FG008|Overall Study|Lack of Efficacy|0|||
105748905|NCT02504268|364732583|FG000|Overall Study|Poor/Non-Compliance|3|||
105748906|NCT02504268|364732584|FG001|Overall Study|Poor/Non-Compliance|2|||
105748907|NCT02504268|364732585|FG002|Overall Study|Poor/Non-Compliance|3|||
105748908|NCT02504268|364732586|FG003|Overall Study|Poor/Non-Compliance|0|||
105748909|NCT02504268|364732587|FG004|Overall Study|Poor/Non-Compliance|0|||
105748910|NCT02504268|364732588|FG005|Overall Study|Poor/Non-Compliance|0|||
105748911|NCT02504268|364732589|FG006|Overall Study|Poor/Non-Compliance|0|||
105748912|NCT02504268|364732590|FG007|Overall Study|Poor/Non-Compliance|0|||
105748913|NCT02504268|364732591|FG008|Overall Study|Poor/Non-Compliance|0|||
105748914|NCT02504268|364732583|FG000|Overall Study|Not Disclosed|1|||
105748915|NCT02504268|364732584|FG001|Overall Study|Not Disclosed|0|||
105748916|NCT02504268|364732585|FG002|Overall Study|Not Disclosed|2|||
105748917|NCT02504268|364732586|FG003|Overall Study|Not Disclosed|0|||
105748918|NCT02504268|364732587|FG004|Overall Study|Not Disclosed|0|||
105748919|NCT02504268|364732588|FG005|Overall Study|Not Disclosed|0|||
105748920|NCT02504268|364732589|FG006|Overall Study|Not Disclosed|0|||
105748921|NCT02504268|364732590|FG007|Overall Study|Not Disclosed|0|||
105748922|NCT02504268|364732591|FG008|Overall Study|Not Disclosed|0|||
105748923|NCT03025217|364732592|FG000|Overall Study|Pregnancy|1|||
105748924|NCT03025217|364732592|FG000|Overall Study|Lost to Follow-up|1|||
105748925|NCT03025217|364732592|FG000|Overall Study|Not eligible, poor English|2|||
105748926|NCT04069156|364732593|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
105748927|NCT04069156|364732594|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
105748928|NCT04069156|364732593|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
105748929|NCT04069156|364732594|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
105748930|NCT04069156|364732593|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
105748931|NCT04069156|364732594|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
105748932|NCT04069156|364732593|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
105748933|NCT04069156|364732594|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
105748934|NCT02208024|364732595|FG000|Overall Study|Withdrawal by Subject|1|||
105748935|NCT01958125|364732596|FG000|Overall Study|Missing diary data|2|||
105748936|NCT01958125|364732597|FG001|Overall Study|Missing diary data|6|||
105748937|NCT01958125|364732596|FG000|Overall Study|No headache attacks|0|||
105748938|NCT01958125|364732597|FG001|Overall Study|No headache attacks|2|||
105748939|NCT04804033|364732599|FG000|Period 1: DBT Phase|Adverse Event|1|||
105748940|NCT04804033|364732600|FG001|Period 1: DBT Phase|Adverse Event|5|||
105748941|NCT04804033|364732601|FG002|Period 1: DBT Phase|Adverse Event|3|||
105748942|NCT04804033|364732602|FG003|Period 1: DBT Phase|Adverse Event|4|||
105748943|NCT04804033|364732599|FG000|Period 1: DBT Phase|Death|1|||
105748944|NCT04804033|364732600|FG001|Period 1: DBT Phase|Death|0|||
105748945|NCT04804033|364732601|FG002|Period 1: DBT Phase|Death|0|||
105748946|NCT04804033|364732602|FG003|Period 1: DBT Phase|Death|0|||
105748947|NCT04804033|364732599|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
105748948|NCT04804033|364732600|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
105748949|NCT04804033|364732601|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
105748950|NCT04804033|364732602|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
105748951|NCT04804033|364732599|FG000|Period 1: DBT Phase|Non-compliance|1|||
105748952|NCT04804033|364732600|FG001|Period 1: DBT Phase|Non-compliance|0|||
105748953|NCT04804033|364732601|FG002|Period 1: DBT Phase|Non-compliance|1|||
105748954|NCT04804033|364732602|FG003|Period 1: DBT Phase|Non-compliance|2|||
105748955|NCT04804033|364732599|FG000|Period 1: DBT Phase|Other|0|||
105748956|NCT04804033|364732600|FG001|Period 1: DBT Phase|Other|1|||
105748957|NCT04804033|364732601|FG002|Period 1: DBT Phase|Other|0|||
105748958|NCT04804033|364732602|FG003|Period 1: DBT Phase|Other|0|||
105748959|NCT04804033|364732599|FG000|Period 1: DBT Phase|Pregnancy|2|||
105748960|NCT04804033|364732600|FG001|Period 1: DBT Phase|Pregnancy|0|||
105748961|NCT04804033|364732601|FG002|Period 1: DBT Phase|Pregnancy|0|||
105748962|NCT04804033|364732602|FG003|Period 1: DBT Phase|Pregnancy|0|||
105748963|NCT04804033|364732599|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
105748964|NCT04804033|364732600|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
105748965|NCT04804033|364732601|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
105748966|NCT04804033|364732602|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
105748967|NCT04804033|364732599|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
105748968|NCT04804033|364732600|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
105748969|NCT04804033|364732601|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
105748970|NCT04804033|364732602|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
105748971|NCT04804033|364732599|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
105748972|NCT04804033|364732600|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
105748973|NCT04804033|364732601|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
105748974|NCT04804033|364732602|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
105748975|NCT04804033|364732599|FG000|Period 2: OLE Phase|Adverse Event|3|||
105748976|NCT04804033|364732600|FG001|Period 2: OLE Phase|Adverse Event|4|||
105748977|NCT04804033|364732601|FG002|Period 2: OLE Phase|Adverse Event|2|||
105748978|NCT04804033|364732602|FG003|Period 2: OLE Phase|Adverse Event|0|||
105748979|NCT04804033|364732599|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
105748980|NCT04804033|364732600|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
105748981|NCT04804033|364732601|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
105748982|NCT04804033|364732602|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
105748983|NCT04804033|364732599|FG000|Period 2: OLE Phase|Non-compliance|2|||
105748984|NCT04804033|364732600|FG001|Period 2: OLE Phase|Non-compliance|2|||
105748985|NCT04804033|364732601|FG002|Period 2: OLE Phase|Non-compliance|0|||
105748986|NCT04804033|364732602|FG003|Period 2: OLE Phase|Non-compliance|1|||
105748987|NCT04804033|364732599|FG000|Period 2: OLE Phase|Other|0|||
105748988|NCT04804033|364732600|FG001|Period 2: OLE Phase|Other|2|||
105748989|NCT04804033|364732601|FG002|Period 2: OLE Phase|Other|0|||
105748990|NCT04804033|364732602|FG003|Period 2: OLE Phase|Other|0|||
105748991|NCT04804033|364732599|FG000|Period 2: OLE Phase|Physician Decision|1|||
105748992|NCT04804033|364732600|FG001|Period 2: OLE Phase|Physician Decision|1|||
105748993|NCT04804033|364732601|FG002|Period 2: OLE Phase|Physician Decision|0|||
105748994|NCT04804033|364732602|FG003|Period 2: OLE Phase|Physician Decision|0|||
105748995|NCT04804033|364732599|FG000|Period 2: OLE Phase|Pregnancy|0|||
105748996|NCT04804033|364732600|FG001|Period 2: OLE Phase|Pregnancy|0|||
105748997|NCT04804033|364732601|FG002|Period 2: OLE Phase|Pregnancy|2|||
105748998|NCT04804033|364732602|FG003|Period 2: OLE Phase|Pregnancy|0|||
105748999|NCT04804033|364732599|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
105749000|NCT04804033|364732600|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
105749001|NCT04804033|364732601|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
105749002|NCT04804033|364732602|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
105749003|NCT04804033|364732599|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
105749004|NCT04804033|364732600|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
105749005|NCT04804033|364732601|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
105749006|NCT04804033|364732602|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
105749007|NCT04804033|364732599|FG000|Period 2: OLE Phase|Not reported|0|||
105749008|NCT04804033|364732600|FG001|Period 2: OLE Phase|Not reported|2|||
105749009|NCT04804033|364732601|FG002|Period 2: OLE Phase|Not reported|0|||
105749010|NCT04804033|364732602|FG003|Period 2: OLE Phase|Not reported|0|||
105749011|NCT04804033|364732599|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
105749012|NCT04804033|364732600|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
105749013|NCT04804033|364732601|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
105749014|NCT04804033|364732602|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
105749015|NCT04804033|364732599|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
105749016|NCT04804033|364732600|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
105749017|NCT04804033|364732601|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
105749018|NCT04804033|364732602|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
105749019|NCT04804033|364732599|FG000|Period 3: Follow-up Phase|Other|0|||
105749020|NCT04804033|364732600|FG001|Period 3: Follow-up Phase|Other|1|||
105749021|NCT04804033|364732601|FG002|Period 3: Follow-up Phase|Other|2|||
105749022|NCT04804033|364732602|FG003|Period 3: Follow-up Phase|Other|1|||
105749023|NCT04804033|364732599|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
105749024|NCT04804033|364732600|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
105749025|NCT04804033|364732601|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
105749026|NCT04804033|364732602|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
105749027|NCT04804033|364732599|FG000|Period 3: Follow-up Phase|Not reported|18|||
105749028|NCT04804033|364732600|FG001|Period 3: Follow-up Phase|Not reported|15|||
105749029|NCT04804033|364732601|FG002|Period 3: Follow-up Phase|Not reported|1|||
105749030|NCT04804033|364732602|FG003|Period 3: Follow-up Phase|Not reported|4|||
105749031|NCT00862849|364732607|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
105749032|NCT00862849|364732608|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
105749033|NCT00862849|364732609|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
105749034|NCT00862849|364732610|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
105749035|NCT00862849|364732611|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
105749036|NCT00862849|364732612|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
105749037|NCT00862849|364732607|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
105749038|NCT00862849|364732608|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
105749039|NCT00862849|364732609|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
105749040|NCT00862849|364732610|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
105749041|NCT00862849|364732611|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
105749042|NCT00862849|364732612|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
105749043|NCT01153763|364732623|FG000|Overall Study|Study Closed|16|||
105749044|NCT01153763|364732623|FG000|Overall Study|Lost to Follow-up|1|||
105749045|NCT01153763|364732623|FG000|Overall Study|Physician Decision|2|||
105749046|NCT01153763|364732623|FG000|Overall Study|Withdrawal by Subject|2|||
105749047|NCT01019486|364732624|FG000|Overall Study|Withdrawal by Subject|1|||
105749048|NCT01019486|364732625|FG001|Overall Study|Withdrawal by Subject|1|||
105749049|NCT01019486|364732626|FG002|Overall Study|Withdrawal by Subject|1|||
105749050|NCT03029650|364732628|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
105760845|NCT01831804|364778040|FG004|Overall Study|Adverse Event|0|||
105749051|NCT03029650|364732629|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
105749052|NCT03029650|364732628|FG000|Washout (1 Week)|Physician Decision|0|||
105749053|NCT03029650|364732629|FG001|Washout (1 Week)|Physician Decision|1|||
105749054|NCT02605447|364732631|FG000|Overall Study|Death|66|||
105749055|NCT02605447|364732631|FG000|Overall Study|Physician Decision|1|||
105749056|NCT02605447|364732631|FG000|Overall Study|Lost to Follow-up|24|||
105749057|NCT02605447|364732631|FG000|Overall Study|Withdrawal by Subject|10|||
105749058|NCT02605447|364732631|FG000|Overall Study|Not disclosed|1|||
105749059|NCT03628508|364732635|FG000|Overall Study|Lost to Follow-up|1|||
105749060|NCT05836818|364732638|FG000|Overall Study|Physician Decision|1|||
105749061|NCT05836818|364732639|FG001|Overall Study|Physician Decision|1|||
105749062|NCT05836818|364732640|FG002|Overall Study|Physician Decision|0|||
105749063|NCT05836818|364732638|FG000|Overall Study|Withdrawal by Subject|0|||
105749064|NCT05836818|364732639|FG001|Overall Study|Withdrawal by Subject|0|||
105749065|NCT05836818|364732640|FG002|Overall Study|Withdrawal by Subject|1|||
105749066|NCT05836818|364732638|FG000|Overall Study|Later found to be previously vaccinated|0|||
105749067|NCT05836818|364732639|FG001|Overall Study|Later found to be previously vaccinated|1|||
105749068|NCT05836818|364732640|FG002|Overall Study|Later found to be previously vaccinated|3|||
105749069|NCT05836818|364732638|FG000|Overall Study|Pregnancy|0|||
105749070|NCT05836818|364732639|FG001|Overall Study|Pregnancy|1|||
105749071|NCT05836818|364732640|FG002|Overall Study|Pregnancy|0|||
105749072|NCT05836818|364732638|FG000|Overall Study|Allergic to vaccines|0|||
105749073|NCT05836818|364732639|FG001|Overall Study|Allergic to vaccines|1|||
105749074|NCT05836818|364732640|FG002|Overall Study|Allergic to vaccines|0|||
105749075|NCT03011840|364732641|FG000|Overall Study|Not received PIL in post PIL phase|0|||
105749076|NCT03011840|364732642|FG001|Overall Study|Not received PIL in post PIL phase|21|||
105749077|NCT01552928|364732643|FG000|Period 3|Adverse Event|0|||
105749078|NCT01552928|364732644|FG001|Period 3|Adverse Event|0|||
105749079|NCT01552928|364732645|FG002|Period 3|Adverse Event|1|||
105749080|NCT01552928|364732646|FG003|Period 3|Adverse Event|0|||
105749081|NCT01454401|364732650|FG000|Overall Study|Death|1|||
105749082|NCT01454401|364732650|FG000|Overall Study|hospitalised|1|||
105749083|NCT01454401|364732650|FG000|Overall Study|osteomyelitis|2|||
105749084|NCT01454401|364732650|FG000|Overall Study|non-adherence|1|||
105749085|NCT03260205|364732653|FG000|Overall Study|Adverse Event|2|||
105749086|NCT03260205|364732654|FG001|Overall Study|Adverse Event|0|||
105749087|NCT03260205|364732655|FG002|Overall Study|Adverse Event|2|||
105749088|NCT03260205|364732656|FG003|Overall Study|Adverse Event|2|||
105749089|NCT03260205|364732657|FG004|Overall Study|Adverse Event|4|||
105749090|NCT03260205|364732653|FG000|Overall Study|Lost to Follow-up|2|||
105749091|NCT03260205|364732654|FG001|Overall Study|Lost to Follow-up|2|||
105749092|NCT03260205|364732655|FG002|Overall Study|Lost to Follow-up|1|||
105749093|NCT03260205|364732656|FG003|Overall Study|Lost to Follow-up|1|||
105749094|NCT03260205|364732657|FG004|Overall Study|Lost to Follow-up|5|||
105749095|NCT03260205|364732653|FG000|Overall Study|Protocol Violation|0|||
105749096|NCT03260205|364732654|FG001|Overall Study|Protocol Violation|0|||
105749097|NCT03260205|364732655|FG002|Overall Study|Protocol Violation|2|||
105749098|NCT03260205|364732656|FG003|Overall Study|Protocol Violation|0|||
105749099|NCT03260205|364732657|FG004|Overall Study|Protocol Violation|1|||
105749100|NCT03260205|364732653|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
105749101|NCT03260205|364732654|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
105749102|NCT03260205|364732655|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
105749103|NCT03260205|364732656|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
105749104|NCT03260205|364732657|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
105749105|NCT03260205|364732653|FG000|Overall Study|Other: Unspecified|0|||
105749106|NCT03260205|364732654|FG001|Overall Study|Other: Unspecified|0|||
105749107|NCT03260205|364732655|FG002|Overall Study|Other: Unspecified|3|||
105749108|NCT03260205|364732656|FG003|Overall Study|Other: Unspecified|1|||
105749109|NCT03260205|364732657|FG004|Overall Study|Other: Unspecified|1|||
105749110|NCT03260205|364732653|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
105749111|NCT03260205|364732654|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
105749112|NCT03260205|364732655|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
105749113|NCT03260205|364732656|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
105749114|NCT03260205|364732657|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
105749115|NCT01116687|364734273|FG000|Overall Study|Withdrawal by Subject|4|||
105749116|NCT00424528|364734274|FG000|Overall Study|Adverse Event|2|||
105749117|NCT00424528|364734275|FG001|Overall Study|Adverse Event|1|||
105749118|NCT00424528|364734276|FG002|Overall Study|Adverse Event|2|||
105749119|NCT00424528|364734274|FG000|Overall Study|Protocol Violation|1|||
105749120|NCT00424528|364734275|FG001|Overall Study|Protocol Violation|1|||
105749121|NCT00424528|364734276|FG002|Overall Study|Protocol Violation|0|||
105749122|NCT00424528|364734274|FG000|Overall Study|Lost to Follow-up|0|||
105749123|NCT00424528|364734275|FG001|Overall Study|Lost to Follow-up|1|||
105749124|NCT00424528|364734276|FG002|Overall Study|Lost to Follow-up|0|||
105749125|NCT00424528|364734274|FG000|Overall Study|noncompliance with study requirements|2|||
105749126|NCT00424528|364734275|FG001|Overall Study|noncompliance with study requirements|1|||
105749127|NCT00424528|364734276|FG002|Overall Study|noncompliance with study requirements|2|||
105749128|NCT02115113|364734277|FG000|Participants in Run-in Period|Death|0|||
105749129|NCT02115113|364734278|FG001|Participants in Run-in Period|Death|0|||
105749130|NCT02115113|364734279|FG002|Participants in Run-in Period|Death|1|||
105749131|NCT02115113|364734277|FG000|Participants in Run-in Period|Administrative problems|0|||
105749132|NCT02115113|364734278|FG001|Participants in Run-in Period|Administrative problems|0|||
105749133|NCT02115113|364734279|FG002|Participants in Run-in Period|Administrative problems|1|||
105749134|NCT02115113|364734277|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
105749135|NCT02115113|364734278|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
105749136|NCT02115113|364734279|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
105749137|NCT02115113|364734277|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
105749138|NCT02115113|364734278|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
105749139|NCT02115113|364734279|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
105749140|NCT02115113|364734277|FG000|Participants Randomized|Lost to Follow-up|1|||
105749141|NCT02115113|364734278|FG001|Participants Randomized|Lost to Follow-up|0|||
105749142|NCT02115113|364734279|FG002|Participants Randomized|Lost to Follow-up|0|||
105749143|NCT02115113|364734277|FG000|Participants Randomized|Death|1|||
105749144|NCT02115113|364734278|FG001|Participants Randomized|Death|0|||
105749145|NCT02115113|364734279|FG002|Participants Randomized|Death|0|||
105749146|NCT00789191|364734283|FG000|Overall Study|Adverse Event|2|||
105749147|NCT00789191|364734284|FG001|Overall Study|Adverse Event|4|||
105749148|NCT00789191|364734283|FG000|Overall Study|Lack of Efficacy|0|||
105749149|NCT00789191|364734284|FG001|Overall Study|Lack of Efficacy|5|||
105749150|NCT00789191|364734283|FG000|Overall Study|Protocol Violation|5|||
105749151|NCT00789191|364734284|FG001|Overall Study|Protocol Violation|3|||
105749152|NCT00789191|364734283|FG000|Overall Study|Withdrawal Criteria|2|||
105749153|NCT00789191|364734284|FG001|Overall Study|Withdrawal Criteria|4|||
105749154|NCT00789191|364734283|FG000|Overall Study|Unclassified|5|||
105749155|NCT00789191|364734284|FG001|Overall Study|Unclassified|3|||
105749156|NCT01009983|364734285|FG000|Overall Study|necessary scans not completed|1|||
105749157|NCT00762372|364734286|FG000|Overall Study|Adverse Event|1|||
105749158|NCT00762372|364734287|FG001|Overall Study|Adverse Event|0|||
105749159|NCT00762372|364734288|FG002|Overall Study|Adverse Event|0|||
105749160|NCT02395653|364734289|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
105749161|NCT02395653|364734289|FG000|Overall Study|Consent Withdrawn at Screening|1|||
105749162|NCT02395653|364734289|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
105749163|NCT02395653|364734289|FG000|Overall Study|Investigator Decision at Screening|1|||
105749164|NCT02395653|364734289|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
105749165|NCT02395653|364734289|FG000|Overall Study|Withdrawal by Subject|1|||
105749166|NCT02395653|364734289|FG000|Overall Study|Lost to Follow-up|1|||
105749167|NCT02616185|364734290|FG000|Overall Study|Death|0|||
105749168|NCT02616185|364734291|FG001|Overall Study|Death|0|||
105749169|NCT02616185|364734292|FG002|Overall Study|Death|0|||
105749170|NCT02616185|364734293|FG003|Overall Study|Death|1|||
105749171|NCT02616185|364734294|FG004|Overall Study|Death|2|||
105749172|NCT02616185|364734295|FG005|Overall Study|Death|0|||
105749173|NCT02616185|364734296|FG006|Overall Study|Death|0|||
105749174|NCT02616185|364734297|FG007|Overall Study|Death|2|||
105749175|NCT02616185|364734298|FG008|Overall Study|Death|1|||
105749176|NCT02616185|364734290|FG000|Overall Study|Study terminated by sponsor|0|||
105749177|NCT02616185|364734291|FG001|Overall Study|Study terminated by sponsor|0|||
105749178|NCT02616185|364734292|FG002|Overall Study|Study terminated by sponsor|1|||
105749179|NCT02616185|364734293|FG003|Overall Study|Study terminated by sponsor|0|||
105749180|NCT02616185|364734294|FG004|Overall Study|Study terminated by sponsor|0|||
105749181|NCT02616185|364734295|FG005|Overall Study|Study terminated by sponsor|0|||
105749182|NCT02616185|364734296|FG006|Overall Study|Study terminated by sponsor|5|||
105749183|NCT02616185|364734297|FG007|Overall Study|Study terminated by sponsor|2|||
105749184|NCT02616185|364734298|FG008|Overall Study|Study terminated by sponsor|0|||
105749185|NCT02616185|364734290|FG000|Overall Study|Participant refused further follow-up|1|||
105749186|NCT02616185|364734291|FG001|Overall Study|Participant refused further follow-up|1|||
105749187|NCT02616185|364734292|FG002|Overall Study|Participant refused further follow-up|2|||
105749188|NCT02616185|364734293|FG003|Overall Study|Participant refused further follow-up|3|||
105749189|NCT02616185|364734294|FG004|Overall Study|Participant refused further follow-up|4|||
105749190|NCT02616185|364734295|FG005|Overall Study|Participant refused further follow-up|0|||
105749191|NCT02616185|364734296|FG006|Overall Study|Participant refused further follow-up|3|||
105749192|NCT02616185|364734297|FG007|Overall Study|Participant refused further follow-up|4|||
105749193|NCT02616185|364734298|FG008|Overall Study|Participant refused further follow-up|3|||
105749194|NCT02616185|364734290|FG000|Overall Study|Not reported|0|||
105749195|NCT02616185|364734291|FG001|Overall Study|Not reported|0|||
105749196|NCT02616185|364734292|FG002|Overall Study|Not reported|0|||
105749197|NCT02616185|364734293|FG003|Overall Study|Not reported|1|||
105749198|NCT02616185|364734294|FG004|Overall Study|Not reported|3|||
105749199|NCT02616185|364734295|FG005|Overall Study|Not reported|1|||
105749200|NCT02616185|364734296|FG006|Overall Study|Not reported|0|||
105749201|NCT02616185|364734297|FG007|Overall Study|Not reported|5|||
105749202|NCT02616185|364734298|FG008|Overall Study|Not reported|2|||
105749203|NCT01346371|364734299|FG000|Overall Study|Lost to Follow-up|2|||
105749204|NCT01346371|364734300|FG001|Overall Study|Lost to Follow-up|0|||
105749205|NCT00487084|364734305|FG000|Overall Study|Did not receive intervention|4|||
105749206|NCT00487084|364734306|FG001|Overall Study|Did not receive intervention|3|||
105749207|NCT00487084|364734307|FG002|Overall Study|Did not receive intervention|5|||
105749208|NCT01626352|364734310|FG000|Overall Study|Disease Progression|3|||
105749209|NCT01626352|364734310|FG000|Overall Study|Intercurrent Illness|2|||
105749210|NCT01626352|364734310|FG000|Overall Study|Death|2|||
105749211|NCT01626352|364734310|FG000|Overall Study|Withdrawal by Subject|1|||
105749212|NCT01626352|364734310|FG000|Overall Study|Non-Compliance|1|||
105749213|NCT01626352|364734310|FG000|Overall Study|Never Treated|1|||
105749214|NCT03446651|364734313|FG000|Overall Study|Lost to Follow-up|4|||
105749215|NCT03446651|364734314|FG001|Overall Study|Lost to Follow-up|0|||
105749216|NCT03446651|364734313|FG000|Overall Study|Open Label Participants|5|||
105749217|NCT03446651|364734314|FG001|Overall Study|Open Label Participants|0|||
105749218|NCT00343291|364734315|FG000|Overall Study|Adverse Event|13|||
105749219|NCT00343291|364734316|FG001|Overall Study|Adverse Event|13|||
105749220|NCT00343291|364734315|FG000|Overall Study|Death|3|||
105749221|NCT00343291|364734316|FG001|Overall Study|Death|2|||
105749222|NCT00343291|364734315|FG000|Overall Study|Progressive disease|33|||
105749223|NCT00343291|364734316|FG001|Overall Study|Progressive disease|34|||
105749224|NCT00343291|364734315|FG000|Overall Study|Withdrawal by Subject|0|||
105749225|NCT00343291|364734316|FG001|Overall Study|Withdrawal by Subject|2|||
105749226|NCT00343291|364734315|FG000|Overall Study|Other|8|||
105749227|NCT00343291|364734316|FG001|Overall Study|Other|5|||
105749228|NCT04831515|364734317|FG000|First Intervention|Adverse Event|0|||
105749229|NCT04831515|364734318|FG001|First Intervention|Adverse Event|1|||
105749230|NCT02156492|364734321|FG000|Period 1|No Reason Given|0|||
105749231|NCT02156492|364734322|FG001|Period 1|No Reason Given|1|||
105749232|NCT02156492|364734323|FG002|Period 1|No Reason Given|0|||
105749233|NCT02156492|364734321|FG000|Period 3|Adverse Event|0|||
105749234|NCT02156492|364734322|FG001|Period 3|Adverse Event|1|||
105749235|NCT02156492|364734323|FG002|Period 3|Adverse Event|0|||
105749236|NCT02420223|364734331|FG000|Overall Study|Adverse Event|1|||
105749237|NCT02420223|364734332|FG001|Overall Study|Adverse Event|0|||
105749238|NCT02420223|364734331|FG000|Overall Study|Physician Decision|0|||
105749239|NCT02420223|364734332|FG001|Overall Study|Physician Decision|2|||
105749240|NCT01332019|364734333|FG000|Overall Study|Was Not Dosed|1|||
105749241|NCT01332019|364734334|FG001|Overall Study|Was Not Dosed|0|||
105749242|NCT01332019|364734333|FG000|Overall Study|Other|16|||
105749243|NCT01332019|364734334|FG001|Overall Study|Other|18|||
105749244|NCT01332019|364734333|FG000|Overall Study|Death|2|||
105749245|NCT01332019|364734334|FG001|Overall Study|Death|1|||
105749246|NCT01332019|364734333|FG000|Overall Study|Physician Decision|4|||
105749247|NCT01332019|364734334|FG001|Overall Study|Physician Decision|3|||
105749248|NCT01332019|364734333|FG000|Overall Study|Withdrawal by Subject|73|||
105749249|NCT01332019|364734334|FG001|Overall Study|Withdrawal by Subject|71|||
105749250|NCT01332019|364734333|FG000|Overall Study|Lost to Follow-up|4|||
105749251|NCT01332019|364734334|FG001|Overall Study|Lost to Follow-up|7|||
105749252|NCT01332019|364734333|FG000|Overall Study|Adverse Event|13|||
105749253|NCT01332019|364734334|FG001|Overall Study|Adverse Event|22|||
105749254|NCT00871377|364734337|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
105749255|NCT00871377|364734338|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
105749256|NCT00871377|364734339|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
105749257|NCT00871377|364734340|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
105749258|NCT00871377|364734341|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
105749259|NCT00871377|364734342|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
105749260|NCT00871377|364734337|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
105749261|NCT00871377|364734338|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
105749262|NCT00871377|364734339|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
105749263|NCT00871377|364734340|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
105749264|NCT00871377|364734341|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
105749265|NCT00871377|364734342|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
105749266|NCT00871377|364734337|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
105749267|NCT00871377|364734338|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749268|NCT00871377|364734339|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749269|NCT00871377|364734340|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749270|NCT00871377|364734341|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749271|NCT00871377|364734342|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749272|NCT00871377|364734337|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749273|NCT00871377|364734338|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749274|NCT00871377|364734339|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749275|NCT00871377|364734340|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749276|NCT00871377|364734341|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749277|NCT00871377|364734342|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
105749278|NCT00871377|364734337|FG000|Third Intervention (10 Weeks)|Death|0|||
105749279|NCT00871377|364734338|FG001|Third Intervention (10 Weeks)|Death|0|||
105749280|NCT00871377|364734339|FG002|Third Intervention (10 Weeks)|Death|0|||
105749281|NCT00871377|364734340|FG003|Third Intervention (10 Weeks)|Death|1|||
105749282|NCT00871377|364734341|FG004|Third Intervention (10 Weeks)|Death|0|||
105749283|NCT00871377|364734342|FG005|Third Intervention (10 Weeks)|Death|0|||
105749284|NCT01944969|364734344|FG000|Overall Study|Adverse Event|1|||
105749285|NCT01944969|364734344|FG000|Overall Study|Lack of Efficacy|1|||
105749286|NCT01944969|364734344|FG000|Overall Study|Non-compliance with IMP|1|||
105749287|NCT01944969|364734344|FG000|Overall Study|Administrative or other reasons|23|||
105749288|NCT00310388|364734345|FG000|Primary Reporting Phase|Adverse Event|101|||
105749289|NCT00310388|364734346|FG001|Primary Reporting Phase|Adverse Event|0|||
105749290|NCT00310388|364734345|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
105749291|NCT00310388|364734346|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
105749292|NCT00310388|364734345|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
105749293|NCT00310388|364734346|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
105749294|NCT00310388|364734345|FG000|Primary Reporting Phase|Protocol Violation|10|||
105749295|NCT00310388|364734346|FG001|Primary Reporting Phase|Protocol Violation|0|||
105749296|NCT00310388|364734345|FG000|Primary Reporting Phase|Pregnancy|3|||
105749297|NCT00310388|364734346|FG001|Primary Reporting Phase|Pregnancy|0|||
105749298|NCT00310388|364734345|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
105749299|NCT00310388|364734346|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
105749300|NCT00310388|364734345|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
105749301|NCT00310388|364734346|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
105749302|NCT00310388|364734345|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
105749303|NCT00310388|364734346|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
105749304|NCT00310388|364734345|FG000|Primary Reporting Phase|Physician Decision|2|||
105749305|NCT00310388|364734346|FG001|Primary Reporting Phase|Physician Decision|0|||
105749306|NCT00310388|364734345|FG000|Primary Reporting Phase|Request of the sponsor|19|||
105749307|NCT00310388|364734346|FG001|Primary Reporting Phase|Request of the sponsor|0|||
105749308|NCT00310388|364734345|FG000|Primary Reporting Phase|Failed to return|8|||
105749309|NCT00310388|364734346|FG001|Primary Reporting Phase|Failed to return|0|||
105749310|NCT00310388|364734345|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
105749311|NCT00310388|364734346|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
105749312|NCT00310388|364734345|FG000|Primary Reporting Phase|Participant request|2|||
105749313|NCT00310388|364734346|FG001|Primary Reporting Phase|Participant request|0|||
105749314|NCT00310388|364734345|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
105749315|NCT00310388|364734346|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
105749316|NCT00310388|364734345|FG000|Primary Reporting Phase|Discontinuation of study|1|||
105749317|NCT00310388|364734346|FG001|Primary Reporting Phase|Discontinuation of study|0|||
105749318|NCT00310388|364734345|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
105749319|NCT00310388|364734346|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
105749320|NCT00310388|364734345|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
105749321|NCT00310388|364734346|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
105749322|NCT00310388|364734345|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
105749323|NCT00310388|364734346|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
105749324|NCT00310388|364734345|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
105749325|NCT00310388|364734346|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
105749326|NCT00310388|364734345|FG000|Primary Reporting Phase|Participant passed away|1|||
105749327|NCT00310388|364734346|FG001|Primary Reporting Phase|Participant passed away|0|||
105483381|NCT00976508|363782684|FG001|Overall Study|Subject Enrolled in Hospice|0|||
105749328|NCT00310388|364734345|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
105749329|NCT00310388|364734346|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
105749330|NCT00310388|364734345|FG000|Primary Reporting Phase|Missing|1|||
105749331|NCT00310388|364734346|FG001|Primary Reporting Phase|Missing|0|||
105749332|NCT00310388|364734345|FG000|Primary Reporting Phase|Other|1|||
105483382|NCT00976508|363782683|FG000|Overall Study|Terminated by the Sponsor|0|||
105359725|NCT02457195|363322338|FG000|Overall Study|Protocol Violation|2|||
105749333|NCT00310388|364734346|FG001|Primary Reporting Phase|Other|0|||
105749334|NCT00310388|364734345|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
105749335|NCT00310388|364734346|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
105749336|NCT00310388|364734345|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
105749337|NCT00310388|364734346|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
105749338|NCT00310388|364734345|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
105749339|NCT00310388|364734346|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
105749340|NCT00310388|364734345|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
105749341|NCT00310388|364734346|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
105749342|NCT01610076|364734349|FG000|Overall Study|Technical issue with video|0|||
105749343|NCT01610076|364734350|FG001|Overall Study|Technical issue with video|1|||
105749344|NCT01610076|364734349|FG000|Overall Study|Lost to Follow-up|3|||
105749345|NCT01610076|364734350|FG001|Overall Study|Lost to Follow-up|4|||
105749346|NCT04017442|364734352|FG000|Overall Study|Withdrawal by Subject|0|||
105749347|NCT04017442|364734353|FG001|Overall Study|Withdrawal by Subject|3|||
105749348|NCT04017442|364734352|FG000|Overall Study|Lost to Follow-up|21|||
105749349|NCT04017442|364734353|FG001|Overall Study|Lost to Follow-up|19|||
105749350|NCT00082758|364734358|FG000|Overall Study|Adverse Event|0|||
105749351|NCT00082758|364734359|FG001|Overall Study|Adverse Event|2|||
105749352|NCT00082758|364734360|FG002|Overall Study|Adverse Event|0|||
105749353|NCT00082758|364734358|FG000|Overall Study|Lack of Efficacy|12|||
105749354|NCT00082758|364734359|FG001|Overall Study|Lack of Efficacy|13|||
105749355|NCT00082758|364734360|FG002|Overall Study|Lack of Efficacy|0|||
105749356|NCT00082758|364734358|FG000|Overall Study|Physician Decision|0|||
105749357|NCT00082758|364734359|FG001|Overall Study|Physician Decision|1|||
105749358|NCT00082758|364734360|FG002|Overall Study|Physician Decision|0|||
105749359|NCT00082758|364734358|FG000|Overall Study|Withdrawal by Subject|3|||
105749360|NCT00082758|364734359|FG001|Overall Study|Withdrawal by Subject|0|||
105749361|NCT00082758|364734360|FG002|Overall Study|Withdrawal by Subject|0|||
105749362|NCT00082758|364734358|FG000|Overall Study|Protocol Violation|0|||
105749363|NCT00082758|364734359|FG001|Overall Study|Protocol Violation|1|||
105749364|NCT00082758|364734360|FG002|Overall Study|Protocol Violation|0|||
105749365|NCT00937560|364734361|FG000|Initial Treatment|Death|6|||
105749366|NCT00937560|364734361|FG000|Initial Treatment|Withdraw consent|3|||
105749367|NCT00937560|364734361|FG000|Initial Treatment|Adverse Event|1|||
105749368|NCT00937560|364734361|FG000|Initial Treatment|Lost to Follow-up|1|||
105749369|NCT00937560|364734361|FG000|Initial Treatment|No end of study page|10|||
105749370|NCT00937560|364734361|FG000|Maintenance Treatment|Death|12|||
105749371|NCT00937560|364734361|FG000|Maintenance Treatment|Withdraw consent|5|||
105749372|NCT00937560|364734361|FG000|Maintenance Treatment|According to protocol|1|||
105749373|NCT03421964|364734362|FG000|Overall Study|Lost to Follow-up|11|||
105749374|NCT03421964|364734363|FG001|Overall Study|Lost to Follow-up|21|||
105749375|NCT03421964|364734362|FG000|Overall Study|Withdrawal by Subject|9|||
105749376|NCT03421964|364734363|FG001|Overall Study|Withdrawal by Subject|3|||
105749377|NCT03421964|364734362|FG000|Overall Study|Incarcerated|1|||
105749378|NCT03421964|364734363|FG001|Overall Study|Incarcerated|0|||
105749379|NCT03421964|364734362|FG000|Overall Study|Inpt Treatment Facility|1|||
105749380|NCT03421964|364734363|FG001|Overall Study|Inpt Treatment Facility|1|||
105749381|NCT03421964|364734362|FG000|Overall Study|Virtual Platform Issues|1|||
105749382|NCT03421964|364734363|FG001|Overall Study|Virtual Platform Issues|1|||
105749383|NCT02938585|364734364|FG000|Overall Study|Withdrawal by parent or guardian|0|||
105749384|NCT02938585|364734365|FG001|Overall Study|Withdrawal by parent or guardian|1|||
105749385|NCT02938585|364734366|FG002|Overall Study|Withdrawal by parent or guardian|0|||
105749386|NCT02938585|364734367|FG003|Overall Study|Withdrawal by parent or guardian|0|||
105749387|NCT02938585|364734364|FG000|Overall Study|Withdrawal by Subject|0|||
105749388|NCT02938585|364734365|FG001|Overall Study|Withdrawal by Subject|0|||
105749389|NCT02938585|364734366|FG002|Overall Study|Withdrawal by Subject|0|||
105749390|NCT02938585|364734367|FG003|Overall Study|Withdrawal by Subject|5|||
105749391|NCT01774344|364734368|FG000|Overall Study|Withdrawal by Subject|3|||
105749392|NCT01774344|364734369|FG001|Overall Study|Withdrawal by Subject|10|||
105749393|NCT01774344|364734368|FG000|Overall Study|Protocol Violation|0|||
105749394|NCT01774344|364734369|FG001|Overall Study|Protocol Violation|1|||
105749395|NCT01774344|364734368|FG000|Overall Study|Lost to Follow-up|4|||
105749396|NCT01774344|364734369|FG001|Overall Study|Lost to Follow-up|10|||
105749397|NCT01774344|364734368|FG000|Overall Study|End of survival follow-up not available|2|||
105749398|NCT01774344|364734369|FG001|Overall Study|End of survival follow-up not available|2|||
105749399|NCT01774344|364734368|FG000|Overall Study|Data collection finished|4|||
105749400|NCT01774344|364734369|FG001|Overall Study|Data collection finished|14|||
105749401|NCT01774344|364734368|FG000|Overall Study|Other|0|||
105749402|NCT01774344|364734369|FG001|Overall Study|Other|1|||
105749403|NCT01774344|364734368|FG000|Overall Study|Did not enter Survival Follow up|49|||
105749404|NCT01774344|364734369|FG001|Overall Study|Did not enter Survival Follow up|83|||
105749405|NCT03364608|364734370|FG000|Overall Study|Withdrawal by Subject|4|||
105749406|NCT03364608|364734370|FG000|Overall Study|Protocol Violation|2|||
105749407|NCT03364608|364734370|FG000|Overall Study|Lost to Follow-up|2|||
105749408|NCT04096326|364734371|FG000|Overall Study|Withdrawal by Subject|0|||
105749409|NCT04096326|364734372|FG001|Overall Study|Withdrawal by Subject|0|||
105749410|NCT04096326|364734373|FG002|Overall Study|Withdrawal by Subject|0|||
105749411|NCT04096326|364734374|FG003|Overall Study|Withdrawal by Subject|0|||
105749412|NCT04096326|364734375|FG004|Overall Study|Withdrawal by Subject|0|||
105749413|NCT04096326|364734376|FG005|Overall Study|Withdrawal by Subject|0|||
105749414|NCT04096326|364734377|FG006|Overall Study|Withdrawal by Subject|1|||
105749415|NCT04096326|364734378|FG007|Overall Study|Withdrawal by Subject|0|||
105749416|NCT04096326|364734379|FG008|Overall Study|Withdrawal by Subject|0|||
105749417|NCT04096326|364734380|FG009|Overall Study|Withdrawal by Subject|0|||
105749418|NCT04096326|364734371|FG000|Overall Study|Lost to Follow-up|0|||
105749419|NCT04096326|364734372|FG001|Overall Study|Lost to Follow-up|1|||
105749420|NCT04096326|364734373|FG002|Overall Study|Lost to Follow-up|0|||
105749421|NCT04096326|364734374|FG003|Overall Study|Lost to Follow-up|0|||
105749422|NCT04096326|364734375|FG004|Overall Study|Lost to Follow-up|0|||
105749423|NCT04096326|364734376|FG005|Overall Study|Lost to Follow-up|0|||
105749424|NCT04096326|364734377|FG006|Overall Study|Lost to Follow-up|0|||
105749425|NCT04096326|364734378|FG007|Overall Study|Lost to Follow-up|0|||
105749426|NCT04096326|364734379|FG008|Overall Study|Lost to Follow-up|0|||
105749427|NCT04096326|364734380|FG009|Overall Study|Lost to Follow-up|0|||
105749428|NCT04096326|364734371|FG000|Overall Study|COVID-19-related reasons|0|||
105749429|NCT04096326|364734372|FG001|Overall Study|COVID-19-related reasons|0|||
105749430|NCT04096326|364734373|FG002|Overall Study|COVID-19-related reasons|0|||
105749431|NCT04096326|364734374|FG003|Overall Study|COVID-19-related reasons|0|||
105749432|NCT04096326|364734375|FG004|Overall Study|COVID-19-related reasons|1|||
105749433|NCT04096326|364734376|FG005|Overall Study|COVID-19-related reasons|5|||
105749434|NCT04096326|364734377|FG006|Overall Study|COVID-19-related reasons|0|||
105749435|NCT04096326|364734378|FG007|Overall Study|COVID-19-related reasons|0|||
105749436|NCT04096326|364734379|FG008|Overall Study|COVID-19-related reasons|0|||
105749437|NCT04096326|364734380|FG009|Overall Study|COVID-19-related reasons|0|||
105749438|NCT02108600|364734381|FG000|Overall Study|Withdrawal by Subject|2|||
105749439|NCT02108600|364734382|FG001|Overall Study|Withdrawal by Subject|0|||
105749440|NCT02108600|364734381|FG000|Overall Study|Lost to Follow-up|1|||
105749441|NCT02108600|364734382|FG001|Overall Study|Lost to Follow-up|1|||
105749442|NCT03150095|364734385|FG000|Overall Study|Death|0|||
105749443|NCT03150095|364734386|FG001|Overall Study|Death|1|||
105749444|NCT03150095|364734385|FG000|Overall Study|Lost to Follow-up|1|||
105749445|NCT03150095|364734386|FG001|Overall Study|Lost to Follow-up|1|||
105749446|NCT03150095|364734385|FG000|Overall Study|Withdrawal by Subject|4|||
105749447|NCT03150095|364734386|FG001|Overall Study|Withdrawal by Subject|0|||
105749448|NCT03150095|364734385|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
105749449|NCT03150095|364734386|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
105749450|NCT00617409|364734388|FG000|Overall Study|Withdrawal by Subject|4|||
105749451|NCT00617409|364734389|FG001|Overall Study|Withdrawal by Subject|1|||
105749452|NCT00617409|364734390|FG002|Overall Study|Withdrawal by Subject|2|||
105749453|NCT00617409|364734388|FG000|Overall Study|Adverse Event|0|||
105749454|NCT00617409|364734389|FG001|Overall Study|Adverse Event|2|||
105749455|NCT00617409|364734390|FG002|Overall Study|Adverse Event|3|||
105749456|NCT00617409|364734388|FG000|Overall Study|Disease Progression|8|||
105749457|NCT00617409|364734389|FG001|Overall Study|Disease Progression|8|||
105749458|NCT00617409|364734390|FG002|Overall Study|Disease Progression|18|||
105749459|NCT00617409|364734388|FG000|Overall Study|Death|3|||
105749460|NCT00617409|364734389|FG001|Overall Study|Death|5|||
105749461|NCT00617409|364734390|FG002|Overall Study|Death|4|||
105749462|NCT00617409|364734388|FG000|Overall Study|Alternative Therapy|1|||
105749463|NCT00617409|364734389|FG001|Overall Study|Alternative Therapy|2|||
105749464|NCT00617409|364734390|FG002|Overall Study|Alternative Therapy|0|||
105749465|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
105749466|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
105749467|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
105483383|NCT00976508|363782684|FG001|Overall Study|Terminated by the Sponsor|1|||
105483384|NCT00095238|363782685|FG000|Overall Study|Lack of Efficacy|9|||
105483385|NCT00095238|363782686|FG001|Overall Study|Lack of Efficacy|9|||
105483386|NCT00095238|363782685|FG000|Overall Study|Adverse Event|331|||
105749468|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
105749469|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
105749470|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
105749471|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
105749472|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
105749473|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
105749474|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
105483387|NCT00095238|363782686|FG001|Overall Study|Adverse Event|287|||
105749475|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
105749476|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
105749477|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
105483388|NCT00095238|363782685|FG000|Overall Study|Subject Withdrew Consent|208|||
105749478|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
105749479|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
105749480|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
105749481|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
105749482|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
105749483|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
105749484|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
105749485|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
105749486|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
105749487|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
105749488|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
105749489|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Other|8|||
105749490|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Other|7|||
105749491|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Other|4|||
105749492|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
105749493|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
105749494|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
105749495|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
105749496|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
105749497|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
105749498|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
105749499|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
105749500|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
105749501|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105749502|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
105749503|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105749504|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
105749505|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
105749506|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
105749507|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
105749508|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
105749509|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
105749510|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
105749511|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
105749512|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
105749513|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Other|5|||
105749514|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Other|5|||
105749515|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Other|4|||
105749516|NCT01363713|364734409|FG000|Overall Study|Adverse Event|1|||
105749517|NCT01363713|364734409|FG000|Overall Study|Protocol Violation|3|||
105749518|NCT01363713|364734409|FG000|Overall Study|Withdrawal by Subject|2|||
105749519|NCT03943953|364734410|FG000|Trial of ITG 1|Lost to Follow-up|19|||
105749520|NCT03943953|364734411|FG001|Trial of ITG 1|Lost to Follow-up|1|||
105749521|NCT03943953|364734410|FG000|Trial of ITG 2|Lost to Follow-up|8|||
105749522|NCT03943953|364734411|FG001|Trial of ITG 2|Lost to Follow-up|0|||
105749523|NCT03943953|364734410|FG000|Trial of ITG 3|Lost to Follow-up|2|||
105749524|NCT03943953|364734411|FG001|Trial of ITG 3|Lost to Follow-up|0|||
105749525|NCT03943953|364734410|FG000|Trial of ITG 4|Lost to Follow-up|2|||
105749526|NCT03943953|364734411|FG001|Trial of ITG 4|Lost to Follow-up|0|||
105749527|NCT00511342|364734412|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
105749528|NCT00511342|364734413|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
105749529|NCT00511342|364734412|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
105749530|NCT00511342|364734413|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
105749531|NCT00511342|364734412|FG000|Overall Study|Pregnancy|0|||
105749532|NCT00511342|364734413|FG001|Overall Study|Pregnancy|1|||
105749533|NCT00511342|364734412|FG000|Overall Study|Pregnancy wish|0|||
105749534|NCT00511342|364734413|FG001|Overall Study|Pregnancy wish|1|||
105565408|NCT04512066|364066767|FG002|Extension Period|Lost to Follow-up|5|||
105749535|NCT00511342|364734412|FG000|Overall Study|Lost to Follow-up|1|||
105749536|NCT00511342|364734413|FG001|Overall Study|Lost to Follow-up|5|||
105749537|NCT00511342|364734412|FG000|Overall Study|Other Reason|2|||
105749538|NCT00511342|364734413|FG001|Overall Study|Other Reason|2|||
105749539|NCT00668200|364734423|FG000|Overall Study|Withdrawal by Subject|2|||
105749540|NCT00668200|364734423|FG000|Overall Study|Lost to Follow-up|1|||
105749541|NCT00718666|364734424|FG000|Booster Phase Year 5|No active participation request|0|||
105749542|NCT00718666|364734425|FG001|Booster Phase Year 5|No active participation request|0|||
105749543|NCT00718666|364734426|FG002|Booster Phase Year 5|No active participation request|1|||
105749544|NCT00718666|364734424|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
105749545|NCT00718666|364734425|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
105749546|NCT00718666|364734426|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
105749547|NCT00718666|364734424|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
105749548|NCT00718666|364734425|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
105749549|NCT00718666|364734426|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
105749550|NCT00718666|364734424|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
105749551|NCT00718666|364734425|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
105749552|NCT00718666|364734426|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
105749553|NCT00997321|364734427|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
105749554|NCT00997321|364734428|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
105749555|NCT02509598|364734429|FG000|Overall Study|Withdrawal by Subject|1|||
105749556|NCT02196038|364734430|FG000|Overall Study|Death|16|||
105749557|NCT02196038|364734431|FG001|Overall Study|Death|21|||
105749558|NCT02196038|364734430|FG000|Overall Study|Withdrawal by Subject|0|||
105749559|NCT02196038|364734431|FG001|Overall Study|Withdrawal by Subject|1|||
105749560|NCT02196038|364734430|FG000|Overall Study|Lost to Follow-up|1|||
105749561|NCT02196038|364734431|FG001|Overall Study|Lost to Follow-up|0|||
105749562|NCT00421343|364734432|FG000|Overall Study|Death|1|||
105749563|NCT00421343|364734432|FG000|Overall Study|Withdrawal by Subject|2|||
105749564|NCT00421343|364734432|FG000|Overall Study|Lost to Follow-up|3|||
105749565|NCT01276457|364734440|FG000|Core Study|Adverse Event|6|||
105749566|NCT01276457|364734441|FG001|Core Study|Adverse Event|3|||
105749567|NCT01276457|364734440|FG000|Core Study|Lost to Follow-up|1|||
105749568|NCT01276457|364734441|FG001|Core Study|Lost to Follow-up|2|||
105749569|NCT01276457|364734440|FG000|Core Study|Administrative problems|1|||
105749570|NCT01276457|364734441|FG001|Core Study|Administrative problems|1|||
105749571|NCT01276457|364734440|FG000|Core Study|Death|2|||
105749572|NCT01276457|364734441|FG001|Core Study|Death|2|||
105749573|NCT01276457|364734440|FG000|Core Study|Lack of Efficacy|3|||
105749574|NCT01276457|364734441|FG001|Core Study|Lack of Efficacy|12|||
105749575|NCT01276457|364734440|FG000|Extension Study|Lost to Follow-up|3|||
105749576|NCT01276457|364734441|FG001|Extension Study|Lost to Follow-up|0|||
105749577|NCT01276457|364734440|FG000|Extension Study|Death|0|||
105749578|NCT01276457|364734441|FG001|Extension Study|Death|1|||
105749579|NCT01276457|364734440|FG000|Extension Study|Lack of Efficacy|3|||
105749580|NCT01276457|364734441|FG001|Extension Study|Lack of Efficacy|1|||
105749581|NCT02993146|364734444|FG000|Overall Study|Withdrawal by Subject|0|||
105749582|NCT02993146|364734445|FG001|Overall Study|Withdrawal by Subject|0|||
105749583|NCT02993146|364734446|FG002|Overall Study|Withdrawal by Subject|1|||
105749584|NCT02993146|364734447|FG003|Overall Study|Withdrawal by Subject|1|||
105749585|NCT01599754|364734448|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
105749586|NCT01599754|364734449|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
105749587|NCT01599754|364734448|FG000|Overall Study|Participant noncompliance|4|||
105749588|NCT01599754|364734449|FG001|Overall Study|Participant noncompliance|4|||
105749589|NCT01599754|364734448|FG000|Overall Study|Lost to Follow-up|13|||
105749590|NCT01599754|364734449|FG001|Overall Study|Lost to Follow-up|6|||
105749591|NCT01599754|364734448|FG000|Overall Study|Death|31|||
105749592|NCT01599754|364734449|FG001|Overall Study|Death|33|||
105749593|NCT01599754|364734448|FG000|Overall Study|Adverse Event|3|||
105749594|NCT01599754|364734449|FG001|Overall Study|Adverse Event|2|||
105749595|NCT01599754|364734448|FG000|Overall Study|Investigator decision|1|||
105749596|NCT01599754|364734449|FG001|Overall Study|Investigator decision|3|||
105749597|NCT01599754|364734448|FG000|Overall Study|Withdrawal by Subject|24|||
105749598|NCT01599754|364734449|FG001|Overall Study|Withdrawal by Subject|25|||
105749599|NCT01599754|364734448|FG000|Overall Study|Study terminated by sponsor|282|||
105749600|NCT01599754|364734449|FG001|Overall Study|Study terminated by sponsor|285|||
105749601|NCT02429258|364736591|FG000|Overall Study|Withdrawal by Subject|2|||
105749602|NCT02429258|364736592|FG001|Overall Study|Withdrawal by Subject|0|||
105749603|NCT02429258|364736591|FG000|Overall Study|Protocol Violation|0|||
105749604|NCT02429258|364736592|FG001|Overall Study|Protocol Violation|1|||
105749605|NCT02670915|364736593|FG000|Overall Study|Withdrawal by Subject|0|||
105749606|NCT02670915|364736594|FG001|Overall Study|Withdrawal by Subject|1|||
105749607|NCT02670915|364736595|FG002|Overall Study|Withdrawal by Subject|4|||
105749608|NCT02670915|364736593|FG000|Overall Study|Withdrawal by parent/guardian|4|||
105749609|NCT02670915|364736594|FG001|Overall Study|Withdrawal by parent/guardian|4|||
105749610|NCT02670915|364736595|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105749611|NCT02670915|364736593|FG000|Overall Study|Unclassified|0|||
105749612|NCT02670915|364736594|FG001|Overall Study|Unclassified|3|||
105749613|NCT02670915|364736595|FG002|Overall Study|Unclassified|0|||
105749614|NCT00818207|364736599|FG000|Overall Study|Adverse Event|6|||
105749615|NCT00818207|364736600|FG001|Overall Study|Adverse Event|0|||
105749616|NCT00818207|364736599|FG000|Overall Study|Lost to Follow-up|160|||
105749617|NCT00818207|364736600|FG001|Overall Study|Lost to Follow-up|146|||
105749618|NCT00818207|364736599|FG000|Overall Study|Multiple reasons|11|||
105749619|NCT00818207|364736600|FG001|Overall Study|Multiple reasons|12|||
105749620|NCT00818207|364736599|FG000|Overall Study|Withdrawal by Subject|42|||
105749621|NCT00818207|364736600|FG001|Overall Study|Withdrawal by Subject|104|||
105749622|NCT00818207|364736599|FG000|Overall Study|Death|3|||
105749623|NCT00818207|364736600|FG001|Overall Study|Death|5|||
105749624|NCT02494778|364736601|FG000|Overall Study|Death|3|||
105749625|NCT02494778|364736601|FG000|Overall Study|Other|173|||
105749626|NCT02494778|364736601|FG000|Overall Study|Lack of Efficacy|4|||
105749627|NCT02494778|364736601|FG000|Overall Study|Adverse Event|18|||
105749628|NCT02494778|364736601|FG000|Overall Study|Withdrawal by Subject|20|||
105749629|NCT02494778|364736601|FG000|Overall Study|Lost to Follow-up|2|||
105749630|NCT02494778|364736601|FG000|Overall Study|Noncompliant with study drug admin.|1|||
105749631|NCT00967226|364736602|FG000|Overall Study|Adverse Event|0|||
105749632|NCT00967226|364736603|FG001|Overall Study|Adverse Event|5|||
105749633|NCT00967226|364736602|FG000|Overall Study|Protocol Violation|2|||
105749634|NCT00967226|364736603|FG001|Overall Study|Protocol Violation|0|||
105749635|NCT00967226|364736602|FG000|Overall Study|Physician Decision|0|||
105749636|NCT00967226|364736603|FG001|Overall Study|Physician Decision|1|||
105749637|NCT02174861|364736608|FG000|Overall Study|Decision by sponsor|8|||
105749638|NCT02174861|364736608|FG000|Overall Study|Withdrawal by Subject|124|||
105749639|NCT02174861|364736608|FG000|Overall Study|Lost to Follow-up|26|||
105749640|NCT00605722|364736609|FG000|Overall Study|Adverse Event|6|||
105749641|NCT00605722|364736609|FG000|Overall Study|Insufficient therapeutic response|44|||
105749642|NCT00605722|364736609|FG000|Overall Study|Failure to return|1|||
105749643|NCT02622724|364736610|FG000|Overall Study|Death|51|||
105749644|NCT02622724|364736611|FG001|Overall Study|Death|53|||
105749645|NCT02622724|364736610|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
105749646|NCT02622724|364736611|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
105749647|NCT02622724|364736610|FG000|Overall Study|Early termination of study|38|||
105749648|NCT02622724|364736611|FG001|Overall Study|Early termination of study|43|||
105749649|NCT00296725|364736612|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
105749650|NCT00296725|364736612|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
105749651|NCT00296725|364736612|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
105483389|NCT00095238|363782686|FG001|Overall Study|Subject Withdrew Consent|223|||
105749652|NCT00356863|364736613|FG000|Overall Study|Death|16|||
105749653|NCT00356863|364736614|FG001|Overall Study|Death|32|||
105749654|NCT00356863|364736613|FG000|Overall Study|Lost to Follow-up|76|||
105749655|NCT00356863|364736614|FG001|Overall Study|Lost to Follow-up|43|||
105483390|NCT00095238|363782685|FG000|Overall Study|Death|154|||
105749656|NCT04032171|364736621|FG000|Overall Study|Study Termination|1|||
105749657|NCT04032171|364736622|FG001|Overall Study|Study Termination|0|||
105749658|NCT02124707|364736627|FG000|Overall Study|Adverse Event|5|||
105749659|NCT02124707|364736627|FG000|Overall Study|Physician Decision|1|||
105749660|NCT02124707|364736627|FG000|Overall Study|Death|1|||
105749661|NCT00781599|364736628|FG000|Overall Study|Lost to Follow-up|7|||
105749662|NCT00781599|364736629|FG001|Overall Study|Lost to Follow-up|4|||
105483391|NCT00095238|363782686|FG001|Overall Study|Death|170|||
105749663|NCT00987623|364736630|FG000|Overall Study|Lost to Follow-up|2|||
105749664|NCT00987623|364736631|FG001|Overall Study|Lost to Follow-up|1|||
105749665|NCT00987623|364736630|FG000|Overall Study|Time/job conflict|2|||
105749666|NCT00987623|364736631|FG001|Overall Study|Time/job conflict|0|||
105749667|NCT00987623|364736630|FG000|Overall Study|Discomfort|1|||
105749668|NCT00987623|364736631|FG001|Overall Study|Discomfort|0|||
105749669|NCT00987623|364736630|FG000|Overall Study|Biomicroscopy|0|||
105749670|NCT00987623|364736631|FG001|Overall Study|Biomicroscopy|1|||
105749671|NCT00987623|364736630|FG000|Overall Study|Influenza|0|||
105749672|NCT00987623|364736631|FG001|Overall Study|Influenza|1|||
105749673|NCT02512068|364736632|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
105749674|NCT02512068|364736633|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
105749675|NCT02512068|364736632|FG000|Overall Study|Major Protocol Deviation|1|||
105749676|NCT02512068|364736633|FG001|Overall Study|Major Protocol Deviation|0|||
105749677|NCT02512068|364736632|FG000|Overall Study|Voluntary Withdrawal|0|||
105749678|NCT02512068|364736633|FG001|Overall Study|Voluntary Withdrawal|1|||
105749679|NCT02512068|364736632|FG000|Overall Study|Lack of Efficacy|0|||
105749680|NCT02512068|364736633|FG001|Overall Study|Lack of Efficacy|1|||
105749681|NCT02512068|364736632|FG000|Overall Study|Reason Not Specified|3|||
105749682|NCT02512068|364736633|FG001|Overall Study|Reason Not Specified|5|||
105749683|NCT03471767|364736636|FG000|Overall Study|Withdrawal by Subject|3|||
105749684|NCT03471767|364736637|FG001|Overall Study|Withdrawal by Subject|1|||
105749685|NCT03471767|364736636|FG000|Overall Study|Adverse Event|1|||
105749686|NCT03471767|364736637|FG001|Overall Study|Adverse Event|0|||
105749687|NCT03471767|364736636|FG000|Overall Study|Lost to Follow-up|1|||
105749688|NCT03471767|364736637|FG001|Overall Study|Lost to Follow-up|0|||
105749689|NCT03471767|364736636|FG000|Overall Study|PI Withdrawal|1|||
105749690|NCT03471767|364736637|FG001|Overall Study|PI Withdrawal|3|||
105749691|NCT00678587|364736643|FG000|Overall Study|Adverse Event|3|||
105749692|NCT00678587|364736644|FG001|Overall Study|Adverse Event|3|||
105749693|NCT00678587|364736643|FG000|Overall Study|Lack of Efficacy|1|||
105749694|NCT00678587|364736644|FG001|Overall Study|Lack of Efficacy|0|||
105749695|NCT00678587|364736643|FG000|Overall Study|Protocol Violation|2|||
105749696|NCT00678587|364736644|FG001|Overall Study|Protocol Violation|1|||
105749697|NCT00678587|364736643|FG000|Overall Study|Study Closed/Terminated|1|||
105749698|NCT00678587|364736644|FG001|Overall Study|Study Closed/Terminated|0|||
105749699|NCT00678587|364736643|FG000|Overall Study|Lost to Follow-up|3|||
105749700|NCT00678587|364736644|FG001|Overall Study|Lost to Follow-up|5|||
105749701|NCT00678587|364736643|FG000|Overall Study|Investigator Discretion|2|||
105749702|NCT00678587|364736644|FG001|Overall Study|Investigator Discretion|6|||
105749703|NCT00678587|364736643|FG000|Overall Study|Withdrew Consent|8|||
105749704|NCT00678587|364736644|FG001|Overall Study|Withdrew Consent|3|||
105749705|NCT03806179|364736647|FG000|Overall Study|Progressive disease|0|||
105749706|NCT03806179|364736648|FG001|Overall Study|Progressive disease|2|||
105749707|NCT01151579|364736649|FG000|Overall Study|Physician Decision|3|||
105749708|NCT01151579|364736650|FG001|Overall Study|Physician Decision|1|||
105749709|NCT01151579|364736649|FG000|Overall Study|Withdrawal by Subject|3|||
105749710|NCT01151579|364736650|FG001|Overall Study|Withdrawal by Subject|2|||
105749711|NCT01151579|364736649|FG000|Overall Study|Not meet inclusion criteria|6|||
105749712|NCT01151579|364736650|FG001|Overall Study|Not meet inclusion criteria|4|||
105749713|NCT03633227|364736653|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
105749714|NCT03633227|364736654|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
105749715|NCT03633227|364736653|FG000|Double Blind (DB), up to Week 48|Death|2|||
105749716|NCT03633227|364736654|FG001|Double Blind (DB), up to Week 48|Death|1|||
105749717|NCT03633227|364736653|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
105749718|NCT03633227|364736654|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
105749719|NCT03633227|364736653|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
105749720|NCT03633227|364736654|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
105749721|NCT03633227|364736653|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
105749722|NCT03633227|364736654|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
105749723|NCT03633227|364736653|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
105749724|NCT03633227|364736654|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
105749725|NCT03633227|364736653|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
105749726|NCT03633227|364736654|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
105749727|NCT03633227|364736653|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
105749728|NCT03633227|364736654|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
105749729|NCT03633227|364736653|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
105749730|NCT03633227|364736654|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
105749731|NCT03633227|364736653|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
105749732|NCT03633227|364736654|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
105749733|NCT03633227|364736653|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
105749734|NCT03633227|364736654|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
105749735|NCT03633227|364736653|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
105749736|NCT03633227|364736654|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
105801582|NCT01078623|364930586|FG008|Treatment Period 4|Withdrawal by Subject|0|||
105749737|NCT01606761|364736655|FG000|Prior to Week 24|Lost to Follow-up|0|||
105749738|NCT01606761|364736656|FG001|Prior to Week 24|Lost to Follow-up|3|||
105749739|NCT01606761|364736657|FG002|Prior to Week 24|Lost to Follow-up|2|||
105749740|NCT01606761|364736658|FG003|Prior to Week 24|Lost to Follow-up|0|||
105749741|NCT01606761|364736659|FG004|Prior to Week 24|Lost to Follow-up|0|||
105749742|NCT01606761|364736655|FG000|Prior to Week 24|Withdrawal by Subject|12|||
105749743|NCT01606761|364736656|FG001|Prior to Week 24|Withdrawal by Subject|10|||
105749744|NCT01606761|364736657|FG002|Prior to Week 24|Withdrawal by Subject|9|||
105749745|NCT01606761|364736658|FG003|Prior to Week 24|Withdrawal by Subject|0|||
105749746|NCT01606761|364736659|FG004|Prior to Week 24|Withdrawal by Subject|0|||
105749747|NCT01606761|364736655|FG000|Prior to Week 24|Adverse Event|11|||
105749748|NCT01606761|364736656|FG001|Prior to Week 24|Adverse Event|18|||
105749749|NCT01606761|364736657|FG002|Prior to Week 24|Adverse Event|22|||
105749750|NCT01606761|364736658|FG003|Prior to Week 24|Adverse Event|0|||
105749751|NCT01606761|364736659|FG004|Prior to Week 24|Adverse Event|0|||
105749752|NCT01606761|364736655|FG000|Prior to Week 24|Lack of Efficacy|15|||
105749753|NCT01606761|364736656|FG001|Prior to Week 24|Lack of Efficacy|14|||
105749754|NCT01606761|364736657|FG002|Prior to Week 24|Lack of Efficacy|8|||
105749755|NCT01606761|364736658|FG003|Prior to Week 24|Lack of Efficacy|0|||
105749756|NCT01606761|364736659|FG004|Prior to Week 24|Lack of Efficacy|0|||
105749757|NCT01606761|364736655|FG000|Prior to Week 24|Physician Decision|0|||
105749758|NCT01606761|364736656|FG001|Prior to Week 24|Physician Decision|3|||
105749759|NCT01606761|364736657|FG002|Prior to Week 24|Physician Decision|1|||
105749760|NCT01606761|364736658|FG003|Prior to Week 24|Physician Decision|0|||
105749761|NCT01606761|364736659|FG004|Prior to Week 24|Physician Decision|0|||
105749762|NCT01606761|364736655|FG000|Prior to Week 24|Other|4|||
105749763|NCT01606761|364736656|FG001|Prior to Week 24|Other|7|||
105749764|NCT01606761|364736657|FG002|Prior to Week 24|Other|5|||
105749765|NCT01606761|364736658|FG003|Prior to Week 24|Other|0|||
105749766|NCT01606761|364736659|FG004|Prior to Week 24|Other|0|||
105749767|NCT01606761|364736655|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
105749768|NCT01606761|364736656|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
105749769|NCT01606761|364736657|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
105749770|NCT01606761|364736658|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
105359726|NCT02457195|363322338|FG000|Overall Study|Withdrawal by Subject|4|||
105359727|NCT00618826|363322341|FG000|Overall Study|Adverse Event|1|||
105359728|NCT01509664|363322343|FG000|Overall Study|Lost to Follow-up|15|||
105359729|NCT01509664|363322344|FG001|Overall Study|Lost to Follow-up|21|||
105359730|NCT00996034|363322347|FG000|Overall Study|Lost to Follow-up|2|||
105359731|NCT00996034|363322347|FG000|Overall Study|withdrawn by PI|1|||
105359732|NCT02420262|363322351|FG000|Overall Study|Adverse Event|1|||
105359733|NCT02420262|363322352|FG001|Overall Study|Adverse Event|0|||
105359734|NCT02420262|363322351|FG000|Overall Study|Withdrawal by Subject|1|||
105359735|NCT02420262|363322352|FG001|Overall Study|Withdrawal by Subject|4|||
105359736|NCT02420262|363322351|FG000|Overall Study|Unclassified|0|||
105359737|NCT02420262|363322352|FG001|Overall Study|Unclassified|1|||
105359738|NCT01737879|363322355|FG000|Overall Study|Death|1|||
105359739|NCT01737879|363322355|FG000|Overall Study|Sponsor decision|40|||
105359740|NCT00977613|363322356|FG000|Overall Study|Lost to Follow-up|16|||
105359741|NCT05285787|363322358|FG000|Overall Study|Withdrawal by Subject|1|||
105359742|NCT05568797|363322359|FG000|Overall Study|Adverse Event|0|||
105359743|NCT05568797|363322360|FG001|Overall Study|Adverse Event|8|||
105359744|NCT05568797|363322359|FG000|Overall Study|Lost to Follow-up|2|||
105749771|NCT01606761|364736659|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
105749772|NCT01606761|364736655|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
105749773|NCT01606761|364736656|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
105359745|NCT05568797|363322360|FG001|Overall Study|Lost to Follow-up|3|||
105359746|NCT05568797|363322359|FG000|Overall Study|Withdrawal by Subject|1|||
105565409|NCT04512066|364066768|FG003|Extension Period|Lost to Follow-up|2|||
105359747|NCT05568797|363322360|FG001|Overall Study|Withdrawal by Subject|10|||
105749774|NCT01606761|364736657|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
105749775|NCT01606761|364736658|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
105749776|NCT01606761|364736659|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
105483392|NCT00095238|363782685|FG000|Overall Study|Lost to Follow-up|19|||
105483393|NCT00095238|363782686|FG001|Overall Study|Lost to Follow-up|24|||
105483394|NCT00095238|363782685|FG000|Overall Study|Noncompliance|44|||
105483395|NCT00095238|363782686|FG001|Overall Study|Noncompliance|45|||
105483396|NCT00095238|363782685|FG000|Overall Study|No longer met study criteria|4|||
105483397|NCT00095238|363782686|FG001|Overall Study|No longer met study criteria|5|||
105483398|NCT00095238|363782685|FG000|Overall Study|Study terminated by sponsor|0|||
105483399|NCT00095238|363782686|FG001|Overall Study|Study terminated by sponsor|1|||
105483400|NCT00095238|363782685|FG000|Overall Study|Missing|1|||
105483401|NCT00095238|363782686|FG001|Overall Study|Missing|0|||
105483402|NCT00095238|363782685|FG000|Overall Study|Other Reasons|87|||
105483403|NCT00095238|363782686|FG001|Overall Study|Other Reasons|88|||
105483404|NCT05338671|363782687|FG000|Overall Study|Lost to Follow-up|2|||
105483405|NCT05338671|363782688|FG001|Overall Study|Lost to Follow-up|2|||
105483406|NCT05338671|363782687|FG000|Overall Study|Root canal completed in a single visit|1|||
105483407|NCT05338671|363782688|FG001|Overall Study|Root canal completed in a single visit|0|||
105483408|NCT04391049|363782689|FG000|Overall Study|Protocol Violation|1|||
105483409|NCT00075270|363782690|FG000|Overall Study|Withdrawal by Subject|28|||
105483410|NCT00075270|363782691|FG001|Overall Study|Withdrawal by Subject|21|||
105483411|NCT00075270|363782690|FG000|Overall Study|Lost to Follow-up|25|||
105483412|NCT00075270|363782691|FG001|Overall Study|Lost to Follow-up|28|||
105483413|NCT00075270|363782690|FG000|Overall Study|Protocol Violation|0|||
105483414|NCT00075270|363782691|FG001|Overall Study|Protocol Violation|2|||
105483415|NCT00075270|363782690|FG000|Overall Study|Death|198|||
105483416|NCT00075270|363782691|FG001|Overall Study|Death|215|||
105483417|NCT00075270|363782690|FG000|Overall Study|Other/Unknown|9|||
105483418|NCT00075270|363782691|FG001|Overall Study|Other/Unknown|5|||
105483419|NCT00075270|363782690|FG000|Overall Study|Missing|26|||
105483420|NCT00075270|363782691|FG001|Overall Study|Missing|13|||
105483421|NCT03874429|363782692|FG000|Overall Study|Adverse Event|2|||
105483422|NCT03874429|363782693|FG001|Overall Study|Adverse Event|2|||
105483423|NCT03874429|363782692|FG000|Overall Study|Lack of Efficacy|0|||
105483424|NCT03874429|363782693|FG001|Overall Study|Lack of Efficacy|1|||
105483425|NCT03874429|363782692|FG000|Overall Study|Covid-19 pandemic|4|||
105483426|NCT03874429|363782693|FG001|Overall Study|Covid-19 pandemic|2|||
105483427|NCT02160002|363782694|FG000|Overall Study|Withdrawal by Subject|2|||
105749777|NCT01606761|364736655|FG000|Week 24 to Week 52|Adverse Event|0|||
105749778|NCT01606761|364736656|FG001|Week 24 to Week 52|Adverse Event|11|||
105483428|NCT02160002|363782695|FG001|Overall Study|Withdrawal by Subject|1|||
105749779|NCT01606761|364736657|FG002|Week 24 to Week 52|Adverse Event|14|||
105749780|NCT01606761|364736658|FG003|Week 24 to Week 52|Adverse Event|3|||
105749781|NCT01606761|364736659|FG004|Week 24 to Week 52|Adverse Event|15|||
105749782|NCT01606761|364736655|FG000|Week 24 to Week 52|Death|0|||
105749783|NCT01606761|364736656|FG001|Week 24 to Week 52|Death|0|||
105749784|NCT01606761|364736657|FG002|Week 24 to Week 52|Death|2|||
105749785|NCT01606761|364736658|FG003|Week 24 to Week 52|Death|1|||
105749786|NCT01606761|364736659|FG004|Week 24 to Week 52|Death|0|||
105749787|NCT01606761|364736655|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
105749788|NCT01606761|364736656|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
105749789|NCT01606761|364736657|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
105749790|NCT01606761|364736658|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
105749791|NCT01606761|364736659|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
105749792|NCT01606761|364736655|FG000|Week 24 to Week 52|Physician Decision|0|||
105483429|NCT00246571|363782696|FG000|Overall Study|Adverse Event|7|||
105483430|NCT00246571|363782697|FG001|Overall Study|Adverse Event|0|||
105483431|NCT00246571|363782696|FG000|Overall Study|Protocol Violation|0|||
105483432|NCT00246571|363782697|FG001|Overall Study|Protocol Violation|1|||
105483433|NCT00246571|363782696|FG000|Overall Study|Withdrawal by Subject|2|||
105483434|NCT00246571|363782697|FG001|Overall Study|Withdrawal by Subject|3|||
105483435|NCT00246571|363782696|FG000|Overall Study|Lack of Efficacy|84|||
105483436|NCT00246571|363782697|FG001|Overall Study|Lack of Efficacy|21|||
105483437|NCT00246571|363782696|FG000|Overall Study|Death|17|||
105483438|NCT00246571|363782697|FG001|Overall Study|Death|3|||
105483439|NCT00246571|363782696|FG000|Overall Study|Sponsor|0|||
105483440|NCT00246571|363782697|FG001|Overall Study|Sponsor|1|||
105749793|NCT01606761|364736656|FG001|Week 24 to Week 52|Physician Decision|1|||
105749794|NCT01606761|364736657|FG002|Week 24 to Week 52|Physician Decision|1|||
105749795|NCT01606761|364736658|FG003|Week 24 to Week 52|Physician Decision|0|||
105749796|NCT01606761|364736659|FG004|Week 24 to Week 52|Physician Decision|0|||
105801583|NCT01078623|364930587|FG009|Treatment Period 4|Withdrawal by Subject|0|||
105801584|NCT01078623|364930588|FG010|Treatment Period 4|Withdrawal by Subject|0|||
105801585|NCT01078623|364930589|FG011|Treatment Period 4|Withdrawal by Subject|0|||
105801586|NCT01078623|364930590|FG012|Treatment Period 4|Withdrawal by Subject|0|||
105801587|NCT01078623|364930591|FG013|Treatment Period 4|Withdrawal by Subject|0|||
105801588|NCT01078623|364930592|FG014|Treatment Period 4|Withdrawal by Subject|0|||
105801589|NCT01078623|364930593|FG015|Treatment Period 4|Withdrawal by Subject|1|||
105801590|NCT01078623|364930594|FG016|Treatment Period 4|Withdrawal by Subject|0|||
105801591|NCT01078623|364930595|FG017|Treatment Period 4|Withdrawal by Subject|0|||
105801592|NCT01078623|364930596|FG018|Treatment Period 4|Withdrawal by Subject|0|||
105801593|NCT01078623|364930597|FG019|Treatment Period 4|Withdrawal by Subject|0|||
105801594|NCT01725113|364930598|FG000|Overall Study|Kidney Transplant|1|||
105801595|NCT01725113|364930599|FG001|Overall Study|Kidney Transplant|1|||
105801596|NCT01725113|364930598|FG000|Overall Study|Withdrawal by Subject|0|||
105801597|NCT01725113|364930599|FG001|Overall Study|Withdrawal by Subject|1|||
105801598|NCT02480010|364930601|FG000|Overall Study|Adverse Event|3|||
105801599|NCT02480010|364930602|FG001|Overall Study|Adverse Event|1|||
105359748|NCT05568797|363322359|FG000|Overall Study|Other|2|||
105359749|NCT05568797|363322360|FG001|Overall Study|Other|2|||
105359750|NCT01839916|363322361|FG000|Overall Study|Death|9|||
105359751|NCT01839916|363322361|FG000|Overall Study|Physician Decision|17|||
105359752|NCT01839916|363322361|FG000|Overall Study|Relapse|12|||
105359753|NCT01839916|363322361|FG000|Overall Study|GVHD|2|||
105359754|NCT01839916|363322361|FG000|Overall Study|Graft Failure|1|||
105359755|NCT02106351|363322362|FG000|Treatment Cycle 1|Adverse Event|2|||
105359756|NCT02106351|363322363|FG001|Treatment Cycle 1|Adverse Event|0|||
105359757|NCT02106351|363322364|FG002|Treatment Cycle 1|Adverse Event|0|||
105359758|NCT02106351|363322362|FG000|Treatment Cycle 1|Consent withdrawn|1|||
105359759|NCT02106351|363322363|FG001|Treatment Cycle 1|Consent withdrawn|0|||
105359760|NCT02106351|363322364|FG002|Treatment Cycle 1|Consent withdrawn|2|||
105359761|NCT02106351|363322362|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
105359762|NCT02106351|363322363|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
105359763|NCT02106351|363322364|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
105359764|NCT02106351|363322362|FG000|Treatment Cycle 1|Other|0|||
105359765|NCT02106351|363322363|FG001|Treatment Cycle 1|Other|3|||
105359766|NCT02106351|363322364|FG002|Treatment Cycle 1|Other|1|||
105359767|NCT02106351|363322362|FG000|Treatment Cycle 1|Randomised but not treated|1|||
105359768|NCT02106351|363322363|FG001|Treatment Cycle 1|Randomised but not treated|0|||
105359769|NCT02106351|363322364|FG002|Treatment Cycle 1|Randomised but not treated|1|||
105359770|NCT02106351|363322362|FG000|Treatment Cycle 2|Adverse Event|0|||
105359771|NCT02106351|363322363|FG001|Treatment Cycle 2|Adverse Event|2|||
105359772|NCT02106351|363322364|FG002|Treatment Cycle 2|Adverse Event|0|||
105359773|NCT02106351|363322362|FG000|Treatment Cycle 2|Consent withdrawn|0|||
105359774|NCT02106351|363322363|FG001|Treatment Cycle 2|Consent withdrawn|1|||
105359775|NCT02106351|363322364|FG002|Treatment Cycle 2|Consent withdrawn|1|||
105359776|NCT02106351|363322362|FG000|Treatment Cycle 2|Other|0|||
105359777|NCT02106351|363322363|FG001|Treatment Cycle 2|Other|2|||
105359778|NCT02106351|363322364|FG002|Treatment Cycle 2|Other|2|||
105359779|NCT02106351|363322362|FG000|Treatment Cycle 3|Adverse Event|0|||
105359780|NCT02106351|363322363|FG001|Treatment Cycle 3|Adverse Event|1|||
105801600|NCT02480010|364930601|FG000|Overall Study|Death|1|||
105359781|NCT02106351|363322364|FG002|Treatment Cycle 3|Adverse Event|0|||
105359782|NCT02106351|363322362|FG000|Treatment Cycle 3|Consent withdrawn|0|||
105359783|NCT02106351|363322363|FG001|Treatment Cycle 3|Consent withdrawn|0|||
105801601|NCT02480010|364930602|FG001|Overall Study|Death|0|||
105359784|NCT02106351|363322364|FG002|Treatment Cycle 3|Consent withdrawn|2|||
105359785|NCT02106351|363322362|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
105359786|NCT02106351|363322363|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
105359787|NCT02106351|363322364|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
105359788|NCT02106351|363322362|FG000|Treatment Cycle 3|Other|0|||
105749797|NCT01606761|364736655|FG000|Week 24 to Week 52|Other|0|||
105749798|NCT01606761|364736656|FG001|Week 24 to Week 52|Other|1|||
105749799|NCT01606761|364736657|FG002|Week 24 to Week 52|Other|5|||
105749800|NCT01606761|364736658|FG003|Week 24 to Week 52|Other|2|||
105749801|NCT01606761|364736659|FG004|Week 24 to Week 52|Other|2|||
105749802|NCT01606761|364736655|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
105749803|NCT01606761|364736656|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
105749804|NCT01606761|364736657|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
105749805|NCT01606761|364736658|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
105749806|NCT01606761|364736659|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
105749807|NCT01606761|364736655|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
105749808|NCT01606761|364736656|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
105749809|NCT01606761|364736657|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
105749810|NCT01606761|364736658|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
105749811|NCT01606761|364736659|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
105749812|NCT01606761|364736655|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
105749813|NCT01606761|364736656|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
105749814|NCT01606761|364736657|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
105749815|NCT01606761|364736658|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
105749816|NCT01606761|364736659|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
105749817|NCT01606761|364736655|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
105749818|NCT01606761|364736656|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
105749819|NCT01606761|364736657|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
105749820|NCT01606761|364736658|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
105749821|NCT01606761|364736659|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
105749822|NCT02951988|364736675|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
105749823|NCT02951988|364736676|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
105749824|NCT02951988|364736677|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
105749825|NCT02951988|364736678|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
105749826|NCT02951988|364736675|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
105749827|NCT02951988|364736676|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
105749828|NCT02951988|364736677|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
105749829|NCT02951988|364736678|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
105749830|NCT02951988|364736675|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
105749831|NCT02951988|364736676|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
105749832|NCT02951988|364736677|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
105749833|NCT02951988|364736678|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
105749834|NCT02951988|364736675|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
105749835|NCT02951988|364736676|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
105749836|NCT02951988|364736677|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
105749837|NCT02951988|364736678|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
105749838|NCT02951988|364736675|FG000|Open-Label Treatment Period|Protocol Violation|22|||
105749839|NCT02951988|364736676|FG001|Open-Label Treatment Period|Protocol Violation|0|||
105749840|NCT02951988|364736677|FG002|Open-Label Treatment Period|Protocol Violation|0|||
105749841|NCT02951988|364736678|FG003|Open-Label Treatment Period|Protocol Violation|0|||
105749842|NCT02951988|364736675|FG000|Open-Label Treatment Period|Pregnancy|2|||
105749843|NCT02951988|364736676|FG001|Open-Label Treatment Period|Pregnancy|0|||
105749844|NCT02951988|364736677|FG002|Open-Label Treatment Period|Pregnancy|0|||
105749845|NCT02951988|364736678|FG003|Open-Label Treatment Period|Pregnancy|0|||
105749846|NCT02951988|364736675|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
105749847|NCT02951988|364736676|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
105749848|NCT02951988|364736677|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
105749849|NCT02951988|364736678|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
105749850|NCT02951988|364736675|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
105749851|NCT02951988|364736676|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
105749852|NCT02951988|364736677|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
105749853|NCT02951988|364736678|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
105749854|NCT02951988|364736675|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
105749855|NCT02951988|364736676|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
105749856|NCT02951988|364736677|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
105749857|NCT02951988|364736678|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
105801602|NCT02480010|364930601|FG000|Overall Study|Insufficient therapeutic response|31|||
105483441|NCT00246571|363782696|FG000|Overall Study|Did not meet entrance criteria|2|||
105801603|NCT02480010|364930602|FG001|Overall Study|Insufficient therapeutic response|29|||
105483442|NCT00246571|363782697|FG001|Overall Study|Did not meet entrance criteria|1|||
105483443|NCT00246571|363782696|FG000|Overall Study|Laboratory abnormalities|1|||
105483444|NCT00246571|363782697|FG001|Overall Study|Laboratory abnormalities|0|||
105483445|NCT00246571|363782696|FG000|Overall Study|Crossover participants|0|||
105483446|NCT00246571|363782697|FG001|Overall Study|Crossover participants|74|||
105749858|NCT02951988|364736675|FG000|Open-Label Treatment Period|Adverse Event|45|||
105749859|NCT02951988|364736676|FG001|Open-Label Treatment Period|Adverse Event|0|||
105749860|NCT02951988|364736677|FG002|Open-Label Treatment Period|Adverse Event|0|||
105749861|NCT02951988|364736678|FG003|Open-Label Treatment Period|Adverse Event|0|||
105749862|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
105749863|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
105749864|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
105749865|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
105749866|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
105749867|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
105749868|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
105749869|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
105749870|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
105749871|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
105749872|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
105749873|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
105749874|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
105749875|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
105749876|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
105749877|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
105749878|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Pregnancy|0|||
105749879|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Pregnancy|1|||
105749880|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Pregnancy|1|||
105749881|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Pregnancy|0|||
105749882|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105749883|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
105749884|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
105749885|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
105749886|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105749887|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
105749888|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
105749889|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
105749890|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105749891|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Adverse Event|8|||
105749892|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Adverse Event|3|||
105749893|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Adverse Event|6|||
105749894|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
105749895|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
105749896|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
105749897|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
105749898|NCT01341652|364736685|FG000|Overall Study|Incorrect Random Assignment|0|||
105749899|NCT01341652|364736686|FG001|Overall Study|Incorrect Random Assignment|1|||
105749900|NCT01341652|364736685|FG000|Overall Study|ineligible; presence metastatic disease|0|||
105749901|NCT01341652|364736686|FG001|Overall Study|ineligible; presence metastatic disease|1|||
105749902|NCT00632463|364736688|FG000|Overall Study|Adverse Event|0|||
105749903|NCT00632463|364736689|FG001|Overall Study|Adverse Event|1|||
105749904|NCT00632463|364736690|FG002|Overall Study|Adverse Event|0|||
105749905|NCT04146467|364736695|FG000|Overall Study|Adverse Event|0|||
105749906|NCT04146467|364736696|FG001|Overall Study|Adverse Event|1|||
105749907|NCT04146467|364736695|FG000|Overall Study|Lost to Follow-up|0|||
105749908|NCT04146467|364736696|FG001|Overall Study|Lost to Follow-up|2|||
105749909|NCT00621855|364736698|FG000|Overall Study|Adverse Event|32|||
105749910|NCT00621855|364736699|FG001|Overall Study|Adverse Event|31|||
105749911|NCT00621855|364736700|FG002|Overall Study|Adverse Event|48|||
105749912|NCT00621855|364736701|FG003|Overall Study|Adverse Event|34|||
105359789|NCT02106351|363322363|FG001|Treatment Cycle 3|Other|2|||
105359790|NCT02106351|363322364|FG002|Treatment Cycle 3|Other|3|||
105749913|NCT00621855|364736702|FG004|Overall Study|Adverse Event|31|||
105749914|NCT00621855|364736698|FG000|Overall Study|Lost to Follow-up|0|||
105749915|NCT00621855|364736699|FG001|Overall Study|Lost to Follow-up|1|||
105749916|NCT00621855|364736700|FG002|Overall Study|Lost to Follow-up|3|||
105749917|NCT00621855|364736701|FG003|Overall Study|Lost to Follow-up|4|||
105749918|NCT00621855|364736702|FG004|Overall Study|Lost to Follow-up|1|||
105749919|NCT00621855|364736698|FG000|Overall Study|Protocol Violation|16|||
105749920|NCT00621855|364736699|FG001|Overall Study|Protocol Violation|8|||
105749921|NCT00621855|364736700|FG002|Overall Study|Protocol Violation|6|||
105749922|NCT00621855|364736701|FG003|Overall Study|Protocol Violation|7|||
105749923|NCT00621855|364736702|FG004|Overall Study|Protocol Violation|8|||
105749924|NCT00621855|364736698|FG000|Overall Study|Withdrawal by Subject|16|||
105749925|NCT00621855|364736699|FG001|Overall Study|Withdrawal by Subject|11|||
105749926|NCT00621855|364736700|FG002|Overall Study|Withdrawal by Subject|13|||
105749927|NCT00621855|364736701|FG003|Overall Study|Withdrawal by Subject|13|||
105749928|NCT00621855|364736702|FG004|Overall Study|Withdrawal by Subject|9|||
105749929|NCT00621855|364736698|FG000|Overall Study|Other|9|||
105749930|NCT00621855|364736699|FG001|Overall Study|Other|7|||
105749931|NCT00621855|364736700|FG002|Overall Study|Other|6|||
105749932|NCT00621855|364736701|FG003|Overall Study|Other|5|||
105749933|NCT00621855|364736702|FG004|Overall Study|Other|4|||
105749934|NCT00621855|364736698|FG000|Overall Study|Patients did not receive study drug|3|||
105749935|NCT00621855|364736699|FG001|Overall Study|Patients did not receive study drug|3|||
105749936|NCT00621855|364736700|FG002|Overall Study|Patients did not receive study drug|5|||
105749937|NCT00621855|364736701|FG003|Overall Study|Patients did not receive study drug|4|||
105749938|NCT00621855|364736702|FG004|Overall Study|Patients did not receive study drug|2|||
105749939|NCT03731364|364736703|FG000|Overall Study|Adverse Event|0|||
105749940|NCT03731364|364736704|FG001|Overall Study|Adverse Event|0|||
105749941|NCT03731364|364736705|FG002|Overall Study|Adverse Event|1|||
105749942|NCT03731364|364736706|FG003|Overall Study|Adverse Event|2|||
105749943|NCT03731364|364736707|FG004|Overall Study|Adverse Event|1|||
105749944|NCT02953782|364736708|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
105749945|NCT02953782|364736709|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
105749946|NCT02953782|364736710|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
105749947|NCT02953782|364736711|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
105749948|NCT02953782|364736712|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
105749949|NCT02953782|364736713|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
105749950|NCT02953782|364736714|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
105749951|NCT02953782|364736715|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
105749952|NCT02953782|364736708|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
105749953|NCT02953782|364736709|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
105749954|NCT02953782|364736710|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
105749955|NCT02953782|364736711|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
105749956|NCT02953782|364736712|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
105749957|NCT02953782|364736713|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
105749958|NCT02953782|364736714|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
105749959|NCT02953782|364736715|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
105749960|NCT02953782|364736708|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
105749961|NCT02953782|364736709|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
105749962|NCT02953782|364736710|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
105749963|NCT02953782|364736711|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
105749964|NCT02953782|364736712|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
105749965|NCT02953782|364736713|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
105749966|NCT02953782|364736714|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
105749967|NCT02953782|364736715|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
105483447|NCT04896229|363782698|FG000|Overall Study|Lost to Follow-up|113|||
105749968|NCT02953782|364736708|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
105749969|NCT02953782|364736709|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
105749970|NCT02953782|364736710|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
105801604|NCT02480010|364930601|FG000|Overall Study|Refused Treatment|0|||
105483448|NCT04896229|363782699|FG001|Overall Study|Lost to Follow-up|113|||
105483449|NCT01129024|363782703|FG000|Overall Study|Physician Decision|5|||
105483450|NCT01129024|363782703|FG000|Overall Study|Study Terminated by Sponsor|8|||
105483451|NCT01129024|363782703|FG000|Overall Study|Withdrawal by Subject|2|||
105483452|NCT01129024|363782703|FG000|Overall Study|Lack of Efficacy|3|||
105483453|NCT01129024|363782703|FG000|Overall Study|Needed a Platelet Transfusion|1|||
105483454|NCT00275821|363782705|FG000|Overall Study|Adverse Event|4|||
105483455|NCT00275821|363782706|FG001|Overall Study|Adverse Event|12|||
105483456|NCT00275821|363782707|FG002|Overall Study|Adverse Event|5|||
105483457|NCT00275821|363782705|FG000|Overall Study|Administrative problems|3|||
105483458|NCT00275821|363782706|FG001|Overall Study|Administrative problems|4|||
105483459|NCT00275821|363782707|FG002|Overall Study|Administrative problems|4|||
105483460|NCT00275821|363782705|FG000|Overall Study|Withdrawal by Subject|0|||
105483461|NCT00275821|363782706|FG001|Overall Study|Withdrawal by Subject|2|||
105483462|NCT00275821|363782707|FG002|Overall Study|Withdrawal by Subject|1|||
105483463|NCT00275821|363782705|FG000|Overall Study|Lost to Follow-up|0|||
105483464|NCT00275821|363782706|FG001|Overall Study|Lost to Follow-up|1|||
105483465|NCT00275821|363782707|FG002|Overall Study|Lost to Follow-up|1|||
105483466|NCT00275821|363782705|FG000|Overall Study|Death|0|||
105483467|NCT00275821|363782706|FG001|Overall Study|Death|2|||
105483468|NCT00275821|363782707|FG002|Overall Study|Death|1|||
105483469|NCT00275821|363782705|FG000|Overall Study|Lack of Efficacy|2|||
105483470|NCT00275821|363782706|FG001|Overall Study|Lack of Efficacy|1|||
105483471|NCT00275821|363782707|FG002|Overall Study|Lack of Efficacy|0|||
105483472|NCT00275821|363782705|FG000|Overall Study|Protocol Violation|5|||
105483473|NCT00275821|363782706|FG001|Overall Study|Protocol Violation|1|||
105483474|NCT00275821|363782707|FG002|Overall Study|Protocol Violation|0|||
105483475|NCT00992589|363782708|FG000|Open-Label Phase|Adverse Event|4|||
105483476|NCT00992589|363782709|FG001|Open-Label Phase|Adverse Event|0|||
105483477|NCT00992589|363782710|FG002|Open-Label Phase|Adverse Event|0|||
105483478|NCT00992589|363782711|FG003|Open-Label Phase|Adverse Event|0|||
105483479|NCT00992589|363782708|FG000|Open-Label Phase|Withdrawal by Subject|20|||
105483480|NCT00992589|363782709|FG001|Open-Label Phase|Withdrawal by Subject|0|||
105483481|NCT00992589|363782710|FG002|Open-Label Phase|Withdrawal by Subject|0|||
105483482|NCT00992589|363782711|FG003|Open-Label Phase|Withdrawal by Subject|0|||
105483483|NCT00992589|363782708|FG000|Open-Label Phase|Lost to Follow-up|1|||
105483484|NCT00992589|363782709|FG001|Open-Label Phase|Lost to Follow-up|0|||
105483485|NCT00992589|363782710|FG002|Open-Label Phase|Lost to Follow-up|0|||
105483486|NCT00992589|363782711|FG003|Open-Label Phase|Lost to Follow-up|0|||
105483487|NCT00992589|363782708|FG000|Open-Label Phase|Protocol Violation|3|||
105483488|NCT00992589|363782709|FG001|Open-Label Phase|Protocol Violation|0|||
105483489|NCT00992589|363782710|FG002|Open-Label Phase|Protocol Violation|0|||
105483490|NCT00992589|363782711|FG003|Open-Label Phase|Protocol Violation|0|||
105483491|NCT00992589|363782708|FG000|Open-Label Phase|Physician Decision|4|||
105483492|NCT00992589|363782709|FG001|Open-Label Phase|Physician Decision|0|||
105483493|NCT00992589|363782710|FG002|Open-Label Phase|Physician Decision|0|||
105483494|NCT00992589|363782711|FG003|Open-Label Phase|Physician Decision|0|||
105483495|NCT00992589|363782708|FG000|Open-Label Phase|Other|45|||
105483496|NCT00992589|363782709|FG001|Open-Label Phase|Other|0|||
105483497|NCT00992589|363782710|FG002|Open-Label Phase|Other|0|||
105483498|NCT00992589|363782711|FG003|Open-Label Phase|Other|0|||
105483499|NCT00992589|363782708|FG000|Double-Blind Phase|Adverse Event|0|||
105483500|NCT00992589|363782709|FG001|Double-Blind Phase|Adverse Event|6|||
105483501|NCT00992589|363782710|FG002|Double-Blind Phase|Adverse Event|2|||
105483502|NCT00992589|363782711|FG003|Double-Blind Phase|Adverse Event|3|||
105483503|NCT00992589|363782708|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
105483504|NCT00992589|363782709|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
105483505|NCT00992589|363782710|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
105483506|NCT00992589|363782711|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
105483507|NCT00992589|363782708|FG000|Double-Blind Phase|Lost to Follow-up|0|||
105483508|NCT00992589|363782709|FG001|Double-Blind Phase|Lost to Follow-up|0|||
105483509|NCT00992589|363782710|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105483510|NCT00992589|363782711|FG003|Double-Blind Phase|Lost to Follow-up|2|||
105483511|NCT00992589|363782708|FG000|Double-Blind Phase|Other|0|||
105483512|NCT00992589|363782709|FG001|Double-Blind Phase|Other|1|||
105483513|NCT00992589|363782710|FG002|Double-Blind Phase|Other|6|||
105483514|NCT00992589|363782711|FG003|Double-Blind Phase|Other|3|||
105483515|NCT00045942|363782712|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
105483516|NCT00045942|363782713|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
105483517|NCT00045942|363782714|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
105483518|NCT00045942|363782715|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
105483519|NCT00045942|363782716|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
105483520|NCT00045942|363782717|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
105749971|NCT02953782|364736711|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
105749972|NCT02953782|364736712|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
105749973|NCT02953782|364736713|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
105749974|NCT02953782|364736714|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
105483521|NCT00045942|363782718|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
105483522|NCT00045942|363782719|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
105359791|NCT02106351|363322362|FG000|Treatment Cycle 4|Consent withdrawn|0|||
105359792|NCT02106351|363322363|FG001|Treatment Cycle 4|Consent withdrawn|0|||
105359793|NCT02106351|363322364|FG002|Treatment Cycle 4|Consent withdrawn|2|||
105359794|NCT02106351|363322362|FG000|Treatment Cycle 4|Other|0|||
105359795|NCT02106351|363322363|FG001|Treatment Cycle 4|Other|1|||
105359796|NCT02106351|363322364|FG002|Treatment Cycle 4|Other|0|||
105749975|NCT02953782|364736715|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
105749976|NCT02953782|364736708|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
105749977|NCT02953782|364736709|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
105749978|NCT02953782|364736710|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
105749979|NCT02953782|364736711|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
105749980|NCT02953782|364736712|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
105749981|NCT02953782|364736713|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
105749982|NCT02953782|364736714|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
105749983|NCT02953782|364736715|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
105749984|NCT02953782|364736708|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
105749985|NCT02953782|364736709|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
105749986|NCT02953782|364736710|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
105749987|NCT02953782|364736711|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
105749988|NCT02953782|364736712|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
105760846|NCT01831804|364778041|FG005|Overall Study|Adverse Event|0|||
105760847|NCT01831804|364778042|FG006|Overall Study|Adverse Event|1|||
105760848|NCT01831804|364778043|FG007|Overall Study|Adverse Event|0|||
105760849|NCT01831804|364778044|FG008|Overall Study|Adverse Event|1|||
105760850|NCT01831804|364778036|FG000|Overall Study|Protocol Violation|0|||
105760851|NCT01831804|364778037|FG001|Overall Study|Protocol Violation|0|||
105760852|NCT01831804|364778038|FG002|Overall Study|Protocol Violation|2|||
105760853|NCT01831804|364778039|FG003|Overall Study|Protocol Violation|0|||
105760854|NCT01831804|364778040|FG004|Overall Study|Protocol Violation|0|||
105760855|NCT01831804|364778041|FG005|Overall Study|Protocol Violation|0|||
105760856|NCT01831804|364778042|FG006|Overall Study|Protocol Violation|0|||
105760857|NCT01831804|364778043|FG007|Overall Study|Protocol Violation|0|||
105760858|NCT01831804|364778044|FG008|Overall Study|Protocol Violation|0|||
105760859|NCT01831804|364778036|FG000|Overall Study|Protocol defined stopping criteria|1|||
105760860|NCT01831804|364778037|FG001|Overall Study|Protocol defined stopping criteria|1|||
105760861|NCT01831804|364778038|FG002|Overall Study|Protocol defined stopping criteria|3|||
105760862|NCT01831804|364778039|FG003|Overall Study|Protocol defined stopping criteria|0|||
105760863|NCT01831804|364778040|FG004|Overall Study|Protocol defined stopping criteria|1|||
105760864|NCT01831804|364778041|FG005|Overall Study|Protocol defined stopping criteria|0|||
105760865|NCT01831804|364778042|FG006|Overall Study|Protocol defined stopping criteria|0|||
105760866|NCT01831804|364778043|FG007|Overall Study|Protocol defined stopping criteria|0|||
105760867|NCT01831804|364778044|FG008|Overall Study|Protocol defined stopping criteria|0|||
105760868|NCT01831804|364778036|FG000|Overall Study|Lost to Follow-up|0|||
105760869|NCT01831804|364778037|FG001|Overall Study|Lost to Follow-up|0|||
105760870|NCT01831804|364778038|FG002|Overall Study|Lost to Follow-up|1|||
105760871|NCT01831804|364778039|FG003|Overall Study|Lost to Follow-up|0|||
105760872|NCT01831804|364778040|FG004|Overall Study|Lost to Follow-up|0|||
105760873|NCT01831804|364778041|FG005|Overall Study|Lost to Follow-up|0|||
105760874|NCT01831804|364778042|FG006|Overall Study|Lost to Follow-up|0|||
105760875|NCT01831804|364778043|FG007|Overall Study|Lost to Follow-up|0|||
105760876|NCT01831804|364778044|FG008|Overall Study|Lost to Follow-up|1|||
105760877|NCT01831804|364778036|FG000|Overall Study|Investigator discretion|0|||
105760878|NCT01831804|364778037|FG001|Overall Study|Investigator discretion|0|||
105760879|NCT01831804|364778038|FG002|Overall Study|Investigator discretion|0|||
105760880|NCT01831804|364778039|FG003|Overall Study|Investigator discretion|0|||
105760881|NCT01831804|364778040|FG004|Overall Study|Investigator discretion|1|||
105760882|NCT01831804|364778041|FG005|Overall Study|Investigator discretion|0|||
105760883|NCT01831804|364778042|FG006|Overall Study|Investigator discretion|0|||
105760884|NCT01831804|364778043|FG007|Overall Study|Investigator discretion|1|||
105760885|NCT01831804|364778044|FG008|Overall Study|Investigator discretion|0|||
105760886|NCT01831804|364778036|FG000|Overall Study|Withdrew Consent|0|||
105749989|NCT02953782|364736713|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
105749990|NCT02953782|364736714|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
105749991|NCT02953782|364736715|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
105749992|NCT02953782|364736708|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
105749993|NCT02953782|364736709|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
105749994|NCT02953782|364736710|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
105749995|NCT02953782|364736711|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
105749996|NCT02953782|364736712|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
105749997|NCT02953782|364736713|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
105749998|NCT02953782|364736714|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
105749999|NCT02953782|364736715|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
105750000|NCT02953782|364736708|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
105750001|NCT02953782|364736709|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
105750002|NCT02953782|364736710|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
105750003|NCT02953782|364736711|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
105750004|NCT02953782|364736712|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
105750005|NCT02953782|364736713|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
105750006|NCT02953782|364736714|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
105750007|NCT02953782|364736715|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
105750008|NCT01934192|364736716|FG000|Overall Study|Protocol Violation|0|||
105750009|NCT01934192|364736717|FG001|Overall Study|Protocol Violation|0|||
105750010|NCT01934192|364736718|FG002|Overall Study|Protocol Violation|0|||
105750011|NCT01934192|364736719|FG003|Overall Study|Protocol Violation|1|||
105750012|NCT01934192|364736716|FG000|Overall Study|Other: reached stopping criteria|6|||
105750013|NCT01934192|364736717|FG001|Overall Study|Other: reached stopping criteria|5|||
105483523|NCT00045942|363782720|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
105750014|NCT01934192|364736718|FG002|Overall Study|Other: reached stopping criteria|1|||
105750015|NCT01934192|364736719|FG003|Overall Study|Other: reached stopping criteria|0|||
105359797|NCT00069823|363322365|FG000|Overall Study|Did not have follow-up diary cards|6|||
105359798|NCT00069823|363322366|FG001|Overall Study|Did not have follow-up diary cards|3|||
105483524|NCT00045942|363782712|FG000|PKC412A2104 (Core)|Adverse Event|5|||
105483525|NCT00045942|363782713|FG001|PKC412A2104 (Core)|Adverse Event|0|||
105483526|NCT00045942|363782714|FG002|PKC412A2104 (Core)|Adverse Event|0|||
105483527|NCT00045942|363782715|FG003|PKC412A2104 (Core)|Adverse Event|0|||
105483528|NCT00045942|363782716|FG004|PKC412A2104 (Core)|Adverse Event|0|||
105483529|NCT00045942|363782717|FG005|PKC412A2104 (Core)|Adverse Event|0|||
105483530|NCT00045942|363782718|FG006|PKC412A2104 (Core)|Adverse Event|0|||
105483531|NCT00045942|363782719|FG007|PKC412A2104 (Core)|Adverse Event|0|||
105483532|NCT00045942|363782720|FG008|PKC412A2104 (Core)|Adverse Event|0|||
105483533|NCT00045942|363782712|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
105483534|NCT00045942|363782713|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
105483535|NCT00045942|363782714|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
105483536|NCT00045942|363782715|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
105483537|NCT00045942|363782716|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
105750016|NCT01934192|364736716|FG000|Overall Study|Physician Decision|3|||
105750017|NCT01934192|364736717|FG001|Overall Study|Physician Decision|2|||
105750018|NCT01934192|364736718|FG002|Overall Study|Physician Decision|0|||
105750019|NCT01934192|364736719|FG003|Overall Study|Physician Decision|0|||
105750020|NCT02357849|364736720|FG000|Overall Study|Withdrawal by Subject|2|||
105750021|NCT02357849|364736721|FG001|Overall Study|Withdrawal by Subject|3|||
105750022|NCT04105244|364736722|FG000|Overall Study|Withdrawal by Subject|10|||
105750023|NCT04105244|364736723|FG001|Overall Study|Withdrawal by Subject|12|||
105750024|NCT04105244|364736722|FG000|Overall Study|Lost to Follow-up|20|||
105750025|NCT04105244|364736723|FG001|Overall Study|Lost to Follow-up|15|||
105750026|NCT04105244|364736722|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
105750027|NCT04105244|364736723|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
105750028|NCT04105244|364736722|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
105750029|NCT04105244|364736723|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
105750030|NCT02756650|364736724|FG000|Overall Study|Physician Decision|1|||
105750031|NCT02756650|364736724|FG000|Overall Study|Adverse Event|1|||
105750032|NCT04031404|364738710|FG000|Baseline|Lost to Follow-up|0|||
105750033|NCT04031404|364738711|FG001|Baseline|Lost to Follow-up|1|||
105750034|NCT04031404|364738710|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
105750035|NCT04031404|364738711|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
105750036|NCT04031404|364738710|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
105750037|NCT04031404|364738711|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
105750038|NCT04031404|364738710|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
105750039|NCT04031404|364738711|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
105750040|NCT04031404|364738710|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
105750041|NCT04031404|364738711|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
105801605|NCT02480010|364930602|FG001|Overall Study|Refused Treatment|3|||
105483538|NCT00045942|363782717|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
105483539|NCT00045942|363782718|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
105483540|NCT00045942|363782719|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
105483541|NCT00045942|363782720|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
105483542|NCT00045942|363782712|FG000|PKC412A2104 (Core)|Death|1|||
105483543|NCT00045942|363782713|FG001|PKC412A2104 (Core)|Death|0|||
105483544|NCT00045942|363782714|FG002|PKC412A2104 (Core)|Death|0|||
105483545|NCT00045942|363782715|FG003|PKC412A2104 (Core)|Death|0|||
105483546|NCT00045942|363782716|FG004|PKC412A2104 (Core)|Death|0|||
105483547|NCT00045942|363782717|FG005|PKC412A2104 (Core)|Death|0|||
105483548|NCT00045942|363782718|FG006|PKC412A2104 (Core)|Death|0|||
105483549|NCT00045942|363782719|FG007|PKC412A2104 (Core)|Death|0|||
105483550|NCT00045942|363782720|FG008|PKC412A2104 (Core)|Death|0|||
105750042|NCT03712345|364738716|FG000|Overall Study|Failure to meet randomization criteria|0|||
105750043|NCT03712345|364738717|FG001|Overall Study|Failure to meet randomization criteria|0|||
105750044|NCT03712345|364738718|FG002|Overall Study|Failure to meet randomization criteria|1|||
105750045|NCT05254613|364738719|FG000|Overall Study|Lost to Follow-up|0|||
105750046|NCT05254613|364738720|FG001|Overall Study|Lost to Follow-up|0|||
105750047|NCT05254613|364738721|FG002|Overall Study|Lost to Follow-up|1|||
105750048|NCT02924688|364738722|FG000|Overall Study|Adverse Event|9|||
105801606|NCT01830920|364930604|FG000|Overall Study|Adverse Event|1|||
105483551|NCT00045942|363782712|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
105483552|NCT00045942|363782713|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
105483553|NCT00045942|363782714|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
105750049|NCT02924688|364738723|FG001|Overall Study|Adverse Event|3|||
105750050|NCT02924688|364738724|FG002|Overall Study|Adverse Event|2|||
105750051|NCT02924688|364738725|FG003|Overall Study|Adverse Event|2|||
105750052|NCT02924688|364738726|FG004|Overall Study|Adverse Event|3|||
105750053|NCT02924688|364738727|FG005|Overall Study|Adverse Event|2|||
105750054|NCT02924688|364738722|FG000|Overall Study|Lack of Efficacy|2|||
105750055|NCT02924688|364738723|FG001|Overall Study|Lack of Efficacy|3|||
105750056|NCT02924688|364738724|FG002|Overall Study|Lack of Efficacy|4|||
105750057|NCT02924688|364738725|FG003|Overall Study|Lack of Efficacy|2|||
105750058|NCT02924688|364738726|FG004|Overall Study|Lack of Efficacy|1|||
105750059|NCT02924688|364738727|FG005|Overall Study|Lack of Efficacy|1|||
105750060|NCT02924688|364738722|FG000|Overall Study|Protocol Violation|3|||
105750061|NCT02924688|364738723|FG001|Overall Study|Protocol Violation|7|||
105750062|NCT02924688|364738724|FG002|Overall Study|Protocol Violation|5|||
105750063|NCT02924688|364738725|FG003|Overall Study|Protocol Violation|6|||
105750064|NCT02924688|364738726|FG004|Overall Study|Protocol Violation|2|||
105750065|NCT02924688|364738727|FG005|Overall Study|Protocol Violation|2|||
105750066|NCT02924688|364738722|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
105750067|NCT02924688|364738723|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
105750068|NCT02924688|364738724|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
105750069|NCT02924688|364738725|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
105750070|NCT02924688|364738726|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
105750071|NCT02924688|364738727|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
105750072|NCT02924688|364738722|FG000|Overall Study|Lost to Follow-up|2|||
105750073|NCT02924688|364738723|FG001|Overall Study|Lost to Follow-up|4|||
105750074|NCT02924688|364738724|FG002|Overall Study|Lost to Follow-up|2|||
105750075|NCT02924688|364738725|FG003|Overall Study|Lost to Follow-up|4|||
105750076|NCT02924688|364738726|FG004|Overall Study|Lost to Follow-up|2|||
105750077|NCT02924688|364738727|FG005|Overall Study|Lost to Follow-up|4|||
105750078|NCT02924688|364738722|FG000|Overall Study|Physician Decision|2|||
105750079|NCT02924688|364738723|FG001|Overall Study|Physician Decision|1|||
105750080|NCT02924688|364738724|FG002|Overall Study|Physician Decision|0|||
105750081|NCT02924688|364738725|FG003|Overall Study|Physician Decision|1|||
105750082|NCT02924688|364738726|FG004|Overall Study|Physician Decision|1|||
105750083|NCT02924688|364738727|FG005|Overall Study|Physician Decision|1|||
105750084|NCT02924688|364738722|FG000|Overall Study|Withdrawal by Subject|14|||
105750085|NCT02924688|364738723|FG001|Overall Study|Withdrawal by Subject|13|||
105750086|NCT02924688|364738724|FG002|Overall Study|Withdrawal by Subject|9|||
105750087|NCT02924688|364738725|FG003|Overall Study|Withdrawal by Subject|12|||
105750088|NCT02924688|364738726|FG004|Overall Study|Withdrawal by Subject|13|||
105750089|NCT02924688|364738727|FG005|Overall Study|Withdrawal by Subject|14|||
105750090|NCT02370498|364738731|FG000|Overall Study|Adverse Event|10|||
105750091|NCT02370498|364738732|FG001|Overall Study|Adverse Event|8|||
105750092|NCT02370498|364738731|FG000|Overall Study|Death|263|||
105750093|NCT02370498|364738732|FG001|Overall Study|Death|265|||
105750094|NCT02370498|364738731|FG000|Overall Study|Protocol Violation|1|||
105750095|NCT02370498|364738732|FG001|Overall Study|Protocol Violation|2|||
105750096|NCT02370498|364738731|FG000|Overall Study|Withdrawal by Subject|7|||
105750097|NCT02370498|364738732|FG001|Overall Study|Withdrawal by Subject|12|||
105750098|NCT02370498|364738731|FG000|Overall Study|Sponsor's decision|15|||
105750099|NCT02370498|364738732|FG001|Overall Study|Sponsor's decision|9|||
105750100|NCT03225716|364738733|FG000|Overall Study|Withdrawal by Subject|2|||
105750101|NCT03225716|364738734|FG001|Overall Study|Withdrawal by Subject|2|||
105801607|NCT01830920|364930605|FG001|Overall Study|Adverse Event|0|||
105483554|NCT00045942|363782715|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
105483555|NCT00045942|363782716|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
105483556|NCT00045942|363782717|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
105483557|NCT00045942|363782718|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
105483558|NCT00045942|363782719|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
105483559|NCT00045942|363782720|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
105483560|NCT00045942|363782712|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
105483561|NCT00045942|363782713|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
105483562|NCT00045942|363782714|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
105483563|NCT00045942|363782715|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
105483564|NCT00045942|363782716|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
105483565|NCT00045942|363782717|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
105483566|NCT00045942|363782718|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
105483567|NCT00045942|363782719|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
105483568|NCT00045942|363782720|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
105483569|NCT00045942|363782712|FG000|PKC412A2104E1|Lack of Efficacy|0|||
105483570|NCT00045942|363782713|FG001|PKC412A2104E1|Lack of Efficacy|11|||
105483571|NCT00045942|363782714|FG002|PKC412A2104E1|Lack of Efficacy|11|||
105483572|NCT00045942|363782715|FG003|PKC412A2104E1|Lack of Efficacy|23|||
105483573|NCT00045942|363782716|FG004|PKC412A2104E1|Lack of Efficacy|17|||
105483574|NCT00045942|363782717|FG005|PKC412A2104E1|Lack of Efficacy|0|||
105483575|NCT00045942|363782718|FG006|PKC412A2104E1|Lack of Efficacy|0|||
105483576|NCT00045942|363782719|FG007|PKC412A2104E1|Lack of Efficacy|0|||
105483577|NCT00045942|363782720|FG008|PKC412A2104E1|Lack of Efficacy|0|||
105483578|NCT00045942|363782712|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
105565410|NCT04512066|364066769|FG004|Extension Period|Lost to Follow-up|3|||
105565411|NCT04512066|364066770|FG005|Extension Period|Lost to Follow-up|2|||
105565412|NCT04512066|364066765|FG000|Extension Period|Non-compliance with study drug|0|||
105750102|NCT03225716|364738735|FG002|Overall Study|Withdrawal by Subject|0|||
105750103|NCT03225716|364738733|FG000|Overall Study|Lack of Efficacy|1|||
105750104|NCT03225716|364738734|FG001|Overall Study|Lack of Efficacy|0|||
105750105|NCT03225716|364738735|FG002|Overall Study|Lack of Efficacy|0|||
105359799|NCT00520039|363322369|FG000|Overall Study|Exclusion criteria met at first visit|7|||
105359800|NCT00520039|363322370|FG001|Overall Study|Exclusion criteria met at first visit|5|||
105359801|NCT01210482|363322371|FG000|Overall Study|Protocol Violation|1|||
105359802|NCT01210482|363322371|FG000|Overall Study|Case Report Forms were not collected|18|||
105359803|NCT01210482|363322371|FG000|Overall Study|Duplicated|2|||
105359804|NCT01210482|363322371|FG000|Overall Study|No Drug Administration|28|||
105359805|NCT05176717|363322372|FG000|Overall Study|Sponsor Decision|1|||
105750106|NCT03225716|364738733|FG000|Overall Study|Adverse Event|2|||
105750107|NCT03225716|364738734|FG001|Overall Study|Adverse Event|0|||
105750108|NCT03225716|364738735|FG002|Overall Study|Adverse Event|1|||
105750109|NCT03225716|364738733|FG000|Overall Study|Study early termination by Sponsor|0|||
105750110|NCT03225716|364738734|FG001|Overall Study|Study early termination by Sponsor|0|||
105750111|NCT03225716|364738735|FG002|Overall Study|Study early termination by Sponsor|2|||
105750112|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
105750113|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
105750114|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
105750115|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
105750116|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
105750117|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
105750118|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
105750119|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
105750120|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
105750121|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
105750122|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
105750123|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
105750124|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
105750125|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
105750126|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
105750127|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
105750128|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
105750129|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
105750130|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
105750131|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
105750132|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
105750133|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
105359806|NCT05176717|363322373|FG001|Overall Study|Sponsor Decision|2|||
105565413|NCT04512066|364066766|FG001|Extension Period|Non-compliance with study drug|1|||
105565414|NCT04512066|364066767|FG002|Extension Period|Non-compliance with study drug|0|||
105565415|NCT04512066|364066768|FG003|Extension Period|Non-compliance with study drug|0|||
105565416|NCT04512066|364066769|FG004|Extension Period|Non-compliance with study drug|0|||
105565417|NCT04512066|364066770|FG005|Extension Period|Non-compliance with study drug|1|||
105565418|NCT04512066|364066765|FG000|Extension Period|Other|0|||
105565419|NCT04512066|364066766|FG001|Extension Period|Other|2|||
105565420|NCT04512066|364066767|FG002|Extension Period|Other|0|||
105565421|NCT04512066|364066768|FG003|Extension Period|Other|0|||
105750134|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
105750135|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
105750136|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
105750137|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
105750138|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
105750139|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
105750140|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
105801608|NCT01830920|364930606|FG002|Overall Study|Adverse Event|1|||
105801609|NCT01830920|364930607|FG003|Overall Study|Adverse Event|0|||
105801610|NCT01830920|364930608|FG004|Overall Study|Adverse Event|0|||
105359807|NCT05176717|363322374|FG002|Overall Study|Sponsor Decision|2|||
105359808|NCT02058589|363322375|FG000|Overall Study|Serious Adverse Event|1|||
105359809|NCT02058589|363322376|FG001|Overall Study|Serious Adverse Event|1|||
105359810|NCT02058589|363322375|FG000|Overall Study|Non-Serious Adverse Event|1|||
105359811|NCT02058589|363322376|FG001|Overall Study|Non-Serious Adverse Event|0|||
105359812|NCT02058589|363322375|FG000|Overall Study|Withdrawal by Subject|0|||
105359813|NCT02058589|363322376|FG001|Overall Study|Withdrawal by Subject|1|||
105359814|NCT00490971|363322382|FG000|Acute/Continuation|Adverse Event|62|||
105359815|NCT00490971|363322383|FG001|Acute/Continuation|Adverse Event|13|||
105359816|NCT00490971|363322384|FG002|Acute/Continuation|Adverse Event|0|||
105359817|NCT00490971|363322385|FG003|Acute/Continuation|Adverse Event|0|||
105359818|NCT00490971|363322386|FG004|Acute/Continuation|Adverse Event|0|||
105359819|NCT00490971|363322382|FG000|Acute/Continuation|Death|2|||
105359820|NCT00490971|363322383|FG001|Acute/Continuation|Death|0|||
105359821|NCT00490971|363322384|FG002|Acute/Continuation|Death|0|||
105359822|NCT00490971|363322385|FG003|Acute/Continuation|Death|0|||
105359823|NCT00490971|363322386|FG004|Acute/Continuation|Death|0|||
105359824|NCT00490971|363322382|FG000|Acute/Continuation|Lack of Efficacy|106|||
105359825|NCT00490971|363322383|FG001|Acute/Continuation|Lack of Efficacy|12|||
105359826|NCT00490971|363322384|FG002|Acute/Continuation|Lack of Efficacy|0|||
105359827|NCT00490971|363322385|FG003|Acute/Continuation|Lack of Efficacy|0|||
105359828|NCT00490971|363322386|FG004|Acute/Continuation|Lack of Efficacy|0|||
105359829|NCT00490971|363322382|FG000|Acute/Continuation|Lost to Follow-up|23|||
105359830|NCT00490971|363322383|FG001|Acute/Continuation|Lost to Follow-up|7|||
105359831|NCT00490971|363322384|FG002|Acute/Continuation|Lost to Follow-up|0|||
105359832|NCT00490971|363322385|FG003|Acute/Continuation|Lost to Follow-up|0|||
105359833|NCT00490971|363322386|FG004|Acute/Continuation|Lost to Follow-up|0|||
105359834|NCT00490971|363322382|FG000|Acute/Continuation|Protocol Violation|10|||
105359835|NCT00490971|363322383|FG001|Acute/Continuation|Protocol Violation|2|||
105750141|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
105359836|NCT00490971|363322384|FG002|Acute/Continuation|Protocol Violation|0|||
105359837|NCT00490971|363322385|FG003|Acute/Continuation|Protocol Violation|0|||
105359838|NCT00490971|363322386|FG004|Acute/Continuation|Protocol Violation|0|||
105359839|NCT00490971|363322382|FG000|Acute/Continuation|Withdrawal by Subject|92|||
105359840|NCT00490971|363322383|FG001|Acute/Continuation|Withdrawal by Subject|24|||
105750142|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
105750143|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
105750144|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
105750145|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
105750146|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
105750147|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
105750148|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
105750149|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
105750150|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
105750151|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
105750152|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
105750153|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
105750154|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
105750155|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
105750156|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
105750157|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
105750158|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
105750159|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
105750160|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
105750161|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
105750162|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
105750163|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
105750164|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
105750165|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
105750166|NCT03444870|364738736|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105750167|NCT03444870|364738737|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105750168|NCT03444870|364738738|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105750169|NCT03444870|364738739|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105750170|NCT03444870|364738740|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
105750171|NCT03444870|364738741|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
105750172|NCT03444870|364738736|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
105750173|NCT03444870|364738737|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
105750174|NCT03444870|364738738|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
105750175|NCT03444870|364738739|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
105750176|NCT03444870|364738740|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
105750177|NCT03444870|364738741|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
105750178|NCT03444870|364738736|FG000|Open-Label Extension (OLE) Period|Death|0|||
105750179|NCT03444870|364738737|FG001|Open-Label Extension (OLE) Period|Death|0|||
105750180|NCT03444870|364738738|FG002|Open-Label Extension (OLE) Period|Death|0|||
105750181|NCT03444870|364738739|FG003|Open-Label Extension (OLE) Period|Death|0|||
105750182|NCT03444870|364738740|FG004|Open-Label Extension (OLE) Period|Death|1|||
105750183|NCT03444870|364738741|FG005|Open-Label Extension (OLE) Period|Death|0|||
105750184|NCT00501046|364738756|FG000|Overall Study|Adverse Event|21|||
105750185|NCT00501046|364738757|FG001|Overall Study|Adverse Event|25|||
105750186|NCT00501046|364738756|FG000|Overall Study|Death|23|||
105750187|NCT00501046|364738757|FG001|Overall Study|Death|30|||
105750188|NCT00501046|364738756|FG000|Overall Study|Lost to Follow-up|14|||
105750189|NCT00501046|364738757|FG001|Overall Study|Lost to Follow-up|13|||
105750190|NCT00501046|364738756|FG000|Overall Study|Physician Decision|7|||
105801611|NCT01830920|364930604|FG000|Overall Study|Withdrawal by Subject|2|||
105750191|NCT00501046|364738757|FG001|Overall Study|Physician Decision|2|||
105750192|NCT00501046|364738756|FG000|Overall Study|Pregnancy|0|||
105565422|NCT04512066|364066769|FG004|Extension Period|Other|0|||
105565423|NCT04512066|364066770|FG005|Extension Period|Other|0|||
105565424|NCT04512066|364066765|FG000|Extension Period|Physician Decision|0|||
105565425|NCT04512066|364066766|FG001|Extension Period|Physician Decision|2|||
105565426|NCT04512066|364066767|FG002|Extension Period|Physician Decision|0|||
105565427|NCT04512066|364066768|FG003|Extension Period|Physician Decision|1|||
105565428|NCT04512066|364066769|FG004|Extension Period|Physician Decision|1|||
105565429|NCT04512066|364066770|FG005|Extension Period|Physician Decision|0|||
105565430|NCT04512066|364066765|FG000|Extension Period|Withdrawal by Subject|0|||
105565431|NCT04512066|364066766|FG001|Extension Period|Withdrawal by Subject|3|||
105565432|NCT04512066|364066767|FG002|Extension Period|Withdrawal by Subject|7|||
105565433|NCT04512066|364066768|FG003|Extension Period|Withdrawal by Subject|11|||
105565434|NCT04512066|364066769|FG004|Extension Period|Withdrawal by Subject|8|||
105565435|NCT04512066|364066770|FG005|Extension Period|Withdrawal by Subject|4|||
105565436|NCT00316173|364066773|FG000|Run-in Phase|Adverse Event|1|||
105565437|NCT00316173|364066774|FG001|Run-in Phase|Adverse Event|0|||
105565438|NCT00316173|364066773|FG000|Run-in Phase|Protocol Violation|1|||
105565439|NCT00316173|364066774|FG001|Run-in Phase|Protocol Violation|0|||
105565440|NCT00316173|364066773|FG000|Run-in Phase|Study Follow-up Stopped|5|||
105565441|NCT00316173|364066774|FG001|Run-in Phase|Study Follow-up Stopped|0|||
105565442|NCT00316173|364066773|FG000|Treatment Phase|Adverse Event|0|||
105565443|NCT00316173|364066774|FG001|Treatment Phase|Adverse Event|1|||
105565444|NCT00316173|364066773|FG000|Treatment Phase|Lack of Efficacy|0|||
105565445|NCT00316173|364066774|FG001|Treatment Phase|Lack of Efficacy|3|||
105565446|NCT00316173|364066773|FG000|Treatment Phase|Lost to Follow-up|0|||
105565447|NCT00316173|364066774|FG001|Treatment Phase|Lost to Follow-up|3|||
105565448|NCT00316173|364066773|FG000|Treatment Phase|Withdrawal by Subject|0|||
105565449|NCT00316173|364066774|FG001|Treatment Phase|Withdrawal by Subject|1|||
105565450|NCT00316173|364066773|FG000|Treatment Phase|Study Follow-up Stopped|0|||
105565451|NCT00316173|364066774|FG001|Treatment Phase|Study Follow-up Stopped|34|||
105565452|NCT00511875|364066775|FG000|Overall Study|Lost to Follow-up|4|||
105565453|NCT00511875|364066776|FG001|Overall Study|Lost to Follow-up|0|||
105565454|NCT00511875|364066775|FG000|Overall Study|Missing variables|1|||
105565455|NCT00511875|364066776|FG001|Overall Study|Missing variables|0|||
105565456|NCT01678131|364066779|FG000|Overall Study|Adverse Event|0|||
105750193|NCT00501046|364738757|FG001|Overall Study|Pregnancy|3|||
105565457|NCT01678131|364066780|FG001|Overall Study|Adverse Event|1|||
105565458|NCT01678131|364066781|FG002|Overall Study|Adverse Event|0|||
105565459|NCT01678131|364066779|FG000|Overall Study|Withdrawal by Subject|0|||
105565460|NCT01678131|364066780|FG001|Overall Study|Withdrawal by Subject|0|||
105750194|NCT00501046|364738756|FG000|Overall Study|Protocol Violation|2|||
105750195|NCT00501046|364738757|FG001|Overall Study|Protocol Violation|1|||
105750196|NCT00501046|364738756|FG000|Overall Study|Withdrawal by Subject|84|||
105750197|NCT00501046|364738757|FG001|Overall Study|Withdrawal by Subject|83|||
105750198|NCT00501046|364738756|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
105750199|NCT00501046|364738757|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
105359841|NCT00490971|363322384|FG002|Acute/Continuation|Withdrawal by Subject|0|||
105359842|NCT00490971|363322385|FG003|Acute/Continuation|Withdrawal by Subject|0|||
105750200|NCT01397552|364738758|FG000|Overall Study|Adverse Event|1|||
105750201|NCT01397552|364738759|FG001|Overall Study|Adverse Event|0|||
105565461|NCT01678131|364066781|FG002|Overall Study|Withdrawal by Subject|2|||
105565462|NCT01489189|364066786|FG000|Overall Study|Withdrawal by Subject|20|||
105565463|NCT01489189|364066787|FG001|Overall Study|Withdrawal by Subject|23|||
105565464|NCT01489189|364066786|FG000|Overall Study|Death|10|||
105565465|NCT01489189|364066787|FG001|Overall Study|Death|8|||
105565466|NCT01489189|364066786|FG000|Overall Study|Missed Visit|1|||
105750202|NCT01397552|364738758|FG000|Overall Study|Withdrawal by Subject|2|||
105750203|NCT01397552|364738759|FG001|Overall Study|Withdrawal by Subject|1|||
105750204|NCT00423735|364738760|FG000|Overall Study|Ineligible / No protocol treatment|8|||
105750205|NCT00423735|364738761|FG001|Overall Study|Ineligible / No protocol treatment|6|||
105565467|NCT01489189|364066787|FG001|Overall Study|Missed Visit|4|||
105565468|NCT00766675|364068576|FG000|Overall Study|Adverse Event|16|||
105565469|NCT00766675|364068576|FG000|Overall Study|Lost to Follow-up|2|||
105565470|NCT00766675|364068576|FG000|Overall Study|Withdrawal by Subject|11|||
105565471|NCT00766675|364068576|FG000|Overall Study|Protocol Violation|8|||
105565472|NCT00766675|364068576|FG000|Overall Study|Participant took prohibited medication|1|||
105565473|NCT00766675|364068576|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
105565474|NCT00766675|364068576|FG000|Overall Study|Insufficient therapy|1|||
105565475|NCT01984697|364068580|FG000|Overall Study|Adverse Event|0|||
105565476|NCT01984697|364068581|FG001|Overall Study|Adverse Event|0|||
105565477|NCT01984697|364068582|FG002|Overall Study|Adverse Event|2|||
105565478|NCT01984697|364068583|FG003|Overall Study|Adverse Event|0|||
105565479|NCT01984697|364068584|FG004|Overall Study|Adverse Event|0|||
105565480|NCT01984697|364068580|FG000|Overall Study|Lost to Follow-up|14|||
105565481|NCT01984697|364068581|FG001|Overall Study|Lost to Follow-up|5|||
105565482|NCT01984697|364068582|FG002|Overall Study|Lost to Follow-up|10|||
105565483|NCT01984697|364068583|FG003|Overall Study|Lost to Follow-up|6|||
105565484|NCT01984697|364068584|FG004|Overall Study|Lost to Follow-up|21|||
105565485|NCT01984697|364068580|FG000|Overall Study|Physician Decision|3|||
105565486|NCT01984697|364068581|FG001|Overall Study|Physician Decision|0|||
105750206|NCT00423735|364738762|FG002|Overall Study|Ineligible / No protocol treatment|0|||
105565487|NCT01984697|364068582|FG002|Overall Study|Physician Decision|0|||
105565488|NCT01984697|364068583|FG003|Overall Study|Physician Decision|1|||
105565489|NCT01984697|364068584|FG004|Overall Study|Physician Decision|0|||
105565490|NCT01984697|364068580|FG000|Overall Study|Protocol Violation|8|||
105565491|NCT01984697|364068581|FG001|Overall Study|Protocol Violation|5|||
105565492|NCT01984697|364068582|FG002|Overall Study|Protocol Violation|3|||
105565493|NCT01984697|364068583|FG003|Overall Study|Protocol Violation|2|||
105750207|NCT00992784|364738763|FG000|Overall Study|Adverse Event|2|||
105565494|NCT01984697|364068584|FG004|Overall Study|Protocol Violation|0|||
105565495|NCT01984697|364068580|FG000|Overall Study|Withdrawal by Subject|15|||
105565496|NCT01984697|364068581|FG001|Overall Study|Withdrawal by Subject|21|||
105565497|NCT01984697|364068582|FG002|Overall Study|Withdrawal by Subject|13|||
105565498|NCT01984697|364068583|FG003|Overall Study|Withdrawal by Subject|11|||
105565499|NCT01984697|364068584|FG004|Overall Study|Withdrawal by Subject|13|||
105565500|NCT01984697|364068580|FG000|Overall Study|Missed last follow-up visit|1|||
105565501|NCT01984697|364068581|FG001|Overall Study|Missed last follow-up visit|0|||
105565502|NCT01984697|364068582|FG002|Overall Study|Missed last follow-up visit|0|||
105565503|NCT01984697|364068583|FG003|Overall Study|Missed last follow-up visit|0|||
105565504|NCT01984697|364068584|FG004|Overall Study|Missed last follow-up visit|0|||
105565505|NCT01984697|364068580|FG000|Overall Study|Death|0|||
105565506|NCT01984697|364068581|FG001|Overall Study|Death|0|||
105565507|NCT01984697|364068582|FG002|Overall Study|Death|0|||
105565508|NCT01984697|364068583|FG003|Overall Study|Death|1|||
105565509|NCT01984697|364068584|FG004|Overall Study|Death|0|||
105565510|NCT01984697|364068580|FG000|Overall Study|Pregnancy|2|||
105565511|NCT01984697|364068581|FG001|Overall Study|Pregnancy|0|||
105565512|NCT01984697|364068582|FG002|Overall Study|Pregnancy|1|||
105565513|NCT01984697|364068583|FG003|Overall Study|Pregnancy|0|||
105565514|NCT01984697|364068584|FG004|Overall Study|Pregnancy|1|||
105565515|NCT02044848|364068585|FG000|Overall Study|Administrative Problems|2|||
105565516|NCT02044848|364068586|FG001|Overall Study|Administrative Problems|3|||
105750208|NCT00992784|364738764|FG001|Overall Study|Adverse Event|1|||
105750209|NCT00992784|364738765|FG002|Overall Study|Adverse Event|0|||
105750210|NCT00992784|364738763|FG000|Overall Study|Withdrawal by Subject|1|||
105750211|NCT00992784|364738764|FG001|Overall Study|Withdrawal by Subject|1|||
105750212|NCT00992784|364738765|FG002|Overall Study|Withdrawal by Subject|1|||
105750213|NCT01088438|364738769|FG000|Overall Study|Withdrawal by Subject|11|||
105750214|NCT01088438|364738770|FG001|Overall Study|Withdrawal by Subject|6|||
105750215|NCT01088438|364738769|FG000|Overall Study|Lost to Follow-up|18|||
105750216|NCT01088438|364738770|FG001|Overall Study|Lost to Follow-up|30|||
105750217|NCT03521687|364738774|FG000|Overall Study|Adverse Event|4|||
105750218|NCT03521687|364738774|FG000|Overall Study|Physician Decision|1|||
105750219|NCT00608530|364738775|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
105750220|NCT00608530|364738776|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
105750221|NCT00608530|364738777|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
105750222|NCT00608530|364738778|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
105750223|NCT00608530|364738775|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
105359843|NCT00490971|363322386|FG004|Acute/Continuation|Withdrawal by Subject|0|||
105359844|NCT00490971|363322382|FG000|Acute/Continuation|Other|11|||
105359845|NCT00490971|363322383|FG001|Acute/Continuation|Other|4|||
105359846|NCT00490971|363322384|FG002|Acute/Continuation|Other|0|||
105359847|NCT00490971|363322385|FG003|Acute/Continuation|Other|0|||
105359848|NCT00490971|363322386|FG004|Acute/Continuation|Other|0|||
105359849|NCT00490971|363322382|FG000|Maintenance|Adverse Event|0|||
105359850|NCT00490971|363322383|FG001|Maintenance|Adverse Event|0|||
105359851|NCT00490971|363322384|FG002|Maintenance|Adverse Event|4|||
105359852|NCT00490971|363322385|FG003|Maintenance|Adverse Event|5|||
105359853|NCT00490971|363322386|FG004|Maintenance|Adverse Event|7|||
105359854|NCT00490971|363322382|FG000|Maintenance|Death|0|||
105359855|NCT00490971|363322383|FG001|Maintenance|Death|0|||
105359856|NCT00490971|363322384|FG002|Maintenance|Death|0|||
105359857|NCT00490971|363322385|FG003|Maintenance|Death|2|||
105359858|NCT00490971|363322386|FG004|Maintenance|Death|0|||
105359859|NCT00490971|363322382|FG000|Maintenance|Lost to Follow-up|0|||
105565517|NCT00695786|364068587|FG000|Overall Study|Adverse Event|0|||
105565518|NCT00695786|364068588|FG001|Overall Study|Adverse Event|3|||
105750224|NCT00608530|364738776|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
105359860|NCT00490971|363322383|FG001|Maintenance|Lost to Follow-up|0|||
105359861|NCT00490971|363322384|FG002|Maintenance|Lost to Follow-up|5|||
105359862|NCT00490971|363322385|FG003|Maintenance|Lost to Follow-up|8|||
105359863|NCT00490971|363322386|FG004|Maintenance|Lost to Follow-up|10|||
105359864|NCT00490971|363322382|FG000|Maintenance|Pregnancy|0|||
105565519|NCT00695786|364068589|FG002|Overall Study|Adverse Event|4|||
105565520|NCT00695786|364068590|FG003|Overall Study|Adverse Event|2|||
105565521|NCT00695786|364068587|FG000|Overall Study|Lost to Follow-up|0|||
105565522|NCT00695786|364068588|FG001|Overall Study|Lost to Follow-up|5|||
105565523|NCT00695786|364068589|FG002|Overall Study|Lost to Follow-up|1|||
105565524|NCT00695786|364068590|FG003|Overall Study|Lost to Follow-up|1|||
105565525|NCT00695786|364068587|FG000|Overall Study|Withdrawal by Subject|0|||
105565526|NCT00695786|364068588|FG001|Overall Study|Withdrawal by Subject|4|||
105565527|NCT00695786|364068589|FG002|Overall Study|Withdrawal by Subject|3|||
105565528|NCT00695786|364068590|FG003|Overall Study|Withdrawal by Subject|1|||
105565529|NCT00695786|364068587|FG000|Overall Study|Deemed Ineligible|1|||
105565530|NCT00695786|364068588|FG001|Overall Study|Deemed Ineligible|0|||
105565531|NCT00695786|364068589|FG002|Overall Study|Deemed Ineligible|0|||
105565532|NCT00695786|364068590|FG003|Overall Study|Deemed Ineligible|0|||
105565533|NCT00695786|364068587|FG000|Overall Study|Lack of Efficacy|0|||
105565534|NCT00695786|364068588|FG001|Overall Study|Lack of Efficacy|0|||
105565535|NCT00695786|364068589|FG002|Overall Study|Lack of Efficacy|0|||
105565536|NCT00695786|364068590|FG003|Overall Study|Lack of Efficacy|4|||
105565537|NCT02259517|364068597|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
105750225|NCT00608530|364738777|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
105750226|NCT00608530|364738778|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
105750227|NCT00608530|364738775|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
105750228|NCT00608530|364738776|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
105750229|NCT00608530|364738777|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
105750230|NCT00608530|364738778|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
105750231|NCT00608530|364738775|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
105359865|NCT00490971|363322383|FG001|Maintenance|Pregnancy|0|||
105359866|NCT00490971|363322384|FG002|Maintenance|Pregnancy|1|||
105359867|NCT00490971|363322385|FG003|Maintenance|Pregnancy|0|||
105359868|NCT00490971|363322386|FG004|Maintenance|Pregnancy|0|||
105359869|NCT00490971|363322382|FG000|Maintenance|Protocol Violation|0|||
105359870|NCT00490971|363322383|FG001|Maintenance|Protocol Violation|0|||
105359871|NCT00490971|363322384|FG002|Maintenance|Protocol Violation|4|||
105359872|NCT00490971|363322385|FG003|Maintenance|Protocol Violation|1|||
105359873|NCT00490971|363322386|FG004|Maintenance|Protocol Violation|1|||
105359874|NCT00490971|363322382|FG000|Maintenance|Withdrawal by Subject|0|||
105359875|NCT00490971|363322383|FG001|Maintenance|Withdrawal by Subject|0|||
105359876|NCT00490971|363322384|FG002|Maintenance|Withdrawal by Subject|26|||
105359877|NCT00490971|363322385|FG003|Maintenance|Withdrawal by Subject|28|||
105359878|NCT00490971|363322386|FG004|Maintenance|Withdrawal by Subject|18|||
105359879|NCT00490971|363322382|FG000|Maintenance|Other|0|||
105359880|NCT00490971|363322383|FG001|Maintenance|Other|0|||
105359881|NCT00490971|363322384|FG002|Maintenance|Other|11|||
105359882|NCT00490971|363322385|FG003|Maintenance|Other|9|||
105359883|NCT00490971|363322386|FG004|Maintenance|Other|3|||
105359884|NCT04754542|363322388|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
105359885|NCT04754542|363322389|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
105359886|NCT05259163|363323689|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
105359887|NCT05259163|363323690|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
105359888|NCT05251233|363323693|FG000|Overall Study|Disease progression - did not start treatment|0|||
105359889|NCT05251233|363323694|FG001|Overall Study|Disease progression - did not start treatment|0|||
105359890|NCT05251233|363323695|FG002|Overall Study|Disease progression - did not start treatment|5|||
105359891|NCT05251233|363323693|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
105359892|NCT05251233|363323694|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
105359893|NCT05251233|363323695|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
105359894|NCT05251233|363323693|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
105750232|NCT00608530|364738776|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
105750233|NCT00608530|364738777|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
105750234|NCT00608530|364738778|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
105750235|NCT00608530|364738775|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
105750236|NCT00608530|364738776|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
105750237|NCT00608530|364738777|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
105750238|NCT00608530|364738778|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
105750239|NCT00608530|364738775|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
105750240|NCT00608530|364738776|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
105750241|NCT00608530|364738777|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
105750242|NCT00608530|364738778|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
105750243|NCT01952730|364738779|FG000|Overall Study|FDA shut down core lab used by study|1|||
105750244|NCT01357915|364738783|FG000|Overall Study|Lost to Follow-up|3|||
105750245|NCT01357915|364738784|FG001|Overall Study|Lost to Follow-up|0|||
105750246|NCT00973921|364738789|FG000|Overall Study|IVUS results were not available|9|||
105750247|NCT05086289|364738790|FG000|Overall Study|Adverse Event|4|||
105750248|NCT05086289|364738791|FG001|Overall Study|Adverse Event|2|||
105359895|NCT05251233|363323694|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
105359896|NCT05251233|363323695|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
105565538|NCT02259517|364068598|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
105565539|NCT02259517|364068599|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
105565540|NCT02259517|364068597|FG000|Overall Study|Withdrawal by Subject|0|||
105750249|NCT05086289|364738790|FG000|Overall Study|Lost to Follow-up|2|||
105801612|NCT01830920|364930605|FG001|Overall Study|Withdrawal by Subject|2|||
105801613|NCT01830920|364930606|FG002|Overall Study|Withdrawal by Subject|1|||
105801614|NCT01830920|364930607|FG003|Overall Study|Withdrawal by Subject|7|||
105801615|NCT01830920|364930608|FG004|Overall Study|Withdrawal by Subject|1|||
105801616|NCT01830920|364930604|FG000|Overall Study|Death|3|||
105801617|NCT01830920|364930605|FG001|Overall Study|Death|3|||
105801618|NCT01830920|364930606|FG002|Overall Study|Death|5|||
105801619|NCT01830920|364930607|FG003|Overall Study|Death|4|||
105801620|NCT01830920|364930608|FG004|Overall Study|Death|4|||
105801621|NCT01830920|364930604|FG000|Overall Study|Other|15|||
105801622|NCT01830920|364930605|FG001|Overall Study|Other|1|||
105801623|NCT01830920|364930606|FG002|Overall Study|Other|1|||
105801624|NCT01830920|364930607|FG003|Overall Study|Other|5|||
105801625|NCT01830920|364930608|FG004|Overall Study|Other|3|||
105801626|NCT02217345|364930609|FG000|Overall Study|Lost to Follow-up|2|||
105801627|NCT02217345|364930610|FG001|Overall Study|Lost to Follow-up|1|||
105801628|NCT02217345|364930609|FG000|Overall Study|Withdrawal by Subject|3|||
105801629|NCT02217345|364930610|FG001|Overall Study|Withdrawal by Subject|2|||
105801630|NCT02217345|364930609|FG000|Overall Study|Adverse Event|2|||
105801631|NCT02217345|364930610|FG001|Overall Study|Adverse Event|1|||
105801632|NCT02217345|364930609|FG000|Overall Study|Physician Decision|0|||
105801633|NCT02217345|364930610|FG001|Overall Study|Physician Decision|1|||
105801634|NCT00950599|364930612|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801635|NCT00950599|364930613|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801636|NCT00950599|364930614|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801637|NCT00950599|364930615|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
105750250|NCT05086289|364738791|FG001|Overall Study|Lost to Follow-up|0|||
105750251|NCT05086289|364738790|FG000|Overall Study|Non-compliance with study drug|2|||
105750252|NCT05086289|364738791|FG001|Overall Study|Non-compliance with study drug|1|||
105750253|NCT05086289|364738790|FG000|Overall Study|Physician Decision|2|||
105750254|NCT05086289|364738791|FG001|Overall Study|Physician Decision|0|||
105750255|NCT05086289|364738790|FG000|Overall Study|Withdrawal by Subject|5|||
105750256|NCT05086289|364738791|FG001|Overall Study|Withdrawal by Subject|2|||
105750257|NCT02045212|364738792|FG000|Overall Study|Adverse Event|0|||
105750258|NCT02045212|364738793|FG001|Overall Study|Adverse Event|1|||
105750259|NCT02045212|364738792|FG000|Overall Study|Withdrawal by Subject|1|||
105750260|NCT02045212|364738793|FG001|Overall Study|Withdrawal by Subject|0|||
105750261|NCT02045212|364738792|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
105750262|NCT02045212|364738793|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
105750263|NCT04799405|364738794|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
105750264|NCT01029002|364738795|FG000|Overall Study|Lost to Follow-up|2|||
105750265|NCT01029002|364738796|FG001|Overall Study|Lost to Follow-up|4|||
105750266|NCT00926796|364738797|FG000|Overall Study|Did not receive randomized treatment|4|||
105750267|NCT00926796|364738798|FG001|Overall Study|Did not receive randomized treatment|7|||
105750268|NCT00926796|364738797|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
105750269|NCT00926796|364738798|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
105750270|NCT00926796|364738797|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
105750271|NCT00926796|364738798|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
105750272|NCT00926796|364738797|FG000|Overall Study|Adverse Event|7|||
105750273|NCT00926796|364738798|FG001|Overall Study|Adverse Event|14|||
105750274|NCT00926796|364738797|FG000|Overall Study|Lost to Follow-up|22|||
105750275|NCT00926796|364738798|FG001|Overall Study|Lost to Follow-up|13|||
105750276|NCT00926796|364738797|FG000|Overall Study|Protocol Violation|15|||
105750277|NCT00926796|364738798|FG001|Overall Study|Protocol Violation|11|||
105750278|NCT00926796|364738797|FG000|Overall Study|Withdrawal by Subject|1|||
105750279|NCT00926796|364738798|FG001|Overall Study|Withdrawal by Subject|0|||
105750280|NCT00101192|364738802|FG000|Overall Study|Ineligible|6|||
105750281|NCT00101192|364738802|FG000|Overall Study|Inevaluable|1|||
105750282|NCT02618928|364738805|FG000|Overall Study|Failure to Return|28|||
105760887|NCT01831804|364778037|FG001|Overall Study|Withdrew Consent|1|||
105801638|NCT00950599|364930616|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801639|NCT00950599|364930617|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801640|NCT00950599|364930618|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801641|NCT00950599|364930619|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801642|NCT00950599|364930620|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801643|NCT00950599|364930621|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801644|NCT00950599|364930612|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105801645|NCT00950599|364930613|FG001|Double-Blind Treatment Period|Adverse Event|1|||
105801646|NCT00950599|364930614|FG002|Double-Blind Treatment Period|Adverse Event|1|||
105801647|NCT00950599|364930615|FG003|Double-Blind Treatment Period|Adverse Event|1|||
105801648|NCT00950599|364930616|FG004|Double-Blind Treatment Period|Adverse Event|1|||
105801649|NCT00950599|364930617|FG005|Double-Blind Treatment Period|Adverse Event|1|||
105801650|NCT00950599|364930618|FG006|Double-Blind Treatment Period|Adverse Event|0|||
105801651|NCT00950599|364930619|FG007|Double-Blind Treatment Period|Adverse Event|0|||
105801652|NCT00950599|364930620|FG008|Double-Blind Treatment Period|Adverse Event|0|||
105801653|NCT00950599|364930621|FG009|Double-Blind Treatment Period|Adverse Event|0|||
105801654|NCT00950599|364930612|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
105801655|NCT00950599|364930613|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
105801656|NCT00950599|364930614|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
105801657|NCT00950599|364930615|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
105801658|NCT00950599|364930616|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
105801659|NCT00950599|364930617|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
105801660|NCT00950599|364930618|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
105801661|NCT00950599|364930619|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
105801662|NCT00950599|364930620|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
105801663|NCT00950599|364930621|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
105359897|NCT05251233|363323693|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
105359898|NCT05251233|363323694|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
105801664|NCT00950599|364930612|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105565541|NCT02259517|364068598|FG001|Overall Study|Withdrawal by Subject|0|||
105565542|NCT02259517|364068599|FG002|Overall Study|Withdrawal by Subject|3|||
105565543|NCT01289418|364068602|FG000|Day 8 Survey|email address invalid|283|||
105565544|NCT01289418|364068602|FG000|Day 8 Survey|participants did not complete the survey|1935|||
105565545|NCT01289418|364068602|FG000|Day 29 Survey|email address invalid|283|||
105565546|NCT01289418|364068602|FG000|Day 29 Survey|participants did not complete the survey|2185|||
105359899|NCT05251233|363323695|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
105359900|NCT05251233|363323693|FG000|Overall Study|Death - did not start treatment|3|||
105359901|NCT05251233|363323694|FG001|Overall Study|Death - did not start treatment|0|||
105359902|NCT05251233|363323695|FG002|Overall Study|Death - did not start treatment|0|||
105359903|NCT05251233|363323693|FG000|Overall Study|Withdrawal by Subject|2|||
105359904|NCT05251233|363323694|FG001|Overall Study|Withdrawal by Subject|2|||
105359905|NCT05251233|363323695|FG002|Overall Study|Withdrawal by Subject|0|||
105359906|NCT05251233|363323693|FG000|Overall Study|Other complicating disease|2|||
105359907|NCT05251233|363323694|FG001|Overall Study|Other complicating disease|1|||
105359908|NCT05251233|363323695|FG002|Overall Study|Other complicating disease|0|||
105359909|NCT05251233|363323693|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
105359910|NCT05251233|363323694|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
105359911|NCT05251233|363323695|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
105359912|NCT05251233|363323693|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
105359913|NCT05251233|363323694|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
105359914|NCT05251233|363323695|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
105359915|NCT00669318|363323703|FG000|Overall Study|Withdrawal by Subject|2|||
105359916|NCT00762762|363323704|FG000|Overall Study|Did not return for appointments|6|||
105359917|NCT00762762|363323705|FG001|Overall Study|Did not return for appointments|8|||
105359918|NCT00493012|363323708|FG000|Overall Study|Lost to Follow-up|18|||
105359919|NCT00493012|363323709|FG001|Overall Study|Lost to Follow-up|17|||
105359920|NCT04147247|363323710|FG000|Overall Study|Progressive disease|3|||
105359921|NCT04147247|363323711|FG001|Overall Study|Progressive disease|3|||
105359922|NCT04147247|363323712|FG002|Overall Study|Progressive disease|4|||
105359923|NCT04147247|363323713|FG003|Overall Study|Progressive disease|4|||
105359924|NCT04147247|363323714|FG004|Overall Study|Progressive disease|3|||
105359925|NCT04147247|363323710|FG000|Overall Study|Physician Decision|0|||
105359926|NCT04147247|363323711|FG001|Overall Study|Physician Decision|1|||
105359927|NCT04147247|363323712|FG002|Overall Study|Physician Decision|0|||
105359928|NCT04147247|363323713|FG003|Overall Study|Physician Decision|0|||
105359929|NCT04147247|363323714|FG004|Overall Study|Physician Decision|0|||
105359930|NCT04147247|363323710|FG000|Overall Study|Clinical Disease Progression|0|||
105359931|NCT04147247|363323711|FG001|Overall Study|Clinical Disease Progression|0|||
105359932|NCT04147247|363323712|FG002|Overall Study|Clinical Disease Progression|0|||
105359933|NCT04147247|363323713|FG003|Overall Study|Clinical Disease Progression|0|||
105359934|NCT04147247|363323714|FG004|Overall Study|Clinical Disease Progression|1|||
105359935|NCT04147247|363323710|FG000|Overall Study|Adverse Event|0|||
105359936|NCT04147247|363323711|FG001|Overall Study|Adverse Event|0|||
105359937|NCT04147247|363323712|FG002|Overall Study|Adverse Event|1|||
105359938|NCT04147247|363323713|FG003|Overall Study|Adverse Event|0|||
105359939|NCT04147247|363323714|FG004|Overall Study|Adverse Event|1|||
105359940|NCT00305227|363323719|FG000|Overall Study|Lost to Follow-up|7|||
105359941|NCT00305227|363323720|FG001|Overall Study|Lost to Follow-up|6|||
105359942|NCT01705080|363323721|FG000|Overall Study|Missed visit|10|||
105359943|NCT01705080|363323722|FG001|Overall Study|Missed visit|4|||
105359944|NCT01705080|363323723|FG002|Overall Study|Missed visit|1|||
105359945|NCT01705080|363323721|FG000|Overall Study|Death|4|||
105359946|NCT01705080|363323722|FG001|Overall Study|Death|4|||
105359947|NCT01705080|363323723|FG002|Overall Study|Death|6|||
105359948|NCT01705080|363323721|FG000|Overall Study|Withdrawal by Subject|61|||
105359949|NCT01705080|363323722|FG001|Overall Study|Withdrawal by Subject|44|||
105359950|NCT01705080|363323723|FG002|Overall Study|Withdrawal by Subject|9|||
105359951|NCT00113295|363323725|FG000|Overall Study|Adverse Event|4|||
105359952|NCT00113295|363323726|FG001|Overall Study|Adverse Event|1|||
105359953|NCT00113295|363323725|FG000|Overall Study|Unrelated Medical Illness|1|||
105359954|NCT00113295|363323726|FG001|Overall Study|Unrelated Medical Illness|0|||
105359955|NCT03130959|363323727|FG000|Overall Study|Disease progression|19|||
105359956|NCT03130959|363323728|FG001|Overall Study|Disease progression|7|||
105565547|NCT01061333|364068605|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
105359957|NCT03130959|363323729|FG002|Overall Study|Disease progression|12|||
105359958|NCT03130959|363323730|FG003|Overall Study|Disease progression|7|||
105359959|NCT03130959|363323731|FG004|Overall Study|Disease progression|12|||
105359960|NCT03130959|363323732|FG005|Overall Study|Disease progression|3|||
105359961|NCT03130959|363323733|FG006|Overall Study|Disease progression|6|||
105359962|NCT03130959|363323734|FG007|Overall Study|Disease progression|3|||
105359963|NCT03130959|363323735|FG008|Overall Study|Disease progression|15|||
105359964|NCT03130959|363323736|FG009|Overall Study|Disease progression|8|||
105359965|NCT03130959|363323727|FG000|Overall Study|Study drug toxicity|2|||
105359966|NCT03130959|363323728|FG001|Overall Study|Study drug toxicity|2|||
105359967|NCT03130959|363323729|FG002|Overall Study|Study drug toxicity|1|||
105359968|NCT03130959|363323730|FG003|Overall Study|Study drug toxicity|2|||
105359969|NCT03130959|363323731|FG004|Overall Study|Study drug toxicity|1|||
105359970|NCT03130959|363323732|FG005|Overall Study|Study drug toxicity|1|||
105359971|NCT03130959|363323733|FG006|Overall Study|Study drug toxicity|3|||
105359972|NCT03130959|363323734|FG007|Overall Study|Study drug toxicity|0|||
105359973|NCT03130959|363323735|FG008|Overall Study|Study drug toxicity|3|||
105359974|NCT03130959|363323736|FG009|Overall Study|Study drug toxicity|3|||
105359975|NCT03130959|363323727|FG000|Overall Study|Other reasons|0|||
105359976|NCT03130959|363323728|FG001|Overall Study|Other reasons|0|||
105565548|NCT01061333|364068606|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
105565549|NCT03704584|364068607|FG000|Overall Study|Withdrawal by Subject|1|||
105359977|NCT03130959|363323729|FG002|Overall Study|Other reasons|0|||
105359978|NCT03130959|363323730|FG003|Overall Study|Other reasons|0|||
105359979|NCT03130959|363323731|FG004|Overall Study|Other reasons|0|||
105359980|NCT03130959|363323732|FG005|Overall Study|Other reasons|1|||
105359981|NCT03130959|363323733|FG006|Overall Study|Other reasons|1|||
105565550|NCT03704584|364068608|FG001|Overall Study|Withdrawal by Subject|0|||
105565551|NCT03185832|364068609|FG000|Overall Study|Death|9|||
105565552|NCT03185832|364068610|FG001|Overall Study|Death|14|||
105565553|NCT03185832|364068611|FG002|Overall Study|Death|9|||
105359982|NCT03130959|363323734|FG007|Overall Study|Other reasons|0|||
105359983|NCT03130959|363323735|FG008|Overall Study|Other reasons|0|||
105359984|NCT03130959|363323736|FG009|Overall Study|Other reasons|0|||
105359985|NCT03130959|363323727|FG000|Overall Study|Subject request to discontinue therapy|0|||
105359986|NCT03130959|363323728|FG001|Overall Study|Subject request to discontinue therapy|0|||
105359987|NCT03130959|363323729|FG002|Overall Study|Subject request to discontinue therapy|1|||
105359988|NCT03130959|363323730|FG003|Overall Study|Subject request to discontinue therapy|1|||
105359989|NCT03130959|363323731|FG004|Overall Study|Subject request to discontinue therapy|0|||
105359990|NCT03130959|363323732|FG005|Overall Study|Subject request to discontinue therapy|0|||
105359991|NCT03130959|363323733|FG006|Overall Study|Subject request to discontinue therapy|1|||
105359992|NCT03130959|363323734|FG007|Overall Study|Subject request to discontinue therapy|1|||
105359993|NCT03130959|363323735|FG008|Overall Study|Subject request to discontinue therapy|0|||
105359994|NCT03130959|363323736|FG009|Overall Study|Subject request to discontinue therapy|0|||
105359995|NCT03130959|363323727|FG000|Overall Study|Not reported|0|||
105359996|NCT03130959|363323728|FG001|Overall Study|Not reported|0|||
105359997|NCT03130959|363323729|FG002|Overall Study|Not reported|0|||
105359998|NCT03130959|363323730|FG003|Overall Study|Not reported|1|||
105359999|NCT03130959|363323731|FG004|Overall Study|Not reported|0|||
105360000|NCT03130959|363323732|FG005|Overall Study|Not reported|1|||
105360001|NCT03130959|363323733|FG006|Overall Study|Not reported|0|||
105360002|NCT03130959|363323734|FG007|Overall Study|Not reported|0|||
105360003|NCT03130959|363323735|FG008|Overall Study|Not reported|0|||
105360004|NCT03130959|363323736|FG009|Overall Study|Not reported|1|||
105360005|NCT03130959|363323727|FG000|Overall Study|Adverse Event unrelated to drug|0|||
105360006|NCT03130959|363323728|FG001|Overall Study|Adverse Event unrelated to drug|0|||
105360007|NCT03130959|363323729|FG002|Overall Study|Adverse Event unrelated to drug|1|||
105360008|NCT03130959|363323730|FG003|Overall Study|Adverse Event unrelated to drug|1|||
105360009|NCT03130959|363323731|FG004|Overall Study|Adverse Event unrelated to drug|1|||
105360010|NCT03130959|363323732|FG005|Overall Study|Adverse Event unrelated to drug|0|||
105360011|NCT03130959|363323733|FG006|Overall Study|Adverse Event unrelated to drug|1|||
105360012|NCT03130959|363323734|FG007|Overall Study|Adverse Event unrelated to drug|0|||
105360013|NCT03130959|363323735|FG008|Overall Study|Adverse Event unrelated to drug|1|||
105360014|NCT03130959|363323736|FG009|Overall Study|Adverse Event unrelated to drug|1|||
105360015|NCT03130959|363323727|FG000|Overall Study|Participant withdrew consent|0|||
105360016|NCT03130959|363323728|FG001|Overall Study|Participant withdrew consent|1|||
105360017|NCT03130959|363323729|FG002|Overall Study|Participant withdrew consent|0|||
105360018|NCT03130959|363323730|FG003|Overall Study|Participant withdrew consent|2|||
105360019|NCT03130959|363323731|FG004|Overall Study|Participant withdrew consent|1|||
105360020|NCT03130959|363323732|FG005|Overall Study|Participant withdrew consent|0|||
105360021|NCT03130959|363323733|FG006|Overall Study|Participant withdrew consent|0|||
105360022|NCT03130959|363323734|FG007|Overall Study|Participant withdrew consent|0|||
105360023|NCT03130959|363323735|FG008|Overall Study|Participant withdrew consent|0|||
105360024|NCT03130959|363323736|FG009|Overall Study|Participant withdrew consent|2|||
105360025|NCT03130959|363323727|FG000|Overall Study|Administrative reason by sponsor|1|||
105360026|NCT03130959|363323728|FG001|Overall Study|Administrative reason by sponsor|0|||
105360027|NCT03130959|363323729|FG002|Overall Study|Administrative reason by sponsor|1|||
105360028|NCT03130959|363323730|FG003|Overall Study|Administrative reason by sponsor|0|||
105360029|NCT03130959|363323731|FG004|Overall Study|Administrative reason by sponsor|0|||
105360030|NCT03130959|363323732|FG005|Overall Study|Administrative reason by sponsor|0|||
105360031|NCT03130959|363323733|FG006|Overall Study|Administrative reason by sponsor|0|||
105565554|NCT03185832|364068612|FG003|Overall Study|Death|7|||
105565555|NCT03185832|364068609|FG000|Overall Study|Withdrawn - vital status available|0|||
105565556|NCT03185832|364068610|FG001|Overall Study|Withdrawn - vital status available|1|||
105760888|NCT01831804|364778038|FG002|Overall Study|Withdrew Consent|0|||
105483579|NCT00045942|363782713|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
105483580|NCT00045942|363782714|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
105483581|NCT00045942|363782715|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
105483582|NCT00045942|363782716|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
105483583|NCT00045942|363782717|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
105483584|NCT00045942|363782718|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
105483585|NCT00045942|363782719|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
105801665|NCT00950599|364930613|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
105801666|NCT00950599|364930614|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
105801667|NCT00950599|364930615|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
105801668|NCT00950599|364930616|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
105801669|NCT00950599|364930617|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
105801670|NCT00950599|364930618|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
105801671|NCT00950599|364930619|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
105801672|NCT00950599|364930620|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
105801673|NCT00950599|364930621|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
105801674|NCT00950599|364930612|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
105801675|NCT00950599|364930613|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
105801676|NCT00950599|364930614|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801677|NCT00950599|364930615|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801678|NCT00950599|364930616|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801679|NCT00950599|364930617|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801680|NCT00950599|364930618|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801681|NCT00950599|364930619|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
105801682|NCT00950599|364930620|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801683|NCT00950599|364930621|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801684|NCT00950599|364930612|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
105801685|NCT00950599|364930613|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
105801686|NCT00950599|364930614|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
105360032|NCT03130959|363323734|FG007|Overall Study|Administrative reason by sponsor|0|||
105360033|NCT03130959|363323735|FG008|Overall Study|Administrative reason by sponsor|0|||
105360034|NCT03130959|363323736|FG009|Overall Study|Administrative reason by sponsor|0|||
105360035|NCT03130959|363323727|FG000|Overall Study|Lost to Follow-up|1|||
105360036|NCT03130959|363323728|FG001|Overall Study|Lost to Follow-up|0|||
105360037|NCT03130959|363323729|FG002|Overall Study|Lost to Follow-up|0|||
105360038|NCT03130959|363323730|FG003|Overall Study|Lost to Follow-up|0|||
105360039|NCT03130959|363323731|FG004|Overall Study|Lost to Follow-up|0|||
105360040|NCT03130959|363323732|FG005|Overall Study|Lost to Follow-up|0|||
105360041|NCT03130959|363323733|FG006|Overall Study|Lost to Follow-up|0|||
105750283|NCT02618928|364738805|FG000|Overall Study|Insufficient Virological Response|1|||
105750284|NCT02618928|364738805|FG000|Overall Study|Withdrawal by Subject|2|||
105750285|NCT02618928|364738805|FG000|Overall Study|Death|3|||
105360042|NCT03130959|363323734|FG007|Overall Study|Lost to Follow-up|0|||
105360043|NCT03130959|363323735|FG008|Overall Study|Lost to Follow-up|0|||
105360044|NCT03130959|363323736|FG009|Overall Study|Lost to Follow-up|0|||
105360045|NCT00577772|363323737|FG000|Overall Study|Lost to Follow-up|0|||
105360046|NCT00577772|363323738|FG001|Overall Study|Lost to Follow-up|1|||
105360047|NCT02824224|363323739|FG000|Overall Study|Discontinued, IUS expulsion|0|||
105360048|NCT02824224|363323740|FG001|Overall Study|Discontinued, IUS expulsion|1|||
105360049|NCT02824224|363323739|FG000|Overall Study|Did not show up for allocation visit|2|||
105360050|NCT02824224|363323740|FG001|Overall Study|Did not show up for allocation visit|0|||
105360051|NCT00856999|363323743|FG000|Overall Study|Withdrawal by Subject|5|||
105360052|NCT04131712|363323748|FG000|Overall Study|COVID related|0|||
105360053|NCT04131712|363323749|FG001|Overall Study|COVID related|0|||
105360054|NCT04131712|363323750|FG002|Overall Study|COVID related|2|||
105360055|NCT04131712|363323751|FG003|Overall Study|COVID related|0|||
105360056|NCT04131712|363323748|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
105360057|NCT04131712|363323749|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
105360058|NCT04131712|363323750|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
105750286|NCT02618928|364738805|FG000|Overall Study|Other|11|||
105750287|NCT02618928|364738805|FG000|Overall Study|Missing|6|||
105750288|NCT02618928|364738805|FG000|Overall Study|Treatment Never Started|7|||
105750289|NCT00264849|364738812|FG000|Overall Study|Adverse Event|7|||
105750290|NCT00264849|364738813|FG001|Overall Study|Adverse Event|2|||
105750291|NCT00264849|364738812|FG000|Overall Study|Withdrawal by Subject|7|||
105750292|NCT00264849|364738813|FG001|Overall Study|Withdrawal by Subject|11|||
105801687|NCT00950599|364930615|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
105360059|NCT04131712|363323751|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
105360060|NCT02299388|363323752|FG000|Overall Study|Withdrawal by Subject|0|||
105750293|NCT00264849|364738812|FG000|Overall Study|Protocol Violation|5|||
105750294|NCT00264849|364738813|FG001|Overall Study|Protocol Violation|3|||
105750295|NCT00264849|364738812|FG000|Overall Study|Lack of Efficacy|1|||
105750296|NCT00264849|364738813|FG001|Overall Study|Lack of Efficacy|6|||
105750297|NCT00264849|364738812|FG000|Overall Study|Lost to Follow-up|0|||
105750298|NCT00264849|364738813|FG001|Overall Study|Lost to Follow-up|2|||
105750299|NCT00264849|364738812|FG000|Overall Study|Death|0|||
105750300|NCT00264849|364738813|FG001|Overall Study|Death|1|||
105750301|NCT00264849|364738812|FG000|Overall Study|Administrative Problems|2|||
105750302|NCT00264849|364738813|FG001|Overall Study|Administrative Problems|0|||
105750303|NCT00099359|364738814|FG000|Overall Study|Death|11|||
105750304|NCT00099359|364738815|FG001|Overall Study|Death|15|||
105750305|NCT00099359|364738816|FG002|Overall Study|Death|17|||
105750306|NCT00099359|364738814|FG000|Overall Study|Withdrawal by Subject|19|||
105750307|NCT00099359|364738815|FG001|Overall Study|Withdrawal by Subject|19|||
105750308|NCT00099359|364738816|FG002|Overall Study|Withdrawal by Subject|23|||
105750309|NCT00099359|364738814|FG000|Overall Study|Lost to Follow-up|15|||
105750310|NCT00099359|364738815|FG001|Overall Study|Lost to Follow-up|24|||
105750311|NCT00099359|364738816|FG002|Overall Study|Lost to Follow-up|24|||
105750312|NCT00099359|364738814|FG000|Overall Study|moved out of area|9|||
105750313|NCT00099359|364738815|FG001|Overall Study|moved out of area|7|||
105750314|NCT00099359|364738816|FG002|Overall Study|moved out of area|4|||
105750315|NCT01982773|364738817|FG000|Overall Study|Withdrawal by Subject|1|||
105565557|NCT03185832|364068611|FG002|Overall Study|Withdrawn - vital status available|1|||
105750316|NCT01982773|364738818|FG001|Overall Study|Withdrawal by Subject|3|||
105750317|NCT01982773|364738817|FG000|Overall Study|Lost to Follow-up|7|||
105750318|NCT01982773|364738818|FG001|Overall Study|Lost to Follow-up|1|||
105360061|NCT02299388|363323753|FG001|Overall Study|Withdrawal by Subject|1|||
105360062|NCT00103662|363323754|FG000|Overall Study|Entered Rescue Procedure|0|||
105360063|NCT00103662|363323755|FG001|Overall Study|Entered Rescue Procedure|7|||
105360064|NCT00103662|363323754|FG000|Overall Study|Death|7|||
105360065|NCT00103662|363323755|FG001|Overall Study|Death|7|||
105360066|NCT00103662|363323754|FG000|Overall Study|Elective Withdrawal|5|||
105360067|NCT00103662|363323755|FG001|Overall Study|Elective Withdrawal|5|||
105360068|NCT00103662|363323754|FG000|Overall Study|Lost to Follow-up|0|||
105360069|NCT00103662|363323755|FG001|Overall Study|Lost to Follow-up|1|||
105360070|NCT00103662|363323754|FG000|Overall Study|Other|6|||
105360071|NCT00103662|363323755|FG001|Overall Study|Other|9|||
105360072|NCT00103662|363323754|FG000|Overall Study|Failed mobilization|0|||
105360073|NCT00103662|363323755|FG001|Overall Study|Failed mobilization|4|||
105360074|NCT00103662|363323754|FG000|Overall Study|Intercurrent illness|1|||
105360075|NCT00103662|363323755|FG001|Overall Study|Intercurrent illness|0|||
105360076|NCT03334188|363323756|FG000|Overall Study|Withdrawal by Subject|0|||
105360077|NCT03334188|363323757|FG001|Overall Study|Withdrawal by Subject|1|||
105360078|NCT03334188|363323756|FG000|Overall Study|Death|1|||
105360079|NCT03334188|363323757|FG001|Overall Study|Death|0|||
105360080|NCT03334188|363323756|FG000|Overall Study|Never had qualifying clinic visit|7|||
105360081|NCT03334188|363323757|FG001|Overall Study|Never had qualifying clinic visit|7|||
105360082|NCT03373760|363323758|FG000|Overall Study|Adverse Event|8|||
105360083|NCT03373760|363323758|FG000|Overall Study|Disease Progression|46|||
105360084|NCT03373760|363323758|FG000|Overall Study|Death|4|||
105360085|NCT01869777|363323765|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
105360086|NCT00613366|363323768|FG000|Overall Study|Withdrawal by Subject|3|||
105360087|NCT00613366|363323769|FG001|Overall Study|Withdrawal by Subject|2|||
105360088|NCT00130689|363323770|FG000|Overall Study|Progressive Disease|29|||
105360089|NCT00130689|363323770|FG000|Overall Study|Death|1|||
105360090|NCT00130689|363323770|FG000|Overall Study|Clinical Deterioration|4|||
105360091|NCT00130689|363323770|FG000|Overall Study|Withdrawal by Subject|3|||
105360092|NCT00130689|363323770|FG000|Overall Study|Ineligible|6|||
105750319|NCT02509494|364738819|FG000|Overall Study|Lost to Follow-up|8|||
105750320|NCT02509494|364738820|FG001|Overall Study|Lost to Follow-up|47|||
105360093|NCT00766597|363323771|FG000|Overall Study|Unexpected closure of study|4|||
105750321|NCT02509494|364738821|FG002|Overall Study|Lost to Follow-up|19|||
105360094|NCT00766597|363323771|FG000|Overall Study|Without CCR5-tropic virus|5|||
105360095|NCT00878800|363323780|FG000|Overall Study|Adverse Event|0|||
105360096|NCT00878800|363323781|FG001|Overall Study|Adverse Event|0|||
105360097|NCT00878800|363323782|FG002|Overall Study|Adverse Event|2|||
105360098|NCT00878800|363323783|FG003|Overall Study|Adverse Event|0|||
105360099|NCT00878800|363323784|FG004|Overall Study|Adverse Event|1|||
105360100|NCT00878800|363323780|FG000|Overall Study|Progressive disease|1|||
105750322|NCT02509494|364738822|FG003|Overall Study|Lost to Follow-up|6|||
105750323|NCT02509494|364738823|FG004|Overall Study|Lost to Follow-up|3|||
105750324|NCT02509494|364738824|FG005|Overall Study|Lost to Follow-up|3|||
105750325|NCT02509494|364738825|FG006|Overall Study|Lost to Follow-up|1|||
105750326|NCT02509494|364738826|FG007|Overall Study|Lost to Follow-up|3|||
105750327|NCT02509494|364738827|FG008|Overall Study|Lost to Follow-up|1|||
105750328|NCT02509494|364738819|FG000|Overall Study|Physician Decision|2|||
105750329|NCT02509494|364738820|FG001|Overall Study|Physician Decision|1|||
105360101|NCT00878800|363323781|FG001|Overall Study|Progressive disease|5|||
105360102|NCT00878800|363323782|FG002|Overall Study|Progressive disease|6|||
105360103|NCT00878800|363323783|FG003|Overall Study|Progressive disease|5|||
105750330|NCT02509494|364738821|FG002|Overall Study|Physician Decision|0|||
105750331|NCT02509494|364738822|FG003|Overall Study|Physician Decision|0|||
105750332|NCT02509494|364738823|FG004|Overall Study|Physician Decision|0|||
105750333|NCT02509494|364738824|FG005|Overall Study|Physician Decision|0|||
105750334|NCT02509494|364738825|FG006|Overall Study|Physician Decision|0|||
105750335|NCT02509494|364738826|FG007|Overall Study|Physician Decision|0|||
105750336|NCT02509494|364738827|FG008|Overall Study|Physician Decision|0|||
105750337|NCT02509494|364738819|FG000|Overall Study|Withdrawal by Subject|4|||
105750338|NCT02509494|364738820|FG001|Overall Study|Withdrawal by Subject|17|||
105750339|NCT02509494|364738821|FG002|Overall Study|Withdrawal by Subject|7|||
105750340|NCT02509494|364738822|FG003|Overall Study|Withdrawal by Subject|5|||
105750341|NCT02509494|364738823|FG004|Overall Study|Withdrawal by Subject|0|||
105750342|NCT02509494|364738824|FG005|Overall Study|Withdrawal by Subject|6|||
105750343|NCT02509494|364738825|FG006|Overall Study|Withdrawal by Subject|1|||
105750344|NCT02509494|364738826|FG007|Overall Study|Withdrawal by Subject|2|||
105750345|NCT02509494|364738827|FG008|Overall Study|Withdrawal by Subject|1|||
105750346|NCT02509494|364738819|FG000|Overall Study|Death|0|||
105750347|NCT02509494|364738820|FG001|Overall Study|Death|1|||
105750348|NCT02509494|364738821|FG002|Overall Study|Death|0|||
105750349|NCT02509494|364738822|FG003|Overall Study|Death|0|||
105750350|NCT02509494|364738823|FG004|Overall Study|Death|1|||
105750351|NCT02509494|364738824|FG005|Overall Study|Death|0|||
105750352|NCT02509494|364738825|FG006|Overall Study|Death|0|||
105750353|NCT02509494|364738826|FG007|Overall Study|Death|1|||
105750354|NCT02509494|364738827|FG008|Overall Study|Death|0|||
105801688|NCT00950599|364930616|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
105360104|NCT00878800|363323784|FG004|Overall Study|Progressive disease|13|||
105360105|NCT00878800|363323780|FG000|Overall Study|Withdrew consent|1|||
105360106|NCT00878800|363323781|FG001|Overall Study|Withdrew consent|1|||
105360107|NCT00878800|363323782|FG002|Overall Study|Withdrew consent|0|||
105360108|NCT00878800|363323783|FG003|Overall Study|Withdrew consent|1|||
105360109|NCT00878800|363323784|FG004|Overall Study|Withdrew consent|1|||
105360110|NCT00878800|363323780|FG000|Overall Study|Death|0|||
105360111|NCT00878800|363323781|FG001|Overall Study|Death|0|||
105360112|NCT00878800|363323782|FG002|Overall Study|Death|1|||
105360113|NCT00878800|363323783|FG003|Overall Study|Death|0|||
105360114|NCT00878800|363323784|FG004|Overall Study|Death|0|||
105360115|NCT00878800|363323780|FG000|Overall Study|Other|1|||
105360116|NCT00878800|363323781|FG001|Overall Study|Other|1|||
105360117|NCT00878800|363323782|FG002|Overall Study|Other|0|||
105360118|NCT00878800|363323783|FG003|Overall Study|Other|0|||
105360119|NCT00878800|363323784|FG004|Overall Study|Other|1|||
105360120|NCT03318003|363323785|FG000|Overall Study|Withdrawal by Subject|1|||
105750355|NCT02509494|364738819|FG000|Overall Study|Other|0|||
105750356|NCT02509494|364738820|FG001|Overall Study|Other|4|||
105360121|NCT03318003|363323786|FG001|Overall Study|Withdrawal by Subject|1|||
105750357|NCT02509494|364738821|FG002|Overall Study|Other|5|||
105750358|NCT02509494|364738822|FG003|Overall Study|Other|0|||
105750359|NCT02509494|364738823|FG004|Overall Study|Other|0|||
105750360|NCT02509494|364738824|FG005|Overall Study|Other|0|||
105750361|NCT02509494|364738825|FG006|Overall Study|Other|0|||
105750362|NCT02509494|364738826|FG007|Overall Study|Other|0|||
105750363|NCT02509494|364738827|FG008|Overall Study|Other|0|||
105750364|NCT02509494|364738819|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105750365|NCT02509494|364738820|FG001|Overall Study|Non-Compliance With Study Drug|11|||
105360122|NCT03318003|363323785|FG000|Overall Study|fetal loss|0|||
105360123|NCT03318003|363323786|FG001|Overall Study|fetal loss|1|||
105360124|NCT00715299|363323787|FG000|Overall Study|Withdrawal by Subject|1|||
105360125|NCT00715299|363323787|FG000|Overall Study|Adverse Event|3|||
105360126|NCT00715299|363323787|FG000|Overall Study|failed the pre-screen exercise test|2|||
105360127|NCT01711983|363323788|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
105360128|NCT01711983|363323788|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
105360129|NCT01711983|363323788|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
105750366|NCT02509494|364738821|FG002|Overall Study|Non-Compliance With Study Drug|7|||
105750367|NCT02509494|364738822|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105750368|NCT02509494|364738823|FG004|Overall Study|Non-Compliance With Study Drug|1|||
105750369|NCT02509494|364738824|FG005|Overall Study|Non-Compliance With Study Drug|2|||
105750370|NCT02509494|364738825|FG006|Overall Study|Non-Compliance With Study Drug|1|||
105750371|NCT02509494|364738826|FG007|Overall Study|Non-Compliance With Study Drug|1|||
105750372|NCT02509494|364738827|FG008|Overall Study|Non-Compliance With Study Drug|0|||
105750373|NCT02104804|364738828|FG000|Overall Study|Did not take study medication|0|||
105750374|NCT02104804|364738829|FG001|Overall Study|Did not take study medication|1|||
105750375|NCT02104804|364738828|FG000|Overall Study|Study specific discontinuation criteria|6|||
105750376|NCT02104804|364738829|FG001|Overall Study|Study specific discontinuation criteria|1|||
105750377|NCT02104804|364738828|FG000|Overall Study|Other listed|2|||
105750378|NCT02104804|364738829|FG001|Overall Study|Other listed|1|||
105750379|NCT02104804|364738828|FG000|Overall Study|Protocol Violation|0|||
105750380|NCT02104804|364738829|FG001|Overall Study|Protocol Violation|1|||
105750381|NCT02104804|364738828|FG000|Overall Study|Adverse Event|4|||
105750382|NCT02104804|364738829|FG001|Overall Study|Adverse Event|3|||
105750383|NCT02104804|364738828|FG000|Overall Study|Withdrawal by Subject|4|||
105750384|NCT02104804|364738829|FG001|Overall Study|Withdrawal by Subject|12|||
105750385|NCT05319080|364738831|FG000|Overall Study|Withdrawal by Subject|2|||
105750386|NCT05319080|364738831|FG000|Overall Study|Physician Decision|4|||
105750387|NCT00751114|364738832|FG000|Overall Study|Adverse Event|2|||
105750388|NCT00751114|364738833|FG001|Overall Study|Adverse Event|4|||
105750389|NCT00751114|364738832|FG000|Overall Study|Protocol Violation|8|||
105750390|NCT00751114|364738833|FG001|Overall Study|Protocol Violation|9|||
105750391|NCT00751114|364738832|FG000|Overall Study|Withdrawal by Subject|9|||
105565558|NCT03185832|364068612|FG003|Overall Study|Withdrawn - vital status available|4|||
105750392|NCT00751114|364738833|FG001|Overall Study|Withdrawal by Subject|4|||
105750393|NCT00751114|364738832|FG000|Overall Study|Lost to Follow-up|4|||
105750394|NCT00751114|364738833|FG001|Overall Study|Lost to Follow-up|7|||
105750395|NCT00751114|364738832|FG000|Overall Study|Lack of Efficacy|0|||
105750396|NCT00751114|364738833|FG001|Overall Study|Lack of Efficacy|7|||
105750397|NCT00751114|364738832|FG000|Overall Study|Not Treated|13|||
105750398|NCT00751114|364738833|FG001|Overall Study|Not Treated|1|||
105750399|NCT00751114|364738832|FG000|Overall Study|Out of country for 2 months|1|||
105360130|NCT01711983|363323788|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
105360131|NCT00735943|363323793|FG000|Overall Study|Lost to Follow-up|1|||
105360132|NCT00735943|363323793|FG000|Overall Study|Adverse Event|1|||
105360133|NCT00447772|363323799|FG000|Overall Study|Lack of Efficacy|3|||
105360134|NCT00447772|363323799|FG000|Overall Study|Insufficient compliance|6|||
105360135|NCT00447772|363323799|FG000|Overall Study|Discontinuation of drug therapy|1|||
105750400|NCT00751114|364738833|FG001|Overall Study|Out of country for 2 months|0|||
105750401|NCT00751114|364738832|FG000|Overall Study|Move to another city|1|||
105750402|NCT00751114|364738833|FG001|Overall Study|Move to another city|0|||
105750403|NCT02358369|364738838|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
105750404|NCT02358369|364738839|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
105750405|NCT02358369|364738840|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
105750406|NCT02358369|364738841|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
105750407|NCT02358369|364738842|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
105750408|NCT02358369|364738838|FG000|Treatment Period A/B|Adverse Event|0|||
105750409|NCT02358369|364738839|FG001|Treatment Period A/B|Adverse Event|0|||
105360136|NCT00447772|363323799|FG000|Overall Study|Lost to Follow-up|9|||
105360137|NCT00447772|363323799|FG000|Overall Study|Withdrawal by Subject|1|||
105360138|NCT00447772|363323799|FG000|Overall Study|Unable to attend all study visits|2|||
105360139|NCT00447772|363323799|FG000|Overall Study|Adverse Event|1|||
105750410|NCT02358369|364738840|FG002|Treatment Period A/B|Adverse Event|1|||
105750411|NCT02358369|364738841|FG003|Treatment Period A/B|Adverse Event|2|||
105750412|NCT02358369|364738842|FG004|Treatment Period A/B|Adverse Event|0|||
105750413|NCT02358369|364738838|FG000|Treatment Period A/B|Death|0|||
105750414|NCT02358369|364738839|FG001|Treatment Period A/B|Death|0|||
105750415|NCT02358369|364738840|FG002|Treatment Period A/B|Death|1|||
105750416|NCT02358369|364738841|FG003|Treatment Period A/B|Death|0|||
105750417|NCT02358369|364738842|FG004|Treatment Period A/B|Death|0|||
105750418|NCT02358369|364738838|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
105750419|NCT02358369|364738839|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
105750420|NCT02358369|364738840|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
105750421|NCT02358369|364738841|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
105750422|NCT02358369|364738842|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
105750423|NCT02358369|364738838|FG000|Treatment Period C|Adverse Event|0|||
105750424|NCT02358369|364738839|FG001|Treatment Period C|Adverse Event|0|||
105750425|NCT02358369|364738840|FG002|Treatment Period C|Adverse Event|0|||
105750426|NCT02358369|364738841|FG003|Treatment Period C|Adverse Event|0|||
105750427|NCT02358369|364738842|FG004|Treatment Period C|Adverse Event|7|||
105750428|NCT04465396|364738843|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
105750429|NCT04465396|364738844|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
105750430|NCT04465396|364738845|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
105750431|NCT04465396|364738846|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
105750432|NCT03095521|364738850|FG000|Overall Study|Withdrawal by Subject|0|||
105750433|NCT03095521|364738851|FG001|Overall Study|Withdrawal by Subject|1|||
105750434|NCT03095521|364738850|FG000|Overall Study|Lost to Follow-up|0|||
105750435|NCT03095521|364738851|FG001|Overall Study|Lost to Follow-up|1|||
105750436|NCT03076190|364738852|FG000|Overall Study|Lost to Follow-up|9|||
105750437|NCT03076190|364738853|FG001|Overall Study|Lost to Follow-up|34|||
105750438|NCT03076190|364738852|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
105750439|NCT03076190|364738853|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
105750440|NCT03259490|364738854|FG000|Period 1|Withdrawal by Subject|0|||
105750441|NCT03259490|364738855|FG001|Period 1|Withdrawal by Subject|1|||
105750442|NCT03259490|364738854|FG000|Period 2|Protocol Violation|1|||
105750443|NCT03259490|364738855|FG001|Period 2|Protocol Violation|0|||
105750444|NCT00434122|364738856|FG000|Overall Study|Non-compliance with protocol|0|||
105750445|NCT00434122|364738857|FG001|Overall Study|Non-compliance with protocol|1|||
105750446|NCT00434122|364738856|FG000|Overall Study|loss of subject contact|1|||
105750447|NCT00434122|364738857|FG001|Overall Study|loss of subject contact|1|||
105750448|NCT00434122|364738856|FG000|Overall Study|Personal reasons|1|||
105750449|NCT00434122|364738857|FG001|Overall Study|Personal reasons|1|||
105750450|NCT00434122|364738856|FG000|Overall Study|Large follicle size|2|||
105750451|NCT00434122|364738857|FG001|Overall Study|Large follicle size|2|||
105750452|NCT00434122|364738856|FG000|Overall Study|Low follicular response.|1|||
105750453|NCT00434122|364738857|FG001|Overall Study|Low follicular response.|2|||
105750454|NCT00434122|364738856|FG000|Overall Study|Travelling of subject.|1|||
105750455|NCT00434122|364738857|FG001|Overall Study|Travelling of subject.|0|||
105750456|NCT01963208|364738858|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
105750457|NCT01963208|364738859|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
105750458|NCT01963208|364738860|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
105750459|NCT01963208|364738861|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
105750460|NCT01963208|364738862|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
105360140|NCT00447772|363323799|FG000|Overall Study|Patient relocated|1|||
105750461|NCT01963208|364738863|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
105565559|NCT01083641|364068614|FG000|Overall Study|Withdrawal by Subject|2|||
105565560|NCT03439189|364068615|FG000|Overall Study|Protocol Violation|19|||
105565561|NCT03439189|364068615|FG000|Overall Study|Lack of Efficacy|63|||
105565562|NCT01777321|364068616|FG000|Overall Study|Withdrawal by Subject|0|||
105360141|NCT00447772|363323799|FG000|Overall Study|Incomplete documentation at visit 1|1|||
105360142|NCT00447772|363323799|FG000|Overall Study|Chemotherapy for lung cancer|1|||
105565563|NCT01777321|364068617|FG001|Overall Study|Withdrawal by Subject|1|||
105565564|NCT03386032|364068618|FG000|Overall Study|Lack of Efficacy|6|||
105565565|NCT03386032|364068619|FG001|Overall Study|Lack of Efficacy|2|||
105565566|NCT03386032|364068620|FG002|Overall Study|Lack of Efficacy|0|||
105565567|NCT03386032|364068618|FG000|Overall Study|Adverse Event|2|||
105565568|NCT03386032|364068619|FG001|Overall Study|Adverse Event|2|||
105750462|NCT01963208|364738858|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
105750463|NCT01963208|364738859|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
105750464|NCT01963208|364738860|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
105750465|NCT01963208|364738861|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
105750466|NCT01963208|364738862|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
105750467|NCT01963208|364738863|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
105750468|NCT01963208|364738858|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
105750469|NCT01963208|364738859|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
105750470|NCT01963208|364738860|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
105750471|NCT01963208|364738861|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
105360143|NCT00447772|363323799|FG000|Overall Study|Premature re-injection required|1|||
105360144|NCT01896193|363323800|FG000|Overall Study|Lack of Efficacy|20|||
105360145|NCT01896193|363323801|FG001|Overall Study|Lack of Efficacy|11|||
105360146|NCT01896193|363323800|FG000|Overall Study|Protocol Violation|0|||
105360147|NCT01896193|363323801|FG001|Overall Study|Protocol Violation|1|||
105360148|NCT01896193|363323800|FG000|Overall Study|Withdrew Consent|1|||
105360149|NCT01896193|363323801|FG001|Overall Study|Withdrew Consent|0|||
105360150|NCT02849743|363323802|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
105360151|NCT02849743|363323803|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
105360152|NCT02849743|363323802|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
105360153|NCT02849743|363323803|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
105360154|NCT03874013|363323804|FG000|Overall Study|Adverse Event|0|||
105360155|NCT03874013|363323805|FG001|Overall Study|Adverse Event|1|||
105360156|NCT01096160|363323806|FG000|Overall Study|Adverse Event|0|||
105360157|NCT01096160|363323807|FG001|Overall Study|Adverse Event|0|||
105360158|NCT01096160|363323808|FG002|Overall Study|Adverse Event|1|||
105360159|NCT01096160|363323809|FG003|Overall Study|Adverse Event|0|||
105360160|NCT01096160|363323810|FG004|Overall Study|Adverse Event|0|||
105360161|NCT01096160|363323811|FG005|Overall Study|Adverse Event|0|||
105360162|NCT01096160|363323812|FG006|Overall Study|Adverse Event|0|||
105360163|NCT01096160|363323813|FG007|Overall Study|Adverse Event|0|||
105360164|NCT01096160|363323814|FG008|Overall Study|Adverse Event|0|||
105360165|NCT01096160|363323815|FG009|Overall Study|Adverse Event|1|||
105360166|NCT01096160|363323806|FG000|Overall Study|Met stopping criteria per protocol|0|||
105360167|NCT01096160|363323807|FG001|Overall Study|Met stopping criteria per protocol|0|||
105360168|NCT01096160|363323808|FG002|Overall Study|Met stopping criteria per protocol|0|||
105360169|NCT01096160|363323809|FG003|Overall Study|Met stopping criteria per protocol|0|||
105360170|NCT01096160|363323810|FG004|Overall Study|Met stopping criteria per protocol|1|||
105360171|NCT01096160|363323811|FG005|Overall Study|Met stopping criteria per protocol|0|||
105360172|NCT01096160|363323812|FG006|Overall Study|Met stopping criteria per protocol|2|||
105360173|NCT01096160|363323813|FG007|Overall Study|Met stopping criteria per protocol|0|||
105360174|NCT01096160|363323814|FG008|Overall Study|Met stopping criteria per protocol|2|||
105360175|NCT01096160|363323815|FG009|Overall Study|Met stopping criteria per protocol|0|||
105360176|NCT00705757|363323816|FG000|Overall Study|Lack of Efficacy|5|||
105360177|NCT00705757|363323817|FG001|Overall Study|Lack of Efficacy|1|||
105565569|NCT03386032|364068620|FG002|Overall Study|Adverse Event|0|||
105565570|NCT03386032|364068618|FG000|Overall Study|Withdrawal by Subject|1|||
105360178|NCT00705757|363323818|FG002|Overall Study|Lack of Efficacy|3|||
105360179|NCT00705757|363323816|FG000|Overall Study|Lost to Follow-up|7|||
105360180|NCT00705757|363323817|FG001|Overall Study|Lost to Follow-up|6|||
105360181|NCT00705757|363323818|FG002|Overall Study|Lost to Follow-up|6|||
105360182|NCT00705757|363323816|FG000|Overall Study|Withdrawal by Subject|1|||
105565571|NCT03386032|364068619|FG001|Overall Study|Withdrawal by Subject|0|||
105565572|NCT03386032|364068620|FG002|Overall Study|Withdrawal by Subject|0|||
105750472|NCT01963208|364738862|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
105750473|NCT01963208|364738863|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
105750474|NCT01963208|364738858|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
105750475|NCT01963208|364738859|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
105750476|NCT01963208|364738860|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
105750477|NCT01963208|364738861|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
105750478|NCT01963208|364738862|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
105750479|NCT01963208|364738863|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
105750480|NCT01963208|364738858|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
105750481|NCT01963208|364738859|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
105750482|NCT01963208|364738860|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
105750483|NCT01963208|364738861|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
105760889|NCT01831804|364778039|FG003|Overall Study|Withdrew Consent|0|||
105360183|NCT00705757|363323817|FG001|Overall Study|Withdrawal by Subject|1|||
105360184|NCT00705757|363323818|FG002|Overall Study|Withdrawal by Subject|2|||
105360185|NCT01300247|363323819|FG000|Overall Study|Death|1|||
105360186|NCT01300247|363323820|FG001|Overall Study|Death|1|||
105360187|NCT01300247|363323819|FG000|Overall Study|Lost to Follow-up|2|||
105360188|NCT01300247|363323820|FG001|Overall Study|Lost to Follow-up|0|||
105360189|NCT01300247|363323819|FG000|Overall Study|Withdrawal by Subject|1|||
105360190|NCT01300247|363323820|FG001|Overall Study|Withdrawal by Subject|0|||
105360191|NCT01300247|363323819|FG000|Overall Study|Non-Compliance|0|||
105360192|NCT01300247|363323820|FG001|Overall Study|Non-Compliance|1|||
105360193|NCT00673257|363323823|FG000|Overall Study|Withdrawal by Subject|4|||
105360194|NCT00673257|363323823|FG000|Overall Study|Unable to obtain specimen|1|||
105360195|NCT05415462|363323827|FG000|Overall Study|Death|18|||
105360196|NCT05415462|363323828|FG001|Overall Study|Death|10|||
105360197|NCT05415462|363323827|FG000|Overall Study|Lost to Follow-up|72|||
105360198|NCT05415462|363323828|FG001|Overall Study|Lost to Follow-up|64|||
105360199|NCT05415462|363323827|FG000|Overall Study|Physician Decision|5|||
105360200|NCT05415462|363323828|FG001|Overall Study|Physician Decision|5|||
105360201|NCT05415462|363323827|FG000|Overall Study|Protocol Deviation|1|||
105360202|NCT05415462|363323828|FG001|Overall Study|Protocol Deviation|0|||
105360203|NCT05415462|363323827|FG000|Overall Study|Withdrawal by Subject|129|||
105360204|NCT05415462|363323828|FG001|Overall Study|Withdrawal by Subject|101|||
105360205|NCT05415462|363323827|FG000|Overall Study|Other Than Specified|8|||
105360206|NCT05415462|363323828|FG001|Overall Study|Other Than Specified|8|||
105360207|NCT00753675|363323829|FG000|Overall Study|other reason|11|||
105360208|NCT00753675|363323830|FG001|Overall Study|other reason|12|||
105360209|NCT00753675|363323831|FG002|Overall Study|other reason|13|||
105360210|NCT00753675|363323829|FG000|Overall Study|Death|1|||
105360211|NCT00753675|363323830|FG001|Overall Study|Death|2|||
105360212|NCT00753675|363323831|FG002|Overall Study|Death|4|||
105360213|NCT00753675|363323829|FG000|Overall Study|Adverse Event|11|||
105360214|NCT00753675|363323830|FG001|Overall Study|Adverse Event|9|||
105360215|NCT00753675|363323831|FG002|Overall Study|Adverse Event|4|||
105360216|NCT00753675|363323829|FG000|Overall Study|Objective progression of disease|35|||
105360217|NCT00753675|363323830|FG001|Overall Study|Objective progression of disease|35|||
105360218|NCT00753675|363323831|FG002|Overall Study|Objective progression of disease|35|||
105360219|NCT00753675|363323829|FG000|Overall Study|Withdrawal by Subject|0|||
105360220|NCT00753675|363323830|FG001|Overall Study|Withdrawal by Subject|1|||
105360221|NCT00753675|363323831|FG002|Overall Study|Withdrawal by Subject|0|||
105360222|NCT00753675|363323829|FG000|Overall Study|Lost to Follow-up|1|||
105360223|NCT00753675|363323830|FG001|Overall Study|Lost to Follow-up|0|||
105360224|NCT00753675|363323831|FG002|Overall Study|Lost to Follow-up|0|||
105565573|NCT03386032|364068618|FG000|Overall Study|Lost to Follow-up|9|||
105565574|NCT03386032|364068619|FG001|Overall Study|Lost to Follow-up|3|||
105565575|NCT03386032|364068620|FG002|Overall Study|Lost to Follow-up|0|||
105760890|NCT01831804|364778040|FG004|Overall Study|Withdrew Consent|0|||
105750484|NCT01963208|364738862|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
105750485|NCT01963208|364738863|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
105750486|NCT01963208|364738858|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
105750487|NCT01963208|364738859|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
105750488|NCT01963208|364738860|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
105750489|NCT01963208|364738861|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
105750490|NCT01963208|364738862|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
105750491|NCT01963208|364738863|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
105750492|NCT01963208|364738858|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
105750493|NCT01963208|364738859|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
105750494|NCT01963208|364738860|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
105750495|NCT01963208|364738861|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
105750496|NCT01963208|364738862|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
105750497|NCT01963208|364738863|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
105750498|NCT01963208|364738858|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
105750499|NCT01963208|364738859|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
105750500|NCT01963208|364738860|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
105750501|NCT01963208|364738861|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
105750502|NCT01963208|364738862|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
105750503|NCT01963208|364738863|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
105750504|NCT01963208|364738858|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
105565576|NCT03122119|364068627|FG000|Overall Study|Did not meet eligibility critria|1|||
105565577|NCT04425902|364068628|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
105565578|NCT00790452|364068644|FG000|Overall Study|Drug supply issue|1|||
105565579|NCT00790452|364068645|FG001|Overall Study|Drug supply issue|0|||
105565580|NCT00742079|364068646|FG000|Overall Study|Lost to Follow-up|0|||
105565581|NCT00742079|364068647|FG001|Overall Study|Lost to Follow-up|1|||
105565582|NCT03518125|364068648|FG000|Overall Study|Lost to Follow-up|0|||
105565583|NCT03518125|364068649|FG001|Overall Study|Lost to Follow-up|2|||
105565584|NCT03518125|364068650|FG002|Overall Study|Lost to Follow-up|0|||
105565585|NCT03518125|364068651|FG003|Overall Study|Lost to Follow-up|0|||
105565586|NCT03518125|364068652|FG004|Overall Study|Lost to Follow-up|3|||
105565587|NCT03518125|364068653|FG005|Overall Study|Lost to Follow-up|5|||
105565588|NCT03518125|364068648|FG000|Overall Study|Physician Decision|0|||
105565589|NCT03518125|364068649|FG001|Overall Study|Physician Decision|1|||
105565590|NCT03518125|364068650|FG002|Overall Study|Physician Decision|0|||
105565591|NCT03518125|364068651|FG003|Overall Study|Physician Decision|0|||
105565592|NCT03518125|364068652|FG004|Overall Study|Physician Decision|0|||
105565593|NCT03518125|364068653|FG005|Overall Study|Physician Decision|0|||
105565594|NCT03518125|364068648|FG000|Overall Study|Withdrawal by Subject|1|||
105565595|NCT03518125|364068649|FG001|Overall Study|Withdrawal by Subject|1|||
105565596|NCT03518125|364068650|FG002|Overall Study|Withdrawal by Subject|0|||
105565597|NCT03518125|364068651|FG003|Overall Study|Withdrawal by Subject|1|||
105360225|NCT00672633|363323832|FG000|Overall Study|Withdrawal by Subject|0|||
105360226|NCT00672633|363323833|FG001|Overall Study|Withdrawal by Subject|1|||
105565598|NCT03518125|364068652|FG004|Overall Study|Withdrawal by Subject|1|||
105565599|NCT03518125|364068653|FG005|Overall Study|Withdrawal by Subject|3|||
105565600|NCT03518125|364068648|FG000|Overall Study|Missed Day 394 Visit|1|||
105565601|NCT03518125|364068649|FG001|Overall Study|Missed Day 394 Visit|0|||
105565602|NCT03518125|364068650|FG002|Overall Study|Missed Day 394 Visit|0|||
105760891|NCT01831804|364778041|FG005|Overall Study|Withdrew Consent|0|||
105360227|NCT00534638|363323834|FG000|Overall Study|Withdrawal by Subject|3|||
105750505|NCT01963208|364738859|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
105750506|NCT01963208|364738860|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
105750507|NCT01963208|364738861|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
105750508|NCT01963208|364738862|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
105750509|NCT01963208|364738863|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
105750510|NCT01963208|364738858|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
105565603|NCT03518125|364068651|FG003|Overall Study|Missed Day 394 Visit|0|||
105565604|NCT03518125|364068652|FG004|Overall Study|Missed Day 394 Visit|0|||
105565605|NCT03518125|364068653|FG005|Overall Study|Missed Day 394 Visit|0|||
105565606|NCT02093663|364068654|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
105565607|NCT02093663|364068655|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
105565608|NCT02093663|364068656|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
105565609|NCT02093663|364068657|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
105565610|NCT02093663|364068658|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
105565611|NCT02093663|364068654|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
105565612|NCT02093663|364068655|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
105565613|NCT02093663|364068656|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
105565614|NCT02093663|364068657|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
105565615|NCT02093663|364068658|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
105565616|NCT02093663|364068654|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
105565617|NCT02093663|364068655|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
105565618|NCT02093663|364068656|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
105565619|NCT02093663|364068657|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
105565620|NCT02093663|364068658|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
105565621|NCT02093663|364068654|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
105565622|NCT02093663|364068655|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
105565623|NCT02093663|364068656|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
105565624|NCT02093663|364068657|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
105565625|NCT02093663|364068658|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
105565626|NCT02093663|364068654|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
105565627|NCT02093663|364068655|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
105565628|NCT02093663|364068656|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
105565629|NCT02093663|364068657|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
105565630|NCT02093663|364068658|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
105565631|NCT02093663|364068654|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
105565632|NCT02093663|364068655|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
105565633|NCT02093663|364068656|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
105565634|NCT02093663|364068657|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
105565635|NCT02093663|364068658|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
105565636|NCT02093663|364068654|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
105565637|NCT02093663|364068655|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
105565638|NCT02093663|364068656|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
105565639|NCT02093663|364068657|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
105565640|NCT02093663|364068658|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
105750511|NCT01963208|364738859|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
105760892|NCT01831804|364778042|FG006|Overall Study|Withdrew Consent|0|||
105565641|NCT02093663|364068654|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
105565642|NCT02093663|364068655|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
105565643|NCT02093663|364068656|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
105565644|NCT02093663|364068657|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
105565645|NCT02093663|364068658|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
105750512|NCT01963208|364738860|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
105750513|NCT01963208|364738861|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
105750514|NCT01963208|364738862|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
105750515|NCT01963208|364738863|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
105750516|NCT01963208|364738858|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
105801689|NCT00950599|364930617|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
105750517|NCT01963208|364738859|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
105750518|NCT01963208|364738860|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
105801690|NCT00950599|364930618|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
105565646|NCT02093663|364068654|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
105565647|NCT02093663|364068655|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
105565648|NCT02093663|364068656|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
105565649|NCT02093663|364068657|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
105565650|NCT02093663|364068658|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
105565651|NCT04207840|364068659|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
105565652|NCT04207840|364068660|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
105750519|NCT01963208|364738861|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
105750520|NCT01963208|364738862|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
105750521|NCT01963208|364738863|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
105565653|NCT04207840|364068661|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
105565654|NCT04207840|364068659|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
105565655|NCT04207840|364068660|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
105750522|NCT01963208|364738858|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
105565656|NCT04207840|364068661|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
105565657|NCT01966003|364068664|FG000|Overall Study|Death|43|||
105565658|NCT01966003|364068665|FG001|Overall Study|Death|36|||
105565659|NCT01966003|364068664|FG000|Overall Study|Protocol Violation|6|||
105565660|NCT01966003|364068665|FG001|Overall Study|Protocol Violation|4|||
105565661|NCT01966003|364068664|FG000|Overall Study|Lost to Follow-up|4|||
105565662|NCT01966003|364068665|FG001|Overall Study|Lost to Follow-up|3|||
105565663|NCT01966003|364068664|FG000|Overall Study|Physician Decision|12|||
105565664|NCT01966003|364068665|FG001|Overall Study|Physician Decision|13|||
105565665|NCT01966003|364068664|FG000|Overall Study|Withdrawal by Subject|29|||
105565666|NCT01966003|364068665|FG001|Overall Study|Withdrawal by Subject|19|||
105565667|NCT01966003|364068664|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
105565668|NCT01966003|364068665|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
105565669|NCT01966003|364068664|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
105565670|NCT01966003|364068665|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
105750523|NCT01963208|364738859|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
105750524|NCT01963208|364738860|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
105750525|NCT01963208|364738861|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
105750526|NCT01963208|364738862|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
105750527|NCT01963208|364738863|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
105750528|NCT01963208|364738858|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
105750529|NCT01963208|364738859|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
105750530|NCT01963208|364738860|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
105750531|NCT01963208|364738861|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
105750532|NCT01963208|364738862|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
105750533|NCT01963208|364738863|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
105750534|NCT01963208|364738858|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
105750535|NCT01963208|364738859|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
105750536|NCT01963208|364738860|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
105750537|NCT01963208|364738861|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
105750538|NCT01963208|364738862|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
105750539|NCT01963208|364738863|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
105750540|NCT01536119|364738866|FG000|Overall Study|Lost to Follow-up|17|||
105750541|NCT01536119|364738867|FG001|Overall Study|Lost to Follow-up|14|||
105750542|NCT00448916|364738868|FG000|Overall Study|Adverse Event|2|||
105750543|NCT00448916|364738869|FG001|Overall Study|Adverse Event|2|||
105750544|NCT00448916|364738870|FG002|Overall Study|Adverse Event|3|||
105750545|NCT00448916|364738871|FG003|Overall Study|Adverse Event|2|||
105750546|NCT00448916|364738868|FG000|Overall Study|Lack of Efficacy|1|||
105750547|NCT00448916|364738869|FG001|Overall Study|Lack of Efficacy|0|||
105750548|NCT00448916|364738870|FG002|Overall Study|Lack of Efficacy|2|||
105750549|NCT00448916|364738871|FG003|Overall Study|Lack of Efficacy|1|||
105750550|NCT00448916|364738868|FG000|Overall Study|Withdrawal by Subject|3|||
105750551|NCT00448916|364738869|FG001|Overall Study|Withdrawal by Subject|3|||
105750552|NCT00448916|364738870|FG002|Overall Study|Withdrawal by Subject|1|||
105750553|NCT00448916|364738871|FG003|Overall Study|Withdrawal by Subject|1|||
105750554|NCT00448916|364738868|FG000|Overall Study|Other|1|||
105750555|NCT00448916|364738869|FG001|Overall Study|Other|0|||
105750556|NCT00448916|364738870|FG002|Overall Study|Other|0|||
105750557|NCT00448916|364738871|FG003|Overall Study|Other|0|||
105750558|NCT00448916|364738868|FG000|Overall Study|Lost to Follow-up|0|||
105750559|NCT00448916|364738869|FG001|Overall Study|Lost to Follow-up|1|||
105750560|NCT00448916|364738870|FG002|Overall Study|Lost to Follow-up|0|||
105750561|NCT00448916|364738871|FG003|Overall Study|Lost to Follow-up|1|||
105750562|NCT00448916|364738868|FG000|Overall Study|Protocol Violation|0|||
105565671|NCT01966003|364068664|FG000|Overall Study|Other|1|||
105565672|NCT01966003|364068665|FG001|Overall Study|Other|1|||
105750563|NCT00448916|364738869|FG001|Overall Study|Protocol Violation|0|||
105750564|NCT00448916|364738870|FG002|Overall Study|Protocol Violation|0|||
105750565|NCT00448916|364738871|FG003|Overall Study|Protocol Violation|1|||
105750566|NCT01185249|364738872|FG000|Overall Study|Patients discharged or change in status|42|||
105750567|NCT01810042|364738877|FG000|Overall Study|Lost to Follow-up|10|||
105750568|NCT02164513|364738878|FG000|Overall Study|Adverse Event|162|||
105750569|NCT02164513|364738879|FG001|Overall Study|Adverse Event|180|||
105750570|NCT02164513|364738880|FG002|Overall Study|Adverse Event|111|||
105750571|NCT02164513|364738878|FG000|Overall Study|Other: Study Closed or terminated|5|||
105750572|NCT02164513|364738879|FG001|Overall Study|Other: Study Closed or terminated|2|||
105750573|NCT02164513|364738880|FG002|Overall Study|Other: Study Closed or terminated|4|||
105750574|NCT02164513|364738878|FG000|Overall Study|Lost to Follow-up|30|||
105750575|NCT02164513|364738879|FG001|Overall Study|Lost to Follow-up|36|||
105750576|NCT02164513|364738880|FG002|Overall Study|Lost to Follow-up|22|||
105750577|NCT02164513|364738878|FG000|Overall Study|Physician Decision|47|||
105750578|NCT02164513|364738879|FG001|Overall Study|Physician Decision|57|||
105750579|NCT02164513|364738880|FG002|Overall Study|Physician Decision|28|||
105750580|NCT02164513|364738878|FG000|Overall Study|Withdrawal by Subject|192|||
105750581|NCT02164513|364738879|FG001|Overall Study|Withdrawal by Subject|261|||
105750582|NCT02164513|364738880|FG002|Overall Study|Withdrawal by Subject|130|||
105750583|NCT02164513|364738878|FG000|Overall Study|Other: Reason not provided by site|1|||
105750584|NCT02164513|364738879|FG001|Overall Study|Other: Reason not provided by site|0|||
105750585|NCT02164513|364738880|FG002|Overall Study|Other: Reason not provided by site|0|||
105750586|NCT03707158|364738881|FG000|Midtreatment|Lost to Follow-up|16|||
105750587|NCT03707158|364738882|FG001|Midtreatment|Lost to Follow-up|7|||
105750588|NCT03707158|364738881|FG000|Midtreatment|Withdrawal by Subject|28|||
105750589|NCT03707158|364738882|FG001|Midtreatment|Withdrawal by Subject|19|||
105750590|NCT03707158|364738881|FG000|Posttreatment|Lost to Follow-up|0|||
105750591|NCT03707158|364738882|FG001|Posttreatment|Lost to Follow-up|5|||
105750592|NCT03707158|364738881|FG000|Follow-up|Lost to Follow-up|19|||
105750593|NCT03707158|364738882|FG001|Follow-up|Lost to Follow-up|18|||
105750594|NCT03707158|364738881|FG000|Follow-up|Withdrawal by Subject|13|||
105750595|NCT03707158|364738882|FG001|Follow-up|Withdrawal by Subject|6|||
105750596|NCT04569084|364738883|FG000|Overall Study|Adverse Event|10|||
105750597|NCT04569084|364738884|FG001|Overall Study|Adverse Event|14|||
105750598|NCT04569084|364738883|FG000|Overall Study|Death|2|||
105750599|NCT04569084|364738884|FG001|Overall Study|Death|3|||
105750600|NCT04569084|364738883|FG000|Overall Study|Lost to Follow-up|1|||
105750601|NCT04569084|364738884|FG001|Overall Study|Lost to Follow-up|1|||
105750602|NCT04569084|364738883|FG000|Overall Study|Physician Decision|3|||
105750603|NCT04569084|364738884|FG001|Overall Study|Physician Decision|3|||
105750604|NCT04569084|364738883|FG000|Overall Study|Protocol Violation|2|||
105750605|NCT04569084|364738884|FG001|Overall Study|Protocol Violation|1|||
105750606|NCT04569084|364738883|FG000|Overall Study|Withdrawal by Subject|20|||
105750607|NCT04569084|364738884|FG001|Overall Study|Withdrawal by Subject|21|||
105750608|NCT04569084|364738883|FG000|Overall Study|Study terminated by sponsor|26|||
105750609|NCT04569084|364738884|FG001|Overall Study|Study terminated by sponsor|23|||
105750610|NCT04569084|364738883|FG000|Overall Study|Other|3|||
105750611|NCT04569084|364738884|FG001|Overall Study|Other|5|||
105750612|NCT02773238|364738885|FG000|Overall Study|Lack of Efficacy|4|||
105750613|NCT01208038|364738886|FG000|Overall Study|Withdrawal by Subject|1|||
105750614|NCT01877382|364738889|FG000|Dose Escalation|Progressive disease|2|||
105750615|NCT01877382|364738890|FG001|Dose Escalation|Progressive disease|0|||
105750616|NCT01877382|364738891|FG002|Dose Escalation|Progressive disease|1|||
105750617|NCT01877382|364738892|FG003|Dose Escalation|Progressive disease|6|||
105750618|NCT01877382|364738893|FG004|Dose Escalation|Progressive disease|1|||
105750619|NCT01877382|364738894|FG005|Dose Escalation|Progressive disease|0|||
105750620|NCT01877382|364738895|FG006|Dose Escalation|Progressive disease|3|||
105750621|NCT01877382|364738896|FG007|Dose Escalation|Progressive disease|10|||
105750622|NCT01877382|364738897|FG008|Dose Escalation|Progressive disease|4|||
105750623|NCT01877382|364738898|FG009|Dose Escalation|Progressive disease|2|||
105750624|NCT01877382|364738899|FG010|Dose Escalation|Progressive disease|3|||
105750625|NCT01877382|364738900|FG011|Dose Escalation|Progressive disease|3|||
105750626|NCT01877382|364738901|FG012|Dose Escalation|Progressive disease|13|||
105750627|NCT01877382|364738902|FG013|Dose Escalation|Progressive disease|1|||
105750628|NCT01877382|364738903|FG014|Dose Escalation|Progressive disease|0|||
105750629|NCT01877382|364738889|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
105750630|NCT01877382|364738890|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750631|NCT01877382|364738891|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750632|NCT01877382|364738892|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
105750633|NCT01877382|364738893|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750634|NCT01877382|364738894|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750635|NCT01877382|364738895|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
105750636|NCT01877382|364738896|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750637|NCT01877382|364738897|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750638|NCT01877382|364738898|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750639|NCT01877382|364738899|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750640|NCT01877382|364738900|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750641|NCT01877382|364738901|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750642|NCT01877382|364738902|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750643|NCT01877382|364738903|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750644|NCT01877382|364738889|FG000|Dose Escalation|Clinical progression|0|||
105750645|NCT01877382|364738890|FG001|Dose Escalation|Clinical progression|1|||
105750646|NCT01877382|364738891|FG002|Dose Escalation|Clinical progression|0|||
105750647|NCT01877382|364738892|FG003|Dose Escalation|Clinical progression|2|||
105750648|NCT01877382|364738893|FG004|Dose Escalation|Clinical progression|0|||
105750649|NCT01877382|364738894|FG005|Dose Escalation|Clinical progression|0|||
105750650|NCT01877382|364738895|FG006|Dose Escalation|Clinical progression|1|||
105750651|NCT01877382|364738896|FG007|Dose Escalation|Clinical progression|0|||
105750652|NCT01877382|364738897|FG008|Dose Escalation|Clinical progression|0|||
105750653|NCT01877382|364738898|FG009|Dose Escalation|Clinical progression|1|||
105750654|NCT01877382|364738899|FG010|Dose Escalation|Clinical progression|0|||
105750655|NCT01877382|364738900|FG011|Dose Escalation|Clinical progression|0|||
105750656|NCT01877382|364738901|FG012|Dose Escalation|Clinical progression|2|||
105750657|NCT01877382|364738902|FG013|Dose Escalation|Clinical progression|1|||
105750658|NCT01877382|364738903|FG014|Dose Escalation|Clinical progression|0|||
105750659|NCT01877382|364738889|FG000|Dose Escalation|Adverse Event|0|||
105565673|NCT01538472|364068668|FG000|Overall Study|Disease Progression|3|||
105565674|NCT01538472|364068668|FG000|Overall Study|Death|1|||
105750660|NCT01877382|364738890|FG001|Dose Escalation|Adverse Event|0|||
105565675|NCT02309112|364068669|FG000|Overall Study|Withdrawal by Subject|1|||
105565676|NCT02309112|364068670|FG001|Overall Study|Withdrawal by Subject|0|||
105750661|NCT01877382|364738891|FG002|Dose Escalation|Adverse Event|0|||
105750662|NCT01877382|364738892|FG003|Dose Escalation|Adverse Event|4|||
105750663|NCT01877382|364738893|FG004|Dose Escalation|Adverse Event|1|||
105750664|NCT01877382|364738894|FG005|Dose Escalation|Adverse Event|2|||
105750665|NCT01877382|364738895|FG006|Dose Escalation|Adverse Event|1|||
105750666|NCT01877382|364738896|FG007|Dose Escalation|Adverse Event|2|||
105750667|NCT01877382|364738897|FG008|Dose Escalation|Adverse Event|0|||
105750668|NCT01877382|364738898|FG009|Dose Escalation|Adverse Event|0|||
105750669|NCT01877382|364738899|FG010|Dose Escalation|Adverse Event|0|||
105750670|NCT01877382|364738900|FG011|Dose Escalation|Adverse Event|0|||
105750671|NCT01877382|364738901|FG012|Dose Escalation|Adverse Event|1|||
105750672|NCT01877382|364738902|FG013|Dose Escalation|Adverse Event|0|||
105750673|NCT01877382|364738903|FG014|Dose Escalation|Adverse Event|0|||
105750674|NCT01877382|364738889|FG000|Dose Escalation|Withdrawal by Subject|0|||
105750675|NCT01877382|364738890|FG001|Dose Escalation|Withdrawal by Subject|0|||
105750676|NCT01877382|364738891|FG002|Dose Escalation|Withdrawal by Subject|0|||
105565677|NCT02309112|364068671|FG002|Overall Study|Withdrawal by Subject|1|||
105750677|NCT01877382|364738892|FG003|Dose Escalation|Withdrawal by Subject|0|||
105750678|NCT01877382|364738893|FG004|Dose Escalation|Withdrawal by Subject|0|||
105750679|NCT01877382|364738894|FG005|Dose Escalation|Withdrawal by Subject|3|||
105750680|NCT01877382|364738895|FG006|Dose Escalation|Withdrawal by Subject|2|||
105750681|NCT01877382|364738896|FG007|Dose Escalation|Withdrawal by Subject|1|||
105750682|NCT01877382|364738897|FG008|Dose Escalation|Withdrawal by Subject|1|||
105750683|NCT01877382|364738898|FG009|Dose Escalation|Withdrawal by Subject|0|||
105750684|NCT01877382|364738899|FG010|Dose Escalation|Withdrawal by Subject|0|||
105750685|NCT01877382|364738900|FG011|Dose Escalation|Withdrawal by Subject|0|||
105750686|NCT01877382|364738901|FG012|Dose Escalation|Withdrawal by Subject|0|||
105750687|NCT01877382|364738902|FG013|Dose Escalation|Withdrawal by Subject|0|||
105750688|NCT01877382|364738903|FG014|Dose Escalation|Withdrawal by Subject|0|||
105750689|NCT01877382|364738889|FG000|Dose Escalation|Protocol Violation|0|||
105750690|NCT01877382|364738890|FG001|Dose Escalation|Protocol Violation|0|||
105750691|NCT01877382|364738891|FG002|Dose Escalation|Protocol Violation|0|||
105750692|NCT01877382|364738892|FG003|Dose Escalation|Protocol Violation|0|||
105750693|NCT01877382|364738893|FG004|Dose Escalation|Protocol Violation|0|||
105750694|NCT01877382|364738894|FG005|Dose Escalation|Protocol Violation|0|||
105750695|NCT01877382|364738895|FG006|Dose Escalation|Protocol Violation|1|||
105750696|NCT01877382|364738896|FG007|Dose Escalation|Protocol Violation|0|||
105750697|NCT01877382|364738897|FG008|Dose Escalation|Protocol Violation|0|||
105750698|NCT01877382|364738898|FG009|Dose Escalation|Protocol Violation|0|||
105750699|NCT01877382|364738899|FG010|Dose Escalation|Protocol Violation|0|||
105750700|NCT01877382|364738900|FG011|Dose Escalation|Protocol Violation|0|||
105750701|NCT01877382|364738901|FG012|Dose Escalation|Protocol Violation|0|||
105750702|NCT01877382|364738902|FG013|Dose Escalation|Protocol Violation|0|||
105750703|NCT01877382|364738903|FG014|Dose Escalation|Protocol Violation|0|||
105750704|NCT01877382|364738889|FG000|Dose Escalation|Study terminated by sponsor|0|||
105750705|NCT01877382|364738890|FG001|Dose Escalation|Study terminated by sponsor|0|||
105750706|NCT01877382|364738891|FG002|Dose Escalation|Study terminated by sponsor|0|||
105750707|NCT01877382|364738892|FG003|Dose Escalation|Study terminated by sponsor|0|||
105750708|NCT01877382|364738893|FG004|Dose Escalation|Study terminated by sponsor|0|||
105750709|NCT01877382|364738894|FG005|Dose Escalation|Study terminated by sponsor|0|||
105750710|NCT01877382|364738895|FG006|Dose Escalation|Study terminated by sponsor|0|||
105750711|NCT01877382|364738896|FG007|Dose Escalation|Study terminated by sponsor|1|||
105565678|NCT02309112|364068669|FG000|Overall Study|Lost to Follow-up|0|||
105565679|NCT02309112|364068670|FG001|Overall Study|Lost to Follow-up|1|||
105750712|NCT01877382|364738897|FG008|Dose Escalation|Study terminated by sponsor|1|||
105565680|NCT02309112|364068671|FG002|Overall Study|Lost to Follow-up|0|||
105565681|NCT00509236|364068682|FG000|Overall Study|Adverse Event|7|||
105565682|NCT00509236|364068683|FG001|Overall Study|Adverse Event|9|||
105565683|NCT00509236|364068682|FG000|Overall Study|Withdrawal by Subject|5|||
105565684|NCT00509236|364068683|FG001|Overall Study|Withdrawal by Subject|10|||
105565685|NCT00509236|364068682|FG000|Overall Study|Protocol Violation|3|||
105565686|NCT00509236|364068683|FG001|Overall Study|Protocol Violation|0|||
105565687|NCT00509236|364068682|FG000|Overall Study|Excluded Medication|1|||
105565688|NCT00509236|364068683|FG001|Overall Study|Excluded Medication|1|||
105565689|NCT00509236|364068682|FG000|Overall Study|Scheduled Kidney Transplant|1|||
105565690|NCT00509236|364068683|FG001|Overall Study|Scheduled Kidney Transplant|0|||
105565691|NCT04555096|364068688|FG000|Overall Study|Death|4|||
105565692|NCT04555096|364068689|FG001|Overall Study|Death|4|||
105565693|NCT04555096|364068688|FG000|Overall Study|Withdrawal by Subject|1|||
105565694|NCT04555096|364068689|FG001|Overall Study|Withdrawal by Subject|0|||
105565695|NCT04555096|364068688|FG000|Overall Study|Other|0|||
105565696|NCT04555096|364068689|FG001|Overall Study|Other|1|||
105565697|NCT03056534|364068691|FG000|Overall Study|Participant withdrew consent|8|||
105565698|NCT03056534|364068691|FG000|Overall Study|Participant not able to return|6|||
105565699|NCT03056534|364068691|FG000|Overall Study|Lost to Follow-up|37|||
105565700|NCT03056534|364068691|FG000|Overall Study|Investigator judgment|1|||
105565701|NCT03056534|364068691|FG000|Overall Study|Death|4|||
105565702|NCT03056534|364068691|FG000|Overall Study|Adverse Event|1|||
105565703|NCT03056534|364068691|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
105565704|NCT05375955|364068693|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
105565705|NCT05375955|364068694|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
105565706|NCT05375955|364068695|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
105565707|NCT05375955|364068696|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
105565708|NCT05375955|364068697|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
105565709|NCT05375955|364068698|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
105565710|NCT05375955|364068699|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
105565711|NCT05375955|364068693|FG000|Treatment (12 Weeks)|Physician Decision|4|||
105565712|NCT05375955|364068694|FG001|Treatment (12 Weeks)|Physician Decision|1|||
105565713|NCT05375955|364068695|FG002|Treatment (12 Weeks)|Physician Decision|3|||
105565714|NCT05375955|364068696|FG003|Treatment (12 Weeks)|Physician Decision|0|||
105565715|NCT05375955|364068697|FG004|Treatment (12 Weeks)|Physician Decision|0|||
105565716|NCT05375955|364068698|FG005|Treatment (12 Weeks)|Physician Decision|1|||
105565717|NCT05375955|364068699|FG006|Treatment (12 Weeks)|Physician Decision|0|||
105750713|NCT01877382|364738898|FG009|Dose Escalation|Study terminated by sponsor|0|||
105760893|NCT01831804|364778043|FG007|Overall Study|Withdrew Consent|2|||
105565718|NCT05375955|364068693|FG000|Treatment (12 Weeks)|Other|0|||
105750714|NCT01877382|364738899|FG010|Dose Escalation|Study terminated by sponsor|0|||
105750715|NCT01877382|364738900|FG011|Dose Escalation|Study terminated by sponsor|0|||
105750716|NCT01877382|364738901|FG012|Dose Escalation|Study terminated by sponsor|3|||
105750717|NCT01877382|364738902|FG013|Dose Escalation|Study terminated by sponsor|0|||
105750718|NCT01877382|364738903|FG014|Dose Escalation|Study terminated by sponsor|0|||
105750719|NCT01877382|364738889|FG000|Dose Escalation|Death|0|||
105750720|NCT01877382|364738890|FG001|Dose Escalation|Death|0|||
105750721|NCT01877382|364738891|FG002|Dose Escalation|Death|0|||
105750722|NCT01877382|364738892|FG003|Dose Escalation|Death|0|||
105750723|NCT01877382|364738893|FG004|Dose Escalation|Death|0|||
105750724|NCT01877382|364738894|FG005|Dose Escalation|Death|0|||
105750725|NCT01877382|364738895|FG006|Dose Escalation|Death|0|||
105750726|NCT01877382|364738896|FG007|Dose Escalation|Death|1|||
105750727|NCT01877382|364738897|FG008|Dose Escalation|Death|0|||
105750728|NCT01877382|364738898|FG009|Dose Escalation|Death|0|||
105750729|NCT01877382|364738899|FG010|Dose Escalation|Death|0|||
105750730|NCT01877382|364738900|FG011|Dose Escalation|Death|0|||
105750731|NCT01877382|364738901|FG012|Dose Escalation|Death|1|||
105750732|NCT01877382|364738902|FG013|Dose Escalation|Death|1|||
105750733|NCT01877382|364738903|FG014|Dose Escalation|Death|0|||
105750734|NCT01877382|364738889|FG000|Dose Expansion|Progressive disease|0|||
105750735|NCT01877382|364738890|FG001|Dose Expansion|Progressive disease|0|||
105750736|NCT01877382|364738891|FG002|Dose Expansion|Progressive disease|0|||
105750737|NCT01877382|364738892|FG003|Dose Expansion|Progressive disease|0|||
105750738|NCT01877382|364738893|FG004|Dose Expansion|Progressive disease|0|||
105750739|NCT01877382|364738894|FG005|Dose Expansion|Progressive disease|0|||
105750740|NCT01877382|364738895|FG006|Dose Expansion|Progressive disease|0|||
105750741|NCT01877382|364738896|FG007|Dose Expansion|Progressive disease|0|||
105750742|NCT01877382|364738897|FG008|Dose Expansion|Progressive disease|0|||
105750743|NCT01877382|364738898|FG009|Dose Expansion|Progressive disease|0|||
105750744|NCT01877382|364738899|FG010|Dose Expansion|Progressive disease|0|||
105750745|NCT01877382|364738900|FG011|Dose Expansion|Progressive disease|0|||
105750746|NCT01877382|364738901|FG012|Dose Expansion|Progressive disease|0|||
105750747|NCT01877382|364738902|FG013|Dose Expansion|Progressive disease|0|||
105750748|NCT01877382|364738903|FG014|Dose Expansion|Progressive disease|11|||
105750749|NCT01877382|364738889|FG000|Dose Expansion|Clinical progression|0|||
105750750|NCT01877382|364738890|FG001|Dose Expansion|Clinical progression|0|||
105801691|NCT00950599|364930619|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
105801692|NCT00950599|364930620|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
105750751|NCT01877382|364738891|FG002|Dose Expansion|Clinical progression|0|||
105750752|NCT01877382|364738892|FG003|Dose Expansion|Clinical progression|0|||
105750753|NCT01877382|364738893|FG004|Dose Expansion|Clinical progression|0|||
105750754|NCT01877382|364738894|FG005|Dose Expansion|Clinical progression|0|||
105750755|NCT01877382|364738895|FG006|Dose Expansion|Clinical progression|0|||
105750756|NCT01877382|364738896|FG007|Dose Expansion|Clinical progression|0|||
105750757|NCT01877382|364738897|FG008|Dose Expansion|Clinical progression|0|||
105750758|NCT01877382|364738898|FG009|Dose Expansion|Clinical progression|0|||
105750759|NCT01877382|364738899|FG010|Dose Expansion|Clinical progression|0|||
105750760|NCT01877382|364738900|FG011|Dose Expansion|Clinical progression|0|||
105750761|NCT01877382|364738901|FG012|Dose Expansion|Clinical progression|0|||
105750762|NCT01877382|364738902|FG013|Dose Expansion|Clinical progression|0|||
105750763|NCT01877382|364738903|FG014|Dose Expansion|Clinical progression|6|||
105750764|NCT01877382|364738889|FG000|Dose Expansion|Adverse Event|0|||
105750765|NCT01877382|364738890|FG001|Dose Expansion|Adverse Event|0|||
105750766|NCT01877382|364738891|FG002|Dose Expansion|Adverse Event|0|||
105750767|NCT01877382|364738892|FG003|Dose Expansion|Adverse Event|0|||
105750768|NCT01877382|364738893|FG004|Dose Expansion|Adverse Event|0|||
105750769|NCT01877382|364738894|FG005|Dose Expansion|Adverse Event|0|||
105750770|NCT01877382|364738895|FG006|Dose Expansion|Adverse Event|0|||
105750771|NCT01877382|364738896|FG007|Dose Expansion|Adverse Event|0|||
105750772|NCT01877382|364738897|FG008|Dose Expansion|Adverse Event|0|||
105750773|NCT01877382|364738898|FG009|Dose Expansion|Adverse Event|0|||
105750774|NCT01877382|364738899|FG010|Dose Expansion|Adverse Event|0|||
105750775|NCT01877382|364738900|FG011|Dose Expansion|Adverse Event|0|||
105750776|NCT01877382|364738901|FG012|Dose Expansion|Adverse Event|0|||
105750777|NCT01877382|364738902|FG013|Dose Expansion|Adverse Event|0|||
105750778|NCT01877382|364738903|FG014|Dose Expansion|Adverse Event|1|||
105750779|NCT01877382|364738889|FG000|Dose Expansion|Death|0|||
105750780|NCT01877382|364738890|FG001|Dose Expansion|Death|0|||
105750781|NCT01877382|364738891|FG002|Dose Expansion|Death|0|||
105750782|NCT01877382|364738892|FG003|Dose Expansion|Death|0|||
105750783|NCT01877382|364738893|FG004|Dose Expansion|Death|0|||
105750784|NCT01877382|364738894|FG005|Dose Expansion|Death|0|||
105750785|NCT01877382|364738895|FG006|Dose Expansion|Death|0|||
105750786|NCT01877382|364738896|FG007|Dose Expansion|Death|0|||
105750787|NCT01877382|364738897|FG008|Dose Expansion|Death|0|||
105750788|NCT01877382|364738898|FG009|Dose Expansion|Death|0|||
105750789|NCT01877382|364738899|FG010|Dose Expansion|Death|0|||
105750790|NCT01877382|364738900|FG011|Dose Expansion|Death|0|||
105750791|NCT01877382|364738901|FG012|Dose Expansion|Death|0|||
105750792|NCT01877382|364738902|FG013|Dose Expansion|Death|0|||
105750793|NCT01877382|364738903|FG014|Dose Expansion|Death|1|||
105750794|NCT01877382|364738889|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750795|NCT01877382|364738890|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750796|NCT01877382|364738891|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750797|NCT01877382|364738892|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750798|NCT01877382|364738893|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750799|NCT01877382|364738894|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750800|NCT01877382|364738895|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750801|NCT01877382|364738896|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750802|NCT01877382|364738897|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750803|NCT01877382|364738898|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750804|NCT01877382|364738899|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750805|NCT01877382|364738900|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750806|NCT01877382|364738901|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750807|NCT01877382|364738902|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750808|NCT01877382|364738903|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
105750809|NCT00808249|364738906|FG000|Overall Study|Adverse Event|4|||
105750810|NCT00808249|364738907|FG001|Overall Study|Adverse Event|7|||
105750811|NCT00808249|364738908|FG002|Overall Study|Adverse Event|10|||
105750812|NCT00808249|364738909|FG003|Overall Study|Adverse Event|6|||
105750813|NCT00808249|364738906|FG000|Overall Study|Lost to Follow-up|2|||
105750814|NCT00808249|364738907|FG001|Overall Study|Lost to Follow-up|3|||
105750815|NCT00808249|364738908|FG002|Overall Study|Lost to Follow-up|3|||
105750816|NCT00808249|364738909|FG003|Overall Study|Lost to Follow-up|5|||
105750817|NCT00808249|364738906|FG000|Overall Study|Withdrawal by Subject|4|||
105750818|NCT00808249|364738907|FG001|Overall Study|Withdrawal by Subject|0|||
105750819|NCT00808249|364738908|FG002|Overall Study|Withdrawal by Subject|2|||
105750820|NCT00808249|364738909|FG003|Overall Study|Withdrawal by Subject|4|||
105750821|NCT00808249|364738906|FG000|Overall Study|Protocol Violation|3|||
105750822|NCT00808249|364738907|FG001|Overall Study|Protocol Violation|3|||
105750823|NCT00808249|364738908|FG002|Overall Study|Protocol Violation|3|||
105750824|NCT00808249|364738909|FG003|Overall Study|Protocol Violation|0|||
105750825|NCT00808249|364738906|FG000|Overall Study|Lack of Efficacy|1|||
105750826|NCT00808249|364738907|FG001|Overall Study|Lack of Efficacy|1|||
105750827|NCT00808249|364738908|FG002|Overall Study|Lack of Efficacy|0|||
105750828|NCT00808249|364738909|FG003|Overall Study|Lack of Efficacy|0|||
105750829|NCT00808249|364738906|FG000|Overall Study|study specific discontinuation criteria|1|||
105750830|NCT00808249|364738907|FG001|Overall Study|study specific discontinuation criteria|0|||
105750831|NCT00808249|364738908|FG002|Overall Study|study specific discontinuation criteria|1|||
105750832|NCT00808249|364738909|FG003|Overall Study|study specific discontinuation criteria|0|||
105750833|NCT00808249|364738906|FG000|Overall Study|All other reasons|2|||
105750834|NCT00808249|364738907|FG001|Overall Study|All other reasons|1|||
105750835|NCT00808249|364738908|FG002|Overall Study|All other reasons|3|||
105750836|NCT00808249|364738909|FG003|Overall Study|All other reasons|1|||
105750837|NCT00479557|364738910|FG000|Overall Study|Death|0|||
105750838|NCT00479557|364738911|FG001|Overall Study|Death|0|||
105750839|NCT00479557|364738912|FG002|Overall Study|Death|0|||
105750840|NCT00479557|364738913|FG003|Overall Study|Death|0|||
105750841|NCT00479557|364738914|FG004|Overall Study|Death|0|||
105750842|NCT00479557|364738915|FG005|Overall Study|Death|1|||
105750843|NCT00479557|364738916|FG006|Overall Study|Death|0|||
105750844|NCT00479557|364738910|FG000|Overall Study|Lack of Efficacy|1|||
105750845|NCT00479557|364738911|FG001|Overall Study|Lack of Efficacy|0|||
105750846|NCT00479557|364738912|FG002|Overall Study|Lack of Efficacy|0|||
105750847|NCT00479557|364738913|FG003|Overall Study|Lack of Efficacy|0|||
105750848|NCT00479557|364738914|FG004|Overall Study|Lack of Efficacy|0|||
105750849|NCT00479557|364738915|FG005|Overall Study|Lack of Efficacy|0|||
105750850|NCT00479557|364738916|FG006|Overall Study|Lack of Efficacy|0|||
105750851|NCT00479557|364738910|FG000|Overall Study|Lost to Follow-up|0|||
105750852|NCT00479557|364738911|FG001|Overall Study|Lost to Follow-up|2|||
105750853|NCT00479557|364738912|FG002|Overall Study|Lost to Follow-up|0|||
105750854|NCT00479557|364738913|FG003|Overall Study|Lost to Follow-up|2|||
105565719|NCT05375955|364068694|FG001|Treatment (12 Weeks)|Other|1|||
105750855|NCT00479557|364738914|FG004|Overall Study|Lost to Follow-up|0|||
105750856|NCT00479557|364738915|FG005|Overall Study|Lost to Follow-up|0|||
105750857|NCT00479557|364738916|FG006|Overall Study|Lost to Follow-up|0|||
105750858|NCT00479557|364738910|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
105750859|NCT00479557|364738911|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
105750860|NCT00479557|364738912|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
105750861|NCT00479557|364738913|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
105750862|NCT00479557|364738914|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
105750863|NCT00479557|364738915|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
105750864|NCT00479557|364738916|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
105750865|NCT00479557|364738910|FG000|Overall Study|AE not related to Study Drug|1|||
105750866|NCT00479557|364738911|FG001|Overall Study|AE not related to Study Drug|3|||
105750867|NCT00479557|364738912|FG002|Overall Study|AE not related to Study Drug|0|||
105750868|NCT00479557|364738913|FG003|Overall Study|AE not related to Study Drug|0|||
105750869|NCT00479557|364738914|FG004|Overall Study|AE not related to Study Drug|2|||
105750870|NCT00479557|364738915|FG005|Overall Study|AE not related to Study Drug|2|||
105750871|NCT00479557|364738916|FG006|Overall Study|AE not related to Study Drug|1|||
105750872|NCT00479557|364738910|FG000|Overall Study|Caregiver Request|2|||
105750873|NCT00479557|364738911|FG001|Overall Study|Caregiver Request|2|||
105750874|NCT00479557|364738912|FG002|Overall Study|Caregiver Request|2|||
105750875|NCT00479557|364738913|FG003|Overall Study|Caregiver Request|0|||
105750876|NCT00479557|364738914|FG004|Overall Study|Caregiver Request|1|||
105750877|NCT00479557|364738915|FG005|Overall Study|Caregiver Request|2|||
105750878|NCT00479557|364738916|FG006|Overall Study|Caregiver Request|0|||
105750879|NCT00479557|364738910|FG000|Overall Study|Investigator Request|0|||
105750880|NCT00479557|364738911|FG001|Overall Study|Investigator Request|0|||
105750881|NCT00479557|364738912|FG002|Overall Study|Investigator Request|1|||
105750882|NCT00479557|364738913|FG003|Overall Study|Investigator Request|0|||
105750883|NCT00479557|364738914|FG004|Overall Study|Investigator Request|0|||
105750884|NCT00479557|364738915|FG005|Overall Study|Investigator Request|0|||
105750885|NCT00479557|364738916|FG006|Overall Study|Investigator Request|0|||
105750886|NCT00479557|364738910|FG000|Overall Study|Subject Request|3|||
105750887|NCT00479557|364738911|FG001|Overall Study|Subject Request|0|||
105750888|NCT00479557|364738912|FG002|Overall Study|Subject Request|1|||
105750889|NCT00479557|364738913|FG003|Overall Study|Subject Request|1|||
105750890|NCT00479557|364738914|FG004|Overall Study|Subject Request|1|||
105750891|NCT00479557|364738915|FG005|Overall Study|Subject Request|4|||
105565720|NCT05375955|364068695|FG002|Treatment (12 Weeks)|Other|0|||
105750892|NCT00479557|364738916|FG006|Overall Study|Subject Request|1|||
105750893|NCT00479557|364738910|FG000|Overall Study|Other|2|||
105750894|NCT00479557|364738911|FG001|Overall Study|Other|3|||
105750895|NCT00479557|364738912|FG002|Overall Study|Other|1|||
105750896|NCT00479557|364738913|FG003|Overall Study|Other|0|||
105801693|NCT00950599|364930621|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
105750897|NCT00479557|364738914|FG004|Overall Study|Other|0|||
105750898|NCT00479557|364738915|FG005|Overall Study|Other|3|||
105750899|NCT00479557|364738916|FG006|Overall Study|Other|0|||
105750900|NCT00333619|364740741|FG000|Overall Study|Death|12|||
105750901|NCT00333619|364740742|FG001|Overall Study|Death|6|||
105565721|NCT05375955|364068696|FG003|Treatment (12 Weeks)|Other|0|||
105565722|NCT05375955|364068697|FG004|Treatment (12 Weeks)|Other|0|||
105565723|NCT05375955|364068698|FG005|Treatment (12 Weeks)|Other|0|||
105565724|NCT05375955|364068699|FG006|Treatment (12 Weeks)|Other|0|||
105565725|NCT05375955|364068693|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
105565726|NCT05375955|364068694|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
105565727|NCT05375955|364068695|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
105565728|NCT05375955|364068696|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
105750902|NCT00333619|364740741|FG000|Overall Study|Withdrawal by Subject|6|||
105750903|NCT00333619|364740742|FG001|Overall Study|Withdrawal by Subject|1|||
105750904|NCT00333619|364740741|FG000|Overall Study|Lost to Follow-up|3|||
105750905|NCT00333619|364740742|FG001|Overall Study|Lost to Follow-up|3|||
105750906|NCT02690207|364740749|FG000|Overall Study|Lost to Follow-up|48|||
105750907|NCT02690207|364740749|FG000|Overall Study|Withdrawal by Subject|46|||
105565729|NCT05375955|364068697|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
105565730|NCT05375955|364068698|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
105565731|NCT05375955|364068699|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
105565732|NCT05375955|364068693|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
105565733|NCT05375955|364068694|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
105565734|NCT05375955|364068695|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
105750908|NCT02690207|364740749|FG000|Overall Study|Protocol Violation|2|||
105750909|NCT02690207|364740749|FG000|Overall Study|Serious adverse event|110|||
105750910|NCT02690207|364740749|FG000|Overall Study|Non-serious Adverse Event|18|||
105750911|NCT02690207|364740749|FG000|Overall Study|Migrated/moved from study area|5|||
105750912|NCT02690207|364740749|FG000|Overall Study|Suspected HZ Episode|1|||
105750913|NCT02690207|364740749|FG000|Overall Study|Other reasons for withdrawal|23|||
105750914|NCT01369849|364740750|FG000|Overall Study|Ineligible prior to treatment|0|||
105750915|NCT01369849|364740751|FG001|Overall Study|Ineligible prior to treatment|0|||
105750916|NCT01369849|364740752|FG002|Overall Study|Ineligible prior to treatment|1|||
105750917|NCT01369849|364740750|FG000|Overall Study|Ineligible after receiving treatment|0|||
105750918|NCT01369849|364740751|FG001|Overall Study|Ineligible after receiving treatment|1|||
105750919|NCT01369849|364740752|FG002|Overall Study|Ineligible after receiving treatment|0|||
105750920|NCT00174785|364740753|FG000|Overall Study|Adverse Event|293|||
105750921|NCT00174785|364740754|FG001|Overall Study|Adverse Event|191|||
105750922|NCT00174785|364740753|FG000|Overall Study|Protocol Violation|14|||
105750923|NCT00174785|364740754|FG001|Overall Study|Protocol Violation|14|||
105750924|NCT00174785|364740753|FG000|Overall Study|Withdrawal by Subject|173|||
105750925|NCT00174785|364740754|FG001|Overall Study|Withdrawal by Subject|175|||
105565735|NCT05375955|364068696|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
105565736|NCT05375955|364068697|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
105565737|NCT05375955|364068698|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
105565738|NCT05375955|364068699|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
105565739|NCT05375955|364068693|FG000|Treatment (12 Weeks)|Pregnancy|0|||
105750926|NCT00174785|364740753|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
105750927|NCT00174785|364740754|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
105750928|NCT00174785|364740753|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
105750929|NCT00174785|364740754|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
105750930|NCT00174785|364740753|FG000|Overall Study|Other prohibited medication|5|||
105750931|NCT00174785|364740754|FG001|Overall Study|Other prohibited medication|3|||
105750932|NCT00174785|364740753|FG000|Overall Study|Family request|6|||
105750933|NCT00174785|364740754|FG001|Overall Study|Family request|8|||
105565740|NCT05375955|364068694|FG001|Treatment (12 Weeks)|Pregnancy|0|||
105750934|NCT00174785|364740753|FG000|Overall Study|Not pre-specified/Not coded|56|||
105750935|NCT00174785|364740754|FG001|Overall Study|Not pre-specified/Not coded|70|||
105750936|NCT01754922|364740755|FG000|Overall Study|Adverse Event|0|||
105750937|NCT01754922|364740756|FG001|Overall Study|Adverse Event|1|||
105750938|NCT01093755|364740757|FG000|Overall Study|Withdrawal by Subject|3|||
105750939|NCT01093755|364740758|FG001|Overall Study|Withdrawal by Subject|4|||
105750940|NCT02106455|364740761|FG000|Overall Study|Case Report Form Uncollected|6|||
105750941|NCT02106455|364740761|FG000|Overall Study|Protocol Deviation|2|||
105750942|NCT03558555|364740766|FG000|Overall Study|Lost to Follow-up|2|||
105750943|NCT03558555|364740767|FG001|Overall Study|Lost to Follow-up|1|||
105750944|NCT00194025|364740768|FG000|Overall Study|Adverse Event|1|||
105750945|NCT00194025|364740768|FG000|Overall Study|non-adherence with study medication|4|||
105750946|NCT00289185|364740780|FG000|Overall Study|Withdrawal by Subject|4|||
105750947|NCT00289185|364740781|FG001|Overall Study|Withdrawal by Subject|8|||
105750948|NCT00289185|364740780|FG000|Overall Study|Lost to Follow-up|23|||
105801694|NCT00950599|364930612|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
105801695|NCT00950599|364930613|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
105801696|NCT00950599|364930614|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
105801697|NCT00950599|364930615|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
105801698|NCT00950599|364930616|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
105801699|NCT00950599|364930617|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
105801700|NCT00950599|364930618|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
105801701|NCT00950599|364930619|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
105801702|NCT00950599|364930620|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
105801703|NCT00950599|364930621|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
105801704|NCT00950599|364930612|FG000|Follow-Up Period|Adverse Event|0|||
105801705|NCT00950599|364930613|FG001|Follow-Up Period|Adverse Event|0|||
105801706|NCT00950599|364930614|FG002|Follow-Up Period|Adverse Event|0|||
105801707|NCT00950599|364930615|FG003|Follow-Up Period|Adverse Event|0|||
105801708|NCT00950599|364930616|FG004|Follow-Up Period|Adverse Event|0|||
105801709|NCT00950599|364930617|FG005|Follow-Up Period|Adverse Event|0|||
105801710|NCT00950599|364930618|FG006|Follow-Up Period|Adverse Event|0|||
105801711|NCT00950599|364930619|FG007|Follow-Up Period|Adverse Event|0|||
105801712|NCT00950599|364930620|FG008|Follow-Up Period|Adverse Event|1|||
105801713|NCT00950599|364930621|FG009|Follow-Up Period|Adverse Event|0|||
105801714|NCT00950599|364930612|FG000|Follow-Up Period|Lack of Efficacy|0|||
105801715|NCT00950599|364930613|FG001|Follow-Up Period|Lack of Efficacy|0|||
105801716|NCT00950599|364930614|FG002|Follow-Up Period|Lack of Efficacy|0|||
105801717|NCT00950599|364930615|FG003|Follow-Up Period|Lack of Efficacy|0|||
105801718|NCT00950599|364930616|FG004|Follow-Up Period|Lack of Efficacy|0|||
105801719|NCT00950599|364930617|FG005|Follow-Up Period|Lack of Efficacy|0|||
105801720|NCT00950599|364930618|FG006|Follow-Up Period|Lack of Efficacy|0|||
105801721|NCT00950599|364930619|FG007|Follow-Up Period|Lack of Efficacy|0|||
105801722|NCT00950599|364930620|FG008|Follow-Up Period|Lack of Efficacy|3|||
105801723|NCT00950599|364930621|FG009|Follow-Up Period|Lack of Efficacy|0|||
105801724|NCT00950599|364930612|FG000|Follow-Up Period|Lost to Follow-up|0|||
105801725|NCT00950599|364930613|FG001|Follow-Up Period|Lost to Follow-up|0|||
105801726|NCT00950599|364930614|FG002|Follow-Up Period|Lost to Follow-up|0|||
105801727|NCT00950599|364930615|FG003|Follow-Up Period|Lost to Follow-up|0|||
105565741|NCT05375955|364068695|FG002|Treatment (12 Weeks)|Pregnancy|1|||
105565742|NCT05375955|364068696|FG003|Treatment (12 Weeks)|Pregnancy|0|||
105565743|NCT05375955|364068697|FG004|Treatment (12 Weeks)|Pregnancy|0|||
105565744|NCT05375955|364068698|FG005|Treatment (12 Weeks)|Pregnancy|0|||
105565745|NCT05375955|364068699|FG006|Treatment (12 Weeks)|Pregnancy|0|||
105565746|NCT05375955|364068693|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
105565747|NCT05375955|364068694|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
105565748|NCT05375955|364068695|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
105565749|NCT05375955|364068696|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
105565750|NCT05375955|364068697|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
105565751|NCT05375955|364068698|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
105565752|NCT05375955|364068699|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
105565753|NCT05375955|364068693|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
105565754|NCT05375955|364068694|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
105565755|NCT05375955|364068695|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
105565756|NCT05375955|364068696|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
105565757|NCT05375955|364068697|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
105565758|NCT05375955|364068698|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
105565759|NCT05375955|364068699|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
105565760|NCT05375955|364068693|FG000|Follow-up (up to 5 Weeks)|Other|0|||
105565761|NCT05375955|364068694|FG001|Follow-up (up to 5 Weeks)|Other|1|||
105565762|NCT05375955|364068695|FG002|Follow-up (up to 5 Weeks)|Other|0|||
105565763|NCT05375955|364068696|FG003|Follow-up (up to 5 Weeks)|Other|0|||
105801728|NCT00950599|364930616|FG004|Follow-Up Period|Lost to Follow-up|0|||
105801729|NCT00950599|364930617|FG005|Follow-Up Period|Lost to Follow-up|0|||
105801730|NCT00950599|364930618|FG006|Follow-Up Period|Lost to Follow-up|0|||
105801731|NCT00950599|364930619|FG007|Follow-Up Period|Lost to Follow-up|0|||
105801732|NCT00950599|364930620|FG008|Follow-Up Period|Lost to Follow-up|5|||
105801733|NCT00950599|364930621|FG009|Follow-Up Period|Lost to Follow-up|1|||
105801734|NCT00950599|364930612|FG000|Follow-Up Period|Physician Decision|0|||
105801735|NCT00950599|364930613|FG001|Follow-Up Period|Physician Decision|0|||
105801736|NCT00950599|364930614|FG002|Follow-Up Period|Physician Decision|0|||
105801737|NCT00950599|364930615|FG003|Follow-Up Period|Physician Decision|0|||
105801738|NCT00950599|364930616|FG004|Follow-Up Period|Physician Decision|0|||
105801739|NCT00950599|364930617|FG005|Follow-Up Period|Physician Decision|0|||
105801740|NCT00950599|364930618|FG006|Follow-Up Period|Physician Decision|0|||
105801741|NCT00950599|364930619|FG007|Follow-Up Period|Physician Decision|0|||
105801742|NCT00950599|364930620|FG008|Follow-Up Period|Physician Decision|1|||
105801743|NCT00950599|364930621|FG009|Follow-Up Period|Physician Decision|0|||
105801744|NCT00950599|364930612|FG000|Follow-Up Period|Poor/Noncompliance|0|||
105801745|NCT00950599|364930613|FG001|Follow-Up Period|Poor/Noncompliance|0|||
105801746|NCT00950599|364930614|FG002|Follow-Up Period|Poor/Noncompliance|0|||
105801747|NCT00950599|364930615|FG003|Follow-Up Period|Poor/Noncompliance|0|||
105801748|NCT00950599|364930616|FG004|Follow-Up Period|Poor/Noncompliance|0|||
105801749|NCT00950599|364930617|FG005|Follow-Up Period|Poor/Noncompliance|0|||
105801750|NCT00950599|364930618|FG006|Follow-Up Period|Poor/Noncompliance|0|||
105801751|NCT00950599|364930619|FG007|Follow-Up Period|Poor/Noncompliance|0|||
105801752|NCT00950599|364930620|FG008|Follow-Up Period|Poor/Noncompliance|1|||
105801753|NCT00950599|364930621|FG009|Follow-Up Period|Poor/Noncompliance|0|||
105801754|NCT00950599|364930612|FG000|Follow-Up Period|Subject withdrew Consent|0|||
105801755|NCT00950599|364930613|FG001|Follow-Up Period|Subject withdrew Consent|0|||
105801756|NCT00950599|364930614|FG002|Follow-Up Period|Subject withdrew Consent|0|||
105801757|NCT00950599|364930615|FG003|Follow-Up Period|Subject withdrew Consent|0|||
105801758|NCT00950599|364930616|FG004|Follow-Up Period|Subject withdrew Consent|0|||
105801759|NCT00950599|364930617|FG005|Follow-Up Period|Subject withdrew Consent|0|||
105801760|NCT00950599|364930618|FG006|Follow-Up Period|Subject withdrew Consent|0|||
105801761|NCT00950599|364930619|FG007|Follow-Up Period|Subject withdrew Consent|0|||
105801762|NCT00950599|364930620|FG008|Follow-Up Period|Subject withdrew Consent|2|||
105801763|NCT00950599|364930621|FG009|Follow-Up Period|Subject withdrew Consent|1|||
105801764|NCT02436135|364930622|FG000|Overall Study|Progressive Disease|3|||
105801765|NCT02436135|364930623|FG001|Overall Study|Progressive Disease|1|||
105801766|NCT02436135|364930622|FG000|Overall Study|Investigator Discretion|1|||
105801767|NCT02436135|364930623|FG001|Overall Study|Investigator Discretion|2|||
105801768|NCT02436135|364930622|FG000|Overall Study|Adverse Event|1|||
105801769|NCT02436135|364930623|FG001|Overall Study|Adverse Event|0|||
105801770|NCT02436135|364930622|FG000|Overall Study|Withdrawal by Participant|1|||
105801771|NCT02436135|364930623|FG001|Overall Study|Withdrawal by Participant|0|||
105801772|NCT02436135|364930622|FG000|Overall Study|Study Terminated By Sponsor|0|||
105801773|NCT02436135|364930623|FG001|Overall Study|Study Terminated By Sponsor|1|||
105801774|NCT02729194|364930624|FG000|Overall Study|Withdrawal by Subject|3|||
105801775|NCT01361607|364930626|FG000|Overall Study|Adverse Event|38|||
105801776|NCT01361607|364930627|FG001|Overall Study|Adverse Event|29|||
105565764|NCT05375955|364068697|FG004|Follow-up (up to 5 Weeks)|Other|0|||
105801777|NCT01361607|364930626|FG000|Overall Study|Withdrawal by Subject|19|||
105801778|NCT01361607|364930627|FG001|Overall Study|Withdrawal by Subject|8|||
105801779|NCT01361607|364930626|FG000|Overall Study|Withdrawal by Investigator|5|||
105801780|NCT01361607|364930627|FG001|Overall Study|Withdrawal by Investigator|3|||
105801781|NCT01361607|364930626|FG000|Overall Study|Lost to Follow-up|1|||
105801782|NCT01361607|364930627|FG001|Overall Study|Lost to Follow-up|0|||
105750949|NCT00289185|364740781|FG001|Overall Study|Lost to Follow-up|17|||
105750950|NCT00289185|364740780|FG000|Overall Study|Death|1|||
105750951|NCT00289185|364740781|FG001|Overall Study|Death|1|||
105750952|NCT01658579|364740782|FG000|Treatment Period A|Other|0|||
105750953|NCT01658579|364740783|FG001|Treatment Period A|Other|0|||
105750954|NCT01658579|364740784|FG002|Treatment Period A|Other|1|||
105750955|NCT01658579|364740785|FG003|Treatment Period A|Other|1|||
105750956|NCT01658579|364740782|FG000|Treatment Period A|Adverse Event|1|||
105750957|NCT01658579|364740783|FG001|Treatment Period A|Adverse Event|0|||
105750958|NCT01658579|364740784|FG002|Treatment Period A|Adverse Event|0|||
105750959|NCT01658579|364740785|FG003|Treatment Period A|Adverse Event|0|||
105750960|NCT01658579|364740782|FG000|Treatment Period B|Other|0|||
105750961|NCT01658579|364740783|FG001|Treatment Period B|Other|0|||
105750962|NCT01658579|364740784|FG002|Treatment Period B|Other|0|||
105750963|NCT01658579|364740785|FG003|Treatment Period B|Other|1|||
105750964|NCT01124448|364740786|FG000|Overall Study|Lost to Follow-up|0|||
105750965|NCT01124448|364740787|FG001|Overall Study|Lost to Follow-up|3|||
105801783|NCT01361607|364930626|FG000|Overall Study|Met Withdrawal Criteria|1|||
105801784|NCT01361607|364930627|FG001|Overall Study|Met Withdrawal Criteria|1|||
105801785|NCT01809314|364930628|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
105801786|NCT01809314|364930628|FG000|Overall Study|Adverse Event|6|||
105801787|NCT01809314|364930628|FG000|Overall Study|Insufficient Therapeutic Response|14|||
105801788|NCT01809314|364930628|FG000|Overall Study|Lost to Follow-up|724|||
105801789|NCT01684722|364930629|FG000|Overall Study|Lost to Follow-up|78|||
105801790|NCT01684722|364930630|FG001|Overall Study|Lost to Follow-up|56|||
105801791|NCT01684722|364930631|FG002|Overall Study|Lost to Follow-up|75|||
105801792|NCT01684722|364930632|FG003|Overall Study|Lost to Follow-up|89|||
105801793|NCT01684722|364930629|FG000|Overall Study|Death|19|||
105801794|NCT01684722|364930630|FG001|Overall Study|Death|21|||
105801795|NCT01684722|364930631|FG002|Overall Study|Death|19|||
105801796|NCT01684722|364930632|FG003|Overall Study|Death|21|||
105750966|NCT01124448|364740786|FG000|Overall Study|Protocol Violation|2|||
105750967|NCT01124448|364740787|FG001|Overall Study|Protocol Violation|0|||
105750968|NCT02432040|364740788|FG000|Overall Study|Lack of Efficacy|3|||
105750969|NCT02432040|364740789|FG001|Overall Study|Lack of Efficacy|0|||
105750970|NCT02432040|364740788|FG000|Overall Study|Lost to Follow-up|4|||
105750971|NCT02432040|364740789|FG001|Overall Study|Lost to Follow-up|5|||
105750972|NCT02432040|364740788|FG000|Overall Study|Physician Decision|1|||
105750973|NCT02432040|364740789|FG001|Overall Study|Physician Decision|1|||
105750974|NCT03198754|364740790|FG000|Overall Study|Withdrawal by Subject|5|||
105750975|NCT03198754|364740791|FG001|Overall Study|Withdrawal by Subject|4|||
105483586|NCT00045942|363782720|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
105483587|NCT00045942|363782712|FG000|PKC412A2104E1|Adverse Event|0|||
105483588|NCT00045942|363782713|FG001|PKC412A2104E1|Adverse Event|1|||
105483589|NCT00045942|363782714|FG002|PKC412A2104E1|Adverse Event|1|||
105750976|NCT03198754|364740790|FG000|Overall Study|Lost to Follow-up|4|||
105750977|NCT03198754|364740791|FG001|Overall Study|Lost to Follow-up|3|||
105750978|NCT03198754|364740790|FG000|Overall Study|Ineligible|2|||
105801797|NCT00219557|364930634|FG000|Phase 1|Lack of Efficacy|3|||
105801798|NCT00219557|364930635|FG001|Phase 1|Lack of Efficacy|0|||
105801799|NCT00219557|364930636|FG002|Phase 1|Lack of Efficacy|0|||
105750979|NCT03198754|364740791|FG001|Overall Study|Ineligible|1|||
105750980|NCT02108951|364740792|FG000|Overall Study|Lost to Follow-up|1|||
105750981|NCT02108951|364740792|FG000|Overall Study|Patient's/guardian's decision|1|||
105750982|NCT02108951|364740792|FG000|Overall Study|Study Terminated by Sponsor|14|||
105750983|NCT00305253|364740795|FG000|Overall Study|Withdrawal by Subject|0|||
105750984|NCT00305253|364740796|FG001|Overall Study|Withdrawal by Subject|1|||
105750985|NCT01098461|364740797|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
105750986|NCT01098461|364740798|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
105750987|NCT01098461|364740799|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
105750988|NCT01098461|364740800|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
105750989|NCT01098461|364740797|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
105750990|NCT01098461|364740798|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
105750991|NCT01098461|364740799|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
105750992|NCT01098461|364740800|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
105750993|NCT01098461|364740797|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
105750994|NCT01098461|364740798|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
105750995|NCT01098461|364740799|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
105750996|NCT01098461|364740800|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
105750997|NCT01098461|364740797|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
105750998|NCT01098461|364740798|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
105750999|NCT01098461|364740799|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
105751000|NCT01098461|364740800|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
105751001|NCT01098461|364740797|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
105751002|NCT01098461|364740798|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
105751003|NCT01098461|364740799|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
105751004|NCT01098461|364740800|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
105751005|NCT01098461|364740797|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
105751006|NCT01098461|364740798|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
105751007|NCT01098461|364740799|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
105751008|NCT01098461|364740800|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
105751009|NCT01098461|364740797|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
105751010|NCT01098461|364740798|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
105751011|NCT01098461|364740799|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
105751012|NCT01098461|364740800|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
105751013|NCT01514188|364740801|FG000|Overall Study|Adverse Event|3|||
105751014|NCT01514188|364740802|FG001|Overall Study|Adverse Event|5|||
105751015|NCT01514188|364740801|FG000|Overall Study|Withdrawal by Subject|2|||
105751016|NCT01514188|364740802|FG001|Overall Study|Withdrawal by Subject|4|||
105751017|NCT01514188|364740801|FG000|Overall Study|Protocol Violation|2|||
105751018|NCT01514188|364740802|FG001|Overall Study|Protocol Violation|4|||
105751019|NCT01514188|364740801|FG000|Overall Study|Physician Decision|0|||
105751020|NCT01514188|364740802|FG001|Overall Study|Physician Decision|2|||
105751021|NCT01514188|364740801|FG000|Overall Study|Disease Progression|13|||
105751022|NCT01514188|364740802|FG001|Overall Study|Disease Progression|14|||
105751023|NCT01514188|364740801|FG000|Overall Study|Death|1|||
105751024|NCT01514188|364740802|FG001|Overall Study|Death|3|||
105751025|NCT01514188|364740801|FG000|Overall Study|Other|2|||
105751026|NCT01514188|364740802|FG001|Overall Study|Other|1|||
105751027|NCT02932332|364740803|FG000|Overall Study|Withdrawal by Subject|1|||
105751028|NCT02932332|364740804|FG001|Overall Study|Withdrawal by Subject|1|||
105751029|NCT02932332|364740805|FG002|Overall Study|Withdrawal by Subject|0|||
105751030|NCT02932332|364740806|FG003|Overall Study|Withdrawal by Subject|1|||
105751031|NCT02932332|364740803|FG000|Overall Study|Chest pain|0|||
105751032|NCT02932332|364740804|FG001|Overall Study|Chest pain|0|||
105751033|NCT02932332|364740805|FG002|Overall Study|Chest pain|0|||
105751034|NCT02932332|364740806|FG003|Overall Study|Chest pain|1|||
105751035|NCT02932332|364740803|FG000|Overall Study|Not Dyspneic cough|1|||
105751036|NCT02932332|364740804|FG001|Overall Study|Not Dyspneic cough|2|||
105751037|NCT02932332|364740805|FG002|Overall Study|Not Dyspneic cough|1|||
105751038|NCT02932332|364740806|FG003|Overall Study|Not Dyspneic cough|0|||
105751039|NCT05373706|364740807|FG000|Overall Study|Lost to Follow-up|2|||
105751040|NCT05373706|364740808|FG001|Overall Study|Lost to Follow-up|2|||
105483590|NCT00045942|363782715|FG003|PKC412A2104E1|Adverse Event|3|||
105483591|NCT00045942|363782716|FG004|PKC412A2104E1|Adverse Event|6|||
105483592|NCT00045942|363782717|FG005|PKC412A2104E1|Adverse Event|0|||
105483593|NCT00045942|363782718|FG006|PKC412A2104E1|Adverse Event|0|||
105483594|NCT00045942|363782719|FG007|PKC412A2104E1|Adverse Event|0|||
105483595|NCT00045942|363782720|FG008|PKC412A2104E1|Adverse Event|0|||
105483596|NCT00045942|363782712|FG000|PKC412A2104E1|Death|0|||
105483597|NCT00045942|363782713|FG001|PKC412A2104E1|Death|4|||
105483598|NCT00045942|363782714|FG002|PKC412A2104E1|Death|1|||
105483599|NCT00045942|363782715|FG003|PKC412A2104E1|Death|1|||
105483600|NCT00045942|363782716|FG004|PKC412A2104E1|Death|1|||
105751041|NCT01486784|364740809|FG000|Overall Study|Withdrawal by Subject|0|||
105751042|NCT01486784|364740810|FG001|Overall Study|Withdrawal by Subject|0|||
105751043|NCT01486784|364740811|FG002|Overall Study|Withdrawal by Subject|1|||
105751044|NCT01486784|364740812|FG003|Overall Study|Withdrawal by Subject|0|||
105751045|NCT01486784|364740813|FG004|Overall Study|Withdrawal by Subject|1|||
105751046|NCT01486784|364740814|FG005|Overall Study|Withdrawal by Subject|2|||
105751047|NCT01486784|364740809|FG000|Overall Study|Subject did not meet entry criteria|0|||
105751048|NCT01486784|364740810|FG001|Overall Study|Subject did not meet entry criteria|0|||
105751049|NCT01486784|364740811|FG002|Overall Study|Subject did not meet entry criteria|0|||
105751050|NCT01486784|364740812|FG003|Overall Study|Subject did not meet entry criteria|0|||
105751051|NCT01486784|364740813|FG004|Overall Study|Subject did not meet entry criteria|1|||
105751052|NCT01486784|364740814|FG005|Overall Study|Subject did not meet entry criteria|0|||
105751053|NCT01486784|364740809|FG000|Overall Study|Death|0|||
105751054|NCT01486784|364740810|FG001|Overall Study|Death|0|||
105751055|NCT01486784|364740811|FG002|Overall Study|Death|0|||
105751056|NCT01486784|364740812|FG003|Overall Study|Death|0|||
105751057|NCT01486784|364740813|FG004|Overall Study|Death|0|||
105751058|NCT01486784|364740814|FG005|Overall Study|Death|1|||
105751059|NCT01021852|364740815|FG000|Treatment Period 1|Adverse Event|3|||
105751060|NCT01021852|364740816|FG001|Treatment Period 1|Adverse Event|1|||
105751061|NCT01021852|364740817|FG002|Treatment Period 1|Adverse Event|1|||
105751062|NCT01021852|364740818|FG003|Treatment Period 1|Adverse Event|0|||
105751063|NCT01021852|364740819|FG004|Treatment Period 1|Adverse Event|2|||
105751064|NCT01021852|364740820|FG005|Treatment Period 1|Adverse Event|2|||
105751065|NCT01021852|364740821|FG006|Treatment Period 1|Adverse Event|0|||
105751066|NCT01021852|364740822|FG007|Treatment Period 1|Adverse Event|0|||
105751067|NCT01021852|364740815|FG000|Treatment Period 1|Pregnancy|0|||
105751068|NCT01021852|364740816|FG001|Treatment Period 1|Pregnancy|0|||
105751069|NCT01021852|364740817|FG002|Treatment Period 1|Pregnancy|1|||
105751070|NCT01021852|364740818|FG003|Treatment Period 1|Pregnancy|0|||
105751071|NCT01021852|364740819|FG004|Treatment Period 1|Pregnancy|0|||
105751072|NCT01021852|364740820|FG005|Treatment Period 1|Pregnancy|0|||
105751073|NCT01021852|364740821|FG006|Treatment Period 1|Pregnancy|0|||
105751074|NCT01021852|364740822|FG007|Treatment Period 1|Pregnancy|0|||
105751075|NCT01021852|364740815|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105751076|NCT01021852|364740816|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105751077|NCT01021852|364740817|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105751078|NCT01021852|364740818|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105751079|NCT01021852|364740819|FG004|Treatment Period 1|Withdrawal by Subject|1|||
105751080|NCT01021852|364740820|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105751081|NCT01021852|364740821|FG006|Treatment Period 1|Withdrawal by Subject|0|||
105751082|NCT01021852|364740822|FG007|Treatment Period 1|Withdrawal by Subject|1|||
105751083|NCT01021852|364740815|FG000|Treatment Period 1|Not Treated|0|||
105751084|NCT01021852|364740816|FG001|Treatment Period 1|Not Treated|0|||
105751085|NCT01021852|364740817|FG002|Treatment Period 1|Not Treated|0|||
105751086|NCT01021852|364740818|FG003|Treatment Period 1|Not Treated|2|||
105751087|NCT01021852|364740819|FG004|Treatment Period 1|Not Treated|0|||
105751088|NCT01021852|364740820|FG005|Treatment Period 1|Not Treated|0|||
105751089|NCT01021852|364740821|FG006|Treatment Period 1|Not Treated|0|||
105751090|NCT01021852|364740822|FG007|Treatment Period 1|Not Treated|0|||
105751091|NCT01021852|364740815|FG000|Washout Period-Placebo|Adverse Event|0|||
105751092|NCT01021852|364740816|FG001|Washout Period-Placebo|Adverse Event|0|||
105751093|NCT01021852|364740817|FG002|Washout Period-Placebo|Adverse Event|0|||
105751094|NCT01021852|364740818|FG003|Washout Period-Placebo|Adverse Event|1|||
105751095|NCT01021852|364740819|FG004|Washout Period-Placebo|Adverse Event|0|||
105751096|NCT01021852|364740820|FG005|Washout Period-Placebo|Adverse Event|1|||
105751097|NCT01021852|364740821|FG006|Washout Period-Placebo|Adverse Event|0|||
105751098|NCT01021852|364740822|FG007|Washout Period-Placebo|Adverse Event|0|||
105751099|NCT01021852|364740815|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
105751100|NCT01021852|364740816|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
105751101|NCT01021852|364740817|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
105751102|NCT01021852|364740818|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
105751103|NCT01021852|364740819|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
105751104|NCT01021852|364740820|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
105751105|NCT01021852|364740821|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
105751106|NCT01021852|364740822|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
105751107|NCT01021852|364740815|FG000|Washout Period-Placebo|Protocol Violation|0|||
105751108|NCT01021852|364740816|FG001|Washout Period-Placebo|Protocol Violation|0|||
105751109|NCT01021852|364740817|FG002|Washout Period-Placebo|Protocol Violation|0|||
105751110|NCT01021852|364740818|FG003|Washout Period-Placebo|Protocol Violation|0|||
105751111|NCT01021852|364740819|FG004|Washout Period-Placebo|Protocol Violation|0|||
105751112|NCT01021852|364740820|FG005|Washout Period-Placebo|Protocol Violation|0|||
105751113|NCT01021852|364740821|FG006|Washout Period-Placebo|Protocol Violation|1|||
105751114|NCT01021852|364740822|FG007|Washout Period-Placebo|Protocol Violation|0|||
105751115|NCT01021852|364740815|FG000|Washout Period-No Drug|Adverse Event|1|||
105751116|NCT01021852|364740816|FG001|Washout Period-No Drug|Adverse Event|0|||
105751117|NCT01021852|364740817|FG002|Washout Period-No Drug|Adverse Event|0|||
105751118|NCT01021852|364740818|FG003|Washout Period-No Drug|Adverse Event|0|||
105751119|NCT01021852|364740819|FG004|Washout Period-No Drug|Adverse Event|0|||
105751120|NCT01021852|364740820|FG005|Washout Period-No Drug|Adverse Event|1|||
105751121|NCT01021852|364740821|FG006|Washout Period-No Drug|Adverse Event|0|||
105751122|NCT01021852|364740822|FG007|Washout Period-No Drug|Adverse Event|0|||
105751123|NCT01021852|364740815|FG000|Treatment Period 2|Adverse Event|0|||
105751124|NCT01021852|364740816|FG001|Treatment Period 2|Adverse Event|1|||
105751125|NCT01021852|364740817|FG002|Treatment Period 2|Adverse Event|0|||
105751126|NCT01021852|364740818|FG003|Treatment Period 2|Adverse Event|0|||
105751127|NCT01021852|364740819|FG004|Treatment Period 2|Adverse Event|1|||
105751128|NCT01021852|364740820|FG005|Treatment Period 2|Adverse Event|0|||
105751129|NCT01021852|364740821|FG006|Treatment Period 2|Adverse Event|1|||
105751130|NCT01021852|364740822|FG007|Treatment Period 2|Adverse Event|0|||
105751131|NCT01021852|364740815|FG000|Treatment Period 2|Lack of Efficacy|0|||
105751132|NCT01021852|364740816|FG001|Treatment Period 2|Lack of Efficacy|0|||
105751133|NCT01021852|364740817|FG002|Treatment Period 2|Lack of Efficacy|0|||
105801800|NCT00219557|364930634|FG000|Phase 1|Adverse Event|2|||
105751134|NCT01021852|364740818|FG003|Treatment Period 2|Lack of Efficacy|0|||
105751135|NCT01021852|364740819|FG004|Treatment Period 2|Lack of Efficacy|0|||
105751136|NCT01021852|364740820|FG005|Treatment Period 2|Lack of Efficacy|1|||
105751137|NCT01021852|364740821|FG006|Treatment Period 2|Lack of Efficacy|0|||
105751138|NCT01021852|364740822|FG007|Treatment Period 2|Lack of Efficacy|0|||
105751139|NCT01021852|364740815|FG000|Treatment Period 2|Physician Decision|0|||
105751140|NCT01021852|364740816|FG001|Treatment Period 2|Physician Decision|0|||
105751141|NCT01021852|364740817|FG002|Treatment Period 2|Physician Decision|1|||
105751142|NCT01021852|364740818|FG003|Treatment Period 2|Physician Decision|0|||
105751143|NCT01021852|364740819|FG004|Treatment Period 2|Physician Decision|0|||
105751144|NCT01021852|364740820|FG005|Treatment Period 2|Physician Decision|0|||
105751145|NCT01021852|364740821|FG006|Treatment Period 2|Physician Decision|0|||
105751146|NCT01021852|364740822|FG007|Treatment Period 2|Physician Decision|0|||
105751147|NCT01021852|364740815|FG000|Treatment Period 2|Protocol Violation|0|||
105801801|NCT00219557|364930635|FG001|Phase 1|Adverse Event|0|||
105751148|NCT01021852|364740816|FG001|Treatment Period 2|Protocol Violation|0|||
105751149|NCT01021852|364740817|FG002|Treatment Period 2|Protocol Violation|0|||
105751150|NCT01021852|364740818|FG003|Treatment Period 2|Protocol Violation|0|||
105751151|NCT01021852|364740819|FG004|Treatment Period 2|Protocol Violation|1|||
105751152|NCT01021852|364740820|FG005|Treatment Period 2|Protocol Violation|0|||
105751153|NCT01021852|364740821|FG006|Treatment Period 2|Protocol Violation|1|||
105751154|NCT01021852|364740822|FG007|Treatment Period 2|Protocol Violation|0|||
105751155|NCT01021852|364740815|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105751156|NCT01021852|364740816|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105751157|NCT01021852|364740817|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105751158|NCT01021852|364740818|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105751159|NCT01021852|364740819|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105360228|NCT00534638|363323835|FG001|Overall Study|Withdrawal by Subject|4|||
105360229|NCT00534638|363323834|FG000|Overall Study|Migrated/moved from study area|13|||
105751160|NCT01021852|364740820|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105751161|NCT01021852|364740821|FG006|Treatment Period 2|Withdrawal by Subject|1|||
105751162|NCT01021852|364740822|FG007|Treatment Period 2|Withdrawal by Subject|2|||
105751163|NCT02841787|364740823|FG000|Overall Study|Lost to Follow-up|1|||
105751164|NCT02841787|364740824|FG001|Overall Study|Lost to Follow-up|0|||
105751165|NCT02841787|364740825|FG002|Overall Study|Lost to Follow-up|0|||
105751166|NCT02841787|364740823|FG000|Overall Study|Symptoms dropped below threshold|1|||
105751167|NCT02841787|364740824|FG001|Overall Study|Symptoms dropped below threshold|0|||
105751168|NCT02841787|364740825|FG002|Overall Study|Symptoms dropped below threshold|0|||
105751169|NCT02841787|364740823|FG000|Overall Study|Withdrawal by Subject|1|||
105751170|NCT02841787|364740824|FG001|Overall Study|Withdrawal by Subject|4|||
105751171|NCT02841787|364740825|FG002|Overall Study|Withdrawal by Subject|0|||
105751172|NCT00712322|364740831|FG000|Overall Study|Protocol deviation|0|||
105751173|NCT00712322|364740832|FG001|Overall Study|Protocol deviation|1|||
105751174|NCT00712322|364740833|FG002|Overall Study|Protocol deviation|0|||
105751175|NCT01025817|364740835|FG000|Completed Study Medication|Adverse Event|66|||
105751176|NCT01025817|364740836|FG001|Completed Study Medication|Adverse Event|39|||
105751177|NCT01025817|364740835|FG000|Completed Study Medication|Protocol Deviation|9|||
105751178|NCT01025817|364740836|FG001|Completed Study Medication|Protocol Deviation|8|||
105751179|NCT01025817|364740835|FG000|Completed Study Medication|Withdrawal by Subject|8|||
105751180|NCT01025817|364740836|FG001|Completed Study Medication|Withdrawal by Subject|9|||
105360230|NCT00534638|363323835|FG001|Overall Study|Migrated/moved from study area|11|||
105360231|NCT00534638|363323834|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
105751181|NCT01025817|364740835|FG000|Completed Study Medication|Administrative problems|7|||
105751182|NCT01025817|364740836|FG001|Completed Study Medication|Administrative problems|5|||
105751183|NCT01025817|364740835|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
105751184|NCT01025817|364740836|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
105483601|NCT00045942|363782717|FG005|PKC412A2104E1|Death|0|||
105751185|NCT01025817|364740835|FG000|Completed Study Medication|Abnormal test procedure|4|||
105360232|NCT00534638|363323835|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
105751186|NCT01025817|364740836|FG001|Completed Study Medication|Abnormal test procedure|0|||
105751187|NCT01025817|364740835|FG000|Completed Study Medication|Graft loss|2|||
105751188|NCT01025817|364740836|FG001|Completed Study Medication|Graft loss|5|||
105751189|NCT01025817|364740835|FG000|Completed Study Medication|Death|2|||
105751190|NCT01025817|364740836|FG001|Completed Study Medication|Death|2|||
105751191|NCT01025817|364740835|FG000|Completed Study Medication|Abnormal lab values|0|||
105751192|NCT01025817|364740836|FG001|Completed Study Medication|Abnormal lab values|2|||
105751193|NCT01025817|364740835|FG000|Completed Study Medication|Subject no longer required study drug|0|||
105751194|NCT01025817|364740836|FG001|Completed Study Medication|Subject no longer required study drug|1|||
105751195|NCT01025817|364740835|FG000|Completed Study Medication|Lost to Follow-up|0|||
105751196|NCT01025817|364740836|FG001|Completed Study Medication|Lost to Follow-up|1|||
105751197|NCT01025817|364740835|FG000|Completed Study|Withdrawal by Subject|8|||
105751198|NCT01025817|364740836|FG001|Completed Study|Withdrawal by Subject|16|||
105751199|NCT01025817|364740835|FG000|Completed Study|Death|6|||
105751200|NCT01025817|364740836|FG001|Completed Study|Death|5|||
105751201|NCT01025817|364740835|FG000|Completed Study|Missing|2|||
105751202|NCT01025817|364740836|FG001|Completed Study|Missing|0|||
105751203|NCT01025817|364740835|FG000|Completed Study|Lost to Follow-up|0|||
105751204|NCT01025817|364740836|FG001|Completed Study|Lost to Follow-up|1|||
105751205|NCT02237157|364740837|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
105751206|NCT02237157|364740838|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
105751207|NCT02237157|364740839|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
105751208|NCT02237157|364740840|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
105751209|NCT02237157|364740837|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
105751210|NCT02237157|364740838|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
105751211|NCT02237157|364740839|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
105751212|NCT02237157|364740840|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
105751213|NCT01996748|364740841|FG000|Overall Study|Personal reason|1|||
105751214|NCT01996748|364740842|FG001|Overall Study|Personal reason|0|||
105751215|NCT01996748|364740841|FG000|Overall Study|Physician Decision|2|||
105751216|NCT01996748|364740842|FG001|Overall Study|Physician Decision|0|||
105751217|NCT01996748|364740841|FG000|Overall Study|Adverse Event|1|||
105751218|NCT01996748|364740842|FG001|Overall Study|Adverse Event|4|||
105751219|NCT01996748|364740841|FG000|Overall Study|Withdrawal by Subject|0|||
105751220|NCT01996748|364740842|FG001|Overall Study|Withdrawal by Subject|1|||
105751221|NCT01996748|364740841|FG000|Overall Study|Lost to Follow-up|4|||
105751222|NCT01996748|364740842|FG001|Overall Study|Lost to Follow-up|1|||
105751223|NCT00488592|364740845|FG000|Overall Study|Withdrawal by Subject|1|||
105751224|NCT00488592|364740845|FG000|Overall Study|Disease progression|1|||
105751225|NCT00488592|364740845|FG000|Overall Study|Enrolled but not treated|1|||
105751226|NCT00603980|364740847|FG000|Study Qualification|Protocol Violation|3|||
105751227|NCT00603980|364740847|FG000|Study Qualification|Inconsistent data reporting|13|||
105751228|NCT00603980|364740847|FG000|Main Study|14th subject completed trial|1|||
105751229|NCT00702052|364740848|FG000|Overall Study|Adverse Event|23|||
105751230|NCT00702052|364740848|FG000|Overall Study|Disease Progression|30|||
105360233|NCT00534638|363323834|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
105360234|NCT00534638|363323835|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
105360235|NCT00534638|363323834|FG000|Overall Study|Other|1685|||
105360236|NCT00534638|363323835|FG001|Overall Study|Other|902|||
105565765|NCT05375955|364068698|FG005|Follow-up (up to 5 Weeks)|Other|0|||
105565766|NCT05375955|364068699|FG006|Follow-up (up to 5 Weeks)|Other|0|||
105565767|NCT05375955|364068693|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
105751231|NCT00702052|364740848|FG000|Overall Study|Withdrawal by Subject|5|||
105751232|NCT01627067|364740849|FG000|Overall Study|Screen Failure|1|||
105751233|NCT01096849|364740853|FG000|Overall Study|Consent Withdrawn|1|||
105751234|NCT01096849|364740854|FG001|Overall Study|Consent Withdrawn|4|||
105751235|NCT01096849|364740855|FG002|Overall Study|Consent Withdrawn|2|||
105751236|NCT01096849|364740853|FG000|Overall Study|Lack of Efficacy|0|||
105751237|NCT01096849|364740854|FG001|Overall Study|Lack of Efficacy|2|||
105751238|NCT01096849|364740855|FG002|Overall Study|Lack of Efficacy|0|||
105801802|NCT00219557|364930636|FG002|Phase 1|Adverse Event|0|||
105801803|NCT00219557|364930634|FG000|Phase 1|Withdrawal by Subject|1|||
105801804|NCT00219557|364930635|FG001|Phase 1|Withdrawal by Subject|0|||
105801805|NCT00219557|364930636|FG002|Phase 1|Withdrawal by Subject|0|||
105801806|NCT00219557|364930634|FG000|Phase 1|Started chemotherapy at other institute|1|||
105801807|NCT00219557|364930635|FG001|Phase 1|Started chemotherapy at other institute|0|||
105801808|NCT00219557|364930636|FG002|Phase 1|Started chemotherapy at other institute|0|||
105801809|NCT00219557|364930634|FG000|Phase 2|Lack of Efficacy|0|||
105801810|NCT00219557|364930635|FG001|Phase 2|Lack of Efficacy|21|||
105801811|NCT00219557|364930636|FG002|Phase 2|Lack of Efficacy|15|||
105801812|NCT00219557|364930634|FG000|Phase 2|Adverse Event|0|||
105801813|NCT00219557|364930635|FG001|Phase 2|Adverse Event|22|||
105801814|NCT00219557|364930636|FG002|Phase 2|Adverse Event|2|||
105801815|NCT00219557|364930634|FG000|Phase 2|Death|0|||
105801816|NCT00219557|364930635|FG001|Phase 2|Death|8|||
105801817|NCT00219557|364930636|FG002|Phase 2|Death|2|||
105801818|NCT00219557|364930634|FG000|Phase 2|Other|0|||
105801819|NCT00219557|364930635|FG001|Phase 2|Other|8|||
105801820|NCT00219557|364930636|FG002|Phase 2|Other|6|||
105801821|NCT00219557|364930634|FG000|Phase 2|Withdrawal by Subject|0|||
105801822|NCT00219557|364930635|FG001|Phase 2|Withdrawal by Subject|9|||
105801823|NCT00219557|364930636|FG002|Phase 2|Withdrawal by Subject|5|||
105801824|NCT00219557|364930634|FG000|Phase 2|Treatment not received|0|||
105565768|NCT05375955|364068694|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
105565769|NCT05375955|364068695|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
105565770|NCT05375955|364068696|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
105565771|NCT05375955|364068697|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
105565772|NCT05375955|364068698|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
105801825|NCT00219557|364930635|FG001|Phase 2|Treatment not received|1|||
105801826|NCT00219557|364930636|FG002|Phase 2|Treatment not received|3|||
105801827|NCT01427803|364930639|FG000|Overall Study|Lost to Follow-up|32|||
105801828|NCT01427803|364930640|FG001|Overall Study|Lost to Follow-up|26|||
105801829|NCT01427803|364930639|FG000|Overall Study|Withdrawal by Subject|20|||
105801830|NCT01427803|364930640|FG001|Overall Study|Withdrawal by Subject|0|||
105801831|NCT01427803|364930639|FG000|Overall Study|Unable to complete full treatment period|6|||
105801832|NCT01427803|364930640|FG001|Overall Study|Unable to complete full treatment period|0|||
105801833|NCT01427803|364930639|FG000|Overall Study|Protocol Violation|1|||
105801834|NCT01427803|364930640|FG001|Overall Study|Protocol Violation|0|||
105801835|NCT01427803|364930639|FG000|Overall Study|Physician Decision|3|||
105801836|NCT01427803|364930640|FG001|Overall Study|Physician Decision|0|||
105801837|NCT01427803|364930639|FG000|Overall Study|did not take product|1|||
105801838|NCT01427803|364930640|FG001|Overall Study|did not take product|0|||
105801839|NCT01612156|364930644|FG000|Overall Study|Protocol Violation|2|||
105801840|NCT01612156|364930645|FG001|Overall Study|Protocol Violation|0|||
105801841|NCT00373685|364930646|FG000|Overall Study|Death|2|||
105801842|NCT00373685|364930647|FG001|Overall Study|Death|1|||
105801843|NCT00373685|364930646|FG000|Overall Study|Adverse Event|278|||
105801844|NCT00373685|364930647|FG001|Overall Study|Adverse Event|253|||
105801845|NCT00373685|364930646|FG000|Overall Study|Insufficient clinical response|169|||
105801846|NCT00373685|364930647|FG001|Overall Study|Insufficient clinical response|119|||
105801847|NCT00373685|364930646|FG000|Overall Study|Did not meet entrance criteria|167|||
105801848|NCT00373685|364930647|FG001|Overall Study|Did not meet entrance criteria|184|||
105801849|NCT00373685|364930646|FG000|Overall Study|Lost to follow up|83|||
105801850|NCT00373685|364930647|FG001|Overall Study|Lost to follow up|103|||
105801851|NCT00373685|364930646|FG000|Overall Study|No longer willing to participate|337|||
105801852|NCT00373685|364930647|FG001|Overall Study|No longer willing to participate|352|||
105801853|NCT00373685|364930646|FG000|Overall Study|Other|149|||
105801854|NCT00373685|364930647|FG001|Overall Study|Other|146|||
105801855|NCT00373685|364930646|FG000|Overall Study|Protocol Violation|191|||
105801856|NCT00373685|364930647|FG001|Overall Study|Protocol Violation|182|||
105801857|NCT00373685|364930646|FG000|Overall Study|Final Status Unknown|12|||
105801858|NCT00373685|364930647|FG001|Overall Study|Final Status Unknown|4|||
105801859|NCT00373685|364930646|FG000|Overall Study|Randomized, not treated|51|||
105801860|NCT00373685|364930647|FG001|Overall Study|Randomized, not treated|77|||
105801861|NCT02570165|364930648|FG000|Overall Study|Adverse Event|1|||
105801862|NCT02570165|364930649|FG001|Overall Study|Adverse Event|0|||
105801863|NCT02570165|364930650|FG002|Overall Study|Adverse Event|2|||
105801864|NCT02570165|364930651|FG003|Overall Study|Adverse Event|0|||
105801865|NCT02570165|364930652|FG004|Overall Study|Adverse Event|0|||
105801866|NCT02570165|364930653|FG005|Overall Study|Adverse Event|0|||
105801867|NCT02570165|364930654|FG006|Overall Study|Adverse Event|0|||
105801868|NCT02570165|364930648|FG000|Overall Study|Lack of Efficacy|0|||
105801869|NCT02570165|364930649|FG001|Overall Study|Lack of Efficacy|1|||
105801870|NCT02570165|364930650|FG002|Overall Study|Lack of Efficacy|0|||
105801871|NCT02570165|364930651|FG003|Overall Study|Lack of Efficacy|0|||
105801872|NCT02570165|364930652|FG004|Overall Study|Lack of Efficacy|4|||
105801873|NCT02570165|364930653|FG005|Overall Study|Lack of Efficacy|0|||
105801874|NCT02570165|364930654|FG006|Overall Study|Lack of Efficacy|0|||
105801875|NCT02570165|364930648|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
105801876|NCT02570165|364930649|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
105801877|NCT02570165|364930650|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
105801878|NCT02570165|364930651|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
105801879|NCT02570165|364930652|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
105801880|NCT02570165|364930653|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
105801881|NCT02570165|364930654|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
105801882|NCT02570165|364930648|FG000|Overall Study|Lost to Follow-up|0|||
105801883|NCT02570165|364930649|FG001|Overall Study|Lost to Follow-up|0|||
105801884|NCT02570165|364930650|FG002|Overall Study|Lost to Follow-up|1|||
105801885|NCT02570165|364930651|FG003|Overall Study|Lost to Follow-up|1|||
105801886|NCT02570165|364930652|FG004|Overall Study|Lost to Follow-up|0|||
105801887|NCT02570165|364930653|FG005|Overall Study|Lost to Follow-up|0|||
105801888|NCT02570165|364930654|FG006|Overall Study|Lost to Follow-up|0|||
105801889|NCT02570165|364930648|FG000|Overall Study|Physician Decision|0|||
105801890|NCT02570165|364930649|FG001|Overall Study|Physician Decision|1|||
105801891|NCT02570165|364930650|FG002|Overall Study|Physician Decision|0|||
105801892|NCT02570165|364930651|FG003|Overall Study|Physician Decision|0|||
105801893|NCT02570165|364930652|FG004|Overall Study|Physician Decision|0|||
105801894|NCT02570165|364930653|FG005|Overall Study|Physician Decision|0|||
105801895|NCT02570165|364930654|FG006|Overall Study|Physician Decision|0|||
105483602|NCT00045942|363782718|FG006|PKC412A2104E1|Death|0|||
105801896|NCT02570165|364930648|FG000|Overall Study|Withdrawal by Subject|0|||
105801897|NCT02570165|364930649|FG001|Overall Study|Withdrawal by Subject|0|||
105801898|NCT02570165|364930650|FG002|Overall Study|Withdrawal by Subject|0|||
105801899|NCT02570165|364930651|FG003|Overall Study|Withdrawal by Subject|2|||
105801900|NCT02570165|364930652|FG004|Overall Study|Withdrawal by Subject|1|||
105801901|NCT02570165|364930653|FG005|Overall Study|Withdrawal by Subject|0|||
105801902|NCT02570165|364930654|FG006|Overall Study|Withdrawal by Subject|0|||
105801903|NCT02570165|364930648|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
105801904|NCT02570165|364930649|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
105801905|NCT02570165|364930650|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
105801906|NCT02570165|364930651|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
105801907|NCT02570165|364930652|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
105801908|NCT02570165|364930653|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
105801909|NCT02570165|364930654|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
105801910|NCT02570165|364930648|FG000|Overall Study|Withdrawal Request by GSK|0|||
105801911|NCT02570165|364930649|FG001|Overall Study|Withdrawal Request by GSK|0|||
105801912|NCT02570165|364930650|FG002|Overall Study|Withdrawal Request by GSK|2|||
105801913|NCT02570165|364930651|FG003|Overall Study|Withdrawal Request by GSK|0|||
105801914|NCT02570165|364930652|FG004|Overall Study|Withdrawal Request by GSK|0|||
105801915|NCT02570165|364930653|FG005|Overall Study|Withdrawal Request by GSK|0|||
105801916|NCT02570165|364930654|FG006|Overall Study|Withdrawal Request by GSK|0|||
105801917|NCT01208402|364930655|FG000|Overall Study|Withdrawal by Subject|1|||
105801918|NCT01208402|364930656|FG001|Overall Study|Withdrawal by Subject|0|||
105801919|NCT05288673|364930657|FG000|Overall Study|Consent withdrawn by subject|0|||
105801920|NCT05288673|364930658|FG001|Overall Study|Consent withdrawn by subject|0|||
105801921|NCT05288673|364930659|FG002|Overall Study|Consent withdrawn by subject|1|||
105801922|NCT01335464|364930660|FG000|Overall Study|Adverse Event|15|||
105801923|NCT01335464|364930661|FG001|Overall Study|Adverse Event|25|||
105801924|NCT01335464|364930660|FG000|Overall Study|Non compliant with protocol|2|||
105801925|NCT01335464|364930661|FG001|Overall Study|Non compliant with protocol|0|||
105801926|NCT01335464|364930660|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
105801927|NCT01335464|364930661|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
105801928|NCT01335464|364930660|FG000|Overall Study|Not treated|2|||
105801929|NCT01335464|364930661|FG001|Overall Study|Not treated|0|||
105801930|NCT01335464|364930660|FG000|Overall Study|Reason other than those stated above|1|||
105801931|NCT01335464|364930661|FG001|Overall Study|Reason other than those stated above|1|||
105801932|NCT03156270|364930662|FG000|Overall Study|Failed pre-treatment screening|1|||
105801933|NCT03156270|364930662|FG000|Overall Study|Lost to Follow-up|1|||
105801934|NCT00591253|364930663|FG000|Overall Study|Adverse Event|3|||
105801935|NCT00591253|364930664|FG001|Overall Study|Adverse Event|3|||
105801936|NCT00591253|364930665|FG002|Overall Study|Adverse Event|1|||
105801937|NCT00591253|364930663|FG000|Overall Study|Protocol Violation|2|||
105801938|NCT00591253|364930664|FG001|Overall Study|Protocol Violation|2|||
105801939|NCT00591253|364930665|FG002|Overall Study|Protocol Violation|2|||
105801940|NCT00591253|364930663|FG000|Overall Study|Lost to Follow-up|2|||
105801941|NCT00591253|364930664|FG001|Overall Study|Lost to Follow-up|4|||
105801942|NCT00591253|364930665|FG002|Overall Study|Lost to Follow-up|0|||
105801943|NCT00591253|364930663|FG000|Overall Study|Withdrawal by Subject|1|||
105801944|NCT00591253|364930664|FG001|Overall Study|Withdrawal by Subject|7|||
105801945|NCT00591253|364930665|FG002|Overall Study|Withdrawal by Subject|6|||
105801946|NCT00591253|364930663|FG000|Overall Study|Lack of Efficacy|1|||
105801947|NCT00591253|364930664|FG001|Overall Study|Lack of Efficacy|0|||
105801948|NCT00591253|364930665|FG002|Overall Study|Lack of Efficacy|3|||
105801949|NCT00591253|364930663|FG000|Overall Study|Other|5|||
105801950|NCT00591253|364930664|FG001|Overall Study|Other|5|||
105801951|NCT00591253|364930665|FG002|Overall Study|Other|3|||
105801952|NCT01504867|364930666|FG000|Overall Study|Inclusion criteria not met|2|||
105801953|NCT01504867|364930667|FG001|Overall Study|Inclusion criteria not met|2|||
105801954|NCT01504867|364930666|FG000|Overall Study|Consent revoked|5|||
105801955|NCT01504867|364930667|FG001|Overall Study|Consent revoked|1|||
105801956|NCT00571922|364930668|FG000|Overall Study|Completion unknown|36|||
105801957|NCT00571922|364930669|FG001|Overall Study|Completion unknown|36|||
105565773|NCT05375955|364068699|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
105565774|NCT05375955|364068693|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
105801958|NCT01254045|364930680|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
105565775|NCT05375955|364068694|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
105565776|NCT05375955|364068695|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
105801959|NCT01254045|364930681|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
105801960|NCT01254045|364930682|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
105801961|NCT01254045|364930683|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
105801962|NCT01254045|364930684|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
105801963|NCT01254045|364930685|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
105801964|NCT02971605|364930686|FG000|Overall Study|Withdrawal by Subject|1|||
105801965|NCT02110706|364930687|FG000|Overall Study|Adverse Event|2|||
105801966|NCT02110706|364930688|FG001|Overall Study|Adverse Event|3|||
105801967|NCT02110706|364930687|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
105801968|NCT02110706|364930688|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
105801969|NCT02533999|364930689|FG000|Overall Study|Lost to Follow-up|3|||
105801970|NCT02533999|364930690|FG001|Overall Study|Lost to Follow-up|5|||
105801971|NCT02533999|364930689|FG000|Overall Study|Protocol Violation|3|||
105801972|NCT02533999|364930690|FG001|Overall Study|Protocol Violation|0|||
105801973|NCT02533999|364930689|FG000|Overall Study|Adverse Event|0|||
105801974|NCT02533999|364930690|FG001|Overall Study|Adverse Event|1|||
105801975|NCT02533999|364930689|FG000|Overall Study|Randomized but intervention not received|0|||
105801976|NCT02533999|364930690|FG001|Overall Study|Randomized but intervention not received|1|||
105801977|NCT00597207|364930693|FG000|Overall Study|Lost to Follow-up|5|||
105801978|NCT00597207|364930694|FG001|Overall Study|Lost to Follow-up|7|||
105801979|NCT00520351|364930695|FG000|First Intervention|Withdrawal by Subject|1|||
105801980|NCT00520351|364930696|FG001|First Intervention|Withdrawal by Subject|1|||
105801981|NCT01261325|364930699|FG000|Overall Study|Lack of Efficacy|1|||
105801982|NCT01261325|364930700|FG001|Overall Study|Lack of Efficacy|1|||
105801983|NCT01261325|364930701|FG002|Overall Study|Lack of Efficacy|0|||
105801984|NCT01261325|364930699|FG000|Overall Study|Withdrawal by Subject|2|||
105801985|NCT01261325|364930700|FG001|Overall Study|Withdrawal by Subject|2|||
105801986|NCT01261325|364930701|FG002|Overall Study|Withdrawal by Subject|4|||
105801987|NCT01261325|364930699|FG000|Overall Study|SAE, non-fatal|1|||
105801988|NCT01261325|364930700|FG001|Overall Study|SAE, non-fatal|5|||
105801989|NCT01261325|364930701|FG002|Overall Study|SAE, non-fatal|1|||
105801990|NCT01261325|364930699|FG000|Overall Study|AE, non-serious non-fatal|9|||
105801991|NCT01261325|364930700|FG001|Overall Study|AE, non-serious non-fatal|15|||
105801992|NCT01261325|364930701|FG002|Overall Study|AE, non-serious non-fatal|13|||
105801993|NCT01261325|364930699|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
105801994|NCT01261325|364930700|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
105801995|NCT01261325|364930701|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
105801996|NCT01261325|364930699|FG000|Overall Study|Non Compliance|2|||
105801997|NCT01261325|364930700|FG001|Overall Study|Non Compliance|0|||
105801998|NCT01261325|364930701|FG002|Overall Study|Non Compliance|0|||
105801999|NCT01261325|364930699|FG000|Overall Study|Patient Randomized by Mistake|0|||
105802000|NCT01261325|364930700|FG001|Overall Study|Patient Randomized by Mistake|1|||
105802001|NCT01261325|364930701|FG002|Overall Study|Patient Randomized by Mistake|0|||
105802002|NCT01261325|364930699|FG000|Overall Study|Erroneously Randomized|1|||
105802003|NCT01261325|364930700|FG001|Overall Study|Erroneously Randomized|0|||
105802004|NCT01261325|364930701|FG002|Overall Study|Erroneously Randomized|0|||
105802005|NCT01261325|364930699|FG000|Overall Study|Screen Failure|1|||
105802006|NCT01261325|364930700|FG001|Overall Study|Screen Failure|0|||
105802007|NCT01261325|364930701|FG002|Overall Study|Screen Failure|0|||
105802008|NCT01261325|364930699|FG000|Overall Study|Randomized in Error|0|||
105802009|NCT01261325|364930700|FG001|Overall Study|Randomized in Error|0|||
105802010|NCT01261325|364930701|FG002|Overall Study|Randomized in Error|1|||
105802011|NCT01261325|364930699|FG000|Overall Study|Protocol Violation|0|||
105802012|NCT01261325|364930700|FG001|Overall Study|Protocol Violation|3|||
105802013|NCT01261325|364930701|FG002|Overall Study|Protocol Violation|1|||
105802014|NCT01261325|364930699|FG000|Overall Study|Lost to Follow-up|0|||
105802015|NCT01261325|364930700|FG001|Overall Study|Lost to Follow-up|1|||
105802016|NCT01261325|364930701|FG002|Overall Study|Lost to Follow-up|3|||
105802017|NCT01261325|364930699|FG000|Overall Study|AE, serious fatal|0|||
105802018|NCT01261325|364930700|FG001|Overall Study|AE, serious fatal|0|||
105802019|NCT01261325|364930701|FG002|Overall Study|AE, serious fatal|2|||
105802020|NCT03077828|364930702|FG000|Treatment Cycles|Death|1|||
105802021|NCT03077828|364930702|FG000|Treatment Cycles|Withdrawal by Subject|1|||
105802022|NCT03077828|364930702|FG000|Treatment Cycles|Screen Fail|2|||
105802023|NCT03077828|364930702|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
105802024|NCT03077828|364930702|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
105802025|NCT03077828|364930702|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
105802026|NCT03077828|364930702|FG000|Follow-up|Patients still in follow-up|15|||
105802027|NCT03443869|364930705|FG000|Overall Study|Death|3|||
105802028|NCT03443869|364930706|FG001|Overall Study|Death|3|||
105802029|NCT03443869|364930705|FG000|Overall Study|Withdrawal by Subject|34|||
105802030|NCT03443869|364930706|FG001|Overall Study|Withdrawal by Subject|22|||
105802031|NCT03443869|364930705|FG000|Overall Study|Lost to Follow-up|1|||
105802032|NCT03443869|364930706|FG001|Overall Study|Lost to Follow-up|2|||
105802033|NCT03443869|364930705|FG000|Overall Study|Physician Decision|3|||
105802034|NCT03443869|364930706|FG001|Overall Study|Physician Decision|3|||
105802035|NCT03443869|364930705|FG000|Overall Study|Other|4|||
105802036|NCT03443869|364930706|FG001|Overall Study|Other|4|||
105802037|NCT00096486|364930707|FG000|Overall Study|Withdrawal by Subject|0|||
105802038|NCT00096486|364930708|FG001|Overall Study|Withdrawal by Subject|0|||
105802039|NCT00096486|364930709|FG002|Overall Study|Withdrawal by Subject|1|||
105802040|NCT00096486|364930710|FG003|Overall Study|Withdrawal by Subject|1|||
105802041|NCT00096486|364930707|FG000|Overall Study|Not Treated|0|||
105802042|NCT00096486|364930708|FG001|Overall Study|Not Treated|0|||
105802043|NCT00096486|364930709|FG002|Overall Study|Not Treated|1|||
105802044|NCT00096486|364930710|FG003|Overall Study|Not Treated|1|||
105802045|NCT01559818|364930711|FG000|Overall Study|Physician Decision|1|||
105360237|NCT02100839|363325896|FG000|Multiple Ascending Dose|Adverse Event|2|||
105360238|NCT02100839|363325897|FG001|Multiple Ascending Dose|Adverse Event|0|||
105360239|NCT02100839|363325896|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
105360240|NCT02100839|363325897|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
105360241|NCT01000974|363325898|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
105360242|NCT01000974|363325899|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
105360243|NCT01000974|363325900|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
105360244|NCT01000974|363325898|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
105565777|NCT05375955|364068696|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
105360245|NCT01000974|363325899|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
105360246|NCT01000974|363325900|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
105360247|NCT01000974|363325898|FG000|Primary Vaccination Phase|Protocol Violation|40|||
105360248|NCT01000974|363325899|FG001|Primary Vaccination Phase|Protocol Violation|3|||
105360249|NCT01000974|363325900|FG002|Primary Vaccination Phase|Protocol Violation|2|||
105360250|NCT01000974|363325898|FG000|Primary Vaccination Phase|Adverse Event|14|||
105360251|NCT01000974|363325899|FG001|Primary Vaccination Phase|Adverse Event|2|||
105360252|NCT01000974|363325900|FG002|Primary Vaccination Phase|Adverse Event|2|||
105360253|NCT01000974|363325898|FG000|Primary Vaccination Phase|Other|4|||
105360254|NCT01000974|363325899|FG001|Primary Vaccination Phase|Other|9|||
105565778|NCT05375955|364068697|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
105751239|NCT01096849|364740853|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
105751240|NCT01096849|364740854|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
105751241|NCT01096849|364740855|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
105751242|NCT01096849|364740853|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
105751243|NCT01096849|364740854|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
105751244|NCT01096849|364740855|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
105751245|NCT01096849|364740853|FG000|Overall Study|Administrative Reasons|0|||
105751246|NCT01096849|364740854|FG001|Overall Study|Administrative Reasons|1|||
105751247|NCT01096849|364740855|FG002|Overall Study|Administrative Reasons|2|||
105751248|NCT01096849|364740853|FG000|Overall Study|Lost to Follow-up|1|||
105751249|NCT01096849|364740854|FG001|Overall Study|Lost to Follow-up|3|||
105751250|NCT01096849|364740855|FG002|Overall Study|Lost to Follow-up|1|||
105751251|NCT04167306|364740856|FG000|Overall Study|Lost to Follow-up|2|||
105751252|NCT04167306|364740857|FG001|Overall Study|Lost to Follow-up|2|||
105751253|NCT04167306|364740858|FG002|Overall Study|Lost to Follow-up|5|||
105751254|NCT04167306|364740859|FG003|Overall Study|Lost to Follow-up|5|||
105751255|NCT04167306|364740856|FG000|Overall Study|Adverse Event|13|||
105751256|NCT04167306|364740857|FG001|Overall Study|Adverse Event|14|||
105751257|NCT04167306|364740858|FG002|Overall Study|Adverse Event|5|||
105751258|NCT04167306|364740859|FG003|Overall Study|Adverse Event|4|||
105751259|NCT04167306|364740856|FG000|Overall Study|Withdrawal by Subject|4|||
105751260|NCT04167306|364740857|FG001|Overall Study|Withdrawal by Subject|6|||
105751261|NCT04167306|364740858|FG002|Overall Study|Withdrawal by Subject|8|||
105751262|NCT04167306|364740859|FG003|Overall Study|Withdrawal by Subject|3|||
105751263|NCT04167306|364740856|FG000|Overall Study|covid|1|||
105751264|NCT04167306|364740857|FG001|Overall Study|covid|1|||
105751265|NCT04167306|364740858|FG002|Overall Study|covid|2|||
105751266|NCT04167306|364740859|FG003|Overall Study|covid|1|||
105802046|NCT01559818|364930711|FG000|Overall Study|Pregnancy|1|||
105802047|NCT01559818|364930711|FG000|Overall Study|Study terminated by Sponsor|4|||
105751267|NCT04167306|364740856|FG000|Overall Study|concomitant medication|0|||
105751268|NCT04167306|364740857|FG001|Overall Study|concomitant medication|0|||
105751269|NCT04167306|364740858|FG002|Overall Study|concomitant medication|0|||
105751270|NCT04167306|364740859|FG003|Overall Study|concomitant medication|1|||
105751271|NCT04167306|364740856|FG000|Overall Study|Alcohol treatment|0|||
105751272|NCT04167306|364740857|FG001|Overall Study|Alcohol treatment|4|||
105751273|NCT04167306|364740858|FG002|Overall Study|Alcohol treatment|3|||
105751274|NCT04167306|364740859|FG003|Overall Study|Alcohol treatment|2|||
105751275|NCT04167306|364740856|FG000|Overall Study|non-compliance|0|||
105751276|NCT04167306|364740857|FG001|Overall Study|non-compliance|0|||
105751277|NCT04167306|364740858|FG002|Overall Study|non-compliance|1|||
105751278|NCT04167306|364740859|FG003|Overall Study|non-compliance|0|||
105751279|NCT04167306|364740856|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
105751280|NCT04167306|364740857|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
105751281|NCT04167306|364740858|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
105751282|NCT04167306|364740859|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
105751283|NCT01232894|364740860|FG000|Overall Study|Lost to Follow-up|0|||
105751284|NCT01232894|364740861|FG001|Overall Study|Lost to Follow-up|1|||
105751285|NCT01232894|364740860|FG000|Overall Study|Death|1|||
105751286|NCT01232894|364740861|FG001|Overall Study|Death|0|||
105751287|NCT01232894|364740860|FG000|Overall Study|Protocol Violation|1|||
105751288|NCT01232894|364740861|FG001|Overall Study|Protocol Violation|1|||
105751289|NCT01232894|364740860|FG000|Overall Study|Withdrawal by Subject|8|||
105751290|NCT01232894|364740861|FG001|Overall Study|Withdrawal by Subject|5|||
105751291|NCT01232894|364740860|FG000|Overall Study|Physician Decision|2|||
105751292|NCT01232894|364740861|FG001|Overall Study|Physician Decision|1|||
105751293|NCT03970395|364740862|FG000|Overall Study|Withdrawal by Subject|3|||
105751294|NCT03970395|364740863|FG001|Overall Study|Withdrawal by Subject|4|||
105751295|NCT03970395|364740862|FG000|Overall Study|Lost to Follow-up|4|||
105751296|NCT03970395|364740863|FG001|Overall Study|Lost to Follow-up|8|||
105751297|NCT00403559|364740864|FG000|Overall Study|Adverse Event|0|||
105751298|NCT00403559|364740865|FG001|Overall Study|Adverse Event|1|||
105751299|NCT00403559|364740864|FG000|Overall Study|Lost to Follow-up|3|||
105751300|NCT00403559|364740865|FG001|Overall Study|Lost to Follow-up|3|||
105751301|NCT00403559|364740864|FG000|Overall Study|Withdrawal by Subject|1|||
105751302|NCT00403559|364740865|FG001|Overall Study|Withdrawal by Subject|0|||
105751303|NCT00929734|364740866|FG000|Overall Study|Lost to Follow-up|2|||
105751304|NCT00929734|364740867|FG001|Overall Study|Lost to Follow-up|1|||
105751305|NCT00929734|364740866|FG000|Overall Study|Withdrawal by Subject|0|||
105751306|NCT00929734|364740867|FG001|Overall Study|Withdrawal by Subject|2|||
105751307|NCT02921919|364740868|FG000|Overall Study|Other|5|||
105751308|NCT02921919|364740869|FG001|Overall Study|Other|6|||
105751309|NCT02921919|364740868|FG000|Overall Study|Lost to Follow-up|0|||
105751310|NCT02921919|364740869|FG001|Overall Study|Lost to Follow-up|1|||
105751311|NCT02921919|364740868|FG000|Overall Study|Withdrawal by Subject|5|||
105751312|NCT02921919|364740869|FG001|Overall Study|Withdrawal by Subject|1|||
105751313|NCT02921919|364740868|FG000|Overall Study|Disease Progression|47|||
105751314|NCT02921919|364740869|FG001|Overall Study|Disease Progression|38|||
105751315|NCT02921919|364740868|FG000|Overall Study|Physician Decision|3|||
105751316|NCT02921919|364740869|FG001|Overall Study|Physician Decision|2|||
105751317|NCT02921919|364740868|FG000|Overall Study|Adverse Event|6|||
105751318|NCT02921919|364740869|FG001|Overall Study|Adverse Event|4|||
105751319|NCT01449682|364740870|FG000|Overall Study|Death|0|||
105751320|NCT01449682|364740871|FG001|Overall Study|Death|1|||
105751321|NCT01449682|364740870|FG000|Overall Study|Adverse Event|1|||
105360255|NCT01000974|363325900|FG002|Primary Vaccination Phase|Other|12|||
105360256|NCT01000974|363325898|FG000|Booster Vaccination Phase|Protocol Violation|0|||
105360257|NCT01000974|363325899|FG001|Booster Vaccination Phase|Protocol Violation|0|||
105483603|NCT00045942|363782719|FG007|PKC412A2104E1|Death|0|||
105751322|NCT01449682|364740871|FG001|Overall Study|Adverse Event|0|||
105751323|NCT03550131|364740873|FG000|Overall Study|Lost to Follow-up|16|||
105751324|NCT03550131|364740874|FG001|Overall Study|Lost to Follow-up|24|||
105751325|NCT03550131|364740873|FG000|Overall Study|Withdrawal by Subject|36|||
105751326|NCT03550131|364740874|FG001|Overall Study|Withdrawal by Subject|28|||
105751327|NCT03550131|364740873|FG000|Overall Study|Illness of dyad member|10|||
105751328|NCT03550131|364740874|FG001|Overall Study|Illness of dyad member|2|||
105751329|NCT03550131|364740873|FG000|Overall Study|Death of person with dementia|4|||
105751330|NCT03550131|364740874|FG001|Overall Study|Death of person with dementia|8|||
105751331|NCT02112994|364740875|FG000|Overall Study|Progressive Disease|0|||
105751332|NCT02112994|364740876|FG001|Overall Study|Progressive Disease|0|||
105751333|NCT02112994|364740877|FG002|Overall Study|Progressive Disease|1|||
105751334|NCT02112994|364740875|FG000|Overall Study|Pregnancy|0|||
105751335|NCT02112994|364740876|FG001|Overall Study|Pregnancy|1|||
105751336|NCT02112994|364740877|FG002|Overall Study|Pregnancy|1|||
105751337|NCT02112994|364740875|FG000|Overall Study|Liver Transplant|0|||
105751338|NCT02112994|364740876|FG001|Overall Study|Liver Transplant|1|||
105751339|NCT02112994|364740877|FG002|Overall Study|Liver Transplant|0|||
105751340|NCT02112994|364740875|FG000|Overall Study|Withdrawal by Subject|0|||
105360258|NCT01000974|363325900|FG002|Booster Vaccination Phase|Protocol Violation|2|||
105751341|NCT02112994|364740876|FG001|Overall Study|Withdrawal by Subject|0|||
105751342|NCT02112994|364740877|FG002|Overall Study|Withdrawal by Subject|1|||
105751343|NCT00414960|364740878|FG000|Overall Study|Adverse Event|4|||
105751344|NCT00414960|364740879|FG001|Overall Study|Adverse Event|0|||
105751345|NCT00414960|364740878|FG000|Overall Study|Withdrawal by Subject|3|||
105751346|NCT00414960|364740879|FG001|Overall Study|Withdrawal by Subject|0|||
105751347|NCT00414960|364740878|FG000|Overall Study|Physician Decision|0|||
105751348|NCT00414960|364740879|FG001|Overall Study|Physician Decision|1|||
105751349|NCT04633473|364740880|FG000|Overall Study|Withdrawal by Subject|6|||
105751350|NCT04387136|364740882|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
105751351|NCT04387136|364740883|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
105751352|NCT03294681|364740886|FG000|Overall Study|Withdrawal by Subject|1|||
105751353|NCT03089216|364740887|FG000|Overall Study|Adverse Event|0|||
105751354|NCT03089216|364740888|FG001|Overall Study|Adverse Event|0|||
105751355|NCT03089216|364740889|FG002|Overall Study|Adverse Event|0|||
105751356|NCT03089216|364740890|FG003|Overall Study|Adverse Event|1|||
105751357|NCT01348425|364740893|FG000|Overall Study|Imaging was not taken.|1|||
105751358|NCT01348425|364740894|FG001|Overall Study|Imaging was not taken.|1|||
105751359|NCT02720016|364740895|FG000|Overall Study|Separation of couple|6|||
105751360|NCT02720016|364740896|FG001|Overall Study|Separation of couple|8|||
105751361|NCT02720016|364740897|FG002|Overall Study|Separation of couple|2|||
105751362|NCT02720016|364740895|FG000|Overall Study|Withdrawal by Subject|6|||
105751363|NCT02720016|364740896|FG001|Overall Study|Withdrawal by Subject|6|||
105360259|NCT01000974|363325898|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
105751364|NCT02720016|364740897|FG002|Overall Study|Withdrawal by Subject|4|||
105751365|NCT02720016|364740895|FG000|Overall Study|Scheduling issues|2|||
105751366|NCT02720016|364740896|FG001|Overall Study|Scheduling issues|4|||
105751367|NCT02720016|364740897|FG002|Overall Study|Scheduling issues|7|||
105751368|NCT02720016|364740895|FG000|Overall Study|Childcare|2|||
105751369|NCT02720016|364740896|FG001|Overall Study|Childcare|0|||
105751370|NCT02720016|364740897|FG002|Overall Study|Childcare|2|||
105751371|NCT02720016|364740895|FG000|Overall Study|Withdrawal by PI|2|||
105751372|NCT02720016|364740896|FG001|Overall Study|Withdrawal by PI|2|||
105751373|NCT02720016|364740897|FG002|Overall Study|Withdrawal by PI|0|||
105751374|NCT02720016|364740895|FG000|Overall Study|Moved away|2|||
105751375|NCT02720016|364740896|FG001|Overall Study|Moved away|0|||
105751376|NCT02720016|364740897|FG002|Overall Study|Moved away|0|||
105751377|NCT02720016|364740895|FG000|Overall Study|Not Primary Health Concern|0|||
105751378|NCT02720016|364740896|FG001|Overall Study|Not Primary Health Concern|0|||
105751379|NCT02720016|364740897|FG002|Overall Study|Not Primary Health Concern|2|||
105751380|NCT02720016|364740895|FG000|Overall Study|Transportation issues|0|||
105751381|NCT02720016|364740896|FG001|Overall Study|Transportation issues|0|||
105751382|NCT02720016|364740897|FG002|Overall Study|Transportation issues|1|||
105751383|NCT02720016|364740895|FG000|Overall Study|Other|0|||
105751384|NCT02720016|364740896|FG001|Overall Study|Other|0|||
105751385|NCT02720016|364740897|FG002|Overall Study|Other|2|||
105751386|NCT04501679|364740900|FG000|Overall Study|Pregnancy|0|||
105751387|NCT04501679|364740901|FG001|Overall Study|Pregnancy|1|||
105751388|NCT04501679|364740900|FG000|Overall Study|Adverse Event|4|||
105751389|NCT04501679|364740901|FG001|Overall Study|Adverse Event|2|||
105751390|NCT04501679|364740900|FG000|Overall Study|Withdrawal by Subject|2|||
105751391|NCT04501679|364740901|FG001|Overall Study|Withdrawal by Subject|0|||
105751392|NCT04501679|364740900|FG000|Overall Study|Physician Decision|1|||
105751393|NCT04501679|364740901|FG001|Overall Study|Physician Decision|0|||
105751394|NCT04501679|364740900|FG000|Overall Study|Lost to Follow-up|2|||
105751395|NCT04501679|364740901|FG001|Overall Study|Lost to Follow-up|0|||
105751396|NCT00205699|364742418|FG000|Overall Study|Lost to Follow-up|1|||
105751397|NCT00205699|364742419|FG001|Overall Study|Lost to Follow-up|3|||
105751398|NCT00205699|364742420|FG002|Overall Study|Lost to Follow-up|5|||
105751399|NCT00205699|364742418|FG000|Overall Study|Adverse Event|1|||
105751400|NCT00205699|364742419|FG001|Overall Study|Adverse Event|0|||
105751401|NCT00205699|364742420|FG002|Overall Study|Adverse Event|0|||
105751402|NCT00205699|364742418|FG000|Overall Study|Withdrawal by Subject|1|||
105751403|NCT00205699|364742419|FG001|Overall Study|Withdrawal by Subject|2|||
105751404|NCT00205699|364742420|FG002|Overall Study|Withdrawal by Subject|1|||
105751405|NCT00205699|364742418|FG000|Overall Study|Lack of Efficacy|0|||
105751406|NCT00205699|364742419|FG001|Overall Study|Lack of Efficacy|1|||
105751407|NCT00205699|364742420|FG002|Overall Study|Lack of Efficacy|0|||
105751408|NCT01114373|364742421|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
105751409|NCT01114373|364742422|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
105751410|NCT01114373|364742421|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
105751411|NCT01114373|364742422|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
105751412|NCT01114373|364742421|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
105751413|NCT01114373|364742422|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
105751414|NCT01114373|364742421|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
105751415|NCT01114373|364742422|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
105751416|NCT01170702|364742430|FG000|Overall Study|Exclusion criteria met after consent|1|||
105751417|NCT01170702|364742431|FG001|Overall Study|Exclusion criteria met after consent|2|||
105751418|NCT01170702|364742432|FG002|Overall Study|Exclusion criteria met after consent|0|||
105751419|NCT01170702|364742433|FG003|Overall Study|Exclusion criteria met after consent|2|||
105751420|NCT00229203|364742434|FG000|Overall Study|Progressive disease|18|||
105751421|NCT00229203|364742435|FG001|Overall Study|Progressive disease|9|||
105751422|NCT00229203|364742434|FG000|Overall Study|Toxicity|6|||
105751423|NCT00229203|364742435|FG001|Overall Study|Toxicity|1|||
105751424|NCT00229203|364742434|FG000|Overall Study|Death|4|||
105802048|NCT01559818|364930711|FG000|Overall Study|Withdrawal by Subject|1|||
105802049|NCT03705169|364930713|FG000|Overall Study|Lost to Follow-up|0|||
105802050|NCT03705169|364930714|FG001|Overall Study|Lost to Follow-up|0|||
105802051|NCT03705169|364930715|FG002|Overall Study|Lost to Follow-up|0|||
105751425|NCT00229203|364742435|FG001|Overall Study|Death|2|||
105751426|NCT00229203|364742434|FG000|Overall Study|Other|3|||
105751427|NCT00229203|364742435|FG001|Overall Study|Other|3|||
105751428|NCT00229203|364742434|FG000|Overall Study|Withdrawal by Subject|1|||
105802052|NCT03705169|364930716|FG003|Overall Study|Lost to Follow-up|2|||
105802053|NCT03705169|364930717|FG004|Overall Study|Lost to Follow-up|0|||
105802054|NCT03705169|364930718|FG005|Overall Study|Lost to Follow-up|2|||
105802055|NCT03705169|364930719|FG006|Overall Study|Lost to Follow-up|1|||
105802056|NCT03705169|364930720|FG007|Overall Study|Lost to Follow-up|0|||
105360260|NCT01000974|363325899|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
105360261|NCT01000974|363325900|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
105751429|NCT00229203|364742435|FG001|Overall Study|Withdrawal by Subject|4|||
105751430|NCT04321252|364742436|FG000|Overall Study|Withdrawal by Subject|0|||
105751431|NCT04321252|364742437|FG001|Overall Study|Withdrawal by Subject|0|||
105751432|NCT04321252|364742438|FG002|Overall Study|Withdrawal by Subject|0|||
105751433|NCT04321252|364742439|FG003|Overall Study|Withdrawal by Subject|0|||
105751434|NCT04321252|364742440|FG004|Overall Study|Withdrawal by Subject|0|||
105751435|NCT04321252|364742441|FG005|Overall Study|Withdrawal by Subject|1|||
105802057|NCT03705169|364930721|FG008|Overall Study|Lost to Follow-up|0|||
105751436|NCT04321252|364742442|FG006|Overall Study|Withdrawal by Subject|0|||
105802058|NCT03705169|364930722|FG009|Overall Study|Lost to Follow-up|1|||
105483604|NCT00045942|363782720|FG008|PKC412A2104E1|Death|0|||
105483605|NCT00045942|363782712|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
105751437|NCT04321252|364742443|FG007|Overall Study|Withdrawal by Subject|0|||
105751438|NCT04321252|364742444|FG008|Overall Study|Withdrawal by Subject|0|||
105802059|NCT03705169|364930713|FG000|Overall Study|Adverse Event|0|||
105565779|NCT05375955|364068698|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
105565780|NCT05375955|364068699|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
105565781|NCT04027348|364068702|FG000|Overall Study|Adverse Event|2|||
105565782|NCT01313286|364068703|FG000|Period 1|Withdrawal by Subject|2|||
105565783|NCT01313286|364068704|FG001|Period 1|Withdrawal by Subject|0|||
105565784|NCT00733980|364068713|FG000|Overall Study|Adverse Event|5|||
105565785|NCT00733980|364068714|FG001|Overall Study|Adverse Event|2|||
105565786|NCT00733980|364068713|FG000|Overall Study|Lack of Efficacy|0|||
105565787|NCT00733980|364068714|FG001|Overall Study|Lack of Efficacy|1|||
105565788|NCT00733980|364068713|FG000|Overall Study|Protocol Violation|2|||
105565789|NCT00733980|364068714|FG001|Overall Study|Protocol Violation|1|||
105565790|NCT00733980|364068713|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
105565791|NCT00733980|364068714|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
105565792|NCT00733980|364068713|FG000|Overall Study|Lost to Follow-up|6|||
105565793|NCT00733980|364068714|FG001|Overall Study|Lost to Follow-up|11|||
105565794|NCT00733980|364068713|FG000|Overall Study|Physician Decision|2|||
105565795|NCT00733980|364068714|FG001|Overall Study|Physician Decision|3|||
105565796|NCT00733980|364068713|FG000|Overall Study|Withdrawal by Subject|6|||
105565797|NCT00733980|364068714|FG001|Overall Study|Withdrawal by Subject|2|||
105565798|NCT04843930|364068715|FG000|Randomization|Withdrawal by Subject|6|||
105565799|NCT04843930|364068716|FG001|Randomization|Withdrawal by Subject|6|||
105565800|NCT04843930|364068717|FG002|Randomization|Withdrawal by Subject|0|||
105565801|NCT04843930|364068718|FG003|Randomization|Withdrawal by Subject|0|||
105565802|NCT04843930|364068715|FG000|Week 6 Assessment|Adverse Event|3|||
105565803|NCT04843930|364068716|FG001|Week 6 Assessment|Adverse Event|0|||
105565804|NCT04843930|364068717|FG002|Week 6 Assessment|Adverse Event|0|||
105565805|NCT04843930|364068718|FG003|Week 6 Assessment|Adverse Event|0|||
105565806|NCT04843930|364068715|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
105565807|NCT04843930|364068716|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
105565808|NCT04843930|364068717|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
105565809|NCT04843930|364068718|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
105565810|NCT04843930|364068715|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
105565811|NCT04843930|364068716|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
105565812|NCT04843930|364068717|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
105565813|NCT04843930|364068718|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
105565814|NCT00779779|364068719|FG000|Overall Study|Adverse Event|1|||
105565815|NCT00779779|364068719|FG000|Overall Study|Protocol Violation|14|||
105565816|NCT00779779|364068719|FG000|Overall Study|Withdrawal by Subject|4|||
105565817|NCT00779779|364068719|FG000|Overall Study|Lost to Follow-up|5|||
105565818|NCT05158296|364068720|FG000|Overall Study|Sponsor Decision|2|||
105565819|NCT05158296|364068721|FG001|Overall Study|Sponsor Decision|3|||
105565820|NCT05158296|364068722|FG002|Overall Study|Sponsor Decision|2|||
105565821|NCT00117156|364068724|FG000|Overall Study|Adverse Event|9|||
105565822|NCT00117156|364068724|FG000|Overall Study|Physician Decision|1|||
105565823|NCT00117156|364068724|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
105565824|NCT00633464|364068733|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
105565825|NCT00633464|364068734|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
105565826|NCT00633464|364068733|FG000|Overall Study|Never Treated (Randomized in error)|0|||
105565827|NCT00633464|364068734|FG001|Overall Study|Never Treated (Randomized in error)|1|||
105751439|NCT00579501|364742445|FG000|Overall Study|Death|1|||
105751440|NCT00579501|364742445|FG000|Overall Study|End of neoadjuvant therapy|25|||
105751441|NCT00579501|364742445|FG000|Overall Study|toxicity|1|||
105751442|NCT00579501|364742445|FG000|Overall Study|Secondary lesion|1|||
105751443|NCT00579501|364742445|FG000|Overall Study|Radiation therapy before surgery|1|||
105751444|NCT01089582|364742446|FG000|Overall Study|Death|2|||
105751445|NCT01089582|364742446|FG000|Overall Study|Adverse Event|15|||
105751446|NCT01089582|364742446|FG000|Overall Study|Lost to Follow-up|8|||
105751447|NCT01089582|364742446|FG000|Overall Study|Other|4|||
105751448|NCT01089582|364742446|FG000|Overall Study|Withdrawal by Subject|1|||
105751449|NCT01199055|364742451|FG000|Overall Study|Death|0|||
105751450|NCT01199055|364742452|FG001|Overall Study|Death|1|||
105751451|NCT01199055|364742453|FG002|Overall Study|Death|0|||
105751452|NCT01199055|364742451|FG000|Overall Study|Physician Decision|0|||
105751453|NCT01199055|364742452|FG001|Overall Study|Physician Decision|1|||
105565828|NCT00112580|364068737|FG000|Overall Study|Adverse Event|1|||
105565829|NCT00112580|364068738|FG001|Overall Study|Adverse Event|2|||
105565830|NCT00112580|364068737|FG000|Overall Study|Disease progression|5|||
105751454|NCT01199055|364742453|FG002|Overall Study|Physician Decision|1|||
105751455|NCT01199055|364742451|FG000|Overall Study|Progressive disease|2|||
105751456|NCT01199055|364742452|FG001|Overall Study|Progressive disease|1|||
105751457|NCT01199055|364742453|FG002|Overall Study|Progressive disease|2|||
105751458|NCT01199055|364742451|FG000|Overall Study|Withdrawal by Subject|0|||
105751459|NCT01199055|364742452|FG001|Overall Study|Withdrawal by Subject|0|||
105565831|NCT00112580|364068738|FG001|Overall Study|Disease progression|16|||
105760894|NCT01831804|364778044|FG008|Overall Study|Withdrew Consent|0|||
105751460|NCT01199055|364742453|FG002|Overall Study|Withdrawal by Subject|1|||
105751461|NCT03341923|364742454|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
105751462|NCT03341923|364742455|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
105751463|NCT00084929|364742456|FG000|Overall Study|ineligible - medical contraindication|1|||
105751464|NCT00084929|364742456|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
105751465|NCT00084929|364742456|FG000|Overall Study|Ineligible - Medical history|6|||
105751466|NCT00084929|364742456|FG000|Overall Study|Withdrawal by Subject|10|||
105751467|NCT00084929|364742456|FG000|Overall Study|Missing/incomplete CTC exam|9|||
105751468|NCT00084929|364742456|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
105751469|NCT00844649|364742457|FG000|Overall Study|Progressive Disease|196|||
105751470|NCT00844649|364742458|FG001|Overall Study|Progressive Disease|245|||
105751471|NCT00844649|364742457|FG000|Overall Study|Adverse Event|128|||
105751472|NCT00844649|364742458|FG001|Overall Study|Adverse Event|73|||
105751473|NCT00844649|364742457|FG000|Overall Study|Physician Decision|25|||
105751474|NCT00844649|364742458|FG001|Overall Study|Physician Decision|18|||
105751475|NCT00844649|364742457|FG000|Overall Study|Protocol Violation|10|||
105751476|NCT00844649|364742458|FG001|Overall Study|Protocol Violation|6|||
105751477|NCT00844649|364742457|FG000|Overall Study|Withdrawal by Subject|28|||
105751478|NCT00844649|364742458|FG001|Overall Study|Withdrawal by Subject|39|||
105751479|NCT00844649|364742457|FG000|Overall Study|Other|7|||
105751480|NCT00844649|364742458|FG001|Overall Study|Other|10|||
105751481|NCT00844649|364742457|FG000|Overall Study|Withdrew prior to starting treatment|11|||
105751482|NCT00844649|364742458|FG001|Overall Study|Withdrew prior to starting treatment|27|||
105751483|NCT03337152|364742460|FG000|Overall Study|Physician Decision|1|||
105751484|NCT03337152|364742461|FG001|Overall Study|Physician Decision|0|||
105751485|NCT03337152|364742460|FG000|Overall Study|Lost to Follow-up|1|||
105751486|NCT03337152|364742461|FG001|Overall Study|Lost to Follow-up|3|||
105751487|NCT03337152|364742460|FG000|Overall Study|Adverse Event|3|||
105751488|NCT03337152|364742461|FG001|Overall Study|Adverse Event|1|||
105751489|NCT03337152|364742460|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
105751490|NCT03337152|364742461|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
105751491|NCT04397718|364742462|FG000|Overall Study|Death|7|||
105751492|NCT04397718|364742463|FG001|Overall Study|Death|11|||
105751493|NCT04397718|364742462|FG000|Overall Study|Lost to Follow-up|0|||
105751494|NCT04397718|364742463|FG001|Overall Study|Lost to Follow-up|4|||
105751495|NCT00077610|364742464|FG000|Overall Study|Adverse Event|9|||
105751496|NCT00077610|364742465|FG001|Overall Study|Adverse Event|7|||
105751497|NCT00077610|364742466|FG002|Overall Study|Adverse Event|1|||
105751498|NCT00077610|364742464|FG000|Overall Study|Lost to Follow-up|0|||
105751499|NCT00077610|364742465|FG001|Overall Study|Lost to Follow-up|1|||
105751500|NCT00077610|364742466|FG002|Overall Study|Lost to Follow-up|2|||
105751501|NCT00077610|364742464|FG000|Overall Study|Withdrawal by Subject|4|||
105751502|NCT00077610|364742465|FG001|Overall Study|Withdrawal by Subject|10|||
105751503|NCT00077610|364742466|FG002|Overall Study|Withdrawal by Subject|6|||
105751504|NCT00077610|364742464|FG000|Overall Study|Death|17|||
105751505|NCT00077610|364742465|FG001|Overall Study|Death|13|||
105751506|NCT00077610|364742466|FG002|Overall Study|Death|13|||
105751507|NCT00077610|364742464|FG000|Overall Study|Renal transplant|12|||
105751508|NCT00077610|364742465|FG001|Overall Study|Renal transplant|15|||
105751509|NCT00077610|364742466|FG002|Overall Study|Renal transplant|11|||
105751510|NCT00077610|364742464|FG000|Overall Study|Withdrew from dialysis care|5|||
105751511|NCT00077610|364742465|FG001|Overall Study|Withdrew from dialysis care|0|||
105751512|NCT00077610|364742466|FG002|Overall Study|Withdrew from dialysis care|3|||
105751513|NCT00077610|364742464|FG000|Overall Study|Insufficient Therapeutic Response|1|||
105751514|NCT00077610|364742465|FG001|Overall Study|Insufficient Therapeutic Response|0|||
105751515|NCT00077610|364742466|FG002|Overall Study|Insufficient Therapeutic Response|0|||
105751516|NCT00077610|364742464|FG000|Overall Study|Multiple blood transfusions|0|||
105751517|NCT00077610|364742465|FG001|Overall Study|Multiple blood transfusions|0|||
105751518|NCT00077610|364742466|FG002|Overall Study|Multiple blood transfusions|1|||
105751519|NCT00077610|364742464|FG000|Overall Study|Principal Investigator's decision|1|||
105751520|NCT00077610|364742465|FG001|Overall Study|Principal Investigator's decision|0|||
105751521|NCT00077610|364742466|FG002|Overall Study|Principal Investigator's decision|1|||
105751522|NCT00077610|364742464|FG000|Overall Study|Worsening of health condition|1|||
105751523|NCT00077610|364742465|FG001|Overall Study|Worsening of health condition|1|||
105751524|NCT00077610|364742466|FG002|Overall Study|Worsening of health condition|0|||
105751525|NCT00077610|364742464|FG000|Overall Study|Given Epogen in hospital|1|||
105751526|NCT00077610|364742465|FG001|Overall Study|Given Epogen in hospital|0|||
105751527|NCT00077610|364742466|FG002|Overall Study|Given Epogen in hospital|0|||
105751528|NCT00077610|364742464|FG000|Overall Study|Transferred to other unit|0|||
105751529|NCT00077610|364742465|FG001|Overall Study|Transferred to other unit|0|||
105751530|NCT00077610|364742466|FG002|Overall Study|Transferred to other unit|1|||
105751531|NCT00077610|364742464|FG000|Overall Study|Transferred to nursing home|0|||
105751532|NCT00077610|364742465|FG001|Overall Study|Transferred to nursing home|0|||
105751533|NCT00077610|364742466|FG002|Overall Study|Transferred to nursing home|1|||
105751534|NCT00077610|364742464|FG000|Overall Study|Transfer to satellite unit|1|||
105751535|NCT00077610|364742465|FG001|Overall Study|Transfer to satellite unit|0|||
105751536|NCT00077610|364742466|FG002|Overall Study|Transfer to satellite unit|0|||
105751537|NCT00077610|364742464|FG000|Overall Study|Transfer to other center for surgery|1|||
105751538|NCT00077610|364742465|FG001|Overall Study|Transfer to other center for surgery|0|||
105751539|NCT00077610|364742466|FG002|Overall Study|Transfer to other center for surgery|0|||
105751540|NCT00077610|364742464|FG000|Overall Study|Change in dialysis modality|1|||
105751541|NCT00077610|364742465|FG001|Overall Study|Change in dialysis modality|0|||
105751542|NCT00077610|364742466|FG002|Overall Study|Change in dialysis modality|0|||
105751543|NCT00077610|364742464|FG000|Overall Study|Relocation|0|||
105751544|NCT00077610|364742465|FG001|Overall Study|Relocation|8|||
105751545|NCT00077610|364742466|FG002|Overall Study|Relocation|5|||
105751546|NCT00077610|364742464|FG000|Overall Study|Financial issues|0|||
105751547|NCT00077610|364742465|FG001|Overall Study|Financial issues|1|||
105751548|NCT00077610|364742466|FG002|Overall Study|Financial issues|0|||
105751549|NCT00077610|364742464|FG000|Overall Study|Sponsors decision to withdraw|0|||
105751550|NCT00077610|364742465|FG001|Overall Study|Sponsors decision to withdraw|0|||
105751551|NCT00077610|364742466|FG002|Overall Study|Sponsors decision to withdraw|1|||
105751552|NCT02493426|364742481|FG000|Overall Study|Withdrawal by Subject|0|||
105751553|NCT02493426|364742482|FG001|Overall Study|Withdrawal by Subject|1|||
105751554|NCT01069523|364742483|FG000|Overall Study|Withdrawal by Subject|4|||
105751555|NCT01069523|364742484|FG001|Overall Study|Withdrawal by Subject|7|||
105751556|NCT01875367|364742486|FG000|Overall Study|Not complete at least 2 questionaries|4|||
105751557|NCT01875367|364742487|FG001|Overall Study|Not complete at least 2 questionaries|2|||
105565832|NCT00112580|364068737|FG000|Overall Study|Participant withdrew consent|2|||
105565833|NCT00112580|364068738|FG001|Overall Study|Participant withdrew consent|1|||
105751558|NCT01875367|364742486|FG000|Overall Study|Not receive study treatment|1|||
105751559|NCT01875367|364742487|FG001|Overall Study|Not receive study treatment|0|||
105751560|NCT01479374|364742491|FG000|Overall Study|Adverse Event|2|||
105751561|NCT01479374|364742492|FG001|Overall Study|Adverse Event|1|||
105751562|NCT01479374|364742493|FG002|Overall Study|Adverse Event|0|||
105751563|NCT01479374|364742491|FG000|Overall Study|Lost to Follow-up|1|||
105751564|NCT01479374|364742492|FG001|Overall Study|Lost to Follow-up|2|||
105751565|NCT01479374|364742493|FG002|Overall Study|Lost to Follow-up|0|||
105751566|NCT01479374|364742491|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
105751567|NCT01479374|364742492|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
105751568|NCT01479374|364742493|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
105751569|NCT01479374|364742491|FG000|Overall Study|Other|0|||
105751570|NCT01479374|364742492|FG001|Overall Study|Other|4|||
105565834|NCT03445065|364068741|FG000|Overall Study|Withdrawal by Subject|3|||
105565835|NCT03445065|364068742|FG001|Overall Study|Withdrawal by Subject|6|||
105565836|NCT03445065|364068743|FG002|Overall Study|Withdrawal by Subject|2|||
105565837|NCT03445065|364068744|FG003|Overall Study|Withdrawal by Subject|2|||
105565838|NCT03445065|364068741|FG000|Overall Study|Other|4|||
105565839|NCT03445065|364068742|FG001|Overall Study|Other|3|||
105565840|NCT03445065|364068743|FG002|Overall Study|Other|3|||
105751571|NCT01479374|364742493|FG002|Overall Study|Other|5|||
105751572|NCT04533815|364742494|FG000|Overall Study|Adverse Event|2|||
105751573|NCT04533815|364742494|FG000|Overall Study|Site withdrew|5|||
105751574|NCT01551758|364742495|FG000|Overall Study|Adverse Event|29|||
105751575|NCT01551758|364742496|FG001|Overall Study|Adverse Event|43|||
105751576|NCT01551758|364742495|FG000|Overall Study|Lack of Efficacy|0|||
105751577|NCT01551758|364742496|FG001|Overall Study|Lack of Efficacy|1|||
105751578|NCT01551758|364742495|FG000|Overall Study|Protocol Violation|5|||
105751579|NCT01551758|364742496|FG001|Overall Study|Protocol Violation|6|||
105751580|NCT01551758|364742495|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
105751581|NCT01551758|364742496|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
105751582|NCT01551758|364742495|FG000|Overall Study|Lost to Follow-up|29|||
105751583|NCT01551758|364742496|FG001|Overall Study|Lost to Follow-up|25|||
105751584|NCT01551758|364742495|FG000|Overall Study|Physician Decision|9|||
105751585|NCT01551758|364742496|FG001|Overall Study|Physician Decision|3|||
105751586|NCT01551758|364742495|FG000|Overall Study|Withdrawal by Subject|14|||
105751587|NCT01551758|364742496|FG001|Overall Study|Withdrawal by Subject|17|||
105751588|NCT03670641|364742497|FG000|Overall Study|Lost to Follow-up|3|||
105751589|NCT00242580|364742500|FG000|Overall Study|Adverse Event|3|||
105751590|NCT00242580|364742501|FG001|Overall Study|Adverse Event|0|||
105751591|NCT00242580|364742502|FG002|Overall Study|Adverse Event|2|||
105751592|NCT00242580|364742500|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105751593|NCT00242580|364742501|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
105751594|NCT00242580|364742502|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
105751595|NCT00242580|364742500|FG000|Overall Study|Protocol Violation|0|||
105751596|NCT00242580|364742501|FG001|Overall Study|Protocol Violation|0|||
105751597|NCT00242580|364742502|FG002|Overall Study|Protocol Violation|1|||
105751598|NCT00242580|364742500|FG000|Overall Study|Subject withdrew consent|2|||
105751599|NCT00242580|364742501|FG001|Overall Study|Subject withdrew consent|2|||
105751600|NCT00242580|364742502|FG002|Overall Study|Subject withdrew consent|5|||
105751601|NCT00242580|364742500|FG000|Overall Study|Lost to Follow-up|0|||
105751602|NCT00242580|364742501|FG001|Overall Study|Lost to Follow-up|3|||
105751603|NCT00242580|364742502|FG002|Overall Study|Lost to Follow-up|0|||
105751604|NCT00242580|364742500|FG000|Overall Study|Death|1|||
105751605|NCT00242580|364742501|FG001|Overall Study|Death|2|||
105751606|NCT00242580|364742502|FG002|Overall Study|Death|1|||
105751607|NCT01737840|364742510|FG000|Overall Study|Diagnosed with an other pathology|2|||
105751608|NCT01737840|364742511|FG001|Overall Study|Diagnosed with an other pathology|2|||
105751609|NCT01189435|364742512|FG000|Overall Study|Withdrawal by Subject|1|||
105751610|NCT01189435|364742512|FG000|Overall Study|Physician Decision|1|||
105751611|NCT01253421|364742513|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
105751612|NCT01253421|364742514|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
105751613|NCT01253421|364742515|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
105751614|NCT01253421|364742516|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
105565841|NCT03445065|364068744|FG003|Overall Study|Other|1|||
105751615|NCT01253421|364742517|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
105751616|NCT01253421|364742513|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
105751617|NCT01253421|364742514|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
105751618|NCT01253421|364742515|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
105751619|NCT01253421|364742516|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
105751620|NCT01253421|364742517|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
105751621|NCT01253421|364742513|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
105751622|NCT01253421|364742514|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
105751623|NCT01253421|364742515|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
105751624|NCT01253421|364742516|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
105565842|NCT03181399|364070980|FG000|6 Months on Treatment|Protocol non-compliance|7|||
105565843|NCT03181399|364070980|FG000|6 Months on Treatment|Adverse Event|4|||
105751625|NCT01253421|364742517|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
105751626|NCT01253421|364742513|FG000|Assessment and Scheduling|Physician Decision|1|||
105565844|NCT03181399|364070980|FG000|6 Months on Treatment|Tried alternative treatment|2|||
105565845|NCT03181399|364070980|FG000|6 Months on Treatment|Lost to Follow-up|2|||
105565846|NCT03181399|364070980|FG000|6 Months on Treatment|Personal reasons|1|||
105565847|NCT03181399|364070980|FG000|3 Months Off-treatment|Parent unable to travel|1|||
105565848|NCT02276066|364070983|FG000|Overall Study|Lost to Follow-up|21|||
105565849|NCT02276066|364070984|FG001|Overall Study|Lost to Follow-up|11|||
105751627|NCT01253421|364742514|FG001|Assessment and Scheduling|Physician Decision|0|||
105751628|NCT01253421|364742515|FG002|Assessment and Scheduling|Physician Decision|0|||
105751629|NCT01253421|364742516|FG003|Assessment and Scheduling|Physician Decision|0|||
105751630|NCT01253421|364742517|FG004|Assessment and Scheduling|Physician Decision|0|||
105751631|NCT01253421|364742513|FG000|Drug+Scanning Visit|Physician Decision|0|||
105751632|NCT01253421|364742514|FG001|Drug+Scanning Visit|Physician Decision|0|||
105751633|NCT01253421|364742515|FG002|Drug+Scanning Visit|Physician Decision|0|||
105751634|NCT01253421|364742516|FG003|Drug+Scanning Visit|Physician Decision|0|||
105751635|NCT01253421|364742517|FG004|Drug+Scanning Visit|Physician Decision|1|||
105751636|NCT00980980|364742518|FG000|Overall Study|Withdrawal by Hospital|0|||
105751637|NCT00980980|364742519|FG001|Overall Study|Withdrawal by Hospital|1|||
105751638|NCT00980980|364742520|FG002|Overall Study|Withdrawal by Hospital|0|||
105751639|NCT03666858|364742522|FG000|Cohort 1|Adverse Event|1|||
105751640|NCT03666858|364742523|FG001|Cohort 1|Adverse Event|0|||
105751641|NCT03666858|364742522|FG000|Cohort 2|Adverse Event|0|||
105751642|NCT03666858|364742523|FG001|Cohort 2|Adverse Event|1|||
105751643|NCT00121992|364742524|FG000|Overall Study|Treatment not received|2|||
105751644|NCT00121992|364742525|FG001|Overall Study|Treatment not received|11|||
105751645|NCT03282357|364742526|FG000|Overall Study|Lost to Follow-up|3|||
105751646|NCT03282357|364742526|FG000|Overall Study|Withdrawal by Subject|4|||
105751647|NCT03282357|364742526|FG000|Overall Study|Adverse Event|1|||
105751648|NCT03282357|364742526|FG000|Overall Study|Other|9|||
105751649|NCT03722784|364742533|FG000|Overall Study|Withdrawal by Subject|1|||
105751650|NCT03722784|364742534|FG001|Overall Study|Withdrawal by Subject|0|||
105751651|NCT03722784|364742533|FG000|Overall Study|Physician Decision|1|||
105751652|NCT03722784|364742534|FG001|Overall Study|Physician Decision|1|||
105751653|NCT03722784|364742533|FG000|Overall Study|Protocol Violation|0|||
105751654|NCT03722784|364742534|FG001|Overall Study|Protocol Violation|1|||
105751655|NCT00910429|364742535|FG000|Overall Study|Death|18|||
105751656|NCT00910429|364742536|FG001|Overall Study|Death|12|||
105751657|NCT00910429|364742535|FG000|Overall Study|Withdrawal by Subject|3|||
105751658|NCT00910429|364742536|FG001|Overall Study|Withdrawal by Subject|2|||
105751659|NCT00910429|364742535|FG000|Overall Study|Protocol Violation|1|||
105751660|NCT00910429|364742536|FG001|Overall Study|Protocol Violation|0|||
105751661|NCT00910429|364742535|FG000|Overall Study|Lost to Follow-up|2|||
105751662|NCT00910429|364742536|FG001|Overall Study|Lost to Follow-up|1|||
105751663|NCT00910429|364742535|FG000|Overall Study|Adverse Event|10|||
105751664|NCT00910429|364742536|FG001|Overall Study|Adverse Event|5|||
105751665|NCT00910429|364742535|FG000|Overall Study|Drug non-compliance|1|||
105751666|NCT00910429|364742536|FG001|Overall Study|Drug non-compliance|0|||
105751667|NCT00910429|364742535|FG000|Overall Study|Lack of Efficacy|4|||
105751668|NCT00910429|364742536|FG001|Overall Study|Lack of Efficacy|1|||
105751669|NCT01317615|364742537|FG000|Overall Study|Disease progression|25|||
105751670|NCT01317615|364742537|FG000|Overall Study|New cancer therapy|5|||
105751671|NCT01317615|364742537|FG000|Overall Study|Death|6|||
105751672|NCT01317615|364742537|FG000|Overall Study|Withdrawal by Subject|5|||
105751673|NCT01317615|364742537|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105751674|NCT01317615|364742537|FG000|Overall Study|Adverse Event|7|||
105751675|NCT04191577|364742539|FG000|Overall Study|Withdrawal by Subject|2|||
105751676|NCT04191577|364742540|FG001|Overall Study|Withdrawal by Subject|2|||
105751677|NCT04191577|364742541|FG002|Overall Study|Withdrawal by Subject|1|||
105751678|NCT04191577|364742539|FG000|Overall Study|Physician Decision|1|||
105751679|NCT04191577|364742540|FG001|Overall Study|Physician Decision|1|||
105751680|NCT04191577|364742541|FG002|Overall Study|Physician Decision|0|||
105751681|NCT04191577|364742539|FG000|Overall Study|Adverse Event|0|||
105751682|NCT04191577|364742540|FG001|Overall Study|Adverse Event|0|||
105751683|NCT04191577|364742541|FG002|Overall Study|Adverse Event|1|||
105751684|NCT04191577|364742539|FG000|Overall Study|Death|0|||
105751685|NCT04191577|364742540|FG001|Overall Study|Death|0|||
105751686|NCT04191577|364742541|FG002|Overall Study|Death|1|||
105565850|NCT05050578|364070985|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
105565851|NCT05050578|364070986|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
105565852|NCT05050578|364070985|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
105565853|NCT05050578|364070986|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
105751687|NCT00349752|364742542|FG000|Overall Study|Adverse Event|8|||
105751688|NCT00349752|364742543|FG001|Overall Study|Adverse Event|12|||
105751689|NCT00349752|364742542|FG000|Overall Study|Lack of Efficacy|37|||
105751690|NCT00349752|364742543|FG001|Overall Study|Lack of Efficacy|42|||
105751691|NCT00349752|364742542|FG000|Overall Study|Lost to Follow-up|4|||
105751692|NCT00349752|364742543|FG001|Overall Study|Lost to Follow-up|2|||
105751693|NCT00349752|364742542|FG000|Overall Study|Personal reasons|6|||
105751694|NCT00349752|364742543|FG001|Overall Study|Personal reasons|5|||
105751695|NCT00349752|364742542|FG000|Overall Study|Other: Required exclusionary medication|0|||
105751696|NCT00349752|364742543|FG001|Overall Study|Other: Required exclusionary medication|1|||
105751697|NCT00349752|364742542|FG000|Overall Study|Other: Non compliance|0|||
105751698|NCT00349752|364742543|FG001|Overall Study|Other: Non compliance|1|||
105751699|NCT00349752|364742542|FG000|Overall Study|Other: Patient stopped steroids|0|||
105760895|NCT01342952|364778052|FG000|Overall Study|Adverse Event|0|||
105751700|NCT00349752|364742543|FG001|Overall Study|Other: Patient stopped steroids|1|||
105751701|NCT00349752|364742542|FG000|Overall Study|Other: Patient's steroid use|1|||
105751702|NCT00349752|364742543|FG001|Overall Study|Other: Patient's steroid use|0|||
105751703|NCT00349752|364742542|FG000|Overall Study|Other: Ineligible|1|||
105751704|NCT00349752|364742543|FG001|Overall Study|Other: Ineligible|0|||
105751705|NCT00349752|364742542|FG000|Overall Study|Other: Inadvertently unblinded|1|||
105751706|NCT00349752|364742543|FG001|Overall Study|Other: Inadvertently unblinded|0|||
105751707|NCT00349752|364742542|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
105751708|NCT00349752|364742543|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
105751709|NCT03521193|364742545|FG000|Overall Study|Withdrawal by Subject|8|||
105751710|NCT03521193|364742546|FG001|Overall Study|Withdrawal by Subject|0|||
105751711|NCT03521193|364742545|FG000|Overall Study|non compliant to ASA treatment|8|||
105751712|NCT03521193|364742546|FG001|Overall Study|non compliant to ASA treatment|0|||
105751713|NCT00738374|364742547|FG000|Induction Treatment Phase|Adverse Event|14|||
105751714|NCT00738374|364742548|FG001|Induction Treatment Phase|Adverse Event|0|||
105751715|NCT00738374|364742549|FG002|Induction Treatment Phase|Adverse Event|0|||
105751716|NCT00738374|364742550|FG003|Induction Treatment Phase|Adverse Event|0|||
105751717|NCT00738374|364742547|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
105751718|NCT00738374|364742548|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
105751719|NCT00738374|364742549|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
105751720|NCT00738374|364742550|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
105751721|NCT00738374|364742547|FG000|Induction Treatment Phase|Physician Decision|2|||
105751722|NCT00738374|364742548|FG001|Induction Treatment Phase|Physician Decision|0|||
105751723|NCT00738374|364742549|FG002|Induction Treatment Phase|Physician Decision|0|||
105751724|NCT00738374|364742550|FG003|Induction Treatment Phase|Physician Decision|0|||
105751725|NCT00738374|364742547|FG000|Induction Treatment Phase|Protocol Violation|2|||
105751726|NCT00738374|364742548|FG001|Induction Treatment Phase|Protocol Violation|0|||
105751727|NCT00738374|364742549|FG002|Induction Treatment Phase|Protocol Violation|0|||
105751728|NCT00738374|364742550|FG003|Induction Treatment Phase|Protocol Violation|0|||
105751729|NCT00738374|364742547|FG000|Induction Treatment Phase|Non-compliance|1|||
105751730|NCT00738374|364742548|FG001|Induction Treatment Phase|Non-compliance|0|||
105751731|NCT00738374|364742549|FG002|Induction Treatment Phase|Non-compliance|0|||
105751732|NCT00738374|364742550|FG003|Induction Treatment Phase|Non-compliance|0|||
105751733|NCT00738374|364742547|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
105751734|NCT00738374|364742548|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
105751735|NCT00738374|364742549|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
105751736|NCT00738374|364742550|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
105751737|NCT00738374|364742547|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
105751738|NCT00738374|364742548|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
105751739|NCT00738374|364742549|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
105360262|NCT01000974|363325898|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
105360263|NCT01000974|363325899|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
105360264|NCT01000974|363325900|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
105360265|NCT01000974|363325898|FG000|Booster Vaccination Phase|Other|24|||
105360266|NCT01000974|363325899|FG001|Booster Vaccination Phase|Other|6|||
105360267|NCT01000974|363325900|FG002|Booster Vaccination Phase|Other|4|||
105360268|NCT00522548|363325906|FG000|Overall Study|Adverse Event|2|||
105360269|NCT00522548|363325907|FG001|Overall Study|Adverse Event|2|||
105360270|NCT00522548|363325906|FG000|Overall Study|Withdrawal by Subject|0|||
105360271|NCT00522548|363325907|FG001|Overall Study|Withdrawal by Subject|2|||
105751740|NCT00738374|364742550|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
105751741|NCT00738374|364742547|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
105751742|NCT00738374|364742548|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
105751743|NCT00738374|364742549|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
105751744|NCT00738374|364742550|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
105751745|NCT00738374|364742547|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
105751746|NCT00738374|364742548|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
105751747|NCT00738374|364742549|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
105760896|NCT01342952|364778053|FG001|Overall Study|Adverse Event|5|||
105751748|NCT00738374|364742550|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
105751749|NCT00738374|364742547|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
105751750|NCT00738374|364742548|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
105751751|NCT00738374|364742549|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
105751752|NCT00738374|364742550|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
105751753|NCT00738374|364742547|FG000|Maintenance Treatment/Observation Phase|Other|0|||
105751754|NCT00738374|364742548|FG001|Maintenance Treatment/Observation Phase|Other|1|||
105751755|NCT00738374|364742549|FG002|Maintenance Treatment/Observation Phase|Other|0|||
105751756|NCT00738374|364742550|FG003|Maintenance Treatment/Observation Phase|Other|0|||
105751757|NCT00064350|364742553|FG000|Induction Treatment|Disease Progression|5|||
105751758|NCT00064350|364742554|FG001|Induction Treatment|Disease Progression|1|||
105751759|NCT00064350|364742555|FG002|Induction Treatment|Disease Progression|110|||
105751760|NCT00064350|364742553|FG000|Induction Treatment|Adverse Event|0|||
105751761|NCT00064350|364742554|FG001|Induction Treatment|Adverse Event|2|||
105751762|NCT00064350|364742555|FG002|Induction Treatment|Adverse Event|49|||
105751763|NCT00064350|364742553|FG000|Induction Treatment|Death|0|||
105751764|NCT00064350|364742554|FG001|Induction Treatment|Death|0|||
105751765|NCT00064350|364742555|FG002|Induction Treatment|Death|9|||
105751766|NCT00064350|364742553|FG000|Induction Treatment|Withdrawal by Subject|0|||
105751767|NCT00064350|364742554|FG001|Induction Treatment|Withdrawal by Subject|0|||
105751768|NCT00064350|364742555|FG002|Induction Treatment|Withdrawal by Subject|21|||
105751769|NCT00064350|364742553|FG000|Induction Treatment|Ineligible or never started treatment|3|||
105751770|NCT00064350|364742554|FG001|Induction Treatment|Ineligible or never started treatment|6|||
105751771|NCT00064350|364742555|FG002|Induction Treatment|Ineligible or never started treatment|34|||
105751772|NCT00064350|364742553|FG000|Induction Treatment|Other|0|||
105751773|NCT00064350|364742554|FG001|Induction Treatment|Other|0|||
105751774|NCT00064350|364742555|FG002|Induction Treatment|Other|13|||
105751775|NCT00064350|364742553|FG000|Randomization|Adverse Event|8|||
105751776|NCT00064350|364742554|FG001|Randomization|Adverse Event|3|||
105751777|NCT00064350|364742555|FG002|Randomization|Adverse Event|0|||
105751778|NCT00064350|364742553|FG000|Randomization|Death|3|||
105751779|NCT00064350|364742554|FG001|Randomization|Death|0|||
105751780|NCT00064350|364742555|FG002|Randomization|Death|0|||
105751781|NCT00064350|364742553|FG000|Randomization|Withdrawal by Subject|1|||
105751782|NCT00064350|364742554|FG001|Randomization|Withdrawal by Subject|0|||
105751783|NCT00064350|364742555|FG002|Randomization|Withdrawal by Subject|0|||
105751784|NCT00064350|364742553|FG000|Randomization|Ineligible or never started treatment|9|||
105751785|NCT00064350|364742554|FG001|Randomization|Ineligible or never started treatment|15|||
105751786|NCT00064350|364742555|FG002|Randomization|Ineligible or never started treatment|0|||
105751787|NCT00064350|364742553|FG000|Randomization|Other|5|||
105751788|NCT00064350|364742554|FG001|Randomization|Other|0|||
105751789|NCT00064350|364742555|FG002|Randomization|Other|0|||
105751790|NCT00064350|364742553|FG000|Cross-Over|Adverse Event|0|||
105751791|NCT00064350|364742554|FG001|Cross-Over|Adverse Event|1|||
105565854|NCT05050578|364070985|FG000|Period 2, 30 Days|Protocol Violation|0|||
105565855|NCT05050578|364070986|FG001|Period 2, 30 Days|Protocol Violation|1|||
105565856|NCT02472652|364070987|FG000|Overall Study|Lost to Follow-up|1|||
105565857|NCT01191840|364070988|FG000|Overall Study|withdrew consent|2|||
105565858|NCT01191840|364070989|FG001|Overall Study|withdrew consent|1|||
105565859|NCT01191840|364070988|FG000|Overall Study|Subject discontinued treatment|1|||
105565860|NCT01191840|364070989|FG001|Overall Study|Subject discontinued treatment|2|||
105565861|NCT01191840|364070988|FG000|Overall Study|Lost to Follow-up|4|||
105565862|NCT01191840|364070989|FG001|Overall Study|Lost to Follow-up|6|||
105565863|NCT01191840|364070988|FG000|Overall Study|Non Staph Infection|4|||
105565864|NCT01191840|364070989|FG001|Overall Study|Non Staph Infection|3|||
105565865|NCT01191840|364070988|FG000|Overall Study|ineligible at enrollment|1|||
105565866|NCT01191840|364070989|FG001|Overall Study|ineligible at enrollment|0|||
105565867|NCT01191840|364070988|FG000|Overall Study|IRB approval lapse|0|||
105565868|NCT01191840|364070989|FG001|Overall Study|IRB approval lapse|2|||
105751792|NCT00064350|364742555|FG002|Cross-Over|Adverse Event|0|||
105751793|NCT00064350|364742553|FG000|Cross-Over|Death|1|||
105751794|NCT00064350|364742554|FG001|Cross-Over|Death|3|||
105565869|NCT01191840|364070988|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
105565870|NCT01191840|364070989|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
105565871|NCT01191840|364070988|FG000|Overall Study|Withdrawal by Subject|2|||
105751795|NCT00064350|364742555|FG002|Cross-Over|Death|0|||
105751796|NCT00064350|364742553|FG000|Cross-Over|Withdrawal by Subject|2|||
105751797|NCT00064350|364742554|FG001|Cross-Over|Withdrawal by Subject|2|||
105751798|NCT00064350|364742555|FG002|Cross-Over|Withdrawal by Subject|0|||
105751799|NCT00064350|364742553|FG000|Cross-Over|Ineligible or never started treatment|3|||
105751800|NCT00064350|364742554|FG001|Cross-Over|Ineligible or never started treatment|6|||
105751801|NCT00064350|364742555|FG002|Cross-Over|Ineligible or never started treatment|0|||
105751802|NCT00064350|364742553|FG000|Cross-Over|Other|0|||
105751803|NCT00064350|364742554|FG001|Cross-Over|Other|2|||
105751804|NCT00064350|364742555|FG002|Cross-Over|Other|0|||
105751805|NCT03600714|364742558|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
105751806|NCT03784027|364742561|FG000|Period 1|Withdrawal by Subject|0|||
105751807|NCT03784027|364742562|FG001|Period 1|Withdrawal by Subject|1|||
105751808|NCT01179347|364744558|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
105751809|NCT01179347|364744559|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
105751810|NCT01179347|364744558|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
105751811|NCT01179347|364744559|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
105751812|NCT01179347|364744558|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
105751813|NCT01179347|364744559|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
105751814|NCT01179347|364744558|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
105751815|NCT01179347|364744559|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
105751816|NCT01179347|364744558|FG000|Double-blind Period (12 Weeks)|Other|2|||
105751817|NCT01179347|364744559|FG001|Double-blind Period (12 Weeks)|Other|4|||
105751818|NCT01179347|364744558|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
105751819|NCT01179347|364744559|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
105751820|NCT01179347|364744558|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
105751821|NCT01179347|364744559|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
105751822|NCT01179347|364744558|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
105751823|NCT01179347|364744559|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
105751824|NCT01179347|364744558|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
105751825|NCT01179347|364744559|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
105751826|NCT01179347|364744558|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
105751827|NCT01179347|364744559|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
105751828|NCT01179347|364744558|FG000|Open-label Period (12 Weeks)|Other|7|||
105751829|NCT01179347|364744559|FG001|Open-label Period (12 Weeks)|Other|4|||
105751830|NCT01283997|364744560|FG000|Overall Study|Physician Decision|8|||
105751831|NCT01283997|364744561|FG001|Overall Study|Physician Decision|10|||
105751832|NCT01283997|364744560|FG000|Overall Study|Withdrawal by Subject|3|||
105751833|NCT01283997|364744561|FG001|Overall Study|Withdrawal by Subject|2|||
105751834|NCT01283997|364744560|FG000|Overall Study|Physically unable to continue|0|||
105751835|NCT01283997|364744561|FG001|Overall Study|Physically unable to continue|1|||
105751836|NCT01283997|364744560|FG000|Overall Study|Progressive disease|1|||
105751837|NCT01283997|364744561|FG001|Overall Study|Progressive disease|0|||
105751838|NCT01283997|364744560|FG000|Overall Study|Other|4|||
105751839|NCT01283997|364744561|FG001|Overall Study|Other|4|||
105751840|NCT01677624|364744562|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
105751841|NCT00839423|364744568|FG000|Overall Study|Adverse Event|4|||
105751842|NCT00839423|364744569|FG001|Overall Study|Adverse Event|3|||
105751843|NCT00839423|364744570|FG002|Overall Study|Adverse Event|7|||
105751844|NCT00839423|364744571|FG003|Overall Study|Adverse Event|16|||
105751845|NCT00839423|364744568|FG000|Overall Study|Lack of Efficacy|6|||
105751846|NCT00839423|364744569|FG001|Overall Study|Lack of Efficacy|6|||
105751847|NCT00839423|364744570|FG002|Overall Study|Lack of Efficacy|3|||
105751848|NCT00839423|364744571|FG003|Overall Study|Lack of Efficacy|2|||
105751849|NCT00839423|364744568|FG000|Overall Study|Non-compliance|0|||
105751850|NCT00839423|364744569|FG001|Overall Study|Non-compliance|0|||
105751851|NCT00839423|364744570|FG002|Overall Study|Non-compliance|0|||
105751852|NCT00839423|364744571|FG003|Overall Study|Non-compliance|1|||
105751853|NCT00839423|364744568|FG000|Overall Study|Protocol Violation|0|||
105751854|NCT00839423|364744569|FG001|Overall Study|Protocol Violation|1|||
105751855|NCT00839423|364744570|FG002|Overall Study|Protocol Violation|2|||
105751856|NCT00839423|364744571|FG003|Overall Study|Protocol Violation|0|||
105751857|NCT00839423|364744568|FG000|Overall Study|Withdrawal of consent|4|||
105751858|NCT00839423|364744569|FG001|Overall Study|Withdrawal of consent|0|||
105751859|NCT00839423|364744570|FG002|Overall Study|Withdrawal of consent|4|||
105751860|NCT00839423|364744571|FG003|Overall Study|Withdrawal of consent|1|||
105751861|NCT00839423|364744568|FG000|Overall Study|Lost to Follow-up|1|||
105751862|NCT00839423|364744569|FG001|Overall Study|Lost to Follow-up|0|||
105751863|NCT00839423|364744570|FG002|Overall Study|Lost to Follow-up|1|||
105751864|NCT00839423|364744571|FG003|Overall Study|Lost to Follow-up|0|||
105751865|NCT00839423|364744568|FG000|Overall Study|Administrative or other reasons|3|||
105751866|NCT00839423|364744569|FG001|Overall Study|Administrative or other reasons|0|||
105751867|NCT00839423|364744570|FG002|Overall Study|Administrative or other reasons|1|||
105751868|NCT00839423|364744571|FG003|Overall Study|Administrative or other reasons|0|||
105751869|NCT01071096|364744572|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
105751870|NCT01071096|364744573|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
105751871|NCT01885078|364744576|FG000|Treatment Period|Adverse Event|52|||
105751872|NCT01885078|364744577|FG001|Treatment Period|Adverse Event|136|||
105751873|NCT01885078|364744578|FG002|Treatment Period|Adverse Event|30|||
105751874|NCT01885078|364744579|FG003|Treatment Period|Adverse Event|73|||
105751875|NCT01885078|364744580|FG004|Treatment Period|Adverse Event|17|||
105751876|NCT01885078|364744581|FG005|Treatment Period|Adverse Event|72|||
105751877|NCT01885078|364744582|FG006|Treatment Period|Adverse Event|24|||
105751878|NCT01885078|364744583|FG007|Treatment Period|Adverse Event|5|||
105751879|NCT01885078|364744584|FG008|Treatment Period|Adverse Event|0|||
105751880|NCT01885078|364744585|FG009|Treatment Period|Adverse Event|0|||
105751881|NCT01885078|364744576|FG000|Treatment Period|Death|13|||
105751882|NCT01885078|364744577|FG001|Treatment Period|Death|33|||
105751883|NCT01885078|364744578|FG002|Treatment Period|Death|5|||
105751884|NCT01885078|364744579|FG003|Treatment Period|Death|9|||
105751885|NCT01885078|364744580|FG004|Treatment Period|Death|2|||
105751886|NCT01885078|364744581|FG005|Treatment Period|Death|10|||
105751887|NCT01885078|364744582|FG006|Treatment Period|Death|3|||
105751888|NCT01885078|364744583|FG007|Treatment Period|Death|2|||
105751889|NCT01885078|364744584|FG008|Treatment Period|Death|0|||
105751890|NCT01885078|364744585|FG009|Treatment Period|Death|0|||
105751891|NCT01885078|364744576|FG000|Treatment Period|Lack of Efficacy|12|||
105751892|NCT01885078|364744577|FG001|Treatment Period|Lack of Efficacy|33|||
105751893|NCT01885078|364744578|FG002|Treatment Period|Lack of Efficacy|10|||
105751894|NCT01885078|364744579|FG003|Treatment Period|Lack of Efficacy|23|||
105751895|NCT01885078|364744580|FG004|Treatment Period|Lack of Efficacy|24|||
105751896|NCT01885078|364744581|FG005|Treatment Period|Lack of Efficacy|58|||
105751897|NCT01885078|364744582|FG006|Treatment Period|Lack of Efficacy|9|||
105751898|NCT01885078|364744583|FG007|Treatment Period|Lack of Efficacy|5|||
105751899|NCT01885078|364744584|FG008|Treatment Period|Lack of Efficacy|0|||
105751900|NCT01885078|364744585|FG009|Treatment Period|Lack of Efficacy|0|||
105751901|NCT01885078|364744576|FG000|Treatment Period|Lost to Follow-up|16|||
105751902|NCT01885078|364744577|FG001|Treatment Period|Lost to Follow-up|19|||
105751903|NCT01885078|364744578|FG002|Treatment Period|Lost to Follow-up|7|||
105751904|NCT01885078|364744579|FG003|Treatment Period|Lost to Follow-up|9|||
105360272|NCT02915159|363325908|FG000|Overall Study|Participant no longer meets criteria|2|||
105360273|NCT02915159|363325909|FG001|Overall Study|Participant no longer meets criteria|0|||
105360274|NCT02915159|363325908|FG000|Overall Study|poor/non-compliance|1|||
105360275|NCT02915159|363325909|FG001|Overall Study|poor/non-compliance|0|||
105360276|NCT02915159|363325908|FG000|Overall Study|Participant withdrew consent|5|||
105360277|NCT02915159|363325909|FG001|Overall Study|Participant withdrew consent|1|||
105751905|NCT01885078|364744580|FG004|Treatment Period|Lost to Follow-up|2|||
105751906|NCT01885078|364744581|FG005|Treatment Period|Lost to Follow-up|8|||
105751907|NCT01885078|364744582|FG006|Treatment Period|Lost to Follow-up|2|||
105751908|NCT01885078|364744583|FG007|Treatment Period|Lost to Follow-up|0|||
105565872|NCT01191840|364070989|FG001|Overall Study|Withdrawal by Subject|0|||
105751909|NCT01885078|364744584|FG008|Treatment Period|Lost to Follow-up|0|||
105751910|NCT01885078|364744585|FG009|Treatment Period|Lost to Follow-up|0|||
105751911|NCT01885078|364744576|FG000|Treatment Period|Physician Decision|19|||
105751912|NCT01885078|364744577|FG001|Treatment Period|Physician Decision|21|||
105751913|NCT01885078|364744578|FG002|Treatment Period|Physician Decision|5|||
105751914|NCT01885078|364744579|FG003|Treatment Period|Physician Decision|12|||
105751915|NCT01885078|364744580|FG004|Treatment Period|Physician Decision|9|||
105360278|NCT02915159|363325908|FG000|Overall Study|Request to discontinue treatment|1|||
105751916|NCT01885078|364744581|FG005|Treatment Period|Physician Decision|24|||
105751917|NCT01885078|364744582|FG006|Treatment Period|Physician Decision|4|||
105751918|NCT01885078|364744583|FG007|Treatment Period|Physician Decision|3|||
105751919|NCT01885078|364744584|FG008|Treatment Period|Physician Decision|0|||
105751920|NCT01885078|364744585|FG009|Treatment Period|Physician Decision|0|||
105751921|NCT01885078|364744576|FG000|Treatment Period|Protocol Violation|3|||
105751922|NCT01885078|364744577|FG001|Treatment Period|Protocol Violation|5|||
105751923|NCT01885078|364744578|FG002|Treatment Period|Protocol Violation|0|||
105751924|NCT01885078|364744579|FG003|Treatment Period|Protocol Violation|3|||
105751925|NCT01885078|364744580|FG004|Treatment Period|Protocol Violation|1|||
105751926|NCT01885078|364744581|FG005|Treatment Period|Protocol Violation|6|||
105751927|NCT01885078|364744582|FG006|Treatment Period|Protocol Violation|0|||
105751928|NCT01885078|364744583|FG007|Treatment Period|Protocol Violation|0|||
105751929|NCT01885078|364744584|FG008|Treatment Period|Protocol Violation|0|||
105751930|NCT01885078|364744585|FG009|Treatment Period|Protocol Violation|0|||
105751931|NCT01885078|364744576|FG000|Treatment Period|Sponsor Decision|245|||
105751932|NCT01885078|364744577|FG001|Treatment Period|Sponsor Decision|648|||
105751933|NCT01885078|364744578|FG002|Treatment Period|Sponsor Decision|49|||
105751934|NCT01885078|364744579|FG003|Treatment Period|Sponsor Decision|90|||
105751935|NCT01885078|364744580|FG004|Treatment Period|Sponsor Decision|20|||
105751936|NCT01885078|364744581|FG005|Treatment Period|Sponsor Decision|38|||
105751937|NCT01885078|364744582|FG006|Treatment Period|Sponsor Decision|162|||
105751938|NCT01885078|364744583|FG007|Treatment Period|Sponsor Decision|3|||
105751939|NCT01885078|364744584|FG008|Treatment Period|Sponsor Decision|0|||
105751940|NCT01885078|364744585|FG009|Treatment Period|Sponsor Decision|0|||
105751941|NCT01885078|364744576|FG000|Treatment Period|Withdrawal by Subject|72|||
105751942|NCT01885078|364744577|FG001|Treatment Period|Withdrawal by Subject|132|||
105751943|NCT01885078|364744578|FG002|Treatment Period|Withdrawal by Subject|25|||
105751944|NCT01885078|364744579|FG003|Treatment Period|Withdrawal by Subject|63|||
105751945|NCT01885078|364744580|FG004|Treatment Period|Withdrawal by Subject|15|||
105751946|NCT01885078|364744581|FG005|Treatment Period|Withdrawal by Subject|34|||
105751947|NCT01885078|364744582|FG006|Treatment Period|Withdrawal by Subject|17|||
105751948|NCT01885078|364744583|FG007|Treatment Period|Withdrawal by Subject|10|||
105751949|NCT01885078|364744584|FG008|Treatment Period|Withdrawal by Subject|0|||
105751950|NCT01885078|364744585|FG009|Treatment Period|Withdrawal by Subject|0|||
105751951|NCT01885078|364744576|FG000|Treatment Period|Other|0|||
105751952|NCT01885078|364744577|FG001|Treatment Period|Other|0|||
105751953|NCT01885078|364744578|FG002|Treatment Period|Other|0|||
105751954|NCT01885078|364744579|FG003|Treatment Period|Other|1|||
105751955|NCT01885078|364744580|FG004|Treatment Period|Other|0|||
105751956|NCT01885078|364744581|FG005|Treatment Period|Other|0|||
105751957|NCT01885078|364744582|FG006|Treatment Period|Other|0|||
105751958|NCT01885078|364744583|FG007|Treatment Period|Other|0|||
105751959|NCT01885078|364744584|FG008|Treatment Period|Other|0|||
105751960|NCT01885078|364744585|FG009|Treatment Period|Other|0|||
105751961|NCT01885078|364744576|FG000|Step-down Period|Sponsor Decision|0|||
105751962|NCT01885078|364744577|FG001|Step-down Period|Sponsor Decision|0|||
105751963|NCT01885078|364744578|FG002|Step-down Period|Sponsor Decision|0|||
105751964|NCT01885078|364744579|FG003|Step-down Period|Sponsor Decision|0|||
105751965|NCT01885078|364744580|FG004|Step-down Period|Sponsor Decision|0|||
105751966|NCT01885078|364744581|FG005|Step-down Period|Sponsor Decision|0|||
105751967|NCT01885078|364744582|FG006|Step-down Period|Sponsor Decision|0|||
105751968|NCT01885078|364744583|FG007|Step-down Period|Sponsor Decision|0|||
105751969|NCT01885078|364744584|FG008|Step-down Period|Sponsor Decision|1|||
105751970|NCT01885078|364744585|FG009|Step-down Period|Sponsor Decision|1|||
105751971|NCT01885078|364744576|FG000|Step-down Period|Adverse Event|0|||
105751972|NCT01885078|364744577|FG001|Step-down Period|Adverse Event|0|||
105751973|NCT01885078|364744578|FG002|Step-down Period|Adverse Event|0|||
105751974|NCT01885078|364744579|FG003|Step-down Period|Adverse Event|0|||
105751975|NCT01885078|364744580|FG004|Step-down Period|Adverse Event|0|||
105751976|NCT01885078|364744581|FG005|Step-down Period|Adverse Event|0|||
105751977|NCT01885078|364744582|FG006|Step-down Period|Adverse Event|0|||
105751978|NCT01885078|364744583|FG007|Step-down Period|Adverse Event|0|||
105751979|NCT01885078|364744584|FG008|Step-down Period|Adverse Event|29|||
105751980|NCT01885078|364744585|FG009|Step-down Period|Adverse Event|38|||
105751981|NCT01885078|364744576|FG000|Step-down Period|Withdrawal by Subject|0|||
105751982|NCT01885078|364744577|FG001|Step-down Period|Withdrawal by Subject|0|||
105751983|NCT01885078|364744578|FG002|Step-down Period|Withdrawal by Subject|0|||
105751984|NCT01885078|364744579|FG003|Step-down Period|Withdrawal by Subject|0|||
105751985|NCT01885078|364744580|FG004|Step-down Period|Withdrawal by Subject|0|||
105751986|NCT01885078|364744581|FG005|Step-down Period|Withdrawal by Subject|0|||
105751987|NCT01885078|364744582|FG006|Step-down Period|Withdrawal by Subject|0|||
105751988|NCT01885078|364744583|FG007|Step-down Period|Withdrawal by Subject|0|||
105751989|NCT01885078|364744584|FG008|Step-down Period|Withdrawal by Subject|25|||
105751990|NCT01885078|364744585|FG009|Step-down Period|Withdrawal by Subject|15|||
105751991|NCT01885078|364744576|FG000|Step-down Period|Physician Decision|0|||
105751992|NCT01885078|364744577|FG001|Step-down Period|Physician Decision|0|||
105751993|NCT01885078|364744578|FG002|Step-down Period|Physician Decision|0|||
105751994|NCT01885078|364744579|FG003|Step-down Period|Physician Decision|0|||
105751995|NCT01885078|364744580|FG004|Step-down Period|Physician Decision|0|||
105751996|NCT01885078|364744581|FG005|Step-down Period|Physician Decision|0|||
105751997|NCT01885078|364744582|FG006|Step-down Period|Physician Decision|0|||
105751998|NCT01885078|364744583|FG007|Step-down Period|Physician Decision|0|||
105751999|NCT01885078|364744584|FG008|Step-down Period|Physician Decision|7|||
105752000|NCT01885078|364744585|FG009|Step-down Period|Physician Decision|2|||
105752001|NCT01885078|364744576|FG000|Step-down Period|Death|0|||
105752002|NCT01885078|364744577|FG001|Step-down Period|Death|0|||
105752003|NCT01885078|364744578|FG002|Step-down Period|Death|0|||
105752004|NCT01885078|364744579|FG003|Step-down Period|Death|0|||
105752005|NCT01885078|364744580|FG004|Step-down Period|Death|0|||
105752006|NCT01885078|364744581|FG005|Step-down Period|Death|0|||
105752007|NCT01885078|364744582|FG006|Step-down Period|Death|0|||
105752008|NCT01885078|364744583|FG007|Step-down Period|Death|0|||
105752009|NCT01885078|364744584|FG008|Step-down Period|Death|4|||
105752010|NCT01885078|364744585|FG009|Step-down Period|Death|3|||
105752011|NCT01885078|364744576|FG000|Step-down Period|Lost to Follow-up|0|||
105752012|NCT01885078|364744577|FG001|Step-down Period|Lost to Follow-up|0|||
105752013|NCT01885078|364744578|FG002|Step-down Period|Lost to Follow-up|0|||
105752014|NCT01885078|364744579|FG003|Step-down Period|Lost to Follow-up|0|||
105752015|NCT01885078|364744580|FG004|Step-down Period|Lost to Follow-up|0|||
105752016|NCT01885078|364744581|FG005|Step-down Period|Lost to Follow-up|0|||
105752017|NCT01885078|364744582|FG006|Step-down Period|Lost to Follow-up|0|||
105752018|NCT01885078|364744583|FG007|Step-down Period|Lost to Follow-up|0|||
105752019|NCT01885078|364744584|FG008|Step-down Period|Lost to Follow-up|1|||
105752020|NCT01885078|364744585|FG009|Step-down Period|Lost to Follow-up|1|||
105752021|NCT01885078|364744576|FG000|Step-down Period|Lack of Efficacy|0|||
105752022|NCT01885078|364744577|FG001|Step-down Period|Lack of Efficacy|0|||
105752023|NCT01885078|364744578|FG002|Step-down Period|Lack of Efficacy|0|||
105752024|NCT01885078|364744579|FG003|Step-down Period|Lack of Efficacy|0|||
105752025|NCT01885078|364744580|FG004|Step-down Period|Lack of Efficacy|0|||
105752026|NCT01885078|364744581|FG005|Step-down Period|Lack of Efficacy|0|||
105752027|NCT01885078|364744582|FG006|Step-down Period|Lack of Efficacy|0|||
105752028|NCT01885078|364744583|FG007|Step-down Period|Lack of Efficacy|0|||
105752029|NCT01885078|364744584|FG008|Step-down Period|Lack of Efficacy|1|||
105752030|NCT01885078|364744585|FG009|Step-down Period|Lack of Efficacy|0|||
105752031|NCT01885078|364744576|FG000|Step-down Period|Protocol Violation|0|||
105752032|NCT01885078|364744577|FG001|Step-down Period|Protocol Violation|0|||
105752033|NCT01885078|364744578|FG002|Step-down Period|Protocol Violation|0|||
105752034|NCT01885078|364744579|FG003|Step-down Period|Protocol Violation|0|||
105752035|NCT01885078|364744580|FG004|Step-down Period|Protocol Violation|0|||
105752036|NCT01885078|364744581|FG005|Step-down Period|Protocol Violation|0|||
105752037|NCT01885078|364744582|FG006|Step-down Period|Protocol Violation|0|||
105752038|NCT01885078|364744583|FG007|Step-down Period|Protocol Violation|0|||
105752039|NCT01885078|364744584|FG008|Step-down Period|Protocol Violation|1|||
105752040|NCT01885078|364744585|FG009|Step-down Period|Protocol Violation|1|||
105752041|NCT03115112|364744586|FG000|Overall Study|Adverse Event|5|||
105752042|NCT03115112|364744587|FG001|Overall Study|Adverse Event|1|||
105752043|NCT03115112|364744586|FG000|Overall Study|Withdrawal by Subject|4|||
105752044|NCT03115112|364744587|FG001|Overall Study|Withdrawal by Subject|2|||
105752045|NCT03115112|364744586|FG000|Overall Study|Lost to Follow-up|0|||
105752046|NCT03115112|364744587|FG001|Overall Study|Lost to Follow-up|1|||
105752047|NCT03115112|364744586|FG000|Overall Study|Death|1|||
105752048|NCT03115112|364744587|FG001|Overall Study|Death|0|||
105752049|NCT03115112|364744586|FG000|Overall Study|Pregnancy|1|||
105752050|NCT03115112|364744587|FG001|Overall Study|Pregnancy|0|||
105752051|NCT03115112|364744586|FG000|Overall Study|Site closure|1|||
105752052|NCT03115112|364744587|FG001|Overall Study|Site closure|1|||
105752053|NCT02168803|364744588|FG000|Overall Study|Lost to Follow-up|1|||
105752054|NCT02168803|364744589|FG001|Overall Study|Lost to Follow-up|0|||
105752055|NCT02168803|364744590|FG002|Overall Study|Lost to Follow-up|1|||
105752056|NCT02168803|364744588|FG000|Overall Study|Withdrawal by Subject|1|||
105752057|NCT02168803|364744589|FG001|Overall Study|Withdrawal by Subject|1|||
105752058|NCT02168803|364744590|FG002|Overall Study|Withdrawal by Subject|2|||
105752059|NCT02168803|364744588|FG000|Overall Study|Physician Decision|0|||
105752060|NCT02168803|364744589|FG001|Overall Study|Physician Decision|1|||
105752061|NCT02168803|364744590|FG002|Overall Study|Physician Decision|0|||
105752062|NCT02168803|364744588|FG000|Overall Study|Adverse Event|0|||
105752063|NCT02168803|364744589|FG001|Overall Study|Adverse Event|1|||
105752064|NCT02168803|364744590|FG002|Overall Study|Adverse Event|1|||
105752065|NCT02168803|364744588|FG000|Overall Study|Death|0|||
105752066|NCT02168803|364744589|FG001|Overall Study|Death|0|||
105752067|NCT02168803|364744590|FG002|Overall Study|Death|1|||
105752068|NCT02168803|364744588|FG000|Overall Study|Sponsor Decision|0|||
105752069|NCT02168803|364744589|FG001|Overall Study|Sponsor Decision|0|||
105752070|NCT02168803|364744590|FG002|Overall Study|Sponsor Decision|1|||
105752071|NCT01107405|364744591|FG000|Overall Study|Adverse Event|1|||
105752072|NCT01107405|364744592|FG001|Overall Study|Adverse Event|1|||
105752073|NCT01107405|364744593|FG002|Overall Study|Adverse Event|0|||
105752074|NCT01107405|364744594|FG003|Overall Study|Adverse Event|0|||
105752075|NCT01107405|364744595|FG004|Overall Study|Adverse Event|2|||
105752076|NCT01107405|364744591|FG000|Overall Study|Withdrawal by Subject|1|||
105752077|NCT01107405|364744592|FG001|Overall Study|Withdrawal by Subject|0|||
105752078|NCT01107405|364744593|FG002|Overall Study|Withdrawal by Subject|1|||
105752079|NCT01107405|364744594|FG003|Overall Study|Withdrawal by Subject|2|||
105752080|NCT01107405|364744595|FG004|Overall Study|Withdrawal by Subject|1|||
105752081|NCT01107405|364744591|FG000|Overall Study|Protocol Violation|0|||
105752082|NCT01107405|364744592|FG001|Overall Study|Protocol Violation|0|||
105752083|NCT01107405|364744593|FG002|Overall Study|Protocol Violation|1|||
105752084|NCT01107405|364744594|FG003|Overall Study|Protocol Violation|1|||
105752085|NCT01107405|364744595|FG004|Overall Study|Protocol Violation|0|||
105752086|NCT01653158|364744596|FG000|Overall Study|Death|0|||
105752087|NCT01653158|364744597|FG001|Overall Study|Death|0|||
105752088|NCT01653158|364744598|FG002|Overall Study|Death|0|||
105752089|NCT01653158|364744599|FG003|Overall Study|Death|1|||
105752090|NCT01653158|364744600|FG004|Overall Study|Death|0|||
105752091|NCT01653158|364744601|FG005|Overall Study|Death|0|||
105752092|NCT01653158|364744602|FG006|Overall Study|Death|0|||
105752093|NCT01653158|364744603|FG007|Overall Study|Death|2|||
105752094|NCT01653158|364744596|FG000|Overall Study|Adverse Event|0|||
105752095|NCT01653158|364744597|FG001|Overall Study|Adverse Event|0|||
105360279|NCT02915159|363325909|FG001|Overall Study|Request to discontinue treatment|2|||
105360280|NCT02915159|363325908|FG000|Overall Study|Adverse Event|2|||
105360281|NCT02915159|363325909|FG001|Overall Study|Adverse Event|2|||
105360282|NCT02915159|363325908|FG000|Overall Study|Lack of Efficacy|0|||
105360283|NCT02915159|363325909|FG001|Overall Study|Lack of Efficacy|3|||
105360284|NCT03442088|363325910|FG000|Overall Study|Adverse Event|1|||
105360285|NCT03442088|363325910|FG000|Overall Study|Lack of Efficacy|2|||
105360286|NCT03442088|363325910|FG000|Overall Study|Lost to Follow-up|2|||
105360287|NCT00105989|363325911|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
105360288|NCT00105989|363325912|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
105360289|NCT00105989|363325911|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
105360290|NCT00105989|363325912|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
105360291|NCT00105989|363325911|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
105360292|NCT00105989|363325912|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
105360293|NCT00105989|363325911|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
105360294|NCT00105989|363325912|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
105360295|NCT00105989|363325911|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
105360296|NCT00105989|363325912|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
105360297|NCT00105989|363325911|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
105360298|NCT00105989|363325912|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
105360299|NCT00105989|363325911|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
105360300|NCT00105989|363325912|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
105360301|NCT00105989|363325911|FG000|Acute - Open Label: Week 0-10|Death|1|||
105360302|NCT00105989|363325912|FG001|Acute - Open Label: Week 0-10|Death|0|||
105360303|NCT00105989|363325911|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
105360304|NCT00105989|363325912|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
105360305|NCT00105989|363325911|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
105360306|NCT00105989|363325912|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
105360307|NCT00105989|363325911|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
105360308|NCT00105989|363325912|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
105360309|NCT00105989|363325911|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
105360310|NCT00105989|363325912|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
105360311|NCT00105989|363325911|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
105360312|NCT00105989|363325912|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
105752096|NCT01653158|364744598|FG002|Overall Study|Adverse Event|0|||
105752097|NCT01653158|364744599|FG003|Overall Study|Adverse Event|1|||
105752098|NCT01653158|364744600|FG004|Overall Study|Adverse Event|0|||
105752099|NCT01653158|364744601|FG005|Overall Study|Adverse Event|0|||
105752100|NCT01653158|364744602|FG006|Overall Study|Adverse Event|0|||
105752101|NCT01653158|364744603|FG007|Overall Study|Adverse Event|3|||
105752102|NCT01653158|364744596|FG000|Overall Study|Other|0|||
105752103|NCT01653158|364744597|FG001|Overall Study|Other|0|||
105752104|NCT01653158|364744598|FG002|Overall Study|Other|0|||
105752105|NCT01653158|364744599|FG003|Overall Study|Other|0|||
105752106|NCT01653158|364744600|FG004|Overall Study|Other|0|||
105752107|NCT01653158|364744601|FG005|Overall Study|Other|0|||
105752108|NCT01653158|364744602|FG006|Overall Study|Other|0|||
105752109|NCT01653158|364744603|FG007|Overall Study|Other|1|||
105752110|NCT01653158|364744596|FG000|Overall Study|Progressive disease|0|||
105752111|NCT01653158|364744597|FG001|Overall Study|Progressive disease|0|||
105752112|NCT01653158|364744598|FG002|Overall Study|Progressive disease|0|||
105752113|NCT01653158|364744599|FG003|Overall Study|Progressive disease|0|||
105752114|NCT01653158|364744600|FG004|Overall Study|Progressive disease|1|||
105752115|NCT01653158|364744601|FG005|Overall Study|Progressive disease|1|||
105752116|NCT01653158|364744602|FG006|Overall Study|Progressive disease|2|||
105752117|NCT01653158|364744603|FG007|Overall Study|Progressive disease|9|||
105752118|NCT01653158|364744596|FG000|Overall Study|Withdrawal by Subject|1|||
105752119|NCT01653158|364744597|FG001|Overall Study|Withdrawal by Subject|0|||
105752120|NCT01653158|364744598|FG002|Overall Study|Withdrawal by Subject|0|||
105752121|NCT01653158|364744599|FG003|Overall Study|Withdrawal by Subject|0|||
105752122|NCT01653158|364744600|FG004|Overall Study|Withdrawal by Subject|0|||
105752123|NCT01653158|364744601|FG005|Overall Study|Withdrawal by Subject|0|||
105752124|NCT01653158|364744602|FG006|Overall Study|Withdrawal by Subject|0|||
105752125|NCT01653158|364744603|FG007|Overall Study|Withdrawal by Subject|0|||
105752126|NCT00980343|364744606|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
105752127|NCT00980343|364744607|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
105752128|NCT00848250|364744613|FG000|Overall Study|surgery was completed without cardiopulm|0|||
105752129|NCT00848250|364744614|FG001|Overall Study|surgery was completed without cardiopulm|1|||
105752130|NCT01205451|364744615|FG000|Overall Study|Lost to Follow-up|1|||
105752131|NCT01205451|364744616|FG001|Overall Study|Lost to Follow-up|1|||
105752132|NCT01205451|364744615|FG000|Overall Study|Withdrawal by Subject|5|||
105752133|NCT01205451|364744616|FG001|Overall Study|Withdrawal by Subject|9|||
105752134|NCT03457103|364744617|FG000|Overall Study|illness/hospitalization|4|||
105752135|NCT03457103|364744618|FG001|Overall Study|illness/hospitalization|2|||
105752136|NCT03457103|364744617|FG000|Overall Study|Lost to Follow-up|2|||
105752137|NCT03457103|364744618|FG001|Overall Study|Lost to Follow-up|1|||
105752138|NCT03457103|364744617|FG000|Overall Study|Withdrawal by Subject|1|||
105752139|NCT03457103|364744618|FG001|Overall Study|Withdrawal by Subject|2|||
105752140|NCT03457103|364744617|FG000|Overall Study|financial/ insurance issues|1|||
105752141|NCT03457103|364744618|FG001|Overall Study|financial/ insurance issues|1|||
105752142|NCT03004469|364744619|FG000|Overall Study|Adverse Event|6|||
105752143|NCT03004469|364744620|FG001|Overall Study|Adverse Event|4|||
105752144|NCT03004469|364744621|FG002|Overall Study|Adverse Event|6|||
105752145|NCT03004469|364744619|FG000|Overall Study|Lack of Efficacy|1|||
105752146|NCT03004469|364744620|FG001|Overall Study|Lack of Efficacy|0|||
105752147|NCT03004469|364744621|FG002|Overall Study|Lack of Efficacy|1|||
105752148|NCT03004469|364744619|FG000|Overall Study|Lost to Follow-up|23|||
105752149|NCT03004469|364744620|FG001|Overall Study|Lost to Follow-up|14|||
105752150|NCT03004469|364744621|FG002|Overall Study|Lost to Follow-up|6|||
105752151|NCT03004469|364744619|FG000|Overall Study|Non-Compliance with Study Drug|2|||
105752152|NCT03004469|364744620|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105752153|NCT03004469|364744621|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105752154|NCT03004469|364744619|FG000|Overall Study|Protocol Violation|0|||
105565873|NCT00089141|364070995|FG000|Overall Study|Termination of trial|18|||
105565874|NCT00089141|364070996|FG001|Overall Study|Termination of trial|24|||
105752155|NCT03004469|364744620|FG001|Overall Study|Protocol Violation|0|||
105565875|NCT00508261|364070997|FG000|Overall Study|Other|0|||
105565876|NCT00508261|364070998|FG001|Overall Study|Other|1|||
105565877|NCT00508261|364070999|FG002|Overall Study|Other|1|||
105752156|NCT03004469|364744621|FG002|Overall Study|Protocol Violation|1|||
105752157|NCT03004469|364744619|FG000|Overall Study|Withdrawal by Subject|29|||
105752158|NCT03004469|364744620|FG001|Overall Study|Withdrawal by Subject|27|||
105752159|NCT03004469|364744621|FG002|Overall Study|Withdrawal by Subject|10|||
105752160|NCT03004469|364744619|FG000|Overall Study|Other unspecified reason|0|||
105752161|NCT03004469|364744620|FG001|Overall Study|Other unspecified reason|4|||
105752162|NCT03004469|364744621|FG002|Overall Study|Other unspecified reason|1|||
105752163|NCT00259740|364744622|FG000|Overall Study|Physician Decision|1|||
105752164|NCT00259740|364744623|FG001|Overall Study|Physician Decision|1|||
105752165|NCT00259740|364744622|FG000|Overall Study|Adverse Event|0|||
105752166|NCT00259740|364744623|FG001|Overall Study|Adverse Event|2|||
105752167|NCT00259740|364744622|FG000|Overall Study|Withdrawal by Subject|2|||
105752168|NCT00259740|364744623|FG001|Overall Study|Withdrawal by Subject|6|||
105752169|NCT00259740|364744622|FG000|Overall Study|Death|1|||
105752170|NCT00259740|364744623|FG001|Overall Study|Death|1|||
105752171|NCT00259740|364744622|FG000|Overall Study|Disease progression|19|||
105752172|NCT00259740|364744623|FG001|Overall Study|Disease progression|36|||
105752173|NCT00259740|364744622|FG000|Overall Study|Ongoing|17|||
105752174|NCT00259740|364744623|FG001|Overall Study|Ongoing|3|||
105752175|NCT00259740|364744622|FG000|Overall Study|Other|3|||
105752176|NCT00259740|364744623|FG001|Overall Study|Other|0|||
105752177|NCT00259740|364744622|FG000|Overall Study|Requirement for alternative therapy|0|||
105752178|NCT00259740|364744623|FG001|Overall Study|Requirement for alternative therapy|4|||
105752179|NCT00502320|364744624|FG000|Overall Study|Lost to Follow-up|1|||
105752180|NCT00502320|364744625|FG001|Overall Study|Lost to Follow-up|1|||
105752181|NCT00502320|364744624|FG000|Overall Study|Withdrew Consent|1|||
105752182|NCT00502320|364744625|FG001|Overall Study|Withdrew Consent|0|||
105752183|NCT00502320|364744624|FG000|Overall Study|No longer met criteria|1|||
105752184|NCT00502320|364744625|FG001|Overall Study|No longer met criteria|0|||
105752185|NCT00502320|364744624|FG000|Overall Study|Screen Failure|0|||
105752186|NCT00502320|364744625|FG001|Overall Study|Screen Failure|1|||
105752187|NCT00502320|364744624|FG000|Overall Study|Adverse Event|3|||
105752188|NCT00502320|364744625|FG001|Overall Study|Adverse Event|5|||
105752189|NCT02394808|364744626|FG000|Period 1|Unsatisfactory lens fitting|0|||
105752190|NCT02394808|364744627|FG001|Period 1|Unsatisfactory lens fitting|1|||
105752191|NCT02394808|364744626|FG000|Period 2|Lost to Follow-up|1|||
105752192|NCT02394808|364744627|FG001|Period 2|Lost to Follow-up|0|||
105752193|NCT00125190|364744628|FG000|Overall Study|Subject/Parent Decision|7|||
105752194|NCT00125190|364744628|FG000|Overall Study|Non-compliance|2|||
105752195|NCT00125190|364744628|FG000|Overall Study|Adverse Event|1|||
105752196|NCT00125190|364744628|FG000|Overall Study|Other|1|||
105752197|NCT00125190|364744628|FG000|Overall Study|Lost to Follow-up|4|||
105752198|NCT00916370|364744632|FG000|Overall Study|Death|3|||
105752199|NCT00916370|364744633|FG001|Overall Study|Death|1|||
105752200|NCT00916370|364744632|FG000|Overall Study|Withdrawal by Subject|2|||
105752201|NCT00916370|364744633|FG001|Overall Study|Withdrawal by Subject|0|||
105752202|NCT00916370|364744632|FG000|Overall Study|Physician Decision|0|||
105752203|NCT00916370|364744633|FG001|Overall Study|Physician Decision|1|||
105752204|NCT03105700|364744638|FG000|Overall Study|screen fail|3|||
105752205|NCT03105700|364744638|FG000|Overall Study|Lost to Follow-up|4|||
105752206|NCT01586156|364744639|FG000|Overall Study|Pregnancy|0|||
105752207|NCT01586156|364744640|FG001|Overall Study|Pregnancy|1|||
105752208|NCT01586156|364744641|FG002|Overall Study|Pregnancy|0|||
105752209|NCT00547378|364744642|FG000|Randomized Cohort|Withdrawal by Subject|7|||
105752210|NCT00547378|364744643|FG001|Randomized Cohort|Withdrawal by Subject|5|||
105752211|NCT00547378|364744644|FG002|Randomized Cohort|Withdrawal by Subject|0|||
105752212|NCT00547378|364744642|FG000|Randomized Cohort|Death|0|||
105752213|NCT00547378|364744643|FG001|Randomized Cohort|Death|1|||
105752214|NCT00547378|364744644|FG002|Randomized Cohort|Death|0|||
105752215|NCT00547378|364744642|FG000|Randomized Cohort|Lost to Follow-up|1|||
105752216|NCT00547378|364744643|FG001|Randomized Cohort|Lost to Follow-up|0|||
105752217|NCT00547378|364744644|FG002|Randomized Cohort|Lost to Follow-up|0|||
105752218|NCT00547378|364744642|FG000|Randomized Cohort|Adverse Event|1|||
105752219|NCT00547378|364744643|FG001|Randomized Cohort|Adverse Event|0|||
105752220|NCT00547378|364744644|FG002|Randomized Cohort|Adverse Event|0|||
105752221|NCT00547378|364744642|FG000|Randomized Cohort|Other reasons|2|||
105752222|NCT00547378|364744643|FG001|Randomized Cohort|Other reasons|0|||
105752223|NCT00547378|364744644|FG002|Randomized Cohort|Other reasons|0|||
105752224|NCT00547378|364744642|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
105752225|NCT00547378|364744643|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
105752226|NCT00547378|364744644|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
105752227|NCT00547378|364744642|FG000|All Implanted Cohort|Adverse Event|4|||
105752228|NCT00547378|364744643|FG001|All Implanted Cohort|Adverse Event|10|||
105752229|NCT00547378|364744644|FG002|All Implanted Cohort|Adverse Event|17|||
105752230|NCT00547378|364744642|FG000|All Implanted Cohort|Lost to Follow-up|0|||
105752231|NCT00547378|364744643|FG001|All Implanted Cohort|Lost to Follow-up|1|||
105752232|NCT00547378|364744644|FG002|All Implanted Cohort|Lost to Follow-up|14|||
105752233|NCT00547378|364744642|FG000|All Implanted Cohort|Death|3|||
105752234|NCT00547378|364744643|FG001|All Implanted Cohort|Death|1|||
105752235|NCT00547378|364744644|FG002|All Implanted Cohort|Death|4|||
105752236|NCT00547378|364744642|FG000|All Implanted Cohort|Physician Decision|0|||
105752237|NCT00547378|364744643|FG001|All Implanted Cohort|Physician Decision|2|||
105752238|NCT00547378|364744644|FG002|All Implanted Cohort|Physician Decision|6|||
105752239|NCT00547378|364744642|FG000|All Implanted Cohort|Site closure|2|||
105752240|NCT00547378|364744643|FG001|All Implanted Cohort|Site closure|0|||
105752241|NCT00547378|364744644|FG002|All Implanted Cohort|Site closure|1|||
105752242|NCT00547378|364744642|FG000|All Implanted Cohort|Other reasons|1|||
105752243|NCT00547378|364744643|FG001|All Implanted Cohort|Other reasons|0|||
105752244|NCT00547378|364744644|FG002|All Implanted Cohort|Other reasons|1|||
105752245|NCT02768194|364744645|FG000|Period 1|Adverse Event|0|||
105752246|NCT02768194|364744646|FG001|Period 1|Adverse Event|0|||
105752247|NCT02768194|364744647|FG002|Period 1|Adverse Event|0|||
105752248|NCT02768194|364744648|FG003|Period 1|Adverse Event|1|||
105752249|NCT02768194|364744649|FG004|Period 1|Adverse Event|0|||
105752250|NCT02768194|364744650|FG005|Period 1|Adverse Event|0|||
105752251|NCT02768194|364744645|FG000|Period 2|Other (Reason not specified)|1|||
105752252|NCT02768194|364744646|FG001|Period 2|Other (Reason not specified)|0|||
105752253|NCT02768194|364744647|FG002|Period 2|Other (Reason not specified)|0|||
105752254|NCT02768194|364744648|FG003|Period 2|Other (Reason not specified)|0|||
105752255|NCT02768194|364744649|FG004|Period 2|Other (Reason not specified)|0|||
105752256|NCT02768194|364744650|FG005|Period 2|Other (Reason not specified)|0|||
105752257|NCT02768194|364744645|FG000|Period 3|Other (Reason not specified)|0|||
105752258|NCT02768194|364744646|FG001|Period 3|Other (Reason not specified)|1|||
105752259|NCT02768194|364744647|FG002|Period 3|Other (Reason not specified)|0|||
105752260|NCT02768194|364744648|FG003|Period 3|Other (Reason not specified)|0|||
105752261|NCT02768194|364744649|FG004|Period 3|Other (Reason not specified)|0|||
105752262|NCT02768194|364744650|FG005|Period 3|Other (Reason not specified)|0|||
105752263|NCT01318512|364744651|FG000|Maintenance Period (6 Months)|Death|2|||
105752264|NCT01318512|364744651|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
105752265|NCT04863014|364744652|FG000|Overall Study|Lost to Follow-up|3|||
105752266|NCT04863014|364744653|FG001|Overall Study|Lost to Follow-up|2|||
105752267|NCT04863014|364744652|FG000|Overall Study|Subject Decision|0|||
105752268|NCT04863014|364744653|FG001|Overall Study|Subject Decision|4|||
105752269|NCT00975195|364744657|FG000|Overall Study|Adverse Event|108|||
105752270|NCT00975195|364744658|FG001|Overall Study|Adverse Event|101|||
105752271|NCT00975195|364744657|FG000|Overall Study|Lack of Efficacy|6|||
105752272|NCT00975195|364744658|FG001|Overall Study|Lack of Efficacy|6|||
105565878|NCT00508261|364071000|FG003|Overall Study|Other|0|||
105752273|NCT00975195|364744657|FG000|Overall Study|Protocol Violation|27|||
105752274|NCT00975195|364744658|FG001|Overall Study|Protocol Violation|23|||
105752275|NCT00975195|364744657|FG000|Overall Study|Lost to Follow-up|9|||
105752276|NCT00975195|364744658|FG001|Overall Study|Lost to Follow-up|7|||
105752277|NCT00975195|364744657|FG000|Overall Study|Withdrawal by Subject|48|||
105752278|NCT00975195|364744658|FG001|Overall Study|Withdrawal by Subject|61|||
105752279|NCT00975195|364744657|FG000|Overall Study|Other reason not defined above|29|||
105752280|NCT00975195|364744658|FG001|Overall Study|Other reason not defined above|33|||
105752281|NCT00975195|364744657|FG000|Overall Study|Not treated|1|||
105752282|NCT00975195|364744658|FG001|Overall Study|Not treated|2|||
105752283|NCT00363246|364744659|FG000|Overall Study|Death|40|||
105752284|NCT00363246|364744659|FG000|Overall Study|Withdrawal by Subject|19|||
105752285|NCT00363246|364744659|FG000|Overall Study|Lost to Follow-up|14|||
105752286|NCT00363246|364744659|FG000|Overall Study|Bad health|6|||
105752287|NCT00363246|364744659|FG000|Overall Study|Stopped using wheelchair|11|||
105752288|NCT00363246|364744659|FG000|Overall Study|Subject expressed security concerns|2|||
105752289|NCT00363246|364744659|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
105752290|NCT01822691|364744660|FG000|Overall Study|Withdrawal by Subject|2|||
105752291|NCT01553916|364744661|FG000|Overall Study|Withdrawal by Subject|2|||
105565879|NCT00508261|364070997|FG000|Overall Study|Serious Adverse Event|0|||
105752292|NCT01553916|364744661|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
105565880|NCT00508261|364070998|FG001|Overall Study|Serious Adverse Event|1|||
105752293|NCT04348591|364744666|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
105752294|NCT04348591|364744667|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
105752295|NCT04348591|364744666|FG000|Imaging Session (120 Min)|Physician Decision|0|||
105752296|NCT04348591|364744667|FG001|Imaging Session (120 Min)|Physician Decision|1|||
105752297|NCT04348591|364744666|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
105752298|NCT04348591|364744667|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
105752299|NCT01778127|364744668|FG000|Overall Study|Lost to Follow-up|5|||
105752300|NCT01778127|364744669|FG001|Overall Study|Lost to Follow-up|1|||
105752301|NCT01778127|364744670|FG002|Overall Study|Lost to Follow-up|2|||
105752302|NCT01778127|364744668|FG000|Overall Study|Withdrawal by Subject|3|||
105752303|NCT01778127|364744669|FG001|Overall Study|Withdrawal by Subject|1|||
105752304|NCT01778127|364744670|FG002|Overall Study|Withdrawal by Subject|4|||
105752305|NCT01968954|364744671|FG000|Overall Study|Adverse Event|6|||
105752306|NCT01968954|364744672|FG001|Overall Study|Adverse Event|3|||
105752307|NCT01968954|364744671|FG000|Overall Study|Death|1|||
105752308|NCT01968954|364744672|FG001|Overall Study|Death|2|||
105752309|NCT01968954|364744671|FG000|Overall Study|Lost to Follow-up|6|||
105752310|NCT01968954|364744672|FG001|Overall Study|Lost to Follow-up|4|||
105752311|NCT01968954|364744671|FG000|Overall Study|Withdrawal by Subject|20|||
105752312|NCT01968954|364744672|FG001|Overall Study|Withdrawal by Subject|23|||
105752313|NCT01968954|364744671|FG000|Overall Study|Other|7|||
105752314|NCT01968954|364744672|FG001|Overall Study|Other|8|||
105752315|NCT01968954|364744671|FG000|Overall Study|Protocol Violation|0|||
105752316|NCT01968954|364744672|FG001|Overall Study|Protocol Violation|1|||
105752317|NCT01968954|364744671|FG000|Overall Study|Did not met inclusion criteria|0|||
105752318|NCT01968954|364744672|FG001|Overall Study|Did not met inclusion criteria|2|||
105752319|NCT02648724|364744673|FG000|Overall Study|Withdrawal by Subject|0|||
105752320|NCT02648724|364744674|FG001|Overall Study|Withdrawal by Subject|1|||
105752321|NCT02648724|364744675|FG002|Overall Study|Withdrawal by Subject|1|||
105752322|NCT02648724|364744676|FG003|Overall Study|Withdrawal by Subject|0|||
105752323|NCT02648724|364744677|FG004|Overall Study|Withdrawal by Subject|1|||
105752324|NCT02648724|364744678|FG005|Overall Study|Withdrawal by Subject|0|||
105752325|NCT02648724|364744679|FG006|Overall Study|Withdrawal by Subject|0|||
105752326|NCT02648724|364744673|FG000|Overall Study|Progressive disease|2|||
105752327|NCT02648724|364744674|FG001|Overall Study|Progressive disease|2|||
105752328|NCT02648724|364744675|FG002|Overall Study|Progressive disease|2|||
105752329|NCT02648724|364744676|FG003|Overall Study|Progressive disease|3|||
105752330|NCT02648724|364744677|FG004|Overall Study|Progressive disease|22|||
105752331|NCT02648724|364744678|FG005|Overall Study|Progressive disease|7|||
105752332|NCT02648724|364744679|FG006|Overall Study|Progressive disease|8|||
105752333|NCT02648724|364744673|FG000|Overall Study|Other reason (unknown)|1|||
105752334|NCT02648724|364744674|FG001|Overall Study|Other reason (unknown)|0|||
105752335|NCT02648724|364744675|FG002|Overall Study|Other reason (unknown)|0|||
105752336|NCT02648724|364744676|FG003|Overall Study|Other reason (unknown)|0|||
105752337|NCT02648724|364744677|FG004|Overall Study|Other reason (unknown)|0|||
105752338|NCT02648724|364744678|FG005|Overall Study|Other reason (unknown)|0|||
105752339|NCT02648724|364744679|FG006|Overall Study|Other reason (unknown)|0|||
105752340|NCT02648724|364744673|FG000|Overall Study|Protocol Violation|0|||
105752341|NCT02648724|364744674|FG001|Overall Study|Protocol Violation|0|||
105752342|NCT02648724|364744675|FG002|Overall Study|Protocol Violation|0|||
105752343|NCT02648724|364744676|FG003|Overall Study|Protocol Violation|0|||
105752344|NCT02648724|364744677|FG004|Overall Study|Protocol Violation|1|||
105752345|NCT02648724|364744678|FG005|Overall Study|Protocol Violation|0|||
105752346|NCT02648724|364744679|FG006|Overall Study|Protocol Violation|0|||
105752347|NCT02648724|364744673|FG000|Overall Study|Death|0|||
105752348|NCT02648724|364744674|FG001|Overall Study|Death|0|||
105752349|NCT02648724|364744675|FG002|Overall Study|Death|0|||
105752350|NCT02648724|364744676|FG003|Overall Study|Death|0|||
105752351|NCT02648724|364744677|FG004|Overall Study|Death|0|||
105752352|NCT02648724|364744678|FG005|Overall Study|Death|0|||
105752353|NCT02648724|364744679|FG006|Overall Study|Death|3|||
105752354|NCT02648724|364744673|FG000|Overall Study|Physician Decision|0|||
105752355|NCT02648724|364744674|FG001|Overall Study|Physician Decision|0|||
105565881|NCT00508261|364070999|FG002|Overall Study|Serious Adverse Event|0|||
105565882|NCT00508261|364071000|FG003|Overall Study|Serious Adverse Event|0|||
105752356|NCT02648724|364744675|FG002|Overall Study|Physician Decision|0|||
105752357|NCT02648724|364744676|FG003|Overall Study|Physician Decision|0|||
105752358|NCT02648724|364744677|FG004|Overall Study|Physician Decision|1|||
105752359|NCT02648724|364744678|FG005|Overall Study|Physician Decision|0|||
105752360|NCT02648724|364744679|FG006|Overall Study|Physician Decision|1|||
105752361|NCT02648724|364744673|FG000|Overall Study|Transferred to named patient program|0|||
105752362|NCT02648724|364744674|FG001|Overall Study|Transferred to named patient program|0|||
105752363|NCT02648724|364744675|FG002|Overall Study|Transferred to named patient program|0|||
105752364|NCT02648724|364744676|FG003|Overall Study|Transferred to named patient program|0|||
105752365|NCT02648724|364744677|FG004|Overall Study|Transferred to named patient program|0|||
105752366|NCT02648724|364744678|FG005|Overall Study|Transferred to named patient program|1|||
105752367|NCT02648724|364744679|FG006|Overall Study|Transferred to named patient program|0|||
105752368|NCT03655717|364744682|FG000|Overall Study|Withdrawal by Subject|4|||
105752369|NCT03655717|364744683|FG001|Overall Study|Withdrawal by Subject|8|||
105752370|NCT03655717|364744684|FG002|Overall Study|Withdrawal by Subject|1|||
105752371|NCT03655717|364744685|FG003|Overall Study|Withdrawal by Subject|0|||
105752372|NCT03655717|364744686|FG004|Overall Study|Withdrawal by Subject|0|||
105752373|NCT03655717|364744687|FG005|Overall Study|Withdrawal by Subject|1|||
105752374|NCT03655717|364744688|FG006|Overall Study|Withdrawal by Subject|3|||
105752375|NCT03655717|364744689|FG007|Overall Study|Withdrawal by Subject|1|||
105752376|NCT03655717|364744690|FG008|Overall Study|Withdrawal by Subject|2|||
105752377|NCT03655717|364744691|FG009|Overall Study|Withdrawal by Subject|0|||
105752378|NCT03655717|364744692|FG010|Overall Study|Withdrawal by Subject|0|||
105752379|NCT03655717|364744693|FG011|Overall Study|Withdrawal by Subject|1|||
105752380|NCT03655717|364744694|FG012|Overall Study|Withdrawal by Subject|0|||
105752381|NCT03655717|364744695|FG013|Overall Study|Withdrawal by Subject|3|||
105752382|NCT03655717|364744696|FG014|Overall Study|Withdrawal by Subject|0|||
105752383|NCT03655717|364744697|FG015|Overall Study|Withdrawal by Subject|1|||
105752384|NCT03655717|364744698|FG016|Overall Study|Withdrawal by Subject|0|||
105752385|NCT03655717|364744699|FG017|Overall Study|Withdrawal by Subject|0|||
105752386|NCT03655717|364744700|FG018|Overall Study|Withdrawal by Subject|1|||
105752387|NCT03655717|364744701|FG019|Overall Study|Withdrawal by Subject|0|||
105752388|NCT03655717|364744702|FG020|Overall Study|Withdrawal by Subject|0|||
105752389|NCT03655717|364744703|FG021|Overall Study|Withdrawal by Subject|1|||
105752390|NCT03655717|364744704|FG022|Overall Study|Withdrawal by Subject|2|||
105752391|NCT03655717|364744705|FG023|Overall Study|Withdrawal by Subject|1|||
105752392|NCT03655717|364744706|FG024|Overall Study|Withdrawal by Subject|1|||
105752393|NCT03655717|364744707|FG025|Overall Study|Withdrawal by Subject|0|||
105752394|NCT03655717|364744682|FG000|Overall Study|Physician Decision|3|||
105752395|NCT03655717|364744683|FG001|Overall Study|Physician Decision|3|||
105752396|NCT03655717|364744684|FG002|Overall Study|Physician Decision|0|||
105752397|NCT03655717|364744685|FG003|Overall Study|Physician Decision|0|||
105752398|NCT03655717|364744686|FG004|Overall Study|Physician Decision|0|||
105752399|NCT03655717|364744687|FG005|Overall Study|Physician Decision|0|||
105752400|NCT03655717|364744688|FG006|Overall Study|Physician Decision|0|||
105360313|NCT00105989|363325911|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
105360314|NCT00105989|363325912|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
105565883|NCT00508261|364070997|FG000|Overall Study|Withdrawal by Subject|3|||
105565884|NCT00508261|364070998|FG001|Overall Study|Withdrawal by Subject|4|||
105752401|NCT03655717|364744689|FG007|Overall Study|Physician Decision|0|||
105752402|NCT03655717|364744690|FG008|Overall Study|Physician Decision|0|||
105752403|NCT03655717|364744691|FG009|Overall Study|Physician Decision|1|||
105752404|NCT03655717|364744692|FG010|Overall Study|Physician Decision|0|||
105752405|NCT03655717|364744693|FG011|Overall Study|Physician Decision|0|||
105752406|NCT03655717|364744694|FG012|Overall Study|Physician Decision|0|||
105752407|NCT03655717|364744695|FG013|Overall Study|Physician Decision|0|||
105752408|NCT03655717|364744696|FG014|Overall Study|Physician Decision|0|||
105752409|NCT03655717|364744697|FG015|Overall Study|Physician Decision|0|||
105752410|NCT03655717|364744698|FG016|Overall Study|Physician Decision|0|||
105752411|NCT03655717|364744699|FG017|Overall Study|Physician Decision|0|||
105752412|NCT03655717|364744700|FG018|Overall Study|Physician Decision|0|||
105752413|NCT03655717|364744701|FG019|Overall Study|Physician Decision|1|||
105752414|NCT03655717|364744702|FG020|Overall Study|Physician Decision|0|||
105752415|NCT03655717|364744703|FG021|Overall Study|Physician Decision|0|||
105752416|NCT03655717|364744704|FG022|Overall Study|Physician Decision|0|||
105360315|NCT00105989|363325911|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
105360316|NCT00105989|363325912|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
105360317|NCT00105989|363325911|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
105360318|NCT00105989|363325912|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
105360319|NCT00105989|363325911|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
105360320|NCT00105989|363325912|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
105360321|NCT00105989|363325911|FG000|Continuation - Open Label:Week 10-34|Death|0|||
105360322|NCT00105989|363325912|FG001|Continuation - Open Label:Week 10-34|Death|0|||
105360323|NCT00105989|363325911|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
105360324|NCT00105989|363325912|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
105360325|NCT00105989|363325911|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
105360326|NCT00105989|363325912|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
105360327|NCT00105989|363325911|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
105360328|NCT00105989|363325912|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
105360329|NCT00105989|363325911|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
105565885|NCT00508261|364070999|FG002|Overall Study|Withdrawal by Subject|4|||
105752417|NCT03655717|364744705|FG023|Overall Study|Physician Decision|1|||
105752418|NCT03655717|364744706|FG024|Overall Study|Physician Decision|0|||
105752419|NCT03655717|364744707|FG025|Overall Study|Physician Decision|0|||
105752420|NCT03655717|364744682|FG000|Overall Study|Lost to Follow-up|3|||
105752421|NCT03655717|364744683|FG001|Overall Study|Lost to Follow-up|1|||
105752422|NCT03655717|364744684|FG002|Overall Study|Lost to Follow-up|0|||
105752423|NCT03655717|364744685|FG003|Overall Study|Lost to Follow-up|1|||
105752424|NCT03655717|364744686|FG004|Overall Study|Lost to Follow-up|0|||
105752425|NCT03655717|364744687|FG005|Overall Study|Lost to Follow-up|1|||
105752426|NCT03655717|364744688|FG006|Overall Study|Lost to Follow-up|0|||
105752427|NCT03655717|364744689|FG007|Overall Study|Lost to Follow-up|0|||
105360330|NCT00105989|363325912|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
105360331|NCT00105989|363325911|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
105360332|NCT00105989|363325912|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
105360333|NCT00105989|363325911|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
105360334|NCT00105989|363325912|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
105360335|NCT00105989|363325911|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
105360336|NCT00105989|363325912|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
105360337|NCT00105989|363325911|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
105360338|NCT00105989|363325912|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
105360339|NCT00105989|363325911|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
105360340|NCT00105989|363325912|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
105360341|NCT00105989|363325911|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
105565886|NCT00508261|364071000|FG003|Overall Study|Withdrawal by Subject|0|||
105752428|NCT03655717|364744690|FG008|Overall Study|Lost to Follow-up|0|||
105752429|NCT03655717|364744691|FG009|Overall Study|Lost to Follow-up|0|||
105752430|NCT03655717|364744692|FG010|Overall Study|Lost to Follow-up|0|||
105752431|NCT03655717|364744693|FG011|Overall Study|Lost to Follow-up|1|||
105752432|NCT03655717|364744694|FG012|Overall Study|Lost to Follow-up|0|||
105752433|NCT03655717|364744695|FG013|Overall Study|Lost to Follow-up|0|||
105752434|NCT03655717|364744696|FG014|Overall Study|Lost to Follow-up|0|||
105565887|NCT00508261|364070997|FG000|Overall Study|Migrated/ moved from study area|0|||
105360342|NCT00105989|363325912|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
105565888|NCT00508261|364070998|FG001|Overall Study|Migrated/ moved from study area|1|||
105565889|NCT00508261|364070999|FG002|Overall Study|Migrated/ moved from study area|0|||
105752435|NCT03655717|364744697|FG015|Overall Study|Lost to Follow-up|0|||
105752436|NCT03655717|364744698|FG016|Overall Study|Lost to Follow-up|0|||
105752437|NCT03655717|364744699|FG017|Overall Study|Lost to Follow-up|0|||
105752438|NCT03655717|364744700|FG018|Overall Study|Lost to Follow-up|0|||
105752439|NCT03655717|364744701|FG019|Overall Study|Lost to Follow-up|0|||
105752440|NCT03655717|364744702|FG020|Overall Study|Lost to Follow-up|0|||
105752441|NCT03655717|364744703|FG021|Overall Study|Lost to Follow-up|0|||
105752442|NCT03655717|364744704|FG022|Overall Study|Lost to Follow-up|0|||
105752443|NCT03655717|364744705|FG023|Overall Study|Lost to Follow-up|0|||
105752444|NCT03655717|364744706|FG024|Overall Study|Lost to Follow-up|0|||
105752445|NCT03655717|364744707|FG025|Overall Study|Lost to Follow-up|0|||
105752446|NCT00675103|364744708|FG000|Overall Study|Lack of Efficacy|2|||
105752447|NCT00675103|364744708|FG000|Overall Study|Adverse Event|1|||
105752448|NCT03288493|364744712|FG000|Overall Study|Withdrawal by Subject|4|||
105752449|NCT03288493|364744713|FG001|Overall Study|Withdrawal by Subject|0|||
105752450|NCT03288493|364744714|FG002|Overall Study|Withdrawal by Subject|0|||
105752451|NCT03288493|364744715|FG003|Overall Study|Withdrawal by Subject|0|||
105752452|NCT03288493|364744716|FG004|Overall Study|Withdrawal by Subject|0|||
105752453|NCT03288493|364744717|FG005|Overall Study|Withdrawal by Subject|2|||
105752454|NCT03288493|364744718|FG006|Overall Study|Withdrawal by Subject|0|||
105752455|NCT03288493|364744712|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
105752456|NCT03288493|364744713|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
105752457|NCT03288493|364744714|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
105752458|NCT03288493|364744715|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
105752459|NCT03288493|364744716|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
105752460|NCT03288493|364744717|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
105752461|NCT03288493|364744718|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
105752462|NCT03288493|364744712|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
105752463|NCT03288493|364744713|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
105752464|NCT03288493|364744714|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
105752465|NCT03288493|364744715|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
105752466|NCT03288493|364744716|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
105752467|NCT03288493|364744717|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
105752468|NCT03288493|364744718|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
105752469|NCT03288493|364744712|FG000|Overall Study|Death|2|||
105752470|NCT03288493|364744713|FG001|Overall Study|Death|0|||
105752471|NCT03288493|364744714|FG002|Overall Study|Death|0|||
105752472|NCT03288493|364744715|FG003|Overall Study|Death|0|||
105752473|NCT03288493|364744716|FG004|Overall Study|Death|0|||
105752474|NCT03288493|364744717|FG005|Overall Study|Death|0|||
105752475|NCT03288493|364744718|FG006|Overall Study|Death|0|||
105752476|NCT03288493|364744712|FG000|Overall Study|other reason not listed above|2|||
105752477|NCT03288493|364744713|FG001|Overall Study|other reason not listed above|0|||
105752478|NCT03288493|364744714|FG002|Overall Study|other reason not listed above|0|||
105752479|NCT03288493|364744715|FG003|Overall Study|other reason not listed above|0|||
105752480|NCT03288493|364744716|FG004|Overall Study|other reason not listed above|0|||
105752481|NCT03288493|364744717|FG005|Overall Study|other reason not listed above|0|||
105752482|NCT03288493|364744718|FG006|Overall Study|other reason not listed above|0|||
105752483|NCT04092816|364746378|FG000|Overall Study|Lost to Follow-up|1|||
105752484|NCT04092816|364746379|FG001|Overall Study|Lost to Follow-up|2|||
105752485|NCT00369967|364746381|FG000|Overall Study|Lost to Follow-up|23|||
105752486|NCT00369967|364746382|FG001|Overall Study|Lost to Follow-up|12|||
105752487|NCT01747811|364746383|FG000|Overall Study|Lack of Efficacy|2|||
105752488|NCT01747811|364746384|FG001|Overall Study|Lack of Efficacy|4|||
105752489|NCT01263093|364746385|FG000|Washout|Physician Decision|1|||
105752490|NCT01263093|364746386|FG001|Washout|Physician Decision|0|||
105752491|NCT01263093|364746385|FG000|Period 2|Adverse Event|1|||
105752492|NCT01263093|364746386|FG001|Period 2|Adverse Event|0|||
105752493|NCT00280150|364746387|FG000|Overall Study|Adverse Event|0|||
105752494|NCT00280150|364746388|FG001|Overall Study|Adverse Event|1|||
105752495|NCT00280150|364746389|FG002|Overall Study|Adverse Event|2|||
105752496|NCT00280150|364746390|FG003|Overall Study|Adverse Event|3|||
105752497|NCT00280150|364746387|FG000|Overall Study|Lack of Efficacy|0|||
105752498|NCT00280150|364746388|FG001|Overall Study|Lack of Efficacy|0|||
105752499|NCT00280150|364746389|FG002|Overall Study|Lack of Efficacy|0|||
105752500|NCT00280150|364746390|FG003|Overall Study|Lack of Efficacy|3|||
105752501|NCT00280150|364746387|FG000|Overall Study|Physician Decision|0|||
105752502|NCT00280150|364746388|FG001|Overall Study|Physician Decision|0|||
105752503|NCT00280150|364746389|FG002|Overall Study|Physician Decision|0|||
105752504|NCT00280150|364746390|FG003|Overall Study|Physician Decision|1|||
105752505|NCT00280150|364746387|FG000|Overall Study|Protocol Violation|0|||
105752506|NCT00280150|364746388|FG001|Overall Study|Protocol Violation|0|||
105752507|NCT00280150|364746389|FG002|Overall Study|Protocol Violation|0|||
105752508|NCT00280150|364746390|FG003|Overall Study|Protocol Violation|1|||
105752509|NCT00280150|364746387|FG000|Overall Study|Withdrawal by Subject|0|||
105752510|NCT00280150|364746388|FG001|Overall Study|Withdrawal by Subject|0|||
105752511|NCT00280150|364746389|FG002|Overall Study|Withdrawal by Subject|0|||
105752512|NCT00280150|364746390|FG003|Overall Study|Withdrawal by Subject|1|||
105752513|NCT00280150|364746387|FG000|Overall Study|Did not get consolidation therapy|3|||
105752514|NCT00280150|364746388|FG001|Overall Study|Did not get consolidation therapy|0|||
105752515|NCT00280150|364746389|FG002|Overall Study|Did not get consolidation therapy|3|||
105752516|NCT00280150|364746390|FG003|Overall Study|Did not get consolidation therapy|0|||
105752517|NCT00280150|364746387|FG000|Overall Study|Declining Performance Status|0|||
105752518|NCT00280150|364746388|FG001|Overall Study|Declining Performance Status|0|||
105752519|NCT00280150|364746389|FG002|Overall Study|Declining Performance Status|0|||
105752520|NCT00280150|364746390|FG003|Overall Study|Declining Performance Status|1|||
105752521|NCT02871401|364746399|FG000|Overall Study|Adverse Event|1|||
105752522|NCT02871401|364746400|FG001|Overall Study|Adverse Event|0|||
105752523|NCT01120379|364746401|FG000|One Year Timepoint|Withdrawal by Subject|41|||
105752524|NCT01120379|364746401|FG000|One Year Timepoint|Lost to Follow-up|115|||
105752525|NCT01120379|364746401|FG000|One Year Timepoint|Death|108|||
105752526|NCT01120379|364746401|FG000|One Year Timepoint|Physician Decision|9|||
105752527|NCT01120379|364746401|FG000|One Year Timepoint|Any other reason for early termination|5|||
105802060|NCT03705169|364930714|FG001|Overall Study|Adverse Event|0|||
105802061|NCT03705169|364930715|FG002|Overall Study|Adverse Event|0|||
105802062|NCT03705169|364930716|FG003|Overall Study|Adverse Event|1|||
105802063|NCT03705169|364930717|FG004|Overall Study|Adverse Event|0|||
105802064|NCT03705169|364930718|FG005|Overall Study|Adverse Event|0|||
105752528|NCT01120379|364746401|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
105802065|NCT03705169|364930719|FG006|Overall Study|Adverse Event|0|||
105802066|NCT03705169|364930720|FG007|Overall Study|Adverse Event|0|||
105752529|NCT01120379|364746401|FG000|Two Year Timepoint|Lost to Follow-up|87|||
105752530|NCT01120379|364746401|FG000|Two Year Timepoint|Death|123|||
105752531|NCT01120379|364746401|FG000|Two Year Timepoint|Physician Decision|12|||
105752532|NCT01120379|364746401|FG000|Two Year Timepoint|Any other reason for early termination|4|||
105752533|NCT01120379|364746401|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
105752534|NCT01120379|364746401|FG000|Three Year Timepoint|Lost to Follow-up|43|||
105752535|NCT01120379|364746401|FG000|Three Year Timepoint|Death|120|||
105752536|NCT01120379|364746401|FG000|Three Year Timepoint|Physician Decision|9|||
105752537|NCT01120379|364746401|FG000|Three Year Timepoint|Any other reason for early termination|17|||
105752538|NCT01120379|364746401|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
105752539|NCT01120379|364746401|FG000|Four Year Timepoint|Lost to Follow-up|10|||
105752540|NCT01120379|364746401|FG000|Four Year Timepoint|Death|131|||
105752541|NCT01120379|364746401|FG000|Four Year Timepoint|Physician Decision|5|||
105752542|NCT01120379|364746401|FG000|Four Year Timepoint|Any other reason for early termination|217|||
105752543|NCT04656418|364746402|FG000|Overall Study|Withdrawal by Subject|1|||
105752544|NCT04656418|364746403|FG001|Overall Study|Withdrawal by Subject|3|||
105752545|NCT03162055|364746404|FG000|Overall Study|Adverse Event|6|||
105752546|NCT03162055|364746405|FG001|Overall Study|Adverse Event|5|||
105752547|NCT03162055|364746404|FG000|Overall Study|Death|3|||
105752548|NCT03162055|364746405|FG001|Overall Study|Death|3|||
105752549|NCT03162055|364746404|FG000|Overall Study|Lost to Follow-up|0|||
105752550|NCT03162055|364746405|FG001|Overall Study|Lost to Follow-up|1|||
105752551|NCT03162055|364746404|FG000|Overall Study|Study-specific withdrawal criteria|22|||
105752552|NCT03162055|364746405|FG001|Overall Study|Study-specific withdrawal criteria|14|||
105752553|NCT03162055|364746404|FG000|Overall Study|Withdrawal by Subject|17|||
105752554|NCT03162055|364746405|FG001|Overall Study|Withdrawal by Subject|2|||
105752555|NCT03162055|364746404|FG000|Overall Study|Did not receive treatment|2|||
105752556|NCT03162055|364746405|FG001|Overall Study|Did not receive treatment|0|||
105752557|NCT03162055|364746404|FG000|Overall Study|Incorrect randomization|4|||
105752558|NCT03162055|364746405|FG001|Overall Study|Incorrect randomization|3|||
105752559|NCT03162055|364746404|FG000|Overall Study|Other|8|||
105752560|NCT03162055|364746405|FG001|Overall Study|Other|15|||
105752561|NCT01617655|364746406|FG000|Overall Study|Adverse Event|2|||
105752562|NCT01617655|364746407|FG001|Overall Study|Adverse Event|3|||
105752563|NCT01617655|364746406|FG000|Overall Study|Poor compliance to protocol|1|||
105752564|NCT01617655|364746407|FG001|Overall Study|Poor compliance to protocol|4|||
105752565|NCT01617655|364746406|FG000|Overall Study|Participants moved|0|||
105752566|NCT01617655|364746407|FG001|Overall Study|Participants moved|4|||
105752567|NCT01617655|364746406|FG000|Overall Study|Consent withdrawn by participant|1|||
105752568|NCT01617655|364746407|FG001|Overall Study|Consent withdrawn by participant|1|||
105752569|NCT01617655|364746406|FG000|Overall Study|Last visit outside protocol visit window|1|||
105752570|NCT01617655|364746407|FG001|Overall Study|Last visit outside protocol visit window|10|||
105752571|NCT01617655|364746406|FG000|Overall Study|Site closure|3|||
105752572|NCT01617655|364746407|FG001|Overall Study|Site closure|5|||
105752573|NCT01617655|364746406|FG000|Overall Study|Other than specified above|1|||
105752574|NCT01617655|364746407|FG001|Overall Study|Other than specified above|2|||
105752575|NCT00485589|364746408|FG000|Overall Study|Death|2|||
105752576|NCT00485589|364746409|FG001|Overall Study|Death|2|||
105752577|NCT00485589|364746410|FG002|Overall Study|Death|0|||
105752578|NCT00485589|364746408|FG000|Overall Study|Failure to return|6|||
105752579|NCT00485589|364746409|FG001|Overall Study|Failure to return|5|||
105752580|NCT00485589|364746410|FG002|Overall Study|Failure to return|1|||
105752581|NCT00485589|364746408|FG000|Overall Study|Protocol Violation|1|||
105752582|NCT00485589|364746409|FG001|Overall Study|Protocol Violation|0|||
105752583|NCT00485589|364746410|FG002|Overall Study|Protocol Violation|0|||
105752584|NCT00485589|364746408|FG000|Overall Study|Violation of selection criteria at entry|0|||
105752585|NCT00485589|364746409|FG001|Overall Study|Violation of selection criteria at entry|3|||
105752586|NCT00485589|364746410|FG002|Overall Study|Violation of selection criteria at entry|1|||
105752587|NCT00485589|364746408|FG000|Overall Study|Administrative/Other|1|||
105752588|NCT00485589|364746409|FG001|Overall Study|Administrative/Other|2|||
105752589|NCT00485589|364746410|FG002|Overall Study|Administrative/Other|1|||
105752590|NCT00485589|364746408|FG000|Overall Study|Insufficient therapeutic response|10|||
105752591|NCT00485589|364746409|FG001|Overall Study|Insufficient therapeutic response|3|||
105752592|NCT00485589|364746410|FG002|Overall Study|Insufficient therapeutic response|1|||
105752593|NCT00485589|364746408|FG000|Overall Study|Refused treatment/did not cooperate|1|||
105752594|NCT00485589|364746409|FG001|Overall Study|Refused treatment/did not cooperate|0|||
105752595|NCT00485589|364746410|FG002|Overall Study|Refused treatment/did not cooperate|2|||
105752596|NCT00485589|364746408|FG000|Overall Study|Withdrawal by Subject|3|||
105752597|NCT00485589|364746409|FG001|Overall Study|Withdrawal by Subject|2|||
105752598|NCT00485589|364746410|FG002|Overall Study|Withdrawal by Subject|2|||
105752599|NCT00485589|364746408|FG000|Overall Study|Adverse Event|3|||
105752600|NCT00485589|364746409|FG001|Overall Study|Adverse Event|3|||
105752601|NCT00485589|364746410|FG002|Overall Study|Adverse Event|10|||
105752602|NCT02585999|364746411|FG000|Overall Study|Lost to Follow-up|1|||
105752603|NCT02585999|364746411|FG000|Overall Study|Protocol Violation|1|||
105752604|NCT00120289|364746412|FG000|Overall Study|Death|96|||
105752605|NCT00120289|364746413|FG001|Overall Study|Death|82|||
105752606|NCT00120289|364746412|FG000|Overall Study|Lost to Follow-up|11|||
105752607|NCT00120289|364746413|FG001|Overall Study|Lost to Follow-up|14|||
105752608|NCT00120289|364746412|FG000|Overall Study|Withdrawal by Subject|14|||
105752609|NCT00120289|364746413|FG001|Overall Study|Withdrawal by Subject|13|||
105752610|NCT01061736|364746415|FG000|Overall Study|Dose regimen not selected|0|||
105752611|NCT01061736|364746416|FG001|Overall Study|Dose regimen not selected|0|||
105752612|NCT01061736|364746417|FG002|Overall Study|Dose regimen not selected|0|||
105752613|NCT01061736|364746418|FG003|Overall Study|Dose regimen not selected|0|||
105752614|NCT01061736|364746419|FG004|Overall Study|Dose regimen not selected|0|||
105752615|NCT01061736|364746420|FG005|Overall Study|Dose regimen not selected|0|||
105752616|NCT01061736|364746421|FG006|Overall Study|Dose regimen not selected|79|||
105752617|NCT01061736|364746422|FG007|Overall Study|Dose regimen not selected|0|||
105752618|NCT01061736|364746423|FG008|Overall Study|Dose regimen not selected|0|||
105752619|NCT01061736|364746424|FG009|Overall Study|Dose regimen not selected|0|||
105752620|NCT01061736|364746415|FG000|Overall Study|Adverse Event|13|||
105752621|NCT01061736|364746416|FG001|Overall Study|Adverse Event|1|||
105752622|NCT01061736|364746417|FG002|Overall Study|Adverse Event|3|||
105752623|NCT01061736|364746418|FG003|Overall Study|Adverse Event|2|||
105752624|NCT01061736|364746419|FG004|Overall Study|Adverse Event|4|||
105752625|NCT01061736|364746420|FG005|Overall Study|Adverse Event|1|||
105752626|NCT01061736|364746421|FG006|Overall Study|Adverse Event|4|||
105752627|NCT01061736|364746422|FG007|Overall Study|Adverse Event|63|||
105752628|NCT01061736|364746423|FG008|Overall Study|Adverse Event|67|||
105752629|NCT01061736|364746424|FG009|Overall Study|Adverse Event|34|||
105752630|NCT01061736|364746415|FG000|Overall Study|Lack of Efficacy|0|||
105752631|NCT01061736|364746416|FG001|Overall Study|Lack of Efficacy|2|||
105752632|NCT01061736|364746417|FG002|Overall Study|Lack of Efficacy|1|||
105752633|NCT01061736|364746418|FG003|Overall Study|Lack of Efficacy|1|||
105752634|NCT01061736|364746419|FG004|Overall Study|Lack of Efficacy|1|||
105752635|NCT01061736|364746420|FG005|Overall Study|Lack of Efficacy|2|||
105752636|NCT01061736|364746421|FG006|Overall Study|Lack of Efficacy|1|||
105752637|NCT01061736|364746422|FG007|Overall Study|Lack of Efficacy|9|||
105752638|NCT01061736|364746423|FG008|Overall Study|Lack of Efficacy|9|||
105752639|NCT01061736|364746424|FG009|Overall Study|Lack of Efficacy|10|||
105752640|NCT01061736|364746415|FG000|Overall Study|Poor compliance to protocol|0|||
105752641|NCT01061736|364746416|FG001|Overall Study|Poor compliance to protocol|0|||
105752642|NCT01061736|364746417|FG002|Overall Study|Poor compliance to protocol|0|||
105752643|NCT01061736|364746418|FG003|Overall Study|Poor compliance to protocol|0|||
105752644|NCT01061736|364746419|FG004|Overall Study|Poor compliance to protocol|0|||
105752645|NCT01061736|364746420|FG005|Overall Study|Poor compliance to protocol|0|||
105752646|NCT01061736|364746421|FG006|Overall Study|Poor compliance to protocol|0|||
105752647|NCT01061736|364746422|FG007|Overall Study|Poor compliance to protocol|2|||
105752648|NCT01061736|364746423|FG008|Overall Study|Poor compliance to protocol|5|||
105752649|NCT01061736|364746424|FG009|Overall Study|Poor compliance to protocol|9|||
105752650|NCT01061736|364746415|FG000|Overall Study|Not treated|0|||
105752651|NCT01061736|364746416|FG001|Overall Study|Not treated|0|||
105752652|NCT01061736|364746417|FG002|Overall Study|Not treated|0|||
105752653|NCT01061736|364746418|FG003|Overall Study|Not treated|0|||
105752654|NCT01061736|364746419|FG004|Overall Study|Not treated|1|||
105752655|NCT01061736|364746420|FG005|Overall Study|Not treated|0|||
105752656|NCT01061736|364746421|FG006|Overall Study|Not treated|0|||
105752657|NCT01061736|364746422|FG007|Overall Study|Not treated|2|||
105752658|NCT01061736|364746423|FG008|Overall Study|Not treated|1|||
105752659|NCT01061736|364746424|FG009|Overall Study|Not treated|0|||
105752660|NCT01061736|364746415|FG000|Overall Study|Other than specified above|0|||
105752661|NCT01061736|364746416|FG001|Overall Study|Other than specified above|1|||
105752662|NCT01061736|364746417|FG002|Overall Study|Other than specified above|2|||
105752663|NCT01061736|364746418|FG003|Overall Study|Other than specified above|0|||
105752664|NCT01061736|364746419|FG004|Overall Study|Other than specified above|1|||
105752665|NCT01061736|364746420|FG005|Overall Study|Other than specified above|0|||
105752666|NCT01061736|364746421|FG006|Overall Study|Other than specified above|0|||
105752667|NCT01061736|364746422|FG007|Overall Study|Other than specified above|18|||
105752668|NCT01061736|364746423|FG008|Overall Study|Other than specified above|15|||
105752669|NCT01061736|364746424|FG009|Overall Study|Other than specified above|21|||
105752670|NCT01207388|364746425|FG000|Overall Study|Death|67|||
105752671|NCT01207388|364746425|FG000|Overall Study|Withdrawal by Subject|1|||
105752672|NCT01895452|364746434|FG000|Overall Study|Adverse Event|1|||
105752673|NCT01895452|364746435|FG001|Overall Study|Adverse Event|4|||
105752674|NCT01895452|364746434|FG000|Overall Study|Lost to Follow-up|1|||
105752675|NCT01895452|364746435|FG001|Overall Study|Lost to Follow-up|5|||
105752676|NCT01895452|364746434|FG000|Overall Study|Pregnancy|0|||
105752677|NCT01895452|364746435|FG001|Overall Study|Pregnancy|1|||
105752678|NCT01895452|364746434|FG000|Overall Study|Withdrawal by Subject|2|||
105752679|NCT01895452|364746435|FG001|Overall Study|Withdrawal by Subject|14|||
105752680|NCT01895452|364746434|FG000|Overall Study|Underlying disease|0|||
105752681|NCT01895452|364746435|FG001|Overall Study|Underlying disease|3|||
105752682|NCT01895452|364746434|FG000|Overall Study|Noncompliance with study drug|0|||
105752683|NCT01895452|364746435|FG001|Overall Study|Noncompliance with study drug|1|||
105752684|NCT01954251|364746436|FG000|Overall Study|Adverse Event|5|||
105752685|NCT01954251|364746437|FG001|Overall Study|Adverse Event|7|||
105752686|NCT01954251|364746436|FG000|Overall Study|Lost to Follow-up|6|||
105752687|NCT01954251|364746437|FG001|Overall Study|Lost to Follow-up|6|||
105752688|NCT01954251|364746436|FG000|Overall Study|Withdrawal by Subject|2|||
105752689|NCT01954251|364746437|FG001|Overall Study|Withdrawal by Subject|6|||
105752690|NCT00190983|364746440|FG000|Overall Study|Inevaluable (never treated)|2|||
105752691|NCT02287402|364746441|FG000|Treatment Period|Adverse Event|17|||
105752692|NCT02287402|364746441|FG000|Treatment Period|Voluntary Withdrawal|10|||
105752693|NCT02287402|364746441|FG000|Follow-up|Lost to Follow-up|1|||
105752694|NCT02287402|364746441|FG000|Follow-up|Voluntary Withdrawal|2|||
105752695|NCT01844830|364746442|FG000|Overall Study|Withdrawal by Subject|1|||
105752696|NCT01844830|364746443|FG001|Overall Study|Withdrawal by Subject|0|||
105752697|NCT04247815|364746444|FG000|Overall Study|Adverse Event|1|||
105752698|NCT04247815|364746445|FG001|Overall Study|Adverse Event|0|||
105752699|NCT04247815|364746444|FG000|Overall Study|Withdrawal by Subject|1|||
105752700|NCT04247815|364746445|FG001|Overall Study|Withdrawal by Subject|0|||
105752701|NCT04247815|364746444|FG000|Overall Study|Protocol Violation|0|||
105752702|NCT04247815|364746445|FG001|Overall Study|Protocol Violation|1|||
105752703|NCT02207556|364746446|FG000|Overall Study|Physician Decision|1|||
105752704|NCT02207556|364746447|FG001|Overall Study|Physician Decision|0|||
105752705|NCT02207556|364746446|FG000|Overall Study|Withdrawal by Subject|1|||
105752706|NCT02207556|364746447|FG001|Overall Study|Withdrawal by Subject|0|||
105752707|NCT02207556|364746446|FG000|Overall Study|Death|0|||
105752708|NCT02207556|364746447|FG001|Overall Study|Death|5|||
105752709|NCT00089479|364746453|FG000|Overall Study|Death|108|||
105752710|NCT00089479|364746454|FG001|Overall Study|Death|75|||
105752711|NCT00089479|364746453|FG000|Overall Study|Withdrawal by Subject|86|||
105752712|NCT00089479|364746454|FG001|Overall Study|Withdrawal by Subject|107|||
105752713|NCT00089479|364746453|FG000|Overall Study|Lost to Follow-up|137|||
105752714|NCT00089479|364746454|FG001|Overall Study|Lost to Follow-up|107|||
105752715|NCT04724733|364746455|FG000|Overall Study|Lost to Follow-up|1|||
105802067|NCT03705169|364930721|FG008|Overall Study|Adverse Event|0|||
105802068|NCT03705169|364930722|FG009|Overall Study|Adverse Event|0|||
105802069|NCT03705169|364930713|FG000|Overall Study|Site Closure|0|||
105802070|NCT03705169|364930714|FG001|Overall Study|Site Closure|0|||
105802071|NCT03705169|364930715|FG002|Overall Study|Site Closure|0|||
105802072|NCT03705169|364930716|FG003|Overall Study|Site Closure|1|||
105802073|NCT03705169|364930717|FG004|Overall Study|Site Closure|0|||
105802074|NCT03705169|364930718|FG005|Overall Study|Site Closure|0|||
105802075|NCT03705169|364930719|FG006|Overall Study|Site Closure|0|||
105802076|NCT03705169|364930720|FG007|Overall Study|Site Closure|0|||
105802077|NCT03705169|364930721|FG008|Overall Study|Site Closure|0|||
105802078|NCT03705169|364930722|FG009|Overall Study|Site Closure|0|||
105802079|NCT03705169|364930713|FG000|Overall Study|Did not receive study treatment|0|||
105802080|NCT03705169|364930714|FG001|Overall Study|Did not receive study treatment|0|||
105802081|NCT03705169|364930715|FG002|Overall Study|Did not receive study treatment|0|||
105802082|NCT03705169|364930716|FG003|Overall Study|Did not receive study treatment|1|||
105802083|NCT03705169|364930717|FG004|Overall Study|Did not receive study treatment|0|||
105802084|NCT03705169|364930718|FG005|Overall Study|Did not receive study treatment|0|||
105802085|NCT03705169|364930719|FG006|Overall Study|Did not receive study treatment|0|||
105802086|NCT03705169|364930720|FG007|Overall Study|Did not receive study treatment|0|||
105802087|NCT03705169|364930721|FG008|Overall Study|Did not receive study treatment|0|||
105802088|NCT03705169|364930722|FG009|Overall Study|Did not receive study treatment|0|||
105802089|NCT03705169|364930713|FG000|Overall Study|Concerns about study visit compliance|0|||
105752716|NCT04724733|364746456|FG001|Overall Study|Lost to Follow-up|1|||
105752717|NCT04724733|364746457|FG002|Overall Study|Lost to Follow-up|1|||
105752718|NCT04511819|364746458|FG000|Overall Study|Non-compliance with study drug|5|||
105752719|NCT04511819|364746459|FG001|Overall Study|Non-compliance with study drug|1|||
105752720|NCT04511819|364746458|FG000|Overall Study|Withdrawal by Subject|0|||
105752721|NCT04511819|364746459|FG001|Overall Study|Withdrawal by Subject|3|||
105752722|NCT04511819|364746458|FG000|Overall Study|Adverse Event|0|||
105752723|NCT04511819|364746459|FG001|Overall Study|Adverse Event|1|||
105752724|NCT04511819|364746458|FG000|Overall Study|Protocol deviation|1|||
105752725|NCT04511819|364746459|FG001|Overall Study|Protocol deviation|0|||
105752726|NCT01742078|364746460|FG000|Overall Study|Withdrawal by Subject|0|||
105752727|NCT01742078|364746461|FG001|Overall Study|Withdrawal by Subject|0|||
105752728|NCT01742078|364746462|FG002|Overall Study|Withdrawal by Subject|0|||
105752729|NCT01742078|364746463|FG003|Overall Study|Withdrawal by Subject|1|||
105752730|NCT01742078|364746464|FG004|Overall Study|Withdrawal by Subject|0|||
105752731|NCT01742078|364746465|FG005|Overall Study|Withdrawal by Subject|0|||
105752732|NCT01742078|364746466|FG006|Overall Study|Withdrawal by Subject|0|||
105752733|NCT01742078|364746467|FG007|Overall Study|Withdrawal by Subject|0|||
105752734|NCT01742078|364746468|FG008|Overall Study|Withdrawal by Subject|0|||
105752735|NCT04580394|364746469|FG000|First Intervention|Incorrectly Randomized|1|||
105752736|NCT04580394|364746469|FG000|First Intervention|Physician Decision|1|||
105752737|NCT04580394|364746469|FG000|First Intervention|Lost to Follow-up|1|||
105752738|NCT04580394|364746469|FG000|Washout (One Week)|Withdrawal by Subject|1|||
105752739|NCT04580394|364746469|FG000|Washout (One Week)|Adverse Event|1|||
105752740|NCT04580394|364746469|FG000|Washout (One Week)|Withdrawal by Subject|2|||
105752741|NCT04580394|364746469|FG000|Third Intervention|Adverse Event|1|||
105752742|NCT04580394|364746469|FG000|Third Intervention|Withdrawal by Subject|1|||
105752743|NCT04580394|364746469|FG000|Washout (One Week)|Withdrawal by Subject|2|||
105752744|NCT00642746|364746472|FG000|Overall Study|Patient unevaluable|1|||
105752745|NCT00642746|364746473|FG001|Overall Study|Patient unevaluable|0|||
105752746|NCT00424294|364746477|FG000|Overall Study|Adverse Event|4|||
105752747|NCT00424294|364746478|FG001|Overall Study|Adverse Event|10|||
105752748|NCT00424294|364746477|FG000|Overall Study|Lack of Efficacy|2|||
105752749|NCT00424294|364746478|FG001|Overall Study|Lack of Efficacy|1|||
105752750|NCT00424294|364746477|FG000|Overall Study|Withdrawal by Subject|1|||
105752751|NCT00424294|364746478|FG001|Overall Study|Withdrawal by Subject|2|||
105752752|NCT00424294|364746477|FG000|Overall Study|Other|0|||
105752753|NCT00424294|364746478|FG001|Overall Study|Other|2|||
105752754|NCT00424294|364746477|FG000|Overall Study|Randomized but not Treated|1|||
105752755|NCT00424294|364746478|FG001|Overall Study|Randomized but not Treated|0|||
105752756|NCT01797965|364746481|FG000|Overall Study|Adverse Event|104|||
105752757|NCT01797965|364746482|FG001|Overall Study|Adverse Event|129|||
105752758|NCT01797965|364746483|FG002|Overall Study|Adverse Event|4|||
105752759|NCT01797965|364746484|FG003|Overall Study|Adverse Event|21|||
105752760|NCT01797965|364746481|FG000|Overall Study|Lost to Follow-up|9|||
105752761|NCT01797965|364746482|FG001|Overall Study|Lost to Follow-up|8|||
105752762|NCT01797965|364746483|FG002|Overall Study|Lost to Follow-up|1|||
105752763|NCT01797965|364746484|FG003|Overall Study|Lost to Follow-up|2|||
105752764|NCT01797965|364746481|FG000|Overall Study|Consent withdrawn|130|||
105752765|NCT01797965|364746482|FG001|Overall Study|Consent withdrawn|117|||
105752766|NCT01797965|364746483|FG002|Overall Study|Consent withdrawn|3|||
105752767|NCT01797965|364746484|FG003|Overall Study|Consent withdrawn|35|||
105752768|NCT01797965|364746481|FG000|Overall Study|Investigator decision|21|||
105752769|NCT01797965|364746482|FG001|Overall Study|Investigator decision|15|||
105752770|NCT01797965|364746483|FG002|Overall Study|Investigator decision|0|||
105752771|NCT01797965|364746484|FG003|Overall Study|Investigator decision|0|||
105752772|NCT01797965|364746481|FG000|Overall Study|Death|2|||
105752773|NCT01797965|364746482|FG001|Overall Study|Death|4|||
105752774|NCT01797965|364746483|FG002|Overall Study|Death|0|||
105752775|NCT01797965|364746484|FG003|Overall Study|Death|0|||
105752776|NCT01797965|364746481|FG000|Overall Study|Disease progression, defined by protocol|3|||
105752777|NCT01797965|364746482|FG001|Overall Study|Disease progression, defined by protocol|1|||
105752778|NCT01797965|364746483|FG002|Overall Study|Disease progression, defined by protocol|0|||
105752779|NCT01797965|364746484|FG003|Overall Study|Disease progression, defined by protocol|0|||
105752780|NCT01797965|364746481|FG000|Overall Study|Reason Not Specified|280|||
105752781|NCT01797965|364746482|FG001|Overall Study|Reason Not Specified|295|||
105752782|NCT01797965|364746483|FG002|Overall Study|Reason Not Specified|0|||
105752783|NCT01797965|364746484|FG003|Overall Study|Reason Not Specified|15|||
105752784|NCT00304915|364746485|FG000|Overall Study|Lost to Follow-up|11|||
105752785|NCT00304915|364746486|FG001|Overall Study|Lost to Follow-up|11|||
105752786|NCT00304915|364746485|FG000|Overall Study|Death|4|||
105752787|NCT00304915|364746486|FG001|Overall Study|Death|5|||
105752788|NCT00304915|364746485|FG000|Overall Study|Withdrawal by Subject|3|||
105752789|NCT00304915|364746486|FG001|Overall Study|Withdrawal by Subject|0|||
105752790|NCT03442829|364746489|FG000|Overall Study|Scheduling clash|3|||
105752791|NCT03442829|364746490|FG001|Overall Study|Scheduling clash|1|||
105565890|NCT00508261|364071000|FG003|Overall Study|Migrated/ moved from study area|0|||
105565891|NCT00508261|364070997|FG000|Overall Study|Lost to Follow-up|0|||
105565892|NCT00508261|364070998|FG001|Overall Study|Lost to Follow-up|1|||
105565893|NCT00508261|364070999|FG002|Overall Study|Lost to Follow-up|1|||
105565894|NCT00508261|364071000|FG003|Overall Study|Lost to Follow-up|1|||
105565895|NCT00180479|364071001|FG000|Overall Study|Death|4|||
105565896|NCT00180479|364071002|FG001|Overall Study|Death|2|||
105565897|NCT00180479|364071001|FG000|Overall Study|Lost to Follow-up|9|||
105565898|NCT00180479|364071002|FG001|Overall Study|Lost to Follow-up|7|||
105565899|NCT00180479|364071001|FG000|Overall Study|Withdrawal by Subject|3|||
105565900|NCT00180479|364071002|FG001|Overall Study|Withdrawal by Subject|3|||
105565901|NCT00180479|364071001|FG000|Overall Study|Informed consent not signed|0|||
105565902|NCT00180479|364071002|FG001|Overall Study|Informed consent not signed|1|||
105565903|NCT05168579|364071009|FG000|Overall Study|Lack of Consent|1|||
105565904|NCT05168579|364071010|FG001|Overall Study|Lack of Consent|0|||
105565905|NCT05168579|364071009|FG000|Overall Study|Conflicts with time|2|||
105565906|NCT05168579|364071010|FG001|Overall Study|Conflicts with time|0|||
105565907|NCT05168579|364071009|FG000|Overall Study|Time slots were full|3|||
105565908|NCT05168579|364071010|FG001|Overall Study|Time slots were full|0|||
105565909|NCT05168579|364071009|FG000|Overall Study|Lost to Follow-up|0|||
105565910|NCT05168579|364071010|FG001|Overall Study|Lost to Follow-up|15|||
105565911|NCT00514683|364071011|FG000|Overall Study|Not treated|2|||
105565912|NCT00514683|364071012|FG001|Overall Study|Not treated|1|||
105565913|NCT00514683|364071013|FG002|Overall Study|Not treated|0|||
105565914|NCT00514683|364071014|FG003|Overall Study|Not treated|0|||
105565915|NCT00514683|364071015|FG004|Overall Study|Not treated|1|||
105565916|NCT00514683|364071011|FG000|Overall Study|Adverse Event|21|||
105565917|NCT00514683|364071012|FG001|Overall Study|Adverse Event|20|||
105565918|NCT00514683|364071013|FG002|Overall Study|Adverse Event|15|||
105565919|NCT00514683|364071014|FG003|Overall Study|Adverse Event|13|||
105565920|NCT00514683|364071015|FG004|Overall Study|Adverse Event|27|||
105565921|NCT00514683|364071011|FG000|Overall Study|Protocol Violation|1|||
105565922|NCT00514683|364071012|FG001|Overall Study|Protocol Violation|1|||
105565923|NCT00514683|364071013|FG002|Overall Study|Protocol Violation|0|||
105565924|NCT00514683|364071014|FG003|Overall Study|Protocol Violation|1|||
105565925|NCT00514683|364071015|FG004|Overall Study|Protocol Violation|0|||
105565926|NCT00514683|364071011|FG000|Overall Study|Withdrawal by Subject|2|||
105565927|NCT00514683|364071012|FG001|Overall Study|Withdrawal by Subject|2|||
105565928|NCT00514683|364071013|FG002|Overall Study|Withdrawal by Subject|1|||
105752792|NCT03442829|364746489|FG000|Overall Study|Illness unrelated to study|1|||
105752793|NCT03442829|364746490|FG001|Overall Study|Illness unrelated to study|1|||
105752794|NCT03491553|364746493|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
105752795|NCT03491553|364746494|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
105752796|NCT03491553|364746495|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
105752797|NCT03491553|364746496|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
105752798|NCT03491553|364746497|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
105752799|NCT03491553|364746498|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
105752800|NCT03491553|364746493|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
105752801|NCT03491553|364746494|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
105752802|NCT03491553|364746495|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
105752803|NCT03491553|364746496|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
105752804|NCT03491553|364746497|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
105752805|NCT03491553|364746498|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
105752806|NCT04404010|364746505|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
105752807|NCT04404010|364746506|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
105752808|NCT00586924|364746507|FG000|Overall Study|Adverse event/serious adverse event|0|||
105752809|NCT00586924|364746508|FG001|Overall Study|Adverse event/serious adverse event|0|||
105752810|NCT00586924|364746509|FG002|Overall Study|Adverse event/serious adverse event|0|||
105752811|NCT00586924|364746510|FG003|Overall Study|Adverse event/serious adverse event|1|||
105752812|NCT00586924|364746511|FG004|Overall Study|Adverse event/serious adverse event|0|||
105752813|NCT00586924|364746512|FG005|Overall Study|Adverse event/serious adverse event|2|||
105752814|NCT00586924|364746507|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
105752815|NCT00586924|364746508|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
105760897|NCT01342952|364778054|FG002|Overall Study|Adverse Event|1|||
105565929|NCT00514683|364071014|FG003|Overall Study|Withdrawal by Subject|0|||
105565930|NCT00514683|364071015|FG004|Overall Study|Withdrawal by Subject|4|||
105565931|NCT00514683|364071011|FG000|Overall Study|Reason other than listed above|0|||
105565932|NCT00514683|364071012|FG001|Overall Study|Reason other than listed above|1|||
105565933|NCT00514683|364071013|FG002|Overall Study|Reason other than listed above|2|||
105565934|NCT00514683|364071014|FG003|Overall Study|Reason other than listed above|0|||
105565935|NCT00514683|364071015|FG004|Overall Study|Reason other than listed above|1|||
105565936|NCT00335452|364071016|FG000|Overall Study|Death|156|||
105565937|NCT00335452|364071017|FG001|Overall Study|Death|144|||
105565938|NCT00335452|364071018|FG002|Overall Study|Death|158|||
105565939|NCT00335452|364071019|FG003|Overall Study|Death|129|||
105565940|NCT00335452|364071016|FG000|Overall Study|Lost to Follow-up|2|||
105565941|NCT00335452|364071017|FG001|Overall Study|Lost to Follow-up|3|||
105565942|NCT00335452|364071018|FG002|Overall Study|Lost to Follow-up|1|||
105565943|NCT00335452|364071019|FG003|Overall Study|Lost to Follow-up|2|||
105565944|NCT02736825|364071020|FG000|Overall Study|Lost to Follow-up|10|||
105565945|NCT02736825|364071021|FG001|Overall Study|Lost to Follow-up|11|||
105565946|NCT02736825|364071020|FG000|Overall Study|Early Termination|0|||
105565947|NCT02736825|364071021|FG001|Overall Study|Early Termination|1|||
105565948|NCT05044325|364071024|FG000|Part A:Treatment Period 1|Adverse Event|0|||
105565949|NCT05044325|364071025|FG001|Part A:Treatment Period 1|Adverse Event|0|||
105565950|NCT05044325|364071026|FG002|Part A:Treatment Period 1|Adverse Event|0|||
105565951|NCT05044325|364071027|FG003|Part A:Treatment Period 1|Adverse Event|0|||
105565952|NCT05044325|364071028|FG004|Part A:Treatment Period 1|Adverse Event|0|||
105565953|NCT05044325|364071029|FG005|Part A:Treatment Period 1|Adverse Event|1|||
105565954|NCT05044325|364071030|FG006|Part A:Treatment Period 1|Adverse Event|0|||
105565955|NCT05044325|364071031|FG007|Part A:Treatment Period 1|Adverse Event|1|||
105565956|NCT05044325|364071032|FG008|Part A:Treatment Period 1|Adverse Event|0|||
105565957|NCT05044325|364071033|FG009|Part A:Treatment Period 1|Adverse Event|0|||
105565958|NCT05044325|364071024|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
105565959|NCT05044325|364071025|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
105565960|NCT05044325|364071026|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
105565961|NCT05044325|364071027|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
105565962|NCT05044325|364071028|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
105565963|NCT05044325|364071029|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
105565964|NCT05044325|364071030|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
105565965|NCT05044325|364071031|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
105565966|NCT05044325|364071032|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
105565967|NCT05044325|364071033|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
105565968|NCT05044325|364071024|FG000|Part A:Treatment Period 1|Physician Decision|0|||
105565969|NCT05044325|364071025|FG001|Part A:Treatment Period 1|Physician Decision|0|||
105565970|NCT05044325|364071026|FG002|Part A:Treatment Period 1|Physician Decision|0|||
105565971|NCT05044325|364071027|FG003|Part A:Treatment Period 1|Physician Decision|0|||
105565972|NCT05044325|364071028|FG004|Part A:Treatment Period 1|Physician Decision|0|||
105565973|NCT05044325|364071029|FG005|Part A:Treatment Period 1|Physician Decision|0|||
105565974|NCT05044325|364071030|FG006|Part A:Treatment Period 1|Physician Decision|1|||
105565975|NCT05044325|364071031|FG007|Part A:Treatment Period 1|Physician Decision|0|||
105565976|NCT05044325|364071032|FG008|Part A:Treatment Period 1|Physician Decision|0|||
105565977|NCT05044325|364071033|FG009|Part A:Treatment Period 1|Physician Decision|0|||
105565978|NCT05044325|364071024|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
105565979|NCT05044325|364071025|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
105565980|NCT05044325|364071026|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
105565981|NCT05044325|364071027|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
105360343|NCT00105989|363325911|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
105360344|NCT00105989|363325912|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
105752816|NCT00586924|364746509|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
105752817|NCT00586924|364746510|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
105752818|NCT00586924|364746511|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
105752819|NCT00586924|364746512|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
105752820|NCT00586924|364746507|FG000|Overall Study|Disease progression|0|||
105752821|NCT00586924|364746508|FG001|Overall Study|Disease progression|0|||
105752822|NCT00586924|364746509|FG002|Overall Study|Disease progression|0|||
105752823|NCT00586924|364746510|FG003|Overall Study|Disease progression|1|||
105565982|NCT05044325|364071028|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
105565983|NCT05044325|364071029|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
105565984|NCT05044325|364071030|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
105565985|NCT05044325|364071031|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
105565986|NCT05044325|364071032|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
105565987|NCT05044325|364071033|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
105752824|NCT00586924|364746511|FG004|Overall Study|Disease progression|1|||
105752825|NCT00586924|364746512|FG005|Overall Study|Disease progression|0|||
105752826|NCT00586924|364746507|FG000|Overall Study|Development of neutralizing antibodies|2|||
105760898|NCT01342952|364778055|FG003|Overall Study|Adverse Event|0|||
105565988|NCT05044325|364071024|FG000|Part A:Treatment Period 2|Adverse Event|0|||
105565989|NCT05044325|364071025|FG001|Part A:Treatment Period 2|Adverse Event|1|||
105565990|NCT05044325|364071026|FG002|Part A:Treatment Period 2|Adverse Event|0|||
105565991|NCT05044325|364071027|FG003|Part A:Treatment Period 2|Adverse Event|0|||
105565992|NCT05044325|364071028|FG004|Part A:Treatment Period 2|Adverse Event|1|||
105565993|NCT05044325|364071029|FG005|Part A:Treatment Period 2|Adverse Event|1|||
105565994|NCT05044325|364071030|FG006|Part A:Treatment Period 2|Adverse Event|0|||
105565995|NCT05044325|364071031|FG007|Part A:Treatment Period 2|Adverse Event|0|||
105565996|NCT05044325|364071032|FG008|Part A:Treatment Period 2|Adverse Event|0|||
105565997|NCT05044325|364071033|FG009|Part A:Treatment Period 2|Adverse Event|0|||
105565998|NCT05044325|364071024|FG000|Part A:Treatment Period 2|Physician Decision|0|||
105565999|NCT05044325|364071025|FG001|Part A:Treatment Period 2|Physician Decision|0|||
105566000|NCT05044325|364071026|FG002|Part A:Treatment Period 2|Physician Decision|0|||
105566001|NCT05044325|364071027|FG003|Part A:Treatment Period 2|Physician Decision|0|||
105566002|NCT05044325|364071028|FG004|Part A:Treatment Period 2|Physician Decision|0|||
105566003|NCT05044325|364071029|FG005|Part A:Treatment Period 2|Physician Decision|1|||
105566004|NCT05044325|364071030|FG006|Part A:Treatment Period 2|Physician Decision|0|||
105566005|NCT05044325|364071031|FG007|Part A:Treatment Period 2|Physician Decision|0|||
105566006|NCT05044325|364071032|FG008|Part A:Treatment Period 2|Physician Decision|0|||
105566007|NCT05044325|364071033|FG009|Part A:Treatment Period 2|Physician Decision|0|||
105566008|NCT05044325|364071024|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
105566009|NCT05044325|364071025|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
105566010|NCT05044325|364071026|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
105566011|NCT05044325|364071027|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
105566012|NCT05044325|364071028|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
105566013|NCT05044325|364071029|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
105566014|NCT05044325|364071030|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
105566015|NCT05044325|364071031|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
105566016|NCT05044325|364071032|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
105566017|NCT05044325|364071033|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
105566018|NCT02901626|364071034|FG000|Overall Study|Lost to Follow-up|1|||
105566019|NCT02901626|364071035|FG001|Overall Study|Lost to Follow-up|1|||
105566020|NCT00827541|364071036|FG000|Overall Study|Exitus|1|||
105566021|NCT00827541|364071037|FG001|Overall Study|Exitus|8|||
105566022|NCT00827541|364071036|FG000|Overall Study|Other|1|||
105566023|NCT00827541|364071037|FG001|Overall Study|Other|3|||
105566024|NCT00827541|364071036|FG000|Overall Study|Pathogen not susceptible|1|||
105566025|NCT00827541|364071037|FG001|Overall Study|Pathogen not susceptible|0|||
105752827|NCT00586924|364746508|FG001|Overall Study|Development of neutralizing antibodies|2|||
105752828|NCT00586924|364746509|FG002|Overall Study|Development of neutralizing antibodies|2|||
105752829|NCT00586924|364746510|FG003|Overall Study|Development of neutralizing antibodies|0|||
105752830|NCT00586924|364746511|FG004|Overall Study|Development of neutralizing antibodies|0|||
105752831|NCT00586924|364746512|FG005|Overall Study|Development of neutralizing antibodies|22|||
105752832|NCT00586924|364746507|FG000|Overall Study|Complete response|0|||
105752833|NCT00586924|364746508|FG001|Overall Study|Complete response|1|||
105752834|NCT00586924|364746509|FG002|Overall Study|Complete response|0|||
105752835|NCT00586924|364746510|FG003|Overall Study|Complete response|0|||
105752836|NCT00586924|364746511|FG004|Overall Study|Complete response|2|||
105566026|NCT00827541|364071036|FG000|Overall Study|Lack of effectiveness|1|||
105566027|NCT00827541|364071037|FG001|Overall Study|Lack of effectiveness|0|||
105566028|NCT04810221|364071038|FG000|Overall Study|Physician Decision|3|||
105566029|NCT03642938|364071039|FG000|Overall Study|Withdrawal by Subject|0|||
105566030|NCT03642938|364071040|FG001|Overall Study|Withdrawal by Subject|0|||
105566031|NCT03642938|364071041|FG002|Overall Study|Withdrawal by Subject|0|||
105566032|NCT03642938|364071042|FG003|Overall Study|Withdrawal by Subject|1|||
105566033|NCT04439136|364071043|FG000|Overall Study|Ineligible|1|||
105566034|NCT04439136|364071043|FG000|Overall Study|Never Started Treatment|2|||
105566035|NCT04439136|364071043|FG000|Overall Study|Adverse Event|4|||
105566036|NCT04439136|364071043|FG000|Overall Study|Death|3|||
105752837|NCT00586924|364746512|FG005|Overall Study|Complete response|2|||
105752838|NCT00586924|364746507|FG000|Overall Study|Other|1|||
105752839|NCT00586924|364746508|FG001|Overall Study|Other|0|||
105752840|NCT00586924|364746509|FG002|Overall Study|Other|1|||
105752841|NCT00586924|364746510|FG003|Overall Study|Other|1|||
105752842|NCT00586924|364746511|FG004|Overall Study|Other|1|||
105752843|NCT00586924|364746512|FG005|Overall Study|Other|6|||
105752844|NCT00536978|364746513|FG000|Overall Study|Not eligible for Adback Infusion|22|||
105752845|NCT00118482|364746514|FG000|Overall Study|Lost to Follow-up|7|||
105752846|NCT00118482|364746515|FG001|Overall Study|Lost to Follow-up|7|||
105752847|NCT00118482|364746514|FG000|Overall Study|Withdrawal by Subject|23|||
105752848|NCT00118482|364746515|FG001|Overall Study|Withdrawal by Subject|22|||
105752849|NCT02128763|364746519|FG000|Overall Study|Death|1|||
105752850|NCT02128763|364746520|FG001|Overall Study|Death|0|||
105752851|NCT02128763|364746519|FG000|Overall Study|Lost to Follow-up|19|||
105752852|NCT02128763|364746520|FG001|Overall Study|Lost to Follow-up|16|||
105752853|NCT00819585|364746521|FG000|Core Study|Adverse Event|2|||
105752854|NCT00819585|364746522|FG001|Core Study|Adverse Event|1|||
105752855|NCT00819585|364746523|FG002|Core Study|Adverse Event|1|||
105752856|NCT00819585|364746524|FG003|Core Study|Adverse Event|4|||
105752857|NCT00819585|364746525|FG004|Core Study|Adverse Event|1|||
105752858|NCT00819585|364746526|FG005|Core Study|Adverse Event|0|||
105752859|NCT00819585|364746527|FG006|Core Study|Adverse Event|2|||
105752860|NCT00819585|364746528|FG007|Core Study|Adverse Event|0|||
105752861|NCT00819585|364746529|FG008|Core Study|Adverse Event|0|||
105752862|NCT00819585|364746530|FG009|Core Study|Adverse Event|0|||
105752863|NCT00819585|364746531|FG010|Core Study|Adverse Event|0|||
105752864|NCT00819585|364746521|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
105752865|NCT00819585|364746522|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
105752866|NCT00819585|364746523|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
105752867|NCT00819585|364746524|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
105752868|NCT00819585|364746525|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
105752869|NCT00819585|364746526|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
105752870|NCT00819585|364746527|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
105752871|NCT00819585|364746528|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
105752872|NCT00819585|364746529|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
105752873|NCT00819585|364746530|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
105752874|NCT00819585|364746531|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
105752875|NCT00819585|364746521|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752876|NCT00819585|364746522|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
105752877|NCT00819585|364746523|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752878|NCT00819585|364746524|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752879|NCT00819585|364746525|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752880|NCT00819585|364746526|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752881|NCT00819585|364746527|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
105752882|NCT00819585|364746528|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752883|NCT00819585|364746529|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752884|NCT00819585|364746530|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752885|NCT00819585|364746531|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752886|NCT00819585|364746521|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
105752887|NCT00819585|364746522|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
105752888|NCT00819585|364746523|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
105752889|NCT00819585|364746524|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
105752890|NCT00819585|364746525|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
105752891|NCT00819585|364746526|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
105752892|NCT00819585|364746527|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
105752893|NCT00819585|364746528|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
105752894|NCT00819585|364746529|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
105752895|NCT00819585|364746530|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
105752896|NCT00819585|364746531|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
105752897|NCT00819585|364746521|FG000|Core Study|Subject Withdrew Consent|0|||
105752898|NCT00819585|364746522|FG001|Core Study|Subject Withdrew Consent|3|||
105752899|NCT00819585|364746523|FG002|Core Study|Subject Withdrew Consent|2|||
105752900|NCT00819585|364746524|FG003|Core Study|Subject Withdrew Consent|1|||
105752901|NCT00819585|364746525|FG004|Core Study|Subject Withdrew Consent|0|||
105752902|NCT00819585|364746526|FG005|Core Study|Subject Withdrew Consent|0|||
105752903|NCT00819585|364746527|FG006|Core Study|Subject Withdrew Consent|3|||
105752904|NCT00819585|364746528|FG007|Core Study|Subject Withdrew Consent|0|||
105752905|NCT00819585|364746529|FG008|Core Study|Subject Withdrew Consent|0|||
105752906|NCT00819585|364746530|FG009|Core Study|Subject Withdrew Consent|0|||
105752907|NCT00819585|364746531|FG010|Core Study|Subject Withdrew Consent|0|||
105752908|NCT00819585|364746521|FG000|Core Study|Lost to Follow-up|2|||
105752909|NCT00819585|364746522|FG001|Core Study|Lost to Follow-up|1|||
105752910|NCT00819585|364746523|FG002|Core Study|Lost to Follow-up|2|||
105752911|NCT00819585|364746524|FG003|Core Study|Lost to Follow-up|0|||
105752912|NCT00819585|364746525|FG004|Core Study|Lost to Follow-up|1|||
105752913|NCT00819585|364746526|FG005|Core Study|Lost to Follow-up|1|||
105752914|NCT00819585|364746527|FG006|Core Study|Lost to Follow-up|1|||
105752915|NCT00819585|364746528|FG007|Core Study|Lost to Follow-up|0|||
105752916|NCT00819585|364746529|FG008|Core Study|Lost to Follow-up|0|||
105752917|NCT00819585|364746530|FG009|Core Study|Lost to Follow-up|0|||
105752918|NCT00819585|364746531|FG010|Core Study|Lost to Follow-up|0|||
105752919|NCT00819585|364746521|FG000|Core Study|Administrative Problems|0|||
105752920|NCT00819585|364746522|FG001|Core Study|Administrative Problems|0|||
105752921|NCT00819585|364746523|FG002|Core Study|Administrative Problems|0|||
105752922|NCT00819585|364746524|FG003|Core Study|Administrative Problems|0|||
105752923|NCT00819585|364746525|FG004|Core Study|Administrative Problems|0|||
105752924|NCT00819585|364746526|FG005|Core Study|Administrative Problems|0|||
105752925|NCT00819585|364746527|FG006|Core Study|Administrative Problems|2|||
105752926|NCT00819585|364746528|FG007|Core Study|Administrative Problems|0|||
105752927|NCT00819585|364746529|FG008|Core Study|Administrative Problems|0|||
105752928|NCT00819585|364746530|FG009|Core Study|Administrative Problems|0|||
105752929|NCT00819585|364746531|FG010|Core Study|Administrative Problems|0|||
105752930|NCT00819585|364746521|FG000|Core Study|Death|0|||
105752931|NCT00819585|364746522|FG001|Core Study|Death|0|||
105752932|NCT00819585|364746523|FG002|Core Study|Death|0|||
105752933|NCT00819585|364746524|FG003|Core Study|Death|0|||
105752934|NCT00819585|364746525|FG004|Core Study|Death|0|||
105752935|NCT00819585|364746526|FG005|Core Study|Death|0|||
105752936|NCT00819585|364746527|FG006|Core Study|Death|1|||
105752937|NCT00819585|364746528|FG007|Core Study|Death|0|||
105752938|NCT00819585|364746529|FG008|Core Study|Death|0|||
105752939|NCT00819585|364746530|FG009|Core Study|Death|0|||
105752940|NCT00819585|364746531|FG010|Core Study|Death|0|||
105752941|NCT00819585|364746521|FG000|Core Study|Protocol Violation|0|||
105752942|NCT00819585|364746522|FG001|Core Study|Protocol Violation|0|||
105752943|NCT00819585|364746523|FG002|Core Study|Protocol Violation|1|||
105752944|NCT00819585|364746524|FG003|Core Study|Protocol Violation|0|||
105752945|NCT00819585|364746525|FG004|Core Study|Protocol Violation|0|||
105752946|NCT00819585|364746526|FG005|Core Study|Protocol Violation|1|||
105752947|NCT00819585|364746527|FG006|Core Study|Protocol Violation|3|||
105752948|NCT00819585|364746528|FG007|Core Study|Protocol Violation|0|||
105752949|NCT00819585|364746529|FG008|Core Study|Protocol Violation|0|||
105752950|NCT00819585|364746530|FG009|Core Study|Protocol Violation|0|||
105752951|NCT00819585|364746531|FG010|Core Study|Protocol Violation|0|||
105752952|NCT00819585|364746521|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
105752953|NCT00819585|364746522|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
105752954|NCT00819585|364746523|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
105752955|NCT00819585|364746524|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
105752956|NCT00819585|364746525|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
105752957|NCT00819585|364746526|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
105752958|NCT00819585|364746527|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
105752959|NCT00819585|364746528|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
105752960|NCT00819585|364746529|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
105752961|NCT00819585|364746530|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
105752962|NCT00819585|364746531|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
105752963|NCT00819585|364746521|FG000|Extension Study|Subject Withdrew Consent|0|||
105752964|NCT00819585|364746522|FG001|Extension Study|Subject Withdrew Consent|0|||
105752965|NCT00819585|364746523|FG002|Extension Study|Subject Withdrew Consent|0|||
105752966|NCT00819585|364746524|FG003|Extension Study|Subject Withdrew Consent|0|||
105752967|NCT00819585|364746525|FG004|Extension Study|Subject Withdrew Consent|0|||
105752968|NCT00819585|364746526|FG005|Extension Study|Subject Withdrew Consent|0|||
105752969|NCT00819585|364746527|FG006|Extension Study|Subject Withdrew Consent|0|||
105752970|NCT00819585|364746528|FG007|Extension Study|Subject Withdrew Consent|0|||
105752971|NCT00819585|364746529|FG008|Extension Study|Subject Withdrew Consent|3|||
105752972|NCT00819585|364746530|FG009|Extension Study|Subject Withdrew Consent|0|||
105752973|NCT00819585|364746531|FG010|Extension Study|Subject Withdrew Consent|1|||
105752974|NCT00819585|364746521|FG000|Extension Study|Lost to Follow-up|0|||
105752975|NCT00819585|364746522|FG001|Extension Study|Lost to Follow-up|0|||
105752976|NCT00819585|364746523|FG002|Extension Study|Lost to Follow-up|0|||
105752977|NCT00819585|364746524|FG003|Extension Study|Lost to Follow-up|0|||
105752978|NCT00819585|364746525|FG004|Extension Study|Lost to Follow-up|0|||
105752979|NCT00819585|364746526|FG005|Extension Study|Lost to Follow-up|0|||
105752980|NCT00819585|364746527|FG006|Extension Study|Lost to Follow-up|0|||
105752981|NCT00819585|364746528|FG007|Extension Study|Lost to Follow-up|0|||
105752982|NCT00819585|364746529|FG008|Extension Study|Lost to Follow-up|2|||
105752983|NCT00819585|364746530|FG009|Extension Study|Lost to Follow-up|1|||
105752984|NCT00819585|364746531|FG010|Extension Study|Lost to Follow-up|1|||
105752985|NCT00819585|364746521|FG000|Extension Study|Death|0|||
105752986|NCT00819585|364746522|FG001|Extension Study|Death|0|||
105752987|NCT00819585|364746523|FG002|Extension Study|Death|0|||
105752988|NCT00819585|364746524|FG003|Extension Study|Death|0|||
105360345|NCT00105989|363325911|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
105360346|NCT00105989|363325912|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
105360347|NCT02907463|363325914|FG000|Overall Study|Lost to Follow-up|17|||
105360348|NCT02907463|363325914|FG000|Overall Study|Death|10|||
105360349|NCT02907463|363325914|FG000|Overall Study|Withdrawal by Subject|4|||
105360350|NCT02907463|363325914|FG000|Overall Study|MIS Approach was not used|2|||
105360351|NCT02907463|363325914|FG000|Overall Study|Not Implanted with Study Device|2|||
105360352|NCT02907463|363325914|FG000|Overall Study|Device Explanted|1|||
105360353|NCT02907463|363325914|FG000|Overall Study|Missing Exit Form|1|||
105360354|NCT05225558|363325915|FG000|Overall Study|Withdrawal by Subject|4|||
105360355|NCT05225558|363325916|FG001|Overall Study|Withdrawal by Subject|3|||
105360356|NCT05225558|363325915|FG000|Overall Study|Adverse Event|1|||
105360357|NCT05225558|363325916|FG001|Overall Study|Adverse Event|0|||
105360358|NCT05225558|363325915|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
105360359|NCT05225558|363325916|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
105360360|NCT05225558|363325915|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
105360361|NCT05225558|363325916|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
105360362|NCT02896569|363325918|FG000|Overall Study|Lost to Follow-up|2|||
105360363|NCT02896569|363325919|FG001|Overall Study|Lost to Follow-up|1|||
105360364|NCT02896569|363325918|FG000|Overall Study|Physician Decision|1|||
105360365|NCT02896569|363325919|FG001|Overall Study|Physician Decision|3|||
105360366|NCT02896569|363325918|FG000|Overall Study|Adverse Event|0|||
105360367|NCT02896569|363325919|FG001|Overall Study|Adverse Event|1|||
105360368|NCT02896569|363325918|FG000|Overall Study|Withdrawal by Subject|1|||
105360369|NCT02896569|363325919|FG001|Overall Study|Withdrawal by Subject|0|||
105360370|NCT01462630|363325920|FG000|Overall Study|Did not initiate therapy|3|||
105360371|NCT01462630|363325920|FG000|Overall Study|Death|1|||
105360372|NCT01462630|363325920|FG000|Overall Study|Protocol Violation|2|||
105360373|NCT01462630|363325920|FG000|Overall Study|Adverse Event|1|||
105360374|NCT01765296|363325921|FG000|Overall Study|Protocol Violation|0|||
105360375|NCT01765296|363325922|FG001|Overall Study|Protocol Violation|5|||
105360376|NCT01765296|363325923|FG002|Overall Study|Protocol Violation|4|||
105360377|NCT01765296|363325921|FG000|Overall Study|Withdrawal by Subject|4|||
105360378|NCT01765296|363325922|FG001|Overall Study|Withdrawal by Subject|2|||
105360379|NCT01765296|363325923|FG002|Overall Study|Withdrawal by Subject|2|||
105360380|NCT01765296|363325921|FG000|Overall Study|Adverse Event|1|||
105360381|NCT01765296|363325922|FG001|Overall Study|Adverse Event|13|||
105360382|NCT01765296|363325923|FG002|Overall Study|Adverse Event|5|||
105360383|NCT01765296|363325921|FG000|Overall Study|Lack of Efficacy|0|||
105360384|NCT01765296|363325922|FG001|Overall Study|Lack of Efficacy|0|||
105752989|NCT00819585|364746525|FG004|Extension Study|Death|0|||
105752990|NCT00819585|364746526|FG005|Extension Study|Death|0|||
105752991|NCT00819585|364746527|FG006|Extension Study|Death|0|||
105752992|NCT00819585|364746528|FG007|Extension Study|Death|0|||
105752993|NCT00819585|364746529|FG008|Extension Study|Death|2|||
105752994|NCT00819585|364746530|FG009|Extension Study|Death|0|||
105752995|NCT00819585|364746531|FG010|Extension Study|Death|0|||
105752996|NCT01973452|364746532|FG000|Overall Study|Lack of Efficacy|0|||
105752997|NCT01973452|364746533|FG001|Overall Study|Lack of Efficacy|1|||
105752998|NCT01973452|364746532|FG000|Overall Study|Lost to Follow-up|1|||
105752999|NCT01973452|364746533|FG001|Overall Study|Lost to Follow-up|0|||
105753000|NCT01973452|364746532|FG000|Overall Study|Withdrawal by Subject|10|||
105753001|NCT01973452|364746533|FG001|Overall Study|Withdrawal by Subject|9|||
105753002|NCT01973452|364746532|FG000|Overall Study|Ineligible|1|||
105753003|NCT01973452|364746533|FG001|Overall Study|Ineligible|1|||
105753004|NCT01973452|364746532|FG000|Overall Study|Surgery canceled by participant|5|||
105753005|NCT01973452|364746533|FG001|Overall Study|Surgery canceled by participant|3|||
105753006|NCT02198651|364748014|FG000|Lead-in Period|Withdrew consent|13|||
105753007|NCT02198651|364748015|FG001|Lead-in Period|Withdrew consent|0|||
105753008|NCT02198651|364748016|FG002|Lead-in Period|Withdrew consent|0|||
105753009|NCT02198651|364748017|FG003|Lead-in Period|Withdrew consent|0|||
105753010|NCT02198651|364748018|FG004|Lead-in Period|Withdrew consent|0|||
105753011|NCT02198651|364748014|FG000|Lead-in Period|Adverse Event|2|||
105753012|NCT02198651|364748015|FG001|Lead-in Period|Adverse Event|0|||
105753013|NCT02198651|364748016|FG002|Lead-in Period|Adverse Event|0|||
105753014|NCT02198651|364748017|FG003|Lead-in Period|Adverse Event|0|||
105753015|NCT02198651|364748018|FG004|Lead-in Period|Adverse Event|0|||
105753016|NCT02198651|364748014|FG000|Lead-in Period|Other, not specified|22|||
105753017|NCT02198651|364748015|FG001|Lead-in Period|Other, not specified|0|||
105753018|NCT02198651|364748016|FG002|Lead-in Period|Other, not specified|0|||
105753019|NCT02198651|364748017|FG003|Lead-in Period|Other, not specified|0|||
105753020|NCT02198651|364748018|FG004|Lead-in Period|Other, not specified|0|||
105753021|NCT02198651|364748014|FG000|Double-blind Period|Withdrew consent|0|||
105753022|NCT02198651|364748015|FG001|Double-blind Period|Withdrew consent|4|||
105753023|NCT02198651|364748016|FG002|Double-blind Period|Withdrew consent|0|||
105753024|NCT02198651|364748017|FG003|Double-blind Period|Withdrew consent|0|||
105753025|NCT02198651|364748018|FG004|Double-blind Period|Withdrew consent|0|||
105753026|NCT02198651|364748014|FG000|Double-blind Period|Adverse Event|0|||
105753027|NCT02198651|364748015|FG001|Double-blind Period|Adverse Event|1|||
105753028|NCT02198651|364748016|FG002|Double-blind Period|Adverse Event|0|||
105753029|NCT02198651|364748017|FG003|Double-blind Period|Adverse Event|0|||
105753030|NCT02198651|364748018|FG004|Double-blind Period|Adverse Event|0|||
105753031|NCT02198651|364748014|FG000|Double-blind Period|Other, not specified|0|||
105753032|NCT02198651|364748015|FG001|Double-blind Period|Other, not specified|4|||
105753033|NCT02198651|364748016|FG002|Double-blind Period|Other, not specified|1|||
105753034|NCT02198651|364748017|FG003|Double-blind Period|Other, not specified|0|||
105753035|NCT02198651|364748018|FG004|Double-blind Period|Other, not specified|0|||
105753036|NCT02198651|364748014|FG000|Open-label Rescue Period|Withdrew consent|0|||
105753037|NCT02198651|364748015|FG001|Open-label Rescue Period|Withdrew consent|0|||
105753038|NCT02198651|364748016|FG002|Open-label Rescue Period|Withdrew consent|0|||
105753039|NCT02198651|364748017|FG003|Open-label Rescue Period|Withdrew consent|2|||
105753040|NCT02198651|364748018|FG004|Open-label Rescue Period|Withdrew consent|0|||
105753041|NCT02198651|364748014|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
105753042|NCT02198651|364748015|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
105753043|NCT02198651|364748016|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
105753044|NCT02198651|364748017|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
105753045|NCT02198651|364748018|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
105753046|NCT04095442|364748022|FG000|Overall Study|Lost to Follow-up|0|||
105753047|NCT04095442|364748023|FG001|Overall Study|Lost to Follow-up|1|||
105753048|NCT04095442|364748022|FG000|Overall Study|Screen failure|1|||
105753049|NCT04095442|364748023|FG001|Overall Study|Screen failure|0|||
105753050|NCT00255034|364748027|FG000|Overall Study|Withdrawal by Subject|15|||
105753051|NCT00255034|364748028|FG001|Overall Study|Withdrawal by Subject|38|||
105753052|NCT00574119|364748032|FG000|Overall Study|Adverse Event|1|||
105753053|NCT00574119|364748032|FG000|Overall Study|Protocol Violation|1|||
105753054|NCT00574119|364748032|FG000|Overall Study|Withdrawal by Subject|1|||
105753055|NCT00574119|364748032|FG000|Overall Study|Physician Decision|1|||
105753056|NCT04124692|364748036|FG000|Overall Study|Medical reason|0|||
105753057|NCT04124692|364748037|FG001|Overall Study|Medical reason|1|||
105753058|NCT04124692|364748036|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
105566037|NCT04439136|364071043|FG000|Overall Study|Disease Progression|27|||
105753059|NCT04124692|364748037|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
105753060|NCT04124692|364748036|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
105753061|NCT04124692|364748037|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
105753062|NCT04124692|364748036|FG000|Overall Study|Lost to Follow-up|2|||
105753063|NCT04124692|364748037|FG001|Overall Study|Lost to Follow-up|4|||
105753064|NCT04124692|364748036|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
105753065|NCT04124692|364748037|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
105753066|NCT00363051|364748038|FG000|Overall Study|Adminstrative problems|1|||
105566038|NCT04439136|364071043|FG000|Overall Study|Alternative Therapy|1|||
105566039|NCT04439136|364071043|FG000|Overall Study|Increased Tumor Burden|1|||
105566040|NCT04439136|364071043|FG000|Overall Study|Symptomatic Detrioration|1|||
105566041|NCT02347657|364071044|FG000|Overall Study|Physician Decision|0|||
105566042|NCT02347657|364071045|FG001|Overall Study|Physician Decision|1|||
105566043|NCT02347657|364071044|FG000|Overall Study|Adverse Event|8|||
105566044|NCT02347657|364071045|FG001|Overall Study|Adverse Event|4|||
105566045|NCT02347657|364071044|FG000|Overall Study|Withdrawal by Subject|6|||
105566046|NCT02347657|364071045|FG001|Overall Study|Withdrawal by Subject|7|||
105566047|NCT02347657|364071044|FG000|Overall Study|Randomized but not treated|1|||
105566048|NCT02347657|364071045|FG001|Overall Study|Randomized but not treated|0|||
105566049|NCT02347657|364071044|FG000|Overall Study|Other|3|||
105566050|NCT02347657|364071045|FG001|Overall Study|Other|3|||
105566051|NCT01264380|364071046|FG000|Period C|Disease Progression|0|||
105566052|NCT01264380|364071047|FG001|Period C|Disease Progression|0|||
105566053|NCT01264380|364071048|FG002|Period C|Disease Progression|4|||
105566054|NCT01264380|364071046|FG000|Period C|Death|0|||
105566055|NCT01264380|364071047|FG001|Period C|Death|0|||
105360385|NCT01765296|363325923|FG002|Overall Study|Lack of Efficacy|2|||
105566056|NCT01264380|364071048|FG002|Period C|Death|2|||
105566057|NCT01264380|364071046|FG000|Period C|Follow-up for survival status|0|||
105566058|NCT01264380|364071047|FG001|Period C|Follow-up for survival status|0|||
105566059|NCT01264380|364071048|FG002|Period C|Follow-up for survival status|6|||
105566060|NCT01264380|364071046|FG000|Period C|Withdrawal by Subject|0|||
105753067|NCT00363051|364748039|FG001|Overall Study|Adminstrative problems|1|||
105753068|NCT00363051|364748038|FG000|Overall Study|Adverse Event|21|||
105753069|NCT00363051|364748039|FG001|Overall Study|Adverse Event|12|||
105753070|NCT00363051|364748038|FG000|Overall Study|New Cancer Therapy|2|||
105753071|NCT00363051|364748039|FG001|Overall Study|New Cancer Therapy|1|||
105753072|NCT00363051|364748038|FG000|Overall Study|Withdrawal by Subject|11|||
105753073|NCT00363051|364748039|FG001|Overall Study|Withdrawal by Subject|3|||
105753074|NCT00363051|364748038|FG000|Overall Study|Lost to Follow-up|0|||
105753075|NCT00363051|364748039|FG001|Overall Study|Lost to Follow-up|1|||
105753076|NCT00363051|364748038|FG000|Overall Study|Protocol Violation|0|||
105753077|NCT00363051|364748039|FG001|Overall Study|Protocol Violation|2|||
105753078|NCT00363051|364748038|FG000|Overall Study|Death|3|||
105753079|NCT00363051|364748039|FG001|Overall Study|Death|2|||
105753080|NCT01957709|364748040|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
105753081|NCT00650091|364748054|FG000|Amended Study Design|Withdrawal by Subject|12|||
105753082|NCT00650091|364748055|FG001|Amended Study Design|Withdrawal by Subject|11|||
105753083|NCT00650091|364748056|FG002|Amended Study Design|Withdrawal by Subject|0|||
105753084|NCT00650091|364748054|FG000|Amended Study Design|Physician Decision|5|||
105753085|NCT00650091|364748055|FG001|Amended Study Design|Physician Decision|0|||
105753086|NCT00650091|364748056|FG002|Amended Study Design|Physician Decision|0|||
105753087|NCT00650091|364748054|FG000|Amended Study Design|Adverse Event|1|||
105753088|NCT00650091|364748055|FG001|Amended Study Design|Adverse Event|4|||
105753089|NCT00650091|364748056|FG002|Amended Study Design|Adverse Event|0|||
105753090|NCT00650091|364748054|FG000|Amended Study Design|Lung transplantation|4|||
105753091|NCT00650091|364748055|FG001|Amended Study Design|Lung transplantation|2|||
105753092|NCT00650091|364748056|FG002|Amended Study Design|Lung transplantation|0|||
105753093|NCT00650091|364748054|FG000|Amended Study Design|Other|1|||
105753094|NCT00650091|364748055|FG001|Amended Study Design|Other|3|||
105753095|NCT00650091|364748056|FG002|Amended Study Design|Other|0|||
105753096|NCT01204697|364748057|FG000|Overall Study|Death|26|||
105753097|NCT01204697|364748058|FG001|Overall Study|Death|27|||
105753098|NCT01204697|364748057|FG000|Overall Study|Lost to Follow-up|3|||
105753099|NCT01204697|364748058|FG001|Overall Study|Lost to Follow-up|4|||
105753100|NCT01204697|364748057|FG000|Overall Study|Withdrawal by Subject|2|||
105753101|NCT01204697|364748058|FG001|Overall Study|Withdrawal by Subject|4|||
105753102|NCT01204697|364748057|FG000|Overall Study|Randomized, but not treated|0|||
105753103|NCT01204697|364748058|FG001|Overall Study|Randomized, but not treated|1|||
105753104|NCT01677507|364748060|FG000|Initial Assignment|Adverse Event|0|||
105753105|NCT01677507|364748061|FG001|Initial Assignment|Adverse Event|1|||
105753106|NCT01677507|364748060|FG000|Initial Assignment|Protocol Violation|0|||
105753107|NCT01677507|364748061|FG001|Initial Assignment|Protocol Violation|1|||
105753108|NCT01677507|364748060|FG000|Second Assigment|Withdrawal by Subject|2|||
105753109|NCT01677507|364748061|FG001|Second Assigment|Withdrawal by Subject|2|||
105753110|NCT01677507|364748060|FG000|Second Assigment|Adverse Event|1|||
105753111|NCT01677507|364748061|FG001|Second Assigment|Adverse Event|3|||
105753112|NCT01194869|364748062|FG000|Overall Study|Disease Progression|2|||
105753113|NCT01194869|364748062|FG000|Overall Study|Toxicity|2|||
105753114|NCT00213980|364748063|FG000|Overall Study|Withdrawal by Subject|3|||
105753115|NCT00213980|364748064|FG001|Overall Study|Withdrawal by Subject|1|||
105753116|NCT00213980|364748063|FG000|Overall Study|Adverse Event|1|||
105753117|NCT00213980|364748064|FG001|Overall Study|Adverse Event|1|||
105753118|NCT00213980|364748063|FG000|Overall Study|Disease progression|0|||
105753119|NCT00213980|364748064|FG001|Overall Study|Disease progression|2|||
105753120|NCT00213980|364748063|FG000|Overall Study|Developed ovarian cancer|1|||
105753121|NCT00213980|364748064|FG001|Overall Study|Developed ovarian cancer|0|||
105753122|NCT00213980|364748063|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
105753123|NCT00213980|364748064|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
105753124|NCT00098020|364748074|FG000|Overall Study|Adverse Event|2|||
105753125|NCT00098020|364748074|FG000|Overall Study|Lost to Follow-up|1|||
105753126|NCT00098020|364748074|FG000|Overall Study|elevated liver enzymes|1|||
105753127|NCT00098020|364748074|FG000|Overall Study|Low urine PCR|1|||
105753128|NCT00098020|364748074|FG000|Overall Study|Low epidermal growth factor receptor|1|||
105753129|NCT01453998|364748076|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
105753130|NCT01453998|364748077|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
105753131|NCT01453998|364748078|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
105753132|NCT03495453|364748079|FG000|Overall Study|Withdrawal by Subject|0|||
105753133|NCT03495453|364748080|FG001|Overall Study|Withdrawal by Subject|1|||
105753134|NCT00085917|364748081|FG000|Overall Study|Adverse Event|4|||
105753135|NCT00085917|364748082|FG001|Overall Study|Adverse Event|3|||
105753136|NCT00209170|364748083|FG000|Overall Study|Adverse Event|0|||
105753137|NCT00209170|364748084|FG001|Overall Study|Adverse Event|1|||
105753138|NCT00209170|364748083|FG000|Overall Study|Withdrawal by Subject|2|||
105753139|NCT00209170|364748084|FG001|Overall Study|Withdrawal by Subject|1|||
105753140|NCT00209170|364748083|FG000|Overall Study|Lack of Efficacy|0|||
105753141|NCT00209170|364748084|FG001|Overall Study|Lack of Efficacy|1|||
105753142|NCT01879319|364748088|FG000|Overall Study|Withdrawal by Subject|1|||
105753143|NCT01879319|364748089|FG001|Overall Study|Withdrawal by Subject|0|||
105753144|NCT01879319|364748088|FG000|Overall Study|Lost to Follow-up|1|||
105753145|NCT01879319|364748089|FG001|Overall Study|Lost to Follow-up|5|||
105753146|NCT01360762|364748090|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
105753147|NCT01360762|364748090|FG000|Main Study Period (12-month Treatment)|Death|5|||
105753148|NCT01360762|364748090|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
105753149|NCT01360762|364748090|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
105753150|NCT01360762|364748090|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
105753151|NCT01360762|364748090|FG000|Whole Study Period|Lost to Follow-up|10|||
105753152|NCT01360762|364748090|FG000|Whole Study Period|Death|7|||
105753153|NCT01360762|364748090|FG000|Whole Study Period|Patient relapsed|18|||
105753154|NCT01360762|364748090|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
105753155|NCT02767856|364748091|FG000|Overall Study|Lost to Follow-up|9|||
105753156|NCT02767856|364748092|FG001|Overall Study|Lost to Follow-up|1|||
105753157|NCT02767856|364748091|FG000|Overall Study|Withdrawal by Subject|2|||
105753158|NCT02767856|364748092|FG001|Overall Study|Withdrawal by Subject|1|||
105753159|NCT00843843|364748095|FG000|Overall Study|Physician Decision|1|||
105753160|NCT00843843|364748096|FG001|Overall Study|Physician Decision|1|||
105753161|NCT00843843|364748095|FG000|Overall Study|Protocol Violation|1|||
105753162|NCT00843843|364748096|FG001|Overall Study|Protocol Violation|1|||
105753163|NCT00589979|364748097|FG000|Run-In Period|Adverse Event|5|||
105753164|NCT00589979|364748098|FG001|Run-In Period|Adverse Event|0|||
105360386|NCT01576575|363325924|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
105360387|NCT01576575|363325924|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
105360388|NCT01576575|363325924|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
105360389|NCT00627497|363325927|FG000|Overall Study|Lost to Follow-up|1|||
105360390|NCT00627497|363325928|FG001|Overall Study|Lost to Follow-up|1|||
105360391|NCT00627497|363325929|FG002|Overall Study|Lost to Follow-up|0|||
105360392|NCT00627497|363325930|FG003|Overall Study|Lost to Follow-up|0|||
105753165|NCT00589979|364748099|FG002|Run-In Period|Adverse Event|0|||
105753166|NCT00589979|364748097|FG000|Run-In Period|Protocol Violation|3|||
105753167|NCT00589979|364748098|FG001|Run-In Period|Protocol Violation|0|||
105360393|NCT06060496|363325931|FG000|Overall Study|Withdrawal by Subject|2|||
105360394|NCT06060496|363325931|FG000|Overall Study|Lost to Follow-up|2|||
105360395|NCT00186485|363325938|FG000|Overall Study|Lost to Follow-up|3|||
105360396|NCT03243305|363325942|FG000|Overall Study|Lost to Follow-up|250|||
105753168|NCT00589979|364748099|FG002|Run-In Period|Protocol Violation|0|||
105753169|NCT00589979|364748097|FG000|Run-In Period|Did not qualify for randomization|54|||
105753170|NCT00589979|364748098|FG001|Run-In Period|Did not qualify for randomization|0|||
105753171|NCT00589979|364748099|FG002|Run-In Period|Did not qualify for randomization|0|||
105753172|NCT00589979|364748097|FG000|Run-In Period|Withdrawal by Subject|10|||
105753173|NCT00589979|364748098|FG001|Run-In Period|Withdrawal by Subject|0|||
105753174|NCT00589979|364748099|FG002|Run-In Period|Withdrawal by Subject|0|||
105753175|NCT00589979|364748097|FG000|Run-In Period|Informed Consent Withdrawn|4|||
105753176|NCT00589979|364748098|FG001|Run-In Period|Informed Consent Withdrawn|0|||
105753177|NCT00589979|364748099|FG002|Run-In Period|Informed Consent Withdrawn|0|||
105753178|NCT00589979|364748097|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
105753179|NCT00589979|364748098|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
105753180|NCT00589979|364748099|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
105753181|NCT00589979|364748097|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
105753182|NCT00589979|364748098|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
105753183|NCT00589979|364748099|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
105753184|NCT00589979|364748097|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
105753185|NCT00589979|364748098|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
105753186|NCT00589979|364748099|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
105753187|NCT00589979|364748097|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
105753188|NCT00589979|364748098|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
105753189|NCT00589979|364748099|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
105753190|NCT00589979|364748097|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
105753191|NCT00589979|364748098|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
105753192|NCT00589979|364748099|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
105753193|NCT00589979|364748097|FG000|Double-Blind Treatment Period 2|Other|0|||
105753194|NCT00589979|364748098|FG001|Double-Blind Treatment Period 2|Other|0|||
105753195|NCT00589979|364748099|FG002|Double-Blind Treatment Period 2|Other|1|||
105753196|NCT00589979|364748097|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
105753197|NCT00589979|364748098|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
105753198|NCT00589979|364748099|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
105753199|NCT00589979|364748097|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
105753200|NCT00589979|364748098|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
105753201|NCT00589979|364748099|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
105753202|NCT00976950|364748100|FG000|Overall Study|Adverse Event|3|||
105753203|NCT00976950|364748100|FG000|Overall Study|Events with no relationship to Aptivus|3|||
105753204|NCT02662985|364748101|FG000|Treatment Period 1|Adverse Event|0|||
105753205|NCT02662985|364748102|FG001|Treatment Period 1|Adverse Event|2|||
105753206|NCT02662985|364748101|FG000|Treatment Period 1|Protocol Violation|0|||
105753207|NCT02662985|364748102|FG001|Treatment Period 1|Protocol Violation|1|||
105753208|NCT02662985|364748101|FG000|Treatment Period 1|Physician Decision|1|||
105753209|NCT02662985|364748102|FG001|Treatment Period 1|Physician Decision|0|||
105753210|NCT02662985|364748101|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105753211|NCT02662985|364748102|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105753212|NCT02662985|364748101|FG000|Treatment Period 2|Lack of Efficacy|0|||
105753213|NCT02662985|364748102|FG001|Treatment Period 2|Lack of Efficacy|1|||
105753214|NCT02662985|364748101|FG000|Treatment Period 2|Lost to Follow-up|1|||
105753215|NCT02662985|364748102|FG001|Treatment Period 2|Lost to Follow-up|0|||
105753216|NCT02662985|364748101|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
105753217|NCT02662985|364748102|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
105753218|NCT02662985|364748101|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
105753219|NCT02662985|364748102|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
105753220|NCT02662985|364748101|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
105753221|NCT02662985|364748102|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
105753222|NCT02662985|364748101|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
105753223|NCT02662985|364748102|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
105753224|NCT02662985|364748101|FG000|Treatment Period 3 (Extension Period)|Death|0|||
105753225|NCT02662985|364748102|FG001|Treatment Period 3 (Extension Period)|Death|1|||
105753226|NCT01397448|364748103|FG000|Overall Study|Adverse Event|4|||
105753227|NCT01397448|364748104|FG001|Overall Study|Adverse Event|4|||
105753228|NCT01397448|364748105|FG002|Overall Study|Adverse Event|6|||
105753229|NCT01397448|364748103|FG000|Overall Study|Withdrawal by Subject|4|||
105753230|NCT01397448|364748104|FG001|Overall Study|Withdrawal by Subject|4|||
105753231|NCT01397448|364748105|FG002|Overall Study|Withdrawal by Subject|3|||
105753232|NCT01397448|364748103|FG000|Overall Study|Lack of Efficacy|2|||
105753233|NCT01397448|364748104|FG001|Overall Study|Lack of Efficacy|0|||
105753234|NCT01397448|364748105|FG002|Overall Study|Lack of Efficacy|5|||
105753235|NCT01397448|364748103|FG000|Overall Study|Other|8|||
105753236|NCT01397448|364748104|FG001|Overall Study|Other|7|||
105753237|NCT01397448|364748105|FG002|Overall Study|Other|4|||
105753238|NCT01511107|364748106|FG000|Overall Study|Ineligible|3|||
105753239|NCT01511107|364748107|FG001|Overall Study|Ineligible|2|||
105753240|NCT01511107|364748106|FG000|Overall Study|Lost to Follow-up|10|||
105753241|NCT01511107|364748107|FG001|Overall Study|Lost to Follow-up|19|||
105753242|NCT01511107|364748106|FG000|Overall Study|Withdrawal by Subject|9|||
105753243|NCT01511107|364748107|FG001|Overall Study|Withdrawal by Subject|20|||
105753244|NCT02120157|364748110|FG000|Overall Study|Death|8|||
105753245|NCT00441103|364748114|FG000|Overall Study|Adverse Event|2|||
105753246|NCT00441103|364748115|FG001|Overall Study|Adverse Event|1|||
105753247|NCT00441103|364748114|FG000|Overall Study|Death|1|||
105753248|NCT00441103|364748115|FG001|Overall Study|Death|0|||
105753249|NCT00441103|364748114|FG000|Overall Study|Disease Progression|2|||
105753250|NCT00441103|364748115|FG001|Overall Study|Disease Progression|0|||
105753251|NCT00441103|364748114|FG000|Overall Study|Lost to Follow-up|1|||
105753252|NCT00441103|364748115|FG001|Overall Study|Lost to Follow-up|0|||
105753253|NCT00441103|364748114|FG000|Overall Study|Protocol Violation|1|||
105753254|NCT00441103|364748115|FG001|Overall Study|Protocol Violation|0|||
105753255|NCT00441103|364748114|FG000|Overall Study|Participant unable to use Rebiject II|1|||
105753256|NCT00441103|364748115|FG001|Overall Study|Participant unable to use Rebiject II|0|||
105753257|NCT00441103|364748114|FG000|Overall Study|Participant refused MRI|1|||
105753258|NCT00441103|364748115|FG001|Overall Study|Participant refused MRI|0|||
105753259|NCT00441103|364748114|FG000|Overall Study|Inclusion criteria absent|1|||
105753260|NCT00441103|364748115|FG001|Overall Study|Inclusion criteria absent|0|||
105753261|NCT00441103|364748114|FG000|Overall Study|Non-compliant|0|||
105753262|NCT00441103|364748115|FG001|Overall Study|Non-compliant|1|||
105753263|NCT00441103|364748114|FG000|Overall Study|Participant decided to withdraw|1|||
105753264|NCT00441103|364748115|FG001|Overall Study|Participant decided to withdraw|0|||
105753265|NCT00441103|364748114|FG000|Overall Study|Participant's reason|0|||
105753266|NCT00441103|364748115|FG001|Overall Study|Participant's reason|1|||
105753267|NCT00441103|364748114|FG000|Overall Study|Participant decided to stop|0|||
105753268|NCT00441103|364748115|FG001|Overall Study|Participant decided to stop|1|||
105753269|NCT01577160|364748116|FG000|Overall Study|Adverse Event|9|||
105753270|NCT01577160|364748116|FG000|Overall Study|Lack of Efficacy|15|||
105753271|NCT01577160|364748116|FG000|Overall Study|Lost to Follow-up|40|||
105753272|NCT01577160|364748116|FG000|Overall Study|Withdrawal by Subject|18|||
105753273|NCT01577160|364748116|FG000|Overall Study|Subject Uncooperative|7|||
105753274|NCT01577160|364748116|FG000|Overall Study|Other|9|||
105753275|NCT01029886|364748120|FG000|Overall Study|Adverse Event|12|||
105753276|NCT01029886|364748121|FG001|Overall Study|Adverse Event|25|||
105753277|NCT01029886|364748120|FG000|Overall Study|Lost to Follow-up|1|||
105566061|NCT01264380|364071047|FG001|Period C|Withdrawal by Subject|0|||
105566062|NCT01264380|364071048|FG002|Period C|Withdrawal by Subject|1|||
105566063|NCT01264380|364071046|FG000|Period C|Adverse Event|0|||
105566064|NCT01264380|364071047|FG001|Period C|Adverse Event|0|||
105566065|NCT01264380|364071048|FG002|Period C|Adverse Event|1|||
105566066|NCT02013388|364071051|FG000|Overall Study|work emergency|1|||
105566067|NCT02013388|364071052|FG001|Overall Study|work emergency|0|||
105566068|NCT02013388|364071053|FG002|Overall Study|work emergency|0|||
105566069|NCT02013388|364071054|FG003|Overall Study|work emergency|0|||
105566070|NCT02013388|364071055|FG004|Overall Study|work emergency|1|||
105566071|NCT02013388|364071056|FG005|Overall Study|work emergency|0|||
105566072|NCT02013388|364071057|FG006|Overall Study|work emergency|0|||
105566073|NCT02013388|364071058|FG007|Overall Study|work emergency|0|||
105566074|NCT00429663|364071059|FG000|Overall Study|Lost to Follow-up|24|||
105566075|NCT00429663|364071060|FG001|Overall Study|Lost to Follow-up|31|||
105566076|NCT00429663|364071059|FG000|Overall Study|Physician Decision|6|||
105566077|NCT00429663|364071060|FG001|Overall Study|Physician Decision|3|||
105566078|NCT00429663|364071059|FG000|Overall Study|Withdrawal by Subject|2|||
105566079|NCT00429663|364071060|FG001|Overall Study|Withdrawal by Subject|5|||
105566080|NCT00429663|364071059|FG000|Overall Study|Death|4|||
105566081|NCT00429663|364071060|FG001|Overall Study|Death|0|||
105566082|NCT00508404|364071066|FG000|Overall Study|Ongoing at Data Cut-off|12|||
105566083|NCT00508404|364071066|FG000|Overall Study|Adverse Event|2|||
105566084|NCT00508404|364071066|FG000|Overall Study|Death|16|||
105566085|NCT00508404|364071066|FG000|Overall Study|Physician Decision|2|||
105566086|NCT00508404|364071066|FG000|Overall Study|Withdrawal by Subject|3|||
105566087|NCT00508404|364071066|FG000|Overall Study|Protocol-specified Criteria|2|||
105566088|NCT00508404|364071066|FG000|Overall Study|Lost to Follow-up|2|||
105566089|NCT00508404|364071066|FG000|Overall Study|Other - Not Specified|3|||
105566090|NCT01559454|364071067|FG000|Overall Study|Lost to Follow-up|3|||
105566091|NCT01559454|364071068|FG001|Overall Study|Lost to Follow-up|2|||
105566092|NCT01559454|364071067|FG000|Overall Study|Withdrawal by Subject|0|||
105566093|NCT01559454|364071068|FG001|Overall Study|Withdrawal by Subject|1|||
105566094|NCT01559454|364071067|FG000|Overall Study|Physician Decision|0|||
105566095|NCT01559454|364071068|FG001|Overall Study|Physician Decision|1|||
105566096|NCT01559454|364071067|FG000|Overall Study|Protocol Violation|0|||
105566097|NCT01559454|364071068|FG001|Overall Study|Protocol Violation|1|||
105566098|NCT01559454|364071067|FG000|Overall Study|Lack of Efficacy|0|||
105566099|NCT01559454|364071068|FG001|Overall Study|Lack of Efficacy|1|||
105566100|NCT01119768|364071069|FG000|Treatment Period|Lack of Efficacy|18|||
105566101|NCT01119768|364071070|FG001|Treatment Period|Lack of Efficacy|25|||
105566102|NCT00674570|364071072|FG000|Overall Study|Withdrawal by Subject|0|||
105566103|NCT00674570|364071073|FG001|Overall Study|Withdrawal by Subject|2|||
105566104|NCT00674570|364071074|FG002|Overall Study|Withdrawal by Subject|0|||
105566105|NCT01337986|364071075|FG000|Overall Study|Adverse Event|2|||
105566106|NCT01337986|364071076|FG001|Overall Study|Adverse Event|2|||
105566107|NCT01337986|364071075|FG000|Overall Study|Lost to Follow-up|1|||
105566108|NCT01337986|364071076|FG001|Overall Study|Lost to Follow-up|0|||
105566109|NCT01337986|364071075|FG000|Overall Study|Protocol Violation|0|||
105566110|NCT01337986|364071076|FG001|Overall Study|Protocol Violation|3|||
105566111|NCT00058422|364071079|FG000|Overall Study|Not treated|2|||
105566112|NCT01520402|364071081|FG000|Overall Study|Withdrawal by Subject|2|||
105566113|NCT01520402|364071081|FG000|Overall Study|Physician Decision|3|||
105566114|NCT00106184|364071094|FG000|Overall Study|Withdrawal by Subject|3|||
105566115|NCT00106184|364071095|FG001|Overall Study|Withdrawal by Subject|2|||
105566116|NCT00643123|364071102|FG000|Overall Study|Lost to Follow-up|4|||
105566117|NCT00643123|364071103|FG001|Overall Study|Lost to Follow-up|0|||
105566118|NCT00643123|364071102|FG000|Overall Study|Withdrawal by Subject|1|||
105566119|NCT00643123|364071103|FG001|Overall Study|Withdrawal by Subject|1|||
105566120|NCT02569437|364071110|FG000|Overall Study|Lost to Follow-up|12|||
105566121|NCT02569437|364071111|FG001|Overall Study|Lost to Follow-up|14|||
105566122|NCT00441701|364071112|FG000|Overall Study|Adverse Event|3|||
105360397|NCT03243305|363325942|FG000|Overall Study|Withdrawal by Subject|170|||
105360398|NCT03243305|363325942|FG000|Overall Study|Pregnancy|104|||
105360399|NCT03243305|363325942|FG000|Overall Study|Non-Compliance with Study Drug|38|||
105360400|NCT03243305|363325942|FG000|Overall Study|Adverse Event|23|||
105566123|NCT00441701|364071113|FG001|Overall Study|Adverse Event|2|||
105566124|NCT00441701|364071114|FG002|Overall Study|Adverse Event|1|||
105566125|NCT00441701|364071115|FG003|Overall Study|Adverse Event|0|||
105566126|NCT00441701|364071116|FG004|Overall Study|Adverse Event|2|||
105566127|NCT00441701|364071117|FG005|Overall Study|Adverse Event|2|||
105566128|NCT00441701|364071118|FG006|Overall Study|Adverse Event|0|||
105566129|NCT00441701|364071119|FG007|Overall Study|Adverse Event|0|||
105566130|NCT00441701|364071120|FG008|Overall Study|Adverse Event|0|||
105566131|NCT00441701|364071121|FG009|Overall Study|Adverse Event|0|||
105566132|NCT00441701|364071112|FG000|Overall Study|Lack of Efficacy|2|||
105566133|NCT00441701|364071113|FG001|Overall Study|Lack of Efficacy|0|||
105566134|NCT00441701|364071114|FG002|Overall Study|Lack of Efficacy|2|||
105566135|NCT00441701|364071115|FG003|Overall Study|Lack of Efficacy|2|||
105566136|NCT00441701|364071116|FG004|Overall Study|Lack of Efficacy|0|||
105753278|NCT01029886|364748121|FG001|Overall Study|Lost to Follow-up|0|||
105753279|NCT01029886|364748120|FG000|Overall Study|Physician Decision|2|||
105753280|NCT01029886|364748121|FG001|Overall Study|Physician Decision|6|||
105753281|NCT01029886|364748120|FG000|Overall Study|Protocol Violation|17|||
105753282|NCT01029886|364748121|FG001|Overall Study|Protocol Violation|5|||
105753283|NCT01029886|364748120|FG000|Overall Study|Withdrawal by Subject|8|||
105753284|NCT01029886|364748121|FG001|Overall Study|Withdrawal by Subject|18|||
105753285|NCT01029886|364748120|FG000|Overall Study|Entry Criteria Not Met|13|||
105753286|NCT01029886|364748121|FG001|Overall Study|Entry Criteria Not Met|5|||
105753287|NCT01029886|364748120|FG000|Overall Study|Sponsor Decision|1|||
105753288|NCT01029886|364748121|FG001|Overall Study|Sponsor Decision|0|||
105753289|NCT01029886|364748120|FG000|Overall Study|Loss Glucose Control|7|||
105753290|NCT01029886|364748121|FG001|Overall Study|Loss Glucose Control|1|||
105753291|NCT00417976|364748124|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
105753292|NCT00417976|364748124|FG000|Overall Study|Treatment -related toxicity|2|||
105753293|NCT00645567|364748129|FG000|Overall Study|Adverse Event|1|||
105753294|NCT04664855|364748130|FG000|Overall Study|Withdrawal by Subject|0|||
105753295|NCT04664855|364748131|FG001|Overall Study|Withdrawal by Subject|2|||
105753296|NCT05127421|364748132|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
105753297|NCT05127421|364748133|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
105753298|NCT05127421|364748134|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
105753299|NCT05127421|364748135|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
105753300|NCT05127421|364748132|FG000|4-Week Double-Blind Period|Physician Decision|1|||
105753301|NCT05127421|364748133|FG001|4-Week Double-Blind Period|Physician Decision|0|||
105753302|NCT05127421|364748134|FG002|4-Week Double-Blind Period|Physician Decision|0|||
105753303|NCT05127421|364748135|FG003|4-Week Double-Blind Period|Physician Decision|0|||
105753304|NCT05127421|364748132|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
105753305|NCT05127421|364748133|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
105753306|NCT05127421|364748134|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
105753307|NCT05127421|364748135|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
105753308|NCT05127421|364748132|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
105753309|NCT05127421|364748133|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
105753310|NCT05127421|364748134|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
105753311|NCT05127421|364748135|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
105753312|NCT05127421|364748132|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
105753313|NCT05127421|364748133|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
105753314|NCT05127421|364748134|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
105753315|NCT05127421|364748135|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
105753316|NCT05127421|364748132|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
105753317|NCT05127421|364748133|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
105753318|NCT05127421|364748134|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
105753319|NCT05127421|364748135|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
105753320|NCT05127421|364748132|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
105753321|NCT05127421|364748133|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
105753322|NCT05127421|364748134|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
105753323|NCT05127421|364748135|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
105753324|NCT05127421|364748132|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
105753325|NCT05127421|364748133|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
105753326|NCT05127421|364748134|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
105753327|NCT05127421|364748135|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
105753328|NCT02219087|364748136|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
105753329|NCT02219087|364748137|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
105753330|NCT00255086|364748138|FG000|Overall Study|Adverse Event|1|||
105753331|NCT00255086|364748139|FG001|Overall Study|Adverse Event|1|||
105753332|NCT00255086|364748138|FG000|Overall Study|Protocol Violation|1|||
105753333|NCT00255086|364748139|FG001|Overall Study|Protocol Violation|1|||
105753334|NCT02365584|364748148|FG000|Overall Study|Adverse Event|2|||
105753335|NCT02365584|364748149|FG001|Overall Study|Adverse Event|2|||
105753336|NCT02365584|364748148|FG000|Overall Study|Withdrawal by Subject|1|||
105753337|NCT02365584|364748149|FG001|Overall Study|Withdrawal by Subject|0|||
105753338|NCT02365584|364748148|FG000|Overall Study|Disease Progression|9|||
105753339|NCT02365584|364748149|FG001|Overall Study|Disease Progression|12|||
105753340|NCT00632541|364748150|FG000|Overall Study|Adverse Event|7|||
105753341|NCT01842607|364748152|FG000|Overall Study|Adverse Event|11|||
105753342|NCT01842607|364748152|FG000|Overall Study|Lack of Efficacy|19|||
105753343|NCT01842607|364748152|FG000|Overall Study|Protocol Violation|8|||
105753344|NCT01842607|364748152|FG000|Overall Study|Protocol defined stopping criteria|2|||
105753345|NCT01842607|364748152|FG000|Overall Study|Lost to Follow-up|3|||
105753346|NCT01842607|364748152|FG000|Overall Study|Physician Decision|9|||
105753347|NCT01842607|364748152|FG000|Overall Study|Withdrawal by Subject|14|||
105753348|NCT00012012|364748153|FG000|Overall Study|Protocol Violation|1|||
105753349|NCT00012012|364748154|FG001|Overall Study|Protocol Violation|1|||
105753350|NCT00012012|364748153|FG000|Overall Study|Withdrawal by Subject|0|||
105753351|NCT00012012|364748154|FG001|Overall Study|Withdrawal by Subject|2|||
105753352|NCT03519516|364748155|FG000|Overall Study|Adverse Event|0|||
105753353|NCT03519516|364748156|FG001|Overall Study|Adverse Event|1|||
105753354|NCT00964158|364748157|FG000|Overall Study|Lost to Follow-up|0|||
105753355|NCT00964158|364748158|FG001|Overall Study|Lost to Follow-up|1|||
105753356|NCT00964158|364748159|FG002|Overall Study|Lost to Follow-up|2|||
105753357|NCT00964158|364748157|FG000|Overall Study|Withdrawal by Subject|0|||
105753358|NCT00964158|364748158|FG001|Overall Study|Withdrawal by Subject|0|||
105753359|NCT00964158|364748159|FG002|Overall Study|Withdrawal by Subject|6|||
105753360|NCT02721251|364748160|FG000|Overall Study|Withdrawal by Subject|8|||
105753361|NCT02721251|364748161|FG001|Overall Study|Withdrawal by Subject|7|||
105753362|NCT02721251|364748162|FG002|Overall Study|Withdrawal by Subject|9|||
105753363|NCT02721251|364748160|FG000|Overall Study|poor adherence|2|||
105753364|NCT02721251|364748161|FG001|Overall Study|poor adherence|2|||
105753365|NCT02721251|364748162|FG002|Overall Study|poor adherence|2|||
105753366|NCT02017899|364750141|FG000|Overall Study|Withdrawal by Subject|0|||
105753367|NCT02017899|364750142|FG001|Overall Study|Withdrawal by Subject|0|||
105753368|NCT02017899|364750143|FG002|Overall Study|Withdrawal by Subject|0|||
105753369|NCT02017899|364750144|FG003|Overall Study|Withdrawal by Subject|1|||
105753370|NCT02017899|364750145|FG004|Overall Study|Withdrawal by Subject|1|||
105753371|NCT02017899|364750146|FG005|Overall Study|Withdrawal by Subject|0|||
105753372|NCT01146951|364750147|FG000|Overall Study|Adverse Event|4|||
105753373|NCT01146951|364750148|FG001|Overall Study|Adverse Event|1|||
105753374|NCT02126670|364750149|FG000|Overall Study|Withdrawal by Subject|1|||
105753375|NCT02126670|364750150|FG001|Overall Study|Withdrawal by Subject|0|||
105753376|NCT02126670|364750151|FG002|Overall Study|Withdrawal by Subject|0|||
105753377|NCT02126670|364750152|FG003|Overall Study|Withdrawal by Subject|1|||
105753378|NCT03363919|364750153|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
105753379|NCT03363919|364750154|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
105753380|NCT03363919|364750153|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
105753381|NCT03363919|364750154|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
105753382|NCT00424346|364750155|FG000|Core Study|Adverse Event|5|||
105753383|NCT00424346|364750156|FG001|Core Study|Adverse Event|3|||
105753384|NCT00424346|364750157|FG002|Core Study|Adverse Event|1|||
105753385|NCT00424346|364750158|FG003|Core Study|Adverse Event|1|||
105753386|NCT00424346|364750155|FG000|Core Study|Abnormal Laboratory Values|0|||
105753387|NCT00424346|364750156|FG001|Core Study|Abnormal Laboratory Values|1|||
105753388|NCT00424346|364750157|FG002|Core Study|Abnormal Laboratory Values|0|||
105753389|NCT00424346|364750158|FG003|Core Study|Abnormal Laboratory Values|0|||
105753390|NCT00424346|364750155|FG000|Core Study|Lack of Efficacy|1|||
105753391|NCT00424346|364750156|FG001|Core Study|Lack of Efficacy|3|||
105753392|NCT00424346|364750157|FG002|Core Study|Lack of Efficacy|0|||
105753393|NCT00424346|364750158|FG003|Core Study|Lack of Efficacy|4|||
105753394|NCT00424346|364750155|FG000|Core Study|Withdrawal by Subject|1|||
105753395|NCT00424346|364750156|FG001|Core Study|Withdrawal by Subject|0|||
105753396|NCT00424346|364750157|FG002|Core Study|Withdrawal by Subject|0|||
105753397|NCT00424346|364750158|FG003|Core Study|Withdrawal by Subject|2|||
105566137|NCT00441701|364071117|FG005|Overall Study|Lack of Efficacy|1|||
105566138|NCT00441701|364071118|FG006|Overall Study|Lack of Efficacy|0|||
105566139|NCT00441701|364071119|FG007|Overall Study|Lack of Efficacy|0|||
105566140|NCT00441701|364071120|FG008|Overall Study|Lack of Efficacy|0|||
105566141|NCT00441701|364071121|FG009|Overall Study|Lack of Efficacy|0|||
105566142|NCT00441701|364071112|FG000|Overall Study|Withdrawal by Subject|0|||
105566143|NCT00441701|364071113|FG001|Overall Study|Withdrawal by Subject|2|||
105566144|NCT00441701|364071114|FG002|Overall Study|Withdrawal by Subject|1|||
105566145|NCT00441701|364071115|FG003|Overall Study|Withdrawal by Subject|1|||
105566146|NCT00441701|364071116|FG004|Overall Study|Withdrawal by Subject|0|||
105566147|NCT00441701|364071117|FG005|Overall Study|Withdrawal by Subject|0|||
105566148|NCT00441701|364071118|FG006|Overall Study|Withdrawal by Subject|0|||
105566149|NCT00441701|364071119|FG007|Overall Study|Withdrawal by Subject|0|||
105566150|NCT00441701|364071120|FG008|Overall Study|Withdrawal by Subject|0|||
105566151|NCT00441701|364071121|FG009|Overall Study|Withdrawal by Subject|0|||
105566152|NCT00077064|364071122|FG000|Overall Study|Adverse Event|0|||
105566153|NCT00077064|364071123|FG001|Overall Study|Adverse Event|4|||
105566154|NCT00077064|364071122|FG000|Overall Study|Patient refusal|0|||
105566155|NCT00077064|364071123|FG001|Overall Study|Patient refusal|2|||
105566156|NCT02007434|364071124|FG000|Overall Study|Lost to Follow-up|0|||
105566157|NCT02007434|364071125|FG001|Overall Study|Lost to Follow-up|1|||
105566158|NCT02007434|364071126|FG002|Overall Study|Lost to Follow-up|0|||
105566159|NCT02007434|364071127|FG003|Overall Study|Lost to Follow-up|0|||
105566160|NCT02007434|364071128|FG004|Overall Study|Lost to Follow-up|0|||
105566161|NCT02007434|364071129|FG005|Overall Study|Lost to Follow-up|0|||
105566162|NCT02007434|364071130|FG006|Overall Study|Lost to Follow-up|0|||
105566163|NCT02007434|364071131|FG007|Overall Study|Lost to Follow-up|0|||
105566164|NCT02007434|364071124|FG000|Overall Study|Non-compliance|1|||
105566165|NCT02007434|364071125|FG001|Overall Study|Non-compliance|0|||
105566166|NCT02007434|364071126|FG002|Overall Study|Non-compliance|1|||
105566167|NCT02007434|364071127|FG003|Overall Study|Non-compliance|0|||
105566168|NCT02007434|364071128|FG004|Overall Study|Non-compliance|0|||
105566169|NCT02007434|364071129|FG005|Overall Study|Non-compliance|0|||
105566170|NCT02007434|364071130|FG006|Overall Study|Non-compliance|0|||
105566171|NCT02007434|364071131|FG007|Overall Study|Non-compliance|0|||
105753398|NCT00424346|364750155|FG000|Core Study|Lost to Follow-up|1|||
105753399|NCT00424346|364750156|FG001|Core Study|Lost to Follow-up|1|||
105753400|NCT00424346|364750157|FG002|Core Study|Lost to Follow-up|0|||
105753401|NCT00424346|364750158|FG003|Core Study|Lost to Follow-up|0|||
105360401|NCT03243305|363325942|FG000|Overall Study|No sexually active|26|||
105566172|NCT03299686|364071132|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
105566173|NCT03299686|364071133|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
105753402|NCT00424346|364750155|FG000|Core Study|Administrative Problems|1|||
105566174|NCT03299686|364071132|FG000|Treatment Epoch|Physician Decision|1|||
105566175|NCT03299686|364071133|FG001|Treatment Epoch|Physician Decision|0|||
105566176|NCT03299686|364071132|FG000|Treatment Epoch|Adverse Event|8|||
105566177|NCT03299686|364071133|FG001|Treatment Epoch|Adverse Event|4|||
105566178|NCT03299686|364071132|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
105566179|NCT03299686|364071133|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
105566180|NCT02535364|364071134|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
105566181|NCT02535364|364071134|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
105566182|NCT02535364|364071134|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
105566183|NCT02535364|364071134|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
105566184|NCT02535364|364071134|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
105566185|NCT02535364|364071134|FG000|Part B Screening|Death|2|||
105566186|NCT02535364|364071134|FG000|Part B Screening|Physician Decision|1|||
105566187|NCT02535364|364071134|FG000|Part B Screening|Withdrawal by Subject|1|||
105566188|NCT02535364|364071134|FG000|Part B Screening|Adverse Event|1|||
105566189|NCT02535364|364071134|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
105566190|NCT02535364|364071134|FG000|Study Treatment|Death|1|||
105566191|NCT02535364|364071134|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
105566192|NCT02535364|364071134|FG000|12-Month Follow-up Period|Disease progression|22|||
105566193|NCT02535364|364071134|FG000|12-Month Follow-up Period|Death|5|||
105566194|NCT02535364|364071134|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
105566195|NCT02535364|364071134|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
105566196|NCT02535364|364071134|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
105566197|NCT00571701|364071135|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
105566198|NCT00571701|364071136|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
105566199|NCT00571701|364071135|FG000|First Intervention 12 Months|Death|1|||
105566200|NCT00571701|364071136|FG001|First Intervention 12 Months|Death|0|||
105566201|NCT00571701|364071135|FG000|Second Intervention 12 Months|Adverse Event|0|||
105566202|NCT00571701|364071136|FG001|Second Intervention 12 Months|Adverse Event|1|||
105566203|NCT00571701|364071135|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
105566204|NCT00571701|364071136|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
105566205|NCT02634788|364071137|FG000|Overall Study|Adverse Event|0|||
105566206|NCT02634788|364071138|FG001|Overall Study|Adverse Event|8|||
105566207|NCT02634788|364071139|FG002|Overall Study|Adverse Event|3|||
105566208|NCT02634788|364071140|FG003|Overall Study|Adverse Event|1|||
105566209|NCT02634788|364071137|FG000|Overall Study|Lack of Efficacy|4|||
105566210|NCT02634788|364071138|FG001|Overall Study|Lack of Efficacy|0|||
105566211|NCT02634788|364071139|FG002|Overall Study|Lack of Efficacy|1|||
105566212|NCT02634788|364071140|FG003|Overall Study|Lack of Efficacy|4|||
105566213|NCT02634788|364071137|FG000|Overall Study|Lost to Follow-up|0|||
105566214|NCT02634788|364071138|FG001|Overall Study|Lost to Follow-up|1|||
105566215|NCT02634788|364071139|FG002|Overall Study|Lost to Follow-up|0|||
105566216|NCT02634788|364071140|FG003|Overall Study|Lost to Follow-up|0|||
105566217|NCT02634788|364071137|FG000|Overall Study|Withdrawal by Subject|0|||
105566218|NCT02634788|364071138|FG001|Overall Study|Withdrawal by Subject|1|||
105566219|NCT02634788|364071139|FG002|Overall Study|Withdrawal by Subject|1|||
105566220|NCT02634788|364071140|FG003|Overall Study|Withdrawal by Subject|0|||
105566221|NCT00855595|364071141|FG000|Overall Study|Withdrawal by Subject|1|||
105566222|NCT00855595|364071142|FG001|Overall Study|Withdrawal by Subject|2|||
105566223|NCT00855595|364071141|FG000|Overall Study|Lost to Follow-up|3|||
105566224|NCT00855595|364071142|FG001|Overall Study|Lost to Follow-up|3|||
105566225|NCT00855595|364071141|FG000|Overall Study|Adverse Event|1|||
105566226|NCT00855595|364071142|FG001|Overall Study|Adverse Event|1|||
105566227|NCT00855595|364071141|FG000|Overall Study|patient moved out of state|1|||
105566228|NCT00855595|364071142|FG001|Overall Study|patient moved out of state|0|||
105566229|NCT00855595|364071141|FG000|Overall Study|patient left country|0|||
105566230|NCT00855595|364071142|FG001|Overall Study|patient left country|1|||
105566231|NCT01060553|364071143|FG000|Overall Study|Lost to Follow-up|3|||
105566232|NCT01060553|364071144|FG001|Overall Study|Lost to Follow-up|5|||
105566233|NCT01060553|364071143|FG000|Overall Study|Withdrawal by Subject|5|||
105566234|NCT01060553|364071144|FG001|Overall Study|Withdrawal by Subject|5|||
105753403|NCT00424346|364750156|FG001|Core Study|Administrative Problems|0|||
105753404|NCT00424346|364750157|FG002|Core Study|Administrative Problems|1|||
105753405|NCT00424346|364750158|FG003|Core Study|Administrative Problems|0|||
105753406|NCT00424346|364750155|FG000|Core Study|Protocol Violation|0|||
105753407|NCT00424346|364750156|FG001|Core Study|Protocol Violation|0|||
105566235|NCT01060553|364071143|FG000|Overall Study|Lack of Efficacy|1|||
105566236|NCT01060553|364071144|FG001|Overall Study|Lack of Efficacy|0|||
105566237|NCT04035200|364071145|FG000|Overall Study|Lost to Follow-up|0|||
105753408|NCT00424346|364750157|FG002|Core Study|Protocol Violation|2|||
105753409|NCT00424346|364750158|FG003|Core Study|Protocol Violation|0|||
105753410|NCT00424346|364750155|FG000|Extension Phase|Adverse Event|0|||
105360402|NCT03243305|363325942|FG000|Overall Study|Physician Decision|22|||
105753411|NCT00424346|364750156|FG001|Extension Phase|Adverse Event|9|||
105753412|NCT00424346|364750157|FG002|Extension Phase|Adverse Event|5|||
105753413|NCT00424346|364750158|FG003|Extension Phase|Adverse Event|4|||
105753414|NCT00424346|364750155|FG000|Extension Phase|Lack of Efficacy|0|||
105753415|NCT00424346|364750156|FG001|Extension Phase|Lack of Efficacy|16|||
105753416|NCT00424346|364750157|FG002|Extension Phase|Lack of Efficacy|14|||
105753417|NCT00424346|364750158|FG003|Extension Phase|Lack of Efficacy|11|||
105753418|NCT00424346|364750155|FG000|Extension Phase|Withdrawal by Subject|0|||
105753419|NCT00424346|364750156|FG001|Extension Phase|Withdrawal by Subject|5|||
105753420|NCT00424346|364750157|FG002|Extension Phase|Withdrawal by Subject|3|||
105753421|NCT00424346|364750158|FG003|Extension Phase|Withdrawal by Subject|4|||
105753422|NCT00424346|364750155|FG000|Extension Phase|Lost to Follow-up|0|||
105753423|NCT00424346|364750156|FG001|Extension Phase|Lost to Follow-up|2|||
105753424|NCT00424346|364750157|FG002|Extension Phase|Lost to Follow-up|0|||
105753425|NCT00424346|364750158|FG003|Extension Phase|Lost to Follow-up|0|||
105753426|NCT00424346|364750155|FG000|Extension Phase|Administrative Problems|0|||
105753427|NCT00424346|364750156|FG001|Extension Phase|Administrative Problems|69|||
105753428|NCT00424346|364750157|FG002|Extension Phase|Administrative Problems|32|||
105753429|NCT00424346|364750158|FG003|Extension Phase|Administrative Problems|35|||
105753430|NCT00424346|364750155|FG000|Extension Phase|Death|0|||
105753431|NCT00424346|364750156|FG001|Extension Phase|Death|0|||
105753432|NCT00424346|364750157|FG002|Extension Phase|Death|0|||
105753433|NCT00424346|364750158|FG003|Extension Phase|Death|1|||
105753434|NCT00424346|364750155|FG000|Extension Phase|Protocol Violation|0|||
105753435|NCT00424346|364750156|FG001|Extension Phase|Protocol Violation|1|||
105753436|NCT00424346|364750157|FG002|Extension Phase|Protocol Violation|1|||
105753437|NCT00424346|364750158|FG003|Extension Phase|Protocol Violation|0|||
105753438|NCT00781963|364750161|FG000|Overall Study|Death|3|||
105753439|NCT00781963|364750162|FG001|Overall Study|Death|0|||
105753440|NCT00781963|364750161|FG000|Overall Study|Lost to Follow-up|2|||
105753441|NCT00781963|364750162|FG001|Overall Study|Lost to Follow-up|1|||
105753442|NCT00781963|364750161|FG000|Overall Study|Withdrawal by Subject|3|||
105753443|NCT00781963|364750162|FG001|Overall Study|Withdrawal by Subject|1|||
105753444|NCT00781963|364750161|FG000|Overall Study|Refused follow-up|9|||
105753445|NCT00781963|364750162|FG001|Overall Study|Refused follow-up|0|||
105753446|NCT02064205|364750163|FG000|Overall Study|Withdrawal by Subject|1|||
105753447|NCT01149343|364750170|FG000|Overall Study|Withdrawal by Subject|1|||
105753448|NCT01149343|364750171|FG001|Overall Study|Withdrawal by Subject|1|||
105753449|NCT01149343|364750172|FG002|Overall Study|Withdrawal by Subject|1|||
105753450|NCT01149343|364750173|FG003|Overall Study|Withdrawal by Subject|5|||
105753451|NCT01149343|364750170|FG000|Overall Study|Death|10|||
105753452|NCT01149343|364750171|FG001|Overall Study|Death|13|||
105753453|NCT01149343|364750172|FG002|Overall Study|Death|18|||
105753454|NCT01149343|364750173|FG003|Overall Study|Death|18|||
105566238|NCT04035200|364071146|FG001|Overall Study|Lost to Follow-up|1|||
105566239|NCT04035200|364071147|FG002|Overall Study|Lost to Follow-up|0|||
105753455|NCT01149343|364750170|FG000|Overall Study|Lost to Follow-up|1|||
105753456|NCT01149343|364750171|FG001|Overall Study|Lost to Follow-up|0|||
105753457|NCT01149343|364750172|FG002|Overall Study|Lost to Follow-up|0|||
105753458|NCT01149343|364750173|FG003|Overall Study|Lost to Follow-up|1|||
105566240|NCT04035200|364071145|FG000|Overall Study|Withdrawal by Subject|1|||
105753459|NCT01149343|364750170|FG000|Overall Study|Other|8|||
105753460|NCT01149343|364750171|FG001|Overall Study|Other|10|||
105753461|NCT01149343|364750172|FG002|Overall Study|Other|2|||
105753462|NCT01149343|364750173|FG003|Overall Study|Other|14|||
105753463|NCT01149343|364750170|FG000|Overall Study|Sponsor study termination|0|||
105566241|NCT04035200|364071146|FG001|Overall Study|Withdrawal by Subject|4|||
105566242|NCT04035200|364071147|FG002|Overall Study|Withdrawal by Subject|4|||
105753464|NCT01149343|364750171|FG001|Overall Study|Sponsor study termination|0|||
105753465|NCT01149343|364750172|FG002|Overall Study|Sponsor study termination|0|||
105753466|NCT01149343|364750173|FG003|Overall Study|Sponsor study termination|2|||
105753467|NCT01149343|364750170|FG000|Overall Study|Recurrence / Progressive disease|0|||
105753468|NCT01149343|364750171|FG001|Overall Study|Recurrence / Progressive disease|0|||
105753469|NCT01149343|364750172|FG002|Overall Study|Recurrence / Progressive disease|1|||
105753470|NCT01149343|364750173|FG003|Overall Study|Recurrence / Progressive disease|0|||
105753471|NCT02505542|364750192|FG000|Part A: Open-Label Period|Adverse Event|31|||
105753472|NCT02505542|364750193|FG001|Part A: Open-Label Period|Adverse Event|0|||
105753473|NCT02505542|364750194|FG002|Part A: Open-Label Period|Adverse Event|0|||
105753474|NCT02505542|364750195|FG003|Part A: Open-Label Period|Adverse Event|0|||
105753475|NCT02505542|364750192|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
105753476|NCT02505542|364750193|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
105760899|NCT01342952|364778052|FG000|Overall Study|Lost to Follow-up|0|||
105753477|NCT02505542|364750194|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
105753478|NCT02505542|364750195|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
105753479|NCT02505542|364750192|FG000|Part A: Open-Label Period|Protocol Violation|1|||
105753480|NCT02505542|364750193|FG001|Part A: Open-Label Period|Protocol Violation|0|||
105753481|NCT02505542|364750194|FG002|Part A: Open-Label Period|Protocol Violation|0|||
105753482|NCT02505542|364750195|FG003|Part A: Open-Label Period|Protocol Violation|0|||
105753483|NCT02505542|364750192|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
105753484|NCT02505542|364750193|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
105753485|NCT02505542|364750194|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
105753486|NCT02505542|364750195|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
105753487|NCT02505542|364750192|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
105753488|NCT02505542|364750193|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
105753489|NCT02505542|364750194|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
105753490|NCT02505542|364750195|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
105753491|NCT02505542|364750192|FG000|Part A: Open-Label Period|New medical history available|1|||
105753492|NCT02505542|364750193|FG001|Part A: Open-Label Period|New medical history available|0|||
105753493|NCT02505542|364750194|FG002|Part A: Open-Label Period|New medical history available|0|||
105753494|NCT02505542|364750195|FG003|Part A: Open-Label Period|New medical history available|0|||
105753495|NCT02505542|364750192|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
105753496|NCT02505542|364750193|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
105753497|NCT02505542|364750194|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
105753498|NCT02505542|364750195|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
105753499|NCT02505542|364750192|FG000|Part A: Open-Label Period|Pregnancy|2|||
105753500|NCT02505542|364750193|FG001|Part A: Open-Label Period|Pregnancy|0|||
105753501|NCT02505542|364750194|FG002|Part A: Open-Label Period|Pregnancy|0|||
105753502|NCT02505542|364750195|FG003|Part A: Open-Label Period|Pregnancy|0|||
105753503|NCT02505542|364750192|FG000|Part A: Open-Label Period|Sponsor directive|1|||
105753504|NCT02505542|364750193|FG001|Part A: Open-Label Period|Sponsor directive|0|||
105753505|NCT02505542|364750194|FG002|Part A: Open-Label Period|Sponsor directive|0|||
105753506|NCT02505542|364750195|FG003|Part A: Open-Label Period|Sponsor directive|0|||
105753507|NCT02505542|364750192|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
105753508|NCT02505542|364750193|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
105566243|NCT04035200|364071145|FG000|Overall Study|COVID-19|1|||
105566244|NCT04035200|364071146|FG001|Overall Study|COVID-19|0|||
105566245|NCT04035200|364071147|FG002|Overall Study|COVID-19|0|||
105566246|NCT04035200|364071145|FG000|Overall Study|Early Termination|0|||
105566247|NCT04035200|364071146|FG001|Overall Study|Early Termination|1|||
105566248|NCT04035200|364071147|FG002|Overall Study|Early Termination|0|||
105566249|NCT04035200|364071145|FG000|Overall Study|Non-compliance|0|||
105566250|NCT04035200|364071146|FG001|Overall Study|Non-compliance|1|||
105566251|NCT04035200|364071147|FG002|Overall Study|Non-compliance|0|||
105566252|NCT03138733|364071149|FG000|Overall Study|Death|17|||
105566253|NCT03138733|364071150|FG001|Overall Study|Death|18|||
105566254|NCT03138733|364071149|FG000|Overall Study|Withdrawal by Subject|11|||
105566255|NCT03138733|364071150|FG001|Overall Study|Withdrawal by Subject|6|||
105566256|NCT03138733|364071149|FG000|Overall Study|Lost to Follow-up|3|||
105566257|NCT03138733|364071150|FG001|Overall Study|Lost to Follow-up|2|||
105566258|NCT03138733|364071149|FG000|Overall Study|Adverse Event|1|||
105566259|NCT03138733|364071150|FG001|Overall Study|Adverse Event|0|||
105566260|NCT03138733|364071149|FG000|Overall Study|Protocol Violation|1|||
105566261|NCT03138733|364071150|FG001|Overall Study|Protocol Violation|3|||
105566262|NCT03138733|364071149|FG000|Overall Study|Administrative or logistical reason|1|||
105566263|NCT03138733|364071150|FG001|Overall Study|Administrative or logistical reason|0|||
105566264|NCT03138733|364071149|FG000|Overall Study|The patient was transferred to another hospital|1|||
105566265|NCT03138733|364071150|FG001|Overall Study|The patient was transferred to another hospital|0|||
105566266|NCT02063828|364071151|FG000|Overall Study|Withdrawal by Subject|4|||
105566267|NCT02063828|364071152|FG001|Overall Study|Withdrawal by Subject|6|||
105566268|NCT02063828|364071153|FG002|Overall Study|Withdrawal by Subject|3|||
105566269|NCT02063828|364071151|FG000|Overall Study|Death|0|||
105566270|NCT02063828|364071152|FG001|Overall Study|Death|0|||
105566271|NCT02063828|364071153|FG002|Overall Study|Death|1|||
105566272|NCT02178566|364071154|FG000|Overall Study|patient did not complete due to noncompliance|0|||
105566273|NCT02178566|364071155|FG001|Overall Study|patient did not complete due to noncompliance|1|||
105566274|NCT03764072|364071156|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
105566275|NCT03764072|364071157|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
105566276|NCT03764072|364071158|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
105566277|NCT03764072|364071159|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
105566278|NCT03764072|364071160|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
105566279|NCT03764072|364071161|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
105566280|NCT03764072|364071156|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
105566281|NCT03764072|364071157|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
105566282|NCT03764072|364071158|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
105566283|NCT03764072|364071159|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
105566284|NCT03764072|364071160|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
105566285|NCT03764072|364071161|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
105566286|NCT03764072|364071156|FG000|Overall Study|Lost to Follow-up|0|||
105566287|NCT03764072|364071157|FG001|Overall Study|Lost to Follow-up|0|||
105566288|NCT03764072|364071158|FG002|Overall Study|Lost to Follow-up|0|||
105566289|NCT03764072|364071159|FG003|Overall Study|Lost to Follow-up|0|||
105566290|NCT03764072|364071160|FG004|Overall Study|Lost to Follow-up|1|||
105566291|NCT03764072|364071161|FG005|Overall Study|Lost to Follow-up|0|||
105566292|NCT01122381|364071164|FG000|Overall Study|study terminated early|0|||
105566293|NCT01122381|364071165|FG001|Overall Study|study terminated early|1|||
105566294|NCT00941798|364071166|FG000|Overall Study|Withdrawal by Subject|72|||
105566295|NCT00941798|364071167|FG001|Overall Study|Withdrawal by Subject|74|||
105566296|NCT00941798|364071166|FG000|Overall Study|Adverse Event|43|||
105566297|NCT00941798|364071167|FG001|Overall Study|Adverse Event|23|||
105566298|NCT00941798|364071166|FG000|Overall Study|Lost to Follow-up|29|||
105566299|NCT00941798|364071167|FG001|Overall Study|Lost to Follow-up|23|||
105566300|NCT00941798|364071166|FG000|Overall Study|Protocol Violation|17|||
105566301|NCT00941798|364071167|FG001|Overall Study|Protocol Violation|20|||
105566302|NCT00941798|364071166|FG000|Overall Study|Administrative problems|13|||
105566303|NCT00941798|364071167|FG001|Overall Study|Administrative problems|23|||
105566304|NCT00941798|364071166|FG000|Overall Study|Lack of Efficacy|10|||
105753509|NCT02505542|364750194|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
105753510|NCT02505542|364750195|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
105566305|NCT00941798|364071167|FG001|Overall Study|Lack of Efficacy|17|||
105566306|NCT00941798|364071166|FG000|Overall Study|Patient's inability to use device|6|||
105566307|NCT00941798|364071167|FG001|Overall Study|Patient's inability to use device|1|||
105566308|NCT00941798|364071166|FG000|Overall Study|Abnormal test procedure results|3|||
105566309|NCT00941798|364071167|FG001|Overall Study|Abnormal test procedure results|1|||
105566310|NCT00941798|364071166|FG000|Overall Study|Abnormal laboratory values|1|||
105753511|NCT02505542|364750192|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
105753512|NCT02505542|364750193|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
105566311|NCT00941798|364071167|FG001|Overall Study|Abnormal laboratory values|2|||
105566312|NCT00941798|364071166|FG000|Overall Study|Death|0|||
105566313|NCT00941798|364071167|FG001|Overall Study|Death|1|||
105566314|NCT05597722|364071170|FG000|Overall Study|Study was terminated|6|||
105566315|NCT05597722|364071171|FG001|Overall Study|Study was terminated|1|||
105566316|NCT03750006|364071175|FG000|Overall Study|Withdrawal by Subject|8|||
105566317|NCT03750006|364071175|FG000|Overall Study|COVID PANDEMIC|11|||
105566318|NCT01728792|364072919|FG000|Overall Study|Withdrawal of Consent|1|||
105753513|NCT02505542|364750194|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
105753514|NCT02505542|364750195|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
105753515|NCT02505542|364750192|FG000|Part A: Open-Label Period|Non-compliance|1|||
105753516|NCT02505542|364750193|FG001|Part A: Open-Label Period|Non-compliance|0|||
105753517|NCT02505542|364750194|FG002|Part A: Open-Label Period|Non-compliance|0|||
105753518|NCT02505542|364750195|FG003|Part A: Open-Label Period|Non-compliance|0|||
105753519|NCT02505542|364750192|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
105753520|NCT02505542|364750193|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
105753521|NCT02505542|364750194|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
105753522|NCT02505542|364750195|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
105753523|NCT02505542|364750192|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
105753524|NCT02505542|364750193|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
105753525|NCT02505542|364750194|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
105753526|NCT02505542|364750195|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
105753527|NCT02505542|364750192|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
105753528|NCT02505542|364750193|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
105753529|NCT02505542|364750194|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
105753530|NCT02505542|364750195|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
105566319|NCT01728792|364072920|FG001|Overall Study|Withdrawal of Consent|1|||
105566320|NCT01728792|364072921|FG002|Overall Study|Withdrawal of Consent|0|||
105566321|NCT01728792|364072922|FG003|Overall Study|Withdrawal of Consent|1|||
105566322|NCT01728792|364072923|FG004|Overall Study|Withdrawal of Consent|0|||
105566323|NCT01728792|364072919|FG000|Overall Study|Lost to Follow-up|2|||
105566324|NCT01728792|364072920|FG001|Overall Study|Lost to Follow-up|1|||
105566325|NCT01728792|364072921|FG002|Overall Study|Lost to Follow-up|4|||
105566326|NCT01728792|364072922|FG003|Overall Study|Lost to Follow-up|2|||
105566327|NCT01728792|364072923|FG004|Overall Study|Lost to Follow-up|0|||
105566328|NCT04244396|364072926|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
105566329|NCT04244396|364072926|FG000|Overall Study|Withdrawal by Subject|2|||
105566330|NCT04244396|364072926|FG000|Overall Study|Study termination|37|||
105566331|NCT01679301|364072929|FG000|Screening Period|screen failure|3|||
105566332|NCT01679301|364072930|FG001|Screening Period|screen failure|0|||
105566333|NCT01679301|364072931|FG002|Screening Period|screen failure|0|||
105566334|NCT02026232|364072932|FG000|Overall Study|incomplete visit/missing data|3|||
105566335|NCT02026232|364072933|FG001|Overall Study|incomplete visit/missing data|2|||
105566336|NCT01582789|364072936|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
105566337|NCT01582789|364072937|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
105566338|NCT04170686|364072938|FG000|Screening|Physician Decision|12|||
105566339|NCT04170686|364072939|FG001|Screening|Physician Decision|13|||
105566340|NCT04170686|364072938|FG000|Randomization and Treatment|Lost to Follow-up|26|||
105566341|NCT04170686|364072939|FG001|Randomization and Treatment|Lost to Follow-up|15|||
105566342|NCT04525547|364072940|FG000|Overall Study|Not treated with Ofev|2|||
105566343|NCT04525547|364072940|FG000|Overall Study|Off-label use|2|||
105566344|NCT04525547|364072940|FG000|Overall Study|Lost to Follow-up|1|||
105566345|NCT01242748|364072941|FG000|Overall Study|Adverse Event|10|||
105566346|NCT01242748|364072942|FG001|Overall Study|Adverse Event|5|||
105566347|NCT01242748|364072941|FG000|Overall Study|Lost to Follow-up|6|||
105566348|NCT01242748|364072942|FG001|Overall Study|Lost to Follow-up|2|||
105566349|NCT01242748|364072941|FG000|Overall Study|Physician Decision|3|||
105566350|NCT01242748|364072942|FG001|Overall Study|Physician Decision|2|||
105566351|NCT01242748|364072941|FG000|Overall Study|Protocol Violation|1|||
105566352|NCT01242748|364072942|FG001|Overall Study|Protocol Violation|0|||
105566353|NCT01242748|364072941|FG000|Overall Study|Withdrawal by Subject|10|||
105566354|NCT01242748|364072942|FG001|Overall Study|Withdrawal by Subject|2|||
105566355|NCT01242748|364072941|FG000|Overall Study|Miscellaneous reasons|8|||
105566356|NCT01242748|364072942|FG001|Overall Study|Miscellaneous reasons|3|||
105566357|NCT05056870|364072943|FG000|Period 1|Site COVID-19 Related|3|||
105566358|NCT05056870|364072944|FG001|Period 1|Site COVID-19 Related|3|||
105566359|NCT05056870|364072943|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
105566360|NCT05056870|364072944|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
105566361|NCT05056870|364072943|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
105566362|NCT05056870|364072944|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
105566363|NCT05056870|364072943|FG000|Period 2|COVID-19 Related|1|||
105566364|NCT05056870|364072944|FG001|Period 2|COVID-19 Related|0|||
105566365|NCT05056870|364072943|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
105566366|NCT05056870|364072944|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
105566367|NCT02487498|364072945|FG000|Period: Period 1|Adverse Event|2|||
105566368|NCT02487498|364072946|FG001|Period: Period 1|Adverse Event|4|||
105566369|NCT02487498|364072945|FG000|Period: Period 1|Subject/guardian decision|2|||
105566370|NCT02487498|364072946|FG001|Period: Period 1|Subject/guardian decision|4|||
105566371|NCT02487498|364072945|FG000|Period: Period 1|Lost to Follow-up|0|||
105566372|NCT02487498|364072946|FG001|Period: Period 1|Lost to Follow-up|2|||
105566373|NCT02487498|364072945|FG000|Period: Period 1|Lack of Efficacy|1|||
105566374|NCT02487498|364072946|FG001|Period: Period 1|Lack of Efficacy|0|||
105566375|NCT02487498|364072945|FG000|Period: Period 1|Physician Decision|0|||
105566376|NCT02487498|364072946|FG001|Period: Period 1|Physician Decision|1|||
105566377|NCT02487498|364072945|FG000|Period: Period 1|Protocol deviation|1|||
105566378|NCT02487498|364072946|FG001|Period: Period 1|Protocol deviation|0|||
105566379|NCT02487498|364072945|FG000|Period: Washout|Subject/guardian decision|0|||
105566380|NCT02487498|364072946|FG001|Period: Washout|Subject/guardian decision|5|||
105566381|NCT02487498|364072945|FG000|Period: Washout|Lack of Efficacy|1|||
105566382|NCT02487498|364072946|FG001|Period: Washout|Lack of Efficacy|1|||
105566383|NCT02487498|364072945|FG000|Period: Washout|Physician Decision|1|||
105566384|NCT02487498|364072946|FG001|Period: Washout|Physician Decision|0|||
105566385|NCT02487498|364072945|FG000|Period: Washout|Non-compliance with study treatment|0|||
105566386|NCT02487498|364072946|FG001|Period: Washout|Non-compliance with study treatment|1|||
105566387|NCT02487498|364072945|FG000|Period: Period 2|Adverse Event|2|||
105566388|NCT02487498|364072946|FG001|Period: Period 2|Adverse Event|2|||
105566389|NCT02487498|364072945|FG000|Period: Period 2|Subject/guardian decision|2|||
105566390|NCT02487498|364072946|FG001|Period: Period 2|Subject/guardian decision|1|||
105566391|NCT02487498|364072945|FG000|Period: Period 2|Lost to Follow-up|1|||
105566392|NCT02487498|364072946|FG001|Period: Period 2|Lost to Follow-up|1|||
105566393|NCT02487498|364072945|FG000|Period: Period 2|Death|0|||
105566394|NCT02487498|364072946|FG001|Period: Period 2|Death|1|||
105566395|NCT02487498|364072945|FG000|Period: Period 2|Physician Decision|1|||
105566396|NCT02487498|364072946|FG001|Period: Period 2|Physician Decision|0|||
105566397|NCT00676130|364072953|FG000|Overall Study|Lost to Follow-up|0|||
105566398|NCT00676130|364072954|FG001|Overall Study|Lost to Follow-up|1|||
105566399|NCT00676130|364072953|FG000|Overall Study|Found ineligible|3|||
105566400|NCT00676130|364072954|FG001|Overall Study|Found ineligible|2|||
105566401|NCT00676130|364072953|FG000|Overall Study|Withdrawal by Subject|0|||
105566402|NCT00676130|364072954|FG001|Overall Study|Withdrawal by Subject|1|||
105566403|NCT01564368|364072955|FG000|Overall Study|Ineligible|18|||
105566404|NCT01564368|364072955|FG000|Overall Study|Not Randomized in Parent study|116|||
105566405|NCT01564368|364072955|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
105566406|NCT01564368|364072955|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
105566407|NCT00755222|364072956|FG000|Overall Study|Withdrawal by Subject|4|||
105566408|NCT00755222|364072957|FG001|Overall Study|Withdrawal by Subject|2|||
105566409|NCT00755222|364072956|FG000|Overall Study|Adverse Event|2|||
105566410|NCT00755222|364072957|FG001|Overall Study|Adverse Event|0|||
105566411|NCT00755222|364072956|FG000|Overall Study|Protocol Violation|2|||
105566412|NCT00755222|364072957|FG001|Overall Study|Protocol Violation|0|||
105566413|NCT01802437|364072958|FG000|Overall Study|Lost to Follow-up|1|||
105753531|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Adverse Event|0|||
105566414|NCT01802437|364072959|FG001|Overall Study|Lost to Follow-up|0|||
105566415|NCT01802437|364072958|FG000|Overall Study|Withdrawal by Subject|3|||
105566416|NCT01802437|364072959|FG001|Overall Study|Withdrawal by Subject|4|||
105566417|NCT04082884|364072960|FG000|Overall Study|Withdrawal by Subject|1|||
105566418|NCT00331344|364072961|FG000|Phase I|Adverse Event|0|||
105566419|NCT00331344|364072962|FG001|Phase I|Adverse Event|0|||
105566420|NCT00331344|364072963|FG002|Phase I|Adverse Event|0|||
105566421|NCT00331344|364072964|FG003|Phase I|Adverse Event|1|||
105566422|NCT00331344|364072965|FG004|Phase I|Adverse Event|2|||
105566423|NCT00331344|364072966|FG005|Phase I|Adverse Event|2|||
105566424|NCT00331344|364072967|FG006|Phase I|Adverse Event|0|||
105566425|NCT00331344|364072968|FG007|Phase I|Adverse Event|1|||
105566426|NCT00331344|364072969|FG008|Phase I|Adverse Event|0|||
105566427|NCT00331344|364072961|FG000|Phase II|Death|0|||
105566428|NCT00331344|364072962|FG001|Phase II|Death|0|||
105566429|NCT00331344|364072963|FG002|Phase II|Death|0|||
105566430|NCT00331344|364072964|FG003|Phase II|Death|0|||
105566431|NCT00331344|364072965|FG004|Phase II|Death|0|||
105566432|NCT00331344|364072966|FG005|Phase II|Death|0|||
105566433|NCT00331344|364072967|FG006|Phase II|Death|0|||
105566434|NCT00331344|364072968|FG007|Phase II|Death|0|||
105566435|NCT00331344|364072969|FG008|Phase II|Death|4|||
105566436|NCT01373931|364072977|FG000|Lead-in Period|Adverse Event|2|||
105566437|NCT01373931|364072978|FG001|Lead-in Period|Adverse Event|0|||
105566438|NCT01373931|364072977|FG000|Period 1|Adverse Event|2|||
105566439|NCT01373931|364072978|FG001|Period 1|Adverse Event|0|||
105566440|NCT01373931|364072977|FG000|Period 1|Withdrawal by Subject|0|||
105566441|NCT01373931|364072978|FG001|Period 1|Withdrawal by Subject|2|||
105566442|NCT02940574|364072979|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
105566443|NCT02940574|364072980|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
105566444|NCT02940574|364072979|FG000|1-year Follow-up|Lost to Follow-up|3|||
105566445|NCT02940574|364072980|FG001|1-year Follow-up|Lost to Follow-up|4|||
105566446|NCT00387894|364072981|FG000|Overall Study|Withdrawal by Subject|1|||
105566447|NCT00659490|364072982|FG000|Overall Study|Lost to Follow-up|2|||
105566448|NCT00659490|364072983|FG001|Overall Study|Lost to Follow-up|0|||
105566449|NCT00659490|364072984|FG002|Overall Study|Lost to Follow-up|1|||
105566450|NCT05674890|364072989|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
105566451|NCT05674890|364072990|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
105566452|NCT05674890|364072989|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
105566453|NCT05674890|364072990|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
105566454|NCT05674890|364072989|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
105566455|NCT05674890|364072990|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
105566456|NCT01649232|364072991|FG000|Overall Study|Physician Decision|2|||
105566457|NCT01649232|364072992|FG001|Overall Study|Physician Decision|0|||
105566458|NCT02228967|364072993|FG000|Overall Study|Lost to Follow-up|146|||
105566459|NCT02228967|364072994|FG001|Overall Study|Lost to Follow-up|142|||
105566460|NCT02228967|364072993|FG000|Overall Study|Withdrawal by Subject|13|||
105566461|NCT02228967|364072994|FG001|Overall Study|Withdrawal by Subject|18|||
105566462|NCT01750879|364072997|FG000|Overall Study|Adverse Event|8|||
105566463|NCT01750879|364072998|FG001|Overall Study|Adverse Event|0|||
105566464|NCT01750879|364072997|FG000|Overall Study|Lack of Efficacy|1|||
105566465|NCT01750879|364072998|FG001|Overall Study|Lack of Efficacy|0|||
105566466|NCT01750879|364072997|FG000|Overall Study|Withdrawal by Subject|1|||
105566467|NCT01750879|364072998|FG001|Overall Study|Withdrawal by Subject|0|||
105566468|NCT01750879|364072997|FG000|Overall Study|Did not complete per protocol|0|||
105566469|NCT01750879|364072998|FG001|Overall Study|Did not complete per protocol|3|||
105566470|NCT00520975|364072999|FG000|Overall Study|Disease progression|31|||
105566471|NCT00520975|364073000|FG001|Overall Study|Disease progression|23|||
105566472|NCT00520975|364072999|FG000|Overall Study|Adverse Event|7|||
105566473|NCT00520975|364073000|FG001|Overall Study|Adverse Event|10|||
105566474|NCT00520975|364072999|FG000|Overall Study|Death|0|||
105566475|NCT00520975|364073000|FG001|Overall Study|Death|2|||
105566476|NCT00520975|364072999|FG000|Overall Study|Withdrawal by Subject|3|||
105566477|NCT00520975|364073000|FG001|Overall Study|Withdrawal by Subject|5|||
105566478|NCT00520975|364072999|FG000|Overall Study|Other therapy|2|||
105566479|NCT00520975|364073000|FG001|Overall Study|Other therapy|4|||
105566480|NCT00520975|364072999|FG000|Overall Study|Other reasons|4|||
105566481|NCT00520975|364073000|FG001|Overall Study|Other reasons|2|||
105566482|NCT00520975|364072999|FG000|Overall Study|Not start protocol therapy|1|||
105566483|NCT00520975|364073000|FG001|Overall Study|Not start protocol therapy|2|||
105566484|NCT04382924|364073002|FG000|Overall Study|Death|2|||
105566485|NCT04382924|364073003|FG001|Overall Study|Death|5|||
105566486|NCT04382924|364073004|FG002|Overall Study|Death|4|||
105566487|NCT04382924|364073002|FG000|Overall Study|Protocol Violation|0|||
105566488|NCT04382924|364073003|FG001|Overall Study|Protocol Violation|1|||
105566489|NCT04382924|364073004|FG002|Overall Study|Protocol Violation|1|||
105566490|NCT04382924|364073002|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
105566491|NCT04382924|364073003|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
105760900|NCT01342952|364778053|FG001|Overall Study|Lost to Follow-up|2|||
105566492|NCT04382924|364073004|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
105566493|NCT04382924|364073002|FG000|Overall Study|Withdrawal by Subject|6|||
105566494|NCT04382924|364073003|FG001|Overall Study|Withdrawal by Subject|3|||
105566495|NCT04382924|364073004|FG002|Overall Study|Withdrawal by Subject|6|||
105566496|NCT01114204|364073008|FG000|Overall Study|Adverse Event|3|||
105566497|NCT01114204|364073009|FG001|Overall Study|Adverse Event|2|||
105566498|NCT01114204|364073008|FG000|Overall Study|Lost to Follow-up|1|||
105566499|NCT01114204|364073009|FG001|Overall Study|Lost to Follow-up|0|||
105566500|NCT01114204|364073008|FG000|Overall Study|Withdrawal by Subject|10|||
105566501|NCT01114204|364073009|FG001|Overall Study|Withdrawal by Subject|6|||
105566502|NCT01114204|364073008|FG000|Overall Study|Death|1|||
105566503|NCT01114204|364073009|FG001|Overall Study|Death|0|||
105566504|NCT01114204|364073008|FG000|Overall Study|Other-Personal reasons|2|||
105566505|NCT01114204|364073009|FG001|Overall Study|Other-Personal reasons|0|||
105566506|NCT01114204|364073008|FG000|Overall Study|Other-Medical monitor request|1|||
105566507|NCT01114204|364073009|FG001|Overall Study|Other-Medical monitor request|0|||
105566508|NCT01114204|364073008|FG000|Overall Study|Other-Participant request|2|||
105566509|NCT01114204|364073009|FG001|Overall Study|Other-Participant request|0|||
105566510|NCT01114204|364073008|FG000|Overall Study|Other-Protocol Violation|1|||
105566511|NCT01114204|364073009|FG001|Overall Study|Other-Protocol Violation|0|||
105566512|NCT01330316|364073016|FG000|Overall Study|Adverse Event|2|||
105566513|NCT01330316|364073017|FG001|Overall Study|Adverse Event|2|||
105566514|NCT01330316|364073016|FG000|Overall Study|Lack of Efficacy|0|||
105566515|NCT01330316|364073017|FG001|Overall Study|Lack of Efficacy|10|||
105566516|NCT01330316|364073016|FG000|Overall Study|Lost to Follow-up|0|||
105566517|NCT01330316|364073017|FG001|Overall Study|Lost to Follow-up|1|||
105566518|NCT01330316|364073016|FG000|Overall Study|Withdrawal by Subject|0|||
105566519|NCT01330316|364073017|FG001|Overall Study|Withdrawal by Subject|1|||
105566520|NCT01330316|364073016|FG000|Overall Study|other than above|0|||
105566521|NCT01330316|364073017|FG001|Overall Study|other than above|1|||
105566522|NCT03633929|364073023|FG000|Overall Study|Lost to Follow-up|1|||
105566523|NCT03633929|364073023|FG000|Overall Study|Did not login to software. Did not participate|3|||
105566524|NCT02487472|364073024|FG000|Overall Study|Did not complete telephonic interviews|9|||
105566525|NCT02487472|364073024|FG000|Overall Study|Other|2|||
105566526|NCT02034708|364073029|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
105566527|NCT02034708|364073030|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
105566528|NCT02034708|364073029|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
105566529|NCT02034708|364073030|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
105566530|NCT02034708|364073029|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
105566531|NCT02034708|364073030|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
105566532|NCT02034708|364073029|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
105566533|NCT02034708|364073030|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
105566534|NCT03988166|364073033|FG000|Overall Study|Lost to Follow-up|2|||
105566535|NCT03988166|364073033|FG000|Overall Study|Death|1|||
105566536|NCT02552238|364073034|FG000|Overall Study|Withdrawal by Subject|2|||
105566537|NCT02552238|364073034|FG000|Overall Study|Adverse Event|2|||
105566538|NCT05076149|364073035|FG000|Overall Study|Adverse Event|3|||
105566539|NCT05076149|364073036|FG001|Overall Study|Adverse Event|9|||
105566540|NCT05076149|364073035|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
105566541|NCT05076149|364073036|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
105566542|NCT05076149|364073035|FG000|Overall Study|Lost to Follow-up|0|||
105566543|NCT05076149|364073036|FG001|Overall Study|Lost to Follow-up|1|||
105566544|NCT05076149|364073035|FG000|Overall Study|Commercial drug is available for participant|0|||
105566545|NCT05076149|364073036|FG001|Overall Study|Commercial drug is available for participant|1|||
105566546|NCT05076149|364073035|FG000|Overall Study|Other non compliance|1|||
105566547|NCT05076149|364073036|FG001|Overall Study|Other non compliance|1|||
105566548|NCT05076149|364073035|FG000|Overall Study|Physician Decision|0|||
105566549|NCT05076149|364073036|FG001|Overall Study|Physician Decision|1|||
105566550|NCT05076149|364073035|FG000|Overall Study|Other|5|||
105566551|NCT05076149|364073036|FG001|Overall Study|Other|4|||
105566552|NCT00782496|364073037|FG000|Overall Study|Lost to Follow-up|14|||
105566553|NCT00782496|364073038|FG001|Overall Study|Lost to Follow-up|15|||
105566554|NCT02070484|364073044|FG000|Overall Study|Withdrawal by Subject|1|||
105566555|NCT02070484|364073045|FG001|Overall Study|Withdrawal by Subject|0|||
105566556|NCT02658630|364073046|FG000|Overall Study|Withdrawal by Subject|4|||
105566557|NCT00085202|364073047|FG000|Overall Study|Still on therapy|2|||
105566558|NCT00085202|364073048|FG001|Overall Study|Still on therapy|0|||
105566559|NCT00085202|364073047|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
105566560|NCT00085202|364073048|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
105566561|NCT00085202|364073047|FG000|Overall Study|Excessive toxicity|6|||
105360403|NCT03243305|363325942|FG000|Overall Study|Protocol Violation|22|||
105360404|NCT03243305|363325942|FG000|Overall Study|Study method no longer primary method|12|||
105566562|NCT00085202|364073048|FG001|Overall Study|Excessive toxicity|5|||
105566563|NCT00085202|364073047|FG000|Overall Study|Non-specified|3|||
105566564|NCT00085202|364073048|FG001|Overall Study|Non-specified|5|||
105566565|NCT00085202|364073047|FG000|Overall Study|Withdrawal by Subject|2|||
105566566|NCT00085202|364073048|FG001|Overall Study|Withdrawal by Subject|1|||
105566567|NCT00085202|364073047|FG000|Overall Study|Physician Decision|4|||
105360405|NCT03243305|363325942|FG000|Overall Study|Study Terminated by Sponsor|1|||
105566568|NCT00085202|364073048|FG001|Overall Study|Physician Decision|1|||
105566569|NCT00085202|364073047|FG000|Overall Study|Progressive disease|1|||
105566570|NCT00085202|364073048|FG001|Overall Study|Progressive disease|11|||
105566571|NCT03238300|364073049|FG000|Baseline (Before Intervention)|Physician Decision|0|||
105566572|NCT03238300|364073050|FG001|Baseline (Before Intervention)|Physician Decision|1|||
105566573|NCT03238300|364073049|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
105566574|NCT03238300|364073050|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
105566575|NCT03238300|364073049|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
105566576|NCT03238300|364073050|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
105566577|NCT03238300|364073049|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
105566578|NCT03238300|364073050|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
105566579|NCT00263328|364073052|FG000|Overall Study|Death|0|||
105566580|NCT00263328|364073053|FG001|Overall Study|Death|0|||
105566581|NCT00263328|364073054|FG002|Overall Study|Death|1|||
105566582|NCT00263328|364073052|FG000|Overall Study|Lost to Follow-up|1|||
105566583|NCT00263328|364073053|FG001|Overall Study|Lost to Follow-up|1|||
105566584|NCT00263328|364073054|FG002|Overall Study|Lost to Follow-up|0|||
105566585|NCT00263328|364073052|FG000|Overall Study|Withdrawal by Subject|3|||
105566586|NCT00263328|364073053|FG001|Overall Study|Withdrawal by Subject|0|||
105566587|NCT00263328|364073054|FG002|Overall Study|Withdrawal by Subject|1|||
105566588|NCT00263328|364073052|FG000|Overall Study|Other|3|||
105566589|NCT00263328|364073053|FG001|Overall Study|Other|0|||
105566590|NCT00263328|364073054|FG002|Overall Study|Other|1|||
105566591|NCT00263328|364073052|FG000|Overall Study|Adverse Event|1|||
105566592|NCT00263328|364073053|FG001|Overall Study|Adverse Event|1|||
105566593|NCT00263328|364073054|FG002|Overall Study|Adverse Event|4|||
105566594|NCT00622180|364073055|FG000|Overall Study|Lost to Follow-up|1|||
105566595|NCT00622180|364073056|FG001|Overall Study|Lost to Follow-up|2|||
105566596|NCT02332590|364073059|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
105566597|NCT02332590|364073060|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
105566598|NCT02332590|364073059|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
105566599|NCT02332590|364073060|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
105566600|NCT02332590|364073059|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
105566601|NCT02332590|364073060|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
105566602|NCT02332590|364073059|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
105566603|NCT02332590|364073060|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
105566604|NCT02332590|364073059|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
105566605|NCT02332590|364073060|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
105566606|NCT02332590|364073059|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
105566607|NCT02332590|364073060|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
105566608|NCT02332590|364073059|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
105566609|NCT02332590|364073060|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
105566610|NCT02332590|364073059|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
105753532|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Adverse Event|0|||
105566611|NCT02332590|364073060|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
105566612|NCT02332590|364073059|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
105566613|NCT02332590|364073060|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
105566614|NCT00445679|364073063|FG000|Overall Study|Adverse Event|22|||
105566615|NCT00445679|364073064|FG001|Overall Study|Adverse Event|12|||
105566616|NCT00445679|364073065|FG002|Overall Study|Adverse Event|30|||
105566617|NCT00445679|364073066|FG003|Overall Study|Adverse Event|19|||
105566618|NCT00445679|364073063|FG000|Overall Study|Failed to return|1|||
105566619|NCT00445679|364073064|FG001|Overall Study|Failed to return|3|||
105566620|NCT00445679|364073065|FG002|Overall Study|Failed to return|2|||
105566621|NCT00445679|364073066|FG003|Overall Study|Failed to return|2|||
105566622|NCT00445679|364073063|FG000|Overall Study|Physician Decision|0|||
105566623|NCT00445679|364073064|FG001|Overall Study|Physician Decision|0|||
105566624|NCT00445679|364073065|FG002|Overall Study|Physician Decision|1|||
105566625|NCT00445679|364073066|FG003|Overall Study|Physician Decision|0|||
105566626|NCT00445679|364073063|FG000|Overall Study|Lost to Follow-up|10|||
105566627|NCT00445679|364073064|FG001|Overall Study|Lost to Follow-up|6|||
105566628|NCT00445679|364073065|FG002|Overall Study|Lost to Follow-up|6|||
105566629|NCT00445679|364073066|FG003|Overall Study|Lost to Follow-up|5|||
105566630|NCT00445679|364073063|FG000|Overall Study|Compliance|3|||
105566631|NCT00445679|364073064|FG001|Overall Study|Compliance|2|||
105566632|NCT00445679|364073065|FG002|Overall Study|Compliance|1|||
105566633|NCT00445679|364073066|FG003|Overall Study|Compliance|2|||
105566634|NCT00445679|364073063|FG000|Overall Study|Withdrawal of Informed Consent|0|||
105566635|NCT00445679|364073064|FG001|Overall Study|Withdrawal of Informed Consent|0|||
105566636|NCT00445679|364073065|FG002|Overall Study|Withdrawal of Informed Consent|1|||
105566637|NCT00445679|364073066|FG003|Overall Study|Withdrawal of Informed Consent|0|||
105566638|NCT00445679|364073063|FG000|Overall Study|Protocol Violation|2|||
105566639|NCT00445679|364073064|FG001|Overall Study|Protocol Violation|3|||
105566640|NCT00445679|364073065|FG002|Overall Study|Protocol Violation|3|||
105566641|NCT00445679|364073066|FG003|Overall Study|Protocol Violation|1|||
105566642|NCT00445679|364073063|FG000|Overall Study|Withdrawal by Subject|8|||
105566643|NCT00445679|364073064|FG001|Overall Study|Withdrawal by Subject|14|||
105566644|NCT00445679|364073065|FG002|Overall Study|Withdrawal by Subject|20|||
105566645|NCT00445679|364073066|FG003|Overall Study|Withdrawal by Subject|18|||
105566646|NCT00445679|364073063|FG000|Overall Study|Lack of Efficacy|2|||
105566647|NCT00445679|364073064|FG001|Overall Study|Lack of Efficacy|6|||
105566648|NCT00445679|364073065|FG002|Overall Study|Lack of Efficacy|2|||
105566649|NCT00445679|364073066|FG003|Overall Study|Lack of Efficacy|0|||
105566650|NCT03474549|364073071|FG000|Overall Study|Death|31|||
105566651|NCT03474549|364073071|FG000|Overall Study|Lost to Follow-up|4|||
105566652|NCT03474549|364073071|FG000|Overall Study|Withdrawal by Subject|2|||
105566653|NCT00404495|364073075|FG000|Overall Study|Death|37|||
105566654|NCT00404495|364073076|FG001|Overall Study|Death|11|||
105566655|NCT00404495|364073075|FG000|Overall Study|Lost to Follow-up|5|||
105566656|NCT00404495|364073076|FG001|Overall Study|Lost to Follow-up|0|||
105566657|NCT00404495|364073075|FG000|Overall Study|Other|1|||
105566658|NCT00404495|364073076|FG001|Overall Study|Other|0|||
105566659|NCT00404495|364073075|FG000|Overall Study|Withdrawal by Subject|1|||
105566660|NCT00404495|364073076|FG001|Overall Study|Withdrawal by Subject|0|||
105566661|NCT04108000|364073077|FG000|Overall Study|Death of patient|1|||
105566662|NCT04108000|364073078|FG001|Overall Study|Death of patient|0|||
105566663|NCT04108000|364073079|FG002|Overall Study|Death of patient|1|||
105566664|NCT04108000|364073080|FG003|Overall Study|Death of patient|0|||
105566665|NCT04108000|364073077|FG000|Overall Study|Withdrawal by Subject|2|||
105566666|NCT04108000|364073078|FG001|Overall Study|Withdrawal by Subject|2|||
105566667|NCT04108000|364073079|FG002|Overall Study|Withdrawal by Subject|0|||
105566668|NCT04108000|364073080|FG003|Overall Study|Withdrawal by Subject|0|||
105566669|NCT04108000|364073077|FG000|Overall Study|Death of surrogate partner|0|||
105566670|NCT04108000|364073078|FG001|Overall Study|Death of surrogate partner|1|||
105566671|NCT04108000|364073079|FG002|Overall Study|Death of surrogate partner|0|||
105566672|NCT04108000|364073080|FG003|Overall Study|Death of surrogate partner|1|||
105566673|NCT03535337|364073087|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
105566674|NCT03535337|364073088|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
105360406|NCT03243305|363325942|FG000|Overall Study|Early terminations|267|||
105360407|NCT00905424|363325945|FG000|Overall Study|Lost to Follow-up|3|||
105566675|NCT03535337|364073089|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
105566676|NCT03535337|364073090|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
105566677|NCT03535337|364073091|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
105566678|NCT03535337|364073092|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
105566679|NCT03535337|364073093|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
105566680|NCT03535337|364073094|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
105566681|NCT03535337|364073095|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
105566682|NCT03535337|364073096|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
105566683|NCT01147822|364074785|FG000|Overall Study|Lost to Follow-up|14|||
105566684|NCT01147822|364074786|FG001|Overall Study|Lost to Follow-up|6|||
105566685|NCT01147822|364074785|FG000|Overall Study|Withdrawal by Subject|10|||
105566686|NCT01147822|364074786|FG001|Overall Study|Withdrawal by Subject|16|||
105566687|NCT01147822|364074785|FG000|Overall Study|Physician Decision|9|||
105566688|NCT01147822|364074786|FG001|Overall Study|Physician Decision|8|||
105566689|NCT01147822|364074785|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
105566690|NCT01147822|364074786|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
105566691|NCT01147822|364074785|FG000|Overall Study|Protocol Violation|1|||
105566692|NCT01147822|364074786|FG001|Overall Study|Protocol Violation|1|||
105753533|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Adverse Event|1|||
105753534|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Adverse Event|3|||
105753535|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
105753536|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
105753537|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
105753538|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
105753539|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
105753540|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
105753541|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
105753542|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
105753543|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
105753544|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
105753545|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
105753546|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
105753547|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
105753548|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
105753549|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
105753550|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
105753551|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
105753552|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
105753553|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
105753554|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
105753555|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
105753556|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
105753557|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
105753558|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
105753559|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Miscalculation|0|||
105753560|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Miscalculation|1|||
105753561|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Miscalculation|0|||
105753562|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Miscalculation|0|||
105753563|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
105753564|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
105753565|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
105753566|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
105566693|NCT00642902|364074789|FG000|Overall Study|Adverse Event|0|||
105566694|NCT00642902|364074790|FG001|Overall Study|Adverse Event|1|||
105566695|NCT00642902|364074791|FG002|Overall Study|Adverse Event|3|||
105566696|NCT00642902|364074792|FG003|Overall Study|Adverse Event|1|||
105566697|NCT00642902|364074789|FG000|Overall Study|Lost to Follow-up|1|||
105566698|NCT00642902|364074790|FG001|Overall Study|Lost to Follow-up|1|||
105566699|NCT00642902|364074791|FG002|Overall Study|Lost to Follow-up|0|||
105566700|NCT00642902|364074792|FG003|Overall Study|Lost to Follow-up|0|||
105566701|NCT00642902|364074789|FG000|Overall Study|Lack of Efficacy|0|||
105566702|NCT00642902|364074790|FG001|Overall Study|Lack of Efficacy|3|||
105566703|NCT00642902|364074791|FG002|Overall Study|Lack of Efficacy|3|||
105566704|NCT00642902|364074792|FG003|Overall Study|Lack of Efficacy|0|||
105566705|NCT00642902|364074789|FG000|Overall Study|Death|1|||
105566706|NCT00642902|364074790|FG001|Overall Study|Death|0|||
105566707|NCT00642902|364074791|FG002|Overall Study|Death|0|||
105566708|NCT00642902|364074792|FG003|Overall Study|Death|0|||
105566709|NCT00642902|364074789|FG000|Overall Study|Premature termination of clinical trial|37|||
105566710|NCT00642902|364074790|FG001|Overall Study|Premature termination of clinical trial|32|||
105566711|NCT00642902|364074791|FG002|Overall Study|Premature termination of clinical trial|35|||
105566712|NCT00642902|364074792|FG003|Overall Study|Premature termination of clinical trial|35|||
105566713|NCT00642902|364074789|FG000|Overall Study|Randomized, but not treated|0|||
105566714|NCT00642902|364074790|FG001|Overall Study|Randomized, but not treated|0|||
105566715|NCT00642902|364074791|FG002|Overall Study|Randomized, but not treated|1|||
105566716|NCT00642902|364074792|FG003|Overall Study|Randomized, but not treated|0|||
105566717|NCT00642902|364074789|FG000|Overall Study|Other|1|||
105566718|NCT00642902|364074790|FG001|Overall Study|Other|5|||
105566719|NCT00642902|364074791|FG002|Overall Study|Other|1|||
105566720|NCT00642902|364074792|FG003|Overall Study|Other|4|||
105566721|NCT02173054|364074793|FG000|Overall Study|lack of compliance|1|||
105566722|NCT02173054|364074794|FG001|Overall Study|lack of compliance|0|||
105566723|NCT02173054|364074795|FG002|Overall Study|lack of compliance|0|||
105566724|NCT02173054|364074793|FG000|Overall Study|Withdrawal by Subject|0|||
105566725|NCT02173054|364074794|FG001|Overall Study|Withdrawal by Subject|0|||
105566726|NCT02173054|364074795|FG002|Overall Study|Withdrawal by Subject|1|||
105566727|NCT00215540|364074806|FG000|Overall Study|Withdrew from study medication|1|||
105566728|NCT00215540|364074807|FG001|Overall Study|Withdrew from study medication|0|||
105566729|NCT00215540|364074808|FG002|Overall Study|Withdrew from study medication|0|||
105566730|NCT01059643|364074809|FG000|Overall Study|Adverse Event|3|||
105566731|NCT01059643|364074809|FG000|Overall Study|Withdrawal by Subject|2|||
105566732|NCT01059643|364074809|FG000|Overall Study|Physician Decision|1|||
105566733|NCT03010462|364074810|FG000|Overall Study|Withdrawal by Subject|3|||
105566734|NCT03010462|364074811|FG001|Overall Study|Withdrawal by Subject|1|||
105566735|NCT02207725|364074812|FG000|Overall Study|Did Not Receive Treatment|0|||
105566736|NCT02207725|364074813|FG001|Overall Study|Did Not Receive Treatment|1|||
105566737|NCT02207725|364074814|FG002|Overall Study|Did Not Receive Treatment|1|||
105566738|NCT02207725|364074815|FG003|Overall Study|Did Not Receive Treatment|1|||
105566739|NCT00246337|364074818|FG000|Overall Study|Lost to Follow-up|3|||
105566740|NCT00246337|364074819|FG001|Overall Study|Lost to Follow-up|0|||
105566741|NCT00246337|364074820|FG002|Overall Study|Lost to Follow-up|0|||
105566742|NCT00246337|364074821|FG003|Overall Study|Lost to Follow-up|0|||
105566743|NCT00246337|364074822|FG004|Overall Study|Lost to Follow-up|2|||
105566744|NCT00246337|364074823|FG005|Overall Study|Lost to Follow-up|2|||
105566745|NCT00246337|364074824|FG006|Overall Study|Lost to Follow-up|1|||
105566746|NCT00246337|364074825|FG007|Overall Study|Lost to Follow-up|2|||
105566747|NCT00246337|364074826|FG008|Overall Study|Lost to Follow-up|0|||
105566748|NCT00246337|364074818|FG000|Overall Study|Protocol Violation|1|||
105566749|NCT00246337|364074819|FG001|Overall Study|Protocol Violation|0|||
105566750|NCT00246337|364074820|FG002|Overall Study|Protocol Violation|0|||
105566751|NCT00246337|364074821|FG003|Overall Study|Protocol Violation|0|||
105566752|NCT00246337|364074822|FG004|Overall Study|Protocol Violation|1|||
105566753|NCT00246337|364074823|FG005|Overall Study|Protocol Violation|0|||
105566754|NCT00246337|364074824|FG006|Overall Study|Protocol Violation|1|||
105566755|NCT00246337|364074825|FG007|Overall Study|Protocol Violation|1|||
105566756|NCT00246337|364074826|FG008|Overall Study|Protocol Violation|0|||
105566757|NCT00246337|364074818|FG000|Overall Study|Withdrawal by Subject|2|||
105566758|NCT00246337|364074819|FG001|Overall Study|Withdrawal by Subject|0|||
105566759|NCT00246337|364074820|FG002|Overall Study|Withdrawal by Subject|0|||
105566760|NCT00246337|364074821|FG003|Overall Study|Withdrawal by Subject|0|||
105566761|NCT00246337|364074822|FG004|Overall Study|Withdrawal by Subject|0|||
105566762|NCT00246337|364074823|FG005|Overall Study|Withdrawal by Subject|0|||
105566763|NCT00246337|364074824|FG006|Overall Study|Withdrawal by Subject|1|||
105566764|NCT00246337|364074825|FG007|Overall Study|Withdrawal by Subject|1|||
105566765|NCT00246337|364074826|FG008|Overall Study|Withdrawal by Subject|0|||
105566766|NCT00246337|364074818|FG000|Overall Study|Lack of Qualifying Event|8|||
105566767|NCT00246337|364074819|FG001|Overall Study|Lack of Qualifying Event|2|||
105566768|NCT00246337|364074820|FG002|Overall Study|Lack of Qualifying Event|1|||
105566769|NCT00246337|364074821|FG003|Overall Study|Lack of Qualifying Event|1|||
105566770|NCT00246337|364074822|FG004|Overall Study|Lack of Qualifying Event|1|||
105566771|NCT00246337|364074823|FG005|Overall Study|Lack of Qualifying Event|3|||
105566772|NCT00246337|364074824|FG006|Overall Study|Lack of Qualifying Event|3|||
105566773|NCT00246337|364074825|FG007|Overall Study|Lack of Qualifying Event|2|||
105566774|NCT00246337|364074826|FG008|Overall Study|Lack of Qualifying Event|5|||
105566775|NCT00246337|364074818|FG000|Overall Study|Site Terminated|10|||
105566776|NCT00246337|364074819|FG001|Overall Study|Site Terminated|0|||
105566777|NCT00246337|364074820|FG002|Overall Study|Site Terminated|0|||
105566778|NCT00246337|364074821|FG003|Overall Study|Site Terminated|0|||
105566779|NCT00246337|364074822|FG004|Overall Study|Site Terminated|0|||
105566780|NCT00246337|364074823|FG005|Overall Study|Site Terminated|7|||
105566781|NCT00246337|364074824|FG006|Overall Study|Site Terminated|1|||
105566782|NCT00246337|364074825|FG007|Overall Study|Site Terminated|6|||
105566783|NCT00246337|364074826|FG008|Overall Study|Site Terminated|2|||
105566784|NCT00246337|364074818|FG000|Overall Study|Abnormal baseline lab values|7|||
105566785|NCT00246337|364074819|FG001|Overall Study|Abnormal baseline lab values|0|||
105566786|NCT00246337|364074820|FG002|Overall Study|Abnormal baseline lab values|2|||
105566787|NCT00246337|364074821|FG003|Overall Study|Abnormal baseline lab values|0|||
105566788|NCT00246337|364074822|FG004|Overall Study|Abnormal baseline lab values|0|||
105566789|NCT00246337|364074823|FG005|Overall Study|Abnormal baseline lab values|2|||
105566790|NCT00246337|364074824|FG006|Overall Study|Abnormal baseline lab values|2|||
105566791|NCT00246337|364074825|FG007|Overall Study|Abnormal baseline lab values|0|||
105566792|NCT00246337|364074826|FG008|Overall Study|Abnormal baseline lab values|4|||
105566793|NCT00246337|364074818|FG000|Overall Study|Overwhelmed|0|||
105566794|NCT00246337|364074819|FG001|Overall Study|Overwhelmed|0|||
105566795|NCT00246337|364074820|FG002|Overall Study|Overwhelmed|0|||
105566796|NCT00246337|364074821|FG003|Overall Study|Overwhelmed|0|||
105566797|NCT00246337|364074822|FG004|Overall Study|Overwhelmed|0|||
105566798|NCT00246337|364074823|FG005|Overall Study|Overwhelmed|1|||
105566799|NCT00246337|364074824|FG006|Overall Study|Overwhelmed|0|||
105566800|NCT00246337|364074825|FG007|Overall Study|Overwhelmed|0|||
105566801|NCT00246337|364074826|FG008|Overall Study|Overwhelmed|0|||
105566802|NCT00246337|364074818|FG000|Overall Study|Protocol Violator|1|||
105566803|NCT00246337|364074819|FG001|Overall Study|Protocol Violator|0|||
105566804|NCT00246337|364074820|FG002|Overall Study|Protocol Violator|0|||
105566805|NCT00246337|364074821|FG003|Overall Study|Protocol Violator|0|||
105566806|NCT00246337|364074822|FG004|Overall Study|Protocol Violator|0|||
105566807|NCT00246337|364074823|FG005|Overall Study|Protocol Violator|0|||
105566808|NCT00246337|364074824|FG006|Overall Study|Protocol Violator|0|||
105566809|NCT00246337|364074825|FG007|Overall Study|Protocol Violator|0|||
105566810|NCT00246337|364074826|FG008|Overall Study|Protocol Violator|0|||
105566811|NCT00246337|364074818|FG000|Overall Study|Reported as completing trial in error|0|||
105566812|NCT00246337|364074819|FG001|Overall Study|Reported as completing trial in error|0|||
105566813|NCT00246337|364074820|FG002|Overall Study|Reported as completing trial in error|0|||
105566814|NCT00246337|364074821|FG003|Overall Study|Reported as completing trial in error|0|||
105566815|NCT00246337|364074822|FG004|Overall Study|Reported as completing trial in error|0|||
105566816|NCT00246337|364074823|FG005|Overall Study|Reported as completing trial in error|0|||
105566817|NCT00246337|364074824|FG006|Overall Study|Reported as completing trial in error|0|||
105566818|NCT00246337|364074825|FG007|Overall Study|Reported as completing trial in error|1|||
105566819|NCT00246337|364074826|FG008|Overall Study|Reported as completing trial in error|0|||
105566820|NCT01226511|364074827|FG000|Acute Treatment Period|Adverse Event|7|||
105566821|NCT01226511|364074828|FG001|Acute Treatment Period|Adverse Event|6|||
105566822|NCT01226511|364074827|FG000|Acute Treatment Period|Lack of Efficacy|2|||
105566823|NCT01226511|364074828|FG001|Acute Treatment Period|Lack of Efficacy|1|||
105566824|NCT01226511|364074827|FG000|Acute Treatment Period|Lost to Follow-up|3|||
105566825|NCT01226511|364074828|FG001|Acute Treatment Period|Lost to Follow-up|6|||
105566826|NCT01226511|364074827|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
105753567|NCT01464788|364750196|FG000|Overall Study|Lost to Follow-up|0|||
105753568|NCT01464788|364750197|FG001|Overall Study|Lost to Follow-up|1|||
105753569|NCT01464788|364750198|FG002|Overall Study|Lost to Follow-up|0|||
105753570|NCT01464788|364750196|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
105753571|NCT01464788|364750197|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
105753572|NCT01464788|364750198|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
105753573|NCT01594333|364750201|FG000|Overall Study|Death|96|||
105753574|NCT01594333|364750202|FG001|Overall Study|Death|83|||
105753575|NCT01594333|364750201|FG000|Overall Study|Lost to Follow-up|5|||
105753576|NCT01594333|364750202|FG001|Overall Study|Lost to Follow-up|5|||
105753577|NCT01594333|364750201|FG000|Overall Study|Withdrawal by Subject|60|||
105753578|NCT01594333|364750202|FG001|Overall Study|Withdrawal by Subject|63|||
105566827|NCT01226511|364074828|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
105753579|NCT00400712|364750203|FG000|Overall Study|Death|1|||
105753580|NCT00400712|364750204|FG001|Overall Study|Death|0|||
105753581|NCT00400712|364750203|FG000|Overall Study|Withdrawal by Subject|11|||
105753582|NCT00400712|364750204|FG001|Overall Study|Withdrawal by Subject|12|||
105753583|NCT00400712|364750203|FG000|Overall Study|Physician Decision|5|||
105753584|NCT00400712|364750204|FG001|Overall Study|Physician Decision|4|||
105753585|NCT02670330|364750205|FG000|Overall Study|Protocol Deviation|1|||
105753586|NCT02670330|364750206|FG001|Overall Study|Protocol Deviation|0|||
105753587|NCT02670330|364750205|FG000|Overall Study|Study Terminated By Sponsor|36|||
105753588|NCT02670330|364750206|FG001|Overall Study|Study Terminated By Sponsor|43|||
105753589|NCT02670330|364750205|FG000|Overall Study|Adverse Event|1|||
105753590|NCT02670330|364750206|FG001|Overall Study|Adverse Event|3|||
105753591|NCT02670330|364750205|FG000|Overall Study|Withdrawal by Subject|34|||
105566828|NCT01226511|364074827|FG000|Acute Treatment Period|Protocol Violation|5|||
105566829|NCT01226511|364074828|FG001|Acute Treatment Period|Protocol Violation|5|||
105566830|NCT01226511|364074827|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
105753592|NCT02670330|364750206|FG001|Overall Study|Withdrawal by Subject|29|||
105753593|NCT02670330|364750205|FG000|Overall Study|Lost to Follow-up|3|||
105753594|NCT02670330|364750206|FG001|Overall Study|Lost to Follow-up|2|||
105753595|NCT03691610|364750212|FG000|Overall Study|Adverse Event|0|||
105566831|NCT01226511|364074828|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
105566832|NCT01226511|364074827|FG000|Extension Treatment Period|Adverse Event|8|||
105753596|NCT03691610|364750213|FG001|Overall Study|Adverse Event|1|||
105753597|NCT03691610|364750214|FG002|Overall Study|Adverse Event|0|||
105753598|NCT03691610|364750215|FG003|Overall Study|Adverse Event|0|||
105753599|NCT03691610|364750212|FG000|Overall Study|Protocol Deviation|15|||
105753600|NCT03691610|364750213|FG001|Overall Study|Protocol Deviation|8|||
105753601|NCT03691610|364750214|FG002|Overall Study|Protocol Deviation|1|||
105753602|NCT03691610|364750215|FG003|Overall Study|Protocol Deviation|2|||
105753603|NCT03691610|364750212|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
105753604|NCT03691610|364750213|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
105753605|NCT03691610|364750214|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
105566833|NCT01226511|364074828|FG001|Extension Treatment Period|Adverse Event|8|||
105753606|NCT03691610|364750215|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
105753607|NCT03691610|364750212|FG000|Overall Study|Lost to Follow-up|20|||
105753608|NCT03691610|364750213|FG001|Overall Study|Lost to Follow-up|11|||
105753609|NCT03691610|364750214|FG002|Overall Study|Lost to Follow-up|5|||
105753610|NCT03691610|364750215|FG003|Overall Study|Lost to Follow-up|2|||
105753611|NCT00878215|364750217|FG000|Overall Study|Determined to be ineligible|0|||
105753612|NCT00878215|364750218|FG001|Overall Study|Determined to be ineligible|10|||
105753613|NCT00878215|364750219|FG002|Overall Study|Determined to be ineligible|0|||
105753614|NCT00878215|364750220|FG003|Overall Study|Determined to be ineligible|0|||
105753615|NCT05294211|364750222|FG000|Overall Study|Withdrawal by Subject|3|||
105753616|NCT05294211|364750222|FG000|Overall Study|Physician Decision|2|||
105753617|NCT05294211|364750222|FG000|Overall Study|Progressed to active labor|1|||
105753618|NCT05294211|364750222|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
105753619|NCT05294211|364750222|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
105753620|NCT00406783|364750223|FG000|Overall Study|Adverse Event|4|||
105753621|NCT00406783|364750224|FG001|Overall Study|Adverse Event|4|||
105753622|NCT00406783|364750223|FG000|Overall Study|Treatment Failure|2|||
105753623|NCT00406783|364750224|FG001|Overall Study|Treatment Failure|3|||
105566834|NCT01226511|364074827|FG000|Extension Treatment Period|Lack of Efficacy|3|||
105753624|NCT00406783|364750223|FG000|Overall Study|Lost to Follow-up|3|||
105566835|NCT01226511|364074828|FG001|Extension Treatment Period|Lack of Efficacy|2|||
105566836|NCT01226511|364074827|FG000|Extension Treatment Period|Lost to Follow-up|4|||
105566837|NCT01226511|364074828|FG001|Extension Treatment Period|Lost to Follow-up|3|||
105566838|NCT01226511|364074827|FG000|Extension Treatment Period|Protocol Violation|2|||
105566839|NCT01226511|364074828|FG001|Extension Treatment Period|Protocol Violation|2|||
105566840|NCT01226511|364074827|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
105566841|NCT01226511|364074828|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
105566842|NCT01226511|364074827|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
105566843|NCT01226511|364074828|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
105566844|NCT01226511|364074827|FG000|Extension Treatment Period|Sponsor Decision|1|||
105566845|NCT01226511|364074828|FG001|Extension Treatment Period|Sponsor Decision|1|||
105566846|NCT01226511|364074827|FG000|Taper Period|Adverse Event|1|||
105566847|NCT01226511|364074828|FG001|Taper Period|Adverse Event|0|||
105566848|NCT01226511|364074827|FG000|Taper Period|Lost to Follow-up|2|||
105566849|NCT01226511|364074828|FG001|Taper Period|Lost to Follow-up|2|||
105566850|NCT01226511|364074827|FG000|Taper Period|Protocol Violation|1|||
105566851|NCT01226511|364074828|FG001|Taper Period|Protocol Violation|0|||
105566852|NCT01226511|364074827|FG000|Taper Period|Parent/Caregiver Decision|1|||
105566853|NCT01226511|364074828|FG001|Taper Period|Parent/Caregiver Decision|1|||
105566854|NCT01722162|364074830|FG000|Overall Study|Withdrawal by Subject|1|||
105566855|NCT01722162|364074831|FG001|Overall Study|Withdrawal by Subject|1|||
105566856|NCT01722162|364074830|FG000|Overall Study|Found ineligible|1|||
105566857|NCT01722162|364074831|FG001|Overall Study|Found ineligible|0|||
105566858|NCT01722162|364074830|FG000|Overall Study|Unrelated to study adverse event|2|||
105566859|NCT01722162|364074831|FG001|Overall Study|Unrelated to study adverse event|2|||
105566860|NCT01722162|364074830|FG000|Overall Study|Adverse Event|1|||
105566861|NCT01722162|364074831|FG001|Overall Study|Adverse Event|1|||
105566862|NCT01722162|364074830|FG000|Overall Study|Insurance denial post enrollment|0|||
105566863|NCT01722162|364074831|FG001|Overall Study|Insurance denial post enrollment|1|||
105566864|NCT01722162|364074830|FG000|Overall Study|Noncompliance|0|||
105566865|NCT01722162|364074831|FG001|Overall Study|Noncompliance|1|||
105753625|NCT00406783|364750224|FG001|Overall Study|Lost to Follow-up|0|||
105753626|NCT00406783|364750223|FG000|Overall Study|Withdrawal by Subject|1|||
105753627|NCT00406783|364750224|FG001|Overall Study|Withdrawal by Subject|4|||
105753628|NCT00406783|364750223|FG000|Overall Study|Protocol Violation|4|||
105753629|NCT00406783|364750224|FG001|Overall Study|Protocol Violation|4|||
105753630|NCT03334396|364750225|FG000|Overall Study|Adverse Event|1|||
105753631|NCT03334396|364750226|FG001|Overall Study|Adverse Event|0|||
105753632|NCT03334396|364750227|FG002|Overall Study|Adverse Event|1|||
105753633|NCT03334396|364750228|FG003|Overall Study|Adverse Event|0|||
105566866|NCT03124199|364074832|FG000|Overall Study|Lost to Follow-up|4|||
105566867|NCT02798211|364074833|FG000|Period 1|Adverse Event|1|||
105566868|NCT02798211|364074834|FG001|Period 1|Adverse Event|1|||
105566869|NCT02798211|364074835|FG002|Period 1|Adverse Event|0|||
105753634|NCT03334396|364750229|FG004|Overall Study|Adverse Event|0|||
105566870|NCT02798211|364074836|FG003|Period 1|Adverse Event|0|||
105566871|NCT02798211|364074837|FG004|Period 1|Adverse Event|0|||
105753635|NCT03334396|364750230|FG005|Overall Study|Adverse Event|0|||
105753636|NCT03334396|364750231|FG006|Overall Study|Adverse Event|0|||
105753637|NCT03334396|364750232|FG007|Overall Study|Adverse Event|0|||
105753638|NCT03334396|364750225|FG000|Overall Study|Lack of Efficacy|10|||
105753639|NCT03334396|364750226|FG001|Overall Study|Lack of Efficacy|4|||
105753640|NCT03334396|364750227|FG002|Overall Study|Lack of Efficacy|1|||
105753641|NCT03334396|364750228|FG003|Overall Study|Lack of Efficacy|3|||
105753642|NCT03334396|364750229|FG004|Overall Study|Lack of Efficacy|1|||
105753643|NCT03334396|364750230|FG005|Overall Study|Lack of Efficacy|0|||
105753644|NCT03334396|364750231|FG006|Overall Study|Lack of Efficacy|0|||
105753645|NCT03334396|364750232|FG007|Overall Study|Lack of Efficacy|1|||
105753646|NCT03334396|364750225|FG000|Overall Study|Lost to Follow-up|0|||
105753647|NCT03334396|364750226|FG001|Overall Study|Lost to Follow-up|0|||
105753648|NCT03334396|364750227|FG002|Overall Study|Lost to Follow-up|1|||
105753649|NCT03334396|364750228|FG003|Overall Study|Lost to Follow-up|0|||
105753650|NCT03334396|364750229|FG004|Overall Study|Lost to Follow-up|0|||
105753651|NCT03334396|364750230|FG005|Overall Study|Lost to Follow-up|0|||
105753652|NCT03334396|364750231|FG006|Overall Study|Lost to Follow-up|1|||
105753653|NCT03334396|364750232|FG007|Overall Study|Lost to Follow-up|0|||
105753654|NCT03334396|364750225|FG000|Overall Study|Physician Decision|1|||
105566872|NCT02798211|364074838|FG005|Period 1|Adverse Event|0|||
105566873|NCT02798211|364074833|FG000|Period 1|Lost to Follow-up|2|||
105566874|NCT02798211|364074834|FG001|Period 1|Lost to Follow-up|1|||
105566875|NCT02798211|364074835|FG002|Period 1|Lost to Follow-up|0|||
105566876|NCT02798211|364074836|FG003|Period 1|Lost to Follow-up|0|||
105566877|NCT02798211|364074837|FG004|Period 1|Lost to Follow-up|0|||
105566878|NCT02798211|364074838|FG005|Period 1|Lost to Follow-up|0|||
105566879|NCT02798211|364074833|FG000|Period 1|Protocol Violation|0|||
105566880|NCT02798211|364074834|FG001|Period 1|Protocol Violation|0|||
105566881|NCT02798211|364074835|FG002|Period 1|Protocol Violation|2|||
105566882|NCT02798211|364074836|FG003|Period 1|Protocol Violation|0|||
105566883|NCT02798211|364074837|FG004|Period 1|Protocol Violation|0|||
105566884|NCT02798211|364074838|FG005|Period 1|Protocol Violation|0|||
105566885|NCT02798211|364074833|FG000|Period 1|Withdrawal by Subject|1|||
105566886|NCT02798211|364074834|FG001|Period 1|Withdrawal by Subject|1|||
105566887|NCT02798211|364074835|FG002|Period 1|Withdrawal by Subject|0|||
105566888|NCT02798211|364074836|FG003|Period 1|Withdrawal by Subject|0|||
105566889|NCT02798211|364074837|FG004|Period 1|Withdrawal by Subject|0|||
105566890|NCT02798211|364074838|FG005|Period 1|Withdrawal by Subject|0|||
105566891|NCT02798211|364074833|FG000|Period 1|Death|0|||
105566892|NCT02798211|364074834|FG001|Period 1|Death|0|||
105566893|NCT02798211|364074835|FG002|Period 1|Death|1|||
105566894|NCT02798211|364074836|FG003|Period 1|Death|0|||
105566895|NCT02798211|364074837|FG004|Period 1|Death|0|||
105566896|NCT02798211|364074838|FG005|Period 1|Death|0|||
105566897|NCT02798211|364074833|FG000|Period 1|Withdrawal of Informed Consent|2|||
105566898|NCT02798211|364074834|FG001|Period 1|Withdrawal of Informed Consent|7|||
105566899|NCT02798211|364074835|FG002|Period 1|Withdrawal of Informed Consent|3|||
105566900|NCT02798211|364074836|FG003|Period 1|Withdrawal of Informed Consent|0|||
105566901|NCT02798211|364074837|FG004|Period 1|Withdrawal of Informed Consent|0|||
105566902|NCT02798211|364074838|FG005|Period 1|Withdrawal of Informed Consent|0|||
105566903|NCT02798211|364074833|FG000|Period 2|Withdrawal by Subject|2|||
105566904|NCT02798211|364074834|FG001|Period 2|Withdrawal by Subject|0|||
105566905|NCT02798211|364074835|FG002|Period 2|Withdrawal by Subject|0|||
105566906|NCT02798211|364074836|FG003|Period 2|Withdrawal by Subject|0|||
105566907|NCT02798211|364074837|FG004|Period 2|Withdrawal by Subject|2|||
105566908|NCT02798211|364074838|FG005|Period 2|Withdrawal by Subject|2|||
105566909|NCT02798211|364074833|FG000|Period 2|Adverse Event|5|||
105566910|NCT02798211|364074834|FG001|Period 2|Adverse Event|0|||
105566911|NCT02798211|364074835|FG002|Period 2|Adverse Event|0|||
105566912|NCT02798211|364074836|FG003|Period 2|Adverse Event|0|||
105566913|NCT02798211|364074837|FG004|Period 2|Adverse Event|1|||
105566914|NCT02798211|364074838|FG005|Period 2|Adverse Event|0|||
105566915|NCT02798211|364074833|FG000|Period 2|Lack of Efficacy|1|||
105566916|NCT02798211|364074834|FG001|Period 2|Lack of Efficacy|0|||
105566917|NCT02798211|364074835|FG002|Period 2|Lack of Efficacy|0|||
105566918|NCT02798211|364074836|FG003|Period 2|Lack of Efficacy|1|||
105566919|NCT02798211|364074837|FG004|Period 2|Lack of Efficacy|0|||
105566920|NCT02798211|364074838|FG005|Period 2|Lack of Efficacy|1|||
105566921|NCT02798211|364074833|FG000|Period 2|Lost to Follow-up|3|||
105566922|NCT02798211|364074834|FG001|Period 2|Lost to Follow-up|0|||
105566923|NCT02798211|364074835|FG002|Period 2|Lost to Follow-up|0|||
105566924|NCT02798211|364074836|FG003|Period 2|Lost to Follow-up|0|||
105566925|NCT02798211|364074837|FG004|Period 2|Lost to Follow-up|2|||
105566926|NCT02798211|364074838|FG005|Period 2|Lost to Follow-up|0|||
105566927|NCT02798211|364074833|FG000|Period 2|Physician Decision|1|||
105566928|NCT02798211|364074834|FG001|Period 2|Physician Decision|0|||
105566929|NCT02798211|364074835|FG002|Period 2|Physician Decision|0|||
105566930|NCT02798211|364074836|FG003|Period 2|Physician Decision|1|||
105566931|NCT02798211|364074837|FG004|Period 2|Physician Decision|1|||
105566932|NCT02798211|364074838|FG005|Period 2|Physician Decision|0|||
105566933|NCT02798211|364074833|FG000|Period 2|Pregnancy|0|||
105566934|NCT02798211|364074834|FG001|Period 2|Pregnancy|0|||
105566935|NCT02798211|364074835|FG002|Period 2|Pregnancy|0|||
105566936|NCT02798211|364074836|FG003|Period 2|Pregnancy|2|||
105566937|NCT02798211|364074837|FG004|Period 2|Pregnancy|0|||
105566938|NCT02798211|364074838|FG005|Period 2|Pregnancy|0|||
105566939|NCT02798211|364074833|FG000|Period 2|Technical problems|1|||
105566940|NCT02798211|364074834|FG001|Period 2|Technical problems|0|||
105566941|NCT02798211|364074835|FG002|Period 2|Technical problems|0|||
105566942|NCT02798211|364074836|FG003|Period 2|Technical problems|1|||
105566943|NCT02798211|364074837|FG004|Period 2|Technical problems|0|||
105566944|NCT02798211|364074838|FG005|Period 2|Technical problems|0|||
105566945|NCT02798211|364074833|FG000|Period 2|Withdrawal of Informed Consent|1|||
105566946|NCT02798211|364074834|FG001|Period 2|Withdrawal of Informed Consent|0|||
105566947|NCT02798211|364074835|FG002|Period 2|Withdrawal of Informed Consent|0|||
105566948|NCT02798211|364074836|FG003|Period 2|Withdrawal of Informed Consent|2|||
105566949|NCT02798211|364074837|FG004|Period 2|Withdrawal of Informed Consent|2|||
105566950|NCT02798211|364074838|FG005|Period 2|Withdrawal of Informed Consent|3|||
105566951|NCT05292534|364074839|FG000|Overall Study|Protocol Violation|3|||
105566952|NCT05292534|364074840|FG001|Overall Study|Protocol Violation|4|||
105566953|NCT05292534|364074839|FG000|Overall Study|Withdrawal by Subject|0|||
105566954|NCT05292534|364074840|FG001|Overall Study|Withdrawal by Subject|1|||
105566955|NCT01782872|364074841|FG000|Overall Study|Protocol Violation|0|||
105566956|NCT01782872|364074842|FG001|Overall Study|Protocol Violation|0|||
105566957|NCT01782872|364074843|FG002|Overall Study|Protocol Violation|0|||
105566958|NCT01782872|364074844|FG003|Overall Study|Protocol Violation|1|||
105566959|NCT01782872|364074841|FG000|Overall Study|Withdrawal by Subject|0|||
105566960|NCT01782872|364074842|FG001|Overall Study|Withdrawal by Subject|1|||
105566961|NCT01782872|364074843|FG002|Overall Study|Withdrawal by Subject|0|||
105753655|NCT03334396|364750226|FG001|Overall Study|Physician Decision|0|||
105753656|NCT03334396|364750227|FG002|Overall Study|Physician Decision|0|||
105753657|NCT03334396|364750228|FG003|Overall Study|Physician Decision|0|||
105566962|NCT01782872|364074844|FG003|Overall Study|Withdrawal by Subject|0|||
105566963|NCT01892345|364074845|FG000|Overall Study|Adverse Event|0|||
105566964|NCT01892345|364074846|FG001|Overall Study|Adverse Event|2|||
105753658|NCT03334396|364750229|FG004|Overall Study|Physician Decision|0|||
105753659|NCT03334396|364750230|FG005|Overall Study|Physician Decision|0|||
105753660|NCT03334396|364750231|FG006|Overall Study|Physician Decision|0|||
105753661|NCT03334396|364750232|FG007|Overall Study|Physician Decision|0|||
105566965|NCT01892345|364074845|FG000|Overall Study|Death|1|||
105566966|NCT01892345|364074846|FG001|Overall Study|Death|0|||
105566967|NCT01892345|364074845|FG000|Overall Study|Lost to Follow-up|3|||
105753662|NCT03334396|364750225|FG000|Overall Study|Withdrawal by Subject|10|||
105753663|NCT03334396|364750226|FG001|Overall Study|Withdrawal by Subject|5|||
105566968|NCT01892345|364074846|FG001|Overall Study|Lost to Follow-up|0|||
105566969|NCT01892345|364074845|FG000|Overall Study|Withdrawal by Subject|12|||
105753664|NCT03334396|364750227|FG002|Overall Study|Withdrawal by Subject|7|||
105566970|NCT01892345|364074846|FG001|Overall Study|Withdrawal by Subject|1|||
105566971|NCT02487810|364074848|FG000|Overall Study|Withdrawal by Subject|1|||
105566972|NCT02487810|364074849|FG001|Overall Study|Withdrawal by Subject|0|||
105566973|NCT01889186|364074850|FG000|Overall Study|Adverse event- not related to progression|18|||
105566974|NCT01889186|364074851|FG001|Overall Study|Adverse event- not related to progression|5|||
105566975|NCT01889186|364074850|FG000|Overall Study|Adverse event- related to progression|7|||
105566976|NCT01889186|364074851|FG001|Overall Study|Adverse event- related to progression|2|||
105566977|NCT01889186|364074850|FG000|Overall Study|COVID-19 logistical restrictions|1|||
105566978|NCT01889186|364074851|FG001|Overall Study|COVID-19 logistical restrictions|0|||
105566979|NCT01889186|364074850|FG000|Overall Study|Investigator request|1|||
105566980|NCT01889186|364074851|FG001|Overall Study|Investigator request|1|||
105566981|NCT01889186|364074850|FG000|Overall Study|Progressive disease- Richter's|12|||
105566982|NCT01889186|364074851|FG001|Overall Study|Progressive disease- Richter's|7|||
105566983|NCT01889186|364074850|FG000|Overall Study|Progressive disease per protocol|46|||
105802090|NCT03705169|364930714|FG001|Overall Study|Concerns about study visit compliance|0|||
105802091|NCT03705169|364930715|FG002|Overall Study|Concerns about study visit compliance|0|||
105802092|NCT03705169|364930716|FG003|Overall Study|Concerns about study visit compliance|1|||
105802093|NCT03705169|364930717|FG004|Overall Study|Concerns about study visit compliance|0|||
105802094|NCT03705169|364930718|FG005|Overall Study|Concerns about study visit compliance|0|||
105802095|NCT03705169|364930719|FG006|Overall Study|Concerns about study visit compliance|0|||
105802096|NCT03705169|364930720|FG007|Overall Study|Concerns about study visit compliance|0|||
105802097|NCT03705169|364930721|FG008|Overall Study|Concerns about study visit compliance|0|||
105802098|NCT03705169|364930722|FG009|Overall Study|Concerns about study visit compliance|0|||
105802099|NCT00185211|364930723|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
105802100|NCT00185211|364930724|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
105802101|NCT00185211|364930723|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
105802102|NCT00185211|364930724|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
105802103|NCT00185211|364930723|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
105802104|NCT00185211|364930724|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
105566984|NCT01889186|364074851|FG001|Overall Study|Progressive disease per protocol|17|||
105566985|NCT01889186|364074850|FG000|Overall Study|Stem cell transplant|2|||
105566986|NCT01889186|364074851|FG001|Overall Study|Stem cell transplant|1|||
105566987|NCT01889186|364074850|FG000|Overall Study|Withdrew consent|2|||
105566988|NCT01889186|364074851|FG001|Overall Study|Withdrew consent|3|||
105566989|NCT01889186|364074850|FG000|Overall Study|Other, not specified|18|||
105566990|NCT01889186|364074851|FG001|Overall Study|Other, not specified|15|||
105566991|NCT00621543|364074852|FG000|Overall Study|Lost to Follow-up|23|||
105360408|NCT00905424|363325946|FG001|Overall Study|Lost to Follow-up|3|||
105566992|NCT01287611|364074855|FG000|Overall Study|Lost to Follow-up|29|||
105566993|NCT01287611|364074856|FG001|Overall Study|Lost to Follow-up|16|||
105566994|NCT01287611|364074855|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
105566995|NCT01287611|364074856|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
105566996|NCT02255357|364074859|FG000|Overall Study|Physician Decision|10|||
105360409|NCT00905424|363325945|FG000|Overall Study|Withdrawal by Subject|1|||
105566997|NCT02255357|364074860|FG001|Overall Study|Physician Decision|24|||
105566998|NCT02192970|364074861|FG000|Overall Study|Lost to Follow-up|6|||
105566999|NCT02192970|364074862|FG001|Overall Study|Lost to Follow-up|0|||
105567000|NCT04074590|364074865|FG000|Overall Study|Adverse Event|1|||
105567001|NCT04074590|364074866|FG001|Overall Study|Adverse Event|0|||
105567002|NCT04074590|364074865|FG000|Overall Study|Physician Decision|1|||
105567003|NCT04074590|364074866|FG001|Overall Study|Physician Decision|0|||
105567004|NCT04074590|364074865|FG000|Overall Study|Withdrawal by Subject|2|||
105567005|NCT04074590|364074866|FG001|Overall Study|Withdrawal by Subject|0|||
105567006|NCT02709005|364074867|FG000|Overall Study|Lost to Follow-up|1|||
105567007|NCT02709005|364074868|FG001|Overall Study|Lost to Follow-up|1|||
105567008|NCT02709005|364074867|FG000|Overall Study|Withdrawal by Subject|3|||
105567009|NCT02709005|364074868|FG001|Overall Study|Withdrawal by Subject|0|||
105567010|NCT01282801|364074875|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
105567011|NCT01282801|364074876|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
105567012|NCT01364597|364074880|FG000|Overall Study|Adverse Event|4|||
105567013|NCT01364597|364074881|FG001|Overall Study|Adverse Event|5|||
105567014|NCT01364597|364074882|FG002|Overall Study|Adverse Event|16|||
105567015|NCT01364597|364074883|FG003|Overall Study|Adverse Event|7|||
105567016|NCT01364597|364074880|FG000|Overall Study|Lack of Efficacy|4|||
105567017|NCT01364597|364074881|FG001|Overall Study|Lack of Efficacy|4|||
105567018|NCT01364597|364074882|FG002|Overall Study|Lack of Efficacy|23|||
105567019|NCT01364597|364074883|FG003|Overall Study|Lack of Efficacy|8|||
105567020|NCT01364597|364074880|FG000|Overall Study|Protocol Violation|0|||
105567021|NCT01364597|364074881|FG001|Overall Study|Protocol Violation|0|||
105567022|NCT01364597|364074882|FG002|Overall Study|Protocol Violation|2|||
105567023|NCT01364597|364074883|FG003|Overall Study|Protocol Violation|0|||
105567024|NCT01364597|364074880|FG000|Overall Study|Lost to Follow-up|0|||
105567025|NCT01364597|364074881|FG001|Overall Study|Lost to Follow-up|0|||
105567026|NCT01364597|364074882|FG002|Overall Study|Lost to Follow-up|5|||
105567027|NCT01364597|364074883|FG003|Overall Study|Lost to Follow-up|3|||
105567028|NCT01364597|364074880|FG000|Overall Study|Withdrawal by Subject|4|||
105567029|NCT01364597|364074881|FG001|Overall Study|Withdrawal by Subject|1|||
105567030|NCT01364597|364074882|FG002|Overall Study|Withdrawal by Subject|18|||
105567031|NCT01364597|364074883|FG003|Overall Study|Withdrawal by Subject|6|||
105567032|NCT01364597|364074880|FG000|Overall Study|Non compliance|1|||
105567033|NCT01364597|364074881|FG001|Overall Study|Non compliance|0|||
105567034|NCT01364597|364074882|FG002|Overall Study|Non compliance|1|||
105567035|NCT01364597|364074883|FG003|Overall Study|Non compliance|0|||
105567036|NCT01364597|364074880|FG000|Overall Study|Lack of compliance|1|||
105567037|NCT01364597|364074881|FG001|Overall Study|Lack of compliance|0|||
105567038|NCT01364597|364074882|FG002|Overall Study|Lack of compliance|0|||
105567039|NCT01364597|364074883|FG003|Overall Study|Lack of compliance|0|||
105567040|NCT01364597|364074880|FG000|Overall Study|End of treatment epilepsy|1|||
105567041|NCT01364597|364074881|FG001|Overall Study|End of treatment epilepsy|0|||
105567042|NCT01364597|364074882|FG002|Overall Study|End of treatment epilepsy|0|||
105567043|NCT01364597|364074883|FG003|Overall Study|End of treatment epilepsy|0|||
105567044|NCT01364597|364074880|FG000|Overall Study|No Seizures|1|||
105567045|NCT01364597|364074881|FG001|Overall Study|No Seizures|0|||
105567046|NCT01364597|364074882|FG002|Overall Study|No Seizures|0|||
105567047|NCT01364597|364074883|FG003|Overall Study|No Seizures|0|||
105567048|NCT01364597|364074880|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
105567049|NCT01364597|364074881|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
105567050|NCT01364597|364074882|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
105567051|NCT01364597|364074883|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
105567052|NCT01364597|364074880|FG000|Overall Study|Cure|1|||
105567053|NCT01364597|364074881|FG001|Overall Study|Cure|0|||
105567054|NCT01364597|364074882|FG002|Overall Study|Cure|0|||
105567055|NCT01364597|364074883|FG003|Overall Study|Cure|0|||
105753665|NCT03334396|364750228|FG003|Overall Study|Withdrawal by Subject|2|||
105753666|NCT03334396|364750229|FG004|Overall Study|Withdrawal by Subject|2|||
105753667|NCT03334396|364750230|FG005|Overall Study|Withdrawal by Subject|1|||
105753668|NCT03334396|364750231|FG006|Overall Study|Withdrawal by Subject|2|||
105567056|NCT01364597|364074880|FG000|Overall Study|Patient was moving|0|||
105567057|NCT01364597|364074881|FG001|Overall Study|Patient was moving|1|||
105567058|NCT01364597|364074882|FG002|Overall Study|Patient was moving|0|||
105753669|NCT03334396|364750232|FG007|Overall Study|Withdrawal by Subject|0|||
105567059|NCT01364597|364074883|FG003|Overall Study|Patient was moving|0|||
105567060|NCT01364597|364074880|FG000|Overall Study|Seizures resolved|0|||
105567061|NCT01364597|364074881|FG001|Overall Study|Seizures resolved|0|||
105753670|NCT03334396|364750225|FG000|Overall Study|Pregnancy|0|||
105753671|NCT03334396|364750226|FG001|Overall Study|Pregnancy|1|||
105753672|NCT03334396|364750227|FG002|Overall Study|Pregnancy|0|||
105753673|NCT03334396|364750228|FG003|Overall Study|Pregnancy|0|||
105753674|NCT03334396|364750229|FG004|Overall Study|Pregnancy|0|||
105753675|NCT03334396|364750230|FG005|Overall Study|Pregnancy|0|||
105753676|NCT03334396|364750231|FG006|Overall Study|Pregnancy|0|||
105753677|NCT03334396|364750232|FG007|Overall Study|Pregnancy|0|||
105567062|NCT01364597|364074882|FG002|Overall Study|Seizures resolved|1|||
105567063|NCT01364597|364074883|FG003|Overall Study|Seizures resolved|0|||
105567064|NCT01364597|364074880|FG000|Overall Study|Patient became seizure-free after surgery|0|||
105567065|NCT01364597|364074881|FG001|Overall Study|Patient became seizure-free after surgery|0|||
105567066|NCT01364597|364074882|FG002|Overall Study|Patient became seizure-free after surgery|1|||
105567067|NCT01364597|364074883|FG003|Overall Study|Patient became seizure-free after surgery|0|||
105567068|NCT01364597|364074880|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
105567069|NCT01364597|364074881|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
105567070|NCT01364597|364074882|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
105567071|NCT01364597|364074883|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
105567072|NCT01364597|364074880|FG000|Overall Study|Patient cured from Epilepsy|0|||
105567073|NCT01364597|364074881|FG001|Overall Study|Patient cured from Epilepsy|0|||
105753678|NCT03334396|364750225|FG000|Overall Study|Ineligible|0|||
105753679|NCT03334396|364750226|FG001|Overall Study|Ineligible|1|||
105753680|NCT03334396|364750227|FG002|Overall Study|Ineligible|0|||
105753681|NCT03334396|364750228|FG003|Overall Study|Ineligible|0|||
105753682|NCT03334396|364750229|FG004|Overall Study|Ineligible|0|||
105753683|NCT03334396|364750230|FG005|Overall Study|Ineligible|0|||
105753684|NCT03334396|364750231|FG006|Overall Study|Ineligible|0|||
105753685|NCT03334396|364750232|FG007|Overall Study|Ineligible|0|||
105753686|NCT03334396|364750225|FG000|Overall Study|Started New Job|1|||
105753687|NCT03334396|364750226|FG001|Overall Study|Started New Job|0|||
105753688|NCT03334396|364750227|FG002|Overall Study|Started New Job|0|||
105753689|NCT03334396|364750228|FG003|Overall Study|Started New Job|0|||
105753690|NCT03334396|364750229|FG004|Overall Study|Started New Job|0|||
105753691|NCT03334396|364750230|FG005|Overall Study|Started New Job|0|||
105753692|NCT03334396|364750231|FG006|Overall Study|Started New Job|0|||
105753693|NCT03334396|364750232|FG007|Overall Study|Started New Job|0|||
105753694|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
105753695|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
105753696|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
105753697|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
105753698|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
105753699|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
105753700|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
105753701|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
105753702|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
105753703|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
105753704|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
105753705|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
105753706|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
105753707|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
105753708|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
105753709|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
105753710|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Missing|3|||
105753711|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Missing|1|||
105753712|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
105753713|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
105753714|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
105753715|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
105753716|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
105753717|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
105753718|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
105753719|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
105753720|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
105753721|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
105753722|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
105753723|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
105753724|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
105753725|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
105753726|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
105753727|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
105753728|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
105753729|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
105753730|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Missing|3|||
105753731|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Missing|0|||
105753732|NCT01969799|364750235|FG000|Overall Study|Adverse Event|0|||
105753733|NCT01969799|364750236|FG001|Overall Study|Adverse Event|1|||
105753734|NCT01969799|364750235|FG000|Overall Study|Death|16|||
105753735|NCT01969799|364750236|FG001|Overall Study|Death|11|||
105753736|NCT01969799|364750235|FG000|Overall Study|Lost to Follow-up|0|||
105753737|NCT01969799|364750236|FG001|Overall Study|Lost to Follow-up|2|||
105753738|NCT01969799|364750235|FG000|Overall Study|Physician Decision|1|||
105753739|NCT01969799|364750236|FG001|Overall Study|Physician Decision|0|||
105753740|NCT02927873|364750237|FG000|Overall Study|Lost to Follow-up|0|||
105753741|NCT02927873|364750238|FG001|Overall Study|Lost to Follow-up|1|||
105753742|NCT02927873|364750239|FG002|Overall Study|Lost to Follow-up|0|||
105753743|NCT02927873|364750240|FG003|Overall Study|Lost to Follow-up|0|||
105753744|NCT02927873|364750241|FG004|Overall Study|Lost to Follow-up|0|||
105753745|NCT02927873|364750242|FG005|Overall Study|Lost to Follow-up|0|||
105753746|NCT02927873|364750237|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105753747|NCT02927873|364750238|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
105753748|NCT02927873|364750239|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105753749|NCT02927873|364750240|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105753750|NCT02927873|364750241|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105753751|NCT02927873|364750242|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105753752|NCT02927873|364750237|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753753|NCT02927873|364750238|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753754|NCT02927873|364750239|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753755|NCT02927873|364750240|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753756|NCT02927873|364750241|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753757|NCT02927873|364750242|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105753758|NCT02927873|364750237|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
105753759|NCT02927873|364750238|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
105753760|NCT02927873|364750239|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
105753761|NCT02927873|364750240|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
105753762|NCT02927873|364750241|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
105753763|NCT02927873|364750242|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
105753764|NCT02927873|364750237|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
105753765|NCT02927873|364750238|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
105753766|NCT02927873|364750239|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
105753767|NCT02927873|364750240|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
105753768|NCT02927873|364750241|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
105753769|NCT02927873|364750242|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
105753770|NCT02927873|364750237|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
105753771|NCT02927873|364750238|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
105753772|NCT02927873|364750239|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
105753773|NCT02927873|364750240|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
105753774|NCT02927873|364750241|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
105753775|NCT02927873|364750242|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
105802105|NCT00185211|364930723|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
105802106|NCT00185211|364930724|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
105802107|NCT00185211|364930723|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
105802108|NCT00185211|364930724|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
105802109|NCT00185211|364930723|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
105802110|NCT00185211|364930724|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
105802111|NCT00185211|364930723|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
105802112|NCT00185211|364930724|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
105802113|NCT00185211|364930723|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
105802114|NCT00185211|364930724|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
105802115|NCT00185211|364930723|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
105802116|NCT00185211|364930724|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
105802117|NCT00185211|364930723|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
105802118|NCT00185211|364930724|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
105567074|NCT01364597|364074882|FG002|Overall Study|Patient cured from Epilepsy|1|||
105567075|NCT01364597|364074883|FG003|Overall Study|Patient cured from Epilepsy|0|||
105567076|NCT01364597|364074880|FG000|Overall Study|Investigator decision|0|||
105567077|NCT01364597|364074881|FG001|Overall Study|Investigator decision|0|||
105567078|NCT01364597|364074882|FG002|Overall Study|Investigator decision|1|||
105567079|NCT01364597|364074883|FG003|Overall Study|Investigator decision|0|||
105567080|NCT01364597|364074880|FG000|Overall Study|Sponsor recommended discontinuation|0|||
105567081|NCT01364597|364074881|FG001|Overall Study|Sponsor recommended discontinuation|0|||
105567082|NCT01364597|364074882|FG002|Overall Study|Sponsor recommended discontinuation|0|||
105567083|NCT01364597|364074883|FG003|Overall Study|Sponsor recommended discontinuation|1|||
105753776|NCT02034474|364750243|FG000|Overall Study|Adverse Event|3|||
105753777|NCT02034474|364750244|FG001|Overall Study|Adverse Event|2|||
105753778|NCT02034474|364750243|FG000|Overall Study|Withdrawal by Subject|1|||
105753779|NCT02034474|364750244|FG001|Overall Study|Withdrawal by Subject|2|||
105753780|NCT01391819|364750250|FG000|Overall Study|Withdrawal by Subject|56|||
105753781|NCT01391819|364750250|FG000|Overall Study|Migrated/moved from study area|82|||
105753782|NCT01391819|364750250|FG000|Overall Study|Lost to Follow-up|252|||
105753783|NCT01391819|364750250|FG000|Overall Study|Death|3|||
105753784|NCT01391819|364750250|FG000|Overall Study|Other|9|||
105753785|NCT03629041|364750251|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
105753786|NCT03629041|364750252|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
105753787|NCT03629041|364750253|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
105753788|NCT03629041|364750254|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
105753789|NCT00393913|364750256|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
105753790|NCT00393913|364750256|FG000|Initial Assessment|Withdrawal by Subject|16|||
105753791|NCT00393913|364750256|FG000|CPAP|Withdrawal by Subject|3|||
105753792|NCT00393913|364750256|FG000|CPAP|Physician Decision|1|||
105753793|NCT00393913|364750256|FG000|CPAP|TEchnical problem with CPAP|3|||
105753794|NCT03488251|364750257|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
105753795|NCT03488251|364750258|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
105753796|NCT03488251|364750259|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
105753797|NCT03488251|364750260|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
105753798|NCT03488251|364750257|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
105753799|NCT03488251|364750258|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
105753800|NCT03488251|364750259|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
105753801|NCT03488251|364750260|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
105753802|NCT03488251|364750257|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
105753803|NCT03488251|364750258|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
105753804|NCT03488251|364750259|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
105753805|NCT03488251|364750260|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
105802119|NCT00185211|364930723|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
105753806|NCT03488251|364750257|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
105753807|NCT03488251|364750258|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
105753808|NCT03488251|364750259|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
105753809|NCT03488251|364750260|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
105753810|NCT03488251|364750257|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
105753811|NCT03488251|364750258|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
105753812|NCT03488251|364750259|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
105753813|NCT03488251|364750260|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
105753814|NCT00178464|364750263|FG000|Overall Study|Withdrawal by Subject|1|||
105753815|NCT00178464|364750263|FG000|Overall Study|Physician Decision|1|||
105753816|NCT00870818|364750264|FG000|Overall Study|Lost to Follow-up|3|||
105753817|NCT00870818|364750265|FG001|Overall Study|Lost to Follow-up|2|||
105753818|NCT00870818|364750266|FG002|Overall Study|Lost to Follow-up|1|||
105753819|NCT00870818|364750267|FG003|Overall Study|Lost to Follow-up|0|||
105753820|NCT00870818|364750268|FG004|Overall Study|Lost to Follow-up|0|||
105753821|NCT00870818|364750264|FG000|Overall Study|Withdrawal by Subject|0|||
105753822|NCT00870818|364750265|FG001|Overall Study|Withdrawal by Subject|0|||
105753823|NCT00870818|364750266|FG002|Overall Study|Withdrawal by Subject|1|||
105753824|NCT00870818|364750267|FG003|Overall Study|Withdrawal by Subject|2|||
105753825|NCT00870818|364750268|FG004|Overall Study|Withdrawal by Subject|0|||
105753826|NCT00870818|364750264|FG000|Overall Study|Terminated by sponsor|29|||
105753827|NCT00870818|364750265|FG001|Overall Study|Terminated by sponsor|70|||
105753828|NCT00870818|364750266|FG002|Overall Study|Terminated by sponsor|36|||
105753829|NCT00870818|364750267|FG003|Overall Study|Terminated by sponsor|36|||
105753830|NCT00870818|364750268|FG004|Overall Study|Terminated by sponsor|38|||
105753831|NCT00870818|364750264|FG000|Overall Study|Other|0|||
105753832|NCT00870818|364750265|FG001|Overall Study|Other|1|||
105753833|NCT00870818|364750266|FG002|Overall Study|Other|0|||
105753834|NCT00870818|364750267|FG003|Overall Study|Other|0|||
105753835|NCT00870818|364750268|FG004|Overall Study|Other|0|||
105753836|NCT00995670|364750269|FG000|Overall Study|Failed arterial cannulation|1|||
105753837|NCT00995670|364750270|FG001|Overall Study|Failed arterial cannulation|0|||
105753838|NCT00995670|364750271|FG002|Overall Study|Failed arterial cannulation|3|||
105753839|NCT02227108|364750272|FG000|Overall Study|Did not receive treatment|2|||
105753840|NCT02227108|364750272|FG000|Overall Study|Other|3|||
105753841|NCT02227108|364750272|FG000|Overall Study|Progressive disease|17|||
105753842|NCT02227108|364750272|FG000|Overall Study|Initiation of alternative therapy|2|||
105753843|NCT02227108|364750272|FG000|Overall Study|Investigator discretion|1|||
105753844|NCT02227108|364750272|FG000|Overall Study|Adverse Event|6|||
105753845|NCT02486952|364750273|FG000|Overall Study|Not Started Induction Therapy|3|||
105753846|NCT02486952|364750273|FG000|Overall Study|Adverse Event|1|||
105753847|NCT02486952|364750273|FG000|Overall Study|Death|15|||
105753848|NCT02486952|364750273|FG000|Overall Study|Lack of Efficacy|3|||
105753849|NCT02486952|364750273|FG000|Overall Study|Lost to Follow-up|26|||
105753850|NCT02486952|364750273|FG000|Overall Study|Other|2|||
105753851|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
105753852|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
105753853|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
105753854|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
105567084|NCT01364597|364074880|FG000|Overall Study|Parents went abroad with the patient|0|||
105567085|NCT01364597|364074881|FG001|Overall Study|Parents went abroad with the patient|0|||
105567086|NCT01364597|364074882|FG002|Overall Study|Parents went abroad with the patient|1|||
105567087|NCT01364597|364074883|FG003|Overall Study|Parents went abroad with the patient|0|||
105567088|NCT01364597|364074880|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
105567089|NCT01364597|364074881|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
105567090|NCT01364597|364074882|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
105567091|NCT01364597|364074883|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
105567092|NCT01364597|364074880|FG000|Overall Study|BRV administration dropout|0|||
105567093|NCT01364597|364074881|FG001|Overall Study|BRV administration dropout|0|||
105567094|NCT01364597|364074882|FG002|Overall Study|BRV administration dropout|1|||
105567095|NCT01364597|364074883|FG003|Overall Study|BRV administration dropout|0|||
105567096|NCT01364597|364074880|FG000|Overall Study|Dropout|0|||
105567097|NCT01364597|364074881|FG001|Overall Study|Dropout|0|||
105567098|NCT01364597|364074882|FG002|Overall Study|Dropout|3|||
105567099|NCT01364597|364074883|FG003|Overall Study|Dropout|1|||
105567100|NCT01364597|364074880|FG000|Overall Study|Unreliable subject|0|||
105567101|NCT01364597|364074881|FG001|Overall Study|Unreliable subject|0|||
105567102|NCT01364597|364074882|FG002|Overall Study|Unreliable subject|0|||
105567103|NCT01364597|364074883|FG003|Overall Study|Unreliable subject|1|||
105567104|NCT01364597|364074880|FG000|Overall Study|Other|0|||
105567105|NCT01364597|364074881|FG001|Overall Study|Other|0|||
105567106|NCT01364597|364074882|FG002|Overall Study|Other|0|||
105567107|NCT01364597|364074883|FG003|Overall Study|Other|1|||
105567108|NCT01498822|364074884|FG000|Overall Study|Protocol Violation|8|||
105567109|NCT01498822|364074885|FG001|Overall Study|Protocol Violation|4|||
105567110|NCT01498822|364074884|FG000|Overall Study|Other Reason|5|||
105567111|NCT01498822|364074885|FG001|Overall Study|Other Reason|2|||
105567112|NCT01498822|364074884|FG000|Overall Study|Lack of Efficacy|7|||
105567113|NCT01498822|364074885|FG001|Overall Study|Lack of Efficacy|2|||
105567114|NCT01498822|364074884|FG000|Overall Study|AE, non-serious non-fatal|8|||
105567115|NCT01498822|364074885|FG001|Overall Study|AE, non-serious non-fatal|17|||
105567116|NCT01498822|364074884|FG000|Overall Study|SAE, non-fatal|2|||
105567117|NCT01498822|364074885|FG001|Overall Study|SAE, non-fatal|2|||
105567118|NCT01498822|364074884|FG000|Overall Study|Adverse Event, serious fatal|1|||
105567119|NCT01498822|364074885|FG001|Overall Study|Adverse Event, serious fatal|1|||
105567120|NCT01498822|364074884|FG000|Overall Study|Withdrawal by Subject|15|||
105567121|NCT01498822|364074885|FG001|Overall Study|Withdrawal by Subject|25|||
105567122|NCT01498822|364074884|FG000|Overall Study|Lost to Follow-up|8|||
105567123|NCT01498822|364074885|FG001|Overall Study|Lost to Follow-up|3|||
105567124|NCT03131960|364074887|FG000|Overall Study|Adverse Event|0|||
105567125|NCT03131960|364074888|FG001|Overall Study|Adverse Event|1|||
105567126|NCT04707196|364074889|FG000|Overall Study|Withdrawal by Subject|9|||
105567127|NCT04707196|364074890|FG001|Overall Study|Withdrawal by Subject|6|||
105567128|NCT04707196|364074889|FG000|Overall Study|Lost to Follow-up|1|||
105567129|NCT04707196|364074890|FG001|Overall Study|Lost to Follow-up|0|||
105567130|NCT04707196|364074889|FG000|Overall Study|Protocol Violation|4|||
105567131|NCT04707196|364074890|FG001|Overall Study|Protocol Violation|1|||
105567132|NCT04707196|364074889|FG000|Overall Study|Adverse Event|2|||
105567133|NCT04707196|364074890|FG001|Overall Study|Adverse Event|2|||
105567134|NCT04707196|364074889|FG000|Overall Study|Death|3|||
105567135|NCT04707196|364074890|FG001|Overall Study|Death|1|||
105567136|NCT04707196|364074889|FG000|Overall Study|Non-compliance with study drug|1|||
105567137|NCT04707196|364074890|FG001|Overall Study|Non-compliance with study drug|0|||
105567138|NCT04707196|364074889|FG000|Overall Study|Progressive disease|9|||
105567139|NCT04707196|364074890|FG001|Overall Study|Progressive disease|10|||
105567140|NCT01862796|364074891|FG000|Overall Study|Prohibited medications|0|||
105567141|NCT01862796|364074892|FG001|Overall Study|Prohibited medications|0|||
105567142|NCT01862796|364074893|FG002|Overall Study|Prohibited medications|1|||
105802120|NCT00185211|364930724|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
105802121|NCT00185211|364930723|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
105802122|NCT00185211|364930724|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
105802123|NCT00382291|364932520|FG000|Overall Study|Adverse Event|1|||
105802124|NCT00382291|364932521|FG001|Overall Study|Adverse Event|2|||
105802125|NCT00382291|364932522|FG002|Overall Study|Adverse Event|2|||
105567143|NCT04404478|364074894|FG000|Overall Study|Withdrawal by Subject|1|||
105567144|NCT04404478|364074895|FG001|Overall Study|Withdrawal by Subject|3|||
105567145|NCT03002038|364074904|FG000|Overall Study|Adverse Event|3|||
105802126|NCT00382291|364932520|FG000|Overall Study|Protocol Violation|1|||
105753855|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
105753856|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
105753857|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
105753858|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
105753859|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
105753860|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
105753861|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
105753862|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
105753863|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
105753864|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
105753865|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
105753866|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
105753867|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
105753868|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
105753869|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
105753870|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
105753871|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
105753872|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
105753873|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
105753874|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
105753875|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
105753876|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
105753877|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
105753878|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
105753879|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
105753880|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
105753881|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
105753882|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
105753883|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
105753884|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
105753885|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
105753886|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
105753887|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
105753888|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
105753889|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
105753890|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
105753891|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
105753892|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
105753893|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
105753894|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
105753895|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
105753896|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
105753897|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
105753898|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
105753899|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
105753900|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
105753901|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
105753902|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
105753903|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
105753904|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
105753905|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
105753906|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
105753907|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
105753908|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
105753909|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
105753910|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
105753911|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
105753912|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
105802127|NCT00382291|364932521|FG001|Overall Study|Protocol Violation|0|||
105802128|NCT00382291|364932522|FG002|Overall Study|Protocol Violation|0|||
105802129|NCT00382291|364932520|FG000|Overall Study|Temporary study suspension|2|||
105360410|NCT00905424|363325946|FG001|Overall Study|Withdrawal by Subject|2|||
105567146|NCT03002038|364074905|FG001|Overall Study|Adverse Event|1|||
105567147|NCT03002038|364074904|FG000|Overall Study|Withdrawal by Subject|8|||
105802130|NCT00382291|364932521|FG001|Overall Study|Temporary study suspension|2|||
105802131|NCT00382291|364932522|FG002|Overall Study|Temporary study suspension|5|||
105802132|NCT00382291|364932520|FG000|Overall Study|Withdrawal by Subject|0|||
105802133|NCT00382291|364932521|FG001|Overall Study|Withdrawal by Subject|2|||
105802134|NCT00382291|364932522|FG002|Overall Study|Withdrawal by Subject|0|||
105802135|NCT00382291|364932520|FG000|Overall Study|Physician Decision|0|||
105802136|NCT00382291|364932521|FG001|Overall Study|Physician Decision|1|||
105802137|NCT00382291|364932522|FG002|Overall Study|Physician Decision|0|||
105802138|NCT00382291|364932520|FG000|Overall Study|Lack of Efficacy|0|||
105802139|NCT00382291|364932521|FG001|Overall Study|Lack of Efficacy|0|||
105802140|NCT00382291|364932522|FG002|Overall Study|Lack of Efficacy|1|||
105802141|NCT01375010|364932523|FG000|Overall Study|Lost to Follow-up|8|||
105802142|NCT01375010|364932524|FG001|Overall Study|Lost to Follow-up|2|||
105567148|NCT03002038|364074905|FG001|Overall Study|Withdrawal by Subject|4|||
105802143|NCT01375010|364932523|FG000|Overall Study|Withdrawal by Subject|4|||
105802144|NCT01375010|364932524|FG001|Overall Study|Withdrawal by Subject|2|||
105802145|NCT02266706|364932525|FG000|Overall Study|Withdrawal by Subject|0|||
105802146|NCT02266706|364932526|FG001|Overall Study|Withdrawal by Subject|1|||
105802147|NCT02266706|364932527|FG002|Overall Study|Withdrawal by Subject|1|||
105802148|NCT02266706|364932528|FG003|Overall Study|Withdrawal by Subject|0|||
105802149|NCT02266706|364932529|FG004|Overall Study|Withdrawal by Subject|0|||
105753913|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
105753914|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
105753915|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
105753916|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
105753917|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
105753918|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
105753919|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
105753920|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
105753921|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
105753922|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
105753923|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
105753924|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
105753925|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
105753926|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
105753927|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
105753928|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
105753929|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
105753930|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
105753931|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Administrative|1|||
105753932|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Administrative|2|||
105753933|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Administrative|3|||
105753934|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Administrative|1|||
105753935|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Administrative|0|||
105753936|NCT03814590|364750279|FG000|Overall Study|Adverse Event|0|||
105753937|NCT03814590|364750280|FG001|Overall Study|Adverse Event|0|||
105753938|NCT03814590|364750281|FG002|Overall Study|Adverse Event|0|||
105753939|NCT03814590|364750282|FG003|Overall Study|Adverse Event|0|||
105753940|NCT03814590|364750283|FG004|Overall Study|Adverse Event|0|||
105753941|NCT03814590|364750284|FG005|Overall Study|Adverse Event|1|||
105753942|NCT03814590|364750285|FG006|Overall Study|Adverse Event|1|||
105753943|NCT03814590|364750286|FG007|Overall Study|Adverse Event|1|||
105753944|NCT03814590|364750287|FG008|Overall Study|Adverse Event|0|||
105753945|NCT03814590|364750288|FG009|Overall Study|Adverse Event|0|||
105753946|NCT03814590|364750289|FG010|Overall Study|Adverse Event|1|||
105753947|NCT03814590|364750290|FG011|Overall Study|Adverse Event|0|||
105753948|NCT03814590|364750291|FG012|Overall Study|Adverse Event|3|||
105753949|NCT03814590|364750292|FG013|Overall Study|Adverse Event|0|||
105753950|NCT03814590|364750279|FG000|Overall Study|Lost to Follow-up|0|||
105753951|NCT03814590|364750280|FG001|Overall Study|Lost to Follow-up|2|||
105753952|NCT03814590|364750281|FG002|Overall Study|Lost to Follow-up|1|||
105753953|NCT03814590|364750282|FG003|Overall Study|Lost to Follow-up|0|||
105753954|NCT03814590|364750283|FG004|Overall Study|Lost to Follow-up|1|||
105753955|NCT03814590|364750284|FG005|Overall Study|Lost to Follow-up|1|||
105753956|NCT03814590|364750285|FG006|Overall Study|Lost to Follow-up|1|||
105753957|NCT03814590|364750286|FG007|Overall Study|Lost to Follow-up|1|||
105753958|NCT03814590|364750287|FG008|Overall Study|Lost to Follow-up|0|||
105753959|NCT03814590|364750288|FG009|Overall Study|Lost to Follow-up|0|||
105753960|NCT03814590|364750289|FG010|Overall Study|Lost to Follow-up|1|||
105753961|NCT03814590|364750290|FG011|Overall Study|Lost to Follow-up|0|||
105753962|NCT03814590|364750291|FG012|Overall Study|Lost to Follow-up|0|||
105753963|NCT03814590|364750292|FG013|Overall Study|Lost to Follow-up|1|||
105753964|NCT03814590|364750279|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753965|NCT03814590|364750280|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753966|NCT03814590|364750281|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753967|NCT03814590|364750282|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753968|NCT03814590|364750283|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753969|NCT03814590|364750284|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753970|NCT03814590|364750285|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753971|NCT03814590|364750286|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753972|NCT03814590|364750287|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753973|NCT03814590|364750288|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
105753974|NCT03814590|364750289|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753975|NCT03814590|364750290|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753976|NCT03814590|364750291|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753977|NCT03814590|364750292|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753978|NCT03814590|364750279|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
105760901|NCT01342952|364778054|FG002|Overall Study|Lost to Follow-up|0|||
105802150|NCT02266706|364932530|FG005|Overall Study|Withdrawal by Subject|1|||
105802151|NCT02266706|364932531|FG006|Overall Study|Withdrawal by Subject|0|||
105802152|NCT02266706|364932532|FG007|Overall Study|Withdrawal by Subject|0|||
105802153|NCT02266706|364932533|FG008|Overall Study|Withdrawal by Subject|0|||
105802154|NCT02266706|364932525|FG000|Overall Study|Screen failure|0|||
105802155|NCT02266706|364932526|FG001|Overall Study|Screen failure|0|||
105802156|NCT02266706|364932527|FG002|Overall Study|Screen failure|0|||
105802157|NCT02266706|364932528|FG003|Overall Study|Screen failure|0|||
105802158|NCT02266706|364932529|FG004|Overall Study|Screen failure|0|||
105802159|NCT02266706|364932530|FG005|Overall Study|Screen failure|1|||
105802160|NCT02266706|364932531|FG006|Overall Study|Screen failure|1|||
105802161|NCT02266706|364932532|FG007|Overall Study|Screen failure|0|||
105802162|NCT02266706|364932533|FG008|Overall Study|Screen failure|0|||
105802163|NCT02266706|364932525|FG000|Overall Study|Enrollment in another study|0|||
105802164|NCT02266706|364932526|FG001|Overall Study|Enrollment in another study|0|||
105802165|NCT02266706|364932527|FG002|Overall Study|Enrollment in another study|0|||
105802166|NCT02266706|364932528|FG003|Overall Study|Enrollment in another study|1|||
105567149|NCT03002038|364074904|FG000|Overall Study|Immigration to another region|0|||
105760902|NCT01342952|364778055|FG003|Overall Study|Lost to Follow-up|0|||
105760903|NCT01342952|364778052|FG000|Overall Study|Withdrawal by Subject|1|||
105760904|NCT01342952|364778053|FG001|Overall Study|Withdrawal by Subject|1|||
105760905|NCT01342952|364778054|FG002|Overall Study|Withdrawal by Subject|0|||
105760906|NCT01342952|364778055|FG003|Overall Study|Withdrawal by Subject|0|||
105760907|NCT01342952|364778052|FG000|Overall Study|Physician Decision|3|||
105760908|NCT01342952|364778053|FG001|Overall Study|Physician Decision|3|||
105760909|NCT01342952|364778054|FG002|Overall Study|Physician Decision|1|||
105760910|NCT01342952|364778055|FG003|Overall Study|Physician Decision|0|||
105760911|NCT02156804|364778056|FG000|Overall Study|Withdrawal by Subject|1|||
105760912|NCT00294684|364778061|FG000|Overall Study|Lost to Follow-up|5|||
105760913|NCT00294684|364778062|FG001|Overall Study|Lost to Follow-up|8|||
105760914|NCT04362813|364778063|FG000|Overall Study|Death|12|||
105760915|NCT04362813|364778064|FG001|Overall Study|Death|16|||
105760916|NCT04362813|364778063|FG000|Overall Study|Withdrawal by Subject|3|||
105760917|NCT04362813|364778064|FG001|Overall Study|Withdrawal by Subject|1|||
105760918|NCT04362813|364778063|FG000|Overall Study|Protocol Violation|0|||
105760919|NCT04362813|364778064|FG001|Overall Study|Protocol Violation|3|||
105753979|NCT03814590|364750280|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
105753980|NCT03814590|364750281|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
105753981|NCT03814590|364750282|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
105753982|NCT03814590|364750283|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
105753983|NCT03814590|364750284|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
105753984|NCT03814590|364750285|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
105753985|NCT03814590|364750286|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
105753986|NCT03814590|364750287|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
105753987|NCT03814590|364750288|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
105753988|NCT03814590|364750289|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
105753989|NCT03814590|364750290|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
105753990|NCT03814590|364750291|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
105753991|NCT03814590|364750292|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
105753992|NCT03814590|364750279|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753993|NCT03814590|364750280|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753994|NCT03814590|364750281|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753995|NCT03814590|364750282|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753996|NCT03814590|364750283|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753997|NCT03814590|364750284|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753998|NCT03814590|364750285|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753999|NCT03814590|364750286|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105754000|NCT03814590|364750287|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105754001|NCT03814590|364750288|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105754002|NCT03814590|364750289|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105754003|NCT03814590|364750290|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105754004|NCT03814590|364750291|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105754005|NCT03814590|364750292|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105754006|NCT03814590|364750279|FG000|Overall Study|UNKNOWN REASON|0|||
105754007|NCT03814590|364750280|FG001|Overall Study|UNKNOWN REASON|0|||
105754008|NCT03814590|364750281|FG002|Overall Study|UNKNOWN REASON|0|||
105754009|NCT03814590|364750282|FG003|Overall Study|UNKNOWN REASON|0|||
105754010|NCT03814590|364750283|FG004|Overall Study|UNKNOWN REASON|0|||
105754011|NCT03814590|364750284|FG005|Overall Study|UNKNOWN REASON|0|||
105754012|NCT03814590|364750285|FG006|Overall Study|UNKNOWN REASON|0|||
105754013|NCT03814590|364750286|FG007|Overall Study|UNKNOWN REASON|1|||
105754014|NCT03814590|364750287|FG008|Overall Study|UNKNOWN REASON|0|||
105754015|NCT03814590|364750288|FG009|Overall Study|UNKNOWN REASON|0|||
105754016|NCT03814590|364750289|FG010|Overall Study|UNKNOWN REASON|0|||
105754017|NCT03814590|364750290|FG011|Overall Study|UNKNOWN REASON|0|||
105754018|NCT03814590|364750291|FG012|Overall Study|UNKNOWN REASON|0|||
105754019|NCT03814590|364750292|FG013|Overall Study|UNKNOWN REASON|0|||
105754020|NCT01935336|364750293|FG000|Overall Study|Adverse Event|1|||
105754021|NCT01935336|364750294|FG001|Overall Study|Adverse Event|0|||
105754022|NCT01935336|364750295|FG002|Overall Study|Adverse Event|0|||
105754023|NCT01935336|364750296|FG003|Overall Study|Adverse Event|0|||
105754024|NCT01935336|364750293|FG000|Overall Study|Progressive disease|5|||
105754025|NCT01935336|364750294|FG001|Overall Study|Progressive disease|3|||
105754026|NCT01935336|364750295|FG002|Overall Study|Progressive disease|47|||
105754027|NCT01935336|364750296|FG003|Overall Study|Progressive disease|66|||
105754028|NCT01401465|364750297|FG000|Treatment Period 1|Adverse Event|4|||
105754029|NCT01401465|364750298|FG001|Treatment Period 1|Adverse Event|1|||
105754030|NCT01401465|364750297|FG000|Treatment Period 1|Pregnancy|0|||
105754031|NCT01401465|364750298|FG001|Treatment Period 1|Pregnancy|1|||
105754032|NCT01401465|364750297|FG000|Treatment Period 1|Protocol Violation|5|||
105754033|NCT01401465|364750298|FG001|Treatment Period 1|Protocol Violation|0|||
105754034|NCT01401465|364750297|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105754035|NCT01401465|364750298|FG001|Treatment Period 1|Withdrawal by Subject|4|||
105754036|NCT01401465|364750297|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
105754037|NCT01401465|364750298|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
105754038|NCT01401465|364750297|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
105754039|NCT01401465|364750298|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
105567150|NCT03002038|364074905|FG001|Overall Study|Immigration to another region|2|||
105567151|NCT03351738|364074910|FG000|Overall Study|Withdrawal by Subject|0|||
105567152|NCT03351738|364074911|FG001|Overall Study|Withdrawal by Subject|1|||
105567153|NCT03351738|364074912|FG002|Overall Study|Withdrawal by Subject|0|||
105567154|NCT03351738|364074913|FG003|Overall Study|Withdrawal by Subject|1|||
105567155|NCT03351738|364074914|FG004|Overall Study|Withdrawal by Subject|0|||
105802167|NCT02266706|364932529|FG004|Overall Study|Enrollment in another study|0|||
105567156|NCT03351738|364074915|FG005|Overall Study|Withdrawal by Subject|0|||
105567157|NCT02904902|364074918|FG000|Overall Study|Withdrawal by Subject|1|||
105567158|NCT00946296|364074920|FG000|Overall Study|Physician Decision|3|||
105567159|NCT00946296|364074921|FG001|Overall Study|Physician Decision|0|||
105567160|NCT01320943|364074922|FG000|Overall Study|Lost to Follow-up|1|||
105567161|NCT01320943|364074923|FG001|Overall Study|Lost to Follow-up|0|||
105567162|NCT01320943|364074922|FG000|Overall Study|Physician Decision|0|||
105567163|NCT01320943|364074923|FG001|Overall Study|Physician Decision|1|||
105567164|NCT01320943|364074922|FG000|Overall Study|Randomized but not Treated|0|||
105567165|NCT01320943|364074923|FG001|Overall Study|Randomized but not Treated|1|||
105567166|NCT01552954|364074927|FG000|Overall Study|Adverse Event|1|||
105567167|NCT01552954|364074928|FG001|Overall Study|Adverse Event|2|||
105567168|NCT01552954|364074927|FG000|Overall Study|Lost to Follow-up|1|||
105567169|NCT01552954|364074928|FG001|Overall Study|Lost to Follow-up|1|||
105567170|NCT01552954|364074927|FG000|Overall Study|Withdrawal by Subject|1|||
105567171|NCT01552954|364074928|FG001|Overall Study|Withdrawal by Subject|1|||
105567172|NCT01552954|364074927|FG000|Overall Study|Protocol Violation|1|||
105567173|NCT01552954|364074928|FG001|Overall Study|Protocol Violation|2|||
105567174|NCT01552954|364074927|FG000|Overall Study|diagnosed DM|1|||
105567175|NCT01552954|364074928|FG001|Overall Study|diagnosed DM|0|||
105567176|NCT02036645|364074929|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
105567177|NCT02036645|364074930|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
105567178|NCT02036645|364074931|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
105567179|NCT02036645|364074932|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
105567180|NCT02036645|364074933|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
105567181|NCT02036645|364074934|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
105567182|NCT02036645|364074935|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
105567183|NCT02036645|364074936|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
105567184|NCT02036645|364074937|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
105567185|NCT02036645|364074938|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
105567186|NCT02036645|364074939|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
105567187|NCT02036645|364074940|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
105567188|NCT02036645|364074929|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
105567189|NCT02036645|364074930|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
105567190|NCT02036645|364074931|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
105567191|NCT02036645|364074932|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
105567192|NCT02036645|364074933|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
105754040|NCT01401465|364750297|FG000|Treatment Period 1|Scheduling Difficulties|1|||
105754041|NCT01401465|364750298|FG001|Treatment Period 1|Scheduling Difficulties|1|||
105754042|NCT01401465|364750297|FG000|Treatment Period 2|Lost to Follow-up|0|||
105754043|NCT01401465|364750298|FG001|Treatment Period 2|Lost to Follow-up|1|||
105754044|NCT01401465|364750297|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105754045|NCT01401465|364750298|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105754046|NCT00986427|364750299|FG000|Overall Study|Lost to Follow-up|2|||
105754047|NCT00986427|364750300|FG001|Overall Study|Lost to Follow-up|0|||
105567193|NCT02036645|364074934|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
105567194|NCT02036645|364074935|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
105567195|NCT02036645|364074936|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
105567196|NCT02036645|364074937|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
105567197|NCT02036645|364074938|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
105567198|NCT02036645|364074939|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
105567199|NCT02036645|364074940|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
105567200|NCT01693692|364074941|FG000|Overall Study|Withdrawal by Subject|12|||
105567201|NCT01693692|364074942|FG001|Overall Study|Withdrawal by Subject|10|||
105567202|NCT01693692|364074943|FG002|Overall Study|Withdrawal by Subject|11|||
105567203|NCT01693692|364074941|FG000|Overall Study|Adverse Event|7|||
105567204|NCT01693692|364074942|FG001|Overall Study|Adverse Event|14|||
105567205|NCT01693692|364074943|FG002|Overall Study|Adverse Event|9|||
105567206|NCT01693692|364074941|FG000|Overall Study|Physician Decision|0|||
105567207|NCT01693692|364074942|FG001|Overall Study|Physician Decision|0|||
105567208|NCT01693692|364074943|FG002|Overall Study|Physician Decision|1|||
105567209|NCT01693692|364074941|FG000|Overall Study|Protocol Violation|5|||
105567210|NCT01693692|364074942|FG001|Overall Study|Protocol Violation|4|||
105567211|NCT01693692|364074943|FG002|Overall Study|Protocol Violation|6|||
105567212|NCT01693692|364074941|FG000|Overall Study|Lost to Follow-up|2|||
105567213|NCT01693692|364074942|FG001|Overall Study|Lost to Follow-up|2|||
105567214|NCT01693692|364074943|FG002|Overall Study|Lost to Follow-up|3|||
105802168|NCT02266706|364932530|FG005|Overall Study|Enrollment in another study|0|||
105802169|NCT02266706|364932531|FG006|Overall Study|Enrollment in another study|0|||
105567215|NCT01693692|364074941|FG000|Overall Study|Other|4|||
105567216|NCT01693692|364074942|FG001|Overall Study|Other|4|||
105802170|NCT02266706|364932532|FG007|Overall Study|Enrollment in another study|0|||
105567217|NCT01693692|364074943|FG002|Overall Study|Other|6|||
105567218|NCT02719990|364074944|FG000|Overall Study|Physician Decision|2|||
105567219|NCT02719990|364074944|FG000|Overall Study|Withdrawal by Subject|2|||
105567220|NCT02719990|364074944|FG000|Overall Study|Study Terminated By Sponsor|32|||
105567221|NCT02010632|364074945|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
105802171|NCT02266706|364932533|FG008|Overall Study|Enrollment in another study|0|||
105802172|NCT02614703|364932534|FG000|Overall Study|Withdrawal by Subject|7|||
105802173|NCT02614703|364932535|FG001|Overall Study|Withdrawal by Subject|1|||
105802174|NCT01977352|364932536|FG000|Overall Study|Lost to Follow-up|1|||
105802175|NCT01977352|364932537|FG001|Overall Study|Lost to Follow-up|2|||
105802176|NCT02092961|364932538|FG000|Overall Study|Not reported|1|||
105802177|NCT02092961|364932539|FG001|Overall Study|Not reported|0|||
105802178|NCT02092961|364932540|FG002|Overall Study|Not reported|1|||
105802179|NCT02092961|364932538|FG000|Overall Study|Study stopped|13|||
105802180|NCT02092961|364932539|FG001|Overall Study|Study stopped|9|||
105802181|NCT02092961|364932540|FG002|Overall Study|Study stopped|12|||
105802182|NCT02092961|364932538|FG000|Overall Study|Lack of therapeutic response|2|||
105567222|NCT02010632|364074946|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
105567223|NCT01778556|364074947|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
105567224|NCT01778556|364074948|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
105567225|NCT01778556|364074947|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
105567226|NCT01778556|364074948|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
105567227|NCT01778556|364074947|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
105567228|NCT01778556|364074948|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
105567229|NCT01778556|364074947|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
105802183|NCT02092961|364932539|FG001|Overall Study|Lack of therapeutic response|1|||
105802184|NCT02092961|364932540|FG002|Overall Study|Lack of therapeutic response|3|||
105802185|NCT02092961|364932538|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
105802186|NCT02092961|364932539|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
105802187|NCT02092961|364932540|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
105802188|NCT02092961|364932538|FG000|Overall Study|Adverse Event|2|||
105802189|NCT02092961|364932539|FG001|Overall Study|Adverse Event|4|||
105802190|NCT02092961|364932540|FG002|Overall Study|Adverse Event|0|||
105802191|NCT02270983|364932541|FG000|Overall Study|Adverse Event|3|||
105567230|NCT01778556|364074948|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
105567231|NCT01412801|364074953|FG000|Overall Study|Death|0|||
105567232|NCT01412801|364074954|FG001|Overall Study|Death|1|||
105567233|NCT01412801|364074955|FG002|Overall Study|Death|0|||
105567234|NCT01412801|364074956|FG003|Overall Study|Death|4|||
105567235|NCT01412801|364074957|FG004|Overall Study|Death|2|||
105567236|NCT01412801|364074958|FG005|Overall Study|Death|2|||
105567237|NCT01412801|364074953|FG000|Overall Study|Lost to Follow-up|1|||
105567238|NCT01412801|364074954|FG001|Overall Study|Lost to Follow-up|2|||
105567239|NCT01412801|364074955|FG002|Overall Study|Lost to Follow-up|4|||
105567240|NCT01412801|364074956|FG003|Overall Study|Lost to Follow-up|0|||
105567241|NCT01412801|364074957|FG004|Overall Study|Lost to Follow-up|1|||
105567242|NCT01412801|364074958|FG005|Overall Study|Lost to Follow-up|1|||
105567243|NCT01412801|364074953|FG000|Overall Study|Withdrawal by Subject|3|||
105567244|NCT01412801|364074954|FG001|Overall Study|Withdrawal by Subject|2|||
105567245|NCT01412801|364074955|FG002|Overall Study|Withdrawal by Subject|1|||
105567246|NCT01412801|364074956|FG003|Overall Study|Withdrawal by Subject|0|||
105567247|NCT01412801|364074957|FG004|Overall Study|Withdrawal by Subject|0|||
105567248|NCT01412801|364074958|FG005|Overall Study|Withdrawal by Subject|0|||
105567249|NCT01412801|364074953|FG000|Overall Study|Relocated to another area|0|||
105567250|NCT01412801|364074954|FG001|Overall Study|Relocated to another area|0|||
105567251|NCT01412801|364074955|FG002|Overall Study|Relocated to another area|2|||
105567252|NCT01412801|364074956|FG003|Overall Study|Relocated to another area|0|||
105567253|NCT01412801|364074957|FG004|Overall Study|Relocated to another area|0|||
105567254|NCT01412801|364074958|FG005|Overall Study|Relocated to another area|0|||
105567255|NCT00116272|364074959|FG000|Overall Study|Lost to Follow-up|11|||
105567256|NCT00116272|364074960|FG001|Overall Study|Lost to Follow-up|6|||
105567257|NCT03188120|364074961|FG000|Overall Study|Adverse Event|4|||
105567258|NCT03188120|364074961|FG000|Overall Study|Insufficient Effectiveness|8|||
105567259|NCT03188120|364074961|FG000|Overall Study|Improved|12|||
105567260|NCT03188120|364074961|FG000|Overall Study|Lost to Follow-up|7|||
105567261|NCT03188120|364074961|FG000|Overall Study|Other than specified|3|||
105567262|NCT03188120|364074961|FG000|Overall Study|No visit after the first visit|13|||
105567263|NCT01235403|364074962|FG000|Overall Study|Adverse Event|14|||
105567264|NCT01235403|364074962|FG000|Overall Study|Lost to Follow-up|2|||
105567265|NCT01235403|364074962|FG000|Overall Study|Withdrawal by Subject|4|||
105567266|NCT01235403|364074962|FG000|Overall Study|Lack of Efficacy|2|||
105567267|NCT01235403|364074962|FG000|Overall Study|Other reasons for premature termination|4|||
105567268|NCT02296190|364074963|FG000|Overall Study|Lost to Follow-up|0|||
105567269|NCT02296190|364074964|FG001|Overall Study|Lost to Follow-up|0|||
105567270|NCT02296190|364074965|FG002|Overall Study|Lost to Follow-up|0|||
105567271|NCT02296190|364074966|FG003|Overall Study|Lost to Follow-up|0|||
105567272|NCT02296190|364074967|FG004|Overall Study|Lost to Follow-up|1|||
105567273|NCT02296190|364074968|FG005|Overall Study|Lost to Follow-up|0|||
105567274|NCT02296190|364074963|FG000|Overall Study|Failure to induce PSVT|6|||
105567275|NCT02296190|364074964|FG001|Overall Study|Failure to induce PSVT|10|||
105567276|NCT02296190|364074965|FG002|Overall Study|Failure to induce PSVT|5|||
105567277|NCT02296190|364074966|FG003|Overall Study|Failure to induce PSVT|13|||
105567278|NCT02296190|364074967|FG004|Overall Study|Failure to induce PSVT|8|||
105567279|NCT02296190|364074968|FG005|Overall Study|Failure to induce PSVT|0|||
105567280|NCT02296190|364074963|FG000|Overall Study|Physician Decision|1|||
105567281|NCT02296190|364074964|FG001|Overall Study|Physician Decision|1|||
105567282|NCT02296190|364074965|FG002|Overall Study|Physician Decision|0|||
105567283|NCT02296190|364074966|FG003|Overall Study|Physician Decision|1|||
105567284|NCT02296190|364074967|FG004|Overall Study|Physician Decision|2|||
105567285|NCT02296190|364074968|FG005|Overall Study|Physician Decision|0|||
105567286|NCT02296190|364074963|FG000|Overall Study|Withdrawal by Subject|0|||
105567287|NCT02296190|364074964|FG001|Overall Study|Withdrawal by Subject|1|||
105567288|NCT02296190|364074965|FG002|Overall Study|Withdrawal by Subject|0|||
105567289|NCT02296190|364074966|FG003|Overall Study|Withdrawal by Subject|0|||
105567290|NCT02296190|364074967|FG004|Overall Study|Withdrawal by Subject|0|||
105567291|NCT02296190|364074968|FG005|Overall Study|Withdrawal by Subject|0|||
105567292|NCT02296190|364074963|FG000|Overall Study|PSVT < 5 minutes|5|||
105567293|NCT02296190|364074964|FG001|Overall Study|PSVT < 5 minutes|6|||
105567294|NCT02296190|364074965|FG002|Overall Study|PSVT < 5 minutes|6|||
105567295|NCT02296190|364074966|FG003|Overall Study|PSVT < 5 minutes|6|||
105567296|NCT02296190|364074967|FG004|Overall Study|PSVT < 5 minutes|5|||
105567297|NCT02296190|364074968|FG005|Overall Study|PSVT < 5 minutes|0|||
105567298|NCT02296190|364074963|FG000|Overall Study|Patient was given Propofol|0|||
105567299|NCT02296190|364074964|FG001|Overall Study|Patient was given Propofol|1|||
105567300|NCT02296190|364074965|FG002|Overall Study|Patient was given Propofol|0|||
105567301|NCT02296190|364074966|FG003|Overall Study|Patient was given Propofol|1|||
105567302|NCT02296190|364074967|FG004|Overall Study|Patient was given Propofol|0|||
105567303|NCT02296190|364074968|FG005|Overall Study|Patient was given Propofol|0|||
105567304|NCT02296190|364074963|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
105567305|NCT02296190|364074964|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
105567306|NCT02296190|364074965|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
105567307|NCT02296190|364074966|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
105567308|NCT02296190|364074967|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
105567309|NCT02296190|364074968|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
105567310|NCT02296190|364074963|FG000|Overall Study|Blood pressure <100 after sedation|0|||
105567311|NCT02296190|364074964|FG001|Overall Study|Blood pressure <100 after sedation|0|||
105567312|NCT02296190|364074965|FG002|Overall Study|Blood pressure <100 after sedation|0|||
105567313|NCT02296190|364074966|FG003|Overall Study|Blood pressure <100 after sedation|1|||
105567314|NCT02296190|364074967|FG004|Overall Study|Blood pressure <100 after sedation|0|||
105567315|NCT02296190|364074968|FG005|Overall Study|Blood pressure <100 after sedation|0|||
105567316|NCT02296190|364074963|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
105567317|NCT02296190|364074964|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
105567318|NCT02296190|364074965|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
105567319|NCT02296190|364074966|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
105567320|NCT02296190|364074967|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
105567321|NCT02296190|364074968|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
105567322|NCT02296190|364074963|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
105567323|NCT02296190|364074964|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
105567324|NCT02296190|364074965|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
105567325|NCT02296190|364074966|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
105567326|NCT02296190|364074967|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
105567327|NCT02296190|364074968|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
105567328|NCT02296190|364074963|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
105567329|NCT02296190|364074964|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
105567330|NCT02296190|364074965|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
105567331|NCT02296190|364074966|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
105567332|NCT02296190|364074967|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
105567333|NCT02296190|364074968|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
105567334|NCT02296190|364074963|FG000|Overall Study|Lab result not available in time|1|||
105567335|NCT02296190|364074964|FG001|Overall Study|Lab result not available in time|0|||
105567336|NCT02296190|364074965|FG002|Overall Study|Lab result not available in time|0|||
105567337|NCT02296190|364074966|FG003|Overall Study|Lab result not available in time|0|||
105567338|NCT02296190|364074967|FG004|Overall Study|Lab result not available in time|0|||
105567339|NCT02296190|364074968|FG005|Overall Study|Lab result not available in time|0|||
105567340|NCT02978443|364074969|FG000|Overall Study|Withdrawal by Subject|1|||
105567341|NCT02978443|364074969|FG000|Overall Study|Adverse Event|3|||
105567342|NCT02978443|364074969|FG000|Overall Study|Disease Progression on study|6|||
105567343|NCT02978443|364074969|FG000|Overall Study|Death|1|||
105567344|NCT02978443|364074969|FG000|Overall Study|Physician Decision|1|||
105567345|NCT02978443|364074969|FG000|Overall Study|Switch to alternative therapy|1|||
105567346|NCT02978443|364074969|FG000|Overall Study|Refused further treatment|1|||
105567347|NCT01987817|364074970|FG000|Overall Study|Adverse Event|4|||
105567348|NCT01987817|364074971|FG001|Overall Study|Adverse Event|0|||
105567349|NCT01987817|364074970|FG000|Overall Study|Withdrawal by Subject|1|||
105567350|NCT01987817|364074971|FG001|Overall Study|Withdrawal by Subject|1|||
105567351|NCT01987817|364074970|FG000|Overall Study|Physician Decision|1|||
105567352|NCT01987817|364074971|FG001|Overall Study|Physician Decision|0|||
105567353|NCT00661661|364074972|FG000|Overall Study|Adverse Event|99|||
105567354|NCT00661661|364074973|FG001|Overall Study|Adverse Event|24|||
105567355|NCT00661661|364074972|FG000|Overall Study|Lack of Efficacy|3|||
105567356|NCT00661661|364074973|FG001|Overall Study|Lack of Efficacy|2|||
105567357|NCT00661661|364074972|FG000|Overall Study|Lost to Follow-up|0|||
105567358|NCT00661661|364074973|FG001|Overall Study|Lost to Follow-up|1|||
105567359|NCT00661661|364074972|FG000|Overall Study|Withdrawal by Subject|15|||
105567360|NCT00661661|364074973|FG001|Overall Study|Withdrawal by Subject|5|||
105567361|NCT00661661|364074972|FG000|Overall Study|Other|22|||
105567362|NCT00661661|364074973|FG001|Overall Study|Other|7|||
105567363|NCT00661661|364074972|FG000|Overall Study|Not assigned treatment|1|||
105567364|NCT00661661|364074973|FG001|Overall Study|Not assigned treatment|0|||
105567365|NCT01353222|364074976|FG000|Overall Study|Death|30|||
105567366|NCT01353222|364074977|FG001|Overall Study|Death|30|||
105567367|NCT01353222|364074976|FG000|Overall Study|Withdrawal by Subject|8|||
105567368|NCT01353222|364074977|FG001|Overall Study|Withdrawal by Subject|5|||
105567369|NCT01353222|364074976|FG000|Overall Study|Study Terminated|31|||
105567370|NCT01353222|364074977|FG001|Overall Study|Study Terminated|37|||
105567371|NCT01353222|364074976|FG000|Overall Study|Site closed research department|1|||
105567372|NCT01353222|364074977|FG001|Overall Study|Site closed research department|0|||
105567373|NCT01654601|364074978|FG000|1st Administration|Withdrawal by Subject|2|||
105567374|NCT01654601|364074979|FG001|1st Administration|Withdrawal by Subject|0|||
105567375|NCT01654601|364074978|FG000|1st Administration|Protocol Violation|0|||
105567376|NCT01654601|364074979|FG001|1st Administration|Protocol Violation|2|||
105567377|NCT01654601|364074978|FG000|2nd Administration|Adverse Event|1|||
105567378|NCT01654601|364074979|FG001|2nd Administration|Adverse Event|0|||
105567379|NCT01654601|364074978|FG000|2nd Administration|Protocol Violation|0|||
105567380|NCT01654601|364074979|FG001|2nd Administration|Protocol Violation|1|||
105802192|NCT02270983|364932542|FG001|Overall Study|Adverse Event|2|||
105802193|NCT02270983|364932543|FG002|Overall Study|Adverse Event|6|||
105802194|NCT02270983|364932541|FG000|Overall Study|Lack of Efficacy|2|||
105802195|NCT02270983|364932542|FG001|Overall Study|Lack of Efficacy|1|||
105802196|NCT02270983|364932543|FG002|Overall Study|Lack of Efficacy|1|||
105802197|NCT02270983|364932541|FG000|Overall Study|Withdrawal by Subject|1|||
105802198|NCT02270983|364932542|FG001|Overall Study|Withdrawal by Subject|0|||
105802199|NCT02270983|364932543|FG002|Overall Study|Withdrawal by Subject|2|||
105802200|NCT02270983|364932541|FG000|Overall Study|Lost to Follow-up|1|||
105802201|NCT02270983|364932542|FG001|Overall Study|Lost to Follow-up|1|||
105802202|NCT02270983|364932543|FG002|Overall Study|Lost to Follow-up|2|||
105802203|NCT02270983|364932541|FG000|Overall Study|Protocol Violation|1|||
105802204|NCT02270983|364932542|FG001|Overall Study|Protocol Violation|1|||
105802205|NCT02270983|364932543|FG002|Overall Study|Protocol Violation|1|||
105802206|NCT02270983|364932541|FG000|Overall Study|family emergency|0|||
105802207|NCT02270983|364932542|FG001|Overall Study|family emergency|1|||
105802208|NCT02270983|364932543|FG002|Overall Study|family emergency|0|||
105802209|NCT02270983|364932541|FG000|Overall Study|study procedure non-compliance|1|||
105802210|NCT02270983|364932542|FG001|Overall Study|study procedure non-compliance|0|||
105802211|NCT02270983|364932543|FG002|Overall Study|study procedure non-compliance|0|||
105802212|NCT02270983|364932541|FG000|Overall Study|moved away from study site|0|||
105802213|NCT02270983|364932542|FG001|Overall Study|moved away from study site|1|||
105802214|NCT02270983|364932543|FG002|Overall Study|moved away from study site|0|||
105802215|NCT00854620|364932544|FG000|Overall Study|Adverse Event|1|||
105754048|NCT00986427|364750299|FG000|Overall Study|Lack of Efficacy|1|||
105754049|NCT00986427|364750300|FG001|Overall Study|Lack of Efficacy|0|||
105754050|NCT00986427|364750299|FG000|Overall Study|Withdrawal by Subject|1|||
105754051|NCT00986427|364750300|FG001|Overall Study|Withdrawal by Subject|0|||
105754052|NCT01115738|364750301|FG000|Overall Study|Death|1|||
105754053|NCT01115738|364750302|FG001|Overall Study|Death|0|||
105754054|NCT01115738|364750303|FG002|Overall Study|Death|0|||
105754055|NCT01115738|364750301|FG000|Overall Study|Lost to Follow-up|0|||
105754056|NCT01115738|364750302|FG001|Overall Study|Lost to Follow-up|0|||
105754057|NCT01115738|364750303|FG002|Overall Study|Lost to Follow-up|1|||
105754058|NCT01115738|364750301|FG000|Overall Study|Physician Decision|18|||
105754059|NCT01115738|364750302|FG001|Overall Study|Physician Decision|15|||
105754060|NCT01115738|364750303|FG002|Overall Study|Physician Decision|17|||
105754061|NCT01115738|364750301|FG000|Overall Study|Withdrawal by Subject|6|||
105754062|NCT01115738|364750302|FG001|Overall Study|Withdrawal by Subject|6|||
105754063|NCT01115738|364750303|FG002|Overall Study|Withdrawal by Subject|9|||
105754064|NCT03245723|364750304|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
105754065|NCT03245723|364750305|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
105754066|NCT03245723|364750304|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
105754067|NCT03245723|364750305|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
105754068|NCT03245723|364750304|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
105754069|NCT03245723|364750305|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
105754070|NCT03245723|364750304|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
105754071|NCT03245723|364750305|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
105754072|NCT03337139|364750307|FG000|Phase I|Withdrawal by Subject|10|||
105754073|NCT03337139|364750308|FG001|Phase I|Withdrawal by Subject|0|||
105754074|NCT00077376|364750309|FG000|Overall Study|Adverse Event|8|||
105754075|NCT00077376|364750309|FG000|Overall Study|Withdrawal by Subject|2|||
105754076|NCT00077376|364750309|FG000|Overall Study|Death|1|||
105754077|NCT00077376|364750309|FG000|Overall Study|Physician Decision|1|||
105754078|NCT00077376|364750309|FG000|Overall Study|Alternative therapy|5|||
105754079|NCT00077376|364750309|FG000|Overall Study|Complicating disease|1|||
105754080|NCT00077376|364750309|FG000|Overall Study|Still on treatment|1|||
105754081|NCT00077376|364750309|FG000|Overall Study|Symptomatic deterioration|1|||
105754082|NCT00077376|364750309|FG000|Overall Study|Surgery|1|||
105754083|NCT00077376|364750309|FG000|Overall Study|Insurance ran out|1|||
105754084|NCT01736254|364750310|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
105754085|NCT01736254|364750310|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
105754086|NCT01255306|364751615|FG000|Overall Study|Physician Decision|1|||
105754087|NCT01255306|364751616|FG001|Overall Study|Physician Decision|1|||
105754088|NCT00453180|364751621|FG000|Overall Study|Lost to Follow-up|2|||
105754089|NCT00453180|364751622|FG001|Overall Study|Lost to Follow-up|1|||
105754090|NCT00453180|364751621|FG000|Overall Study|Adverse Event|1|||
105754091|NCT00453180|364751622|FG001|Overall Study|Adverse Event|2|||
105754092|NCT00804843|364751626|FG000|Overall Study|Protocol Violation|1|||
105754093|NCT00804843|364751627|FG001|Overall Study|Protocol Violation|0|||
105754094|NCT00804843|364751626|FG000|Overall Study|Adverse Event|8|||
105754095|NCT00804843|364751627|FG001|Overall Study|Adverse Event|5|||
105754096|NCT00804843|364751626|FG000|Overall Study|Withdrawal by Subject|1|||
105754097|NCT00804843|364751627|FG001|Overall Study|Withdrawal by Subject|2|||
105754098|NCT01975246|364751634|FG000|Overall Study|Adverse Event|2|||
105754099|NCT01975246|364751635|FG001|Overall Study|Adverse Event|1|||
105754100|NCT01975246|364751634|FG000|Overall Study|Lack of Efficacy|1|||
105754101|NCT01975246|364751635|FG001|Overall Study|Lack of Efficacy|0|||
105754102|NCT01975246|364751634|FG000|Overall Study|Protocol Violation|1|||
105754103|NCT01975246|364751635|FG001|Overall Study|Protocol Violation|0|||
105754104|NCT01975246|364751634|FG000|Overall Study|Other than stated|0|||
105754105|NCT01975246|364751635|FG001|Overall Study|Other than stated|1|||
105754106|NCT01646398|364751642|FG000|Overall Study|Withdrawal by Subject|1|||
105754107|NCT01646398|364751643|FG001|Overall Study|Withdrawal by Subject|0|||
105754108|NCT02499575|364751644|FG000|Overall Study|Protocol Violation|0|||
105754109|NCT02499575|364751645|FG001|Overall Study|Protocol Violation|1|||
105754110|NCT02586077|364751646|FG000|Overall Study|Withdrawal by Subject|1|||
105754111|NCT02586077|364751646|FG000|Overall Study|Physician Decision|4|||
105754112|NCT02586077|364751646|FG000|Overall Study|Lost to Follow-up|3|||
105754113|NCT03287245|364751647|FG000|Overall Study|Study terminated by sponsor|3|||
105754114|NCT03287245|364751648|FG001|Overall Study|Study terminated by sponsor|0|||
105754115|NCT03287245|364751649|FG002|Overall Study|Study terminated by sponsor|3|||
105754116|NCT03287245|364751650|FG003|Overall Study|Study terminated by sponsor|1|||
105754117|NCT03287245|364751647|FG000|Overall Study|Adverse Event|1|||
105754118|NCT03287245|364751648|FG001|Overall Study|Adverse Event|0|||
105754119|NCT03287245|364751649|FG002|Overall Study|Adverse Event|0|||
105754120|NCT03287245|364751650|FG003|Overall Study|Adverse Event|0|||
105754121|NCT03287245|364751647|FG000|Overall Study|Withdrawal by Subject|8|||
105754122|NCT03287245|364751648|FG001|Overall Study|Withdrawal by Subject|3|||
105754123|NCT03287245|364751649|FG002|Overall Study|Withdrawal by Subject|3|||
105754124|NCT03287245|364751650|FG003|Overall Study|Withdrawal by Subject|0|||
105754125|NCT03287245|364751647|FG000|Overall Study|Physician Decision|3|||
105754126|NCT03287245|364751648|FG001|Overall Study|Physician Decision|2|||
105754127|NCT03287245|364751649|FG002|Overall Study|Physician Decision|0|||
105754128|NCT03287245|364751650|FG003|Overall Study|Physician Decision|0|||
105754129|NCT00949910|364751651|FG000|Overall Study|Progressive Disease|3750|||
105754130|NCT00949910|364751651|FG000|Overall Study|Symptomatic Deterioration|1088|||
105754131|NCT00949910|364751651|FG000|Overall Study|Lost to Follow-up|100|||
105754132|NCT00949910|364751651|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
105754133|NCT00949910|364751651|FG000|Overall Study|Participant Refusal|390|||
105754134|NCT00949910|364751651|FG000|Overall Study|Death Due to Malignant Disease|456|||
105754135|NCT00949910|364751651|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
105754136|NCT00949910|364751651|FG000|Overall Study|Death Due to Adverse Event|115|||
105754137|NCT00949910|364751651|FG000|Overall Study|Death Due to Toxicity|3|||
105754138|NCT00949910|364751651|FG000|Overall Study|Death from Unknown Cause|5|||
105754139|NCT00949910|364751651|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
105754140|NCT00949910|364751651|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
105754141|NCT00949910|364751651|FG000|Overall Study|Switched to Commercial Treatment|4|||
105754142|NCT00949910|364751651|FG000|Overall Study|Violation of Eligibility|23|||
105754143|NCT00949910|364751651|FG000|Overall Study|Logistical Reasons|13|||
105754144|NCT00949910|364751651|FG000|Overall Study|Non-Compliance|10|||
105754145|NCT00949910|364751651|FG000|Overall Study|Prolonged Dosing Interruption|4|||
105754146|NCT00949910|364751651|FG000|Overall Study|Adverse Event|83|||
105754147|NCT00949910|364751651|FG000|Overall Study|Serious Adverse Event|6|||
105802216|NCT01623830|364932547|FG000|Overall Study|Withdrawal by Subject|6|||
105754148|NCT00949910|364751651|FG000|Overall Study|Physician/Participant Decision|7|||
105754149|NCT00949910|364751651|FG000|Overall Study|Other|4|||
105754150|NCT00949910|364751651|FG000|Overall Study|No Data|9|||
105754151|NCT03297216|364751660|FG000|Overall Study|Death|0|||
105754152|NCT03297216|364751661|FG001|Overall Study|Death|1|||
105754153|NCT03297216|364751660|FG000|Overall Study|Miscarriage|0|||
105754154|NCT03297216|364751661|FG001|Overall Study|Miscarriage|2|||
105754155|NCT03297216|364751660|FG000|Overall Study|Lost to Follow-up|3|||
105754156|NCT03297216|364751661|FG001|Overall Study|Lost to Follow-up|2|||
105754157|NCT03434418|364751662|FG000|Overall Study|Disease Progression|11|||
105754158|NCT03434418|364751662|FG000|Overall Study|Adverse Event|2|||
105754159|NCT03434418|364751662|FG000|Overall Study|Physician Decision|1|||
105754160|NCT03434418|364751662|FG000|Overall Study|Decline in Performance Status (PS)|1|||
105754161|NCT02062463|364751663|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
105754162|NCT02062463|364751664|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
105754163|NCT02062463|364751665|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
105754164|NCT02062463|364751666|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
105754165|NCT02062463|364751663|FG000|Stage 2|Adverse Event|0|||
105754166|NCT02062463|364751664|FG001|Stage 2|Adverse Event|0|||
105754167|NCT02062463|364751665|FG002|Stage 2|Adverse Event|12|||
105754168|NCT02062463|364751666|FG003|Stage 2|Adverse Event|20|||
105754169|NCT02062463|364751663|FG000|Stage 2|Lack of Efficacy|0|||
105754170|NCT02062463|364751664|FG001|Stage 2|Lack of Efficacy|0|||
105754171|NCT02062463|364751665|FG002|Stage 2|Lack of Efficacy|3|||
105754172|NCT02062463|364751666|FG003|Stage 2|Lack of Efficacy|4|||
105754173|NCT02062463|364751663|FG000|Stage 2|Lost to Follow-up|0|||
105754174|NCT02062463|364751664|FG001|Stage 2|Lost to Follow-up|0|||
105754175|NCT02062463|364751665|FG002|Stage 2|Lost to Follow-up|20|||
105754176|NCT02062463|364751666|FG003|Stage 2|Lost to Follow-up|20|||
105754177|NCT02062463|364751663|FG000|Stage 2|Non-Compliance|0|||
105754178|NCT02062463|364751664|FG001|Stage 2|Non-Compliance|0|||
105754179|NCT02062463|364751665|FG002|Stage 2|Non-Compliance|0|||
105754180|NCT02062463|364751666|FG003|Stage 2|Non-Compliance|1|||
105754181|NCT02062463|364751663|FG000|Stage 2|Other than specified|0|||
105754182|NCT02062463|364751664|FG001|Stage 2|Other than specified|0|||
105754183|NCT02062463|364751665|FG002|Stage 2|Other than specified|3|||
105754184|NCT02062463|364751666|FG003|Stage 2|Other than specified|1|||
105754185|NCT02062463|364751663|FG000|Stage 2|Withdrawal by Subject|0|||
105754186|NCT02062463|364751664|FG001|Stage 2|Withdrawal by Subject|0|||
105754187|NCT02062463|364751665|FG002|Stage 2|Withdrawal by Subject|15|||
105754188|NCT02062463|364751666|FG003|Stage 2|Withdrawal by Subject|10|||
105754189|NCT01956240|364751671|FG000|Overall Study|Lost to Follow-up|6|||
105754190|NCT01956240|364751672|FG001|Overall Study|Lost to Follow-up|20|||
105754191|NCT01956240|364751671|FG000|Overall Study|Adverse Event|17|||
105754192|NCT01956240|364751672|FG001|Overall Study|Adverse Event|4|||
105754193|NCT00600028|364751675|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
105754194|NCT00600028|364751676|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
105754195|NCT00600028|364751675|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
105754196|NCT00600028|364751676|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
105802217|NCT01623830|364932548|FG001|Overall Study|Withdrawal by Subject|7|||
105802218|NCT01623830|364932547|FG000|Overall Study|Exclusion from Study|1|||
105802219|NCT01623830|364932548|FG001|Overall Study|Exclusion from Study|2|||
105802220|NCT04242186|364932549|FG000|Overall Study|Death|5|||
105802221|NCT01792284|364932550|FG000|Lead-in Period|Adverse Event|15|||
105802222|NCT01792284|364932551|FG001|Lead-in Period|Adverse Event|0|||
105802223|NCT01792284|364932552|FG002|Lead-in Period|Adverse Event|0|||
105802224|NCT01792284|364932550|FG000|Lead-in Period|Lost to Follow-up|2|||
105802225|NCT01792284|364932551|FG001|Lead-in Period|Lost to Follow-up|0|||
105802226|NCT01792284|364932552|FG002|Lead-in Period|Lost to Follow-up|0|||
105802227|NCT01792284|364932550|FG000|Lead-in Period|Protocol Violation|1|||
105802228|NCT01792284|364932551|FG001|Lead-in Period|Protocol Violation|0|||
105802229|NCT01792284|364932552|FG002|Lead-in Period|Protocol Violation|0|||
105802230|NCT01792284|364932550|FG000|Lead-in Period|Withdrawal by Subject|10|||
105802231|NCT01792284|364932551|FG001|Lead-in Period|Withdrawal by Subject|0|||
105802232|NCT01792284|364932552|FG002|Lead-in Period|Withdrawal by Subject|0|||
105802233|NCT01792284|364932550|FG000|Lead-in Period|Physician Decision|1|||
105802234|NCT01792284|364932551|FG001|Lead-in Period|Physician Decision|0|||
105802235|NCT01792284|364932552|FG002|Lead-in Period|Physician Decision|0|||
105802236|NCT01792284|364932550|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
105802237|NCT01792284|364932551|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
105802238|NCT01792284|364932552|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
105802239|NCT01792284|364932550|FG000|Randomization Period 1|Withdrawal by Subject|0|||
105802240|NCT01792284|364932551|FG001|Randomization Period 1|Withdrawal by Subject|1|||
105802241|NCT01792284|364932552|FG002|Randomization Period 1|Withdrawal by Subject|1|||
105802242|NCT01792284|364932550|FG000|Randomization Period 1|Physician Decision|0|||
105802243|NCT01792284|364932551|FG001|Randomization Period 1|Physician Decision|1|||
105802244|NCT01792284|364932552|FG002|Randomization Period 1|Physician Decision|1|||
105802245|NCT01792284|364932550|FG000|Randomization Period 1|Adverse Event|0|||
105802246|NCT01792284|364932551|FG001|Randomization Period 1|Adverse Event|0|||
105567381|NCT00116844|364074980|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
105567382|NCT00116844|364074981|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
105754197|NCT00600028|364751675|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
105754198|NCT00600028|364751676|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
105754199|NCT01830816|364751679|FG000|Overall Study|Progressive Disease|12|||
105754200|NCT01830816|364751680|FG001|Overall Study|Progressive Disease|7|||
105754201|NCT01830816|364751681|FG002|Overall Study|Progressive Disease|7|||
105754202|NCT01830816|364751679|FG000|Overall Study|Adverse Event|3|||
105754203|NCT01830816|364751680|FG001|Overall Study|Adverse Event|4|||
105754204|NCT01830816|364751681|FG002|Overall Study|Adverse Event|0|||
105754205|NCT01830816|364751679|FG000|Overall Study|Study Terminated by Sponsor|1|||
105754206|NCT01830816|364751680|FG001|Overall Study|Study Terminated by Sponsor|1|||
105754207|NCT01830816|364751681|FG002|Overall Study|Study Terminated by Sponsor|0|||
105754208|NCT01830816|364751679|FG000|Overall Study|Withdrawal by Subject|1|||
105754209|NCT01830816|364751680|FG001|Overall Study|Withdrawal by Subject|1|||
105754210|NCT01830816|364751681|FG002|Overall Study|Withdrawal by Subject|0|||
105754211|NCT01830816|364751679|FG000|Overall Study|Lost to Follow-up|0|||
105754212|NCT01830816|364751680|FG001|Overall Study|Lost to Follow-up|1|||
105754213|NCT01830816|364751681|FG002|Overall Study|Lost to Follow-up|0|||
105754214|NCT01830816|364751679|FG000|Overall Study|Symptomatic Deterioration|1|||
105754215|NCT01830816|364751680|FG001|Overall Study|Symptomatic Deterioration|0|||
105754216|NCT01830816|364751681|FG002|Overall Study|Symptomatic Deterioration|0|||
105754217|NCT01830816|364751679|FG000|Overall Study|Reason not Specified|2|||
105754218|NCT01830816|364751680|FG001|Overall Study|Reason not Specified|0|||
105754219|NCT01830816|364751681|FG002|Overall Study|Reason not Specified|0|||
105754220|NCT03587584|364751682|FG000|Overall Study|SOC deviations|4|||
105802247|NCT01792284|364932552|FG002|Randomization Period 1|Adverse Event|2|||
105802248|NCT01792284|364932550|FG000|Randomization Period 1|Lost to Follow-up|0|||
105802249|NCT01792284|364932551|FG001|Randomization Period 1|Lost to Follow-up|0|||
105802250|NCT01792284|364932552|FG002|Randomization Period 1|Lost to Follow-up|1|||
105802251|NCT01792284|364932550|FG000|Randomization Period 2|Protocol Violation|0|||
105567383|NCT00116844|364074980|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
105802252|NCT01792284|364932551|FG001|Randomization Period 2|Protocol Violation|1|||
105802253|NCT01792284|364932552|FG002|Randomization Period 2|Protocol Violation|0|||
105802254|NCT01792284|364932550|FG000|Randomization Period 2|Withdrawal by Subject|0|||
105802255|NCT01792284|364932551|FG001|Randomization Period 2|Withdrawal by Subject|2|||
105802256|NCT01792284|364932552|FG002|Randomization Period 2|Withdrawal by Subject|0|||
105802257|NCT02257632|364932553|FG000|Overall Study|Withdrawal by Subject|0|||
105802258|NCT02257632|364932554|FG001|Overall Study|Withdrawal by Subject|1|||
105802259|NCT02257632|364932553|FG000|Overall Study|Adverse Event|1|||
105802260|NCT02257632|364932554|FG001|Overall Study|Adverse Event|2|||
105802261|NCT01605461|364932555|FG000|Overall Study|Lost to Follow-up|3|||
105802262|NCT01605461|364932555|FG000|Overall Study|Withdrawal by Subject|1|||
105802263|NCT01169649|364932556|FG000|Overall Study|Patient Not Treated|3|||
105802264|NCT01847313|364932557|FG000|Overall Study|Death|0|||
105802265|NCT01847313|364932558|FG001|Overall Study|Death|1|||
105802266|NCT01847313|364932557|FG000|Overall Study|Withdrawal by Subject|0|||
105802267|NCT01847313|364932558|FG001|Overall Study|Withdrawal by Subject|1|||
105802268|NCT02370784|364932559|FG000|Overall Study|Patient started prohibited medication|0|||
105802269|NCT02370784|364932560|FG001|Overall Study|Patient started prohibited medication|1|||
105802270|NCT02962882|364932562|FG000|Overall Study|Adverse Event|2|||
105802271|NCT02962882|364932562|FG000|Overall Study|Withdrawal by Subject|2|||
105802272|NCT02962882|364932562|FG000|Overall Study|Transfer from ICU|32|||
105802273|NCT01663714|364932563|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
105802274|NCT01663714|364932563|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
105802275|NCT01663714|364932563|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
105802276|NCT01663714|364932563|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
105802277|NCT01663714|364932563|FG000|Long-Term Follow-Up|Death|4|||
105802278|NCT01663714|364932563|FG000|Long-Term Follow-Up|Non-compliance|1|||
105802279|NCT02280421|364932564|FG000|Washout (2 Weeks)|Adverse Event|0|||
105802280|NCT02280421|364932565|FG001|Washout (2 Weeks)|Adverse Event|1|||
105802281|NCT02280421|364932564|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
105802282|NCT02280421|364932565|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
105802283|NCT00515073|364932570|FG000|Overall Study|Withdrawal by Subject|1|||
105802284|NCT00515073|364932570|FG000|Overall Study|Physician Decision|1|||
105802285|NCT02764489|364932571|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
105802286|NCT02764489|364932572|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
105802287|NCT02764489|364932571|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
105802288|NCT02764489|364932572|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
105802289|NCT02764489|364932571|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
105802290|NCT02764489|364932572|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
105802291|NCT02764489|364932571|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
105802292|NCT02764489|364932572|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
105802293|NCT00660790|364932575|FG000|Baseline to 3 Months|Death|1|||
105802294|NCT00660790|364932575|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
105802295|NCT00660790|364932575|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
105802296|NCT03549130|364932576|FG000|Overall Study|Adverse Event|0|||
105802297|NCT03549130|364932577|FG001|Overall Study|Adverse Event|1|||
105802298|NCT03549130|364932576|FG000|Overall Study|Lost to Follow-up|0|||
105802299|NCT03549130|364932577|FG001|Overall Study|Lost to Follow-up|1|||
105802300|NCT02038634|364932578|FG000|Overall Study|Lost to Follow-up|0|||
105802301|NCT02038634|364932579|FG001|Overall Study|Lost to Follow-up|1|||
105802302|NCT00463866|364932580|FG000|Overall Study|Adverse Event|70|||
105802303|NCT00463866|364932581|FG001|Overall Study|Adverse Event|93|||
105802304|NCT00463866|364932580|FG000|Overall Study|Withdrawal by Subject|81|||
105802305|NCT00463866|364932581|FG001|Overall Study|Withdrawal by Subject|79|||
105360411|NCT00905424|363325945|FG000|Overall Study|Adverse Event|4|||
105360412|NCT00905424|363325946|FG001|Overall Study|Adverse Event|2|||
105360413|NCT00905424|363325945|FG000|Overall Study|Non-compliance with study medication|2|||
105360414|NCT00905424|363325946|FG001|Overall Study|Non-compliance with study medication|0|||
105360415|NCT00905424|363325945|FG000|Overall Study|Sponsor decision|1|||
105360416|NCT00905424|363325946|FG001|Overall Study|Sponsor decision|0|||
105360417|NCT00905424|363325945|FG000|Overall Study|Positive urine drug screen|0|||
105360418|NCT00905424|363325946|FG001|Overall Study|Positive urine drug screen|1|||
105360419|NCT00905424|363325945|FG000|Overall Study|Non-adherence to visit schedule|0|||
105567384|NCT00116844|364074981|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
105802306|NCT00463866|364932580|FG000|Overall Study|Lost to Follow-up|46|||
105802307|NCT00463866|364932581|FG001|Overall Study|Lost to Follow-up|55|||
105802308|NCT00463866|364932580|FG000|Overall Study|Incorrect Enrolment|64|||
105360420|NCT00905424|363325946|FG001|Overall Study|Non-adherence to visit schedule|1|||
105360421|NCT00991289|363325947|FG000|Overall Study|Adverse Event|1|||
105802309|NCT00463866|364932581|FG001|Overall Study|Incorrect Enrolment|66|||
105802310|NCT00463866|364932580|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
105802311|NCT00463866|364932581|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
105802312|NCT00463866|364932580|FG000|Overall Study|Safety Reason|1|||
105802313|NCT00463866|364932581|FG001|Overall Study|Safety Reason|3|||
105754221|NCT03587584|364751683|FG001|Overall Study|SOC deviations|6|||
105754222|NCT03587584|364751682|FG000|Overall Study|Incomplete data|0|||
105754223|NCT03587584|364751683|FG001|Overall Study|Incomplete data|3|||
105754224|NCT00387348|364751684|FG000|Overall Study|Death|1|||
105754225|NCT00387348|364751685|FG001|Overall Study|Death|1|||
105754226|NCT00387348|364751686|FG002|Overall Study|Death|0|||
105754227|NCT00387348|364751684|FG000|Overall Study|Physician Decision|1|||
105754228|NCT00387348|364751685|FG001|Overall Study|Physician Decision|0|||
105754229|NCT00387348|364751686|FG002|Overall Study|Physician Decision|1|||
105754230|NCT00387348|364751684|FG000|Overall Study|Withdrawal by Subject|0|||
105754231|NCT00387348|364751685|FG001|Overall Study|Withdrawal by Subject|2|||
105754232|NCT00387348|364751686|FG002|Overall Study|Withdrawal by Subject|2|||
105754233|NCT00387348|364751684|FG000|Overall Study|Adverse Event|1|||
105754234|NCT00387348|364751685|FG001|Overall Study|Adverse Event|0|||
105754235|NCT00387348|364751686|FG002|Overall Study|Adverse Event|1|||
105754236|NCT00830115|364751687|FG000|Overall Study|Adverse Event|2|||
105754237|NCT00830115|364751687|FG000|Overall Study|Improvement/recovery|1|||
105754238|NCT00571688|364751691|FG000|Overall Study|Lost to Follow-up|3|||
105754239|NCT00571688|364751692|FG001|Overall Study|Lost to Follow-up|6|||
105754240|NCT00571688|364751691|FG000|Overall Study|subject did not tolerate Consta|1|||
105754241|NCT00571688|364751692|FG001|Overall Study|subject did not tolerate Consta|0|||
105754242|NCT00571688|364751691|FG000|Overall Study|subject moved out of the area|1|||
105754243|NCT00571688|364751692|FG001|Overall Study|subject moved out of the area|0|||
105754244|NCT02022033|364751693|FG000|Overall Study|Physician Decision|1|||
105754245|NCT01103778|364751694|FG000|Overall Study|Lost to Follow-up|1|||
105754246|NCT01103778|364751694|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
105754247|NCT01103778|364751694|FG000|Overall Study|Screen failure|1|||
105754248|NCT03067129|364751695|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
105754249|NCT03067129|364751696|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
105754250|NCT03067129|364751697|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
105754251|NCT03067129|364751698|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
105754252|NCT03067129|364751695|FG000|Overall Study|Withdrawal by Subject|0|||
105754253|NCT03067129|364751696|FG001|Overall Study|Withdrawal by Subject|0|||
105754254|NCT03067129|364751697|FG002|Overall Study|Withdrawal by Subject|1|||
105754255|NCT03067129|364751698|FG003|Overall Study|Withdrawal by Subject|2|||
105754256|NCT03067129|364751695|FG000|Overall Study|Lost to Follow-up|5|||
105754257|NCT03067129|364751696|FG001|Overall Study|Lost to Follow-up|5|||
105754258|NCT03067129|364751697|FG002|Overall Study|Lost to Follow-up|4|||
105754259|NCT03067129|364751698|FG003|Overall Study|Lost to Follow-up|3|||
105754260|NCT03247413|364751699|FG000|Overall Study|Lost to Follow-up|28|||
105754261|NCT00565058|364751700|FG000|Overall Study|Adverse Event|1|||
105754262|NCT00565058|364751701|FG001|Overall Study|Adverse Event|0|||
105754263|NCT01838590|364751702|FG000|Overall Study|Lack of Efficacy|12|||
105754264|NCT01838590|364751703|FG001|Overall Study|Lack of Efficacy|4|||
105754265|NCT01838590|364751702|FG000|Overall Study|Lost to Follow-up|0|||
105754266|NCT01838590|364751703|FG001|Overall Study|Lost to Follow-up|1|||
105754267|NCT02802878|364751704|FG000|Overall Study|Withdrawal by Subject|3|||
105754268|NCT02802878|364751705|FG001|Overall Study|Withdrawal by Subject|3|||
105754269|NCT02802878|364751704|FG000|Overall Study|Protocol Violation|1|||
105754270|NCT02802878|364751705|FG001|Overall Study|Protocol Violation|0|||
105754271|NCT01996904|364751706|FG000|Overall Study|Lost to Follow-up|38|||
105754272|NCT01996904|364751707|FG001|Overall Study|Lost to Follow-up|27|||
105754273|NCT01608724|364751708|FG000|Overall Study|Withdrawal by Subject|131|||
105754274|NCT01608724|364751708|FG000|Overall Study|Lost to Follow-up|41|||
105754275|NCT01608724|364751708|FG000|Overall Study|Study-specific discontinuation criteria|32|||
105754276|NCT01608724|364751708|FG000|Overall Study|Adverse Event|29|||
105754277|NCT01608724|364751708|FG000|Overall Study|Protocol Violation|6|||
105754278|NCT01608724|364751708|FG000|Overall Study|bood sugar too high, etc.|3|||
105754279|NCT01608724|364751708|FG000|Overall Study|Safety reasons|1|||
105754280|NCT00717366|364751709|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
105754281|NCT00717366|364751710|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
105754282|NCT00717366|364751709|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
105754283|NCT00717366|364751710|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
105754284|NCT00717366|364751709|FG000|Core Study Period (20 Weeks)|Death|0|||
105754285|NCT00717366|364751710|FG001|Core Study Period (20 Weeks)|Death|1|||
105754286|NCT00717366|364751709|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
105754287|NCT00717366|364751710|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
105754288|NCT00717366|364751709|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
105754289|NCT00717366|364751710|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
105754290|NCT00717366|364751709|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
105754291|NCT00717366|364751710|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
105754292|NCT00717366|364751709|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
105754293|NCT00717366|364751710|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
105754294|NCT00622869|364751711|FG000|Overall Study|Subject Withdrew Consent|13|||
105754295|NCT00622869|364751712|FG001|Overall Study|Subject Withdrew Consent|17|||
105754296|NCT00622869|364751713|FG002|Overall Study|Subject Withdrew Consent|11|||
105754297|NCT00622869|364751711|FG000|Overall Study|Administrative Problems|11|||
105754298|NCT00622869|364751712|FG001|Overall Study|Administrative Problems|17|||
105754299|NCT00622869|364751713|FG002|Overall Study|Administrative Problems|13|||
105754300|NCT00622869|364751711|FG000|Overall Study|Death|12|||
105754301|NCT00622869|364751712|FG001|Overall Study|Death|15|||
105754302|NCT00622869|364751713|FG002|Overall Study|Death|10|||
105754303|NCT00622869|364751711|FG000|Overall Study|Lost to Follow-up|2|||
105754304|NCT00622869|364751712|FG001|Overall Study|Lost to Follow-up|4|||
105754305|NCT00622869|364751713|FG002|Overall Study|Lost to Follow-up|2|||
105754306|NCT00622869|364751711|FG000|Overall Study|Graft Loss|5|||
105754307|NCT00622869|364751712|FG001|Overall Study|Graft Loss|3|||
105754308|NCT00622869|364751713|FG002|Overall Study|Graft Loss|2|||
105754309|NCT00622869|364751711|FG000|Overall Study|Missing|0|||
105754310|NCT00622869|364751712|FG001|Overall Study|Missing|1|||
105754311|NCT00622869|364751713|FG002|Overall Study|Missing|1|||
105754312|NCT00438399|364751717|FG000|Overall Study|Lost to Follow-up|2|||
105754313|NCT00438399|364751718|FG001|Overall Study|Lost to Follow-up|2|||
105754314|NCT00438399|364751719|FG002|Overall Study|Lost to Follow-up|1|||
105754315|NCT00438399|364751720|FG003|Overall Study|Lost to Follow-up|1|||
105754316|NCT00438399|364751721|FG004|Overall Study|Lost to Follow-up|1|||
105754317|NCT00438399|364751722|FG005|Overall Study|Lost to Follow-up|1|||
105754318|NCT00438399|364751717|FG000|Overall Study|Adverse Event|0|||
105754319|NCT00438399|364751718|FG001|Overall Study|Adverse Event|0|||
105754320|NCT00438399|364751719|FG002|Overall Study|Adverse Event|1|||
105754321|NCT00438399|364751720|FG003|Overall Study|Adverse Event|1|||
105754322|NCT00438399|364751721|FG004|Overall Study|Adverse Event|0|||
105754323|NCT00438399|364751722|FG005|Overall Study|Adverse Event|1|||
105754324|NCT00438399|364751717|FG000|Overall Study|Withdrawal by Subject|5|||
105754325|NCT00438399|364751718|FG001|Overall Study|Withdrawal by Subject|6|||
105754326|NCT00438399|364751719|FG002|Overall Study|Withdrawal by Subject|3|||
105754327|NCT00438399|364751720|FG003|Overall Study|Withdrawal by Subject|2|||
105754328|NCT00438399|364751721|FG004|Overall Study|Withdrawal by Subject|2|||
105754329|NCT00438399|364751722|FG005|Overall Study|Withdrawal by Subject|2|||
105754330|NCT00438399|364751717|FG000|Overall Study|Protocol Violation|0|||
105754331|NCT00438399|364751718|FG001|Overall Study|Protocol Violation|0|||
105754332|NCT00438399|364751719|FG002|Overall Study|Protocol Violation|1|||
105754333|NCT00438399|364751720|FG003|Overall Study|Protocol Violation|0|||
105754334|NCT00438399|364751721|FG004|Overall Study|Protocol Violation|0|||
105754335|NCT00438399|364751722|FG005|Overall Study|Protocol Violation|1|||
105754336|NCT00438399|364751717|FG000|Overall Study|Subje stopped study|0|||
105754337|NCT00438399|364751718|FG001|Overall Study|Subje stopped study|0|||
105754338|NCT00438399|364751719|FG002|Overall Study|Subje stopped study|1|||
105754339|NCT00438399|364751720|FG003|Overall Study|Subje stopped study|0|||
105754340|NCT00438399|364751721|FG004|Overall Study|Subje stopped study|0|||
105754341|NCT00438399|364751722|FG005|Overall Study|Subje stopped study|0|||
105754342|NCT00438399|364751717|FG000|Overall Study|Pregnancy|0|||
105754343|NCT00438399|364751718|FG001|Overall Study|Pregnancy|0|||
105754344|NCT00438399|364751719|FG002|Overall Study|Pregnancy|0|||
105754345|NCT00438399|364751720|FG003|Overall Study|Pregnancy|0|||
105754346|NCT00438399|364751721|FG004|Overall Study|Pregnancy|0|||
105754347|NCT00438399|364751722|FG005|Overall Study|Pregnancy|1|||
105754348|NCT00438399|364751717|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
105754349|NCT00438399|364751718|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
105754350|NCT00438399|364751719|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
105754351|NCT00438399|364751720|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
105760920|NCT04362813|364778063|FG000|Overall Study|Lost to Follow-up|1|||
105760921|NCT04362813|364778064|FG001|Overall Study|Lost to Follow-up|1|||
105760922|NCT04362813|364778063|FG000|Overall Study|Enrolled but did not receive treatment|2|||
105760923|NCT04362813|364778064|FG001|Overall Study|Enrolled but did not receive treatment|4|||
105760924|NCT00961116|364778065|FG000|Washout Period of 7 Days|Adverse Event|1|||
105760925|NCT00961116|364778066|FG001|Washout Period of 7 Days|Adverse Event|1|||
105760926|NCT00961116|364778065|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
105760927|NCT00961116|364778066|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105760928|NCT00961116|364778065|FG000|Washout Period of 7 Days|Protocol Violation|0|||
105760929|NCT00961116|364778066|FG001|Washout Period of 7 Days|Protocol Violation|1|||
105760930|NCT03407170|364778070|FG000|Overall Study|Adverse Event|1|||
105760931|NCT00425100|364778076|FG000|Overall Study|Adverse Event|36|||
105760932|NCT00425100|364778076|FG000|Overall Study|Lack of Efficacy|4|||
105760933|NCT00425100|364778076|FG000|Overall Study|Lost to Follow-up|2|||
105760934|NCT00425100|364778076|FG000|Overall Study|Protocol Violation|4|||
105760935|NCT00425100|364778076|FG000|Overall Study|Withdrawal by Subject|7|||
105760936|NCT01235728|364778078|FG000|Overall Study|Protocol Violation|0|||
105760937|NCT01235728|364778079|FG001|Overall Study|Protocol Violation|0|||
105760938|NCT01235728|364778080|FG002|Overall Study|Protocol Violation|0|||
105760939|NCT01235728|364778081|FG003|Overall Study|Protocol Violation|1|||
105760940|NCT01235728|364778082|FG004|Overall Study|Protocol Violation|0|||
105760941|NCT01235728|364778083|FG005|Overall Study|Protocol Violation|0|||
105760942|NCT01235728|364778084|FG006|Overall Study|Protocol Violation|0|||
105760943|NCT01235728|364778085|FG007|Overall Study|Protocol Violation|0|||
105760944|NCT02565615|364778086|FG000|Overall Study|Death|0|||
105760945|NCT02565615|364778087|FG001|Overall Study|Death|1|||
105760946|NCT02565615|364778088|FG002|Overall Study|Death|0|||
105760947|NCT02565615|364778089|FG003|Overall Study|Death|0|||
105760948|NCT02565615|364778090|FG004|Overall Study|Death|4|||
105760949|NCT02565615|364778086|FG000|Overall Study|Not willing to participate in study|2|||
105760950|NCT02565615|364778087|FG001|Overall Study|Not willing to participate in study|21|||
105760951|NCT02565615|364778088|FG002|Overall Study|Not willing to participate in study|0|||
105760952|NCT02565615|364778089|FG003|Overall Study|Not willing to participate in study|1|||
105760953|NCT02565615|364778090|FG004|Overall Study|Not willing to participate in study|169|||
105760954|NCT02565615|364778086|FG000|Overall Study|Lost to Follow-up|0|||
105760955|NCT02565615|364778087|FG001|Overall Study|Lost to Follow-up|4|||
105760956|NCT02565615|364778088|FG002|Overall Study|Lost to Follow-up|0|||
105760957|NCT02565615|364778089|FG003|Overall Study|Lost to Follow-up|1|||
105760958|NCT02565615|364778090|FG004|Overall Study|Lost to Follow-up|765|||
105760959|NCT02565615|364778086|FG000|Overall Study|Not meeting eligibility criteria|0|||
105760960|NCT02565615|364778087|FG001|Overall Study|Not meeting eligibility criteria|7|||
105760961|NCT02565615|364778088|FG002|Overall Study|Not meeting eligibility criteria|0|||
105760962|NCT02565615|364778089|FG003|Overall Study|Not meeting eligibility criteria|0|||
105760963|NCT02565615|364778090|FG004|Overall Study|Not meeting eligibility criteria|25|||
105760964|NCT02565615|364778086|FG000|Overall Study|Reason not defined|0|||
105760965|NCT02565615|364778087|FG001|Overall Study|Reason not defined|2|||
105760966|NCT02565615|364778088|FG002|Overall Study|Reason not defined|0|||
105760967|NCT02565615|364778089|FG003|Overall Study|Reason not defined|1|||
105760968|NCT02565615|364778090|FG004|Overall Study|Reason not defined|62|||
105760969|NCT02565615|364778086|FG000|Overall Study|Adverse Event|1|||
105760970|NCT02565615|364778087|FG001|Overall Study|Adverse Event|1|||
105760971|NCT02565615|364778088|FG002|Overall Study|Adverse Event|0|||
105760972|NCT02565615|364778089|FG003|Overall Study|Adverse Event|0|||
105760973|NCT02565615|364778090|FG004|Overall Study|Adverse Event|9|||
105760974|NCT02565615|364778086|FG000|Overall Study|Untreated|0|||
105760975|NCT02565615|364778087|FG001|Overall Study|Untreated|0|||
105760976|NCT02565615|364778088|FG002|Overall Study|Untreated|0|||
105760977|NCT02565615|364778089|FG003|Overall Study|Untreated|0|||
105760978|NCT02565615|364778090|FG004|Overall Study|Untreated|567|||
105760979|NCT00861380|364778093|FG000|Overall Study|Withdrawal Information not recorded|8427|||
105760980|NCT00861380|364778094|FG001|Overall Study|Withdrawal Information not recorded|9112|||
105760981|NCT00861380|364778095|FG002|Overall Study|Withdrawal Information not recorded|8872|||
105760982|NCT00861380|364778096|FG003|Overall Study|Withdrawal Information not recorded|3689|||
105760983|NCT00861380|364778097|FG004|Overall Study|Withdrawal Information not recorded|1812|||
105802314|NCT00463866|364932580|FG000|Overall Study|Mis-Randomization of subject|0|||
105802315|NCT00463866|364932581|FG001|Overall Study|Mis-Randomization of subject|1|||
105802316|NCT00463866|364932580|FG000|Overall Study|Other|22|||
105802317|NCT00463866|364932581|FG001|Overall Study|Other|22|||
105802318|NCT02265952|364932582|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
105802319|NCT02265952|364932583|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
105802320|NCT02265952|364932582|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
105802321|NCT02265952|364932583|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
105802322|NCT04313283|364932587|FG000|Overall Study|did not complete intervention|4|||
105802323|NCT01170364|364932609|FG000|Overall Study|Protocol Violation|4|||
105802324|NCT01170364|364932610|FG001|Overall Study|Protocol Violation|1|||
105802325|NCT04132232|364932611|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
105802326|NCT04132232|364932612|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
105802327|NCT04132232|364932611|FG000|Overall Study|Lost to Follow-up|6|||
105802328|NCT04132232|364932612|FG001|Overall Study|Lost to Follow-up|7|||
105802329|NCT00368537|364932618|FG000|Randomization|No study drug dosed|13|||
105802330|NCT00368537|364932619|FG001|Randomization|No study drug dosed|6|||
105802331|NCT00368537|364932618|FG000|Baseline Participants|Lost to Follow-up|16|||
105802332|NCT00368537|364932619|FG001|Baseline Participants|Lost to Follow-up|17|||
105802333|NCT00368537|364932618|FG000|Baseline Participants|Withdrawal by Subject|6|||
105802334|NCT00368537|364932619|FG001|Baseline Participants|Withdrawal by Subject|4|||
105802335|NCT00368537|364932618|FG000|Baseline Participants|Death|1|||
105802336|NCT00368537|364932619|FG001|Baseline Participants|Death|2|||
105802337|NCT00368537|364932618|FG000|Baseline Participants|No susceptibility|1|||
105802338|NCT00368537|364932619|FG001|Baseline Participants|No susceptibility|0|||
105802339|NCT00368537|364932618|FG000|Baseline Participants|Patient uncompliant|0|||
105802340|NCT00368537|364932619|FG001|Baseline Participants|Patient uncompliant|1|||
105802341|NCT01368276|364932631|FG000|Overall Study|Death|1|||
105802342|NCT01368276|364932632|FG001|Overall Study|Death|10|||
105802343|NCT01427920|364932633|FG000|Overall Study|Adverse Event|1|||
105802344|NCT01427920|364932634|FG001|Overall Study|Adverse Event|2|||
105802345|NCT01427920|364932633|FG000|Overall Study|Lack of Efficacy|1|||
105802346|NCT01427920|364932634|FG001|Overall Study|Lack of Efficacy|0|||
105802347|NCT01427920|364932633|FG000|Overall Study|Protocol Violation|1|||
105802348|NCT01427920|364932634|FG001|Overall Study|Protocol Violation|3|||
105802349|NCT01427920|364932633|FG000|Overall Study|Withdrawal Criteria|4|||
105802350|NCT01427920|364932634|FG001|Overall Study|Withdrawal Criteria|4|||
105802351|NCT01427920|364932633|FG000|Overall Study|Unclassified|2|||
105802352|NCT01427920|364932634|FG001|Overall Study|Unclassified|8|||
105802353|NCT01717456|364932636|FG000|End of Treatment|Physician Decision|0|||
105802354|NCT01717456|364932637|FG001|End of Treatment|Physician Decision|1|||
105802355|NCT01717456|364932636|FG000|End of Treatment|Lost to Follow-up|0|||
105802356|NCT01717456|364932637|FG001|End of Treatment|Lost to Follow-up|1|||
105802357|NCT01717456|364932636|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
105802358|NCT01717456|364932637|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
105802359|NCT01967888|364932644|FG000|Overall Study|Lost to Follow-up|6|||
105802360|NCT01967888|364932645|FG001|Overall Study|Lost to Follow-up|4|||
105802361|NCT01967888|364932644|FG000|Overall Study|Withdrawal by Subject|1|||
105802362|NCT01967888|364932645|FG001|Overall Study|Withdrawal by Subject|1|||
105802363|NCT01967888|364932644|FG000|Overall Study|Did Not Have Transplant|1|||
105802364|NCT01967888|364932645|FG001|Overall Study|Did Not Have Transplant|0|||
105802365|NCT01967888|364932644|FG000|Overall Study|Research visit not done, data recorded|1|||
105802366|NCT01967888|364932645|FG001|Overall Study|Research visit not done, data recorded|0|||
105802367|NCT01967888|364932644|FG000|Overall Study|Subject excluded after randomization|1|||
105802368|NCT01967888|364932645|FG001|Overall Study|Subject excluded after randomization|0|||
105802369|NCT01967888|364932644|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
105802370|NCT01967888|364932645|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
105802371|NCT01967888|364932644|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
105802372|NCT01967888|364932645|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
105802373|NCT01401478|364932648|FG000|Overall Study|Study drug not available|6|||
105802374|NCT01401478|364932648|FG000|Overall Study|Adverse Event|5|||
105802375|NCT01401478|364932648|FG000|Overall Study|Hyperphosphatemia|5|||
105802376|NCT01401478|364932648|FG000|Overall Study|Lost to Follow-up|5|||
105802377|NCT01401478|364932648|FG000|Overall Study|Kidney transplantation|3|||
105802378|NCT01401478|364932648|FG000|Overall Study|Withdrawal by Subject|3|||
105802379|NCT01401478|364932648|FG000|Overall Study|Blood samples not available|1|||
105802380|NCT01401478|364932648|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
105802381|NCT01401478|364932648|FG000|Overall Study|Low intact parathyroid hormone|1|||
105802382|NCT01401478|364932648|FG000|Overall Study|Serious adverse event|1|||
105802383|NCT03255031|364932649|FG000|Overall Study|Adverse Event|5|||
105802384|NCT03255031|364932650|FG001|Overall Study|Adverse Event|3|||
105802385|NCT03255031|364932649|FG000|Overall Study|Physician Decision|2|||
105802386|NCT03255031|364932650|FG001|Overall Study|Physician Decision|1|||
105802387|NCT03255031|364932649|FG000|Overall Study|Withdrawal by Subject|9|||
105802388|NCT03255031|364932650|FG001|Overall Study|Withdrawal by Subject|3|||
105802389|NCT01664494|364932653|FG000|Overall Study|Withdrawal by Subject|27|||
105802390|NCT01664494|364932653|FG000|Overall Study|Death|18|||
105802391|NCT01664494|364932653|FG000|Overall Study|Other|49|||
105802392|NCT01664494|364932653|FG000|Overall Study|Lost to Follow-up|99|||
105802393|NCT01138150|364932656|FG000|Overall Study|blood unable to be processed|0|||
105802394|NCT01138150|364932657|FG001|Overall Study|blood unable to be processed|1|||
105802395|NCT01138150|364932656|FG000|Overall Study|Physician Decision|1|||
105802396|NCT01138150|364932657|FG001|Overall Study|Physician Decision|0|||
105802397|NCT01328054|364932659|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
105802398|NCT01328054|364932660|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
105802399|NCT01328054|364932659|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
105802400|NCT01328054|364932660|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
105802401|NCT01328054|364932659|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
105802402|NCT01328054|364932660|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
105802403|NCT02390219|364932669|FG000|Overall Study|Death|1|||
105802404|NCT02390219|364932669|FG000|Overall Study|Physician Decision|1|||
105802405|NCT02390219|364932669|FG000|Overall Study|Adverse Event|6|||
105802406|NCT02390219|364932669|FG000|Overall Study|Withdrawal by Subject|1|||
105802407|NCT02390219|364932669|FG000|Overall Study|Lost to Follow-up|2|||
105802408|NCT02390219|364932669|FG000|Overall Study|Other|2|||
105802409|NCT01337050|364932670|FG000|Overall Study|Death|0|||
105802410|NCT01337050|364932671|FG001|Overall Study|Death|0|||
105802411|NCT01337050|364932672|FG002|Overall Study|Death|4|||
105802412|NCT01337050|364932670|FG000|Overall Study|Other|4|||
105802413|NCT01337050|364932671|FG001|Overall Study|Other|6|||
105802414|NCT01337050|364932672|FG002|Overall Study|Other|8|||
105802415|NCT01337050|364932670|FG000|Overall Study|Participants refused further follow-up|0|||
105802416|NCT01337050|364932671|FG001|Overall Study|Participants refused further follow-up|7|||
105802417|NCT01337050|364932672|FG002|Overall Study|Participants refused further follow-up|7|||
105802418|NCT00656019|364932673|FG000|Overall Study|Not Eligible|10|||
105802419|NCT00656019|364932674|FG001|Overall Study|Not Eligible|0|||
105802420|NCT00656019|364932675|FG002|Overall Study|Not Eligible|0|||
105802421|NCT00656019|364932676|FG003|Overall Study|Not Eligible|0|||
105802422|NCT00656019|364932673|FG000|Overall Study|Withdrawal by Subject|2|||
105802423|NCT00656019|364932674|FG001|Overall Study|Withdrawal by Subject|0|||
105802424|NCT00656019|364932675|FG002|Overall Study|Withdrawal by Subject|0|||
105802425|NCT00656019|364932676|FG003|Overall Study|Withdrawal by Subject|0|||
105802426|NCT00656019|364932673|FG000|Overall Study|Lost to Follow-up|2|||
105754352|NCT00438399|364751721|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
105754353|NCT00438399|364751722|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
105754354|NCT01364233|364751723|FG000|Overall Study|Lost to Follow-up|1|||
105754355|NCT00302718|364751724|FG000|Overall Study|Participant left the hospital|1|||
105754356|NCT00302718|364751725|FG001|Overall Study|Participant left the hospital|0|||
105754357|NCT00302718|364751726|FG002|Overall Study|Participant left the hospital|0|||
105754358|NCT00302718|364751727|FG003|Overall Study|Participant left the hospital|1|||
105754359|NCT00302718|364751724|FG000|Overall Study|Withdrawal by Subject|0|||
105754360|NCT00302718|364751725|FG001|Overall Study|Withdrawal by Subject|1|||
105754361|NCT00302718|364751726|FG002|Overall Study|Withdrawal by Subject|0|||
105754362|NCT00302718|364751727|FG003|Overall Study|Withdrawal by Subject|0|||
105754363|NCT00302718|364751724|FG000|Overall Study|Participant left primary care setting|0|||
105754364|NCT00302718|364751725|FG001|Overall Study|Participant left primary care setting|0|||
105754365|NCT00302718|364751726|FG002|Overall Study|Participant left primary care setting|2|||
105754366|NCT00302718|364751727|FG003|Overall Study|Participant left primary care setting|1|||
105754367|NCT04900038|364751728|FG000|Overall Study|Adverse Event|1|||
105754368|NCT04900038|364751729|FG001|Overall Study|Adverse Event|0|||
105754369|NCT04900038|364751730|FG002|Overall Study|Adverse Event|1|||
105754370|NCT04900038|364751731|FG003|Overall Study|Adverse Event|1|||
105754371|NCT04900038|364751728|FG000|Overall Study|Withdrawal by Subject|0|||
105754372|NCT04900038|364751729|FG001|Overall Study|Withdrawal by Subject|1|||
105754373|NCT04900038|364751730|FG002|Overall Study|Withdrawal by Subject|0|||
105754374|NCT04900038|364751731|FG003|Overall Study|Withdrawal by Subject|0|||
105360422|NCT00991289|363325947|FG000|Overall Study|Physician Decision|2|||
105754375|NCT04900038|364751728|FG000|Overall Study|Study terminated by sponsor|18|||
105754376|NCT04900038|364751729|FG001|Overall Study|Study terminated by sponsor|15|||
105360423|NCT00991289|363325947|FG000|Overall Study|Withdrawal by Subject|3|||
105802427|NCT00656019|364932674|FG001|Overall Study|Lost to Follow-up|1|||
105802428|NCT00656019|364932675|FG002|Overall Study|Lost to Follow-up|0|||
105802429|NCT00656019|364932676|FG003|Overall Study|Lost to Follow-up|0|||
105802430|NCT01360632|364932679|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
105802431|NCT01360632|364932680|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
105802432|NCT01360632|364932681|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
105802433|NCT01360632|364932682|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
105360424|NCT00991289|363325947|FG000|Overall Study|Lost to Follow-up|4|||
105754377|NCT04900038|364751730|FG002|Overall Study|Study terminated by sponsor|17|||
105754378|NCT04900038|364751731|FG003|Overall Study|Study terminated by sponsor|14|||
105754379|NCT04900038|364751728|FG000|Overall Study|Protocol Deviation|1|||
105754380|NCT04900038|364751729|FG001|Overall Study|Protocol Deviation|1|||
105754381|NCT04900038|364751730|FG002|Overall Study|Protocol Deviation|0|||
105754382|NCT04900038|364751731|FG003|Overall Study|Protocol Deviation|0|||
105754383|NCT04900038|364751728|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
105754384|NCT04900038|364751729|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
105754385|NCT04900038|364751730|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
105754386|NCT04900038|364751731|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
105754387|NCT04900038|364751728|FG000|Overall Study|Lost to Follow-up|0|||
105754388|NCT04900038|364751729|FG001|Overall Study|Lost to Follow-up|0|||
105754389|NCT04900038|364751730|FG002|Overall Study|Lost to Follow-up|0|||
105754390|NCT04900038|364751731|FG003|Overall Study|Lost to Follow-up|1|||
105754391|NCT04111107|364751732|FG000|Overall Study|Withdrawal by Subject|6|||
105754392|NCT04111107|364751732|FG000|Overall Study|Declining Health|5|||
105754393|NCT01714817|364751733|FG000|Year 1 Period|Lack of Efficacy|11|||
105754394|NCT01714817|364751734|FG001|Year 1 Period|Lack of Efficacy|9|||
105754395|NCT01714817|364751733|FG000|Year 1 Period|Adverse Event|20|||
105754396|NCT01714817|364751734|FG001|Year 1 Period|Adverse Event|17|||
105754397|NCT01714817|364751733|FG000|Year 1 Period|Withdrawal by Subject|6|||
105754398|NCT01714817|364751734|FG001|Year 1 Period|Withdrawal by Subject|7|||
105754399|NCT01714817|364751733|FG000|Year 1 Period|Death|1|||
105754400|NCT01714817|364751734|FG001|Year 1 Period|Death|1|||
105754401|NCT01714817|364751733|FG000|Year 1 Period|Lost to Follow-up|0|||
105754402|NCT01714817|364751734|FG001|Year 1 Period|Lost to Follow-up|2|||
105754403|NCT01714817|364751733|FG000|Year 1 Period|Poor / non-compliance|0|||
105754404|NCT01714817|364751734|FG001|Year 1 Period|Poor / non-compliance|1|||
105754405|NCT01714817|364751733|FG000|Year 1 Period|Pregnancy|2|||
105754406|NCT01714817|364751734|FG001|Year 1 Period|Pregnancy|0|||
105754407|NCT01714817|364751733|FG000|Year 1 Period|Participant no longer meets criteria|6|||
105754408|NCT01714817|364751734|FG001|Year 1 Period|Participant no longer meets criteria|2|||
105754409|NCT01714817|364751733|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
105754410|NCT01714817|364751734|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
105754411|NCT01714817|364751733|FG000|Year 1 Period|Change in Concomitant Medication|0|||
105754412|NCT01714817|364751734|FG001|Year 1 Period|Change in Concomitant Medication|1|||
105754413|NCT01714817|364751733|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
105754414|NCT01714817|364751734|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
105754415|NCT01714817|364751733|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
105754416|NCT01714817|364751734|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
105754417|NCT01714817|364751733|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
105754418|NCT01714817|364751734|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
105754419|NCT01714817|364751733|FG000|Year 2 Period|Lack of Efficacy|4|||
105754420|NCT01714817|364751734|FG001|Year 2 Period|Lack of Efficacy|12|||
105754421|NCT01714817|364751733|FG000|Year 2 Period|Adverse Event|7|||
105754422|NCT01714817|364751734|FG001|Year 2 Period|Adverse Event|6|||
105754423|NCT01714817|364751733|FG000|Year 2 Period|Participant request to stop treatment|4|||
105754424|NCT01714817|364751734|FG001|Year 2 Period|Participant request to stop treatment|4|||
105754425|NCT01714817|364751733|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
105754426|NCT01714817|364751734|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
105754427|NCT01714817|364751733|FG000|Year 2 Period|Participant withdrew consent|1|||
105754428|NCT01714817|364751734|FG001|Year 2 Period|Participant withdrew consent|5|||
105754429|NCT01714817|364751733|FG000|Year 2 Period|Participant no longer meets criteria|1|||
105754430|NCT01714817|364751734|FG001|Year 2 Period|Participant no longer meets criteria|4|||
105754431|NCT01714817|364751733|FG000|Year 2 Period|Lost to Follow-up|2|||
105754432|NCT01714817|364751734|FG001|Year 2 Period|Lost to Follow-up|0|||
105754433|NCT01714817|364751733|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
105754434|NCT01714817|364751734|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
105360425|NCT00991289|363325947|FG000|Overall Study|Protocol Violation|2|||
105754435|NCT01714817|364751733|FG000|Year 2 Period|Pregnancy|1|||
105754436|NCT01714817|364751734|FG001|Year 2 Period|Pregnancy|1|||
105754437|NCT01714817|364751733|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
105754438|NCT01714817|364751734|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
105754439|NCT01714817|364751733|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
105754440|NCT01714817|364751734|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
105754441|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
105754442|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
105754443|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
105754444|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
105754445|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
105754446|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
105754447|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
105802434|NCT01360632|364932683|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
105802435|NCT01360632|364932679|FG000|Phase A (8 Weeks)|Adverse Event|60|||
105802436|NCT01360632|364932680|FG001|Phase A (8 Weeks)|Adverse Event|0|||
105802437|NCT01360632|364932681|FG002|Phase A (8 Weeks)|Adverse Event|0|||
105802438|NCT01360632|364932682|FG003|Phase A (8 Weeks)|Adverse Event|0|||
105802439|NCT01360632|364932683|FG004|Phase A (8 Weeks)|Adverse Event|0|||
105802440|NCT01360632|364932679|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
105802441|NCT01360632|364932680|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
105802442|NCT01360632|364932681|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
105802443|NCT01360632|364932682|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
105802444|NCT01360632|364932683|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
105802445|NCT01360632|364932679|FG000|Phase A (8 Weeks)|Physician Decision|10|||
105802446|NCT01360632|364932680|FG001|Phase A (8 Weeks)|Physician Decision|0|||
105802447|NCT01360632|364932681|FG002|Phase A (8 Weeks)|Physician Decision|0|||
105802448|NCT01360632|364932682|FG003|Phase A (8 Weeks)|Physician Decision|0|||
105802449|NCT01360632|364932683|FG004|Phase A (8 Weeks)|Physician Decision|0|||
105802450|NCT01360632|364932679|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
105802451|NCT01360632|364932680|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
105802452|NCT01360632|364932681|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
105802453|NCT01360632|364932682|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
105802454|NCT01360632|364932683|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
105802455|NCT01360632|364932679|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
105802456|NCT01360632|364932680|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
105802457|NCT01360632|364932681|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
105802458|NCT01360632|364932682|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
105802459|NCT01360632|364932683|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
105802460|NCT01360632|364932679|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
105802461|NCT01360632|364932680|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
105802462|NCT01360632|364932681|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
105802463|NCT01360632|364932682|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
105802464|NCT01360632|364932683|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
105802465|NCT01360632|364932679|FG000|Phase B (6 Weeks)|Adverse Event|0|||
105802466|NCT01360632|364932680|FG001|Phase B (6 Weeks)|Adverse Event|3|||
105802467|NCT01360632|364932681|FG002|Phase B (6 Weeks)|Adverse Event|9|||
105802468|NCT01360632|364932682|FG003|Phase B (6 Weeks)|Adverse Event|3|||
105802469|NCT01360632|364932683|FG004|Phase B (6 Weeks)|Adverse Event|0|||
105802470|NCT01360632|364932679|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
105802471|NCT01360632|364932680|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
105802472|NCT01360632|364932681|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
105802473|NCT01360632|364932682|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
105802474|NCT01360632|364932683|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
105802475|NCT01360632|364932679|FG000|Phase B (6 Weeks)|Physician Decision|0|||
105802476|NCT01360632|364932680|FG001|Phase B (6 Weeks)|Physician Decision|0|||
105802477|NCT01360632|364932681|FG002|Phase B (6 Weeks)|Physician Decision|0|||
105802478|NCT01360632|364932682|FG003|Phase B (6 Weeks)|Physician Decision|1|||
105802479|NCT01360632|364932683|FG004|Phase B (6 Weeks)|Physician Decision|0|||
105802480|NCT01360632|364932679|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
105802481|NCT01360632|364932680|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
105802482|NCT01360632|364932681|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
105802483|NCT01360632|364932682|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
105802484|NCT01360632|364932683|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
105802485|NCT01360632|364932679|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
105802486|NCT01360632|364932680|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
105802487|NCT01360632|364932681|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
105802488|NCT01360632|364932682|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
105802489|NCT01360632|364932683|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
105802490|NCT01360632|364932679|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
105802491|NCT01360632|364932680|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
105802492|NCT01360632|364932681|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
105802493|NCT01360632|364932682|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
105802494|NCT01360632|364932683|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
105802495|NCT01360632|364932679|FG000|Phase A+|Lost to Follow-up|0|||
105802496|NCT01360632|364932680|FG001|Phase A+|Lost to Follow-up|0|||
105802497|NCT01360632|364932681|FG002|Phase A+|Lost to Follow-up|0|||
105802498|NCT01360632|364932682|FG003|Phase A+|Lost to Follow-up|0|||
105802499|NCT01360632|364932683|FG004|Phase A+|Lost to Follow-up|2|||
105802500|NCT01360632|364932679|FG000|Phase A+|Adverse Event|0|||
105802501|NCT01360632|364932680|FG001|Phase A+|Adverse Event|0|||
105802502|NCT01360632|364932681|FG002|Phase A+|Adverse Event|0|||
105802503|NCT01360632|364932682|FG003|Phase A+|Adverse Event|0|||
105802504|NCT01360632|364932683|FG004|Phase A+|Adverse Event|2|||
105802505|NCT01360632|364932679|FG000|Phase A+|Met Withdrawal Criteria|0|||
105802506|NCT01360632|364932680|FG001|Phase A+|Met Withdrawal Criteria|0|||
105802507|NCT01360632|364932681|FG002|Phase A+|Met Withdrawal Criteria|0|||
105802508|NCT01360632|364932682|FG003|Phase A+|Met Withdrawal Criteria|0|||
105802509|NCT01360632|364932683|FG004|Phase A+|Met Withdrawal Criteria|7|||
105802510|NCT01360632|364932679|FG000|Phase A+|Physician Decision|0|||
105802511|NCT01360632|364932680|FG001|Phase A+|Physician Decision|0|||
105754448|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
105754449|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
105754450|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
105754451|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
105754452|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
105754453|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
105754454|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
105754455|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
105754456|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
105754457|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
105754458|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
105754459|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
105754460|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
105754461|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
105754462|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
105754463|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
105754464|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
105754465|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
105754466|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
105754467|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
105754468|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
105754469|NCT01244191|364751735|FG000|Overall Study|Progressive disease|295|||
105754470|NCT01244191|364751736|FG001|Overall Study|Progressive disease|350|||
105754471|NCT01244191|364751735|FG000|Overall Study|Clinical disease progression|54|||
105754472|NCT01244191|364751736|FG001|Overall Study|Clinical disease progression|36|||
105754473|NCT01244191|364751735|FG000|Overall Study|Adverse Event|65|||
105754474|NCT01244191|364751736|FG001|Overall Study|Adverse Event|48|||
105754475|NCT01244191|364751735|FG000|Overall Study|Death|22|||
105754476|NCT01244191|364751736|FG001|Overall Study|Death|29|||
105754477|NCT01244191|364751735|FG000|Overall Study|Lost to Follow-up|0|||
105754478|NCT01244191|364751736|FG001|Overall Study|Lost to Follow-up|2|||
105754479|NCT01244191|364751735|FG000|Overall Study|Protocol Violation|1|||
105754480|NCT01244191|364751736|FG001|Overall Study|Protocol Violation|2|||
105754481|NCT01244191|364751735|FG000|Overall Study|Withdrawal by Subject|31|||
105754482|NCT01244191|364751736|FG001|Overall Study|Withdrawal by Subject|23|||
105754483|NCT01244191|364751735|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
105754484|NCT01244191|364751736|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
105754485|NCT00646113|364753641|FG000|Overall Study|Lost to Follow-up|5|||
105754486|NCT00646113|364753641|FG000|Overall Study|Adverse Event|3|||
105754487|NCT01337167|364753642|FG000|Infant Series|Adverse Event|1|||
105754488|NCT01337167|364753643|FG001|Infant Series|Adverse Event|1|||
105754489|NCT01337167|364753642|FG000|Infant Series|Death|1|||
105754490|NCT01337167|364753643|FG001|Infant Series|Death|1|||
105754491|NCT01337167|364753642|FG000|Infant Series|Lost to Follow-up|13|||
105754492|NCT01337167|364753643|FG001|Infant Series|Lost to Follow-up|7|||
105754493|NCT01337167|364753642|FG000|Infant Series|Non-compliance with study drug|2|||
105754494|NCT01337167|364753643|FG001|Infant Series|Non-compliance with study drug|1|||
105754495|NCT01337167|364753642|FG000|Infant Series|Physician Decision|3|||
105754496|NCT01337167|364753643|FG001|Infant Series|Physician Decision|1|||
105754497|NCT01337167|364753642|FG000|Infant Series|Protocol Violation|22|||
105754498|NCT01337167|364753643|FG001|Infant Series|Protocol Violation|9|||
105754499|NCT01337167|364753642|FG000|Infant Series|Withdrawal by Subject|15|||
105754500|NCT01337167|364753643|FG001|Infant Series|Withdrawal by Subject|4|||
105754501|NCT01337167|364753642|FG000|Infant Series|Randomized but not vaccinated|5|||
105754502|NCT01337167|364753643|FG001|Infant Series|Randomized but not vaccinated|3|||
105754503|NCT01337167|364753642|FG000|Interim Period|Lost to Follow-up|51|||
105754504|NCT01337167|364753643|FG001|Interim Period|Lost to Follow-up|23|||
105567385|NCT00116844|364074980|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
105754505|NCT01337167|364753642|FG000|Interim Period|Non-compliance with study drug|1|||
105754506|NCT01337167|364753643|FG001|Interim Period|Non-compliance with study drug|0|||
105754507|NCT01337167|364753642|FG000|Interim Period|Physician Decision|6|||
105754508|NCT01337167|364753643|FG001|Interim Period|Physician Decision|3|||
105754509|NCT01337167|364753642|FG000|Interim Period|Protocol Violation|5|||
105754510|NCT01337167|364753643|FG001|Interim Period|Protocol Violation|3|||
105754511|NCT01337167|364753642|FG000|Interim Period|Withdrawal by Subject|18|||
105754512|NCT01337167|364753643|FG001|Interim Period|Withdrawal by Subject|10|||
105754513|NCT01337167|364753642|FG000|Interim Period|Other protocol criterion not met|0|||
105754514|NCT01337167|364753643|FG001|Interim Period|Other protocol criterion not met|1|||
105754515|NCT01337167|364753642|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
105360426|NCT00227539|363325948|FG000|Overall Study|Protocol Violation|1|||
105754516|NCT01337167|364753643|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
105754517|NCT01337167|364753642|FG000|Toddler Vaccinations|Protocol Violation|0|||
105754518|NCT01337167|364753643|FG001|Toddler Vaccinations|Protocol Violation|1|||
105754519|NCT01337167|364753642|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
105754520|NCT01337167|364753643|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
105754521|NCT03833817|364753644|FG000|Overall Study|Withdrawal by Subject|3|||
105754522|NCT03833817|364753645|FG001|Overall Study|Withdrawal by Subject|3|||
105754523|NCT03833817|364753644|FG000|Overall Study|Lost to Follow-up|3|||
105754524|NCT03833817|364753645|FG001|Overall Study|Lost to Follow-up|3|||
105754525|NCT00884221|364753646|FG000|Overall Study|Withdrawal by Subject|0|||
105754526|NCT00884221|364753647|FG001|Overall Study|Withdrawal by Subject|3|||
105754527|NCT00884221|364753646|FG000|Overall Study|Adverse Event|6|||
105754528|NCT00884221|364753647|FG001|Overall Study|Adverse Event|3|||
105754529|NCT00884221|364753646|FG000|Overall Study|Protocol Violation|16|||
105754530|NCT00884221|364753647|FG001|Overall Study|Protocol Violation|13|||
105754531|NCT00884221|364753646|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
105754532|NCT00884221|364753647|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
105754533|NCT03073213|364753650|FG000|Multiple Dose Period|Protocol Violation|0|||
105754534|NCT03073213|364753651|FG001|Multiple Dose Period|Protocol Violation|0|||
105754535|NCT03073213|364753652|FG002|Multiple Dose Period|Protocol Violation|1|||
105754536|NCT01993615|364753661|FG000|Overall Study|Death|1|||
105754537|NCT01993615|364753662|FG001|Overall Study|Death|0|||
105754538|NCT01175213|364753665|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
105754539|NCT01175213|364753666|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
105754540|NCT01175213|364753665|FG000|IGSC, 10%/rHuPH20|Death|1|||
105754541|NCT01175213|364753666|FG001|IGSC, 10%/rHuPH20|Death|0|||
105754542|NCT01175213|364753665|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
105754543|NCT01175213|364753666|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
105754544|NCT01175213|364753665|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
105754545|NCT01175213|364753666|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
105754546|NCT01175213|364753665|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
105754547|NCT01175213|364753666|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
105754548|NCT01175213|364753665|FG000|Safety Follow-up|Adverse Event|1|||
105754549|NCT01175213|364753666|FG001|Safety Follow-up|Adverse Event|0|||
105754550|NCT01245764|364753667|FG000|Study Phase A|Other|3|||
105754551|NCT01245764|364753668|FG001|Study Phase A|Other|2|||
105754552|NCT01245764|364753669|FG002|Study Phase A|Other|3|||
105754553|NCT01245764|364753670|FG003|Study Phase A|Other|1|||
105754554|NCT01245764|364753667|FG000|Study Phase A|Protocol Violation|6|||
105754555|NCT01245764|364753668|FG001|Study Phase A|Protocol Violation|3|||
105754556|NCT01245764|364753669|FG002|Study Phase A|Protocol Violation|2|||
105754557|NCT01245764|364753670|FG003|Study Phase A|Protocol Violation|2|||
105754558|NCT01245764|364753667|FG000|Study Phase A|Lost to Follow-up|0|||
105754559|NCT01245764|364753668|FG001|Study Phase A|Lost to Follow-up|0|||
105754560|NCT01245764|364753669|FG002|Study Phase A|Lost to Follow-up|5|||
105754561|NCT01245764|364753670|FG003|Study Phase A|Lost to Follow-up|0|||
105754562|NCT00003476|364753671|FG000|Overall Study|Not evaluable|1|||
105754563|NCT03097614|364753677|FG000|Overall Study|Adverse Event|3|||
105754564|NCT03057951|364753678|FG000|Overall Study|Adverse Event|553|||
105754565|NCT03057951|364753679|FG001|Overall Study|Adverse Event|575|||
105754566|NCT03057951|364753678|FG000|Overall Study|Protocol Violation|30|||
105754567|NCT03057951|364753679|FG001|Overall Study|Protocol Violation|24|||
105754568|NCT03057951|364753678|FG000|Overall Study|Lost to Follow-up|6|||
105754569|NCT03057951|364753679|FG001|Overall Study|Lost to Follow-up|16|||
105754570|NCT03057951|364753678|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
105754571|NCT03057951|364753679|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
105754572|NCT03057951|364753678|FG000|Overall Study|Study drug stopped, reason missing|6|||
105754573|NCT03057951|364753679|FG001|Overall Study|Study drug stopped, reason missing|1|||
105754574|NCT03057951|364753678|FG000|Overall Study|Medical advice|6|||
105754575|NCT03057951|364753679|FG001|Overall Study|Medical advice|2|||
105754576|NCT03057951|364753678|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
105754577|NCT03057951|364753679|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
105802512|NCT01360632|364932681|FG002|Phase A+|Physician Decision|0|||
105802513|NCT01360632|364932682|FG003|Phase A+|Physician Decision|0|||
105802514|NCT01360632|364932683|FG004|Phase A+|Physician Decision|3|||
105802515|NCT01360632|364932679|FG000|Phase A+|Withdrawal by Subject|0|||
105802516|NCT01360632|364932680|FG001|Phase A+|Withdrawal by Subject|0|||
105802517|NCT01360632|364932681|FG002|Phase A+|Withdrawal by Subject|0|||
105802518|NCT01360632|364932682|FG003|Phase A+|Withdrawal by Subject|0|||
105802519|NCT01360632|364932683|FG004|Phase A+|Withdrawal by Subject|8|||
105802520|NCT01360632|364932679|FG000|Phase A+|Protocol Deviation|0|||
105802521|NCT01360632|364932680|FG001|Phase A+|Protocol Deviation|0|||
105802522|NCT01360632|364932681|FG002|Phase A+|Protocol Deviation|0|||
105802523|NCT01360632|364932682|FG003|Phase A+|Protocol Deviation|0|||
105802524|NCT01360632|364932683|FG004|Phase A+|Protocol Deviation|3|||
105802525|NCT02123459|364932685|FG000|Washout Period (1 Day)|Adverse Event|1|||
105802526|NCT02123459|364932686|FG001|Washout Period (1 Day)|Adverse Event|0|||
105802527|NCT02196506|364932691|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
105802528|NCT02196506|364932692|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
105802529|NCT02196506|364932693|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
105567386|NCT00116844|364074981|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
105567387|NCT00116844|364074980|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
105567388|NCT00116844|364074981|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
105567389|NCT00116844|364074980|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
105567390|NCT00116844|364074981|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
105567391|NCT00116844|364074980|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
105567392|NCT00116844|364074981|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
105567393|NCT00116844|364074980|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
105567394|NCT00116844|364074981|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
105567395|NCT00116844|364074980|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
105567396|NCT00116844|364074981|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
105567397|NCT00116844|364074980|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
105567398|NCT00116844|364074981|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
105567399|NCT02969525|364074982|FG000|Double-Blind Period|Adverse Event|0|||
105567400|NCT02969525|364074983|FG001|Double-Blind Period|Adverse Event|0|||
105567401|NCT02969525|364074984|FG002|Double-Blind Period|Adverse Event|1|||
105567402|NCT02969525|364074985|FG003|Double-Blind Period|Adverse Event|1|||
105567403|NCT02969525|364074986|FG004|Double-Blind Period|Adverse Event|0|||
105567404|NCT02969525|364074987|FG005|Double-Blind Period|Adverse Event|0|||
105567405|NCT02969525|364074988|FG006|Double-Blind Period|Adverse Event|0|||
105567406|NCT02969525|364074989|FG007|Double-Blind Period|Adverse Event|0|||
105567407|NCT02969525|364074990|FG008|Double-Blind Period|Adverse Event|0|||
105567408|NCT02969525|364074991|FG009|Double-Blind Period|Adverse Event|0|||
105802530|NCT02196506|364932694|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
105802531|NCT02196506|364932691|FG000|Phase A|Withdrawal by Subject|34|||
105802532|NCT02196506|364932692|FG001|Phase A|Withdrawal by Subject|0|||
105802533|NCT02196506|364932693|FG002|Phase A|Withdrawal by Subject|0|||
105802534|NCT02196506|364932694|FG003|Phase A|Withdrawal by Subject|0|||
105802535|NCT02196506|364932691|FG000|Phase A|Adverse Event|22|||
105802536|NCT02196506|364932692|FG001|Phase A|Adverse Event|0|||
105802537|NCT02196506|364932693|FG002|Phase A|Adverse Event|0|||
105802538|NCT02196506|364932694|FG003|Phase A|Adverse Event|0|||
105802539|NCT02196506|364932691|FG000|Phase A|Lost to Follow-up|9|||
105802540|NCT02196506|364932692|FG001|Phase A|Lost to Follow-up|0|||
105802541|NCT02196506|364932693|FG002|Phase A|Lost to Follow-up|0|||
105802542|NCT02196506|364932694|FG003|Phase A|Lost to Follow-up|0|||
105802543|NCT02196506|364932691|FG000|Phase A|Protocol deviation|12|||
105802544|NCT02196506|364932692|FG001|Phase A|Protocol deviation|0|||
105802545|NCT02196506|364932693|FG002|Phase A|Protocol deviation|0|||
105802546|NCT02196506|364932694|FG003|Phase A|Protocol deviation|0|||
105802547|NCT02196506|364932691|FG000|Phase A|Participant withdrawn by investigator|10|||
105802548|NCT02196506|364932692|FG001|Phase A|Participant withdrawn by investigator|0|||
105567409|NCT02969525|364074992|FG010|Double-Blind Period|Adverse Event|0|||
105567410|NCT02969525|364074993|FG011|Double-Blind Period|Adverse Event|0|||
105567411|NCT02969525|364074982|FG000|Double-Blind Period|LOW EGFR|0|||
105567412|NCT02969525|364074983|FG001|Double-Blind Period|LOW EGFR|0|||
105567413|NCT02969525|364074984|FG002|Double-Blind Period|LOW EGFR|0|||
105567414|NCT02969525|364074985|FG003|Double-Blind Period|LOW EGFR|1|||
105567415|NCT02969525|364074986|FG004|Double-Blind Period|LOW EGFR|0|||
105567416|NCT02969525|364074987|FG005|Double-Blind Period|LOW EGFR|0|||
105567417|NCT02969525|364074988|FG006|Double-Blind Period|LOW EGFR|0|||
105567418|NCT02969525|364074989|FG007|Double-Blind Period|LOW EGFR|0|||
105567419|NCT02969525|364074990|FG008|Double-Blind Period|LOW EGFR|0|||
105567420|NCT02969525|364074991|FG009|Double-Blind Period|LOW EGFR|0|||
105567421|NCT02969525|364074992|FG010|Double-Blind Period|LOW EGFR|0|||
105802549|NCT02196506|364932693|FG002|Phase A|Participant withdrawn by investigator|0|||
105802550|NCT02196506|364932694|FG003|Phase A|Participant withdrawn by investigator|0|||
105802551|NCT02196506|364932691|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
105802552|NCT02196506|364932692|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
105567422|NCT02969525|364074993|FG011|Double-Blind Period|LOW EGFR|0|||
105567423|NCT02969525|364074982|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
105567424|NCT02969525|364074983|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105754578|NCT03057951|364753678|FG000|Overall Study|Investigator decision|2|||
105754579|NCT03057951|364753679|FG001|Overall Study|Investigator decision|0|||
105567425|NCT02969525|364074984|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105567426|NCT02969525|364074985|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
105567427|NCT02969525|364074986|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105567428|NCT02969525|364074987|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105567429|NCT02969525|364074988|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105567430|NCT02969525|364074989|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105567431|NCT02969525|364074990|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105567432|NCT02969525|364074991|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105567433|NCT02969525|364074992|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105567434|NCT02969525|364074993|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105567435|NCT02969525|364074982|FG000|Dose-Blind Period|Adverse Event|0|||
105567436|NCT02969525|364074983|FG001|Dose-Blind Period|Adverse Event|0|||
105567437|NCT02969525|364074984|FG002|Dose-Blind Period|Adverse Event|0|||
105567438|NCT02969525|364074985|FG003|Dose-Blind Period|Adverse Event|0|||
105567439|NCT02969525|364074986|FG004|Dose-Blind Period|Adverse Event|0|||
105360427|NCT00426764|363325949|FG000|Overall Study|Protocol Violation|1|||
105360428|NCT00426764|363325949|FG000|Overall Study|Withdrawal by Subject|4|||
105360429|NCT00426764|363325949|FG000|Overall Study|Physician Decision|6|||
105360430|NCT00426764|363325949|FG000|Overall Study|Compassionate Use|1|||
105360431|NCT00426764|363325949|FG000|Overall Study|Progressive Disease|83|||
105360432|NCT00426764|363325949|FG000|Overall Study|Adverse Event|24|||
105360433|NCT00426764|363325949|FG000|Overall Study|Other|1|||
105360434|NCT00426764|363325949|FG000|Overall Study|Death|1|||
105567440|NCT02969525|364074987|FG005|Dose-Blind Period|Adverse Event|0|||
105754580|NCT03057951|364753678|FG000|Overall Study|Patient decision|5|||
105754581|NCT03057951|364753679|FG001|Overall Study|Patient decision|2|||
105754582|NCT03057951|364753678|FG000|Overall Study|Not attending study visits|3|||
105754583|NCT03057951|364753679|FG001|Overall Study|Not attending study visits|0|||
105754584|NCT03057951|364753678|FG000|Overall Study|Patient moved away|3|||
105754585|NCT03057951|364753679|FG001|Overall Study|Patient moved away|4|||
105754586|NCT03057951|364753678|FG000|Overall Study|Other reason than stated above|23|||
105754587|NCT03057951|364753679|FG001|Overall Study|Other reason than stated above|29|||
105754588|NCT03057951|364753678|FG000|Overall Study|Not treated|2|||
105754589|NCT03057951|364753679|FG001|Overall Study|Not treated|1|||
105754590|NCT00696436|364753681|FG000|Overall Study|Adverse Event|7|||
105754591|NCT00696436|364753682|FG001|Overall Study|Adverse Event|9|||
105754592|NCT00696436|364753683|FG002|Overall Study|Adverse Event|8|||
105754593|NCT00696436|364753684|FG003|Overall Study|Adverse Event|6|||
105754594|NCT00696436|364753685|FG004|Overall Study|Adverse Event|4|||
105754595|NCT00696436|364753681|FG000|Overall Study|Protocol Violation|3|||
105754596|NCT00696436|364753682|FG001|Overall Study|Protocol Violation|2|||
105754597|NCT00696436|364753683|FG002|Overall Study|Protocol Violation|2|||
105360435|NCT00426764|363325949|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
105567441|NCT02969525|364074988|FG006|Dose-Blind Period|Adverse Event|0|||
105567442|NCT02969525|364074989|FG007|Dose-Blind Period|Adverse Event|0|||
105567443|NCT02969525|364074990|FG008|Dose-Blind Period|Adverse Event|0|||
105567444|NCT02969525|364074991|FG009|Dose-Blind Period|Adverse Event|1|||
105754598|NCT00696436|364753684|FG003|Overall Study|Protocol Violation|0|||
105754599|NCT00696436|364753685|FG004|Overall Study|Protocol Violation|1|||
105754600|NCT00696436|364753681|FG000|Overall Study|Lost to Follow-up|1|||
105754601|NCT00696436|364753682|FG001|Overall Study|Lost to Follow-up|6|||
105754602|NCT00696436|364753683|FG002|Overall Study|Lost to Follow-up|2|||
105754603|NCT00696436|364753684|FG003|Overall Study|Lost to Follow-up|4|||
105754604|NCT00696436|364753685|FG004|Overall Study|Lost to Follow-up|3|||
105567445|NCT02969525|364074992|FG010|Dose-Blind Period|Adverse Event|1|||
105567446|NCT02969525|364074993|FG011|Dose-Blind Period|Adverse Event|1|||
105567447|NCT02969525|364074982|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
105567448|NCT02969525|364074983|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
105567449|NCT02969525|364074984|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
105567450|NCT02969525|364074985|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
105567451|NCT02969525|364074986|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
105567452|NCT02969525|364074987|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
105567453|NCT02969525|364074988|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
105567454|NCT02969525|364074989|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
105567455|NCT02969525|364074990|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
105567456|NCT02969525|364074991|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
105567457|NCT02969525|364074992|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
105567458|NCT02969525|364074993|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
105567459|NCT02969525|364074982|FG000|Dose-Blind Period|Non-cooperating patient|0|||
105567460|NCT02969525|364074983|FG001|Dose-Blind Period|Non-cooperating patient|0|||
105567461|NCT02969525|364074984|FG002|Dose-Blind Period|Non-cooperating patient|0|||
105567462|NCT02969525|364074985|FG003|Dose-Blind Period|Non-cooperating patient|0|||
105567463|NCT02969525|364074986|FG004|Dose-Blind Period|Non-cooperating patient|0|||
105567464|NCT02969525|364074987|FG005|Dose-Blind Period|Non-cooperating patient|0|||
105567465|NCT02969525|364074988|FG006|Dose-Blind Period|Non-cooperating patient|0|||
105567466|NCT02969525|364074989|FG007|Dose-Blind Period|Non-cooperating patient|0|||
105567467|NCT02969525|364074990|FG008|Dose-Blind Period|Non-cooperating patient|0|||
105567468|NCT02969525|364074991|FG009|Dose-Blind Period|Non-cooperating patient|0|||
105567469|NCT02969525|364074992|FG010|Dose-Blind Period|Non-cooperating patient|0|||
105567470|NCT02969525|364074993|FG011|Dose-Blind Period|Non-cooperating patient|1|||
105567471|NCT02969525|364074982|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
105567472|NCT02969525|364074983|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
105567473|NCT02969525|364074984|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
105567474|NCT02969525|364074985|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
105567475|NCT02969525|364074986|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
105567476|NCT02969525|364074987|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
105567477|NCT02969525|364074988|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
105567478|NCT02969525|364074989|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
105567479|NCT02969525|364074990|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
105567480|NCT02969525|364074991|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
105567481|NCT02969525|364074992|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
105567482|NCT02969525|364074993|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
105567483|NCT04398537|364074994|FG000|Overall Study|Physician Decision|10|||
105567484|NCT04398537|364074995|FG001|Overall Study|Physician Decision|15|||
105567485|NCT02272725|364074996|FG000|Overall Study|equipment malfunction|2|||
105802553|NCT02196506|364932693|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
105802554|NCT02196506|364932694|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
105802555|NCT02196506|364932691|FG000|Phase B|Lack of Efficacy|0|||
105802556|NCT02196506|364932692|FG001|Phase B|Lack of Efficacy|1|||
105802557|NCT02196506|364932693|FG002|Phase B|Lack of Efficacy|2|||
105802558|NCT02196506|364932694|FG003|Phase B|Lack of Efficacy|0|||
105802559|NCT02196506|364932691|FG000|Phase B|Withdrawal by Participant|0|||
105802560|NCT02196506|364932692|FG001|Phase B|Withdrawal by Participant|8|||
105802561|NCT02196506|364932693|FG002|Phase B|Withdrawal by Participant|1|||
105802562|NCT02196506|364932694|FG003|Phase B|Withdrawal by Participant|0|||
105802563|NCT02196506|364932691|FG000|Phase B|Adverse Event|0|||
105802564|NCT02196506|364932692|FG001|Phase B|Adverse Event|4|||
105802565|NCT02196506|364932693|FG002|Phase B|Adverse Event|1|||
105802566|NCT02196506|364932694|FG003|Phase B|Adverse Event|0|||
105802567|NCT02196506|364932691|FG000|Phase B|Lost to Follow-up|0|||
105802568|NCT02196506|364932692|FG001|Phase B|Lost to Follow-up|2|||
105802569|NCT02196506|364932693|FG002|Phase B|Lost to Follow-up|1|||
105802570|NCT02196506|364932694|FG003|Phase B|Lost to Follow-up|0|||
105802571|NCT02196506|364932691|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
105754605|NCT00696436|364753681|FG000|Overall Study|Withdrawal by Subject|4|||
105754606|NCT00696436|364753682|FG001|Overall Study|Withdrawal by Subject|11|||
105754607|NCT00696436|364753683|FG002|Overall Study|Withdrawal by Subject|5|||
105754608|NCT00696436|364753684|FG003|Overall Study|Withdrawal by Subject|7|||
105754609|NCT00696436|364753685|FG004|Overall Study|Withdrawal by Subject|1|||
105754610|NCT00696436|364753681|FG000|Overall Study|Lack of Efficacy|3|||
105754611|NCT00696436|364753682|FG001|Overall Study|Lack of Efficacy|1|||
105754612|NCT00696436|364753683|FG002|Overall Study|Lack of Efficacy|5|||
105754613|NCT00696436|364753684|FG003|Overall Study|Lack of Efficacy|2|||
105754614|NCT00696436|364753685|FG004|Overall Study|Lack of Efficacy|4|||
105754615|NCT00696436|364753681|FG000|Overall Study|Participant Unavailability|2|||
105754616|NCT00696436|364753682|FG001|Overall Study|Participant Unavailability|0|||
105754617|NCT00696436|364753683|FG002|Overall Study|Participant Unavailability|2|||
105754618|NCT00696436|364753684|FG003|Overall Study|Participant Unavailability|1|||
105754619|NCT00696436|364753685|FG004|Overall Study|Participant Unavailability|0|||
105754620|NCT00696436|364753681|FG000|Overall Study|Administrative Error|2|||
105754621|NCT00696436|364753682|FG001|Overall Study|Administrative Error|0|||
105754622|NCT00696436|364753683|FG002|Overall Study|Administrative Error|2|||
105754623|NCT00696436|364753684|FG003|Overall Study|Administrative Error|0|||
105754624|NCT00696436|364753685|FG004|Overall Study|Administrative Error|0|||
105754625|NCT00696436|364753681|FG000|Overall Study|Participant Non-compliance|0|||
105754626|NCT00696436|364753682|FG001|Overall Study|Participant Non-compliance|0|||
105754627|NCT00696436|364753683|FG002|Overall Study|Participant Non-compliance|1|||
105754628|NCT00696436|364753684|FG003|Overall Study|Participant Non-compliance|2|||
105754629|NCT00696436|364753685|FG004|Overall Study|Participant Non-compliance|0|||
105754630|NCT00696436|364753681|FG000|Overall Study|Administrative Decision|1|||
105754631|NCT00696436|364753682|FG001|Overall Study|Administrative Decision|0|||
105754632|NCT00696436|364753683|FG002|Overall Study|Administrative Decision|0|||
105754633|NCT00696436|364753684|FG003|Overall Study|Administrative Decision|0|||
105754634|NCT00696436|364753685|FG004|Overall Study|Administrative Decision|0|||
105754635|NCT00696436|364753681|FG000|Overall Study|Missing|0|||
105754636|NCT00696436|364753682|FG001|Overall Study|Missing|1|||
105754637|NCT00696436|364753683|FG002|Overall Study|Missing|1|||
105754638|NCT00696436|364753684|FG003|Overall Study|Missing|0|||
105754639|NCT00696436|364753685|FG004|Overall Study|Missing|0|||
105754640|NCT02282982|364753686|FG000|Overall Study|Lost to Follow-up|15|||
105754641|NCT02282982|364753686|FG000|Overall Study|Withdrew consent|2|||
105754642|NCT02282982|364753686|FG000|Overall Study|Death|4|||
105754643|NCT02282982|364753686|FG000|Overall Study|Lack of product|156|||
105754644|NCT02282982|364753686|FG000|Overall Study|Palivizumab is ended|11|||
105754645|NCT02282982|364753686|FG000|Overall Study|Other, not specified|18|||
105754646|NCT03172481|364753690|FG000|Double-blind|Withdrawal by Subject|1|||
105754647|NCT03172481|364753691|FG001|Double-blind|Withdrawal by Subject|0|||
105754648|NCT02716194|364753692|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
105754649|NCT02716194|364753693|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
105754650|NCT02716194|364753694|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
105754651|NCT00971425|364753695|FG000|Overall Study|Adverse Event|1|||
105754652|NCT00971425|364753696|FG001|Overall Study|Adverse Event|1|||
105754653|NCT00971425|364753695|FG000|Overall Study|Withdrawal by Subject|0|||
105754654|NCT00971425|364753696|FG001|Overall Study|Withdrawal by Subject|1|||
105754655|NCT01925612|364753707|FG000|Overall Study|Progressive Disease|1|||
105754656|NCT01925612|364753708|FG001|Overall Study|Progressive Disease|1|||
105754657|NCT01925612|364753709|FG002|Overall Study|Progressive Disease|1|||
105754658|NCT01925612|364753710|FG003|Overall Study|Progressive Disease|0|||
105754659|NCT01925612|364753711|FG004|Overall Study|Progressive Disease|0|||
105754660|NCT01925612|364753707|FG000|Overall Study|Adverse Event|3|||
105754661|NCT01925612|364753708|FG001|Overall Study|Adverse Event|3|||
105754662|NCT01925612|364753709|FG002|Overall Study|Adverse Event|0|||
105754663|NCT01925612|364753710|FG003|Overall Study|Adverse Event|1|||
105754664|NCT01925612|364753711|FG004|Overall Study|Adverse Event|2|||
105754665|NCT00225147|364753714|FG000|Open-label Phase|Lost to Follow-up|0|||
105754666|NCT00225147|364753715|FG001|Open-label Phase|Lost to Follow-up|0|||
105754667|NCT00225147|364753716|FG002|Open-label Phase|Lost to Follow-up|0|||
105754668|NCT00225147|364753717|FG003|Open-label Phase|Lost to Follow-up|4|||
105754669|NCT00225147|364753714|FG000|Open-label Phase|Withdrawal by Subject|0|||
105754670|NCT00225147|364753715|FG001|Open-label Phase|Withdrawal by Subject|0|||
105754671|NCT00225147|364753716|FG002|Open-label Phase|Withdrawal by Subject|0|||
105754672|NCT00225147|364753717|FG003|Open-label Phase|Withdrawal by Subject|6|||
105754673|NCT04019795|364753718|FG000|Overall Study|Withdrawal by Subject|1|||
105754674|NCT04019795|364753719|FG001|Overall Study|Withdrawal by Subject|2|||
105754675|NCT04019795|364753720|FG002|Overall Study|Withdrawal by Subject|2|||
105754676|NCT04019795|364753721|FG003|Overall Study|Withdrawal by Subject|1|||
105754677|NCT04019795|364753718|FG000|Overall Study|Lost to Follow-up|0|||
105754678|NCT04019795|364753719|FG001|Overall Study|Lost to Follow-up|1|||
105754679|NCT04019795|364753720|FG002|Overall Study|Lost to Follow-up|1|||
105754680|NCT04019795|364753721|FG003|Overall Study|Lost to Follow-up|2|||
105754681|NCT04019795|364753718|FG000|Overall Study|Treatment non-compliance|3|||
105754682|NCT04019795|364753719|FG001|Overall Study|Treatment non-compliance|1|||
105754683|NCT04019795|364753720|FG002|Overall Study|Treatment non-compliance|2|||
105754684|NCT04019795|364753721|FG003|Overall Study|Treatment non-compliance|0|||
105754685|NCT04019795|364753718|FG000|Overall Study|Physician Decision|0|||
105754686|NCT04019795|364753719|FG001|Overall Study|Physician Decision|0|||
105754687|NCT04019795|364753720|FG002|Overall Study|Physician Decision|1|||
105754688|NCT04019795|364753721|FG003|Overall Study|Physician Decision|0|||
105754689|NCT04019795|364753718|FG000|Overall Study|Adverse Event|1|||
105754690|NCT04019795|364753719|FG001|Overall Study|Adverse Event|0|||
105754691|NCT04019795|364753720|FG002|Overall Study|Adverse Event|0|||
105754692|NCT04019795|364753721|FG003|Overall Study|Adverse Event|0|||
105754693|NCT02899377|364753727|FG000|Overall Study|Adverse Event|1|||
105754694|NCT02899377|364753728|FG001|Overall Study|Adverse Event|0|||
105754695|NCT00340834|364753731|FG000|Core Phase of Study|Adverse Event|26|||
105754696|NCT00340834|364753732|FG001|Core Phase of Study|Adverse Event|9|||
105754697|NCT00340834|364753733|FG002|Core Phase of Study|Adverse Event|9|||
105754698|NCT00340834|364753734|FG003|Core Phase of Study|Adverse Event|0|||
105754699|NCT00340834|364753735|FG004|Core Phase of Study|Adverse Event|0|||
105754700|NCT00340834|364753731|FG000|Core Phase of Study|Withdrawal by Subject|11|||
105754701|NCT00340834|364753732|FG001|Core Phase of Study|Withdrawal by Subject|9|||
105754702|NCT00340834|364753733|FG002|Core Phase of Study|Withdrawal by Subject|16|||
105754703|NCT00340834|364753734|FG003|Core Phase of Study|Withdrawal by Subject|0|||
105754704|NCT00340834|364753735|FG004|Core Phase of Study|Withdrawal by Subject|0|||
105754705|NCT00340834|364753731|FG000|Core Phase of Study|Administrative Problems|6|||
105754706|NCT00340834|364753732|FG001|Core Phase of Study|Administrative Problems|2|||
105754707|NCT00340834|364753733|FG002|Core Phase of Study|Administrative Problems|7|||
105754708|NCT00340834|364753734|FG003|Core Phase of Study|Administrative Problems|0|||
105754709|NCT00340834|364753735|FG004|Core Phase of Study|Administrative Problems|0|||
105754710|NCT00340834|364753731|FG000|Core Phase of Study|Lack of Efficacy|3|||
105754711|NCT00340834|364753732|FG001|Core Phase of Study|Lack of Efficacy|3|||
105754712|NCT00340834|364753733|FG002|Core Phase of Study|Lack of Efficacy|7|||
105754713|NCT00340834|364753734|FG003|Core Phase of Study|Lack of Efficacy|0|||
105754714|NCT00340834|364753735|FG004|Core Phase of Study|Lack of Efficacy|0|||
105754715|NCT00340834|364753731|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
105754716|NCT00340834|364753732|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
105754717|NCT00340834|364753733|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
105754718|NCT00340834|364753734|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
105754719|NCT00340834|364753735|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
105754720|NCT00340834|364753731|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
105754721|NCT00340834|364753732|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
105754722|NCT00340834|364753733|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
105754723|NCT00340834|364753734|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
105754724|NCT00340834|364753735|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
105802572|NCT02196506|364932692|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
105802573|NCT02196506|364932693|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
105754725|NCT00340834|364753731|FG000|Core Phase of Study|Lost to Follow-up|1|||
105754726|NCT00340834|364753732|FG001|Core Phase of Study|Lost to Follow-up|1|||
105754727|NCT00340834|364753733|FG002|Core Phase of Study|Lost to Follow-up|4|||
105754728|NCT00340834|364753734|FG003|Core Phase of Study|Lost to Follow-up|0|||
105754729|NCT00340834|364753735|FG004|Core Phase of Study|Lost to Follow-up|0|||
105754730|NCT00340834|364753731|FG000|Core Phase of Study|Death|2|||
105802574|NCT02196506|364932694|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
105754731|NCT00340834|364753732|FG001|Core Phase of Study|Death|0|||
105754732|NCT00340834|364753733|FG002|Core Phase of Study|Death|0|||
105754733|NCT00340834|364753734|FG003|Core Phase of Study|Death|0|||
105754734|NCT00340834|364753735|FG004|Core Phase of Study|Death|0|||
105754735|NCT00340834|364753731|FG000|Core Phase of Study|Protocol Violation|0|||
105754736|NCT00340834|364753732|FG001|Core Phase of Study|Protocol Violation|0|||
105754737|NCT00340834|364753733|FG002|Core Phase of Study|Protocol Violation|2|||
105754738|NCT00340834|364753734|FG003|Core Phase of Study|Protocol Violation|0|||
105754739|NCT00340834|364753735|FG004|Core Phase of Study|Protocol Violation|0|||
105802575|NCT02196506|364932691|FG000|Phase A+|Withdrawal by Participant|0|||
105802576|NCT02196506|364932692|FG001|Phase A+|Withdrawal by Participant|0|||
105802577|NCT02196506|364932693|FG002|Phase A+|Withdrawal by Participant|0|||
105567486|NCT02272725|364074997|FG001|Overall Study|equipment malfunction|0|||
105567487|NCT01679236|364076874|FG000|Overall Study|Lost to Follow-up|15|||
105567488|NCT01679236|364076875|FG001|Overall Study|Lost to Follow-up|15|||
105567489|NCT01659658|364076878|FG000|Overall Study|Withdrawal by Patient|18|||
105567490|NCT01659658|364076879|FG001|Overall Study|Withdrawal by Patient|4|||
105802578|NCT02196506|364932694|FG003|Phase A+|Withdrawal by Participant|5|||
105802579|NCT02196506|364932691|FG000|Phase A+|Adverse Event|0|||
105802580|NCT02196506|364932692|FG001|Phase A+|Adverse Event|0|||
105802581|NCT02196506|364932693|FG002|Phase A+|Adverse Event|0|||
105802582|NCT02196506|364932694|FG003|Phase A+|Adverse Event|1|||
105802583|NCT02196506|364932691|FG000|Phase A+|Lost to Follow-up|0|||
105802584|NCT02196506|364932692|FG001|Phase A+|Lost to Follow-up|0|||
105802585|NCT02196506|364932693|FG002|Phase A+|Lost to Follow-up|0|||
105802586|NCT02196506|364932694|FG003|Phase A+|Lost to Follow-up|6|||
105802587|NCT02196506|364932691|FG000|Phase A+|Participant withdrawn by investigator|0|||
105802588|NCT02196506|364932692|FG001|Phase A+|Participant withdrawn by investigator|0|||
105802589|NCT02196506|364932693|FG002|Phase A+|Participant withdrawn by investigator|0|||
105802590|NCT02196506|364932694|FG003|Phase A+|Participant withdrawn by investigator|1|||
105567491|NCT01659658|364076880|FG002|Overall Study|Withdrawal by Patient|2|||
105567492|NCT01659658|364076881|FG003|Overall Study|Withdrawal by Patient|0|||
105567493|NCT01659658|364076882|FG004|Overall Study|Withdrawal by Patient|11|||
105567494|NCT01659658|364076878|FG000|Overall Study|Study Terminated by Sponsor|9|||
105567495|NCT01659658|364076879|FG001|Overall Study|Study Terminated by Sponsor|7|||
105567496|NCT01659658|364076880|FG002|Overall Study|Study Terminated by Sponsor|0|||
105567497|NCT01659658|364076881|FG003|Overall Study|Study Terminated by Sponsor|1|||
105567498|NCT01659658|364076882|FG004|Overall Study|Study Terminated by Sponsor|4|||
105567499|NCT01659658|364076878|FG000|Overall Study|Reason not Specified|61|||
105567500|NCT01659658|364076879|FG001|Overall Study|Reason not Specified|15|||
105567501|NCT01659658|364076880|FG002|Overall Study|Reason not Specified|8|||
105567502|NCT01659658|364076881|FG003|Overall Study|Reason not Specified|1|||
105567503|NCT01659658|364076882|FG004|Overall Study|Reason not Specified|34|||
105567504|NCT01659658|364076878|FG000|Overall Study|Lost to Follow-up|2|||
105567505|NCT01659658|364076879|FG001|Overall Study|Lost to Follow-up|0|||
105567506|NCT01659658|364076880|FG002|Overall Study|Lost to Follow-up|0|||
105567507|NCT01659658|364076881|FG003|Overall Study|Lost to Follow-up|0|||
105567508|NCT01659658|364076882|FG004|Overall Study|Lost to Follow-up|0|||
105567509|NCT02202434|364076883|FG000|Overall Study|Death|70|||
105567510|NCT02202434|364076884|FG001|Overall Study|Death|39|||
105567511|NCT02202434|364076885|FG002|Overall Study|Death|13|||
105567512|NCT02202434|364076886|FG003|Overall Study|Death|27|||
105567513|NCT02202434|364076883|FG000|Overall Study|Lost to Follow-up|1|||
105567514|NCT02202434|364076884|FG001|Overall Study|Lost to Follow-up|1|||
105567515|NCT02202434|364076885|FG002|Overall Study|Lost to Follow-up|1|||
105567516|NCT02202434|364076886|FG003|Overall Study|Lost to Follow-up|0|||
105567517|NCT02202434|364076883|FG000|Overall Study|Physician Decision|2|||
105567518|NCT02202434|364076884|FG001|Overall Study|Physician Decision|3|||
105567519|NCT02202434|364076885|FG002|Overall Study|Physician Decision|0|||
105567520|NCT02202434|364076886|FG003|Overall Study|Physician Decision|0|||
105567521|NCT02202434|364076883|FG000|Overall Study|Withdrawal by Subject|13|||
105567522|NCT02202434|364076884|FG001|Overall Study|Withdrawal by Subject|14|||
105567523|NCT02202434|364076885|FG002|Overall Study|Withdrawal by Subject|1|||
105567524|NCT02202434|364076886|FG003|Overall Study|Withdrawal by Subject|4|||
105567525|NCT02202434|364076883|FG000|Overall Study|Completed Study|1|||
105567526|NCT02202434|364076884|FG001|Overall Study|Completed Study|0|||
105567527|NCT02202434|364076885|FG002|Overall Study|Completed Study|0|||
105567528|NCT02202434|364076886|FG003|Overall Study|Completed Study|0|||
105567529|NCT02202434|364076883|FG000|Overall Study|Visit Missed|21|||
105567530|NCT02202434|364076884|FG001|Overall Study|Visit Missed|12|||
105567531|NCT02202434|364076885|FG002|Overall Study|Visit Missed|0|||
105567532|NCT02202434|364076886|FG003|Overall Study|Visit Missed|5|||
105567533|NCT02202434|364076883|FG000|Overall Study|Other|1|||
105567534|NCT02202434|364076884|FG001|Overall Study|Other|0|||
105567535|NCT02202434|364076885|FG002|Overall Study|Other|0|||
105567536|NCT02202434|364076886|FG003|Overall Study|Other|1|||
105567537|NCT01160484|364076891|FG000|Overall Study|Lack of Efficacy|9|||
105567538|NCT01160484|364076891|FG000|Overall Study|Adverse Event|6|||
105567539|NCT01160484|364076891|FG000|Overall Study|Withdrawal by Subject|2|||
105567540|NCT01160484|364076891|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
105802591|NCT00254397|364932695|FG000|Overall Study|Disease Progression|4|||
105802592|NCT00254397|364932696|FG001|Overall Study|Disease Progression|1|||
105567541|NCT01108458|364076892|FG000|Overall Study|Withdrawal by Subject|1|||
105567542|NCT03328143|364076893|FG000|Overall Study|Declined|3|||
105567543|NCT03328143|364076893|FG000|Overall Study|Required increased sedation|4|||
105567544|NCT03328143|364076893|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
105567545|NCT03328143|364076893|FG000|Overall Study|Surgery cancelled|1|||
105802593|NCT00254397|364932697|FG002|Overall Study|Disease Progression|16|||
105802594|NCT00254397|364932698|FG003|Overall Study|Disease Progression|23|||
105802595|NCT00254397|364932695|FG000|Overall Study|Non-Compliant|0|||
105802596|NCT00254397|364932696|FG001|Overall Study|Non-Compliant|0|||
105567546|NCT02494921|364076894|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
105567547|NCT02494921|364076895|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
105567548|NCT02494921|364076896|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
105567549|NCT02494921|364076897|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
105567550|NCT02494921|364076898|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
105567551|NCT02494921|364076894|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
105567552|NCT02494921|364076895|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
105567553|NCT02494921|364076896|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
105567554|NCT02494921|364076897|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
105567555|NCT02494921|364076898|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
105567556|NCT02494921|364076894|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
105567557|NCT02494921|364076895|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
105567558|NCT02494921|364076896|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
105567559|NCT02494921|364076897|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
105567560|NCT02494921|364076898|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
105567561|NCT02421666|364076899|FG000|6-month Follow-up|Lost to Follow-up|8|||
105567562|NCT02421666|364076900|FG001|6-month Follow-up|Lost to Follow-up|7|||
105567563|NCT02421666|364076899|FG000|6-month Follow-up|Withdrawal by Subject|5|||
105567564|NCT02421666|364076900|FG001|6-month Follow-up|Withdrawal by Subject|6|||
105567565|NCT02421666|364076899|FG000|12-month Follow-up|Lost to Follow-up|5|||
105567566|NCT02421666|364076900|FG001|12-month Follow-up|Lost to Follow-up|5|||
105567567|NCT02421666|364076899|FG000|12-month Follow-up|Withdrawal by Subject|6|||
105567568|NCT02421666|364076900|FG001|12-month Follow-up|Withdrawal by Subject|11|||
105567569|NCT00105235|364076903|FG000|Overall Study|Death|4|||
105567570|NCT00105235|364076903|FG000|Overall Study|Physician Decision|1|||
105567571|NCT00105235|364076903|FG000|Overall Study|Withdrawal by Subject|2|||
105567572|NCT03261271|364076905|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
105567573|NCT03261271|364076906|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
105567574|NCT00991341|364076911|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
105567575|NCT00991341|364076912|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
105567576|NCT00991341|364076911|FG000|Overall Study|Death|3|||
105567577|NCT00991341|364076912|FG001|Overall Study|Death|0|||
105567578|NCT00991341|364076911|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
105567579|NCT00991341|364076912|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
105567580|NCT00991341|364076911|FG000|Overall Study|Physician Decision|1|||
105567581|NCT00991341|364076912|FG001|Overall Study|Physician Decision|2|||
105567582|NCT00991341|364076911|FG000|Overall Study|Withdrawal by Subject|3|||
105567583|NCT00991341|364076912|FG001|Overall Study|Withdrawal by Subject|4|||
105567584|NCT03145766|364076917|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
105567585|NCT03145766|364076918|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
105802597|NCT00254397|364932697|FG002|Overall Study|Non-Compliant|0|||
105802598|NCT00254397|364932698|FG003|Overall Study|Non-Compliant|1|||
105802599|NCT00254397|364932695|FG000|Overall Study|Adverse Event|2|||
105802600|NCT00254397|364932696|FG001|Overall Study|Adverse Event|0|||
105802601|NCT00254397|364932697|FG002|Overall Study|Adverse Event|3|||
105802602|NCT00254397|364932698|FG003|Overall Study|Adverse Event|1|||
105567586|NCT03145766|364076919|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
105567587|NCT03145766|364076920|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
105567588|NCT03145766|364076921|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
105567589|NCT03145766|364076917|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
105567590|NCT03145766|364076918|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
105802603|NCT01070394|364932699|FG000|Overall Study|Adverse Event|6|||
105754740|NCT00340834|364753731|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
105754741|NCT00340834|364753732|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
105754742|NCT00340834|364753733|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
105754743|NCT00340834|364753734|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
105754744|NCT00340834|364753735|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
105754745|NCT00340834|364753731|FG000|Extension Phase of Study|Subject withdrew consent|26|||
105754746|NCT00340834|364753732|FG001|Extension Phase of Study|Subject withdrew consent|31|||
105754747|NCT00340834|364753733|FG002|Extension Phase of Study|Subject withdrew consent|0|||
105754748|NCT00340834|364753734|FG003|Extension Phase of Study|Subject withdrew consent|12|||
105754749|NCT00340834|364753735|FG004|Extension Phase of Study|Subject withdrew consent|15|||
105754750|NCT00340834|364753731|FG000|Extension Phase of Study|Adverse Event|21|||
105754751|NCT00340834|364753732|FG001|Extension Phase of Study|Adverse Event|22|||
105754752|NCT00340834|364753733|FG002|Extension Phase of Study|Adverse Event|0|||
105754753|NCT00340834|364753734|FG003|Extension Phase of Study|Adverse Event|19|||
105754754|NCT00340834|364753735|FG004|Extension Phase of Study|Adverse Event|7|||
105754755|NCT00340834|364753731|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
105754756|NCT00340834|364753732|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
105754757|NCT00340834|364753733|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
105754758|NCT00340834|364753734|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
105754759|NCT00340834|364753735|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
105754760|NCT00340834|364753731|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
105754761|NCT00340834|364753732|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
105754762|NCT00340834|364753733|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
105754763|NCT00340834|364753734|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
105754764|NCT00340834|364753735|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
105754765|NCT00340834|364753731|FG000|Extension Phase of Study|Lost to Follow-up|1|||
105754766|NCT00340834|364753732|FG001|Extension Phase of Study|Lost to Follow-up|1|||
105754767|NCT00340834|364753733|FG002|Extension Phase of Study|Lost to Follow-up|0|||
105754768|NCT00340834|364753734|FG003|Extension Phase of Study|Lost to Follow-up|2|||
105754769|NCT00340834|364753735|FG004|Extension Phase of Study|Lost to Follow-up|3|||
105754770|NCT00340834|364753731|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
105754771|NCT00340834|364753732|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
105754772|NCT00340834|364753733|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
105754773|NCT00340834|364753734|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
105754774|NCT00340834|364753735|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
105754775|NCT00340834|364753731|FG000|Extension Phase of Study|Administrative problems|3|||
105754776|NCT00340834|364753732|FG001|Extension Phase of Study|Administrative problems|0|||
105754777|NCT00340834|364753733|FG002|Extension Phase of Study|Administrative problems|0|||
105754778|NCT00340834|364753734|FG003|Extension Phase of Study|Administrative problems|1|||
105754779|NCT00340834|364753735|FG004|Extension Phase of Study|Administrative problems|1|||
105754780|NCT00340834|364753731|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
105754781|NCT00340834|364753732|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
105754782|NCT00340834|364753733|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
105754783|NCT00340834|364753734|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
105754784|NCT00340834|364753735|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
105754785|NCT00340834|364753731|FG000|Extension Phase of Study|Protocol Violation|3|||
105754786|NCT00340834|364753732|FG001|Extension Phase of Study|Protocol Violation|0|||
105754787|NCT00340834|364753733|FG002|Extension Phase of Study|Protocol Violation|0|||
105754788|NCT00340834|364753734|FG003|Extension Phase of Study|Protocol Violation|0|||
105754789|NCT00340834|364753735|FG004|Extension Phase of Study|Protocol Violation|0|||
105754790|NCT00340834|364753731|FG000|Extension Phase of Study|Death|0|||
105754791|NCT00340834|364753732|FG001|Extension Phase of Study|Death|0|||
105754792|NCT00340834|364753733|FG002|Extension Phase of Study|Death|0|||
105754793|NCT00340834|364753734|FG003|Extension Phase of Study|Death|0|||
105754794|NCT00340834|364753735|FG004|Extension Phase of Study|Death|1|||
105754795|NCT03372603|364753736|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
105754796|NCT03372603|364753737|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
105754797|NCT03372603|364753736|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
105754798|NCT03372603|364753737|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
105754799|NCT03084718|364753738|FG000|Overall Study|Withdrawal by Subject|4|||
105754800|NCT03084718|364753739|FG001|Overall Study|Withdrawal by Subject|3|||
105754801|NCT03084718|364753740|FG002|Overall Study|Withdrawal by Subject|4|||
105754802|NCT03084718|364753741|FG003|Overall Study|Withdrawal by Subject|0|||
105754803|NCT03084718|364753742|FG004|Overall Study|Withdrawal by Subject|0|||
105360436|NCT00379899|363325950|FG000|Overall Study|Adverse Event|7|||
105360437|NCT00379899|363325951|FG001|Overall Study|Adverse Event|3|||
105360438|NCT00379899|363325950|FG000|Overall Study|Death|10|||
105360439|NCT00379899|363325951|FG001|Overall Study|Death|10|||
105754804|NCT03084718|364753738|FG000|Overall Study|Physician Decision|1|||
105754805|NCT03084718|364753739|FG001|Overall Study|Physician Decision|0|||
105754806|NCT03084718|364753740|FG002|Overall Study|Physician Decision|0|||
105754807|NCT03084718|364753741|FG003|Overall Study|Physician Decision|0|||
105754808|NCT03084718|364753742|FG004|Overall Study|Physician Decision|0|||
105754809|NCT03084718|364753738|FG000|Overall Study|Adverse Event|3|||
105754810|NCT03084718|364753739|FG001|Overall Study|Adverse Event|5|||
105754811|NCT03084718|364753740|FG002|Overall Study|Adverse Event|5|||
105754812|NCT03084718|364753741|FG003|Overall Study|Adverse Event|8|||
105754813|NCT03084718|364753742|FG004|Overall Study|Adverse Event|2|||
105754814|NCT03084718|364753738|FG000|Overall Study|Lack of Efficacy|2|||
105754815|NCT03084718|364753739|FG001|Overall Study|Lack of Efficacy|0|||
105754816|NCT03084718|364753740|FG002|Overall Study|Lack of Efficacy|1|||
105754817|NCT03084718|364753741|FG003|Overall Study|Lack of Efficacy|4|||
105754818|NCT03084718|364753742|FG004|Overall Study|Lack of Efficacy|0|||
105754819|NCT03084718|364753738|FG000|Overall Study|Lost to Follow-up|0|||
105754820|NCT03084718|364753739|FG001|Overall Study|Lost to Follow-up|1|||
105754821|NCT03084718|364753740|FG002|Overall Study|Lost to Follow-up|0|||
105754822|NCT03084718|364753741|FG003|Overall Study|Lost to Follow-up|0|||
105754823|NCT03084718|364753742|FG004|Overall Study|Lost to Follow-up|2|||
105754824|NCT03084718|364753738|FG000|Overall Study|Protocol Violation|0|||
105754825|NCT03084718|364753739|FG001|Overall Study|Protocol Violation|0|||
105754826|NCT03084718|364753740|FG002|Overall Study|Protocol Violation|1|||
105754827|NCT03084718|364753741|FG003|Overall Study|Protocol Violation|0|||
105754828|NCT03084718|364753742|FG004|Overall Study|Protocol Violation|0|||
105754829|NCT03084718|364753738|FG000|Overall Study|Death|0|||
105754830|NCT03084718|364753739|FG001|Overall Study|Death|1|||
105754831|NCT03084718|364753740|FG002|Overall Study|Death|0|||
105754832|NCT03084718|364753741|FG003|Overall Study|Death|0|||
105754833|NCT03084718|364753742|FG004|Overall Study|Death|0|||
105754834|NCT03084718|364753738|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
105754835|NCT03084718|364753739|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
105754836|NCT03084718|364753740|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
105754837|NCT03084718|364753741|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
105754838|NCT03084718|364753742|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
105754839|NCT03986190|364753743|FG000|Overall Study|Withdrawal by Subject|12|||
105754840|NCT03986190|364753744|FG001|Overall Study|Withdrawal by Subject|0|||
105754841|NCT02806947|364753745|FG000|Overall Study|Withdrawal by Subject|5|||
105754842|NCT02806947|364753746|FG001|Overall Study|Withdrawal by Subject|1|||
105754843|NCT04929613|364753747|FG000|Overall Study|Withdrawal by Subject|12|||
105754844|NCT00865189|364753751|FG000|Overall Study|Other|1|||
105754845|NCT00865189|364753752|FG001|Overall Study|Other|2|||
105754846|NCT00865189|364753751|FG000|Overall Study|Death|4|||
105754847|NCT00865189|364753752|FG001|Overall Study|Death|11|||
105754848|NCT00865189|364753751|FG000|Overall Study|Lost to Follow-up|6|||
105754849|NCT00865189|364753752|FG001|Overall Study|Lost to Follow-up|6|||
105754850|NCT00865189|364753751|FG000|Overall Study|Withdrawal by Subject|1|||
105754851|NCT00865189|364753752|FG001|Overall Study|Withdrawal by Subject|0|||
105754852|NCT00664209|364753756|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
105754853|NCT00664209|364753756|FG000|Study Treatment Period|Physician Decision|4|||
105754854|NCT00664209|364753756|FG000|Study Treatment Period|Withdrawal by Subject|2|||
105754855|NCT00091026|364753767|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
105754856|NCT00091026|364753768|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
105754857|NCT00091026|364753767|FG000|Overall Study|Patient withdrew and never received trea|0|||
105754858|NCT00091026|364753768|FG001|Overall Study|Patient withdrew and never received trea|2|||
105754859|NCT00091026|364753767|FG000|Overall Study|Unknown-never received treatment|0|||
105754860|NCT00091026|364753768|FG001|Overall Study|Unknown-never received treatment|1|||
105754861|NCT00418379|364753769|FG000|Year 1|Adverse Event|9|||
105754862|NCT00418379|364753770|FG001|Year 1|Adverse Event|15|||
105754863|NCT00418379|364753771|FG002|Year 1|Adverse Event|3|||
105754864|NCT00418379|364753769|FG000|Year 1|Withdrawal by Subject|7|||
105754865|NCT00418379|364753770|FG001|Year 1|Withdrawal by Subject|8|||
105754866|NCT00418379|364753771|FG002|Year 1|Withdrawal by Subject|5|||
105754867|NCT00418379|364753769|FG000|Year 1|Any other reason not above-mentioned|2|||
105754868|NCT00418379|364753770|FG001|Year 1|Any other reason not above-mentioned|5|||
105754869|NCT00418379|364753771|FG002|Year 1|Any other reason not above-mentioned|7|||
105754870|NCT00418379|364753769|FG000|Year 2|Adverse Event|5|||
105754871|NCT00418379|364753770|FG001|Year 2|Adverse Event|2|||
105754872|NCT00418379|364753771|FG002|Year 2|Adverse Event|1|||
105754873|NCT00418379|364753769|FG000|Year 2|Withdrawal by Subject|1|||
105754874|NCT00418379|364753770|FG001|Year 2|Withdrawal by Subject|1|||
105754875|NCT00418379|364753771|FG002|Year 2|Withdrawal by Subject|3|||
105754876|NCT00418379|364753769|FG000|Year 2|Any other reason not above-mentioned|2|||
105754877|NCT00418379|364753770|FG001|Year 2|Any other reason not above-mentioned|1|||
105754878|NCT00418379|364753771|FG002|Year 2|Any other reason not above-mentioned|6|||
105754879|NCT00418379|364753769|FG000|Year 3|Withdrawal by Subject|1|||
105754880|NCT00418379|364753770|FG001|Year 3|Withdrawal by Subject|1|||
105754881|NCT00418379|364753771|FG002|Year 3|Withdrawal by Subject|2|||
105754882|NCT00418379|364753769|FG000|Year 3|Any other reason not above-mentioned|2|||
105754883|NCT00418379|364753770|FG001|Year 3|Any other reason not above-mentioned|1|||
105754884|NCT00418379|364753771|FG002|Year 3|Any other reason not above-mentioned|1|||
105754885|NCT00418379|364753769|FG000|Year 4|Adverse Event|0|||
105754886|NCT00418379|364753770|FG001|Year 4|Adverse Event|1|||
105754887|NCT00418379|364753771|FG002|Year 4|Adverse Event|0|||
105754888|NCT00418379|364753769|FG000|Year 4|Withdrawal by Subject|2|||
105754889|NCT00418379|364753770|FG001|Year 4|Withdrawal by Subject|3|||
105754890|NCT00418379|364753771|FG002|Year 4|Withdrawal by Subject|2|||
105754891|NCT00418379|364753769|FG000|Year 4|Any other reason not above-mentioned|1|||
105754892|NCT00418379|364753770|FG001|Year 4|Any other reason not above-mentioned|1|||
105754893|NCT00418379|364753771|FG002|Year 4|Any other reason not above-mentioned|0|||
105754894|NCT00418379|364753769|FG000|Year 5|Adverse Event|0|||
105754895|NCT00418379|364753770|FG001|Year 5|Adverse Event|1|||
105754896|NCT00418379|364753771|FG002|Year 5|Adverse Event|0|||
105754897|NCT00418379|364753769|FG000|Year 5|Any other reason not above-mentioned|2|||
105754898|NCT00418379|364753770|FG001|Year 5|Any other reason not above-mentioned|4|||
105754899|NCT00418379|364753771|FG002|Year 5|Any other reason not above-mentioned|3|||
105754900|NCT01764256|364753772|FG000|Received All Vaccinations|Adverse Event|1|||
105754901|NCT01764256|364753773|FG001|Received All Vaccinations|Adverse Event|1|||
105754902|NCT01764256|364753774|FG002|Received All Vaccinations|Adverse Event|0|||
105754903|NCT01764256|364753775|FG003|Received All Vaccinations|Adverse Event|0|||
105754904|NCT01764256|364753772|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
105754905|NCT01764256|364753773|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
105754906|NCT01764256|364753774|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
105754907|NCT01764256|364753775|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
105754908|NCT01764256|364753772|FG000|Received All Vaccinations|Lost to Follow-up|1|||
105754909|NCT01764256|364753773|FG001|Received All Vaccinations|Lost to Follow-up|0|||
105754910|NCT01764256|364753774|FG002|Received All Vaccinations|Lost to Follow-up|0|||
105754911|NCT01764256|364753775|FG003|Received All Vaccinations|Lost to Follow-up|0|||
105754912|NCT01764256|364753772|FG000|Completed Study|Lost to Follow-up|0|||
105754913|NCT01764256|364753773|FG001|Completed Study|Lost to Follow-up|0|||
105754914|NCT01764256|364753774|FG002|Completed Study|Lost to Follow-up|0|||
105754915|NCT01764256|364753775|FG003|Completed Study|Lost to Follow-up|1|||
105754916|NCT01354431|364753779|FG000|Pre-Treatment Period|Not reported|1|||
105360440|NCT00379899|363325950|FG000|Overall Study|Lost to Follow-up|2|||
105754917|NCT01354431|364753780|FG001|Pre-Treatment Period|Not reported|0|||
105754918|NCT01354431|364753781|FG002|Pre-Treatment Period|Not reported|0|||
105754919|NCT01354431|364753779|FG000|Treatment Period|Disease Progression|50|||
105754920|NCT01354431|364753780|FG001|Treatment Period|Disease Progression|40|||
105754921|NCT01354431|364753781|FG002|Treatment Period|Disease Progression|44|||
105754922|NCT01354431|364753779|FG000|Treatment Period|Study Drug Toxicity|5|||
105754923|NCT01354431|364753780|FG001|Treatment Period|Study Drug Toxicity|8|||
105754924|NCT01354431|364753781|FG002|Treatment Period|Study Drug Toxicity|4|||
105754925|NCT01354431|364753779|FG000|Treatment Period|Death|0|||
105754926|NCT01354431|364753780|FG001|Treatment Period|Death|1|||
105754927|NCT01354431|364753781|FG002|Treatment Period|Death|0|||
105754928|NCT01354431|364753779|FG000|Treatment Period|AE unrelated to study drug|1|||
105754929|NCT01354431|364753780|FG001|Treatment Period|AE unrelated to study drug|2|||
105754930|NCT01354431|364753781|FG002|Treatment Period|AE unrelated to study drug|5|||
105754931|NCT01354431|364753779|FG000|Treatment Period|Participant request to discontinue|2|||
105754932|NCT01354431|364753780|FG001|Treatment Period|Participant request to discontinue|2|||
105754933|NCT01354431|364753781|FG002|Treatment Period|Participant request to discontinue|1|||
105754934|NCT01354431|364753779|FG000|Treatment Period|Participant withdrew consent|0|||
105754935|NCT01354431|364753780|FG001|Treatment Period|Participant withdrew consent|1|||
105754936|NCT01354431|364753781|FG002|Treatment Period|Participant withdrew consent|0|||
105754937|NCT01354431|364753779|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
105754938|NCT01354431|364753780|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
105754939|NCT01354431|364753781|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
105754940|NCT00634114|364753782|FG000|Overall Study|Adverse Event|6|||
105754941|NCT00634114|364753783|FG001|Overall Study|Adverse Event|8|||
105754942|NCT00634114|364753784|FG002|Overall Study|Adverse Event|3|||
105754943|NCT00634114|364753782|FG000|Overall Study|Withdrawal by Subject|9|||
105754944|NCT00634114|364753783|FG001|Overall Study|Withdrawal by Subject|6|||
105754945|NCT00634114|364753784|FG002|Overall Study|Withdrawal by Subject|11|||
105754946|NCT00634114|364753782|FG000|Overall Study|Lost to Follow-up|0|||
105754947|NCT00634114|364753783|FG001|Overall Study|Lost to Follow-up|0|||
105754948|NCT00634114|364753784|FG002|Overall Study|Lost to Follow-up|1|||
105754949|NCT00634114|364753782|FG000|Overall Study|Protocol Violation|3|||
105754950|NCT00634114|364753783|FG001|Overall Study|Protocol Violation|3|||
105754951|NCT00634114|364753784|FG002|Overall Study|Protocol Violation|1|||
105754952|NCT00634114|364753782|FG000|Overall Study|Pregnancy|1|||
105754953|NCT00634114|364753783|FG001|Overall Study|Pregnancy|0|||
105754954|NCT00634114|364753784|FG002|Overall Study|Pregnancy|0|||
105754955|NCT00634114|364753782|FG000|Overall Study|Incorrect enrolment|0|||
105754956|NCT00634114|364753783|FG001|Overall Study|Incorrect enrolment|1|||
105754957|NCT00634114|364753784|FG002|Overall Study|Incorrect enrolment|0|||
105754958|NCT00634114|364753782|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
105754959|NCT00634114|364753783|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
105754960|NCT00634114|364753784|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
105754961|NCT00634114|364753782|FG000|Overall Study|Difficult to continue|3|||
105754962|NCT00634114|364753783|FG001|Overall Study|Difficult to continue|1|||
105754963|NCT00634114|364753784|FG002|Overall Study|Difficult to continue|1|||
105754964|NCT00634114|364753782|FG000|Overall Study|Other reason|1|||
105754965|NCT00634114|364753783|FG001|Overall Study|Other reason|1|||
105754966|NCT00634114|364753784|FG002|Overall Study|Other reason|1|||
105754967|NCT03699631|364753787|FG000|Overall Study|Adverse Event|3|||
105754968|NCT00585923|364753788|FG000|Overall Study|Physician decided not to continue|31|||
105754969|NCT00585923|364753789|FG001|Overall Study|Physician decided not to continue|33|||
105754970|NCT02121756|364753790|FG000|Overall Study|Adverse Event|3|||
105754971|NCT02121756|364753791|FG001|Overall Study|Adverse Event|0|||
105754972|NCT02121756|364753790|FG000|Overall Study|Protocol Violation|1|||
105754973|NCT02121756|364753791|FG001|Overall Study|Protocol Violation|1|||
105754974|NCT02121756|364753790|FG000|Overall Study|Physician Decision|2|||
105754975|NCT02121756|364753791|FG001|Overall Study|Physician Decision|1|||
105754976|NCT00138424|364753794|FG000|Overall Study|Physician Decision|0|||
105754977|NCT00138424|364753795|FG001|Overall Study|Physician Decision|1|||
105754978|NCT00138424|364753796|FG002|Overall Study|Physician Decision|0|||
105754979|NCT00138424|364753797|FG003|Overall Study|Physician Decision|0|||
105754980|NCT04311177|364753798|FG000|Overall Study|Adverse Event|3|||
105754981|NCT04311177|364753799|FG001|Overall Study|Adverse Event|1|||
105754982|NCT04311177|364753798|FG000|Overall Study|Physician Decision|4|||
105754983|NCT04311177|364753799|FG001|Overall Study|Physician Decision|3|||
105754984|NCT04311177|364753798|FG000|Overall Study|Withdrawal by Subject|1|||
105360441|NCT00379899|363325951|FG001|Overall Study|Lost to Follow-up|4|||
105754985|NCT04311177|364753799|FG001|Overall Study|Withdrawal by Subject|0|||
105754986|NCT02176291|364753800|FG000|Overall Study|Death|1|||
105754987|NCT02176291|364753801|FG001|Overall Study|Death|0|||
105754988|NCT02176291|364753800|FG000|Overall Study|non compliance with protocol|2|||
105360442|NCT00379899|363325950|FG000|Overall Study|Physician Decision|3|||
105360443|NCT00379899|363325951|FG001|Overall Study|Physician Decision|4|||
105360444|NCT00379899|363325950|FG000|Overall Study|Withdrawal by Subject|5|||
105360445|NCT00379899|363325951|FG001|Overall Study|Withdrawal by Subject|5|||
105483606|NCT00045942|363782713|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
105483607|NCT00045942|363782714|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
105483608|NCT00045942|363782715|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
105802604|NCT01070394|364932699|FG000|Overall Study|Withdrawal by Subject|1|||
105806515|NCT03038113|364949009|FG009|Overall Study|Withdrawal by Subject|0|||
105806516|NCT03038113|364949010|FG010|Overall Study|Withdrawal by Subject|0|||
105806517|NCT03038113|364949011|FG011|Overall Study|Withdrawal by Subject|0|||
105806518|NCT03038113|364949012|FG012|Overall Study|Withdrawal by Subject|0|||
105806519|NCT03038113|364949013|FG013|Overall Study|Withdrawal by Subject|1|||
105806520|NCT03038113|364949000|FG000|Overall Study|Lost to Follow-up|0|||
105806521|NCT03038113|364949001|FG001|Overall Study|Lost to Follow-up|0|||
105806522|NCT03038113|364949002|FG002|Overall Study|Lost to Follow-up|0|||
105806523|NCT03038113|364949003|FG003|Overall Study|Lost to Follow-up|0|||
105806524|NCT03038113|364949004|FG004|Overall Study|Lost to Follow-up|0|||
105806525|NCT03038113|364949005|FG005|Overall Study|Lost to Follow-up|0|||
105806526|NCT03038113|364949006|FG006|Overall Study|Lost to Follow-up|1|||
105806527|NCT03038113|364949007|FG007|Overall Study|Lost to Follow-up|0|||
105806528|NCT03038113|364949008|FG008|Overall Study|Lost to Follow-up|0|||
105806529|NCT03038113|364949009|FG009|Overall Study|Lost to Follow-up|0|||
105806530|NCT03038113|364949010|FG010|Overall Study|Lost to Follow-up|0|||
105567591|NCT03145766|364076919|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
105567592|NCT03145766|364076920|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
105567593|NCT03145766|364076921|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
105567594|NCT03145766|364076917|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
105567595|NCT03145766|364076918|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
105567596|NCT03145766|364076919|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
105567597|NCT03145766|364076920|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
105567598|NCT03145766|364076921|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
105567599|NCT03145766|364076917|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
105567600|NCT03145766|364076918|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
105567601|NCT03145766|364076919|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
105567602|NCT03145766|364076920|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
105567603|NCT03145766|364076921|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
105567604|NCT03145766|364076917|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
105567605|NCT03145766|364076918|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
105567606|NCT03145766|364076919|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
105567607|NCT03145766|364076920|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
105567608|NCT03145766|364076921|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
105567609|NCT03145766|364076917|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
105567610|NCT03145766|364076918|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
105567611|NCT03145766|364076919|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
105567612|NCT03145766|364076920|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
105567613|NCT03145766|364076921|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
105567614|NCT03145766|364076917|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
105567615|NCT03145766|364076918|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
105567616|NCT03145766|364076919|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
105567617|NCT03145766|364076920|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
105567618|NCT03145766|364076921|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
105567619|NCT04461795|364076924|FG000|Overall Study|Lost to Follow-up|2|||
105567620|NCT04461795|364076924|FG000|Overall Study|Withdrawal by Subject|2|||
105567621|NCT04461795|364076924|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
105567622|NCT00615264|364076926|FG000|Overall Study|Withdrawal by Subject|17|||
105567623|NCT00615264|364076927|FG001|Overall Study|Withdrawal by Subject|19|||
105567624|NCT00615264|364076926|FG000|Overall Study|Lost to Follow-up|6|||
105567625|NCT00615264|364076927|FG001|Overall Study|Lost to Follow-up|13|||
105567626|NCT00615264|364076926|FG000|Overall Study|Adverse Event|8|||
105567627|NCT00615264|364076927|FG001|Overall Study|Adverse Event|5|||
105567628|NCT00615264|364076926|FG000|Overall Study|Death|1|||
105567629|NCT00615264|364076927|FG001|Overall Study|Death|1|||
105567630|NCT00615264|364076926|FG000|Overall Study|Protocol Violation|11|||
105567631|NCT00615264|364076927|FG001|Overall Study|Protocol Violation|7|||
105567632|NCT00615264|364076926|FG000|Overall Study|Not defined|7|||
105567633|NCT00615264|364076927|FG001|Overall Study|Not defined|4|||
105567634|NCT00615264|364076926|FG000|Overall Study|Dermal Hypersensitivity|0|||
105567635|NCT00615264|364076927|FG001|Overall Study|Dermal Hypersensitivity|3|||
105567636|NCT01492686|364076928|FG000|Double-blind Phase|Adverse Event|0|||
105567637|NCT01492686|364076929|FG001|Double-blind Phase|Adverse Event|2|||
105567638|NCT01492686|364076928|FG000|Double-blind Phase|Physician Decision|0|||
105806531|NCT03038113|364949011|FG011|Overall Study|Lost to Follow-up|0|||
105806532|NCT03038113|364949012|FG012|Overall Study|Lost to Follow-up|0|||
105806533|NCT03038113|364949013|FG013|Overall Study|Lost to Follow-up|0|||
105806534|NCT03209570|364949015|FG000|Overall Study|Death|1|||
105806535|NCT03209570|364949016|FG001|Overall Study|Death|0|||
105806536|NCT03209570|364949015|FG000|Overall Study|Incomplete Data|8|||
105567639|NCT01492686|364076929|FG001|Double-blind Phase|Physician Decision|1|||
105567640|NCT01492686|364076928|FG000|Double-blind Phase|Withdrawal by Subject|0|||
105567641|NCT01492686|364076929|FG001|Double-blind Phase|Withdrawal by Subject|2|||
105567642|NCT01492686|364076928|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
105567643|NCT01492686|364076929|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
105567644|NCT01492686|364076928|FG000|Open-label Phase|Adverse Event|1|||
105567645|NCT01492686|364076929|FG001|Open-label Phase|Adverse Event|2|||
105567646|NCT01492686|364076928|FG000|Open-label Phase|Physician Decision|1|||
105567647|NCT01492686|364076929|FG001|Open-label Phase|Physician Decision|0|||
105567648|NCT01492686|364076928|FG000|Open-label Phase|Withdrawal by Subject|6|||
105567649|NCT01492686|364076929|FG001|Open-label Phase|Withdrawal by Subject|7|||
105567650|NCT01492686|364076928|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
105567651|NCT01492686|364076929|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
105567652|NCT01982435|364076931|FG000|Overall Study|Adverse Event|1|||
105567653|NCT01982435|364076932|FG001|Overall Study|Adverse Event|0|||
105567654|NCT04887948|364076933|FG000|Overall Study|Death|1|||
105567655|NCT04887948|364076934|FG001|Overall Study|Death|0|||
105567656|NCT04887948|364076935|FG002|Overall Study|Death|0|||
105567657|NCT04887948|364076933|FG000|Overall Study|Lost to Follow-up|1|||
105567658|NCT04887948|364076934|FG001|Overall Study|Lost to Follow-up|0|||
105567659|NCT04887948|364076935|FG002|Overall Study|Lost to Follow-up|3|||
105567660|NCT04887948|364076933|FG000|Overall Study|Physician Decision|0|||
105567661|NCT04887948|364076934|FG001|Overall Study|Physician Decision|4|||
105567662|NCT04887948|364076935|FG002|Overall Study|Physician Decision|1|||
105567663|NCT04887948|364076933|FG000|Overall Study|Protocol Violation|1|||
105567664|NCT04887948|364076934|FG001|Overall Study|Protocol Violation|1|||
105567665|NCT04887948|364076935|FG002|Overall Study|Protocol Violation|0|||
105567666|NCT04887948|364076933|FG000|Overall Study|Withdrawal by Subject|0|||
105567667|NCT04887948|364076934|FG001|Overall Study|Withdrawal by Subject|6|||
105567668|NCT04887948|364076935|FG002|Overall Study|Withdrawal by Subject|1|||
105567669|NCT04887948|364076933|FG000|Overall Study|No longer met eligibility criteria|1|||
105567670|NCT04887948|364076934|FG001|Overall Study|No longer met eligibility criteria|2|||
105567671|NCT04887948|364076935|FG002|Overall Study|No longer met eligibility criteria|1|||
105567672|NCT04887948|364076933|FG000|Overall Study|Other|2|||
105567673|NCT04887948|364076934|FG001|Overall Study|Other|1|||
105567674|NCT04887948|364076935|FG002|Overall Study|Other|1|||
105567675|NCT03086018|364076937|FG000|Final Testing for End of Trial|Adverse Event|1|||
105567676|NCT03086018|364076937|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
105567677|NCT02748694|364076938|FG000|Overall Study|Voluntary Withdrawal|0|||
105567678|NCT02748694|364076939|FG001|Overall Study|Voluntary Withdrawal|0|||
105567679|NCT02748694|364076940|FG002|Overall Study|Voluntary Withdrawal|0|||
105567680|NCT02748694|364076941|FG003|Overall Study|Voluntary Withdrawal|0|||
105567681|NCT02748694|364076942|FG004|Overall Study|Voluntary Withdrawal|0|||
105567682|NCT02748694|364076943|FG005|Overall Study|Voluntary Withdrawal|0|||
105567683|NCT02748694|364076944|FG006|Overall Study|Voluntary Withdrawal|0|||
105567684|NCT02748694|364076945|FG007|Overall Study|Voluntary Withdrawal|0|||
105567685|NCT02748694|364076946|FG008|Overall Study|Voluntary Withdrawal|0|||
105567686|NCT02748694|364076947|FG009|Overall Study|Voluntary Withdrawal|0|||
105567687|NCT02748694|364076948|FG010|Overall Study|Voluntary Withdrawal|0|||
105567688|NCT02748694|364076949|FG011|Overall Study|Voluntary Withdrawal|0|||
105567689|NCT02748694|364076950|FG012|Overall Study|Voluntary Withdrawal|0|||
105567690|NCT02748694|364076951|FG013|Overall Study|Voluntary Withdrawal|0|||
105567691|NCT02748694|364076952|FG014|Overall Study|Voluntary Withdrawal|2|||
105567692|NCT01473381|364076953|FG000|Overall Study|Adverse Event|8|||
105567693|NCT01473381|364076954|FG001|Overall Study|Adverse Event|20|||
105567694|NCT01473381|364076955|FG002|Overall Study|Adverse Event|25|||
105567695|NCT01473381|364076956|FG003|Overall Study|Adverse Event|17|||
105567696|NCT01473381|364076953|FG000|Overall Study|Insufficient Therapeutic Response|10|||
105567697|NCT01473381|364076954|FG001|Overall Study|Insufficient Therapeutic Response|1|||
105567698|NCT01473381|364076955|FG002|Overall Study|Insufficient Therapeutic Response|2|||
105567699|NCT01473381|364076956|FG003|Overall Study|Insufficient Therapeutic Response|3|||
105567700|NCT01473381|364076953|FG000|Overall Study|Protocol Violation|17|||
105567701|NCT01473381|364076954|FG001|Overall Study|Protocol Violation|23|||
105567702|NCT01473381|364076955|FG002|Overall Study|Protocol Violation|19|||
105567703|NCT01473381|364076956|FG003|Overall Study|Protocol Violation|17|||
105567704|NCT01473381|364076953|FG000|Overall Study|Withdrawal of Consent|20|||
105754989|NCT02176291|364753801|FG001|Overall Study|non compliance with protocol|0|||
105754990|NCT02176291|364753800|FG000|Overall Study|Withdrawal by Subject|2|||
105754991|NCT02176291|364753801|FG001|Overall Study|Withdrawal by Subject|0|||
105754992|NCT02815293|364753802|FG000|Overall Study|Study termination by sponsor|10|||
105754993|NCT02815293|364753803|FG001|Overall Study|Study termination by sponsor|7|||
105754994|NCT02815293|364753804|FG002|Overall Study|Study termination by sponsor|0|||
105754995|NCT02815293|364753802|FG000|Overall Study|Participants not randomized|0|||
105754996|NCT02815293|364753803|FG001|Overall Study|Participants not randomized|0|||
105754997|NCT02815293|364753804|FG002|Overall Study|Participants not randomized|18|||
105754998|NCT02815293|364753802|FG000|Overall Study|Adverse Event|0|||
105754999|NCT02815293|364753803|FG001|Overall Study|Adverse Event|1|||
105755000|NCT02815293|364753804|FG002|Overall Study|Adverse Event|0|||
105755001|NCT02159469|364753805|FG000|Overall Study|Missing Completion status|1|||
105755002|NCT02159469|364753805|FG000|Overall Study|Adverse Event|5|||
105755003|NCT02159469|364753805|FG000|Overall Study|Non-compliance|2|||
105755004|NCT02159469|364753805|FG000|Overall Study|Withdrawal by Subject|9|||
105755005|NCT02159469|364753805|FG000|Overall Study|Lost to Follow-up|1|||
105755006|NCT02159469|364753805|FG000|Overall Study|Sponsor's request|2|||
105755007|NCT02159469|364753805|FG000|Overall Study|Met Stopping Criteria|3|||
105755008|NCT02159469|364753805|FG000|Overall Study|Other|1|||
105755009|NCT02159469|364753805|FG000|Overall Study|Multiple|29|||
105755010|NCT00592553|364753808|FG000|Overall Study|Protocol Noncompliance|1|||
105755011|NCT00592553|364753809|FG001|Overall Study|Protocol Noncompliance|0|||
105755012|NCT00592553|364753810|FG002|Overall Study|Protocol Noncompliance|0|||
105755013|NCT01669811|364753815|FG000|Overall Study|Investigator decision|0|||
105755014|NCT01669811|364753816|FG001|Overall Study|Investigator decision|1|||
105755015|NCT01669811|364753815|FG000|Overall Study|Withdrawal by Subject|1|||
105755016|NCT01669811|364753816|FG001|Overall Study|Withdrawal by Subject|2|||
105755017|NCT01669811|364753815|FG000|Overall Study|Adverse Event|2|||
105755018|NCT01669811|364753816|FG001|Overall Study|Adverse Event|6|||
105755019|NCT01669811|364753815|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
105755020|NCT01669811|364753816|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
105755021|NCT02554253|364753819|FG000|Overall Study|ineligible after enrollment|1|||
105755022|NCT02554253|364753820|FG001|Overall Study|ineligible after enrollment|0|||
105755023|NCT02554253|364753819|FG000|Overall Study|converted to transcatheter procedure|0|||
105755024|NCT02554253|364753820|FG001|Overall Study|converted to transcatheter procedure|1|||
105755025|NCT02554253|364753819|FG000|Overall Study|received both drugs|0|||
105755026|NCT02554253|364753820|FG001|Overall Study|received both drugs|1|||
105755027|NCT01561560|364753821|FG000|First Two Weeks of Wear|Time/job conflict|0|||
105755028|NCT01561560|364753822|FG001|First Two Weeks of Wear|Time/job conflict|1|||
105755029|NCT01561560|364753821|FG000|First Two Weeks of Wear|Adverse Event|0|||
105755030|NCT01561560|364753822|FG001|First Two Weeks of Wear|Adverse Event|1|||
105755031|NCT01561560|364753821|FG000|Second Two Weeks of Wear|Adverse Event|0|||
105755032|NCT01561560|364753822|FG001|Second Two Weeks of Wear|Adverse Event|1|||
105755033|NCT01871896|364753823|FG000|Overall Study|Lost to Follow-up|1|||
105755034|NCT02310906|364755705|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
105567705|NCT01473381|364076954|FG001|Overall Study|Withdrawal of Consent|21|||
105567706|NCT01473381|364076955|FG002|Overall Study|Withdrawal of Consent|20|||
105567707|NCT01473381|364076956|FG003|Overall Study|Withdrawal of Consent|26|||
105567708|NCT01473381|364076953|FG000|Overall Study|Lost to Follow-up|25|||
105567709|NCT01473381|364076954|FG001|Overall Study|Lost to Follow-up|28|||
105567710|NCT01473381|364076955|FG002|Overall Study|Lost to Follow-up|35|||
105567711|NCT01473381|364076956|FG003|Overall Study|Lost to Follow-up|23|||
105567712|NCT01473381|364076953|FG000|Overall Study|Other Reasons|0|||
105567713|NCT01473381|364076954|FG001|Overall Study|Other Reasons|0|||
105567714|NCT01473381|364076955|FG002|Overall Study|Other Reasons|1|||
105567715|NCT01473381|364076956|FG003|Overall Study|Other Reasons|3|||
105567716|NCT00659984|364076957|FG000|Overall Study|Adverse Event|1|||
105567717|NCT02228395|364076958|FG000|First Intervention Period|No longer willing to participate|1|||
105567718|NCT02228395|364076959|FG001|First Intervention Period|No longer willing to participate|0|||
105567719|NCT02228395|364076960|FG002|First Intervention Period|No longer willing to participate|0|||
105567720|NCT02228395|364076958|FG000|First Intervention Period|Unable to comply with study dates|0|||
105567721|NCT02228395|364076959|FG001|First Intervention Period|Unable to comply with study dates|1|||
105567722|NCT02228395|364076960|FG002|First Intervention Period|Unable to comply with study dates|1|||
105567723|NCT04026165|364076965|FG000|Run-in Placebo Period|Enrollment Error|13|||
105567724|NCT04026165|364076966|FG001|Run-in Placebo Period|Enrollment Error|0|||
105567725|NCT04026165|364076967|FG002|Run-in Placebo Period|Enrollment Error|0|||
105567726|NCT04026165|364076968|FG003|Run-in Placebo Period|Enrollment Error|0|||
105567727|NCT04026165|364076965|FG000|Run-in Placebo Period|Run-in Failure|4|||
105567728|NCT04026165|364076966|FG001|Run-in Placebo Period|Run-in Failure|0|||
105567729|NCT04026165|364076967|FG002|Run-in Placebo Period|Run-in Failure|0|||
105567730|NCT04026165|364076968|FG003|Run-in Placebo Period|Run-in Failure|0|||
105755035|NCT02310906|364755706|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
105755036|NCT02310906|364755707|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
105755037|NCT02310906|364755708|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
105755038|NCT02310906|364755705|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
105755039|NCT02310906|364755706|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
105755040|NCT02310906|364755707|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
105567731|NCT04026165|364076965|FG000|Run-in Placebo Period|Protocol Violation|2|||
105567732|NCT04026165|364076966|FG001|Run-in Placebo Period|Protocol Violation|0|||
105567733|NCT04026165|364076967|FG002|Run-in Placebo Period|Protocol Violation|0|||
105567734|NCT04026165|364076968|FG003|Run-in Placebo Period|Protocol Violation|0|||
105567735|NCT04026165|364076965|FG000|Run-in Placebo Period|Withdrew Consent|2|||
105567736|NCT04026165|364076966|FG001|Run-in Placebo Period|Withdrew Consent|0|||
105567737|NCT04026165|364076967|FG002|Run-in Placebo Period|Withdrew Consent|0|||
105567738|NCT04026165|364076968|FG003|Run-in Placebo Period|Withdrew Consent|0|||
105567739|NCT04026165|364076965|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
105567740|NCT04026165|364076966|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
105567741|NCT04026165|364076967|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
105567742|NCT04026165|364076968|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
105567743|NCT04026165|364076965|FG000|Run-in SEL Period|Run-in Failure|0|||
105567744|NCT04026165|364076966|FG001|Run-in SEL Period|Run-in Failure|26|||
105567745|NCT04026165|364076967|FG002|Run-in SEL Period|Run-in Failure|0|||
105567746|NCT04026165|364076968|FG003|Run-in SEL Period|Run-in Failure|0|||
105567747|NCT04026165|364076965|FG000|Run-in SEL Period|Withdrew Consent|0|||
105567748|NCT04026165|364076966|FG001|Run-in SEL Period|Withdrew Consent|10|||
105567749|NCT04026165|364076967|FG002|Run-in SEL Period|Withdrew Consent|0|||
105567750|NCT04026165|364076968|FG003|Run-in SEL Period|Withdrew Consent|0|||
105567751|NCT04026165|364076965|FG000|Run-in SEL Period|Enrollment Error|0|||
105567752|NCT04026165|364076966|FG001|Run-in SEL Period|Enrollment Error|4|||
105567753|NCT04026165|364076967|FG002|Run-in SEL Period|Enrollment Error|0|||
105567754|NCT04026165|364076968|FG003|Run-in SEL Period|Enrollment Error|0|||
105567755|NCT04026165|364076965|FG000|Run-in SEL Period|Protocol Violation|0|||
105567756|NCT04026165|364076966|FG001|Run-in SEL Period|Protocol Violation|3|||
105567757|NCT04026165|364076967|FG002|Run-in SEL Period|Protocol Violation|0|||
105567758|NCT04026165|364076968|FG003|Run-in SEL Period|Protocol Violation|0|||
105567759|NCT04026165|364076965|FG000|Run-in SEL Period|Investigator's Discretion|0|||
105567760|NCT04026165|364076966|FG001|Run-in SEL Period|Investigator's Discretion|2|||
105567761|NCT04026165|364076967|FG002|Run-in SEL Period|Investigator's Discretion|0|||
105567762|NCT04026165|364076968|FG003|Run-in SEL Period|Investigator's Discretion|0|||
105567763|NCT04026165|364076965|FG000|Run-in SEL Period|Death|0|||
105567764|NCT04026165|364076966|FG001|Run-in SEL Period|Death|1|||
105567765|NCT04026165|364076967|FG002|Run-in SEL Period|Death|0|||
105567766|NCT04026165|364076968|FG003|Run-in SEL Period|Death|0|||
105567767|NCT04026165|364076965|FG000|Randomized Period|Withdrew Consent|0|||
105567768|NCT04026165|364076966|FG001|Randomized Period|Withdrew Consent|0|||
105567769|NCT04026165|364076967|FG002|Randomized Period|Withdrew Consent|5|||
105567770|NCT04026165|364076968|FG003|Randomized Period|Withdrew Consent|8|||
105567771|NCT04026165|364076965|FG000|Randomized Period|Death|0|||
105567772|NCT04026165|364076966|FG001|Randomized Period|Death|0|||
105567773|NCT04026165|364076967|FG002|Randomized Period|Death|5|||
105567774|NCT04026165|364076968|FG003|Randomized Period|Death|7|||
105567775|NCT04026165|364076965|FG000|Randomized Period|Investigator's Discretion|0|||
105567776|NCT04026165|364076966|FG001|Randomized Period|Investigator's Discretion|0|||
105567777|NCT04026165|364076967|FG002|Randomized Period|Investigator's Discretion|2|||
105567778|NCT04026165|364076968|FG003|Randomized Period|Investigator's Discretion|2|||
105567779|NCT04026165|364076965|FG000|Randomized Period|Lost to Follow-up|0|||
105567780|NCT04026165|364076966|FG001|Randomized Period|Lost to Follow-up|0|||
105567781|NCT04026165|364076967|FG002|Randomized Period|Lost to Follow-up|2|||
105567782|NCT04026165|364076968|FG003|Randomized Period|Lost to Follow-up|2|||
105567783|NCT04710927|364076969|FG000|Overall Study|Lost to Follow-up|7|||
105567784|NCT04710927|364076970|FG001|Overall Study|Lost to Follow-up|6|||
105567785|NCT04710927|364076971|FG002|Overall Study|Lost to Follow-up|5|||
105567786|NCT00985985|364076972|FG000|Overall Study|Adverse Event|4|||
105567787|NCT00985985|364076973|FG001|Overall Study|Adverse Event|2|||
105567788|NCT00985985|364076974|FG002|Overall Study|Adverse Event|2|||
105567789|NCT00985985|364076975|FG003|Overall Study|Adverse Event|2|||
105567790|NCT00985985|364076972|FG000|Overall Study|Lost to Follow-up|4|||
105567791|NCT00985985|364076973|FG001|Overall Study|Lost to Follow-up|11|||
105567792|NCT00985985|364076974|FG002|Overall Study|Lost to Follow-up|2|||
105567793|NCT00985985|364076975|FG003|Overall Study|Lost to Follow-up|3|||
105567794|NCT00985985|364076972|FG000|Overall Study|Protocol Violation|1|||
105567795|NCT00985985|364076973|FG001|Overall Study|Protocol Violation|2|||
105567796|NCT00985985|364076974|FG002|Overall Study|Protocol Violation|0|||
105567797|NCT00985985|364076975|FG003|Overall Study|Protocol Violation|1|||
105567798|NCT00985985|364076972|FG000|Overall Study|Lack of Efficacy|5|||
105567799|NCT00985985|364076973|FG001|Overall Study|Lack of Efficacy|6|||
105567800|NCT00985985|364076974|FG002|Overall Study|Lack of Efficacy|1|||
105567801|NCT00985985|364076975|FG003|Overall Study|Lack of Efficacy|3|||
105567802|NCT00985985|364076972|FG000|Overall Study|Withdrawal by Subject|4|||
105567803|NCT00985985|364076973|FG001|Overall Study|Withdrawal by Subject|2|||
105567804|NCT00985985|364076974|FG002|Overall Study|Withdrawal by Subject|2|||
105567805|NCT00985985|364076975|FG003|Overall Study|Withdrawal by Subject|2|||
105567806|NCT00985985|364076972|FG000|Overall Study|Other Reason|6|||
105567807|NCT00985985|364076973|FG001|Overall Study|Other Reason|1|||
105567808|NCT00985985|364076974|FG002|Overall Study|Other Reason|4|||
105567809|NCT00985985|364076975|FG003|Overall Study|Other Reason|2|||
105567810|NCT04954586|364076978|FG000|Overall Study|Withdrawal by Subject|5|||
105567811|NCT04000594|364076979|FG000|Overall Study|Withdrawal by Subject|1|||
105567812|NCT04000594|364076980|FG001|Overall Study|Withdrawal by Subject|0|||
105567813|NCT04000594|364076981|FG002|Overall Study|Withdrawal by Subject|0|||
105567814|NCT04522180|364076983|FG000|Overall Study|Investigator judgement|3|||
105567815|NCT04522180|364076984|FG001|Overall Study|Investigator judgement|4|||
105567816|NCT04522180|364076983|FG000|Overall Study|Voluntary withdrawal|1|||
105567817|NCT04522180|364076984|FG001|Overall Study|Voluntary withdrawal|0|||
105567818|NCT04522180|364076983|FG000|Overall Study|Pregnancy|0|||
105567819|NCT04522180|364076984|FG001|Overall Study|Pregnancy|1|||
105567820|NCT04522180|364076983|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
105567821|NCT04522180|364076984|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
105567822|NCT04522180|364076983|FG000|Overall Study|Reason not specified|8|||
105567823|NCT04522180|364076984|FG001|Overall Study|Reason not specified|5|||
105567824|NCT03489057|364076986|FG000|Overall Study|Lost to Follow-up|16|||
105567825|NCT03489057|364076987|FG001|Overall Study|Lost to Follow-up|16|||
105567826|NCT03489057|364076988|FG002|Overall Study|Lost to Follow-up|14|||
105567827|NCT03489057|364076989|FG003|Overall Study|Lost to Follow-up|14|||
105567828|NCT03489057|364076986|FG000|Overall Study|Withdrawal by Subject|12|||
105567829|NCT03489057|364076987|FG001|Overall Study|Withdrawal by Subject|12|||
105567830|NCT03489057|364076988|FG002|Overall Study|Withdrawal by Subject|8|||
105567831|NCT03489057|364076989|FG003|Overall Study|Withdrawal by Subject|8|||
105567832|NCT03489057|364076986|FG000|Overall Study|Protocol Violation|7|||
105567833|NCT03489057|364076987|FG001|Overall Study|Protocol Violation|7|||
105567834|NCT03489057|364076988|FG002|Overall Study|Protocol Violation|2|||
105567835|NCT03489057|364076989|FG003|Overall Study|Protocol Violation|2|||
105567836|NCT01368900|364076992|FG000|Overall Study|Lost to Follow-up|7|||
105567837|NCT02158884|364076993|FG000|Baseline Assessment|Missed performance assessment|3|||
105567838|NCT02158884|364076993|FG000|Baseline Assessment|Missed SMFA|1|||
105567839|NCT02158884|364076993|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
105567840|NCT02158884|364076993|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
105567841|NCT02158884|364076993|FG000|6 Month Assessment|Missed SMFA|20|||
105567842|NCT02158884|364076993|FG000|12 Month Assessment|Missed SMFA|17|||
105567843|NCT00654901|364076994|FG000|Overall Study|Lost to Follow-up|1|||
105567844|NCT00654901|364076995|FG001|Overall Study|Lost to Follow-up|0|||
105567845|NCT00654901|364076996|FG002|Overall Study|Lost to Follow-up|1|||
105567846|NCT00654901|364076997|FG003|Overall Study|Lost to Follow-up|0|||
105567847|NCT00654901|364076994|FG000|Overall Study|Withdrawal by Subject|3|||
105567848|NCT00654901|364076995|FG001|Overall Study|Withdrawal by Subject|0|||
105567849|NCT00654901|364076996|FG002|Overall Study|Withdrawal by Subject|1|||
105567850|NCT00654901|364076997|FG003|Overall Study|Withdrawal by Subject|0|||
105567851|NCT01852058|364077000|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
105567852|NCT01852058|364077001|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
105567853|NCT01852058|364077002|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
105567854|NCT01852058|364077003|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
105360446|NCT00379899|363325950|FG000|Overall Study|Ineligibility determined|0|||
105360447|NCT00379899|363325951|FG001|Overall Study|Ineligibility determined|1|||
105567855|NCT01852058|364077004|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
105567856|NCT01852058|364077005|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
105567857|NCT01852058|364077006|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
105567858|NCT01852058|364077007|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
105567859|NCT01852058|364077008|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
105360448|NCT00379899|363325950|FG000|Overall Study|Noncompliance|1|||
105802605|NCT03372083|364934487|FG000|Overall Study|Adverse Event|3|||
105567860|NCT01852058|364077009|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
105567861|NCT01852058|364077010|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
105567862|NCT01852058|364077011|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
105567863|NCT01852058|364077000|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
105567864|NCT01852058|364077001|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
105567865|NCT01852058|364077002|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
105567866|NCT01852058|364077003|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
105567867|NCT01852058|364077004|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
105567868|NCT01852058|364077005|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
105567869|NCT01852058|364077006|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
105567870|NCT01852058|364077007|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
105567871|NCT01852058|364077008|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
105567872|NCT01852058|364077009|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
105567873|NCT01852058|364077010|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
105567874|NCT01852058|364077011|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
105567875|NCT01852058|364077000|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
105567876|NCT01852058|364077001|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
105567877|NCT01852058|364077002|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
105567878|NCT01852058|364077003|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
105567879|NCT01852058|364077004|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
105567880|NCT01852058|364077005|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
105567881|NCT01852058|364077006|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
105567882|NCT01852058|364077007|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
105567883|NCT01852058|364077008|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
105567884|NCT01852058|364077009|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
105567885|NCT01852058|364077010|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
105567886|NCT01852058|364077011|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
105802606|NCT03372083|364934487|FG000|Overall Study|Physician Decision|1|||
105802607|NCT03372083|364934487|FG000|Overall Study|Withdrawal by Subject|1|||
105802608|NCT03769181|364934490|FG000|Overall Study|Adverse Event|1|||
105802609|NCT03769181|364934491|FG001|Overall Study|Adverse Event|0|||
105802610|NCT03769181|364934492|FG002|Overall Study|Adverse Event|2|||
105802611|NCT03769181|364934493|FG003|Overall Study|Adverse Event|4|||
105802612|NCT03769181|364934490|FG000|Overall Study|Withdrawal by Subject|1|||
105802613|NCT03769181|364934491|FG001|Overall Study|Withdrawal by Subject|0|||
105802614|NCT03769181|364934492|FG002|Overall Study|Withdrawal by Subject|2|||
105567887|NCT01852058|364077000|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
105567888|NCT01852058|364077001|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
105567889|NCT01852058|364077002|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
105802615|NCT03769181|364934493|FG003|Overall Study|Withdrawal by Subject|1|||
105755041|NCT02310906|364755708|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
105755042|NCT02310906|364755705|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
105755043|NCT02310906|364755706|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
105755044|NCT02310906|364755707|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
105755045|NCT02310906|364755708|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
105755046|NCT02310906|364755705|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
105755047|NCT02310906|364755706|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
105755048|NCT02310906|364755707|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
105755049|NCT02310906|364755708|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
105755050|NCT01840228|364755717|FG000|Overall Study|Lost to Follow-up|1|||
105755051|NCT01840228|364755718|FG001|Overall Study|Lost to Follow-up|1|||
105755052|NCT03654755|364755719|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
105755053|NCT03654755|364755720|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
105755054|NCT03654755|364755721|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
105755055|NCT03654755|364755719|FG000|Overall Study|Withdrawal by Subject|2|||
105755056|NCT03654755|364755720|FG001|Overall Study|Withdrawal by Subject|4|||
105755057|NCT03654755|364755721|FG002|Overall Study|Withdrawal by Subject|8|||
105755058|NCT03654755|364755719|FG000|Overall Study|Lost to Follow-up|1|||
105755059|NCT03654755|364755720|FG001|Overall Study|Lost to Follow-up|3|||
105755060|NCT03654755|364755721|FG002|Overall Study|Lost to Follow-up|7|||
105755061|NCT03654755|364755719|FG000|Overall Study|Physician Decision|0|||
105755062|NCT03654755|364755720|FG001|Overall Study|Physician Decision|1|||
105755063|NCT03654755|364755721|FG002|Overall Study|Physician Decision|0|||
105755064|NCT03654755|364755719|FG000|Overall Study|Adverse Event|0|||
105755065|NCT03654755|364755720|FG001|Overall Study|Adverse Event|0|||
105755066|NCT03654755|364755721|FG002|Overall Study|Adverse Event|4|||
105755067|NCT03654755|364755719|FG000|Overall Study|Lack of Efficacy|0|||
105755068|NCT03654755|364755720|FG001|Overall Study|Lack of Efficacy|0|||
105755069|NCT03654755|364755721|FG002|Overall Study|Lack of Efficacy|1|||
105755070|NCT01429077|364755724|FG000|Overall Study|Lost to Follow-up|0|||
105755071|NCT01429077|364755725|FG001|Overall Study|Lost to Follow-up|3|||
105755072|NCT01413542|364755727|FG000|Overall Study|Physician Decision|1|||
105755073|NCT01413542|364755728|FG001|Overall Study|Physician Decision|0|||
105755074|NCT01413542|364755729|FG002|Overall Study|Physician Decision|3|||
105755075|NCT01413542|364755730|FG003|Overall Study|Physician Decision|0|||
105755076|NCT01413542|364755727|FG000|Overall Study|Adverse Event|0|||
105755077|NCT01413542|364755728|FG001|Overall Study|Adverse Event|0|||
105755078|NCT01413542|364755729|FG002|Overall Study|Adverse Event|0|||
105755079|NCT01413542|364755730|FG003|Overall Study|Adverse Event|1|||
105755080|NCT00830804|364755731|FG000|Overall Study|Lost to Follow-up|4|||
105755081|NCT00830804|364755731|FG000|Overall Study|Death|1|||
105755082|NCT00830804|364755731|FG000|Overall Study|Unable to get to clinic|7|||
105755083|NCT00830804|364755731|FG000|Overall Study|Consent withdrawn|2|||
105755084|NCT00830804|364755731|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
105755085|NCT00510068|364755734|FG000|Double-blind Period|Disease progression|98|||
105755086|NCT00510068|364755735|FG001|Double-blind Period|Disease progression|169|||
105755087|NCT00510068|364755734|FG000|Double-blind Period|Final primary analysis|52|||
105755088|NCT00510068|364755735|FG001|Double-blind Period|Final primary analysis|18|||
105755089|NCT00510068|364755734|FG000|Double-blind Period|Adverse Event|37|||
105755090|NCT00510068|364755735|FG001|Double-blind Period|Adverse Event|7|||
105755091|NCT00510068|364755734|FG000|Double-blind Period|Withdrawal by Subject|8|||
105755092|NCT00510068|364755735|FG001|Double-blind Period|Withdrawal by Subject|6|||
105755093|NCT00510068|364755734|FG000|Double-blind Period|Death|4|||
105755094|NCT00510068|364755735|FG001|Double-blind Period|Death|3|||
105755095|NCT00510068|364755734|FG000|Double-blind Period|Abnormal test result (s)|1|||
105755096|NCT00510068|364755735|FG001|Double-blind Period|Abnormal test result (s)|0|||
105755097|NCT00510068|364755734|FG000|Double-blind Period|Lost to Follow-up|1|||
105755098|NCT00510068|364755735|FG001|Double-blind Period|Lost to Follow-up|0|||
105755099|NCT00510068|364755734|FG000|Double-blind Period|Protocol Violation|6|||
105755100|NCT00510068|364755735|FG001|Double-blind Period|Protocol Violation|0|||
105755101|NCT00510068|364755734|FG000|Open-label Period|Disease Progression|124|||
105755102|NCT00510068|364755735|FG001|Open-label Period|Disease Progression|0|||
105755103|NCT00510068|364755734|FG000|Open-label Period|Adverse Event|46|||
105755104|NCT00510068|364755735|FG001|Open-label Period|Adverse Event|0|||
105755105|NCT00510068|364755734|FG000|Open-label Period|Withdrawal by Subject|21|||
105755106|NCT00510068|364755735|FG001|Open-label Period|Withdrawal by Subject|0|||
105755107|NCT00510068|364755734|FG000|Open-label Period|Administrative problems|17|||
105755108|NCT00510068|364755735|FG001|Open-label Period|Administrative problems|0|||
105755109|NCT00510068|364755734|FG000|Open-label Period|Death|7|||
105755110|NCT00510068|364755735|FG001|Open-label Period|Death|0|||
105755111|NCT00510068|364755734|FG000|Open-label Period|New cancer therapy|7|||
105755112|NCT00510068|364755735|FG001|Open-label Period|New cancer therapy|0|||
105755113|NCT00510068|364755734|FG000|Open-label Period|Protocol Violation|2|||
105755114|NCT00510068|364755735|FG001|Open-label Period|Protocol Violation|0|||
105755115|NCT00510068|364755734|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
105755116|NCT00510068|364755735|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
105755117|NCT02180217|364755738|FG000|Overall Study|Adverse Event|3|||
105755118|NCT02180217|364755739|FG001|Overall Study|Adverse Event|2|||
105755119|NCT02180217|364755740|FG002|Overall Study|Adverse Event|22|||
105755120|NCT02180217|364755738|FG000|Overall Study|Death|1|||
105755121|NCT02180217|364755739|FG001|Overall Study|Death|1|||
105755122|NCT02180217|364755740|FG002|Overall Study|Death|0|||
105755123|NCT02180217|364755738|FG000|Overall Study|Withdrawal by Subject|1|||
105755124|NCT02180217|364755739|FG001|Overall Study|Withdrawal by Subject|1|||
105755125|NCT02180217|364755740|FG002|Overall Study|Withdrawal by Subject|4|||
105755126|NCT02180217|364755738|FG000|Overall Study|Subject/Guardian decision|5|||
105755127|NCT02180217|364755739|FG001|Overall Study|Subject/Guardian decision|3|||
105755128|NCT02180217|364755740|FG002|Overall Study|Subject/Guardian decision|6|||
105755129|NCT02180217|364755738|FG000|Overall Study|Physician Decision|1|||
105755130|NCT02180217|364755739|FG001|Overall Study|Physician Decision|1|||
105755131|NCT02180217|364755740|FG002|Overall Study|Physician Decision|6|||
105755132|NCT02180217|364755738|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105755133|NCT02180217|364755739|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105755134|NCT02180217|364755740|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105755135|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
105755136|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
105755137|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
105755138|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
105755139|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
105755140|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
105755141|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Death|1|||
105755142|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Death|3|||
105755143|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
105755144|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
105755145|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
105755146|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
105755147|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
105755148|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
105755149|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
105755150|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
105755151|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
105755152|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
105755153|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
105755154|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
105755155|NCT01181102|364755743|FG000|Overall Study|Adverse Event|28|||
105755156|NCT01181102|364755744|FG001|Overall Study|Adverse Event|26|||
105755157|NCT01181102|364755743|FG000|Overall Study|Lack of Efficacy|3|||
105755158|NCT01181102|364755744|FG001|Overall Study|Lack of Efficacy|1|||
105755159|NCT01181102|364755743|FG000|Overall Study|Lost to Follow-up|2|||
105755160|NCT01181102|364755744|FG001|Overall Study|Lost to Follow-up|0|||
105755161|NCT01181102|364755743|FG000|Overall Study|Physician Decision|3|||
105755162|NCT01181102|364755744|FG001|Overall Study|Physician Decision|1|||
105755163|NCT01181102|364755743|FG000|Overall Study|Protocol Violation|5|||
105755164|NCT01181102|364755744|FG001|Overall Study|Protocol Violation|6|||
105755165|NCT01181102|364755743|FG000|Overall Study|Withdrawal by Subject|10|||
105755166|NCT01181102|364755744|FG001|Overall Study|Withdrawal by Subject|12|||
105755167|NCT00239837|364755755|FG000|Overall Study|Lost to Follow-up|3|||
105755168|NCT00239837|364755756|FG001|Overall Study|Lost to Follow-up|7|||
105360449|NCT00379899|363325951|FG001|Overall Study|Noncompliance|1|||
105567890|NCT01852058|364077003|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
105567891|NCT01852058|364077004|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
105567892|NCT01852058|364077005|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
105567893|NCT01852058|364077006|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
105567894|NCT01852058|364077007|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
105567895|NCT01852058|364077008|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
105567896|NCT01852058|364077009|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
105567897|NCT01852058|364077010|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
105567898|NCT01852058|364077011|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
105567899|NCT01852058|364077000|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
105567900|NCT01852058|364077001|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
105567901|NCT01852058|364077002|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
105567902|NCT01852058|364077003|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
105567903|NCT01852058|364077004|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
105567904|NCT01852058|364077005|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
105567905|NCT01852058|364077006|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
105567906|NCT01852058|364077007|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
105567907|NCT01852058|364077008|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
105567908|NCT01852058|364077009|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
105567909|NCT01852058|364077010|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
105567910|NCT01852058|364077011|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
105567911|NCT01852058|364077000|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
105567912|NCT01852058|364077001|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
105567913|NCT01852058|364077002|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
105755169|NCT01153893|364755757|FG000|Overall Study|Adverse Event|1|||
105755170|NCT01153893|364755758|FG001|Overall Study|Adverse Event|0|||
105755171|NCT03176277|364755759|FG000|Part A Dose Escalation Study|Adverse Event|1|||
105755172|NCT03176277|364755760|FG001|Part A Dose Escalation Study|Adverse Event|0|||
105755173|NCT03176277|364755761|FG002|Part A Dose Escalation Study|Adverse Event|1|||
105755174|NCT03176277|364755762|FG003|Part A Dose Escalation Study|Adverse Event|0|||
105755175|NCT03176277|364755759|FG000|Part A Dose Escalation Study|Physician Decision|1|||
105755176|NCT03176277|364755760|FG001|Part A Dose Escalation Study|Physician Decision|1|||
105755177|NCT03176277|364755761|FG002|Part A Dose Escalation Study|Physician Decision|2|||
105755178|NCT03176277|364755762|FG003|Part A Dose Escalation Study|Physician Decision|0|||
105755179|NCT03176277|364755759|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
105755180|NCT03176277|364755760|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
105755181|NCT03176277|364755761|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
105755182|NCT03176277|364755762|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
105755183|NCT03176277|364755759|FG000|Part A Dose Escalation Study|Progressive disease|3|||
105755184|NCT03176277|364755760|FG001|Part A Dose Escalation Study|Progressive disease|1|||
105755185|NCT03176277|364755761|FG002|Part A Dose Escalation Study|Progressive disease|3|||
105755186|NCT03176277|364755762|FG003|Part A Dose Escalation Study|Progressive disease|0|||
105755187|NCT02940626|364755764|FG000|Overall Study|Death|40|||
105755188|NCT02940626|364755765|FG001|Overall Study|Death|32|||
105755189|NCT02940626|364755764|FG000|Overall Study|Lost to Follow-up|5|||
105755190|NCT02940626|364755765|FG001|Overall Study|Lost to Follow-up|2|||
105755191|NCT02940626|364755764|FG000|Overall Study|Withdrawal by Subject|1|||
105755192|NCT02940626|364755765|FG001|Overall Study|Withdrawal by Subject|0|||
105755193|NCT02940626|364755764|FG000|Overall Study|Transfer to Hospice Care|1|||
105755194|NCT02940626|364755765|FG001|Overall Study|Transfer to Hospice Care|0|||
105755195|NCT02940626|364755764|FG000|Overall Study|Prohibited Concomitant Medication|0|||
105755196|NCT02940626|364755765|FG001|Overall Study|Prohibited Concomitant Medication|1|||
105755197|NCT01324622|364755768|FG000|Overall Study|Lost to Follow-up|7|||
105755198|NCT01324622|364755769|FG001|Overall Study|Lost to Follow-up|7|||
105755199|NCT01324622|364755768|FG000|Overall Study|Death|1|||
105755200|NCT01324622|364755769|FG001|Overall Study|Death|0|||
105755201|NCT01324622|364755768|FG000|Overall Study|Lack of Efficacy|1|||
105755202|NCT01324622|364755769|FG001|Overall Study|Lack of Efficacy|0|||
105755203|NCT00618449|364755770|FG000|Overall Study|Lost to Follow-up|98|||
105755204|NCT00618449|364755771|FG001|Overall Study|Lost to Follow-up|110|||
105755205|NCT01441115|364755772|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
105755206|NCT00574496|364755777|FG000|Overall Study|Withdrawal by Subject|1|||
105755207|NCT00413062|364755778|FG000|Overall Study|Adverse event/serious adverse event|289|||
105755208|NCT00413062|364755779|FG001|Overall Study|Adverse event/serious adverse event|56|||
105755209|NCT00413062|364755778|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
105755210|NCT00413062|364755779|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
105755211|NCT00413062|364755778|FG000|Overall Study|Withdrawal of informed consent|111|||
105755212|NCT00413062|364755779|FG001|Overall Study|Withdrawal of informed consent|36|||
105755213|NCT00413062|364755778|FG000|Overall Study|Pregnancy|15|||
105755214|NCT00413062|364755779|FG001|Overall Study|Pregnancy|5|||
105755215|NCT00413062|364755778|FG000|Overall Study|Pregnancy wish|17|||
105755216|NCT00413062|364755779|FG001|Overall Study|Pregnancy wish|6|||
105755217|NCT00413062|364755778|FG000|Overall Study|Lost to Follow-up|175|||
105755218|NCT00413062|364755779|FG001|Overall Study|Lost to Follow-up|73|||
105755219|NCT00413062|364755778|FG000|Overall Study|Other reason|70|||
105755220|NCT00413062|364755779|FG001|Overall Study|Other reason|34|||
105755221|NCT03454412|364755781|FG000|Baseline Assesment|Physician Decision|12|||
105755222|NCT02475395|364755782|FG000|Overall Study|Protocol Violation|30|||
105755223|NCT02475395|364755783|FG001|Overall Study|Protocol Violation|3|||
105755224|NCT01927419|364755784|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
105755225|NCT01927419|364755785|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
105755226|NCT01927419|364755784|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
105755227|NCT01927419|364755785|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
105755228|NCT01927419|364755784|FG000|Treatment Period|Disease progression|17|||
105755229|NCT01927419|364755785|FG001|Treatment Period|Disease progression|20|||
105755230|NCT01927419|364755784|FG000|Treatment Period|Study drug toxicity|48|||
105755231|NCT01927419|364755785|FG001|Treatment Period|Study drug toxicity|10|||
105755232|NCT01927419|364755784|FG000|Treatment Period|Death|0|||
105755233|NCT01927419|364755785|FG001|Treatment Period|Death|1|||
105755234|NCT01927419|364755784|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
105755235|NCT01927419|364755785|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
105567914|NCT01852058|364077003|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
105567915|NCT01852058|364077004|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
105567916|NCT01852058|364077005|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
105567917|NCT01852058|364077006|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
105567918|NCT01852058|364077007|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
105567919|NCT01852058|364077008|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
105567920|NCT01852058|364077009|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
105567921|NCT01852058|364077010|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
105567922|NCT01852058|364077011|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
105567923|NCT01852058|364077000|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
105567924|NCT01852058|364077001|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
105567925|NCT01852058|364077002|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
105567926|NCT01852058|364077003|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
105567927|NCT01852058|364077004|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
105567928|NCT01852058|364077005|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
105567929|NCT01852058|364077006|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
105567930|NCT01852058|364077007|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
105567931|NCT01852058|364077008|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
105567932|NCT01852058|364077009|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
105567933|NCT01852058|364077010|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
105567934|NCT01852058|364077011|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
105567935|NCT01852058|364077000|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
105567936|NCT01852058|364077001|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
105567937|NCT01852058|364077002|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
105567938|NCT01852058|364077003|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
105567939|NCT01852058|364077004|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
105567940|NCT01852058|364077005|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
105567941|NCT01852058|364077006|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
105567942|NCT01852058|364077007|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
105567943|NCT01852058|364077008|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
105567944|NCT01852058|364077009|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
105567945|NCT01852058|364077010|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
105567946|NCT01852058|364077011|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
105567947|NCT01852058|364077000|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
105567948|NCT01852058|364077001|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
105567949|NCT01852058|364077002|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
105567950|NCT01852058|364077003|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
105567951|NCT01852058|364077004|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
105567952|NCT01852058|364077005|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
105567953|NCT01852058|364077006|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
105567954|NCT01852058|364077007|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
105567955|NCT01852058|364077008|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
105567956|NCT01852058|364077009|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
105567957|NCT01852058|364077010|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
105567958|NCT01852058|364077011|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
105567959|NCT01301274|364077012|FG000|Overall Study|Physician Decision|2|||
105567960|NCT01301274|364077013|FG001|Overall Study|Physician Decision|1|||
105567961|NCT02636270|364077014|FG000|Overall Study|Adverse Event|1|||
105567962|NCT02636270|364077015|FG001|Overall Study|Adverse Event|0|||
105567963|NCT02636270|364077016|FG002|Overall Study|Adverse Event|0|||
105567964|NCT02636270|364077014|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
105567965|NCT02636270|364077015|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
105567966|NCT02636270|364077016|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
105567967|NCT01119898|364077017|FG000|Overall Study|Adverse Event|4|||
105567968|NCT01119898|364077018|FG001|Overall Study|Adverse Event|5|||
105567969|NCT01119898|364077017|FG000|Overall Study|Withdrawal by Subject|1|||
105567970|NCT01119898|364077018|FG001|Overall Study|Withdrawal by Subject|4|||
105567971|NCT01119898|364077017|FG000|Overall Study|Lack of Efficacy|0|||
105567972|NCT01119898|364077018|FG001|Overall Study|Lack of Efficacy|2|||
105567973|NCT01119898|364077017|FG000|Overall Study|Protocol Violation|1|||
105567974|NCT01119898|364077018|FG001|Overall Study|Protocol Violation|1|||
105567975|NCT01119898|364077017|FG000|Overall Study|Medical procedure|1|||
105802616|NCT03769181|364934490|FG000|Overall Study|Progressive disease|9|||
105360450|NCT00379899|363325950|FG000|Overall Study|Parathyroidectomy|0|||
105567976|NCT01119898|364077018|FG001|Overall Study|Medical procedure|0|||
105567977|NCT01119898|364077017|FG000|Overall Study|Randomized in error did not participate|1|||
105567978|NCT01119898|364077018|FG001|Overall Study|Randomized in error did not participate|0|||
105567979|NCT01833143|364077019|FG000|Overall Study|Not Treated|1|||
105567980|NCT03995784|364077020|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
105567981|NCT02946918|364077023|FG000|Overall Study|Patient unblinded himself|1|||
105567982|NCT02946918|364077024|FG001|Overall Study|Patient unblinded himself|0|||
105567983|NCT02946918|364077023|FG000|Overall Study|Physician Decision|0|||
105567984|NCT02946918|364077024|FG001|Overall Study|Physician Decision|2|||
105567985|NCT02946918|364077023|FG000|Overall Study|Ran out of study medication|0|||
105567986|NCT02946918|364077024|FG001|Overall Study|Ran out of study medication|1|||
105567987|NCT00069784|364077025|FG000|Overall Study|Adverse Event|105|||
105567988|NCT00069784|364077026|FG001|Overall Study|Adverse Event|0|||
105567989|NCT00069784|364077025|FG000|Overall Study|Withdrawal by Subject|1090|||
105567990|NCT00069784|364077026|FG001|Overall Study|Withdrawal by Subject|0|||
105567991|NCT00069784|364077025|FG000|Overall Study|Other|17|||
105567992|NCT00069784|364077026|FG001|Overall Study|Other|0|||
105567993|NCT00738101|364077027|FG000|Overall Study|Physician Decision|5|||
105567994|NCT00738101|364077027|FG000|Overall Study|Death|1|||
105567995|NCT00738101|364077027|FG000|Overall Study|Repeat enrollment|1|||
105567996|NCT01786330|364077029|FG000|Overall Study|Withdrawal by Subject|0|||
105567997|NCT01786330|364077030|FG001|Overall Study|Withdrawal by Subject|1|||
105567998|NCT01786330|364077029|FG000|Overall Study|Lost to Follow-up|0|||
105567999|NCT01786330|364077030|FG001|Overall Study|Lost to Follow-up|1|||
105568000|NCT01786330|364077029|FG000|Overall Study|Excluded intraoperatively|0|||
105568001|NCT01786330|364077030|FG001|Overall Study|Excluded intraoperatively|1|||
105568002|NCT01786330|364077029|FG000|Overall Study|Protocol Violation|1|||
105568003|NCT01786330|364077030|FG001|Overall Study|Protocol Violation|0|||
105568004|NCT02172625|364077033|FG000|Overall Study|Adverse Event|0|||
105568005|NCT02172625|364077034|FG001|Overall Study|Adverse Event|1|||
105568006|NCT02172625|364077033|FG000|Overall Study|Pregnancy|0|||
105568007|NCT02172625|364077034|FG001|Overall Study|Pregnancy|1|||
105568008|NCT02172625|364077033|FG000|Overall Study|car accident|0|||
105568009|NCT02172625|364077034|FG001|Overall Study|car accident|1|||
105568010|NCT03315130|364077035|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
105568011|NCT03315130|364077036|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
105568012|NCT03315130|364077037|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
105568013|NCT03315130|364077038|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
105568014|NCT03315130|364077035|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
105568015|NCT03315130|364077036|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
105568016|NCT03315130|364077037|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
105568017|NCT03315130|364077038|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
105568018|NCT03315130|364077035|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
105568019|NCT03315130|364077036|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
105568020|NCT03315130|364077037|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
105568021|NCT03315130|364077038|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
105568022|NCT03315130|364077035|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
105568023|NCT03315130|364077036|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
105568024|NCT03315130|364077037|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
105568025|NCT03315130|364077038|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
105568026|NCT03315130|364077035|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
105568027|NCT03315130|364077036|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
105568028|NCT03315130|364077037|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
105568029|NCT03315130|364077038|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
105568030|NCT03315130|364077035|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
105568031|NCT03315130|364077036|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
105568032|NCT03315130|364077037|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
105568033|NCT03315130|364077038|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
105568034|NCT02089230|364077042|FG000|Overall Study|Death|0|||
105568035|NCT02089230|364077043|FG001|Overall Study|Death|0|||
105568036|NCT02089230|364077044|FG002|Overall Study|Death|2|||
105568037|NCT02089230|364077042|FG000|Overall Study|Seeking Alternative Therapy|0|||
105568038|NCT02089230|364077043|FG001|Overall Study|Seeking Alternative Therapy|0|||
105568039|NCT02089230|364077044|FG002|Overall Study|Seeking Alternative Therapy|4|||
105568040|NCT04277455|364079208|FG000|Overall Study|Lost to Follow-up|1|||
105568041|NCT00803101|364079209|FG000|Overall Study|Death / Serious Adverse Event|4|||
105755236|NCT01927419|364755784|FG000|Treatment Period|Participant request to discontinue|12|||
105755237|NCT01927419|364755785|FG001|Treatment Period|Participant request to discontinue|4|||
105755238|NCT01927419|364755784|FG000|Treatment Period|Withdrawal by Subject|1|||
105755239|NCT01927419|364755785|FG001|Treatment Period|Withdrawal by Subject|1|||
105755240|NCT01927419|364755784|FG000|Treatment Period|Maximum Clinical Benefit|6|||
105755241|NCT01927419|364755785|FG001|Treatment Period|Maximum Clinical Benefit|2|||
105755242|NCT01927419|364755784|FG000|Treatment Period|Other reasons|3|||
105755243|NCT01927419|364755785|FG001|Treatment Period|Other reasons|4|||
105755244|NCT01927419|364755784|FG000|Treatment Period|Not Reported|1|||
105755245|NCT01927419|364755785|FG001|Treatment Period|Not Reported|1|||
105755246|NCT03730194|364755788|FG000|First Stage Treatment|Withdrawal by Subject|1|||
105755247|NCT03730194|364755789|FG001|First Stage Treatment|Withdrawal by Subject|1|||
105755248|NCT03730194|364755790|FG002|First Stage Treatment|Withdrawal by Subject|0|||
105755249|NCT03730194|364755791|FG003|First Stage Treatment|Withdrawal by Subject|0|||
105755250|NCT03730194|364755792|FG004|First Stage Treatment|Withdrawal by Subject|0|||
105755251|NCT03730194|364755793|FG005|First Stage Treatment|Withdrawal by Subject|0|||
105755252|NCT03730194|364755788|FG000|First Stage Treatment|Protocol Violation|3|||
105755253|NCT03730194|364755789|FG001|First Stage Treatment|Protocol Violation|3|||
105755254|NCT03730194|364755790|FG002|First Stage Treatment|Protocol Violation|0|||
105755255|NCT03730194|364755791|FG003|First Stage Treatment|Protocol Violation|0|||
105755256|NCT03730194|364755792|FG004|First Stage Treatment|Protocol Violation|0|||
105755257|NCT03730194|364755793|FG005|First Stage Treatment|Protocol Violation|0|||
105755258|NCT01681576|364755794|FG000|Period 1|Adverse Event|1|||
105755259|NCT01681576|364755795|FG001|Period 1|Adverse Event|0|||
105755260|NCT01681576|364755794|FG000|Period 1|Protocol Deviation|1|||
105755261|NCT01681576|364755795|FG001|Period 1|Protocol Deviation|0|||
105755262|NCT01681576|364755794|FG000|Period 2|subject/guardian decision|3|||
105755263|NCT01681576|364755795|FG001|Period 2|subject/guardian decision|1|||
105755264|NCT01681576|364755794|FG000|Period 2|Non-compliance with study treatment|1|||
105755265|NCT01681576|364755795|FG001|Period 2|Non-compliance with study treatment|0|||
105755266|NCT00115765|364755796|FG000|Overall Study|Withdrawal by Subject|22|||
105755267|NCT00115765|364755797|FG001|Overall Study|Withdrawal by Subject|53|||
105755268|NCT00115765|364755798|FG002|Overall Study|Withdrawal by Subject|76|||
105755269|NCT00115765|364755799|FG003|Overall Study|Withdrawal by Subject|15|||
105755270|NCT00115765|364755796|FG000|Overall Study|Physician Decision|4|||
105755271|NCT00115765|364755797|FG001|Overall Study|Physician Decision|15|||
105755272|NCT00115765|364755798|FG002|Overall Study|Physician Decision|18|||
105755273|NCT00115765|364755799|FG003|Overall Study|Physician Decision|13|||
105755274|NCT00115765|364755796|FG000|Overall Study|Lost to Follow-up|3|||
105755275|NCT00115765|364755797|FG001|Overall Study|Lost to Follow-up|20|||
105755276|NCT00115765|364755798|FG002|Overall Study|Lost to Follow-up|18|||
105755277|NCT00115765|364755799|FG003|Overall Study|Lost to Follow-up|1|||
105755278|NCT00115765|364755796|FG000|Overall Study|Other|6|||
105755279|NCT00115765|364755797|FG001|Overall Study|Other|12|||
105360451|NCT00379899|363325951|FG001|Overall Study|Parathyroidectomy|2|||
105360452|NCT00379899|363325950|FG000|Overall Study|Renal transplantation|5|||
105755280|NCT00115765|364755798|FG002|Overall Study|Other|9|||
105755281|NCT00115765|364755799|FG003|Overall Study|Other|2|||
105755282|NCT01518244|364755802|FG000|Overall Study|Adverse Event|3|||
105755283|NCT03543358|364755803|FG000|Overall Study|Death|1|||
105755284|NCT03543358|364755804|FG001|Overall Study|Death|0|||
105755285|NCT03543358|364755803|FG000|Overall Study|Disease Progression|1|||
105755286|NCT03543358|364755804|FG001|Overall Study|Disease Progression|0|||
105755287|NCT03543358|364755803|FG000|Overall Study|Parent Study Closure|1|||
105755288|NCT03543358|364755804|FG001|Overall Study|Parent Study Closure|0|||
105755289|NCT01766817|364755807|FG000|Overall Study|Drug-related adverse event|1|||
105755290|NCT01766817|364755808|FG001|Overall Study|Drug-related adverse event|2|||
105755291|NCT01766817|364755809|FG002|Overall Study|Drug-related adverse event|1|||
105755292|NCT01766817|364755807|FG000|Overall Study|Drug-unrelated adverse event|3|||
105755293|NCT01766817|364755808|FG001|Overall Study|Drug-unrelated adverse event|3|||
105755294|NCT01766817|364755809|FG002|Overall Study|Drug-unrelated adverse event|3|||
105755295|NCT01766817|364755807|FG000|Overall Study|Death|1|||
105755296|NCT01766817|364755808|FG001|Overall Study|Death|1|||
105755297|NCT01766817|364755809|FG002|Overall Study|Death|0|||
105755298|NCT01766817|364755807|FG000|Overall Study|Unable to take study drug|0|||
105755299|NCT01766817|364755808|FG001|Overall Study|Unable to take study drug|1|||
105755300|NCT01766817|364755809|FG002|Overall Study|Unable to take study drug|0|||
105755301|NCT01766817|364755807|FG000|Overall Study|Withdrawal by Subject|2|||
105755302|NCT01766817|364755808|FG001|Overall Study|Withdrawal by Subject|0|||
105755303|NCT01766817|364755809|FG002|Overall Study|Withdrawal by Subject|3|||
105755304|NCT01766817|364755807|FG000|Overall Study|Subject non-compliance|0|||
105755305|NCT01766817|364755808|FG001|Overall Study|Subject non-compliance|1|||
105755306|NCT01766817|364755809|FG002|Overall Study|Subject non-compliance|2|||
105755307|NCT01766817|364755807|FG000|Overall Study|Physician Decision|3|||
105755308|NCT01766817|364755808|FG001|Overall Study|Physician Decision|3|||
105755309|NCT01766817|364755809|FG002|Overall Study|Physician Decision|4|||
105755310|NCT01766817|364755807|FG000|Overall Study|Other|1|||
105755311|NCT01766817|364755808|FG001|Overall Study|Other|0|||
105755312|NCT01766817|364755809|FG002|Overall Study|Other|0|||
105755313|NCT01928485|364755812|FG000|Overall Study|Physician Decision|0|||
105755314|NCT01928485|364755813|FG001|Overall Study|Physician Decision|1|||
105755315|NCT03589885|364755814|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
105755316|NCT03589885|364755815|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
105755317|NCT03589885|364755816|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
105755318|NCT03589885|364755817|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
105755319|NCT03589885|364755818|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
105755320|NCT03589885|364755814|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
105755321|NCT03589885|364755815|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
105755322|NCT03589885|364755816|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
105755323|NCT03589885|364755817|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
105755324|NCT03589885|364755818|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
105755325|NCT03589885|364755814|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
105755326|NCT03589885|364755815|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
105755327|NCT03589885|364755816|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
105755328|NCT03589885|364755817|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
105755329|NCT03589885|364755818|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
105755330|NCT03589885|364755814|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
105568042|NCT00803101|364079210|FG001|Overall Study|Death / Serious Adverse Event|6|||
105568043|NCT00803101|364079209|FG000|Overall Study|Withdrawal by Subject|6|||
105568044|NCT00803101|364079210|FG001|Overall Study|Withdrawal by Subject|4|||
105568045|NCT00803101|364079209|FG000|Overall Study|Lost to Follow-up|2|||
105568046|NCT00803101|364079210|FG001|Overall Study|Lost to Follow-up|2|||
105568047|NCT00803101|364079209|FG000|Overall Study|Protocol Violation|1|||
105568048|NCT00803101|364079210|FG001|Overall Study|Protocol Violation|7|||
105568049|NCT00803101|364079209|FG000|Overall Study|Surgery finished outside protocol window|1|||
105568050|NCT00803101|364079210|FG001|Overall Study|Surgery finished outside protocol window|1|||
105568051|NCT00803101|364079209|FG000|Overall Study|Patient died outside SAE report period|1|||
105568052|NCT00803101|364079210|FG001|Overall Study|Patient died outside SAE report period|0|||
105568053|NCT00803101|364079209|FG000|Overall Study|Patient did not attend scheduled visit|2|||
105568054|NCT00803101|364079210|FG001|Overall Study|Patient did not attend scheduled visit|1|||
105568055|NCT00803101|364079209|FG000|Overall Study|Patient did not have surgery|1|||
105568056|NCT00803101|364079210|FG001|Overall Study|Patient did not have surgery|1|||
105568057|NCT01382602|364079211|FG000|Overall Study|Protocol Violation|0|||
105568058|NCT01382602|364079212|FG001|Overall Study|Protocol Violation|3|||
105568059|NCT01382602|364079211|FG000|Overall Study|Withdrawal by Subject|0|||
105568060|NCT01382602|364079212|FG001|Overall Study|Withdrawal by Subject|1|||
105568061|NCT02790073|364079213|FG000|Overall Study|Death|1|||
105568062|NCT02790073|364079213|FG000|Overall Study|Withdrawal from HD|1|||
105568063|NCT02790073|364079213|FG000|Overall Study|Withdrawal by Subject|1|||
105568064|NCT03587142|364079221|FG000|Overall Study|Lost to Follow-up|5|||
105568065|NCT03587142|364079222|FG001|Overall Study|Lost to Follow-up|3|||
105568066|NCT03587142|364079221|FG000|Overall Study|Did not complete the f4 visit|3|||
105568067|NCT03587142|364079222|FG001|Overall Study|Did not complete the f4 visit|7|||
105568068|NCT00691132|364079223|FG000|Overall Study|Adverse Event|2|||
105568069|NCT00691132|364079224|FG001|Overall Study|Adverse Event|3|||
105568070|NCT00691132|364079223|FG000|Overall Study|Withdrawal by Subject|10|||
105568071|NCT00691132|364079224|FG001|Overall Study|Withdrawal by Subject|10|||
105568072|NCT01959347|364079225|FG000|Overall Study|Protocol Violation|9|||
105568073|NCT01959347|364079226|FG001|Overall Study|Protocol Violation|7|||
105568074|NCT05061537|364079229|FG000|Treatment Phase|Progressive disease|0|||
105568075|NCT05061537|364079230|FG001|Treatment Phase|Progressive disease|1|||
105568076|NCT05061537|364079231|FG002|Treatment Phase|Progressive disease|2|||
105568077|NCT05061537|364079232|FG003|Treatment Phase|Progressive disease|0|||
105568078|NCT05061537|364079233|FG004|Treatment Phase|Progressive disease|0|||
105568079|NCT05061537|364079229|FG000|Treatment Phase|Adverse Event|0|||
105568080|NCT05061537|364079230|FG001|Treatment Phase|Adverse Event|0|||
105568081|NCT05061537|364079231|FG002|Treatment Phase|Adverse Event|2|||
105568082|NCT05061537|364079232|FG003|Treatment Phase|Adverse Event|0|||
105568083|NCT05061537|364079233|FG004|Treatment Phase|Adverse Event|0|||
105568084|NCT05061537|364079229|FG000|Treatment Phase|Global deterioration of health status|0|||
105568085|NCT05061537|364079230|FG001|Treatment Phase|Global deterioration of health status|1|||
105802617|NCT03769181|364934491|FG001|Overall Study|Progressive disease|7|||
105802618|NCT03769181|364934492|FG002|Overall Study|Progressive disease|13|||
105802619|NCT03769181|364934493|FG003|Overall Study|Progressive disease|6|||
105802620|NCT03769181|364934490|FG000|Overall Study|Other - Unspecified|2|||
105802621|NCT03769181|364934491|FG001|Overall Study|Other - Unspecified|1|||
105802622|NCT03769181|364934492|FG002|Overall Study|Other - Unspecified|0|||
105802623|NCT03769181|364934493|FG003|Overall Study|Other - Unspecified|0|||
105802624|NCT00928252|364934494|FG000|Overall Study|Physician Decision|3|||
105802625|NCT03341273|364934497|FG000|Overall Study|Lost to Follow-up|7|||
105802626|NCT03341273|364934498|FG001|Overall Study|Lost to Follow-up|7|||
105802627|NCT03341273|364934497|FG000|Overall Study|Withdrawal by Subject|4|||
105802628|NCT03341273|364934498|FG001|Overall Study|Withdrawal by Subject|2|||
105802629|NCT03341273|364934497|FG000|Overall Study|Physician Decision|1|||
105802630|NCT03341273|364934498|FG001|Overall Study|Physician Decision|0|||
105802631|NCT03341273|364934497|FG000|Overall Study|Protocol Violation|0|||
105802632|NCT03341273|364934498|FG001|Overall Study|Protocol Violation|1|||
105802633|NCT03341273|364934497|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
105360453|NCT00379899|363325951|FG001|Overall Study|Renal transplantation|4|||
105360454|NCT00379899|363325950|FG000|Overall Study|Coronary artery bypass graft|1|||
105360455|NCT00379899|363325951|FG001|Overall Study|Coronary artery bypass graft|1|||
105568086|NCT05061537|364079231|FG002|Treatment Phase|Global deterioration of health status|0|||
105568087|NCT05061537|364079232|FG003|Treatment Phase|Global deterioration of health status|0|||
105568088|NCT05061537|364079233|FG004|Treatment Phase|Global deterioration of health status|0|||
105568089|NCT05061537|364079229|FG000|Follow up|Other|2|||
105568090|NCT05061537|364079230|FG001|Follow up|Other|0|||
105568091|NCT05061537|364079231|FG002|Follow up|Other|2|||
105568092|NCT05061537|364079232|FG003|Follow up|Other|0|||
105568093|NCT05061537|364079233|FG004|Follow up|Other|0|||
105568094|NCT05061537|364079229|FG000|Follow up|Study terminated by sponsor|0|||
105568095|NCT05061537|364079230|FG001|Follow up|Study terminated by sponsor|0|||
105802634|NCT03341273|364934498|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
105802635|NCT03341273|364934497|FG000|Overall Study|Became ineligible after enrollment|1|||
105802636|NCT03341273|364934498|FG001|Overall Study|Became ineligible after enrollment|0|||
105802637|NCT03341273|364934497|FG000|Overall Study|Not Eligible at Enrollment|0|||
105802638|NCT03341273|364934498|FG001|Overall Study|Not Eligible at Enrollment|1|||
105802639|NCT03341273|364934497|FG000|Overall Study|Participant incarcerated|1|||
105802640|NCT03341273|364934498|FG001|Overall Study|Participant incarcerated|0|||
105802641|NCT04228302|364934499|FG000|Overall Study|Adverse Event|0|||
105802642|NCT04228302|364934500|FG001|Overall Study|Adverse Event|0|||
105802643|NCT04228302|364934501|FG002|Overall Study|Adverse Event|0|||
105802644|NCT04228302|364934502|FG003|Overall Study|Adverse Event|0|||
105802645|NCT04228302|364934503|FG004|Overall Study|Adverse Event|1|||
105802646|NCT04228302|364934504|FG005|Overall Study|Adverse Event|0|||
105802647|NCT00667719|364934516|FG000|Overall Study|Adverse Event|39|||
105802648|NCT00667719|364934516|FG000|Overall Study|Abnormal Test Procedure|1|||
105802649|NCT00667719|364934516|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
105802650|NCT00667719|364934516|FG000|Overall Study|Protocol Violation|3|||
105802651|NCT00667719|364934516|FG000|Overall Study|Withdrawal by Subject|17|||
105802652|NCT00667719|364934516|FG000|Overall Study|Lost to Follow-up|8|||
105802653|NCT00078819|364934517|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
105802654|NCT00078819|364934518|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
105802655|NCT00078819|364934519|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
105802656|NCT00078819|364934520|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
105802657|NCT00078819|364934517|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
105802658|NCT00078819|364934518|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
105802659|NCT00078819|364934519|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
105802660|NCT00078819|364934520|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
105568096|NCT05061537|364079231|FG002|Follow up|Study terminated by sponsor|2|||
105802661|NCT00078819|364934517|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
105802662|NCT00078819|364934518|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
105568097|NCT05061537|364079232|FG003|Follow up|Study terminated by sponsor|0|||
105568098|NCT05061537|364079233|FG004|Follow up|Study terminated by sponsor|0|||
105568099|NCT05061537|364079229|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
105568100|NCT05061537|364079230|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
105568101|NCT05061537|364079231|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
105568102|NCT05061537|364079232|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
105568103|NCT05061537|364079233|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
105568104|NCT05061537|364079229|FG000|Long-term Follow-up|Death|0|||
105568105|NCT05061537|364079230|FG001|Long-term Follow-up|Death|1|||
105568106|NCT05061537|364079231|FG002|Long-term Follow-up|Death|0|||
105568107|NCT05061537|364079232|FG003|Long-term Follow-up|Death|0|||
105568108|NCT05061537|364079233|FG004|Long-term Follow-up|Death|0|||
105568109|NCT03502616|364079234|FG000|Up to Week 16|Withdrawal by Subject|1|||
105568110|NCT03502616|364079235|FG001|Up to Week 16|Withdrawal by Subject|2|||
105568111|NCT03502616|364079234|FG000|Up to Week 16|Lost to Follow-up|0|||
105568112|NCT03502616|364079235|FG001|Up to Week 16|Lost to Follow-up|1|||
105568113|NCT03502616|364079234|FG000|Up to Week 16|Randomized, but not treated|1|||
105568114|NCT03502616|364079235|FG001|Up to Week 16|Randomized, but not treated|0|||
105568115|NCT03502616|364079234|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
105568116|NCT03502616|364079235|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
105568117|NCT03502616|364079234|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
105568118|NCT03502616|364079235|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
105568119|NCT01691521|364079236|FG000|Overall Study|Adverse Event|4|||
105568120|NCT01691521|364079237|FG001|Overall Study|Adverse Event|0|||
105568121|NCT01691521|364079238|FG002|Overall Study|Adverse Event|1|||
105568122|NCT01691521|364079236|FG000|Overall Study|Lack of Efficacy|1|||
105568123|NCT01691521|364079237|FG001|Overall Study|Lack of Efficacy|1|||
105568124|NCT01691521|364079238|FG002|Overall Study|Lack of Efficacy|2|||
105568125|NCT01691521|364079236|FG000|Overall Study|Protocol Violation|0|||
105568126|NCT01691521|364079237|FG001|Overall Study|Protocol Violation|3|||
105568127|NCT01691521|364079238|FG002|Overall Study|Protocol Violation|0|||
105568128|NCT01691521|364079236|FG000|Overall Study|Lost to Follow-up|0|||
105568129|NCT01691521|364079237|FG001|Overall Study|Lost to Follow-up|2|||
105568130|NCT01691521|364079238|FG002|Overall Study|Lost to Follow-up|2|||
105568131|NCT01691521|364079236|FG000|Overall Study|Physician Decision|2|||
105568132|NCT01691521|364079237|FG001|Overall Study|Physician Decision|1|||
105568133|NCT01691521|364079238|FG002|Overall Study|Physician Decision|0|||
105568134|NCT01691521|364079236|FG000|Overall Study|Withdrawal by Subject|5|||
105568135|NCT01691521|364079237|FG001|Overall Study|Withdrawal by Subject|9|||
105802663|NCT00078819|364934519|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
105568136|NCT01691521|364079238|FG002|Overall Study|Withdrawal by Subject|4|||
105568137|NCT01480596|364079239|FG000|Overall Study|Adverse Event|3|||
105568138|NCT01480596|364079240|FG001|Overall Study|Adverse Event|0|||
105568139|NCT01480596|364079239|FG000|Overall Study|MG exacerbation or change in medication|2|||
105568140|NCT01480596|364079240|FG001|Overall Study|MG exacerbation or change in medication|2|||
105568141|NCT04503096|364079243|FG000|Overall Study|Withdrawal by Subject|3|||
105568142|NCT02343003|364079244|FG000|Overall Study|Withdrawal by Subject|9|||
105568143|NCT02343003|364079245|FG001|Overall Study|Withdrawal by Subject|4|||
105568144|NCT02343003|364079244|FG000|Overall Study|Lost to Follow-up|5|||
105568145|NCT02343003|364079245|FG001|Overall Study|Lost to Follow-up|1|||
105568146|NCT02343003|364079244|FG000|Overall Study|Protocol Violation|1|||
105568147|NCT02343003|364079245|FG001|Overall Study|Protocol Violation|0|||
105568148|NCT02343003|364079244|FG000|Overall Study|Death|0|||
105568149|NCT02343003|364079245|FG001|Overall Study|Death|1|||
105568150|NCT02343003|364079244|FG000|Overall Study|exclusion criteria met|1|||
105568151|NCT02343003|364079245|FG001|Overall Study|exclusion criteria met|1|||
105568152|NCT02343003|364079244|FG000|Overall Study|terminated by sponsor|2|||
105568153|NCT02343003|364079245|FG001|Overall Study|terminated by sponsor|0|||
105568154|NCT01785563|364079247|FG000|Overall Study|Physician Decision|10|||
105568155|NCT01785563|364079247|FG000|Overall Study|Withdrawal by Subject|1|||
105568156|NCT01785563|364079247|FG000|Overall Study|Protocol Violation|2|||
105568157|NCT03954743|364079249|FG000|Overall Study|Adverse Event|1|||
105568158|NCT03954743|364079250|FG001|Overall Study|Adverse Event|0|||
105568159|NCT03954743|364079249|FG000|Overall Study|Lost to Follow-up|6|||
105568160|NCT03954743|364079250|FG001|Overall Study|Lost to Follow-up|4|||
105568161|NCT03954743|364079249|FG000|Overall Study|Protocol Violation|1|||
105568162|NCT03954743|364079250|FG001|Overall Study|Protocol Violation|0|||
105568163|NCT03954743|364079249|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
105568164|NCT03954743|364079250|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
105568165|NCT03954743|364079249|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
105568166|NCT03954743|364079250|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105568167|NCT00860067|364079253|FG000|Overall Study|Lost to Follow-up|46|||
105568168|NCT00860067|364079254|FG001|Overall Study|Lost to Follow-up|9|||
105568169|NCT00860067|364079255|FG002|Overall Study|Lost to Follow-up|9|||
105568170|NCT00860067|364079253|FG000|Overall Study|Withdrawal by Subject|4|||
105568171|NCT00860067|364079254|FG001|Overall Study|Withdrawal by Subject|0|||
105568172|NCT00860067|364079255|FG002|Overall Study|Withdrawal by Subject|0|||
105568173|NCT00860067|364079253|FG000|Overall Study|Pregnancy|1|||
105568174|NCT00860067|364079254|FG001|Overall Study|Pregnancy|0|||
105568175|NCT00860067|364079255|FG002|Overall Study|Pregnancy|0|||
105568176|NCT00770432|364079258|FG000|Overall Study|Other|4|||
105568177|NCT00770432|364079259|FG001|Overall Study|Other|6|||
105568178|NCT00770432|364079258|FG000|Overall Study|Non-compliance|0|||
105568179|NCT00770432|364079259|FG001|Overall Study|Non-compliance|1|||
105568180|NCT02756832|364079265|FG000|Overall Study|Lost for Observation after Baseline|6|||
105568181|NCT02756832|364079265|FG000|Overall Study|Lost for Observation|13|||
105568182|NCT02756832|364079265|FG000|Overall Study|Patient's Unwillingness|12|||
105568183|NCT02756832|364079265|FG000|Overall Study|Insufficient Efficacy|2|||
105568184|NCT02756832|364079265|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
105568185|NCT02756832|364079265|FG000|Overall Study|Reason not Specified|9|||
105568186|NCT02756832|364079265|FG000|Overall Study|Protocol Deviation|10|||
105568187|NCT03579290|364079266|FG000|Overall Study|Lost to Follow-up|9|||
105568188|NCT03485911|364079267|FG000|Part 1|Perceived lack of efficacy|1|||
105568189|NCT03485911|364079268|FG001|Part 1|Perceived lack of efficacy|1|||
105568190|NCT03485911|364079269|FG002|Part 1|Perceived lack of efficacy|2|||
105568191|NCT03485911|364079270|FG003|Part 1|Perceived lack of efficacy|0|||
105568192|NCT03485911|364079267|FG000|Part 1|Subject withdrew consent|0|||
105568193|NCT03485911|364079268|FG001|Part 1|Subject withdrew consent|1|||
105568194|NCT03485911|364079269|FG002|Part 1|Subject withdrew consent|0|||
105568195|NCT03485911|364079270|FG003|Part 1|Subject withdrew consent|1|||
105568196|NCT03485911|364079267|FG000|Part 1|Lab abnormalities/AEs|3|||
105568197|NCT03485911|364079268|FG001|Part 1|Lab abnormalities/AEs|1|||
105568198|NCT03485911|364079269|FG002|Part 1|Lab abnormalities/AEs|1|||
105568199|NCT03485911|364079270|FG003|Part 1|Lab abnormalities/AEs|0|||
105568200|NCT03485911|364079267|FG000|Part 1|Withdrew Consent prior to dosing|0|||
105568201|NCT03485911|364079268|FG001|Part 1|Withdrew Consent prior to dosing|0|||
105568202|NCT03485911|364079269|FG002|Part 1|Withdrew Consent prior to dosing|0|||
105568203|NCT03485911|364079270|FG003|Part 1|Withdrew Consent prior to dosing|1|||
105568204|NCT03485911|364079267|FG000|Part 1|Other NOS|0|||
105568205|NCT03485911|364079268|FG001|Part 1|Other NOS|0|||
105568206|NCT03485911|364079269|FG002|Part 1|Other NOS|0|||
105755331|NCT03589885|364755815|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
105755332|NCT03589885|364755816|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
105755333|NCT03589885|364755817|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
105755334|NCT03589885|364755818|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
105755335|NCT03589885|364755814|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
105755336|NCT03589885|364755815|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
105755337|NCT03589885|364755816|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
105755338|NCT03589885|364755817|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
105755339|NCT03589885|364755818|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
105755340|NCT03589885|364755814|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
105755341|NCT03589885|364755815|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
105755342|NCT03589885|364755816|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
105755343|NCT03589885|364755817|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
105755344|NCT03589885|364755818|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
105755345|NCT03589885|364755814|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
105755346|NCT03589885|364755815|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
105755347|NCT03589885|364755816|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
105755348|NCT03589885|364755817|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
105755349|NCT03589885|364755818|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
105755350|NCT03589885|364755814|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
105755351|NCT03589885|364755815|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
105360456|NCT00379899|363325950|FG000|Overall Study|Other protocol-specified criteria|3|||
105360457|NCT00379899|363325951|FG001|Overall Study|Other protocol-specified criteria|4|||
105360458|NCT00379899|363325950|FG000|Overall Study|Other|3|||
105755352|NCT03589885|364755816|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
105755353|NCT03589885|364755817|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
105755354|NCT03589885|364755818|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
105755355|NCT02260648|364755824|FG000|Overall Study|Adverse Event|3|||
105755356|NCT02260648|364755825|FG001|Overall Study|Adverse Event|0|||
105755357|NCT02260648|364755826|FG002|Overall Study|Adverse Event|1|||
105755358|NCT02260648|364755824|FG000|Overall Study|Withdrawal by Subject|1|||
105755359|NCT02260648|364755825|FG001|Overall Study|Withdrawal by Subject|1|||
105755360|NCT02260648|364755826|FG002|Overall Study|Withdrawal by Subject|0|||
105755361|NCT02260648|364755824|FG000|Overall Study|Protocol Violation|1|||
105755362|NCT02260648|364755825|FG001|Overall Study|Protocol Violation|0|||
105755363|NCT02260648|364755826|FG002|Overall Study|Protocol Violation|0|||
105755364|NCT02260648|364755824|FG000|Overall Study|Discontinue Due to Study Termination|13|||
105755365|NCT02260648|364755825|FG001|Overall Study|Discontinue Due to Study Termination|12|||
105755366|NCT02260648|364755826|FG002|Overall Study|Discontinue Due to Study Termination|7|||
105755367|NCT04093258|364755827|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
105568207|NCT03485911|364079270|FG003|Part 1|Other NOS|1|||
105360459|NCT00379899|363325951|FG001|Overall Study|Other|1|||
105360460|NCT01922258|363325954|FG000|Overall Study|Lost to Follow-up|1|||
105360461|NCT01922258|363325955|FG001|Overall Study|Lost to Follow-up|1|||
105360462|NCT01922258|363325954|FG000|Overall Study|Adverse Event|9|||
105360463|NCT01922258|363325955|FG001|Overall Study|Adverse Event|2|||
105360464|NCT01922258|363325954|FG000|Overall Study|Met Withdrawal Criteria|0|||
105360465|NCT01922258|363325955|FG001|Overall Study|Met Withdrawal Criteria|4|||
105360466|NCT01922258|363325954|FG000|Overall Study|Withdrawn by the Investigator|1|||
105755368|NCT04093258|364755828|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
105360467|NCT01922258|363325955|FG001|Overall Study|Withdrawn by the Investigator|4|||
105360468|NCT01922258|363325954|FG000|Overall Study|Withdrawal by participant|5|||
105568208|NCT03485911|364079267|FG000|Part 2|Perceived lack of efficacy|5|||
105755369|NCT00594204|364755830|FG000|Overall Study|Adverse Event|15|||
105755370|NCT00594204|364755831|FG001|Overall Study|Adverse Event|3|||
105568209|NCT03485911|364079268|FG001|Part 2|Perceived lack of efficacy|3|||
105568210|NCT03485911|364079269|FG002|Part 2|Perceived lack of efficacy|0|||
105568211|NCT03485911|364079270|FG003|Part 2|Perceived lack of efficacy|2|||
105755371|NCT00594204|364755830|FG000|Overall Study|Lost to Follow-up|9|||
105755372|NCT00594204|364755831|FG001|Overall Study|Lost to Follow-up|5|||
105360469|NCT01922258|363325955|FG001|Overall Study|Withdrawal by participant|5|||
105360470|NCT01166750|363325956|FG000|Overall Study|Lost to Follow-up|1|||
105360471|NCT01166750|363325957|FG001|Overall Study|Lost to Follow-up|0|||
105360472|NCT05225389|363325958|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
105360473|NCT04552132|363325959|FG000|Overall Study|Lost to Follow-up|4|||
105360474|NCT04552132|363325960|FG001|Overall Study|Lost to Follow-up|3|||
105360475|NCT04552132|363325959|FG000|Overall Study|Protocol Violation|1|||
105360476|NCT04552132|363325960|FG001|Overall Study|Protocol Violation|0|||
105360477|NCT03804268|363325961|FG000|Overall Study|Adverse Event|2|||
105360478|NCT03804268|363325962|FG001|Overall Study|Adverse Event|2|||
105360479|NCT03804268|363325961|FG000|Overall Study|Withdrawal by Subject|2|||
105360480|NCT03804268|363325962|FG001|Overall Study|Withdrawal by Subject|0|||
105568212|NCT03485911|364079267|FG000|Part 2|Subject withdrew consent|1|||
105568213|NCT03485911|364079268|FG001|Part 2|Subject withdrew consent|0|||
105755373|NCT00594204|364755830|FG000|Overall Study|Withdrawal by Subject|23|||
105755374|NCT00594204|364755831|FG001|Overall Study|Withdrawal by Subject|29|||
105755375|NCT00594204|364755830|FG000|Overall Study|Other|4|||
105755376|NCT00594204|364755831|FG001|Overall Study|Other|3|||
105755377|NCT00594204|364755830|FG000|Overall Study|Lack of Efficacy|3|||
105755378|NCT00594204|364755831|FG001|Overall Study|Lack of Efficacy|4|||
105755379|NCT00594204|364755830|FG000|Overall Study|Randomized but not treated|4|||
105755380|NCT00594204|364755831|FG001|Overall Study|Randomized but not treated|1|||
105755381|NCT00567541|364755832|FG000|Overall Study|Adverse Event|0|||
105755382|NCT00567541|364755833|FG001|Overall Study|Adverse Event|1|||
105755383|NCT00805545|364755834|FG000|Overall Study|Protocol Violation|3|||
105755384|NCT00805545|364755835|FG001|Overall Study|Protocol Violation|2|||
105755385|NCT00805545|364755834|FG000|Overall Study|Protocol Violation|3|||
105755386|NCT00805545|364755835|FG001|Overall Study|Protocol Violation|1|||
105755387|NCT00507416|364755836|FG000|Overall Study|Adverse Event|58|||
105755388|NCT00507416|364755837|FG001|Overall Study|Adverse Event|67|||
105755389|NCT00507416|364755838|FG002|Overall Study|Adverse Event|65|||
105755390|NCT00507416|364755836|FG000|Overall Study|Protocol Violation|1|||
105755391|NCT00507416|364755837|FG001|Overall Study|Protocol Violation|2|||
105755392|NCT00507416|364755838|FG002|Overall Study|Protocol Violation|0|||
105755393|NCT00507416|364755836|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
105755394|NCT00507416|364755837|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
105755395|NCT00507416|364755838|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
105755396|NCT00507416|364755836|FG000|Overall Study|Progressive Disease|20|||
105755397|NCT00507416|364755837|FG001|Overall Study|Progressive Disease|10|||
105755398|NCT00507416|364755838|FG002|Overall Study|Progressive Disease|13|||
105755399|NCT00507416|364755836|FG000|Overall Study|Patient declined further treatment|18|||
105755400|NCT00507416|364755837|FG001|Overall Study|Patient declined further treatment|14|||
105755401|NCT00507416|364755838|FG002|Overall Study|Patient declined further treatment|11|||
105755402|NCT00507416|364755836|FG000|Overall Study|Other|11|||
105755403|NCT00507416|364755837|FG001|Overall Study|Other|16|||
105755404|NCT00507416|364755838|FG002|Overall Study|Other|13|||
105755405|NCT00507416|364755836|FG000|Overall Study|Did not Receive Study Treatment|3|||
105755406|NCT00507416|364755837|FG001|Overall Study|Did not Receive Study Treatment|9|||
105755407|NCT00507416|364755838|FG002|Overall Study|Did not Receive Study Treatment|4|||
105755408|NCT03101514|364755841|FG000|Overall Study|Withdrawal by Subject|4|||
105755409|NCT03101514|364755841|FG000|Overall Study|Protocol Violation|2|||
105755410|NCT03101514|364755841|FG000|Overall Study|patient's information was incomplete|1|||
105755411|NCT02379390|364755844|FG000|Overall Study|Adverse Event|1|||
105755412|NCT02379390|364755845|FG001|Overall Study|Adverse Event|1|||
105755413|NCT02379390|364755844|FG000|Overall Study|Investigator's decision|1|||
105755414|NCT02379390|364755845|FG001|Overall Study|Investigator's decision|0|||
105755415|NCT02379390|364755844|FG000|Overall Study|Study Termination|0|||
105755416|NCT02379390|364755845|FG001|Overall Study|Study Termination|1|||
105755417|NCT04142216|364755848|FG000|Overall Study|Hospitalization|0|||
105755418|NCT04142216|364755849|FG001|Overall Study|Hospitalization|2|||
105755419|NCT04142216|364755848|FG000|Overall Study|Death|3|||
105755420|NCT04142216|364755849|FG001|Overall Study|Death|1|||
105755421|NCT04142216|364755848|FG000|Overall Study|Referral to another hemodialysis unit|3|||
105755422|NCT04142216|364755849|FG001|Overall Study|Referral to another hemodialysis unit|2|||
105755423|NCT04142216|364755848|FG000|Overall Study|Use of clove|0|||
105755424|NCT04142216|364755849|FG001|Overall Study|Use of clove|1|||
105755425|NCT01054976|364755852|FG000|Overall Study|Adverse Event|16|||
105755426|NCT01054976|364755852|FG000|Overall Study|Uncooperative participations to study|7|||
105755427|NCT01054976|364755852|FG000|Overall Study|Withdrawal by Subject|4|||
105755428|NCT01054976|364755852|FG000|Overall Study|Other|8|||
105755429|NCT02555657|364755853|FG000|Overall Study|Death|274|||
105755430|NCT02555657|364755854|FG001|Overall Study|Death|262|||
105360481|NCT03804268|363325961|FG000|Overall Study|Lost to Follow-up|1|||
105360482|NCT03804268|363325962|FG001|Overall Study|Lost to Follow-up|0|||
105568214|NCT03485911|364079269|FG002|Part 2|Subject withdrew consent|2|||
105755431|NCT02555657|364755853|FG000|Overall Study|Physician Decision|0|||
105755432|NCT02555657|364755854|FG001|Overall Study|Physician Decision|1|||
105755433|NCT02555657|364755853|FG000|Overall Study|Sponsor Decision|27|||
105755434|NCT02555657|364755854|FG001|Overall Study|Sponsor Decision|15|||
105755435|NCT02555657|364755853|FG000|Overall Study|Withdrawal by Subject|11|||
105755436|NCT02555657|364755854|FG001|Overall Study|Withdrawal by Subject|32|||
105755437|NCT00493974|364755855|FG000|Overall Study|Death|1|||
105755438|NCT00493974|364755856|FG001|Overall Study|Death|2|||
105755439|NCT00493974|364755855|FG000|Overall Study|Withdrawal by Subject|8|||
105755440|NCT00493974|364755856|FG001|Overall Study|Withdrawal by Subject|6|||
105755441|NCT00493974|364755855|FG000|Overall Study|Lost to Follow-up|4|||
105755442|NCT00493974|364755856|FG001|Overall Study|Lost to Follow-up|6|||
105755443|NCT01578785|364755858|FG000|Overall Study|Withdrawal by Subject|0|||
105755444|NCT01578785|364755859|FG001|Overall Study|Withdrawal by Subject|1|||
105755445|NCT01578785|364755858|FG000|Overall Study|Study terminated by sponsor|59|||
105755446|NCT01578785|364755859|FG001|Overall Study|Study terminated by sponsor|118|||
105755447|NCT00475540|364755861|FG000|36 Months|Lost to Follow-up|4|||
105360483|NCT03804268|363325961|FG000|Overall Study|Physician Decision|2|||
105360484|NCT03804268|363325962|FG001|Overall Study|Physician Decision|0|||
105360485|NCT02716779|363325963|FG000|Monotherapy|Adverse Event|0|||
105360486|NCT02716779|363325964|FG001|Monotherapy|Adverse Event|1|||
105360487|NCT02716779|363325965|FG002|Monotherapy|Adverse Event|1|||
105360488|NCT02716779|363325963|FG000|Combination Therapy|Adverse Event|0|||
105360489|NCT02716779|363325964|FG001|Combination Therapy|Adverse Event|2|||
105360490|NCT02716779|363325965|FG002|Combination Therapy|Adverse Event|1|||
105360491|NCT02600923|363325966|FG000|Overall Study|Death|10|||
105360492|NCT02600923|363325966|FG000|Overall Study|Adverse Event|3|||
105360493|NCT02600923|363325966|FG000|Overall Study|Global deterioration of health status|2|||
105360494|NCT02600923|363325966|FG000|Overall Study|Insufficient clinical response|6|||
105360495|NCT02600923|363325966|FG000|Overall Study|Lost to Follow-up|1|||
105755448|NCT00475540|364755862|FG001|36 Months|Lost to Follow-up|4|||
105755449|NCT00475540|364755861|FG000|36 Months|Death|1|||
105755450|NCT00475540|364755862|FG001|36 Months|Death|2|||
105755451|NCT00475540|364755861|FG000|36 Months|Censored due to reoperation|3|||
105755452|NCT00475540|364755862|FG001|36 Months|Censored due to reoperation|0|||
105755453|NCT00377429|364755863|FG000|Overall Study|Withdrawal by Subject|5|||
105755454|NCT00377429|364755863|FG000|Overall Study|Adverse Event|8|||
105755455|NCT00377429|364755863|FG000|Overall Study|Physician Decision|1|||
105755456|NCT00377429|364755863|FG000|Overall Study|Patient non-compliance|1|||
105360496|NCT02600923|363325966|FG000|Overall Study|Withdrawal by Subject|5|||
105360497|NCT02600923|363325966|FG000|Overall Study|Objective progression or relapse|50|||
105360498|NCT02600923|363325966|FG000|Overall Study|Study terminated by Sponsor|53|||
105360499|NCT02600923|363325966|FG000|Overall Study|Not treated|1|||
105755457|NCT02559206|364755869|FG000|Overall Study|Adverse Event|0|||
105755458|NCT02559206|364755870|FG001|Overall Study|Adverse Event|4|||
105755459|NCT02559206|364755871|FG002|Overall Study|Adverse Event|1|||
105755460|NCT02559206|364755872|FG003|Overall Study|Adverse Event|5|||
105755461|NCT02559206|364755873|FG004|Overall Study|Adverse Event|3|||
105755462|NCT02559206|364755874|FG005|Overall Study|Adverse Event|0|||
105755463|NCT02559206|364755875|FG006|Overall Study|Adverse Event|1|||
105755464|NCT02559206|364755876|FG007|Overall Study|Adverse Event|0|||
105755465|NCT02559206|364755869|FG000|Overall Study|Protocol Violation|1|||
105755466|NCT02559206|364755870|FG001|Overall Study|Protocol Violation|0|||
105755467|NCT02559206|364755871|FG002|Overall Study|Protocol Violation|1|||
105755468|NCT02559206|364755872|FG003|Overall Study|Protocol Violation|0|||
105755469|NCT02559206|364755873|FG004|Overall Study|Protocol Violation|0|||
105755470|NCT02559206|364755874|FG005|Overall Study|Protocol Violation|2|||
105755471|NCT02559206|364755875|FG006|Overall Study|Protocol Violation|0|||
105755472|NCT02559206|364755876|FG007|Overall Study|Protocol Violation|0|||
105755473|NCT02559206|364755869|FG000|Overall Study|Withdrawal by Subject|3|||
105755474|NCT02559206|364755870|FG001|Overall Study|Withdrawal by Subject|3|||
105755475|NCT02559206|364755871|FG002|Overall Study|Withdrawal by Subject|1|||
105755476|NCT02559206|364755872|FG003|Overall Study|Withdrawal by Subject|3|||
105755477|NCT02559206|364755873|FG004|Overall Study|Withdrawal by Subject|5|||
105755478|NCT02559206|364755874|FG005|Overall Study|Withdrawal by Subject|4|||
105755479|NCT02559206|364755875|FG006|Overall Study|Withdrawal by Subject|1|||
105568215|NCT03485911|364079270|FG003|Part 2|Subject withdrew consent|1|||
105755480|NCT02559206|364755876|FG007|Overall Study|Withdrawal by Subject|2|||
105755481|NCT02559206|364755869|FG000|Overall Study|Lost to Follow-up|3|||
105755482|NCT02559206|364755870|FG001|Overall Study|Lost to Follow-up|5|||
105755483|NCT02559206|364755871|FG002|Overall Study|Lost to Follow-up|3|||
105755484|NCT02559206|364755872|FG003|Overall Study|Lost to Follow-up|3|||
105755485|NCT02559206|364755873|FG004|Overall Study|Lost to Follow-up|2|||
105755486|NCT02559206|364755874|FG005|Overall Study|Lost to Follow-up|5|||
105755487|NCT02559206|364755875|FG006|Overall Study|Lost to Follow-up|1|||
105755488|NCT02559206|364755876|FG007|Overall Study|Lost to Follow-up|4|||
105755489|NCT02559206|364755869|FG000|Overall Study|Lack of Efficacy|1|||
105755490|NCT02559206|364755870|FG001|Overall Study|Lack of Efficacy|0|||
105755491|NCT02559206|364755871|FG002|Overall Study|Lack of Efficacy|3|||
105755492|NCT02559206|364755872|FG003|Overall Study|Lack of Efficacy|2|||
105755493|NCT02559206|364755873|FG004|Overall Study|Lack of Efficacy|2|||
105755494|NCT02559206|364755874|FG005|Overall Study|Lack of Efficacy|3|||
105755495|NCT02559206|364755875|FG006|Overall Study|Lack of Efficacy|3|||
105755496|NCT02559206|364755876|FG007|Overall Study|Lack of Efficacy|3|||
105755497|NCT02559206|364755869|FG000|Overall Study|Other Not Specified|0|||
105755498|NCT02559206|364755870|FG001|Overall Study|Other Not Specified|0|||
105755499|NCT02559206|364755871|FG002|Overall Study|Other Not Specified|0|||
105755500|NCT02559206|364755872|FG003|Overall Study|Other Not Specified|1|||
105755501|NCT02559206|364755873|FG004|Overall Study|Other Not Specified|0|||
105755502|NCT02559206|364755874|FG005|Overall Study|Other Not Specified|0|||
105755503|NCT02559206|364755875|FG006|Overall Study|Other Not Specified|0|||
105755504|NCT02559206|364755876|FG007|Overall Study|Other Not Specified|0|||
105755505|NCT02947022|364755877|FG000|Overall Study|Study Stopped|1|||
105755506|NCT00571519|364758193|FG000|Overall Study|Subject withdrew consent|0|||
105755507|NCT00571519|364758194|FG001|Overall Study|Subject withdrew consent|1|||
105755508|NCT00571519|364758195|FG002|Overall Study|Subject withdrew consent|0|||
105755509|NCT00571519|364758196|FG003|Overall Study|Subject withdrew consent|2|||
105755510|NCT00571519|364758197|FG004|Overall Study|Subject withdrew consent|1|||
105755511|NCT00571519|364758198|FG005|Overall Study|Subject withdrew consent|1|||
105755512|NCT00571519|364758199|FG006|Overall Study|Subject withdrew consent|2|||
105755513|NCT00571519|364758193|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
105755514|NCT00571519|364758194|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
105755515|NCT00571519|364758195|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
105755516|NCT00571519|364758196|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
105755517|NCT00571519|364758197|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
105755518|NCT00571519|364758198|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
105755519|NCT00571519|364758199|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
105755520|NCT00571519|364758193|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
105755521|NCT00571519|364758194|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
105755522|NCT00571519|364758195|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
105755523|NCT00571519|364758196|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
105755524|NCT00571519|364758197|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
105755525|NCT00571519|364758198|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
105755526|NCT00571519|364758199|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
105755527|NCT00571519|364758193|FG000|Overall Study|Termination of study by Sponsor|2|||
105755528|NCT00571519|364758194|FG001|Overall Study|Termination of study by Sponsor|7|||
105755529|NCT00571519|364758195|FG002|Overall Study|Termination of study by Sponsor|10|||
105755530|NCT00571519|364758196|FG003|Overall Study|Termination of study by Sponsor|24|||
105755531|NCT00571519|364758197|FG004|Overall Study|Termination of study by Sponsor|8|||
105755532|NCT00571519|364758198|FG005|Overall Study|Termination of study by Sponsor|9|||
105755533|NCT00571519|364758199|FG006|Overall Study|Termination of study by Sponsor|22|||
105755534|NCT00571519|364758193|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
105755535|NCT00571519|364758194|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
105755536|NCT00571519|364758195|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
105755537|NCT00571519|364758196|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
105755538|NCT00571519|364758197|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
105755539|NCT00571519|364758198|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
105755540|NCT00571519|364758199|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
105755541|NCT05263921|364758201|FG000|Overall Study|Other: family emergency.|0|||
105755542|NCT05263921|364758202|FG001|Overall Study|Other: family emergency.|0|||
105755543|NCT05263921|364758203|FG002|Overall Study|Other: family emergency.|1|||
105755544|NCT05263921|364758204|FG003|Overall Study|Other: family emergency.|0|||
105755545|NCT02701192|364758207|FG000|Overall Study|Protocol Violation|2|||
105755546|NCT02701192|364758207|FG000|Overall Study|Lost to Follow-up|4|||
105755547|NCT02862548|364758208|FG000|Randomized Phase (Up to Week 48)|Death|0|||
105755548|NCT02862548|364758209|FG001|Randomized Phase (Up to Week 48)|Death|1|||
105755549|NCT02862548|364758208|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
105755550|NCT02862548|364758209|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
105755551|NCT02862548|364758208|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
105755552|NCT02862548|364758209|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
105568216|NCT03485911|364079267|FG000|Part 2|Lab abnormalities/AEs|1|||
105755553|NCT02862548|364758208|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
105755554|NCT02862548|364758209|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
105483609|NCT00045942|363782716|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
105483610|NCT00045942|363782717|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
105755555|NCT00880763|364758210|FG000|Extension Period (Part 2)|Adverse Event|0|||
105755556|NCT00880763|364758211|FG001|Extension Period (Part 2)|Adverse Event|0|||
105755557|NCT00880763|364758212|FG002|Extension Period (Part 2)|Adverse Event|1|||
105755558|NCT00880763|364758213|FG003|Extension Period (Part 2)|Adverse Event|1|||
105755559|NCT00880763|364758210|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
105755560|NCT00880763|364758211|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
105755561|NCT00880763|364758212|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
105755562|NCT00880763|364758213|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
105755563|NCT00880763|364758210|FG000|Extension Period (Part 2)|Physician Decision|0|||
105755564|NCT00880763|364758211|FG001|Extension Period (Part 2)|Physician Decision|1|||
105755565|NCT00880763|364758212|FG002|Extension Period (Part 2)|Physician Decision|1|||
105755566|NCT00880763|364758213|FG003|Extension Period (Part 2)|Physician Decision|0|||
105755567|NCT00880763|364758210|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
105755568|NCT00880763|364758211|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
105755569|NCT00880763|364758212|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
105755570|NCT00880763|364758213|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
105755571|NCT02667457|364758215|FG000|Overall Study|Withdrawal by Subject|1|||
105755572|NCT02667457|364758216|FG001|Overall Study|Withdrawal by Subject|0|||
105755573|NCT02667457|364758215|FG000|Overall Study|Other Reason|0|||
105483611|NCT00045942|363782718|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
105483612|NCT00045942|363782719|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
105483613|NCT00045942|363782720|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
105483614|NCT00045942|363782712|FG000|PKC412A2104E2|Lost to Follow-up|0|||
105483615|NCT00045942|363782713|FG001|PKC412A2104E2|Lost to Follow-up|0|||
105483616|NCT00045942|363782714|FG002|PKC412A2104E2|Lost to Follow-up|0|||
105483617|NCT00045942|363782715|FG003|PKC412A2104E2|Lost to Follow-up|0|||
105483618|NCT00045942|363782716|FG004|PKC412A2104E2|Lost to Follow-up|0|||
105483619|NCT00045942|363782717|FG005|PKC412A2104E2|Lost to Follow-up|0|||
105483620|NCT00045942|363782718|FG006|PKC412A2104E2|Lost to Follow-up|0|||
105483621|NCT00045942|363782719|FG007|PKC412A2104E2|Lost to Follow-up|3|||
105483622|NCT00045942|363782720|FG008|PKC412A2104E2|Lost to Follow-up|0|||
105483623|NCT00045942|363782712|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
105483624|NCT00045942|363782713|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
105483625|NCT00045942|363782714|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
105483626|NCT00045942|363782715|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
105483627|NCT00045942|363782716|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
105483628|NCT00045942|363782717|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
105483629|NCT00045942|363782718|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
105483630|NCT00045942|363782719|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
105483631|NCT00045942|363782720|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
105483632|NCT00045942|363782712|FG000|PKC412A2104E2|Lack of Efficacy|0|||
105483633|NCT00045942|363782713|FG001|PKC412A2104E2|Lack of Efficacy|0|||
105483634|NCT00045942|363782714|FG002|PKC412A2104E2|Lack of Efficacy|0|||
105483635|NCT00045942|363782715|FG003|PKC412A2104E2|Lack of Efficacy|0|||
105483636|NCT00045942|363782716|FG004|PKC412A2104E2|Lack of Efficacy|0|||
105483637|NCT00045942|363782717|FG005|PKC412A2104E2|Lack of Efficacy|3|||
105483638|NCT00045942|363782718|FG006|PKC412A2104E2|Lack of Efficacy|2|||
105483639|NCT00045942|363782719|FG007|PKC412A2104E2|Lack of Efficacy|2|||
105483640|NCT00045942|363782720|FG008|PKC412A2104E2|Lack of Efficacy|6|||
105483641|NCT00045942|363782712|FG000|PKC412A2104E2|Adverse Event|0|||
105483642|NCT00045942|363782713|FG001|PKC412A2104E2|Adverse Event|0|||
105483643|NCT00045942|363782714|FG002|PKC412A2104E2|Adverse Event|0|||
105483644|NCT00045942|363782715|FG003|PKC412A2104E2|Adverse Event|0|||
105483645|NCT00045942|363782716|FG004|PKC412A2104E2|Adverse Event|0|||
105483646|NCT00045942|363782717|FG005|PKC412A2104E2|Adverse Event|4|||
105483647|NCT00045942|363782718|FG006|PKC412A2104E2|Adverse Event|3|||
105483648|NCT00045942|363782719|FG007|PKC412A2104E2|Adverse Event|1|||
105483649|NCT00045942|363782720|FG008|PKC412A2104E2|Adverse Event|0|||
105483650|NCT00045942|363782712|FG000|PKC412A2104E2|Death|0|||
105483651|NCT00045942|363782713|FG001|PKC412A2104E2|Death|0|||
105483652|NCT00045942|363782714|FG002|PKC412A2104E2|Death|0|||
105483653|NCT00045942|363782715|FG003|PKC412A2104E2|Death|0|||
105483654|NCT00045942|363782716|FG004|PKC412A2104E2|Death|0|||
105483655|NCT00045942|363782717|FG005|PKC412A2104E2|Death|1|||
105483656|NCT00045942|363782718|FG006|PKC412A2104E2|Death|2|||
105483657|NCT00045942|363782719|FG007|PKC412A2104E2|Death|0|||
105483658|NCT00045942|363782720|FG008|PKC412A2104E2|Death|0|||
105483659|NCT00686634|363782723|FG000|Overall Study|Protocol Violation|6|||
105483660|NCT00924781|363782729|FG000|Overall Study|Study terminated by sponsor|12|||
105483661|NCT00924781|363782730|FG001|Overall Study|Study terminated by sponsor|10|||
105483662|NCT02296138|363782731|FG000|Overall Study|Adverse Event|348|||
105483663|NCT02296138|363782732|FG001|Overall Study|Adverse Event|259|||
105483664|NCT02296138|363782731|FG000|Overall Study|Lack of Efficacy|59|||
105568217|NCT03485911|364079268|FG001|Part 2|Lab abnormalities/AEs|2|||
105568218|NCT03485911|364079269|FG002|Part 2|Lab abnormalities/AEs|0|||
105568219|NCT03485911|364079270|FG003|Part 2|Lab abnormalities/AEs|0|||
105568220|NCT03485911|364079267|FG000|Part 2|Other NOS|0|||
105802664|NCT00078819|364934520|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
105802665|NCT00078819|364934517|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
105568221|NCT03485911|364079268|FG001|Part 2|Other NOS|1|||
105568222|NCT03485911|364079269|FG002|Part 2|Other NOS|0|||
105568223|NCT03485911|364079270|FG003|Part 2|Other NOS|0|||
105568224|NCT03485911|364079267|FG000|Part 2|Intercurrent illness/new medical condition|1|||
105568225|NCT03485911|364079268|FG001|Part 2|Intercurrent illness/new medical condition|0|||
105568226|NCT03485911|364079269|FG002|Part 2|Intercurrent illness/new medical condition|0|||
105568227|NCT03485911|364079270|FG003|Part 2|Intercurrent illness/new medical condition|0|||
105568228|NCT03485911|364079267|FG000|Part 2|Investigator judgement|1|||
105568229|NCT03485911|364079268|FG001|Part 2|Investigator judgement|0|||
105568230|NCT03485911|364079269|FG002|Part 2|Investigator judgement|0|||
105568231|NCT03485911|364079270|FG003|Part 2|Investigator judgement|0|||
105568232|NCT03485911|364079267|FG000|Part 3|Perceived lack of efficacy|2|||
105568233|NCT03485911|364079268|FG001|Part 3|Perceived lack of efficacy|2|||
105568234|NCT03485911|364079269|FG002|Part 3|Perceived lack of efficacy|2|||
105568235|NCT03485911|364079270|FG003|Part 3|Perceived lack of efficacy|0|||
105568236|NCT03485911|364079267|FG000|Part 3|Subject withdrew consent|1|||
105568237|NCT03485911|364079268|FG001|Part 3|Subject withdrew consent|4|||
105568238|NCT03485911|364079269|FG002|Part 3|Subject withdrew consent|0|||
105568239|NCT03485911|364079270|FG003|Part 3|Subject withdrew consent|1|||
105568240|NCT03485911|364079267|FG000|Part 3|Lab abnormalities/AEs|1|||
105568241|NCT03485911|364079268|FG001|Part 3|Lab abnormalities/AEs|1|||
105568242|NCT03485911|364079269|FG002|Part 3|Lab abnormalities/AEs|0|||
105568243|NCT03485911|364079270|FG003|Part 3|Lab abnormalities/AEs|2|||
105568244|NCT03485911|364079267|FG000|Part 3|Other NOS|1|||
105568245|NCT03485911|364079268|FG001|Part 3|Other NOS|1|||
105568246|NCT03485911|364079269|FG002|Part 3|Other NOS|0|||
105568247|NCT03485911|364079270|FG003|Part 3|Other NOS|0|||
105568248|NCT03485911|364079267|FG000|Part 3|Intercurrent illness/new medical condition|0|||
105568249|NCT03485911|364079268|FG001|Part 3|Intercurrent illness/new medical condition|1|||
105568250|NCT03485911|364079269|FG002|Part 3|Intercurrent illness/new medical condition|1|||
105568251|NCT03485911|364079270|FG003|Part 3|Intercurrent illness/new medical condition|0|||
105568252|NCT03485911|364079267|FG000|Part 3|Sponsor discontinuation|1|||
105568253|NCT03485911|364079268|FG001|Part 3|Sponsor discontinuation|0|||
105568254|NCT03485911|364079269|FG002|Part 3|Sponsor discontinuation|0|||
105802666|NCT00078819|364934518|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
105802667|NCT00078819|364934519|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
105802668|NCT00078819|364934520|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
105802669|NCT00078819|364934517|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
105802670|NCT00078819|364934518|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
105802671|NCT00078819|364934519|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
105802672|NCT00078819|364934520|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
105802673|NCT00078819|364934517|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
105802674|NCT00078819|364934518|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
105802675|NCT00078819|364934519|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
105802676|NCT00078819|364934520|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
105802677|NCT00078819|364934517|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
105802678|NCT00078819|364934518|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
105802679|NCT00078819|364934519|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
105568255|NCT03485911|364079270|FG003|Part 3|Sponsor discontinuation|0|||
105568256|NCT03485911|364079267|FG000|Part 3|Berotralstat provided by alternative means|13|||
105568257|NCT03485911|364079268|FG001|Part 3|Berotralstat provided by alternative means|13|||
105568258|NCT03485911|364079269|FG002|Part 3|Berotralstat provided by alternative means|7|||
105568259|NCT03485911|364079270|FG003|Part 3|Berotralstat provided by alternative means|7|||
105568260|NCT01375205|364079271|FG000|Overall Study|Lost to Follow-up|15|||
105568261|NCT01375205|364079272|FG001|Overall Study|Lost to Follow-up|12|||
105568262|NCT01375205|364079271|FG000|Overall Study|Withdrawal by Subject|6|||
105568263|NCT01375205|364079272|FG001|Overall Study|Withdrawal by Subject|1|||
105568264|NCT01674621|364079273|FG000|Overall Study|Adverse Event|3|||
105568265|NCT01674621|364079274|FG001|Overall Study|Adverse Event|2|||
105568266|NCT01674621|364079275|FG002|Overall Study|Adverse Event|5|||
105568267|NCT01674621|364079276|FG003|Overall Study|Adverse Event|5|||
105568268|NCT01674621|364079277|FG004|Overall Study|Adverse Event|1|||
105568269|NCT01674621|364079273|FG000|Overall Study|Inability to Complete Study Procedures|0|||
105568270|NCT01674621|364079274|FG001|Overall Study|Inability to Complete Study Procedures|0|||
105568271|NCT01674621|364079275|FG002|Overall Study|Inability to Complete Study Procedures|0|||
105568272|NCT01674621|364079276|FG003|Overall Study|Inability to Complete Study Procedures|0|||
105568273|NCT01674621|364079277|FG004|Overall Study|Inability to Complete Study Procedures|2|||
105568274|NCT01674621|364079273|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
105568275|NCT01674621|364079274|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
105568276|NCT01674621|364079275|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
105568277|NCT01674621|364079276|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
105568278|NCT01674621|364079277|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
105568279|NCT01674621|364079273|FG000|Overall Study|Withdrawal by Subject|2|||
105568280|NCT01674621|364079274|FG001|Overall Study|Withdrawal by Subject|5|||
105568281|NCT01674621|364079275|FG002|Overall Study|Withdrawal by Subject|2|||
105568282|NCT01674621|364079276|FG003|Overall Study|Withdrawal by Subject|0|||
105568283|NCT01674621|364079277|FG004|Overall Study|Withdrawal by Subject|1|||
105568284|NCT01674621|364079273|FG000|Overall Study|Other than specified|0|||
105568285|NCT01674621|364079274|FG001|Overall Study|Other than specified|1|||
105568286|NCT01674621|364079275|FG002|Overall Study|Other than specified|0|||
105568287|NCT01674621|364079276|FG003|Overall Study|Other than specified|0|||
105568288|NCT01674621|364079277|FG004|Overall Study|Other than specified|2|||
105568289|NCT01859793|364079280|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
105568290|NCT01859793|364079281|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
105568291|NCT01859793|364079280|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
105568292|NCT01859793|364079281|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
105568293|NCT01859793|364079280|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
105568294|NCT01859793|364079281|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
105568295|NCT01859793|364079280|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
105568296|NCT01859793|364079281|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
105568297|NCT01735396|364079282|FG000|Overall Study|not evaluable|1|||
105568298|NCT01148862|364079283|FG000|Second Intervention|Withdrawal by Subject|0|||
105568299|NCT01148862|364079284|FG001|Second Intervention|Withdrawal by Subject|2|||
105568300|NCT00744263|364079287|FG000|Overall Study|Death|3006|||
105568301|NCT00744263|364079288|FG001|Overall Study|Death|3005|||
105568302|NCT00744263|364079287|FG000|Overall Study|Lost to Follow-up|2038|||
105568303|NCT00744263|364079288|FG001|Overall Study|Lost to Follow-up|2135|||
105568304|NCT00744263|364079287|FG000|Overall Study|Withdrawal by Subject|166|||
105568305|NCT00744263|364079288|FG001|Overall Study|Withdrawal by Subject|150|||
105568306|NCT00744263|364079287|FG000|Overall Study|Physician Decision|20|||
105568307|NCT00744263|364079288|FG001|Overall Study|Physician Decision|23|||
105568308|NCT00744263|364079287|FG000|Overall Study|Protocol Violation|3|||
105568309|NCT00744263|364079288|FG001|Overall Study|Protocol Violation|5|||
105568310|NCT00744263|364079287|FG000|Overall Study|Adverse Event|1|||
105568311|NCT00744263|364079288|FG001|Overall Study|Adverse Event|0|||
105568312|NCT00744263|364079287|FG000|Overall Study|Other|2|||
105568313|NCT00744263|364079288|FG001|Overall Study|Other|2|||
105568314|NCT05004688|364079299|FG000|Overall Study|Protocol Violation|7|||
105568315|NCT05004688|364079299|FG000|Overall Study|Physician Decision|2|||
105568316|NCT05004688|364079299|FG000|Overall Study|Withdrawal by Subject|2|||
105568317|NCT00895622|364079300|FG000|Overall Study|Protocol Violation|5|||
105568318|NCT00895622|364079301|FG001|Overall Study|Protocol Violation|4|||
105568319|NCT00895622|364079302|FG002|Overall Study|Protocol Violation|4|||
105568320|NCT03724396|364079303|FG000|Overall Study|Lost to Follow-up|1|||
105568321|NCT03724396|364079304|FG001|Overall Study|Lost to Follow-up|1|||
105568322|NCT03724396|364079303|FG000|Overall Study|Withdrawal by Subject|1|||
105568323|NCT03724396|364079304|FG001|Overall Study|Withdrawal by Subject|0|||
105568324|NCT03879408|364079305|FG000|Overall Study|Lost to Follow-up|0|||
105568325|NCT03879408|364079306|FG001|Overall Study|Lost to Follow-up|3|||
105568326|NCT03879408|364079307|FG002|Overall Study|Lost to Follow-up|2|||
105568327|NCT03879408|364079308|FG003|Overall Study|Lost to Follow-up|1|||
105568328|NCT03879408|364079309|FG004|Overall Study|Lost to Follow-up|0|||
105568329|NCT03879408|364079305|FG000|Overall Study|Withdrawal by Subject|2|||
105568330|NCT03879408|364079306|FG001|Overall Study|Withdrawal by Subject|1|||
105568331|NCT03879408|364079307|FG002|Overall Study|Withdrawal by Subject|1|||
105568332|NCT03879408|364079308|FG003|Overall Study|Withdrawal by Subject|0|||
105568333|NCT03879408|364079309|FG004|Overall Study|Withdrawal by Subject|1|||
105568334|NCT01490125|364079310|FG000|Period I|Adverse Event|4|||
105568335|NCT01490125|364079311|FG001|Period I|Adverse Event|1|||
105568336|NCT01490125|364079312|FG002|Period I|Adverse Event|1|||
105568337|NCT01490125|364079313|FG003|Period I|Adverse Event|3|||
105360500|NCT00792909|363325967|FG000|Overall Study|Withdrawal by Subject|0|||
105568338|NCT01490125|364079314|FG004|Period I|Adverse Event|2|||
105568339|NCT01490125|364079315|FG005|Period I|Adverse Event|4|||
105568340|NCT01490125|364079310|FG000|Period I|Protocol Violation|1|||
105568341|NCT01490125|364079311|FG001|Period I|Protocol Violation|1|||
105568342|NCT01490125|364079312|FG002|Period I|Protocol Violation|1|||
105568343|NCT01490125|364079313|FG003|Period I|Protocol Violation|1|||
105568344|NCT01490125|364079314|FG004|Period I|Protocol Violation|0|||
105568345|NCT01490125|364079315|FG005|Period I|Protocol Violation|0|||
105568346|NCT01490125|364079310|FG000|Period I|Withdrawal by Subject|1|||
105568347|NCT01490125|364079311|FG001|Period I|Withdrawal by Subject|3|||
105360501|NCT00792909|363325968|FG001|Overall Study|Withdrawal by Subject|1|||
105568348|NCT01490125|364079312|FG002|Period I|Withdrawal by Subject|2|||
105568349|NCT01490125|364079313|FG003|Period I|Withdrawal by Subject|1|||
105568350|NCT01490125|364079314|FG004|Period I|Withdrawal by Subject|2|||
105568351|NCT01490125|364079315|FG005|Period I|Withdrawal by Subject|1|||
105568352|NCT01490125|364079310|FG000|Period II|Adverse Event|2|||
105568353|NCT01490125|364079311|FG001|Period II|Adverse Event|3|||
105568354|NCT01490125|364079312|FG002|Period II|Adverse Event|2|||
105568355|NCT01490125|364079313|FG003|Period II|Adverse Event|2|||
105568356|NCT01490125|364079314|FG004|Period II|Adverse Event|4|||
105568357|NCT01490125|364079315|FG005|Period II|Adverse Event|2|||
105568358|NCT01490125|364079310|FG000|Period II|Protocol Violation|0|||
105568359|NCT01490125|364079311|FG001|Period II|Protocol Violation|0|||
105568360|NCT01490125|364079312|FG002|Period II|Protocol Violation|1|||
105568361|NCT01490125|364079313|FG003|Period II|Protocol Violation|1|||
105568362|NCT01490125|364079314|FG004|Period II|Protocol Violation|0|||
105568363|NCT01490125|364079315|FG005|Period II|Protocol Violation|0|||
105568364|NCT01490125|364079310|FG000|Period II|Lost to Follow-up|0|||
105568365|NCT01490125|364079311|FG001|Period II|Lost to Follow-up|1|||
105568366|NCT01490125|364079312|FG002|Period II|Lost to Follow-up|0|||
105568367|NCT01490125|364079313|FG003|Period II|Lost to Follow-up|0|||
105568368|NCT01490125|364079314|FG004|Period II|Lost to Follow-up|0|||
105568369|NCT01490125|364079315|FG005|Period II|Lost to Follow-up|0|||
105568370|NCT01490125|364079310|FG000|Period II|Withdrawal by Subject|1|||
105568371|NCT01490125|364079311|FG001|Period II|Withdrawal by Subject|0|||
105568372|NCT01490125|364079312|FG002|Period II|Withdrawal by Subject|0|||
105568373|NCT01490125|364079313|FG003|Period II|Withdrawal by Subject|0|||
105568374|NCT01490125|364079314|FG004|Period II|Withdrawal by Subject|0|||
105568375|NCT01490125|364079315|FG005|Period II|Withdrawal by Subject|0|||
105568376|NCT01490125|364079310|FG000|Period III|Adverse Event|3|||
105568377|NCT01490125|364079311|FG001|Period III|Adverse Event|1|||
105568378|NCT01490125|364079312|FG002|Period III|Adverse Event|0|||
105568379|NCT01490125|364079313|FG003|Period III|Adverse Event|1|||
105568380|NCT01490125|364079314|FG004|Period III|Adverse Event|0|||
105568381|NCT01490125|364079315|FG005|Period III|Adverse Event|0|||
105568382|NCT01490125|364079310|FG000|Period III|Death|0|||
105568383|NCT01490125|364079311|FG001|Period III|Death|0|||
105568384|NCT01490125|364079312|FG002|Period III|Death|0|||
105568385|NCT01490125|364079313|FG003|Period III|Death|1|||
105568386|NCT01490125|364079314|FG004|Period III|Death|0|||
105360502|NCT00792909|363325969|FG002|Overall Study|Withdrawal by Subject|0|||
105755574|NCT02667457|364758216|FG001|Overall Study|Other Reason|2|||
105755575|NCT02475850|364758217|FG000|Overall Study|Death|155|||
105755576|NCT02475850|364758218|FG001|Overall Study|Death|141|||
105755577|NCT02475850|364758217|FG000|Overall Study|Lost to Follow-up|217|||
105755578|NCT02475850|364758218|FG001|Overall Study|Lost to Follow-up|188|||
105755579|NCT02475850|364758217|FG000|Overall Study|Withdrawal by Subject|221|||
105755580|NCT02475850|364758218|FG001|Overall Study|Withdrawal by Subject|155|||
105755581|NCT01253187|364758221|FG000|Period 2|Withdrawal by Subject|0|||
105755582|NCT01253187|364758222|FG001|Period 2|Withdrawal by Subject|0|||
105755583|NCT01253187|364758223|FG002|Period 2|Withdrawal by Subject|0|||
105755584|NCT01253187|364758224|FG003|Period 2|Withdrawal by Subject|0|||
105755585|NCT01253187|364758225|FG004|Period 2|Withdrawal by Subject|1|||
105755586|NCT01253187|364758226|FG005|Period 2|Withdrawal by Subject|0|||
105755587|NCT01253187|364758221|FG000|Period 3|Pregnancy|1|||
105755588|NCT01253187|364758222|FG001|Period 3|Pregnancy|0|||
105755589|NCT01253187|364758223|FG002|Period 3|Pregnancy|0|||
105755590|NCT01253187|364758224|FG003|Period 3|Pregnancy|0|||
105755591|NCT01253187|364758225|FG004|Period 3|Pregnancy|0|||
105755592|NCT01253187|364758226|FG005|Period 3|Pregnancy|0|||
105755593|NCT01253187|364758221|FG000|Period 3|difficulty with blood sampling|0|||
105755594|NCT01253187|364758222|FG001|Period 3|difficulty with blood sampling|1|||
105755595|NCT01253187|364758223|FG002|Period 3|difficulty with blood sampling|0|||
105755596|NCT01253187|364758224|FG003|Period 3|difficulty with blood sampling|0|||
105755597|NCT01253187|364758225|FG004|Period 3|difficulty with blood sampling|0|||
105755598|NCT01253187|364758226|FG005|Period 3|difficulty with blood sampling|0|||
105755599|NCT01253187|364758221|FG000|Period 3|non-compliance|0|||
105755600|NCT01253187|364758222|FG001|Period 3|non-compliance|0|||
105568387|NCT01490125|364079315|FG005|Period III|Death|0|||
105755601|NCT01253187|364758223|FG002|Period 3|non-compliance|0|||
105568388|NCT01490125|364079310|FG000|Period III|Lack of Efficacy|0|||
105568389|NCT01490125|364079311|FG001|Period III|Lack of Efficacy|0|||
105568390|NCT01490125|364079312|FG002|Period III|Lack of Efficacy|0|||
105568391|NCT01490125|364079313|FG003|Period III|Lack of Efficacy|0|||
105568392|NCT01490125|364079314|FG004|Period III|Lack of Efficacy|1|||
105755602|NCT01253187|364758224|FG003|Period 3|non-compliance|0|||
105755603|NCT01253187|364758225|FG004|Period 3|non-compliance|1|||
105568393|NCT01490125|364079315|FG005|Period III|Lack of Efficacy|0|||
105568394|NCT02237508|364079317|FG000|Overall Study|Withdrawal by Subject|0|||
105568395|NCT02237508|364079318|FG001|Overall Study|Withdrawal by Subject|2|||
105568396|NCT02237508|364079319|FG002|Overall Study|Withdrawal by Subject|0|||
105568397|NCT02237508|364079320|FG003|Overall Study|Withdrawal by Subject|1|||
105755604|NCT01253187|364758226|FG005|Period 3|non-compliance|0|||
105755605|NCT02759562|364758229|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
105568398|NCT02237508|364079321|FG004|Overall Study|Withdrawal by Subject|0|||
105755606|NCT02759562|364758230|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
105755607|NCT02759562|364758229|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
105755608|NCT02759562|364758230|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
105755609|NCT00505752|364758234|FG000|Overall Study|Adverse Event|1|||
105755610|NCT00505752|364758235|FG001|Overall Study|Adverse Event|0|||
105755611|NCT00505752|364758236|FG002|Overall Study|Adverse Event|1|||
105755612|NCT00505752|364758237|FG003|Overall Study|Adverse Event|0|||
105755613|NCT00505752|364758234|FG000|Overall Study|Lost to Follow-up|1|||
105755614|NCT00505752|364758235|FG001|Overall Study|Lost to Follow-up|0|||
105755615|NCT00505752|364758236|FG002|Overall Study|Lost to Follow-up|0|||
105755616|NCT00505752|364758237|FG003|Overall Study|Lost to Follow-up|0|||
105755617|NCT00505752|364758234|FG000|Overall Study|Lack of ovarian response|1|||
105755618|NCT00505752|364758235|FG001|Overall Study|Lack of ovarian response|3|||
105755619|NCT00505752|364758236|FG002|Overall Study|Lack of ovarian response|0|||
105755620|NCT00505752|364758237|FG003|Overall Study|Lack of ovarian response|0|||
105755621|NCT00505752|364758234|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
105755622|NCT00505752|364758235|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
105755623|NCT00505752|364758236|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
105755624|NCT00505752|364758237|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
105755625|NCT00505752|364758234|FG000|Overall Study|No oocytes retrieved|0|||
105755626|NCT00505752|364758235|FG001|Overall Study|No oocytes retrieved|2|||
105755627|NCT00505752|364758236|FG002|Overall Study|No oocytes retrieved|0|||
105755628|NCT00505752|364758237|FG003|Overall Study|No oocytes retrieved|1|||
105755629|NCT00505752|364758234|FG000|Overall Study|No Fertilization|1|||
105755630|NCT00505752|364758235|FG001|Overall Study|No Fertilization|1|||
105755631|NCT00505752|364758236|FG002|Overall Study|No Fertilization|2|||
105755632|NCT00505752|364758237|FG003|Overall Study|No Fertilization|1|||
105755633|NCT00505752|364758234|FG000|Overall Study|All embryos/blastocysts discarded|0|||
105755634|NCT00505752|364758235|FG001|Overall Study|All embryos/blastocysts discarded|0|||
105755635|NCT00505752|364758236|FG002|Overall Study|All embryos/blastocysts discarded|1|||
105755636|NCT00505752|364758237|FG003|Overall Study|All embryos/blastocysts discarded|1|||
105755637|NCT00505752|364758234|FG000|Overall Study|Other|1|||
105755638|NCT00505752|364758235|FG001|Overall Study|Other|2|||
105755639|NCT00505752|364758236|FG002|Overall Study|Other|1|||
105755640|NCT00505752|364758237|FG003|Overall Study|Other|2|||
105755641|NCT03024255|364758240|FG000|Overall Study|Adverse Event|1|||
105755642|NCT03024255|364758241|FG001|Overall Study|Adverse Event|4|||
105755643|NCT03024255|364758242|FG002|Overall Study|Adverse Event|8|||
105755644|NCT03024255|364758243|FG003|Overall Study|Adverse Event|0|||
105755645|NCT03024255|364758240|FG000|Overall Study|Withdrawal by Subject|3|||
105755646|NCT03024255|364758241|FG001|Overall Study|Withdrawal by Subject|1|||
105755647|NCT03024255|364758242|FG002|Overall Study|Withdrawal by Subject|0|||
105755648|NCT03024255|364758243|FG003|Overall Study|Withdrawal by Subject|3|||
105755649|NCT03024255|364758240|FG000|Overall Study|Protocol Violation|0|||
105755650|NCT03024255|364758241|FG001|Overall Study|Protocol Violation|0|||
105755651|NCT03024255|364758242|FG002|Overall Study|Protocol Violation|2|||
105755652|NCT03024255|364758243|FG003|Overall Study|Protocol Violation|0|||
105755653|NCT03024255|364758240|FG000|Overall Study|Lost to Follow-up|1|||
105755654|NCT03024255|364758241|FG001|Overall Study|Lost to Follow-up|2|||
105755655|NCT03024255|364758242|FG002|Overall Study|Lost to Follow-up|1|||
105755656|NCT03024255|364758243|FG003|Overall Study|Lost to Follow-up|1|||
105755657|NCT03024255|364758240|FG000|Overall Study|Lack of Efficacy|1|||
105755658|NCT03024255|364758241|FG001|Overall Study|Lack of Efficacy|0|||
105755659|NCT03024255|364758242|FG002|Overall Study|Lack of Efficacy|0|||
105755660|NCT03024255|364758243|FG003|Overall Study|Lack of Efficacy|0|||
105755661|NCT03024255|364758240|FG000|Overall Study|Protocol Noncompliance|1|||
105755662|NCT03024255|364758241|FG001|Overall Study|Protocol Noncompliance|1|||
105755663|NCT03024255|364758242|FG002|Overall Study|Protocol Noncompliance|0|||
105568399|NCT02237508|364079322|FG005|Overall Study|Withdrawal by Subject|1|||
105755664|NCT03024255|364758243|FG003|Overall Study|Protocol Noncompliance|1|||
105755665|NCT03625141|364758244|FG000|Overall Study|Adverse Event|0|||
105568400|NCT02237508|364079323|FG006|Overall Study|Withdrawal by Subject|1|||
105755666|NCT03625141|364758245|FG001|Overall Study|Adverse Event|2|||
105755667|NCT03625141|364758244|FG000|Overall Study|Study Terminated By Sponsor|1|||
105755668|NCT03625141|364758245|FG001|Overall Study|Study Terminated By Sponsor|13|||
105755669|NCT03625141|364758244|FG000|Overall Study|Withdrawal by Subject|3|||
105755670|NCT03625141|364758245|FG001|Overall Study|Withdrawal by Subject|0|||
105755671|NCT03625141|364758244|FG000|Overall Study|Withdrawal Of Consent|0|||
105755672|NCT03625141|364758245|FG001|Overall Study|Withdrawal Of Consent|1|||
105755673|NCT03625141|364758244|FG000|Overall Study|Death|11|||
105755674|NCT03625141|364758245|FG001|Overall Study|Death|47|||
105755675|NCT03625141|364758244|FG000|Overall Study|Progressive Disease|0|||
105755676|NCT03625141|364758245|FG001|Overall Study|Progressive Disease|2|||
105755677|NCT00433446|364758252|FG000|Overall Study|Adverse Event|4|||
105568401|NCT02237508|364079324|FG007|Overall Study|Withdrawal by Subject|0|||
105568402|NCT02237508|364079325|FG008|Overall Study|Withdrawal by Subject|1|||
105568403|NCT02237508|364079326|FG009|Overall Study|Withdrawal by Subject|0|||
105568404|NCT02237508|364079317|FG000|Overall Study|Physician Decision|0|||
105568405|NCT02237508|364079318|FG001|Overall Study|Physician Decision|1|||
105568406|NCT02237508|364079319|FG002|Overall Study|Physician Decision|0|||
105568407|NCT02237508|364079320|FG003|Overall Study|Physician Decision|0|||
105568408|NCT02237508|364079321|FG004|Overall Study|Physician Decision|0|||
105568409|NCT02237508|364079322|FG005|Overall Study|Physician Decision|0|||
105568410|NCT02237508|364079323|FG006|Overall Study|Physician Decision|0|||
105802680|NCT00078819|364934520|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
105568411|NCT02237508|364079324|FG007|Overall Study|Physician Decision|0|||
105568412|NCT02237508|364079325|FG008|Overall Study|Physician Decision|0|||
105568413|NCT02237508|364079326|FG009|Overall Study|Physician Decision|0|||
105568414|NCT02237508|364079317|FG000|Overall Study|Protocol Violation|0|||
105568415|NCT02237508|364079318|FG001|Overall Study|Protocol Violation|0|||
105568416|NCT02237508|364079319|FG002|Overall Study|Protocol Violation|1|||
105568417|NCT02237508|364079320|FG003|Overall Study|Protocol Violation|0|||
105568418|NCT02237508|364079321|FG004|Overall Study|Protocol Violation|0|||
105568419|NCT02237508|364079322|FG005|Overall Study|Protocol Violation|0|||
105568420|NCT02237508|364079323|FG006|Overall Study|Protocol Violation|0|||
105568421|NCT02237508|364079324|FG007|Overall Study|Protocol Violation|0|||
105568422|NCT02237508|364079325|FG008|Overall Study|Protocol Violation|0|||
105568423|NCT02237508|364079326|FG009|Overall Study|Protocol Violation|0|||
105568424|NCT02277743|364079331|FG000|Overall Study|Protocol Violation|1|||
105568425|NCT02277743|364079332|FG001|Overall Study|Protocol Violation|1|||
105568426|NCT02277743|364079333|FG002|Overall Study|Protocol Violation|1|||
105568427|NCT02277743|364079331|FG000|Overall Study|Adverse Event|10|||
105568428|NCT02277743|364079332|FG001|Overall Study|Adverse Event|6|||
105568429|NCT02277743|364079333|FG002|Overall Study|Adverse Event|6|||
105568430|NCT02277743|364079331|FG000|Overall Study|Lack of Efficacy|11|||
105568431|NCT02277743|364079332|FG001|Overall Study|Lack of Efficacy|4|||
105568432|NCT02277743|364079333|FG002|Overall Study|Lack of Efficacy|3|||
105568433|NCT02277743|364079331|FG000|Overall Study|Other than specified above|18|||
105568434|NCT02277743|364079332|FG001|Overall Study|Other than specified above|5|||
105568435|NCT02277743|364079333|FG002|Overall Study|Other than specified above|16|||
105568436|NCT01224158|364079334|FG000|Overall Study|Withdrawal by Subject|1|||
105568437|NCT01224158|364079335|FG001|Overall Study|Withdrawal by Subject|0|||
105568438|NCT03976466|364079338|FG000|Overall Study|Lost to Follow-up|1|||
105568439|NCT03976466|364079339|FG001|Overall Study|Lost to Follow-up|3|||
105568440|NCT02055157|364079340|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
105568441|NCT02055157|364079341|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
105568442|NCT02055157|364079342|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
105568443|NCT02055157|364079343|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
105568444|NCT02055157|364079340|FG000|Initial 6 Months|Adverse Event|0|||
105568445|NCT02055157|364079341|FG001|Initial 6 Months|Adverse Event|0|||
105568446|NCT02055157|364079342|FG002|Initial 6 Months|Adverse Event|0|||
105568447|NCT02055157|364079343|FG003|Initial 6 Months|Adverse Event|1|||
105568448|NCT02055157|364079340|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
105568449|NCT02055157|364079341|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
105568450|NCT02055157|364079342|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
105568451|NCT02055157|364079343|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
105568452|NCT02055157|364079340|FG000|18-month Extension|Investigator decision|0|||
105568453|NCT02055157|364079341|FG001|18-month Extension|Investigator decision|1|||
105568454|NCT02055157|364079342|FG002|18-month Extension|Investigator decision|0|||
105568455|NCT02055157|364079343|FG003|18-month Extension|Investigator decision|0|||
105568456|NCT02055157|364079340|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
105568457|NCT02055157|364079341|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
105568458|NCT02055157|364079342|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
105568459|NCT02055157|364079343|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
105568460|NCT01931735|364079344|FG000|Randomized Phase|Lost to Follow-up|2|||
105802681|NCT00078819|364934517|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
105802682|NCT00078819|364934518|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
105802683|NCT00078819|364934519|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
105802684|NCT00078819|364934520|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
105802685|NCT00619619|364934521|FG000|Overall Study|Physician Decision|0|||
105802686|NCT00619619|364934522|FG001|Overall Study|Physician Decision|0|||
105802687|NCT00619619|364934523|FG002|Overall Study|Physician Decision|1|||
105802688|NCT00619619|364934524|FG003|Overall Study|Physician Decision|0|||
105568461|NCT01931735|364079345|FG001|Randomized Phase|Lost to Follow-up|2|||
105568462|NCT01931735|364079346|FG002|Randomized Phase|Lost to Follow-up|5|||
105568463|NCT01931735|364079347|FG003|Randomized Phase|Lost to Follow-up|0|||
105568464|NCT01931735|364079344|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
105568465|NCT01931735|364079345|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
105568466|NCT01931735|364079346|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
105802689|NCT00619619|364934525|FG004|Overall Study|Physician Decision|0|||
105802690|NCT00619619|364934526|FG005|Overall Study|Physician Decision|0|||
105802691|NCT00619619|364934527|FG006|Overall Study|Physician Decision|0|||
105802692|NCT00619619|364934528|FG007|Overall Study|Physician Decision|0|||
105802693|NCT00619619|364934521|FG000|Overall Study|Protocol Violation|0|||
105802694|NCT00619619|364934522|FG001|Overall Study|Protocol Violation|0|||
105802695|NCT00619619|364934523|FG002|Overall Study|Protocol Violation|0|||
105802696|NCT00619619|364934524|FG003|Overall Study|Protocol Violation|1|||
105802697|NCT00619619|364934525|FG004|Overall Study|Protocol Violation|0|||
105802698|NCT00619619|364934526|FG005|Overall Study|Protocol Violation|0|||
105802699|NCT00619619|364934527|FG006|Overall Study|Protocol Violation|1|||
105802700|NCT00619619|364934528|FG007|Overall Study|Protocol Violation|1|||
105802701|NCT00619619|364934521|FG000|Overall Study|Adverse Event|0|||
105802702|NCT00619619|364934522|FG001|Overall Study|Adverse Event|0|||
105802703|NCT00619619|364934523|FG002|Overall Study|Adverse Event|0|||
105802704|NCT00619619|364934524|FG003|Overall Study|Adverse Event|0|||
105802705|NCT00619619|364934525|FG004|Overall Study|Adverse Event|2|||
105802706|NCT00619619|364934526|FG005|Overall Study|Adverse Event|0|||
105802707|NCT00619619|364934527|FG006|Overall Study|Adverse Event|0|||
105802708|NCT00619619|364934528|FG007|Overall Study|Adverse Event|2|||
105802709|NCT01159769|364934529|FG000|Overall Study|Adverse Event|1|||
105802710|NCT00323609|364934530|FG000|Overall Study|Death|16|||
105802711|NCT00323609|364934531|FG001|Overall Study|Death|21|||
105802712|NCT00323609|364934532|FG002|Overall Study|Death|0|||
105802713|NCT00323609|364934533|FG003|Overall Study|Death|0|||
105802714|NCT00323609|364934530|FG000|Overall Study|Lost to Follow-up|9|||
105802715|NCT00323609|364934531|FG001|Overall Study|Lost to Follow-up|10|||
105802716|NCT00323609|364934532|FG002|Overall Study|Lost to Follow-up|0|||
105802717|NCT00323609|364934533|FG003|Overall Study|Lost to Follow-up|0|||
105802718|NCT00323609|364934530|FG000|Overall Study|Physician Decision|2|||
105802719|NCT00323609|364934531|FG001|Overall Study|Physician Decision|0|||
105568467|NCT01931735|364079347|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
105568468|NCT01931735|364079344|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
105568469|NCT01931735|364079345|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
105568470|NCT01931735|364079346|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
105568471|NCT01931735|364079347|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
105568472|NCT01395823|364079350|FG000|Overall Study|Death|4|||
105568473|NCT01395823|364079351|FG001|Overall Study|Death|4|||
105568474|NCT01395823|364079350|FG000|Overall Study|Physician Decision|3|||
105568475|NCT01395823|364079351|FG001|Overall Study|Physician Decision|1|||
105568476|NCT01395823|364079350|FG000|Overall Study|Lost to Follow-up|1|||
105568477|NCT01395823|364079351|FG001|Overall Study|Lost to Follow-up|0|||
105568478|NCT01395823|364079350|FG000|Overall Study|Transplant|1|||
105568479|NCT01395823|364079351|FG001|Overall Study|Transplant|0|||
105802720|NCT00323609|364934532|FG002|Overall Study|Physician Decision|0|||
105802721|NCT00323609|364934533|FG003|Overall Study|Physician Decision|1|||
105802722|NCT00323609|364934530|FG000|Overall Study|Withdrawal by Subject|11|||
105802723|NCT00323609|364934531|FG001|Overall Study|Withdrawal by Subject|23|||
105802724|NCT00323609|364934532|FG002|Overall Study|Withdrawal by Subject|4|||
105802725|NCT00323609|364934533|FG003|Overall Study|Withdrawal by Subject|4|||
105802726|NCT00323609|364934530|FG000|Overall Study|Other non-VCF-related medical condition|3|||
105802727|NCT00323609|364934531|FG001|Overall Study|Other non-VCF-related medical condition|2|||
105802728|NCT00323609|364934532|FG002|Overall Study|Other non-VCF-related medical condition|0|||
105568480|NCT01395823|364079350|FG000|Overall Study|GI symptoms|1|||
105568481|NCT01395823|364079351|FG001|Overall Study|GI symptoms|0|||
105568482|NCT01395823|364079350|FG000|Overall Study|Withdrawal by Subject|5|||
105568483|NCT01395823|364079351|FG001|Overall Study|Withdrawal by Subject|4|||
105568484|NCT00652938|364079362|FG000|Overall Study|Adverse Event|1|||
105568485|NCT00652938|364079363|FG001|Overall Study|Adverse Event|0|||
105568486|NCT00652938|364079364|FG002|Overall Study|Adverse Event|2|||
105568487|NCT00652938|364079362|FG000|Overall Study|Withdrawal by Subject|0|||
105568488|NCT00652938|364079363|FG001|Overall Study|Withdrawal by Subject|6|||
105568489|NCT00652938|364079364|FG002|Overall Study|Withdrawal by Subject|1|||
105568490|NCT00652938|364079362|FG000|Overall Study|Lost to Follow-up|0|||
105568491|NCT00652938|364079363|FG001|Overall Study|Lost to Follow-up|0|||
105568492|NCT00652938|364079364|FG002|Overall Study|Lost to Follow-up|2|||
105802729|NCT00323609|364934533|FG003|Overall Study|Other non-VCF-related medical condition|0|||
105802730|NCT00323609|364934530|FG000|Overall Study|Sponsor discontinued trial|29|||
105802731|NCT00323609|364934531|FG001|Overall Study|Sponsor discontinued trial|29|||
105802732|NCT00323609|364934532|FG002|Overall Study|Sponsor discontinued trial|0|||
105802733|NCT00323609|364934533|FG003|Overall Study|Sponsor discontinued trial|0|||
105806537|NCT03209570|364949016|FG001|Overall Study|Incomplete Data|10|||
105568493|NCT00652938|364079362|FG000|Overall Study|fear of blood sampling|0|||
105568494|NCT00652938|364079363|FG001|Overall Study|fear of blood sampling|1|||
105568495|NCT00652938|364079364|FG002|Overall Study|fear of blood sampling|0|||
105568496|NCT00717314|364079365|FG000|Overall Study|Adverse Event|3|||
105568497|NCT00717314|364079366|FG001|Overall Study|Adverse Event|2|||
105568498|NCT00717314|364079365|FG000|Overall Study|Protocol Violation|1|||
105568499|NCT00717314|364079366|FG001|Overall Study|Protocol Violation|0|||
105568500|NCT00717314|364079365|FG000|Overall Study|Lost to Follow-up|1|||
105568501|NCT00717314|364079366|FG001|Overall Study|Lost to Follow-up|5|||
105568502|NCT00717314|364079365|FG000|Overall Study|Withdrawal by Subject|1|||
105568503|NCT00717314|364079366|FG001|Overall Study|Withdrawal by Subject|3|||
105568504|NCT01919970|364079369|FG000|Overall Study|Withdrawal by Subject|3|||
105568505|NCT01919970|364079370|FG001|Overall Study|Withdrawal by Subject|0|||
105568506|NCT00682643|364079372|FG000|Overall Study|Adverse Event|12|||
105568507|NCT00682643|364079373|FG001|Overall Study|Adverse Event|23|||
105802734|NCT00323609|364934530|FG000|Overall Study|Unrelenting or severe back pain|1|||
105802735|NCT00323609|364934531|FG001|Overall Study|Unrelenting or severe back pain|1|||
105802736|NCT00323609|364934532|FG002|Overall Study|Unrelenting or severe back pain|0|||
105802737|NCT00323609|364934533|FG003|Overall Study|Unrelenting or severe back pain|0|||
105802738|NCT00323609|364934530|FG000|Overall Study|Logistical withdrawal|9|||
105568508|NCT00682643|364079372|FG000|Overall Study|Lack of Efficacy|2|||
105568509|NCT00682643|364079373|FG001|Overall Study|Lack of Efficacy|0|||
105568510|NCT00682643|364079372|FG000|Overall Study|Protocol Violation|38|||
105568511|NCT00682643|364079373|FG001|Overall Study|Protocol Violation|76|||
105568512|NCT00682643|364079372|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
105568513|NCT00682643|364079373|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
105568514|NCT00682643|364079372|FG000|Overall Study|Lost to Follow-up|1|||
105568515|NCT00682643|364079373|FG001|Overall Study|Lost to Follow-up|6|||
105568516|NCT00682643|364079372|FG000|Overall Study|Physician Decision|2|||
105568517|NCT00682643|364079373|FG001|Overall Study|Physician Decision|6|||
105568518|NCT00682643|364079372|FG000|Overall Study|Withdrawal by Subject|19|||
105568519|NCT00682643|364079373|FG001|Overall Study|Withdrawal by Subject|53|||
105568520|NCT00682643|364079372|FG000|Overall Study|Did Not Receive Study Drug|1|||
105568521|NCT00682643|364079373|FG001|Overall Study|Did Not Receive Study Drug|1|||
105568522|NCT01521884|364079375|FG000|Overall Study|Non Responders|10|||
105568523|NCT01521884|364079375|FG000|Overall Study|Adverse Event|5|||
105568524|NCT01521884|364079375|FG000|Overall Study|Pregnancy|1|||
105568525|NCT01521884|364079375|FG000|Overall Study|Withdrawal by Subject|1|||
105568526|NCT01521884|364079375|FG000|Overall Study|Physician Decision|2|||
105568527|NCT01521884|364079375|FG000|Overall Study|Protocol Violation|3|||
105568528|NCT01521884|364079375|FG000|Overall Study|Participant non-eligible|1|||
105568529|NCT01521884|364079375|FG000|Overall Study|Lost to Follow-up|4|||
105568530|NCT03565068|364079376|FG000|Overall Study|Protocol Violation|0|||
105568531|NCT03565068|364079377|FG001|Overall Study|Protocol Violation|0|||
105568532|NCT03565068|364079378|FG002|Overall Study|Protocol Violation|0|||
105568533|NCT03565068|364079379|FG003|Overall Study|Protocol Violation|0|||
105568534|NCT03565068|364079380|FG004|Overall Study|Protocol Violation|1|||
105568535|NCT03565068|364079381|FG005|Overall Study|Protocol Violation|0|||
105568536|NCT03565068|364079382|FG006|Overall Study|Protocol Violation|0|||
105568537|NCT03565068|364079383|FG007|Overall Study|Protocol Violation|1|||
105568538|NCT03565068|364079384|FG008|Overall Study|Protocol Violation|0|||
105568539|NCT03565068|364079376|FG000|Overall Study|Sponsor decision|0|||
105802739|NCT00323609|364934531|FG001|Overall Study|Logistical withdrawal|5|||
105802740|NCT00323609|364934532|FG002|Overall Study|Logistical withdrawal|0|||
105802741|NCT00323609|364934533|FG003|Overall Study|Logistical withdrawal|1|||
105802742|NCT00323609|364934530|FG000|Overall Study|Other reason|11|||
105802743|NCT00323609|364934531|FG001|Overall Study|Other reason|8|||
105802744|NCT00323609|364934532|FG002|Overall Study|Other reason|4|||
105802745|NCT00323609|364934533|FG003|Overall Study|Other reason|9|||
105802746|NCT01827371|364934535|FG000|Overall Study|Adverse Event|0|||
105802747|NCT01827371|364934536|FG001|Overall Study|Adverse Event|0|||
105360503|NCT00941304|363325970|FG000|Overall Study|Lost to Follow-up|1|||
105360504|NCT00941304|363325971|FG001|Overall Study|Lost to Follow-up|0|||
105360505|NCT00941304|363325972|FG002|Overall Study|Lost to Follow-up|0|||
105360506|NCT00941304|363325973|FG003|Overall Study|Lost to Follow-up|0|||
105360507|NCT00941304|363325974|FG004|Overall Study|Lost to Follow-up|0|||
105360508|NCT03293394|363325975|FG000|Follow-up (6 Months)|Adverse Event|4|||
105360509|NCT03293394|363325976|FG001|Follow-up (6 Months)|Adverse Event|2|||
105802748|NCT01827371|364934537|FG002|Overall Study|Adverse Event|4|||
105802749|NCT01827371|364934538|FG003|Overall Study|Adverse Event|2|||
105802750|NCT01827371|364934535|FG000|Overall Study|Lost to Follow-up|0|||
105802751|NCT01827371|364934536|FG001|Overall Study|Lost to Follow-up|2|||
105802752|NCT01827371|364934537|FG002|Overall Study|Lost to Follow-up|0|||
105802753|NCT01827371|364934538|FG003|Overall Study|Lost to Follow-up|4|||
105802754|NCT01827371|364934535|FG000|Overall Study|Protocol Violation|1|||
105360510|NCT03311841|363325977|FG000|14-day Wash-out|Adverse Event|0|||
105360511|NCT03311841|363325978|FG001|14-day Wash-out|Adverse Event|1|||
105360512|NCT03311841|363325979|FG002|14-day Wash-out|Adverse Event|0|||
105568540|NCT03565068|364079377|FG001|Overall Study|Sponsor decision|0|||
105568541|NCT03565068|364079378|FG002|Overall Study|Sponsor decision|0|||
105568542|NCT03565068|364079379|FG003|Overall Study|Sponsor decision|0|||
105568543|NCT03565068|364079380|FG004|Overall Study|Sponsor decision|1|||
105568544|NCT03565068|364079381|FG005|Overall Study|Sponsor decision|1|||
105568545|NCT03565068|364079382|FG006|Overall Study|Sponsor decision|0|||
105568546|NCT03565068|364079383|FG007|Overall Study|Sponsor decision|0|||
105802755|NCT01827371|364934536|FG001|Overall Study|Protocol Violation|0|||
105755678|NCT00433446|364758252|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
105755679|NCT00433446|364758252|FG000|Overall Study|Progression|44|||
105755680|NCT00433446|364758252|FG000|Overall Study|Other - Not Protocol specified|3|||
105755681|NCT00433446|364758252|FG000|Overall Study|Ineligible|9|||
105755682|NCT03819218|364758253|FG000|Overall Study|Protocol Violation|1|||
105755683|NCT02680587|364758254|FG000|Overall Study|Withdrawal by Subject|1|||
105755684|NCT02680587|364758255|FG001|Overall Study|Withdrawal by Subject|0|||
105755685|NCT01231607|364758259|FG000|Overall Study|Adverse Event|0|||
105755686|NCT01231607|364758260|FG001|Overall Study|Adverse Event|8|||
105755687|NCT01231607|364758261|FG002|Overall Study|Adverse Event|4|||
105755688|NCT01231607|364758262|FG003|Overall Study|Adverse Event|4|||
105755689|NCT01231607|364758263|FG004|Overall Study|Adverse Event|5|||
105755690|NCT01231607|364758259|FG000|Overall Study|Lost to Follow-up|13|||
105755691|NCT01231607|364758260|FG001|Overall Study|Lost to Follow-up|11|||
105755692|NCT01231607|364758261|FG002|Overall Study|Lost to Follow-up|10|||
105755693|NCT01231607|364758262|FG003|Overall Study|Lost to Follow-up|10|||
105755694|NCT01231607|364758263|FG004|Overall Study|Lost to Follow-up|4|||
105755695|NCT01231607|364758259|FG000|Overall Study|Physician Decision|4|||
105755696|NCT01231607|364758260|FG001|Overall Study|Physician Decision|4|||
105755697|NCT01231607|364758261|FG002|Overall Study|Physician Decision|3|||
105755698|NCT01231607|364758262|FG003|Overall Study|Physician Decision|5|||
105755699|NCT01231607|364758263|FG004|Overall Study|Physician Decision|4|||
105755700|NCT01231607|364758259|FG000|Overall Study|Protocol Violation|3|||
105755701|NCT01231607|364758260|FG001|Overall Study|Protocol Violation|2|||
105755702|NCT01231607|364758261|FG002|Overall Study|Protocol Violation|0|||
105755703|NCT01231607|364758262|FG003|Overall Study|Protocol Violation|2|||
105755704|NCT01231607|364758263|FG004|Overall Study|Protocol Violation|2|||
105755705|NCT01231607|364758259|FG000|Overall Study|Withdrawal by Subject|9|||
105755706|NCT01231607|364758260|FG001|Overall Study|Withdrawal by Subject|9|||
105755707|NCT01231607|364758261|FG002|Overall Study|Withdrawal by Subject|14|||
105755708|NCT01231607|364758262|FG003|Overall Study|Withdrawal by Subject|17|||
105755709|NCT01231607|364758263|FG004|Overall Study|Withdrawal by Subject|9|||
105755710|NCT02501902|364758264|FG000|Overall Study|Subject Refused Further Follow-up|0|||
105755711|NCT02501902|364758265|FG001|Overall Study|Subject Refused Further Follow-up|0|||
105755712|NCT02501902|364758266|FG002|Overall Study|Subject Refused Further Follow-up|0|||
105755713|NCT02501902|364758267|FG003|Overall Study|Subject Refused Further Follow-up|0|||
105755714|NCT02501902|364758268|FG004|Overall Study|Subject Refused Further Follow-up|0|||
105755715|NCT02501902|364758269|FG005|Overall Study|Subject Refused Further Follow-up|0|||
105755716|NCT02501902|364758270|FG006|Overall Study|Subject Refused Further Follow-up|0|||
105755717|NCT02501902|364758271|FG007|Overall Study|Subject Refused Further Follow-up|1|||
105755718|NCT02501902|364758264|FG000|Overall Study|Study Terminated by Sponsor|0|||
105755719|NCT02501902|364758265|FG001|Overall Study|Study Terminated by Sponsor|3|||
105755720|NCT02501902|364758266|FG002|Overall Study|Study Terminated by Sponsor|0|||
105755721|NCT02501902|364758267|FG003|Overall Study|Study Terminated by Sponsor|1|||
105755722|NCT02501902|364758268|FG004|Overall Study|Study Terminated by Sponsor|1|||
105755723|NCT02501902|364758269|FG005|Overall Study|Study Terminated by Sponsor|0|||
105755724|NCT02501902|364758270|FG006|Overall Study|Study Terminated by Sponsor|2|||
105755725|NCT02501902|364758271|FG007|Overall Study|Study Terminated by Sponsor|4|||
105755726|NCT02501902|364758264|FG000|Overall Study|Death|3|||
105755727|NCT02501902|364758265|FG001|Overall Study|Death|4|||
105755728|NCT02501902|364758266|FG002|Overall Study|Death|4|||
105755729|NCT02501902|364758267|FG003|Overall Study|Death|10|||
105755730|NCT02501902|364758268|FG004|Overall Study|Death|10|||
105755731|NCT02501902|364758269|FG005|Overall Study|Death|11|||
105755732|NCT02501902|364758270|FG006|Overall Study|Death|7|||
105755733|NCT02501902|364758271|FG007|Overall Study|Death|15|||
105755734|NCT03325556|364758272|FG000|Open-label Period|Lack of Response in OL period|70|||
105755735|NCT03325556|364758273|FG001|Open-label Period|Lack of Response in OL period|0|||
105755736|NCT03325556|364758274|FG002|Open-label Period|Lack of Response in OL period|0|||
105755737|NCT03325556|364758272|FG000|Open-label Period|Adverse Event|27|||
105755738|NCT03325556|364758273|FG001|Open-label Period|Adverse Event|0|||
105755739|NCT03325556|364758274|FG002|Open-label Period|Adverse Event|0|||
105755740|NCT03325556|364758272|FG000|Open-label Period|Death|1|||
105755741|NCT03325556|364758273|FG001|Open-label Period|Death|0|||
105755742|NCT03325556|364758274|FG002|Open-label Period|Death|0|||
105755743|NCT03325556|364758272|FG000|Open-label Period|Lost to Follow-up|1|||
105755744|NCT03325556|364758273|FG001|Open-label Period|Lost to Follow-up|0|||
105755745|NCT03325556|364758274|FG002|Open-label Period|Lost to Follow-up|0|||
105755746|NCT03325556|364758272|FG000|Open-label Period|Non-compliance with study drug|5|||
105755747|NCT03325556|364758273|FG001|Open-label Period|Non-compliance with study drug|0|||
105755748|NCT03325556|364758274|FG002|Open-label Period|Non-compliance with study drug|0|||
105755749|NCT03325556|364758272|FG000|Open-label Period|Use of prohibited medication|1|||
105755750|NCT03325556|364758273|FG001|Open-label Period|Use of prohibited medication|0|||
105755751|NCT03325556|364758274|FG002|Open-label Period|Use of prohibited medication|0|||
105360513|NCT03311841|363325980|FG003|14-day Wash-out|Adverse Event|0|||
105755752|NCT03325556|364758272|FG000|Open-label Period|Protocol Violation|4|||
105755753|NCT03325556|364758273|FG001|Open-label Period|Protocol Violation|0|||
105755754|NCT03325556|364758274|FG002|Open-label Period|Protocol Violation|0|||
105755755|NCT03325556|364758272|FG000|Open-label Period|Withdrawal by Subject|17|||
105755756|NCT03325556|364758273|FG001|Open-label Period|Withdrawal by Subject|0|||
105755757|NCT03325556|364758274|FG002|Open-label Period|Withdrawal by Subject|0|||
105755758|NCT03325556|364758272|FG000|Open-label Period|Not otherwise specified|8|||
105755759|NCT03325556|364758273|FG001|Open-label Period|Not otherwise specified|0|||
105755760|NCT03325556|364758274|FG002|Open-label Period|Not otherwise specified|0|||
105755761|NCT03325556|364758272|FG000|Open-label Period|Administrative discont. at study termination|41|||
105755762|NCT03325556|364758273|FG001|Open-label Period|Administrative discont. at study termination|0|||
105755763|NCT03325556|364758274|FG002|Open-label Period|Administrative discont. at study termination|0|||
105755764|NCT03325556|364758272|FG000|Double-blind Period|Relapse|0|||
105755765|NCT03325556|364758273|FG001|Double-blind Period|Relapse|15|||
105755766|NCT03325556|364758274|FG002|Double-blind Period|Relapse|34|||
105755767|NCT03325556|364758272|FG000|Double-blind Period|Adverse Event|0|||
105755768|NCT03325556|364758273|FG001|Double-blind Period|Adverse Event|3|||
105755769|NCT03325556|364758274|FG002|Double-blind Period|Adverse Event|1|||
105755770|NCT03325556|364758272|FG000|Double-blind Period|Noncompliance with study drug|0|||
105755771|NCT03325556|364758273|FG001|Double-blind Period|Noncompliance with study drug|0|||
105755772|NCT03325556|364758274|FG002|Double-blind Period|Noncompliance with study drug|1|||
105755773|NCT03325556|364758272|FG000|Double-blind Period|Use of prohibited medication|0|||
105755774|NCT03325556|364758273|FG001|Double-blind Period|Use of prohibited medication|1|||
105755775|NCT03325556|364758274|FG002|Double-blind Period|Use of prohibited medication|0|||
105755776|NCT03325556|364758272|FG000|Double-blind Period|Physician Decision|0|||
105755777|NCT03325556|364758273|FG001|Double-blind Period|Physician Decision|0|||
105755778|NCT03325556|364758274|FG002|Double-blind Period|Physician Decision|1|||
105755779|NCT03325556|364758272|FG000|Double-blind Period|Withdrawal by Subject|0|||
105755780|NCT03325556|364758273|FG001|Double-blind Period|Withdrawal by Subject|6|||
105755781|NCT03325556|364758274|FG002|Double-blind Period|Withdrawal by Subject|4|||
105755782|NCT03325556|364758272|FG000|Double-blind Period|Not otherwise specified|0|||
105755783|NCT03325556|364758273|FG001|Double-blind Period|Not otherwise specified|1|||
105755784|NCT03325556|364758274|FG002|Double-blind Period|Not otherwise specified|5|||
105755785|NCT03325556|364758272|FG000|Double-blind Period|Administrative discont. at study termination|0|||
105755786|NCT03325556|364758273|FG001|Double-blind Period|Administrative discont. at study termination|35|||
105755787|NCT03325556|364758274|FG002|Double-blind Period|Administrative discont. at study termination|31|||
105755788|NCT01767519|364758285|FG000|Overall Study|Other Reasons|4|||
105755789|NCT01767519|364758286|FG001|Overall Study|Other Reasons|4|||
105755790|NCT01767519|364758287|FG002|Overall Study|Other Reasons|2|||
105755791|NCT01767519|364758285|FG000|Overall Study|Protocol Violation|0|||
105755792|NCT01767519|364758286|FG001|Overall Study|Protocol Violation|3|||
105755793|NCT01767519|364758287|FG002|Overall Study|Protocol Violation|0|||
105755794|NCT01767519|364758285|FG000|Overall Study|Personal Reasons|1|||
105755795|NCT01767519|364758286|FG001|Overall Study|Personal Reasons|0|||
105755796|NCT01767519|364758287|FG002|Overall Study|Personal Reasons|0|||
105755797|NCT01767519|364758285|FG000|Overall Study|Lost to Follow-up|3|||
105755798|NCT01767519|364758286|FG001|Overall Study|Lost to Follow-up|1|||
105755799|NCT01767519|364758287|FG002|Overall Study|Lost to Follow-up|2|||
105755800|NCT01767519|364758285|FG000|Overall Study|Lack of Efficacy|1|||
105755801|NCT01767519|364758286|FG001|Overall Study|Lack of Efficacy|0|||
105755802|NCT01767519|364758287|FG002|Overall Study|Lack of Efficacy|0|||
105755803|NCT01767519|364758285|FG000|Overall Study|Adverse Event|5|||
105755804|NCT01767519|364758286|FG001|Overall Study|Adverse Event|5|||
105755805|NCT01767519|364758287|FG002|Overall Study|Adverse Event|1|||
105755806|NCT01890512|364758290|FG000|Overall Study|Physician Decision|1|||
105755807|NCT01890512|364758290|FG000|Overall Study|Withdrawal by Subject|1|||
105755808|NCT01890512|364758290|FG000|Overall Study|Protocol Violation|1|||
105755809|NCT00946881|364758291|FG000|First Treatment|Withdrawal by Subject|1|||
105755810|NCT00946881|364758291|FG000|First Treatment|Patient relocated to another state|1|||
105755811|NCT00946881|364758291|FG000|Retreatment|Withdrawal by Subject|1|||
105755812|NCT02157506|364758296|FG000|Overall Study|Adverse Event|0|||
105755813|NCT02157506|364758297|FG001|Overall Study|Adverse Event|1|||
105755814|NCT02157506|364758298|FG002|Overall Study|Adverse Event|0|||
105755815|NCT02157506|364758299|FG003|Overall Study|Adverse Event|0|||
105755816|NCT02157506|364758300|FG004|Overall Study|Adverse Event|0|||
105755817|NCT02157506|364758296|FG000|Overall Study|Lost to Follow-up|0|||
105755818|NCT02157506|364758297|FG001|Overall Study|Lost to Follow-up|0|||
105755819|NCT02157506|364758298|FG002|Overall Study|Lost to Follow-up|1|||
105755820|NCT02157506|364758299|FG003|Overall Study|Lost to Follow-up|0|||
105755821|NCT02157506|364758300|FG004|Overall Study|Lost to Follow-up|0|||
105755822|NCT00764478|364758303|FG000|Overall Study|Adverse Event|1|||
105755823|NCT00764478|364758304|FG001|Overall Study|Adverse Event|1|||
105755824|NCT00764478|364758305|FG002|Overall Study|Adverse Event|1|||
105755825|NCT00764478|364758303|FG000|Overall Study|Withdrawal by Subject|7|||
105755826|NCT00764478|364758304|FG001|Overall Study|Withdrawal by Subject|12|||
105755827|NCT00764478|364758305|FG002|Overall Study|Withdrawal by Subject|1|||
105755828|NCT00764478|364758303|FG000|Overall Study|Lost to Follow-up|7|||
105755829|NCT00764478|364758304|FG001|Overall Study|Lost to Follow-up|8|||
105755830|NCT00764478|364758305|FG002|Overall Study|Lost to Follow-up|5|||
105755831|NCT00764478|364758303|FG000|Overall Study|Protocol Violation|0|||
105755832|NCT00764478|364758304|FG001|Overall Study|Protocol Violation|1|||
105755833|NCT00764478|364758305|FG002|Overall Study|Protocol Violation|1|||
105755834|NCT02270684|364758306|FG000|Overall Study|Lost to Follow-up|0|||
105755835|NCT02270684|364758307|FG001|Overall Study|Lost to Follow-up|3|||
105755836|NCT02270684|364758306|FG000|Overall Study|Study terminated|1|||
105755837|NCT02270684|364758307|FG001|Overall Study|Study terminated|0|||
105755838|NCT00643604|364758311|FG000|Overall Study|Death|1|||
105755839|NCT02702011|364758315|FG000|Overall Study|Withdrawal by Subject|0|||
105755840|NCT02702011|364758316|FG001|Overall Study|Withdrawal by Subject|1|||
105755841|NCT02702011|364758317|FG002|Overall Study|Withdrawal by Subject|0|||
105755842|NCT02702011|364758318|FG003|Overall Study|Withdrawal by Subject|0|||
105755843|NCT01740388|364758322|FG000|Overall Study|Withdrawal by Subject|1|||
105755844|NCT01740388|364758323|FG001|Overall Study|Withdrawal by Subject|2|||
105755845|NCT01740388|364758322|FG000|Overall Study|Lost to Follow-up|2|||
105755846|NCT01740388|364758323|FG001|Overall Study|Lost to Follow-up|0|||
105755847|NCT01740388|364758322|FG000|Overall Study|Physician Decision|2|||
105755848|NCT01740388|364758323|FG001|Overall Study|Physician Decision|6|||
105755849|NCT01740388|364758322|FG000|Overall Study|Subjects missing data, completed|41|||
105755850|NCT01740388|364758323|FG001|Overall Study|Subjects missing data, completed|36|||
105755851|NCT00862121|364758326|FG000|Overall Study|Adverse Event|1|||
105755852|NCT00862121|364758327|FG001|Overall Study|Adverse Event|2|||
105755853|NCT00862121|364758326|FG000|Overall Study|Lack of Efficacy|0|||
105755854|NCT00862121|364758327|FG001|Overall Study|Lack of Efficacy|3|||
105755855|NCT00862121|364758326|FG000|Overall Study|Protocol Violation|0|||
105755856|NCT00862121|364758327|FG001|Overall Study|Protocol Violation|1|||
105755857|NCT00862121|364758326|FG000|Overall Study|Exclusion criterion violation|0|||
105755858|NCT00862121|364758327|FG001|Overall Study|Exclusion criterion violation|1|||
105755859|NCT00862121|364758326|FG000|Overall Study|Incorrect randomisation|0|||
105755860|NCT00862121|364758327|FG001|Overall Study|Incorrect randomisation|1|||
105755861|NCT01582971|364758328|FG000|Overall Study|Death|2|||
105755862|NCT01582971|364758329|FG001|Overall Study|Death|1|||
105755863|NCT01582971|364758328|FG000|Overall Study|Lost to Follow-up|18|||
105755864|NCT01582971|364758329|FG001|Overall Study|Lost to Follow-up|21|||
105755865|NCT01582971|364758328|FG000|Overall Study|Withdrawal by Subject|4|||
105755866|NCT01582971|364758329|FG001|Overall Study|Withdrawal by Subject|2|||
105755867|NCT01582971|364758328|FG000|Overall Study|Other|15|||
105755868|NCT01582971|364758329|FG001|Overall Study|Other|13|||
105755869|NCT02007954|364758332|FG000|Overall Study|Received liver transplant|3|||
105755870|NCT02007954|364758332|FG000|Overall Study|Switch in treatment modality|2|||
105755871|NCT02007954|364758332|FG000|Overall Study|Disease progression and unrelated AE|1|||
105755872|NCT02007954|364758332|FG000|Overall Study|Death|1|||
105755873|NCT01195363|364758334|FG000|Overall Study|Lost to Follow-up|7|||
105755874|NCT01195363|364758335|FG001|Overall Study|Lost to Follow-up|4|||
105755875|NCT01195363|364758334|FG000|Overall Study|Adverse Event|3|||
105755876|NCT01195363|364758335|FG001|Overall Study|Adverse Event|1|||
105755877|NCT01195363|364758334|FG000|Overall Study|Lack of Efficacy|0|||
105755878|NCT01195363|364758335|FG001|Overall Study|Lack of Efficacy|4|||
105755879|NCT01195363|364758334|FG000|Overall Study|incarceration|1|||
105755880|NCT01195363|364758335|FG001|Overall Study|incarceration|0|||
105755881|NCT02188719|364758336|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
105755882|NCT02188719|364758337|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
105755883|NCT02188719|364758338|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
105755884|NCT02188719|364758339|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
105755885|NCT01763866|364758340|FG000|Overall Study|Withdrawal by Subject|2|||
105755886|NCT01763866|364758341|FG001|Overall Study|Withdrawal by Subject|1|||
105755887|NCT01763866|364758342|FG002|Overall Study|Withdrawal by Subject|4|||
105755888|NCT01763866|364758343|FG003|Overall Study|Withdrawal by Subject|0|||
105755889|NCT01763866|364758344|FG004|Overall Study|Withdrawal by Subject|0|||
105755890|NCT01763866|364758345|FG005|Overall Study|Withdrawal by Subject|3|||
105755891|NCT01763866|364758346|FG006|Overall Study|Withdrawal by Subject|4|||
105755892|NCT01763866|364758347|FG007|Overall Study|Withdrawal by Subject|0|||
105755893|NCT01763866|364758348|FG008|Overall Study|Withdrawal by Subject|1|||
105755894|NCT01763866|364758349|FG009|Overall Study|Withdrawal by Subject|1|||
105755895|NCT01763866|364758350|FG010|Overall Study|Withdrawal by Subject|2|||
105755896|NCT01763866|364758351|FG011|Overall Study|Withdrawal by Subject|2|||
105755897|NCT01763866|364758352|FG012|Overall Study|Withdrawal by Subject|2|||
105755898|NCT01763866|364758353|FG013|Overall Study|Withdrawal by Subject|0|||
105755899|NCT01763866|364758354|FG014|Overall Study|Withdrawal by Subject|6|||
105755900|NCT01763866|364758355|FG015|Overall Study|Withdrawal by Subject|3|||
105802756|NCT01827371|364934537|FG002|Overall Study|Protocol Violation|0|||
105802757|NCT01827371|364934538|FG003|Overall Study|Protocol Violation|0|||
105802758|NCT01827371|364934535|FG000|Overall Study|Withdrawal by Subject|1|||
105802759|NCT01827371|364934536|FG001|Overall Study|Withdrawal by Subject|2|||
105802760|NCT01827371|364934537|FG002|Overall Study|Withdrawal by Subject|2|||
105802761|NCT01827371|364934538|FG003|Overall Study|Withdrawal by Subject|3|||
105802762|NCT01827371|364934535|FG000|Overall Study|Physician Decision|0|||
105802763|NCT01827371|364934536|FG001|Overall Study|Physician Decision|1|||
105802764|NCT01827371|364934537|FG002|Overall Study|Physician Decision|0|||
105802765|NCT01827371|364934538|FG003|Overall Study|Physician Decision|1|||
105802766|NCT01827371|364934535|FG000|Overall Study|Temporary study halt to vaccinations|11|||
105802767|NCT01827371|364934536|FG001|Overall Study|Temporary study halt to vaccinations|2|||
105802768|NCT01827371|364934537|FG002|Overall Study|Temporary study halt to vaccinations|5|||
105802769|NCT01827371|364934538|FG003|Overall Study|Temporary study halt to vaccinations|13|||
105802770|NCT00475852|364934542|FG000|Overall Study|Death|444|||
105802771|NCT00475852|364934543|FG001|Overall Study|Death|456|||
105802772|NCT00475852|364934542|FG000|Overall Study|Withdrawal by Subject|19|||
105802773|NCT00475852|364934543|FG001|Overall Study|Withdrawal by Subject|24|||
105802774|NCT00475852|364934542|FG000|Overall Study|Lost to Follow-up|54|||
105802775|NCT00475852|364934543|FG001|Overall Study|Lost to Follow-up|68|||
105802776|NCT00297479|364934544|FG000|Overall Study|Lost to Follow-up|37|||
105802777|NCT00297479|364934545|FG001|Overall Study|Lost to Follow-up|54|||
105802778|NCT00297479|364934546|FG002|Overall Study|Lost to Follow-up|51|||
105802779|NCT03196791|364934547|FG000|Overall Study|Protocol Violation|7|||
105802780|NCT03196791|364934548|FG001|Overall Study|Protocol Violation|3|||
105802781|NCT03196791|364934547|FG000|Overall Study|Withdrawal by Subject|3|||
105802782|NCT03196791|364934548|FG001|Overall Study|Withdrawal by Subject|2|||
105802783|NCT03063632|364934552|FG000|Overall Study|Death|4|||
105802784|NCT03063632|364934553|FG001|Overall Study|Death|6|||
105802785|NCT03063632|364934552|FG000|Overall Study|Lost to Follow-up|0|||
105802786|NCT03063632|364934553|FG001|Overall Study|Lost to Follow-up|1|||
105802787|NCT03063632|364934552|FG000|Overall Study|Withdrawal by Subject|0|||
105802788|NCT03063632|364934553|FG001|Overall Study|Withdrawal by Subject|2|||
105802789|NCT03063632|364934552|FG000|Overall Study|Physician Decision|2|||
105802790|NCT03063632|364934553|FG001|Overall Study|Physician Decision|0|||
105802791|NCT03063632|364934552|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
105802792|NCT03063632|364934553|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
105802793|NCT01698320|364934558|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
105802794|NCT01698320|364934559|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
105802795|NCT01698320|364934560|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
105802796|NCT01698320|364934558|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
105802797|NCT01698320|364934559|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
105802798|NCT01698320|364934560|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
105802799|NCT01698320|364934558|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
105802800|NCT01698320|364934559|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
105802801|NCT01698320|364934560|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
105802802|NCT01698320|364934558|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
105802803|NCT01698320|364934559|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
105802804|NCT01698320|364934560|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
105802805|NCT01698320|364934558|FG000|12-Week Double-Blind Period|Adverse Event|0|||
105802806|NCT01698320|364934559|FG001|12-Week Double-Blind Period|Adverse Event|1|||
105802807|NCT01698320|364934560|FG002|12-Week Double-Blind Period|Adverse Event|1|||
105802808|NCT01698320|364934558|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
105802809|NCT01698320|364934559|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
105802810|NCT01698320|364934560|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
105802811|NCT01698320|364934558|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
105802812|NCT01698320|364934559|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
105568547|NCT03565068|364079384|FG008|Overall Study|Sponsor decision|0|||
105568548|NCT03565068|364079376|FG000|Overall Study|Withdrawal by Subject|0|||
105568549|NCT03565068|364079377|FG001|Overall Study|Withdrawal by Subject|0|||
105568550|NCT03565068|364079378|FG002|Overall Study|Withdrawal by Subject|1|||
105568551|NCT03565068|364079379|FG003|Overall Study|Withdrawal by Subject|0|||
105568552|NCT03565068|364079380|FG004|Overall Study|Withdrawal by Subject|2|||
105568553|NCT03565068|364079381|FG005|Overall Study|Withdrawal by Subject|0|||
105568554|NCT03565068|364079382|FG006|Overall Study|Withdrawal by Subject|1|||
105568555|NCT03565068|364079383|FG007|Overall Study|Withdrawal by Subject|5|||
105568556|NCT03565068|364079384|FG008|Overall Study|Withdrawal by Subject|1|||
105802813|NCT01698320|364934560|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
105802814|NCT01698320|364934558|FG000|12-Week Double-Blind Period|Pregnancy|0|||
105802815|NCT01698320|364934559|FG001|12-Week Double-Blind Period|Pregnancy|1|||
105802816|NCT01698320|364934560|FG002|12-Week Double-Blind Period|Pregnancy|1|||
105568557|NCT03565068|364079376|FG000|Overall Study|Physician Decision|0|||
105568558|NCT03565068|364079377|FG001|Overall Study|Physician Decision|0|||
105568559|NCT03565068|364079378|FG002|Overall Study|Physician Decision|0|||
105568560|NCT03565068|364079379|FG003|Overall Study|Physician Decision|0|||
105568561|NCT03565068|364079380|FG004|Overall Study|Physician Decision|0|||
105568562|NCT03565068|364079381|FG005|Overall Study|Physician Decision|0|||
105568563|NCT03565068|364079382|FG006|Overall Study|Physician Decision|0|||
105802817|NCT01698320|364934558|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
105802818|NCT01698320|364934559|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
105802819|NCT01698320|364934560|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
105802820|NCT01698320|364934558|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
105802821|NCT01698320|364934559|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
105802822|NCT01698320|364934560|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
105802823|NCT01698320|364934558|FG000|40-Week Open-Label Period|Adverse Event|0|||
105802824|NCT01698320|364934559|FG001|40-Week Open-Label Period|Adverse Event|3|||
105802825|NCT01698320|364934560|FG002|40-Week Open-Label Period|Adverse Event|2|||
105568564|NCT03565068|364079383|FG007|Overall Study|Physician Decision|1|||
105568565|NCT03565068|364079384|FG008|Overall Study|Physician Decision|0|||
105568566|NCT03565068|364079376|FG000|Overall Study|Lost to Follow-up|0|||
105568567|NCT03565068|364079377|FG001|Overall Study|Lost to Follow-up|0|||
105568568|NCT03565068|364079378|FG002|Overall Study|Lost to Follow-up|0|||
105568569|NCT03565068|364079379|FG003|Overall Study|Lost to Follow-up|0|||
105568570|NCT03565068|364079380|FG004|Overall Study|Lost to Follow-up|0|||
105568571|NCT03565068|364079381|FG005|Overall Study|Lost to Follow-up|0|||
105568572|NCT03565068|364079382|FG006|Overall Study|Lost to Follow-up|0|||
105568573|NCT03565068|364079383|FG007|Overall Study|Lost to Follow-up|1|||
105568574|NCT03565068|364079384|FG008|Overall Study|Lost to Follow-up|0|||
105568575|NCT01435655|364079391|FG000|Overall Study|Death|2|||
105568576|NCT01435655|364079391|FG000|Overall Study|Other|1|||
105568577|NCT01436201|364079392|FG000|Overall Study|Adverse Event|2|||
105568578|NCT01436201|364079392|FG000|Overall Study|Withdrawal by Subject|1|||
105568579|NCT01436201|364079392|FG000|Overall Study|Protocol Violation|1|||
105568580|NCT00110890|364079393|FG000|Overall Study|Adverse Event|30|||
105568581|NCT00110890|364079394|FG001|Overall Study|Adverse Event|7|||
105568582|NCT00110890|364079393|FG000|Overall Study|Death|16|||
105568583|NCT00110890|364079394|FG001|Overall Study|Death|9|||
105568584|NCT00110890|364079393|FG000|Overall Study|Lost to Follow-up|3|||
105568585|NCT00110890|364079394|FG001|Overall Study|Lost to Follow-up|1|||
105568586|NCT00110890|364079393|FG000|Overall Study|Physician Decision|4|||
105568587|NCT00110890|364079394|FG001|Overall Study|Physician Decision|5|||
105568588|NCT00110890|364079393|FG000|Overall Study|Withdrawal by Subject|17|||
105568589|NCT00110890|364079394|FG001|Overall Study|Withdrawal by Subject|5|||
105568590|NCT00110890|364079393|FG000|Overall Study|Protocol Deviation|1|||
105568591|NCT00110890|364079394|FG001|Overall Study|Protocol Deviation|0|||
105568592|NCT00110890|364079393|FG000|Overall Study|Noncompliance|10|||
105568593|NCT00110890|364079394|FG001|Overall Study|Noncompliance|0|||
105802826|NCT01698320|364934558|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
105802827|NCT01698320|364934559|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
105802828|NCT01698320|364934560|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
105802829|NCT01698320|364934558|FG000|40-Week Open-Label Period|Pregnancy|0|||
105802830|NCT01698320|364934559|FG001|40-Week Open-Label Period|Pregnancy|2|||
105802831|NCT01698320|364934560|FG002|40-Week Open-Label Period|Pregnancy|1|||
105802832|NCT01698320|364934558|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
105802833|NCT01698320|364934559|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
105802834|NCT01698320|364934560|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
105802835|NCT01698320|364934558|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
105802836|NCT01698320|364934559|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
105802837|NCT01698320|364934560|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
105802838|NCT01783496|364934561|FG000|Overall Study|Lost to Follow-up|0|||
105802839|NCT01783496|364934562|FG001|Overall Study|Lost to Follow-up|0|||
105802840|NCT01783496|364934563|FG002|Overall Study|Lost to Follow-up|0|||
105802841|NCT01783496|364934564|FG003|Overall Study|Lost to Follow-up|2|||
105802842|NCT01783496|364934565|FG004|Overall Study|Lost to Follow-up|0|||
105802843|NCT01783496|364934566|FG005|Overall Study|Lost to Follow-up|1|||
105802844|NCT01783496|364934561|FG000|Overall Study|Withdrawal by Subject|1|||
105802845|NCT01783496|364934562|FG001|Overall Study|Withdrawal by Subject|0|||
105802846|NCT01783496|364934563|FG002|Overall Study|Withdrawal by Subject|0|||
105802847|NCT01783496|364934564|FG003|Overall Study|Withdrawal by Subject|0|||
105802848|NCT01783496|364934565|FG004|Overall Study|Withdrawal by Subject|0|||
105568594|NCT00110890|364079393|FG000|Overall Study|Kidney Transplant|16|||
105806538|NCT03209570|364949015|FG000|Overall Study|Protocol Violation|1|||
105568595|NCT00110890|364079394|FG001|Overall Study|Kidney Transplant|12|||
105568596|NCT00110890|364079393|FG000|Overall Study|Invest. Product Commercially Available|217|||
105568597|NCT00110890|364079394|FG001|Overall Study|Invest. Product Commercially Available|110|||
105568598|NCT00110890|364079393|FG000|Overall Study|Other|34|||
105568599|NCT00110890|364079394|FG001|Overall Study|Other|23|||
105568600|NCT00110890|364079393|FG000|Overall Study|Ineligibility determined|3|||
105802849|NCT01783496|364934566|FG005|Overall Study|Withdrawal by Subject|0|||
105802850|NCT01280981|364934573|FG000|Overall Study|Withdrawal by Subject|11|||
105802851|NCT01280981|364934573|FG000|Overall Study|Protocol Violation|2|||
105802852|NCT01280981|364934573|FG000|Overall Study|Lack of Efficacy|13|||
105802853|NCT01280981|364934573|FG000|Overall Study|Lost to Follow-up|3|||
105802854|NCT01280981|364934573|FG000|Overall Study|Adverse Event|6|||
105802855|NCT01280981|364934573|FG000|Overall Study|Irregular or discontinued menses|3|||
105802856|NCT01280981|364934573|FG000|Overall Study|Failed to return|45|||
105802857|NCT01280981|364934573|FG000|Overall Study|Non-compliance with protocol|3|||
105802858|NCT01280981|364934573|FG000|Overall Study|Withdrawal of consent|3|||
105802859|NCT01280981|364934573|FG000|Overall Study|Elective surgery|2|||
105802860|NCT01280981|364934573|FG000|Overall Study|Study site closure|1|||
105802861|NCT05085964|364934574|FG000|Overall Study|Premature termination of study|21|||
105802862|NCT05085964|364934575|FG001|Overall Study|Premature termination of study|0|||
105802863|NCT00545233|364934576|FG000|Overall Study|Adverse Event|10|||
105802864|NCT00545233|364934577|FG001|Overall Study|Adverse Event|5|||
105802865|NCT00545233|364934576|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
105802866|NCT00545233|364934577|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
105802867|NCT00545233|364934576|FG000|Overall Study|Protocol Violation|2|||
105802868|NCT00545233|364934577|FG001|Overall Study|Protocol Violation|0|||
105802869|NCT00545233|364934576|FG000|Overall Study|Refused Treatment|9|||
105802870|NCT00545233|364934577|FG001|Overall Study|Refused Treatment|7|||
105802871|NCT00545233|364934576|FG000|Overall Study|Failure to Return|4|||
105802872|NCT00545233|364934577|FG001|Overall Study|Failure to Return|6|||
105802873|NCT00545233|364934576|FG000|Overall Study|Insufficient response|14|||
105802874|NCT00545233|364934577|FG001|Overall Study|Insufficient response|15|||
105802875|NCT00545233|364934576|FG000|Overall Study|Physician Decision|2|||
105802876|NCT00545233|364934577|FG001|Overall Study|Physician Decision|1|||
105802877|NCT01783730|364934578|FG000|Overall Study|Failed to meet inclusion criteria|6|||
105802878|NCT00252187|364934579|FG000|Overall Study|Adverse Event|3|||
105802879|NCT00252187|364934580|FG001|Overall Study|Adverse Event|1|||
105802880|NCT00252187|364934579|FG000|Overall Study|Withdrawal by Subject|1|||
105802881|NCT00252187|364934580|FG001|Overall Study|Withdrawal by Subject|0|||
105802882|NCT01086215|364934585|FG000|Overall Study|Death|14|||
105802883|NCT01086215|364934586|FG001|Overall Study|Death|8|||
105802884|NCT01086215|364934587|FG002|Overall Study|Death|8|||
105802885|NCT01086215|364934588|FG003|Overall Study|Death|1|||
105802886|NCT01086215|364934585|FG000|Overall Study|Lost to Follow-up|22|||
105802887|NCT01086215|364934586|FG001|Overall Study|Lost to Follow-up|39|||
105802888|NCT01086215|364934587|FG002|Overall Study|Lost to Follow-up|18|||
105802889|NCT01086215|364934588|FG003|Overall Study|Lost to Follow-up|2|||
105802890|NCT03469271|364934591|FG000|Overall Study|Withdrawal by Subject|2|||
105802891|NCT03469271|364934592|FG001|Overall Study|Withdrawal by Subject|0|||
105802892|NCT03469271|364934593|FG002|Overall Study|Withdrawal by Subject|0|||
105802893|NCT03469271|364934594|FG003|Overall Study|Withdrawal by Subject|1|||
105802894|NCT03264066|364934595|FG000|Overall Study|Adverse Event|1|||
105802895|NCT03264066|364934596|FG001|Overall Study|Adverse Event|1|||
105802896|NCT03264066|364934597|FG002|Overall Study|Adverse Event|0|||
105802897|NCT03264066|364934598|FG003|Overall Study|Adverse Event|0|||
105802898|NCT03264066|364934599|FG004|Overall Study|Adverse Event|0|||
105802899|NCT03264066|364934600|FG005|Overall Study|Adverse Event|0|||
105802900|NCT03264066|364934595|FG000|Overall Study|Death|12|||
105802901|NCT03264066|364934596|FG001|Overall Study|Death|12|||
105802902|NCT03264066|364934597|FG002|Overall Study|Death|8|||
105802903|NCT03264066|364934598|FG003|Overall Study|Death|10|||
105802904|NCT03264066|364934599|FG004|Overall Study|Death|6|||
105802905|NCT03264066|364934600|FG005|Overall Study|Death|1|||
105802906|NCT03264066|364934595|FG000|Overall Study|Lost to Follow-up|1|||
105802907|NCT03264066|364934596|FG001|Overall Study|Lost to Follow-up|0|||
105802908|NCT03264066|364934597|FG002|Overall Study|Lost to Follow-up|0|||
105802909|NCT03264066|364934598|FG003|Overall Study|Lost to Follow-up|0|||
105802910|NCT03264066|364934599|FG004|Overall Study|Lost to Follow-up|0|||
105802911|NCT03264066|364934600|FG005|Overall Study|Lost to Follow-up|0|||
105802912|NCT03264066|364934595|FG000|Overall Study|Progressive Disease|0|||
105802913|NCT03264066|364934596|FG001|Overall Study|Progressive Disease|2|||
105802914|NCT03264066|364934597|FG002|Overall Study|Progressive Disease|1|||
105802915|NCT03264066|364934598|FG003|Overall Study|Progressive Disease|0|||
105802916|NCT03264066|364934599|FG004|Overall Study|Progressive Disease|0|||
105802917|NCT03264066|364934600|FG005|Overall Study|Progressive Disease|0|||
105802918|NCT03264066|364934595|FG000|Overall Study|Study Terminated by Sponsor|5|||
105802919|NCT03264066|364934596|FG001|Overall Study|Study Terminated by Sponsor|5|||
105802920|NCT03264066|364934597|FG002|Overall Study|Study Terminated by Sponsor|8|||
105802921|NCT03264066|364934598|FG003|Overall Study|Study Terminated by Sponsor|5|||
105802922|NCT03264066|364934599|FG004|Overall Study|Study Terminated by Sponsor|1|||
105802923|NCT03264066|364934600|FG005|Overall Study|Study Terminated by Sponsor|2|||
105802924|NCT03264066|364934595|FG000|Overall Study|Withdrawal by Subject|1|||
105802925|NCT03264066|364934596|FG001|Overall Study|Withdrawal by Subject|0|||
105755901|NCT01763866|364758356|FG016|Overall Study|Withdrawal by Subject|0|||
105755902|NCT01763866|364758357|FG017|Overall Study|Withdrawal by Subject|1|||
105755903|NCT01763866|364758358|FG018|Overall Study|Withdrawal by Subject|1|||
105755904|NCT01763866|364758359|FG019|Overall Study|Withdrawal by Subject|1|||
105755905|NCT01763866|364758360|FG020|Overall Study|Withdrawal by Subject|2|||
105755906|NCT01763866|364758361|FG021|Overall Study|Withdrawal by Subject|1|||
105755907|NCT01763866|364758362|FG022|Overall Study|Withdrawal by Subject|2|||
105755908|NCT01763866|364758363|FG023|Overall Study|Withdrawal by Subject|1|||
105755909|NCT01763866|364758340|FG000|Overall Study|Decision by sponsor|0|||
105755910|NCT01763866|364758341|FG001|Overall Study|Decision by sponsor|0|||
105755911|NCT01763866|364758342|FG002|Overall Study|Decision by sponsor|1|||
105755912|NCT01763866|364758343|FG003|Overall Study|Decision by sponsor|0|||
105755913|NCT01763866|364758344|FG004|Overall Study|Decision by sponsor|2|||
105755914|NCT01763866|364758345|FG005|Overall Study|Decision by sponsor|0|||
105755915|NCT01763866|364758346|FG006|Overall Study|Decision by sponsor|2|||
105755916|NCT01763866|364758347|FG007|Overall Study|Decision by sponsor|0|||
105755917|NCT01763866|364758348|FG008|Overall Study|Decision by sponsor|2|||
105755918|NCT01763866|364758349|FG009|Overall Study|Decision by sponsor|0|||
105755919|NCT01763866|364758350|FG010|Overall Study|Decision by sponsor|6|||
105755920|NCT01763866|364758351|FG011|Overall Study|Decision by sponsor|0|||
105755921|NCT01763866|364758352|FG012|Overall Study|Decision by sponsor|1|||
105755922|NCT01763866|364758353|FG013|Overall Study|Decision by sponsor|0|||
105755923|NCT01763866|364758354|FG014|Overall Study|Decision by sponsor|5|||
105755924|NCT01763866|364758355|FG015|Overall Study|Decision by sponsor|0|||
105755925|NCT01763866|364758356|FG016|Overall Study|Decision by sponsor|0|||
105755926|NCT01763866|364758357|FG017|Overall Study|Decision by sponsor|0|||
105755927|NCT01763866|364758358|FG018|Overall Study|Decision by sponsor|4|||
105755928|NCT01763866|364758359|FG019|Overall Study|Decision by sponsor|0|||
105755929|NCT01763866|364758360|FG020|Overall Study|Decision by sponsor|2|||
105755930|NCT01763866|364758361|FG021|Overall Study|Decision by sponsor|0|||
105755931|NCT01763866|364758362|FG022|Overall Study|Decision by sponsor|1|||
105755932|NCT01763866|364758363|FG023|Overall Study|Decision by sponsor|0|||
105755933|NCT01763866|364758340|FG000|Overall Study|Lost to Follow-up|0|||
105755934|NCT01763866|364758341|FG001|Overall Study|Lost to Follow-up|0|||
105755935|NCT01763866|364758342|FG002|Overall Study|Lost to Follow-up|0|||
105755936|NCT01763866|364758343|FG003|Overall Study|Lost to Follow-up|0|||
105755937|NCT01763866|364758344|FG004|Overall Study|Lost to Follow-up|0|||
105755938|NCT01763866|364758345|FG005|Overall Study|Lost to Follow-up|0|||
105755939|NCT01763866|364758346|FG006|Overall Study|Lost to Follow-up|1|||
105755940|NCT01763866|364758347|FG007|Overall Study|Lost to Follow-up|0|||
105755941|NCT01763866|364758348|FG008|Overall Study|Lost to Follow-up|0|||
105755942|NCT01763866|364758349|FG009|Overall Study|Lost to Follow-up|0|||
105755943|NCT01763866|364758350|FG010|Overall Study|Lost to Follow-up|0|||
105755944|NCT01763866|364758351|FG011|Overall Study|Lost to Follow-up|0|||
105755945|NCT01763866|364758352|FG012|Overall Study|Lost to Follow-up|1|||
105755946|NCT01763866|364758353|FG013|Overall Study|Lost to Follow-up|0|||
105755947|NCT01763866|364758354|FG014|Overall Study|Lost to Follow-up|1|||
105755948|NCT01763866|364758355|FG015|Overall Study|Lost to Follow-up|0|||
105755949|NCT01763866|364758356|FG016|Overall Study|Lost to Follow-up|0|||
105755950|NCT01763866|364758357|FG017|Overall Study|Lost to Follow-up|0|||
105755951|NCT01763866|364758358|FG018|Overall Study|Lost to Follow-up|1|||
105755952|NCT01763866|364758359|FG019|Overall Study|Lost to Follow-up|1|||
105755953|NCT01763866|364758360|FG020|Overall Study|Lost to Follow-up|0|||
105755954|NCT01763866|364758361|FG021|Overall Study|Lost to Follow-up|0|||
105755955|NCT01763866|364758362|FG022|Overall Study|Lost to Follow-up|0|||
105755956|NCT01763866|364758363|FG023|Overall Study|Lost to Follow-up|1|||
105755957|NCT01763866|364758340|FG000|Overall Study|Death|0|||
105755958|NCT01763866|364758341|FG001|Overall Study|Death|0|||
105755959|NCT01763866|364758342|FG002|Overall Study|Death|0|||
105755960|NCT01763866|364758343|FG003|Overall Study|Death|0|||
105755961|NCT01763866|364758344|FG004|Overall Study|Death|0|||
105755962|NCT01763866|364758345|FG005|Overall Study|Death|0|||
105755963|NCT01763866|364758346|FG006|Overall Study|Death|0|||
105755964|NCT01763866|364758347|FG007|Overall Study|Death|0|||
105755965|NCT01763866|364758348|FG008|Overall Study|Death|0|||
105755966|NCT01763866|364758349|FG009|Overall Study|Death|0|||
105755967|NCT01763866|364758350|FG010|Overall Study|Death|0|||
105755968|NCT01763866|364758351|FG011|Overall Study|Death|0|||
105755969|NCT01763866|364758352|FG012|Overall Study|Death|0|||
105755970|NCT01763866|364758353|FG013|Overall Study|Death|0|||
105755971|NCT01763866|364758354|FG014|Overall Study|Death|0|||
105755972|NCT01763866|364758355|FG015|Overall Study|Death|0|||
105755973|NCT01763866|364758356|FG016|Overall Study|Death|1|||
105755974|NCT01763866|364758357|FG017|Overall Study|Death|0|||
105755975|NCT01763866|364758358|FG018|Overall Study|Death|0|||
105755976|NCT01763866|364758359|FG019|Overall Study|Death|0|||
105755977|NCT01763866|364758360|FG020|Overall Study|Death|0|||
105755978|NCT01763866|364758361|FG021|Overall Study|Death|0|||
105755979|NCT01763866|364758362|FG022|Overall Study|Death|0|||
105802926|NCT03264066|364934597|FG002|Overall Study|Withdrawal by Subject|0|||
105802927|NCT03264066|364934598|FG003|Overall Study|Withdrawal by Subject|5|||
105802928|NCT03264066|364934599|FG004|Overall Study|Withdrawal by Subject|0|||
105802929|NCT03264066|364934600|FG005|Overall Study|Withdrawal by Subject|0|||
105802930|NCT03361956|364934601|FG000|Overall Study|Adverse Event|1|||
105802931|NCT03361956|364934602|FG001|Overall Study|Adverse Event|0|||
105802932|NCT03361956|364934603|FG002|Overall Study|Adverse Event|1|||
105802933|NCT03361956|364934604|FG003|Overall Study|Adverse Event|1|||
105802934|NCT03361956|364934605|FG004|Overall Study|Adverse Event|0|||
105802935|NCT03361956|364934601|FG000|Overall Study|Other|0|||
105802936|NCT03361956|364934602|FG001|Overall Study|Other|0|||
105802937|NCT03361956|364934603|FG002|Overall Study|Other|0|||
105802938|NCT03361956|364934604|FG003|Overall Study|Other|1|||
105802939|NCT03361956|364934605|FG004|Overall Study|Other|0|||
105802940|NCT03361956|364934601|FG000|Overall Study|Withdrawal by Subject|2|||
105802941|NCT03361956|364934602|FG001|Overall Study|Withdrawal by Subject|2|||
105802942|NCT03361956|364934603|FG002|Overall Study|Withdrawal by Subject|2|||
105802943|NCT03361956|364934604|FG003|Overall Study|Withdrawal by Subject|0|||
105802944|NCT03361956|364934605|FG004|Overall Study|Withdrawal by Subject|3|||
105802945|NCT03361956|364934601|FG000|Overall Study|Disease Relapse|0|||
105802946|NCT03361956|364934602|FG001|Overall Study|Disease Relapse|0|||
105802947|NCT03361956|364934603|FG002|Overall Study|Disease Relapse|1|||
105802948|NCT03361956|364934604|FG003|Overall Study|Disease Relapse|0|||
105802949|NCT03361956|364934605|FG004|Overall Study|Disease Relapse|0|||
105802950|NCT03361956|364934601|FG000|Overall Study|Physician Decision|0|||
105802951|NCT03361956|364934602|FG001|Overall Study|Physician Decision|2|||
105802952|NCT03361956|364934603|FG002|Overall Study|Physician Decision|0|||
105802953|NCT03361956|364934604|FG003|Overall Study|Physician Decision|1|||
105802954|NCT03361956|364934605|FG004|Overall Study|Physician Decision|0|||
105802955|NCT03361956|364934601|FG000|Overall Study|Lost to Follow-up|0|||
105802956|NCT03361956|364934602|FG001|Overall Study|Lost to Follow-up|0|||
105802957|NCT03361956|364934603|FG002|Overall Study|Lost to Follow-up|1|||
105802958|NCT03361956|364934604|FG003|Overall Study|Lost to Follow-up|1|||
105802959|NCT03361956|364934605|FG004|Overall Study|Lost to Follow-up|2|||
105802960|NCT00871728|364934611|FG000|Overall Study|Adverse Event|1|||
105568601|NCT00110890|364079394|FG001|Overall Study|Ineligibility determined|0|||
105568602|NCT00110890|364079393|FG000|Overall Study|Requirement for alternative therapy|0|||
105568603|NCT00110890|364079394|FG001|Overall Study|Requirement for alternative therapy|1|||
105568604|NCT00110890|364079393|FG000|Overall Study|Disease progression|0|||
105568605|NCT00110890|364079394|FG001|Overall Study|Disease progression|1|||
105568606|NCT00110890|364079393|FG000|Overall Study|Parathyroidectomy|0|||
105568607|NCT00110890|364079394|FG001|Overall Study|Parathyroidectomy|1|||
105568608|NCT00110890|364079393|FG000|Overall Study|Did not enter follow-up phase|10|||
105568609|NCT00110890|364079394|FG001|Overall Study|Did not enter follow-up phase|4|||
105568610|NCT02839343|364079395|FG000|Overall Study|Withdrawal by Subject|3|||
105568611|NCT02839343|364079396|FG001|Overall Study|Withdrawal by Subject|1|||
105568612|NCT02839343|364079395|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
105568613|NCT02839343|364079396|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
105568614|NCT02839343|364079395|FG000|Overall Study|Adverse Event|1|||
105568615|NCT02839343|364079396|FG001|Overall Study|Adverse Event|0|||
105568616|NCT00709059|364079399|FG000|Overall Study|Lost to Follow-up|34|||
105568617|NCT00709059|364079399|FG000|Overall Study|Withdrawal by Subject|19|||
105568618|NCT00709059|364079399|FG000|Overall Study|Physician Decision|7|||
105568619|NCT00709059|364079399|FG000|Overall Study|Disease complication|3|||
105568620|NCT00709059|364079399|FG000|Overall Study|Side effects|20|||
105568621|NCT00709059|364079399|FG000|Overall Study|Serious side effects|11|||
105568622|NCT01338012|364079400|FG000|Overall Study|Death|4|||
105568623|NCT01338012|364079400|FG000|Overall Study|Study terminated|4|||
105568624|NCT02799472|364081239|FG000|Overall Study|Withdrawal by Subject|2|||
105568625|NCT02799472|364081240|FG001|Overall Study|Withdrawal by Subject|4|||
105568626|NCT02799472|364081239|FG000|Overall Study|Lack of Efficacy|2|||
105568627|NCT02799472|364081240|FG001|Overall Study|Lack of Efficacy|0|||
105568628|NCT02799472|364081239|FG000|Overall Study|Lost to Follow-up|0|||
105568629|NCT02799472|364081240|FG001|Overall Study|Lost to Follow-up|1|||
105568630|NCT02801669|364081241|FG000|Overall Study|Death|66|||
105568631|NCT02801669|364081242|FG001|Overall Study|Death|69|||
105802961|NCT00871728|364934611|FG000|Overall Study|Protocol Violation|7|||
105802962|NCT00871728|364934611|FG000|Overall Study|Lost to Follow-up|2|||
105802963|NCT00871728|364934611|FG000|Overall Study|Failed to Visit Hospital|4|||
105802964|NCT00871728|364934611|FG000|Overall Study|Participant Non-compliance|1|||
105568632|NCT02801669|364081241|FG000|Overall Study|Withdrawal by Subject|81|||
105568633|NCT02801669|364081242|FG001|Overall Study|Withdrawal by Subject|77|||
105568634|NCT02801669|364081241|FG000|Overall Study|Other|4|||
105802965|NCT00871728|364934611|FG000|Overall Study|Withdrawal of Informed Consent|5|||
105802966|NCT03404206|364934614|FG000|Overall Study|Withdrawal by Subject|1|||
105802967|NCT03404206|364934615|FG001|Overall Study|Withdrawal by Subject|1|||
105568635|NCT02801669|364081242|FG001|Overall Study|Other|6|||
105568636|NCT02696564|364081243|FG000|Overall Study|Death|1|||
105802968|NCT03404206|364934616|FG002|Overall Study|Withdrawal by Subject|0|||
105568637|NCT02696564|364081244|FG001|Overall Study|Death|2|||
105568638|NCT02696564|364081243|FG000|Overall Study|Withdrawal by Subject|3|||
105568639|NCT02696564|364081244|FG001|Overall Study|Withdrawal by Subject|2|||
105568640|NCT02696564|364081243|FG000|Overall Study|Lost to Follow-up|3|||
105568641|NCT02696564|364081244|FG001|Overall Study|Lost to Follow-up|3|||
105568642|NCT02696564|364081243|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
105568643|NCT02696564|364081244|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
105568644|NCT02696564|364081243|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
105568645|NCT02696564|364081244|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
105568646|NCT02696564|364081243|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
105568647|NCT02696564|364081244|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
105568648|NCT02696564|364081243|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
105568649|NCT02696564|364081244|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
105568650|NCT02696564|364081243|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
105568651|NCT02696564|364081244|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
105568652|NCT00185640|364081245|FG000|Overall Study|Not Eligible|4|||
105802969|NCT03404206|364934614|FG000|Overall Study|Lost to Follow-up|3|||
105802970|NCT03404206|364934615|FG001|Overall Study|Lost to Follow-up|1|||
105802971|NCT03404206|364934616|FG002|Overall Study|Lost to Follow-up|0|||
105802972|NCT00146770|364934624|FG000|Overall Study|Adverse Event|2|||
105802973|NCT00146770|364934625|FG001|Overall Study|Adverse Event|0|||
105802974|NCT00146770|364934624|FG000|Overall Study|Pregnancy|1|||
105802975|NCT00146770|364934625|FG001|Overall Study|Pregnancy|0|||
105802976|NCT00146770|364934624|FG000|Overall Study|Withdrawal by Subject|2|||
105802977|NCT00146770|364934625|FG001|Overall Study|Withdrawal by Subject|0|||
105802978|NCT02826603|364934632|FG000|Overall Study|Adverse Event|17|||
105802979|NCT02826603|364934633|FG001|Overall Study|Adverse Event|9|||
105802980|NCT02826603|364934632|FG000|Overall Study|Lack of Efficacy|4|||
105802981|NCT02826603|364934633|FG001|Overall Study|Lack of Efficacy|9|||
105802982|NCT02826603|364934632|FG000|Overall Study|Lost to Follow-up|13|||
105802983|NCT02826603|364934633|FG001|Overall Study|Lost to Follow-up|12|||
105802984|NCT02826603|364934632|FG000|Overall Study|Noncompliance with treatment|0|||
105802985|NCT02826603|364934633|FG001|Overall Study|Noncompliance with treatment|2|||
105802986|NCT02826603|364934632|FG000|Overall Study|Physician Decision|1|||
105802987|NCT02826603|364934633|FG001|Overall Study|Physician Decision|7|||
105802988|NCT02826603|364934632|FG000|Overall Study|Pregnancy|1|||
105802989|NCT02826603|364934633|FG001|Overall Study|Pregnancy|2|||
105755980|NCT01763866|364758363|FG023|Overall Study|Death|0|||
105755981|NCT00966693|364758374|FG000|Overall Study|Adverse Event|0|||
105755982|NCT00966693|364758375|FG001|Overall Study|Adverse Event|0|||
105755983|NCT00966693|364758376|FG002|Overall Study|Adverse Event|1|||
105755984|NCT00966693|364758377|FG003|Overall Study|Adverse Event|2|||
105755985|NCT00966693|364758374|FG000|Overall Study|Death|0|||
105755986|NCT00966693|364758375|FG001|Overall Study|Death|0|||
105755987|NCT00966693|364758376|FG002|Overall Study|Death|1|||
105755988|NCT00966693|364758377|FG003|Overall Study|Death|0|||
105755989|NCT00966693|364758374|FG000|Overall Study|Withdrawal by Subject|1|||
105755990|NCT00966693|364758375|FG001|Overall Study|Withdrawal by Subject|0|||
105755991|NCT00966693|364758376|FG002|Overall Study|Withdrawal by Subject|0|||
105755992|NCT00966693|364758377|FG003|Overall Study|Withdrawal by Subject|5|||
105755993|NCT00966693|364758374|FG000|Overall Study|Disease Progression|0|||
105755994|NCT00966693|364758375|FG001|Overall Study|Disease Progression|0|||
105755995|NCT00966693|364758376|FG002|Overall Study|Disease Progression|1|||
105755996|NCT00966693|364758377|FG003|Overall Study|Disease Progression|16|||
105755997|NCT00171314|364758378|FG000|Overall Study|Adverse Event|44|||
105755998|NCT00171314|364758379|FG001|Overall Study|Adverse Event|41|||
105755999|NCT00171314|364758378|FG000|Overall Study|Lack of Efficacy|19|||
105756000|NCT00171314|364758379|FG001|Overall Study|Lack of Efficacy|14|||
105756001|NCT00171314|364758378|FG000|Overall Study|Withdrawal by Subject|9|||
105756002|NCT00171314|364758379|FG001|Overall Study|Withdrawal by Subject|6|||
105756003|NCT00171314|364758378|FG000|Overall Study|Abnormal Test Procedure Results|9|||
105802990|NCT02826603|364934632|FG000|Overall Study|Protocol Violation|3|||
105802991|NCT02826603|364934633|FG001|Overall Study|Protocol Violation|3|||
105802992|NCT02826603|364934632|FG000|Overall Study|Withdrawal by Subject|20|||
105802993|NCT02826603|364934633|FG001|Overall Study|Withdrawal by Subject|19|||
105756004|NCT00171314|364758379|FG001|Overall Study|Abnormal Test Procedure Results|3|||
105756005|NCT00171314|364758378|FG000|Overall Study|Protocol Violation|3|||
105756006|NCT00171314|364758379|FG001|Overall Study|Protocol Violation|7|||
105756007|NCT00171314|364758378|FG000|Overall Study|Administrative Problems|4|||
105756008|NCT00171314|364758379|FG001|Overall Study|Administrative Problems|3|||
105756009|NCT00171314|364758378|FG000|Overall Study|Lost to Follow-up|1|||
105756010|NCT00171314|364758379|FG001|Overall Study|Lost to Follow-up|3|||
105802994|NCT02826603|364934632|FG000|Overall Study|Death|2|||
105802995|NCT02826603|364934633|FG001|Overall Study|Death|0|||
105802996|NCT02826603|364934632|FG000|Overall Study|New therapy for study indication|0|||
105756011|NCT00171314|364758378|FG000|Overall Study|Death|2|||
105756012|NCT00171314|364758379|FG001|Overall Study|Death|1|||
105756013|NCT02293902|364758383|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
105756014|NCT02293902|364758384|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
105756015|NCT02293902|364758385|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
105756016|NCT02293902|364758386|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
105756017|NCT02293902|364758387|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
105756018|NCT02293902|364758383|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
105756019|NCT02293902|364758384|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
105756020|NCT02293902|364758385|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
105756021|NCT02293902|364758386|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
105756022|NCT02293902|364758387|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
105756023|NCT02293902|364758383|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
105756024|NCT02293902|364758384|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
105756025|NCT02293902|364758385|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
105756026|NCT02293902|364758386|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
105756027|NCT02293902|364758387|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
105756028|NCT02293902|364758383|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
105756029|NCT02293902|364758384|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
105756030|NCT02293902|364758385|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
105756031|NCT02293902|364758386|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
105756032|NCT02293902|364758387|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
105756033|NCT02293902|364758383|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
105756034|NCT02293902|364758384|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
105756035|NCT02293902|364758385|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
105756036|NCT02293902|364758386|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
105756037|NCT02293902|364758387|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
105756038|NCT00562640|364760083|FG000|Overall Study|Death|0|||
105756039|NCT00562640|364760084|FG001|Overall Study|Death|1|||
105756040|NCT00562640|364760085|FG002|Overall Study|Death|1|||
105756041|NCT00562640|364760086|FG003|Overall Study|Death|0|||
105756042|NCT02658968|364760087|FG000|Received Rituximab|Adverse Event|0|||
105756043|NCT02658968|364760088|FG001|Received Rituximab|Adverse Event|0|||
105756044|NCT02658968|364760089|FG002|Received Rituximab|Adverse Event|0|||
105756045|NCT02658968|364760090|FG003|Received Rituximab|Adverse Event|0|||
105756046|NCT02658968|364760091|FG004|Received Rituximab|Adverse Event|1|||
105756047|NCT02658968|364760087|FG000|Received Rituximab|Progressive disease|0|||
105756048|NCT02658968|364760088|FG001|Received Rituximab|Progressive disease|0|||
105756049|NCT02658968|364760089|FG002|Received Rituximab|Progressive disease|0|||
105756050|NCT02658968|364760090|FG003|Received Rituximab|Progressive disease|0|||
105756051|NCT02658968|364760091|FG004|Received Rituximab|Progressive disease|1|||
105756052|NCT02658968|364760087|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
105756053|NCT02658968|364760088|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
105756054|NCT02658968|364760089|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
105756055|NCT02658968|364760090|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
105756056|NCT02658968|364760091|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
105756057|NCT02658968|364760087|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
105756058|NCT02658968|364760088|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
105756059|NCT02658968|364760089|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
105756060|NCT02658968|364760090|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
105756061|NCT02658968|364760091|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
105756062|NCT02658968|364760087|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
105756063|NCT02658968|364760088|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
105756064|NCT02658968|364760089|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
105756065|NCT02658968|364760090|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
105756066|NCT02658968|364760091|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
105756067|NCT02658968|364760087|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
105756068|NCT02658968|364760088|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
105756069|NCT02658968|364760089|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
105756070|NCT02658968|364760090|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
105756071|NCT02658968|364760091|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
105756072|NCT02658968|364760087|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
105756073|NCT02658968|364760088|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
105756074|NCT02658968|364760089|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
105756075|NCT02658968|364760090|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
105756076|NCT02658968|364760091|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
105756077|NCT00603733|364760096|FG000|Active Phase ITT|Adverse Event|8|||
105756078|NCT00603733|364760097|FG001|Active Phase ITT|Adverse Event|7|||
105756079|NCT00603733|364760096|FG000|Active Phase ITT|Withdrawal by Subject|0|||
105756080|NCT00603733|364760097|FG001|Active Phase ITT|Withdrawal by Subject|3|||
105756081|NCT00603733|364760096|FG000|Active Phase ITT|Lost to Follow-up|0|||
105756082|NCT00603733|364760097|FG001|Active Phase ITT|Lost to Follow-up|1|||
105756083|NCT00603733|364760096|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
105756084|NCT00603733|364760097|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
105756085|NCT00603733|364760096|FG000|Active Phase ITT|Lack of Efficacy|1|||
105756086|NCT00603733|364760097|FG001|Active Phase ITT|Lack of Efficacy|2|||
105756087|NCT00603733|364760096|FG000|Active Phase ITT|Subject moved, site closed|1|||
105756088|NCT00603733|364760097|FG001|Active Phase ITT|Subject moved, site closed|1|||
105756089|NCT00603733|364760096|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
105756090|NCT00603733|364760097|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
105756091|NCT00603733|364760096|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
105756092|NCT00603733|364760097|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
105756093|NCT00603733|364760096|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
105756094|NCT00603733|364760097|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
105756095|NCT00603733|364760096|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
105756096|NCT00603733|364760097|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
105756097|NCT00603733|364760096|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
105756098|NCT00603733|364760097|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
105756099|NCT00603733|364760096|FG000|Maintenance Phase ITT|Adverse Event|3|||
105756100|NCT00603733|364760097|FG001|Maintenance Phase ITT|Adverse Event|6|||
105756101|NCT00603733|364760096|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
105756102|NCT00603733|364760097|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
105756103|NCT00603733|364760096|FG000|Maintenance Phase ITT|Protocol Violation|1|||
105756104|NCT00603733|364760097|FG001|Maintenance Phase ITT|Protocol Violation|1|||
105756105|NCT00603733|364760096|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
105756106|NCT00603733|364760097|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
105756107|NCT00603733|364760096|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
105756108|NCT00603733|364760097|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
105756109|NCT00603733|364760096|FG000|Maintenance Phase ITT|Physician Decision|0|||
105756110|NCT00603733|364760097|FG001|Maintenance Phase ITT|Physician Decision|1|||
105756111|NCT00603733|364760096|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
105756112|NCT00603733|364760097|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
105756113|NCT02700919|364760098|FG000|Overall Study|Physician Decision|1|||
105756114|NCT02700919|364760099|FG001|Overall Study|Physician Decision|0|||
105756115|NCT02700919|364760100|FG002|Overall Study|Physician Decision|0|||
105756116|NCT02700919|364760098|FG000|Overall Study|Protocol Violation|1|||
105756117|NCT02700919|364760099|FG001|Overall Study|Protocol Violation|0|||
105756118|NCT02700919|364760100|FG002|Overall Study|Protocol Violation|0|||
105756119|NCT02700919|364760098|FG000|Overall Study|Adverse Event|1|||
105756120|NCT02700919|364760099|FG001|Overall Study|Adverse Event|3|||
105756121|NCT02700919|364760100|FG002|Overall Study|Adverse Event|1|||
105756122|NCT02700919|364760098|FG000|Overall Study|Withdrawal by Subject|5|||
105756123|NCT02700919|364760099|FG001|Overall Study|Withdrawal by Subject|8|||
105756124|NCT02700919|364760100|FG002|Overall Study|Withdrawal by Subject|2|||
105756125|NCT02700919|364760098|FG000|Overall Study|Lost to Follow-up|2|||
105756126|NCT02700919|364760099|FG001|Overall Study|Lost to Follow-up|0|||
105756127|NCT02700919|364760100|FG002|Overall Study|Lost to Follow-up|0|||
105756128|NCT02700919|364760098|FG000|Overall Study|Other|2|||
105756129|NCT02700919|364760099|FG001|Overall Study|Other|1|||
105756130|NCT02700919|364760100|FG002|Overall Study|Other|1|||
105756131|NCT02150213|364760106|FG000|Overall Study|Lost to Follow-up|1|||
105756132|NCT02150213|364760106|FG000|Overall Study|Withdrawal by Subject|1|||
105756133|NCT01297309|364760110|FG000|Overall Study|Eligibility failure|2|||
105756134|NCT01297309|364760110|FG000|Overall Study|Screen failure|2|||
105756135|NCT01297309|364760110|FG000|Overall Study|Withdrawal by Subject|5|||
105756136|NCT01297309|364760110|FG000|Overall Study|Adverse Event|1|||
105756137|NCT01297309|364760110|FG000|Overall Study|Investigator Decision|2|||
105756138|NCT01297309|364760110|FG000|Overall Study|Death|1|||
105756139|NCT01297309|364760110|FG000|Overall Study|Participant not entering extensionperiod|1|||
105756140|NCT03039738|364760111|FG000|Overall Study|Incomplete data sets|54|||
105756141|NCT03039738|364760112|FG001|Overall Study|Incomplete data sets|0|||
105756142|NCT02670928|364760114|FG000|Overall Study|Adverse Event|3|||
105756143|NCT02670928|364760115|FG001|Overall Study|Adverse Event|1|||
105756144|NCT02670928|364760114|FG000|Overall Study|Withdrawal by Subject|4|||
105802997|NCT02826603|364934633|FG001|Overall Study|New therapy for study indication|1|||
105802998|NCT00003102|364934636|FG000|Overall Study|Physician Decision|1|||
105756145|NCT02670928|364760115|FG001|Overall Study|Withdrawal by Subject|0|||
105756146|NCT02670928|364760114|FG000|Overall Study|Lost to Follow-up|1|||
105756147|NCT02670928|364760115|FG001|Overall Study|Lost to Follow-up|0|||
105756148|NCT02670928|364760114|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
105756149|NCT02670928|364760115|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
105756150|NCT04681729|364760116|FG000|Overall Study|Lack of Efficacy|2|||
105756151|NCT04681729|364760117|FG001|Overall Study|Lack of Efficacy|2|||
105756152|NCT04681729|364760116|FG000|Overall Study|Withdrawal by Subject|8|||
105756153|NCT04681729|364760117|FG001|Overall Study|Withdrawal by Subject|9|||
105756154|NCT02678312|364760118|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
105756155|NCT02678312|364760119|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
105756156|NCT02678312|364760120|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
105756157|NCT02678312|364760121|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
105756158|NCT02678312|364760122|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
105756159|NCT02678312|364760118|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
105756160|NCT02678312|364760119|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
105756161|NCT02678312|364760120|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
105756162|NCT02678312|364760121|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
105756163|NCT02678312|364760122|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
105756164|NCT02678312|364760118|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
105756165|NCT02678312|364760119|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
105756166|NCT02678312|364760120|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
105756167|NCT02678312|364760121|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
105756168|NCT02678312|364760122|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
105756169|NCT02678312|364760118|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
105756170|NCT02678312|364760119|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
105756171|NCT02678312|364760120|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
105756172|NCT02678312|364760121|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
105756173|NCT02678312|364760122|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
105756174|NCT02678312|364760118|FG000|Part 2 Double Blind Epoch|Death|0|||
105756175|NCT02678312|364760119|FG001|Part 2 Double Blind Epoch|Death|0|||
105756176|NCT02678312|364760120|FG002|Part 2 Double Blind Epoch|Death|0|||
105756177|NCT02678312|364760121|FG003|Part 2 Double Blind Epoch|Death|8|||
105756178|NCT02678312|364760122|FG004|Part 2 Double Blind Epoch|Death|12|||
105756179|NCT02678312|364760118|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
105756180|NCT02678312|364760119|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
105756181|NCT02678312|364760120|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
105756182|NCT02678312|364760121|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
105756183|NCT02678312|364760122|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
105756184|NCT02678312|364760118|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
105756185|NCT02678312|364760119|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
105756186|NCT02678312|364760120|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
105756187|NCT02678312|364760121|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
105756188|NCT02678312|364760122|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
105756189|NCT02678312|364760118|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
105756190|NCT02678312|364760119|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
105756191|NCT02678312|364760120|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
105756192|NCT02678312|364760121|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
105756193|NCT02678312|364760122|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
105756194|NCT00912340|364760125|FG000|Overall Study|Adverse Event|2|||
105756195|NCT00912340|364760126|FG001|Overall Study|Adverse Event|4|||
105756196|NCT00912340|364760127|FG002|Overall Study|Adverse Event|0|||
105756197|NCT00912340|364760125|FG000|Overall Study|Protocol revised to remove arm|0|||
105756198|NCT00912340|364760126|FG001|Overall Study|Protocol revised to remove arm|0|||
105756199|NCT00912340|364760127|FG002|Overall Study|Protocol revised to remove arm|4|||
105756200|NCT01517412|364760130|FG000|Overall Study|Adverse Event|10|||
105756201|NCT01517412|364760131|FG001|Overall Study|Adverse Event|11|||
105756202|NCT01517412|364760130|FG000|Overall Study|Lack of Efficacy|10|||
105756203|NCT01517412|364760131|FG001|Overall Study|Lack of Efficacy|5|||
105756204|NCT01517412|364760130|FG000|Overall Study|Poor compliance to protocol|8|||
105756205|NCT01517412|364760131|FG001|Overall Study|Poor compliance to protocol|3|||
105756206|NCT01517412|364760130|FG000|Overall Study|Other than specified above|8|||
105756207|NCT01517412|364760131|FG001|Overall Study|Other than specified above|5|||
105756208|NCT02215616|364760139|FG000|Overall Study|Sponsor requested to stop study drug|0|||
105756209|NCT02215616|364760140|FG001|Overall Study|Sponsor requested to stop study drug|0|||
105756210|NCT02215616|364760141|FG002|Overall Study|Sponsor requested to stop study drug|1|||
105756211|NCT02215616|364760142|FG003|Overall Study|Sponsor requested to stop study drug|4|||
105756212|NCT02215616|364760139|FG000|Overall Study|Death|1|||
105756213|NCT02215616|364760140|FG001|Overall Study|Death|0|||
105756214|NCT02215616|364760141|FG002|Overall Study|Death|0|||
105756215|NCT02215616|364760142|FG003|Overall Study|Death|0|||
105756216|NCT02215616|364760139|FG000|Overall Study|Adverse Event|7|||
105756217|NCT02215616|364760140|FG001|Overall Study|Adverse Event|4|||
105756218|NCT02215616|364760141|FG002|Overall Study|Adverse Event|9|||
105756219|NCT02215616|364760142|FG003|Overall Study|Adverse Event|2|||
105756220|NCT02215616|364760139|FG000|Overall Study|Withdrawal by Subject|1|||
105756221|NCT02215616|364760140|FG001|Overall Study|Withdrawal by Subject|8|||
105802999|NCT00003102|364934637|FG001|Overall Study|Physician Decision|1|||
105803000|NCT00003102|364934638|FG002|Overall Study|Physician Decision|0|||
105803001|NCT00003102|364934636|FG000|Overall Study|Progressive Disease|0|||
105803002|NCT00003102|364934637|FG001|Overall Study|Progressive Disease|1|||
105803003|NCT00003102|364934638|FG002|Overall Study|Progressive Disease|0|||
105803004|NCT00003102|364934636|FG000|Overall Study|Adverse Event|0|||
105803005|NCT00003102|364934637|FG001|Overall Study|Adverse Event|1|||
105803006|NCT00003102|364934638|FG002|Overall Study|Adverse Event|1|||
105568653|NCT00185640|364081245|FG000|Overall Study|Withdrawal by Subject|3|||
105568654|NCT00185640|364081245|FG000|Overall Study|Death|138|||
105568655|NCT02312856|364081249|FG000|Overall Study|Death|1|||
105568656|NCT02312856|364081249|FG000|Overall Study|Lost to Follow-up|3|||
105568657|NCT02508532|364081256|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
105568658|NCT02508532|364081257|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
105568659|NCT02508532|364081258|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
105568660|NCT02508532|364081259|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
105568661|NCT02508532|364081260|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
105568662|NCT02508532|364081261|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
105568663|NCT02508532|364081262|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
105756222|NCT02215616|364760141|FG002|Overall Study|Withdrawal by Subject|2|||
105756223|NCT02215616|364760142|FG003|Overall Study|Withdrawal by Subject|5|||
105756224|NCT02215616|364760139|FG000|Overall Study|Non-compliance|0|||
105756225|NCT02215616|364760140|FG001|Overall Study|Non-compliance|2|||
105756226|NCT02215616|364760141|FG002|Overall Study|Non-compliance|1|||
105756227|NCT02215616|364760142|FG003|Overall Study|Non-compliance|0|||
105756228|NCT02215616|364760139|FG000|Overall Study|Protocol Violation|0|||
105756229|NCT02215616|364760140|FG001|Overall Study|Protocol Violation|2|||
105756230|NCT02215616|364760141|FG002|Overall Study|Protocol Violation|0|||
105756231|NCT02215616|364760142|FG003|Overall Study|Protocol Violation|0|||
105756232|NCT02215616|364760139|FG000|Overall Study|Lost to Follow-up|1|||
105756233|NCT02215616|364760140|FG001|Overall Study|Lost to Follow-up|1|||
105756234|NCT02215616|364760141|FG002|Overall Study|Lost to Follow-up|0|||
105756235|NCT02215616|364760142|FG003|Overall Study|Lost to Follow-up|1|||
105756236|NCT02215616|364760139|FG000|Overall Study|Other than specified|1|||
105756237|NCT02215616|364760140|FG001|Overall Study|Other than specified|0|||
105756238|NCT02215616|364760141|FG002|Overall Study|Other than specified|1|||
105756239|NCT02215616|364760142|FG003|Overall Study|Other than specified|1|||
105756240|NCT04624672|364760148|FG000|Overall Study|Early Study Closure|2|||
105756241|NCT04624672|364760149|FG001|Overall Study|Early Study Closure|1|||
105756242|NCT03472040|364760150|FG000|Overall Study|Physician Decision|0|||
105756243|NCT03472040|364760151|FG001|Overall Study|Physician Decision|3|||
105756244|NCT03472040|364760150|FG000|Overall Study|Withdrawal by Subject|10|||
105756245|NCT03472040|364760151|FG001|Overall Study|Withdrawal by Subject|23|||
105756246|NCT03472040|364760150|FG000|Overall Study|Perceived Lack of Efficacy|29|||
105756247|NCT03472040|364760151|FG001|Overall Study|Perceived Lack of Efficacy|30|||
105756248|NCT03472040|364760150|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
105756249|NCT03472040|364760151|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
105756250|NCT03472040|364760150|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
105756251|NCT03472040|364760151|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
105756252|NCT03472040|364760150|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
105756253|NCT03472040|364760151|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
105756254|NCT03472040|364760150|FG000|Overall Study|Subject Non-compliance|2|||
105756255|NCT03472040|364760151|FG001|Overall Study|Subject Non-compliance|5|||
105756256|NCT03472040|364760150|FG000|Overall Study|Discontinuation due to Rash|0|||
105756257|NCT03472040|364760151|FG001|Overall Study|Discontinuation due to Rash|1|||
105756258|NCT03472040|364760150|FG000|Overall Study|Subsequent Ineligibility|0|||
105756259|NCT03472040|364760151|FG001|Overall Study|Subsequent Ineligibility|2|||
105756260|NCT03472040|364760150|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
105803007|NCT00003102|364934636|FG000|Overall Study|Death|0|||
105803008|NCT00003102|364934637|FG001|Overall Study|Death|0|||
105360514|NCT03311841|363325981|FG004|14-day Wash-out|Adverse Event|0|||
105756261|NCT03472040|364760151|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
105756262|NCT02685995|364760158|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
105803009|NCT00003102|364934638|FG002|Overall Study|Death|1|||
105803010|NCT00583596|364934639|FG000|Overall Study|Lost to Follow-up|110|||
105803011|NCT00583596|364934639|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
105803012|NCT00583596|364934639|FG000|Overall Study|Death|2|||
105803013|NCT00583596|364934639|FG000|Overall Study|Withdrawal by Subject|6|||
105803014|NCT00583596|364934639|FG000|Overall Study|Lost to Follow-up|94|||
105803015|NCT00583596|364934639|FG000|Overall Study|Data not complete|1|||
105803016|NCT00583596|364934639|FG000|Overall Study|Not consented|15|||
105803017|NCT00583596|364934639|FG000|Overall Study|Outside f-up window|26|||
105803018|NCT03558997|364934644|FG000|Overall Study|Adverse Event|0|||
105803019|NCT03558997|364934645|FG001|Overall Study|Adverse Event|2|||
105803020|NCT03558997|364934646|FG002|Overall Study|Adverse Event|5|||
105803021|NCT03558997|364934647|FG003|Overall Study|Adverse Event|1|||
105803022|NCT03558997|364934644|FG000|Overall Study|Physician Decision|0|||
105803023|NCT03558997|364934645|FG001|Overall Study|Physician Decision|0|||
105803024|NCT03558997|364934646|FG002|Overall Study|Physician Decision|1|||
105803025|NCT03558997|364934647|FG003|Overall Study|Physician Decision|0|||
105803026|NCT03558997|364934644|FG000|Overall Study|Withdrawal by Subject|1|||
105803027|NCT03558997|364934645|FG001|Overall Study|Withdrawal by Subject|0|||
105803028|NCT03558997|364934646|FG002|Overall Study|Withdrawal by Subject|1|||
105803029|NCT03558997|364934647|FG003|Overall Study|Withdrawal by Subject|1|||
105803030|NCT03558997|364934644|FG000|Overall Study|Lost to Follow-up|0|||
105803031|NCT03558997|364934645|FG001|Overall Study|Lost to Follow-up|0|||
105803032|NCT03558997|364934646|FG002|Overall Study|Lost to Follow-up|1|||
105803033|NCT03558997|364934647|FG003|Overall Study|Lost to Follow-up|0|||
105803034|NCT00616928|364934648|FG000|Overall Study|Adverse Event|6|||
105803035|NCT00616928|364934649|FG001|Overall Study|Adverse Event|3|||
105803036|NCT00616928|364934650|FG002|Overall Study|Adverse Event|2|||
105803037|NCT00616928|364934651|FG003|Overall Study|Adverse Event|2|||
105803038|NCT00616928|364934648|FG000|Overall Study|Other|51|||
105803039|NCT00616928|364934649|FG001|Overall Study|Other|8|||
105803040|NCT00616928|364934650|FG002|Overall Study|Other|15|||
105803041|NCT00616928|364934651|FG003|Overall Study|Other|5|||
105803042|NCT00616928|364934648|FG000|Overall Study|Lost to Follow-up|5|||
105803043|NCT00616928|364934649|FG001|Overall Study|Lost to Follow-up|7|||
105803044|NCT00616928|364934650|FG002|Overall Study|Lost to Follow-up|0|||
105803045|NCT00616928|364934651|FG003|Overall Study|Lost to Follow-up|0|||
105803046|NCT04049552|364934654|FG000|Overall Study|Lost to Follow-up|1|||
105803047|NCT04409002|364934655|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
105803048|NCT03740100|364934658|FG000|Overall Study|Adverse Event|1|||
105803049|NCT03740100|364934658|FG000|Overall Study|Death|1|||
105803050|NCT03083132|364934660|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
105803051|NCT03083132|364934661|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
105803052|NCT03083132|364934660|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
105803053|NCT03083132|364934661|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
105803054|NCT03083132|364934660|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
105803055|NCT03083132|364934661|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
105803056|NCT01588106|364934662|FG000|Overall Study|Withdrawal by Subject|5|||
105803057|NCT01588106|364934663|FG001|Overall Study|Withdrawal by Subject|4|||
105803058|NCT00066807|364934671|FG000|Overall Study|Study was terminated early|14|||
105803059|NCT00066807|364934672|FG001|Overall Study|Study was terminated early|15|||
105803060|NCT05028751|364934673|FG000|Overall Study|Study Terminated by Sponsor|3|||
105803061|NCT05028751|364934674|FG001|Overall Study|Study Terminated by Sponsor|0|||
105803062|NCT05028751|364934675|FG002|Overall Study|Study Terminated by Sponsor|0|||
105803063|NCT05028751|364934676|FG003|Overall Study|Study Terminated by Sponsor|0|||
105803064|NCT05028751|364934673|FG000|Overall Study|Death|9|||
105803065|NCT05028751|364934674|FG001|Overall Study|Death|3|||
105803066|NCT05028751|364934675|FG002|Overall Study|Death|2|||
105360515|NCT03311841|363325977|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
105360516|NCT03311841|363325978|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
105360517|NCT03311841|363325979|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
105360518|NCT03311841|363325980|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
105803067|NCT05028751|364934676|FG003|Overall Study|Death|4|||
105803068|NCT05028751|364934673|FG000|Overall Study|Withdrawal by Subject|0|||
105803069|NCT05028751|364934674|FG001|Overall Study|Withdrawal by Subject|0|||
105803070|NCT05028751|364934675|FG002|Overall Study|Withdrawal by Subject|1|||
105803071|NCT05028751|364934676|FG003|Overall Study|Withdrawal by Subject|0|||
105803072|NCT05028751|364934673|FG000|Overall Study|Miscellaneous|2|||
105803073|NCT05028751|364934674|FG001|Overall Study|Miscellaneous|0|||
105360519|NCT03311841|363325981|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
105803074|NCT05028751|364934675|FG002|Overall Study|Miscellaneous|0|||
105803075|NCT05028751|364934676|FG003|Overall Study|Miscellaneous|0|||
105803076|NCT00972153|364934680|FG000|Overall Study|Equipment malfunction during case|0|||
105803077|NCT00972153|364934681|FG001|Overall Study|Equipment malfunction during case|1|||
105803078|NCT00972153|364934682|FG002|Overall Study|Equipment malfunction during case|0|||
105803079|NCT02919475|364936487|FG000|Overall Study|Adverse Event|3|||
105803080|NCT02919475|364936488|FG001|Overall Study|Adverse Event|3|||
105803081|NCT02919475|364936489|FG002|Overall Study|Adverse Event|3|||
105803082|NCT02919475|364936490|FG003|Overall Study|Adverse Event|9|||
105803083|NCT02919475|364936491|FG004|Overall Study|Adverse Event|2|||
105803084|NCT02919475|364936487|FG000|Overall Study|Death|0|||
105803085|NCT02919475|364936488|FG001|Overall Study|Death|1|||
105803086|NCT02919475|364936489|FG002|Overall Study|Death|0|||
105803087|NCT02919475|364936490|FG003|Overall Study|Death|0|||
105803088|NCT02919475|364936491|FG004|Overall Study|Death|0|||
105803089|NCT02919475|364936487|FG000|Overall Study|Lost to Follow-up|0|||
105803090|NCT02919475|364936488|FG001|Overall Study|Lost to Follow-up|0|||
105803091|NCT02919475|364936489|FG002|Overall Study|Lost to Follow-up|0|||
105803092|NCT02919475|364936490|FG003|Overall Study|Lost to Follow-up|1|||
105803093|NCT02919475|364936491|FG004|Overall Study|Lost to Follow-up|0|||
105803094|NCT02919475|364936487|FG000|Overall Study|Withdrawal by Subject|2|||
105803095|NCT02919475|364936488|FG001|Overall Study|Withdrawal by Subject|3|||
105803096|NCT02919475|364936489|FG002|Overall Study|Withdrawal by Subject|1|||
105803097|NCT02919475|364936490|FG003|Overall Study|Withdrawal by Subject|2|||
105803098|NCT02919475|364936491|FG004|Overall Study|Withdrawal by Subject|2|||
105803099|NCT02919475|364936487|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
105803100|NCT02919475|364936488|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
105803101|NCT02919475|364936489|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
105803102|NCT02919475|364936490|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
105803103|NCT02919475|364936491|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105803104|NCT00693784|364936493|FG000|Overall Study|Lost to Follow-up|2|||
105803105|NCT00693784|364936493|FG000|Overall Study|Withdrawal by Subject|2|||
105803106|NCT01664052|364936495|FG000|Phase 1|No device placement|6|||
105803107|NCT01664052|364936496|FG001|Phase 1|No device placement|0|||
105803108|NCT01664052|364936495|FG000|Phase 1|No HSG 1 hr post placement|1|||
105803109|NCT01664052|364936496|FG001|Phase 1|No HSG 1 hr post placement|0|||
105803110|NCT01664052|364936495|FG000|Phase 2|No device placement|0|||
105803111|NCT01664052|364936496|FG001|Phase 2|No device placement|4|||
105803112|NCT01042977|364936497|FG000|Overall Study|Adverse Event|4|||
105803113|NCT01042977|364936498|FG001|Overall Study|Adverse Event|12|||
105803114|NCT01042977|364936497|FG000|Overall Study|Death|2|||
105803115|NCT01042977|364936498|FG001|Overall Study|Death|1|||
105803116|NCT01042977|364936497|FG000|Overall Study|Withdrawal by Subject|8|||
105803117|NCT01042977|364936498|FG001|Overall Study|Withdrawal by Subject|16|||
105803118|NCT01042977|364936497|FG000|Overall Study|Lost to Follow-up|0|||
105803119|NCT01042977|364936498|FG001|Overall Study|Lost to Follow-up|2|||
105803120|NCT01042977|364936497|FG000|Overall Study|Poor/non-compliance|3|||
105803121|NCT01042977|364936498|FG001|Overall Study|Poor/non-compliance|4|||
105803122|NCT01042977|364936497|FG000|Overall Study|Subject no longer meets study criteria|15|||
105803123|NCT01042977|364936498|FG001|Overall Study|Subject no longer meets study criteria|13|||
105803124|NCT01042977|364936497|FG000|Overall Study|Incorrect enrollment|6|||
105803125|NCT01042977|364936498|FG001|Overall Study|Incorrect enrollment|4|||
105803126|NCT01042977|364936497|FG000|Overall Study|Safety|0|||
105803127|NCT01042977|364936498|FG001|Overall Study|Safety|2|||
105803128|NCT01042977|364936497|FG000|Overall Study|Administrative reason by sponsor|0|||
105803129|NCT01042977|364936498|FG001|Overall Study|Administrative reason by sponsor|1|||
105803130|NCT01042977|364936497|FG000|Overall Study|Various|3|||
105803131|NCT01042977|364936498|FG001|Overall Study|Various|0|||
105803132|NCT01677910|364936503|FG000|Double-Blind Treatment Period|Adverse Event|6|||
105803133|NCT01677910|364936504|FG001|Double-Blind Treatment Period|Adverse Event|2|||
105803134|NCT01677910|364936505|FG002|Double-Blind Treatment Period|Adverse Event|3|||
105803135|NCT01677910|364936506|FG003|Double-Blind Treatment Period|Adverse Event|0|||
105803136|NCT01677910|364936503|FG000|Double-Blind Treatment Period|Physician Decision|0|||
105803137|NCT01677910|364936504|FG001|Double-Blind Treatment Period|Physician Decision|0|||
105803138|NCT01677910|364936505|FG002|Double-Blind Treatment Period|Physician Decision|1|||
105803139|NCT01677910|364936506|FG003|Double-Blind Treatment Period|Physician Decision|0|||
105803140|NCT01677910|364936503|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
105803141|NCT01677910|364936504|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
105803142|NCT01677910|364936505|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
105803143|NCT01677910|364936506|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
105803144|NCT01677910|364936503|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
105803145|NCT01677910|364936504|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
105803146|NCT01677910|364936505|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
105803147|NCT01677910|364936506|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
105803148|NCT01677910|364936503|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
105803149|NCT01677910|364936504|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
105803150|NCT01677910|364936505|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
105803151|NCT01677910|364936506|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
105803152|NCT01677910|364936503|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
105803153|NCT01677910|364936504|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
105803154|NCT01677910|364936505|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
105803155|NCT01677910|364936506|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
105803156|NCT01677910|364936503|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
105756263|NCT02685995|364760159|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
105756264|NCT00868166|364760160|FG000|Overall Study|Death|58|||
105756265|NCT00868166|364760161|FG001|Overall Study|Death|65|||
105756266|NCT00868166|364760160|FG000|Overall Study|Withdrawal by Subject|33|||
105756267|NCT00868166|364760161|FG001|Overall Study|Withdrawal by Subject|25|||
105756268|NCT00868166|364760160|FG000|Overall Study|Protocol Violation|1|||
105756269|NCT00868166|364760161|FG001|Overall Study|Protocol Violation|0|||
105756270|NCT00868166|364760160|FG000|Overall Study|Lost to Follow-up|1|||
105756271|NCT00868166|364760161|FG001|Overall Study|Lost to Follow-up|3|||
105756272|NCT00868166|364760160|FG000|Overall Study|Adverse Event|9|||
105756273|NCT00868166|364760161|FG001|Overall Study|Adverse Event|10|||
105756274|NCT00868166|364760160|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
105756275|NCT00868166|364760161|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
105756276|NCT00868166|364760160|FG000|Overall Study|Non-compliance with IMP|1|||
105756277|NCT00868166|364760161|FG001|Overall Study|Non-compliance with IMP|1|||
105756278|NCT00126581|364760164|FG000|Overall Study|Adverse Event|3|||
105756279|NCT00126581|364760165|FG001|Overall Study|Adverse Event|7|||
105756280|NCT00126581|364760164|FG000|Overall Study|Death|3|||
105756281|NCT00126581|364760165|FG001|Overall Study|Death|2|||
105756282|NCT00126581|364760164|FG000|Overall Study|Withdrawal by Subject|1|||
105756283|NCT00126581|364760165|FG001|Overall Study|Withdrawal by Subject|4|||
105756284|NCT00126581|364760164|FG000|Overall Study|Alternative therapy|3|||
105756285|NCT00126581|364760165|FG001|Overall Study|Alternative therapy|3|||
105756286|NCT00126581|364760164|FG000|Overall Study|Other illness/MD discretion|3|||
105756287|NCT00126581|364760165|FG001|Overall Study|Other illness/MD discretion|4|||
105756288|NCT00793182|364760166|FG000|Overall Study|Adverse Event|0|||
105756289|NCT00793182|364760167|FG001|Overall Study|Adverse Event|1|||
105756290|NCT01188538|364760170|FG000|Overall Study|Lost to Follow-up|0|||
105756291|NCT01188538|364760171|FG001|Overall Study|Lost to Follow-up|1|||
105756292|NCT01797445|364760174|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
105756293|NCT01797445|364760175|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
105756294|NCT01797445|364760174|FG000|Double-Blind Phase|Adverse Event|3|||
105756295|NCT01797445|364760175|FG001|Double-Blind Phase|Adverse Event|0|||
105756296|NCT01797445|364760174|FG000|Double-Blind Phase|Death|5|||
105756297|NCT01797445|364760175|FG001|Double-Blind Phase|Death|4|||
105756298|NCT01797445|364760174|FG000|Double-Blind Phase|Pregnancy|0|||
105756299|NCT01797445|364760175|FG001|Double-Blind Phase|Pregnancy|1|||
105756300|NCT01797445|364760174|FG000|Double-Blind Phase|Lack of Efficacy|1|||
105756301|NCT01797445|364760175|FG001|Double-Blind Phase|Lack of Efficacy|2|||
105756302|NCT01797445|364760174|FG000|Double-Blind Phase|Investigator's Discretion|15|||
105756303|NCT01797445|364760175|FG001|Double-Blind Phase|Investigator's Discretion|17|||
105756304|NCT01797445|364760174|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
105756305|NCT01797445|364760175|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
105756306|NCT01797445|364760174|FG000|Double-Blind Phase|Protocol Violation|0|||
105756307|NCT01797445|364760175|FG001|Double-Blind Phase|Protocol Violation|1|||
105756308|NCT01797445|364760174|FG000|Double-Blind Phase|Withdrew Consent|20|||
105756309|NCT01797445|364760175|FG001|Double-Blind Phase|Withdrew Consent|35|||
105756310|NCT01797445|364760174|FG000|Double-Blind Phase|Lost to Follow-up|34|||
105756311|NCT01797445|364760175|FG001|Double-Blind Phase|Lost to Follow-up|26|||
105756312|NCT01797445|364760174|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
105756313|NCT01797445|364760175|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
105756314|NCT01595438|364760178|FG000|Overall Study|Lost to Follow-up|20|||
105756315|NCT01595438|364760179|FG001|Overall Study|Lost to Follow-up|20|||
105756316|NCT01595438|364760178|FG000|Overall Study|Withdrawal by Subject|12|||
105756317|NCT01595438|364760179|FG001|Overall Study|Withdrawal by Subject|12|||
105756318|NCT01595438|364760178|FG000|Overall Study|Other Eligibility criteria|11|||
105756319|NCT01595438|364760179|FG001|Overall Study|Other Eligibility criteria|9|||
105756320|NCT01280266|364760180|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
105756321|NCT01280266|364760181|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
105756322|NCT01280266|364760180|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
105756323|NCT01280266|364760181|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
105756324|NCT01381718|364760182|FG000|Overall Study|Withdrawal by Subject|2|||
105756325|NCT01381718|364760183|FG001|Overall Study|Withdrawal by Subject|5|||
105756326|NCT01381718|364760182|FG000|Overall Study|Lost to Follow-up|3|||
105756327|NCT01381718|364760183|FG001|Overall Study|Lost to Follow-up|5|||
105756328|NCT01381718|364760182|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
105756329|NCT01381718|364760183|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
105756330|NCT00618995|364760188|FG000|Period 1|Adverse Event|0|||
105756331|NCT00618995|364760189|FG001|Period 1|Adverse Event|0|||
105803157|NCT01677910|364936504|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
105803158|NCT01677910|364936505|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
105803159|NCT01677910|364936506|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
105803160|NCT01677910|364936503|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
105803161|NCT01677910|364936504|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
105803162|NCT01677910|364936505|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
105803163|NCT01677910|364936506|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
105803164|NCT01677910|364936503|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
105803165|NCT01677910|364936504|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
105803166|NCT01677910|364936505|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
105803167|NCT01677910|364936506|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
105803168|NCT01677910|364936503|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
105803169|NCT01677910|364936504|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
105803170|NCT01677910|364936505|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
105803171|NCT01677910|364936506|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
105803172|NCT00606684|364936507|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
105803173|NCT00606684|364936508|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
105803174|NCT00606684|364936509|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
105803175|NCT00606684|364936510|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
105803176|NCT00606684|364936511|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
105803177|NCT00606684|364936512|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
105803178|NCT00606684|364936513|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
105803179|NCT00606684|364936507|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
105803180|NCT00606684|364936508|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
105803181|NCT00606684|364936509|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
105803182|NCT00606684|364936510|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
105803183|NCT00606684|364936511|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
105803184|NCT00606684|364936512|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
105803185|NCT00606684|364936513|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
105803186|NCT00606684|364936507|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
105803187|NCT00606684|364936508|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
105803188|NCT00606684|364936509|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
105803189|NCT00606684|364936510|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
105803190|NCT00606684|364936511|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
105803191|NCT00606684|364936512|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
105803192|NCT00606684|364936513|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
105803193|NCT00606684|364936507|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
105803194|NCT00606684|364936508|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
105803195|NCT00606684|364936509|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
105803196|NCT00606684|364936510|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
105803197|NCT00606684|364936511|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
105803198|NCT00606684|364936512|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
105803199|NCT00606684|364936513|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
105803200|NCT00606684|364936507|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
105803201|NCT00606684|364936508|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
105803202|NCT00606684|364936509|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
105803203|NCT00606684|364936510|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
105803204|NCT00606684|364936511|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
105803205|NCT00606684|364936512|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
105803206|NCT00606684|364936513|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
105803207|NCT00606684|364936507|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
105803208|NCT00606684|364936508|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
105803209|NCT00606684|364936509|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
105803210|NCT00606684|364936510|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
105803211|NCT00606684|364936511|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
105803212|NCT00606684|364936512|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
105803213|NCT00606684|364936513|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
105803214|NCT00606684|364936507|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
105803215|NCT00606684|364936508|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
105756332|NCT00618995|364760190|FG002|Period 1|Adverse Event|1|||
105756333|NCT00618995|364760191|FG003|Period 1|Adverse Event|0|||
105756334|NCT00618995|364760188|FG000|Period 1|Protocol Violation|0|||
105756335|NCT00618995|364760189|FG001|Period 1|Protocol Violation|1|||
105756336|NCT00618995|364760190|FG002|Period 1|Protocol Violation|1|||
105756337|NCT00618995|364760191|FG003|Period 1|Protocol Violation|0|||
105756338|NCT00618995|364760188|FG000|Period 2|Protocol Violation|0|||
105756339|NCT00618995|364760189|FG001|Period 2|Protocol Violation|0|||
105756340|NCT00618995|364760190|FG002|Period 2|Protocol Violation|1|||
105756341|NCT00618995|364760191|FG003|Period 2|Protocol Violation|0|||
105756342|NCT00618995|364760188|FG000|Period 4|Adverse Event|1|||
105756343|NCT00618995|364760189|FG001|Period 4|Adverse Event|0|||
105756344|NCT00618995|364760190|FG002|Period 4|Adverse Event|0|||
105756345|NCT00618995|364760191|FG003|Period 4|Adverse Event|0|||
105756346|NCT00065442|364760195|FG000|Overall Study|Lost to Follow-up|1|||
105756347|NCT00065442|364760196|FG001|Overall Study|Lost to Follow-up|1|||
105756348|NCT00065442|364760195|FG000|Overall Study|Death|121|||
105756349|NCT00065442|364760196|FG001|Overall Study|Death|210|||
105756350|NCT00065442|364760195|FG000|Overall Study|Withdrawal by Subject|3|||
105756351|NCT00065442|364760196|FG001|Overall Study|Withdrawal by Subject|9|||
105756352|NCT02029638|364760197|FG000|Overall Study|Death|0|||
105756353|NCT02029638|364760198|FG001|Overall Study|Death|0|||
105756354|NCT02029638|364760199|FG002|Overall Study|Death|1|||
105756355|NCT02029638|364760197|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
105756356|NCT02029638|364760198|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
105756357|NCT02029638|364760199|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
105756358|NCT01153841|364760202|FG000|Overall Study|Adverse Event|1|||
105756359|NCT01153841|364760203|FG001|Overall Study|Adverse Event|0|||
105756360|NCT01153841|364760202|FG000|Overall Study|Withdrawal by Subject|1|||
105756361|NCT01153841|364760203|FG001|Overall Study|Withdrawal by Subject|0|||
105756362|NCT01153841|364760202|FG000|Overall Study|Protocol Violation|2|||
105756363|NCT01153841|364760203|FG001|Overall Study|Protocol Violation|0|||
105756364|NCT01153841|364760202|FG000|Overall Study|Lost to Follow-up|2|||
105756365|NCT01153841|364760203|FG001|Overall Study|Lost to Follow-up|0|||
105756366|NCT03428997|364760216|FG000|Overall Study|Sponsor decision.|1|||
105756367|NCT03428997|364760216|FG000|Overall Study|Withdrawal by Subject|3|||
105756368|NCT03428997|364760216|FG000|Overall Study|Lost to Follow-up|4|||
105756369|NCT00965146|364760218|FG000|Overall Study|Death|7|||
105756370|NCT00965146|364760218|FG000|Overall Study|Lost to Follow-up|22|||
105756371|NCT00965146|364760218|FG000|Overall Study|Withdrawal by Subject|17|||
105756372|NCT00965146|364760218|FG000|Overall Study|Unable to return|1|||
105756373|NCT00965146|364760218|FG000|Overall Study|Unwilling to return|11|||
105756374|NCT00965146|364760218|FG000|Overall Study|Intercurrent illness|1|||
105756375|NCT00965146|364760218|FG000|Overall Study|Revision / Removal of Study Implant|6|||
105756376|NCT00965146|364760218|FG000|Overall Study|Overall Study Termination|145|||
105756377|NCT00425113|364760219|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
105756378|NCT00425113|364760220|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
105756379|NCT00425113|364760219|FG000|Overall Study|diagnosis of abdominal TB|0|||
105756380|NCT00425113|364760220|FG001|Overall Study|diagnosis of abdominal TB|1|||
105756381|NCT00425113|364760219|FG000|Overall Study|missing study drug more than 14 days|0|||
105756382|NCT00425113|364760220|FG001|Overall Study|missing study drug more than 14 days|1|||
105756383|NCT00425113|364760219|FG000|Overall Study|Withdrawal by Subject|1|||
105756384|NCT00425113|364760220|FG001|Overall Study|Withdrawal by Subject|0|||
105756385|NCT00936117|364760221|FG000|Overall Study|Adverse Event|7|||
105756386|NCT00936117|364760221|FG000|Overall Study|Unable to continue oral medication|3|||
105756387|NCT01309841|364760224|FG000|Overall Study|Other|0|||
105756388|NCT01309841|364760225|FG001|Overall Study|Other|1|||
105756389|NCT01309841|364760226|FG002|Overall Study|Other|1|||
105756390|NCT01309841|364760224|FG000|Overall Study|Lost to Follow-up|7|||
105756391|NCT01309841|364760225|FG001|Overall Study|Lost to Follow-up|6|||
105756392|NCT01309841|364760226|FG002|Overall Study|Lost to Follow-up|4|||
105756393|NCT01309841|364760224|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
105756394|NCT01309841|364760225|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
105756395|NCT01309841|364760226|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
105756396|NCT01309841|364760224|FG000|Overall Study|Lack of Efficacy|0|||
105756397|NCT01309841|364760225|FG001|Overall Study|Lack of Efficacy|0|||
105360520|NCT01497067|363325986|FG000|Overall Study|Lost to Follow-up|56|||
105756398|NCT01309841|364760226|FG002|Overall Study|Lack of Efficacy|2|||
105756399|NCT01309841|364760224|FG000|Overall Study|Adverse Event|9|||
105756400|NCT01309841|364760225|FG001|Overall Study|Adverse Event|22|||
105756401|NCT01309841|364760226|FG002|Overall Study|Adverse Event|11|||
105756402|NCT01309841|364760224|FG000|Overall Study|Death|1|||
105756403|NCT01309841|364760225|FG001|Overall Study|Death|0|||
105756404|NCT01309841|364760226|FG002|Overall Study|Death|0|||
105756405|NCT01309841|364760224|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
105756406|NCT01309841|364760225|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
105756407|NCT01309841|364760226|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
105756408|NCT01309841|364760224|FG000|Overall Study|Withdrawal by Subject|17|||
105756409|NCT01309841|364760225|FG001|Overall Study|Withdrawal by Subject|6|||
105756410|NCT01309841|364760226|FG002|Overall Study|Withdrawal by Subject|13|||
105756411|NCT01309841|364760224|FG000|Overall Study|Did Not Receive Treatment|2|||
105756412|NCT01309841|364760225|FG001|Overall Study|Did Not Receive Treatment|0|||
105756413|NCT01309841|364760226|FG002|Overall Study|Did Not Receive Treatment|1|||
105756414|NCT01309841|364760224|FG000|Overall Study|Severe non-compliance with protocol|0|||
105756415|NCT01309841|364760225|FG001|Overall Study|Severe non-compliance with protocol|5|||
105756416|NCT01309841|364760226|FG002|Overall Study|Severe non-compliance with protocol|2|||
105756417|NCT00050960|364760227|FG000|Overall Study|Progressive Disease|137|||
105756418|NCT00050960|364760228|FG001|Overall Study|Progressive Disease|93|||
105756419|NCT00050960|364760227|FG000|Overall Study|Stable Disease|19|||
105756420|NCT00050960|364760228|FG001|Overall Study|Stable Disease|48|||
105756421|NCT00050960|364760227|FG000|Overall Study|Partial Response|14|||
105756422|NCT00050960|364760228|FG001|Overall Study|Partial Response|19|||
105756423|NCT00050960|364760227|FG000|Overall Study|Complete Response|0|||
105756424|NCT00050960|364760228|FG001|Overall Study|Complete Response|2|||
105756425|NCT00050960|364760227|FG000|Overall Study|Adverse Event|62|||
105756426|NCT00050960|364760228|FG001|Overall Study|Adverse Event|61|||
105756427|NCT00050960|364760227|FG000|Overall Study|Lost to Follow-up|0|||
105756428|NCT00050960|364760228|FG001|Overall Study|Lost to Follow-up|1|||
105756429|NCT00050960|364760227|FG000|Overall Study|Withdrawal by Subject|23|||
105756430|NCT00050960|364760228|FG001|Overall Study|Withdrawal by Subject|18|||
105756431|NCT00050960|364760227|FG000|Overall Study|Administrative|31|||
105756432|NCT00050960|364760228|FG001|Overall Study|Administrative|46|||
105756433|NCT00050960|364760227|FG000|Overall Study|Non-compliance|3|||
105756434|NCT00050960|364760228|FG001|Overall Study|Non-compliance|1|||
105756435|NCT00050960|364760227|FG000|Overall Study|Death|13|||
105756436|NCT00050960|364760228|FG001|Overall Study|Death|15|||
105756437|NCT00305604|364760229|FG000|Overall Study|Adverse Event|6|||
105756438|NCT00305604|364760230|FG001|Overall Study|Adverse Event|3|||
105756439|NCT00305604|364760229|FG000|Overall Study|Lack of Efficacy|11|||
105756440|NCT00305604|364760230|FG001|Overall Study|Lack of Efficacy|18|||
105756441|NCT00305604|364760229|FG000|Overall Study|Lost to Follow-up|0|||
105756442|NCT00305604|364760230|FG001|Overall Study|Lost to Follow-up|4|||
105756443|NCT00305604|364760229|FG000|Overall Study|Protocol Violation|2|||
105756444|NCT00305604|364760230|FG001|Overall Study|Protocol Violation|1|||
105756445|NCT00305604|364760229|FG000|Overall Study|Withdrawal by Subject|12|||
105756446|NCT00305604|364760230|FG001|Overall Study|Withdrawal by Subject|21|||
105756447|NCT00305604|364760229|FG000|Overall Study|Patient moved|1|||
105756448|NCT00305604|364760230|FG001|Overall Study|Patient moved|0|||
105756449|NCT00764946|364760231|FG000|Overall Study|Lack of Efficacy|1|||
105756450|NCT00764946|364760232|FG001|Overall Study|Lack of Efficacy|0|||
105756451|NCT00764946|364760233|FG002|Overall Study|Lack of Efficacy|0|||
105756452|NCT00764946|364760231|FG000|Overall Study|Lost to Follow-up|3|||
105756453|NCT00764946|364760232|FG001|Overall Study|Lost to Follow-up|4|||
105756454|NCT00764946|364760233|FG002|Overall Study|Lost to Follow-up|0|||
105756455|NCT00764946|364760231|FG000|Overall Study|Physician Decision|2|||
105803216|NCT00606684|364936509|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
105756456|NCT00764946|364760232|FG001|Overall Study|Physician Decision|4|||
105756457|NCT00764946|364760233|FG002|Overall Study|Physician Decision|0|||
105803217|NCT00606684|364936510|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
105756458|NCT00764946|364760231|FG000|Overall Study|Adverse Event|3|||
105756459|NCT00764946|364760232|FG001|Overall Study|Adverse Event|2|||
105756460|NCT00764946|364760233|FG002|Overall Study|Adverse Event|1|||
105756461|NCT00764946|364760231|FG000|Overall Study|Withdrawal by Subject|3|||
105803218|NCT00606684|364936511|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
105803219|NCT00606684|364936512|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
105803220|NCT00606684|364936513|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
105803221|NCT00606684|364936507|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105803222|NCT00606684|364936508|FG001|Double-Blind Treatment Period|Adverse Event|3|||
105803223|NCT00606684|364936509|FG002|Double-Blind Treatment Period|Adverse Event|2|||
105803224|NCT00606684|364936510|FG003|Double-Blind Treatment Period|Adverse Event|4|||
105803225|NCT00606684|364936511|FG004|Double-Blind Treatment Period|Adverse Event|2|||
105803226|NCT00606684|364936512|FG005|Double-Blind Treatment Period|Adverse Event|0|||
105803227|NCT00606684|364936513|FG006|Double-Blind Treatment Period|Adverse Event|1|||
105803228|NCT00606684|364936507|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
105803229|NCT00606684|364936508|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
105803230|NCT00606684|364936509|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
105803231|NCT00606684|364936510|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
105803232|NCT00606684|364936511|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
105803233|NCT00606684|364936512|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
105803234|NCT00606684|364936513|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
105803235|NCT00606684|364936507|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
105803236|NCT00606684|364936508|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
105803237|NCT00606684|364936509|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
105803238|NCT00606684|364936510|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
105803239|NCT00606684|364936511|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
105803240|NCT00606684|364936512|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
105803241|NCT00606684|364936513|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
105803242|NCT00606684|364936507|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
105803243|NCT00606684|364936508|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
105803244|NCT00606684|364936509|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
105803245|NCT00606684|364936510|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
105803246|NCT00606684|364936511|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
105803247|NCT00606684|364936512|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
105803248|NCT00606684|364936513|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
105803249|NCT00606684|364936507|FG000|Double-Blind Treatment Period|Physician Decision|0|||
105803250|NCT00606684|364936508|FG001|Double-Blind Treatment Period|Physician Decision|5|||
105803251|NCT00606684|364936509|FG002|Double-Blind Treatment Period|Physician Decision|1|||
105803252|NCT00606684|364936510|FG003|Double-Blind Treatment Period|Physician Decision|0|||
105803253|NCT00606684|364936511|FG004|Double-Blind Treatment Period|Physician Decision|3|||
105803254|NCT00606684|364936512|FG005|Double-Blind Treatment Period|Physician Decision|1|||
105803255|NCT00606684|364936513|FG006|Double-Blind Treatment Period|Physician Decision|2|||
105803256|NCT00606684|364936507|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105803257|NCT00606684|364936508|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105803258|NCT00606684|364936509|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105803259|NCT00606684|364936510|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
105803260|NCT00606684|364936511|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105803261|NCT00606684|364936512|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
105803262|NCT00606684|364936513|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105803263|NCT02763579|364936514|FG000|Global Period|Death|167|||
105803264|NCT02763579|364936515|FG001|Global Period|Death|151|||
105803265|NCT02763579|364936516|FG002|Global Period|Death|0|||
105803266|NCT02763579|364936517|FG003|Global Period|Death|0|||
105803267|NCT02763579|364936514|FG000|Global Period|Lost to Follow-up|2|||
105803268|NCT02763579|364936515|FG001|Global Period|Lost to Follow-up|4|||
105803269|NCT02763579|364936516|FG002|Global Period|Lost to Follow-up|0|||
105803270|NCT02763579|364936517|FG003|Global Period|Lost to Follow-up|0|||
105803271|NCT02763579|364936514|FG000|Global Period|Physician Decision|0|||
105803272|NCT02763579|364936515|FG001|Global Period|Physician Decision|2|||
105803273|NCT02763579|364936516|FG002|Global Period|Physician Decision|0|||
105803274|NCT02763579|364936517|FG003|Global Period|Physician Decision|0|||
105803275|NCT02763579|364936514|FG000|Global Period|Study Terminated By Sponsor|21|||
105803276|NCT02763579|364936515|FG001|Global Period|Study Terminated By Sponsor|26|||
105803277|NCT02763579|364936516|FG002|Global Period|Study Terminated By Sponsor|0|||
105803278|NCT02763579|364936517|FG003|Global Period|Study Terminated By Sponsor|0|||
105803279|NCT02763579|364936514|FG000|Global Period|Withdrawal by Subject|12|||
105803280|NCT02763579|364936515|FG001|Global Period|Withdrawal by Subject|18|||
105803281|NCT02763579|364936516|FG002|Global Period|Withdrawal by Subject|0|||
105803282|NCT02763579|364936517|FG003|Global Period|Withdrawal by Subject|0|||
105803283|NCT02763579|364936514|FG000|China Period|Death|0|||
105803284|NCT02763579|364936515|FG001|China Period|Death|0|||
105803285|NCT02763579|364936516|FG002|China Period|Death|46|||
105803286|NCT02763579|364936517|FG003|China Period|Death|48|||
105803287|NCT02763579|364936514|FG000|China Period|Lost to Follow-up|0|||
105803288|NCT02763579|364936515|FG001|China Period|Lost to Follow-up|0|||
105803289|NCT02763579|364936516|FG002|China Period|Lost to Follow-up|1|||
105803290|NCT02763579|364936517|FG003|China Period|Lost to Follow-up|1|||
105803291|NCT02763579|364936514|FG000|China Period|Physician Decision|0|||
105803292|NCT02763579|364936515|FG001|China Period|Physician Decision|0|||
105803293|NCT02763579|364936516|FG002|China Period|Physician Decision|0|||
105803294|NCT02763579|364936517|FG003|China Period|Physician Decision|1|||
105803295|NCT02763579|364936514|FG000|China Period|Study Terminated By Sponsor|0|||
105803296|NCT02763579|364936515|FG001|China Period|Study Terminated By Sponsor|0|||
105803297|NCT02763579|364936516|FG002|China Period|Study Terminated By Sponsor|3|||
105803298|NCT02763579|364936517|FG003|China Period|Study Terminated By Sponsor|4|||
105803299|NCT02763579|364936514|FG000|China Period|Withdrawal by Subject|0|||
105803300|NCT02763579|364936515|FG001|China Period|Withdrawal by Subject|0|||
105803301|NCT02763579|364936516|FG002|China Period|Withdrawal by Subject|3|||
105803302|NCT02763579|364936517|FG003|China Period|Withdrawal by Subject|3|||
105803303|NCT01034137|364936527|FG000|Overall Study|Adverse Event|9|||
105803304|NCT01034137|364936528|FG001|Overall Study|Adverse Event|10|||
105803305|NCT01034137|364936529|FG002|Overall Study|Adverse Event|8|||
105803306|NCT01034137|364936527|FG000|Overall Study|Withdrawal by Subject|4|||
105803307|NCT01034137|364936528|FG001|Overall Study|Withdrawal by Subject|3|||
105803308|NCT01034137|364936529|FG002|Overall Study|Withdrawal by Subject|3|||
105803309|NCT01034137|364936527|FG000|Overall Study|Lack of Efficacy|9|||
105803310|NCT01034137|364936528|FG001|Overall Study|Lack of Efficacy|4|||
105803311|NCT01034137|364936529|FG002|Overall Study|Lack of Efficacy|13|||
105803312|NCT01034137|364936527|FG000|Overall Study|Protocol Violation|2|||
105803313|NCT01034137|364936528|FG001|Overall Study|Protocol Violation|2|||
105803314|NCT01034137|364936529|FG002|Overall Study|Protocol Violation|1|||
105803315|NCT01034137|364936527|FG000|Overall Study|Refused treatment or did not cooperate|2|||
105803316|NCT01034137|364936528|FG001|Overall Study|Refused treatment or did not cooperate|0|||
105803317|NCT01034137|364936529|FG002|Overall Study|Refused treatment or did not cooperate|1|||
105803318|NCT01034137|364936527|FG000|Overall Study|Administrative or other|2|||
105803319|NCT01034137|364936528|FG001|Overall Study|Administrative or other|3|||
105803320|NCT01034137|364936529|FG002|Overall Study|Administrative or other|4|||
105803321|NCT01764854|364936535|FG000|Overall Study|Adverse Event|0|||
105803322|NCT01764854|364936536|FG001|Overall Study|Adverse Event|0|||
105803323|NCT01764854|364936537|FG002|Overall Study|Adverse Event|2|||
105803324|NCT01764854|364936538|FG003|Overall Study|Adverse Event|0|||
105803325|NCT01764854|364936535|FG000|Overall Study|Withdrawal by Subject|0|||
105803326|NCT01764854|364936536|FG001|Overall Study|Withdrawal by Subject|0|||
105803327|NCT01764854|364936537|FG002|Overall Study|Withdrawal by Subject|1|||
105803328|NCT01764854|364936538|FG003|Overall Study|Withdrawal by Subject|0|||
105803329|NCT01764854|364936535|FG000|Overall Study|relocation|0|||
105803330|NCT01764854|364936536|FG001|Overall Study|relocation|0|||
105803331|NCT01764854|364936537|FG002|Overall Study|relocation|2|||
105803332|NCT01764854|364936538|FG003|Overall Study|relocation|0|||
105803333|NCT01764854|364936535|FG000|Overall Study|Protocol Violation|0|||
105803334|NCT01764854|364936536|FG001|Overall Study|Protocol Violation|0|||
105803335|NCT01764854|364936537|FG002|Overall Study|Protocol Violation|1|||
105803336|NCT01764854|364936538|FG003|Overall Study|Protocol Violation|2|||
105803337|NCT01703741|364936540|FG000|Overall Study|Withdrawal by Subject|6|||
105803338|NCT01703741|364936540|FG000|Overall Study|Adverse Event|2|||
105756462|NCT00764946|364760232|FG001|Overall Study|Withdrawal by Subject|6|||
105756463|NCT00764946|364760233|FG002|Overall Study|Withdrawal by Subject|2|||
105756464|NCT00764946|364760231|FG000|Overall Study|Never Treated|1|||
105756465|NCT00764946|364760232|FG001|Overall Study|Never Treated|1|||
105756466|NCT00764946|364760233|FG002|Overall Study|Never Treated|1|||
105756467|NCT04685499|364760235|FG000|Overall Study|Study Terminated Early|1|||
105756468|NCT00006604|364760236|FG000|Overall Study|Met study objective - no further FU|1|||
105756469|NCT00006604|364760237|FG001|Overall Study|Met study objective - no further FU|0|||
105756470|NCT00006604|364760238|FG002|Overall Study|Met study objective - no further FU|0|||
105756471|NCT00006604|364760239|FG003|Overall Study|Met study objective - no further FU|0|||
105756472|NCT00006604|364760240|FG004|Overall Study|Met study objective - no further FU|0|||
105756473|NCT00006604|364760241|FG005|Overall Study|Met study objective - no further FU|0|||
105756474|NCT00006604|364760242|FG006|Overall Study|Met study objective - no further FU|0|||
105756475|NCT00006604|364760243|FG007|Overall Study|Met study objective - no further FU|0|||
105756476|NCT00006604|364760244|FG008|Overall Study|Met study objective - no further FU|0|||
105756477|NCT00006604|364760245|FG009|Overall Study|Met study objective - no further FU|0|||
105756478|NCT00006604|364760246|FG010|Overall Study|Met study objective - no further FU|0|||
105756479|NCT00006604|364760247|FG011|Overall Study|Met study objective - no further FU|0|||
105756480|NCT00006604|364760248|FG012|Overall Study|Met study objective - no further FU|0|||
105756481|NCT00006604|364760249|FG013|Overall Study|Met study objective - no further FU|0|||
105756482|NCT00006604|364760250|FG014|Overall Study|Met study objective - no further FU|1|||
105756483|NCT00006604|364760251|FG015|Overall Study|Met study objective - no further FU|1|||
105756484|NCT00006604|364760252|FG016|Overall Study|Met study objective - no further FU|0|||
105756485|NCT00006604|364760236|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
105756486|NCT00006604|364760237|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
105756487|NCT00006604|364760238|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
105756488|NCT00006604|364760239|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
105756489|NCT00006604|364760240|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
105756490|NCT00006604|364760241|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
105756491|NCT00006604|364760242|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
105756492|NCT00006604|364760243|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
105756493|NCT00006604|364760244|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
105756494|NCT00006604|364760245|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
105756495|NCT00006604|364760246|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
105756496|NCT00006604|364760247|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
105756497|NCT00006604|364760248|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
105756498|NCT00006604|364760249|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
105756499|NCT00006604|364760250|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
105756500|NCT00006604|364760251|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
105756501|NCT00006604|364760252|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
105756502|NCT00006604|364760236|FG000|Overall Study|Death|0|||
105756503|NCT00006604|364760237|FG001|Overall Study|Death|0|||
105756504|NCT00006604|364760238|FG002|Overall Study|Death|0|||
105756505|NCT00006604|364760239|FG003|Overall Study|Death|0|||
105756506|NCT00006604|364760240|FG004|Overall Study|Death|0|||
105756507|NCT00006604|364760241|FG005|Overall Study|Death|0|||
105756508|NCT00006604|364760242|FG006|Overall Study|Death|0|||
105756509|NCT00006604|364760243|FG007|Overall Study|Death|0|||
105756510|NCT00006604|364760244|FG008|Overall Study|Death|0|||
105756511|NCT00006604|364760245|FG009|Overall Study|Death|1|||
105756512|NCT00006604|364760246|FG010|Overall Study|Death|1|||
105756513|NCT00006604|364760247|FG011|Overall Study|Death|1|||
105756514|NCT00006604|364760248|FG012|Overall Study|Death|0|||
105756515|NCT00006604|364760249|FG013|Overall Study|Death|0|||
105756516|NCT00006604|364760250|FG014|Overall Study|Death|0|||
105756517|NCT00006604|364760251|FG015|Overall Study|Death|0|||
105756518|NCT00006604|364760252|FG016|Overall Study|Death|0|||
105756519|NCT00006604|364760236|FG000|Overall Study|Severe debilitation, unable to continue|0|||
105756520|NCT00006604|364760237|FG001|Overall Study|Severe debilitation, unable to continue|0|||
105756521|NCT00006604|364760238|FG002|Overall Study|Severe debilitation, unable to continue|0|||
105756522|NCT00006604|364760239|FG003|Overall Study|Severe debilitation, unable to continue|0|||
105756523|NCT00006604|364760240|FG004|Overall Study|Severe debilitation, unable to continue|0|||
105756524|NCT00006604|364760241|FG005|Overall Study|Severe debilitation, unable to continue|0|||
105756525|NCT00006604|364760242|FG006|Overall Study|Severe debilitation, unable to continue|3|||
105756526|NCT00006604|364760243|FG007|Overall Study|Severe debilitation, unable to continue|0|||
105756527|NCT00006604|364760244|FG008|Overall Study|Severe debilitation, unable to continue|0|||
105756528|NCT00006604|364760245|FG009|Overall Study|Severe debilitation, unable to continue|5|||
105756529|NCT00006604|364760246|FG010|Overall Study|Severe debilitation, unable to continue|0|||
105756530|NCT00006604|364760247|FG011|Overall Study|Severe debilitation, unable to continue|2|||
105756531|NCT00006604|364760248|FG012|Overall Study|Severe debilitation, unable to continue|1|||
105756532|NCT00006604|364760249|FG013|Overall Study|Severe debilitation, unable to continue|0|||
105756533|NCT00006604|364760250|FG014|Overall Study|Severe debilitation, unable to continue|2|||
105756534|NCT00006604|364760251|FG015|Overall Study|Severe debilitation, unable to continue|0|||
105756535|NCT00006604|364760252|FG016|Overall Study|Severe debilitation, unable to continue|0|||
105756536|NCT00006604|364760236|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
105756537|NCT00006604|364760237|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
105756538|NCT00006604|364760238|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
105756539|NCT00006604|364760239|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
105756540|NCT00006604|364760240|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
105756541|NCT00006604|364760241|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
105756542|NCT00006604|364760242|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
105756543|NCT00006604|364760243|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
105756544|NCT00006604|364760244|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
105756545|NCT00006604|364760245|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
105756546|NCT00006604|364760246|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
105756547|NCT00006604|364760247|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
105756548|NCT00006604|364760248|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
105756549|NCT00006604|364760249|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
105756550|NCT00006604|364760250|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
105756551|NCT00006604|364760251|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
105756552|NCT00006604|364760252|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
105756553|NCT00006604|364760236|FG000|Overall Study|Site closing|0|||
105756554|NCT00006604|364760237|FG001|Overall Study|Site closing|0|||
105756555|NCT00006604|364760238|FG002|Overall Study|Site closing|1|||
105756556|NCT00006604|364760239|FG003|Overall Study|Site closing|1|||
105756557|NCT00006604|364760240|FG004|Overall Study|Site closing|0|||
105756558|NCT00006604|364760241|FG005|Overall Study|Site closing|0|||
105756559|NCT00006604|364760242|FG006|Overall Study|Site closing|0|||
105756560|NCT00006604|364760243|FG007|Overall Study|Site closing|1|||
105756561|NCT00006604|364760244|FG008|Overall Study|Site closing|0|||
105756562|NCT00006604|364760245|FG009|Overall Study|Site closing|0|||
105756563|NCT00006604|364760246|FG010|Overall Study|Site closing|0|||
105756564|NCT00006604|364760247|FG011|Overall Study|Site closing|1|||
105756565|NCT00006604|364760248|FG012|Overall Study|Site closing|1|||
105756566|NCT00006604|364760249|FG013|Overall Study|Site closing|1|||
105756567|NCT00006604|364760250|FG014|Overall Study|Site closing|0|||
105756568|NCT00006604|364760251|FG015|Overall Study|Site closing|0|||
105756569|NCT00006604|364760252|FG016|Overall Study|Site closing|1|||
105756570|NCT00006604|364760236|FG000|Overall Study|Withdrawal by Subject|1|||
105756571|NCT00006604|364760237|FG001|Overall Study|Withdrawal by Subject|0|||
105756572|NCT00006604|364760238|FG002|Overall Study|Withdrawal by Subject|2|||
105756573|NCT00006604|364760239|FG003|Overall Study|Withdrawal by Subject|0|||
105756574|NCT00006604|364760240|FG004|Overall Study|Withdrawal by Subject|1|||
105756575|NCT00006604|364760241|FG005|Overall Study|Withdrawal by Subject|2|||
105756576|NCT00006604|364760242|FG006|Overall Study|Withdrawal by Subject|2|||
105756577|NCT00006604|364760243|FG007|Overall Study|Withdrawal by Subject|0|||
105756578|NCT00006604|364760244|FG008|Overall Study|Withdrawal by Subject|1|||
105756579|NCT00006604|364760245|FG009|Overall Study|Withdrawal by Subject|3|||
105756580|NCT00006604|364760246|FG010|Overall Study|Withdrawal by Subject|2|||
105756581|NCT00006604|364760247|FG011|Overall Study|Withdrawal by Subject|0|||
105756582|NCT00006604|364760248|FG012|Overall Study|Withdrawal by Subject|1|||
105756583|NCT00006604|364760249|FG013|Overall Study|Withdrawal by Subject|2|||
105756584|NCT00006604|364760250|FG014|Overall Study|Withdrawal by Subject|1|||
105756585|NCT00006604|364760251|FG015|Overall Study|Withdrawal by Subject|0|||
105756586|NCT00006604|364760252|FG016|Overall Study|Withdrawal by Subject|1|||
105756587|NCT00006604|364760236|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
105756588|NCT00006604|364760237|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
105756589|NCT00006604|364760238|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
105756590|NCT00006604|364760239|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
105756591|NCT00006604|364760240|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
105756592|NCT00006604|364760241|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
105756593|NCT00006604|364760242|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
105756594|NCT00006604|364760243|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
105756595|NCT00006604|364760244|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
105756596|NCT00006604|364760245|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
105756597|NCT00006604|364760246|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
105756598|NCT00006604|364760247|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
105756599|NCT00006604|364760248|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
105756600|NCT00006604|364760249|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
105756601|NCT00006604|364760250|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
105360521|NCT01497067|363325986|FG000|Overall Study|Adverse Event|3|||
105360522|NCT01497067|363325986|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
105360523|NCT01497067|363325986|FG000|Overall Study|Other|13|||
105360524|NCT02472886|363325989|FG000|Overall Study|Lack of Efficacy|0|||
105360525|NCT02472886|363325990|FG001|Overall Study|Lack of Efficacy|2|||
105360526|NCT02472886|363325991|FG002|Overall Study|Lack of Efficacy|1|||
105360527|NCT01765569|363325995|FG000|Period B|Withdrawal by Subject|1|||
105360528|NCT01765569|363325995|FG000|Period C|Death|1|||
105360529|NCT05216835|363326000|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
105360530|NCT05216835|363326001|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
105360531|NCT05216835|363326002|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
105360532|NCT05216835|363326003|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
105360533|NCT05216835|363326004|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
105756602|NCT00006604|364760251|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
105756603|NCT00006604|364760252|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
105756604|NCT00006604|364760236|FG000|Overall Study|Lost to Follow-up|0|||
105756605|NCT00006604|364760237|FG001|Overall Study|Lost to Follow-up|0|||
105756606|NCT00006604|364760238|FG002|Overall Study|Lost to Follow-up|0|||
105756607|NCT00006604|364760239|FG003|Overall Study|Lost to Follow-up|0|||
105756608|NCT00006604|364760240|FG004|Overall Study|Lost to Follow-up|0|||
105756609|NCT00006604|364760241|FG005|Overall Study|Lost to Follow-up|0|||
105756610|NCT00006604|364760242|FG006|Overall Study|Lost to Follow-up|0|||
105756611|NCT00006604|364760243|FG007|Overall Study|Lost to Follow-up|1|||
105756612|NCT00006604|364760244|FG008|Overall Study|Lost to Follow-up|0|||
105756613|NCT00006604|364760245|FG009|Overall Study|Lost to Follow-up|2|||
105756614|NCT00006604|364760246|FG010|Overall Study|Lost to Follow-up|0|||
105756615|NCT00006604|364760247|FG011|Overall Study|Lost to Follow-up|0|||
105756616|NCT00006604|364760248|FG012|Overall Study|Lost to Follow-up|0|||
105756617|NCT00006604|364760249|FG013|Overall Study|Lost to Follow-up|0|||
105756618|NCT00006604|364760250|FG014|Overall Study|Lost to Follow-up|0|||
105756619|NCT00006604|364760251|FG015|Overall Study|Lost to Follow-up|1|||
105756620|NCT00006604|364760252|FG016|Overall Study|Lost to Follow-up|3|||
105756621|NCT00006604|364760236|FG000|Overall Study|Other Reason|0|||
105756622|NCT00006604|364760237|FG001|Overall Study|Other Reason|0|||
105756623|NCT00006604|364760238|FG002|Overall Study|Other Reason|0|||
105756624|NCT00006604|364760239|FG003|Overall Study|Other Reason|0|||
105756625|NCT00006604|364760240|FG004|Overall Study|Other Reason|0|||
105756626|NCT00006604|364760241|FG005|Overall Study|Other Reason|1|||
105756627|NCT00006604|364760242|FG006|Overall Study|Other Reason|0|||
105756628|NCT00006604|364760243|FG007|Overall Study|Other Reason|0|||
105756629|NCT00006604|364760244|FG008|Overall Study|Other Reason|0|||
105756630|NCT00006604|364760245|FG009|Overall Study|Other Reason|1|||
105756631|NCT00006604|364760246|FG010|Overall Study|Other Reason|0|||
105756632|NCT00006604|364760247|FG011|Overall Study|Other Reason|0|||
105756633|NCT00006604|364760248|FG012|Overall Study|Other Reason|0|||
105756634|NCT00006604|364760249|FG013|Overall Study|Other Reason|0|||
105756635|NCT00006604|364760250|FG014|Overall Study|Other Reason|0|||
105756636|NCT00006604|364760251|FG015|Overall Study|Other Reason|0|||
105756637|NCT00006604|364760252|FG016|Overall Study|Other Reason|0|||
105756638|NCT02431468|364760253|FG000|Overall Study|Adverse Event|2|||
105756639|NCT02431468|364760254|FG001|Overall Study|Adverse Event|4|||
105756640|NCT02431468|364760255|FG002|Overall Study|Adverse Event|5|||
105756641|NCT02431468|364760253|FG000|Overall Study|Withdrawal by Subject|4|||
105756642|NCT02431468|364760254|FG001|Overall Study|Withdrawal by Subject|12|||
105756643|NCT02431468|364760255|FG002|Overall Study|Withdrawal by Subject|2|||
105756644|NCT02431468|364760253|FG000|Overall Study|noncompliance, investigator termination,|2|||
105756645|NCT02431468|364760254|FG001|Overall Study|noncompliance, investigator termination,|2|||
105756646|NCT02431468|364760255|FG002|Overall Study|noncompliance, investigator termination,|2|||
105756647|NCT01361919|364760256|FG000|Overall Study|technical issues|10|||
105756648|NCT01361919|364760257|FG001|Overall Study|technical issues|12|||
105756649|NCT01361919|364760258|FG002|Overall Study|technical issues|10|||
105756650|NCT01056341|364760259|FG000|Overall Study|Treatment Intolerance|0|||
105756651|NCT01056341|364760260|FG001|Overall Study|Treatment Intolerance|2|||
105756652|NCT01056341|364760261|FG002|Overall Study|Treatment Intolerance|0|||
105756653|NCT01056341|364760262|FG003|Overall Study|Treatment Intolerance|2|||
105756654|NCT01056341|364760263|FG004|Overall Study|Treatment Intolerance|0|||
105756655|NCT01056341|364760259|FG000|Overall Study|Lack of Efficacy|32|||
105756656|NCT01056341|364760260|FG001|Overall Study|Lack of Efficacy|30|||
105756657|NCT01056341|364760261|FG002|Overall Study|Lack of Efficacy|7|||
105756658|NCT01056341|364760262|FG003|Overall Study|Lack of Efficacy|25|||
105756659|NCT01056341|364760263|FG004|Overall Study|Lack of Efficacy|9|||
105360534|NCT05216835|363326005|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
105360535|NCT05216835|363326006|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
105756660|NCT01056341|364760259|FG000|Overall Study|Other reasons|4|||
105756661|NCT01056341|364760260|FG001|Overall Study|Other reasons|4|||
105756662|NCT01056341|364760261|FG002|Overall Study|Other reasons|8|||
105756663|NCT01056341|364760262|FG003|Overall Study|Other reasons|9|||
105756664|NCT01056341|364760263|FG004|Overall Study|Other reasons|5|||
105803339|NCT01703741|364936540|FG000|Overall Study|Physician Decision|2|||
105803340|NCT01703741|364936540|FG000|Overall Study|Protocol Violation|1|||
105803341|NCT01703741|364936540|FG000|Overall Study|Lost to Follow-up|3|||
105803342|NCT01703741|364936540|FG000|Overall Study|Subject did not want to continue|2|||
105803343|NCT01703741|364936540|FG000|Overall Study|Subject cannot comply with study visits|1|||
105803344|NCT01703741|364936540|FG000|Overall Study|Subject started testosterone injections|1|||
105803345|NCT00672620|364936542|FG000|Overall Study|Adverse Event|7|||
105803346|NCT00672620|364936543|FG001|Overall Study|Adverse Event|7|||
105803347|NCT00672620|364936544|FG002|Overall Study|Adverse Event|12|||
105803348|NCT00672620|364936545|FG003|Overall Study|Adverse Event|17|||
105803349|NCT00672620|364936542|FG000|Overall Study|Lack of Efficacy|1|||
105803350|NCT00672620|364936543|FG001|Overall Study|Lack of Efficacy|2|||
105803351|NCT00672620|364936544|FG002|Overall Study|Lack of Efficacy|2|||
105803352|NCT00672620|364936545|FG003|Overall Study|Lack of Efficacy|0|||
105803353|NCT00672620|364936542|FG000|Overall Study|Noncompliance with Study Drug|3|||
105803354|NCT00672620|364936543|FG001|Overall Study|Noncompliance with Study Drug|4|||
105803355|NCT00672620|364936544|FG002|Overall Study|Noncompliance with Study Drug|0|||
105803356|NCT00672620|364936545|FG003|Overall Study|Noncompliance with Study Drug|2|||
105756665|NCT01086150|364760264|FG000|Overall Study|Withdrawal by Subject|0|||
105756666|NCT01086150|364760265|FG001|Overall Study|Withdrawal by Subject|4|||
105756667|NCT01086150|364760266|FG002|Overall Study|Withdrawal by Subject|1|||
105756668|NCT01086150|364760264|FG000|Overall Study|Lost to Follow-up|0|||
105756669|NCT01086150|364760265|FG001|Overall Study|Lost to Follow-up|1|||
105756670|NCT01086150|364760266|FG002|Overall Study|Lost to Follow-up|0|||
105756671|NCT01086150|364760264|FG000|Overall Study|Screen Failure|0|||
105756672|NCT01086150|364760265|FG001|Overall Study|Screen Failure|1|||
105756673|NCT01086150|364760266|FG002|Overall Study|Screen Failure|0|||
105756674|NCT03956225|364760270|FG000|Overall Study|Lack of Efficacy|1|||
105756675|NCT03956225|364760271|FG001|Overall Study|Lack of Efficacy|1|||
105756676|NCT03956225|364760270|FG000|Overall Study|Lost to Follow-up|0|||
105756677|NCT03956225|364760271|FG001|Overall Study|Lost to Follow-up|1|||
105756678|NCT03956225|364760270|FG000|Overall Study|Withdrawal by Subject|2|||
105756679|NCT03956225|364760271|FG001|Overall Study|Withdrawal by Subject|1|||
105756680|NCT03956225|364760270|FG000|Overall Study|Other Reasons|2|||
105756681|NCT03956225|364760271|FG001|Overall Study|Other Reasons|1|||
105756682|NCT00039741|364760272|FG000|Overall Study|Death|0|||
105756683|NCT00039741|364760273|FG001|Overall Study|Death|1|||
105756684|NCT00039741|364760274|FG002|Overall Study|Death|0|||
105756685|NCT00039741|364760275|FG003|Overall Study|Death|0|||
105756686|NCT00039741|364760272|FG000|Overall Study|Lost to Follow-up|3|||
105756687|NCT00039741|364760273|FG001|Overall Study|Lost to Follow-up|1|||
105756688|NCT00039741|364760274|FG002|Overall Study|Lost to Follow-up|5|||
105756689|NCT00039741|364760275|FG003|Overall Study|Lost to Follow-up|2|||
105756690|NCT00039741|364760272|FG000|Overall Study|Confounding medical condition|1|||
105756691|NCT00039741|364760273|FG001|Overall Study|Confounding medical condition|0|||
105756692|NCT00039741|364760274|FG002|Overall Study|Confounding medical condition|0|||
105756693|NCT00039741|364760275|FG003|Overall Study|Confounding medical condition|0|||
105756694|NCT00039741|364760272|FG000|Overall Study|Not able to get to clinic|5|||
105756695|NCT00039741|364760273|FG001|Overall Study|Not able to get to clinic|2|||
105756696|NCT00039741|364760274|FG002|Overall Study|Not able to get to clinic|0|||
105756697|NCT00039741|364760275|FG003|Overall Study|Not able to get to clinic|3|||
105756698|NCT00039741|364760272|FG000|Overall Study|Moved|3|||
105756699|NCT00039741|364760273|FG001|Overall Study|Moved|2|||
105756700|NCT00039741|364760274|FG002|Overall Study|Moved|3|||
105756701|NCT00039741|364760275|FG003|Overall Study|Moved|6|||
105756702|NCT00039741|364760272|FG000|Overall Study|Non-compliance with protocol|1|||
105756703|NCT00039741|364760273|FG001|Overall Study|Non-compliance with protocol|0|||
105756704|NCT00039741|364760274|FG002|Overall Study|Non-compliance with protocol|1|||
105756705|NCT00039741|364760275|FG003|Overall Study|Non-compliance with protocol|0|||
105756706|NCT00039741|364760272|FG000|Overall Study|Withdrew consent|0|||
105756707|NCT00039741|364760273|FG001|Overall Study|Withdrew consent|5|||
105756708|NCT00039741|364760274|FG002|Overall Study|Withdrew consent|0|||
105756709|NCT00039741|364760275|FG003|Overall Study|Withdrew consent|1|||
105756710|NCT00039741|364760272|FG000|Overall Study|Missed final visit|2|||
105756711|NCT00039741|364760273|FG001|Overall Study|Missed final visit|1|||
105756712|NCT00039741|364760274|FG002|Overall Study|Missed final visit|2|||
105756713|NCT00039741|364760275|FG003|Overall Study|Missed final visit|2|||
105756714|NCT00293423|364760276|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
105756715|NCT00293423|364760277|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
105756716|NCT00293423|364760276|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
105756717|NCT00293423|364760277|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
105803357|NCT00672620|364936542|FG000|Overall Study|Protocol Deviations|5|||
105803358|NCT00672620|364936543|FG001|Overall Study|Protocol Deviations|7|||
105803359|NCT00672620|364936544|FG002|Overall Study|Protocol Deviations|2|||
105803360|NCT00672620|364936545|FG003|Overall Study|Protocol Deviations|5|||
105803361|NCT00672620|364936542|FG000|Overall Study|Withdrawal of Consent|6|||
105803362|NCT00672620|364936543|FG001|Overall Study|Withdrawal of Consent|12|||
105803363|NCT00672620|364936544|FG002|Overall Study|Withdrawal of Consent|5|||
105803364|NCT00672620|364936545|FG003|Overall Study|Withdrawal of Consent|6|||
105803365|NCT00672620|364936542|FG000|Overall Study|Lost to Follow-up|8|||
105803366|NCT00672620|364936543|FG001|Overall Study|Lost to Follow-up|19|||
105803367|NCT00672620|364936544|FG002|Overall Study|Lost to Follow-up|8|||
105803368|NCT00672620|364936545|FG003|Overall Study|Lost to Follow-up|11|||
105803369|NCT00672620|364936542|FG000|Overall Study|Reason not Specified|3|||
105803370|NCT00672620|364936543|FG001|Overall Study|Reason not Specified|3|||
105803371|NCT00672620|364936544|FG002|Overall Study|Reason not Specified|2|||
105803372|NCT00672620|364936545|FG003|Overall Study|Reason not Specified|1|||
105803373|NCT02965820|364936546|FG000|Period 2, Second 30 Days|Adverse Event|1|||
105803374|NCT02965820|364936547|FG001|Period 2, Second 30 Days|Adverse Event|1|||
105803375|NCT02741271|364936550|FG000|Overall Study|Lost to Follow-up|2|||
105803376|NCT02741271|364936551|FG001|Overall Study|Lost to Follow-up|0|||
105803377|NCT02741271|364936550|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105803378|NCT02741271|364936551|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
105803379|NCT03652961|364936552|FG000|Overall Study|Lost to Follow-up|3|||
105803380|NCT03652961|364936552|FG000|Overall Study|Screen Failure|1|||
105803381|NCT00410410|364936553|FG000|Induction Period (IP)|Death|1|||
105803382|NCT00410410|364936554|FG001|Induction Period (IP)|Death|0|||
105803383|NCT00410410|364936555|FG002|Induction Period (IP)|Death|0|||
105803384|NCT00410410|364936556|FG003|Induction Period (IP)|Death|0|||
105803385|NCT00410410|364936557|FG004|Induction Period (IP)|Death|0|||
105803386|NCT00410410|364936558|FG005|Induction Period (IP)|Death|0|||
105803387|NCT00410410|364936559|FG006|Induction Period (IP)|Death|0|||
105803388|NCT00410410|364936560|FG007|Induction Period (IP)|Death|0|||
105803389|NCT00410410|364936561|FG008|Induction Period (IP)|Death|0|||
105803390|NCT00410410|364936553|FG000|Induction Period (IP)|Adverse Event|3|||
105803391|NCT00410410|364936554|FG001|Induction Period (IP)|Adverse Event|4|||
105803392|NCT00410410|364936555|FG002|Induction Period (IP)|Adverse Event|2|||
105483665|NCT02296138|363782732|FG001|Overall Study|Lack of Efficacy|37|||
105803393|NCT00410410|364936556|FG003|Induction Period (IP)|Adverse Event|4|||
105803394|NCT00410410|364936557|FG004|Induction Period (IP)|Adverse Event|1|||
105803395|NCT00410410|364936558|FG005|Induction Period (IP)|Adverse Event|0|||
105803396|NCT00410410|364936559|FG006|Induction Period (IP)|Adverse Event|0|||
105803397|NCT00410410|364936560|FG007|Induction Period (IP)|Adverse Event|0|||
105803398|NCT00410410|364936561|FG008|Induction Period (IP)|Adverse Event|0|||
105803399|NCT00410410|364936553|FG000|Induction Period (IP)|Lack of Efficacy|26|||
105756718|NCT00293423|364760276|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
105756719|NCT00293423|364760277|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
105756720|NCT00293423|364760276|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
105756721|NCT00293423|364760277|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
105756722|NCT00293423|364760276|FG000|Surgical Resection|processing error during surgical resection|1|||
105756723|NCT00293423|364760277|FG001|Surgical Resection|processing error during surgical resection|0|||
105756724|NCT00293423|364760276|FG000|Surgical Resection|Withdrawal by Subject|4|||
105756725|NCT00293423|364760277|FG001|Surgical Resection|Withdrawal by Subject|0|||
105756726|NCT00293423|364760276|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
105756727|NCT00293423|364760277|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
105756728|NCT01529385|364760278|FG000|Overall Study|Lost to Follow-up|2|||
105756729|NCT01529385|364760279|FG001|Overall Study|Lost to Follow-up|1|||
105756730|NCT01021813|364760283|FG000|DB Treatment Phase|Adverse Event|60|||
105756731|NCT01021813|364760284|FG001|DB Treatment Phase|Adverse Event|22|||
105756732|NCT01021813|364760285|FG002|DB Treatment Phase|Adverse Event|0|||
105756733|NCT01021813|364760286|FG003|DB Treatment Phase|Adverse Event|0|||
105756734|NCT01021813|364760287|FG004|DB Treatment Phase|Adverse Event|0|||
105756735|NCT01021813|364760283|FG000|DB Treatment Phase|Lack of Efficacy|44|||
105756736|NCT01021813|364760284|FG001|DB Treatment Phase|Lack of Efficacy|28|||
105756737|NCT01021813|364760285|FG002|DB Treatment Phase|Lack of Efficacy|0|||
105756738|NCT01021813|364760286|FG003|DB Treatment Phase|Lack of Efficacy|0|||
105756739|NCT01021813|364760287|FG004|DB Treatment Phase|Lack of Efficacy|0|||
105756740|NCT01021813|364760283|FG000|DB Treatment Phase|Lost to Follow-up|14|||
105756741|NCT01021813|364760284|FG001|DB Treatment Phase|Lost to Follow-up|12|||
105756742|NCT01021813|364760285|FG002|DB Treatment Phase|Lost to Follow-up|0|||
105756743|NCT01021813|364760286|FG003|DB Treatment Phase|Lost to Follow-up|0|||
105756744|NCT01021813|364760287|FG004|DB Treatment Phase|Lost to Follow-up|0|||
105756745|NCT01021813|364760283|FG000|DB Treatment Phase|Physician Decision|17|||
105756746|NCT01021813|364760284|FG001|DB Treatment Phase|Physician Decision|8|||
105756747|NCT01021813|364760285|FG002|DB Treatment Phase|Physician Decision|0|||
105756748|NCT01021813|364760286|FG003|DB Treatment Phase|Physician Decision|0|||
105756749|NCT01021813|364760287|FG004|DB Treatment Phase|Physician Decision|0|||
105756750|NCT01021813|364760283|FG000|DB Treatment Phase|Pregnancy|1|||
105756751|NCT01021813|364760284|FG001|DB Treatment Phase|Pregnancy|0|||
105756752|NCT01021813|364760285|FG002|DB Treatment Phase|Pregnancy|0|||
105756753|NCT01021813|364760286|FG003|DB Treatment Phase|Pregnancy|0|||
105756754|NCT01021813|364760287|FG004|DB Treatment Phase|Pregnancy|0|||
105756755|NCT01021813|364760283|FG000|DB Treatment Phase|Protocol Violation|4|||
105756756|NCT01021813|364760284|FG001|DB Treatment Phase|Protocol Violation|3|||
105756757|NCT01021813|364760285|FG002|DB Treatment Phase|Protocol Violation|0|||
105756758|NCT01021813|364760286|FG003|DB Treatment Phase|Protocol Violation|0|||
105756759|NCT01021813|364760287|FG004|DB Treatment Phase|Protocol Violation|0|||
105756760|NCT01021813|364760283|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
105756761|NCT01021813|364760284|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
105756762|NCT01021813|364760285|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
105756763|NCT01021813|364760286|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
105756764|NCT01021813|364760287|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
105756765|NCT01021813|364760283|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
105756766|NCT01021813|364760284|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
105756767|NCT01021813|364760285|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
105756768|NCT01021813|364760286|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
105756769|NCT01021813|364760287|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
105756770|NCT01021813|364760283|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
105756771|NCT01021813|364760284|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
105756772|NCT01021813|364760285|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
105756773|NCT01021813|364760286|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
105756774|NCT01021813|364760287|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
105756775|NCT01021813|364760283|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
105756776|NCT01021813|364760284|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
105756777|NCT01021813|364760285|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
105756778|NCT01021813|364760286|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
105756779|NCT01021813|364760287|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
105756780|NCT01021813|364760283|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
105756781|NCT01021813|364760284|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
105756782|NCT01021813|364760285|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
105570318|NCT03573908|364086749|FG001|Treatment Period|Other, Not Specified|6|||
105756783|NCT01021813|364760286|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
105756784|NCT01021813|364760287|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
105803400|NCT00410410|364936554|FG001|Induction Period (IP)|Lack of Efficacy|24|||
105803401|NCT00410410|364936555|FG002|Induction Period (IP)|Lack of Efficacy|8|||
105803402|NCT00410410|364936556|FG003|Induction Period (IP)|Lack of Efficacy|8|||
105803403|NCT00410410|364936557|FG004|Induction Period (IP)|Lack of Efficacy|7|||
105803404|NCT00410410|364936558|FG005|Induction Period (IP)|Lack of Efficacy|7|||
105803405|NCT00410410|364936559|FG006|Induction Period (IP)|Lack of Efficacy|0|||
105803406|NCT00410410|364936560|FG007|Induction Period (IP)|Lack of Efficacy|0|||
105803407|NCT00410410|364936561|FG008|Induction Period (IP)|Lack of Efficacy|0|||
105803408|NCT00410410|364936553|FG000|Induction Period (IP)|Lost to Follow-up|2|||
105803409|NCT00410410|364936554|FG001|Induction Period (IP)|Lost to Follow-up|2|||
105803410|NCT00410410|364936555|FG002|Induction Period (IP)|Lost to Follow-up|2|||
105803411|NCT00410410|364936556|FG003|Induction Period (IP)|Lost to Follow-up|3|||
105803412|NCT00410410|364936557|FG004|Induction Period (IP)|Lost to Follow-up|0|||
105803413|NCT00410410|364936558|FG005|Induction Period (IP)|Lost to Follow-up|1|||
105803414|NCT00410410|364936559|FG006|Induction Period (IP)|Lost to Follow-up|0|||
105803415|NCT00410410|364936560|FG007|Induction Period (IP)|Lost to Follow-up|0|||
105803416|NCT00410410|364936561|FG008|Induction Period (IP)|Lost to Follow-up|0|||
105803417|NCT00410410|364936553|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
105803418|NCT00410410|364936554|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
105803419|NCT00410410|364936555|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
105803420|NCT00410410|364936556|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
105803421|NCT00410410|364936557|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
105803422|NCT00410410|364936558|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
105803423|NCT00410410|364936559|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
105803424|NCT00410410|364936560|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
105803425|NCT00410410|364936561|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
105803426|NCT00410410|364936553|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803427|NCT00410410|364936554|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803428|NCT00410410|364936555|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
105803429|NCT00410410|364936556|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803430|NCT00410410|364936557|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803431|NCT00410410|364936558|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803432|NCT00410410|364936559|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803433|NCT00410410|364936560|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803434|NCT00410410|364936561|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803435|NCT00410410|364936553|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
105803436|NCT00410410|364936554|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
105803437|NCT00410410|364936555|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
105803438|NCT00410410|364936556|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
105803439|NCT00410410|364936557|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
105803440|NCT00410410|364936558|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
105803441|NCT00410410|364936559|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
105803442|NCT00410410|364936560|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
105803443|NCT00410410|364936561|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
105803444|NCT00410410|364936553|FG000|Induction Period (IP)|Other|0|||
105803445|NCT00410410|364936554|FG001|Induction Period (IP)|Other|0|||
105803446|NCT00410410|364936555|FG002|Induction Period (IP)|Other|1|||
105803447|NCT00410410|364936556|FG003|Induction Period (IP)|Other|0|||
105803448|NCT00410410|364936557|FG004|Induction Period (IP)|Other|0|||
105803449|NCT00410410|364936558|FG005|Induction Period (IP)|Other|0|||
105803450|NCT00410410|364936559|FG006|Induction Period (IP)|Other|0|||
105803451|NCT00410410|364936560|FG007|Induction Period (IP)|Other|0|||
105803452|NCT00410410|364936561|FG008|Induction Period (IP)|Other|0|||
105803453|NCT00410410|364936553|FG000|Maintenance Period (MP)|Death|0|||
105803454|NCT00410410|364936554|FG001|Maintenance Period (MP)|Death|0|||
105803455|NCT00410410|364936555|FG002|Maintenance Period (MP)|Death|0|||
105803456|NCT00410410|364936556|FG003|Maintenance Period (MP)|Death|0|||
105803457|NCT00410410|364936557|FG004|Maintenance Period (MP)|Death|0|||
105803458|NCT00410410|364936558|FG005|Maintenance Period (MP)|Death|0|||
105803459|NCT00410410|364936559|FG006|Maintenance Period (MP)|Death|1|||
105803460|NCT00410410|364936560|FG007|Maintenance Period (MP)|Death|0|||
105803461|NCT00410410|364936561|FG008|Maintenance Period (MP)|Death|0|||
105803462|NCT00410410|364936553|FG000|Maintenance Period (MP)|Adverse Event|0|||
105803463|NCT00410410|364936554|FG001|Maintenance Period (MP)|Adverse Event|0|||
105803464|NCT00410410|364936555|FG002|Maintenance Period (MP)|Adverse Event|0|||
105803465|NCT00410410|364936556|FG003|Maintenance Period (MP)|Adverse Event|0|||
105803466|NCT00410410|364936557|FG004|Maintenance Period (MP)|Adverse Event|0|||
105803467|NCT00410410|364936558|FG005|Maintenance Period (MP)|Adverse Event|0|||
105803468|NCT00410410|364936559|FG006|Maintenance Period (MP)|Adverse Event|1|||
105803469|NCT00410410|364936560|FG007|Maintenance Period (MP)|Adverse Event|3|||
105803470|NCT00410410|364936561|FG008|Maintenance Period (MP)|Adverse Event|0|||
105803471|NCT00410410|364936553|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
105803472|NCT00410410|364936554|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
105803473|NCT00410410|364936555|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
105803474|NCT00410410|364936556|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
105806539|NCT03209570|364949016|FG001|Overall Study|Protocol Violation|0|||
105803475|NCT00410410|364936557|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
105803476|NCT00410410|364936558|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
105803477|NCT00410410|364936559|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
105803478|NCT00410410|364936560|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
105803479|NCT00410410|364936561|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
105803480|NCT00410410|364936553|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
105803481|NCT00410410|364936554|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
105803482|NCT00410410|364936555|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
105803483|NCT00410410|364936556|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
105803484|NCT00410410|364936557|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
105803485|NCT00410410|364936558|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
105803486|NCT00410410|364936559|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
105803487|NCT00410410|364936560|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
105803488|NCT00410410|364936561|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
105803489|NCT00410410|364936553|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
105803490|NCT00410410|364936554|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
105803491|NCT00410410|364936555|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
105803492|NCT00410410|364936556|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
105803493|NCT00410410|364936557|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
105803494|NCT00410410|364936558|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
105803495|NCT00410410|364936559|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
105803496|NCT00410410|364936560|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
105803497|NCT00410410|364936561|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
105803498|NCT00410410|364936553|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
105803499|NCT00410410|364936554|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
105803500|NCT00410410|364936555|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
105803501|NCT00410410|364936556|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
105803502|NCT00410410|364936557|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
105803503|NCT00410410|364936558|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
105803504|NCT00410410|364936559|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
105803505|NCT00410410|364936560|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
105803506|NCT00410410|364936561|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
105803507|NCT00410410|364936553|FG000|Open-Label Period (OL)|Death|0|||
105803508|NCT00410410|364936554|FG001|Open-Label Period (OL)|Death|0|||
105803509|NCT00410410|364936555|FG002|Open-Label Period (OL)|Death|0|||
105803510|NCT00410410|364936556|FG003|Open-Label Period (OL)|Death|0|||
105803511|NCT00410410|364936557|FG004|Open-Label Period (OL)|Death|0|||
105803512|NCT00410410|364936558|FG005|Open-Label Period (OL)|Death|0|||
105803513|NCT00410410|364936559|FG006|Open-Label Period (OL)|Death|0|||
105803514|NCT00410410|364936560|FG007|Open-Label Period (OL)|Death|0|||
105803515|NCT00410410|364936561|FG008|Open-Label Period (OL)|Death|1|||
105803516|NCT00410410|364936553|FG000|Open-Label Period (OL)|Adverse Event|0|||
105803517|NCT00410410|364936554|FG001|Open-Label Period (OL)|Adverse Event|0|||
105803518|NCT00410410|364936555|FG002|Open-Label Period (OL)|Adverse Event|0|||
105803519|NCT00410410|364936556|FG003|Open-Label Period (OL)|Adverse Event|0|||
105803520|NCT00410410|364936557|FG004|Open-Label Period (OL)|Adverse Event|0|||
105803521|NCT00410410|364936558|FG005|Open-Label Period (OL)|Adverse Event|0|||
105803522|NCT00410410|364936559|FG006|Open-Label Period (OL)|Adverse Event|0|||
105803523|NCT00410410|364936560|FG007|Open-Label Period (OL)|Adverse Event|0|||
105803524|NCT00410410|364936561|FG008|Open-Label Period (OL)|Adverse Event|10|||
105803525|NCT00410410|364936553|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
105803526|NCT00410410|364936554|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
105803527|NCT00410410|364936555|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
105803528|NCT00410410|364936556|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
105803529|NCT00410410|364936557|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
105803530|NCT00410410|364936558|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
105803531|NCT00410410|364936559|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
105803532|NCT00410410|364936560|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
105803533|NCT00410410|364936561|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
105803534|NCT00410410|364936553|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
105803535|NCT00410410|364936554|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
105803536|NCT00410410|364936555|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
105803537|NCT00410410|364936556|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
105803538|NCT00410410|364936557|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
105803539|NCT00410410|364936558|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
105803540|NCT00410410|364936559|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
105803541|NCT00410410|364936560|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
105803542|NCT00410410|364936561|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
105803543|NCT00410410|364936553|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
105803544|NCT00410410|364936554|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
105568664|NCT02508532|364081263|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
105803545|NCT00410410|364936555|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
105803546|NCT00410410|364936556|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
105803547|NCT00410410|364936557|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
105803548|NCT00410410|364936558|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
105803549|NCT00410410|364936559|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
105803550|NCT00410410|364936560|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
105803551|NCT00410410|364936561|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
105803552|NCT00410410|364936553|FG000|Open-Label Period (OL)|Pregnancy|0|||
105803553|NCT00410410|364936554|FG001|Open-Label Period (OL)|Pregnancy|0|||
105803554|NCT00410410|364936555|FG002|Open-Label Period (OL)|Pregnancy|0|||
105803555|NCT00410410|364936556|FG003|Open-Label Period (OL)|Pregnancy|0|||
105803556|NCT00410410|364936557|FG004|Open-Label Period (OL)|Pregnancy|0|||
105803557|NCT00410410|364936558|FG005|Open-Label Period (OL)|Pregnancy|0|||
105803558|NCT00410410|364936559|FG006|Open-Label Period (OL)|Pregnancy|0|||
105803559|NCT00410410|364936560|FG007|Open-Label Period (OL)|Pregnancy|0|||
105803560|NCT00410410|364936561|FG008|Open-Label Period (OL)|Pregnancy|1|||
105803561|NCT00410410|364936553|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803562|NCT00410410|364936554|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803563|NCT00410410|364936555|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803564|NCT00410410|364936556|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803565|NCT00410410|364936557|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803566|NCT00410410|364936558|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803567|NCT00410410|364936559|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803568|NCT00410410|364936560|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803569|NCT00410410|364936561|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
105803570|NCT00410410|364936553|FG000|Open-Label Period (OL)|Other|0|||
105803571|NCT00410410|364936554|FG001|Open-Label Period (OL)|Other|0|||
105803572|NCT00410410|364936555|FG002|Open-Label Period (OL)|Other|0|||
105803573|NCT00410410|364936556|FG003|Open-Label Period (OL)|Other|0|||
105803574|NCT00410410|364936557|FG004|Open-Label Period (OL)|Other|0|||
105803575|NCT00410410|364936558|FG005|Open-Label Period (OL)|Other|0|||
105803576|NCT00410410|364936559|FG006|Open-Label Period (OL)|Other|0|||
105803577|NCT00410410|364936560|FG007|Open-Label Period (OL)|Other|0|||
105803578|NCT00410410|364936561|FG008|Open-Label Period (OL)|Other|7|||
105803579|NCT01023269|364936562|FG000|Overall Study|early termination of the study|2|||
105803580|NCT01023269|364936563|FG001|Overall Study|early termination of the study|0|||
105803581|NCT01953783|364936564|FG000|Overall Study|Progressive disease|2|||
105803582|NCT00903383|364936566|FG000|Overall Study|Adverse Event|1|||
105803583|NCT00903383|364936567|FG001|Overall Study|Adverse Event|2|||
105803584|NCT00903383|364936568|FG002|Overall Study|Adverse Event|3|||
105803585|NCT00903383|364936569|FG003|Overall Study|Adverse Event|1|||
105803586|NCT00903383|364936566|FG000|Overall Study|Physician Decision|1|||
105803587|NCT00903383|364936567|FG001|Overall Study|Physician Decision|2|||
105803588|NCT00903383|364936568|FG002|Overall Study|Physician Decision|0|||
105803589|NCT00903383|364936569|FG003|Overall Study|Physician Decision|0|||
105803590|NCT00903383|364936566|FG000|Overall Study|Lost to Follow-up|0|||
105803591|NCT00903383|364936567|FG001|Overall Study|Lost to Follow-up|0|||
105803592|NCT00903383|364936568|FG002|Overall Study|Lost to Follow-up|0|||
105803593|NCT00903383|364936569|FG003|Overall Study|Lost to Follow-up|1|||
105803594|NCT00903383|364936566|FG000|Overall Study|Decision of Sponsor|1|||
105803595|NCT00903383|364936567|FG001|Overall Study|Decision of Sponsor|0|||
105803596|NCT00903383|364936568|FG002|Overall Study|Decision of Sponsor|0|||
105803597|NCT00903383|364936569|FG003|Overall Study|Decision of Sponsor|0|||
105803598|NCT00903383|364936566|FG000|Overall Study|Withdrawal by Subject|4|||
105803599|NCT00903383|364936567|FG001|Overall Study|Withdrawal by Subject|1|||
105803600|NCT00903383|364936568|FG002|Overall Study|Withdrawal by Subject|0|||
105803601|NCT00903383|364936569|FG003|Overall Study|Withdrawal by Subject|2|||
105803602|NCT00903383|364936566|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
105803603|NCT00903383|364936567|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
105803604|NCT00903383|364936568|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
105803605|NCT00903383|364936569|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
105803606|NCT00903383|364936566|FG000|Overall Study|Patient Decision|0|||
105803607|NCT00903383|364936567|FG001|Overall Study|Patient Decision|0|||
105803608|NCT00903383|364936568|FG002|Overall Study|Patient Decision|0|||
105803609|NCT00903383|364936569|FG003|Overall Study|Patient Decision|1|||
105803610|NCT00479401|364936570|FG000|Overall Study|Adverse Event|24|||
105803611|NCT00479401|364936571|FG001|Overall Study|Adverse Event|20|||
105803612|NCT00479401|364936572|FG002|Overall Study|Adverse Event|4|||
105803613|NCT00479401|364936570|FG000|Overall Study|Lack of Efficacy|2|||
105803614|NCT00479401|364936571|FG001|Overall Study|Lack of Efficacy|2|||
105803615|NCT00479401|364936572|FG002|Overall Study|Lack of Efficacy|4|||
105803616|NCT00479401|364936570|FG000|Overall Study|Protocol Violation|2|||
105803617|NCT00479401|364936571|FG001|Overall Study|Protocol Violation|1|||
105803618|NCT00479401|364936572|FG002|Overall Study|Protocol Violation|1|||
105803619|NCT00479401|364936570|FG000|Overall Study|Lost to Follow-up|1|||
105756785|NCT01021813|364760283|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
105756786|NCT01021813|364760284|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
105756787|NCT01021813|364760285|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
105756788|NCT01021813|364760286|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
105756789|NCT01021813|364760287|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
105756790|NCT01512108|364761522|FG000|Overall Study|Adverse Event|9|||
105756791|NCT01512108|364761523|FG001|Overall Study|Adverse Event|4|||
105756792|NCT01512108|364761522|FG000|Overall Study|Protocol Violation|1|||
105756793|NCT01512108|364761523|FG001|Overall Study|Protocol Violation|2|||
105756794|NCT01512108|364761522|FG000|Overall Study|Withdrawal Criteria|1|||
105756795|NCT01512108|364761523|FG001|Overall Study|Withdrawal Criteria|0|||
105756796|NCT01512108|364761522|FG000|Overall Study|Unclassified|11|||
105756797|NCT01512108|364761523|FG001|Overall Study|Unclassified|3|||
105756798|NCT02109744|364761527|FG000|Overall Study|Death|1|||
105756799|NCT02109744|364761528|FG001|Overall Study|Death|1|||
105756800|NCT02109744|364761527|FG000|Overall Study|no marrow exam|1|||
105756801|NCT02109744|364761528|FG001|Overall Study|no marrow exam|0|||
105756802|NCT01827319|364761533|FG000|Overall Study|Lost to Follow-up|3|||
105756803|NCT03927911|364761536|FG000|Overall Study|problems with eDiary|0|||
105756804|NCT03927911|364761537|FG001|Overall Study|problems with eDiary|1|||
105756805|NCT03927911|364761538|FG002|Overall Study|problems with eDiary|0|||
105756806|NCT03927911|364761539|FG003|Overall Study|problems with eDiary|1|||
105756807|NCT03927911|364761540|FG004|Overall Study|problems with eDiary|0|||
105756808|NCT03927911|364761541|FG005|Overall Study|problems with eDiary|4|||
105756809|NCT03927911|364761536|FG000|Overall Study|Adverse Event|0|||
105756810|NCT03927911|364761537|FG001|Overall Study|Adverse Event|0|||
105756811|NCT03927911|364761538|FG002|Overall Study|Adverse Event|0|||
105756812|NCT03927911|364761539|FG003|Overall Study|Adverse Event|0|||
105756813|NCT03927911|364761540|FG004|Overall Study|Adverse Event|0|||
105756814|NCT03927911|364761541|FG005|Overall Study|Adverse Event|1|||
105756815|NCT03927911|364761536|FG000|Overall Study|not treated -study terminated by sponsor|0|||
105756816|NCT03927911|364761537|FG001|Overall Study|not treated -study terminated by sponsor|1|||
105756817|NCT03927911|364761538|FG002|Overall Study|not treated -study terminated by sponsor|0|||
105756818|NCT03927911|364761539|FG003|Overall Study|not treated -study terminated by sponsor|0|||
105756819|NCT03927911|364761540|FG004|Overall Study|not treated -study terminated by sponsor|0|||
105756820|NCT03927911|364761541|FG005|Overall Study|not treated -study terminated by sponsor|0|||
105756821|NCT03927911|364761536|FG000|Overall Study|Surgery cancelled|0|||
105756822|NCT03927911|364761537|FG001|Overall Study|Surgery cancelled|0|||
105756823|NCT03927911|364761538|FG002|Overall Study|Surgery cancelled|0|||
105756824|NCT03927911|364761539|FG003|Overall Study|Surgery cancelled|1|||
105756825|NCT03927911|364761540|FG004|Overall Study|Surgery cancelled|0|||
105756826|NCT03927911|364761541|FG005|Overall Study|Surgery cancelled|1|||
105756827|NCT03927911|364761536|FG000|Overall Study|Protocol Violation|0|||
105756828|NCT03927911|364761537|FG001|Overall Study|Protocol Violation|0|||
105756829|NCT03927911|364761538|FG002|Overall Study|Protocol Violation|0|||
105756830|NCT03927911|364761539|FG003|Overall Study|Protocol Violation|0|||
105756831|NCT03927911|364761540|FG004|Overall Study|Protocol Violation|0|||
105756832|NCT03927911|364761541|FG005|Overall Study|Protocol Violation|1|||
105756833|NCT03728140|364761548|FG000|Overall Study|Abnormal embryo transfer operation|10|||
105756834|NCT03728140|364761549|FG001|Overall Study|Abnormal embryo transfer operation|7|||
105756835|NCT02384395|364761550|FG000|Overall Study|Physician Decision|4|||
105756836|NCT02384395|364761550|FG000|Overall Study|Withdrawal by Subject|3|||
105756837|NCT02384395|364761550|FG000|Overall Study|Lost to Follow-up|3|||
105756838|NCT02267278|364761551|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
105756839|NCT02267278|364761551|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
105756840|NCT02267278|364761551|FG000|Overall Study|Developed new cancer diagnoses|2|||
105756841|NCT02267278|364761551|FG000|Overall Study|prescribed prohibited medication|1|||
105756842|NCT00415519|364761552|FG000|Overall Study|Adverse Event|1|||
105756843|NCT00415519|364761553|FG001|Overall Study|Adverse Event|0|||
105756844|NCT00415519|364761552|FG000|Overall Study|Withdrawal by Subject|2|||
105756845|NCT00415519|364761553|FG001|Overall Study|Withdrawal by Subject|0|||
105756846|NCT00415519|364761552|FG000|Overall Study|Patient's convenience|1|||
105756847|NCT00415519|364761553|FG001|Overall Study|Patient's convenience|0|||
105756848|NCT00367341|364761555|FG000|Overall Study|Physician Decision|1|||
105756849|NCT00367341|364761556|FG001|Overall Study|Physician Decision|0|||
105756850|NCT00367341|364761555|FG000|Overall Study|Protocol Violation|1|||
105756851|NCT00367341|364761556|FG001|Overall Study|Protocol Violation|0|||
105756852|NCT01705587|364761557|FG000|Overall Study|Withdrawal by Subject|0|||
105756853|NCT01705587|364761558|FG001|Overall Study|Withdrawal by Subject|1|||
105756854|NCT02119026|364761561|FG000|1st-line Treatment|Adverse Event|9|||
105756855|NCT02119026|364761562|FG001|1st-line Treatment|Adverse Event|14|||
105756856|NCT02119026|364761561|FG000|1st-line Treatment|Physician Decision|3|||
105756857|NCT02119026|364761562|FG001|1st-line Treatment|Physician Decision|8|||
105756858|NCT02119026|364761561|FG000|1st-line Treatment|Withdrawal by Subject|4|||
105756859|NCT02119026|364761562|FG001|1st-line Treatment|Withdrawal by Subject|10|||
105803620|NCT00479401|364936571|FG001|Overall Study|Lost to Follow-up|1|||
105803621|NCT00479401|364936572|FG002|Overall Study|Lost to Follow-up|1|||
105803622|NCT00479401|364936570|FG000|Overall Study|Withdrawal by Subject|16|||
105803623|NCT00479401|364936571|FG001|Overall Study|Withdrawal by Subject|10|||
105803624|NCT00479401|364936572|FG002|Overall Study|Withdrawal by Subject|2|||
105803625|NCT00479401|364936570|FG000|Overall Study|Exclusion criteria, relocation|4|||
105803626|NCT00479401|364936571|FG001|Overall Study|Exclusion criteria, relocation|3|||
105803627|NCT00479401|364936572|FG002|Overall Study|Exclusion criteria, relocation|0|||
105803628|NCT01430104|364936575|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
105803629|NCT01076166|364936576|FG000|Overall Study|Adverse Event|3|||
105803630|NCT01076166|364936576|FG000|Overall Study|Symptoms improved/resolved|6|||
105803631|NCT00481247|364936580|FG000|Overall Study|Death|0|||
105803632|NCT00481247|364936581|FG001|Overall Study|Death|1|||
105803633|NCT00481247|364936580|FG000|Overall Study|Disease progression|18|||
105803634|NCT00481247|364936581|FG001|Overall Study|Disease progression|22|||
105803635|NCT00481247|364936580|FG000|Overall Study|Intolerance|42|||
105803636|NCT00481247|364936581|FG001|Overall Study|Intolerance|17|||
105803637|NCT00481247|364936580|FG000|Overall Study|Treatment failure|10|||
105803638|NCT00481247|364936581|FG001|Overall Study|Treatment failure|14|||
105803639|NCT00481247|364936580|FG000|Overall Study|AE unrelated to study drug|13|||
105803640|NCT00481247|364936581|FG001|Overall Study|AE unrelated to study drug|4|||
105803641|NCT00481247|364936580|FG000|Overall Study|Withdrawal by Subject|8|||
105803642|NCT00481247|364936581|FG001|Overall Study|Withdrawal by Subject|13|||
105803643|NCT00481247|364936580|FG000|Overall Study|Pregnancy|2|||
105803644|NCT00481247|364936581|FG001|Overall Study|Pregnancy|1|||
105803645|NCT00481247|364936580|FG000|Overall Study|Lost to Follow-up|1|||
105803646|NCT00481247|364936581|FG001|Overall Study|Lost to Follow-up|2|||
105803647|NCT00481247|364936580|FG000|Overall Study|Poor compliance/noncompliance|1|||
105803648|NCT00481247|364936581|FG001|Overall Study|Poor compliance/noncompliance|7|||
105803649|NCT00481247|364936580|FG000|Overall Study|Administrative reason by sponsor|157|||
105803650|NCT00481247|364936581|FG001|Overall Study|Administrative reason by sponsor|162|||
105803651|NCT00481247|364936580|FG000|Overall Study|Varied|6|||
105803652|NCT00481247|364936581|FG001|Overall Study|Varied|15|||
105803653|NCT00481247|364936580|FG000|Overall Study|Did not receive treatment|1|||
105803654|NCT00481247|364936581|FG001|Overall Study|Did not receive treatment|2|||
105803655|NCT00446654|364936582|FG000|Overall Study|Withdrawal by Subject|1|||
105803656|NCT00446654|364936583|FG001|Overall Study|Withdrawal by Subject|0|||
105803657|NCT00446654|364936582|FG000|Overall Study|Adverse Event|1|||
105803658|NCT00446654|364936583|FG001|Overall Study|Adverse Event|0|||
105803659|NCT01841359|364936590|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
105803660|NCT01841359|364936590|FG000|Overall Study|Concommitant medical issues|2|||
105803661|NCT01841359|364936590|FG000|Overall Study|Adverse Event|3|||
105803662|NCT01841359|364936590|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
105803663|NCT04896385|364936593|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
105803664|NCT04896385|364936594|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
105803665|NCT04896385|364936595|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
105803666|NCT04896385|364936596|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
105803667|NCT04896385|364936593|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
105803668|NCT04896385|364936594|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
105803669|NCT04896385|364936595|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
105803670|NCT04896385|364936596|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
105803671|NCT04896385|364936593|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
105803672|NCT04896385|364936594|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
105803673|NCT04896385|364936595|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
105803674|NCT04896385|364936596|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
105803675|NCT04896385|364936593|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
105803676|NCT04896385|364936594|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
105803677|NCT04896385|364936595|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
105803678|NCT04896385|364936596|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
105803679|NCT04896385|364936593|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
105803680|NCT04896385|364936594|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
105803681|NCT04896385|364936595|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
105803682|NCT04896385|364936596|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
105803683|NCT04896385|364936593|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
105803684|NCT04896385|364936594|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
105803685|NCT04896385|364936595|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
105803686|NCT04896385|364936596|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
105803687|NCT01875445|364936597|FG000|Overall Study|Lost to Follow-up|5|||
105803688|NCT01875445|364936598|FG001|Overall Study|Lost to Follow-up|0|||
105803689|NCT01875445|364936597|FG000|Overall Study|Withdrawal by Subject|2|||
105803690|NCT01875445|364936598|FG001|Overall Study|Withdrawal by Subject|0|||
105803691|NCT05017493|364936599|FG000|Overall Study|Withdrawal by Subject|26|||
105803692|NCT05017493|364936600|FG001|Overall Study|Withdrawal by Subject|0|||
105803693|NCT05017493|364936599|FG000|Overall Study|Physician Decision|15|||
105803694|NCT05017493|364936600|FG001|Overall Study|Physician Decision|0|||
105803695|NCT05017493|364936599|FG000|Overall Study|Protocol Violation|81|||
105803696|NCT05017493|364936600|FG001|Overall Study|Protocol Violation|0|||
105803697|NCT02280356|364936609|FG000|Overall Study|Not Treated|2|||
105803698|NCT02280356|364936609|FG000|Overall Study|Withdrawal by Subject|1|||
105803699|NCT02280356|364936609|FG000|Overall Study|Not evaluable|2|||
105803700|NCT01484028|364936610|FG000|Period 1|Lost to Follow-up|0|||
105803701|NCT01484028|364936611|FG001|Period 1|Lost to Follow-up|1|||
105803702|NCT01484028|364936612|FG002|Period 1|Lost to Follow-up|0|||
105803703|NCT01484028|364936613|FG003|Period 1|Lost to Follow-up|0|||
105803704|NCT01484028|364936610|FG000|Period 1|Non-Compliance to Protocol|0|||
105803705|NCT01484028|364936611|FG001|Period 1|Non-Compliance to Protocol|1|||
105803706|NCT01484028|364936612|FG002|Period 1|Non-Compliance to Protocol|0|||
105803707|NCT01484028|364936613|FG003|Period 1|Non-Compliance to Protocol|1|||
105803708|NCT01484028|364936610|FG000|Period 1|Lens Discomfort|0|||
105803709|NCT01484028|364936611|FG001|Period 1|Lens Discomfort|1|||
105803710|NCT01484028|364936612|FG002|Period 1|Lens Discomfort|0|||
105803711|NCT01484028|364936613|FG003|Period 1|Lens Discomfort|0|||
105803712|NCT03493698|364936614|FG000|Treatment Period C|Adverse Event|1|||
105803713|NCT03493698|364936614|FG000|Treatment Period C|Withdrawal by Subject|1|||
105803714|NCT00395083|364936615|FG000|Overall Study|Withdrawal by Subject|6|||
105803715|NCT00395083|364936616|FG001|Overall Study|Withdrawal by Subject|5|||
105803716|NCT00395083|364936615|FG000|Overall Study|Developed another disease|4|||
105803717|NCT00395083|364936616|FG001|Overall Study|Developed another disease|3|||
105803718|NCT03760510|364936617|FG000|Overall Study|Not ventilated for 24 hours|105|||
105803719|NCT03760510|364936618|FG001|Overall Study|Not ventilated for 24 hours|97|||
105803720|NCT04147715|364936623|FG000|Overall Study|Adverse Event|0|||
105803721|NCT04147715|364936624|FG001|Overall Study|Adverse Event|0|||
105803722|NCT04147715|364936625|FG002|Overall Study|Adverse Event|0|||
105803723|NCT04147715|364936626|FG003|Overall Study|Adverse Event|0|||
105803724|NCT04147715|364936627|FG004|Overall Study|Adverse Event|0|||
105803725|NCT04147715|364936628|FG005|Overall Study|Adverse Event|0|||
105803726|NCT04147715|364936629|FG006|Overall Study|Adverse Event|0|||
105803727|NCT04147715|364936630|FG007|Overall Study|Adverse Event|2|||
105803728|NCT04147715|364936631|FG008|Overall Study|Adverse Event|1|||
105803729|NCT04147715|364936632|FG009|Overall Study|Adverse Event|0|||
105803730|NCT04147715|364936633|FG010|Overall Study|Adverse Event|0|||
105803731|NCT04147715|364936634|FG011|Overall Study|Adverse Event|0|||
105803732|NCT00926289|364936636|FG000|Overall Study|Adverse Event|9|||
105803733|NCT00926289|364936637|FG001|Overall Study|Adverse Event|11|||
105803734|NCT00926289|364936636|FG000|Overall Study|Protocol Violation|8|||
105803735|NCT00926289|364936637|FG001|Overall Study|Protocol Violation|12|||
105803736|NCT00926289|364936636|FG000|Overall Study|Lost to Follow-up|3|||
105803737|NCT00926289|364936637|FG001|Overall Study|Lost to Follow-up|6|||
105803738|NCT00926289|364936636|FG000|Overall Study|Withdrawal by Subject|4|||
105803739|NCT00926289|364936637|FG001|Overall Study|Withdrawal by Subject|4|||
105803740|NCT00926289|364936636|FG000|Overall Study|Other|1|||
105803741|NCT00926289|364936637|FG001|Overall Study|Other|3|||
105803742|NCT01199601|364936640|FG000|Overall Study|Lost to Follow-up|47|||
105803743|NCT01199601|364936641|FG001|Overall Study|Lost to Follow-up|66|||
105803744|NCT01199601|364936640|FG000|Overall Study|Withdrawal by Subject|15|||
105803745|NCT01199601|364936641|FG001|Overall Study|Withdrawal by Subject|3|||
105803746|NCT01199601|364936640|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
105803747|NCT01199601|364936641|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
105803748|NCT02629965|364936643|FG000|Period 1|Adverse Event|1|||
105803749|NCT02629965|364936644|FG001|Period 1|Adverse Event|0|||
105803750|NCT02629965|364936643|FG000|Period 1|Unexpected worsening of disease|2|||
105803751|NCT02629965|364936644|FG001|Period 1|Unexpected worsening of disease|0|||
105803752|NCT02629965|364936643|FG000|Period 1|Other than listed above|1|||
105803753|NCT02629965|364936644|FG001|Period 1|Other than listed above|2|||
105803754|NCT02629965|364936643|FG000|Period 2|Adverse Event|1|||
105803755|NCT02629965|364936644|FG001|Period 2|Adverse Event|0|||
105803756|NCT00299728|364936647|FG000|Overall Study|Lost to Follow-up|0|||
105803757|NCT00299728|364936648|FG001|Overall Study|Lost to Follow-up|1|||
105803758|NCT00299728|364936647|FG000|Overall Study|Withdrawal by Subject|0|||
105803759|NCT00299728|364936648|FG001|Overall Study|Withdrawal by Subject|1|||
105803760|NCT00299728|364936647|FG000|Overall Study|Progressive disease|0|||
105803761|NCT00299728|364936648|FG001|Overall Study|Progressive disease|1|||
105803762|NCT03387059|364936651|FG000|Overall Study|Study termination|5|||
105803763|NCT03387059|364936652|FG001|Overall Study|Study termination|4|||
105756860|NCT02119026|364761561|FG000|1st-line Treatment|Patient condition or compliance|6|||
105756861|NCT02119026|364761562|FG001|1st-line Treatment|Patient condition or compliance|4|||
105756862|NCT02119026|364761561|FG000|1st-line Treatment|Surgery of metastases|2|||
105756863|NCT02119026|364761562|FG001|1st-line Treatment|Surgery of metastases|1|||
105756864|NCT02119026|364761561|FG000|1st-line Treatment|Death|2|||
105756865|NCT02119026|364761562|FG001|1st-line Treatment|Death|1|||
105756866|NCT02119026|364761561|FG000|2nd-line Treatment|Lost to Follow-up|2|||
105756867|NCT02119026|364761562|FG001|2nd-line Treatment|Lost to Follow-up|0|||
105756868|NCT02119026|364761561|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
105756869|NCT02119026|364761562|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
105756870|NCT02119026|364761561|FG000|2nd-line Treatment|Adverse Event|4|||
105756871|NCT02119026|364761562|FG001|2nd-line Treatment|Adverse Event|1|||
105756872|NCT04295356|364761563|FG000|Overall Study|Physician Decision|1|||
105756873|NCT04295356|364761564|FG001|Overall Study|Physician Decision|0|||
105756874|NCT04295356|364761563|FG000|Overall Study|Lost to Follow-up|0|||
105756875|NCT04295356|364761564|FG001|Overall Study|Lost to Follow-up|3|||
105756876|NCT04295356|364761563|FG000|Overall Study|Protocol Violation|0|||
105756877|NCT04295356|364761564|FG001|Overall Study|Protocol Violation|1|||
105756878|NCT00469209|364761571|FG000|Overall Study|Adverse Event|1|||
105756879|NCT00469209|364761572|FG001|Overall Study|Adverse Event|0|||
105756880|NCT00469209|364761573|FG002|Overall Study|Adverse Event|1|||
105756881|NCT00712933|364761574|FG000|Overall Study|Adverse Event|69|||
105756882|NCT00712933|364761574|FG000|Overall Study|Lack of Efficacy|6|||
105756883|NCT00712933|364761574|FG000|Overall Study|Lost to Follow-up|22|||
105756884|NCT00712933|364761574|FG000|Overall Study|Non-compliance with study drug|13|||
105756885|NCT00712933|364761574|FG000|Overall Study|Other Pregnancy|37|||
105756886|NCT00712933|364761574|FG000|Overall Study|Sponsor decision|14|||
105756887|NCT00712933|364761574|FG000|Overall Study|Withdrew consent|4|||
105756888|NCT00712933|364761574|FG000|Overall Study|Hip replacement surgery|1|||
105756889|NCT00712933|364761574|FG000|Overall Study|Involved in Clinical research|3|||
105756890|NCT00712933|364761574|FG000|Overall Study|Participant hospitalized|1|||
105756891|NCT00712933|364761574|FG000|Overall Study|Participant travelled overseas|2|||
105756892|NCT00712933|364761574|FG000|Overall Study|Death of patient|1|||
105756893|NCT00712933|364761574|FG000|Overall Study|Other Physician decision|1|||
105756894|NCT00712933|364761574|FG000|Overall Study|Not committed to contraception|1|||
105756895|NCT00712933|364761574|FG000|Overall Study|Participant received medication|1|||
105756896|NCT00712933|364761574|FG000|Overall Study|Physician Decision|36|||
105756897|NCT00712933|364761574|FG000|Overall Study|Protocol Violation|4|||
105756898|NCT00712933|364761574|FG000|Overall Study|Withdrawal by Subject|151|||
105756899|NCT01329341|364761575|FG000|Overall Study|Withdrawal by Subject|44|||
105756900|NCT00448760|364761578|FG000|Overall Study|Death|3|||
105756901|NCT01295580|364761579|FG000|Overall Study|Protocol Violation|4|||
105756902|NCT01295580|364761580|FG001|Overall Study|Protocol Violation|2|||
105756903|NCT01295580|364761579|FG000|Overall Study|Withdrawal by Subject|1|||
105756904|NCT01295580|364761580|FG001|Overall Study|Withdrawal by Subject|4|||
105756905|NCT01295580|364761579|FG000|Overall Study|Adverse Event|2|||
105756906|NCT01295580|364761580|FG001|Overall Study|Adverse Event|1|||
105756907|NCT01295580|364761579|FG000|Overall Study|Lost to Follow-up|1|||
105756908|NCT01295580|364761580|FG001|Overall Study|Lost to Follow-up|0|||
105803764|NCT03586830|364936653|FG000|Overall Study|Site terminated by Sponsor|1|||
105803765|NCT03586830|364936654|FG001|Overall Study|Site terminated by Sponsor|4|||
105803766|NCT03586830|364936655|FG002|Overall Study|Site terminated by Sponsor|3|||
105803767|NCT03586830|364936656|FG003|Overall Study|Site terminated by Sponsor|3|||
105803768|NCT03586830|364936653|FG000|Overall Study|Lost to Follow-up|0|||
105803769|NCT03586830|364936654|FG001|Overall Study|Lost to Follow-up|2|||
105803770|NCT03586830|364936655|FG002|Overall Study|Lost to Follow-up|2|||
105803771|NCT03586830|364936656|FG003|Overall Study|Lost to Follow-up|1|||
105803772|NCT03586830|364936653|FG000|Overall Study|Withdrawal by Subject|1|||
105803773|NCT03586830|364936654|FG001|Overall Study|Withdrawal by Subject|0|||
105803774|NCT03586830|364936655|FG002|Overall Study|Withdrawal by Subject|3|||
105803775|NCT03586830|364936656|FG003|Overall Study|Withdrawal by Subject|1|||
105803776|NCT00275028|364938588|FG000|Overall Study|Withdrew consent before treatment began|1|||
105803777|NCT00275028|364938588|FG000|Overall Study|Withdrawal by Subject|5|||
105803778|NCT00275028|364938588|FG000|Overall Study|Adverse Event|9|||
105803779|NCT00275028|364938588|FG000|Overall Study|Progressive Disease|30|||
105803780|NCT00275028|364938588|FG000|Overall Study|Physician Decision|2|||
105803781|NCT01059071|364938591|FG000|Overall Study|Lack of Efficacy|1|||
105803782|NCT01059071|364938592|FG001|Overall Study|Lack of Efficacy|4|||
105803783|NCT01059071|364938593|FG002|Overall Study|Lack of Efficacy|2|||
105803784|NCT01059071|364938594|FG003|Overall Study|Lack of Efficacy|3|||
105803785|NCT01059071|364938591|FG000|Overall Study|Withdrawal by Subject|1|||
105803786|NCT01059071|364938592|FG001|Overall Study|Withdrawal by Subject|0|||
105803787|NCT01059071|364938593|FG002|Overall Study|Withdrawal by Subject|0|||
105803788|NCT01059071|364938594|FG003|Overall Study|Withdrawal by Subject|2|||
105803789|NCT01059071|364938591|FG000|Overall Study|Physician Decision|0|||
105803790|NCT01059071|364938592|FG001|Overall Study|Physician Decision|0|||
105803791|NCT01059071|364938593|FG002|Overall Study|Physician Decision|0|||
105803792|NCT01059071|364938594|FG003|Overall Study|Physician Decision|1|||
105803793|NCT03840811|364938603|FG000|Overall Study|Lost to Follow-up|0|||
105803794|NCT03840811|364938604|FG001|Overall Study|Lost to Follow-up|0|||
105803795|NCT03840811|364938605|FG002|Overall Study|Lost to Follow-up|1|||
105803796|NCT01904383|364938606|FG000|Overall Study|CRF not collected|117|||
105803797|NCT01904383|364938606|FG000|Overall Study|Reason not listed|147|||
105803798|NCT01904383|364938606|FG000|Overall Study|Lost to Follow-up|674|||
105803799|NCT01904383|364938606|FG000|Overall Study|Lack of Efficacy|370|||
105803800|NCT01904383|364938606|FG000|Overall Study|Improvement|141|||
105803801|NCT01904383|364938606|FG000|Overall Study|Adverse Event|271|||
105803802|NCT01904383|364938606|FG000|Overall Study|No patient visit after entry|54|||
105803803|NCT01294592|364938607|FG000|Overall Study|Adverse Event|28|||
105803804|NCT01294592|364938608|FG001|Overall Study|Adverse Event|13|||
105803805|NCT01294592|364938607|FG000|Overall Study|Lack of Efficacy|7|||
105803806|NCT01294592|364938608|FG001|Overall Study|Lack of Efficacy|5|||
105803807|NCT01294592|364938607|FG000|Overall Study|Protocol Violation|1|||
105803808|NCT01294592|364938608|FG001|Overall Study|Protocol Violation|7|||
105803809|NCT01294592|364938607|FG000|Overall Study|Lost to Follow-up|7|||
105803810|NCT01294592|364938608|FG001|Overall Study|Lost to Follow-up|9|||
105803811|NCT01294592|364938607|FG000|Overall Study|Physician Decision|6|||
105803812|NCT01294592|364938608|FG001|Overall Study|Physician Decision|11|||
105803813|NCT01294592|364938607|FG000|Overall Study|Withdrawal by Subject|28|||
105803814|NCT01294592|364938608|FG001|Overall Study|Withdrawal by Subject|28|||
105803815|NCT01084005|364938609|FG000|Overall Study|Adverse Event|1|||
105803816|NCT01084005|364938610|FG001|Overall Study|Adverse Event|8|||
105803817|NCT01084005|364938609|FG000|Overall Study|Protocol Violation|3|||
105803818|NCT01084005|364938610|FG001|Overall Study|Protocol Violation|7|||
105803819|NCT01084005|364938609|FG000|Overall Study|Withdrawal by Subject|1|||
105803820|NCT01084005|364938610|FG001|Overall Study|Withdrawal by Subject|1|||
105803821|NCT00549198|364938611|FG000|Overall Study|Adverse Event|28|||
105803822|NCT00549198|364938612|FG001|Overall Study|Adverse Event|26|||
105803823|NCT00549198|364938611|FG000|Overall Study|Insufficient Viral Load Response|4|||
105803824|NCT00549198|364938612|FG001|Overall Study|Insufficient Viral Load Response|2|||
105803825|NCT00549198|364938611|FG000|Overall Study|Protocol-defined Virological Failure|7|||
105803826|NCT00549198|364938612|FG001|Overall Study|Protocol-defined Virological Failure|0|||
105803827|NCT00549198|364938611|FG000|Overall Study|Non-compliance|2|||
105803828|NCT00549198|364938612|FG001|Overall Study|Non-compliance|4|||
105803829|NCT00549198|364938611|FG000|Overall Study|Lost to Follow-up|7|||
105803830|NCT00549198|364938612|FG001|Overall Study|Lost to Follow-up|8|||
105756909|NCT01295580|364761579|FG000|Overall Study|Lack of Efficacy|1|||
105756910|NCT01295580|364761580|FG001|Overall Study|Lack of Efficacy|0|||
105756911|NCT01295580|364761579|FG000|Overall Study|Other: inconvenience|1|||
105756912|NCT01295580|364761580|FG001|Overall Study|Other: inconvenience|0|||
105756913|NCT01295580|364761579|FG000|Overall Study|Other: family objection|0|||
105756914|NCT01295580|364761580|FG001|Overall Study|Other: family objection|1|||
105756915|NCT04603391|364761583|FG000|First Intervention (4 Days)|Adverse Event|1|||
105756916|NCT04603391|364761584|FG001|First Intervention (4 Days)|Adverse Event|0|||
105756917|NCT04603391|364761583|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
105756918|NCT04603391|364761584|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
105756919|NCT02759861|364761585|FG000|Overall Study|Death|1|||
105756920|NCT05590767|364761589|FG000|Overall Study|Protocol Violation|1|||
105756921|NCT05590767|364761589|FG000|Overall Study|surgery canceled|1|||
105756922|NCT05590767|364761589|FG000|Overall Study|interscalene brachial block not performed|1|||
105756923|NCT00992186|364761590|FG000|Overall Study|Withdrawal by Subject|2|||
105756924|NCT00992186|364761590|FG000|Overall Study|Protocol Violation|1|||
105756925|NCT00992186|364761590|FG000|Overall Study|Physician Decision|1|||
105756926|NCT00992186|364761590|FG000|Overall Study|Adverse Event|9|||
105756927|NCT00992186|364761590|FG000|Overall Study|Progressive Disease|30|||
105756928|NCT00992186|364761590|FG000|Overall Study|Refusal To Receive Study Agent|3|||
105756929|NCT02378883|364761592|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
105756930|NCT02378883|364761592|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
105756931|NCT02378883|364761592|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
105756932|NCT02378883|364761592|FG000|30 Day Follow-Up|Physician Decision|2|||
105756933|NCT02378883|364761592|FG000|30 Day Follow-Up|Missed Visit|2|||
105756934|NCT02378883|364761592|FG000|30 Day Follow-Up|Death|1|||
105756935|NCT02378883|364761592|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
105756936|NCT02378883|364761592|FG000|12 Months Follow-Up|Death|2|||
105756937|NCT00318565|364761593|FG000|Overall Study|Excluded per protocol|24|||
105756938|NCT03037307|364761594|FG000|Period 1|Did Not Meet Study Criteria|0|||
105756939|NCT03037307|364761595|FG001|Period 1|Did Not Meet Study Criteria|0|||
105756940|NCT03037307|364761596|FG002|Period 1|Did Not Meet Study Criteria|0|||
105756941|NCT03037307|364761597|FG003|Period 1|Did Not Meet Study Criteria|1|||
105756942|NCT03037307|364761598|FG004|Period 1|Did Not Meet Study Criteria|0|||
105756943|NCT03037307|364761599|FG005|Period 1|Did Not Meet Study Criteria|0|||
105756944|NCT00691093|364761601|FG000|Overall Study|Adverse Event|1|||
105756945|NCT00691093|364761601|FG000|Overall Study|Lost to Follow-up|1|||
105756946|NCT00691093|364761601|FG000|Overall Study|Lack of Efficacy|1|||
105756947|NCT00691093|364761601|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
105756948|NCT00270998|364761602|FG000|3 Month Follow-up|Adverse Event|1|||
105756949|NCT00270998|364761603|FG001|3 Month Follow-up|Adverse Event|0|||
105756950|NCT00270998|364761604|FG002|3 Month Follow-up|Adverse Event|0|||
105756951|NCT00270998|364761602|FG000|3 Month Follow-up|Lack of Efficacy|1|||
105756952|NCT00270998|364761603|FG001|3 Month Follow-up|Lack of Efficacy|2|||
105756953|NCT00270998|364761604|FG002|3 Month Follow-up|Lack of Efficacy|1|||
105756954|NCT00270998|364761602|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
105756955|NCT00270998|364761603|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
105756956|NCT00270998|364761604|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
105756957|NCT00270998|364761602|FG000|3 Month Follow-up|Pessary did not fit|12|||
105756958|NCT00270998|364761603|FG001|3 Month Follow-up|Pessary did not fit|0|||
105756959|NCT00270998|364761604|FG002|3 Month Follow-up|Pessary did not fit|0|||
105756960|NCT00270998|364761602|FG000|3 Month Follow-up|Personal/family health|1|||
105756961|NCT00270998|364761603|FG001|3 Month Follow-up|Personal/family health|1|||
105756962|NCT00270998|364761604|FG002|3 Month Follow-up|Personal/family health|0|||
105756963|NCT00270998|364761602|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
105756964|NCT00270998|364761603|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
105756965|NCT00270998|364761604|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
105756966|NCT00270998|364761602|FG000|12 Month Follow-up|Lack of Efficacy|5|||
105756967|NCT00270998|364761603|FG001|12 Month Follow-up|Lack of Efficacy|4|||
105756968|NCT00270998|364761604|FG002|12 Month Follow-up|Lack of Efficacy|3|||
105756969|NCT00270998|364761602|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
105756970|NCT00270998|364761603|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
105756971|NCT00270998|364761604|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
105756972|NCT00270998|364761602|FG000|12 Month Follow-up|Pessary did not fit|1|||
105756973|NCT00270998|364761603|FG001|12 Month Follow-up|Pessary did not fit|0|||
105756974|NCT00270998|364761604|FG002|12 Month Follow-up|Pessary did not fit|0|||
105756975|NCT00270998|364761602|FG000|12 Month Follow-up|Personal/family health|0|||
105756976|NCT00270998|364761603|FG001|12 Month Follow-up|Personal/family health|5|||
105756977|NCT00270998|364761604|FG002|12 Month Follow-up|Personal/family health|1|||
105756978|NCT00270998|364761602|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
105756979|NCT00270998|364761603|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
105756980|NCT00270998|364761604|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
105803831|NCT00549198|364938611|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
105803832|NCT00549198|364938612|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
105803833|NCT00549198|364938611|FG000|Overall Study|Protocol Violation|7|||
105803834|NCT00549198|364938612|FG001|Overall Study|Protocol Violation|2|||
105803835|NCT00549198|364938611|FG000|Overall Study|Investigator Decision|4|||
105803836|NCT00549198|364938612|FG001|Overall Study|Investigator Decision|3|||
105803837|NCT00549198|364938611|FG000|Overall Study|Withdrawal by Subject|7|||
105803838|NCT00549198|364938612|FG001|Overall Study|Withdrawal by Subject|7|||
105803839|NCT00549198|364938611|FG000|Overall Study|Disease Progression|1|||
105803840|NCT00549198|364938612|FG001|Overall Study|Disease Progression|0|||
105803841|NCT00549198|364938611|FG000|Overall Study|Participant Moved|2|||
105803842|NCT00549198|364938612|FG001|Overall Study|Participant Moved|0|||
105803843|NCT00549198|364938611|FG000|Overall Study|Participant not able to perform Week 96|1|||
105803844|NCT00549198|364938612|FG001|Overall Study|Participant not able to perform Week 96|0|||
105803845|NCT00549198|364938611|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
105803846|NCT00549198|364938612|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
105803847|NCT00549198|364938611|FG000|Overall Study|Prohibited Medication|1|||
105803848|NCT00549198|364938612|FG001|Overall Study|Prohibited Medication|2|||
105803849|NCT00549198|364938611|FG000|Overall Study|Participant planning pregnancy|1|||
105803850|NCT00549198|364938612|FG001|Overall Study|Participant planning pregnancy|0|||
105803851|NCT00549198|364938611|FG000|Overall Study|Participant overweight, no scan possible|1|||
105803852|NCT00549198|364938612|FG001|Overall Study|Participant overweight, no scan possible|0|||
105803853|NCT00549198|364938611|FG000|Overall Study|No scan facilities|0|||
105803854|NCT00549198|364938612|FG001|Overall Study|No scan facilities|2|||
105803855|NCT00549198|364938611|FG000|Overall Study|Pregnancy|0|||
105803856|NCT00549198|364938612|FG001|Overall Study|Pregnancy|3|||
105803857|NCT00549198|364938611|FG000|Overall Study|Not Exposed to Study Drug|3|||
105803858|NCT00549198|364938612|FG001|Overall Study|Not Exposed to Study Drug|4|||
105803859|NCT01473758|364938614|FG000|Cycle 1|Adverse Event|10|||
105803860|NCT01473758|364938615|FG001|Cycle 1|Adverse Event|2|||
105803861|NCT01473758|364938616|FG002|Cycle 1|Adverse Event|0|||
105803862|NCT01473758|364938617|FG003|Cycle 1|Adverse Event|0|||
105803863|NCT01473758|364938614|FG000|Cycle 1|Withdrawal by Subject|1|||
105803864|NCT01473758|364938615|FG001|Cycle 1|Withdrawal by Subject|1|||
105803865|NCT01473758|364938616|FG002|Cycle 1|Withdrawal by Subject|0|||
105803866|NCT01473758|364938617|FG003|Cycle 1|Withdrawal by Subject|0|||
105803867|NCT01473758|364938614|FG000|Cycle 2|Adverse Event|0|||
105803868|NCT01473758|364938615|FG001|Cycle 2|Adverse Event|0|||
105803869|NCT01473758|364938616|FG002|Cycle 2|Adverse Event|5|||
105803870|NCT01473758|364938617|FG003|Cycle 2|Adverse Event|0|||
105803871|NCT03650400|364938619|FG000|Overall Study|Study terminated by sponsor|0|||
105803872|NCT03650400|364938620|FG001|Overall Study|Study terminated by sponsor|5|||
105803873|NCT03572933|364938623|FG000|Overall Study|Adverse Event|4|||
105803874|NCT03572933|364938624|FG001|Overall Study|Adverse Event|1|||
105803875|NCT03572933|364938623|FG000|Overall Study|Withdrawal by Subject|0|||
105803876|NCT03572933|364938624|FG001|Overall Study|Withdrawal by Subject|1|||
105803877|NCT02049359|364938629|FG000|Overall Study|Lost to Follow-up|26|||
105803878|NCT02049359|364938630|FG001|Overall Study|Lost to Follow-up|19|||
105803879|NCT03377556|364938631|FG000|Overall Study|Adverse Event|5|||
105803880|NCT03377556|364938631|FG000|Overall Study|Refusal unrelated to adverse events|1|||
105803881|NCT03377556|364938631|FG000|Overall Study|Progression/relapse|38|||
105803882|NCT03377556|364938631|FG000|Overall Study|Death|3|||
105803883|NCT00112489|364938657|FG000|Overall Study|Refused further treatment|8|||
105803884|NCT00112489|364938657|FG000|Overall Study|Adverse Event|12|||
105803885|NCT00112489|364938657|FG000|Overall Study|Death|2|||
105803886|NCT00112489|364938657|FG000|Overall Study|Other, Not Specified|9|||
105803887|NCT00112489|364938657|FG000|Overall Study|Patient never treated|2|||
105803888|NCT00112489|364938657|FG000|Overall Study|Ineligible|7|||
105803889|NCT01797120|364938658|FG000|Overall Study|Disesae progression|37|||
105803890|NCT01797120|364938659|FG001|Overall Study|Disesae progression|49|||
105803891|NCT01797120|364938658|FG000|Overall Study|Adverse Event|13|||
105803892|NCT01797120|364938659|FG001|Overall Study|Adverse Event|5|||
105803893|NCT01797120|364938658|FG000|Overall Study|Withdrawal by Subject|6|||
105803894|NCT01797120|364938659|FG001|Overall Study|Withdrawal by Subject|6|||
105803895|NCT01797120|364938658|FG000|Overall Study|Symptomatic progression|2|||
105803896|NCT01797120|364938659|FG001|Overall Study|Symptomatic progression|1|||
105803897|NCT01797120|364938658|FG000|Overall Study|Non-compliance|1|||
105803898|NCT01797120|364938659|FG001|Overall Study|Non-compliance|0|||
105803899|NCT01797120|364938658|FG000|Overall Study|Physician Decision|3|||
105803900|NCT01797120|364938659|FG001|Overall Study|Physician Decision|0|||
105803901|NCT01797120|364938658|FG000|Overall Study|still on treatment|2|||
105803902|NCT01797120|364938659|FG001|Overall Study|still on treatment|4|||
105803903|NCT01797120|364938658|FG000|Overall Study|never start protocol therapy|2|||
105803904|NCT01797120|364938659|FG001|Overall Study|never start protocol therapy|0|||
105803905|NCT01567306|364938660|FG000|Overall Study|Protocol Violation|2|||
105803906|NCT01567306|364938661|FG001|Overall Study|Protocol Violation|2|||
105803907|NCT01567306|364938662|FG002|Overall Study|Protocol Violation|0|||
105803908|NCT01567306|364938663|FG003|Overall Study|Protocol Violation|3|||
105803909|NCT01567306|364938664|FG004|Overall Study|Protocol Violation|1|||
105803910|NCT01567306|364938665|FG005|Overall Study|Protocol Violation|1|||
105803911|NCT01567306|364938660|FG000|Overall Study|Change site living|1|||
105803912|NCT01567306|364938661|FG001|Overall Study|Change site living|0|||
105803913|NCT01567306|364938662|FG002|Overall Study|Change site living|0|||
105803914|NCT01567306|364938663|FG003|Overall Study|Change site living|0|||
105803915|NCT01567306|364938664|FG004|Overall Study|Change site living|0|||
105803916|NCT01567306|364938665|FG005|Overall Study|Change site living|0|||
105803917|NCT01567306|364938660|FG000|Overall Study|Adverse Event|0|||
105803918|NCT01567306|364938661|FG001|Overall Study|Adverse Event|0|||
105803919|NCT01567306|364938662|FG002|Overall Study|Adverse Event|0|||
105803920|NCT01567306|364938663|FG003|Overall Study|Adverse Event|2|||
105803921|NCT01567306|364938664|FG004|Overall Study|Adverse Event|4|||
105803922|NCT01567306|364938665|FG005|Overall Study|Adverse Event|1|||
105803923|NCT01567306|364938660|FG000|Overall Study|Lost to Follow-up|0|||
105803924|NCT01567306|364938661|FG001|Overall Study|Lost to Follow-up|0|||
105803925|NCT01567306|364938662|FG002|Overall Study|Lost to Follow-up|0|||
105803926|NCT01567306|364938663|FG003|Overall Study|Lost to Follow-up|0|||
105803927|NCT01567306|364938664|FG004|Overall Study|Lost to Follow-up|2|||
105803928|NCT01567306|364938665|FG005|Overall Study|Lost to Follow-up|0|||
105803929|NCT01567306|364938660|FG000|Overall Study|Withdrawal by Subject|0|||
105803930|NCT01567306|364938661|FG001|Overall Study|Withdrawal by Subject|0|||
105803931|NCT01567306|364938662|FG002|Overall Study|Withdrawal by Subject|0|||
105803932|NCT01567306|364938663|FG003|Overall Study|Withdrawal by Subject|0|||
105803933|NCT01567306|364938664|FG004|Overall Study|Withdrawal by Subject|0|||
105803934|NCT01567306|364938665|FG005|Overall Study|Withdrawal by Subject|1|||
105803935|NCT01489956|364938666|FG000|Overall Study|Lost to Follow-up|1|||
105803936|NCT01489956|364938667|FG001|Overall Study|Lost to Follow-up|0|||
105803937|NCT01489956|364938668|FG002|Overall Study|Lost to Follow-up|0|||
105803938|NCT01489956|364938666|FG000|Overall Study|Withdrawal by Subject|0|||
105803939|NCT01489956|364938667|FG001|Overall Study|Withdrawal by Subject|0|||
105803940|NCT01489956|364938668|FG002|Overall Study|Withdrawal by Subject|1|||
105803941|NCT02114931|364938669|FG000|Overall Study|Withdrawal by Subject|15|||
105803942|NCT02114931|364938670|FG001|Overall Study|Withdrawal by Subject|18|||
105803943|NCT02114931|364938669|FG000|Overall Study|Adverse Event|4|||
105803944|NCT02114931|364938670|FG001|Overall Study|Adverse Event|6|||
105803945|NCT02114931|364938669|FG000|Overall Study|Lost to Follow-up|3|||
105803946|NCT02114931|364938670|FG001|Overall Study|Lost to Follow-up|3|||
105803947|NCT02114931|364938669|FG000|Overall Study|Physician Decision|1|||
105803948|NCT02114931|364938670|FG001|Overall Study|Physician Decision|2|||
105803949|NCT02114931|364938669|FG000|Overall Study|Other|2|||
105803950|NCT02114931|364938670|FG001|Overall Study|Other|1|||
105803951|NCT03565211|364938671|FG000|Overall Study|Withdrawal by Subject|2|||
105803952|NCT03565211|364938671|FG000|Overall Study|Lost to Follow-up|1|||
105803953|NCT03565211|364938671|FG000|Overall Study|Adverse Event|44|||
105803954|NCT03565211|364938671|FG000|Overall Study|Personal issues|1|||
105803955|NCT04133519|364938676|FG000|Overall Study|Withdrawal by Subject|5|||
105803956|NCT04133519|364938677|FG001|Overall Study|Withdrawal by Subject|4|||
105803957|NCT04133519|364938676|FG000|Overall Study|Protocol Violation|0|||
105803958|NCT04133519|364938677|FG001|Overall Study|Protocol Violation|1|||
105803959|NCT04133519|364938676|FG000|Overall Study|Never started treatment|1|||
105756981|NCT01896856|364761605|FG000|Overall Study|Transportation issues / Non-compliance|0|||
105756982|NCT01896856|364761606|FG001|Overall Study|Transportation issues / Non-compliance|0|||
105756983|NCT01896856|364761607|FG002|Overall Study|Transportation issues / Non-compliance|1|||
105756984|NCT01896856|364761608|FG003|Overall Study|Transportation issues / Non-compliance|0|||
105756985|NCT01896856|364761609|FG004|Overall Study|Transportation issues / Non-compliance|0|||
105756986|NCT01896856|364761610|FG005|Overall Study|Transportation issues / Non-compliance|0|||
105756987|NCT00282867|364761611|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
105756988|NCT00282867|364761612|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
105756989|NCT00282867|364761613|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
105756990|NCT01700985|364761616|FG000|Overall Study|Incarcerated|0|||
105756991|NCT01700985|364761617|FG001|Overall Study|Incarcerated|1|||
105756992|NCT02677220|364761618|FG000|Overall Study|Adverse Event|1|||
105756993|NCT01504971|364761620|FG000|Overall Study|Physician Decision|13|||
105756994|NCT01357889|364761621|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
105756995|NCT01357889|364761622|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
105756996|NCT01357889|364761621|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
105756997|NCT01357889|364761622|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
105756998|NCT01357889|364761621|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
105756999|NCT01357889|364761622|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
105757000|NCT01357889|364761621|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
105757001|NCT01357889|364761622|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
105757002|NCT01357889|364761621|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
105757003|NCT01357889|364761622|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
105757004|NCT01357889|364761621|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
105757005|NCT01357889|364761622|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
105757006|NCT01357889|364761621|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
105757007|NCT01357889|364761622|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
105757008|NCT01357889|364761621|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
105757009|NCT01357889|364761622|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
105757010|NCT01357889|364761621|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
105757011|NCT01357889|364761622|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
105757012|NCT01357889|364761621|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
105757013|NCT01357889|364761622|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
105757014|NCT01357889|364761621|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
105757015|NCT01357889|364761622|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
105757016|NCT01357889|364761621|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
105757017|NCT01357889|364761622|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
105757018|NCT01357889|364761621|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
105757019|NCT01357889|364761622|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
105757020|NCT03970824|364761623|FG000|Overall Study|Withdrawal by Subject|1|||
105757021|NCT03970824|364761624|FG001|Overall Study|Withdrawal by Subject|1|||
105757022|NCT03970824|364761625|FG002|Overall Study|Withdrawal by Subject|3|||
105757023|NCT03970824|364761623|FG000|Overall Study|Lost to Follow-up|0|||
105757024|NCT03970824|364761624|FG001|Overall Study|Lost to Follow-up|2|||
105757025|NCT03970824|364761625|FG002|Overall Study|Lost to Follow-up|1|||
105757026|NCT03970824|364761623|FG000|Overall Study|Adverse Event|1|||
105757027|NCT03970824|364761624|FG001|Overall Study|Adverse Event|0|||
105757028|NCT03970824|364761625|FG002|Overall Study|Adverse Event|0|||
105757029|NCT01248364|364761626|FG000|Overall Study|Adverse Event|0|||
105757030|NCT01248364|364761627|FG001|Overall Study|Adverse Event|1|||
105757031|NCT01248364|364761628|FG002|Overall Study|Adverse Event|0|||
105757032|NCT01248364|364761629|FG003|Overall Study|Adverse Event|0|||
105757033|NCT02146248|364761630|FG000|Overall Study|Withdrawal by Subject|2|||
105757034|NCT01167582|364761631|FG000|Overall Study|Lost to Follow-up|0|||
105757035|NCT01167582|364761632|FG001|Overall Study|Lost to Follow-up|1|||
105757036|NCT00575094|364761633|FG000|Overall Study|Adverse Event|2|||
105757037|NCT00575094|364761633|FG000|Overall Study|Withdrawal by Subject|1|||
105757038|NCT03498287|364761636|FG000|Overall Study|Withdrawal by Subject|3|||
105757039|NCT03498287|364761637|FG001|Overall Study|Withdrawal by Subject|0|||
105757040|NCT03498287|364761636|FG000|Overall Study|Protocol Violation|0|||
105757041|NCT03498287|364761637|FG001|Overall Study|Protocol Violation|4|||
105757042|NCT03498287|364761636|FG000|Overall Study|Adverse Event|0|||
105757043|NCT03498287|364761637|FG001|Overall Study|Adverse Event|1|||
105757044|NCT02921763|364761638|FG000|Overall Study|Adverse Event|4|||
105757045|NCT02921763|364761638|FG000|Overall Study|Lost to Follow-up|4|||
105757046|NCT02921763|364761638|FG000|Overall Study|Lack of Efficacy|3|||
105757047|NCT02921763|364761638|FG000|Overall Study|Protocol Violation|2|||
105757048|NCT02921763|364761638|FG000|Overall Study|Withdrawal by Subject|2|||
105757049|NCT02921763|364761638|FG000|Overall Study|Physician Decision|1|||
105757050|NCT02921763|364761638|FG000|Overall Study|No data obtained|2|||
105757051|NCT01374217|364761639|FG000|Overall Study|Lack of Efficacy|13|||
105757052|NCT03371732|364761640|FG000|Overall Study|Withdrawal by Subject|9|||
105803960|NCT04133519|364938677|FG001|Overall Study|Never started treatment|1|||
105803961|NCT03840135|364938678|FG000|Overall Study|Protocol Violation|6|||
105803962|NCT03840135|364938679|FG001|Overall Study|Protocol Violation|1|||
105803963|NCT03840135|364938678|FG000|Overall Study|Withdrawal by Subject|1|||
105803964|NCT03840135|364938679|FG001|Overall Study|Withdrawal by Subject|0|||
105803965|NCT02063698|364938680|FG000|Overall Study|did not complete booklet for days 2-8|1|||
105803966|NCT02063698|364938681|FG001|Overall Study|did not complete booklet for days 2-8|2|||
105803967|NCT01092702|364938682|FG000|Overall Study|Withdrawal by Subject|7|||
105803968|NCT01092702|364938682|FG000|Overall Study|Lost to Follow-up|2|||
105803969|NCT03412019|364938685|FG000|Overall Study|Withdrawal by Subject|1|||
105803970|NCT03412019|364938686|FG001|Overall Study|Withdrawal by Subject|1|||
105803971|NCT00415532|364938687|FG000|Treatment Period|Adverse Event|2|||
105803972|NCT00415532|364938688|FG001|Treatment Period|Adverse Event|3|||
105803973|NCT00415532|364938687|FG000|Treatment Period|Death|2|||
105803974|NCT00415532|364938688|FG001|Treatment Period|Death|1|||
105803975|NCT00415532|364938687|FG000|Treatment Period|Lost to Follow-up|1|||
105803976|NCT00415532|364938688|FG001|Treatment Period|Lost to Follow-up|1|||
105803977|NCT00415532|364938687|FG000|Treatment Period|Protocol Violation|1|||
105803978|NCT00415532|364938688|FG001|Treatment Period|Protocol Violation|0|||
105803979|NCT00415532|364938687|FG000|Treatment Period|Withdrawal by Subject|6|||
105803980|NCT00415532|364938688|FG001|Treatment Period|Withdrawal by Subject|6|||
105803981|NCT00415532|364938687|FG000|Treatment Period|Other|2|||
105803982|NCT00415532|364938688|FG001|Treatment Period|Other|2|||
105803983|NCT00415532|364938687|FG000|Treatment Period|Ineligibility determined|1|||
105803984|NCT00415532|364938688|FG001|Treatment Period|Ineligibility determined|1|||
105803985|NCT00415532|364938687|FG000|Treatment Period|Noncompliance|1|||
105803986|NCT00415532|364938688|FG001|Treatment Period|Noncompliance|1|||
105803987|NCT00415532|364938687|FG000|Treatment Period|Requirement for alternative therapy|1|||
105803988|NCT00415532|364938688|FG001|Treatment Period|Requirement for alternative therapy|0|||
105803989|NCT00415532|364938687|FG000|Safety Follow Up Period|Adverse Event|1|||
105803990|NCT00415532|364938688|FG001|Safety Follow Up Period|Adverse Event|3|||
105803991|NCT00415532|364938687|FG000|Safety Follow Up Period|Death|3|||
105803992|NCT00415532|364938688|FG001|Safety Follow Up Period|Death|0|||
105803993|NCT00415532|364938687|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
105803994|NCT00415532|364938688|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
105803995|NCT00415532|364938687|FG000|Safety Follow Up Period|Other|1|||
105803996|NCT00415532|364938688|FG001|Safety Follow Up Period|Other|4|||
105803997|NCT00415532|364938687|FG000|Safety Follow Up Period|Ineligibility determined|1|||
105803998|NCT00415532|364938688|FG001|Safety Follow Up Period|Ineligibility determined|1|||
105803999|NCT00415532|364938687|FG000|Safety Follow Up Period|Noncompliance|1|||
105804000|NCT00415532|364938688|FG001|Safety Follow Up Period|Noncompliance|0|||
105804001|NCT00415532|364938687|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
105804002|NCT00415532|364938688|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
105804003|NCT00686920|364938690|FG000|Overall Study|Death|45|||
105804004|NCT00686920|364938691|FG001|Overall Study|Death|14|||
105804005|NCT00686920|364938690|FG000|Overall Study|Liver Transplant|23|||
105804006|NCT00686920|364938691|FG001|Overall Study|Liver Transplant|8|||
105804007|NCT00686920|364938690|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
105804008|NCT00686920|364938691|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
105804009|NCT00686920|364938690|FG000|Overall Study|Withdrawal by Subject|23|||
105804010|NCT00686920|364938691|FG001|Overall Study|Withdrawal by Subject|5|||
105804011|NCT00686920|364938690|FG000|Overall Study|Protocol Violation|2|||
105804012|NCT00686920|364938691|FG001|Overall Study|Protocol Violation|1|||
105804013|NCT00686920|364938690|FG000|Overall Study|Adverse Event|10|||
105804014|NCT00686920|364938691|FG001|Overall Study|Adverse Event|2|||
105804015|NCT00686920|364938690|FG000|Overall Study|Personal Reason|0|||
105804016|NCT00686920|364938691|FG001|Overall Study|Personal Reason|1|||
105804017|NCT00686920|364938690|FG000|Overall Study|Lost to Follow-up|15|||
105804018|NCT00686920|364938691|FG001|Overall Study|Lost to Follow-up|3|||
105804019|NCT00686920|364938690|FG000|Overall Study|Moved to Another State|1|||
105804020|NCT00686920|364938691|FG001|Overall Study|Moved to Another State|0|||
105804021|NCT00686920|364938690|FG000|Overall Study|Transferred to Nursing Home|1|||
105804022|NCT00686920|364938691|FG001|Overall Study|Transferred to Nursing Home|0|||
105804023|NCT00686920|364938690|FG000|Overall Study|Noncompliance|9|||
105804024|NCT00686920|364938691|FG001|Overall Study|Noncompliance|0|||
105804025|NCT00686920|364938690|FG000|Overall Study|Principal Investigator Decision|2|||
105804026|NCT00686920|364938691|FG001|Overall Study|Principal Investigator Decision|0|||
105804027|NCT00947011|364938698|FG000|Overall Study|Study was terminated,PI left institution|12|||
105804028|NCT01141283|364938699|FG000|Overall Study|Adverse Event|56|||
105804029|NCT01141283|364938699|FG000|Overall Study|Lost to Follow-up|4|||
105757053|NCT03371732|364761641|FG001|Overall Study|Withdrawal by Subject|3|||
105757054|NCT03371732|364761640|FG000|Overall Study|Refusal to continue|3|||
105757055|NCT03371732|364761641|FG001|Overall Study|Refusal to continue|4|||
105757056|NCT02581982|364761642|FG000|Overall Study|Lack of Efficacy|12|||
105757057|NCT02581982|364761642|FG000|Overall Study|Adverse Event|3|||
105757058|NCT02581982|364761642|FG000|Overall Study|Physician Decision|1|||
105757059|NCT00599027|364761643|FG000|Overall Study|Withdrawal by Subject|1|||
105757060|NCT00599027|364761644|FG001|Overall Study|Withdrawal by Subject|1|||
105757061|NCT00599027|364761643|FG000|Overall Study|Adverse Event|0|||
105757062|NCT00599027|364761644|FG001|Overall Study|Adverse Event|1|||
105757063|NCT00599027|364761643|FG000|Overall Study|Treatment Failure|0|||
105757064|NCT00599027|364761644|FG001|Overall Study|Treatment Failure|1|||
105757065|NCT01586806|364761645|FG000|Overall Study|Protocol Violation|0|||
105757066|NCT01586806|364761646|FG001|Overall Study|Protocol Violation|1|||
105757067|NCT01586806|364761647|FG002|Overall Study|Protocol Violation|0|||
105757068|NCT01586806|364761645|FG000|Overall Study|Withdrawal by Subject|1|||
105757069|NCT01586806|364761646|FG001|Overall Study|Withdrawal by Subject|0|||
105757070|NCT01586806|364761647|FG002|Overall Study|Withdrawal by Subject|0|||
105757071|NCT01586806|364761645|FG000|Overall Study|Lost to Follow-up|2|||
105757072|NCT01586806|364761646|FG001|Overall Study|Lost to Follow-up|3|||
105757073|NCT01586806|364761647|FG002|Overall Study|Lost to Follow-up|2|||
105757074|NCT01033487|364761648|FG000|Fourth Intervention Period|Adverse Event|0|||
105757075|NCT01033487|364761649|FG001|Fourth Intervention Period|Adverse Event|0|||
105757076|NCT01033487|364761650|FG002|Fourth Intervention Period|Adverse Event|0|||
105757077|NCT01033487|364761651|FG003|Fourth Intervention Period|Adverse Event|0|||
105757078|NCT01033487|364761652|FG004|Fourth Intervention Period|Adverse Event|0|||
105757079|NCT01033487|364761653|FG005|Fourth Intervention Period|Adverse Event|0|||
105757080|NCT01033487|364761654|FG006|Fourth Intervention Period|Adverse Event|0|||
105757081|NCT01033487|364761655|FG007|Fourth Intervention Period|Adverse Event|0|||
105757082|NCT01033487|364761656|FG008|Fourth Intervention Period|Adverse Event|1|||
105757083|NCT01033487|364761657|FG009|Fourth Intervention Period|Adverse Event|0|||
105757084|NCT02031432|364761659|FG000|Overall Study|Protocol Violation|1|||
105757085|NCT02031432|364761659|FG000|Overall Study|Lack of Efficacy|5|||
105757086|NCT02031432|364761659|FG000|Overall Study|Cancer Progression|2|||
105757087|NCT02031432|364761659|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
105757088|NCT02031432|364761659|FG000|Overall Study|Adverse Event|8|||
105757089|NCT02031432|364761659|FG000|Overall Study|Withdrawal by Subject|5|||
105757090|NCT02031432|364761659|FG000|Overall Study|Lost to Follow-up|1|||
105757091|NCT02031432|364761659|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
105757092|NCT02031432|364761659|FG000|Overall Study|Death|10|||
105757093|NCT01688635|364761660|FG000|Washout 1|Withdrawal by Subject|1|||
105757094|NCT01688635|364761661|FG001|Washout 1|Withdrawal by Subject|0|||
105757095|NCT01688635|364761660|FG000|Washout 1|Adverse Event|0|||
105757096|NCT01688635|364761661|FG001|Washout 1|Adverse Event|1|||
105757097|NCT01688635|364761660|FG000|Washout 1|Physician Decision|0|||
105757098|NCT01688635|364761661|FG001|Washout 1|Physician Decision|1|||
105757099|NCT01688635|364761660|FG000|Washout 2|Physician Decision|1|||
105757100|NCT01688635|364761661|FG001|Washout 2|Physician Decision|0|||
105757101|NCT01688635|364761660|FG000|Washout 2|Withdrawal by Subject|1|||
105757102|NCT01688635|364761661|FG001|Washout 2|Withdrawal by Subject|0|||
105757103|NCT01688635|364761660|FG000|Washout 2|Sponsor Decision|1|||
105757104|NCT01688635|364761661|FG001|Washout 2|Sponsor Decision|2|||
105757105|NCT01688635|364761660|FG000|Washout 3|Withdrawal by Subject|1|||
105757106|NCT01688635|364761661|FG001|Washout 3|Withdrawal by Subject|0|||
105757107|NCT01265420|364761663|FG000|Overall Study|Lost to Follow-up|1|||
105757108|NCT03947255|364762915|FG000|Overall Study|Study Closure by Sponsor|2|||
105757109|NCT03947255|364762916|FG001|Overall Study|Study Closure by Sponsor|2|||
105757110|NCT03947255|364762915|FG000|Overall Study|Withdrawal by Subject|2|||
105757111|NCT03947255|364762916|FG001|Overall Study|Withdrawal by Subject|2|||
105757112|NCT03947255|364762915|FG000|Overall Study|Lost to Follow-up|2|||
105757113|NCT03947255|364762916|FG001|Overall Study|Lost to Follow-up|0|||
105757114|NCT03947255|364762915|FG000|Overall Study|Death|0|||
105757115|NCT03947255|364762916|FG001|Overall Study|Death|2|||
105757116|NCT03287869|364762917|FG000|Overall Study|Adverse Event|14|||
105757117|NCT03287869|364762918|FG001|Overall Study|Adverse Event|12|||
105757118|NCT03287869|364762917|FG000|Overall Study|Lack of Efficacy|1|||
105757119|NCT03287869|364762918|FG001|Overall Study|Lack of Efficacy|0|||
105757120|NCT03287869|364762917|FG000|Overall Study|Lost to Follow-up|13|||
105757121|NCT03287869|364762918|FG001|Overall Study|Lost to Follow-up|19|||
105757122|NCT03287869|364762917|FG000|Overall Study|Non-Compliance With Study Drug|5|||
105757123|NCT03287869|364762918|FG001|Overall Study|Non-Compliance With Study Drug|9|||
105757124|NCT03287869|364762917|FG000|Overall Study|Progressive Disease|1|||
105757125|NCT03287869|364762918|FG001|Overall Study|Progressive Disease|0|||
105757126|NCT03287869|364762917|FG000|Overall Study|Protocol Deviation|2|||
105757127|NCT03287869|364762918|FG001|Overall Study|Protocol Deviation|1|||
105757128|NCT03287869|364762917|FG000|Overall Study|Withdrawal by Subject|36|||
105757129|NCT03287869|364762918|FG001|Overall Study|Withdrawal by Subject|43|||
105757130|NCT03287869|364762917|FG000|Overall Study|Early Closure of the Site|0|||
105757131|NCT03287869|364762918|FG001|Overall Study|Early Closure of the Site|1|||
105757132|NCT03287869|364762917|FG000|Overall Study|Physician Decision|5|||
105757133|NCT03287869|364762918|FG001|Overall Study|Physician Decision|5|||
105757134|NCT03287869|364762917|FG000|Overall Study|Reason not Specified|6|||
105757135|NCT03287869|364762918|FG001|Overall Study|Reason not Specified|3|||
105757136|NCT03488238|364762919|FG000|Overall Study|Equipment malfunction|1|||
105757137|NCT03488238|364762919|FG000|Overall Study|Adverse Event|1|||
105757138|NCT01293006|364762920|FG000|Period 2|Lost to Follow-up|1|||
105757139|NCT01293006|364762921|FG001|Period 2|Lost to Follow-up|0|||
105757140|NCT01293006|364762922|FG002|Period 2|Lost to Follow-up|0|||
105757141|NCT01293006|364762923|FG003|Period 2|Lost to Follow-up|0|||
105757142|NCT00525785|364762927|FG000|Overall Study|Withdrawal by Subject|1|||
105757143|NCT00525785|364762927|FG000|Overall Study|Lack of Efficacy|1|||
105757144|NCT00525785|364762927|FG000|Overall Study|Physician Decision|1|||
105757145|NCT01357980|364762932|FG000|Overall Study|Lack of Efficacy|0|||
105757146|NCT01357980|364762933|FG001|Overall Study|Lack of Efficacy|1|||
105757147|NCT01357980|364762934|FG002|Overall Study|Lack of Efficacy|0|||
105757148|NCT01357980|364762935|FG003|Overall Study|Lack of Efficacy|0|||
105757149|NCT01357980|364762932|FG000|Overall Study|Consent withdrawn|0|||
105757150|NCT01357980|364762933|FG001|Overall Study|Consent withdrawn|0|||
105757151|NCT01357980|364762934|FG002|Overall Study|Consent withdrawn|1|||
105757152|NCT01357980|364762935|FG003|Overall Study|Consent withdrawn|0|||
105757153|NCT04507776|364762936|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
105757154|NCT01624506|364762937|FG000|Overall Study|Lost to Follow-up|29|||
105757155|NCT01624506|364762938|FG001|Overall Study|Lost to Follow-up|15|||
105757156|NCT01624506|364762937|FG000|Overall Study|Withdrawal by Subject|9|||
105757157|NCT01624506|364762938|FG001|Overall Study|Withdrawal by Subject|2|||
105757158|NCT01624506|364762937|FG000|Overall Study|Death|1|||
105757159|NCT01624506|364762938|FG001|Overall Study|Death|0|||
105757160|NCT01624506|364762937|FG000|Overall Study|LINX explants|23|||
105757161|NCT01624506|364762938|FG001|Overall Study|LINX explants|0|||
105757162|NCT01624506|364762937|FG000|Overall Study|Adverse Event|3|||
105757163|NCT01624506|364762938|FG001|Overall Study|Adverse Event|0|||
105757164|NCT01281189|364762941|FG000|Overall Study|Adverse Event|7|||
105757165|NCT01281189|364762942|FG001|Overall Study|Adverse Event|9|||
105757166|NCT01281189|364762941|FG000|Overall Study|Lost to Follow-up|6|||
105757167|NCT01281189|364762942|FG001|Overall Study|Lost to Follow-up|4|||
105757168|NCT01281189|364762941|FG000|Overall Study|Withdrawal by Subject|21|||
105757169|NCT01281189|364762942|FG001|Overall Study|Withdrawal by Subject|24|||
105757170|NCT01281189|364762941|FG000|Overall Study|Physician Decision|2|||
105757171|NCT01281189|364762942|FG001|Overall Study|Physician Decision|3|||
105757172|NCT01281189|364762941|FG000|Overall Study|Death|103|||
105757173|NCT01281189|364762942|FG001|Overall Study|Death|91|||
105757174|NCT01281189|364762941|FG000|Overall Study|Other|8|||
105757175|NCT01281189|364762942|FG001|Overall Study|Other|12|||
105757176|NCT00877006|364762946|FG000|Treatment Period|Death|2|||
105757177|NCT00877006|364762947|FG001|Treatment Period|Death|1|||
105757178|NCT00877006|364762946|FG000|Treatment Period|Adverse Event|10|||
105757179|NCT00877006|364762947|FG001|Treatment Period|Adverse Event|3|||
105757180|NCT00877006|364762946|FG000|Treatment Period|Withdrawal by Subject|2|||
105757181|NCT00877006|364762947|FG001|Treatment Period|Withdrawal by Subject|3|||
105757182|NCT00877006|364762946|FG000|Treatment Period|Protocol Violation|1|||
105757183|NCT00877006|364762947|FG001|Treatment Period|Protocol Violation|0|||
105757184|NCT00877006|364762946|FG000|Treatment Period|Lost to Follow-up|0|||
105757185|NCT00877006|364762947|FG001|Treatment Period|Lost to Follow-up|1|||
105757186|NCT00877006|364762946|FG000|Treatment Period|Disease Progression|1|||
105757187|NCT00877006|364762947|FG001|Treatment Period|Disease Progression|2|||
105757188|NCT00877006|364762946|FG000|Treatment Period|Started New Treatment Regimen|2|||
105757189|NCT00877006|364762947|FG001|Treatment Period|Started New Treatment Regimen|5|||
105757190|NCT00877006|364762946|FG000|Treatment Period|Other|4|||
105757191|NCT00877006|364762947|FG001|Treatment Period|Other|4|||
105757192|NCT00877006|364762946|FG000|Treatment Period|Randomized but Not Treated|3|||
105757193|NCT00877006|364762947|FG001|Treatment Period|Randomized but Not Treated|8|||
105757194|NCT00877006|364762946|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
105757195|NCT00877006|364762947|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
105757196|NCT00877006|364762946|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
105757197|NCT00877006|364762947|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
105757198|NCT00877006|364762946|FG000|Long-Term Follow-up Period|Death|26|||
105757199|NCT00877006|364762947|FG001|Long-Term Follow-up Period|Death|18|||
105757200|NCT00877006|364762946|FG000|Long-Term Follow-up Period|Other|7|||
105757201|NCT00877006|364762947|FG001|Long-Term Follow-up Period|Other|9|||
105757202|NCT00817206|364762948|FG000|Overall Study|Adverse Event|10|||
105757203|NCT00817206|364762949|FG001|Overall Study|Adverse Event|3|||
105757204|NCT00817206|364762948|FG000|Overall Study|Protocol Violation|0|||
105757205|NCT00817206|364762949|FG001|Overall Study|Protocol Violation|2|||
105757206|NCT00817206|364762948|FG000|Overall Study|Lost to Follow-up|0|||
105757207|NCT00817206|364762949|FG001|Overall Study|Lost to Follow-up|1|||
105757208|NCT00817206|364762948|FG000|Overall Study|Death|2|||
105757209|NCT00817206|364762949|FG001|Overall Study|Death|0|||
105757210|NCT00817206|364762948|FG000|Overall Study|Withdrawal by Subject|7|||
105804030|NCT01141283|364938699|FG000|Overall Study|Withdrawal by Subject|14|||
105804031|NCT01141283|364938699|FG000|Overall Study|Administrative|4|||
105804032|NCT01141283|364938699|FG000|Overall Study|Lack of Efficacy|10|||
105804033|NCT02974114|364938702|FG000|Overall Study|Other (Not specified)|0|||
105804034|NCT02974114|364938703|FG001|Overall Study|Other (Not specified)|1|||
105804035|NCT02974114|364938704|FG002|Overall Study|Other (Not specified)|2|||
105804036|NCT01620983|364938705|FG000|Overall Study|Lost to Follow-up|8|||
105804037|NCT01620983|364938706|FG001|Overall Study|Lost to Follow-up|4|||
105804038|NCT01620983|364938707|FG002|Overall Study|Lost to Follow-up|9|||
105804039|NCT01620983|364938705|FG000|Overall Study|Withdrawal by Subject|6|||
105804040|NCT01620983|364938706|FG001|Overall Study|Withdrawal by Subject|8|||
105804041|NCT01620983|364938707|FG002|Overall Study|Withdrawal by Subject|1|||
105804042|NCT01620983|364938705|FG000|Overall Study|Death|2|||
105804043|NCT01620983|364938706|FG001|Overall Study|Death|0|||
105804044|NCT01620983|364938707|FG002|Overall Study|Death|0|||
105804045|NCT01620983|364938705|FG000|Overall Study|Physician Decision|3|||
105804046|NCT01620983|364938706|FG001|Overall Study|Physician Decision|10|||
105804047|NCT01620983|364938707|FG002|Overall Study|Physician Decision|5|||
105804048|NCT01580020|364938708|FG000|Overall Study|Lack of Efficacy|0|||
105757211|NCT00817206|364762949|FG001|Overall Study|Withdrawal by Subject|3|||
105757212|NCT00817206|364762948|FG000|Overall Study|Physician Decision|2|||
105757213|NCT00817206|364762949|FG001|Overall Study|Physician Decision|0|||
105757214|NCT02273037|364762951|FG000|Overall Study|Lost to Follow-up|1|||
105757215|NCT02273037|364762952|FG001|Overall Study|Lost to Follow-up|0|||
105757216|NCT02273037|364762951|FG000|Overall Study|Delivered before monitoring initiated|1|||
105757217|NCT02273037|364762952|FG001|Overall Study|Delivered before monitoring initiated|3|||
105757218|NCT02273037|364762951|FG000|Overall Study|Breech delivery|2|||
105757219|NCT02273037|364762952|FG001|Overall Study|Breech delivery|3|||
105757220|NCT02273037|364762951|FG000|Overall Study|Multiple delivery|2|||
105757221|NCT02273037|364762952|FG001|Overall Study|Multiple delivery|2|||
105757222|NCT02273037|364762951|FG000|Overall Study|Other complication|2|||
105757223|NCT02273037|364762952|FG001|Overall Study|Other complication|0|||
105757224|NCT00851253|364762953|FG000|Overall Study|Disease Progression|1|||
105757225|NCT00851253|364762954|FG001|Overall Study|Disease Progression|0|||
105757226|NCT02062398|364762955|FG000|Overall Study|Implant removal|1|||
105757227|NCT01779648|364762956|FG000|Overall Study|Protocol Violation|1|||
105757228|NCT01779648|364762957|FG001|Overall Study|Protocol Violation|0|||
105757229|NCT02786836|364762960|FG000|Overall Study|Death|1|||
105757230|NCT02786836|364762960|FG000|Overall Study|Lack of Efficacy|2|||
105757231|NCT02786836|364762960|FG000|Overall Study|Protocol Violation|3|||
105757232|NCT02786836|364762960|FG000|Overall Study|Withdrawal by Subject|3|||
105757233|NCT02786836|364762960|FG000|Overall Study|Liver Transplantation|2|||
105757234|NCT02786836|364762960|FG000|Overall Study|Device or Pharmacy Issues|3|||
105757235|NCT01106391|364762961|FG000|Overall Study|Death|12|||
105757236|NCT01106391|364762961|FG000|Overall Study|Withdrawal by Subject|7|||
105757237|NCT00881361|364762962|FG000|Overall Study|Terminated prior to surgery|27|||
105757238|NCT00881361|364762963|FG001|Overall Study|Terminated prior to surgery|7|||
105757239|NCT00881361|364762964|FG002|Overall Study|Terminated prior to surgery|0|||
105757240|NCT00881361|364762962|FG000|Overall Study|Ineligible|17|||
105757241|NCT00881361|364762963|FG001|Overall Study|Ineligible|2|||
105804049|NCT01580020|364938709|FG001|Overall Study|Lack of Efficacy|5|||
105757242|NCT00881361|364762964|FG002|Overall Study|Ineligible|2|||
105804050|NCT01580020|364938710|FG002|Overall Study|Lack of Efficacy|0|||
105804051|NCT01580020|364938711|FG003|Overall Study|Lack of Efficacy|1|||
105804052|NCT01580020|364938708|FG000|Overall Study|Withdrawal by Subject|0|||
105804053|NCT01580020|364938709|FG001|Overall Study|Withdrawal by Subject|1|||
105757243|NCT03017846|364762965|FG000|Overall Study|Lost to Follow-up|3|||
105757244|NCT03017846|364762965|FG000|Overall Study|Adverse Event|2|||
105757245|NCT02988219|364762967|FG000|Overall Study|Lack of Efficacy|1|||
105757246|NCT02988219|364762968|FG001|Overall Study|Lack of Efficacy|1|||
105757247|NCT02988219|364762967|FG000|Overall Study|Withdrawal by Subject|0|||
105757248|NCT02988219|364762968|FG001|Overall Study|Withdrawal by Subject|2|||
105757249|NCT01522443|364762969|FG000|Overall Study|No longer receiving clinical benefit|36|||
105757250|NCT01522443|364762970|FG001|Overall Study|No longer receiving clinical benefit|28|||
105757251|NCT01522443|364762969|FG000|Overall Study|Adverse Event|10|||
105757252|NCT01522443|364762970|FG001|Overall Study|Adverse Event|15|||
105757253|NCT01522443|364762969|FG000|Overall Study|Withdrawal by Subject|5|||
105757254|NCT01522443|364762970|FG001|Overall Study|Withdrawal by Subject|8|||
105757255|NCT01522443|364762969|FG000|Overall Study|No study treatment given|1|||
105757256|NCT01522443|364762970|FG001|Overall Study|No study treatment given|1|||
105757257|NCT01522443|364762969|FG000|Overall Study|Other|1|||
105757258|NCT01522443|364762970|FG001|Overall Study|Other|3|||
105757259|NCT00118911|364762971|FG000|Overall Study|Withdrawal by Subject|2|||
105757260|NCT00118911|364762972|FG001|Overall Study|Withdrawal by Subject|5|||
105757261|NCT00830960|364762973|FG000|Overall Study|Death|5|||
105757262|NCT00830960|364762974|FG001|Overall Study|Death|4|||
105757263|NCT00830960|364762975|FG002|Overall Study|Death|3|||
105757264|NCT00830960|364762976|FG003|Overall Study|Death|2|||
105757265|NCT00830960|364762977|FG004|Overall Study|Death|6|||
105757266|NCT00830960|364762978|FG005|Overall Study|Death|1|||
105757267|NCT00830960|364762973|FG000|Overall Study|Lost to Follow-up|1|||
105757268|NCT00830960|364762974|FG001|Overall Study|Lost to Follow-up|1|||
105757269|NCT00830960|364762975|FG002|Overall Study|Lost to Follow-up|1|||
105757270|NCT00830960|364762976|FG003|Overall Study|Lost to Follow-up|0|||
105757271|NCT00830960|364762977|FG004|Overall Study|Lost to Follow-up|0|||
105757272|NCT00830960|364762978|FG005|Overall Study|Lost to Follow-up|1|||
105757273|NCT00830960|364762973|FG000|Overall Study|Withdrawal by Subject|19|||
105757274|NCT00830960|364762974|FG001|Overall Study|Withdrawal by Subject|19|||
105757275|NCT00830960|364762975|FG002|Overall Study|Withdrawal by Subject|18|||
105757276|NCT00830960|364762976|FG003|Overall Study|Withdrawal by Subject|23|||
105757277|NCT00830960|364762977|FG004|Overall Study|Withdrawal by Subject|16|||
105757278|NCT00830960|364762978|FG005|Overall Study|Withdrawal by Subject|21|||
105757279|NCT00830960|364762973|FG000|Overall Study|Sponsor Decision|1|||
105757280|NCT00830960|364762974|FG001|Overall Study|Sponsor Decision|2|||
105757281|NCT00830960|364762975|FG002|Overall Study|Sponsor Decision|3|||
105757282|NCT00830960|364762976|FG003|Overall Study|Sponsor Decision|4|||
105757283|NCT00830960|364762977|FG004|Overall Study|Sponsor Decision|5|||
105757284|NCT00830960|364762978|FG005|Overall Study|Sponsor Decision|7|||
105757285|NCT00830960|364762973|FG000|Overall Study|No study drug received|7|||
105757286|NCT00830960|364762974|FG001|Overall Study|No study drug received|2|||
105757287|NCT00830960|364762975|FG002|Overall Study|No study drug received|4|||
105757288|NCT00830960|364762976|FG003|Overall Study|No study drug received|3|||
105757289|NCT00830960|364762977|FG004|Overall Study|No study drug received|5|||
105757290|NCT00830960|364762978|FG005|Overall Study|No study drug received|7|||
105757291|NCT00776555|364762979|FG000|Overall Study|Study terminated|3|||
105757292|NCT00776555|364762980|FG001|Overall Study|Study terminated|0|||
105757293|NCT02855450|364762981|FG000|Overall Study|Adverse Event|1|||
105757294|NCT02855450|364762982|FG001|Overall Study|Adverse Event|0|||
105757295|NCT02855450|364762981|FG000|Overall Study|Lost to Follow-up|4|||
105757296|NCT02855450|364762982|FG001|Overall Study|Lost to Follow-up|0|||
105757297|NCT03483116|364762983|FG000|Overall Study|Adverse Event|0|||
105757298|NCT03483116|364762984|FG001|Overall Study|Adverse Event|1|||
105757299|NCT03483116|364762985|FG002|Overall Study|Adverse Event|0|||
105757300|NCT03483116|364762986|FG003|Overall Study|Adverse Event|1|||
105757301|NCT03483116|364762983|FG000|Overall Study|Protocol Violation|1|||
105757302|NCT03483116|364762984|FG001|Overall Study|Protocol Violation|0|||
105757303|NCT03483116|364762985|FG002|Overall Study|Protocol Violation|0|||
105757304|NCT03483116|364762986|FG003|Overall Study|Protocol Violation|7|||
105757305|NCT03483116|364762983|FG000|Overall Study|Lost to Follow-up|9|||
105757306|NCT03483116|364762984|FG001|Overall Study|Lost to Follow-up|4|||
105757307|NCT03483116|364762985|FG002|Overall Study|Lost to Follow-up|9|||
105757308|NCT03483116|364762986|FG003|Overall Study|Lost to Follow-up|5|||
105757309|NCT03483116|364762983|FG000|Overall Study|Death|1|||
105757310|NCT03483116|364762984|FG001|Overall Study|Death|0|||
105757311|NCT03483116|364762985|FG002|Overall Study|Death|2|||
105757312|NCT03483116|364762986|FG003|Overall Study|Death|1|||
105757313|NCT03483116|364762983|FG000|Overall Study|Withdrawal by Subject|14|||
105804054|NCT01580020|364938710|FG002|Overall Study|Withdrawal by Subject|1|||
105804055|NCT01580020|364938711|FG003|Overall Study|Withdrawal by Subject|0|||
105804056|NCT01580020|364938708|FG000|Overall Study|Adverse Event|1|||
105804057|NCT01580020|364938709|FG001|Overall Study|Adverse Event|1|||
105804058|NCT01580020|364938710|FG002|Overall Study|Adverse Event|1|||
105804059|NCT01580020|364938711|FG003|Overall Study|Adverse Event|1|||
105804060|NCT01580020|364938708|FG000|Overall Study|Administrative Problems|0|||
105804061|NCT01580020|364938709|FG001|Overall Study|Administrative Problems|0|||
105804062|NCT01580020|364938710|FG002|Overall Study|Administrative Problems|1|||
105804063|NCT01580020|364938711|FG003|Overall Study|Administrative Problems|0|||
105804064|NCT01580020|364938708|FG000|Overall Study|Lost to Follow-up|0|||
105804065|NCT01580020|364938709|FG001|Overall Study|Lost to Follow-up|0|||
105804066|NCT01580020|364938710|FG002|Overall Study|Lost to Follow-up|1|||
105804067|NCT01580020|364938711|FG003|Overall Study|Lost to Follow-up|0|||
105804068|NCT03124381|364938718|FG000|Overall Study|Lost to Follow-up|1|||
105804069|NCT03124381|364938719|FG001|Overall Study|Lost to Follow-up|1|||
105804070|NCT03124381|364938718|FG000|Overall Study|Withdrawal by Subject|6|||
105804071|NCT03124381|364938719|FG001|Overall Study|Withdrawal by Subject|3|||
105804072|NCT03124381|364938718|FG000|Overall Study|Protocol Violation|0|||
105804073|NCT03124381|364938719|FG001|Overall Study|Protocol Violation|1|||
105804074|NCT03124381|364938718|FG000|Overall Study|Adverse Event|1|||
105804075|NCT03124381|364938719|FG001|Overall Study|Adverse Event|1|||
105804076|NCT03124381|364938718|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
105804077|NCT03124381|364938719|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
105804078|NCT03210259|364938720|FG000|12-Week Run-in Period|Adverse Event|1|||
105804079|NCT03210259|364938721|FG001|12-Week Run-in Period|Adverse Event|0|||
105804080|NCT03210259|364938722|FG002|12-Week Run-in Period|Adverse Event|0|||
105804081|NCT03210259|364938720|FG000|12-Week Run-in Period|Death|1|||
105804082|NCT03210259|364938721|FG001|12-Week Run-in Period|Death|0|||
105804083|NCT03210259|364938722|FG002|12-Week Run-in Period|Death|0|||
105804084|NCT03210259|364938720|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
105804085|NCT03210259|364938721|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
105804086|NCT03210259|364938722|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
105804087|NCT03210259|364938720|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
105804088|NCT03210259|364938721|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
105804089|NCT03210259|364938722|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
105804090|NCT03210259|364938720|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
105804091|NCT03210259|364938721|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
105804092|NCT03210259|364938722|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
105804093|NCT03210259|364938720|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
105804094|NCT03210259|364938721|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
105804095|NCT03210259|364938722|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
105804096|NCT03210259|364938720|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
105804097|NCT03210259|364938721|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
105804098|NCT03210259|364938722|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
105804099|NCT03210259|364938720|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
105804100|NCT03210259|364938721|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
105804101|NCT03210259|364938722|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
105804102|NCT03210259|364938720|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
105804103|NCT03210259|364938721|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
105804104|NCT03210259|364938722|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
105804105|NCT03210259|364938720|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
105804106|NCT03210259|364938721|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
105804107|NCT03210259|364938722|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
105804108|NCT03210259|364938720|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
105804109|NCT03210259|364938721|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
105804110|NCT03210259|364938722|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
105804111|NCT02087059|364938723|FG000|Overall Study|Disease Progression|1|||
105804112|NCT02087059|364938723|FG000|Overall Study|Adverse Event|5|||
105804113|NCT02087059|364938723|FG000|Overall Study|Lost to Follow-up|1|||
105804114|NCT01102777|364938726|FG000|Overall Study|Death|2|||
105804115|NCT01102777|364938727|FG001|Overall Study|Death|6|||
105804116|NCT01102777|364938726|FG000|Overall Study|Lost to Follow-up|7|||
105804117|NCT01102777|364938727|FG001|Overall Study|Lost to Follow-up|10|||
105804118|NCT00706706|364938728|FG000|Overall Study|Death|53|||
105804119|NCT00706706|364938728|FG000|Overall Study|Lost to Follow-up|7|||
105804120|NCT00706706|364938728|FG000|Overall Study|Study endpoint had reached|45|||
105804121|NCT01306253|364938729|FG000|Overall Study|Lost to Follow-up|1|||
105804122|NCT01306253|364938730|FG001|Overall Study|Lost to Follow-up|1|||
105483666|NCT02296138|363782731|FG000|Overall Study|Protocol Violation|35|||
105804123|NCT00771901|364938731|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
105804124|NCT00771901|364938732|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
105804125|NCT00771901|364938733|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
105804126|NCT00408876|364938734|FG000|Overall Study|Adverse Event|9|||
105804127|NCT00408876|364938735|FG001|Overall Study|Adverse Event|17|||
105757314|NCT03483116|364762984|FG001|Overall Study|Withdrawal by Subject|16|||
105757315|NCT03483116|364762985|FG002|Overall Study|Withdrawal by Subject|14|||
105757316|NCT03483116|364762986|FG003|Overall Study|Withdrawal by Subject|16|||
105757317|NCT03483116|364762983|FG000|Overall Study|Unknown other reason|3|||
105757318|NCT03483116|364762984|FG001|Overall Study|Unknown other reason|2|||
105757319|NCT03483116|364762985|FG002|Overall Study|Unknown other reason|1|||
105757320|NCT03483116|364762986|FG003|Overall Study|Unknown other reason|1|||
105757321|NCT00426556|364762987|FG000|Phase I - Core Phase|Disease Progression|0|||
105757322|NCT00426556|364762988|FG001|Phase I - Core Phase|Disease Progression|6|||
105757323|NCT00426556|364762989|FG002|Phase I - Core Phase|Disease Progression|2|||
105757324|NCT00426556|364762990|FG003|Phase I - Core Phase|Disease Progression|0|||
105757325|NCT00426556|364762987|FG000|Phase I - Core Phase|Adverse Event|1|||
105757326|NCT00426556|364762988|FG001|Phase I - Core Phase|Adverse Event|3|||
105757327|NCT00426556|364762989|FG002|Phase I - Core Phase|Adverse Event|1|||
105757328|NCT00426556|364762990|FG003|Phase I - Core Phase|Adverse Event|0|||
105757329|NCT00426556|364762987|FG000|Phase I - Core Phase|Death|0|||
105757330|NCT00426556|364762988|FG001|Phase I - Core Phase|Death|1|||
105757331|NCT00426556|364762989|FG002|Phase I - Core Phase|Death|0|||
105757332|NCT00426556|364762990|FG003|Phase I - Core Phase|Death|0|||
105757333|NCT00426556|364762987|FG000|Phase I - Extension Phase|Adverse Event|0|||
105757334|NCT00426556|364762988|FG001|Phase I - Extension Phase|Adverse Event|1|||
105757335|NCT00426556|364762989|FG002|Phase I - Extension Phase|Adverse Event|1|||
105757336|NCT00426556|364762990|FG003|Phase I - Extension Phase|Adverse Event|0|||
105757337|NCT00426556|364762987|FG000|Phase I - Extension Phase|Disease Progression|5|||
105757338|NCT00426556|364762988|FG001|Phase I - Extension Phase|Disease Progression|5|||
105757339|NCT00426556|364762989|FG002|Phase I - Extension Phase|Disease Progression|6|||
105757340|NCT00426556|364762990|FG003|Phase I - Extension Phase|Disease Progression|0|||
105757341|NCT00426556|364762987|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
105757342|NCT00426556|364762988|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
105757343|NCT00426556|364762989|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
105757344|NCT00426556|364762990|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
105757345|NCT00426556|364762987|FG000|Phase II - Core Phase|Disease Progression|0|||
105757346|NCT00426556|364762988|FG001|Phase II - Core Phase|Disease Progression|0|||
105757347|NCT00426556|364762989|FG002|Phase II - Core Phase|Disease Progression|0|||
105757348|NCT00426556|364762990|FG003|Phase II - Core Phase|Disease Progression|16|||
105757349|NCT00426556|364762987|FG000|Phase II - Core Phase|Adverse Event|0|||
105757350|NCT00426556|364762988|FG001|Phase II - Core Phase|Adverse Event|0|||
105757351|NCT00426556|364762989|FG002|Phase II - Core Phase|Adverse Event|0|||
105757352|NCT00426556|364762990|FG003|Phase II - Core Phase|Adverse Event|8|||
105757353|NCT00426556|364762987|FG000|Phase II - Extension Phase|Disease Progression|0|||
105757354|NCT00426556|364762988|FG001|Phase II - Extension Phase|Disease Progression|0|||
105757355|NCT00426556|364762989|FG002|Phase II - Extension Phase|Disease Progression|0|||
105757356|NCT00426556|364762990|FG003|Phase II - Extension Phase|Disease Progression|21|||
105757357|NCT00426556|364762987|FG000|Phase II - Extension Phase|Adverse Event|0|||
105757358|NCT00426556|364762988|FG001|Phase II - Extension Phase|Adverse Event|0|||
105757359|NCT00426556|364762989|FG002|Phase II - Extension Phase|Adverse Event|0|||
105757360|NCT00426556|364762990|FG003|Phase II - Extension Phase|Adverse Event|2|||
105757361|NCT05159362|364762993|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
105757362|NCT05159362|364762994|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
105757363|NCT05159362|364762995|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
105757364|NCT01376245|364762996|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
105757365|NCT01376245|364762997|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
105757366|NCT01376245|364762998|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
105757367|NCT01376245|364762999|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
105757368|NCT01376245|364763000|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
105757369|NCT01376245|364762996|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
105757370|NCT01376245|364762997|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
105757371|NCT01376245|364762998|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
105757372|NCT01376245|364762999|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
105757373|NCT01376245|364763000|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
105757374|NCT01376245|364762996|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
105757375|NCT01376245|364762997|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
105757376|NCT01376245|364762998|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
105757377|NCT01376245|364762999|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
105757378|NCT01376245|364763000|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
105804128|NCT00408876|364938736|FG002|Overall Study|Adverse Event|27|||
105804129|NCT00408876|364938737|FG003|Overall Study|Adverse Event|10|||
105757379|NCT01376245|364762996|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
105804130|NCT00408876|364938734|FG000|Overall Study|Withdrawal by Subject|3|||
105804131|NCT00408876|364938735|FG001|Overall Study|Withdrawal by Subject|6|||
105360536|NCT05216835|363326007|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
105804132|NCT00408876|364938736|FG002|Overall Study|Withdrawal by Subject|6|||
105804133|NCT00408876|364938737|FG003|Overall Study|Withdrawal by Subject|14|||
105804134|NCT00408876|364938734|FG000|Overall Study|Lack of Efficacy|2|||
105804135|NCT00408876|364938735|FG001|Overall Study|Lack of Efficacy|4|||
105804136|NCT00408876|364938736|FG002|Overall Study|Lack of Efficacy|5|||
105804137|NCT00408876|364938737|FG003|Overall Study|Lack of Efficacy|6|||
105804138|NCT00408876|364938734|FG000|Overall Study|Lost to Follow-up|1|||
105804139|NCT00408876|364938735|FG001|Overall Study|Lost to Follow-up|6|||
105804140|NCT00408876|364938736|FG002|Overall Study|Lost to Follow-up|5|||
105804141|NCT00408876|364938737|FG003|Overall Study|Lost to Follow-up|2|||
105804142|NCT00408876|364938734|FG000|Overall Study|Protocol Violation|0|||
105804143|NCT00408876|364938735|FG001|Overall Study|Protocol Violation|3|||
105804144|NCT00408876|364938736|FG002|Overall Study|Protocol Violation|4|||
105804145|NCT00408876|364938737|FG003|Overall Study|Protocol Violation|3|||
105804146|NCT00408876|364938734|FG000|Overall Study|Physician Decision|1|||
105804147|NCT00408876|364938735|FG001|Overall Study|Physician Decision|0|||
105804148|NCT00408876|364938736|FG002|Overall Study|Physician Decision|3|||
105804149|NCT00408876|364938737|FG003|Overall Study|Physician Decision|0|||
105804150|NCT02006147|364938738|FG000|Overall Study|Protocol Violation|1|||
105804151|NCT02006147|364938739|FG001|Overall Study|Protocol Violation|1|||
105804152|NCT02006147|364938740|FG002|Overall Study|Protocol Violation|0|||
105804153|NCT02006147|364938741|FG003|Overall Study|Protocol Violation|0|||
105804154|NCT02006147|364938738|FG000|Overall Study|Withdrawal by Subject|0|||
105804155|NCT02006147|364938739|FG001|Overall Study|Withdrawal by Subject|1|||
105804156|NCT02006147|364938740|FG002|Overall Study|Withdrawal by Subject|0|||
105804157|NCT02006147|364938741|FG003|Overall Study|Withdrawal by Subject|0|||
105804158|NCT02006147|364938738|FG000|Overall Study|Withdrawal by Sponsor|1|||
105804159|NCT02006147|364938739|FG001|Overall Study|Withdrawal by Sponsor|0|||
105804160|NCT02006147|364938740|FG002|Overall Study|Withdrawal by Sponsor|0|||
105804161|NCT02006147|364938741|FG003|Overall Study|Withdrawal by Sponsor|0|||
105804162|NCT02668302|364938748|FG000|Overall Study|Withdrawal by Subject|1|||
105804163|NCT02668302|364938749|FG001|Overall Study|Withdrawal by Subject|0|||
105804164|NCT00895583|364938750|FG000|Overall Study|Adverse Event|28|||
105804165|NCT00895583|364938751|FG001|Overall Study|Adverse Event|4|||
105804166|NCT00895583|364938750|FG000|Overall Study|Death|2|||
105804167|NCT00895583|364938751|FG001|Overall Study|Death|1|||
105804168|NCT00895583|364938750|FG000|Overall Study|Physician Decision|3|||
105804169|NCT00895583|364938751|FG001|Overall Study|Physician Decision|1|||
105804170|NCT00895583|364938750|FG000|Overall Study|Lost to Follow-up|1|||
105804171|NCT00895583|364938751|FG001|Overall Study|Lost to Follow-up|3|||
105804172|NCT00895583|364938750|FG000|Overall Study|Protocol Violation|1|||
105804173|NCT00895583|364938751|FG001|Overall Study|Protocol Violation|0|||
105804174|NCT00895583|364938750|FG000|Overall Study|Withdrawal by Subject|4|||
105804175|NCT00895583|364938751|FG001|Overall Study|Withdrawal by Subject|2|||
105804176|NCT00895583|364938750|FG000|Overall Study|Lack of Efficacy|5|||
105804177|NCT00895583|364938751|FG001|Overall Study|Lack of Efficacy|0|||
105804178|NCT00895583|364938750|FG000|Overall Study|Other|0|||
105804179|NCT00895583|364938751|FG001|Overall Study|Other|1|||
105804180|NCT00526890|364938752|FG000|Overall Study|Adverse Event|2|||
105804181|NCT00095199|364938753|FG000|Overall Study|Adverse Event|40|||
105804182|NCT00095199|364938754|FG001|Overall Study|Adverse Event|22|||
105804183|NCT00095199|364938755|FG002|Overall Study|Adverse Event|26|||
105804184|NCT00095199|364938756|FG003|Overall Study|Adverse Event|11|||
105804185|NCT00095199|364938753|FG000|Overall Study|Progressive disease|213|||
105804186|NCT00095199|364938754|FG001|Overall Study|Progressive disease|179|||
105804187|NCT00095199|364938755|FG002|Overall Study|Progressive disease|105|||
105804188|NCT00095199|364938756|FG003|Overall Study|Progressive disease|98|||
105804189|NCT00095199|364938753|FG000|Overall Study|Death|10|||
105804190|NCT00095199|364938754|FG001|Overall Study|Death|6|||
105804191|NCT00095199|364938755|FG002|Overall Study|Death|11|||
105804192|NCT00095199|364938756|FG003|Overall Study|Death|9|||
105804193|NCT00095199|364938753|FG000|Overall Study|Withdrawal by Subject|21|||
105804194|NCT00095199|364938754|FG001|Overall Study|Withdrawal by Subject|16|||
105804195|NCT00095199|364938755|FG002|Overall Study|Withdrawal by Subject|13|||
105804196|NCT00095199|364938756|FG003|Overall Study|Withdrawal by Subject|22|||
105804197|NCT00095199|364938753|FG000|Overall Study|Protocol Violation|4|||
105804198|NCT00095199|364938754|FG001|Overall Study|Protocol Violation|4|||
105804199|NCT00095199|364938755|FG002|Overall Study|Protocol Violation|2|||
105804200|NCT00095199|364938756|FG003|Overall Study|Protocol Violation|0|||
105804201|NCT00095199|364938753|FG000|Overall Study|Liver function test results elevated|0|||
105804202|NCT00095199|364938754|FG001|Overall Study|Liver function test results elevated|0|||
105804203|NCT00095199|364938755|FG002|Overall Study|Liver function test results elevated|1|||
105804204|NCT00095199|364938756|FG003|Overall Study|Liver function test results elevated|1|||
105804205|NCT00095199|364938753|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
105804206|NCT00095199|364938754|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
105757380|NCT01376245|364762997|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
105757381|NCT01376245|364762998|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
105757382|NCT01376245|364762999|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
105757383|NCT01376245|364763000|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
105757384|NCT01376245|364762996|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
105757385|NCT01376245|364762997|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
105757386|NCT01376245|364762998|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
105757387|NCT01376245|364762999|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
105757388|NCT01376245|364763000|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
105757389|NCT01376245|364762996|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
105757390|NCT01376245|364762997|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
105757391|NCT01376245|364762998|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
105757392|NCT01376245|364762999|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
105757393|NCT01376245|364763000|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
105757394|NCT01376245|364762996|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
105757395|NCT01376245|364762997|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
105757396|NCT01376245|364762998|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
105757397|NCT01376245|364762999|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
105757398|NCT01376245|364763000|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
105757399|NCT01376245|364762996|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
105757400|NCT01376245|364762997|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
105757401|NCT01376245|364762998|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
105757402|NCT01376245|364762999|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
105757403|NCT01376245|364763000|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
105757404|NCT01376245|364762996|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
105757405|NCT01376245|364762997|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
105757406|NCT01376245|364762998|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
105757407|NCT01376245|364762999|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
105757408|NCT01376245|364763000|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
105757409|NCT01376245|364762996|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105757410|NCT01376245|364762997|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
105757411|NCT01376245|364762998|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105757412|NCT01376245|364762999|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
105757413|NCT01376245|364763000|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
105757414|NCT01376245|364762996|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
105757415|NCT01376245|364762997|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
105757416|NCT01376245|364762998|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
105757417|NCT01376245|364762999|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
105757418|NCT01376245|364763000|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
105757419|NCT01376245|364762996|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
105757420|NCT01376245|364762997|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
105757421|NCT01376245|364762998|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
105757422|NCT01376245|364762999|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
105757423|NCT01376245|364763000|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
105757424|NCT01335698|364763001|FG000|Treatment Stage 1|Lack of Efficacy|3|||
105757425|NCT01335698|364763002|FG001|Treatment Stage 1|Lack of Efficacy|1|||
105757426|NCT01335698|364763003|FG002|Treatment Stage 1|Lack of Efficacy|3|||
105757427|NCT01335698|364763004|FG003|Treatment Stage 1|Lack of Efficacy|3|||
105757428|NCT01335698|364763005|FG004|Treatment Stage 1|Lack of Efficacy|1|||
105757429|NCT01335698|364763001|FG000|Treatment Stage 1|Adverse Event|1|||
105757430|NCT01335698|364763002|FG001|Treatment Stage 1|Adverse Event|2|||
105757431|NCT01335698|364763003|FG002|Treatment Stage 1|Adverse Event|2|||
105757432|NCT01335698|364763004|FG003|Treatment Stage 1|Adverse Event|1|||
105757433|NCT01335698|364763005|FG004|Treatment Stage 1|Adverse Event|1|||
105757434|NCT01335698|364763001|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
105757435|NCT01335698|364763002|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
105757436|NCT01335698|364763003|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
105757437|NCT01335698|364763004|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
105757438|NCT01335698|364763005|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
105757439|NCT01335698|364763001|FG000|Treatment Stage 1|Lost to Follow-up|1|||
105757440|NCT01335698|364763002|FG001|Treatment Stage 1|Lost to Follow-up|1|||
105757441|NCT01335698|364763003|FG002|Treatment Stage 1|Lost to Follow-up|0|||
105757442|NCT01335698|364763004|FG003|Treatment Stage 1|Lost to Follow-up|0|||
105757443|NCT01335698|364763005|FG004|Treatment Stage 1|Lost to Follow-up|0|||
105757444|NCT01335698|364763001|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
105757445|NCT01335698|364763002|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
105757446|NCT01335698|364763003|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
105757447|NCT01335698|364763004|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
105757448|NCT01335698|364763005|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
105757449|NCT01335698|364763001|FG000|Treatment Stage 1|No longer meets study criteria|1|||
105757450|NCT01335698|364763002|FG001|Treatment Stage 1|No longer meets study criteria|1|||
105757451|NCT01335698|364763003|FG002|Treatment Stage 1|No longer meets study criteria|0|||
105757452|NCT01335698|364763004|FG003|Treatment Stage 1|No longer meets study criteria|1|||
105757453|NCT01335698|364763005|FG004|Treatment Stage 1|No longer meets study criteria|0|||
105757454|NCT01335698|364763001|FG000|Treatment Stage 1|Other|1|||
105757455|NCT01335698|364763002|FG001|Treatment Stage 1|Other|0|||
105757456|NCT01335698|364763003|FG002|Treatment Stage 1|Other|0|||
105757457|NCT01335698|364763004|FG003|Treatment Stage 1|Other|1|||
105757458|NCT01335698|364763005|FG004|Treatment Stage 1|Other|0|||
105757459|NCT01335698|364763001|FG000|Treatment Stage 2|Lack of Efficacy|2|||
105757460|NCT01335698|364763002|FG001|Treatment Stage 2|Lack of Efficacy|1|||
105757461|NCT01335698|364763003|FG002|Treatment Stage 2|Lack of Efficacy|3|||
105757462|NCT01335698|364763004|FG003|Treatment Stage 2|Lack of Efficacy|1|||
105757463|NCT01335698|364763005|FG004|Treatment Stage 2|Lack of Efficacy|0|||
105757464|NCT01335698|364763001|FG000|Treatment Stage 2|Adverse Event|2|||
105757465|NCT01335698|364763002|FG001|Treatment Stage 2|Adverse Event|0|||
105757466|NCT01335698|364763003|FG002|Treatment Stage 2|Adverse Event|0|||
105757467|NCT01335698|364763004|FG003|Treatment Stage 2|Adverse Event|3|||
105757468|NCT01335698|364763005|FG004|Treatment Stage 2|Adverse Event|0|||
105757469|NCT01335698|364763001|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
105757470|NCT01335698|364763002|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
105757471|NCT01335698|364763003|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
105757472|NCT01335698|364763004|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
105757473|NCT01335698|364763005|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
105757474|NCT01335698|364763001|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
105757475|NCT01335698|364763002|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
105757476|NCT01335698|364763003|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
105757477|NCT01335698|364763004|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
105757478|NCT01335698|364763005|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
105757479|NCT01335698|364763001|FG000|Treatment Stage 2|Lost to Follow-up|1|||
105757480|NCT01335698|364763002|FG001|Treatment Stage 2|Lost to Follow-up|0|||
105757481|NCT01335698|364763003|FG002|Treatment Stage 2|Lost to Follow-up|0|||
105757482|NCT01335698|364763004|FG003|Treatment Stage 2|Lost to Follow-up|0|||
105757483|NCT01335698|364763005|FG004|Treatment Stage 2|Lost to Follow-up|0|||
105757484|NCT01335698|364763001|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
105757485|NCT01335698|364763002|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
105757486|NCT01335698|364763003|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
105757487|NCT01335698|364763004|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
105757488|NCT01335698|364763005|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
105757489|NCT01335698|364763001|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
105757490|NCT01335698|364763002|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
105757491|NCT01335698|364763003|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
105757492|NCT01335698|364763004|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
105757493|NCT01335698|364763005|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
105757494|NCT01335698|364763001|FG000|Treatment Stage 2|Switched to another formulation|1|||
105757495|NCT01335698|364763002|FG001|Treatment Stage 2|Switched to another formulation|1|||
105757496|NCT01335698|364763003|FG002|Treatment Stage 2|Switched to another formulation|0|||
105757497|NCT01335698|364763004|FG003|Treatment Stage 2|Switched to another formulation|0|||
105757498|NCT01335698|364763005|FG004|Treatment Stage 2|Switched to another formulation|0|||
105757499|NCT00416312|364763006|FG000|Overall Study|tumors not visible on imaging|2|||
105757500|NCT02727660|364763009|FG000|Overall Study|Lack of Efficacy|40|||
105757501|NCT02727660|364763010|FG001|Overall Study|Lack of Efficacy|40|||
105757502|NCT02727660|364763011|FG002|Overall Study|Lack of Efficacy|70|||
105757503|NCT02727660|364763009|FG000|Overall Study|Adverse Event|28|||
105757504|NCT02727660|364763010|FG001|Overall Study|Adverse Event|21|||
105757505|NCT02727660|364763011|FG002|Overall Study|Adverse Event|32|||
105757506|NCT02727660|364763009|FG000|Overall Study|Withdrawal by Subject|26|||
105757507|NCT02727660|364763010|FG001|Overall Study|Withdrawal by Subject|25|||
105757508|NCT02727660|364763011|FG002|Overall Study|Withdrawal by Subject|30|||
105757509|NCT02727660|364763009|FG000|Overall Study|Physician Decision|3|||
105757510|NCT02727660|364763010|FG001|Overall Study|Physician Decision|8|||
105757511|NCT02727660|364763011|FG002|Overall Study|Physician Decision|14|||
105757512|NCT02727660|364763009|FG000|Overall Study|Lost to Follow-up|5|||
105757513|NCT02727660|364763010|FG001|Overall Study|Lost to Follow-up|9|||
105757514|NCT02727660|364763011|FG002|Overall Study|Lost to Follow-up|8|||
105757515|NCT02727660|364763009|FG000|Overall Study|Protocol Violation|7|||
105757516|NCT02727660|364763010|FG001|Overall Study|Protocol Violation|5|||
105757517|NCT02727660|364763011|FG002|Overall Study|Protocol Violation|5|||
105757518|NCT02727660|364763009|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
105757519|NCT02727660|364763010|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
105757520|NCT02727660|364763011|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
105757521|NCT02727660|364763009|FG000|Overall Study|Administrative Reasons|2|||
105757522|NCT02727660|364763010|FG001|Overall Study|Administrative Reasons|3|||
105757523|NCT02727660|364763011|FG002|Overall Study|Administrative Reasons|4|||
105757524|NCT00105560|364763012|FG000|Overall Study|Lost to Follow-up|1|||
105757525|NCT01182337|364763018|FG000|Overall Study|Withdrawal by Subject|3|||
105757526|NCT01182337|364763019|FG001|Overall Study|Withdrawal by Subject|1|||
105757527|NCT01182337|364763018|FG000|Overall Study|Lost to Follow-up|0|||
105757528|NCT01182337|364763019|FG001|Overall Study|Lost to Follow-up|1|||
105757529|NCT03103906|364763020|FG000|Overall Study|Adverse Event|2|||
105757530|NCT03103906|364763021|FG001|Overall Study|Adverse Event|3|||
105757531|NCT03103906|364763020|FG000|Overall Study|Other|2|||
105757532|NCT03103906|364763021|FG001|Overall Study|Other|0|||
105757533|NCT03571256|364763022|FG000|Overall Study|Adverse Event|3|||
105757534|NCT03571256|364763023|FG001|Overall Study|Adverse Event|0|||
105757535|NCT03571256|364763024|FG002|Overall Study|Adverse Event|1|||
105757536|NCT03571256|364763022|FG000|Overall Study|Withdrawal by Subject|3|||
105757537|NCT03571256|364763023|FG001|Overall Study|Withdrawal by Subject|1|||
105757538|NCT03571256|364763024|FG002|Overall Study|Withdrawal by Subject|1|||
105757539|NCT03571256|364763022|FG000|Overall Study|Other than specified|0|||
105757540|NCT03571256|364763023|FG001|Overall Study|Other than specified|1|||
105757541|NCT03571256|364763024|FG002|Overall Study|Other than specified|1|||
105757542|NCT03571256|364763022|FG000|Overall Study|Protocol Violation|0|||
105757543|NCT03571256|364763023|FG001|Overall Study|Protocol Violation|1|||
105757544|NCT03571256|364763024|FG002|Overall Study|Protocol Violation|1|||
105757545|NCT00772382|364763027|FG000|Overall Study|Adverse Event|19|||
105757546|NCT00772382|364763027|FG000|Overall Study|Death|6|||
105757547|NCT00772382|364763027|FG000|Overall Study|Lack of Efficacy|4|||
105757548|NCT00772382|364763027|FG000|Overall Study|Physician Decision|5|||
105757549|NCT00772382|364763027|FG000|Overall Study|Protocol Violation|1|||
105757550|NCT00772382|364763027|FG000|Overall Study|Withdrawal by Subject|10|||
105757551|NCT00772382|364763027|FG000|Overall Study|Other Reasons|10|||
105757552|NCT01641991|364763031|FG000|Overall Study|Physician Decision|0|||
105757553|NCT01641991|364763032|FG001|Overall Study|Physician Decision|1|||
105757554|NCT01641991|364763033|FG002|Overall Study|Physician Decision|7|||
105757555|NCT01641991|364763034|FG003|Overall Study|Physician Decision|5|||
105757556|NCT01641991|364763031|FG000|Overall Study|Withdrawal by Subject|4|||
105757557|NCT01641991|364763032|FG001|Overall Study|Withdrawal by Subject|2|||
105757558|NCT01641991|364763033|FG002|Overall Study|Withdrawal by Subject|1|||
105757559|NCT01641991|364763034|FG003|Overall Study|Withdrawal by Subject|5|||
105757560|NCT01641991|364763031|FG000|Overall Study|Adverse Event|2|||
105757561|NCT01641991|364763032|FG001|Overall Study|Adverse Event|1|||
105757562|NCT01641991|364763033|FG002|Overall Study|Adverse Event|2|||
105757563|NCT01641991|364763034|FG003|Overall Study|Adverse Event|1|||
105757564|NCT01641991|364763031|FG000|Overall Study|Lost to Follow-up|0|||
105757565|NCT01641991|364763032|FG001|Overall Study|Lost to Follow-up|2|||
105757566|NCT01641991|364763033|FG002|Overall Study|Lost to Follow-up|3|||
105757567|NCT01641991|364763034|FG003|Overall Study|Lost to Follow-up|1|||
105757568|NCT01641991|364763031|FG000|Overall Study|Protocol Violation|1|||
105757569|NCT01641991|364763032|FG001|Overall Study|Protocol Violation|1|||
105757570|NCT01641991|364763033|FG002|Overall Study|Protocol Violation|3|||
105757571|NCT01641991|364763034|FG003|Overall Study|Protocol Violation|0|||
105757572|NCT01641991|364763031|FG000|Overall Study|Pregnancy|0|||
105757573|NCT01641991|364763032|FG001|Overall Study|Pregnancy|0|||
105757574|NCT01641991|364763033|FG002|Overall Study|Pregnancy|1|||
105757575|NCT01641991|364763034|FG003|Overall Study|Pregnancy|0|||
105757576|NCT01641991|364763031|FG000|Overall Study|no longer eligible|2|||
105757577|NCT01641991|364763032|FG001|Overall Study|no longer eligible|1|||
105757578|NCT01641991|364763033|FG002|Overall Study|no longer eligible|0|||
105757579|NCT01641991|364763034|FG003|Overall Study|no longer eligible|4|||
105757580|NCT02807363|364763035|FG000|Dosing Period|Adverse Event|0|||
105757581|NCT02807363|364763036|FG001|Dosing Period|Adverse Event|1|||
105757582|NCT02807363|364763037|FG002|Dosing Period|Adverse Event|0|||
105757583|NCT02807363|364763038|FG003|Dosing Period|Adverse Event|0|||
105757584|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
105757585|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
105757586|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
105757587|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
105757588|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
105757589|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
105757590|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
105757591|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
105757592|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
105757593|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
105757594|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
105757595|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
105757596|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
105757597|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
105757598|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
105757599|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
105757600|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
105757601|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
105757602|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
105757603|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
105757604|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
105757605|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
105757606|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
105757607|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
105757608|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
105757609|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
105757610|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
105757611|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
105757612|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
105757613|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
105757614|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
105757615|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
105757616|NCT00476996|364763039|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
105757617|NCT00476996|364763040|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
105757618|NCT00476996|364763041|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
105757619|NCT00476996|364763042|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
105757620|NCT00476996|364763039|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
105757621|NCT00476996|364763040|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
105757622|NCT00476996|364763041|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
105757623|NCT00476996|364763042|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
105757624|NCT00476996|364763039|FG000|OLE Phase (From Week 48)|Death|0|||
105757625|NCT00476996|364763040|FG001|OLE Phase (From Week 48)|Death|0|||
105757626|NCT00476996|364763041|FG002|OLE Phase (From Week 48)|Death|0|||
105757627|NCT00476996|364763042|FG003|OLE Phase (From Week 48)|Death|7|||
105757628|NCT00476996|364763039|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
105757629|NCT00476996|364763040|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
105757630|NCT00476996|364763041|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
105757631|NCT00476996|364763042|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
105757632|NCT00476996|364763039|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
105757633|NCT00476996|364763040|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
105757634|NCT00476996|364763041|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
105757635|NCT00476996|364763042|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
105757636|NCT00476996|364763039|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
105757637|NCT00476996|364763040|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
105757638|NCT00476996|364763041|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
105757639|NCT00476996|364763042|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
105757640|NCT00476996|364763039|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
105757641|NCT00476996|364763040|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
105360537|NCT05216835|363326000|FG000|Overall Study|Death|0|||
105757642|NCT00476996|364763041|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
105757643|NCT00476996|364763042|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
105757644|NCT03219567|364763043|FG000|Overall Study|Withdrawal by Subject|0|||
105757645|NCT03219567|364763044|FG001|Overall Study|Withdrawal by Subject|1|||
105757646|NCT02939599|364763046|FG000|Overall Study|Adverse Event|1|||
105757647|NCT02939599|364763047|FG001|Overall Study|Adverse Event|0|||
105757648|NCT02939599|364763046|FG000|Overall Study|Study Terminated By Sponsor|2|||
105757649|NCT02939599|364763047|FG001|Overall Study|Study Terminated By Sponsor|2|||
105757650|NCT02148211|364763054|FG000|Overall Study|Lost to Follow-up|352|||
105757651|NCT02726113|364763058|FG000|Total Enrollment|Physician Decision|0|||
105757652|NCT02726113|364763059|FG001|Total Enrollment|Physician Decision|1|||
105757653|NCT02726113|364763058|FG000|Total Enrollment|Protocol Violation|1|||
105757654|NCT02726113|364763059|FG001|Total Enrollment|Protocol Violation|0|||
105757655|NCT02726113|364763058|FG000|Total Enrollment|Withdrawal by Subject|2|||
105757656|NCT02726113|364763059|FG001|Total Enrollment|Withdrawal by Subject|1|||
105757657|NCT02726113|364763058|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
105757658|NCT02726113|364763059|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
105757659|NCT02726113|364763058|FG000|Genomic Analysis|Protocol Violation|1|||
105757660|NCT02726113|364763059|FG001|Genomic Analysis|Protocol Violation|0|||
105757661|NCT02726113|364763058|FG000|Genomic Analysis|Withdrawal by Subject|2|||
105757662|NCT02726113|364763059|FG001|Genomic Analysis|Withdrawal by Subject|1|||
105757663|NCT02726113|364763058|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
105757664|NCT02726113|364763059|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
105757665|NCT01617187|364763062|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
105757666|NCT01617187|364763063|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
105757667|NCT01617187|364763064|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
105757668|NCT01617187|364763065|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
105757669|NCT01617187|364763062|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
105757670|NCT01617187|364763063|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
105757671|NCT01617187|364763064|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
105757672|NCT01617187|364763065|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
105757673|NCT01617187|364763062|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
105757674|NCT01617187|364763063|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
105757675|NCT01617187|364763064|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
105757676|NCT01617187|364763065|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
105757677|NCT01617187|364763062|FG000|Treatment Through Study Completion|Adverse Event|1|||
105757678|NCT01617187|364763063|FG001|Treatment Through Study Completion|Adverse Event|1|||
105757679|NCT01617187|364763064|FG002|Treatment Through Study Completion|Adverse Event|0|||
105757680|NCT01617187|364763065|FG003|Treatment Through Study Completion|Adverse Event|1|||
105757681|NCT01617187|364763062|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
105757682|NCT01617187|364763063|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
105757683|NCT01617187|364763064|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
105757684|NCT01617187|364763065|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
105757685|NCT01617187|364763062|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
105757686|NCT01617187|364763063|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
105757687|NCT01617187|364763064|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
105757688|NCT01617187|364763065|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
105757689|NCT01617187|364763062|FG000|Treatment Through Study Completion|Protocol Violation|1|||
105757690|NCT01617187|364763063|FG001|Treatment Through Study Completion|Protocol Violation|0|||
105757691|NCT01617187|364763064|FG002|Treatment Through Study Completion|Protocol Violation|0|||
105757692|NCT01617187|364763065|FG003|Treatment Through Study Completion|Protocol Violation|1|||
105757693|NCT02843178|364765350|FG000|Overall Study|Lost to Follow-up|8|||
105757694|NCT02843178|364765351|FG001|Overall Study|Lost to Follow-up|8|||
105757695|NCT02843178|364765352|FG002|Overall Study|Lost to Follow-up|6|||
105757696|NCT02843178|364765353|FG003|Overall Study|Lost to Follow-up|3|||
105757697|NCT02843178|364765350|FG000|Overall Study|Withdrawal by Subject|0|||
105757698|NCT02843178|364765351|FG001|Overall Study|Withdrawal by Subject|0|||
105757699|NCT02843178|364765352|FG002|Overall Study|Withdrawal by Subject|1|||
105757700|NCT02843178|364765353|FG003|Overall Study|Withdrawal by Subject|1|||
105757701|NCT02420795|364765354|FG000|Overall Study|Withdrawal by Subject|1|||
105757702|NCT02420795|364765355|FG001|Overall Study|Withdrawal by Subject|0|||
105757703|NCT02420795|364765356|FG002|Overall Study|Withdrawal by Subject|0|||
105757704|NCT02420795|364765354|FG000|Overall Study|Adverse Event|1|||
105757705|NCT02420795|364765355|FG001|Overall Study|Adverse Event|0|||
105757706|NCT02420795|364765356|FG002|Overall Study|Adverse Event|0|||
105757707|NCT02420795|364765354|FG000|Overall Study|Progressive disease|2|||
105757708|NCT02420795|364765355|FG001|Overall Study|Progressive disease|2|||
105757709|NCT02420795|364765356|FG002|Overall Study|Progressive disease|4|||
105757710|NCT02420795|364765354|FG000|Overall Study|Death|0|||
105757711|NCT02420795|364765355|FG001|Overall Study|Death|0|||
105804207|NCT00095199|364938755|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
105804208|NCT00095199|364938756|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
105804209|NCT00095199|364938753|FG000|Overall Study|Physician Decision|5|||
105804210|NCT00095199|364938754|FG001|Overall Study|Physician Decision|6|||
105804211|NCT00095199|364938755|FG002|Overall Study|Physician Decision|1|||
105804212|NCT00095199|364938756|FG003|Overall Study|Physician Decision|1|||
105804213|NCT00095199|364938753|FG000|Overall Study|Not eligible|1|||
105804214|NCT00095199|364938754|FG001|Overall Study|Not eligible|7|||
105804215|NCT00095199|364938755|FG002|Overall Study|Not eligible|0|||
105804216|NCT00095199|364938756|FG003|Overall Study|Not eligible|1|||
105804217|NCT00095199|364938753|FG000|Overall Study|Started Palliative Radiotherapy|1|||
105804218|NCT00095199|364938754|FG001|Overall Study|Started Palliative Radiotherapy|0|||
105804219|NCT00095199|364938755|FG002|Overall Study|Started Palliative Radiotherapy|0|||
105804220|NCT00095199|364938756|FG003|Overall Study|Started Palliative Radiotherapy|0|||
105804221|NCT00095199|364938753|FG000|Overall Study|Started radiotherapy regimen|0|||
105804222|NCT00095199|364938754|FG001|Overall Study|Started radiotherapy regimen|1|||
105804223|NCT00095199|364938755|FG002|Overall Study|Started radiotherapy regimen|0|||
105804224|NCT00095199|364938756|FG003|Overall Study|Started radiotherapy regimen|0|||
105804225|NCT00095199|364938753|FG000|Overall Study|Primary tumor removed in other surgery|0|||
105804226|NCT00095199|364938754|FG001|Overall Study|Primary tumor removed in other surgery|1|||
105804227|NCT00095199|364938755|FG002|Overall Study|Primary tumor removed in other surgery|0|||
105804228|NCT00095199|364938756|FG003|Overall Study|Primary tumor removed in other surgery|0|||
105804229|NCT00095199|364938753|FG000|Overall Study|Data inadvertently lost by site|1|||
105804230|NCT00095199|364938754|FG001|Overall Study|Data inadvertently lost by site|0|||
105804231|NCT00095199|364938755|FG002|Overall Study|Data inadvertently lost by site|0|||
105804232|NCT00095199|364938756|FG003|Overall Study|Data inadvertently lost by site|0|||
105804233|NCT02995837|364938758|FG000|Overall Study|Lost to Follow-up|9|||
105804234|NCT02995837|364938759|FG001|Overall Study|Lost to Follow-up|8|||
105804235|NCT00633152|364940280|FG000|Overall Study|Adverse Event|1|||
105804236|NCT00633152|364940281|FG001|Overall Study|Adverse Event|0|||
105804237|NCT00633152|364940280|FG000|Overall Study|Randomized, did not receive study drug|5|||
105804238|NCT00633152|364940281|FG001|Overall Study|Randomized, did not receive study drug|2|||
105804239|NCT00633152|364940280|FG000|Overall Study|Withdrawal by Subject|1|||
105804240|NCT00633152|364940281|FG001|Overall Study|Withdrawal by Subject|1|||
105804241|NCT00633152|364940280|FG000|Overall Study|Lost to Follow-up|4|||
105804242|NCT00633152|364940281|FG001|Overall Study|Lost to Follow-up|1|||
105757712|NCT02420795|364765356|FG002|Overall Study|Death|1|||
105757713|NCT01002742|364765357|FG000|Overall Study|Determined to be ineligible|0|||
105757714|NCT01002742|364765358|FG001|Overall Study|Determined to be ineligible|1|||
105757715|NCT00656084|364765361|FG000|Overall Study|Adverse Event|4|||
105757716|NCT00656084|364765361|FG000|Overall Study|Withdrawal by Subject|1|||
105757717|NCT00656084|364765361|FG000|Overall Study|Patient Request|1|||
105757718|NCT00656084|364765361|FG000|Overall Study|Investigator Request|1|||
105757719|NCT01494987|364765362|FG000|Overall Study|Adverse Event|6|||
105757720|NCT01494987|364765363|FG001|Overall Study|Adverse Event|5|||
105757721|NCT01494987|364765362|FG000|Overall Study|Hyperglycemia|6|||
105757722|NCT01494987|364765363|FG001|Overall Study|Hyperglycemia|4|||
105757723|NCT01494987|364765362|FG000|Overall Study|Investigator's Discretion|1|||
105757724|NCT01494987|364765363|FG001|Overall Study|Investigator's Discretion|2|||
105804243|NCT00633152|364940280|FG000|Overall Study|Miscellaneous Other|3|||
105804244|NCT00633152|364940281|FG001|Overall Study|Miscellaneous Other|2|||
105804245|NCT00472446|364940282|FG000|Overall Study|Protocol Violation|0|||
105804246|NCT00472446|364940283|FG001|Overall Study|Protocol Violation|0|||
105804247|NCT00472446|364940284|FG002|Overall Study|Protocol Violation|0|||
105757725|NCT01494987|364765362|FG000|Overall Study|Lost to Follow-up|1|||
105757726|NCT01494987|364765363|FG001|Overall Study|Lost to Follow-up|1|||
105757727|NCT01494987|364765362|FG000|Overall Study|Protocol Violation|3|||
105757728|NCT01494987|364765363|FG001|Overall Study|Protocol Violation|3|||
105757729|NCT01494987|364765362|FG000|Overall Study|Subject Non-Compliance|9|||
105757730|NCT01494987|364765363|FG001|Overall Study|Subject Non-Compliance|10|||
105757731|NCT01494987|364765362|FG000|Overall Study|Subject Withdrew Consent|2|||
105757732|NCT01494987|364765363|FG001|Overall Study|Subject Withdrew Consent|3|||
105757733|NCT00436982|364765364|FG000|Overall Study|Withdrawal by Subject|3|||
105757734|NCT00436982|364765365|FG001|Overall Study|Withdrawal by Subject|1|||
105757735|NCT00436982|364765364|FG000|Overall Study|Did not receive allocated intervention|0|||
105757736|NCT00436982|364765365|FG001|Overall Study|Did not receive allocated intervention|1|||
105757737|NCT00436982|364765364|FG000|Overall Study|no RSA data|1|||
105757738|NCT00436982|364765365|FG001|Overall Study|no RSA data|2|||
105757739|NCT00953225|364765369|FG000|Overall Study|Withdrawal by Subject|2|||
105757740|NCT00953225|364765370|FG001|Overall Study|Withdrawal by Subject|0|||
105757741|NCT00640146|364765371|FG000|Overall Study|Adverse Event|2|||
105757742|NCT00640146|364765372|FG001|Overall Study|Adverse Event|0|||
105757743|NCT00640146|364765371|FG000|Overall Study|Lost to Follow-up|0|||
105757744|NCT00640146|364765372|FG001|Overall Study|Lost to Follow-up|1|||
105757745|NCT00640146|364765371|FG000|Overall Study|Lack of Efficacy|0|||
105757746|NCT00640146|364765372|FG001|Overall Study|Lack of Efficacy|1|||
105757747|NCT00640146|364765371|FG000|Overall Study|Withdrawal by Subject|1|||
105757748|NCT00640146|364765372|FG001|Overall Study|Withdrawal by Subject|1|||
105757749|NCT00640146|364765371|FG000|Overall Study|Randomized but not treated|1|||
105757750|NCT00640146|364765372|FG001|Overall Study|Randomized but not treated|3|||
105757751|NCT05742841|364765374|FG000|Overall Study|Withdrawal by Subject|1|||
105757752|NCT05742841|364765374|FG000|Overall Study|Lost to Follow-up|1|||
105757753|NCT02455388|364765375|FG000|Overall Study|Protocol Violation|1|||
105757754|NCT02455388|364765376|FG001|Overall Study|Protocol Violation|0|||
105757755|NCT02455388|364765377|FG002|Overall Study|Protocol Violation|4|||
105757756|NCT02455388|364765375|FG000|Overall Study|Withdrawal by Subject|0|||
105757757|NCT02455388|364765376|FG001|Overall Study|Withdrawal by Subject|0|||
105757758|NCT02455388|364765377|FG002|Overall Study|Withdrawal by Subject|7|||
105757759|NCT01316939|364765378|FG000|Overall Study|Study closed/terminated|26|||
105757760|NCT01316939|364765379|FG001|Overall Study|Study closed/terminated|25|||
105757761|NCT01316939|364765380|FG002|Overall Study|Study closed/terminated|23|||
105757762|NCT01316939|364765378|FG000|Overall Study|Lack of Efficacy|24|||
105757763|NCT01316939|364765379|FG001|Overall Study|Lack of Efficacy|25|||
105757764|NCT01316939|364765380|FG002|Overall Study|Lack of Efficacy|25|||
105757765|NCT01316939|364765378|FG000|Overall Study|Adverse Event|9|||
105757766|NCT01316939|364765379|FG001|Overall Study|Adverse Event|12|||
105757767|NCT01316939|364765380|FG002|Overall Study|Adverse Event|11|||
105757768|NCT01316939|364765378|FG000|Overall Study|Withdrawal by Subject|1|||
105757769|NCT01316939|364765379|FG001|Overall Study|Withdrawal by Subject|3|||
105757770|NCT01316939|364765380|FG002|Overall Study|Withdrawal by Subject|6|||
105757771|NCT01316939|364765378|FG000|Overall Study|Physician Decision|2|||
105757772|NCT01316939|364765379|FG001|Overall Study|Physician Decision|2|||
105757773|NCT01316939|364765380|FG002|Overall Study|Physician Decision|1|||
105757774|NCT01316939|364765378|FG000|Overall Study|Lost to Follow-up|0|||
105757775|NCT01316939|364765379|FG001|Overall Study|Lost to Follow-up|0|||
105757776|NCT01316939|364765380|FG002|Overall Study|Lost to Follow-up|2|||
105757777|NCT01316939|364765378|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
105757778|NCT01316939|364765379|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
105757779|NCT01316939|364765380|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
105757780|NCT01316939|364765378|FG000|Overall Study|Protocol Violation|0|||
105757781|NCT01316939|364765379|FG001|Overall Study|Protocol Violation|1|||
105757782|NCT01316939|364765380|FG002|Overall Study|Protocol Violation|0|||
105757783|NCT02254551|364765381|FG000|Dose Escalation|Physician Decision|1|||
105757784|NCT02254551|364765381|FG000|Dose Escalation|Dose-limiting toxicity|2|||
105757785|NCT04847141|364765382|FG000|Overall Study|Adverse Event|1|||
105757786|NCT04847141|364765383|FG001|Overall Study|Adverse Event|0|||
105757787|NCT04847141|364765384|FG002|Overall Study|Adverse Event|1|||
105757788|NCT04847141|364765382|FG000|Overall Study|Withdrawal by Subject|2|||
105757789|NCT04847141|364765383|FG001|Overall Study|Withdrawal by Subject|4|||
105757790|NCT04847141|364765384|FG002|Overall Study|Withdrawal by Subject|3|||
105757791|NCT04847141|364765382|FG000|Overall Study|Lost to Follow-up|7|||
105757792|NCT04847141|364765383|FG001|Overall Study|Lost to Follow-up|5|||
105757793|NCT04847141|364765384|FG002|Overall Study|Lost to Follow-up|7|||
105757794|NCT04847141|364765382|FG000|Overall Study|Reason not Specified|0|||
105804248|NCT00472446|364940285|FG003|Overall Study|Protocol Violation|1|||
105757795|NCT04847141|364765383|FG001|Overall Study|Reason not Specified|1|||
105757796|NCT04847141|364765384|FG002|Overall Study|Reason not Specified|0|||
105757797|NCT04058158|364765385|FG000|Period 1|Death|1|||
105757798|NCT04058158|364765386|FG001|Period 1|Death|0|||
105804249|NCT00472446|364940282|FG000|Overall Study|Reintervention|0|||
105804250|NCT00472446|364940283|FG001|Overall Study|Reintervention|0|||
105757799|NCT04058158|364765385|FG000|Period 1|Adverse Event|1|||
105757800|NCT04058158|364765386|FG001|Period 1|Adverse Event|1|||
105757801|NCT04058158|364765385|FG000|Period 1|Pregnancy|0|||
105757802|NCT04058158|364765386|FG001|Period 1|Pregnancy|1|||
105757803|NCT01634113|364765387|FG000|Overall Study|Not treated|0|||
105757804|NCT01634113|364765388|FG001|Overall Study|Not treated|0|||
105757805|NCT01634113|364765389|FG002|Overall Study|Not treated|1|||
105757806|NCT00324740|364765390|FG000|Overall Study|Withdrawal by Subject|1|||
105757807|NCT00324740|364765391|FG001|Overall Study|Withdrawal by Subject|0|||
105757808|NCT00324740|364765392|FG002|Overall Study|Withdrawal by Subject|1|||
105757809|NCT00520299|364765395|FG000|Overall Study|Withdrawal by Subject|0|||
105757810|NCT00520299|364765396|FG001|Overall Study|Withdrawal by Subject|0|||
105757811|NCT00520299|364765397|FG002|Overall Study|Withdrawal by Subject|2|||
105757812|NCT00520299|364765395|FG000|Overall Study|Progressive disease|0|||
105757813|NCT00520299|364765396|FG001|Overall Study|Progressive disease|3|||
105757814|NCT00520299|364765397|FG002|Overall Study|Progressive disease|4|||
105757815|NCT01352845|364765398|FG000|Overall Study|Lost to Follow-up|313|||
105757816|NCT01352845|364765399|FG001|Overall Study|Lost to Follow-up|92|||
105757817|NCT01352845|364765398|FG000|Overall Study|No Longer Willing to Participate|205|||
105757818|NCT01352845|364765399|FG001|Overall Study|No Longer Willing to Participate|58|||
105757819|NCT01352845|364765398|FG000|Overall Study|Withdrawal by Subject|48|||
105757820|NCT01352845|364765399|FG001|Overall Study|Withdrawal by Subject|16|||
105757821|NCT01352845|364765398|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
105757822|NCT01352845|364765399|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
105757823|NCT01352845|364765398|FG000|Overall Study|Pregnancy|27|||
105757824|NCT01352845|364765399|FG001|Overall Study|Pregnancy|7|||
105757825|NCT01352845|364765398|FG000|Overall Study|Adverse Event|22|||
105757826|NCT01352845|364765399|FG001|Overall Study|Adverse Event|6|||
105757827|NCT01352845|364765398|FG000|Overall Study|Other|17|||
105757828|NCT01352845|364765399|FG001|Overall Study|Other|7|||
105757829|NCT01352845|364765398|FG000|Overall Study|Protocol Violation|12|||
105757830|NCT01352845|364765399|FG001|Overall Study|Protocol Violation|6|||
105757831|NCT01352845|364765398|FG000|Overall Study|Death|3|||
105757832|NCT01352845|364765399|FG001|Overall Study|Death|0|||
105757833|NCT02528253|364765404|FG000|Overall Study|Adverse Event|3|||
105757834|NCT02528253|364765405|FG001|Overall Study|Adverse Event|4|||
105757835|NCT02528253|364765406|FG002|Overall Study|Adverse Event|4|||
105757836|NCT02528253|364765407|FG003|Overall Study|Adverse Event|8|||
105757837|NCT02528253|364765408|FG004|Overall Study|Adverse Event|18|||
105757838|NCT02528253|364765404|FG000|Overall Study|Death|2|||
105757839|NCT02528253|364765405|FG001|Overall Study|Death|2|||
105757840|NCT02528253|364765406|FG002|Overall Study|Death|1|||
105757841|NCT02528253|364765407|FG003|Overall Study|Death|0|||
105757842|NCT02528253|364765408|FG004|Overall Study|Death|1|||
105757843|NCT02528253|364765404|FG000|Overall Study|Insufficient clinical response|7|||
105757844|NCT02528253|364765405|FG001|Overall Study|Insufficient clinical response|10|||
105757845|NCT02528253|364765406|FG002|Overall Study|Insufficient clinical response|13|||
105757846|NCT02528253|364765407|FG003|Overall Study|Insufficient clinical response|12|||
105757847|NCT02528253|364765408|FG004|Overall Study|Insufficient clinical response|16|||
105757848|NCT02528253|364765404|FG000|Overall Study|Lost to Follow-up|16|||
105757849|NCT02528253|364765405|FG001|Overall Study|Lost to Follow-up|9|||
105757850|NCT02528253|364765406|FG002|Overall Study|Lost to Follow-up|31|||
105757851|NCT02528253|364765407|FG003|Overall Study|Lost to Follow-up|16|||
105757852|NCT02528253|364765408|FG004|Overall Study|Lost to Follow-up|34|||
105757853|NCT02528253|364765404|FG000|Overall Study|Other|21|||
105757854|NCT02528253|364765405|FG001|Overall Study|Other|22|||
105757855|NCT02528253|364765406|FG002|Overall Study|Other|58|||
105757856|NCT02528253|364765407|FG003|Overall Study|Other|52|||
105757857|NCT02528253|364765408|FG004|Overall Study|Other|76|||
105757858|NCT02528253|364765404|FG000|Overall Study|Withdrawal by Subject|25|||
105757859|NCT02528253|364765405|FG001|Overall Study|Withdrawal by Subject|20|||
105757860|NCT02528253|364765406|FG002|Overall Study|Withdrawal by Subject|29|||
105757861|NCT02528253|364765407|FG003|Overall Study|Withdrawal by Subject|48|||
105757862|NCT02528253|364765408|FG004|Overall Study|Withdrawal by Subject|73|||
105757863|NCT02528253|364765404|FG000|Overall Study|Protocol Violation|1|||
105757864|NCT02528253|364765405|FG001|Overall Study|Protocol Violation|2|||
105757865|NCT02528253|364765406|FG002|Overall Study|Protocol Violation|4|||
105757866|NCT02528253|364765407|FG003|Overall Study|Protocol Violation|0|||
105757867|NCT02528253|364765408|FG004|Overall Study|Protocol Violation|4|||
105757868|NCT02528253|364765404|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
105757869|NCT02528253|364765405|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
105757870|NCT02528253|364765406|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
105757871|NCT02528253|364765407|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
105757872|NCT02528253|364765408|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
105757873|NCT02293993|364765410|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
105757874|NCT02293993|364765411|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
105804251|NCT00472446|364940284|FG002|Overall Study|Reintervention|1|||
105757875|NCT02293993|364765412|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
105757876|NCT02293993|364765413|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
105757877|NCT02293993|364765410|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
105804252|NCT00472446|364940285|FG003|Overall Study|Reintervention|1|||
105804253|NCT00472446|364940282|FG000|Overall Study|Questionnaires not returned|5|||
105804254|NCT00472446|364940283|FG001|Overall Study|Questionnaires not returned|6|||
105804255|NCT00472446|364940284|FG002|Overall Study|Questionnaires not returned|6|||
105804256|NCT00472446|364940285|FG003|Overall Study|Questionnaires not returned|4|||
105804257|NCT00827827|364940286|FG000|Overall Study|Lost to Follow-up|3|||
105804258|NCT00827827|364940287|FG001|Overall Study|Lost to Follow-up|0|||
105804259|NCT00827827|364940286|FG000|Overall Study|Fall at home- hospitalization|1|||
105804260|NCT00827827|364940287|FG001|Overall Study|Fall at home- hospitalization|0|||
105804261|NCT00827827|364940286|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
105804262|NCT00827827|364940287|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
105804263|NCT00827827|364940286|FG000|Overall Study|Gout|1|||
105804264|NCT00827827|364940287|FG001|Overall Study|Gout|0|||
105804265|NCT00827827|364940286|FG000|Overall Study|Transportation issues|1|||
105804266|NCT00827827|364940287|FG001|Overall Study|Transportation issues|0|||
105804267|NCT00827827|364940286|FG000|Overall Study|Burned with water at home|1|||
105804268|NCT00827827|364940287|FG001|Overall Study|Burned with water at home|0|||
105804269|NCT01339910|364940295|FG000|Overall Study|Withdrawal by Subject|1|||
105804270|NCT01339910|364940296|FG001|Overall Study|Withdrawal by Subject|0|||
105804271|NCT01339910|364940295|FG000|Overall Study|Physician Decision|1|||
105804272|NCT01339910|364940296|FG001|Overall Study|Physician Decision|0|||
105804273|NCT01339910|364940295|FG000|Overall Study|Disease relapse|1|||
105804274|NCT01339910|364940296|FG001|Overall Study|Disease relapse|4|||
105804275|NCT01399723|364940297|FG000|Overall Study|Lost to Follow-up|0|||
105804276|NCT01399723|364940298|FG001|Overall Study|Lost to Follow-up|1|||
105804277|NCT00295854|364940300|FG000|Overall Study|Adverse Event|7|||
105804278|NCT00295854|364940301|FG001|Overall Study|Adverse Event|7|||
105804279|NCT00295854|364940302|FG002|Overall Study|Adverse Event|6|||
105804280|NCT00295854|364940300|FG000|Overall Study|Protocol Violation|1|||
105804281|NCT00295854|364940301|FG001|Overall Study|Protocol Violation|1|||
105804282|NCT00295854|364940302|FG002|Overall Study|Protocol Violation|1|||
105804283|NCT00295854|364940300|FG000|Overall Study|Lost to Follow-up|2|||
105804284|NCT00295854|364940301|FG001|Overall Study|Lost to Follow-up|0|||
105804285|NCT00295854|364940302|FG002|Overall Study|Lost to Follow-up|1|||
105804286|NCT00295854|364940300|FG000|Overall Study|Withdrawal by Subject|3|||
105804287|NCT00295854|364940301|FG001|Overall Study|Withdrawal by Subject|7|||
105804288|NCT00295854|364940302|FG002|Overall Study|Withdrawal by Subject|4|||
105804289|NCT00295854|364940300|FG000|Overall Study|did not continue to meet criteria|1|||
105804290|NCT00295854|364940301|FG001|Overall Study|did not continue to meet criteria|1|||
105804291|NCT00295854|364940302|FG002|Overall Study|did not continue to meet criteria|2|||
105804292|NCT00295854|364940300|FG000|Overall Study|required a prohibited medication|1|||
105804293|NCT00295854|364940301|FG001|Overall Study|required a prohibited medication|0|||
105804294|NCT00295854|364940302|FG002|Overall Study|required a prohibited medication|0|||
105804295|NCT00295854|364940300|FG000|Overall Study|Other|3|||
105804296|NCT00295854|364940301|FG001|Overall Study|Other|5|||
105804297|NCT00295854|364940302|FG002|Overall Study|Other|1|||
105804298|NCT00772577|364940303|FG000|Overall Study|Adverse Event|6|||
105804299|NCT00772577|364940304|FG001|Overall Study|Adverse Event|3|||
105804300|NCT00772577|364940303|FG000|Overall Study|Abnormal laboratory values|0|||
105804301|NCT00772577|364940304|FG001|Overall Study|Abnormal laboratory values|1|||
105804302|NCT00772577|364940303|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105804303|NCT00772577|364940304|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
105804304|NCT00772577|364940303|FG000|Overall Study|Patient withdrew consent|8|||
105804305|NCT00772577|364940304|FG001|Overall Study|Patient withdrew consent|5|||
105804306|NCT00772577|364940303|FG000|Overall Study|Lost to Follow-up|4|||
105804307|NCT00772577|364940304|FG001|Overall Study|Lost to Follow-up|3|||
105804308|NCT00772577|364940303|FG000|Overall Study|Administrative problems|2|||
105804309|NCT00772577|364940304|FG001|Overall Study|Administrative problems|1|||
105804310|NCT00772577|364940303|FG000|Overall Study|Protocol Deviation|3|||
105804311|NCT00772577|364940304|FG001|Overall Study|Protocol Deviation|2|||
105804312|NCT03211156|364940305|FG000|Overall Study|Withdrawal by Subject|0|||
105804313|NCT03211156|364940306|FG001|Overall Study|Withdrawal by Subject|2|||
105804314|NCT03211156|364940305|FG000|Overall Study|Lost to Follow-up|1|||
105804315|NCT03211156|364940306|FG001|Overall Study|Lost to Follow-up|1|||
105804316|NCT03211156|364940305|FG000|Overall Study|Adverse Event|1|||
105804317|NCT03211156|364940306|FG001|Overall Study|Adverse Event|0|||
105804318|NCT05266456|364940308|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
105804319|NCT05266456|364940309|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
105804320|NCT05266456|364940310|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
105804321|NCT05266456|364940311|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
105804322|NCT05266456|364940308|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
105804323|NCT05266456|364940309|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
105804324|NCT05266456|364940310|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
105804325|NCT05266456|364940311|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
105804326|NCT05266456|364940308|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
105804327|NCT05266456|364940309|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
105804328|NCT05266456|364940310|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
105804329|NCT05266456|364940311|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
105804330|NCT05266456|364940308|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
105804331|NCT05266456|364940309|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
105804332|NCT05266456|364940310|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
105804333|NCT05266456|364940311|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
105804334|NCT05266456|364940308|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
105804335|NCT05266456|364940309|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
105804336|NCT05266456|364940310|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
105804337|NCT05266456|364940311|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
105804338|NCT01724359|364940312|FG000|Overall Study|Adverse Event|10|||
105804339|NCT01724359|364940312|FG000|Overall Study|Death|1|||
105804340|NCT01724359|364940312|FG000|Overall Study|Other|20|||
105804341|NCT01821625|364940319|FG000|Overall Study|Withdrawal by Subject|2|||
105804342|NCT01821625|364940319|FG000|Overall Study|Lack of Efficacy|2|||
105804343|NCT01821625|364940319|FG000|Overall Study|Adverse Event|1|||
105804344|NCT01821625|364940319|FG000|Overall Study|Medical contraindication|1|||
105804345|NCT00320593|364940320|FG000|Overall Study|Lost to Follow-up|3|||
105804346|NCT00320593|364940321|FG001|Overall Study|Lost to Follow-up|0|||
105804347|NCT00320593|364940320|FG000|Overall Study|Moved to another state|1|||
105804348|NCT00320593|364940321|FG001|Overall Study|Moved to another state|0|||
105804349|NCT00320593|364940320|FG000|Overall Study|Withdrawal by Subject|2|||
105804350|NCT00320593|364940321|FG001|Overall Study|Withdrawal by Subject|1|||
105804351|NCT00320593|364940320|FG000|Overall Study|Withdrawal by clinical center|1|||
105804352|NCT00320593|364940321|FG001|Overall Study|Withdrawal by clinical center|0|||
105804353|NCT00457665|364940322|FG000|12 Months|Drug allergy|1|||
105804354|NCT00457665|364940323|FG001|12 Months|Drug allergy|1|||
105804355|NCT00457665|364940322|FG000|12 Months|High HIV viral load|5|||
105804356|NCT00457665|364940323|FG001|12 Months|High HIV viral load|1|||
105804357|NCT00457665|364940322|FG000|12 Months|Lipodystrophy|2|||
105804358|NCT00457665|364940323|FG001|12 Months|Lipodystrophy|0|||
105804359|NCT00457665|364940322|FG000|12 Months|Withdrawal by Subject|0|||
105804360|NCT00457665|364940323|FG001|12 Months|Withdrawal by Subject|2|||
105804361|NCT00457665|364940322|FG000|12 Months|Abnormal Liver function tests|0|||
105804362|NCT00457665|364940323|FG001|12 Months|Abnormal Liver function tests|5|||
105804363|NCT00457665|364940322|FG000|24 Months|Withdrawal by Subject|3|||
105804364|NCT00457665|364940323|FG001|24 Months|Withdrawal by Subject|2|||
105804365|NCT00457665|364940322|FG000|24 Months|Lipodystrophy|1|||
105804366|NCT00457665|364940323|FG001|24 Months|Lipodystrophy|1|||
105804367|NCT00457665|364940322|FG000|24 Months|Abnormal liver function tests|1|||
105804368|NCT00457665|364940323|FG001|24 Months|Abnormal liver function tests|5|||
105804369|NCT01722266|364940324|FG000|Overall Study|Withdrawal by Subject|1|||
105804370|NCT01722266|364940325|FG001|Overall Study|Withdrawal by Subject|2|||
105804371|NCT01722266|364940326|FG002|Overall Study|Withdrawal by Subject|0|||
105804372|NCT01722266|364940327|FG003|Overall Study|Withdrawal by Subject|0|||
105804373|NCT01722266|364940324|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
105804374|NCT01722266|364940325|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
105804375|NCT01722266|364940326|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
105804376|NCT01722266|364940327|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
105804377|NCT01722266|364940324|FG000|Overall Study|Dropped out due to Nausea|0|||
105804378|NCT01722266|364940325|FG001|Overall Study|Dropped out due to Nausea|0|||
105804379|NCT01722266|364940326|FG002|Overall Study|Dropped out due to Nausea|2|||
105804380|NCT01722266|364940327|FG003|Overall Study|Dropped out due to Nausea|0|||
105804381|NCT02535000|364940331|FG000|Overall Study|Cancellation of surgery.|1|||
105804382|NCT02535000|364940332|FG001|Overall Study|Cancellation of surgery.|2|||
105804383|NCT03811249|364940333|FG000|Overall Study|Withdrawal by Subject|44|||
105804384|NCT03811249|364940333|FG000|Overall Study|Missed Visit|24|||
105804385|NCT04317781|364940334|FG000|Overall Study|Adverse Event|1|||
105804386|NCT04317781|364940334|FG000|Overall Study|Disease relapse|1|||
105804387|NCT04317781|364940334|FG000|Overall Study|Withdrawal by Subject|1|||
105804388|NCT02151461|364940354|FG000|Overall Study|Adverse Event|5|||
105804389|NCT02151461|364940355|FG001|Overall Study|Adverse Event|1|||
105804390|NCT02151461|364940356|FG002|Overall Study|Adverse Event|0|||
105804391|NCT02151461|364940357|FG003|Overall Study|Adverse Event|2|||
105804392|NCT02151461|364940354|FG000|Overall Study|Lost to Follow-up|0|||
105804393|NCT02151461|364940355|FG001|Overall Study|Lost to Follow-up|0|||
105804394|NCT02151461|364940356|FG002|Overall Study|Lost to Follow-up|1|||
105804395|NCT02151461|364940357|FG003|Overall Study|Lost to Follow-up|1|||
105804396|NCT02151461|364940354|FG000|Overall Study|Withdrawal by Subject|1|||
105804397|NCT02151461|364940355|FG001|Overall Study|Withdrawal by Subject|0|||
105804398|NCT02151461|364940356|FG002|Overall Study|Withdrawal by Subject|1|||
105804399|NCT02151461|364940357|FG003|Overall Study|Withdrawal by Subject|1|||
105804400|NCT02151461|364940354|FG000|Overall Study|Treatment discontinuation|0|||
105804401|NCT02151461|364940355|FG001|Overall Study|Treatment discontinuation|0|||
105804402|NCT02151461|364940356|FG002|Overall Study|Treatment discontinuation|1|||
105804403|NCT02151461|364940357|FG003|Overall Study|Treatment discontinuation|0|||
105804404|NCT00871169|364940358|FG000|Overall Study|Protocol Violation|1|||
105804405|NCT00871169|364940358|FG000|Overall Study|Patient did not receive study treatment|2|||
105804406|NCT02168270|364940359|FG000|Overall Study|Lack of Efficacy|4|||
105804407|NCT00638157|364940363|FG000|Overall Study|Adverse Event|0|||
105804408|NCT00638157|364940364|FG001|Overall Study|Adverse Event|1|||
105804409|NCT00638157|364940363|FG000|Overall Study|Clinical (symptomatic) failure|1|||
105804410|NCT00638157|364940364|FG001|Overall Study|Clinical (symptomatic) failure|1|||
105804411|NCT00638157|364940363|FG000|Overall Study|Microbiological failure|1|||
105804412|NCT00638157|364940364|FG001|Overall Study|Microbiological failure|0|||
105804413|NCT00638157|364940363|FG000|Overall Study|Lost to Follow-up|1|||
105804414|NCT00638157|364940364|FG001|Overall Study|Lost to Follow-up|0|||
105804415|NCT00638157|364940363|FG000|Overall Study|Physician Decision|1|||
105804416|NCT00638157|364940364|FG001|Overall Study|Physician Decision|0|||
105804417|NCT00638157|364940363|FG000|Overall Study|Other|1|||
105804418|NCT00638157|364940364|FG001|Overall Study|Other|2|||
105804419|NCT00638157|364940363|FG000|Overall Study|Randomized, not treated|2|||
105804420|NCT00638157|364940364|FG001|Overall Study|Randomized, not treated|0|||
105804421|NCT00593333|364940365|FG000|Overall Study|Lost to Follow-up|10|||
105804422|NCT00593333|364940366|FG001|Overall Study|Lost to Follow-up|11|||
105804423|NCT01851590|364940368|FG000|Overall Study|Withdrawal by Subject|0|||
105804424|NCT01851590|364940369|FG001|Overall Study|Withdrawal by Subject|0|||
105804425|NCT01851590|364940370|FG002|Overall Study|Withdrawal by Subject|1|||
105804426|NCT01851590|364940368|FG000|Overall Study|Adverse Event|0|||
105804427|NCT01851590|364940369|FG001|Overall Study|Adverse Event|0|||
105804428|NCT01851590|364940370|FG002|Overall Study|Adverse Event|2|||
105804429|NCT01851590|364940368|FG000|Overall Study|Lack of Efficacy|0|||
105804430|NCT01851590|364940369|FG001|Overall Study|Lack of Efficacy|1|||
105804431|NCT01851590|364940370|FG002|Overall Study|Lack of Efficacy|0|||
105804432|NCT03402893|364940379|FG000|Overall Study|Withdrawal by Subject|1|||
105804433|NCT01193517|364940381|FG000|Overall Study|Early Progression|1|||
105804434|NCT01193517|364940382|FG001|Overall Study|Early Progression|0|||
105804435|NCT01193517|364940383|FG002|Overall Study|Early Progression|0|||
105804436|NCT02115256|364940384|FG000|Overall Study|Withdrawal by Subject|0|||
105804437|NCT02115256|364940385|FG001|Overall Study|Withdrawal by Subject|1|||
105804438|NCT00753714|364940386|FG000|Overall Study|Lack of Efficacy|21|||
105804439|NCT00753714|364940387|FG001|Overall Study|Lack of Efficacy|34|||
105804440|NCT00753714|364940386|FG000|Overall Study|Adverse Event|26|||
105804441|NCT00753714|364940387|FG001|Overall Study|Adverse Event|18|||
105804442|NCT00753714|364940386|FG000|Overall Study|Protocol Violation|1|||
105804443|NCT00753714|364940387|FG001|Overall Study|Protocol Violation|0|||
105804444|NCT00753714|364940386|FG000|Overall Study|Lost to Follow-up|0|||
105804445|NCT00753714|364940387|FG001|Overall Study|Lost to Follow-up|1|||
105804446|NCT00753714|364940386|FG000|Overall Study|Withdrawal by Subject|2|||
105804447|NCT00753714|364940387|FG001|Overall Study|Withdrawal by Subject|1|||
105804448|NCT00753714|364940386|FG000|Overall Study|Death|3|||
105804449|NCT00753714|364940387|FG001|Overall Study|Death|3|||
105804450|NCT00753714|364940386|FG000|Overall Study|Other|7|||
105804451|NCT00753714|364940387|FG001|Overall Study|Other|5|||
105804452|NCT02607800|364940388|FG000|Overall Study|Lost to Follow-up|7|||
105804453|NCT02607800|364940389|FG001|Overall Study|Lost to Follow-up|10|||
105804454|NCT02607800|364940388|FG000|Overall Study|Withdrew Consent|2|||
105804455|NCT02607800|364940389|FG001|Overall Study|Withdrew Consent|0|||
105804456|NCT02607800|364940388|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
105804457|NCT02607800|364940389|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
105804458|NCT01512979|364940397|FG000|Overall Study|Adverse Event|2|||
105804459|NCT01512979|364940398|FG001|Overall Study|Adverse Event|2|||
105804460|NCT01512979|364940397|FG000|Overall Study|Protocol Violation|1|||
105804461|NCT01512979|364940398|FG001|Overall Study|Protocol Violation|4|||
105804462|NCT01512979|364940397|FG000|Overall Study|Lost to Follow-up|2|||
105804463|NCT01512979|364940398|FG001|Overall Study|Lost to Follow-up|5|||
105804464|NCT01512979|364940397|FG000|Overall Study|Withdrawal by Subject|1|||
105804465|NCT01512979|364940398|FG001|Overall Study|Withdrawal by Subject|2|||
105804466|NCT01512979|364940397|FG000|Overall Study|Reason other than stated above|13|||
105804467|NCT01512979|364940398|FG001|Overall Study|Reason other than stated above|9|||
105804468|NCT01533428|364940403|FG000|Overall Study|Adverse Event|0|||
105804469|NCT01533428|364940404|FG001|Overall Study|Adverse Event|1|||
105804470|NCT01533428|364940403|FG000|Overall Study|Lost to Follow-up|2|||
105804471|NCT01533428|364940404|FG001|Overall Study|Lost to Follow-up|1|||
105757878|NCT02293993|364765411|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
105757879|NCT02293993|364765412|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
105757880|NCT02293993|364765413|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
105757881|NCT02293993|364765410|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
105757882|NCT02293993|364765411|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
105757883|NCT02293993|364765412|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
105757884|NCT02293993|364765413|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
105757885|NCT02293993|364765410|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
105757886|NCT02293993|364765411|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
105757887|NCT02293993|364765412|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
105757888|NCT02293993|364765413|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
105757889|NCT02293993|364765410|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
105757890|NCT02293993|364765411|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
105757891|NCT02293993|364765412|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
105757892|NCT02293993|364765413|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
105757893|NCT00094835|364765414|FG000|Overall Study|Physician Decision|1|||
105757894|NCT00094835|364765415|FG001|Overall Study|Physician Decision|0|||
105757895|NCT00094835|364765416|FG002|Overall Study|Physician Decision|0|||
105757896|NCT00094835|364765417|FG003|Overall Study|Physician Decision|0|||
105757897|NCT00094835|364765418|FG004|Overall Study|Physician Decision|0|||
105757898|NCT00094835|364765419|FG005|Overall Study|Physician Decision|1|||
105757899|NCT00094835|364765420|FG006|Overall Study|Physician Decision|0|||
105757900|NCT00094835|364765414|FG000|Overall Study|Withdrawal by Subject|0|||
105757901|NCT00094835|364765415|FG001|Overall Study|Withdrawal by Subject|0|||
105757902|NCT00094835|364765416|FG002|Overall Study|Withdrawal by Subject|0|||
105757903|NCT00094835|364765417|FG003|Overall Study|Withdrawal by Subject|0|||
105757904|NCT00094835|364765418|FG004|Overall Study|Withdrawal by Subject|0|||
105757905|NCT00094835|364765419|FG005|Overall Study|Withdrawal by Subject|0|||
105757906|NCT00094835|364765420|FG006|Overall Study|Withdrawal by Subject|1|||
105757907|NCT00094835|364765414|FG000|Overall Study|Lost to Follow-up|0|||
105757908|NCT00094835|364765415|FG001|Overall Study|Lost to Follow-up|0|||
105757909|NCT00094835|364765416|FG002|Overall Study|Lost to Follow-up|0|||
105757910|NCT00094835|364765417|FG003|Overall Study|Lost to Follow-up|0|||
105757911|NCT00094835|364765418|FG004|Overall Study|Lost to Follow-up|1|||
105757912|NCT00094835|364765419|FG005|Overall Study|Lost to Follow-up|0|||
105757913|NCT00094835|364765420|FG006|Overall Study|Lost to Follow-up|0|||
105757914|NCT00094835|364765414|FG000|Overall Study|Death|1|||
105757915|NCT00094835|364765415|FG001|Overall Study|Death|0|||
105757916|NCT00094835|364765416|FG002|Overall Study|Death|0|||
105757917|NCT00094835|364765417|FG003|Overall Study|Death|0|||
105757918|NCT00094835|364765418|FG004|Overall Study|Death|1|||
105757919|NCT00094835|364765419|FG005|Overall Study|Death|0|||
105757920|NCT00094835|364765420|FG006|Overall Study|Death|0|||
105757921|NCT00094835|364765414|FG000|Overall Study|Non-compliance|1|||
105757922|NCT00094835|364765415|FG001|Overall Study|Non-compliance|2|||
105757923|NCT00094835|364765416|FG002|Overall Study|Non-compliance|2|||
105757924|NCT00094835|364765417|FG003|Overall Study|Non-compliance|0|||
105757925|NCT00094835|364765418|FG004|Overall Study|Non-compliance|2|||
105757926|NCT00094835|364765419|FG005|Overall Study|Non-compliance|2|||
105757927|NCT00094835|364765420|FG006|Overall Study|Non-compliance|1|||
105757928|NCT00094835|364765414|FG000|Overall Study|Other|1|||
105757929|NCT00094835|364765415|FG001|Overall Study|Other|1|||
105757930|NCT00094835|364765416|FG002|Overall Study|Other|1|||
105757931|NCT00094835|364765417|FG003|Overall Study|Other|1|||
105757932|NCT00094835|364765418|FG004|Overall Study|Other|0|||
105757933|NCT00094835|364765419|FG005|Overall Study|Other|0|||
105757934|NCT00094835|364765420|FG006|Overall Study|Other|0|||
105757935|NCT03628599|364765421|FG000|Overall Study|Adverse Event|0|||
105757936|NCT03628599|364765422|FG001|Overall Study|Adverse Event|1|||
105757937|NCT00728936|364765426|FG000|Overall Study|Withdrawal by Subject|0|||
105757938|NCT00728936|364765427|FG001|Overall Study|Withdrawal by Subject|0|||
105757939|NCT00728936|364765428|FG002|Overall Study|Withdrawal by Subject|0|||
105757940|NCT00728936|364765429|FG003|Overall Study|Withdrawal by Subject|0|||
105757941|NCT00728936|364765430|FG004|Overall Study|Withdrawal by Subject|0|||
105757942|NCT00728936|364765431|FG005|Overall Study|Withdrawal by Subject|1|||
105757943|NCT00728936|364765432|FG006|Overall Study|Withdrawal by Subject|0|||
105757944|NCT00438464|364765433|FG000|Overall Study|Terminated Early|14|||
105757945|NCT00438464|364765434|FG001|Overall Study|Terminated Early|5|||
105757946|NCT00438464|364765433|FG000|Overall Study|Incomplete data submission|0|||
105757947|NCT00438464|364765434|FG001|Overall Study|Incomplete data submission|2|||
105757948|NCT00132314|364765435|FG000|Overall Study|Lost to Follow-up|70|||
105757949|NCT00132314|364765436|FG001|Overall Study|Lost to Follow-up|62|||
105757950|NCT00132314|364765435|FG000|Overall Study|Lacked SSN|1|||
105804472|NCT01533428|364940403|FG000|Overall Study|Withdrawal by Subject|7|||
105804473|NCT01533428|364940404|FG001|Overall Study|Withdrawal by Subject|6|||
105804474|NCT01078090|364940412|FG000|Overall Study|Lost to Follow-up|2363|||
105804475|NCT01078090|364940412|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
105804476|NCT01078090|364940412|FG000|Overall Study|Lack of Efficacy|1193|||
105804477|NCT01078090|364940412|FG000|Overall Study|ADR and lack of efficacy|61|||
105804478|NCT01078090|364940412|FG000|Overall Study|Other|523|||
105804479|NCT04535583|364940413|FG000|Overall Study|Lost to Follow-up|1|||
105804480|NCT04535583|364940413|FG000|Overall Study|Physician Decision|1|||
105804481|NCT04535583|364940413|FG000|Overall Study|Withdrawal by Subject|1|||
105804482|NCT00745251|364940414|FG000|Overall Study|Adverse Event|1|||
105804483|NCT00745251|364940415|FG001|Overall Study|Adverse Event|2|||
105804484|NCT00745251|364940414|FG000|Overall Study|Withdrawal by Subject|1|||
105804485|NCT00745251|364940415|FG001|Overall Study|Withdrawal by Subject|1|||
105804486|NCT02669264|364940417|FG000|Overall Study|Death|5|||
105804487|NCT02669264|364940418|FG001|Overall Study|Death|5|||
105757951|NCT00132314|364765436|FG001|Overall Study|Lacked SSN|3|||
105757952|NCT00132314|364765435|FG000|Overall Study|Refused intervention at baseline|2|||
105757953|NCT00132314|364765436|FG001|Overall Study|Refused intervention at baseline|7|||
105757954|NCT02905825|364765442|FG000|Overall Study|Protocol Violation|11|||
105757955|NCT02905825|364765442|FG000|Overall Study|Device Malfunction|1|||
105757956|NCT00092677|364765460|FG000|Overall Study|Lost to Follow-up|0|||
105757957|NCT00092677|364765461|FG001|Overall Study|Lost to Follow-up|2|||
105757958|NCT00092677|364765460|FG000|Overall Study|Adminstrative|5|||
105757959|NCT00092677|364765461|FG001|Overall Study|Adminstrative|9|||
105757960|NCT02966353|364765462|FG000|Overall Study|Withdrawal by Subject|7|||
105757961|NCT02966353|364765462|FG000|Overall Study|Adverse Event|4|||
105757962|NCT02966353|364765462|FG000|Overall Study|Death|4|||
105757963|NCT02966353|364765462|FG000|Overall Study|Physician Decision|3|||
105757964|NCT02966353|364765462|FG000|Overall Study|Progressive disease|2|||
105757965|NCT02966353|364765462|FG000|Overall Study|Protocol deviation|2|||
105757966|NCT01090102|364765463|FG000|First 12 Weeks|Withdrawal by Subject|1|||
105757967|NCT01090102|364765464|FG001|First 12 Weeks|Withdrawal by Subject|1|||
105757968|NCT01090102|364765463|FG000|First 12 Weeks|Adverse Event|2|||
105757969|NCT01090102|364765464|FG001|First 12 Weeks|Adverse Event|0|||
105757970|NCT01090102|364765463|FG000|First 12 Weeks|Death|1|||
105757971|NCT01090102|364765464|FG001|First 12 Weeks|Death|1|||
105757972|NCT01090102|364765463|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
105757973|NCT01090102|364765464|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
105757974|NCT01019252|364765467|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
105757975|NCT01019252|364765468|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
105757976|NCT01019252|364765467|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
105757977|NCT01019252|364765468|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
105757978|NCT01019252|364765467|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
105757979|NCT01019252|364765468|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
105757980|NCT01019252|364765467|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
105757981|NCT01019252|364765468|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
105757982|NCT04154943|364765469|FG000|Overall Study|Study Ongoing|68|||
105757983|NCT04154943|364765469|FG000|Overall Study|Lost to Follow-up|1|||
105757984|NCT04154943|364765469|FG000|Overall Study|Decision by the Investigator|1|||
105757985|NCT04154943|364765469|FG000|Overall Study|Death|5|||
105757986|NCT04154943|364765469|FG000|Overall Study|Withdrawal by Subject|4|||
105757987|NCT00985738|364765471|FG000|Overall Study|Study closed prematurely|8|||
105757988|NCT00985738|364765472|FG001|Overall Study|Study closed prematurely|8|||
105757989|NCT02227849|364765473|FG000|Overall Study|Adverse Event|4|||
105757990|NCT02227849|364765473|FG000|Overall Study|Physician Decision|1|||
105757991|NCT02227849|364765473|FG000|Overall Study|Withdrawal by Subject|3|||
105757992|NCT02563925|364765476|FG000|Overall Study|Withdrawal by Subject|2|||
105757993|NCT00879437|364765479|FG000|Overall Study|Protocol Violation|0|||
105757994|NCT00879437|364765480|FG001|Overall Study|Protocol Violation|1|||
105757995|NCT00879437|364765479|FG000|Overall Study|Death|1|||
105757996|NCT00879437|364765480|FG001|Overall Study|Death|0|||
105804488|NCT02669264|364940419|FG002|Overall Study|Death|3|||
105804489|NCT02669264|364940420|FG003|Overall Study|Death|3|||
105757997|NCT01315847|364765481|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
105757998|NCT01315847|364765482|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
105757999|NCT01315847|364765481|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
105758000|NCT01315847|364765482|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
105758001|NCT03448224|364765484|FG000|Overall Study|Provided same answer to every question|1|||
105804490|NCT02669264|364940421|FG004|Overall Study|Death|3|||
105804491|NCT02669264|364940422|FG005|Overall Study|Death|6|||
105804492|NCT02669264|364940423|FG006|Overall Study|Death|3|||
105804493|NCT02669264|364940417|FG000|Overall Study|Withdrawal by Subject|0|||
105804494|NCT02669264|364940418|FG001|Overall Study|Withdrawal by Subject|1|||
105804495|NCT02669264|364940419|FG002|Overall Study|Withdrawal by Subject|0|||
105804496|NCT02669264|364940420|FG003|Overall Study|Withdrawal by Subject|0|||
105804497|NCT02669264|364940421|FG004|Overall Study|Withdrawal by Subject|1|||
105758002|NCT03448224|364765485|FG001|Overall Study|Provided same answer to every question|0|||
105758003|NCT03495817|364765486|FG000|26 Week Open Label|Adverse Event|3|||
105758004|NCT03495817|364765486|FG000|26 Week Open Label|Withdrawal by Subject|4|||
105758005|NCT03495817|364765486|FG000|26 Week Open Label|Lost to Follow-up|1|||
105758006|NCT03495817|364765486|FG000|26 Week Extension|Lost to Follow-up|2|||
105758007|NCT01117012|364765487|FG000|Overall Study|Adverse Event|0|||
105758008|NCT01117012|364765488|FG001|Overall Study|Adverse Event|1|||
105758009|NCT01117012|364765487|FG000|Overall Study|Death|1|||
105758010|NCT01117012|364765488|FG001|Overall Study|Death|1|||
105758011|NCT01117012|364765487|FG000|Overall Study|Withdrawal by Subject|3|||
105758012|NCT01117012|364765488|FG001|Overall Study|Withdrawal by Subject|0|||
105758013|NCT01117012|364765487|FG000|Overall Study|Undefined|4|||
105758014|NCT01117012|364765488|FG001|Overall Study|Undefined|3|||
105758015|NCT03695393|364765489|FG000|Overall Study|Death|3|||
105758016|NCT03695393|364765490|FG001|Overall Study|Death|1|||
105758017|NCT03695393|364765489|FG000|Overall Study|Lost to Follow-up|0|||
105758018|NCT03695393|364765490|FG001|Overall Study|Lost to Follow-up|1|||
105758019|NCT00673894|364765493|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
105758020|NCT00673894|364765494|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
105758021|NCT00673894|364765493|FG000|First Intervention 4 Weeks|Adverse Event|1|||
105758022|NCT00673894|364765494|FG001|First Intervention 4 Weeks|Adverse Event|0|||
105758023|NCT00844285|364765496|FG000|Overall Study|Other|0|||
105758024|NCT00844285|364765497|FG001|Overall Study|Other|1|||
105758025|NCT00844285|364765498|FG002|Overall Study|Other|0|||
105758026|NCT00844285|364765496|FG000|Overall Study|Other than specified|95|||
105758027|NCT00844285|364765497|FG001|Overall Study|Other than specified|129|||
105758028|NCT00844285|364765498|FG002|Overall Study|Other than specified|12|||
105758029|NCT00844285|364765496|FG000|Overall Study|Site closure|256|||
105758030|NCT00844285|364765497|FG001|Overall Study|Site closure|450|||
105758031|NCT00844285|364765498|FG002|Overall Study|Site closure|50|||
105758032|NCT00844285|364765496|FG000|Overall Study|Follow-up < 8 years|16|||
105758033|NCT00844285|364765497|FG001|Overall Study|Follow-up < 8 years|23|||
105758034|NCT00844285|364765498|FG002|Overall Study|Follow-up < 8 years|4|||
105758035|NCT00844285|364765496|FG000|Overall Study|Protocol Violation|26|||
105758036|NCT00844285|364765497|FG001|Overall Study|Protocol Violation|28|||
105758037|NCT00844285|364765498|FG002|Overall Study|Protocol Violation|54|||
105758038|NCT00844285|364765496|FG000|Overall Study|Death|22|||
105758039|NCT00844285|364765497|FG001|Overall Study|Death|21|||
105758040|NCT00844285|364765498|FG002|Overall Study|Death|8|||
105758041|NCT00844285|364765496|FG000|Overall Study|Withdrew Consent|344|||
105758042|NCT00844285|364765497|FG001|Overall Study|Withdrew Consent|466|||
105758043|NCT00844285|364765498|FG002|Overall Study|Withdrew Consent|70|||
105758044|NCT00844285|364765496|FG000|Overall Study|Lost to Follow-up|330|||
105758045|NCT00844285|364765497|FG001|Overall Study|Lost to Follow-up|486|||
105758046|NCT00844285|364765498|FG002|Overall Study|Lost to Follow-up|74|||
105758047|NCT00405821|364765501|FG000|Overall Study|Death|5|||
105758048|NCT00405821|364765502|FG001|Overall Study|Death|7|||
105758049|NCT00405821|364765501|FG000|Overall Study|Lost to Follow-up|7|||
105758050|NCT00405821|364765502|FG001|Overall Study|Lost to Follow-up|7|||
105758051|NCT00405821|364765501|FG000|Overall Study|Protocol Violation|1|||
105758052|NCT00405821|364765502|FG001|Overall Study|Protocol Violation|0|||
105758053|NCT00405821|364765501|FG000|Overall Study|initiated ART|9|||
105758054|NCT00405821|364765502|FG001|Overall Study|initiated ART|8|||
105758055|NCT04682353|364765503|FG000|Overall Study|Lost to Follow-up|0|||
105758056|NCT04682353|364765504|FG001|Overall Study|Lost to Follow-up|1|||
105758057|NCT04682353|364765505|FG002|Overall Study|Lost to Follow-up|0|||
105758058|NCT04682353|364765506|FG003|Overall Study|Lost to Follow-up|1|||
105758059|NCT04682353|364765503|FG000|Overall Study|Personal reasons|0|||
105758060|NCT04682353|364765504|FG001|Overall Study|Personal reasons|1|||
105758061|NCT04682353|364765505|FG002|Overall Study|Personal reasons|0|||
105758062|NCT04682353|364765506|FG003|Overall Study|Personal reasons|0|||
105758063|NCT01769469|364765516|FG000|Overall Study|Consent Withdrawn|5|||
105804498|NCT02669264|364940422|FG005|Overall Study|Withdrawal by Subject|0|||
105758064|NCT01769469|364765516|FG000|Overall Study|Moved Out Of Area|3|||
105758065|NCT01769469|364765516|FG000|Overall Study|Lost to Follow-up|17|||
105758066|NCT01769469|364765516|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
105758067|NCT01769469|364765516|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
105758068|NCT00862654|364765517|FG000|Overall Study|Lack of Efficacy|1|||
105758069|NCT00862654|364765518|FG001|Overall Study|Lack of Efficacy|0|||
105758070|NCT00862654|364765519|FG002|Overall Study|Lack of Efficacy|1|||
105758071|NCT00862654|364765520|FG003|Overall Study|Lack of Efficacy|0|||
105758072|NCT00862654|364765517|FG000|Overall Study|Lost to Follow-up|1|||
105758073|NCT00862654|364765518|FG001|Overall Study|Lost to Follow-up|2|||
105758074|NCT00862654|364765519|FG002|Overall Study|Lost to Follow-up|1|||
105758075|NCT00862654|364765520|FG003|Overall Study|Lost to Follow-up|3|||
105758076|NCT00862654|364765517|FG000|Overall Study|Adverse Event|0|||
105758077|NCT00862654|364765518|FG001|Overall Study|Adverse Event|1|||
105758078|NCT00862654|364765519|FG002|Overall Study|Adverse Event|1|||
105758079|NCT00862654|364765520|FG003|Overall Study|Adverse Event|0|||
105804499|NCT02669264|364940423|FG006|Overall Study|Withdrawal by Subject|0|||
105804500|NCT02669264|364940417|FG000|Overall Study|Lost to Follow-up|0|||
105804501|NCT02669264|364940418|FG001|Overall Study|Lost to Follow-up|0|||
105804502|NCT02669264|364940419|FG002|Overall Study|Lost to Follow-up|0|||
105804503|NCT02669264|364940420|FG003|Overall Study|Lost to Follow-up|0|||
105804504|NCT02669264|364940421|FG004|Overall Study|Lost to Follow-up|1|||
105804505|NCT02669264|364940422|FG005|Overall Study|Lost to Follow-up|0|||
105804506|NCT02669264|364940423|FG006|Overall Study|Lost to Follow-up|0|||
105804507|NCT02669264|364940417|FG000|Overall Study|Miscellaneous|0|||
105804508|NCT02669264|364940418|FG001|Overall Study|Miscellaneous|0|||
105804509|NCT02669264|364940419|FG002|Overall Study|Miscellaneous|0|||
105804510|NCT02669264|364940420|FG003|Overall Study|Miscellaneous|0|||
105804511|NCT02669264|364940421|FG004|Overall Study|Miscellaneous|0|||
105804512|NCT02669264|364940422|FG005|Overall Study|Miscellaneous|0|||
105804513|NCT02669264|364940423|FG006|Overall Study|Miscellaneous|2|||
105804514|NCT03280537|364940426|FG000|Overall Study|Withdrawal by Subject|2|||
105804515|NCT03280537|364940427|FG001|Overall Study|Withdrawal by Subject|4|||
105804516|NCT00669955|364940428|FG000|Overall Study|Adverse Event|3|||
105804517|NCT00669955|364940429|FG001|Overall Study|Adverse Event|5|||
105804518|NCT00669955|364940428|FG000|Overall Study|Death|0|||
105804519|NCT00669955|364940429|FG001|Overall Study|Death|1|||
105804520|NCT00669955|364940428|FG000|Overall Study|Withdrawal by Subject|2|||
105804521|NCT00669955|364940429|FG001|Overall Study|Withdrawal by Subject|3|||
105804522|NCT00669955|364940428|FG000|Overall Study|Lost to Follow-up|5|||
105804523|NCT00669955|364940429|FG001|Overall Study|Lost to Follow-up|7|||
105804524|NCT00669955|364940428|FG000|Overall Study|Protocol Violation|2|||
105804525|NCT00669955|364940429|FG001|Overall Study|Protocol Violation|7|||
105804526|NCT00669955|364940428|FG000|Overall Study|Investigator Sponsor Judgement|0|||
105804527|NCT00669955|364940429|FG001|Overall Study|Investigator Sponsor Judgement|1|||
105804528|NCT00669955|364940428|FG000|Overall Study|not compliant with study drug/visit|2|||
105804529|NCT00669955|364940429|FG001|Overall Study|not compliant with study drug/visit|3|||
105804530|NCT01890707|364940430|FG000|Overall Study|Lost to Follow-up|1|||
105804531|NCT01890707|364940431|FG001|Overall Study|Lost to Follow-up|1|||
105804532|NCT01859702|364940432|FG000|Overall Study|Protocol deviation|3|||
105804533|NCT01859702|364940432|FG000|Overall Study|Adverse Event|2|||
105804534|NCT04317053|364940438|FG000|Overall Study|Withdrawn (screen failure)|4|||
105804535|NCT04317053|364940439|FG001|Overall Study|Withdrawn (screen failure)|2|||
105804536|NCT01077713|364940440|FG000|Overall Study|Withdrawal by Subject|1|||
105804537|NCT01077713|364940441|FG001|Overall Study|Withdrawal by Subject|2|||
105804538|NCT01077713|364940440|FG000|Overall Study|Progressive Disease (PD)|0|||
105804539|NCT01077713|364940441|FG001|Overall Study|Progressive Disease (PD)|1|||
105804540|NCT01077713|364940440|FG000|Overall Study|Death|28|||
105804541|NCT01077713|364940441|FG001|Overall Study|Death|29|||
105804542|NCT01077713|364940440|FG000|Overall Study|Lost to Follow-up|1|||
105804543|NCT01077713|364940441|FG001|Overall Study|Lost to Follow-up|1|||
105804544|NCT01077713|364940440|FG000|Overall Study|Adverse Event|2|||
105804545|NCT01077713|364940441|FG001|Overall Study|Adverse Event|1|||
105804546|NCT01077713|364940440|FG000|Overall Study|Other|4|||
105804547|NCT01077713|364940441|FG001|Overall Study|Other|2|||
105804548|NCT00982410|364941829|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
105804549|NCT00982410|364941830|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
105804550|NCT00982410|364941829|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
105804551|NCT00982410|364941830|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
105804552|NCT00982410|364941829|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
105804553|NCT00982410|364941830|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
105804554|NCT00982410|364941829|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
105804555|NCT00982410|364941830|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
105804556|NCT00982410|364941829|FG000|6-month Follow-up Assessment|participant no transportation|1|||
105804557|NCT00982410|364941830|FG001|6-month Follow-up Assessment|participant no transportation|0|||
105804558|NCT00982410|364941829|FG000|6-month Follow-up Assessment|incarceration|0|||
105804559|NCT00982410|364941830|FG001|6-month Follow-up Assessment|incarceration|2|||
105804560|NCT00982410|364941829|FG000|6-month Follow-up Assessment|patent surgery|0|||
105804561|NCT00982410|364941830|FG001|6-month Follow-up Assessment|patent surgery|1|||
105804562|NCT00982410|364941829|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
105804563|NCT00982410|364941830|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
105804564|NCT00982410|364941829|FG000|12-month Follow-up Assessment|Death|0|||
105804565|NCT00982410|364941830|FG001|12-month Follow-up Assessment|Death|2|||
105804566|NCT00982410|364941829|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
105804567|NCT00982410|364941830|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
105804568|NCT00982410|364941829|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
105804569|NCT00982410|364941830|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
105804570|NCT00982410|364941829|FG000|12-month Follow-up Assessment|incarceration|2|||
105804571|NCT00982410|364941830|FG001|12-month Follow-up Assessment|incarceration|1|||
105804572|NCT00982410|364941829|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
105804573|NCT00982410|364941830|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
105804574|NCT03322462|364941831|FG000|Overall Study|Technical difficulties|2|||
105804575|NCT03322462|364941831|FG000|Overall Study|Other|1|||
105804576|NCT01393990|364941832|FG000|Overall Study|Adverse Event|0|||
105804577|NCT01393990|364941833|FG001|Overall Study|Adverse Event|0|||
105804578|NCT01393990|364941834|FG002|Overall Study|Adverse Event|0|||
105804579|NCT01393990|364941835|FG003|Overall Study|Adverse Event|0|||
105804580|NCT01393990|364941836|FG004|Overall Study|Adverse Event|0|||
105804581|NCT01393990|364941837|FG005|Overall Study|Adverse Event|0|||
105804582|NCT01393990|364941838|FG006|Overall Study|Adverse Event|0|||
105804583|NCT01393990|364941839|FG007|Overall Study|Adverse Event|0|||
105804584|NCT01393990|364941840|FG008|Overall Study|Adverse Event|0|||
105804585|NCT01393990|364941841|FG009|Overall Study|Adverse Event|0|||
105804586|NCT01393990|364941842|FG010|Overall Study|Adverse Event|0|||
105804587|NCT01393990|364941843|FG011|Overall Study|Adverse Event|0|||
105804588|NCT01393990|364941844|FG012|Overall Study|Adverse Event|0|||
105804589|NCT01393990|364941845|FG013|Overall Study|Adverse Event|0|||
105804590|NCT01393990|364941846|FG014|Overall Study|Adverse Event|1|||
105804591|NCT01393990|364941847|FG015|Overall Study|Adverse Event|1|||
105804592|NCT01393990|364941848|FG016|Overall Study|Adverse Event|0|||
105804593|NCT01393990|364941849|FG017|Overall Study|Adverse Event|0|||
105804594|NCT01393990|364941832|FG000|Overall Study|Progressive Disease|1|||
105804595|NCT01393990|364941833|FG001|Overall Study|Progressive Disease|0|||
105804596|NCT01393990|364941834|FG002|Overall Study|Progressive Disease|0|||
105804597|NCT01393990|364941835|FG003|Overall Study|Progressive Disease|1|||
105804598|NCT01393990|364941836|FG004|Overall Study|Progressive Disease|1|||
105804599|NCT01393990|364941837|FG005|Overall Study|Progressive Disease|1|||
105804600|NCT01393990|364941838|FG006|Overall Study|Progressive Disease|1|||
105804601|NCT01393990|364941839|FG007|Overall Study|Progressive Disease|1|||
105804602|NCT01393990|364941840|FG008|Overall Study|Progressive Disease|3|||
105804603|NCT01393990|364941841|FG009|Overall Study|Progressive Disease|1|||
105804604|NCT01393990|364941842|FG010|Overall Study|Progressive Disease|0|||
105804605|NCT01393990|364941843|FG011|Overall Study|Progressive Disease|0|||
105804606|NCT01393990|364941844|FG012|Overall Study|Progressive Disease|0|||
105360538|NCT05216835|363326001|FG001|Overall Study|Death|0|||
105360539|NCT05216835|363326002|FG002|Overall Study|Death|0|||
105360540|NCT05216835|363326003|FG003|Overall Study|Death|1|||
105360541|NCT05216835|363326004|FG004|Overall Study|Death|1|||
105360542|NCT05216835|363326005|FG005|Overall Study|Death|1|||
105360543|NCT05216835|363326006|FG006|Overall Study|Death|1|||
105360544|NCT05216835|363326007|FG007|Overall Study|Death|1|||
105360545|NCT05216835|363326000|FG000|Overall Study|Physician Decision|0|||
105360546|NCT05216835|363326001|FG001|Overall Study|Physician Decision|0|||
105360547|NCT05216835|363326002|FG002|Overall Study|Physician Decision|0|||
105360548|NCT05216835|363326003|FG003|Overall Study|Physician Decision|0|||
105360549|NCT05216835|363326004|FG004|Overall Study|Physician Decision|0|||
105360550|NCT05216835|363326005|FG005|Overall Study|Physician Decision|1|||
105360551|NCT05216835|363326006|FG006|Overall Study|Physician Decision|1|||
105360552|NCT05216835|363326007|FG007|Overall Study|Physician Decision|0|||
105360553|NCT05216835|363326000|FG000|Overall Study|Study terminated by Sponsor|0|||
105360554|NCT05216835|363326001|FG001|Overall Study|Study terminated by Sponsor|0|||
105360555|NCT05216835|363326002|FG002|Overall Study|Study terminated by Sponsor|0|||
105360556|NCT05216835|363326003|FG003|Overall Study|Study terminated by Sponsor|0|||
105360557|NCT05216835|363326004|FG004|Overall Study|Study terminated by Sponsor|0|||
105360558|NCT05216835|363326005|FG005|Overall Study|Study terminated by Sponsor|0|||
105360559|NCT05216835|363326006|FG006|Overall Study|Study terminated by Sponsor|0|||
105360560|NCT05216835|363326007|FG007|Overall Study|Study terminated by Sponsor|1|||
105360561|NCT05216835|363326000|FG000|Overall Study|Withdrawal by Subject|1|||
105360562|NCT05216835|363326001|FG001|Overall Study|Withdrawal by Subject|0|||
105360563|NCT05216835|363326002|FG002|Overall Study|Withdrawal by Subject|1|||
105568665|NCT02508532|364081264|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
105758080|NCT00862654|364765517|FG000|Overall Study|Pregnancy|1|||
105360564|NCT05216835|363326003|FG003|Overall Study|Withdrawal by Subject|0|||
105360565|NCT05216835|363326004|FG004|Overall Study|Withdrawal by Subject|1|||
105360566|NCT05216835|363326005|FG005|Overall Study|Withdrawal by Subject|0|||
105360567|NCT05216835|363326006|FG006|Overall Study|Withdrawal by Subject|0|||
105360568|NCT05216835|363326007|FG007|Overall Study|Withdrawal by Subject|1|||
105360569|NCT05216835|363326000|FG000|Overall Study|Other|0|||
105758081|NCT00862654|364765518|FG001|Overall Study|Pregnancy|1|||
105758082|NCT00862654|364765519|FG002|Overall Study|Pregnancy|0|||
105758083|NCT00862654|364765520|FG003|Overall Study|Pregnancy|0|||
105758084|NCT00862654|364765517|FG000|Overall Study|Withdrawal by Subject|2|||
105758085|NCT00862654|364765518|FG001|Overall Study|Withdrawal by Subject|2|||
105758086|NCT00862654|364765519|FG002|Overall Study|Withdrawal by Subject|2|||
105758087|NCT00862654|364765520|FG003|Overall Study|Withdrawal by Subject|3|||
105758088|NCT00862654|364765517|FG000|Overall Study|Subject mistake|0|||
105758089|NCT00862654|364765518|FG001|Overall Study|Subject mistake|1|||
105804607|NCT01393990|364941845|FG013|Overall Study|Progressive Disease|1|||
105804608|NCT01393990|364941846|FG014|Overall Study|Progressive Disease|6|||
105804609|NCT01393990|364941847|FG015|Overall Study|Progressive Disease|1|||
105804610|NCT01393990|364941848|FG016|Overall Study|Progressive Disease|0|||
105804611|NCT01393990|364941849|FG017|Overall Study|Progressive Disease|0|||
105804612|NCT01393990|364941832|FG000|Overall Study|Death|0|||
105804613|NCT01393990|364941833|FG001|Overall Study|Death|0|||
105804614|NCT01393990|364941834|FG002|Overall Study|Death|0|||
105804615|NCT01393990|364941835|FG003|Overall Study|Death|0|||
105804616|NCT01393990|364941836|FG004|Overall Study|Death|1|||
105804617|NCT01393990|364941837|FG005|Overall Study|Death|0|||
105804618|NCT01393990|364941838|FG006|Overall Study|Death|0|||
105804619|NCT01393990|364941839|FG007|Overall Study|Death|0|||
105804620|NCT01393990|364941840|FG008|Overall Study|Death|0|||
105804621|NCT01393990|364941841|FG009|Overall Study|Death|0|||
105804622|NCT01393990|364941842|FG010|Overall Study|Death|0|||
105804623|NCT01393990|364941843|FG011|Overall Study|Death|0|||
105804624|NCT01393990|364941844|FG012|Overall Study|Death|0|||
105804625|NCT01393990|364941845|FG013|Overall Study|Death|1|||
105804626|NCT01393990|364941846|FG014|Overall Study|Death|1|||
105804627|NCT01393990|364941847|FG015|Overall Study|Death|0|||
105804628|NCT01393990|364941848|FG016|Overall Study|Death|0|||
105804629|NCT01393990|364941849|FG017|Overall Study|Death|0|||
105804630|NCT01393990|364941832|FG000|Overall Study|Withdrawal by Subject|0|||
105804631|NCT01393990|364941833|FG001|Overall Study|Withdrawal by Subject|0|||
105804632|NCT01393990|364941834|FG002|Overall Study|Withdrawal by Subject|0|||
105804633|NCT01393990|364941835|FG003|Overall Study|Withdrawal by Subject|0|||
105804634|NCT01393990|364941836|FG004|Overall Study|Withdrawal by Subject|0|||
105804635|NCT01393990|364941837|FG005|Overall Study|Withdrawal by Subject|0|||
105804636|NCT01393990|364941838|FG006|Overall Study|Withdrawal by Subject|0|||
105804637|NCT01393990|364941839|FG007|Overall Study|Withdrawal by Subject|0|||
105804638|NCT01393990|364941840|FG008|Overall Study|Withdrawal by Subject|0|||
105804639|NCT01393990|364941841|FG009|Overall Study|Withdrawal by Subject|0|||
105804640|NCT01393990|364941842|FG010|Overall Study|Withdrawal by Subject|0|||
105804641|NCT01393990|364941843|FG011|Overall Study|Withdrawal by Subject|0|||
105804642|NCT01393990|364941844|FG012|Overall Study|Withdrawal by Subject|0|||
105804643|NCT01393990|364941845|FG013|Overall Study|Withdrawal by Subject|0|||
105804644|NCT01393990|364941846|FG014|Overall Study|Withdrawal by Subject|1|||
105804645|NCT01393990|364941847|FG015|Overall Study|Withdrawal by Subject|1|||
105804646|NCT01393990|364941848|FG016|Overall Study|Withdrawal by Subject|0|||
105804647|NCT01393990|364941849|FG017|Overall Study|Withdrawal by Subject|0|||
105804648|NCT00331630|364941855|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
105804649|NCT00331630|364941855|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
105804650|NCT00331630|364941855|FG000|Follow up for 5 Years|Death|5|||
105804651|NCT00331630|364941855|FG000|Follow up for 5 Years|Data collection was stopped|24|||
105804652|NCT00720798|364941858|FG000|Overall Study|Adverse Event|304|||
105804653|NCT00720798|364941858|FG000|Overall Study|Death|39|||
105804654|NCT00720798|364941858|FG000|Overall Study|Insufficient Therapeutic Response|129|||
105804655|NCT00720798|364941858|FG000|Overall Study|Protocol Violation|4|||
105804656|NCT00720798|364941858|FG000|Overall Study|Refused Treatment|151|||
105804657|NCT00720798|364941858|FG000|Overall Study|Failure to Return|46|||
105804658|NCT00720798|364941858|FG000|Overall Study|Reason not Specified|83|||
105804659|NCT03342898|364941859|FG000|Overall Study|Adverse Event|3|||
105804660|NCT03342898|364941860|FG001|Overall Study|Adverse Event|1|||
105804661|NCT03342898|364941861|FG002|Overall Study|Adverse Event|0|||
105804662|NCT03342898|364941859|FG000|Overall Study|Lost to Follow-up|44|||
105804663|NCT03342898|364941860|FG001|Overall Study|Lost to Follow-up|40|||
105804664|NCT03342898|364941861|FG002|Overall Study|Lost to Follow-up|42|||
105804665|NCT03342898|364941859|FG000|Overall Study|Withdrawal of Consent|5|||
105804666|NCT03342898|364941860|FG001|Overall Study|Withdrawal of Consent|9|||
105804667|NCT03342898|364941861|FG002|Overall Study|Withdrawal of Consent|11|||
105804668|NCT03342898|364941859|FG000|Overall Study|Death|0|||
105804669|NCT03342898|364941860|FG001|Overall Study|Death|1|||
105804670|NCT03342898|364941861|FG002|Overall Study|Death|1|||
105568666|NCT02508532|364081256|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
105758090|NCT00862654|364765519|FG002|Overall Study|Subject mistake|0|||
105758091|NCT00862654|364765520|FG003|Overall Study|Subject mistake|0|||
105758092|NCT00862654|364765517|FG000|Overall Study|Familly constraint|0|||
105758093|NCT00862654|364765518|FG001|Overall Study|Familly constraint|1|||
105758094|NCT00862654|364765519|FG002|Overall Study|Familly constraint|0|||
105758095|NCT00862654|364765520|FG003|Overall Study|Familly constraint|0|||
105758096|NCT00862654|364765517|FG000|Overall Study|Never used study drugs|1|||
105758097|NCT00862654|364765518|FG001|Overall Study|Never used study drugs|0|||
105758098|NCT00862654|364765519|FG002|Overall Study|Never used study drugs|0|||
105758099|NCT00862654|364765520|FG003|Overall Study|Never used study drugs|0|||
105758100|NCT00862654|364765517|FG000|Overall Study|Included after end of inclusions|0|||
105758101|NCT00862654|364765518|FG001|Overall Study|Included after end of inclusions|0|||
105758102|NCT00862654|364765519|FG002|Overall Study|Included after end of inclusions|1|||
105758103|NCT00862654|364765520|FG003|Overall Study|Included after end of inclusions|0|||
105758104|NCT00889681|364765530|FG000|Overall Study|Not meeting qualification Criteria|2|||
105758105|NCT00889681|364765530|FG000|Overall Study|Insurance disapproval|1|||
105758106|NCT00871572|364765531|FG000|Overall Study|Adverse Event|0|||
105758107|NCT00871572|364765532|FG001|Overall Study|Adverse Event|2|||
105758108|NCT00871572|364765533|FG002|Overall Study|Adverse Event|0|||
105758109|NCT00871572|364765534|FG003|Overall Study|Adverse Event|3|||
105758110|NCT00871572|364765531|FG000|Overall Study|Investigator Decision|0|||
105758111|NCT00871572|364765532|FG001|Overall Study|Investigator Decision|1|||
105758112|NCT00871572|364765533|FG002|Overall Study|Investigator Decision|0|||
105758113|NCT00871572|364765534|FG003|Overall Study|Investigator Decision|1|||
105758114|NCT00871572|364765531|FG000|Overall Study|Lost to Follow-up|0|||
105758115|NCT00871572|364765532|FG001|Overall Study|Lost to Follow-up|1|||
105758116|NCT00871572|364765533|FG002|Overall Study|Lost to Follow-up|0|||
105758117|NCT00871572|364765534|FG003|Overall Study|Lost to Follow-up|1|||
105758118|NCT00871572|364765531|FG000|Overall Study|Protocol Violation|0|||
105758119|NCT00871572|364765532|FG001|Overall Study|Protocol Violation|0|||
105568667|NCT02508532|364081257|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
105568668|NCT02508532|364081258|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
105758120|NCT00871572|364765533|FG002|Overall Study|Protocol Violation|1|||
105758121|NCT00871572|364765534|FG003|Overall Study|Protocol Violation|1|||
105758122|NCT00871572|364765531|FG000|Overall Study|Sponsor Decision|1|||
105758123|NCT00871572|364765532|FG001|Overall Study|Sponsor Decision|0|||
105758124|NCT00871572|364765533|FG002|Overall Study|Sponsor Decision|0|||
105568669|NCT02508532|364081259|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
105758125|NCT00871572|364765534|FG003|Overall Study|Sponsor Decision|0|||
105804671|NCT03342898|364941859|FG000|Overall Study|Reason not Specified|2|||
105804672|NCT03342898|364941860|FG001|Overall Study|Reason not Specified|2|||
105804673|NCT03342898|364941861|FG002|Overall Study|Reason not Specified|0|||
105804674|NCT02497391|364941862|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
105804675|NCT02497391|364941863|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
105804676|NCT02497391|364941864|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
105804677|NCT02497391|364941865|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
105804678|NCT02497391|364941866|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
105804679|NCT02497391|364941867|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
105804680|NCT02497391|364941862|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
105804681|NCT02497391|364941863|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
105804682|NCT02497391|364941864|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
105804683|NCT02497391|364941865|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
105804684|NCT02497391|364941866|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
105804685|NCT02497391|364941867|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
105804686|NCT02497391|364941862|FG000|Period 3 (14 Days)|Adverse Event|0|||
105804687|NCT02497391|364941863|FG001|Period 3 (14 Days)|Adverse Event|1|||
105804688|NCT02497391|364941864|FG002|Period 3 (14 Days)|Adverse Event|0|||
105804689|NCT02497391|364941865|FG003|Period 3 (14 Days)|Adverse Event|0|||
105804690|NCT02497391|364941866|FG004|Period 3 (14 Days)|Adverse Event|0|||
105804691|NCT02497391|364941867|FG005|Period 3 (14 Days)|Adverse Event|0|||
105804692|NCT02497391|364941862|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
105804693|NCT02497391|364941863|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
105804694|NCT02497391|364941864|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
105804695|NCT02497391|364941865|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
105804696|NCT02497391|364941866|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
105804697|NCT02497391|364941867|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
105804698|NCT02497391|364941862|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
105804699|NCT02497391|364941863|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
105804700|NCT02497391|364941864|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
105804701|NCT02497391|364941865|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
105804702|NCT02497391|364941866|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
105804703|NCT02497391|364941867|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
105804704|NCT03031899|364941871|FG000|Overall Study|Protocol Violation|1|||
105804705|NCT03031899|364941871|FG000|Overall Study|lesion disappeared after stopping habit|1|||
105804706|NCT03705351|364941872|FG000|Overall Study|Study termination|3|||
105804707|NCT03705351|364941872|FG000|Overall Study|Death|1|||
105804708|NCT03705351|364941872|FG000|Overall Study|Lack of Efficacy|2|||
105804709|NCT03705351|364941872|FG000|Overall Study|Withdrawal by Subject|1|||
105804710|NCT03273387|364941874|FG000|Overall Study|Death|2|||
105804711|NCT03273387|364941875|FG001|Overall Study|Death|2|||
105804712|NCT03273387|364941874|FG000|Overall Study|Withdrawal by Subject|1|||
105804713|NCT03273387|364941875|FG001|Overall Study|Withdrawal by Subject|1|||
105804714|NCT01907087|364941876|FG000|Overall Study|Withdrawal by Subject|1|||
105804715|NCT05216978|364941877|FG000|Overall Study|Withdrawal by Subject|3|||
105804716|NCT05216978|364941877|FG000|Overall Study|Lost to Follow-up|5|||
105804717|NCT02180061|364941878|FG000|Overall Study|Adverse Event|4|||
105804718|NCT02180061|364941879|FG001|Overall Study|Adverse Event|2|||
105804719|NCT02180061|364941878|FG000|Overall Study|Clinical Progression|5|||
105804720|NCT02180061|364941879|FG001|Overall Study|Clinical Progression|1|||
105804721|NCT02180061|364941878|FG000|Overall Study|Progressive Disease|15|||
105804722|NCT02180061|364941879|FG001|Overall Study|Progressive Disease|5|||
105804723|NCT02180061|364941878|FG000|Overall Study|Physician Decision|1|||
105804724|NCT02180061|364941879|FG001|Overall Study|Physician Decision|0|||
105804725|NCT00658320|364941884|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
105804726|NCT00658320|364941885|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
105804727|NCT00658320|364941884|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
105804728|NCT00658320|364941885|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
105804729|NCT00658320|364941884|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
105804730|NCT00658320|364941885|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
105804731|NCT00658320|364941884|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
105758126|NCT00871572|364765531|FG000|Overall Study|Withdrawal by Subject|1|||
105758127|NCT00871572|364765532|FG001|Overall Study|Withdrawal by Subject|2|||
105758128|NCT00871572|364765533|FG002|Overall Study|Withdrawal by Subject|3|||
105758129|NCT00871572|364765534|FG003|Overall Study|Withdrawal by Subject|1|||
105758130|NCT04176445|364765538|FG000|Overall Study|Adverse Event|0|||
105758131|NCT04176445|364765539|FG001|Overall Study|Adverse Event|1|||
105758132|NCT04176445|364765538|FG000|Overall Study|change plans weaning after first intervention|0|||
105758133|NCT04176445|364765539|FG001|Overall Study|change plans weaning after first intervention|1|||
105758134|NCT01686958|364765540|FG000|Overall Study|Withdrawal by Subject|1|||
105758135|NCT03479216|364765541|FG000|Overall Study|Withdrawal by Subject|3|||
105758136|NCT03479216|364765542|FG001|Overall Study|Withdrawal by Subject|2|||
105758137|NCT03479216|364765541|FG000|Overall Study|Physician Decision|2|||
105758138|NCT03479216|364765542|FG001|Overall Study|Physician Decision|3|||
105758139|NCT01999946|364765547|FG000|Overall Study|Participant not released from jail|2|||
105758140|NCT01999946|364765548|FG001|Overall Study|Participant not released from jail|2|||
105758141|NCT01999946|364765549|FG002|Overall Study|Participant not released from jail|0|||
105758142|NCT01999946|364765547|FG000|Overall Study|Not included in primary outcome analysis|0|||
105758143|NCT01999946|364765548|FG001|Overall Study|Not included in primary outcome analysis|0|||
105758144|NCT01999946|364765549|FG002|Overall Study|Not included in primary outcome analysis|79|||
105758145|NCT03326869|364767141|FG000|Overall Study|Study data has been lost to natural disa|1|||
105758146|NCT03326869|364767142|FG001|Overall Study|Study data has been lost to natural disa|1|||
105758147|NCT03788967|364767143|FG000|Overall Study|Lost to Follow-up|14|||
105758148|NCT03788967|364767144|FG001|Overall Study|Lost to Follow-up|10|||
105758149|NCT03788967|364767143|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
105758150|NCT03788967|364767144|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
105758151|NCT03788967|364767143|FG000|Overall Study|Participant Withdrawal of Consent|13|||
105758152|NCT03788967|364767144|FG001|Overall Study|Participant Withdrawal of Consent|5|||
105758153|NCT03788967|364767143|FG000|Overall Study|Adverse Event|1|||
105758154|NCT03788967|364767144|FG001|Overall Study|Adverse Event|1|||
105758155|NCT03788967|364767143|FG000|Overall Study|COVID-19|1|||
105758156|NCT03788967|364767144|FG001|Overall Study|COVID-19|2|||
105758157|NCT04432376|364767145|FG000|Double-blind Treatment Period|Adverse Event|2|||
105758158|NCT04432376|364767146|FG001|Double-blind Treatment Period|Adverse Event|6|||
105758159|NCT04432376|364767147|FG002|Double-blind Treatment Period|Adverse Event|0|||
105758160|NCT04432376|364767145|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
105758161|NCT04432376|364767146|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
105758162|NCT04432376|364767147|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
105758163|NCT04432376|364767145|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
105758164|NCT04432376|364767146|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
105758165|NCT04432376|364767147|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105758166|NCT04432376|364767145|FG000|Double-blind Treatment Period|Protocol Violation|0|||
105758167|NCT04432376|364767146|FG001|Double-blind Treatment Period|Protocol Violation|1|||
105758168|NCT04432376|364767147|FG002|Double-blind Treatment Period|Protocol Violation|0|||
105758169|NCT04432376|364767145|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
105758170|NCT04432376|364767146|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
105758171|NCT04432376|364767147|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
105758172|NCT01824693|364767148|FG000|Overall Study|Death|0|||
105758173|NCT01824693|364767149|FG001|Overall Study|Death|1|||
105758174|NCT01824693|364767150|FG002|Overall Study|Death|0|||
105758175|NCT01824693|364767148|FG000|Overall Study|Physician Decision|1|||
105758176|NCT01824693|364767149|FG001|Overall Study|Physician Decision|1|||
105758177|NCT01824693|364767150|FG002|Overall Study|Physician Decision|1|||
105758178|NCT01824693|364767148|FG000|Overall Study|Withdrawal by Subject|0|||
105758179|NCT01824693|364767149|FG001|Overall Study|Withdrawal by Subject|0|||
105758180|NCT01824693|364767150|FG002|Overall Study|Withdrawal by Subject|1|||
105758181|NCT01824693|364767148|FG000|Overall Study|Progressive Disease|0|||
105758182|NCT01824693|364767149|FG001|Overall Study|Progressive Disease|5|||
105758183|NCT01824693|364767150|FG002|Overall Study|Progressive Disease|0|||
105758184|NCT01824693|364767148|FG000|Overall Study|Ineligible|0|||
105758185|NCT01824693|364767149|FG001|Overall Study|Ineligible|0|||
105758186|NCT01824693|364767150|FG002|Overall Study|Ineligible|3|||
105758187|NCT01824693|364767148|FG000|Overall Study|No Transplant Planned|0|||
105758188|NCT01824693|364767149|FG001|Overall Study|No Transplant Planned|0|||
105758189|NCT01824693|364767150|FG002|Overall Study|No Transplant Planned|10|||
105758190|NCT02591238|364767151|FG000|Overall Study|Pregnancy|1|||
105758191|NCT02591238|364767152|FG001|Overall Study|Pregnancy|0|||
105758192|NCT02591238|364767153|FG002|Overall Study|Pregnancy|0|||
105758193|NCT02591238|364767154|FG003|Overall Study|Pregnancy|0|||
105758194|NCT02591238|364767151|FG000|Overall Study|Withdrawal by Subject|0|||
105758195|NCT02591238|364767152|FG001|Overall Study|Withdrawal by Subject|0|||
105758196|NCT02591238|364767153|FG002|Overall Study|Withdrawal by Subject|0|||
105758197|NCT02591238|364767154|FG003|Overall Study|Withdrawal by Subject|1|||
105758198|NCT02591238|364767151|FG000|Overall Study|influenza|0|||
105758199|NCT02591238|364767152|FG001|Overall Study|influenza|0|||
105758200|NCT02591238|364767153|FG002|Overall Study|influenza|0|||
105758201|NCT02591238|364767154|FG003|Overall Study|influenza|1|||
105758202|NCT02591238|364767151|FG000|Overall Study|personal circumstances|0|||
105758203|NCT02591238|364767152|FG001|Overall Study|personal circumstances|0|||
105758204|NCT02591238|364767153|FG002|Overall Study|personal circumstances|0|||
105758205|NCT02591238|364767154|FG003|Overall Study|personal circumstances|1|||
105758206|NCT02591238|364767151|FG000|Overall Study|personal circumstances|0|||
105758207|NCT02591238|364767152|FG001|Overall Study|personal circumstances|1|||
105758208|NCT02591238|364767153|FG002|Overall Study|personal circumstances|0|||
105758209|NCT02591238|364767154|FG003|Overall Study|personal circumstances|0|||
105758210|NCT00801892|364767155|FG000|Main Study Period|Withdrawal by Subject|0|||
105758211|NCT00801892|364767156|FG001|Main Study Period|Withdrawal by Subject|1|||
105758212|NCT00801892|364767155|FG000|Sham Crossover Period|Lost to Follow-up|0|||
105758213|NCT00801892|364767156|FG001|Sham Crossover Period|Lost to Follow-up|2|||
105758214|NCT01711541|364767157|FG000|Overall Study|Cancel prior to treatment|0|||
105758215|NCT01711541|364767158|FG001|Overall Study|Cancel prior to treatment|0|||
105758216|NCT01711541|364767159|FG002|Overall Study|Cancel prior to treatment|0|||
105758217|NCT01711541|364767160|FG003|Overall Study|Cancel prior to treatment|1|||
105758218|NCT01711541|364767161|FG004|Overall Study|Cancel prior to treatment|0|||
105758219|NCT01711541|364767157|FG000|Overall Study|Ineligible|0|||
105758220|NCT01711541|364767158|FG001|Overall Study|Ineligible|1|||
105758221|NCT01711541|364767159|FG002|Overall Study|Ineligible|0|||
105758222|NCT01711541|364767160|FG003|Overall Study|Ineligible|0|||
105758223|NCT01711541|364767161|FG004|Overall Study|Ineligible|0|||
105758224|NCT03943446|364767162|FG000|Overall Study|Lost to Follow-up|0|||
105758225|NCT03943446|364767163|FG001|Overall Study|Lost to Follow-up|0|||
105758226|NCT03943446|364767164|FG002|Overall Study|Lost to Follow-up|1|||
105758227|NCT03943446|364767162|FG000|Overall Study|Withdrawal by Subject|1|||
105758228|NCT03943446|364767163|FG001|Overall Study|Withdrawal by Subject|1|||
105758229|NCT03943446|364767164|FG002|Overall Study|Withdrawal by Subject|2|||
105758230|NCT03943446|364767162|FG000|Overall Study|Study Terminated by Sponsor|1|||
105758231|NCT03943446|364767163|FG001|Overall Study|Study Terminated by Sponsor|2|||
105758232|NCT03943446|364767164|FG002|Overall Study|Study Terminated by Sponsor|1|||
105758233|NCT03943446|364767162|FG000|Overall Study|Reason not Specified|5|||
105758234|NCT03943446|364767163|FG001|Overall Study|Reason not Specified|1|||
105758235|NCT03943446|364767164|FG002|Overall Study|Reason not Specified|3|||
105758236|NCT01136746|364767165|FG000|Overall Study|Lost to Follow-up|0|||
105758237|NCT01136746|364767166|FG001|Overall Study|Lost to Follow-up|2|||
105758238|NCT01136746|364767165|FG000|Overall Study|Protocol Violation|2|||
105758239|NCT01136746|364767166|FG001|Overall Study|Protocol Violation|1|||
105758240|NCT01136746|364767165|FG000|Overall Study|Death|1|||
105758241|NCT01136746|364767166|FG001|Overall Study|Death|0|||
105758242|NCT00093470|364767167|FG000|Overall Study|Disease progression|39|||
105758243|NCT00093470|364767168|FG001|Overall Study|Disease progression|0|||
105758244|NCT00093470|364767167|FG000|Overall Study|Adverse Event|15|||
105758245|NCT00093470|364767168|FG001|Overall Study|Adverse Event|0|||
105758246|NCT00093470|364767167|FG000|Overall Study|Death|2|||
105758247|NCT00093470|364767168|FG001|Overall Study|Death|0|||
105758248|NCT00093470|364767167|FG000|Overall Study|Withdrawal by Subject|8|||
105758249|NCT00093470|364767168|FG001|Overall Study|Withdrawal by Subject|0|||
105758250|NCT00093470|364767167|FG000|Overall Study|Alternative therapy|2|||
105758251|NCT00093470|364767168|FG001|Overall Study|Alternative therapy|0|||
105758252|NCT00093470|364767167|FG000|Overall Study|Other complicating disease|3|||
105758253|NCT00093470|364767168|FG001|Overall Study|Other complicating disease|0|||
105758254|NCT00093470|364767167|FG000|Overall Study|Physician Decision|2|||
105758255|NCT00093470|364767168|FG001|Overall Study|Physician Decision|0|||
105758256|NCT00093470|364767167|FG000|Overall Study|Never started treatment|1|||
105758257|NCT00093470|364767168|FG001|Overall Study|Never started treatment|0|||
105758258|NCT00093470|364767167|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
105758259|NCT00093470|364767168|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
105758260|NCT02514772|364767169|FG000|Overall Study|Adverse Event|1|||
105758261|NCT02514772|364767170|FG001|Overall Study|Adverse Event|0|||
105758262|NCT02514772|364767169|FG000|Overall Study|Death|0|||
105758263|NCT02514772|364767170|FG001|Overall Study|Death|1|||
105758264|NCT02514772|364767169|FG000|Overall Study|Withdrawal by Subject|2|||
105758265|NCT02514772|364767170|FG001|Overall Study|Withdrawal by Subject|1|||
105758266|NCT04671342|364767171|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
105758267|NCT04671342|364767171|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
105758268|NCT04671342|364767171|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
105758269|NCT04671342|364767171|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
105758270|NCT04671342|364767171|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
105758271|NCT04671342|364767171|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
105758272|NCT01415908|364767172|FG000|Overall Study|Withdrawal by Subject|1|||
105758273|NCT01415908|364767173|FG001|Overall Study|Withdrawal by Subject|0|||
105758274|NCT04067011|364767174|FG000|Overall Study|Not Treated|8|||
105758275|NCT04067011|364767175|FG001|Overall Study|Not Treated|7|||
105758276|NCT04067011|364767176|FG002|Overall Study|Not Treated|5|||
105758277|NCT04067011|364767174|FG000|Overall Study|Adverse Event|2|||
105758278|NCT04067011|364767175|FG001|Overall Study|Adverse Event|1|||
105758279|NCT04067011|364767176|FG002|Overall Study|Adverse Event|0|||
105758280|NCT04067011|364767174|FG000|Overall Study|Withdrawal by Subject|6|||
105758281|NCT04067011|364767175|FG001|Overall Study|Withdrawal by Subject|2|||
105758282|NCT04067011|364767176|FG002|Overall Study|Withdrawal by Subject|1|||
105758283|NCT04067011|364767174|FG000|Overall Study|Lost to Follow-up|0|||
105758284|NCT04067011|364767175|FG001|Overall Study|Lost to Follow-up|0|||
105758285|NCT04067011|364767176|FG002|Overall Study|Lost to Follow-up|1|||
105758286|NCT04067011|364767174|FG000|Overall Study|Physician Decision|1|||
105758287|NCT04067011|364767175|FG001|Overall Study|Physician Decision|1|||
105758288|NCT04067011|364767176|FG002|Overall Study|Physician Decision|0|||
105758289|NCT04067011|364767174|FG000|Overall Study|Other Reasons|2|||
105758290|NCT04067011|364767175|FG001|Overall Study|Other Reasons|0|||
105758291|NCT04067011|364767176|FG002|Overall Study|Other Reasons|1|||
105758292|NCT04067011|364767174|FG000|Overall Study|Missing|0|||
105758293|NCT04067011|364767175|FG001|Overall Study|Missing|2|||
105758294|NCT04067011|364767176|FG002|Overall Study|Missing|0|||
105758295|NCT02034552|364767177|FG000|Overall Study|Never treated|3|||
105758296|NCT02034552|364767178|FG001|Overall Study|Never treated|2|||
105758297|NCT02034552|364767179|FG002|Overall Study|Never treated|0|||
105758298|NCT02034552|364767177|FG000|Overall Study|Radiological progression|3|||
105758299|NCT02034552|364767178|FG001|Overall Study|Radiological progression|5|||
105758300|NCT02034552|364767179|FG002|Overall Study|Radiological progression|4|||
105758301|NCT02034552|364767177|FG000|Overall Study|AE not assoc. with disease progression|1|||
105758302|NCT02034552|364767178|FG001|Overall Study|AE not assoc. with disease progression|4|||
105758303|NCT02034552|364767179|FG002|Overall Study|AE not assoc. with disease progression|2|||
105758304|NCT02034552|364767177|FG000|Overall Study|AE associated with disease progression|0|||
105758305|NCT02034552|364767178|FG001|Overall Study|AE associated with disease progression|1|||
105758306|NCT02034552|364767179|FG002|Overall Study|AE associated with disease progression|0|||
105758307|NCT02034552|364767177|FG000|Overall Study|Withdrawal by Subject|2|||
105758308|NCT02034552|364767178|FG001|Overall Study|Withdrawal by Subject|1|||
105758309|NCT02034552|364767179|FG002|Overall Study|Withdrawal by Subject|1|||
105758310|NCT02034552|364767177|FG000|Overall Study|Non-compliance with study drug|0|||
105758311|NCT02034552|364767178|FG001|Overall Study|Non-compliance with study drug|0|||
105758312|NCT02034552|364767179|FG002|Overall Study|Non-compliance with study drug|1|||
105758313|NCT02034552|364767177|FG000|Overall Study|Clinical progression|5|||
105758314|NCT02034552|364767178|FG001|Overall Study|Clinical progression|7|||
105758315|NCT02034552|364767179|FG002|Overall Study|Clinical progression|9|||
105758316|NCT01419015|364767180|FG000|Overall Study|Death|2|||
105758317|NCT01188096|364767181|FG000|Overall Study|progression of disease|4|||
105758318|NCT01188096|364767181|FG000|Overall Study|Withdrawal by Subject|2|||
105758319|NCT04209530|364767185|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
105758320|NCT04209530|364767186|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
105758321|NCT04209530|364767185|FG000|Overall Study|Withdrawal by Subject|0|||
105758322|NCT04209530|364767186|FG001|Overall Study|Withdrawal by Subject|1|||
105758323|NCT02197897|364767187|FG000|Overall Study|not eligible|1|||
105758324|NCT02513771|364767191|FG000|Overall Study|Lost to Follow-up|1|||
105758325|NCT02513771|364767192|FG001|Overall Study|Lost to Follow-up|1|||
105758326|NCT02513771|364767191|FG000|Overall Study|Not being able to get to clinic|1|||
105758327|NCT02513771|364767192|FG001|Overall Study|Not being able to get to clinic|0|||
105758328|NCT00510484|364767197|FG000|Wash-out Period|Adverse Event|0|||
105758329|NCT00510484|364767198|FG001|Wash-out Period|Adverse Event|1|||
105758330|NCT01373918|364767199|FG000|Overall Study|Physician Decision|0|||
105758331|NCT01373918|364767200|FG001|Overall Study|Physician Decision|1|||
105758332|NCT03004976|364767201|FG000|Overall Study|Lost to Follow-up|7|||
105758333|NCT03004976|364767202|FG001|Overall Study|Lost to Follow-up|5|||
105758334|NCT03004976|364767201|FG000|Overall Study|Physician Decision|1|||
105758335|NCT03004976|364767202|FG001|Overall Study|Physician Decision|0|||
105758336|NCT03004976|364767201|FG000|Overall Study|Withdrawal by Subject|1|||
105758337|NCT03004976|364767202|FG001|Overall Study|Withdrawal by Subject|0|||
105758338|NCT03004976|364767201|FG000|Overall Study|Death|4|||
105758339|NCT03004976|364767202|FG001|Overall Study|Death|1|||
105758340|NCT02533401|364767205|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
105758341|NCT02533401|364767205|FG000|Overall Study|Death|5|||
105758342|NCT02533401|364767205|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
105758343|NCT02533401|364767205|FG000|Overall Study|Lost to Follow-up|1|||
105758344|NCT02533401|364767205|FG000|Overall Study|Violation of Selection Criteria|1|||
105758345|NCT00291499|364767206|FG000|Overall Study|Adverse Event|3|||
105758346|NCT00291499|364767207|FG001|Overall Study|Adverse Event|8|||
105804732|NCT00658320|364941885|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
105804733|NCT01405950|364941886|FG000|Overall Study|Withdrawal by Subject|1|||
105804734|NCT01405950|364941887|FG001|Overall Study|Withdrawal by Subject|0|||
105804735|NCT01405950|364941888|FG002|Overall Study|Withdrawal by Subject|0|||
105804736|NCT01405950|364941889|FG003|Overall Study|Withdrawal by Subject|0|||
105804737|NCT01381900|364941898|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
105804738|NCT01381900|364941899|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
105804739|NCT01381900|364941900|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
105804740|NCT01381900|364941898|FG000|Overall Study|Adverse Event|4|||
105804741|NCT01381900|364941899|FG001|Overall Study|Adverse Event|6|||
105804742|NCT01381900|364941900|FG002|Overall Study|Adverse Event|7|||
105804743|NCT01381900|364941898|FG000|Overall Study|Noncompliance with study drug|0|||
105804744|NCT01381900|364941899|FG001|Overall Study|Noncompliance with study drug|0|||
105804745|NCT01381900|364941900|FG002|Overall Study|Noncompliance with study drug|1|||
105804746|NCT01381900|364941898|FG000|Overall Study|Physician Decision|0|||
105804747|NCT01381900|364941899|FG001|Overall Study|Physician Decision|1|||
105804748|NCT01381900|364941900|FG002|Overall Study|Physician Decision|1|||
105804749|NCT01381900|364941898|FG000|Overall Study|Protocol Violation|0|||
105804750|NCT01381900|364941899|FG001|Overall Study|Protocol Violation|1|||
105804751|NCT01381900|364941900|FG002|Overall Study|Protocol Violation|1|||
105804752|NCT01381900|364941898|FG000|Overall Study|Withdrawal by Subject|0|||
105804753|NCT01381900|364941899|FG001|Overall Study|Withdrawal by Subject|0|||
105804754|NCT01381900|364941900|FG002|Overall Study|Withdrawal by Subject|1|||
105804755|NCT01381900|364941898|FG000|Overall Study|Early withdraw|3|||
105804756|NCT01381900|364941899|FG001|Overall Study|Early withdraw|1|||
105804757|NCT01381900|364941900|FG002|Overall Study|Early withdraw|1|||
105804758|NCT02410252|364941901|FG000|Overall Study|Withdrawal by Subject|4|||
105804759|NCT02410252|364941901|FG000|Overall Study|Physician Decision|2|||
105804760|NCT00685919|364941902|FG000|Overall Study|Withdrawal by Subject|0|||
105804761|NCT00685919|364941903|FG001|Overall Study|Withdrawal by Subject|0|||
105804762|NCT00685919|364941904|FG002|Overall Study|Withdrawal by Subject|1|||
105804763|NCT00685919|364941905|FG003|Overall Study|Withdrawal by Subject|0|||
105804764|NCT00685919|364941902|FG000|Overall Study|Physician Decision|1|||
105804765|NCT00685919|364941903|FG001|Overall Study|Physician Decision|0|||
105804766|NCT00685919|364941904|FG002|Overall Study|Physician Decision|0|||
105804767|NCT00685919|364941905|FG003|Overall Study|Physician Decision|0|||
105804768|NCT01590433|364941908|FG000|Overall Study|Lost to Follow-up|20|||
105804769|NCT01590433|364941909|FG001|Overall Study|Lost to Follow-up|8|||
105804770|NCT01590433|364941908|FG000|Overall Study|Withdrawal by Subject|21|||
105804771|NCT01590433|364941909|FG001|Overall Study|Withdrawal by Subject|11|||
105804772|NCT01590433|364941908|FG000|Overall Study|Adverse Event|11|||
105804773|NCT01590433|364941909|FG001|Overall Study|Adverse Event|3|||
105804774|NCT02732561|364941912|FG000|Overall Study|Lost to Follow-up|1|||
105804775|NCT02732561|364941913|FG001|Overall Study|Lost to Follow-up|1|||
105804776|NCT02732561|364941912|FG000|Overall Study|Withdrawal by Subject|1|||
105804777|NCT02732561|364941913|FG001|Overall Study|Withdrawal by Subject|0|||
105804778|NCT01452529|364941917|FG000|Run-in Period|Adverse Event|96|||
105804779|NCT01452529|364941918|FG001|Run-in Period|Adverse Event|0|||
105804780|NCT01452529|364941919|FG002|Run-in Period|Adverse Event|0|||
105804781|NCT01452529|364941917|FG000|Run-in Period|Withdrawal by Subject|49|||
105804782|NCT01452529|364941918|FG001|Run-in Period|Withdrawal by Subject|0|||
105804783|NCT01452529|364941919|FG002|Run-in Period|Withdrawal by Subject|0|||
105804784|NCT01452529|364941917|FG000|Run-in Period|Lost to Follow-up|19|||
105804785|NCT01452529|364941918|FG001|Run-in Period|Lost to Follow-up|0|||
105804786|NCT01452529|364941919|FG002|Run-in Period|Lost to Follow-up|0|||
105804787|NCT01452529|364941917|FG000|Run-in Period|Lack of Efficacy|46|||
105804788|NCT01452529|364941918|FG001|Run-in Period|Lack of Efficacy|0|||
105804789|NCT01452529|364941919|FG002|Run-in Period|Lack of Efficacy|0|||
105804790|NCT01452529|364941917|FG000|Run-in Period|Confirmed or suspected diversion|23|||
105804791|NCT01452529|364941918|FG001|Run-in Period|Confirmed or suspected diversion|0|||
105804792|NCT01452529|364941919|FG002|Run-in Period|Confirmed or suspected diversion|0|||
105804793|NCT01452529|364941917|FG000|Run-in Period|Administrative|21|||
105804794|NCT01452529|364941918|FG001|Run-in Period|Administrative|0|||
105804795|NCT01452529|364941919|FG002|Run-in Period|Administrative|0|||
105804796|NCT01452529|364941917|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
105804797|NCT01452529|364941918|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
105804798|NCT01452529|364941919|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
105804799|NCT01452529|364941917|FG000|Double-blind (DB) Period|Adverse Event|0|||
105804800|NCT01452529|364941918|FG001|Double-blind (DB) Period|Adverse Event|18|||
105804801|NCT01452529|364941919|FG002|Double-blind (DB) Period|Adverse Event|11|||
105804802|NCT01452529|364941917|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
105804803|NCT01452529|364941918|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
105804804|NCT01452529|364941919|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
105758347|NCT00291499|364767206|FG000|Overall Study|Change to other therapy|2|||
105758348|NCT00291499|364767207|FG001|Overall Study|Change to other therapy|1|||
105758349|NCT00291499|364767206|FG000|Overall Study|Intercurrent illness|1|||
105758350|NCT00291499|364767207|FG001|Overall Study|Intercurrent illness|0|||
105758351|NCT00291499|364767206|FG000|Overall Study|Protocol Violation|2|||
105758352|NCT00291499|364767207|FG001|Overall Study|Protocol Violation|2|||
105758353|NCT00291499|364767206|FG000|Overall Study|Other reasons|1|||
105758354|NCT00291499|364767207|FG001|Overall Study|Other reasons|4|||
105758355|NCT01143714|364767213|FG000|Overall Study|Adverse Event|4|||
105758356|NCT01143714|364767214|FG001|Overall Study|Adverse Event|2|||
105758357|NCT01143714|364767213|FG000|Overall Study|Withdrawal by Subject|1|||
105758358|NCT01143714|364767214|FG001|Overall Study|Withdrawal by Subject|0|||
105758359|NCT01143714|364767213|FG000|Overall Study|Subject non-compliance|0|||
105758360|NCT01143714|364767214|FG001|Overall Study|Subject non-compliance|1|||
105758361|NCT01143714|364767213|FG000|Overall Study|wound closed = deemed healed|1|||
105758362|NCT01143714|364767214|FG001|Overall Study|wound closed = deemed healed|0|||
105758363|NCT01143714|364767213|FG000|Overall Study|wound size increased|1|||
105758364|NCT01143714|364767214|FG001|Overall Study|wound size increased|0|||
105758365|NCT01387074|364767215|FG000|Overall Study|Lost to Follow-up|7|||
105758366|NCT01387074|364767215|FG000|Overall Study|Lack of Efficacy|1|||
105758367|NCT03892707|364767218|FG000|Overall Study|Screen failure|6|||
105758368|NCT03892707|364767219|FG001|Overall Study|Screen failure|0|||
105758369|NCT03892707|364767218|FG000|Overall Study|Pain resolution|0|||
105758370|NCT03892707|364767219|FG001|Overall Study|Pain resolution|4|||
105758371|NCT03892707|364767218|FG000|Overall Study|Withdrawal by Subject|0|||
105758372|NCT03892707|364767219|FG001|Overall Study|Withdrawal by Subject|1|||
105758373|NCT03892707|364767218|FG000|Overall Study|Other (long business trip)|0|||
105758374|NCT03892707|364767219|FG001|Overall Study|Other (long business trip)|1|||
105758375|NCT01082367|364767220|FG000|Double-blind Period|Administrative problems|0|||
105758376|NCT01082367|364767221|FG001|Double-blind Period|Administrative problems|1|||
105758377|NCT01082367|364767220|FG000|Double-blind Period|Lack of Efficacy|5|||
105758378|NCT01082367|364767221|FG001|Double-blind Period|Lack of Efficacy|11|||
105758379|NCT01082367|364767220|FG000|Double-blind Period|Adverse Event|0|||
105758380|NCT01082367|364767221|FG001|Double-blind Period|Adverse Event|1|||
105758381|NCT01082367|364767220|FG000|Follow-up (F-U) Period|Administrative problems|1|||
105758382|NCT01082367|364767221|FG001|Follow-up (F-U) Period|Administrative problems|0|||
105758383|NCT01082367|364767220|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
105758384|NCT01082367|364767221|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
105758385|NCT01082367|364767220|FG000|Follow-up (F-U) Period|Adverse Event|0|||
105758386|NCT01082367|364767221|FG001|Follow-up (F-U) Period|Adverse Event|1|||
105758387|NCT02016898|364767222|FG000|Overall Study|Death|1|||
105758388|NCT02016898|364767223|FG001|Overall Study|Death|1|||
105758389|NCT02016898|364767222|FG000|Overall Study|Lost to Follow-up|4|||
105758390|NCT02016898|364767223|FG001|Overall Study|Lost to Follow-up|4|||
105758391|NCT01665768|364767226|FG000|Overall Study|Adverse Event|3|||
105758392|NCT01665768|364767226|FG000|Overall Study|Lack of Efficacy|19|||
105758393|NCT01665768|364767226|FG000|Overall Study|Withdrawal by Subject|1|||
105758394|NCT01588353|364767230|FG000|Step2|Withdrawal by Subject|0|||
105758395|NCT01588353|364767231|FG001|Step2|Withdrawal by Subject|1|||
105758396|NCT01588353|364767232|FG002|Step2|Withdrawal by Subject|0|||
105758397|NCT01588353|364767230|FG000|Step3|Adverse Event|0|||
105758398|NCT01588353|364767231|FG001|Step3|Adverse Event|0|||
105758399|NCT01588353|364767232|FG002|Step3|Adverse Event|2|||
105758400|NCT00810810|364767233|FG000|Overall Study|Withdrawal by Subject|0|||
105758401|NCT00810810|364767234|FG001|Overall Study|Withdrawal by Subject|8|||
105758402|NCT00810810|364767235|FG002|Overall Study|Withdrawal by Subject|10|||
105758403|NCT00810810|364767236|FG003|Overall Study|Withdrawal by Subject|8|||
105758404|NCT00810810|364767233|FG000|Overall Study|Physician Decision|0|||
105758405|NCT00810810|364767234|FG001|Overall Study|Physician Decision|3|||
105758406|NCT00810810|364767235|FG002|Overall Study|Physician Decision|1|||
105758407|NCT00810810|364767236|FG003|Overall Study|Physician Decision|5|||
105758408|NCT03074149|364767240|FG000|Overall Study|Reason unknown|22|||
105758409|NCT03074149|364767241|FG001|Overall Study|Reason unknown|35|||
105758410|NCT03074149|364767240|FG000|Overall Study|Death|10|||
105758411|NCT03074149|364767241|FG001|Overall Study|Death|45|||
105758412|NCT01001234|364767243|FG000|Overall Study|Withdrawal by Subject|2|||
105758413|NCT01001234|364767244|FG001|Overall Study|Withdrawal by Subject|0|||
105758414|NCT01001234|364767245|FG002|Overall Study|Withdrawal by Subject|3|||
105758415|NCT01001234|364767246|FG003|Overall Study|Withdrawal by Subject|0|||
105758416|NCT01001234|364767247|FG004|Overall Study|Withdrawal by Subject|0|||
105758417|NCT01001234|364767243|FG000|Overall Study|Protocol Violation|34|||
105758418|NCT01001234|364767244|FG001|Overall Study|Protocol Violation|3|||
105758419|NCT01001234|364767245|FG002|Overall Study|Protocol Violation|19|||
105758420|NCT01001234|364767246|FG003|Overall Study|Protocol Violation|18|||
105758421|NCT01001234|364767247|FG004|Overall Study|Protocol Violation|0|||
105758422|NCT01001234|364767243|FG000|Overall Study|Lost to Follow-up|0|||
105758423|NCT01001234|364767244|FG001|Overall Study|Lost to Follow-up|0|||
105758424|NCT01001234|364767245|FG002|Overall Study|Lost to Follow-up|1|||
105758425|NCT01001234|364767246|FG003|Overall Study|Lost to Follow-up|2|||
105758426|NCT01001234|364767247|FG004|Overall Study|Lost to Follow-up|0|||
105758427|NCT01001234|364767243|FG000|Overall Study|Physician Decision|1|||
105758428|NCT01001234|364767244|FG001|Overall Study|Physician Decision|0|||
105758429|NCT01001234|364767245|FG002|Overall Study|Physician Decision|0|||
105758430|NCT01001234|364767246|FG003|Overall Study|Physician Decision|0|||
105758431|NCT01001234|364767247|FG004|Overall Study|Physician Decision|0|||
105758432|NCT01001234|364767243|FG000|Overall Study|Not Treated: Adverse Event|1|||
105758433|NCT01001234|364767244|FG001|Overall Study|Not Treated: Adverse Event|0|||
105758434|NCT01001234|364767245|FG002|Overall Study|Not Treated: Adverse Event|0|||
105758435|NCT01001234|364767246|FG003|Overall Study|Not Treated: Adverse Event|0|||
105758436|NCT01001234|364767247|FG004|Overall Study|Not Treated: Adverse Event|0|||
105758437|NCT01001234|364767243|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
105758438|NCT01001234|364767244|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
105758439|NCT01001234|364767245|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
105758440|NCT01001234|364767246|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
105758441|NCT01001234|364767247|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
105758442|NCT01001234|364767243|FG000|Overall Study|Not Treated: Protocol Violation|3|||
105758443|NCT01001234|364767244|FG001|Overall Study|Not Treated: Protocol Violation|0|||
105758444|NCT01001234|364767245|FG002|Overall Study|Not Treated: Protocol Violation|0|||
105758445|NCT01001234|364767246|FG003|Overall Study|Not Treated: Protocol Violation|0|||
105758446|NCT01001234|364767247|FG004|Overall Study|Not Treated: Protocol Violation|0|||
105758447|NCT01001234|364767243|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
105758448|NCT01001234|364767244|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
105758449|NCT01001234|364767245|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
105758450|NCT01001234|364767246|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
105758451|NCT01001234|364767247|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
105758452|NCT01001234|364767243|FG000|Overall Study|Not Treated: Pregnancy|3|||
105758453|NCT01001234|364767244|FG001|Overall Study|Not Treated: Pregnancy|0|||
105758454|NCT01001234|364767245|FG002|Overall Study|Not Treated: Pregnancy|0|||
105758455|NCT01001234|364767246|FG003|Overall Study|Not Treated: Pregnancy|0|||
105758456|NCT01001234|364767247|FG004|Overall Study|Not Treated: Pregnancy|0|||
105758457|NCT01001234|364767243|FG000|Overall Study|Not Treated: Physician Decision|37|||
105758458|NCT01001234|364767244|FG001|Overall Study|Not Treated: Physician Decision|4|||
105758459|NCT01001234|364767245|FG002|Overall Study|Not Treated: Physician Decision|0|||
105758460|NCT01001234|364767246|FG003|Overall Study|Not Treated: Physician Decision|0|||
105758461|NCT01001234|364767247|FG004|Overall Study|Not Treated: Physician Decision|0|||
105758462|NCT01001234|364767243|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
105758463|NCT01001234|364767244|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
105758464|NCT01001234|364767245|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
105758465|NCT01001234|364767246|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
105758466|NCT01001234|364767247|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
105758467|NCT02559713|364767248|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
105758468|NCT00326417|364767252|FG000|Overall Study|Withdrawal by Subject|0|||
105758469|NCT00326417|364767253|FG001|Overall Study|Withdrawal by Subject|0|||
105758470|NCT00326417|364767254|FG002|Overall Study|Withdrawal by Subject|1|||
105758471|NCT00326417|364767255|FG003|Overall Study|Withdrawal by Subject|0|||
105758472|NCT00326417|364767252|FG000|Overall Study|Arm Closed|7|||
105758473|NCT00326417|364767253|FG001|Overall Study|Arm Closed|0|||
105758474|NCT00326417|364767254|FG002|Overall Study|Arm Closed|0|||
105758475|NCT00326417|364767255|FG003|Overall Study|Arm Closed|3|||
105758476|NCT00326417|364767252|FG000|Overall Study|Death|7|||
105758477|NCT00326417|364767253|FG001|Overall Study|Death|0|||
105758478|NCT00326417|364767254|FG002|Overall Study|Death|0|||
105758479|NCT00326417|364767255|FG003|Overall Study|Death|0|||
105758480|NCT01164865|364767258|FG000|Overall Study|Lost to Follow-up|2|||
105758481|NCT01164865|364767259|FG001|Overall Study|Lost to Follow-up|1|||
105758482|NCT00192036|364767260|FG000|Overall Study|Protocol Violation|3|||
105758483|NCT00192036|364767260|FG000|Overall Study|Adverse Event|6|||
105758484|NCT00192036|364767260|FG000|Overall Study|Patient/Physician Perception|1|||
105758485|NCT00192036|364767260|FG000|Overall Study|Objective Tumor Progression|4|||
105758486|NCT00192036|364767260|FG000|Overall Study|Clinical Disease Progression|1|||
105758487|NCT00192036|364767260|FG000|Overall Study|Death|1|||
105758488|NCT00192036|364767260|FG000|Overall Study|Unknown or Not Specified|5|||
105758489|NCT02394795|364767263|FG000|Overall Study|Adverse Event|92|||
105758490|NCT02394795|364767264|FG001|Overall Study|Adverse Event|70|||
105758491|NCT02394795|364767263|FG000|Overall Study|Lost to Follow-up|0|||
105758492|NCT02394795|364767264|FG001|Overall Study|Lost to Follow-up|1|||
105758493|NCT02394795|364767263|FG000|Overall Study|Withdrawal by Subject|17|||
105758494|NCT02394795|364767264|FG001|Overall Study|Withdrawal by Subject|26|||
105804805|NCT01452529|364941917|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
105804806|NCT01452529|364941918|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
105804807|NCT01452529|364941919|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
105804808|NCT01452529|364941917|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
105804809|NCT01452529|364941918|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
105804810|NCT01452529|364941919|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
105804811|NCT01452529|364941917|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
105804812|NCT01452529|364941918|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
105804813|NCT01452529|364941919|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
105804814|NCT01452529|364941917|FG000|Double-blind (DB) Period|Administrative|0|||
105804815|NCT01452529|364941918|FG001|Double-blind (DB) Period|Administrative|11|||
105804816|NCT01452529|364941919|FG002|Double-blind (DB) Period|Administrative|7|||
105804817|NCT03551730|364941920|FG000|Overall Study|Adverse Event|1|||
105804818|NCT03551730|364941921|FG001|Overall Study|Adverse Event|0|||
105804819|NCT03551730|364941922|FG002|Overall Study|Adverse Event|0|||
105804820|NCT03551730|364941923|FG003|Overall Study|Adverse Event|0|||
105804821|NCT01165684|364941927|FG000|Overall Study|Adverse Event|1|||
105804822|NCT01165684|364941928|FG001|Overall Study|Adverse Event|1|||
105804823|NCT01165684|364941927|FG000|Overall Study|Lack of Efficacy|2|||
105804824|NCT01165684|364941928|FG001|Overall Study|Lack of Efficacy|1|||
105804825|NCT01165684|364941927|FG000|Overall Study|Protocol Violation|7|||
105804826|NCT01165684|364941928|FG001|Overall Study|Protocol Violation|15|||
105804827|NCT01165684|364941927|FG000|Overall Study|Withdrawal Criteria|2|||
105804828|NCT01165684|364941928|FG001|Overall Study|Withdrawal Criteria|13|||
105804829|NCT01165684|364941927|FG000|Overall Study|Unclassified|16|||
105804830|NCT01165684|364941928|FG001|Overall Study|Unclassified|22|||
105804831|NCT03347695|364941929|FG000|Overall Study|Death|0|||
105804832|NCT03347695|364941930|FG001|Overall Study|Death|4|||
105804833|NCT03347695|364941929|FG000|Overall Study|Lost to Follow-up|0|||
105804834|NCT03347695|364941930|FG001|Overall Study|Lost to Follow-up|1|||
105804835|NCT00671879|364941935|FG000|Overall Study|Withdrawal by Subject|0|||
105804836|NCT00671879|364941936|FG001|Overall Study|Withdrawal by Subject|4|||
105804837|NCT00671879|364941937|FG002|Overall Study|Withdrawal by Subject|6|||
105804838|NCT04633837|364941938|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
105804839|NCT04633837|364941939|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
105804840|NCT01886300|364941940|FG000|Overall Study|Trial terminated by sponsor|16|||
105804841|NCT02884206|364941941|FG000|Valsartan Run-in Period|Death|1|||
105804842|NCT02884206|364941942|FG001|Valsartan Run-in Period|Death|0|||
105804843|NCT02884206|364941943|FG002|Valsartan Run-in Period|Death|0|||
105804844|NCT02884206|364941941|FG000|Valsartan Run-in Period|Adverse Event|31|||
105804845|NCT02884206|364941942|FG001|Valsartan Run-in Period|Adverse Event|0|||
105804846|NCT02884206|364941943|FG002|Valsartan Run-in Period|Adverse Event|0|||
105804847|NCT02884206|364941941|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
105804848|NCT02884206|364941942|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
105804849|NCT02884206|364941943|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
105804850|NCT02884206|364941941|FG000|Valsartan Run-in Period|Protocol deviation|4|||
105804851|NCT02884206|364941942|FG001|Valsartan Run-in Period|Protocol deviation|0|||
105804852|NCT02884206|364941943|FG002|Valsartan Run-in Period|Protocol deviation|0|||
105804853|NCT02884206|364941941|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
105804854|NCT02884206|364941942|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
105804855|NCT02884206|364941943|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
105804856|NCT02884206|364941941|FG000|Valsartan Run-in Period|Physician Decision|1|||
105804857|NCT02884206|364941942|FG001|Valsartan Run-in Period|Physician Decision|0|||
105804858|NCT02884206|364941943|FG002|Valsartan Run-in Period|Physician Decision|0|||
105804859|NCT02884206|364941941|FG000|LCZ696 Run-in Period|Adverse Event|38|||
105804860|NCT02884206|364941942|FG001|LCZ696 Run-in Period|Adverse Event|0|||
105804861|NCT02884206|364941943|FG002|LCZ696 Run-in Period|Adverse Event|0|||
105804862|NCT02884206|364941941|FG000|LCZ696 Run-in Period|Death|2|||
105804863|NCT02884206|364941942|FG001|LCZ696 Run-in Period|Death|0|||
105804864|NCT02884206|364941943|FG002|LCZ696 Run-in Period|Death|0|||
105360570|NCT05216835|363326001|FG001|Overall Study|Other|1|||
105804865|NCT02884206|364941941|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
105804866|NCT02884206|364941942|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
105804867|NCT02884206|364941943|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
105804868|NCT02884206|364941941|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
105804869|NCT02884206|364941942|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
105804870|NCT02884206|364941943|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
105804871|NCT02884206|364941941|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
105804872|NCT02884206|364941942|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
105804873|NCT02884206|364941943|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
105804874|NCT02884206|364941941|FG000|LCZ696 Run-in Period|Physician Decision|1|||
105804875|NCT02884206|364941942|FG001|LCZ696 Run-in Period|Physician Decision|0|||
105804876|NCT02884206|364941943|FG002|LCZ696 Run-in Period|Physician Decision|0|||
105804877|NCT02884206|364941941|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
105758495|NCT02394795|364767263|FG000|Overall Study|Lack of Efficacy|181|||
105758496|NCT02394795|364767264|FG001|Overall Study|Lack of Efficacy|211|||
105758497|NCT02394795|364767263|FG000|Overall Study|Death|4|||
105758498|NCT02394795|364767264|FG001|Overall Study|Death|5|||
105758499|NCT02394795|364767263|FG000|Overall Study|Physician Decision|109|||
105758500|NCT02394795|364767264|FG001|Overall Study|Physician Decision|93|||
105758501|NCT01957787|364767266|FG000|Overall Study|Death|18|||
105758502|NCT01957787|364767266|FG000|Overall Study|Lost to Follow-up|3|||
105758503|NCT01957787|364767266|FG000|Overall Study|Withdrawal by Subject|3|||
105758504|NCT01957787|364767266|FG000|Overall Study|Entered Hospice or Similar Program|2|||
105758505|NCT01957787|364767266|FG000|Overall Study|Index Tumor(s) Resected|2|||
105758506|NCT01957787|364767266|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
105758507|NCT01957787|364767266|FG000|Overall Study|Local therapy, not cryoablation|6|||
105758508|NCT03846219|364767270|FG000|Overall Study|Withdrawal by Subject|3|||
105758509|NCT03846219|364767271|FG001|Overall Study|Withdrawal by Subject|2|||
105758510|NCT03846219|364767272|FG002|Overall Study|Withdrawal by Subject|2|||
105758511|NCT03846219|364767270|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
105758512|NCT03846219|364767271|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
105758513|NCT03846219|364767272|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
105758514|NCT03846219|364767270|FG000|Overall Study|Physician Decision|0|||
105758515|NCT03846219|364767271|FG001|Overall Study|Physician Decision|0|||
105758516|NCT03846219|364767272|FG002|Overall Study|Physician Decision|2|||
105758517|NCT02671461|364767277|FG000|Treatment|Adverse Event|0|||
105758518|NCT02671461|364767278|FG001|Treatment|Adverse Event|0|||
105758519|NCT02671461|364767279|FG002|Treatment|Adverse Event|1|||
105758520|NCT02671461|364767277|FG000|Treatment|Administrative Reason by Sponsor|1|||
105758521|NCT02671461|364767278|FG001|Treatment|Administrative Reason by Sponsor|3|||
105758522|NCT02671461|364767279|FG002|Treatment|Administrative Reason by Sponsor|4|||
105758523|NCT02671461|364767277|FG000|Treatment|Randomized, not treated|1|||
105758524|NCT02671461|364767278|FG001|Treatment|Randomized, not treated|0|||
105758525|NCT02671461|364767279|FG002|Treatment|Randomized, not treated|0|||
105758526|NCT02671461|364767277|FG000|Follow-up|Withdrawal by Subject|1|||
105758527|NCT02671461|364767278|FG001|Follow-up|Withdrawal by Subject|0|||
105758528|NCT02671461|364767279|FG002|Follow-up|Withdrawal by Subject|0|||
105758529|NCT02671461|364767277|FG000|Follow-up|Lost to Follow-up|0|||
105758530|NCT02671461|364767278|FG001|Follow-up|Lost to Follow-up|0|||
105758531|NCT02671461|364767279|FG002|Follow-up|Lost to Follow-up|1|||
105758532|NCT02671461|364767277|FG000|Follow-up|Administrative Reason by Sponsor|0|||
105758533|NCT02671461|364767278|FG001|Follow-up|Administrative Reason by Sponsor|1|||
105758534|NCT02671461|364767279|FG002|Follow-up|Administrative Reason by Sponsor|0|||
105758535|NCT01181778|364767280|FG000|Overall Study|Physician Decision|48|||
105758536|NCT01924299|364767283|FG000|Period 2|Withdrawal by Subject|1|||
105758537|NCT01924299|364767284|FG001|Period 2|Withdrawal by Subject|0|||
105758538|NCT01924299|364767283|FG000|Period 2|Adverse Event|0|||
105758539|NCT01924299|364767284|FG001|Period 2|Adverse Event|1|||
105758540|NCT00617656|364767285|FG000|Overall Study|Inclusion error|4|||
105758541|NCT00617656|364767286|FG001|Overall Study|Inclusion error|4|||
105758542|NCT00617656|364767287|FG002|Overall Study|Inclusion error|0|||
105758543|NCT00617656|364767288|FG003|Overall Study|Inclusion error|0|||
105758544|NCT00617656|364767285|FG000|Overall Study|Missing data|44|||
105758545|NCT00617656|364767286|FG001|Overall Study|Missing data|30|||
105758546|NCT00617656|364767287|FG002|Overall Study|Missing data|13|||
105758547|NCT00617656|364767288|FG003|Overall Study|Missing data|6|||
105758548|NCT00617656|364767285|FG000|Overall Study|Withdrawal by Subject|0|||
105758549|NCT00617656|364767286|FG001|Overall Study|Withdrawal by Subject|2|||
105758550|NCT00617656|364767287|FG002|Overall Study|Withdrawal by Subject|0|||
105758551|NCT00617656|364767288|FG003|Overall Study|Withdrawal by Subject|0|||
105758552|NCT02079519|364767289|FG000|Overall Study|Disease Progression|9|||
105758553|NCT02079519|364767289|FG000|Overall Study|Adverse Event|1|||
105758554|NCT05200455|364767290|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
105758555|NCT01602549|364767293|FG000|Overall Study|Protocol Violation|0|||
105758556|NCT01602549|364767294|FG001|Overall Study|Protocol Violation|1|||
105758557|NCT01602549|364767293|FG000|Overall Study|Withdrawal by Subject|1|||
105758558|NCT01602549|364767294|FG001|Overall Study|Withdrawal by Subject|0|||
105758559|NCT03700736|364767295|FG000|Overall Study|Pregnancy|1|||
105758560|NCT03700736|364767296|FG001|Overall Study|Pregnancy|1|||
105758561|NCT03700736|364767295|FG000|Overall Study|Withdrawal by Subject|2|||
105758562|NCT03700736|364767296|FG001|Overall Study|Withdrawal by Subject|6|||
105758563|NCT00642018|364767297|FG000|Overall Study|Adverse Event|11|||
105758564|NCT00642018|364767298|FG001|Overall Study|Adverse Event|36|||
105758565|NCT00642018|364767297|FG000|Overall Study|Withdrawal by Subject|4|||
105758566|NCT00642018|364767298|FG001|Overall Study|Withdrawal by Subject|10|||
105758567|NCT00642018|364767297|FG000|Overall Study|Progressive Disease|13|||
105758568|NCT00642018|364767298|FG001|Overall Study|Progressive Disease|18|||
105758569|NCT00642018|364767297|FG000|Overall Study|Physician Decision|0|||
105758570|NCT00642018|364767298|FG001|Overall Study|Physician Decision|10|||
105758571|NCT00642018|364767297|FG000|Overall Study|Protocol Violation|0|||
105758572|NCT00642018|364767298|FG001|Overall Study|Protocol Violation|1|||
105758573|NCT00642018|364767297|FG000|Overall Study|Death|0|||
105758574|NCT00642018|364767298|FG001|Overall Study|Death|3|||
105758575|NCT00642018|364767297|FG000|Overall Study|Entry Criteria Not Met|0|||
105758576|NCT00642018|364767298|FG001|Overall Study|Entry Criteria Not Met|1|||
105758577|NCT01601704|364769166|FG000|Overall Study|Randomized but not dispensed study med|1|||
105758578|NCT01601704|364769167|FG001|Overall Study|Randomized but not dispensed study med|4|||
105758579|NCT03518034|364769168|FG000|Overall Study|Not Treated|5|||
105758580|NCT03518034|364769169|FG001|Overall Study|Not Treated|1|||
105758581|NCT03518034|364769168|FG000|Overall Study|Withdrawal by Subject|309|||
105758582|NCT03518034|364769169|FG001|Overall Study|Withdrawal by Subject|351|||
105758583|NCT03518034|364769168|FG000|Overall Study|Lost to Follow-up|446|||
105758584|NCT03518034|364769169|FG001|Overall Study|Lost to Follow-up|458|||
105758585|NCT03518034|364769168|FG000|Overall Study|Adverse Event|138|||
105758586|NCT03518034|364769169|FG001|Overall Study|Adverse Event|130|||
105758587|NCT03518034|364769168|FG000|Overall Study|Lack of Efficacy|11|||
105758588|NCT03518034|364769169|FG001|Overall Study|Lack of Efficacy|23|||
105758589|NCT03518034|364769168|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
105758590|NCT03518034|364769169|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
105758591|NCT03518034|364769168|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
105758592|NCT03518034|364769169|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
105758593|NCT03518034|364769168|FG000|Overall Study|Other, Not Specified|84|||
105758594|NCT03518034|364769169|FG001|Overall Study|Other, Not Specified|53|||
105758595|NCT03518034|364769168|FG000|Overall Study|Reason Missing|2|||
105758596|NCT03518034|364769169|FG001|Overall Study|Reason Missing|3|||
105758597|NCT03351478|364769175|FG000|Overall Study|At the subject's own request|11|||
105758598|NCT03351478|364769176|FG001|Overall Study|At the subject's own request|12|||
105758599|NCT03351478|364769177|FG002|Overall Study|At the subject's own request|5|||
105758600|NCT03351478|364769175|FG000|Overall Study|Adverse Event|1|||
105758601|NCT03351478|364769176|FG001|Overall Study|Adverse Event|2|||
105758602|NCT03351478|364769177|FG002|Overall Study|Adverse Event|1|||
105758603|NCT03351478|364769175|FG000|Overall Study|Poor compliance to protocol|1|||
105758604|NCT03351478|364769176|FG001|Overall Study|Poor compliance to protocol|0|||
105758605|NCT03351478|364769177|FG002|Overall Study|Poor compliance to protocol|0|||
105758606|NCT03351478|364769175|FG000|Overall Study|Reason not Specified|1|||
105758607|NCT03351478|364769176|FG001|Overall Study|Reason not Specified|3|||
105758608|NCT03351478|364769177|FG002|Overall Study|Reason not Specified|0|||
105758609|NCT03351478|364769175|FG000|Overall Study|Lost to Follow-up|0|||
105758610|NCT03351478|364769176|FG001|Overall Study|Lost to Follow-up|0|||
105758611|NCT03351478|364769177|FG002|Overall Study|Lost to Follow-up|1|||
105758612|NCT03485222|364769180|FG000|Overall Study|Death|0|||
105758613|NCT03485222|364769181|FG001|Overall Study|Death|1|||
105758614|NCT03485222|364769180|FG000|Overall Study|Lost to Follow-up|2|||
105758615|NCT03485222|364769181|FG001|Overall Study|Lost to Follow-up|1|||
105758616|NCT03657810|364769182|FG000|Overall Study|Adverse Event|0|||
105758617|NCT03657810|364769183|FG001|Overall Study|Adverse Event|1|||
105758618|NCT03657810|364769184|FG002|Overall Study|Adverse Event|0|||
105758619|NCT03657810|364769182|FG000|Overall Study|Lack of Efficacy|4|||
105758620|NCT03657810|364769183|FG001|Overall Study|Lack of Efficacy|1|||
105758621|NCT03657810|364769184|FG002|Overall Study|Lack of Efficacy|3|||
105758622|NCT03657810|364769182|FG000|Overall Study|Protocol Violation|1|||
105758623|NCT03657810|364769183|FG001|Overall Study|Protocol Violation|0|||
105758624|NCT03657810|364769184|FG002|Overall Study|Protocol Violation|0|||
105758625|NCT03657810|364769182|FG000|Overall Study|Lost to Follow-up|0|||
105758626|NCT03657810|364769183|FG001|Overall Study|Lost to Follow-up|1|||
105758627|NCT03657810|364769184|FG002|Overall Study|Lost to Follow-up|0|||
105758628|NCT03657810|364769182|FG000|Overall Study|Not provided|0|||
105758629|NCT03657810|364769183|FG001|Overall Study|Not provided|1|||
105758630|NCT03657810|364769184|FG002|Overall Study|Not provided|0|||
105758631|NCT00688545|364769185|FG000|Overall Study|Lost to Follow-up|1|||
105758632|NCT00688545|364769186|FG001|Overall Study|Lost to Follow-up|4|||
105758633|NCT00688545|364769185|FG000|Overall Study|Insurance/cost of drug|0|||
105758634|NCT00688545|364769186|FG001|Overall Study|Insurance/cost of drug|1|||
105758635|NCT00688545|364769185|FG000|Overall Study|Withdrawal by Subject|2|||
105758636|NCT00688545|364769186|FG001|Overall Study|Withdrawal by Subject|3|||
105758637|NCT00688545|364769185|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
105758638|NCT00688545|364769186|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
105758639|NCT03911869|364769187|FG000|Safety Lead-in Phase|Death|7|||
105758640|NCT03911869|364769188|FG001|Safety Lead-in Phase|Death|0|||
105758641|NCT03911869|364769189|FG002|Safety Lead-in Phase|Death|0|||
105568670|NCT02508532|364081260|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
105758642|NCT03911869|364769187|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
105758643|NCT03911869|364769188|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
105758644|NCT03911869|364769189|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
105758645|NCT03911869|364769187|FG000|Safety Lead-in Phase|Other|1|||
105758646|NCT03911869|364769188|FG001|Safety Lead-in Phase|Other|0|||
105758647|NCT03911869|364769189|FG002|Safety Lead-in Phase|Other|0|||
105758648|NCT03911869|364769187|FG000|Phase 2|Death|0|||
105758649|NCT03911869|364769188|FG001|Phase 2|Death|3|||
105758650|NCT03911869|364769189|FG002|Phase 2|Death|0|||
105758651|NCT01878097|364769190|FG000|Baseline|Surveys not fully completed|2497|||
105758652|NCT01878097|364769191|FG001|Baseline|Surveys not fully completed|1800|||
105758653|NCT01878097|364769190|FG000|Implementation Year 1|Surveys not fully completed|3202|||
105758654|NCT01878097|364769191|FG001|Implementation Year 1|Surveys not fully completed|2549|||
105758655|NCT01878097|364769190|FG000|Implementation Year 2|Surveys not fully completed|3281|||
105758656|NCT01878097|364769191|FG001|Implementation Year 2|Surveys not fully completed|2841|||
105758657|NCT01878097|364769190|FG000|Implementation Year 3|Surveys not fully completed|3494|||
105758658|NCT01878097|364769191|FG001|Implementation Year 3|Surveys not fully completed|2980|||
105758659|NCT01878097|364769190|FG000|Implementation Year 4|Surveys not fully completed|3604|||
105758660|NCT01878097|364769191|FG001|Implementation Year 4|Surveys not fully completed|3007|||
105758661|NCT02580240|364769205|FG000|Overall Study|Physician Decision|2|||
105758662|NCT02580240|364769206|FG001|Overall Study|Physician Decision|0|||
105758663|NCT01527110|364769207|FG000|Overall Study|Adverse Event|1|||
105758664|NCT00527072|364769208|FG000|Overall Study|Adverse Event|13|||
105758665|NCT00527072|364769208|FG000|Overall Study|Lack of Efficacy|11|||
105758666|NCT00527072|364769208|FG000|Overall Study|Lost to Follow-up|3|||
105758667|NCT00527072|364769208|FG000|Overall Study|Protocol Violation|2|||
105758668|NCT00527072|364769208|FG000|Overall Study|Withdrawal by Subject|7|||
105758669|NCT01590212|364769209|FG000|Overall Study|Withdrawal by Subject|2|||
105758670|NCT01590212|364769210|FG001|Overall Study|Withdrawal by Subject|2|||
105758671|NCT01590212|364769211|FG002|Overall Study|Withdrawal by Subject|2|||
105758672|NCT01590212|364769209|FG000|Overall Study|Lost to Follow-up|1|||
105758673|NCT01590212|364769210|FG001|Overall Study|Lost to Follow-up|2|||
105758674|NCT01590212|364769211|FG002|Overall Study|Lost to Follow-up|3|||
105758675|NCT01532570|364769214|FG000|Overall Study|Lack of Efficacy|1|||
105758676|NCT01532570|364769215|FG001|Overall Study|Lack of Efficacy|0|||
105758677|NCT01532570|364769216|FG002|Overall Study|Lack of Efficacy|0|||
105758678|NCT01532570|364769217|FG003|Overall Study|Lack of Efficacy|0|||
105758679|NCT01532570|364769214|FG000|Overall Study|Withdrawal by Subject|0|||
105758680|NCT01532570|364769215|FG001|Overall Study|Withdrawal by Subject|1|||
105758681|NCT01532570|364769216|FG002|Overall Study|Withdrawal by Subject|0|||
105758682|NCT01532570|364769217|FG003|Overall Study|Withdrawal by Subject|0|||
105758683|NCT05552859|364769220|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
105758684|NCT05552859|364769221|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
105758685|NCT01807949|364769222|FG000|Overall Study|Adverse Event|1|||
105758686|NCT01807949|364769223|FG001|Overall Study|Adverse Event|2|||
105758687|NCT01807949|364769224|FG002|Overall Study|Adverse Event|2|||
105758688|NCT01807949|364769222|FG000|Overall Study|Withdrawal by Subject|1|||
105758689|NCT01807949|364769223|FG001|Overall Study|Withdrawal by Subject|2|||
105758690|NCT01807949|364769224|FG002|Overall Study|Withdrawal by Subject|2|||
105758691|NCT01807949|364769222|FG000|Overall Study|Non-Compliance|0|||
105758692|NCT01807949|364769223|FG001|Overall Study|Non-Compliance|0|||
105758693|NCT01807949|364769224|FG002|Overall Study|Non-Compliance|1|||
105758694|NCT01807949|364769222|FG000|Overall Study|Undefined|0|||
105758695|NCT01807949|364769223|FG001|Overall Study|Undefined|1|||
105758696|NCT01807949|364769224|FG002|Overall Study|Undefined|2|||
105758697|NCT01807949|364769222|FG000|Overall Study|Randomized But Not Treated|0|||
105758698|NCT01807949|364769223|FG001|Overall Study|Randomized But Not Treated|2|||
105758699|NCT01807949|364769224|FG002|Overall Study|Randomized But Not Treated|2|||
105758700|NCT01306032|364769225|FG000|First Intervention|Adverse Event|1|||
105758701|NCT01306032|364769226|FG001|First Intervention|Adverse Event|0|||
105758702|NCT01306032|364769227|FG002|First Intervention|Adverse Event|1|||
105758703|NCT01306032|364769228|FG003|First Intervention|Adverse Event|0|||
105758704|NCT01306032|364769229|FG004|First Intervention|Adverse Event|0|||
105758705|NCT01306032|364769230|FG005|First Intervention|Adverse Event|1|||
105758706|NCT01306032|364769225|FG000|First Intervention|Withdrawal by Subject|0|||
105758707|NCT01306032|364769226|FG001|First Intervention|Withdrawal by Subject|2|||
105758708|NCT01306032|364769227|FG002|First Intervention|Withdrawal by Subject|0|||
105758709|NCT01306032|364769228|FG003|First Intervention|Withdrawal by Subject|1|||
105758710|NCT01306032|364769229|FG004|First Intervention|Withdrawal by Subject|0|||
105758711|NCT01306032|364769230|FG005|First Intervention|Withdrawal by Subject|0|||
105758712|NCT01306032|364769225|FG000|First Intervention|Death|0|||
105758713|NCT01306032|364769226|FG001|First Intervention|Death|0|||
105758714|NCT01306032|364769227|FG002|First Intervention|Death|1|||
105758715|NCT01306032|364769228|FG003|First Intervention|Death|0|||
105758716|NCT01306032|364769229|FG004|First Intervention|Death|0|||
105758717|NCT01306032|364769230|FG005|First Intervention|Death|0|||
105758718|NCT01306032|364769225|FG000|First Intervention|Ineligible|0|||
105758719|NCT01306032|364769226|FG001|First Intervention|Ineligible|0|||
105758720|NCT01306032|364769227|FG002|First Intervention|Ineligible|0|||
105758721|NCT01306032|364769228|FG003|First Intervention|Ineligible|0|||
105758722|NCT01306032|364769229|FG004|First Intervention|Ineligible|0|||
105758723|NCT01306032|364769230|FG005|First Intervention|Ineligible|1|||
105758724|NCT01306032|364769225|FG000|First Intervention|Progressive disease|0|||
105758725|NCT01306032|364769226|FG001|First Intervention|Progressive disease|0|||
105758726|NCT01306032|364769227|FG002|First Intervention|Progressive disease|0|||
105758727|NCT01306032|364769228|FG003|First Intervention|Progressive disease|0|||
105758728|NCT01306032|364769229|FG004|First Intervention|Progressive disease|2|||
105758729|NCT01306032|364769230|FG005|First Intervention|Progressive disease|0|||
105758730|NCT01306032|364769225|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
105758731|NCT01306032|364769226|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
105758732|NCT01306032|364769227|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
105758733|NCT01306032|364769228|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
105758734|NCT01306032|364769229|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
105758735|NCT01306032|364769230|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
105758736|NCT01306032|364769225|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
105758737|NCT01306032|364769226|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
105758738|NCT01306032|364769227|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
105758739|NCT01306032|364769228|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
105758740|NCT01306032|364769229|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
105758741|NCT01306032|364769230|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
105758742|NCT04992546|364769231|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
105758743|NCT04992546|364769231|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
105758744|NCT04992546|364769231|FG000|Open-Label Treatment Period|Adverse Event|3|||
105758745|NCT04992546|364769231|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
105758746|NCT00555568|364769232|FG000|Overall Study|Lost to Follow-up|26|||
105758747|NCT00555568|364769233|FG001|Overall Study|Lost to Follow-up|16|||
105758748|NCT00555568|364769234|FG002|Overall Study|Lost to Follow-up|16|||
105758749|NCT00064077|364769235|FG000|Overall Study|Improper prior treatment|1|||
105758750|NCT00064077|364769236|FG001|Overall Study|Improper prior treatment|0|||
105758751|NCT00064077|364769237|FG002|Overall Study|Improper prior treatment|0|||
105758752|NCT00064077|364769238|FG003|Overall Study|Improper prior treatment|0|||
105758753|NCT00064077|364769235|FG000|Overall Study|Poor risk|2|||
105758754|NCT00064077|364769236|FG001|Overall Study|Poor risk|0|||
105758755|NCT00064077|364769237|FG002|Overall Study|Poor risk|1|||
105758756|NCT00064077|364769238|FG003|Overall Study|Poor risk|1|||
105758757|NCT00064077|364769235|FG000|Overall Study|Pathology|10|||
105758758|NCT00064077|364769236|FG001|Overall Study|Pathology|7|||
105758759|NCT00064077|364769237|FG002|Overall Study|Pathology|3|||
105758760|NCT00064077|364769238|FG003|Overall Study|Pathology|4|||
105758761|NCT00064077|364769235|FG000|Overall Study|No surgery|0|||
105758762|NCT00064077|364769236|FG001|Overall Study|No surgery|0|||
105758763|NCT00064077|364769237|FG002|Overall Study|No surgery|1|||
105758764|NCT00064077|364769238|FG003|Overall Study|No surgery|0|||
105758765|NCT00064077|364769235|FG000|Overall Study|No tumor|0|||
105758766|NCT00064077|364769236|FG001|Overall Study|No tumor|0|||
105758767|NCT00064077|364769237|FG002|Overall Study|No tumor|1|||
105758768|NCT00064077|364769238|FG003|Overall Study|No tumor|0|||
105804878|NCT02884206|364941942|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
105758769|NCT00064077|364769235|FG000|Overall Study|Other reasons|2|||
105758770|NCT00064077|364769236|FG001|Overall Study|Other reasons|2|||
105758771|NCT00064077|364769237|FG002|Overall Study|Other reasons|1|||
105758772|NCT00064077|364769238|FG003|Overall Study|Other reasons|2|||
105758773|NCT00067470|364769239|FG000|Overall Study|Withdrawal by Subject|0|||
105758774|NCT00067470|364769240|FG001|Overall Study|Withdrawal by Subject|1|||
105758775|NCT01170221|364769246|FG000|Overall Study|Lost to Follow-up|22|||
105758776|NCT01170221|364769247|FG001|Overall Study|Lost to Follow-up|21|||
105758777|NCT01170221|364769246|FG000|Overall Study|Withdrawal by Subject|9|||
105758778|NCT01170221|364769247|FG001|Overall Study|Withdrawal by Subject|7|||
105758779|NCT01170221|364769246|FG000|Overall Study|Subject completed only screening and LFU|1|||
105758780|NCT01170221|364769247|FG001|Overall Study|Subject completed only screening and LFU|0|||
105758781|NCT01170221|364769246|FG000|Overall Study|Randomized but not treated|1|||
105758782|NCT01170221|364769247|FG001|Overall Study|Randomized but not treated|0|||
105758783|NCT02693691|364769248|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
105758784|NCT02693691|364769248|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
105758785|NCT02693691|364769248|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
105758786|NCT02693691|364769248|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
105758787|NCT02693691|364769248|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
105758788|NCT02693691|364769248|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
105758789|NCT02693691|364769248|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
105758790|NCT00636441|364769253|FG000|Overall Study|Adverse Event|0|||
105758791|NCT00636441|364769254|FG001|Overall Study|Adverse Event|1|||
105758792|NCT00636441|364769255|FG002|Overall Study|Adverse Event|1|||
105758793|NCT00636441|364769256|FG003|Overall Study|Adverse Event|0|||
105758794|NCT00636441|364769257|FG004|Overall Study|Adverse Event|0|||
105758795|NCT00636441|364769258|FG005|Overall Study|Adverse Event|1|||
105758796|NCT00636441|364769259|FG006|Overall Study|Adverse Event|0|||
105758797|NCT00636441|364769253|FG000|Overall Study|Late, ineligible|0|||
105758798|NCT00636441|364769254|FG001|Overall Study|Late, ineligible|0|||
105758799|NCT00636441|364769255|FG002|Overall Study|Late, ineligible|0|||
105758800|NCT00636441|364769256|FG003|Overall Study|Late, ineligible|0|||
105758801|NCT00636441|364769257|FG004|Overall Study|Late, ineligible|0|||
105758802|NCT00636441|364769258|FG005|Overall Study|Late, ineligible|0|||
105758803|NCT00636441|364769259|FG006|Overall Study|Late, ineligible|1|||
105758804|NCT00636441|364769253|FG000|Overall Study|Screen Failure|0|||
105758805|NCT00636441|364769254|FG001|Overall Study|Screen Failure|0|||
105758806|NCT00636441|364769255|FG002|Overall Study|Screen Failure|0|||
105758807|NCT00636441|364769256|FG003|Overall Study|Screen Failure|0|||
105758808|NCT00636441|364769257|FG004|Overall Study|Screen Failure|0|||
105758809|NCT00636441|364769258|FG005|Overall Study|Screen Failure|0|||
105758810|NCT00636441|364769259|FG006|Overall Study|Screen Failure|17|||
105758811|NCT01162304|364769261|FG000|Overall Study|Beck scale to high|11|||
105758812|NCT01192204|364769262|FG000|Overall Study|could not keep recall appointments|1|||
105758813|NCT01192204|364769263|FG001|Overall Study|could not keep recall appointments|0|||
105758814|NCT03379376|364769264|FG000|Overall Study|Lost to Follow-up|2|||
105758815|NCT03379376|364769264|FG000|Overall Study|Did not wish to complete follow up|1|||
105758816|NCT03379376|364769264|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
105758817|NCT03379376|364769264|FG000|Overall Study|Death|1|||
105758818|NCT00729326|364769265|FG000|Overall Study|Lost to Follow-up|2|||
105758819|NCT00729326|364769266|FG001|Overall Study|Lost to Follow-up|0|||
105758820|NCT00729326|364769265|FG000|Overall Study|Physician Decision|0|||
105758821|NCT00729326|364769266|FG001|Overall Study|Physician Decision|1|||
105758822|NCT00729326|364769265|FG000|Overall Study|Protocol Violation|3|||
105758823|NCT00729326|364769266|FG001|Overall Study|Protocol Violation|2|||
105758824|NCT00729326|364769265|FG000|Overall Study|Subject Decision|4|||
105758825|NCT00729326|364769266|FG001|Overall Study|Subject Decision|4|||
105758826|NCT00729326|364769265|FG000|Overall Study|Sponsor Decision|1|||
105758827|NCT00729326|364769266|FG001|Overall Study|Sponsor Decision|2|||
105758828|NCT02247401|364769267|FG000|Overall Study|Adverse Event|1|||
105758829|NCT02247401|364769268|FG001|Overall Study|Adverse Event|0|||
105758830|NCT02247401|364769269|FG002|Overall Study|Adverse Event|0|||
105758831|NCT02247401|364769267|FG000|Overall Study|Withdrawal by Subject|4|||
105758832|NCT02247401|364769268|FG001|Overall Study|Withdrawal by Subject|1|||
105758833|NCT02247401|364769269|FG002|Overall Study|Withdrawal by Subject|1|||
105758834|NCT02247401|364769267|FG000|Overall Study|Lost to Follow-up|1|||
105758835|NCT02247401|364769268|FG001|Overall Study|Lost to Follow-up|1|||
105758836|NCT02247401|364769269|FG002|Overall Study|Lost to Follow-up|1|||
105758837|NCT04169061|364769274|FG000|Overall Study|Adverse Event|2|||
105758838|NCT04169061|364769274|FG000|Overall Study|Death|1|||
105758839|NCT04169061|364769274|FG000|Overall Study|Withdrawal by Subject|1|||
105758840|NCT04169061|364769274|FG000|Overall Study|Protocol Violation|1|||
105758841|NCT04585451|364769275|FG000|Overall Study|Withdrawal by Subject|26|||
105758842|NCT04585451|364769276|FG001|Overall Study|Withdrawal by Subject|0|||
105758843|NCT05425719|364769279|FG000|Overall Study|Lost to Follow-up|4|||
105758844|NCT05425719|364769280|FG001|Overall Study|Lost to Follow-up|0|||
105758845|NCT05425719|364769279|FG000|Overall Study|Withdrew consent|1|||
105758846|NCT05425719|364769280|FG001|Overall Study|Withdrew consent|1|||
105758847|NCT02193828|364769283|FG000|Overall Study|Withdrawal by Subject|0|||
105758848|NCT02193828|364769284|FG001|Overall Study|Withdrawal by Subject|0|||
105758849|NCT02193828|364769285|FG002|Overall Study|Withdrawal by Subject|1|||
105758850|NCT02193828|364769286|FG003|Overall Study|Withdrawal by Subject|1|||
105758851|NCT04377672|364769287|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
105758852|NCT03954444|364769288|FG000|Overall Study|Withdrawal by Subject|5|||
105758853|NCT03954444|364769289|FG001|Overall Study|Withdrawal by Subject|5|||
105758854|NCT03954444|364769290|FG002|Overall Study|Withdrawal by Subject|5|||
105758855|NCT03954444|364769288|FG000|Overall Study|Adverse Event|1|||
105758856|NCT03954444|364769289|FG001|Overall Study|Adverse Event|3|||
105758857|NCT03954444|364769290|FG002|Overall Study|Adverse Event|2|||
105804879|NCT02884206|364941943|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
105804880|NCT02884206|364941941|FG000|Double-Blind Period|Death|0|||
105804881|NCT02884206|364941942|FG001|Double-Blind Period|Death|28|||
105804882|NCT02884206|364941943|FG002|Double-Blind Period|Death|39|||
105804883|NCT02884206|364941941|FG000|Double-Blind Period|Patient/guardian decision|0|||
105804884|NCT02884206|364941942|FG001|Double-Blind Period|Patient/guardian decision|10|||
105804885|NCT02884206|364941943|FG002|Double-Blind Period|Patient/guardian decision|13|||
105804886|NCT02884206|364941941|FG000|Double-Blind Period|Lost to Follow-up|0|||
105804887|NCT02884206|364941942|FG001|Double-Blind Period|Lost to Follow-up|4|||
105804888|NCT02884206|364941943|FG002|Double-Blind Period|Lost to Follow-up|4|||
105804889|NCT02884206|364941941|FG000|Double-Blind Period|Physician Decision|0|||
105758858|NCT03954444|364769288|FG000|Overall Study|Protocol Violation|0|||
105758859|NCT03954444|364769289|FG001|Overall Study|Protocol Violation|3|||
105758860|NCT03954444|364769290|FG002|Overall Study|Protocol Violation|5|||
105758861|NCT03954444|364769288|FG000|Overall Study|Use of prohibited therapy|1|||
105758862|NCT03954444|364769289|FG001|Overall Study|Use of prohibited therapy|1|||
105758863|NCT03954444|364769290|FG002|Overall Study|Use of prohibited therapy|2|||
105758864|NCT03954444|364769288|FG000|Overall Study|Lost to Follow-up|1|||
105758865|NCT03954444|364769289|FG001|Overall Study|Lost to Follow-up|0|||
105758866|NCT03954444|364769290|FG002|Overall Study|Lost to Follow-up|1|||
105758867|NCT03954444|364769288|FG000|Overall Study|Non-compliant with study drug application|2|||
105758868|NCT03954444|364769289|FG001|Overall Study|Non-compliant with study drug application|2|||
105758869|NCT03954444|364769290|FG002|Overall Study|Non-compliant with study drug application|0|||
105758870|NCT03954444|364769288|FG000|Overall Study|Administrative reasons|0|||
105758871|NCT03954444|364769289|FG001|Overall Study|Administrative reasons|0|||
105758872|NCT03954444|364769290|FG002|Overall Study|Administrative reasons|1|||
105758873|NCT03954444|364769288|FG000|Overall Study|Miscellaneous|3|||
105758874|NCT03954444|364769289|FG001|Overall Study|Miscellaneous|2|||
105758875|NCT03954444|364769290|FG002|Overall Study|Miscellaneous|1|||
105758876|NCT02447458|364769293|FG000|Overall Study|Other|0|||
105758877|NCT02447458|364769294|FG001|Overall Study|Other|0|||
105758878|NCT02447458|364769295|FG002|Overall Study|Other|1|||
105758879|NCT02447458|364769296|FG003|Overall Study|Other|0|||
105758880|NCT02447458|364769297|FG004|Overall Study|Other|0|||
105758881|NCT02447458|364769298|FG005|Overall Study|Other|0|||
105758882|NCT02472795|364769302|FG000|Overall Study|Adverse Event|0|||
105758883|NCT02472795|364769303|FG001|Overall Study|Adverse Event|1|||
105758884|NCT02472795|364769304|FG002|Overall Study|Adverse Event|0|||
105758885|NCT02472795|364769305|FG003|Overall Study|Adverse Event|0|||
105758886|NCT02472795|364769306|FG004|Overall Study|Adverse Event|2|||
105758887|NCT02472795|364769302|FG000|Overall Study|Withdrawal by Subject|0|||
105758888|NCT02472795|364769303|FG001|Overall Study|Withdrawal by Subject|0|||
105758889|NCT02472795|364769304|FG002|Overall Study|Withdrawal by Subject|0|||
105758890|NCT02472795|364769305|FG003|Overall Study|Withdrawal by Subject|0|||
105758891|NCT02472795|364769306|FG004|Overall Study|Withdrawal by Subject|1|||
105758892|NCT01392378|364769307|FG000|Infant Series|Adverse Event|0|||
105758893|NCT01392378|364769308|FG001|Infant Series|Adverse Event|0|||
105758894|NCT01392378|364769309|FG002|Infant Series|Adverse Event|0|||
105758895|NCT01392378|364769310|FG003|Infant Series|Adverse Event|1|||
105758896|NCT01392378|364769311|FG004|Infant Series|Adverse Event|0|||
105758897|NCT01392378|364769307|FG000|Infant Series|Lost to Follow-up|0|||
105758898|NCT01392378|364769308|FG001|Infant Series|Lost to Follow-up|0|||
105758899|NCT01392378|364769309|FG002|Infant Series|Lost to Follow-up|0|||
105758900|NCT01392378|364769310|FG003|Infant Series|Lost to Follow-up|1|||
105758901|NCT01392378|364769311|FG004|Infant Series|Lost to Follow-up|0|||
105758902|NCT01392378|364769307|FG000|Infant Series|Protocol Violation|0|||
105758903|NCT01392378|364769308|FG001|Infant Series|Protocol Violation|1|||
105758904|NCT01392378|364769309|FG002|Infant Series|Protocol Violation|0|||
105758905|NCT01392378|364769310|FG003|Infant Series|Protocol Violation|0|||
105758906|NCT01392378|364769311|FG004|Infant Series|Protocol Violation|0|||
105758907|NCT01392378|364769307|FG000|Infant Series|Withdrawal by Parent|4|||
105758908|NCT01392378|364769308|FG001|Infant Series|Withdrawal by Parent|1|||
105804890|NCT02884206|364941942|FG001|Double-Blind Period|Physician Decision|2|||
105758909|NCT01392378|364769309|FG002|Infant Series|Withdrawal by Parent|0|||
105758910|NCT01392378|364769310|FG003|Infant Series|Withdrawal by Parent|0|||
105804891|NCT02884206|364941943|FG002|Double-Blind Period|Physician Decision|0|||
105804892|NCT02884206|364941941|FG000|Double-Blind Period|Adverse Event|0|||
105758911|NCT01392378|364769311|FG004|Infant Series|Withdrawal by Parent|0|||
105758912|NCT01392378|364769307|FG000|After Infant Series|Lost to Follow-up|0|||
105758913|NCT01392378|364769308|FG001|After Infant Series|Lost to Follow-up|0|||
105758914|NCT01392378|364769309|FG002|After Infant Series|Lost to Follow-up|1|||
105758915|NCT01392378|364769310|FG003|After Infant Series|Lost to Follow-up|0|||
105758916|NCT01392378|364769311|FG004|After Infant Series|Lost to Follow-up|0|||
105758917|NCT01392378|364769307|FG000|After Infant Series|Withdrawal by Parent|0|||
105758918|NCT01392378|364769308|FG001|After Infant Series|Withdrawal by Parent|1|||
105758919|NCT01392378|364769309|FG002|After Infant Series|Withdrawal by Parent|1|||
105758920|NCT01392378|364769310|FG003|After Infant Series|Withdrawal by Parent|0|||
105758921|NCT01392378|364769311|FG004|After Infant Series|Withdrawal by Parent|1|||
105758922|NCT01392378|364769307|FG000|Toddler Dose|Lost to Follow-up|0|||
105758923|NCT01392378|364769308|FG001|Toddler Dose|Lost to Follow-up|0|||
105758924|NCT01392378|364769309|FG002|Toddler Dose|Lost to Follow-up|0|||
105758925|NCT01392378|364769310|FG003|Toddler Dose|Lost to Follow-up|1|||
105758926|NCT01392378|364769311|FG004|Toddler Dose|Lost to Follow-up|0|||
105758927|NCT01392378|364769307|FG000|Toddler Dose|Withdrawal by Parent|0|||
105758928|NCT01392378|364769308|FG001|Toddler Dose|Withdrawal by Parent|1|||
105758929|NCT01392378|364769309|FG002|Toddler Dose|Withdrawal by Parent|0|||
105758930|NCT01392378|364769310|FG003|Toddler Dose|Withdrawal by Parent|1|||
105758931|NCT01392378|364769311|FG004|Toddler Dose|Withdrawal by Parent|1|||
105758932|NCT02322411|364769314|FG000|Overall Study|Lost to Follow-up|4|||
105758933|NCT02322411|364769315|FG001|Overall Study|Lost to Follow-up|7|||
105758934|NCT02322411|364769314|FG000|Overall Study|Withdrawal by Subject|1|||
105758935|NCT02322411|364769315|FG001|Overall Study|Withdrawal by Subject|0|||
105758936|NCT01419080|364769319|FG000|Overall Study|Withdrawal by Subject|75|||
105758937|NCT01419080|364769319|FG000|Overall Study|Death|30|||
105758938|NCT01419080|364769319|FG000|Overall Study|Lost to Follow-up|23|||
105758939|NCT01419080|364769319|FG000|Overall Study|Too Ill|3|||
105758940|NCT01998880|364769320|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
105758941|NCT01998880|364769321|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
105758942|NCT01998880|364769320|FG000|Overall Study|Disease Progression|1|||
105758943|NCT01998880|364769321|FG001|Overall Study|Disease Progression|8|||
105758944|NCT01998880|364769320|FG000|Overall Study|Withdrew Consent|2|||
105758945|NCT01998880|364769321|FG001|Overall Study|Withdrew Consent|1|||
105758946|NCT01998880|364769320|FG000|Overall Study|Death|3|||
105758947|NCT01998880|364769321|FG001|Overall Study|Death|6|||
105758948|NCT01998880|364769320|FG000|Overall Study|Insufficient Therapeutic Response|1|||
105758949|NCT01998880|364769321|FG001|Overall Study|Insufficient Therapeutic Response|5|||
105758950|NCT01998880|364769320|FG000|Overall Study|Administrative/Other|1|||
105758951|NCT01998880|364769321|FG001|Overall Study|Administrative/Other|1|||
105758952|NCT01998880|364769320|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
105758953|NCT01998880|364769321|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
105758954|NCT01998880|364769320|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
105758955|NCT01998880|364769321|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
105758956|NCT01998880|364769320|FG000|Overall Study|Did Not Receive Treatment|3|||
105758957|NCT01998880|364769321|FG001|Overall Study|Did Not Receive Treatment|2|||
105758958|NCT02248857|364769322|FG000|3 Month|Withdrawal by Subject|9|||
105758959|NCT02248857|364769323|FG001|3 Month|Withdrawal by Subject|3|||
105758960|NCT02248857|364769324|FG002|3 Month|Withdrawal by Subject|4|||
105758961|NCT02248857|364769322|FG000|3 Month|Unable to reach for 3 month|35|||
105758962|NCT02248857|364769323|FG001|3 Month|Unable to reach for 3 month|29|||
105758963|NCT02248857|364769324|FG002|3 Month|Unable to reach for 3 month|26|||
105758964|NCT02248857|364769322|FG000|3 Month|Partially completed, unable to finish|2|||
105758965|NCT02248857|364769323|FG001|3 Month|Partially completed, unable to finish|2|||
105758966|NCT02248857|364769324|FG002|3 Month|Partially completed, unable to finish|1|||
105758967|NCT02248857|364769322|FG000|6 Month|Lost to Follow-up|27|||
105758968|NCT02248857|364769323|FG001|6 Month|Lost to Follow-up|26|||
105758969|NCT02248857|364769324|FG002|6 Month|Lost to Follow-up|15|||
105758970|NCT02248857|364769322|FG000|6 Month|Partially completed, unable to finish|0|||
105758971|NCT02248857|364769323|FG001|6 Month|Partially completed, unable to finish|1|||
105758972|NCT02248857|364769324|FG002|6 Month|Partially completed, unable to finish|0|||
105758973|NCT02248857|364769322|FG000|6 Month|Withdrawal by Subject|0|||
105758974|NCT02248857|364769323|FG001|6 Month|Withdrawal by Subject|2|||
105758975|NCT02248857|364769324|FG002|6 Month|Withdrawal by Subject|2|||
105758976|NCT02248857|364769322|FG000|6 Month|Death|1|||
105758977|NCT02248857|364769323|FG001|6 Month|Death|0|||
105758978|NCT02248857|364769324|FG002|6 Month|Death|0|||
105758979|NCT01575899|364769327|FG000|Overall Study|Lost to Follow-up|3|||
105758980|NCT01575899|364769328|FG001|Overall Study|Lost to Follow-up|4|||
105758981|NCT01575899|364769329|FG002|Overall Study|Lost to Follow-up|2|||
105758982|NCT01575899|364769327|FG000|Overall Study|Protocol Violation|2|||
105758983|NCT01575899|364769328|FG001|Overall Study|Protocol Violation|1|||
105758984|NCT01575899|364769329|FG002|Overall Study|Protocol Violation|0|||
105758985|NCT03136367|364769330|FG000|T1 Consultation|discontinued mistakenly included|2|||
105758986|NCT03136367|364769331|FG001|T1 Consultation|discontinued mistakenly included|6|||
105758987|NCT03136367|364769332|FG002|T1 Consultation|discontinued mistakenly included|1|||
105804893|NCT02884206|364941942|FG001|Double-Blind Period|Adverse Event|0|||
105804894|NCT02884206|364941943|FG002|Double-Blind Period|Adverse Event|3|||
105804895|NCT02884206|364941941|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
105804896|NCT02884206|364941942|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
105804897|NCT02884206|364941943|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
105804898|NCT03907280|364941964|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
105804899|NCT03907280|364941965|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
105804900|NCT03907280|364941966|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
105804901|NCT05751629|364941967|FG000|Overall Study|Withdrawal by Subject|6|||
105804902|NCT05751629|364941967|FG000|Overall Study|Death|25|||
105804903|NCT05751629|364941967|FG000|Overall Study|Study Site Closed|9|||
105804904|NCT05751629|364941967|FG000|Overall Study|Physician Decision|1|||
105804905|NCT01909466|364941968|FG000|Overall Study|Lost to Follow-up|5|||
105804906|NCT01909466|364941969|FG001|Overall Study|Lost to Follow-up|7|||
105804907|NCT01909466|364941968|FG000|Overall Study|Adverse Event|3|||
105804908|NCT01909466|364941969|FG001|Overall Study|Adverse Event|4|||
105804909|NCT01909466|364941968|FG000|Overall Study|Met Withdrawal Criteria|0|||
105804910|NCT01909466|364941969|FG001|Overall Study|Met Withdrawal Criteria|3|||
105804911|NCT01909466|364941968|FG000|Overall Study|Physician Decision|2|||
105804912|NCT01909466|364941969|FG001|Overall Study|Physician Decision|0|||
105804913|NCT01909466|364941968|FG000|Overall Study|Withdrawal by Subject|11|||
105804914|NCT01909466|364941969|FG001|Overall Study|Withdrawal by Subject|9|||
105804915|NCT01909466|364941968|FG000|Overall Study|Lack of Efficacy|1|||
105804916|NCT01909466|364941969|FG001|Overall Study|Lack of Efficacy|0|||
105804917|NCT02231710|364941970|FG000|Overall Study|Physician Decision|1|||
105804918|NCT03487796|364941975|FG000|Overall Study|Lost to Follow-up|18|||
105804919|NCT03487796|364941976|FG001|Overall Study|Lost to Follow-up|6|||
105804920|NCT01894984|364941977|FG000|Overall Study|Other|314|||
105804921|NCT01894984|364941978|FG001|Overall Study|Other|175|||
105804922|NCT02555618|364941979|FG000|Overall Study|Sponsor's Circumstances|1|||
105804923|NCT02555618|364941980|FG001|Overall Study|Sponsor's Circumstances|0|||
105804924|NCT01798485|364941981|FG000|Overall Study|Adverse Event|32|||
105804925|NCT01798485|364941982|FG001|Overall Study|Adverse Event|40|||
105804926|NCT01798485|364941981|FG000|Overall Study|Withdrawal by Subject|27|||
105804927|NCT01798485|364941982|FG001|Overall Study|Withdrawal by Subject|31|||
105804928|NCT01798485|364941981|FG000|Overall Study|Lost to Follow-up|0|||
105804929|NCT01798485|364941982|FG001|Overall Study|Lost to Follow-up|3|||
105804930|NCT01798485|364941981|FG000|Overall Study|Physician Decision|14|||
105804931|NCT01798485|364941982|FG001|Overall Study|Physician Decision|10|||
105804932|NCT01798485|364941981|FG000|Overall Study|Objective Disease Progression|152|||
105804933|NCT01798485|364941982|FG001|Overall Study|Objective Disease Progression|106|||
105804934|NCT01798485|364941981|FG000|Overall Study|Death|25|||
105804935|NCT01798485|364941982|FG001|Overall Study|Death|22|||
105804936|NCT01798485|364941981|FG000|Overall Study|Sponsor Decision|61|||
105804937|NCT01798485|364941982|FG001|Overall Study|Sponsor Decision|54|||
105804938|NCT01798485|364941981|FG000|Overall Study|Clinical Progression|35|||
105804939|NCT01798485|364941982|FG001|Overall Study|Clinical Progression|24|||
105804940|NCT01620489|364941983|FG000|Overall Study|Adverse Event|17|||
105804941|NCT01620489|364941984|FG001|Overall Study|Adverse Event|4|||
105804942|NCT01620489|364941983|FG000|Overall Study|Protocol Violation|0|||
105804943|NCT01620489|364941984|FG001|Overall Study|Protocol Violation|3|||
105804944|NCT01620489|364941983|FG000|Overall Study|Withdrawal Criteria|17|||
105804945|NCT01620489|364941984|FG001|Overall Study|Withdrawal Criteria|25|||
105804946|NCT01620489|364941983|FG000|Overall Study|Unclassified|1|||
105804947|NCT01620489|364941984|FG001|Overall Study|Unclassified|2|||
105804948|NCT01121900|364941985|FG000|First Intervention Period|Adverse Event|1|||
105804949|NCT01121900|364941986|FG001|First Intervention Period|Adverse Event|1|||
105804950|NCT01121900|364941985|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
105804951|NCT01121900|364941986|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105804952|NCT00566709|364941991|FG000|Overall Study|Protocol Violation|5|||
105804953|NCT00566709|364941992|FG001|Overall Study|Protocol Violation|0|||
105758988|NCT03136367|364769330|FG000|T1 Consultation|Discontinued other|0|||
105758989|NCT03136367|364769331|FG001|T1 Consultation|Discontinued other|1|||
105758990|NCT03136367|364769332|FG002|T1 Consultation|Discontinued other|0|||
105758991|NCT03136367|364769330|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
105758992|NCT03136367|364769331|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
105758993|NCT03136367|364769332|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
105758994|NCT03136367|364769330|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
105758995|NCT03136367|364769331|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
105758996|NCT03136367|364769332|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
105758997|NCT03136367|364769330|FG000|T2 Post-consultation|Discontinued other|0|||
105758998|NCT03136367|364769331|FG001|T2 Post-consultation|Discontinued other|2|||
105758999|NCT03136367|364769332|FG002|T2 Post-consultation|Discontinued other|6|||
105759000|NCT03136367|364769330|FG000|T2 Post-consultation|Discontinued transferred care|0|||
105759001|NCT03136367|364769331|FG001|T2 Post-consultation|Discontinued transferred care|0|||
105759002|NCT03136367|364769332|FG002|T2 Post-consultation|Discontinued transferred care|3|||
105759003|NCT03136367|364769330|FG000|T2 Post-consultation|Discontinued lost contact|0|||
105759004|NCT03136367|364769331|FG001|T2 Post-consultation|Discontinued lost contact|1|||
105759005|NCT03136367|364769332|FG002|T2 Post-consultation|Discontinued lost contact|0|||
105759006|NCT03136367|364769330|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
105759007|NCT03136367|364769331|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
105759008|NCT03136367|364769332|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
105759009|NCT03136367|364769330|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
105759010|NCT03136367|364769331|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
105759011|NCT03136367|364769332|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
105759012|NCT03136367|364769330|FG000|T3 1 Week After Surgery|other discontinued|2|||
105759013|NCT03136367|364769331|FG001|T3 1 Week After Surgery|other discontinued|4|||
105759014|NCT03136367|364769332|FG002|T3 1 Week After Surgery|other discontinued|3|||
105759015|NCT03136367|364769330|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
105759016|NCT03136367|364769331|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
105759017|NCT03136367|364769332|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
105759018|NCT03136367|364769330|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
105759019|NCT03136367|364769331|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
105759020|NCT03136367|364769332|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
105759021|NCT03136367|364769330|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
105759022|NCT03136367|364769331|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
105759023|NCT03136367|364769332|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
105759024|NCT03136367|364769330|FG000|T4 12 Weeks After Surgery|Death|0|||
105759025|NCT03136367|364769331|FG001|T4 12 Weeks After Surgery|Death|1|||
105759026|NCT03136367|364769332|FG002|T4 12 Weeks After Surgery|Death|3|||
105759027|NCT03136367|364769330|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
105759028|NCT03136367|364769331|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
105759029|NCT03136367|364769332|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
105759030|NCT03136367|364769330|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
105759031|NCT03136367|364769331|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
105759032|NCT03136367|364769332|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
105759033|NCT03136367|364769330|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
105804954|NCT01626859|364941995|FG000|Overall Study|Adverse Event|1|||
105804955|NCT01626859|364941996|FG001|Overall Study|Adverse Event|3|||
105804956|NCT01626859|364941997|FG002|Overall Study|Adverse Event|2|||
105759034|NCT03136367|364769331|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
105759035|NCT03136367|364769332|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
105759036|NCT03136367|364769330|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
105759037|NCT03136367|364769331|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
105759038|NCT03136367|364769332|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
105804957|NCT01626859|364941995|FG000|Overall Study|Physician Decision|0|||
105759039|NCT03136367|364769330|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
105759040|NCT03136367|364769331|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
105759041|NCT03136367|364769332|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
105759042|NCT03136367|364769330|FG000|T5 1 Year After Surgery|Death|0|||
105759043|NCT03136367|364769331|FG001|T5 1 Year After Surgery|Death|0|||
105759044|NCT03136367|364769332|FG002|T5 1 Year After Surgery|Death|1|||
105759045|NCT03136367|364769330|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
105759046|NCT03136367|364769331|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
105759047|NCT03136367|364769332|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
105759048|NCT03136367|364769330|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
105759049|NCT03136367|364769331|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
105759050|NCT03136367|364769332|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
105759051|NCT03136367|364769330|FG000|T5 1 Year After Surgery|study ended before due|31|||
105759052|NCT03136367|364769331|FG001|T5 1 Year After Surgery|study ended before due|103|||
105759053|NCT03136367|364769332|FG002|T5 1 Year After Surgery|study ended before due|110|||
105759054|NCT03136367|364769330|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
105759055|NCT03136367|364769331|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
105759056|NCT03136367|364769332|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
105759057|NCT01412151|364771493|FG000|Week 0 - 306 - Treatment Period|Death|1|||
105759058|NCT01412151|364771493|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
105759059|NCT01412151|364771493|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
105759060|NCT01412151|364771493|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
105759061|NCT02007252|364771500|FG000|Overall Study|Administrative problems|3|||
105759062|NCT02007252|364771501|FG001|Overall Study|Administrative problems|7|||
105759063|NCT02007252|364771500|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105759064|NCT02007252|364771501|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105759065|NCT02007252|364771500|FG000|Overall Study|Adverse Event|7|||
105759066|NCT02007252|364771501|FG001|Overall Study|Adverse Event|4|||
105759067|NCT04325906|364771502|FG000|Overall Study|Withdrawal by Subject|2|||
105759068|NCT04325906|364771503|FG001|Overall Study|Withdrawal by Subject|0|||
105759069|NCT02137837|364771504|FG000|Overall Study|Adverse Event|0|||
105759070|NCT02137837|364771505|FG001|Overall Study|Adverse Event|2|||
105759071|NCT02137837|364771506|FG002|Overall Study|Adverse Event|1|||
105759072|NCT02137837|364771504|FG000|Overall Study|Refusal unrelated to adverse event|2|||
105759073|NCT02137837|364771505|FG001|Overall Study|Refusal unrelated to adverse event|2|||
105759074|NCT02137837|364771506|FG002|Overall Study|Refusal unrelated to adverse event|1|||
105759075|NCT02137837|364771504|FG000|Overall Study|Progression/relapse|9|||
105759076|NCT02137837|364771505|FG001|Overall Study|Progression/relapse|7|||
105759077|NCT02137837|364771506|FG002|Overall Study|Progression/relapse|7|||
105759078|NCT02137837|364771504|FG000|Overall Study|Not protocol specified|2|||
105759079|NCT02137837|364771505|FG001|Overall Study|Not protocol specified|1|||
105759080|NCT02137837|364771506|FG002|Overall Study|Not protocol specified|3|||
105568671|NCT02508532|364081261|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
105568672|NCT02508532|364081262|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
105804958|NCT01626859|364941996|FG001|Overall Study|Physician Decision|1|||
105360571|NCT05216835|363326002|FG002|Overall Study|Other|0|||
105360572|NCT05216835|363326003|FG003|Overall Study|Other|0|||
105360573|NCT05216835|363326004|FG004|Overall Study|Other|0|||
105360574|NCT05216835|363326005|FG005|Overall Study|Other|0|||
105568673|NCT02508532|364081263|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
105568674|NCT02508532|364081264|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
105568675|NCT02508532|364081256|FG000|Part 2 - Treatment|Disease Progression|0|||
105568676|NCT02508532|364081257|FG001|Part 2 - Treatment|Disease Progression|0|||
105568677|NCT02508532|364081258|FG002|Part 2 - Treatment|Disease Progression|0|||
105568678|NCT02508532|364081259|FG003|Part 2 - Treatment|Disease Progression|0|||
105568679|NCT02508532|364081260|FG004|Part 2 - Treatment|Disease Progression|0|||
105568680|NCT02508532|364081261|FG005|Part 2 - Treatment|Disease Progression|0|||
105568681|NCT02508532|364081262|FG006|Part 2 - Treatment|Disease Progression|0|||
105568682|NCT02508532|364081263|FG007|Part 2 - Treatment|Disease Progression|0|||
105568683|NCT02508532|364081264|FG008|Part 2 - Treatment|Disease Progression|118|||
105568684|NCT02508532|364081256|FG000|Part 2 - Treatment|Adverse Event|0|||
105568685|NCT02508532|364081257|FG001|Part 2 - Treatment|Adverse Event|0|||
105568686|NCT02508532|364081258|FG002|Part 2 - Treatment|Adverse Event|0|||
105568687|NCT02508532|364081259|FG003|Part 2 - Treatment|Adverse Event|0|||
105568688|NCT02508532|364081260|FG004|Part 2 - Treatment|Adverse Event|0|||
105568689|NCT02508532|364081261|FG005|Part 2 - Treatment|Adverse Event|0|||
105568690|NCT02508532|364081262|FG006|Part 2 - Treatment|Adverse Event|0|||
105568691|NCT02508532|364081263|FG007|Part 2 - Treatment|Adverse Event|0|||
105568692|NCT02508532|364081264|FG008|Part 2 - Treatment|Adverse Event|49|||
105568693|NCT02508532|364081256|FG000|Part 2 - Treatment|Physician Decision|0|||
105568694|NCT02508532|364081257|FG001|Part 2 - Treatment|Physician Decision|0|||
105568695|NCT02508532|364081258|FG002|Part 2 - Treatment|Physician Decision|0|||
105568696|NCT02508532|364081259|FG003|Part 2 - Treatment|Physician Decision|0|||
105568697|NCT02508532|364081260|FG004|Part 2 - Treatment|Physician Decision|0|||
105568698|NCT02508532|364081261|FG005|Part 2 - Treatment|Physician Decision|0|||
105759081|NCT02141217|364771507|FG000|Overall Study|Adverse Event|1|||
105759082|NCT02141217|364771508|FG001|Overall Study|Adverse Event|2|||
105759083|NCT02141217|364771507|FG000|Overall Study|Protocol Violation|1|||
105759084|NCT02141217|364771508|FG001|Overall Study|Protocol Violation|4|||
105759085|NCT02141217|364771507|FG000|Overall Study|Withdrawal by Subject|6|||
105759086|NCT02141217|364771508|FG001|Overall Study|Withdrawal by Subject|0|||
105804959|NCT01626859|364941997|FG002|Overall Study|Physician Decision|0|||
105804960|NCT01626859|364941995|FG000|Overall Study|Withdrawal by Subject|1|||
105804961|NCT01626859|364941996|FG001|Overall Study|Withdrawal by Subject|4|||
105804962|NCT01626859|364941997|FG002|Overall Study|Withdrawal by Subject|2|||
105804963|NCT02330081|364941998|FG000|Overall Study|Adverse Event|1|||
105804964|NCT02330081|364941998|FG000|Overall Study|Donation did not meet criteria|1|||
105804965|NCT02330081|364941998|FG000|Overall Study|Protocol Violation|6|||
105804966|NCT01688037|364941999|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
105804967|NCT01688037|364942000|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
105804968|NCT01688037|364942001|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
105804969|NCT01688037|364941999|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
105804970|NCT01688037|364942000|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
105804971|NCT01688037|364942001|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
105804972|NCT01688037|364941999|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
105804973|NCT01688037|364942000|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
105804974|NCT01688037|364942001|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
105804975|NCT01688037|364941999|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
105804976|NCT01688037|364942000|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
105804977|NCT01688037|364942001|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
105804978|NCT01688037|364941999|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
105804979|NCT01688037|364942000|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
105568699|NCT02508532|364081262|FG006|Part 2 - Treatment|Physician Decision|0|||
105568700|NCT02508532|364081263|FG007|Part 2 - Treatment|Physician Decision|0|||
105568701|NCT02508532|364081264|FG008|Part 2 - Treatment|Physician Decision|12|||
105568702|NCT02508532|364081256|FG000|Part 2 - Treatment|Administrative|0|||
105568703|NCT02508532|364081257|FG001|Part 2 - Treatment|Administrative|0|||
105568704|NCT02508532|364081258|FG002|Part 2 - Treatment|Administrative|0|||
105568705|NCT02508532|364081259|FG003|Part 2 - Treatment|Administrative|0|||
105568706|NCT02508532|364081260|FG004|Part 2 - Treatment|Administrative|0|||
105568707|NCT02508532|364081261|FG005|Part 2 - Treatment|Administrative|0|||
105568708|NCT02508532|364081262|FG006|Part 2 - Treatment|Administrative|0|||
105568709|NCT02508532|364081263|FG007|Part 2 - Treatment|Administrative|0|||
105568710|NCT02508532|364081264|FG008|Part 2 - Treatment|Administrative|3|||
105568711|NCT02508532|364081256|FG000|Part 2 - Treatment|Sponsor Decision|0|||
105568712|NCT02508532|364081257|FG001|Part 2 - Treatment|Sponsor Decision|0|||
105568713|NCT02508532|364081258|FG002|Part 2 - Treatment|Sponsor Decision|0|||
105568714|NCT02508532|364081259|FG003|Part 2 - Treatment|Sponsor Decision|0|||
105568715|NCT02508532|364081260|FG004|Part 2 - Treatment|Sponsor Decision|0|||
105568716|NCT02508532|364081261|FG005|Part 2 - Treatment|Sponsor Decision|0|||
105568717|NCT02508532|364081262|FG006|Part 2 - Treatment|Sponsor Decision|0|||
105568718|NCT02508532|364081263|FG007|Part 2 - Treatment|Sponsor Decision|0|||
105568719|NCT02508532|364081264|FG008|Part 2 - Treatment|Sponsor Decision|28|||
105568720|NCT02508532|364081256|FG000|Part 2 - Treatment|Death|0|||
105568721|NCT02508532|364081257|FG001|Part 2 - Treatment|Death|0|||
105568722|NCT02508532|364081258|FG002|Part 2 - Treatment|Death|0|||
105568723|NCT02508532|364081259|FG003|Part 2 - Treatment|Death|0|||
105568724|NCT02508532|364081260|FG004|Part 2 - Treatment|Death|0|||
105568725|NCT02508532|364081261|FG005|Part 2 - Treatment|Death|0|||
105568726|NCT02508532|364081262|FG006|Part 2 - Treatment|Death|0|||
105568727|NCT02508532|364081263|FG007|Part 2 - Treatment|Death|0|||
105568728|NCT02508532|364081264|FG008|Part 2 - Treatment|Death|1|||
105568729|NCT02508532|364081256|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
105568730|NCT02508532|364081257|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
105568731|NCT02508532|364081258|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
105568732|NCT02508532|364081259|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
105568733|NCT02508532|364081260|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
105568734|NCT02508532|364081261|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
105568735|NCT02508532|364081262|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
105568736|NCT02508532|364081263|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
105568737|NCT02508532|364081264|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
105568738|NCT02508532|364081256|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
105568739|NCT02508532|364081257|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
105568740|NCT02508532|364081258|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
105568741|NCT02508532|364081259|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
105568742|NCT02508532|364081260|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
105568743|NCT02508532|364081261|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
105568744|NCT02508532|364081262|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
105568745|NCT02508532|364081263|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
105568746|NCT02508532|364081264|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
105568747|NCT02508532|364081256|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
105568748|NCT02508532|364081257|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
105568749|NCT02508532|364081258|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
105759087|NCT02141217|364771507|FG000|Overall Study|Lost to Follow-up|1|||
105759088|NCT02141217|364771508|FG001|Overall Study|Lost to Follow-up|1|||
105759089|NCT02141217|364771507|FG000|Overall Study|Physician Decision|1|||
105759090|NCT02141217|364771508|FG001|Overall Study|Physician Decision|0|||
105759091|NCT02141217|364771507|FG000|Overall Study|Surgical Intervention|1|||
105759092|NCT02141217|364771508|FG001|Overall Study|Surgical Intervention|1|||
105759093|NCT01181141|364771511|FG000|Overall Study|Adverse Event|2|||
105759094|NCT01181141|364771512|FG001|Overall Study|Adverse Event|1|||
105759095|NCT01181141|364771511|FG000|Overall Study|Lack of Efficacy|1|||
105759096|NCT01181141|364771512|FG001|Overall Study|Lack of Efficacy|0|||
105759097|NCT01181141|364771511|FG000|Overall Study|Lost to Follow-up|1|||
105759098|NCT01181141|364771512|FG001|Overall Study|Lost to Follow-up|1|||
105759099|NCT01181141|364771511|FG000|Overall Study|Physician Decision|2|||
105759100|NCT01181141|364771512|FG001|Overall Study|Physician Decision|0|||
105759101|NCT01181141|364771511|FG000|Overall Study|Protocol Violation|3|||
105759102|NCT01181141|364771512|FG001|Overall Study|Protocol Violation|1|||
105759103|NCT01181141|364771511|FG000|Overall Study|Withdrawal by Subject|3|||
105759104|NCT01181141|364771512|FG001|Overall Study|Withdrawal by Subject|1|||
105759105|NCT02001688|364771513|FG000|Overall Study|Withdrawal by Subject|0|||
105759106|NCT02001688|364771514|FG001|Overall Study|Withdrawal by Subject|0|||
105759107|NCT02001688|364771515|FG002|Overall Study|Withdrawal by Subject|1|||
105568750|NCT02508532|364081259|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
105568751|NCT02508532|364081260|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
105568752|NCT02508532|364081261|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
105568753|NCT02508532|364081262|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
105568754|NCT02508532|364081263|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
105568755|NCT02508532|364081264|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
105568756|NCT02508532|364081256|FG000|Part 1 and Part 2 End of Study|Death|0|||
105759108|NCT02001688|364771513|FG000|Overall Study|Adverse Event|0|||
105568757|NCT02508532|364081257|FG001|Part 1 and Part 2 End of Study|Death|4|||
105759109|NCT02001688|364771514|FG001|Overall Study|Adverse Event|1|||
105759110|NCT02001688|364771515|FG002|Overall Study|Adverse Event|0|||
105759111|NCT02151682|364771518|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
105759112|NCT02151682|364771519|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
105759113|NCT02151682|364771520|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
105759114|NCT02151682|364771521|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
105759115|NCT02151682|364771522|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
105759116|NCT02151682|364771523|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
105759117|NCT02151682|364771518|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
105759118|NCT02151682|364771519|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
105759119|NCT02151682|364771520|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
105759120|NCT02151682|364771521|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
105759121|NCT02151682|364771522|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
105759122|NCT02151682|364771523|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
105759123|NCT02151682|364771518|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
105759124|NCT02151682|364771519|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
105759125|NCT02151682|364771520|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
105759126|NCT02151682|364771521|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
105759127|NCT02151682|364771522|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
105759128|NCT02151682|364771523|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
105759129|NCT02151682|364771518|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
105759130|NCT02151682|364771519|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
105759131|NCT02151682|364771520|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
105759132|NCT02151682|364771521|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
105759133|NCT02151682|364771522|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
105759134|NCT02151682|364771523|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
105759135|NCT02151682|364771518|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
105759136|NCT02151682|364771519|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
105759137|NCT02151682|364771520|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
105759138|NCT02151682|364771521|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
105759139|NCT02151682|364771522|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
105759140|NCT02151682|364771523|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
105759141|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
105759142|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
105759143|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
105759144|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
105759145|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
105759146|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
105759147|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
105759148|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
105759149|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
105759150|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
105759151|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
105759152|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
105759153|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
105759154|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
105759155|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
105759156|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
105759157|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
105759158|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
105759159|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
105759160|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
105759161|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
105759162|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
105759163|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
105759164|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
105759165|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
105759166|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
105759167|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
105759168|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
105759169|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
105759170|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
105759171|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
105759172|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
105759173|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
105759174|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
105759175|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
105759176|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
105759177|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
105759178|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
105759179|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
105759180|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
105759181|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
105759182|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
105759183|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
105759184|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
105759185|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
105759186|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
105759187|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
105759188|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
105759189|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
105759190|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
105759191|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
105759192|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
105759193|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
105759194|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
105759195|NCT02151682|364771518|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
105759196|NCT02151682|364771519|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
105759197|NCT02151682|364771520|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
105759198|NCT02151682|364771521|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
105759199|NCT02151682|364771522|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
105759200|NCT02151682|364771523|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
105759201|NCT02151682|364771518|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
105759202|NCT02151682|364771519|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
105759203|NCT02151682|364771520|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
105759204|NCT02151682|364771521|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
105759205|NCT02151682|364771522|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
105759206|NCT02151682|364771523|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
105759207|NCT02151682|364771518|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
105804980|NCT01688037|364942001|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
105759208|NCT02151682|364771519|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
105759209|NCT02151682|364771520|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
105759210|NCT02151682|364771521|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
105759211|NCT02151682|364771522|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
105759212|NCT02151682|364771523|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
105759213|NCT02151682|364771518|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
105759214|NCT02151682|364771519|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
105759215|NCT02151682|364771520|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
105759216|NCT02151682|364771521|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
105759217|NCT02151682|364771522|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
105759218|NCT02151682|364771523|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
105759219|NCT05441540|364771525|FG000|Overall Study|Withdrawal by Subject|2|||
105759220|NCT00813917|364771526|FG000|Overall Study|Adverse Event|0|||
105759221|NCT00813917|364771527|FG001|Overall Study|Adverse Event|1|||
105759222|NCT00813917|364771526|FG000|Overall Study|Withdrawal by Subject|3|||
105759223|NCT00813917|364771527|FG001|Overall Study|Withdrawal by Subject|4|||
105759224|NCT00813917|364771526|FG000|Overall Study|Lost to Follow-up|3|||
105759225|NCT00813917|364771527|FG001|Overall Study|Lost to Follow-up|1|||
105759226|NCT00168064|364771528|FG000|Overall Study|Adverse Event|26|||
105759227|NCT00168064|364771529|FG001|Overall Study|Adverse Event|22|||
105759228|NCT00168064|364771528|FG000|Overall Study|Withdrawal by Subject|3|||
105759229|NCT00168064|364771529|FG001|Overall Study|Withdrawal by Subject|4|||
105759230|NCT00168064|364771528|FG000|Overall Study|Lack of Efficacy|4|||
105759231|NCT00168064|364771529|FG001|Overall Study|Lack of Efficacy|4|||
105759232|NCT00168064|364771528|FG000|Overall Study|Lost to Follow-up|4|||
105759233|NCT00168064|364771529|FG001|Overall Study|Lost to Follow-up|3|||
105759234|NCT00168064|364771528|FG000|Overall Study|Non-compliance|2|||
105759235|NCT00168064|364771529|FG001|Overall Study|Non-compliance|3|||
105759236|NCT00168064|364771528|FG000|Overall Study|Concurrent Illness|4|||
105759237|NCT00168064|364771529|FG001|Overall Study|Concurrent Illness|3|||
105759238|NCT00168064|364771528|FG000|Overall Study|Subject's Best interest|2|||
105759239|NCT00168064|364771529|FG001|Overall Study|Subject's Best interest|2|||
105759240|NCT00168064|364771528|FG000|Overall Study|Various|4|||
105759241|NCT00168064|364771529|FG001|Overall Study|Various|3|||
105759242|NCT00290589|364771530|FG000|Overall Study|Lost to Follow-up|2|||
105759243|NCT00290589|364771531|FG001|Overall Study|Lost to Follow-up|2|||
105759244|NCT02980692|364771532|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
105759245|NCT02980692|364771533|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
105759246|NCT02980692|364771534|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
105759247|NCT02980692|364771535|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
105759248|NCT02980692|364771536|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
105759249|NCT02980692|364771532|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
105759250|NCT02980692|364771533|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
105804981|NCT01688037|364941999|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
105804982|NCT01688037|364942000|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
105759251|NCT02980692|364771534|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
105804983|NCT01688037|364942001|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
105759252|NCT02980692|364771535|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
105759253|NCT02980692|364771536|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
105759254|NCT02980692|364771532|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
105759255|NCT02980692|364771533|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
105759256|NCT02980692|364771534|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
105759257|NCT02980692|364771535|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
105759258|NCT02980692|364771536|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
105759259|NCT02980692|364771532|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
105759260|NCT02980692|364771533|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
105759261|NCT02980692|364771534|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
105759262|NCT02980692|364771535|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
105759263|NCT02980692|364771536|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
105759264|NCT02980692|364771532|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
105759265|NCT02980692|364771533|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
105759266|NCT02980692|364771534|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
105759267|NCT02980692|364771535|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
105759268|NCT02980692|364771536|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
105759269|NCT02980692|364771532|FG000|Double Blind Placebo Controlled Period|Other|1|||
105759270|NCT02980692|364771533|FG001|Double Blind Placebo Controlled Period|Other|0|||
105759271|NCT02980692|364771534|FG002|Double Blind Placebo Controlled Period|Other|0|||
105759272|NCT02980692|364771535|FG003|Double Blind Placebo Controlled Period|Other|0|||
105759273|NCT02980692|364771536|FG004|Double Blind Placebo Controlled Period|Other|1|||
105759274|NCT02980692|364771532|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
105759275|NCT02980692|364771533|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
105759276|NCT02980692|364771534|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
105759277|NCT02980692|364771535|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
105759278|NCT02980692|364771536|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
105759279|NCT02980692|364771532|FG000|Double-blind Follow-up Period|Adverse Event|0|||
105759280|NCT02980692|364771533|FG001|Double-blind Follow-up Period|Adverse Event|0|||
105759281|NCT02980692|364771534|FG002|Double-blind Follow-up Period|Adverse Event|0|||
105759282|NCT02980692|364771535|FG003|Double-blind Follow-up Period|Adverse Event|1|||
105759283|NCT02980692|364771536|FG004|Double-blind Follow-up Period|Adverse Event|1|||
105759284|NCT02980692|364771532|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
105759285|NCT02980692|364771533|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
105759286|NCT02980692|364771534|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
105759287|NCT02980692|364771535|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
105360575|NCT05216835|363326006|FG006|Overall Study|Other|0|||
105360576|NCT05216835|363326007|FG007|Overall Study|Other|0|||
105360577|NCT00096538|363326008|FG000|Overall Study|Withdrawal by Subject|1|||
105360578|NCT03283930|363326009|FG000|Overall Study|Scheduling conflict|8|||
105360579|NCT03283930|363326010|FG001|Overall Study|Scheduling conflict|10|||
105360580|NCT03283930|363326009|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
105360581|NCT03283930|363326010|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
105360582|NCT03283930|363326009|FG000|Overall Study|Technical software issue|2|||
105360583|NCT03283930|363326010|FG001|Overall Study|Technical software issue|2|||
105360584|NCT05502302|363326013|FG000|Overall Study|Lost to Follow-up|6|||
105360585|NCT05502302|363326013|FG000|Overall Study|Death|2|||
105360586|NCT00571662|363326014|FG000|Overall Study|Withdrawal by Subject|2|||
105360587|NCT00571662|363326014|FG000|Overall Study|psychiatric instability|1|||
105360588|NCT00571662|363326014|FG000|Overall Study|Adverse Event|5|||
105360589|NCT02155985|363326015|FG000|Overall Study|Withdrawal by Subject|0|||
105360590|NCT02155985|363326016|FG001|Overall Study|Withdrawal by Subject|0|||
105759288|NCT02980692|364771536|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
105759289|NCT02980692|364771532|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
105759290|NCT02980692|364771533|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
105759291|NCT02980692|364771534|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
105759292|NCT02980692|364771535|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
105759293|NCT02980692|364771536|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
105759294|NCT02980692|364771532|FG000|Double-blind Follow-up Period|Pregnancy|0|||
105759295|NCT02980692|364771533|FG001|Double-blind Follow-up Period|Pregnancy|0|||
105759296|NCT02980692|364771534|FG002|Double-blind Follow-up Period|Pregnancy|1|||
105759297|NCT02980692|364771535|FG003|Double-blind Follow-up Period|Pregnancy|1|||
105759298|NCT02980692|364771536|FG004|Double-blind Follow-up Period|Pregnancy|0|||
105759299|NCT02980692|364771532|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
105759300|NCT02980692|364771533|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
105759301|NCT02980692|364771534|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
105759302|NCT02980692|364771535|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
105759303|NCT02980692|364771536|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
105759304|NCT02980692|364771532|FG000|Double-blind Follow-up Period|Other|0|||
105759305|NCT02980692|364771533|FG001|Double-blind Follow-up Period|Other|0|||
105759306|NCT02980692|364771534|FG002|Double-blind Follow-up Period|Other|1|||
105759307|NCT02980692|364771535|FG003|Double-blind Follow-up Period|Other|1|||
105759308|NCT02980692|364771536|FG004|Double-blind Follow-up Period|Other|3|||
105759309|NCT01438307|364771539|FG000|Overall Study|Death|1|||
105759310|NCT01438307|364771540|FG001|Overall Study|Death|1|||
105759311|NCT04702984|364771543|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
105759312|NCT03862495|364771549|FG000|Overall Study|Lost to Follow-up|37|||
105759313|NCT03862495|364771550|FG001|Overall Study|Lost to Follow-up|35|||
105759314|NCT00615914|364771551|FG000|Overall Study|Adverse Event|274|||
105759315|NCT00615914|364771551|FG000|Overall Study|Death|20|||
105759316|NCT00615914|364771551|FG000|Overall Study|Lack of Efficacy|59|||
105759317|NCT00615914|364771551|FG000|Overall Study|Lost to Follow-up|187|||
105759318|NCT00615914|364771551|FG000|Overall Study|Withdrawal by Subject|16|||
105759319|NCT00615914|364771551|FG000|Overall Study|Physician Decision|4|||
105759320|NCT00615914|364771551|FG000|Overall Study|No data was collected.|65|||
105759321|NCT00615914|364771551|FG000|Overall Study|No treatment|2|||
105759322|NCT00615914|364771551|FG000|Overall Study|Irregularly enrolled patients|10|||
105759323|NCT01467661|364771552|FG000|Overall Study|Adverse Event|16|||
105759324|NCT01467661|364771552|FG000|Overall Study|Withdrawal by Subject|1|||
105759325|NCT01467661|364771552|FG000|Overall Study|Lack of Efficacy|3|||
105759326|NCT01467661|364771552|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
105759327|NCT03814005|364771555|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
105759328|NCT03814005|364771556|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
105759329|NCT03814005|364771557|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
105759330|NCT03814005|364771555|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
105759331|NCT03814005|364771556|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
105759332|NCT03814005|364771557|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
105759333|NCT03814005|364771555|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
105759334|NCT03814005|364771556|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
105759335|NCT03814005|364771557|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
105759336|NCT03814005|364771555|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
105759337|NCT03814005|364771556|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
105759338|NCT03814005|364771557|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
105759339|NCT03814005|364771555|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
105759340|NCT03814005|364771556|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
105759341|NCT03814005|364771557|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
105759342|NCT03814005|364771555|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
105759343|NCT03814005|364771556|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
105759344|NCT03814005|364771557|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
105759345|NCT03395223|364771558|FG000|Overall Study|Lost to Follow-up|3|||
105759346|NCT03395223|364771558|FG000|Overall Study|Other|1|||
105759347|NCT01409993|364771559|FG000|Overall Study|Adverse Event|4|||
105759348|NCT01409993|364771560|FG001|Overall Study|Adverse Event|4|||
105759349|NCT01409993|364771561|FG002|Overall Study|Adverse Event|3|||
105759350|NCT01409993|364771562|FG003|Overall Study|Adverse Event|1|||
105759351|NCT01409993|364771559|FG000|Overall Study|Withdrawal by Subject|0|||
105759352|NCT01409993|364771560|FG001|Overall Study|Withdrawal by Subject|0|||
105759353|NCT01409993|364771561|FG002|Overall Study|Withdrawal by Subject|0|||
105759354|NCT01409993|364771562|FG003|Overall Study|Withdrawal by Subject|4|||
105759355|NCT01409993|364771559|FG000|Overall Study|Lost to Follow-up|0|||
105759356|NCT01409993|364771560|FG001|Overall Study|Lost to Follow-up|1|||
105759357|NCT01409993|364771561|FG002|Overall Study|Lost to Follow-up|0|||
105759358|NCT01409993|364771562|FG003|Overall Study|Lost to Follow-up|0|||
105759359|NCT01148693|364771567|FG000|Overall Study|Attempts for cannulation were failed|13|||
105759360|NCT01148693|364771568|FG001|Overall Study|Attempts for cannulation were failed|10|||
105759361|NCT01074658|364771569|FG000|Overall Study|No implant attempted|19|||
105759362|NCT01732107|364771572|FG000|Overall Study|Adverse Event|2|||
105759363|NCT01732107|364771572|FG000|Overall Study|Disease Progression|8|||
105759364|NCT01732107|364771572|FG000|Overall Study|Physician Decision|1|||
105759365|NCT01732107|364771572|FG000|Overall Study|Withdrawal by Subject|2|||
105759366|NCT02849626|364771573|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
105759367|NCT02849626|364771574|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
105759368|NCT02849626|364771575|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
105759369|NCT02849626|364771576|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
105759370|NCT02849626|364771573|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
105759371|NCT02849626|364771574|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
105759372|NCT02849626|364771575|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
105759373|NCT02849626|364771576|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
105759374|NCT02849626|364771573|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
105759375|NCT02849626|364771574|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
105759376|NCT02849626|364771575|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
105759377|NCT02849626|364771576|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
105759378|NCT02849626|364771573|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
105759379|NCT02849626|364771574|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
105759380|NCT02849626|364771575|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
105759381|NCT02849626|364771576|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
105759382|NCT02849626|364771573|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
105759383|NCT02849626|364771574|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
105759384|NCT02849626|364771575|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
105759385|NCT02849626|364771576|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
105759386|NCT02849626|364771573|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
105759387|NCT02849626|364771574|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
105759388|NCT02849626|364771575|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
105759389|NCT02849626|364771576|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
105759390|NCT02849626|364771573|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
105759391|NCT02849626|364771574|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
105759392|NCT02849626|364771575|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
105759393|NCT02849626|364771576|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
105759394|NCT02849626|364771573|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
105759395|NCT02849626|364771574|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
105759396|NCT02849626|364771575|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
105759397|NCT02849626|364771576|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
105759398|NCT02849626|364771573|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
105759399|NCT02849626|364771574|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
105759400|NCT02849626|364771575|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
105759401|NCT02849626|364771576|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
105759402|NCT02849626|364771573|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
105759403|NCT02849626|364771574|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
105759404|NCT02849626|364771575|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
105759405|NCT02849626|364771576|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
105759406|NCT02849626|364771573|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
105759407|NCT02849626|364771574|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
105759408|NCT02849626|364771575|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
105759409|NCT02849626|364771576|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
105568758|NCT02508532|364081258|FG002|Part 1 and Part 2 End of Study|Death|2|||
105568759|NCT02508532|364081259|FG003|Part 1 and Part 2 End of Study|Death|4|||
105568760|NCT02508532|364081260|FG004|Part 1 and Part 2 End of Study|Death|3|||
105759410|NCT01185704|364771577|FG000|Overall Study|Randomized but not treated|3|||
105759411|NCT01185704|364771578|FG001|Overall Study|Randomized but not treated|3|||
105759412|NCT01185704|364771577|FG000|Overall Study|Lack of ovarian response|5|||
105759413|NCT01185704|364771578|FG001|Overall Study|Lack of ovarian response|1|||
105759414|NCT01185704|364771577|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
105759415|NCT01185704|364771578|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
105759416|NCT01185704|364771577|FG000|Overall Study|Ectopic pregnancy|0|||
105759417|NCT01185704|364771578|FG001|Overall Study|Ectopic pregnancy|1|||
105759418|NCT01654523|364771579|FG000|Overall Study|Withdrawal by Subject|1|||
105759419|NCT04354155|364771586|FG000|Overall Study|Withdrawal by Subject|1|||
105759420|NCT04354155|364771586|FG000|Overall Study|Did not meet criteria for study intervention|1|||
105759421|NCT00187889|364771587|FG000|Overall Study|Withdrawal by Subject|6|||
105759422|NCT00187889|364771588|FG001|Overall Study|Withdrawal by Subject|4|||
105759423|NCT04046341|364771589|FG000|Overall Study|Lost to Follow-up|2|||
105759424|NCT04046341|364771589|FG000|Overall Study|Withdrawal by Subject|1|||
105759425|NCT02133742|364771590|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
105759426|NCT02133742|364771590|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
105759427|NCT02133742|364771590|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
105759428|NCT02133742|364771590|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
105759429|NCT02133742|364771590|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
105759430|NCT00405652|364771591|FG000|Overall Study|Adverse Event|4|||
105759431|NCT03505749|364771592|FG000|Overall Study|Lost to Follow-up|7|||
105759432|NCT03505749|364771593|FG001|Overall Study|Lost to Follow-up|11|||
105759433|NCT03505749|364771592|FG000|Overall Study|Withdrawal by Subject|6|||
105759434|NCT03505749|364771593|FG001|Overall Study|Withdrawal by Subject|0|||
105759435|NCT03505749|364771592|FG000|Overall Study|Discharged from treatment|3|||
105759436|NCT03505749|364771593|FG001|Overall Study|Discharged from treatment|6|||
105759437|NCT00435994|364771595|FG000|Overall Study|Lost to Follow-up|7|||
105759438|NCT00435994|364771596|FG001|Overall Study|Lost to Follow-up|0|||
105759439|NCT00435994|364771597|FG002|Overall Study|Lost to Follow-up|0|||
105759440|NCT01151540|364771598|FG000|Overall Study|Other|2|||
105759441|NCT01151540|364771598|FG000|Overall Study|Adverse event, non-fatal|4|||
105759442|NCT01151540|364771598|FG000|Overall Study|Withdrawal by Subject|7|||
105759443|NCT02807844|364771601|FG000|Overall Study|Physician Decision|0|||
105759444|NCT02807844|364771602|FG001|Overall Study|Physician Decision|0|||
105759445|NCT02807844|364771603|FG002|Overall Study|Physician Decision|0|||
105759446|NCT02807844|364771604|FG003|Overall Study|Physician Decision|0|||
105759447|NCT02807844|364771605|FG004|Overall Study|Physician Decision|0|||
105759448|NCT02807844|364771606|FG005|Overall Study|Physician Decision|0|||
105759449|NCT02807844|364771607|FG006|Overall Study|Physician Decision|3|||
105759450|NCT02807844|364771608|FG007|Overall Study|Physician Decision|0|||
105759451|NCT02807844|364771609|FG008|Overall Study|Physician Decision|1|||
105759452|NCT02807844|364771610|FG009|Overall Study|Physician Decision|2|||
105759453|NCT02807844|364771601|FG000|Overall Study|Death|0|||
105759454|NCT02807844|364771602|FG001|Overall Study|Death|0|||
105759455|NCT02807844|364771603|FG002|Overall Study|Death|2|||
105759456|NCT02807844|364771604|FG003|Overall Study|Death|4|||
105759457|NCT02807844|364771605|FG004|Overall Study|Death|1|||
105759458|NCT02807844|364771606|FG005|Overall Study|Death|2|||
105759459|NCT02807844|364771607|FG006|Overall Study|Death|1|||
105759460|NCT02807844|364771608|FG007|Overall Study|Death|2|||
105759461|NCT02807844|364771609|FG008|Overall Study|Death|0|||
105759462|NCT02807844|364771610|FG009|Overall Study|Death|1|||
105759463|NCT02807844|364771601|FG000|Overall Study|Withdrawal by Subject|0|||
105759464|NCT02807844|364771602|FG001|Overall Study|Withdrawal by Subject|0|||
105759465|NCT02807844|364771603|FG002|Overall Study|Withdrawal by Subject|2|||
105759466|NCT02807844|364771604|FG003|Overall Study|Withdrawal by Subject|1|||
105804984|NCT01688037|364941999|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
105804985|NCT01688037|364942000|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
105759467|NCT02807844|364771605|FG004|Overall Study|Withdrawal by Subject|1|||
105759468|NCT02807844|364771606|FG005|Overall Study|Withdrawal by Subject|0|||
105759469|NCT02807844|364771607|FG006|Overall Study|Withdrawal by Subject|1|||
105759470|NCT02807844|364771608|FG007|Overall Study|Withdrawal by Subject|0|||
105759471|NCT02807844|364771609|FG008|Overall Study|Withdrawal by Subject|0|||
105759472|NCT02807844|364771610|FG009|Overall Study|Withdrawal by Subject|0|||
105759473|NCT02807844|364771601|FG000|Overall Study|Progressive disease|5|||
105759474|NCT02807844|364771602|FG001|Overall Study|Progressive disease|12|||
105759475|NCT02807844|364771603|FG002|Overall Study|Progressive disease|8|||
105759476|NCT02807844|364771604|FG003|Overall Study|Progressive disease|8|||
105759477|NCT02807844|364771605|FG004|Overall Study|Progressive disease|3|||
105759478|NCT02807844|364771606|FG005|Overall Study|Progressive disease|8|||
105759479|NCT02807844|364771607|FG006|Overall Study|Progressive disease|14|||
105759480|NCT02807844|364771608|FG007|Overall Study|Progressive disease|17|||
105759481|NCT02807844|364771609|FG008|Overall Study|Progressive disease|19|||
105759482|NCT02807844|364771610|FG009|Overall Study|Progressive disease|15|||
105759483|NCT02807844|364771601|FG000|Overall Study|Adverse Event|1|||
105759484|NCT02807844|364771602|FG001|Overall Study|Adverse Event|0|||
105759485|NCT02807844|364771603|FG002|Overall Study|Adverse Event|0|||
105759486|NCT02807844|364771604|FG003|Overall Study|Adverse Event|0|||
105759487|NCT02807844|364771605|FG004|Overall Study|Adverse Event|1|||
105759488|NCT02807844|364771606|FG005|Overall Study|Adverse Event|1|||
105759489|NCT02807844|364771607|FG006|Overall Study|Adverse Event|1|||
105759490|NCT02807844|364771608|FG007|Overall Study|Adverse Event|1|||
105759491|NCT02807844|364771609|FG008|Overall Study|Adverse Event|1|||
105759492|NCT02807844|364771610|FG009|Overall Study|Adverse Event|2|||
105759493|NCT03097029|364771611|FG000|Overall Study|Withdrawal by Subject|1|||
105759494|NCT01412060|364771612|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
105759495|NCT01412060|364771613|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
105759496|NCT01412060|364771614|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
105759497|NCT01412060|364771612|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
105759498|NCT01412060|364771613|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
105759499|NCT01412060|364771614|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
105759500|NCT01412060|364771612|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
105759501|NCT01412060|364771613|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
105759502|NCT01412060|364771614|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
105759503|NCT01412060|364771612|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
105759504|NCT01412060|364771613|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
105759505|NCT01412060|364771614|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
105759506|NCT01412060|364771612|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
105759507|NCT01412060|364771613|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
105759508|NCT01412060|364771614|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
105759509|NCT01412060|364771612|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
105759510|NCT01412060|364771613|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
105759511|NCT01412060|364771614|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
105759512|NCT01412060|364771612|FG000|Period Between RIP and SP|Adverse Event|4|||
105759513|NCT01412060|364771613|FG001|Period Between RIP and SP|Adverse Event|0|||
105759514|NCT01412060|364771614|FG002|Period Between RIP and SP|Adverse Event|0|||
105759515|NCT01412060|364771612|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
105759516|NCT01412060|364771613|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
105759517|NCT01412060|364771614|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
105759518|NCT01412060|364771612|FG000|Period Between RIP and SP|Protocol Violation|2|||
105759519|NCT01412060|364771613|FG001|Period Between RIP and SP|Protocol Violation|0|||
105759520|NCT01412060|364771614|FG002|Period Between RIP and SP|Protocol Violation|0|||
105759521|NCT01412060|364771612|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
105759522|NCT01412060|364771613|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
105759523|NCT01412060|364771614|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
105759524|NCT01412060|364771612|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
105759525|NCT01412060|364771613|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
105759526|NCT01412060|364771614|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
105759527|NCT01412060|364771612|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
105759528|NCT01412060|364771613|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
105759529|NCT01412060|364771614|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
105759530|NCT01412060|364771612|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
105759531|NCT01412060|364771613|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
105759532|NCT01412060|364771614|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
105759533|NCT01412060|364771612|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
105759534|NCT01412060|364771613|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
105759535|NCT01412060|364771614|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
105759536|NCT01412060|364771612|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
105568761|NCT02508532|364081261|FG005|Part 1 and Part 2 End of Study|Death|0|||
105759537|NCT01412060|364771613|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
105759538|NCT01412060|364771614|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
105759539|NCT01412060|364771612|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
105759540|NCT01412060|364771613|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
105759541|NCT01412060|364771614|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
105759542|NCT01412060|364771612|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
105568762|NCT02508532|364081262|FG006|Part 1 and Part 2 End of Study|Death|0|||
105568763|NCT02508532|364081263|FG007|Part 1 and Part 2 End of Study|Death|1|||
105568764|NCT02508532|364081264|FG008|Part 1 and Part 2 End of Study|Death|111|||
105568765|NCT02508532|364081256|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
105568766|NCT02508532|364081257|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
105568767|NCT02508532|364081258|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
105568768|NCT02508532|364081259|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
105568769|NCT02508532|364081260|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
105568770|NCT02508532|364081261|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
105568771|NCT02508532|364081262|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
105568772|NCT02508532|364081263|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
105568773|NCT02508532|364081264|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
105568774|NCT02508532|364081256|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
105568775|NCT02508532|364081257|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
105568776|NCT02508532|364081258|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
105568777|NCT02508532|364081259|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
105568778|NCT02508532|364081260|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
105568779|NCT02508532|364081261|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
105568780|NCT02508532|364081262|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
105568781|NCT02508532|364081263|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
105568782|NCT02508532|364081264|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
105568783|NCT02508532|364081256|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
105568784|NCT02508532|364081257|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
105568785|NCT02508532|364081258|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
105568786|NCT02508532|364081259|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
105568787|NCT02508532|364081260|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
105568788|NCT02508532|364081261|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
105568789|NCT02508532|364081262|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
105568790|NCT02508532|364081263|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
105568791|NCT02508532|364081264|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
105568792|NCT02508532|364081256|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
105568793|NCT02508532|364081257|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
105568794|NCT02508532|364081258|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
105568795|NCT02508532|364081259|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
105568796|NCT02508532|364081260|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
105568797|NCT02508532|364081261|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
105568798|NCT02508532|364081262|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
105568799|NCT02508532|364081263|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
105568800|NCT02508532|364081264|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
105568801|NCT02508532|364081256|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
105568802|NCT02508532|364081257|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
105568803|NCT02508532|364081258|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
105759543|NCT01412060|364771613|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
105759544|NCT01412060|364771614|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
105759545|NCT01412060|364771612|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
105759546|NCT01412060|364771613|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
105759547|NCT01412060|364771614|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
105759548|NCT01412060|364771612|FG000|Period Between SP and DBP|Protocol Violation|2|||
105759549|NCT01412060|364771613|FG001|Period Between SP and DBP|Protocol Violation|0|||
105759550|NCT01412060|364771614|FG002|Period Between SP and DBP|Protocol Violation|0|||
105759551|NCT01412060|364771612|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
105759552|NCT01412060|364771613|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
105759553|NCT01412060|364771614|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
105759554|NCT01412060|364771612|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
105568804|NCT02508532|364081259|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
105568805|NCT02508532|364081260|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
105568806|NCT02508532|364081261|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
105568807|NCT02508532|364081262|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
105568808|NCT02508532|364081263|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
105568809|NCT02508532|364081264|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
105568810|NCT03745222|364081275|FG000|Overall Study|Withdrawal by Subject|0|||
105568811|NCT03745222|364081276|FG001|Overall Study|Withdrawal by Subject|1|||
105568812|NCT03745222|364081277|FG002|Overall Study|Withdrawal by Subject|0|||
105759555|NCT01412060|364771613|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
105568813|NCT00792103|364081278|FG000|Overall Study|Enrolled, not treated|15|||
105568814|NCT00792103|364081278|FG000|Overall Study|Lost to Follow-up|17|||
105759556|NCT01412060|364771614|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
105759557|NCT01412060|364771612|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
105568815|NCT00792103|364081278|FG000|Overall Study|Adverse Event|25|||
105568816|NCT00792103|364081278|FG000|Overall Study|Withdrawal by Subject|52|||
105568817|NCT00792103|364081278|FG000|Overall Study|Protocol Violation|10|||
105568818|NCT00792103|364081278|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
105759558|NCT01412060|364771613|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
105759559|NCT01412060|364771614|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
105759560|NCT01412060|364771612|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
105759561|NCT01412060|364771613|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
105759562|NCT01412060|364771614|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
105759563|NCT01412060|364771612|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
105759564|NCT01412060|364771613|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
105759565|NCT01412060|364771614|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
105759566|NCT01412060|364771612|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
105759567|NCT01412060|364771613|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
105759568|NCT01412060|364771614|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
105759569|NCT01412060|364771612|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
105759570|NCT01412060|364771613|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
105759571|NCT01412060|364771614|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
105759572|NCT01412060|364771612|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
105759573|NCT01412060|364771613|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
105759574|NCT01412060|364771614|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
105759575|NCT01412060|364771612|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
105759576|NCT01412060|364771613|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
105759577|NCT01412060|364771614|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
105759578|NCT01412060|364771612|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
105759579|NCT01412060|364771613|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
105759580|NCT01412060|364771614|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
105804986|NCT01688037|364942001|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
105804987|NCT01688037|364941999|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
105804988|NCT01688037|364942000|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
105568819|NCT01572389|364081279|FG000|Overall Study|Death|1|||
105568820|NCT01572389|364081280|FG001|Overall Study|Death|3|||
105568821|NCT01572389|364081279|FG000|Overall Study|Withdrawal by Subject|14|||
105568822|NCT01572389|364081280|FG001|Overall Study|Withdrawal by Subject|2|||
105568823|NCT01572389|364081279|FG000|Overall Study|Lost to Follow-up|25|||
105568824|NCT01572389|364081280|FG001|Overall Study|Lost to Follow-up|14|||
105568825|NCT01572389|364081279|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
105568826|NCT01572389|364081280|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
105568827|NCT01111838|364081281|FG000|Overall Study|Patient Ineligible|2|||
105568828|NCT01111838|364081281|FG000|Overall Study|Not Treated|3|||
105568829|NCT01111838|364081281|FG000|Overall Study|Clinical deterioration|1|||
105568830|NCT01111838|364081281|FG000|Overall Study|Other Complicating Disease|1|||
105568831|NCT01287520|364081282|FG000|Overall Study|Adverse Event|2|||
105568832|NCT01287520|364081283|FG001|Overall Study|Adverse Event|2|||
105804989|NCT01688037|364942001|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
105568833|NCT01287520|364081284|FG002|Overall Study|Adverse Event|2|||
105568834|NCT01287520|364081285|FG003|Overall Study|Adverse Event|1|||
105568835|NCT01287520|364081286|FG004|Overall Study|Adverse Event|1|||
105568836|NCT01287520|364081287|FG005|Overall Study|Adverse Event|2|||
105759581|NCT00004732|364771617|FG000|Overall Study|Withdrawal by Subject|36|||
105759582|NCT00004732|364771618|FG001|Overall Study|Withdrawal by Subject|64|||
105568837|NCT01287520|364081288|FG006|Overall Study|Adverse Event|0|||
105568838|NCT01287520|364081289|FG007|Overall Study|Adverse Event|2|||
105568839|NCT01287520|364081290|FG008|Overall Study|Adverse Event|0|||
105568840|NCT01287520|364081282|FG000|Overall Study|Physician Decision|1|||
105568841|NCT01287520|364081283|FG001|Overall Study|Physician Decision|1|||
105568842|NCT01287520|364081284|FG002|Overall Study|Physician Decision|2|||
105568843|NCT01287520|364081285|FG003|Overall Study|Physician Decision|0|||
105568844|NCT01287520|364081286|FG004|Overall Study|Physician Decision|1|||
105568845|NCT01287520|364081287|FG005|Overall Study|Physician Decision|1|||
105568846|NCT01287520|364081288|FG006|Overall Study|Physician Decision|0|||
105568847|NCT01287520|364081289|FG007|Overall Study|Physician Decision|1|||
105568848|NCT01287520|364081290|FG008|Overall Study|Physician Decision|0|||
105568849|NCT01287520|364081282|FG000|Overall Study|Progressive disease|0|||
105568850|NCT01287520|364081283|FG001|Overall Study|Progressive disease|4|||
105568851|NCT01287520|364081284|FG002|Overall Study|Progressive disease|1|||
105568852|NCT01287520|364081285|FG003|Overall Study|Progressive disease|6|||
105568853|NCT01287520|364081286|FG004|Overall Study|Progressive disease|1|||
105759583|NCT00004732|364771617|FG000|Overall Study|Lost to Follow-up|33|||
105759584|NCT00004732|364771618|FG001|Overall Study|Lost to Follow-up|47|||
105759585|NCT00753688|364771619|FG000|Overall Study|Death|102|||
105759586|NCT00753688|364771620|FG001|Overall Study|Death|203|||
105759587|NCT00753688|364771619|FG000|Overall Study|Missing|4|||
105759588|NCT00753688|364771620|FG001|Overall Study|Missing|9|||
105759589|NCT00753688|364771619|FG000|Overall Study|Participant Withdrew Consent|2|||
105759590|NCT00753688|364771620|FG001|Overall Study|Participant Withdrew Consent|2|||
105759591|NCT00753688|364771619|FG000|Overall Study|Ongoing - in Follow-up|15|||
105759592|NCT00753688|364771620|FG001|Overall Study|Ongoing - in Follow-up|31|||
105759593|NCT00753688|364771619|FG000|Overall Study|Adverse Event|0|||
105759594|NCT00753688|364771620|FG001|Overall Study|Adverse Event|1|||
105759595|NCT00108953|364771621|FG000|Follow-up|Death|18|||
105759596|NCT00108953|364771622|FG001|Follow-up|Death|26|||
105759597|NCT00108953|364771621|FG000|Follow-up|Lost to Follow-up|1|||
105759598|NCT00108953|364771622|FG001|Follow-up|Lost to Follow-up|1|||
105759599|NCT00108953|364771621|FG000|Follow-up|Study terminated by sponsor|10|||
105759600|NCT00108953|364771622|FG001|Follow-up|Study terminated by sponsor|6|||
105759601|NCT04294095|364771625|FG000|Overall Study|Adverse Event|1|||
105759602|NCT04294095|364771626|FG001|Overall Study|Adverse Event|0|||
105759603|NCT04126031|364771628|FG000|Part A|Withdrawal by Subject|0|||
105759604|NCT04126031|364771629|FG001|Part A|Withdrawal by Subject|0|||
105759605|NCT04126031|364771630|FG002|Part A|Withdrawal by Subject|1|||
105759606|NCT04126031|364771631|FG003|Part A|Withdrawal by Subject|0|||
105759607|NCT04126031|364771632|FG004|Part A|Withdrawal by Subject|0|||
105759608|NCT04126031|364771633|FG005|Part A|Withdrawal by Subject|0|||
105759609|NCT04126031|364771628|FG000|Part A|Other|1|||
105759610|NCT04126031|364771629|FG001|Part A|Other|0|||
105759611|NCT04126031|364771630|FG002|Part A|Other|0|||
105759612|NCT04126031|364771631|FG003|Part A|Other|0|||
105759613|NCT04126031|364771632|FG004|Part A|Other|0|||
105568854|NCT01287520|364081287|FG005|Overall Study|Progressive disease|0|||
105568855|NCT01287520|364081288|FG006|Overall Study|Progressive disease|2|||
105759614|NCT04126031|364771633|FG005|Part A|Other|0|||
105759615|NCT04126031|364771628|FG000|Part B|Adverse Event|0|||
105759616|NCT04126031|364771629|FG001|Part B|Adverse Event|0|||
105759617|NCT04126031|364771630|FG002|Part B|Adverse Event|0|||
105759618|NCT04126031|364771631|FG003|Part B|Adverse Event|0|||
105759619|NCT04126031|364771632|FG004|Part B|Adverse Event|0|||
105804990|NCT01688037|364941999|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
105568856|NCT01287520|364081289|FG007|Overall Study|Progressive disease|2|||
105568857|NCT01287520|364081290|FG008|Overall Study|Progressive disease|4|||
105568858|NCT01287520|364081282|FG000|Overall Study|Withdrawal by Subject|0|||
105759620|NCT04126031|364771633|FG005|Part B|Adverse Event|2|||
105759621|NCT04126031|364771628|FG000|Part B|Pre-existing hypertransaminasemia|0|||
105759622|NCT04126031|364771629|FG001|Part B|Pre-existing hypertransaminasemia|0|||
105568859|NCT01287520|364081283|FG001|Overall Study|Withdrawal by Subject|0|||
105568860|NCT01287520|364081284|FG002|Overall Study|Withdrawal by Subject|0|||
105568861|NCT01287520|364081285|FG003|Overall Study|Withdrawal by Subject|0|||
105568862|NCT01287520|364081286|FG004|Overall Study|Withdrawal by Subject|0|||
105568863|NCT01287520|364081287|FG005|Overall Study|Withdrawal by Subject|1|||
105759623|NCT04126031|364771630|FG002|Part B|Pre-existing hypertransaminasemia|0|||
105759624|NCT04126031|364771631|FG003|Part B|Pre-existing hypertransaminasemia|0|||
105759625|NCT04126031|364771632|FG004|Part B|Pre-existing hypertransaminasemia|1|||
105759626|NCT04126031|364771633|FG005|Part B|Pre-existing hypertransaminasemia|0|||
105759627|NCT02177175|364771637|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
105759628|NCT02177175|364771638|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
105759629|NCT00260429|364771639|FG000|Overall Study|failure to follow appointments|1|||
105759630|NCT00260429|364771640|FG001|Overall Study|failure to follow appointments|0|||
105568864|NCT01287520|364081288|FG006|Overall Study|Withdrawal by Subject|0|||
105568865|NCT01287520|364081289|FG007|Overall Study|Withdrawal by Subject|0|||
105568866|NCT01287520|364081290|FG008|Overall Study|Withdrawal by Subject|1|||
105568867|NCT02768662|364081291|FG000|Overall Study|Adverse Event|1|||
105568868|NCT02768662|364081291|FG000|Overall Study|Lost to Follow-up|4|||
105568869|NCT02768662|364081291|FG000|Overall Study|Withdrawal by Subject|3|||
105568870|NCT02768662|364081291|FG000|Overall Study|Study terminated by Sponsor|78|||
105568871|NCT00499863|364081294|FG000|Overall Study|Lack of Efficacy|21|||
105568872|NCT00499863|364081295|FG001|Overall Study|Lack of Efficacy|27|||
105568873|NCT00499863|364081294|FG000|Overall Study|Protocol Violation|12|||
105568874|NCT00499863|364081295|FG001|Overall Study|Protocol Violation|7|||
105568875|NCT00499863|364081294|FG000|Overall Study|Withdrawal by Subject|6|||
105568876|NCT00499863|364081295|FG001|Overall Study|Withdrawal by Subject|4|||
105568877|NCT00499863|364081294|FG000|Overall Study|Adverse Event|8|||
105568878|NCT00499863|364081295|FG001|Overall Study|Adverse Event|2|||
105568879|NCT00499863|364081294|FG000|Overall Study|Sponsor decision|2|||
105568880|NCT00499863|364081295|FG001|Overall Study|Sponsor decision|2|||
105568881|NCT00499863|364081294|FG000|Overall Study|Lost to Follow-up|1|||
105568882|NCT00499863|364081295|FG001|Overall Study|Lost to Follow-up|1|||
105568883|NCT03303469|364081296|FG000|Overall Study|Lost to Follow-up|2|||
105759631|NCT00260429|364771639|FG000|Overall Study|scheduled hand surgery|1|||
105759632|NCT00260429|364771640|FG001|Overall Study|scheduled hand surgery|0|||
105759633|NCT00131664|364771641|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
105759634|NCT00131664|364771642|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
105759635|NCT00131664|364771643|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
105759636|NCT00131664|364771644|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
105568884|NCT01800201|364081297|FG000|Overall Study|Withdrawal by Subject|2|||
105568885|NCT01800201|364081298|FG001|Overall Study|Withdrawal by Subject|0|||
105568886|NCT01800201|364081297|FG000|Overall Study|patient privacy concerns|1|||
105568887|NCT01800201|364081298|FG001|Overall Study|patient privacy concerns|1|||
105568888|NCT01800201|364081297|FG000|Overall Study|did not want to use device|0|||
105568889|NCT01800201|364081298|FG001|Overall Study|did not want to use device|1|||
105568890|NCT01800201|364081297|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
105568891|NCT01800201|364081298|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
105568892|NCT00708435|364081301|FG000|Overall Study|Death / Serious Adverse Event|10|||
105568893|NCT00708435|364081302|FG001|Overall Study|Death / Serious Adverse Event|5|||
105568894|NCT00708435|364081301|FG000|Overall Study|Lost to Follow-up|9|||
105568895|NCT00708435|364081302|FG001|Overall Study|Lost to Follow-up|4|||
105568896|NCT00708435|364081301|FG000|Overall Study|Withdrawal by Subject|3|||
105568897|NCT00708435|364081302|FG001|Overall Study|Withdrawal by Subject|7|||
105568898|NCT00708435|364081301|FG000|Overall Study|Adverse Event|1|||
105568899|NCT00708435|364081302|FG001|Overall Study|Adverse Event|0|||
105568900|NCT00708435|364081301|FG000|Overall Study|Protocol Violation|0|||
105568901|NCT00708435|364081302|FG001|Overall Study|Protocol Violation|1|||
105568902|NCT00708435|364081301|FG000|Overall Study|Intervention by primary care physician|1|||
105568903|NCT00708435|364081302|FG001|Overall Study|Intervention by primary care physician|0|||
105568904|NCT00708435|364081301|FG000|Overall Study|Refused hospitalization|1|||
105759637|NCT00131664|364771645|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
105759638|NCT00131664|364771646|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
105568905|NCT00708435|364081302|FG001|Overall Study|Refused hospitalization|0|||
105568906|NCT02635724|364081317|FG000|Overall Study|Withdrawal by Subject|0|||
105568907|NCT02635724|364081318|FG001|Overall Study|Withdrawal by Subject|1|||
105568908|NCT02635724|364081319|FG002|Overall Study|Withdrawal by Subject|0|||
105568909|NCT02387996|364081324|FG000|Overall Study|Disease Progression|167|||
105568910|NCT02387996|364081324|FG000|Overall Study|Study Drug Toxicity|31|||
105568911|NCT02387996|364081324|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
105568912|NCT02387996|364081324|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
105568913|NCT02387996|364081324|FG000|Overall Study|Subject Withdrew Consent|5|||
105568914|NCT02387996|364081324|FG000|Overall Study|Lost to Follow-up|1|||
105568915|NCT02387996|364081324|FG000|Overall Study|Poor/Non-Compliance|1|||
105568916|NCT02387996|364081324|FG000|Overall Study|Other Reasons|5|||
105568917|NCT02387996|364081324|FG000|Overall Study|Death|1|||
105568918|NCT01453348|364081325|FG000|Overall Study|Death|0|||
105568919|NCT01453348|364081326|FG001|Overall Study|Death|0|||
105568920|NCT01453348|364081327|FG002|Overall Study|Death|1|||
105568921|NCT01453348|364081325|FG000|Overall Study|Withdrawal by Subject|0|||
105568922|NCT01453348|364081326|FG001|Overall Study|Withdrawal by Subject|1|||
105568923|NCT01453348|364081327|FG002|Overall Study|Withdrawal by Subject|0|||
105568924|NCT01453348|364081325|FG000|Overall Study|Protocol Violation|1|||
105568925|NCT01453348|364081326|FG001|Overall Study|Protocol Violation|0|||
105568926|NCT01453348|364081327|FG002|Overall Study|Protocol Violation|0|||
105568927|NCT04359771|364081328|FG000|Overall Study|Lack of Efficacy|2|||
105568928|NCT04359771|364081329|FG001|Overall Study|Lack of Efficacy|2|||
105568929|NCT00622713|364081341|FG000|Overall Study|Adverse Event|35|||
105568930|NCT00622713|364081341|FG000|Overall Study|Administrative problems|4|||
105568931|NCT00622713|364081341|FG000|Overall Study|Withdrawal by Subject|11|||
105568932|NCT00622713|364081341|FG000|Overall Study|Lost to Follow-up|5|||
105568933|NCT00622713|364081341|FG000|Overall Study|Death|2|||
105568934|NCT00622713|364081341|FG000|Overall Study|Subject no longer required study drug|1|||
105568935|NCT00622713|364081341|FG000|Overall Study|Did not meet eligibility criteria|1|||
105483667|NCT02296138|363782732|FG001|Overall Study|Protocol Violation|36|||
105483668|NCT02296138|363782731|FG000|Overall Study|Lost to Follow-up|9|||
105483669|NCT02296138|363782732|FG001|Overall Study|Lost to Follow-up|12|||
105483670|NCT02296138|363782731|FG000|Overall Study|Withdrawal by Subject|184|||
105483671|NCT02296138|363782732|FG001|Overall Study|Withdrawal by Subject|131|||
105483672|NCT02296138|363782731|FG000|Overall Study|Not Treated|1|||
105483673|NCT02296138|363782732|FG001|Overall Study|Not Treated|1|||
105483674|NCT02296138|363782731|FG000|Overall Study|Patients with data irregularities|10|||
105483675|NCT02296138|363782732|FG001|Overall Study|Patients with data irregularities|11|||
105483676|NCT02296138|363782731|FG000|Overall Study|Other than specified|15|||
105483677|NCT02296138|363782732|FG001|Overall Study|Other than specified|13|||
105483678|NCT01925989|363782735|FG000|Period 1|Sponsor Decision|1|||
105483679|NCT01925989|363782736|FG001|Period 1|Sponsor Decision|1|||
105483680|NCT01925989|363782737|FG002|Period 1|Sponsor Decision|0|||
105483681|NCT01925989|363782735|FG000|Period 1|Withdrawal by Subject|0|||
105483682|NCT01925989|363782736|FG001|Period 1|Withdrawal by Subject|1|||
105483683|NCT01925989|363782737|FG002|Period 1|Withdrawal by Subject|0|||
105483684|NCT01119937|363782738|FG000|Overall Study|Adverse Event|11|||
105483685|NCT01119937|363782739|FG001|Overall Study|Adverse Event|5|||
105483686|NCT01119937|363782738|FG000|Overall Study|Protocol deviation|3|||
105483687|NCT01119937|363782739|FG001|Overall Study|Protocol deviation|1|||
105483688|NCT01119937|363782738|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
105483689|NCT01119937|363782739|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105483690|NCT01119937|363782738|FG000|Overall Study|Withdrawal by Subject|2|||
105483691|NCT01119937|363782739|FG001|Overall Study|Withdrawal by Subject|1|||
105483692|NCT00420641|363782740|FG000|Overall Study|Adverse Event|3|||
105483693|NCT00420641|363782741|FG001|Overall Study|Adverse Event|25|||
105483694|NCT00420641|363782742|FG002|Overall Study|Adverse Event|10|||
105483695|NCT00420641|363782740|FG000|Overall Study|Lost to Follow-up|2|||
105483696|NCT00420641|363782741|FG001|Overall Study|Lost to Follow-up|4|||
105483697|NCT00420641|363782742|FG002|Overall Study|Lost to Follow-up|2|||
105483698|NCT00420641|363782740|FG000|Overall Study|Protocol Violation|8|||
105483699|NCT00420641|363782741|FG001|Overall Study|Protocol Violation|8|||
105483700|NCT00420641|363782742|FG002|Overall Study|Protocol Violation|7|||
105483701|NCT00420641|363782740|FG000|Overall Study|Withdrawal by Subject|15|||
105483702|NCT00420641|363782741|FG001|Overall Study|Withdrawal by Subject|21|||
105483703|NCT00420641|363782742|FG002|Overall Study|Withdrawal by Subject|14|||
105483704|NCT00420641|363782740|FG000|Overall Study|Lack of Efficacy|6|||
105483705|NCT00420641|363782741|FG001|Overall Study|Lack of Efficacy|5|||
105483706|NCT00420641|363782742|FG002|Overall Study|Lack of Efficacy|4|||
105483707|NCT00420641|363782740|FG000|Overall Study|Non-compliance|7|||
105483708|NCT00420641|363782741|FG001|Overall Study|Non-compliance|5|||
105483709|NCT00420641|363782742|FG002|Overall Study|Non-compliance|4|||
105483710|NCT00420641|363782740|FG000|Overall Study|Other|4|||
105483711|NCT00420641|363782741|FG001|Overall Study|Other|4|||
105483712|NCT00420641|363782742|FG002|Overall Study|Other|3|||
105483713|NCT01944839|363782746|FG000|Overall Study|Physician Decision|2|||
105483714|NCT01944839|363782747|FG001|Overall Study|Physician Decision|2|||
105483715|NCT01944839|363782746|FG000|Overall Study|Protocol Violation|0|||
105483716|NCT01944839|363782747|FG001|Overall Study|Protocol Violation|1|||
105483717|NCT01944839|363782746|FG000|Overall Study|Adverse Event|10|||
105483718|NCT01944839|363782747|FG001|Overall Study|Adverse Event|5|||
105483719|NCT01944839|363782746|FG000|Overall Study|Withdrawal by Subject|9|||
105483720|NCT01944839|363782747|FG001|Overall Study|Withdrawal by Subject|17|||
105483721|NCT01944839|363782746|FG000|Overall Study|Lost to Follow-up|1|||
105483722|NCT01944839|363782747|FG001|Overall Study|Lost to Follow-up|0|||
105483723|NCT01944839|363782746|FG000|Overall Study|Subject non-compliance|0|||
105483724|NCT01944839|363782747|FG001|Overall Study|Subject non-compliance|3|||
105568936|NCT01462162|364081343|FG000|Overall Study|Adverse Event|5|||
105759639|NCT00131664|364771641|FG000|First Period (First 6 Months)|Death|0|||
105759640|NCT00131664|364771642|FG001|First Period (First 6 Months)|Death|1|||
105759641|NCT00131664|364771643|FG002|First Period (First 6 Months)|Death|0|||
105759642|NCT00131664|364771644|FG003|First Period (First 6 Months)|Death|0|||
105759643|NCT00131664|364771645|FG004|First Period (First 6 Months)|Death|0|||
105759644|NCT00131664|364771646|FG005|First Period (First 6 Months)|Death|0|||
105759645|NCT00131664|364771641|FG000|First Period (First 6 Months)|Protocol Violation|2|||
105568937|NCT01462162|364081343|FG000|Overall Study|Lack of Efficacy|4|||
105568938|NCT01462162|364081343|FG000|Overall Study|Abnormal laboratory parameters|1|||
105568939|NCT01462162|364081343|FG000|Overall Study|Other|2|||
105568940|NCT00909480|364081344|FG000|Overall Study|Adverse Event|5|||
105568941|NCT00909480|364081345|FG001|Overall Study|Adverse Event|3|||
105568942|NCT00909480|364081344|FG000|Overall Study|Protocol Violation|6|||
105568943|NCT00909480|364081345|FG001|Overall Study|Protocol Violation|8|||
105568944|NCT00909480|364081344|FG000|Overall Study|Withdrawal criteria|9|||
105568945|NCT00909480|364081345|FG001|Overall Study|Withdrawal criteria|11|||
105568946|NCT00909480|364081344|FG000|Overall Study|Unclassified|18|||
105568947|NCT00909480|364081345|FG001|Overall Study|Unclassified|19|||
105568948|NCT01013792|364081354|FG000|Overall Study|Study suspended|2|||
105568949|NCT01013792|364081355|FG001|Overall Study|Study suspended|1|||
105568950|NCT01013792|364081354|FG000|Overall Study|Adverse Event|0|||
105568951|NCT01013792|364081355|FG001|Overall Study|Adverse Event|3|||
105568952|NCT01013792|364081354|FG000|Overall Study|Lost to Follow-up|0|||
105568953|NCT01013792|364081355|FG001|Overall Study|Lost to Follow-up|1|||
105568954|NCT03635489|364081359|FG000|Overall Study|Death|19|||
105568955|NCT03635489|364081360|FG001|Overall Study|Death|13|||
105568956|NCT03635489|364081359|FG000|Overall Study|Lost to Follow-up|1|||
105568957|NCT03635489|364081360|FG001|Overall Study|Lost to Follow-up|2|||
105568958|NCT03635489|364081359|FG000|Overall Study|Withdrawal by Subject|1|||
105568959|NCT03635489|364081360|FG001|Overall Study|Withdrawal by Subject|2|||
105568960|NCT03635489|364081359|FG000|Overall Study|Study Ended by Sponsor|28|||
105568961|NCT03635489|364081360|FG001|Overall Study|Study Ended by Sponsor|34|||
105568962|NCT03520400|364081361|FG000|Overall Study|Physician Decision|15|||
105568963|NCT03520400|364081362|FG001|Overall Study|Physician Decision|7|||
105568964|NCT01807650|364081363|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
105568965|NCT01807650|364081363|FG000|Overall Study|Adverse Event|5|||
105568966|NCT01807650|364081363|FG000|Overall Study|Other|2|||
105568967|NCT00909428|364081364|FG000|Overall Study|Lost to Follow-up|13|||
105568968|NCT00909428|364081365|FG001|Overall Study|Lost to Follow-up|10|||
105568969|NCT00909428|364081366|FG002|Overall Study|Lost to Follow-up|9|||
105568970|NCT00736489|364081369|FG000|Period 1|Lost to Follow-up|1|||
105568971|NCT00736489|364081370|FG001|Period 1|Lost to Follow-up|0|||
105568972|NCT00736489|364081371|FG002|Period 1|Lost to Follow-up|0|||
105568973|NCT00736489|364081372|FG003|Period 1|Lost to Follow-up|0|||
105568974|NCT00736489|364081373|FG004|Period 1|Lost to Follow-up|0|||
105568975|NCT00736489|364081374|FG005|Period 1|Lost to Follow-up|0|||
105568976|NCT00736489|364081369|FG000|Period 1|Withdrawal by Subject|0|||
105568977|NCT00736489|364081370|FG001|Period 1|Withdrawal by Subject|0|||
105568978|NCT00736489|364081371|FG002|Period 1|Withdrawal by Subject|0|||
105568979|NCT00736489|364081372|FG003|Period 1|Withdrawal by Subject|0|||
105568980|NCT00736489|364081373|FG004|Period 1|Withdrawal by Subject|0|||
105568981|NCT00736489|364081374|FG005|Period 1|Withdrawal by Subject|1|||
105568982|NCT01933880|364081375|FG000|Overall Study|Withdrawal by Subject|5|||
105568983|NCT01933880|364081376|FG001|Overall Study|Withdrawal by Subject|0|||
105568984|NCT01933880|364081375|FG000|Overall Study|Lack of Efficacy|1|||
105568985|NCT01933880|364081376|FG001|Overall Study|Lack of Efficacy|0|||
105568986|NCT01933880|364081375|FG000|Overall Study|Concomitant medication Interference|0|||
105759646|NCT00131664|364771642|FG001|First Period (First 6 Months)|Protocol Violation|2|||
105759647|NCT00131664|364771643|FG002|First Period (First 6 Months)|Protocol Violation|1|||
105483725|NCT00548405|363782748|FG000|Overall Study|Adverse Event|6|||
105483726|NCT00548405|363782749|FG001|Overall Study|Adverse Event|2|||
105483727|NCT00548405|363782750|FG002|Overall Study|Adverse Event|0|||
105483728|NCT00548405|363782748|FG000|Overall Study|Lack of Efficacy|6|||
105483729|NCT00548405|363782749|FG001|Overall Study|Lack of Efficacy|0|||
105483730|NCT00548405|363782750|FG002|Overall Study|Lack of Efficacy|0|||
105483731|NCT00548405|363782748|FG000|Overall Study|Physician Decision|3|||
105483732|NCT00548405|363782749|FG001|Overall Study|Physician Decision|4|||
105483733|NCT00548405|363782750|FG002|Overall Study|Physician Decision|1|||
105483734|NCT00548405|363782748|FG000|Overall Study|Pregnancy|1|||
105483735|NCT00548405|363782749|FG001|Overall Study|Pregnancy|0|||
105483736|NCT00548405|363782750|FG002|Overall Study|Pregnancy|0|||
105483737|NCT00548405|363782748|FG000|Overall Study|Protocol Violation|1|||
105483738|NCT00548405|363782749|FG001|Overall Study|Protocol Violation|0|||
105483739|NCT00548405|363782750|FG002|Overall Study|Protocol Violation|0|||
105483740|NCT00548405|363782748|FG000|Overall Study|Withdrawal by Subject|36|||
105483741|NCT00548405|363782749|FG001|Overall Study|Withdrawal by Subject|12|||
105483742|NCT00548405|363782750|FG002|Overall Study|Withdrawal by Subject|5|||
105483743|NCT00548405|363782748|FG000|Overall Study|Lost to Follow-up|1|||
105568987|NCT01933880|364081376|FG001|Overall Study|Concomitant medication Interference|1|||
105568988|NCT01933880|364081375|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
105568989|NCT01933880|364081376|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
105568990|NCT01933880|364081375|FG000|Overall Study|Other|4|||
105568991|NCT01933880|364081376|FG001|Overall Study|Other|0|||
105568992|NCT01933880|364081375|FG000|Overall Study|Protocol Violation|1|||
105568993|NCT01933880|364081376|FG001|Overall Study|Protocol Violation|0|||
105568994|NCT02234063|364081377|FG000|Overall Study|Lost to Follow-up|235|||
105568995|NCT02234063|364081378|FG001|Overall Study|Lost to Follow-up|42|||
105568996|NCT02234063|364081377|FG000|Overall Study|Withdrawal by Subject|20|||
105568997|NCT02234063|364081378|FG001|Overall Study|Withdrawal by Subject|1|||
105568998|NCT01125722|364081379|FG000|Overall Study|Withdrawal by Subject|2|||
105568999|NCT01125722|364081380|FG001|Overall Study|Withdrawal by Subject|1|||
105569000|NCT01125722|364081379|FG000|Overall Study|Lost to Follow-up|1|||
105759648|NCT00131664|364771644|FG003|First Period (First 6 Months)|Protocol Violation|0|||
105759649|NCT00131664|364771645|FG004|First Period (First 6 Months)|Protocol Violation|0|||
105759650|NCT00131664|364771646|FG005|First Period (First 6 Months)|Protocol Violation|0|||
105759651|NCT00131664|364771641|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
105569001|NCT01125722|364081380|FG001|Overall Study|Lost to Follow-up|0|||
105569002|NCT02090634|364081381|FG000|Overall Study|Lost to Follow-up|0|||
105569003|NCT02090634|364081382|FG001|Overall Study|Lost to Follow-up|1|||
105569004|NCT02090634|364081381|FG000|Overall Study|Death|0|||
105569005|NCT02090634|364081382|FG001|Overall Study|Death|1|||
105569006|NCT02090634|364081381|FG000|Overall Study|Protocol Violation|3|||
105569007|NCT02090634|364081382|FG001|Overall Study|Protocol Violation|1|||
105569008|NCT02090634|364081381|FG000|Overall Study|Adverse Event|2|||
105569009|NCT02090634|364081382|FG001|Overall Study|Adverse Event|0|||
105569010|NCT00118898|364081391|FG000|Overall Study|Death|6|||
105569011|NCT00118898|364081392|FG001|Overall Study|Death|11|||
105569012|NCT00118898|364081393|FG002|Overall Study|Death|6|||
105569013|NCT00118898|364081394|FG003|Overall Study|Death|8|||
105569014|NCT00118898|364081391|FG000|Overall Study|Lost to Follow-up|26|||
105569015|NCT00118898|364081392|FG001|Overall Study|Lost to Follow-up|34|||
105569016|NCT00118898|364081393|FG002|Overall Study|Lost to Follow-up|33|||
105569017|NCT00118898|364081394|FG003|Overall Study|Lost to Follow-up|33|||
105569018|NCT00118898|364081391|FG000|Overall Study|Withdrawal by Subject|10|||
105569019|NCT00118898|364081392|FG001|Overall Study|Withdrawal by Subject|5|||
105569020|NCT00118898|364081393|FG002|Overall Study|Withdrawal by Subject|8|||
105569021|NCT00118898|364081394|FG003|Overall Study|Withdrawal by Subject|8|||
105569022|NCT00118898|364081391|FG000|Overall Study|Site Closure|33|||
105569023|NCT00118898|364081392|FG001|Overall Study|Site Closure|31|||
105569024|NCT00118898|364081393|FG002|Overall Study|Site Closure|28|||
105569025|NCT00118898|364081394|FG003|Overall Study|Site Closure|37|||
105569026|NCT00118898|364081391|FG000|Overall Study|Severe debilitation|1|||
105569027|NCT00118898|364081392|FG001|Overall Study|Severe debilitation|4|||
105569028|NCT00118898|364081393|FG002|Overall Study|Severe debilitation|6|||
105569029|NCT00118898|364081394|FG003|Overall Study|Severe debilitation|4|||
105569030|NCT00118898|364081391|FG000|Overall Study|Not compliant with requirements|11|||
105569031|NCT00118898|364081392|FG001|Overall Study|Not compliant with requirements|13|||
105569032|NCT00118898|364081393|FG002|Overall Study|Not compliant with requirements|11|||
105569033|NCT00118898|364081394|FG003|Overall Study|Not compliant with requirements|11|||
105569034|NCT00118898|364081391|FG000|Overall Study|Not able to get to clinic|34|||
105569035|NCT00118898|364081392|FG001|Overall Study|Not able to get to clinic|43|||
105569036|NCT00118898|364081393|FG002|Overall Study|Not able to get to clinic|31|||
105569037|NCT00118898|364081394|FG003|Overall Study|Not able to get to clinic|40|||
105759652|NCT00131664|364771642|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
105759653|NCT00131664|364771643|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
105759654|NCT00131664|364771644|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
105759655|NCT00131664|364771645|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
105759656|NCT00131664|364771646|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
105759657|NCT00131664|364771641|FG000|First Period (First 6 Months)|Adverse Event|9|||
105759658|NCT00131664|364771642|FG001|First Period (First 6 Months)|Adverse Event|4|||
105759659|NCT00131664|364771643|FG002|First Period (First 6 Months)|Adverse Event|5|||
105759660|NCT00131664|364771644|FG003|First Period (First 6 Months)|Adverse Event|0|||
105569038|NCT00384059|364081395|FG000|Infant Series|Not consented|2|||
105569039|NCT00384059|364081396|FG001|Infant Series|Not consented|6|||
105569040|NCT00384059|364081395|FG000|Infant Series|Withdrawal by Subject|2|||
105569041|NCT00384059|364081396|FG001|Infant Series|Withdrawal by Subject|2|||
105569042|NCT00384059|364081395|FG000|Infant Series|Adverse Event|1|||
105569043|NCT00384059|364081396|FG001|Infant Series|Adverse Event|2|||
105569044|NCT00384059|364081395|FG000|Infant Series|Protocol Violation|1|||
105569045|NCT00384059|364081396|FG001|Infant Series|Protocol Violation|2|||
105569046|NCT00384059|364081395|FG000|Infant Series|Lost to Follow-up|0|||
105569047|NCT00384059|364081396|FG001|Infant Series|Lost to Follow-up|1|||
105804991|NCT01688037|364942000|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
105804992|NCT01688037|364942001|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
105804993|NCT01688037|364941999|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
105804994|NCT01688037|364942000|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
105804995|NCT01688037|364942001|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
105804996|NCT03111147|364942002|FG000|Overall Study|Lost to Follow-up|2|||
105569048|NCT00384059|364081395|FG000|After Infant Series|Protocol Violation|2|||
105569049|NCT00384059|364081396|FG001|After Infant Series|Protocol Violation|3|||
105569050|NCT00384059|364081395|FG000|After Infant Series|Withdrawal by Subject|2|||
105759661|NCT00131664|364771645|FG004|First Period (First 6 Months)|Adverse Event|0|||
105759662|NCT00131664|364771646|FG005|First Period (First 6 Months)|Adverse Event|0|||
105759663|NCT00131664|364771641|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
105569051|NCT00384059|364081396|FG001|After Infant Series|Withdrawal by Subject|2|||
105569052|NCT00384059|364081395|FG000|After Infant Series|Failed to Return|0|||
105569053|NCT00384059|364081396|FG001|After Infant Series|Failed to Return|2|||
105759664|NCT00131664|364771642|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
105759665|NCT00131664|364771643|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
105759666|NCT00131664|364771644|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
105759667|NCT00131664|364771645|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
105569054|NCT00384059|364081395|FG000|After Infant Series|Adverse Event|0|||
105569055|NCT00384059|364081396|FG001|After Infant Series|Adverse Event|1|||
105569056|NCT00384059|364081395|FG000|After Infant Series|Physician Decision|0|||
105569057|NCT00384059|364081396|FG001|After Infant Series|Physician Decision|1|||
105569058|NCT00384059|364081395|FG000|After Infant Series|Lost to Follow-up|0|||
105569059|NCT00384059|364081396|FG001|After Infant Series|Lost to Follow-up|1|||
105569060|NCT00384059|364081395|FG000|Toddler Dose|Lost to Follow-up|1|||
105569061|NCT00384059|364081396|FG001|Toddler Dose|Lost to Follow-up|1|||
105569062|NCT00384059|364081395|FG000|Toddler Dose|Failed to return|0|||
105569063|NCT00384059|364081396|FG001|Toddler Dose|Failed to return|1|||
105569064|NCT03559218|364083130|FG000|Overall Study|Withdrawal by Subject|1|||
105569065|NCT03559218|364083131|FG001|Overall Study|Withdrawal by Subject|0|||
105569066|NCT01062763|364083132|FG000|Overall Study|Adverse Event|3|||
105569067|NCT01062763|364083133|FG001|Overall Study|Adverse Event|4|||
105569068|NCT02305381|364083134|FG000|Overall Study|Unclassified|5|||
105569069|NCT02305381|364083135|FG001|Overall Study|Unclassified|5|||
105569070|NCT02305381|364083136|FG002|Overall Study|Unclassified|7|||
105569071|NCT04439253|364083137|FG000|Overall Study|Adverse Event|1|||
105569072|NCT04439253|364083137|FG000|Overall Study|Disease progression|2|||
105569073|NCT04439253|364083137|FG000|Overall Study|Complicating disease|1|||
105569074|NCT02991482|364083138|FG000|Overall Study|Disease progression|56|||
105569075|NCT02991482|364083139|FG001|Overall Study|Disease progression|47|||
105569076|NCT02991482|364083138|FG000|Overall Study|Death|4|||
105569077|NCT02991482|364083139|FG001|Overall Study|Death|4|||
105569078|NCT02991482|364083138|FG000|Overall Study|Adverse Event|1|||
105569079|NCT02991482|364083139|FG001|Overall Study|Adverse Event|6|||
105569080|NCT02991482|364083138|FG000|Overall Study|Patient decision|1|||
105569081|NCT02991482|364083139|FG001|Overall Study|Patient decision|1|||
105569082|NCT02991482|364083138|FG000|Overall Study|Physician Decision|0|||
105569083|NCT02991482|364083139|FG001|Overall Study|Physician Decision|6|||
105569084|NCT02991482|364083138|FG000|Overall Study|Clinical deterioration|1|||
105569085|NCT02991482|364083139|FG001|Overall Study|Clinical deterioration|0|||
105569086|NCT02991482|364083138|FG000|Overall Study|Patient feeling too unwell|1|||
105759668|NCT00131664|364771646|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
105759669|NCT00131664|364771641|FG000|First Period (First 6 Months)|Administrative reasons|2|||
105759670|NCT00131664|364771642|FG001|First Period (First 6 Months)|Administrative reasons|0|||
105759671|NCT00131664|364771643|FG002|First Period (First 6 Months)|Administrative reasons|5|||
105759672|NCT00131664|364771644|FG003|First Period (First 6 Months)|Administrative reasons|0|||
105759673|NCT00131664|364771645|FG004|First Period (First 6 Months)|Administrative reasons|0|||
105759674|NCT00131664|364771646|FG005|First Period (First 6 Months)|Administrative reasons|0|||
105759675|NCT00131664|364771641|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
105759676|NCT00131664|364771642|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
105804997|NCT03111147|364942003|FG001|Overall Study|Lost to Follow-up|5|||
105759677|NCT00131664|364771643|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
105569087|NCT02991482|364083139|FG001|Overall Study|Patient feeling too unwell|0|||
105569088|NCT02991482|364083138|FG000|Overall Study|Worsening of performance status|0|||
105569089|NCT02991482|364083139|FG001|Overall Study|Worsening of performance status|1|||
105569090|NCT02991482|364083138|FG000|Overall Study|Death prior to study drug initiation|1|||
105569091|NCT02991482|364083139|FG001|Overall Study|Death prior to study drug initiation|0|||
105569092|NCT02991482|364083138|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
105569093|NCT02991482|364083139|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
105569094|NCT01682213|364083147|FG000|Overall Study|Withdrawal by Subject|2|||
105569095|NCT01181726|364083148|FG000|First Intervention|Adverse Event|1|||
105569096|NCT01181726|364083149|FG001|First Intervention|Adverse Event|0|||
105569097|NCT04836858|364083150|FG000|Overall Study|Adverse Event|0|||
105569098|NCT04836858|364083151|FG001|Overall Study|Adverse Event|0|||
105569099|NCT04836858|364083152|FG002|Overall Study|Adverse Event|0|||
105569100|NCT04836858|364083153|FG003|Overall Study|Adverse Event|1|||
105569101|NCT04836858|364083150|FG000|Overall Study|Lost to Follow-up|1|||
105569102|NCT04836858|364083151|FG001|Overall Study|Lost to Follow-up|0|||
105569103|NCT04836858|364083152|FG002|Overall Study|Lost to Follow-up|0|||
105569104|NCT04836858|364083153|FG003|Overall Study|Lost to Follow-up|0|||
105569105|NCT04836858|364083150|FG000|Overall Study|Subject/Guardian decision|3|||
105569106|NCT04836858|364083151|FG001|Overall Study|Subject/Guardian decision|0|||
105569107|NCT04836858|364083152|FG002|Overall Study|Subject/Guardian decision|0|||
105569108|NCT04836858|364083153|FG003|Overall Study|Subject/Guardian decision|1|||
105569109|NCT04836858|364083150|FG000|Overall Study|Randomized but not treated|4|||
105569110|NCT04836858|364083151|FG001|Overall Study|Randomized but not treated|0|||
105569111|NCT04836858|364083152|FG002|Overall Study|Randomized but not treated|0|||
105569112|NCT04836858|364083153|FG003|Overall Study|Randomized but not treated|0|||
105569113|NCT03430063|364083159|FG000|Overall Study|Adverse Event|0|||
105569114|NCT03430063|364083160|FG001|Overall Study|Adverse Event|1|||
105569115|NCT03430063|364083161|FG002|Overall Study|Adverse Event|0|||
105569116|NCT03430063|364083159|FG000|Overall Study|Death|3|||
105569117|NCT03430063|364083160|FG001|Overall Study|Death|2|||
105569118|NCT03430063|364083161|FG002|Overall Study|Death|3|||
105569119|NCT03430063|364083159|FG000|Overall Study|Lost to Follow-up|0|||
105360591|NCT02155985|363326017|FG002|Overall Study|Withdrawal by Subject|1|||
105360592|NCT02155985|363326015|FG000|Overall Study|Lost to Follow-up|1|||
105569120|NCT03430063|364083160|FG001|Overall Study|Lost to Follow-up|1|||
105569121|NCT03430063|364083161|FG002|Overall Study|Lost to Follow-up|0|||
105569122|NCT03430063|364083159|FG000|Overall Study|Withdrawal by Subject|0|||
105569123|NCT03430063|364083160|FG001|Overall Study|Withdrawal by Subject|0|||
105569124|NCT03430063|364083161|FG002|Overall Study|Withdrawal by Subject|1|||
105569125|NCT03430063|364083159|FG000|Overall Study|Withdrawal of consent|3|||
105569126|NCT03430063|364083160|FG001|Overall Study|Withdrawal of consent|1|||
105569127|NCT03430063|364083161|FG002|Overall Study|Withdrawal of consent|2|||
105569128|NCT03430063|364083159|FG000|Overall Study|Progressive disease|1|||
105569129|NCT03430063|364083160|FG001|Overall Study|Progressive disease|2|||
105569130|NCT03430063|364083161|FG002|Overall Study|Progressive disease|1|||
105569131|NCT03430063|364083159|FG000|Overall Study|Other un-specified|1|||
105569132|NCT03430063|364083160|FG001|Overall Study|Other un-specified|1|||
105569133|NCT03430063|364083161|FG002|Overall Study|Other un-specified|0|||
105569134|NCT03430063|364083159|FG000|Overall Study|Randomized, but never treated|0|||
105569135|NCT03430063|364083160|FG001|Overall Study|Randomized, but never treated|0|||
105569136|NCT03430063|364083161|FG002|Overall Study|Randomized, but never treated|1|||
105569137|NCT03505476|364083167|FG000|Overall Study|Physician Decision|18|||
105569138|NCT03505476|364083167|FG000|Overall Study|Device Malfunctioned|101|||
105569139|NCT03505476|364083167|FG000|Overall Study|Data Corrupt|6|||
105569140|NCT03505476|364083167|FG000|Overall Study|Device application insufficiant|3|||
105569141|NCT01350141|364083168|FG000|Overall Study|Lost to Follow-up|1|||
105569142|NCT01350141|364083169|FG001|Overall Study|Lost to Follow-up|0|||
105569143|NCT01350141|364083170|FG002|Overall Study|Lost to Follow-up|1|||
105569144|NCT01350141|364083168|FG000|Overall Study|Withdrawal by Subject|1|||
105569145|NCT01350141|364083169|FG001|Overall Study|Withdrawal by Subject|0|||
105759678|NCT00131664|364771644|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
105360593|NCT02155985|363326016|FG001|Overall Study|Lost to Follow-up|0|||
105569146|NCT01350141|364083170|FG002|Overall Study|Withdrawal by Subject|0|||
105569147|NCT01350141|364083168|FG000|Overall Study|Randomized but not treated|1|||
105569148|NCT01350141|364083169|FG001|Overall Study|Randomized but not treated|0|||
105569149|NCT01350141|364083170|FG002|Overall Study|Randomized but not treated|0|||
105569150|NCT02424591|364083171|FG000|Overall Study|Protocol Violation|2|||
105569151|NCT02424591|364083172|FG001|Overall Study|Protocol Violation|3|||
105569152|NCT01446796|364083173|FG000|Overall Study|Withdrawal by Subject|1|||
105569153|NCT01446796|364083174|FG001|Overall Study|Withdrawal by Subject|0|||
105569154|NCT01576367|364083175|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105569155|NCT01576367|364083175|FG000|Overall Study|Moved to commercial use after 6 months|1|||
105569156|NCT00312702|364083176|FG000|Immunization Phase|Lost to Follow-up|0|||
105569157|NCT00312702|364083177|FG001|Immunization Phase|Lost to Follow-up|1|||
105569158|NCT00312702|364083178|FG002|Immunization Phase|Lost to Follow-up|0|||
105569159|NCT03812536|364083183|FG000|Overall Study|Protocol Violation|2|||
105569160|NCT03812536|364083184|FG001|Overall Study|Protocol Violation|0|||
105569161|NCT03812536|364083183|FG000|Overall Study|Withdrawal by Subject|1|||
105569162|NCT03812536|364083184|FG001|Overall Study|Withdrawal by Subject|1|||
105569163|NCT01216163|364083185|FG000|Overall Study|Withdrawal by Subject|1|||
105569164|NCT01216163|364083186|FG001|Overall Study|Withdrawal by Subject|1|||
105569165|NCT01216163|364083187|FG002|Overall Study|Withdrawal by Subject|0|||
105569166|NCT02914314|364083188|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
105569167|NCT02914314|364083189|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
105569168|NCT02914314|364083190|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
105569169|NCT02914314|364083191|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
105569170|NCT02914314|364083188|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
105569171|NCT02914314|364083189|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
105569172|NCT02914314|364083190|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
105569173|NCT02914314|364083191|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
105569174|NCT02914314|364083188|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
105569175|NCT02914314|364083189|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
105569176|NCT02914314|364083190|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
105569177|NCT02914314|364083191|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
105569178|NCT02914314|364083188|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
105569179|NCT02914314|364083189|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
105569180|NCT02914314|364083190|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
105569181|NCT02914314|364083191|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
105569182|NCT02914314|364083188|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
105569183|NCT02914314|364083189|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
105569184|NCT02914314|364083190|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
105569185|NCT02914314|364083191|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
105569186|NCT04702568|364083192|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
105569187|NCT04702568|364083193|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
105569188|NCT04702568|364083192|FG000|Overall Study|Pregnancy|1|||
105569189|NCT04702568|364083193|FG001|Overall Study|Pregnancy|0|||
105569190|NCT04702568|364083192|FG000|Overall Study|Bone marrow transplant|1|||
105569191|NCT04702568|364083193|FG001|Overall Study|Bone marrow transplant|0|||
105569192|NCT04702568|364083192|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
105569193|NCT04702568|364083193|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
105569194|NCT04702568|364083192|FG000|Overall Study|Withdrawal by Subject|0|||
105569195|NCT04702568|364083193|FG001|Overall Study|Withdrawal by Subject|2|||
105569196|NCT02002182|364083198|FG000|Overall Study|Withdraw from study|3|||
105569197|NCT02002182|364083199|FG001|Overall Study|Withdraw from study|1|||
105569198|NCT02002182|364083198|FG000|Overall Study|Health Reasons|1|||
105569199|NCT02002182|364083199|FG001|Overall Study|Health Reasons|0|||
105569200|NCT02002182|364083198|FG000|Overall Study|Death|1|||
105569201|NCT02002182|364083199|FG001|Overall Study|Death|0|||
105569202|NCT04599101|364083200|FG000|Overall Study|Lost to Follow-up|5|||
105569203|NCT04599101|364083201|FG001|Overall Study|Lost to Follow-up|5|||
105569204|NCT04146896|364083204|FG000|Overall Study|Adverse Event|5|||
105569205|NCT04146896|364083205|FG001|Overall Study|Adverse Event|8|||
105569206|NCT04146896|364083204|FG000|Overall Study|Lack of Efficacy|3|||
105569207|NCT04146896|364083205|FG001|Overall Study|Lack of Efficacy|2|||
105569208|NCT04146896|364083204|FG000|Overall Study|Lost to Follow-up|0|||
105569209|NCT04146896|364083205|FG001|Overall Study|Lost to Follow-up|1|||
105569210|NCT04146896|364083204|FG000|Overall Study|Non-compliance|5|||
105569211|NCT04146896|364083205|FG001|Overall Study|Non-compliance|4|||
105569212|NCT04146896|364083204|FG000|Overall Study|Withdrawal by Subject|3|||
105569213|NCT04146896|364083205|FG001|Overall Study|Withdrawal by Subject|5|||
105569214|NCT04146896|364083204|FG000|Overall Study|Randomized in error|1|||
105569215|NCT04146896|364083205|FG001|Overall Study|Randomized in error|2|||
105569216|NCT01597505|364083206|FG000|Overall Study|Physician Decision|5|||
105569217|NCT01597505|364083207|FG001|Overall Study|Physician Decision|0|||
105569218|NCT01597505|364083206|FG000|Overall Study|Adverse Event|19|||
105569219|NCT01597505|364083207|FG001|Overall Study|Adverse Event|7|||
105569220|NCT01597505|364083206|FG000|Overall Study|Lost to Follow-up|4|||
105569221|NCT01597505|364083207|FG001|Overall Study|Lost to Follow-up|2|||
105569222|NCT01597505|364083206|FG000|Overall Study|Withdrawal by Subject|10|||
105569223|NCT01597505|364083207|FG001|Overall Study|Withdrawal by Subject|18|||
105569224|NCT01597505|364083206|FG000|Overall Study|Other|5|||
105569225|NCT01597505|364083207|FG001|Overall Study|Other|6|||
105569226|NCT01597505|364083206|FG000|Overall Study|Missing|1|||
105569227|NCT01597505|364083207|FG001|Overall Study|Missing|0|||
105569228|NCT01515189|364083209|FG000|Induction|Disease Progression|109|||
105569229|NCT01515189|364083210|FG001|Induction|Disease Progression|155|||
105569230|NCT01515189|364083209|FG000|Induction|Study drug toxicity|86|||
105569231|NCT01515189|364083210|FG001|Induction|Study drug toxicity|36|||
105569232|NCT01515189|364083209|FG000|Induction|Death|24|||
105569233|NCT01515189|364083210|FG001|Induction|Death|17|||
105804998|NCT03111147|364942002|FG000|Overall Study|Withdrawal by Subject|4|||
105759679|NCT00131664|364771645|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
105759680|NCT00131664|364771646|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
105759681|NCT00131664|364771641|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
105759682|NCT00131664|364771642|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
105759683|NCT00131664|364771643|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
105759684|NCT00131664|364771644|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
105759685|NCT00131664|364771645|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
105759686|NCT00131664|364771646|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
105759687|NCT00131664|364771641|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
105759688|NCT00131664|364771642|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
105759689|NCT00131664|364771643|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
105759690|NCT00131664|364771644|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
105759691|NCT00131664|364771645|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
105759692|NCT00131664|364771646|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
105759693|NCT00131664|364771641|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
105759694|NCT00131664|364771642|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
105759695|NCT00131664|364771643|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
105759696|NCT00131664|364771644|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
105759697|NCT00131664|364771645|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
105759698|NCT00131664|364771646|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
105759699|NCT00131664|364771641|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
105759700|NCT00131664|364771642|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
105759701|NCT00131664|364771643|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
105759702|NCT00131664|364771644|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
105759703|NCT00131664|364771645|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
105759704|NCT00131664|364771646|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
105759705|NCT00131664|364771641|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
105759706|NCT00131664|364771642|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
105759707|NCT00131664|364771643|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
105759708|NCT00131664|364771644|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
105759709|NCT00131664|364771645|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
105759710|NCT00131664|364771646|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
105759711|NCT00892957|364771647|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
105759712|NCT00892957|364771648|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
105759713|NCT00892957|364771647|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
105759714|NCT00892957|364771648|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
105759715|NCT02091921|364771649|FG000|Overall Study|Adverse Event|3|||
105759716|NCT01626989|364771657|FG000|Screening Period|Screen Failure|15|||
105759717|NCT01626989|364771658|FG001|Screening Period|Screen Failure|0|||
105759718|NCT01626989|364771659|FG002|Screening Period|Screen Failure|0|||
105759719|NCT01626989|364771657|FG000|Screening Period|Withdrawal by Subject|2|||
105759720|NCT01626989|364771658|FG001|Screening Period|Withdrawal by Subject|0|||
105759721|NCT01626989|364771659|FG002|Screening Period|Withdrawal by Subject|0|||
105759722|NCT04876599|364771662|FG000|Overall Study|Missed|2|||
105759723|NCT04876599|364771663|FG001|Overall Study|Missed|0|||
105759724|NCT04876599|364771662|FG000|Overall Study|Declined|2|||
105759725|NCT04876599|364771663|FG001|Overall Study|Declined|3|||
105759726|NCT03175562|364771664|FG000|Overall Study|Adverse Event|1|||
105759727|NCT03175562|364771664|FG000|Overall Study|Lost to Follow-up|3|||
105759728|NCT03175562|364771664|FG000|Overall Study|Withdrawal by Subject|7|||
105759729|NCT03175562|364771664|FG000|Overall Study|Other (Not Specified)|5|||
105759730|NCT02146833|364771665|FG000|Overall Study|Death|10|||
105759731|NCT02146833|364771665|FG000|Overall Study|No longer consented to study treatment|1|||
105759732|NCT01770145|364773748|FG000|Baseline|Adverse Event|20|||
105759733|NCT01770145|364773748|FG000|Baseline|Withdrawal by Subject|1|||
105759734|NCT01770145|364773748|FG000|Baseline|Lost to Follow-up|1|||
105759735|NCT01770145|364773748|FG000|Baseline|Unable to define optimal dose|4|||
105759736|NCT01770145|364773748|FG000|Treatment|Adverse Event|3|||
105759737|NCT01770145|364773748|FG000|Treatment|Withdrawal by Subject|1|||
105759738|NCT02332798|364773749|FG000|Overall Study|Unwilling to Participate in Study|0|||
105759739|NCT02332798|364773750|FG001|Overall Study|Unwilling to Participate in Study|1|||
105483744|NCT00548405|363782749|FG001|Overall Study|Lost to Follow-up|1|||
105483745|NCT00548405|363782750|FG002|Overall Study|Lost to Follow-up|2|||
105483746|NCT00548405|363782748|FG000|Overall Study|Death|0|||
105483747|NCT00548405|363782749|FG001|Overall Study|Death|1|||
105483748|NCT00548405|363782750|FG002|Overall Study|Death|1|||
105483749|NCT00548405|363782748|FG000|Overall Study|Sponsor decision|1|||
105483750|NCT00548405|363782749|FG001|Overall Study|Sponsor decision|0|||
105483751|NCT00548405|363782750|FG002|Overall Study|Sponsor decision|0|||
105483752|NCT00548405|363782748|FG000|Overall Study|Randomized but not treated|1|||
105483753|NCT00548405|363782749|FG001|Overall Study|Randomized but not treated|0|||
105483754|NCT00548405|363782750|FG002|Overall Study|Randomized but not treated|0|||
105483755|NCT00266877|363782753|FG000|Overall Study|Death|1|||
105759740|NCT02332798|364773751|FG002|Overall Study|Unwilling to Participate in Study|1|||
105759741|NCT02332798|364773749|FG000|Overall Study|Positive Urine Drug Test|0|||
105759742|NCT02332798|364773750|FG001|Overall Study|Positive Urine Drug Test|1|||
105759743|NCT02332798|364773751|FG002|Overall Study|Positive Urine Drug Test|0|||
105483756|NCT00266877|363782754|FG001|Overall Study|Death|1|||
105483757|NCT00266877|363782755|FG002|Overall Study|Death|1|||
105483758|NCT00266877|363782753|FG000|Overall Study|Adverse Event|6|||
105483759|NCT00266877|363782754|FG001|Overall Study|Adverse Event|4|||
105569234|NCT01515189|364083209|FG000|Induction|Adverse Event|14|||
105759744|NCT02332798|364773749|FG000|Overall Study|Abnormal Laboratory Findings|1|||
105759745|NCT02332798|364773750|FG001|Overall Study|Abnormal Laboratory Findings|0|||
105759746|NCT02332798|364773751|FG002|Overall Study|Abnormal Laboratory Findings|0|||
105759747|NCT00595868|364773752|FG000|Overall Study|Lost to Follow-up|45|||
105759748|NCT00595868|364773753|FG001|Overall Study|Lost to Follow-up|50|||
105759749|NCT05406440|364773754|FG000|Overall Study|Lost to Follow-up|0|||
105759750|NCT05406440|364773755|FG001|Overall Study|Lost to Follow-up|0|||
105759751|NCT05406440|364773756|FG002|Overall Study|Lost to Follow-up|0|||
105759752|NCT05406440|364773757|FG003|Overall Study|Lost to Follow-up|0|||
105759753|NCT05406440|364773758|FG004|Overall Study|Lost to Follow-up|2|||
105483760|NCT00266877|363782755|FG002|Overall Study|Adverse Event|1|||
105569235|NCT01515189|364083210|FG001|Induction|Adverse Event|9|||
105569236|NCT01515189|364083209|FG000|Induction|Withdrawal by Subject|3|||
105569237|NCT01515189|364083210|FG001|Induction|Withdrawal by Subject|9|||
105569238|NCT01515189|364083209|FG000|Induction|No longer meets study criteria|0|||
105569239|NCT01515189|364083210|FG001|Induction|No longer meets study criteria|2|||
105569240|NCT01515189|364083209|FG000|Induction|Lost to Follow-up|1|||
105569241|NCT01515189|364083210|FG001|Induction|Lost to Follow-up|0|||
105569242|NCT01515189|364083209|FG000|Induction|Other|0|||
105569243|NCT01515189|364083210|FG001|Induction|Other|4|||
105569244|NCT01515189|364083209|FG000|First Re-Induction Phase|Disease progression|6|||
105569245|NCT01515189|364083210|FG001|First Re-Induction Phase|Disease progression|14|||
105569246|NCT01515189|364083209|FG000|First Re-Induction Phase|Study drug toxicity|5|||
105569247|NCT01515189|364083210|FG001|First Re-Induction Phase|Study drug toxicity|0|||
105569248|NCT01515189|364083209|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
105569249|NCT01515189|364083210|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
105569250|NCT01515189|364083209|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
105569251|NCT01515189|364083210|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
105569252|NCT01515189|364083209|FG000|First Re-Induction Phase|Other|1|||
105569253|NCT01515189|364083210|FG001|First Re-Induction Phase|Other|0|||
105569254|NCT05400746|364083211|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
105569255|NCT05400746|364083212|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
105569256|NCT05400746|364083213|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
105569257|NCT05454410|364083214|FG000|Overall Study|Withdrawal by Subject|0|||
105483761|NCT00266877|363782753|FG000|Overall Study|Physician Decision|2|||
105569258|NCT05454410|364083215|FG001|Overall Study|Withdrawal by Subject|0|||
105569259|NCT05454410|364083216|FG002|Overall Study|Withdrawal by Subject|1|||
105759754|NCT05406440|364773759|FG005|Overall Study|Lost to Follow-up|0|||
105759755|NCT05406440|364773760|FG006|Overall Study|Lost to Follow-up|0|||
105483762|NCT00266877|363782754|FG001|Overall Study|Physician Decision|1|||
105483763|NCT00266877|363782755|FG002|Overall Study|Physician Decision|1|||
105759756|NCT05406440|364773754|FG000|Overall Study|Physician Decision|0|||
105483764|NCT00266877|363782753|FG000|Overall Study|Withdrawal by Subject|3|||
105483765|NCT00266877|363782754|FG001|Overall Study|Withdrawal by Subject|1|||
105483766|NCT00266877|363782755|FG002|Overall Study|Withdrawal by Subject|1|||
105569260|NCT05454410|364083217|FG003|Overall Study|Withdrawal by Subject|1|||
105569261|NCT05014412|364083218|FG000|Overall Study|Death|11|||
105569262|NCT05014412|364083219|FG001|Overall Study|Death|7|||
105569263|NCT05014412|364083220|FG002|Overall Study|Death|4|||
105569264|NCT05014412|364083221|FG003|Overall Study|Death|7|||
105759757|NCT05406440|364773755|FG001|Overall Study|Physician Decision|0|||
105569265|NCT05014412|364083218|FG000|Overall Study|Withdrawal by Subject|1|||
105569266|NCT05014412|364083219|FG001|Overall Study|Withdrawal by Subject|1|||
105569267|NCT05014412|364083220|FG002|Overall Study|Withdrawal by Subject|1|||
105569268|NCT05014412|364083221|FG003|Overall Study|Withdrawal by Subject|2|||
105569269|NCT05014412|364083218|FG000|Overall Study|Ongoing|21|||
105569270|NCT05014412|364083219|FG001|Overall Study|Ongoing|4|||
105569271|NCT05014412|364083220|FG002|Overall Study|Ongoing|6|||
105569272|NCT05014412|364083221|FG003|Overall Study|Ongoing|20|||
105569273|NCT05807919|364083222|FG000|Overall Study|Received antibiotics - excluded|0|||
105569274|NCT05807919|364083223|FG001|Overall Study|Received antibiotics - excluded|1|||
105569275|NCT05807919|364083222|FG000|Overall Study|Withdrawal by Subject|0|||
105569276|NCT05807919|364083223|FG001|Overall Study|Withdrawal by Subject|3|||
105569277|NCT05807919|364083222|FG000|Overall Study|Adverse Event|1|||
105569278|NCT05807919|364083223|FG001|Overall Study|Adverse Event|1|||
105569279|NCT01905046|364083224|FG000|Months 13-24|Withdrawal by Subject|10|||
105569280|NCT01905046|364083225|FG001|Months 13-24|Withdrawal by Subject|10|||
105569281|NCT01905046|364083224|FG000|Months 13-24|Adverse Event|3|||
105569282|NCT01905046|364083225|FG001|Months 13-24|Adverse Event|2|||
105759758|NCT05406440|364773756|FG002|Overall Study|Physician Decision|0|||
105569283|NCT01905046|364083224|FG000|Months 13-24|Protocol Violation|3|||
105569284|NCT01905046|364083225|FG001|Months 13-24|Protocol Violation|3|||
105569285|NCT01905046|364083224|FG000|Months 13-24|Physician Decision|1|||
105569286|NCT01905046|364083225|FG001|Months 13-24|Physician Decision|0|||
105569287|NCT02421939|364083231|FG000|Overall Study|Progressive disease|70|||
105569288|NCT02421939|364083232|FG001|Overall Study|Progressive disease|16|||
105569289|NCT02421939|364083231|FG000|Overall Study|Lack of Efficacy|21|||
105569290|NCT02421939|364083232|FG001|Overall Study|Lack of Efficacy|31|||
105569291|NCT02421939|364083231|FG000|Overall Study|Death|36|||
105569292|NCT02421939|364083232|FG001|Overall Study|Death|10|||
105569293|NCT02421939|364083231|FG000|Overall Study|Disease relapse|33|||
105569294|NCT02421939|364083232|FG001|Overall Study|Disease relapse|2|||
105569295|NCT02421939|364083231|FG000|Overall Study|Adverse Event|28|||
105569296|NCT02421939|364083232|FG001|Overall Study|Adverse Event|5|||
105569297|NCT02421939|364083231|FG000|Overall Study|Withdrawal by Subject|5|||
105569298|NCT02421939|364083232|FG001|Overall Study|Withdrawal by Subject|24|||
105569299|NCT02421939|364083231|FG000|Overall Study|Physician Decision|11|||
105569300|NCT02421939|364083232|FG001|Overall Study|Physician Decision|11|||
105569301|NCT02421939|364083231|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
105569302|NCT02421939|364083232|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
105569303|NCT02421939|364083231|FG000|Overall Study|Miscellaneous|4|||
105569304|NCT02421939|364083232|FG001|Overall Study|Miscellaneous|5|||
105569305|NCT02421939|364083231|FG000|Overall Study|Protocol deviation|1|||
105569306|NCT02421939|364083232|FG001|Overall Study|Protocol deviation|1|||
105569307|NCT04043962|364083233|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
105569308|NCT04043962|364083233|FG000|Post-Treatment|Withdrawal by Subject|5|||
105569309|NCT04043962|364083233|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
105569310|NCT00990340|364083234|FG000|First 14-day Treatment|Not Compliant|2|||
105569311|NCT00990340|364083235|FG001|First 14-day Treatment|Not Compliant|1|||
105569312|NCT00990340|364083234|FG000|First 14-day Treatment|Lost to Follow-up|2|||
105569313|NCT00990340|364083235|FG001|First 14-day Treatment|Lost to Follow-up|1|||
105569314|NCT00990340|364083234|FG000|First 14-day Treatment|Protocol Violation|2|||
105569315|NCT00990340|364083235|FG001|First 14-day Treatment|Protocol Violation|2|||
105569316|NCT01336621|364083236|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
105569317|NCT01336621|364083236|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
105759759|NCT05406440|364773757|FG003|Overall Study|Physician Decision|0|||
105759760|NCT05406440|364773758|FG004|Overall Study|Physician Decision|1|||
105759761|NCT05406440|364773759|FG005|Overall Study|Physician Decision|0|||
105759762|NCT05406440|364773760|FG006|Overall Study|Physician Decision|0|||
105759763|NCT05406440|364773754|FG000|Overall Study|Withdrawal by Subject|0|||
105759764|NCT05406440|364773755|FG001|Overall Study|Withdrawal by Subject|0|||
105759765|NCT05406440|364773756|FG002|Overall Study|Withdrawal by Subject|0|||
105759766|NCT05406440|364773757|FG003|Overall Study|Withdrawal by Subject|0|||
105759767|NCT05406440|364773758|FG004|Overall Study|Withdrawal by Subject|0|||
105759768|NCT05406440|364773759|FG005|Overall Study|Withdrawal by Subject|2|||
105569318|NCT01336621|364083236|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
105569319|NCT01336621|364083236|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
105569320|NCT01336621|364083236|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
105569321|NCT01336621|364083236|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
105569322|NCT01336621|364083236|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
105569323|NCT01336621|364083236|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
105569324|NCT01336621|364083236|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
105569325|NCT01336621|364083236|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
105569326|NCT01336621|364083236|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
105569327|NCT01336621|364083236|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
105759769|NCT05406440|364773760|FG006|Overall Study|Withdrawal by Subject|0|||
105483767|NCT00266877|363782753|FG000|Overall Study|Disease Progression|72|||
105483768|NCT00266877|363782754|FG001|Overall Study|Disease Progression|37|||
105483769|NCT00266877|363782755|FG002|Overall Study|Disease Progression|23|||
105483770|NCT00266877|363782753|FG000|Overall Study|Symptomatic Deterioration|6|||
105483771|NCT00266877|363782754|FG001|Overall Study|Symptomatic Deterioration|3|||
105483772|NCT00266877|363782755|FG002|Overall Study|Symptomatic Deterioration|1|||
105483773|NCT00266877|363782753|FG000|Overall Study|Hospitalization|1|||
105483774|NCT00266877|363782754|FG001|Overall Study|Hospitalization|0|||
105483775|NCT00266877|363782755|FG002|Overall Study|Hospitalization|0|||
105483776|NCT00266877|363782753|FG000|Overall Study|Concomitant Radiotherapy|0|||
105483777|NCT00266877|363782754|FG001|Overall Study|Concomitant Radiotherapy|1|||
105483778|NCT00266877|363782755|FG002|Overall Study|Concomitant Radiotherapy|0|||
105483779|NCT01077375|363782759|FG000|Overall Study|Adverse Event|2|||
105483780|NCT01077375|363782760|FG001|Overall Study|Adverse Event|15|||
105483781|NCT01077375|363782759|FG000|Overall Study|Lack of Efficacy|6|||
105483782|NCT01077375|363782760|FG001|Overall Study|Lack of Efficacy|8|||
105483783|NCT01077375|363782759|FG000|Overall Study|Withdrawal by Subject|0|||
105483784|NCT01077375|363782760|FG001|Overall Study|Withdrawal by Subject|6|||
105483785|NCT01077375|363782759|FG000|Overall Study|Lost to Follow-up|2|||
105483786|NCT01077375|363782760|FG001|Overall Study|Lost to Follow-up|5|||
105569328|NCT01336621|364083236|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
105569329|NCT01336621|364083236|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
105569330|NCT01576718|364083237|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
105569331|NCT01576718|364083238|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
105569332|NCT01576718|364083239|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
105569333|NCT01576718|364083240|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
105483787|NCT01077375|363782759|FG000|Overall Study|Other Reason|0|||
105483788|NCT01077375|363782760|FG001|Overall Study|Other Reason|1|||
105483789|NCT00400153|363782763|FG000|Overall Study|AE due to study disease worsening|14|||
105483790|NCT00400153|363782764|FG001|Overall Study|AE due to study disease worsening|19|||
105569334|NCT01576718|364083241|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
105569335|NCT01576718|364083242|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
105569336|NCT01576718|364083243|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
105569337|NCT01576718|364083237|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
105569338|NCT01576718|364083238|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
105569339|NCT01576718|364083239|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
105569340|NCT01576718|364083240|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
105569341|NCT01576718|364083241|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
105569342|NCT01576718|364083242|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
105569343|NCT01576718|364083243|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
105483791|NCT00400153|363782765|FG002|Overall Study|AE due to study disease worsening|20|||
105483792|NCT00400153|363782763|FG000|Overall Study|AE due to other disease worsening|2|||
105759770|NCT02687711|364773761|FG000|Overall Study|Adverse Event|89|||
105759771|NCT02687711|364773761|FG000|Overall Study|Lack of Efficacy|70|||
105759772|NCT02687711|364773761|FG000|Overall Study|Lost to Follow-up|20|||
105360594|NCT02155985|363326017|FG002|Overall Study|Lost to Follow-up|0|||
105360595|NCT00101868|363326020|FG000|Overall Study|Death|10|||
105759773|NCT02687711|364773761|FG000|Overall Study|Consent withdrawn|15|||
105759774|NCT02687711|364773761|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
105759775|NCT02687711|364773761|FG000|Overall Study|Too expensive|4|||
105759776|NCT02687711|364773761|FG000|Overall Study|Participant moved abroad|1|||
105759777|NCT02687711|364773761|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
105360596|NCT00101868|363326021|FG001|Overall Study|Death|10|||
105483793|NCT00400153|363782764|FG001|Overall Study|AE due to other disease worsening|1|||
105483794|NCT00400153|363782765|FG002|Overall Study|AE due to other disease worsening|0|||
105483795|NCT00400153|363782763|FG000|Overall Study|AE due to other condition|3|||
105483796|NCT00400153|363782764|FG001|Overall Study|AE due to other condition|14|||
105569344|NCT01576718|364083237|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
105569345|NCT01576718|364083238|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
105569346|NCT01576718|364083239|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
105569347|NCT01576718|364083240|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
105569348|NCT01576718|364083241|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
105569349|NCT01576718|364083242|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
105569350|NCT01576718|364083243|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
105483797|NCT00400153|363782765|FG002|Overall Study|AE due to other condition|15|||
105483798|NCT00400153|363782763|FG000|Overall Study|Protocol Violation|7|||
105483799|NCT00400153|363782764|FG001|Overall Study|Protocol Violation|4|||
105483800|NCT00400153|363782765|FG002|Overall Study|Protocol Violation|9|||
105483801|NCT00400153|363782763|FG000|Overall Study|Lost to Follow-up|2|||
105483802|NCT00400153|363782764|FG001|Overall Study|Lost to Follow-up|1|||
105569351|NCT01576718|364083237|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
105483803|NCT00400153|363782765|FG002|Overall Study|Lost to Follow-up|4|||
105483804|NCT00400153|363782763|FG000|Overall Study|Withdrawal by Subject|12|||
105483805|NCT00400153|363782764|FG001|Overall Study|Withdrawal by Subject|11|||
105483806|NCT00400153|363782765|FG002|Overall Study|Withdrawal by Subject|10|||
105483807|NCT00400153|363782763|FG000|Overall Study|Other reasons - not mentioned above|8|||
105483808|NCT00400153|363782764|FG001|Overall Study|Other reasons - not mentioned above|5|||
105483809|NCT00400153|363782765|FG002|Overall Study|Other reasons - not mentioned above|3|||
105483810|NCT01150474|363782768|FG000|Overall Study|Withdrawal by Subject|5|||
105483811|NCT01150474|363782769|FG001|Overall Study|Withdrawal by Subject|2|||
105483812|NCT01150474|363782768|FG000|Overall Study|Cancer found|1|||
105483813|NCT01150474|363782769|FG001|Overall Study|Cancer found|0|||
105483814|NCT01150474|363782768|FG000|Overall Study|Multiple Studies|0|||
105483815|NCT01150474|363782769|FG001|Overall Study|Multiple Studies|1|||
105483816|NCT01150474|363782768|FG000|Overall Study|Rectotomy|1|||
105483817|NCT01150474|363782769|FG001|Overall Study|Rectotomy|0|||
105483818|NCT01150474|363782768|FG000|Overall Study|Drug did not arrive in time|1|||
105483819|NCT01150474|363782769|FG001|Overall Study|Drug did not arrive in time|0|||
105483820|NCT01150474|363782768|FG000|Overall Study|Drug not administered|1|||
105483821|NCT01150474|363782769|FG001|Overall Study|Drug not administered|0|||
105483822|NCT01150474|363782768|FG000|Overall Study|Surgery Changed|1|||
105483823|NCT01150474|363782769|FG001|Overall Study|Surgery Changed|0|||
105483824|NCT03104816|363782770|FG000|Overall Study|Lack of Efficacy|0|||
105483825|NCT03104816|363782771|FG001|Overall Study|Lack of Efficacy|2|||
105483826|NCT03104816|363782772|FG002|Overall Study|Lack of Efficacy|0|||
105483827|NCT03104816|363782770|FG000|Overall Study|Protocol Violation|2|||
105569352|NCT01576718|364083238|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
105569353|NCT01576718|364083239|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
105569354|NCT01576718|364083240|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
105569355|NCT01576718|364083241|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
105569356|NCT01576718|364083242|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
105569357|NCT01576718|364083243|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
105569358|NCT01576718|364083237|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
105759778|NCT02687711|364773761|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
105569359|NCT01576718|364083238|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
105569360|NCT01576718|364083239|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
105569361|NCT01576718|364083240|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
105569362|NCT01576718|364083241|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
105569363|NCT01576718|364083242|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
105569364|NCT01576718|364083243|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
105569365|NCT01576718|364083237|FG000|Treatment Period|Adverse Event|0|||
105569366|NCT01576718|364083238|FG001|Treatment Period|Adverse Event|1|||
105569367|NCT01576718|364083239|FG002|Treatment Period|Adverse Event|1|||
105569368|NCT01576718|364083240|FG003|Treatment Period|Adverse Event|1|||
105569369|NCT01576718|364083241|FG004|Treatment Period|Adverse Event|1|||
105569370|NCT01576718|364083242|FG005|Treatment Period|Adverse Event|1|||
105569371|NCT01576718|364083243|FG006|Treatment Period|Adverse Event|0|||
105759779|NCT02687711|364773761|FG000|Overall Study|Disliked taste|1|||
105759780|NCT02687711|364773761|FG000|Overall Study|Low mood|1|||
105759781|NCT02687711|364773761|FG000|Overall Study|Side effects|1|||
105483828|NCT03104816|363782771|FG001|Overall Study|Protocol Violation|0|||
105483829|NCT03104816|363782772|FG002|Overall Study|Protocol Violation|2|||
105483830|NCT00811642|363782773|FG000|Overall Study|Adverse Event|3|||
105483831|NCT00811642|363782773|FG000|Overall Study|Protocol Violation|1|||
105483832|NCT00811642|363782773|FG000|Overall Study|Death|2|||
105483833|NCT00811642|363782773|FG000|Overall Study|Withdrawal by Subject|7|||
105483834|NCT00811642|363782773|FG000|Overall Study|Cumulative use of antifungal agent|2|||
105569372|NCT01576718|364083237|FG000|Treatment Period|Withdrawal by Subject|0|||
105569373|NCT01576718|364083238|FG001|Treatment Period|Withdrawal by Subject|1|||
105759782|NCT02687711|364773761|FG000|Overall Study|Change of Hospital|1|||
105759783|NCT02687711|364773761|FG000|Overall Study|Liver Encephalopathy|1|||
105759784|NCT02687711|364773761|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
105483835|NCT01006603|363782776|FG000|Overall Study|Withdrawal by Subject|17|||
105483836|NCT01006603|363782777|FG001|Overall Study|Withdrawal by Subject|19|||
105483837|NCT01006603|363782776|FG000|Overall Study|Lost to Follow-up|0|||
105483838|NCT01006603|363782777|FG001|Overall Study|Lost to Follow-up|1|||
105483839|NCT01006603|363782776|FG000|Overall Study|Safety reason|1|||
105483840|NCT01006603|363782777|FG001|Overall Study|Safety reason|1|||
105483841|NCT01006603|363782776|FG000|Overall Study|Protocol Violation|1|||
105483842|NCT01006603|363782777|FG001|Overall Study|Protocol Violation|3|||
105483843|NCT01006603|363782776|FG000|Overall Study|Incorrect enrolment|0|||
105483844|NCT01006603|363782777|FG001|Overall Study|Incorrect enrolment|2|||
105483845|NCT01006603|363782776|FG000|Overall Study|Adverse Event|15|||
105483846|NCT01006603|363782777|FG001|Overall Study|Adverse Event|7|||
105483847|NCT01006603|363782776|FG000|Overall Study|Death|1|||
105483848|NCT01006603|363782777|FG001|Overall Study|Death|1|||
105483849|NCT01006603|363782776|FG000|Overall Study|Study specific discontinuation criteria|33|||
105483850|NCT01006603|363782777|FG001|Overall Study|Study specific discontinuation criteria|34|||
105483851|NCT01006603|363782776|FG000|Overall Study|Other|3|||
105483852|NCT01006603|363782777|FG001|Overall Study|Other|7|||
105483853|NCT01340872|363784208|FG000|Double-blind Phase|Adverse Event|6|||
105483854|NCT01340872|363784209|FG001|Double-blind Phase|Adverse Event|4|||
105483855|NCT01340872|363784210|FG002|Double-blind Phase|Adverse Event|0|||
105483856|NCT01340872|363784211|FG003|Double-blind Phase|Adverse Event|0|||
105483857|NCT01340872|363784208|FG000|Double-blind Phase|Withdrawal by Subject|3|||
105759785|NCT02687711|364773761|FG000|Overall Study|Withdrawn due to intake interruption|1|||
105483858|NCT01340872|363784209|FG001|Double-blind Phase|Withdrawal by Subject|5|||
105483859|NCT01340872|363784210|FG002|Double-blind Phase|Withdrawal by Subject|0|||
105759786|NCT02687711|364773761|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
105759787|NCT02687711|364773761|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
105759788|NCT02687711|364773761|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
105759789|NCT03077243|364773762|FG000|Overall Study|Death|1|||
105759790|NCT03077243|364773763|FG001|Overall Study|Death|2|||
105759791|NCT03077243|364773764|FG002|Overall Study|Death|0|||
105759792|NCT03077243|364773765|FG003|Overall Study|Death|0|||
105759793|NCT03077243|364773762|FG000|Overall Study|Withdrawal by Subject|1|||
105759794|NCT03077243|364773763|FG001|Overall Study|Withdrawal by Subject|3|||
105804999|NCT03111147|364942003|FG001|Overall Study|Withdrawal by Subject|3|||
105805000|NCT03111147|364942002|FG000|Overall Study|Protocol Violation|2|||
105483860|NCT01340872|363784211|FG003|Double-blind Phase|Withdrawal by Subject|0|||
105483861|NCT01340872|363784208|FG000|Double-blind Phase|Lost to Follow-up|0|||
105483862|NCT01340872|363784209|FG001|Double-blind Phase|Lost to Follow-up|1|||
105483863|NCT01340872|363784210|FG002|Double-blind Phase|Lost to Follow-up|0|||
105483864|NCT01340872|363784211|FG003|Double-blind Phase|Lost to Follow-up|0|||
105483865|NCT01340872|363784208|FG000|Double-blind Phase|Protocol Violation|0|||
105483866|NCT01340872|363784209|FG001|Double-blind Phase|Protocol Violation|1|||
105483867|NCT01340872|363784210|FG002|Double-blind Phase|Protocol Violation|0|||
105483868|NCT01340872|363784211|FG003|Double-blind Phase|Protocol Violation|0|||
105483869|NCT01340872|363784208|FG000|Open-label Phase|Physician Decision|0|||
105483870|NCT01340872|363784209|FG001|Open-label Phase|Physician Decision|0|||
105483871|NCT01340872|363784210|FG002|Open-label Phase|Physician Decision|2|||
105483872|NCT01340872|363784211|FG003|Open-label Phase|Physician Decision|1|||
105483873|NCT01340872|363784208|FG000|Open-label Phase|Pregnancy|0|||
105483874|NCT01340872|363784209|FG001|Open-label Phase|Pregnancy|0|||
105483875|NCT01340872|363784210|FG002|Open-label Phase|Pregnancy|1|||
105483876|NCT01340872|363784211|FG003|Open-label Phase|Pregnancy|0|||
105483877|NCT01340872|363784208|FG000|Open-label Phase|Adverse Event|0|||
105483878|NCT01340872|363784209|FG001|Open-label Phase|Adverse Event|0|||
105483879|NCT01340872|363784210|FG002|Open-label Phase|Adverse Event|8|||
105483880|NCT01340872|363784211|FG003|Open-label Phase|Adverse Event|4|||
105483881|NCT01340872|363784208|FG000|Open-label Phase|Withdrawal by Subject|0|||
105483882|NCT01340872|363784209|FG001|Open-label Phase|Withdrawal by Subject|0|||
105483883|NCT01340872|363784210|FG002|Open-label Phase|Withdrawal by Subject|1|||
105483884|NCT01340872|363784211|FG003|Open-label Phase|Withdrawal by Subject|6|||
105483885|NCT01340872|363784208|FG000|Open-label Phase|Worsening of IBD|0|||
105483886|NCT01340872|363784209|FG001|Open-label Phase|Worsening of IBD|0|||
105483887|NCT01340872|363784210|FG002|Open-label Phase|Worsening of IBD|1|||
105483888|NCT01340872|363784211|FG003|Open-label Phase|Worsening of IBD|0|||
105483889|NCT03039621|363784214|FG000|Overall Study|Violation of inclusion criteria|3|||
105483890|NCT03039621|363784215|FG001|Overall Study|Violation of inclusion criteria|2|||
105483891|NCT03039621|363784214|FG000|Overall Study|Non-compliance with protocol requirement|4|||
105483892|NCT03039621|363784215|FG001|Overall Study|Non-compliance with protocol requirement|5|||
105483893|NCT03039621|363784214|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
105483894|NCT03039621|363784215|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
105483895|NCT03039621|363784214|FG000|Overall Study|Violation of non-inclusion criteria|1|||
105483896|NCT03039621|363784215|FG001|Overall Study|Violation of non-inclusion criteria|2|||
105483897|NCT02656680|363784217|FG000|Overall Study|Lost to Follow-up|0|||
105483898|NCT02656680|363784218|FG001|Overall Study|Lost to Follow-up|1|||
105483899|NCT02656680|363784219|FG002|Overall Study|Lost to Follow-up|7|||
105483900|NCT00134784|363784220|FG000|Overall Study|Withdrawal by Subject|2|||
105483901|NCT00134784|363784221|FG001|Overall Study|Withdrawal by Subject|2|||
105483902|NCT00134784|363784222|FG002|Overall Study|Withdrawal by Subject|2|||
105483903|NCT00134784|363784223|FG003|Overall Study|Withdrawal by Subject|1|||
105483904|NCT00464490|363784224|FG000|Overall Study|Physician Decision|11|||
105483905|NCT00464490|363784225|FG001|Overall Study|Physician Decision|11|||
105483906|NCT03739242|363784226|FG000|Overall Study|Withdrawal by Subject|1|||
105483907|NCT03739242|363784227|FG001|Overall Study|Withdrawal by Subject|1|||
105483908|NCT03739242|363784226|FG000|Overall Study|Protocol Violation|0|||
105483909|NCT03739242|363784227|FG001|Overall Study|Protocol Violation|1|||
105483910|NCT04352127|363784228|FG000|Overall Study|Unable to obtain readings|4|||
105483911|NCT04352127|363784229|FG001|Overall Study|Unable to obtain readings|1|||
105483912|NCT00997438|363784233|FG000|Overall Study|Blood draw difficulty|2|||
105483913|NCT00997438|363784234|FG001|Overall Study|Blood draw difficulty|0|||
105483914|NCT00997438|363784235|FG002|Overall Study|Blood draw difficulty|1|||
105483915|NCT00997438|363784233|FG000|Overall Study|Withdrawal by Subject|1|||
105483916|NCT00997438|363784234|FG001|Overall Study|Withdrawal by Subject|1|||
105483917|NCT00997438|363784235|FG002|Overall Study|Withdrawal by Subject|0|||
105483918|NCT00997438|363784233|FG000|Overall Study|Exclusion criteria at visit 1|2|||
105483919|NCT00997438|363784234|FG001|Overall Study|Exclusion criteria at visit 1|2|||
105483920|NCT00997438|363784235|FG002|Overall Study|Exclusion criteria at visit 1|3|||
105483921|NCT04393298|363784236|FG000|Overall Study|Adverse Event|0|||
105483922|NCT04393298|363784237|FG001|Overall Study|Adverse Event|0|||
105483923|NCT04393298|363784238|FG002|Overall Study|Adverse Event|0|||
105569374|NCT01576718|364083239|FG002|Treatment Period|Withdrawal by Subject|1|||
105569375|NCT01576718|364083240|FG003|Treatment Period|Withdrawal by Subject|0|||
105759795|NCT03077243|364773764|FG002|Overall Study|Withdrawal by Subject|0|||
105759796|NCT03077243|364773765|FG003|Overall Study|Withdrawal by Subject|0|||
105759797|NCT03077243|364773762|FG000|Overall Study|Physician Decision|1|||
105759798|NCT03077243|364773763|FG001|Overall Study|Physician Decision|0|||
105759799|NCT03077243|364773764|FG002|Overall Study|Physician Decision|0|||
105759800|NCT03077243|364773765|FG003|Overall Study|Physician Decision|0|||
105759801|NCT03077243|364773762|FG000|Overall Study|Research at two study sites terminated early|0|||
105759802|NCT03077243|364773763|FG001|Overall Study|Research at two study sites terminated early|0|||
105759803|NCT03077243|364773764|FG002|Overall Study|Research at two study sites terminated early|0|||
105759804|NCT03077243|364773765|FG003|Overall Study|Research at two study sites terminated early|69|||
105759805|NCT02848313|364773766|FG000|Overall Study|Adverse Event|1|||
105759806|NCT02848313|364773767|FG001|Overall Study|Adverse Event|2|||
105759807|NCT02848313|364773766|FG000|Overall Study|Lack of Efficacy|0|||
105759808|NCT02848313|364773767|FG001|Overall Study|Lack of Efficacy|1|||
105759809|NCT02848313|364773766|FG000|Overall Study|Withdrawal by Subject|1|||
105759810|NCT02848313|364773767|FG001|Overall Study|Withdrawal by Subject|1|||
105759811|NCT02848313|364773766|FG000|Overall Study|Lost to follow up|1|||
105759812|NCT02848313|364773767|FG001|Overall Study|Lost to follow up|0|||
105759813|NCT01544478|364773768|FG000|Overall Study|Adverse Event|1|||
105759814|NCT01544478|364773768|FG000|Overall Study|Death|1|||
105759815|NCT01544478|364773768|FG000|Overall Study|Lost to Follow-up|48|||
105759816|NCT01544478|364773768|FG000|Overall Study|Physician Decision|15|||
105759817|NCT01544478|364773768|FG000|Overall Study|Pregnancy|1|||
105759818|NCT01544478|364773768|FG000|Overall Study|Withdrawal by Subject|52|||
105805001|NCT03111147|364942003|FG001|Overall Study|Protocol Violation|1|||
105805002|NCT03111147|364942002|FG000|Overall Study|Death|1|||
105805003|NCT03111147|364942003|FG001|Overall Study|Death|1|||
105805004|NCT00003782|364942007|FG000|Overall Study|No follow up data|30|||
105805005|NCT00003782|364942008|FG001|Overall Study|No follow up data|31|||
105805006|NCT00003782|364942009|FG002|Overall Study|No follow up data|26|||
105805007|NCT03118739|364942010|FG000|Overall Study|Physician Decision|0|||
105805008|NCT03118739|364942011|FG001|Overall Study|Physician Decision|1|||
105805009|NCT03118739|364942010|FG000|Overall Study|Withdrawal by Subject|5|||
105805010|NCT03118739|364942011|FG001|Overall Study|Withdrawal by Subject|3|||
105805011|NCT03118739|364942010|FG000|Overall Study|Lost to Follow-up|2|||
105805012|NCT03118739|364942011|FG001|Overall Study|Lost to Follow-up|0|||
105805013|NCT00409188|364943331|FG000|Overall Study|Ongoing at data cut-off|383|||
105805014|NCT00409188|364943332|FG001|Overall Study|Ongoing at data cut-off|175|||
105805015|NCT02468557|364943337|FG000|Overall Study|Adverse Event|1|||
105805016|NCT02468557|364943337|FG000|Overall Study|Death|1|||
105805017|NCT02468557|364943337|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
105805018|NCT02468557|364943337|FG000|Overall Study|All Enrolled but Never Dosed|4|||
105805019|NCT04014959|364943339|FG000|Baseline MRI and Assessments|Physician Decision|2|||
105805020|NCT04014959|364943339|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
105805021|NCT04014959|364943339|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
105805022|NCT02004847|364943342|FG000|Overall Study|Protocol Violation|1|||
105805023|NCT02004847|364943343|FG001|Overall Study|Protocol Violation|1|||
105805024|NCT02034799|364943344|FG000|Overall Study|Withdrawal by Subject|0|||
105805025|NCT02034799|364943345|FG001|Overall Study|Withdrawal by Subject|2|||
105805026|NCT02034799|364943344|FG000|Overall Study|Lost to Follow-up|0|||
105805027|NCT02034799|364943345|FG001|Overall Study|Lost to Follow-up|1|||
105805028|NCT02034799|364943344|FG000|Overall Study|Death|2|||
105805029|NCT02034799|364943345|FG001|Overall Study|Death|1|||
105805030|NCT00759148|364943352|FG000|Overall Study|Adverse Event|1|||
105805031|NCT00759148|364943353|FG001|Overall Study|Adverse Event|6|||
105805032|NCT00759148|364943352|FG000|Overall Study|Withdrawal by Subject|3|||
105805033|NCT00759148|364943353|FG001|Overall Study|Withdrawal by Subject|7|||
105805034|NCT00759148|364943352|FG000|Overall Study|Lost to Follow-up|3|||
105805035|NCT00759148|364943353|FG001|Overall Study|Lost to Follow-up|9|||
105569376|NCT01576718|364083241|FG004|Treatment Period|Withdrawal by Subject|2|||
105759819|NCT00212758|364773771|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
105759820|NCT00212758|364773772|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
105759821|NCT00212758|364773771|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
105483924|NCT04393298|363784239|FG003|Overall Study|Adverse Event|0|||
105483925|NCT04393298|363784240|FG004|Overall Study|Adverse Event|1|||
105483926|NCT04393298|363784241|FG005|Overall Study|Adverse Event|0|||
105483927|NCT04393298|363784242|FG006|Overall Study|Adverse Event|0|||
105483928|NCT04393298|363784243|FG007|Overall Study|Adverse Event|0|||
105483929|NCT04393298|363784244|FG008|Overall Study|Adverse Event|2|||
105483930|NCT04393298|363784245|FG009|Overall Study|Adverse Event|0|||
105483931|NCT04393298|363784246|FG010|Overall Study|Adverse Event|0|||
105483932|NCT04393298|363784247|FG011|Overall Study|Adverse Event|0|||
105483933|NCT04393298|363784248|FG012|Overall Study|Adverse Event|1|||
105483934|NCT04393298|363784249|FG013|Overall Study|Adverse Event|1|||
105483935|NCT04393298|363784250|FG014|Overall Study|Adverse Event|0|||
105483936|NCT04393298|363784236|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
105483937|NCT04393298|363784237|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
105483938|NCT04393298|363784238|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
105483939|NCT04393298|363784239|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
105483940|NCT04393298|363784240|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
105483941|NCT04393298|363784241|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
105483942|NCT04393298|363784242|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
105483943|NCT04393298|363784243|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
105483944|NCT04393298|363784244|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
105483945|NCT04393298|363784245|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
105483946|NCT04393298|363784246|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
105483947|NCT04393298|363784247|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
105759822|NCT00212758|364773772|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
105759823|NCT03510910|364773773|FG000|Overall Study|Incomplete Survey|2|||
105759824|NCT03510910|364773774|FG001|Overall Study|Incomplete Survey|3|||
105759825|NCT03170258|364773779|FG000|Overall Study|Physician Decision|4|||
105759826|NCT03170258|364773780|FG001|Overall Study|Physician Decision|0|||
105759827|NCT03170258|364773779|FG000|Overall Study|Equipment issues|1|||
105569377|NCT01576718|364083242|FG005|Treatment Period|Withdrawal by Subject|4|||
105569378|NCT01576718|364083243|FG006|Treatment Period|Withdrawal by Subject|2|||
105569379|NCT01576718|364083237|FG000|Treatment Period|Physician Decision|0|||
105569380|NCT01576718|364083238|FG001|Treatment Period|Physician Decision|1|||
105569381|NCT01576718|364083239|FG002|Treatment Period|Physician Decision|1|||
105569382|NCT01576718|364083240|FG003|Treatment Period|Physician Decision|1|||
105569383|NCT01576718|364083241|FG004|Treatment Period|Physician Decision|1|||
105569384|NCT01576718|364083242|FG005|Treatment Period|Physician Decision|0|||
105569385|NCT01576718|364083243|FG006|Treatment Period|Physician Decision|0|||
105569386|NCT01576718|364083237|FG000|Treatment Period|Protocol Violation|0|||
105569387|NCT01576718|364083238|FG001|Treatment Period|Protocol Violation|5|||
105759828|NCT03170258|364773780|FG001|Overall Study|Equipment issues|0|||
105759829|NCT03170258|364773779|FG000|Overall Study|Medication|1|||
105759830|NCT03170258|364773780|FG001|Overall Study|Medication|0|||
105759831|NCT03170258|364773779|FG000|Overall Study|Sleep issues|1|||
105759832|NCT03170258|364773780|FG001|Overall Study|Sleep issues|0|||
105759833|NCT01563107|364773785|FG000|Overall Study|Physician Decision|0|||
105759834|NCT01563107|364773786|FG001|Overall Study|Physician Decision|1|||
105759835|NCT01563107|364773787|FG002|Overall Study|Physician Decision|1|||
105759836|NCT01563107|364773788|FG003|Overall Study|Physician Decision|3|||
105759837|NCT01563107|364773785|FG000|Overall Study|Withdrawal by Subject|1|||
105759838|NCT01563107|364773786|FG001|Overall Study|Withdrawal by Subject|2|||
105759839|NCT01563107|364773787|FG002|Overall Study|Withdrawal by Subject|1|||
105759840|NCT01563107|364773788|FG003|Overall Study|Withdrawal by Subject|2|||
105759841|NCT01175590|364773791|FG000|Overall Study|Lost to Follow-up|1|||
105759842|NCT01175590|364773792|FG001|Overall Study|Lost to Follow-up|0|||
105759843|NCT01175590|364773791|FG000|Overall Study|Withdrawal by Subject|0|||
105759844|NCT01175590|364773792|FG001|Overall Study|Withdrawal by Subject|2|||
105759845|NCT01175590|364773791|FG000|Overall Study|Adverse Event|4|||
105759846|NCT01175590|364773792|FG001|Overall Study|Adverse Event|0|||
105759847|NCT01175590|364773791|FG000|Overall Study|Physician Decision|1|||
105759848|NCT01175590|364773792|FG001|Overall Study|Physician Decision|4|||
105483948|NCT04393298|363784248|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
105483949|NCT04393298|363784249|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
105483950|NCT04393298|363784250|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
105569388|NCT01576718|364083239|FG002|Treatment Period|Protocol Violation|4|||
105569389|NCT01576718|364083240|FG003|Treatment Period|Protocol Violation|10|||
105759849|NCT01175590|364773791|FG000|Overall Study|Lack of Efficacy|1|||
105569390|NCT01576718|364083241|FG004|Treatment Period|Protocol Violation|6|||
105759850|NCT01175590|364773792|FG001|Overall Study|Lack of Efficacy|1|||
105759851|NCT01175590|364773791|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
105759852|NCT01175590|364773792|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
105759853|NCT01175590|364773791|FG000|Overall Study|Treated not as randomized|3|||
105759854|NCT01175590|364773792|FG001|Overall Study|Treated not as randomized|2|||
105569391|NCT01576718|364083242|FG005|Treatment Period|Protocol Violation|8|||
105569392|NCT01576718|364083243|FG006|Treatment Period|Protocol Violation|12|||
105569393|NCT01576718|364083237|FG000|Treatment Period|Sponsor request|0|||
105569394|NCT01576718|364083238|FG001|Treatment Period|Sponsor request|1|||
105569395|NCT01576718|364083239|FG002|Treatment Period|Sponsor request|0|||
105569396|NCT01576718|364083240|FG003|Treatment Period|Sponsor request|0|||
105569397|NCT01576718|364083241|FG004|Treatment Period|Sponsor request|0|||
105569398|NCT01576718|364083242|FG005|Treatment Period|Sponsor request|1|||
105569399|NCT01576718|364083243|FG006|Treatment Period|Sponsor request|0|||
105569400|NCT01576718|364083237|FG000|Treatment Period|Met stopping criteria|0|||
105569401|NCT01576718|364083238|FG001|Treatment Period|Met stopping criteria|16|||
105759855|NCT01175590|364773791|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
105759856|NCT01175590|364773792|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
105759857|NCT01175590|364773791|FG000|Overall Study|Protocol Violation|0|||
105759858|NCT01175590|364773792|FG001|Overall Study|Protocol Violation|1|||
105759859|NCT00666536|364773793|FG000|Overall Study|Adverse Event|9|||
105759860|NCT00666536|364773794|FG001|Overall Study|Adverse Event|19|||
105759861|NCT00666536|364773793|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105759862|NCT00666536|364773794|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105569402|NCT01576718|364083239|FG002|Treatment Period|Met stopping criteria|13|||
105569403|NCT01576718|364083240|FG003|Treatment Period|Met stopping criteria|19|||
105569404|NCT01576718|364083241|FG004|Treatment Period|Met stopping criteria|16|||
105569405|NCT01576718|364083242|FG005|Treatment Period|Met stopping criteria|33|||
105569406|NCT01576718|364083243|FG006|Treatment Period|Met stopping criteria|15|||
105569407|NCT01576718|364083237|FG000|Treatment Period|Lost to Follow-up|0|||
105569408|NCT01576718|364083238|FG001|Treatment Period|Lost to Follow-up|0|||
105569409|NCT01576718|364083239|FG002|Treatment Period|Lost to Follow-up|0|||
105569410|NCT01576718|364083240|FG003|Treatment Period|Lost to Follow-up|0|||
105569411|NCT01576718|364083241|FG004|Treatment Period|Lost to Follow-up|1|||
105569412|NCT01576718|364083242|FG005|Treatment Period|Lost to Follow-up|0|||
105569413|NCT01576718|364083243|FG006|Treatment Period|Lost to Follow-up|0|||
105569414|NCT01576718|364083237|FG000|Treatment Period|Noncompliance to study medication|0|||
105569415|NCT01576718|364083238|FG001|Treatment Period|Noncompliance to study medication|0|||
105569416|NCT01576718|364083239|FG002|Treatment Period|Noncompliance to study medication|0|||
105569417|NCT01576718|364083240|FG003|Treatment Period|Noncompliance to study medication|0|||
105569418|NCT01576718|364083241|FG004|Treatment Period|Noncompliance to study medication|0|||
105569419|NCT01576718|364083242|FG005|Treatment Period|Noncompliance to study medication|1|||
105569420|NCT01576718|364083243|FG006|Treatment Period|Noncompliance to study medication|1|||
105569421|NCT01874145|364083245|FG000|Core Period|Non-compliance|1|||
105569422|NCT01874145|364083246|FG001|Core Period|Non-compliance|0|||
105569423|NCT01874145|364083245|FG000|Core Period|Protocol Violation|1|||
105759863|NCT00666536|364773793|FG000|Overall Study|Protocol deviation(s)|8|||
105759864|NCT00666536|364773794|FG001|Overall Study|Protocol deviation(s)|6|||
105759865|NCT00666536|364773793|FG000|Overall Study|Withdrawal by Subject|10|||
105759866|NCT00666536|364773794|FG001|Overall Study|Withdrawal by Subject|9|||
105759867|NCT00666536|364773793|FG000|Overall Study|Lost to Follow-up|4|||
105759868|NCT00666536|364773794|FG001|Overall Study|Lost to Follow-up|3|||
105759869|NCT02327078|364773795|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
105759870|NCT02327078|364773796|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
105759871|NCT02327078|364773797|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
105759872|NCT02327078|364773798|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
105759873|NCT02327078|364773799|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
105759874|NCT02327078|364773800|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
105759875|NCT02327078|364773801|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
105759876|NCT02327078|364773802|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
105759877|NCT02327078|364773803|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
105759878|NCT02327078|364773795|FG000|Overall Study|Death|2|||
105759879|NCT02327078|364773796|FG001|Overall Study|Death|4|||
105759880|NCT02327078|364773797|FG002|Overall Study|Death|10|||
105759881|NCT02327078|364773798|FG003|Overall Study|Death|6|||
105759882|NCT02327078|364773799|FG004|Overall Study|Death|4|||
105759883|NCT02327078|364773800|FG005|Overall Study|Death|3|||
105759884|NCT02327078|364773801|FG006|Overall Study|Death|2|||
105569424|NCT01874145|364083246|FG001|Core Period|Protocol Violation|1|||
105569425|NCT01874145|364083245|FG000|Core Period|Physician Decision|1|||
105569426|NCT01874145|364083246|FG001|Core Period|Physician Decision|1|||
105569427|NCT01874145|364083245|FG000|Core Period|Adverse Event|0|||
105759885|NCT02327078|364773802|FG007|Overall Study|Death|51|||
105759886|NCT02327078|364773803|FG008|Overall Study|Death|97|||
105759887|NCT02327078|364773795|FG000|Overall Study|Lost to Follow-up|0|||
105569428|NCT01874145|364083246|FG001|Core Period|Adverse Event|1|||
105759888|NCT02327078|364773796|FG001|Overall Study|Lost to Follow-up|1|||
105759889|NCT02327078|364773797|FG002|Overall Study|Lost to Follow-up|1|||
105759890|NCT02327078|364773798|FG003|Overall Study|Lost to Follow-up|0|||
105805036|NCT00759148|364943352|FG000|Overall Study|Treatment Failure|6|||
105805037|NCT00759148|364943353|FG001|Overall Study|Treatment Failure|10|||
105805038|NCT00759148|364943352|FG000|Overall Study|Reason not given|1|||
105805039|NCT00759148|364943353|FG001|Overall Study|Reason not given|0|||
105805040|NCT03381248|364943354|FG000|0-6 Months|Withdrawal by Subject|4|||
105805041|NCT03381248|364943355|FG001|0-6 Months|Withdrawal by Subject|1|||
105805042|NCT03381248|364943354|FG000|0-6 Months|Lost to Follow-up|3|||
105805043|NCT03381248|364943355|FG001|0-6 Months|Lost to Follow-up|2|||
105805044|NCT03381248|364943354|FG000|0-6 Months|Lack of Efficacy|1|||
105805045|NCT03381248|364943355|FG001|0-6 Months|Lack of Efficacy|0|||
105805046|NCT03381248|364943354|FG000|0-6 Months|Adverse Event|1|||
105805047|NCT03381248|364943355|FG001|0-6 Months|Adverse Event|0|||
105805048|NCT03381248|364943354|FG000|0-6 Months|Protocol Violation|2|||
105805049|NCT03381248|364943355|FG001|0-6 Months|Protocol Violation|1|||
105805050|NCT03381248|364943354|FG000|0-6 Months|Physician Decision|1|||
105805051|NCT03381248|364943355|FG001|0-6 Months|Physician Decision|0|||
105483951|NCT04393298|363784236|FG000|Overall Study|Lack of Efficacy|0|||
105483952|NCT04393298|363784237|FG001|Overall Study|Lack of Efficacy|0|||
105483953|NCT04393298|363784238|FG002|Overall Study|Lack of Efficacy|0|||
105483954|NCT04393298|363784239|FG003|Overall Study|Lack of Efficacy|0|||
105483955|NCT04393298|363784240|FG004|Overall Study|Lack of Efficacy|0|||
105483956|NCT04393298|363784241|FG005|Overall Study|Lack of Efficacy|0|||
105483957|NCT04393298|363784242|FG006|Overall Study|Lack of Efficacy|0|||
105483958|NCT04393298|363784243|FG007|Overall Study|Lack of Efficacy|0|||
105483959|NCT04393298|363784244|FG008|Overall Study|Lack of Efficacy|0|||
105483960|NCT04393298|363784245|FG009|Overall Study|Lack of Efficacy|0|||
105483961|NCT04393298|363784246|FG010|Overall Study|Lack of Efficacy|0|||
105483962|NCT04393298|363784247|FG011|Overall Study|Lack of Efficacy|0|||
105483963|NCT04393298|363784248|FG012|Overall Study|Lack of Efficacy|0|||
105483964|NCT04393298|363784249|FG013|Overall Study|Lack of Efficacy|0|||
105483965|NCT04393298|363784250|FG014|Overall Study|Lack of Efficacy|1|||
105483966|NCT04393298|363784236|FG000|Overall Study|Progression|1|||
105483967|NCT04393298|363784237|FG001|Overall Study|Progression|0|||
105483968|NCT04393298|363784238|FG002|Overall Study|Progression|0|||
105483969|NCT04393298|363784239|FG003|Overall Study|Progression|0|||
105483970|NCT04393298|363784240|FG004|Overall Study|Progression|0|||
105483971|NCT04393298|363784241|FG005|Overall Study|Progression|0|||
105483972|NCT04393298|363784242|FG006|Overall Study|Progression|0|||
105483973|NCT04393298|363784243|FG007|Overall Study|Progression|0|||
105483974|NCT04393298|363784244|FG008|Overall Study|Progression|0|||
105483975|NCT04393298|363784245|FG009|Overall Study|Progression|0|||
105483976|NCT04393298|363784246|FG010|Overall Study|Progression|1|||
105805052|NCT03381248|364943354|FG000|0-6 Months|Planning another procedure|1|||
105805053|NCT03381248|364943355|FG001|0-6 Months|Planning another procedure|2|||
105483977|NCT04393298|363784247|FG011|Overall Study|Progression|1|||
105483978|NCT04393298|363784248|FG012|Overall Study|Progression|0|||
105483979|NCT04393298|363784249|FG013|Overall Study|Progression|0|||
105483980|NCT04393298|363784250|FG014|Overall Study|Progression|0|||
105805054|NCT03381248|364943354|FG000|6-12 Months|Withdrawal by Subject|1|||
105805055|NCT03381248|364943355|FG001|6-12 Months|Withdrawal by Subject|3|||
105483981|NCT04393298|363784236|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
105569429|NCT01874145|364083245|FG000|Core Period|Withdrawal by Subject|0|||
105569430|NCT01874145|364083246|FG001|Core Period|Withdrawal by Subject|4|||
105569431|NCT01874145|364083245|FG000|Extension Period|Adverse Event|3|||
105569432|NCT01874145|364083246|FG001|Extension Period|Adverse Event|2|||
105569433|NCT01874145|364083245|FG000|Extension Period|Withdrawal by Subject|2|||
105569434|NCT01874145|364083246|FG001|Extension Period|Withdrawal by Subject|1|||
105483982|NCT04393298|363784237|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
105483983|NCT04393298|363784238|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
105483984|NCT04393298|363784239|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
105483985|NCT04393298|363784240|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
105569435|NCT01874145|364083245|FG000|Extension Period|Lost to Follow-up|1|||
105569436|NCT01874145|364083246|FG001|Extension Period|Lost to Follow-up|1|||
105569437|NCT02487095|364083247|FG000|Dose Expansion|Unable to scan/restage participant|0|||
105569438|NCT02487095|364083248|FG001|Dose Expansion|Unable to scan/restage participant|0|||
105483986|NCT04393298|363784241|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
105483987|NCT04393298|363784242|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
105483988|NCT04393298|363784243|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
105483989|NCT04393298|363784244|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
105483990|NCT04393298|363784245|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
105483991|NCT04393298|363784246|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
105483992|NCT04393298|363784247|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
105483993|NCT04393298|363784248|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
105483994|NCT04393298|363784249|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
105483995|NCT04393298|363784250|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
105483996|NCT04393298|363784236|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
105483997|NCT04393298|363784237|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
105483998|NCT04393298|363784238|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
105483999|NCT04393298|363784239|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
105484000|NCT04393298|363784240|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
105484001|NCT04393298|363784241|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
105484002|NCT04393298|363784242|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
105484003|NCT04393298|363784243|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
105484004|NCT04393298|363784244|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
105484005|NCT04393298|363784245|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
105484006|NCT04393298|363784246|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
105484007|NCT04393298|363784247|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
105484008|NCT04393298|363784248|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
105484009|NCT04393298|363784249|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
105484010|NCT04393298|363784250|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
105484011|NCT04393298|363784236|FG000|Overall Study|Clinical Progression|0|||
105484012|NCT04393298|363784237|FG001|Overall Study|Clinical Progression|2|||
105484013|NCT04393298|363784238|FG002|Overall Study|Clinical Progression|0|||
105484014|NCT04393298|363784239|FG003|Overall Study|Clinical Progression|0|||
105484015|NCT04393298|363784240|FG004|Overall Study|Clinical Progression|0|||
105484016|NCT04393298|363784241|FG005|Overall Study|Clinical Progression|0|||
105484017|NCT04393298|363784242|FG006|Overall Study|Clinical Progression|0|||
105484018|NCT04393298|363784243|FG007|Overall Study|Clinical Progression|0|||
105484019|NCT04393298|363784244|FG008|Overall Study|Clinical Progression|0|||
105484020|NCT04393298|363784245|FG009|Overall Study|Clinical Progression|0|||
105484021|NCT04393298|363784246|FG010|Overall Study|Clinical Progression|0|||
105484022|NCT04393298|363784247|FG011|Overall Study|Clinical Progression|0|||
105569439|NCT02487095|364083249|FG002|Dose Expansion|Unable to scan/restage participant|0|||
105569440|NCT02487095|364083250|FG003|Dose Expansion|Unable to scan/restage participant|0|||
105569441|NCT02487095|364083251|FG004|Dose Expansion|Unable to scan/restage participant|1|||
105569442|NCT04631705|364083252|FG000|Overall Study|Withdrawal by Subject|0|||
105569443|NCT04631705|364083253|FG001|Overall Study|Withdrawal by Subject|0|||
105569444|NCT04631705|364083254|FG002|Overall Study|Withdrawal by Subject|0|||
105569445|NCT04631705|364083255|FG003|Overall Study|Withdrawal by Subject|0|||
105569446|NCT04631705|364083256|FG004|Overall Study|Withdrawal by Subject|0|||
105569447|NCT04631705|364083257|FG005|Overall Study|Withdrawal by Subject|0|||
105569448|NCT04631705|364083258|FG006|Overall Study|Withdrawal by Subject|1|||
105484023|NCT04393298|363784248|FG012|Overall Study|Clinical Progression|0|||
105484024|NCT04393298|363784249|FG013|Overall Study|Clinical Progression|0|||
105484025|NCT04393298|363784250|FG014|Overall Study|Clinical Progression|0|||
105569449|NCT04631705|364083259|FG007|Overall Study|Withdrawal by Subject|0|||
105569450|NCT04631705|364083260|FG008|Overall Study|Withdrawal by Subject|0|||
105569451|NCT02130284|364083261|FG000|Overall Study|Withdrawal by Subject|3|||
105759891|NCT02327078|364773799|FG004|Overall Study|Lost to Follow-up|0|||
105759892|NCT02327078|364773800|FG005|Overall Study|Lost to Follow-up|0|||
105759893|NCT02327078|364773801|FG006|Overall Study|Lost to Follow-up|0|||
105569452|NCT02130284|364083261|FG000|Overall Study|Subject Withdrew Consent|1|||
105569453|NCT02130284|364083261|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
105569454|NCT02130284|364083261|FG000|Overall Study|Subject was screened as backup for study|3|||
105569455|NCT02130284|364083261|FG000|Overall Study|Screen Failure|1|||
105569456|NCT01875185|364083262|FG000|Overall Study|study was terminated|52|||
105569457|NCT01875185|364083263|FG001|Overall Study|study was terminated|48|||
105569458|NCT04838613|364083266|FG000|Overall Study|Withdrawal by Subject|3|||
105569459|NCT04838613|364083267|FG001|Overall Study|Withdrawal by Subject|6|||
105569460|NCT04838613|364083266|FG000|Overall Study|Protocol Deviation|3|||
105569461|NCT04838613|364083267|FG001|Overall Study|Protocol Deviation|2|||
105569462|NCT04838613|364083266|FG000|Overall Study|Technical Problems|0|||
105569463|NCT04838613|364083267|FG001|Overall Study|Technical Problems|5|||
105569464|NCT04838613|364083266|FG000|Overall Study|Physician Decision|2|||
105569465|NCT04838613|364083267|FG001|Overall Study|Physician Decision|0|||
105569466|NCT02613221|364083272|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
105569467|NCT02613221|364083272|FG000|Overall Study|Adverse Event|2|||
105569468|NCT02613221|364083272|FG000|Overall Study|Voluntary Discontinuation|1|||
105569469|NCT02613221|364083272|FG000|Overall Study|Delayed Treatment|1|||
105569470|NCT02613221|364083272|FG000|Overall Study|Enrolled but Not Treated|1|||
105569471|NCT01893827|364083276|FG000|Overall Study|Lost to Follow-up|19|||
105569472|NCT01893827|364083277|FG001|Overall Study|Lost to Follow-up|26|||
105569473|NCT03389477|364083280|FG000|Step 1|Withdrawal by Subject|1|||
105569474|NCT03389477|364083281|FG001|Step 1|Withdrawal by Subject|0|||
105569475|NCT03389477|364083280|FG000|Step 2|Withdrawal by Subject|1|||
105569476|NCT03389477|364083281|FG001|Step 2|Withdrawal by Subject|2|||
105569477|NCT03389477|364083280|FG000|Step 2|Disease progression|1|||
105569478|NCT03389477|364083281|FG001|Step 2|Disease progression|0|||
105569479|NCT03389477|364083280|FG000|Step 2|Death|0|||
105569480|NCT03389477|364083281|FG001|Step 2|Death|1|||
105569481|NCT03389477|364083280|FG000|Step 2|Poor performance status and nutrition|0|||
105569482|NCT03389477|364083281|FG001|Step 2|Poor performance status and nutrition|1|||
105569483|NCT03389477|364083280|FG000|Step 3|Withdrawal after 3 cycles|0|||
105759894|NCT02327078|364773802|FG007|Overall Study|Lost to Follow-up|2|||
105484026|NCT04393298|363784236|FG000|Overall Study|Disease Progression|0|||
105484027|NCT04393298|363784237|FG001|Overall Study|Disease Progression|1|||
105484028|NCT04393298|363784238|FG002|Overall Study|Disease Progression|0|||
105484029|NCT04393298|363784239|FG003|Overall Study|Disease Progression|0|||
105484030|NCT04393298|363784240|FG004|Overall Study|Disease Progression|0|||
105484031|NCT04393298|363784241|FG005|Overall Study|Disease Progression|3|||
105484032|NCT04393298|363784242|FG006|Overall Study|Disease Progression|2|||
105484033|NCT04393298|363784243|FG007|Overall Study|Disease Progression|1|||
105484034|NCT04393298|363784244|FG008|Overall Study|Disease Progression|2|||
105484035|NCT04393298|363784245|FG009|Overall Study|Disease Progression|1|||
105484036|NCT04393298|363784246|FG010|Overall Study|Disease Progression|0|||
105484037|NCT04393298|363784247|FG011|Overall Study|Disease Progression|3|||
105484038|NCT04393298|363784248|FG012|Overall Study|Disease Progression|0|||
105484039|NCT04393298|363784249|FG013|Overall Study|Disease Progression|0|||
105484040|NCT04393298|363784250|FG014|Overall Study|Disease Progression|1|||
105484041|NCT04393298|363784236|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
105484042|NCT04393298|363784237|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
105484043|NCT04393298|363784238|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
105484044|NCT04393298|363784239|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
105484045|NCT04393298|363784240|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
105484046|NCT04393298|363784241|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
105484047|NCT04393298|363784242|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
105484048|NCT04393298|363784243|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
105484049|NCT04393298|363784244|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
105484050|NCT04393298|363784245|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
105484051|NCT04393298|363784246|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
105484052|NCT04393298|363784247|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
105484053|NCT04393298|363784248|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
105759895|NCT02327078|364773803|FG008|Overall Study|Lost to Follow-up|5|||
105759896|NCT02327078|364773795|FG000|Overall Study|Site Terminated by Sponsor|1|||
105484054|NCT04393298|363784249|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
105484055|NCT04393298|363784250|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
105484056|NCT04393298|363784236|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
105569484|NCT03389477|364083281|FG001|Step 3|Withdrawal after 3 cycles|1|||
105569485|NCT03389477|364083280|FG000|Step 3|Still receiving active treatment|4|||
105569486|NCT03389477|364083281|FG001|Step 3|Still receiving active treatment|0|||
105569487|NCT03389477|364083280|FG000|Step 3|Progressive disease after 2 cycles|1|||
105569488|NCT03389477|364083281|FG001|Step 3|Progressive disease after 2 cycles|0|||
105569489|NCT01065350|364083282|FG000|Overall Study|Received incorrect drug allocation|0|||
105569490|NCT01065350|364083283|FG001|Overall Study|Received incorrect drug allocation|1|||
105759897|NCT02327078|364773796|FG001|Overall Study|Site Terminated by Sponsor|0|||
105569491|NCT02217280|364083292|FG000|Overall Study|Withdrawal by Subject|2|||
105569492|NCT02217280|364083292|FG000|Overall Study|Post-consent sceen fail|2|||
105569493|NCT01518946|364083293|FG000|Open-label Phase|Other|4|||
105569494|NCT01518946|364083294|FG001|Open-label Phase|Other|0|||
105569495|NCT01518946|364083295|FG002|Open-label Phase|Other|0|||
105569496|NCT01518946|364083293|FG000|Randomized Phase (First Intervention)|Other|0|||
105569497|NCT01518946|364083294|FG001|Randomized Phase (First Intervention)|Other|1|||
105569498|NCT01518946|364083295|FG002|Randomized Phase (First Intervention)|Other|0|||
105569499|NCT01493960|364085140|FG000|Overall Study|Adverse Event|0|||
105569500|NCT01493960|364085141|FG001|Overall Study|Adverse Event|1|||
105569501|NCT01493960|364085140|FG000|Overall Study|Lack of Efficacy|15|||
105569502|NCT01493960|364085141|FG001|Overall Study|Lack of Efficacy|9|||
105569503|NCT01493960|364085140|FG000|Overall Study|Protocol Violation|3|||
105569504|NCT01493960|364085141|FG001|Overall Study|Protocol Violation|0|||
105569505|NCT01493960|364085140|FG000|Overall Study|Withdrawal by Subject|10|||
105569506|NCT01493960|364085141|FG001|Overall Study|Withdrawal by Subject|4|||
105569507|NCT01493960|364085140|FG000|Overall Study|Non-specified|4|||
105569508|NCT01493960|364085141|FG001|Overall Study|Non-specified|4|||
105569509|NCT00284141|364085142|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
105569510|NCT00284141|364085142|FG000|Overall Study|Adverse Event|19|||
105569511|NCT00284141|364085142|FG000|Overall Study|Participant's request|9|||
105569512|NCT00284141|364085142|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
105569513|NCT00284141|364085142|FG000|Overall Study|Clinical deterioration / death|2|||
105569514|NCT00284141|364085142|FG000|Overall Study|General decline|1|||
105569515|NCT00284141|364085142|FG000|Overall Study|Pneumonia|1|||
105569516|NCT00284141|364085142|FG000|Overall Study|Did not take study medication|2|||
105569517|NCT00284141|364085142|FG000|Overall Study|Ongoing treatment|2|||
105569518|NCT02714868|364085147|FG000|Overall Study|Withdrawal by Subject|3|||
105569519|NCT02714868|364085148|FG001|Overall Study|Withdrawal by Subject|0|||
105569520|NCT02714868|364085147|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
105569521|NCT02714868|364085148|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
105569522|NCT02714868|364085147|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
105569523|NCT02714868|364085148|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
105569524|NCT00369681|364085149|FG000|Overall Study|Death|1|||
105569525|NCT01250119|364085152|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
105569526|NCT01250119|364085153|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
105569527|NCT01250119|364085152|FG000|Diagnostic Phase|Participants Not Tested|44|||
105569528|NCT01250119|364085153|FG001|Diagnostic Phase|Participants Not Tested|0|||
105569529|NCT01250119|364085152|FG000|Treatment Phase|Progressive Disease|0|||
105569530|NCT01250119|364085153|FG001|Treatment Phase|Progressive Disease|32|||
105569531|NCT01250119|364085152|FG000|Treatment Phase|Death|0|||
105569532|NCT01250119|364085153|FG001|Treatment Phase|Death|2|||
105569533|NCT01250119|364085152|FG000|Treatment Phase|Withdrawal by Subject|0|||
105569534|NCT01250119|364085153|FG001|Treatment Phase|Withdrawal by Subject|1|||
105569535|NCT01250119|364085152|FG000|Treatment Phase|Adverse Event|0|||
105569536|NCT01250119|364085153|FG001|Treatment Phase|Adverse Event|2|||
105569537|NCT01250119|364085152|FG000|Treatment Phase|Unknown reason|0|||
105569538|NCT01250119|364085153|FG001|Treatment Phase|Unknown reason|4|||
105569539|NCT02243202|364085154|FG000|Overall Study|Adverse Event|5|||
105569540|NCT02243202|364085155|FG001|Overall Study|Adverse Event|6|||
105569541|NCT02243202|364085156|FG002|Overall Study|Adverse Event|10|||
105569542|NCT02243202|364085157|FG003|Overall Study|Adverse Event|4|||
105569543|NCT02243202|364085154|FG000|Overall Study|Lost to Follow-up|9|||
105569544|NCT02243202|364085155|FG001|Overall Study|Lost to Follow-up|9|||
105759898|NCT02327078|364773797|FG002|Overall Study|Site Terminated by Sponsor|1|||
105360597|NCT00101868|363326020|FG000|Overall Study|Withdrawal by Subject|8|||
105360598|NCT00101868|363326021|FG001|Overall Study|Withdrawal by Subject|9|||
105360599|NCT00101868|363326020|FG000|Overall Study|Protocol Violation|3|||
105360600|NCT00101868|363326021|FG001|Overall Study|Protocol Violation|0|||
105360601|NCT00101868|363326020|FG000|Overall Study|Lost to Follow-up|8|||
105569545|NCT02243202|364085156|FG002|Overall Study|Lost to Follow-up|14|||
105569546|NCT02243202|364085157|FG003|Overall Study|Lost to Follow-up|11|||
105569547|NCT02243202|364085154|FG000|Overall Study|Protocol Violation|3|||
105569548|NCT02243202|364085155|FG001|Overall Study|Protocol Violation|1|||
105569549|NCT02243202|364085156|FG002|Overall Study|Protocol Violation|2|||
105569550|NCT02243202|364085157|FG003|Overall Study|Protocol Violation|1|||
105569551|NCT02243202|364085154|FG000|Overall Study|Withdrawal by Subject|7|||
105569552|NCT02243202|364085155|FG001|Overall Study|Withdrawal by Subject|6|||
105569553|NCT02243202|364085156|FG002|Overall Study|Withdrawal by Subject|4|||
105569554|NCT02243202|364085157|FG003|Overall Study|Withdrawal by Subject|4|||
105569555|NCT02243202|364085154|FG000|Overall Study|Other|1|||
105569556|NCT02243202|364085155|FG001|Overall Study|Other|3|||
105569557|NCT02243202|364085156|FG002|Overall Study|Other|1|||
105569558|NCT02243202|364085157|FG003|Overall Study|Other|2|||
105569559|NCT02243202|364085154|FG000|Overall Study|Randomized but not received treatment|0|||
105569560|NCT02243202|364085155|FG001|Overall Study|Randomized but not received treatment|0|||
105569561|NCT02243202|364085156|FG002|Overall Study|Randomized but not received treatment|0|||
105569562|NCT02243202|364085157|FG003|Overall Study|Randomized but not received treatment|1|||
105569563|NCT02287584|364085161|FG000|the Double-blind Phase|Adverse Event|17|||
105569564|NCT02287584|364085162|FG001|the Double-blind Phase|Adverse Event|17|||
105569565|NCT02287584|364085163|FG002|the Double-blind Phase|Adverse Event|12|||
105569566|NCT02287584|364085164|FG003|the Double-blind Phase|Adverse Event|0|||
105569567|NCT02287584|364085165|FG004|the Double-blind Phase|Adverse Event|0|||
105569568|NCT02287584|364085166|FG005|the Double-blind Phase|Adverse Event|0|||
105569569|NCT02287584|364085161|FG000|the Double-blind Phase|Lack of Efficacy|18|||
105569570|NCT02287584|364085162|FG001|the Double-blind Phase|Lack of Efficacy|8|||
105569571|NCT02287584|364085163|FG002|the Double-blind Phase|Lack of Efficacy|8|||
105569572|NCT02287584|364085164|FG003|the Double-blind Phase|Lack of Efficacy|0|||
105569573|NCT02287584|364085165|FG004|the Double-blind Phase|Lack of Efficacy|0|||
105569574|NCT02287584|364085166|FG005|the Double-blind Phase|Lack of Efficacy|0|||
105569575|NCT02287584|364085161|FG000|the Double-blind Phase|Lost to Follow-up|0|||
105569576|NCT02287584|364085162|FG001|the Double-blind Phase|Lost to Follow-up|1|||
105569577|NCT02287584|364085163|FG002|the Double-blind Phase|Lost to Follow-up|1|||
105569578|NCT02287584|364085164|FG003|the Double-blind Phase|Lost to Follow-up|0|||
105569579|NCT02287584|364085165|FG004|the Double-blind Phase|Lost to Follow-up|0|||
105569580|NCT02287584|364085166|FG005|the Double-blind Phase|Lost to Follow-up|0|||
105569581|NCT02287584|364085161|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
105569582|NCT02287584|364085162|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
105569583|NCT02287584|364085163|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
105569584|NCT02287584|364085164|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
105569585|NCT02287584|364085165|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
105569586|NCT02287584|364085166|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
105569587|NCT02287584|364085161|FG000|the Double-blind Phase|Pregnancy|0|||
105569588|NCT02287584|364085162|FG001|the Double-blind Phase|Pregnancy|1|||
105569589|NCT02287584|364085163|FG002|the Double-blind Phase|Pregnancy|0|||
105569590|NCT02287584|364085164|FG003|the Double-blind Phase|Pregnancy|0|||
105569591|NCT02287584|364085165|FG004|the Double-blind Phase|Pregnancy|0|||
105569592|NCT02287584|364085166|FG005|the Double-blind Phase|Pregnancy|0|||
105569593|NCT02287584|364085161|FG000|the Double-blind Phase|Protocol Violation|0|||
105569594|NCT02287584|364085162|FG001|the Double-blind Phase|Protocol Violation|3|||
105569595|NCT02287584|364085163|FG002|the Double-blind Phase|Protocol Violation|0|||
105569596|NCT02287584|364085164|FG003|the Double-blind Phase|Protocol Violation|0|||
105569597|NCT02287584|364085165|FG004|the Double-blind Phase|Protocol Violation|0|||
105569598|NCT02287584|364085166|FG005|the Double-blind Phase|Protocol Violation|0|||
105569599|NCT02287584|364085161|FG000|the Double-blind Phase|other reasons|0|||
105569600|NCT02287584|364085162|FG001|the Double-blind Phase|other reasons|0|||
105569601|NCT02287584|364085163|FG002|the Double-blind Phase|other reasons|1|||
105569602|NCT02287584|364085164|FG003|the Double-blind Phase|other reasons|0|||
105569603|NCT02287584|364085165|FG004|the Double-blind Phase|other reasons|0|||
105569604|NCT02287584|364085166|FG005|the Double-blind Phase|other reasons|0|||
105569605|NCT02287584|364085161|FG000|the Open-label Phase|Did not receive drug|0|||
105569606|NCT02287584|364085162|FG001|the Open-label Phase|Did not receive drug|0|||
105569607|NCT02287584|364085163|FG002|the Open-label Phase|Did not receive drug|0|||
105569608|NCT02287584|364085164|FG003|the Open-label Phase|Did not receive drug|7|||
105569609|NCT02287584|364085165|FG004|the Open-label Phase|Did not receive drug|6|||
105569610|NCT02287584|364085166|FG005|the Open-label Phase|Did not receive drug|4|||
105569611|NCT02287584|364085161|FG000|the Open-label Phase|Adverse Event|0|||
105569612|NCT02287584|364085162|FG001|the Open-label Phase|Adverse Event|0|||
105569613|NCT02287584|364085163|FG002|the Open-label Phase|Adverse Event|0|||
105569614|NCT02287584|364085164|FG003|the Open-label Phase|Adverse Event|15|||
105569615|NCT02287584|364085165|FG004|the Open-label Phase|Adverse Event|12|||
105569616|NCT02287584|364085166|FG005|the Open-label Phase|Adverse Event|16|||
105569617|NCT02287584|364085161|FG000|the Open-label Phase|Lack of Efficacy|0|||
105569618|NCT02287584|364085162|FG001|the Open-label Phase|Lack of Efficacy|0|||
105569619|NCT02287584|364085163|FG002|the Open-label Phase|Lack of Efficacy|0|||
105569620|NCT02287584|364085164|FG003|the Open-label Phase|Lack of Efficacy|8|||
105569621|NCT02287584|364085165|FG004|the Open-label Phase|Lack of Efficacy|3|||
105569622|NCT02287584|364085166|FG005|the Open-label Phase|Lack of Efficacy|7|||
105569623|NCT02287584|364085161|FG000|the Open-label Phase|Lost to Follow-up|0|||
105569624|NCT02287584|364085162|FG001|the Open-label Phase|Lost to Follow-up|0|||
105569625|NCT02287584|364085163|FG002|the Open-label Phase|Lost to Follow-up|0|||
105569626|NCT02287584|364085164|FG003|the Open-label Phase|Lost to Follow-up|4|||
105569627|NCT02287584|364085165|FG004|the Open-label Phase|Lost to Follow-up|1|||
105569628|NCT02287584|364085166|FG005|the Open-label Phase|Lost to Follow-up|2|||
105569629|NCT02287584|364085161|FG000|the Open-label Phase|Withdrawal by Subject|0|||
105569630|NCT02287584|364085162|FG001|the Open-label Phase|Withdrawal by Subject|0|||
105569631|NCT02287584|364085163|FG002|the Open-label Phase|Withdrawal by Subject|0|||
105569632|NCT02287584|364085164|FG003|the Open-label Phase|Withdrawal by Subject|18|||
105569633|NCT02287584|364085165|FG004|the Open-label Phase|Withdrawal by Subject|29|||
105569634|NCT02287584|364085166|FG005|the Open-label Phase|Withdrawal by Subject|21|||
105569635|NCT02287584|364085161|FG000|the Open-label Phase|non-compliance|0|||
105569636|NCT02287584|364085162|FG001|the Open-label Phase|non-compliance|0|||
105569637|NCT02287584|364085163|FG002|the Open-label Phase|non-compliance|0|||
105569638|NCT02287584|364085164|FG003|the Open-label Phase|non-compliance|2|||
105569639|NCT02287584|364085165|FG004|the Open-label Phase|non-compliance|5|||
105569640|NCT02287584|364085166|FG005|the Open-label Phase|non-compliance|1|||
105569641|NCT02287584|364085161|FG000|the Open-label Phase|other reasons|0|||
105569642|NCT02287584|364085162|FG001|the Open-label Phase|other reasons|0|||
105569643|NCT02287584|364085163|FG002|the Open-label Phase|other reasons|0|||
105569644|NCT02287584|364085164|FG003|the Open-label Phase|other reasons|3|||
105569645|NCT02287584|364085165|FG004|the Open-label Phase|other reasons|6|||
105569646|NCT02287584|364085166|FG005|the Open-label Phase|other reasons|6|||
105569647|NCT00787319|364085167|FG000|Overall Study|Lost to Follow-up|2|||
105569648|NCT00787319|364085167|FG000|Overall Study|Withdrawal by Subject|15|||
105569649|NCT00787319|364085167|FG000|Overall Study|Adverse Event|3|||
105569650|NCT00787319|364085167|FG000|Overall Study|Objective progression or relapse|30|||
105569651|NCT00787319|364085167|FG000|Overall Study|Lack of Efficacy|1|||
105569652|NCT00787319|364085167|FG000|Overall Study|Budget exhausted/exceeded|1|||
105569653|NCT00787319|364085167|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
105569654|NCT00787319|364085167|FG000|Overall Study|No health insurance reimbursement|2|||
105569655|NCT00787319|364085167|FG000|Overall Study|Stabilized disease findings|3|||
105569656|NCT00787319|364085167|FG000|Overall Study|Inactive disease|5|||
105569657|NCT04415151|364085168|FG000|Overall Study|Death|1|||
105569658|NCT04415151|364085169|FG001|Overall Study|Death|1|||
105569659|NCT04415151|364085168|FG000|Overall Study|Withdrawal by Subject|1|||
105569660|NCT04415151|364085169|FG001|Overall Study|Withdrawal by Subject|0|||
105569661|NCT01641926|364085170|FG000|Overall Study|Adverse Event|5|||
105569662|NCT01641926|364085171|FG001|Overall Study|Adverse Event|2|||
105569663|NCT01641926|364085172|FG002|Overall Study|Adverse Event|3|||
105569664|NCT01641926|364085173|FG003|Overall Study|Adverse Event|1|||
105484057|NCT04393298|363784237|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
105484058|NCT04393298|363784238|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
105484059|NCT04393298|363784239|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
105484060|NCT04393298|363784240|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
105484061|NCT04393298|363784241|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
105484062|NCT04393298|363784242|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
105484063|NCT04393298|363784243|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
105484064|NCT04393298|363784244|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
105484065|NCT04393298|363784245|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
105484066|NCT04393298|363784246|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
105484067|NCT04393298|363784247|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
105484068|NCT04393298|363784248|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
105484069|NCT04393298|363784249|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
105484070|NCT04393298|363784250|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
105484071|NCT04393298|363784236|FG000|Overall Study|Progressive Disease (PD)|0|||
105484072|NCT04393298|363784237|FG001|Overall Study|Progressive Disease (PD)|0|||
105484073|NCT04393298|363784238|FG002|Overall Study|Progressive Disease (PD)|0|||
105484074|NCT04393298|363784239|FG003|Overall Study|Progressive Disease (PD)|3|||
105484075|NCT04393298|363784240|FG004|Overall Study|Progressive Disease (PD)|0|||
105484076|NCT04393298|363784241|FG005|Overall Study|Progressive Disease (PD)|0|||
105484077|NCT04393298|363784242|FG006|Overall Study|Progressive Disease (PD)|0|||
105484078|NCT04393298|363784243|FG007|Overall Study|Progressive Disease (PD)|0|||
105484079|NCT04393298|363784244|FG008|Overall Study|Progressive Disease (PD)|0|||
105484080|NCT04393298|363784245|FG009|Overall Study|Progressive Disease (PD)|0|||
105484081|NCT04393298|363784246|FG010|Overall Study|Progressive Disease (PD)|0|||
105484082|NCT04393298|363784247|FG011|Overall Study|Progressive Disease (PD)|0|||
105484083|NCT04393298|363784248|FG012|Overall Study|Progressive Disease (PD)|0|||
105484084|NCT04393298|363784249|FG013|Overall Study|Progressive Disease (PD)|0|||
105484085|NCT04393298|363784250|FG014|Overall Study|Progressive Disease (PD)|0|||
105484086|NCT04393298|363784236|FG000|Overall Study|Started a New Cancer Treatment|0|||
105484087|NCT04393298|363784237|FG001|Overall Study|Started a New Cancer Treatment|0|||
105484088|NCT04393298|363784238|FG002|Overall Study|Started a New Cancer Treatment|0|||
105569665|NCT01641926|364085170|FG000|Overall Study|Lost to Follow-up|2|||
105569666|NCT01641926|364085171|FG001|Overall Study|Lost to Follow-up|2|||
105569667|NCT01641926|364085172|FG002|Overall Study|Lost to Follow-up|1|||
105569668|NCT01641926|364085173|FG003|Overall Study|Lost to Follow-up|0|||
105569669|NCT01641926|364085170|FG000|Overall Study|Physician Decision|6|||
105569670|NCT01641926|364085171|FG001|Overall Study|Physician Decision|5|||
105484089|NCT04393298|363784239|FG003|Overall Study|Started a New Cancer Treatment|0|||
105569671|NCT01641926|364085172|FG002|Overall Study|Physician Decision|0|||
105484090|NCT04393298|363784240|FG004|Overall Study|Started a New Cancer Treatment|1|||
105484091|NCT04393298|363784241|FG005|Overall Study|Started a New Cancer Treatment|0|||
105569672|NCT01641926|364085173|FG003|Overall Study|Physician Decision|1|||
105569673|NCT01641926|364085170|FG000|Overall Study|Protocol Violation|1|||
105569674|NCT01641926|364085171|FG001|Overall Study|Protocol Violation|0|||
105569675|NCT01641926|364085172|FG002|Overall Study|Protocol Violation|0|||
105569676|NCT01641926|364085173|FG003|Overall Study|Protocol Violation|1|||
105569677|NCT01641926|364085170|FG000|Overall Study|Withdrawal by Subject|13|||
105569678|NCT01641926|364085171|FG001|Overall Study|Withdrawal by Subject|5|||
105569679|NCT01641926|364085172|FG002|Overall Study|Withdrawal by Subject|6|||
105569680|NCT01641926|364085173|FG003|Overall Study|Withdrawal by Subject|1|||
105569681|NCT01641926|364085170|FG000|Overall Study|Not Treated|1|||
105569682|NCT01641926|364085171|FG001|Overall Study|Not Treated|1|||
105569683|NCT01641926|364085172|FG002|Overall Study|Not Treated|1|||
105569684|NCT01641926|364085173|FG003|Overall Study|Not Treated|0|||
105569685|NCT03528174|364085181|FG000|Overall Study|Adverse Event|1|||
105569686|NCT03528174|364085181|FG000|Overall Study|sensors dislodged|1|||
105569687|NCT04251065|364085187|FG000|Overall Study|Death|2|||
105569688|NCT04251065|364085187|FG000|Overall Study|Lack of Efficacy|3|||
105569689|NCT04251065|364085187|FG000|Overall Study|Death|1|||
105569690|NCT01054573|364085188|FG000|Overall Study|Adverse Event|1|||
105569691|NCT01054573|364085189|FG001|Overall Study|Adverse Event|0|||
105569692|NCT01054573|364085190|FG002|Overall Study|Adverse Event|1|||
105569693|NCT01054573|364085191|FG003|Overall Study|Adverse Event|1|||
105569694|NCT01054573|364085188|FG000|Overall Study|Lost to Follow-up|0|||
105569695|NCT01054573|364085189|FG001|Overall Study|Lost to Follow-up|2|||
105569696|NCT01054573|364085190|FG002|Overall Study|Lost to Follow-up|0|||
105569697|NCT01054573|364085191|FG003|Overall Study|Lost to Follow-up|0|||
105569698|NCT01054573|364085188|FG000|Overall Study|Withdrawal by Subject|0|||
105569699|NCT01054573|364085189|FG001|Overall Study|Withdrawal by Subject|2|||
105569700|NCT01054573|364085190|FG002|Overall Study|Withdrawal by Subject|2|||
105569701|NCT01054573|364085191|FG003|Overall Study|Withdrawal by Subject|1|||
105569702|NCT01719237|364085195|FG000|Overall Study|Physician Decision|0|||
105569703|NCT01719237|364085196|FG001|Overall Study|Physician Decision|1|||
105569704|NCT01725386|364085197|FG000|Overall Study|Death|84|||
105569705|NCT01725386|364085198|FG001|Overall Study|Death|40|||
105569706|NCT01725386|364085197|FG000|Overall Study|Lost to Follow-up|81|||
105569707|NCT01725386|364085198|FG001|Overall Study|Lost to Follow-up|6|||
105569708|NCT01725386|364085197|FG000|Overall Study|Withdrawal by Subject|10|||
105569709|NCT01725386|364085198|FG001|Overall Study|Withdrawal by Subject|0|||
105569710|NCT00152009|364085206|FG000|Overall Study|Adverse Event|9|||
105569711|NCT00152009|364085207|FG001|Overall Study|Adverse Event|13|||
105569712|NCT00152009|364085208|FG002|Overall Study|Adverse Event|20|||
105569713|NCT00152009|364085209|FG003|Overall Study|Adverse Event|1|||
105569714|NCT00152009|364085206|FG000|Overall Study|Protocol Violation|3|||
105569715|NCT00152009|364085207|FG001|Overall Study|Protocol Violation|0|||
105569716|NCT00152009|364085208|FG002|Overall Study|Protocol Violation|0|||
105569717|NCT00152009|364085209|FG003|Overall Study|Protocol Violation|1|||
105569718|NCT00152009|364085206|FG000|Overall Study|Withdrawal by Subject|2|||
105569719|NCT00152009|364085207|FG001|Overall Study|Withdrawal by Subject|3|||
105569720|NCT00152009|364085208|FG002|Overall Study|Withdrawal by Subject|4|||
105569721|NCT00152009|364085209|FG003|Overall Study|Withdrawal by Subject|9|||
105569722|NCT00152009|364085206|FG000|Overall Study|Lost to Follow-up|2|||
105569723|NCT00152009|364085207|FG001|Overall Study|Lost to Follow-up|4|||
105569724|NCT00152009|364085208|FG002|Overall Study|Lost to Follow-up|3|||
105569725|NCT00152009|364085209|FG003|Overall Study|Lost to Follow-up|3|||
105569726|NCT00152009|364085206|FG000|Overall Study|Lack of Efficacy|8|||
105569727|NCT00152009|364085207|FG001|Overall Study|Lack of Efficacy|6|||
105569728|NCT00152009|364085208|FG002|Overall Study|Lack of Efficacy|7|||
105569729|NCT00152009|364085209|FG003|Overall Study|Lack of Efficacy|15|||
105569730|NCT00152009|364085206|FG000|Overall Study|ECG abnormalities|2|||
105569731|NCT00152009|364085207|FG001|Overall Study|ECG abnormalities|2|||
105569732|NCT00152009|364085208|FG002|Overall Study|ECG abnormalities|2|||
105569733|NCT00152009|364085209|FG003|Overall Study|ECG abnormalities|1|||
105569734|NCT00152009|364085206|FG000|Overall Study|Sponsor's decision|3|||
105569735|NCT00152009|364085207|FG001|Overall Study|Sponsor's decision|3|||
105569736|NCT00152009|364085208|FG002|Overall Study|Sponsor's decision|1|||
105569737|NCT00152009|364085209|FG003|Overall Study|Sponsor's decision|3|||
105569738|NCT01306201|364085212|FG000|Overall Study|Arrhythmia|4|||
105805056|NCT03381248|364943354|FG000|6-12 Months|Lost to Follow-up|0|||
105569739|NCT01306201|364085212|FG000|Overall Study|Files could not be processed|3|||
105569740|NCT01306201|364085212|FG000|Overall Study|Files unreadable|3|||
105569741|NCT00423852|364085216|FG000|Overall Study|Removed pior to the high-dose portion|3|||
105569742|NCT04145037|364085221|FG000|Overall Study|Study terminated|2|||
105569743|NCT04145037|364085222|FG001|Overall Study|Study terminated|0|||
105569744|NCT04145037|364085221|FG000|Overall Study|Withdrawal by Subject|1|||
105569745|NCT04145037|364085222|FG001|Overall Study|Withdrawal by Subject|0|||
105569746|NCT04145037|364085221|FG000|Overall Study|Lost to Follow-up|1|||
105569747|NCT04145037|364085222|FG001|Overall Study|Lost to Follow-up|0|||
105569748|NCT04772053|364085223|FG000|Overall Study|Physician Decision|2|||
105569749|NCT04772053|364085223|FG000|Overall Study|Withdrawal by Subject|3|||
105569750|NCT04772053|364085223|FG000|Overall Study|Study Terminated by Sponsor|1|||
105569751|NCT00525265|364085224|FG000|Overall Study|Protocol Violation|1|||
105569752|NCT00525265|364085225|FG001|Overall Study|Protocol Violation|0|||
105569753|NCT00733499|364085233|FG000|Pre-operative|Protocol Violation|0|||
105569754|NCT00733499|364085234|FG001|Pre-operative|Protocol Violation|1|||
105569755|NCT00733499|364085233|FG000|3 Months Follow-up|Death|1|||
105569756|NCT00733499|364085234|FG001|3 Months Follow-up|Death|2|||
105569757|NCT00733499|364085233|FG000|6 Months Follow-up|Death|0|||
105569758|NCT00733499|364085234|FG001|6 Months Follow-up|Death|2|||
105569759|NCT00733499|364085233|FG000|6 Months Follow-up|Adverse Event|0|||
105569760|NCT00733499|364085234|FG001|6 Months Follow-up|Adverse Event|1|||
105569761|NCT00733499|364085233|FG000|12 Months Follow-up|Death|2|||
105569762|NCT00733499|364085234|FG001|12 Months Follow-up|Death|1|||
105569763|NCT00733499|364085233|FG000|24 Months Follow-up|Death|0|||
105569764|NCT00733499|364085234|FG001|24 Months Follow-up|Death|1|||
105569765|NCT00733499|364085233|FG000|5 Year Followup|Adverse Event|2|||
105569766|NCT00733499|364085234|FG001|5 Year Followup|Adverse Event|2|||
105569767|NCT00733499|364085233|FG000|5 Year Followup|Non device related AE|0|||
105569768|NCT00733499|364085234|FG001|5 Year Followup|Non device related AE|1|||
105569769|NCT00733499|364085233|FG000|5 Year Followup|Revision of Study Implant|0|||
105569770|NCT00733499|364085234|FG001|5 Year Followup|Revision of Study Implant|1|||
105569771|NCT00733499|364085233|FG000|5 Year Followup|Lost to Follow-up|2|||
105569772|NCT00733499|364085234|FG001|5 Year Followup|Lost to Follow-up|0|||
105569773|NCT00733499|364085233|FG000|5 Year Followup|Death|13|||
105569774|NCT00733499|364085234|FG001|5 Year Followup|Death|19|||
105569775|NCT00733499|364085233|FG000|5 Year Followup|missing, unable to locate|0|||
105569776|NCT00733499|364085234|FG001|5 Year Followup|missing, unable to locate|1|||
105569777|NCT00733499|364085233|FG000|5 Year Followup|Withdrawal by Subject|4|||
105569778|NCT00733499|364085234|FG001|5 Year Followup|Withdrawal by Subject|1|||
105569779|NCT00733499|364085233|FG000|10 Year Followup|Death|9|||
105569780|NCT00733499|364085234|FG001|10 Year Followup|Death|7|||
105569781|NCT00733499|364085233|FG000|10 Year Followup|Adverse Event|3|||
105569782|NCT00733499|364085234|FG001|10 Year Followup|Adverse Event|3|||
105569783|NCT00733499|364085233|FG000|10 Year Followup|Lost to Follow-up|3|||
105569784|NCT00733499|364085234|FG001|10 Year Followup|Lost to Follow-up|2|||
105569785|NCT00733499|364085233|FG000|10 Year Followup|Withdrawal by Subject|5|||
105569786|NCT00733499|364085234|FG001|10 Year Followup|Withdrawal by Subject|5|||
105569787|NCT00733499|364085233|FG000|10 Year Followup|missing, unable to locate|0|||
105569788|NCT00733499|364085234|FG001|10 Year Followup|missing, unable to locate|2|||
105569789|NCT00943306|364085235|FG000|Overall Study|Physician Decision|1|||
105569790|NCT00943306|364085235|FG000|Overall Study|Death|1|||
105569791|NCT00943306|364085235|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
105569792|NCT02739347|364085236|FG000|Overall Study|Adverse Event|3|||
105569793|NCT02739347|364085237|FG001|Overall Study|Adverse Event|0|||
105569794|NCT02739347|364085236|FG000|Overall Study|Protocol Violation|0|||
105569795|NCT02739347|364085237|FG001|Overall Study|Protocol Violation|1|||
105569796|NCT02739347|364085236|FG000|Overall Study|Lost to Follow-up|0|||
105569797|NCT02739347|364085237|FG001|Overall Study|Lost to Follow-up|2|||
105569798|NCT03929562|364085238|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
105569799|NCT03929562|364085239|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
105569800|NCT03929562|364085238|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
105569801|NCT03929562|364085239|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
105569802|NCT03929562|364085238|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
105569803|NCT03929562|364085239|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
105569804|NCT02404389|364085240|FG000|Overall Study|Adverse Event|1|||
105569805|NCT02404389|364085241|FG001|Overall Study|Adverse Event|0|||
105569806|NCT02404389|364085242|FG002|Overall Study|Adverse Event|1|||
105569807|NCT02404389|364085243|FG003|Overall Study|Adverse Event|0|||
105569808|NCT02404389|364085244|FG004|Overall Study|Adverse Event|2|||
105569809|NCT02404389|364085240|FG000|Overall Study|Subject/guardian decision|1|||
105569810|NCT02404389|364085241|FG001|Overall Study|Subject/guardian decision|0|||
105569811|NCT02404389|364085242|FG002|Overall Study|Subject/guardian decision|0|||
105569812|NCT02404389|364085243|FG003|Overall Study|Subject/guardian decision|1|||
105569813|NCT02404389|364085244|FG004|Overall Study|Subject/guardian decision|1|||
105569814|NCT01036022|364085245|FG000|Overall Study|Adverse Event|1|||
105569815|NCT01036022|364085246|FG001|Overall Study|Adverse Event|3|||
105569816|NCT01036022|364085247|FG002|Overall Study|Adverse Event|2|||
105569817|NCT01036022|364085248|FG003|Overall Study|Adverse Event|1|||
105569818|NCT01036022|364085249|FG004|Overall Study|Adverse Event|0|||
105569819|NCT01036022|364085250|FG005|Overall Study|Adverse Event|2|||
105569820|NCT01036022|364085245|FG000|Overall Study|Lack of Efficacy|1|||
105569821|NCT01036022|364085246|FG001|Overall Study|Lack of Efficacy|1|||
105569822|NCT01036022|364085247|FG002|Overall Study|Lack of Efficacy|1|||
105569823|NCT01036022|364085248|FG003|Overall Study|Lack of Efficacy|0|||
105569824|NCT01036022|364085249|FG004|Overall Study|Lack of Efficacy|1|||
105569825|NCT01036022|364085250|FG005|Overall Study|Lack of Efficacy|1|||
105569826|NCT01036022|364085245|FG000|Overall Study|Physician Decision|0|||
105569827|NCT01036022|364085246|FG001|Overall Study|Physician Decision|0|||
105569828|NCT01036022|364085247|FG002|Overall Study|Physician Decision|1|||
105569829|NCT01036022|364085248|FG003|Overall Study|Physician Decision|0|||
105569830|NCT01036022|364085249|FG004|Overall Study|Physician Decision|0|||
105569831|NCT01036022|364085250|FG005|Overall Study|Physician Decision|0|||
105569832|NCT01036022|364085245|FG000|Overall Study|Withdrawal by Subject|0|||
105569833|NCT01036022|364085246|FG001|Overall Study|Withdrawal by Subject|0|||
105569834|NCT01036022|364085247|FG002|Overall Study|Withdrawal by Subject|0|||
105569835|NCT01036022|364085248|FG003|Overall Study|Withdrawal by Subject|1|||
105569836|NCT01036022|364085249|FG004|Overall Study|Withdrawal by Subject|2|||
105569837|NCT01036022|364085250|FG005|Overall Study|Withdrawal by Subject|0|||
105569838|NCT03324880|364085251|FG000|Overall Study|Adverse Event|0|||
105569839|NCT03324880|364085252|FG001|Overall Study|Adverse Event|2|||
105569840|NCT03324880|364085251|FG000|Overall Study|Withdrawal by Subject|2|||
105569841|NCT03324880|364085252|FG001|Overall Study|Withdrawal by Subject|2|||
105569842|NCT03324880|364085251|FG000|Overall Study|Lost to Follow-up|0|||
105569843|NCT03324880|364085252|FG001|Overall Study|Lost to Follow-up|1|||
105569844|NCT03324880|364085251|FG000|Overall Study|Product Recall|0|||
105569845|NCT03324880|364085252|FG001|Overall Study|Product Recall|1|||
105569846|NCT03300570|364085253|FG000|Overall Study|Adverse Event|0|||
105569847|NCT03300570|364085254|FG001|Overall Study|Adverse Event|1|||
105569848|NCT03300570|364085253|FG000|Overall Study|Withdrawal by Subject|1|||
105569849|NCT03300570|364085254|FG001|Overall Study|Withdrawal by Subject|0|||
105569850|NCT03300570|364085253|FG000|Overall Study|Inadequate bowel prep|1|||
105569851|NCT03300570|364085254|FG001|Overall Study|Inadequate bowel prep|0|||
105569852|NCT00576732|364085256|FG000|DOUBLE BLIND|Adverse Event|0|||
105569853|NCT00576732|364085257|FG001|DOUBLE BLIND|Adverse Event|0|||
105569854|NCT00576732|364085258|FG002|DOUBLE BLIND|Adverse Event|1|||
105569855|NCT00576732|364085259|FG003|DOUBLE BLIND|Adverse Event|0|||
105569856|NCT00576732|364085260|FG004|DOUBLE BLIND|Adverse Event|0|||
105569857|NCT00576732|364085261|FG005|DOUBLE BLIND|Adverse Event|0|||
105569858|NCT00576732|364085256|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
105569859|NCT00576732|364085257|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
105569860|NCT00576732|364085258|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
105569861|NCT00576732|364085259|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
105569862|NCT00576732|364085260|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
105569863|NCT00576732|364085261|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
105569864|NCT00576732|364085256|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
105569865|NCT00576732|364085257|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
105569866|NCT00576732|364085258|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
105569867|NCT00576732|364085259|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
105569868|NCT00576732|364085260|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
105569869|NCT00576732|364085261|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
105569870|NCT00576732|364085256|FG000|DOUBLE BLIND|OTHER|0|||
105569871|NCT00576732|364085257|FG001|DOUBLE BLIND|OTHER|2|||
105569872|NCT00576732|364085258|FG002|DOUBLE BLIND|OTHER|1|||
105569873|NCT00576732|364085259|FG003|DOUBLE BLIND|OTHER|0|||
105569874|NCT00576732|364085260|FG004|DOUBLE BLIND|OTHER|0|||
105569875|NCT00576732|364085261|FG005|DOUBLE BLIND|OTHER|0|||
105569876|NCT00576732|364085256|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
105569877|NCT00576732|364085257|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
105569878|NCT00576732|364085258|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
105569879|NCT00576732|364085259|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
105569880|NCT00576732|364085260|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
105569881|NCT00576732|364085261|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
105569882|NCT00576732|364085256|FG000|DOUBLE BLIND|Protocol Violation|1|||
105569883|NCT00576732|364085257|FG001|DOUBLE BLIND|Protocol Violation|0|||
105569884|NCT00576732|364085258|FG002|DOUBLE BLIND|Protocol Violation|0|||
105569885|NCT00576732|364085259|FG003|DOUBLE BLIND|Protocol Violation|0|||
105569886|NCT00576732|364085260|FG004|DOUBLE BLIND|Protocol Violation|0|||
105759899|NCT02327078|364773798|FG003|Overall Study|Site Terminated by Sponsor|4|||
105569887|NCT00576732|364085261|FG005|DOUBLE BLIND|Protocol Violation|0|||
105569888|NCT00576732|364085256|FG000|OPEN LABEL|Adverse Event|0|||
105569889|NCT00576732|364085257|FG001|OPEN LABEL|Adverse Event|0|||
105569890|NCT00576732|364085258|FG002|OPEN LABEL|Adverse Event|0|||
105569891|NCT00576732|364085259|FG003|OPEN LABEL|Adverse Event|4|||
105569892|NCT00576732|364085260|FG004|OPEN LABEL|Adverse Event|0|||
105569893|NCT00576732|364085261|FG005|OPEN LABEL|Adverse Event|1|||
105569894|NCT00576732|364085256|FG000|OPEN LABEL|Lost to Follow-up|0|||
105569895|NCT00576732|364085257|FG001|OPEN LABEL|Lost to Follow-up|0|||
105569896|NCT00576732|364085258|FG002|OPEN LABEL|Lost to Follow-up|0|||
105569897|NCT00576732|364085259|FG003|OPEN LABEL|Lost to Follow-up|2|||
105759900|NCT02327078|364773799|FG004|Overall Study|Site Terminated by Sponsor|0|||
105484092|NCT04393298|363784242|FG006|Overall Study|Started a New Cancer Treatment|0|||
105484093|NCT04393298|363784243|FG007|Overall Study|Started a New Cancer Treatment|0|||
105484094|NCT04393298|363784244|FG008|Overall Study|Started a New Cancer Treatment|0|||
105484095|NCT04393298|363784245|FG009|Overall Study|Started a New Cancer Treatment|0|||
105484096|NCT04393298|363784246|FG010|Overall Study|Started a New Cancer Treatment|0|||
105484097|NCT04393298|363784247|FG011|Overall Study|Started a New Cancer Treatment|0|||
105484098|NCT04393298|363784248|FG012|Overall Study|Started a New Cancer Treatment|0|||
105484099|NCT04393298|363784249|FG013|Overall Study|Started a New Cancer Treatment|0|||
105484100|NCT04393298|363784250|FG014|Overall Study|Started a New Cancer Treatment|0|||
105484101|NCT04393298|363784236|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
105484102|NCT04393298|363784237|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
105484103|NCT04393298|363784238|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
105484104|NCT04393298|363784239|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
105484105|NCT04393298|363784240|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
105484106|NCT04393298|363784241|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
105484107|NCT04393298|363784242|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
105484108|NCT04393298|363784243|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
105484109|NCT04393298|363784244|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
105484110|NCT04393298|363784245|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
105484111|NCT04393298|363784246|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
105484112|NCT04393298|363784247|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
105484113|NCT04393298|363784248|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
105484114|NCT04393298|363784249|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
105484115|NCT04393298|363784250|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
105484116|NCT04393298|363784236|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
105484117|NCT04393298|363784237|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
105484118|NCT04393298|363784238|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
105484119|NCT04393298|363784239|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
105484120|NCT04393298|363784240|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
105484121|NCT04393298|363784241|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
105484122|NCT04393298|363784242|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
105484123|NCT04393298|363784243|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
105484124|NCT04393298|363784244|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
105484125|NCT04393298|363784245|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
105484126|NCT04393298|363784246|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
105484127|NCT04393298|363784247|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
105484128|NCT04393298|363784248|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
105484129|NCT04393298|363784249|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
105484130|NCT04393298|363784250|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
105484131|NCT04393298|363784236|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
105484132|NCT04393298|363784237|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
105484133|NCT04393298|363784238|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
105484134|NCT04393298|363784239|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
105484135|NCT04393298|363784240|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
105484136|NCT04393298|363784241|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
105484137|NCT04393298|363784242|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
105484138|NCT04393298|363784243|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
105484139|NCT04393298|363784244|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
105484140|NCT04393298|363784245|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
105484141|NCT04393298|363784246|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
105484142|NCT04393298|363784247|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
105484143|NCT04393298|363784248|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
105484144|NCT04393298|363784249|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
105484145|NCT04393298|363784250|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
105484146|NCT04393298|363784236|FG000|Overall Study|Death|0|||
105484147|NCT04393298|363784237|FG001|Overall Study|Death|0|||
105484148|NCT04393298|363784238|FG002|Overall Study|Death|0|||
105484149|NCT04393298|363784239|FG003|Overall Study|Death|0|||
105484150|NCT04393298|363784240|FG004|Overall Study|Death|0|||
105484151|NCT04393298|363784241|FG005|Overall Study|Death|1|||
105484152|NCT04393298|363784242|FG006|Overall Study|Death|1|||
105484153|NCT04393298|363784243|FG007|Overall Study|Death|0|||
105484154|NCT04393298|363784244|FG008|Overall Study|Death|1|||
105484155|NCT04393298|363784245|FG009|Overall Study|Death|1|||
105484156|NCT04393298|363784246|FG010|Overall Study|Death|0|||
105484157|NCT04393298|363784247|FG011|Overall Study|Death|1|||
105484158|NCT04393298|363784248|FG012|Overall Study|Death|1|||
105484159|NCT04393298|363784249|FG013|Overall Study|Death|0|||
105484160|NCT04393298|363784250|FG014|Overall Study|Death|1|||
105484161|NCT04393298|363784236|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
105484162|NCT04393298|363784237|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
105484163|NCT04393298|363784238|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
105484164|NCT04393298|363784239|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
105484165|NCT04393298|363784240|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
105484166|NCT04393298|363784241|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
105484167|NCT04393298|363784242|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
105484168|NCT04393298|363784243|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
105569898|NCT00576732|364085260|FG004|OPEN LABEL|Lost to Follow-up|1|||
105569899|NCT00576732|364085261|FG005|OPEN LABEL|Lost to Follow-up|1|||
105569900|NCT00576732|364085256|FG000|OPEN LABEL|Withdrawal by Subject|0|||
105569901|NCT00576732|364085257|FG001|OPEN LABEL|Withdrawal by Subject|0|||
105569902|NCT00576732|364085258|FG002|OPEN LABEL|Withdrawal by Subject|0|||
105569903|NCT00576732|364085259|FG003|OPEN LABEL|Withdrawal by Subject|1|||
105569904|NCT00576732|364085260|FG004|OPEN LABEL|Withdrawal by Subject|0|||
105569905|NCT00576732|364085261|FG005|OPEN LABEL|Withdrawal by Subject|1|||
105569906|NCT00576732|364085256|FG000|OPEN LABEL|OTHER|0|||
105569907|NCT00576732|364085257|FG001|OPEN LABEL|OTHER|0|||
105569908|NCT00576732|364085258|FG002|OPEN LABEL|OTHER|0|||
105569909|NCT00576732|364085259|FG003|OPEN LABEL|OTHER|0|||
105569910|NCT00576732|364085260|FG004|OPEN LABEL|OTHER|0|||
105484169|NCT04393298|363784244|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
105569911|NCT00576732|364085261|FG005|OPEN LABEL|OTHER|2|||
105569912|NCT00576732|364085256|FG000|OPEN LABEL|Lack of Efficacy|0|||
105569913|NCT00576732|364085257|FG001|OPEN LABEL|Lack of Efficacy|0|||
105569914|NCT00576732|364085258|FG002|OPEN LABEL|Lack of Efficacy|0|||
105569915|NCT00576732|364085259|FG003|OPEN LABEL|Lack of Efficacy|2|||
105569916|NCT00576732|364085260|FG004|OPEN LABEL|Lack of Efficacy|2|||
105569917|NCT00576732|364085261|FG005|OPEN LABEL|Lack of Efficacy|3|||
105569918|NCT00576732|364085256|FG000|OPEN LABEL|Protocol Violation|0|||
105569919|NCT00576732|364085257|FG001|OPEN LABEL|Protocol Violation|0|||
105569920|NCT00576732|364085258|FG002|OPEN LABEL|Protocol Violation|0|||
105569921|NCT00576732|364085259|FG003|OPEN LABEL|Protocol Violation|2|||
105569922|NCT00576732|364085260|FG004|OPEN LABEL|Protocol Violation|1|||
105569923|NCT00576732|364085261|FG005|OPEN LABEL|Protocol Violation|0|||
105569924|NCT01547299|364085265|FG000|Overall Study|Withdrawal by Subject|2|||
105569925|NCT01547299|364085266|FG001|Overall Study|Withdrawal by Subject|2|||
105484170|NCT04393298|363784245|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
105484171|NCT04393298|363784246|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
105569926|NCT02087501|364085267|FG000|Overall Study|Death|7|||
105569927|NCT02087501|364085267|FG000|Overall Study|Open repair of aneurysm|1|||
105569928|NCT02087501|364085267|FG000|Overall Study|Lost to Follow-up|2|||
105569929|NCT03682705|364085268|FG000|Overall Study|Adverse Event|1|||
105569930|NCT03682705|364085269|FG001|Overall Study|Adverse Event|1|||
105569931|NCT03682705|364085270|FG002|Overall Study|Adverse Event|1|||
105569932|NCT03682705|364085271|FG003|Overall Study|Adverse Event|0|||
105569933|NCT03682705|364085272|FG004|Overall Study|Adverse Event|1|||
105569934|NCT03682705|364085273|FG005|Overall Study|Adverse Event|1|||
105569935|NCT03682705|364085268|FG000|Overall Study|Withdrawal by Subject|1|||
105569936|NCT03682705|364085269|FG001|Overall Study|Withdrawal by Subject|3|||
105569937|NCT03682705|364085270|FG002|Overall Study|Withdrawal by Subject|2|||
105569938|NCT03682705|364085271|FG003|Overall Study|Withdrawal by Subject|4|||
105569939|NCT03682705|364085272|FG004|Overall Study|Withdrawal by Subject|0|||
105569940|NCT03682705|364085273|FG005|Overall Study|Withdrawal by Subject|1|||
105569941|NCT03682705|364085268|FG000|Overall Study|Other, not specified|0|||
105569942|NCT03682705|364085269|FG001|Overall Study|Other, not specified|0|||
105569943|NCT03682705|364085270|FG002|Overall Study|Other, not specified|0|||
105569944|NCT03682705|364085271|FG003|Overall Study|Other, not specified|1|||
105569945|NCT03682705|364085272|FG004|Overall Study|Other, not specified|2|||
105569946|NCT03682705|364085273|FG005|Overall Study|Other, not specified|0|||
105569947|NCT03682705|364085268|FG000|Overall Study|Lost to Follow-up|0|||
105484172|NCT04393298|363784247|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
105569948|NCT03682705|364085269|FG001|Overall Study|Lost to Follow-up|0|||
105569949|NCT03682705|364085270|FG002|Overall Study|Lost to Follow-up|0|||
105569950|NCT03682705|364085271|FG003|Overall Study|Lost to Follow-up|0|||
105569951|NCT03682705|364085272|FG004|Overall Study|Lost to Follow-up|3|||
105569952|NCT03682705|364085273|FG005|Overall Study|Lost to Follow-up|0|||
105569953|NCT00402337|364085274|FG000|Overall Study|Adverse Event|0|||
105569954|NCT00402337|364085275|FG001|Overall Study|Adverse Event|2|||
105569955|NCT00402337|364085276|FG002|Overall Study|Adverse Event|2|||
105569956|NCT00402337|364085277|FG003|Overall Study|Adverse Event|3|||
105569957|NCT00402337|364085278|FG004|Overall Study|Adverse Event|2|||
105569958|NCT00402337|364085274|FG000|Overall Study|Noncompliance|0|||
105569959|NCT00402337|364085275|FG001|Overall Study|Noncompliance|0|||
105569960|NCT00402337|364085276|FG002|Overall Study|Noncompliance|0|||
105569961|NCT00402337|364085277|FG003|Overall Study|Noncompliance|0|||
105484173|NCT04393298|363784248|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
105484174|NCT04393298|363784249|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
105569962|NCT00402337|364085278|FG004|Overall Study|Noncompliance|2|||
105569963|NCT00402337|364085274|FG000|Overall Study|Withdrawal by Subject|5|||
105569964|NCT00402337|364085275|FG001|Overall Study|Withdrawal by Subject|3|||
105759901|NCT02327078|364773800|FG005|Overall Study|Site Terminated by Sponsor|0|||
105759902|NCT02327078|364773801|FG006|Overall Study|Site Terminated by Sponsor|0|||
105759903|NCT02327078|364773802|FG007|Overall Study|Site Terminated by Sponsor|11|||
105484175|NCT04393298|363784250|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
105759904|NCT02327078|364773803|FG008|Overall Study|Site Terminated by Sponsor|25|||
105484176|NCT04393298|363784236|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
105484177|NCT04393298|363784237|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
105484178|NCT04393298|363784238|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
105484179|NCT04393298|363784239|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
105484180|NCT04393298|363784240|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
105484181|NCT04393298|363784241|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
105484182|NCT04393298|363784242|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
105484183|NCT04393298|363784243|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
105484184|NCT04393298|363784244|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
105484185|NCT04393298|363784245|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
105484186|NCT04393298|363784246|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
105484187|NCT04393298|363784247|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
105484188|NCT04393298|363784248|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
105484189|NCT04393298|363784249|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
105484190|NCT04393298|363784250|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
105484191|NCT04393298|363784236|FG000|Overall Study|Patient Passed Away|0|||
105484192|NCT04393298|363784237|FG001|Overall Study|Patient Passed Away|0|||
105484193|NCT04393298|363784238|FG002|Overall Study|Patient Passed Away|0|||
105484194|NCT04393298|363784239|FG003|Overall Study|Patient Passed Away|0|||
105484195|NCT04393298|363784240|FG004|Overall Study|Patient Passed Away|0|||
105484196|NCT04393298|363784241|FG005|Overall Study|Patient Passed Away|0|||
105484197|NCT04393298|363784242|FG006|Overall Study|Patient Passed Away|0|||
105484198|NCT04393298|363784243|FG007|Overall Study|Patient Passed Away|1|||
105484199|NCT04393298|363784244|FG008|Overall Study|Patient Passed Away|0|||
105484200|NCT04393298|363784245|FG009|Overall Study|Patient Passed Away|0|||
105484201|NCT04393298|363784246|FG010|Overall Study|Patient Passed Away|0|||
105484202|NCT04393298|363784247|FG011|Overall Study|Patient Passed Away|0|||
105484203|NCT04393298|363784248|FG012|Overall Study|Patient Passed Away|0|||
105484204|NCT04393298|363784249|FG013|Overall Study|Patient Passed Away|0|||
105484205|NCT04393298|363784250|FG014|Overall Study|Patient Passed Away|0|||
105484206|NCT04393298|363784236|FG000|Overall Study|Patient Deceased|0|||
105484207|NCT04393298|363784237|FG001|Overall Study|Patient Deceased|0|||
105484208|NCT04393298|363784238|FG002|Overall Study|Patient Deceased|0|||
105484209|NCT04393298|363784239|FG003|Overall Study|Patient Deceased|0|||
105484210|NCT04393298|363784240|FG004|Overall Study|Patient Deceased|0|||
105484211|NCT04393298|363784241|FG005|Overall Study|Patient Deceased|0|||
105484212|NCT04393298|363784242|FG006|Overall Study|Patient Deceased|0|||
105484213|NCT04393298|363784243|FG007|Overall Study|Patient Deceased|1|||
105484214|NCT04393298|363784244|FG008|Overall Study|Patient Deceased|0|||
105484215|NCT04393298|363784245|FG009|Overall Study|Patient Deceased|0|||
105484216|NCT04393298|363784246|FG010|Overall Study|Patient Deceased|0|||
105484217|NCT04393298|363784247|FG011|Overall Study|Patient Deceased|0|||
105484218|NCT04393298|363784248|FG012|Overall Study|Patient Deceased|0|||
105484219|NCT04393298|363784249|FG013|Overall Study|Patient Deceased|0|||
105484220|NCT04393298|363784250|FG014|Overall Study|Patient Deceased|0|||
105484221|NCT04393298|363784236|FG000|Overall Study|Patient Discharged to Hospice|0|||
105484222|NCT04393298|363784237|FG001|Overall Study|Patient Discharged to Hospice|0|||
105569965|NCT00402337|364085276|FG002|Overall Study|Withdrawal by Subject|1|||
105569966|NCT00402337|364085277|FG003|Overall Study|Withdrawal by Subject|6|||
105569967|NCT00402337|364085278|FG004|Overall Study|Withdrawal by Subject|4|||
105484223|NCT04393298|363784238|FG002|Overall Study|Patient Discharged to Hospice|0|||
105484224|NCT04393298|363784239|FG003|Overall Study|Patient Discharged to Hospice|0|||
105484225|NCT04393298|363784240|FG004|Overall Study|Patient Discharged to Hospice|0|||
105484226|NCT04393298|363784241|FG005|Overall Study|Patient Discharged to Hospice|0|||
105484227|NCT04393298|363784242|FG006|Overall Study|Patient Discharged to Hospice|0|||
105484228|NCT04393298|363784243|FG007|Overall Study|Patient Discharged to Hospice|0|||
105484229|NCT04393298|363784244|FG008|Overall Study|Patient Discharged to Hospice|1|||
105484230|NCT04393298|363784245|FG009|Overall Study|Patient Discharged to Hospice|0|||
105484231|NCT04393298|363784246|FG010|Overall Study|Patient Discharged to Hospice|0|||
105484232|NCT04393298|363784247|FG011|Overall Study|Patient Discharged to Hospice|0|||
105484233|NCT04393298|363784248|FG012|Overall Study|Patient Discharged to Hospice|0|||
105484234|NCT04393298|363784249|FG013|Overall Study|Patient Discharged to Hospice|0|||
105569968|NCT00402337|364085274|FG000|Overall Study|Lost to Follow-up|0|||
105759905|NCT02327078|364773795|FG000|Overall Study|Physician Decision|0|||
105759906|NCT02327078|364773796|FG001|Overall Study|Physician Decision|0|||
105759907|NCT02327078|364773797|FG002|Overall Study|Physician Decision|0|||
105759908|NCT02327078|364773798|FG003|Overall Study|Physician Decision|1|||
105759909|NCT02327078|364773799|FG004|Overall Study|Physician Decision|0|||
105759910|NCT02327078|364773800|FG005|Overall Study|Physician Decision|0|||
105759911|NCT02327078|364773801|FG006|Overall Study|Physician Decision|0|||
105759912|NCT02327078|364773802|FG007|Overall Study|Physician Decision|0|||
105759913|NCT02327078|364773803|FG008|Overall Study|Physician Decision|1|||
105759914|NCT02327078|364773795|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
105759915|NCT02327078|364773796|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
105759916|NCT02327078|364773797|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
105759917|NCT02327078|364773798|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
105759918|NCT02327078|364773799|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
105759919|NCT02327078|364773800|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
105759920|NCT02327078|364773801|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
105759921|NCT02327078|364773802|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
105759922|NCT02327078|364773803|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
105759923|NCT02327078|364773795|FG000|Overall Study|Reason not Specified|0|||
105759924|NCT02327078|364773796|FG001|Overall Study|Reason not Specified|0|||
105759925|NCT02327078|364773797|FG002|Overall Study|Reason not Specified|0|||
105759926|NCT02327078|364773798|FG003|Overall Study|Reason not Specified|0|||
105759927|NCT02327078|364773799|FG004|Overall Study|Reason not Specified|0|||
105759928|NCT02327078|364773800|FG005|Overall Study|Reason not Specified|0|||
105759929|NCT02327078|364773801|FG006|Overall Study|Reason not Specified|0|||
105759930|NCT02327078|364773802|FG007|Overall Study|Reason not Specified|5|||
105759931|NCT02327078|364773803|FG008|Overall Study|Reason not Specified|12|||
105759932|NCT00247273|364773809|FG000|Overall Study|Adverse Event|85|||
105759933|NCT00247273|364773810|FG001|Overall Study|Adverse Event|80|||
105759934|NCT00247273|364773809|FG000|Overall Study|Physician Decision|6|||
105759935|NCT00247273|364773810|FG001|Overall Study|Physician Decision|3|||
105759936|NCT00247273|364773809|FG000|Overall Study|Lost to Follow-up|7|||
105759937|NCT00247273|364773810|FG001|Overall Study|Lost to Follow-up|7|||
105484235|NCT04393298|363784250|FG014|Overall Study|Patient Discharged to Hospice|0|||
105484236|NCT04393298|363784236|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
105484237|NCT04393298|363784237|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
105484238|NCT04393298|363784238|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
105484239|NCT04393298|363784239|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
105484240|NCT04393298|363784240|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
105484241|NCT04393298|363784241|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
105484242|NCT04393298|363784242|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
105484243|NCT04393298|363784243|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
105484244|NCT04393298|363784244|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
105484245|NCT04393298|363784245|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
105484246|NCT04393298|363784246|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
105484247|NCT04393298|363784247|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
105484248|NCT04393298|363784248|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
105484249|NCT04393298|363784249|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
105484250|NCT04393298|363784250|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
105484251|NCT04393298|363784236|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
105484252|NCT04393298|363784237|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
105484253|NCT04393298|363784238|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
105484254|NCT04393298|363784239|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
105484255|NCT04393298|363784240|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
105484256|NCT04393298|363784241|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
105484257|NCT04393298|363784242|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
105484258|NCT04393298|363784243|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
105484259|NCT04393298|363784244|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
105484260|NCT04393298|363784245|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
105484261|NCT04393298|363784246|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
105484262|NCT04393298|363784247|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
105484263|NCT04393298|363784248|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
105759938|NCT00247273|364773809|FG000|Overall Study|Withdrawal by Subject|46|||
105759939|NCT00247273|364773810|FG001|Overall Study|Withdrawal by Subject|47|||
105759940|NCT00247273|364773809|FG000|Overall Study|Did not take any study drug|2|||
105805057|NCT03381248|364943355|FG001|6-12 Months|Lost to Follow-up|2|||
105360602|NCT00101868|363326021|FG001|Overall Study|Lost to Follow-up|13|||
105360603|NCT02329327|363326022|FG000|Overall Study|Death|78|||
105360604|NCT02329327|363326023|FG001|Overall Study|Death|0|||
105360605|NCT02329327|363326022|FG000|Overall Study|Withdrawal by Subject|3|||
105360606|NCT02329327|363326023|FG001|Overall Study|Withdrawal by Subject|0|||
105360607|NCT02329327|363326022|FG000|Overall Study|Lost to Follow-up|4|||
105360608|NCT02329327|363326023|FG001|Overall Study|Lost to Follow-up|0|||
105360609|NCT03560869|363326024|FG000|Overall Study|Withdrawal by Subject|3|||
105360610|NCT03560869|363326025|FG001|Overall Study|Withdrawal by Subject|4|||
105360611|NCT03560869|363326024|FG000|Overall Study|Screening failure|4|||
105360612|NCT03560869|363326025|FG001|Overall Study|Screening failure|4|||
105360613|NCT03560869|363326024|FG000|Overall Study|Withdrawal by PI|0|||
105360614|NCT03560869|363326025|FG001|Overall Study|Withdrawal by PI|1|||
105360615|NCT01801111|363326026|FG000|Overall Study|Adverse Event|12|||
105360616|NCT01801111|363326026|FG000|Overall Study|Death|8|||
105360617|NCT01801111|363326026|FG000|Overall Study|Physician Decision|5|||
105360618|NCT01801111|363326026|FG000|Overall Study|Other|1|||
105360619|NCT01801111|363326026|FG000|Overall Study|Withdrawal by Subject|4|||
105360620|NCT01801111|363326026|FG000|Overall Study|Study Terminated by Sponsor|27|||
105360621|NCT01801111|363326026|FG000|Overall Study|Progressive Disease|81|||
105360622|NCT05404711|363326027|FG000|Completed Study Visit|Withdrawal by Subject|1|||
105360623|NCT05404711|363326027|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
105360624|NCT05404711|363326027|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
105360625|NCT05404711|363326027|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
105360626|NCT05404711|363326027|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
105360627|NCT05404711|363326027|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
105360628|NCT03284853|363326029|FG000|Overall Study|Adverse Event|40|||
105360629|NCT03284853|363326030|FG001|Overall Study|Adverse Event|4|||
105360630|NCT03284853|363326029|FG000|Overall Study|Withdrawal by Subject|5|||
105360631|NCT03284853|363326030|FG001|Overall Study|Withdrawal by Subject|1|||
105360632|NCT03284853|363326029|FG000|Overall Study|Lost to Follow-up|1|||
105360633|NCT03284853|363326030|FG001|Overall Study|Lost to Follow-up|0|||
105360634|NCT03284853|363326029|FG000|Overall Study|Lack of Efficacy|1|||
105360635|NCT03284853|363326030|FG001|Overall Study|Lack of Efficacy|0|||
105360636|NCT03284853|363326029|FG000|Overall Study|Disallowed Concurrent Medication|1|||
105360637|NCT03284853|363326030|FG001|Overall Study|Disallowed Concurrent Medication|1|||
105360638|NCT03284853|363326029|FG000|Overall Study|Protocol Violation|3|||
105360639|NCT03284853|363326030|FG001|Overall Study|Protocol Violation|3|||
105360640|NCT03284853|363326029|FG000|Overall Study|Death|0|||
105360641|NCT03284853|363326030|FG001|Overall Study|Death|1|||
105360642|NCT03284853|363326029|FG000|Overall Study|Other - Reason not reported in CSR|4|||
105360643|NCT03284853|363326030|FG001|Overall Study|Other - Reason not reported in CSR|3|||
105484264|NCT04393298|363784249|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
105484265|NCT04393298|363784250|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
105484266|NCT03754972|363784253|FG000|Overall Study|Protocol Violation|25|||
105484267|NCT04418661|363784258|FG000|Overall Study|Adverse Event|0|||
105484268|NCT04418661|363784259|FG001|Overall Study|Adverse Event|1|||
105484269|NCT04418661|363784260|FG002|Overall Study|Adverse Event|5|||
105484270|NCT04418661|363784261|FG003|Overall Study|Adverse Event|3|||
105484271|NCT04418661|363784262|FG004|Overall Study|Adverse Event|0|||
105484272|NCT04418661|363784263|FG005|Overall Study|Adverse Event|2|||
105484273|NCT04418661|363784258|FG000|Overall Study|Progressive disease|4|||
105484274|NCT04418661|363784259|FG001|Overall Study|Progressive disease|11|||
105484275|NCT04418661|363784260|FG002|Overall Study|Progressive disease|6|||
105484276|NCT04418661|363784261|FG003|Overall Study|Progressive disease|11|||
105484277|NCT04418661|363784262|FG004|Overall Study|Progressive disease|1|||
105484278|NCT04418661|363784263|FG005|Overall Study|Progressive disease|12|||
105484279|NCT04418661|363784258|FG000|Overall Study|Withdrawal by Subject|0|||
105484280|NCT04418661|363784259|FG001|Overall Study|Withdrawal by Subject|1|||
105484281|NCT04418661|363784260|FG002|Overall Study|Withdrawal by Subject|0|||
105484282|NCT04418661|363784261|FG003|Overall Study|Withdrawal by Subject|1|||
105484283|NCT04418661|363784262|FG004|Overall Study|Withdrawal by Subject|0|||
105484284|NCT04418661|363784263|FG005|Overall Study|Withdrawal by Subject|0|||
105484285|NCT04418661|363784258|FG000|Overall Study|Other|0|||
105484286|NCT04418661|363784259|FG001|Overall Study|Other|0|||
105484287|NCT04418661|363784260|FG002|Overall Study|Other|1|||
105484288|NCT04418661|363784261|FG003|Overall Study|Other|3|||
105484289|NCT04418661|363784262|FG004|Overall Study|Other|0|||
105484290|NCT04418661|363784263|FG005|Overall Study|Other|1|||
105484291|NCT00934648|363784264|FG000|Overall Study|Failure to return|8|||
105484292|NCT00934648|363784264|FG000|Overall Study|Withdrawal by Subject|1|||
105484293|NCT01534182|363784272|FG000|Overall Study|Administrative problems|1|||
105484294|NCT01534182|363784273|FG001|Overall Study|Administrative problems|0|||
105484295|NCT01534182|363784272|FG000|Overall Study|Withdrawal by Subject|4|||
105484296|NCT01534182|363784273|FG001|Overall Study|Withdrawal by Subject|7|||
105484297|NCT01534182|363784272|FG000|Overall Study|Adverse Event|7|||
105484298|NCT01534182|363784273|FG001|Overall Study|Adverse Event|3|||
105805058|NCT03381248|364943354|FG000|6-12 Months|Protocol Violation|3|||
105360644|NCT04376515|363326035|FG000|Overall Study|Found to have been vaccinated before study start|6|||
105360645|NCT04376515|363326036|FG001|Overall Study|Found to have been vaccinated before study start|6|||
105360646|NCT03430856|363326038|FG000|Overall Study|Adverse Event|0|||
105360647|NCT03430856|363326039|FG001|Overall Study|Adverse Event|1|||
105360648|NCT03430856|363326040|FG002|Overall Study|Adverse Event|0|||
105360649|NCT03430856|363326038|FG000|Overall Study|Rescue criteria|1|||
105360650|NCT03430856|363326039|FG001|Overall Study|Rescue criteria|1|||
105484299|NCT02514473|363784274|FG000|Overall Study|Adverse Event|0|||
105484300|NCT02514473|363784275|FG001|Overall Study|Adverse Event|2|||
105484301|NCT02514473|363784274|FG000|Overall Study|Withdrawal by Subject|2|||
105484302|NCT02514473|363784275|FG001|Overall Study|Withdrawal by Subject|1|||
105484303|NCT02514473|363784274|FG000|Overall Study|Lost to Follow-up|0|||
105484304|NCT02514473|363784275|FG001|Overall Study|Lost to Follow-up|1|||
105484305|NCT02514473|363784274|FG000|Overall Study|Other|1|||
105484306|NCT02514473|363784275|FG001|Overall Study|Other|1|||
105484307|NCT03222492|363784276|FG000|Overall Study|Withdrawal by Subject|0|||
105484308|NCT03222492|363784277|FG001|Overall Study|Withdrawal by Subject|0|||
105484309|NCT03222492|363784278|FG002|Overall Study|Withdrawal by Subject|1|||
105484310|NCT03222492|363784279|FG003|Overall Study|Withdrawal by Subject|0|||
105484311|NCT03222492|363784276|FG000|Overall Study|COVID-19 related|0|||
105484312|NCT03222492|363784277|FG001|Overall Study|COVID-19 related|0|||
105484313|NCT03222492|363784278|FG002|Overall Study|COVID-19 related|1|||
105484314|NCT03222492|363784279|FG003|Overall Study|COVID-19 related|0|||
105484315|NCT00674154|363784280|FG000|Overall Study|Withdrawal by Subject|3|||
105484316|NCT00674154|363784281|FG001|Overall Study|Withdrawal by Subject|1|||
105484317|NCT00674154|363784280|FG000|Overall Study|Did not want parathyroidectomy|0|||
105484318|NCT00674154|363784281|FG001|Overall Study|Did not want parathyroidectomy|2|||
105484319|NCT00609362|363784285|FG000|Overall Study|Withdrawal by Subject|2|||
105484320|NCT00609362|363784286|FG001|Overall Study|Withdrawal by Subject|1|||
105484321|NCT00609362|363784285|FG000|Overall Study|Adverse Event|1|||
105484322|NCT00609362|363784286|FG001|Overall Study|Adverse Event|0|||
105484323|NCT04559529|363784287|FG000|First Intervention (1 Day)|Adverse Event|0|||
105484324|NCT04559529|363784288|FG001|First Intervention (1 Day)|Adverse Event|0|||
105484325|NCT04559529|363784289|FG002|First Intervention (1 Day)|Adverse Event|0|||
105484326|NCT04559529|363784290|FG003|First Intervention (1 Day)|Adverse Event|1|||
105484327|NCT04559529|363784287|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
105484328|NCT04559529|363784288|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
105484329|NCT04559529|363784289|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
105484330|NCT04559529|363784290|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
105484331|NCT04559529|363784287|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
105484332|NCT04559529|363784288|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
105484333|NCT04559529|363784289|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
105484334|NCT04559529|363784290|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
105484335|NCT05093790|363784291|FG000|Overall Study|Failure to meet continuation criteria|0|||
105484336|NCT05093790|363784292|FG001|Overall Study|Failure to meet continuation criteria|0|||
105484337|NCT05093790|363784293|FG002|Overall Study|Failure to meet continuation criteria|1|||
105484338|NCT05093790|363784294|FG003|Overall Study|Failure to meet continuation criteria|0|||
105484339|NCT05093790|363784291|FG000|Overall Study|Adverse Event|1|||
105484340|NCT05093790|363784292|FG001|Overall Study|Adverse Event|0|||
105484341|NCT05093790|363784293|FG002|Overall Study|Adverse Event|0|||
105484342|NCT05093790|363784294|FG003|Overall Study|Adverse Event|0|||
105484343|NCT04971226|363784296|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
105484344|NCT04971226|363784297|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
105484345|NCT04971226|363784298|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
105484346|NCT04971226|363784299|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
105569969|NCT00402337|364085275|FG001|Overall Study|Lost to Follow-up|0|||
105484347|NCT04971226|363784296|FG000|Overall Study|Adverse Event|6|||
105484348|NCT04971226|363784297|FG001|Overall Study|Adverse Event|5|||
105484349|NCT04971226|363784298|FG002|Overall Study|Adverse Event|11|||
105484350|NCT04971226|363784299|FG003|Overall Study|Adverse Event|10|||
105484351|NCT04971226|363784296|FG000|Overall Study|Progressive disease|2|||
105805059|NCT03381248|364943355|FG001|6-12 Months|Protocol Violation|2|||
105805060|NCT03381248|364943354|FG000|6-12 Months|Planning another procedure|6|||
105805061|NCT03381248|364943355|FG001|6-12 Months|Planning another procedure|2|||
105805062|NCT03381248|364943354|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
105805063|NCT03381248|364943355|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
105805064|NCT03381248|364943354|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
105805065|NCT03381248|364943355|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
105805066|NCT03381248|364943354|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
105805067|NCT03381248|364943355|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
105805068|NCT01387282|364943360|FG000|Overall Study|Death|47|||
105805069|NCT01387282|364943361|FG001|Overall Study|Death|16|||
105805070|NCT01387282|364943360|FG000|Overall Study|Other|5|||
105805071|NCT01387282|364943361|FG001|Overall Study|Other|1|||
105805072|NCT01387282|364943360|FG000|Overall Study|Unrelated AE|6|||
105805073|NCT01387282|364943361|FG001|Overall Study|Unrelated AE|4|||
105805074|NCT01387282|364943360|FG000|Overall Study|Withdrawal by patient|33|||
105805075|NCT01387282|364943361|FG001|Overall Study|Withdrawal by patient|23|||
105805076|NCT01387282|364943360|FG000|Overall Study|Study drug-related AE|2|||
105805077|NCT01387282|364943361|FG001|Overall Study|Study drug-related AE|2|||
105805078|NCT01387282|364943360|FG000|Overall Study|Lost to Follow-up|4|||
105805079|NCT01387282|364943361|FG001|Overall Study|Lost to Follow-up|1|||
105805080|NCT01806597|364943364|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
105805081|NCT01806597|364943365|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
105805082|NCT01806597|364943366|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
105805083|NCT01806597|364943367|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
105805084|NCT01806597|364943368|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
105805085|NCT01806597|364943369|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
105805086|NCT01806597|364943364|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
105805087|NCT01806597|364943365|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
105805088|NCT01806597|364943366|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
105805089|NCT01806597|364943367|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
105805090|NCT01806597|364943368|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
105805091|NCT01806597|364943369|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
105805092|NCT01806597|364943364|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
105805093|NCT01806597|364943365|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
105805094|NCT01806597|364943366|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
105805095|NCT01806597|364943367|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
105805096|NCT01806597|364943368|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
105805097|NCT01806597|364943369|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
105805098|NCT01806597|364943364|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
105805099|NCT01806597|364943365|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
105805100|NCT01806597|364943366|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
105805101|NCT01806597|364943367|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
105805102|NCT01806597|364943368|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
105360651|NCT03430856|363326040|FG002|Overall Study|Rescue criteria|0|||
105805103|NCT01806597|364943369|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
105805104|NCT01806597|364943364|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
105569970|NCT00402337|364085276|FG002|Overall Study|Lost to Follow-up|1|||
105569971|NCT00402337|364085277|FG003|Overall Study|Lost to Follow-up|2|||
105569972|NCT00402337|364085278|FG004|Overall Study|Lost to Follow-up|0|||
105569973|NCT00402337|364085274|FG000|Overall Study|Physician Decision|0|||
105569974|NCT00402337|364085275|FG001|Overall Study|Physician Decision|0|||
105569975|NCT00402337|364085276|FG002|Overall Study|Physician Decision|0|||
105569976|NCT00402337|364085277|FG003|Overall Study|Physician Decision|1|||
105569977|NCT00402337|364085278|FG004|Overall Study|Physician Decision|0|||
105569978|NCT00402337|364085274|FG000|Overall Study|Other Reason|0|||
105569979|NCT00402337|364085275|FG001|Overall Study|Other Reason|1|||
105569980|NCT00402337|364085276|FG002|Overall Study|Other Reason|0|||
105569981|NCT00402337|364085277|FG003|Overall Study|Other Reason|0|||
105569982|NCT00402337|364085278|FG004|Overall Study|Other Reason|0|||
105569983|NCT03108157|364085279|FG000|Overall Study|Protocol Violation|15|||
105569984|NCT03108157|364085280|FG001|Overall Study|Protocol Violation|4|||
105569985|NCT03287414|364085281|FG000|Treatment Epoch|Adverse Event|0|||
105569986|NCT03287414|364085282|FG001|Treatment Epoch|Adverse Event|1|||
105569987|NCT03287414|364085281|FG000|Treatment Epoch|Study terminated by sponsor|2|||
105569988|NCT03287414|364085282|FG001|Treatment Epoch|Study terminated by sponsor|2|||
105569989|NCT03287414|364085281|FG000|Treatment Epoch|Subject/Guardian decision|4|||
105569990|NCT03287414|364085282|FG001|Treatment Epoch|Subject/Guardian decision|0|||
105569991|NCT03287414|364085281|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
105569992|NCT03287414|364085282|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
105569993|NCT03287414|364085281|FG000|Treatment Epoch|Withdrawal by Subject|1|||
105569994|NCT03287414|364085282|FG001|Treatment Epoch|Withdrawal by Subject|0|||
105569995|NCT03287414|364085281|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
105569996|NCT03287414|364085282|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
105569997|NCT03287414|364085281|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
105569998|NCT03287414|364085282|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
105569999|NCT01396317|364085289|FG000|Overall Study|Adverse Event|1|||
105570000|NCT01396317|364085290|FG001|Overall Study|Adverse Event|0|||
105570001|NCT00539279|364085292|FG000|Treatment|Withdrawal by Subject|10|||
105570002|NCT00539279|364085293|FG001|Treatment|Withdrawal by Subject|8|||
105570003|NCT00539279|364085292|FG000|Treatment|Death|1|||
105360652|NCT03430856|363326038|FG000|Overall Study|Voluntary withdrawal of consent|1|||
105360653|NCT03430856|363326039|FG001|Overall Study|Voluntary withdrawal of consent|1|||
105360654|NCT03430856|363326040|FG002|Overall Study|Voluntary withdrawal of consent|1|||
105360655|NCT01949142|363326041|FG000|Overall Study|Withdrawal of consent|1|||
105360656|NCT01949142|363326042|FG001|Overall Study|Withdrawal of consent|0|||
105360657|NCT01949142|363326041|FG000|Overall Study|Lost to Follow-up|1|||
105360658|NCT01949142|363326042|FG001|Overall Study|Lost to Follow-up|1|||
105360659|NCT01949142|363326041|FG000|Overall Study|Parent changed their mind|1|||
105360660|NCT01949142|363326042|FG001|Overall Study|Parent changed their mind|0|||
105360661|NCT01395810|363326047|FG000|Overall Study|Adverse Event|0|||
105360662|NCT01395810|363326048|FG001|Overall Study|Adverse Event|1|||
105360663|NCT01395810|363326049|FG002|Overall Study|Adverse Event|0|||
105360664|NCT01395810|363326050|FG003|Overall Study|Adverse Event|0|||
105360665|NCT01395810|363326047|FG000|Overall Study|Lack of Efficacy|0|||
105360666|NCT01395810|363326048|FG001|Overall Study|Lack of Efficacy|1|||
105570004|NCT00539279|364085293|FG001|Treatment|Death|0|||
105570005|NCT00539279|364085292|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
105570006|NCT00539279|364085293|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
105570007|NCT00539279|364085292|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
105360667|NCT01395810|363326049|FG002|Overall Study|Lack of Efficacy|0|||
105570008|NCT00539279|364085293|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
105570009|NCT04287868|364085297|FG000|Overall Study|Screening fail|1|||
105570010|NCT04287868|364085298|FG001|Overall Study|Screening fail|0|||
105570011|NCT02073097|364085299|FG000|Overall Study|Adverse Event|0|||
105570012|NCT02073097|364085300|FG001|Overall Study|Adverse Event|0|||
105570013|NCT02073097|364085301|FG002|Overall Study|Adverse Event|0|||
105360668|NCT01395810|363326050|FG003|Overall Study|Lack of Efficacy|0|||
105360669|NCT01395810|363326047|FG000|Overall Study|Withdrawal criteria|0|||
105759941|NCT00247273|364773810|FG001|Overall Study|Did not take any study drug|0|||
105570014|NCT02073097|364085302|FG003|Overall Study|Adverse Event|0|||
105570015|NCT02073097|364085303|FG004|Overall Study|Adverse Event|0|||
105570016|NCT02073097|364085304|FG005|Overall Study|Adverse Event|0|||
105570017|NCT02073097|364085305|FG006|Overall Study|Adverse Event|0|||
105570018|NCT02073097|364085306|FG007|Overall Study|Adverse Event|2|||
105570019|NCT02073097|364085299|FG000|Overall Study|Withdrawal by Subject|0|||
105570020|NCT02073097|364085300|FG001|Overall Study|Withdrawal by Subject|0|||
105570021|NCT02073097|364085301|FG002|Overall Study|Withdrawal by Subject|0|||
105570022|NCT02073097|364085302|FG003|Overall Study|Withdrawal by Subject|0|||
105570023|NCT02073097|364085303|FG004|Overall Study|Withdrawal by Subject|0|||
105570024|NCT02073097|364085304|FG005|Overall Study|Withdrawal by Subject|0|||
105570025|NCT02073097|364085305|FG006|Overall Study|Withdrawal by Subject|0|||
105570026|NCT02073097|364085306|FG007|Overall Study|Withdrawal by Subject|2|||
105570027|NCT02073097|364085299|FG000|Overall Study|Death|0|||
105570028|NCT02073097|364085300|FG001|Overall Study|Death|0|||
105570029|NCT02073097|364085301|FG002|Overall Study|Death|0|||
105570030|NCT02073097|364085302|FG003|Overall Study|Death|0|||
105570031|NCT02073097|364085303|FG004|Overall Study|Death|0|||
105570032|NCT02073097|364085304|FG005|Overall Study|Death|0|||
105570033|NCT02073097|364085305|FG006|Overall Study|Death|0|||
105570034|NCT02073097|364085306|FG007|Overall Study|Death|1|||
105570035|NCT02073097|364085299|FG000|Overall Study|Physician Decision|0|||
105570036|NCT02073097|364085300|FG001|Overall Study|Physician Decision|0|||
105570037|NCT02073097|364085301|FG002|Overall Study|Physician Decision|0|||
105570038|NCT02073097|364085302|FG003|Overall Study|Physician Decision|0|||
105570039|NCT02073097|364085303|FG004|Overall Study|Physician Decision|0|||
105570040|NCT02073097|364085304|FG005|Overall Study|Physician Decision|0|||
105570041|NCT02073097|364085305|FG006|Overall Study|Physician Decision|0|||
105570042|NCT02073097|364085306|FG007|Overall Study|Physician Decision|1|||
105570043|NCT01862991|364086617|FG000|Overall Study|Lost to Follow-up|2|||
105570044|NCT01862991|364086618|FG001|Overall Study|Lost to Follow-up|1|||
105759942|NCT03805971|364773812|FG000|Overall Study|Withdrawal by Subject|1|||
105484352|NCT04971226|363784297|FG001|Overall Study|Progressive disease|0|||
105484353|NCT04971226|363784298|FG002|Overall Study|Progressive disease|3|||
105484354|NCT04971226|363784299|FG003|Overall Study|Progressive disease|1|||
105484355|NCT04971226|363784296|FG000|Overall Study|Protocol Deviation|1|||
105484356|NCT04971226|363784297|FG001|Overall Study|Protocol Deviation|0|||
105484357|NCT04971226|363784298|FG002|Overall Study|Protocol Deviation|1|||
105484358|NCT04971226|363784299|FG003|Overall Study|Protocol Deviation|1|||
105484359|NCT04971226|363784296|FG000|Overall Study|Subject Decision|0|||
105484360|NCT04971226|363784297|FG001|Overall Study|Subject Decision|1|||
105484361|NCT04971226|363784298|FG002|Overall Study|Subject Decision|1|||
105484362|NCT04971226|363784299|FG003|Overall Study|Subject Decision|1|||
105484363|NCT04971226|363784296|FG000|Overall Study|Pregnancy|0|||
105484364|NCT04971226|363784297|FG001|Overall Study|Pregnancy|0|||
105570045|NCT01862991|364086619|FG002|Overall Study|Lost to Follow-up|1|||
105570046|NCT01862991|364086617|FG000|Overall Study|Protocol Violation|1|||
105570047|NCT01862991|364086618|FG001|Overall Study|Protocol Violation|0|||
105570048|NCT01862991|364086619|FG002|Overall Study|Protocol Violation|0|||
105570049|NCT05648357|364086631|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
105570050|NCT03585296|364086633|FG000|Overall Study|Adverse Event|1|||
105570051|NCT03585296|364086633|FG000|Overall Study|Lost to Follow-up|2|||
105570052|NCT03585296|364086633|FG000|Overall Study|Withdrawal by Subject|2|||
105570053|NCT00539643|364086634|FG000|Overall Study|Adverse Event|1|||
105570054|NCT00539643|364086635|FG001|Overall Study|Adverse Event|0|||
105484365|NCT04971226|363784298|FG002|Overall Study|Pregnancy|0|||
105484366|NCT04971226|363784299|FG003|Overall Study|Pregnancy|1|||
105570055|NCT00539643|364086634|FG000|Overall Study|Death|2|||
105570056|NCT00539643|364086635|FG001|Overall Study|Death|1|||
105570057|NCT00539643|364086634|FG000|Overall Study|Physician Decision|3|||
105570058|NCT00539643|364086635|FG001|Overall Study|Physician Decision|1|||
105570059|NCT00539643|364086634|FG000|Overall Study|Withdrawal by Subject|0|||
105570060|NCT00539643|364086635|FG001|Overall Study|Withdrawal by Subject|1|||
105570061|NCT03673462|364086636|FG000|Overall Study|Adverse Event|11|||
105570062|NCT03673462|364086637|FG001|Overall Study|Adverse Event|1|||
105570063|NCT03673462|364086636|FG000|Overall Study|Protocol Violation|25|||
105570064|NCT03673462|364086637|FG001|Overall Study|Protocol Violation|11|||
105570065|NCT03673462|364086636|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
105570066|NCT03673462|364086637|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
105570067|NCT03673462|364086636|FG000|Overall Study|Lost to Follow-up|102|||
105570068|NCT03673462|364086637|FG001|Overall Study|Lost to Follow-up|19|||
105570069|NCT03097861|364086638|FG000|Overall Study|Adverse Event|3|||
105570070|NCT03097861|364086639|FG001|Overall Study|Adverse Event|8|||
105570071|NCT03097861|364086640|FG002|Overall Study|Adverse Event|4|||
105570072|NCT03097861|364086638|FG000|Overall Study|Investigator Decision|0|||
105570073|NCT03097861|364086639|FG001|Overall Study|Investigator Decision|1|||
105570074|NCT03097861|364086640|FG002|Overall Study|Investigator Decision|0|||
105570075|NCT03097861|364086638|FG000|Overall Study|Lost to Follow-up|0|||
105570076|NCT03097861|364086639|FG001|Overall Study|Lost to Follow-up|7|||
105570077|NCT03097861|364086640|FG002|Overall Study|Lost to Follow-up|1|||
105570078|NCT03097861|364086638|FG000|Overall Study|Withdrawal by Subject|1|||
105570079|NCT03097861|364086639|FG001|Overall Study|Withdrawal by Subject|5|||
105570080|NCT03097861|364086640|FG002|Overall Study|Withdrawal by Subject|3|||
105570081|NCT03097861|364086638|FG000|Overall Study|Reason not provided|3|||
105570082|NCT03097861|364086639|FG001|Overall Study|Reason not provided|1|||
105570083|NCT03097861|364086640|FG002|Overall Study|Reason not provided|1|||
105570084|NCT01153269|364086642|FG000|Overall Study|Withdrawal by Subject|1|||
105570085|NCT01153269|364086642|FG000|Overall Study|Antiretroviral therapy break|1|||
105570086|NCT03541044|364086643|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
105570087|NCT03541044|364086644|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
105570088|NCT03541044|364086643|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
105570089|NCT03541044|364086644|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
105570090|NCT00988221|364086649|FG000|Part I|Adverse Event|0|||
105570091|NCT00988221|364086650|FG001|Part I|Adverse Event|1|||
105570092|NCT00988221|364086651|FG002|Part I|Adverse Event|2|||
105570093|NCT00988221|364086652|FG003|Part I|Adverse Event|0|||
105759943|NCT03805971|364773812|FG000|Overall Study|Protocol Violation|2|||
105759944|NCT03276572|364773813|FG000|Overall Study|In follow-up|0|||
105759945|NCT03276572|364773814|FG001|Overall Study|In follow-up|0|||
105759946|NCT03276572|364773815|FG002|Overall Study|In follow-up|0|||
105759947|NCT03276572|364773816|FG003|Overall Study|In follow-up|0|||
105484367|NCT04971226|363784296|FG000|Overall Study|Participants not treated|1|||
105484368|NCT04971226|363784297|FG001|Overall Study|Participants not treated|0|||
105484369|NCT04971226|363784298|FG002|Overall Study|Participants not treated|2|||
105484370|NCT04971226|363784299|FG003|Overall Study|Participants not treated|1|||
105570094|NCT00988221|364086649|FG000|Part I|Insufficient Therapeutic Response|4|||
105570095|NCT00988221|364086650|FG001|Part I|Insufficient Therapeutic Response|6|||
105570096|NCT00988221|364086651|FG002|Part I|Insufficient Therapeutic Response|5|||
105570097|NCT00988221|364086652|FG003|Part I|Insufficient Therapeutic Response|0|||
105570098|NCT00988221|364086649|FG000|Part I|Refused Treatment|0|||
105484371|NCT00627445|363784300|FG000|Overall Study|Adverse Event|3|||
105360670|NCT01395810|363326048|FG001|Overall Study|Withdrawal criteria|2|||
105360671|NCT01395810|363326049|FG002|Overall Study|Withdrawal criteria|0|||
105360672|NCT01395810|363326050|FG003|Overall Study|Withdrawal criteria|0|||
105360673|NCT01395810|363326047|FG000|Overall Study|Unclassified|2|||
105360674|NCT01395810|363326048|FG001|Overall Study|Unclassified|0|||
105360675|NCT01395810|363326049|FG002|Overall Study|Unclassified|0|||
105360676|NCT01395810|363326050|FG003|Overall Study|Unclassified|0|||
105360677|NCT05027815|363326051|FG000|Overall Study|Death|2|||
105360678|NCT05027815|363326052|FG001|Overall Study|Death|1|||
105360679|NCT03677869|363326056|FG000|Overall Study|Withdrawal by Subject|1|||
105360680|NCT02624947|363328054|FG000|Maternal Participants|Adverse Event|5|||
105360681|NCT02624947|363328055|FG001|Maternal Participants|Adverse Event|0|||
105360682|NCT02624947|363328054|FG000|Maternal Participants|Investigator Decision|5|||
105360683|NCT02624947|363328055|FG001|Maternal Participants|Investigator Decision|3|||
105360684|NCT02624947|363328054|FG000|Maternal Participants|Lost to Follow-up|54|||
105484372|NCT00627445|363784301|FG001|Overall Study|Adverse Event|3|||
105484373|NCT00627445|363784300|FG000|Overall Study|Lack of Efficacy|0|||
105484374|NCT00627445|363784301|FG001|Overall Study|Lack of Efficacy|1|||
105484375|NCT00627445|363784300|FG000|Overall Study|Other|6|||
105484376|NCT00627445|363784301|FG001|Overall Study|Other|8|||
105484377|NCT04098224|363784302|FG000|Overall Study|Adverse Event|1|||
105484378|NCT04098224|363784303|FG001|Overall Study|Adverse Event|0|||
105484379|NCT04098224|363784302|FG000|Overall Study|Physician Decision|1|||
105484380|NCT04098224|363784303|FG001|Overall Study|Physician Decision|0|||
105484381|NCT04098224|363784302|FG000|Overall Study|Patient not required enteral feeding|1|||
105484382|NCT04098224|363784303|FG001|Overall Study|Patient not required enteral feeding|0|||
105484383|NCT04098224|363784302|FG000|Overall Study|Patient failure nasogastric tube|1|||
105484384|NCT04098224|363784303|FG001|Overall Study|Patient failure nasogastric tube|0|||
105484385|NCT04098224|363784302|FG000|Overall Study|Patient early extubation|1|||
105484386|NCT04098224|363784303|FG001|Overall Study|Patient early extubation|3|||
105484387|NCT00247611|363784305|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
105484388|NCT00247611|363784306|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
105484389|NCT00247611|363784305|FG000|Baselined|Completed baseline only|9|||
105484390|NCT00247611|363784306|FG001|Baselined|Completed baseline only|8|||
105484391|NCT02582684|363784308|FG000|Overall Study|Unable to contact subject/parent|4|||
105484392|NCT02582684|363784308|FG000|Overall Study|Subject not able to get to clinic|10|||
105484393|NCT02582684|363784308|FG000|Overall Study|Subject withdrew consent|1|||
105484394|NCT02582684|363784308|FG000|Overall Study|Found to be ineligible after enrollment|2|||
105484395|NCT00783302|363784309|FG000|Overall Study|Lost to Follow-up|17|||
105484396|NCT00783302|363784309|FG000|Overall Study|Technical Problems|11|||
105484397|NCT00783302|363784309|FG000|Overall Study|Protocol Violation|3|||
105484398|NCT00783302|363784309|FG000|Overall Study|Physician Decision|1|||
105484399|NCT00783302|363784309|FG000|Overall Study|Withdrawal by Subject|3|||
105484400|NCT00402233|363784312|FG000|Overall Study|Adverse Event|1|||
105484401|NCT00402233|363784313|FG001|Overall Study|Adverse Event|7|||
105484402|NCT00402233|363784314|FG002|Overall Study|Adverse Event|9|||
105484403|NCT00402233|363784315|FG003|Overall Study|Adverse Event|9|||
105484404|NCT00402233|363784312|FG000|Overall Study|Protocol Violation|0|||
105484405|NCT00402233|363784313|FG001|Overall Study|Protocol Violation|1|||
105484406|NCT00402233|363784314|FG002|Overall Study|Protocol Violation|0|||
105484407|NCT00402233|363784315|FG003|Overall Study|Protocol Violation|0|||
105484408|NCT00402233|363784312|FG000|Overall Study|Withdrawal by Subject|2|||
105484409|NCT00402233|363784313|FG001|Overall Study|Withdrawal by Subject|1|||
105484410|NCT00402233|363784314|FG002|Overall Study|Withdrawal by Subject|2|||
105484411|NCT00402233|363784315|FG003|Overall Study|Withdrawal by Subject|2|||
105484412|NCT00402233|363784312|FG000|Overall Study|Worsening of disease under study|2|||
105484413|NCT00402233|363784313|FG001|Overall Study|Worsening of disease under study|0|||
105484414|NCT00402233|363784314|FG002|Overall Study|Worsening of disease under study|0|||
105484415|NCT00402233|363784315|FG003|Overall Study|Worsening of disease under study|0|||
105484416|NCT00402233|363784312|FG000|Overall Study|Worsening of other pre-existing disease|0|||
105484417|NCT00402233|363784313|FG001|Overall Study|Worsening of other pre-existing disease|1|||
105805105|NCT01806597|364943365|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
105360685|NCT02624947|363328055|FG001|Maternal Participants|Lost to Follow-up|24|||
105360686|NCT02624947|363328054|FG000|Maternal Participants|Non Compliance|8|||
105360687|NCT02624947|363328055|FG001|Maternal Participants|Non Compliance|5|||
105360688|NCT02624947|363328054|FG000|Maternal Participants|Sponsor Request|1|||
105360689|NCT02624947|363328055|FG001|Maternal Participants|Sponsor Request|1|||
105360690|NCT02624947|363328054|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
105484418|NCT00402233|363784314|FG002|Overall Study|Worsening of other pre-existing disease|0|||
105484419|NCT00402233|363784315|FG003|Overall Study|Worsening of other pre-existing disease|0|||
105484420|NCT00725842|363784316|FG000|Overall Study|Lost to Follow-up|19|||
105484421|NCT00725842|363784316|FG000|Overall Study|Death|1|||
105484422|NCT00725842|363784316|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
105484423|NCT00725842|363784316|FG000|Overall Study|Consent date prior to study start date|5|||
105805106|NCT01806597|364943366|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
105805107|NCT01806597|364943367|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
105805108|NCT01806597|364943368|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
105805109|NCT01806597|364943369|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
105805110|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
105805111|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
105805112|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
105805113|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
105805114|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
105805115|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
105805116|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
105805117|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
105805118|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
105805119|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
105805120|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
105805121|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
105805122|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
105805123|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
105805124|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
105805125|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
105805126|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
105805127|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
105805128|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
105805129|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
105805130|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
105805131|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
105805132|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
105805133|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
105805134|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
105805135|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
105805136|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
105805137|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
105805138|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
105805139|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
105805140|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
105805141|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
105805142|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
105805143|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
105805144|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
105805145|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
105805146|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
105805147|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
105805148|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
105805149|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
105805150|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
105805151|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
105805152|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
105805153|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
105805154|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
105805155|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
105805156|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
105805157|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
105805158|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
105805159|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
105805160|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
105484424|NCT00725842|363784316|FG000|Overall Study|Inclusion criterion not met|1|||
105484425|NCT00725842|363784316|FG000|Overall Study|No Visit 1 data|1|||
105484426|NCT00927940|363784319|FG000|Overall Study|Death|1|||
105484427|NCT00827931|363784321|FG000|Overall Study|Death|3|||
105484428|NCT00827931|363784322|FG001|Overall Study|Death|5|||
105805161|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
105484429|NCT00827931|363784321|FG000|Overall Study|Adverse Event|1|||
105484430|NCT00827931|363784322|FG001|Overall Study|Adverse Event|0|||
105805162|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
105805163|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
105805164|NCT01806597|364943364|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
105805165|NCT01806597|364943365|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
105805166|NCT01806597|364943366|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
105805167|NCT01806597|364943367|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
105805168|NCT01806597|364943368|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
105805169|NCT01806597|364943369|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
105805170|NCT01806597|364943364|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
105805171|NCT01806597|364943365|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
105805172|NCT01806597|364943366|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
105805173|NCT01806597|364943367|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
105805174|NCT01806597|364943368|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
105805175|NCT01806597|364943369|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
105805176|NCT01806597|364943364|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
105805177|NCT01806597|364943365|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
105805178|NCT01806597|364943366|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
105805179|NCT01806597|364943367|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
105805180|NCT01806597|364943368|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
105805181|NCT01806597|364943369|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
105805182|NCT01806597|364943364|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
105805183|NCT01806597|364943365|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
105805184|NCT01806597|364943366|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
105805185|NCT01806597|364943367|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
105805186|NCT01806597|364943368|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
105805187|NCT01806597|364943369|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
105805188|NCT01806597|364943364|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
105805189|NCT01806597|364943365|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
105805190|NCT01806597|364943366|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
105805191|NCT01806597|364943367|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
105805192|NCT01806597|364943368|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
105805193|NCT01806597|364943369|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
105805194|NCT02482805|364943370|FG000|Overall Study|Lost to Follow-up|4|||
105805195|NCT02482805|364943371|FG001|Overall Study|Lost to Follow-up|4|||
105805196|NCT02482805|364943372|FG002|Overall Study|Lost to Follow-up|0|||
105805197|NCT01073020|364943373|FG000|Overall Study|Withdrawal by Subject|6|||
105805198|NCT01073020|364943374|FG001|Overall Study|Withdrawal by Subject|4|||
105805199|NCT01073020|364943375|FG002|Overall Study|Withdrawal by Subject|1|||
105805200|NCT01073020|364943376|FG003|Overall Study|Withdrawal by Subject|2|||
105805201|NCT01073020|364943373|FG000|Overall Study|Physician Decision|1|||
105805202|NCT01073020|364943374|FG001|Overall Study|Physician Decision|0|||
105805203|NCT01073020|364943375|FG002|Overall Study|Physician Decision|2|||
105805204|NCT01073020|364943376|FG003|Overall Study|Physician Decision|0|||
105805205|NCT01073020|364943373|FG000|Overall Study|Death|0|||
105805206|NCT01073020|364943374|FG001|Overall Study|Death|1|||
105805207|NCT01073020|364943375|FG002|Overall Study|Death|0|||
105805208|NCT01073020|364943376|FG003|Overall Study|Death|0|||
105805209|NCT01466686|364943377|FG000|Overall Study|Withdrawal by Subject|1|||
105805210|NCT01772368|364943381|FG000|Overall Study|Adverse Event|1|||
105805211|NCT01772368|364943381|FG000|Overall Study|Withdrawal by Subject|3|||
105805212|NCT01772368|364943381|FG000|Overall Study|Protocol Violation|2|||
105805213|NCT01772368|364943381|FG000|Overall Study|Other|1|||
105805214|NCT02008721|364943392|FG000|Overall Study|Withdrawal by Subject|5|||
105805215|NCT02008721|364943393|FG001|Overall Study|Withdrawal by Subject|1|||
105805216|NCT02008721|364943392|FG000|Overall Study|Death|4|||
105805217|NCT02008721|364943393|FG001|Overall Study|Death|2|||
105805218|NCT02008721|364943392|FG000|Overall Study|Adverse Event|3|||
105805219|NCT02008721|364943393|FG001|Overall Study|Adverse Event|5|||
105805220|NCT02008721|364943392|FG000|Overall Study|Protocol Violation|3|||
105805221|NCT02008721|364943393|FG001|Overall Study|Protocol Violation|2|||
105805222|NCT04081337|364943394|FG000|Overall Study|Adverse Event|0|||
105805223|NCT04081337|364943395|FG001|Overall Study|Adverse Event|1|||
105805224|NCT04081337|364943394|FG000|Overall Study|Withdrawal by Subject|2|||
105805225|NCT04081337|364943395|FG001|Overall Study|Withdrawal by Subject|0|||
105805226|NCT04081337|364943394|FG000|Overall Study|Physician Decision|1|||
105805227|NCT04081337|364943395|FG001|Overall Study|Physician Decision|2|||
105805228|NCT04081337|364943394|FG000|Overall Study|Lost to Follow-up|1|||
105805229|NCT04081337|364943395|FG001|Overall Study|Lost to Follow-up|0|||
105484431|NCT00827931|363784321|FG000|Overall Study|Lost to Follow-up|1|||
105805230|NCT04272775|364943399|FG000|Overall Study|Study Terminated by Sponsor|1|||
105484432|NCT00827931|363784322|FG001|Overall Study|Lost to Follow-up|0|||
105805231|NCT04272775|364943400|FG001|Overall Study|Study Terminated by Sponsor|0|||
105805232|NCT04272775|364943399|FG000|Overall Study|Protocol Violation|0|||
105805233|NCT04272775|364943400|FG001|Overall Study|Protocol Violation|1|||
105805234|NCT04272775|364943399|FG000|Overall Study|Symptomatic Deterioration|1|||
105805235|NCT04272775|364943400|FG001|Overall Study|Symptomatic Deterioration|1|||
105805236|NCT04272775|364943399|FG000|Overall Study|Withdrawal by Subject|1|||
105805237|NCT04272775|364943400|FG001|Overall Study|Withdrawal by Subject|2|||
105805238|NCT04272775|364943399|FG000|Overall Study|Adverse Event|1|||
105805239|NCT04272775|364943400|FG001|Overall Study|Adverse Event|2|||
105805240|NCT04272775|364943399|FG000|Overall Study|Progressive Disease|3|||
105805241|NCT04272775|364943400|FG001|Overall Study|Progressive Disease|1|||
105805242|NCT00738673|364943403|FG000|Overall Study|Adverse Event|1|||
105805243|NCT00738673|364943404|FG001|Overall Study|Adverse Event|0|||
105805244|NCT00738673|364943403|FG000|Overall Study|Lack of Efficacy|19|||
105805245|NCT00738673|364943404|FG001|Overall Study|Lack of Efficacy|8|||
105805246|NCT00738673|364943403|FG000|Overall Study|Protocol Violation|1|||
105805247|NCT00738673|364943404|FG001|Overall Study|Protocol Violation|2|||
105805248|NCT00738673|364943403|FG000|Overall Study|Withdrawal by Subject|3|||
105805249|NCT00738673|364943404|FG001|Overall Study|Withdrawal by Subject|1|||
105484433|NCT00827931|363784321|FG000|Overall Study|Withdrawal by Subject|0|||
105484434|NCT00827931|363784322|FG001|Overall Study|Withdrawal by Subject|1|||
105484435|NCT00827931|363784321|FG000|Overall Study|Other|1|||
105484436|NCT00827931|363784322|FG001|Overall Study|Other|0|||
105484437|NCT03579602|363784325|FG000|Overall Study|Subject unable to receive study drug|0|||
105484438|NCT03579602|363784326|FG001|Overall Study|Subject unable to receive study drug|2|||
105484439|NCT03579602|363784325|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
105484440|NCT03579602|363784326|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
105805250|NCT00752791|364943405|FG000|Overall Study|Adverse Event|7|||
105805251|NCT00752791|364943405|FG000|Overall Study|Withdrawal by Subject|1|||
105805252|NCT00752791|364943405|FG000|Overall Study|Physician Decision|1|||
105805253|NCT00752791|364943405|FG000|Overall Study|Death|1|||
105805254|NCT00752791|364943405|FG000|Overall Study|Renal transplant|3|||
105805255|NCT00752791|364943405|FG000|Overall Study|Switched to hemodialysis|2|||
105805256|NCT00752791|364943405|FG000|Overall Study|Protocol deviation|1|||
105805257|NCT01977092|364943406|FG000|Overall Study|Death|3|||
105805258|NCT01977092|364943407|FG001|Overall Study|Death|4|||
105805259|NCT01977092|364943406|FG000|Overall Study|Lost to Follow-up|23|||
105805260|NCT01977092|364943407|FG001|Overall Study|Lost to Follow-up|14|||
105805261|NCT01977092|364943406|FG000|Overall Study|Withdrawal by Subject|2|||
105805262|NCT01977092|364943407|FG001|Overall Study|Withdrawal by Subject|1|||
105805263|NCT01977092|364943406|FG000|Overall Study|In prison|3|||
105805264|NCT01977092|364943407|FG001|Overall Study|In prison|11|||
105805265|NCT00678392|364943408|FG000|Overall Study|Adverse Event|0|||
105805266|NCT00678392|364943409|FG001|Overall Study|Adverse Event|6|||
105805267|NCT00678392|364943408|FG000|Overall Study|Death|280|||
105805268|NCT00678392|364943409|FG001|Overall Study|Death|269|||
105805269|NCT00678392|364943408|FG000|Overall Study|Lost to Follow-up|15|||
105805270|NCT00678392|364943409|FG001|Overall Study|Lost to Follow-up|13|||
105805271|NCT00678392|364943408|FG000|Overall Study|Objective Progression or Relapse|3|||
105805272|NCT00678392|364943409|FG001|Overall Study|Objective Progression or Relapse|8|||
105805273|NCT00678392|364943408|FG000|Overall Study|Sponsor's Decision|1|||
105805274|NCT00678392|364943409|FG001|Overall Study|Sponsor's Decision|2|||
105805275|NCT00678392|364943408|FG000|Overall Study|Withdrawal by Subject|4|||
105484441|NCT02793622|363784327|FG000|Overall Study|Lost to Follow-up|31|||
105484442|NCT02793622|363784328|FG001|Overall Study|Lost to Follow-up|19|||
105484443|NCT02793622|363784327|FG000|Overall Study|Withdrawal by Subject|21|||
105484444|NCT02793622|363784328|FG001|Overall Study|Withdrawal by Subject|17|||
105484445|NCT02793622|363784327|FG000|Overall Study|Adverse Event|0|||
105484446|NCT02793622|363784328|FG001|Overall Study|Adverse Event|1|||
105484447|NCT02793622|363784327|FG000|Overall Study|Protocol Violation|1|||
105484448|NCT02793622|363784328|FG001|Overall Study|Protocol Violation|5|||
105484449|NCT01075191|363784329|FG000|Overall Study|Death|1|||
105805276|NCT00678392|364943409|FG001|Overall Study|Withdrawal by Subject|4|||
105805277|NCT00678392|364943408|FG000|Overall Study|Randomized But Not Treated|2|||
105484450|NCT01075191|363784329|FG000|Overall Study|Intensification|3|||
105484451|NCT01075191|363784329|FG000|Overall Study|Co-morbidities|1|||
105484452|NCT01075191|363784329|FG000|Overall Study|Adverse Event|4|||
105484453|NCT01075191|363784329|FG000|Overall Study|Noncompliance|3|||
105484454|NCT01075191|363784329|FG000|Overall Study|Therapy Break|3|||
105805278|NCT00678392|364943409|FG001|Overall Study|Randomized But Not Treated|7|||
105805279|NCT00678392|364943408|FG000|Overall Study|Other|56|||
105805280|NCT00678392|364943409|FG001|Overall Study|Other|53|||
105805281|NCT02385526|364943415|FG000|Overall Study|Withdrawal by Subject|0|||
105805282|NCT02385526|364943416|FG001|Overall Study|Withdrawal by Subject|2|||
105805283|NCT02385526|364943417|FG002|Overall Study|Withdrawal by Subject|0|||
105805284|NCT02385526|364943415|FG000|Overall Study|Lost to Follow-up|0|||
105805285|NCT02385526|364943416|FG001|Overall Study|Lost to Follow-up|1|||
105805286|NCT02385526|364943417|FG002|Overall Study|Lost to Follow-up|0|||
105805287|NCT02385526|364943415|FG000|Overall Study|Physician Decision|1|||
105805288|NCT02385526|364943416|FG001|Overall Study|Physician Decision|0|||
105805289|NCT02385526|364943417|FG002|Overall Study|Physician Decision|0|||
105805290|NCT02385526|364943415|FG000|Overall Study|Protocol Violation|1|||
105805291|NCT02385526|364943416|FG001|Overall Study|Protocol Violation|0|||
105805292|NCT02385526|364943417|FG002|Overall Study|Protocol Violation|0|||
105805293|NCT00441584|364943418|FG000|Overall Study|Lack of Efficacy|79|||
105805294|NCT00441584|364943418|FG000|Overall Study|Withdrawal by Subject|8|||
105805295|NCT00441584|364943418|FG000|Overall Study|Adverse Event|6|||
105805296|NCT00441584|364943418|FG000|Overall Study|Protocol Violation|5|||
105805297|NCT00441584|364943418|FG000|Overall Study|Lost to Follow-up|4|||
105805298|NCT00441584|364943418|FG000|Overall Study|Failure to meet eligibility criteria|3|||
105805299|NCT03263819|364943422|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
105805300|NCT03263819|364943423|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
105805301|NCT01952574|364943427|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
105805302|NCT01952574|364943428|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
105805303|NCT01952574|364943429|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
105805304|NCT01952574|364943430|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
105805305|NCT01952574|364943431|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105805306|NCT01952574|364943432|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105805307|NCT01952574|364943433|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105805308|NCT01952574|364943427|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
105805309|NCT01952574|364943428|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
105805310|NCT01952574|364943429|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
105805311|NCT01952574|364943430|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
105805312|NCT01952574|364943431|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
105805313|NCT01952574|364943432|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
105805314|NCT01952574|364943433|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
105805315|NCT01952574|364943427|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
105805316|NCT01952574|364943428|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
105805317|NCT01952574|364943429|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
105805318|NCT01952574|364943430|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
105805319|NCT01952574|364943431|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
105805320|NCT01952574|364943432|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
105805321|NCT01952574|364943433|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
105805322|NCT01952574|364943427|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
105805323|NCT01952574|364943428|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
105805324|NCT01952574|364943429|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
105805325|NCT01952574|364943430|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
105805326|NCT01952574|364943431|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
105805327|NCT01952574|364943432|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
105805328|NCT01952574|364943433|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
105805329|NCT01952574|364943427|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
105805330|NCT01952574|364943428|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
105805331|NCT01952574|364943429|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
105805332|NCT01952574|364943430|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
105805333|NCT01952574|364943431|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
105805334|NCT01952574|364943432|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
105805335|NCT01952574|364943433|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
105805336|NCT01952574|364943427|FG000|Open-label Treatment Phase|Missing|0|||
105805337|NCT01952574|364943428|FG001|Open-label Treatment Phase|Missing|0|||
105805338|NCT01952574|364943429|FG002|Open-label Treatment Phase|Missing|0|||
105805339|NCT01952574|364943430|FG003|Open-label Treatment Phase|Missing|0|||
105805340|NCT01952574|364943431|FG004|Open-label Treatment Phase|Missing|4|||
105805341|NCT01952574|364943432|FG005|Open-label Treatment Phase|Missing|0|||
105805342|NCT01952574|364943433|FG006|Open-label Treatment Phase|Missing|0|||
105805343|NCT01952574|364943427|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
105805344|NCT01952574|364943428|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
105805345|NCT01952574|364943429|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
105805346|NCT01952574|364943430|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
105805347|NCT01952574|364943431|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
105805348|NCT01952574|364943432|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
105805349|NCT01952574|364943433|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
105805350|NCT01952574|364943427|FG000|Open-label Treatment Phase|Death|0|||
105805351|NCT01952574|364943428|FG001|Open-label Treatment Phase|Death|0|||
105805352|NCT01952574|364943429|FG002|Open-label Treatment Phase|Death|0|||
105805353|NCT01952574|364943430|FG003|Open-label Treatment Phase|Death|0|||
105805354|NCT01952574|364943431|FG004|Open-label Treatment Phase|Death|1|||
105805355|NCT01952574|364943432|FG005|Open-label Treatment Phase|Death|0|||
105805356|NCT01952574|364943433|FG006|Open-label Treatment Phase|Death|0|||
105805357|NCT01952574|364943427|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
105805358|NCT01952574|364943428|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
105805359|NCT01952574|364943429|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
105805360|NCT01952574|364943430|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
105805361|NCT01952574|364943431|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
105484455|NCT01075191|363784329|FG000|Overall Study|Patient's Wish|2|||
105484456|NCT01075191|363784329|FG000|Overall Study|Unknown Reasons|1|||
105484457|NCT00555425|363784330|FG000|Overall Study|Missed Medication > 1 wk|34|||
105484458|NCT00555425|363784331|FG001|Overall Study|Missed Medication > 1 wk|15|||
105484459|NCT00555425|363784330|FG000|Overall Study|Missed 3 physician management visits|1|||
105484460|NCT00555425|363784331|FG001|Overall Study|Missed 3 physician management visits|0|||
105805362|NCT01952574|364943432|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
105805363|NCT01952574|364943433|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
105805364|NCT01952574|364943427|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
105805365|NCT01952574|364943428|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
105805366|NCT01952574|364943429|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
105805367|NCT01952574|364943430|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
105805368|NCT01952574|364943431|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
105805369|NCT01952574|364943432|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
105805370|NCT01952574|364943433|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
105805371|NCT00770991|364943436|FG000|Overall Study|Physician Decision|2|||
105805372|NCT00770991|364943437|FG001|Overall Study|Physician Decision|0|||
105805373|NCT00770991|364943436|FG000|Overall Study|Withdrawal by Subject|1|||
105805374|NCT00770991|364943437|FG001|Overall Study|Withdrawal by Subject|0|||
105805375|NCT00770991|364943436|FG000|Overall Study|Adverse Event|1|||
105805376|NCT00770991|364943437|FG001|Overall Study|Adverse Event|5|||
105805377|NCT00770991|364943436|FG000|Overall Study|Pregnancy|1|||
105805378|NCT00770991|364943437|FG001|Overall Study|Pregnancy|0|||
105805379|NCT01992107|364943440|FG000|Overall Study|Administrative reasons|2|||
105805380|NCT01992107|364943441|FG001|Overall Study|Administrative reasons|0|||
105805381|NCT01992107|364943442|FG002|Overall Study|Administrative reasons|0|||
105805382|NCT01992107|364943440|FG000|Overall Study|Adverse Event|0|||
105805383|NCT01992107|364943441|FG001|Overall Study|Adverse Event|1|||
105805384|NCT01992107|364943442|FG002|Overall Study|Adverse Event|0|||
105805385|NCT01992107|364943440|FG000|Overall Study|Lost to Follow-up|46|||
105805386|NCT01992107|364943441|FG001|Overall Study|Lost to Follow-up|22|||
105805387|NCT01992107|364943442|FG002|Overall Study|Lost to Follow-up|26|||
105805388|NCT01992107|364943440|FG000|Overall Study|noncompliance and were unavailable|7|||
105805389|NCT01992107|364943441|FG001|Overall Study|noncompliance and were unavailable|3|||
105805390|NCT01992107|364943442|FG002|Overall Study|noncompliance and were unavailable|2|||
105805391|NCT01992107|364943440|FG000|Overall Study|Withdrawal by Subject|13|||
105805392|NCT01992107|364943441|FG001|Overall Study|Withdrawal by Subject|7|||
105805393|NCT01992107|364943442|FG002|Overall Study|Withdrawal by Subject|8|||
105805394|NCT01388647|364943453|FG000|Overall Study|Adverse Event|1|||
105805395|NCT01388647|364943454|FG001|Overall Study|Adverse Event|2|||
105805396|NCT01842958|364943455|FG000|Overall Study|Lost to Follow-up|1|||
105805397|NCT01842958|364943456|FG001|Overall Study|Lost to Follow-up|1|||
105805398|NCT01829477|364943457|FG000|Overall Study|Study Terminated by Sponsor|15|||
105805399|NCT01829477|364943458|FG001|Overall Study|Study Terminated by Sponsor|15|||
105484461|NCT00555425|363784330|FG000|Overall Study|Met criteria for protective transfer|16|||
105805400|NCT01829477|364943457|FG000|Overall Study|Withdrawal by Subject|1|||
105805401|NCT01829477|364943458|FG001|Overall Study|Withdrawal by Subject|0|||
105805402|NCT01001169|364943459|FG000|Overall Study|Withdrawal by Subject|2|||
105805403|NCT01001169|364943460|FG001|Overall Study|Withdrawal by Subject|1|||
105805404|NCT02536378|364943463|FG000|Overall Study|Physician Decision|0|||
105805405|NCT02536378|364943464|FG001|Overall Study|Physician Decision|2|||
105484462|NCT00555425|363784331|FG001|Overall Study|Met criteria for protective transfer|3|||
105484463|NCT00555425|363784330|FG000|Overall Study|Became pregnant and transferred care|0|||
105805406|NCT02536378|364943463|FG000|Overall Study|Withdrawal by Subject|0|||
105805407|NCT02536378|364943464|FG001|Overall Study|Withdrawal by Subject|1|||
105805408|NCT02536378|364943463|FG000|Overall Study|Death|1|||
105805409|NCT02536378|364943464|FG001|Overall Study|Death|2|||
105805410|NCT02536378|364943463|FG000|Overall Study|Patient refused further follow up|6|||
105805411|NCT02536378|364943464|FG001|Overall Study|Patient refused further follow up|2|||
105570099|NCT00988221|364086650|FG001|Part I|Refused Treatment|2|||
105570100|NCT00988221|364086651|FG002|Part I|Refused Treatment|1|||
105570101|NCT00988221|364086652|FG003|Part I|Refused Treatment|0|||
105570102|NCT00988221|364086649|FG000|Part I|Lost to Follow-up|0|||
105570103|NCT00988221|364086650|FG001|Part I|Lost to Follow-up|1|||
105570104|NCT00988221|364086651|FG002|Part I|Lost to Follow-up|0|||
105570105|NCT00988221|364086652|FG003|Part I|Lost to Follow-up|0|||
105570106|NCT00988221|364086649|FG000|Part II|Adverse Event|1|||
105570107|NCT00988221|364086650|FG001|Part II|Adverse Event|0|||
105570108|NCT00988221|364086651|FG002|Part II|Adverse Event|0|||
105570109|NCT00988221|364086652|FG003|Part II|Adverse Event|1|||
105570110|NCT00988221|364086649|FG000|Part II|Withdrawal by Subject|0|||
105570111|NCT00988221|364086650|FG001|Part II|Withdrawal by Subject|0|||
105570112|NCT00988221|364086651|FG002|Part II|Withdrawal by Subject|2|||
105570113|NCT00988221|364086652|FG003|Part II|Withdrawal by Subject|2|||
105570114|NCT00988221|364086649|FG000|Part II|Reason not Specified|0|||
105570115|NCT00988221|364086650|FG001|Part II|Reason not Specified|0|||
105570116|NCT00988221|364086651|FG002|Part II|Reason not Specified|1|||
105570117|NCT00988221|364086652|FG003|Part II|Reason not Specified|0|||
105570118|NCT00988221|364086649|FG000|Part III|Adverse Event|1|||
105570119|NCT00988221|364086650|FG001|Part III|Adverse Event|0|||
105570120|NCT00988221|364086651|FG002|Part III|Adverse Event|1|||
105570121|NCT00988221|364086652|FG003|Part III|Adverse Event|0|||
105570122|NCT00988221|364086649|FG000|Part III|Insufficient Therapeutic Response|0|||
105570123|NCT00988221|364086650|FG001|Part III|Insufficient Therapeutic Response|1|||
105570124|NCT00988221|364086651|FG002|Part III|Insufficient Therapeutic Response|1|||
105570125|NCT00988221|364086652|FG003|Part III|Insufficient Therapeutic Response|0|||
105570126|NCT00988221|364086649|FG000|Part III|Refused Treatment|0|||
105570127|NCT00988221|364086650|FG001|Part III|Refused Treatment|0|||
105570128|NCT00988221|364086651|FG002|Part III|Refused Treatment|1|||
105570129|NCT00988221|364086652|FG003|Part III|Refused Treatment|0|||
105570130|NCT01540565|364086655|FG000|Overall Study|Ineligible|2|||
105570131|NCT04399356|364086656|FG000|Overall Study|Lost to Follow-up|1|||
105570132|NCT04399356|364086657|FG001|Overall Study|Lost to Follow-up|1|||
105570133|NCT04399356|364086656|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
105570134|NCT04399356|364086657|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
105570135|NCT04399356|364086656|FG000|Overall Study|Withdrawal by Subject|1|||
105570136|NCT04399356|364086657|FG001|Overall Study|Withdrawal by Subject|0|||
105570137|NCT00954733|364086658|FG000|Overall Study|blood gas machine did not work|1|||
105570138|NCT01834222|364086663|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
105570139|NCT02712398|364086664|FG000|Overall Study|Withdrawal by Subject|6|||
105570140|NCT02712398|364086664|FG000|Overall Study|Lost to Follow-up|6|||
105570141|NCT02712398|364086664|FG000|Overall Study|Sponsor Decision|1|||
105570142|NCT02712398|364086664|FG000|Overall Study|Physician Decision|1|||
105570143|NCT02712398|364086664|FG000|Overall Study|Death|2|||
105570144|NCT02712398|364086664|FG000|Overall Study|Re-operation|21|||
105570145|NCT01617005|364086667|FG000|Overall Study|Pregnancy|1|||
105570146|NCT01617005|364086667|FG000|Overall Study|Lack of motivation for treatment|1|||
105570147|NCT03107377|364086671|FG000|Overall Study|Adverse Event|3|||
105570148|NCT03107377|364086672|FG001|Overall Study|Adverse Event|3|||
105570149|NCT03107377|364086671|FG000|Overall Study|Protocol Violation|9|||
105570150|NCT03107377|364086672|FG001|Overall Study|Protocol Violation|12|||
105570151|NCT03107377|364086671|FG000|Overall Study|Physician Decision|3|||
105570152|NCT03107377|364086672|FG001|Overall Study|Physician Decision|6|||
105570153|NCT03107377|364086671|FG000|Overall Study|Pregnancy|7|||
105570154|NCT03107377|364086672|FG001|Overall Study|Pregnancy|7|||
105570155|NCT03107377|364086671|FG000|Overall Study|Withdrawal by Subject|16|||
105570156|NCT03107377|364086672|FG001|Overall Study|Withdrawal by Subject|22|||
105570157|NCT03107377|364086671|FG000|Overall Study|Lost to Follow-up|37|||
105570158|NCT03107377|364086672|FG001|Overall Study|Lost to Follow-up|34|||
105570159|NCT03107377|364086671|FG000|Overall Study|Other reason not specified|16|||
105570160|NCT03107377|364086672|FG001|Overall Study|Other reason not specified|15|||
105570161|NCT02118337|364086673|FG000|Overall Study|Other|1|||
105570162|NCT02118337|364086674|FG001|Overall Study|Other|0|||
105570163|NCT02118337|364086675|FG002|Overall Study|Other|0|||
105570164|NCT02118337|364086676|FG003|Overall Study|Other|0|||
105570165|NCT02118337|364086677|FG004|Overall Study|Other|2|||
105570166|NCT02118337|364086678|FG005|Overall Study|Other|3|||
105570167|NCT02118337|364086679|FG006|Overall Study|Other|1|||
105570168|NCT02118337|364086680|FG007|Overall Study|Other|28|||
105570169|NCT02118337|364086681|FG008|Overall Study|Other|15|||
105570170|NCT02118337|364086673|FG000|Overall Study|Lost to Follow-up|0|||
105570171|NCT02118337|364086674|FG001|Overall Study|Lost to Follow-up|0|||
105570172|NCT02118337|364086675|FG002|Overall Study|Lost to Follow-up|0|||
105570173|NCT02118337|364086676|FG003|Overall Study|Lost to Follow-up|0|||
105570174|NCT02118337|364086677|FG004|Overall Study|Lost to Follow-up|0|||
105570175|NCT02118337|364086678|FG005|Overall Study|Lost to Follow-up|0|||
105570176|NCT02118337|364086679|FG006|Overall Study|Lost to Follow-up|0|||
105570177|NCT02118337|364086680|FG007|Overall Study|Lost to Follow-up|1|||
105570178|NCT02118337|364086681|FG008|Overall Study|Lost to Follow-up|0|||
105570179|NCT02118337|364086673|FG000|Overall Study|Withdrawal by Subject|1|||
105805412|NCT00798889|364943465|FG000|Overall Study|Adverse Event|53|||
105805413|NCT00798889|364943465|FG000|Overall Study|Protocol Violation|2|||
105805414|NCT00798889|364943465|FG000|Overall Study|Withdrawal by Subject|31|||
105805415|NCT00798889|364943465|FG000|Overall Study|Lost to Follow-up|1|||
105805416|NCT00798889|364943465|FG000|Overall Study|Lack of Efficacy|213|||
105805417|NCT00798889|364943465|FG000|Overall Study|Decision of Sponsor|11|||
105805418|NCT00798889|364943465|FG000|Overall Study|Enrolled, Not treated|3|||
105805419|NCT00617461|364943466|FG000|First Treatment Intervention Period|Adverse Event|2|||
105805420|NCT00617461|364943467|FG001|First Treatment Intervention Period|Adverse Event|0|||
105805421|NCT00617461|364943466|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
105805422|NCT00617461|364943467|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
105805423|NCT00617461|364943466|FG000|First Treatment Intervention Period|Protocol Violation|2|||
105805424|NCT00617461|364943467|FG001|First Treatment Intervention Period|Protocol Violation|1|||
105805425|NCT00617461|364943466|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
105805426|NCT00617461|364943467|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
105805427|NCT00617461|364943466|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
105805428|NCT00617461|364943467|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
105805429|NCT00617461|364943466|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
105805430|NCT00617461|364943467|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
105805431|NCT00617461|364943466|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
105805432|NCT00617461|364943467|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
105805433|NCT00617461|364943466|FG000|Second Treatment Intervention Period|Adverse Event|0|||
105805434|NCT00617461|364943467|FG001|Second Treatment Intervention Period|Adverse Event|1|||
105805435|NCT00617461|364943466|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
105805436|NCT00617461|364943467|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
105805437|NCT00617461|364943466|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
105805438|NCT00617461|364943467|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
105805439|NCT00617461|364943466|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
105805440|NCT00617461|364943467|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
105805441|NCT01738581|364943469|FG000|Overall Study|Lost to Follow-up|1|||
105805442|NCT01738581|364943470|FG001|Overall Study|Lost to Follow-up|0|||
105805443|NCT00210626|364943471|FG000|Overall Study|Adverse Event|1|||
105805444|NCT00210626|364943472|FG001|Overall Study|Adverse Event|2|||
105805445|NCT00210626|364943471|FG000|Overall Study|Protocol Violation|1|||
105805446|NCT00210626|364943472|FG001|Overall Study|Protocol Violation|5|||
105805447|NCT00210626|364943471|FG000|Overall Study|Lost to Follow-up|11|||
105805448|NCT00210626|364943472|FG001|Overall Study|Lost to Follow-up|11|||
105805449|NCT00210626|364943471|FG000|Overall Study|Death|1|||
105805450|NCT00210626|364943472|FG001|Overall Study|Death|0|||
105805451|NCT00210626|364943471|FG000|Overall Study|Withdrawal by Subject|29|||
105805452|NCT00210626|364943472|FG001|Overall Study|Withdrawal by Subject|20|||
105805453|NCT00210626|364943471|FG000|Overall Study|Physician Decision|0|||
105805454|NCT00210626|364943472|FG001|Overall Study|Physician Decision|2|||
105805455|NCT00210626|364943471|FG000|Overall Study|Sponser Request|1|||
105805456|NCT00210626|364943472|FG001|Overall Study|Sponser Request|0|||
105805457|NCT00210626|364943471|FG000|Overall Study|Other|4|||
105805458|NCT00210626|364943472|FG001|Overall Study|Other|5|||
105805459|NCT01965652|364943473|FG000|Overall Study|Adverse Event|40|||
105805460|NCT01965652|364943474|FG001|Overall Study|Adverse Event|37|||
105805461|NCT01965652|364943473|FG000|Overall Study|Withdrawal by Subject|62|||
105805462|NCT01965652|364943474|FG001|Overall Study|Withdrawal by Subject|69|||
105805463|NCT01965652|364943473|FG000|Overall Study|Lost to Follow-up|53|||
105805464|NCT01965652|364943474|FG001|Overall Study|Lost to Follow-up|40|||
105805465|NCT01965652|364943473|FG000|Overall Study|Protocol Violation|34|||
105805466|NCT01965652|364943474|FG001|Overall Study|Protocol Violation|38|||
105805467|NCT01965652|364943473|FG000|Overall Study|Death|3|||
105805468|NCT01965652|364943474|FG001|Overall Study|Death|4|||
105805469|NCT01965652|364943473|FG000|Overall Study|Other - Miscellaneous|18|||
105805470|NCT01965652|364943474|FG001|Overall Study|Other - Miscellaneous|21|||
105805471|NCT01965652|364943473|FG000|Overall Study|Pregnancy|0|||
105805472|NCT01965652|364943474|FG001|Overall Study|Pregnancy|1|||
105805473|NCT01348542|364943475|FG000|Overall Study|Withdrawal by Subject|3|||
105805474|NCT01348542|364943476|FG001|Overall Study|Withdrawal by Subject|0|||
105805475|NCT01907737|364944916|FG000|Overall Study|Withdrawal by Subject|1|||
105805476|NCT04527471|364944922|FG000|Overall Study|Adverse Event|1|||
105805477|NCT04527471|364944923|FG001|Overall Study|Adverse Event|0|||
105805478|NCT04527471|364944922|FG000|Overall Study|Lost to Follow-up|1|||
105805479|NCT04527471|364944923|FG001|Overall Study|Lost to Follow-up|0|||
105805480|NCT01003886|364944926|FG000|Overall Study|Lack of Efficacy|5|||
105805481|NCT01003886|364944926|FG000|Overall Study|Lost to Follow-up|169|||
105805482|NCT01003886|364944926|FG000|Overall Study|Withdrawal by Subject|39|||
105805483|NCT01003886|364944926|FG000|Overall Study|Other|14|||
105805484|NCT01003886|364944926|FG000|Overall Study|Adverse Event|3|||
105805485|NCT04467697|364944927|FG000|Overall Study|Adverse Event|2|||
105805486|NCT04467697|364944927|FG000|Overall Study|Lost to Follow-up|6|||
105805487|NCT04467697|364944927|FG000|Overall Study|Withdrawal by Subject|9|||
105484464|NCT00555425|363784331|FG001|Overall Study|Became pregnant and transferred care|1|||
105484465|NCT00592774|363784332|FG000|Overall Study|Adverse Event|5|||
105484466|NCT00592774|363784333|FG001|Overall Study|Adverse Event|19|||
105484467|NCT00592774|363784334|FG002|Overall Study|Adverse Event|2|||
105484468|NCT00592774|363784335|FG003|Overall Study|Adverse Event|14|||
105484469|NCT00592774|363784336|FG004|Overall Study|Adverse Event|8|||
105484470|NCT00592774|363784332|FG000|Overall Study|Protocol Violation|0|||
105484471|NCT00592774|363784333|FG001|Overall Study|Protocol Violation|1|||
105484472|NCT00592774|363784334|FG002|Overall Study|Protocol Violation|0|||
105484473|NCT00592774|363784335|FG003|Overall Study|Protocol Violation|0|||
105484474|NCT00592774|363784336|FG004|Overall Study|Protocol Violation|1|||
105484475|NCT00592774|363784332|FG000|Overall Study|Withdrawal by Subject|3|||
105484476|NCT00592774|363784333|FG001|Overall Study|Withdrawal by Subject|7|||
105484477|NCT00592774|363784334|FG002|Overall Study|Withdrawal by Subject|0|||
105484478|NCT00592774|363784335|FG003|Overall Study|Withdrawal by Subject|0|||
105484479|NCT00592774|363784336|FG004|Overall Study|Withdrawal by Subject|0|||
105484480|NCT00592774|363784332|FG000|Overall Study|Lack of Efficacy|3|||
105484481|NCT00592774|363784333|FG001|Overall Study|Lack of Efficacy|3|||
105484482|NCT00592774|363784334|FG002|Overall Study|Lack of Efficacy|0|||
105484483|NCT00592774|363784335|FG003|Overall Study|Lack of Efficacy|0|||
105484484|NCT00592774|363784336|FG004|Overall Study|Lack of Efficacy|2|||
105484485|NCT00592774|363784332|FG000|Overall Study|Physician Decision|0|||
105484486|NCT00592774|363784333|FG001|Overall Study|Physician Decision|1|||
105484487|NCT00592774|363784334|FG002|Overall Study|Physician Decision|1|||
105484488|NCT00592774|363784335|FG003|Overall Study|Physician Decision|0|||
105484489|NCT00592774|363784336|FG004|Overall Study|Physician Decision|1|||
105484490|NCT00592774|363784332|FG000|Overall Study|Other|0|||
105484491|NCT00592774|363784333|FG001|Overall Study|Other|1|||
105484492|NCT00592774|363784334|FG002|Overall Study|Other|1|||
105484493|NCT00592774|363784335|FG003|Overall Study|Other|0|||
105484494|NCT00592774|363784336|FG004|Overall Study|Other|2|||
105484495|NCT02674854|363784337|FG000|Overall Study|Adverse Event|17|||
105484496|NCT02674854|363784338|FG001|Overall Study|Adverse Event|15|||
105484497|NCT02674854|363784339|FG002|Overall Study|Adverse Event|5|||
105484498|NCT02674854|363784337|FG000|Overall Study|Withdrawal by Subject|1|||
105484499|NCT02674854|363784338|FG001|Overall Study|Withdrawal by Subject|5|||
105484500|NCT02674854|363784339|FG002|Overall Study|Withdrawal by Subject|4|||
105484501|NCT02674854|363784337|FG000|Overall Study|No-compliant subject|1|||
105484502|NCT02674854|363784338|FG001|Overall Study|No-compliant subject|0|||
105484503|NCT02674854|363784339|FG002|Overall Study|No-compliant subject|1|||
105484504|NCT02674854|363784337|FG000|Overall Study|Lost to Follow-up|1|||
105484505|NCT02674854|363784338|FG001|Overall Study|Lost to Follow-up|0|||
105484506|NCT02674854|363784339|FG002|Overall Study|Lost to Follow-up|2|||
105484507|NCT02674854|363784337|FG000|Overall Study|Lack of Efficacy|0|||
105484508|NCT02674854|363784338|FG001|Overall Study|Lack of Efficacy|3|||
105484509|NCT02674854|363784339|FG002|Overall Study|Lack of Efficacy|0|||
105484510|NCT02674854|363784337|FG000|Overall Study|Disallowed Concurrent Medication|2|||
105484511|NCT02674854|363784338|FG001|Overall Study|Disallowed Concurrent Medication|2|||
105484512|NCT02674854|363784339|FG002|Overall Study|Disallowed Concurrent Medication|0|||
105484513|NCT02674854|363784337|FG000|Overall Study|Protocol Violation|1|||
105484514|NCT02674854|363784338|FG001|Overall Study|Protocol Violation|1|||
105360691|NCT02624947|363328055|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
105484515|NCT02674854|363784339|FG002|Overall Study|Protocol Violation|2|||
105484516|NCT02674854|363784337|FG000|Overall Study|Death|0|||
105484517|NCT02674854|363784338|FG001|Overall Study|Death|1|||
105484518|NCT02674854|363784339|FG002|Overall Study|Death|0|||
105484519|NCT02674854|363784337|FG000|Overall Study|Subject missed V6.2|1|||
105484520|NCT02674854|363784338|FG001|Overall Study|Subject missed V6.2|0|||
105484521|NCT02674854|363784339|FG002|Overall Study|Subject missed V6.2|0|||
105484522|NCT00913692|363784340|FG000|Screening (4 Months)|Physician Decision|3|||
105484523|NCT00913692|363784340|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
105484524|NCT00913692|363784340|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
105484525|NCT03985878|363784342|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
105759948|NCT03276572|364773817|FG004|Overall Study|In follow-up|0|||
105759949|NCT03276572|364773818|FG005|Overall Study|In follow-up|1|||
105759950|NCT03276572|364773819|FG006|Overall Study|In follow-up|1|||
105759951|NCT03276572|364773813|FG000|Overall Study|Lost to Follow-up|0|||
105759952|NCT03276572|364773814|FG001|Overall Study|Lost to Follow-up|0|||
105759953|NCT03276572|364773815|FG002|Overall Study|Lost to Follow-up|0|||
105759954|NCT03276572|364773816|FG003|Overall Study|Lost to Follow-up|0|||
105759955|NCT03276572|364773817|FG004|Overall Study|Lost to Follow-up|0|||
105759956|NCT03276572|364773818|FG005|Overall Study|Lost to Follow-up|0|||
105759957|NCT03276572|364773819|FG006|Overall Study|Lost to Follow-up|1|||
105759958|NCT01213264|364773826|FG000|Overall Study|Adverse Event|1|||
105759959|NCT01213264|364773827|FG001|Overall Study|Adverse Event|0|||
105759960|NCT01213264|364773828|FG002|Overall Study|Adverse Event|0|||
105759961|NCT01213264|364773826|FG000|Overall Study|Lost to Follow-up|1|||
105759962|NCT01213264|364773827|FG001|Overall Study|Lost to Follow-up|2|||
105759963|NCT01213264|364773828|FG002|Overall Study|Lost to Follow-up|6|||
105360692|NCT02624947|363328054|FG000|Maternal Participants|Miscellaneous|23|||
105360693|NCT02624947|363328055|FG001|Maternal Participants|Miscellaneous|15|||
105360694|NCT02624947|363328054|FG000|Infant Participants|Adverse Event|18|||
105360695|NCT02624947|363328055|FG001|Infant Participants|Adverse Event|11|||
105360696|NCT02624947|363328054|FG000|Infant Participants|Investigator Decision|5|||
105360697|NCT02624947|363328055|FG001|Infant Participants|Investigator Decision|4|||
105360698|NCT02624947|363328054|FG000|Infant Participants|Lost to Follow-up|93|||
105360699|NCT02624947|363328055|FG001|Infant Participants|Lost to Follow-up|58|||
105360700|NCT02624947|363328054|FG000|Infant Participants|Non Compliance|17|||
105360701|NCT02624947|363328055|FG001|Infant Participants|Non Compliance|7|||
105360702|NCT02624947|363328054|FG000|Infant Participants|Sponsor Request|0|||
105360703|NCT02624947|363328055|FG001|Infant Participants|Sponsor Request|1|||
105484526|NCT03985878|363784342|FG000|Overall Study|Study Terminated by Sponsor|12|||
105759964|NCT00105183|364773832|FG000|Overall Study|Death|19|||
105759965|NCT00105183|364773833|FG001|Overall Study|Death|13|||
105759966|NCT00105183|364773834|FG002|Overall Study|Death|15|||
105759967|NCT00105183|364773832|FG000|Overall Study|Withdrawal by Subject|1|||
105759968|NCT00105183|364773833|FG001|Overall Study|Withdrawal by Subject|1|||
105759969|NCT00105183|364773834|FG002|Overall Study|Withdrawal by Subject|4|||
105759970|NCT00105183|364773832|FG000|Overall Study|Physician Decision|1|||
105759971|NCT00105183|364773833|FG001|Overall Study|Physician Decision|2|||
105759972|NCT00105183|364773834|FG002|Overall Study|Physician Decision|3|||
105759973|NCT00105183|364773832|FG000|Overall Study|Lost to Follow-up|0|||
105759974|NCT00105183|364773833|FG001|Overall Study|Lost to Follow-up|1|||
105759975|NCT00105183|364773834|FG002|Overall Study|Lost to Follow-up|1|||
105759976|NCT00105183|364773832|FG000|Overall Study|Other reason|1|||
105759977|NCT00105183|364773833|FG001|Overall Study|Other reason|2|||
105759978|NCT00105183|364773834|FG002|Overall Study|Other reason|0|||
105759979|NCT01855945|364773839|FG000|Overall Study|Adverse Event|0|||
105759980|NCT01855945|364773840|FG001|Overall Study|Adverse Event|0|||
105759981|NCT01855945|364773841|FG002|Overall Study|Adverse Event|0|||
105759982|NCT01855945|364773842|FG003|Overall Study|Adverse Event|0|||
105759983|NCT01855945|364773843|FG004|Overall Study|Adverse Event|0|||
105759984|NCT01855945|364773844|FG005|Overall Study|Adverse Event|0|||
105759985|NCT01855945|364773845|FG006|Overall Study|Adverse Event|1|||
105759986|NCT01855945|364773846|FG007|Overall Study|Adverse Event|0|||
105759987|NCT01855945|364773847|FG008|Overall Study|Adverse Event|0|||
105759988|NCT01855945|364773848|FG009|Overall Study|Adverse Event|0|||
105759989|NCT01855945|364773849|FG010|Overall Study|Adverse Event|0|||
105759990|NCT01855945|364773850|FG011|Overall Study|Adverse Event|0|||
105759991|NCT01855945|364773839|FG000|Overall Study|Death|0|||
105759992|NCT01855945|364773840|FG001|Overall Study|Death|0|||
105759993|NCT01855945|364773841|FG002|Overall Study|Death|0|||
105759994|NCT01855945|364773842|FG003|Overall Study|Death|0|||
105759995|NCT01855945|364773843|FG004|Overall Study|Death|0|||
105759996|NCT01855945|364773844|FG005|Overall Study|Death|0|||
105759997|NCT01855945|364773845|FG006|Overall Study|Death|2|||
105759998|NCT01855945|364773846|FG007|Overall Study|Death|0|||
105759999|NCT01855945|364773847|FG008|Overall Study|Death|0|||
105760000|NCT01855945|364773848|FG009|Overall Study|Death|0|||
105760001|NCT01855945|364773849|FG010|Overall Study|Death|0|||
105760002|NCT01855945|364773850|FG011|Overall Study|Death|0|||
105760003|NCT01855945|364773839|FG000|Overall Study|Lost to Follow-up|11|||
105760004|NCT01855945|364773840|FG001|Overall Study|Lost to Follow-up|10|||
105760005|NCT01855945|364773841|FG002|Overall Study|Lost to Follow-up|7|||
105760006|NCT01855945|364773842|FG003|Overall Study|Lost to Follow-up|3|||
105760007|NCT01855945|364773843|FG004|Overall Study|Lost to Follow-up|0|||
105760008|NCT01855945|364773844|FG005|Overall Study|Lost to Follow-up|3|||
105760009|NCT01855945|364773845|FG006|Overall Study|Lost to Follow-up|4|||
105760010|NCT01855945|364773846|FG007|Overall Study|Lost to Follow-up|7|||
105760011|NCT01855945|364773847|FG008|Overall Study|Lost to Follow-up|2|||
105760012|NCT01855945|364773848|FG009|Overall Study|Lost to Follow-up|0|||
105760013|NCT01855945|364773849|FG010|Overall Study|Lost to Follow-up|0|||
105760014|NCT01855945|364773850|FG011|Overall Study|Lost to Follow-up|2|||
105760015|NCT01855945|364773839|FG000|Overall Study|Other - Unclassified|1|||
105760016|NCT01855945|364773840|FG001|Overall Study|Other - Unclassified|1|||
105760017|NCT01855945|364773841|FG002|Overall Study|Other - Unclassified|1|||
105360704|NCT02624947|363328054|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
105360705|NCT02624947|363328055|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
105360706|NCT02624947|363328054|FG000|Infant Participants|Miscellaneous|50|||
105760018|NCT01855945|364773842|FG003|Overall Study|Other - Unclassified|0|||
105760019|NCT01855945|364773843|FG004|Overall Study|Other - Unclassified|0|||
105760020|NCT01855945|364773844|FG005|Overall Study|Other - Unclassified|0|||
105760021|NCT01855945|364773845|FG006|Overall Study|Other - Unclassified|2|||
105760022|NCT01855945|364773846|FG007|Overall Study|Other - Unclassified|1|||
105360707|NCT02624947|363328055|FG001|Infant Participants|Miscellaneous|26|||
105760023|NCT01855945|364773847|FG008|Overall Study|Other - Unclassified|0|||
105760024|NCT01855945|364773848|FG009|Overall Study|Other - Unclassified|0|||
105760025|NCT01855945|364773849|FG010|Overall Study|Other - Unclassified|1|||
105760026|NCT01855945|364773850|FG011|Overall Study|Other - Unclassified|0|||
105805488|NCT04467697|364944927|FG000|Overall Study|Protocol Violation|3|||
105805489|NCT02192905|364944928|FG000|Overall Study|Lost to Follow-up|1|||
105805490|NCT02637076|364944929|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
105805491|NCT02637076|364944930|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
105805492|NCT02637076|364944929|FG000|Overall Study|Withdrawal by Subject|0|||
105805493|NCT02637076|364944930|FG001|Overall Study|Withdrawal by Subject|4|||
105805494|NCT02043366|364944933|FG000|Overall Study|Lost to Follow-up|2|||
105805495|NCT02043366|364944934|FG001|Overall Study|Lost to Follow-up|2|||
105805496|NCT02043366|364944935|FG002|Overall Study|Lost to Follow-up|2|||
105805497|NCT02043366|364944936|FG003|Overall Study|Lost to Follow-up|2|||
105805498|NCT02043366|364944937|FG004|Overall Study|Lost to Follow-up|2|||
105805499|NCT02043366|364944938|FG005|Overall Study|Lost to Follow-up|2|||
105805500|NCT02736227|364944939|FG000|Overall Study|Withdrawal by Subject|0|||
105805501|NCT02736227|364944940|FG001|Overall Study|Withdrawal by Subject|0|||
105805502|NCT02736227|364944941|FG002|Overall Study|Withdrawal by Subject|1|||
105805503|NCT02736227|364944939|FG000|Overall Study|Physician Decision|0|||
105805504|NCT02736227|364944940|FG001|Overall Study|Physician Decision|0|||
105805505|NCT02736227|364944941|FG002|Overall Study|Physician Decision|5|||
105805506|NCT02736227|364944939|FG000|Overall Study|Non Compliant|0|||
105805507|NCT02736227|364944940|FG001|Overall Study|Non Compliant|0|||
105805508|NCT02736227|364944941|FG002|Overall Study|Non Compliant|2|||
105805509|NCT04120194|364944945|FG000|Overall Study|Lost to Follow-up|11|||
105805510|NCT04120194|364944946|FG001|Overall Study|Lost to Follow-up|8|||
105805511|NCT04120194|364944945|FG000|Overall Study|Adverse Event|4|||
105805512|NCT04120194|364944946|FG001|Overall Study|Adverse Event|5|||
105805513|NCT04120194|364944945|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
105805514|NCT04120194|364944946|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
105805515|NCT04120194|364944945|FG000|Overall Study|Miscellaneous|4|||
105805516|NCT04120194|364944946|FG001|Overall Study|Miscellaneous|5|||
105805517|NCT00989261|364944947|FG000|Overall Study|Still in follow up|12|||
105805518|NCT00989261|364944948|FG001|Overall Study|Still in follow up|21|||
105805519|NCT00989261|364944947|FG000|Overall Study|Withdrawal by Subject|0|||
105805520|NCT00989261|364944948|FG001|Overall Study|Withdrawal by Subject|1|||
105805521|NCT00989261|364944947|FG000|Overall Study|Lost to Follow-up|3|||
105805522|NCT00989261|364944948|FG001|Overall Study|Lost to Follow-up|0|||
105805523|NCT02927847|364944949|FG000|Overall Study|Lost to Follow-up|1|||
105805524|NCT02927847|364944950|FG001|Overall Study|Lost to Follow-up|0|||
105805525|NCT02927847|364944949|FG000|Overall Study|Withdrawal by Subject|4|||
105805526|NCT02927847|364944950|FG001|Overall Study|Withdrawal by Subject|2|||
105805527|NCT02927847|364944949|FG000|Overall Study|PI withdrawn due to missed visits|1|||
105805528|NCT02927847|364944950|FG001|Overall Study|PI withdrawn due to missed visits|1|||
105805529|NCT00553540|364944951|FG000|Overall Study|discharged after first visit|2|||
105805530|NCT00553540|364944952|FG001|Overall Study|discharged after first visit|5|||
105805531|NCT03882047|364944953|FG000|Overall Study|Adverse Event|0|||
105805532|NCT03882047|364944954|FG001|Overall Study|Adverse Event|2|||
105805533|NCT03882047|364944955|FG002|Overall Study|Adverse Event|2|||
105805534|NCT03882047|364944953|FG000|Overall Study|Treatment Failure|3|||
105805535|NCT03882047|364944954|FG001|Overall Study|Treatment Failure|3|||
105805536|NCT03882047|364944955|FG002|Overall Study|Treatment Failure|12|||
105805537|NCT03882047|364944953|FG000|Overall Study|Lost to Follow-up|0|||
105805538|NCT03882047|364944954|FG001|Overall Study|Lost to Follow-up|1|||
105805539|NCT03882047|364944955|FG002|Overall Study|Lost to Follow-up|0|||
105805540|NCT03882047|364944953|FG000|Overall Study|Did Not Wish to Continue|1|||
105805541|NCT03882047|364944954|FG001|Overall Study|Did Not Wish to Continue|4|||
105805542|NCT03882047|364944955|FG002|Overall Study|Did Not Wish to Continue|1|||
105805543|NCT03882047|364944953|FG000|Overall Study|Noncompliance With Protocol|2|||
105805544|NCT03882047|364944954|FG001|Overall Study|Noncompliance With Protocol|0|||
105805545|NCT03882047|364944955|FG002|Overall Study|Noncompliance With Protocol|0|||
105805546|NCT03882047|364944953|FG000|Overall Study|Did Not Meet Eligibility|0|||
105805547|NCT03882047|364944954|FG001|Overall Study|Did Not Meet Eligibility|0|||
105805548|NCT03882047|364944955|FG002|Overall Study|Did Not Meet Eligibility|1|||
105805549|NCT03870997|364944957|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
105805550|NCT03870997|364944958|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
105805551|NCT03870997|364944959|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
105805552|NCT03870997|364944960|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
105805553|NCT03870997|364944961|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
105805554|NCT03870997|364944962|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
105805555|NCT01689974|364944964|FG000|Overall Study|Termination of Study|5|||
105805556|NCT01689974|364944965|FG001|Overall Study|Termination of Study|5|||
105805557|NCT00681863|364944966|FG000|Overall Study|Adverse Event|1|||
105805558|NCT00681863|364944966|FG000|Overall Study|Lost to Follow-up|2|||
105805559|NCT00681863|364944966|FG000|Overall Study|Lack of Efficacy|2|||
105805560|NCT00681863|364944966|FG000|Overall Study|Other|18|||
105805561|NCT01107535|364944967|FG000|Overall Study|Death|5|||
105805562|NCT00585351|364944972|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
105484527|NCT03985878|363784342|FG000|Overall Study|Withdrawal by Subject|1|||
105484528|NCT01470989|363784345|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
105484529|NCT01470989|363784346|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
105484530|NCT01470989|363784345|FG000|Overall Study|Adverse Event|2|||
105484531|NCT01470989|363784346|FG001|Overall Study|Adverse Event|5|||
105484532|NCT01470989|363784345|FG000|Overall Study|Abnormal laboratory value|1|||
105484533|NCT01470989|363784346|FG001|Overall Study|Abnormal laboratory value|1|||
105484534|NCT01470989|363784345|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105484535|NCT01470989|363784346|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
105484536|NCT01470989|363784345|FG000|Overall Study|Withdrawal by Subject|19|||
105484537|NCT01470989|363784346|FG001|Overall Study|Withdrawal by Subject|17|||
105484538|NCT01470989|363784345|FG000|Overall Study|Lost to Follow-up|18|||
105484539|NCT01470989|363784346|FG001|Overall Study|Lost to Follow-up|13|||
105484540|NCT01470989|363784345|FG000|Overall Study|Administrative problems|2|||
105484541|NCT01470989|363784346|FG001|Overall Study|Administrative problems|4|||
105484542|NCT01470989|363784345|FG000|Overall Study|Death|2|||
105484543|NCT01470989|363784346|FG001|Overall Study|Death|2|||
105484544|NCT01470989|363784345|FG000|Overall Study|Protocol deviation|1|||
105484545|NCT01470989|363784346|FG001|Overall Study|Protocol deviation|2|||
105484546|NCT00969280|363784347|FG000|Overall Study|Protocol Violation|2|||
105484547|NCT00969280|363784348|FG001|Overall Study|Protocol Violation|1|||
105484548|NCT00969280|363784347|FG000|Overall Study|Withdrawal by Subject|0|||
105484549|NCT00969280|363784348|FG001|Overall Study|Withdrawal by Subject|1|||
105484550|NCT00969280|363784347|FG000|Overall Study|infection of influenza A(H1N1)|0|||
105484551|NCT00969280|363784348|FG001|Overall Study|infection of influenza A(H1N1)|1|||
105484552|NCT02290431|363784349|FG000|Overall Study|Adverse Event|20|||
105484553|NCT02290431|363784349|FG000|Overall Study|Progressive disease|4|||
105484554|NCT02290431|363784349|FG000|Overall Study|Study terminated by Sponsor|1|||
105484555|NCT02290431|363784349|FG000|Overall Study|Physician Decision|2|||
105484556|NCT00282347|363784355|FG000|Treatment Period|Death|2|||
105484557|NCT00282347|363784356|FG001|Treatment Period|Death|0|||
105570180|NCT02118337|364086674|FG001|Overall Study|Withdrawal by Subject|3|||
105570181|NCT02118337|364086675|FG002|Overall Study|Withdrawal by Subject|2|||
105570182|NCT02118337|364086676|FG003|Overall Study|Withdrawal by Subject|1|||
105570183|NCT02118337|364086677|FG004|Overall Study|Withdrawal by Subject|2|||
105570184|NCT02118337|364086678|FG005|Overall Study|Withdrawal by Subject|2|||
105570185|NCT02118337|364086679|FG006|Overall Study|Withdrawal by Subject|1|||
105570186|NCT02118337|364086680|FG007|Overall Study|Withdrawal by Subject|4|||
105570187|NCT02118337|364086681|FG008|Overall Study|Withdrawal by Subject|2|||
105570188|NCT02118337|364086673|FG000|Overall Study|Death|2|||
105760027|NCT01855945|364773839|FG000|Overall Study|Withdrawal by Subject|4|||
105760028|NCT01855945|364773840|FG001|Overall Study|Withdrawal by Subject|0|||
105760029|NCT01855945|364773841|FG002|Overall Study|Withdrawal by Subject|4|||
105760030|NCT01855945|364773842|FG003|Overall Study|Withdrawal by Subject|1|||
105760031|NCT01855945|364773843|FG004|Overall Study|Withdrawal by Subject|1|||
105760032|NCT01855945|364773844|FG005|Overall Study|Withdrawal by Subject|0|||
105760033|NCT01855945|364773845|FG006|Overall Study|Withdrawal by Subject|1|||
105760034|NCT01855945|364773846|FG007|Overall Study|Withdrawal by Subject|0|||
105760035|NCT01855945|364773847|FG008|Overall Study|Withdrawal by Subject|0|||
105760036|NCT01855945|364773848|FG009|Overall Study|Withdrawal by Subject|2|||
105760037|NCT01855945|364773849|FG010|Overall Study|Withdrawal by Subject|4|||
105760038|NCT01855945|364773850|FG011|Overall Study|Withdrawal by Subject|1|||
105760039|NCT01135017|364773851|FG000|Overall Study|Adverse Event|3|||
105760040|NCT01135017|364773852|FG001|Overall Study|Adverse Event|8|||
105760041|NCT01135017|364773851|FG000|Overall Study|Other than above|3|||
105760042|NCT01135017|364773852|FG001|Overall Study|Other than above|4|||
105760043|NCT01803711|364773853|FG000|Overall Study|Adverse Event|1|||
105760044|NCT01803711|364773854|FG001|Overall Study|Adverse Event|1|||
105760045|NCT00432562|364773855|FG000|Overall Study|Death|3|||
105760046|NCT00432562|364773856|FG001|Overall Study|Death|0|||
105760047|NCT03332303|364773857|FG000|Overall Study|Participant did not dose|1|||
105570189|NCT02118337|364086674|FG001|Overall Study|Death|2|||
105570190|NCT02118337|364086675|FG002|Overall Study|Death|1|||
105570191|NCT02118337|364086676|FG003|Overall Study|Death|2|||
105760048|NCT03332303|364773858|FG001|Overall Study|Participant did not dose|2|||
105760049|NCT03332303|364773859|FG002|Overall Study|Participant did not dose|0|||
105570192|NCT02118337|364086677|FG004|Overall Study|Death|5|||
105570193|NCT02118337|364086678|FG005|Overall Study|Death|1|||
105760050|NCT03332303|364773857|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
105760051|NCT03332303|364773858|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
105484558|NCT00282347|363784355|FG000|Treatment Period|Lost to Follow-up|2|||
105484559|NCT00282347|363784356|FG001|Treatment Period|Lost to Follow-up|5|||
105484560|NCT00282347|363784355|FG000|Treatment Period|Withdrawal by Subject|1|||
105484561|NCT00282347|363784356|FG001|Treatment Period|Withdrawal by Subject|3|||
105484562|NCT00282347|363784355|FG000|Treatment Period|Physician Decision|0|||
105570194|NCT02118337|364086679|FG006|Overall Study|Death|2|||
105805563|NCT00585351|364944973|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
105805564|NCT00585351|364944974|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
105805565|NCT00585351|364944975|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
105805566|NCT00585351|364944976|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
105805567|NCT00585351|364944977|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
105805568|NCT00585351|364944978|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
105805569|NCT00585351|364944979|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
105805570|NCT00585351|364944972|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
105805571|NCT00585351|364944973|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
105805572|NCT00585351|364944974|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
105805573|NCT00585351|364944975|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
105805574|NCT00585351|364944976|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
105805575|NCT00585351|364944977|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
105805576|NCT00585351|364944978|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
105805577|NCT00585351|364944979|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
105805578|NCT00585351|364944972|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
105805579|NCT00585351|364944973|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
105805580|NCT00585351|364944974|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
105805581|NCT00585351|364944975|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
105805582|NCT00585351|364944976|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
105805583|NCT00585351|364944977|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
105805584|NCT00585351|364944978|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
105805585|NCT00585351|364944979|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
105805586|NCT00585351|364944972|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
105805587|NCT00585351|364944973|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
105805588|NCT00585351|364944974|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
105805589|NCT00585351|364944975|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
105805590|NCT00585351|364944976|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
105805591|NCT00585351|364944977|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
105360708|NCT04826484|363328062|FG000|Overall Study|Lost to Follow-up|2|||
105360709|NCT04826484|363328063|FG001|Overall Study|Lost to Follow-up|0|||
105360710|NCT02250300|363328064|FG000|Expansion Phase|Death|6|||
105360711|NCT02250300|363328065|FG001|Expansion Phase|Death|7|||
105360712|NCT02250300|363328066|FG002|Expansion Phase|Death|0|||
105360713|NCT02250300|363328067|FG003|Expansion Phase|Death|0|||
105360714|NCT03872843|363328073|FG000|Overall Study|Lost to Follow-up|5|||
105360715|NCT03872843|363328074|FG001|Overall Study|Lost to Follow-up|7|||
105360716|NCT02121795|363328075|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
105360717|NCT02121795|363328076|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
105360718|NCT02121795|363328075|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
105360719|NCT02121795|363328076|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
105360720|NCT02121795|363328075|FG000|Double-Blind Phase|Lost to Follow-up|7|||
105360721|NCT02121795|363328076|FG001|Double-Blind Phase|Lost to Follow-up|4|||
105360722|NCT02121795|363328075|FG000|Double-Blind Phase|Physician Decision|2|||
105360723|NCT02121795|363328076|FG001|Double-Blind Phase|Physician Decision|5|||
105360724|NCT02121795|363328075|FG000|Double-Blind Phase|Adverse Event|5|||
105360725|NCT02121795|363328076|FG001|Double-Blind Phase|Adverse Event|0|||
105360726|NCT02121795|363328075|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
105360727|NCT02121795|363328076|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
105360728|NCT02121795|363328075|FG000|Double-Blind Phase|Protocol Violation|0|||
105360729|NCT02121795|363328076|FG001|Double-Blind Phase|Protocol Violation|3|||
105360730|NCT02121795|363328075|FG000|Double-Blind Phase|Death|1|||
105360731|NCT02121795|363328076|FG001|Double-Blind Phase|Death|1|||
105360732|NCT02121795|363328075|FG000|Open-Label Phase|Physician Decision|8|||
105484563|NCT00282347|363784356|FG001|Treatment Period|Physician Decision|1|||
105760052|NCT03332303|364773859|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
105760053|NCT03332303|364773857|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
105760054|NCT03332303|364773858|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
105760055|NCT03332303|364773859|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
105760056|NCT03332303|364773857|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
105760057|NCT03332303|364773858|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
105760058|NCT03332303|364773859|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
105360733|NCT02121795|363328076|FG001|Open-Label Phase|Physician Decision|8|||
105360734|NCT02121795|363328075|FG000|Open-Label Phase|Withdrawal by Subject|3|||
105360735|NCT02121795|363328076|FG001|Open-Label Phase|Withdrawal by Subject|2|||
105484564|NCT00282347|363784355|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
105484565|NCT00282347|363784356|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
105805592|NCT00585351|364944978|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
105805593|NCT00585351|364944979|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
105805594|NCT00585351|364944972|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
105805595|NCT00585351|364944973|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
105805596|NCT00585351|364944974|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
105805597|NCT00585351|364944975|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
105805598|NCT00585351|364944976|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
105805599|NCT00585351|364944977|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
105805600|NCT00585351|364944978|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
105805601|NCT00585351|364944979|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
105805602|NCT00585351|364944972|FG000|Enrollment Period (Intervention)|Death|0|||
105805603|NCT00585351|364944973|FG001|Enrollment Period (Intervention)|Death|0|||
105805604|NCT00585351|364944974|FG002|Enrollment Period (Intervention)|Death|0|||
105805605|NCT00585351|364944975|FG003|Enrollment Period (Intervention)|Death|0|||
105805606|NCT00585351|364944976|FG004|Enrollment Period (Intervention)|Death|1|||
105805607|NCT00585351|364944977|FG005|Enrollment Period (Intervention)|Death|0|||
105805608|NCT00585351|364944978|FG006|Enrollment Period (Intervention)|Death|1|||
105805609|NCT00585351|364944979|FG007|Enrollment Period (Intervention)|Death|0|||
105805610|NCT00585351|364944972|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
105805611|NCT00585351|364944973|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
105805612|NCT00585351|364944974|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
105805613|NCT00585351|364944975|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
105805614|NCT00585351|364944976|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
105805615|NCT00585351|364944977|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
105805616|NCT00585351|364944978|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
105805617|NCT00585351|364944979|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
105805618|NCT00192296|364944980|FG000|Overall Study|Withdrawal by Subject|0|||
105805619|NCT00192296|364944981|FG001|Overall Study|Withdrawal by Subject|1|||
105805620|NCT00192296|364944982|FG002|Overall Study|Withdrawal by Subject|0|||
105805621|NCT00192296|364944983|FG003|Overall Study|Withdrawal by Subject|0|||
105805622|NCT00358826|364944984|FG000|Core Study|Adverse Event|1|||
105805623|NCT00358826|364944985|FG001|Core Study|Adverse Event|3|||
105805624|NCT00358826|364944986|FG002|Core Study|Adverse Event|1|||
105360736|NCT02121795|363328075|FG000|Open-Label Phase|Lost to Follow-up|1|||
105360737|NCT02121795|363328076|FG001|Open-Label Phase|Lost to Follow-up|0|||
105360738|NCT00281697|363328077|FG000|Overall Study|> 60 days since last dose of study drug|4|||
105360739|NCT00281697|363328078|FG001|Overall Study|> 60 days since last dose of study drug|4|||
105360740|NCT00281697|363328077|FG000|Overall Study|Adverse Event|54|||
105360741|NCT00281697|363328078|FG001|Overall Study|Adverse Event|15|||
105360742|NCT00281697|363328077|FG000|Overall Study|Death|8|||
105360743|NCT00281697|363328078|FG001|Overall Study|Death|3|||
105360744|NCT00281697|363328077|FG000|Overall Study|Disease progression|279|||
105360745|NCT00281697|363328078|FG001|Overall Study|Disease progression|149|||
105360746|NCT00281697|363328077|FG000|Overall Study|Other|5|||
105360747|NCT00281697|363328078|FG001|Overall Study|Other|6|||
105360748|NCT00281697|363328077|FG000|Overall Study|Physician's decision to withdraw|15|||
105360749|NCT00281697|363328078|FG001|Overall Study|Physician's decision to withdraw|12|||
105360750|NCT00281697|363328077|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
105360751|NCT00281697|363328078|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
105360752|NCT00281697|363328077|FG000|Overall Study|Did not receive study drug|3|||
105360753|NCT00281697|363328078|FG001|Overall Study|Did not receive study drug|2|||
105360754|NCT01714544|363328079|FG000|Overall Study|Lost to Follow-up|1|||
105360755|NCT01714544|363328079|FG000|Overall Study|Physician Decision|1|||
105360756|NCT01714544|363328079|FG000|Overall Study|Withdrawal by Subject|1|||
105805625|NCT00358826|364944987|FG003|Core Study|Adverse Event|1|||
105805626|NCT00358826|364944988|FG004|Core Study|Adverse Event|0|||
105805627|NCT00358826|364944989|FG005|Core Study|Adverse Event|0|||
105805628|NCT00358826|364944990|FG006|Core Study|Adverse Event|0|||
105360757|NCT00572455|363328080|FG000|Stage I (14 Days)|Adverse Event|0|||
105360758|NCT00572455|363328081|FG001|Stage I (14 Days)|Adverse Event|0|||
105805629|NCT00358826|364944991|FG007|Core Study|Adverse Event|0|||
105805630|NCT00358826|364944984|FG000|Core Study|Withdrawal by Subject|2|||
105805631|NCT00358826|364944985|FG001|Core Study|Withdrawal by Subject|2|||
105805632|NCT00358826|364944986|FG002|Core Study|Withdrawal by Subject|0|||
105805633|NCT00358826|364944987|FG003|Core Study|Withdrawal by Subject|0|||
105805634|NCT00358826|364944988|FG004|Core Study|Withdrawal by Subject|0|||
105805635|NCT00358826|364944989|FG005|Core Study|Withdrawal by Subject|0|||
105805636|NCT00358826|364944990|FG006|Core Study|Withdrawal by Subject|0|||
105805637|NCT00358826|364944991|FG007|Core Study|Withdrawal by Subject|0|||
105805638|NCT00358826|364944984|FG000|Core Study|Lost to Follow-up|0|||
105805639|NCT00358826|364944985|FG001|Core Study|Lost to Follow-up|0|||
105805640|NCT00358826|364944986|FG002|Core Study|Lost to Follow-up|0|||
105805641|NCT00358826|364944987|FG003|Core Study|Lost to Follow-up|1|||
105805642|NCT00358826|364944988|FG004|Core Study|Lost to Follow-up|0|||
105805643|NCT00358826|364944989|FG005|Core Study|Lost to Follow-up|0|||
105805644|NCT00358826|364944990|FG006|Core Study|Lost to Follow-up|0|||
105805645|NCT00358826|364944991|FG007|Core Study|Lost to Follow-up|0|||
105805646|NCT00358826|364944984|FG000|Core Study|Physician Decision|0|||
105805647|NCT00358826|364944985|FG001|Core Study|Physician Decision|0|||
105805648|NCT00358826|364944986|FG002|Core Study|Physician Decision|1|||
105360759|NCT00572455|363328082|FG002|Stage I (14 Days)|Adverse Event|0|||
105760059|NCT03332303|364773857|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
105760060|NCT03332303|364773858|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
105760061|NCT03332303|364773859|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
105760062|NCT03332303|364773857|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
105760063|NCT03332303|364773858|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
105760064|NCT03332303|364773859|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
105760065|NCT03332303|364773857|FG000|Overall Study|Participant had a significant protocol deviation|0|||
105760066|NCT03332303|364773858|FG001|Overall Study|Participant had a significant protocol deviation|1|||
105760067|NCT03332303|364773859|FG002|Overall Study|Participant had a significant protocol deviation|0|||
105760068|NCT01230749|364773867|FG000|Overall Study|Adverse Event|0|||
105760069|NCT01230749|364773868|FG001|Overall Study|Adverse Event|0|||
105760070|NCT01230749|364773869|FG002|Overall Study|Adverse Event|0|||
105760071|NCT01230749|364773870|FG003|Overall Study|Adverse Event|1|||
105760072|NCT01230749|364773867|FG000|Overall Study|Physician Decision|0|||
105760073|NCT01230749|364773868|FG001|Overall Study|Physician Decision|0|||
105760074|NCT01230749|364773869|FG002|Overall Study|Physician Decision|1|||
105760075|NCT01230749|364773870|FG003|Overall Study|Physician Decision|0|||
105760076|NCT01230749|364773867|FG000|Overall Study|Withdrawal by Subject|0|||
105760077|NCT01230749|364773868|FG001|Overall Study|Withdrawal by Subject|1|||
105760078|NCT01230749|364773869|FG002|Overall Study|Withdrawal by Subject|0|||
105760079|NCT01230749|364773870|FG003|Overall Study|Withdrawal by Subject|0|||
105760080|NCT01230749|364773867|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
105760081|NCT01230749|364773868|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
105760082|NCT01230749|364773869|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
105760083|NCT01230749|364773870|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
105760084|NCT00555906|364773871|FG000|Phase 1|Objective Progression or Relapse|3|||
105760085|NCT00555906|364773872|FG001|Phase 1|Objective Progression or Relapse|5|||
105760086|NCT00555906|364773873|FG002|Phase 1|Objective Progression or Relapse|3|||
105760087|NCT00555906|364773874|FG003|Phase 1|Objective Progression or Relapse|1|||
105760088|NCT00555906|364773875|FG004|Phase 1|Objective Progression or Relapse|0|||
105760089|NCT00555906|364773871|FG000|Phase 1|Global Deterioration of Health Status|0|||
105760090|NCT00555906|364773872|FG001|Phase 1|Global Deterioration of Health Status|1|||
105760091|NCT00555906|364773873|FG002|Phase 1|Global Deterioration of Health Status|1|||
105760092|NCT00555906|364773874|FG003|Phase 1|Global Deterioration of Health Status|1|||
105760093|NCT00555906|364773875|FG004|Phase 1|Global Deterioration of Health Status|0|||
105760094|NCT00555906|364773871|FG000|Phase 1|Adverse Event|0|||
105760095|NCT00555906|364773872|FG001|Phase 1|Adverse Event|0|||
105760096|NCT00555906|364773873|FG002|Phase 1|Adverse Event|3|||
105760097|NCT00555906|364773874|FG003|Phase 1|Adverse Event|2|||
105760098|NCT00555906|364773875|FG004|Phase 1|Adverse Event|0|||
105760099|NCT00555906|364773871|FG000|Phase 1|Withdrawal by Subject|0|||
105760100|NCT00555906|364773872|FG001|Phase 1|Withdrawal by Subject|0|||
105760101|NCT00555906|364773873|FG002|Phase 1|Withdrawal by Subject|0|||
105760102|NCT00555906|364773874|FG003|Phase 1|Withdrawal by Subject|1|||
105805649|NCT00358826|364944987|FG003|Core Study|Physician Decision|0|||
105805650|NCT00358826|364944988|FG004|Core Study|Physician Decision|0|||
105805651|NCT00358826|364944989|FG005|Core Study|Physician Decision|0|||
105805652|NCT00358826|364944990|FG006|Core Study|Physician Decision|0|||
105805653|NCT00358826|364944991|FG007|Core Study|Physician Decision|0|||
105805654|NCT00358826|364944984|FG000|MDCT Substudy|Adverse Event|0|||
105805655|NCT00358826|364944985|FG001|MDCT Substudy|Adverse Event|0|||
105805656|NCT00358826|364944986|FG002|MDCT Substudy|Adverse Event|0|||
105805657|NCT00358826|364944987|FG003|MDCT Substudy|Adverse Event|0|||
105805658|NCT00358826|364944988|FG004|MDCT Substudy|Adverse Event|1|||
105805659|NCT00358826|364944989|FG005|MDCT Substudy|Adverse Event|0|||
105805660|NCT00358826|364944990|FG006|MDCT Substudy|Adverse Event|0|||
105805661|NCT00358826|364944991|FG007|MDCT Substudy|Adverse Event|0|||
105805662|NCT00358826|364944984|FG000|MDCT Substudy|Lost to Follow-up|0|||
105805663|NCT00358826|364944985|FG001|MDCT Substudy|Lost to Follow-up|0|||
105805664|NCT00358826|364944986|FG002|MDCT Substudy|Lost to Follow-up|0|||
105805665|NCT00358826|364944987|FG003|MDCT Substudy|Lost to Follow-up|0|||
105805666|NCT00358826|364944988|FG004|MDCT Substudy|Lost to Follow-up|0|||
105805667|NCT00358826|364944989|FG005|MDCT Substudy|Lost to Follow-up|1|||
105805668|NCT00358826|364944990|FG006|MDCT Substudy|Lost to Follow-up|0|||
105805669|NCT00358826|364944991|FG007|MDCT Substudy|Lost to Follow-up|0|||
105805670|NCT00358826|364944984|FG000|MDCT Substudy|Withdrawal by Subject|0|||
105805671|NCT00358826|364944985|FG001|MDCT Substudy|Withdrawal by Subject|0|||
105805672|NCT00358826|364944986|FG002|MDCT Substudy|Withdrawal by Subject|0|||
105805673|NCT00358826|364944987|FG003|MDCT Substudy|Withdrawal by Subject|0|||
105805674|NCT00358826|364944988|FG004|MDCT Substudy|Withdrawal by Subject|0|||
105805675|NCT00358826|364944989|FG005|MDCT Substudy|Withdrawal by Subject|1|||
105805676|NCT00358826|364944990|FG006|MDCT Substudy|Withdrawal by Subject|0|||
105805677|NCT00358826|364944991|FG007|MDCT Substudy|Withdrawal by Subject|0|||
105805678|NCT00283686|364944998|FG000|Overall Study|Death|1|||
105805679|NCT00283686|364944999|FG001|Overall Study|Death|1|||
105805680|NCT00283686|364945000|FG002|Overall Study|Death|1|||
105805681|NCT00283686|364945001|FG003|Overall Study|Death|0|||
105805682|NCT00283686|364944998|FG000|Overall Study|Lost to Follow-up|21|||
105805683|NCT00283686|364944999|FG001|Overall Study|Lost to Follow-up|31|||
105805684|NCT00283686|364945000|FG002|Overall Study|Lost to Follow-up|26|||
105805685|NCT00283686|364945001|FG003|Overall Study|Lost to Follow-up|20|||
105805686|NCT00283686|364944998|FG000|Overall Study|Less than full participation|7|||
105805687|NCT00283686|364944999|FG001|Overall Study|Less than full participation|9|||
105805688|NCT00283686|364945000|FG002|Overall Study|Less than full participation|6|||
105805689|NCT00283686|364945001|FG003|Overall Study|Less than full participation|12|||
105805690|NCT02649231|364945005|FG000|Overall Study|Adverse Event|0|||
105805691|NCT02649231|364945006|FG001|Overall Study|Adverse Event|0|||
105805692|NCT02649231|364945007|FG002|Overall Study|Adverse Event|0|||
105805693|NCT02649231|364945008|FG003|Overall Study|Adverse Event|1|||
105805694|NCT02649231|364945005|FG000|Overall Study|Lost to Follow-up|2|||
105805695|NCT02649231|364945006|FG001|Overall Study|Lost to Follow-up|1|||
105805696|NCT02649231|364945007|FG002|Overall Study|Lost to Follow-up|1|||
105805697|NCT02649231|364945008|FG003|Overall Study|Lost to Follow-up|0|||
105805698|NCT02649231|364945005|FG000|Overall Study|Withdrawal by Subject|0|||
105805699|NCT02649231|364945006|FG001|Overall Study|Withdrawal by Subject|1|||
105805700|NCT02649231|364945007|FG002|Overall Study|Withdrawal by Subject|0|||
105805701|NCT02649231|364945008|FG003|Overall Study|Withdrawal by Subject|1|||
105805702|NCT02649231|364945005|FG000|Overall Study|Protocol Violation|2|||
105805703|NCT02649231|364945006|FG001|Overall Study|Protocol Violation|1|||
105805704|NCT02649231|364945007|FG002|Overall Study|Protocol Violation|1|||
105805705|NCT02649231|364945008|FG003|Overall Study|Protocol Violation|0|||
105805706|NCT02175966|364945009|FG000|Follow-up Period|Lack of Efficacy|10|||
105805707|NCT02175966|364945010|FG001|Follow-up Period|Lack of Efficacy|6|||
105805708|NCT01752920|364945011|FG000|Overall Study|Adverse Event|1|||
105805709|NCT01752920|364945012|FG001|Overall Study|Adverse Event|0|||
105805710|NCT01752920|364945013|FG002|Overall Study|Adverse Event|5|||
105805711|NCT01752920|364945014|FG003|Overall Study|Adverse Event|10|||
105805712|NCT01752920|364945011|FG000|Overall Study|Clinical Disease Progression|6|||
105805713|NCT01752920|364945012|FG001|Overall Study|Clinical Disease Progression|4|||
105805714|NCT01752920|364945013|FG002|Overall Study|Clinical Disease Progression|1|||
105805715|NCT01752920|364945014|FG003|Overall Study|Clinical Disease Progression|13|||
105805716|NCT01752920|364945011|FG000|Overall Study|Physician Decision|1|||
105805717|NCT01752920|364945012|FG001|Overall Study|Physician Decision|0|||
105570195|NCT02118337|364086680|FG007|Overall Study|Death|9|||
105805718|NCT01752920|364945013|FG002|Overall Study|Physician Decision|0|||
105805719|NCT01752920|364945014|FG003|Overall Study|Physician Decision|3|||
105805720|NCT01752920|364945011|FG000|Overall Study|Radiographic Disease Progression|20|||
105805721|NCT01752920|364945012|FG001|Overall Study|Radiographic Disease Progression|7|||
105805722|NCT01752920|364945013|FG002|Overall Study|Radiographic Disease Progression|12|||
105805723|NCT01752920|364945014|FG003|Overall Study|Radiographic Disease Progression|29|||
105805724|NCT01752920|364945011|FG000|Overall Study|Study Terminated by Sponsor|0|||
105805725|NCT01752920|364945012|FG001|Overall Study|Study Terminated by Sponsor|0|||
105805726|NCT01752920|364945013|FG002|Overall Study|Study Terminated by Sponsor|0|||
105805727|NCT01752920|364945014|FG003|Overall Study|Study Terminated by Sponsor|1|||
105805728|NCT01752920|364945011|FG000|Overall Study|Withdrawal by Subject|0|||
105805729|NCT01752920|364945012|FG001|Overall Study|Withdrawal by Subject|1|||
105805730|NCT01752920|364945013|FG002|Overall Study|Withdrawal by Subject|0|||
105805731|NCT01752920|364945014|FG003|Overall Study|Withdrawal by Subject|1|||
105805732|NCT01752920|364945011|FG000|Overall Study|Lack of clinical benefit|1|||
105805733|NCT01752920|364945012|FG001|Overall Study|Lack of clinical benefit|1|||
105805734|NCT01752920|364945013|FG002|Overall Study|Lack of clinical benefit|1|||
105805735|NCT01752920|364945014|FG003|Overall Study|Lack of clinical benefit|1|||
105805736|NCT01154153|364945017|FG000|Overall Study|Poor compliance to protocol|2|||
105805737|NCT01154153|364945018|FG001|Overall Study|Poor compliance to protocol|0|||
105805738|NCT01154153|364945017|FG000|Overall Study|Unable to use labs|2|||
105805739|NCT01154153|364945018|FG001|Overall Study|Unable to use labs|3|||
105805740|NCT01154153|364945017|FG000|Overall Study|Withdrew consent|1|||
105805741|NCT01154153|364945018|FG001|Overall Study|Withdrew consent|0|||
105805742|NCT02611752|364945019|FG000|Overall Study|Adverse Event|0|||
105805743|NCT02611752|364945020|FG001|Overall Study|Adverse Event|1|||
105805744|NCT00321711|364945024|FG000|Part A|Adverse Event|3|||
105805745|NCT00321711|364945025|FG001|Part A|Adverse Event|3|||
105805746|NCT00321711|364945026|FG002|Part A|Adverse Event|2|||
105805747|NCT00321711|364945027|FG003|Part A|Adverse Event|0|||
105805748|NCT00321711|364945028|FG004|Part A|Adverse Event|0|||
105805749|NCT00321711|364945024|FG000|Part A|Withdrawal by Subject|1|||
105805750|NCT00321711|364945025|FG001|Part A|Withdrawal by Subject|1|||
105805751|NCT00321711|364945026|FG002|Part A|Withdrawal by Subject|1|||
105805752|NCT00321711|364945027|FG003|Part A|Withdrawal by Subject|0|||
105805753|NCT00321711|364945028|FG004|Part A|Withdrawal by Subject|0|||
105805754|NCT00321711|364945024|FG000|Part A|Disease progression|0|||
105805755|NCT00321711|364945025|FG001|Part A|Disease progression|1|||
105805756|NCT00321711|364945026|FG002|Part A|Disease progression|0|||
105805757|NCT00321711|364945027|FG003|Part A|Disease progression|0|||
105805758|NCT00321711|364945028|FG004|Part A|Disease progression|0|||
105805759|NCT00321711|364945024|FG000|Part A|Requirement for alternative therapy|0|||
105805760|NCT00321711|364945025|FG001|Part A|Requirement for alternative therapy|2|||
105805761|NCT00321711|364945026|FG002|Part A|Requirement for alternative therapy|1|||
105805762|NCT00321711|364945027|FG003|Part A|Requirement for alternative therapy|0|||
105805763|NCT00321711|364945028|FG004|Part A|Requirement for alternative therapy|0|||
105805764|NCT00321711|364945024|FG000|Part A|Physician Decision|0|||
105805765|NCT00321711|364945025|FG001|Part A|Physician Decision|1|||
105805766|NCT00321711|364945026|FG002|Part A|Physician Decision|3|||
105805767|NCT00321711|364945027|FG003|Part A|Physician Decision|0|||
105805768|NCT00321711|364945028|FG004|Part A|Physician Decision|0|||
105805769|NCT00321711|364945024|FG000|Part A|Other|1|||
105805770|NCT00321711|364945025|FG001|Part A|Other|2|||
105805771|NCT00321711|364945026|FG002|Part A|Other|3|||
105805772|NCT00321711|364945027|FG003|Part A|Other|0|||
105805773|NCT00321711|364945028|FG004|Part A|Other|0|||
105805774|NCT00321711|364945024|FG000|Part A|Protocol deviation|0|||
105805775|NCT00321711|364945025|FG001|Part A|Protocol deviation|0|||
105805776|NCT00321711|364945026|FG002|Part A|Protocol deviation|1|||
105805777|NCT00321711|364945027|FG003|Part A|Protocol deviation|0|||
105805778|NCT00321711|364945028|FG004|Part A|Protocol deviation|0|||
105805779|NCT00321711|364945024|FG000|Part B|Noncompliance|0|||
105805780|NCT00321711|364945025|FG001|Part B|Noncompliance|0|||
105805781|NCT00321711|364945026|FG002|Part B|Noncompliance|0|||
105805782|NCT00321711|364945027|FG003|Part B|Noncompliance|0|||
105805783|NCT00321711|364945028|FG004|Part B|Noncompliance|1|||
105805784|NCT00321711|364945024|FG000|Part B|Adverse Event|0|||
105805785|NCT00321711|364945025|FG001|Part B|Adverse Event|0|||
105805786|NCT00321711|364945026|FG002|Part B|Adverse Event|0|||
105805787|NCT00321711|364945027|FG003|Part B|Adverse Event|2|||
105805788|NCT00321711|364945028|FG004|Part B|Adverse Event|1|||
105484566|NCT00282347|363784355|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
105484567|NCT00282347|363784356|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
105805789|NCT00321711|364945024|FG000|Part B|Disease progression|0|||
105484568|NCT00282347|363784355|FG000|Safety Follow-up Period|Physician Decision|1|||
105484569|NCT00282347|363784356|FG001|Safety Follow-up Period|Physician Decision|1|||
105484570|NCT00282347|363784355|FG000|Safety Follow-up Period|Protocol Deviation|0|||
105484571|NCT00282347|363784356|FG001|Safety Follow-up Period|Protocol Deviation|2|||
105805790|NCT00321711|364945025|FG001|Part B|Disease progression|0|||
105805791|NCT00321711|364945026|FG002|Part B|Disease progression|0|||
105805792|NCT00321711|364945027|FG003|Part B|Disease progression|1|||
105805793|NCT00321711|364945028|FG004|Part B|Disease progression|0|||
105805794|NCT00321711|364945024|FG000|Part B|Physician Decision|0|||
105805795|NCT00321711|364945025|FG001|Part B|Physician Decision|0|||
105805796|NCT00321711|364945026|FG002|Part B|Physician Decision|0|||
105805797|NCT00321711|364945027|FG003|Part B|Physician Decision|1|||
105805798|NCT00321711|364945028|FG004|Part B|Physician Decision|2|||
105805799|NCT00321711|364945024|FG000|Part B|Death|0|||
105805800|NCT00321711|364945025|FG001|Part B|Death|0|||
105805801|NCT00321711|364945026|FG002|Part B|Death|0|||
105805802|NCT00321711|364945027|FG003|Part B|Death|2|||
105805803|NCT00321711|364945028|FG004|Part B|Death|1|||
105805804|NCT02843074|364945029|FG000|Overall Study|Withdrawal by Subject|5|||
105760103|NCT00555906|364773875|FG004|Phase 1|Withdrawal by Subject|0|||
105760104|NCT00555906|364773871|FG000|Phase 2|Adverse Event|0|||
105760105|NCT00555906|364773872|FG001|Phase 2|Adverse Event|0|||
105760106|NCT00555906|364773873|FG002|Phase 2|Adverse Event|0|||
105760107|NCT00555906|364773874|FG003|Phase 2|Adverse Event|0|||
105760108|NCT00555906|364773875|FG004|Phase 2|Adverse Event|4|||
105760109|NCT00555906|364773871|FG000|Phase 2|Global Deterioration of Health Status|0|||
105760110|NCT00555906|364773872|FG001|Phase 2|Global Deterioration of Health Status|0|||
105760111|NCT00555906|364773873|FG002|Phase 2|Global Deterioration of Health Status|0|||
105760112|NCT00555906|364773874|FG003|Phase 2|Global Deterioration of Health Status|0|||
105760113|NCT00555906|364773875|FG004|Phase 2|Global Deterioration of Health Status|2|||
105760114|NCT00555906|364773871|FG000|Phase 2|Objective Progression or Relapse|0|||
105760115|NCT00555906|364773872|FG001|Phase 2|Objective Progression or Relapse|0|||
105760116|NCT00555906|364773873|FG002|Phase 2|Objective Progression or Relapse|0|||
105760117|NCT00555906|364773874|FG003|Phase 2|Objective Progression or Relapse|0|||
105760118|NCT00555906|364773875|FG004|Phase 2|Objective Progression or Relapse|16|||
105760119|NCT00555906|364773871|FG000|Phase 2|Withdrawal by Subject|0|||
105760120|NCT00555906|364773872|FG001|Phase 2|Withdrawal by Subject|0|||
105760121|NCT00555906|364773873|FG002|Phase 2|Withdrawal by Subject|0|||
105760122|NCT00555906|364773874|FG003|Phase 2|Withdrawal by Subject|0|||
105760123|NCT00555906|364773875|FG004|Phase 2|Withdrawal by Subject|2|||
105760124|NCT00555906|364773871|FG000|Phase 2|Other|0|||
105760125|NCT00555906|364773872|FG001|Phase 2|Other|0|||
105760126|NCT00555906|364773873|FG002|Phase 2|Other|0|||
105760127|NCT00555906|364773874|FG003|Phase 2|Other|0|||
105760128|NCT00555906|364773875|FG004|Phase 2|Other|6|||
105760129|NCT00555906|364773871|FG000|Phase 2|Randomized but not Treated|0|||
105760130|NCT00555906|364773872|FG001|Phase 2|Randomized but not Treated|0|||
105760131|NCT00555906|364773873|FG002|Phase 2|Randomized but not Treated|0|||
105760132|NCT00555906|364773874|FG003|Phase 2|Randomized but not Treated|0|||
105760133|NCT00555906|364773875|FG004|Phase 2|Randomized but not Treated|2|||
105760134|NCT01313208|364773876|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
105760135|NCT01313208|364773877|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
105760136|NCT01313208|364773876|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
105760137|NCT01313208|364773877|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
105760138|NCT01313208|364773876|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
105760139|NCT01313208|364773877|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
105760140|NCT01313208|364773876|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
105760141|NCT01313208|364773877|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
105760142|NCT01313208|364773876|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
105760143|NCT01313208|364773877|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
105760144|NCT01313208|364773876|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
105760145|NCT01313208|364773877|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
105760146|NCT01313208|364773876|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
105760147|NCT01313208|364773877|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
105760148|NCT01313208|364773876|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
105760149|NCT01313208|364773877|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
105760150|NCT01313208|364773876|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
105760151|NCT01313208|364773877|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
105760152|NCT05109702|364773883|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
105760153|NCT05109702|364773884|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
105760154|NCT05109702|364773885|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
105760155|NCT05109702|364773883|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
105805805|NCT02843074|364945029|FG000|Overall Study|Progressive disease|1|||
105805806|NCT02843074|364945029|FG000|Overall Study|Physician Decision|1|||
105360760|NCT00572455|363328083|FG003|Stage I (14 Days)|Adverse Event|0|||
105360761|NCT00572455|363328084|FG004|Stage I (14 Days)|Adverse Event|0|||
105360762|NCT00572455|363328085|FG005|Stage I (14 Days)|Adverse Event|3|||
105760156|NCT05109702|364773884|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
105760157|NCT05109702|364773885|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
105760158|NCT05109702|364773883|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
105760159|NCT05109702|364773884|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
105760160|NCT05109702|364773885|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
105760161|NCT05109702|364773883|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
105760162|NCT05109702|364773884|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
105760163|NCT05109702|364773885|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
105760164|NCT05109702|364773883|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
105760165|NCT05109702|364773884|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
105760166|NCT05109702|364773885|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
105760167|NCT03094832|364773886|FG000|Overall Study|Lost to Follow-up|0|||
105360763|NCT00572455|363328086|FG006|Stage I (14 Days)|Adverse Event|0|||
105360764|NCT00572455|363328087|FG007|Stage I (14 Days)|Adverse Event|0|||
105760168|NCT03094832|364773887|FG001|Overall Study|Lost to Follow-up|0|||
105760169|NCT03094832|364773888|FG002|Overall Study|Lost to Follow-up|0|||
105760170|NCT03094832|364773889|FG003|Overall Study|Lost to Follow-up|1|||
105484572|NCT00282347|363784355|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
105760171|NCT03094832|364773890|FG004|Overall Study|Lost to Follow-up|1|||
105760172|NCT03094832|364773886|FG000|Overall Study|Death|1|||
105760173|NCT03094832|364773887|FG001|Overall Study|Death|0|||
105760174|NCT03094832|364773888|FG002|Overall Study|Death|0|||
105760175|NCT03094832|364773889|FG003|Overall Study|Death|0|||
105760176|NCT03094832|364773890|FG004|Overall Study|Death|0|||
105760177|NCT03094832|364773886|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105760178|NCT03094832|364773887|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105760179|NCT03094832|364773888|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105760180|NCT03094832|364773889|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
105760181|NCT03094832|364773890|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
105760182|NCT03094832|364773886|FG000|Overall Study|Other|13|||
105760183|NCT03094832|364773887|FG001|Overall Study|Other|20|||
105760184|NCT03094832|364773888|FG002|Overall Study|Other|1|||
105760185|NCT03094832|364773889|FG003|Overall Study|Other|7|||
105760186|NCT03094832|364773890|FG004|Overall Study|Other|1|||
105760187|NCT00788697|364773897|FG000|Overall Study|No study drug administered|12|||
105760188|NCT00788697|364773897|FG000|Overall Study|Training Patients|74|||
105760189|NCT00788697|364773897|FG000|Overall Study|no truth standard procedure available|5|||
105760190|NCT00788697|364773897|FG000|Overall Study|Technically inadequate truth standard|1|||
105760191|NCT00788697|364773897|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
105760192|NCT03199638|364773898|FG000|Overall Study|inability to drink glutamine during regularly|0|||
105760193|NCT03199638|364773899|FG001|Overall Study|inability to drink glutamine during regularly|2|||
105760194|NCT02261883|364773900|FG000|Overall Study|Death|3|||
105760195|NCT02261883|364773901|FG001|Overall Study|Death|2|||
105760196|NCT02261883|364773900|FG000|Overall Study|Physician Decision|1|||
105760197|NCT02261883|364773901|FG001|Overall Study|Physician Decision|0|||
105760198|NCT02261883|364773900|FG000|Overall Study|Protocol Violation|1|||
105760199|NCT02261883|364773901|FG001|Overall Study|Protocol Violation|0|||
105760200|NCT02261883|364773900|FG000|Overall Study|Withdrawal by Subject|0|||
105760201|NCT02261883|364773901|FG001|Overall Study|Withdrawal by Subject|1|||
105760202|NCT02261883|364773900|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
105760203|NCT02261883|364773901|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
105760204|NCT00709124|364773902|FG000|Overall Study|Death|3|||
105760205|NCT00709124|364773903|FG001|Overall Study|Death|1|||
105760206|NCT00709124|364773902|FG000|Overall Study|encephalopathy; can't do assessment|1|||
105760207|NCT00709124|364773903|FG001|Overall Study|encephalopathy; can't do assessment|0|||
105760208|NCT00373490|364773904|FG000|Overall Study|Adverse Event|0|||
105760209|NCT00373490|364773905|FG001|Overall Study|Adverse Event|1|||
105760210|NCT00373490|364773904|FG000|Overall Study|Lack of Efficacy|9|||
105760211|NCT00373490|364773905|FG001|Overall Study|Lack of Efficacy|4|||
105760212|NCT00373490|364773904|FG000|Overall Study|Withdrawal by Subject|0|||
105760213|NCT00373490|364773905|FG001|Overall Study|Withdrawal by Subject|1|||
105760214|NCT02674685|364773913|FG000|Overall Study|Withdrawal by Subject|4|||
105760215|NCT02713789|364773915|FG000|Overall Study|Lost to Follow-up|0|||
105760216|NCT02713789|364773916|FG001|Overall Study|Lost to Follow-up|1|||
105760217|NCT02713789|364773917|FG002|Overall Study|Lost to Follow-up|1|||
105760218|NCT03549117|364773918|FG000|Overall Study|Withdrawal by Subject|1|||
105760219|NCT03549117|364773919|FG001|Overall Study|Withdrawal by Subject|0|||
105760220|NCT00903370|364773920|FG000|Overall Study|Death|13|||
105760221|NCT00903370|364773921|FG001|Overall Study|Death|10|||
105760222|NCT00903370|364773920|FG000|Overall Study|Withdrawal by Subject|9|||
105760223|NCT00903370|364773921|FG001|Overall Study|Withdrawal by Subject|6|||
105760224|NCT00903370|364773920|FG000|Overall Study|Lost to Follow-up|6|||
105760225|NCT00903370|364773921|FG001|Overall Study|Lost to Follow-up|8|||
105760226|NCT00367432|364773922|FG000|First Period (16 Weeks)|Adverse Event|6|||
105760227|NCT00367432|364773923|FG001|First Period (16 Weeks)|Adverse Event|0|||
105760228|NCT00367432|364773922|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
105760229|NCT00367432|364773923|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
105760230|NCT00367432|364773922|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
105760231|NCT00367432|364773923|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
105760232|NCT00367432|364773922|FG000|First Period (16 Weeks)|Other Reason|2|||
105760233|NCT00367432|364773923|FG001|First Period (16 Weeks)|Other Reason|0|||
105760234|NCT00367432|364773922|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
105760235|NCT00367432|364773923|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
105760236|NCT00367432|364773922|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
105760237|NCT00367432|364773923|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
105760238|NCT00367432|364773922|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
105760239|NCT00367432|364773923|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
105760240|NCT00367432|364773922|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
105760241|NCT00367432|364773923|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
105760242|NCT00367432|364773922|FG000|Second Period (up to 54 Months)|Other Reason|6|||
105805807|NCT02843074|364945029|FG000|Overall Study|Lost to Follow-up|1|||
105805808|NCT02843074|364945029|FG000|Overall Study|Death|9|||
105805809|NCT01186978|364945030|FG000|Overall Study|Withdrawal by Subject|1|||
105805810|NCT00947856|364945031|FG000|Treatment Period|Progressive Disease|33|||
105805811|NCT00947856|364945032|FG001|Treatment Period|Progressive Disease|12|||
105805812|NCT00947856|364945031|FG000|Treatment Period|Adverse Event|15|||
105805813|NCT00947856|364945032|FG001|Treatment Period|Adverse Event|9|||
105805814|NCT00947856|364945031|FG000|Treatment Period|Physician Decision|14|||
105805815|NCT00947856|364945032|FG001|Treatment Period|Physician Decision|6|||
105805816|NCT00947856|364945031|FG000|Treatment Period|Study Stopped by Sponsor|4|||
105805817|NCT00947856|364945032|FG001|Treatment Period|Study Stopped by Sponsor|4|||
105805818|NCT00947856|364945031|FG000|Treatment Period|Withdrawal by Subject|12|||
105805819|NCT00947856|364945032|FG001|Treatment Period|Withdrawal by Subject|1|||
105805820|NCT00947856|364945031|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
105805821|NCT00947856|364945032|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
105805822|NCT00947856|364945031|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
105805823|NCT00947856|364945032|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
105805824|NCT00947856|364945031|FG000|Follow-up Period|Lost to Follow-up|7|||
105805825|NCT00947856|364945032|FG001|Follow-up Period|Lost to Follow-up|0|||
105805826|NCT00947856|364945031|FG000|Follow-up Period|Patient unavailable for site visits|1|||
105805827|NCT00947856|364945032|FG001|Follow-up Period|Patient unavailable for site visits|0|||
105805828|NCT00947856|364945031|FG000|Follow-up Period|Withdrawal by Subject|1|||
105805829|NCT00947856|364945032|FG001|Follow-up Period|Withdrawal by Subject|0|||
105805830|NCT00543439|364945036|FG000|Period 1|Adverse Event|0|||
105805831|NCT00543439|364945037|FG001|Period 1|Adverse Event|2|||
105805832|NCT00543439|364945038|FG002|Period 1|Adverse Event|1|||
105805833|NCT00543439|364945036|FG000|Period 1|Withdrawal by Subject|1|||
105805834|NCT00543439|364945037|FG001|Period 1|Withdrawal by Subject|1|||
105805835|NCT00543439|364945038|FG002|Period 1|Withdrawal by Subject|0|||
105805836|NCT00543439|364945036|FG000|Period 1|Physician Decision|0|||
105805837|NCT00543439|364945037|FG001|Period 1|Physician Decision|0|||
105805838|NCT00543439|364945038|FG002|Period 1|Physician Decision|1|||
105805839|NCT00543439|364945036|FG000|Period 2|Protocol Violation|1|||
105805840|NCT00543439|364945037|FG001|Period 2|Protocol Violation|0|||
105805841|NCT00543439|364945038|FG002|Period 2|Protocol Violation|1|||
105805842|NCT00543439|364945036|FG000|Period 2|Adverse Event|0|||
105805843|NCT00543439|364945037|FG001|Period 2|Adverse Event|1|||
105805844|NCT00543439|364945038|FG002|Period 2|Adverse Event|1|||
105805845|NCT05476679|364945039|FG000|Overall Study|Withdrawal by Subject|0|||
105805846|NCT05476679|364945040|FG001|Overall Study|Withdrawal by Subject|0|||
105805847|NCT05476679|364945041|FG002|Overall Study|Withdrawal by Subject|0|||
105805848|NCT05476679|364945042|FG003|Overall Study|Withdrawal by Subject|1|||
105805849|NCT05476679|364945043|FG004|Overall Study|Withdrawal by Subject|0|||
105805850|NCT05476679|364945039|FG000|Overall Study|Lost to Follow-up|0|||
105805851|NCT05476679|364945040|FG001|Overall Study|Lost to Follow-up|0|||
105805852|NCT05476679|364945041|FG002|Overall Study|Lost to Follow-up|0|||
105805853|NCT05476679|364945042|FG003|Overall Study|Lost to Follow-up|1|||
105805854|NCT05476679|364945043|FG004|Overall Study|Lost to Follow-up|0|||
105805855|NCT01211769|364945044|FG000|Overall Study|Lost to Follow-up|7|||
105805856|NCT01211769|364945045|FG001|Overall Study|Lost to Follow-up|9|||
105805857|NCT01211769|364945046|FG002|Overall Study|Lost to Follow-up|5|||
105805858|NCT01211769|364945047|FG003|Overall Study|Lost to Follow-up|9|||
105805859|NCT01211769|364945044|FG000|Overall Study|Physician Decision|2|||
105805860|NCT01211769|364945045|FG001|Overall Study|Physician Decision|0|||
105805861|NCT01211769|364945046|FG002|Overall Study|Physician Decision|2|||
105805862|NCT01211769|364945047|FG003|Overall Study|Physician Decision|1|||
105805863|NCT01211769|364945044|FG000|Overall Study|Adverse Event|0|||
105805864|NCT01211769|364945045|FG001|Overall Study|Adverse Event|1|||
105805865|NCT01211769|364945046|FG002|Overall Study|Adverse Event|1|||
105805866|NCT01211769|364945047|FG003|Overall Study|Adverse Event|1|||
105805867|NCT01214330|364945048|FG000|Overall Study|Withdrawal by Subject|2|||
105805868|NCT01214330|364945048|FG000|Overall Study|Withdrawal by Subject|2|||
105805869|NCT01862328|364945050|FG000|Overall Study|Progressive Disease|3|||
105805870|NCT01862328|364945051|FG001|Overall Study|Progressive Disease|11|||
105805871|NCT01862328|364945052|FG002|Overall Study|Progressive Disease|5|||
105805872|NCT01862328|364945053|FG003|Overall Study|Progressive Disease|6|||
105805873|NCT01862328|364945054|FG004|Overall Study|Progressive Disease|7|||
105805874|NCT01862328|364945055|FG005|Overall Study|Progressive Disease|4|||
105805875|NCT01862328|364945056|FG006|Overall Study|Progressive Disease|3|||
105805876|NCT01862328|364945050|FG000|Overall Study|Adverse Event|0|||
105805877|NCT01862328|364945051|FG001|Overall Study|Adverse Event|4|||
105805878|NCT01862328|364945052|FG002|Overall Study|Adverse Event|0|||
105805879|NCT01862328|364945053|FG003|Overall Study|Adverse Event|1|||
105805880|NCT01862328|364945054|FG004|Overall Study|Adverse Event|0|||
105805881|NCT01862328|364945055|FG005|Overall Study|Adverse Event|2|||
105805882|NCT01862328|364945056|FG006|Overall Study|Adverse Event|4|||
105805883|NCT01862328|364945050|FG000|Overall Study|Other|0|||
105805884|NCT01862328|364945051|FG001|Overall Study|Other|2|||
105805885|NCT01862328|364945052|FG002|Overall Study|Other|1|||
105805886|NCT01862328|364945053|FG003|Overall Study|Other|0|||
105805887|NCT01862328|364945054|FG004|Overall Study|Other|4|||
105760243|NCT00367432|364773923|FG001|Second Period (up to 54 Months)|Other Reason|2|||
105760244|NCT00014911|364773924|FG000|Overall Study|Adverse Event|1|||
105760245|NCT00014911|364773924|FG000|Overall Study|Lost to Follow-up|1|||
105760246|NCT00014911|364773924|FG000|Overall Study|Withdrawal by Subject|6|||
105760247|NCT00014911|364773924|FG000|Overall Study|Unknown Reasons|2|||
105760248|NCT00014911|364773924|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
105760249|NCT00676208|364773925|FG000|Overall Study|Lost to Follow-up|0|||
105760250|NCT00676208|364773926|FG001|Overall Study|Lost to Follow-up|2|||
105760251|NCT00676208|364773925|FG000|Overall Study|Incomplete data|2|||
105760252|NCT00676208|364773926|FG001|Overall Study|Incomplete data|4|||
105760253|NCT01270958|364773927|FG000|Overall Study|Lost to Follow-up|2|||
105760254|NCT01270958|364773927|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
105760255|NCT00888615|364773934|FG000|Overall Study|No treatment|2|||
105760256|NCT00628758|364773935|FG000|Overall Study|Adverse Event|2|||
105760257|NCT00628758|364773936|FG001|Overall Study|Adverse Event|3|||
105760258|NCT00628758|364773935|FG000|Overall Study|Withdrawal by Subject|6|||
105760259|NCT00628758|364773936|FG001|Overall Study|Withdrawal by Subject|3|||
105760260|NCT00628758|364773935|FG000|Overall Study|Death|1|||
105760261|NCT00628758|364773936|FG001|Overall Study|Death|0|||
105760262|NCT00628758|364773935|FG000|Overall Study|Protocol Violation|5|||
105760263|NCT00628758|364773936|FG001|Overall Study|Protocol Violation|1|||
105760264|NCT00628758|364773935|FG000|Overall Study|Lost to Follow-up|25|||
105760265|NCT00628758|364773936|FG001|Overall Study|Lost to Follow-up|31|||
105760266|NCT00628758|364773935|FG000|Overall Study|Pregnancy|2|||
105760267|NCT00628758|364773936|FG001|Overall Study|Pregnancy|2|||
105760268|NCT00628758|364773935|FG000|Overall Study|Investigator Moved|3|||
105760269|NCT00628758|364773936|FG001|Overall Study|Investigator Moved|0|||
105760270|NCT00628758|364773935|FG000|Overall Study|Treatment Failure|0|||
105760271|NCT00628758|364773936|FG001|Overall Study|Treatment Failure|2|||
105760272|NCT04179786|364773937|FG000|Overall Study|Withdrawal by Subject|8|||
105760273|NCT01938001|364773938|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
105760274|NCT01938001|364773939|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
105760275|NCT01938001|364773938|FG000|Pre-Treatment|Death|1|||
105760276|NCT01938001|364773939|FG001|Pre-Treatment|Death|0|||
105760277|NCT01938001|364773938|FG000|Treatment|Death|2|||
105760278|NCT01938001|364773939|FG001|Treatment|Death|0|||
105760279|NCT01938001|364773938|FG000|Treatment|Adverse Event|14|||
105760280|NCT01938001|364773939|FG001|Treatment|Adverse Event|8|||
105760281|NCT01938001|364773938|FG000|Treatment|Progressive Disease|21|||
105760282|NCT01938001|364773939|FG001|Treatment|Progressive Disease|54|||
105760283|NCT01938001|364773938|FG000|Treatment|Withdrawal by Subject|13|||
105760284|NCT01938001|364773939|FG001|Treatment|Withdrawal by Subject|7|||
105760285|NCT01938001|364773938|FG000|Treatment|Other reasons|2|||
105760286|NCT01938001|364773939|FG001|Treatment|Other reasons|1|||
105760287|NCT04186663|364773944|FG000|Overall Study|Lost to Follow-up|1|||
105760288|NCT04186663|364773944|FG000|Overall Study|Unable to complete blood draw|3|||
105760289|NCT00719862|364773945|FG000|Overall Study|Adverse Event|1|||
105760290|NCT00719862|364773946|FG001|Overall Study|Adverse Event|2|||
105760291|NCT00719862|364773945|FG000|Overall Study|Lack of Efficacy|3|||
105760292|NCT00719862|364773946|FG001|Overall Study|Lack of Efficacy|0|||
105760293|NCT00719862|364773945|FG000|Overall Study|Non-Compliance|1|||
105760294|NCT00719862|364773946|FG001|Overall Study|Non-Compliance|0|||
105760295|NCT00719862|364773945|FG000|Overall Study|Withdrawal by Subject|1|||
105760296|NCT00719862|364773946|FG001|Overall Study|Withdrawal by Subject|0|||
105760297|NCT00719862|364773945|FG000|Overall Study|Lost to Follow-up|0|||
105760298|NCT00719862|364773946|FG001|Overall Study|Lost to Follow-up|1|||
105484573|NCT00282347|363784356|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
105760299|NCT00719862|364773945|FG000|Overall Study|Other|2|||
105760300|NCT00719862|364773946|FG001|Overall Study|Other|3|||
105760301|NCT01184846|364773947|FG000|Overall Study|Adverse Event|2|||
105760302|NCT01184846|364773947|FG000|Overall Study|Insufficient response|1|||
105760303|NCT02483078|364773948|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
105760304|NCT02483078|364773949|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
105760305|NCT02483078|364773948|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
105760306|NCT02483078|364773949|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
105760307|NCT02483078|364773948|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
105760308|NCT02483078|364773949|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
105760309|NCT02483078|364773948|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
105760310|NCT02483078|364773949|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
105760311|NCT02483078|364773948|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
105760312|NCT02483078|364773949|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
105760313|NCT02483078|364773948|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
105760314|NCT02483078|364773949|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
105760315|NCT02853032|364773950|FG000|Overall Study|Adverse Event|4|||
105484574|NCT00282347|363784355|FG000|B Cell Follow-up Period|Physician Decision|1|||
105760316|NCT02853032|364773951|FG001|Overall Study|Adverse Event|0|||
105760317|NCT02853032|364773950|FG000|Overall Study|Withdrawal by Subject|3|||
105760318|NCT02853032|364773951|FG001|Overall Study|Withdrawal by Subject|1|||
105484575|NCT00282347|363784356|FG001|B Cell Follow-up Period|Physician Decision|0|||
105484576|NCT00282347|363784355|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
105484577|NCT00282347|363784356|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
105484578|NCT00734747|363784360|FG000|SRS Procedure|No staples placed|3|||
105484579|NCT00734747|363784360|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
105484580|NCT03603509|363785465|FG000|Overall Study|Lost to Follow-up|3|||
105484581|NCT03603509|363785466|FG001|Overall Study|Lost to Follow-up|4|||
105484582|NCT01246466|363785469|FG000|Overall Study|Death|1|||
105484583|NCT01246466|363785469|FG000|Overall Study|Withdrawal by Subject|1|||
105484584|NCT01727700|363785472|FG000|Overall Study|Adverse Event|0|||
105484585|NCT01727700|363785473|FG001|Overall Study|Adverse Event|7|||
105484586|NCT01727700|363785474|FG002|Overall Study|Adverse Event|1|||
105484587|NCT01727700|363785472|FG000|Overall Study|Particpant withdrew consent|0|||
105484588|NCT01727700|363785473|FG001|Overall Study|Particpant withdrew consent|3|||
105484589|NCT01727700|363785474|FG002|Overall Study|Particpant withdrew consent|1|||
105484590|NCT01727700|363785472|FG000|Overall Study|Protocol Violation|2|||
105484591|NCT01727700|363785473|FG001|Overall Study|Protocol Violation|0|||
105484592|NCT01727700|363785474|FG002|Overall Study|Protocol Violation|0|||
105484593|NCT01842633|363785477|FG000|Overall Study|Screen Failure|1|||
105484594|NCT01842633|363785478|FG001|Overall Study|Screen Failure|0|||
105484595|NCT01842633|363785479|FG002|Overall Study|Screen Failure|0|||
105484596|NCT01842633|363785477|FG000|Overall Study|Adverse Event|1|||
105484597|NCT01842633|363785478|FG001|Overall Study|Adverse Event|1|||
105484598|NCT01842633|363785479|FG002|Overall Study|Adverse Event|0|||
105484599|NCT01842633|363785477|FG000|Overall Study|Withdrawal by Subject|0|||
105570196|NCT02118337|364086681|FG008|Overall Study|Death|4|||
105570197|NCT04296890|364086692|FG000|Overall Study|Withdrawal by Subject|1|||
105570198|NCT04296890|364086692|FG000|Overall Study|Death|62|||
105760319|NCT02853032|364773950|FG000|Overall Study|Requested to withdraw from all treatment|2|||
105760320|NCT02853032|364773951|FG001|Overall Study|Requested to withdraw from all treatment|2|||
105760321|NCT00719953|364773952|FG000|Overall Study|Adverse Event|4|||
105760322|NCT01410799|364773953|FG000|Overall Study|PI decision|13|||
105760323|NCT03682055|364776029|FG000|Overall Study|Lack of Efficacy|1|||
105760324|NCT03682055|364776030|FG001|Overall Study|Lack of Efficacy|2|||
105760325|NCT03682055|364776031|FG002|Overall Study|Lack of Efficacy|1|||
105760326|NCT03682055|364776032|FG003|Overall Study|Lack of Efficacy|2|||
105760327|NCT03682055|364776033|FG004|Overall Study|Lack of Efficacy|1|||
105760328|NCT03682055|364776034|FG005|Overall Study|Lack of Efficacy|3|||
105760329|NCT03682055|364776029|FG000|Overall Study|Withdrawal by Subject|0|||
105760330|NCT03682055|364776030|FG001|Overall Study|Withdrawal by Subject|0|||
105760331|NCT03682055|364776031|FG002|Overall Study|Withdrawal by Subject|0|||
105760332|NCT03682055|364776032|FG003|Overall Study|Withdrawal by Subject|0|||
105760333|NCT03682055|364776033|FG004|Overall Study|Withdrawal by Subject|0|||
105760334|NCT03682055|364776034|FG005|Overall Study|Withdrawal by Subject|1|||
105760335|NCT03682055|364776029|FG000|Overall Study|Termination of Study by Sponsor|0|||
105760336|NCT03682055|364776030|FG001|Overall Study|Termination of Study by Sponsor|0|||
105760337|NCT03682055|364776031|FG002|Overall Study|Termination of Study by Sponsor|0|||
105760338|NCT03682055|364776032|FG003|Overall Study|Termination of Study by Sponsor|0|||
105760339|NCT03682055|364776033|FG004|Overall Study|Termination of Study by Sponsor|0|||
105760340|NCT03682055|364776034|FG005|Overall Study|Termination of Study by Sponsor|3|||
105760341|NCT03127852|364776036|FG000|Overall Study|Withdrawal by Subject|4|||
105760342|NCT03127852|364776037|FG001|Overall Study|Withdrawal by Subject|1|||
105760343|NCT03127852|364776036|FG000|Overall Study|Death|1|||
105760344|NCT03127852|364776037|FG001|Overall Study|Death|1|||
105760345|NCT00859573|364776038|FG000|Overall Study|Withdrawal by Subject|4|||
105760346|NCT00859573|364776039|FG001|Overall Study|Withdrawal by Subject|1|||
105760347|NCT00859573|364776038|FG000|Overall Study|Physician Decision|1|||
105760348|NCT00859573|364776039|FG001|Overall Study|Physician Decision|1|||
105760349|NCT03621189|364776040|FG000|Overall Study|Withdrawal by Subject|0|||
105760350|NCT03621189|364776041|FG001|Overall Study|Withdrawal by Subject|3|||
105760351|NCT03621189|364776040|FG000|Overall Study|Physician Decision|0|||
105760352|NCT03621189|364776041|FG001|Overall Study|Physician Decision|2|||
105760353|NCT02574481|364776042|FG000|Overall Study|Withdrawal by Subject|29|||
105760354|NCT02574481|364776043|FG001|Overall Study|Withdrawal by Subject|15|||
105760355|NCT02574481|364776044|FG002|Overall Study|Withdrawal by Subject|4|||
105760356|NCT02574481|364776045|FG003|Overall Study|Withdrawal by Subject|1|||
105760357|NCT02574481|364776042|FG000|Overall Study|Adverse Event|5|||
105760358|NCT02574481|364776043|FG001|Overall Study|Adverse Event|1|||
105760359|NCT02574481|364776044|FG002|Overall Study|Adverse Event|1|||
105760360|NCT02574481|364776045|FG003|Overall Study|Adverse Event|0|||
105484600|NCT01842633|363785478|FG001|Overall Study|Withdrawal by Subject|1|||
105484601|NCT01842633|363785479|FG002|Overall Study|Withdrawal by Subject|0|||
105484602|NCT01842633|363785477|FG000|Overall Study|Technical issues|1|||
105484603|NCT01842633|363785478|FG001|Overall Study|Technical issues|0|||
105484604|NCT01842633|363785479|FG002|Overall Study|Technical issues|0|||
105484605|NCT00603590|363785480|FG000|Overall Study|Did not attend study clinic|39|||
105484606|NCT00603590|363785481|FG001|Overall Study|Did not attend study clinic|30|||
105805888|NCT01862328|364945055|FG005|Overall Study|Other|0|||
105805889|NCT01862328|364945056|FG006|Overall Study|Other|1|||
105805890|NCT01862328|364945050|FG000|Overall Study|Withdrawal by Subject|1|||
105805891|NCT01862328|364945051|FG001|Overall Study|Withdrawal by Subject|1|||
105805892|NCT01862328|364945052|FG002|Overall Study|Withdrawal by Subject|0|||
105805893|NCT01862328|364945053|FG003|Overall Study|Withdrawal by Subject|0|||
105805894|NCT01862328|364945054|FG004|Overall Study|Withdrawal by Subject|1|||
105805895|NCT01862328|364945055|FG005|Overall Study|Withdrawal by Subject|1|||
105805896|NCT01862328|364945056|FG006|Overall Study|Withdrawal by Subject|1|||
105805897|NCT01862328|364945050|FG000|Overall Study|Symptomatic Deterioration|0|||
105805898|NCT01862328|364945051|FG001|Overall Study|Symptomatic Deterioration|0|||
105805899|NCT01862328|364945052|FG002|Overall Study|Symptomatic Deterioration|0|||
105805900|NCT01862328|364945053|FG003|Overall Study|Symptomatic Deterioration|0|||
105805901|NCT01862328|364945054|FG004|Overall Study|Symptomatic Deterioration|0|||
105805902|NCT01862328|364945055|FG005|Overall Study|Symptomatic Deterioration|0|||
105805903|NCT01862328|364945056|FG006|Overall Study|Symptomatic Deterioration|1|||
105805904|NCT00686036|364945065|FG000|Overall Study|Adverse Event|3|||
105805905|NCT00686036|364945066|FG001|Overall Study|Adverse Event|0|||
105805906|NCT00686036|364945065|FG000|Overall Study|Withdrawal by Subject|3|||
105805907|NCT00686036|364945066|FG001|Overall Study|Withdrawal by Subject|1|||
105805908|NCT00686036|364945065|FG000|Overall Study|Study terminated by AstraZeneca|2|||
105805909|NCT00686036|364945066|FG001|Overall Study|Study terminated by AstraZeneca|1|||
105805910|NCT00686036|364945065|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
105805911|NCT00686036|364945066|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
105805912|NCT00686036|364945065|FG000|Overall Study|Other reasons not identified|0|||
105805913|NCT00686036|364945066|FG001|Overall Study|Other reasons not identified|4|||
105805914|NCT00467584|364945067|FG000|Overall Study|Withdrawal by Subject|4|||
105805915|NCT00467584|364945068|FG001|Overall Study|Withdrawal by Subject|5|||
105805916|NCT00467584|364945069|FG002|Overall Study|Withdrawal by Subject|1|||
105805917|NCT02292238|364945072|FG000|Overall Study|Protocol Violation|1|||
105805918|NCT02292238|364945073|FG001|Overall Study|Protocol Violation|2|||
105805919|NCT02292238|364945072|FG000|Overall Study|Withdrawal by Subject|2|||
105805920|NCT02292238|364945073|FG001|Overall Study|Withdrawal by Subject|1|||
105805921|NCT02292238|364945072|FG000|Overall Study|Lost to Follow-up|1|||
105805922|NCT02292238|364945073|FG001|Overall Study|Lost to Follow-up|0|||
105805923|NCT02292238|364945072|FG000|Overall Study|Physician Decision|0|||
105805924|NCT02292238|364945073|FG001|Overall Study|Physician Decision|1|||
105805925|NCT02666430|364945074|FG000|Period 1|Lost to Follow-up|1|||
105805926|NCT02666430|364945075|FG001|Period 1|Lost to Follow-up|0|||
105805927|NCT02666430|364945074|FG000|Period 1|Adverse Event|0|||
105805928|NCT02666430|364945075|FG001|Period 1|Adverse Event|1|||
105805929|NCT02666430|364945074|FG000|Period 2|Withdrawal by Subject|1|||
105805930|NCT02666430|364945075|FG001|Period 2|Withdrawal by Subject|4|||
105805931|NCT02666430|364945074|FG000|Period 3|Lost to Follow-up|1|||
105805932|NCT02666430|364945075|FG001|Period 3|Lost to Follow-up|0|||
105805933|NCT01960816|364945078|FG000|Overall Study|Lost to Follow-up|1|||
105805934|NCT01118728|364945082|FG000|Overall Study|Adverse Event|17|||
105805935|NCT01118728|364945082|FG000|Overall Study|Lack of Efficacy|27|||
105805936|NCT01118728|364945082|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
105805937|NCT01118728|364945082|FG000|Overall Study|Withdrawal by Subject|3|||
105805938|NCT01118728|364945082|FG000|Overall Study|Lost to Follow-up|4|||
105805939|NCT04345471|364945083|FG000|Overall Study|Adverse Event|8|||
105805940|NCT04345471|364945084|FG001|Overall Study|Adverse Event|5|||
105805941|NCT04345471|364945085|FG002|Overall Study|Adverse Event|6|||
105805942|NCT04345471|364945083|FG000|Overall Study|Lack of Efficacy|1|||
105805943|NCT04345471|364945084|FG001|Overall Study|Lack of Efficacy|1|||
105805944|NCT04345471|364945085|FG002|Overall Study|Lack of Efficacy|0|||
105805945|NCT04345471|364945083|FG000|Overall Study|Protocol Violation|0|||
105805946|NCT04345471|364945084|FG001|Overall Study|Protocol Violation|1|||
105805947|NCT04345471|364945085|FG002|Overall Study|Protocol Violation|2|||
105805948|NCT04345471|364945083|FG000|Overall Study|Withdrawal by Subject|10|||
105805949|NCT04345471|364945084|FG001|Overall Study|Withdrawal by Subject|5|||
105484607|NCT00603590|363785480|FG000|Overall Study|Refused blood test|5|||
105484608|NCT00603590|363785481|FG001|Overall Study|Refused blood test|1|||
105805950|NCT04345471|364945085|FG002|Overall Study|Withdrawal by Subject|10|||
105805951|NCT03896490|364945122|FG000|Overall Study|Withdrawal by Subject|1|||
105805952|NCT03896490|364945123|FG001|Overall Study|Withdrawal by Subject|1|||
105805953|NCT00433381|364946861|FG000|Overall Study|Ineligible / no protocol treatment|3|||
105805954|NCT00433381|364946862|FG001|Overall Study|Ineligible / no protocol treatment|3|||
105805955|NCT02806232|364946865|FG000|Overall Study|Lost to Follow-up|1|||
105805956|NCT02806232|364946866|FG001|Overall Study|Lost to Follow-up|2|||
105805957|NCT02806232|364946867|FG002|Overall Study|Lost to Follow-up|1|||
105805958|NCT02806232|364946868|FG003|Overall Study|Lost to Follow-up|0|||
105805959|NCT02806232|364946869|FG004|Overall Study|Lost to Follow-up|0|||
105805960|NCT02806232|364946870|FG005|Overall Study|Lost to Follow-up|1|||
105805961|NCT02806232|364946871|FG006|Overall Study|Lost to Follow-up|0|||
105484609|NCT00603590|363785480|FG000|Overall Study|Patient discontinued study drug|22|||
105484610|NCT00603590|363785481|FG001|Overall Study|Patient discontinued study drug|15|||
105484611|NCT00603590|363785480|FG000|Overall Study|Adverse Event|2|||
105484612|NCT00603590|363785481|FG001|Overall Study|Adverse Event|0|||
105484613|NCT00603590|363785480|FG000|Overall Study|Lost to Follow-up|8|||
105484614|NCT00603590|363785481|FG001|Overall Study|Lost to Follow-up|4|||
105484615|NCT00603590|363785480|FG000|Overall Study|Cardiovascular event|0|||
105484616|NCT00603590|363785481|FG001|Overall Study|Cardiovascular event|1|||
105484617|NCT03699475|363785484|FG000|Overall Study|Death|1|||
105484618|NCT00137839|363785485|FG000|Overall Study|Adverse Event|7|||
105484619|NCT00137839|363785485|FG000|Overall Study|Physician Decision|7|||
105484620|NCT00137839|363785485|FG000|Overall Study|Death|8|||
105484621|NCT00137839|363785485|FG000|Overall Study|Disease Progression|60|||
105484622|NCT00137839|363785485|FG000|Overall Study|Not Start Treatment|1|||
105484623|NCT00137839|363785485|FG000|Overall Study|Prolonged Treatment Delay|1|||
105484624|NCT01099709|363785486|FG000|Period 1|Withdrawal by Subject|0|||
105484625|NCT01099709|363785487|FG001|Period 1|Withdrawal by Subject|1|||
105484626|NCT01099709|363785486|FG000|Period 1|Positive cotinine test|0|||
105484627|NCT01099709|363785487|FG001|Period 1|Positive cotinine test|1|||
105484628|NCT01099709|363785486|FG000|Period 1|Adverse Event|1|||
105484629|NCT01099709|363785487|FG001|Period 1|Adverse Event|0|||
105484630|NCT02882152|363785488|FG000|Overall Study|Lost to Follow-up|1|||
105484631|NCT02882152|363785489|FG001|Overall Study|Lost to Follow-up|0|||
105484632|NCT02616601|363785490|FG000|Overall Study|Withdrawal by Subject|4|||
105484633|NCT02616601|363785491|FG001|Overall Study|Withdrawal by Subject|4|||
105484634|NCT02616601|363785492|FG002|Overall Study|Withdrawal by Subject|3|||
105484635|NCT02616601|363785490|FG000|Overall Study|Adverse Event|2|||
105484636|NCT02616601|363785491|FG001|Overall Study|Adverse Event|0|||
105484637|NCT02616601|363785492|FG002|Overall Study|Adverse Event|2|||
105484638|NCT02616601|363785490|FG000|Overall Study|Death|1|||
105484639|NCT02616601|363785491|FG001|Overall Study|Death|0|||
105484640|NCT02616601|363785492|FG002|Overall Study|Death|0|||
105484641|NCT02616601|363785490|FG000|Overall Study|Lost to Follow-up|1|||
105484642|NCT02616601|363785491|FG001|Overall Study|Lost to Follow-up|0|||
105484643|NCT02616601|363785492|FG002|Overall Study|Lost to Follow-up|1|||
105484644|NCT02616601|363785490|FG000|Overall Study|Non-Compliance with Test Article|1|||
105760361|NCT02574481|364776042|FG000|Overall Study|Visit Missed|15|||
105760362|NCT02574481|364776043|FG001|Overall Study|Visit Missed|7|||
105760363|NCT02574481|364776044|FG002|Overall Study|Visit Missed|5|||
105760364|NCT02574481|364776045|FG003|Overall Study|Visit Missed|0|||
105760365|NCT02574481|364776042|FG000|Overall Study|Other|7|||
105760366|NCT02574481|364776043|FG001|Overall Study|Other|2|||
105760367|NCT02574481|364776044|FG002|Overall Study|Other|0|||
105760368|NCT02574481|364776045|FG003|Overall Study|Other|0|||
105760369|NCT02574481|364776042|FG000|Overall Study|Death|48|||
105760370|NCT02574481|364776043|FG001|Overall Study|Death|26|||
105760371|NCT02574481|364776044|FG002|Overall Study|Death|12|||
105760372|NCT02574481|364776045|FG003|Overall Study|Death|4|||
105760373|NCT02574481|364776042|FG000|Overall Study|Physician Decision|5|||
105760374|NCT02574481|364776043|FG001|Overall Study|Physician Decision|2|||
105760375|NCT02574481|364776044|FG002|Overall Study|Physician Decision|0|||
105760376|NCT02574481|364776045|FG003|Overall Study|Physician Decision|0|||
105760377|NCT02574481|364776042|FG000|Overall Study|Lost to Follow-up|5|||
105760378|NCT02574481|364776043|FG001|Overall Study|Lost to Follow-up|1|||
105760379|NCT02574481|364776044|FG002|Overall Study|Lost to Follow-up|3|||
105760380|NCT02574481|364776045|FG003|Overall Study|Lost to Follow-up|0|||
105760381|NCT02959970|364776048|FG000|Overall Study|Adverse Event|1|||
105760382|NCT02959970|364776049|FG001|Overall Study|Adverse Event|0|||
105760383|NCT02959970|364776048|FG000|Overall Study|Withdrawal by Subject|0|||
105760384|NCT02959970|364776049|FG001|Overall Study|Withdrawal by Subject|2|||
105760385|NCT02959970|364776048|FG000|Overall Study|Lost to Follow-up|1|||
105760386|NCT02959970|364776049|FG001|Overall Study|Lost to Follow-up|5|||
105760387|NCT00948428|364776052|FG000|Overall Study|Withdrawal by Subject|6|||
105760388|NCT00948428|364776053|FG001|Overall Study|Withdrawal by Subject|12|||
105760389|NCT00948428|364776054|FG002|Overall Study|Withdrawal by Subject|7|||
105760390|NCT00948428|364776052|FG000|Overall Study|Adverse Event|6|||
105760391|NCT00948428|364776053|FG001|Overall Study|Adverse Event|3|||
105760392|NCT00948428|364776054|FG002|Overall Study|Adverse Event|0|||
105760393|NCT00948428|364776052|FG000|Overall Study|Lost to Follow-up|2|||
105805962|NCT02806232|364946872|FG007|Overall Study|Lost to Follow-up|0|||
105484645|NCT02616601|363785491|FG001|Overall Study|Non-Compliance with Test Article|0|||
105484646|NCT02616601|363785492|FG002|Overall Study|Non-Compliance with Test Article|1|||
105484647|NCT01397825|363785502|FG000|Overall Study|Progressive Disease|10|||
105484648|NCT01397825|363785503|FG001|Overall Study|Progressive Disease|3|||
105484649|NCT01397825|363785504|FG002|Overall Study|Progressive Disease|11|||
105484650|NCT01397825|363785505|FG003|Overall Study|Progressive Disease|1|||
105484651|NCT01397825|363785506|FG004|Overall Study|Progressive Disease|0|||
105484652|NCT01397825|363785502|FG000|Overall Study|Symptomatic Deterioration|2|||
105760394|NCT00948428|364776053|FG001|Overall Study|Lost to Follow-up|1|||
105760395|NCT00948428|364776054|FG002|Overall Study|Lost to Follow-up|1|||
105805963|NCT02806232|364946873|FG008|Overall Study|Lost to Follow-up|0|||
105805964|NCT02806232|364946865|FG000|Overall Study|Withdrawal by Subject|0|||
105805965|NCT02806232|364946866|FG001|Overall Study|Withdrawal by Subject|2|||
105805966|NCT02806232|364946867|FG002|Overall Study|Withdrawal by Subject|0|||
105805967|NCT02806232|364946868|FG003|Overall Study|Withdrawal by Subject|0|||
105805968|NCT02806232|364946869|FG004|Overall Study|Withdrawal by Subject|2|||
105805969|NCT02806232|364946870|FG005|Overall Study|Withdrawal by Subject|1|||
105805970|NCT02806232|364946871|FG006|Overall Study|Withdrawal by Subject|0|||
105805971|NCT02806232|364946872|FG007|Overall Study|Withdrawal by Subject|0|||
105805972|NCT02806232|364946873|FG008|Overall Study|Withdrawal by Subject|0|||
105805973|NCT00598559|364946874|FG000|Overall Study|Adverse Event|11|||
105805974|NCT00598559|364946875|FG001|Overall Study|Adverse Event|7|||
105805975|NCT00598559|364946876|FG002|Overall Study|Adverse Event|0|||
105805976|NCT00598559|364946874|FG000|Overall Study|Withdrawal by Subject|2|||
105805977|NCT00598559|364946875|FG001|Overall Study|Withdrawal by Subject|2|||
105805978|NCT00598559|364946876|FG002|Overall Study|Withdrawal by Subject|0|||
105805979|NCT00598559|364946874|FG000|Overall Study|Protocol Non-compliance|1|||
105805980|NCT00598559|364946875|FG001|Overall Study|Protocol Non-compliance|0|||
105805981|NCT00598559|364946876|FG002|Overall Study|Protocol Non-compliance|0|||
105805982|NCT00598559|364946874|FG000|Overall Study|Early discharge from hospital|9|||
105805983|NCT00598559|364946875|FG001|Overall Study|Early discharge from hospital|12|||
105805984|NCT00598559|364946876|FG002|Overall Study|Early discharge from hospital|3|||
105805985|NCT00598559|364946874|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
105805986|NCT00598559|364946875|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
105805987|NCT00598559|364946876|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
105805988|NCT01133821|364946877|FG000|Overall Study|Lost to Follow-up|8|||
105805989|NCT01133821|364946878|FG001|Overall Study|Lost to Follow-up|11|||
105805990|NCT01133821|364946877|FG000|Overall Study|Withdrawal by Subject|8|||
105805991|NCT01133821|364946878|FG001|Overall Study|Withdrawal by Subject|3|||
105805992|NCT01133821|364946877|FG000|Overall Study|preferred other treatment|1|||
105805993|NCT01133821|364946878|FG001|Overall Study|preferred other treatment|1|||
105805994|NCT01133821|364946877|FG000|Overall Study|Protocol Violation|0|||
105805995|NCT01133821|364946878|FG001|Overall Study|Protocol Violation|1|||
105805996|NCT01133821|364946877|FG000|Overall Study|Refused participation|1|||
105805997|NCT01133821|364946878|FG001|Overall Study|Refused participation|3|||
105805998|NCT00608205|364946879|FG000|Overall Study|Adverse Event|3|||
105805999|NCT00608205|364946880|FG001|Overall Study|Adverse Event|2|||
105806000|NCT00608205|364946879|FG000|Overall Study|Patient non-compliant|0|||
105806001|NCT00608205|364946880|FG001|Overall Study|Patient non-compliant|1|||
105806002|NCT01799590|364946883|FG000|Overall Study|Adverse Event|13|||
105806003|NCT01799590|364946884|FG001|Overall Study|Adverse Event|7|||
105806004|NCT01799590|364946885|FG002|Overall Study|Adverse Event|5|||
105806005|NCT01799590|364946883|FG000|Overall Study|Pregnancy|2|||
105806006|NCT01799590|364946884|FG001|Overall Study|Pregnancy|0|||
105806007|NCT01799590|364946885|FG002|Overall Study|Pregnancy|0|||
105806008|NCT01799590|364946883|FG000|Overall Study|Lack of Efficacy|3|||
105806009|NCT01799590|364946884|FG001|Overall Study|Lack of Efficacy|1|||
105806010|NCT01799590|364946885|FG002|Overall Study|Lack of Efficacy|3|||
105806011|NCT01799590|364946883|FG000|Overall Study|Participants convenience|4|||
105806012|NCT01799590|364946884|FG001|Overall Study|Participants convenience|4|||
105806013|NCT01799590|364946885|FG002|Overall Study|Participants convenience|2|||
105806014|NCT01799590|364946883|FG000|Overall Study|Aggravation of complications|0|||
105806015|NCT01799590|364946884|FG001|Overall Study|Aggravation of complications|1|||
105806016|NCT01799590|364946885|FG002|Overall Study|Aggravation of complications|1|||
105806017|NCT01799590|364946883|FG000|Overall Study|Using drugs with restricted days of use|0|||
105806018|NCT01799590|364946884|FG001|Overall Study|Using drugs with restricted days of use|3|||
105806019|NCT01799590|364946885|FG002|Overall Study|Using drugs with restricted days of use|2|||
105806020|NCT01799590|364946883|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
105806021|NCT01799590|364946884|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
105806022|NCT01799590|364946885|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
105806023|NCT01799590|364946883|FG000|Overall Study|Other|3|||
105806024|NCT01799590|364946884|FG001|Overall Study|Other|0|||
105806025|NCT01799590|364946885|FG002|Overall Study|Other|1|||
105806026|NCT00891774|364946886|FG000|Overall Study|Lost to Follow-up|5|||
105806027|NCT00891774|364946886|FG000|Overall Study|Illness (Self/Mother)|3|||
105360765|NCT00572455|363328088|FG008|Stage I (14 Days)|Adverse Event|0|||
105360766|NCT00572455|363328089|FG009|Stage I (14 Days)|Adverse Event|0|||
105806028|NCT00891774|364946886|FG000|Overall Study|Withdrawal by Subject|2|||
105806029|NCT00891774|364946886|FG000|Overall Study|Protocol Violation|4|||
105806030|NCT03175120|364946888|FG000|Overall Study|Adverse Event|2|||
105806031|NCT03175120|364946889|FG001|Overall Study|Adverse Event|2|||
105806032|NCT03175120|364946888|FG000|Overall Study|Protocol Violation|5|||
105806033|NCT03175120|364946889|FG001|Overall Study|Protocol Violation|2|||
105806034|NCT03175120|364946888|FG000|Overall Study|Lost to Follow-up|1|||
105806035|NCT03175120|364946889|FG001|Overall Study|Lost to Follow-up|0|||
105806036|NCT03175120|364946888|FG000|Overall Study|Withdrawal by Subject|2|||
105806037|NCT03175120|364946889|FG001|Overall Study|Withdrawal by Subject|5|||
105484653|NCT01397825|363785503|FG001|Overall Study|Symptomatic Deterioration|0|||
105484654|NCT01397825|363785504|FG002|Overall Study|Symptomatic Deterioration|4|||
105484655|NCT01397825|363785505|FG003|Overall Study|Symptomatic Deterioration|0|||
105484656|NCT01397825|363785506|FG004|Overall Study|Symptomatic Deterioration|0|||
105484657|NCT01397825|363785502|FG000|Overall Study|Adverse Event|0|||
105484658|NCT01397825|363785503|FG001|Overall Study|Adverse Event|1|||
105484659|NCT01397825|363785504|FG002|Overall Study|Adverse Event|5|||
105484660|NCT01397825|363785505|FG003|Overall Study|Adverse Event|1|||
105484661|NCT01397825|363785506|FG004|Overall Study|Adverse Event|0|||
105484662|NCT01397825|363785502|FG000|Overall Study|Withdrawal by Subject|1|||
105484663|NCT01397825|363785503|FG001|Overall Study|Withdrawal by Subject|0|||
105484664|NCT01397825|363785504|FG002|Overall Study|Withdrawal by Subject|5|||
105484665|NCT01397825|363785505|FG003|Overall Study|Withdrawal by Subject|1|||
105484666|NCT01397825|363785506|FG004|Overall Study|Withdrawal by Subject|0|||
105484667|NCT01653132|363785513|FG000|First Intervention|Protocol Violation|1|||
105484668|NCT01653132|363785514|FG001|First Intervention|Protocol Violation|0|||
105484669|NCT03828370|363785515|FG000|3 Month Follow-up|Lost to Follow-up|4|||
105484670|NCT03828370|363785516|FG001|3 Month Follow-up|Lost to Follow-up|12|||
105806038|NCT03175120|364946888|FG000|Overall Study|Other|2|||
105806039|NCT03175120|364946889|FG001|Overall Study|Other|3|||
105806040|NCT01958281|364946890|FG000|Overall Study|Lack of Efficacy|5|||
105806041|NCT01958281|364946891|FG001|Overall Study|Lack of Efficacy|2|||
105806042|NCT01958281|364946892|FG002|Overall Study|Lack of Efficacy|0|||
105806043|NCT01958281|364946890|FG000|Overall Study|Adverse Event|0|||
105806044|NCT01958281|364946891|FG001|Overall Study|Adverse Event|2|||
105806045|NCT01958281|364946892|FG002|Overall Study|Adverse Event|0|||
105806046|NCT01958281|364946890|FG000|Overall Study|Withdrew Consent|1|||
105806047|NCT01958281|364946891|FG001|Overall Study|Withdrew Consent|0|||
105806048|NCT01958281|364946892|FG002|Overall Study|Withdrew Consent|0|||
105806049|NCT02784106|364946895|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
105806050|NCT02784106|364946896|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
105806051|NCT02784106|364946897|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
105806052|NCT02784106|364946898|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
105806053|NCT02784106|364946895|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
105806054|NCT02784106|364946896|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
105806055|NCT02784106|364946897|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
105806056|NCT02784106|364946898|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
105806057|NCT02784106|364946895|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
105806058|NCT02784106|364946896|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
105806059|NCT02784106|364946897|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
105806060|NCT02784106|364946898|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
105806061|NCT02784106|364946895|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
105806062|NCT02784106|364946896|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
105806063|NCT02784106|364946897|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
105806064|NCT02784106|364946898|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
105806065|NCT02784106|364946895|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
105806066|NCT02784106|364946896|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
105806067|NCT02784106|364946897|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
105806068|NCT02784106|364946898|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
105806069|NCT02784106|364946895|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
105806070|NCT02784106|364946896|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
105484671|NCT03828370|363785515|FG000|9 Month Follow up|Lost to Follow-up|12|||
105484672|NCT03828370|363785516|FG001|9 Month Follow up|Lost to Follow-up|20|||
105806071|NCT02784106|364946897|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
105806072|NCT02784106|364946898|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
105806073|NCT03341507|364946900|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
105806074|NCT01338636|364946902|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
105806075|NCT03532009|364946903|FG000|Overall Study|Other|1|||
105806076|NCT03532009|364946904|FG001|Overall Study|Other|1|||
105806077|NCT03532009|364946903|FG000|Overall Study|Death|1|||
105806078|NCT03532009|364946904|FG001|Overall Study|Death|1|||
105484673|NCT01029405|363785517|FG000|Overall Study|Withdrawal by Subject|0|||
105484674|NCT01029405|363785518|FG001|Overall Study|Withdrawal by Subject|1|||
105806079|NCT03532009|364946903|FG000|Overall Study|Withdrawal by Patient|0|||
105806080|NCT03532009|364946904|FG001|Overall Study|Withdrawal by Patient|2|||
105806081|NCT02035137|364946905|FG000|Overall Study|Physician Decision|0|||
105484675|NCT01029405|363785519|FG002|Overall Study|Withdrawal by Subject|2|||
105484676|NCT01029405|363785520|FG003|Overall Study|Withdrawal by Subject|0|||
105484677|NCT01029405|363785517|FG000|Overall Study|Protocol Violation|0|||
105484678|NCT01029405|363785518|FG001|Overall Study|Protocol Violation|0|||
105484679|NCT01029405|363785519|FG002|Overall Study|Protocol Violation|0|||
105484680|NCT01029405|363785520|FG003|Overall Study|Protocol Violation|1|||
105484681|NCT01029405|363785517|FG000|Overall Study|Adverse Event|0|||
105806082|NCT02035137|364946906|FG001|Overall Study|Physician Decision|0|||
105806083|NCT02035137|364946907|FG002|Overall Study|Physician Decision|1|||
105806084|NCT02035137|364946905|FG000|Overall Study|Withdrawal by Subject|0|||
105806085|NCT02035137|364946906|FG001|Overall Study|Withdrawal by Subject|1|||
105806086|NCT02035137|364946907|FG002|Overall Study|Withdrawal by Subject|2|||
105806087|NCT02035137|364946905|FG000|Overall Study|Ineligible|0|||
105806088|NCT02035137|364946906|FG001|Overall Study|Ineligible|1|||
105806089|NCT02035137|364946907|FG002|Overall Study|Ineligible|2|||
105806090|NCT02035137|364946905|FG000|Overall Study|Disease progression prior to treatment start|2|||
105806091|NCT02035137|364946906|FG001|Overall Study|Disease progression prior to treatment start|0|||
105806092|NCT02035137|364946907|FG002|Overall Study|Disease progression prior to treatment start|0|||
105806093|NCT02022007|364946908|FG000|Overall Study|Withdrawal by Subject|1|||
105806094|NCT02022007|364946909|FG001|Overall Study|Withdrawal by Subject|1|||
105806095|NCT02022007|364946910|FG002|Overall Study|Withdrawal by Subject|1|||
105806096|NCT02022007|364946908|FG000|Overall Study|Noncompliant|0|||
105806097|NCT02022007|364946909|FG001|Overall Study|Noncompliant|0|||
105806098|NCT02022007|364946910|FG002|Overall Study|Noncompliant|1|||
105806099|NCT02444533|364946917|FG000|Overall Study|Not able to complete forms|0|||
105806100|NCT02444533|364946918|FG001|Overall Study|Not able to complete forms|2|||
105806101|NCT02444533|364946917|FG000|Overall Study|Only gave post-procedure complications|2|||
105806102|NCT02444533|364946918|FG001|Overall Study|Only gave post-procedure complications|2|||
105806103|NCT03567057|364946920|FG000|Overall Study|Adverse Event|56|||
105806104|NCT03567057|364946921|FG001|Overall Study|Adverse Event|53|||
105806105|NCT03567057|364946922|FG002|Overall Study|Adverse Event|28|||
105806106|NCT03567057|364946920|FG000|Overall Study|Withdrawal by Subject|22|||
105806107|NCT03567057|364946921|FG001|Overall Study|Withdrawal by Subject|24|||
105806108|NCT03567057|364946922|FG002|Overall Study|Withdrawal by Subject|13|||
105806109|NCT03567057|364946920|FG000|Overall Study|Lost to Follow-up|3|||
105806110|NCT03567057|364946921|FG001|Overall Study|Lost to Follow-up|5|||
105806111|NCT03567057|364946922|FG002|Overall Study|Lost to Follow-up|2|||
105806112|NCT03567057|364946920|FG000|Overall Study|COVID-19 pandemic|4|||
105806113|NCT03567057|364946921|FG001|Overall Study|COVID-19 pandemic|3|||
105806114|NCT03567057|364946922|FG002|Overall Study|COVID-19 pandemic|0|||
105806115|NCT03567057|364946920|FG000|Overall Study|Non-compliance with study drug|4|||
105806116|NCT03567057|364946921|FG001|Overall Study|Non-compliance with study drug|2|||
105806117|NCT03567057|364946922|FG002|Overall Study|Non-compliance with study drug|0|||
105806118|NCT03567057|364946920|FG000|Overall Study|Lack of Efficacy|3|||
105806119|NCT03567057|364946921|FG001|Overall Study|Lack of Efficacy|0|||
105806120|NCT03567057|364946922|FG002|Overall Study|Lack of Efficacy|1|||
105806121|NCT03567057|364946920|FG000|Overall Study|Death|1|||
105806122|NCT03567057|364946921|FG001|Overall Study|Death|0|||
105806123|NCT03567057|364946922|FG002|Overall Study|Death|0|||
105806124|NCT03567057|364946920|FG000|Overall Study|Physician Decision|1|||
105806125|NCT03567057|364946921|FG001|Overall Study|Physician Decision|0|||
105806126|NCT03567057|364946922|FG002|Overall Study|Physician Decision|0|||
105360767|NCT00572455|363328090|FG010|Stage I (14 Days)|Adverse Event|0|||
105360768|NCT00572455|363328091|FG011|Stage I (14 Days)|Adverse Event|0|||
105360769|NCT00572455|363328092|FG012|Stage I (14 Days)|Adverse Event|0|||
105806127|NCT03567057|364946920|FG000|Overall Study|Unstable medical condition|1|||
105806128|NCT03567057|364946921|FG001|Overall Study|Unstable medical condition|0|||
105806129|NCT03567057|364946922|FG002|Overall Study|Unstable medical condition|0|||
105806130|NCT03567057|364946920|FG000|Overall Study|Medical history event|0|||
105806131|NCT03567057|364946921|FG001|Overall Study|Medical history event|0|||
105806132|NCT03567057|364946922|FG002|Overall Study|Medical history event|1|||
105806133|NCT03567057|364946920|FG000|Overall Study|Other|0|||
105806134|NCT03567057|364946921|FG001|Overall Study|Other|0|||
105806135|NCT03567057|364946922|FG002|Overall Study|Other|1|||
105806136|NCT01006707|364946923|FG000|Study Session 1|Lost to Follow-up|2|||
105806137|NCT01006707|364946924|FG001|Study Session 1|Lost to Follow-up|0|||
105806138|NCT01006707|364946925|FG002|Study Session 1|Lost to Follow-up|0|||
105806139|NCT01006707|364946923|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
105806140|NCT01006707|364946924|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
105806141|NCT01006707|364946925|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
105806142|NCT00952484|364946926|FG000|Overall Study|Withdrawal by Subject|0|||
105806143|NCT00952484|364946927|FG001|Overall Study|Withdrawal by Subject|1|||
105806144|NCT00952484|364946928|FG002|Overall Study|Withdrawal by Subject|0|||
105806145|NCT00886483|364946930|FG000|Overall Study|Lost to Follow-up|0|||
105806146|NCT00886483|364946931|FG001|Overall Study|Lost to Follow-up|1|||
105806147|NCT00886483|364946930|FG000|Overall Study|Pursue medications|1|||
105360770|NCT00572455|363328093|FG013|Stage I (14 Days)|Adverse Event|0|||
105806148|NCT00886483|364946931|FG001|Overall Study|Pursue medications|2|||
105806149|NCT00886483|364946930|FG000|Overall Study|Distance to center, poor grades|1|||
105806150|NCT00886483|364946931|FG001|Overall Study|Distance to center, poor grades|0|||
105806151|NCT03465891|364946934|FG000|Overall Study|Withdrawal by Subject|0|||
105360771|NCT00572455|363328080|FG000|Stage I (14 Days)|Other|0|||
105806152|NCT03465891|364946935|FG001|Overall Study|Withdrawal by Subject|1|||
105806153|NCT03465891|364946934|FG000|Overall Study|Disease progression|1|||
105806154|NCT03465891|364946935|FG001|Overall Study|Disease progression|0|||
105760396|NCT00948428|364776052|FG000|Overall Study|Death|2|||
105760397|NCT00948428|364776053|FG001|Overall Study|Death|0|||
105760398|NCT00948428|364776054|FG002|Overall Study|Death|0|||
105760399|NCT00948428|364776052|FG000|Overall Study|Intercurrent Illness|1|||
105760400|NCT00948428|364776053|FG001|Overall Study|Intercurrent Illness|0|||
105760401|NCT00948428|364776054|FG002|Overall Study|Intercurrent Illness|0|||
105760402|NCT00948428|364776052|FG000|Overall Study|Non-compliance|1|||
105760403|NCT00948428|364776053|FG001|Overall Study|Non-compliance|2|||
105760404|NCT00948428|364776054|FG002|Overall Study|Non-compliance|0|||
105760405|NCT00010803|364776057|FG000|Overall Study|Withdrawal by Subject|97|||
105760406|NCT00010803|364776058|FG001|Overall Study|Withdrawal by Subject|98|||
105760407|NCT00607919|364776059|FG000|Acute Phase|Adverse Event|9|||
105760408|NCT00607919|364776060|FG001|Acute Phase|Adverse Event|2|||
105760409|NCT00607919|364776059|FG000|Acute Phase|Entry Criteria Not Met|1|||
105760410|NCT00607919|364776060|FG001|Acute Phase|Entry Criteria Not Met|1|||
105760411|NCT00607919|364776059|FG000|Acute Phase|Lack of Efficacy|1|||
105760412|NCT00607919|364776060|FG001|Acute Phase|Lack of Efficacy|2|||
105760413|NCT00607919|364776059|FG000|Acute Phase|Lost to Follow-up|9|||
105760414|NCT00607919|364776060|FG001|Acute Phase|Lost to Follow-up|3|||
105760415|NCT00607919|364776059|FG000|Acute Phase|Parent/Caregiver Decision|6|||
105760416|NCT00607919|364776060|FG001|Acute Phase|Parent/Caregiver Decision|4|||
105760417|NCT00607919|364776059|FG000|Acute Phase|Protocol Violation|5|||
105760418|NCT00607919|364776060|FG001|Acute Phase|Protocol Violation|1|||
105760419|NCT00607919|364776059|FG000|Acute Phase|Withdrawal by Subject|3|||
105760420|NCT00607919|364776060|FG001|Acute Phase|Withdrawal by Subject|3|||
105760421|NCT00607919|364776059|FG000|Open-Label Phase|Adverse Event|1|||
105760422|NCT00607919|364776060|FG001|Open-Label Phase|Adverse Event|5|||
105760423|NCT00607919|364776059|FG000|Open-Label Phase|Lost to Follow-up|4|||
105760424|NCT00607919|364776060|FG001|Open-Label Phase|Lost to Follow-up|1|||
105760425|NCT00607919|364776059|FG000|Open-Label Phase|Protocol Violation|2|||
105760426|NCT00607919|364776060|FG001|Open-Label Phase|Protocol Violation|2|||
105760427|NCT00607919|364776059|FG000|Open-Label Phase|Withdrawal by Subject|2|||
105760428|NCT00607919|364776060|FG001|Open-Label Phase|Withdrawal by Subject|2|||
105760429|NCT00607919|364776059|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
105760430|NCT00607919|364776060|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
105760431|NCT00762268|364776061|FG000|Overall Study|Withdrawal by Subject|3|||
105760432|NCT00762268|364776062|FG001|Overall Study|Withdrawal by Subject|3|||
105760433|NCT00150345|364776064|FG000|Overall Study|Death|5|||
105760434|NCT00150345|364776065|FG001|Overall Study|Death|2|||
105760435|NCT00150345|364776064|FG000|Overall Study|Adverse Event|8|||
105760436|NCT00150345|364776065|FG001|Overall Study|Adverse Event|6|||
105760437|NCT00150345|364776064|FG000|Overall Study|Lack of Efficacy|5|||
105760438|NCT00150345|364776065|FG001|Overall Study|Lack of Efficacy|4|||
105760439|NCT00150345|364776064|FG000|Overall Study|Withdrawal by Subject|3|||
105760440|NCT00150345|364776065|FG001|Overall Study|Withdrawal by Subject|4|||
105760441|NCT00150345|364776064|FG000|Overall Study|Laboratory abnormality|1|||
105760442|NCT00150345|364776065|FG001|Overall Study|Laboratory abnormality|2|||
105760443|NCT00150345|364776064|FG000|Overall Study|Other|12|||
105760444|NCT00150345|364776065|FG001|Overall Study|Other|14|||
105760445|NCT01392742|364776066|FG000|Overall Study|Premature study termination|42|||
105760446|NCT01392742|364776066|FG000|Overall Study|Failure to return|35|||
105760447|NCT01392742|364776066|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
105760448|NCT01392742|364776066|FG000|Overall Study|Lost to Follow-up|34|||
105760449|NCT01392742|364776066|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
105760450|NCT01392742|364776066|FG000|Overall Study|ITR and Protocol deviation|1|||
105760451|NCT01392742|364776066|FG000|Overall Study|Adverse event/intercurrent illness|17|||
105760452|NCT01392742|364776066|FG000|Overall Study|Protocol Violation|14|||
105760453|NCT01392742|364776066|FG000|Overall Study|Other|3|||
105760454|NCT01392742|364776066|FG000|Overall Study|Missing information|13|||
105760455|NCT01457924|364776067|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
105760456|NCT01457924|364776068|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
105760457|NCT01457924|364776069|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
105760458|NCT01457924|364776070|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
105760459|NCT01457924|364776071|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
105760460|NCT01457924|364776067|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
105760461|NCT01457924|364776068|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
105760462|NCT01457924|364776069|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
105760463|NCT01457924|364776070|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
105760464|NCT01457924|364776071|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
105760465|NCT01457924|364776067|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
105760466|NCT01457924|364776068|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
105760467|NCT01457924|364776069|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
105570199|NCT04296890|364086692|FG000|Overall Study|Lost to Follow-up|3|||
105570200|NCT04296890|364086692|FG000|Overall Study|Other than specified|2|||
105760468|NCT01457924|364776070|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
105760469|NCT01457924|364776071|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
105760470|NCT01457924|364776067|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
105760471|NCT01457924|364776068|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
105760472|NCT01457924|364776069|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
105760473|NCT01457924|364776070|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
105760474|NCT01457924|364776071|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
105760475|NCT01457924|364776067|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
105760476|NCT01457924|364776068|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
105760477|NCT01457924|364776069|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
105760478|NCT01457924|364776070|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
105760479|NCT01457924|364776071|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
105760480|NCT01457924|364776067|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
105760481|NCT01457924|364776068|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
105760482|NCT01457924|364776069|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
105760483|NCT01457924|364776070|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
105760484|NCT01457924|364776071|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
105760485|NCT01457924|364776067|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
105760486|NCT01457924|364776068|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
105760487|NCT01457924|364776069|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
105760488|NCT01457924|364776070|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
105760489|NCT01457924|364776071|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
105760490|NCT01457924|364776067|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
105760491|NCT01457924|364776068|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
105760492|NCT01457924|364776069|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
105760493|NCT01457924|364776070|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
105760494|NCT01457924|364776071|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
105760495|NCT01457924|364776067|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
105760496|NCT01457924|364776068|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
105760497|NCT01457924|364776069|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
105760498|NCT01457924|364776070|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
105760499|NCT01457924|364776071|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
105760500|NCT01457924|364776067|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
105760501|NCT01457924|364776068|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
105760502|NCT01457924|364776069|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
105760503|NCT01457924|364776070|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
105760504|NCT01457924|364776071|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
105760505|NCT01457924|364776067|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
105760506|NCT01457924|364776068|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
105760507|NCT01457924|364776069|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
105760508|NCT01457924|364776070|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
105760509|NCT01457924|364776071|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
105760510|NCT01457924|364776067|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
105760511|NCT01457924|364776068|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
105760512|NCT01457924|364776069|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
105760513|NCT01457924|364776070|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
105760514|NCT01457924|364776071|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
105760515|NCT01457924|364776067|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
105760516|NCT01457924|364776068|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
105760517|NCT01457924|364776069|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
105760518|NCT01457924|364776070|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
105760519|NCT01457924|364776071|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
105760520|NCT01989754|364776072|FG000|Overall Study|Withdrawal by Subject|10|||
105760521|NCT01989754|364776073|FG001|Overall Study|Withdrawal by Subject|14|||
105760522|NCT01989754|364776072|FG000|Overall Study|Lost to Follow-up|28|||
105760523|NCT01989754|364776073|FG001|Overall Study|Lost to Follow-up|20|||
105760524|NCT01989754|364776072|FG000|Overall Study|Closed Site|1|||
105760525|NCT01989754|364776073|FG001|Overall Study|Closed Site|1|||
105760526|NCT01369225|364776076|FG000|Overall Study|Withdrawal by Subject|1|||
105760527|NCT01369225|364776077|FG001|Overall Study|Withdrawal by Subject|0|||
105760528|NCT01369225|364776078|FG002|Overall Study|Withdrawal by Subject|2|||
105760529|NCT01369225|364776079|FG003|Overall Study|Withdrawal by Subject|1|||
105360772|NCT00572455|363328081|FG001|Stage I (14 Days)|Other|0|||
105760530|NCT01369225|364776080|FG004|Overall Study|Withdrawal by Subject|0|||
105760531|NCT01369225|364776081|FG005|Overall Study|Withdrawal by Subject|0|||
105760532|NCT01369225|364776076|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
105806155|NCT01716754|364946942|FG000|Overall Study|Death|0|||
105760533|NCT01369225|364776077|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
105760534|NCT01369225|364776078|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
105760535|NCT01369225|364776079|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
105760536|NCT01369225|364776080|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
105760537|NCT01369225|364776081|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
105760538|NCT01369225|364776076|FG000|Overall Study|Other|1|||
105760539|NCT01369225|364776077|FG001|Overall Study|Other|0|||
105760540|NCT01369225|364776078|FG002|Overall Study|Other|0|||
105760541|NCT01369225|364776079|FG003|Overall Study|Other|0|||
105760542|NCT01369225|364776080|FG004|Overall Study|Other|1|||
105760543|NCT01369225|364776081|FG005|Overall Study|Other|0|||
105760544|NCT01369225|364776076|FG000|Overall Study|Adverse Event|0|||
105760545|NCT01369225|364776077|FG001|Overall Study|Adverse Event|0|||
105760546|NCT01369225|364776078|FG002|Overall Study|Adverse Event|0|||
105760547|NCT01369225|364776079|FG003|Overall Study|Adverse Event|1|||
105760548|NCT01369225|364776080|FG004|Overall Study|Adverse Event|1|||
105760549|NCT01369225|364776081|FG005|Overall Study|Adverse Event|0|||
105760550|NCT00792701|364776082|FG000|Overall Study|Adverse Event|0|||
105760551|NCT00792701|364776083|FG001|Overall Study|Adverse Event|22|||
105760552|NCT00792701|364776082|FG000|Overall Study|Ineligible|1|||
105760553|NCT00792701|364776083|FG001|Overall Study|Ineligible|3|||
105760554|NCT00792701|364776082|FG000|Overall Study|Withdrawal by Subject|1|||
105760555|NCT00792701|364776083|FG001|Overall Study|Withdrawal by Subject|19|||
105760556|NCT00792701|364776082|FG000|Overall Study|Not protocol specified|17|||
105760557|NCT00792701|364776083|FG001|Overall Study|Not protocol specified|0|||
105760558|NCT00563368|364776086|FG000|Overall Study|Lost to Follow-up|14|||
105760559|NCT00563368|364776087|FG001|Overall Study|Lost to Follow-up|14|||
105760560|NCT00563368|364776088|FG002|Overall Study|Lost to Follow-up|12|||
105760561|NCT00563368|364776089|FG003|Overall Study|Lost to Follow-up|6|||
105760562|NCT00563368|364776090|FG004|Overall Study|Lost to Follow-up|9|||
105760563|NCT00563368|364776091|FG005|Overall Study|Lost to Follow-up|8|||
105760564|NCT00563368|364776092|FG006|Overall Study|Lost to Follow-up|9|||
105760565|NCT00563368|364776086|FG000|Overall Study|Adverse Event|3|||
105760566|NCT00563368|364776087|FG001|Overall Study|Adverse Event|4|||
105760567|NCT00563368|364776088|FG002|Overall Study|Adverse Event|5|||
105760568|NCT00563368|364776089|FG003|Overall Study|Adverse Event|9|||
105760569|NCT00563368|364776090|FG004|Overall Study|Adverse Event|6|||
105760570|NCT00563368|364776091|FG005|Overall Study|Adverse Event|10|||
105760571|NCT00563368|364776092|FG006|Overall Study|Adverse Event|17|||
105760572|NCT00563368|364776086|FG000|Overall Study|Withdrawal by Subject|11|||
105760573|NCT00563368|364776087|FG001|Overall Study|Withdrawal by Subject|6|||
105760574|NCT00563368|364776088|FG002|Overall Study|Withdrawal by Subject|5|||
105760575|NCT00563368|364776089|FG003|Overall Study|Withdrawal by Subject|7|||
105760576|NCT00563368|364776090|FG004|Overall Study|Withdrawal by Subject|8|||
105760577|NCT00563368|364776091|FG005|Overall Study|Withdrawal by Subject|5|||
105760578|NCT00563368|364776092|FG006|Overall Study|Withdrawal by Subject|4|||
105760579|NCT00563368|364776086|FG000|Overall Study|protocol non-compliance|1|||
105760580|NCT00563368|364776087|FG001|Overall Study|protocol non-compliance|1|||
105760581|NCT00563368|364776088|FG002|Overall Study|protocol non-compliance|2|||
105760582|NCT00563368|364776089|FG003|Overall Study|protocol non-compliance|1|||
105760583|NCT00563368|364776090|FG004|Overall Study|protocol non-compliance|0|||
105760584|NCT00563368|364776091|FG005|Overall Study|protocol non-compliance|1|||
105570201|NCT02541383|364086693|FG000|Overall Study|Death|50|||
105570202|NCT02541383|364086694|FG001|Overall Study|Death|37|||
105570203|NCT02541383|364086695|FG002|Overall Study|Death|48|||
105570204|NCT02541383|364086696|FG003|Overall Study|Death|41|||
105570205|NCT02541383|364086697|FG004|Overall Study|Death|21|||
105760585|NCT00563368|364776092|FG006|Overall Study|protocol non-compliance|3|||
105760586|NCT00563368|364776086|FG000|Overall Study|Pregnancy|1|||
105760587|NCT00563368|364776087|FG001|Overall Study|Pregnancy|0|||
105760588|NCT00563368|364776088|FG002|Overall Study|Pregnancy|1|||
105760589|NCT00563368|364776089|FG003|Overall Study|Pregnancy|2|||
105760590|NCT00563368|364776090|FG004|Overall Study|Pregnancy|1|||
105760591|NCT00563368|364776091|FG005|Overall Study|Pregnancy|2|||
105760592|NCT00563368|364776092|FG006|Overall Study|Pregnancy|0|||
105760593|NCT00563368|364776086|FG000|Overall Study|requirement for restricted medication|0|||
105760594|NCT00563368|364776087|FG001|Overall Study|requirement for restricted medication|0|||
105760595|NCT00563368|364776088|FG002|Overall Study|requirement for restricted medication|2|||
105760596|NCT00563368|364776089|FG003|Overall Study|requirement for restricted medication|0|||
105760597|NCT00563368|364776090|FG004|Overall Study|requirement for restricted medication|0|||
105760598|NCT00563368|364776091|FG005|Overall Study|requirement for restricted medication|0|||
105760599|NCT00563368|364776092|FG006|Overall Study|requirement for restricted medication|0|||
105760600|NCT00563368|364776086|FG000|Overall Study|Other|5|||
105760601|NCT00563368|364776087|FG001|Overall Study|Other|5|||
105760602|NCT00563368|364776088|FG002|Overall Study|Other|3|||
105760603|NCT00563368|364776089|FG003|Overall Study|Other|4|||
105760604|NCT00563368|364776090|FG004|Overall Study|Other|4|||
105570206|NCT02541383|364086698|FG005|Overall Study|Death|25|||
105760605|NCT00563368|364776091|FG005|Overall Study|Other|4|||
105760606|NCT00563368|364776092|FG006|Overall Study|Other|0|||
105760607|NCT01819506|364776095|FG000|Overall Study|Physician Decision|5|||
105760608|NCT01819506|364776096|FG001|Overall Study|Physician Decision|2|||
105484682|NCT01029405|363785518|FG001|Overall Study|Adverse Event|0|||
105484683|NCT01029405|363785519|FG002|Overall Study|Adverse Event|1|||
105484684|NCT01029405|363785520|FG003|Overall Study|Adverse Event|1|||
105484685|NCT01029405|363785517|FG000|Overall Study|Lost to Follow-up|2|||
105484686|NCT01029405|363785518|FG001|Overall Study|Lost to Follow-up|1|||
105484687|NCT01029405|363785519|FG002|Overall Study|Lost to Follow-up|1|||
105484688|NCT01029405|363785520|FG003|Overall Study|Lost to Follow-up|2|||
105484689|NCT01029405|363785517|FG000|Overall Study|Other|0|||
105484690|NCT01029405|363785518|FG001|Overall Study|Other|1|||
105484691|NCT01029405|363785519|FG002|Overall Study|Other|0|||
105484692|NCT01029405|363785520|FG003|Overall Study|Other|1|||
105484693|NCT00409175|363785521|FG000|Overall Study|Adverse Event|4|||
105484694|NCT00409175|363785522|FG001|Overall Study|Adverse Event|3|||
105484695|NCT00409175|363785521|FG000|Overall Study|Withdrawal by Subject|1|||
105484696|NCT00409175|363785522|FG001|Overall Study|Withdrawal by Subject|2|||
105484697|NCT00409175|363785521|FG000|Overall Study|Negative genotype|0|||
105484698|NCT00409175|363785522|FG001|Overall Study|Negative genotype|1|||
105484699|NCT00409175|363785521|FG000|Overall Study|Liver transplantation|13|||
105484700|NCT00409175|363785522|FG001|Overall Study|Liver transplantation|13|||
105760609|NCT01819506|364776095|FG000|Overall Study|Withdrawal by Subject|3|||
105760610|NCT01819506|364776096|FG001|Overall Study|Withdrawal by Subject|3|||
105760611|NCT00050622|364776097|FG000|Overall Study|Adverse Event|1|||
105760612|NCT04581863|364776098|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
105760613|NCT04581863|364776099|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
105760614|NCT02920450|364776100|FG000|Overall Study|Death|1|||
105760615|NCT02920450|364776101|FG001|Overall Study|Death|0|||
105760616|NCT02920450|364776102|FG002|Overall Study|Death|0|||
105760617|NCT02920450|364776103|FG003|Overall Study|Death|0|||
105484701|NCT01860846|363785523|FG000|Overall Study|Lost to Follow-up|33|||
105484702|NCT00868517|363785524|FG000|Overall Study|Withdrawal by Subject|3|||
105484703|NCT00868517|363785525|FG001|Overall Study|Withdrawal by Subject|3|||
105484704|NCT00868517|363785526|FG002|Overall Study|Withdrawal by Subject|2|||
105484705|NCT00868517|363785524|FG000|Overall Study|Protocol Violation|1|||
105484706|NCT00868517|363785525|FG001|Overall Study|Protocol Violation|1|||
105484707|NCT00868517|363785526|FG002|Overall Study|Protocol Violation|0|||
105484708|NCT00723203|363785527|FG000|Overall Study|Withdrawal by Subject|3|||
105484709|NCT03901456|363785533|FG000|Overall Study|Withdrawal by Subject|0|||
105484710|NCT03901456|363785534|FG001|Overall Study|Withdrawal by Subject|0|||
105484711|NCT03901456|363785535|FG002|Overall Study|Withdrawal by Subject|1|||
105484712|NCT03901456|363785533|FG000|Overall Study|Lost to Follow-up|0|||
105484713|NCT03901456|363785534|FG001|Overall Study|Lost to Follow-up|1|||
105484714|NCT03901456|363785535|FG002|Overall Study|Lost to Follow-up|0|||
105484715|NCT00768469|363785537|FG000|Overall Study|Adverse Event|0|||
105484716|NCT00768469|363785538|FG001|Overall Study|Adverse Event|2|||
105484717|NCT00768469|363785537|FG000|Overall Study|Disease Progression|3|||
105484718|NCT00768469|363785538|FG001|Overall Study|Disease Progression|4|||
105484719|NCT00768469|363785537|FG000|Overall Study|Withdrawal by Subject|0|||
105484720|NCT00768469|363785538|FG001|Overall Study|Withdrawal by Subject|1|||
105484721|NCT01878149|363785539|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
105484722|NCT01878149|363785540|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
105484723|NCT04672252|363785541|FG000|Overall Study|Protocol Violation|1|||
105484724|NCT04672252|363785542|FG001|Overall Study|Protocol Violation|0|||
105484725|NCT04391569|363785545|FG000|Overall Study|Death|15|||
105484726|NCT04391569|363785546|FG001|Overall Study|Death|10|||
105484727|NCT04391569|363785545|FG000|Overall Study|Withdrawal by Subject|1|||
105484728|NCT04391569|363785546|FG001|Overall Study|Withdrawal by Subject|0|||
105484729|NCT04391569|363785545|FG000|Overall Study|Lost to Follow-up|3|||
105760618|NCT02920450|364776100|FG000|Overall Study|Withdrawal by Subject|1|||
105760619|NCT02920450|364776101|FG001|Overall Study|Withdrawal by Subject|0|||
105760620|NCT02920450|364776102|FG002|Overall Study|Withdrawal by Subject|0|||
105760621|NCT02920450|364776103|FG003|Overall Study|Withdrawal by Subject|0|||
105760622|NCT00225212|364776104|FG000|Overall Study|Disease progression|2|||
105760623|NCT00225212|364776104|FG000|Overall Study|Death|1|||
105760624|NCT00225212|364776104|FG000|Overall Study|Adverse Event|2|||
105484730|NCT04391569|363785546|FG001|Overall Study|Lost to Follow-up|2|||
105484731|NCT04391569|363785545|FG000|Overall Study|Lack of Efficacy|0|||
105484732|NCT04391569|363785546|FG001|Overall Study|Lack of Efficacy|1|||
105484733|NCT04391569|363785545|FG000|Overall Study|Participant discharged to hospice facility|0|||
105484734|NCT04391569|363785546|FG001|Overall Study|Participant discharged to hospice facility|1|||
105484735|NCT04391569|363785545|FG000|Overall Study|Participant family decision|1|||
105484736|NCT04391569|363785546|FG001|Overall Study|Participant family decision|0|||
105484737|NCT04391569|363785545|FG000|Overall Study|Participant discharged prematurely|1|||
105484738|NCT04391569|363785546|FG001|Overall Study|Participant discharged prematurely|0|||
105484739|NCT03025035|363785547|FG000|Overall Study|Death|2|||
105484740|NCT03025035|363785547|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
105484741|NCT02241889|363785548|FG000|Overall Study|device issues|0|||
105484742|NCT02241889|363785549|FG001|Overall Study|device issues|0|||
105806156|NCT01716754|364946943|FG001|Overall Study|Death|0|||
105806157|NCT01716754|364946944|FG002|Overall Study|Death|0|||
105806158|NCT01716754|364946945|FG003|Overall Study|Death|1|||
105806159|NCT01716754|364946942|FG000|Overall Study|Protocol deviation|0|||
105806160|NCT01716754|364946943|FG001|Overall Study|Protocol deviation|2|||
105806161|NCT01716754|364946944|FG002|Overall Study|Protocol deviation|7|||
105806162|NCT01716754|364946945|FG003|Overall Study|Protocol deviation|2|||
105806163|NCT01716754|364946942|FG000|Overall Study|Non-compliance with study treatment|0|||
105484743|NCT02241889|363785550|FG002|Overall Study|device issues|1|||
105806164|NCT01716754|364946943|FG001|Overall Study|Non-compliance with study treatment|0|||
105806165|NCT01716754|364946944|FG002|Overall Study|Non-compliance with study treatment|1|||
105806166|NCT01716754|364946945|FG003|Overall Study|Non-compliance with study treatment|0|||
105806167|NCT01716754|364946942|FG000|Overall Study|Physician Decision|1|||
105806168|NCT01716754|364946943|FG001|Overall Study|Physician Decision|0|||
105806169|NCT01716754|364946944|FG002|Overall Study|Physician Decision|0|||
105806170|NCT01716754|364946945|FG003|Overall Study|Physician Decision|0|||
105806171|NCT01716754|364946942|FG000|Overall Study|Lost to Follow-up|1|||
105806172|NCT01716754|364946943|FG001|Overall Study|Lost to Follow-up|0|||
105806173|NCT01716754|364946944|FG002|Overall Study|Lost to Follow-up|0|||
105806174|NCT01716754|364946945|FG003|Overall Study|Lost to Follow-up|1|||
105806175|NCT01716754|364946942|FG000|Overall Study|Adverse Event|4|||
105806176|NCT01716754|364946943|FG001|Overall Study|Adverse Event|2|||
105806177|NCT01716754|364946944|FG002|Overall Study|Adverse Event|2|||
105806178|NCT01716754|364946945|FG003|Overall Study|Adverse Event|1|||
105806179|NCT01716754|364946942|FG000|Overall Study|Withdrawal by Subject|5|||
105806180|NCT01716754|364946943|FG001|Overall Study|Withdrawal by Subject|0|||
105806181|NCT01716754|364946944|FG002|Overall Study|Withdrawal by Subject|4|||
105806182|NCT01716754|364946945|FG003|Overall Study|Withdrawal by Subject|3|||
105806183|NCT00696709|364946948|FG000|Overall Study|Withdrawal by Subject|1|||
105806184|NCT00696709|364946949|FG001|Overall Study|Withdrawal by Subject|2|||
105806185|NCT00696709|364946950|FG002|Overall Study|Withdrawal by Subject|1|||
105806186|NCT00696709|364946951|FG003|Overall Study|Withdrawal by Subject|4|||
105806187|NCT00696709|364946952|FG004|Overall Study|Withdrawal by Subject|3|||
105806188|NCT00696709|364946948|FG000|Overall Study|Protocol Violation|1|||
105806189|NCT00696709|364946949|FG001|Overall Study|Protocol Violation|0|||
105806190|NCT00696709|364946950|FG002|Overall Study|Protocol Violation|0|||
105806191|NCT00696709|364946951|FG003|Overall Study|Protocol Violation|0|||
105806192|NCT00696709|364946952|FG004|Overall Study|Protocol Violation|0|||
105806193|NCT00696709|364946948|FG000|Overall Study|Lost to Follow-up|1|||
105806194|NCT00696709|364946949|FG001|Overall Study|Lost to Follow-up|1|||
105806195|NCT00696709|364946950|FG002|Overall Study|Lost to Follow-up|0|||
105806196|NCT00696709|364946951|FG003|Overall Study|Lost to Follow-up|0|||
105806197|NCT00696709|364946952|FG004|Overall Study|Lost to Follow-up|0|||
105806198|NCT00696709|364946948|FG000|Overall Study|Adverse Event|0|||
105806199|NCT00696709|364946949|FG001|Overall Study|Adverse Event|0|||
105806200|NCT00696709|364946950|FG002|Overall Study|Adverse Event|0|||
105806201|NCT00696709|364946951|FG003|Overall Study|Adverse Event|1|||
105806202|NCT00696709|364946952|FG004|Overall Study|Adverse Event|0|||
105806203|NCT00310856|364946953|FG000|Overall Study|Withdrawal by Subject|2|||
105806204|NCT00310856|364946954|FG001|Overall Study|Withdrawal by Subject|2|||
105360773|NCT00572455|363328082|FG002|Stage I (14 Days)|Other|0|||
105484744|NCT02241889|363785551|FG003|Overall Study|device issues|0|||
105806205|NCT00310856|364946955|FG002|Overall Study|Withdrawal by Subject|2|||
105806206|NCT00310856|364946953|FG000|Overall Study|Lost to Follow-up|1|||
105806207|NCT00310856|364946954|FG001|Overall Study|Lost to Follow-up|2|||
105806208|NCT00310856|364946955|FG002|Overall Study|Lost to Follow-up|6|||
105806209|NCT00310856|364946953|FG000|Overall Study|Inappropriate enrollment|1|||
105806210|NCT00310856|364946954|FG001|Overall Study|Inappropriate enrollment|1|||
105806211|NCT00310856|364946955|FG002|Overall Study|Inappropriate enrollment|0|||
105806212|NCT00310856|364946953|FG000|Overall Study|Unable to classify|1|||
105806213|NCT00310856|364946954|FG001|Overall Study|Unable to classify|0|||
105806214|NCT00310856|364946955|FG002|Overall Study|Unable to classify|0|||
105806215|NCT01227668|364946958|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
105806216|NCT01227668|364946959|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
105806217|NCT01227668|364946958|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
105806218|NCT01227668|364946959|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
105806219|NCT01227668|364946958|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
105806220|NCT01227668|364946959|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
105806221|NCT01227668|364946958|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
105806222|NCT01227668|364946959|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
105806223|NCT01227668|364946958|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
105806224|NCT01227668|364946959|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
105806225|NCT01227668|364946958|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
105806226|NCT01227668|364946959|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
105806227|NCT01227668|364946958|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
105806228|NCT01227668|364946959|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
105806229|NCT01227668|364946958|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
105806230|NCT01227668|364946959|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
105806231|NCT01227668|364946958|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
105806232|NCT01227668|364946959|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
105806233|NCT01227668|364946958|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
105806234|NCT01227668|364946959|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
105806235|NCT01227668|364946958|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
105806236|NCT01227668|364946959|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
105806237|NCT01227668|364946958|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
105806238|NCT01227668|364946959|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
105806239|NCT02473510|364946960|FG000|Overall Study|Lost to Follow-up|1|||
105806240|NCT02473510|364946961|FG001|Overall Study|Lost to Follow-up|2|||
105806241|NCT01709383|364946962|FG000|Overall Study|Lost to Follow-up|1|||
105806242|NCT01709383|364946963|FG001|Overall Study|Lost to Follow-up|0|||
105806243|NCT00278512|364946964|FG000|Overall Study|Death|1|||
105806244|NCT00278512|364946965|FG001|Overall Study|Death|0|||
105806245|NCT01202747|364946966|FG000|Overall Study|Withdrawal by Subject|1|||
105806246|NCT02521948|364946967|FG000|Overall Study|Adverse Event|2|||
105806247|NCT02521948|364946967|FG000|Overall Study|Death|4|||
105806248|NCT02521948|364946967|FG000|Overall Study|Lost to Follow-up|1|||
105806249|NCT02521948|364946967|FG000|Overall Study|Did not attend one or both follow-ups|6|||
105806250|NCT04000009|364946968|FG000|Overall Study|Adverse Event|13|||
105806251|NCT04000009|364946968|FG000|Overall Study|Lack of Efficacy|7|||
105806252|NCT04000009|364946968|FG000|Overall Study|Lost to Follow-up|8|||
105806253|NCT04000009|364946968|FG000|Overall Study|Noncompliance with study drug|4|||
105806254|NCT04000009|364946968|FG000|Overall Study|Physician Decision|1|||
105806255|NCT04000009|364946968|FG000|Overall Study|Use of prohibited medication|3|||
105806256|NCT04000009|364946968|FG000|Overall Study|Pregnancy|1|||
105806257|NCT04000009|364946968|FG000|Overall Study|Withdrawal by Subject|22|||
105806258|NCT04000009|364946968|FG000|Overall Study|Study terminated by sponsor|98|||
105806259|NCT04000009|364946968|FG000|Overall Study|Not further specified|8|||
105806260|NCT00679783|364946969|FG000|Overall Study|Adverse Event|0|||
105806261|NCT00679783|364946970|FG001|Overall Study|Adverse Event|0|||
105806262|NCT00679783|364946971|FG002|Overall Study|Adverse Event|0|||
105806263|NCT00679783|364946972|FG003|Overall Study|Adverse Event|3|||
105806264|NCT00679783|364946973|FG004|Overall Study|Adverse Event|0|||
105806265|NCT00679783|364946974|FG005|Overall Study|Adverse Event|0|||
105806266|NCT00679783|364946975|FG006|Overall Study|Adverse Event|1|||
105806267|NCT00679783|364946969|FG000|Overall Study|Lack of Efficacy|0|||
105806268|NCT00679783|364946970|FG001|Overall Study|Lack of Efficacy|1|||
105806269|NCT00679783|364946971|FG002|Overall Study|Lack of Efficacy|0|||
105806270|NCT00679783|364946972|FG003|Overall Study|Lack of Efficacy|2|||
105360774|NCT00572455|363328083|FG003|Stage I (14 Days)|Other|0|||
105360775|NCT00572455|363328084|FG004|Stage I (14 Days)|Other|1|||
105360776|NCT00572455|363328085|FG005|Stage I (14 Days)|Other|0|||
105360777|NCT00572455|363328086|FG006|Stage I (14 Days)|Other|0|||
105360778|NCT00572455|363328087|FG007|Stage I (14 Days)|Other|0|||
105360779|NCT00572455|363328088|FG008|Stage I (14 Days)|Other|0|||
105360780|NCT00572455|363328089|FG009|Stage I (14 Days)|Other|0|||
105360781|NCT00572455|363328090|FG010|Stage I (14 Days)|Other|0|||
105360782|NCT00572455|363328091|FG011|Stage I (14 Days)|Other|0|||
105360783|NCT00572455|363328092|FG012|Stage I (14 Days)|Other|0|||
105806271|NCT00679783|364946973|FG004|Overall Study|Lack of Efficacy|0|||
105806272|NCT00679783|364946974|FG005|Overall Study|Lack of Efficacy|0|||
105806273|NCT00679783|364946975|FG006|Overall Study|Lack of Efficacy|0|||
105806274|NCT00679783|364946969|FG000|Overall Study|Withdrawal by Subject|0|||
105806275|NCT00679783|364946970|FG001|Overall Study|Withdrawal by Subject|0|||
105806276|NCT00679783|364946971|FG002|Overall Study|Withdrawal by Subject|1|||
105806277|NCT00679783|364946972|FG003|Overall Study|Withdrawal by Subject|1|||
105806278|NCT00679783|364946973|FG004|Overall Study|Withdrawal by Subject|0|||
105806279|NCT00679783|364946974|FG005|Overall Study|Withdrawal by Subject|0|||
105360784|NCT00572455|363328093|FG013|Stage I (14 Days)|Other|0|||
105806280|NCT00679783|364946975|FG006|Overall Study|Withdrawal by Subject|0|||
105806281|NCT00679783|364946969|FG000|Overall Study|Not Captured|0|||
105806282|NCT00679783|364946970|FG001|Overall Study|Not Captured|0|||
105806283|NCT00679783|364946971|FG002|Overall Study|Not Captured|0|||
105806284|NCT00679783|364946972|FG003|Overall Study|Not Captured|5|||
105806285|NCT00679783|364946973|FG004|Overall Study|Not Captured|0|||
105806286|NCT00679783|364946974|FG005|Overall Study|Not Captured|0|||
105806287|NCT00679783|364946975|FG006|Overall Study|Not Captured|0|||
105806288|NCT00679783|364946969|FG000|Overall Study|Ongoing at data cut-off|2|||
105806289|NCT00679783|364946970|FG001|Overall Study|Ongoing at data cut-off|2|||
105806290|NCT00679783|364946971|FG002|Overall Study|Ongoing at data cut-off|0|||
105806291|NCT00679783|364946972|FG003|Overall Study|Ongoing at data cut-off|9|||
105806292|NCT00679783|364946973|FG004|Overall Study|Ongoing at data cut-off|1|||
105806293|NCT00679783|364946974|FG005|Overall Study|Ongoing at data cut-off|0|||
105806294|NCT00679783|364946975|FG006|Overall Study|Ongoing at data cut-off|0|||
105806295|NCT00905489|364946976|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
105806296|NCT00905489|364946976|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
105806297|NCT00905489|364946976|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
105806298|NCT01754259|364946979|FG000|Overall Study|Withdrawal by Subject|2|||
105806299|NCT01754259|364946980|FG001|Overall Study|Withdrawal by Subject|4|||
105806300|NCT01754259|364946979|FG000|Overall Study|Adverse Event|3|||
105806301|NCT01754259|364946980|FG001|Overall Study|Adverse Event|1|||
105806302|NCT01754259|364946979|FG000|Overall Study|Lost to Follow-up|0|||
105806303|NCT01754259|364946980|FG001|Overall Study|Lost to Follow-up|1|||
105806304|NCT00814320|364946983|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
105806305|NCT00814320|364946984|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
105806306|NCT00814320|364946983|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
105806307|NCT00814320|364946984|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
105806308|NCT00814320|364946983|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
105806309|NCT00814320|364946984|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
105806310|NCT00814320|364946983|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
105806311|NCT00814320|364946984|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
105806312|NCT00814320|364946983|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
105806313|NCT00814320|364946984|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
105806314|NCT00814320|364946983|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
105806315|NCT00814320|364946984|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
105806316|NCT00814320|364946983|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
105806317|NCT00814320|364946984|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
105806318|NCT00814320|364946983|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
105806319|NCT00814320|364946984|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
105806320|NCT00814320|364946983|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
105806321|NCT00814320|364946984|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
105806322|NCT00814320|364946983|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
105806323|NCT00814320|364946984|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
105806324|NCT00491504|364946985|FG000|Overall Study|Adverse Event|0|||
105806325|NCT00491504|364946986|FG001|Overall Study|Adverse Event|1|||
105806326|NCT00491504|364946987|FG002|Overall Study|Adverse Event|0|||
105806327|NCT00491504|364946988|FG003|Overall Study|Adverse Event|0|||
105806328|NCT00491504|364946985|FG000|Overall Study|Withdrawal by Subject|0|||
105806329|NCT00491504|364946986|FG001|Overall Study|Withdrawal by Subject|0|||
105806330|NCT00491504|364946987|FG002|Overall Study|Withdrawal by Subject|1|||
105806331|NCT00491504|364946988|FG003|Overall Study|Withdrawal by Subject|2|||
105806332|NCT00491504|364946985|FG000|Overall Study|Protocol Violation|0|||
105806333|NCT00491504|364946986|FG001|Overall Study|Protocol Violation|0|||
105806334|NCT00491504|364946987|FG002|Overall Study|Protocol Violation|3|||
105806335|NCT00491504|364946988|FG003|Overall Study|Protocol Violation|2|||
105806336|NCT01748890|364947003|FG000|Overall Study|Insufficient recruitment for analysis|4|||
105806337|NCT03850509|364947004|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
105806338|NCT03850509|364947005|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
105806339|NCT01200394|364947006|FG000|Overall Study|Adverse Event|0|||
105806340|NCT01200394|364947007|FG001|Overall Study|Adverse Event|14|||
105806341|NCT01200394|364947006|FG000|Overall Study|Death|1|||
105806342|NCT01200394|364947007|FG001|Overall Study|Death|0|||
105806343|NCT01200394|364947006|FG000|Overall Study|Lost to Follow-up|0|||
105570207|NCT02541383|364086693|FG000|Overall Study|Lost to Follow-up|5|||
105570208|NCT02541383|364086694|FG001|Overall Study|Lost to Follow-up|3|||
105570209|NCT02541383|364086695|FG002|Overall Study|Lost to Follow-up|1|||
105570210|NCT02541383|364086696|FG003|Overall Study|Lost to Follow-up|1|||
105570211|NCT02541383|364086697|FG004|Overall Study|Lost to Follow-up|3|||
105570212|NCT02541383|364086698|FG005|Overall Study|Lost to Follow-up|0|||
105570213|NCT02541383|364086693|FG000|Overall Study|Consent withdrawn|5|||
105570214|NCT02541383|364086694|FG001|Overall Study|Consent withdrawn|6|||
105570215|NCT02541383|364086695|FG002|Overall Study|Consent withdrawn|1|||
105570216|NCT02541383|364086696|FG003|Overall Study|Consent withdrawn|1|||
105570217|NCT02541383|364086697|FG004|Overall Study|Consent withdrawn|0|||
105570218|NCT02541383|364086698|FG005|Overall Study|Consent withdrawn|0|||
105570219|NCT02541383|364086693|FG000|Overall Study|Sponsor's decision|1|||
105570220|NCT02541383|364086694|FG001|Overall Study|Sponsor's decision|1|||
105570221|NCT02541383|364086695|FG002|Overall Study|Sponsor's decision|0|||
105570222|NCT02541383|364086696|FG003|Overall Study|Sponsor's decision|0|||
105570223|NCT02541383|364086697|FG004|Overall Study|Sponsor's decision|0|||
105570224|NCT02541383|364086698|FG005|Overall Study|Sponsor's decision|0|||
105760625|NCT00225212|364776104|FG000|Overall Study|Intercurrent illness|1|||
105760626|NCT00968708|364776106|FG000|Overall Study|Adverse Event|169|||
105760627|NCT00968708|364776107|FG001|Overall Study|Adverse Event|150|||
105760628|NCT00968708|364776106|FG000|Overall Study|Major Protocol Deviation|0|||
105760629|NCT00968708|364776107|FG001|Overall Study|Major Protocol Deviation|1|||
105760630|NCT00968708|364776106|FG000|Overall Study|Lost to Follow-up|19|||
105760631|NCT00968708|364776107|FG001|Overall Study|Lost to Follow-up|11|||
105760632|NCT00968708|364776106|FG000|Overall Study|Voluntary Withdrawal|104|||
105760633|NCT00968708|364776107|FG001|Overall Study|Voluntary Withdrawal|101|||
105760634|NCT00968708|364776106|FG000|Overall Study|Investigator Discretion|0|||
105760635|NCT00968708|364776107|FG001|Overall Study|Investigator Discretion|1|||
105760636|NCT00968708|364776106|FG000|Overall Study|Other|26|||
105760637|NCT00968708|364776107|FG001|Overall Study|Other|34|||
105760638|NCT01851863|364776108|FG000|Overall Study|Did not receive study medication|2|||
105760639|NCT01851863|364776109|FG001|Overall Study|Did not receive study medication|5|||
105760640|NCT01851863|364776110|FG002|Overall Study|Did not receive study medication|3|||
105760641|NCT01851863|364776111|FG003|Overall Study|Did not receive study medication|0|||
105760642|NCT01851863|364776108|FG000|Overall Study|Lost to Follow-up|3|||
105760643|NCT01851863|364776109|FG001|Overall Study|Lost to Follow-up|4|||
105760644|NCT01851863|364776110|FG002|Overall Study|Lost to Follow-up|2|||
105760645|NCT01851863|364776111|FG003|Overall Study|Lost to Follow-up|3|||
105760646|NCT02999100|364776116|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
105760647|NCT02999100|364776117|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
105760648|NCT02999100|364776118|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
105760649|NCT02999100|364776119|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
105760650|NCT02999100|364776120|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
105760651|NCT02999100|364776121|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
105760652|NCT02999100|364776116|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
105806344|NCT01200394|364947007|FG001|Overall Study|Lost to Follow-up|1|||
105806345|NCT01200394|364947006|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
105570225|NCT00728962|364086699|FG000|Implant Placement Surgery|Adverse Event|8|||
105570226|NCT00728962|364086699|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
105570227|NCT00728962|364086699|FG000|Implant Placement Surgery|Protocol Violation|1|||
105570228|NCT00728962|364086699|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
105570229|NCT00728962|364086699|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
105570230|NCT00405639|364086710|FG000|Overall Study|Withdrawal by Subject|1|||
105570231|NCT00405639|364086711|FG001|Overall Study|Withdrawal by Subject|0|||
105760653|NCT02999100|364776117|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
105760654|NCT02999100|364776118|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
105760655|NCT02999100|364776119|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
105760656|NCT02999100|364776120|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
105760657|NCT02999100|364776121|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
105760658|NCT02999100|364776116|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
105760659|NCT02999100|364776117|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
105760660|NCT02999100|364776118|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
105760661|NCT02999100|364776119|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
105760662|NCT02999100|364776120|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
105806346|NCT01200394|364947007|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
105806347|NCT01200394|364947006|FG000|Overall Study|Protocol Violation|0|||
105806348|NCT01200394|364947007|FG001|Overall Study|Protocol Violation|3|||
105806349|NCT01200394|364947006|FG000|Overall Study|Withdrawal by Subject|0|||
105806350|NCT01200394|364947007|FG001|Overall Study|Withdrawal by Subject|5|||
105806351|NCT01200394|364947006|FG000|Overall Study|Other|0|||
105806352|NCT01200394|364947007|FG001|Overall Study|Other|1|||
105484745|NCT02241889|363785552|FG004|Overall Study|device issues|0|||
105484746|NCT02241889|363785553|FG005|Overall Study|device issues|0|||
105484747|NCT02241889|363785548|FG000|Overall Study|Withdrawal by Subject|0|||
105484748|NCT02241889|363785549|FG001|Overall Study|Withdrawal by Subject|0|||
105484749|NCT02241889|363785550|FG002|Overall Study|Withdrawal by Subject|0|||
105484750|NCT02241889|363785551|FG003|Overall Study|Withdrawal by Subject|0|||
105484751|NCT02241889|363785552|FG004|Overall Study|Withdrawal by Subject|0|||
105484752|NCT02241889|363785553|FG005|Overall Study|Withdrawal by Subject|1|||
105806353|NCT02100956|364947008|FG000|At Least One Week Between Injections|Adverse Event|0|||
105806354|NCT02100956|364947009|FG001|At Least One Week Between Injections|Adverse Event|1|||
105806355|NCT01896297|364947011|FG000|Overall Study|Died in post treatment phase|1|||
105806356|NCT00385541|364947012|FG000|Overall Study|severe pain, clinician requested unblind|0|||
105806357|NCT00385541|364947013|FG001|Overall Study|severe pain, clinician requested unblind|1|||
105806358|NCT01893138|364947014|FG000|Double-Blind Period|Withdrawal by Subject|1|||
105806359|NCT01893138|364947015|FG001|Double-Blind Period|Withdrawal by Subject|1|||
105484753|NCT00484185|363785554|FG000|Overall Study|Lost to Follow-up|44|||
105570232|NCT00405639|364086710|FG000|Overall Study|Adverse Event|1|||
105484754|NCT00484185|363785554|FG000|Overall Study|Other|20|||
105484755|NCT00484185|363785554|FG000|Overall Study|Randomized but not treated|5|||
105484756|NCT00484185|363785554|FG000|Overall Study|Death|2|||
105806360|NCT01893138|364947014|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
105806361|NCT01893138|364947015|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
105806362|NCT01893138|364947014|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
105806363|NCT01893138|364947015|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
105806364|NCT01893138|364947014|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
105806365|NCT01893138|364947015|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
105806366|NCT01893138|364947014|FG000|Open Label - Unblinded Period|Adverse Event|1|||
105806367|NCT01893138|364947015|FG001|Open Label - Unblinded Period|Adverse Event|0|||
105806368|NCT01326026|364947022|FG000|Overall Study|Adverse Event|4|||
105806369|NCT01326026|364947023|FG001|Overall Study|Adverse Event|3|||
105806370|NCT01326026|364947022|FG000|Overall Study|Withdrawal Criteria|5|||
105806371|NCT01326026|364947023|FG001|Overall Study|Withdrawal Criteria|7|||
105806372|NCT01326026|364947022|FG000|Overall Study|Other|3|||
105806373|NCT01326026|364947023|FG001|Overall Study|Other|3|||
105806374|NCT00434161|364948955|FG000|Overall Study|Adverse Event|5|||
105806375|NCT00434161|364948956|FG001|Overall Study|Adverse Event|1|||
105806376|NCT00434161|364948957|FG002|Overall Study|Adverse Event|4|||
105806377|NCT00434161|364948955|FG000|Overall Study|Lost to Follow-up|0|||
105806378|NCT00434161|364948956|FG001|Overall Study|Lost to Follow-up|1|||
105806379|NCT00434161|364948957|FG002|Overall Study|Lost to Follow-up|0|||
105806380|NCT00434161|364948955|FG000|Overall Study|Death|1|||
105806381|NCT00434161|364948956|FG001|Overall Study|Death|0|||
105806382|NCT00434161|364948957|FG002|Overall Study|Death|1|||
105806383|NCT00434161|364948955|FG000|Overall Study|Non-Compliance|1|||
105806384|NCT00434161|364948956|FG001|Overall Study|Non-Compliance|1|||
105806385|NCT00434161|364948957|FG002|Overall Study|Non-Compliance|0|||
105806386|NCT00434161|364948955|FG000|Overall Study|Withdrawal by Subject|2|||
105806387|NCT00434161|364948956|FG001|Overall Study|Withdrawal by Subject|0|||
105806388|NCT00434161|364948957|FG002|Overall Study|Withdrawal by Subject|3|||
105806389|NCT00434161|364948955|FG000|Overall Study|Logistical error study assessments|1|||
105806390|NCT00434161|364948956|FG001|Overall Study|Logistical error study assessments|0|||
105806391|NCT00434161|364948957|FG002|Overall Study|Logistical error study assessments|3|||
105806392|NCT02451670|364948962|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
105806393|NCT02451670|364948963|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
105806394|NCT00673361|364948979|FG000|Overall Study|Screen Failure|2|||
105806395|NCT00829413|364948980|FG000|Overall Study|No study drug admimnistered|13|||
105806396|NCT00829413|364948980|FG000|Overall Study|Training Patients|67|||
105806397|NCT00829413|364948980|FG000|Overall Study|No truth standard procedure available|9|||
105806398|NCT00829413|364948980|FG000|Overall Study|Technically inadequate truth standard|2|||
105806399|NCT00829413|364948980|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
105806400|NCT01464827|364948981|FG000|Overall Study|Adverse Event|0|||
105806401|NCT01464827|364948982|FG001|Overall Study|Adverse Event|0|||
105806402|NCT01464827|364948983|FG002|Overall Study|Adverse Event|0|||
105806403|NCT01464827|364948984|FG003|Overall Study|Adverse Event|0|||
105806404|NCT01464827|364948985|FG004|Overall Study|Adverse Event|0|||
105806405|NCT01464827|364948986|FG005|Overall Study|Adverse Event|0|||
105806406|NCT01464827|364948987|FG006|Overall Study|Adverse Event|0|||
105806407|NCT01464827|364948988|FG007|Overall Study|Adverse Event|0|||
105806408|NCT01464827|364948989|FG008|Overall Study|Adverse Event|0|||
105806409|NCT01464827|364948990|FG009|Overall Study|Adverse Event|0|||
105806410|NCT01464827|364948991|FG010|Overall Study|Adverse Event|0|||
105806411|NCT01464827|364948992|FG011|Overall Study|Adverse Event|0|||
105806412|NCT01464827|364948993|FG012|Overall Study|Adverse Event|1|||
105806413|NCT01464827|364948994|FG013|Overall Study|Adverse Event|0|||
105806414|NCT01464827|364948981|FG000|Overall Study|Withdrawal by Subject|1|||
105806415|NCT01464827|364948982|FG001|Overall Study|Withdrawal by Subject|0|||
105806416|NCT01464827|364948983|FG002|Overall Study|Withdrawal by Subject|0|||
105360785|NCT00572455|363328080|FG000|Stage II (28 Days)|Adverse Event|0|||
105360786|NCT00572455|363328081|FG001|Stage II (28 Days)|Adverse Event|0|||
105806417|NCT01464827|364948984|FG003|Overall Study|Withdrawal by Subject|0|||
105806418|NCT01464827|364948985|FG004|Overall Study|Withdrawal by Subject|1|||
105806419|NCT01464827|364948986|FG005|Overall Study|Withdrawal by Subject|0|||
105806420|NCT01464827|364948987|FG006|Overall Study|Withdrawal by Subject|0|||
105806421|NCT01464827|364948988|FG007|Overall Study|Withdrawal by Subject|1|||
105806422|NCT01464827|364948989|FG008|Overall Study|Withdrawal by Subject|0|||
105806423|NCT01464827|364948990|FG009|Overall Study|Withdrawal by Subject|0|||
105360787|NCT00572455|363328082|FG002|Stage II (28 Days)|Adverse Event|0|||
105360788|NCT00572455|363328083|FG003|Stage II (28 Days)|Adverse Event|0|||
105360789|NCT00572455|363328084|FG004|Stage II (28 Days)|Adverse Event|0|||
105806424|NCT01464827|364948991|FG010|Overall Study|Withdrawal by Subject|0|||
105806425|NCT01464827|364948992|FG011|Overall Study|Withdrawal by Subject|0|||
105806426|NCT01464827|364948993|FG012|Overall Study|Withdrawal by Subject|0|||
105806427|NCT01464827|364948994|FG013|Overall Study|Withdrawal by Subject|0|||
105806428|NCT01464827|364948981|FG000|Overall Study|Lost to Follow-up|0|||
105806429|NCT01464827|364948982|FG001|Overall Study|Lost to Follow-up|2|||
105806430|NCT01464827|364948983|FG002|Overall Study|Lost to Follow-up|0|||
105360790|NCT00572455|363328085|FG005|Stage II (28 Days)|Adverse Event|0|||
105484757|NCT02650921|363785556|FG000|Overall Study|Withdrawal by Subject|4|||
105484758|NCT02650921|363785556|FG000|Overall Study|Lost to Follow-up|2|||
105484759|NCT02650921|363785556|FG000|Overall Study|Adverse Event|1|||
105484760|NCT02650921|363785556|FG000|Overall Study|Due to Medical Condition|1|||
105484761|NCT03562767|363785559|FG000|Overall Study|Physician Decision|2|||
105484762|NCT03562767|363785560|FG001|Overall Study|Physician Decision|0|||
105484763|NCT03562767|363785561|FG002|Overall Study|Physician Decision|0|||
105484764|NCT03562767|363785559|FG000|Overall Study|Logistic Reason|1|||
105484765|NCT03562767|363785560|FG001|Overall Study|Logistic Reason|3|||
105484766|NCT03562767|363785561|FG002|Overall Study|Logistic Reason|0|||
105484767|NCT02048241|363785564|FG000|Overall Study|Withdrawal by Subject|0|||
105484768|NCT02048241|363785565|FG001|Overall Study|Withdrawal by Subject|1|||
105484769|NCT01853618|363785566|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
105484770|NCT01853618|363785567|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
105484771|NCT01853618|363785568|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
105484772|NCT01853618|363785569|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
105484773|NCT01853618|363785570|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
105484774|NCT01853618|363785566|FG000|Overall Study|Progressive disease|1|||
105484775|NCT01853618|363785567|FG001|Overall Study|Progressive disease|1|||
105484776|NCT01853618|363785568|FG002|Overall Study|Progressive disease|1|||
105484777|NCT01853618|363785569|FG003|Overall Study|Progressive disease|1|||
105484778|NCT01853618|363785570|FG004|Overall Study|Progressive disease|2|||
105484779|NCT01853618|363785566|FG000|Overall Study|Physician Decision|0|||
105484780|NCT01853618|363785567|FG001|Overall Study|Physician Decision|1|||
105484781|NCT01853618|363785568|FG002|Overall Study|Physician Decision|1|||
105484782|NCT01853618|363785569|FG003|Overall Study|Physician Decision|0|||
105484783|NCT01853618|363785570|FG004|Overall Study|Physician Decision|0|||
105484784|NCT01853618|363785566|FG000|Overall Study|Refused further treatment|0|||
105484785|NCT01853618|363785567|FG001|Overall Study|Refused further treatment|0|||
105484786|NCT01853618|363785568|FG002|Overall Study|Refused further treatment|0|||
105484787|NCT01853618|363785569|FG003|Overall Study|Refused further treatment|0|||
105484788|NCT01853618|363785570|FG004|Overall Study|Refused further treatment|1|||
105484789|NCT05615935|363785573|FG000|Overall Study|Lost to Follow-up|1|||
105484790|NCT05615935|363785574|FG001|Overall Study|Lost to Follow-up|1|||
105484791|NCT01658813|363785575|FG000|Overall Study|Disease progression|3|||
105484792|NCT00938886|363785576|FG000|Overall Study|Death|0|||
105484793|NCT00938886|363785577|FG001|Overall Study|Death|1|||
105484794|NCT00938886|363785576|FG000|Overall Study|Withdrawal by Subject|4|||
105484795|NCT00938886|363785577|FG001|Overall Study|Withdrawal by Subject|7|||
105484796|NCT00938886|363785576|FG000|Overall Study|Lost to Follow-up|3|||
105484797|NCT00938886|363785577|FG001|Overall Study|Lost to Follow-up|2|||
105484798|NCT01585584|363785584|FG000|Overall Study|Lack of Efficacy|1|||
105484799|NCT01585584|363785584|FG000|Overall Study|Withdrawal by Subject|1|||
105484800|NCT01585584|363785584|FG000|Overall Study|Physician Decision|2|||
105484801|NCT00527488|363785585|FG000|Overall Study|Withdrawn prior to dosing|0|||
105484802|NCT00527488|363785586|FG001|Overall Study|Withdrawn prior to dosing|1|||
105484803|NCT00527488|363785587|FG002|Overall Study|Withdrawn prior to dosing|1|||
105484804|NCT00527488|363785588|FG003|Overall Study|Withdrawn prior to dosing|0|||
105484805|NCT04480424|363785591|FG000|Overall Study|Withdrawal by Subject|0|||
105484806|NCT04480424|363785592|FG001|Overall Study|Withdrawal by Subject|2|||
105484807|NCT04480424|363785591|FG000|Overall Study|Lost to Follow-up|3|||
105484808|NCT04480424|363785592|FG001|Overall Study|Lost to Follow-up|3|||
105484809|NCT04480424|363785591|FG000|Overall Study|Death|14|||
105484810|NCT04480424|363785592|FG001|Overall Study|Death|16|||
105484811|NCT04480424|363785591|FG000|Overall Study|Reason not Specified|5|||
105484812|NCT04480424|363785592|FG001|Overall Study|Reason not Specified|5|||
105484813|NCT01163318|363785593|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
105484814|NCT01163318|363785593|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
105484815|NCT01163318|363785593|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
105484816|NCT01163318|363785593|FG000|Overall Study|Participants Without Case Report Form|7|||
105484817|NCT01163318|363785593|FG000|Overall Study|Multiple Reasons Per Participant|224|||
105484818|NCT00910247|363786976|FG000|Overall Study|Adverse Event|15|||
105484819|NCT00910247|363786976|FG000|Overall Study|Death|2|||
105484820|NCT00910247|363786976|FG000|Overall Study|Lost to Follow-up|10|||
105484821|NCT00910247|363786976|FG000|Overall Study|Physician Decision|3|||
105484822|NCT00910247|363786976|FG000|Overall Study|Protocol Violation|10|||
105484823|NCT00910247|363786976|FG000|Overall Study|Withdrawal by Subject|25|||
105484824|NCT00910247|363786976|FG000|Overall Study|Not collected|4|||
105484825|NCT00504582|363786977|FG000|Overall Study|Lost to Follow-up|1|||
105484826|NCT00504582|363786978|FG001|Overall Study|Lost to Follow-up|0|||
105484827|NCT00504582|363786979|FG002|Overall Study|Lost to Follow-up|0|||
105484828|NCT01992159|363786982|FG000|Overall Study|Withdrawal by Subject|4|||
105484829|NCT01992159|363786983|FG001|Overall Study|Withdrawal by Subject|7|||
105806540|NCT03209570|364949015|FG000|Overall Study|Withdrawal by Subject|0|||
105806541|NCT03209570|364949016|FG001|Overall Study|Withdrawal by Subject|3|||
105806542|NCT00723554|364949017|FG000|Overall Study|Adverse Event|12|||
105806543|NCT00723554|364949017|FG000|Overall Study|Investigator's judgement|5|||
105806544|NCT00723554|364949017|FG000|Overall Study|Inhaled medication other than iloprost|4|||
105806545|NCT00723554|364949017|FG000|Overall Study|Withdrawal of consent|3|||
105806546|NCT00723554|364949017|FG000|Overall Study|Other|3|||
105806547|NCT00723554|364949017|FG000|Overall Study|Lost to Follow-up|1|||
105806548|NCT00723554|364949017|FG000|Overall Study|Non-compliance|1|||
105806549|NCT01405820|364949019|FG000|Randomized Treatment Period|Adverse Event|3|||
105806550|NCT01405820|364949020|FG001|Randomized Treatment Period|Adverse Event|3|||
105806551|NCT01405820|364949021|FG002|Randomized Treatment Period|Adverse Event|3|||
105806552|NCT01405820|364949022|FG003|Randomized Treatment Period|Adverse Event|0|||
105806553|NCT01405820|364949023|FG004|Randomized Treatment Period|Adverse Event|2|||
105806554|NCT01405820|364949024|FG005|Randomized Treatment Period|Adverse Event|1|||
105806555|NCT01405820|364949019|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
105806556|NCT01405820|364949020|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
105806557|NCT01405820|364949021|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
105806558|NCT01405820|364949022|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
105806559|NCT01405820|364949023|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
105806560|NCT01405820|364949024|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
105806561|NCT01405820|364949019|FG000|Randomized Treatment Period|Other|2|||
105806562|NCT01405820|364949020|FG001|Randomized Treatment Period|Other|2|||
105806563|NCT01405820|364949021|FG002|Randomized Treatment Period|Other|1|||
105806564|NCT01405820|364949022|FG003|Randomized Treatment Period|Other|1|||
105806565|NCT01405820|364949023|FG004|Randomized Treatment Period|Other|0|||
105806566|NCT01405820|364949024|FG005|Randomized Treatment Period|Other|0|||
105806567|NCT01405820|364949019|FG000|Randomized Treatment Period|Physician Decision|0|||
105806568|NCT01405820|364949020|FG001|Randomized Treatment Period|Physician Decision|2|||
105806569|NCT01405820|364949021|FG002|Randomized Treatment Period|Physician Decision|1|||
105806570|NCT01405820|364949022|FG003|Randomized Treatment Period|Physician Decision|0|||
105806571|NCT01405820|364949023|FG004|Randomized Treatment Period|Physician Decision|0|||
105806572|NCT01405820|364949024|FG005|Randomized Treatment Period|Physician Decision|0|||
105806573|NCT01405820|364949019|FG000|Randomized Treatment Period|Rescue|0|||
105806574|NCT01405820|364949020|FG001|Randomized Treatment Period|Rescue|1|||
105806575|NCT01405820|364949021|FG002|Randomized Treatment Period|Rescue|13|||
105806576|NCT01405820|364949022|FG003|Randomized Treatment Period|Rescue|10|||
105806577|NCT01405820|364949023|FG004|Randomized Treatment Period|Rescue|8|||
105570319|NCT03573908|364086750|FG002|Treatment Period|Other, Not Specified|0|||
105570320|NCT03573908|364086751|FG003|Treatment Period|Other, Not Specified|0|||
105570321|NCT03573908|364086752|FG004|Treatment Period|Other, Not Specified|0|||
105570322|NCT03573908|364086748|FG000|Randomized Withdrawal Period|Adverse Event|0|||
105570323|NCT03573908|364086749|FG001|Randomized Withdrawal Period|Adverse Event|0|||
105570324|NCT03573908|364086750|FG002|Randomized Withdrawal Period|Adverse Event|3|||
105570325|NCT03573908|364086751|FG003|Randomized Withdrawal Period|Adverse Event|0|||
105570326|NCT03573908|364086752|FG004|Randomized Withdrawal Period|Adverse Event|0|||
105570327|NCT03573908|364086748|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105570328|NCT03573908|364086749|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105570329|NCT03573908|364086750|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105570330|NCT03573908|364086751|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105570331|NCT03573908|364086752|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
105570332|NCT03573908|364086748|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
105570333|NCT03573908|364086749|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
105570334|NCT03573908|364086750|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
105570335|NCT03573908|364086751|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
105570336|NCT03573908|364086752|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
105570337|NCT03573908|364086748|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
105570338|NCT03573908|364086749|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
105570339|NCT03573908|364086750|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
105570340|NCT03573908|364086751|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
105570341|NCT03573908|364086752|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
105570342|NCT02669095|364086758|FG000|Overall Study|Adverse Event|1|||
105806578|NCT01405820|364949024|FG005|Randomized Treatment Period|Rescue|8|||
105570343|NCT02669095|364086759|FG001|Overall Study|Adverse Event|0|||
105570344|NCT02669095|364086758|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
105570345|NCT02669095|364086759|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
105570346|NCT02669095|364086758|FG000|Overall Study|Torn Lens|0|||
105570347|NCT02669095|364086759|FG001|Overall Study|Torn Lens|1|||
105806579|NCT01405820|364949019|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
105806580|NCT01405820|364949020|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
105806581|NCT01405820|364949021|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
105806582|NCT01405820|364949022|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
105570348|NCT02669095|364086758|FG000|Overall Study|Visit 5 assessments not completed|0|||
105806583|NCT01405820|364949023|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
105806584|NCT01405820|364949024|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
105806585|NCT01405820|364949019|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
105806586|NCT01405820|364949020|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
105806587|NCT01405820|364949021|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
105806588|NCT01405820|364949022|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
105806589|NCT01405820|364949023|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
105806590|NCT01405820|364949024|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
105806591|NCT01405820|364949019|FG000|Randomized Treatment Period|Death|0|||
105806592|NCT01405820|364949020|FG001|Randomized Treatment Period|Death|0|||
105806593|NCT01405820|364949021|FG002|Randomized Treatment Period|Death|0|||
105806594|NCT01405820|364949022|FG003|Randomized Treatment Period|Death|1|||
105806595|NCT01405820|364949023|FG004|Randomized Treatment Period|Death|0|||
105806596|NCT01405820|364949024|FG005|Randomized Treatment Period|Death|0|||
105806597|NCT01405820|364949019|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
105806598|NCT01405820|364949020|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
105806599|NCT01405820|364949021|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
105806600|NCT01405820|364949022|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
105806601|NCT01405820|364949023|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
105806602|NCT01405820|364949024|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
105806603|NCT01405820|364949019|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
105806604|NCT01405820|364949020|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
105806605|NCT01405820|364949021|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
105806606|NCT01405820|364949022|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
105806607|NCT01405820|364949023|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
105806608|NCT01405820|364949024|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
105806609|NCT01405820|364949019|FG000|Open-Label Treatment Period|Other|1|||
105806610|NCT01405820|364949020|FG001|Open-Label Treatment Period|Other|1|||
105806611|NCT01405820|364949021|FG002|Open-Label Treatment Period|Other|1|||
105806612|NCT01405820|364949022|FG003|Open-Label Treatment Period|Other|1|||
105806613|NCT01405820|364949023|FG004|Open-Label Treatment Period|Other|1|||
105806614|NCT01405820|364949024|FG005|Open-Label Treatment Period|Other|1|||
105806615|NCT01405820|364949019|FG000|Open-Label Treatment Period|Physician Decision|0|||
105806616|NCT01405820|364949020|FG001|Open-Label Treatment Period|Physician Decision|0|||
105806617|NCT01405820|364949021|FG002|Open-Label Treatment Period|Physician Decision|1|||
105806618|NCT01405820|364949022|FG003|Open-Label Treatment Period|Physician Decision|2|||
105806619|NCT01405820|364949023|FG004|Open-Label Treatment Period|Physician Decision|1|||
105806620|NCT01405820|364949024|FG005|Open-Label Treatment Period|Physician Decision|0|||
105806621|NCT01405820|364949019|FG000|Open-Label Treatment Period|Adverse Event|0|||
105806622|NCT01405820|364949020|FG001|Open-Label Treatment Period|Adverse Event|0|||
105806623|NCT01405820|364949021|FG002|Open-Label Treatment Period|Adverse Event|0|||
105806624|NCT01405820|364949022|FG003|Open-Label Treatment Period|Adverse Event|1|||
105806625|NCT01405820|364949023|FG004|Open-Label Treatment Period|Adverse Event|0|||
105806626|NCT01405820|364949024|FG005|Open-Label Treatment Period|Adverse Event|0|||
105806627|NCT03222141|364949027|FG000|Overall Study|Death|15|||
105806628|NCT03222141|364949027|FG000|Overall Study|Lost to Follow-up|3|||
105806629|NCT02087046|364949028|FG000|Overall Study|Adverse Event|4|||
105806630|NCT02087046|364949028|FG000|Overall Study|Death|1|||
105806631|NCT02087046|364949028|FG000|Overall Study|Lost to Follow-up|3|||
105806632|NCT02087046|364949028|FG000|Overall Study|Withdrawal by Subject|2|||
105806633|NCT02087046|364949028|FG000|Overall Study|Physician Decision|1|||
105806634|NCT01214603|364949029|FG000|Overall Study|Adverse Event|0|||
105484986|NCT01895361|363787033|FG002|Overall Study|Withdrawal by Subject|6|||
105484987|NCT01895361|363787031|FG000|Overall Study|Lack of Efficacy|0|||
105484988|NCT01895361|363787032|FG001|Overall Study|Lack of Efficacy|1|||
105806635|NCT01214603|364949030|FG001|Overall Study|Adverse Event|0|||
105806636|NCT01214603|364949031|FG002|Overall Study|Adverse Event|1|||
105806637|NCT01214603|364949029|FG000|Overall Study|Death|1|||
105806638|NCT01214603|364949030|FG001|Overall Study|Death|0|||
105806639|NCT01214603|364949031|FG002|Overall Study|Death|0|||
105806640|NCT01214603|364949029|FG000|Overall Study|Progressive Disease|4|||
105484989|NCT01895361|363787033|FG002|Overall Study|Lack of Efficacy|0|||
105484990|NCT01895361|363787031|FG000|Overall Study|Reasons different from categories above|7|||
105806641|NCT01214603|364949030|FG001|Overall Study|Progressive Disease|1|||
105806642|NCT01214603|364949031|FG002|Overall Study|Progressive Disease|3|||
105806643|NCT01507896|364949032|FG000|Overall Study|Withdrawal by Subject|1|||
105806644|NCT01507896|364949032|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
105806645|NCT00490061|364949033|FG000|Overall Study|Physician Decision|1|||
105806646|NCT01155583|364949034|FG000|Phase I|Screen failure - did not start treatment|0|||
105484991|NCT01895361|363787032|FG001|Overall Study|Reasons different from categories above|3|||
105484992|NCT01895361|363787033|FG002|Overall Study|Reasons different from categories above|4|||
105806647|NCT01155583|364949035|FG001|Phase I|Screen failure - did not start treatment|0|||
105806648|NCT01155583|364949036|FG002|Phase I|Screen failure - did not start treatment|0|||
105806649|NCT01155583|364949037|FG003|Phase I|Screen failure - did not start treatment|0|||
105806650|NCT01155583|364949038|FG004|Phase I|Screen failure - did not start treatment|1|||
105806651|NCT01155583|364949039|FG005|Phase I|Screen failure - did not start treatment|0|||
105806652|NCT01155583|364949040|FG006|Phase I|Screen failure - did not start treatment|0|||
105806653|NCT01155583|364949041|FG007|Phase I|Screen failure - did not start treatment|2|||
105806654|NCT01155583|364949042|FG008|Phase I|Screen failure - did not start treatment|0|||
105806655|NCT01155583|364949034|FG000|Phase I|Withdrawal by Subject|0|||
105806656|NCT01155583|364949035|FG001|Phase I|Withdrawal by Subject|0|||
105806657|NCT01155583|364949036|FG002|Phase I|Withdrawal by Subject|0|||
105806658|NCT01155583|364949037|FG003|Phase I|Withdrawal by Subject|0|||
105806659|NCT01155583|364949038|FG004|Phase I|Withdrawal by Subject|0|||
105806660|NCT01155583|364949039|FG005|Phase I|Withdrawal by Subject|0|||
105806661|NCT01155583|364949040|FG006|Phase I|Withdrawal by Subject|0|||
105806662|NCT01155583|364949041|FG007|Phase I|Withdrawal by Subject|1|||
105806663|NCT01155583|364949042|FG008|Phase I|Withdrawal by Subject|0|||
105806664|NCT04274192|364949049|FG000|Overall Study|Protocol Violation|1|||
105806665|NCT04274192|364949050|FG001|Overall Study|Protocol Violation|0|||
105806666|NCT02482571|364949051|FG000|Overall Study|Adverse Event|1|||
105806667|NCT02482571|364949051|FG000|Overall Study|Scanner or Respiract failure|3|||
105806668|NCT02482571|364949051|FG000|Overall Study|Withdrawal by Subject|4|||
105806669|NCT01185288|364949052|FG000|Overall Study|Adverse Event|7|||
105806670|NCT01185288|364949053|FG001|Overall Study|Adverse Event|6|||
105806671|NCT01185288|364949052|FG000|Overall Study|Withdrawal by Subject|6|||
105806672|NCT01185288|364949053|FG001|Overall Study|Withdrawal by Subject|4|||
105806673|NCT01185288|364949052|FG000|Overall Study|Lost to Follow-up|2|||
105806674|NCT01185288|364949053|FG001|Overall Study|Lost to Follow-up|5|||
105806675|NCT01185288|364949052|FG000|Overall Study|Lack of Efficacy|2|||
105806676|NCT01185288|364949053|FG001|Overall Study|Lack of Efficacy|0|||
105806677|NCT01185288|364949052|FG000|Overall Study|Investigator discretion|1|||
105806678|NCT01185288|364949053|FG001|Overall Study|Investigator discretion|0|||
105806679|NCT01185288|364949052|FG000|Overall Study|Did not meet inclusion criteria|1|||
105806680|NCT01185288|364949053|FG001|Overall Study|Did not meet inclusion criteria|0|||
105806681|NCT01185288|364949052|FG000|Overall Study|Noncompliance|0|||
105806682|NCT01185288|364949053|FG001|Overall Study|Noncompliance|1|||
105806683|NCT01789320|364949054|FG000|Overall Study|Re-enrolled into study|1|||
105806684|NCT01789320|364949054|FG000|Overall Study|Lost to Follow-up|1|||
105806685|NCT03775681|364949055|FG000|Overall Study|Physician Decision|3|||
105806686|NCT02789111|364949056|FG000|Overall Study|Withdrawal by Subject|1|||
105806687|NCT02789111|364949057|FG001|Overall Study|Withdrawal by Subject|4|||
105806688|NCT01488578|364949058|FG000|Overall Study|Protocol Violation|1836|||
105806689|NCT01626885|364949059|FG000|Overall Study|Adverse Event|8|||
105806690|NCT01626885|364949059|FG000|Overall Study|Withdrawal by Subject|4|||
105806691|NCT03271528|364949060|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
105806692|NCT03271528|364949061|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
105806693|NCT03271528|364949060|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
105806694|NCT03271528|364949061|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
105806695|NCT03271528|364949060|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
105806696|NCT03271528|364949061|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
105806697|NCT03271528|364949060|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
105806698|NCT03271528|364949061|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
105806699|NCT03271528|364949060|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
105806700|NCT03271528|364949061|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
105806701|NCT03271528|364949060|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
105806702|NCT03271528|364949061|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
105806703|NCT03271528|364949060|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
105570349|NCT02669095|364086759|FG001|Overall Study|Visit 5 assessments not completed|1|||
105570350|NCT03757234|364086760|FG000|Overall Study|Adverse Event|0|||
105806704|NCT03271528|364949061|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
105806705|NCT00717756|364949063|FG000|Overall Study|Withdrawal by Subject|1|||
105806706|NCT00306384|364949064|FG000|Overall Study|Adverse Event|103|||
105806707|NCT00306384|364949065|FG001|Overall Study|Adverse Event|87|||
105806708|NCT00306384|364949066|FG002|Overall Study|Adverse Event|40|||
105806709|NCT00306384|364949064|FG000|Overall Study|Major protocol deviation|43|||
105806710|NCT00306384|364949065|FG001|Overall Study|Major protocol deviation|51|||
105806711|NCT00306384|364949066|FG002|Overall Study|Major protocol deviation|18|||
105806712|NCT00306384|364949064|FG000|Overall Study|Lost to Follow-up|57|||
105806713|NCT00306384|364949065|FG001|Overall Study|Lost to Follow-up|41|||
105806714|NCT00306384|364949066|FG002|Overall Study|Lost to Follow-up|35|||
105806715|NCT00306384|364949064|FG000|Overall Study|Voluntary withdrawal|199|||
105806716|NCT00306384|364949065|FG001|Overall Study|Voluntary withdrawal|187|||
105806717|NCT00306384|364949066|FG002|Overall Study|Voluntary withdrawal|91|||
105806718|NCT00306384|364949064|FG000|Overall Study|Study termination|1|||
105806719|NCT00306384|364949065|FG001|Overall Study|Study termination|0|||
105806720|NCT00306384|364949066|FG002|Overall Study|Study termination|1|||
105806721|NCT00306384|364949064|FG000|Overall Study|Pregnancy|3|||
105806722|NCT00306384|364949065|FG001|Overall Study|Pregnancy|1|||
105806723|NCT00306384|364949066|FG002|Overall Study|Pregnancy|1|||
105806724|NCT00306384|364949064|FG000|Overall Study|Lack of Efficacy|26|||
105806725|NCT00306384|364949065|FG001|Overall Study|Lack of Efficacy|40|||
105806726|NCT00306384|364949066|FG002|Overall Study|Lack of Efficacy|38|||
105806727|NCT00306384|364949064|FG000|Overall Study|Investigator discretion|28|||
105806728|NCT00306384|364949065|FG001|Overall Study|Investigator discretion|31|||
105806729|NCT00306384|364949066|FG002|Overall Study|Investigator discretion|21|||
105806730|NCT00306384|364949064|FG000|Overall Study|Other|80|||
105806731|NCT00306384|364949065|FG001|Overall Study|Other|70|||
105806732|NCT00306384|364949066|FG002|Overall Study|Other|32|||
105806733|NCT00306384|364949064|FG000|Overall Study|Site closure|2|||
105806734|NCT00306384|364949065|FG001|Overall Study|Site closure|0|||
105806735|NCT00306384|364949066|FG002|Overall Study|Site closure|0|||
105806736|NCT00673790|364949067|FG000|Overall Study|Adverse Event|23|||
105806737|NCT00673790|364949068|FG001|Overall Study|Adverse Event|14|||
105806738|NCT00673790|364949069|FG002|Overall Study|Adverse Event|2|||
105806739|NCT00673790|364949067|FG000|Overall Study|Lack of Efficacy|2|||
105806740|NCT00673790|364949068|FG001|Overall Study|Lack of Efficacy|2|||
105806741|NCT00673790|364949069|FG002|Overall Study|Lack of Efficacy|2|||
105806742|NCT00673790|364949067|FG000|Overall Study|Protocol Violation|6|||
105806743|NCT00673790|364949068|FG001|Overall Study|Protocol Violation|9|||
105806744|NCT00673790|364949069|FG002|Overall Study|Protocol Violation|1|||
105806745|NCT00673790|364949067|FG000|Overall Study|Withdrawal by Subject|7|||
105806746|NCT00673790|364949068|FG001|Overall Study|Withdrawal by Subject|4|||
105806747|NCT00673790|364949069|FG002|Overall Study|Withdrawal by Subject|1|||
105806748|NCT00673790|364949067|FG000|Overall Study|Lost to Follow-up|6|||
105806749|NCT00673790|364949068|FG001|Overall Study|Lost to Follow-up|6|||
105806750|NCT00673790|364949069|FG002|Overall Study|Lost to Follow-up|5|||
105806751|NCT00673790|364949067|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
105806752|NCT00673790|364949068|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
105806753|NCT00673790|364949069|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
105806754|NCT00673790|364949067|FG000|Overall Study|Poor compliance|1|||
105806755|NCT00673790|364949068|FG001|Overall Study|Poor compliance|0|||
105806756|NCT00673790|364949069|FG002|Overall Study|Poor compliance|0|||
105806757|NCT00673790|364949067|FG000|Overall Study|Participated in two Nebivolol studies|0|||
105806758|NCT00673790|364949068|FG001|Overall Study|Participated in two Nebivolol studies|0|||
105806759|NCT00673790|364949069|FG002|Overall Study|Participated in two Nebivolol studies|1|||
105806760|NCT00673790|364949067|FG000|Overall Study|Unconfirmed pregnancy|0|||
105806761|NCT00673790|364949068|FG001|Overall Study|Unconfirmed pregnancy|1|||
105806762|NCT00673790|364949069|FG002|Overall Study|Unconfirmed pregnancy|0|||
105806763|NCT00673790|364949067|FG000|Overall Study|Randomization criteria not met|0|||
105806764|NCT00673790|364949068|FG001|Overall Study|Randomization criteria not met|1|||
105806765|NCT00673790|364949069|FG002|Overall Study|Randomization criteria not met|0|||
105484993|NCT01209832|363787037|FG000|Period 1|Sponsor Decision and was not dosed|1|||
105484994|NCT01209832|363787037|FG000|Period 2|Sponsor Decision|1|||
105484995|NCT01268579|363787038|FG000|Overall Study|Adverse Event|1|||
105484996|NCT01268579|363787038|FG000|Overall Study|Withdrawal by Subject|2|||
105484997|NCT00761150|363787039|FG000|Open-label Period|Adverse Event|36|||
105484998|NCT00761150|363787040|FG001|Open-label Period|Adverse Event|0|||
105484999|NCT00761150|363787041|FG002|Open-label Period|Adverse Event|0|||
105485000|NCT00761150|363787039|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
105485001|NCT00761150|363787040|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
105806766|NCT01873859|364949070|FG000|Overall Study|Withdrawal by Subject|0|||
105806767|NCT01873859|364949071|FG001|Overall Study|Withdrawal by Subject|4|||
105806768|NCT01364870|364949072|FG000|Overall Study|Withdrawal by Subject|13|||
105806769|NCT01364870|364949073|FG001|Overall Study|Withdrawal by Subject|24|||
105806770|NCT01364870|364949074|FG002|Overall Study|Withdrawal by Subject|10|||
105806771|NCT01364870|364949072|FG000|Overall Study|Adverse Event|8|||
105806772|NCT01364870|364949073|FG001|Overall Study|Adverse Event|6|||
105806773|NCT01364870|364949074|FG002|Overall Study|Adverse Event|4|||
105485002|NCT00761150|363787041|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
105485003|NCT00761150|363787039|FG000|Open-label Period|Lost to Follow-up|7|||
105806774|NCT01364870|364949072|FG000|Overall Study|Protocol Violation|1|||
105806775|NCT01364870|364949073|FG001|Overall Study|Protocol Violation|0|||
105806776|NCT01364870|364949074|FG002|Overall Study|Protocol Violation|0|||
105806777|NCT00601484|364949075|FG000|Overall Study|Adverse Event|0|||
105806778|NCT00601484|364949076|FG001|Overall Study|Adverse Event|1|||
105806779|NCT00601484|364949075|FG000|Overall Study|Lost to Follow-up|4|||
105806780|NCT00601484|364949076|FG001|Overall Study|Lost to Follow-up|3|||
105806781|NCT00601484|364949075|FG000|Overall Study|Lack of Efficacy|0|||
105806782|NCT00601484|364949076|FG001|Overall Study|Lack of Efficacy|2|||
105806783|NCT00601484|364949075|FG000|Overall Study|Withdrawal by Subject|1|||
105806784|NCT00601484|364949076|FG001|Overall Study|Withdrawal by Subject|1|||
105806785|NCT00601484|364949075|FG000|Overall Study|Randomized, but not treated|0|||
105806786|NCT00601484|364949076|FG001|Overall Study|Randomized, but not treated|1|||
105806787|NCT00969332|364949081|FG000|Overall Study|Physician Decision|8|||
105806788|NCT00969332|364949081|FG000|Overall Study|Withdrawal by Subject|3|||
105806789|NCT03828461|364949082|FG000|Overall Study|Lost to Follow-up|1|||
105806790|NCT03828461|364949082|FG000|Overall Study|Withdrawal by Subject|3|||
105806791|NCT03035227|364949083|FG000|Overall Study|study stopped due to PI leaving institut|1|||
105806792|NCT03035227|364949084|FG001|Overall Study|study stopped due to PI leaving institut|1|||
105806793|NCT03529955|364949085|FG000|Overall Study|Adverse Event|1|||
105806794|NCT03529955|364949085|FG000|Overall Study|Lack of Efficacy|1|||
105806795|NCT00859469|364949086|FG000|Overall Study|Adverse Event|2|||
105806796|NCT00859469|364949086|FG000|Overall Study|Lack of Efficacy|9|||
105806797|NCT00859469|364949086|FG000|Overall Study|Withdrawal by Subject|1|||
105806798|NCT00859469|364949086|FG000|Overall Study|Death|16|||
105806799|NCT02742181|364949087|FG000|Overall Study|Physician Decision|1|||
105806800|NCT02742181|364949088|FG001|Overall Study|Physician Decision|0|||
105806801|NCT01309919|364949105|FG000|Overall Study|Did not receive a postpartum IUD|17|||
105806802|NCT01309919|364949106|FG001|Overall Study|Did not receive a postpartum IUD|48|||
105806803|NCT00319449|364949107|FG000|Overall Study|Subject did not wish to continue|1|||
105806804|NCT00319449|364949108|FG001|Overall Study|Subject did not wish to continue|0|||
105806805|NCT00319449|364949107|FG000|Overall Study|Noncompliance with the protocol|1|||
105806806|NCT00319449|364949108|FG001|Overall Study|Noncompliance with the protocol|0|||
105806807|NCT02102490|364949109|FG000|Overall Study|Death|6|||
105806808|NCT02102490|364949109|FG000|Overall Study|Lost to Follow-up|1|||
105806809|NCT00752856|364949114|FG000|Overall Study|randomized but did not do viral kinetics|0|||
105806810|NCT00752856|364949115|FG001|Overall Study|randomized but did not do viral kinetics|1|||
105806811|NCT02260492|364949116|FG000|Overall Study|Adverse Event|6|||
105806812|NCT02260492|364949117|FG001|Overall Study|Adverse Event|1|||
105806813|NCT02260492|364949118|FG002|Overall Study|Adverse Event|2|||
105806814|NCT02260492|364949116|FG000|Overall Study|Death|0|||
105806815|NCT02260492|364949117|FG001|Overall Study|Death|1|||
105806816|NCT02260492|364949118|FG002|Overall Study|Death|0|||
105806817|NCT02260492|364949116|FG000|Overall Study|Lost to Follow-up|12|||
105806818|NCT02260492|364949117|FG001|Overall Study|Lost to Follow-up|9|||
105806819|NCT02260492|364949118|FG002|Overall Study|Lost to Follow-up|0|||
105806820|NCT02260492|364949116|FG000|Overall Study|Physician Decision|2|||
105806821|NCT02260492|364949117|FG001|Overall Study|Physician Decision|0|||
105806822|NCT02260492|364949118|FG002|Overall Study|Physician Decision|1|||
105806823|NCT02260492|364949116|FG000|Overall Study|Withdrawal by Subject|3|||
105806824|NCT02260492|364949117|FG001|Overall Study|Withdrawal by Subject|2|||
105806825|NCT02260492|364949118|FG002|Overall Study|Withdrawal by Subject|2|||
105806826|NCT00996736|364949119|FG000|Overall Study|Death|1|||
105806827|NCT00996736|364949120|FG001|Overall Study|Death|1|||
105806828|NCT00996736|364949119|FG000|Overall Study|Lost to Follow-up|15|||
105806829|NCT00996736|364949120|FG001|Overall Study|Lost to Follow-up|14|||
105806830|NCT00996736|364949119|FG000|Overall Study|Visit not within 3-month window|5|||
105806831|NCT00996736|364949120|FG001|Overall Study|Visit not within 3-month window|3|||
105806832|NCT02688608|364949121|FG000|Overall Study|Lost to Follow-up|1|||
105806833|NCT02456909|364949122|FG000|Overall Study|Did not receive allocated intervention|24|||
105806834|NCT02456909|364949123|FG001|Overall Study|Did not receive allocated intervention|26|||
105806835|NCT02456909|364949122|FG000|Overall Study|Did not complete the primary outcome|0|||
105806836|NCT02456909|364949123|FG001|Overall Study|Did not complete the primary outcome|1|||
105806837|NCT03997448|364950508|FG000|Study Treatment|Disease Progression|1|||
105806838|NCT03997448|364950508|FG000|Study Treatment|Symptomatic Deterioration|1|||
105806839|NCT03997448|364950508|FG000|Follow up|Death|2|||
105806840|NCT03997448|364950508|FG000|Follow up|study terminated|1|||
105806841|NCT00125359|364950509|FG000|Overall Study|Death|4|||
105806842|NCT00125359|364950509|FG000|Overall Study|Adverse Event|5|||
105806843|NCT00125359|364950509|FG000|Overall Study|Physician Decision|14|||
105806844|NCT00461500|364950510|FG000|Overall Study|Adverse Event|1|||
105806845|NCT00461500|364950511|FG001|Overall Study|Adverse Event|0|||
105806846|NCT00461500|364950510|FG000|Overall Study|Lack of Efficacy|0|||
105806847|NCT00461500|364950511|FG001|Overall Study|Lack of Efficacy|1|||
105806848|NCT00461500|364950510|FG000|Overall Study|Expired Drug Treatment|1|||
105806849|NCT00461500|364950511|FG001|Overall Study|Expired Drug Treatment|1|||
105806850|NCT00461500|364950510|FG000|Overall Study|Study Stopped|1|||
105806851|NCT00461500|364950511|FG001|Overall Study|Study Stopped|2|||
105806852|NCT00461500|364950510|FG000|Overall Study|Drug Treatment Misuse|1|||
105806853|NCT00461500|364950511|FG001|Overall Study|Drug Treatment Misuse|0|||
105570351|NCT03757234|364086761|FG001|Overall Study|Adverse Event|0|||
105570352|NCT03757234|364086762|FG002|Overall Study|Adverse Event|0|||
105806854|NCT00461500|364950510|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
105806855|NCT00461500|364950511|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
105806856|NCT00461500|364950510|FG000|Overall Study|Lost to Follow-up|2|||
105806857|NCT00461500|364950511|FG001|Overall Study|Lost to Follow-up|2|||
105806858|NCT00555009|364950521|FG000|Overall Study|Withdrawal by Subject|0|||
105806859|NCT00555009|364950522|FG001|Overall Study|Withdrawal by Subject|1|||
105806860|NCT00555009|364950521|FG000|Overall Study|Terminated by Sponsor|2|||
105806861|NCT00555009|364950522|FG001|Overall Study|Terminated by Sponsor|5|||
105806862|NCT02058628|364950523|FG000|Overall Study|Adverse Event|1|||
105806863|NCT02058628|364950524|FG001|Overall Study|Adverse Event|0|||
105806864|NCT02058628|364950523|FG000|Overall Study|Withdrawal by Subject|2|||
105806865|NCT02058628|364950524|FG001|Overall Study|Withdrawal by Subject|2|||
105806866|NCT02058628|364950523|FG000|Overall Study|Lost to Follow-up|2|||
105806867|NCT02058628|364950524|FG001|Overall Study|Lost to Follow-up|4|||
105806868|NCT02058628|364950523|FG000|Overall Study|Not in time schedule|0|||
105806869|NCT02058628|364950524|FG001|Overall Study|Not in time schedule|1|||
105806870|NCT02058628|364950523|FG000|Overall Study|The visit date was not in timeline|0|||
105806871|NCT02058628|364950524|FG001|Overall Study|The visit date was not in timeline|1|||
105806872|NCT02058628|364950523|FG000|Overall Study|A lot of time for study for participant|1|||
105806873|NCT02058628|364950524|FG001|Overall Study|A lot of time for study for participant|0|||
105806874|NCT02058628|364950523|FG000|Overall Study|Non compliance|1|||
105806875|NCT02058628|364950524|FG001|Overall Study|Non compliance|0|||
105806876|NCT02961920|364950525|FG000|Overall Study|did not achive stydy protocol schedule|1|||
105806877|NCT02961920|364950526|FG001|Overall Study|did not achive stydy protocol schedule|1|||
105806878|NCT02668783|364950529|FG000|Overall Study|Pregnancy|0|||
105806879|NCT02668783|364950530|FG001|Overall Study|Pregnancy|1|||
105806880|NCT02668783|364950529|FG000|Overall Study|Protocol Violation|2|||
105806881|NCT02668783|364950530|FG001|Overall Study|Protocol Violation|1|||
105806882|NCT02668783|364950529|FG000|Overall Study|Study terminated by sponsor|9|||
105806883|NCT02668783|364950530|FG001|Overall Study|Study terminated by sponsor|10|||
105806884|NCT02668783|364950529|FG000|Overall Study|Subject moved|1|||
105806885|NCT02668783|364950530|FG001|Overall Study|Subject moved|0|||
105806886|NCT02668783|364950529|FG000|Overall Study|Withdrawal by Subject|1|||
105806887|NCT02668783|364950530|FG001|Overall Study|Withdrawal by Subject|0|||
105806888|NCT00909727|364950531|FG000|Overall Study|Adverse Event|1|||
105806889|NCT00909727|364950532|FG001|Overall Study|Adverse Event|0|||
105806890|NCT00909727|364950531|FG000|Overall Study|Wrong Genotype|1|||
105806891|NCT00909727|364950532|FG001|Overall Study|Wrong Genotype|0|||
105806892|NCT00909727|364950531|FG000|Overall Study|Withdrawal of Consent|1|||
105806893|NCT00909727|364950532|FG001|Overall Study|Withdrawal of Consent|0|||
105806894|NCT00909727|364950531|FG000|Overall Study|Prohibited Medication|1|||
105806895|NCT00909727|364950532|FG001|Overall Study|Prohibited Medication|0|||
105806896|NCT01296932|364950534|FG000|Overall Study|Dose limiting toxicity|0|||
105806897|NCT01296932|364950535|FG001|Overall Study|Dose limiting toxicity|0|||
105806898|NCT01296932|364950536|FG002|Overall Study|Dose limiting toxicity|0|||
105806899|NCT01296932|364950537|FG003|Overall Study|Dose limiting toxicity|0|||
105806900|NCT01296932|364950538|FG004|Overall Study|Dose limiting toxicity|0|||
105570353|NCT03757234|364086763|FG003|Overall Study|Adverse Event|0|||
105570354|NCT03757234|364086764|FG004|Overall Study|Adverse Event|1|||
105570355|NCT03757234|364086760|FG000|Overall Study|Lost to Follow-up|1|||
105806901|NCT01296932|364950539|FG005|Overall Study|Dose limiting toxicity|0|||
105806902|NCT01296932|364950540|FG006|Overall Study|Dose limiting toxicity|1|||
105806903|NCT01296932|364950541|FG007|Overall Study|Dose limiting toxicity|0|||
105806904|NCT01296932|364950542|FG008|Overall Study|Dose limiting toxicity|1|||
105806905|NCT01296932|364950534|FG000|Overall Study|Progressive disease|2|||
105806906|NCT01296932|364950535|FG001|Overall Study|Progressive disease|0|||
105806907|NCT01296932|364950536|FG002|Overall Study|Progressive disease|1|||
105806908|NCT01296932|364950537|FG003|Overall Study|Progressive disease|1|||
105360902|NCT01051557|363328105|FG002|Overall Study|Withdrawal by Subject|1|||
105360903|NCT01051557|363328106|FG003|Overall Study|Withdrawal by Subject|0|||
105360904|NCT01051557|363328107|FG004|Overall Study|Withdrawal by Subject|2|||
105360905|NCT01051557|363328108|FG005|Overall Study|Withdrawal by Subject|0|||
105360906|NCT01051557|363328109|FG006|Overall Study|Withdrawal by Subject|1|||
105360907|NCT01051557|363328103|FG000|Overall Study|Adverse Event|0|||
105360908|NCT01051557|363328104|FG001|Overall Study|Adverse Event|0|||
105360909|NCT01051557|363328105|FG002|Overall Study|Adverse Event|0|||
105360910|NCT01051557|363328106|FG003|Overall Study|Adverse Event|1|||
105360911|NCT01051557|363328107|FG004|Overall Study|Adverse Event|1|||
105360912|NCT01051557|363328108|FG005|Overall Study|Adverse Event|3|||
105570356|NCT03757234|364086761|FG001|Overall Study|Lost to Follow-up|0|||
105570357|NCT03757234|364086762|FG002|Overall Study|Lost to Follow-up|0|||
105570358|NCT03757234|364086763|FG003|Overall Study|Lost to Follow-up|0|||
105806909|NCT01296932|364950538|FG004|Overall Study|Progressive disease|2|||
105806910|NCT01296932|364950539|FG005|Overall Study|Progressive disease|3|||
105360913|NCT01051557|363328109|FG006|Overall Study|Adverse Event|4|||
105806911|NCT01296932|364950540|FG006|Overall Study|Progressive disease|1|||
105806912|NCT01296932|364950541|FG007|Overall Study|Progressive disease|0|||
105806913|NCT01296932|364950542|FG008|Overall Study|Progressive disease|0|||
105806914|NCT01296932|364950534|FG000|Overall Study|Withdrawal by Subject|0|||
105806915|NCT01296932|364950535|FG001|Overall Study|Withdrawal by Subject|0|||
105806916|NCT01296932|364950536|FG002|Overall Study|Withdrawal by Subject|1|||
105806917|NCT01296932|364950537|FG003|Overall Study|Withdrawal by Subject|1|||
105806918|NCT01296932|364950538|FG004|Overall Study|Withdrawal by Subject|0|||
105806919|NCT01296932|364950539|FG005|Overall Study|Withdrawal by Subject|0|||
105806920|NCT01296932|364950540|FG006|Overall Study|Withdrawal by Subject|3|||
105806921|NCT01296932|364950541|FG007|Overall Study|Withdrawal by Subject|0|||
105806922|NCT01296932|364950542|FG008|Overall Study|Withdrawal by Subject|0|||
105806923|NCT01296932|364950534|FG000|Overall Study|Adverse Event|1|||
105806924|NCT01296932|364950535|FG001|Overall Study|Adverse Event|1|||
105806925|NCT01296932|364950536|FG002|Overall Study|Adverse Event|1|||
105806926|NCT01296932|364950537|FG003|Overall Study|Adverse Event|2|||
105806927|NCT01296932|364950538|FG004|Overall Study|Adverse Event|1|||
105806928|NCT01296932|364950539|FG005|Overall Study|Adverse Event|0|||
105806929|NCT01296932|364950540|FG006|Overall Study|Adverse Event|0|||
105806930|NCT01296932|364950541|FG007|Overall Study|Adverse Event|0|||
105806931|NCT01296932|364950542|FG008|Overall Study|Adverse Event|1|||
105806932|NCT01296932|364950534|FG000|Overall Study|Investigator decision|0|||
105806933|NCT01296932|364950535|FG001|Overall Study|Investigator decision|1|||
105806934|NCT01296932|364950536|FG002|Overall Study|Investigator decision|0|||
105806935|NCT01296932|364950537|FG003|Overall Study|Investigator decision|1|||
105806936|NCT01296932|364950538|FG004|Overall Study|Investigator decision|0|||
105806937|NCT01296932|364950539|FG005|Overall Study|Investigator decision|0|||
105806938|NCT01296932|364950540|FG006|Overall Study|Investigator decision|1|||
105806939|NCT01296932|364950541|FG007|Overall Study|Investigator decision|0|||
105806940|NCT01296932|364950542|FG008|Overall Study|Investigator decision|1|||
105806941|NCT01296932|364950534|FG000|Overall Study|No clinical benefit anymore|0|||
105806942|NCT01296932|364950535|FG001|Overall Study|No clinical benefit anymore|1|||
105806943|NCT01296932|364950536|FG002|Overall Study|No clinical benefit anymore|0|||
105806944|NCT01296932|364950537|FG003|Overall Study|No clinical benefit anymore|0|||
105806945|NCT01296932|364950538|FG004|Overall Study|No clinical benefit anymore|0|||
105806946|NCT01296932|364950539|FG005|Overall Study|No clinical benefit anymore|0|||
105806947|NCT01296932|364950540|FG006|Overall Study|No clinical benefit anymore|0|||
105806948|NCT01296932|364950541|FG007|Overall Study|No clinical benefit anymore|0|||
105806949|NCT01296932|364950542|FG008|Overall Study|No clinical benefit anymore|0|||
105806950|NCT01296932|364950534|FG000|Overall Study|Physician Decision|0|||
105806951|NCT01296932|364950535|FG001|Overall Study|Physician Decision|0|||
105806952|NCT01296932|364950536|FG002|Overall Study|Physician Decision|1|||
105806953|NCT01296932|364950537|FG003|Overall Study|Physician Decision|0|||
105806954|NCT01296932|364950538|FG004|Overall Study|Physician Decision|0|||
105806955|NCT01296932|364950539|FG005|Overall Study|Physician Decision|0|||
105806956|NCT01296932|364950540|FG006|Overall Study|Physician Decision|0|||
105806957|NCT01296932|364950541|FG007|Overall Study|Physician Decision|0|||
105806958|NCT01296932|364950542|FG008|Overall Study|Physician Decision|0|||
105806959|NCT01296932|364950534|FG000|Overall Study|IV problems, administration not possible|0|||
105806960|NCT01296932|364950535|FG001|Overall Study|IV problems, administration not possible|0|||
105806961|NCT01296932|364950536|FG002|Overall Study|IV problems, administration not possible|1|||
105806962|NCT01296932|364950537|FG003|Overall Study|IV problems, administration not possible|0|||
105806963|NCT01296932|364950538|FG004|Overall Study|IV problems, administration not possible|0|||
105806964|NCT01296932|364950539|FG005|Overall Study|IV problems, administration not possible|0|||
105806965|NCT01296932|364950540|FG006|Overall Study|IV problems, administration not possible|0|||
105485004|NCT00761150|363787040|FG001|Open-label Period|Lost to Follow-up|0|||
105485005|NCT00761150|363787041|FG002|Open-label Period|Lost to Follow-up|0|||
105485006|NCT00761150|363787039|FG000|Open-label Period|Lack of Efficacy|4|||
105485007|NCT00761150|363787040|FG001|Open-label Period|Lack of Efficacy|0|||
105806966|NCT01296932|364950541|FG007|Overall Study|IV problems, administration not possible|0|||
105806967|NCT01296932|364950542|FG008|Overall Study|IV problems, administration not possible|0|||
105806968|NCT01296932|364950534|FG000|Overall Study|per protocol|0|||
105806969|NCT01296932|364950535|FG001|Overall Study|per protocol|0|||
105806970|NCT01296932|364950536|FG002|Overall Study|per protocol|1|||
105806971|NCT01296932|364950537|FG003|Overall Study|per protocol|1|||
105806972|NCT01296932|364950538|FG004|Overall Study|per protocol|0|||
105485008|NCT00761150|363787041|FG002|Open-label Period|Lack of Efficacy|0|||
105806973|NCT01296932|364950539|FG005|Overall Study|per protocol|0|||
105806974|NCT01296932|364950540|FG006|Overall Study|per protocol|0|||
105485009|NCT00761150|363787039|FG000|Open-label Period|Withdrawal by Subject|5|||
105806975|NCT01296932|364950541|FG007|Overall Study|per protocol|0|||
105806976|NCT01296932|364950542|FG008|Overall Study|per protocol|0|||
105806977|NCT01296932|364950534|FG000|Overall Study|Low benefit and too many side effects|0|||
105806978|NCT01296932|364950535|FG001|Overall Study|Low benefit and too many side effects|0|||
105806979|NCT01296932|364950536|FG002|Overall Study|Low benefit and too many side effects|0|||
105485010|NCT00761150|363787040|FG001|Open-label Period|Withdrawal by Subject|0|||
105485011|NCT00761150|363787041|FG002|Open-label Period|Withdrawal by Subject|0|||
105485012|NCT00761150|363787039|FG000|Open-label Period|Noncompliance|2|||
105485013|NCT00761150|363787040|FG001|Open-label Period|Noncompliance|0|||
105485014|NCT00761150|363787041|FG002|Open-label Period|Noncompliance|0|||
105485015|NCT00761150|363787039|FG000|Open-label Period|Other|5|||
105760984|NCT00861380|364778098|FG005|Overall Study|Withdrawal Information not recorded|6249|||
105760985|NCT00861380|364778099|FG006|Overall Study|Withdrawal Information not recorded|3020|||
105760986|NCT00659126|364778100|FG000|Overall Study|Adverse Event|2|||
105760987|NCT00659126|364778101|FG001|Overall Study|Adverse Event|2|||
105760988|NCT00659126|364778100|FG000|Overall Study|Screen failure|1|||
105760989|NCT00659126|364778101|FG001|Overall Study|Screen failure|1|||
105760990|NCT00659126|364778100|FG000|Overall Study|Technical problems with MRI|0|||
105760991|NCT00659126|364778101|FG001|Overall Study|Technical problems with MRI|1|||
105760992|NCT02228564|364778102|FG000|Overall Study|Withdrawal by Subject|10|||
105760993|NCT02228564|364778102|FG000|Overall Study|Death|11|||
105760994|NCT02228564|364778102|FG000|Overall Study|Physician Decision|5|||
105760995|NCT02228564|364778102|FG000|Overall Study|Lost to Follow-up|17|||
105760996|NCT02228564|364778102|FG000|Overall Study|Other|6|||
105760997|NCT00637377|364778103|FG000|Overall Study|Adverse Event|2|||
105760998|NCT00637377|364778104|FG001|Overall Study|Adverse Event|6|||
105760999|NCT00637377|364778105|FG002|Overall Study|Adverse Event|8|||
105761000|NCT00637377|364778106|FG003|Overall Study|Adverse Event|9|||
105761001|NCT00637377|364778103|FG000|Overall Study|Death|1|||
105761002|NCT00637377|364778104|FG001|Overall Study|Death|3|||
105761003|NCT00637377|364778105|FG002|Overall Study|Death|2|||
105761004|NCT00637377|364778106|FG003|Overall Study|Death|1|||
105761005|NCT00637377|364778103|FG000|Overall Study|Lack of Efficacy|0|||
105761006|NCT00637377|364778104|FG001|Overall Study|Lack of Efficacy|0|||
105761007|NCT00637377|364778105|FG002|Overall Study|Lack of Efficacy|1|||
105761008|NCT00637377|364778106|FG003|Overall Study|Lack of Efficacy|1|||
105761009|NCT00637377|364778103|FG000|Overall Study|Lost to Follow-up|4|||
105761010|NCT00637377|364778104|FG001|Overall Study|Lost to Follow-up|1|||
105761011|NCT00637377|364778105|FG002|Overall Study|Lost to Follow-up|2|||
105761012|NCT00637377|364778106|FG003|Overall Study|Lost to Follow-up|2|||
105761013|NCT00637377|364778103|FG000|Overall Study|Protocol Violation|2|||
105761014|NCT00637377|364778104|FG001|Overall Study|Protocol Violation|1|||
105761015|NCT00637377|364778105|FG002|Overall Study|Protocol Violation|1|||
105761016|NCT00637377|364778106|FG003|Overall Study|Protocol Violation|0|||
105761017|NCT00637377|364778103|FG000|Overall Study|Withdrawal by Subject|11|||
105761018|NCT00637377|364778104|FG001|Overall Study|Withdrawal by Subject|15|||
105761019|NCT00637377|364778105|FG002|Overall Study|Withdrawal by Subject|13|||
105761020|NCT00637377|364778106|FG003|Overall Study|Withdrawal by Subject|11|||
105761021|NCT00637377|364778103|FG000|Overall Study|Other (no further information available)|7|||
105761022|NCT00637377|364778104|FG001|Overall Study|Other (no further information available)|6|||
105761023|NCT00637377|364778105|FG002|Overall Study|Other (no further information available)|10|||
105761024|NCT00637377|364778106|FG003|Overall Study|Other (no further information available)|5|||
105761025|NCT02925312|364778107|FG000|Overall Study|Lost to Follow-up|25|||
105761026|NCT02925312|364778108|FG001|Overall Study|Lost to Follow-up|0|||
105761027|NCT02925312|364778107|FG000|Overall Study|Adverse Event|2|||
105761028|NCT02925312|364778108|FG001|Overall Study|Adverse Event|0|||
105761029|NCT01455415|364778116|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
105761030|NCT01455415|364778117|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
105761031|NCT01455415|364778116|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
105761032|NCT01455415|364778117|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
105761033|NCT01455415|364778116|FG000|Period 1|Drug Error not Associated to AE|0|||
105761034|NCT01455415|364778117|FG001|Period 1|Drug Error not Associated to AE|1|||
105761035|NCT01455415|364778116|FG000|Period 1|AE Not Related to Study Drug|2|||
105761036|NCT01455415|364778117|FG001|Period 1|AE Not Related to Study Drug|6|||
105761037|NCT01455415|364778116|FG000|Period 1|Withdrawal by Subject|4|||
105761038|NCT01455415|364778117|FG001|Period 1|Withdrawal by Subject|5|||
105761039|NCT01455415|364778116|FG000|Period 1|Unspecified Reason|1|||
105761040|NCT01455415|364778117|FG001|Period 1|Unspecified Reason|1|||
105761041|NCT01455415|364778116|FG000|Period 1|Protocol Violation|0|||
105761042|NCT01455415|364778117|FG001|Period 1|Protocol Violation|2|||
105761043|NCT01455415|364778116|FG000|Washout|AE Related to Study Drug|2|||
105761044|NCT01455415|364778117|FG001|Washout|AE Related to Study Drug|0|||
105761045|NCT01455415|364778116|FG000|Washout|Lost to Follow-up|1|||
105761046|NCT01455415|364778117|FG001|Washout|Lost to Follow-up|0|||
105761047|NCT01455415|364778116|FG000|Washout|Drug Error not Associated to AE|2|||
105761048|NCT01455415|364778117|FG001|Washout|Drug Error not Associated to AE|1|||
105806980|NCT01296932|364950537|FG003|Overall Study|Low benefit and too many side effects|0|||
105485016|NCT00761150|363787040|FG001|Open-label Period|Other|0|||
105761049|NCT01455415|364778116|FG000|Washout|AE Not Related to Study Drug|2|||
105761050|NCT01455415|364778117|FG001|Washout|AE Not Related to Study Drug|3|||
105761051|NCT01455415|364778116|FG000|Washout|Unspecified Reason|1|||
105761052|NCT01455415|364778117|FG001|Washout|Unspecified Reason|2|||
105761053|NCT01455415|364778116|FG000|Washout|Protocol Violation|0|||
105806981|NCT01296932|364950538|FG004|Overall Study|Low benefit and too many side effects|0|||
105806982|NCT01296932|364950539|FG005|Overall Study|Low benefit and too many side effects|0|||
105806983|NCT01296932|364950540|FG006|Overall Study|Low benefit and too many side effects|0|||
105806984|NCT01296932|364950541|FG007|Overall Study|Low benefit and too many side effects|1|||
105806985|NCT01296932|364950542|FG008|Overall Study|Low benefit and too many side effects|0|||
105806986|NCT01296932|364950534|FG000|Overall Study|No adequate treatment response|0|||
105806987|NCT01296932|364950535|FG001|Overall Study|No adequate treatment response|0|||
105806988|NCT01296932|364950536|FG002|Overall Study|No adequate treatment response|0|||
105806989|NCT01296932|364950537|FG003|Overall Study|No adequate treatment response|0|||
105806990|NCT01296932|364950538|FG004|Overall Study|No adequate treatment response|0|||
105806991|NCT01296932|364950539|FG005|Overall Study|No adequate treatment response|0|||
105806992|NCT01296932|364950540|FG006|Overall Study|No adequate treatment response|0|||
105806993|NCT01296932|364950541|FG007|Overall Study|No adequate treatment response|1|||
105806994|NCT01296932|364950542|FG008|Overall Study|No adequate treatment response|0|||
105806995|NCT01296932|364950534|FG000|Overall Study|Dosage already reduced, AE still present|0|||
105761054|NCT01455415|364778117|FG001|Washout|Protocol Violation|1|||
105761055|NCT01455415|364778116|FG000|Period 2|AE Related to Study Drug|1|||
105761056|NCT01455415|364778117|FG001|Period 2|AE Related to Study Drug|2|||
105761057|NCT01455415|364778116|FG000|Period 2|Lost to Follow-up|2|||
105761058|NCT01455415|364778117|FG001|Period 2|Lost to Follow-up|1|||
105761059|NCT01455415|364778116|FG000|Period 2|AE Not Related to Study Drug|2|||
105761060|NCT01455415|364778117|FG001|Period 2|AE Not Related to Study Drug|1|||
105761061|NCT01455415|364778116|FG000|Period 2|Lack of Efficacy|2|||
105761062|NCT01455415|364778117|FG001|Period 2|Lack of Efficacy|0|||
105761063|NCT01455415|364778116|FG000|Period 2|Withdrawal by Subject|2|||
105761064|NCT01455415|364778117|FG001|Period 2|Withdrawal by Subject|3|||
105761065|NCT01455415|364778116|FG000|Period 2|Unspecified Reason|2|||
105761066|NCT01455415|364778117|FG001|Period 2|Unspecified Reason|3|||
105761067|NCT01455415|364778116|FG000|Period 2|Protocol Violation|2|||
105761068|NCT01455415|364778117|FG001|Period 2|Protocol Violation|0|||
105761069|NCT01455415|364778116|FG000|Follow-up|AE Related to Study Drug|0|||
105761070|NCT01455415|364778117|FG001|Follow-up|AE Related to Study Drug|1|||
105761071|NCT01455415|364778116|FG000|Follow-up|Lack of Efficacy|0|||
105761072|NCT01455415|364778117|FG001|Follow-up|Lack of Efficacy|1|||
105761073|NCT01455415|364778116|FG000|Follow-up|Withdrawal by Subject|2|||
105761074|NCT01455415|364778117|FG001|Follow-up|Withdrawal by Subject|0|||
105761075|NCT01455415|364778116|FG000|Follow-up|Unspecified Reason|1|||
105761076|NCT01455415|364778117|FG001|Follow-up|Unspecified Reason|0|||
105761077|NCT03205982|364778118|FG000|Overall Study|Lost to Follow-up|20|||
105761078|NCT03205982|364778119|FG001|Overall Study|Lost to Follow-up|19|||
105761079|NCT03205982|364778118|FG000|Overall Study|Withdrawal by Subject|4|||
105761080|NCT03205982|364778119|FG001|Overall Study|Withdrawal by Subject|3|||
105761081|NCT03205982|364778118|FG000|Overall Study|Withdrawal by PI|0|||
105761082|NCT03205982|364778119|FG001|Overall Study|Withdrawal by PI|1|||
105761083|NCT01496274|364778120|FG000|Overall Study|Protocol Violation|0|||
105761084|NCT01496274|364778121|FG001|Overall Study|Protocol Violation|1|||
105761085|NCT01496274|364778120|FG000|Overall Study|Adverse Event|1|||
105761086|NCT01496274|364778121|FG001|Overall Study|Adverse Event|1|||
105761087|NCT01496274|364778120|FG000|Overall Study|Withdrawal by Subject|2|||
105761088|NCT01496274|364778121|FG001|Overall Study|Withdrawal by Subject|0|||
105761089|NCT01496274|364778120|FG000|Overall Study|Lost to Follow-up|0|||
105761090|NCT01496274|364778121|FG001|Overall Study|Lost to Follow-up|3|||
105761091|NCT01459068|364778125|FG000|Overall Study|Withdrawal by Subject|8|||
105806996|NCT01296932|364950535|FG001|Overall Study|Dosage already reduced, AE still present|0|||
105806997|NCT01296932|364950536|FG002|Overall Study|Dosage already reduced, AE still present|0|||
105806998|NCT01296932|364950537|FG003|Overall Study|Dosage already reduced, AE still present|0|||
105806999|NCT01296932|364950538|FG004|Overall Study|Dosage already reduced, AE still present|0|||
105807000|NCT01296932|364950539|FG005|Overall Study|Dosage already reduced, AE still present|0|||
105807001|NCT01296932|364950540|FG006|Overall Study|Dosage already reduced, AE still present|0|||
105807002|NCT01296932|364950541|FG007|Overall Study|Dosage already reduced, AE still present|0|||
105807003|NCT01296932|364950542|FG008|Overall Study|Dosage already reduced, AE still present|1|||
105807004|NCT02688400|364950547|FG000|Overall Study|Protocol Violation|2|||
105807005|NCT02688400|364950548|FG001|Overall Study|Protocol Violation|5|||
105807006|NCT02688400|364950547|FG000|Overall Study|Lack of Efficacy|7|||
105807007|NCT02688400|364950548|FG001|Overall Study|Lack of Efficacy|7|||
105807008|NCT02688400|364950547|FG000|Overall Study|Adverse Event|21|||
105807009|NCT02688400|364950548|FG001|Overall Study|Adverse Event|12|||
105807010|NCT02688400|364950547|FG000|Overall Study|Withdrawal by Subject|15|||
105360914|NCT04668209|363328110|FG000|Overall Study|Withdrawal by Subject|2|||
105360915|NCT04668209|363328111|FG001|Overall Study|Withdrawal by Subject|2|||
105360916|NCT04668209|363328110|FG000|Overall Study|Lost to Follow-up|3|||
105360917|NCT04668209|363328111|FG001|Overall Study|Lost to Follow-up|4|||
105360918|NCT04668209|363328110|FG000|Overall Study|Subject Expired|2|||
105360919|NCT04668209|363328111|FG001|Overall Study|Subject Expired|0|||
105360920|NCT04668209|363328110|FG000|Overall Study|Withdrawn from study|0|||
105761092|NCT01459068|364778126|FG001|Overall Study|Withdrawal by Subject|18|||
105761093|NCT01459068|364778125|FG000|Overall Study|Lost to Follow-up|31|||
105807011|NCT02688400|364950548|FG001|Overall Study|Withdrawal by Subject|13|||
105807012|NCT02688400|364950547|FG000|Overall Study|No study medication intake|1|||
105360921|NCT04668209|363328111|FG001|Overall Study|Withdrawn from study|1|||
105360922|NCT04668209|363328110|FG000|Overall Study|Adverse Event|0|||
105761094|NCT01459068|364778126|FG001|Overall Study|Lost to Follow-up|15|||
105761095|NCT01459068|364778125|FG000|Overall Study|Death|0|||
105761096|NCT01459068|364778126|FG001|Overall Study|Death|1|||
105761097|NCT00196196|364778127|FG000|Overall Study|Withdrawal by Subject|2|||
105761098|NCT00196196|364778127|FG000|Overall Study|Did not have required condition (hydroce|5|||
105761099|NCT02096042|364778128|FG000|Overall Study|Disease Progression|1|||
105761100|NCT02096042|364778129|FG001|Overall Study|Disease Progression|0|||
105761101|NCT02096042|364778130|FG002|Overall Study|Disease Progression|0|||
105807013|NCT02688400|364950548|FG001|Overall Study|No study medication intake|4|||
105807014|NCT02688400|364950547|FG000|Overall Study|Lost to Follow-up|0|||
105807015|NCT02688400|364950548|FG001|Overall Study|Lost to Follow-up|3|||
105807016|NCT01075763|364950551|FG000|Overall Study|Lost to Follow-up|2|||
105807017|NCT01075763|364950552|FG001|Overall Study|Lost to Follow-up|1|||
105807018|NCT01075763|364950551|FG000|Overall Study|Lack of Efficacy|0|||
105485017|NCT00761150|363787041|FG002|Open-label Period|Other|0|||
105485018|NCT00761150|363787039|FG000|Double-blind Period|Lack of Efficacy|0|||
105485019|NCT00761150|363787040|FG001|Double-blind Period|Lack of Efficacy|2|||
105485020|NCT00761150|363787041|FG002|Double-blind Period|Lack of Efficacy|19|||
105485021|NCT00761150|363787039|FG000|Double-blind Period|Adverse Event|0|||
105485022|NCT00761150|363787040|FG001|Double-blind Period|Adverse Event|3|||
105485023|NCT00761150|363787041|FG002|Double-blind Period|Adverse Event|3|||
105485024|NCT00761150|363787039|FG000|Double-blind Period|Withdrawal by Subject|0|||
105485025|NCT00761150|363787040|FG001|Double-blind Period|Withdrawal by Subject|3|||
105485026|NCT00761150|363787041|FG002|Double-blind Period|Withdrawal by Subject|2|||
105485027|NCT00761150|363787039|FG000|Double-blind Period|Lost to Follow-up|0|||
105485028|NCT00761150|363787040|FG001|Double-blind Period|Lost to Follow-up|2|||
105485029|NCT00761150|363787041|FG002|Double-blind Period|Lost to Follow-up|1|||
105485030|NCT00761150|363787039|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
105485031|NCT00761150|363787040|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
105485032|NCT00761150|363787041|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
105485033|NCT00761150|363787039|FG000|Double-blind Period|Noncompliance|0|||
105485034|NCT00761150|363787040|FG001|Double-blind Period|Noncompliance|1|||
105485035|NCT00761150|363787041|FG002|Double-blind Period|Noncompliance|0|||
105485036|NCT00761150|363787039|FG000|Double-blind Period|Other|0|||
105485037|NCT00761150|363787040|FG001|Double-blind Period|Other|3|||
105485038|NCT00761150|363787041|FG002|Double-blind Period|Other|3|||
105485039|NCT03312751|363787042|FG000|Overall Study|Death|7|||
105570359|NCT03757234|364086764|FG004|Overall Study|Lost to Follow-up|1|||
105807019|NCT01075763|364950552|FG001|Overall Study|Lack of Efficacy|1|||
105807020|NCT01075763|364950551|FG000|Overall Study|Withdrawal by Subject|2|||
105807021|NCT01075763|364950552|FG001|Overall Study|Withdrawal by Subject|2|||
105807022|NCT00124020|364950554|FG000|Overall Study|Death|67|||
105807023|NCT00124020|364950555|FG001|Overall Study|Death|71|||
105807024|NCT00124020|364950554|FG000|Overall Study|Withdrawal by Subject|13|||
105807025|NCT00124020|364950555|FG001|Overall Study|Withdrawal by Subject|11|||
105807026|NCT00124020|364950554|FG000|Overall Study|Lost to Follow-up|5|||
105807027|NCT00124020|364950555|FG001|Overall Study|Lost to Follow-up|8|||
105807028|NCT00124020|364950554|FG000|Overall Study|Other|1|||
105807029|NCT00124020|364950555|FG001|Overall Study|Other|1|||
105807030|NCT00124020|364950554|FG000|Overall Study|Transfer to another hospital|2|||
105807031|NCT00124020|364950555|FG001|Overall Study|Transfer to another hospital|0|||
105807032|NCT00268346|364950557|FG000|Overall Study|Adverse Event|0|||
105807033|NCT00268346|364950558|FG001|Overall Study|Adverse Event|1|||
105807034|NCT00268346|364950557|FG000|Overall Study|Death|0|||
105807035|NCT00268346|364950558|FG001|Overall Study|Death|1|||
105807036|NCT00268346|364950557|FG000|Overall Study|Withdrawal by Subject|0|||
105807037|NCT00268346|364950558|FG001|Overall Study|Withdrawal by Subject|1|||
105807038|NCT01751412|364950559|FG000|Overall Study|Disease Progression Before Treatment|1|||
105807039|NCT01673009|364950560|FG000|Overall Study|Physician Decision|5|||
105807040|NCT01673009|364950560|FG000|Overall Study|Withdrawal by Subject|8|||
105807041|NCT04161144|364950563|FG000|Overall Study|Withdrawal by Subject|0|||
105807042|NCT04161144|364950564|FG001|Overall Study|Withdrawal by Subject|1|||
105807043|NCT04161144|364950563|FG000|Overall Study|Protocol Violation|1|||
105807044|NCT04161144|364950564|FG001|Overall Study|Protocol Violation|0|||
105807045|NCT00449072|364950565|FG000|Overall Study|Adverse Event|3|||
105807046|NCT00449072|364950566|FG001|Overall Study|Adverse Event|1|||
105807047|NCT00449072|364950565|FG000|Overall Study|Protocol Violation|14|||
105807048|NCT00449072|364950566|FG001|Overall Study|Protocol Violation|12|||
105807049|NCT00449072|364950565|FG000|Overall Study|Lost to Follow-up|5|||
105807050|NCT00449072|364950566|FG001|Overall Study|Lost to Follow-up|7|||
105807051|NCT00449072|364950565|FG000|Overall Study|Withdrawal by Subject|11|||
105807052|NCT00449072|364950566|FG001|Overall Study|Withdrawal by Subject|8|||
105807053|NCT00449072|364950565|FG000|Overall Study|Lack of Efficacy|1|||
105807054|NCT00449072|364950566|FG001|Overall Study|Lack of Efficacy|1|||
105807055|NCT00449072|364950565|FG000|Overall Study|Physician Decision|1|||
105807056|NCT00449072|364950566|FG001|Overall Study|Physician Decision|0|||
105807057|NCT00449072|364950565|FG000|Overall Study|Not treated|0|||
105807058|NCT00449072|364950566|FG001|Overall Study|Not treated|1|||
105485040|NCT03312751|363787043|FG001|Overall Study|Death|9|||
105485041|NCT03312751|363787042|FG000|Overall Study|Study discontinuation due to other reason|0|||
105570360|NCT03757234|364086760|FG000|Overall Study|Withdrawal by Subject|1|||
105807059|NCT00449072|364950565|FG000|Overall Study|Excluded medication|0|||
105807060|NCT00449072|364950566|FG001|Overall Study|Excluded medication|2|||
105807061|NCT00449072|364950565|FG000|Overall Study|Non-compliance|2|||
105485042|NCT03312751|363787043|FG001|Overall Study|Study discontinuation due to other reason|1|||
105485043|NCT02692651|363787044|FG000|Study Treatment|Death|7|||
105807062|NCT00449072|364950566|FG001|Overall Study|Non-compliance|5|||
105807063|NCT00449072|364950565|FG000|Overall Study|Sponsor decision|1|||
105807064|NCT00449072|364950566|FG001|Overall Study|Sponsor decision|3|||
105807065|NCT00449072|364950565|FG000|Overall Study|Relocation|3|||
105807066|NCT00449072|364950566|FG001|Overall Study|Relocation|2|||
105807067|NCT00576901|364950576|FG000|Overall Study|Withdrawal by Subject|1|||
105807068|NCT00576901|364950576|FG000|Overall Study|Disease course|1|||
105807069|NCT00576901|364950576|FG000|Overall Study|Protocol Violation|1|||
105807070|NCT01259869|364950577|FG000|Overall Study|Duplicated registration|1|||
105807071|NCT01333033|364950578|FG000|Overall Study|Ineligible|0|||
105807072|NCT01333033|364950579|FG001|Overall Study|Ineligible|0|||
105807073|NCT01333033|364950580|FG002|Overall Study|Ineligible|0|||
105807074|NCT01333033|364950581|FG003|Overall Study|Ineligible|0|||
105807075|NCT01333033|364950582|FG004|Overall Study|Ineligible|6|||
105807076|NCT01333033|364950583|FG005|Overall Study|Ineligible|8|||
105807077|NCT01333033|364950578|FG000|Overall Study|Withdrawal by Subject|0|||
105807078|NCT01333033|364950579|FG001|Overall Study|Withdrawal by Subject|0|||
105807079|NCT01333033|364950580|FG002|Overall Study|Withdrawal by Subject|0|||
105807080|NCT01333033|364950581|FG003|Overall Study|Withdrawal by Subject|0|||
105807081|NCT01333033|364950582|FG004|Overall Study|Withdrawal by Subject|4|||
105807082|NCT01333033|364950583|FG005|Overall Study|Withdrawal by Subject|2|||
105807083|NCT01333033|364950578|FG000|Overall Study|PET inevaluable|0|||
105807084|NCT01333033|364950579|FG001|Overall Study|PET inevaluable|0|||
105807085|NCT01333033|364950580|FG002|Overall Study|PET inevaluable|0|||
105807086|NCT01333033|364950581|FG003|Overall Study|PET inevaluable|0|||
105807087|NCT01333033|364950582|FG004|Overall Study|PET inevaluable|2|||
105807088|NCT01333033|364950583|FG005|Overall Study|PET inevaluable|4|||
105807089|NCT01333033|364950578|FG000|Overall Study|Adverse Event|0|||
105807090|NCT01333033|364950579|FG001|Overall Study|Adverse Event|0|||
105807091|NCT01333033|364950580|FG002|Overall Study|Adverse Event|0|||
105807092|NCT01333033|364950581|FG003|Overall Study|Adverse Event|0|||
105807093|NCT01333033|364950582|FG004|Overall Study|Adverse Event|2|||
105807094|NCT01333033|364950583|FG005|Overall Study|Adverse Event|1|||
105807095|NCT01333033|364950578|FG000|Overall Study|Progression|0|||
105807096|NCT01333033|364950579|FG001|Overall Study|Progression|0|||
105807097|NCT01333033|364950580|FG002|Overall Study|Progression|0|||
105807098|NCT01333033|364950581|FG003|Overall Study|Progression|0|||
105807099|NCT01333033|364950582|FG004|Overall Study|Progression|0|||
105807100|NCT01333033|364950583|FG005|Overall Study|Progression|1|||
105807101|NCT01333033|364950578|FG000|Overall Study|MD Decision|0|||
105807102|NCT01333033|364950579|FG001|Overall Study|MD Decision|0|||
105807103|NCT01333033|364950580|FG002|Overall Study|MD Decision|0|||
105807104|NCT01333033|364950581|FG003|Overall Study|MD Decision|0|||
105807105|NCT01333033|364950582|FG004|Overall Study|MD Decision|0|||
105807106|NCT01333033|364950583|FG005|Overall Study|MD Decision|2|||
105807107|NCT03687125|364950584|FG000|Overall Study|Progressive Disease|2|||
105807108|NCT03687125|364950585|FG001|Overall Study|Progressive Disease|1|||
105807109|NCT03687125|364950584|FG000|Overall Study|Protocol Violation|1|||
105807110|NCT03687125|364950585|FG001|Overall Study|Protocol Violation|0|||
105807111|NCT05034731|364950586|FG000|Overall Study|Screen fail|1|||
105807112|NCT05034731|364950587|FG001|Overall Study|Screen fail|1|||
105807113|NCT00113490|364950588|FG000|Overall Study|Withdrawal by Subject|1|||
105807114|NCT00113490|364950589|FG001|Overall Study|Withdrawal by Subject|3|||
105807115|NCT00113490|364950588|FG000|Overall Study|Lost to Follow-up|1|||
105807116|NCT00113490|364950589|FG001|Overall Study|Lost to Follow-up|0|||
105807117|NCT02040766|364950590|FG000|Overall Study|Adverse Event|1|||
105360923|NCT04668209|363328111|FG001|Overall Study|Adverse Event|1|||
105360924|NCT00536510|363328112|FG000|Overall Study|Adverse Event|27|||
105360925|NCT00536510|363328113|FG001|Overall Study|Adverse Event|4|||
105360926|NCT00536510|363328112|FG000|Overall Study|Lost to Follow-up|11|||
105360927|NCT00536510|363328113|FG001|Overall Study|Lost to Follow-up|8|||
105807118|NCT02040766|364950591|FG001|Overall Study|Adverse Event|1|||
105807119|NCT02040766|364950592|FG002|Overall Study|Adverse Event|1|||
105807120|NCT02040766|364950593|FG003|Overall Study|Adverse Event|0|||
105807121|NCT02040766|364950594|FG004|Overall Study|Adverse Event|2|||
105807122|NCT02040766|364950590|FG000|Overall Study|Withdrawal by Subject|4|||
105807123|NCT02040766|364950591|FG001|Overall Study|Withdrawal by Subject|3|||
105807124|NCT02040766|364950592|FG002|Overall Study|Withdrawal by Subject|2|||
105807125|NCT02040766|364950593|FG003|Overall Study|Withdrawal by Subject|3|||
105807126|NCT02040766|364950594|FG004|Overall Study|Withdrawal by Subject|2|||
105807127|NCT02040766|364950590|FG000|Overall Study|Non-compliance|0|||
105807128|NCT02040766|364950591|FG001|Overall Study|Non-compliance|1|||
105807129|NCT02040766|364950592|FG002|Overall Study|Non-compliance|0|||
105807130|NCT02040766|364950593|FG003|Overall Study|Non-compliance|0|||
105807131|NCT02040766|364950594|FG004|Overall Study|Non-compliance|0|||
105360928|NCT00536510|363328112|FG000|Overall Study|Protocol Violation|4|||
105807132|NCT02040766|364950590|FG000|Overall Study|Protocol Violation|2|||
105807133|NCT02040766|364950591|FG001|Overall Study|Protocol Violation|1|||
105807134|NCT02040766|364950592|FG002|Overall Study|Protocol Violation|2|||
105807135|NCT02040766|364950593|FG003|Overall Study|Protocol Violation|3|||
105807136|NCT02040766|364950594|FG004|Overall Study|Protocol Violation|0|||
105807137|NCT02040766|364950590|FG000|Overall Study|Lost to Follow-up|4|||
105807138|NCT02040766|364950591|FG001|Overall Study|Lost to Follow-up|1|||
105807139|NCT02040766|364950592|FG002|Overall Study|Lost to Follow-up|3|||
105807140|NCT02040766|364950593|FG003|Overall Study|Lost to Follow-up|1|||
105807141|NCT02040766|364950594|FG004|Overall Study|Lost to Follow-up|4|||
105807142|NCT02040766|364950590|FG000|Overall Study|Not reported|1|||
105807143|NCT02040766|364950591|FG001|Overall Study|Not reported|0|||
105807144|NCT02040766|364950592|FG002|Overall Study|Not reported|0|||
105807145|NCT02040766|364950593|FG003|Overall Study|Not reported|0|||
105807146|NCT02040766|364950594|FG004|Overall Study|Not reported|0|||
105807147|NCT02040766|364950590|FG000|Overall Study|Lack of Efficacy|6|||
105807148|NCT02040766|364950591|FG001|Overall Study|Lack of Efficacy|3|||
105807149|NCT02040766|364950592|FG002|Overall Study|Lack of Efficacy|4|||
105807150|NCT02040766|364950593|FG003|Overall Study|Lack of Efficacy|6|||
105807151|NCT02040766|364950594|FG004|Overall Study|Lack of Efficacy|5|||
105807152|NCT02970669|364950598|FG000|Double-blind Period|Adverse Event|4|||
105807153|NCT02970669|364950599|FG001|Double-blind Period|Adverse Event|0|||
105807154|NCT02970669|364950598|FG000|Double-blind Period|Death|1|||
105807155|NCT02970669|364950599|FG001|Double-blind Period|Death|0|||
105807156|NCT02970669|364950598|FG000|Double-blind Period|Study terminated by sponsor|1|||
105807157|NCT02970669|364950599|FG001|Double-blind Period|Study terminated by sponsor|2|||
105807158|NCT02970669|364950598|FG000|Double-blind Period|Physician Decision|0|||
105807159|NCT02970669|364950599|FG001|Double-blind Period|Physician Decision|2|||
105807160|NCT02970669|364950598|FG000|Double-blind Period|Withdrawal by Subject|2|||
105807161|NCT02970669|364950599|FG001|Double-blind Period|Withdrawal by Subject|2|||
105807162|NCT02970669|364950598|FG000|Open-label Period|Withdrawal by Subject|2|||
105807163|NCT02970669|364950599|FG001|Open-label Period|Withdrawal by Subject|2|||
105807164|NCT02970669|364950598|FG000|Open-label Period|Adverse Event|1|||
105807165|NCT02970669|364950599|FG001|Open-label Period|Adverse Event|0|||
105807166|NCT02970669|364950598|FG000|Open-label Period|Physician Decision|1|||
105807167|NCT02970669|364950599|FG001|Open-label Period|Physician Decision|0|||
105807168|NCT00876733|364950600|FG000|Overall Study|Adverse Event|34|||
105807169|NCT00876733|364950601|FG001|Overall Study|Adverse Event|20|||
105807170|NCT00876733|364950602|FG002|Overall Study|Adverse Event|10|||
105807171|NCT00876733|364950603|FG003|Overall Study|Adverse Event|3|||
105807172|NCT00876733|364950600|FG000|Overall Study|Lack of Efficacy|17|||
105807173|NCT00876733|364950601|FG001|Overall Study|Lack of Efficacy|9|||
105807174|NCT00876733|364950602|FG002|Overall Study|Lack of Efficacy|10|||
105807175|NCT00876733|364950603|FG003|Overall Study|Lack of Efficacy|1|||
105807176|NCT00876733|364950600|FG000|Overall Study|Lost to Follow-up|26|||
105807177|NCT00876733|364950601|FG001|Overall Study|Lost to Follow-up|10|||
105807178|NCT00876733|364950602|FG002|Overall Study|Lost to Follow-up|3|||
105807179|NCT00876733|364950603|FG003|Overall Study|Lost to Follow-up|2|||
105807180|NCT00876733|364950600|FG000|Overall Study|Data not available|14|||
105807181|NCT00876733|364950601|FG001|Overall Study|Data not available|3|||
105807182|NCT00876733|364950602|FG002|Overall Study|Data not available|7|||
105807183|NCT00876733|364950603|FG003|Overall Study|Data not available|1|||
105807184|NCT01564758|364950604|FG000|Overall Study|Death|8|||
105807185|NCT01564758|364950604|FG000|Overall Study|Adverse Event|3|||
105807186|NCT01564758|364950604|FG000|Overall Study|Other|3|||
105807187|NCT00601354|364950607|FG000|Overall Study|Lost to Follow-up|4|||
105807188|NCT00601354|364950608|FG001|Overall Study|Lost to Follow-up|5|||
105807189|NCT02486796|364950612|FG000|Overall Study|Withdrawal by Subject|1|||
105807190|NCT02486796|364950613|FG001|Overall Study|Withdrawal by Subject|1|||
105807191|NCT02486796|364950612|FG000|Overall Study|Physician Decision|1|||
105807192|NCT02486796|364950613|FG001|Overall Study|Physician Decision|0|||
105807193|NCT02041702|364950615|FG000|Overall Study|Lost to Follow-up|1|||
105807194|NCT02041702|364950616|FG001|Overall Study|Lost to Follow-up|6|||
105807195|NCT02041702|364950615|FG000|Overall Study|Death|4|||
105807196|NCT02041702|364950616|FG001|Overall Study|Death|0|||
105807197|NCT02041702|364950615|FG000|Overall Study|Withdrawal by Subject|4|||
105807198|NCT02041702|364950616|FG001|Overall Study|Withdrawal by Subject|3|||
105807199|NCT02041702|364950615|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
105807200|NCT02041702|364950616|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
105807201|NCT02041702|364950615|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
105807202|NCT02041702|364950616|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
105807203|NCT01855126|364950617|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
105360929|NCT00536510|363328113|FG001|Overall Study|Protocol Violation|5|||
105360930|NCT00536510|363328112|FG000|Overall Study|Withdrawal by Subject|16|||
105807204|NCT01855126|364950618|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
105807205|NCT01855126|364950617|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
105807206|NCT01855126|364950618|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
105807207|NCT02308111|364950619|FG000|Overall Study|Adverse Event|31|||
105360931|NCT00536510|363328113|FG001|Overall Study|Withdrawal by Subject|9|||
105807208|NCT02308111|364950620|FG001|Overall Study|Adverse Event|19|||
105807209|NCT02308111|364950619|FG000|Overall Study|Death|9|||
105807210|NCT02308111|364950620|FG001|Overall Study|Death|6|||
105807211|NCT02308111|364950619|FG000|Overall Study|Lost to Follow-up|2|||
105807212|NCT02308111|364950620|FG001|Overall Study|Lost to Follow-up|7|||
105807213|NCT02308111|364950619|FG000|Overall Study|Physician Decision|6|||
105807214|NCT02308111|364950620|FG001|Overall Study|Physician Decision|17|||
105807215|NCT02308111|364950619|FG000|Overall Study|Protocol Violation|0|||
105807216|NCT02308111|364950620|FG001|Overall Study|Protocol Violation|1|||
105807217|NCT02308111|364950619|FG000|Overall Study|Withdrawal by Subject|28|||
105807218|NCT02308111|364950620|FG001|Overall Study|Withdrawal by Subject|38|||
105807219|NCT02308111|364950619|FG000|Overall Study|Study Terminated by Sponsor|72|||
105807220|NCT02308111|364950620|FG001|Overall Study|Study Terminated by Sponsor|61|||
105807221|NCT02308111|364950619|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
105807222|NCT02308111|364950620|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
105807223|NCT02308111|364950619|FG000|Overall Study|Site Closure|3|||
105807224|NCT02308111|364950620|FG001|Overall Study|Site Closure|3|||
105807225|NCT02308111|364950619|FG000|Overall Study|Non-compliance with Study Drug|3|||
105807226|NCT02308111|364950620|FG001|Overall Study|Non-compliance with Study Drug|1|||
105807227|NCT02308111|364950619|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
105807228|NCT02308111|364950620|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
105807229|NCT02308111|364950619|FG000|Overall Study|Liver Transplant|3|||
105807230|NCT02308111|364950620|FG001|Overall Study|Liver Transplant|3|||
105807231|NCT02308111|364950619|FG000|Overall Study|Liver Transplant Waitlist|2|||
105807232|NCT02308111|364950620|FG001|Overall Study|Liver Transplant Waitlist|2|||
105807233|NCT02308111|364950619|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
105807234|NCT02308111|364950620|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
105807235|NCT00576199|364950623|FG000|Overall Study|Adverse Event|12|||
105807236|NCT00576199|364950623|FG000|Overall Study|Insufficient Therapeutic Response|14|||
105807237|NCT00576199|364950623|FG000|Overall Study|Refused Treatment|2|||
105807238|NCT00576199|364950623|FG000|Overall Study|Reason Unspecified|2|||
105807239|NCT01463683|364950627|FG000|Overall Study|Adverse Event|2|||
105807240|NCT01463683|364950628|FG001|Overall Study|Adverse Event|0|||
105807241|NCT01463683|364950629|FG002|Overall Study|Adverse Event|0|||
105807242|NCT01463683|364950627|FG000|Overall Study|Lost to Follow-up|10|||
105807243|NCT01463683|364950628|FG001|Overall Study|Lost to Follow-up|9|||
105807244|NCT01463683|364950629|FG002|Overall Study|Lost to Follow-up|7|||
105807245|NCT01463683|364950627|FG000|Overall Study|Physician Decision|0|||
105807246|NCT01463683|364950628|FG001|Overall Study|Physician Decision|3|||
105807247|NCT01463683|364950629|FG002|Overall Study|Physician Decision|1|||
105807248|NCT01463683|364950627|FG000|Overall Study|Pregnancy|2|||
105807249|NCT01463683|364950628|FG001|Overall Study|Pregnancy|2|||
105807250|NCT01463683|364950629|FG002|Overall Study|Pregnancy|1|||
105807251|NCT01463683|364950627|FG000|Overall Study|Withdrawal by Subject|5|||
105807252|NCT01463683|364950628|FG001|Overall Study|Withdrawal by Subject|17|||
105807253|NCT01463683|364950629|FG002|Overall Study|Withdrawal by Subject|2|||
105807254|NCT01618305|364950630|FG000|Overall Study|Death|0|||
105807255|NCT01618305|364950631|FG001|Overall Study|Death|1|||
105807256|NCT01618305|364950630|FG000|Overall Study|Lost to Follow-up|11|||
105807257|NCT01618305|364950631|FG001|Overall Study|Lost to Follow-up|7|||
105807258|NCT01618305|364950630|FG000|Overall Study|Protocol Violation|1|||
105807259|NCT01618305|364950631|FG001|Overall Study|Protocol Violation|0|||
105807260|NCT01618305|364950630|FG000|Overall Study|Withdrawal by Subject|3|||
105807261|NCT01618305|364950631|FG001|Overall Study|Withdrawal by Subject|2|||
105807262|NCT02708277|364950632|FG000|Overall Study|Lost to Follow-up|7|||
105807263|NCT02708277|364950633|FG001|Overall Study|Lost to Follow-up|4|||
105807264|NCT00911859|364950634|FG000|Treatment Period|Adverse Event|3|||
105807265|NCT00911859|364950635|FG001|Treatment Period|Adverse Event|3|||
105807266|NCT00911859|364950636|FG002|Treatment Period|Adverse Event|7|||
105807267|NCT00911859|364950634|FG000|Treatment Period|Death|1|||
105807268|NCT00911859|364950635|FG001|Treatment Period|Death|3|||
105807269|NCT00911859|364950636|FG002|Treatment Period|Death|5|||
105807270|NCT00911859|364950634|FG000|Treatment Period|Lack of Efficacy|1|||
105807271|NCT00911859|364950635|FG001|Treatment Period|Lack of Efficacy|7|||
105807272|NCT00911859|364950636|FG002|Treatment Period|Lack of Efficacy|5|||
105807273|NCT00911859|364950634|FG000|Treatment Period|Physician Decision|3|||
105807274|NCT00911859|364950635|FG001|Treatment Period|Physician Decision|3|||
105807275|NCT00911859|364950636|FG002|Treatment Period|Physician Decision|3|||
105807276|NCT00911859|364950634|FG000|Treatment Period|Withdrawal by Subject|0|||
105807277|NCT00911859|364950635|FG001|Treatment Period|Withdrawal by Subject|4|||
105807278|NCT00911859|364950636|FG002|Treatment Period|Withdrawal by Subject|5|||
105807279|NCT00911859|364950634|FG000|Treatment Period|Did not receive study treatment|0|||
105807280|NCT00911859|364950635|FG001|Treatment Period|Did not receive study treatment|1|||
105807281|NCT00911859|364950636|FG002|Treatment Period|Did not receive study treatment|0|||
105807282|NCT00911859|364950634|FG000|Maintainance Period|Lack of Efficacy|0|||
105807283|NCT00911859|364950635|FG001|Maintainance Period|Lack of Efficacy|0|||
105807284|NCT00911859|364950636|FG002|Maintainance Period|Lack of Efficacy|9|||
105807285|NCT00911859|364950634|FG000|Maintainance Period|Physician Decision|0|||
105807286|NCT00911859|364950635|FG001|Maintainance Period|Physician Decision|0|||
105807287|NCT00911859|364950636|FG002|Maintainance Period|Physician Decision|9|||
105807288|NCT00911859|364950634|FG000|Maintainance Period|Withdrawal by Subject|0|||
105807289|NCT00911859|364950635|FG001|Maintainance Period|Withdrawal by Subject|0|||
105807290|NCT00911859|364950636|FG002|Maintainance Period|Withdrawal by Subject|3|||
105807291|NCT00911859|364950634|FG000|Follow-up Period|Death|5|||
105485044|NCT02692651|363787045|FG001|Study Treatment|Death|3|||
105485045|NCT02692651|363787044|FG000|Study Treatment|comfort care|1|||
105485046|NCT02692651|363787045|FG001|Study Treatment|comfort care|1|||
105807292|NCT00911859|364950635|FG001|Follow-up Period|Death|8|||
105807293|NCT00911859|364950636|FG002|Follow-up Period|Death|10|||
105807294|NCT00911859|364950634|FG000|Follow-up Period|Lost to Follow-up|1|||
105807295|NCT00911859|364950635|FG001|Follow-up Period|Lost to Follow-up|1|||
105807296|NCT00911859|364950636|FG002|Follow-up Period|Lost to Follow-up|0|||
105807297|NCT00911859|364950634|FG000|Follow-up Period|Withdrawal by Subject|0|||
105807298|NCT00911859|364950635|FG001|Follow-up Period|Withdrawal by Subject|4|||
105807299|NCT00911859|364950636|FG002|Follow-up Period|Withdrawal by Subject|4|||
105807300|NCT00911859|364950634|FG000|Follow-up Period|Study terminated by sponsor|5|||
105807301|NCT00911859|364950635|FG001|Follow-up Period|Study terminated by sponsor|33|||
105807302|NCT00911859|364950636|FG002|Follow-up Period|Study terminated by sponsor|27|||
105485047|NCT02692651|363787044|FG000|Study Treatment|Protocol violation per treating team preference|8|||
105485048|NCT02692651|363787045|FG001|Study Treatment|Protocol violation per treating team preference|6|||
105485049|NCT02692651|363787044|FG000|Post Study Treatment Follow-up|Death|4|||
105807303|NCT03538756|364950637|FG000|Long-Term Follow-up|Adverse Event|0|||
105807304|NCT03538756|364950638|FG001|Long-Term Follow-up|Adverse Event|0|||
105807305|NCT03538756|364950639|FG002|Long-Term Follow-up|Adverse Event|6|||
105807306|NCT03538756|364950637|FG000|Long-Term Follow-up|Death|0|||
105807307|NCT03538756|364950638|FG001|Long-Term Follow-up|Death|0|||
105807308|NCT03538756|364950639|FG002|Long-Term Follow-up|Death|1|||
105807309|NCT03538756|364950637|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
105807310|NCT03538756|364950638|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
105807311|NCT03538756|364950639|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
105807312|NCT03538756|364950637|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
105807313|NCT03538756|364950638|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
105807314|NCT03538756|364950639|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
105807315|NCT03538756|364950637|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
105807316|NCT03538756|364950638|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
105807317|NCT03538756|364950639|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
105807318|NCT01497938|364950642|FG000|Overall Study|Adverse Event|0|||
105807319|NCT01497938|364950643|FG001|Overall Study|Adverse Event|1|||
105807320|NCT01497938|364950642|FG000|Overall Study|Physician Decision|0|||
105807321|NCT01497938|364950643|FG001|Overall Study|Physician Decision|1|||
105807322|NCT01497938|364950642|FG000|Overall Study|Withdrawal by Subject|4|||
105807323|NCT01497938|364950643|FG001|Overall Study|Withdrawal by Subject|0|||
105807324|NCT01497938|364950642|FG000|Overall Study|Device Violation|1|||
105807325|NCT01497938|364950643|FG001|Overall Study|Device Violation|0|||
105807326|NCT03433001|364952066|FG000|Overall Study|Lack of Efficacy|109|||
105807327|NCT03433001|364952066|FG000|Overall Study|Adverse Event|69|||
105807328|NCT03433001|364952066|FG000|Overall Study|Withdrawal by Subject|10|||
105807329|NCT03433001|364952066|FG000|Overall Study|Death|12|||
105807330|NCT03433001|364952066|FG000|Overall Study|Lost to Follow-up|4|||
105807331|NCT03433001|364952066|FG000|Overall Study|Other|25|||
105807332|NCT00289458|364952067|FG000|Overall Study|Death|1|||
105807333|NCT00289458|364952068|FG001|Overall Study|Death|0|||
105807334|NCT00289458|364952069|FG002|Overall Study|Death|0|||
105807335|NCT00289458|364952067|FG000|Overall Study|Physician Decision|3|||
105807336|NCT00289458|364952068|FG001|Overall Study|Physician Decision|4|||
105807337|NCT00289458|364952069|FG002|Overall Study|Physician Decision|2|||
105807338|NCT00289458|364952067|FG000|Overall Study|Withdrawal by Subject|2|||
105807339|NCT00289458|364952068|FG001|Overall Study|Withdrawal by Subject|2|||
105807340|NCT00289458|364952069|FG002|Overall Study|Withdrawal by Subject|4|||
105807341|NCT01007916|364952073|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
105807342|NCT01007916|364952074|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
105807343|NCT01007916|364952073|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
105807344|NCT01007916|364952074|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
105807345|NCT00387712|364952075|FG000|Overall Study|Physician Decision|6|||
105807346|NCT00387712|364952076|FG001|Overall Study|Physician Decision|4|||
105807347|NCT00387712|364952075|FG000|Overall Study|Lost to Follow-up|17|||
105807348|NCT00387712|364952076|FG001|Overall Study|Lost to Follow-up|20|||
105807349|NCT00387712|364952075|FG000|Overall Study|Withdrawal by Subject|6|||
105485050|NCT02692651|363787045|FG001|Post Study Treatment Follow-up|Death|4|||
105485051|NCT03490981|363787046|FG000|Overall Study|Lost to Follow-up|1|||
105807350|NCT00387712|364952076|FG001|Overall Study|Withdrawal by Subject|12|||
105807351|NCT00322556|364952077|FG000|Overall Study|Adverse Event|1|||
105485052|NCT03490981|363787047|FG001|Overall Study|Lost to Follow-up|2|||
105807352|NCT00322556|364952077|FG000|Overall Study|Withdrawal by Subject|1|||
105807353|NCT00322556|364952077|FG000|Overall Study|Lost to Follow-up|3|||
105807354|NCT00322556|364952077|FG000|Overall Study|Other Reason|7|||
105807355|NCT02040428|364952078|FG000|Overall Study|Death|4|||
105807356|NCT02040428|364952079|FG001|Overall Study|Death|3|||
105807357|NCT02040428|364952078|FG000|Overall Study|Withdrawal by Subject|1|||
105807358|NCT02040428|364952079|FG001|Overall Study|Withdrawal by Subject|1|||
105807359|NCT00901628|364952080|FG000|Overall Study|disconnection of catheter|4|||
105807360|NCT00901628|364952081|FG001|Overall Study|disconnection of catheter|8|||
105807361|NCT00901628|364952080|FG000|Overall Study|disconnection of drain|0|||
105807362|NCT00901628|364952081|FG001|Overall Study|disconnection of drain|1|||
105807363|NCT00901628|364952080|FG000|Overall Study|peroneal nerve palsy|0|||
105807364|NCT00901628|364952081|FG001|Overall Study|peroneal nerve palsy|1|||
105807365|NCT01927757|364952082|FG000|Overall Study|Withdrawal by Subject|14|||
105807366|NCT01927757|364952082|FG000|Overall Study|Lost to Follow-up|2|||
105807367|NCT01927757|364952082|FG000|Overall Study|Decision by Sponsor|2|||
105807368|NCT01927757|364952082|FG000|Overall Study|Other|1|||
105807369|NCT01927757|364952082|FG000|Overall Study|Ethical Reasons|4|||
105807370|NCT04480463|364952083|FG000|Overall Study|Death|0|||
105807371|NCT04480463|364952084|FG001|Overall Study|Death|1|||
105807372|NCT04480463|364952083|FG000|Overall Study|Adverse Event|6|||
105807373|NCT04480463|364952084|FG001|Overall Study|Adverse Event|8|||
105807374|NCT04480463|364952083|FG000|Overall Study|Lost to Follow-up|3|||
105807375|NCT04480463|364952084|FG001|Overall Study|Lost to Follow-up|2|||
105807376|NCT04480463|364952083|FG000|Overall Study|Physician Decision|2|||
105807377|NCT04480463|364952084|FG001|Overall Study|Physician Decision|5|||
105807378|NCT04480463|364952083|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
105807379|NCT04480463|364952084|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
105807380|NCT04480463|364952083|FG000|Overall Study|Protocol Violation|2|||
105807381|NCT04480463|364952084|FG001|Overall Study|Protocol Violation|1|||
105807382|NCT04480463|364952083|FG000|Overall Study|Withdrawal by Subject|6|||
105807383|NCT04480463|364952084|FG001|Overall Study|Withdrawal by Subject|7|||
105807384|NCT04480463|364952083|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
105807385|NCT04480463|364952084|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
105807386|NCT04480463|364952083|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
105807387|NCT04480463|364952084|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
105807388|NCT04480463|364952083|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
105807389|NCT04480463|364952084|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
105807390|NCT04480463|364952083|FG000|Overall Study|Other|6|||
105807391|NCT04480463|364952084|FG001|Overall Study|Other|4|||
105807392|NCT01691859|364952086|FG000|Overall Study|Adverse Event|19|||
105807393|NCT01691859|364952086|FG000|Overall Study|Lack of Efficacy|11|||
105807394|NCT01691859|364952086|FG000|Overall Study|Protocol Violation|4|||
105807395|NCT01691859|364952086|FG000|Overall Study|Product commercially available|221|||
105807396|NCT01691859|364952086|FG000|Overall Study|Study closed/terminated|50|||
105807397|NCT01691859|364952086|FG000|Overall Study|Lost to Follow-up|5|||
105807398|NCT01691859|364952086|FG000|Overall Study|Physician Decision|6|||
105807399|NCT01691859|364952086|FG000|Overall Study|Withdrawal by Subject|31|||
105807400|NCT02295774|364952087|FG000|Overall Study|Physician Decision|1|||
105807401|NCT02295774|364952087|FG000|Overall Study|Withdrawal by Subject|2|||
105807402|NCT02710071|364952092|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
105807403|NCT02710071|364952093|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
105807404|NCT02710071|364952092|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
105807405|NCT02710071|364952093|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
105807406|NCT03731182|364952096|FG000|Overall Study|Lost to Follow-up|2|||
105807407|NCT03731182|364952097|FG001|Overall Study|Lost to Follow-up|0|||
105807408|NCT03731182|364952096|FG000|Overall Study|Physician Decision|1|||
105807409|NCT03731182|364952097|FG001|Overall Study|Physician Decision|0|||
105807410|NCT03731182|364952096|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
105807411|NCT03731182|364952097|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
105807412|NCT02637557|364952098|FG000|Overall Study|Adverse Event|3|||
105807413|NCT02637557|364952099|FG001|Overall Study|Adverse Event|1|||
105807414|NCT02637557|364952100|FG002|Overall Study|Adverse Event|3|||
105807415|NCT02637557|364952101|FG003|Overall Study|Adverse Event|3|||
105485053|NCT00282464|363787054|FG000|Overall Study|Adverse Event|26|||
105485054|NCT00282464|363787055|FG001|Overall Study|Adverse Event|20|||
105485055|NCT00282464|363787054|FG000|Overall Study|Lack of Efficacy|8|||
105485056|NCT00282464|363787055|FG001|Overall Study|Lack of Efficacy|8|||
105485057|NCT00282464|363787054|FG000|Overall Study|Lost to Follow-up|10|||
105485058|NCT00282464|363787055|FG001|Overall Study|Lost to Follow-up|10|||
105485059|NCT00282464|363787054|FG000|Overall Study|Withdrawal by Subject|24|||
105485060|NCT00282464|363787055|FG001|Overall Study|Withdrawal by Subject|10|||
105485061|NCT00282464|363787054|FG000|Overall Study|laboratory abnormality|1|||
105485062|NCT00282464|363787055|FG001|Overall Study|laboratory abnormality|2|||
105807416|NCT02637557|364952098|FG000|Overall Study|Lost to Follow-up|1|||
105807417|NCT02637557|364952099|FG001|Overall Study|Lost to Follow-up|1|||
105807418|NCT02637557|364952100|FG002|Overall Study|Lost to Follow-up|0|||
105807419|NCT02637557|364952101|FG003|Overall Study|Lost to Follow-up|1|||
105807420|NCT02637557|364952098|FG000|Overall Study|Physician Decision|1|||
105485063|NCT00282464|363787054|FG000|Overall Study|Protocol Violation|0|||
105485064|NCT00282464|363787055|FG001|Overall Study|Protocol Violation|7|||
105485065|NCT00282464|363787054|FG000|Overall Study|Patient moved|1|||
105485066|NCT00282464|363787055|FG001|Overall Study|Patient moved|0|||
105485067|NCT00282464|363787054|FG000|Overall Study|patient non-compliant|3|||
105761102|NCT02762708|364778134|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
105761103|NCT02762708|364778135|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
105761104|NCT02762708|364778136|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
105761105|NCT02762708|364778137|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
105761106|NCT00669032|364778140|FG000|Overall Study|Lost to Follow-up|6|||
105761107|NCT00669032|364778141|FG001|Overall Study|Lost to Follow-up|5|||
105761108|NCT00669032|364778140|FG000|Overall Study|Lack of Efficacy|8|||
105761109|NCT00669032|364778141|FG001|Overall Study|Lack of Efficacy|19|||
105761110|NCT00669032|364778140|FG000|Overall Study|Withdrawal by Subject|12|||
105761111|NCT00669032|364778141|FG001|Overall Study|Withdrawal by Subject|13|||
105761112|NCT00669032|364778140|FG000|Overall Study|Adverse Event|12|||
105761113|NCT00669032|364778141|FG001|Overall Study|Adverse Event|16|||
105761114|NCT00669032|364778140|FG000|Overall Study|Physician Decision|1|||
105761115|NCT00669032|364778141|FG001|Overall Study|Physician Decision|1|||
105761116|NCT00669032|364778140|FG000|Overall Study|No fulfilment of the selection criteria|5|||
105761117|NCT00669032|364778141|FG001|Overall Study|No fulfilment of the selection criteria|5|||
105761118|NCT01468701|364778150|FG000|Overall Study|Not eligible|91|||
105761119|NCT01468701|364778151|FG001|Overall Study|Not eligible|140|||
105761120|NCT01468701|364778152|FG002|Overall Study|Not eligible|29|||
105761121|NCT01468701|364778153|FG003|Overall Study|Not eligible|12|||
105761122|NCT01468701|364778154|FG004|Overall Study|Not eligible|22|||
105761123|NCT01468701|364778155|FG005|Overall Study|Not eligible|2|||
105761124|NCT01468701|364778156|FG006|Overall Study|Not eligible|39|||
105761125|NCT01468701|364778157|FG007|Overall Study|Not eligible|1|||
105761126|NCT01468701|364778158|FG008|Overall Study|Not eligible|40|||
105761127|NCT01468701|364778159|FG009|Overall Study|Not eligible|126|||
105761128|NCT01468701|364778160|FG010|Overall Study|Not eligible|39|||
105761129|NCT01468701|364778161|FG011|Overall Study|Not eligible|33|||
105761130|NCT01468701|364778162|FG012|Overall Study|Not eligible|1|||
105761131|NCT01468701|364778163|FG013|Overall Study|Not eligible|19|||
105761132|NCT01468701|364778164|FG014|Overall Study|Not eligible|1|||
105761133|NCT01468701|364778165|FG015|Overall Study|Not eligible|32|||
105761134|NCT01468701|364778166|FG016|Overall Study|Not eligible|0|||
105761135|NCT01468701|364778150|FG000|Overall Study|Lost to Follow-up|306|||
105761136|NCT01468701|364778151|FG001|Overall Study|Lost to Follow-up|0|||
105761137|NCT01468701|364778152|FG002|Overall Study|Lost to Follow-up|0|||
105761138|NCT01468701|364778153|FG003|Overall Study|Lost to Follow-up|0|||
105761139|NCT01468701|364778154|FG004|Overall Study|Lost to Follow-up|0|||
105761140|NCT01468701|364778155|FG005|Overall Study|Lost to Follow-up|0|||
105761141|NCT01468701|364778156|FG006|Overall Study|Lost to Follow-up|0|||
105761142|NCT01468701|364778157|FG007|Overall Study|Lost to Follow-up|0|||
105761143|NCT01468701|364778158|FG008|Overall Study|Lost to Follow-up|215|||
105761144|NCT01468701|364778159|FG009|Overall Study|Lost to Follow-up|309|||
105761145|NCT01468701|364778160|FG010|Overall Study|Lost to Follow-up|224|||
105761146|NCT01468701|364778161|FG011|Overall Study|Lost to Follow-up|212|||
105761147|NCT01468701|364778162|FG012|Overall Study|Lost to Follow-up|11|||
105761148|NCT01468701|364778163|FG013|Overall Study|Lost to Follow-up|164|||
105761149|NCT01468701|364778164|FG014|Overall Study|Lost to Follow-up|17|||
105761150|NCT01468701|364778165|FG015|Overall Study|Lost to Follow-up|127|||
105761151|NCT01468701|364778166|FG016|Overall Study|Lost to Follow-up|1|||
105761152|NCT01468701|364778150|FG000|Overall Study|Withdrawal by Subject|165|||
105761153|NCT01468701|364778151|FG001|Overall Study|Withdrawal by Subject|0|||
105761154|NCT01468701|364778152|FG002|Overall Study|Withdrawal by Subject|0|||
105761155|NCT01468701|364778153|FG003|Overall Study|Withdrawal by Subject|0|||
105761156|NCT01468701|364778154|FG004|Overall Study|Withdrawal by Subject|0|||
105761157|NCT01468701|364778155|FG005|Overall Study|Withdrawal by Subject|0|||
105761158|NCT01468701|364778156|FG006|Overall Study|Withdrawal by Subject|0|||
105761159|NCT01468701|364778157|FG007|Overall Study|Withdrawal by Subject|0|||
105761160|NCT01468701|364778158|FG008|Overall Study|Withdrawal by Subject|83|||
105761161|NCT01468701|364778159|FG009|Overall Study|Withdrawal by Subject|88|||
105761162|NCT01468701|364778160|FG010|Overall Study|Withdrawal by Subject|100|||
105761163|NCT01468701|364778161|FG011|Overall Study|Withdrawal by Subject|114|||
105761164|NCT01468701|364778162|FG012|Overall Study|Withdrawal by Subject|9|||
105761165|NCT01468701|364778163|FG013|Overall Study|Withdrawal by Subject|47|||
105761166|NCT01468701|364778164|FG014|Overall Study|Withdrawal by Subject|6|||
105761167|NCT01468701|364778165|FG015|Overall Study|Withdrawal by Subject|31|||
105761168|NCT01468701|364778166|FG016|Overall Study|Withdrawal by Subject|0|||
105761169|NCT01468701|364778150|FG000|Overall Study|Other reasons than listed|437|||
105761170|NCT01468701|364778151|FG001|Overall Study|Other reasons than listed|0|||
105761171|NCT01468701|364778152|FG002|Overall Study|Other reasons than listed|0|||
105761172|NCT01468701|364778153|FG003|Overall Study|Other reasons than listed|0|||
105761173|NCT01468701|364778154|FG004|Overall Study|Other reasons than listed|0|||
105761174|NCT01468701|364778155|FG005|Overall Study|Other reasons than listed|0|||
105761175|NCT01468701|364778156|FG006|Overall Study|Other reasons than listed|0|||
105761176|NCT01468701|364778157|FG007|Overall Study|Other reasons than listed|0|||
105807421|NCT02637557|364952099|FG001|Overall Study|Physician Decision|0|||
105807422|NCT02637557|364952100|FG002|Overall Study|Physician Decision|0|||
105807423|NCT02637557|364952101|FG003|Overall Study|Physician Decision|0|||
105807424|NCT02637557|364952098|FG000|Overall Study|Protocol Violation|2|||
105807425|NCT02637557|364952099|FG001|Overall Study|Protocol Violation|0|||
105807426|NCT02637557|364952100|FG002|Overall Study|Protocol Violation|2|||
105807427|NCT02637557|364952101|FG003|Overall Study|Protocol Violation|1|||
105807428|NCT02637557|364952098|FG000|Overall Study|Withdrawal by Subject|1|||
105807429|NCT02637557|364952099|FG001|Overall Study|Withdrawal by Subject|3|||
105807430|NCT02637557|364952100|FG002|Overall Study|Withdrawal by Subject|4|||
105761177|NCT01468701|364778158|FG008|Overall Study|Other reasons than listed|318|||
105761178|NCT01468701|364778159|FG009|Overall Study|Other reasons than listed|658|||
105761179|NCT01468701|364778160|FG010|Overall Study|Other reasons than listed|433|||
105761180|NCT01468701|364778161|FG011|Overall Study|Other reasons than listed|504|||
105761181|NCT01468701|364778162|FG012|Overall Study|Other reasons than listed|28|||
105761182|NCT01468701|364778163|FG013|Overall Study|Other reasons than listed|239|||
105807431|NCT02637557|364952101|FG003|Overall Study|Withdrawal by Subject|2|||
105807432|NCT04604184|364952108|FG000|Overall Study|Adverse Event|5|||
105807433|NCT04604184|364952109|FG001|Overall Study|Adverse Event|5|||
105807434|NCT04604184|364952108|FG000|Overall Study|Death|2|||
105807435|NCT04604184|364952109|FG001|Overall Study|Death|1|||
105807436|NCT04604184|364952108|FG000|Overall Study|Withdrawal by Subject|1|||
105807437|NCT04604184|364952109|FG001|Overall Study|Withdrawal by Subject|3|||
105807438|NCT04604184|364952108|FG000|Overall Study|Not treated|2|||
105807439|NCT04604184|364952109|FG001|Overall Study|Not treated|2|||
105807440|NCT04604184|364952108|FG000|Overall Study|Due to sponsor decision|9|||
105807441|NCT04604184|364952109|FG001|Overall Study|Due to sponsor decision|7|||
105807442|NCT04604184|364952108|FG000|Overall Study|Physician Decision|0|||
105807443|NCT04604184|364952109|FG001|Overall Study|Physician Decision|1|||
105807444|NCT04604184|364952108|FG000|Overall Study|Transfer to healthcare|1|||
105807445|NCT04604184|364952109|FG001|Overall Study|Transfer to healthcare|0|||
105807446|NCT02711956|364952112|FG000|Overall Study|Adverse Event|0|||
105807447|NCT02711956|364952113|FG001|Overall Study|Adverse Event|0|||
105807448|NCT02711956|364952114|FG002|Overall Study|Adverse Event|0|||
105807449|NCT02711956|364952115|FG003|Overall Study|Adverse Event|1|||
105807450|NCT02711956|364952116|FG004|Overall Study|Adverse Event|2|||
105807451|NCT02711956|364952117|FG005|Overall Study|Adverse Event|0|||
105807452|NCT02711956|364952118|FG006|Overall Study|Adverse Event|0|||
105807453|NCT02711956|364952119|FG007|Overall Study|Adverse Event|1|||
105807454|NCT02711956|364952120|FG008|Overall Study|Adverse Event|1|||
105807455|NCT02711956|364952121|FG009|Overall Study|Adverse Event|1|||
105807456|NCT02711956|364952122|FG010|Overall Study|Adverse Event|1|||
105807457|NCT02711956|364952123|FG011|Overall Study|Adverse Event|0|||
105807458|NCT02711956|364952124|FG012|Overall Study|Adverse Event|0|||
105807459|NCT02711956|364952125|FG013|Overall Study|Adverse Event|0|||
105360932|NCT00536510|363328112|FG000|Overall Study|Flushing with Product|20|||
105761183|NCT01468701|364778164|FG014|Overall Study|Other reasons than listed|39|||
105761184|NCT01468701|364778165|FG015|Overall Study|Other reasons than listed|172|||
105761185|NCT01468701|364778166|FG016|Overall Study|Other reasons than listed|0|||
105761186|NCT01468701|364778150|FG000|Overall Study|No end of study case report form|0|||
105761187|NCT01468701|364778151|FG001|Overall Study|No end of study case report form|0|||
105761188|NCT01468701|364778152|FG002|Overall Study|No end of study case report form|0|||
105761189|NCT01468701|364778153|FG003|Overall Study|No end of study case report form|0|||
105761190|NCT01468701|364778154|FG004|Overall Study|No end of study case report form|0|||
105761191|NCT01468701|364778155|FG005|Overall Study|No end of study case report form|0|||
105761192|NCT01468701|364778156|FG006|Overall Study|No end of study case report form|0|||
105761193|NCT01468701|364778157|FG007|Overall Study|No end of study case report form|0|||
105761194|NCT01468701|364778158|FG008|Overall Study|No end of study case report form|4|||
105761195|NCT01468701|364778159|FG009|Overall Study|No end of study case report form|1|||
105761196|NCT01468701|364778160|FG010|Overall Study|No end of study case report form|2|||
105761197|NCT01468701|364778161|FG011|Overall Study|No end of study case report form|3|||
105761198|NCT01468701|364778162|FG012|Overall Study|No end of study case report form|0|||
105761199|NCT01468701|364778163|FG013|Overall Study|No end of study case report form|1|||
105761200|NCT01468701|364778164|FG014|Overall Study|No end of study case report form|0|||
105761201|NCT01468701|364778165|FG015|Overall Study|No end of study case report form|0|||
105761202|NCT01468701|364778166|FG016|Overall Study|No end of study case report form|0|||
105761203|NCT01468701|364778150|FG000|Overall Study|Not being followed up|0|||
105807460|NCT02711956|364952126|FG014|Overall Study|Adverse Event|2|||
105807461|NCT02711956|364952112|FG000|Overall Study|Physician Decision|0|||
105807462|NCT02711956|364952113|FG001|Overall Study|Physician Decision|0|||
105807463|NCT02711956|364952114|FG002|Overall Study|Physician Decision|0|||
105807464|NCT02711956|364952115|FG003|Overall Study|Physician Decision|2|||
105807465|NCT02711956|364952116|FG004|Overall Study|Physician Decision|0|||
105761204|NCT01468701|364778151|FG001|Overall Study|Not being followed up|4963|||
105807466|NCT02711956|364952117|FG005|Overall Study|Physician Decision|0|||
105807467|NCT02711956|364952118|FG006|Overall Study|Physician Decision|0|||
105807468|NCT02711956|364952119|FG007|Overall Study|Physician Decision|0|||
105807469|NCT02711956|364952120|FG008|Overall Study|Physician Decision|0|||
105807470|NCT02711956|364952121|FG009|Overall Study|Physician Decision|0|||
105807471|NCT02711956|364952122|FG010|Overall Study|Physician Decision|0|||
105807472|NCT02711956|364952123|FG011|Overall Study|Physician Decision|0|||
105807473|NCT02711956|364952124|FG012|Overall Study|Physician Decision|0|||
105807474|NCT02711956|364952125|FG013|Overall Study|Physician Decision|0|||
105807475|NCT02711956|364952126|FG014|Overall Study|Physician Decision|0|||
105807476|NCT02711956|364952112|FG000|Overall Study|Withdrawal by Subject|0|||
105807477|NCT02711956|364952113|FG001|Overall Study|Withdrawal by Subject|0|||
105807478|NCT02711956|364952114|FG002|Overall Study|Withdrawal by Subject|0|||
105807479|NCT02711956|364952115|FG003|Overall Study|Withdrawal by Subject|0|||
105807480|NCT02711956|364952116|FG004|Overall Study|Withdrawal by Subject|0|||
105807481|NCT02711956|364952117|FG005|Overall Study|Withdrawal by Subject|0|||
105807482|NCT02711956|364952118|FG006|Overall Study|Withdrawal by Subject|1|||
105807483|NCT02711956|364952119|FG007|Overall Study|Withdrawal by Subject|0|||
105807484|NCT02711956|364952120|FG008|Overall Study|Withdrawal by Subject|0|||
105807485|NCT02711956|364952121|FG009|Overall Study|Withdrawal by Subject|0|||
105807486|NCT02711956|364952122|FG010|Overall Study|Withdrawal by Subject|0|||
105807487|NCT02711956|364952123|FG011|Overall Study|Withdrawal by Subject|1|||
105807488|NCT02711956|364952124|FG012|Overall Study|Withdrawal by Subject|6|||
105807489|NCT02711956|364952125|FG013|Overall Study|Withdrawal by Subject|0|||
105807490|NCT02711956|364952126|FG014|Overall Study|Withdrawal by Subject|1|||
105807491|NCT02711956|364952112|FG000|Overall Study|Clinical progression|1|||
105807492|NCT02711956|364952113|FG001|Overall Study|Clinical progression|0|||
105807493|NCT02711956|364952114|FG002|Overall Study|Clinical progression|0|||
105807494|NCT02711956|364952115|FG003|Overall Study|Clinical progression|0|||
105807495|NCT02711956|364952116|FG004|Overall Study|Clinical progression|0|||
105807496|NCT02711956|364952117|FG005|Overall Study|Clinical progression|0|||
105807497|NCT02711956|364952118|FG006|Overall Study|Clinical progression|1|||
105807498|NCT02711956|364952119|FG007|Overall Study|Clinical progression|0|||
105807499|NCT02711956|364952120|FG008|Overall Study|Clinical progression|1|||
105807500|NCT02711956|364952121|FG009|Overall Study|Clinical progression|0|||
105807501|NCT02711956|364952122|FG010|Overall Study|Clinical progression|0|||
105807502|NCT02711956|364952123|FG011|Overall Study|Clinical progression|2|||
105807503|NCT02711956|364952124|FG012|Overall Study|Clinical progression|4|||
105807504|NCT02711956|364952125|FG013|Overall Study|Clinical progression|1|||
105807505|NCT02711956|364952126|FG014|Overall Study|Clinical progression|1|||
105807506|NCT02711956|364952112|FG000|Overall Study|Radiographic progression|1|||
105807507|NCT02711956|364952113|FG001|Overall Study|Radiographic progression|1|||
105807508|NCT02711956|364952114|FG002|Overall Study|Radiographic progression|2|||
105807509|NCT02711956|364952115|FG003|Overall Study|Radiographic progression|0|||
105807510|NCT02711956|364952116|FG004|Overall Study|Radiographic progression|1|||
105807511|NCT02711956|364952117|FG005|Overall Study|Radiographic progression|0|||
105807512|NCT02711956|364952118|FG006|Overall Study|Radiographic progression|0|||
105807513|NCT02711956|364952119|FG007|Overall Study|Radiographic progression|0|||
105807514|NCT02711956|364952120|FG008|Overall Study|Radiographic progression|2|||
105807515|NCT02711956|364952121|FG009|Overall Study|Radiographic progression|1|||
105807516|NCT02711956|364952122|FG010|Overall Study|Radiographic progression|0|||
105807517|NCT02711956|364952123|FG011|Overall Study|Radiographic progression|5|||
105807518|NCT02711956|364952124|FG012|Overall Study|Radiographic progression|3|||
105807519|NCT02711956|364952125|FG013|Overall Study|Radiographic progression|0|||
105807520|NCT02711956|364952126|FG014|Overall Study|Radiographic progression|1|||
105807521|NCT02711956|364952112|FG000|Overall Study|PSA progression with clinical progression|0|||
105807522|NCT02711956|364952113|FG001|Overall Study|PSA progression with clinical progression|0|||
105360933|NCT00536510|363328113|FG001|Overall Study|Flushing with Product|0|||
105360934|NCT00536510|363328112|FG000|Overall Study|Laboratory Adverse Event|2|||
105360935|NCT00536510|363328113|FG001|Overall Study|Laboratory Adverse Event|1|||
105360936|NCT00536510|363328112|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
105360937|NCT00536510|363328113|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
105360938|NCT02169505|363328120|FG000|Overall Study|Withdrawal by Subject|1|||
105807523|NCT02711956|364952114|FG002|Overall Study|PSA progression with clinical progression|0|||
105807524|NCT02711956|364952115|FG003|Overall Study|PSA progression with clinical progression|0|||
105360939|NCT01135524|363328121|FG000|Overall Study|Withdrawal by Subject|14|||
105360940|NCT01135524|363328121|FG000|Overall Study|Adverse Event|20|||
105360941|NCT01135524|363328121|FG000|Overall Study|Lost to Follow-up|3|||
105485068|NCT00282464|363787055|FG001|Overall Study|patient non-compliant|0|||
105807525|NCT02711956|364952116|FG004|Overall Study|PSA progression with clinical progression|1|||
105807526|NCT02711956|364952117|FG005|Overall Study|PSA progression with clinical progression|0|||
105807527|NCT02711956|364952118|FG006|Overall Study|PSA progression with clinical progression|0|||
105807528|NCT02711956|364952119|FG007|Overall Study|PSA progression with clinical progression|0|||
105807529|NCT02711956|364952120|FG008|Overall Study|PSA progression with clinical progression|0|||
105807530|NCT02711956|364952121|FG009|Overall Study|PSA progression with clinical progression|0|||
105807531|NCT02711956|364952122|FG010|Overall Study|PSA progression with clinical progression|0|||
105360942|NCT01135524|363328121|FG000|Overall Study|Administrative|151|||
105807532|NCT02711956|364952123|FG011|Overall Study|PSA progression with clinical progression|0|||
105807533|NCT02711956|364952124|FG012|Overall Study|PSA progression with clinical progression|1|||
105807534|NCT02711956|364952125|FG013|Overall Study|PSA progression with clinical progression|1|||
105807535|NCT02711956|364952126|FG014|Overall Study|PSA progression with clinical progression|0|||
105807536|NCT02711956|364952112|FG000|Overall Study|PSA progression with radiographic progression|0|||
105807537|NCT02711956|364952113|FG001|Overall Study|PSA progression with radiographic progression|1|||
105807538|NCT02711956|364952114|FG002|Overall Study|PSA progression with radiographic progression|0|||
105807539|NCT02711956|364952115|FG003|Overall Study|PSA progression with radiographic progression|0|||
105807540|NCT02711956|364952116|FG004|Overall Study|PSA progression with radiographic progression|0|||
105807541|NCT02711956|364952117|FG005|Overall Study|PSA progression with radiographic progression|2|||
105807542|NCT02711956|364952118|FG006|Overall Study|PSA progression with radiographic progression|2|||
105807543|NCT02711956|364952119|FG007|Overall Study|PSA progression with radiographic progression|1|||
105807544|NCT02711956|364952120|FG008|Overall Study|PSA progression with radiographic progression|0|||
105807545|NCT02711956|364952121|FG009|Overall Study|PSA progression with radiographic progression|1|||
105807546|NCT02711956|364952122|FG010|Overall Study|PSA progression with radiographic progression|0|||
105807547|NCT02711956|364952123|FG011|Overall Study|PSA progression with radiographic progression|1|||
105807548|NCT02711956|364952124|FG012|Overall Study|PSA progression with radiographic progression|2|||
105807549|NCT02711956|364952125|FG013|Overall Study|PSA progression with radiographic progression|3|||
105807550|NCT02711956|364952126|FG014|Overall Study|PSA progression with radiographic progression|3|||
105807551|NCT03734237|364952127|FG000|Overall Study|Lost to Follow-up|1|||
105807552|NCT03734237|364952128|FG001|Overall Study|Lost to Follow-up|3|||
105807553|NCT03734237|364952129|FG002|Overall Study|Lost to Follow-up|0|||
105807554|NCT03734237|364952127|FG000|Overall Study|Withdrawal by Subject|7|||
105807555|NCT03734237|364952128|FG001|Overall Study|Withdrawal by Subject|9|||
105807556|NCT03734237|364952129|FG002|Overall Study|Withdrawal by Subject|10|||
105485069|NCT00282464|363787054|FG000|Overall Study|patient no show|0|||
105485070|NCT00282464|363787055|FG001|Overall Study|patient no show|1|||
105807557|NCT00175019|364952130|FG000|Overall Study|Adverse Event|54|||
105807558|NCT00175019|364952131|FG001|Overall Study|Adverse Event|22|||
105807559|NCT00175019|364952132|FG002|Overall Study|Adverse Event|2|||
105807560|NCT00175019|364952130|FG000|Overall Study|Protocol Violation|6|||
105807561|NCT00175019|364952131|FG001|Overall Study|Protocol Violation|3|||
105807562|NCT00175019|364952132|FG002|Overall Study|Protocol Violation|3|||
105807563|NCT00175019|364952130|FG000|Overall Study|Lost to Follow-up|42|||
105807564|NCT00175019|364952131|FG001|Overall Study|Lost to Follow-up|39|||
105807565|NCT00175019|364952132|FG002|Overall Study|Lost to Follow-up|9|||
105807566|NCT00175019|364952130|FG000|Overall Study|Did not continue under Amendment 4|1|||
105807567|NCT00175019|364952131|FG001|Overall Study|Did not continue under Amendment 4|1|||
105807568|NCT00175019|364952132|FG002|Overall Study|Did not continue under Amendment 4|2|||
105807569|NCT00175019|364952130|FG000|Overall Study|Personal Reason(s)|39|||
105807570|NCT00175019|364952131|FG001|Overall Study|Personal Reason(s)|31|||
105807571|NCT00175019|364952132|FG002|Overall Study|Personal Reason(s)|8|||
105807572|NCT00175019|364952130|FG000|Overall Study|Therapeutic Failure|10|||
105807573|NCT00175019|364952131|FG001|Overall Study|Therapeutic Failure|38|||
105807574|NCT00175019|364952132|FG002|Overall Study|Therapeutic Failure|22|||
105807575|NCT00175019|364952130|FG000|Overall Study|Gout Flare|2|||
105807576|NCT00175019|364952131|FG001|Overall Study|Gout Flare|3|||
105807577|NCT00175019|364952132|FG002|Overall Study|Gout Flare|0|||
105807578|NCT00175019|364952130|FG000|Overall Study|Reason Not Specified|40|||
105807579|NCT00175019|364952131|FG001|Overall Study|Reason Not Specified|34|||
105807580|NCT00175019|364952132|FG002|Overall Study|Reason Not Specified|11|||
105807581|NCT02324465|364952137|FG000|Overall Study|device failure|0|||
105807582|NCT02324465|364952138|FG001|Overall Study|device failure|1|||
105807583|NCT01612000|364952143|FG000|Overall Study|Lost to Follow-up|6|||
105807584|NCT01612000|364952144|FG001|Overall Study|Lost to Follow-up|4|||
105807585|NCT01612000|364952145|FG002|Overall Study|Lost to Follow-up|4|||
105807586|NCT01612000|364952146|FG003|Overall Study|Lost to Follow-up|8|||
105807587|NCT01612000|364952143|FG000|Overall Study|Physician Decision|0|||
105807588|NCT01612000|364952144|FG001|Overall Study|Physician Decision|0|||
105807589|NCT01612000|364952145|FG002|Overall Study|Physician Decision|1|||
105807590|NCT01612000|364952146|FG003|Overall Study|Physician Decision|0|||
105807591|NCT01612000|364952143|FG000|Overall Study|Withdrawal by Subject|3|||
105807592|NCT01612000|364952144|FG001|Overall Study|Withdrawal by Subject|1|||
105807593|NCT01612000|364952145|FG002|Overall Study|Withdrawal by Subject|2|||
105807594|NCT01612000|364952146|FG003|Overall Study|Withdrawal by Subject|2|||
105807595|NCT02173704|364952147|FG000|Overall Study|Adverse Event|1|||
105807596|NCT02173704|364952148|FG001|Overall Study|Adverse Event|0|||
105807597|NCT02173704|364952147|FG000|Overall Study|Lost to Follow-up|1|||
105807598|NCT02173704|364952148|FG001|Overall Study|Lost to Follow-up|0|||
105807599|NCT02173704|364952147|FG000|Overall Study|Other|1|||
105485071|NCT00282464|363787054|FG000|Overall Study|patient incarcerated|0|||
105485072|NCT00282464|363787055|FG001|Overall Study|patient incarcerated|1|||
105485073|NCT00282464|363787054|FG000|Overall Study|family crisis|0|||
105807600|NCT02173704|364952148|FG001|Overall Study|Other|0|||
105807601|NCT02173704|364952147|FG000|Overall Study|Protocol Violation|1|||
105807602|NCT02173704|364952148|FG001|Overall Study|Protocol Violation|0|||
105807603|NCT02173704|364952147|FG000|Overall Study|Withdrawal by Subject|9|||
105807604|NCT02173704|364952148|FG001|Overall Study|Withdrawal by Subject|4|||
105807605|NCT00419926|364952149|FG000|Overall Study|Withdrawal by Subject|7|||
105807606|NCT00419926|364952150|FG001|Overall Study|Withdrawal by Subject|3|||
105807607|NCT00419926|364952149|FG000|Overall Study|Administrative Problem|4|||
105807608|NCT00419926|364952150|FG001|Overall Study|Administrative Problem|4|||
105807609|NCT00419926|364952149|FG000|Overall Study|Lost to Follow-up|1|||
105807610|NCT00419926|364952150|FG001|Overall Study|Lost to Follow-up|2|||
105807611|NCT00419926|364952149|FG000|Overall Study|Death|2|||
105807612|NCT00419926|364952150|FG001|Overall Study|Death|1|||
105807613|NCT00368966|364952151|FG000|Infant Series|Withdrawal by Subject|11|||
105807614|NCT00368966|364952152|FG001|Infant Series|Withdrawal by Subject|6|||
105807615|NCT00368966|364952151|FG000|Infant Series|Protocol Violation|2|||
105807616|NCT00368966|364952152|FG001|Infant Series|Protocol Violation|1|||
105807617|NCT00368966|364952151|FG000|Infant Series|Lost to Follow-up|2|||
105807618|NCT00368966|364952152|FG001|Infant Series|Lost to Follow-up|0|||
105807619|NCT00368966|364952151|FG000|Infant Series|Randomization error|0|||
105807620|NCT00368966|364952152|FG001|Infant Series|Randomization error|1|||
105807621|NCT00368966|364952151|FG000|Infant Series|Failed to meet eligibility criteria|0|||
105807622|NCT00368966|364952152|FG001|Infant Series|Failed to meet eligibility criteria|1|||
105807623|NCT00368966|364952151|FG000|Infant Series|Adverse Event|0|||
105807624|NCT00368966|364952152|FG001|Infant Series|Adverse Event|1|||
105807625|NCT00368966|364952151|FG000|Infant Series|Failed to return|1|||
105807626|NCT00368966|364952152|FG001|Infant Series|Failed to return|0|||
105807627|NCT00368966|364952151|FG000|After Infant|Failed to return|3|||
105807628|NCT00368966|364952152|FG001|After Infant|Failed to return|1|||
105807629|NCT00368966|364952151|FG000|After Infant|Adverse Event|1|||
105807630|NCT00368966|364952152|FG001|After Infant|Adverse Event|2|||
105807631|NCT00368966|364952151|FG000|After Infant|Withdrawal by Subject|1|||
105807632|NCT00368966|364952152|FG001|After Infant|Withdrawal by Subject|1|||
105360943|NCT01135524|363328121|FG000|Overall Study|Lack of Efficacy|8|||
105360944|NCT00943397|363328122|FG000|Overall Study|Adverse Event|0|||
105360945|NCT00943397|363328123|FG001|Overall Study|Adverse Event|6|||
105360946|NCT00943397|363328122|FG000|Overall Study|Lost to Follow-up|0|||
105360947|NCT00943397|363328123|FG001|Overall Study|Lost to Follow-up|4|||
105360948|NCT00943397|363328122|FG000|Overall Study|Protocol Violation|2|||
105360949|NCT00943397|363328123|FG001|Overall Study|Protocol Violation|5|||
105360950|NCT00943397|363328122|FG000|Overall Study|Withdrawal by Subject|1|||
105360951|NCT00943397|363328123|FG001|Overall Study|Withdrawal by Subject|1|||
105360952|NCT00943397|363328122|FG000|Overall Study|Site terminated and other|12|||
105360953|NCT00943397|363328123|FG001|Overall Study|Site terminated and other|56|||
105360954|NCT04878055|363328124|FG000|Overall Study|Patient transferred in another department|0|||
105360955|NCT04878055|363328125|FG001|Overall Study|Patient transferred in another department|2|||
105360956|NCT04878055|363328124|FG000|Overall Study|Physician Decision|1|||
105360957|NCT04878055|363328125|FG001|Overall Study|Physician Decision|1|||
105360958|NCT04878055|363328124|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
105360959|NCT04878055|363328125|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
105360960|NCT04878055|363328124|FG000|Overall Study|Adverse Event|12|||
105360961|NCT04878055|363328125|FG001|Overall Study|Adverse Event|7|||
105360962|NCT04878055|363328124|FG000|Overall Study|Other|5|||
105360963|NCT04878055|363328125|FG001|Overall Study|Other|0|||
105360964|NCT04878055|363328124|FG000|Overall Study|Withdrawal by Subject|7|||
105360965|NCT04878055|363328125|FG001|Overall Study|Withdrawal by Subject|3|||
105360966|NCT04878055|363328124|FG000|Overall Study|Lost to Follow-up|10|||
105360967|NCT04878055|363328125|FG001|Overall Study|Lost to Follow-up|1|||
105360968|NCT01968811|363328126|FG000|Overall Study|Protocol Violation|4|||
105360969|NCT01968811|363328126|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
105360970|NCT01254656|363328127|FG000|Overall Study|Discontinued due to termination of study|40|||
105485074|NCT00282464|363787055|FG001|Overall Study|family crisis|1|||
105485075|NCT00282464|363787054|FG000|Overall Study|dispensed wrong kit|0|||
105485076|NCT00282464|363787055|FG001|Overall Study|dispensed wrong kit|1|||
105807633|NCT00368966|364952151|FG000|After Infant|Death|1|||
105807634|NCT00368966|364952152|FG001|After Infant|Death|0|||
105807635|NCT00368966|364952151|FG000|After Infant|Lost to Follow-up|0|||
105807636|NCT00368966|364952152|FG001|After Infant|Lost to Follow-up|1|||
105807637|NCT00368966|364952151|FG000|Toddler Dose|Withdrawal by Subject|1|||
105807638|NCT00368966|364952152|FG001|Toddler Dose|Withdrawal by Subject|1|||
105360971|NCT01254656|363328128|FG001|Overall Study|Discontinued due to termination of study|39|||
105360972|NCT01254656|363328129|FG002|Overall Study|Discontinued due to termination of study|13|||
105360973|NCT01254656|363328127|FG000|Overall Study|Lack of Efficacy|3|||
105807639|NCT00368966|364952151|FG000|Toddler Dose|Lost to Follow-up|0|||
105807640|NCT00368966|364952152|FG001|Toddler Dose|Lost to Follow-up|2|||
105360974|NCT01254656|363328128|FG001|Overall Study|Lack of Efficacy|0|||
105807641|NCT01595009|364952153|FG000|Core|Patients completed per protocol|85|||
105360975|NCT01254656|363328129|FG002|Overall Study|Lack of Efficacy|0|||
105360976|NCT01254656|363328127|FG000|Overall Study|Lost to Follow-up|1|||
105761205|NCT01468701|364778152|FG002|Overall Study|Not being followed up|1755|||
105761206|NCT01468701|364778153|FG003|Overall Study|Not being followed up|703|||
105761207|NCT01468701|364778154|FG004|Overall Study|Not being followed up|1714|||
105761208|NCT01468701|364778155|FG005|Overall Study|Not being followed up|126|||
105761209|NCT01468701|364778156|FG006|Overall Study|Not being followed up|1170|||
105761210|NCT01468701|364778157|FG007|Overall Study|Not being followed up|4|||
105761211|NCT01468701|364778158|FG008|Overall Study|Not being followed up|0|||
105761212|NCT01468701|364778159|FG009|Overall Study|Not being followed up|0|||
105761213|NCT01468701|364778160|FG010|Overall Study|Not being followed up|0|||
105761214|NCT01468701|364778161|FG011|Overall Study|Not being followed up|0|||
105761215|NCT01468701|364778162|FG012|Overall Study|Not being followed up|0|||
105761216|NCT01468701|364778163|FG013|Overall Study|Not being followed up|0|||
105761217|NCT01468701|364778164|FG014|Overall Study|Not being followed up|0|||
105761218|NCT01468701|364778165|FG015|Overall Study|Not being followed up|0|||
105761219|NCT01468701|364778166|FG016|Overall Study|Not being followed up|0|||
105761220|NCT01068717|364778168|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
105761221|NCT01068717|364778169|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
105761222|NCT01068717|364778170|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
105761223|NCT01068717|364778171|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
105761224|NCT01822223|364778174|FG000|Overall Study|Death|0|||
105761225|NCT01822223|364778175|FG001|Overall Study|Death|1|||
105761226|NCT02679781|364778176|FG000|Overall Study|Lost to Follow-up|1|||
105761227|NCT02679781|364778177|FG001|Overall Study|Lost to Follow-up|2|||
105761228|NCT02679781|364778176|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
105761229|NCT02679781|364778177|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
105761230|NCT00631540|364778186|FG000|Overall Study|Withdrawal by Subject|5|||
105761231|NCT00631540|364778186|FG000|Overall Study|Death|4|||
105761232|NCT00631540|364778186|FG000|Overall Study|Lost to Follow-up|2|||
105761233|NCT00631540|364778186|FG000|Overall Study|Core Lab Data Unavailable|3|||
105761234|NCT00970268|364778187|FG000|Overall Study|Withdrawal by Subject|12|||
105761235|NCT00970268|364778188|FG001|Overall Study|Withdrawal by Subject|19|||
105761236|NCT00970268|364778187|FG000|Overall Study|Adverse Event|15|||
105761237|NCT00970268|364778188|FG001|Overall Study|Adverse Event|12|||
105761238|NCT00970268|364778187|FG000|Overall Study|Lack of Efficacy|3|||
105761239|NCT00970268|364778188|FG001|Overall Study|Lack of Efficacy|6|||
105761240|NCT00970268|364778187|FG000|Overall Study|Protocol Violation|4|||
105761241|NCT00970268|364778188|FG001|Overall Study|Protocol Violation|7|||
105761242|NCT00970268|364778187|FG000|Overall Study|Other Reason|3|||
105761243|NCT00970268|364778188|FG001|Overall Study|Other Reason|1|||
105761244|NCT00970268|364778187|FG000|Overall Study|COPD Exacerbation|4|||
105761245|NCT00970268|364778188|FG001|Overall Study|COPD Exacerbation|2|||
105761246|NCT00970268|364778187|FG000|Overall Study|Lost to Follow-up|1|||
105761247|NCT00970268|364778188|FG001|Overall Study|Lost to Follow-up|2|||
105761248|NCT00970268|364778187|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
105761249|NCT00970268|364778188|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
105761250|NCT03032510|364778189|FG000|Overall Study|Adverse Event|5|||
105761251|NCT03032510|364778190|FG001|Overall Study|Adverse Event|2|||
105761252|NCT03032510|364778189|FG000|Overall Study|Lost to Follow-up|8|||
105761253|NCT03032510|364778190|FG001|Overall Study|Lost to Follow-up|7|||
105761254|NCT03032510|364778189|FG000|Overall Study|Withdrawal by Subject|8|||
105761255|NCT03032510|364778190|FG001|Overall Study|Withdrawal by Subject|7|||
105761256|NCT03032510|364778189|FG000|Overall Study|Subject noncompliance|4|||
105761257|NCT03032510|364778190|FG001|Overall Study|Subject noncompliance|2|||
105761258|NCT03032510|364778189|FG000|Overall Study|Physician Decision|2|||
105761259|NCT03032510|364778190|FG001|Overall Study|Physician Decision|0|||
105761260|NCT01601470|364778191|FG000|Period 2 - LCZ696|Physician Decision|1|||
105761261|NCT01203787|364778192|FG000|Overall Study|Death|12|||
105761262|NCT01203787|364778193|FG001|Overall Study|Death|10|||
105761263|NCT01203787|364778192|FG000|Overall Study|Withdrawal by Subject|6|||
105761264|NCT01203787|364778193|FG001|Overall Study|Withdrawal by Subject|2|||
105761265|NCT01203787|364778192|FG000|Overall Study|Lost to Follow-up|2|||
105761266|NCT01203787|364778193|FG001|Overall Study|Lost to Follow-up|0|||
105761267|NCT01203787|364778192|FG000|Overall Study|Adverse Event|11|||
105761268|NCT01203787|364778193|FG001|Overall Study|Adverse Event|15|||
105761269|NCT03404518|364778194|FG000|Overall Study|Lost to Follow-up|28|||
105761270|NCT03404518|364778195|FG001|Overall Study|Lost to Follow-up|30|||
105761271|NCT03404518|364778194|FG000|Overall Study|Protocol Violation|13|||
105761272|NCT03404518|364778195|FG001|Overall Study|Protocol Violation|6|||
105761273|NCT04021706|364781316|FG000|Overall Study|Adverse Event|2|||
105761274|NCT04021706|364781317|FG001|Overall Study|Adverse Event|0|||
105761275|NCT04021706|364781316|FG000|Overall Study|Withdrawal by Subject|1|||
105807642|NCT01595009|364952154|FG001|Core|Patients completed per protocol|44|||
105807643|NCT01595009|364952155|FG002|Core|Patients completed per protocol|0|||
105807644|NCT01595009|364952156|FG003|Core|Patients completed per protocol|0|||
105807645|NCT01595009|364952153|FG000|Core|Adverse Event|19|||
105807646|NCT01595009|364952154|FG001|Core|Adverse Event|23|||
105807647|NCT01595009|364952155|FG002|Core|Adverse Event|0|||
105807648|NCT01595009|364952156|FG003|Core|Adverse Event|0|||
105807649|NCT01595009|364952153|FG000|Core|Disease progression|14|||
105807650|NCT01595009|364952154|FG001|Core|Disease progression|26|||
105807651|NCT01595009|364952155|FG002|Core|Disease progression|0|||
105807652|NCT01595009|364952156|FG003|Core|Disease progression|0|||
105761276|NCT04021706|364781317|FG001|Overall Study|Withdrawal by Subject|2|||
105761277|NCT04021706|364781316|FG000|Overall Study|Physician Decision|1|||
105761278|NCT04021706|364781317|FG001|Overall Study|Physician Decision|0|||
105761279|NCT00107172|364781325|FG000|Overall Study|Withdrawal by Subject|1|||
105761280|NCT00107172|364781326|FG001|Overall Study|Withdrawal by Subject|0|||
105761281|NCT00107172|364781325|FG000|Overall Study|Death|0|||
105761282|NCT00107172|364781326|FG001|Overall Study|Death|2|||
105761283|NCT00107172|364781325|FG000|Overall Study|Other Reason|4|||
105761284|NCT00107172|364781326|FG001|Overall Study|Other Reason|3|||
105761285|NCT02688153|364781327|FG000|Overall Study|Death|7|||
105761286|NCT02688153|364781328|FG001|Overall Study|Death|5|||
105761287|NCT02688153|364781327|FG000|Overall Study|Withdrawal by Subject|4|||
105761288|NCT02688153|364781328|FG001|Overall Study|Withdrawal by Subject|2|||
105761289|NCT02688153|364781327|FG000|Overall Study|Valve Explant|1|||
105761290|NCT02688153|364781328|FG001|Overall Study|Valve Explant|0|||
105761291|NCT02688153|364781327|FG000|Overall Study|Conversion to Commercial Valve|3|||
105761292|NCT02688153|364781328|FG001|Overall Study|Conversion to Commercial Valve|0|||
105761293|NCT01102140|364781329|FG000|Overall Study|Lost to Follow-up|1|||
105761294|NCT01102140|364781330|FG001|Overall Study|Lost to Follow-up|0|||
105761295|NCT01102140|364781329|FG000|Overall Study|Investigator terminated study|2|||
105761296|NCT01102140|364781330|FG001|Overall Study|Investigator terminated study|2|||
105761297|NCT04268303|364781334|FG000|Overall Study|Lost to Follow-up|1|||
105761298|NCT04268303|364781335|FG001|Overall Study|Lost to Follow-up|1|||
105761299|NCT04268303|364781336|FG002|Overall Study|Lost to Follow-up|2|||
105761300|NCT04268303|364781334|FG000|Overall Study|Withdrawal by Subject|0|||
105761301|NCT04268303|364781335|FG001|Overall Study|Withdrawal by Subject|1|||
105761302|NCT04268303|364781336|FG002|Overall Study|Withdrawal by Subject|1|||
105761303|NCT04268303|364781334|FG000|Overall Study|Adverse Event|2|||
105761304|NCT04268303|364781335|FG001|Overall Study|Adverse Event|0|||
105761305|NCT04268303|364781336|FG002|Overall Study|Adverse Event|0|||
105761306|NCT00355134|364781337|FG000|Core Phase|Withdrawal by Subject|35|||
105761307|NCT00355134|364781338|FG001|Core Phase|Withdrawal by Subject|24|||
105761308|NCT00355134|364781339|FG002|Core Phase|Withdrawal by Subject|35|||
105761309|NCT00355134|364781340|FG003|Core Phase|Withdrawal by Subject|0|||
105761310|NCT00355134|364781341|FG004|Core Phase|Withdrawal by Subject|0|||
105761311|NCT00355134|364781337|FG000|Core Phase|Adverse Event|28|||
105761312|NCT00355134|364781338|FG001|Core Phase|Adverse Event|22|||
105761313|NCT00355134|364781339|FG002|Core Phase|Adverse Event|16|||
105761314|NCT00355134|364781340|FG003|Core Phase|Adverse Event|0|||
105761315|NCT00355134|364781341|FG004|Core Phase|Adverse Event|0|||
105761316|NCT00355134|364781337|FG000|Core Phase|Lost to Follow-up|17|||
105761317|NCT00355134|364781338|FG001|Core Phase|Lost to Follow-up|13|||
105761318|NCT00355134|364781339|FG002|Core Phase|Lost to Follow-up|21|||
105761319|NCT00355134|364781340|FG003|Core Phase|Lost to Follow-up|0|||
105761320|NCT00355134|364781341|FG004|Core Phase|Lost to Follow-up|0|||
105761321|NCT00355134|364781337|FG000|Core Phase|Abnormal laboratory value(s)|19|||
105761322|NCT00355134|364781338|FG001|Core Phase|Abnormal laboratory value(s)|14|||
105761323|NCT00355134|364781339|FG002|Core Phase|Abnormal laboratory value(s)|2|||
105761324|NCT00355134|364781340|FG003|Core Phase|Abnormal laboratory value(s)|0|||
105761325|NCT00355134|364781341|FG004|Core Phase|Abnormal laboratory value(s)|0|||
105761326|NCT00355134|364781337|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
105761327|NCT00355134|364781338|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
105761328|NCT00355134|364781339|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
105761329|NCT00355134|364781340|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
105761330|NCT00355134|364781341|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
105761331|NCT00355134|364781337|FG000|Core Phase|Administrative problems|5|||
105761332|NCT00355134|364781338|FG001|Core Phase|Administrative problems|3|||
105761333|NCT00355134|364781339|FG002|Core Phase|Administrative problems|5|||
105761334|NCT00355134|364781340|FG003|Core Phase|Administrative problems|0|||
105761335|NCT00355134|364781341|FG004|Core Phase|Administrative problems|0|||
105761336|NCT00355134|364781337|FG000|Core Phase|Protocol Violation|3|||
105761337|NCT00355134|364781338|FG001|Core Phase|Protocol Violation|2|||
105761338|NCT00355134|364781339|FG002|Core Phase|Protocol Violation|2|||
105807653|NCT01595009|364952153|FG000|Core|Withdrawal by Subject|4|||
105761339|NCT00355134|364781340|FG003|Core Phase|Protocol Violation|0|||
105761340|NCT00355134|364781341|FG004|Core Phase|Protocol Violation|0|||
105761341|NCT00355134|364781337|FG000|Core Phase|Abnormal test procedure result(s)|1|||
105807654|NCT01595009|364952154|FG001|Core|Withdrawal by Subject|17|||
105807655|NCT01595009|364952155|FG002|Core|Withdrawal by Subject|0|||
105807656|NCT01595009|364952156|FG003|Core|Withdrawal by Subject|0|||
105807657|NCT01595009|364952153|FG000|Core|Death|3|||
105807658|NCT01595009|364952154|FG001|Core|Death|6|||
105807659|NCT01595009|364952155|FG002|Core|Death|0|||
105807660|NCT01595009|364952156|FG003|Core|Death|0|||
105807661|NCT01595009|364952153|FG000|Core|Lost to Follow-up|1|||
105807662|NCT01595009|364952154|FG001|Core|Lost to Follow-up|2|||
105807663|NCT01595009|364952155|FG002|Core|Lost to Follow-up|0|||
105807664|NCT01595009|364952156|FG003|Core|Lost to Follow-up|0|||
105807665|NCT01595009|364952153|FG000|Core|Protocol deviation|0|||
105807666|NCT01595009|364952154|FG001|Core|Protocol deviation|1|||
105807667|NCT01595009|364952155|FG002|Core|Protocol deviation|0|||
105807668|NCT01595009|364952156|FG003|Core|Protocol deviation|0|||
105807669|NCT01595009|364952153|FG000|Core|Administrative problems|0|||
105807670|NCT01595009|364952154|FG001|Core|Administrative problems|1|||
105807671|NCT01595009|364952155|FG002|Core|Administrative problems|0|||
105807672|NCT01595009|364952156|FG003|Core|Administrative problems|0|||
105807673|NCT01595009|364952153|FG000|Extension|Administrative problems|0|||
105807674|NCT01595009|364952154|FG001|Extension|Administrative problems|0|||
105807675|NCT01595009|364952155|FG002|Extension|Administrative problems|0|||
105807676|NCT01595009|364952156|FG003|Extension|Administrative problems|1|||
105807677|NCT01595009|364952153|FG000|Extension|Patients completed per protocol|0|||
105807678|NCT01595009|364952154|FG001|Extension|Patients completed per protocol|0|||
105807679|NCT01595009|364952155|FG002|Extension|Patients completed per protocol|0|||
105807680|NCT01595009|364952156|FG003|Extension|Patients completed per protocol|2|||
105807681|NCT01595009|364952153|FG000|Extension|Disease progression|0|||
105807682|NCT01595009|364952154|FG001|Extension|Disease progression|0|||
105807683|NCT01595009|364952155|FG002|Extension|Disease progression|4|||
105807684|NCT01595009|364952156|FG003|Extension|Disease progression|7|||
105807685|NCT01595009|364952153|FG000|Extension|Adverse Event|0|||
105807686|NCT01595009|364952154|FG001|Extension|Adverse Event|0|||
105807687|NCT01595009|364952155|FG002|Extension|Adverse Event|0|||
105807688|NCT01595009|364952156|FG003|Extension|Adverse Event|1|||
105807689|NCT00662025|364952157|FG000|Overall Study|Objective progression or relapse|51|||
105807690|NCT00662025|364952157|FG000|Overall Study|Adverse Event|7|||
105807691|NCT00662025|364952157|FG000|Overall Study|Withdrawal by Subject|1|||
105807692|NCT00662025|364952157|FG000|Overall Study|Results of other clinical study|2|||
105807693|NCT00662025|364952157|FG000|Overall Study|Target lesion cannot be evaluated|1|||
105807694|NCT00662025|364952157|FG000|Overall Study|Domestic circumstances|1|||
105807695|NCT00290745|364952158|FG000|Overall Study|Withdrawal by Subject|4|||
105807696|NCT00290745|364952158|FG000|Overall Study|Physician Decision|2|||
105807697|NCT00290745|364952158|FG000|Overall Study|Surgery after 3 months for progression|3|||
105807698|NCT00290745|364952158|FG000|Overall Study|Baseline MRI not available|3|||
105807699|NCT03267264|364952159|FG000|Overall Study|Withdrawal by Subject|1|||
105807700|NCT03267264|364952160|FG001|Overall Study|Withdrawal by Subject|0|||
105807701|NCT03267264|364952161|FG002|Overall Study|Withdrawal by Subject|2|||
105807702|NCT03267264|364952162|FG003|Overall Study|Withdrawal by Subject|4|||
105807703|NCT01336894|364952163|FG000|Follow-up|Study terminated prematurely|2|||
105807704|NCT01336894|364952164|FG001|Follow-up|Study terminated prematurely|7|||
105807705|NCT01498484|364952165|FG000|Overall Study|Death|6|||
105807706|NCT01498484|364952166|FG001|Overall Study|Death|3|||
105807707|NCT01498484|364952167|FG002|Overall Study|Death|1|||
105807708|NCT01498484|364952168|FG003|Overall Study|Death|1|||
105807709|NCT01498484|364952169|FG004|Overall Study|Death|0|||
105807710|NCT01498484|364952170|FG005|Overall Study|Death|0|||
105807711|NCT01498484|364952171|FG006|Overall Study|Death|10|||
105807712|NCT01498484|364952172|FG007|Overall Study|Death|1|||
105807713|NCT01498484|364952173|FG008|Overall Study|Death|0|||
105807714|NCT01498484|364952165|FG000|Overall Study|Physician Decision|3|||
105807715|NCT01498484|364952166|FG001|Overall Study|Physician Decision|2|||
105807716|NCT01498484|364952167|FG002|Overall Study|Physician Decision|1|||
105807717|NCT01498484|364952168|FG003|Overall Study|Physician Decision|1|||
105360977|NCT01254656|363328128|FG001|Overall Study|Lost to Follow-up|0|||
105360978|NCT01254656|363328129|FG002|Overall Study|Lost to Follow-up|2|||
105360979|NCT01254656|363328127|FG000|Overall Study|Withdrawal by Subject|2|||
105360980|NCT01254656|363328128|FG001|Overall Study|Withdrawal by Subject|2|||
105360981|NCT01254656|363328129|FG002|Overall Study|Withdrawal by Subject|1|||
105360982|NCT01254656|363328127|FG000|Overall Study|Pregnancy|0|||
105360983|NCT01254656|363328128|FG001|Overall Study|Pregnancy|0|||
105807718|NCT01498484|364952169|FG004|Overall Study|Physician Decision|0|||
105807719|NCT01498484|364952170|FG005|Overall Study|Physician Decision|0|||
105807720|NCT01498484|364952171|FG006|Overall Study|Physician Decision|8|||
105807721|NCT01498484|364952172|FG007|Overall Study|Physician Decision|13|||
105807722|NCT01498484|364952173|FG008|Overall Study|Physician Decision|1|||
105360984|NCT01254656|363328129|FG002|Overall Study|Pregnancy|2|||
105807723|NCT01498484|364952165|FG000|Overall Study|Adverse Event|0|||
105807724|NCT01498484|364952166|FG001|Overall Study|Adverse Event|0|||
105807725|NCT01498484|364952167|FG002|Overall Study|Adverse Event|0|||
105807726|NCT01498484|364952168|FG003|Overall Study|Adverse Event|0|||
105807727|NCT01498484|364952169|FG004|Overall Study|Adverse Event|0|||
105485077|NCT00282464|363787054|FG000|Overall Study|dropped due to missed visits|0|||
105485078|NCT00282464|363787055|FG001|Overall Study|dropped due to missed visits|1|||
105485079|NCT00475423|363787056|FG000|Overall Study|Protocol Violation|5|||
105485080|NCT00475423|363787056|FG000|Overall Study|Adverse Event|4|||
105485081|NCT00475423|363787056|FG000|Overall Study|Withdrawal by Subject|6|||
105485082|NCT00475423|363787056|FG000|Overall Study|Lack of Efficacy|8|||
105485083|NCT00475423|363787056|FG000|Overall Study|Death|1|||
105485084|NCT00475423|363787056|FG000|Overall Study|Reason not specified|1|||
105485085|NCT00475423|363787056|FG000|Overall Study|Lost to Follow-up|7|||
105485086|NCT01609478|363787057|FG000|Overall Study|Adverse Event|3|||
105485087|NCT01609478|363787058|FG001|Overall Study|Adverse Event|1|||
105485088|NCT01609478|363787059|FG002|Overall Study|Adverse Event|5|||
105485089|NCT01609478|363787057|FG000|Overall Study|Protocol Deviation|0|||
105485090|NCT01609478|363787058|FG001|Overall Study|Protocol Deviation|1|||
105485091|NCT01609478|363787059|FG002|Overall Study|Protocol Deviation|1|||
105485092|NCT01609478|363787057|FG000|Overall Study|Non-Compliance with study treatment|1|||
105485093|NCT01609478|363787058|FG001|Overall Study|Non-Compliance with study treatment|0|||
105485094|NCT01609478|363787059|FG002|Overall Study|Non-Compliance with study treatment|0|||
105485095|NCT01609478|363787057|FG000|Overall Study|Physician Decision|1|||
105485096|NCT01609478|363787058|FG001|Overall Study|Physician Decision|0|||
105485097|NCT01609478|363787059|FG002|Overall Study|Physician Decision|1|||
105485098|NCT01609478|363787057|FG000|Overall Study|Withdrawal by Subject|2|||
105485099|NCT01609478|363787058|FG001|Overall Study|Withdrawal by Subject|0|||
105485100|NCT01609478|363787059|FG002|Overall Study|Withdrawal by Subject|2|||
105485101|NCT01056380|363787061|FG000|Overall Study|Lost to Follow-up|2|||
105807728|NCT01498484|364952170|FG005|Overall Study|Adverse Event|1|||
105485102|NCT01056380|363787062|FG001|Overall Study|Lost to Follow-up|3|||
105485103|NCT01624870|363787063|FG000|Overall Study|Death|19|||
105485104|NCT01624870|363787063|FG000|Overall Study|Withdrawal by Subject|1|||
105485105|NCT01624870|363787063|FG000|Overall Study|CoreValve not implanted|6|||
105485106|NCT01624870|363787063|FG000|Overall Study|Lost to follow up|1|||
105807729|NCT01498484|364952171|FG006|Overall Study|Adverse Event|0|||
105807730|NCT01498484|364952172|FG007|Overall Study|Adverse Event|0|||
105807731|NCT01498484|364952173|FG008|Overall Study|Adverse Event|0|||
105807732|NCT01498484|364952165|FG000|Overall Study|Withdrawal by Subject|0|||
105807733|NCT01498484|364952166|FG001|Overall Study|Withdrawal by Subject|0|||
105807734|NCT01498484|364952167|FG002|Overall Study|Withdrawal by Subject|0|||
105807735|NCT01498484|364952168|FG003|Overall Study|Withdrawal by Subject|1|||
105807736|NCT01498484|364952169|FG004|Overall Study|Withdrawal by Subject|0|||
105807737|NCT01498484|364952170|FG005|Overall Study|Withdrawal by Subject|0|||
105807738|NCT01498484|364952171|FG006|Overall Study|Withdrawal by Subject|1|||
105807739|NCT01498484|364952172|FG007|Overall Study|Withdrawal by Subject|0|||
105807740|NCT01498484|364952173|FG008|Overall Study|Withdrawal by Subject|0|||
105807741|NCT01498484|364952165|FG000|Overall Study|Other|5|||
105807742|NCT01498484|364952166|FG001|Overall Study|Other|2|||
105807743|NCT01498484|364952167|FG002|Overall Study|Other|0|||
105807744|NCT01498484|364952168|FG003|Overall Study|Other|0|||
105807745|NCT01498484|364952169|FG004|Overall Study|Other|1|||
105807746|NCT01498484|364952170|FG005|Overall Study|Other|0|||
105807747|NCT01498484|364952171|FG006|Overall Study|Other|3|||
105807748|NCT01498484|364952172|FG007|Overall Study|Other|0|||
105807749|NCT01498484|364952173|FG008|Overall Study|Other|1|||
105807750|NCT01620177|364952175|FG000|Overall Study|Failure at Screening Visit|43|||
105807751|NCT01620177|364952175|FG000|Overall Study|Withdrawal by Subject|26|||
105807752|NCT01620177|364952175|FG000|Overall Study|Lost to Follow-up|7|||
105807753|NCT01620177|364952175|FG000|Overall Study|Physician Decision|2|||
105807754|NCT01620177|364952175|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
105807755|NCT01446913|364952179|FG000|Overall Study|Significant illness|1|||
105807756|NCT01446913|364952180|FG001|Overall Study|Significant illness|1|||
105807757|NCT01446913|364952181|FG002|Overall Study|Significant illness|1|||
105807758|NCT01446913|364952179|FG000|Overall Study|Withdrawal by Subject|5|||
105807759|NCT01446913|364952180|FG001|Overall Study|Withdrawal by Subject|3|||
105807760|NCT01446913|364952181|FG002|Overall Study|Withdrawal by Subject|5|||
105807761|NCT01446913|364952179|FG000|Overall Study|Physician Decision|0|||
105807762|NCT01446913|364952180|FG001|Overall Study|Physician Decision|0|||
105807763|NCT01446913|364952181|FG002|Overall Study|Physician Decision|2|||
105807764|NCT01446913|364952179|FG000|Overall Study|Lost to Follow-up|3|||
105807765|NCT01446913|364952180|FG001|Overall Study|Lost to Follow-up|5|||
105807766|NCT01446913|364952181|FG002|Overall Study|Lost to Follow-up|3|||
105807767|NCT00423800|364952182|FG000|Overall Study|Protocol Violation|0|||
105807768|NCT00423800|364952183|FG001|Overall Study|Protocol Violation|1|||
105807769|NCT00619385|364952186|FG000|Overall Study|Adverse Event|0|||
105807770|NCT00619385|364952187|FG001|Overall Study|Adverse Event|0|||
105807771|NCT00619385|364952188|FG002|Overall Study|Adverse Event|3|||
105807772|NCT00619385|364952186|FG000|Overall Study|Other|1|||
105807773|NCT00619385|364952187|FG001|Overall Study|Other|2|||
105807774|NCT00619385|364952188|FG002|Overall Study|Other|1|||
105807775|NCT00203307|364952193|FG000|First Intervention|Adverse Event|2|||
105807776|NCT00203307|364952194|FG001|First Intervention|Adverse Event|0|||
105807777|NCT03504852|364952195|FG000|Overall Study|Withdrawal of informed consent|2|||
105807778|NCT03504852|364952196|FG001|Overall Study|Withdrawal of informed consent|1|||
105807779|NCT03504852|364952197|FG002|Overall Study|Withdrawal of informed consent|0|||
105485107|NCT02217527|363787066|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
105485108|NCT02217527|363787067|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
105485109|NCT02217527|363787066|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
105485110|NCT02217527|363787067|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
105807780|NCT03504852|364952195|FG000|Overall Study|Withdrawal by Subject|5|||
105807781|NCT03504852|364952196|FG001|Overall Study|Withdrawal by Subject|5|||
105807782|NCT03504852|364952197|FG002|Overall Study|Withdrawal by Subject|1|||
105807783|NCT03504852|364952195|FG000|Overall Study|Lost to Follow-up|4|||
105807784|NCT03504852|364952196|FG001|Overall Study|Lost to Follow-up|1|||
105807785|NCT03504852|364952197|FG002|Overall Study|Lost to Follow-up|0|||
105807786|NCT03504852|364952195|FG000|Overall Study|New therapy for study indication|1|||
105807787|NCT03504852|364952196|FG001|Overall Study|New therapy for study indication|0|||
105807788|NCT03504852|364952197|FG002|Overall Study|New therapy for study indication|0|||
105807789|NCT03504852|364952195|FG000|Overall Study|Lack of Efficacy|1|||
105807790|NCT03504852|364952196|FG001|Overall Study|Lack of Efficacy|2|||
105807791|NCT03504852|364952197|FG002|Overall Study|Lack of Efficacy|0|||
105807792|NCT03504852|364952195|FG000|Overall Study|Death|0|||
105807793|NCT03504852|364952196|FG001|Overall Study|Death|1|||
105807794|NCT03504852|364952197|FG002|Overall Study|Death|0|||
105807795|NCT03504852|364952195|FG000|Overall Study|Adverse Event|4|||
105807796|NCT03504852|364952196|FG001|Overall Study|Adverse Event|8|||
105807797|NCT03504852|364952197|FG002|Overall Study|Adverse Event|2|||
105807798|NCT01066052|364952198|FG000|Overall Study|Enrolled But Not Treated|3|||
105807799|NCT01066052|364952199|FG001|Overall Study|Enrolled But Not Treated|0|||
105807800|NCT02220907|364952200|FG000|Overall Study|Adverse Event|7|||
105360985|NCT01254656|363328127|FG000|Overall Study|Adverse Event|1|||
105807801|NCT02220907|364952200|FG000|Overall Study|Physician Decision|1|||
105761342|NCT00355134|364781338|FG001|Core Phase|Abnormal test procedure result(s)|2|||
105761343|NCT00355134|364781339|FG002|Core Phase|Abnormal test procedure result(s)|1|||
105761344|NCT00355134|364781340|FG003|Core Phase|Abnormal test procedure result(s)|0|||
105761345|NCT00355134|364781341|FG004|Core Phase|Abnormal test procedure result(s)|0|||
105761346|NCT00355134|364781337|FG000|Core Phase|Condition no longer requires study drug|1|||
105761347|NCT00355134|364781338|FG001|Core Phase|Condition no longer requires study drug|0|||
105761348|NCT00355134|364781339|FG002|Core Phase|Condition no longer requires study drug|1|||
105761349|NCT00355134|364781340|FG003|Core Phase|Condition no longer requires study drug|0|||
105761350|NCT00355134|364781341|FG004|Core Phase|Condition no longer requires study drug|0|||
105761351|NCT00355134|364781337|FG000|Extension Phase|Withdrawal by Subject|7|||
105761352|NCT00355134|364781338|FG001|Extension Phase|Withdrawal by Subject|11|||
105761353|NCT00355134|364781339|FG002|Extension Phase|Withdrawal by Subject|0|||
105761354|NCT00355134|364781340|FG003|Extension Phase|Withdrawal by Subject|7|||
105761355|NCT00355134|364781341|FG004|Extension Phase|Withdrawal by Subject|5|||
105761356|NCT00355134|364781337|FG000|Extension Phase|Adverse Event|13|||
105761357|NCT00355134|364781338|FG001|Extension Phase|Adverse Event|9|||
105761358|NCT00355134|364781339|FG002|Extension Phase|Adverse Event|0|||
105761359|NCT00355134|364781340|FG003|Extension Phase|Adverse Event|3|||
105761360|NCT00355134|364781341|FG004|Extension Phase|Adverse Event|5|||
105761361|NCT00355134|364781337|FG000|Extension Phase|Lost to Follow-up|2|||
105761362|NCT00355134|364781338|FG001|Extension Phase|Lost to Follow-up|6|||
105761363|NCT00355134|364781339|FG002|Extension Phase|Lost to Follow-up|0|||
105761364|NCT00355134|364781340|FG003|Extension Phase|Lost to Follow-up|2|||
105761365|NCT00355134|364781341|FG004|Extension Phase|Lost to Follow-up|4|||
105761366|NCT00355134|364781337|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
105761367|NCT00355134|364781338|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
105761368|NCT00355134|364781339|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
105761369|NCT00355134|364781340|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
105761370|NCT00355134|364781341|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
105761371|NCT00355134|364781337|FG000|Extension Phase|Administrative problems|2|||
105761372|NCT00355134|364781338|FG001|Extension Phase|Administrative problems|4|||
105761373|NCT00355134|364781339|FG002|Extension Phase|Administrative problems|0|||
105761374|NCT00355134|364781340|FG003|Extension Phase|Administrative problems|1|||
105761375|NCT00355134|364781341|FG004|Extension Phase|Administrative problems|1|||
105761376|NCT00355134|364781337|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
105761377|NCT00355134|364781338|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
105761378|NCT00355134|364781339|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
105761379|NCT00355134|364781340|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
105761380|NCT00355134|364781341|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
105761381|NCT00355134|364781337|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
105761382|NCT00355134|364781338|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
105761383|NCT00355134|364781339|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
105761384|NCT00355134|364781340|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
105761385|NCT00355134|364781341|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
105761386|NCT00355134|364781337|FG000|Extension Phase|Protocol Violation|0|||
105761387|NCT00355134|364781338|FG001|Extension Phase|Protocol Violation|0|||
105761388|NCT00355134|364781339|FG002|Extension Phase|Protocol Violation|0|||
105761389|NCT00355134|364781340|FG003|Extension Phase|Protocol Violation|1|||
105761390|NCT00355134|364781341|FG004|Extension Phase|Protocol Violation|0|||
105761391|NCT01135394|364781345|FG000|Screening|Lost to Follow-up|2|||
105761392|NCT01135394|364781345|FG000|Screening|Withdrawal by Subject|10|||
105761393|NCT01135394|364781345|FG000|Screening|Screening failure|16|||
105761394|NCT01135394|364781345|FG000|Screening|Physician Decision|5|||
105761395|NCT01135394|364781345|FG000|Baseline Assessment|Withdrawal by Subject|9|||
105761396|NCT01135394|364781345|FG000|Baseline Assessment|Physician Decision|3|||
105761397|NCT01135394|364781345|FG000|Baseline Assessment|Lost to Follow-up|2|||
105761398|NCT01135394|364781345|FG000|Baseline Assessment|Adverse Event|1|||
105761399|NCT01135394|364781345|FG000|Study Treatment|Withdrawal by Subject|1|||
105761400|NCT01135394|364781345|FG000|Study Treatment|Physician Decision|1|||
105761401|NCT01135394|364781345|FG000|Study Treatment|Adverse Event|2|||
105761402|NCT01742091|364781348|FG000|Overall Study|Adverse Event|0|||
105761403|NCT01742091|364781349|FG001|Overall Study|Adverse Event|0|||
105761404|NCT01742091|364781350|FG002|Overall Study|Adverse Event|0|||
105761405|NCT01742091|364781351|FG003|Overall Study|Adverse Event|0|||
105761406|NCT01742091|364781352|FG004|Overall Study|Adverse Event|1|||
105761407|NCT01742091|364781353|FG005|Overall Study|Adverse Event|0|||
105761408|NCT01742091|364781348|FG000|Overall Study|Physician Decision|0|||
105761409|NCT01742091|364781349|FG001|Overall Study|Physician Decision|0|||
105761410|NCT01742091|364781350|FG002|Overall Study|Physician Decision|0|||
105761411|NCT01742091|364781351|FG003|Overall Study|Physician Decision|0|||
105761412|NCT01742091|364781352|FG004|Overall Study|Physician Decision|0|||
105761413|NCT01742091|364781353|FG005|Overall Study|Physician Decision|1|||
105761414|NCT01742091|364781348|FG000|Overall Study|Withdrawal by Subject|0|||
105761415|NCT01742091|364781349|FG001|Overall Study|Withdrawal by Subject|0|||
105761416|NCT01742091|364781350|FG002|Overall Study|Withdrawal by Subject|0|||
105807802|NCT02220907|364952200|FG000|Overall Study|Withdrawal by Subject|2|||
105807803|NCT02220907|364952200|FG000|Overall Study|Conflict with the stopping criteria|1|||
105807804|NCT02729896|364952201|FG000|Overall Study|Death|0|||
105807805|NCT02729896|364952202|FG001|Overall Study|Death|2|||
105807806|NCT02729896|364952203|FG002|Overall Study|Death|13|||
105807807|NCT02729896|364952201|FG000|Overall Study|Lost to Follow-up|0|||
105807808|NCT02729896|364952202|FG001|Overall Study|Lost to Follow-up|2|||
105807809|NCT02729896|364952203|FG002|Overall Study|Lost to Follow-up|3|||
105807810|NCT02729896|364952201|FG000|Overall Study|Other|0|||
105807811|NCT02729896|364952202|FG001|Overall Study|Other|2|||
105807812|NCT02729896|364952203|FG002|Overall Study|Other|0|||
105807813|NCT02729896|364952201|FG000|Overall Study|Physician Decision|1|||
105807814|NCT02729896|364952202|FG001|Overall Study|Physician Decision|2|||
105807815|NCT02729896|364952203|FG002|Overall Study|Physician Decision|3|||
105807816|NCT02729896|364952201|FG000|Overall Study|Progressive Disease|0|||
105807817|NCT02729896|364952202|FG001|Overall Study|Progressive Disease|1|||
105807818|NCT02729896|364952203|FG002|Overall Study|Progressive Disease|0|||
105807819|NCT02729896|364952201|FG000|Overall Study|Withdrawal by Subject|1|||
105807820|NCT02729896|364952202|FG001|Overall Study|Withdrawal by Subject|0|||
105807821|NCT02729896|364952203|FG002|Overall Study|Withdrawal by Subject|3|||
105807822|NCT00582309|364952204|FG000|Overall Study|Protocol Violation|0|||
105807823|NCT00582309|364952205|FG001|Overall Study|Protocol Violation|0|||
105807824|NCT00582309|364952206|FG002|Overall Study|Protocol Violation|2|||
105807825|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
105807826|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
105807827|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
105807828|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
105807829|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
105807830|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
105807831|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
105807832|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
105807833|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
105807834|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
105807835|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
105807836|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
105807837|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
105807838|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
105807839|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
105807840|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
105807841|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
105807842|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
105807843|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
105807844|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
105807845|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
105807846|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
105807847|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
105807848|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
105807849|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
105807850|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
105807851|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
105807852|NCT00455533|364952211|FG000|Period Two: Randomized Period|Death|0|||
105807853|NCT00455533|364952212|FG001|Period Two: Randomized Period|Death|0|||
105807854|NCT00455533|364952213|FG002|Period Two: Randomized Period|Death|3|||
105807855|NCT00455533|364952211|FG000|Period Two: Randomized Period|Disease Progression|0|||
105807856|NCT00455533|364952212|FG001|Period Two: Randomized Period|Disease Progression|1|||
105807857|NCT00455533|364952213|FG002|Period Two: Randomized Period|Disease Progression|1|||
105807858|NCT00455533|364952211|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
105807859|NCT00455533|364952212|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
105807860|NCT00455533|364952213|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
105807861|NCT00455533|364952211|FG000|Period Two: Randomized Period|Other - need reasons|0|||
105807862|NCT00455533|364952212|FG001|Period Two: Randomized Period|Other - need reasons|1|||
105807863|NCT00455533|364952213|FG002|Period Two: Randomized Period|Other - need reasons|0|||
105807864|NCT00455533|364952211|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
105807865|NCT00455533|364952212|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
105807866|NCT00455533|364952213|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
105807867|NCT00455533|364952211|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
105807868|NCT00455533|364952212|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
105807869|NCT00455533|364952213|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
105807870|NCT01736553|364952218|FG000|Overall Study|Death|12|||
105807871|NCT01736553|364952219|FG001|Overall Study|Death|0|||
105807872|NCT01736553|364952218|FG000|Overall Study|Withdrawal by Subject|5|||
105807873|NCT01736553|364952219|FG001|Overall Study|Withdrawal by Subject|2|||
105807874|NCT01736553|364952218|FG000|Overall Study|Lost to Follow-up|2|||
105807875|NCT01736553|364952219|FG001|Overall Study|Lost to Follow-up|2|||
105807876|NCT02415959|364952220|FG000|Overall Study|Adverse Event|0|||
105807877|NCT02415959|364952221|FG001|Overall Study|Adverse Event|1|||
105807878|NCT02415959|364952222|FG002|Overall Study|Adverse Event|0|||
105807879|NCT02415959|364952223|FG003|Overall Study|Adverse Event|0|||
105807880|NCT02415959|364952224|FG004|Overall Study|Adverse Event|0|||
105807881|NCT02415959|364952220|FG000|Overall Study|Protocol Violation|0|||
105807882|NCT02415959|364952221|FG001|Overall Study|Protocol Violation|0|||
105807883|NCT02415959|364952222|FG002|Overall Study|Protocol Violation|0|||
105807884|NCT02415959|364952223|FG003|Overall Study|Protocol Violation|1|||
105807885|NCT02415959|364952224|FG004|Overall Study|Protocol Violation|0|||
105807886|NCT01048333|364952225|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
105807887|NCT01048333|364952226|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
105807888|NCT01048333|364952227|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
105807889|NCT01048333|364952228|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
105807890|NCT01048333|364952229|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
105807891|NCT01048333|364952230|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
105807892|NCT00634179|364952234|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
105807893|NCT00767325|364952235|FG000|Overall Study|Lack of Efficacy|2|||
105807894|NCT00767325|364952235|FG000|Overall Study|Adverse Event|7|||
105807895|NCT00767325|364952235|FG000|Overall Study|Lost to Follow-up|3|||
105807896|NCT00767325|364952235|FG000|Overall Study|No longer met study criteria|2|||
105807897|NCT00767325|364952235|FG000|Overall Study|Missed visit due to family reasons|1|||
105807898|NCT04603937|364952241|FG000|Overall Study|Adverse Event|9|||
105807899|NCT04603937|364952242|FG001|Overall Study|Adverse Event|10|||
105807900|NCT04603937|364952241|FG000|Overall Study|Withdrawal by Subject|7|||
105807901|NCT04603937|364952242|FG001|Overall Study|Withdrawal by Subject|6|||
105807902|NCT04603937|364952241|FG000|Overall Study|Lost to Follow-up|5|||
105807903|NCT04603937|364952242|FG001|Overall Study|Lost to Follow-up|6|||
105807904|NCT04603937|364952241|FG000|Overall Study|Physician Decision|0|||
105807905|NCT04603937|364952242|FG001|Overall Study|Physician Decision|1|||
105807906|NCT04603937|364952241|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
105807907|NCT04603937|364952242|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
105807908|NCT00770315|364952245|FG000|Overall Study|Adverse Event|11|||
105807909|NCT00770315|364952246|FG001|Overall Study|Adverse Event|17|||
105807910|NCT00770315|364952247|FG002|Overall Study|Adverse Event|16|||
105807911|NCT00770315|364952248|FG003|Overall Study|Adverse Event|6|||
105807912|NCT00770315|364952245|FG000|Overall Study|Lost to Follow-up|9|||
105807913|NCT00770315|364952246|FG001|Overall Study|Lost to Follow-up|5|||
105807914|NCT00770315|364952247|FG002|Overall Study|Lost to Follow-up|10|||
105807915|NCT00770315|364952248|FG003|Overall Study|Lost to Follow-up|3|||
105807916|NCT00770315|364952245|FG000|Overall Study|Withdrawal by Subject|13|||
105807917|NCT00770315|364952246|FG001|Overall Study|Withdrawal by Subject|17|||
105807918|NCT00770315|364952247|FG002|Overall Study|Withdrawal by Subject|24|||
105807919|NCT00770315|364952248|FG003|Overall Study|Withdrawal by Subject|20|||
105807920|NCT00770315|364952245|FG000|Overall Study|Noncompliance with Protocol|7|||
105807921|NCT00770315|364952246|FG001|Overall Study|Noncompliance with Protocol|4|||
105807922|NCT00770315|364952247|FG002|Overall Study|Noncompliance with Protocol|7|||
105807923|NCT00770315|364952248|FG003|Overall Study|Noncompliance with Protocol|9|||
105807924|NCT02585258|364952249|FG000|Overall Study|Adverse Event|28|||
105807925|NCT02585258|364952250|FG001|Overall Study|Adverse Event|29|||
105807926|NCT02585258|364952249|FG000|Overall Study|Death|3|||
105807927|NCT02585258|364952250|FG001|Overall Study|Death|2|||
105807928|NCT02585258|364952249|FG000|Overall Study|Lack of Efficacy|7|||
105807929|NCT02585258|364952250|FG001|Overall Study|Lack of Efficacy|9|||
105807930|NCT02585258|364952249|FG000|Overall Study|includes covid-related access problems|42|||
105807931|NCT02585258|364952250|FG001|Overall Study|includes covid-related access problems|46|||
105807932|NCT02585258|364952249|FG000|Overall Study|Lost to Follow-up|5|||
105807933|NCT02585258|364952250|FG001|Overall Study|Lost to Follow-up|2|||
105807934|NCT01621490|364954863|FG000|Overall Study|Subject no longer meets study criteria|0|||
105807935|NCT01621490|364954864|FG001|Overall Study|Subject no longer meets study criteria|0|||
105807936|NCT01621490|364954865|FG002|Overall Study|Subject no longer meets study criteria|0|||
105807937|NCT01621490|364954866|FG003|Overall Study|Subject no longer meets study criteria|0|||
105807938|NCT01621490|364954867|FG004|Overall Study|Subject no longer meets study criteria|1|||
105807939|NCT01621490|364954868|FG005|Overall Study|Subject no longer meets study criteria|0|||
105807940|NCT01621490|364954869|FG006|Overall Study|Subject no longer meets study criteria|0|||
105807941|NCT01621490|364954870|FG007|Overall Study|Subject no longer meets study criteria|0|||
105570361|NCT03757234|364086761|FG001|Overall Study|Withdrawal by Subject|1|||
105570362|NCT03757234|364086762|FG002|Overall Study|Withdrawal by Subject|0|||
105570363|NCT03757234|364086763|FG003|Overall Study|Withdrawal by Subject|1|||
105570364|NCT03757234|364086764|FG004|Overall Study|Withdrawal by Subject|2|||
105807942|NCT01621490|364954871|FG008|Overall Study|Subject no longer meets study criteria|0|||
105570365|NCT03757234|364086760|FG000|Overall Study|Other|1|||
105570366|NCT03757234|364086761|FG001|Overall Study|Other|1|||
105570367|NCT03757234|364086762|FG002|Overall Study|Other|0|||
105570368|NCT03757234|364086763|FG003|Overall Study|Other|0|||
105570369|NCT03757234|364086764|FG004|Overall Study|Other|0|||
105570370|NCT03935217|364088182|FG000|Overall Study|Adverse Event|1|||
105570371|NCT03935217|364088183|FG001|Overall Study|Adverse Event|0|||
105570372|NCT03935217|364088182|FG000|Overall Study|Lost to Follow-up|0|||
105570373|NCT03935217|364088183|FG001|Overall Study|Lost to Follow-up|1|||
105570374|NCT03935217|364088182|FG000|Overall Study|Withdrawal by Subject|0|||
105570375|NCT03935217|364088183|FG001|Overall Study|Withdrawal by Subject|2|||
105570376|NCT03285295|364088186|FG000|Alinity s HBsAg|Protocol Violation|11|||
105570377|NCT03285295|364088187|FG001|Alinity s HBsAg|Protocol Violation|0|||
105570378|NCT03285295|364088188|FG002|Alinity s HBsAg|Protocol Violation|0|||
105570379|NCT03285295|364088189|FG003|Alinity s HBsAg|Protocol Violation|0|||
105570380|NCT03285295|364088190|FG004|Alinity s HBsAg|Protocol Violation|0|||
105570381|NCT03285295|364088186|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
105570382|NCT03285295|364088187|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
105570383|NCT03285295|364088188|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
105570384|NCT03285295|364088189|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
105570385|NCT03285295|364088190|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
105570386|NCT03285295|364088186|FG000|Alinity s HBsAg|No Results Generated|74|||
105570387|NCT03285295|364088187|FG001|Alinity s HBsAg|No Results Generated|6|||
105807943|NCT01621490|364954872|FG009|Overall Study|Subject no longer meets study criteria|0|||
105807944|NCT01621490|364954873|FG010|Overall Study|Subject no longer meets study criteria|0|||
105807945|NCT01621490|364954863|FG000|Overall Study|Maximum clinical benefit|3|||
105807946|NCT01621490|364954864|FG001|Overall Study|Maximum clinical benefit|2|||
105807947|NCT01621490|364954865|FG002|Overall Study|Maximum clinical benefit|0|||
105807948|NCT01621490|364954866|FG003|Overall Study|Maximum clinical benefit|0|||
105807949|NCT01621490|364954867|FG004|Overall Study|Maximum clinical benefit|0|||
105807950|NCT01621490|364954868|FG005|Overall Study|Maximum clinical benefit|0|||
105807951|NCT01621490|364954869|FG006|Overall Study|Maximum clinical benefit|1|||
105807952|NCT01621490|364954870|FG007|Overall Study|Maximum clinical benefit|2|||
105807953|NCT01621490|364954871|FG008|Overall Study|Maximum clinical benefit|2|||
105807954|NCT01621490|364954872|FG009|Overall Study|Maximum clinical benefit|0|||
105360986|NCT01254656|363328128|FG001|Overall Study|Adverse Event|1|||
105807955|NCT01621490|364954873|FG010|Overall Study|Maximum clinical benefit|0|||
105807956|NCT01621490|364954863|FG000|Overall Study|Withdrawal by Subject|1|||
105807957|NCT01621490|364954864|FG001|Overall Study|Withdrawal by Subject|0|||
105807958|NCT01621490|364954865|FG002|Overall Study|Withdrawal by Subject|0|||
105807959|NCT01621490|364954866|FG003|Overall Study|Withdrawal by Subject|0|||
105807960|NCT01621490|364954867|FG004|Overall Study|Withdrawal by Subject|0|||
105807961|NCT01621490|364954868|FG005|Overall Study|Withdrawal by Subject|1|||
105570388|NCT03285295|364088188|FG002|Alinity s HBsAg|No Results Generated|0|||
105570389|NCT03285295|364088189|FG003|Alinity s HBsAg|No Results Generated|0|||
105570390|NCT03285295|364088190|FG004|Alinity s HBsAg|No Results Generated|0|||
105570391|NCT03285295|364088186|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
105570392|NCT03285295|364088187|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
105807962|NCT01621490|364954869|FG006|Overall Study|Withdrawal by Subject|0|||
105570393|NCT03285295|364088188|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
105570394|NCT03285295|364088189|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
105570395|NCT03285295|364088190|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
105570396|NCT03285295|364088186|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
105570397|NCT03285295|364088187|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
105570398|NCT03285295|364088188|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
105570399|NCT03285295|364088189|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
105570400|NCT03285295|364088190|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
105570401|NCT03285295|364088186|FG000|Alinity s HTLV I/II|No Results Generated|70|||
105570402|NCT03285295|364088187|FG001|Alinity s HTLV I/II|No Results Generated|0|||
105570403|NCT03285295|364088188|FG002|Alinity s HTLV I/II|No Results Generated|0|||
105570404|NCT03285295|364088189|FG003|Alinity s HTLV I/II|No Results Generated|0|||
105570405|NCT03285295|364088190|FG004|Alinity s HTLV I/II|No Results Generated|0|||
105570406|NCT03285295|364088186|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
105570407|NCT03285295|364088187|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
105570408|NCT03285295|364088188|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
105570409|NCT03285295|364088189|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
105570410|NCT03285295|364088190|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
105570411|NCT03285295|364088186|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
105570412|NCT03285295|364088187|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
105570413|NCT03285295|364088188|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
105570414|NCT03285295|364088189|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
105807963|NCT01621490|364954870|FG007|Overall Study|Withdrawal by Subject|0|||
105807964|NCT01621490|364954871|FG008|Overall Study|Withdrawal by Subject|0|||
105807965|NCT01621490|364954872|FG009|Overall Study|Withdrawal by Subject|0|||
105807966|NCT01621490|364954873|FG010|Overall Study|Withdrawal by Subject|0|||
105807967|NCT01621490|364954863|FG000|Overall Study|Subject request to discontinue study|1|||
105807968|NCT01621490|364954864|FG001|Overall Study|Subject request to discontinue study|3|||
105807969|NCT01621490|364954865|FG002|Overall Study|Subject request to discontinue study|1|||
105807970|NCT01621490|364954866|FG003|Overall Study|Subject request to discontinue study|1|||
105807971|NCT01621490|364954867|FG004|Overall Study|Subject request to discontinue study|0|||
105807972|NCT01621490|364954868|FG005|Overall Study|Subject request to discontinue study|2|||
105807973|NCT01621490|364954869|FG006|Overall Study|Subject request to discontinue study|1|||
105570415|NCT03285295|364088190|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
105570416|NCT03285295|364088186|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
105570417|NCT03285295|364088187|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
105570418|NCT03285295|364088188|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
105570419|NCT03285295|364088189|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
105570420|NCT03285295|364088190|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
105570421|NCT03285295|364088186|FG000|Alinity s Anti-HCV|No Results Generated|71|||
105570422|NCT03285295|364088187|FG001|Alinity s Anti-HCV|No Results Generated|0|||
105570423|NCT03285295|364088188|FG002|Alinity s Anti-HCV|No Results Generated|0|||
105570424|NCT03285295|364088189|FG003|Alinity s Anti-HCV|No Results Generated|0|||
105570425|NCT03285295|364088190|FG004|Alinity s Anti-HCV|No Results Generated|0|||
105570426|NCT03285295|364088186|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
105570427|NCT03285295|364088187|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
105807974|NCT01621490|364954870|FG007|Overall Study|Subject request to discontinue study|0|||
105807975|NCT01621490|364954871|FG008|Overall Study|Subject request to discontinue study|1|||
105807976|NCT01621490|364954872|FG009|Overall Study|Subject request to discontinue study|0|||
105807977|NCT01621490|364954873|FG010|Overall Study|Subject request to discontinue study|0|||
105807978|NCT01621490|364954863|FG000|Overall Study|Adverse event unrelated to study drug|1|||
105807979|NCT01621490|364954864|FG001|Overall Study|Adverse event unrelated to study drug|1|||
105807980|NCT01621490|364954865|FG002|Overall Study|Adverse event unrelated to study drug|0|||
105807981|NCT01621490|364954866|FG003|Overall Study|Adverse event unrelated to study drug|0|||
105807982|NCT01621490|364954867|FG004|Overall Study|Adverse event unrelated to study drug|0|||
105807983|NCT01621490|364954868|FG005|Overall Study|Adverse event unrelated to study drug|0|||
105807984|NCT01621490|364954869|FG006|Overall Study|Adverse event unrelated to study drug|0|||
105485111|NCT01589770|363787073|FG000|Overall Study|EGFR <60ml/min|6|||
105485112|NCT01589770|363787074|FG001|Overall Study|EGFR <60ml/min|4|||
105485113|NCT01589770|363787073|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
105485114|NCT01589770|363787074|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
105485115|NCT01715129|363787075|FG000|Overall Study|Adverse Event, fatal|1|||
105485116|NCT01715129|363787075|FG000|Overall Study|Lack of Efficacy|3|||
105485117|NCT01715129|363787075|FG000|Overall Study|Protocol Violation|1|||
105485118|NCT01715129|363787075|FG000|Overall Study|Consent Withdrawn|2|||
105485119|NCT01715129|363787075|FG000|Overall Study|Lost to Follow-up|1|||
105485120|NCT01715129|363787075|FG000|Overall Study|Other|1|||
105485121|NCT01423604|363787078|FG000|Safety Run-In|Adverse Event|3|||
105485122|NCT01423604|363787079|FG001|Safety Run-In|Adverse Event|0|||
105485123|NCT01423604|363787078|FG000|Safety Run-In|Death|1|||
105485124|NCT01423604|363787079|FG001|Safety Run-In|Death|0|||
105485125|NCT01423604|363787078|FG000|Safety Run-In|Physician Decision|1|||
105485126|NCT01423604|363787079|FG001|Safety Run-In|Physician Decision|0|||
105485127|NCT01423604|363787078|FG000|Safety Run-In|Disease progression|3|||
105485128|NCT01423604|363787079|FG001|Safety Run-In|Disease progression|0|||
105485129|NCT01423604|363787078|FG000|Safety Run-In|Patient decision|1|||
105485130|NCT01423604|363787079|FG001|Safety Run-In|Patient decision|0|||
105485131|NCT01423604|363787078|FG000|Randomized|Adverse Event|4|||
105485132|NCT01423604|363787079|FG001|Randomized|Adverse Event|10|||
105485133|NCT01423604|363787078|FG000|Randomized|Death|1|||
105485134|NCT01423604|363787079|FG001|Randomized|Death|0|||
105485135|NCT01423604|363787078|FG000|Randomized|Physician Decision|16|||
105485136|NCT01423604|363787079|FG001|Randomized|Physician Decision|13|||
105485137|NCT01423604|363787078|FG000|Randomized|Other - unspecified|37|||
105485138|NCT01423604|363787079|FG001|Randomized|Other - unspecified|31|||
105485139|NCT01423604|363787078|FG000|Randomized|Patient decision|5|||
105485140|NCT01423604|363787079|FG001|Randomized|Patient decision|9|||
105485141|NCT04738318|363787082|FG000|Overall Study|Protocol Violation|1|||
105485142|NCT04738318|363787083|FG001|Overall Study|Protocol Violation|0|||
105485143|NCT04231981|363787084|FG000|Overall Study|Adverse Event|1|||
105485144|NCT04231981|363787084|FG000|Overall Study|Death|16|||
105485145|NCT04231981|363787084|FG000|Overall Study|Lost to Follow-up|1|||
105485146|NCT02581943|363787085|FG000|Overall Study|Death|5|||
105485147|NCT02581943|363787086|FG001|Overall Study|Death|2|||
105485148|NCT02581943|363787085|FG000|Overall Study|Disease Progression|12|||
105485149|NCT02581943|363787086|FG001|Overall Study|Disease Progression|15|||
105485150|NCT02581943|363787085|FG000|Overall Study|Withdrawal by Subject|1|||
105485151|NCT02581943|363787086|FG001|Overall Study|Withdrawal by Subject|2|||
105485152|NCT02889562|363787087|FG000|Overall Study|Physician Decision|0|||
105485153|NCT02889562|363787088|FG001|Overall Study|Physician Decision|1|||
105485154|NCT02889562|363787087|FG000|Overall Study|Withdrawal by Subject|0|||
105485155|NCT02889562|363787088|FG001|Overall Study|Withdrawal by Subject|1|||
105485156|NCT00219544|363787089|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
105485157|NCT00219544|363787090|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
105485158|NCT00219544|363787089|FG000|Single Blind Treatment Period|Adverse Event|9|||
105485159|NCT00219544|363787090|FG001|Single Blind Treatment Period|Adverse Event|0|||
105485160|NCT00219544|363787089|FG000|Single Blind Treatment Period|Protocol Violation|4|||
105485161|NCT00219544|363787090|FG001|Single Blind Treatment Period|Protocol Violation|0|||
105485162|NCT00219544|363787089|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
105485163|NCT00219544|363787090|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
105485164|NCT00219544|363787089|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
105485165|NCT00219544|363787090|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
105485166|NCT00219544|363787089|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
105485167|NCT00219544|363787090|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
105485168|NCT00570232|363787091|FG000|Overall Study|Adverse Event|10|||
105485169|NCT00570232|363787091|FG000|Overall Study|discontinued due to medical condition|3|||
105485170|NCT00570232|363787091|FG000|Overall Study|discontinued due to recurrence|8|||
105485171|NCT00570232|363787091|FG000|Overall Study|discontinued due to noncompliance|2|||
105485172|NCT01007253|363787094|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
105485173|NCT01007253|363787095|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
105485174|NCT01007253|363787096|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
105570428|NCT03285295|364088188|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
105570429|NCT03285295|364088189|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
105570430|NCT03285295|364088190|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
105570431|NCT03285295|364088186|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
105570432|NCT03285295|364088187|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
105807985|NCT01621490|364954870|FG007|Overall Study|Adverse event unrelated to study drug|2|||
105807986|NCT01621490|364954871|FG008|Overall Study|Adverse event unrelated to study drug|0|||
105807987|NCT01621490|364954872|FG009|Overall Study|Adverse event unrelated to study drug|0|||
105807988|NCT01621490|364954873|FG010|Overall Study|Adverse event unrelated to study drug|0|||
105807989|NCT01621490|364954863|FG000|Overall Study|Disease progression|27|||
105570433|NCT03285295|364088188|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
105570434|NCT03285295|364088189|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
105570435|NCT03285295|364088190|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
105570436|NCT03285295|364088186|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
105570437|NCT03285295|364088187|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
105570438|NCT03285295|364088188|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
105570439|NCT03285295|364088189|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
105570440|NCT03285295|364088190|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
105570441|NCT03285295|364088186|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
105570442|NCT03285295|364088187|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
105570443|NCT03285295|364088188|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
105570444|NCT03285295|364088189|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
105570445|NCT03285295|364088190|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
105570446|NCT03285295|364088186|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
105570447|NCT03285295|364088187|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
105570448|NCT03285295|364088188|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
105570449|NCT03285295|364088189|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
105570450|NCT03285295|364088190|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
105570451|NCT03285295|364088186|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
105570452|NCT03285295|364088187|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
105570453|NCT03285295|364088188|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
105570454|NCT03285295|364088189|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
105570455|NCT03285295|364088190|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
105570456|NCT03285295|364088186|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
105570457|NCT03285295|364088187|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
105570458|NCT03285295|364088188|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
105570459|NCT03285295|364088189|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
105570460|NCT03285295|364088190|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
105570461|NCT03285295|364088186|FG000|Alinity s Anti-HBc|No Results Generated|70|||
105570462|NCT03285295|364088187|FG001|Alinity s Anti-HBc|No Results Generated|0|||
105570463|NCT03285295|364088188|FG002|Alinity s Anti-HBc|No Results Generated|0|||
105570464|NCT03285295|364088189|FG003|Alinity s Anti-HBc|No Results Generated|0|||
105570465|NCT03285295|364088190|FG004|Alinity s Anti-HBc|No Results Generated|0|||
105570466|NCT03285295|364088186|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
105570467|NCT03285295|364088187|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
105570468|NCT03285295|364088188|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
105570469|NCT03285295|364088189|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
105570470|NCT03285295|364088190|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
105570471|NCT03285295|364088186|FG000|Alinity s Chagas|Protocol Violation|76|||
105570472|NCT03285295|364088187|FG001|Alinity s Chagas|Protocol Violation|0|||
105570473|NCT03285295|364088188|FG002|Alinity s Chagas|Protocol Violation|0|||
105570474|NCT03285295|364088189|FG003|Alinity s Chagas|Protocol Violation|0|||
105570475|NCT03285295|364088190|FG004|Alinity s Chagas|Protocol Violation|0|||
105570476|NCT03285295|364088186|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
105570477|NCT03285295|364088187|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
105570478|NCT03285295|364088188|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
105570479|NCT03285295|364088189|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
105570480|NCT03285295|364088190|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
105570481|NCT03285295|364088186|FG000|Alinity s Chagas|No Results Generated|105|||
105570482|NCT03285295|364088187|FG001|Alinity s Chagas|No Results Generated|0|||
105807990|NCT01621490|364954864|FG001|Overall Study|Disease progression|28|||
105807991|NCT01621490|364954865|FG002|Overall Study|Disease progression|1|||
105807992|NCT01621490|364954866|FG003|Overall Study|Disease progression|5|||
105807993|NCT01621490|364954867|FG004|Overall Study|Disease progression|3|||
105807994|NCT01621490|364954868|FG005|Overall Study|Disease progression|8|||
105485175|NCT01007253|363787097|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
105485176|NCT00814801|363787098|FG000|Overall Study|Adverse Event|15|||
105485177|NCT00814801|363787099|FG001|Overall Study|Adverse Event|16|||
105485178|NCT00814801|363787100|FG002|Overall Study|Adverse Event|19|||
105485179|NCT00814801|363787098|FG000|Overall Study|Withdrawal by Subject|9|||
105485180|NCT00814801|363787099|FG001|Overall Study|Withdrawal by Subject|11|||
105485181|NCT00814801|363787100|FG002|Overall Study|Withdrawal by Subject|14|||
105807995|NCT01621490|364954869|FG006|Overall Study|Disease progression|7|||
105807996|NCT01621490|364954870|FG007|Overall Study|Disease progression|1|||
105807997|NCT01621490|364954871|FG008|Overall Study|Disease progression|4|||
105807998|NCT01621490|364954872|FG009|Overall Study|Disease progression|1|||
105807999|NCT01621490|364954873|FG010|Overall Study|Disease progression|1|||
105808000|NCT01621490|364954863|FG000|Overall Study|Study drug toxicity|1|||
105808001|NCT01621490|364954864|FG001|Overall Study|Study drug toxicity|4|||
105808002|NCT01621490|364954865|FG002|Overall Study|Study drug toxicity|5|||
105570483|NCT03285295|364088188|FG002|Alinity s Chagas|No Results Generated|0|||
105570484|NCT03285295|364088189|FG003|Alinity s Chagas|No Results Generated|0|||
105570485|NCT03285295|364088190|FG004|Alinity s Chagas|No Results Generated|0|||
105570486|NCT03285295|364088186|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
105570487|NCT03285295|364088187|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
105570488|NCT03285295|364088188|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
105570489|NCT03285295|364088189|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
105570490|NCT03285295|364088190|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
105570491|NCT03075501|364088191|FG000|Overall Study|Scheduling difficulties|15|||
105570492|NCT03075501|364088192|FG001|Overall Study|Scheduling difficulties|9|||
105570493|NCT03610737|364088193|FG000|Overall Study|Withdrawal by Subject|1|||
105570494|NCT03610737|364088194|FG001|Overall Study|Withdrawal by Subject|5|||
105570495|NCT03610737|364088193|FG000|Overall Study|Death|1|||
105570496|NCT03610737|364088194|FG001|Overall Study|Death|0|||
105570497|NCT03610737|364088193|FG000|Overall Study|Not treated|5|||
105570498|NCT03610737|364088194|FG001|Overall Study|Not treated|2|||
105570499|NCT03610737|364088193|FG000|Overall Study|Missed Visit|1|||
105570500|NCT03610737|364088194|FG001|Overall Study|Missed Visit|2|||
105570501|NCT02392611|364088197|FG000|Overall Study|Adverse Event|0|||
105570502|NCT02392611|364088198|FG001|Overall Study|Adverse Event|0|||
105570503|NCT02392611|364088199|FG002|Overall Study|Adverse Event|0|||
105570504|NCT02392611|364088200|FG003|Overall Study|Adverse Event|1|||
105570505|NCT02392611|364088201|FG004|Overall Study|Adverse Event|0|||
105570506|NCT02392611|364088202|FG005|Overall Study|Adverse Event|0|||
105570507|NCT02392611|364088203|FG006|Overall Study|Adverse Event|0|||
105570508|NCT02392611|364088204|FG007|Overall Study|Adverse Event|0|||
105570509|NCT02392611|364088205|FG008|Overall Study|Adverse Event|0|||
105570510|NCT02392611|364088197|FG000|Overall Study|Progressive disease|0|||
105570511|NCT02392611|364088198|FG001|Overall Study|Progressive disease|0|||
105570512|NCT02392611|364088199|FG002|Overall Study|Progressive disease|0|||
105570513|NCT02392611|364088200|FG003|Overall Study|Progressive disease|2|||
105570514|NCT02392611|364088201|FG004|Overall Study|Progressive disease|1|||
105570515|NCT02392611|364088202|FG005|Overall Study|Progressive disease|0|||
105570516|NCT02392611|364088203|FG006|Overall Study|Progressive disease|0|||
105570517|NCT02392611|364088204|FG007|Overall Study|Progressive disease|0|||
105570518|NCT02392611|364088205|FG008|Overall Study|Progressive disease|0|||
105570519|NCT02392611|364088197|FG000|Overall Study|Death|1|||
105570520|NCT02392611|364088198|FG001|Overall Study|Death|0|||
105570521|NCT02392611|364088199|FG002|Overall Study|Death|0|||
105570522|NCT02392611|364088200|FG003|Overall Study|Death|0|||
105570523|NCT02392611|364088201|FG004|Overall Study|Death|0|||
105570524|NCT02392611|364088202|FG005|Overall Study|Death|1|||
105570525|NCT02392611|364088203|FG006|Overall Study|Death|0|||
105570526|NCT02392611|364088204|FG007|Overall Study|Death|0|||
105570527|NCT02392611|364088205|FG008|Overall Study|Death|0|||
105485182|NCT00814801|363787098|FG000|Overall Study|Inappropriate as a subject|1|||
105485183|NCT00814801|363787099|FG001|Overall Study|Inappropriate as a subject|1|||
105485184|NCT00814801|363787100|FG002|Overall Study|Inappropriate as a subject|1|||
105570528|NCT02392611|364088197|FG000|Overall Study|Withdrawal by Subject|0|||
105570529|NCT02392611|364088198|FG001|Overall Study|Withdrawal by Subject|0|||
105570530|NCT02392611|364088199|FG002|Overall Study|Withdrawal by Subject|0|||
105570531|NCT02392611|364088200|FG003|Overall Study|Withdrawal by Subject|1|||
105485185|NCT00814801|363787098|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
105485186|NCT00814801|363787099|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
105485187|NCT00814801|363787100|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
105570532|NCT02392611|364088201|FG004|Overall Study|Withdrawal by Subject|0|||
105570533|NCT02392611|364088202|FG005|Overall Study|Withdrawal by Subject|0|||
105570534|NCT02392611|364088203|FG006|Overall Study|Withdrawal by Subject|0|||
105570535|NCT02392611|364088204|FG007|Overall Study|Withdrawal by Subject|0|||
105570536|NCT02392611|364088205|FG008|Overall Study|Withdrawal by Subject|0|||
105570537|NCT02392611|364088197|FG000|Overall Study|Lost to Follow-up|0|||
105570538|NCT02392611|364088198|FG001|Overall Study|Lost to Follow-up|0|||
105570539|NCT02392611|364088199|FG002|Overall Study|Lost to Follow-up|0|||
105360987|NCT01254656|363328129|FG002|Overall Study|Adverse Event|0|||
105570540|NCT02392611|364088200|FG003|Overall Study|Lost to Follow-up|0|||
105570541|NCT02392611|364088201|FG004|Overall Study|Lost to Follow-up|0|||
105570542|NCT02392611|364088202|FG005|Overall Study|Lost to Follow-up|0|||
105570543|NCT02392611|364088203|FG006|Overall Study|Lost to Follow-up|1|||
105570544|NCT02392611|364088204|FG007|Overall Study|Lost to Follow-up|0|||
105570545|NCT02392611|364088205|FG008|Overall Study|Lost to Follow-up|0|||
105570546|NCT02392611|364088197|FG000|Overall Study|Enrolled, not treated|0|||
105570547|NCT02392611|364088198|FG001|Overall Study|Enrolled, not treated|0|||
105570548|NCT02392611|364088199|FG002|Overall Study|Enrolled, not treated|0|||
105570549|NCT02392611|364088200|FG003|Overall Study|Enrolled, not treated|2|||
105570550|NCT02392611|364088201|FG004|Overall Study|Enrolled, not treated|0|||
105570551|NCT02392611|364088202|FG005|Overall Study|Enrolled, not treated|0|||
105570552|NCT02392611|364088203|FG006|Overall Study|Enrolled, not treated|0|||
105570553|NCT02392611|364088204|FG007|Overall Study|Enrolled, not treated|0|||
105570554|NCT02392611|364088205|FG008|Overall Study|Enrolled, not treated|0|||
105570555|NCT00255346|364088208|FG000|Overall Study|Adverse Event|1|||
105570556|NCT00255346|364088209|FG001|Overall Study|Adverse Event|0|||
105570557|NCT00255346|364088210|FG002|Overall Study|Adverse Event|0|||
105761417|NCT01742091|364781351|FG003|Overall Study|Withdrawal by Subject|1|||
105570558|NCT00255346|364088211|FG003|Overall Study|Adverse Event|0|||
105570559|NCT00255346|364088212|FG004|Overall Study|Adverse Event|0|||
105570560|NCT05266963|364088215|FG000|Drug Period A|Withdrawal by Subject|0|||
105570561|NCT05266963|364088216|FG001|Drug Period A|Withdrawal by Subject|1|||
105570562|NCT00393523|364088217|FG000|Overall Study|Lost to Follow-up|0|||
105570563|NCT00393523|364088218|FG001|Overall Study|Lost to Follow-up|0|||
105570564|NCT00393523|364088219|FG002|Overall Study|Lost to Follow-up|0|||
105761418|NCT01742091|364781352|FG004|Overall Study|Withdrawal by Subject|0|||
105761419|NCT01742091|364781353|FG005|Overall Study|Withdrawal by Subject|0|||
105761420|NCT01742091|364781348|FG000|Overall Study|Lost to Follow-up|0|||
105761421|NCT01742091|364781349|FG001|Overall Study|Lost to Follow-up|0|||
105761422|NCT01742091|364781350|FG002|Overall Study|Lost to Follow-up|0|||
105761423|NCT01742091|364781351|FG003|Overall Study|Lost to Follow-up|0|||
105761424|NCT01742091|364781352|FG004|Overall Study|Lost to Follow-up|0|||
105761425|NCT01742091|364781353|FG005|Overall Study|Lost to Follow-up|1|||
105761426|NCT02088541|364781354|FG000|Overall Study|Adverse Event|3|||
105761427|NCT02088541|364781355|FG001|Overall Study|Adverse Event|0|||
105761428|NCT02088541|364781356|FG002|Overall Study|Adverse Event|3|||
105761429|NCT02088541|364781357|FG003|Overall Study|Adverse Event|3|||
105761430|NCT02088541|364781358|FG004|Overall Study|Adverse Event|0|||
105761431|NCT02088541|364781354|FG000|Overall Study|Death|51|||
105761432|NCT02088541|364781355|FG001|Overall Study|Death|21|||
105761433|NCT02088541|364781356|FG002|Overall Study|Death|85|||
105761434|NCT02088541|364781357|FG003|Overall Study|Death|28|||
105761435|NCT02088541|364781358|FG004|Overall Study|Death|38|||
105761436|NCT02088541|364781354|FG000|Overall Study|Lost to Follow-up|2|||
105761437|NCT02088541|364781355|FG001|Overall Study|Lost to Follow-up|0|||
105761438|NCT02088541|364781356|FG002|Overall Study|Lost to Follow-up|1|||
105761439|NCT02088541|364781357|FG003|Overall Study|Lost to Follow-up|0|||
105761440|NCT02088541|364781358|FG004|Overall Study|Lost to Follow-up|0|||
105761441|NCT02088541|364781354|FG000|Overall Study|Physician Decision|2|||
105761442|NCT02088541|364781355|FG001|Overall Study|Physician Decision|1|||
105761443|NCT02088541|364781356|FG002|Overall Study|Physician Decision|2|||
105761444|NCT02088541|364781357|FG003|Overall Study|Physician Decision|0|||
105761445|NCT02088541|364781358|FG004|Overall Study|Physician Decision|2|||
105761446|NCT02088541|364781354|FG000|Overall Study|Disease progression|7|||
105761447|NCT02088541|364781355|FG001|Overall Study|Disease progression|1|||
105761448|NCT02088541|364781356|FG002|Overall Study|Disease progression|2|||
105761449|NCT02088541|364781357|FG003|Overall Study|Disease progression|3|||
105761450|NCT02088541|364781358|FG004|Overall Study|Disease progression|1|||
105761451|NCT02088541|364781354|FG000|Overall Study|Study terminated by sponsor|1|||
105761452|NCT02088541|364781355|FG001|Overall Study|Study terminated by sponsor|1|||
105761453|NCT02088541|364781356|FG002|Overall Study|Study terminated by sponsor|12|||
105761454|NCT02088541|364781357|FG003|Overall Study|Study terminated by sponsor|2|||
105570565|NCT00393523|364088220|FG003|Overall Study|Lost to Follow-up|2|||
105570566|NCT00393523|364088221|FG004|Overall Study|Lost to Follow-up|1|||
105761455|NCT02088541|364781358|FG004|Overall Study|Study terminated by sponsor|6|||
105570567|NCT00393523|364088217|FG000|Overall Study|Protocol Violation|6|||
105570568|NCT00393523|364088218|FG001|Overall Study|Protocol Violation|2|||
105761456|NCT02088541|364781354|FG000|Overall Study|Withdrawal by Subject|3|||
105808003|NCT01621490|364954866|FG003|Overall Study|Study drug toxicity|3|||
105570569|NCT00393523|364088219|FG002|Overall Study|Protocol Violation|0|||
105570570|NCT00393523|364088220|FG003|Overall Study|Protocol Violation|1|||
105570571|NCT00393523|364088221|FG004|Overall Study|Protocol Violation|0|||
105570572|NCT00393523|364088217|FG000|Overall Study|Withdrawal by Subject|6|||
105570573|NCT00393523|364088218|FG001|Overall Study|Withdrawal by Subject|7|||
105761457|NCT02088541|364781355|FG001|Overall Study|Withdrawal by Subject|2|||
105761458|NCT02088541|364781356|FG002|Overall Study|Withdrawal by Subject|9|||
105761459|NCT02088541|364781357|FG003|Overall Study|Withdrawal by Subject|7|||
105761460|NCT02088541|364781358|FG004|Overall Study|Withdrawal by Subject|10|||
105808004|NCT01621490|364954867|FG004|Overall Study|Study drug toxicity|1|||
105570574|NCT00393523|364088219|FG002|Overall Study|Withdrawal by Subject|2|||
105570575|NCT00393523|364088220|FG003|Overall Study|Withdrawal by Subject|3|||
105570576|NCT00393523|364088221|FG004|Overall Study|Withdrawal by Subject|0|||
105570577|NCT00393523|364088217|FG000|Overall Study|Difficulties in specimen collection|0|||
105570578|NCT00393523|364088218|FG001|Overall Study|Difficulties in specimen collection|0|||
105570579|NCT00393523|364088219|FG002|Overall Study|Difficulties in specimen collection|1|||
105570580|NCT00393523|364088220|FG003|Overall Study|Difficulties in specimen collection|0|||
105808005|NCT01621490|364954868|FG005|Overall Study|Study drug toxicity|10|||
105808006|NCT01621490|364954869|FG006|Overall Study|Study drug toxicity|1|||
105808007|NCT01621490|364954870|FG007|Overall Study|Study drug toxicity|4|||
105808008|NCT01621490|364954871|FG008|Overall Study|Study drug toxicity|1|||
105761461|NCT02088541|364781354|FG000|Overall Study|Other|2|||
105761462|NCT02088541|364781355|FG001|Overall Study|Other|1|||
105761463|NCT02088541|364781356|FG002|Overall Study|Other|3|||
105761464|NCT02088541|364781357|FG003|Overall Study|Other|1|||
105761465|NCT02088541|364781358|FG004|Overall Study|Other|1|||
105761466|NCT03750240|364781359|FG000|Overall Study|Technical Difficulties|2|||
105761467|NCT03706040|364781360|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
105761468|NCT03706040|364781361|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
105761469|NCT03706040|364781362|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
105761470|NCT03706040|364781363|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
105761471|NCT03706040|364781364|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
105761472|NCT03706040|364781365|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
105761473|NCT03706040|364781366|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
105761474|NCT03706040|364781360|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
105761475|NCT03706040|364781361|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
105761476|NCT03706040|364781362|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
105761477|NCT03706040|364781363|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
105761478|NCT03706040|364781364|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
105761479|NCT03706040|364781365|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
105761480|NCT03706040|364781366|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
105761481|NCT03706040|364781360|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
105761482|NCT03706040|364781361|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
105761483|NCT03706040|364781362|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
105761484|NCT03706040|364781363|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
105761485|NCT03706040|364781364|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
105761486|NCT03706040|364781365|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
105761487|NCT03706040|364781366|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
105761488|NCT03706040|364781360|FG000|Period A (Week 0 to Week 16)|Other|2|||
105761489|NCT03706040|364781361|FG001|Period A (Week 0 to Week 16)|Other|0|||
105761490|NCT03706040|364781362|FG002|Period A (Week 0 to Week 16)|Other|2|||
105761491|NCT03706040|364781363|FG003|Period A (Week 0 to Week 16)|Other|0|||
105761492|NCT03706040|364781364|FG004|Period A (Week 0 to Week 16)|Other|0|||
105761493|NCT03706040|364781365|FG005|Period A (Week 0 to Week 16)|Other|0|||
105761494|NCT03706040|364781366|FG006|Period A (Week 0 to Week 16)|Other|0|||
105761495|NCT03706040|364781360|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
105761496|NCT03706040|364781361|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
105761497|NCT03706040|364781362|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
105761498|NCT03706040|364781363|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
105761499|NCT03706040|364781364|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
105761500|NCT03706040|364781365|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
105761501|NCT03706040|364781366|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
105761502|NCT03706040|364781360|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
105761503|NCT03706040|364781361|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
105761504|NCT03706040|364781362|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
105761505|NCT03706040|364781363|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
105761506|NCT03706040|364781364|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
105761507|NCT03706040|364781365|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
105761508|NCT03706040|364781366|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
105761509|NCT03706040|364781360|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105761510|NCT03706040|364781361|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105761511|NCT03706040|364781362|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105761512|NCT03706040|364781363|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105761513|NCT03706040|364781364|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105761514|NCT03706040|364781365|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
105761515|NCT03706040|364781366|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
105761516|NCT03706040|364781360|FG000|Period B (Week 16 to Week 52)|Other|0|||
105761517|NCT03706040|364781361|FG001|Period B (Week 16 to Week 52)|Other|0|||
105761518|NCT03706040|364781362|FG002|Period B (Week 16 to Week 52)|Other|0|||
105808009|NCT01621490|364954872|FG009|Overall Study|Study drug toxicity|0|||
105360988|NCT01254656|363328127|FG000|Overall Study|Death|0|||
105761519|NCT03706040|364781363|FG003|Period B (Week 16 to Week 52)|Other|4|||
105761520|NCT03706040|364781364|FG004|Period B (Week 16 to Week 52)|Other|5|||
105808010|NCT01621490|364954873|FG010|Overall Study|Study drug toxicity|0|||
105808011|NCT01621490|364954863|FG000|Overall Study|Death|0|||
105808012|NCT01621490|364954864|FG001|Overall Study|Death|0|||
105808013|NCT01621490|364954865|FG002|Overall Study|Death|0|||
105808014|NCT01621490|364954866|FG003|Overall Study|Death|0|||
105808015|NCT01621490|364954867|FG004|Overall Study|Death|0|||
105808016|NCT01621490|364954868|FG005|Overall Study|Death|0|||
105808017|NCT01621490|364954869|FG006|Overall Study|Death|0|||
105808018|NCT01621490|364954870|FG007|Overall Study|Death|0|||
105808019|NCT01621490|364954871|FG008|Overall Study|Death|1|||
105570581|NCT00393523|364088221|FG004|Overall Study|Difficulties in specimen collection|0|||
105570582|NCT00393523|364088217|FG000|Overall Study|Vaccine supply issue|0|||
105570583|NCT00393523|364088218|FG001|Overall Study|Vaccine supply issue|0|||
105570584|NCT00393523|364088219|FG002|Overall Study|Vaccine supply issue|1|||
105570585|NCT00393523|364088220|FG003|Overall Study|Vaccine supply issue|0|||
105570586|NCT00393523|364088221|FG004|Overall Study|Vaccine supply issue|0|||
105570587|NCT00980005|364088222|FG000|Overall Study|Withdrawal by Subject|6|||
105570588|NCT00980005|364088223|FG001|Overall Study|Withdrawal by Subject|17|||
105570589|NCT00980005|364088222|FG000|Overall Study|Lost to Follow-up|37|||
105570590|NCT00980005|364088223|FG001|Overall Study|Lost to Follow-up|43|||
105570591|NCT00980005|364088222|FG000|Overall Study|Other|4|||
105570592|NCT00980005|364088223|FG001|Overall Study|Other|3|||
105570593|NCT05952297|364088224|FG000|Overall Study|Withdrawal by Subject|1|||
105808020|NCT01621490|364954872|FG009|Overall Study|Death|0|||
105808021|NCT01621490|364954873|FG010|Overall Study|Death|0|||
105808022|NCT01621490|364954863|FG000|Overall Study|Other reasons|7|||
105808023|NCT01621490|364954864|FG001|Overall Study|Other reasons|6|||
105808024|NCT01621490|364954865|FG002|Overall Study|Other reasons|4|||
105808025|NCT01621490|364954866|FG003|Overall Study|Other reasons|1|||
105808026|NCT01621490|364954867|FG004|Overall Study|Other reasons|1|||
105808027|NCT01621490|364954868|FG005|Overall Study|Other reasons|3|||
105808028|NCT01621490|364954869|FG006|Overall Study|Other reasons|1|||
105808029|NCT01621490|364954870|FG007|Overall Study|Other reasons|1|||
105808030|NCT01621490|364954871|FG008|Overall Study|Other reasons|1|||
105808031|NCT01621490|364954872|FG009|Overall Study|Other reasons|0|||
105808032|NCT01621490|364954873|FG010|Overall Study|Other reasons|0|||
105808033|NCT01144663|364954878|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
105808034|NCT01144663|364954879|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
105808035|NCT01144663|364954880|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
105808036|NCT01144663|364954881|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
105808037|NCT01144663|364954878|FG000|Primary Vaccination Phase|Adverse Event|1|||
105808038|NCT01144663|364954879|FG001|Primary Vaccination Phase|Adverse Event|0|||
105808039|NCT01144663|364954880|FG002|Primary Vaccination Phase|Adverse Event|0|||
105485188|NCT00814801|363787098|FG000|Overall Study|Missing or change of caregiver|6|||
105485189|NCT00814801|363787099|FG001|Overall Study|Missing or change of caregiver|2|||
105485190|NCT00814801|363787100|FG002|Overall Study|Missing or change of caregiver|4|||
105485191|NCT00814801|363787098|FG000|Overall Study|Non-compliance|0|||
105485192|NCT00814801|363787099|FG001|Overall Study|Non-compliance|1|||
105485193|NCT00814801|363787100|FG002|Overall Study|Non-compliance|1|||
105485194|NCT00814801|363787098|FG000|Overall Study|Other|2|||
105485195|NCT00814801|363787099|FG001|Overall Study|Other|6|||
105485196|NCT00814801|363787100|FG002|Overall Study|Other|4|||
105485197|NCT00586664|363787101|FG000|Overall Study|Withdrawal by Subject|3|||
105485198|NCT00586664|363787102|FG001|Overall Study|Withdrawal by Subject|7|||
105485199|NCT00586664|363787103|FG002|Overall Study|Withdrawal by Subject|1|||
105485200|NCT00586664|363787101|FG000|Overall Study|Exclusion criteria met|2|||
105485201|NCT00586664|363787102|FG001|Overall Study|Exclusion criteria met|0|||
105485202|NCT00586664|363787103|FG002|Overall Study|Exclusion criteria met|0|||
105808040|NCT01144663|364954881|FG003|Primary Vaccination Phase|Adverse Event|1|||
105808041|NCT01144663|364954878|FG000|Primary Vaccination Phase|Protocol Violation|2|||
105485203|NCT01077154|363787110|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
105808042|NCT01144663|364954879|FG001|Primary Vaccination Phase|Protocol Violation|0|||
105485204|NCT01077154|363787111|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
105485205|NCT01077154|363787110|FG000|Overall Study|Withdrawal by Subject|369|||
105485206|NCT01077154|363787111|FG001|Overall Study|Withdrawal by Subject|385|||
105570594|NCT05952297|364088225|FG001|Overall Study|Withdrawal by Subject|0|||
105570595|NCT00098254|364088226|FG000|Overall Study|Adverse Event|2|||
105485207|NCT01077154|363787110|FG000|Overall Study|Death|215|||
105485208|NCT01077154|363787111|FG001|Overall Study|Death|214|||
105485209|NCT01077154|363787110|FG000|Overall Study|Lost to Follow-up|43|||
105570596|NCT00098254|364088226|FG000|Overall Study|Death|1|||
105570597|NCT02100722|364088230|FG000|Overall Study|Withdrawal pre-procedure|4|||
105570598|NCT02100722|364088231|FG001|Overall Study|Withdrawal pre-procedure|9|||
105570599|NCT02100722|364088230|FG000|Overall Study|Withdrawal post-procedure|0|||
105808043|NCT01144663|364954880|FG002|Primary Vaccination Phase|Protocol Violation|1|||
105808044|NCT01144663|364954881|FG003|Primary Vaccination Phase|Protocol Violation|0|||
105485210|NCT01077154|363787111|FG001|Overall Study|Lost to Follow-up|35|||
105808045|NCT01144663|364954878|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
105808046|NCT01144663|364954879|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
105808047|NCT01144663|364954880|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
105570600|NCT02100722|364088231|FG001|Overall Study|Withdrawal post-procedure|3|||
105570601|NCT02100722|364088230|FG000|Overall Study|Lost to Follow-up|2|||
105808048|NCT01144663|364954881|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
105808049|NCT01144663|364954878|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
105808050|NCT01144663|364954879|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
105808051|NCT01144663|364954880|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
105808052|NCT01144663|364954881|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
105808053|NCT01144663|364954878|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
105808054|NCT01144663|364954879|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
105808055|NCT01144663|364954880|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
105808056|NCT01144663|364954881|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
105808057|NCT01144663|364954878|FG000|Primary Vaccination Phase|Other|0|||
105808058|NCT01144663|364954879|FG001|Primary Vaccination Phase|Other|1|||
105808059|NCT01144663|364954880|FG002|Primary Vaccination Phase|Other|0|||
105570602|NCT02100722|364088231|FG001|Overall Study|Lost to Follow-up|2|||
105570603|NCT02100722|364088230|FG000|Overall Study|Continuing on study|751|||
105570604|NCT02100722|364088231|FG001|Overall Study|Continuing on study|729|||
105570605|NCT03787680|364088233|FG000|Overall Study|Physician Decision|2|||
105570606|NCT03787680|364088234|FG001|Overall Study|Physician Decision|3|||
105570607|NCT03787680|364088233|FG000|Overall Study|Adverse Event|7|||
105570608|NCT03787680|364088234|FG001|Overall Study|Adverse Event|3|||
105570609|NCT03787680|364088233|FG000|Overall Study|Withdrawal by Subject|2|||
105570610|NCT03787680|364088234|FG001|Overall Study|Withdrawal by Subject|1|||
105570611|NCT05229653|364088239|FG000|Overall Study|Lost to Follow-up|1|||
105570612|NCT05229653|364088240|FG001|Overall Study|Lost to Follow-up|0|||
105570613|NCT02204579|364088241|FG000|Overall Study|Screen failures|2|||
105570614|NCT00265330|364088245|FG000|Overall Study|Adverse Event|41|||
105570615|NCT00265330|364088245|FG000|Overall Study|Lost to Follow-up|8|||
105570616|NCT00265330|364088245|FG000|Overall Study|Withdrawal by Subject|34|||
105570617|NCT00265330|364088245|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
105570618|NCT00265330|364088245|FG000|Overall Study|Lack of Efficacy|4|||
105570619|NCT00265330|364088245|FG000|Overall Study|Family Scheduling Conflicts|1|||
105570620|NCT00265330|364088245|FG000|Overall Study|Began Taking Formulary Geodon|1|||
105570621|NCT00265330|364088245|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
105570622|NCT00265330|364088245|FG000|Overall Study|Site Closed by Sponsor|1|||
105570623|NCT00265330|364088245|FG000|Overall Study|Principal Investigators Request|1|||
105570624|NCT00265330|364088245|FG000|Overall Study|Withdrew Consent|1|||
105570625|NCT00265330|364088245|FG000|Overall Study|Protocol Violation|1|||
105570626|NCT02213328|364088246|FG000|Overall Study|Withdrawal by Subject|10|||
105570627|NCT02213328|364088246|FG000|Overall Study|Physician Decision|2|||
105570628|NCT02213328|364088246|FG000|Overall Study|Lost to Follow-up|16|||
105570629|NCT01126060|364088249|FG000|Overall Study|Protocol Violation|0|||
105570630|NCT01126060|364088250|FG001|Overall Study|Protocol Violation|2|||
105570631|NCT00856661|364088251|FG000|Overall Study|Death|15|||
105570632|NCT00856661|364088252|FG001|Overall Study|Death|18|||
105570633|NCT00856661|364088251|FG000|Overall Study|Protocol Violation|2|||
105570634|NCT00856661|364088252|FG001|Overall Study|Protocol Violation|1|||
105570635|NCT00856661|364088251|FG000|Overall Study|Withdrawal by Subject|1|||
105570636|NCT00856661|364088252|FG001|Overall Study|Withdrawal by Subject|2|||
105570637|NCT00856661|364088251|FG000|Overall Study|Lost to Follow-up|1|||
105570638|NCT00856661|364088252|FG001|Overall Study|Lost to Follow-up|3|||
105570639|NCT00856661|364088251|FG000|Overall Study|Physician Judgement|8|||
105808060|NCT01144663|364954881|FG003|Primary Vaccination Phase|Other|2|||
105808061|NCT01144663|364954878|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
105360989|NCT01254656|363328128|FG001|Overall Study|Death|1|||
105360990|NCT01254656|363328129|FG002|Overall Study|Death|0|||
105360991|NCT00411450|363328130|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
105570640|NCT00856661|364088252|FG001|Overall Study|Physician Judgement|5|||
105570641|NCT01279343|364088253|FG000|Overall Study|Did not receive treatment|2|||
105360992|NCT01064414|363328135|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
105360993|NCT01064414|363328136|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
105570642|NCT01279343|364088254|FG001|Overall Study|Did not receive treatment|6|||
105570643|NCT04534114|364088255|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
105570644|NCT04534114|364088256|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
105570645|NCT04534114|364088257|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
105570646|NCT04534114|364088258|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
105570647|NCT04534114|364088255|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
105570648|NCT04534114|364088256|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
105570649|NCT04534114|364088257|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
105570650|NCT04534114|364088258|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
105570651|NCT04534114|364088255|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
105570652|NCT04534114|364088256|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
105808062|NCT01144663|364954879|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
105570653|NCT04534114|364088257|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
105570654|NCT04534114|364088258|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
105761521|NCT03706040|364781365|FG005|Period B (Week 16 to Week 52)|Other|23|||
105761522|NCT03706040|364781366|FG006|Period B (Week 16 to Week 52)|Other|17|||
105761523|NCT00927758|364781367|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
105761524|NCT00927758|364781368|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
105761525|NCT00927758|364781369|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
105761526|NCT00927758|364781370|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
105761527|NCT00927758|364781371|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
105761528|NCT00927758|364781372|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
105761529|NCT00927758|364781367|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
105761530|NCT00927758|364781368|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
105761531|NCT00927758|364781369|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
105761532|NCT00927758|364781370|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
105761533|NCT00927758|364781371|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
105761534|NCT00927758|364781372|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
105761535|NCT00439725|364781374|FG000|Treatment Period|Withdrawal by Subject|22|||
105761536|NCT00439725|364781375|FG001|Treatment Period|Withdrawal by Subject|19|||
105761537|NCT00439725|364781374|FG000|Treatment Period|Study terminated by sponsor|156|||
105761538|NCT00439725|364781375|FG001|Treatment Period|Study terminated by sponsor|148|||
105761539|NCT00439725|364781374|FG000|Treatment Period|Site closed by investigator|1|||
105761540|NCT00439725|364781375|FG001|Treatment Period|Site closed by investigator|2|||
105761541|NCT00439725|364781374|FG000|Treatment Period|Adverse Event|39|||
105761542|NCT00439725|364781375|FG001|Treatment Period|Adverse Event|18|||
105761543|NCT00439725|364781374|FG000|Treatment Period|Physician Decision|1|||
105761544|NCT00439725|364781375|FG001|Treatment Period|Physician Decision|1|||
105761545|NCT00439725|364781374|FG000|Treatment Period|Protocol Violation|2|||
105761546|NCT00439725|364781375|FG001|Treatment Period|Protocol Violation|1|||
105761547|NCT00439725|364781374|FG000|Treatment Period|Clinical endpoint reached|6|||
105761548|NCT00439725|364781375|FG001|Treatment Period|Clinical endpoint reached|50|||
105761549|NCT00439725|364781374|FG000|Treatment Period|Technical problems|1|||
105761550|NCT00439725|364781375|FG001|Treatment Period|Technical problems|0|||
105761551|NCT00439725|364781374|FG000|Treatment Period|Lost to Follow-up|1|||
105761552|NCT00439725|364781375|FG001|Treatment Period|Lost to Follow-up|1|||
105761553|NCT00439725|364781374|FG000|Treatment Period|Participant convenience|1|||
105761554|NCT00439725|364781375|FG001|Treatment Period|Participant convenience|0|||
105761555|NCT00439725|364781374|FG000|Treatment Period|Protocol driven decision point|1|||
105761556|NCT00439725|364781375|FG001|Treatment Period|Protocol driven decision point|1|||
105761557|NCT00439725|364781374|FG000|Treatment Period|Death|1|||
105761558|NCT00439725|364781375|FG001|Treatment Period|Death|1|||
105761559|NCT00439725|364781374|FG000|Treatment Period|Participant did not receive treatment|4|||
105761560|NCT00439725|364781375|FG001|Treatment Period|Participant did not receive treatment|4|||
105761561|NCT00439725|364781374|FG000|Observational Period|Withdrawal by Subject|2|||
105761562|NCT00439725|364781375|FG001|Observational Period|Withdrawal by Subject|2|||
105761563|NCT00439725|364781374|FG000|Observational Period|Lost to Follow-up|0|||
105761564|NCT00439725|364781375|FG001|Observational Period|Lost to Follow-up|1|||
105761565|NCT00439725|364781374|FG000|Observational Period|Death|0|||
105761566|NCT00439725|364781375|FG001|Observational Period|Death|2|||
105761567|NCT00439725|364781374|FG000|Observational Period|Study termination by sponsor|1|||
105761568|NCT00439725|364781375|FG001|Observational Period|Study termination by sponsor|1|||
105761569|NCT00439725|364781374|FG000|Observational Period|Clinical endpoint reached|3|||
105761570|NCT00439725|364781375|FG001|Observational Period|Clinical endpoint reached|1|||
105761571|NCT00439725|364781374|FG000|Observational Period|Technical problems|1|||
105761572|NCT00439725|364781375|FG001|Observational Period|Technical problems|0|||
105761573|NCT00439725|364781374|FG000|Observational Period|Participant convenience|1|||
105761574|NCT00439725|364781375|FG001|Observational Period|Participant convenience|0|||
105761575|NCT01432457|364781376|FG000|Overall Study|Adverse Event|7|||
105761576|NCT01432457|364781377|FG001|Overall Study|Adverse Event|10|||
105761577|NCT01432457|364781378|FG002|Overall Study|Adverse Event|16|||
105761578|NCT01432457|364781376|FG000|Overall Study|Lack of Efficacy|2|||
105761579|NCT01432457|364781377|FG001|Overall Study|Lack of Efficacy|1|||
105761580|NCT01432457|364781378|FG002|Overall Study|Lack of Efficacy|1|||
105761581|NCT01432457|364781376|FG000|Overall Study|Lost to Follow-up|11|||
105761582|NCT01432457|364781377|FG001|Overall Study|Lost to Follow-up|15|||
105761583|NCT01432457|364781378|FG002|Overall Study|Lost to Follow-up|20|||
105761584|NCT01432457|364781376|FG000|Overall Study|Protocol Violation|3|||
105761585|NCT01432457|364781377|FG001|Overall Study|Protocol Violation|2|||
105761586|NCT01432457|364781378|FG002|Overall Study|Protocol Violation|6|||
105761587|NCT01432457|364781376|FG000|Overall Study|Withdrawal by Subject|6|||
105761588|NCT01432457|364781377|FG001|Overall Study|Withdrawal by Subject|11|||
105761589|NCT01432457|364781378|FG002|Overall Study|Withdrawal by Subject|9|||
105761590|NCT01432457|364781376|FG000|Overall Study|Reasons not defined|2|||
105761591|NCT01432457|364781377|FG001|Overall Study|Reasons not defined|3|||
105570655|NCT04534114|364088255|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
105570656|NCT04534114|364088256|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
105570657|NCT04534114|364088257|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
105570658|NCT04534114|364088258|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
105570659|NCT04534114|364088255|FG000|Main Treatment Period|Physician Decision|0|||
105570660|NCT04534114|364088256|FG001|Main Treatment Period|Physician Decision|0|||
105570661|NCT04534114|364088257|FG002|Main Treatment Period|Physician Decision|0|||
105570662|NCT04534114|364088258|FG003|Main Treatment Period|Physician Decision|1|||
105570663|NCT04534114|364088255|FG000|Main Treatment Period|Death|1|||
105570664|NCT04534114|364088256|FG001|Main Treatment Period|Death|0|||
105570665|NCT04534114|364088257|FG002|Main Treatment Period|Death|0|||
105570666|NCT04534114|364088258|FG003|Main Treatment Period|Death|1|||
105570667|NCT04534114|364088255|FG000|Main Treatment Period|Other reason|1|||
105570668|NCT04534114|364088256|FG001|Main Treatment Period|Other reason|1|||
105570669|NCT04534114|364088257|FG002|Main Treatment Period|Other reason|0|||
105570670|NCT04534114|364088258|FG003|Main Treatment Period|Other reason|0|||
105570671|NCT04534114|364088255|FG000|Main Treatment Period|Participant decision|1|||
105570672|NCT04534114|364088256|FG001|Main Treatment Period|Participant decision|3|||
105570673|NCT04534114|364088257|FG002|Main Treatment Period|Participant decision|3|||
105570674|NCT04534114|364088258|FG003|Main Treatment Period|Participant decision|1|||
105570675|NCT04534114|364088255|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
105570676|NCT04534114|364088256|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
105570677|NCT04534114|364088257|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
105570678|NCT04534114|364088258|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
105570679|NCT04534114|364088255|FG000|Main Treatment Period|Adverse Event|4|||
105570680|NCT04534114|364088256|FG001|Main Treatment Period|Adverse Event|2|||
105570681|NCT04534114|364088257|FG002|Main Treatment Period|Adverse Event|1|||
105570682|NCT04534114|364088258|FG003|Main Treatment Period|Adverse Event|2|||
105570683|NCT04534114|364088255|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
105570684|NCT04534114|364088256|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
105570685|NCT04534114|364088257|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
105570686|NCT04534114|364088258|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
105570687|NCT04534114|364088255|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
105570688|NCT04534114|364088256|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
105570689|NCT04534114|364088257|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
105570690|NCT04534114|364088258|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
105570691|NCT04534114|364088255|FG000|Extension Treatment Period|Other reason|0|||
105570692|NCT04534114|364088256|FG001|Extension Treatment Period|Other reason|1|||
105570693|NCT04534114|364088257|FG002|Extension Treatment Period|Other reason|0|||
105570694|NCT04534114|364088258|FG003|Extension Treatment Period|Other reason|0|||
105570695|NCT04534114|364088255|FG000|Extension Treatment Period|Death|0|||
105570696|NCT04534114|364088256|FG001|Extension Treatment Period|Death|0|||
105570697|NCT04534114|364088257|FG002|Extension Treatment Period|Death|1|||
105570698|NCT04534114|364088258|FG003|Extension Treatment Period|Death|2|||
105570699|NCT04534114|364088255|FG000|Extension Treatment Period|Adverse Event|0|||
105570700|NCT04534114|364088256|FG001|Extension Treatment Period|Adverse Event|1|||
105570701|NCT04534114|364088257|FG002|Extension Treatment Period|Adverse Event|0|||
105570702|NCT04534114|364088258|FG003|Extension Treatment Period|Adverse Event|1|||
105570703|NCT04534114|364088255|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
105570704|NCT04534114|364088256|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
105570705|NCT04534114|364088257|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
105570706|NCT04534114|364088258|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
105570707|NCT02759185|364088259|FG000|Stage 1|Adverse Event|0|||
105570708|NCT02759185|364088260|FG001|Stage 1|Adverse Event|1|||
105570709|NCT02759185|364088261|FG002|Stage 1|Adverse Event|3|||
105570710|NCT02759185|364088262|FG003|Stage 1|Adverse Event|0|||
105570711|NCT02759185|364088263|FG004|Stage 1|Adverse Event|0|||
105570712|NCT02759185|364088264|FG005|Stage 1|Adverse Event|0|||
105570713|NCT02759185|364088265|FG006|Stage 1|Adverse Event|0|||
105570714|NCT02759185|364088259|FG000|Stage 1|Withdrawal by Subject|1|||
105570715|NCT02759185|364088260|FG001|Stage 1|Withdrawal by Subject|0|||
105570716|NCT02759185|364088261|FG002|Stage 1|Withdrawal by Subject|0|||
105570717|NCT02759185|364088262|FG003|Stage 1|Withdrawal by Subject|0|||
105570718|NCT02759185|364088263|FG004|Stage 1|Withdrawal by Subject|0|||
105570719|NCT02759185|364088264|FG005|Stage 1|Withdrawal by Subject|0|||
105570720|NCT02759185|364088265|FG006|Stage 1|Withdrawal by Subject|0|||
105570721|NCT02759185|364088259|FG000|Stage 2|Adverse Event|0|||
105570722|NCT02759185|364088260|FG001|Stage 2|Adverse Event|0|||
105570723|NCT02759185|364088261|FG002|Stage 2|Adverse Event|0|||
105570724|NCT02759185|364088262|FG003|Stage 2|Adverse Event|0|||
105570725|NCT02759185|364088263|FG004|Stage 2|Adverse Event|1|||
105570726|NCT02759185|364088264|FG005|Stage 2|Adverse Event|2|||
105570727|NCT02759185|364088265|FG006|Stage 2|Adverse Event|0|||
105570728|NCT02759185|364088259|FG000|Stage 2|Withdrawal by Subject|0|||
105570729|NCT02759185|364088260|FG001|Stage 2|Withdrawal by Subject|0|||
105570730|NCT02759185|364088261|FG002|Stage 2|Withdrawal by Subject|0|||
105570731|NCT02759185|364088262|FG003|Stage 2|Withdrawal by Subject|0|||
105570732|NCT02759185|364088263|FG004|Stage 2|Withdrawal by Subject|1|||
105570733|NCT02759185|364088264|FG005|Stage 2|Withdrawal by Subject|1|||
105570734|NCT02759185|364088265|FG006|Stage 2|Withdrawal by Subject|1|||
105570735|NCT03916744|364088266|FG000|Overall Study|Withdrawal by Subject|0|||
105570736|NCT03916744|364088267|FG001|Overall Study|Withdrawal by Subject|1|||
105570737|NCT03916744|364088268|FG002|Overall Study|Withdrawal by Subject|2|||
105570738|NCT03176238|364088269|FG000|Overall Study|Unacceptable AEs|15|||
105570739|NCT03176238|364088270|FG001|Overall Study|Unacceptable AEs|8|||
105570740|NCT03176238|364088269|FG000|Overall Study|Abnormal lab value(s)|2|||
105570741|NCT03176238|364088270|FG001|Overall Study|Abnormal lab value(s)|0|||
105570742|NCT03176238|364088269|FG000|Overall Study|Inter-current illness|0|||
105570743|NCT03176238|364088270|FG001|Overall Study|Inter-current illness|1|||
105570744|NCT03176238|364088269|FG000|Overall Study|Consent withdrawal|14|||
105570745|NCT03176238|364088270|FG001|Overall Study|Consent withdrawal|2|||
105570746|NCT03176238|364088269|FG000|Overall Study|Lost to Follow-up|3|||
105570747|NCT03176238|364088270|FG001|Overall Study|Lost to Follow-up|0|||
105570748|NCT03176238|364088269|FG000|Overall Study|Administrative problems|1|||
105570749|NCT03176238|364088270|FG001|Overall Study|Administrative problems|0|||
105570750|NCT03176238|364088269|FG000|Overall Study|Death|3|||
105570751|NCT03176238|364088270|FG001|Overall Study|Death|0|||
105570752|NCT03176238|364088269|FG000|Overall Study|Disease Progression|133|||
105570753|NCT03176238|364088270|FG001|Overall Study|Disease Progression|22|||
105570754|NCT03176238|364088269|FG000|Overall Study|Tx duration completed per EAP|0|||
105570755|NCT03176238|364088270|FG001|Overall Study|Tx duration completed per EAP|1|||
105570756|NCT03176238|364088269|FG000|Overall Study|Patient is switched to commercial drug|16|||
105570757|NCT03176238|364088270|FG001|Overall Study|Patient is switched to commercial drug|1|||
105570758|NCT03176238|364088269|FG000|Overall Study|Protocol Violation|1|||
105570759|NCT03176238|364088270|FG001|Overall Study|Protocol Violation|0|||
105570760|NCT03176238|364088269|FG000|Overall Study|Changes in the patient's condition|2|||
105570761|NCT03176238|364088270|FG001|Overall Study|Changes in the patient's condition|1|||
105570762|NCT03176238|364088269|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
105570763|NCT03176238|364088270|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
105570764|NCT04524598|364088271|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
105570765|NCT04524598|364088272|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
105570766|NCT04524598|364088273|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
105570767|NCT04524598|364088274|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
105570768|NCT04524598|364088275|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
105570769|NCT04524598|364088271|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
105570770|NCT04524598|364088272|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
105570771|NCT04524598|364088273|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
105570772|NCT04524598|364088274|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
105570773|NCT04524598|364088275|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
105570774|NCT04524598|364088271|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
105570775|NCT04524598|364088272|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
105570776|NCT04524598|364088273|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
105570777|NCT04524598|364088274|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
105570778|NCT04524598|364088275|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
105570779|NCT04524598|364088271|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
105570780|NCT04524598|364088272|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
105570781|NCT04524598|364088273|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
105570782|NCT04524598|364088274|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
105570783|NCT04524598|364088275|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
105570784|NCT04524598|364088271|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
105570785|NCT04524598|364088272|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
105570786|NCT04524598|364088273|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
105570787|NCT04524598|364088274|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
105570788|NCT04524598|364088275|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
105570789|NCT04524598|364088271|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
105808063|NCT01144663|364954880|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
105570790|NCT04524598|364088272|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
105570791|NCT04524598|364088273|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
105570792|NCT04524598|364088274|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
105570793|NCT04524598|364088275|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
105570794|NCT04524598|364088271|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
105570795|NCT04524598|364088272|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
105626664|NCT04167553|364298142|FG002|Overall Study|Withdrawal by Subject|1|||
105570796|NCT04524598|364088273|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
105570797|NCT04524598|364088274|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
105570798|NCT04524598|364088275|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
105570799|NCT04395183|364088276|FG000|Overall Study|Withdrawal by Subject|1|||
105570800|NCT04395183|364088277|FG001|Overall Study|Withdrawal by Subject|0|||
105570801|NCT04395183|364088278|FG002|Overall Study|Withdrawal by Subject|2|||
105570802|NCT04395183|364088279|FG003|Overall Study|Withdrawal by Subject|2|||
105570803|NCT01008475|364088280|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
105570804|NCT01008475|364088281|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
105570805|NCT01008475|364088282|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
105570806|NCT01008475|364088283|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
105570807|NCT01008475|364088284|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
105570808|NCT01008475|364088285|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
105570809|NCT01008475|364088286|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
105570810|NCT02668016|364088287|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
105570811|NCT02668016|364088287|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
105570812|NCT02668016|364088287|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
105570813|NCT02668016|364088287|FG000|Month 4|Withdrawal due to severe symptoms|1|||
105570814|NCT02668016|364088287|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
105570815|NCT02668016|364088287|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
105570816|NCT02668016|364088287|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
105570817|NCT02668016|364088287|FG000|Month 6|Withdrawal due to severe symptoms|2|||
105570818|NCT02668016|364088287|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
105570819|NCT02668016|364088287|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
105570820|NCT02668016|364088287|FG000|Month 8|Withdrawal due to severe symptoms|1|||
105570821|NCT02668016|364088287|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
105570822|NCT02668016|364088287|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
105570823|NCT02668016|364088287|FG000|Month 10|Withdrawal due to severe symptoms|1|||
105570824|NCT02668016|364088287|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
105570825|NCT03556358|364088288|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
105570826|NCT03556358|364088289|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
105570827|NCT03556358|364088288|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
105570828|NCT03556358|364088289|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
105570829|NCT03556358|364088288|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
105570830|NCT03556358|364088289|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
105570831|NCT03556358|364088288|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
105570832|NCT03556358|364088289|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
105570833|NCT03556358|364088288|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
105570834|NCT03556358|364088289|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
105570835|NCT03556358|364088288|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
105570836|NCT03556358|364088289|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
105570837|NCT03556358|364088288|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
105570838|NCT03556358|364088289|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
105570839|NCT00399763|364088297|FG000|Overall Study|Lost to Follow-up|2|||
105570840|NCT00399763|364088298|FG001|Overall Study|Lost to Follow-up|3|||
105570841|NCT05067933|364088305|FG000|Overall Study|Withdrawal by Subject|2|||
105570842|NCT05067933|364088306|FG001|Overall Study|Withdrawal by Subject|0|||
105570843|NCT05067933|364088307|FG002|Overall Study|Withdrawal by Subject|0|||
105570844|NCT05067933|364088308|FG003|Overall Study|Withdrawal by Subject|0|||
105570845|NCT05067933|364088309|FG004|Overall Study|Withdrawal by Subject|0|||
105570846|NCT05067933|364088310|FG005|Overall Study|Withdrawal by Subject|0|||
105570847|NCT05067933|364088305|FG000|Overall Study|Lost to Follow-up|1|||
105570848|NCT05067933|364088306|FG001|Overall Study|Lost to Follow-up|1|||
105570849|NCT05067933|364088307|FG002|Overall Study|Lost to Follow-up|1|||
105570850|NCT05067933|364088308|FG003|Overall Study|Lost to Follow-up|2|||
105570851|NCT05067933|364088309|FG004|Overall Study|Lost to Follow-up|1|||
105570852|NCT05067933|364088310|FG005|Overall Study|Lost to Follow-up|0|||
105570853|NCT05067933|364088305|FG000|Overall Study|Miscellaneous|1|||
105570854|NCT05067933|364088306|FG001|Overall Study|Miscellaneous|0|||
105570855|NCT05067933|364088307|FG002|Overall Study|Miscellaneous|0|||
105570856|NCT05067933|364088308|FG003|Overall Study|Miscellaneous|0|||
105570857|NCT05067933|364088309|FG004|Overall Study|Miscellaneous|0|||
105570858|NCT05067933|364088310|FG005|Overall Study|Miscellaneous|0|||
105570859|NCT05067933|364088305|FG000|Overall Study|Death|0|||
105360994|NCT01064414|363328137|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
105808064|NCT01144663|364954881|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
105485211|NCT01077154|363787110|FG000|Overall Study|Noncompliance|22|||
105485212|NCT01077154|363787111|FG001|Overall Study|Noncompliance|20|||
105485213|NCT01077154|363787110|FG000|Overall Study|Disease Progression|18|||
105485214|NCT01077154|363787111|FG001|Overall Study|Disease Progression|20|||
105485215|NCT01077154|363787110|FG000|Overall Study|Ineligibility Determined|10|||
105485216|NCT01077154|363787111|FG001|Overall Study|Ineligibility Determined|14|||
105485217|NCT01077154|363787110|FG000|Overall Study|Other|14|||
105485218|NCT01077154|363787111|FG001|Overall Study|Other|11|||
105485219|NCT01077154|363787110|FG000|Overall Study|Adverse Event|9|||
105485220|NCT01077154|363787111|FG001|Overall Study|Adverse Event|9|||
105485221|NCT01077154|363787110|FG000|Overall Study|Administrative Decision|1|||
105485222|NCT01077154|363787111|FG001|Overall Study|Administrative Decision|6|||
105485223|NCT01077154|363787110|FG000|Overall Study|Protocol Deviation|1|||
105485224|NCT01077154|363787111|FG001|Overall Study|Protocol Deviation|0|||
105485225|NCT00604214|363787112|FG000|Baseline to Day 28|Death|223|||
105485226|NCT00604214|363787113|FG001|Baseline to Day 28|Death|202|||
105485227|NCT00604214|363787112|FG000|Baseline to Day 28|Lost to Follow-up|2|||
105485228|NCT00604214|363787113|FG001|Baseline to Day 28|Lost to Follow-up|4|||
105485229|NCT00604214|363787112|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
105485230|NCT00604214|363787113|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
105485231|NCT00604214|363787112|FG000|Day 29 to Day 90|Death|64|||
105485232|NCT00604214|363787113|FG001|Day 29 to Day 90|Death|67|||
105485233|NCT00604214|363787112|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
105485234|NCT00604214|363787113|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
105485235|NCT00604214|363787112|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
105485236|NCT00604214|363787113|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
105485237|NCT00604214|363787112|FG000|Day 91 to Day 180|Death|19|||
105485238|NCT00604214|363787113|FG001|Day 91 to Day 180|Death|23|||
105485239|NCT00604214|363787112|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
105485240|NCT00604214|363787113|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
105485241|NCT00604214|363787112|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
105485242|NCT00604214|363787113|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
105485243|NCT05985980|363787114|FG000|Overall Study|Withdrawal by Subject|1|||
105485244|NCT05985980|363787114|FG000|Overall Study|Withdrawal by Subject|1|||
105485245|NCT05985980|363787114|FG000|Overall Study|Withdrawal by Subject|1|||
105485246|NCT05985980|363787114|FG000|Overall Study|Withdrawal by Subject|1|||
105485247|NCT04030026|363787116|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
105485248|NCT04030026|363787117|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
105485249|NCT04030026|363787116|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
105485250|NCT04030026|363787117|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
105485251|NCT04030026|363787116|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
105485252|NCT04030026|363787117|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
105485253|NCT04030026|363787116|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
105485254|NCT04030026|363787117|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
105485255|NCT04030026|363787116|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
105485256|NCT04030026|363787117|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
105485257|NCT04030026|363787116|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
105485258|NCT04030026|363787117|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
105485259|NCT04030026|363787116|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
105485260|NCT04030026|363787117|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
105485261|NCT00523367|363787122|FG000|Overall Study|19 screen failures|19|||
105485262|NCT00523367|363787122|FG000|Overall Study|4 Withdrawn by PI|4|||
105485263|NCT00782795|363787123|FG000|Overall Study|Withdrawal by Subject|1|||
105485264|NCT00782795|363787124|FG001|Overall Study|Withdrawal by Subject|2|||
105485265|NCT04158648|363787128|FG000|Overall Study|Ongoing in the Study|69|||
105485266|NCT04158648|363787128|FG000|Overall Study|Withdrawal by Subject|4|||
105485267|NCT00336583|363788406|FG000|Overall Study|Lost to Follow-up|1|||
105485268|NCT00336583|363788406|FG000|Overall Study|Death|1|||
105485269|NCT01527357|363788409|FG000|Overall Study|Death|8|||
105485270|NCT01527357|363788410|FG001|Overall Study|Death|2|||
105485271|NCT01527357|363788409|FG000|Overall Study|Lost to Follow-up|6|||
105485272|NCT01527357|363788410|FG001|Overall Study|Lost to Follow-up|4|||
105485273|NCT01527357|363788409|FG000|Overall Study|Withdrew Consent|1|||
105485274|NCT01527357|363788410|FG001|Overall Study|Withdrew Consent|1|||
105485275|NCT01527357|363788409|FG000|Overall Study|Non-compliance|0|||
105485276|NCT01527357|363788410|FG001|Overall Study|Non-compliance|1|||
105485277|NCT01527357|363788409|FG000|Overall Study|No Day 29 Visit|0|||
105485278|NCT01527357|363788410|FG001|Overall Study|No Day 29 Visit|1|||
105485279|NCT01527357|363788409|FG000|Overall Study|Did Not Receive Treatment|2|||
105485280|NCT01527357|363788410|FG001|Overall Study|Did Not Receive Treatment|0|||
105485281|NCT01142089|363788411|FG000|Overall Study|Physician Decision|1|||
105485282|NCT01142089|363788412|FG001|Overall Study|Physician Decision|0|||
105485283|NCT01142089|363788411|FG000|Overall Study|Withdrawal by Subject|1|||
105485284|NCT01142089|363788412|FG001|Overall Study|Withdrawal by Subject|2|||
105485285|NCT01142089|363788411|FG000|Overall Study|Use of prohibited medications|0|||
105485286|NCT01142089|363788412|FG001|Overall Study|Use of prohibited medications|1|||
105485287|NCT01142089|363788411|FG000|Overall Study|Noncompliance with study procedures|2|||
105485288|NCT01142089|363788412|FG001|Overall Study|Noncompliance with study procedures|1|||
105485289|NCT01142089|363788411|FG000|Overall Study|Patient required rescue medication|8|||
105485290|NCT01142089|363788412|FG001|Overall Study|Patient required rescue medication|17|||
105485291|NCT01757691|363788413|FG000|Overall Study|Administrative problems|2|||
105485292|NCT01757691|363788414|FG001|Overall Study|Administrative problems|0|||
105485293|NCT00773383|363788417|FG000|Overall Study|Adverse Event|4|||
105485294|NCT00773383|363788417|FG000|Overall Study|Death|1|||
105570860|NCT05067933|364088306|FG001|Overall Study|Death|0|||
105570861|NCT05067933|364088307|FG002|Overall Study|Death|0|||
105570862|NCT05067933|364088308|FG003|Overall Study|Death|1|||
105570863|NCT05067933|364088309|FG004|Overall Study|Death|0|||
105570864|NCT05067933|364088310|FG005|Overall Study|Death|0|||
105570865|NCT01657266|364088316|FG000|Overall Study|Lost to Follow-up|2|||
105570866|NCT01657266|364088317|FG001|Overall Study|Lost to Follow-up|2|||
105570867|NCT01657266|364088316|FG000|Overall Study|Adverse Event|2|||
105570868|NCT01657266|364088317|FG001|Overall Study|Adverse Event|3|||
105570869|NCT00457639|364088323|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
105570870|NCT00457639|364088324|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
105570871|NCT00457639|364088323|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
105570872|NCT00457639|364088324|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
105570873|NCT00457639|364088323|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
105570874|NCT00457639|364088324|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
105570875|NCT02395133|364088325|FG000|Overall Study|Adverse Event|4|||
105570876|NCT02395133|364088326|FG001|Overall Study|Adverse Event|1|||
105570877|NCT02395133|364088327|FG002|Overall Study|Adverse Event|3|||
105570878|NCT02395133|364088328|FG003|Overall Study|Adverse Event|0|||
105570879|NCT02395133|364088325|FG000|Overall Study|Lack of Efficacy|1|||
105570880|NCT02395133|364088326|FG001|Overall Study|Lack of Efficacy|0|||
105570881|NCT02395133|364088327|FG002|Overall Study|Lack of Efficacy|1|||
105570882|NCT02395133|364088328|FG003|Overall Study|Lack of Efficacy|1|||
105570883|NCT02395133|364088325|FG000|Overall Study|Protocol Violation|1|||
105570884|NCT02395133|364088326|FG001|Overall Study|Protocol Violation|1|||
105570885|NCT02395133|364088327|FG002|Overall Study|Protocol Violation|0|||
105761592|NCT01432457|364781378|FG002|Overall Study|Reasons not defined|4|||
105761593|NCT01432457|364781376|FG000|Overall Study|Did not take study drug|6|||
105761594|NCT01432457|364781377|FG001|Overall Study|Did not take study drug|6|||
105761595|NCT01432457|364781378|FG002|Overall Study|Did not take study drug|3|||
105761596|NCT01105936|364781379|FG000|Period 1|Adverse Event|0|||
105761597|NCT01105936|364781380|FG001|Period 1|Adverse Event|0|||
105761598|NCT01105936|364781381|FG002|Period 1|Adverse Event|0|||
105761599|NCT01105936|364781382|FG003|Period 1|Adverse Event|1|||
105761600|NCT01105936|364781379|FG000|Period 2|Adverse Event|1|||
105761601|NCT01105936|364781380|FG001|Period 2|Adverse Event|0|||
105761602|NCT01105936|364781381|FG002|Period 2|Adverse Event|0|||
105761603|NCT01105936|364781382|FG003|Period 2|Adverse Event|0|||
105761604|NCT01105936|364781379|FG000|Period 3|Protocol Violation|0|||
105761605|NCT01105936|364781380|FG001|Period 3|Protocol Violation|2|||
105761606|NCT01105936|364781381|FG002|Period 3|Protocol Violation|0|||
105761607|NCT01105936|364781382|FG003|Period 3|Protocol Violation|0|||
105761608|NCT01673490|364781383|FG000|Overall Study|Lost to Follow-up|1|||
105761609|NCT01673490|364781383|FG000|Overall Study|Adverse Event|3|||
105761610|NCT01673490|364781383|FG000|Overall Study|Withdrawal by Subject|3|||
105761611|NCT04134728|364781384|FG000|Overall Study|Adverse Event|3|||
105761612|NCT04134728|364781385|FG001|Overall Study|Adverse Event|2|||
105761613|NCT04134728|364781386|FG002|Overall Study|Adverse Event|9|||
105761614|NCT04134728|364781387|FG003|Overall Study|Adverse Event|0|||
105761615|NCT04134728|364781388|FG004|Overall Study|Adverse Event|0|||
105761616|NCT04134728|364781389|FG005|Overall Study|Adverse Event|0|||
105761617|NCT04134728|364781384|FG000|Overall Study|Lack of Efficacy|3|||
105761618|NCT04134728|364781385|FG001|Overall Study|Lack of Efficacy|3|||
105761619|NCT04134728|364781386|FG002|Overall Study|Lack of Efficacy|1|||
105761620|NCT04134728|364781387|FG003|Overall Study|Lack of Efficacy|2|||
105761621|NCT04134728|364781388|FG004|Overall Study|Lack of Efficacy|0|||
105761622|NCT04134728|364781389|FG005|Overall Study|Lack of Efficacy|0|||
105761623|NCT04134728|364781384|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
105761624|NCT04134728|364781385|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105761625|NCT04134728|364781386|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
105761626|NCT04134728|364781387|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105761627|NCT04134728|364781388|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105761628|NCT04134728|364781389|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105808065|NCT01144663|364954878|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
105570886|NCT02395133|364088328|FG003|Overall Study|Protocol Violation|3|||
105570887|NCT02395133|364088325|FG000|Overall Study|Lost to Follow-up|0|||
105570888|NCT02395133|364088326|FG001|Overall Study|Lost to Follow-up|1|||
105570889|NCT02395133|364088327|FG002|Overall Study|Lost to Follow-up|1|||
105570890|NCT02395133|364088328|FG003|Overall Study|Lost to Follow-up|0|||
105761629|NCT04134728|364781384|FG000|Overall Study|Protocol Deviation|0|||
105761630|NCT04134728|364781385|FG001|Overall Study|Protocol Deviation|0|||
105570891|NCT02395133|364088325|FG000|Overall Study|Pregnancy|0|||
105761631|NCT04134728|364781386|FG002|Overall Study|Protocol Deviation|1|||
105761632|NCT04134728|364781387|FG003|Overall Study|Protocol Deviation|0|||
105761633|NCT04134728|364781388|FG004|Overall Study|Protocol Deviation|0|||
105761634|NCT04134728|364781389|FG005|Overall Study|Protocol Deviation|0|||
105761635|NCT04134728|364781384|FG000|Overall Study|Informed Consent Withdrawn|3|||
105761636|NCT04134728|364781385|FG001|Overall Study|Informed Consent Withdrawn|6|||
105761637|NCT04134728|364781386|FG002|Overall Study|Informed Consent Withdrawn|8|||
105485295|NCT00773383|363788417|FG000|Overall Study|Progression of Disease|23|||
105485296|NCT00773383|363788417|FG000|Overall Study|Other|2|||
105485297|NCT00773383|363788417|FG000|Overall Study|No study dose received|1|||
105485298|NCT02919969|363788420|FG000|Overall Study|Lack of Efficacy|22|||
105485299|NCT02919969|363788420|FG000|Overall Study|Death|4|||
105485300|NCT02919969|363788420|FG000|Overall Study|Physician Decision|3|||
105485301|NCT02919969|363788420|FG000|Overall Study|Withdrawal by Subject|2|||
105485302|NCT00371761|363788422|FG000|Overall Study|Adverse Event|1|||
105485303|NCT00371761|363788423|FG001|Overall Study|Adverse Event|1|||
105485304|NCT00371761|363788422|FG000|Overall Study|Withdrawal by Subject|1|||
105485305|NCT00371761|363788423|FG001|Overall Study|Withdrawal by Subject|3|||
105485306|NCT00371761|363788422|FG000|Overall Study|Investigator Judgment|2|||
105485307|NCT00371761|363788423|FG001|Overall Study|Investigator Judgment|3|||
105485308|NCT00371761|363788422|FG000|Overall Study|Study termination|4|||
105485309|NCT00371761|363788423|FG001|Overall Study|Study termination|3|||
105485310|NCT03718299|363788425|FG000|Overall Study|Adverse Event|1|||
105485311|NCT03718299|363788425|FG000|Overall Study|Withdrawal by Subject|6|||
105485312|NCT03718299|363788425|FG000|Overall Study|Physician Decision|2|||
105485313|NCT03718299|363788425|FG000|Overall Study|Lost to Follow-up|1|||
105485314|NCT01362595|363788426|FG000|Overall Study|Screen failure|10|||
105485315|NCT01362595|363788426|FG000|Overall Study|Withdrawal by Subject|2|||
105485316|NCT00959374|363788427|FG000|Overall Study|Withdrawal by Subject|2|||
105485317|NCT00959374|363788427|FG000|Overall Study|Lost to Follow-up|14|||
105485318|NCT00959374|363788427|FG000|Overall Study|Death|1|||
105485319|NCT00959374|363788427|FG000|Overall Study|Protocol Violation|1|||
105485320|NCT00959374|363788427|FG000|Overall Study|Implant Removed/Not Replaced|4|||
105485321|NCT00959374|363788427|FG000|Overall Study|Physician Decision|1|||
105485322|NCT01475071|363788428|FG000|Overall Study|Physician Decision|1|||
105485323|NCT01475071|363788428|FG000|Overall Study|Withdrawal by Subject|6|||
105485324|NCT01475071|363788428|FG000|Overall Study|Lost to Follow-up|1|||
105485325|NCT00718081|363788429|FG000|Overall Study|Adverse Event|0|||
105485326|NCT00718081|363788430|FG001|Overall Study|Adverse Event|1|||
105485327|NCT00718081|363788431|FG002|Overall Study|Adverse Event|0|||
105485328|NCT00718081|363788429|FG000|Overall Study|Lack of Efficacy|7|||
105485329|NCT00718081|363788430|FG001|Overall Study|Lack of Efficacy|3|||
105485330|NCT00718081|363788431|FG002|Overall Study|Lack of Efficacy|21|||
105485331|NCT01205581|363788438|FG000|Overall Study|Withdrawal by Subject|1|||
105485332|NCT01205581|363788439|FG001|Overall Study|Withdrawal by Subject|0|||
105485333|NCT01205581|363788440|FG002|Overall Study|Withdrawal by Subject|0|||
105485334|NCT01205581|363788441|FG003|Overall Study|Withdrawal by Subject|0|||
105485335|NCT01205581|363788442|FG004|Overall Study|Withdrawal by Subject|0|||
105485336|NCT01205581|363788443|FG005|Overall Study|Withdrawal by Subject|0|||
105485337|NCT04535167|363788444|FG000|Treatment|Adverse Event|0|||
105485338|NCT04535167|363788445|FG001|Treatment|Adverse Event|0|||
105485339|NCT04535167|363788446|FG002|Treatment|Adverse Event|0|||
105485340|NCT04535167|363788447|FG003|Treatment|Adverse Event|0|||
105485341|NCT04535167|363788448|FG004|Treatment|Adverse Event|0|||
105485342|NCT04535167|363788449|FG005|Treatment|Adverse Event|0|||
105485343|NCT04535167|363788450|FG006|Treatment|Adverse Event|1|||
105485344|NCT04535167|363788444|FG000|Follow-Up|Death|0|||
105485345|NCT04535167|363788445|FG001|Follow-Up|Death|0|||
105485346|NCT04535167|363788446|FG002|Follow-Up|Death|0|||
105485347|NCT04535167|363788447|FG003|Follow-Up|Death|0|||
105485348|NCT04535167|363788448|FG004|Follow-Up|Death|0|||
105485349|NCT04535167|363788449|FG005|Follow-Up|Death|0|||
105485350|NCT04535167|363788450|FG006|Follow-Up|Death|1|||
105485351|NCT04535167|363788444|FG000|Follow-Up|Lost to Follow-up|0|||
105485352|NCT04535167|363788445|FG001|Follow-Up|Lost to Follow-up|0|||
105485353|NCT04535167|363788446|FG002|Follow-Up|Lost to Follow-up|0|||
105485354|NCT04535167|363788447|FG003|Follow-Up|Lost to Follow-up|1|||
105485355|NCT04535167|363788448|FG004|Follow-Up|Lost to Follow-up|0|||
105485356|NCT04535167|363788449|FG005|Follow-Up|Lost to Follow-up|0|||
105485357|NCT04535167|363788450|FG006|Follow-Up|Lost to Follow-up|0|||
105485358|NCT02579928|363788451|FG000|Overall Study|Withdrawal by Subject|1|||
105485359|NCT02579928|363788452|FG001|Overall Study|Withdrawal by Subject|0|||
105485360|NCT01993836|363788455|FG000|Overall Study|Surgery Cancelled|3|||
105485361|NCT01993836|363788456|FG001|Overall Study|Surgery Cancelled|0|||
105485362|NCT01993836|363788457|FG002|Overall Study|Surgery Cancelled|0|||
105485363|NCT01993836|363788455|FG000|Overall Study|Physician Decision|2|||
105485364|NCT01993836|363788456|FG001|Overall Study|Physician Decision|1|||
105485365|NCT01993836|363788457|FG002|Overall Study|Physician Decision|0|||
105570892|NCT02395133|364088326|FG001|Overall Study|Pregnancy|0|||
105570893|NCT02395133|364088327|FG002|Overall Study|Pregnancy|3|||
105570894|NCT02395133|364088328|FG003|Overall Study|Pregnancy|0|||
105570895|NCT02395133|364088325|FG000|Overall Study|Consent withdrawn with no reason given|1|||
105570896|NCT02395133|364088326|FG001|Overall Study|Consent withdrawn with no reason given|3|||
105570897|NCT02395133|364088327|FG002|Overall Study|Consent withdrawn with no reason given|0|||
105570898|NCT02395133|364088328|FG003|Overall Study|Consent withdrawn with no reason given|2|||
105570899|NCT02395133|364088325|FG000|Overall Study|Consent withdrawn with personal reason|0|||
105570900|NCT02395133|364088326|FG001|Overall Study|Consent withdrawn with personal reason|1|||
105570901|NCT02395133|364088327|FG002|Overall Study|Consent withdrawn with personal reason|0|||
105570902|NCT02395133|364088328|FG003|Overall Study|Consent withdrawn with personal reason|3|||
105570903|NCT02395133|364088325|FG000|Overall Study|Sponsor decision|2|||
105570904|NCT02395133|364088326|FG001|Overall Study|Sponsor decision|0|||
105570905|NCT02395133|364088327|FG002|Overall Study|Sponsor decision|0|||
105570906|NCT02395133|364088328|FG003|Overall Study|Sponsor decision|1|||
105570907|NCT02395133|364088325|FG000|Overall Study|Other than specified above|5|||
105570908|NCT02395133|364088326|FG001|Overall Study|Other than specified above|2|||
105570909|NCT02395133|364088327|FG002|Overall Study|Other than specified above|2|||
105570910|NCT02395133|364088328|FG003|Overall Study|Other than specified above|4|||
105570911|NCT00962247|364088331|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
105570912|NCT00962247|364088331|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
105570913|NCT00510458|364088332|FG000|Overall Study|5 year not evaluable/missed|21|||
105570914|NCT00510458|364088332|FG000|Overall Study|Death|1|||
105570915|NCT00510458|364088332|FG000|Overall Study|Terminated|14|||
105570916|NCT00510458|364088332|FG000|Overall Study|Lost to Follow-up|6|||
105808066|NCT01144663|364954879|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
105808067|NCT01144663|364954880|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
105808068|NCT01144663|364954881|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
105808069|NCT01144663|364954878|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
105808070|NCT01144663|364954879|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
105570917|NCT00510458|364088332|FG000|Overall Study|Withdrawal by Subject|3|||
105570918|NCT00510458|364088332|FG000|Overall Study|Revision|2|||
105570919|NCT00524030|364088340|FG000|Overall Study|Lack of Efficacy|10|||
105570920|NCT00524030|364088341|FG001|Overall Study|Lack of Efficacy|24|||
105570921|NCT00524030|364088340|FG000|Overall Study|Lost to Follow-up|0|||
105570922|NCT00524030|364088341|FG001|Overall Study|Lost to Follow-up|2|||
105570923|NCT00524030|364088340|FG000|Overall Study|Withdrawal by Subject|3|||
105570924|NCT00524030|364088341|FG001|Overall Study|Withdrawal by Subject|8|||
105570925|NCT00524030|364088340|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
105570926|NCT00524030|364088341|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
105360995|NCT01064414|363328135|FG000|Core Period: Baseline to Week 26|Death|0|||
105360996|NCT01064414|363328136|FG001|Core Period: Baseline to Week 26|Death|1|||
105360997|NCT01064414|363328137|FG002|Core Period: Baseline to Week 26|Death|0|||
105360998|NCT01064414|363328135|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
105360999|NCT01064414|363328136|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
105361000|NCT01064414|363328137|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
105361001|NCT01064414|363328135|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
105361002|NCT01064414|363328136|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
105361003|NCT01064414|363328137|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
105361004|NCT01064414|363328135|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
105361005|NCT01064414|363328136|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
105361006|NCT01064414|363328137|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
105361007|NCT01064414|363328135|FG000|Core Period: Baseline to Week 26|Other|4|||
105361008|NCT01064414|363328136|FG001|Core Period: Baseline to Week 26|Other|7|||
105361009|NCT01064414|363328137|FG002|Core Period: Baseline to Week 26|Other|2|||
105361010|NCT01064414|363328135|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
105361011|NCT01064414|363328136|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
105361012|NCT01064414|363328137|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
105361013|NCT01064414|363328135|FG000|Extension Period: Week 26 to Week 52|Death|0|||
105361014|NCT01064414|363328136|FG001|Extension Period: Week 26 to Week 52|Death|1|||
105361015|NCT01064414|363328137|FG002|Extension Period: Week 26 to Week 52|Death|0|||
105361016|NCT01064414|363328135|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
105361017|NCT01064414|363328136|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
105361018|NCT01064414|363328137|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
105361019|NCT01064414|363328135|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
105361020|NCT01064414|363328136|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
105361021|NCT01064414|363328137|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
105570927|NCT00524030|364088340|FG000|Overall Study|Protocol Violation|0|||
105808071|NCT01144663|364954880|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
105361022|NCT01064414|363328135|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
105361023|NCT01064414|363328136|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
105570928|NCT00524030|364088341|FG001|Overall Study|Protocol Violation|1|||
105570929|NCT00524030|364088340|FG000|Overall Study|Pregnancy|1|||
105570930|NCT00524030|364088341|FG001|Overall Study|Pregnancy|0|||
105570931|NCT00524030|364088340|FG000|Overall Study|Adverse Event|3|||
105570932|NCT00524030|364088341|FG001|Overall Study|Adverse Event|21|||
105570933|NCT00524030|364088340|FG000|Overall Study|Death|0|||
105570934|NCT00524030|364088341|FG001|Overall Study|Death|1|||
105570935|NCT00462670|364089576|FG000|Overall Study|Adverse Event|3|||
105570936|NCT00462670|364089577|FG001|Overall Study|Adverse Event|5|||
105570937|NCT00462670|364089576|FG000|Overall Study|Lack of Efficacy|1|||
105570938|NCT00462670|364089577|FG001|Overall Study|Lack of Efficacy|0|||
105485366|NCT01993836|363788455|FG000|Overall Study|Death|0|||
105485367|NCT01993836|363788456|FG001|Overall Study|Death|2|||
105485368|NCT01993836|363788457|FG002|Overall Study|Death|0|||
105485369|NCT01993836|363788455|FG000|Overall Study|Withdrawal by Subject|12|||
105485370|NCT01993836|363788456|FG001|Overall Study|Withdrawal by Subject|10|||
105485371|NCT01993836|363788457|FG002|Overall Study|Withdrawal by Subject|5|||
105485372|NCT02195687|363788458|FG000|Overall Study|Personal Reasons|1|||
105485373|NCT02195687|363788459|FG001|Overall Study|Personal Reasons|1|||
105485374|NCT02195687|363788458|FG000|Overall Study|Lost to Follow-up|4|||
105485375|NCT02195687|363788459|FG001|Overall Study|Lost to Follow-up|1|||
105485376|NCT02361580|363788460|FG000|Overall Study|Lost to Follow-up|6|||
105485377|NCT02361580|363788461|FG001|Overall Study|Lost to Follow-up|3|||
105485378|NCT04369924|363788464|FG000|Overall Study|Lost to Follow-up|302|||
105485379|NCT04369924|363788465|FG001|Overall Study|Lost to Follow-up|339|||
105485380|NCT03780400|363788466|FG000|Overall Study|Lost to Follow-up|5|||
105485381|NCT03780400|363788466|FG000|Overall Study|Withdrawal by Subject|2|||
105485382|NCT02480712|363788467|FG000|Overall Study|Enrolled but Never Treated|1|||
105485383|NCT02480712|363788467|FG000|Overall Study|Lost to Follow-up|5|||
105485384|NCT02480712|363788467|FG000|Overall Study|Withdrew Consent|3|||
105485385|NCT02480712|363788467|FG000|Overall Study|Death|1|||
105485386|NCT02480712|363788467|FG000|Overall Study|Lack of Efficacy|1|||
105485387|NCT01857310|363788468|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
105485388|NCT01857310|363788469|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
105485389|NCT02554279|363788470|FG000|Overall Study|Adverse Event|2|||
105570939|NCT00462670|364089576|FG000|Overall Study|Protocol Violation|1|||
105570940|NCT00462670|364089577|FG001|Overall Study|Protocol Violation|0|||
105485390|NCT02554279|363788471|FG001|Overall Study|Adverse Event|5|||
105570941|NCT00462670|364089576|FG000|Overall Study|Resolution of signs and symptoms|0|||
105808072|NCT01144663|364954881|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
105808073|NCT01144663|364954878|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
105808074|NCT01144663|364954879|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
105808075|NCT01144663|364954880|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
105808076|NCT01144663|364954881|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
105808077|NCT01144663|364954878|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
105808078|NCT01144663|364954879|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
105808079|NCT01144663|364954880|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
105808080|NCT01144663|364954881|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
105808081|NCT01144663|364954878|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
105808082|NCT01144663|364954879|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
105808083|NCT01144663|364954880|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
105808084|NCT01144663|364954881|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
105808085|NCT01267266|364954883|FG000|Enrollment Phase|Withdrawal by Subject|2|||
105808086|NCT01267266|364954884|FG001|Enrollment Phase|Withdrawal by Subject|0|||
105808087|NCT01267266|364954883|FG000|Lead-in Phase|Lack of Efficacy|20|||
105808088|NCT01267266|364954884|FG001|Lead-in Phase|Lack of Efficacy|0|||
105808089|NCT01267266|364954883|FG000|Lead-in Phase|Adverse Event|2|||
105808090|NCT01267266|364954884|FG001|Lead-in Phase|Adverse Event|0|||
105808091|NCT01267266|364954883|FG000|Lead-in Phase|Withdrawal by Subject|1|||
105808092|NCT01267266|364954884|FG001|Lead-in Phase|Withdrawal by Subject|0|||
105808093|NCT01335477|364954885|FG000|Overall Study|Adverse Event|30|||
105808094|NCT01335477|364954886|FG001|Overall Study|Adverse Event|42|||
105808095|NCT01335477|364954885|FG000|Overall Study|Non compliant with protocol|0|||
105808096|NCT01335477|364954886|FG001|Overall Study|Non compliant with protocol|2|||
105808097|NCT01335477|364954885|FG000|Overall Study|Lost to Follow-up|1|||
105808098|NCT01335477|364954886|FG001|Overall Study|Lost to Follow-up|2|||
105808099|NCT01335477|364954885|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
105808100|NCT01335477|364954886|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
105808101|NCT01335477|364954885|FG000|Overall Study|Not treated|1|||
105485391|NCT02554279|363788470|FG000|Overall Study|Lost to Follow-up|3|||
105485392|NCT02554279|363788471|FG001|Overall Study|Lost to Follow-up|2|||
105485393|NCT02554279|363788470|FG000|Overall Study|Withdrawal by Subject|6|||
105485394|NCT02554279|363788471|FG001|Overall Study|Withdrawal by Subject|4|||
105485395|NCT02554279|363788470|FG000|Overall Study|Protocol Violation|2|||
105485396|NCT02554279|363788471|FG001|Overall Study|Protocol Violation|1|||
105485397|NCT02554279|363788470|FG000|Overall Study|Other reason|19|||
105485398|NCT02554279|363788471|FG001|Overall Study|Other reason|6|||
105485399|NCT00812487|363788472|FG000|Overall Study|Lost to Follow-up|2|||
105485400|NCT00812487|363788473|FG001|Overall Study|Lost to Follow-up|0|||
105485401|NCT00812487|363788472|FG000|Overall Study|Withdrawal by Subject|3|||
105485402|NCT00812487|363788473|FG001|Overall Study|Withdrawal by Subject|2|||
105485403|NCT00812487|363788472|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
105485404|NCT00812487|363788473|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
105485405|NCT00812487|363788472|FG000|Overall Study|Protocol Violation|0|||
105485406|NCT00812487|363788473|FG001|Overall Study|Protocol Violation|1|||
105485407|NCT02360605|363788474|FG000|Overall Study|Withdrawal by Subject|4|||
105485408|NCT02360605|363788475|FG001|Overall Study|Withdrawal by Subject|9|||
105485409|NCT02360605|363788474|FG000|Overall Study|Lost to Follow-up|7|||
105485410|NCT02360605|363788475|FG001|Overall Study|Lost to Follow-up|8|||
105485411|NCT02360605|363788474|FG000|Overall Study|Death|0|||
105485412|NCT02360605|363788475|FG001|Overall Study|Death|1|||
105485413|NCT05463198|363788476|FG000|Overall Study|Withdrawal by Subject|19|||
105485414|NCT05463198|363788476|FG000|Overall Study|Procedure Notes Missing|18|||
105485415|NCT00274924|363788479|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
105485416|NCT00274924|363788480|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
105485417|NCT00274924|363788481|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
105485418|NCT00274924|363788479|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
105485419|NCT00274924|363788480|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
105485420|NCT00274924|363788481|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
105485421|NCT00274924|363788479|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
105485422|NCT00274924|363788480|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
105485423|NCT00274924|363788481|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
105485424|NCT00274924|363788479|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
105485425|NCT00274924|363788480|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
105485426|NCT00274924|363788481|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
105485427|NCT00274924|363788479|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
105485428|NCT00274924|363788480|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
105485429|NCT00274924|363788481|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
105485430|NCT00274924|363788479|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
105485431|NCT00274924|363788480|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
105808102|NCT01335477|364954886|FG001|Overall Study|Not treated|2|||
105808103|NCT01335477|364954885|FG000|Overall Study|Reason other than those stated above|2|||
105808104|NCT01335477|364954886|FG001|Overall Study|Reason other than those stated above|2|||
105808105|NCT03740698|364954887|FG000|Overall Study|Physician Decision|0|||
105808106|NCT03740698|364954888|FG001|Overall Study|Physician Decision|1|||
105808107|NCT03740698|364954889|FG002|Overall Study|Physician Decision|1|||
105808108|NCT01469364|364954890|FG000|Overall Study|Adverse Event|1|||
105808109|NCT01469364|364954890|FG000|Overall Study|Withdrawal by Subject|1|||
105808110|NCT00832078|364954891|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
105808111|NCT00832078|364954892|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
105808112|NCT00832078|364954891|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
105808113|NCT00832078|364954892|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
105808114|NCT01767597|364954893|FG000|Overall Study|Incomplete intervention|3|||
105808115|NCT01767597|364954894|FG001|Overall Study|Incomplete intervention|1|||
105808116|NCT01767597|364954893|FG000|Overall Study|Withdrawal by Subject|1|||
105808117|NCT01767597|364954894|FG001|Overall Study|Withdrawal by Subject|0|||
105808118|NCT00836927|364954896|FG000|Overall Study|Progressive disease|2|||
105808119|NCT00836927|364954897|FG001|Overall Study|Progressive disease|0|||
105808120|NCT00836927|364954898|FG002|Overall Study|Progressive disease|0|||
105808121|NCT00836927|364954899|FG003|Overall Study|Progressive disease|1|||
105808122|NCT00836927|364954900|FG004|Overall Study|Progressive disease|1|||
105485432|NCT00274924|363788481|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
105485433|NCT00274924|363788479|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
105485434|NCT00274924|363788480|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
105485435|NCT00274924|363788481|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
105485436|NCT00274924|363788479|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
105485437|NCT00274924|363788480|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
105485438|NCT00274924|363788481|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
105485439|NCT00274924|363788479|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
105485440|NCT00274924|363788480|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
105485441|NCT00274924|363788481|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
105485442|NCT00274924|363788479|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
105485443|NCT00274924|363788480|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
105485444|NCT00274924|363788481|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
105485445|NCT00274924|363788479|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
105485446|NCT00274924|363788480|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
105485447|NCT00274924|363788481|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
105485448|NCT00274924|363788479|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
105485449|NCT00274924|363788480|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
105485450|NCT00274924|363788481|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
105485451|NCT00274924|363788479|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
105485452|NCT00274924|363788480|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
105485453|NCT00274924|363788481|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
105485454|NCT00740051|363788482|FG000|Overall Study|Lack of Efficacy|2|||
105485455|NCT00740051|363788483|FG001|Overall Study|Lack of Efficacy|5|||
105485456|NCT00740051|363788482|FG000|Overall Study|Adverse Event|1|||
105485457|NCT00740051|363788483|FG001|Overall Study|Adverse Event|4|||
105485458|NCT00740051|363788482|FG000|Overall Study|Protocol Violation|2|||
105485459|NCT00740051|363788483|FG001|Overall Study|Protocol Violation|6|||
105485460|NCT00740051|363788482|FG000|Overall Study|Lost to Follow-up|3|||
105485461|NCT00740051|363788483|FG001|Overall Study|Lost to Follow-up|8|||
105485462|NCT00740051|363788482|FG000|Overall Study|Withdrawal by Subject|6|||
105485463|NCT00740051|363788483|FG001|Overall Study|Withdrawal by Subject|8|||
105485464|NCT00740051|363788482|FG000|Overall Study|Other reason (not specified)|4|||
105485465|NCT00740051|363788483|FG001|Overall Study|Other reason (not specified)|1|||
105485466|NCT01903525|363788485|FG000|Overall Study|Lost to Follow-up|5|||
105485467|NCT01903525|363788486|FG001|Overall Study|Lost to Follow-up|9|||
105485468|NCT01903525|363788485|FG000|Overall Study|Adverse Event|0|||
105485469|NCT01903525|363788486|FG001|Overall Study|Adverse Event|1|||
105485470|NCT00991952|363788487|FG000|Overall Study|Adverse Event|0|||
105485471|NCT00991952|363788488|FG001|Overall Study|Adverse Event|1|||
105485472|NCT02093026|363788489|FG000|Overall Study|Adverse Event|26|||
105485473|NCT02093026|363788489|FG000|Overall Study|Death|10|||
105485474|NCT02093026|363788489|FG000|Overall Study|Other|157|||
105485475|NCT01673282|363788490|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
105485476|NCT01673282|363788491|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
105485477|NCT01673282|363788490|FG000|Overall Study|Lack of Efficacy|9|||
105485478|NCT01673282|363788491|FG001|Overall Study|Lack of Efficacy|2|||
105485479|NCT01673282|363788490|FG000|Overall Study|Lost to Follow-up|11|||
105485480|NCT01673282|363788491|FG001|Overall Study|Lost to Follow-up|10|||
105485481|NCT01673282|363788490|FG000|Overall Study|Withdrawal by Subject|3|||
105485482|NCT01673282|363788491|FG001|Overall Study|Withdrawal by Subject|3|||
105485483|NCT01673282|363788490|FG000|Overall Study|Other|1|||
105485484|NCT01673282|363788491|FG001|Overall Study|Other|6|||
105808123|NCT00836927|364954896|FG000|Overall Study|Withdrawal by Subject|1|||
105808124|NCT00836927|364954897|FG001|Overall Study|Withdrawal by Subject|0|||
105808125|NCT00836927|364954898|FG002|Overall Study|Withdrawal by Subject|0|||
105808126|NCT00836927|364954899|FG003|Overall Study|Withdrawal by Subject|0|||
105808127|NCT00836927|364954900|FG004|Overall Study|Withdrawal by Subject|0|||
105808128|NCT00614055|364954902|FG000|Overall Study|Adverse Event|1|||
105808129|NCT00614055|364954903|FG001|Overall Study|Adverse Event|0|||
105808130|NCT00614055|364954904|FG002|Overall Study|Adverse Event|0|||
105808131|NCT00614055|364954902|FG000|Overall Study|Protocol Violation|2|||
105808132|NCT00614055|364954903|FG001|Overall Study|Protocol Violation|2|||
105808133|NCT00614055|364954904|FG002|Overall Study|Protocol Violation|1|||
105808134|NCT00614055|364954902|FG000|Overall Study|Lack of Efficacy|0|||
105808135|NCT00614055|364954903|FG001|Overall Study|Lack of Efficacy|0|||
105808136|NCT00614055|364954904|FG002|Overall Study|Lack of Efficacy|2|||
105485485|NCT00582816|363788493|FG000|Overall Study|Engraftment Failure|3|||
105485486|NCT04381988|363788496|FG000|Overall Study|The study was terminated|4|||
105485487|NCT04381988|363788497|FG001|Overall Study|The study was terminated|0|||
105485488|NCT02106923|363788498|FG000|Overall Study|Protocol Violation|0|||
105485489|NCT02106923|363788499|FG001|Overall Study|Protocol Violation|0|||
105485490|NCT02106923|363788500|FG002|Overall Study|Protocol Violation|0|||
105485491|NCT02106923|363788501|FG003|Overall Study|Protocol Violation|0|||
105485492|NCT02106923|363788502|FG004|Overall Study|Protocol Violation|0|||
105485493|NCT02106923|363788503|FG005|Overall Study|Protocol Violation|1|||
105485494|NCT03485495|363788504|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
105485495|NCT03485495|363788505|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
105485496|NCT02915874|363788507|FG000|Overall Study|Lost to Follow-up|5|||
105485497|NCT02915874|363788508|FG001|Overall Study|Lost to Follow-up|4|||
105485498|NCT02915874|363788507|FG000|Overall Study|Withdrawal by Subject|1|||
105485499|NCT02915874|363788508|FG001|Overall Study|Withdrawal by Subject|1|||
105485500|NCT02915874|363788507|FG000|Overall Study|Started New Anxiety Medication|0|||
105485501|NCT02915874|363788508|FG001|Overall Study|Started New Anxiety Medication|1|||
105485502|NCT03915860|363788509|FG000|Overall Study|Adverse Event|3|||
105485503|NCT03915860|363788509|FG000|Overall Study|Withdrawal by Subject|6|||
105485504|NCT03915860|363788509|FG000|Overall Study|Lost to Follow-up|2|||
105485505|NCT03915860|363788509|FG000|Overall Study|Other than specified|3|||
105485506|NCT02195011|363788510|FG000|Overall Study|Adverse Event|4|||
105485507|NCT02195011|363788511|FG001|Overall Study|Adverse Event|0|||
105485508|NCT02195011|363788510|FG000|Overall Study|Progressive Disease|18|||
105485509|NCT02195011|363788511|FG001|Overall Study|Progressive Disease|1|||
105485510|NCT02195011|363788510|FG000|Overall Study|Withdrawal by Subject|3|||
105485511|NCT02195011|363788511|FG001|Overall Study|Withdrawal by Subject|0|||
105485512|NCT00424255|363788513|FG000|Overall Study|Death|115|||
105485513|NCT00424255|363788514|FG001|Overall Study|Death|111|||
105485514|NCT00424255|363788513|FG000|Overall Study|Lost to Follow-up|26|||
105485515|NCT00424255|363788514|FG001|Overall Study|Lost to Follow-up|20|||
105485516|NCT00424255|363788513|FG000|Overall Study|Protocol Violation|0|||
105485517|NCT00424255|363788514|FG001|Overall Study|Protocol Violation|1|||
105485518|NCT00424255|363788513|FG000|Overall Study|Withdrawal by Subject|34|||
105485519|NCT00424255|363788514|FG001|Overall Study|Withdrawal by Subject|38|||
105485520|NCT00424255|363788513|FG000|Overall Study|Physician Decision|3|||
105485521|NCT00424255|363788514|FG001|Overall Study|Physician Decision|7|||
105485522|NCT00424255|363788513|FG000|Overall Study|Cognitive Disturbance|1|||
105485523|NCT00424255|363788514|FG001|Overall Study|Cognitive Disturbance|0|||
105485524|NCT00424255|363788513|FG000|Overall Study|Non-compliance by Participants|1|||
105485525|NCT00424255|363788514|FG001|Overall Study|Non-compliance by Participants|0|||
105485526|NCT00424255|363788513|FG000|Overall Study|Fatigue|1|||
105485527|NCT00424255|363788514|FG001|Overall Study|Fatigue|0|||
105485528|NCT00424255|363788513|FG000|Overall Study|Disease Progression|0|||
105485529|NCT00424255|363788514|FG001|Overall Study|Disease Progression|2|||
105485530|NCT00424255|363788513|FG000|Overall Study|Sponsor Terminated Study|161|||
105485531|NCT00424255|363788514|FG001|Overall Study|Sponsor Terminated Study|167|||
105485532|NCT01226121|363788515|FG000|Overall Study|Lost to Follow-up|2|||
105485533|NCT01226121|363788516|FG001|Overall Study|Lost to Follow-up|0|||
105485534|NCT01226121|363788517|FG002|Overall Study|Lost to Follow-up|1|||
105485535|NCT04221230|363788520|FG000|Overall Study|Lost to Follow-up|12|||
105485536|NCT04221230|363788521|FG001|Overall Study|Lost to Follow-up|12|||
105485537|NCT04221230|363788520|FG000|Overall Study|Protocol Violation|2|||
105485538|NCT04221230|363788521|FG001|Overall Study|Protocol Violation|2|||
105485539|NCT04221230|363788520|FG000|Overall Study|Adverse Event|0|||
105485540|NCT04221230|363788521|FG001|Overall Study|Adverse Event|8|||
105485541|NCT04221230|363788520|FG000|Overall Study|Physician Decision|1|||
105485542|NCT04221230|363788521|FG001|Overall Study|Physician Decision|0|||
105485543|NCT04221230|363788520|FG000|Overall Study|Withdrawal by Subject|13|||
105485544|NCT04221230|363788521|FG001|Overall Study|Withdrawal by Subject|11|||
105485545|NCT04221230|363788520|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105485546|NCT04221230|363788521|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105485547|NCT04221230|363788520|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105485548|NCT04221230|363788521|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
105485549|NCT04221230|363788520|FG000|Overall Study|Pregnancy|0|||
105570942|NCT00462670|364089577|FG001|Overall Study|Resolution of signs and symptoms|2|||
105570943|NCT02110732|364089578|FG000|Overall Study|Physician Decision|5|||
105570944|NCT02110732|364089579|FG001|Overall Study|Physician Decision|2|||
105570945|NCT02110732|364089578|FG000|Overall Study|Lost to Follow-up|1|||
105570946|NCT02110732|364089579|FG001|Overall Study|Lost to Follow-up|1|||
105570947|NCT01642602|364089580|FG000|Overall Study|Adverse Event|2|||
105570948|NCT00871403|364089581|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
105570949|NCT00871403|364089582|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
105570950|NCT00871403|364089583|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
105570951|NCT00871403|364089581|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
105570952|NCT00871403|364089582|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
105570953|NCT00871403|364089583|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
105570954|NCT00871403|364089581|FG000|Combination Treatment Phase|Adverse Event|0|||
105570955|NCT00871403|364089582|FG001|Combination Treatment Phase|Adverse Event|17|||
105570956|NCT00871403|364089583|FG002|Combination Treatment Phase|Adverse Event|2|||
105570957|NCT00871403|364089581|FG000|Combination Treatment Phase|Disease Progression|0|||
105570958|NCT00871403|364089582|FG001|Combination Treatment Phase|Disease Progression|8|||
105570959|NCT00871403|364089583|FG002|Combination Treatment Phase|Disease Progression|5|||
105570960|NCT00871403|364089581|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
105570961|NCT00871403|364089582|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
105570962|NCT00871403|364089583|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
105808137|NCT00614055|364954902|FG000|Overall Study|Unclassified|1|||
105808138|NCT00614055|364954903|FG001|Overall Study|Unclassified|4|||
105808139|NCT00614055|364954904|FG002|Overall Study|Unclassified|2|||
105361024|NCT01064414|363328137|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
105808140|NCT00096265|364954915|FG000|Overall Study|Ineligible|1|||
105808141|NCT00096265|364954916|FG001|Overall Study|Ineligible|0|||
105808142|NCT00096265|364954917|FG002|Overall Study|Ineligible|0|||
105570963|NCT00871403|364089581|FG000|Combination Treatment Phase|Physician Decision|0|||
105570964|NCT00871403|364089582|FG001|Combination Treatment Phase|Physician Decision|1|||
105570965|NCT00871403|364089583|FG002|Combination Treatment Phase|Physician Decision|3|||
105570966|NCT00871403|364089581|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
105570967|NCT00871403|364089582|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
105570968|NCT00871403|364089583|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
105570969|NCT00871403|364089581|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
105570970|NCT00871403|364089582|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
105570971|NCT00871403|364089583|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
105570972|NCT03075904|364089584|FG000|Overall Study|Physician Decision|3|||
105808143|NCT02891200|364954918|FG000|Overall Study|Lost to Follow-up|31|||
105808144|NCT02891200|364954919|FG001|Overall Study|Lost to Follow-up|36|||
105808145|NCT02891200|364954918|FG000|Overall Study|Death|10|||
105808146|NCT02891200|364954919|FG001|Overall Study|Death|9|||
105570973|NCT03075904|364089584|FG000|Overall Study|Need for Medication not Permitted|1|||
105570974|NCT02367716|364089585|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
105570975|NCT01993823|364089586|FG000|Overall Study|Requested by the patient|6|||
105570976|NCT01993823|364089587|FG001|Overall Study|Requested by the patient|11|||
105570977|NCT01993823|364089586|FG000|Overall Study|Protocol Violation|0|||
105570978|NCT01993823|364089587|FG001|Overall Study|Protocol Violation|1|||
105570979|NCT01993823|364089586|FG000|Overall Study|Lost to Follow-up|1|||
105570980|NCT01993823|364089587|FG001|Overall Study|Lost to Follow-up|4|||
105570981|NCT00927355|364089588|FG000|Overall Study|Adverse Event|1|||
105570982|NCT00927355|364089589|FG001|Overall Study|Adverse Event|1|||
105570983|NCT03066622|364089590|FG000|Overall Study|Lost to Follow-up|24|||
105570984|NCT03066622|364089591|FG001|Overall Study|Lost to Follow-up|25|||
105570985|NCT03066622|364089590|FG000|Overall Study|Withdrawal by Subject|2|||
105570986|NCT03066622|364089591|FG001|Overall Study|Withdrawal by Subject|1|||
105570987|NCT02567825|364089592|FG000|Overall Study|No follow-up post-randomization|5|||
105570988|NCT02567825|364089593|FG001|Overall Study|No follow-up post-randomization|1|||
105570989|NCT02567825|364089592|FG000|Overall Study|Follow-up less than 23 months|16|||
105570990|NCT02567825|364089593|FG001|Overall Study|Follow-up less than 23 months|20|||
105570991|NCT02281760|364089595|FG000|Overall Study|Withdrawal by Subject|1|||
105570992|NCT00154310|364089596|FG000|Overall Study|Adverse Event|19|||
105570993|NCT00154310|364089597|FG001|Overall Study|Adverse Event|9|||
105570994|NCT00154310|364089596|FG000|Overall Study|Lack of Efficacy|5|||
105570995|NCT00154310|364089597|FG001|Overall Study|Lack of Efficacy|4|||
105570996|NCT00154310|364089596|FG000|Overall Study|Protocol Violation|4|||
105570997|NCT00154310|364089597|FG001|Overall Study|Protocol Violation|2|||
105570998|NCT00154310|364089596|FG000|Overall Study|Withdrawal by Subject|9|||
105570999|NCT00154310|364089597|FG001|Overall Study|Withdrawal by Subject|3|||
105571000|NCT00154310|364089596|FG000|Overall Study|Lost to Follow-up|0|||
105571001|NCT00154310|364089597|FG001|Overall Study|Lost to Follow-up|8|||
105571002|NCT00154310|364089596|FG000|Overall Study|Administrative problems|0|||
105571003|NCT00154310|364089597|FG001|Overall Study|Administrative problems|1|||
105571004|NCT00154310|364089596|FG000|Overall Study|Death|0|||
105808147|NCT02891200|364954918|FG000|Overall Study|Withdrawal by Subject|1|||
105571005|NCT00154310|364089597|FG001|Overall Study|Death|1|||
105571006|NCT03101241|364089598|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
105571007|NCT03101241|364089599|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
105571008|NCT03101241|364089598|FG000|Overall Study|Participant withdrew consent|3|||
105571009|NCT03101241|364089599|FG001|Overall Study|Participant withdrew consent|1|||
105571010|NCT03101241|364089598|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
105571011|NCT03101241|364089599|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
105571012|NCT03101241|364089598|FG000|Overall Study|Lost to Follow-up|2|||
105571013|NCT03101241|364089599|FG001|Overall Study|Lost to Follow-up|0|||
105571014|NCT03101241|364089598|FG000|Overall Study|Lack of Efficacy|0|||
105571015|NCT03101241|364089599|FG001|Overall Study|Lack of Efficacy|1|||
105571016|NCT03101241|364089598|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
105571017|NCT03101241|364089599|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
105571018|NCT03592277|364089600|FG000|Overall Study|Withdrawal by Subject|6|||
105571019|NCT03592277|364089601|FG001|Overall Study|Withdrawal by Subject|8|||
105571020|NCT04581200|364089602|FG000|Overall Study|Lost to Follow-up|6|||
105571021|NCT04581200|364089603|FG001|Overall Study|Lost to Follow-up|5|||
105571022|NCT01781390|364089604|FG000|Overall Study|Withdrawal of Consent|0|||
105571023|NCT01781390|364089605|FG001|Overall Study|Withdrawal of Consent|3|||
105571024|NCT01781390|364089606|FG002|Overall Study|Withdrawal of Consent|1|||
105571025|NCT01781390|364089604|FG000|Overall Study|Lost to Follow-up|1|||
105571026|NCT01781390|364089605|FG001|Overall Study|Lost to Follow-up|1|||
105571027|NCT01781390|364089606|FG002|Overall Study|Lost to Follow-up|1|||
105571028|NCT01781390|364089604|FG000|Overall Study|Adverse Event|1|||
105571029|NCT01781390|364089605|FG001|Overall Study|Adverse Event|2|||
105571030|NCT01781390|364089606|FG002|Overall Study|Adverse Event|1|||
105571031|NCT01781390|364089604|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
105571032|NCT01781390|364089605|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
105571033|NCT01781390|364089606|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
105571034|NCT04488003|364089607|FG000|Assessed for Eligibility|Screen Failure|24|||
105571035|NCT04488003|364089608|FG001|Assessed for Eligibility|Screen Failure|0|||
105571036|NCT04488003|364089609|FG002|Assessed for Eligibility|Screen Failure|0|||
105808148|NCT02891200|364954919|FG001|Overall Study|Withdrawal by Subject|4|||
105571037|NCT04488003|364089607|FG000|Assessed for Eligibility|Adverse Event|1|||
105761638|NCT04134728|364781387|FG003|Overall Study|Informed Consent Withdrawn|1|||
105808149|NCT02232074|364954920|FG000|Overall Study|Withdrawal by Subject|5|||
105808150|NCT02232074|364954921|FG001|Overall Study|Withdrawal by Subject|3|||
105808151|NCT02232074|364954920|FG000|Overall Study|No legal concerns at baseline|36|||
105808152|NCT02232074|364954921|FG001|Overall Study|No legal concerns at baseline|41|||
105808153|NCT02232074|364954920|FG000|Overall Study|deemed ineligible|0|||
105808154|NCT02232074|364954921|FG001|Overall Study|deemed ineligible|1|||
105808155|NCT04820842|364954922|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
105808156|NCT04820842|364954923|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
105808157|NCT04820842|364954924|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
105808158|NCT04820842|364954925|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
105808159|NCT04820842|364954926|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
105808160|NCT04820842|364954927|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
105761639|NCT04134728|364781388|FG004|Overall Study|Informed Consent Withdrawn|1|||
105808161|NCT04820842|364954928|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
105808162|NCT04820842|364954922|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
105808163|NCT04820842|364954923|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
105808164|NCT04820842|364954924|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
105808165|NCT04820842|364954925|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808166|NCT04820842|364954926|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808167|NCT04820842|364954927|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808168|NCT04820842|364954928|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808169|NCT04820842|364954922|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
105808170|NCT04820842|364954923|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
105761640|NCT04134728|364781389|FG005|Overall Study|Informed Consent Withdrawn|0|||
105761641|NCT04134728|364781384|FG000|Overall Study|Physician Decision|2|||
105761642|NCT04134728|364781385|FG001|Overall Study|Physician Decision|0|||
105761643|NCT04134728|364781386|FG002|Overall Study|Physician Decision|0|||
105761644|NCT04134728|364781387|FG003|Overall Study|Physician Decision|0|||
105761645|NCT04134728|364781388|FG004|Overall Study|Physician Decision|0|||
105761646|NCT04134728|364781389|FG005|Overall Study|Physician Decision|0|||
105808171|NCT04820842|364954924|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
105808172|NCT04820842|364954925|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
105808173|NCT04820842|364954926|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
105808174|NCT04820842|364954927|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
105808175|NCT04820842|364954928|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
105808176|NCT04820842|364954922|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808177|NCT04820842|364954923|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808178|NCT04820842|364954924|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808179|NCT04820842|364954925|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
105808180|NCT04820842|364954926|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808181|NCT04820842|364954927|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808182|NCT04820842|364954928|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
105808183|NCT01579474|364954929|FG000|Overall Study|Adverse Event|1|||
105808184|NCT01579474|364954930|FG001|Overall Study|Adverse Event|13|||
105808185|NCT01579474|364954931|FG002|Overall Study|Adverse Event|2|||
105808186|NCT01579474|364954932|FG003|Overall Study|Adverse Event|0|||
105808187|NCT01579474|364954933|FG004|Overall Study|Adverse Event|0|||
105808188|NCT01579474|364954934|FG005|Overall Study|Adverse Event|1|||
105808189|NCT01579474|364954929|FG000|Overall Study|Lack of Efficacy|1|||
105808190|NCT01579474|364954930|FG001|Overall Study|Lack of Efficacy|0|||
105808191|NCT01579474|364954931|FG002|Overall Study|Lack of Efficacy|0|||
105808192|NCT01579474|364954932|FG003|Overall Study|Lack of Efficacy|0|||
105808193|NCT01579474|364954933|FG004|Overall Study|Lack of Efficacy|1|||
105761647|NCT04134728|364781384|FG000|Overall Study|Lost to Follow-up|1|||
105761648|NCT04134728|364781385|FG001|Overall Study|Lost to Follow-up|2|||
105761649|NCT04134728|364781386|FG002|Overall Study|Lost to Follow-up|1|||
105761650|NCT04134728|364781387|FG003|Overall Study|Lost to Follow-up|0|||
105761651|NCT04134728|364781388|FG004|Overall Study|Lost to Follow-up|0|||
105761652|NCT04134728|364781389|FG005|Overall Study|Lost to Follow-up|1|||
105761653|NCT04134728|364781384|FG000|Overall Study|Investigator Site Closed|0|||
105761654|NCT04134728|364781385|FG001|Overall Study|Investigator Site Closed|1|||
105761655|NCT04134728|364781386|FG002|Overall Study|Investigator Site Closed|1|||
105761656|NCT04134728|364781387|FG003|Overall Study|Investigator Site Closed|0|||
105761657|NCT04134728|364781388|FG004|Overall Study|Investigator Site Closed|0|||
105761658|NCT04134728|364781389|FG005|Overall Study|Investigator Site Closed|0|||
105761659|NCT00379236|364781390|FG000|Double-blind|Adverse Event|11|||
105761660|NCT00379236|364781391|FG001|Double-blind|Adverse Event|6|||
105761661|NCT00379236|364781392|FG002|Double-blind|Adverse Event|0|||
105761662|NCT00379236|364781390|FG000|Double-blind|Protocol Violation|3|||
105761663|NCT00379236|364781391|FG001|Double-blind|Protocol Violation|3|||
105761664|NCT00379236|364781392|FG002|Double-blind|Protocol Violation|0|||
105761665|NCT00379236|364781390|FG000|Double-blind|Withdrawal by Subject|12|||
105761666|NCT00379236|364781391|FG001|Double-blind|Withdrawal by Subject|13|||
105761667|NCT00379236|364781392|FG002|Double-blind|Withdrawal by Subject|0|||
105761668|NCT00379236|364781390|FG000|Double-blind|Lost to Follow-up|4|||
105761669|NCT00379236|364781391|FG001|Double-blind|Lost to Follow-up|3|||
105761670|NCT00379236|364781392|FG002|Double-blind|Lost to Follow-up|0|||
105761671|NCT00379236|364781390|FG000|Double-blind|Use of exclusionary medication|1|||
105761672|NCT00379236|364781391|FG001|Double-blind|Use of exclusionary medication|2|||
105761673|NCT00379236|364781392|FG002|Double-blind|Use of exclusionary medication|0|||
105761674|NCT00379236|364781390|FG000|Double-blind|Other|3|||
105761675|NCT00379236|364781391|FG001|Double-blind|Other|7|||
105761676|NCT00379236|364781392|FG002|Double-blind|Other|0|||
105761677|NCT00379236|364781390|FG000|Double-blind|Data could not be retrieved|2|||
105761678|NCT00379236|364781391|FG001|Double-blind|Data could not be retrieved|2|||
105761679|NCT00379236|364781392|FG002|Double-blind|Data could not be retrieved|0|||
105761680|NCT00379236|364781390|FG000|Open-label Extension|Adverse Event|0|||
105761681|NCT00379236|364781391|FG001|Open-label Extension|Adverse Event|0|||
105761682|NCT00379236|364781392|FG002|Open-label Extension|Adverse Event|13|||
105761683|NCT00379236|364781390|FG000|Open-label Extension|Protocol Violation|0|||
105761684|NCT00379236|364781391|FG001|Open-label Extension|Protocol Violation|0|||
105761685|NCT00379236|364781392|FG002|Open-label Extension|Protocol Violation|7|||
105761686|NCT00379236|364781390|FG000|Open-label Extension|Withdrawal by Subject|0|||
105761687|NCT00379236|364781391|FG001|Open-label Extension|Withdrawal by Subject|0|||
105761688|NCT00379236|364781392|FG002|Open-label Extension|Withdrawal by Subject|13|||
105761689|NCT00379236|364781390|FG000|Open-label Extension|Lost to Follow-up|0|||
105761690|NCT00379236|364781391|FG001|Open-label Extension|Lost to Follow-up|0|||
105761691|NCT00379236|364781392|FG002|Open-label Extension|Lost to Follow-up|12|||
105761692|NCT00379236|364781390|FG000|Open-label Extension|Use of exclusionary medication|0|||
105761693|NCT00379236|364781391|FG001|Open-label Extension|Use of exclusionary medication|0|||
105808194|NCT01579474|364954934|FG005|Overall Study|Lack of Efficacy|0|||
105808195|NCT01579474|364954929|FG000|Overall Study|Withdrawal by Subject|1|||
105808196|NCT01579474|364954930|FG001|Overall Study|Withdrawal by Subject|0|||
105808197|NCT01579474|364954931|FG002|Overall Study|Withdrawal by Subject|0|||
105808198|NCT01579474|364954932|FG003|Overall Study|Withdrawal by Subject|0|||
105808199|NCT01579474|364954933|FG004|Overall Study|Withdrawal by Subject|0|||
105808200|NCT01579474|364954934|FG005|Overall Study|Withdrawal by Subject|0|||
105808201|NCT00130520|364954935|FG000|Overall Study|Adverse Event|11|||
105808202|NCT00130520|364954935|FG000|Overall Study|Death|1|||
105808203|NCT00130520|364954935|FG000|Overall Study|Physician Decision|1|||
105808204|NCT00130520|364954935|FG000|Overall Study|Withdrawal by Subject|1|||
105808205|NCT00130520|364954935|FG000|Overall Study|Disease Progression|23|||
105808206|NCT00130520|364954935|FG000|Overall Study|Protocol non-compliance|1|||
105808207|NCT00130520|364954935|FG000|Overall Study|Did not meet re-treatment criteria|1|||
105808208|NCT02006706|364954943|FG000|Overall Study|Lost to Follow-up|1|||
105808209|NCT05487456|364954944|FG000|Overall Study|Withdrawal by Subject|0|||
105808210|NCT05487456|364954945|FG001|Overall Study|Withdrawal by Subject|0|||
105808211|NCT05487456|364954946|FG002|Overall Study|Withdrawal by Subject|1|||
105808212|NCT05487456|364954947|FG003|Overall Study|Withdrawal by Subject|0|||
105808213|NCT01844583|364954948|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
105808214|NCT01844583|364954949|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
105808215|NCT01625377|364954950|FG000|Overall Study|Death|1|||
105808216|NCT01625377|364954951|FG001|Overall Study|Death|1|||
105808217|NCT01625377|364954950|FG000|Overall Study|Administrative Problem|1|||
105808218|NCT01625377|364954951|FG001|Overall Study|Administrative Problem|1|||
105808219|NCT01625377|364954950|FG000|Overall Study|Protocol Violation|0|||
105808220|NCT01625377|364954951|FG001|Overall Study|Protocol Violation|3|||
105808221|NCT01625377|364954950|FG000|Overall Study|Adverse Event|3|||
105808222|NCT01625377|364954951|FG001|Overall Study|Adverse Event|16|||
105808223|NCT01625377|364954950|FG000|Overall Study|Graft loss|1|||
105808224|NCT01625377|364954951|FG001|Overall Study|Graft loss|0|||
105808225|NCT01625377|364954950|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105808226|NCT01625377|364954951|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105808227|NCT01625377|364954950|FG000|Overall Study|Abnormal laboratory values|1|||
105808228|NCT01625377|364954951|FG001|Overall Study|Abnormal laboratory values|0|||
105808229|NCT03294538|364954952|FG000|Overall Study|Adverse Event|0|||
105808230|NCT03294538|364954953|FG001|Overall Study|Adverse Event|1|||
105808231|NCT03294538|364954954|FG002|Overall Study|Adverse Event|1|||
105808232|NCT03294538|364954952|FG000|Overall Study|Lost to Follow-up|1|||
105808233|NCT03294538|364954953|FG001|Overall Study|Lost to Follow-up|0|||
105808234|NCT03294538|364954954|FG002|Overall Study|Lost to Follow-up|0|||
105808235|NCT03294538|364954952|FG000|Overall Study|Outside of Visit Window|4|||
105808236|NCT03294538|364954953|FG001|Overall Study|Outside of Visit Window|4|||
105808237|NCT03294538|364954954|FG002|Overall Study|Outside of Visit Window|1|||
105808238|NCT02207621|364954956|FG000|Overall Study|Adverse Event|71|||
105808239|NCT02207621|364954957|FG001|Overall Study|Adverse Event|15|||
105808240|NCT02207621|364954958|FG002|Overall Study|Adverse Event|132|||
105808241|NCT02207621|364954956|FG000|Overall Study|Withdrawal by Subject|9|||
105808242|NCT02207621|364954957|FG001|Overall Study|Withdrawal by Subject|9|||
105808243|NCT02207621|364954958|FG002|Overall Study|Withdrawal by Subject|13|||
105808244|NCT02207621|364954956|FG000|Overall Study|Non-Compliant|3|||
105808245|NCT02207621|364954957|FG001|Overall Study|Non-Compliant|3|||
105808246|NCT02207621|364954958|FG002|Overall Study|Non-Compliant|1|||
105808247|NCT02207621|364954956|FG000|Overall Study|Lost to Follow-up|1|||
105808248|NCT02207621|364954957|FG001|Overall Study|Lost to Follow-up|0|||
105808249|NCT02207621|364954958|FG002|Overall Study|Lost to Follow-up|3|||
105808250|NCT02207621|364954956|FG000|Overall Study|Lack of Efficacy|10|||
105808251|NCT02207621|364954957|FG001|Overall Study|Lack of Efficacy|2|||
105808252|NCT02207621|364954958|FG002|Overall Study|Lack of Efficacy|4|||
105808253|NCT02207621|364954956|FG000|Overall Study|Disallowed Concurrent Medication|2|||
105808254|NCT02207621|364954957|FG001|Overall Study|Disallowed Concurrent Medication|5|||
105808255|NCT02207621|364954958|FG002|Overall Study|Disallowed Concurrent Medication|2|||
105808256|NCT02207621|364954956|FG000|Overall Study|Physician Decision|1|||
105808257|NCT02207621|364954957|FG001|Overall Study|Physician Decision|2|||
105808258|NCT02207621|364954958|FG002|Overall Study|Physician Decision|2|||
105808259|NCT02207621|364954956|FG000|Overall Study|Protocol Violation|4|||
105808260|NCT02207621|364954957|FG001|Overall Study|Protocol Violation|10|||
105808261|NCT02207621|364954958|FG002|Overall Study|Protocol Violation|6|||
105808262|NCT02207621|364954956|FG000|Overall Study|Death|2|||
105808263|NCT02207621|364954957|FG001|Overall Study|Death|0|||
105808264|NCT02207621|364954958|FG002|Overall Study|Death|0|||
105808265|NCT02207621|364954956|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
105808266|NCT02207621|364954957|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
105808267|NCT02207621|364954958|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
105808268|NCT00958256|364954961|FG000|Overall Study|Adverse Event|3|||
105808269|NCT03036579|364954968|FG000|2 Years|Lost to Follow-up|1|||
105808270|NCT03036579|364954969|FG001|2 Years|Lost to Follow-up|0|||
105808271|NCT03036579|364954968|FG000|3 Years|Lost to Follow-up|0|||
105808272|NCT03036579|364954969|FG001|3 Years|Lost to Follow-up|1|||
105808273|NCT01090765|364954970|FG000|Overall Study|Patient withdrew consent|0|||
105808274|NCT01090765|364954971|FG001|Overall Study|Patient withdrew consent|0|||
105808275|NCT01090765|364954972|FG002|Overall Study|Patient withdrew consent|0|||
105808276|NCT01090765|364954973|FG003|Overall Study|Patient withdrew consent|0|||
105808277|NCT01090765|364954974|FG004|Overall Study|Patient withdrew consent|1|||
105808278|NCT01090765|364954975|FG005|Overall Study|Patient withdrew consent|1|||
105808279|NCT01090765|364954970|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
105808280|NCT01090765|364954971|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
105808281|NCT01090765|364954972|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
105808282|NCT01090765|364954973|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
105808283|NCT01090765|364954974|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
105808284|NCT01090765|364954975|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
105808285|NCT01090765|364954970|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
105808286|NCT01090765|364954971|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
105808287|NCT01090765|364954972|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
105808288|NCT01090765|364954973|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
105808289|NCT01090765|364954974|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
105808290|NCT01090765|364954975|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
105808291|NCT02398188|364954978|FG000|Overall Study|Adverse Event|2|||
105485550|NCT04221230|363788521|FG001|Overall Study|Pregnancy|1|||
105485551|NCT04221230|363788520|FG000|Overall Study|Other|1|||
105485552|NCT04221230|363788521|FG001|Overall Study|Other|2|||
105485553|NCT03036800|363788528|FG000|Overall Study|Protocol Violation|1|||
105485554|NCT03036800|363788529|FG001|Overall Study|Protocol Violation|0|||
105485555|NCT03036800|363788528|FG000|Overall Study|Non-compliance|1|||
105485556|NCT03036800|363788529|FG001|Overall Study|Non-compliance|0|||
105485557|NCT03036800|363788528|FG000|Overall Study|Lost to Follow-up|1|||
105571038|NCT04488003|364089608|FG001|Assessed for Eligibility|Adverse Event|0|||
105571039|NCT04488003|364089609|FG002|Assessed for Eligibility|Adverse Event|0|||
105808292|NCT02398188|364954979|FG001|Overall Study|Adverse Event|3|||
105808293|NCT02398188|364954978|FG000|Overall Study|Lost to Follow-up|5|||
105808294|NCT02398188|364954979|FG001|Overall Study|Lost to Follow-up|0|||
105808295|NCT02398188|364954978|FG000|Overall Study|Non-compliance|4|||
105808296|NCT02398188|364954979|FG001|Overall Study|Non-compliance|4|||
105808297|NCT02398188|364954978|FG000|Overall Study|Protocol Violation|6|||
105808298|NCT02398188|364954979|FG001|Overall Study|Protocol Violation|10|||
105808299|NCT02398188|364954978|FG000|Overall Study|Sponsor Decision|2|||
105808300|NCT02398188|364954979|FG001|Overall Study|Sponsor Decision|1|||
105808301|NCT02398188|364954978|FG000|Overall Study|Pregnancy|1|||
105808302|NCT02398188|364954979|FG001|Overall Study|Pregnancy|0|||
105808303|NCT02398188|364954978|FG000|Overall Study|Withdrawal by Subject|7|||
105485558|NCT03036800|363788529|FG001|Overall Study|Lost to Follow-up|0|||
105485559|NCT03036800|363788528|FG000|Overall Study|Death|1|||
105808304|NCT02398188|364954979|FG001|Overall Study|Withdrawal by Subject|16|||
105808305|NCT00782509|364954980|FG000|Overall Study|Adverse Event|20|||
105808306|NCT00782509|364954981|FG001|Overall Study|Adverse Event|10|||
105808307|NCT00782509|364954982|FG002|Overall Study|Adverse Event|20|||
105808308|NCT00782509|364954980|FG000|Overall Study|Lost to Follow-up|1|||
105808309|NCT00782509|364954981|FG001|Overall Study|Lost to Follow-up|2|||
105808310|NCT00782509|364954982|FG002|Overall Study|Lost to Follow-up|3|||
105808311|NCT00782509|364954980|FG000|Overall Study|Withdrawal by Subject|3|||
105808312|NCT00782509|364954981|FG001|Overall Study|Withdrawal by Subject|5|||
105808313|NCT00782509|364954982|FG002|Overall Study|Withdrawal by Subject|8|||
105808314|NCT00782509|364954980|FG000|Overall Study|Non compliance with protocol|2|||
105571040|NCT04488003|364089607|FG000|Assessed for Eligibility|Death|1|||
105571041|NCT04488003|364089608|FG001|Assessed for Eligibility|Death|0|||
105571042|NCT04488003|364089609|FG002|Assessed for Eligibility|Death|0|||
105571043|NCT04488003|364089607|FG000|Assessed for Eligibility|Physician Decision|1|||
105571044|NCT04488003|364089608|FG001|Assessed for Eligibility|Physician Decision|0|||
105571045|NCT04488003|364089609|FG002|Assessed for Eligibility|Physician Decision|0|||
105571046|NCT04488003|364089607|FG000|Allocated to Treatment|Progressive Disease|51|||
105571047|NCT04488003|364089608|FG001|Allocated to Treatment|Progressive Disease|0|||
105571048|NCT04488003|364089609|FG002|Allocated to Treatment|Progressive Disease|0|||
105571049|NCT04488003|364089607|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
105571050|NCT04488003|364089608|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
105571051|NCT04488003|364089609|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
105571052|NCT04488003|364089607|FG000|Allocated to Treatment|Adverse Event|6|||
105571053|NCT04488003|364089608|FG001|Allocated to Treatment|Adverse Event|0|||
105571054|NCT04488003|364089609|FG002|Allocated to Treatment|Adverse Event|0|||
105571055|NCT04488003|364089607|FG000|Allocated to Treatment|Other|5|||
105571056|NCT04488003|364089608|FG001|Allocated to Treatment|Other|0|||
105571057|NCT04488003|364089609|FG002|Allocated to Treatment|Other|0|||
105571058|NCT04488003|364089607|FG000|Allocated to Treatment|Physician Decision|4|||
105571059|NCT04488003|364089608|FG001|Allocated to Treatment|Physician Decision|0|||
105571060|NCT04488003|364089609|FG002|Allocated to Treatment|Physician Decision|0|||
105571061|NCT04488003|364089607|FG000|Allocated to Treatment|Death|4|||
105571062|NCT04488003|364089608|FG001|Allocated to Treatment|Death|0|||
105571063|NCT04488003|364089609|FG002|Allocated to Treatment|Death|0|||
105571064|NCT01346514|364089610|FG000|Overall Study|Lost to Follow-up|19|||
105571065|NCT01346514|364089611|FG001|Overall Study|Lost to Follow-up|30|||
105571066|NCT01346514|364089610|FG000|Overall Study|Withdrawal by Subject|7|||
105571067|NCT01346514|364089611|FG001|Overall Study|Withdrawal by Subject|3|||
105571068|NCT01346514|364089610|FG000|Overall Study|Death|3|||
105571069|NCT01346514|364089611|FG001|Overall Study|Death|4|||
105571070|NCT00979602|364089612|FG000|Overall Study|Serious Adverse Event|5|||
105571071|NCT00979602|364089613|FG001|Overall Study|Serious Adverse Event|3|||
105571072|NCT00979602|364089612|FG000|Overall Study|Protocol Violation|3|||
105571073|NCT00979602|364089613|FG001|Overall Study|Protocol Violation|0|||
105571074|NCT00979602|364089612|FG000|Overall Study|Withdrawal by Subject|31|||
105571075|NCT00979602|364089613|FG001|Overall Study|Withdrawal by Subject|25|||
105571076|NCT00979602|364089612|FG000|Overall Study|Lost to Follow-up|100|||
105571077|NCT00979602|364089613|FG001|Overall Study|Lost to Follow-up|96|||
105571078|NCT00979602|364089612|FG000|Overall Study|Migrated/moved from study area|3|||
105571079|NCT00979602|364089613|FG001|Overall Study|Migrated/moved from study area|6|||
105571080|NCT00979602|364089612|FG000|Overall Study|Others|3|||
105571081|NCT00979602|364089613|FG001|Overall Study|Others|3|||
105571082|NCT05796518|364089621|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
105571083|NCT03500640|364089622|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
105571084|NCT03500640|364089623|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
105571085|NCT03500640|364089624|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
105571086|NCT03500640|364089622|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
105571087|NCT03500640|364089623|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
105571088|NCT03500640|364089624|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
105571089|NCT03500640|364089622|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
105571090|NCT03500640|364089623|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
105571091|NCT03500640|364089624|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
105571092|NCT03500640|364089622|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
105571093|NCT03500640|364089623|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
105571094|NCT03500640|364089624|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
105571095|NCT03500640|364089622|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
105571096|NCT03500640|364089623|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
105571097|NCT03500640|364089624|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
105571098|NCT03500640|364089622|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
105571099|NCT03500640|364089623|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
105571100|NCT03500640|364089624|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
105808315|NCT00782509|364954981|FG001|Overall Study|Non compliance with protocol|0|||
105808316|NCT00782509|364954982|FG002|Overall Study|Non compliance with protocol|0|||
105808317|NCT00782509|364954980|FG000|Overall Study|Other reasons not stated above|5|||
105571101|NCT03500640|364089622|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
105571102|NCT03500640|364089623|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
105571103|NCT03500640|364089624|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
105571104|NCT03500640|364089622|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
105571105|NCT03500640|364089623|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
105571106|NCT03500640|364089624|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
105571107|NCT03500640|364089622|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
105571108|NCT03500640|364089623|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
105571109|NCT03500640|364089624|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
105571110|NCT03500640|364089622|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
105571111|NCT03500640|364089623|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
105571112|NCT03500640|364089624|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
105571113|NCT02513563|364089627|FG000|Overall Study|Death|4|||
105571114|NCT02513563|364089627|FG000|Overall Study|Withdrawal by Subject|4|||
105571115|NCT02513563|364089627|FG000|Overall Study|Physician Decision|1|||
105571116|NCT02521285|364089628|FG000|Overall Study|Lost to Follow-up|1|||
105571117|NCT02521285|364089629|FG001|Overall Study|Lost to Follow-up|1|||
105571118|NCT02521285|364089628|FG000|Overall Study|Withdrawal by Subject|1|||
105571119|NCT02521285|364089629|FG001|Overall Study|Withdrawal by Subject|1|||
105571120|NCT02521285|364089628|FG000|Overall Study|Adverse Event|0|||
105571121|NCT02521285|364089629|FG001|Overall Study|Adverse Event|1|||
105571122|NCT02954458|364089630|FG000|Overall Study|Adverse Event|0|||
105571123|NCT02954458|364089631|FG001|Overall Study|Adverse Event|0|||
105571124|NCT02954458|364089632|FG002|Overall Study|Adverse Event|0|||
105571125|NCT02954458|364089633|FG003|Overall Study|Adverse Event|1|||
105571126|NCT02954458|364089630|FG000|Overall Study|Withdrawal by Subject|0|||
105808318|NCT00782509|364954981|FG001|Overall Study|Other reasons not stated above|2|||
105808319|NCT00782509|364954982|FG002|Overall Study|Other reasons not stated above|3|||
105808320|NCT00782509|364954980|FG000|Overall Study|Lack of Efficacy|10|||
105808321|NCT00782509|364954981|FG001|Overall Study|Lack of Efficacy|5|||
105808322|NCT00782509|364954982|FG002|Overall Study|Lack of Efficacy|2|||
105808323|NCT04041570|364954988|FG000|Overall Study|Moved from Area|0|||
105808324|NCT04041570|364954989|FG001|Overall Study|Moved from Area|2|||
105808325|NCT02419313|364954990|FG000|First Intervention|Lost to Follow-up|2|||
105808326|NCT02419313|364954991|FG001|First Intervention|Lost to Follow-up|0|||
105808327|NCT02419313|364954990|FG000|Second Intervention|Lost to Follow-up|1|||
105808328|NCT02419313|364954991|FG001|Second Intervention|Lost to Follow-up|0|||
105808329|NCT02204371|364954992|FG000|Overall Study|Adverse Event|1|||
105808330|NCT01180244|364954993|FG000|Overall Study|Lack of Efficacy|0|||
105808331|NCT01180244|364954994|FG001|Overall Study|Lack of Efficacy|7|||
105808332|NCT01180244|364954993|FG000|Overall Study|Physician Decision|3|||
105808333|NCT01180244|364954994|FG001|Overall Study|Physician Decision|0|||
105808334|NCT01180244|364954993|FG000|Overall Study|Adverse Event|1|||
105808335|NCT01180244|364954994|FG001|Overall Study|Adverse Event|0|||
105808336|NCT01180244|364954993|FG000|Overall Study|Withdrawal by Subject|0|||
105808337|NCT01180244|364954994|FG001|Overall Study|Withdrawal by Subject|1|||
105808338|NCT01180244|364954993|FG000|Overall Study|Protocol Violation|1|||
105808339|NCT01180244|364954994|FG001|Overall Study|Protocol Violation|0|||
105808340|NCT01180244|364954993|FG000|Overall Study|Lost to Follow-up|1|||
105808341|NCT01180244|364954994|FG001|Overall Study|Lost to Follow-up|0|||
105808342|NCT00384033|364954995|FG000|Overall Study|Adverse Event|10|||
105808343|NCT00384033|364954996|FG001|Overall Study|Adverse Event|8|||
105808344|NCT00384033|364954997|FG002|Overall Study|Adverse Event|11|||
105571127|NCT02954458|364089631|FG001|Overall Study|Withdrawal by Subject|0|||
105571128|NCT02954458|364089632|FG002|Overall Study|Withdrawal by Subject|0|||
105571129|NCT02954458|364089633|FG003|Overall Study|Withdrawal by Subject|1|||
105571130|NCT02954458|364089630|FG000|Overall Study|Physician Decision|0|||
105571131|NCT02954458|364089631|FG001|Overall Study|Physician Decision|0|||
105571132|NCT02954458|364089632|FG002|Overall Study|Physician Decision|1|||
105571133|NCT02954458|364089633|FG003|Overall Study|Physician Decision|1|||
105571134|NCT02954458|364089630|FG000|Overall Study|Lost to Follow-up|1|||
105571135|NCT02954458|364089631|FG001|Overall Study|Lost to Follow-up|0|||
105571136|NCT02954458|364089632|FG002|Overall Study|Lost to Follow-up|0|||
105571137|NCT02954458|364089633|FG003|Overall Study|Lost to Follow-up|1|||
105571138|NCT02954458|364089630|FG000|Overall Study|Death|0|||
105571139|NCT02954458|364089631|FG001|Overall Study|Death|0|||
105571140|NCT02954458|364089632|FG002|Overall Study|Death|0|||
105571141|NCT02954458|364089633|FG003|Overall Study|Death|1|||
105571142|NCT02954458|364089630|FG000|Overall Study|Other|0|||
105571143|NCT02954458|364089631|FG001|Overall Study|Other|0|||
105571144|NCT02954458|364089632|FG002|Overall Study|Other|0|||
105571145|NCT02954458|364089633|FG003|Overall Study|Other|7|||
105808345|NCT00384033|364954998|FG003|Overall Study|Adverse Event|20|||
105808346|NCT00384033|364954995|FG000|Overall Study|Failed to return|1|||
105808347|NCT00384033|364954996|FG001|Overall Study|Failed to return|3|||
105808348|NCT00384033|364954997|FG002|Overall Study|Failed to return|2|||
105808349|NCT00384033|364954998|FG003|Overall Study|Failed to return|2|||
105808350|NCT00384033|364954995|FG000|Overall Study|Physician Decision|1|||
105571146|NCT01845974|364089634|FG000|Overall Study|screen failure|1|||
105571147|NCT01845974|364089635|FG001|Overall Study|screen failure|0|||
105571148|NCT00594217|364089636|FG000|Overall Study|Withdrawal by Subject|1|||
105571149|NCT00594217|364089637|FG001|Overall Study|Withdrawal by Subject|3|||
105571150|NCT03006848|364089638|FG000|Overall Study|Adverse Event|1|||
105571151|NCT03006848|364089638|FG000|Overall Study|Physician Decision|1|||
105571152|NCT03006848|364089638|FG000|Overall Study|Lack of Efficacy|16|||
105571153|NCT01483937|364089640|FG000|Overall Study|Withdrawal by Subject|4|||
105571154|NCT01483937|364089641|FG001|Overall Study|Withdrawal by Subject|3|||
105571155|NCT01686581|364089644|FG000|Overall Study|Side-effects or Health Problems|15|||
105571156|NCT01686581|364089644|FG000|Overall Study|Lack of Efficacy|90|||
105571157|NCT01686581|364089644|FG000|Overall Study|Participant Concerned about Risks|6|||
105571158|NCT01686581|364089644|FG000|Overall Study|Thinks Injections Too Painful|8|||
105571159|NCT01686581|364089644|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
105571160|NCT01686581|364089644|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
105571161|NCT01686581|364089644|FG000|Overall Study|Thinks it is Inconvenient|17|||
105571162|NCT01686581|364089644|FG000|Overall Study|Other Miscellaneous Reasons|36|||
105571163|NCT01686581|364089644|FG000|Overall Study|Reason Missing|1|||
105571164|NCT02965703|364089645|FG000|Overall Study|Withdrawal by Subject|6|||
105571165|NCT02965703|364089646|FG001|Overall Study|Withdrawal by Subject|3|||
105571166|NCT02965703|364089647|FG002|Overall Study|Withdrawal by Subject|1|||
105571167|NCT02965703|364089645|FG000|Overall Study|Protocol Violation|1|||
105571168|NCT02965703|364089646|FG001|Overall Study|Protocol Violation|0|||
105571169|NCT02965703|364089647|FG002|Overall Study|Protocol Violation|0|||
105571170|NCT02965703|364089645|FG000|Overall Study|Adverse Event|1|||
105571171|NCT02965703|364089646|FG001|Overall Study|Adverse Event|1|||
105571172|NCT02965703|364089647|FG002|Overall Study|Adverse Event|0|||
105571173|NCT02965703|364089645|FG000|Overall Study|Lost to Follow-up|2|||
105571174|NCT02965703|364089646|FG001|Overall Study|Lost to Follow-up|1|||
105571175|NCT02965703|364089647|FG002|Overall Study|Lost to Follow-up|1|||
105571176|NCT02223754|364089650|FG000|Period 1|Adverse Event|1|||
105571177|NCT02223754|364089651|FG001|Period 1|Adverse Event|0|||
105571178|NCT02223754|364089650|FG000|Period 1|Lost to Follow-up|0|||
105571179|NCT02223754|364089651|FG001|Period 1|Lost to Follow-up|1|||
105571180|NCT02223754|364089650|FG000|Period 1|Protocol Violation|2|||
105571181|NCT02223754|364089651|FG001|Period 1|Protocol Violation|4|||
105571182|NCT02223754|364089650|FG000|Period 1|Withdrawal by Subject|0|||
105571183|NCT02223754|364089651|FG001|Period 1|Withdrawal by Subject|4|||
105571184|NCT02223754|364089650|FG000|Period 1|Test Article No Longer Available|1|||
105571185|NCT02223754|364089651|FG001|Period 1|Test Article No Longer Available|5|||
105571186|NCT02223754|364089650|FG000|Period 1|Unsatisfactory Visual Response|0|||
105571187|NCT02223754|364089651|FG001|Period 1|Unsatisfactory Visual Response|1|||
105571188|NCT02223754|364089650|FG000|Period 2|Adverse Event|0|||
105571189|NCT02223754|364089651|FG001|Period 2|Adverse Event|1|||
105571190|NCT02223754|364089650|FG000|Period 2|Protocol Violation|1|||
105571191|NCT02223754|364089651|FG001|Period 2|Protocol Violation|0|||
105571192|NCT02223754|364089650|FG000|Period 2|Lens Discomfort|1|||
105571193|NCT02223754|364089651|FG001|Period 2|Lens Discomfort|1|||
105571194|NCT02223754|364089650|FG000|Period 2|Lost to Follow-up|1|||
105571195|NCT02223754|364089651|FG001|Period 2|Lost to Follow-up|0|||
105571196|NCT02223754|364089650|FG000|Period 2|Test Article No Longer Available|0|||
105571197|NCT02223754|364089651|FG001|Period 2|Test Article No Longer Available|1|||
105571198|NCT04182880|364089657|FG000|Overall Study|Pregnancy|1|||
105571199|NCT04182880|364089658|FG001|Overall Study|Pregnancy|0|||
105571200|NCT02716038|364089659|FG000|Overall Study|Not evaluable|1|||
105571201|NCT02716038|364089659|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
105571202|NCT02716038|364089659|FG000|Overall Study|Unresectable|3|||
105571203|NCT00550550|364089660|FG000|Overall Study|Adverse Event|13|||
105571204|NCT00550550|364089661|FG001|Overall Study|Adverse Event|5|||
105571205|NCT00550550|364089660|FG000|Overall Study|Treatment Failure|0|||
105571206|NCT00550550|364089661|FG001|Overall Study|Treatment Failure|1|||
105571207|NCT00550550|364089660|FG000|Overall Study|Lost to Follow-up|4|||
105571208|NCT00550550|364089661|FG001|Overall Study|Lost to Follow-up|0|||
105571209|NCT00550550|364089660|FG000|Overall Study|Withdrawal by Subject|10|||
105571210|NCT00550550|364089661|FG001|Overall Study|Withdrawal by Subject|8|||
105571211|NCT00550550|364089660|FG000|Overall Study|Protocol Violation|5|||
105571212|NCT00550550|364089661|FG001|Overall Study|Protocol Violation|14|||
105571213|NCT00550550|364089660|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
105571214|NCT00550550|364089661|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
105571215|NCT00550550|364089660|FG000|Overall Study|Randomized But Not Treated|1|||
105571216|NCT00550550|364089661|FG001|Overall Study|Randomized But Not Treated|0|||
105571217|NCT04152343|364089662|FG000|Overall Study|Transplanted|5|||
105571218|NCT04152343|364089662|FG000|Overall Study|Death|20|||
105571219|NCT04152343|364089662|FG000|Overall Study|Lost to Follow-up|3|||
105808351|NCT00384033|364954996|FG001|Overall Study|Physician Decision|0|||
105808352|NCT00384033|364954997|FG002|Overall Study|Physician Decision|0|||
105571220|NCT01965938|364089667|FG000|Overall Study|Withdrawal by Subject|1|||
105571221|NCT01965938|364089668|FG001|Overall Study|Withdrawal by Subject|0|||
105571222|NCT01164228|364089669|FG000|Overall Study|Progression|24|||
105485560|NCT03036800|363788529|FG001|Overall Study|Death|0|||
105485561|NCT03036800|363788528|FG000|Overall Study|Tolerance|5|||
105485562|NCT03036800|363788529|FG001|Overall Study|Tolerance|0|||
105485563|NCT03036800|363788528|FG000|Overall Study|Unknown/no reason given|50|||
105761694|NCT00379236|364781392|FG002|Open-label Extension|Use of exclusionary medication|3|||
105761695|NCT00379236|364781390|FG000|Open-label Extension|Other|0|||
105761696|NCT00379236|364781391|FG001|Open-label Extension|Other|0|||
105761697|NCT00379236|364781392|FG002|Open-label Extension|Other|7|||
105761698|NCT03382262|364781395|FG000|Overall Study|Physician Decision|0|||
105761699|NCT03382262|364781396|FG001|Overall Study|Physician Decision|0|||
105761700|NCT03382262|364781397|FG002|Overall Study|Physician Decision|1|||
105761701|NCT03382262|364781398|FG003|Overall Study|Physician Decision|0|||
105761702|NCT03382262|364781395|FG000|Overall Study|Withdrawal by Subject|0|||
105761703|NCT03382262|364781396|FG001|Overall Study|Withdrawal by Subject|0|||
105761704|NCT03382262|364781397|FG002|Overall Study|Withdrawal by Subject|0|||
105761705|NCT03382262|364781398|FG003|Overall Study|Withdrawal by Subject|1|||
105761706|NCT02940860|364781399|FG000|Overall Study|Non-serious AE|1|||
105761707|NCT02940860|364781400|FG001|Overall Study|Non-serious AE|2|||
105761708|NCT02940860|364781399|FG000|Overall Study|Serious AE|7|||
105761709|NCT02940860|364781400|FG001|Overall Study|Serious AE|3|||
105761710|NCT02940860|364781399|FG000|Overall Study|Withdrawal by Subject|19|||
105761711|NCT02940860|364781400|FG001|Overall Study|Withdrawal by Subject|9|||
105761712|NCT02940860|364781399|FG000|Overall Study|Lost to Follow-up|13|||
105761713|NCT02940860|364781400|FG001|Overall Study|Lost to Follow-up|7|||
105761714|NCT02940860|364781399|FG000|Overall Study|Physician Decision|5|||
105761715|NCT02940860|364781400|FG001|Overall Study|Physician Decision|3|||
105761716|NCT02940860|364781399|FG000|Overall Study|Sponsor Decision|0|||
105761717|NCT02940860|364781400|FG001|Overall Study|Sponsor Decision|1|||
105761718|NCT02940860|364781399|FG000|Overall Study|Protocol Violation|0|||
105761719|NCT02940860|364781400|FG001|Overall Study|Protocol Violation|2|||
105761720|NCT02940860|364781399|FG000|Overall Study|Death|3|||
105761721|NCT02940860|364781400|FG001|Overall Study|Death|2|||
105761722|NCT02940860|364781399|FG000|Overall Study|Moved, poor venous access, transport|6|||
105761723|NCT02940860|364781400|FG001|Overall Study|Moved, poor venous access, transport|4|||
105761724|NCT02940860|364781399|FG000|Overall Study|Not treated|2|||
105761725|NCT02940860|364781400|FG001|Overall Study|Not treated|2|||
105761726|NCT04914819|364781401|FG000|Overall Study|Pregnancy|3|||
105761727|NCT04914819|364781402|FG001|Overall Study|Pregnancy|1|||
105761728|NCT04914819|364781401|FG000|Overall Study|Discontinued study|4|||
105761729|NCT04914819|364781402|FG001|Overall Study|Discontinued study|1|||
105761730|NCT04914819|364781401|FG000|Overall Study|Lost to Follow-up|7|||
105761731|NCT04914819|364781402|FG001|Overall Study|Lost to Follow-up|0|||
105761732|NCT02431793|364781408|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
105761733|NCT02431793|364781409|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
105761734|NCT02431793|364781410|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
105761735|NCT02431793|364781408|FG000|Overall Study|Withdrawal by Subject|7|||
105761736|NCT02431793|364781409|FG001|Overall Study|Withdrawal by Subject|5|||
105761737|NCT02431793|364781410|FG002|Overall Study|Withdrawal by Subject|5|||
105761738|NCT02431793|364781408|FG000|Overall Study|Lost to Follow-up|101|||
105761739|NCT02431793|364781409|FG001|Overall Study|Lost to Follow-up|122|||
105761740|NCT02431793|364781410|FG002|Overall Study|Lost to Follow-up|104|||
105761741|NCT00233324|364781411|FG000|Main Study|Death|68|||
105761742|NCT00233324|364781412|FG001|Main Study|Death|60|||
105761743|NCT00233324|364781413|FG002|Main Study|Death|62|||
105761744|NCT00233324|364781414|FG003|Main Study|Death|47|||
105761745|NCT00233324|364781411|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
105761746|NCT00233324|364781412|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
105761747|NCT00233324|364781413|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
105761748|NCT00233324|364781414|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
105761749|NCT00233324|364781411|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
105761750|NCT00233324|364781412|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
105485564|NCT03036800|363788529|FG001|Overall Study|Unknown/no reason given|39|||
105485565|NCT00829933|363788530|FG000|Overall Study|Adverse Event|2|||
105761751|NCT00233324|364781413|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
105761752|NCT00233324|364781414|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
105761753|NCT03907969|364781419|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
105761754|NCT03907969|364781420|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
105761755|NCT03907969|364781421|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
105761756|NCT03907969|364781422|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
105761757|NCT03907969|364781423|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
105761758|NCT03907969|364781424|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
105761759|NCT03907969|364781425|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
105761760|NCT03907969|364781426|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
105761761|NCT03907969|364781427|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
105761762|NCT03907969|364781428|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
105761763|NCT03907969|364781429|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
105761764|NCT03907969|364781419|FG000|Monotherapy Part A|Progressive Disease|0|||
105761765|NCT03907969|364781420|FG001|Monotherapy Part A|Progressive Disease|1|||
105761766|NCT03907969|364781421|FG002|Monotherapy Part A|Progressive Disease|0|||
105761767|NCT03907969|364781422|FG003|Monotherapy Part A|Progressive Disease|0|||
105761768|NCT03907969|364781423|FG004|Monotherapy Part A|Progressive Disease|0|||
105761769|NCT03907969|364781424|FG005|Monotherapy Part A|Progressive Disease|1|||
105761770|NCT03907969|364781425|FG006|Monotherapy Part A|Progressive Disease|2|||
105761771|NCT03907969|364781426|FG007|Monotherapy Part A|Progressive Disease|0|||
105761772|NCT03907969|364781427|FG008|Monotherapy Part A|Progressive Disease|0|||
105761773|NCT03907969|364781428|FG009|Monotherapy Part A|Progressive Disease|0|||
105761774|NCT03907969|364781429|FG010|Monotherapy Part A|Progressive Disease|0|||
105761775|NCT03907969|364781419|FG000|Monotherapy Part A|Death|0|||
105761776|NCT03907969|364781420|FG001|Monotherapy Part A|Death|0|||
105761777|NCT03907969|364781421|FG002|Monotherapy Part A|Death|1|||
105761778|NCT03907969|364781422|FG003|Monotherapy Part A|Death|1|||
105761779|NCT03907969|364781423|FG004|Monotherapy Part A|Death|0|||
105761780|NCT03907969|364781424|FG005|Monotherapy Part A|Death|1|||
105761781|NCT03907969|364781425|FG006|Monotherapy Part A|Death|0|||
105761782|NCT03907969|364781426|FG007|Monotherapy Part A|Death|0|||
105761783|NCT03907969|364781427|FG008|Monotherapy Part A|Death|0|||
105761784|NCT03907969|364781428|FG009|Monotherapy Part A|Death|0|||
105761785|NCT03907969|364781429|FG010|Monotherapy Part A|Death|0|||
105761786|NCT03907969|364781419|FG000|Combination Therapy Part A|Adverse Event|0|||
105761787|NCT03907969|364781420|FG001|Combination Therapy Part A|Adverse Event|0|||
105761788|NCT03907969|364781421|FG002|Combination Therapy Part A|Adverse Event|0|||
105761789|NCT03907969|364781422|FG003|Combination Therapy Part A|Adverse Event|0|||
105761790|NCT03907969|364781423|FG004|Combination Therapy Part A|Adverse Event|0|||
105761791|NCT03907969|364781424|FG005|Combination Therapy Part A|Adverse Event|0|||
105761792|NCT03907969|364781425|FG006|Combination Therapy Part A|Adverse Event|0|||
105761793|NCT03907969|364781426|FG007|Combination Therapy Part A|Adverse Event|0|||
105761794|NCT03907969|364781427|FG008|Combination Therapy Part A|Adverse Event|0|||
105761795|NCT03907969|364781428|FG009|Combination Therapy Part A|Adverse Event|1|||
105761796|NCT03907969|364781429|FG010|Combination Therapy Part A|Adverse Event|1|||
105761797|NCT03907969|364781419|FG000|Combination Therapy Part A|Progressive disease|0|||
105761798|NCT03907969|364781420|FG001|Combination Therapy Part A|Progressive disease|0|||
105761799|NCT03907969|364781421|FG002|Combination Therapy Part A|Progressive disease|0|||
105761800|NCT03907969|364781422|FG003|Combination Therapy Part A|Progressive disease|0|||
105761801|NCT03907969|364781423|FG004|Combination Therapy Part A|Progressive disease|0|||
105761802|NCT03907969|364781424|FG005|Combination Therapy Part A|Progressive disease|0|||
105761803|NCT03907969|364781425|FG006|Combination Therapy Part A|Progressive disease|0|||
105761804|NCT03907969|364781426|FG007|Combination Therapy Part A|Progressive disease|1|||
105761805|NCT03907969|364781427|FG008|Combination Therapy Part A|Progressive disease|0|||
105761806|NCT03907969|364781428|FG009|Combination Therapy Part A|Progressive disease|2|||
105761807|NCT03907969|364781429|FG010|Combination Therapy Part A|Progressive disease|3|||
105761808|NCT03907969|364781419|FG000|Combination Therapy Part A|Death|0|||
105761809|NCT03907969|364781420|FG001|Combination Therapy Part A|Death|0|||
105761810|NCT03907969|364781421|FG002|Combination Therapy Part A|Death|0|||
105761811|NCT03907969|364781422|FG003|Combination Therapy Part A|Death|0|||
105761812|NCT03907969|364781423|FG004|Combination Therapy Part A|Death|0|||
105761813|NCT03907969|364781424|FG005|Combination Therapy Part A|Death|0|||
105761814|NCT03907969|364781425|FG006|Combination Therapy Part A|Death|0|||
105761815|NCT03907969|364781426|FG007|Combination Therapy Part A|Death|0|||
105761816|NCT03907969|364781427|FG008|Combination Therapy Part A|Death|1|||
105761817|NCT03907969|364781428|FG009|Combination Therapy Part A|Death|0|||
105761818|NCT03907969|364781429|FG010|Combination Therapy Part A|Death|1|||
105761819|NCT03907969|364781419|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
105761820|NCT03907969|364781420|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
105761821|NCT03907969|364781421|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
105761822|NCT03907969|364781422|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
105761823|NCT03907969|364781423|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
105761824|NCT03907969|364781424|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
105761825|NCT03907969|364781425|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
105761826|NCT03907969|364781426|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
105761827|NCT03907969|364781427|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
105761828|NCT03907969|364781428|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
105761829|NCT03907969|364781429|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
105761830|NCT03907969|364781419|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
105761831|NCT03907969|364781420|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
105761832|NCT03907969|364781421|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
105808353|NCT00384033|364954998|FG003|Overall Study|Physician Decision|0|||
105808354|NCT00384033|364954995|FG000|Overall Study|Lost to Follow-up|6|||
105808355|NCT00384033|364954996|FG001|Overall Study|Lost to Follow-up|12|||
105761833|NCT03907969|364781422|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
105761834|NCT03907969|364781423|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
105761835|NCT03907969|364781424|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
105761836|NCT03907969|364781425|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
105761837|NCT03907969|364781426|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
105761838|NCT03907969|364781427|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
105761839|NCT03907969|364781428|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
105761840|NCT03907969|364781429|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
105761841|NCT03907969|364781419|FG000|Combination Therapy Part A|Physician Decision|0|||
105761842|NCT03907969|364781420|FG001|Combination Therapy Part A|Physician Decision|0|||
105761843|NCT03907969|364781421|FG002|Combination Therapy Part A|Physician Decision|0|||
105761844|NCT03907969|364781422|FG003|Combination Therapy Part A|Physician Decision|0|||
105761845|NCT03907969|364781423|FG004|Combination Therapy Part A|Physician Decision|0|||
105761846|NCT03907969|364781424|FG005|Combination Therapy Part A|Physician Decision|0|||
105761847|NCT03907969|364781425|FG006|Combination Therapy Part A|Physician Decision|0|||
105761848|NCT03907969|364781426|FG007|Combination Therapy Part A|Physician Decision|1|||
105761849|NCT03907969|364781427|FG008|Combination Therapy Part A|Physician Decision|0|||
105761850|NCT03907969|364781428|FG009|Combination Therapy Part A|Physician Decision|0|||
105761851|NCT03907969|364781429|FG010|Combination Therapy Part A|Physician Decision|1|||
105761852|NCT04839393|364781431|FG000|Overall Study|Adverse Event|0|||
105761853|NCT04839393|364781432|FG001|Overall Study|Adverse Event|0|||
105761854|NCT04839393|364781433|FG002|Overall Study|Adverse Event|2|||
105761855|NCT04839393|364781431|FG000|Overall Study|Withdrawal by participant|0|||
105761856|NCT04839393|364781432|FG001|Overall Study|Withdrawal by participant|0|||
105761857|NCT04839393|364781433|FG002|Overall Study|Withdrawal by participant|1|||
105761858|NCT01709708|364781434|FG000|Overall Study|Protocol Violation|1|||
105761859|NCT01709708|364781435|FG001|Overall Study|Protocol Violation|2|||
105761860|NCT00653328|364781440|FG000|Overall Study|Withdrawal by Subject|1|||
105761861|NCT00653328|364781440|FG000|Overall Study|Adverse Event|2|||
105761862|NCT00653328|364781440|FG000|Overall Study|Disease progression|10|||
105761863|NCT00653328|364781440|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
105761864|NCT02911519|364781445|FG000|Overall Study|Lost to Follow-up|2|||
105761865|NCT02911519|364781446|FG001|Overall Study|Lost to Follow-up|2|||
105761866|NCT02911519|364781445|FG000|Overall Study|Death|0|||
105761867|NCT02911519|364781446|FG001|Overall Study|Death|2|||
105761868|NCT00407550|364781447|FG000|Overall Study|Adverse Event|0|||
105761869|NCT00407550|364781448|FG001|Overall Study|Adverse Event|1|||
105761870|NCT00407550|364781447|FG000|Overall Study|Withdrawal by Subject|0|||
105761871|NCT00407550|364781448|FG001|Overall Study|Withdrawal by Subject|2|||
105761872|NCT00407550|364781447|FG000|Overall Study|Death|1|||
105761873|NCT00407550|364781448|FG001|Overall Study|Death|0|||
105761874|NCT00407550|364781447|FG000|Overall Study|Insurance or Other medical condition|2|||
105761875|NCT00407550|364781448|FG001|Overall Study|Insurance or Other medical condition|1|||
105761876|NCT00724815|364781450|FG000|Overall Study|Randomized, not treated|31|||
105761877|NCT00724815|364781451|FG001|Overall Study|Randomized, not treated|30|||
105761878|NCT00724815|364781450|FG000|Overall Study|Adverse Event|5|||
105761879|NCT00724815|364781451|FG001|Overall Study|Adverse Event|3|||
105761880|NCT00724815|364781450|FG000|Overall Study|Lost to Follow-up|4|||
105761881|NCT00724815|364781451|FG001|Overall Study|Lost to Follow-up|1|||
105761882|NCT00724815|364781450|FG000|Overall Study|Other Various|3|||
105761883|NCT00724815|364781451|FG001|Overall Study|Other Various|5|||
105761884|NCT00810043|364781452|FG000|Overall Study|Withdrawal by Subject|1|||
105761885|NCT00810043|364781453|FG001|Overall Study|Withdrawal by Subject|0|||
105761886|NCT00810043|364781454|FG002|Overall Study|Withdrawal by Subject|2|||
105761887|NCT00810043|364781452|FG000|Overall Study|Lost to Follow-up|1|||
105761888|NCT00810043|364781453|FG001|Overall Study|Lost to Follow-up|0|||
105761889|NCT00810043|364781454|FG002|Overall Study|Lost to Follow-up|0|||
105761890|NCT00810043|364781452|FG000|Overall Study|Physician Decision|0|||
105761891|NCT00810043|364781453|FG001|Overall Study|Physician Decision|0|||
105761892|NCT00810043|364781454|FG002|Overall Study|Physician Decision|2|||
105761893|NCT00810043|364781452|FG000|Overall Study|Death|2|||
105761894|NCT00810043|364781453|FG001|Overall Study|Death|0|||
105761895|NCT00810043|364781454|FG002|Overall Study|Death|0|||
105761896|NCT00810043|364781452|FG000|Overall Study|Unrelated medical problem|0|||
105761897|NCT00810043|364781453|FG001|Overall Study|Unrelated medical problem|1|||
105761898|NCT00810043|364781454|FG002|Overall Study|Unrelated medical problem|0|||
105761899|NCT00810043|364781452|FG000|Overall Study|Non-medical problem|0|||
105808356|NCT00384033|364954997|FG002|Overall Study|Lost to Follow-up|7|||
105808357|NCT00384033|364954998|FG003|Overall Study|Lost to Follow-up|7|||
105808358|NCT00384033|364954995|FG000|Overall Study|Other|2|||
105808359|NCT00384033|364954996|FG001|Overall Study|Other|0|||
105808360|NCT00384033|364954997|FG002|Overall Study|Other|0|||
105808361|NCT00384033|364954998|FG003|Overall Study|Other|0|||
105808362|NCT00384033|364954995|FG000|Overall Study|Protocol Violation|5|||
105808363|NCT00384033|364954996|FG001|Overall Study|Protocol Violation|0|||
105808364|NCT00384033|364954997|FG002|Overall Study|Protocol Violation|5|||
105808365|NCT00384033|364954998|FG003|Overall Study|Protocol Violation|6|||
105808366|NCT00384033|364954995|FG000|Overall Study|Withdrawal by Subject|6|||
105808367|NCT00384033|364954996|FG001|Overall Study|Withdrawal by Subject|2|||
105808368|NCT00384033|364954997|FG002|Overall Study|Withdrawal by Subject|5|||
105808369|NCT00384033|364954998|FG003|Overall Study|Withdrawal by Subject|2|||
105808370|NCT00384033|364954995|FG000|Overall Study|Lack of Efficacy|7|||
105808371|NCT00384033|364954996|FG001|Overall Study|Lack of Efficacy|3|||
105808372|NCT00384033|364954997|FG002|Overall Study|Lack of Efficacy|3|||
105808373|NCT00384033|364954998|FG003|Overall Study|Lack of Efficacy|1|||
105808374|NCT00384033|364954995|FG000|Overall Study|Randomized but not treated|3|||
105808375|NCT00384033|364954996|FG001|Overall Study|Randomized but not treated|7|||
105808376|NCT00384033|364954997|FG002|Overall Study|Randomized but not treated|10|||
105808377|NCT00384033|364954998|FG003|Overall Study|Randomized but not treated|2|||
105571223|NCT01164228|364089670|FG001|Overall Study|Progression|25|||
105571224|NCT01164228|364089669|FG000|Overall Study|Adverse Event|13|||
105571225|NCT01164228|364089670|FG001|Overall Study|Adverse Event|7|||
105571226|NCT01164228|364089669|FG000|Overall Study|Death|1|||
105571227|NCT01164228|364089670|FG001|Overall Study|Death|1|||
105571228|NCT01164228|364089669|FG000|Overall Study|Withdrawal by Subject|2|||
105571229|NCT01164228|364089670|FG001|Overall Study|Withdrawal by Subject|0|||
105571230|NCT01164228|364089669|FG000|Overall Study|Physician Decision|1|||
105571231|NCT01164228|364089670|FG001|Overall Study|Physician Decision|2|||
105571232|NCT01164228|364089669|FG000|Overall Study|Symptomatic deterioration|1|||
105571233|NCT01164228|364089670|FG001|Overall Study|Symptomatic deterioration|0|||
105571234|NCT01164228|364089669|FG000|Overall Study|Never started treatment|1|||
105808378|NCT03349333|364954999|FG000|Overall Study|Progression of Disease|36|||
105808379|NCT03349333|364954999|FG000|Overall Study|Adverse Event|11|||
105808380|NCT03349333|364954999|FG000|Overall Study|Other|6|||
105808381|NCT03349333|364954999|FG000|Overall Study|Withdrawal by Subject|5|||
105808382|NCT03349333|364954999|FG000|Overall Study|Conditions interfere with participation|2|||
105808383|NCT03349333|364954999|FG000|Overall Study|Physician Decision|2|||
105808384|NCT03349333|364954999|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
105808385|NCT03349333|364954999|FG000|Overall Study|Patients in treatment less than 24 month|8|||
105808386|NCT00760383|364955000|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
105808387|NCT00760383|364955001|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
105808388|NCT02737306|364955006|FG000|Overall Study|Adverse Event|3|||
105808389|NCT02737306|364955007|FG001|Overall Study|Adverse Event|0|||
105808390|NCT02737306|364955006|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
105808391|NCT02737306|364955007|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
105808392|NCT01966042|364955008|FG000|Overall Study|Death|2|||
105808393|NCT03361423|364955009|FG000|Overall Study|Withdrawal by Subject|4|||
105571235|NCT01164228|364089670|FG001|Overall Study|Never started treatment|3|||
105571236|NCT01164228|364089669|FG000|Overall Study|Ineligible|1|||
105571237|NCT01164228|364089670|FG001|Overall Study|Ineligible|0|||
105571238|NCT01709305|364089675|FG000|Phase 1|Clinical Adverse Event|80|||
105571239|NCT01709305|364089676|FG001|Phase 1|Clinical Adverse Event|0|||
105808394|NCT03361423|364955010|FG001|Overall Study|Withdrawal by Subject|3|||
105808395|NCT03361423|364955009|FG000|Overall Study|Did not treat|19|||
105808396|NCT03361423|364955010|FG001|Overall Study|Did not treat|18|||
105808397|NCT03361423|364955009|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
105808398|NCT03361423|364955010|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
105808399|NCT03361423|364955009|FG000|Overall Study|Missing data|4|||
105808400|NCT03361423|364955010|FG001|Overall Study|Missing data|1|||
105808401|NCT01254409|364955011|FG000|Overall Study|Adverse Event|0|||
105808402|NCT01254409|364955012|FG001|Overall Study|Adverse Event|1|||
105808403|NCT01254409|364955013|FG002|Overall Study|Adverse Event|0|||
105808404|NCT01254409|364955014|FG003|Overall Study|Adverse Event|0|||
105808405|NCT02015793|364955017|FG000|Overall Study|Adverse Event|3|||
105571240|NCT01709305|364089677|FG002|Phase 1|Clinical Adverse Event|0|||
105571241|NCT01709305|364089678|FG003|Phase 1|Clinical Adverse Event|0|||
105571242|NCT01709305|364089679|FG004|Phase 1|Clinical Adverse Event|0|||
105571243|NCT01709305|364089675|FG000|Phase 1|Death|2|||
105571244|NCT01709305|364089676|FG001|Phase 1|Death|0|||
105808406|NCT02015793|364955018|FG001|Overall Study|Adverse Event|3|||
105808407|NCT02015793|364955017|FG000|Overall Study|Withdrawal by Subject|1|||
105808408|NCT02015793|364955018|FG001|Overall Study|Withdrawal by Subject|1|||
105808409|NCT00249821|364955021|FG000|Overall Study|Technical problem|0|||
105571245|NCT01709305|364089677|FG002|Phase 1|Death|0|||
105571246|NCT01709305|364089678|FG003|Phase 1|Death|0|||
105571247|NCT01709305|364089679|FG004|Phase 1|Death|0|||
105571248|NCT01709305|364089675|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
105571249|NCT01709305|364089676|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
105571250|NCT01709305|364089677|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
105571251|NCT01709305|364089678|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
105571252|NCT01709305|364089679|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
105571253|NCT01709305|364089675|FG000|Phase 1|Laboratory Adverse Event|16|||
105571254|NCT01709305|364089676|FG001|Phase 1|Laboratory Adverse Event|0|||
105571255|NCT01709305|364089677|FG002|Phase 1|Laboratory Adverse Event|0|||
105571256|NCT01709305|364089678|FG003|Phase 1|Laboratory Adverse Event|0|||
105571257|NCT01709305|364089679|FG004|Phase 1|Laboratory Adverse Event|0|||
105571258|NCT01709305|364089675|FG000|Phase 1|Lost to Follow-up|147|||
105571259|NCT01709305|364089676|FG001|Phase 1|Lost to Follow-up|0|||
105571260|NCT01709305|364089677|FG002|Phase 1|Lost to Follow-up|0|||
105571261|NCT01709305|364089678|FG003|Phase 1|Lost to Follow-up|0|||
105571262|NCT01709305|364089679|FG004|Phase 1|Lost to Follow-up|0|||
105571263|NCT01709305|364089675|FG000|Phase 1|Travel, moving, etc.|30|||
105571264|NCT01709305|364089676|FG001|Phase 1|Travel, moving, etc.|0|||
105571265|NCT01709305|364089677|FG002|Phase 1|Travel, moving, etc.|0|||
105571266|NCT01709305|364089678|FG003|Phase 1|Travel, moving, etc.|0|||
105571267|NCT01709305|364089679|FG004|Phase 1|Travel, moving, etc.|0|||
105571268|NCT01709305|364089675|FG000|Phase 1|Physician Decision|13|||
105571269|NCT01709305|364089676|FG001|Phase 1|Physician Decision|0|||
105571270|NCT01709305|364089677|FG002|Phase 1|Physician Decision|0|||
105571271|NCT01709305|364089678|FG003|Phase 1|Physician Decision|0|||
105571272|NCT01709305|364089679|FG004|Phase 1|Physician Decision|0|||
105571273|NCT01709305|364089675|FG000|Phase 1|Protocol Violation|118|||
105571274|NCT01709305|364089676|FG001|Phase 1|Protocol Violation|0|||
105571275|NCT01709305|364089677|FG002|Phase 1|Protocol Violation|0|||
105571276|NCT01709305|364089678|FG003|Phase 1|Protocol Violation|0|||
105571277|NCT01709305|364089679|FG004|Phase 1|Protocol Violation|0|||
105571278|NCT01709305|364089675|FG000|Phase 1|Withdrawal by Subject|218|||
105571279|NCT01709305|364089676|FG001|Phase 1|Withdrawal by Subject|0|||
105571280|NCT01709305|364089677|FG002|Phase 1|Withdrawal by Subject|0|||
105571281|NCT01709305|364089678|FG003|Phase 1|Withdrawal by Subject|0|||
105571282|NCT01709305|364089679|FG004|Phase 1|Withdrawal by Subject|0|||
105571283|NCT01709305|364089675|FG000|Phase 2|Clinical Adverse Event|0|||
105571284|NCT01709305|364089676|FG001|Phase 2|Clinical Adverse Event|10|||
105571285|NCT01709305|364089677|FG002|Phase 2|Clinical Adverse Event|10|||
105571286|NCT01709305|364089678|FG003|Phase 2|Clinical Adverse Event|6|||
105571287|NCT01709305|364089679|FG004|Phase 2|Clinical Adverse Event|11|||
105571288|NCT01709305|364089675|FG000|Phase 2|Death|0|||
105571289|NCT01709305|364089676|FG001|Phase 2|Death|0|||
105571290|NCT01709305|364089677|FG002|Phase 2|Death|1|||
105571291|NCT01709305|364089678|FG003|Phase 2|Death|0|||
105571292|NCT01709305|364089679|FG004|Phase 2|Death|0|||
105571293|NCT01709305|364089675|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
105571294|NCT01709305|364089676|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
105571295|NCT01709305|364089677|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
105571296|NCT01709305|364089678|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
105571297|NCT01709305|364089679|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
105571298|NCT01709305|364089675|FG000|Phase 2|Laboratory Adverse Event|0|||
105808410|NCT00249821|364955022|FG001|Overall Study|Technical problem|1|||
105808411|NCT04104646|364955023|FG000|Overall Study|Withdrawal by Subject|1|||
105808412|NCT04104646|364955024|FG001|Overall Study|Withdrawal by Subject|1|||
105808413|NCT04104646|364955023|FG000|Overall Study|Lost to Follow-up|1|||
105808414|NCT04104646|364955024|FG001|Overall Study|Lost to Follow-up|0|||
105808415|NCT04104646|364955023|FG000|Overall Study|Physician Decision|2|||
105808416|NCT04104646|364955024|FG001|Overall Study|Physician Decision|0|||
105808417|NCT00319956|364955025|FG000|Overall Study|Death|20|||
105808418|NCT00319956|364955026|FG001|Overall Study|Death|24|||
105808419|NCT01656889|364955027|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
105808420|NCT01656889|364955028|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
105808421|NCT01656889|364955027|FG000|Treatment Period, 12 Weeks|Death|0|||
105808422|NCT01656889|364955028|FG001|Treatment Period, 12 Weeks|Death|1|||
105485566|NCT00829933|363788531|FG001|Overall Study|Adverse Event|3|||
105485567|NCT00829933|363788532|FG002|Overall Study|Adverse Event|2|||
105485568|NCT00829933|363788533|FG003|Overall Study|Adverse Event|1|||
105485569|NCT00829933|363788530|FG000|Overall Study|Death|0|||
105485570|NCT00829933|363788531|FG001|Overall Study|Death|0|||
105485571|NCT00829933|363788532|FG002|Overall Study|Death|1|||
105485572|NCT00829933|363788533|FG003|Overall Study|Death|1|||
105485573|NCT00829933|363788530|FG000|Overall Study|Lack of Efficacy|0|||
105485574|NCT00829933|363788531|FG001|Overall Study|Lack of Efficacy|1|||
105485575|NCT00829933|363788532|FG002|Overall Study|Lack of Efficacy|0|||
105485576|NCT00829933|363788533|FG003|Overall Study|Lack of Efficacy|0|||
105485577|NCT00829933|363788530|FG000|Overall Study|Physician Decision|5|||
105485578|NCT00829933|363788531|FG001|Overall Study|Physician Decision|7|||
105485579|NCT00829933|363788532|FG002|Overall Study|Physician Decision|8|||
105485580|NCT00829933|363788533|FG003|Overall Study|Physician Decision|1|||
105485581|NCT00829933|363788530|FG000|Overall Study|Pregnancy|0|||
105485582|NCT00829933|363788531|FG001|Overall Study|Pregnancy|0|||
105485583|NCT00829933|363788532|FG002|Overall Study|Pregnancy|0|||
105485584|NCT00829933|363788533|FG003|Overall Study|Pregnancy|2|||
105485585|NCT00829933|363788530|FG000|Overall Study|Protocol Violation|2|||
105485586|NCT00829933|363788531|FG001|Overall Study|Protocol Violation|1|||
105485587|NCT00829933|363788532|FG002|Overall Study|Protocol Violation|0|||
105485588|NCT00829933|363788533|FG003|Overall Study|Protocol Violation|0|||
105485589|NCT00829933|363788530|FG000|Overall Study|withdrew before treatment started|5|||
105485590|NCT00829933|363788531|FG001|Overall Study|withdrew before treatment started|1|||
105485591|NCT00829933|363788532|FG002|Overall Study|withdrew before treatment started|2|||
105485592|NCT00829933|363788533|FG003|Overall Study|withdrew before treatment started|9|||
105485593|NCT00491556|363788538|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
105485594|NCT00491556|363788539|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
105485595|NCT00491556|363788538|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
105485596|NCT00491556|363788539|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
105485597|NCT00491556|363788538|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
105485598|NCT00491556|363788539|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
105485599|NCT00491556|363788538|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
105485600|NCT00491556|363788539|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
105485601|NCT00491556|363788538|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
105808423|NCT01656889|364955027|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
105808424|NCT01656889|364955028|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
105808425|NCT01656889|364955027|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
105808426|NCT01656889|364955028|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
105808427|NCT01656889|364955027|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
105808428|NCT01656889|364955028|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
105808429|NCT01656889|364955027|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
105808430|NCT01656889|364955028|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
105808431|NCT01656889|364955027|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
105808432|NCT01656889|364955028|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
105808433|NCT01656889|364955027|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
105808434|NCT01656889|364955028|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
105808435|NCT01656889|364955027|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
105808436|NCT01656889|364955028|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
105808437|NCT01656889|364955027|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
105808438|NCT01656889|364955028|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
105808439|NCT01565083|364955032|FG000|Overall Study|Withdrawal by Subject|6|||
105808440|NCT01565083|364955033|FG001|Overall Study|Withdrawal by Subject|4|||
105808441|NCT01565083|364955032|FG000|Overall Study|Lost to Follow-up|2|||
105808442|NCT01565083|364955033|FG001|Overall Study|Lost to Follow-up|7|||
105808443|NCT01565083|364955032|FG000|Overall Study|Death|22|||
105808444|NCT01565083|364955033|FG001|Overall Study|Death|23|||
105808445|NCT01565083|364955032|FG000|Overall Study|Other|3|||
105808446|NCT01565083|364955033|FG001|Overall Study|Other|5|||
105808447|NCT01346410|364955034|FG000|Overall Study|Death|1|||
105808448|NCT02576990|364955035|FG000|Overall Study|Death|29|||
105808449|NCT02576990|364955036|FG001|Overall Study|Death|18|||
105808450|NCT02576990|364955035|FG000|Overall Study|Physician Decision|1|||
105808451|NCT02576990|364955036|FG001|Overall Study|Physician Decision|0|||
105808452|NCT02576990|364955035|FG000|Overall Study|Screen failure|2|||
105808453|NCT02576990|364955036|FG001|Overall Study|Screen failure|0|||
105808454|NCT02576990|364955035|FG000|Overall Study|Sponsor's decision|24|||
105808455|NCT02576990|364955036|FG001|Overall Study|Sponsor's decision|4|||
105808456|NCT02576990|364955035|FG000|Overall Study|Withdrawal by Subject|0|||
105808457|NCT02576990|364955036|FG001|Overall Study|Withdrawal by Subject|2|||
105808458|NCT00979628|364955037|FG000|Overall Study|received regimen < 24 hours|7|||
105808459|NCT00979628|364955038|FG001|Overall Study|received regimen < 24 hours|6|||
105808460|NCT00979628|364955039|FG002|Overall Study|received regimen < 24 hours|5|||
105808461|NCT00979628|364955037|FG000|Overall Study|received steroids|1|||
105808462|NCT00979628|364955038|FG001|Overall Study|received steroids|1|||
105808463|NCT00979628|364955039|FG002|Overall Study|received steroids|0|||
105808464|NCT00979628|364955037|FG000|Overall Study|transferred to ICU|1|||
105808465|NCT00979628|364955038|FG001|Overall Study|transferred to ICU|2|||
105808466|NCT00979628|364955039|FG002|Overall Study|transferred to ICU|1|||
105808467|NCT03008460|364955042|FG000|Overall Study|Protocol deviation|0|||
105808468|NCT03008460|364955043|FG001|Overall Study|Protocol deviation|2|||
105808469|NCT03008460|364955042|FG000|Overall Study|Study drug not dispensed|0|||
105808470|NCT03008460|364955043|FG001|Overall Study|Study drug not dispensed|1|||
105808471|NCT03008460|364955042|FG000|Overall Study|Adverse Event|0|||
105571299|NCT01709305|364089676|FG001|Phase 2|Laboratory Adverse Event|1|||
105571300|NCT01709305|364089677|FG002|Phase 2|Laboratory Adverse Event|0|||
105571301|NCT01709305|364089678|FG003|Phase 2|Laboratory Adverse Event|1|||
105571302|NCT01709305|364089679|FG004|Phase 2|Laboratory Adverse Event|1|||
105571303|NCT01709305|364089675|FG000|Phase 2|Lost to Follow-up|0|||
105571304|NCT01709305|364089676|FG001|Phase 2|Lost to Follow-up|10|||
105571305|NCT01709305|364089677|FG002|Phase 2|Lost to Follow-up|6|||
105571306|NCT01709305|364089678|FG003|Phase 2|Lost to Follow-up|9|||
105571307|NCT01709305|364089679|FG004|Phase 2|Lost to Follow-up|5|||
105571308|NCT01709305|364089675|FG000|Phase 2|Travel, moving, etc.|0|||
105571309|NCT01709305|364089676|FG001|Phase 2|Travel, moving, etc.|2|||
105571310|NCT01709305|364089677|FG002|Phase 2|Travel, moving, etc.|3|||
105571311|NCT01709305|364089678|FG003|Phase 2|Travel, moving, etc.|3|||
105571312|NCT01709305|364089679|FG004|Phase 2|Travel, moving, etc.|5|||
105571313|NCT01709305|364089675|FG000|Phase 2|Physician Decision|0|||
105571314|NCT01709305|364089676|FG001|Phase 2|Physician Decision|2|||
105571315|NCT01709305|364089677|FG002|Phase 2|Physician Decision|0|||
105571316|NCT01709305|364089678|FG003|Phase 2|Physician Decision|1|||
105808472|NCT03008460|364955043|FG001|Overall Study|Adverse Event|1|||
105808473|NCT03008460|364955042|FG000|Overall Study|Withdrawal by Subject|5|||
105808474|NCT03008460|364955043|FG001|Overall Study|Withdrawal by Subject|6|||
105808475|NCT03008460|364955042|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
105571317|NCT01709305|364089679|FG004|Phase 2|Physician Decision|2|||
105571318|NCT01709305|364089675|FG000|Phase 2|Protocol Violation|0|||
105571319|NCT01709305|364089676|FG001|Phase 2|Protocol Violation|19|||
105571320|NCT01709305|364089677|FG002|Phase 2|Protocol Violation|19|||
105571321|NCT01709305|364089678|FG003|Phase 2|Protocol Violation|13|||
105571322|NCT01709305|364089679|FG004|Phase 2|Protocol Violation|9|||
105571323|NCT01709305|364089675|FG000|Phase 2|Withdrawal by Subject|0|||
105571324|NCT01709305|364089676|FG001|Phase 2|Withdrawal by Subject|8|||
105571325|NCT01709305|364089677|FG002|Phase 2|Withdrawal by Subject|6|||
105571326|NCT01709305|364089678|FG003|Phase 2|Withdrawal by Subject|15|||
105571327|NCT01709305|364089679|FG004|Phase 2|Withdrawal by Subject|12|||
105571328|NCT02041923|364089680|FG000|Overall Study|Lost to Follow-up|26|||
105571329|NCT02041923|364089681|FG001|Overall Study|Lost to Follow-up|30|||
105571330|NCT00621296|364089682|FG000|Overall Study|Adverse Event|2|||
105571331|NCT00621296|364089682|FG000|Overall Study|Lack of Efficacy|1|||
105571332|NCT00621296|364089682|FG000|Overall Study|Physician Decision|7|||
105571333|NCT00621296|364089682|FG000|Overall Study|Unmatch Criteria|1|||
105571334|NCT00621296|364089682|FG000|Overall Study|Stopping Criteria|3|||
105571335|NCT00381641|364089685|FG000|Overall Study|Withdrawal by Subject|0|||
105571336|NCT00381641|364089686|FG001|Overall Study|Withdrawal by Subject|2|||
105571337|NCT00976703|364091136|FG000|Overall Study|Physician Decision|1|||
105571338|NCT00976703|364091137|FG001|Overall Study|Physician Decision|1|||
105571339|NCT00976703|364091136|FG000|Overall Study|ineligible for study|2|||
105571340|NCT00976703|364091137|FG001|Overall Study|ineligible for study|2|||
105571341|NCT00975221|364091138|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
105571342|NCT00975221|364091139|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
105571343|NCT00975221|364091138|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
105571344|NCT00975221|364091139|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
105571345|NCT00975221|364091138|FG000|Titration Phase (Weeks 1-12)|Other|0|||
105571346|NCT00975221|364091139|FG001|Titration Phase (Weeks 1-12)|Other|1|||
105571347|NCT00975221|364091138|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
105571348|NCT00975221|364091139|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
105571349|NCT00975221|364091138|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
105571350|NCT00975221|364091139|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
105571351|NCT00975221|364091138|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
105571352|NCT00975221|364091139|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
105571353|NCT00840996|364091142|FG000|Overall Study|Withdrawal by Subject|1|||
105571354|NCT00840996|364091143|FG001|Overall Study|Withdrawal by Subject|0|||
105571355|NCT03093428|364091150|FG000|Overall Study|Not eligible for treatment|2|||
105571356|NCT03093428|364091151|FG001|Overall Study|Not eligible for treatment|1|||
105571357|NCT03093428|364091150|FG000|Overall Study|Progression|14|||
105571358|NCT03093428|364091151|FG001|Overall Study|Progression|4|||
105571359|NCT03093428|364091150|FG000|Overall Study|Death|1|||
105571360|NCT03093428|364091151|FG001|Overall Study|Death|0|||
105571361|NCT03093428|364091150|FG000|Overall Study|Adverse Event|1|||
105571362|NCT03093428|364091151|FG001|Overall Study|Adverse Event|0|||
105571363|NCT03093428|364091150|FG000|Overall Study|Withdrawal by Subject|1|||
105571364|NCT03093428|364091151|FG001|Overall Study|Withdrawal by Subject|1|||
105571365|NCT00519896|364091156|FG000|Overall Study|Protocol Violation|1|||
105571366|NCT00519896|364091156|FG000|Overall Study|Adverse Event|1|||
105571367|NCT00810082|364091157|FG000|Overall Study|Lost to Follow-up|0|||
105571368|NCT00810082|364091158|FG001|Overall Study|Lost to Follow-up|4|||
105571369|NCT04741802|364091167|FG000|Overall Study|Death|1|||
105361025|NCT01064414|363328135|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
105361026|NCT01064414|363328136|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
105361027|NCT01064414|363328137|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
105361028|NCT01064414|363328135|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
105361029|NCT01064414|363328136|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
105361030|NCT01064414|363328137|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
105361031|NCT01064414|363328135|FG000|Extension Period: Week 26 to Week 52|Other|5|||
105361032|NCT01064414|363328136|FG001|Extension Period: Week 26 to Week 52|Other|2|||
105361033|NCT01064414|363328137|FG002|Extension Period: Week 26 to Week 52|Other|1|||
105361034|NCT03286218|363328141|FG000|Qualification Phase Period 1|Adverse Event|1|||
105361035|NCT03286218|363328142|FG001|Qualification Phase Period 1|Adverse Event|0|||
105361036|NCT03286218|363328143|FG002|Qualification Phase Period 1|Adverse Event|0|||
105361037|NCT03286218|363328144|FG003|Qualification Phase Period 1|Adverse Event|0|||
105361038|NCT03286218|363328145|FG004|Qualification Phase Period 1|Adverse Event|0|||
105361039|NCT03286218|363328146|FG005|Qualification Phase Period 1|Adverse Event|0|||
105361040|NCT03286218|363328147|FG006|Qualification Phase Period 1|Adverse Event|0|||
105571370|NCT04741802|364091167|FG000|Overall Study|Lost to Follow-up|11|||
105571371|NCT01460160|364091168|FG000|Treatment Phase|Lack of Efficacy|3|||
105571372|NCT01460160|364091168|FG000|Treatment Phase|Study Drug Toxicity|2|||
105571373|NCT01460160|364091168|FG000|Treatment Phase|Adverse Event|8|||
105571374|NCT01460160|364091168|FG000|Treatment Phase|Withdrawal by Subject|4|||
105571375|NCT01460160|364091168|FG000|Treatment Phase|Death|2|||
105571376|NCT01460160|364091168|FG000|Treatment Phase|Other reasons|9|||
105571377|NCT01460160|364091168|FG000|Follow-up Phase|Withdrawal by Subject|4|||
105571378|NCT01460160|364091168|FG000|Follow-up Phase|Death|14|||
105571379|NCT01460160|364091168|FG000|Follow-up Phase|Lost to Follow-up|7|||
105571380|NCT01460160|364091168|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
105571381|NCT01460160|364091168|FG000|Follow-up Phase|Other and not reported reasons|5|||
105571382|NCT04041440|364091172|FG000|Overall Study|Withdrawal by Subject|0|||
105571383|NCT04041440|364091173|FG001|Overall Study|Withdrawal by Subject|1|||
105571384|NCT04041440|364091172|FG000|Overall Study|Lost to Follow-up|0|||
105571385|NCT04041440|364091173|FG001|Overall Study|Lost to Follow-up|1|||
105571386|NCT01381874|364091174|FG000|Overall Study|Lost to Follow-up|1|||
105571387|NCT01381874|364091175|FG001|Overall Study|Lost to Follow-up|1|||
105571388|NCT01381874|364091176|FG002|Overall Study|Lost to Follow-up|0|||
105571389|NCT01381874|364091174|FG000|Overall Study|Withdrawal by Subject|9|||
105571390|NCT01381874|364091175|FG001|Overall Study|Withdrawal by Subject|10|||
105571391|NCT01381874|364091176|FG002|Overall Study|Withdrawal by Subject|9|||
105571392|NCT01381874|364091174|FG000|Overall Study|Other|67|||
105571393|NCT01381874|364091175|FG001|Overall Study|Other|52|||
105571394|NCT01381874|364091176|FG002|Overall Study|Other|67|||
105571395|NCT03447730|364091180|FG000|Overall Study|Adverse Event|0|||
105571396|NCT03447730|364091181|FG001|Overall Study|Adverse Event|2|||
105571397|NCT03447730|364091182|FG002|Overall Study|Adverse Event|0|||
105485602|NCT00491556|363788539|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
105485603|NCT00491556|363788538|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
105571398|NCT02086162|364091183|FG000|Overall Study|Withdrawal by Subject|4|||
105571399|NCT02086162|364091184|FG001|Overall Study|Withdrawal by Subject|4|||
105571400|NCT02086162|364091183|FG000|Overall Study|moved|1|||
105571401|NCT02086162|364091184|FG001|Overall Study|moved|1|||
105571402|NCT02086162|364091183|FG000|Overall Study|Lost to Follow-up|4|||
105571403|NCT02086162|364091184|FG001|Overall Study|Lost to Follow-up|2|||
105571404|NCT02086162|364091183|FG000|Overall Study|Death|1|||
105571405|NCT02086162|364091184|FG001|Overall Study|Death|0|||
105571406|NCT03119610|364091188|FG000|Overall Study|Adverse Event|1|||
105571407|NCT03119610|364091189|FG001|Overall Study|Adverse Event|0|||
105571408|NCT03119610|364091188|FG000|Overall Study|Lost to Follow-up|0|||
105571409|NCT03119610|364091189|FG001|Overall Study|Lost to Follow-up|1|||
105571410|NCT01215357|364091190|FG000|Overall Study|Withdrawal by Subject|3|||
105571411|NCT01215357|364091190|FG000|Overall Study|Protocol Violation|9|||
105571412|NCT01350505|364091200|FG000|Overall Study|Lost to Follow-up|4|||
105571413|NCT00007475|364091201|FG000|Overall Study|Withdrawal by Subject|1|||
105571414|NCT00007475|364091202|FG001|Overall Study|Withdrawal by Subject|0|||
105571415|NCT00007475|364091203|FG002|Overall Study|Withdrawal by Subject|0|||
105571416|NCT00007475|364091204|FG003|Overall Study|Withdrawal by Subject|0|||
105571417|NCT00007475|364091201|FG000|Overall Study|Adverse Event|3|||
105571418|NCT00007475|364091202|FG001|Overall Study|Adverse Event|0|||
105571419|NCT00007475|364091203|FG002|Overall Study|Adverse Event|0|||
105571420|NCT00007475|364091204|FG003|Overall Study|Adverse Event|0|||
105571421|NCT02357810|364091206|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
105571422|NCT02357810|364091206|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
105571423|NCT02357810|364091206|FG000|Reached 12 Weeks Response|Adverse Event|5|||
105571424|NCT02357810|364091206|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
105571425|NCT02357810|364091206|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
105571426|NCT02357810|364091206|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
105571427|NCT02357810|364091206|FG000|Reached 12 Weeks Response|Death|1|||
105571428|NCT02357810|364091206|FG000|Reached 12 Weeks Response|Physician Decision|1|||
105571429|NCT02357810|364091206|FG000|Reached 12 Weeks Response|Other|1|||
105571430|NCT02357810|364091206|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
105571431|NCT02357810|364091206|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
105761900|NCT00810043|364781453|FG001|Overall Study|Non-medical problem|0|||
105485604|NCT00491556|363788539|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
105485605|NCT00491556|363788538|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
105485606|NCT00491556|363788539|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
105485607|NCT00491556|363788538|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
105485608|NCT00491556|363788539|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
105571432|NCT02357810|364091206|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
105571433|NCT02357810|364091206|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
105571434|NCT02357810|364091206|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
105571435|NCT02357810|364091206|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
105571436|NCT04091360|364091207|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
105571437|NCT04091360|364091208|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
105571438|NCT04091360|364091209|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
105571439|NCT04091360|364091210|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
105571440|NCT04091360|364091211|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
105571441|NCT04091360|364091212|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
105571442|NCT04091360|364091213|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
105571443|NCT04091360|364091214|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
105485609|NCT00491556|363788538|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
105485610|NCT00491556|363788539|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
105485611|NCT00491556|363788538|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
105485612|NCT00491556|363788539|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
105485613|NCT00491556|363788538|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
105485614|NCT00491556|363788539|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
105485615|NCT00491556|363788538|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
105485616|NCT00491556|363788539|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
105485617|NCT00491556|363788538|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
105485618|NCT00491556|363788539|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
105485619|NCT00491556|363788538|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
105485620|NCT00491556|363788539|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
105485621|NCT00491556|363788538|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
105485622|NCT00491556|363788539|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
105485623|NCT00491556|363788538|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
105485624|NCT00491556|363788539|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
105485625|NCT00491556|363788538|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
105485626|NCT00491556|363788539|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
105485627|NCT00491556|363788538|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
105485628|NCT00491556|363788539|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
105485629|NCT00491556|363788538|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
105485630|NCT00491556|363788539|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
105485631|NCT00491556|363788538|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
105485632|NCT00491556|363788539|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
105485633|NCT02418156|363788540|FG000|Overall Study|Lost to Follow-up|12|||
105485634|NCT02418156|363788540|FG000|Overall Study|Death|2|||
105485635|NCT02418156|363788540|FG000|Overall Study|Physician Decision|1|||
105485636|NCT02418156|363788540|FG000|Overall Study|Withdrawal by Subject|1|||
105485637|NCT02418156|363788540|FG000|Overall Study|Subject refused to return|1|||
105485638|NCT00130442|363789575|FG000|Overall Study|Withdrawal by Subject|0|||
105485639|NCT00130442|363789576|FG001|Overall Study|Withdrawal by Subject|1|||
105485640|NCT00130442|363789575|FG000|Overall Study|did not meet criteria|1|||
105485641|NCT00130442|363789576|FG001|Overall Study|did not meet criteria|1|||
105485642|NCT02093351|363789577|FG000|Part A|Adverse Event|0|||
105485643|NCT02093351|363789578|FG001|Part A|Adverse Event|1|||
105485644|NCT02093351|363789579|FG002|Part A|Adverse Event|1|||
105485645|NCT02093351|363789580|FG003|Part A|Adverse Event|0|||
105485646|NCT02093351|363789577|FG000|Part A|Condition under investigation worsened|2|||
105485647|NCT02093351|363789578|FG001|Part A|Condition under investigation worsened|0|||
105485648|NCT02093351|363789579|FG002|Part A|Condition under investigation worsened|2|||
105485649|NCT02093351|363789580|FG003|Part A|Condition under investigation worsened|0|||
105485650|NCT02093351|363789577|FG000|Part A|Death|0|||
105485651|NCT02093351|363789578|FG001|Part A|Death|1|||
105485652|NCT02093351|363789579|FG002|Part A|Death|0|||
105485653|NCT02093351|363789580|FG003|Part A|Death|0|||
105485654|NCT02093351|363789577|FG000|Part B|Patient decision|0|||
105485655|NCT02093351|363789578|FG001|Part B|Patient decision|0|||
105485656|NCT02093351|363789579|FG002|Part B|Patient decision|0|||
105485657|NCT02093351|363789580|FG003|Part B|Patient decision|3|||
105485658|NCT02093351|363789577|FG000|Part B|Disease progression|0|||
105485659|NCT02093351|363789578|FG001|Part B|Disease progression|0|||
105485660|NCT02093351|363789579|FG002|Part B|Disease progression|0|||
105485661|NCT02093351|363789580|FG003|Part B|Disease progression|4|||
105485662|NCT02093351|363789577|FG000|Part B|Complete response|0|||
105485663|NCT02093351|363789578|FG001|Part B|Complete response|0|||
105485664|NCT02093351|363789579|FG002|Part B|Complete response|0|||
105485665|NCT02093351|363789580|FG003|Part B|Complete response|1|||
105485666|NCT02093351|363789577|FG000|Part B|Adverse event + disease progression|0|||
105485667|NCT02093351|363789578|FG001|Part B|Adverse event + disease progression|0|||
105485668|NCT02093351|363789579|FG002|Part B|Adverse event + disease progression|0|||
105485669|NCT02093351|363789580|FG003|Part B|Adverse event + disease progression|1|||
105485670|NCT02093351|363789577|FG000|Part B|Lack of therapeutic response|0|||
105485671|NCT02093351|363789578|FG001|Part B|Lack of therapeutic response|0|||
105485672|NCT02093351|363789579|FG002|Part B|Lack of therapeutic response|0|||
105761901|NCT00810043|364781454|FG002|Overall Study|Non-medical problem|1|||
105808476|NCT03008460|364955043|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
105808477|NCT03008460|364955042|FG000|Overall Study|End of study visit outside permitted time window|0|||
105808478|NCT03008460|364955043|FG001|Overall Study|End of study visit outside permitted time window|1|||
105485673|NCT02093351|363789580|FG003|Part B|Lack of therapeutic response|12|||
105485674|NCT02093351|363789577|FG000|Part B|Condition under investigation worsened|0|||
105485675|NCT02093351|363789578|FG001|Part B|Condition under investigation worsened|0|||
105485676|NCT02093351|363789579|FG002|Part B|Condition under investigation worsened|0|||
105485677|NCT02093351|363789580|FG003|Part B|Condition under investigation worsened|39|||
105485678|NCT02093351|363789577|FG000|Part B|Adverse Event|0|||
105485679|NCT02093351|363789578|FG001|Part B|Adverse Event|0|||
105485680|NCT02093351|363789579|FG002|Part B|Adverse Event|0|||
105485681|NCT02093351|363789580|FG003|Part B|Adverse Event|2|||
105485682|NCT02093351|363789577|FG000|Part B|Death|0|||
105485683|NCT02093351|363789578|FG001|Part B|Death|0|||
105485684|NCT02093351|363789579|FG002|Part B|Death|0|||
105485685|NCT02093351|363789580|FG003|Part B|Death|1|||
105485686|NCT00920907|363789586|FG000|Induction Period|Adverse Event|0|||
105485687|NCT00920907|363789587|FG001|Induction Period|Adverse Event|2|||
105485688|NCT00920907|363789586|FG000|Induction Period|Death|1|||
105485689|NCT00920907|363789587|FG001|Induction Period|Death|1|||
105485690|NCT00920907|363789586|FG000|Induction Period|Disease Progression|12|||
105485691|NCT00920907|363789587|FG001|Induction Period|Disease Progression|11|||
105485692|NCT00920907|363789586|FG000|Induction Period|Study Drug Toxicity|8|||
105485693|NCT00920907|363789587|FG001|Induction Period|Study Drug Toxicity|6|||
105485694|NCT00920907|363789586|FG000|Induction Period|No longer meets study criteria|0|||
105485695|NCT00920907|363789587|FG001|Induction Period|No longer meets study criteria|1|||
105485696|NCT00920907|363789586|FG000|Induction Period|Withdrawal by Subject|1|||
105485697|NCT00920907|363789587|FG001|Induction Period|Withdrawal by Subject|1|||
105761902|NCT00810043|364781452|FG000|Overall Study|No longer met enrollment criteria|0|||
105761903|NCT00810043|364781453|FG001|Overall Study|No longer met enrollment criteria|0|||
105761904|NCT00810043|364781454|FG002|Overall Study|No longer met enrollment criteria|3|||
105761905|NCT03235726|364781455|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761906|NCT03235726|364781456|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761907|NCT03235726|364781457|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761908|NCT03235726|364781458|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761909|NCT03235726|364781459|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
105761910|NCT03235726|364781460|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761911|NCT03235726|364781461|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761912|NCT03235726|364781462|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761913|NCT03235726|364781463|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761914|NCT03235726|364781464|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761915|NCT03235726|364781455|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761916|NCT03235726|364781456|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761917|NCT03235726|364781457|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761918|NCT03235726|364781458|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761919|NCT03235726|364781459|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
105761920|NCT03235726|364781460|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761921|NCT03235726|364781461|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761922|NCT03235726|364781462|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761923|NCT03235726|364781463|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761924|NCT03235726|364781464|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761925|NCT01628393|364781468|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
105761926|NCT01628393|364781469|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
105761927|NCT01628393|364781470|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
105761928|NCT01628393|364781471|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
105761929|NCT01628393|364781472|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
105761930|NCT01628393|364781468|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
105761931|NCT01628393|364781469|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
105761932|NCT01628393|364781470|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
105761933|NCT01628393|364781471|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
105761934|NCT01628393|364781472|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
105761935|NCT01628393|364781468|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
105761936|NCT01628393|364781469|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
105761937|NCT01628393|364781470|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
105761938|NCT01628393|364781471|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
105761939|NCT01628393|364781472|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
105761940|NCT01628393|364781468|FG000|Blinded Active Extension Period|Adverse Event|0|||
105808479|NCT03008460|364955042|FG000|Overall Study|Lost to Follow-up|1|||
105808480|NCT03008460|364955043|FG001|Overall Study|Lost to Follow-up|3|||
105808481|NCT03131999|364955046|FG000|Overall Study|Withdrawal by Subject|0|||
105808482|NCT03131999|364955047|FG001|Overall Study|Withdrawal by Subject|1|||
105808483|NCT04634409|364955048|FG000|Overall Study|Death|0|||
105808484|NCT04634409|364955049|FG001|Overall Study|Death|0|||
105808485|NCT04634409|364955050|FG002|Overall Study|Death|0|||
105808486|NCT04634409|364955051|FG003|Overall Study|Death|0|||
105808487|NCT04634409|364955052|FG004|Overall Study|Death|0|||
105808488|NCT04634409|364955053|FG005|Overall Study|Death|0|||
105808489|NCT04634409|364955054|FG006|Overall Study|Death|0|||
105808490|NCT04634409|364955055|FG007|Overall Study|Death|0|||
105808491|NCT04634409|364955056|FG008|Overall Study|Death|0|||
105808492|NCT04634409|364955057|FG009|Overall Study|Death|0|||
105808493|NCT04634409|364955058|FG010|Overall Study|Death|1|||
105808494|NCT04634409|364955059|FG011|Overall Study|Death|0|||
105808495|NCT04634409|364955060|FG012|Overall Study|Death|1|||
105808496|NCT04634409|364955061|FG013|Overall Study|Death|0|||
105808497|NCT04634409|364955062|FG014|Overall Study|Death|0|||
105808498|NCT04634409|364955063|FG015|Overall Study|Death|0|||
105361041|NCT03286218|363328148|FG007|Qualification Phase Period 1|Adverse Event|0|||
105808499|NCT04634409|364955064|FG016|Overall Study|Death|0|||
105808500|NCT04634409|364955065|FG017|Overall Study|Death|0|||
105361042|NCT03286218|363328149|FG008|Qualification Phase Period 1|Adverse Event|0|||
105808501|NCT04634409|364955066|FG018|Overall Study|Death|0|||
105808502|NCT04634409|364955067|FG019|Overall Study|Death|0|||
105808503|NCT04634409|364955068|FG020|Overall Study|Death|0|||
105808504|NCT04634409|364955069|FG021|Overall Study|Death|0|||
105808505|NCT04634409|364955070|FG022|Overall Study|Death|0|||
105808506|NCT04634409|364955071|FG023|Overall Study|Death|0|||
105808507|NCT04634409|364955072|FG024|Overall Study|Death|0|||
105485698|NCT00920907|363789586|FG000|Maintenance Period|Disease Progression|3|||
105808508|NCT04634409|364955073|FG025|Overall Study|Death|0|||
105808509|NCT04634409|364955074|FG026|Overall Study|Death|0|||
105808510|NCT04634409|364955048|FG000|Overall Study|Adverse Event|0|||
105808511|NCT04634409|364955049|FG001|Overall Study|Adverse Event|0|||
105808512|NCT04634409|364955050|FG002|Overall Study|Adverse Event|1|||
105808513|NCT04634409|364955051|FG003|Overall Study|Adverse Event|0|||
105808514|NCT04634409|364955052|FG004|Overall Study|Adverse Event|0|||
105808515|NCT04634409|364955053|FG005|Overall Study|Adverse Event|1|||
105808516|NCT04634409|364955054|FG006|Overall Study|Adverse Event|0|||
105808517|NCT04634409|364955055|FG007|Overall Study|Adverse Event|0|||
105808518|NCT04634409|364955056|FG008|Overall Study|Adverse Event|0|||
105808519|NCT04634409|364955057|FG009|Overall Study|Adverse Event|0|||
105808520|NCT04634409|364955058|FG010|Overall Study|Adverse Event|0|||
105808521|NCT04634409|364955059|FG011|Overall Study|Adverse Event|0|||
105808522|NCT04634409|364955060|FG012|Overall Study|Adverse Event|0|||
105808523|NCT04634409|364955061|FG013|Overall Study|Adverse Event|0|||
105808524|NCT04634409|364955062|FG014|Overall Study|Adverse Event|0|||
105808525|NCT04634409|364955063|FG015|Overall Study|Adverse Event|0|||
105808526|NCT04634409|364955064|FG016|Overall Study|Adverse Event|0|||
105808527|NCT04634409|364955065|FG017|Overall Study|Adverse Event|0|||
105808528|NCT04634409|364955066|FG018|Overall Study|Adverse Event|0|||
105808529|NCT04634409|364955067|FG019|Overall Study|Adverse Event|0|||
105808530|NCT04634409|364955068|FG020|Overall Study|Adverse Event|0|||
105808531|NCT04634409|364955069|FG021|Overall Study|Adverse Event|0|||
105808532|NCT04634409|364955070|FG022|Overall Study|Adverse Event|0|||
105808533|NCT04634409|364955071|FG023|Overall Study|Adverse Event|0|||
105808534|NCT04634409|364955072|FG024|Overall Study|Adverse Event|0|||
105808535|NCT04634409|364955073|FG025|Overall Study|Adverse Event|0|||
105808536|NCT04634409|364955074|FG026|Overall Study|Adverse Event|0|||
105808537|NCT04634409|364955048|FG000|Overall Study|Lost to Follow-up|3|||
105808538|NCT04634409|364955049|FG001|Overall Study|Lost to Follow-up|1|||
105808539|NCT04634409|364955050|FG002|Overall Study|Lost to Follow-up|1|||
105808540|NCT04634409|364955051|FG003|Overall Study|Lost to Follow-up|3|||
105808541|NCT04634409|364955052|FG004|Overall Study|Lost to Follow-up|1|||
105808542|NCT04634409|364955053|FG005|Overall Study|Lost to Follow-up|1|||
105808543|NCT04634409|364955054|FG006|Overall Study|Lost to Follow-up|1|||
105808544|NCT04634409|364955055|FG007|Overall Study|Lost to Follow-up|3|||
105808545|NCT04634409|364955056|FG008|Overall Study|Lost to Follow-up|3|||
105808546|NCT04634409|364955057|FG009|Overall Study|Lost to Follow-up|11|||
105485699|NCT00920907|363789587|FG001|Maintenance Period|Disease Progression|7|||
105808547|NCT04634409|364955058|FG010|Overall Study|Lost to Follow-up|8|||
105808548|NCT04634409|364955059|FG011|Overall Study|Lost to Follow-up|15|||
105808549|NCT04634409|364955060|FG012|Overall Study|Lost to Follow-up|3|||
105808550|NCT04634409|364955061|FG013|Overall Study|Lost to Follow-up|2|||
105808551|NCT04634409|364955062|FG014|Overall Study|Lost to Follow-up|7|||
105808552|NCT04634409|364955063|FG015|Overall Study|Lost to Follow-up|0|||
105808553|NCT04634409|364955064|FG016|Overall Study|Lost to Follow-up|0|||
105808554|NCT04634409|364955065|FG017|Overall Study|Lost to Follow-up|0|||
105808555|NCT04634409|364955066|FG018|Overall Study|Lost to Follow-up|0|||
105808556|NCT04634409|364955067|FG019|Overall Study|Lost to Follow-up|0|||
105808557|NCT04634409|364955068|FG020|Overall Study|Lost to Follow-up|0|||
105808558|NCT04634409|364955069|FG021|Overall Study|Lost to Follow-up|0|||
105808559|NCT04634409|364955070|FG022|Overall Study|Lost to Follow-up|0|||
105808560|NCT04634409|364955071|FG023|Overall Study|Lost to Follow-up|0|||
105808561|NCT04634409|364955072|FG024|Overall Study|Lost to Follow-up|0|||
105808562|NCT04634409|364955073|FG025|Overall Study|Lost to Follow-up|0|||
105808563|NCT04634409|364955074|FG026|Overall Study|Lost to Follow-up|0|||
105808564|NCT04634409|364955048|FG000|Overall Study|Withdrawal by Subject|3|||
105808565|NCT04634409|364955049|FG001|Overall Study|Withdrawal by Subject|1|||
105808566|NCT04634409|364955050|FG002|Overall Study|Withdrawal by Subject|6|||
105808567|NCT04634409|364955051|FG003|Overall Study|Withdrawal by Subject|4|||
105808568|NCT04634409|364955052|FG004|Overall Study|Withdrawal by Subject|2|||
105808569|NCT04634409|364955053|FG005|Overall Study|Withdrawal by Subject|0|||
105808570|NCT04634409|364955054|FG006|Overall Study|Withdrawal by Subject|0|||
105808571|NCT04634409|364955055|FG007|Overall Study|Withdrawal by Subject|2|||
105808572|NCT04634409|364955056|FG008|Overall Study|Withdrawal by Subject|3|||
105808573|NCT04634409|364955057|FG009|Overall Study|Withdrawal by Subject|2|||
105808574|NCT04634409|364955058|FG010|Overall Study|Withdrawal by Subject|3|||
105808575|NCT04634409|364955059|FG011|Overall Study|Withdrawal by Subject|2|||
105808576|NCT04634409|364955060|FG012|Overall Study|Withdrawal by Subject|2|||
105808577|NCT04634409|364955061|FG013|Overall Study|Withdrawal by Subject|1|||
105808578|NCT04634409|364955062|FG014|Overall Study|Withdrawal by Subject|5|||
105808579|NCT04634409|364955063|FG015|Overall Study|Withdrawal by Subject|0|||
105808580|NCT04634409|364955064|FG016|Overall Study|Withdrawal by Subject|0|||
105808581|NCT04634409|364955065|FG017|Overall Study|Withdrawal by Subject|1|||
105808582|NCT04634409|364955066|FG018|Overall Study|Withdrawal by Subject|0|||
105808583|NCT04634409|364955067|FG019|Overall Study|Withdrawal by Subject|0|||
105808584|NCT04634409|364955068|FG020|Overall Study|Withdrawal by Subject|0|||
105808585|NCT04634409|364955069|FG021|Overall Study|Withdrawal by Subject|0|||
105808586|NCT04634409|364955070|FG022|Overall Study|Withdrawal by Subject|0|||
105808587|NCT04634409|364955071|FG023|Overall Study|Withdrawal by Subject|1|||
105808588|NCT04634409|364955072|FG024|Overall Study|Withdrawal by Subject|0|||
105808589|NCT04634409|364955073|FG025|Overall Study|Withdrawal by Subject|0|||
105808590|NCT04634409|364955074|FG026|Overall Study|Withdrawal by Subject|0|||
105808591|NCT04634409|364955048|FG000|Overall Study|Other - As reported by Investigator|1|||
105808592|NCT04634409|364955049|FG001|Overall Study|Other - As reported by Investigator|0|||
105808593|NCT04634409|364955050|FG002|Overall Study|Other - As reported by Investigator|0|||
105808594|NCT04634409|364955051|FG003|Overall Study|Other - As reported by Investigator|0|||
105808595|NCT04634409|364955052|FG004|Overall Study|Other - As reported by Investigator|0|||
105808596|NCT04634409|364955053|FG005|Overall Study|Other - As reported by Investigator|0|||
105808597|NCT04634409|364955054|FG006|Overall Study|Other - As reported by Investigator|0|||
105808598|NCT04634409|364955055|FG007|Overall Study|Other - As reported by Investigator|6|||
105808599|NCT04634409|364955056|FG008|Overall Study|Other - As reported by Investigator|4|||
105808600|NCT04634409|364955057|FG009|Overall Study|Other - As reported by Investigator|0|||
105808601|NCT04634409|364955058|FG010|Overall Study|Other - As reported by Investigator|1|||
105808602|NCT04634409|364955059|FG011|Overall Study|Other - As reported by Investigator|2|||
105808603|NCT04634409|364955060|FG012|Overall Study|Other - As reported by Investigator|2|||
105808604|NCT04634409|364955061|FG013|Overall Study|Other - As reported by Investigator|1|||
105808605|NCT04634409|364955062|FG014|Overall Study|Other - As reported by Investigator|0|||
105808606|NCT04634409|364955063|FG015|Overall Study|Other - As reported by Investigator|0|||
105808607|NCT04634409|364955064|FG016|Overall Study|Other - As reported by Investigator|0|||
105808608|NCT04634409|364955065|FG017|Overall Study|Other - As reported by Investigator|0|||
105808609|NCT04634409|364955066|FG018|Overall Study|Other - As reported by Investigator|0|||
105808610|NCT04634409|364955067|FG019|Overall Study|Other - As reported by Investigator|0|||
105808611|NCT04634409|364955068|FG020|Overall Study|Other - As reported by Investigator|0|||
105808612|NCT04634409|364955069|FG021|Overall Study|Other - As reported by Investigator|0|||
105808613|NCT04634409|364955070|FG022|Overall Study|Other - As reported by Investigator|0|||
105808614|NCT04634409|364955071|FG023|Overall Study|Other - As reported by Investigator|0|||
105808615|NCT04634409|364955072|FG024|Overall Study|Other - As reported by Investigator|0|||
105808616|NCT04634409|364955073|FG025|Overall Study|Other - As reported by Investigator|0|||
105808617|NCT04634409|364955074|FG026|Overall Study|Other - As reported by Investigator|0|||
105808618|NCT02154529|364955075|FG000|Overall Study|Death|1|||
105808619|NCT02154529|364955076|FG001|Overall Study|Death|1|||
105808620|NCT02154529|364955077|FG002|Overall Study|Death|5|||
105808621|NCT02154529|364955078|FG003|Overall Study|Death|1|||
105808622|NCT02154529|364955075|FG000|Overall Study|Termination of study by sponsor|2|||
105808623|NCT02154529|364955076|FG001|Overall Study|Termination of study by sponsor|2|||
105808624|NCT02154529|364955077|FG002|Overall Study|Termination of study by sponsor|3|||
105808625|NCT02154529|364955078|FG003|Overall Study|Termination of study by sponsor|1|||
105761941|NCT01628393|364781469|FG001|Blinded Active Extension Period|Adverse Event|1|||
105761942|NCT01628393|364781470|FG002|Blinded Active Extension Period|Adverse Event|0|||
105761943|NCT01628393|364781471|FG003|Blinded Active Extension Period|Adverse Event|2|||
105761944|NCT01628393|364781472|FG004|Blinded Active Extension Period|Adverse Event|2|||
105761945|NCT01628393|364781468|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
105761946|NCT01628393|364781469|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
105761947|NCT01628393|364781470|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
105761948|NCT01628393|364781471|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
105761949|NCT01628393|364781472|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
105761950|NCT01628393|364781468|FG000|Blinded Active Extension Period|Physician Decision|0|||
105761951|NCT01628393|364781469|FG001|Blinded Active Extension Period|Physician Decision|3|||
105761952|NCT01628393|364781470|FG002|Blinded Active Extension Period|Physician Decision|0|||
105761953|NCT01628393|364781471|FG003|Blinded Active Extension Period|Physician Decision|1|||
105761954|NCT01628393|364781472|FG004|Blinded Active Extension Period|Physician Decision|0|||
105761955|NCT01628393|364781468|FG000|Blinded Active Extension Period|Protocol Violation|0|||
105761956|NCT01628393|364781469|FG001|Blinded Active Extension Period|Protocol Violation|0|||
105761957|NCT01628393|364781470|FG002|Blinded Active Extension Period|Protocol Violation|2|||
105761958|NCT01628393|364781471|FG003|Blinded Active Extension Period|Protocol Violation|1|||
105761959|NCT01628393|364781472|FG004|Blinded Active Extension Period|Protocol Violation|0|||
105761960|NCT01628393|364781468|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
105761961|NCT01628393|364781469|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
105761962|NCT01628393|364781470|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
105761963|NCT01628393|364781471|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
105761964|NCT01628393|364781472|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
105761965|NCT03934541|364781479|FG000|Overall Study|Study Terminated by Sponsor|0|||
105761966|NCT03934541|364781480|FG001|Overall Study|Study Terminated by Sponsor|1|||
105761967|NCT03934541|364781481|FG002|Overall Study|Study Terminated by Sponsor|0|||
105761968|NCT03934541|364781482|FG003|Overall Study|Study Terminated by Sponsor|0|||
105761969|NCT04539262|364781485|FG000|Overall Study|Adverse Event|0|||
105761970|NCT04539262|364781486|FG001|Overall Study|Adverse Event|0|||
105761971|NCT04539262|364781487|FG002|Overall Study|Adverse Event|1|||
105761972|NCT04539262|364781488|FG003|Overall Study|Adverse Event|0|||
105761973|NCT04539262|364781489|FG004|Overall Study|Adverse Event|0|||
105761974|NCT04539262|364781490|FG005|Overall Study|Adverse Event|0|||
105761975|NCT04539262|364781491|FG006|Overall Study|Adverse Event|0|||
105761976|NCT04539262|364781492|FG007|Overall Study|Adverse Event|0|||
105761977|NCT04539262|364781485|FG000|Overall Study|Withdrew Consent|0|||
105761978|NCT04539262|364781486|FG001|Overall Study|Withdrew Consent|0|||
105761979|NCT04539262|364781487|FG002|Overall Study|Withdrew Consent|0|||
105761980|NCT04539262|364781488|FG003|Overall Study|Withdrew Consent|1|||
105761981|NCT04539262|364781489|FG004|Overall Study|Withdrew Consent|0|||
105761982|NCT04539262|364781490|FG005|Overall Study|Withdrew Consent|0|||
105761983|NCT04539262|364781491|FG006|Overall Study|Withdrew Consent|0|||
105761984|NCT04539262|364781492|FG007|Overall Study|Withdrew Consent|0|||
105761985|NCT04539262|364781485|FG000|Overall Study|Randomized, Not treated|0|||
105761986|NCT04539262|364781486|FG001|Overall Study|Randomized, Not treated|1|||
105761987|NCT04539262|364781487|FG002|Overall Study|Randomized, Not treated|0|||
105761988|NCT04539262|364781488|FG003|Overall Study|Randomized, Not treated|0|||
105761989|NCT04539262|364781489|FG004|Overall Study|Randomized, Not treated|0|||
105761990|NCT04539262|364781490|FG005|Overall Study|Randomized, Not treated|0|||
105761991|NCT04539262|364781491|FG006|Overall Study|Randomized, Not treated|1|||
105761992|NCT04539262|364781492|FG007|Overall Study|Randomized, Not treated|0|||
105761993|NCT00282568|364781493|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
105761994|NCT00282568|364781493|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
105761995|NCT00282568|364781493|FG000|Extended Treatment Period|Adverse Event|17|||
105761996|NCT00282568|364781493|FG000|Extended Treatment Period|Non-compliance|4|||
105761997|NCT00282568|364781493|FG000|Extended Treatment Period|Physician Decision|1|||
105761998|NCT00282568|364781493|FG000|Extended Treatment Period|Lost to Follow-up|2|||
105761999|NCT03725293|364781494|FG000|Overall Study|Physician Decision|9|||
105762000|NCT03725293|364781495|FG001|Overall Study|Physician Decision|6|||
105762001|NCT03725293|364781494|FG000|Overall Study|alternative vascular access needs|1|||
105762002|NCT03725293|364781495|FG001|Overall Study|alternative vascular access needs|2|||
105762003|NCT03725293|364781494|FG000|Overall Study|venous anatomy screen failures|2|||
105762004|NCT03725293|364781495|FG001|Overall Study|venous anatomy screen failures|1|||
105762005|NCT02143141|364781496|FG000|Overall Study|pain scores at 24 hours not collected|1|||
105762006|NCT02143141|364781497|FG001|Overall Study|pain scores at 24 hours not collected|0|||
105762007|NCT03673956|364781498|FG000|Overall Study|Lost to Follow-up|1|||
105762008|NCT03673956|364781499|FG001|Overall Study|Lost to Follow-up|0|||
105762009|NCT03673956|364781500|FG002|Overall Study|Lost to Follow-up|0|||
105762010|NCT03673956|364781501|FG003|Overall Study|Lost to Follow-up|0|||
105762011|NCT03673956|364781498|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
105762012|NCT03673956|364781499|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
105762013|NCT03673956|364781500|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
105762014|NCT03673956|364781501|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
105762015|NCT04397796|364781502|FG000|Overall Study|Death|3|||
105762016|NCT04397796|364781503|FG001|Overall Study|Death|1|||
105762017|NCT03168555|364781504|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
105762018|NCT03168555|364781504|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
105762019|NCT03168555|364781504|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
105762020|NCT03168555|364781504|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
105762021|NCT01040845|364781505|FG000|Overall Study|Withdrawal by Subject|1|||
105762022|NCT01040845|364781506|FG001|Overall Study|Withdrawal by Subject|1|||
105762023|NCT01040845|364781505|FG000|Overall Study|Physician Decision|1|||
105762024|NCT01040845|364781506|FG001|Overall Study|Physician Decision|0|||
105762025|NCT01981109|364781507|FG000|Overall Study|Death|36|||
105762026|NCT01981109|364781507|FG000|Overall Study|Withdrawal by Subject|40|||
105762027|NCT01981109|364781507|FG000|Overall Study|Lost to Follow-up|9|||
105762028|NCT01981109|364781507|FG000|Overall Study|No Discontinuation Documentation|37|||
105762029|NCT01981109|364781507|FG000|Overall Study|Study Termination|100|||
105762030|NCT01981109|364781507|FG000|Overall Study|No data available|2|||
105762031|NCT00928512|364781522|FG000|Overall Study|Adverse Event|4|||
105762032|NCT00928512|364781523|FG001|Overall Study|Adverse Event|3|||
105762033|NCT00928512|364781524|FG002|Overall Study|Adverse Event|2|||
105762034|NCT00928512|364781525|FG003|Overall Study|Adverse Event|8|||
105762035|NCT00928512|364781526|FG004|Overall Study|Adverse Event|6|||
105762036|NCT00928512|364781522|FG000|Overall Study|Lack of Efficacy|2|||
105762037|NCT00928512|364781523|FG001|Overall Study|Lack of Efficacy|0|||
105808626|NCT02154529|364955075|FG000|Overall Study|Lost to Follow-up|1|||
105361043|NCT03286218|363328150|FG009|Qualification Phase Period 1|Adverse Event|0|||
105361044|NCT03286218|363328151|FG010|Qualification Phase Period 1|Adverse Event|0|||
105361045|NCT03286218|363328152|FG011|Qualification Phase Period 1|Adverse Event|0|||
105361046|NCT03286218|363328141|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
105361047|NCT03286218|363328142|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
105762038|NCT00928512|364781524|FG002|Overall Study|Lack of Efficacy|4|||
105762039|NCT00928512|364781525|FG003|Overall Study|Lack of Efficacy|7|||
105762040|NCT00928512|364781526|FG004|Overall Study|Lack of Efficacy|3|||
105762041|NCT00928512|364781522|FG000|Overall Study|Protocol Violation|0|||
105762042|NCT00928512|364781523|FG001|Overall Study|Protocol Violation|1|||
105762043|NCT00928512|364781524|FG002|Overall Study|Protocol Violation|0|||
105762044|NCT00928512|364781525|FG003|Overall Study|Protocol Violation|1|||
105762045|NCT00928512|364781526|FG004|Overall Study|Protocol Violation|3|||
105762046|NCT00928512|364781522|FG000|Overall Study|Withdrawal by Subject|3|||
105762047|NCT00928512|364781523|FG001|Overall Study|Withdrawal by Subject|0|||
105762048|NCT00928512|364781524|FG002|Overall Study|Withdrawal by Subject|3|||
105762049|NCT00928512|364781525|FG003|Overall Study|Withdrawal by Subject|4|||
105762050|NCT00928512|364781526|FG004|Overall Study|Withdrawal by Subject|0|||
105762051|NCT00928512|364781522|FG000|Overall Study|Lost to Follow-up|1|||
105762052|NCT00928512|364781523|FG001|Overall Study|Lost to Follow-up|1|||
105762053|NCT00928512|364781524|FG002|Overall Study|Lost to Follow-up|2|||
105762054|NCT00928512|364781525|FG003|Overall Study|Lost to Follow-up|1|||
105762055|NCT00928512|364781526|FG004|Overall Study|Lost to Follow-up|3|||
105762056|NCT00928512|364781522|FG000|Overall Study|Administrative Problems|0|||
105762057|NCT00928512|364781523|FG001|Overall Study|Administrative Problems|1|||
105762058|NCT00928512|364781524|FG002|Overall Study|Administrative Problems|0|||
105762059|NCT00928512|364781525|FG003|Overall Study|Administrative Problems|0|||
105762060|NCT00928512|364781526|FG004|Overall Study|Administrative Problems|0|||
105762061|NCT04083794|364781527|FG000|Overall Study|Lost to Follow-up|9|||
105762062|NCT03383614|364781528|FG000|Overall Study|Withdrawal by Subject|0|||
105762063|NCT03383614|364781529|FG001|Overall Study|Withdrawal by Subject|1|||
105762064|NCT03383614|364781530|FG002|Overall Study|Withdrawal by Subject|0|||
105762065|NCT03383614|364781531|FG003|Overall Study|Withdrawal by Subject|0|||
105762066|NCT01296698|364781534|FG000|Overall Study|Adverse Event|1|||
105762067|NCT01296698|364781535|FG001|Overall Study|Adverse Event|0|||
105762068|NCT01296698|364781534|FG000|Overall Study|Death|1|||
105762069|NCT01296698|364781535|FG001|Overall Study|Death|0|||
105762070|NCT01296698|364781534|FG000|Overall Study|Lost to Follow-up|19|||
105762071|NCT01296698|364781535|FG001|Overall Study|Lost to Follow-up|1|||
105762072|NCT01296698|364781534|FG000|Overall Study|Withdrawal by Subject|12|||
105762073|NCT01296698|364781535|FG001|Overall Study|Withdrawal by Subject|0|||
105762074|NCT01296698|364781534|FG000|Overall Study|Difficulty Contacting Subject|2|||
105762075|NCT01296698|364781535|FG001|Overall Study|Difficulty Contacting Subject|0|||
105762076|NCT01296698|364781534|FG000|Overall Study|Study Terminated by Sponsor|209|||
105762077|NCT01296698|364781535|FG001|Overall Study|Study Terminated by Sponsor|12|||
105762078|NCT03639987|364781538|FG000|Overall Study|Study terminated by sponsor|26|||
105762079|NCT03639987|364781539|FG001|Overall Study|Study terminated by sponsor|25|||
105762080|NCT03639987|364781538|FG000|Overall Study|Lost to Follow-up|0|||
105762081|NCT03639987|364781539|FG001|Overall Study|Lost to Follow-up|1|||
105762082|NCT02810951|364781545|FG000|Overall Study|Adverse Event|1|||
105762083|NCT01250756|364781546|FG000|Infant Series|Withdrawal by Subject|4|||
105762084|NCT01250756|364781547|FG001|Infant Series|Withdrawal by Subject|5|||
105762085|NCT01250756|364781546|FG000|Infant Series|Randomized, Not Vaccinated|2|||
105762086|NCT01250756|364781547|FG001|Infant Series|Randomized, Not Vaccinated|2|||
105762087|NCT01250756|364781546|FG000|Infant Series|Other|22|||
105762088|NCT01250756|364781547|FG001|Infant Series|Other|0|||
105762089|NCT01250756|364781546|FG000|After Infant Series|Adverse Event|5|||
105762090|NCT01250756|364781547|FG001|After Infant Series|Adverse Event|2|||
105762091|NCT01250756|364781546|FG000|After Infant Series|Withdrawal by Subject|4|||
105762092|NCT01250756|364781547|FG001|After Infant Series|Withdrawal by Subject|1|||
105762093|NCT01250756|364781546|FG000|After Infant Series|Other|2|||
105762094|NCT01250756|364781547|FG001|After Infant Series|Other|1|||
105762095|NCT01250756|364781546|FG000|Toddler Dose|Adverse Event|0|||
105762096|NCT01250756|364781547|FG001|Toddler Dose|Adverse Event|1|||
105762097|NCT01250756|364781546|FG000|After Toddler Dose|Adverse Event|0|||
105762098|NCT01250756|364781547|FG001|After Toddler Dose|Adverse Event|1|||
105762099|NCT03803202|364781548|FG000|Overall Study|Other|0|||
105762100|NCT03803202|364781549|FG001|Overall Study|Other|1|||
105762101|NCT03803202|364781550|FG002|Overall Study|Other|0|||
105762102|NCT03803202|364781551|FG003|Overall Study|Other|0|||
105762103|NCT03803202|364781552|FG004|Overall Study|Other|0|||
105762104|NCT03803202|364781553|FG005|Overall Study|Other|0|||
105762105|NCT03803202|364781554|FG006|Overall Study|Other|0|||
105762106|NCT03803202|364781555|FG007|Overall Study|Other|0|||
105762107|NCT03803202|364781556|FG008|Overall Study|Other|0|||
105762108|NCT03803202|364781548|FG000|Overall Study|Death|0|||
105762109|NCT03803202|364781549|FG001|Overall Study|Death|0|||
105762110|NCT03803202|364781550|FG002|Overall Study|Death|0|||
105762111|NCT03803202|364781551|FG003|Overall Study|Death|0|||
105762112|NCT03803202|364781552|FG004|Overall Study|Death|0|||
105762113|NCT03803202|364781553|FG005|Overall Study|Death|1|||
105762114|NCT03803202|364781554|FG006|Overall Study|Death|0|||
105762115|NCT03803202|364781555|FG007|Overall Study|Death|0|||
105762116|NCT03803202|364781556|FG008|Overall Study|Death|0|||
105762117|NCT03803202|364781548|FG000|Overall Study|Withdrawal by Subject|0|||
105762118|NCT03803202|364781549|FG001|Overall Study|Withdrawal by Subject|0|||
105762119|NCT03803202|364781550|FG002|Overall Study|Withdrawal by Subject|1|||
105762120|NCT03803202|364781551|FG003|Overall Study|Withdrawal by Subject|0|||
105762121|NCT03803202|364781552|FG004|Overall Study|Withdrawal by Subject|0|||
105762122|NCT03803202|364781553|FG005|Overall Study|Withdrawal by Subject|0|||
105762123|NCT03803202|364781554|FG006|Overall Study|Withdrawal by Subject|0|||
105762124|NCT03803202|364781555|FG007|Overall Study|Withdrawal by Subject|1|||
105762125|NCT03803202|364781556|FG008|Overall Study|Withdrawal by Subject|0|||
105762126|NCT03803202|364781548|FG000|Overall Study|Lost to Follow-up|0|||
105762127|NCT03803202|364781549|FG001|Overall Study|Lost to Follow-up|0|||
105762128|NCT03803202|364781550|FG002|Overall Study|Lost to Follow-up|0|||
105762129|NCT03803202|364781551|FG003|Overall Study|Lost to Follow-up|1|||
105762130|NCT03803202|364781552|FG004|Overall Study|Lost to Follow-up|1|||
105762131|NCT03803202|364781553|FG005|Overall Study|Lost to Follow-up|0|||
105762132|NCT03803202|364781554|FG006|Overall Study|Lost to Follow-up|1|||
105762133|NCT03803202|364781555|FG007|Overall Study|Lost to Follow-up|0|||
105762134|NCT03803202|364781556|FG008|Overall Study|Lost to Follow-up|0|||
105762135|NCT01815580|364781557|FG000|Overall Study|Lost to Follow-up|4|||
105762136|NCT01815580|364781558|FG001|Overall Study|Lost to Follow-up|7|||
105762137|NCT01815580|364781557|FG000|Overall Study|Withdrawal by Subject|3|||
105762138|NCT01815580|364781558|FG001|Overall Study|Withdrawal by Subject|4|||
105762139|NCT01815580|364781557|FG000|Overall Study|Excluded from analysis|5|||
105762140|NCT01815580|364781558|FG001|Overall Study|Excluded from analysis|4|||
105762141|NCT00345540|364781559|FG000|Overall Study|Withdrawal by Subject|1|||
105762142|NCT02999191|364781564|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
105762143|NCT02999191|364781565|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
105762144|NCT02999191|364781566|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
105762145|NCT02657434|364783075|FG000|Overall Study|Study Terminated By Sponsor|64|||
105762146|NCT02657434|364783076|FG001|Overall Study|Study Terminated By Sponsor|82|||
105762147|NCT02657434|364783075|FG000|Overall Study|Death|189|||
105762148|NCT02657434|364783076|FG001|Overall Study|Death|190|||
105762149|NCT02657434|364783075|FG000|Overall Study|Lost to Follow-up|2|||
105762150|NCT02657434|364783076|FG001|Overall Study|Lost to Follow-up|2|||
105762151|NCT02657434|364783075|FG000|Overall Study|Randomization by Error|2|||
105762152|NCT02657434|364783076|FG001|Overall Study|Randomization by Error|0|||
105762153|NCT02657434|364783075|FG000|Overall Study|Withdrawal by Subject|28|||
105762154|NCT02657434|364783076|FG001|Overall Study|Withdrawal by Subject|17|||
105762155|NCT02657434|364783075|FG000|Overall Study|Protocol Violation|1|||
105762156|NCT02657434|364783076|FG001|Overall Study|Protocol Violation|0|||
105762157|NCT02657434|364783075|FG000|Overall Study|Physician Decision|0|||
105762158|NCT02657434|364783076|FG001|Overall Study|Physician Decision|1|||
105762159|NCT00608881|364783077|FG000|Overall Study|Death|22|||
105762160|NCT00608881|364783078|FG001|Overall Study|Death|13|||
105762161|NCT00608881|364783077|FG000|Overall Study|Adverse Event|5|||
105762162|NCT00608881|364783078|FG001|Overall Study|Adverse Event|3|||
105762163|NCT00608881|364783077|FG000|Overall Study|Lost to Follow-up|28|||
105762164|NCT00608881|364783078|FG001|Overall Study|Lost to Follow-up|14|||
105762165|NCT00608881|364783077|FG000|Overall Study|Withdrawal by Subject|18|||
105762166|NCT00608881|364783078|FG001|Overall Study|Withdrawal by Subject|29|||
105808627|NCT02154529|364955076|FG001|Overall Study|Lost to Follow-up|0|||
105808628|NCT02154529|364955077|FG002|Overall Study|Lost to Follow-up|0|||
105808629|NCT02154529|364955078|FG003|Overall Study|Lost to Follow-up|0|||
105808630|NCT00365352|364955079|FG000|Overall Study|Adverse Event|6|||
105808631|NCT00365352|364955080|FG001|Overall Study|Adverse Event|7|||
105808632|NCT00365352|364955081|FG002|Overall Study|Adverse Event|8|||
105808633|NCT00365352|364955079|FG000|Overall Study|Participant Withdrew Consent|8|||
105808634|NCT00365352|364955080|FG001|Overall Study|Participant Withdrew Consent|3|||
105808635|NCT00365352|364955081|FG002|Overall Study|Participant Withdrew Consent|4|||
105808636|NCT00365352|364955079|FG000|Overall Study|Lack of Efficacy|3|||
105808637|NCT00365352|364955080|FG001|Overall Study|Lack of Efficacy|0|||
105808638|NCT00365352|364955081|FG002|Overall Study|Lack of Efficacy|0|||
105808639|NCT00365352|364955079|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
105808640|NCT00365352|364955080|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
105808641|NCT00365352|364955081|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
105808642|NCT00365352|364955079|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
105808643|NCT00365352|364955080|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
105808644|NCT00365352|364955081|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
105808645|NCT00365352|364955079|FG000|Overall Study|Lost to Follow-up|1|||
105808646|NCT00365352|364955080|FG001|Overall Study|Lost to Follow-up|1|||
105808647|NCT00365352|364955081|FG002|Overall Study|Lost to Follow-up|0|||
105808648|NCT00365352|364955079|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
105808649|NCT00365352|364955080|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
105808650|NCT00365352|364955081|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
105808651|NCT02109133|364955083|FG000|Overall Study|Lost to Follow-up|1|||
105808652|NCT02109133|364955084|FG001|Overall Study|Lost to Follow-up|0|||
105808653|NCT00409578|364955085|FG000|Overall Study|Adverse Event|27|||
105808654|NCT00409578|364955086|FG001|Overall Study|Adverse Event|37|||
105808655|NCT00409578|364955087|FG002|Overall Study|Adverse Event|25|||
105808656|NCT00409578|364955088|FG003|Overall Study|Adverse Event|33|||
105808657|NCT00409578|364955085|FG000|Overall Study|Abnormal laboratory value(s)|2|||
105808658|NCT00409578|364955086|FG001|Overall Study|Abnormal laboratory value(s)|2|||
105808659|NCT00409578|364955087|FG002|Overall Study|Abnormal laboratory value(s)|2|||
105808660|NCT00409578|364955088|FG003|Overall Study|Abnormal laboratory value(s)|4|||
105808661|NCT00409578|364955085|FG000|Overall Study|Lack of Efficacy|0|||
105808662|NCT00409578|364955086|FG001|Overall Study|Lack of Efficacy|0|||
105808663|NCT00409578|364955087|FG002|Overall Study|Lack of Efficacy|0|||
105808664|NCT00409578|364955088|FG003|Overall Study|Lack of Efficacy|2|||
105808665|NCT00409578|364955085|FG000|Overall Study|Subject no longer requires study drug|0|||
105808666|NCT00409578|364955086|FG001|Overall Study|Subject no longer requires study drug|0|||
105808667|NCT00409578|364955087|FG002|Overall Study|Subject no longer requires study drug|0|||
105808668|NCT00409578|364955088|FG003|Overall Study|Subject no longer requires study drug|1|||
105808669|NCT00409578|364955085|FG000|Overall Study|Withdrawal by Subject|8|||
105808670|NCT00409578|364955086|FG001|Overall Study|Withdrawal by Subject|15|||
105808671|NCT00409578|364955087|FG002|Overall Study|Withdrawal by Subject|16|||
105808672|NCT00409578|364955088|FG003|Overall Study|Withdrawal by Subject|17|||
105808673|NCT00409578|364955085|FG000|Overall Study|Lost to Follow-up|2|||
105808674|NCT00409578|364955086|FG001|Overall Study|Lost to Follow-up|0|||
105808675|NCT00409578|364955087|FG002|Overall Study|Lost to Follow-up|2|||
105808676|NCT00409578|364955088|FG003|Overall Study|Lost to Follow-up|2|||
105808677|NCT00409578|364955085|FG000|Overall Study|Administrative problems|8|||
105808678|NCT00409578|364955086|FG001|Overall Study|Administrative problems|9|||
105808679|NCT00409578|364955087|FG002|Overall Study|Administrative problems|2|||
105808680|NCT00409578|364955088|FG003|Overall Study|Administrative problems|4|||
105808681|NCT00409578|364955085|FG000|Overall Study|Death|2|||
105808682|NCT00409578|364955086|FG001|Overall Study|Death|4|||
105808683|NCT00409578|364955087|FG002|Overall Study|Death|4|||
105808684|NCT00409578|364955088|FG003|Overall Study|Death|2|||
105808685|NCT00409578|364955085|FG000|Overall Study|Protocol Violation|3|||
105808686|NCT00409578|364955086|FG001|Overall Study|Protocol Violation|2|||
105808687|NCT00409578|364955087|FG002|Overall Study|Protocol Violation|3|||
105808688|NCT00409578|364955088|FG003|Overall Study|Protocol Violation|1|||
105808689|NCT00409578|364955085|FG000|Overall Study|Missing|0|||
105808690|NCT00409578|364955086|FG001|Overall Study|Missing|1|||
105808691|NCT00409578|364955087|FG002|Overall Study|Missing|0|||
105808692|NCT00409578|364955088|FG003|Overall Study|Missing|1|||
105808693|NCT01922349|364955089|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
105808694|NCT01922349|364955090|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
105485700|NCT00920907|363789586|FG000|Maintenance Period|Administrative (study closure)|7|||
105485701|NCT00920907|363789587|FG001|Maintenance Period|Administrative (study closure)|2|||
105485702|NCT00920907|363789586|FG000|Maintenance Period|Study Drug Toxicity|0|||
105485703|NCT00920907|363789587|FG001|Maintenance Period|Study Drug Toxicity|2|||
105808695|NCT01922349|364955091|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
105808696|NCT01922349|364955092|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
105808697|NCT00458302|364956749|FG000|Overall Study|Adverse Event|4|||
105808698|NCT00458302|364956750|FG001|Overall Study|Adverse Event|14|||
105808699|NCT00458302|364956749|FG000|Overall Study|Pregnancy|2|||
105808700|NCT00458302|364956750|FG001|Overall Study|Pregnancy|1|||
105808701|NCT00458302|364956749|FG000|Overall Study|Protocol Violation|0|||
105808702|NCT00458302|364956750|FG001|Overall Study|Protocol Violation|2|||
105808703|NCT00458302|364956749|FG000|Overall Study|Withdrawal by Subject|6|||
105808704|NCT00458302|364956750|FG001|Overall Study|Withdrawal by Subject|4|||
105808705|NCT00458302|364956749|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
105808706|NCT00458302|364956750|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
105808707|NCT00458302|364956749|FG000|Overall Study|Study Termination By Sponsor|1|||
105808708|NCT00458302|364956750|FG001|Overall Study|Study Termination By Sponsor|0|||
105808709|NCT00458302|364956749|FG000|Overall Study|Lost to Follow-up|2|||
105808710|NCT00458302|364956750|FG001|Overall Study|Lost to Follow-up|0|||
105808711|NCT00458302|364956749|FG000|Overall Study|Other|4|||
105808712|NCT00458302|364956750|FG001|Overall Study|Other|2|||
105808713|NCT04582266|364956751|FG000|Overall Study|Lost to Follow-up|7|||
105808714|NCT04582266|364956752|FG001|Overall Study|Lost to Follow-up|5|||
105808715|NCT04582266|364956751|FG000|Overall Study|Withdrawal by Subject|1|||
105808716|NCT04582266|364956752|FG001|Overall Study|Withdrawal by Subject|0|||
105808717|NCT04582266|364956751|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
105808718|NCT04582266|364956752|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
105808719|NCT01341639|364956753|FG000|Infant Series|Protocol Violation|1|||
105808720|NCT01341639|364956754|FG001|Infant Series|Protocol Violation|0|||
105808721|NCT01341639|364956753|FG000|Infant Series|Not Vaccinated|0|||
105808722|NCT01341639|364956754|FG001|Infant Series|Not Vaccinated|1|||
105808723|NCT01341639|364956753|FG000|Infant Series|Adverse Event|0|||
105808724|NCT01341639|364956754|FG001|Infant Series|Adverse Event|5|||
105808725|NCT01341639|364956753|FG000|Infant Series|Withdrawal by Subject|11|||
105808726|NCT01341639|364956754|FG001|Infant Series|Withdrawal by Subject|8|||
105808727|NCT01341639|364956753|FG000|Infant Series|Lost to Follow-up|0|||
105808728|NCT01341639|364956754|FG001|Infant Series|Lost to Follow-up|2|||
105808729|NCT01341639|364956753|FG000|Infant Series|Site 0048 Participants|17|||
105808730|NCT01341639|364956754|FG001|Infant Series|Site 0048 Participants|16|||
105808731|NCT01341639|364956753|FG000|Interim Period|Withdrawal by Subject|6|||
105808732|NCT01341639|364956754|FG001|Interim Period|Withdrawal by Subject|7|||
105808733|NCT01341639|364956753|FG000|Interim Period|Lost to Follow-up|2|||
105808734|NCT01341639|364956754|FG001|Interim Period|Lost to Follow-up|0|||
105808735|NCT01341639|364956753|FG000|Interim Period|Physician Decision|0|||
105808736|NCT01341639|364956754|FG001|Interim Period|Physician Decision|1|||
105808737|NCT01341639|364956753|FG000|Interim Period|Protocol Violation|0|||
105808738|NCT01341639|364956754|FG001|Interim Period|Protocol Violation|1|||
105808739|NCT01341639|364956753|FG000|Post-Treatment|Withdrawal by Subject|0|||
105808740|NCT01341639|364956754|FG001|Post-Treatment|Withdrawal by Subject|1|||
105808741|NCT01341639|364956753|FG000|Post-Treatment|Adverse Event|0|||
105808742|NCT01341639|364956754|FG001|Post-Treatment|Adverse Event|2|||
105808743|NCT01299038|364956757|FG000|Overall Study|Withdrawal by Subject|1|||
105808744|NCT01299038|364956758|FG001|Overall Study|Withdrawal by Subject|0|||
105808745|NCT01162499|364956759|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
105808746|NCT01162499|364956760|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
105808747|NCT03355742|364956761|FG000|Overall Study|Lost to Follow-up|4|||
105808748|NCT03355742|364956761|FG000|Overall Study|Withdrawal by Subject|29|||
105808749|NCT03355742|364956761|FG000|Overall Study|Physician Decision|6|||
105808750|NCT03355742|364956761|FG000|Overall Study|Death|55|||
105485704|NCT00920907|363789586|FG000|Maintenance Period|Death|1|||
105485705|NCT00920907|363789587|FG001|Maintenance Period|Death|1|||
105485706|NCT00920907|363789586|FG000|Maintenance Period|Withdrawal by Subject|1|||
105485707|NCT00920907|363789587|FG001|Maintenance Period|Withdrawal by Subject|0|||
105485708|NCT00920907|363789586|FG000|Maintenance Period|Adverse Event|0|||
105485709|NCT00920907|363789587|FG001|Maintenance Period|Adverse Event|1|||
105808751|NCT03355742|364956761|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
105808752|NCT01165996|364956763|FG000|Overall Study|Death|1|||
105808753|NCT01165996|364956763|FG000|Overall Study|Physician Decision|1|||
105808754|NCT00444795|364956768|FG000|Overall Study|Not Treated|1|||
105808755|NCT00444795|364956768|FG000|Overall Study|Treated Prior to the Contract Date|2|||
105808756|NCT00988169|364956769|FG000|Overall Study|Withdrawal by Subject|1|||
105808757|NCT02322879|364956770|FG000|First Intervention|Physician Decision|1|||
105808758|NCT02322879|364956771|FG001|First Intervention|Physician Decision|0|||
105808759|NCT00582036|364956772|FG000|Overall Study|Withdrawal by Subject|0|||
105808760|NCT00582036|364956773|FG001|Overall Study|Withdrawal by Subject|1|||
105808761|NCT02848599|364956777|FG000|Overall Study|Protocol Violation|7|||
105808762|NCT02848599|364956778|FG001|Overall Study|Protocol Violation|9|||
105808763|NCT02352337|364956779|FG000|Overall Study|Patients never treated|4|||
105808764|NCT02352337|364956780|FG001|Overall Study|Patients never treated|1|||
105361048|NCT03286218|363328143|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
105485710|NCT00039871|363789588|FG000|Overall Study|Adverse Event|165|||
105808765|NCT02352337|364956781|FG002|Overall Study|Patients never treated|2|||
105808766|NCT01787825|364956782|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
105485711|NCT00039871|363789588|FG000|Overall Study|Lost to Follow-up|18|||
105808767|NCT01787825|364956783|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
105808768|NCT01787825|364956782|FG000|Overall Study|Data Not Analyzable|5|||
105808769|NCT01787825|364956783|FG001|Overall Study|Data Not Analyzable|1|||
105808770|NCT00718159|364956784|FG000|Overall Study|Progressive Disease|3|||
105808771|NCT00718159|364956785|FG001|Overall Study|Progressive Disease|3|||
105808772|NCT00718159|364956786|FG002|Overall Study|Progressive Disease|2|||
105808773|NCT00718159|364956787|FG003|Overall Study|Progressive Disease|0|||
105808774|NCT00718159|364956788|FG004|Overall Study|Progressive Disease|6|||
105808775|NCT00718159|364956789|FG005|Overall Study|Progressive Disease|0|||
105808776|NCT00718159|364956790|FG006|Overall Study|Progressive Disease|0|||
105808777|NCT00718159|364956784|FG000|Overall Study|Death due to Adverse Event|0|||
105808778|NCT00718159|364956785|FG001|Overall Study|Death due to Adverse Event|0|||
105808779|NCT00718159|364956786|FG002|Overall Study|Death due to Adverse Event|0|||
105808780|NCT00718159|364956787|FG003|Overall Study|Death due to Adverse Event|2|||
105808781|NCT00718159|364956788|FG004|Overall Study|Death due to Adverse Event|2|||
105808782|NCT00718159|364956789|FG005|Overall Study|Death due to Adverse Event|0|||
105808783|NCT00718159|364956790|FG006|Overall Study|Death due to Adverse Event|0|||
105808784|NCT00718159|364956784|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
105808785|NCT00718159|364956785|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
105808786|NCT00718159|364956786|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
105808787|NCT00718159|364956787|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
105808788|NCT00718159|364956788|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
105808789|NCT00718159|364956789|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
105808790|NCT00718159|364956790|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
105808791|NCT00718159|364956784|FG000|Overall Study|Investigator Decision|0|||
105808792|NCT00718159|364956785|FG001|Overall Study|Investigator Decision|0|||
105808793|NCT00718159|364956786|FG002|Overall Study|Investigator Decision|0|||
105808794|NCT00718159|364956787|FG003|Overall Study|Investigator Decision|0|||
105808795|NCT00718159|364956788|FG004|Overall Study|Investigator Decision|0|||
105808796|NCT00718159|364956789|FG005|Overall Study|Investigator Decision|1|||
105808797|NCT00718159|364956790|FG006|Overall Study|Investigator Decision|1|||
105808798|NCT02228382|364956791|FG000|Overall Study|Death|5|||
105808799|NCT02228382|364956792|FG001|Overall Study|Death|7|||
105808800|NCT02228382|364956793|FG002|Overall Study|Death|5|||
105808801|NCT02228382|364956794|FG003|Overall Study|Death|0|||
105808802|NCT02228382|364956795|FG004|Overall Study|Death|2|||
105808803|NCT02228382|364956791|FG000|Overall Study|Participant refused further follow-up|0|||
105808804|NCT02228382|364956792|FG001|Overall Study|Participant refused further follow-up|0|||
105808805|NCT02228382|364956793|FG002|Overall Study|Participant refused further follow-up|1|||
105808806|NCT02228382|364956794|FG003|Overall Study|Participant refused further follow-up|0|||
105808807|NCT02228382|364956795|FG004|Overall Study|Participant refused further follow-up|0|||
105808808|NCT02228382|364956791|FG000|Overall Study|Study terminated by sponsor|3|||
105808809|NCT02228382|364956792|FG001|Overall Study|Study terminated by sponsor|5|||
105808810|NCT02228382|364956793|FG002|Overall Study|Study terminated by sponsor|7|||
105808811|NCT02228382|364956794|FG003|Overall Study|Study terminated by sponsor|0|||
105808812|NCT02228382|364956795|FG004|Overall Study|Study terminated by sponsor|0|||
105808813|NCT02228382|364956791|FG000|Overall Study|Lost to Follow-up|0|||
105808814|NCT02228382|364956792|FG001|Overall Study|Lost to Follow-up|0|||
105808815|NCT02228382|364956793|FG002|Overall Study|Lost to Follow-up|3|||
105808816|NCT02228382|364956794|FG003|Overall Study|Lost to Follow-up|1|||
105808817|NCT02228382|364956795|FG004|Overall Study|Lost to Follow-up|0|||
105808818|NCT02228382|364956791|FG000|Overall Study|Withdrawal by Subject|0|||
105808819|NCT02228382|364956792|FG001|Overall Study|Withdrawal by Subject|3|||
105808820|NCT02228382|364956793|FG002|Overall Study|Withdrawal by Subject|2|||
105808821|NCT02228382|364956794|FG003|Overall Study|Withdrawal by Subject|1|||
105808822|NCT02228382|364956795|FG004|Overall Study|Withdrawal by Subject|0|||
105808823|NCT02228382|364956791|FG000|Overall Study|Other|2|||
105808824|NCT02228382|364956792|FG001|Overall Study|Other|3|||
105808825|NCT02228382|364956793|FG002|Overall Study|Other|3|||
105808826|NCT02228382|364956794|FG003|Overall Study|Other|0|||
105808827|NCT02228382|364956795|FG004|Overall Study|Other|0|||
105808828|NCT01238848|364956797|FG000|Overall Study|Physician Decision|13|||
105808829|NCT01238848|364956798|FG001|Overall Study|Physician Decision|5|||
105808830|NCT02396381|364956801|FG000|Overall Study|Adverse Event|3|||
105808831|NCT02396381|364956802|FG001|Overall Study|Adverse Event|2|||
105808832|NCT02396381|364956801|FG000|Overall Study|Withdrawal by Subject|33|||
105808833|NCT02396381|364956802|FG001|Overall Study|Withdrawal by Subject|24|||
105485712|NCT00039871|363789588|FG000|Overall Study|Protocol Violation|24|||
105808834|NCT02396381|364956801|FG000|Overall Study|Lost to Follow-up|49|||
105808835|NCT02396381|364956802|FG001|Overall Study|Lost to Follow-up|31|||
105808836|NCT02396381|364956801|FG000|Overall Study|Protocol Violation|1|||
105808837|NCT02396381|364956802|FG001|Overall Study|Protocol Violation|0|||
105808838|NCT02396381|364956801|FG000|Overall Study|Site terminated by sponsor|7|||
105808839|NCT02396381|364956802|FG001|Overall Study|Site terminated by sponsor|8|||
105808840|NCT02396381|364956801|FG000|Overall Study|Physician Decision|5|||
105808841|NCT02396381|364956802|FG001|Overall Study|Physician Decision|5|||
105808842|NCT02396381|364956801|FG000|Overall Study|Pregnancy|2|||
105808843|NCT02396381|364956802|FG001|Overall Study|Pregnancy|0|||
105808844|NCT02396381|364956801|FG000|Overall Study|Non-compliance with study procedures|1|||
105808845|NCT02396381|364956802|FG001|Overall Study|Non-compliance with study procedures|0|||
105808846|NCT02396381|364956801|FG000|Overall Study|Moved out of town/state|1|||
105808847|NCT02396381|364956802|FG001|Overall Study|Moved out of town/state|3|||
105808848|NCT02396381|364956801|FG000|Overall Study|Could not complete visit|1|||
105808849|NCT02396381|364956802|FG001|Overall Study|Could not complete visit|0|||
105808850|NCT02396381|364956801|FG000|Overall Study|Possible conflict of interest|1|||
105808851|NCT02396381|364956802|FG001|Overall Study|Possible conflict of interest|0|||
105808852|NCT02396381|364956801|FG000|Overall Study|Randomization/Screening Error|3|||
105808853|NCT02396381|364956802|FG001|Overall Study|Randomization/Screening Error|1|||
105808854|NCT00576381|364956807|FG000|Overall Study|Reoperation|3|||
105808855|NCT00576381|364956807|FG000|Overall Study|Adverse Event|4|||
105808856|NCT00797108|364956808|FG000|Overall Study|Adverse Event|1|||
105808857|NCT00797108|364956809|FG001|Overall Study|Adverse Event|0|||
105808858|NCT00797108|364956810|FG002|Overall Study|Adverse Event|3|||
105808859|NCT00797108|364956808|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
105808860|NCT00797108|364956809|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
105808861|NCT00797108|364956810|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
105808862|NCT00797108|364956808|FG000|Overall Study|Global Deterioration of Health Status|0|||
105808863|NCT00797108|364956809|FG001|Overall Study|Global Deterioration of Health Status|1|||
105808864|NCT00797108|364956810|FG002|Overall Study|Global Deterioration of Health Status|0|||
105808865|NCT00797108|364956808|FG000|Overall Study|Lack of Efficacy|1|||
105808866|NCT00797108|364956809|FG001|Overall Study|Lack of Efficacy|0|||
105808867|NCT00797108|364956810|FG002|Overall Study|Lack of Efficacy|1|||
105808868|NCT00797108|364956808|FG000|Overall Study|Other|0|||
105808869|NCT00797108|364956809|FG001|Overall Study|Other|0|||
105808870|NCT00797108|364956810|FG002|Overall Study|Other|2|||
105808871|NCT00797108|364956808|FG000|Overall Study|Randomized but not Treated|2|||
105808872|NCT00797108|364956809|FG001|Overall Study|Randomized but not Treated|0|||
105808873|NCT00797108|364956810|FG002|Overall Study|Randomized but not Treated|0|||
105808874|NCT02270736|364956811|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
105808875|NCT02270736|364956812|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
105808876|NCT02270736|364956813|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
105808877|NCT02270736|364956814|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
105808878|NCT02270736|364956815|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
105808879|NCT02270736|364956811|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
105808880|NCT02270736|364956812|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
105808881|NCT02270736|364956813|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
105808882|NCT02270736|364956814|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
105808883|NCT02270736|364956815|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
105808884|NCT02270736|364956811|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
105808885|NCT02270736|364956812|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
105808886|NCT02270736|364956813|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
105808887|NCT02270736|364956814|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
105808888|NCT02270736|364956815|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
105808889|NCT02270736|364956811|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
105808890|NCT02270736|364956812|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
105808891|NCT02270736|364956813|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
105808892|NCT02270736|364956814|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
105808893|NCT02270736|364956815|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
105808894|NCT02270736|364956811|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
105808895|NCT02270736|364956812|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
105808896|NCT02270736|364956813|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
105808897|NCT02270736|364956814|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
105808898|NCT02270736|364956815|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
105808899|NCT02270736|364956811|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
105808900|NCT02270736|364956812|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
105808901|NCT02270736|364956813|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
105808902|NCT02270736|364956814|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
105485713|NCT00039871|363789588|FG000|Overall Study|Withdrawal by Subject|97|||
105485714|NCT00039871|363789588|FG000|Overall Study|Did not meet eligibility criteria|11|||
105808903|NCT02270736|364956815|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
105808904|NCT02270736|364956811|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
105808905|NCT02270736|364956812|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
105808906|NCT02270736|364956813|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
105808907|NCT02270736|364956814|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
105808908|NCT02270736|364956815|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
105808909|NCT02270736|364956811|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
105808910|NCT02270736|364956812|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
105808911|NCT02270736|364956813|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
105808912|NCT02270736|364956814|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
105808913|NCT02270736|364956815|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
105808914|NCT02270736|364956811|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
105808915|NCT02270736|364956812|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
105808916|NCT02270736|364956813|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
105808917|NCT02270736|364956814|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
105808918|NCT02270736|364956815|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
105808919|NCT00262600|364956816|FG000|Overall Study|Lost to Follow-up|17|||
105808920|NCT00262600|364956817|FG001|Overall Study|Lost to Follow-up|31|||
105808921|NCT00262600|364956818|FG002|Overall Study|Lost to Follow-up|41|||
105808922|NCT00262600|364956816|FG000|Overall Study|Withdrawal by Subject|128|||
105808923|NCT00262600|364956817|FG001|Overall Study|Withdrawal by Subject|145|||
105808924|NCT00262600|364956818|FG002|Overall Study|Withdrawal by Subject|139|||
105808925|NCT00262600|364956816|FG000|Overall Study|Not Treated|32|||
105808926|NCT00262600|364956817|FG001|Overall Study|Not Treated|17|||
105808927|NCT00262600|364956818|FG002|Overall Study|Not Treated|24|||
105808928|NCT00262600|364956816|FG000|Overall Study|Other|58|||
105808929|NCT00262600|364956817|FG001|Overall Study|Other|59|||
105808930|NCT00262600|364956818|FG002|Overall Study|Other|62|||
105808931|NCT04471207|364956821|FG000|Overall Study|Lost to Follow-up|4|||
105808932|NCT04471207|364956822|FG001|Overall Study|Lost to Follow-up|1|||
105808933|NCT04471207|364956821|FG000|Overall Study|Medication Contraindication|0|||
105808934|NCT04471207|364956822|FG001|Overall Study|Medication Contraindication|1|||
105808935|NCT04471207|364956821|FG000|Overall Study|Loss of Interest|2|||
105808936|NCT04471207|364956822|FG001|Overall Study|Loss of Interest|1|||
105808937|NCT04471207|364956821|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
105808938|NCT04471207|364956822|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
105808939|NCT04471207|364956821|FG000|Overall Study|Scheduling Conflicts|3|||
105808940|NCT04471207|364956822|FG001|Overall Study|Scheduling Conflicts|1|||
105485715|NCT00039871|363789588|FG000|Overall Study|Administrative|1|||
105485716|NCT00039871|363789588|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
105808941|NCT04471207|364956821|FG000|Overall Study|Physician Decision|1|||
105808942|NCT04471207|364956822|FG001|Overall Study|Physician Decision|0|||
105808943|NCT04471207|364956821|FG000|Overall Study|Unwilling to Use System|0|||
105808944|NCT04471207|364956822|FG001|Overall Study|Unwilling to Use System|1|||
105808945|NCT01860976|364956827|FG000|Blinded Treatment|Adverse Event|1|||
105808946|NCT01860976|364956828|FG001|Blinded Treatment|Adverse Event|3|||
105808947|NCT01860976|364956827|FG000|Blinded Treatment|Lack of Efficacy|5|||
105808948|NCT01860976|364956828|FG001|Blinded Treatment|Lack of Efficacy|12|||
105808949|NCT01860976|364956827|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
105808950|NCT01860976|364956828|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
105808951|NCT01860976|364956827|FG000|Blinded Treatment|Withdrawal by Subject|3|||
105808952|NCT01860976|364956828|FG001|Blinded Treatment|Withdrawal by Subject|5|||
105808953|NCT01860976|364956827|FG000|Blinded Treatment|Subject no longer met criteria|1|||
105808954|NCT01860976|364956828|FG001|Blinded Treatment|Subject no longer met criteria|0|||
105808955|NCT01860976|364956827|FG000|Blinded Treatment|Entered Open-Label in error|0|||
105808956|NCT01860976|364956828|FG001|Blinded Treatment|Entered Open-Label in error|1|||
105808957|NCT01860976|364956827|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
105808958|NCT01860976|364956828|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
105808959|NCT01860976|364956827|FG000|Open-Label|Adverse Event|2|||
105808960|NCT01860976|364956828|FG001|Open-Label|Adverse Event|4|||
105808961|NCT01860976|364956827|FG000|Open-Label|Lack of Efficacy|16|||
105808962|NCT01860976|364956828|FG001|Open-Label|Lack of Efficacy|8|||
105808963|NCT01860976|364956827|FG000|Open-Label|Lost to Follow-up|1|||
105808964|NCT01860976|364956828|FG001|Open-Label|Lost to Follow-up|2|||
105808965|NCT01860976|364956827|FG000|Open-Label|Subject request discontinue treatment|4|||
105808966|NCT01860976|364956828|FG001|Open-Label|Subject request discontinue treatment|3|||
105808967|NCT01860976|364956827|FG000|Open-Label|Withdrawal by Subject|4|||
105808968|NCT01860976|364956828|FG001|Open-Label|Withdrawal by Subject|1|||
105808969|NCT01860976|364956827|FG000|Open-Label|Other Reasons|1|||
105808970|NCT01860976|364956828|FG001|Open-Label|Other Reasons|1|||
105808971|NCT01860976|364956827|FG000|Long Term Extension|Adverse Event|4|||
105808972|NCT01860976|364956828|FG001|Long Term Extension|Adverse Event|0|||
105808973|NCT01860976|364956827|FG000|Long Term Extension|Lack of Efficacy|2|||
105808974|NCT01860976|364956828|FG001|Long Term Extension|Lack of Efficacy|0|||
105808975|NCT01860976|364956827|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
105808976|NCT01860976|364956828|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
105808977|NCT01860976|364956827|FG000|Long Term Extension|Lost to Follow-up|2|||
105808978|NCT01860976|364956828|FG001|Long Term Extension|Lost to Follow-up|0|||
105808979|NCT01860976|364956827|FG000|Long Term Extension|subject withdrew consent|7|||
105808980|NCT01860976|364956828|FG001|Long Term Extension|subject withdrew consent|0|||
105808981|NCT02374918|364956831|FG000|Overall Study|Protocol Violation|2|||
105808982|NCT02374918|364956832|FG001|Overall Study|Protocol Violation|0|||
105808983|NCT02374918|364956833|FG002|Overall Study|Protocol Violation|2|||
105808984|NCT02374918|364956834|FG003|Overall Study|Protocol Violation|1|||
105808985|NCT02374918|364956831|FG000|Overall Study|Withdrawal by Subject|1|||
105808986|NCT02374918|364956832|FG001|Overall Study|Withdrawal by Subject|1|||
105808987|NCT02374918|364956833|FG002|Overall Study|Withdrawal by Subject|1|||
105808988|NCT02374918|364956834|FG003|Overall Study|Withdrawal by Subject|0|||
105808989|NCT02374918|364956831|FG000|Overall Study|Lack of Efficacy|0|||
105485717|NCT00039871|363789588|FG000|Overall Study|Never entered follow-up|7|||
105485718|NCT02186301|363789589|FG000|Overall Study|Progressive Disease|7|||
105485719|NCT02186301|363789590|FG001|Overall Study|Progressive Disease|22|||
105485720|NCT02186301|363789591|FG002|Overall Study|Progressive Disease|27|||
105485721|NCT02186301|363789589|FG000|Overall Study|Adverse Event|5|||
105485722|NCT02186301|363789590|FG001|Overall Study|Adverse Event|5|||
105485723|NCT02186301|363789591|FG002|Overall Study|Adverse Event|5|||
105485724|NCT02186301|363789589|FG000|Overall Study|Death|1|||
105485725|NCT02186301|363789590|FG001|Overall Study|Death|0|||
105485726|NCT02186301|363789591|FG002|Overall Study|Death|0|||
105485727|NCT02186301|363789589|FG000|Overall Study|Withdrawal by Subject|5|||
105485728|NCT02186301|363789590|FG001|Overall Study|Withdrawal by Subject|1|||
105485729|NCT02186301|363789591|FG002|Overall Study|Withdrawal by Subject|3|||
105485730|NCT02186301|363789589|FG000|Overall Study|Physician Decision|1|||
105485731|NCT02186301|363789590|FG001|Overall Study|Physician Decision|0|||
105485732|NCT02186301|363789591|FG002|Overall Study|Physician Decision|1|||
105485733|NCT02186301|363789589|FG000|Overall Study|Study Terminated by Sponsor|1|||
105485734|NCT02186301|363789590|FG001|Overall Study|Study Terminated by Sponsor|0|||
105485735|NCT02186301|363789591|FG002|Overall Study|Study Terminated by Sponsor|11|||
105485736|NCT02186301|363789589|FG000|Overall Study|Protocol Deviation|0|||
105485737|NCT02186301|363789590|FG001|Overall Study|Protocol Deviation|2|||
105485738|NCT02186301|363789591|FG002|Overall Study|Protocol Deviation|0|||
105485739|NCT02186301|363789589|FG000|Overall Study|Missing|0|||
105485740|NCT02186301|363789590|FG001|Overall Study|Missing|0|||
105485741|NCT02186301|363789591|FG002|Overall Study|Missing|2|||
105485742|NCT02186301|363789589|FG000|Overall Study|Other|0|||
105808990|NCT02374918|364956832|FG001|Overall Study|Lack of Efficacy|0|||
105808991|NCT02374918|364956833|FG002|Overall Study|Lack of Efficacy|1|||
105808992|NCT02374918|364956834|FG003|Overall Study|Lack of Efficacy|1|||
105808993|NCT01957488|364956835|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
105571444|NCT04091360|364091215|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
105808994|NCT01957488|364956836|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
105361049|NCT03286218|363328144|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
105808995|NCT01957488|364956837|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
105485743|NCT02186301|363789590|FG001|Overall Study|Other|0|||
105808996|NCT01957488|364956838|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
105361050|NCT03286218|363328145|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
105485744|NCT02186301|363789591|FG002|Overall Study|Other|1|||
105485745|NCT03560739|363789592|FG000|Overall Study|Adverse Event|0|||
105808997|NCT01957488|364956839|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
105808998|NCT01957488|364956840|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
105808999|NCT01957488|364956835|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
105809000|NCT01957488|364956836|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
105809001|NCT01957488|364956837|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
105809002|NCT01957488|364956838|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
105809003|NCT01957488|364956839|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
105809004|NCT01957488|364956840|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
105809005|NCT01957488|364956835|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
105809006|NCT01957488|364956836|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
105809007|NCT01957488|364956837|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
105809008|NCT01957488|364956838|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
105809009|NCT01957488|364956839|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
105809010|NCT01957488|364956840|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
105809011|NCT01957488|364956835|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
105809012|NCT01957488|364956836|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
105809013|NCT01957488|364956837|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
105809014|NCT01957488|364956838|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
105809015|NCT01957488|364956839|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
105809016|NCT01957488|364956840|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
105809017|NCT01957488|364956835|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
105809018|NCT01957488|364956836|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
105809019|NCT01957488|364956837|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
105809020|NCT01957488|364956838|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
105809021|NCT01957488|364956839|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
105809022|NCT01957488|364956840|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
105809023|NCT01957488|364956835|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
105809024|NCT01957488|364956836|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
105809025|NCT01957488|364956837|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
105809026|NCT01957488|364956838|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
105809027|NCT01957488|364956839|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
105809028|NCT01957488|364956840|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
105809029|NCT01957488|364956835|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
105809030|NCT01957488|364956836|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
105809031|NCT01957488|364956837|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
105809032|NCT01957488|364956838|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
105809033|NCT01957488|364956839|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
105809034|NCT01957488|364956840|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
105809035|NCT01957488|364956835|FG000|Test Period 2 (2 Weeks)|Other|1|||
105809036|NCT01957488|364956836|FG001|Test Period 2 (2 Weeks)|Other|0|||
105809037|NCT01957488|364956837|FG002|Test Period 2 (2 Weeks)|Other|0|||
105809038|NCT01957488|364956838|FG003|Test Period 2 (2 Weeks)|Other|0|||
105809039|NCT01957488|364956839|FG004|Test Period 2 (2 Weeks)|Other|0|||
105809040|NCT01957488|364956840|FG005|Test Period 2 (2 Weeks)|Other|0|||
105809041|NCT01957488|364956835|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
105809042|NCT01957488|364956836|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
105809043|NCT01957488|364956837|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
105809044|NCT01957488|364956838|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
105809045|NCT01957488|364956839|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
105809046|NCT01957488|364956840|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
105809047|NCT01957488|364956835|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
105809048|NCT01957488|364956836|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
105809049|NCT01957488|364956837|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
105809050|NCT01957488|364956838|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
105809051|NCT01957488|364956839|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
105809052|NCT01957488|364956840|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
105809053|NCT01957488|364956835|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
105809054|NCT01957488|364956836|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
105809055|NCT01957488|364956837|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
105809056|NCT01957488|364956838|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
105809057|NCT01957488|364956839|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
105809058|NCT01957488|364956840|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
105361051|NCT03286218|363328146|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
105361052|NCT03286218|363328147|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
105361053|NCT03286218|363328148|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
105361054|NCT03286218|363328149|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
105361055|NCT03286218|363328150|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
105361056|NCT03286218|363328151|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
105361057|NCT03286218|363328152|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
105361058|NCT03286218|363328141|FG000|Qualification Phase Period 2|Adverse Event|0|||
105762167|NCT00608881|364783077|FG000|Overall Study|Physician Decision|5|||
105762168|NCT00608881|364783078|FG001|Overall Study|Physician Decision|5|||
105762169|NCT00608881|364783077|FG000|Overall Study|Institutionalized|1|||
105762170|NCT00608881|364783078|FG001|Overall Study|Institutionalized|2|||
105762171|NCT03210220|364783081|FG000|Overall Study|Physician Decision|1|||
105762172|NCT03210220|364783082|FG001|Overall Study|Physician Decision|0|||
105762173|NCT00109772|364783083|FG000|Double-blind Treatment|Adverse Event|14|||
105762174|NCT00109772|364783084|FG001|Double-blind Treatment|Adverse Event|5|||
105762175|NCT00109772|364783083|FG000|Double-blind Treatment|Lack of Efficacy|1|||
105762176|NCT00109772|364783084|FG001|Double-blind Treatment|Lack of Efficacy|0|||
105762177|NCT00109772|364783083|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
105762178|NCT00109772|364783084|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
105762179|NCT00109772|364783083|FG000|Double-blind Treatment|Lost to Follow-up|2|||
105762180|NCT00109772|364783084|FG001|Double-blind Treatment|Lost to Follow-up|3|||
105762181|NCT00109772|364783083|FG000|Double-blind Treatment|Protocol Violation|0|||
105762182|NCT00109772|364783084|FG001|Double-blind Treatment|Protocol Violation|1|||
105762183|NCT00109772|364783083|FG000|Double-blind Treatment|Other|0|||
105762184|NCT00109772|364783084|FG001|Double-blind Treatment|Other|4|||
105762185|NCT00109772|364783083|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
105762186|NCT00109772|364783084|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
105762187|NCT00109772|364783083|FG000|Open-label Extension|Adverse Event|10|||
105762188|NCT00109772|364783084|FG001|Open-label Extension|Adverse Event|19|||
105762189|NCT00109772|364783083|FG000|Open-label Extension|Lack of Efficacy|19|||
105762190|NCT00109772|364783084|FG001|Open-label Extension|Lack of Efficacy|11|||
105762191|NCT00109772|364783083|FG000|Open-label Extension|Withdrawal by Subject|9|||
105762192|NCT00109772|364783084|FG001|Open-label Extension|Withdrawal by Subject|6|||
105762193|NCT00109772|364783083|FG000|Open-label Extension|Lost to Follow-up|1|||
105762194|NCT00109772|364783084|FG001|Open-label Extension|Lost to Follow-up|0|||
105762195|NCT00109772|364783083|FG000|Open-label Extension|Death|0|||
105762196|NCT00109772|364783084|FG001|Open-label Extension|Death|1|||
105762197|NCT00109772|364783083|FG000|Open-label Extension|Protocol Violation|2|||
105762198|NCT00109772|364783084|FG001|Open-label Extension|Protocol Violation|2|||
105762199|NCT00109772|364783083|FG000|Open-label Extension|Other|4|||
105762200|NCT00109772|364783084|FG001|Open-label Extension|Other|10|||
105762201|NCT01599806|364783087|FG000|Overall Study|Lost to Follow-up|20|||
105762202|NCT01599806|364783088|FG001|Overall Study|Lost to Follow-up|20|||
105762203|NCT01599806|364783087|FG000|Overall Study|Withdrawal by Subject|12|||
105762204|NCT01599806|364783088|FG001|Overall Study|Withdrawal by Subject|12|||
105762205|NCT01599806|364783087|FG000|Overall Study|Other Eligibility criteria|11|||
105762206|NCT01599806|364783088|FG001|Overall Study|Other Eligibility criteria|9|||
105762207|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
105762208|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
105762209|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
105762210|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
105762211|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
105762212|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
105762213|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
105762214|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
105762215|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
105762216|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
105762217|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
105762218|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
105762219|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
105762220|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
105762221|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
105762222|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
105762223|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
105762224|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
105762225|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
105762226|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
105762227|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
105762228|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
105762229|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
105762230|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
105361059|NCT03286218|363328142|FG001|Qualification Phase Period 2|Adverse Event|1|||
105571445|NCT04091360|364091216|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
105762231|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
105762232|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
105762233|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
105762234|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
105762235|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
105762236|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
105762237|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
105762238|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
105762239|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
105762240|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
105762241|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
105762242|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
105762243|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
105762244|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
105762245|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
105762246|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
105762247|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
105762248|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
105762249|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
105762250|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
105762251|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
105762252|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
105762253|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
105762254|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
105762255|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
105762256|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
105762257|NCT03689972|364783092|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
105762258|NCT03689972|364783093|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
105762259|NCT03689972|364783094|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
105762260|NCT03689972|364783095|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
105762261|NCT03689972|364783096|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
105762262|NCT03689972|364783092|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
105762263|NCT03689972|364783093|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
105762264|NCT03689972|364783094|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
105762265|NCT03689972|364783095|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
105762266|NCT03689972|364783096|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
105762267|NCT03689972|364783092|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
105762268|NCT03689972|364783093|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
105762269|NCT03689972|364783094|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
105762270|NCT03689972|364783095|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
105762271|NCT03689972|364783096|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
105762272|NCT03689972|364783092|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
105762273|NCT03689972|364783093|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
105762274|NCT03689972|364783094|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
105762275|NCT03689972|364783095|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
105762276|NCT03689972|364783096|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
105762277|NCT03689972|364783092|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
105762278|NCT03689972|364783093|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
105762279|NCT03689972|364783094|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
105762280|NCT03689972|364783095|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
105762281|NCT03689972|364783096|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
105762282|NCT03689972|364783092|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
105762283|NCT03689972|364783093|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
105762284|NCT03689972|364783094|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
105762285|NCT03689972|364783095|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
105762286|NCT03689972|364783096|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
105762287|NCT03689972|364783092|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
105762288|NCT03689972|364783093|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
105762289|NCT03689972|364783094|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
105762290|NCT03689972|364783095|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
105762291|NCT03689972|364783096|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
105762292|NCT03689972|364783092|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
105762293|NCT03689972|364783093|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
105809059|NCT01957488|364956835|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
105809060|NCT01957488|364956836|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
105809061|NCT01957488|364956837|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
105809062|NCT01957488|364956838|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
105809063|NCT01957488|364956839|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
105809064|NCT01957488|364956840|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
105809065|NCT01957488|364956835|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
105809066|NCT01957488|364956836|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
105809067|NCT01957488|364956837|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
105809068|NCT01957488|364956838|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
105809069|NCT01957488|364956839|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
105809070|NCT01957488|364956840|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
105809071|NCT00688064|364956843|FG000|Overall Study|Protocol Violation|0|||
105809072|NCT00688064|364956844|FG001|Overall Study|Protocol Violation|1|||
105809073|NCT00688064|364956843|FG000|Overall Study|Adverse Event|2|||
105809074|NCT00688064|364956844|FG001|Overall Study|Adverse Event|4|||
105809075|NCT00688064|364956843|FG000|Overall Study|Withdrawal by Subject|7|||
105809076|NCT00688064|364956844|FG001|Overall Study|Withdrawal by Subject|7|||
105809077|NCT00688064|364956843|FG000|Overall Study|Lost to Follow-up|10|||
105809078|NCT00688064|364956844|FG001|Overall Study|Lost to Follow-up|10|||
105809079|NCT00688064|364956843|FG000|Overall Study|Lack of Efficacy|0|||
105571446|NCT04091360|364091207|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
105809080|NCT00688064|364956844|FG001|Overall Study|Lack of Efficacy|1|||
105809081|NCT00688064|364956843|FG000|Overall Study|Pregnancy|1|||
105809082|NCT00688064|364956844|FG001|Overall Study|Pregnancy|0|||
105809083|NCT00688064|364956843|FG000|Overall Study|Any other reasons|1|||
105809084|NCT00688064|364956844|FG001|Overall Study|Any other reasons|3|||
105809085|NCT02866175|364956847|FG000|Overall Study|Adverse Event|56|||
105809086|NCT02866175|364956848|FG001|Overall Study|Adverse Event|54|||
105809087|NCT02866175|364956847|FG000|Overall Study|Withdrawal by Subject|31|||
105809088|NCT02866175|364956848|FG001|Overall Study|Withdrawal by Subject|52|||
105809089|NCT02866175|364956847|FG000|Overall Study|Death|30|||
105809090|NCT02866175|364956848|FG001|Overall Study|Death|23|||
105809091|NCT02866175|364956847|FG000|Overall Study|Other|7|||
105809092|NCT02866175|364956848|FG001|Overall Study|Other|14|||
105809093|NCT02866175|364956847|FG000|Overall Study|Progressive disease|1|||
105809094|NCT02866175|364956848|FG001|Overall Study|Progressive disease|1|||
105809095|NCT02866175|364956847|FG000|Overall Study|Lost to Follow-up|2|||
105809096|NCT02866175|364956848|FG001|Overall Study|Lost to Follow-up|0|||
105809097|NCT02866175|364956847|FG000|Overall Study|Lack of Efficacy|0|||
105809098|NCT02866175|364956848|FG001|Overall Study|Lack of Efficacy|1|||
105809099|NCT02866175|364956847|FG000|Overall Study|Physician Decision|3|||
105809100|NCT02866175|364956848|FG001|Overall Study|Physician Decision|15|||
105809101|NCT02866175|364956847|FG000|Overall Study|Did not receive treatment|5|||
105809102|NCT02866175|364956848|FG001|Overall Study|Did not receive treatment|15|||
105809103|NCT02907203|364956850|FG000|Overall Study|Death|1|||
105809104|NCT02907203|364956850|FG000|Overall Study|Lost to Follow-up|3|||
105809105|NCT02907203|364956850|FG000|Overall Study|Withdrawal by Subject|3|||
105809106|NCT02907203|364956850|FG000|Overall Study|Surgical bypass|1|||
105809107|NCT04956666|364956851|FG000|Overall Study|Adverse Event|18|||
105809108|NCT04956666|364956851|FG000|Overall Study|Physician Decision|5|||
105809109|NCT00729859|364956852|FG000|Overall Study|Adverse Event|0|||
105809110|NCT00729859|364956853|FG001|Overall Study|Adverse Event|1|||
105809111|NCT00729859|364956854|FG002|Overall Study|Adverse Event|0|||
105809112|NCT00729859|364956852|FG000|Overall Study|Withdrawal by Subject|0|||
105809113|NCT00729859|364956853|FG001|Overall Study|Withdrawal by Subject|1|||
105809114|NCT00729859|364956854|FG002|Overall Study|Withdrawal by Subject|0|||
105809115|NCT02623829|364956861|FG000|Overall Study|Lost to Follow-up|1|||
105809116|NCT02623829|364956862|FG001|Overall Study|Lost to Follow-up|1|||
105809117|NCT02985151|364956864|FG000|Original Randomization|Withdrawal by Subject|0|||
105809118|NCT02985151|364956865|FG001|Original Randomization|Withdrawal by Subject|1|||
105809119|NCT02750306|364956866|FG000|Overall Study|Withdrawal by Subject|5|||
105809120|NCT02750306|364956867|FG001|Overall Study|Withdrawal by Subject|2|||
105809121|NCT02750306|364956866|FG000|Overall Study|Protocol Violation|1|||
105809122|NCT02750306|364956867|FG001|Overall Study|Protocol Violation|0|||
105809123|NCT00626925|364956869|FG000|Overall Study|Lost to Follow-up|1|||
105809124|NCT00626925|364956870|FG001|Overall Study|Lost to Follow-up|2|||
105809125|NCT00626925|364956869|FG000|Overall Study|relapse|1|||
105809126|NCT00626925|364956870|FG001|Overall Study|relapse|0|||
105809127|NCT00626925|364956869|FG000|Overall Study|Adverse effect|6|||
105809128|NCT00626925|364956870|FG001|Overall Study|Adverse effect|2|||
105809129|NCT00626925|364956869|FG000|Overall Study|Lack of Efficacy|1|||
105809130|NCT00626925|364956870|FG001|Overall Study|Lack of Efficacy|4|||
105809131|NCT00626925|364956869|FG000|Overall Study|Time constraints|3|||
105809132|NCT00626925|364956870|FG001|Overall Study|Time constraints|1|||
105809133|NCT02315898|364956872|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
105809134|NCT02315898|364956873|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
105809135|NCT02315898|364956874|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
105809136|NCT02315898|364956875|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
105809137|NCT02224391|364956876|FG000|Overall Study|Lost to Follow-up|26|||
105809138|NCT02224391|364956877|FG001|Overall Study|Lost to Follow-up|19|||
105809139|NCT02224391|364956876|FG000|Overall Study|Withdrawal by Subject|6|||
105809140|NCT02224391|364956877|FG001|Overall Study|Withdrawal by Subject|5|||
105809141|NCT00818623|364956881|FG000|Overall Study|Adverse Event|1|||
105809142|NCT00818623|364956882|FG001|Overall Study|Adverse Event|0|||
105809143|NCT00818623|364956883|FG002|Overall Study|Adverse Event|1|||
105809144|NCT00818623|364956884|FG003|Overall Study|Adverse Event|0|||
105809145|NCT00818623|364956885|FG004|Overall Study|Adverse Event|0|||
105809146|NCT00818623|364956886|FG005|Overall Study|Adverse Event|1|||
105809147|NCT00818623|364956887|FG006|Overall Study|Adverse Event|0|||
105809148|NCT00818623|364956888|FG007|Overall Study|Adverse Event|0|||
105809149|NCT00818623|364956881|FG000|Overall Study|Bad prostate specific antigen response|0|||
105809150|NCT00818623|364956882|FG001|Overall Study|Bad prostate specific antigen response|3|||
105809151|NCT00818623|364956883|FG002|Overall Study|Bad prostate specific antigen response|2|||
105809152|NCT00818623|364956884|FG003|Overall Study|Bad prostate specific antigen response|5|||
105809153|NCT00818623|364956885|FG004|Overall Study|Bad prostate specific antigen response|0|||
105809154|NCT00818623|364956886|FG005|Overall Study|Bad prostate specific antigen response|1|||
105809155|NCT00818623|364956887|FG006|Overall Study|Bad prostate specific antigen response|0|||
105809156|NCT00818623|364956888|FG007|Overall Study|Bad prostate specific antigen response|0|||
105809157|NCT00818623|364956881|FG000|Overall Study|Withdrawal by Subject|0|||
105809158|NCT00818623|364956882|FG001|Overall Study|Withdrawal by Subject|1|||
105809159|NCT00818623|364956883|FG002|Overall Study|Withdrawal by Subject|1|||
105809160|NCT00818623|364956884|FG003|Overall Study|Withdrawal by Subject|0|||
105809161|NCT00818623|364956885|FG004|Overall Study|Withdrawal by Subject|0|||
105809162|NCT00818623|364956886|FG005|Overall Study|Withdrawal by Subject|1|||
105809163|NCT00818623|364956887|FG006|Overall Study|Withdrawal by Subject|1|||
105809164|NCT00818623|364956888|FG007|Overall Study|Withdrawal by Subject|1|||
105809165|NCT00818623|364956881|FG000|Overall Study|Protocol Violation|1|||
105809166|NCT00818623|364956882|FG001|Overall Study|Protocol Violation|0|||
105809167|NCT00818623|364956883|FG002|Overall Study|Protocol Violation|0|||
105809168|NCT00818623|364956884|FG003|Overall Study|Protocol Violation|0|||
105809169|NCT00818623|364956885|FG004|Overall Study|Protocol Violation|1|||
105809170|NCT00818623|364956886|FG005|Overall Study|Protocol Violation|0|||
105809171|NCT00818623|364956887|FG006|Overall Study|Protocol Violation|1|||
105809172|NCT00818623|364956888|FG007|Overall Study|Protocol Violation|0|||
105809173|NCT00818623|364956881|FG000|Overall Study|Need of additional treatment|0|||
105809174|NCT00818623|364956882|FG001|Overall Study|Need of additional treatment|0|||
105809175|NCT00818623|364956883|FG002|Overall Study|Need of additional treatment|0|||
105809176|NCT00818623|364956884|FG003|Overall Study|Need of additional treatment|0|||
105809177|NCT00818623|364956885|FG004|Overall Study|Need of additional treatment|1|||
105809178|NCT00818623|364956886|FG005|Overall Study|Need of additional treatment|0|||
105809179|NCT00818623|364956887|FG006|Overall Study|Need of additional treatment|0|||
105809180|NCT00818623|364956888|FG007|Overall Study|Need of additional treatment|0|||
105809181|NCT00818623|364956881|FG000|Overall Study|Lack of trial drug at site|0|||
105809182|NCT00818623|364956882|FG001|Overall Study|Lack of trial drug at site|0|||
105762294|NCT03689972|364783094|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
105762295|NCT03689972|364783095|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
105762296|NCT03689972|364783096|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
105762297|NCT03689972|364783092|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
105762298|NCT03689972|364783093|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
105762299|NCT03689972|364783094|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
105762300|NCT03689972|364783095|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
105762301|NCT03689972|364783096|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
105762302|NCT00973622|364783097|FG000|Overall Study|did not attend MRI|14|||
105762303|NCT00973622|364783098|FG001|Overall Study|did not attend MRI|3|||
105762304|NCT00973622|364783097|FG000|Overall Study|did not pass MRI screen|6|||
105809183|NCT00818623|364956883|FG002|Overall Study|Lack of trial drug at site|0|||
105809184|NCT00818623|364956884|FG003|Overall Study|Lack of trial drug at site|0|||
105809185|NCT00818623|364956885|FG004|Overall Study|Lack of trial drug at site|2|||
105809186|NCT00818623|364956886|FG005|Overall Study|Lack of trial drug at site|0|||
105809187|NCT00818623|364956887|FG006|Overall Study|Lack of trial drug at site|1|||
105762305|NCT00973622|364783098|FG001|Overall Study|did not pass MRI screen|0|||
105762306|NCT00973622|364783097|FG000|Overall Study|did not complete rTMS sessions|11|||
105762307|NCT00973622|364783098|FG001|Overall Study|did not complete rTMS sessions|2|||
105762308|NCT01548417|364783099|FG000|Overall Study|Withdrawal by Subject|0|||
105571447|NCT04091360|364091208|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
105762309|NCT01548417|364783100|FG001|Overall Study|Withdrawal by Subject|2|||
105762310|NCT00802867|364783103|FG000|Overall Study|Lost to Follow-up|6|||
105762311|NCT00802867|364783103|FG000|Overall Study|Protocol Violation|6|||
105762312|NCT00802867|364783103|FG000|Overall Study|Withdrawal by Subject|1|||
105762313|NCT01156532|364783104|FG000|Overall Study|Family Reasons|1|||
105762314|NCT01156532|364783104|FG000|Overall Study|Lost to Follow-up|1|||
105762315|NCT03841526|364783105|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
105762316|NCT03841526|364783106|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
105762317|NCT03841526|364783107|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
105762318|NCT03841526|364783108|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
105762319|NCT03841526|364783109|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
105762320|NCT03841526|364783110|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
105762321|NCT03841526|364783105|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
105762322|NCT03841526|364783106|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
105762323|NCT03841526|364783107|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
105762324|NCT03841526|364783108|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
105762325|NCT03841526|364783109|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
105762326|NCT03841526|364783110|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
105762327|NCT03841526|364783105|FG000|Outpatient Phase Treatment|Physician Decision|0|||
105762328|NCT03841526|364783106|FG001|Outpatient Phase Treatment|Physician Decision|1|||
105762329|NCT03841526|364783107|FG002|Outpatient Phase Treatment|Physician Decision|0|||
105762330|NCT03841526|364783108|FG003|Outpatient Phase Treatment|Physician Decision|0|||
105762331|NCT03841526|364783109|FG004|Outpatient Phase Treatment|Physician Decision|0|||
105762332|NCT03841526|364783110|FG005|Outpatient Phase Treatment|Physician Decision|0|||
105762333|NCT03841526|364783105|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
105762334|NCT03841526|364783106|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
105762335|NCT03841526|364783107|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
105762336|NCT03841526|364783108|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
105762337|NCT03841526|364783109|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
105762338|NCT03841526|364783110|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
105762339|NCT00114218|364783111|FG000|Overall Study|Wrong Cell Type|2|||
105762340|NCT00114218|364783111|FG000|Overall Study|Wrong Primary|1|||
105762341|NCT00114218|364783111|FG000|Overall Study|Never Treated|1|||
105762342|NCT00615459|364783113|FG000|Period I|Adverse Event|2|||
105762343|NCT00615459|364783114|FG001|Period I|Adverse Event|0|||
105762344|NCT00615459|364783115|FG002|Period I|Adverse Event|1|||
105762345|NCT00615459|364783116|FG003|Period I|Adverse Event|0|||
105762346|NCT00615459|364783113|FG000|Period I|Subject withdrew consent|1|||
105762347|NCT00615459|364783114|FG001|Period I|Subject withdrew consent|0|||
105762348|NCT00615459|364783115|FG002|Period I|Subject withdrew consent|0|||
105762349|NCT00615459|364783116|FG003|Period I|Subject withdrew consent|1|||
105762350|NCT00615459|364783113|FG000|Period I|Abnormal test procedure results|1|||
105762351|NCT00615459|364783114|FG001|Period I|Abnormal test procedure results|1|||
105762352|NCT00615459|364783115|FG002|Period I|Abnormal test procedure results|1|||
105762353|NCT00615459|364783116|FG003|Period I|Abnormal test procedure results|0|||
105762354|NCT00615459|364783113|FG000|Period II|Adverse Event|1|||
105762355|NCT00615459|364783114|FG001|Period II|Adverse Event|0|||
105762356|NCT00615459|364783115|FG002|Period II|Adverse Event|0|||
105762357|NCT00615459|364783116|FG003|Period II|Adverse Event|0|||
105762358|NCT00615459|364783113|FG000|Period II|Lost to Follow-up|0|||
105762359|NCT00615459|364783114|FG001|Period II|Lost to Follow-up|0|||
105762360|NCT00615459|364783115|FG002|Period II|Lost to Follow-up|0|||
105762361|NCT00615459|364783116|FG003|Period II|Lost to Follow-up|1|||
105762362|NCT00615459|364783113|FG000|Period III|Adverse Event|0|||
105762363|NCT00615459|364783114|FG001|Period III|Adverse Event|1|||
105762364|NCT00615459|364783115|FG002|Period III|Adverse Event|0|||
105762365|NCT00615459|364783116|FG003|Period III|Adverse Event|0|||
105762366|NCT00615459|364783113|FG000|Period III|Administrative problems|0|||
105762367|NCT00615459|364783114|FG001|Period III|Administrative problems|1|||
105762368|NCT00615459|364783115|FG002|Period III|Administrative problems|1|||
105762369|NCT00615459|364783116|FG003|Period III|Administrative problems|0|||
105762370|NCT00615459|364783113|FG000|Period III|Unsatisfactory therapeutic effect|0|||
105762371|NCT00615459|364783114|FG001|Period III|Unsatisfactory therapeutic effect|1|||
105762372|NCT00615459|364783115|FG002|Period III|Unsatisfactory therapeutic effect|0|||
105809188|NCT00818623|364956888|FG007|Overall Study|Lack of trial drug at site|0|||
105809189|NCT00818623|364956881|FG000|Overall Study|Disease progression|0|||
105809190|NCT00818623|364956882|FG001|Overall Study|Disease progression|0|||
105809191|NCT00818623|364956883|FG002|Overall Study|Disease progression|0|||
105809192|NCT00818623|364956884|FG003|Overall Study|Disease progression|0|||
105809193|NCT00818623|364956885|FG004|Overall Study|Disease progression|0|||
105809194|NCT00818623|364956886|FG005|Overall Study|Disease progression|0|||
105809195|NCT00818623|364956887|FG006|Overall Study|Disease progression|1|||
105809196|NCT00818623|364956888|FG007|Overall Study|Disease progression|0|||
105809197|NCT00602030|364956891|FG000|Lead-in Phase|Disease Progression|2|||
105809198|NCT00602030|364956892|FG001|Lead-in Phase|Disease Progression|3|||
105809199|NCT00602030|364956893|FG002|Lead-in Phase|Disease Progression|0|||
105809200|NCT00602030|364956894|FG003|Lead-in Phase|Disease Progression|0|||
105809201|NCT00602030|364956895|FG004|Lead-in Phase|Disease Progression|0|||
105809202|NCT00602030|364956891|FG000|Lead-in Phase|Adverse Event|0|||
105809203|NCT00602030|364956892|FG001|Lead-in Phase|Adverse Event|2|||
105809204|NCT00602030|364956893|FG002|Lead-in Phase|Adverse Event|0|||
105809205|NCT00602030|364956894|FG003|Lead-in Phase|Adverse Event|0|||
105809206|NCT00602030|364956895|FG004|Lead-in Phase|Adverse Event|0|||
105809207|NCT00602030|364956891|FG000|Double-blind Phase|Disease progression|0|||
105809208|NCT00602030|364956892|FG001|Double-blind Phase|Disease progression|0|||
105809209|NCT00602030|364956893|FG002|Double-blind Phase|Disease progression|33|||
105809210|NCT00602030|364956894|FG003|Double-blind Phase|Disease progression|30|||
105809211|NCT00602030|364956895|FG004|Double-blind Phase|Disease progression|0|||
105809212|NCT00602030|364956891|FG000|Double-blind Phase|Adverse Event|0|||
105809213|NCT00602030|364956892|FG001|Double-blind Phase|Adverse Event|0|||
105809214|NCT00602030|364956893|FG002|Double-blind Phase|Adverse Event|9|||
105809215|NCT00602030|364956894|FG003|Double-blind Phase|Adverse Event|18|||
105809216|NCT00602030|364956895|FG004|Double-blind Phase|Adverse Event|0|||
105809217|NCT00602030|364956891|FG000|Double-blind Phase|Consent withdrawal|0|||
105809218|NCT00602030|364956892|FG001|Double-blind Phase|Consent withdrawal|0|||
105809219|NCT00602030|364956893|FG002|Double-blind Phase|Consent withdrawal|4|||
105809220|NCT00602030|364956894|FG003|Double-blind Phase|Consent withdrawal|3|||
105809221|NCT00602030|364956895|FG004|Double-blind Phase|Consent withdrawal|0|||
105809222|NCT00602030|364956891|FG000|Double-blind Phase|Death|0|||
105809223|NCT00602030|364956892|FG001|Double-blind Phase|Death|0|||
105809224|NCT00602030|364956893|FG002|Double-blind Phase|Death|3|||
105809225|NCT00602030|364956894|FG003|Double-blind Phase|Death|3|||
105809226|NCT00602030|364956895|FG004|Double-blind Phase|Death|0|||
105809227|NCT00602030|364956891|FG000|Double-blind Phase|Administrative decision|0|||
105809228|NCT00602030|364956892|FG001|Double-blind Phase|Administrative decision|0|||
105809229|NCT00602030|364956893|FG002|Double-blind Phase|Administrative decision|0|||
105809230|NCT00602030|364956894|FG003|Double-blind Phase|Administrative decision|2|||
105809231|NCT00602030|364956895|FG004|Double-blind Phase|Administrative decision|0|||
105809232|NCT00602030|364956891|FG000|Double-blind Phase|Ineligibility|0|||
105809233|NCT00602030|364956892|FG001|Double-blind Phase|Ineligibility|0|||
105809234|NCT00602030|364956893|FG002|Double-blind Phase|Ineligibility|0|||
105809235|NCT00602030|364956894|FG003|Double-blind Phase|Ineligibility|1|||
105809236|NCT00602030|364956895|FG004|Double-blind Phase|Ineligibility|0|||
105809237|NCT00602030|364956891|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
105809238|NCT00602030|364956892|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
105809239|NCT00602030|364956893|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
105809240|NCT00602030|364956894|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
105809241|NCT00602030|364956895|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
105809242|NCT00602030|364956891|FG000|Double-blind Phase|Reason not specified|0|||
105809243|NCT00602030|364956892|FG001|Double-blind Phase|Reason not specified|0|||
105809244|NCT00602030|364956893|FG002|Double-blind Phase|Reason not specified|4|||
105809245|NCT00602030|364956894|FG003|Double-blind Phase|Reason not specified|2|||
105809246|NCT00602030|364956895|FG004|Double-blind Phase|Reason not specified|0|||
105485746|NCT03560739|363789593|FG001|Overall Study|Adverse Event|1|||
105809247|NCT00602030|364956891|FG000|Crossover Phase|Disease Progression|0|||
105485747|NCT03560739|363789594|FG002|Overall Study|Adverse Event|0|||
105809248|NCT00602030|364956892|FG001|Crossover Phase|Disease Progression|0|||
105809249|NCT00602030|364956893|FG002|Crossover Phase|Disease Progression|0|||
105809250|NCT00602030|364956894|FG003|Crossover Phase|Disease Progression|0|||
105809251|NCT00602030|364956895|FG004|Crossover Phase|Disease Progression|11|||
105485748|NCT03560739|363789595|FG003|Overall Study|Adverse Event|0|||
105809252|NCT00602030|364956891|FG000|Crossover Phase|Adverse Event|0|||
105809253|NCT00602030|364956892|FG001|Crossover Phase|Adverse Event|0|||
105485749|NCT03361176|363789596|FG000|Overall Study|Lost to Follow-up|1|||
105809254|NCT00602030|364956893|FG002|Crossover Phase|Adverse Event|0|||
105809255|NCT00602030|364956894|FG003|Crossover Phase|Adverse Event|0|||
105809256|NCT00602030|364956895|FG004|Crossover Phase|Adverse Event|3|||
105809257|NCT00602030|364956891|FG000|Crossover Phase|Consent withdrawal|0|||
105809258|NCT00602030|364956892|FG001|Crossover Phase|Consent withdrawal|0|||
105809259|NCT00602030|364956893|FG002|Crossover Phase|Consent withdrawal|0|||
105809260|NCT00602030|364956894|FG003|Crossover Phase|Consent withdrawal|0|||
105809261|NCT00602030|364956895|FG004|Crossover Phase|Consent withdrawal|2|||
105361060|NCT03286218|363328143|FG002|Qualification Phase Period 2|Adverse Event|0|||
105361061|NCT03286218|363328144|FG003|Qualification Phase Period 2|Adverse Event|0|||
105361062|NCT03286218|363328145|FG004|Qualification Phase Period 2|Adverse Event|0|||
105361063|NCT03286218|363328146|FG005|Qualification Phase Period 2|Adverse Event|0|||
105361064|NCT03286218|363328147|FG006|Qualification Phase Period 2|Adverse Event|0|||
105361065|NCT03286218|363328148|FG007|Qualification Phase Period 2|Adverse Event|0|||
105762373|NCT00615459|364783116|FG003|Period III|Unsatisfactory therapeutic effect|0|||
105762374|NCT02475629|364783117|FG000|Overall Study|Adverse Event|1|||
105762375|NCT02475629|364783117|FG000|Overall Study|Death|4|||
105762376|NCT02475629|364783117|FG000|Overall Study|Physician Decision|1|||
105762377|NCT02475629|364783117|FG000|Overall Study|Withdrawal by Subject|1|||
105762378|NCT02475629|364783117|FG000|Overall Study|Lost to Follow-up|1|||
105762379|NCT02475629|364783117|FG000|Overall Study|Subject non-compliance|1|||
105762380|NCT03238352|364783118|FG000|Overall Study|Lost to Follow-up|0|||
105762381|NCT03238352|364783119|FG001|Overall Study|Lost to Follow-up|2|||
105762382|NCT03238352|364783120|FG002|Overall Study|Lost to Follow-up|1|||
105762383|NCT03238352|364783118|FG000|Overall Study|Withdrawal by Subject|0|||
105762384|NCT03238352|364783119|FG001|Overall Study|Withdrawal by Subject|1|||
105762385|NCT03238352|364783120|FG002|Overall Study|Withdrawal by Subject|0|||
105762386|NCT01963780|364783121|FG000|Overall Study|Death|7|||
105762387|NCT04153929|364783122|FG000|Overall Study|Other than listed|2|||
105762388|NCT04153929|364783123|FG001|Overall Study|Other than listed|2|||
105762389|NCT04153929|364783124|FG002|Overall Study|Other than listed|0|||
105762390|NCT04153929|364783125|FG003|Overall Study|Other than listed|1|||
105762391|NCT04153929|364783126|FG004|Overall Study|Other than listed|0|||
105762392|NCT04153929|364783127|FG005|Overall Study|Other than listed|2|||
105762393|NCT04153929|364783128|FG006|Overall Study|Other than listed|2|||
105762394|NCT04153929|364783129|FG007|Overall Study|Other than listed|1|||
105762395|NCT04153929|364783122|FG000|Overall Study|Lost to Follow-up|2|||
105762396|NCT04153929|364783123|FG001|Overall Study|Lost to Follow-up|1|||
105762397|NCT04153929|364783124|FG002|Overall Study|Lost to Follow-up|0|||
105762398|NCT04153929|364783125|FG003|Overall Study|Lost to Follow-up|1|||
105762399|NCT04153929|364783126|FG004|Overall Study|Lost to Follow-up|1|||
105762400|NCT04153929|364783127|FG005|Overall Study|Lost to Follow-up|0|||
105762401|NCT04153929|364783128|FG006|Overall Study|Lost to Follow-up|0|||
105762402|NCT04153929|364783129|FG007|Overall Study|Lost to Follow-up|0|||
105762403|NCT04153929|364783122|FG000|Overall Study|Withdrawal by Subject|3|||
105762404|NCT04153929|364783123|FG001|Overall Study|Withdrawal by Subject|1|||
105762405|NCT04153929|364783124|FG002|Overall Study|Withdrawal by Subject|0|||
105762406|NCT04153929|364783125|FG003|Overall Study|Withdrawal by Subject|3|||
105762407|NCT04153929|364783126|FG004|Overall Study|Withdrawal by Subject|1|||
105762408|NCT04153929|364783127|FG005|Overall Study|Withdrawal by Subject|0|||
105762409|NCT04153929|364783128|FG006|Overall Study|Withdrawal by Subject|1|||
105762410|NCT04153929|364783129|FG007|Overall Study|Withdrawal by Subject|0|||
105762411|NCT04153929|364783122|FG000|Overall Study|Protocol Violation|0|||
105762412|NCT04153929|364783123|FG001|Overall Study|Protocol Violation|0|||
105762413|NCT04153929|364783124|FG002|Overall Study|Protocol Violation|0|||
105762414|NCT04153929|364783125|FG003|Overall Study|Protocol Violation|0|||
105762415|NCT04153929|364783126|FG004|Overall Study|Protocol Violation|0|||
105762416|NCT04153929|364783127|FG005|Overall Study|Protocol Violation|0|||
105762417|NCT04153929|364783128|FG006|Overall Study|Protocol Violation|1|||
105762418|NCT04153929|364783129|FG007|Overall Study|Protocol Violation|2|||
105762419|NCT04153929|364783122|FG000|Overall Study|Adverse Event|3|||
105762420|NCT04153929|364783123|FG001|Overall Study|Adverse Event|5|||
105762421|NCT04153929|364783124|FG002|Overall Study|Adverse Event|5|||
105762422|NCT04153929|364783125|FG003|Overall Study|Adverse Event|11|||
105762423|NCT04153929|364783126|FG004|Overall Study|Adverse Event|15|||
105762424|NCT04153929|364783127|FG005|Overall Study|Adverse Event|4|||
105762425|NCT04153929|364783128|FG006|Overall Study|Adverse Event|8|||
105762426|NCT04153929|364783129|FG007|Overall Study|Adverse Event|2|||
105762427|NCT04153929|364783122|FG000|Overall Study|Not treated|1|||
105762428|NCT04153929|364783123|FG001|Overall Study|Not treated|0|||
105762429|NCT04153929|364783124|FG002|Overall Study|Not treated|0|||
105762430|NCT04153929|364783125|FG003|Overall Study|Not treated|0|||
105809262|NCT01654380|364956896|FG000|Part B, Period 1|Physician Decision|0|||
105762431|NCT04153929|364783126|FG004|Overall Study|Not treated|0|||
105762432|NCT04153929|364783127|FG005|Overall Study|Not treated|0|||
105762433|NCT04153929|364783128|FG006|Overall Study|Not treated|1|||
105762434|NCT04153929|364783129|FG007|Overall Study|Not treated|0|||
105762435|NCT00753623|364783130|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
105762436|NCT00753623|364783131|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
105762437|NCT00753623|364783130|FG000|Phase I (14 Days)|Physician Decision|1|||
105762438|NCT00753623|364783131|FG001|Phase I (14 Days)|Physician Decision|2|||
105762439|NCT00753623|364783130|FG000|Phase I (14 Days)|Adverse Event|0|||
105762440|NCT00753623|364783131|FG001|Phase I (14 Days)|Adverse Event|1|||
105762441|NCT00753623|364783130|FG000|Washout (7 Days)|Physician Decision|1|||
105762442|NCT00753623|364783131|FG001|Washout (7 Days)|Physician Decision|0|||
105762443|NCT00753623|364783130|FG000|Phase II (14 Days)|Physician Decision|0|||
105762444|NCT00753623|364783131|FG001|Phase II (14 Days)|Physician Decision|1|||
105571448|NCT04091360|364091209|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
105762445|NCT04423757|364783132|FG000|Overall Study|Adverse Event|2|||
105762446|NCT04423757|364783133|FG001|Overall Study|Adverse Event|0|||
105762447|NCT04423757|364783132|FG000|Overall Study|Not treated|1|||
105762448|NCT04423757|364783133|FG001|Overall Study|Not treated|1|||
105762449|NCT01928082|364783134|FG000|Overall Study|Study terminated.|1|||
105762450|NCT01125293|364783135|FG000|Overall Study|Disease Progression|1|||
105762451|NCT01125293|364783136|FG001|Overall Study|Disease Progression|3|||
105762452|NCT01125293|364783137|FG002|Overall Study|Disease Progression|4|||
105762453|NCT01125293|364783138|FG003|Overall Study|Disease Progression|3|||
105762454|NCT01125293|364783139|FG004|Overall Study|Disease Progression|5|||
105762455|NCT01125293|364783140|FG005|Overall Study|Disease Progression|12|||
105762456|NCT01125293|364783135|FG000|Overall Study|Adverse Event|1|||
105762457|NCT01125293|364783136|FG001|Overall Study|Adverse Event|0|||
105762458|NCT01125293|364783137|FG002|Overall Study|Adverse Event|0|||
105762459|NCT01125293|364783138|FG003|Overall Study|Adverse Event|0|||
105762460|NCT01125293|364783139|FG004|Overall Study|Adverse Event|2|||
105762461|NCT01125293|364783140|FG005|Overall Study|Adverse Event|8|||
105762462|NCT01125293|364783135|FG000|Overall Study|Symptomatic Deterioration|1|||
105762463|NCT01125293|364783136|FG001|Overall Study|Symptomatic Deterioration|0|||
105762464|NCT01125293|364783137|FG002|Overall Study|Symptomatic Deterioration|0|||
105762465|NCT01125293|364783138|FG003|Overall Study|Symptomatic Deterioration|0|||
105762466|NCT01125293|364783139|FG004|Overall Study|Symptomatic Deterioration|0|||
105762467|NCT01125293|364783140|FG005|Overall Study|Symptomatic Deterioration|0|||
105762468|NCT01125293|364783135|FG000|Overall Study|Death|0|||
105762469|NCT01125293|364783136|FG001|Overall Study|Death|0|||
105762470|NCT01125293|364783137|FG002|Overall Study|Death|0|||
105762471|NCT01125293|364783138|FG003|Overall Study|Death|0|||
105762472|NCT01125293|364783139|FG004|Overall Study|Death|1|||
105762473|NCT01125293|364783140|FG005|Overall Study|Death|0|||
105762474|NCT01125293|364783135|FG000|Overall Study|Withdrawal by Subject|0|||
105762475|NCT01125293|364783136|FG001|Overall Study|Withdrawal by Subject|0|||
105762476|NCT01125293|364783137|FG002|Overall Study|Withdrawal by Subject|0|||
105762477|NCT01125293|364783138|FG003|Overall Study|Withdrawal by Subject|0|||
105762478|NCT01125293|364783139|FG004|Overall Study|Withdrawal by Subject|2|||
105762479|NCT01125293|364783140|FG005|Overall Study|Withdrawal by Subject|1|||
105762480|NCT01125293|364783135|FG000|Overall Study|Physician Decision|0|||
105762481|NCT01125293|364783136|FG001|Overall Study|Physician Decision|0|||
105762482|NCT01125293|364783137|FG002|Overall Study|Physician Decision|0|||
105762483|NCT01125293|364783138|FG003|Overall Study|Physician Decision|0|||
105762484|NCT01125293|364783139|FG004|Overall Study|Physician Decision|0|||
105762485|NCT01125293|364783140|FG005|Overall Study|Physician Decision|2|||
105762486|NCT01946412|364783142|FG000|Overall Study|Adverse Event|1|||
105762487|NCT01946412|364783142|FG000|Overall Study|Non-Compliance|1|||
105762488|NCT01946412|364783142|FG000|Overall Study|Continued with commercial Kalydeco|2|||
105762489|NCT01946412|364783142|FG000|Overall Study|Difficulty in swallowing|1|||
105762490|NCT03148756|364783143|FG000|Overall Study|Study Terminated|0|||
105762491|NCT03148756|364783144|FG001|Overall Study|Study Terminated|1|||
105762492|NCT03820726|364783147|FG000|Overall Study|Other than listed|23|||
105762493|NCT03820726|364783147|FG000|Overall Study|Withdrawal by Subject|37|||
105762494|NCT03820726|364783147|FG000|Overall Study|Lost to Follow-up|3|||
105762495|NCT03820726|364783147|FG000|Overall Study|Protocol deviation|1|||
105762496|NCT03820726|364783147|FG000|Overall Study|Adverse Event|146|||
105762497|NCT03820726|364783147|FG000|Overall Study|Not treated|1|||
105762498|NCT02120352|364783150|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
105762499|NCT02120352|364783151|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
105762500|NCT02120352|364783152|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
105762501|NCT02120352|364783153|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
105762502|NCT02120352|364783154|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
105762503|NCT02120352|364783155|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
105762504|NCT02120352|364783156|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
105762505|NCT02120352|364783150|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
105762506|NCT02120352|364783151|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
105762507|NCT02120352|364783152|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
105762508|NCT02120352|364783153|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
105762509|NCT02120352|364783154|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
105762510|NCT02120352|364783155|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
105762511|NCT02120352|364783156|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
105762512|NCT02120352|364783150|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
105762513|NCT02120352|364783151|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
105762514|NCT02120352|364783152|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
105762515|NCT02120352|364783153|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
105762516|NCT02120352|364783154|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
105762517|NCT02120352|364783155|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
105762518|NCT02120352|364783156|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
105762519|NCT02120352|364783150|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
105762520|NCT02120352|364783151|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
105485750|NCT03361176|363789597|FG001|Overall Study|Lost to Follow-up|2|||
105485751|NCT03361176|363789596|FG000|Overall Study|Adverse Event|0|||
105485752|NCT03361176|363789597|FG001|Overall Study|Adverse Event|2|||
105485753|NCT03361176|363789596|FG000|Overall Study|Withdrawal by Subject|0|||
105485754|NCT03361176|363789597|FG001|Overall Study|Withdrawal by Subject|1|||
105485755|NCT02478398|363789598|FG000|Overall Study|Adverse Event|20|||
105485756|NCT02478398|363789599|FG001|Overall Study|Adverse Event|5|||
105485757|NCT02478398|363789598|FG000|Overall Study|Lost to Follow-up|5|||
105485758|NCT02478398|363789599|FG001|Overall Study|Lost to Follow-up|4|||
105809263|NCT01654380|364956897|FG001|Part B, Period 1|Physician Decision|0|||
105809264|NCT01654380|364956898|FG002|Part B, Period 1|Physician Decision|1|||
105809265|NCT01654380|364956899|FG003|Part B, Period 1|Physician Decision|0|||
105809266|NCT00947427|364956900|FG000|Overall Study|Withdrawal by Subject|1|||
105361066|NCT03286218|363328149|FG008|Qualification Phase Period 2|Adverse Event|0|||
105361067|NCT03286218|363328150|FG009|Qualification Phase Period 2|Adverse Event|0|||
105361068|NCT03286218|363328151|FG010|Qualification Phase Period 2|Adverse Event|0|||
105361069|NCT03286218|363328152|FG011|Qualification Phase Period 2|Adverse Event|0|||
105361070|NCT03286218|363328141|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
105361071|NCT03286218|363328142|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
105361072|NCT03286218|363328143|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105361073|NCT03286218|363328144|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105361074|NCT03286218|363328145|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105361075|NCT03286218|363328146|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105361076|NCT03286218|363328147|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105361077|NCT03286218|363328148|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105361078|NCT03286218|363328149|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105361079|NCT03286218|363328150|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105361080|NCT03286218|363328151|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105361081|NCT03286218|363328152|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105361082|NCT03286218|363328141|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
105361083|NCT03286218|363328142|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
105361084|NCT03286218|363328143|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
105361085|NCT03286218|363328144|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
105361086|NCT03286218|363328145|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
105361087|NCT03286218|363328146|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
105361088|NCT03286218|363328147|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
105361089|NCT03286218|363328148|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
105361090|NCT03286218|363328149|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
105361091|NCT03286218|363328150|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
105361092|NCT03286218|363328151|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
105361093|NCT03286218|363328152|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
105361094|NCT03286218|363328141|FG000|Qualification Phase Period 2|Protocol Violation|2|||
105361095|NCT03286218|363328142|FG001|Qualification Phase Period 2|Protocol Violation|0|||
105361096|NCT03286218|363328143|FG002|Qualification Phase Period 2|Protocol Violation|0|||
105361097|NCT03286218|363328144|FG003|Qualification Phase Period 2|Protocol Violation|0|||
105361098|NCT03286218|363328145|FG004|Qualification Phase Period 2|Protocol Violation|0|||
105361099|NCT03286218|363328146|FG005|Qualification Phase Period 2|Protocol Violation|0|||
105361100|NCT03286218|363328147|FG006|Qualification Phase Period 2|Protocol Violation|0|||
105361101|NCT03286218|363328148|FG007|Qualification Phase Period 2|Protocol Violation|0|||
105361102|NCT03286218|363328149|FG008|Qualification Phase Period 2|Protocol Violation|0|||
105361103|NCT03286218|363328150|FG009|Qualification Phase Period 2|Protocol Violation|0|||
105361104|NCT03286218|363328151|FG010|Qualification Phase Period 2|Protocol Violation|0|||
105361105|NCT03286218|363328152|FG011|Qualification Phase Period 2|Protocol Violation|0|||
105361106|NCT03286218|363328141|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
105361107|NCT03286218|363328142|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
105361108|NCT03286218|363328143|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
105361109|NCT03286218|363328144|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
105361110|NCT03286218|363328145|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
105361111|NCT03286218|363328146|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
105361112|NCT03286218|363328147|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
105361113|NCT03286218|363328148|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
105361114|NCT03286218|363328149|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
105361115|NCT03286218|363328150|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
105361116|NCT03286218|363328151|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
105361117|NCT03286218|363328152|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
105485759|NCT02478398|363789598|FG000|Overall Study|Non-Compliance With Study Drug|5|||
105485760|NCT02478398|363789599|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105809267|NCT00947427|364956901|FG001|Overall Study|Withdrawal by Subject|3|||
105809268|NCT00947427|364956900|FG000|Overall Study|Protocol Violation|0|||
105809269|NCT00947427|364956901|FG001|Overall Study|Protocol Violation|1|||
105809270|NCT01937364|364956904|FG000|Overall Study|Adverse Event|2|||
105809271|NCT01937364|364956905|FG001|Overall Study|Adverse Event|1|||
105809272|NCT00936975|364956906|FG000|Overall Study|Withdrawal by Subject|1|||
105809273|NCT00936975|364956906|FG000|Overall Study|Disease progression|3|||
105809274|NCT00936975|364956906|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
105809275|NCT00662129|364956907|FG000|Overall Study|Protocol Violation|1|||
105809276|NCT00662129|364956907|FG000|Overall Study|Cancel prior to beginning treatment|1|||
105809277|NCT00662129|364956907|FG000|Overall Study|Ineligible|1|||
105809278|NCT02427607|364956908|FG000|Overall Study|Withdrawal by Subject|1|||
105809279|NCT02153736|364956909|FG000|Overall Study|Lost to Follow-up|1|||
105809280|NCT02153736|364956910|FG001|Overall Study|Lost to Follow-up|0|||
105809281|NCT02153736|364956909|FG000|Overall Study|Medical status change made ineligible|1|||
105809282|NCT02153736|364956910|FG001|Overall Study|Medical status change made ineligible|0|||
105809283|NCT02153736|364956909|FG000|Overall Study|Death|0|||
105809284|NCT02153736|364956910|FG001|Overall Study|Death|1|||
105809285|NCT02153736|364956909|FG000|Overall Study|Withdrawal by Subject|0|||
105809286|NCT02153736|364956910|FG001|Overall Study|Withdrawal by Subject|1|||
105809287|NCT03283709|364956913|FG000|Overall Study|trial terminated|0|||
105809288|NCT03283709|364956914|FG001|Overall Study|trial terminated|1|||
105809289|NCT03730103|364956915|FG000|Overall Study|Did not meet inclusion criteria|0|||
105809290|NCT03730103|364956916|FG001|Overall Study|Did not meet inclusion criteria|5|||
105809291|NCT00663871|364956917|FG000|Overall Study|Lost to Follow-up|5|||
105809292|NCT00663871|364956918|FG001|Overall Study|Lost to Follow-up|5|||
105809293|NCT00663871|364956917|FG000|Overall Study|Withdrawal by Subject|5|||
105809294|NCT00663871|364956918|FG001|Overall Study|Withdrawal by Subject|2|||
105809295|NCT01058421|364956919|FG000|1 Month Outcomes|Death|10|||
105809296|NCT01058421|364956920|FG001|1 Month Outcomes|Death|6|||
105809297|NCT01058421|364956919|FG000|1 Month Outcomes|Lost to Follow-up|8|||
105809298|NCT01058421|364956920|FG001|1 Month Outcomes|Lost to Follow-up|7|||
105809299|NCT01058421|364956919|FG000|1 Month Outcomes|Remained in Hospital|5|||
105809300|NCT01058421|364956920|FG001|1 Month Outcomes|Remained in Hospital|12|||
105809301|NCT01058421|364956919|FG000|1 Month Outcomes|Remained in Other Facility|16|||
105809302|NCT01058421|364956920|FG001|1 Month Outcomes|Remained in Other Facility|17|||
105809303|NCT01058421|364956919|FG000|3 Month Outcomes|Death|3|||
105809304|NCT01058421|364956920|FG001|3 Month Outcomes|Death|5|||
105809305|NCT01058421|364956919|FG000|3 Month Outcomes|Lost to Follow-up|12|||
105809306|NCT01058421|364956920|FG001|3 Month Outcomes|Lost to Follow-up|11|||
105809307|NCT01058421|364956919|FG000|3 Month Outcomes|Remained in Hospital|0|||
105809308|NCT01058421|364956920|FG001|3 Month Outcomes|Remained in Hospital|2|||
105809309|NCT01058421|364956919|FG000|3 Month Outcomes|Remained in Other Facility|5|||
105809310|NCT01058421|364956920|FG001|3 Month Outcomes|Remained in Other Facility|8|||
105809311|NCT01058421|364956919|FG000|6 Month Outcomes|Death|2|||
105809312|NCT01058421|364956920|FG001|6 Month Outcomes|Death|2|||
105809313|NCT01058421|364956919|FG000|6 Month Outcomes|Lost to Follow-up|16|||
105809314|NCT01058421|364956920|FG001|6 Month Outcomes|Lost to Follow-up|21|||
105809315|NCT01058421|364956919|FG000|6 Month Outcomes|Remained in Other Facility|1|||
105809316|NCT01058421|364956920|FG001|6 Month Outcomes|Remained in Other Facility|3|||
105809317|NCT05200858|364956923|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
105809318|NCT05200858|364956924|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
105809319|NCT05200858|364956925|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
105809320|NCT05200858|364956926|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
105809321|NCT01611090|364956927|FG000|Randomized Period|Lost to Follow-up|8|||
105809322|NCT01611090|364956928|FG001|Randomized Period|Lost to Follow-up|3|||
105809323|NCT01611090|364956929|FG002|Randomized Period|Lost to Follow-up|0|||
105809324|NCT01611090|364956927|FG000|Randomized Period|Withdrawal by Subject|22|||
105809325|NCT01611090|364956928|FG001|Randomized Period|Withdrawal by Subject|26|||
105809326|NCT01611090|364956929|FG002|Randomized Period|Withdrawal by Subject|0|||
105809327|NCT01611090|364956927|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
105809328|NCT01611090|364956928|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
105809329|NCT01611090|364956929|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
105809330|NCT01611090|364956927|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
105809331|NCT01611090|364956928|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
105809332|NCT01611090|364956929|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
105809333|NCT01628120|364959366|FG000|Overall Study|Withdrawal by Subject|7|||
105809334|NCT01628120|364959366|FG000|Overall Study|Adverse Event|12|||
105809335|NCT01628120|364959366|FG000|Overall Study|Lost to Follow-up|1|||
105809336|NCT01628120|364959366|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
105809337|NCT01628120|364959366|FG000|Overall Study|Non-compliant with Study Procedures|1|||
105809338|NCT01628120|364959366|FG000|Overall Study|Not Treated|3|||
105809339|NCT01628120|364959366|FG000|Overall Study|Sponsor Decision|5|||
105809340|NCT01628120|364959366|FG000|Overall Study|Switched Dialysis Method|2|||
105809341|NCT01628120|364959366|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
105809342|NCT01628120|364959366|FG000|Overall Study|Moved or Relocated|5|||
105809343|NCT01628120|364959366|FG000|Overall Study|Kidney Transplant|2|||
105809344|NCT01628120|364959366|FG000|Overall Study|Use of Standard of Care|1|||
105809345|NCT00704418|364959367|FG000|Overall Study|Withdrawal by Subject|2|||
105809346|NCT00704418|364959368|FG001|Overall Study|Withdrawal by Subject|0|||
105809347|NCT00704418|364959367|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
105809348|NCT00704418|364959368|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
105809349|NCT04583579|364959370|FG000|Overall Study|Lost to Follow-up|4|||
105809350|NCT01031537|364959371|FG000|Overall Study|medical reasons not related to study|3|||
105809351|NCT01031537|364959371|FG000|Overall Study|Lack of Efficacy|1|||
105809352|NCT01031537|364959371|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
105809353|NCT01031537|364959371|FG000|Overall Study|moved, met exclusion criteria|10|||
105809354|NCT01031537|364959371|FG000|Overall Study|Withdrawal by Subject|5|||
105809355|NCT01031537|364959371|FG000|Overall Study|PI removal, no longer met eligibility|12|||
105809356|NCT01000337|364959381|FG000|Overall Study|Lost to Follow-up|4|||
105809357|NCT01000337|364959382|FG001|Overall Study|Lost to Follow-up|3|||
105809358|NCT00755326|364959383|FG000|Overall Study|Lost to Follow-up|2|||
105809359|NCT00755326|364959384|FG001|Overall Study|Lost to Follow-up|3|||
105809360|NCT01694485|364959387|FG000|Overall Study|Withdrawal by Subject|20|||
105809361|NCT01694485|364959388|FG001|Overall Study|Withdrawal by Subject|6|||
105809362|NCT01694485|364959389|FG002|Overall Study|Withdrawal by Subject|7|||
105809363|NCT01694485|364959390|FG003|Overall Study|Withdrawal by Subject|25|||
105809364|NCT01694485|364959391|FG004|Overall Study|Withdrawal by Subject|18|||
105809365|NCT01694485|364959387|FG000|Overall Study|Sponsor Decision|3|||
105809366|NCT01694485|364959388|FG001|Overall Study|Sponsor Decision|0|||
105809367|NCT01694485|364959389|FG002|Overall Study|Sponsor Decision|0|||
105809368|NCT01694485|364959390|FG003|Overall Study|Sponsor Decision|2|||
105809369|NCT01694485|364959391|FG004|Overall Study|Sponsor Decision|0|||
105809370|NCT01694485|364959387|FG000|Overall Study|Lost to Follow-up|9|||
105809371|NCT01694485|364959388|FG001|Overall Study|Lost to Follow-up|1|||
105809372|NCT01694485|364959389|FG002|Overall Study|Lost to Follow-up|6|||
105809373|NCT01694485|364959390|FG003|Overall Study|Lost to Follow-up|10|||
105809374|NCT01694485|364959391|FG004|Overall Study|Lost to Follow-up|7|||
105809375|NCT01694485|364959387|FG000|Overall Study|Death|1|||
105809376|NCT01694485|364959388|FG001|Overall Study|Death|0|||
105809377|NCT01694485|364959389|FG002|Overall Study|Death|0|||
105809378|NCT01694485|364959390|FG003|Overall Study|Death|1|||
105809379|NCT01694485|364959391|FG004|Overall Study|Death|0|||
105809380|NCT00625807|364959392|FG000|Overall Study|schedule conflict|2|||
105809381|NCT00625807|364959393|FG001|Overall Study|schedule conflict|8|||
105809382|NCT03522948|364959394|FG000|Overall Study|Lost to Follow-up|1|||
105809383|NCT03937466|364959395|FG000|Overall Study|not eligbile after the 2-week diary|9|||
105809384|NCT03937466|364959395|FG000|Overall Study|never returned their diary|6|||
105809385|NCT03937466|364959395|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
105809386|NCT03937466|364959395|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
105809387|NCT03305055|364959397|FG000|Overall Study|Withdrawal by Subject|0|||
105809388|NCT03305055|364959398|FG001|Overall Study|Withdrawal by Subject|1|||
105809389|NCT03305055|364959397|FG000|Overall Study|Adverse Event|1|||
105809390|NCT03305055|364959398|FG001|Overall Study|Adverse Event|1|||
105809391|NCT00622908|364959399|FG000|Overall Study|Protocol Violation|1|||
105809392|NCT00622908|364959400|FG001|Overall Study|Protocol Violation|0|||
105809393|NCT00622908|364959399|FG000|Overall Study|Adverse Event|0|||
105809394|NCT00622908|364959400|FG001|Overall Study|Adverse Event|1|||
105809395|NCT00622908|364959399|FG000|Overall Study|Lack of Efficacy|1|||
105809396|NCT00622908|364959400|FG001|Overall Study|Lack of Efficacy|7|||
105809397|NCT00622908|364959399|FG000|Overall Study|Lost to Follow-up|1|||
105809398|NCT00622908|364959400|FG001|Overall Study|Lost to Follow-up|0|||
105809399|NCT00622908|364959399|FG000|Overall Study|Refusal|0|||
105809400|NCT00622908|364959400|FG001|Overall Study|Refusal|1|||
105809401|NCT00622908|364959399|FG000|Overall Study|Termination by study sponser|0|||
105809402|NCT00622908|364959400|FG001|Overall Study|Termination by study sponser|1|||
105809403|NCT00819247|364959406|FG000|Overall Study|Adverse Event|0|||
105809404|NCT00819247|364959407|FG001|Overall Study|Adverse Event|5|||
105809405|NCT00819247|364959408|FG002|Overall Study|Adverse Event|3|||
105809406|NCT00819247|364959406|FG000|Overall Study|Insufficient testosterone response|5|||
105809407|NCT00819247|364959407|FG001|Overall Study|Insufficient testosterone response|8|||
105809408|NCT00819247|364959408|FG002|Overall Study|Insufficient testosterone response|10|||
105809409|NCT00819247|364959406|FG000|Overall Study|Withdrawal by Subject|1|||
105809410|NCT00819247|364959407|FG001|Overall Study|Withdrawal by Subject|0|||
105809411|NCT00819247|364959408|FG002|Overall Study|Withdrawal by Subject|0|||
105809412|NCT00819247|364959406|FG000|Overall Study|Protocol Violation|1|||
105809413|NCT00819247|364959407|FG001|Overall Study|Protocol Violation|0|||
105809414|NCT00819247|364959408|FG002|Overall Study|Protocol Violation|1|||
105809415|NCT00819247|364959406|FG000|Overall Study|Mistakenly withdrawn|0|||
105809416|NCT00819247|364959407|FG001|Overall Study|Mistakenly withdrawn|1|||
105809417|NCT00819247|364959408|FG002|Overall Study|Mistakenly withdrawn|0|||
105809418|NCT00819247|364959406|FG000|Overall Study|Bad prostate-specific antigen response|3|||
105809419|NCT00819247|364959407|FG001|Overall Study|Bad prostate-specific antigen response|2|||
105809420|NCT00819247|364959408|FG002|Overall Study|Bad prostate-specific antigen response|0|||
105809421|NCT00819247|364959406|FG000|Overall Study|Other|1|||
105809422|NCT00819247|364959407|FG001|Overall Study|Other|0|||
105809423|NCT00819247|364959408|FG002|Overall Study|Other|0|||
105809424|NCT01325207|364959414|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
105809425|NCT01325207|364959415|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
105809426|NCT01325207|364959416|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
105809427|NCT01325207|364959417|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
105809428|NCT01325207|364959418|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
105809429|NCT01325207|364959419|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
105809430|NCT01325207|364959414|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
105809431|NCT01325207|364959415|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
105809432|NCT01325207|364959416|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
105809433|NCT01325207|364959417|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
105809434|NCT01325207|364959418|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
105809435|NCT01325207|364959419|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
105809436|NCT01325207|364959414|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
105809437|NCT01325207|364959415|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
105809438|NCT01325207|364959416|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
105809439|NCT01325207|364959417|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
105809440|NCT01325207|364959418|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
105809441|NCT01325207|364959419|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
105809442|NCT01325207|364959414|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
105809443|NCT01325207|364959415|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
105809444|NCT01325207|364959416|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
105809445|NCT01325207|364959417|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
105809446|NCT01325207|364959418|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
105809447|NCT01325207|364959419|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
105809448|NCT01325207|364959414|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
105809449|NCT01325207|364959415|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
105809450|NCT01325207|364959416|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
105809451|NCT01325207|364959417|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
105809452|NCT01325207|364959418|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
105809453|NCT01325207|364959419|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
105809454|NCT01325207|364959414|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
105809455|NCT01325207|364959415|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
105809456|NCT01325207|364959416|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
105809457|NCT01325207|364959417|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
105809458|NCT01325207|364959418|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
105809459|NCT01325207|364959419|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
105809460|NCT01325207|364959414|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
105809461|NCT01325207|364959415|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
105809462|NCT01325207|364959416|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
105809463|NCT01325207|364959417|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
105809464|NCT01325207|364959418|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
105809465|NCT01325207|364959419|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
105809466|NCT01974895|364959423|FG000|Overall Study|Protocol Violation|1|||
105809467|NCT01974895|364959424|FG001|Overall Study|Protocol Violation|0|||
105809468|NCT01974895|364959423|FG000|Overall Study|Lost to Follow-up|4|||
105809469|NCT01974895|364959424|FG001|Overall Study|Lost to Follow-up|6|||
105809470|NCT01974895|364959423|FG000|Overall Study|Withdrawal by Subject|0|||
105809471|NCT01974895|364959424|FG001|Overall Study|Withdrawal by Subject|1|||
105809472|NCT01974895|364959423|FG000|Overall Study|Other (Missed Visit)|1|||
105809473|NCT01974895|364959424|FG001|Overall Study|Other (Missed Visit)|0|||
105809474|NCT01974895|364959423|FG000|Overall Study|Other (Reason unknown)|9|||
105809475|NCT01974895|364959424|FG001|Overall Study|Other (Reason unknown)|8|||
105809476|NCT01513148|364959429|FG000|Overall Study|Protocol Violation|2|||
105809477|NCT01513148|364959430|FG001|Overall Study|Protocol Violation|2|||
105809478|NCT01166568|364959436|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
105809479|NCT01166568|364959437|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
105809480|NCT01166568|364959438|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
105485761|NCT02478398|363789598|FG000|Overall Study|Protocol Violation|3|||
105809481|NCT01166568|364959436|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
105809482|NCT01166568|364959437|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
105809483|NCT01166568|364959438|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
105485762|NCT02478398|363789599|FG001|Overall Study|Protocol Violation|1|||
105485763|NCT02478398|363789598|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
105809484|NCT01166568|364959436|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
105809485|NCT01166568|364959437|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
105809486|NCT01166568|364959438|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
105809487|NCT01984242|364959439|FG000|Overall Study|Death|52|||
105809488|NCT01984242|364959440|FG001|Overall Study|Death|50|||
105809489|NCT01984242|364959441|FG002|Overall Study|Death|52|||
105809490|NCT01984242|364959439|FG000|Overall Study|Withdrawal by Subject|5|||
105809491|NCT01984242|364959440|FG001|Overall Study|Withdrawal by Subject|3|||
105809492|NCT01984242|364959441|FG002|Overall Study|Withdrawal by Subject|10|||
105809493|NCT01984242|364959439|FG000|Overall Study|Physician Decision|0|||
105809494|NCT01984242|364959440|FG001|Overall Study|Physician Decision|0|||
105809495|NCT01984242|364959441|FG002|Overall Study|Physician Decision|1|||
105809496|NCT01984242|364959439|FG000|Overall Study|Lost to Follow-up|4|||
105809497|NCT01984242|364959440|FG001|Overall Study|Lost to Follow-up|0|||
105809498|NCT01984242|364959441|FG002|Overall Study|Lost to Follow-up|3|||
105809499|NCT01984242|364959439|FG000|Overall Study|Sponsor Decision|1|||
105809500|NCT01984242|364959440|FG001|Overall Study|Sponsor Decision|0|||
105809501|NCT01984242|364959441|FG002|Overall Study|Sponsor Decision|0|||
105809502|NCT01984242|364959439|FG000|Overall Study|Non-Compliance|1|||
105809503|NCT01984242|364959440|FG001|Overall Study|Non-Compliance|0|||
105809504|NCT01984242|364959441|FG002|Overall Study|Non-Compliance|0|||
105809505|NCT01984242|364959439|FG000|Overall Study|Study terminated by Sponsor|38|||
105809506|NCT01984242|364959440|FG001|Overall Study|Study terminated by Sponsor|50|||
105809507|NCT01984242|364959441|FG002|Overall Study|Study terminated by Sponsor|34|||
105809508|NCT01984242|364959439|FG000|Overall Study|Disease Progression|0|||
105809509|NCT01984242|364959440|FG001|Overall Study|Disease Progression|0|||
105809510|NCT01984242|364959441|FG002|Overall Study|Disease Progression|1|||
105809511|NCT03335371|364959442|FG000|Overall Study|Lost to Follow-up|0|||
105809512|NCT03335371|364959443|FG001|Overall Study|Lost to Follow-up|0|||
105809513|NCT03335371|364959444|FG002|Overall Study|Lost to Follow-up|0|||
105809514|NCT03335371|364959445|FG003|Overall Study|Lost to Follow-up|0|||
105809515|NCT03335371|364959446|FG004|Overall Study|Lost to Follow-up|1|||
105809516|NCT03335371|364959442|FG000|Overall Study|Withdrawal by Subject|0|||
105809517|NCT03335371|364959443|FG001|Overall Study|Withdrawal by Subject|0|||
105809518|NCT03335371|364959444|FG002|Overall Study|Withdrawal by Subject|0|||
105809519|NCT03335371|364959445|FG003|Overall Study|Withdrawal by Subject|0|||
105809520|NCT03335371|364959446|FG004|Overall Study|Withdrawal by Subject|1|||
105809521|NCT03335371|364959442|FG000|Overall Study|Randomization Error|0|||
105809522|NCT03335371|364959443|FG001|Overall Study|Randomization Error|0|||
105809523|NCT03335371|364959444|FG002|Overall Study|Randomization Error|1|||
105809524|NCT03335371|364959445|FG003|Overall Study|Randomization Error|0|||
105809525|NCT03335371|364959446|FG004|Overall Study|Randomization Error|0|||
105809526|NCT00684671|364959447|FG000|Overall Study|Adverse Event|1|||
105809527|NCT00684671|364959448|FG001|Overall Study|Adverse Event|0|||
105809528|NCT00684671|364959449|FG002|Overall Study|Adverse Event|0|||
105809529|NCT00684671|364959447|FG000|Overall Study|Lost to Follow-up|1|||
105809530|NCT00684671|364959448|FG001|Overall Study|Lost to Follow-up|0|||
105809531|NCT00684671|364959449|FG002|Overall Study|Lost to Follow-up|0|||
105809532|NCT00684671|364959447|FG000|Overall Study|Alcoholic dependance|1|||
105809533|NCT00684671|364959448|FG001|Overall Study|Alcoholic dependance|0|||
105809534|NCT00684671|364959449|FG002|Overall Study|Alcoholic dependance|0|||
105809535|NCT01725451|364959452|FG000|Period 1|Withdrawal by Subject|1|||
105809536|NCT01725451|364959453|FG001|Period 1|Withdrawal by Subject|0|||
105809537|NCT01725451|364959454|FG002|Period 1|Withdrawal by Subject|0|||
105809538|NCT01725451|364959455|FG003|Period 1|Withdrawal by Subject|0|||
105809539|NCT01725451|364959452|FG000|Washout From Period 3|Protocol Violation|0|||
105809540|NCT01725451|364959453|FG001|Washout From Period 3|Protocol Violation|0|||
105809541|NCT01725451|364959454|FG002|Washout From Period 3|Protocol Violation|1|||
105809542|NCT01725451|364959455|FG003|Washout From Period 3|Protocol Violation|0|||
105809543|NCT01725451|364959452|FG000|Washout From Period 3|Adverse Event|0|||
105361118|NCT03286218|363328141|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
105361119|NCT03286218|363328142|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
105361120|NCT03286218|363328143|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
105361121|NCT03286218|363328144|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
105361122|NCT03286218|363328145|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
105571449|NCT04091360|364091210|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
105809544|NCT01725451|364959453|FG001|Washout From Period 3|Adverse Event|1|||
105809545|NCT01725451|364959454|FG002|Washout From Period 3|Adverse Event|0|||
105361123|NCT03286218|363328146|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
105809546|NCT01725451|364959455|FG003|Washout From Period 3|Adverse Event|0|||
105809547|NCT01725451|364959452|FG000|Period 4|Adverse Event|0|||
105809548|NCT01725451|364959453|FG001|Period 4|Adverse Event|0|||
105809549|NCT01725451|364959454|FG002|Period 4|Adverse Event|1|||
105809550|NCT01725451|364959455|FG003|Period 4|Adverse Event|0|||
105809551|NCT04543136|364959456|FG000|Overall Study|Withdrawal by Subject|0|||
105809552|NCT04543136|364959457|FG001|Overall Study|Withdrawal by Subject|1|||
105809553|NCT04543136|364959458|FG002|Overall Study|Withdrawal by Subject|0|||
105809554|NCT04543136|364959459|FG003|Overall Study|Withdrawal by Subject|1|||
105809555|NCT04543136|364959460|FG004|Overall Study|Withdrawal by Subject|0|||
105809556|NCT04543136|364959461|FG005|Overall Study|Withdrawal by Subject|0|||
105809557|NCT02978326|364959463|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
105809558|NCT02978326|364959464|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
105809559|NCT02978326|364959465|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
105809560|NCT02978326|364959463|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
105809561|NCT02978326|364959464|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
105809562|NCT02978326|364959465|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
105809563|NCT02978326|364959463|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
105809564|NCT02978326|364959464|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
105809565|NCT02978326|364959465|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
105809566|NCT02978326|364959463|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
105809567|NCT02978326|364959464|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
105809568|NCT02978326|364959465|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
105809569|NCT00437281|364959466|FG000|Overall Study|Adverse Event|0|||
105809570|NCT00437281|364959467|FG001|Overall Study|Adverse Event|0|||
105809571|NCT00437281|364959468|FG002|Overall Study|Adverse Event|0|||
105809572|NCT00437281|364959469|FG003|Overall Study|Adverse Event|1|||
105809573|NCT00437281|364959470|FG004|Overall Study|Adverse Event|0|||
105809574|NCT00437281|364959471|FG005|Overall Study|Adverse Event|1|||
105809575|NCT00437281|364959472|FG006|Overall Study|Adverse Event|0|||
105809576|NCT00437281|364959473|FG007|Overall Study|Adverse Event|0|||
105809577|NCT00437281|364959474|FG008|Overall Study|Adverse Event|0|||
105809578|NCT00437281|364959475|FG009|Overall Study|Adverse Event|1|||
105809579|NCT00437281|364959476|FG010|Overall Study|Adverse Event|0|||
105809580|NCT00437281|364959477|FG011|Overall Study|Adverse Event|0|||
105809581|NCT00437281|364959478|FG012|Overall Study|Adverse Event|0|||
105809582|NCT00437281|364959479|FG013|Overall Study|Adverse Event|1|||
105809583|NCT00437281|364959480|FG014|Overall Study|Adverse Event|1|||
105809584|NCT00437281|364959481|FG015|Overall Study|Adverse Event|0|||
105809585|NCT00437281|364959482|FG016|Overall Study|Adverse Event|0|||
105809586|NCT00437281|364959483|FG017|Overall Study|Adverse Event|0|||
105809587|NCT00437281|364959484|FG018|Overall Study|Adverse Event|1|||
105809588|NCT00437281|364959485|FG019|Overall Study|Adverse Event|0|||
105809589|NCT00437281|364959466|FG000|Overall Study|Lost to Follow-up|0|||
105809590|NCT00437281|364959467|FG001|Overall Study|Lost to Follow-up|0|||
105809591|NCT00437281|364959468|FG002|Overall Study|Lost to Follow-up|0|||
105809592|NCT00437281|364959469|FG003|Overall Study|Lost to Follow-up|0|||
105809593|NCT00437281|364959470|FG004|Overall Study|Lost to Follow-up|0|||
105809594|NCT00437281|364959471|FG005|Overall Study|Lost to Follow-up|0|||
105809595|NCT00437281|364959472|FG006|Overall Study|Lost to Follow-up|0|||
105809596|NCT00437281|364959473|FG007|Overall Study|Lost to Follow-up|0|||
105809597|NCT00437281|364959474|FG008|Overall Study|Lost to Follow-up|0|||
105809598|NCT00437281|364959475|FG009|Overall Study|Lost to Follow-up|0|||
105809599|NCT00437281|364959476|FG010|Overall Study|Lost to Follow-up|0|||
105809600|NCT00437281|364959477|FG011|Overall Study|Lost to Follow-up|0|||
105809601|NCT00437281|364959478|FG012|Overall Study|Lost to Follow-up|0|||
105809602|NCT00437281|364959479|FG013|Overall Study|Lost to Follow-up|0|||
105809603|NCT00437281|364959480|FG014|Overall Study|Lost to Follow-up|0|||
105809604|NCT00437281|364959481|FG015|Overall Study|Lost to Follow-up|0|||
105809605|NCT00437281|364959482|FG016|Overall Study|Lost to Follow-up|0|||
105809606|NCT00437281|364959483|FG017|Overall Study|Lost to Follow-up|0|||
105809607|NCT00437281|364959484|FG018|Overall Study|Lost to Follow-up|0|||
105361124|NCT03286218|363328147|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
105361125|NCT03286218|363328148|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
105361126|NCT03286218|363328149|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
105361127|NCT03286218|363328150|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
105361128|NCT03286218|363328151|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
105361129|NCT03286218|363328152|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
105361130|NCT03286218|363328141|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
105361131|NCT03286218|363328142|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
105809608|NCT00437281|364959485|FG019|Overall Study|Lost to Follow-up|1|||
105809609|NCT03521999|364959489|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
105809610|NCT03521999|364959490|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
105809611|NCT03521999|364959489|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
105809612|NCT03521999|364959490|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
105809613|NCT03521999|364959489|FG000|Completed 3 Month Follow up|Death|0|||
105809614|NCT03521999|364959490|FG001|Completed 3 Month Follow up|Death|1|||
105809615|NCT03521999|364959489|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
105809616|NCT03521999|364959490|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
105809617|NCT00865709|364959493|FG000|Treatment|Adverse Event|9|||
105809618|NCT00865709|364959494|FG001|Treatment|Adverse Event|6|||
105809619|NCT00865709|364959493|FG000|Treatment|Withdrawal by Subject|10|||
105809620|NCT00865709|364959494|FG001|Treatment|Withdrawal by Subject|7|||
105809621|NCT00865709|364959493|FG000|Treatment|Physician Decision|3|||
105809622|NCT00865709|364959494|FG001|Treatment|Physician Decision|2|||
105809623|NCT00865709|364959493|FG000|Treatment|Surgery|8|||
105809624|NCT00865709|364959494|FG001|Treatment|Surgery|3|||
105809625|NCT01485536|364959497|FG000|Overall Study|Withdrawal by Subject|3|||
105809626|NCT01485536|364959497|FG000|Overall Study|Adverse Event|1|||
105809627|NCT00577460|364959498|FG000|Overall Study|Adverse Event|11|||
105809628|NCT00577460|364959499|FG001|Overall Study|Adverse Event|7|||
105809629|NCT00577460|364959500|FG002|Overall Study|Adverse Event|14|||
105809630|NCT00577460|364959498|FG000|Overall Study|Protocol Violation|0|||
105809631|NCT00577460|364959499|FG001|Overall Study|Protocol Violation|1|||
105809632|NCT00577460|364959500|FG002|Overall Study|Protocol Violation|1|||
105809633|NCT00577460|364959498|FG000|Overall Study|Lost to Follow-up|0|||
105809634|NCT00577460|364959499|FG001|Overall Study|Lost to Follow-up|3|||
105809635|NCT00577460|364959500|FG002|Overall Study|Lost to Follow-up|4|||
105809636|NCT00577460|364959498|FG000|Overall Study|Withdrawal by Subject|5|||
105809637|NCT00577460|364959499|FG001|Overall Study|Withdrawal by Subject|5|||
105809638|NCT00577460|364959500|FG002|Overall Study|Withdrawal by Subject|6|||
105809639|NCT00577460|364959498|FG000|Overall Study|Other|0|||
105809640|NCT00577460|364959499|FG001|Overall Study|Other|3|||
105809641|NCT00577460|364959500|FG002|Overall Study|Other|2|||
105809642|NCT01734772|364959501|FG000|Overall Study|Adverse Event|1|||
105809643|NCT01734772|364959502|FG001|Overall Study|Adverse Event|2|||
105809644|NCT01734772|364959501|FG000|Overall Study|Withdrawal by Subject|0|||
105809645|NCT01734772|364959502|FG001|Overall Study|Withdrawal by Subject|1|||
105809646|NCT00329602|364959505|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
105809647|NCT00329602|364959506|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
105809648|NCT00329602|364959507|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
105809649|NCT00329602|364959505|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
105809650|NCT00329602|364959506|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
105809651|NCT00329602|364959507|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
105809652|NCT00329602|364959505|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
105809653|NCT00329602|364959506|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
105809654|NCT00329602|364959507|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
105809655|NCT00329602|364959505|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
105809656|NCT00329602|364959506|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
105809657|NCT00329602|364959507|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
105809658|NCT00329602|364959505|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
105809659|NCT00329602|364959506|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
105809660|NCT00329602|364959507|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
105809661|NCT00329602|364959505|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
105809662|NCT00329602|364959506|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
105809663|NCT00329602|364959507|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
105809664|NCT01867242|364959508|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
105809665|NCT01867242|364959509|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
105809666|NCT01867242|364959510|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
105809667|NCT02275364|364959511|FG000|Period 1|Withdrawal by Subject|1|||
105809668|NCT02275364|364959512|FG001|Period 1|Withdrawal by Subject|0|||
105809669|NCT02275364|364959511|FG000|Period 1|Other reason|1|||
105809670|NCT02275364|364959512|FG001|Period 1|Other reason|0|||
105809671|NCT02579096|364959515|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
105809672|NCT02579096|364959516|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
105809673|NCT02579096|364959515|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
105809674|NCT02579096|364959516|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
105809675|NCT02579096|364959515|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
105809676|NCT02579096|364959516|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
105809677|NCT02579096|364959515|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
105809678|NCT02579096|364959516|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
105809679|NCT02579096|364959515|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
105809680|NCT02579096|364959516|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
105809681|NCT02579096|364959515|FG000|Phase 2, Weeks 25 - 48|Death|2|||
105809682|NCT02579096|364959516|FG001|Phase 2, Weeks 25 - 48|Death|4|||
105809683|NCT02579096|364959515|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
105809684|NCT02579096|364959516|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
105809685|NCT02579096|364959515|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
105809686|NCT02579096|364959516|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
105809687|NCT02579096|364959515|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
105809688|NCT02579096|364959516|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
105809689|NCT02579096|364959515|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
105809690|NCT02579096|364959516|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
105809691|NCT02579096|364959515|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
105809692|NCT02579096|364959516|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
105809693|NCT02579096|364959515|FG000|Phase 3, Weeks 49 - 72|Death|3|||
105809694|NCT02579096|364959516|FG001|Phase 3, Weeks 49 - 72|Death|2|||
105809695|NCT02579096|364959515|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
105809696|NCT02579096|364959516|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
105809697|NCT02579096|364959515|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
105809698|NCT02579096|364959516|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
105809699|NCT02579096|364959515|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
105809700|NCT02579096|364959516|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
105809701|NCT02579096|364959515|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
105809702|NCT02579096|364959516|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
105809703|NCT02579096|364959515|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
105809704|NCT02579096|364959516|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
105809705|NCT02579096|364959515|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
105809706|NCT02579096|364959516|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
105809707|NCT03977584|364959517|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
105809708|NCT03977584|364959518|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
105809709|NCT03977584|364959519|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
105809710|NCT04591626|364959524|FG000|Overall Study|Adverse Event|4|||
105809711|NCT04591626|364959525|FG001|Overall Study|Adverse Event|0|||
105809712|NCT04591626|364959524|FG000|Overall Study|Withdrawal by Subject|5|||
105809713|NCT04591626|364959525|FG001|Overall Study|Withdrawal by Subject|3|||
105809714|NCT04591626|364959524|FG000|Overall Study|Physician Decision|0|||
105809715|NCT04591626|364959525|FG001|Overall Study|Physician Decision|1|||
105809716|NCT04591626|364959524|FG000|Overall Study|Death|0|||
105809717|NCT04591626|364959525|FG001|Overall Study|Death|1|||
105809718|NCT04591626|364959524|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105809719|NCT04591626|364959525|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105809720|NCT02097121|364959526|FG000|Overall Study|Other, not specified|4|||
105809721|NCT02097121|364959527|FG001|Overall Study|Other, not specified|2|||
105809722|NCT02097121|364959528|FG002|Overall Study|Other, not specified|3|||
105809723|NCT02097121|364959526|FG000|Overall Study|Lack of Efficacy|2|||
105809724|NCT02097121|364959527|FG001|Overall Study|Lack of Efficacy|1|||
105809725|NCT02097121|364959528|FG002|Overall Study|Lack of Efficacy|3|||
105809726|NCT02097121|364959526|FG000|Overall Study|Withdrawal by Subject|0|||
105809727|NCT02097121|364959527|FG001|Overall Study|Withdrawal by Subject|1|||
105809728|NCT02097121|364959528|FG002|Overall Study|Withdrawal by Subject|2|||
105809729|NCT02097121|364959526|FG000|Overall Study|Adverse Event|0|||
105809730|NCT02097121|364959527|FG001|Overall Study|Adverse Event|1|||
105809731|NCT02097121|364959528|FG002|Overall Study|Adverse Event|0|||
105809732|NCT02097121|364959526|FG000|Overall Study|Lost to Follow-up|1|||
105809733|NCT02097121|364959527|FG001|Overall Study|Lost to Follow-up|1|||
105809734|NCT02097121|364959528|FG002|Overall Study|Lost to Follow-up|2|||
105809735|NCT03066999|364959530|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
105809736|NCT03066999|364959531|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
105809737|NCT00661999|364959532|FG000|Overall Study|Adverse Event|11|||
105809738|NCT00661999|364959533|FG001|Overall Study|Adverse Event|5|||
105809739|NCT00661999|364959534|FG002|Overall Study|Adverse Event|8|||
105809740|NCT00661999|364959532|FG000|Overall Study|Death|8|||
105809741|NCT00661999|364959533|FG001|Overall Study|Death|6|||
105809742|NCT00661999|364959534|FG002|Overall Study|Death|3|||
105809743|NCT00661999|364959532|FG000|Overall Study|Other Reasons|5|||
105809744|NCT00661999|364959533|FG001|Overall Study|Other Reasons|12|||
105809745|NCT00661999|364959534|FG002|Overall Study|Other Reasons|23|||
105809746|NCT00661999|364959532|FG000|Overall Study|Withdrawal by Subject|30|||
105809747|NCT00661999|364959533|FG001|Overall Study|Withdrawal by Subject|23|||
105809748|NCT00661999|364959534|FG002|Overall Study|Withdrawal by Subject|14|||
105809749|NCT00661999|364959532|FG000|Overall Study|Alternative Treatment|1|||
105809750|NCT00661999|364959533|FG001|Overall Study|Alternative Treatment|0|||
105809751|NCT00661999|364959534|FG002|Overall Study|Alternative Treatment|0|||
105809752|NCT00661999|364959532|FG000|Overall Study|Other Medical Problems|4|||
105809753|NCT00661999|364959533|FG001|Overall Study|Other Medical Problems|4|||
105809754|NCT00661999|364959534|FG002|Overall Study|Other Medical Problems|9|||
105809755|NCT00510510|364959535|FG000|Overall Study|Adverse Event|4|||
105809756|NCT00510510|364959536|FG001|Overall Study|Adverse Event|3|||
105809757|NCT00510510|364959537|FG002|Overall Study|Adverse Event|6|||
105809758|NCT00510510|364959535|FG000|Overall Study|Lack of Efficacy|0|||
105809759|NCT00510510|364959536|FG001|Overall Study|Lack of Efficacy|1|||
105809760|NCT00510510|364959537|FG002|Overall Study|Lack of Efficacy|1|||
105809761|NCT00510510|364959535|FG000|Overall Study|Subjects no longer requires study drug|0|||
105809762|NCT00510510|364959536|FG001|Overall Study|Subjects no longer requires study drug|0|||
105485764|NCT02478398|363789599|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
105485765|NCT02478398|363789598|FG000|Overall Study|Withdrawal By Participant|10|||
105485766|NCT02478398|363789599|FG001|Overall Study|Withdrawal By Participant|4|||
105485767|NCT04389970|363789601|FG000|Overall Study|Lost to Follow-up|1|||
105485768|NCT03123185|363789602|FG000|Overall Study|Withdrawal by Subject|0|||
105485769|NCT03123185|363789603|FG001|Overall Study|Withdrawal by Subject|0|||
105485770|NCT03123185|363789604|FG002|Overall Study|Withdrawal by Subject|0|||
105485771|NCT03123185|363789605|FG003|Overall Study|Withdrawal by Subject|0|||
105762521|NCT02120352|364783152|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
105762522|NCT02120352|364783153|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
105762523|NCT02120352|364783154|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
105762524|NCT02120352|364783155|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
105762525|NCT02120352|364783156|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
105762526|NCT02120352|364783150|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
105762527|NCT02120352|364783151|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
105762528|NCT02120352|364783152|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
105762529|NCT02120352|364783153|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
105762530|NCT02120352|364783154|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
105762531|NCT02120352|364783155|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
105762532|NCT02120352|364783156|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
105762533|NCT02120352|364783150|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
105762534|NCT02120352|364783151|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
105762535|NCT02120352|364783152|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
105762536|NCT02120352|364783153|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
105762537|NCT02120352|364783154|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
105762538|NCT02120352|364783155|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
105762539|NCT02120352|364783156|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
105762540|NCT02120352|364783150|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
105762541|NCT02120352|364783151|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
105762542|NCT02120352|364783152|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
105762543|NCT02120352|364783153|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
105762544|NCT02120352|364783154|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
105762545|NCT02120352|364783155|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
105762546|NCT02120352|364783156|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
105762547|NCT02120352|364783150|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
105762548|NCT02120352|364783151|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
105762549|NCT02120352|364783152|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
105762550|NCT02120352|364783153|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
105762551|NCT02120352|364783154|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
105762552|NCT02120352|364783155|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
105762553|NCT02120352|364783156|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
105762554|NCT02120352|364783150|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
105762555|NCT02120352|364783151|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
105762556|NCT02120352|364783152|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
105762557|NCT02120352|364783153|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
105762558|NCT02120352|364783154|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
105762559|NCT02120352|364783155|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
105762560|NCT02120352|364783156|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
105762561|NCT02120352|364783150|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
105762562|NCT02120352|364783151|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
105762563|NCT02120352|364783152|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
105762564|NCT02120352|364783153|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
105762565|NCT02120352|364783154|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
105762566|NCT02120352|364783155|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
105762567|NCT02120352|364783156|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
105762568|NCT02120352|364783150|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
105762569|NCT02120352|364783151|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
105762570|NCT02120352|364783152|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
105762571|NCT02120352|364783153|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
105762572|NCT02120352|364783154|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
105762573|NCT02120352|364783155|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
105762574|NCT02120352|364783156|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
105762575|NCT02120352|364783150|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
105762576|NCT02120352|364783151|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
105762577|NCT02120352|364783152|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
105762578|NCT02120352|364783153|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
105809763|NCT00510510|364959537|FG002|Overall Study|Subjects no longer requires study drug|2|||
105809764|NCT00510510|364959535|FG000|Overall Study|Withdrawal by Subject|1|||
105809765|NCT00510510|364959536|FG001|Overall Study|Withdrawal by Subject|2|||
105809766|NCT00510510|364959537|FG002|Overall Study|Withdrawal by Subject|3|||
105809767|NCT00510510|364959535|FG000|Overall Study|Lost to Follow-up|0|||
105809768|NCT00510510|364959536|FG001|Overall Study|Lost to Follow-up|0|||
105809769|NCT00510510|364959537|FG002|Overall Study|Lost to Follow-up|1|||
105809770|NCT00510510|364959535|FG000|Overall Study|Protocol Violation|0|||
105809771|NCT00510510|364959536|FG001|Overall Study|Protocol Violation|3|||
105809772|NCT00510510|364959537|FG002|Overall Study|Protocol Violation|4|||
105809773|NCT01361126|364959538|FG000|Overall Study|Sponsor decision|0|||
105809774|NCT01361126|364959539|FG001|Overall Study|Sponsor decision|2|||
105809775|NCT02928848|364959540|FG000|Arm 2|Withdrawal by Subject|1|||
105809776|NCT02928848|364959541|FG001|Arm 2|Withdrawal by Subject|0|||
105809777|NCT00264810|364959542|FG000|Baseline|Withdrawal by Subject|10|||
105809778|NCT00264810|364959543|FG001|Baseline|Withdrawal by Subject|10|||
105809779|NCT00264810|364959542|FG000|Baseline|Physician Decision|7|||
105809780|NCT00264810|364959543|FG001|Baseline|Physician Decision|8|||
105809781|NCT00264810|364959542|FG000|Baseline|Subject Compliance Failure|3|||
105809782|NCT00264810|364959543|FG001|Baseline|Subject Compliance Failure|3|||
105809783|NCT00264810|364959542|FG000|Baseline|Insufficient Seizure Frequency|2|||
105809784|NCT00264810|364959543|FG001|Baseline|Insufficient Seizure Frequency|2|||
105809785|NCT00264810|364959542|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
105809786|NCT00264810|364959543|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
105809787|NCT00264810|364959542|FG000|Baseline|Other|0|||
105809788|NCT00264810|364959543|FG001|Baseline|Other|1|||
105809789|NCT00264810|364959542|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
105809790|NCT00264810|364959543|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
105809791|NCT00264810|364959542|FG000|Stimulation Optimization Period|Death|0|||
105809792|NCT00264810|364959543|FG001|Stimulation Optimization Period|Death|1|||
105809793|NCT00264810|364959542|FG000|Blinded Evaluation Period|Explant due to infection|1|||
105809794|NCT00264810|364959543|FG001|Blinded Evaluation Period|Explant due to infection|1|||
105809795|NCT00264810|364959542|FG000|Open Label Evaluation Period|Explant due to infection|1|||
105809796|NCT00264810|364959543|FG001|Open Label Evaluation Period|Explant due to infection|1|||
105809797|NCT00264810|364959542|FG000|Open Label Evaluation Period|Death|3|||
105809798|NCT00264810|364959543|FG001|Open Label Evaluation Period|Death|2|||
105809799|NCT00264810|364959542|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
105809800|NCT00264810|364959543|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
105809801|NCT02994056|364959545|FG000|Overall Study|Death|8|||
105809802|NCT02994056|364959545|FG000|Overall Study|Withdrew Consent|1|||
105809803|NCT00182091|364959546|FG000|Overall Study|Withdrawal by Subject|1|||
105809804|NCT00182091|364959547|FG001|Overall Study|Withdrawal by Subject|0|||
105809805|NCT00182091|364959548|FG002|Overall Study|Withdrawal by Subject|0|||
105809806|NCT00182091|364959549|FG003|Overall Study|Withdrawal by Subject|0|||
105809807|NCT01835145|364959550|FG000|Overall Study|Ineligible prior to treatment|1|||
105809808|NCT01835145|364959551|FG001|Overall Study|Ineligible prior to treatment|0|||
105809809|NCT04094870|364959552|FG000|Overall Study|Lost to Follow-up|1|||
105809810|NCT04094870|364959553|FG001|Overall Study|Lost to Follow-up|1|||
105809811|NCT02984683|364959556|FG000|Overall Study|Adverse Event|3|||
105809812|NCT02984683|364959557|FG001|Overall Study|Adverse Event|3|||
105809813|NCT02984683|364959556|FG000|Overall Study|Withdrawal by Subject|1|||
105809814|NCT02984683|364959557|FG001|Overall Study|Withdrawal by Subject|0|||
105809815|NCT02984683|364959556|FG000|Overall Study|Disease progression|7|||
105809816|NCT02984683|364959557|FG001|Overall Study|Disease progression|9|||
105809817|NCT04947579|364959560|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
105809818|NCT04947579|364959561|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
105809819|NCT04947579|364959562|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
105809820|NCT04947579|364959563|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
105809821|NCT04947579|364959564|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
105809822|NCT04947579|364959565|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
105809823|NCT04947579|364959560|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
105809824|NCT04947579|364959561|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
105809825|NCT04947579|364959562|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
105809826|NCT04947579|364959563|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
105809827|NCT04947579|364959564|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
105809828|NCT04947579|364959565|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
105809829|NCT04947579|364959560|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
105809830|NCT04947579|364959561|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
105809831|NCT04947579|364959562|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
105809832|NCT04947579|364959563|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
105809833|NCT04947579|364959564|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
105809834|NCT04947579|364959565|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
105809835|NCT04947579|364959560|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
105809836|NCT04947579|364959561|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
105809837|NCT04947579|364959562|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
105809838|NCT04947579|364959563|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
105809839|NCT04947579|364959564|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
105809840|NCT04947579|364959565|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
105809841|NCT04947579|364959560|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
105809842|NCT04947579|364959561|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
105809843|NCT04947579|364959562|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
105809844|NCT04947579|364959563|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
105809845|NCT04947579|364959564|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
105809846|NCT04947579|364959565|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
105809847|NCT04947579|364959560|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
105809848|NCT04947579|364959561|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
105809849|NCT04947579|364959562|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
105809850|NCT04947579|364959563|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
105809851|NCT04947579|364959564|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
105809852|NCT04947579|364959565|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
105809853|NCT04947579|364959560|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
105809854|NCT04947579|364959561|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
105809855|NCT04947579|364959562|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
105809856|NCT04947579|364959563|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
105809857|NCT04947579|364959564|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
105809858|NCT04947579|364959565|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
105809859|NCT04947579|364959560|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
105809860|NCT04947579|364959561|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
105809861|NCT04947579|364959562|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
105809862|NCT04947579|364959563|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
105809863|NCT04947579|364959564|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
105809864|NCT04947579|364959565|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
105809865|NCT04947579|364959560|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
105809866|NCT04947579|364959561|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
105809867|NCT04947579|364959562|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
105809868|NCT04947579|364959563|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
105809869|NCT04947579|364959564|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
105809870|NCT04947579|364959565|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
105809871|NCT04947579|364959560|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
105809872|NCT04947579|364959561|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
105809873|NCT04947579|364959562|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
105809874|NCT04947579|364959563|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
105809875|NCT04947579|364959564|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
105809876|NCT04947579|364959565|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
105809877|NCT04947579|364959560|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
105809878|NCT04947579|364959561|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
105809879|NCT04947579|364959562|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
105809880|NCT04947579|364959563|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
105809881|NCT04947579|364959564|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
105809882|NCT04947579|364959565|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
105809883|NCT00929708|364959566|FG000|Overall Study|Protocol Violation|2|||
105809884|NCT00929708|364959567|FG001|Overall Study|Protocol Violation|1|||
105809885|NCT00929708|364959568|FG002|Overall Study|Protocol Violation|1|||
105809886|NCT00929708|364959569|FG003|Overall Study|Protocol Violation|1|||
105809887|NCT00929708|364959570|FG004|Overall Study|Protocol Violation|1|||
105809888|NCT00929708|364959566|FG000|Overall Study|Withdrawal by Subject|2|||
105809889|NCT00929708|364959567|FG001|Overall Study|Withdrawal by Subject|0|||
105809890|NCT00929708|364959568|FG002|Overall Study|Withdrawal by Subject|0|||
105809891|NCT00929708|364959569|FG003|Overall Study|Withdrawal by Subject|2|||
105809892|NCT00929708|364959570|FG004|Overall Study|Withdrawal by Subject|1|||
105809893|NCT00929708|364959566|FG000|Overall Study|Adverse Event|0|||
105809894|NCT00929708|364959567|FG001|Overall Study|Adverse Event|0|||
105809895|NCT00929708|364959568|FG002|Overall Study|Adverse Event|0|||
105809896|NCT00929708|364959569|FG003|Overall Study|Adverse Event|0|||
105809897|NCT00929708|364959570|FG004|Overall Study|Adverse Event|3|||
105809898|NCT00929708|364959566|FG000|Overall Study|Physician Decision|0|||
105809899|NCT00929708|364959567|FG001|Overall Study|Physician Decision|2|||
105809900|NCT00929708|364959568|FG002|Overall Study|Physician Decision|2|||
105809901|NCT00929708|364959569|FG003|Overall Study|Physician Decision|2|||
105809902|NCT00929708|364959570|FG004|Overall Study|Physician Decision|1|||
105809903|NCT00929708|364959566|FG000|Overall Study|Lost to Follow-up|0|||
105809904|NCT00929708|364959567|FG001|Overall Study|Lost to Follow-up|0|||
105809905|NCT00929708|364959568|FG002|Overall Study|Lost to Follow-up|0|||
105809906|NCT00929708|364959569|FG003|Overall Study|Lost to Follow-up|1|||
105809907|NCT00929708|364959570|FG004|Overall Study|Lost to Follow-up|0|||
105809908|NCT01575054|364959571|FG000|Overall Study|Other Reasons|5|||
105809909|NCT01575054|364959572|FG001|Overall Study|Other Reasons|3|||
105809910|NCT01575054|364959571|FG000|Overall Study|Protocol Violation|2|||
105809911|NCT01575054|364959572|FG001|Overall Study|Protocol Violation|1|||
105809912|NCT01575054|364959571|FG000|Overall Study|Personal Reasons|10|||
105809913|NCT01575054|364959572|FG001|Overall Study|Personal Reasons|11|||
105809914|NCT01575054|364959571|FG000|Overall Study|Lost to Follow-up|3|||
105809915|NCT01575054|364959572|FG001|Overall Study|Lost to Follow-up|3|||
105809916|NCT01575054|364959571|FG000|Overall Study|Adverse Event|9|||
105809917|NCT01575054|364959572|FG001|Overall Study|Adverse Event|8|||
105809918|NCT03309956|364959573|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
105809919|NCT03495869|364959574|FG000|Overall Study|Lost to Follow-up|4|||
105809920|NCT03495869|364959575|FG001|Overall Study|Lost to Follow-up|17|||
105809921|NCT03495869|364959576|FG002|Overall Study|Lost to Follow-up|8|||
105809922|NCT03495869|364959577|FG003|Overall Study|Lost to Follow-up|14|||
105809923|NCT03495869|364959574|FG000|Overall Study|Withdrawal by Subject|0|||
105809924|NCT03495869|364959575|FG001|Overall Study|Withdrawal by Subject|3|||
105809925|NCT03495869|364959576|FG002|Overall Study|Withdrawal by Subject|0|||
105809926|NCT03495869|364959577|FG003|Overall Study|Withdrawal by Subject|3|||
105809927|NCT03495869|364959574|FG000|Overall Study|Dropped from study|0|||
105809928|NCT03495869|364959575|FG001|Overall Study|Dropped from study|7|||
105809929|NCT03495869|364959576|FG002|Overall Study|Dropped from study|2|||
105809930|NCT03495869|364959577|FG003|Overall Study|Dropped from study|4|||
105809931|NCT02768298|364959578|FG000|Overall Study|Adverse Event|1|||
105809932|NCT02768298|364959579|FG001|Overall Study|Adverse Event|4|||
105809933|NCT02768298|364959578|FG000|Overall Study|Death|2|||
105809934|NCT02768298|364959579|FG001|Overall Study|Death|1|||
105809935|NCT02768298|364959578|FG000|Overall Study|Non-compliance with study treatment|0|||
105809936|NCT02768298|364959579|FG001|Overall Study|Non-compliance with study treatment|1|||
105809937|NCT02768298|364959578|FG000|Overall Study|Subject/guardian decision|1|||
105809938|NCT02768298|364959579|FG001|Overall Study|Subject/guardian decision|0|||
105809939|NCT02768298|364959578|FG000|Overall Study|Withdrawal of informed consent|0|||
105809940|NCT02768298|364959579|FG001|Overall Study|Withdrawal of informed consent|1|||
105809941|NCT02346201|364959580|FG000|Overall Study|Adverse Event|3|||
105809942|NCT02346201|364959581|FG001|Overall Study|Adverse Event|2|||
105809943|NCT02346201|364959580|FG000|Overall Study|Lost to Follow-up|1|||
105809944|NCT02346201|364959581|FG001|Overall Study|Lost to Follow-up|0|||
105809945|NCT02346201|364959580|FG000|Overall Study|Withdrawal by Subject|6|||
105809946|NCT02346201|364959581|FG001|Overall Study|Withdrawal by Subject|3|||
105809947|NCT02346201|364959580|FG000|Overall Study|Unavailable for future follow-up|0|||
105809948|NCT02346201|364959581|FG001|Overall Study|Unavailable for future follow-up|1|||
105809949|NCT02346201|364959580|FG000|Overall Study|Physician Decision|0|||
105809950|NCT02346201|364959581|FG001|Overall Study|Physician Decision|1|||
105809951|NCT02346201|364959580|FG000|Overall Study|Missed final visit|0|||
105809952|NCT02346201|364959581|FG001|Overall Study|Missed final visit|2|||
105809953|NCT03708211|364959583|FG000|Overall Study|Progressive Disease|10|||
105809954|NCT03708211|364959584|FG001|Overall Study|Progressive Disease|7|||
105809955|NCT03708211|364959583|FG000|Overall Study|Withdrawal by Subject|0|||
105809956|NCT03708211|364959584|FG001|Overall Study|Withdrawal by Subject|1|||
105809957|NCT03708211|364959583|FG000|Overall Study|Other|2|||
105809958|NCT03708211|364959584|FG001|Overall Study|Other|0|||
105809959|NCT01508936|364959589|FG000|Overall Study|Adverse Event|11|||
105809960|NCT01508936|364959590|FG001|Overall Study|Adverse Event|32|||
105809961|NCT01508936|364959589|FG000|Overall Study|Lack of Efficacy|0|||
105809962|NCT01508936|364959590|FG001|Overall Study|Lack of Efficacy|1|||
105809963|NCT01508936|364959589|FG000|Overall Study|Withdrawal by Subject|4|||
105809964|NCT01508936|364959590|FG001|Overall Study|Withdrawal by Subject|18|||
105485772|NCT03123185|363789606|FG004|Overall Study|Withdrawal by Subject|0|||
105485773|NCT03123185|363789607|FG005|Overall Study|Withdrawal by Subject|0|||
105809965|NCT01508936|364959589|FG000|Overall Study|Protocol Violation|2|||
105809966|NCT01508936|364959590|FG001|Overall Study|Protocol Violation|3|||
105809967|NCT01508936|364959589|FG000|Overall Study|Lost to Follow-up|2|||
105485774|NCT03123185|363789608|FG006|Overall Study|Withdrawal by Subject|0|||
105809968|NCT01508936|364959590|FG001|Overall Study|Lost to Follow-up|9|||
105809969|NCT01508936|364959589|FG000|Overall Study|Other|0|||
105809970|NCT01508936|364959590|FG001|Overall Study|Other|5|||
105485775|NCT03123185|363789609|FG007|Overall Study|Withdrawal by Subject|0|||
105485776|NCT03123185|363789610|FG008|Overall Study|Withdrawal by Subject|0|||
105809971|NCT01508936|364959589|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
105809972|NCT01508936|364959590|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
105809973|NCT02518685|364959593|FG000|Overall Study|Adverse Event|29|||
105809974|NCT02518685|364959594|FG001|Overall Study|Adverse Event|1|||
105809975|NCT02518685|364959593|FG000|Overall Study|Withdrawal by Subject|10|||
105361132|NCT03286218|363328143|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
105361133|NCT03286218|363328144|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
105361134|NCT03286218|363328145|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
105361135|NCT03286218|363328146|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
105361136|NCT03286218|363328147|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
105809976|NCT02518685|364959594|FG001|Overall Study|Withdrawal by Subject|3|||
105809977|NCT02518685|364959593|FG000|Overall Study|relocation, study fatigue|7|||
105809978|NCT02518685|364959594|FG001|Overall Study|relocation, study fatigue|2|||
105809979|NCT02518685|364959593|FG000|Overall Study|Pregnancy|1|||
105809980|NCT02518685|364959594|FG001|Overall Study|Pregnancy|0|||
105809981|NCT02518685|364959593|FG000|Overall Study|Physician Decision|1|||
105809982|NCT02518685|364959594|FG001|Overall Study|Physician Decision|0|||
105809983|NCT02518685|364959593|FG000|Overall Study|Lost to Follow-up|1|||
105809984|NCT02518685|364959594|FG001|Overall Study|Lost to Follow-up|4|||
105809985|NCT02683187|364959595|FG000|Overall Study|Failed IV access|3|||
105809986|NCT02683187|364959595|FG000|Overall Study|Withdrawal by Subject|5|||
105809987|NCT03507439|364961107|FG000|Overall Study|Other|2|||
105809988|NCT03507439|364961108|FG001|Overall Study|Other|1|||
105809989|NCT03507439|364961107|FG000|Overall Study|Withdrawal by Subject|1|||
105809990|NCT03507439|364961108|FG001|Overall Study|Withdrawal by Subject|0|||
105809991|NCT03507439|364961107|FG000|Overall Study|Death|1|||
105809992|NCT03507439|364961108|FG001|Overall Study|Death|1|||
105809993|NCT02742090|364961109|FG000|Overall Study|Adverse Event|10|||
105809994|NCT02742090|364961109|FG000|Overall Study|Death|3|||
105809995|NCT02742090|364961109|FG000|Overall Study|Disease Progression|25|||
105809996|NCT02742090|364961109|FG000|Overall Study|Investigator's Decision|1|||
105809997|NCT02742090|364961109|FG000|Overall Study|Lost to Follow-up|1|||
105809998|NCT02742090|364961109|FG000|Overall Study|Non-compliance with Study|1|||
105809999|NCT02742090|364961109|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
105810000|NCT02742090|364961109|FG000|Overall Study|Withdrawal by Subject|4|||
105810001|NCT02742090|364961109|FG000|Overall Study|Reason Not Specified|1|||
105810002|NCT01506323|364961110|FG000|Overall Study|Lost to Follow-up|5|||
105810003|NCT01506323|364961111|FG001|Overall Study|Lost to Follow-up|4|||
105810004|NCT01506323|364961110|FG000|Overall Study|Withdrawal by Subject|4|||
105810005|NCT01506323|364961111|FG001|Overall Study|Withdrawal by Subject|4|||
105810006|NCT01506323|364961110|FG000|Overall Study|Lack of Efficacy|1|||
105810007|NCT01506323|364961111|FG001|Overall Study|Lack of Efficacy|3|||
105810008|NCT01506323|364961110|FG000|Overall Study|Moved out of area|5|||
105810009|NCT01506323|364961111|FG001|Overall Study|Moved out of area|2|||
105810010|NCT01506323|364961110|FG000|Overall Study|Schedule or Transportation conflict|8|||
105810011|NCT01506323|364961111|FG001|Overall Study|Schedule or Transportation conflict|0|||
105810012|NCT01506323|364961110|FG000|Overall Study|Started another treatment|1|||
105810013|NCT01506323|364961111|FG001|Overall Study|Started another treatment|0|||
105810014|NCT00586521|364961112|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
105810015|NCT03083483|364961120|FG000|Overall Study|Adverse Event|1|||
105810016|NCT03083483|364961121|FG001|Overall Study|Adverse Event|1|||
105810017|NCT03083483|364961122|FG002|Overall Study|Adverse Event|1|||
105810018|NCT03083483|364961120|FG000|Overall Study|Lost to Follow-up|2|||
105810019|NCT03083483|364961121|FG001|Overall Study|Lost to Follow-up|1|||
105810020|NCT03083483|364961122|FG002|Overall Study|Lost to Follow-up|1|||
105810021|NCT03083483|364961120|FG000|Overall Study|technological issues|1|||
105810022|NCT03083483|364961121|FG001|Overall Study|technological issues|0|||
105810023|NCT03083483|364961122|FG002|Overall Study|technological issues|1|||
105810024|NCT00613574|364961123|FG000|Overall Study|Adverse Event|3|||
105810025|NCT00613574|364961123|FG000|Overall Study|Lost to Follow-up|2|||
105810026|NCT00613574|364961123|FG000|Overall Study|Other|1|||
105810027|NCT01769378|364961124|FG000|Overall Study|Adverse Event|10|||
105810028|NCT01769378|364961125|FG001|Overall Study|Adverse Event|0|||
105810029|NCT01769378|364961124|FG000|Overall Study|Entry criteria not met|1|||
105810030|NCT01769378|364961125|FG001|Overall Study|Entry criteria not met|0|||
105810031|NCT01769378|364961124|FG000|Overall Study|Protocol Violation|1|||
105810032|NCT01769378|364961125|FG001|Overall Study|Protocol Violation|1|||
105810033|NCT01769378|364961124|FG000|Overall Study|Withdrawal by Subject|10|||
105810034|NCT01769378|364961125|FG001|Overall Study|Withdrawal by Subject|3|||
105810035|NCT01769378|364961124|FG000|Overall Study|Sponsor Decision|1|||
105810036|NCT01769378|364961125|FG001|Overall Study|Sponsor Decision|0|||
105810037|NCT01769378|364961124|FG000|Overall Study|Lost to Follow-up|2|||
105810038|NCT01769378|364961125|FG001|Overall Study|Lost to Follow-up|0|||
105810039|NCT03519256|364961126|FG000|Overall Study|Disease recurrence|4|||
105810040|NCT03519256|364961127|FG001|Overall Study|Disease recurrence|4|||
105810041|NCT03519256|364961128|FG002|Overall Study|Disease recurrence|5|||
105810042|NCT03519256|364961129|FG003|Overall Study|Disease recurrence|2|||
105810043|NCT03519256|364961126|FG000|Overall Study|Study drug toxicity|0|||
105810044|NCT03519256|364961127|FG001|Overall Study|Study drug toxicity|2|||
105810045|NCT03519256|364961128|FG002|Overall Study|Study drug toxicity|5|||
105810046|NCT03519256|364961129|FG003|Overall Study|Study drug toxicity|2|||
105810047|NCT03519256|364961126|FG000|Overall Study|Adverse event unrelated to study drug|0|||
105810048|NCT03519256|364961127|FG001|Overall Study|Adverse event unrelated to study drug|1|||
105810049|NCT03519256|364961128|FG002|Overall Study|Adverse event unrelated to study drug|1|||
105810050|NCT03519256|364961129|FG003|Overall Study|Adverse event unrelated to study drug|0|||
105810051|NCT03519256|364961126|FG000|Overall Study|Participant request to discontinue study treatment|0|||
105810052|NCT03519256|364961127|FG001|Overall Study|Participant request to discontinue study treatment|0|||
105810053|NCT03519256|364961128|FG002|Overall Study|Participant request to discontinue study treatment|0|||
105810054|NCT03519256|364961129|FG003|Overall Study|Participant request to discontinue study treatment|2|||
105810055|NCT03519256|364961126|FG000|Overall Study|Other reasons|0|||
105810056|NCT03519256|364961127|FG001|Overall Study|Other reasons|0|||
105810057|NCT03519256|364961128|FG002|Overall Study|Other reasons|2|||
105810058|NCT03519256|364961129|FG003|Overall Study|Other reasons|0|||
105810059|NCT03519256|364961126|FG000|Overall Study|Disease progression|6|||
105810060|NCT03519256|364961127|FG001|Overall Study|Disease progression|3|||
105810061|NCT03519256|364961128|FG002|Overall Study|Disease progression|2|||
105810062|NCT03519256|364961129|FG003|Overall Study|Disease progression|1|||
105810063|NCT03519256|364961126|FG000|Overall Study|Lost to Follow-up|0|||
105810064|NCT03519256|364961127|FG001|Overall Study|Lost to Follow-up|1|||
105810065|NCT03519256|364961128|FG002|Overall Study|Lost to Follow-up|0|||
105810066|NCT03519256|364961129|FG003|Overall Study|Lost to Follow-up|0|||
105810067|NCT04828161|364961130|FG000|Overall Study|Withdrawal by Subject|0|||
105810068|NCT04828161|364961131|FG001|Overall Study|Withdrawal by Subject|3|||
105810069|NCT04828161|364961132|FG002|Overall Study|Withdrawal by Subject|3|||
105810070|NCT04828161|364961133|FG003|Overall Study|Withdrawal by Subject|4|||
105810071|NCT04828161|364961130|FG000|Overall Study|Lost to Follow-up|1|||
105810072|NCT04828161|364961131|FG001|Overall Study|Lost to Follow-up|4|||
105810073|NCT04828161|364961132|FG002|Overall Study|Lost to Follow-up|2|||
105810074|NCT04828161|364961133|FG003|Overall Study|Lost to Follow-up|2|||
105810075|NCT04828161|364961130|FG000|Overall Study|Other|2|||
105810076|NCT04828161|364961131|FG001|Overall Study|Other|0|||
105810077|NCT04828161|364961132|FG002|Overall Study|Other|2|||
105810078|NCT04828161|364961133|FG003|Overall Study|Other|0|||
105810079|NCT04828161|364961130|FG000|Overall Study|Death|0|||
105810080|NCT04828161|364961131|FG001|Overall Study|Death|0|||
105810081|NCT04828161|364961132|FG002|Overall Study|Death|0|||
105810082|NCT04828161|364961133|FG003|Overall Study|Death|2|||
105810083|NCT02336737|364961136|FG000|Overall Study|Withdrawal by Subject|5|||
105810084|NCT02336737|364961136|FG000|Overall Study|Physician Decision|8|||
105810085|NCT01755858|364961137|FG000|Overall Study|Adverse Event|1|||
105810086|NCT01755858|364961138|FG001|Overall Study|Adverse Event|1|||
105810087|NCT01631864|364961139|FG000|Overall Study|Withdrawal by Subject|0|||
105810088|NCT01631864|364961140|FG001|Overall Study|Withdrawal by Subject|1|||
105810089|NCT01631864|364961139|FG000|Overall Study|Adverse Event|2|||
105810090|NCT01631864|364961140|FG001|Overall Study|Adverse Event|3|||
105810091|NCT01047345|364961142|FG000|Base Study|Adverse Event|3|||
105810092|NCT01047345|364961143|FG001|Base Study|Adverse Event|0|||
105810093|NCT01047345|364961144|FG002|Base Study|Adverse Event|0|||
105810094|NCT01047345|364961142|FG000|Base Study|Lost to Follow-up|4|||
105810095|NCT01047345|364961143|FG001|Base Study|Lost to Follow-up|1|||
105810096|NCT01047345|364961144|FG002|Base Study|Lost to Follow-up|0|||
105810097|NCT01047345|364961142|FG000|Base Study|Protocol Violation|3|||
105810098|NCT01047345|364961143|FG001|Base Study|Protocol Violation|1|||
105810099|NCT01047345|364961144|FG002|Base Study|Protocol Violation|0|||
105810100|NCT01047345|364961142|FG000|Base Study|Withdrawal by Subject|12|||
105810101|NCT01047345|364961143|FG001|Base Study|Withdrawal by Subject|4|||
105810102|NCT01047345|364961144|FG002|Base Study|Withdrawal by Subject|0|||
105810103|NCT01047345|364961142|FG000|Extension|Withdrawal by Subject|0|||
105810104|NCT01047345|364961143|FG001|Extension|Withdrawal by Subject|0|||
105810105|NCT01047345|364961144|FG002|Extension|Withdrawal by Subject|1|||
105810106|NCT01047345|364961142|FG000|Extension|Lost to Follow-up|0|||
105810107|NCT01047345|364961143|FG001|Extension|Lost to Follow-up|0|||
105810108|NCT01047345|364961144|FG002|Extension|Lost to Follow-up|5|||
105810109|NCT01816477|364961145|FG000|Overall Study|Withdrawal by Subject|13|||
105810110|NCT01816477|364961146|FG001|Overall Study|Withdrawal by Subject|1|||
105810111|NCT01816477|364961145|FG000|Overall Study|Unable to tolerate catheter placement|3|||
105810112|NCT01816477|364961146|FG001|Overall Study|Unable to tolerate catheter placement|0|||
105810113|NCT02162758|364961147|FG000|Overall Study|Study termination|0|||
105810114|NCT02162758|364961148|FG001|Overall Study|Study termination|1|||
105810115|NCT00108732|364961149|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
105810116|NCT00108732|364961149|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
105810117|NCT00108732|364961149|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
105810118|NCT00108732|364961149|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
105810119|NCT00108732|364961149|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
105810120|NCT00108732|364961149|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
105810121|NCT00108732|364961149|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
105810122|NCT02187042|364961150|FG000|Overall Study|Death|1|||
105810123|NCT02187042|364961151|FG001|Overall Study|Death|1|||
105810124|NCT02187042|364961150|FG000|Overall Study|Toxicity|6|||
105810125|NCT02187042|364961151|FG001|Overall Study|Toxicity|5|||
105810126|NCT02187042|364961150|FG000|Overall Study|Participant choice|1|||
105810127|NCT02187042|364961151|FG001|Overall Study|Participant choice|0|||
105810128|NCT02187042|364961150|FG000|Overall Study|Doctor choice|1|||
105810129|NCT02187042|364961151|FG001|Overall Study|Doctor choice|0|||
105810130|NCT02187042|364961150|FG000|Overall Study|Progressive disease|4|||
105810131|NCT02187042|364961151|FG001|Overall Study|Progressive disease|8|||
105810132|NCT01659567|364961154|FG000|Overall Study|Lack of Efficacy|22|||
105810133|NCT01659567|364961154|FG000|Overall Study|Switched to Pegferon|6|||
105810134|NCT01659567|364961154|FG000|Overall Study|Adverse Event|12|||
105810135|NCT01659567|364961154|FG000|Overall Study|Good result at early stage of treatment|5|||
105810136|NCT01659567|364961154|FG000|Overall Study|Withdrawal by Subject|64|||
105810137|NCT01659567|364961154|FG000|Overall Study|Progression of the main disease|1|||
105810138|NCT01659567|364961154|FG000|Overall Study|Other|13|||
105810139|NCT03213210|364961155|FG000|Overall Study|Lost to Follow-up|2|||
105810140|NCT03213210|364961155|FG000|Overall Study|Study termination|3|||
105810141|NCT01915732|364961156|FG000|Overall Study|Withdrawal by Subject|18|||
105810142|NCT01915732|364961157|FG001|Overall Study|Withdrawal by Subject|18|||
105810143|NCT01915732|364961156|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
105810144|NCT01915732|364961157|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
105810145|NCT01915732|364961156|FG000|Overall Study|Adverse Event|12|||
105810146|NCT01915732|364961157|FG001|Overall Study|Adverse Event|4|||
105810147|NCT01915732|364961156|FG000|Overall Study|Protocol Violation|5|||
105810148|NCT01915732|364961157|FG001|Overall Study|Protocol Violation|5|||
105810149|NCT01915732|364961156|FG000|Overall Study|Lack of Efficacy|6|||
105810150|NCT01915732|364961157|FG001|Overall Study|Lack of Efficacy|11|||
105810151|NCT01915732|364961156|FG000|Overall Study|Lost to Follow-up|22|||
105810152|NCT01915732|364961157|FG001|Overall Study|Lost to Follow-up|26|||
105810153|NCT01915732|364961156|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
105810154|NCT01915732|364961157|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
105810155|NCT01915732|364961156|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
105810156|NCT01915732|364961157|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
105810157|NCT01915732|364961156|FG000|Overall Study|Drug Release Error|1|||
105810158|NCT01915732|364961157|FG001|Overall Study|Drug Release Error|0|||
105810159|NCT01915732|364961156|FG000|Overall Study|Recovered|1|||
105810160|NCT01915732|364961157|FG001|Overall Study|Recovered|0|||
105810161|NCT01915732|364961156|FG000|Overall Study|Pregnancy|1|||
105810162|NCT01915732|364961157|FG001|Overall Study|Pregnancy|0|||
105810163|NCT01915732|364961156|FG000|Overall Study|Poor Perceived Efficacy|1|||
105810164|NCT01915732|364961157|FG001|Overall Study|Poor Perceived Efficacy|0|||
105810165|NCT01915732|364961156|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
105810166|NCT01915732|364961157|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
105810167|NCT01915732|364961156|FG000|Overall Study|Got Well|0|||
105810168|NCT01915732|364961157|FG001|Overall Study|Got Well|1|||
105810169|NCT01915732|364961156|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
105810170|NCT01915732|364961157|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
105810171|NCT01915732|364961156|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
105810172|NCT01915732|364961157|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
105810173|NCT01915732|364961156|FG000|Overall Study|Job Transfer|0|||
105810174|NCT01915732|364961157|FG001|Overall Study|Job Transfer|1|||
105810175|NCT01915732|364961156|FG000|Overall Study|Improper Facial Procedure|0|||
105810176|NCT01915732|364961157|FG001|Overall Study|Improper Facial Procedure|1|||
105810177|NCT01915732|364961156|FG000|Overall Study|Poor Conscious Effect|0|||
105810178|NCT01915732|364961157|FG001|Overall Study|Poor Conscious Effect|1|||
105571450|NCT04091360|364091211|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
105810179|NCT00282256|364961158|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
105810180|NCT00282256|364961158|FG000|Extension Treatment Period|Adverse Event|2|||
105810181|NCT00698685|364961159|FG000|Overall Study|Sister withdrew as donor|1|||
105810182|NCT00698685|364961159|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
105810183|NCT00708422|364961160|FG000|Overall Study|Adverse Event|3|||
105810184|NCT00708422|364961161|FG001|Overall Study|Adverse Event|1|||
105810185|NCT00708422|364961160|FG000|Overall Study|Withdrawal by Subject|1|||
105810186|NCT00708422|364961161|FG001|Overall Study|Withdrawal by Subject|0|||
105810187|NCT00299156|364961167|FG000|Period 2 (Randomized)|Screen Failure|0|||
105810188|NCT00299156|364961168|FG001|Period 2 (Randomized)|Screen Failure|1|||
105810189|NCT00299156|364961169|FG002|Period 2 (Randomized)|Screen Failure|0|||
105810190|NCT04652453|364961176|FG000|Overall Study|Death|8|||
105810191|NCT04652453|364961177|FG001|Overall Study|Death|2|||
105810192|NCT04652453|364961178|FG002|Overall Study|Death|0|||
105810193|NCT04652453|364961176|FG000|Overall Study|Hospice|5|||
105810194|NCT04652453|364961177|FG001|Overall Study|Hospice|5|||
105810195|NCT04652453|364961178|FG002|Overall Study|Hospice|0|||
105810196|NCT04652453|364961176|FG000|Overall Study|Withdrawal by Subject|2|||
105810197|NCT04652453|364961177|FG001|Overall Study|Withdrawal by Subject|0|||
105810198|NCT04652453|364961178|FG002|Overall Study|Withdrawal by Subject|0|||
105810199|NCT00536575|364961179|FG000|Overall Study|Withdrawal by Subject|1|||
105810200|NCT00536575|364961179|FG000|Overall Study|Death|1|||
105810201|NCT01089647|364961180|FG000|Overall Study|Lost to Follow-up|2|||
105810202|NCT01089647|364961181|FG001|Overall Study|Lost to Follow-up|2|||
105810203|NCT01089647|364961180|FG000|Overall Study|Withdrawal by Subject|2|||
105810204|NCT01089647|364961181|FG001|Overall Study|Withdrawal by Subject|1|||
105810205|NCT01089647|364961180|FG000|Overall Study|Adverse Event|0|||
105810206|NCT01089647|364961181|FG001|Overall Study|Adverse Event|1|||
105810207|NCT00198029|364961185|FG000|Overall Study|Withdrawal by Subject|4|||
105810208|NCT04117607|364961187|FG000|Overall Study|Early Termination|0|||
105810209|NCT04117607|364961188|FG001|Overall Study|Early Termination|1|||
105810210|NCT04117607|364961189|FG002|Overall Study|Early Termination|0|||
105810211|NCT04117607|364961190|FG003|Overall Study|Early Termination|0|||
105810212|NCT04117607|364961191|FG004|Overall Study|Early Termination|0|||
105810213|NCT04117607|364961192|FG005|Overall Study|Early Termination|0|||
105810214|NCT04117607|364961193|FG006|Overall Study|Early Termination|1|||
105810215|NCT04117607|364961194|FG007|Overall Study|Early Termination|0|||
105810216|NCT04117607|364961195|FG008|Overall Study|Early Termination|0|||
105810217|NCT04117607|364961196|FG009|Overall Study|Early Termination|0|||
105810218|NCT04117607|364961197|FG010|Overall Study|Early Termination|0|||
105810219|NCT04117607|364961198|FG011|Overall Study|Early Termination|0|||
105810220|NCT04117607|364961199|FG012|Overall Study|Early Termination|0|||
105810221|NCT04117607|364961200|FG013|Overall Study|Early Termination|0|||
105810222|NCT01411995|364961208|FG000|Overall Study|Failed IUD insertion|0|||
105810223|NCT01411995|364961209|FG001|Overall Study|Failed IUD insertion|1|||
105810224|NCT04799158|364961210|FG000|Run-In Period|Adverse Event|6|||
105361137|NCT03286218|363328148|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
105361138|NCT03286218|363328149|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
105361139|NCT03286218|363328150|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
105361140|NCT03286218|363328151|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
105361141|NCT03286218|363328152|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
105361142|NCT02532374|363328155|FG000|Overall Study|Withdrawal by Subject|1|||
105361143|NCT02532374|363328155|FG000|Overall Study|Physician Decision|1|||
105361144|NCT03131167|363328156|FG000|Overall Study|Other (Unspecified)|0|||
105361145|NCT03131167|363328157|FG001|Overall Study|Other (Unspecified)|0|||
105361146|NCT03131167|363328158|FG002|Overall Study|Other (Unspecified)|0|||
105361147|NCT03131167|363328159|FG003|Overall Study|Other (Unspecified)|0|||
105361148|NCT03131167|363328160|FG004|Overall Study|Other (Unspecified)|0|||
105361149|NCT03131167|363328161|FG005|Overall Study|Other (Unspecified)|1|||
105361150|NCT03131167|363328162|FG006|Overall Study|Other (Unspecified)|0|||
105361151|NCT03131167|363328163|FG007|Overall Study|Other (Unspecified)|0|||
105361152|NCT03131167|363328164|FG008|Overall Study|Other (Unspecified)|0|||
105361153|NCT03131167|363328165|FG009|Overall Study|Other (Unspecified)|0|||
105361154|NCT03131167|363328166|FG010|Overall Study|Other (Unspecified)|0|||
105361155|NCT03131167|363328167|FG011|Overall Study|Other (Unspecified)|0|||
105361156|NCT03131167|363328168|FG012|Overall Study|Other (Unspecified)|0|||
105361157|NCT01348139|363328169|FG000|Period 1|Adverse Event|1|||
105361158|NCT01348139|363328170|FG001|Period 1|Adverse Event|0|||
105361159|NCT01348139|363328171|FG002|Period 1|Adverse Event|0|||
105361160|NCT01348139|363328172|FG003|Period 1|Adverse Event|0|||
105361161|NCT01348139|363328173|FG004|Period 1|Adverse Event|0|||
105361162|NCT01348139|363328174|FG005|Period 1|Adverse Event|0|||
105361163|NCT02762084|363328177|FG000|Overall Study|Withdrawal by Subject|1|||
105361164|NCT02762084|363328178|FG001|Overall Study|Withdrawal by Subject|0|||
105361165|NCT02762084|363328179|FG002|Overall Study|Withdrawal by Subject|0|||
105361166|NCT02762084|363328177|FG000|Overall Study|Adverse Event|0|||
105361167|NCT02762084|363328178|FG001|Overall Study|Adverse Event|0|||
105361168|NCT02762084|363328179|FG002|Overall Study|Adverse Event|1|||
105361169|NCT02976519|363328182|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
105361170|NCT02976519|363328183|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
105361171|NCT02976519|363328184|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
105361172|NCT02976519|363328185|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
105361173|NCT02976519|363328186|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
105361174|NCT02976519|363328187|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
105361175|NCT02976519|363328188|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
105810225|NCT04799158|364961211|FG001|Run-In Period|Adverse Event|0|||
105810226|NCT04799158|364961212|FG002|Run-In Period|Adverse Event|0|||
105810227|NCT04799158|364961213|FG003|Run-In Period|Adverse Event|0|||
105810228|NCT04799158|364961214|FG004|Run-In Period|Adverse Event|0|||
105810229|NCT04799158|364961210|FG000|Run-In Period|Lost to Follow-up|4|||
105810230|NCT04799158|364961211|FG001|Run-In Period|Lost to Follow-up|0|||
105810231|NCT04799158|364961212|FG002|Run-In Period|Lost to Follow-up|0|||
105810232|NCT04799158|364961213|FG003|Run-In Period|Lost to Follow-up|0|||
105810233|NCT04799158|364961214|FG004|Run-In Period|Lost to Follow-up|0|||
105810234|NCT04799158|364961210|FG000|Run-In Period|Significant Protocol Deviation|1|||
105810235|NCT04799158|364961211|FG001|Run-In Period|Significant Protocol Deviation|0|||
105810236|NCT04799158|364961212|FG002|Run-In Period|Significant Protocol Deviation|0|||
105810237|NCT04799158|364961213|FG003|Run-In Period|Significant Protocol Deviation|0|||
105810238|NCT04799158|364961214|FG004|Run-In Period|Significant Protocol Deviation|0|||
105810239|NCT04799158|364961210|FG000|Run-In Period|Withdrawal by Subject|11|||
105810240|NCT04799158|364961211|FG001|Run-In Period|Withdrawal by Subject|0|||
105810241|NCT04799158|364961212|FG002|Run-In Period|Withdrawal by Subject|0|||
105810242|NCT04799158|364961213|FG003|Run-In Period|Withdrawal by Subject|0|||
105810243|NCT04799158|364961214|FG004|Run-In Period|Withdrawal by Subject|0|||
105810244|NCT04799158|364961210|FG000|Run-In Period|Miscellaneous|3|||
105810245|NCT04799158|364961211|FG001|Run-In Period|Miscellaneous|0|||
105810246|NCT04799158|364961212|FG002|Run-In Period|Miscellaneous|0|||
105810247|NCT04799158|364961213|FG003|Run-In Period|Miscellaneous|0|||
105810248|NCT04799158|364961214|FG004|Run-In Period|Miscellaneous|0|||
105810249|NCT04799158|364961210|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
105810250|NCT04799158|364961211|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
105810251|NCT04799158|364961212|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
105810252|NCT04799158|364961213|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
105810253|NCT04799158|364961214|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
105810254|NCT04799158|364961210|FG000|On-Demand Treatment Period|Adverse Event|0|||
105810255|NCT04799158|364961211|FG001|On-Demand Treatment Period|Adverse Event|1|||
105810256|NCT04799158|364961212|FG002|On-Demand Treatment Period|Adverse Event|0|||
105810257|NCT04799158|364961213|FG003|On-Demand Treatment Period|Adverse Event|0|||
105810258|NCT04799158|364961214|FG004|On-Demand Treatment Period|Adverse Event|1|||
105810259|NCT04799158|364961210|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
105361176|NCT02976519|363328182|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
105810260|NCT04799158|364961211|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
105810261|NCT04799158|364961212|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
105810262|NCT04799158|364961213|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
105810263|NCT04799158|364961214|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
105810264|NCT04799158|364961210|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
105810265|NCT04799158|364961211|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
105810266|NCT04799158|364961212|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
105810267|NCT04799158|364961213|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
105810268|NCT04799158|364961214|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
105810269|NCT04799158|364961210|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
105810270|NCT04799158|364961211|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
105810271|NCT04799158|364961212|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
105810272|NCT04799158|364961213|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
105810273|NCT04799158|364961214|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
105810274|NCT04799158|364961210|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
105810275|NCT04799158|364961211|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
105810276|NCT04799158|364961212|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
105810277|NCT04799158|364961213|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
105810278|NCT04799158|364961214|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
105810279|NCT04799158|364961210|FG000|On-Demand Treatment Period|Miscellaneous|0|||
105810280|NCT04799158|364961211|FG001|On-Demand Treatment Period|Miscellaneous|0|||
105810281|NCT04799158|364961212|FG002|On-Demand Treatment Period|Miscellaneous|0|||
105810282|NCT04799158|364961213|FG003|On-Demand Treatment Period|Miscellaneous|0|||
105810283|NCT04799158|364961214|FG004|On-Demand Treatment Period|Miscellaneous|1|||
105810284|NCT03276975|364961215|FG000|Overall Study|Withdrawal by Subject|1|||
105810285|NCT03276975|364961216|FG001|Overall Study|Withdrawal by Subject|0|||
105810286|NCT02974153|364961217|FG000|Overall Study|Adverse Event|6|||
105810287|NCT02974153|364961218|FG001|Overall Study|Adverse Event|0|||
105810288|NCT02974153|364961219|FG002|Overall Study|Adverse Event|1|||
105810289|NCT02974153|364961217|FG000|Overall Study|Lack of Efficacy|6|||
105810290|NCT02974153|364961218|FG001|Overall Study|Lack of Efficacy|5|||
105810291|NCT02974153|364961219|FG002|Overall Study|Lack of Efficacy|10|||
105810292|NCT02974153|364961217|FG000|Overall Study|Lost to Follow-up|9|||
105810293|NCT02974153|364961218|FG001|Overall Study|Lost to Follow-up|10|||
105810294|NCT02974153|364961219|FG002|Overall Study|Lost to Follow-up|17|||
105810295|NCT02974153|364961217|FG000|Overall Study|Physician Decision|0|||
105810296|NCT02974153|364961218|FG001|Overall Study|Physician Decision|2|||
105810297|NCT02974153|364961219|FG002|Overall Study|Physician Decision|1|||
105810298|NCT02974153|364961217|FG000|Overall Study|Withdrawal by Subject|9|||
105810299|NCT02974153|364961218|FG001|Overall Study|Withdrawal by Subject|16|||
105810300|NCT02974153|364961219|FG002|Overall Study|Withdrawal by Subject|11|||
105810301|NCT02974153|364961217|FG000|Overall Study|Study Burden|8|||
105810302|NCT02974153|364961218|FG001|Overall Study|Study Burden|7|||
105810303|NCT02974153|364961219|FG002|Overall Study|Study Burden|3|||
105810304|NCT02974153|364961217|FG000|Overall Study|Other|14|||
105810305|NCT02974153|364961218|FG001|Overall Study|Other|8|||
105810306|NCT02974153|364961219|FG002|Overall Study|Other|7|||
105810307|NCT02568384|364961224|FG000|Overall Study|Mobile devices incompatible with App|2|||
105810308|NCT00796510|364961235|FG000|Overall Study|Death|1|||
105361177|NCT02976519|363328183|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
105361178|NCT02976519|363328184|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
105361179|NCT02976519|363328185|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
105361180|NCT02976519|363328186|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
105361181|NCT02976519|363328187|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
105361182|NCT02976519|363328188|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
105361183|NCT02976519|363328182|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
105361184|NCT02976519|363328183|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
105361185|NCT02976519|363328184|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
105361186|NCT02976519|363328185|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
105361187|NCT02976519|363328186|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
105485777|NCT03123185|363789611|FG009|Overall Study|Withdrawal by Subject|0|||
105810309|NCT00796510|364961236|FG001|Overall Study|Death|0|||
105810310|NCT00796510|364961235|FG000|Overall Study|Study Terminated|2|||
105810311|NCT00796510|364961236|FG001|Overall Study|Study Terminated|0|||
105810312|NCT01226797|364961237|FG000|Overall Study|Adverse Event|1|||
105810313|NCT01226797|364961238|FG001|Overall Study|Adverse Event|0|||
105810314|NCT01226797|364961237|FG000|Overall Study|No longer willing to participate|1|||
105810315|NCT01226797|364961238|FG001|Overall Study|No longer willing to participate|0|||
105810316|NCT01226797|364961237|FG000|Overall Study|Protocol Violation|0|||
105810317|NCT01226797|364961238|FG001|Overall Study|Protocol Violation|1|||
105810318|NCT02799602|364961239|FG000|Overall Study|Protocol Violation|1|||
105810319|NCT02799602|364961240|FG001|Overall Study|Protocol Violation|0|||
105810320|NCT02799602|364961239|FG000|Overall Study|Physician Decision|5|||
105810321|NCT02799602|364961240|FG001|Overall Study|Physician Decision|6|||
105810322|NCT02799602|364961239|FG000|Overall Study|Lost to Follow-up|4|||
105810323|NCT02799602|364961240|FG001|Overall Study|Lost to Follow-up|2|||
105810324|NCT02799602|364961239|FG000|Overall Study|Additional primary malignancy|11|||
105810325|NCT02799602|364961240|FG001|Overall Study|Additional primary malignancy|6|||
105810326|NCT02799602|364961239|FG000|Overall Study|Non-compliance with study drug|14|||
105810327|NCT02799602|364961240|FG001|Overall Study|Non-compliance with study drug|12|||
105810328|NCT02799602|364961239|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
105810329|NCT02799602|364961240|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
105810330|NCT02799602|364961239|FG000|Overall Study|Withdrawal by Subject|26|||
105810331|NCT02799602|364961240|FG001|Overall Study|Withdrawal by Subject|40|||
105810332|NCT02799602|364961239|FG000|Overall Study|Progressive disease - clinical progression|131|||
105810333|NCT02799602|364961240|FG001|Overall Study|Progressive disease - clinical progression|276|||
105810334|NCT02799602|364961239|FG000|Overall Study|Progressive disease - radiological progression|90|||
105810335|NCT02799602|364961240|FG001|Overall Study|Progressive disease - radiological progression|133|||
105810336|NCT02799602|364961239|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
105810337|NCT02799602|364961240|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
105810338|NCT02799602|364961239|FG000|Overall Study|Death|9|||
105810339|NCT02799602|364961240|FG001|Overall Study|Death|5|||
105810340|NCT02799602|364961239|FG000|Overall Study|Other|287|||
105810341|NCT02799602|364961240|FG001|Overall Study|Other|118|||
105810342|NCT02799602|364961239|FG000|Overall Study|Study drug never administered|0|||
105810343|NCT02799602|364961240|FG001|Overall Study|Study drug never administered|3|||
105810344|NCT02626949|364961241|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
105810345|NCT02626949|364961242|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
105810346|NCT02626949|364961241|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
105810347|NCT02626949|364961242|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
105810348|NCT02626949|364961241|FG000|Enrolled|Lost to Follow-up|7|||
105810349|NCT02626949|364961242|FG001|Enrolled|Lost to Follow-up|6|||
105810350|NCT02626949|364961241|FG000|Enrolled|Withdrawal by Subject|3|||
105810351|NCT02626949|364961242|FG001|Enrolled|Withdrawal by Subject|2|||
105810352|NCT00720122|364961245|FG000|Overall Study|Lost to Follow-up|1|||
105810353|NCT00720122|364961245|FG000|Overall Study|Physician Decision|1|||
105810354|NCT00720122|364961245|FG000|Overall Study|Withdrawal by Subject|7|||
105810355|NCT03072459|364961246|FG000|Overall Study|Device revised/removed|1|||
105810356|NCT03072459|364961246|FG000|Overall Study|Subject not able to return|1|||
105810357|NCT01790568|364961247|FG000|Overall Study|Progression prior to transplant|0|||
105810358|NCT01790568|364961248|FG001|Overall Study|Progression prior to transplant|1|||
105810359|NCT03595657|364961249|FG000|Overall Study|Adverse Event|14|||
105810360|NCT03595657|364961249|FG000|Overall Study|Death|1|||
105810361|NCT03595657|364961249|FG000|Overall Study|Lack of Efficacy|40|||
105810362|NCT03595657|364961249|FG000|Overall Study|Withdrawal by Subject|10|||
105810363|NCT03595657|364961249|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
105810364|NCT03595657|364961249|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
105810365|NCT02199509|364961254|FG000|Overall Study|Suicidal Ideation|0|||
105810366|NCT02199509|364961255|FG001|Overall Study|Suicidal Ideation|1|||
105810367|NCT02199509|364961254|FG000|Overall Study|Misunderstood titration schedule|1|||
105810368|NCT02199509|364961255|FG001|Overall Study|Misunderstood titration schedule|0|||
105810369|NCT00462982|364961261|FG000|Overall Study|Adverse Event|1|||
105810370|NCT00462982|364961261|FG000|Overall Study|Patient Not Treated|2|||
105810371|NCT05188521|364962800|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
105810372|NCT05188521|364962801|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
105810373|NCT00506753|364962802|FG000|Overall Study|Lost to Follow-up|21|||
105810374|NCT00506753|364962803|FG001|Overall Study|Lost to Follow-up|15|||
105810375|NCT01513551|364962804|FG000|Overall Study|Death|0|||
105810376|NCT01513551|364962805|FG001|Overall Study|Death|1|||
105810377|NCT01513551|364962806|FG002|Overall Study|Death|0|||
105810378|NCT01513551|364962804|FG000|Overall Study|Lost to Follow-up|3|||
105810379|NCT01513551|364962805|FG001|Overall Study|Lost to Follow-up|5|||
105810380|NCT01513551|364962806|FG002|Overall Study|Lost to Follow-up|2|||
105810381|NCT01513551|364962804|FG000|Overall Study|Withdrawal by Subject|1|||
105810382|NCT01513551|364962805|FG001|Overall Study|Withdrawal by Subject|0|||
105810383|NCT01513551|364962806|FG002|Overall Study|Withdrawal by Subject|2|||
105810384|NCT01513551|364962804|FG000|Overall Study|Randomized but not vaccinated|0|||
105810385|NCT01513551|364962805|FG001|Overall Study|Randomized but not vaccinated|0|||
105810386|NCT01513551|364962806|FG002|Overall Study|Randomized but not vaccinated|1|||
105810387|NCT02178709|364962807|FG000|Overall Study|Adverse Event|5|||
105810388|NCT02178709|364962807|FG000|Overall Study|Death|2|||
105810389|NCT02178709|364962807|FG000|Overall Study|Withdrawal by Subject|2|||
105810390|NCT02178709|364962807|FG000|Overall Study|Physician Decision|2|||
105810391|NCT02178709|364962807|FG000|Overall Study|Disease Progression|5|||
105810392|NCT01241461|364962808|FG000|Overall Study|Progressive Disease|3|||
105810393|NCT01241461|364962809|FG001|Overall Study|Progressive Disease|6|||
105810394|NCT01379781|364962813|FG000|Overall Study|Lost to Follow-up|11|||
105810395|NCT01379781|364962814|FG001|Overall Study|Lost to Follow-up|8|||
105810396|NCT02247479|364962816|FG000|Overall Study|Adverse Event|8|||
105810397|NCT02247479|364962817|FG001|Overall Study|Adverse Event|9|||
105810398|NCT02247479|364962818|FG002|Overall Study|Adverse Event|8|||
105810399|NCT02247479|364962816|FG000|Overall Study|Death|5|||
105810400|NCT02247479|364962817|FG001|Overall Study|Death|4|||
105810401|NCT02247479|364962818|FG002|Overall Study|Death|6|||
105810402|NCT02247479|364962816|FG000|Overall Study|Lost to Follow-up|3|||
105810403|NCT02247479|364962817|FG001|Overall Study|Lost to Follow-up|3|||
105810404|NCT02247479|364962818|FG002|Overall Study|Lost to Follow-up|1|||
105810405|NCT02247479|364962816|FG000|Overall Study|Non-compliance|0|||
105810406|NCT02247479|364962817|FG001|Overall Study|Non-compliance|0|||
105810407|NCT02247479|364962818|FG002|Overall Study|Non-compliance|1|||
105810408|NCT02247479|364962816|FG000|Overall Study|Withdrawal by Subject|25|||
105810409|NCT02247479|364962817|FG001|Overall Study|Withdrawal by Subject|29|||
105810410|NCT02247479|364962818|FG002|Overall Study|Withdrawal by Subject|24|||
105810411|NCT02247479|364962816|FG000|Overall Study|Study Terminated by Sponsor|98|||
105810412|NCT02247479|364962817|FG001|Overall Study|Study Terminated by Sponsor|88|||
105810413|NCT02247479|364962818|FG002|Overall Study|Study Terminated by Sponsor|94|||
105810414|NCT02247479|364962816|FG000|Overall Study|Physician Decision|1|||
105810415|NCT02247479|364962817|FG001|Overall Study|Physician Decision|0|||
105810416|NCT02247479|364962818|FG002|Overall Study|Physician Decision|2|||
105810417|NCT02247479|364962816|FG000|Overall Study|Unspecified Reason|2|||
105810418|NCT02247479|364962817|FG001|Overall Study|Unspecified Reason|5|||
105810419|NCT02247479|364962818|FG002|Overall Study|Unspecified Reason|2|||
105810420|NCT01132118|364962819|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
105810421|NCT01132118|364962820|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
105810422|NCT01132118|364962819|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
105810423|NCT01132118|364962820|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
105810424|NCT01132118|364962819|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
105810425|NCT01132118|364962820|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
105810426|NCT00094302|364962825|FG000|Overall Study|Lost to Follow-up|43|||
105810427|NCT00094302|364962826|FG001|Overall Study|Lost to Follow-up|41|||
105810428|NCT00094302|364962825|FG000|Overall Study|Physician Decision|5|||
105810429|NCT00094302|364962826|FG001|Overall Study|Physician Decision|8|||
105810430|NCT00094302|364962825|FG000|Overall Study|Withdrawal by Subject|103|||
105810431|NCT00094302|364962826|FG001|Overall Study|Withdrawal by Subject|111|||
105810432|NCT00094302|364962825|FG000|Overall Study|Death|266|||
105810433|NCT00094302|364962826|FG001|Overall Study|Death|246|||
105810434|NCT03329027|364962827|FG000|Overall Study|Lost to Follow-up|1|||
105810435|NCT03329027|364962828|FG001|Overall Study|Lost to Follow-up|0|||
105810436|NCT03329027|364962829|FG002|Overall Study|Lost to Follow-up|1|||
105810437|NCT03329027|364962827|FG000|Overall Study|Protocol Violation|9|||
105810438|NCT03329027|364962828|FG001|Overall Study|Protocol Violation|5|||
105810439|NCT03329027|364962829|FG002|Overall Study|Protocol Violation|7|||
105810440|NCT04849988|364962836|FG000|Overall Study|Lack of Efficacy|3|||
105810441|NCT04849988|364962837|FG001|Overall Study|Lack of Efficacy|4|||
105810442|NCT04849988|364962838|FG002|Overall Study|Lack of Efficacy|1|||
105810443|NCT04849988|364962839|FG003|Overall Study|Lack of Efficacy|4|||
105810444|NCT04849988|364962836|FG000|Overall Study|Other reasons|1|||
105810445|NCT04849988|364962837|FG001|Overall Study|Other reasons|2|||
105810446|NCT04849988|364962838|FG002|Overall Study|Other reasons|2|||
105810447|NCT04849988|364962839|FG003|Overall Study|Other reasons|1|||
105810448|NCT00992407|364962849|FG000|Overall Study|Protocol Violation|2|||
105361188|NCT02976519|363328187|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
105810449|NCT00992407|364962850|FG001|Overall Study|Protocol Violation|1|||
105810450|NCT00992407|364962849|FG000|Overall Study|Lost to Follow-up|3|||
105810451|NCT00992407|364962850|FG001|Overall Study|Lost to Follow-up|3|||
105810452|NCT00992407|364962849|FG000|Overall Study|Adverse Event|3|||
105810453|NCT00992407|364962850|FG001|Overall Study|Adverse Event|2|||
105810454|NCT00992407|364962849|FG000|Overall Study|protocol Violation & Adverse events|2|||
105810455|NCT00992407|364962850|FG001|Overall Study|protocol Violation & Adverse events|4|||
105810456|NCT00992407|364962849|FG000|Overall Study|Other|2|||
105810457|NCT00992407|364962850|FG001|Overall Study|Other|0|||
105810458|NCT00992407|364962849|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
105571451|NCT04091360|364091212|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
105810459|NCT00992407|364962850|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
105810460|NCT00992407|364962849|FG000|Overall Study|Study medication not administered|17|||
105810461|NCT00992407|364962850|FG001|Overall Study|Study medication not administered|13|||
105810462|NCT03738332|364962853|FG000|Overall Study|Withdrawal by Subject|1|||
105810463|NCT00635778|364962863|FG000|Overall Study|Adverse Event|1|||
105810464|NCT00635778|364962864|FG001|Overall Study|Adverse Event|0|||
105810465|NCT00635778|364962865|FG002|Overall Study|Adverse Event|0|||
105810466|NCT00635778|364962866|FG003|Overall Study|Adverse Event|3|||
105810467|NCT00635778|364962867|FG004|Overall Study|Adverse Event|3|||
105810468|NCT00635778|364962868|FG005|Overall Study|Adverse Event|6|||
105810469|NCT00635778|364962869|FG006|Overall Study|Adverse Event|1|||
105810470|NCT00635778|364962863|FG000|Overall Study|Withdrawal by Subject|0|||
105810471|NCT00635778|364962864|FG001|Overall Study|Withdrawal by Subject|0|||
105810472|NCT00635778|364962865|FG002|Overall Study|Withdrawal by Subject|0|||
105810473|NCT00635778|364962866|FG003|Overall Study|Withdrawal by Subject|1|||
105810474|NCT00635778|364962867|FG004|Overall Study|Withdrawal by Subject|0|||
105810475|NCT00635778|364962868|FG005|Overall Study|Withdrawal by Subject|1|||
105810476|NCT00635778|364962869|FG006|Overall Study|Withdrawal by Subject|1|||
105810477|NCT00635778|364962863|FG000|Overall Study|Progressive disease|0|||
105810478|NCT00635778|364962864|FG001|Overall Study|Progressive disease|3|||
105810479|NCT00635778|364962865|FG002|Overall Study|Progressive disease|3|||
105810480|NCT00635778|364962866|FG003|Overall Study|Progressive disease|4|||
105810481|NCT00635778|364962867|FG004|Overall Study|Progressive disease|5|||
105810482|NCT00635778|364962868|FG005|Overall Study|Progressive disease|14|||
105810483|NCT00635778|364962869|FG006|Overall Study|Progressive disease|4|||
105810484|NCT00812253|364962871|FG000|Overall Study|Withdrawal by Subject|3|||
105810485|NCT00812253|364962872|FG001|Overall Study|Withdrawal by Subject|2|||
105810486|NCT00812253|364962871|FG000|Overall Study|Protocol Violation|1|||
105810487|NCT00812253|364962872|FG001|Overall Study|Protocol Violation|1|||
105810488|NCT00812253|364962871|FG000|Overall Study|Lost to Follow-up|2|||
105810489|NCT00812253|364962872|FG001|Overall Study|Lost to Follow-up|0|||
105810490|NCT01884025|364962873|FG000|Overall Study|Lost to Follow-up|3|||
105810491|NCT01884025|364962874|FG001|Overall Study|Lost to Follow-up|4|||
105810492|NCT02918162|364962876|FG000|Overall Study|Withdrawal by Subject|1|||
105810493|NCT02918162|364962876|FG000|Overall Study|Omental Disease|1|||
105810494|NCT00395226|364962877|FG000|Overall Study|Adverse Event|4|||
105810495|NCT00395226|364962878|FG001|Overall Study|Adverse Event|3|||
105810496|NCT00395226|364962877|FG000|Overall Study|Withdrawal by Subject|0|||
105810497|NCT00395226|364962878|FG001|Overall Study|Withdrawal by Subject|1|||
105810498|NCT00395226|364962877|FG000|Overall Study|Lost to Follow-up|0|||
105810499|NCT00395226|364962878|FG001|Overall Study|Lost to Follow-up|1|||
105810500|NCT02655237|364962885|FG000|Overall Study|Adverse Event|10|||
105810501|NCT02655237|364962886|FG001|Overall Study|Adverse Event|7|||
105810502|NCT02655237|364962885|FG000|Overall Study|Protocol Deviation|2|||
105810503|NCT02655237|364962886|FG001|Overall Study|Protocol Deviation|0|||
105810504|NCT02655237|364962885|FG000|Overall Study|Withdrawal by Participant|1|||
105810505|NCT02655237|364962886|FG001|Overall Study|Withdrawal by Participant|2|||
105810506|NCT02655237|364962885|FG000|Overall Study|Lack of Efficacy|0|||
105810507|NCT02655237|364962886|FG001|Overall Study|Lack of Efficacy|1|||
105810508|NCT02655237|364962885|FG000|Overall Study|Recovery Leading to Surgery|2|||
105810509|NCT02655237|364962886|FG001|Overall Study|Recovery Leading to Surgery|1|||
105810510|NCT02655237|364962885|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
105810511|NCT02655237|364962886|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
105810512|NCT02655237|364962885|FG000|Overall Study|Randomized but Not Treated|1|||
105810513|NCT02655237|364962886|FG001|Overall Study|Randomized but Not Treated|0|||
105810514|NCT02132247|364962887|FG000|Overall Study|Protocol Violation|1|||
105810515|NCT02132247|364962888|FG001|Overall Study|Protocol Violation|0|||
105810516|NCT00220701|364962891|FG000|Overall Study|Lost to Follow-up|5|||
105571452|NCT04091360|364091213|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
105810517|NCT00220701|364962892|FG001|Overall Study|Lost to Follow-up|4|||
105810518|NCT02354586|364962895|FG000|Overall Study|Death|230|||
105810519|NCT02354586|364962895|FG000|Overall Study|Withdrawal by Subject|59|||
105810520|NCT02354586|364962895|FG000|Overall Study|Lost to Follow-up|11|||
105810521|NCT02354586|364962895|FG000|Overall Study|Sponsor decision|51|||
105810522|NCT02354586|364962895|FG000|Overall Study|Site closure|2|||
105810523|NCT02354586|364962895|FG000|Overall Study|Intercurrent illness|1|||
105810524|NCT02354586|364962895|FG000|Overall Study|Protocol Violation|3|||
105571453|NCT04091360|364091214|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
105571454|NCT04091360|364091215|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
105571455|NCT04091360|364091216|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
105571456|NCT04091360|364091207|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
105571457|NCT04091360|364091208|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
105571458|NCT04091360|364091209|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
105571459|NCT04091360|364091210|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
105571460|NCT04091360|364091211|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
105571461|NCT04091360|364091212|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
105571462|NCT04091360|364091213|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
105762579|NCT02120352|364783154|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
105762580|NCT02120352|364783155|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
105762581|NCT02120352|364783156|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
105762582|NCT02120352|364783150|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
105762583|NCT02120352|364783151|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
105762584|NCT02120352|364783152|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
105762585|NCT02120352|364783153|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
105762586|NCT02120352|364783154|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
105762587|NCT02120352|364783155|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
105762588|NCT02120352|364783156|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
105762589|NCT02120352|364783150|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
105762590|NCT02120352|364783151|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
105762591|NCT02120352|364783152|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
105762592|NCT02120352|364783153|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
105762593|NCT02120352|364783154|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
105762594|NCT02120352|364783155|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
105810525|NCT02354586|364962895|FG000|Overall Study|Physician Decision|13|||
105810526|NCT02354586|364962895|FG000|Overall Study|Lack of Efficacy|86|||
105810527|NCT02354586|364962895|FG000|Overall Study|Adverse Event|7|||
105810528|NCT00620763|364962899|FG000|Period: First Intervention|Withdrawal by Subject|0|||
105810529|NCT00620763|364962900|FG001|Period: First Intervention|Withdrawal by Subject|2|||
105810530|NCT00620763|364962899|FG000|Period: First Intervention|Protocol Violation|0|||
105810531|NCT00620763|364962900|FG001|Period: First Intervention|Protocol Violation|3|||
105810532|NCT00620763|364962899|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
105810533|NCT00620763|364962900|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
105810534|NCT00524459|364962901|FG000|Overall Study|Withdrawal by Subject|1|||
105810535|NCT00524459|364962901|FG000|Overall Study|Other|1|||
105810536|NCT00783796|364962905|FG000|Overall Study|Did not receive any stent|4|||
105810537|NCT00783796|364962905|FG000|Overall Study|Received non-XIENCE V stent|1|||
105810538|NCT00783796|364962905|FG000|Overall Study|Received commercial XIENCE V stent|1|||
105810539|NCT00084084|364962910|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
105810540|NCT00084084|364962910|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
105810541|NCT01802879|364962911|FG000|Overall Study|Administrative problems|2|||
105810542|NCT01802879|364962911|FG000|Overall Study|Disease progression|6|||
105810543|NCT02116803|364962916|FG000|Overall Study|Adverse Event|2|||
105810544|NCT02116803|364962917|FG001|Overall Study|Adverse Event|1|||
105810545|NCT02116803|364962916|FG000|Overall Study|Physician Decision|1|||
105810546|NCT02116803|364962917|FG001|Overall Study|Physician Decision|0|||
105810547|NCT02116803|364962916|FG000|Overall Study|Progressive disease|4|||
105810548|NCT02116803|364962917|FG001|Overall Study|Progressive disease|0|||
105810549|NCT02116803|364962916|FG000|Overall Study|Study terminated by sponsor|2|||
105571463|NCT04091360|364091214|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
105571464|NCT04091360|364091215|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
105571465|NCT04091360|364091216|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
105571466|NCT00692406|364091217|FG000|Overall Study|PI dropped, bad data|57|||
105810550|NCT02116803|364962917|FG001|Overall Study|Study terminated by sponsor|1|||
105810551|NCT02116803|364962916|FG000|Overall Study|Death|1|||
105810552|NCT02116803|364962917|FG001|Overall Study|Death|0|||
105810553|NCT03019965|364962920|FG000|Overall Study|Withdrawal by Subject|1|||
105810554|NCT03019965|364962921|FG001|Overall Study|Withdrawal by Subject|0|||
105810555|NCT03019965|364962920|FG000|Overall Study|Protocol Violation|1|||
105810556|NCT03019965|364962921|FG001|Overall Study|Protocol Violation|3|||
105810557|NCT03019965|364962920|FG000|Overall Study|viral or fungal infection|3|||
105810558|NCT03019965|364962921|FG001|Overall Study|viral or fungal infection|4|||
105810559|NCT03019965|364962920|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
105810560|NCT03019965|364962921|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
105810561|NCT03019965|364962920|FG000|Overall Study|Physician Decision|1|||
105810562|NCT03019965|364962921|FG001|Overall Study|Physician Decision|1|||
105810563|NCT00927810|364962922|FG000|Overall Study|Withdrawal by Subject|0|||
105810564|NCT00927810|364962923|FG001|Overall Study|Withdrawal by Subject|3|||
105810565|NCT00927810|364962924|FG002|Overall Study|Withdrawal by Subject|0|||
105810566|NCT00927810|364962925|FG003|Overall Study|Withdrawal by Subject|1|||
105810567|NCT00927810|364962922|FG000|Overall Study|Lost to Follow-up|0|||
105810568|NCT00927810|364962923|FG001|Overall Study|Lost to Follow-up|2|||
105810569|NCT00927810|364962924|FG002|Overall Study|Lost to Follow-up|1|||
105810570|NCT00927810|364962925|FG003|Overall Study|Lost to Follow-up|1|||
105810571|NCT00927810|364962922|FG000|Overall Study|Death|0|||
105810572|NCT00927810|364962923|FG001|Overall Study|Death|2|||
105810573|NCT00927810|364962924|FG002|Overall Study|Death|0|||
105571467|NCT02307513|364091218|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
105571468|NCT02307513|364091219|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
105571469|NCT02307513|364091218|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
105810574|NCT00927810|364962925|FG003|Overall Study|Death|0|||
105810575|NCT00927810|364962922|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105810576|NCT00927810|364962923|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105810577|NCT00927810|364962924|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105810578|NCT00927810|364962925|FG003|Overall Study|Abnormal laboratory value(s)|0|||
105810579|NCT00950807|364962927|FG000|Treatment Period 1|Lack of Efficacy|1|||
105810580|NCT00950807|364962928|FG001|Treatment Period 1|Lack of Efficacy|0|||
105810581|NCT00950807|364962929|FG002|Treatment Period 1|Lack of Efficacy|0|||
105810582|NCT00950807|364962930|FG003|Treatment Period 1|Lack of Efficacy|0|||
105810583|NCT00950807|364962931|FG004|Treatment Period 1|Lack of Efficacy|0|||
105810584|NCT00950807|364962932|FG005|Treatment Period 1|Lack of Efficacy|1|||
105810585|NCT00950807|364962933|FG006|Treatment Period 1|Lack of Efficacy|0|||
105810586|NCT00950807|364962934|FG007|Treatment Period 1|Lack of Efficacy|0|||
105810587|NCT00950807|364962935|FG008|Treatment Period 1|Lack of Efficacy|0|||
105810588|NCT00950807|364962936|FG009|Treatment Period 1|Lack of Efficacy|0|||
105810589|NCT00950807|364962927|FG000|Treatment Period 1|Protocol Violation|1|||
105762595|NCT02120352|364783156|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
105762596|NCT02120352|364783150|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
105762597|NCT02120352|364783151|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
105762598|NCT02120352|364783152|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
105762599|NCT02120352|364783153|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
105762600|NCT02120352|364783154|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
105762601|NCT02120352|364783155|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
105762602|NCT02120352|364783156|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
105762603|NCT02120352|364783150|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
105762604|NCT02120352|364783151|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
105762605|NCT02120352|364783152|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
105762606|NCT02120352|364783153|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
105762607|NCT02120352|364783154|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
105762608|NCT02120352|364783155|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
105762609|NCT02120352|364783156|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
105762610|NCT02120352|364783150|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
105762611|NCT02120352|364783151|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
105762612|NCT02120352|364783152|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
105762613|NCT02120352|364783153|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
105762614|NCT02120352|364783154|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
105762615|NCT02120352|364783155|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
105762616|NCT02120352|364783156|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
105762617|NCT02120352|364783150|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
105762618|NCT02120352|364783151|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
105762619|NCT02120352|364783152|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
105762620|NCT02120352|364783153|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
105762621|NCT02120352|364783154|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
105762622|NCT02120352|364783155|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
105762623|NCT02120352|364783156|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
105762624|NCT02120352|364783150|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
105762625|NCT02120352|364783151|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
105762626|NCT02120352|364783152|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
105762627|NCT02120352|364783153|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
105762628|NCT02120352|364783154|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
105762629|NCT02120352|364783155|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
105762630|NCT02120352|364783156|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
105762631|NCT02120352|364783150|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
105762632|NCT02120352|364783151|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
105762633|NCT02120352|364783152|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
105762634|NCT02120352|364783153|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
105762635|NCT02120352|364783154|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
105762636|NCT02120352|364783155|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
105762637|NCT02120352|364783156|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
105762638|NCT02120352|364783150|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
105762639|NCT02120352|364783151|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
105762640|NCT02120352|364783152|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
105762641|NCT02120352|364783153|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
105762642|NCT02120352|364783154|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
105762643|NCT02120352|364783155|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
105762644|NCT02120352|364783156|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
105762645|NCT02120352|364783150|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
105762646|NCT02120352|364783151|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
105762647|NCT02120352|364783152|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
105762648|NCT02120352|364783153|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
105762649|NCT02120352|364783154|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
105762650|NCT02120352|364783155|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
105762651|NCT02120352|364783156|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
105762652|NCT00617591|364783157|FG000|Overall Study|Withdrew consent during Induction|4|||
105762653|NCT00617591|364783157|FG000|Overall Study|Withdrew consent during Maintenance|6|||
105810590|NCT00950807|364962928|FG001|Treatment Period 1|Protocol Violation|0|||
105810591|NCT00950807|364962929|FG002|Treatment Period 1|Protocol Violation|0|||
105810592|NCT00950807|364962930|FG003|Treatment Period 1|Protocol Violation|0|||
105810593|NCT00950807|364962931|FG004|Treatment Period 1|Protocol Violation|0|||
105810594|NCT00950807|364962932|FG005|Treatment Period 1|Protocol Violation|0|||
105810595|NCT00950807|364962933|FG006|Treatment Period 1|Protocol Violation|0|||
105810596|NCT00950807|364962934|FG007|Treatment Period 1|Protocol Violation|0|||
105810597|NCT00950807|364962935|FG008|Treatment Period 1|Protocol Violation|0|||
105810598|NCT00950807|364962936|FG009|Treatment Period 1|Protocol Violation|0|||
105810599|NCT00950807|364962927|FG000|Treatment Period 1|Lost to Follow-up|0|||
105810600|NCT00950807|364962928|FG001|Treatment Period 1|Lost to Follow-up|0|||
105810601|NCT00950807|364962929|FG002|Treatment Period 1|Lost to Follow-up|1|||
105810602|NCT00950807|364962930|FG003|Treatment Period 1|Lost to Follow-up|0|||
105810603|NCT00950807|364962931|FG004|Treatment Period 1|Lost to Follow-up|0|||
105361189|NCT02976519|363328188|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
105361190|NCT02976519|363328182|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
105361191|NCT02976519|363328183|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
105361192|NCT02976519|363328184|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
105361193|NCT02976519|363328185|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
105361194|NCT02976519|363328186|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
105361195|NCT02976519|363328187|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
105361196|NCT02976519|363328188|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
105361197|NCT02976519|363328182|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
105361198|NCT02976519|363328183|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
105361199|NCT02976519|363328184|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
105361200|NCT02976519|363328185|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
105361201|NCT02976519|363328186|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
105361202|NCT02976519|363328187|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
105361203|NCT02976519|363328188|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
105361204|NCT01089127|363328189|FG000|Overall Study|Adverse Event|5|||
105361205|NCT01089127|363328190|FG001|Overall Study|Adverse Event|1|||
105361206|NCT01089127|363328191|FG002|Overall Study|Adverse Event|1|||
105361207|NCT01089127|363328192|FG003|Overall Study|Adverse Event|0|||
105361208|NCT01089127|363328193|FG004|Overall Study|Adverse Event|0|||
105361209|NCT01089127|363328194|FG005|Overall Study|Adverse Event|1|||
105361210|NCT01089127|363328189|FG000|Overall Study|Subject withdrew consent|0|||
105361211|NCT01089127|363328190|FG001|Overall Study|Subject withdrew consent|1|||
105361212|NCT01089127|363328191|FG002|Overall Study|Subject withdrew consent|1|||
105361213|NCT01089127|363328192|FG003|Overall Study|Subject withdrew consent|1|||
105361214|NCT01089127|363328193|FG004|Overall Study|Subject withdrew consent|0|||
105810604|NCT00950807|364962932|FG005|Treatment Period 1|Lost to Follow-up|0|||
105810605|NCT00950807|364962933|FG006|Treatment Period 1|Lost to Follow-up|0|||
105361215|NCT01089127|363328194|FG005|Overall Study|Subject withdrew consent|2|||
105810606|NCT00950807|364962934|FG007|Treatment Period 1|Lost to Follow-up|0|||
105810607|NCT00950807|364962935|FG008|Treatment Period 1|Lost to Follow-up|0|||
105810608|NCT00950807|364962936|FG009|Treatment Period 1|Lost to Follow-up|0|||
105361216|NCT01089127|363328189|FG000|Overall Study|Abnormal test procedure result(s)|2|||
105361217|NCT01089127|363328190|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105361218|NCT01089127|363328191|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105810609|NCT00950807|364962927|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105810610|NCT00950807|364962928|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105810611|NCT00950807|364962929|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105810612|NCT00950807|364962930|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105810613|NCT00950807|364962931|FG004|Treatment Period 1|Withdrawal by Subject|1|||
105810614|NCT00950807|364962932|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105810615|NCT00950807|364962933|FG006|Treatment Period 1|Withdrawal by Subject|0|||
105810616|NCT00950807|364962934|FG007|Treatment Period 1|Withdrawal by Subject|0|||
105810617|NCT00950807|364962935|FG008|Treatment Period 1|Withdrawal by Subject|1|||
105810618|NCT00950807|364962936|FG009|Treatment Period 1|Withdrawal by Subject|0|||
105810619|NCT00950807|364962927|FG000|Treatment Period 1|Adverse Event|0|||
105810620|NCT00950807|364962928|FG001|Treatment Period 1|Adverse Event|0|||
105810621|NCT00950807|364962929|FG002|Treatment Period 1|Adverse Event|0|||
105810622|NCT00950807|364962930|FG003|Treatment Period 1|Adverse Event|0|||
105810623|NCT00950807|364962931|FG004|Treatment Period 1|Adverse Event|0|||
105810624|NCT00950807|364962932|FG005|Treatment Period 1|Adverse Event|1|||
105810625|NCT00950807|364962933|FG006|Treatment Period 1|Adverse Event|0|||
105810626|NCT00950807|364962934|FG007|Treatment Period 1|Adverse Event|0|||
105810627|NCT00950807|364962935|FG008|Treatment Period 1|Adverse Event|0|||
105810628|NCT00950807|364962936|FG009|Treatment Period 1|Adverse Event|0|||
105810629|NCT00950807|364962927|FG000|Washout Period 1|Lack of Efficacy|0|||
105810630|NCT00950807|364962928|FG001|Washout Period 1|Lack of Efficacy|0|||
105810631|NCT00950807|364962929|FG002|Washout Period 1|Lack of Efficacy|0|||
105810632|NCT00950807|364962930|FG003|Washout Period 1|Lack of Efficacy|0|||
105810633|NCT00950807|364962931|FG004|Washout Period 1|Lack of Efficacy|0|||
105810634|NCT00950807|364962932|FG005|Washout Period 1|Lack of Efficacy|0|||
105810635|NCT00950807|364962933|FG006|Washout Period 1|Lack of Efficacy|1|||
105810636|NCT00950807|364962934|FG007|Washout Period 1|Lack of Efficacy|0|||
105810637|NCT00950807|364962935|FG008|Washout Period 1|Lack of Efficacy|0|||
105810638|NCT00950807|364962936|FG009|Washout Period 1|Lack of Efficacy|0|||
105810639|NCT00950807|364962927|FG000|Washout Period 1|Withdrawal by Subject|0|||
105810640|NCT00950807|364962928|FG001|Washout Period 1|Withdrawal by Subject|0|||
105810641|NCT00950807|364962929|FG002|Washout Period 1|Withdrawal by Subject|0|||
105810642|NCT00950807|364962930|FG003|Washout Period 1|Withdrawal by Subject|0|||
105810643|NCT00950807|364962931|FG004|Washout Period 1|Withdrawal by Subject|0|||
105361219|NCT01089127|363328192|FG003|Overall Study|Abnormal test procedure result(s)|0|||
105810644|NCT00950807|364962932|FG005|Washout Period 1|Withdrawal by Subject|0|||
105810645|NCT00950807|364962933|FG006|Washout Period 1|Withdrawal by Subject|0|||
105810646|NCT00950807|364962934|FG007|Washout Period 1|Withdrawal by Subject|0|||
105810647|NCT00950807|364962935|FG008|Washout Period 1|Withdrawal by Subject|1|||
105810648|NCT00950807|364962936|FG009|Washout Period 1|Withdrawal by Subject|0|||
105810649|NCT00950807|364962927|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
105810650|NCT00950807|364962928|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
105810651|NCT00950807|364962929|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
105810652|NCT00950807|364962930|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
105810653|NCT00950807|364962931|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
105810654|NCT00950807|364962932|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
105810655|NCT00950807|364962933|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
105810656|NCT00950807|364962934|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
105810657|NCT00950807|364962935|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
105810658|NCT00950807|364962936|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
105810659|NCT00950807|364962927|FG000|Washout Period 1|Adverse Event|2|||
105810660|NCT00950807|364962928|FG001|Washout Period 1|Adverse Event|0|||
105810661|NCT00950807|364962929|FG002|Washout Period 1|Adverse Event|0|||
105810662|NCT00950807|364962930|FG003|Washout Period 1|Adverse Event|1|||
105810663|NCT00950807|364962931|FG004|Washout Period 1|Adverse Event|1|||
105810664|NCT00950807|364962932|FG005|Washout Period 1|Adverse Event|0|||
105810665|NCT00950807|364962933|FG006|Washout Period 1|Adverse Event|0|||
105810666|NCT00950807|364962934|FG007|Washout Period 1|Adverse Event|0|||
105810667|NCT00950807|364962935|FG008|Washout Period 1|Adverse Event|0|||
105810668|NCT00950807|364962936|FG009|Washout Period 1|Adverse Event|0|||
105810669|NCT00950807|364962927|FG000|Treatment Period 2|Lack of Efficacy|1|||
105810670|NCT00950807|364962928|FG001|Treatment Period 2|Lack of Efficacy|0|||
105810671|NCT00950807|364962929|FG002|Treatment Period 2|Lack of Efficacy|0|||
105810672|NCT00950807|364962930|FG003|Treatment Period 2|Lack of Efficacy|0|||
105810673|NCT00950807|364962931|FG004|Treatment Period 2|Lack of Efficacy|0|||
105810674|NCT00950807|364962932|FG005|Treatment Period 2|Lack of Efficacy|0|||
105810675|NCT00950807|364962933|FG006|Treatment Period 2|Lack of Efficacy|0|||
105810676|NCT00950807|364962934|FG007|Treatment Period 2|Lack of Efficacy|0|||
105810677|NCT00950807|364962935|FG008|Treatment Period 2|Lack of Efficacy|0|||
105810678|NCT00950807|364962936|FG009|Treatment Period 2|Lack of Efficacy|0|||
105810679|NCT00950807|364962927|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105810680|NCT00950807|364962928|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105810681|NCT00950807|364962929|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105810682|NCT00950807|364962930|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105810683|NCT00950807|364962931|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105810684|NCT00950807|364962932|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105810685|NCT00950807|364962933|FG006|Treatment Period 2|Withdrawal by Subject|1|||
105810686|NCT00950807|364962934|FG007|Treatment Period 2|Withdrawal by Subject|2|||
105810687|NCT00950807|364962935|FG008|Treatment Period 2|Withdrawal by Subject|0|||
105810688|NCT00950807|364962936|FG009|Treatment Period 2|Withdrawal by Subject|0|||
105810689|NCT00950807|364962927|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
105810690|NCT00950807|364962928|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810691|NCT00950807|364962929|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810692|NCT00950807|364962930|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810693|NCT00950807|364962931|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810694|NCT00950807|364962932|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810695|NCT00950807|364962933|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810696|NCT00950807|364962934|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810697|NCT00950807|364962935|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810698|NCT00950807|364962936|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810699|NCT00950807|364962927|FG000|Treatment Period 2|Adverse Event|0|||
105810700|NCT00950807|364962928|FG001|Treatment Period 2|Adverse Event|1|||
105810701|NCT00950807|364962929|FG002|Treatment Period 2|Adverse Event|0|||
105810702|NCT00950807|364962930|FG003|Treatment Period 2|Adverse Event|1|||
105810703|NCT00950807|364962931|FG004|Treatment Period 2|Adverse Event|0|||
105810704|NCT00950807|364962932|FG005|Treatment Period 2|Adverse Event|1|||
105810705|NCT00950807|364962933|FG006|Treatment Period 2|Adverse Event|0|||
105810706|NCT00950807|364962934|FG007|Treatment Period 2|Adverse Event|1|||
105810707|NCT00950807|364962935|FG008|Treatment Period 2|Adverse Event|0|||
105810708|NCT00950807|364962936|FG009|Treatment Period 2|Adverse Event|0|||
105810709|NCT00950807|364962927|FG000|Washout Period 2|Lack of Efficacy|1|||
105810710|NCT00950807|364962928|FG001|Washout Period 2|Lack of Efficacy|0|||
105810711|NCT00950807|364962929|FG002|Washout Period 2|Lack of Efficacy|0|||
105810712|NCT00950807|364962930|FG003|Washout Period 2|Lack of Efficacy|0|||
105810713|NCT00950807|364962931|FG004|Washout Period 2|Lack of Efficacy|0|||
105810714|NCT00950807|364962932|FG005|Washout Period 2|Lack of Efficacy|0|||
105810715|NCT00950807|364962933|FG006|Washout Period 2|Lack of Efficacy|0|||
105810716|NCT00950807|364962934|FG007|Washout Period 2|Lack of Efficacy|0|||
105810717|NCT00950807|364962935|FG008|Washout Period 2|Lack of Efficacy|0|||
105810718|NCT00950807|364962936|FG009|Washout Period 2|Lack of Efficacy|0|||
105810719|NCT00950807|364962927|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
105810720|NCT00950807|364962928|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
105810721|NCT00950807|364962929|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
105810722|NCT00950807|364962930|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
105810723|NCT00950807|364962931|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
105810724|NCT00950807|364962932|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
105810725|NCT00950807|364962933|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
105810726|NCT00950807|364962934|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
105810727|NCT00950807|364962935|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
105810728|NCT00950807|364962936|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
105810729|NCT00950807|364962927|FG000|Washout Period 2|Adverse Event|3|||
105810730|NCT00950807|364962928|FG001|Washout Period 2|Adverse Event|0|||
105810731|NCT00950807|364962929|FG002|Washout Period 2|Adverse Event|0|||
105810732|NCT00950807|364962930|FG003|Washout Period 2|Adverse Event|1|||
105810733|NCT00950807|364962931|FG004|Washout Period 2|Adverse Event|0|||
105810734|NCT00950807|364962932|FG005|Washout Period 2|Adverse Event|0|||
105810735|NCT00950807|364962933|FG006|Washout Period 2|Adverse Event|0|||
105810736|NCT00950807|364962934|FG007|Washout Period 2|Adverse Event|0|||
105810737|NCT00950807|364962935|FG008|Washout Period 2|Adverse Event|0|||
105810738|NCT00950807|364962936|FG009|Washout Period 2|Adverse Event|0|||
105810739|NCT00950807|364962927|FG000|Treatment Period 3|Withdrawal by Subject|0|||
105810740|NCT00950807|364962928|FG001|Treatment Period 3|Withdrawal by Subject|0|||
105810741|NCT00950807|364962929|FG002|Treatment Period 3|Withdrawal by Subject|0|||
105810742|NCT00950807|364962930|FG003|Treatment Period 3|Withdrawal by Subject|0|||
105810743|NCT00950807|364962931|FG004|Treatment Period 3|Withdrawal by Subject|0|||
105810744|NCT00950807|364962932|FG005|Treatment Period 3|Withdrawal by Subject|0|||
105810745|NCT00950807|364962933|FG006|Treatment Period 3|Withdrawal by Subject|0|||
105810746|NCT00950807|364962934|FG007|Treatment Period 3|Withdrawal by Subject|0|||
105810747|NCT00950807|364962935|FG008|Treatment Period 3|Withdrawal by Subject|0|||
105810748|NCT00950807|364962936|FG009|Treatment Period 3|Withdrawal by Subject|1|||
105810749|NCT00950807|364962927|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
105810750|NCT00950807|364962928|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810751|NCT00950807|364962929|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810752|NCT00950807|364962930|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810753|NCT00950807|364962931|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810754|NCT00950807|364962932|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810755|NCT00950807|364962933|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810756|NCT00950807|364962934|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
105810757|NCT00950807|364962935|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810758|NCT00950807|364962936|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810759|NCT00950807|364962927|FG000|Treatment Period 3|Adverse Event|0|||
105810760|NCT00950807|364962928|FG001|Treatment Period 3|Adverse Event|0|||
105810761|NCT00950807|364962929|FG002|Treatment Period 3|Adverse Event|0|||
105810762|NCT00950807|364962930|FG003|Treatment Period 3|Adverse Event|0|||
105810763|NCT00950807|364962931|FG004|Treatment Period 3|Adverse Event|0|||
105810764|NCT00950807|364962932|FG005|Treatment Period 3|Adverse Event|0|||
105810765|NCT00950807|364962933|FG006|Treatment Period 3|Adverse Event|1|||
105810766|NCT00950807|364962934|FG007|Treatment Period 3|Adverse Event|0|||
105810767|NCT00950807|364962935|FG008|Treatment Period 3|Adverse Event|0|||
105810768|NCT00950807|364962936|FG009|Treatment Period 3|Adverse Event|0|||
105810769|NCT00891293|364962937|FG000|Overall Study|Adverse Event|2|||
105810770|NCT00891293|364962937|FG000|Overall Study|Protocol Violation|2|||
105810771|NCT00891293|364962937|FG000|Overall Study|Laboratory abnormality|4|||
105810772|NCT00891293|364962937|FG000|Overall Study|Lost to Follow-up|7|||
105810773|NCT00891293|364962937|FG000|Overall Study|Subject withdrew consent|7|||
105810774|NCT00891293|364962937|FG000|Overall Study|Sponsor termination|62|||
105810775|NCT03982433|364962938|FG000|Overall Study|Lost to Follow-up|1|||
105810776|NCT00906347|364962939|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
105810777|NCT00906347|364962940|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
105810778|NCT00906347|364962939|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
105810779|NCT00906347|364962940|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
105810780|NCT00906347|364962939|FG000|Received Study Drug|Refused study drug|1|||
105810781|NCT00906347|364962940|FG001|Received Study Drug|Refused study drug|0|||
105810782|NCT00906347|364962939|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
105810783|NCT00906347|364962940|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
105810784|NCT00984295|364962941|FG000|Overall Study|Lost to Follow-up|31|||
105810785|NCT00984295|364962942|FG001|Overall Study|Lost to Follow-up|12|||
105810786|NCT00984295|364962943|FG002|Overall Study|Lost to Follow-up|13|||
105810787|NCT00984295|364962941|FG000|Overall Study|Protocol Violation|2|||
105810788|NCT00984295|364962942|FG001|Overall Study|Protocol Violation|1|||
105810789|NCT00984295|364962943|FG002|Overall Study|Protocol Violation|4|||
105810790|NCT00984295|364962941|FG000|Overall Study|Withdrawal by Subject|18|||
105361220|NCT01089127|363328193|FG004|Overall Study|Abnormal test procedure result(s)|0|||
105361221|NCT01089127|363328194|FG005|Overall Study|Abnormal test procedure result(s)|0|||
105361222|NCT01089127|363328189|FG000|Overall Study|Lost to Follow-up|1|||
105361223|NCT01089127|363328190|FG001|Overall Study|Lost to Follow-up|1|||
105361224|NCT01089127|363328191|FG002|Overall Study|Lost to Follow-up|0|||
105361225|NCT01089127|363328192|FG003|Overall Study|Lost to Follow-up|0|||
105361226|NCT01089127|363328193|FG004|Overall Study|Lost to Follow-up|1|||
105571470|NCT02307513|364091219|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
105810791|NCT00984295|364962942|FG001|Overall Study|Withdrawal by Subject|9|||
105810792|NCT00984295|364962943|FG002|Overall Study|Withdrawal by Subject|12|||
105810793|NCT00984295|364962941|FG000|Overall Study|CAE - discontinued test vaccine|0|||
105810794|NCT00984295|364962942|FG001|Overall Study|CAE - discontinued test vaccine|1|||
105810795|NCT00984295|364962943|FG002|Overall Study|CAE - discontinued test vaccine|3|||
105810796|NCT00984295|364962941|FG000|Overall Study|Missed one or more blood samplings|3|||
105810797|NCT00984295|364962942|FG001|Overall Study|Missed one or more blood samplings|7|||
105810798|NCT00984295|364962943|FG002|Overall Study|Missed one or more blood samplings|2|||
105810799|NCT00984295|364962941|FG000|Overall Study|Incomplete safety follow-up|11|||
105810800|NCT00984295|364962942|FG001|Overall Study|Incomplete safety follow-up|2|||
105810801|NCT00984295|364962943|FG002|Overall Study|Incomplete safety follow-up|3|||
105810802|NCT00788957|364962952|FG000|Part 1|Death|8|||
105810803|NCT00788957|364962953|FG001|Part 1|Death|0|||
105810804|NCT00788957|364962954|FG002|Part 1|Death|0|||
105810805|NCT00788957|364962955|FG003|Part 1|Death|0|||
105810806|NCT00788957|364962956|FG004|Part 1|Death|0|||
105810807|NCT00788957|364962957|FG005|Part 1|Death|0|||
105810808|NCT00788957|364962952|FG000|Part 1|Lost to Follow-up|1|||
105810809|NCT00788957|364962953|FG001|Part 1|Lost to Follow-up|0|||
105810810|NCT00788957|364962954|FG002|Part 1|Lost to Follow-up|0|||
105810811|NCT00788957|364962955|FG003|Part 1|Lost to Follow-up|0|||
105810812|NCT00788957|364962956|FG004|Part 1|Lost to Follow-up|0|||
105810813|NCT00788957|364962957|FG005|Part 1|Lost to Follow-up|0|||
105810814|NCT00788957|364962952|FG000|Part 2|Withdrawal by Subject|0|||
105810815|NCT00788957|364962953|FG001|Part 2|Withdrawal by Subject|9|||
105810816|NCT00788957|364962954|FG002|Part 2|Withdrawal by Subject|5|||
105810817|NCT00788957|364962955|FG003|Part 2|Withdrawal by Subject|3|||
105810818|NCT00788957|364962956|FG004|Part 2|Withdrawal by Subject|0|||
105810819|NCT00788957|364962957|FG005|Part 2|Withdrawal by Subject|0|||
105810820|NCT00788957|364962952|FG000|Part 2|Death|0|||
105810821|NCT00788957|364962953|FG001|Part 2|Death|32|||
105810822|NCT00788957|364962954|FG002|Part 2|Death|35|||
105810823|NCT00788957|364962955|FG003|Part 2|Death|37|||
105810824|NCT00788957|364962956|FG004|Part 2|Death|0|||
105810825|NCT00788957|364962957|FG005|Part 2|Death|0|||
105810826|NCT00788957|364962952|FG000|Part 2|Lost to Follow-up|0|||
105810827|NCT00788957|364962953|FG001|Part 2|Lost to Follow-up|0|||
105810828|NCT00788957|364962954|FG002|Part 2|Lost to Follow-up|3|||
105810829|NCT00788957|364962955|FG003|Part 2|Lost to Follow-up|0|||
105810830|NCT00788957|364962956|FG004|Part 2|Lost to Follow-up|0|||
105810831|NCT00788957|364962957|FG005|Part 2|Lost to Follow-up|0|||
105810832|NCT00788957|364962952|FG000|Part 2|On-study at time of data cut-off|0|||
105810833|NCT00788957|364962953|FG001|Part 2|On-study at time of data cut-off|1|||
105810834|NCT00788957|364962954|FG002|Part 2|On-study at time of data cut-off|1|||
105810835|NCT00788957|364962955|FG003|Part 2|On-study at time of data cut-off|1|||
105485778|NCT03123185|363789612|FG010|Overall Study|Withdrawal by Subject|0|||
105485779|NCT03123185|363789613|FG011|Overall Study|Withdrawal by Subject|0|||
105485780|NCT03123185|363789614|FG012|Overall Study|Withdrawal by Subject|1|||
105485781|NCT03123185|363789615|FG013|Overall Study|Withdrawal by Subject|0|||
105810836|NCT00788957|364962956|FG004|Part 2|On-study at time of data cut-off|0|||
105810837|NCT00788957|364962957|FG005|Part 2|On-study at time of data cut-off|0|||
105810838|NCT00788957|364962952|FG000|Part 3|Withdrawal by Subject|0|||
105810839|NCT00788957|364962953|FG001|Part 3|Withdrawal by Subject|0|||
105810840|NCT00788957|364962954|FG002|Part 3|Withdrawal by Subject|0|||
105810841|NCT00788957|364962955|FG003|Part 3|Withdrawal by Subject|0|||
105810842|NCT00788957|364962956|FG004|Part 3|Withdrawal by Subject|0|||
105810843|NCT00788957|364962957|FG005|Part 3|Withdrawal by Subject|2|||
105810844|NCT00788957|364962952|FG000|Part 3|Death|0|||
105810845|NCT00788957|364962953|FG001|Part 3|Death|0|||
105810846|NCT00788957|364962954|FG002|Part 3|Death|0|||
105810847|NCT00788957|364962955|FG003|Part 3|Death|0|||
105810848|NCT00788957|364962956|FG004|Part 3|Death|8|||
105810849|NCT00788957|364962957|FG005|Part 3|Death|8|||
105810850|NCT00788957|364962952|FG000|Part 3|On-study at time of data cut-off|0|||
105810851|NCT00788957|364962953|FG001|Part 3|On-study at time of data cut-off|0|||
105810852|NCT00788957|364962954|FG002|Part 3|On-study at time of data cut-off|0|||
105810853|NCT00788957|364962955|FG003|Part 3|On-study at time of data cut-off|0|||
105810854|NCT00788957|364962956|FG004|Part 3|On-study at time of data cut-off|1|||
105810855|NCT00788957|364962957|FG005|Part 3|On-study at time of data cut-off|0|||
105810856|NCT03387098|364962958|FG000|Overall Study|progressive disease|1|||
105810857|NCT03387098|364962958|FG000|Overall Study|Withdrawal by Subject|2|||
105810858|NCT03387098|364962958|FG000|Overall Study|study terminated by sponsor|1|||
105810859|NCT02277769|364962959|FG000|Overall Study|Protocol Violation|3|||
105810860|NCT02277769|364962960|FG001|Overall Study|Protocol Violation|3|||
105810861|NCT02277769|364962961|FG002|Overall Study|Protocol Violation|5|||
105810862|NCT02277769|364962959|FG000|Overall Study|Lack of Efficacy|17|||
105810863|NCT02277769|364962960|FG001|Overall Study|Lack of Efficacy|0|||
105810864|NCT02277769|364962961|FG002|Overall Study|Lack of Efficacy|4|||
105810865|NCT02277769|364962959|FG000|Overall Study|Adverse Event|14|||
105810866|NCT02277769|364962960|FG001|Overall Study|Adverse Event|2|||
105810867|NCT02277769|364962961|FG002|Overall Study|Adverse Event|4|||
105810868|NCT02277769|364962959|FG000|Overall Study|Other than specified above|12|||
105810869|NCT02277769|364962960|FG001|Overall Study|Other than specified above|8|||
105810870|NCT02277769|364962961|FG002|Overall Study|Other than specified above|5|||
105810871|NCT03384745|364962962|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
105810872|NCT03384745|364962963|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
105810873|NCT03384745|364962964|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
105810874|NCT03384745|364962965|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
105810875|NCT03384745|364962966|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
105810876|NCT03384745|364962967|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
105810877|NCT03384745|364962962|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
105810878|NCT03384745|364962963|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
105810879|NCT03384745|364962964|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
105810880|NCT03384745|364962965|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
105810881|NCT03384745|364962966|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
105810882|NCT03384745|364962967|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
105810883|NCT03384745|364962962|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
105810884|NCT03384745|364962963|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
105810885|NCT03384745|364962964|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
105810886|NCT03384745|364962965|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
105810887|NCT03384745|364962966|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
105810888|NCT03384745|364962967|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
105810889|NCT03384745|364962962|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
105810890|NCT03384745|364962963|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
105810891|NCT03384745|364962964|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
105810892|NCT03384745|364962965|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
105810893|NCT03384745|364962966|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
105810894|NCT03384745|364962967|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
105810895|NCT03384745|364962962|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
105810896|NCT03384745|364962963|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
105810897|NCT03384745|364962964|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
105810898|NCT03384745|364962965|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
105810899|NCT03384745|364962966|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
105810900|NCT03384745|364962967|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
105810901|NCT03384745|364962962|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
105810902|NCT03384745|364962963|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
105810903|NCT03384745|364962964|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
105810904|NCT03384745|364962965|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
105810905|NCT03384745|364962966|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
105810906|NCT03384745|364962967|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
105361227|NCT01089127|363328194|FG005|Overall Study|Lost to Follow-up|0|||
105361228|NCT01089127|363328189|FG000|Overall Study|Protocol deviation|0|||
105361229|NCT01089127|363328190|FG001|Overall Study|Protocol deviation|1|||
105361230|NCT01089127|363328191|FG002|Overall Study|Protocol deviation|0|||
105361231|NCT01089127|363328192|FG003|Overall Study|Protocol deviation|0|||
105361232|NCT01089127|363328193|FG004|Overall Study|Protocol deviation|1|||
105361233|NCT01089127|363328194|FG005|Overall Study|Protocol deviation|0|||
105361234|NCT01278342|363328195|FG000|Overall Study|Physician Decision|0|||
105361235|NCT01278342|363328196|FG001|Overall Study|Physician Decision|1|||
105361236|NCT01278342|363328197|FG002|Overall Study|Physician Decision|0|||
105361237|NCT01278342|363328195|FG000|Overall Study|Lost to Follow-up|1|||
105361238|NCT01278342|363328196|FG001|Overall Study|Lost to Follow-up|0|||
105361239|NCT01278342|363328197|FG002|Overall Study|Lost to Follow-up|0|||
105361240|NCT01278342|363328195|FG000|Overall Study|Administrative problems|2|||
105361241|NCT01278342|363328196|FG001|Overall Study|Administrative problems|0|||
105361242|NCT01278342|363328197|FG002|Overall Study|Administrative problems|0|||
105361243|NCT01278342|363328195|FG000|Overall Study|Other|1|||
105810907|NCT03384745|364962962|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
105810908|NCT03384745|364962963|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
105810909|NCT03384745|364962964|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
105810910|NCT03384745|364962965|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
105810911|NCT03384745|364962966|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
105810912|NCT03384745|364962967|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
105810913|NCT03384745|364962962|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
105810914|NCT03384745|364962963|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
105810915|NCT03384745|364962964|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
105810916|NCT03384745|364962965|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
105810917|NCT03384745|364962966|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
105810918|NCT03384745|364962967|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
105810919|NCT03384745|364962962|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
105810920|NCT03384745|364962963|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
105810921|NCT03384745|364962964|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
105810922|NCT03384745|364962965|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
105810923|NCT03384745|364962966|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
105810924|NCT03384745|364962967|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
105810925|NCT03384745|364962962|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
105810926|NCT03384745|364962963|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
105810927|NCT03384745|364962964|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
105810928|NCT03384745|364962965|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
105810929|NCT03384745|364962966|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
105361244|NCT01278342|363328196|FG001|Overall Study|Other|0|||
105571471|NCT02307513|364091218|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
105810930|NCT03384745|364962967|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
105810931|NCT03384745|364962962|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
105361245|NCT01278342|363328197|FG002|Overall Study|Other|0|||
105361246|NCT03200548|363328200|FG000|Overall Study|Withdrawal by Subject|5|||
105361247|NCT03200548|363328201|FG001|Overall Study|Withdrawal by Subject|11|||
105361248|NCT03200548|363328202|FG002|Overall Study|Withdrawal by Subject|7|||
105361249|NCT03200548|363328203|FG003|Overall Study|Withdrawal by Subject|6|||
105361250|NCT02427841|363328206|FG000|Overall Study|Lack of Efficacy|5|||
105361251|NCT02427841|363328206|FG000|Overall Study|Physician Decision|2|||
105361252|NCT02427841|363328206|FG000|Overall Study|Withdrawal by Subject|1|||
105361253|NCT03933449|363328209|FG000|Overall Study|Adverse Event|6|||
105361254|NCT03933449|363328210|FG001|Overall Study|Adverse Event|4|||
105361255|NCT03933449|363328209|FG000|Overall Study|Death|55|||
105361256|NCT03933449|363328210|FG001|Overall Study|Death|57|||
105361257|NCT03933449|363328209|FG000|Overall Study|Sponsor Decision|1|||
105361258|NCT03933449|363328210|FG001|Overall Study|Sponsor Decision|0|||
105361259|NCT01932697|363328211|FG000|Overall Study|Received a different amount of tx|1|||
105361260|NCT01932697|363328212|FG001|Overall Study|Received a different amount of tx|0|||
105361261|NCT01932697|363328211|FG000|Overall Study|Ineligible|1|||
105361262|NCT01932697|363328212|FG001|Overall Study|Ineligible|0|||
105361263|NCT05417412|363328213|FG000|Overall Study|Lost to Follow-up|2|||
105361264|NCT01841970|363328214|FG000|Overall Study|Withdrawal by Subject|1|||
105361265|NCT01841970|363328214|FG000|Overall Study|Physician Decision|2|||
105361266|NCT01841970|363328214|FG000|Overall Study|Lost to Follow-up|8|||
105361267|NCT02592447|363328215|FG000|Overall Study|Lost to Follow-up|1|||
105361268|NCT02592447|363328216|FG001|Overall Study|Lost to Follow-up|0|||
105361269|NCT02592447|363328215|FG000|Overall Study|Ineligible after randomization|1|||
105361270|NCT02592447|363328216|FG001|Overall Study|Ineligible after randomization|0|||
105810932|NCT03384745|364962963|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
105810933|NCT03384745|364962964|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
105810934|NCT03384745|364962965|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
105810935|NCT03384745|364962966|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
105810936|NCT03384745|364962967|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
105810937|NCT02739984|364962969|FG000|Overall Study|Sponsor Decision|1|||
105810938|NCT02739984|364962970|FG001|Overall Study|Sponsor Decision|0|||
105810939|NCT02739984|364962969|FG000|Overall Study|Withdrawal by Subject|1|||
105810940|NCT02739984|364962970|FG001|Overall Study|Withdrawal by Subject|1|||
105810941|NCT02739984|364962969|FG000|Overall Study|Death|0|||
105810942|NCT02739984|364962970|FG001|Overall Study|Death|1|||
105810943|NCT02739984|364962969|FG000|Overall Study|Lost to Follow-up|3|||
105810944|NCT02739984|364962970|FG001|Overall Study|Lost to Follow-up|0|||
105810945|NCT01054599|364962971|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
105361271|NCT02592447|363328215|FG000|Overall Study|Withdrawal by Subject|0|||
105361272|NCT02592447|363328216|FG001|Overall Study|Withdrawal by Subject|1|||
105361273|NCT03478371|363328217|FG000|Overall Study|non-compliance|1|||
105361274|NCT03478371|363328217|FG000|Overall Study|Lost to Follow-up|4|||
105361275|NCT04556760|363328218|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
105361276|NCT04556760|363328219|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
105361277|NCT04556760|363328220|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
105361278|NCT04556760|363328221|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
105361279|NCT04556760|363328222|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
105361280|NCT04556760|363328223|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
105361281|NCT04556760|363328218|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
105361282|NCT04556760|363328219|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
105361283|NCT04556760|363328220|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
105361284|NCT04556760|363328221|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
105361285|NCT04556760|363328222|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
105361286|NCT04556760|363328223|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
105361287|NCT01048541|363328234|FG000|Overall Study|Withdrawal by Subject|1|||
105361288|NCT01048541|363328235|FG001|Overall Study|Withdrawal by Subject|0|||
105361289|NCT00922116|363328236|FG000|Overall Study|Adverse Event|4|||
105361290|NCT00922116|363328236|FG000|Overall Study|Death|1|||
105361291|NCT00922116|363328236|FG000|Overall Study|Lost to Follow-up|1|||
105361292|NCT00922116|363328236|FG000|Overall Study|Withdrawal by Subject|4|||
105361293|NCT00922116|363328236|FG000|Overall Study|Other|5|||
105361294|NCT04607135|363328237|FG000|Overall Study|Physician Decision|1|||
105361295|NCT04607135|363328237|FG000|Overall Study|Withdrawal by Subject|1|||
105361296|NCT04607135|363328237|FG000|Overall Study|Equipment not working|3|||
105361297|NCT02143024|363328238|FG000|Overall Study|Lost to Follow-up|1|||
105361298|NCT02143024|363328239|FG001|Overall Study|Lost to Follow-up|1|||
105361299|NCT02143024|363328238|FG000|Overall Study|Withdrawal by Subject|1|||
105361300|NCT02143024|363328239|FG001|Overall Study|Withdrawal by Subject|0|||
105361301|NCT02346877|363328240|FG000|Overall Study|Adverse Event|1|||
105361302|NCT02346877|363328241|FG001|Overall Study|Adverse Event|0|||
105361303|NCT02346877|363328240|FG000|Overall Study|Administrative Decision|1|||
105361304|NCT02346877|363328241|FG001|Overall Study|Administrative Decision|0|||
105361305|NCT02346877|363328240|FG000|Overall Study|Sponsor Decision|12|||
105361306|NCT02346877|363328241|FG001|Overall Study|Sponsor Decision|0|||
105361307|NCT02346877|363328240|FG000|Overall Study|Missing|5|||
105361308|NCT02346877|363328241|FG001|Overall Study|Missing|0|||
105361309|NCT01683604|363328242|FG000|Overall Study|Adverse Event|2|||
105361310|NCT01683604|363328242|FG000|Overall Study|Lack of Efficacy|1|||
105361311|NCT01683604|363328242|FG000|Overall Study|Other|2|||
105361312|NCT04888494|363328243|FG000|Overall Study|Lost to Follow-up|2|||
105361313|NCT04888494|363328244|FG001|Overall Study|Lost to Follow-up|3|||
105361314|NCT04888494|363328243|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
105361315|NCT04888494|363328244|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
105361316|NCT00103285|363330047|FG000|Induction|Adverse Event|14|||
105361317|NCT00103285|363330048|FG001|Induction|Adverse Event|0|||
105361318|NCT00103285|363330049|FG002|Induction|Adverse Event|0|||
105361319|NCT00103285|363330050|FG003|Induction|Adverse Event|0|||
105361320|NCT00103285|363330051|FG004|Induction|Adverse Event|0|||
105361321|NCT00103285|363330052|FG005|Induction|Adverse Event|0|||
105762654|NCT00376246|364783158|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
105762655|NCT00376246|364783159|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
105762656|NCT00376246|364783158|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
105361322|NCT00103285|363330053|FG006|Induction|Adverse Event|0|||
105361323|NCT00103285|363330054|FG007|Induction|Adverse Event|0|||
105361324|NCT00103285|363330047|FG000|Induction|Death|24|||
105361325|NCT00103285|363330048|FG001|Induction|Death|0|||
105361326|NCT00103285|363330049|FG002|Induction|Death|0|||
105361327|NCT00103285|363330050|FG003|Induction|Death|0|||
105361328|NCT00103285|363330051|FG004|Induction|Death|0|||
105361329|NCT00103285|363330052|FG005|Induction|Death|0|||
105361330|NCT00103285|363330053|FG006|Induction|Death|0|||
105361331|NCT00103285|363330054|FG007|Induction|Death|0|||
105361332|NCT00103285|363330047|FG000|Induction|Physician Decision|103|||
105361333|NCT00103285|363330048|FG001|Induction|Physician Decision|0|||
105361334|NCT00103285|363330049|FG002|Induction|Physician Decision|0|||
105361335|NCT00103285|363330050|FG003|Induction|Physician Decision|0|||
105361336|NCT00103285|363330051|FG004|Induction|Physician Decision|0|||
105762657|NCT00376246|364783159|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
105762658|NCT00376246|364783158|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
105762659|NCT00376246|364783159|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
105361337|NCT00103285|363330052|FG005|Induction|Physician Decision|0|||
105361338|NCT00103285|363330053|FG006|Induction|Physician Decision|0|||
105361339|NCT00103285|363330054|FG007|Induction|Physician Decision|0|||
105762660|NCT01072448|364783164|FG000|Overall Study|Adverse Event|9|||
105810946|NCT01054599|364962972|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
105810947|NCT01054599|364962971|FG000|Overall Study|Protocol Violation|1|||
105810948|NCT01054599|364962972|FG001|Overall Study|Protocol Violation|0|||
105810949|NCT01054599|364962971|FG000|Overall Study|Spells/seizure-like episodes|1|||
105810950|NCT01054599|364962972|FG001|Overall Study|Spells/seizure-like episodes|1|||
105810951|NCT01054599|364962971|FG000|Overall Study|Timing/scheduling difficulties|1|||
105810952|NCT01054599|364962972|FG001|Overall Study|Timing/scheduling difficulties|1|||
105810953|NCT01054599|364962971|FG000|Overall Study|Visual impairment, WTAR <80|0|||
105810954|NCT01054599|364962972|FG001|Overall Study|Visual impairment, WTAR <80|1|||
105810955|NCT01054599|364962971|FG000|Overall Study|Lost to Follow-up|0|||
105810956|NCT01054599|364962972|FG001|Overall Study|Lost to Follow-up|2|||
105810957|NCT01054599|364962971|FG000|Overall Study|Adverse Event|0|||
105810958|NCT01054599|364962972|FG001|Overall Study|Adverse Event|1|||
105810959|NCT01054599|364962971|FG000|Overall Study|Withdrawal by Subject|0|||
105810960|NCT01054599|364962972|FG001|Overall Study|Withdrawal by Subject|1|||
105810961|NCT00475020|364962973|FG000|Overall Study|Physician Decision|3|||
105810962|NCT00475020|364962973|FG000|Overall Study|Insurance Denial|1|||
105810963|NCT00475020|364962973|FG000|Overall Study|Donor not able to donate the last minute|1|||
105810964|NCT03481309|364962977|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
105810965|NCT03481309|364962978|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
105810966|NCT03481309|364962979|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
105810967|NCT03481309|364962980|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
105810968|NCT03481309|364962981|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
105810969|NCT03481309|364962982|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
105810970|NCT00278200|364964851|FG000|Overall Study|Death|1|||
105810971|NCT00278200|364964852|FG001|Overall Study|Death|3|||
105810972|NCT00278200|364964851|FG000|Overall Study|Physician Decision|0|||
105485782|NCT02469038|363789618|FG000|Overall Study|Physician Decision|4|||
105485783|NCT02469038|363789619|FG001|Overall Study|Physician Decision|5|||
105485784|NCT00636987|363789622|FG000|Overall Study|Death|44|||
105485785|NCT00636987|363789622|FG000|Overall Study|Explanted|13|||
105485786|NCT00636987|363789622|FG000|Overall Study|Lost to Follow-up|63|||
105485787|NCT00636987|363789622|FG000|Overall Study|5 year visit window not complete|69|||
105485788|NCT03468543|363789623|FG000|Overall Study|Protocol stopping rules met|3|||
105485789|NCT04179890|363789624|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
105626665|NCT04167553|364298143|FG003|Overall Study|Withdrawal by Subject|2|||
105810973|NCT00278200|364964852|FG001|Overall Study|Physician Decision|1|||
105810974|NCT01691508|364964853|FG000|Overall Study|Adverse Event|3|||
105810975|NCT01691508|364964854|FG001|Overall Study|Adverse Event|3|||
105810976|NCT01691508|364964853|FG000|Overall Study|Withdrawal by Subject|1|||
105361340|NCT00103285|363330047|FG000|Induction|Withdrawal by Subject|1|||
105361341|NCT00103285|363330048|FG001|Induction|Withdrawal by Subject|0|||
105361342|NCT00103285|363330049|FG002|Induction|Withdrawal by Subject|0|||
105361343|NCT00103285|363330050|FG003|Induction|Withdrawal by Subject|0|||
105361344|NCT00103285|363330051|FG004|Induction|Withdrawal by Subject|0|||
105361345|NCT00103285|363330052|FG005|Induction|Withdrawal by Subject|0|||
105361346|NCT00103285|363330053|FG006|Induction|Withdrawal by Subject|0|||
105361347|NCT00103285|363330054|FG007|Induction|Withdrawal by Subject|0|||
105361348|NCT00103285|363330047|FG000|Induction|Ineligible|43|||
105361349|NCT00103285|363330048|FG001|Induction|Ineligible|0|||
105361350|NCT00103285|363330049|FG002|Induction|Ineligible|0|||
105361351|NCT00103285|363330050|FG003|Induction|Ineligible|0|||
105361352|NCT00103285|363330051|FG004|Induction|Ineligible|0|||
105361353|NCT00103285|363330052|FG005|Induction|Ineligible|0|||
105361354|NCT00103285|363330053|FG006|Induction|Ineligible|0|||
105361355|NCT00103285|363330054|FG007|Induction|Ineligible|0|||
105361356|NCT00103285|363330047|FG000|Induction|Refusal|906|||
105361357|NCT00103285|363330048|FG001|Induction|Refusal|0|||
105361358|NCT00103285|363330049|FG002|Induction|Refusal|0|||
105361359|NCT00103285|363330050|FG003|Induction|Refusal|0|||
105361360|NCT00103285|363330051|FG004|Induction|Refusal|0|||
105571472|NCT02307513|364091219|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
105361361|NCT00103285|363330052|FG005|Induction|Refusal|0|||
105361362|NCT00103285|363330053|FG006|Induction|Refusal|0|||
105361363|NCT00103285|363330054|FG007|Induction|Refusal|0|||
105810977|NCT01691508|364964854|FG001|Overall Study|Withdrawal by Subject|0|||
105810978|NCT02322047|364964860|FG000|Overall Study|Physician Decision|1|||
105810979|NCT02322047|364964861|FG001|Overall Study|Physician Decision|0|||
105810980|NCT02322047|364964862|FG002|Overall Study|Physician Decision|0|||
105810981|NCT02322047|364964863|FG003|Overall Study|Physician Decision|0|||
105810982|NCT02322047|364964860|FG000|Overall Study|Withdrawal by Subject|1|||
105810983|NCT02322047|364964861|FG001|Overall Study|Withdrawal by Subject|0|||
105810984|NCT02322047|364964862|FG002|Overall Study|Withdrawal by Subject|0|||
105810985|NCT02322047|364964863|FG003|Overall Study|Withdrawal by Subject|1|||
105810986|NCT02322047|364964860|FG000|Overall Study|Adverse Event|0|||
105810987|NCT02322047|364964861|FG001|Overall Study|Adverse Event|1|||
105810988|NCT02322047|364964862|FG002|Overall Study|Adverse Event|0|||
105810989|NCT02322047|364964863|FG003|Overall Study|Adverse Event|0|||
105810990|NCT02322047|364964860|FG000|Overall Study|Lost to Follow-up|0|||
105810991|NCT02322047|364964861|FG001|Overall Study|Lost to Follow-up|0|||
105810992|NCT02322047|364964862|FG002|Overall Study|Lost to Follow-up|1|||
105810993|NCT02322047|364964863|FG003|Overall Study|Lost to Follow-up|1|||
105810994|NCT05431153|364964864|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105810995|NCT05431153|364964865|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105810996|NCT05431153|364964866|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105810997|NCT05431153|364964867|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105810998|NCT05431153|364964868|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
105810999|NCT05431153|364964869|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105811000|NCT02623959|364964875|FG000|Overall Study|Progression|0|||
105811001|NCT02623959|364964876|FG001|Overall Study|Progression|1|||
105811002|NCT00135707|364964879|FG000|Overall Study|Lost to Follow-up|94|||
105811003|NCT00135707|364964880|FG001|Overall Study|Lost to Follow-up|89|||
105811004|NCT00135707|364964879|FG000|Overall Study|Withdrawal by Subject|0|||
105811005|NCT00135707|364964880|FG001|Overall Study|Withdrawal by Subject|1|||
105811006|NCT00135707|364964879|FG000|Overall Study|Institutional review board request|1|||
105811007|NCT00135707|364964880|FG001|Overall Study|Institutional review board request|0|||
105811008|NCT03093454|364964881|FG000|Overall Study|Withdrawal by Subject|1|||
105811009|NCT03093454|364964882|FG001|Overall Study|Withdrawal by Subject|1|||
105811010|NCT03093454|364964881|FG000|Overall Study|Scheduling conflict|3|||
105811011|NCT03093454|364964882|FG001|Overall Study|Scheduling conflict|1|||
105811012|NCT03093454|364964881|FG000|Overall Study|Physician Decision|2|||
105811013|NCT03093454|364964882|FG001|Overall Study|Physician Decision|1|||
105811014|NCT00421174|364964886|FG000|Overall Study|Withdrawal by Subject|0|||
105811015|NCT00421174|364964887|FG001|Overall Study|Withdrawal by Subject|1|||
105811016|NCT00421174|364964886|FG000|Overall Study|Ineligible due to infection|2|||
105811017|NCT00421174|364964887|FG001|Overall Study|Ineligible due to infection|0|||
105811018|NCT02524379|364964888|FG000|Overall Study|Death|1|||
105811019|NCT02016300|364964890|FG000|Overall Study|Lost to Follow-up|0|||
105811020|NCT02016300|364964891|FG001|Overall Study|Lost to Follow-up|3|||
105811021|NCT02309099|364964892|FG000|Overall Study|Adverse Event|2|||
105811022|NCT02309099|364964893|FG001|Overall Study|Adverse Event|0|||
105811023|NCT00356200|364964894|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
105811024|NCT00356200|364964895|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
105811025|NCT00356200|364964894|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
105811026|NCT00356200|364964895|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
105811027|NCT01545076|364964896|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
105811028|NCT01545076|364964897|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
105811029|NCT01545076|364964898|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
105811030|NCT01545076|364964899|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
105811031|NCT01545076|364964900|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
105811032|NCT01545076|364964896|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
105811033|NCT01545076|364964897|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
105811034|NCT01545076|364964898|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
105811035|NCT01545076|364964899|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
105811036|NCT01545076|364964900|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
105811037|NCT01545076|364964896|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
105811038|NCT01545076|364964897|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
105811039|NCT01545076|364964898|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
105811040|NCT01545076|364964899|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
105811041|NCT01545076|364964900|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
105811042|NCT01545076|364964896|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
105811043|NCT01545076|364964897|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
105811044|NCT01545076|364964898|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
105361364|NCT00103285|363330047|FG000|Induction|Other|258|||
105361365|NCT00103285|363330048|FG001|Induction|Other|0|||
105361366|NCT00103285|363330049|FG002|Induction|Other|0|||
105361367|NCT00103285|363330050|FG003|Induction|Other|0|||
105361368|NCT00103285|363330051|FG004|Induction|Other|0|||
105361369|NCT00103285|363330052|FG005|Induction|Other|0|||
105361370|NCT00103285|363330053|FG006|Induction|Other|0|||
105361371|NCT00103285|363330054|FG007|Induction|Other|0|||
105361372|NCT00103285|363330047|FG000|Response Assignment|Adverse Event|0|||
105361373|NCT00103285|363330048|FG001|Response Assignment|Adverse Event|8|||
105361374|NCT00103285|363330049|FG002|Response Assignment|Adverse Event|3|||
105361375|NCT00103285|363330050|FG003|Response Assignment|Adverse Event|2|||
105361376|NCT00103285|363330051|FG004|Response Assignment|Adverse Event|3|||
105361377|NCT00103285|363330052|FG005|Response Assignment|Adverse Event|1|||
105361378|NCT00103285|363330053|FG006|Response Assignment|Adverse Event|1|||
105361379|NCT00103285|363330054|FG007|Response Assignment|Adverse Event|2|||
105361380|NCT00103285|363330047|FG000|Response Assignment|Death|0|||
105361381|NCT00103285|363330048|FG001|Response Assignment|Death|5|||
105361382|NCT00103285|363330049|FG002|Response Assignment|Death|2|||
105361383|NCT00103285|363330050|FG003|Response Assignment|Death|2|||
105361384|NCT00103285|363330051|FG004|Response Assignment|Death|3|||
105361385|NCT00103285|363330052|FG005|Response Assignment|Death|1|||
105361386|NCT00103285|363330053|FG006|Response Assignment|Death|0|||
105361387|NCT00103285|363330054|FG007|Response Assignment|Death|8|||
105361388|NCT00103285|363330047|FG000|Response Assignment|Lost to Follow-up|0|||
105361389|NCT00103285|363330048|FG001|Response Assignment|Lost to Follow-up|9|||
105361390|NCT00103285|363330049|FG002|Response Assignment|Lost to Follow-up|5|||
105361391|NCT00103285|363330050|FG003|Response Assignment|Lost to Follow-up|5|||
105361392|NCT00103285|363330051|FG004|Response Assignment|Lost to Follow-up|1|||
105361393|NCT00103285|363330052|FG005|Response Assignment|Lost to Follow-up|2|||
105361394|NCT00103285|363330053|FG006|Response Assignment|Lost to Follow-up|2|||
105361395|NCT00103285|363330054|FG007|Response Assignment|Lost to Follow-up|5|||
105361396|NCT00103285|363330047|FG000|Response Assignment|Physician Decision|0|||
105361397|NCT00103285|363330048|FG001|Response Assignment|Physician Decision|13|||
105361398|NCT00103285|363330049|FG002|Response Assignment|Physician Decision|14|||
105361399|NCT00103285|363330050|FG003|Response Assignment|Physician Decision|9|||
105361400|NCT00103285|363330051|FG004|Response Assignment|Physician Decision|13|||
105361401|NCT00103285|363330052|FG005|Response Assignment|Physician Decision|7|||
105361402|NCT00103285|363330053|FG006|Response Assignment|Physician Decision|4|||
105361403|NCT00103285|363330054|FG007|Response Assignment|Physician Decision|35|||
105361404|NCT00103285|363330047|FG000|Response Assignment|Protocol Violation|0|||
105485790|NCT04179890|363789625|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
105485791|NCT04179890|363789624|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
105485792|NCT04179890|363789625|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
105762661|NCT01072448|364783165|FG001|Overall Study|Adverse Event|10|||
105361405|NCT00103285|363330048|FG001|Response Assignment|Protocol Violation|2|||
105361406|NCT00103285|363330049|FG002|Response Assignment|Protocol Violation|0|||
105361407|NCT00103285|363330050|FG003|Response Assignment|Protocol Violation|0|||
105361408|NCT00103285|363330051|FG004|Response Assignment|Protocol Violation|0|||
105361409|NCT00103285|363330052|FG005|Response Assignment|Protocol Violation|0|||
105361410|NCT00103285|363330053|FG006|Response Assignment|Protocol Violation|0|||
105361411|NCT00103285|363330054|FG007|Response Assignment|Protocol Violation|0|||
105361412|NCT00103285|363330047|FG000|Response Assignment|Withdrawal by Subject|0|||
105361413|NCT00103285|363330048|FG001|Response Assignment|Withdrawal by Subject|4|||
105361414|NCT00103285|363330049|FG002|Response Assignment|Withdrawal by Subject|1|||
105361415|NCT00103285|363330050|FG003|Response Assignment|Withdrawal by Subject|1|||
105361416|NCT00103285|363330051|FG004|Response Assignment|Withdrawal by Subject|2|||
105361417|NCT00103285|363330052|FG005|Response Assignment|Withdrawal by Subject|2|||
105361418|NCT00103285|363330053|FG006|Response Assignment|Withdrawal by Subject|0|||
105361419|NCT00103285|363330054|FG007|Response Assignment|Withdrawal by Subject|2|||
105361420|NCT00103285|363330047|FG000|Response Assignment|Ineligible|0|||
105361421|NCT00103285|363330048|FG001|Response Assignment|Ineligible|8|||
105361422|NCT00103285|363330049|FG002|Response Assignment|Ineligible|6|||
105361423|NCT00103285|363330050|FG003|Response Assignment|Ineligible|2|||
105361424|NCT00103285|363330051|FG004|Response Assignment|Ineligible|0|||
105485793|NCT04179890|363789624|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
105811045|NCT01545076|364964899|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
105811046|NCT01545076|364964900|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
105811047|NCT01545076|364964896|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
105811048|NCT01545076|364964897|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
105811049|NCT01545076|364964898|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
105811050|NCT01545076|364964899|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
105811051|NCT01545076|364964900|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
105811052|NCT01545076|364964896|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
105811053|NCT01545076|364964897|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
105811054|NCT01545076|364964898|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
105811055|NCT01545076|364964899|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
105811056|NCT01545076|364964900|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
105811057|NCT01545076|364964896|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
105811058|NCT01545076|364964897|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
105811059|NCT01545076|364964898|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
105811060|NCT01545076|364964899|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
105811061|NCT01545076|364964900|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
105811062|NCT01545076|364964896|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
105811063|NCT01545076|364964897|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
105811064|NCT01545076|364964898|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
105811065|NCT01545076|364964899|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
105811066|NCT01545076|364964900|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
105811067|NCT01545076|364964896|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
105811068|NCT01545076|364964897|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
105811069|NCT01545076|364964898|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
105811070|NCT01545076|364964899|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
105811071|NCT01545076|364964900|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
105811072|NCT02518113|364964901|FG000|Overall Study|Adverse Event|1|||
105361425|NCT00103285|363330052|FG005|Response Assignment|Ineligible|3|||
105361426|NCT00103285|363330053|FG006|Response Assignment|Ineligible|1|||
105485794|NCT04179890|363789625|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
105485795|NCT04179890|363789624|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
105485796|NCT04179890|363789625|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
105485797|NCT04179890|363789624|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
105485798|NCT04179890|363789625|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
105485799|NCT04179890|363789624|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
105485800|NCT04179890|363789625|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
105485801|NCT04179890|363789624|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
105485802|NCT04179890|363789625|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
105485803|NCT04179890|363789624|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
105485804|NCT04179890|363789625|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
105811073|NCT02518113|364964902|FG001|Overall Study|Adverse Event|0|||
105811074|NCT02518113|364964903|FG002|Overall Study|Adverse Event|1|||
105361427|NCT00103285|363330054|FG007|Response Assignment|Ineligible|5|||
105361428|NCT00103285|363330047|FG000|Response Assignment|Refusal|0|||
105361429|NCT00103285|363330048|FG001|Response Assignment|Refusal|53|||
105361430|NCT00103285|363330049|FG002|Response Assignment|Refusal|5|||
105361431|NCT00103285|363330050|FG003|Response Assignment|Refusal|3|||
105361432|NCT00103285|363330051|FG004|Response Assignment|Refusal|25|||
105361433|NCT00103285|363330052|FG005|Response Assignment|Refusal|15|||
105361434|NCT00103285|363330053|FG006|Response Assignment|Refusal|30|||
105361435|NCT00103285|363330054|FG007|Response Assignment|Refusal|10|||
105361436|NCT00103285|363330047|FG000|Response Assignment|Other|0|||
105361437|NCT00103285|363330048|FG001|Response Assignment|Other|30|||
105361438|NCT00103285|363330049|FG002|Response Assignment|Other|48|||
105762662|NCT01072448|364783164|FG000|Overall Study|Subject withdrew consent|4|||
105762663|NCT01072448|364783165|FG001|Overall Study|Subject withdrew consent|9|||
105762664|NCT01072448|364783164|FG000|Overall Study|Protocol deviation|3|||
105762665|NCT01072448|364783165|FG001|Overall Study|Protocol deviation|4|||
105762666|NCT01072448|364783164|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105762667|NCT01072448|364783165|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105762668|NCT01072448|364783164|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105762669|NCT01072448|364783165|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105762670|NCT01072448|364783164|FG000|Overall Study|Lost to Follow-up|1|||
105762671|NCT01072448|364783165|FG001|Overall Study|Lost to Follow-up|1|||
105762672|NCT01072448|364783164|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105762673|NCT01072448|364783165|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105762674|NCT01072448|364783164|FG000|Overall Study|Death|0|||
105762675|NCT01072448|364783165|FG001|Overall Study|Death|2|||
105762676|NCT01400139|364783166|FG000|HYD Core Study|Adverse Event|210|||
105762677|NCT01400139|364783166|FG000|HYD Core Study|Lack of Efficacy|59|||
105762678|NCT01400139|364783166|FG000|HYD Core Study|Withdrawal by Subject|114|||
105762679|NCT01400139|364783166|FG000|HYD Core Study|Lost to Follow-up|39|||
105762680|NCT01400139|364783166|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
105762681|NCT01400139|364783166|FG000|HYD Core Study|Administrative|56|||
105762682|NCT01400139|364783166|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
105762683|NCT01400139|364783166|FG000|HYD Extension Period|Adverse Event|8|||
105762684|NCT01400139|364783166|FG000|HYD Extension Period|Withdrawal by Subject|5|||
105762685|NCT01400139|364783166|FG000|HYD Extension Period|Administrative|10|||
105762686|NCT00249795|364783167|FG000|Overall Study|Not treated|16|||
105762687|NCT00249795|364783168|FG001|Overall Study|Not treated|14|||
105762688|NCT00249795|364783167|FG000|Overall Study|Symptomatic hypotension|127|||
105762689|NCT00249795|364783168|FG001|Overall Study|Symptomatic hypotension|64|||
105762690|NCT00249795|364783167|FG000|Overall Study|Other Serious Adverse Event|84|||
105762691|NCT00249795|364783168|FG001|Overall Study|Other Serious Adverse Event|93|||
105762692|NCT00249795|364783167|FG000|Overall Study|Qualifying condition not present|26|||
105762693|NCT00249795|364783168|FG001|Overall Study|Qualifying condition not present|29|||
105762694|NCT00249795|364783167|FG000|Overall Study|Withdrawal by Subject|678|||
105762695|NCT00249795|364783168|FG001|Overall Study|Withdrawal by Subject|742|||
105762696|NCT00249795|364783167|FG000|Overall Study|Thromboembolic / outcome event|39|||
105762697|NCT00249795|364783168|FG001|Overall Study|Thromboembolic / outcome event|45|||
105762698|NCT00249795|364783167|FG000|Overall Study|Oral anticoagulant required|2|||
105762699|NCT00249795|364783168|FG001|Overall Study|Oral anticoagulant required|0|||
105762700|NCT00249795|364783167|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
105762701|NCT00249795|364783168|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
105762702|NCT00249795|364783167|FG000|Overall Study|Non-compliance|71|||
105762703|NCT00249795|364783168|FG001|Overall Study|Non-compliance|69|||
105762704|NCT00249795|364783167|FG000|Overall Study|Study drug intolerance|3|||
105762705|NCT00249795|364783168|FG001|Overall Study|Study drug intolerance|3|||
105762706|NCT00249795|364783167|FG000|Overall Study|Other adverse events (non-serious)|188|||
105762707|NCT00249795|364783168|FG001|Overall Study|Other adverse events (non-serious)|159|||
105762708|NCT00249795|364783167|FG000|Overall Study|Physician withdrew consent|71|||
105762709|NCT00249795|364783168|FG001|Overall Study|Physician withdrew consent|63|||
105762710|NCT00249795|364783167|FG000|Overall Study|Surgery / procedure|4|||
105762711|NCT00249795|364783168|FG001|Overall Study|Surgery / procedure|5|||
105361439|NCT00103285|363330050|FG003|Response Assignment|Other|38|||
105762712|NCT00249795|364783167|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
105811075|NCT02518113|364964904|FG003|Overall Study|Adverse Event|0|||
105811076|NCT02518113|364964901|FG000|Overall Study|Death|1|||
105811077|NCT02518113|364964902|FG001|Overall Study|Death|2|||
105811078|NCT02518113|364964903|FG002|Overall Study|Death|0|||
105811079|NCT02518113|364964904|FG003|Overall Study|Death|0|||
105811080|NCT02518113|364964901|FG000|Overall Study|Physician Decision|0|||
105811081|NCT02518113|364964902|FG001|Overall Study|Physician Decision|1|||
105811082|NCT02518113|364964903|FG002|Overall Study|Physician Decision|0|||
105811083|NCT02518113|364964904|FG003|Overall Study|Physician Decision|0|||
105811084|NCT02518113|364964901|FG000|Overall Study|Progressive Disease|1|||
105811085|NCT02518113|364964902|FG001|Overall Study|Progressive Disease|2|||
105811086|NCT02518113|364964903|FG002|Overall Study|Progressive Disease|3|||
105811087|NCT02518113|364964904|FG003|Overall Study|Progressive Disease|0|||
105811088|NCT00561730|364964913|FG000|Overall Study|Adverse Event|2|||
105811089|NCT00561730|364964913|FG000|Overall Study|Handling of the drug|1|||
105811090|NCT00561730|364964913|FG000|Overall Study|Lost to Follow-up|5|||
105811091|NCT00561730|364964913|FG000|Overall Study|Not specified reasons|1|||
105811092|NCT00527423|364964918|FG000|Overall Study|Protocol Violation|1|||
105571473|NCT02307513|364091218|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
105811093|NCT00527423|364964918|FG000|Overall Study|Adverse Event|5|||
105811094|NCT00527423|364964918|FG000|Overall Study|Physician Decision|4|||
105811095|NCT00527423|364964918|FG000|Overall Study|Withdrawal by Subject|10|||
105811096|NCT00527423|364964918|FG000|Overall Study|Lost to Follow-up|4|||
105811097|NCT00527423|364964918|FG000|Overall Study|OTHER|4|||
105811098|NCT00527423|364964918|FG000|Overall Study|Death|9|||
105811099|NCT02750761|364964925|FG000|Overall Study|Lost to Follow-up|0|||
105811100|NCT02750761|364964926|FG001|Overall Study|Lost to Follow-up|0|||
105811101|NCT02750761|364964927|FG002|Overall Study|Lost to Follow-up|1|||
105811102|NCT02750761|364964928|FG003|Overall Study|Lost to Follow-up|0|||
105811103|NCT02750761|364964929|FG004|Overall Study|Lost to Follow-up|0|||
105811104|NCT02750761|364964930|FG005|Overall Study|Lost to Follow-up|0|||
105811105|NCT02906709|364964931|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
105811106|NCT02906709|364964932|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
105811107|NCT02906709|364964931|FG000|Phase A (Week 0 to Week 16)|Death|0|||
105811108|NCT02906709|364964932|FG001|Phase A (Week 0 to Week 16)|Death|1|||
105811109|NCT02906709|364964931|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
105811110|NCT02906709|364964932|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
105811111|NCT02906709|364964931|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
105811112|NCT02906709|364964932|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
105811113|NCT03331042|364964934|FG000|Overall Study|Protocol Violation|1|||
105811114|NCT03331042|364964935|FG001|Overall Study|Protocol Violation|0|||
105811115|NCT03331042|364964936|FG002|Overall Study|Protocol Violation|0|||
105811116|NCT03331042|364964937|FG003|Overall Study|Protocol Violation|0|||
105811117|NCT03331042|364964934|FG000|Overall Study|Physician Decision|0|||
105811118|NCT03331042|364964935|FG001|Overall Study|Physician Decision|0|||
105811119|NCT03331042|364964936|FG002|Overall Study|Physician Decision|1|||
105811120|NCT03331042|364964937|FG003|Overall Study|Physician Decision|0|||
105811121|NCT03331042|364964934|FG000|Overall Study|Lost to Follow-up|0|||
105811122|NCT03331042|364964935|FG001|Overall Study|Lost to Follow-up|0|||
105811123|NCT03331042|364964936|FG002|Overall Study|Lost to Follow-up|0|||
105485805|NCT04179890|363789624|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
105485806|NCT04179890|363789625|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
105485807|NCT01653782|363789630|FG000|Overall Study|Withdrawal by Subject|9|||
105485808|NCT01653782|363789631|FG001|Overall Study|Withdrawal by Subject|15|||
105485809|NCT01653782|363789632|FG002|Overall Study|Withdrawal by Subject|4|||
105485810|NCT01653782|363789630|FG000|Overall Study|Lost to Follow-up|7|||
105811124|NCT03331042|364964937|FG003|Overall Study|Lost to Follow-up|1|||
105811125|NCT00623103|364964938|FG000|Overall Study|Adverse Event|70|||
105811126|NCT00623103|364964939|FG001|Overall Study|Adverse Event|60|||
105811127|NCT00623103|364964938|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105811128|NCT00623103|364964939|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
105811129|NCT00623103|364964938|FG000|Overall Study|Withdrawal by Subject|18|||
105811130|NCT00623103|364964939|FG001|Overall Study|Withdrawal by Subject|24|||
105811131|NCT00623103|364964938|FG000|Overall Study|Lost to Follow-up|4|||
105811132|NCT00623103|364964939|FG001|Overall Study|Lost to Follow-up|1|||
105811133|NCT00623103|364964938|FG000|Overall Study|Administrative problems|2|||
105361440|NCT00103285|363330051|FG004|Response Assignment|Other|37|||
105361441|NCT00103285|363330052|FG005|Response Assignment|Other|17|||
105361442|NCT00103285|363330053|FG006|Response Assignment|Other|11|||
105361443|NCT00103285|363330054|FG007|Response Assignment|Other|53|||
105811134|NCT00623103|364964939|FG001|Overall Study|Administrative problems|4|||
105811135|NCT00623103|364964938|FG000|Overall Study|Death|11|||
105811136|NCT00623103|364964939|FG001|Overall Study|Death|11|||
105811137|NCT00623103|364964938|FG000|Overall Study|Protocol deviation|2|||
105811138|NCT00623103|364964939|FG001|Overall Study|Protocol deviation|1|||
105811139|NCT01215942|364964951|FG000|Treatment Period|Adverse Event|15|||
105811140|NCT01215942|364964952|FG001|Treatment Period|Adverse Event|26|||
105811141|NCT01215942|364964951|FG000|Treatment Period|Death|2|||
105811142|NCT01215942|364964952|FG001|Treatment Period|Death|4|||
105811143|NCT01215942|364964951|FG000|Treatment Period|Lack of Efficacy|23|||
105811144|NCT01215942|364964952|FG001|Treatment Period|Lack of Efficacy|62|||
105811145|NCT01215942|364964951|FG000|Treatment Period|Lost to Follow-up|3|||
105811146|NCT01215942|364964952|FG001|Treatment Period|Lost to Follow-up|4|||
105811147|NCT01215942|364964951|FG000|Treatment Period|Withdrawal by Subject|17|||
105811148|NCT01215942|364964952|FG001|Treatment Period|Withdrawal by Subject|40|||
105811149|NCT01215942|364964951|FG000|Treatment Period|Physician Decision|5|||
105811150|NCT01215942|364964952|FG001|Treatment Period|Physician Decision|5|||
105811151|NCT01215942|364964951|FG000|Treatment Period|Protocol Violation|0|||
105811152|NCT01215942|364964952|FG001|Treatment Period|Protocol Violation|1|||
105811153|NCT01215942|364964951|FG000|Treatment Period|Sponsor Decision|349|||
105811154|NCT01215942|364964952|FG001|Treatment Period|Sponsor Decision|530|||
105811155|NCT01215942|364964951|FG000|Post-Treatment Follow-Up Period|Death|0|||
105811156|NCT01215942|364964952|FG001|Post-Treatment Follow-Up Period|Death|1|||
105811157|NCT01215942|364964951|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
105811158|NCT01215942|364964952|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
105811159|NCT01215942|364964951|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
105811160|NCT01215942|364964952|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
105811161|NCT01215942|364964951|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
105811162|NCT01215942|364964952|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
105811163|NCT01215942|364964951|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
105811164|NCT01215942|364964952|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
105811165|NCT01193608|364964953|FG000|Overall Study|Other|0|||
105811166|NCT01193608|364964954|FG001|Overall Study|Other|1|||
105811167|NCT01193608|364964955|FG002|Overall Study|Other|0|||
105811168|NCT01193608|364964956|FG003|Overall Study|Other|0|||
105811169|NCT01193608|364964957|FG004|Overall Study|Other|0|||
105811170|NCT01193608|364964958|FG005|Overall Study|Other|0|||
105361444|NCT01381926|363330057|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
105361445|NCT01381926|363330058|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
105361446|NCT01381926|363330057|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
105361447|NCT01381926|363330058|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
105361448|NCT01845597|363330060|FG000|Overall Study|Death|8|||
105361449|NCT01845597|363330060|FG000|Overall Study|Lost to Follow-up|22|||
105361450|NCT01877668|363330063|FG000|Overall Study|Death|0|||
105361451|NCT01877668|363330064|FG001|Overall Study|Death|0|||
105361452|NCT01877668|363330065|FG002|Overall Study|Death|0|||
105811171|NCT01193608|364964953|FG000|Overall Study|Withdrawal by Subject|0|||
105811172|NCT01193608|364964954|FG001|Overall Study|Withdrawal by Subject|1|||
105361453|NCT01877668|363330066|FG003|Overall Study|Death|1|||
105361454|NCT01877668|363330067|FG004|Overall Study|Death|0|||
105361455|NCT01877668|363330063|FG000|Overall Study|No longer met study criteria|1|||
105361456|NCT01877668|363330064|FG001|Overall Study|No longer met study criteria|0|||
105361457|NCT01877668|363330065|FG002|Overall Study|No longer met study criteria|1|||
105361458|NCT01877668|363330066|FG003|Overall Study|No longer met study criteria|0|||
105361459|NCT01877668|363330067|FG004|Overall Study|No longer met study criteria|0|||
105361460|NCT01877668|363330063|FG000|Overall Study|Insufficient clinical response|0|||
105361461|NCT01877668|363330064|FG001|Overall Study|Insufficient clinical response|1|||
105485811|NCT01653782|363789631|FG001|Overall Study|Lost to Follow-up|3|||
105485812|NCT01653782|363789632|FG002|Overall Study|Lost to Follow-up|2|||
105485813|NCT02677324|363789637|FG000|Overall Study|Disease Progression|6|||
105361462|NCT01877668|363330065|FG002|Overall Study|Insufficient clinical response|2|||
105361463|NCT01877668|363330066|FG003|Overall Study|Insufficient clinical response|2|||
105361464|NCT01877668|363330067|FG004|Overall Study|Insufficient clinical response|0|||
105361465|NCT01877668|363330063|FG000|Overall Study|Lost to Follow-up|0|||
105811173|NCT01193608|364964955|FG002|Overall Study|Withdrawal by Subject|2|||
105811174|NCT01193608|364964956|FG003|Overall Study|Withdrawal by Subject|3|||
105811175|NCT01193608|364964957|FG004|Overall Study|Withdrawal by Subject|3|||
105811176|NCT01193608|364964958|FG005|Overall Study|Withdrawal by Subject|0|||
105485814|NCT02677324|363789637|FG000|Overall Study|Inability to Swallow pills|1|||
105811177|NCT01193608|364964953|FG000|Overall Study|Lost to Follow-up|0|||
105811178|NCT01193608|364964954|FG001|Overall Study|Lost to Follow-up|0|||
105811179|NCT01193608|364964955|FG002|Overall Study|Lost to Follow-up|0|||
105361466|NCT01877668|363330064|FG001|Overall Study|Lost to Follow-up|2|||
105571474|NCT02307513|364091219|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
105571475|NCT02307513|364091218|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
105571476|NCT02307513|364091219|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
105571477|NCT02307513|364091218|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
105571478|NCT02307513|364091219|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
105762713|NCT00249795|364783168|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
105762714|NCT00249795|364783167|FG000|Overall Study|Lightheadedness / dizziness|15|||
105762715|NCT00249795|364783168|FG001|Overall Study|Lightheadedness / dizziness|11|||
105762716|NCT00249795|364783167|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
105762717|NCT00249795|364783168|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
105762718|NCT00249795|364783167|FG000|Overall Study|Other contraindicated medication|1|||
105762719|NCT00249795|364783168|FG001|Overall Study|Other contraindicated medication|1|||
105762720|NCT00249795|364783167|FG000|Overall Study|Event related to cardiac condition|17|||
105762721|NCT00249795|364783168|FG001|Overall Study|Event related to cardiac condition|16|||
105762722|NCT00249795|364783167|FG000|Overall Study|Patient not wish to continue after May08|4|||
105762723|NCT00249795|364783168|FG001|Overall Study|Patient not wish to continue after May08|6|||
105762724|NCT00249795|364783167|FG000|Overall Study|Site not agree to continue after May08|1|||
105762725|NCT00249795|364783168|FG001|Overall Study|Site not agree to continue after May08|1|||
105762726|NCT00249795|364783167|FG000|Overall Study|Lost to Follow-up|0|||
105762727|NCT00249795|364783168|FG001|Overall Study|Lost to Follow-up|2|||
105762728|NCT00249795|364783167|FG000|Overall Study|Missing|0|||
105762729|NCT00249795|364783168|FG001|Overall Study|Missing|1|||
105762730|NCT01142193|364783169|FG000|Overall Study|Adverse Event|12|||
105762731|NCT01142193|364783170|FG001|Overall Study|Adverse Event|4|||
105762732|NCT01142193|364783169|FG000|Overall Study|Lack of Efficacy|2|||
105762733|NCT01142193|364783170|FG001|Overall Study|Lack of Efficacy|1|||
105762734|NCT01142193|364783169|FG000|Overall Study|Physician Decision|1|||
105762735|NCT01142193|364783170|FG001|Overall Study|Physician Decision|1|||
105762736|NCT01142193|364783169|FG000|Overall Study|Withdrawal by Subject|4|||
105762737|NCT01142193|364783170|FG001|Overall Study|Withdrawal by Subject|3|||
105762738|NCT01142193|364783169|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
105762739|NCT01142193|364783170|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
105762740|NCT01142193|364783169|FG000|Overall Study|Other|1|||
105762741|NCT01142193|364783170|FG001|Overall Study|Other|2|||
105762742|NCT01425749|364783173|FG000|Overall Study|progression of melanoma|0|||
105762743|NCT01425749|364783174|FG001|Overall Study|progression of melanoma|1|||
105762744|NCT02910219|364783175|FG000|Overall Study|Withdrawal by Subject|1|||
105762745|NCT02910219|364783176|FG001|Overall Study|Withdrawal by Subject|1|||
105762746|NCT01293084|364783177|FG000|Overall Study|Physician Decision|3|||
105762747|NCT01293084|364783177|FG000|Overall Study|Withdrawal by Subject|2|||
105762748|NCT00701441|364783178|FG000|Overall Study|failure in cpap compliance|0|||
105762749|NCT00701441|364783179|FG001|Overall Study|failure in cpap compliance|4|||
105762750|NCT01015820|364783180|FG000|Overall Study|Suboptimal measurements|1|||
105762751|NCT01015820|364783181|FG001|Overall Study|Suboptimal measurements|0|||
105762752|NCT00718523|364783189|FG000|Overall Study|Withdrawal by Subject|5|||
105762753|NCT00718523|364783190|FG001|Overall Study|Withdrawal by Subject|7|||
105762754|NCT00718523|364783189|FG000|Overall Study|Death|13|||
105762755|NCT00718523|364783190|FG001|Overall Study|Death|17|||
105762756|NCT01313078|364783191|FG000|Overall Study|Death|1|||
105762757|NCT01313078|364783191|FG000|Overall Study|Discontinued study drug|1|||
105762758|NCT01313078|364783191|FG000|Overall Study|Withdrawal by Subject|1|||
105762759|NCT03365947|364783192|FG000|Overall Study|Lost to Follow-up|0|||
105762760|NCT03365947|364783193|FG001|Overall Study|Lost to Follow-up|0|||
105361467|NCT01877668|363330065|FG002|Overall Study|Lost to Follow-up|1|||
105361468|NCT01877668|363330066|FG003|Overall Study|Lost to Follow-up|0|||
105361469|NCT01877668|363330067|FG004|Overall Study|Lost to Follow-up|0|||
105361470|NCT01877668|363330063|FG000|Overall Study|Withdrawal by Subject|2|||
105361471|NCT01877668|363330064|FG001|Overall Study|Withdrawal by Subject|0|||
105361472|NCT01877668|363330065|FG002|Overall Study|Withdrawal by Subject|3|||
105361473|NCT01877668|363330066|FG003|Overall Study|Withdrawal by Subject|2|||
105361474|NCT01877668|363330067|FG004|Overall Study|Withdrawal by Subject|2|||
105361475|NCT01877668|363330063|FG000|Overall Study|Other|1|||
105361476|NCT01877668|363330064|FG001|Overall Study|Other|1|||
105361477|NCT01877668|363330065|FG002|Overall Study|Other|1|||
105361478|NCT01877668|363330066|FG003|Overall Study|Other|1|||
105361479|NCT01877668|363330067|FG004|Overall Study|Other|3|||
105361480|NCT01877668|363330063|FG000|Overall Study|Protocol Violation|1|||
105361481|NCT01877668|363330064|FG001|Overall Study|Protocol Violation|1|||
105361482|NCT01877668|363330065|FG002|Overall Study|Protocol Violation|0|||
105361483|NCT01877668|363330066|FG003|Overall Study|Protocol Violation|0|||
105361484|NCT01877668|363330067|FG004|Overall Study|Protocol Violation|3|||
105361485|NCT01877668|363330063|FG000|Overall Study|Adverse event related to study drug|2|||
105361486|NCT01877668|363330064|FG001|Overall Study|Adverse event related to study drug|2|||
105361487|NCT01877668|363330065|FG002|Overall Study|Adverse event related to study drug|2|||
105361488|NCT01877668|363330066|FG003|Overall Study|Adverse event related to study drug|2|||
105361489|NCT01877668|363330067|FG004|Overall Study|Adverse event related to study drug|1|||
105361490|NCT01877668|363330063|FG000|Overall Study|Adverse event unrelated to study drug|4|||
105361491|NCT01877668|363330064|FG001|Overall Study|Adverse event unrelated to study drug|1|||
105361492|NCT01877668|363330065|FG002|Overall Study|Adverse event unrelated to study drug|2|||
105361493|NCT01877668|363330066|FG003|Overall Study|Adverse event unrelated to study drug|0|||
105361494|NCT01877668|363330067|FG004|Overall Study|Adverse event unrelated to study drug|1|||
105361495|NCT01697800|363330068|FG000|Overall Study|Death|0|||
105361496|NCT01697800|363330069|FG001|Overall Study|Death|1|||
105361497|NCT00954122|363330070|FG000|Overall Study|Withdrawal by Subject|5|||
105361498|NCT00954122|363330070|FG000|Overall Study|Adverse Event|1|||
105361499|NCT00954122|363330070|FG000|Overall Study|Safety Reason|1|||
105361500|NCT03492437|363330078|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105361501|NCT03492437|363330079|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105361502|NCT05133323|363330080|FG000|Overall Study|Lack of Efficacy|0|||
105361503|NCT05133323|363330081|FG001|Overall Study|Lack of Efficacy|0|||
105811180|NCT01193608|364964956|FG003|Overall Study|Lost to Follow-up|0|||
105811181|NCT01193608|364964957|FG004|Overall Study|Lost to Follow-up|1|||
105811182|NCT01193608|364964958|FG005|Overall Study|Lost to Follow-up|2|||
105811183|NCT01193608|364964953|FG000|Overall Study|Adverse Event|0|||
105811184|NCT01193608|364964954|FG001|Overall Study|Adverse Event|0|||
105811185|NCT01193608|364964955|FG002|Overall Study|Adverse Event|0|||
105811186|NCT01193608|364964956|FG003|Overall Study|Adverse Event|0|||
105811187|NCT01193608|364964957|FG004|Overall Study|Adverse Event|1|||
105811188|NCT01193608|364964958|FG005|Overall Study|Adverse Event|0|||
105811189|NCT04471935|364964959|FG000|Overall Study|Withdrawal by Subject|1|||
105811190|NCT04471935|364964959|FG000|Overall Study|Deemed ineligible to participate|1|||
105811191|NCT01766921|364964960|FG000|Overall Study|Administrative Reason|5|||
105811192|NCT01766921|364964961|FG001|Overall Study|Administrative Reason|5|||
105811193|NCT01766921|364964960|FG000|Overall Study|Death|1|||
105811194|NCT01766921|364964961|FG001|Overall Study|Death|1|||
105811195|NCT01766921|364964960|FG000|Overall Study|Lost to Follow-up|1|||
105811196|NCT01766921|364964961|FG001|Overall Study|Lost to Follow-up|3|||
105811197|NCT01766921|364964960|FG000|Overall Study|Unclassified|2|||
105361504|NCT05133323|363330082|FG002|Overall Study|Lack of Efficacy|1|||
105361505|NCT05133323|363330080|FG000|Overall Study|Withdrawal by Subject|2|||
105361506|NCT05133323|363330081|FG001|Overall Study|Withdrawal by Subject|1|||
105361507|NCT05133323|363330082|FG002|Overall Study|Withdrawal by Subject|0|||
105811198|NCT01766921|364964961|FG001|Overall Study|Unclassified|2|||
105811199|NCT01766921|364964960|FG000|Overall Study|Protocol Violation|1|||
105811200|NCT01766921|364964961|FG001|Overall Study|Protocol Violation|1|||
105485815|NCT02677324|363789637|FG000|Overall Study|Non-compliance|1|||
105485816|NCT02677324|363789637|FG000|Overall Study|Lack of Efficacy|1|||
105811201|NCT01766921|364964960|FG000|Overall Study|Withdrawal by Subject|14|||
105811202|NCT01766921|364964961|FG001|Overall Study|Withdrawal by Subject|5|||
105811203|NCT00368277|364964967|FG000|Overall Study|Adverse Event|33|||
105811204|NCT00368277|364964968|FG001|Overall Study|Adverse Event|49|||
105811205|NCT00368277|364964967|FG000|Overall Study|Death|2|||
105811206|NCT00368277|364964968|FG001|Overall Study|Death|1|||
105811207|NCT00368277|364964967|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
105811208|NCT00368277|364964968|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
105811209|NCT00368277|364964967|FG000|Overall Study|Protocol deviation|7|||
105811210|NCT00368277|364964968|FG001|Overall Study|Protocol deviation|0|||
105811211|NCT00368277|364964967|FG000|Overall Study|Patient withdrew consent|32|||
105811212|NCT00368277|364964968|FG001|Overall Study|Patient withdrew consent|28|||
105811213|NCT00368277|364964967|FG000|Overall Study|Lost to Follow-up|8|||
105811214|NCT00368277|364964968|FG001|Overall Study|Lost to Follow-up|6|||
105811215|NCT03922477|364964969|FG000|Overall Study|Death|9|||
105811216|NCT03922477|364964969|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
105811217|NCT03922477|364964969|FG000|Overall Study|Physician Decision|1|||
105811218|NCT03922477|364964969|FG000|Overall Study|Withdrawal by Subject|2|||
105811219|NCT04646109|364964971|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
105811220|NCT04646109|364964972|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
105811221|NCT01606306|364964974|FG000|Overall Study|Lack of Efficacy|2|||
105811222|NCT01606306|364964975|FG001|Overall Study|Lack of Efficacy|1|||
105811223|NCT01606306|364964976|FG002|Overall Study|Lack of Efficacy|4|||
105811224|NCT01606306|364964977|FG003|Overall Study|Lack of Efficacy|4|||
105811225|NCT01606306|364964978|FG004|Overall Study|Lack of Efficacy|1|||
105811226|NCT01606306|364964979|FG005|Overall Study|Lack of Efficacy|2|||
105811227|NCT01606306|364964974|FG000|Overall Study|Adverse Event|1|||
105811228|NCT01606306|364964975|FG001|Overall Study|Adverse Event|0|||
105811229|NCT01606306|364964976|FG002|Overall Study|Adverse Event|1|||
105811230|NCT01606306|364964977|FG003|Overall Study|Adverse Event|1|||
105811231|NCT01606306|364964978|FG004|Overall Study|Adverse Event|2|||
105811232|NCT01606306|364964979|FG005|Overall Study|Adverse Event|0|||
105811233|NCT01606306|364964974|FG000|Overall Study|Lost to Follow-up|7|||
105811234|NCT01606306|364964975|FG001|Overall Study|Lost to Follow-up|4|||
105811235|NCT01606306|364964976|FG002|Overall Study|Lost to Follow-up|5|||
105811236|NCT01606306|364964977|FG003|Overall Study|Lost to Follow-up|4|||
105811237|NCT01606306|364964978|FG004|Overall Study|Lost to Follow-up|3|||
105811238|NCT01606306|364964979|FG005|Overall Study|Lost to Follow-up|5|||
105811239|NCT01606306|364964974|FG000|Overall Study|Withdrawal by Subject|4|||
105811240|NCT01606306|364964975|FG001|Overall Study|Withdrawal by Subject|3|||
105811241|NCT01606306|364964976|FG002|Overall Study|Withdrawal by Subject|4|||
105811242|NCT01606306|364964977|FG003|Overall Study|Withdrawal by Subject|4|||
105811243|NCT01606306|364964978|FG004|Overall Study|Withdrawal by Subject|5|||
105811244|NCT01606306|364964979|FG005|Overall Study|Withdrawal by Subject|4|||
105811245|NCT01606306|364964974|FG000|Overall Study|Physician Decision|1|||
105811246|NCT01606306|364964975|FG001|Overall Study|Physician Decision|2|||
105811247|NCT01606306|364964976|FG002|Overall Study|Physician Decision|0|||
105811248|NCT01606306|364964977|FG003|Overall Study|Physician Decision|0|||
105811249|NCT01606306|364964978|FG004|Overall Study|Physician Decision|0|||
105811250|NCT01606306|364964979|FG005|Overall Study|Physician Decision|0|||
105811251|NCT01759290|364964980|FG000|Overall Study|Subjects withdrawn consent|5|||
105811252|NCT01759290|364964980|FG000|Overall Study|Physician Decision|2|||
105811253|NCT01759290|364964980|FG000|Overall Study|Death|17|||
105811254|NCT01759290|364964980|FG000|Overall Study|Lost to Follow-up|53|||
105811255|NCT01759290|364964980|FG000|Overall Study|Unknown reason|4|||
105811256|NCT00841100|364964981|FG000|Phase 1 (28 Days)|Adverse Event|1|||
105811257|NCT00841100|364964981|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
105811258|NCT01355081|364964984|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
105811259|NCT01355081|364964985|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
105811260|NCT01355081|364964986|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
105811261|NCT01355081|364964984|FG000|Overall Study|Major Protocol Deviation|0|||
105811262|NCT01355081|364964985|FG001|Overall Study|Major Protocol Deviation|1|||
105811263|NCT01355081|364964986|FG002|Overall Study|Major Protocol Deviation|0|||
105811264|NCT01355081|364964984|FG000|Overall Study|Lost to Follow-up|0|||
105811265|NCT01355081|364964985|FG001|Overall Study|Lost to Follow-up|0|||
105811266|NCT01355081|364964986|FG002|Overall Study|Lost to Follow-up|1|||
105811267|NCT01355081|364964984|FG000|Overall Study|Withdrawal of Consent|2|||
105811268|NCT01355081|364964985|FG001|Overall Study|Withdrawal of Consent|3|||
105811269|NCT01355081|364964986|FG002|Overall Study|Withdrawal of Consent|3|||
105811270|NCT01355081|364964984|FG000|Overall Study|Lack of Efficacy|2|||
105811271|NCT01355081|364964985|FG001|Overall Study|Lack of Efficacy|1|||
105811272|NCT01355081|364964986|FG002|Overall Study|Lack of Efficacy|1|||
105811273|NCT01355081|364964984|FG000|Overall Study|Non Compliance with Study Medication|0|||
105811274|NCT01355081|364964985|FG001|Overall Study|Non Compliance with Study Medication|1|||
105811275|NCT01355081|364964986|FG002|Overall Study|Non Compliance with Study Medication|0|||
105811276|NCT03184441|364964987|FG000|Overall Study|Withdrawal by Subject|1|||
105811277|NCT01868009|364964988|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
105811278|NCT01868009|364964989|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
105811279|NCT01868009|364964988|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
105811280|NCT01868009|364964989|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
105811281|NCT01868009|364964988|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
105811282|NCT01868009|364964989|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
105811283|NCT01046253|364964992|FG000|Second Intervention|Adverse Event|0|||
105811284|NCT01046253|364964993|FG001|Second Intervention|Adverse Event|1|||
105811285|NCT01046253|364964992|FG000|Second Intervention|Protocol Violation|0|||
105811286|NCT01046253|364964993|FG001|Second Intervention|Protocol Violation|1|||
105811287|NCT02514174|364964996|FG000|Overall Study|Patient refused to continue medication|1|||
105811288|NCT02514174|364964996|FG000|Overall Study|Adverse Event|2|||
105811289|NCT02514174|364964996|FG000|Overall Study|Study closed by sponsor|9|||
105811290|NCT02514174|364964996|FG000|Overall Study|Progressive disease|11|||
105811291|NCT02514174|364964996|FG000|Overall Study|Treatment change|1|||
105811292|NCT02514174|364964996|FG000|Overall Study|Treated off study with Afatinib.|1|||
105811293|NCT02070744|364964997|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
105811294|NCT02070744|364964998|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
105811295|NCT02070744|364964999|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
105811296|NCT02070744|364965000|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
105811297|NCT02070744|364965001|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
105811298|NCT02070744|364964997|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
105811299|NCT02070744|364964998|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
105811300|NCT02070744|364964999|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
105811301|NCT02070744|364965000|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
105811302|NCT02070744|364965001|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
105811303|NCT02070744|364964997|FG000|OLE Phase (48 Weeks)|Other|0|||
105811304|NCT02070744|364964998|FG001|OLE Phase (48 Weeks)|Other|0|||
105811305|NCT02070744|364964999|FG002|OLE Phase (48 Weeks)|Other|0|||
105811306|NCT02070744|364965000|FG003|OLE Phase (48 Weeks)|Other|0|||
105811307|NCT02070744|364965001|FG004|OLE Phase (48 Weeks)|Other|1|||
105811308|NCT00922779|364965005|FG000|Overall Study|Adverse Event|67|||
105811309|NCT00922779|364965005|FG000|Overall Study|Pregnancy|7|||
105811310|NCT00922779|364965005|FG000|Overall Study|Withdrawal by Subject|308|||
105811311|NCT00922779|364965005|FG000|Overall Study|Lost to Follow-up|44|||
105811312|NCT00922779|364965005|FG000|Overall Study|Other|27|||
105811313|NCT00922779|364965005|FG000|Overall Study|Missing|1874|||
105811314|NCT02507375|364965006|FG000|Overall Study|Progressive Disease|4|||
105811315|NCT02507375|364965007|FG001|Overall Study|Progressive Disease|5|||
105811316|NCT02507375|364965006|FG000|Overall Study|Death|0|||
105811317|NCT02507375|364965007|FG001|Overall Study|Death|1|||
105811318|NCT02507375|364965006|FG000|Overall Study|Refused treatment|0|||
105811319|NCT02507375|364965007|FG001|Overall Study|Refused treatment|1|||
105811320|NCT02507375|364965006|FG000|Overall Study|Adverse Event|0|||
105361508|NCT00994110|363330083|FG000|Overall Study|Withdrawal by Subject|9|||
105571479|NCT02307513|364091218|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
105811321|NCT02507375|364965007|FG001|Overall Study|Adverse Event|1|||
105811322|NCT02158936|364965008|FG000|Overall Study|Study closed/ terminated|57|||
105811323|NCT02158936|364965009|FG001|Overall Study|Study closed/ terminated|77|||
105811324|NCT02158936|364965008|FG000|Overall Study|Azacitidine tx discontinued|53|||
105811325|NCT02158936|364965009|FG001|Overall Study|Azacitidine tx discontinued|46|||
105811326|NCT02158936|364965008|FG000|Overall Study|Adverse Event|39|||
105811327|NCT02158936|364965009|FG001|Overall Study|Adverse Event|24|||
105811328|NCT02158936|364965008|FG000|Overall Study|Withdrawal by Subject|15|||
105811329|NCT02158936|364965009|FG001|Overall Study|Withdrawal by Subject|16|||
105811330|NCT02158936|364965008|FG000|Overall Study|Physician Decision|15|||
105811331|NCT02158936|364965009|FG001|Overall Study|Physician Decision|13|||
105811332|NCT02158936|364965008|FG000|Overall Study|Lost to Follow-up|0|||
105811333|NCT02158936|364965009|FG001|Overall Study|Lost to Follow-up|1|||
105811334|NCT00993616|364965010|FG000|Overall Study|No tumor at entry|1|||
105811335|NCT00993616|364965010|FG000|Overall Study|Never treated|1|||
105811336|NCT02224456|364966511|FG000|Overall Study|Lack of Efficacy|1|||
105811337|NCT02224456|364966511|FG000|Overall Study|Lost to Follow-up|15|||
105811338|NCT02224456|364966511|FG000|Overall Study|Withdrawal by Subject|9|||
105811339|NCT02224456|364966511|FG000|Overall Study|Physician Decision|3|||
105811340|NCT02224456|364966511|FG000|Overall Study|Death|2|||
105811341|NCT02224456|364966511|FG000|Overall Study|Pregnancy|4|||
105811342|NCT02224456|364966511|FG000|Overall Study|Protocol Violation|1|||
105811343|NCT02224456|364966511|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
105811344|NCT02946385|364966512|FG000|Overall Study|Lost to Follow-up|0|||
105811345|NCT02946385|364966513|FG001|Overall Study|Lost to Follow-up|0|||
105811346|NCT02946385|364966514|FG002|Overall Study|Lost to Follow-up|3|||
105811347|NCT02946385|364966515|FG003|Overall Study|Lost to Follow-up|0|||
105811348|NCT02946385|364966516|FG004|Overall Study|Lost to Follow-up|2|||
105811349|NCT02946385|364966517|FG005|Overall Study|Lost to Follow-up|1|||
105811350|NCT01644890|364966518|FG000|Overall Study|Adverse Event|7|||
105811351|NCT01644890|364966519|FG001|Overall Study|Adverse Event|20|||
105811352|NCT01644890|364966518|FG000|Overall Study|Death|1|||
105811353|NCT01644890|364966519|FG001|Overall Study|Death|3|||
105811354|NCT01644890|364966518|FG000|Overall Study|Physician Decision|3|||
105811355|NCT01644890|364966519|FG001|Overall Study|Physician Decision|9|||
105811356|NCT01644890|364966518|FG000|Overall Study|Protocol Violation|6|||
105811357|NCT01644890|364966519|FG001|Overall Study|Protocol Violation|7|||
105811358|NCT01644890|364966518|FG000|Overall Study|Withdrawal by Subject|19|||
105811359|NCT01644890|364966519|FG001|Overall Study|Withdrawal by Subject|27|||
105811360|NCT01644890|364966518|FG000|Overall Study|Progression Disease|160|||
105811361|NCT01644890|364966519|FG001|Overall Study|Progression Disease|131|||
105811362|NCT01644890|364966518|FG000|Overall Study|Clinical Progression|6|||
105811363|NCT01644890|364966519|FG001|Overall Study|Clinical Progression|6|||
105811364|NCT01644890|364966518|FG000|Overall Study|> 28 days since last dose of study drug|6|||
105811365|NCT01644890|364966519|FG001|Overall Study|> 28 days since last dose of study drug|3|||
105811366|NCT01644890|364966518|FG000|Overall Study|Other|8|||
105811367|NCT01644890|364966519|FG001|Overall Study|Other|9|||
105811368|NCT00056160|364966520|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
105811369|NCT00056160|364966521|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
105811370|NCT00056160|364966520|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
105811371|NCT00056160|364966521|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
105811372|NCT00056160|364966520|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
105811373|NCT00056160|364966521|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
105811374|NCT00056160|364966520|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
105811375|NCT00056160|364966521|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
105811376|NCT00056160|364966520|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
105811377|NCT00056160|364966521|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
105811378|NCT00056160|364966520|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
105811379|NCT00056160|364966521|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
105811380|NCT00056160|364966520|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
105811381|NCT00056160|364966521|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
105811382|NCT00056160|364966520|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
105811383|NCT00056160|364966521|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
105811384|NCT00056160|364966520|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
105811385|NCT00056160|364966521|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
105811386|NCT00056160|364966520|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
105811387|NCT00056160|364966521|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
105811388|NCT00056160|364966520|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
105811389|NCT00056160|364966521|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
105811390|NCT00056160|364966520|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
105811391|NCT00056160|364966521|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
105811392|NCT00056160|364966520|FG000|Final Follow-up|Transferred into expanded access study.|3|||
105811393|NCT00056160|364966521|FG001|Final Follow-up|Transferred into expanded access study.|0|||
105811394|NCT00056160|364966520|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
105811395|NCT00056160|364966521|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
105811396|NCT00056160|364966520|FG000|Final Follow-up|Adverse Event|1|||
105811397|NCT00056160|364966521|FG001|Final Follow-up|Adverse Event|0|||
105485817|NCT02677324|363789637|FG000|Overall Study|Medical insurance coverage|1|||
105485818|NCT02677324|363789637|FG000|Overall Study|Adverse Event|1|||
105485819|NCT02677324|363789637|FG000|Overall Study|IgM Myeloma diagnosis|1|||
105811398|NCT03312530|364966523|FG000|Overall Study|Death|5|||
105811399|NCT03312530|364966524|FG001|Overall Study|Death|5|||
105811400|NCT03312530|364966525|FG002|Overall Study|Death|4|||
105811401|NCT03312530|364966526|FG003|Overall Study|Death|10|||
105811402|NCT03312530|364966527|FG004|Overall Study|Death|8|||
105811403|NCT03312530|364966523|FG000|Overall Study|Lost to Follow-up|0|||
105811404|NCT03312530|364966524|FG001|Overall Study|Lost to Follow-up|0|||
105811405|NCT03312530|364966525|FG002|Overall Study|Lost to Follow-up|0|||
105811406|NCT03312530|364966526|FG003|Overall Study|Lost to Follow-up|1|||
105811407|NCT03312530|364966527|FG004|Overall Study|Lost to Follow-up|0|||
105811408|NCT03312530|364966523|FG000|Overall Study|Participant in another sponsor study.|0|||
105811409|NCT03312530|364966524|FG001|Overall Study|Participant in another sponsor study.|0|||
105811410|NCT03312530|364966525|FG002|Overall Study|Participant in another sponsor study.|0|||
105811411|NCT03312530|364966526|FG003|Overall Study|Participant in another sponsor study.|1|||
105811412|NCT03312530|364966527|FG004|Overall Study|Participant in another sponsor study.|0|||
105811413|NCT03312530|364966523|FG000|Overall Study|Study terminated by sponsor|1|||
105811414|NCT03312530|364966524|FG001|Overall Study|Study terminated by sponsor|0|||
105811415|NCT03312530|364966525|FG002|Overall Study|Study terminated by sponsor|2|||
105811416|NCT03312530|364966526|FG003|Overall Study|Study terminated by sponsor|3|||
105811417|NCT03312530|364966527|FG004|Overall Study|Study terminated by sponsor|7|||
105811418|NCT03312530|364966523|FG000|Overall Study|Withdrawal by Subject|0|||
105811419|NCT03312530|364966524|FG001|Overall Study|Withdrawal by Subject|1|||
105811420|NCT03312530|364966525|FG002|Overall Study|Withdrawal by Subject|0|||
105811421|NCT03312530|364966526|FG003|Overall Study|Withdrawal by Subject|0|||
105811422|NCT03312530|364966527|FG004|Overall Study|Withdrawal by Subject|0|||
105811423|NCT03312530|364966523|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
105811424|NCT03312530|364966524|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
105811425|NCT03312530|364966525|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
105811426|NCT03312530|364966526|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
105811427|NCT03312530|364966527|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
105811428|NCT03093324|364966529|FG000|Overall Study|Adverse Event|4|||
105485820|NCT00662532|363789638|FG000|Overall Study|Adverse Event|0|||
105485821|NCT00662532|363789639|FG001|Overall Study|Adverse Event|1|||
105485822|NCT00662532|363789638|FG000|Overall Study|Lost to Follow-up|0|||
105485823|NCT00662532|363789639|FG001|Overall Study|Lost to Follow-up|1|||
105571480|NCT02307513|364091219|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
105571481|NCT02307513|364091218|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
105571482|NCT02307513|364091219|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
105571483|NCT02307513|364091218|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
105571484|NCT02307513|364091219|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
105571485|NCT02307513|364091218|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
105571486|NCT02307513|364091219|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
105571487|NCT02307513|364091218|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
105571488|NCT02307513|364091219|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
105571489|NCT02307513|364091218|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
105571490|NCT02307513|364091219|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
105571491|NCT02307513|364091218|FG000|Long-term Extension|Physician Decision|1|||
105571492|NCT02307513|364091219|FG001|Long-term Extension|Physician Decision|0|||
105571493|NCT01225822|364091220|FG000|Overall Study|Adverse Event|13|||
105571494|NCT01225822|364091221|FG001|Overall Study|Adverse Event|31|||
105571495|NCT01225822|364091222|FG002|Overall Study|Adverse Event|18|||
105571496|NCT01225822|364091223|FG003|Overall Study|Adverse Event|23|||
105571497|NCT01225822|364091224|FG004|Overall Study|Adverse Event|14|||
105571498|NCT01225822|364091220|FG000|Overall Study|Protocol Violation|6|||
105571499|NCT01225822|364091221|FG001|Overall Study|Protocol Violation|8|||
105571500|NCT01225822|364091222|FG002|Overall Study|Protocol Violation|6|||
105571501|NCT01225822|364091223|FG003|Overall Study|Protocol Violation|7|||
105571502|NCT01225822|364091224|FG004|Overall Study|Protocol Violation|4|||
105571503|NCT01225822|364091220|FG000|Overall Study|Lost to Follow-up|0|||
105571504|NCT01225822|364091221|FG001|Overall Study|Lost to Follow-up|0|||
105811429|NCT03093324|364966530|FG001|Overall Study|Adverse Event|15|||
105811430|NCT03093324|364966529|FG000|Overall Study|Lost to Follow-up|1|||
105811431|NCT03093324|364966530|FG001|Overall Study|Lost to Follow-up|0|||
105811432|NCT03093324|364966529|FG000|Overall Study|Protocol Deviation|2|||
105571505|NCT01225822|364091222|FG002|Overall Study|Lost to Follow-up|0|||
105485824|NCT01850602|363789640|FG000|Overall Study|Adverse Event|7|||
105485825|NCT01850602|363789641|FG001|Overall Study|Adverse Event|10|||
105485826|NCT01850602|363789640|FG000|Overall Study|Physician Decision|2|||
105811433|NCT03093324|364966530|FG001|Overall Study|Protocol Deviation|2|||
105811434|NCT03093324|364966529|FG000|Overall Study|Withdrawal by Subject|2|||
105811435|NCT03093324|364966530|FG001|Overall Study|Withdrawal by Subject|2|||
105811436|NCT02458638|364966537|FG000|Overall Study|Death|309|||
105811437|NCT02458638|364966537|FG000|Overall Study|End of Cohort/End of Study|67|||
105811438|NCT02458638|364966537|FG000|Overall Study|Lost to Follow-up|31|||
105811439|NCT02458638|364966537|FG000|Overall Study|Other Reasons|4|||
105811440|NCT02458638|364966537|FG000|Overall Study|Physician Decision|1|||
105811441|NCT02458638|364966537|FG000|Overall Study|Withdrawal by Subject|47|||
105811442|NCT02207231|364966538|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
105811443|NCT02207231|364966539|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
105811444|NCT02207231|364966540|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
105811445|NCT02207231|364966541|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
105811446|NCT02207231|364966538|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
105811447|NCT02207231|364966539|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
105811448|NCT02207231|364966540|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
105811449|NCT02207231|364966541|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
105811450|NCT02207231|364966538|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
105811451|NCT02207231|364966539|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
105811452|NCT02207231|364966540|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
105811453|NCT02207231|364966541|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
105811454|NCT02207231|364966538|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
105811455|NCT02207231|364966539|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
105811456|NCT02207231|364966540|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
105811457|NCT02207231|364966541|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
105811458|NCT02207231|364966538|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
105811459|NCT02207231|364966539|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
105811460|NCT02207231|364966540|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
105811461|NCT02207231|364966541|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
105811462|NCT02207231|364966538|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
105811463|NCT02207231|364966539|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
105811464|NCT02207231|364966540|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
105811465|NCT02207231|364966541|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
105811466|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
105811467|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
105811468|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
105811469|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
105811470|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
105811471|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
105811472|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
105811473|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
105811474|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
105811475|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
105811476|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
105811477|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
105811478|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
105361509|NCT00994110|363330084|FG001|Overall Study|Withdrawal by Subject|9|||
105811479|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
105811480|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
105361510|NCT00994110|363330083|FG000|Overall Study|Not Treated|4|||
105361511|NCT00994110|363330084|FG001|Overall Study|Not Treated|8|||
105361512|NCT00994110|363330083|FG000|Overall Study|Adverse Event|1|||
105361513|NCT00994110|363330084|FG001|Overall Study|Adverse Event|0|||
105361514|NCT00994110|363330083|FG000|Overall Study|Patient not resected|41|||
105361515|NCT00994110|363330084|FG001|Overall Study|Patient not resected|52|||
105361516|NCT00994110|363330083|FG000|Overall Study|Pt not eligible|10|||
105361517|NCT00994110|363330084|FG001|Overall Study|Pt not eligible|5|||
105361518|NCT00666211|363330087|FG000|Overall Study|Withdrawal by Subject|10|||
105361519|NCT00666211|363330088|FG001|Overall Study|Withdrawal by Subject|13|||
105361520|NCT00666211|363330087|FG000|Overall Study|went off medication, no more pain|1|||
105361521|NCT00666211|363330088|FG001|Overall Study|went off medication, no more pain|0|||
105361522|NCT00666211|363330087|FG000|Overall Study|patient non-compliant|6|||
105361523|NCT00666211|363330088|FG001|Overall Study|patient non-compliant|6|||
105361524|NCT00666211|363330087|FG000|Overall Study|disease progression|1|||
105361525|NCT00666211|363330088|FG001|Overall Study|disease progression|8|||
105361526|NCT00666211|363330087|FG000|Overall Study|Lost to Follow-up|2|||
105361527|NCT00666211|363330088|FG001|Overall Study|Lost to Follow-up|0|||
105361528|NCT00666211|363330087|FG000|Overall Study|toxicity|0|||
105361529|NCT00666211|363330088|FG001|Overall Study|toxicity|2|||
105361530|NCT00666211|363330087|FG000|Overall Study|hospital admission|0|||
105361531|NCT00666211|363330088|FG001|Overall Study|hospital admission|5|||
105361532|NCT00666211|363330087|FG000|Overall Study|Death|0|||
105361533|NCT00666211|363330088|FG001|Overall Study|Death|2|||
105361534|NCT00666211|363330087|FG000|Overall Study|off tx for other complicating disease|0|||
105361535|NCT00666211|363330088|FG001|Overall Study|off tx for other complicating disease|1|||
105361536|NCT00666211|363330087|FG000|Overall Study|Physician Decision|0|||
105361537|NCT00666211|363330088|FG001|Overall Study|Physician Decision|1|||
105361538|NCT01111565|363330094|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
105361539|NCT01111565|363330095|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
105485827|NCT01850602|363789641|FG001|Overall Study|Physician Decision|1|||
105485828|NCT01850602|363789640|FG000|Overall Study|Withdrawal by Subject|2|||
105485829|NCT01850602|363789641|FG001|Overall Study|Withdrawal by Subject|4|||
105811481|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
105811482|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
105811483|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
105811484|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
105811485|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
105811486|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
105361540|NCT01111565|363330096|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
105361541|NCT01111565|363330097|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
105361542|NCT01111565|363330098|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
105361543|NCT01111565|363330094|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
105485830|NCT01850602|363789640|FG000|Overall Study|Decrease in serum calcium|2|||
105361544|NCT01111565|363330095|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
105361545|NCT01111565|363330096|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
105361546|NCT01111565|363330097|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
105361547|NCT01111565|363330098|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
105485831|NCT01850602|363789641|FG001|Overall Study|Decrease in serum calcium|3|||
105485832|NCT01850602|363789640|FG000|Overall Study|Increase in serum ferritin|1|||
105485833|NCT01850602|363789641|FG001|Overall Study|Increase in serum ferritin|0|||
105485834|NCT00761748|363789642|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
105485835|NCT00761748|363789643|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
105485836|NCT00761748|363789642|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
105485837|NCT00761748|363789643|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
105485838|NCT01155479|363789646|FG000|Part I|Adverse Event|13|||
105485839|NCT01155479|363789647|FG001|Part I|Adverse Event|8|||
105485840|NCT01155479|363789648|FG002|Part I|Adverse Event|18|||
105485841|NCT01155479|363789649|FG003|Part I|Adverse Event|7|||
105485842|NCT01155479|363789650|FG004|Part I|Adverse Event|6|||
105485843|NCT01155479|363789646|FG000|Part I|Administrative|2|||
105485844|NCT01155479|363789647|FG001|Part I|Administrative|2|||
105485845|NCT01155479|363789648|FG002|Part I|Administrative|2|||
105485846|NCT01155479|363789649|FG003|Part I|Administrative|0|||
105485847|NCT01155479|363789650|FG004|Part I|Administrative|0|||
105485848|NCT01155479|363789646|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
105485849|NCT01155479|363789647|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
105485850|NCT01155479|363789648|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
105485851|NCT01155479|363789649|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
105485852|NCT01155479|363789650|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
105485853|NCT01155479|363789646|FG000|Part I|Withdrawal by Subject|11|||
105485854|NCT01155479|363789647|FG001|Part I|Withdrawal by Subject|13|||
105485855|NCT01155479|363789648|FG002|Part I|Withdrawal by Subject|8|||
105485856|NCT01155479|363789649|FG003|Part I|Withdrawal by Subject|8|||
105485857|NCT01155479|363789650|FG004|Part I|Withdrawal by Subject|9|||
105485858|NCT01155479|363789646|FG000|Part I|Lost to Follow-up|0|||
105485859|NCT01155479|363789647|FG001|Part I|Lost to Follow-up|0|||
105485860|NCT01155479|363789648|FG002|Part I|Lost to Follow-up|1|||
105485861|NCT01155479|363789649|FG003|Part I|Lost to Follow-up|1|||
105485862|NCT01155479|363789650|FG004|Part I|Lost to Follow-up|0|||
105485863|NCT01155479|363789646|FG000|Part I|Treatment Failure|3|||
105485864|NCT01155479|363789647|FG001|Part I|Treatment Failure|0|||
105485865|NCT01155479|363789648|FG002|Part I|Treatment Failure|3|||
105485866|NCT01155479|363789649|FG003|Part I|Treatment Failure|1|||
105485867|NCT01155479|363789650|FG004|Part I|Treatment Failure|2|||
105485868|NCT01155479|363789646|FG000|Part I|Did Not Receive Treatment|4|||
105485869|NCT01155479|363789647|FG001|Part I|Did Not Receive Treatment|2|||
105485870|NCT01155479|363789648|FG002|Part I|Did Not Receive Treatment|2|||
105485871|NCT01155479|363789649|FG003|Part I|Did Not Receive Treatment|6|||
105485872|NCT01155479|363789650|FG004|Part I|Did Not Receive Treatment|1|||
105485873|NCT01155479|363789646|FG000|Part I|Non-Compliance with Protocol|2|||
105485874|NCT01155479|363789647|FG001|Part I|Non-Compliance with Protocol|1|||
105485875|NCT01155479|363789648|FG002|Part I|Non-Compliance with Protocol|3|||
105485876|NCT01155479|363789649|FG003|Part I|Non-Compliance with Protocol|3|||
105485877|NCT01155479|363789650|FG004|Part I|Non-Compliance with Protocol|2|||
105485878|NCT01155479|363789646|FG000|Part II|Adverse Event|7|||
105485879|NCT01155479|363789647|FG001|Part II|Adverse Event|6|||
105485880|NCT01155479|363789648|FG002|Part II|Adverse Event|8|||
105485881|NCT01155479|363789649|FG003|Part II|Adverse Event|3|||
105485882|NCT01155479|363789650|FG004|Part II|Adverse Event|4|||
105485883|NCT01155479|363789646|FG000|Part II|Administrative|43|||
105485884|NCT01155479|363789647|FG001|Part II|Administrative|49|||
105485885|NCT01155479|363789648|FG002|Part II|Administrative|36|||
105485886|NCT01155479|363789649|FG003|Part II|Administrative|38|||
105485887|NCT01155479|363789650|FG004|Part II|Administrative|46|||
105485888|NCT01155479|363789646|FG000|Part II|Withdrawal by Subject|8|||
105485889|NCT01155479|363789647|FG001|Part II|Withdrawal by Subject|4|||
105485890|NCT01155479|363789648|FG002|Part II|Withdrawal by Subject|12|||
105485891|NCT01155479|363789649|FG003|Part II|Withdrawal by Subject|7|||
105485892|NCT01155479|363789650|FG004|Part II|Withdrawal by Subject|3|||
105485893|NCT01155479|363789646|FG000|Part II|Lost to Follow-up|1|||
105485894|NCT01155479|363789647|FG001|Part II|Lost to Follow-up|0|||
105485895|NCT01155479|363789648|FG002|Part II|Lost to Follow-up|0|||
105811487|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
105811488|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
105811489|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
105811490|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
105811491|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
105811492|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
105811493|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
105811494|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
105811495|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
105811496|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
105811497|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
105811498|NCT02207231|364966538|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
105811499|NCT02207231|364966539|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
105811500|NCT02207231|364966540|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
105811501|NCT02207231|364966541|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
105361548|NCT01111565|363330094|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
105361549|NCT01111565|363330095|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
105361550|NCT01111565|363330096|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
105361551|NCT01111565|363330097|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
105361552|NCT01111565|363330098|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
105361553|NCT01111565|363330094|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
105361554|NCT01111565|363330095|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
105361555|NCT01111565|363330096|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
105361556|NCT01111565|363330097|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
105361557|NCT01111565|363330098|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
105361558|NCT01111565|363330094|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
105361559|NCT01111565|363330095|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
105361560|NCT01111565|363330096|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
105361561|NCT01111565|363330097|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
105361562|NCT01111565|363330098|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
105361563|NCT01111565|363330094|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
105361564|NCT01111565|363330095|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
105361565|NCT01111565|363330096|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
105361566|NCT01111565|363330097|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
105361567|NCT01111565|363330098|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
105361568|NCT01111565|363330094|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
105361569|NCT01111565|363330095|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
105361570|NCT01111565|363330096|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
105361571|NCT01111565|363330097|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
105361572|NCT01111565|363330098|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
105361573|NCT01111565|363330094|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
105361574|NCT01111565|363330095|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
105361575|NCT01111565|363330096|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
105361576|NCT01111565|363330097|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
105361577|NCT01111565|363330098|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
105361578|NCT01111565|363330094|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105361579|NCT01111565|363330095|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105361580|NCT01111565|363330096|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
105361581|NCT01111565|363330097|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105361582|NCT01111565|363330098|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105361583|NCT01111565|363330094|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
105361584|NCT01111565|363330095|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
105361585|NCT01111565|363330096|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
105361586|NCT01111565|363330097|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
105361587|NCT01111565|363330098|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
105361588|NCT01111565|363330094|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
105361589|NCT01111565|363330095|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
105361590|NCT01111565|363330096|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
105361591|NCT01111565|363330097|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
105361592|NCT01111565|363330098|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
105361593|NCT01111565|363330094|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
105361594|NCT01111565|363330095|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
105361595|NCT01111565|363330096|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
105361596|NCT01111565|363330097|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
105361597|NCT01111565|363330098|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
105361598|NCT02683239|363330100|FG000|Overall Study|Protocol Violation|35|||
105361599|NCT02683239|363330101|FG001|Overall Study|Protocol Violation|23|||
105361600|NCT02683239|363330102|FG002|Overall Study|Protocol Violation|26|||
105361601|NCT02683239|363330103|FG003|Overall Study|Protocol Violation|4|||
105361602|NCT02683239|363330104|FG004|Overall Study|Protocol Violation|35|||
105361603|NCT02683239|363330105|FG005|Overall Study|Protocol Violation|4|||
105361604|NCT02683239|363330106|FG006|Overall Study|Protocol Violation|5|||
105361605|NCT02683239|363330100|FG000|Overall Study|Adverse Event|64|||
105361606|NCT02683239|363330101|FG001|Overall Study|Adverse Event|39|||
105361607|NCT02683239|363330102|FG002|Overall Study|Adverse Event|42|||
105361608|NCT02683239|363330103|FG003|Overall Study|Adverse Event|16|||
105361609|NCT02683239|363330104|FG004|Overall Study|Adverse Event|189|||
105361610|NCT02683239|363330105|FG005|Overall Study|Adverse Event|9|||
105361611|NCT02683239|363330106|FG006|Overall Study|Adverse Event|9|||
105361612|NCT02683239|363330100|FG000|Overall Study|Physician Decision|38|||
105361613|NCT02683239|363330101|FG001|Overall Study|Physician Decision|19|||
105361614|NCT02683239|363330102|FG002|Overall Study|Physician Decision|14|||
105361615|NCT02683239|363330103|FG003|Overall Study|Physician Decision|73|||
105361616|NCT02683239|363330104|FG004|Overall Study|Physician Decision|143|||
105361617|NCT02683239|363330105|FG005|Overall Study|Physician Decision|14|||
105361618|NCT02683239|363330106|FG006|Overall Study|Physician Decision|15|||
105361619|NCT02683239|363330100|FG000|Overall Study|Withdrawal by Subject|187|||
105361620|NCT02683239|363330101|FG001|Overall Study|Withdrawal by Subject|99|||
105361621|NCT02683239|363330102|FG002|Overall Study|Withdrawal by Subject|91|||
105361622|NCT02683239|363330103|FG003|Overall Study|Withdrawal by Subject|18|||
105361623|NCT02683239|363330104|FG004|Overall Study|Withdrawal by Subject|248|||
105361624|NCT02683239|363330105|FG005|Overall Study|Withdrawal by Subject|22|||
105361625|NCT02683239|363330106|FG006|Overall Study|Withdrawal by Subject|28|||
105361626|NCT02683239|363330100|FG000|Overall Study|Lost to Follow-up|77|||
105361627|NCT02683239|363330101|FG001|Overall Study|Lost to Follow-up|24|||
105361628|NCT02683239|363330102|FG002|Overall Study|Lost to Follow-up|25|||
105361629|NCT02683239|363330103|FG003|Overall Study|Lost to Follow-up|7|||
105361630|NCT02683239|363330104|FG004|Overall Study|Lost to Follow-up|88|||
105361631|NCT02683239|363330105|FG005|Overall Study|Lost to Follow-up|8|||
105361632|NCT02683239|363330106|FG006|Overall Study|Lost to Follow-up|11|||
105361633|NCT02683239|363330100|FG000|Overall Study|Death|9|||
105361634|NCT02683239|363330101|FG001|Overall Study|Death|5|||
105361635|NCT02683239|363330102|FG002|Overall Study|Death|8|||
105361636|NCT02683239|363330103|FG003|Overall Study|Death|0|||
105361637|NCT02683239|363330104|FG004|Overall Study|Death|12|||
105361638|NCT02683239|363330105|FG005|Overall Study|Death|1|||
105361639|NCT02683239|363330106|FG006|Overall Study|Death|0|||
105361640|NCT02683239|363330100|FG000|Overall Study|Lack of Efficacy|50|||
105361641|NCT02683239|363330101|FG001|Overall Study|Lack of Efficacy|23|||
105361642|NCT02683239|363330102|FG002|Overall Study|Lack of Efficacy|12|||
105361643|NCT02683239|363330103|FG003|Overall Study|Lack of Efficacy|2|||
105485896|NCT01155479|363789649|FG003|Part II|Lost to Follow-up|0|||
105485897|NCT01155479|363789650|FG004|Part II|Lost to Follow-up|1|||
105485898|NCT01155479|363789646|FG000|Part II|Treatment Failure|0|||
105485899|NCT01155479|363789647|FG001|Part II|Treatment Failure|1|||
105485900|NCT01155479|363789648|FG002|Part II|Treatment Failure|2|||
105485901|NCT01155479|363789649|FG003|Part II|Treatment Failure|0|||
105485902|NCT01155479|363789650|FG004|Part II|Treatment Failure|1|||
105485903|NCT01155479|363789646|FG000|Part II|Non-Compliance with Protocol|0|||
105485904|NCT01155479|363789647|FG001|Part II|Non-Compliance with Protocol|1|||
105361644|NCT02683239|363330104|FG004|Overall Study|Lack of Efficacy|29|||
105485905|NCT01155479|363789648|FG002|Part II|Non-Compliance with Protocol|0|||
105361645|NCT02683239|363330105|FG005|Overall Study|Lack of Efficacy|2|||
105811502|NCT02207231|364966538|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
105811503|NCT02207231|364966539|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
105811504|NCT02207231|364966540|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
105811505|NCT02207231|364966541|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
105811506|NCT02207231|364966538|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
105811507|NCT02207231|364966539|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
105811508|NCT02207231|364966540|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
105811509|NCT02207231|364966541|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
105811510|NCT02207231|364966538|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
105361646|NCT02683239|363330106|FG006|Overall Study|Lack of Efficacy|3|||
105485906|NCT01155479|363789649|FG003|Part II|Non-Compliance with Protocol|2|||
105811511|NCT02207231|364966539|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
105811512|NCT02207231|364966540|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
105811513|NCT02207231|364966541|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
105811514|NCT02207231|364966538|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
105361647|NCT02683239|363330100|FG000|Overall Study|Missing data|0|||
105361648|NCT02683239|363330101|FG001|Overall Study|Missing data|1|||
105361649|NCT02683239|363330102|FG002|Overall Study|Missing data|1|||
105361650|NCT02683239|363330103|FG003|Overall Study|Missing data|0|||
105361651|NCT02683239|363330104|FG004|Overall Study|Missing data|1|||
105361652|NCT02683239|363330105|FG005|Overall Study|Missing data|0|||
105361653|NCT02683239|363330106|FG006|Overall Study|Missing data|0|||
105361654|NCT00368108|363330107|FG000|Overall Study|Adverse Event|38|||
105361655|NCT00368108|363330108|FG001|Overall Study|Adverse Event|26|||
105361656|NCT00368108|363330109|FG002|Overall Study|Adverse Event|44|||
105361657|NCT00368108|363330107|FG000|Overall Study|Abnormal Laboratory Value|0|||
105361658|NCT00368108|363330108|FG001|Overall Study|Abnormal Laboratory Value|0|||
105361659|NCT00368108|363330109|FG002|Overall Study|Abnormal Laboratory Value|3|||
105361660|NCT00368108|363330107|FG000|Overall Study|Protocol Violation|5|||
105361661|NCT00368108|363330108|FG001|Overall Study|Protocol Violation|9|||
105361662|NCT00368108|363330109|FG002|Overall Study|Protocol Violation|9|||
105361663|NCT00368108|363330107|FG000|Overall Study|Withdrawal by Subject|9|||
105361664|NCT00368108|363330108|FG001|Overall Study|Withdrawal by Subject|3|||
105361665|NCT00368108|363330109|FG002|Overall Study|Withdrawal by Subject|5|||
105361666|NCT00368108|363330107|FG000|Overall Study|Lack of Efficacy|7|||
105485907|NCT01155479|363789650|FG004|Part II|Non-Compliance with Protocol|0|||
105485908|NCT01117792|363789651|FG000|Overall Study|Death|1|||
105485909|NCT01117792|363789651|FG000|Overall Study|Adverse Event|3|||
105485910|NCT00046891|363789652|FG000|Overall Study|Cancels|5|||
105485911|NCT00046891|363789653|FG001|Overall Study|Cancels|9|||
105485912|NCT00046891|363789652|FG000|Overall Study|Ineligible|1|||
105485913|NCT00046891|363789653|FG001|Overall Study|Ineligible|1|||
105485914|NCT00046891|363789652|FG000|Overall Study|Withdrawal by Subject|18|||
105485915|NCT00046891|363789653|FG001|Overall Study|Withdrawal by Subject|15|||
105485916|NCT00046891|363789652|FG000|Overall Study|Adverse Event|5|||
105485917|NCT00046891|363789653|FG001|Overall Study|Adverse Event|5|||
105485918|NCT02009384|363789658|FG000|Overall Study|Death|2|||
105485919|NCT01146860|363789659|FG000|Overall Study|Withdrawal by Subject|0|||
105485920|NCT01146860|363789660|FG001|Overall Study|Withdrawal by Subject|1|||
105485921|NCT00393042|363789662|FG000|First Intervention|Withdrawal by Subject|1|||
105485922|NCT00393042|363789663|FG001|First Intervention|Withdrawal by Subject|2|||
105485923|NCT00393042|363789662|FG000|First Intervention|Lost to Follow-up|3|||
105485924|NCT00393042|363789663|FG001|First Intervention|Lost to Follow-up|3|||
105485925|NCT00393042|363789662|FG000|First Intervention|Protocol Violation|1|||
105485926|NCT00393042|363789663|FG001|First Intervention|Protocol Violation|0|||
105485927|NCT00393042|363789662|FG000|First Intervention|Adverse Event|0|||
105485928|NCT00393042|363789663|FG001|First Intervention|Adverse Event|1|||
105571506|NCT01225822|364091223|FG003|Overall Study|Lost to Follow-up|1|||
105571507|NCT01225822|364091224|FG004|Overall Study|Lost to Follow-up|0|||
105762761|NCT03365947|364783194|FG002|Overall Study|Lost to Follow-up|0|||
105762762|NCT03365947|364783195|FG003|Overall Study|Lost to Follow-up|0|||
105762763|NCT03365947|364783196|FG004|Overall Study|Lost to Follow-up|0|||
105762764|NCT03365947|364783197|FG005|Overall Study|Lost to Follow-up|1|||
105762765|NCT03365947|364783198|FG006|Overall Study|Lost to Follow-up|0|||
105762766|NCT03365947|364783199|FG007|Overall Study|Lost to Follow-up|0|||
105762767|NCT03365947|364783200|FG008|Overall Study|Lost to Follow-up|0|||
105762768|NCT03365947|364783201|FG009|Overall Study|Lost to Follow-up|0|||
105762769|NCT03365947|364783202|FG010|Overall Study|Lost to Follow-up|0|||
105762770|NCT03365947|364783203|FG011|Overall Study|Lost to Follow-up|0|||
105762771|NCT03365947|364783204|FG012|Overall Study|Lost to Follow-up|0|||
105762772|NCT03365947|364783205|FG013|Overall Study|Lost to Follow-up|0|||
105762773|NCT03365947|364783206|FG014|Overall Study|Lost to Follow-up|0|||
105762774|NCT03365947|364783207|FG015|Overall Study|Lost to Follow-up|0|||
105762775|NCT03365947|364783208|FG016|Overall Study|Lost to Follow-up|0|||
105762776|NCT03365947|364783209|FG017|Overall Study|Lost to Follow-up|0|||
105762777|NCT03365947|364783210|FG018|Overall Study|Lost to Follow-up|0|||
105762778|NCT01915095|364783211|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
105762779|NCT01915095|364783212|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
105762780|NCT01915095|364783213|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
105762781|NCT01915095|364783214|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
105762782|NCT01915095|364783215|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
105762783|NCT04018612|364783216|FG000|Overall Study|Withdrawal by Subject|1|||
105762784|NCT04018612|364783217|FG001|Overall Study|Withdrawal by Subject|0|||
105762785|NCT04018612|364783218|FG002|Overall Study|Withdrawal by Subject|1|||
105762786|NCT00462488|364784789|FG000|Overall Study|Protocol Violation|1|||
105485929|NCT00393042|363789662|FG000|Second Intervetion|Adverse Event|0|||
105485930|NCT00393042|363789663|FG001|Second Intervetion|Adverse Event|3|||
105485931|NCT00393042|363789662|FG000|Second Intervetion|Withdrawal by Subject|0|||
105762787|NCT00462488|364784790|FG001|Overall Study|Protocol Violation|0|||
105762788|NCT00462488|364784789|FG000|Overall Study|Lack of Efficacy|19|||
105762789|NCT00462488|364784790|FG001|Overall Study|Lack of Efficacy|17|||
105762790|NCT03984812|364784792|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762791|NCT03984812|364784793|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105361667|NCT00368108|363330108|FG001|Overall Study|Lack of Efficacy|8|||
105361668|NCT00368108|363330109|FG002|Overall Study|Lack of Efficacy|5|||
105361669|NCT00368108|363330107|FG000|Overall Study|Physician Decision|2|||
105361670|NCT00368108|363330108|FG001|Overall Study|Physician Decision|0|||
105361671|NCT00368108|363330109|FG002|Overall Study|Physician Decision|1|||
105361672|NCT00368108|363330107|FG000|Overall Study|Other|3|||
105361673|NCT00368108|363330108|FG001|Overall Study|Other|7|||
105361674|NCT00368108|363330109|FG002|Overall Study|Other|1|||
105361675|NCT04613739|363330110|FG000|Overall Study|Lost to Follow-up|6|||
105361676|NCT04613739|363330111|FG001|Overall Study|Lost to Follow-up|9|||
105361677|NCT04613739|363330110|FG000|Overall Study|potentially duplicative/fraudulent|1|||
105361678|NCT04613739|363330111|FG001|Overall Study|potentially duplicative/fraudulent|3|||
105361679|NCT01831427|363330112|FG000|Overall Study|Adverse Event|0|||
105361680|NCT01831427|363330113|FG001|Overall Study|Adverse Event|1|||
105361681|NCT01831427|363330114|FG002|Overall Study|Adverse Event|0|||
105361682|NCT01831427|363330115|FG003|Overall Study|Adverse Event|0|||
105361683|NCT01831427|363330116|FG004|Overall Study|Adverse Event|0|||
105361684|NCT01831427|363330117|FG005|Overall Study|Adverse Event|1|||
105361685|NCT01831427|363330118|FG006|Overall Study|Adverse Event|0|||
105361686|NCT01831427|363330119|FG007|Overall Study|Adverse Event|1|||
105361687|NCT01831427|363330120|FG008|Overall Study|Adverse Event|0|||
105361688|NCT01831427|363330121|FG009|Overall Study|Adverse Event|0|||
105361689|NCT01831427|363330122|FG010|Overall Study|Adverse Event|2|||
105361690|NCT01831427|363330112|FG000|Overall Study|Investigator's Discretion|0|||
105361691|NCT01831427|363330113|FG001|Overall Study|Investigator's Discretion|0|||
105361692|NCT01831427|363330114|FG002|Overall Study|Investigator's Discretion|0|||
105361693|NCT01831427|363330115|FG003|Overall Study|Investigator's Discretion|1|||
105361694|NCT01831427|363330116|FG004|Overall Study|Investigator's Discretion|0|||
105361695|NCT01831427|363330117|FG005|Overall Study|Investigator's Discretion|0|||
105361696|NCT01831427|363330118|FG006|Overall Study|Investigator's Discretion|0|||
105361697|NCT01831427|363330119|FG007|Overall Study|Investigator's Discretion|0|||
105361698|NCT01831427|363330120|FG008|Overall Study|Investigator's Discretion|0|||
105361699|NCT01831427|363330121|FG009|Overall Study|Investigator's Discretion|0|||
105361700|NCT01831427|363330122|FG010|Overall Study|Investigator's Discretion|0|||
105361701|NCT01831427|363330112|FG000|Overall Study|Withdrew Consent|0|||
105361702|NCT01831427|363330113|FG001|Overall Study|Withdrew Consent|0|||
105361703|NCT01831427|363330114|FG002|Overall Study|Withdrew Consent|0|||
105361704|NCT01831427|363330115|FG003|Overall Study|Withdrew Consent|0|||
105361705|NCT01831427|363330116|FG004|Overall Study|Withdrew Consent|0|||
105361706|NCT01831427|363330117|FG005|Overall Study|Withdrew Consent|0|||
105361707|NCT01831427|363330118|FG006|Overall Study|Withdrew Consent|2|||
105361708|NCT01831427|363330119|FG007|Overall Study|Withdrew Consent|0|||
105361709|NCT01831427|363330120|FG008|Overall Study|Withdrew Consent|0|||
105361710|NCT01831427|363330121|FG009|Overall Study|Withdrew Consent|1|||
105361711|NCT01831427|363330122|FG010|Overall Study|Withdrew Consent|1|||
105361712|NCT01093586|363330123|FG000|Overall Study|Failed to engraft|3|||
105361713|NCT02035553|363330124|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
105361714|NCT02035553|363330125|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
105361715|NCT02035553|363330124|FG000|Overall Study|Adverse Event|10|||
105361716|NCT02035553|363330125|FG001|Overall Study|Adverse Event|6|||
105361717|NCT02035553|363330124|FG000|Overall Study|Physician Decision|3|||
105361718|NCT02035553|363330125|FG001|Overall Study|Physician Decision|2|||
105361719|NCT02035553|363330124|FG000|Overall Study|Lack of Efficacy|1|||
105361720|NCT02035553|363330125|FG001|Overall Study|Lack of Efficacy|1|||
105361721|NCT02035553|363330124|FG000|Overall Study|Withdrawal by Subject|4|||
105361722|NCT02035553|363330125|FG001|Overall Study|Withdrawal by Subject|7|||
105361723|NCT02035553|363330124|FG000|Overall Study|Non-compliance with Study Drug|0|||
105361724|NCT02035553|363330125|FG001|Overall Study|Non-compliance with Study Drug|1|||
105485932|NCT00393042|363789663|FG001|Second Intervetion|Withdrawal by Subject|2|||
105485933|NCT00393042|363789662|FG000|Second Intervetion|Lack of Efficacy|1|||
105485934|NCT00393042|363789663|FG001|Second Intervetion|Lack of Efficacy|0|||
105485935|NCT00393042|363789662|FG000|Second Intervetion|Lost to Follow-up|0|||
105485936|NCT00393042|363789663|FG001|Second Intervetion|Lost to Follow-up|2|||
105361725|NCT02035553|363330124|FG000|Overall Study|Lost to Follow-up|0|||
105361726|NCT02035553|363330125|FG001|Overall Study|Lost to Follow-up|1|||
105361727|NCT02035553|363330124|FG000|Overall Study|Other Reason|0|||
105361728|NCT02035553|363330125|FG001|Overall Study|Other Reason|4|||
105361729|NCT01854697|363330126|FG000|Overall Study|Adverse Event|1|||
105361730|NCT01854697|363330127|FG001|Overall Study|Adverse Event|0|||
105361731|NCT01854697|363330128|FG002|Overall Study|Adverse Event|0|||
105361732|NCT01854697|363330129|FG003|Overall Study|Adverse Event|0|||
105361733|NCT01854697|363330130|FG004|Overall Study|Adverse Event|1|||
105361734|NCT01854697|363330126|FG000|Overall Study|Lost to Follow-up|4|||
105361735|NCT01854697|363330127|FG001|Overall Study|Lost to Follow-up|1|||
105361736|NCT01854697|363330128|FG002|Overall Study|Lost to Follow-up|1|||
105361737|NCT01854697|363330129|FG003|Overall Study|Lost to Follow-up|2|||
105361738|NCT01854697|363330130|FG004|Overall Study|Lost to Follow-up|0|||
105485937|NCT00393042|363789662|FG000|Second Intervetion|Protocol Violation|1|||
105361739|NCT01854697|363330126|FG000|Overall Study|To enter another AbbVie study|1|||
105811515|NCT02207231|364966539|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
105571508|NCT01225822|364091220|FG000|Overall Study|Withdrawal by Subject|6|||
105571509|NCT01225822|364091221|FG001|Overall Study|Withdrawal by Subject|7|||
105571510|NCT01225822|364091222|FG002|Overall Study|Withdrawal by Subject|7|||
105571511|NCT01225822|364091223|FG003|Overall Study|Withdrawal by Subject|11|||
105571512|NCT01225822|364091224|FG004|Overall Study|Withdrawal by Subject|6|||
105571513|NCT01225822|364091220|FG000|Overall Study|Other|13|||
105571514|NCT01225822|364091221|FG001|Overall Study|Other|10|||
105811516|NCT02207231|364966540|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
105811517|NCT02207231|364966541|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
105811518|NCT02207231|364966538|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
105811519|NCT02207231|364966539|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
105811520|NCT02207231|364966540|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
105811521|NCT02207231|364966541|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
105811522|NCT02207231|364966538|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
105811523|NCT02207231|364966539|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
105811524|NCT02207231|364966540|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
105811525|NCT02207231|364966541|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
105811526|NCT01829464|364966550|FG000|Overall Study|Adverse Event|1|||
105811527|NCT01829464|364966551|FG001|Overall Study|Adverse Event|0|||
105811528|NCT01829464|364966552|FG002|Overall Study|Adverse Event|0|||
105811529|NCT01829464|364966550|FG000|Overall Study|Lost to Follow-up|0|||
105811530|NCT01829464|364966551|FG001|Overall Study|Lost to Follow-up|0|||
105811531|NCT01829464|364966552|FG002|Overall Study|Lost to Follow-up|1|||
105811532|NCT01829464|364966550|FG000|Overall Study|Withdrawal by Subject|2|||
105811533|NCT01829464|364966551|FG001|Overall Study|Withdrawal by Subject|0|||
105811534|NCT01829464|364966552|FG002|Overall Study|Withdrawal by Subject|0|||
105811535|NCT01829464|364966550|FG000|Overall Study|Study terminated by sponsor|25|||
105811536|NCT01829464|364966551|FG001|Overall Study|Study terminated by sponsor|28|||
105811537|NCT01829464|364966552|FG002|Overall Study|Study terminated by sponsor|25|||
105811538|NCT01829464|364966550|FG000|Overall Study|Lack of Efficacy|0|||
105811539|NCT01829464|364966551|FG001|Overall Study|Lack of Efficacy|1|||
105811540|NCT01829464|364966552|FG002|Overall Study|Lack of Efficacy|0|||
105811541|NCT04700449|364966557|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
105811542|NCT04700449|364966558|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
105811543|NCT04700449|364966559|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
105811544|NCT04700449|364966560|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
105811545|NCT04700449|364966557|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
105811546|NCT04700449|364966558|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
105811547|NCT04700449|364966559|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
105811548|NCT04700449|364966560|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
105811549|NCT04700449|364966557|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
105811550|NCT04700449|364966558|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
105811551|NCT04700449|364966559|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
105811552|NCT04700449|364966560|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
105811553|NCT04700449|364966557|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
105811554|NCT04700449|364966558|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
105811555|NCT04700449|364966559|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
105811556|NCT04700449|364966560|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
105811557|NCT04700449|364966557|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
105361740|NCT01854697|363330127|FG001|Overall Study|To enter another AbbVie study|0|||
105571515|NCT01225822|364091222|FG002|Overall Study|Other|7|||
105811558|NCT04700449|364966558|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
105811559|NCT04700449|364966559|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
105811560|NCT04700449|364966560|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
105811561|NCT04700449|364966557|FG000|Stage 1: Double-Blind Period|Other|0|||
105811562|NCT04700449|364966558|FG001|Stage 1: Double-Blind Period|Other|0|||
105811563|NCT04700449|364966559|FG002|Stage 1: Double-Blind Period|Other|1|||
105811564|NCT04700449|364966560|FG003|Stage 1: Double-Blind Period|Other|0|||
105361741|NCT01854697|363330128|FG002|Overall Study|To enter another AbbVie study|0|||
105361742|NCT01854697|363330129|FG003|Overall Study|To enter another AbbVie study|0|||
105361743|NCT01854697|363330130|FG004|Overall Study|To enter another AbbVie study|1|||
105361744|NCT01854697|363330126|FG000|Overall Study|Withdrew Consent|0|||
105361745|NCT01854697|363330127|FG001|Overall Study|Withdrew Consent|1|||
105361746|NCT01854697|363330128|FG002|Overall Study|Withdrew Consent|0|||
105361747|NCT01854697|363330129|FG003|Overall Study|Withdrew Consent|1|||
105361748|NCT01854697|363330130|FG004|Overall Study|Withdrew Consent|0|||
105361749|NCT01854697|363330126|FG000|Overall Study|Other|0|||
105361750|NCT01854697|363330127|FG001|Overall Study|Other|1|||
105361751|NCT01854697|363330128|FG002|Overall Study|Other|1|||
105361752|NCT01854697|363330129|FG003|Overall Study|Other|0|||
105485938|NCT00393042|363789663|FG001|Second Intervetion|Protocol Violation|1|||
105762792|NCT03984812|364784794|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
105762793|NCT03984812|364784795|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762794|NCT03984812|364784796|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762795|NCT03984812|364784797|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762796|NCT03984812|364784798|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762797|NCT03984812|364784799|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762798|NCT03984812|364784800|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762799|NCT03984812|364784801|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762800|NCT03984812|364784802|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762801|NCT00446641|364784803|FG000|Overall Study|Withdrawal by Subject|8|||
105762802|NCT00446641|364784804|FG001|Overall Study|Withdrawal by Subject|3|||
105762803|NCT00446641|364784803|FG000|Overall Study|poor compliance|8|||
105762804|NCT00446641|364784804|FG001|Overall Study|poor compliance|6|||
105762805|NCT00446641|364784803|FG000|Overall Study|Lost to Follow-up|1|||
105762806|NCT00446641|364784804|FG001|Overall Study|Lost to Follow-up|1|||
105762807|NCT00443846|364784812|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
105762808|NCT00443846|364784813|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
105762809|NCT00443846|364784812|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
105762810|NCT00443846|364784813|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
105762811|NCT00443846|364784812|FG000|Overall Study|Adverse Event|0|||
105762812|NCT00443846|364784813|FG001|Overall Study|Adverse Event|1|||
105762813|NCT00443846|364784812|FG000|Overall Study|Personal reason|8|||
105762814|NCT00443846|364784813|FG001|Overall Study|Personal reason|3|||
105811565|NCT04700449|364966557|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
105811566|NCT04700449|364966558|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
105811567|NCT04700449|364966559|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
105811568|NCT04700449|364966560|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
105811569|NCT04700449|364966557|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
105811570|NCT04700449|364966558|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
105811571|NCT04700449|364966559|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
105811572|NCT04700449|364966560|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
105811573|NCT04700449|364966557|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
105811574|NCT04700449|364966558|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
105811575|NCT04700449|364966559|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
105811576|NCT04700449|364966560|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
105811577|NCT04700449|364966557|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
105811578|NCT04700449|364966558|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
105811579|NCT04700449|364966559|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
105811580|NCT04700449|364966560|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
105811581|NCT04700449|364966557|FG000|Stage 2 Sub-study 1|Other|1|||
105811582|NCT04700449|364966558|FG001|Stage 2 Sub-study 1|Other|2|||
105811583|NCT04700449|364966559|FG002|Stage 2 Sub-study 1|Other|0|||
105485939|NCT00266864|363789664|FG000|Overall Study|Lost to Follow-up|4|||
105361753|NCT01854697|363330130|FG004|Overall Study|Other|0|||
105811584|NCT04700449|364966560|FG003|Stage 2 Sub-study 1|Other|0|||
105361754|NCT01178125|363330135|FG000|Overall Study|Lost to Follow-up|397|||
105361755|NCT01178125|363330135|FG000|Overall Study|Adverse Event|244|||
105361756|NCT01178125|363330135|FG000|Overall Study|Withdrawal by Subject|209|||
105361757|NCT01178125|363330135|FG000|Overall Study|Noncompliance|184|||
105361758|NCT01178125|363330135|FG000|Overall Study|Pregnancy|55|||
105361759|NCT01178125|363330135|FG000|Overall Study|Other Reason|39|||
105361760|NCT01178125|363330135|FG000|Overall Study|Sponsor Decision|28|||
105361761|NCT01178125|363330135|FG000|Overall Study|Protocol Violation|17|||
105361762|NCT01178125|363330135|FG000|Overall Study|Investigator Decision|5|||
105361763|NCT02948829|363330136|FG000|Overall Study|Lost to Follow-up|2|||
105361764|NCT02948829|363330136|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
105361765|NCT02948829|363330136|FG000|Overall Study|Pregnancy|1|||
105361766|NCT02948829|363330136|FG000|Overall Study|Other: Reason not Specified|8|||
105361767|NCT01004978|363330137|FG000|Overall Study|Disease progression|31|||
105361768|NCT01004978|363330138|FG001|Overall Study|Disease progression|48|||
105361769|NCT01004978|363330137|FG000|Overall Study|Adverse Event|42|||
105361770|NCT01004978|363330138|FG001|Overall Study|Adverse Event|22|||
105361771|NCT01004978|363330137|FG000|Overall Study|Death|3|||
105361772|NCT01004978|363330138|FG001|Overall Study|Death|2|||
105361773|NCT01004978|363330137|FG000|Overall Study|Withdrawal by Subject|16|||
105361774|NCT01004978|363330138|FG001|Overall Study|Withdrawal by Subject|16|||
105361775|NCT01004978|363330137|FG000|Overall Study|Alternative therapy|4|||
105361776|NCT01004978|363330138|FG001|Overall Study|Alternative therapy|8|||
105361777|NCT01004978|363330137|FG000|Overall Study|Physician Decision|6|||
105361778|NCT01004978|363330138|FG001|Overall Study|Physician Decision|3|||
105361779|NCT01004978|363330137|FG000|Overall Study|Other complicating disease|2|||
105361780|NCT01004978|363330138|FG001|Overall Study|Other complicating disease|2|||
105361781|NCT01004978|363330137|FG000|Overall Study|Protocol Violation|2|||
105361782|NCT01004978|363330138|FG001|Overall Study|Protocol Violation|3|||
105361783|NCT01004978|363330137|FG000|Overall Study|Non-compliance|3|||
105361784|NCT01004978|363330138|FG001|Overall Study|Non-compliance|2|||
105361785|NCT01004978|363330137|FG000|Overall Study|Ineligible|1|||
105361786|NCT01004978|363330138|FG001|Overall Study|Ineligible|0|||
105361787|NCT01004978|363330137|FG000|Overall Study|Unblinded|0|||
105361788|NCT01004978|363330138|FG001|Overall Study|Unblinded|1|||
105361789|NCT01004978|363330137|FG000|Overall Study|Performance status worsening|0|||
105361790|NCT01004978|363330138|FG001|Overall Study|Performance status worsening|1|||
105361791|NCT01004978|363330137|FG000|Overall Study|Never started treatment|8|||
105361792|NCT01004978|363330138|FG001|Overall Study|Never started treatment|9|||
105361793|NCT00369915|363330139|FG000|Overall Study|expected side effects|2|||
105361794|NCT00369915|363330140|FG001|Overall Study|expected side effects|1|||
105361795|NCT00369915|363330139|FG000|Overall Study|Withdrawal by Subject|4|||
105361796|NCT00369915|363330140|FG001|Overall Study|Withdrawal by Subject|1|||
105361797|NCT00369915|363330139|FG000|Overall Study|W/drawl by investigators|0|||
105361798|NCT00369915|363330140|FG001|Overall Study|W/drawl by investigators|1|||
105361799|NCT02326272|363330143|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105361800|NCT02326272|363330144|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
105361801|NCT02326272|363330145|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
105361802|NCT02326272|363330146|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105361803|NCT02326272|363330147|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105361804|NCT02326272|363330148|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105361805|NCT02326272|363330149|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105361806|NCT02326272|363330150|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105361807|NCT02326272|363330151|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105361808|NCT02326272|363330152|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105361809|NCT02326272|363330153|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105361810|NCT02326272|363330154|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105361811|NCT02326272|363330155|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105361812|NCT02326272|363330156|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105361813|NCT02326272|363330157|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105361814|NCT02326272|363330143|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
105361815|NCT02326272|363330144|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
105361816|NCT02326272|363330145|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105361817|NCT02326272|363330146|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105361818|NCT02326272|363330147|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105361819|NCT02326272|363330148|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105361820|NCT02326272|363330149|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105361821|NCT02326272|363330150|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105361822|NCT02326272|363330151|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105361823|NCT02326272|363330152|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105361824|NCT02326272|363330153|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105361825|NCT02326272|363330154|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105361826|NCT02326272|363330155|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105571516|NCT01225822|364091223|FG003|Overall Study|Other|10|||
105811585|NCT04700449|364966557|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
105811586|NCT04700449|364966558|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
105811587|NCT04700449|364966559|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
105811588|NCT04700449|364966560|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
105811589|NCT04700449|364966557|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
105811590|NCT04700449|364966558|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
105811591|NCT04700449|364966559|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
105811592|NCT04700449|364966560|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
105811593|NCT04700449|364966557|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
105811594|NCT04700449|364966558|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
105811595|NCT04700449|364966559|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
105811596|NCT04700449|364966560|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
105811597|NCT04700449|364966557|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
105811598|NCT04700449|364966558|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
105811599|NCT04700449|364966559|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
105811600|NCT04700449|364966560|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
105811601|NCT04700449|364966557|FG000|Stage 2 Sub-study 2|Other|0|||
105811602|NCT04700449|364966558|FG001|Stage 2 Sub-study 2|Other|0|||
105811603|NCT04700449|364966559|FG002|Stage 2 Sub-study 2|Other|0|||
105811604|NCT04700449|364966560|FG003|Stage 2 Sub-study 2|Other|5|||
105811605|NCT00502775|364966561|FG000|Overall Study|Adverse Event|1|||
105811606|NCT00502775|364966562|FG001|Overall Study|Adverse Event|2|||
105811607|NCT00502775|364966563|FG002|Overall Study|Adverse Event|1|||
105811608|NCT00502775|364966561|FG000|Overall Study|Protocol Violation|1|||
105811609|NCT00502775|364966562|FG001|Overall Study|Protocol Violation|5|||
105811610|NCT00502775|364966563|FG002|Overall Study|Protocol Violation|2|||
105811611|NCT00502775|364966561|FG000|Overall Study|Withdrawal by Subject|1|||
105811612|NCT00502775|364966562|FG001|Overall Study|Withdrawal by Subject|1|||
105811613|NCT00502775|364966563|FG002|Overall Study|Withdrawal by Subject|2|||
105811614|NCT00502775|364966561|FG000|Overall Study|Sponsor Terminated Study|1|||
105811615|NCT00502775|364966562|FG001|Overall Study|Sponsor Terminated Study|0|||
105811616|NCT00502775|364966563|FG002|Overall Study|Sponsor Terminated Study|1|||
105811617|NCT00502775|364966561|FG000|Overall Study|Non-compliance with eDiary|4|||
105811618|NCT00502775|364966562|FG001|Overall Study|Non-compliance with eDiary|1|||
105811619|NCT00502775|364966563|FG002|Overall Study|Non-compliance with eDiary|1|||
105811620|NCT00502775|364966561|FG000|Overall Study|Subject unable to swallow capsule|1|||
105811621|NCT00502775|364966562|FG001|Overall Study|Subject unable to swallow capsule|0|||
105811622|NCT00502775|364966563|FG002|Overall Study|Subject unable to swallow capsule|1|||
105811623|NCT00502775|364966561|FG000|Overall Study|Logpad compliance <80%|1|||
105811624|NCT00502775|364966562|FG001|Overall Study|Logpad compliance <80%|0|||
105811625|NCT00502775|364966563|FG002|Overall Study|Logpad compliance <80%|0|||
105811626|NCT00502775|364966561|FG000|Overall Study|Randomized in error|0|||
105811627|NCT00502775|364966562|FG001|Overall Study|Randomized in error|1|||
105485940|NCT00266864|363789665|FG001|Overall Study|Lost to Follow-up|1|||
105485941|NCT00266864|363789664|FG000|Overall Study|Withdrawal by Subject|1|||
105811628|NCT00502775|364966563|FG002|Overall Study|Randomized in error|1|||
105811629|NCT00502775|364966561|FG000|Overall Study|Non-compliance|0|||
105811630|NCT00502775|364966562|FG001|Overall Study|Non-compliance|2|||
105811631|NCT00502775|364966563|FG002|Overall Study|Non-compliance|2|||
105811632|NCT00502775|364966561|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
105811633|NCT00502775|364966562|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
105811634|NCT00502775|364966563|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
105811635|NCT00502775|364966561|FG000|Overall Study|Declining pollen counts|0|||
105811636|NCT00502775|364966562|FG001|Overall Study|Declining pollen counts|1|||
105811637|NCT00502775|364966563|FG002|Overall Study|Declining pollen counts|1|||
105485942|NCT00266864|363789665|FG001|Overall Study|Withdrawal by Subject|1|||
105485943|NCT00993044|363789666|FG000|Irinotecan 50 mg|Physician Decision|1|||
105811638|NCT00502775|364966561|FG000|Overall Study|Subject in jail|0|||
105811639|NCT00502775|364966562|FG001|Overall Study|Subject in jail|1|||
105485944|NCT05772702|363789676|FG000|Overall Study|Adverse Event|1|||
105811640|NCT00502775|364966563|FG002|Overall Study|Subject in jail|0|||
105811641|NCT00502775|364966561|FG000|Overall Study|Subject took disallowed drug|0|||
105811642|NCT00502775|364966562|FG001|Overall Study|Subject took disallowed drug|0|||
105811643|NCT00502775|364966563|FG002|Overall Study|Subject took disallowed drug|1|||
105811644|NCT01521559|364966564|FG000|Overall Study|Adverse Event|0|||
105811645|NCT01521559|364966565|FG001|Overall Study|Adverse Event|4|||
105811646|NCT01521559|364966564|FG000|Overall Study|Death|1|||
105811647|NCT01521559|364966565|FG001|Overall Study|Death|0|||
105811648|NCT01521559|364966564|FG000|Overall Study|Withdrawal by Subject|9|||
105811649|NCT01521559|364966565|FG001|Overall Study|Withdrawal by Subject|11|||
105811650|NCT01521559|364966564|FG000|Overall Study|Lost to Follow-up|3|||
105811651|NCT01521559|364966565|FG001|Overall Study|Lost to Follow-up|1|||
105811652|NCT01521559|364966564|FG000|Overall Study|Protocol Violation|1|||
105811653|NCT01521559|364966565|FG001|Overall Study|Protocol Violation|0|||
105811654|NCT01521559|364966564|FG000|Overall Study|Other|1|||
105811655|NCT01521559|364966565|FG001|Overall Study|Other|2|||
105811656|NCT00520741|364966568|FG000|Overall Study|Adverse Event|16|||
105811657|NCT00520741|364966569|FG001|Overall Study|Adverse Event|56|||
105811658|NCT00520741|364966568|FG000|Overall Study|Lack of Efficacy|11|||
105811659|NCT00520741|364966569|FG001|Overall Study|Lack of Efficacy|30|||
105811660|NCT00520741|364966568|FG000|Overall Study|Withdrawal by Subject|0|||
105811661|NCT00520741|364966569|FG001|Overall Study|Withdrawal by Subject|11|||
105811662|NCT00520741|364966568|FG000|Overall Study|Protocol Violation|2|||
105811663|NCT00520741|364966569|FG001|Overall Study|Protocol Violation|15|||
105361827|NCT02326272|363330156|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105361828|NCT02326272|363330157|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105361829|NCT02326272|363330143|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
105361830|NCT02326272|363330144|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
105361831|NCT02326272|363330145|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
105361832|NCT02326272|363330146|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105361833|NCT02326272|363330147|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105361834|NCT02326272|363330148|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105361835|NCT02326272|363330149|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105361836|NCT02326272|363330150|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105361837|NCT02326272|363330151|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105361838|NCT02326272|363330152|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105361839|NCT02326272|363330153|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105361840|NCT02326272|363330154|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105361841|NCT02326272|363330155|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105361842|NCT02326272|363330156|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105361843|NCT02326272|363330157|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105361844|NCT02326272|363330143|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105361845|NCT02326272|363330144|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105361846|NCT02326272|363330145|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
105361847|NCT02326272|363330146|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105361848|NCT02326272|363330147|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105361849|NCT02326272|363330148|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105361850|NCT02326272|363330149|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105361851|NCT02326272|363330150|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105361852|NCT02326272|363330151|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105361853|NCT02326272|363330152|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105361854|NCT02326272|363330153|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105361855|NCT02326272|363330154|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105361856|NCT02326272|363330155|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105361857|NCT02326272|363330156|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105811664|NCT00520741|364966568|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
105811665|NCT00520741|364966569|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
105811666|NCT00520741|364966568|FG000|Overall Study|Lost to Follow-up|4|||
105811667|NCT00520741|364966569|FG001|Overall Study|Lost to Follow-up|4|||
105811668|NCT00520741|364966568|FG000|Overall Study|Other reasons for premature termination|0|||
105361858|NCT02326272|363330157|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105361859|NCT02326272|363330143|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105361860|NCT02326272|363330144|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105361861|NCT02326272|363330145|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
105485945|NCT01909453|363789677|FG000|Overall Study|Ongoing|118|||
105485946|NCT01909453|363789678|FG001|Overall Study|Ongoing|103|||
105811669|NCT00520741|364966569|FG001|Overall Study|Other reasons for premature termination|6|||
105811670|NCT03103100|364966570|FG000|Overall Study|Adverse Event|1|||
105811671|NCT03103100|364966571|FG001|Overall Study|Adverse Event|0|||
105811672|NCT03103100|364966572|FG002|Overall Study|Adverse Event|0|||
105811673|NCT03103100|364966570|FG000|Overall Study|Physician Decision|1|||
105811674|NCT03103100|364966571|FG001|Overall Study|Physician Decision|0|||
105811675|NCT03103100|364966572|FG002|Overall Study|Physician Decision|2|||
105811676|NCT00531206|364966573|FG000|Overall Study|Adverse Event related|5|||
105811677|NCT00531206|364966573|FG000|Overall Study|Lack of Efficacy|2|||
105811678|NCT00531206|364966573|FG000|Overall Study|Lost to Follow-up|5|||
105811679|NCT00531206|364966573|FG000|Overall Study|including non-related adverse events|8|||
105811680|NCT02227862|364966574|FG000|Overall Study|Protocol Violation|7|||
105811681|NCT02227862|364966575|FG001|Overall Study|Protocol Violation|9|||
105811682|NCT02227862|364966574|FG000|Overall Study|Other|0|||
105811683|NCT02227862|364966575|FG001|Overall Study|Other|2|||
105811684|NCT02227862|364966574|FG000|Overall Study|Adverse Event|4|||
105811685|NCT02227862|364966575|FG001|Overall Study|Adverse Event|3|||
105811686|NCT02227862|364966574|FG000|Overall Study|Withdrawal by Subject|7|||
105811687|NCT02227862|364966575|FG001|Overall Study|Withdrawal by Subject|6|||
105811688|NCT02227862|364966574|FG000|Overall Study|Lost to Follow-up|1|||
105811689|NCT02227862|364966575|FG001|Overall Study|Lost to Follow-up|2|||
105811690|NCT01124149|364966576|FG000|Acute Phase|Withdrawal by Subject|22|||
105811691|NCT01124149|364966576|FG000|Acute Phase|Adverse Event|21|||
105811692|NCT01124149|364966576|FG000|Acute Phase|Lack of Efficacy|17|||
105811693|NCT01124149|364966576|FG000|Acute Phase|Protocol Violation|14|||
105811694|NCT01124149|364966576|FG000|Acute Phase|Lost to Follow-up|2|||
105811695|NCT01124149|364966576|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
105811696|NCT01124149|364966576|FG000|Acute Phase|Sponsor request|1|||
105811697|NCT01124149|364966576|FG000|Acute Phase|UC symptoms not ameliorated|1|||
105811698|NCT01124149|364966576|FG000|Acute Phase|Non-compliance|1|||
105811699|NCT01124149|364966576|FG000|Acute Phase|Low hemoglobin|1|||
105811700|NCT01124149|364966576|FG000|Acute Phase|Travelling to another country|1|||
105811701|NCT01124149|364966576|FG000|Acute Phase|Sponsor decision|1|||
105811702|NCT01124149|364966576|FG000|Maintenance Phase|Lack of Efficacy|40|||
105811703|NCT01124149|364966576|FG000|Maintenance Phase|Adverse Event|24|||
105811704|NCT01124149|364966576|FG000|Maintenance Phase|Lost to Follow-up|15|||
105811705|NCT01124149|364966576|FG000|Maintenance Phase|Withdrawal by Subject|10|||
105811706|NCT01124149|364966576|FG000|Maintenance Phase|Protocol Violation|5|||
105811707|NCT01124149|364966576|FG000|Maintenance Phase|Coordinator error|1|||
105811708|NCT01124149|364966576|FG000|Maintenance Phase|Non-compliance|1|||
105811709|NCT01644500|364966579|FG000|Overall Study|Adverse Event|6|||
105811710|NCT01644500|364966580|FG001|Overall Study|Adverse Event|1|||
105811711|NCT01644500|364966581|FG002|Overall Study|Adverse Event|2|||
105485947|NCT01909453|363789679|FG002|Overall Study|Ongoing|83|||
105361862|NCT02326272|363330146|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105361863|NCT02326272|363330147|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105361864|NCT02326272|363330148|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105361865|NCT02326272|363330149|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105361866|NCT02326272|363330150|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105361867|NCT02326272|363330151|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105361868|NCT02326272|363330152|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105571517|NCT01225822|364091224|FG004|Overall Study|Other|7|||
105811712|NCT01644500|364966579|FG000|Overall Study|Death|0|||
105811713|NCT01644500|364966580|FG001|Overall Study|Death|1|||
105811714|NCT01644500|364966581|FG002|Overall Study|Death|0|||
105811715|NCT01644500|364966579|FG000|Overall Study|Lost to Follow-up|3|||
105811716|NCT01644500|364966580|FG001|Overall Study|Lost to Follow-up|8|||
105811717|NCT01644500|364966581|FG002|Overall Study|Lost to Follow-up|0|||
105811718|NCT01644500|364966579|FG000|Overall Study|Protocol Violation|1|||
105811719|NCT01644500|364966580|FG001|Overall Study|Protocol Violation|1|||
105811720|NCT01644500|364966581|FG002|Overall Study|Protocol Violation|0|||
105811721|NCT01644500|364966579|FG000|Overall Study|Withdrawal by Subject|11|||
105811722|NCT01644500|364966580|FG001|Overall Study|Withdrawal by Subject|12|||
105811723|NCT01644500|364966581|FG002|Overall Study|Withdrawal by Subject|12|||
105811724|NCT01644500|364966579|FG000|Overall Study|Physician Decision|1|||
105811725|NCT01644500|364966580|FG001|Overall Study|Physician Decision|1|||
105811726|NCT01644500|364966581|FG002|Overall Study|Physician Decision|1|||
105811727|NCT00634907|364966582|FG000|Overall Study|Withdrawal by Subject|3|||
105811728|NCT00634907|364966583|FG001|Overall Study|Withdrawal by Subject|0|||
105811729|NCT00634907|364966582|FG000|Overall Study|Physician Decision|3|||
105811730|NCT00634907|364966583|FG001|Overall Study|Physician Decision|9|||
105811731|NCT00634907|364966582|FG000|Overall Study|Withdrawal by Subject|11|||
105811732|NCT00634907|364966583|FG001|Overall Study|Withdrawal by Subject|8|||
105811733|NCT00810368|364966588|FG000|Overall Study|Lost to Follow-up|4|||
105811734|NCT00810368|364966589|FG001|Overall Study|Lost to Follow-up|2|||
105811735|NCT00810368|364966588|FG000|Overall Study|Lack of Efficacy|2|||
105811736|NCT00810368|364966589|FG001|Overall Study|Lack of Efficacy|0|||
105811737|NCT00322491|364966592|FG000|Overall Study|Adverse Event|1|||
105811738|NCT00322491|364966593|FG001|Overall Study|Adverse Event|0|||
105811739|NCT00322491|364966592|FG000|Overall Study|Death|1|||
105811740|NCT00322491|364966593|FG001|Overall Study|Death|2|||
105811741|NCT00001849|364966595|FG000|Overall Study|Death|4|||
105811742|NCT00001849|364966595|FG000|Overall Study|Lost to Follow-up|2|||
105811743|NCT00001849|364966595|FG000|Overall Study|Withdrawal by Subject|2|||
105811744|NCT00001849|364966595|FG000|Overall Study|tumor remained occult|6|||
105811745|NCT02166697|364966597|FG000|Overall Study|Protocol Violation|347|||
105811746|NCT01618266|364966601|FG000|Overall Study|Lost to Follow-up|9|||
105811747|NCT01618266|364966601|FG000|Overall Study|Treatment satisfaction|10|||
105811748|NCT01618266|364966601|FG000|Overall Study|Other reasons|11|||
105811749|NCT01618266|364966601|FG000|Overall Study|Lack of Efficacy|23|||
105811750|NCT01618266|364966601|FG000|Overall Study|Protocol Violation|43|||
105811751|NCT02752776|364966604|FG000|Overall Study|Adverse Event|15|||
105811752|NCT02752776|364966605|FG001|Overall Study|Adverse Event|23|||
105811753|NCT02752776|364966606|FG002|Overall Study|Adverse Event|11|||
105811754|NCT02752776|364966604|FG000|Overall Study|Lack of Efficacy|2|||
105811755|NCT02752776|364966605|FG001|Overall Study|Lack of Efficacy|6|||
105811756|NCT02752776|364966606|FG002|Overall Study|Lack of Efficacy|14|||
105811757|NCT02752776|364966604|FG000|Overall Study|Lost to Follow-up|11|||
105811758|NCT02752776|364966605|FG001|Overall Study|Lost to Follow-up|12|||
105571518|NCT00130793|364091225|FG000|Overall Study|Lost to Follow-up|1|||
105811759|NCT02752776|364966606|FG002|Overall Study|Lost to Follow-up|4|||
105811760|NCT02752776|364966604|FG000|Overall Study|Non-compliance with study treatment|0|||
105811761|NCT02752776|364966605|FG001|Overall Study|Non-compliance with study treatment|0|||
105811762|NCT02752776|364966606|FG002|Overall Study|Non-compliance with study treatment|1|||
105811763|NCT02752776|364966604|FG000|Overall Study|Physician Decision|2|||
105811764|NCT02752776|364966605|FG001|Overall Study|Physician Decision|6|||
105811765|NCT02752776|364966606|FG002|Overall Study|Physician Decision|2|||
105811766|NCT02752776|364966604|FG000|Overall Study|Pregnancy|1|||
105811767|NCT02752776|364966605|FG001|Overall Study|Pregnancy|6|||
105811768|NCT02752776|364966606|FG002|Overall Study|Pregnancy|3|||
105811769|NCT02752776|364966604|FG000|Overall Study|Protocol Violation|10|||
105811770|NCT02752776|364966605|FG001|Overall Study|Protocol Violation|13|||
105811771|NCT02752776|364966606|FG002|Overall Study|Protocol Violation|6|||
105811772|NCT02752776|364966604|FG000|Overall Study|Subject/guardian decision|8|||
105811773|NCT02752776|364966605|FG001|Overall Study|Subject/guardian decision|6|||
105811774|NCT02752776|364966606|FG002|Overall Study|Subject/guardian decision|4|||
105811775|NCT02752776|364966604|FG000|Overall Study|Death|0|||
105811776|NCT02752776|364966605|FG001|Overall Study|Death|0|||
105811777|NCT02752776|364966606|FG002|Overall Study|Death|1|||
105811778|NCT02752776|364966604|FG000|Overall Study|Withdrawal by Subject|3|||
105811779|NCT02752776|364966605|FG001|Overall Study|Withdrawal by Subject|4|||
105811780|NCT02752776|364966606|FG002|Overall Study|Withdrawal by Subject|2|||
105811781|NCT02492958|364966607|FG000|Overall Study|Withdrawal by Subject|0|||
105485948|NCT01909453|363789680|FG003|Overall Study|Ongoing|164|||
105485949|NCT01909453|363789681|FG004|Overall Study|Ongoing|50|||
105485950|NCT01909453|363789677|FG000|Overall Study|Death|69|||
105485951|NCT01909453|363789678|FG001|Overall Study|Death|74|||
105485952|NCT01909453|363789679|FG002|Overall Study|Death|88|||
105485953|NCT01909453|363789680|FG003|Overall Study|Death|86|||
105485954|NCT01909453|363789681|FG004|Overall Study|Death|29|||
105485955|NCT01909453|363789677|FG000|Overall Study|Lost to Follow-up|3|||
105485956|NCT01909453|363789678|FG001|Overall Study|Lost to Follow-up|4|||
105485957|NCT01909453|363789679|FG002|Overall Study|Lost to Follow-up|4|||
105485958|NCT01909453|363789680|FG003|Overall Study|Lost to Follow-up|3|||
105485959|NCT01909453|363789681|FG004|Overall Study|Lost to Follow-up|3|||
105485960|NCT01909453|363789677|FG000|Overall Study|Withdrawal by Subject|2|||
105485961|NCT01909453|363789678|FG001|Overall Study|Withdrawal by Subject|13|||
105485962|NCT01909453|363789679|FG002|Overall Study|Withdrawal by Subject|16|||
105485963|NCT01909453|363789680|FG003|Overall Study|Withdrawal by Subject|5|||
105485964|NCT01909453|363789681|FG004|Overall Study|Withdrawal by Subject|4|||
105485965|NCT04224272|363789682|FG000|Part 1 - Dose Finding|Death|4|||
105485966|NCT04224272|363789682|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
105485967|NCT04224272|363789682|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
105485968|NCT04224272|363789682|FG000|Part 2 - Dose Expansion|Death|10|||
105811782|NCT02492958|364966608|FG001|Overall Study|Withdrawal by Subject|0|||
105811783|NCT02492958|364966609|FG002|Overall Study|Withdrawal by Subject|1|||
105811784|NCT02492958|364966610|FG003|Overall Study|Withdrawal by Subject|0|||
105811785|NCT02492958|364966607|FG000|Overall Study|Adverse Event|1|||
105811786|NCT02492958|364966608|FG001|Overall Study|Adverse Event|0|||
105811787|NCT02492958|364966609|FG002|Overall Study|Adverse Event|1|||
105485969|NCT04224272|363789682|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
105485970|NCT04085367|363791348|FG000|Overall Study|Adverse Event|1|||
105485971|NCT04085367|363791349|FG001|Overall Study|Adverse Event|1|||
105485972|NCT04085367|363791348|FG000|Overall Study|Withdrawal by Subject|13|||
105485973|NCT04085367|363791349|FG001|Overall Study|Withdrawal by Subject|4|||
105571519|NCT00130793|364091226|FG001|Overall Study|Lost to Follow-up|4|||
105361869|NCT02326272|363330153|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105361870|NCT02326272|363330154|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105361871|NCT02326272|363330155|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105361872|NCT02326272|363330156|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105485974|NCT04085367|363791348|FG000|Overall Study|Lost to Follow-up|3|||
105485975|NCT04085367|363791349|FG001|Overall Study|Lost to Follow-up|1|||
105485976|NCT04085367|363791348|FG000|Overall Study|Other unspecified|2|||
105811788|NCT02492958|364966610|FG003|Overall Study|Adverse Event|0|||
105811789|NCT01901055|364966611|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
105485977|NCT04085367|363791349|FG001|Overall Study|Other unspecified|1|||
105485978|NCT04085367|363791348|FG000|Overall Study|Status Unknown|1|||
105485979|NCT04085367|363791349|FG001|Overall Study|Status Unknown|1|||
105485980|NCT01879579|363791353|FG000|Overall Study|Phone incompatible with texting platform|3|||
105811790|NCT01901055|364966612|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
105811791|NCT01901055|364966611|FG000|Randomization But Not Titrated|Physician Decision|0|||
105811792|NCT01901055|364966612|FG001|Randomization But Not Titrated|Physician Decision|1|||
105811793|NCT01901055|364966611|FG000|Started Protocol to Week 6|Physician Decision|2|||
105811794|NCT01901055|364966612|FG001|Started Protocol to Week 6|Physician Decision|1|||
105811795|NCT01901055|364966611|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
105811796|NCT01901055|364966612|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
105811797|NCT01901055|364966611|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
105811798|NCT01901055|364966612|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
105811799|NCT01901055|364966611|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
105811800|NCT01901055|364966612|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
105811801|NCT01901055|364966611|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
105811802|NCT01901055|364966612|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
105811803|NCT01901055|364966611|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
105811804|NCT01901055|364966612|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
105811805|NCT01901055|364966611|FG000|Week 24|Withdrawal by Subject|13|||
105811806|NCT01901055|364966612|FG001|Week 24|Withdrawal by Subject|19|||
105811807|NCT01901055|364966611|FG000|Week 24|Physician Decision|1|||
105811808|NCT01901055|364966612|FG001|Week 24|Physician Decision|0|||
105811809|NCT01901055|364966611|FG000|Week 36|Withdrawal by Subject|0|||
105811810|NCT01901055|364966612|FG001|Week 36|Withdrawal by Subject|5|||
105811811|NCT00635154|364966613|FG000|Overall Study|Alternative Treatment|8|||
105811812|NCT00635154|364966613|FG000|Overall Study|Other|4|||
105811813|NCT00635154|364966613|FG000|Overall Study|Still on treatment|21|||
105811814|NCT02540356|364966614|FG000|Overall Study|Terminated due to disease progression|1|||
105811815|NCT02540356|364966615|FG001|Overall Study|Terminated due to disease progression|0|||
105811816|NCT02795104|364966616|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
105485981|NCT01879579|363791354|FG001|Overall Study|Phone incompatible with texting platform|0|||
105485982|NCT01879579|363791353|FG000|Overall Study|Did not enroll in texting platform|1|||
105811817|NCT02795104|364966617|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
105811818|NCT02795104|364966618|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
105811819|NCT02795104|364966616|FG000|Overall Study|Withdrawal by Subject|0|||
105811820|NCT02795104|364966617|FG001|Overall Study|Withdrawal by Subject|2|||
105811821|NCT02795104|364966618|FG002|Overall Study|Withdrawal by Subject|0|||
105811822|NCT02795104|364966616|FG000|Overall Study|Lost to Follow-up|0|||
105811823|NCT02795104|364966617|FG001|Overall Study|Lost to Follow-up|0|||
105811824|NCT02795104|364966618|FG002|Overall Study|Lost to Follow-up|1|||
105811825|NCT02674334|364966619|FG000|Overall Study|Lost to Follow-up|5|||
105811826|NCT02674334|364966620|FG001|Overall Study|Lost to Follow-up|3|||
105811827|NCT02674334|364966619|FG000|Overall Study|participant difficulty breathing|1|||
105811828|NCT02674334|364966620|FG001|Overall Study|participant difficulty breathing|0|||
105811829|NCT02674334|364966619|FG000|Overall Study|NIRS not recording|1|||
105811830|NCT02674334|364966620|FG001|Overall Study|NIRS not recording|0|||
105811831|NCT00386009|364966624|FG000|Overall Study|Adverse Event|0|||
105811832|NCT00386009|364966625|FG001|Overall Study|Adverse Event|2|||
105811833|NCT00386009|364966624|FG000|Overall Study|Death|1|||
105811834|NCT00386009|364966625|FG001|Overall Study|Death|0|||
105811835|NCT00386009|364966624|FG000|Overall Study|Entry Criteria Not Met|0|||
105811836|NCT00386009|364966625|FG001|Overall Study|Entry Criteria Not Met|2|||
105811837|NCT00386009|364966624|FG000|Overall Study|Lost to Follow-up|1|||
105811838|NCT00386009|364966625|FG001|Overall Study|Lost to Follow-up|1|||
105811839|NCT00386009|364966624|FG000|Overall Study|Protocol Violation|1|||
105811840|NCT00386009|364966625|FG001|Overall Study|Protocol Violation|0|||
105811841|NCT00386009|364966624|FG000|Overall Study|Sponsor Decision|1|||
105811842|NCT00386009|364966625|FG001|Overall Study|Sponsor Decision|1|||
105811843|NCT00386009|364966624|FG000|Overall Study|Withdrawal by Subject|5|||
105811844|NCT00386009|364966625|FG001|Overall Study|Withdrawal by Subject|4|||
105811845|NCT00429923|364966630|FG000|Overall Study|Adverse Event|0|||
105811846|NCT00429923|364966631|FG001|Overall Study|Adverse Event|2|||
105811847|NCT00429923|364966632|FG002|Overall Study|Adverse Event|3|||
105811848|NCT00429923|364966630|FG000|Overall Study|Lack of Efficacy|4|||
105811849|NCT00429923|364966631|FG001|Overall Study|Lack of Efficacy|1|||
105811850|NCT00429923|364966632|FG002|Overall Study|Lack of Efficacy|33|||
105811851|NCT00429923|364966630|FG000|Overall Study|Lost to Follow-up|0|||
105811852|NCT00429923|364966631|FG001|Overall Study|Lost to Follow-up|0|||
105811853|NCT00429923|364966632|FG002|Overall Study|Lost to Follow-up|2|||
105811854|NCT00429923|364966630|FG000|Overall Study|Withdrew Consent|1|||
105811855|NCT00429923|364966631|FG001|Overall Study|Withdrew Consent|0|||
105811856|NCT00429923|364966632|FG002|Overall Study|Withdrew Consent|1|||
105811857|NCT00429923|364966630|FG000|Overall Study|Early Termination|0|||
105811858|NCT00429923|364966631|FG001|Overall Study|Early Termination|1|||
105811859|NCT00429923|364966632|FG002|Overall Study|Early Termination|0|||
105811860|NCT02545998|364966639|FG000|Overall Study|Lost to Follow-up|12|||
105811861|NCT02545998|364966640|FG001|Overall Study|Lost to Follow-up|3|||
105811862|NCT02545998|364966639|FG000|Overall Study|Withdrawal by Subject|3|||
105811863|NCT02545998|364966640|FG001|Overall Study|Withdrawal by Subject|2|||
105811864|NCT00918567|364966645|FG000|Overall Study|Lack of Efficacy|3|||
105811865|NCT00918567|364966646|FG001|Overall Study|Lack of Efficacy|1|||
105485983|NCT01879579|363791354|FG001|Overall Study|Did not enroll in texting platform|0|||
105485984|NCT01879579|363791353|FG000|Overall Study|Did not initiate insulin treatment|1|||
105485985|NCT01879579|363791354|FG001|Overall Study|Did not initiate insulin treatment|0|||
105811866|NCT00918567|364966645|FG000|Overall Study|Withdrawal by Subject|1|||
105811867|NCT00918567|364966646|FG001|Overall Study|Withdrawal by Subject|1|||
105811868|NCT00918567|364966645|FG000|Overall Study|Adverse Event|1|||
105811869|NCT00918567|364966646|FG001|Overall Study|Adverse Event|0|||
105811870|NCT00313703|364968339|FG000|Overall Study|Lost to Follow-up|11|||
105811871|NCT00313703|364968340|FG001|Overall Study|Lost to Follow-up|2|||
105811872|NCT00313703|364968341|FG002|Overall Study|Lost to Follow-up|5|||
105811873|NCT00313703|364968342|FG003|Overall Study|Lost to Follow-up|12|||
105811874|NCT01060670|364968345|FG000|Run In|screen failure|0|||
105811875|NCT01060670|364968346|FG001|Run In|screen failure|238|||
105811876|NCT01929109|364968347|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
105811877|NCT01929109|364968348|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
105811878|NCT01929109|364968349|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
105811879|NCT01929109|364968350|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
105811880|NCT01929109|364968351|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
105811881|NCT02761980|364968352|FG000|Overall Study|Adverse Event|4|||
105811882|NCT02761980|364968353|FG001|Overall Study|Adverse Event|6|||
105811883|NCT02761980|364968354|FG002|Overall Study|Adverse Event|5|||
105811884|NCT02761980|364968355|FG003|Overall Study|Adverse Event|6|||
105811885|NCT02761980|364968352|FG000|Overall Study|Withdrawal by Subject|0|||
105811886|NCT02761980|364968353|FG001|Overall Study|Withdrawal by Subject|1|||
105811887|NCT02761980|364968354|FG002|Overall Study|Withdrawal by Subject|0|||
105811888|NCT02761980|364968355|FG003|Overall Study|Withdrawal by Subject|0|||
105811889|NCT02761980|364968352|FG000|Overall Study|Other|0|||
105811890|NCT02761980|364968353|FG001|Overall Study|Other|0|||
105811891|NCT02761980|364968354|FG002|Overall Study|Other|1|||
105811892|NCT02761980|364968355|FG003|Overall Study|Other|0|||
105811893|NCT01052116|364968358|FG000|Overall Study|Lost to Follow-up|11|||
105811894|NCT01052116|364968359|FG001|Overall Study|Lost to Follow-up|17|||
105811895|NCT01052116|364968358|FG000|Overall Study|Withdrawal by Subject|3|||
105811896|NCT01052116|364968359|FG001|Overall Study|Withdrawal by Subject|6|||
105811897|NCT01052116|364968358|FG000|Overall Study|Spirometry not performed|0|||
105811898|NCT01052116|364968359|FG001|Overall Study|Spirometry not performed|4|||
105485986|NCT01879579|363791353|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
105485987|NCT01879579|363791354|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
105811899|NCT00101582|364968365|FG000|Overall Study|Ineligibility determined|0|||
105811900|NCT00101582|364968366|FG001|Overall Study|Ineligibility determined|1|||
105811901|NCT00101582|364968365|FG000|Overall Study|Adverse Event|1|||
105811902|NCT00101582|364968366|FG001|Overall Study|Adverse Event|4|||
105811903|NCT00101582|364968365|FG000|Overall Study|Withdrawal by Subject|6|||
105811904|NCT00101582|364968366|FG001|Overall Study|Withdrawal by Subject|4|||
105811905|NCT00101582|364968365|FG000|Overall Study|Physician Decision|1|||
105811906|NCT00101582|364968366|FG001|Overall Study|Physician Decision|0|||
105811907|NCT00101582|364968365|FG000|Overall Study|Death|3|||
105811908|NCT00101582|364968366|FG001|Overall Study|Death|5|||
105811909|NCT00101582|364968365|FG000|Overall Study|Other|0|||
105811910|NCT00101582|364968366|FG001|Overall Study|Other|1|||
105811911|NCT01402908|364968369|FG000|Overall Study|Withdrawal by Subject|30|||
105811912|NCT01402908|364968370|FG001|Overall Study|Withdrawal by Subject|17|||
105811913|NCT01402908|364968369|FG000|Overall Study|Lost to Follow-up|3|||
105811914|NCT01402908|364968370|FG001|Overall Study|Lost to Follow-up|1|||
105811915|NCT01402908|364968369|FG000|Overall Study|Physician Decision|1|||
105811916|NCT01402908|364968370|FG001|Overall Study|Physician Decision|0|||
105811917|NCT01919190|364968371|FG000|Overall Study|Intra-op findings, etc.|3|||
105811918|NCT01919190|364968372|FG001|Overall Study|Intra-op findings, etc.|0|||
105811919|NCT01739790|364968373|FG000|Overall Study|Early Trial Termination|2|||
105811920|NCT01739790|364968374|FG001|Overall Study|Early Trial Termination|4|||
105811921|NCT02146430|364968375|FG000|Overall Study|Protocol Violation|5|||
105811922|NCT02146430|364968376|FG001|Overall Study|Protocol Violation|4|||
105811923|NCT02146430|364968377|FG002|Overall Study|Protocol Violation|8|||
105811924|NCT02146430|364968378|FG003|Overall Study|Protocol Violation|6|||
105811925|NCT02146430|364968375|FG000|Overall Study|Lack of Efficacy|13|||
105811926|NCT02146430|364968376|FG001|Overall Study|Lack of Efficacy|11|||
105811927|NCT02146430|364968377|FG002|Overall Study|Lack of Efficacy|8|||
105811928|NCT02146430|364968378|FG003|Overall Study|Lack of Efficacy|5|||
105811929|NCT02146430|364968375|FG000|Overall Study|Adverse Event|20|||
105811930|NCT02146430|364968376|FG001|Overall Study|Adverse Event|40|||
105811931|NCT02146430|364968377|FG002|Overall Study|Adverse Event|32|||
105811932|NCT02146430|364968378|FG003|Overall Study|Adverse Event|49|||
105811933|NCT02146430|364968375|FG000|Overall Study|Reason missing or not reported|2|||
105811934|NCT02146430|364968376|FG001|Overall Study|Reason missing or not reported|3|||
105811935|NCT02146430|364968377|FG002|Overall Study|Reason missing or not reported|4|||
105811936|NCT02146430|364968378|FG003|Overall Study|Reason missing or not reported|5|||
105811937|NCT02146430|364968375|FG000|Overall Study|Withdrawal by Subject|27|||
105811938|NCT02146430|364968376|FG001|Overall Study|Withdrawal by Subject|29|||
105811939|NCT02146430|364968377|FG002|Overall Study|Withdrawal by Subject|30|||
105811940|NCT02146430|364968378|FG003|Overall Study|Withdrawal by Subject|34|||
105811941|NCT02581345|364968379|FG000|Part 1: up to Week 16|Adverse Event|3|||
105811942|NCT02581345|364968380|FG001|Part 1: up to Week 16|Adverse Event|8|||
105811943|NCT02581345|364968381|FG002|Part 1: up to Week 16|Adverse Event|0|||
105811944|NCT02581345|364968382|FG003|Part 1: up to Week 16|Adverse Event|0|||
105811945|NCT02581345|364968379|FG000|Part 1: up to Week 16|Physician Decision|2|||
105811946|NCT02581345|364968380|FG001|Part 1: up to Week 16|Physician Decision|4|||
105811947|NCT02581345|364968381|FG002|Part 1: up to Week 16|Physician Decision|0|||
105811948|NCT02581345|364968382|FG003|Part 1: up to Week 16|Physician Decision|0|||
105811949|NCT02581345|364968379|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
105811950|NCT02581345|364968380|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
105811951|NCT02581345|364968381|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
105811952|NCT02581345|364968382|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
105811953|NCT02581345|364968379|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
105811954|NCT02581345|364968380|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
105811955|NCT02581345|364968381|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
105811956|NCT02581345|364968382|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
105811957|NCT02581345|364968379|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
105811958|NCT02581345|364968380|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
105811959|NCT02581345|364968381|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
105811960|NCT02581345|364968382|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
105811961|NCT02581345|364968379|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
105811962|NCT02581345|364968380|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
105811963|NCT02581345|364968381|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
105811964|NCT02581345|364968382|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
105811965|NCT02581345|364968379|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
105811966|NCT02581345|364968380|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
105811967|NCT02581345|364968381|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
105811968|NCT02581345|364968382|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
105811969|NCT02581345|364968379|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
105811970|NCT02581345|364968380|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
105811971|NCT02581345|364968381|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
105811972|NCT02581345|364968382|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
105361873|NCT02326272|363330157|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105361874|NCT02326272|363330143|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105361875|NCT02326272|363330144|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105361876|NCT02326272|363330145|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
105361877|NCT02326272|363330146|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105361878|NCT02326272|363330147|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105361879|NCT02326272|363330148|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105361880|NCT02326272|363330149|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105811973|NCT02581345|364968379|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
105811974|NCT02581345|364968380|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
105811975|NCT02581345|364968381|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
105811976|NCT02581345|364968382|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
105811977|NCT02581345|364968379|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
105811978|NCT02581345|364968380|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
105811979|NCT02581345|364968381|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
105811980|NCT02581345|364968382|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
105361881|NCT02326272|363330150|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105361882|NCT02326272|363330151|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105361883|NCT02326272|363330152|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105361884|NCT02326272|363330153|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105361885|NCT02326272|363330154|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105361886|NCT02326272|363330155|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105361887|NCT02326272|363330156|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105361888|NCT02326272|363330157|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105361889|NCT02326272|363330143|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105361890|NCT02326272|363330144|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105361891|NCT02326272|363330145|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
105361892|NCT02326272|363330146|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105361893|NCT02326272|363330147|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105361894|NCT02326272|363330148|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105361895|NCT02326272|363330149|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105361896|NCT02326272|363330150|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105361897|NCT02326272|363330151|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105361898|NCT02326272|363330152|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105361899|NCT02326272|363330153|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105361900|NCT02326272|363330154|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105361901|NCT02326272|363330155|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105811981|NCT02581345|364968379|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
105811982|NCT02581345|364968380|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
105811983|NCT02581345|364968381|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
105811984|NCT02581345|364968382|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
105811985|NCT02581345|364968379|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
105811986|NCT02581345|364968380|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
105811987|NCT02581345|364968381|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
105811988|NCT02581345|364968382|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
105811989|NCT01893905|364968383|FG000|Overall Study|Withdrawal by Subject|1|||
105811990|NCT01893905|364968384|FG001|Overall Study|Withdrawal by Subject|0|||
105811991|NCT01893905|364968383|FG000|Overall Study|Adverse Event|9|||
105811992|NCT01893905|364968384|FG001|Overall Study|Adverse Event|3|||
105811993|NCT01893905|364968383|FG000|Overall Study|Lack of Efficacy|5|||
105811994|NCT01893905|364968384|FG001|Overall Study|Lack of Efficacy|7|||
105811995|NCT01893905|364968383|FG000|Overall Study|Lost to Follow-up|1|||
105811996|NCT01893905|364968384|FG001|Overall Study|Lost to Follow-up|0|||
105811997|NCT01893905|364968383|FG000|Overall Study|Protocol Violation|6|||
105811998|NCT01893905|364968384|FG001|Overall Study|Protocol Violation|1|||
105811999|NCT01893905|364968383|FG000|Overall Study|Lack of adherence to treatment|2|||
105812000|NCT01893905|364968384|FG001|Overall Study|Lack of adherence to treatment|0|||
105812001|NCT01893905|364968383|FG000|Overall Study|Other reason|1|||
105812002|NCT01893905|364968384|FG001|Overall Study|Other reason|3|||
105812003|NCT01768858|364968385|FG000|Overall Study|Lost to Follow-up|9|||
105812004|NCT01768858|364968385|FG000|Overall Study|Lack of Efficacy|8|||
105812005|NCT01768858|364968385|FG000|Overall Study|Serious Adverse Event|1|||
105812006|NCT01768858|364968385|FG000|Overall Study|Participant moved to Germany|1|||
105812007|NCT01768858|364968385|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
105812008|NCT01768858|364968385|FG000|Overall Study|Exanthema|1|||
105812009|NCT01768858|364968385|FG000|Overall Study|Withdrawal by Subject|1|||
105812010|NCT01367275|364968388|FG000|Overall Study|Ineligible|1|||
105812011|NCT01367275|364968388|FG000|Overall Study|Disease Progression|2|||
105812012|NCT01290263|364968394|FG000|Overall Study|Adverse Event|0|||
105812013|NCT01290263|364968395|FG001|Overall Study|Adverse Event|0|||
105812014|NCT01290263|364968396|FG002|Overall Study|Adverse Event|0|||
105812015|NCT01290263|364968397|FG003|Overall Study|Adverse Event|1|||
105812016|NCT01290263|364968398|FG004|Overall Study|Adverse Event|1|||
105812017|NCT01290263|364968394|FG000|Overall Study|Lack of Efficacy|8|||
105812018|NCT01290263|364968395|FG001|Overall Study|Lack of Efficacy|2|||
105812019|NCT01290263|364968396|FG002|Overall Study|Lack of Efficacy|7|||
105812020|NCT01290263|364968397|FG003|Overall Study|Lack of Efficacy|24|||
105812021|NCT01290263|364968398|FG004|Overall Study|Lack of Efficacy|33|||
105812022|NCT01290263|364968394|FG000|Overall Study|Withdrawal by Subject|3|||
105812023|NCT01290263|364968395|FG001|Overall Study|Withdrawal by Subject|1|||
105812024|NCT01290263|364968396|FG002|Overall Study|Withdrawal by Subject|0|||
105812025|NCT01290263|364968397|FG003|Overall Study|Withdrawal by Subject|1|||
105812026|NCT01290263|364968398|FG004|Overall Study|Withdrawal by Subject|2|||
105812027|NCT01290263|364968394|FG000|Overall Study|Participant Non-Compliance|0|||
105812028|NCT01290263|364968395|FG001|Overall Study|Participant Non-Compliance|0|||
105812029|NCT01290263|364968396|FG002|Overall Study|Participant Non-Compliance|0|||
105812030|NCT01290263|364968397|FG003|Overall Study|Participant Non-Compliance|1|||
105812031|NCT01290263|364968398|FG004|Overall Study|Participant Non-Compliance|1|||
105812032|NCT05346055|364968399|FG000|Overall Study|Withdrawal by Subject|1|||
105812033|NCT05346055|364968399|FG000|Overall Study|Protocol Violation|1|||
105812034|NCT05346055|364968399|FG000|Overall Study|Therapist decision|1|||
105812035|NCT00376220|364968400|FG000|Overall Study|Lost to Follow-up|7|||
105812036|NCT00376220|364968401|FG001|Overall Study|Lost to Follow-up|10|||
105812037|NCT00376220|364968400|FG000|Overall Study|Withdrawal by Subject|3|||
105812038|NCT00376220|364968401|FG001|Overall Study|Withdrawal by Subject|2|||
105812039|NCT03702621|364968416|FG000|Overall Study|Physician Decision|6|||
105812040|NCT03702621|364968417|FG001|Overall Study|Physician Decision|6|||
105812041|NCT00920140|364968418|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
105812042|NCT00920140|364968419|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
105812043|NCT00920140|364968420|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
105812044|NCT00920140|364968421|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
105812045|NCT00920140|364968422|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
105812046|NCT00920140|364968418|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
105812047|NCT00920140|364968419|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
105812048|NCT00920140|364968420|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
105812049|NCT00920140|364968421|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
105812050|NCT00920140|364968422|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
105812051|NCT00920140|364968418|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105812052|NCT00920140|364968419|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
105812053|NCT00920140|364968420|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105812054|NCT00920140|364968421|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105812055|NCT00920140|364968422|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105812056|NCT00920140|364968418|FG000|Phase 2|Adverse Event|0|||
105812057|NCT00920140|364968419|FG001|Phase 2|Adverse Event|0|||
105812058|NCT00920140|364968420|FG002|Phase 2|Adverse Event|14|||
105812059|NCT00920140|364968421|FG003|Phase 2|Adverse Event|2|||
105812060|NCT00920140|364968422|FG004|Phase 2|Adverse Event|3|||
105812061|NCT00920140|364968418|FG000|Phase 2|Lack of Efficacy|0|||
105812062|NCT00920140|364968419|FG001|Phase 2|Lack of Efficacy|0|||
105812063|NCT00920140|364968420|FG002|Phase 2|Lack of Efficacy|29|||
105812064|NCT00920140|364968421|FG003|Phase 2|Lack of Efficacy|14|||
105812065|NCT00920140|364968422|FG004|Phase 2|Lack of Efficacy|5|||
105571520|NCT00130793|364091225|FG000|Overall Study|Withdrew consent|2|||
105571521|NCT00130793|364091226|FG001|Overall Study|Withdrew consent|0|||
105571522|NCT01650519|364091227|FG000|Overall Study|Withdrawal by Subject|1|||
105762815|NCT00443846|364784812|FG000|Overall Study|Lost to Follow-up|1|||
105762816|NCT00443846|364784813|FG001|Overall Study|Lost to Follow-up|2|||
105762817|NCT02580591|364784814|FG000|Overall Study|Adverse Event|0|||
105762818|NCT02580591|364784815|FG001|Overall Study|Adverse Event|1|||
105762819|NCT02580591|364784816|FG002|Overall Study|Adverse Event|2|||
105762820|NCT02580591|364784817|FG003|Overall Study|Adverse Event|5|||
105762821|NCT02580591|364784814|FG000|Overall Study|Protocol Violation|3|||
105762822|NCT02580591|364784815|FG001|Overall Study|Protocol Violation|2|||
105762823|NCT02580591|364784816|FG002|Overall Study|Protocol Violation|1|||
105762824|NCT02580591|364784817|FG003|Overall Study|Protocol Violation|1|||
105762825|NCT02580591|364784814|FG000|Overall Study|Lost to Follow-up|5|||
105762826|NCT02580591|364784815|FG001|Overall Study|Lost to Follow-up|3|||
105762827|NCT02580591|364784816|FG002|Overall Study|Lost to Follow-up|3|||
105762828|NCT02580591|364784817|FG003|Overall Study|Lost to Follow-up|1|||
105762829|NCT02580591|364784814|FG000|Overall Study|Withdrawal by Subject|6|||
105762830|NCT02580591|364784815|FG001|Overall Study|Withdrawal by Subject|1|||
105762831|NCT02580591|364784816|FG002|Overall Study|Withdrawal by Subject|2|||
105762832|NCT02580591|364784817|FG003|Overall Study|Withdrawal by Subject|3|||
105762833|NCT02580591|364784814|FG000|Overall Study|Not treated|1|||
105762834|NCT02580591|364784815|FG001|Overall Study|Not treated|1|||
105762835|NCT02580591|364784816|FG002|Overall Study|Not treated|0|||
105762836|NCT02580591|364784817|FG003|Overall Study|Not treated|0|||
105762837|NCT02580591|364784814|FG000|Overall Study|Other than specified|3|||
105762838|NCT02580591|364784815|FG001|Overall Study|Other than specified|2|||
105762839|NCT02580591|364784816|FG002|Overall Study|Other than specified|5|||
105762840|NCT02580591|364784817|FG003|Overall Study|Other than specified|2|||
105762841|NCT00561340|364784818|FG000|Overall Study|refused to drink pediasure|6|||
105762842|NCT00561340|364784819|FG001|Overall Study|refused to drink pediasure|0|||
105762843|NCT00445341|364784820|FG000|Overall Study|refused further treatment|1|||
105762844|NCT00445341|364784820|FG000|Overall Study|taken off treatment too early|1|||
105762845|NCT00391807|364784822|FG000|Overall Study|Did not receive study medication|23|||
105762846|NCT00391807|364784822|FG000|Overall Study|Adverse Event|177|||
105762847|NCT00391807|364784822|FG000|Overall Study|Pregnancy|25|||
105762848|NCT00391807|364784822|FG000|Overall Study|Lost to Follow-up|227|||
105762849|NCT00391807|364784822|FG000|Overall Study|Withdrawal by Subject|147|||
105762850|NCT00391807|364784822|FG000|Overall Study|Protocol Violation|20|||
105762851|NCT00391807|364784822|FG000|Overall Study|Various|96|||
105762852|NCT01359046|364784823|FG000|Overall Study|Did not receive allocated intervention|6|||
105762853|NCT01359046|364784824|FG001|Overall Study|Did not receive allocated intervention|6|||
105762854|NCT01359046|364784823|FG000|Overall Study|Physician Decision|1|||
105762855|NCT01359046|364784824|FG001|Overall Study|Physician Decision|11|||
105762856|NCT00990249|364784841|FG000|Overall Study|Disease Progression|8|||
105762857|NCT00990249|364784841|FG000|Overall Study|Non-Compliance|1|||
105762858|NCT00990249|364784841|FG000|Overall Study|Death|2|||
105762859|NCT00990249|364784841|FG000|Overall Study|Not treated|2|||
105762860|NCT01061567|364784848|FG000|Overall Study|Adverse Event|32|||
105762861|NCT01061567|364784848|FG000|Overall Study|Death|2|||
105812066|NCT00920140|364968418|FG000|Phase 2|Lost to Follow-up|0|||
105571523|NCT01650519|364091228|FG001|Overall Study|Withdrawal by Subject|0|||
105571524|NCT05458024|364091229|FG000|Overall Study|Withdrawal by Subject|1|||
105762862|NCT01061567|364784848|FG000|Overall Study|Lack of Efficacy|3|||
105762863|NCT01061567|364784848|FG000|Overall Study|Lost to Follow-up|24|||
105762864|NCT01061567|364784848|FG000|Overall Study|Protocol Violation|1|||
105762865|NCT01061567|364784848|FG000|Overall Study|Withdrawal by Subject|11|||
105762866|NCT01061567|364784848|FG000|Overall Study|Other reason than stated above|3|||
105762867|NCT01809197|364784849|FG000|Overall Study|Lost to Follow-up|4|||
105762868|NCT01809197|364784850|FG001|Overall Study|Lost to Follow-up|2|||
105762869|NCT01809197|364784849|FG000|Overall Study|Adverse Event|2|||
105762870|NCT01809197|364784850|FG001|Overall Study|Adverse Event|3|||
105762871|NCT01809197|364784849|FG000|Overall Study|Failed slit lamp exam|1|||
105762872|NCT01809197|364784850|FG001|Overall Study|Failed slit lamp exam|0|||
105762873|NCT01809197|364784849|FG000|Overall Study|Non-Compliance|1|||
105762874|NCT01809197|364784850|FG001|Overall Study|Non-Compliance|1|||
105762875|NCT01809197|364784849|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
105762876|NCT01809197|364784850|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
105762877|NCT01809197|364784849|FG000|Overall Study|Withdrawal by Subject|1|||
105762878|NCT01809197|364784850|FG001|Overall Study|Withdrawal by Subject|1|||
105762879|NCT01809197|364784849|FG000|Overall Study|Product not available|0|||
105762880|NCT01809197|364784850|FG001|Overall Study|Product not available|1|||
105762881|NCT03228394|364784853|FG000|Overall Study|Lost to Follow-up|0|||
105762882|NCT03228394|364784854|FG001|Overall Study|Lost to Follow-up|0|||
105762883|NCT03228394|364784855|FG002|Overall Study|Lost to Follow-up|1|||
105812067|NCT00920140|364968419|FG001|Phase 2|Lost to Follow-up|0|||
105361902|NCT02326272|363330156|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105361903|NCT02326272|363330157|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105361904|NCT02326272|363330143|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105361905|NCT02326272|363330144|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105361906|NCT02326272|363330145|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105361907|NCT02326272|363330146|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105361908|NCT02326272|363330147|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
105361909|NCT02326272|363330148|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
105361910|NCT02326272|363330149|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
105361911|NCT02326272|363330150|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
105361912|NCT02326272|363330151|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
105361913|NCT02326272|363330152|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105361914|NCT02326272|363330153|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105361915|NCT02326272|363330154|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105571525|NCT05458024|364091230|FG001|Overall Study|Withdrawal by Subject|1|||
105571526|NCT05672680|364091231|FG000|Overall Study|Patient Did Not Complete the Form|5|||
105762884|NCT03228394|364784856|FG003|Overall Study|Lost to Follow-up|1|||
105762885|NCT03228394|364784857|FG004|Overall Study|Lost to Follow-up|0|||
105762886|NCT03228394|364784858|FG005|Overall Study|Lost to Follow-up|0|||
105762887|NCT03228394|364784859|FG006|Overall Study|Lost to Follow-up|2|||
105762888|NCT03228394|364784860|FG007|Overall Study|Lost to Follow-up|0|||
105762889|NCT03228394|364784853|FG000|Overall Study|Withdrawal by Subject|0|||
105762890|NCT03228394|364784854|FG001|Overall Study|Withdrawal by Subject|0|||
105762891|NCT03228394|364784855|FG002|Overall Study|Withdrawal by Subject|1|||
105762892|NCT03228394|364784856|FG003|Overall Study|Withdrawal by Subject|0|||
105762893|NCT03228394|364784857|FG004|Overall Study|Withdrawal by Subject|0|||
105762894|NCT03228394|364784858|FG005|Overall Study|Withdrawal by Subject|0|||
105762895|NCT03228394|364784859|FG006|Overall Study|Withdrawal by Subject|1|||
105762896|NCT03228394|364784860|FG007|Overall Study|Withdrawal by Subject|3|||
105762897|NCT03228394|364784853|FG000|Overall Study|Protocol Violation|0|||
105762898|NCT03228394|364784854|FG001|Overall Study|Protocol Violation|0|||
105762899|NCT03228394|364784855|FG002|Overall Study|Protocol Violation|0|||
105762900|NCT03228394|364784856|FG003|Overall Study|Protocol Violation|1|||
105762901|NCT03228394|364784857|FG004|Overall Study|Protocol Violation|0|||
105762902|NCT03228394|364784858|FG005|Overall Study|Protocol Violation|0|||
105762903|NCT03228394|364784859|FG006|Overall Study|Protocol Violation|0|||
105762904|NCT03228394|364784860|FG007|Overall Study|Protocol Violation|0|||
105762905|NCT03228394|364784853|FG000|Overall Study|Physician Decision|0|||
105762906|NCT03228394|364784854|FG001|Overall Study|Physician Decision|0|||
105762907|NCT03228394|364784855|FG002|Overall Study|Physician Decision|0|||
105762908|NCT03228394|364784856|FG003|Overall Study|Physician Decision|0|||
105762909|NCT03228394|364784857|FG004|Overall Study|Physician Decision|0|||
105762910|NCT03228394|364784858|FG005|Overall Study|Physician Decision|0|||
105762911|NCT03228394|364784859|FG006|Overall Study|Physician Decision|1|||
105762912|NCT03228394|364784860|FG007|Overall Study|Physician Decision|0|||
105762913|NCT03228394|364784853|FG000|Overall Study|Noncompliance|0|||
105762914|NCT03228394|364784854|FG001|Overall Study|Noncompliance|0|||
105762915|NCT03228394|364784855|FG002|Overall Study|Noncompliance|0|||
105762916|NCT03228394|364784856|FG003|Overall Study|Noncompliance|0|||
105762917|NCT03228394|364784857|FG004|Overall Study|Noncompliance|0|||
105762918|NCT03228394|364784858|FG005|Overall Study|Noncompliance|0|||
105762919|NCT03228394|364784859|FG006|Overall Study|Noncompliance|1|||
105762920|NCT03228394|364784860|FG007|Overall Study|Noncompliance|0|||
105762921|NCT00268463|364784863|FG000|Overall Study|study terminated due to low accrual|10|||
105762922|NCT00268463|364784864|FG001|Overall Study|study terminated due to low accrual|12|||
105762923|NCT03000686|364784865|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
105762924|NCT03000686|364784866|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
105762925|NCT03000686|364784867|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
105762926|NCT03000686|364784868|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
105762927|NCT01484561|364784871|FG000|Overall Study|Lack of Efficacy|3|||
105762928|NCT01484561|364784872|FG001|Overall Study|Lack of Efficacy|1|||
105762929|NCT01484561|364784871|FG000|Overall Study|Lost to Follow-up|1|||
105762930|NCT01484561|364784872|FG001|Overall Study|Lost to Follow-up|0|||
105762931|NCT01484561|364784871|FG000|Overall Study|Withdrawal by Subject|3|||
105762932|NCT01484561|364784872|FG001|Overall Study|Withdrawal by Subject|0|||
105762933|NCT01484561|364784871|FG000|Overall Study|Other|1|||
105762934|NCT01484561|364784872|FG001|Overall Study|Other|1|||
105762935|NCT01484561|364784871|FG000|Overall Study|Adverse Event|1|||
105762936|NCT01484561|364784872|FG001|Overall Study|Adverse Event|4|||
105762937|NCT00291187|364784873|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
105762938|NCT00291187|364784874|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
105762939|NCT00291187|364784875|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
105762940|NCT00291187|364784876|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
105762941|NCT02443805|364784878|FG000|Overall Study|Adverse Event|100|||
105762942|NCT02443805|364784879|FG001|Overall Study|Adverse Event|18|||
105812068|NCT00920140|364968420|FG002|Phase 2|Lost to Follow-up|0|||
105812069|NCT00920140|364968421|FG003|Phase 2|Lost to Follow-up|1|||
105812070|NCT00920140|364968422|FG004|Phase 2|Lost to Follow-up|0|||
105812071|NCT00920140|364968418|FG000|Phase 2|Physician Decision|0|||
105812072|NCT00920140|364968419|FG001|Phase 2|Physician Decision|0|||
105812073|NCT00920140|364968420|FG002|Phase 2|Physician Decision|3|||
105812074|NCT00920140|364968421|FG003|Phase 2|Physician Decision|3|||
105812075|NCT00920140|364968422|FG004|Phase 2|Physician Decision|2|||
105812076|NCT00920140|364968418|FG000|Phase 2|Withdrawal by Subject|0|||
105812077|NCT00920140|364968419|FG001|Phase 2|Withdrawal by Subject|0|||
105812078|NCT00920140|364968420|FG002|Phase 2|Withdrawal by Subject|4|||
105812079|NCT00920140|364968421|FG003|Phase 2|Withdrawal by Subject|2|||
105812080|NCT00920140|364968422|FG004|Phase 2|Withdrawal by Subject|1|||
105812081|NCT02720510|364968423|FG000|Overall Study|Study Terminated by the sponsor|2|||
105361916|NCT02326272|363330155|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105361917|NCT02326272|363330156|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105812082|NCT02720510|364968424|FG001|Overall Study|Study Terminated by the sponsor|0|||
105812083|NCT02720510|364968423|FG000|Overall Study|Adverse Event|0|||
105812084|NCT02720510|364968424|FG001|Overall Study|Adverse Event|1|||
105812085|NCT02720510|364968423|FG000|Overall Study|Physician Decision|1|||
105812086|NCT02720510|364968424|FG001|Overall Study|Physician Decision|2|||
105812087|NCT00449150|364968425|FG000|Overall Study|Adverse Event|11|||
105812088|NCT00449150|364968426|FG001|Overall Study|Adverse Event|18|||
105812089|NCT00449150|364968427|FG002|Overall Study|Adverse Event|9|||
105812090|NCT00449150|364968425|FG000|Overall Study|Lack of Efficacy|1|||
105812091|NCT00449150|364968426|FG001|Overall Study|Lack of Efficacy|2|||
105812092|NCT00449150|364968427|FG002|Overall Study|Lack of Efficacy|2|||
105812093|NCT00449150|364968425|FG000|Overall Study|Other|16|||
105812094|NCT00449150|364968426|FG001|Overall Study|Other|13|||
105812095|NCT00449150|364968427|FG002|Overall Study|Other|14|||
105812096|NCT00449150|364968425|FG000|Overall Study|Withdrawal by Subject|17|||
105812097|NCT00449150|364968426|FG001|Overall Study|Withdrawal by Subject|18|||
105812098|NCT00449150|364968427|FG002|Overall Study|Withdrawal by Subject|21|||
105812099|NCT00449150|364968425|FG000|Overall Study|Protocol Violation|1|||
105812100|NCT00449150|364968426|FG001|Overall Study|Protocol Violation|2|||
105812101|NCT00449150|364968427|FG002|Overall Study|Protocol Violation|1|||
105812102|NCT00770510|364968428|FG000|Overall Study|Lost to Follow-up|2|||
105812103|NCT00770510|364968428|FG000|Overall Study|Pregnancy|1|||
105812104|NCT00770510|364968428|FG000|Overall Study|Withdrawal by Subject|2|||
105812105|NCT03830164|364968429|FG000|Overall Study|Adverse Event|0|||
105812106|NCT03830164|364968430|FG001|Overall Study|Adverse Event|2|||
105812107|NCT03830164|364968431|FG002|Overall Study|Adverse Event|0|||
105812108|NCT03830164|364968429|FG000|Overall Study|Lack of Efficacy|1|||
105812109|NCT03830164|364968430|FG001|Overall Study|Lack of Efficacy|5|||
105812110|NCT03830164|364968431|FG002|Overall Study|Lack of Efficacy|0|||
105812111|NCT03830164|364968429|FG000|Overall Study|Lost to Follow-up|0|||
105812112|NCT03830164|364968430|FG001|Overall Study|Lost to Follow-up|1|||
105812113|NCT03830164|364968431|FG002|Overall Study|Lost to Follow-up|0|||
105812114|NCT03830164|364968429|FG000|Overall Study|Withdrawal by Subject|1|||
105812115|NCT03830164|364968430|FG001|Overall Study|Withdrawal by Subject|0|||
105812116|NCT03830164|364968431|FG002|Overall Study|Withdrawal by Subject|0|||
105812117|NCT00995553|364968438|FG000|Overall Study|Withdrawal by Subject|2|||
105812118|NCT00995553|364968439|FG001|Overall Study|Withdrawal by Subject|6|||
105812119|NCT01531205|364968440|FG000|Overall Study|Did not proceed to surgery|1|||
105812120|NCT02001558|364968443|FG000|Overall Study|Lost to Follow-up|8|||
105361918|NCT02326272|363330157|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105361919|NCT02326272|363330143|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105361920|NCT02326272|363330144|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105361921|NCT02326272|363330145|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105361922|NCT02326272|363330146|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105361923|NCT02326272|363330147|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105361924|NCT02326272|363330148|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
105361925|NCT02326272|363330149|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
105812121|NCT02001558|364968444|FG001|Overall Study|Lost to Follow-up|14|||
105361926|NCT02326272|363330150|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105361927|NCT02326272|363330151|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
105485988|NCT01879579|363791353|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
105485989|NCT01879579|363791354|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
105812122|NCT04128007|364968445|FG000|Overall Study|Withdrawal by Subject|9|||
105812123|NCT04128007|364968446|FG001|Overall Study|Withdrawal by Subject|6|||
105812124|NCT04128007|364968445|FG000|Overall Study|Protocol Violation|1|||
105812125|NCT04128007|364968446|FG001|Overall Study|Protocol Violation|0|||
105812126|NCT04128007|364968445|FG000|Overall Study|Lost to Follow-up|8|||
105812127|NCT04128007|364968446|FG001|Overall Study|Lost to Follow-up|7|||
105812128|NCT04128007|364968445|FG000|Overall Study|Adverse Event|5|||
105812129|NCT04128007|364968446|FG001|Overall Study|Adverse Event|2|||
105812130|NCT04128007|364968445|FG000|Overall Study|Not reported|0|||
105812131|NCT04128007|364968446|FG001|Overall Study|Not reported|2|||
105812132|NCT01225146|364968447|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
105812133|NCT01225146|364968448|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
105812134|NCT03049488|364968450|FG000|Overall Study|Lost to Follow-up|1|||
105812135|NCT03049488|364968451|FG001|Overall Study|Lost to Follow-up|1|||
105812136|NCT03049488|364968452|FG002|Overall Study|Lost to Follow-up|0|||
105812137|NCT03049488|364968453|FG003|Overall Study|Lost to Follow-up|0|||
105812138|NCT03049488|364968454|FG004|Overall Study|Lost to Follow-up|0|||
105812139|NCT03049488|364968455|FG005|Overall Study|Lost to Follow-up|0|||
105812140|NCT03049488|364968450|FG000|Overall Study|Moved from Area|1|||
105812141|NCT03049488|364968451|FG001|Overall Study|Moved from Area|0|||
105812142|NCT03049488|364968452|FG002|Overall Study|Moved from Area|0|||
105812143|NCT03049488|364968453|FG003|Overall Study|Moved from Area|1|||
105812144|NCT03049488|364968454|FG004|Overall Study|Moved from Area|1|||
105812145|NCT03049488|364968455|FG005|Overall Study|Moved from Area|0|||
105812146|NCT03049488|364968450|FG000|Overall Study|Physician Decision|0|||
105812147|NCT03049488|364968451|FG001|Overall Study|Physician Decision|1|||
105812148|NCT03049488|364968452|FG002|Overall Study|Physician Decision|0|||
105812149|NCT03049488|364968453|FG003|Overall Study|Physician Decision|0|||
105812150|NCT03049488|364968454|FG004|Overall Study|Physician Decision|0|||
105812151|NCT03049488|364968455|FG005|Overall Study|Physician Decision|0|||
105812152|NCT03049488|364968450|FG000|Overall Study|Withdrawal by Subject|0|||
105812153|NCT03049488|364968451|FG001|Overall Study|Withdrawal by Subject|0|||
105812154|NCT03049488|364968452|FG002|Overall Study|Withdrawal by Subject|0|||
105812155|NCT03049488|364968453|FG003|Overall Study|Withdrawal by Subject|1|||
105812156|NCT03049488|364968454|FG004|Overall Study|Withdrawal by Subject|1|||
105812157|NCT03049488|364968455|FG005|Overall Study|Withdrawal by Subject|0|||
105812158|NCT02353169|364968457|FG000|Overall Study|QTc > 450 msec|1|||
105812159|NCT02353169|364968458|FG001|Overall Study|QTc > 450 msec|1|||
105812160|NCT02353169|364968459|FG002|Overall Study|QTc > 450 msec|1|||
105812161|NCT02353169|364968460|FG003|Overall Study|QTc > 450 msec|1|||
105812162|NCT02353169|364968457|FG000|Overall Study|OR team declined|2|||
105812163|NCT02353169|364968458|FG001|Overall Study|OR team declined|0|||
105812164|NCT02353169|364968459|FG002|Overall Study|OR team declined|0|||
105812165|NCT02353169|364968460|FG003|Overall Study|OR team declined|0|||
105812166|NCT02353169|364968457|FG000|Overall Study|Inhalational induction|0|||
105812167|NCT02353169|364968458|FG001|Overall Study|Inhalational induction|2|||
105812168|NCT02353169|364968459|FG002|Overall Study|Inhalational induction|0|||
105812169|NCT02353169|364968460|FG003|Overall Study|Inhalational induction|0|||
105812170|NCT02353169|364968457|FG000|Overall Study|ECG data error|0|||
105812171|NCT02353169|364968458|FG001|Overall Study|ECG data error|3|||
105812172|NCT02353169|364968459|FG002|Overall Study|ECG data error|2|||
105812173|NCT02353169|364968460|FG003|Overall Study|ECG data error|2|||
105812174|NCT02353169|364968457|FG000|Overall Study|Pre-op medication|0|||
105812175|NCT02353169|364968458|FG001|Overall Study|Pre-op medication|0|||
105812176|NCT02353169|364968459|FG002|Overall Study|Pre-op medication|1|||
105812177|NCT02353169|364968460|FG003|Overall Study|Pre-op medication|0|||
105812178|NCT03883906|364968462|FG000|Overall Study|Withdrawal by Subject|2|||
105812179|NCT03883906|364968462|FG000|Overall Study|Physician Decision|5|||
105812180|NCT00874237|364968463|FG000|Overall Study|Physician Decision|0|||
105812181|NCT00874237|364968464|FG001|Overall Study|Physician Decision|1|||
105812182|NCT00874237|364968465|FG002|Overall Study|Physician Decision|0|||
105812183|NCT00874237|364968466|FG003|Overall Study|Physician Decision|0|||
105812184|NCT00874237|364968467|FG004|Overall Study|Physician Decision|0|||
105812185|NCT00874237|364968468|FG005|Overall Study|Physician Decision|0|||
105812186|NCT00874237|364968463|FG000|Overall Study|Withdrawal by Subject|0|||
105812187|NCT00874237|364968464|FG001|Overall Study|Withdrawal by Subject|0|||
105812188|NCT00874237|364968465|FG002|Overall Study|Withdrawal by Subject|1|||
105812189|NCT00874237|364968466|FG003|Overall Study|Withdrawal by Subject|0|||
105812190|NCT00874237|364968467|FG004|Overall Study|Withdrawal by Subject|0|||
105812191|NCT00874237|364968468|FG005|Overall Study|Withdrawal by Subject|0|||
105812192|NCT02468778|364968471|FG000|Overall Study|Death|2|||
105812193|NCT02468778|364968472|FG001|Overall Study|Death|1|||
105812194|NCT02468778|364968473|FG002|Overall Study|Death|0|||
105812195|NCT02468778|364968471|FG000|Overall Study|Lost to Follow-up|1|||
105812196|NCT02468778|364968472|FG001|Overall Study|Lost to Follow-up|2|||
105812197|NCT02468778|364968473|FG002|Overall Study|Lost to Follow-up|2|||
105812198|NCT02468778|364968471|FG000|Overall Study|Withdrawal by Subject|0|||
105812199|NCT02468778|364968472|FG001|Overall Study|Withdrawal by Subject|1|||
105485990|NCT02927067|363791355|FG000|Overall Study|Withdrawn Consent|20|||
105812200|NCT02468778|364968473|FG002|Overall Study|Withdrawal by Subject|1|||
105812201|NCT02672553|364968474|FG000|Overall Study|Death|3|||
105812202|NCT02672553|364968475|FG001|Overall Study|Death|5|||
105812203|NCT02672553|364968474|FG000|Overall Study|Valve Explant|1|||
105812204|NCT02672553|364968475|FG001|Overall Study|Valve Explant|0|||
105812205|NCT02672553|364968474|FG000|Overall Study|Conversion to Commercial Valve|3|||
105812206|NCT02672553|364968475|FG001|Overall Study|Conversion to Commercial Valve|0|||
105812207|NCT02672553|364968474|FG000|Overall Study|Withdrawal by Subject|3|||
105812208|NCT02672553|364968475|FG001|Overall Study|Withdrawal by Subject|3|||
105812209|NCT02672553|364968474|FG000|Overall Study|Intraoperative screen failure|2|||
105812210|NCT02672553|364968475|FG001|Overall Study|Intraoperative screen failure|0|||
105812211|NCT00970281|364968480|FG000|Overall Study|Lack of Efficacy|1|||
105812212|NCT00970281|364968481|FG001|Overall Study|Lack of Efficacy|14|||
105812213|NCT00970281|364968480|FG000|Overall Study|Withdrawal by Subject|0|||
105812214|NCT00970281|364968481|FG001|Overall Study|Withdrawal by Subject|1|||
105812215|NCT00970281|364968480|FG000|Overall Study|Physician Decision|1|||
105812216|NCT00970281|364968481|FG001|Overall Study|Physician Decision|1|||
105812217|NCT01139164|364968484|FG000|Overall Study|Withdrawn prior to study start|0|||
105812218|NCT01139164|364968485|FG001|Overall Study|Withdrawn prior to study start|2|||
105812219|NCT01139164|364968486|FG002|Overall Study|Withdrawn prior to study start|0|||
105812220|NCT00878995|364968489|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
105812221|NCT00878995|364968490|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
105812222|NCT02130466|364968494|FG000|Overall Study|Death|4|||
105812223|NCT02130466|364968495|FG001|Overall Study|Death|1|||
105812224|NCT02130466|364968496|FG002|Overall Study|Death|1|||
105762943|NCT02443805|364784878|FG000|Overall Study|Withdrawal by Subject|73|||
105762944|NCT02443805|364784879|FG001|Overall Study|Withdrawal by Subject|74|||
105762945|NCT02443805|364784878|FG000|Overall Study|Lost to Follow-up|19|||
105762946|NCT02443805|364784879|FG001|Overall Study|Lost to Follow-up|14|||
105762947|NCT02443805|364784878|FG000|Overall Study|Pregnancy|6|||
105762948|NCT02443805|364784879|FG001|Overall Study|Pregnancy|5|||
105762949|NCT02443805|364784878|FG000|Overall Study|Protocol Violation|2|||
105762950|NCT02443805|364784879|FG001|Overall Study|Protocol Violation|4|||
105762951|NCT02443805|364784878|FG000|Overall Study|Lack of Efficacy|1|||
105762952|NCT02443805|364784879|FG001|Overall Study|Lack of Efficacy|1|||
105762953|NCT02443805|364784878|FG000|Overall Study|Non-compliance with study drug|6|||
105762954|NCT02443805|364784879|FG001|Overall Study|Non-compliance with study drug|4|||
105762955|NCT02443805|364784878|FG000|Overall Study|Withdrawal by parent/guardian|3|||
105762956|NCT02443805|364784879|FG001|Overall Study|Withdrawal by parent/guardian|5|||
105762957|NCT02443805|364784878|FG000|Overall Study|Any other reason not above-mentioned|3|||
105762958|NCT02443805|364784879|FG001|Overall Study|Any other reason not above-mentioned|2|||
105762959|NCT02708966|364784880|FG000|Overall Study|Lost to Follow-up|2|||
105762960|NCT02708966|364784881|FG001|Overall Study|Lost to Follow-up|2|||
105762961|NCT00389441|364784882|FG000|Overall Study|Adverse Event|7|||
105762962|NCT00389441|364784882|FG000|Overall Study|Death|4|||
105762963|NCT00389441|364784882|FG000|Overall Study|Lost to Follow-up|2|||
105762964|NCT00389441|364784882|FG000|Overall Study|Withdrawal by Subject|4|||
105762965|NCT00389441|364784882|FG000|Overall Study|Physician Decision|1|||
105762966|NCT00389441|364784882|FG000|Overall Study|Protocol Violation|1|||
105762967|NCT00389441|364784882|FG000|Overall Study|Global deterioration of health status|4|||
105762968|NCT00389441|364784882|FG000|Overall Study|Objective progression or relapse|26|||
105762969|NCT00389441|364784882|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
105762970|NCT00389441|364784882|FG000|Overall Study|Clinical progression|1|||
105762971|NCT02076334|364784884|FG000|Overall Study|Protocol Violation|1|||
105762972|NCT02076334|364784885|FG001|Overall Study|Protocol Violation|0|||
105762973|NCT02076334|364784886|FG002|Overall Study|Protocol Violation|0|||
105762974|NCT02076334|364784887|FG003|Overall Study|Protocol Violation|0|||
105762975|NCT02076334|364784884|FG000|Overall Study|Lost to Follow-up|0|||
105762976|NCT02076334|364784885|FG001|Overall Study|Lost to Follow-up|1|||
105762977|NCT02076334|364784886|FG002|Overall Study|Lost to Follow-up|1|||
105762978|NCT02076334|364784887|FG003|Overall Study|Lost to Follow-up|0|||
105762979|NCT02076334|364784884|FG000|Overall Study|muscle soreness|0|||
105762980|NCT02076334|364784885|FG001|Overall Study|muscle soreness|0|||
105812225|NCT02130466|364968497|FG003|Overall Study|Death|3|||
105812226|NCT02130466|364968498|FG004|Overall Study|Death|2|||
105812227|NCT02130466|364968499|FG005|Overall Study|Death|30|||
105812228|NCT02130466|364968500|FG006|Overall Study|Death|45|||
105762981|NCT02076334|364784886|FG002|Overall Study|muscle soreness|0|||
105762982|NCT02076334|364784887|FG003|Overall Study|muscle soreness|1|||
105762983|NCT01611298|364784888|FG000|Overall Study|Relapsed|2|||
105762984|NCT01975675|364784889|FG000|Overall Study|Death|0|||
105762985|NCT01975675|364784890|FG001|Overall Study|Death|1|||
105762986|NCT01975675|364784891|FG002|Overall Study|Death|0|||
105762987|NCT01975675|364784892|FG003|Overall Study|Death|0|||
105762988|NCT00224003|364784893|FG000|Overall Study|Adverse Event|1|||
105812229|NCT02130466|364968501|FG007|Overall Study|Death|2|||
105812230|NCT02130466|364968502|FG008|Overall Study|Death|3|||
105812231|NCT02130466|364968503|FG009|Overall Study|Death|4|||
105812232|NCT02130466|364968504|FG010|Overall Study|Death|5|||
105812233|NCT02130466|364968505|FG011|Overall Study|Death|3|||
105812234|NCT02130466|364968506|FG012|Overall Study|Death|11|||
105812235|NCT02130466|364968507|FG013|Overall Study|Death|7|||
105812236|NCT02130466|364968494|FG000|Overall Study|Lost to Follow-up|1|||
105812237|NCT02130466|364968495|FG001|Overall Study|Lost to Follow-up|0|||
105812238|NCT02130466|364968496|FG002|Overall Study|Lost to Follow-up|0|||
105812239|NCT02130466|364968497|FG003|Overall Study|Lost to Follow-up|0|||
105812240|NCT02130466|364968498|FG004|Overall Study|Lost to Follow-up|0|||
105812241|NCT02130466|364968499|FG005|Overall Study|Lost to Follow-up|1|||
105812242|NCT02130466|364968500|FG006|Overall Study|Lost to Follow-up|0|||
105812243|NCT02130466|364968501|FG007|Overall Study|Lost to Follow-up|0|||
105812244|NCT02130466|364968502|FG008|Overall Study|Lost to Follow-up|0|||
105812245|NCT02130466|364968503|FG009|Overall Study|Lost to Follow-up|0|||
105812246|NCT02130466|364968504|FG010|Overall Study|Lost to Follow-up|0|||
105812247|NCT02130466|364968505|FG011|Overall Study|Lost to Follow-up|0|||
105812248|NCT02130466|364968506|FG012|Overall Study|Lost to Follow-up|1|||
105812249|NCT02130466|364968507|FG013|Overall Study|Lost to Follow-up|0|||
105812250|NCT02130466|364968494|FG000|Overall Study|Physician Decision|0|||
105812251|NCT02130466|364968495|FG001|Overall Study|Physician Decision|0|||
105812252|NCT02130466|364968496|FG002|Overall Study|Physician Decision|0|||
105812253|NCT02130466|364968497|FG003|Overall Study|Physician Decision|0|||
105812254|NCT02130466|364968498|FG004|Overall Study|Physician Decision|0|||
105812255|NCT02130466|364968499|FG005|Overall Study|Physician Decision|1|||
105812256|NCT02130466|364968500|FG006|Overall Study|Physician Decision|1|||
105812257|NCT02130466|364968501|FG007|Overall Study|Physician Decision|0|||
105812258|NCT02130466|364968502|FG008|Overall Study|Physician Decision|0|||
105812259|NCT02130466|364968503|FG009|Overall Study|Physician Decision|0|||
105812260|NCT02130466|364968504|FG010|Overall Study|Physician Decision|0|||
105812261|NCT02130466|364968505|FG011|Overall Study|Physician Decision|0|||
105812262|NCT02130466|364968506|FG012|Overall Study|Physician Decision|0|||
105812263|NCT02130466|364968507|FG013|Overall Study|Physician Decision|0|||
105812264|NCT02130466|364968494|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
105812265|NCT02130466|364968495|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
105812266|NCT02130466|364968496|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
105812267|NCT02130466|364968497|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
105812268|NCT02130466|364968498|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
105812269|NCT02130466|364968499|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
105812270|NCT02130466|364968500|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
105812271|NCT02130466|364968501|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
105812272|NCT02130466|364968502|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
105812273|NCT02130466|364968503|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
105812274|NCT02130466|364968504|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
105812275|NCT02130466|364968505|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
105812276|NCT02130466|364968506|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
105812277|NCT02130466|364968507|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
105812278|NCT02130466|364968494|FG000|Overall Study|Withdrawal by Subject|1|||
105812279|NCT02130466|364968495|FG001|Overall Study|Withdrawal by Subject|0|||
105812280|NCT02130466|364968496|FG002|Overall Study|Withdrawal by Subject|0|||
105812281|NCT02130466|364968497|FG003|Overall Study|Withdrawal by Subject|0|||
105812282|NCT02130466|364968498|FG004|Overall Study|Withdrawal by Subject|0|||
105812283|NCT02130466|364968499|FG005|Overall Study|Withdrawal by Subject|1|||
105812284|NCT02130466|364968500|FG006|Overall Study|Withdrawal by Subject|0|||
105812285|NCT02130466|364968501|FG007|Overall Study|Withdrawal by Subject|0|||
105812286|NCT02130466|364968502|FG008|Overall Study|Withdrawal by Subject|1|||
105812287|NCT02130466|364968503|FG009|Overall Study|Withdrawal by Subject|0|||
105812288|NCT02130466|364968504|FG010|Overall Study|Withdrawal by Subject|0|||
105812289|NCT02130466|364968505|FG011|Overall Study|Withdrawal by Subject|0|||
105812290|NCT02130466|364968506|FG012|Overall Study|Withdrawal by Subject|0|||
105812291|NCT02130466|364968507|FG013|Overall Study|Withdrawal by Subject|0|||
105812292|NCT01411332|364968508|FG000|Enrollment|Protocol Violation|0|||
105812293|NCT01411332|364968509|FG001|Enrollment|Protocol Violation|1|||
105812294|NCT01411332|364968508|FG000|Enrollment|Withdrawal by Subject|0|||
105812295|NCT01411332|364968509|FG001|Enrollment|Withdrawal by Subject|1|||
105812296|NCT01411332|364968508|FG000|Treatment|Lost to Follow-up|1|||
105812297|NCT01411332|364968509|FG001|Treatment|Lost to Follow-up|0|||
105812298|NCT02170688|364968510|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
105812299|NCT02170688|364968511|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
105812300|NCT02170688|364968512|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
105812301|NCT02170688|364968513|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
105812302|NCT02170688|364968514|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
105812303|NCT02170688|364968510|FG000|Overall Study|Full dose not received|0|||
105361928|NCT02326272|363330152|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
105361929|NCT02326272|363330153|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105361930|NCT02326272|363330154|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105571527|NCT05672680|364091232|FG001|Overall Study|Patient Did Not Complete the Form|4|||
105762989|NCT00224003|364784893|FG000|Overall Study|Protocol Violation|2|||
105762990|NCT00224003|364784893|FG000|Overall Study|Withdrawal by Subject|1|||
105762991|NCT00224003|364784893|FG000|Overall Study|unk|3|||
105762992|NCT02709109|364784898|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
105762993|NCT02709109|364784899|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
105762994|NCT02709109|364784900|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
105762995|NCT02709109|364784901|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
105762996|NCT02709109|364784898|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
105762997|NCT02709109|364784899|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
105762998|NCT02709109|364784900|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
105762999|NCT02709109|364784901|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
105763000|NCT02709109|364784898|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
105763001|NCT02709109|364784899|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
105763002|NCT02709109|364784900|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
105763003|NCT02709109|364784901|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
105763004|NCT02709109|364784898|FG000|Washout Period (28 Days)|Other|2|||
105763005|NCT02709109|364784899|FG001|Washout Period (28 Days)|Other|2|||
105763006|NCT02709109|364784900|FG002|Washout Period (28 Days)|Other|3|||
105763007|NCT02709109|364784901|FG003|Washout Period (28 Days)|Other|0|||
105763008|NCT02709109|364784898|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
105763009|NCT02709109|364784899|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
105763010|NCT02709109|364784900|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
105763011|NCT02709109|364784901|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
105763012|NCT02709109|364784898|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
105763013|NCT02709109|364784899|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
105763014|NCT02709109|364784900|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
105763015|NCT02709109|364784901|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
105763016|NCT02709109|364784898|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
105763017|NCT02709109|364784899|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
105763018|NCT02709109|364784900|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
105763019|NCT02709109|364784901|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
105763020|NCT02709109|364784898|FG000|Treatment Period 2 (28 Days)|Other|0|||
105763021|NCT02709109|364784899|FG001|Treatment Period 2 (28 Days)|Other|0|||
105763022|NCT02709109|364784900|FG002|Treatment Period 2 (28 Days)|Other|1|||
105763023|NCT02709109|364784901|FG003|Treatment Period 2 (28 Days)|Other|0|||
105763024|NCT01202760|364784903|FG000|Overall Study|Entry Criteria Not Met|0|||
105763025|NCT01202760|364784904|FG001|Overall Study|Entry Criteria Not Met|3|||
105763026|NCT01202760|364784905|FG002|Overall Study|Entry Criteria Not Met|1|||
105763027|NCT01202760|364784903|FG000|Overall Study|Adverse Event|11|||
105763028|NCT01202760|364784904|FG001|Overall Study|Adverse Event|9|||
105763029|NCT01202760|364784905|FG002|Overall Study|Adverse Event|10|||
105763030|NCT01202760|364784903|FG000|Overall Study|Death|2|||
105763031|NCT01202760|364784904|FG001|Overall Study|Death|1|||
105763032|NCT01202760|364784905|FG002|Overall Study|Death|0|||
105763033|NCT01202760|364784903|FG000|Overall Study|Lack of Efficacy|6|||
105763034|NCT01202760|364784904|FG001|Overall Study|Lack of Efficacy|8|||
105763035|NCT01202760|364784905|FG002|Overall Study|Lack of Efficacy|7|||
105763036|NCT01202760|364784903|FG000|Overall Study|Lost to Follow-up|0|||
105763037|NCT01202760|364784904|FG001|Overall Study|Lost to Follow-up|2|||
105763038|NCT01202760|364784905|FG002|Overall Study|Lost to Follow-up|1|||
105812304|NCT02170688|364968511|FG001|Overall Study|Full dose not received|1|||
105812305|NCT02170688|364968512|FG002|Overall Study|Full dose not received|0|||
105812306|NCT02170688|364968513|FG003|Overall Study|Full dose not received|0|||
105812307|NCT02170688|364968514|FG004|Overall Study|Full dose not received|0|||
105812308|NCT02170688|364968510|FG000|Overall Study|Physician Decision|0|||
105812309|NCT02170688|364968511|FG001|Overall Study|Physician Decision|0|||
105812310|NCT02170688|364968512|FG002|Overall Study|Physician Decision|1|||
105812311|NCT02170688|364968513|FG003|Overall Study|Physician Decision|0|||
105812312|NCT02170688|364968514|FG004|Overall Study|Physician Decision|0|||
105812313|NCT00679367|364968515|FG000|Overall Study|Adverse Event|7|||
105812314|NCT00679367|364968515|FG000|Overall Study|inability to swallow oral drugs|1|||
105812315|NCT00679367|364968515|FG000|Overall Study|Lack of Efficacy|3|||
105812316|NCT00679367|364968515|FG000|Overall Study|Withdrawal by Subject|1|||
105812317|NCT02448771|364968519|FG000|Overall Study|Disease Progression|30|||
105812318|NCT02448771|364968519|FG000|Overall Study|Unacceptable Toxicity|1|||
105812319|NCT02448771|364968519|FG000|Overall Study|Physician Decision|3|||
105812320|NCT02448771|364968519|FG000|Overall Study|Started new therapy|2|||
105812321|NCT00522457|364968520|FG000|Overall Study|Due to disease progression|16|||
105812322|NCT00522457|364968520|FG000|Overall Study|Adverse Event|2|||
105812323|NCT01691248|364968521|FG000|Overall Study|Protocol Violation|43|||
105812324|NCT01691248|364968522|FG001|Overall Study|Protocol Violation|27|||
105812325|NCT01691248|364968521|FG000|Overall Study|Adverse Event|24|||
105812326|NCT01691248|364968522|FG001|Overall Study|Adverse Event|22|||
105812327|NCT01691248|364968521|FG000|Overall Study|Withdrawal by Subject|20|||
105812328|NCT01691248|364968522|FG001|Overall Study|Withdrawal by Subject|18|||
105812329|NCT01691248|364968521|FG000|Overall Study|Confirmed CDAD|14|||
105812330|NCT01691248|364968522|FG001|Overall Study|Confirmed CDAD|31|||
105812331|NCT01691248|364968521|FG000|Overall Study|Lost to Follow-up|2|||
105812332|NCT01691248|364968522|FG001|Overall Study|Lost to Follow-up|5|||
105812333|NCT01691248|364968521|FG000|Overall Study|Reason not provided|4|||
105812334|NCT01691248|364968522|FG001|Overall Study|Reason not provided|4|||
105812335|NCT01691248|364968521|FG000|Overall Study|Not Treated|4|||
105812336|NCT01691248|364968522|FG001|Overall Study|Not Treated|7|||
105812337|NCT02863575|364968523|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
105812338|NCT02863575|364968524|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
105812339|NCT02863575|364968525|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
105812340|NCT02863575|364968523|FG000|Overall Study|Withdrawal by Subject|0|||
105812341|NCT02863575|364968524|FG001|Overall Study|Withdrawal by Subject|1|||
105812342|NCT02863575|364968525|FG002|Overall Study|Withdrawal by Subject|1|||
105812343|NCT02863575|364968523|FG000|Overall Study|Adverse Event|0|||
105361931|NCT02326272|363330155|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105361932|NCT02326272|363330156|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105361933|NCT02326272|363330157|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105361934|NCT02326272|363330143|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105361935|NCT02326272|363330144|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105361936|NCT02326272|363330145|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105361937|NCT02326272|363330146|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105361938|NCT02326272|363330147|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105361939|NCT02326272|363330148|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
105361940|NCT02326272|363330149|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105361941|NCT02326272|363330150|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
105361942|NCT02326272|363330151|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105361943|NCT02326272|363330152|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105361944|NCT02326272|363330153|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105361945|NCT02326272|363330154|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105361946|NCT02326272|363330155|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105361947|NCT02326272|363330156|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105361948|NCT02326272|363330157|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105361949|NCT02326272|363330143|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105361950|NCT02326272|363330144|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105361951|NCT02326272|363330145|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105361952|NCT02326272|363330146|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105361953|NCT02326272|363330147|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105361954|NCT02326272|363330148|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
105361955|NCT02326272|363330149|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105812344|NCT02863575|364968524|FG001|Overall Study|Adverse Event|1|||
105812345|NCT02863575|364968525|FG002|Overall Study|Adverse Event|0|||
105812346|NCT02785913|364970773|FG000|Overall Study|Adverse Event|5|||
105812347|NCT02785913|364970773|FG000|Overall Study|Death|2|||
105812348|NCT02785913|364970773|FG000|Overall Study|Progression|18|||
105812349|NCT02785913|364970773|FG000|Overall Study|Not protocol specified|1|||
105812350|NCT04540497|364970774|FG000|Overall Study|Adverse Event|0|||
105812351|NCT04540497|364970775|FG001|Overall Study|Adverse Event|2|||
105571528|NCT05672680|364091231|FG000|Overall Study|Procedure Aborted|1|||
105763039|NCT01202760|364784903|FG000|Overall Study|Parent / Caregiver Decision|0|||
105763040|NCT01202760|364784904|FG001|Overall Study|Parent / Caregiver Decision|1|||
105763041|NCT01202760|364784905|FG002|Overall Study|Parent / Caregiver Decision|0|||
105763042|NCT01202760|364784903|FG000|Overall Study|Withdrawal by Subject|17|||
105763043|NCT01202760|364784904|FG001|Overall Study|Withdrawal by Subject|18|||
105763044|NCT01202760|364784905|FG002|Overall Study|Withdrawal by Subject|14|||
105763045|NCT01202760|364784903|FG000|Overall Study|Physician Decision|0|||
105763046|NCT01202760|364784904|FG001|Overall Study|Physician Decision|1|||
105763047|NCT01202760|364784905|FG002|Overall Study|Physician Decision|0|||
105763048|NCT01202760|364784903|FG000|Overall Study|Protocol Violation|7|||
105763049|NCT01202760|364784904|FG001|Overall Study|Protocol Violation|5|||
105763050|NCT01202760|364784905|FG002|Overall Study|Protocol Violation|2|||
105763051|NCT01202760|364784903|FG000|Overall Study|Sponsor Decision|4|||
105763052|NCT01202760|364784904|FG001|Overall Study|Sponsor Decision|4|||
105763053|NCT01202760|364784905|FG002|Overall Study|Sponsor Decision|0|||
105763054|NCT03595384|364784909|FG000|Overall Study|Other time commitments|8|||
105763055|NCT03595384|364784909|FG000|Overall Study|Changes to session time|7|||
105763056|NCT03595384|364784909|FG000|Overall Study|Relocation out of country|1|||
105763057|NCT02224638|364784910|FG000|Overall Study|Adverse Event|1|||
105763058|NCT02224638|364784911|FG001|Overall Study|Adverse Event|1|||
105763059|NCT05563714|364784912|FG000|Overall Study|Death|2|||
105763060|NCT05563714|364784913|FG001|Overall Study|Death|2|||
105763061|NCT05563714|364784914|FG002|Overall Study|Death|0|||
105763062|NCT05563714|364784915|FG003|Overall Study|Death|0|||
105763063|NCT05563714|364784912|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
105763064|NCT05563714|364784913|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
105763065|NCT05563714|364784914|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
105763066|NCT05563714|364784915|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
105763067|NCT05563714|364784912|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
105763068|NCT05563714|364784913|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
105763069|NCT05563714|364784914|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
105763070|NCT05563714|364784915|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
105763071|NCT05563714|364784912|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
105763072|NCT05563714|364784913|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
105763073|NCT05563714|364784914|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
105763074|NCT05563714|364784915|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
105763075|NCT05563714|364784912|FG000|Overall Study|Lost to Follow-up|22|||
105763076|NCT05563714|364784913|FG001|Overall Study|Lost to Follow-up|19|||
105763077|NCT05563714|364784914|FG002|Overall Study|Lost to Follow-up|0|||
105763078|NCT05563714|364784915|FG003|Overall Study|Lost to Follow-up|0|||
105763079|NCT02633046|364784922|FG000|Overall Study|Adverse Event|8|||
105763080|NCT02633046|364784922|FG000|Overall Study|Physician Decision|7|||
105763081|NCT02633046|364784922|FG000|Overall Study|Withdrawal by Subject|8|||
105763082|NCT02633046|364784922|FG000|Overall Study|Increased proteinuria|2|||
105763083|NCT02633046|364784922|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
105763084|NCT02633046|364784922|FG000|Overall Study|Mutual decision patient and physician|1|||
105763085|NCT02142504|364784923|FG000|Overall Study|Protocol Violation|2|||
105763086|NCT02142504|364784924|FG001|Overall Study|Protocol Violation|1|||
105763087|NCT02142504|364784925|FG002|Overall Study|Protocol Violation|2|||
105763088|NCT02142504|364784923|FG000|Overall Study|Adverse Event|2|||
105763089|NCT02142504|364784924|FG001|Overall Study|Adverse Event|3|||
105763090|NCT02142504|364784925|FG002|Overall Study|Adverse Event|4|||
105763091|NCT02142504|364784923|FG000|Overall Study|Lost to Follow-up|12|||
105812352|NCT04540497|364970774|FG000|Overall Study|Lost to Follow-up|1|||
105812353|NCT04540497|364970775|FG001|Overall Study|Lost to Follow-up|0|||
105571529|NCT05672680|364091232|FG001|Overall Study|Procedure Aborted|0|||
105571530|NCT05408468|364091233|FG000|Overall Study|Lost to Follow-up|3|||
105763092|NCT02142504|364784924|FG001|Overall Study|Lost to Follow-up|19|||
105763093|NCT02142504|364784925|FG002|Overall Study|Lost to Follow-up|17|||
105763094|NCT02142504|364784923|FG000|Overall Study|Withdrawal by Subject|7|||
105763095|NCT02142504|364784924|FG001|Overall Study|Withdrawal by Subject|9|||
105763096|NCT02142504|364784925|FG002|Overall Study|Withdrawal by Subject|11|||
105763097|NCT02142504|364784923|FG000|Overall Study|Pregnancy|4|||
105763098|NCT02142504|364784924|FG001|Overall Study|Pregnancy|4|||
105812354|NCT04540497|364970774|FG000|Overall Study|Withdrawal by Subject|1|||
105812355|NCT04540497|364970775|FG001|Overall Study|Withdrawal by Subject|1|||
105812356|NCT04540497|364970774|FG000|Overall Study|Miscellaneous|2|||
105812357|NCT04540497|364970775|FG001|Overall Study|Miscellaneous|1|||
105812358|NCT00275002|364970776|FG000|Overall Study|Death|1|||
105812359|NCT00275002|364970777|FG001|Overall Study|Death|0|||
105812360|NCT00275002|364970776|FG000|Overall Study|Disease progression|21|||
105812361|NCT00275002|364970777|FG001|Overall Study|Disease progression|15|||
105812362|NCT00275002|364970776|FG000|Overall Study|Adverse Event|0|||
105812363|NCT00275002|364970777|FG001|Overall Study|Adverse Event|1|||
105812364|NCT06165744|364970778|FG000|Overall Study|Non device-related adverse event|1|||
105812365|NCT01648166|364970779|FG000|Overall Study|inadequate toenail samples|53|||
105812366|NCT01648166|364970780|FG001|Overall Study|inadequate toenail samples|100|||
105812367|NCT03679741|364970783|FG000|Period 1|No longer meet eligibility criteria|1|||
105812368|NCT03679741|364970784|FG001|Period 1|No longer meet eligibility criteria|0|||
105812369|NCT03679741|364970783|FG000|Period 1|Lost to Follow-up|0|||
105812370|NCT03679741|364970784|FG001|Period 1|Lost to Follow-up|1|||
105812371|NCT03679741|364970783|FG000|Period 1|Adverse Event|1|||
105812372|NCT03679741|364970784|FG001|Period 1|Adverse Event|1|||
105812373|NCT03679741|364970783|FG000|Period 1|Withdrawal by Subject|0|||
105485991|NCT02927067|363791356|FG001|Overall Study|Withdrawn Consent|12|||
105485992|NCT02927067|363791355|FG000|Overall Study|Death|18|||
105485993|NCT02927067|363791356|FG001|Overall Study|Death|31|||
105485994|NCT02927067|363791355|FG000|Overall Study|Adverse Event|13|||
105485995|NCT02927067|363791356|FG001|Overall Study|Adverse Event|10|||
105812374|NCT03679741|364970784|FG001|Period 1|Withdrawal by Subject|1|||
105812375|NCT03679741|364970783|FG000|Period 2|Adverse Event|2|||
105812376|NCT03679741|364970784|FG001|Period 2|Adverse Event|1|||
105812377|NCT03679741|364970783|FG000|Period 2|Withdrawal by Subject|1|||
105812378|NCT03679741|364970784|FG001|Period 2|Withdrawal by Subject|1|||
105812379|NCT03194464|364970789|FG000|Overall Study|data not usable|2|||
105812380|NCT00977106|364970790|FG000|Overall Study|Adverse Event|5|||
105812381|NCT00977106|364970791|FG001|Overall Study|Adverse Event|6|||
105812382|NCT00977106|364970790|FG000|Overall Study|Withdrawal by Subject|2|||
105812383|NCT00977106|364970791|FG001|Overall Study|Withdrawal by Subject|2|||
105812384|NCT00977106|364970790|FG000|Overall Study|Lack of Efficacy|2|||
105812385|NCT00977106|364970791|FG001|Overall Study|Lack of Efficacy|2|||
105812386|NCT00977106|364970790|FG000|Overall Study|Protocol Violation|0|||
105485996|NCT02927067|363791355|FG000|Overall Study|Noncompliance|5|||
105812387|NCT00977106|364970791|FG001|Overall Study|Protocol Violation|1|||
105812388|NCT00977106|364970790|FG000|Overall Study|Other|1|||
105812389|NCT00977106|364970791|FG001|Overall Study|Other|0|||
105812390|NCT00436007|364970801|FG000|Overall Study|Withdrawal by Subject|5|||
105812391|NCT00436007|364970802|FG001|Overall Study|Withdrawal by Subject|3|||
105812392|NCT00436007|364970803|FG002|Overall Study|Withdrawal by Subject|4|||
105812393|NCT00436007|364970801|FG000|Overall Study|Lost to Follow-up|14|||
105812394|NCT00436007|364970802|FG001|Overall Study|Lost to Follow-up|10|||
105812395|NCT00436007|364970803|FG002|Overall Study|Lost to Follow-up|13|||
105812396|NCT00436007|364970801|FG000|Overall Study|Physician Decision|0|||
105812397|NCT00436007|364970802|FG001|Overall Study|Physician Decision|0|||
105812398|NCT00436007|364970803|FG002|Overall Study|Physician Decision|2|||
105812399|NCT00436007|364970801|FG000|Overall Study|Death|0|||
105812400|NCT00436007|364970802|FG001|Overall Study|Death|1|||
105812401|NCT00436007|364970803|FG002|Overall Study|Death|3|||
105485997|NCT02927067|363791356|FG001|Overall Study|Noncompliance|2|||
105812402|NCT00436007|364970801|FG000|Overall Study|Other|0|||
105812403|NCT00436007|364970802|FG001|Overall Study|Other|0|||
105812404|NCT00436007|364970803|FG002|Overall Study|Other|1|||
105812405|NCT02153398|364970804|FG000|Overall Study|Withdrawal by Subject|1|||
105485998|NCT02927067|363791355|FG000|Overall Study|Reason not Specified|4|||
105485999|NCT02927067|363791356|FG001|Overall Study|Reason not Specified|6|||
105486000|NCT01547780|363791361|FG000|Baseline PET Scan|Physician Decision|1|||
105571531|NCT05408468|364091234|FG001|Overall Study|Lost to Follow-up|1|||
105812406|NCT02153398|364970805|FG001|Overall Study|Withdrawal by Subject|0|||
105812407|NCT02153398|364970806|FG002|Overall Study|Withdrawal by Subject|0|||
105812408|NCT02153398|364970807|FG003|Overall Study|Withdrawal by Subject|0|||
105812409|NCT02153398|364970808|FG004|Overall Study|Withdrawal by Subject|0|||
105812410|NCT02153398|364970804|FG000|Overall Study|Adverse Event|0|||
105486001|NCT01547780|363791362|FG001|Baseline PET Scan|Physician Decision|0|||
105486002|NCT01547780|363791363|FG002|Baseline PET Scan|Physician Decision|1|||
105486003|NCT01547780|363791364|FG003|Baseline PET Scan|Physician Decision|0|||
105812411|NCT02153398|364970805|FG001|Overall Study|Adverse Event|0|||
105812412|NCT02153398|364970806|FG002|Overall Study|Adverse Event|1|||
105812413|NCT02153398|364970807|FG003|Overall Study|Adverse Event|1|||
105812414|NCT02153398|364970808|FG004|Overall Study|Adverse Event|0|||
105486004|NCT01547780|363791361|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
105812415|NCT00721409|364970809|FG000|Overall Study|Global deterioration of health status|2|||
105812416|NCT00721409|364970810|FG001|Overall Study|Global deterioration of health status|6|||
105486005|NCT01547780|363791362|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
105812417|NCT00721409|364970811|FG002|Overall Study|Global deterioration of health status|3|||
105812418|NCT00721409|364970809|FG000|Overall Study|Death|0|||
105812419|NCT00721409|364970810|FG001|Overall Study|Death|1|||
105812420|NCT00721409|364970811|FG002|Overall Study|Death|0|||
105812421|NCT00721409|364970809|FG000|Overall Study|Randomized not Treated|0|||
105812422|NCT00721409|364970810|FG001|Overall Study|Randomized not Treated|1|||
105812423|NCT00721409|364970811|FG002|Overall Study|Randomized not Treated|4|||
105812424|NCT00721409|364970809|FG000|Overall Study|Reason not specified|1|||
105812425|NCT00721409|364970810|FG001|Overall Study|Reason not specified|0|||
105812426|NCT00721409|364970811|FG002|Overall Study|Reason not specified|2|||
105812427|NCT00721409|364970809|FG000|Overall Study|Adverse Event|0|||
105812428|NCT00721409|364970810|FG001|Overall Study|Adverse Event|13|||
105812429|NCT00721409|364970811|FG002|Overall Study|Adverse Event|2|||
105812430|NCT00721409|364970809|FG000|Overall Study|Lost to Follow-up|0|||
105812431|NCT00721409|364970810|FG001|Overall Study|Lost to Follow-up|0|||
105812432|NCT00721409|364970811|FG002|Overall Study|Lost to Follow-up|1|||
105812433|NCT00721409|364970809|FG000|Overall Study|Withdrawal by Subject|1|||
105812434|NCT00721409|364970810|FG001|Overall Study|Withdrawal by Subject|6|||
105812435|NCT00721409|364970811|FG002|Overall Study|Withdrawal by Subject|5|||
105812436|NCT00721409|364970809|FG000|Overall Study|Objective progression or relapse|8|||
105812437|NCT00721409|364970810|FG001|Overall Study|Objective progression or relapse|55|||
105812438|NCT00721409|364970811|FG002|Overall Study|Objective progression or relapse|62|||
105812439|NCT02402166|364970813|FG000|Overall Study|Adverse Event|2|||
105812440|NCT02402166|364970813|FG000|Overall Study|Withdrawal by Subject|2|||
105812441|NCT02402166|364970813|FG000|Overall Study|Lost to Follow-up|1|||
105812442|NCT02433678|364970814|FG000|Overall Study|Lost to Follow-up|1|||
105812443|NCT02433678|364970815|FG001|Overall Study|Lost to Follow-up|2|||
105812444|NCT01458405|364970820|FG000|Phase 1 (up to 12 Months)|Other|0|||
105812445|NCT01458405|364970821|FG001|Phase 1 (up to 12 Months)|Other|1|||
105812446|NCT01458405|364970822|FG002|Phase 1 (up to 12 Months)|Other|0|||
105812447|NCT01458405|364970823|FG003|Phase 1 (up to 12 Months)|Other|0|||
105812448|NCT01458405|364970820|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
105812449|NCT01458405|364970821|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
105812450|NCT01458405|364970822|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
105812451|NCT01458405|364970823|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
105812452|NCT01458405|364970820|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
105812453|NCT01458405|364970821|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
105571532|NCT05408468|364091233|FG000|Overall Study|Physician Decision|1|||
105571533|NCT05408468|364091234|FG001|Overall Study|Physician Decision|0|||
105571534|NCT05408468|364091233|FG000|Overall Study|Overwhelmed by clinical situation|3|||
105763099|NCT02142504|364784925|FG002|Overall Study|Pregnancy|2|||
105763100|NCT02142504|364784923|FG000|Overall Study|Physician Decision|0|||
105763101|NCT02142504|364784924|FG001|Overall Study|Physician Decision|1|||
105763102|NCT02142504|364784925|FG002|Overall Study|Physician Decision|3|||
105763103|NCT02142504|364784923|FG000|Overall Study|Reason Not Specified|4|||
105763104|NCT02142504|364784924|FG001|Overall Study|Reason Not Specified|5|||
105763105|NCT02142504|364784925|FG002|Overall Study|Reason Not Specified|4|||
105763106|NCT02427100|364784928|FG000|Overall Study|Lost to Follow-up|0|||
105763107|NCT02427100|364784929|FG001|Overall Study|Lost to Follow-up|2|||
105763108|NCT00166517|364784940|FG000|Overall Study|Lost to Follow-up|1|||
105763109|NCT00166517|364784941|FG001|Overall Study|Lost to Follow-up|0|||
105763110|NCT00166517|364784940|FG000|Overall Study|Protocol Violation|4|||
105763111|NCT00166517|364784941|FG001|Overall Study|Protocol Violation|1|||
105763112|NCT00166517|364784940|FG000|Overall Study|Withdrawal by Subject|0|||
105763113|NCT00166517|364784941|FG001|Overall Study|Withdrawal by Subject|1|||
105763114|NCT02186561|364784943|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
105763115|NCT02186561|364784943|FG000|Enrollment|Enrollment Cap Reached|5|||
105763116|NCT02186561|364784943|FG000|Enrollment|Insurance Denial|2|||
105763117|NCT02186561|364784943|FG000|Enrollment|Withdrawal by Subject|2|||
105763118|NCT02186561|364784943|FG000|Enrollment|Investigator Withdrew Consent|1|||
105763119|NCT02186561|364784943|FG000|30-Day Post Index Procedure Visit|Death|1|||
105763120|NCT02186561|364784943|FG000|1- Year Post Index Procedure Visit|Death|1|||
105763121|NCT02186561|364784943|FG000|1- Year Post Index Procedure Visit|Missed|1|||
105763122|NCT02758613|364784944|FG000|Treatment|Physician and Sponsor Decision|1|||
105763123|NCT02758613|364784945|FG001|Treatment|Physician and Sponsor Decision|0|||
105763124|NCT02758613|364784946|FG002|Treatment|Physician and Sponsor Decision|0|||
105763125|NCT02758613|364784947|FG003|Treatment|Physician and Sponsor Decision|0|||
105763126|NCT02758613|364784944|FG000|Treatment|Withdrawal by Subject|1|||
105763127|NCT02758613|364784945|FG001|Treatment|Withdrawal by Subject|0|||
105763128|NCT02758613|364784946|FG002|Treatment|Withdrawal by Subject|1|||
105763129|NCT02758613|364784947|FG003|Treatment|Withdrawal by Subject|0|||
105763130|NCT00351819|364784948|FG000|Overall Study|Lost to Follow-up|4|||
105763131|NCT00351819|364784949|FG001|Overall Study|Lost to Follow-up|4|||
105812454|NCT01458405|364970822|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
105812455|NCT01458405|364970823|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
105812456|NCT01458405|364970820|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
105812457|NCT01458405|364970821|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
105812458|NCT01458405|364970822|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
105812459|NCT01458405|364970823|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
105812460|NCT00266409|364970824|FG000|Overall Study|Lack of Efficacy|2|||
105812461|NCT00266409|364970825|FG001|Overall Study|Lack of Efficacy|6|||
105812462|NCT00266409|364970826|FG002|Overall Study|Lack of Efficacy|1|||
105812463|NCT00266409|364970827|FG003|Overall Study|Lack of Efficacy|2|||
105812464|NCT00266409|364970824|FG000|Overall Study|Adverse Event|7|||
105812465|NCT00266409|364970825|FG001|Overall Study|Adverse Event|2|||
105812466|NCT00266409|364970826|FG002|Overall Study|Adverse Event|1|||
105812467|NCT00266409|364970827|FG003|Overall Study|Adverse Event|1|||
105812468|NCT00266409|364970824|FG000|Overall Study|Lost to Follow-up|18|||
105812469|NCT00266409|364970825|FG001|Overall Study|Lost to Follow-up|21|||
105812470|NCT00266409|364970826|FG002|Overall Study|Lost to Follow-up|6|||
105812471|NCT00266409|364970827|FG003|Overall Study|Lost to Follow-up|8|||
105812472|NCT00266409|364970824|FG000|Overall Study|Withdrawal by Subject|6|||
105812473|NCT00266409|364970825|FG001|Overall Study|Withdrawal by Subject|10|||
105812474|NCT00266409|364970826|FG002|Overall Study|Withdrawal by Subject|3|||
105812475|NCT00266409|364970827|FG003|Overall Study|Withdrawal by Subject|9|||
105812476|NCT00266409|364970824|FG000|Overall Study|Protocol Violation|5|||
105812477|NCT00266409|364970825|FG001|Overall Study|Protocol Violation|3|||
105812478|NCT00266409|364970826|FG002|Overall Study|Protocol Violation|4|||
105812479|NCT00266409|364970827|FG003|Overall Study|Protocol Violation|2|||
105812480|NCT00266409|364970824|FG000|Overall Study|Other|7|||
105812481|NCT00266409|364970825|FG001|Overall Study|Other|4|||
105812482|NCT00266409|364970826|FG002|Overall Study|Other|2|||
105812483|NCT00266409|364970827|FG003|Overall Study|Other|0|||
105812484|NCT00712010|364970828|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
105812485|NCT01946165|364970829|FG000|Overall Study|Physician Decision|2|||
105812486|NCT01946165|364970830|FG001|Overall Study|Physician Decision|0|||
105812487|NCT01946165|364970829|FG000|Overall Study|Withdrawal by Subject|0|||
105812488|NCT01946165|364970830|FG001|Overall Study|Withdrawal by Subject|2|||
105812489|NCT00454636|364970831|FG000|Overall Study|Adverse Event|10|||
105812490|NCT00454636|364970832|FG001|Overall Study|Adverse Event|6|||
105812491|NCT00454636|364970833|FG002|Overall Study|Adverse Event|9|||
105812492|NCT00454636|364970834|FG003|Overall Study|Adverse Event|15|||
105812493|NCT00454636|364970831|FG000|Overall Study|Disease Progression|11|||
105812494|NCT00454636|364970832|FG001|Overall Study|Disease Progression|12|||
105812495|NCT00454636|364970833|FG002|Overall Study|Disease Progression|4|||
105812496|NCT00454636|364970834|FG003|Overall Study|Disease Progression|11|||
105812497|NCT00454636|364970831|FG000|Overall Study|Protocol Violation|3|||
105812498|NCT00454636|364970832|FG001|Overall Study|Protocol Violation|2|||
105812499|NCT00454636|364970833|FG002|Overall Study|Protocol Violation|3|||
105812500|NCT00454636|364970834|FG003|Overall Study|Protocol Violation|3|||
105812501|NCT00454636|364970831|FG000|Overall Study|Death|6|||
105812502|NCT00454636|364970832|FG001|Overall Study|Death|1|||
105812503|NCT00454636|364970833|FG002|Overall Study|Death|1|||
105361956|NCT02326272|363330150|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105571535|NCT05408468|364091234|FG001|Overall Study|Overwhelmed by clinical situation|0|||
105812504|NCT00454636|364970834|FG003|Overall Study|Death|1|||
105812505|NCT00454636|364970831|FG000|Overall Study|Patient refusal|1|||
105812506|NCT00454636|364970832|FG001|Overall Study|Patient refusal|1|||
105812507|NCT00454636|364970833|FG002|Overall Study|Patient refusal|3|||
105812508|NCT00454636|364970834|FG003|Overall Study|Patient refusal|2|||
105812509|NCT00454636|364970831|FG000|Overall Study|Lost to Follow-up|0|||
105812510|NCT00454636|364970832|FG001|Overall Study|Lost to Follow-up|1|||
105812511|NCT00454636|364970833|FG002|Overall Study|Lost to Follow-up|0|||
105812512|NCT00454636|364970834|FG003|Overall Study|Lost to Follow-up|0|||
105812513|NCT00337571|364970843|FG000|Overall Study|Lack of Efficacy|3|||
105812514|NCT00337571|364970844|FG001|Overall Study|Lack of Efficacy|0|||
105812515|NCT00337571|364970845|FG002|Overall Study|Lack of Efficacy|0|||
105812516|NCT00337571|364970846|FG003|Overall Study|Lack of Efficacy|0|||
105812517|NCT00337571|364970843|FG000|Overall Study|Adverse Event|4|||
105812518|NCT00337571|364970844|FG001|Overall Study|Adverse Event|5|||
105812519|NCT00337571|364970845|FG002|Overall Study|Adverse Event|8|||
105812520|NCT00337571|364970846|FG003|Overall Study|Adverse Event|4|||
105812521|NCT00337571|364970843|FG000|Overall Study|Withdrawal by Subject|2|||
105812522|NCT00337571|364970844|FG001|Overall Study|Withdrawal by Subject|2|||
105812523|NCT00337571|364970845|FG002|Overall Study|Withdrawal by Subject|1|||
105812524|NCT00337571|364970846|FG003|Overall Study|Withdrawal by Subject|0|||
105812525|NCT00337571|364970843|FG000|Overall Study|Lost to Follow-up|3|||
105812526|NCT00337571|364970844|FG001|Overall Study|Lost to Follow-up|1|||
105812527|NCT00337571|364970845|FG002|Overall Study|Lost to Follow-up|0|||
105812528|NCT00337571|364970846|FG003|Overall Study|Lost to Follow-up|1|||
105812529|NCT00337571|364970843|FG000|Overall Study|Poor/noncompliance|1|||
105812530|NCT00337571|364970844|FG001|Overall Study|Poor/noncompliance|1|||
105812531|NCT00337571|364970845|FG002|Overall Study|Poor/noncompliance|1|||
105812532|NCT00337571|364970846|FG003|Overall Study|Poor/noncompliance|1|||
105812533|NCT00337571|364970843|FG000|Overall Study|No longer met study criteria|1|||
105812534|NCT00337571|364970844|FG001|Overall Study|No longer met study criteria|0|||
105812535|NCT00337571|364970845|FG002|Overall Study|No longer met study criteria|0|||
105812536|NCT00337571|364970846|FG003|Overall Study|No longer met study criteria|0|||
105812537|NCT00337571|364970843|FG000|Overall Study|High Potassium level|0|||
105812538|NCT00337571|364970844|FG001|Overall Study|High Potassium level|0|||
105812539|NCT00337571|364970845|FG002|Overall Study|High Potassium level|0|||
105812540|NCT00337571|364970846|FG003|Overall Study|High Potassium level|1|||
105812541|NCT02114697|364970847|FG000|Overall Study|Study terminated|5|||
105812542|NCT02114697|364970848|FG001|Overall Study|Study terminated|4|||
105812543|NCT01399736|364970849|FG000|Overall Study|Withdrawal by Subject|4|||
105812544|NCT01399736|364970850|FG001|Overall Study|Withdrawal by Subject|2|||
105812545|NCT01399736|364970849|FG000|Overall Study|Lost to Follow-up|0|||
105812546|NCT01399736|364970850|FG001|Overall Study|Lost to Follow-up|2|||
105812547|NCT03500484|364970851|FG000|Overall Study|Adverse Event|2|||
105812548|NCT03500484|364970852|FG001|Overall Study|Adverse Event|0|||
105812549|NCT03500484|364970851|FG000|Overall Study|Physician Decision|1|||
105812550|NCT03500484|364970852|FG001|Overall Study|Physician Decision|0|||
105812551|NCT03500484|364970851|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
105812552|NCT03500484|364970852|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
105812553|NCT00948675|364970853|FG000|Overall Study|Lost to Follow-up|1|||
105812554|NCT00948675|364970854|FG001|Overall Study|Lost to Follow-up|0|||
105812555|NCT02143102|364970860|FG000|Overall Study|Lost to Follow-up|11|||
105812556|NCT02143102|364970861|FG001|Overall Study|Lost to Follow-up|0|||
105812557|NCT01370408|364970865|FG000|Overall Study|treatment failure|9|||
105812558|NCT01440283|364970867|FG000|Overall Study|Death|3|||
105812559|NCT01440283|364970867|FG000|Overall Study|Withdrawal by Subject|4|||
105812560|NCT01440283|364970867|FG000|Overall Study|Physician Decision|3|||
105812561|NCT02780687|364970870|FG000|Overall Study|Adverse Event|1|||
105812562|NCT02780687|364970871|FG001|Overall Study|Adverse Event|1|||
105812563|NCT02780687|364970870|FG000|Overall Study|Withdrawal by Subject|2|||
105812564|NCT02780687|364970871|FG001|Overall Study|Withdrawal by Subject|1|||
105812565|NCT02780687|364970870|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
105812566|NCT02780687|364970871|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
105812567|NCT02780687|364970870|FG000|Overall Study|progressive disease|29|||
105812568|NCT02780687|364970871|FG001|Overall Study|progressive disease|6|||
105812569|NCT02430870|364970872|FG000|Part 2|Voluntary Withdrawal|0|||
105812570|NCT02430870|364970873|FG001|Part 2|Voluntary Withdrawal|0|||
105812571|NCT02430870|364970874|FG002|Part 2|Voluntary Withdrawal|0|||
105812572|NCT02430870|364970875|FG003|Part 2|Voluntary Withdrawal|0|||
105812573|NCT02430870|364970876|FG004|Part 2|Voluntary Withdrawal|0|||
105812574|NCT02430870|364970877|FG005|Part 2|Voluntary Withdrawal|0|||
105812575|NCT02430870|364970878|FG006|Part 2|Voluntary Withdrawal|1|||
105812576|NCT02430870|364970879|FG007|Part 2|Voluntary Withdrawal|0|||
105812577|NCT02430870|364970872|FG000|Part 2|Other Reason Not Specified|0|||
105812578|NCT02430870|364970873|FG001|Part 2|Other Reason Not Specified|0|||
105812579|NCT02430870|364970874|FG002|Part 2|Other Reason Not Specified|0|||
105812580|NCT02430870|364970875|FG003|Part 2|Other Reason Not Specified|0|||
105361957|NCT02326272|363330151|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105361958|NCT02326272|363330152|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105361959|NCT02326272|363330153|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105571536|NCT05408468|364091233|FG000|Overall Study|Personal illness precluding participation|1|||
105812581|NCT02430870|364970876|FG004|Part 2|Other Reason Not Specified|0|||
105812582|NCT02430870|364970877|FG005|Part 2|Other Reason Not Specified|0|||
105812583|NCT02430870|364970878|FG006|Part 2|Other Reason Not Specified|0|||
105812584|NCT02430870|364970879|FG007|Part 2|Other Reason Not Specified|1|||
105812585|NCT01199861|364970880|FG000|Overall Study|Administrative problems|1|||
105812586|NCT01199861|364970881|FG001|Overall Study|Administrative problems|0|||
105812587|NCT01199861|364970880|FG000|Overall Study|Adverse Event|1|||
105812588|NCT01199861|364970881|FG001|Overall Study|Adverse Event|0|||
105812589|NCT00669864|364970882|FG000|Overall Study|Lost to Follow-up|2|||
105812590|NCT00669864|364970882|FG000|Overall Study|Protocol Violation|2|||
105812591|NCT00669864|364970882|FG000|Overall Study|Withdrawal by Subject|3|||
105812592|NCT00669864|364970882|FG000|Overall Study|Other|2|||
105812593|NCT01265784|364970883|FG000|Overall Study|Lost to Follow-up|5|||
105571537|NCT05408468|364091234|FG001|Overall Study|Personal illness precluding participation|0|||
105571538|NCT05408468|364091233|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
105763132|NCT00351819|364784948|FG000|Overall Study|Withdrawal by Subject|0|||
105763133|NCT00351819|364784949|FG001|Overall Study|Withdrawal by Subject|4|||
105763134|NCT00351819|364784948|FG000|Overall Study|Elevated PSA|1|||
105763135|NCT00351819|364784949|FG001|Overall Study|Elevated PSA|1|||
105763136|NCT00351819|364784948|FG000|Overall Study|Traumatic ankle fracture|1|||
105763137|NCT00351819|364784949|FG001|Overall Study|Traumatic ankle fracture|0|||
105763138|NCT00351819|364784948|FG000|Overall Study|Unprofessional behavior|1|||
105763139|NCT00351819|364784949|FG001|Overall Study|Unprofessional behavior|0|||
105763140|NCT00351819|364784948|FG000|Overall Study|Non-compliance|0|||
105763141|NCT00351819|364784949|FG001|Overall Study|Non-compliance|1|||
105763142|NCT00351819|364784948|FG000|Overall Study|Incarcerated|0|||
105763143|NCT00351819|364784949|FG001|Overall Study|Incarcerated|1|||
105763144|NCT00351819|364784948|FG000|Overall Study|Enrolled in another trial|0|||
105763145|NCT00351819|364784949|FG001|Overall Study|Enrolled in another trial|1|||
105763146|NCT00719537|364784952|FG000|Overall Study|Withdrawal by Subject|1|||
105763147|NCT00719537|364784953|FG001|Overall Study|Withdrawal by Subject|0|||
105763148|NCT00719537|364784952|FG000|Overall Study|Lost to Follow-up|0|||
105763149|NCT00719537|364784953|FG001|Overall Study|Lost to Follow-up|1|||
105763150|NCT03565991|364787045|FG000|Overall Study|Other|11|||
105763151|NCT03565991|364787046|FG001|Overall Study|Other|0|||
105763152|NCT03565991|364787045|FG000|Overall Study|Global deterioration of health status|14|||
105763153|NCT03565991|364787046|FG001|Overall Study|Global deterioration of health status|4|||
105763154|NCT03565991|364787045|FG000|Overall Study|Withdrawal by Subject|2|||
105763155|NCT03565991|364787046|FG001|Overall Study|Withdrawal by Subject|6|||
105763156|NCT03565991|364787045|FG000|Overall Study|Progressive disease|121|||
105763157|NCT03565991|364787046|FG001|Overall Study|Progressive disease|29|||
105763158|NCT03565991|364787045|FG000|Overall Study|Death|3|||
105763159|NCT03565991|364787046|FG001|Overall Study|Death|0|||
105763160|NCT03565991|364787045|FG000|Overall Study|Adverse Event|7|||
105763161|NCT03565991|364787046|FG001|Overall Study|Adverse Event|2|||
105763162|NCT02715804|364787052|FG000|Overall Study|Death|222|||
105763163|NCT02715804|364787053|FG001|Overall Study|Death|106|||
105763164|NCT02715804|364787052|FG000|Overall Study|Withdrawal by Subject|5|||
105763165|NCT02715804|364787053|FG001|Overall Study|Withdrawal by Subject|4|||
105763166|NCT02715804|364787052|FG000|Overall Study|Other than specified|2|||
105763167|NCT02715804|364787053|FG001|Overall Study|Other than specified|3|||
105763168|NCT00402285|364787055|FG000|Overall Study|insufficient RNA quality|7|||
105763169|NCT00402285|364787056|FG001|Overall Study|insufficient RNA quality|6|||
105763170|NCT00402285|364787057|FG002|Overall Study|insufficient RNA quality|2|||
105763171|NCT00693420|364787061|FG000|Overall Study|Adverse Event|4|||
105763172|NCT00693420|364787062|FG001|Overall Study|Adverse Event|4|||
105763173|NCT00693420|364787061|FG000|Overall Study|Lost to Follow-up|0|||
105763174|NCT00693420|364787062|FG001|Overall Study|Lost to Follow-up|3|||
105763175|NCT00693420|364787061|FG000|Overall Study|Withdrawal by Subject|1|||
105763176|NCT00693420|364787062|FG001|Overall Study|Withdrawal by Subject|0|||
105763177|NCT00693420|364787061|FG000|Overall Study|Protocol Violation|0|||
105763178|NCT00693420|364787062|FG001|Overall Study|Protocol Violation|2|||
105763179|NCT00693420|364787061|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
105763180|NCT00693420|364787062|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
105763181|NCT00693420|364787061|FG000|Overall Study|Personal Reasons|1|||
105763182|NCT00693420|364787062|FG001|Overall Study|Personal Reasons|4|||
105763183|NCT00254163|364787067|FG000|Overall Study|Adverse Event|29|||
105763184|NCT00254163|364787068|FG001|Overall Study|Adverse Event|26|||
105763185|NCT00254163|364787067|FG000|Overall Study|Patient request/withdrew consent|6|||
105763186|NCT00254163|364787068|FG001|Overall Study|Patient request/withdrew consent|4|||
105763187|NCT00254163|364787067|FG000|Overall Study|Investigator request|1|||
105812594|NCT01265784|364970884|FG001|Overall Study|Lost to Follow-up|3|||
105763188|NCT00254163|364787068|FG001|Overall Study|Investigator request|3|||
105763189|NCT00254163|364787067|FG000|Overall Study|Failed entry|1|||
105763190|NCT00254163|364787068|FG001|Overall Study|Failed entry|3|||
105763191|NCT00254163|364787067|FG000|Overall Study|Progressive disease|0|||
105763192|NCT00254163|364787068|FG001|Overall Study|Progressive disease|1|||
105763193|NCT00254163|364787067|FG000|Overall Study|Death|0|||
105763194|NCT00254163|364787068|FG001|Overall Study|Death|1|||
105763195|NCT00254163|364787067|FG000|Overall Study|Other|8|||
105763196|NCT00254163|364787068|FG001|Overall Study|Other|8|||
105763197|NCT05091918|364787071|FG000|Overall Study|Adverse Event|1|||
105763198|NCT05091918|364787071|FG000|Overall Study|Withdrawal by Subject|81|||
105763199|NCT04897594|364787072|FG000|Overall Study|Lost to Follow-up|0|||
105763200|NCT04897594|364787073|FG001|Overall Study|Lost to Follow-up|1|||
105763201|NCT04897594|364787074|FG002|Overall Study|Lost to Follow-up|1|||
105763202|NCT04897594|364787072|FG000|Overall Study|Sponsor Decision|0|||
105812595|NCT01265784|364970885|FG002|Overall Study|Lost to Follow-up|2|||
105812596|NCT01265784|364970883|FG000|Overall Study|Withdrawal by Subject|0|||
105812597|NCT01265784|364970884|FG001|Overall Study|Withdrawal by Subject|5|||
105812598|NCT01265784|364970885|FG002|Overall Study|Withdrawal by Subject|0|||
105812599|NCT01265784|364970883|FG000|Overall Study|Physician Decision|1|||
105812600|NCT01265784|364970884|FG001|Overall Study|Physician Decision|0|||
105812601|NCT01265784|364970885|FG002|Overall Study|Physician Decision|1|||
105812602|NCT01265784|364970883|FG000|Overall Study|Adverse Event|1|||
105812603|NCT01265784|364970884|FG001|Overall Study|Adverse Event|0|||
105812604|NCT01265784|364970885|FG002|Overall Study|Adverse Event|0|||
105812605|NCT01265784|364970883|FG000|Overall Study|Death|3|||
105812606|NCT01265784|364970884|FG001|Overall Study|Death|0|||
105812607|NCT01265784|364970885|FG002|Overall Study|Death|0|||
105812608|NCT01265784|364970883|FG000|Overall Study|Protocol Violation|2|||
105812609|NCT01265784|364970884|FG001|Overall Study|Protocol Violation|0|||
105812610|NCT01265784|364970885|FG002|Overall Study|Protocol Violation|0|||
105812611|NCT01265784|364970883|FG000|Overall Study|Incorrectly Randomized|0|||
105812612|NCT01265784|364970884|FG001|Overall Study|Incorrectly Randomized|0|||
105812613|NCT01265784|364970885|FG002|Overall Study|Incorrectly Randomized|1|||
105812614|NCT00796822|364970886|FG000|Overall Study|Lost to Follow-up|2|||
105812615|NCT00796822|364970887|FG001|Overall Study|Lost to Follow-up|0|||
105812616|NCT00796822|364970886|FG000|Overall Study|Adverse Event|1|||
105812617|NCT00796822|364970887|FG001|Overall Study|Adverse Event|0|||
105812618|NCT00680121|364970888|FG000|Overall Study|Lost to Follow-up|27|||
105812619|NCT00680121|364970889|FG001|Overall Study|Lost to Follow-up|23|||
105812620|NCT02603952|364970904|FG000|Overall Study|Withdrawal by Subject|1|||
105812621|NCT02603952|364970905|FG001|Overall Study|Withdrawal by Subject|0|||
105812622|NCT02603952|364970906|FG002|Overall Study|Withdrawal by Subject|0|||
105812623|NCT02603952|364970907|FG003|Overall Study|Withdrawal by Subject|0|||
105812624|NCT02603952|364970904|FG000|Overall Study|Received oseltamivir by error|0|||
105812625|NCT02603952|364970905|FG001|Overall Study|Received oseltamivir by error|0|||
105812626|NCT02603952|364970906|FG002|Overall Study|Received oseltamivir by error|0|||
105812627|NCT02603952|364970907|FG003|Overall Study|Received oseltamivir by error|1|||
105812628|NCT00162123|364970909|FG000|Overall Study|Disease progression|27|||
105812629|NCT00162123|364970910|FG001|Overall Study|Disease progression|19|||
105812630|NCT00162123|364970911|FG002|Overall Study|Disease progression|10|||
105812631|NCT00162123|364970912|FG003|Overall Study|Disease progression|4|||
105812632|NCT00162123|364970913|FG004|Overall Study|Disease progression|8|||
105812633|NCT00162123|364970914|FG005|Overall Study|Disease progression|3|||
105812634|NCT00162123|364970915|FG006|Overall Study|Disease progression|1|||
105812635|NCT00162123|364970916|FG007|Overall Study|Disease progression|0|||
105812636|NCT00162123|364970909|FG000|Overall Study|Study drug toxicity|6|||
105812637|NCT00162123|364970910|FG001|Overall Study|Study drug toxicity|1|||
105812638|NCT00162123|364970911|FG002|Overall Study|Study drug toxicity|5|||
105812639|NCT00162123|364970912|FG003|Overall Study|Study drug toxicity|0|||
105812640|NCT00162123|364970913|FG004|Overall Study|Study drug toxicity|4|||
105812641|NCT00162123|364970914|FG005|Overall Study|Study drug toxicity|1|||
105812642|NCT00162123|364970915|FG006|Overall Study|Study drug toxicity|1|||
105812643|NCT00162123|364970916|FG007|Overall Study|Study drug toxicity|0|||
105812644|NCT00162123|364970909|FG000|Overall Study|Death|3|||
105812645|NCT00162123|364970910|FG001|Overall Study|Death|3|||
105812646|NCT00162123|364970911|FG002|Overall Study|Death|1|||
105812647|NCT00162123|364970912|FG003|Overall Study|Death|1|||
105812648|NCT00162123|364970913|FG004|Overall Study|Death|1|||
105812649|NCT00162123|364970914|FG005|Overall Study|Death|1|||
105812650|NCT00162123|364970915|FG006|Overall Study|Death|0|||
105812651|NCT00162123|364970916|FG007|Overall Study|Death|0|||
105812652|NCT00162123|364970909|FG000|Overall Study|Withdrawal by Subject|2|||
105812653|NCT00162123|364970910|FG001|Overall Study|Withdrawal by Subject|0|||
105812654|NCT00162123|364970911|FG002|Overall Study|Withdrawal by Subject|2|||
105812655|NCT00162123|364970912|FG003|Overall Study|Withdrawal by Subject|1|||
105812656|NCT00162123|364970913|FG004|Overall Study|Withdrawal by Subject|1|||
105812657|NCT00162123|364970914|FG005|Overall Study|Withdrawal by Subject|2|||
105812658|NCT00162123|364970915|FG006|Overall Study|Withdrawal by Subject|1|||
105812659|NCT00162123|364970916|FG007|Overall Study|Withdrawal by Subject|0|||
105812660|NCT00162123|364970909|FG000|Overall Study|Deterioration without progression|2|||
105812661|NCT00162123|364970910|FG001|Overall Study|Deterioration without progression|2|||
105812662|NCT00162123|364970911|FG002|Overall Study|Deterioration without progression|3|||
105812663|NCT00162123|364970912|FG003|Overall Study|Deterioration without progression|0|||
105812664|NCT00162123|364970913|FG004|Overall Study|Deterioration without progression|1|||
105812665|NCT00162123|364970914|FG005|Overall Study|Deterioration without progression|0|||
105812666|NCT00162123|364970915|FG006|Overall Study|Deterioration without progression|0|||
105812667|NCT00162123|364970916|FG007|Overall Study|Deterioration without progression|0|||
105812668|NCT00162123|364970909|FG000|Overall Study|Adverse Event|1|||
105812669|NCT00162123|364970910|FG001|Overall Study|Adverse Event|2|||
105812670|NCT00162123|364970911|FG002|Overall Study|Adverse Event|0|||
105812671|NCT00162123|364970912|FG003|Overall Study|Adverse Event|2|||
105812672|NCT00162123|364970913|FG004|Overall Study|Adverse Event|1|||
105812673|NCT00162123|364970914|FG005|Overall Study|Adverse Event|0|||
105812674|NCT00162123|364970915|FG006|Overall Study|Adverse Event|0|||
105812675|NCT00162123|364970916|FG007|Overall Study|Adverse Event|0|||
105812676|NCT00162123|364970909|FG000|Overall Study|Not specified (before treatment)|2|||
105812677|NCT00162123|364970910|FG001|Overall Study|Not specified (before treatment)|0|||
105812678|NCT00162123|364970911|FG002|Overall Study|Not specified (before treatment)|0|||
105812679|NCT00162123|364970912|FG003|Overall Study|Not specified (before treatment)|0|||
105812680|NCT00162123|364970913|FG004|Overall Study|Not specified (before treatment)|12|||
105812681|NCT00162123|364970914|FG005|Overall Study|Not specified (before treatment)|1|||
105812682|NCT00162123|364970915|FG006|Overall Study|Not specified (before treatment)|0|||
105812683|NCT00162123|364970916|FG007|Overall Study|Not specified (before treatment)|0|||
105812684|NCT00162123|364970909|FG000|Overall Study|Not specified (after start of treatment)|0|||
105812685|NCT00162123|364970910|FG001|Overall Study|Not specified (after start of treatment)|0|||
105812686|NCT00162123|364970911|FG002|Overall Study|Not specified (after start of treatment)|0|||
105812687|NCT00162123|364970912|FG003|Overall Study|Not specified (after start of treatment)|0|||
105812688|NCT00162123|364970913|FG004|Overall Study|Not specified (after start of treatment)|3|||
105812689|NCT00162123|364970914|FG005|Overall Study|Not specified (after start of treatment)|0|||
105812690|NCT00162123|364970915|FG006|Overall Study|Not specified (after start of treatment)|0|||
105812691|NCT00162123|364970916|FG007|Overall Study|Not specified (after start of treatment)|0|||
105812692|NCT00162123|364970909|FG000|Overall Study|Physician Decision|1|||
105812693|NCT00162123|364970910|FG001|Overall Study|Physician Decision|2|||
105812694|NCT00162123|364970911|FG002|Overall Study|Physician Decision|0|||
105812695|NCT00162123|364970912|FG003|Overall Study|Physician Decision|0|||
105812696|NCT00162123|364970913|FG004|Overall Study|Physician Decision|0|||
105812697|NCT00162123|364970914|FG005|Overall Study|Physician Decision|1|||
105812698|NCT00162123|364970915|FG006|Overall Study|Physician Decision|1|||
105812699|NCT00162123|364970916|FG007|Overall Study|Physician Decision|0|||
105812700|NCT00162123|364970909|FG000|Overall Study|Tumor assessment only (not treated)|0|||
105812701|NCT00162123|364970910|FG001|Overall Study|Tumor assessment only (not treated)|0|||
105812702|NCT00162123|364970911|FG002|Overall Study|Tumor assessment only (not treated)|0|||
105812703|NCT00162123|364970912|FG003|Overall Study|Tumor assessment only (not treated)|0|||
105812704|NCT00162123|364970913|FG004|Overall Study|Tumor assessment only (not treated)|0|||
105812705|NCT00162123|364970914|FG005|Overall Study|Tumor assessment only (not treated)|0|||
105812706|NCT00162123|364970915|FG006|Overall Study|Tumor assessment only (not treated)|0|||
105812707|NCT00162123|364970916|FG007|Overall Study|Tumor assessment only (not treated)|1|||
105812708|NCT00162123|364970909|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
105812709|NCT00162123|364970910|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
105812710|NCT00162123|364970911|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
105812711|NCT00162123|364970912|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
105812712|NCT00162123|364970913|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
105812713|NCT00162123|364970914|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
105812714|NCT00162123|364970915|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
105812715|NCT00162123|364970916|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
105812716|NCT01347710|364970919|FG000|Overall Study|Withdrawal by Subject|2|||
105812717|NCT01347710|364970919|FG000|Overall Study|Adverse Event|4|||
105812718|NCT01347710|364970919|FG000|Overall Study|Angio or SPECT not completed|18|||
105812719|NCT01347710|364970919|FG000|Overall Study|issue with vitals prior to dosing|1|||
105812720|NCT01347710|364970919|FG000|Overall Study|Lost to Follow-up|1|||
105812721|NCT01347710|364970919|FG000|Overall Study|Physician Decision|2|||
105812722|NCT01347710|364970919|FG000|Overall Study|Other|3|||
105812723|NCT01706926|364970920|FG000|Overall Study|Lost to Follow-up|0|||
105812724|NCT01706926|364970921|FG001|Overall Study|Lost to Follow-up|0|||
105812725|NCT01706926|364970922|FG002|Overall Study|Lost to Follow-up|1|||
105812726|NCT01706926|364970923|FG003|Overall Study|Lost to Follow-up|0|||
105812727|NCT01706926|364970920|FG000|Overall Study|Withdrawal by Subject|2|||
105812728|NCT01706926|364970921|FG001|Overall Study|Withdrawal by Subject|0|||
105571539|NCT05408468|364091234|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
105812729|NCT01706926|364970922|FG002|Overall Study|Withdrawal by Subject|1|||
105571540|NCT00747123|364091235|FG000|Overall Study|Investigator's request|0|||
105571541|NCT00747123|364091236|FG001|Overall Study|Investigator's request|0|||
105812730|NCT01706926|364970923|FG003|Overall Study|Withdrawal by Subject|2|||
105812731|NCT01706926|364970920|FG000|Overall Study|Other|4|||
105812732|NCT01706926|364970921|FG001|Overall Study|Other|4|||
105812733|NCT01706926|364970922|FG002|Overall Study|Other|4|||
105812734|NCT01706926|364970923|FG003|Overall Study|Other|3|||
105812735|NCT01439165|364972394|FG000|Overall Study|Protocol Violation|3|||
105812736|NCT01439165|364972395|FG001|Overall Study|Protocol Violation|0|||
105812737|NCT01439165|364972394|FG000|Overall Study|Lost to Follow-up|11|||
105812738|NCT01439165|364972395|FG001|Overall Study|Lost to Follow-up|1|||
105812739|NCT01439165|364972394|FG000|Overall Study|Withdrawal by Subject|7|||
105812740|NCT01439165|364972395|FG001|Overall Study|Withdrawal by Subject|1|||
105812741|NCT03831048|364972403|FG000|Overall Study|Protocol Violation|9|||
105812742|NCT03831048|364972404|FG001|Overall Study|Protocol Violation|3|||
105486006|NCT01547780|363791363|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
105486007|NCT01547780|363791364|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
105486008|NCT00706849|363791367|FG000|Treatment Period|Adverse Event|0|||
105486009|NCT00706849|363791368|FG001|Treatment Period|Adverse Event|9|||
105486010|NCT00706849|363791367|FG000|Treatment Period|Other|0|||
105486011|NCT00706849|363791368|FG001|Treatment Period|Other|1|||
105486012|NCT00706849|363791367|FG000|Follow-up Period|Withdrawal by Subject|0|||
105486013|NCT00706849|363791368|FG001|Follow-up Period|Withdrawal by Subject|2|||
105486014|NCT00706849|363791367|FG000|Follow-up Period|Protocol non-compliance|0|||
105486015|NCT00706849|363791368|FG001|Follow-up Period|Protocol non-compliance|1|||
105486016|NCT01611454|363791369|FG000|Overall Study|Lack of Efficacy|18|||
105486017|NCT01611454|363791370|FG001|Overall Study|Lack of Efficacy|10|||
105486018|NCT01288976|363791371|FG000|Overall Study|Withdrawal by Subject|58|||
105486019|NCT01288976|363791372|FG001|Overall Study|Withdrawal by Subject|12|||
105571542|NCT00747123|364091237|FG002|Overall Study|Investigator's request|1|||
105571543|NCT00747123|364091238|FG003|Overall Study|Investigator's request|0|||
105571544|NCT00747123|364091235|FG000|Overall Study|Withdrew consent|0|||
105571545|NCT00747123|364091236|FG001|Overall Study|Withdrew consent|1|||
105763203|NCT04897594|364787073|FG001|Overall Study|Sponsor Decision|0|||
105763204|NCT04897594|364787074|FG002|Overall Study|Sponsor Decision|1|||
105763205|NCT04897594|364787072|FG000|Overall Study|Withdrawal by Subject|1|||
105763206|NCT04897594|364787073|FG001|Overall Study|Withdrawal by Subject|0|||
105763207|NCT04897594|364787074|FG002|Overall Study|Withdrawal by Subject|1|||
105763208|NCT03051217|364787079|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
105763209|NCT03051217|364787080|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105763210|NCT03051217|364787081|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
105763211|NCT03051217|364787082|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105763212|NCT03051217|364787083|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105763213|NCT03051217|364787084|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105763214|NCT03051217|364787085|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105763215|NCT03051217|364787079|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
105763216|NCT03051217|364787080|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
105763217|NCT03051217|364787081|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
105763218|NCT03051217|364787082|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
105763219|NCT03051217|364787083|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
105763220|NCT03051217|364787084|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
105763221|NCT03051217|364787085|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
105763222|NCT03051217|364787079|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
105763223|NCT03051217|364787080|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
105763224|NCT03051217|364787081|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
105763225|NCT03051217|364787082|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105763226|NCT03051217|364787083|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105763227|NCT03051217|364787084|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105763228|NCT03051217|364787085|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105763229|NCT03051217|364787079|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
105763230|NCT03051217|364787080|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
105763231|NCT03051217|364787081|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
105763232|NCT03051217|364787082|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
105763233|NCT03051217|364787083|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
105763234|NCT03051217|364787084|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
105763235|NCT03051217|364787085|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
105763236|NCT03051217|364787079|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
105763237|NCT03051217|364787080|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
105763238|NCT03051217|364787081|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
105763239|NCT03051217|364787082|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
105763240|NCT03051217|364787083|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
105763241|NCT03051217|364787084|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
105763242|NCT03051217|364787085|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
105763243|NCT03051217|364787079|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
105763244|NCT03051217|364787080|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
105571546|NCT00747123|364091237|FG002|Overall Study|Withdrew consent|0|||
105812743|NCT03831048|364972403|FG000|Overall Study|Death|4|||
105812744|NCT03831048|364972404|FG001|Overall Study|Death|9|||
105571547|NCT00747123|364091238|FG003|Overall Study|Withdrew consent|0|||
105486020|NCT01288976|363791373|FG002|Overall Study|Withdrawal by Subject|9|||
105486021|NCT01288976|363791371|FG000|Overall Study|Death|98|||
105486022|NCT01288976|363791372|FG001|Overall Study|Death|6|||
105486023|NCT01288976|363791373|FG002|Overall Study|Death|4|||
105486024|NCT01288976|363791371|FG000|Overall Study|Data unavailable|22|||
105486025|NCT01288976|363791372|FG001|Overall Study|Data unavailable|9|||
105812745|NCT03831048|364972403|FG000|Overall Study|Re-transplant|0|||
105812746|NCT03831048|364972404|FG001|Overall Study|Re-transplant|2|||
105812747|NCT03831048|364972403|FG000|Overall Study|Protocol violation and death|1|||
105812748|NCT03831048|364972404|FG001|Overall Study|Protocol violation and death|1|||
105812749|NCT00560235|364972406|FG000|Phase 1|Discontinued|8|||
105812750|NCT00560235|364972407|FG001|Phase 1|Discontinued|0|||
105812751|NCT00560235|364972408|FG002|Phase 1|Discontinued|0|||
105486026|NCT01288976|363791373|FG002|Overall Study|Data unavailable|7|||
105486027|NCT01122394|363791374|FG000|Overall Study|Withdrawal by Subject|1|||
105486028|NCT01122394|363791375|FG001|Overall Study|Withdrawal by Subject|1|||
105486029|NCT01122394|363791374|FG000|Overall Study|Lost to Follow-up|2|||
105486030|NCT01122394|363791375|FG001|Overall Study|Lost to Follow-up|2|||
105486031|NCT01122394|363791374|FG000|Overall Study|Adverse Event|0|||
105486032|NCT01122394|363791375|FG001|Overall Study|Adverse Event|1|||
105486033|NCT02446743|363791376|FG000|Overall Study|Withdrawal by Subject|1|||
105486034|NCT02446743|363791377|FG001|Overall Study|Withdrawal by Subject|1|||
105486035|NCT02446743|363791376|FG000|Overall Study|Lost to Follow-up|1|||
105812752|NCT00560235|364972406|FG000|Phase 1B|Discontinued|0|||
105812753|NCT00560235|364972407|FG001|Phase 1B|Discontinued|19|||
105812754|NCT00560235|364972408|FG002|Phase 1B|Discontinued|0|||
105812755|NCT00560235|364972406|FG000|Phase 2|Discontinued|0|||
105812756|NCT00560235|364972407|FG001|Phase 2|Discontinued|0|||
105812757|NCT00560235|364972408|FG002|Phase 2|Discontinued|96|||
105812758|NCT00560235|364972406|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
105812759|NCT00560235|364972407|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
105812760|NCT00560235|364972408|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
105812761|NCT00720096|364972409|FG000|Overall Study|Withdrawal by Subject|0|||
105812762|NCT00720096|364972410|FG001|Overall Study|Withdrawal by Subject|2|||
105812763|NCT00442936|364972411|FG000|Overall Study|Protocol Violation|1|||
105486036|NCT02446743|363791377|FG001|Overall Study|Lost to Follow-up|0|||
105486037|NCT02446743|363791376|FG000|Overall Study|Adverse Event|1|||
105486038|NCT02446743|363791377|FG001|Overall Study|Adverse Event|1|||
105812764|NCT00442936|364972412|FG001|Overall Study|Protocol Violation|0|||
105812765|NCT00442936|364972413|FG002|Overall Study|Protocol Violation|1|||
105812766|NCT00442936|364972414|FG003|Overall Study|Protocol Violation|1|||
105812767|NCT02428699|364972419|FG000|Washout Period 1|Screen Failure|1|||
105812768|NCT02428699|364972420|FG001|Washout Period 1|Screen Failure|2|||
105812769|NCT01506947|364972422|FG000|Overall Study|Lost to Follow-up|7|||
105812770|NCT01506947|364972422|FG000|Overall Study|Adverse Event|5|||
105812771|NCT01506947|364972422|FG000|Overall Study|Death|1|||
105812772|NCT01506947|364972422|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
105812773|NCT02319148|364972429|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
105812774|NCT02319148|364972430|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
105812775|NCT02319148|364972431|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
105812776|NCT02319148|364972432|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
105812777|NCT02319148|364972429|FG000|Second Intervention Period|No longer willing to participate|0|||
105812778|NCT02319148|364972430|FG001|Second Intervention Period|No longer willing to participate|1|||
105812779|NCT02319148|364972431|FG002|Second Intervention Period|No longer willing to participate|0|||
105812780|NCT02319148|364972432|FG003|Second Intervention Period|No longer willing to participate|0|||
105812781|NCT02319148|364972429|FG000|Second Intervention Period|Other|0|||
105812782|NCT02319148|364972430|FG001|Second Intervention Period|Other|0|||
105812783|NCT02319148|364972431|FG002|Second Intervention Period|Other|0|||
105812784|NCT02319148|364972432|FG003|Second Intervention Period|Other|1|||
105812785|NCT01574248|364972433|FG000|Overall Study|Withdrawal by Subject|2|||
105812786|NCT01574248|364972434|FG001|Overall Study|Withdrawal by Subject|0|||
105812787|NCT01574248|364972433|FG000|Overall Study|Missing primary endpoint data|1|||
105812788|NCT01574248|364972434|FG001|Overall Study|Missing primary endpoint data|0|||
105812789|NCT04109222|364972435|FG000|Overall Study|Adverse Event|1|||
105812790|NCT04109222|364972436|FG001|Overall Study|Adverse Event|0|||
105812791|NCT04109222|364972437|FG002|Overall Study|Adverse Event|0|||
105812792|NCT01424722|364972438|FG000|Overall Study|Sponsor terminated investigation|2258|||
105812793|NCT01781286|364972439|FG000|Overall Study|Lost to Follow-up|0|||
105812794|NCT01781286|364972440|FG001|Overall Study|Lost to Follow-up|0|||
105812795|NCT01781286|364972441|FG002|Overall Study|Lost to Follow-up|0|||
105812796|NCT01781286|364972442|FG003|Overall Study|Lost to Follow-up|0|||
105812797|NCT01781286|364972443|FG004|Overall Study|Lost to Follow-up|0|||
105812798|NCT01781286|364972444|FG005|Overall Study|Lost to Follow-up|1|||
105812799|NCT01781286|364972439|FG000|Overall Study|Time Constraints|2|||
105812800|NCT01781286|364972440|FG001|Overall Study|Time Constraints|0|||
105812801|NCT01781286|364972441|FG002|Overall Study|Time Constraints|2|||
105812802|NCT01781286|364972442|FG003|Overall Study|Time Constraints|0|||
105812803|NCT01781286|364972443|FG004|Overall Study|Time Constraints|0|||
105812804|NCT01781286|364972444|FG005|Overall Study|Time Constraints|0|||
105812805|NCT01781286|364972439|FG000|Overall Study|Noncompliance|0|||
105812806|NCT01781286|364972440|FG001|Overall Study|Noncompliance|0|||
105812807|NCT01781286|364972441|FG002|Overall Study|Noncompliance|0|||
105812808|NCT01781286|364972442|FG003|Overall Study|Noncompliance|1|||
105812809|NCT01781286|364972443|FG004|Overall Study|Noncompliance|0|||
105812810|NCT01781286|364972444|FG005|Overall Study|Noncompliance|0|||
105812811|NCT00995410|364972445|FG000|Overall Study|Adverse Event|51|||
105812812|NCT00995410|364972445|FG000|Overall Study|Withdrawal by Subject|7|||
105812813|NCT00995410|364972445|FG000|Overall Study|Lost to Follow-up|2|||
105812814|NCT00995410|364972445|FG000|Overall Study|Misc|28|||
105812815|NCT02483975|364972446|FG000|Overall Study|Adverse Event|0|||
105812816|NCT02483975|364972447|FG001|Overall Study|Adverse Event|1|||
105812817|NCT02483975|364972446|FG000|Overall Study|Lost to Follow-up|0|||
105812818|NCT02483975|364972447|FG001|Overall Study|Lost to Follow-up|1|||
105812819|NCT02483975|364972446|FG000|Overall Study|Physician Decision|2|||
105812820|NCT02483975|364972447|FG001|Overall Study|Physician Decision|0|||
105812821|NCT00818883|364972448|FG000|Overall Study|Adverse Event|28|||
105812822|NCT00818883|364972449|FG001|Overall Study|Adverse Event|19|||
105812823|NCT00818883|364972448|FG000|Overall Study|Protocol Violation|2|||
105812824|NCT00818883|364972449|FG001|Overall Study|Protocol Violation|2|||
105812825|NCT00818883|364972448|FG000|Overall Study|Lost to Follow-up|3|||
105812826|NCT00818883|364972449|FG001|Overall Study|Lost to Follow-up|2|||
105812827|NCT00818883|364972448|FG000|Overall Study|Withdrawal by Subject|16|||
105812828|NCT00818883|364972449|FG001|Overall Study|Withdrawal by Subject|14|||
105812829|NCT00818883|364972448|FG000|Overall Study|Lack of Efficacy|0|||
105812830|NCT00818883|364972449|FG001|Overall Study|Lack of Efficacy|2|||
105812831|NCT00818883|364972448|FG000|Overall Study|Other|2|||
105812832|NCT00818883|364972449|FG001|Overall Study|Other|7|||
105812833|NCT00048048|364972450|FG000|Core Treatment|Withdrawal by Subject|0|||
105812834|NCT00048048|364972451|FG001|Core Treatment|Withdrawal by Subject|0|||
105812835|NCT00048048|364972452|FG002|Core Treatment|Withdrawal by Subject|1|||
105812836|NCT00048048|364972453|FG003|Core Treatment|Withdrawal by Subject|0|||
105812837|NCT00048048|364972454|FG004|Core Treatment|Withdrawal by Subject|0|||
105812838|NCT00048048|364972455|FG005|Core Treatment|Withdrawal by Subject|0|||
105812839|NCT00048048|364972456|FG006|Core Treatment|Withdrawal by Subject|0|||
105812840|NCT00048048|364972457|FG007|Core Treatment|Withdrawal by Subject|0|||
105812841|NCT00048048|364972458|FG008|Core Treatment|Withdrawal by Subject|0|||
105361960|NCT02326272|363330154|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105361961|NCT02326272|363330155|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105361962|NCT02326272|363330156|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105361963|NCT02326272|363330157|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105361964|NCT02326272|363330143|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105361965|NCT02326272|363330144|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105361966|NCT02326272|363330145|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105361967|NCT02326272|363330146|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105361968|NCT02326272|363330147|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105361969|NCT02326272|363330148|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105361970|NCT02326272|363330149|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105361971|NCT02326272|363330150|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
105361972|NCT02326272|363330151|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105361973|NCT02326272|363330152|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105486039|NCT02446743|363791376|FG000|Overall Study|Other|2|||
105812842|NCT00048048|364972459|FG009|Core Treatment|Withdrawal by Subject|0|||
105812843|NCT00048048|364972460|FG010|Core Treatment|Withdrawal by Subject|0|||
105812844|NCT00048048|364972461|FG011|Core Treatment|Withdrawal by Subject|0|||
105812845|NCT00048048|364972450|FG000|Core Treatment|Adverse Event|0|||
105812846|NCT00048048|364972451|FG001|Core Treatment|Adverse Event|0|||
105812847|NCT00048048|364972452|FG002|Core Treatment|Adverse Event|0|||
105812848|NCT00048048|364972453|FG003|Core Treatment|Adverse Event|0|||
105812849|NCT00048048|364972454|FG004|Core Treatment|Adverse Event|0|||
105812850|NCT00048048|364972455|FG005|Core Treatment|Adverse Event|0|||
105812851|NCT00048048|364972456|FG006|Core Treatment|Adverse Event|0|||
105812852|NCT00048048|364972457|FG007|Core Treatment|Adverse Event|1|||
105812853|NCT00048048|364972458|FG008|Core Treatment|Adverse Event|0|||
105812854|NCT00048048|364972459|FG009|Core Treatment|Adverse Event|0|||
105812855|NCT00048048|364972460|FG010|Core Treatment|Adverse Event|0|||
105812856|NCT00048048|364972461|FG011|Core Treatment|Adverse Event|0|||
105812857|NCT00048048|364972450|FG000|Extension Year 1|Early withdrawals|0|||
105812858|NCT00048048|364972451|FG001|Extension Year 1|Early withdrawals|0|||
105812859|NCT00048048|364972452|FG002|Extension Year 1|Early withdrawals|0|||
105812860|NCT00048048|364972453|FG003|Extension Year 1|Early withdrawals|0|||
105812861|NCT00048048|364972454|FG004|Extension Year 1|Early withdrawals|0|||
105812862|NCT00048048|364972455|FG005|Extension Year 1|Early withdrawals|0|||
105812863|NCT00048048|364972456|FG006|Extension Year 1|Early withdrawals|0|||
105812864|NCT00048048|364972457|FG007|Extension Year 1|Early withdrawals|0|||
105812865|NCT00048048|364972458|FG008|Extension Year 1|Early withdrawals|0|||
105812866|NCT00048048|364972459|FG009|Extension Year 1|Early withdrawals|2|||
105812867|NCT00048048|364972460|FG010|Extension Year 1|Early withdrawals|2|||
105812868|NCT00048048|364972461|FG011|Extension Year 1|Early withdrawals|4|||
105812869|NCT00048048|364972450|FG000|Extension Year 2|Early withdrawals|0|||
105812870|NCT00048048|364972451|FG001|Extension Year 2|Early withdrawals|0|||
105812871|NCT00048048|364972452|FG002|Extension Year 2|Early withdrawals|0|||
105812872|NCT00048048|364972453|FG003|Extension Year 2|Early withdrawals|0|||
105812873|NCT00048048|364972454|FG004|Extension Year 2|Early withdrawals|0|||
105812874|NCT00048048|364972455|FG005|Extension Year 2|Early withdrawals|0|||
105812875|NCT00048048|364972456|FG006|Extension Year 2|Early withdrawals|0|||
105812876|NCT00048048|364972457|FG007|Extension Year 2|Early withdrawals|0|||
105812877|NCT00048048|364972458|FG008|Extension Year 2|Early withdrawals|0|||
105812878|NCT00048048|364972459|FG009|Extension Year 2|Early withdrawals|0|||
105812879|NCT00048048|364972460|FG010|Extension Year 2|Early withdrawals|4|||
105812880|NCT00048048|364972461|FG011|Extension Year 2|Early withdrawals|2|||
105812881|NCT02684578|364972462|FG000|Overall Study|Withdrawal by Subject|10|||
105486040|NCT02446743|363791377|FG001|Overall Study|Other|3|||
105763245|NCT03051217|364787081|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
105763246|NCT03051217|364787082|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
105763247|NCT03051217|364787083|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
105763248|NCT03051217|364787084|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
105763249|NCT03051217|364787085|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
105763250|NCT03051217|364787079|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
105763251|NCT03051217|364787080|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
105763252|NCT03051217|364787081|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
105763253|NCT03051217|364787082|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
105812882|NCT02684578|364972463|FG001|Overall Study|Withdrawal by Subject|7|||
105812883|NCT02684578|364972462|FG000|Overall Study|Lost to Follow-up|0|||
105812884|NCT02684578|364972463|FG001|Overall Study|Lost to Follow-up|3|||
105812885|NCT02684578|364972462|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
105812886|NCT02684578|364972463|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
105486041|NCT01736657|363791382|FG000|Overall Study|insufficient vascular access|1|||
105486042|NCT03023046|363791383|FG000|Overall Study|Withdrawal by Subject|1|||
105763254|NCT03051217|364787083|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
105763255|NCT03051217|364787084|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
105763256|NCT03051217|364787085|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
105763257|NCT03051217|364787079|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
105763258|NCT03051217|364787080|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
105763259|NCT03051217|364787081|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
105763260|NCT03051217|364787082|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
105763261|NCT03051217|364787083|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
105763262|NCT03051217|364787084|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
105763263|NCT03051217|364787085|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
105763264|NCT00641706|364787086|FG000|Overall Study|Adverse Event|2|||
105763265|NCT00641706|364787087|FG001|Overall Study|Adverse Event|1|||
105763266|NCT00641706|364787086|FG000|Overall Study|Withdrawal by Subject|6|||
105763267|NCT00641706|364787087|FG001|Overall Study|Withdrawal by Subject|1|||
105763268|NCT00641706|364787086|FG000|Overall Study|Clinical Decline|1|||
105763269|NCT00641706|364787087|FG001|Overall Study|Clinical Decline|0|||
105763270|NCT00641706|364787086|FG000|Overall Study|Lead Investigator Decision|0|||
105763271|NCT00641706|364787087|FG001|Overall Study|Lead Investigator Decision|1|||
105763272|NCT05166603|364787089|FG000|Overall Study|Withdrawal by Subject|68|||
105763273|NCT05166603|364787090|FG001|Overall Study|Withdrawal by Subject|0|||
105763274|NCT03375203|364787091|FG000|Overall Study|Protocol Violation|0|||
105763275|NCT03375203|364787092|FG001|Overall Study|Protocol Violation|0|||
105763276|NCT03375203|364787093|FG002|Overall Study|Protocol Violation|1|||
105763277|NCT03375203|364787094|FG003|Overall Study|Protocol Violation|0|||
105763278|NCT03375203|364787095|FG004|Overall Study|Protocol Violation|0|||
105763279|NCT03375203|364787091|FG000|Overall Study|Adverse Event|2|||
105763280|NCT03375203|364787092|FG001|Overall Study|Adverse Event|3|||
105763281|NCT03375203|364787093|FG002|Overall Study|Adverse Event|0|||
105763282|NCT03375203|364787094|FG003|Overall Study|Adverse Event|2|||
105763283|NCT03375203|364787095|FG004|Overall Study|Adverse Event|2|||
105763284|NCT03375203|364787091|FG000|Overall Study|Withdrawal by Subject|3|||
105763285|NCT03375203|364787092|FG001|Overall Study|Withdrawal by Subject|0|||
105763286|NCT03375203|364787093|FG002|Overall Study|Withdrawal by Subject|1|||
105763287|NCT03375203|364787094|FG003|Overall Study|Withdrawal by Subject|0|||
105763288|NCT03375203|364787095|FG004|Overall Study|Withdrawal by Subject|2|||
105763289|NCT03375203|364787091|FG000|Overall Study|Non-compliance with study drug|1|||
105763290|NCT03375203|364787092|FG001|Overall Study|Non-compliance with study drug|0|||
105763291|NCT03375203|364787093|FG002|Overall Study|Non-compliance with study drug|0|||
105763292|NCT03375203|364787094|FG003|Overall Study|Non-compliance with study drug|0|||
105763293|NCT03375203|364787095|FG004|Overall Study|Non-compliance with study drug|0|||
105763294|NCT03375203|364787091|FG000|Overall Study|Randomized, not treated.|0|||
105763295|NCT03375203|364787092|FG001|Overall Study|Randomized, not treated.|1|||
105763296|NCT03375203|364787093|FG002|Overall Study|Randomized, not treated.|0|||
105763297|NCT03375203|364787094|FG003|Overall Study|Randomized, not treated.|0|||
105763298|NCT03375203|364787095|FG004|Overall Study|Randomized, not treated.|0|||
105763299|NCT01112982|364787097|FG000|Overall Study|Withdrawal by Subject|1|||
105763300|NCT01112982|364787097|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
105763301|NCT02959190|364787098|FG000|Open Label|Adverse Event|5|||
105763302|NCT02959190|364787099|FG001|Open Label|Adverse Event|7|||
105763303|NCT02959190|364787100|FG002|Open Label|Adverse Event|3|||
105763304|NCT02959190|364787101|FG003|Open Label|Adverse Event|4|||
105763305|NCT02959190|364787098|FG000|Open Label|Pregnancy|0|||
105763306|NCT02959190|364787099|FG001|Open Label|Pregnancy|1|||
105763307|NCT02959190|364787100|FG002|Open Label|Pregnancy|0|||
105763308|NCT02959190|364787101|FG003|Open Label|Pregnancy|0|||
105763309|NCT02959190|364787098|FG000|Open Label|Withdrawal by Subject|2|||
105763310|NCT02959190|364787099|FG001|Open Label|Withdrawal by Subject|8|||
105763311|NCT02959190|364787100|FG002|Open Label|Withdrawal by Subject|0|||
105763312|NCT02959190|364787101|FG003|Open Label|Withdrawal by Subject|0|||
105763313|NCT02959190|364787098|FG000|Open Label|Physician Decision|0|||
105763314|NCT02959190|364787099|FG001|Open Label|Physician Decision|0|||
105763315|NCT02959190|364787100|FG002|Open Label|Physician Decision|1|||
105763316|NCT02959190|364787101|FG003|Open Label|Physician Decision|0|||
105763317|NCT02959190|364787098|FG000|Open Label|Protocol Violation|0|||
105763318|NCT02959190|364787099|FG001|Open Label|Protocol Violation|0|||
105763319|NCT02959190|364787100|FG002|Open Label|Protocol Violation|0|||
105763320|NCT02959190|364787101|FG003|Open Label|Protocol Violation|2|||
105763321|NCT02959190|364787098|FG000|Post Treatment Follow Up|Adverse Event|1|||
105763322|NCT02959190|364787099|FG001|Post Treatment Follow Up|Adverse Event|1|||
105763323|NCT02959190|364787100|FG002|Post Treatment Follow Up|Adverse Event|0|||
105763324|NCT02959190|364787101|FG003|Post Treatment Follow Up|Adverse Event|0|||
105763325|NCT02959190|364787098|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
105763326|NCT02959190|364787099|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
105812887|NCT02684578|364972462|FG000|Overall Study|Missing follow-up data|0|||
105812888|NCT02684578|364972463|FG001|Overall Study|Missing follow-up data|1|||
105812889|NCT00973700|364972464|FG000|Overall Study|Withdrawal by Subject|2|||
105812890|NCT00973700|364972465|FG001|Overall Study|Withdrawal by Subject|2|||
105812891|NCT00973700|364972466|FG002|Overall Study|Withdrawal by Subject|8|||
105812892|NCT00973700|364972467|FG003|Overall Study|Withdrawal by Subject|4|||
105812893|NCT00973700|364972468|FG004|Overall Study|Withdrawal by Subject|4|||
105812894|NCT00973700|364972464|FG000|Overall Study|Lost to Follow-up|5|||
105812895|NCT00973700|364972465|FG001|Overall Study|Lost to Follow-up|0|||
105812896|NCT00973700|364972466|FG002|Overall Study|Lost to Follow-up|1|||
105812897|NCT00973700|364972467|FG003|Overall Study|Lost to Follow-up|8|||
105812898|NCT00973700|364972468|FG004|Overall Study|Lost to Follow-up|5|||
105812899|NCT00973700|364972464|FG000|Overall Study|Inappropriate enrolment|0|||
105812900|NCT00973700|364972465|FG001|Overall Study|Inappropriate enrolment|0|||
105812901|NCT00973700|364972466|FG002|Overall Study|Inappropriate enrolment|0|||
105812902|NCT00973700|364972467|FG003|Overall Study|Inappropriate enrolment|4|||
105812903|NCT00973700|364972468|FG004|Overall Study|Inappropriate enrolment|0|||
105812904|NCT00973700|364972464|FG000|Overall Study|Unable to Classify|0|||
105812905|NCT00973700|364972465|FG001|Overall Study|Unable to Classify|0|||
105812906|NCT00973700|364972466|FG002|Overall Study|Unable to Classify|1|||
105812907|NCT00973700|364972467|FG003|Overall Study|Unable to Classify|2|||
105812908|NCT00973700|364972468|FG004|Overall Study|Unable to Classify|1|||
105812909|NCT01179919|364972469|FG000|Overall Study|Protocol Violation|1|||
105812910|NCT01179919|364972469|FG000|Overall Study|Adverse Event|1|||
105812911|NCT00525590|364972470|FG000|Overall Study|Adverse Event|3|||
105812912|NCT00525590|364972470|FG000|Overall Study|Physician Decision|3|||
105812913|NCT00525590|364972470|FG000|Overall Study|Withdrawal by Subject|16|||
105812914|NCT00525590|364972470|FG000|Overall Study|Lost to Follow-up|1|||
105812915|NCT00525590|364972470|FG000|Overall Study|Death|9|||
105812916|NCT00525590|364972470|FG000|Overall Study|Other|13|||
105812917|NCT01890915|364972471|FG000|Overall Study|Adverse Event|1|||
105812918|NCT01890915|364972472|FG001|Overall Study|Adverse Event|0|||
105812919|NCT01890915|364972471|FG000|Overall Study|Protocol Violation|2|||
105812920|NCT01890915|364972472|FG001|Overall Study|Protocol Violation|0|||
105812921|NCT01890915|364972471|FG000|Overall Study|Equipment Malfunction|0|||
105812922|NCT01890915|364972472|FG001|Overall Study|Equipment Malfunction|1|||
105812923|NCT00424489|364972473|FG000|Overall Study|Death|3|||
105812924|NCT02660242|364972482|FG000|Glucose Tabs|Lost to Follow-up|1|||
105812925|NCT02660242|364972482|FG000|Glucagon Injection|Lost to Follow-up|1|||
105812926|NCT01345019|364972484|FG000|Blinded Treatment Phase|Death|147|||
105812927|NCT01345019|364972485|FG001|Blinded Treatment Phase|Death|137|||
105812928|NCT01345019|364972484|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
105812929|NCT01345019|364972485|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
105812930|NCT01345019|364972484|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
105812931|NCT01345019|364972485|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
105812932|NCT01345019|364972484|FG000|Blinded Treatment Phase|Disease Progression|12|||
105812933|NCT01345019|364972485|FG001|Blinded Treatment Phase|Disease Progression|10|||
105812934|NCT01345019|364972484|FG000|Blinded Treatment Phase|Adverse Event|6|||
105812935|NCT01345019|364972485|FG001|Blinded Treatment Phase|Adverse Event|13|||
105812936|NCT01345019|364972484|FG000|Blinded Treatment Phase|Administrative Decision|10|||
105812937|NCT01345019|364972485|FG001|Blinded Treatment Phase|Administrative Decision|8|||
105812938|NCT01345019|364972484|FG000|Blinded Treatment Phase|Noncompliance|5|||
105812939|NCT01345019|364972485|FG001|Blinded Treatment Phase|Noncompliance|3|||
105812940|NCT01345019|364972484|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
105812941|NCT01345019|364972485|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
105812942|NCT01345019|364972484|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
105812943|NCT01345019|364972485|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
105812944|NCT01345019|364972484|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
105812945|NCT01345019|364972485|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
105812946|NCT01345019|364972484|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
105812947|NCT01345019|364972485|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
105812948|NCT01345019|364972484|FG000|Open Label Treatment Phase|Death|49|||
105812949|NCT01345019|364972485|FG001|Open Label Treatment Phase|Death|48|||
105812950|NCT01345019|364972484|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
105812951|NCT01345019|364972485|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
105812952|NCT01345019|364972484|FG000|Open Label Treatment Phase|Adverse Event|30|||
105812953|NCT01345019|364972485|FG001|Open Label Treatment Phase|Adverse Event|51|||
105812954|NCT01345019|364972484|FG000|Open Label Treatment Phase|Administrative Decision|30|||
105812955|NCT01345019|364972485|FG001|Open Label Treatment Phase|Administrative Decision|15|||
105812956|NCT01345019|364972484|FG000|Open Label Treatment Phase|Disease Progression|17|||
105812957|NCT01345019|364972485|FG001|Open Label Treatment Phase|Disease Progression|18|||
105812958|NCT01345019|364972484|FG000|Open Label Treatment Phase|Noncompliance|5|||
105812959|NCT01345019|364972485|FG001|Open Label Treatment Phase|Noncompliance|4|||
105812960|NCT01345019|364972484|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
105812961|NCT01345019|364972485|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
105812962|NCT01345019|364972484|FG000|Open Label Treatment Phase|Pregnancy|1|||
105812963|NCT01345019|364972485|FG001|Open Label Treatment Phase|Pregnancy|0|||
105812964|NCT01345019|364972484|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
105812965|NCT01345019|364972485|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
105812966|NCT01345019|364972484|FG000|Open Label Treatment Phase|Protocol Violation|0|||
105812967|NCT01345019|364972485|FG001|Open Label Treatment Phase|Protocol Violation|1|||
105812968|NCT01492400|364972494|FG000|Overall Study|Miscellaneous Reasons|2|||
105812969|NCT01492400|364972495|FG001|Overall Study|Miscellaneous Reasons|3|||
105812970|NCT01492400|364972494|FG000|Overall Study|Personal Reasons|0|||
105812971|NCT01492400|364972495|FG001|Overall Study|Personal Reasons|5|||
105812972|NCT01492400|364972494|FG000|Overall Study|Lost to Follow-up|3|||
105812973|NCT01492400|364972495|FG001|Overall Study|Lost to Follow-up|1|||
105812974|NCT01492400|364972494|FG000|Overall Study|Pregnancy|0|||
105812975|NCT01492400|364972495|FG001|Overall Study|Pregnancy|1|||
105812976|NCT01492400|364972494|FG000|Overall Study|Lack of Efficacy|1|||
105812977|NCT01492400|364972495|FG001|Overall Study|Lack of Efficacy|1|||
105812978|NCT01492400|364972494|FG000|Overall Study|Adverse Event|10|||
105812979|NCT01492400|364972495|FG001|Overall Study|Adverse Event|5|||
105812980|NCT02899338|364972497|FG000|Overall Study|Adverse Event|1|||
105812981|NCT02899338|364972498|FG001|Overall Study|Adverse Event|2|||
105812982|NCT02899338|364972497|FG000|Overall Study|Withdrawal by Subject|2|||
105812983|NCT02899338|364972498|FG001|Overall Study|Withdrawal by Subject|0|||
105812984|NCT01457053|364972500|FG000|Overall Study|Unable to undergo selected treatment|1|||
105812985|NCT01457053|364972501|FG001|Overall Study|Unable to undergo selected treatment|1|||
105812986|NCT00814463|364972502|FG000|Overall Study|Lost to Follow-up|1|||
105812987|NCT01939197|364972506|FG000|Overall Study|Withdrawal by Subject|1|||
105812988|NCT01939197|364972507|FG001|Overall Study|Withdrawal by Subject|0|||
105486043|NCT00470158|363791384|FG000|Overall Study|Death|0|||
105812989|NCT01939197|364972508|FG002|Overall Study|Withdrawal by Subject|0|||
105812990|NCT01939197|364972509|FG003|Overall Study|Withdrawal by Subject|0|||
105812991|NCT01939197|364972510|FG004|Overall Study|Withdrawal by Subject|1|||
105812992|NCT01939197|364972511|FG005|Overall Study|Withdrawal by Subject|0|||
105812993|NCT01939197|364972512|FG006|Overall Study|Withdrawal by Subject|0|||
105812994|NCT01939197|364972506|FG000|Overall Study|Lost to Follow-up|0|||
105812995|NCT01939197|364972507|FG001|Overall Study|Lost to Follow-up|1|||
105812996|NCT01939197|364972508|FG002|Overall Study|Lost to Follow-up|0|||
105812997|NCT01939197|364972509|FG003|Overall Study|Lost to Follow-up|1|||
105812998|NCT01939197|364972510|FG004|Overall Study|Lost to Follow-up|3|||
105812999|NCT01939197|364972511|FG005|Overall Study|Lost to Follow-up|1|||
105813000|NCT01939197|364972512|FG006|Overall Study|Lost to Follow-up|2|||
105813001|NCT00408902|364972520|FG000|Overall Study|Lack of Efficacy|7|||
105813002|NCT00408902|364972520|FG000|Overall Study|Adverse Event|3|||
105813003|NCT01475474|364972522|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
105813004|NCT01475474|364972522|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
105813005|NCT02343120|364972523|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
105813006|NCT02343120|364972524|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
105813007|NCT02343120|364972525|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
105813008|NCT02343120|364972526|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
105813009|NCT02343120|364972527|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
105813010|NCT02343120|364972523|FG000|Part 1: Dose Escalation|Death|1|||
105813011|NCT02343120|364972524|FG001|Part 1: Dose Escalation|Death|2|||
105813012|NCT02343120|364972525|FG002|Part 1: Dose Escalation|Death|2|||
105813013|NCT02343120|364972526|FG003|Part 1: Dose Escalation|Death|2|||
105813014|NCT02343120|364972527|FG004|Part 1: Dose Escalation|Death|1|||
105813015|NCT02343120|364972523|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
105813016|NCT02343120|364972524|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
105813017|NCT02343120|364972525|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
105813018|NCT02343120|364972526|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
105813019|NCT02343120|364972527|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
105813020|NCT02343120|364972523|FG000|Part 2: Expansion|Sponsor decision|0|||
105813021|NCT02343120|364972524|FG001|Part 2: Expansion|Sponsor decision|0|||
105813022|NCT02343120|364972525|FG002|Part 2: Expansion|Sponsor decision|0|||
105813023|NCT02343120|364972526|FG003|Part 2: Expansion|Sponsor decision|165|||
105813024|NCT02343120|364972527|FG004|Part 2: Expansion|Sponsor decision|67|||
105813025|NCT02343120|364972523|FG000|Part 2: Expansion|Death|0|||
105813026|NCT02343120|364972524|FG001|Part 2: Expansion|Death|0|||
105813027|NCT02343120|364972525|FG002|Part 2: Expansion|Death|0|||
105813028|NCT02343120|364972526|FG003|Part 2: Expansion|Death|74|||
105813029|NCT02343120|364972527|FG004|Part 2: Expansion|Death|17|||
105813030|NCT02343120|364972523|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
105813031|NCT02343120|364972524|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
105813032|NCT02343120|364972525|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
105813033|NCT02343120|364972526|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
105813034|NCT02343120|364972527|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
105813035|NCT02343120|364972523|FG000|Part 2: Expansion|Lost to Follow-up|0|||
105813036|NCT02343120|364972524|FG001|Part 2: Expansion|Lost to Follow-up|0|||
105813037|NCT02343120|364972525|FG002|Part 2: Expansion|Lost to Follow-up|0|||
105813038|NCT02343120|364972526|FG003|Part 2: Expansion|Lost to Follow-up|5|||
105813039|NCT02343120|364972527|FG004|Part 2: Expansion|Lost to Follow-up|2|||
105813040|NCT02343120|364972523|FG000|Part 2: Expansion|Other|0|||
105813041|NCT02343120|364972524|FG001|Part 2: Expansion|Other|0|||
105813042|NCT02343120|364972525|FG002|Part 2: Expansion|Other|0|||
105813043|NCT02343120|364972526|FG003|Part 2: Expansion|Other|1|||
105813044|NCT02343120|364972527|FG004|Part 2: Expansion|Other|5|||
105813045|NCT02343120|364972523|FG000|Part 2: Expansion|Adverse Event|0|||
105813046|NCT02343120|364972524|FG001|Part 2: Expansion|Adverse Event|0|||
105813047|NCT02343120|364972525|FG002|Part 2: Expansion|Adverse Event|0|||
105813048|NCT02343120|364972526|FG003|Part 2: Expansion|Adverse Event|1|||
105813049|NCT02343120|364972527|FG004|Part 2: Expansion|Adverse Event|1|||
105813050|NCT02534493|364972531|FG000|Overall Study|Lost to Follow-up|1|||
105813051|NCT02534493|364972531|FG000|Overall Study|Withdrawal by Subject|1|||
105813052|NCT02339909|364972532|FG000|Overall Study|Became ineligible after randomisation|89|||
105813053|NCT02339909|364972533|FG001|Overall Study|Became ineligible after randomisation|63|||
105813054|NCT02339909|364972534|FG002|Overall Study|Became ineligible after randomisation|71|||
105813055|NCT00860028|364972541|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
105813056|NCT00860028|364972542|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
105813057|NCT01478620|364972543|FG000|Overall Study|Lost to Follow-up|6|||
105813058|NCT04025879|364972544|FG000|Randomization|Participant withdrew consent|0|||
105813059|NCT04025879|364972545|FG001|Randomization|Participant withdrew consent|1|||
105813060|NCT04025879|364972544|FG000|Randomization|Participant no longer met study criteria|1|||
105813061|NCT04025879|364972545|FG001|Randomization|Participant no longer met study criteria|1|||
105813062|NCT04025879|364972544|FG000|Treatment|Ongoing treatment|10|||
105813063|NCT04025879|364972545|FG001|Treatment|Ongoing treatment|8|||
105813064|NCT04025879|364972544|FG000|Treatment|Disease progression/recurrence|36|||
105813065|NCT04025879|364972545|FG001|Treatment|Disease progression/recurrence|72|||
105813066|NCT04025879|364972544|FG000|Treatment|Study drug toxicity|36|||
105813067|NCT04025879|364972545|FG001|Treatment|Study drug toxicity|13|||
105813068|NCT04025879|364972544|FG000|Treatment|Death|2|||
105813069|NCT04025879|364972545|FG001|Treatment|Death|0|||
105813070|NCT04025879|364972544|FG000|Treatment|Adverse event unrelated to study drug|21|||
105813071|NCT04025879|364972545|FG001|Treatment|Adverse event unrelated to study drug|14|||
105813072|NCT04025879|364972544|FG000|Treatment|Participant request to discontinue study treatment|16|||
105813073|NCT04025879|364972545|FG001|Treatment|Participant request to discontinue study treatment|8|||
105813074|NCT04025879|364972544|FG000|Treatment|Participant withdrew consent|1|||
105813075|NCT04025879|364972545|FG001|Treatment|Participant withdrew consent|3|||
105813076|NCT04025879|364972544|FG000|Treatment|Participant no longer meets study criteria|3|||
105813077|NCT04025879|364972545|FG001|Treatment|Participant no longer meets study criteria|2|||
105813078|NCT04025879|364972544|FG000|Treatment|Lost to Follow-up|1|||
105813079|NCT04025879|364972545|FG001|Treatment|Lost to Follow-up|0|||
105813080|NCT04025879|364972544|FG000|Treatment|Other reasons|15|||
105813081|NCT04025879|364972545|FG001|Treatment|Other reasons|17|||
105813082|NCT04025879|364972544|FG000|Treatment|Administrative reason by sponsor|0|||
105813083|NCT04025879|364972545|FG001|Treatment|Administrative reason by sponsor|1|||
105813084|NCT04025879|364972544|FG000|Treatment|Not reported|2|||
105813085|NCT04025879|364972545|FG001|Treatment|Not reported|0|||
105813086|NCT00154102|364972548|FG000|Overall Study|investigational study phase ongoing|7|||
105813087|NCT00154102|364972549|FG001|Overall Study|investigational study phase ongoing|2|||
105813088|NCT01471522|364972551|FG000|Overall Study|Withdrawal by Subject|28|||
105813089|NCT01471522|364972552|FG001|Overall Study|Withdrawal by Subject|22|||
105813090|NCT01471522|364972551|FG000|Overall Study|Lost to Follow-up|36|||
105813091|NCT01471522|364972552|FG001|Overall Study|Lost to Follow-up|26|||
105813092|NCT01432171|364972553|FG000|Overall Study|Death|1|||
105813093|NCT01432171|364972554|FG001|Overall Study|Death|2|||
105813094|NCT01432171|364972553|FG000|Overall Study|Lost to Follow-up|6|||
105813095|NCT01432171|364972554|FG001|Overall Study|Lost to Follow-up|5|||
105813096|NCT01432171|364972553|FG000|Overall Study|Withdrawal by Subject|3|||
105813097|NCT01432171|364972554|FG001|Overall Study|Withdrawal by Subject|1|||
105813098|NCT01432171|364972553|FG000|Overall Study|Noncompliance|2|||
105813099|NCT01432171|364972554|FG001|Overall Study|Noncompliance|3|||
105813100|NCT01432171|364972553|FG000|Overall Study|Insurance denial trial coverage|1|||
105813101|NCT01432171|364972554|FG001|Overall Study|Insurance denial trial coverage|0|||
105813102|NCT01432171|364972553|FG000|Overall Study|Patient moved to palliative care|1|||
105813103|NCT01432171|364972554|FG001|Overall Study|Patient moved to palliative care|0|||
105813104|NCT04888507|364974565|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
105813105|NCT01298570|364974566|FG000|Overall Study|Disease progression, relapse during acti|64|||
105813106|NCT01298570|364974567|FG001|Overall Study|Disease progression, relapse during acti|40|||
105813107|NCT01298570|364974566|FG000|Overall Study|Adverse Event|20|||
105813108|NCT01298570|364974567|FG001|Overall Study|Adverse Event|2|||
105813109|NCT01298570|364974566|FG000|Overall Study|Withdrawal by Subject|21|||
105813110|NCT01298570|364974567|FG001|Overall Study|Withdrawal by Subject|6|||
105813111|NCT01298570|364974566|FG000|Overall Study|Treatment delay > 4 weeks|4|||
105813112|NCT01298570|364974567|FG001|Overall Study|Treatment delay > 4 weeks|5|||
105813113|NCT01298570|364974566|FG000|Overall Study|Physician Decision|4|||
105813114|NCT01298570|364974567|FG001|Overall Study|Physician Decision|2|||
105813115|NCT01298570|364974566|FG000|Overall Study|Other complicating disease|2|||
105813116|NCT01298570|364974567|FG001|Overall Study|Other complicating disease|1|||
105813117|NCT01298570|364974566|FG000|Overall Study|Surgery|2|||
105813118|NCT01298570|364974567|FG001|Overall Study|Surgery|1|||
105813119|NCT01298570|364974566|FG000|Overall Study|Symptomatic progression/deterioration|3|||
105813120|NCT01298570|364974567|FG001|Overall Study|Symptomatic progression/deterioration|2|||
105813121|NCT01298570|364974566|FG000|Overall Study|Death|0|||
105813122|NCT01298570|364974567|FG001|Overall Study|Death|1|||
105361974|NCT02326272|363330153|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105361975|NCT02326272|363330154|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105486044|NCT00470158|363791385|FG001|Overall Study|Death|0|||
105486045|NCT00470158|363791386|FG002|Overall Study|Death|0|||
105813123|NCT01298570|364974566|FG000|Overall Study|Ineligibility|0|||
105813124|NCT01298570|364974567|FG001|Overall Study|Ineligibility|1|||
105813125|NCT05456529|364974577|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
105813126|NCT05456529|364974577|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
105813127|NCT05456529|364974577|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
105813128|NCT05456529|364974577|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
105813129|NCT05456529|364974577|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
105813130|NCT05456529|364974577|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
105813131|NCT05456529|364974577|FG000|44-week Long-term Safety Period|Physician Decision|2|||
105813132|NCT05456529|364974577|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
105813133|NCT05456529|364974577|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
105813134|NCT05456529|364974577|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
105813135|NCT05456529|364974577|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
105813136|NCT00287118|364974578|FG000|Overall Study|Adverse Event|30|||
105813137|NCT00287118|364974578|FG000|Overall Study|Death|1|||
105813138|NCT00287118|364974578|FG000|Overall Study|Lack of Efficacy|11|||
105813139|NCT00287118|364974578|FG000|Overall Study|Lost to Follow-up|1|||
105813140|NCT00287118|364974578|FG000|Overall Study|Protocol Violation|2|||
105813141|NCT00287118|364974578|FG000|Overall Study|Other|7|||
105813142|NCT02564263|364974579|FG000|Overall Study|Adverse Event|31|||
105813143|NCT02564263|364974580|FG001|Overall Study|Adverse Event|29|||
105813144|NCT02564263|364974579|FG000|Overall Study|Death|270|||
105813145|NCT02564263|364974580|FG001|Overall Study|Death|262|||
105813146|NCT02564263|364974579|FG000|Overall Study|Withdrawal by Subject|4|||
105813147|NCT02564263|364974580|FG001|Overall Study|Withdrawal by Subject|19|||
105763327|NCT02959190|364787100|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
105763328|NCT02959190|364787101|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
105763329|NCT02023268|364787102|FG000|Overall Study|Lack of Efficacy|0|||
105763330|NCT02023268|364787103|FG001|Overall Study|Lack of Efficacy|1|||
105763331|NCT02023268|364787102|FG000|Overall Study|Adverse Event|0|||
105763332|NCT02023268|364787103|FG001|Overall Study|Adverse Event|2|||
105763333|NCT02023268|364787102|FG000|Overall Study|Withdrawal by Subject|0|||
105763334|NCT02023268|364787103|FG001|Overall Study|Withdrawal by Subject|1|||
105763335|NCT04445688|364787104|FG000|Washout (One Week)|Adverse Event|2|||
105763336|NCT04445688|364787104|FG000|Washout (One Week)|Withdrawal by Subject|1|||
105763337|NCT00126672|364787106|FG000|Overall Study|Adverse Event|4|||
105763338|NCT00126672|364787106|FG000|Overall Study|Lost to Follow-up|4|||
105763339|NCT01998399|364787108|FG000|Overall Study|Lost to Follow-up|1|||
105763340|NCT01998399|364787109|FG001|Overall Study|Lost to Follow-up|3|||
105763341|NCT01998399|364787108|FG000|Overall Study|Death|4|||
105763342|NCT01998399|364787109|FG001|Overall Study|Death|2|||
105763343|NCT01998399|364787108|FG000|Overall Study|Study stopped before dosing completed|3|||
105763344|NCT01998399|364787109|FG001|Overall Study|Study stopped before dosing completed|3|||
105763345|NCT01998399|364787108|FG000|Overall Study|Withdrawal by Subject|0|||
105763346|NCT01998399|364787109|FG001|Overall Study|Withdrawal by Subject|1|||
105763347|NCT01610206|364787110|FG000|Overall Study|Adverse Event|10|||
105763348|NCT01610206|364787111|FG001|Overall Study|Adverse Event|30|||
105763349|NCT04114539|364787112|FG000|Overall Study|Adverse Event|14|||
105763350|NCT04114539|364787112|FG000|Overall Study|Lost to Follow-up|2|||
105763351|NCT04114539|364787112|FG000|Overall Study|Non-compliance with Protocol|2|||
105813148|NCT02564263|364974579|FG000|Overall Study|Sponsor's decision|9|||
105813149|NCT02564263|364974580|FG001|Overall Study|Sponsor's decision|4|||
105813150|NCT01475838|364974581|FG000|Randomized Phase|Randomized but Not Treated|0|||
105813151|NCT01475838|364974582|FG001|Randomized Phase|Randomized but Not Treated|5|||
105763352|NCT04114539|364787112|FG000|Overall Study|Non-compliance with Study Drug|1|||
105763353|NCT04114539|364787112|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
105763354|NCT04114539|364787112|FG000|Overall Study|Withdrew consent|10|||
105763355|NCT04114539|364787112|FG000|Overall Study|Others not specified|5|||
105763356|NCT04114539|364787112|FG000|Overall Study|Investigator Decision|2|||
105763357|NCT00045630|364787113|FG000|Overall Study|Adverse Event|1|||
105763358|NCT00045630|364787113|FG000|Overall Study|Refusal unrelated to adverse event|1|||
105763359|NCT00045630|364787113|FG000|Overall Study|Progression/relapse|1|||
105763360|NCT00045630|364787113|FG000|Overall Study|Death|1|||
105763361|NCT00045630|364787113|FG000|Overall Study|Ineligible|2|||
105763362|NCT02983799|364787114|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
105763363|NCT02983799|364787115|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
105763364|NCT02983799|364787116|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
105763365|NCT02983799|364787117|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
105763366|NCT02983799|364787118|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
105763367|NCT02983799|364787114|FG000|Overall Study|Death|20|||
105763368|NCT02983799|364787115|FG001|Overall Study|Death|5|||
105763369|NCT02983799|364787116|FG002|Overall Study|Death|23|||
105763370|NCT02983799|364787117|FG003|Overall Study|Death|47|||
105763371|NCT02983799|364787118|FG004|Overall Study|Death|7|||
105763372|NCT02983799|364787114|FG000|Overall Study|Withdrawal by Subject|1|||
105763373|NCT02983799|364787115|FG001|Overall Study|Withdrawal by Subject|0|||
105763374|NCT02983799|364787116|FG002|Overall Study|Withdrawal by Subject|3|||
105763375|NCT02983799|364787117|FG003|Overall Study|Withdrawal by Subject|4|||
105763376|NCT02983799|364787118|FG004|Overall Study|Withdrawal by Subject|1|||
105763377|NCT02983799|364787114|FG000|Overall Study|Protocol Violation|0|||
105763378|NCT02983799|364787115|FG001|Overall Study|Protocol Violation|1|||
105763379|NCT02983799|364787116|FG002|Overall Study|Protocol Violation|0|||
105763380|NCT02983799|364787117|FG003|Overall Study|Protocol Violation|0|||
105763381|NCT02983799|364787118|FG004|Overall Study|Protocol Violation|1|||
105763382|NCT02983799|364787114|FG000|Overall Study|Lost to Follow-up|1|||
105763383|NCT02983799|364787115|FG001|Overall Study|Lost to Follow-up|0|||
105763384|NCT02983799|364787116|FG002|Overall Study|Lost to Follow-up|1|||
105763385|NCT02983799|364787117|FG003|Overall Study|Lost to Follow-up|0|||
105763386|NCT02983799|364787118|FG004|Overall Study|Lost to Follow-up|0|||
105763387|NCT00981747|364787119|FG000|Losartan|Withdrawal by Subject|1|||
105763388|NCT00981747|364787119|FG000|Losartan|Death|1|||
105763389|NCT00981747|364787119|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
105763390|NCT01225172|364787120|FG000|Overall Study|Subject decision to stop|1|||
105763391|NCT01225172|364787121|FG001|Overall Study|Subject decision to stop|0|||
105763392|NCT01225172|364787120|FG000|Overall Study|Subject request to discontinue treatment|3|||
105763393|NCT01225172|364787121|FG001|Overall Study|Subject request to discontinue treatment|1|||
105763394|NCT01225172|364787120|FG000|Overall Study|Subject no longer meets study criteria|1|||
105763395|NCT01225172|364787121|FG001|Overall Study|Subject no longer meets study criteria|0|||
105763396|NCT01225172|364787120|FG000|Overall Study|Withdrawal by Subject|1|||
105763397|NCT01225172|364787121|FG001|Overall Study|Withdrawal by Subject|0|||
105763398|NCT00179517|364787122|FG000|Overall Study|Withdrawal by Subject|2|||
105763399|NCT00179517|364787123|FG001|Overall Study|Withdrawal by Subject|1|||
105763400|NCT03136484|364787124|FG000|Overall Study|Withdrawal by Subject|19|||
105763401|NCT03136484|364787125|FG001|Overall Study|Withdrawal by Subject|14|||
105763402|NCT03136484|364787124|FG000|Overall Study|Lost to Follow-up|7|||
105763403|NCT03136484|364787125|FG001|Overall Study|Lost to Follow-up|8|||
105763404|NCT03136484|364787124|FG000|Overall Study|Death|1|||
105439837|NCT00965419|363615087|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
105763405|NCT03136484|364787125|FG001|Overall Study|Death|0|||
105439838|NCT00965419|363615087|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
105439839|NCT00965419|363615087|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
105439840|NCT00965419|363615087|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
105439841|NCT00965419|363615087|FG000|Follow-up Phase|Adverse Event|9|||
105486046|NCT00470158|363791387|FG003|Overall Study|Death|0|||
105486047|NCT00470158|363791388|FG004|Overall Study|Death|2|||
105486048|NCT00470158|363791384|FG000|Overall Study|Lost to Follow-up|7|||
105486049|NCT00470158|363791385|FG001|Overall Study|Lost to Follow-up|8|||
105486050|NCT00470158|363791386|FG002|Overall Study|Lost to Follow-up|8|||
105763406|NCT00437203|364787126|FG000|Overall Study|Death|0|||
105763407|NCT00437203|364787127|FG001|Overall Study|Death|0|||
105763408|NCT00437203|364787128|FG002|Overall Study|Death|1|||
105763409|NCT00437203|364787129|FG003|Overall Study|Death|0|||
105763410|NCT00437203|364787130|FG004|Overall Study|Death|0|||
105763411|NCT00437203|364787131|FG005|Overall Study|Death|0|||
105763412|NCT00437203|364787132|FG006|Overall Study|Death|0|||
105763413|NCT00437203|364787133|FG007|Overall Study|Death|1|||
105763414|NCT00437203|364787134|FG008|Overall Study|Death|0|||
105763415|NCT00437203|364787135|FG009|Overall Study|Death|1|||
105763416|NCT00437203|364787126|FG000|Overall Study|Adverse Event|1|||
105763417|NCT00437203|364787127|FG001|Overall Study|Adverse Event|1|||
105763418|NCT00437203|364787128|FG002|Overall Study|Adverse Event|0|||
105763419|NCT00437203|364787129|FG003|Overall Study|Adverse Event|0|||
105763420|NCT00437203|364787130|FG004|Overall Study|Adverse Event|0|||
105763421|NCT00437203|364787131|FG005|Overall Study|Adverse Event|0|||
105763422|NCT00437203|364787132|FG006|Overall Study|Adverse Event|0|||
105763423|NCT00437203|364787133|FG007|Overall Study|Adverse Event|1|||
105763424|NCT00437203|364787134|FG008|Overall Study|Adverse Event|0|||
105763425|NCT00437203|364787135|FG009|Overall Study|Adverse Event|1|||
105763426|NCT00437203|364787126|FG000|Overall Study|Study terminated by sponsor|0|||
105763427|NCT00437203|364787127|FG001|Overall Study|Study terminated by sponsor|0|||
105763428|NCT00437203|364787128|FG002|Overall Study|Study terminated by sponsor|0|||
105486051|NCT00470158|363791387|FG003|Overall Study|Lost to Follow-up|5|||
105486052|NCT00470158|363791388|FG004|Overall Study|Lost to Follow-up|4|||
105486053|NCT00470158|363791384|FG000|Overall Study|Protocol Violation|1|||
105486054|NCT00470158|363791385|FG001|Overall Study|Protocol Violation|0|||
105486055|NCT00470158|363791386|FG002|Overall Study|Protocol Violation|0|||
105486056|NCT00470158|363791387|FG003|Overall Study|Protocol Violation|0|||
105486057|NCT00470158|363791388|FG004|Overall Study|Protocol Violation|0|||
105486058|NCT01236118|363791389|FG000|Overall Study|Adverse Event|2|||
105486059|NCT01236118|363791390|FG001|Overall Study|Adverse Event|0|||
105486060|NCT01236118|363791391|FG002|Overall Study|Adverse Event|2|||
105486061|NCT01236118|363791389|FG000|Overall Study|Physician Decision|0|||
105486062|NCT01236118|363791390|FG001|Overall Study|Physician Decision|1|||
105486063|NCT01236118|363791391|FG002|Overall Study|Physician Decision|0|||
105486064|NCT01236118|363791389|FG000|Overall Study|Withdrawal by Subject|0|||
105361976|NCT02326272|363330155|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105361977|NCT02326272|363330156|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105361978|NCT02326272|363330157|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105361979|NCT02326272|363330143|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105361980|NCT02326272|363330144|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105361981|NCT02326272|363330145|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105361982|NCT02326272|363330146|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105361983|NCT02326272|363330147|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105361984|NCT02326272|363330148|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105361985|NCT02326272|363330149|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
105361986|NCT02326272|363330150|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105361987|NCT02326272|363330151|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105361988|NCT02326272|363330152|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105361989|NCT02326272|363330153|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105361990|NCT02326272|363330154|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105361991|NCT02326272|363330155|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105486065|NCT01236118|363791390|FG001|Overall Study|Withdrawal by Subject|0|||
105486066|NCT01236118|363791391|FG002|Overall Study|Withdrawal by Subject|1|||
105486067|NCT03505671|363791392|FG000|Overall Study|Withdrawal by Subject|2|||
105486068|NCT03505671|363791393|FG001|Overall Study|Withdrawal by Subject|1|||
105763429|NCT00437203|364787129|FG003|Overall Study|Study terminated by sponsor|0|||
105763430|NCT00437203|364787130|FG004|Overall Study|Study terminated by sponsor|0|||
105763431|NCT00437203|364787131|FG005|Overall Study|Study terminated by sponsor|0|||
105763432|NCT00437203|364787132|FG006|Overall Study|Study terminated by sponsor|0|||
105763433|NCT00437203|364787133|FG007|Overall Study|Study terminated by sponsor|0|||
105763434|NCT00437203|364787134|FG008|Overall Study|Study terminated by sponsor|1|||
105763435|NCT00437203|364787135|FG009|Overall Study|Study terminated by sponsor|0|||
105763436|NCT00437203|364787126|FG000|Overall Study|Objective progression or relapse|5|||
105763437|NCT00437203|364787127|FG001|Overall Study|Objective progression or relapse|6|||
105763438|NCT00437203|364787128|FG002|Overall Study|Objective progression or relapse|2|||
105763439|NCT00437203|364787129|FG003|Overall Study|Objective progression or relapse|3|||
105763440|NCT00437203|364787130|FG004|Overall Study|Objective progression or relapse|3|||
105361992|NCT02326272|363330156|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105486069|NCT03505671|363791392|FG000|Overall Study|Lost to Follow-up|1|||
105486070|NCT03505671|363791393|FG001|Overall Study|Lost to Follow-up|0|||
105486071|NCT02742246|363791396|FG000|Overall Study|Never initiated treatment|5|||
105486072|NCT02742246|363791397|FG001|Overall Study|Never initiated treatment|3|||
105486073|NCT02742246|363791398|FG002|Overall Study|Never initiated treatment|1|||
105486074|NCT02742246|363791396|FG000|Overall Study|dropped out during treatment|7|||
105361993|NCT02326272|363330157|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105763441|NCT00437203|364787131|FG005|Overall Study|Objective progression or relapse|3|||
105763442|NCT00437203|364787132|FG006|Overall Study|Objective progression or relapse|6|||
105763443|NCT00437203|364787133|FG007|Overall Study|Objective progression or relapse|1|||
105763444|NCT00437203|364787134|FG008|Overall Study|Objective progression or relapse|2|||
105763445|NCT00437203|364787135|FG009|Overall Study|Objective progression or relapse|2|||
105763446|NCT00437203|364787126|FG000|Overall Study|Other|0|||
105763447|NCT00437203|364787127|FG001|Overall Study|Other|1|||
105763448|NCT00437203|364787128|FG002|Overall Study|Other|0|||
105763449|NCT00437203|364787129|FG003|Overall Study|Other|0|||
105763450|NCT00437203|364787130|FG004|Overall Study|Other|0|||
105763451|NCT00437203|364787131|FG005|Overall Study|Other|0|||
105763452|NCT00437203|364787132|FG006|Overall Study|Other|1|||
105763453|NCT00437203|364787133|FG007|Overall Study|Other|0|||
105763454|NCT00437203|364787134|FG008|Overall Study|Other|0|||
105763455|NCT00437203|364787135|FG009|Overall Study|Other|0|||
105763456|NCT04209400|364787136|FG000|Overall Study|Withdrawal by Subject|0|||
105763457|NCT04209400|364787137|FG001|Overall Study|Withdrawal by Subject|1|||
105763458|NCT00856986|364787140|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
105763459|NCT00856986|364787141|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
105763460|NCT00856986|364787142|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
105763461|NCT00856986|364787143|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
105763462|NCT00856986|364787144|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
105763463|NCT00856986|364787140|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
105763464|NCT00856986|364787141|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
105813152|NCT01475838|364974581|FG000|Randomized Phase|Adverse Event|6|||
105813153|NCT01475838|364974582|FG001|Randomized Phase|Adverse Event|1|||
105813154|NCT01475838|364974581|FG000|Randomized Phase|Pregnancy|0|||
105813155|NCT01475838|364974582|FG001|Randomized Phase|Pregnancy|1|||
105813156|NCT01475838|364974581|FG000|Randomized Phase|Investigators Discretion|1|||
105813157|NCT01475838|364974582|FG001|Randomized Phase|Investigators Discretion|2|||
105813158|NCT01475838|364974581|FG000|Randomized Phase|Withdrew Consent|10|||
105361994|NCT02326272|363330143|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105361995|NCT02326272|363330144|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105361996|NCT02326272|363330145|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105361997|NCT02326272|363330146|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105361998|NCT02326272|363330147|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105361999|NCT02326272|363330148|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105362000|NCT02326272|363330149|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105362001|NCT02326272|363330150|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105362002|NCT02326272|363330151|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
105813159|NCT01475838|364974582|FG001|Randomized Phase|Withdrew Consent|14|||
105813160|NCT01475838|364974581|FG000|Randomized Phase|Lost to Follow-up|3|||
105813161|NCT01475838|364974582|FG001|Randomized Phase|Lost to Follow-up|4|||
105813162|NCT01475838|364974581|FG000|Randomized Phase|Participant Noncompliance|1|||
105813163|NCT01475838|364974582|FG001|Randomized Phase|Participant Noncompliance|5|||
105813164|NCT01475838|364974581|FG000|Randomized Phase|Protocol Violation|9|||
105813165|NCT01475838|364974582|FG001|Randomized Phase|Protocol Violation|4|||
105813166|NCT01475838|364974581|FG000|Extension Phase|Participant Noncompliance|1|||
105813167|NCT01475838|364974582|FG001|Extension Phase|Participant Noncompliance|0|||
105813168|NCT00048568|364974588|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
105813169|NCT00048568|364974589|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
105813170|NCT00048568|364974590|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
105813171|NCT00048568|364974588|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
105813172|NCT00048568|364974589|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
105813173|NCT00048568|364974590|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
105813174|NCT00048568|364974588|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
105813175|NCT00048568|364974589|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
105813176|NCT00048568|364974590|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
105813177|NCT00048568|364974588|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
105813178|NCT00048568|364974589|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
105813179|NCT00048568|364974590|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
105813180|NCT00048568|364974588|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
105813181|NCT00048568|364974589|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
105813182|NCT00048568|364974590|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
105813183|NCT00048568|364974588|FG000|Double-Blind Period Days 170 to 365|Death|1|||
105813184|NCT00048568|364974589|FG001|Double-Blind Period Days 170 to 365|Death|1|||
105813185|NCT00048568|364974590|FG002|Double-Blind Period Days 170 to 365|Death|0|||
105813186|NCT00048568|364974588|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
105813187|NCT00048568|364974589|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
105813188|NCT00048568|364974590|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
105813189|NCT00048568|364974588|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
105813190|NCT00048568|364974589|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
105813191|NCT00048568|364974590|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
105813192|NCT00048568|364974588|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
105813193|NCT00048568|364974589|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
105813194|NCT00048568|364974590|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
105813195|NCT00048568|364974588|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
105813196|NCT00048568|364974589|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
105813197|NCT00048568|364974590|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
105813198|NCT00048568|364974588|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
105813199|NCT00048568|364974589|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
105813200|NCT00048568|364974590|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
105813201|NCT00048568|364974588|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
105813202|NCT00048568|364974589|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
105813203|NCT00048568|364974590|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
105813204|NCT00048568|364974588|FG000|Open-Label Period|Death|0|||
105813205|NCT00048568|364974589|FG001|Open-Label Period|Death|0|||
105813206|NCT00048568|364974590|FG002|Open-Label Period|Death|13|||
105813207|NCT00048568|364974588|FG000|Open-Label Period|Adverse Event|0|||
105813208|NCT00048568|364974589|FG001|Open-Label Period|Adverse Event|0|||
105813209|NCT00048568|364974590|FG002|Open-Label Period|Adverse Event|49|||
105813210|NCT00048568|364974588|FG000|Open-Label Period|Lack of Efficacy|0|||
105813211|NCT00048568|364974589|FG001|Open-Label Period|Lack of Efficacy|0|||
105813212|NCT00048568|364974590|FG002|Open-Label Period|Lack of Efficacy|32|||
105813213|NCT00048568|364974588|FG000|Open-Label Period|Withdrawal by Subject|0|||
105813214|NCT00048568|364974589|FG001|Open-Label Period|Withdrawal by Subject|0|||
105813215|NCT00048568|364974590|FG002|Open-Label Period|Withdrawal by Subject|26|||
105813216|NCT00048568|364974588|FG000|Open-Label Period|Pregnancy|0|||
105813217|NCT00048568|364974589|FG001|Open-Label Period|Pregnancy|0|||
105813218|NCT00048568|364974590|FG002|Open-Label Period|Pregnancy|5|||
105813219|NCT00048568|364974588|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
105813220|NCT00048568|364974589|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
105813221|NCT00048568|364974590|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
105813222|NCT00048568|364974588|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
105813223|NCT00048568|364974589|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
105813224|NCT00048568|364974590|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
105813225|NCT00048568|364974588|FG000|Open-Label Period|Unknown Reasons|0|||
105813226|NCT00048568|364974589|FG001|Open-Label Period|Unknown Reasons|0|||
105813227|NCT00048568|364974590|FG002|Open-Label Period|Unknown Reasons|25|||
105813228|NCT00048568|364974588|FG000|Open-Label Period|Lost to Follow-up|0|||
105362003|NCT02326272|363330152|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105813229|NCT00048568|364974589|FG001|Open-Label Period|Lost to Follow-up|0|||
105813230|NCT00048568|364974590|FG002|Open-Label Period|Lost to Follow-up|7|||
105813231|NCT01400425|364974591|FG000|Overall Study|Withdrawal by Subject|10|||
105813232|NCT03594123|364974594|FG000|Overall Study|Lost to Follow-up|0|||
105813233|NCT03594123|364974595|FG001|Overall Study|Lost to Follow-up|1|||
105362004|NCT02326272|363330153|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105813234|NCT03594123|364974594|FG000|Overall Study|Adverse Event|8|||
105813235|NCT03594123|364974595|FG001|Overall Study|Adverse Event|5|||
105813236|NCT03594123|364974594|FG000|Overall Study|Site Terminated by Sponsor|4|||
105486075|NCT02742246|363791397|FG001|Overall Study|dropped out during treatment|13|||
105486076|NCT02742246|363791398|FG002|Overall Study|dropped out during treatment|10|||
105486077|NCT02742246|363791396|FG000|Overall Study|Death|1|||
105486078|NCT02742246|363791397|FG001|Overall Study|Death|0|||
105486079|NCT02742246|363791398|FG002|Overall Study|Death|0|||
105813237|NCT03594123|364974595|FG001|Overall Study|Site Terminated by Sponsor|1|||
105813238|NCT03594123|364974594|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
105813239|NCT03594123|364974595|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
105813240|NCT03594123|364974594|FG000|Overall Study|Lack of Efficacy|1|||
105813241|NCT03594123|364974595|FG001|Overall Study|Lack of Efficacy|0|||
105813242|NCT03594123|364974594|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
105813243|NCT03594123|364974595|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
105813244|NCT01700621|364974596|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
105813245|NCT01700621|364974597|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
105813246|NCT01700621|364974596|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
105813247|NCT01700621|364974597|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
105813248|NCT01700621|364974596|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
105813249|NCT01700621|364974597|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
105813250|NCT03365375|364974598|FG000|Overall Study|Withdrawal by Subject|0|||
105813251|NCT03365375|364974599|FG001|Overall Study|Withdrawal by Subject|1|||
105813252|NCT03365375|364974598|FG000|Overall Study|Lost to Follow-up|0|||
105813253|NCT03365375|364974599|FG001|Overall Study|Lost to Follow-up|4|||
105813254|NCT03992196|364974600|FG000|Enrollment|lost to follow-up prior dosing|1|||
105813255|NCT03992196|364974601|FG001|Enrollment|lost to follow-up prior dosing|0|||
105813256|NCT03992196|364974602|FG002|Enrollment|lost to follow-up prior dosing|0|||
105813257|NCT03992196|364974600|FG000|Treatment|Protocol Violation|0|||
105813258|NCT03992196|364974601|FG001|Treatment|Protocol Violation|0|||
105813259|NCT03992196|364974602|FG002|Treatment|Protocol Violation|1|||
105813260|NCT03992196|364974600|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
105813261|NCT03992196|364974601|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
105813262|NCT03992196|364974602|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
105813263|NCT03992196|364974600|FG000|Treatment|Withdrawal due to non-compliance|0|||
105813264|NCT03992196|364974601|FG001|Treatment|Withdrawal due to non-compliance|0|||
105813265|NCT03992196|364974602|FG002|Treatment|Withdrawal due to non-compliance|1|||
105813266|NCT03992196|364974600|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
105486080|NCT03422627|363791399|FG000|Overall Study|Protocol-specified Criteria|1|||
105486081|NCT03422627|363791400|FG001|Overall Study|Protocol-specified Criteria|1|||
105486082|NCT03422627|363791401|FG002|Overall Study|Protocol-specified Criteria|0|||
105813267|NCT03992196|364974601|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
105486083|NCT03422627|363791402|FG003|Overall Study|Protocol-specified Criteria|0|||
105486084|NCT03422627|363791403|FG004|Overall Study|Protocol-specified Criteria|2|||
105571548|NCT00747123|364091235|FG000|Overall Study|Adverse Event|0|||
105813268|NCT03992196|364974602|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
105813269|NCT03992196|364974600|FG000|Treatment|Withdrawal by parent/guardian|0|||
105813270|NCT03992196|364974601|FG001|Treatment|Withdrawal by parent/guardian|0|||
105813271|NCT03992196|364974602|FG002|Treatment|Withdrawal by parent/guardian|2|||
105813272|NCT01505530|364974605|FG000|Overall Study|Progressive Disease|19|||
105813273|NCT01505530|364974606|FG001|Overall Study|Progressive Disease|17|||
105813274|NCT01505530|364974607|FG002|Overall Study|Progressive Disease|18|||
105813275|NCT01505530|364974605|FG000|Overall Study|Adverse Event|1|||
105813276|NCT01505530|364974606|FG001|Overall Study|Adverse Event|1|||
105813277|NCT01505530|364974607|FG002|Overall Study|Adverse Event|0|||
105813278|NCT01505530|364974605|FG000|Overall Study|Withdrawal by Subject|7|||
105813279|NCT01505530|364974606|FG001|Overall Study|Withdrawal by Subject|8|||
105813280|NCT01505530|364974607|FG002|Overall Study|Withdrawal by Subject|6|||
105813281|NCT01505530|364974605|FG000|Overall Study|Physician Decision|6|||
105813282|NCT01505530|364974606|FG001|Overall Study|Physician Decision|2|||
105813283|NCT01505530|364974607|FG002|Overall Study|Physician Decision|5|||
105813284|NCT01505530|364974605|FG000|Overall Study|Sponsor Decision|1|||
105813285|NCT01505530|364974606|FG001|Overall Study|Sponsor Decision|8|||
105813286|NCT01505530|364974607|FG002|Overall Study|Sponsor Decision|7|||
105813287|NCT01505530|364974605|FG000|Overall Study|Death|7|||
105813288|NCT01505530|364974606|FG001|Overall Study|Death|6|||
105813289|NCT01505530|364974607|FG002|Overall Study|Death|5|||
105813290|NCT01505530|364974605|FG000|Overall Study|entry criteria not met|0|||
105813291|NCT01505530|364974606|FG001|Overall Study|entry criteria not met|1|||
105813292|NCT01505530|364974607|FG002|Overall Study|entry criteria not met|0|||
105362005|NCT02326272|363330154|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105362006|NCT02326272|363330155|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105362007|NCT02326272|363330156|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105362008|NCT02326272|363330157|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105362009|NCT02326272|363330143|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105362010|NCT02326272|363330144|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105486085|NCT03422627|363791399|FG000|Overall Study|Requirement for Alternative Therapy|1|||
105486086|NCT03422627|363791400|FG001|Overall Study|Requirement for Alternative Therapy|1|||
105813293|NCT02388763|364974613|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
105813294|NCT02388763|364974614|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
105813295|NCT02388763|364974613|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
105813296|NCT02388763|364974614|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
105813297|NCT02636907|364974619|FG000|Autoinjector Assessment Period|Adverse Event|2|||
105813298|NCT02636907|364974619|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
105813299|NCT02636907|364974619|FG000|Extension Phase|Adverse Event|2|||
105813300|NCT02636907|364974619|FG000|Extension Phase|Withdrawal by Subject|4|||
105813301|NCT02636907|364974619|FG000|Extension Phase|Physician Decision|1|||
105813302|NCT02636907|364974619|FG000|Extension Phase|Lost to Follow-up|2|||
105813303|NCT02636907|364974619|FG000|Extension Phase|Lack of Efficacy|1|||
105813304|NCT02796664|364974620|FG000|Overall Study|Withdrawal by Subject|0|||
105813305|NCT02796664|364974621|FG001|Overall Study|Withdrawal by Subject|3|||
105813306|NCT02796664|364974620|FG000|Overall Study|Noncompliance|1|||
105813307|NCT02796664|364974621|FG001|Overall Study|Noncompliance|1|||
105813308|NCT02796664|364974620|FG000|Overall Study|Death|0|||
105813309|NCT02796664|364974621|FG001|Overall Study|Death|1|||
105813310|NCT02246478|364974622|FG000|Multiple-dose Phase|Protocol Violation|1|||
105813311|NCT02246478|364974623|FG001|Multiple-dose Phase|Protocol Violation|0|||
105813312|NCT02246478|364974624|FG002|Multiple-dose Phase|Protocol Violation|0|||
105813313|NCT02246478|364974625|FG003|Multiple-dose Phase|Protocol Violation|1|||
105813314|NCT00860405|364974628|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
105813315|NCT00860405|364974629|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
105813316|NCT03980483|364974630|FG000|Overall Study|Adverse Event|13|||
105813317|NCT03980483|364974631|FG001|Overall Study|Adverse Event|29|||
105813318|NCT03980483|364974632|FG002|Overall Study|Adverse Event|11|||
105813319|NCT03980483|364974633|FG003|Overall Study|Adverse Event|2|||
105813320|NCT03980483|364974634|FG004|Overall Study|Adverse Event|2|||
105813321|NCT03980483|364974635|FG005|Overall Study|Adverse Event|2|||
105813322|NCT03980483|364974630|FG000|Overall Study|Lack of Efficacy|7|||
105813323|NCT03980483|364974631|FG001|Overall Study|Lack of Efficacy|6|||
105813324|NCT03980483|364974632|FG002|Overall Study|Lack of Efficacy|0|||
105813325|NCT03980483|364974633|FG003|Overall Study|Lack of Efficacy|3|||
105813326|NCT03980483|364974634|FG004|Overall Study|Lack of Efficacy|1|||
105813327|NCT03980483|364974635|FG005|Overall Study|Lack of Efficacy|1|||
105813328|NCT03980483|364974630|FG000|Overall Study|Lost to Follow-up|2|||
105813329|NCT03980483|364974631|FG001|Overall Study|Lost to Follow-up|4|||
105813330|NCT03980483|364974632|FG002|Overall Study|Lost to Follow-up|2|||
105813331|NCT03980483|364974633|FG003|Overall Study|Lost to Follow-up|1|||
105813332|NCT03980483|364974634|FG004|Overall Study|Lost to Follow-up|2|||
105813333|NCT03980483|364974635|FG005|Overall Study|Lost to Follow-up|0|||
105813334|NCT03980483|364974630|FG000|Overall Study|Protocol Violation|4|||
105813335|NCT03980483|364974631|FG001|Overall Study|Protocol Violation|2|||
105813336|NCT03980483|364974632|FG002|Overall Study|Protocol Violation|1|||
105362011|NCT02326272|363330145|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105813337|NCT03980483|364974633|FG003|Overall Study|Protocol Violation|1|||
105486087|NCT03422627|363791401|FG002|Overall Study|Requirement for Alternative Therapy|2|||
105486088|NCT03422627|363791402|FG003|Overall Study|Requirement for Alternative Therapy|0|||
105486089|NCT03422627|363791403|FG004|Overall Study|Requirement for Alternative Therapy|0|||
105813338|NCT03980483|364974634|FG004|Overall Study|Protocol Violation|0|||
105813339|NCT03980483|364974635|FG005|Overall Study|Protocol Violation|0|||
105813340|NCT03980483|364974630|FG000|Overall Study|Physician Decision|14|||
105813341|NCT03980483|364974631|FG001|Overall Study|Physician Decision|10|||
105813342|NCT03980483|364974632|FG002|Overall Study|Physician Decision|7|||
105813343|NCT03980483|364974633|FG003|Overall Study|Physician Decision|4|||
105813344|NCT03980483|364974634|FG004|Overall Study|Physician Decision|4|||
105813345|NCT03980483|364974635|FG005|Overall Study|Physician Decision|2|||
105813346|NCT03980483|364974630|FG000|Overall Study|Withdrawal by Subject|38|||
105813347|NCT03980483|364974631|FG001|Overall Study|Withdrawal by Subject|21|||
105813348|NCT03980483|364974632|FG002|Overall Study|Withdrawal by Subject|15|||
105813349|NCT03980483|364974633|FG003|Overall Study|Withdrawal by Subject|5|||
105813350|NCT03980483|364974634|FG004|Overall Study|Withdrawal by Subject|3|||
105813351|NCT03980483|364974635|FG005|Overall Study|Withdrawal by Subject|4|||
105813352|NCT03980483|364974630|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
105813353|NCT03980483|364974631|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
105813354|NCT03980483|364974632|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
105813355|NCT03980483|364974633|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
105813356|NCT03980483|364974634|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
105813357|NCT03980483|364974635|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
105813358|NCT03980483|364974630|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
105813359|NCT03980483|364974631|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
105813360|NCT03980483|364974632|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
105813361|NCT03980483|364974633|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
105813362|NCT03980483|364974634|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
105813363|NCT03980483|364974635|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
105813364|NCT03980483|364974630|FG000|Overall Study|Other|0|||
105813365|NCT03980483|364974631|FG001|Overall Study|Other|1|||
105813366|NCT03980483|364974632|FG002|Overall Study|Other|0|||
105813367|NCT03980483|364974633|FG003|Overall Study|Other|0|||
105813368|NCT03980483|364974634|FG004|Overall Study|Other|0|||
105813369|NCT03980483|364974635|FG005|Overall Study|Other|0|||
105813370|NCT00497796|364974636|FG000|Overall Study|Adverse event (not related)|9|||
105813371|NCT00497796|364974637|FG001|Overall Study|Adverse event (not related)|9|||
105813372|NCT00497796|364974636|FG000|Overall Study|Adverse event (related)|5|||
105813373|NCT00497796|364974637|FG001|Overall Study|Adverse event (related)|4|||
105813374|NCT00497796|364974636|FG000|Overall Study|CMV infection or disease treatment|30|||
105813375|NCT00497796|364974637|FG001|Overall Study|CMV infection or disease treatment|4|||
105813376|NCT00497796|364974636|FG000|Overall Study|Consent withdrawn|10|||
105813377|NCT00497796|364974637|FG001|Overall Study|Consent withdrawn|3|||
105813378|NCT00497796|364974636|FG000|Overall Study|Investigator/sponsor discretion|31|||
105813379|NCT00497796|364974637|FG001|Overall Study|Investigator/sponsor discretion|34|||
105813380|NCT00497796|364974636|FG000|Overall Study|Lost to Follow-up|0|||
105813381|NCT00497796|364974637|FG001|Overall Study|Lost to Follow-up|1|||
105813382|NCT00497796|364974636|FG000|Overall Study|Not applicable (randomized not treated)|0|||
105813383|NCT00497796|364974637|FG001|Overall Study|Not applicable (randomized not treated)|4|||
105813384|NCT04276883|364974640|FG000|Overall Study|Withdrawal by Subject|2|||
105813385|NCT04276883|364974641|FG001|Overall Study|Withdrawal by Subject|3|||
105813386|NCT04276883|364974642|FG002|Overall Study|Withdrawal by Subject|6|||
105813387|NCT04276883|364974640|FG000|Overall Study|Lost to Follow-up|1|||
105813388|NCT04276883|364974641|FG001|Overall Study|Lost to Follow-up|3|||
105813389|NCT04276883|364974642|FG002|Overall Study|Lost to Follow-up|0|||
105813390|NCT04276883|364974640|FG000|Overall Study|Adverse Event|0|||
105813391|NCT04276883|364974641|FG001|Overall Study|Adverse Event|1|||
105813392|NCT04276883|364974642|FG002|Overall Study|Adverse Event|0|||
105813393|NCT04276883|364974640|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
105813394|NCT04276883|364974641|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
105813395|NCT04276883|364974642|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
105813396|NCT05277389|364974648|FG000|Overall Study|Lost to Follow-up|1|||
105813397|NCT05277389|364974649|FG001|Overall Study|Lost to Follow-up|4|||
105813398|NCT06096168|364974650|FG000|Overall Study|Death|30|||
105813399|NCT06096168|364974650|FG000|Overall Study|Revision|2|||
105813400|NCT03125200|364974655|FG000|Overall Study|Study Termination|0|||
105813401|NCT03125200|364974656|FG001|Overall Study|Study Termination|0|||
105486090|NCT03422627|363791399|FG000|Overall Study|Disease Progression|1|||
105486091|NCT03422627|363791400|FG001|Overall Study|Disease Progression|0|||
105486092|NCT03422627|363791401|FG002|Overall Study|Disease Progression|1|||
105486093|NCT03422627|363791402|FG003|Overall Study|Disease Progression|2|||
105486094|NCT03422627|363791403|FG004|Overall Study|Disease Progression|0|||
105763465|NCT00856986|364787142|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
105763466|NCT00856986|364787143|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
105763467|NCT00856986|364787144|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
105763468|NCT00856986|364787140|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
105763469|NCT00856986|364787141|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
105763470|NCT00856986|364787142|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
105763471|NCT00856986|364787143|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
105763472|NCT00856986|364787144|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
105763473|NCT00856986|364787140|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
105813402|NCT03125200|364974657|FG002|Overall Study|Study Termination|0|||
105813403|NCT03125200|364974658|FG003|Overall Study|Study Termination|1|||
105813404|NCT03125200|364974659|FG004|Overall Study|Study Termination|1|||
105813405|NCT03125200|364974660|FG005|Overall Study|Study Termination|2|||
105813406|NCT03125200|364974661|FG006|Overall Study|Study Termination|1|||
105813407|NCT03125200|364974655|FG000|Overall Study|Clinical Progression|0|||
105813408|NCT03125200|364974656|FG001|Overall Study|Clinical Progression|0|||
105813409|NCT03125200|364974657|FG002|Overall Study|Clinical Progression|0|||
105813410|NCT03125200|364974658|FG003|Overall Study|Clinical Progression|1|||
105813411|NCT03125200|364974659|FG004|Overall Study|Clinical Progression|0|||
105813412|NCT03125200|364974660|FG005|Overall Study|Clinical Progression|1|||
105813413|NCT03125200|364974661|FG006|Overall Study|Clinical Progression|0|||
105813414|NCT03125200|364974655|FG000|Overall Study|Progressive Disease|2|||
105813415|NCT03125200|364974656|FG001|Overall Study|Progressive Disease|1|||
105813416|NCT03125200|364974657|FG002|Overall Study|Progressive Disease|2|||
105813417|NCT03125200|364974658|FG003|Overall Study|Progressive Disease|1|||
105813418|NCT03125200|364974659|FG004|Overall Study|Progressive Disease|2|||
105813419|NCT03125200|364974660|FG005|Overall Study|Progressive Disease|0|||
105813420|NCT03125200|364974661|FG006|Overall Study|Progressive Disease|1|||
105813421|NCT03125200|364974655|FG000|Overall Study|Lack of Efficacy|0|||
105813422|NCT03125200|364974656|FG001|Overall Study|Lack of Efficacy|0|||
105813423|NCT03125200|364974657|FG002|Overall Study|Lack of Efficacy|0|||
105813424|NCT03125200|364974658|FG003|Overall Study|Lack of Efficacy|1|||
105813425|NCT03125200|364974659|FG004|Overall Study|Lack of Efficacy|0|||
105813426|NCT03125200|364974660|FG005|Overall Study|Lack of Efficacy|0|||
105813427|NCT03125200|364974661|FG006|Overall Study|Lack of Efficacy|0|||
105813428|NCT03125200|364974655|FG000|Overall Study|Toxicity|0|||
105813429|NCT03125200|364974656|FG001|Overall Study|Toxicity|0|||
105813430|NCT03125200|364974657|FG002|Overall Study|Toxicity|0|||
105813431|NCT03125200|364974658|FG003|Overall Study|Toxicity|1|||
105813432|NCT03125200|364974659|FG004|Overall Study|Toxicity|0|||
105813433|NCT03125200|364974660|FG005|Overall Study|Toxicity|0|||
105813434|NCT03125200|364974661|FG006|Overall Study|Toxicity|0|||
105813435|NCT03125200|364974655|FG000|Overall Study|Consent Withdrawn by Subject|0|||
105813436|NCT03125200|364974656|FG001|Overall Study|Consent Withdrawn by Subject|1|||
105813437|NCT03125200|364974657|FG002|Overall Study|Consent Withdrawn by Subject|0|||
105813438|NCT03125200|364974658|FG003|Overall Study|Consent Withdrawn by Subject|0|||
105813439|NCT03125200|364974659|FG004|Overall Study|Consent Withdrawn by Subject|1|||
105813440|NCT03125200|364974660|FG005|Overall Study|Consent Withdrawn by Subject|0|||
105813441|NCT03125200|364974661|FG006|Overall Study|Consent Withdrawn by Subject|1|||
105813442|NCT01569152|364974662|FG000|Phase IIa, Period 1|Early Escape|5|||
105813443|NCT01569152|364974663|FG001|Phase IIa, Period 1|Early Escape|22|||
105813444|NCT01569152|364974664|FG002|Phase IIa, Period 1|Early Escape|0|||
105813445|NCT01569152|364974662|FG000|Phase IIa, Period 1|Adverse Event|4|||
105813446|NCT01569152|364974663|FG001|Phase IIa, Period 1|Adverse Event|0|||
105813447|NCT01569152|364974664|FG002|Phase IIa, Period 1|Adverse Event|0|||
105813448|NCT01569152|364974662|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
105813449|NCT01569152|364974663|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
105813450|NCT01569152|364974664|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
105813451|NCT01569152|364974662|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
105813452|NCT01569152|364974663|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
105813453|NCT01569152|364974664|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
105813454|NCT01569152|364974662|FG000|Phase IIa, Period 1|Protocol Violation|0|||
105813455|NCT01569152|364974663|FG001|Phase IIa, Period 1|Protocol Violation|1|||
105813456|NCT01569152|364974664|FG002|Phase IIa, Period 1|Protocol Violation|0|||
105813457|NCT01569152|364974662|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
105813458|NCT01569152|364974663|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
105813459|NCT01569152|364974664|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
105813460|NCT01569152|364974662|FG000|Safety Extension, Period 3|Adverse Event|0|||
105813461|NCT01569152|364974663|FG001|Safety Extension, Period 3|Adverse Event|0|||
105813462|NCT01569152|364974664|FG002|Safety Extension, Period 3|Adverse Event|4|||
105813463|NCT01569152|364974662|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
105813464|NCT01569152|364974663|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
105813465|NCT01569152|364974664|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
105813466|NCT01569152|364974662|FG000|Safety Extension, Period 3|Physician Decision|0|||
105813467|NCT01569152|364974663|FG001|Safety Extension, Period 3|Physician Decision|0|||
105813468|NCT01569152|364974664|FG002|Safety Extension, Period 3|Physician Decision|2|||
105813469|NCT01569152|364974662|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
105813470|NCT01569152|364974663|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
105813471|NCT01569152|364974664|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
105813472|NCT01766778|364974665|FG000|Overall Study|Adverse Event|4|||
105813473|NCT01766778|364974666|FG001|Overall Study|Adverse Event|4|||
105813474|NCT01766778|364974665|FG000|Overall Study|Withdrawal by Subject|1|||
105813475|NCT01766778|364974666|FG001|Overall Study|Withdrawal by Subject|0|||
105813476|NCT02093689|364974669|FG000|Overall Study|Physician Decision|4|||
105813477|NCT02093689|364974670|FG001|Overall Study|Physician Decision|0|||
105813478|NCT02093689|364974671|FG002|Overall Study|Physician Decision|0|||
105813479|NCT03144687|364974672|FG000|Overall Study|Death|0|||
105813480|NCT03144687|364974673|FG001|Overall Study|Death|2|||
105813481|NCT03144687|364974672|FG000|Overall Study|Lost to Follow-up|0|||
105486095|NCT03422627|363791399|FG000|Overall Study|Adverse Event|2|||
105763474|NCT00856986|364787141|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
105763475|NCT00856986|364787142|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
105763476|NCT00856986|364787143|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
105763477|NCT00856986|364787144|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
105763478|NCT00856986|364787140|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
105763479|NCT00856986|364787141|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
105763480|NCT00856986|364787142|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
105763481|NCT00856986|364787143|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
105763482|NCT00856986|364787144|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
105763483|NCT00856986|364787140|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
105763484|NCT00856986|364787141|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
105763485|NCT00856986|364787142|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
105763486|NCT00856986|364787143|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
105763487|NCT00856986|364787144|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
105763488|NCT00856986|364787140|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
105763489|NCT00856986|364787141|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
105763490|NCT00856986|364787142|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
105763491|NCT00856986|364787143|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
105763492|NCT00856986|364787144|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
105763493|NCT00856986|364787140|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
105763494|NCT00856986|364787141|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
105763495|NCT00856986|364787142|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
105763496|NCT00856986|364787143|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
105763497|NCT00856986|364787144|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
105763498|NCT00856986|364787140|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
105763499|NCT00856986|364787141|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
105763500|NCT00856986|364787142|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
105763501|NCT00856986|364787143|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
105763502|NCT00856986|364787144|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
105763503|NCT00856986|364787140|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
105763504|NCT00856986|364787141|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
105763505|NCT00856986|364787142|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
105763506|NCT00856986|364787143|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
105763507|NCT00856986|364787144|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
105763508|NCT00856986|364787140|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
105763509|NCT00856986|364787141|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
105763510|NCT00856986|364787142|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
105763511|NCT00856986|364787143|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
105763512|NCT00856986|364787144|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
105763513|NCT00856986|364787140|FG000|Main Period, Weeks 0-26|Unclassified|7|||
105763514|NCT00856986|364787141|FG001|Main Period, Weeks 0-26|Unclassified|6|||
105763515|NCT00856986|364787142|FG002|Main Period, Weeks 0-26|Unclassified|7|||
105763516|NCT00856986|364787143|FG003|Main Period, Weeks 0-26|Unclassified|0|||
105763517|NCT00856986|364787144|FG004|Main Period, Weeks 0-26|Unclassified|0|||
105763518|NCT00856986|364787140|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
105763519|NCT00856986|364787141|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
105763520|NCT00856986|364787142|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
105763521|NCT00856986|364787143|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
105763522|NCT00856986|364787144|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
105763523|NCT00856986|364787140|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
105763524|NCT00856986|364787141|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
105763525|NCT00856986|364787142|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
105763526|NCT00856986|364787143|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
105763527|NCT00856986|364787144|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
105763528|NCT00856986|364787140|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
105763529|NCT00856986|364787141|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
105763530|NCT00856986|364787142|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
105763531|NCT00856986|364787143|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
105763532|NCT00856986|364787144|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
105763533|NCT00856986|364787140|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
105763534|NCT00856986|364787141|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
105763535|NCT00856986|364787142|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
105763536|NCT00856986|364787143|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
105763537|NCT00856986|364787144|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
105763538|NCT00856986|364787140|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
105763539|NCT00856986|364787141|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
105763540|NCT00856986|364787142|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
105763541|NCT00856986|364787143|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
105763542|NCT00856986|364787144|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
105763543|NCT00856986|364787140|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
105763544|NCT00856986|364787141|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
105763545|NCT00856986|364787142|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
105763546|NCT00856986|364787143|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
105763547|NCT00856986|364787144|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
105763548|NCT05041062|364787147|FG000|Overall Study|Adverse Event|2|||
105763549|NCT02650895|364787148|FG000|Overall Study|Withdrawal by Subject|0|||
105763550|NCT02650895|364787149|FG001|Overall Study|Withdrawal by Subject|1|||
105763551|NCT02650895|364787150|FG002|Overall Study|Withdrawal by Subject|0|||
105763552|NCT02650895|364787151|FG003|Overall Study|Withdrawal by Subject|0|||
105763553|NCT02650895|364787152|FG004|Overall Study|Withdrawal by Subject|0|||
105763554|NCT02650895|364787153|FG005|Overall Study|Withdrawal by Subject|0|||
105763555|NCT03693404|364787167|FG000|Overall Study|Withdrawal by Subject|1|||
105813482|NCT03144687|364974673|FG001|Overall Study|Lost to Follow-up|1|||
105813483|NCT03144687|364974672|FG000|Overall Study|Physician Decision|0|||
105813484|NCT03144687|364974673|FG001|Overall Study|Physician Decision|1|||
105813485|NCT03144687|364974672|FG000|Overall Study|Withdrawal by Subject|1|||
105813486|NCT03144687|364974673|FG001|Overall Study|Withdrawal by Subject|3|||
105813487|NCT03144687|364974672|FG000|Overall Study|Not Reported|2|||
105813488|NCT03144687|364974673|FG001|Overall Study|Not Reported|0|||
105813489|NCT00683293|364974676|FG000|Overall Study|Withdrawal by Subject|2|||
105813490|NCT00683293|364974677|FG001|Overall Study|Withdrawal by Subject|3|||
105813491|NCT01104662|364974678|FG000|Overall Study|Adverse Event|2|||
105813492|NCT01104662|364974679|FG001|Overall Study|Adverse Event|2|||
105813493|NCT01104662|364974680|FG002|Overall Study|Adverse Event|0|||
105813494|NCT01104662|364974681|FG003|Overall Study|Adverse Event|1|||
105813495|NCT01104662|364974682|FG004|Overall Study|Adverse Event|1|||
105813496|NCT01104662|364974683|FG005|Overall Study|Adverse Event|1|||
105813497|NCT01104662|364974684|FG006|Overall Study|Adverse Event|0|||
105813498|NCT01104662|364974685|FG007|Overall Study|Adverse Event|0|||
105813499|NCT01104662|364974678|FG000|Overall Study|Clinical Failure|1|||
105813500|NCT01104662|364974679|FG001|Overall Study|Clinical Failure|0|||
105813501|NCT01104662|364974680|FG002|Overall Study|Clinical Failure|0|||
105813502|NCT01104662|364974681|FG003|Overall Study|Clinical Failure|0|||
105813503|NCT01104662|364974682|FG004|Overall Study|Clinical Failure|0|||
105813504|NCT01104662|364974683|FG005|Overall Study|Clinical Failure|1|||
105813505|NCT01104662|364974684|FG006|Overall Study|Clinical Failure|0|||
105813506|NCT01104662|364974685|FG007|Overall Study|Clinical Failure|0|||
105813507|NCT01104662|364974678|FG000|Overall Study|Participant left investigator's care|1|||
105813508|NCT01104662|364974679|FG001|Overall Study|Participant left investigator's care|1|||
105813509|NCT01104662|364974680|FG002|Overall Study|Participant left investigator's care|0|||
105813510|NCT01104662|364974681|FG003|Overall Study|Participant left investigator's care|0|||
105813511|NCT01104662|364974682|FG004|Overall Study|Participant left investigator's care|0|||
105813512|NCT01104662|364974683|FG005|Overall Study|Participant left investigator's care|0|||
105813513|NCT01104662|364974684|FG006|Overall Study|Participant left investigator's care|0|||
105813514|NCT01104662|364974685|FG007|Overall Study|Participant left investigator's care|0|||
105813515|NCT01104662|364974678|FG000|Overall Study|Reason not specified|3|||
105813516|NCT01104662|364974679|FG001|Overall Study|Reason not specified|3|||
105813517|NCT01104662|364974680|FG002|Overall Study|Reason not specified|0|||
105813518|NCT01104662|364974681|FG003|Overall Study|Reason not specified|0|||
105813519|NCT01104662|364974682|FG004|Overall Study|Reason not specified|0|||
105813520|NCT01104662|364974683|FG005|Overall Study|Reason not specified|1|||
105813521|NCT01104662|364974684|FG006|Overall Study|Reason not specified|0|||
105813522|NCT01104662|364974685|FG007|Overall Study|Reason not specified|0|||
105813523|NCT01104662|364974678|FG000|Overall Study|Randomized but not treated|3|||
105813524|NCT01104662|364974679|FG001|Overall Study|Randomized but not treated|4|||
105813525|NCT01104662|364974680|FG002|Overall Study|Randomized but not treated|1|||
105813526|NCT01104662|364974681|FG003|Overall Study|Randomized but not treated|0|||
105813527|NCT01104662|364974682|FG004|Overall Study|Randomized but not treated|0|||
105813528|NCT01104662|364974683|FG005|Overall Study|Randomized but not treated|1|||
105813529|NCT01104662|364974684|FG006|Overall Study|Randomized but not treated|0|||
105813530|NCT01104662|364974685|FG007|Overall Study|Randomized but not treated|0|||
105486096|NCT03422627|363791400|FG001|Overall Study|Adverse Event|1|||
105813531|NCT00743197|364974686|FG000|Overall Study|Study terminated due to departure of PI.|1|||
105813532|NCT00743197|364974687|FG001|Overall Study|Study terminated due to departure of PI.|2|||
105813533|NCT01469546|364974688|FG000|Received 5 mg Dose|Adverse Event|13|||
105813534|NCT01469546|364974688|FG000|Received 5 mg Dose|Death|2|||
105813535|NCT01469546|364974688|FG000|Received 5 mg Dose|Protocol Violation|2|||
105486097|NCT03422627|363791401|FG002|Overall Study|Adverse Event|0|||
105813536|NCT01469546|364974688|FG000|Received 5 mg Dose|Progressive Disease|3|||
105813537|NCT01469546|364974688|FG000|Received 5 mg Dose|Physician Decision|3|||
105486098|NCT03422627|363791402|FG003|Overall Study|Adverse Event|0|||
105486099|NCT03422627|363791403|FG004|Overall Study|Adverse Event|2|||
105486100|NCT03422627|363791399|FG000|Overall Study|Ineligibility Determined|0|||
105486101|NCT03422627|363791400|FG001|Overall Study|Ineligibility Determined|1|||
105813538|NCT02888171|364974693|FG000|Overall Study|Lost to Follow-up|2|||
105813539|NCT02888171|364974694|FG001|Overall Study|Lost to Follow-up|1|||
105813540|NCT02888171|364974693|FG000|Overall Study|Withdrawal by Subject|3|||
105813541|NCT02888171|364974694|FG001|Overall Study|Withdrawal by Subject|2|||
105813542|NCT02888171|364974693|FG000|Overall Study|Adverse Event|0|||
105813543|NCT02888171|364974694|FG001|Overall Study|Adverse Event|1|||
105813544|NCT04529109|364974695|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
105813545|NCT04529109|364974696|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
105813546|NCT02801877|364974697|FG000|Overall Study|Lost to Follow-up|1|||
105813547|NCT02801877|364974698|FG001|Overall Study|Lost to Follow-up|1|||
105813548|NCT02801877|364974699|FG002|Overall Study|Lost to Follow-up|2|||
105813549|NCT02801877|364974700|FG003|Overall Study|Lost to Follow-up|0|||
105813550|NCT02801877|364974697|FG000|Overall Study|Never Started Treatment|2|||
105813551|NCT02801877|364974698|FG001|Overall Study|Never Started Treatment|0|||
105813552|NCT02801877|364974699|FG002|Overall Study|Never Started Treatment|4|||
105813553|NCT02801877|364974700|FG003|Overall Study|Never Started Treatment|0|||
105813554|NCT02424188|364975988|FG000|Overall Study|Death|2|||
105813555|NCT02424188|364975989|FG001|Overall Study|Death|2|||
105813556|NCT02424188|364975988|FG000|Overall Study|Lost to Follow-up|1|||
105813557|NCT02424188|364975989|FG001|Overall Study|Lost to Follow-up|3|||
105813558|NCT02424188|364975988|FG000|Overall Study|Incarceration|1|||
105813559|NCT02424188|364975989|FG001|Overall Study|Incarceration|0|||
105813560|NCT00863746|364975990|FG000|Treatment|Not treated|4|||
105813561|NCT00863746|364975991|FG001|Treatment|Not treated|2|||
105813562|NCT00863746|364975990|FG000|Treatment|Adverse Event|41|||
105813563|NCT00863746|364975991|FG001|Treatment|Adverse Event|16|||
105813564|NCT00863746|364975990|FG000|Treatment|non-compliant with study medication|4|||
105813565|NCT00863746|364975991|FG001|Treatment|non-compliant with study medication|0|||
105813566|NCT00863746|364975990|FG000|Treatment|Consent withdrawn|15|||
105813567|NCT00863746|364975991|FG001|Treatment|Consent withdrawn|14|||
105813568|NCT00863746|364975990|FG000|Treatment|Lost to Follow-up|1|||
105813569|NCT00863746|364975991|FG001|Treatment|Lost to Follow-up|0|||
105813570|NCT00863746|364975990|FG000|Treatment|Protocol Violation|5|||
105362012|NCT02326272|363330146|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105813571|NCT00863746|364975991|FG001|Treatment|Protocol Violation|3|||
105813572|NCT00863746|364975990|FG000|Treatment|Other|1|||
105813573|NCT00863746|364975991|FG001|Treatment|Other|0|||
105813574|NCT00863746|364975990|FG000|Survival Follow up|Death|244|||
105813575|NCT00863746|364975991|FG001|Survival Follow up|Death|271|||
105813576|NCT00863746|364975990|FG000|Survival Follow up|Lost to Follow-up|2|||
105813577|NCT00863746|364975991|FG001|Survival Follow up|Lost to Follow-up|1|||
105813578|NCT00863746|364975990|FG000|Survival Follow up|Consent Withdrawn|7|||
105813579|NCT00863746|364975991|FG001|Survival Follow up|Consent Withdrawn|8|||
105813580|NCT03292653|364975992|FG000|Overall Study|Adverse Event|0|||
105813581|NCT03292653|364975993|FG001|Overall Study|Adverse Event|0|||
105813582|NCT03292653|364975994|FG002|Overall Study|Adverse Event|1|||
105813583|NCT03292653|364975992|FG000|Overall Study|Did not Receive Treatment|1|||
105813584|NCT03292653|364975993|FG001|Overall Study|Did not Receive Treatment|0|||
105813585|NCT03292653|364975994|FG002|Overall Study|Did not Receive Treatment|0|||
105813586|NCT05628675|364975995|FG000|Overall Study|Lost to Follow-up|2|||
105813587|NCT05628675|364975995|FG000|Overall Study|Withdrawal by Subject|1|||
105813588|NCT05818137|364975996|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
105813589|NCT05818137|364975996|FG000|Extension Treatment Period|Ongoing participants|44|||
105813590|NCT02497781|364976006|FG000|Overall Study|Withdrawal by Subject|2|||
105813591|NCT02497781|364976007|FG001|Overall Study|Withdrawal by Subject|0|||
105813592|NCT02497781|364976006|FG000|Overall Study|Lack of Efficacy|0|||
105813593|NCT02497781|364976007|FG001|Overall Study|Lack of Efficacy|1|||
105813594|NCT02497781|364976006|FG000|Overall Study|Randomised but not treated|1|||
105813595|NCT02497781|364976007|FG001|Overall Study|Randomised but not treated|1|||
105813596|NCT02497781|364976006|FG000|Overall Study|Lost to Follow-up|1|||
105813597|NCT02497781|364976007|FG001|Overall Study|Lost to Follow-up|1|||
105813598|NCT01249664|364976008|FG000|Overall Study|Withdrawal by Subject|5|||
105813599|NCT01249664|364976009|FG001|Overall Study|Withdrawal by Subject|0|||
105813600|NCT01249664|364976008|FG000|Overall Study|Adverse Event|1|||
105813601|NCT01249664|364976009|FG001|Overall Study|Adverse Event|0|||
105813602|NCT01400113|364976010|FG000|Overall Study|Withdrawal by Subject|1|||
105813603|NCT01400113|364976011|FG001|Overall Study|Withdrawal by Subject|1|||
105813604|NCT00806156|364976014|FG000|Overall Study|Death|35|||
105813605|NCT00806156|364976015|FG001|Overall Study|Death|95|||
105813606|NCT00806156|364976014|FG000|Overall Study|Did not meet eligibility criteria|1|||
105813607|NCT00806156|364976015|FG001|Overall Study|Did not meet eligibility criteria|0|||
105813608|NCT00806156|364976014|FG000|Overall Study|Study terminated by Sponsor|2|||
105813609|NCT00806156|364976015|FG001|Overall Study|Study terminated by Sponsor|40|||
105813610|NCT00806156|364976014|FG000|Overall Study|Consent withdrawn by subject|1|||
105813611|NCT00806156|364976015|FG001|Overall Study|Consent withdrawn by subject|3|||
105813612|NCT00806156|364976014|FG000|Overall Study|Lost to Follow-up|0|||
105813613|NCT00806156|364976015|FG001|Overall Study|Lost to Follow-up|1|||
105813614|NCT01025037|364976020|FG000|Overall Study|Adverse Event|3|||
105813615|NCT01025037|364976020|FG000|Overall Study|Lost to Follow-up|7|||
105813616|NCT01025037|364976020|FG000|Overall Study|Withdrawal by Subject|1|||
105813617|NCT02192099|364976025|FG000|Overall Study|Adverse Event|1|||
105813618|NCT02192099|364976025|FG000|Overall Study|Lost to Follow-up|2|||
105813619|NCT02192099|364976025|FG000|Overall Study|Physician Decision|1|||
105813620|NCT02192099|364976025|FG000|Overall Study|Pregnancy|1|||
105813621|NCT02192099|364976025|FG000|Overall Study|Protocol Violation|8|||
105813622|NCT02192099|364976025|FG000|Overall Study|Study Terminated by Sponsor|32|||
105813623|NCT02192099|364976025|FG000|Overall Study|Withdrawal by Subject|11|||
105813624|NCT02192099|364976025|FG000|Overall Study|Miscellaneous Reasons|5|||
105813625|NCT03247556|364976028|FG000|Overall Study|Adverse Event|1|||
105813626|NCT03247556|364976029|FG001|Overall Study|Adverse Event|4|||
105813627|NCT03247556|364976030|FG002|Overall Study|Adverse Event|5|||
105813628|NCT03247556|364976028|FG000|Overall Study|Lost to Follow-up|5|||
105813629|NCT03247556|364976029|FG001|Overall Study|Lost to Follow-up|5|||
105813630|NCT03247556|364976030|FG002|Overall Study|Lost to Follow-up|4|||
105813631|NCT03247556|364976028|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
105813632|NCT03247556|364976029|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
105813633|NCT03247556|364976030|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
105813634|NCT03247556|364976028|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
105813635|NCT03247556|364976029|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
105813636|NCT03247556|364976030|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
105813637|NCT03247556|364976028|FG000|Overall Study|Protocol Violation|2|||
105813638|NCT03247556|364976029|FG001|Overall Study|Protocol Violation|0|||
105813639|NCT03247556|364976030|FG002|Overall Study|Protocol Violation|1|||
105813640|NCT03247556|364976028|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
105813641|NCT03247556|364976029|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
105813642|NCT03247556|364976030|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
105813643|NCT01856309|364976042|FG000|Overall Study|Death|4|||
105813644|NCT01856309|364976043|FG001|Overall Study|Death|6|||
105813645|NCT01856309|364976044|FG002|Overall Study|Death|11|||
105813646|NCT01856309|364976045|FG003|Overall Study|Death|6|||
105813647|NCT01856309|364976042|FG000|Overall Study|Lost to Follow-up|6|||
105813648|NCT01856309|364976043|FG001|Overall Study|Lost to Follow-up|2|||
105813649|NCT01856309|364976044|FG002|Overall Study|Lost to Follow-up|4|||
105813650|NCT01856309|364976045|FG003|Overall Study|Lost to Follow-up|8|||
105813651|NCT01856309|364976042|FG000|Overall Study|Withdrawal by Subject|11|||
105813652|NCT01856309|364976043|FG001|Overall Study|Withdrawal by Subject|13|||
105813653|NCT01856309|364976044|FG002|Overall Study|Withdrawal by Subject|28|||
105813654|NCT01856309|364976045|FG003|Overall Study|Withdrawal by Subject|26|||
105813655|NCT01856309|364976042|FG000|Overall Study|Other|227|||
105813656|NCT01856309|364976043|FG001|Overall Study|Other|225|||
105813657|NCT01856309|364976044|FG002|Overall Study|Other|447|||
105813658|NCT01856309|364976045|FG003|Overall Study|Other|469|||
105813659|NCT01856309|364976042|FG000|Overall Study|Lack of Efficacy|14|||
105813660|NCT01856309|364976043|FG001|Overall Study|Lack of Efficacy|9|||
105813661|NCT01856309|364976044|FG002|Overall Study|Lack of Efficacy|40|||
105813662|NCT01856309|364976045|FG003|Overall Study|Lack of Efficacy|25|||
105813663|NCT01856309|364976042|FG000|Overall Study|Adverse Event|31|||
105813664|NCT01856309|364976043|FG001|Overall Study|Adverse Event|31|||
105813665|NCT01856309|364976044|FG002|Overall Study|Adverse Event|55|||
105813666|NCT01856309|364976045|FG003|Overall Study|Adverse Event|65|||
105813667|NCT01856309|364976042|FG000|Overall Study|Pregnancy|0|||
105813668|NCT01856309|364976043|FG001|Overall Study|Pregnancy|0|||
105813669|NCT01856309|364976044|FG002|Overall Study|Pregnancy|0|||
105813670|NCT01856309|364976045|FG003|Overall Study|Pregnancy|1|||
105813671|NCT01856309|364976042|FG000|Overall Study|Physician Decision|6|||
105813672|NCT01856309|364976043|FG001|Overall Study|Physician Decision|1|||
105813673|NCT01856309|364976044|FG002|Overall Study|Physician Decision|6|||
105813674|NCT01856309|364976045|FG003|Overall Study|Physician Decision|8|||
105813675|NCT01856309|364976042|FG000|Overall Study|Noncompliance With Study Drug|0|||
105813676|NCT01856309|364976043|FG001|Overall Study|Noncompliance With Study Drug|1|||
105813677|NCT01856309|364976044|FG002|Overall Study|Noncompliance With Study Drug|4|||
105813678|NCT01856309|364976045|FG003|Overall Study|Noncompliance With Study Drug|1|||
105813679|NCT01273181|364976048|FG000|Phase I, Dose 1|Study termination|1|||
105813680|NCT01273181|364976049|FG001|Phase I, Dose 1|Study termination|0|||
105813681|NCT01273181|364976050|FG002|Phase I, Dose 1|Study termination|0|||
105813682|NCT01273181|364976051|FG003|Phase I, Dose 1|Study termination|0|||
105813683|NCT01273181|364976048|FG000|Phase I, Dose 2|Death during treatment|0|||
105813684|NCT01273181|364976049|FG001|Phase I, Dose 2|Death during treatment|1|||
105813685|NCT01273181|364976050|FG002|Phase I, Dose 2|Death during treatment|0|||
105813686|NCT01273181|364976051|FG003|Phase I, Dose 2|Death during treatment|0|||
105813687|NCT01273181|364976048|FG000|Phase 2, Dose 1|Study termination|0|||
105813688|NCT01273181|364976049|FG001|Phase 2, Dose 1|Study termination|0|||
105813689|NCT01273181|364976050|FG002|Phase 2, Dose 1|Study termination|1|||
105813690|NCT01273181|364976051|FG003|Phase 2, Dose 1|Study termination|0|||
105813691|NCT01273181|364976048|FG000|Phase 2, Dose 2|Death during treatment|0|||
105813692|NCT01273181|364976049|FG001|Phase 2, Dose 2|Death during treatment|0|||
105813693|NCT01273181|364976050|FG002|Phase 2, Dose 2|Death during treatment|0|||
105813694|NCT01273181|364976051|FG003|Phase 2, Dose 2|Death during treatment|1|||
105813695|NCT00337077|364976052|FG000|Overall Study|Progressive disease|25|||
105813696|NCT00337077|364976053|FG001|Overall Study|Progressive disease|37|||
105813697|NCT00337077|364976054|FG002|Overall Study|Progressive disease|19|||
105813698|NCT00337077|364976052|FG000|Overall Study|Adverse Event|7|||
105813699|NCT00337077|364976053|FG001|Overall Study|Adverse Event|7|||
105813700|NCT00337077|364976054|FG002|Overall Study|Adverse Event|1|||
105813701|NCT00337077|364976052|FG000|Overall Study|Death|0|||
105813702|NCT00337077|364976053|FG001|Overall Study|Death|1|||
105813703|NCT00337077|364976054|FG002|Overall Study|Death|0|||
105813704|NCT00337077|364976052|FG000|Overall Study|Withdrawal by Subject|7|||
105813705|NCT00337077|364976053|FG001|Overall Study|Withdrawal by Subject|2|||
105813706|NCT00337077|364976054|FG002|Overall Study|Withdrawal by Subject|2|||
105813707|NCT00337077|364976052|FG000|Overall Study|Alternative therapy|1|||
105813708|NCT00337077|364976053|FG001|Overall Study|Alternative therapy|0|||
105813709|NCT00337077|364976054|FG002|Overall Study|Alternative therapy|0|||
105813710|NCT00337077|364976052|FG000|Overall Study|Physician Decision|1|||
105813711|NCT00337077|364976053|FG001|Overall Study|Physician Decision|4|||
105813712|NCT00337077|364976054|FG002|Overall Study|Physician Decision|2|||
105813713|NCT00337077|364976052|FG000|Overall Study|Never started treatment|1|||
105813714|NCT00337077|364976053|FG001|Overall Study|Never started treatment|1|||
105813715|NCT00337077|364976054|FG002|Overall Study|Never started treatment|0|||
105813716|NCT00337077|364976052|FG000|Overall Study|Ineligible|1|||
105813717|NCT00337077|364976053|FG001|Overall Study|Ineligible|1|||
105813718|NCT00337077|364976054|FG002|Overall Study|Ineligible|1|||
105813719|NCT00944697|364976055|FG000|Overall Study|Withdrawal by Subject|1|||
105813720|NCT00944697|364976056|FG001|Overall Study|Withdrawal by Subject|1|||
105813721|NCT00944697|364976055|FG000|Overall Study|Adverse Event|0|||
105813722|NCT00944697|364976056|FG001|Overall Study|Adverse Event|3|||
105813723|NCT00944697|364976055|FG000|Overall Study|Administrative|1|||
105813724|NCT00944697|364976056|FG001|Overall Study|Administrative|1|||
105813725|NCT03657160|364976061|FG000|Overall Study|Adverse Event|5|||
105813726|NCT03657160|364976062|FG001|Overall Study|Adverse Event|6|||
105813727|NCT03657160|364976061|FG000|Overall Study|Protocol Deviation|3|||
105813728|NCT03657160|364976062|FG001|Overall Study|Protocol Deviation|0|||
105813729|NCT03657160|364976061|FG000|Overall Study|Withdrawal by Subject|18|||
105813730|NCT03657160|364976062|FG001|Overall Study|Withdrawal by Subject|16|||
105813731|NCT03657160|364976061|FG000|Overall Study|Site Termination|1|||
105813732|NCT03657160|364976062|FG001|Overall Study|Site Termination|0|||
105813733|NCT03657160|364976061|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
105813734|NCT03657160|364976062|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
105813735|NCT03657160|364976061|FG000|Overall Study|Death|33|||
105813736|NCT03657160|364976062|FG001|Overall Study|Death|26|||
105362013|NCT02326272|363330147|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105813737|NCT03657160|364976061|FG000|Overall Study|Death (COVID-19-Related)|1|||
105813738|NCT03657160|364976062|FG001|Overall Study|Death (COVID-19-Related)|0|||
105813739|NCT03657160|364976061|FG000|Overall Study|Reason Not Specified|5|||
105813740|NCT03657160|364976062|FG001|Overall Study|Reason Not Specified|5|||
105362014|NCT02326272|363330148|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
105362015|NCT02326272|363330149|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
105571549|NCT00747123|364091236|FG001|Overall Study|Adverse Event|1|||
105813741|NCT03657160|364976061|FG000|Overall Study|Other (COVID-19-Related)|0|||
105813742|NCT03657160|364976062|FG001|Overall Study|Other (COVID-19-Related)|1|||
105813743|NCT00604500|364976063|FG000|Overall Study|Adverse Event|2|||
105813744|NCT00604500|364976063|FG000|Overall Study|Protocol Violation|2|||
105813745|NCT00604500|364976063|FG000|Overall Study|Treatment Failure|1|||
105813746|NCT00604500|364976063|FG000|Overall Study|Withdrawal by Subject|4|||
105813747|NCT00604500|364976063|FG000|Overall Study|Administrative|1|||
105813748|NCT00604500|364976063|FG000|Overall Study|Did not meet protocol eligibility|1|||
105813749|NCT00320112|364976064|FG000|Overall Study|Lost to Follow-up|3|||
105813750|NCT00320112|364976065|FG001|Overall Study|Lost to Follow-up|4|||
105813751|NCT00320112|364976064|FG000|Overall Study|Withdrawal by Subject|3|||
105813752|NCT00320112|364976065|FG001|Overall Study|Withdrawal by Subject|0|||
105813753|NCT00320112|364976064|FG000|Overall Study|Death|2|||
105813754|NCT00320112|364976065|FG001|Overall Study|Death|1|||
105813755|NCT02191891|364976066|FG000|Overall Study|Withdrawal by Subject|0|||
105813756|NCT02191891|364976067|FG001|Overall Study|Withdrawal by Subject|1|||
105813757|NCT02191891|364976068|FG002|Overall Study|Withdrawal by Subject|0|||
105813758|NCT02191891|364976069|FG003|Overall Study|Withdrawal by Subject|0|||
105813759|NCT02191891|364976070|FG004|Overall Study|Withdrawal by Subject|1|||
105813760|NCT02191891|364976066|FG000|Overall Study|Adverse Event|0|||
105813761|NCT02191891|364976067|FG001|Overall Study|Adverse Event|1|||
105813762|NCT02191891|364976068|FG002|Overall Study|Adverse Event|0|||
105813763|NCT02191891|364976069|FG003|Overall Study|Adverse Event|0|||
105813764|NCT02191891|364976070|FG004|Overall Study|Adverse Event|2|||
105813765|NCT02191891|364976066|FG000|Overall Study|Disease Progression|4|||
105813766|NCT02191891|364976067|FG001|Overall Study|Disease Progression|10|||
105813767|NCT02191891|364976068|FG002|Overall Study|Disease Progression|4|||
105813768|NCT02191891|364976069|FG003|Overall Study|Disease Progression|2|||
105813769|NCT02191891|364976070|FG004|Overall Study|Disease Progression|7|||
105813770|NCT04006171|364976071|FG000|Overall Study|Withdrawal by Subject|8|||
105813771|NCT04006171|364976072|FG001|Overall Study|Withdrawal by Subject|7|||
105813772|NCT04006171|364976071|FG000|Overall Study|missing serum samples|2|||
105813773|NCT04006171|364976072|FG001|Overall Study|missing serum samples|2|||
105813774|NCT04006171|364976071|FG000|Overall Study|insufficient sample volume|2|||
105813775|NCT04006171|364976072|FG001|Overall Study|insufficient sample volume|3|||
105813776|NCT01448057|364976073|FG000|Overall Study|Protocol Violation|3|||
105813777|NCT01448057|364976074|FG001|Overall Study|Protocol Violation|2|||
105813778|NCT01448057|364976073|FG000|Overall Study|Lost to Follow-up|3|||
105813779|NCT01448057|364976074|FG001|Overall Study|Lost to Follow-up|0|||
105813780|NCT01448057|364976073|FG000|Overall Study|Adverse Event|0|||
105813781|NCT01448057|364976074|FG001|Overall Study|Adverse Event|2|||
105813782|NCT01448057|364976073|FG000|Overall Study|Withdrawal by Subject|2|||
105813783|NCT01448057|364976074|FG001|Overall Study|Withdrawal by Subject|0|||
105813784|NCT00486837|364976076|FG000|Overall Study|Withdrawal by Subject|1|||
105813785|NCT00486837|364976077|FG001|Overall Study|Withdrawal by Subject|0|||
105813786|NCT00486837|364976076|FG000|Overall Study|Adverse Event|1|||
105813787|NCT00486837|364976077|FG001|Overall Study|Adverse Event|1|||
105813788|NCT00486837|364976076|FG000|Overall Study|Protocol Violation|4|||
105813789|NCT00486837|364976077|FG001|Overall Study|Protocol Violation|2|||
105813790|NCT00486837|364976076|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
105813791|NCT00486837|364976077|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
105813792|NCT00414765|364976078|FG000|Overall Study|Adverse Event|5|||
105813793|NCT00414765|364976079|FG001|Overall Study|Adverse Event|9|||
105813794|NCT00414765|364976078|FG000|Overall Study|Withdrawal by Subject|1|||
105813795|NCT00414765|364976079|FG001|Overall Study|Withdrawal by Subject|1|||
105813796|NCT00414765|364976078|FG000|Overall Study|Disease Progression|0|||
105571550|NCT00747123|364091237|FG002|Overall Study|Adverse Event|0|||
105813797|NCT00414765|364976079|FG001|Overall Study|Disease Progression|1|||
105813798|NCT03130699|364976080|FG000|Overall Study|Lost to Follow-up|34|||
105813799|NCT03130699|364976081|FG001|Overall Study|Lost to Follow-up|37|||
105813800|NCT03130699|364976082|FG002|Overall Study|Lost to Follow-up|26|||
105813801|NCT03130699|364976080|FG000|Overall Study|Withdrawal by Subject|5|||
105813802|NCT03130699|364976081|FG001|Overall Study|Withdrawal by Subject|1|||
105813803|NCT03130699|364976082|FG002|Overall Study|Withdrawal by Subject|0|||
105813804|NCT03130699|364976080|FG000|Overall Study|Withdrawal by PI|1|||
105813805|NCT03130699|364976081|FG001|Overall Study|Withdrawal by PI|2|||
105813806|NCT03130699|364976082|FG002|Overall Study|Withdrawal by PI|5|||
105763556|NCT03693404|364787168|FG001|Overall Study|Withdrawal by Subject|0|||
105813807|NCT03130699|364976080|FG000|Overall Study|Death|0|||
105813808|NCT03130699|364976081|FG001|Overall Study|Death|0|||
105813809|NCT03130699|364976082|FG002|Overall Study|Death|1|||
105813810|NCT04977336|364976085|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
105813811|NCT04977336|364976086|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
105813812|NCT04977336|364976087|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
105813813|NCT04977336|364976088|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
105813814|NCT04977336|364976089|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
105813815|NCT04977336|364976085|FG000|Overall Study|Lost to Follow-up|0|||
105813816|NCT04977336|364976086|FG001|Overall Study|Lost to Follow-up|0|||
105763557|NCT03693404|364787167|FG000|Overall Study|Lost to Follow-up|0|||
105763558|NCT03693404|364787168|FG001|Overall Study|Lost to Follow-up|5|||
105763559|NCT03693404|364787167|FG000|Overall Study|Excluded from Analysis|0|||
105763560|NCT03693404|364787168|FG001|Overall Study|Excluded from Analysis|1|||
105763561|NCT01802515|364787169|FG000|Overall Study|Withdrawal by Subject|3|||
105763562|NCT01802515|364787170|FG001|Overall Study|Withdrawal by Subject|0|||
105763563|NCT01802515|364787171|FG002|Overall Study|Withdrawal by Subject|0|||
105763564|NCT01906476|364787174|FG000|Overall Study|Lost to Follow-up|17|||
105813817|NCT04977336|364976087|FG002|Overall Study|Lost to Follow-up|1|||
105813818|NCT04977336|364976088|FG003|Overall Study|Lost to Follow-up|0|||
105813819|NCT04977336|364976089|FG004|Overall Study|Lost to Follow-up|0|||
105813820|NCT01004172|364976090|FG000|Overall Study|Progressive Disease in CNS Only|16|||
105813821|NCT01004172|364976090|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
105813822|NCT01004172|364976090|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
105813823|NCT01004172|364976090|FG000|Overall Study|Adverse Event|1|||
105813824|NCT01004172|364976090|FG000|Overall Study|Physician Decision|1|||
105813825|NCT01004172|364976090|FG000|Overall Study|Symptomatic Deterioration|2|||
105813826|NCT00950872|364976091|FG000|Overall Study|Withdrawal by Subject|1|||
105813827|NCT00950872|364976091|FG000|Overall Study|Did not have surgery|2|||
105813828|NCT00352690|364976093|FG000|Overall Study|Determined to be ineligible|2|||
105813829|NCT00352690|364976094|FG001|Overall Study|Determined to be ineligible|0|||
105813830|NCT01378975|364976095|FG000|Overall Study|Death|77|||
105813831|NCT01378975|364976096|FG001|Overall Study|Death|46|||
105813832|NCT01378975|364976095|FG000|Overall Study|Investigator Request|1|||
105813833|NCT01378975|364976096|FG001|Overall Study|Investigator Request|0|||
105813834|NCT01378975|364976095|FG000|Overall Study|Lost to Follow-up|4|||
105813835|NCT01378975|364976096|FG001|Overall Study|Lost to Follow-up|1|||
105813836|NCT01378975|364976095|FG000|Overall Study|Withdrew Consent|4|||
105813837|NCT01378975|364976096|FG001|Overall Study|Withdrew Consent|3|||
105813838|NCT01030965|364976098|FG000|Overall Study|Lack of Efficacy|3|||
105813839|NCT01030965|364976099|FG001|Overall Study|Lack of Efficacy|2|||
105813840|NCT01030965|364976100|FG002|Overall Study|Lack of Efficacy|0|||
105813841|NCT01030965|364976101|FG003|Overall Study|Lack of Efficacy|3|||
105813842|NCT01030965|364976098|FG000|Overall Study|Protocol Violation|1|||
105813843|NCT01030965|364976099|FG001|Overall Study|Protocol Violation|1|||
105813844|NCT01030965|364976100|FG002|Overall Study|Protocol Violation|1|||
105813845|NCT01030965|364976101|FG003|Overall Study|Protocol Violation|1|||
105813846|NCT01030965|364976098|FG000|Overall Study|Adverse Event|0|||
105813847|NCT01030965|364976099|FG001|Overall Study|Adverse Event|1|||
105813848|NCT01030965|364976100|FG002|Overall Study|Adverse Event|2|||
105813849|NCT01030965|364976101|FG003|Overall Study|Adverse Event|1|||
105813850|NCT01030965|364976098|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
105813851|NCT01030965|364976099|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
105813852|NCT01030965|364976100|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
105813853|NCT01030965|364976101|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
105813854|NCT01030965|364976098|FG000|Overall Study|Withdrawal by Subject|0|||
105813855|NCT01030965|364976099|FG001|Overall Study|Withdrawal by Subject|1|||
105813856|NCT01030965|364976100|FG002|Overall Study|Withdrawal by Subject|0|||
105813857|NCT01030965|364976101|FG003|Overall Study|Withdrawal by Subject|2|||
105813858|NCT02097290|364976102|FG000|Overall Study|Death|6|||
105813859|NCT02097290|364976102|FG000|Overall Study|Total Withdrawals|3|||
105813860|NCT02097290|364976102|FG000|Overall Study|Attempt|8|||
105813861|NCT04803357|364976105|FG000|Overall Study|Withdrawal by Subject|31|||
105813862|NCT04803357|364976106|FG001|Overall Study|Withdrawal by Subject|5|||
105813863|NCT00694551|364976107|FG000|Overall Study|Disease Progression|1|||
105813864|NCT00694551|364976108|FG001|Overall Study|Disease Progression|0|||
105813865|NCT00694551|364976109|FG002|Overall Study|Disease Progression|1|||
105813866|NCT01658943|364976110|FG000|Overall Study|Adverse Event|6|||
105813867|NCT01658943|364976111|FG001|Overall Study|Adverse Event|13|||
105813868|NCT01658943|364976110|FG000|Overall Study|Withdrawal by Subject|9|||
105813869|NCT01658943|364976111|FG001|Overall Study|Withdrawal by Subject|2|||
105813870|NCT01658943|364976110|FG000|Overall Study|Progression/Relapse|39|||
105813871|NCT01658943|364976111|FG001|Overall Study|Progression/Relapse|40|||
105813872|NCT01658943|364976110|FG000|Overall Study|Death|4|||
105813873|NCT01658943|364976111|FG001|Overall Study|Death|2|||
105813874|NCT01658943|364976110|FG000|Overall Study|not protocol specified|4|||
105813875|NCT01658943|364976111|FG001|Overall Study|not protocol specified|1|||
105486102|NCT03422627|363791401|FG002|Overall Study|Ineligibility Determined|0|||
105486103|NCT03422627|363791402|FG003|Overall Study|Ineligibility Determined|0|||
105813876|NCT01658943|364976110|FG000|Overall Study|Not eligible|7|||
105486104|NCT03422627|363791403|FG004|Overall Study|Ineligibility Determined|0|||
105813877|NCT01658943|364976111|FG001|Overall Study|Not eligible|9|||
105813878|NCT01658943|364976110|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
105813879|NCT01658943|364976111|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
105813880|NCT03544138|364976112|FG000|Overall Study|Lost to Follow-up|29|||
105813881|NCT03815942|364977744|FG000|Overall Study|Withdrawal by Subject|0|||
105813882|NCT03815942|364977745|FG001|Overall Study|Withdrawal by Subject|17|||
105813883|NCT03717064|364977746|FG000|Period 2|Adverse Event|1|||
105813884|NCT02841709|364977747|FG000|5th Intervention|Adverse Event|2|||
105813885|NCT02841709|364977748|FG001|5th Intervention|Adverse Event|0|||
105813886|NCT02841709|364977749|FG002|5th Intervention|Adverse Event|0|||
105813887|NCT02841709|364977750|FG003|5th Intervention|Adverse Event|0|||
105813888|NCT02841709|364977751|FG004|5th Intervention|Adverse Event|2|||
105813889|NCT01210001|364977752|FG000|Overall Study|Not treated|1|||
105813890|NCT01210001|364977753|FG001|Overall Study|Not treated|0|||
105813891|NCT01210001|364977754|FG002|Overall Study|Not treated|0|||
105813892|NCT01210001|364977752|FG000|Overall Study|Adverse Event|4|||
105813893|NCT01210001|364977753|FG001|Overall Study|Adverse Event|2|||
105486105|NCT03422627|363791399|FG000|Overall Study|Death|0|||
105813894|NCT01210001|364977754|FG002|Overall Study|Adverse Event|5|||
105813895|NCT01210001|364977752|FG000|Overall Study|Non compliant with protocol|2|||
105813896|NCT01210001|364977753|FG001|Overall Study|Non compliant with protocol|2|||
105813897|NCT01210001|364977754|FG002|Overall Study|Non compliant with protocol|3|||
105813898|NCT01210001|364977752|FG000|Overall Study|Lost to Follow-up|4|||
105813899|NCT01210001|364977753|FG001|Overall Study|Lost to Follow-up|3|||
105813900|NCT01210001|364977754|FG002|Overall Study|Lost to Follow-up|2|||
105486106|NCT03422627|363791400|FG001|Overall Study|Death|1|||
105486107|NCT03422627|363791401|FG002|Overall Study|Death|1|||
105486108|NCT03422627|363791402|FG003|Overall Study|Death|0|||
105813901|NCT01210001|364977752|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
105813902|NCT01210001|364977753|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
105486109|NCT03422627|363791403|FG004|Overall Study|Death|0|||
105486110|NCT03422627|363791399|FG000|Overall Study|Withdrawal by Subject|0|||
105813903|NCT01210001|364977754|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
105813904|NCT01210001|364977752|FG000|Overall Study|Other reason not defined above|2|||
105486111|NCT03422627|363791400|FG001|Overall Study|Withdrawal by Subject|0|||
105813905|NCT01210001|364977753|FG001|Overall Study|Other reason not defined above|2|||
105486112|NCT03422627|363791401|FG002|Overall Study|Withdrawal by Subject|0|||
105486113|NCT03422627|363791402|FG003|Overall Study|Withdrawal by Subject|1|||
105813906|NCT01210001|364977754|FG002|Overall Study|Other reason not defined above|1|||
105813907|NCT00788125|364977755|FG000|Overall Study|Death|6|||
105813908|NCT02684344|364977760|FG000|Overall Study|Withdrawal by Subject|0|||
105813909|NCT02684344|364977761|FG001|Overall Study|Withdrawal by Subject|1|||
105813910|NCT03480425|364977762|FG000|Overall Study|Force transducer technical failure|1|||
105813911|NCT01244126|364977763|FG000|Overall Study|Protocol Violation|3|||
105813912|NCT01244126|364977764|FG001|Overall Study|Protocol Violation|3|||
105813913|NCT01244126|364977765|FG002|Overall Study|Protocol Violation|9|||
105813914|NCT02473640|364977770|FG000|Treatment Period 1|Adverse Event|1|||
105813915|NCT02395822|364977773|FG000|Overall Study|Withdrawal by Subject|1|||
105813916|NCT02395822|364977773|FG000|Overall Study|Death|1|||
105813917|NCT02777528|364977774|FG000|Overall Study|Still in study|24|||
105813918|NCT02777528|364977775|FG001|Overall Study|Still in study|10|||
105813919|NCT02777528|364977776|FG002|Overall Study|Still in study|1|||
105813920|NCT02777528|364977774|FG000|Overall Study|Study Device Explanted|1|||
105813921|NCT02777528|364977775|FG001|Overall Study|Study Device Explanted|0|||
105813922|NCT02777528|364977776|FG002|Overall Study|Study Device Explanted|0|||
105813923|NCT02777528|364977774|FG000|Overall Study|Death|14|||
105813924|NCT02777528|364977775|FG001|Overall Study|Death|7|||
105813925|NCT02777528|364977776|FG002|Overall Study|Death|1|||
105813926|NCT02777528|364977774|FG000|Overall Study|Withdrawal by Subject|2|||
105813927|NCT02777528|364977775|FG001|Overall Study|Withdrawal by Subject|2|||
105813928|NCT02777528|364977776|FG002|Overall Study|Withdrawal by Subject|1|||
105813929|NCT02777528|364977774|FG000|Overall Study|Physician Decision|2|||
105813930|NCT02777528|364977775|FG001|Overall Study|Physician Decision|1|||
105813931|NCT02777528|364977776|FG002|Overall Study|Physician Decision|0|||
105813932|NCT02777528|364977774|FG000|Overall Study|Lost to Follow-up|2|||
105813933|NCT02777528|364977775|FG001|Overall Study|Lost to Follow-up|0|||
105813934|NCT02777528|364977776|FG002|Overall Study|Lost to Follow-up|0|||
105813935|NCT02777528|364977774|FG000|Overall Study|Discontinued due to Other|1|||
105813936|NCT02777528|364977775|FG001|Overall Study|Discontinued due to Other|0|||
105813937|NCT02777528|364977776|FG002|Overall Study|Discontinued due to Other|0|||
105813938|NCT00453362|364977779|FG000|Overall Study|Adverse Event|5|||
105486114|NCT03422627|363791403|FG004|Overall Study|Withdrawal by Subject|0|||
105486115|NCT03584373|363791406|FG000|Overall Study|Lost to Follow-up|7|||
105813939|NCT00453362|364977779|FG000|Overall Study|Death|7|||
105813940|NCT00453362|364977779|FG000|Overall Study|Physician Decision|2|||
105813941|NCT00453362|364977779|FG000|Overall Study|Withdrawal by Subject|3|||
105813942|NCT00453362|364977779|FG000|Overall Study|Progression of disease|56|||
105813943|NCT00453362|364977779|FG000|Overall Study|Screening Failure|14|||
105813944|NCT02127281|364977780|FG000|Overall Study|Lost to Follow-up|1|||
105813945|NCT02127281|364977781|FG001|Overall Study|Lost to Follow-up|0|||
105813946|NCT04885296|364977782|FG000|Period 1|Covid-19 Related|1|||
105813947|NCT04885296|364977783|FG001|Period 1|Covid-19 Related|0|||
105813948|NCT04885296|364977782|FG000|Period 1|Adverse Event|0|||
105813949|NCT04885296|364977783|FG001|Period 1|Adverse Event|1|||
105813950|NCT04885296|364977782|FG000|Period 1|Withdrawal by Subject|1|||
105813951|NCT04885296|364977783|FG001|Period 1|Withdrawal by Subject|1|||
105813952|NCT04885296|364977782|FG000|Period 1|Test Article No Longer Available|1|||
105813953|NCT04885296|364977783|FG001|Period 1|Test Article No Longer Available|0|||
105813954|NCT04885296|364977782|FG000|Period 1|Dispensed Study lens in Error|1|||
105813955|NCT04885296|364977783|FG001|Period 1|Dispensed Study lens in Error|0|||
105813956|NCT04885296|364977782|FG000|Period 1|Lost to Follow-up|1|||
105813957|NCT04885296|364977783|FG001|Period 1|Lost to Follow-up|0|||
105486116|NCT03584373|363791407|FG001|Overall Study|Lost to Follow-up|8|||
105486117|NCT01487577|363791408|FG000|Overall Study|Became ineligible after signing consent|1|||
105813958|NCT04885296|364977782|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
105813959|NCT04885296|364977783|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
105813960|NCT00862979|364977784|FG000|Overall Study|Adverse Event|6|||
105813961|NCT00862979|364977785|FG001|Overall Study|Adverse Event|3|||
105813962|NCT00862979|364977784|FG000|Overall Study|Protocol Violation|0|||
105813963|NCT00862979|364977785|FG001|Overall Study|Protocol Violation|1|||
105813964|NCT00862979|364977784|FG000|Overall Study|Patient withdrew consent|2|||
105813965|NCT00862979|364977785|FG001|Overall Study|Patient withdrew consent|1|||
105813966|NCT00862979|364977784|FG000|Overall Study|Administrative problems|0|||
105813967|NCT00862979|364977785|FG001|Overall Study|Administrative problems|1|||
105813968|NCT00862979|364977784|FG000|Overall Study|Death|0|||
105813969|NCT00862979|364977785|FG001|Overall Study|Death|1|||
105813970|NCT03100903|364977786|FG000|Overall Study|Withdrawal by Subject|0|||
105813971|NCT03100903|364977787|FG001|Overall Study|Withdrawal by Subject|0|||
105813972|NCT03100903|364977788|FG002|Overall Study|Withdrawal by Subject|1|||
105813973|NCT03127137|364977793|FG000|Overall Study|Requested sedation after consent|1|||
105813974|NCT03127137|364977794|FG001|Overall Study|Requested sedation after consent|0|||
105813975|NCT03127137|364977793|FG000|Overall Study|Malfunction in electronic data collection|1|||
105486118|NCT00708201|363791409|FG000|Overall Study|Adverse Event|4|||
105486119|NCT00708201|363791410|FG001|Overall Study|Adverse Event|4|||
105813976|NCT03127137|364977794|FG001|Overall Study|Malfunction in electronic data collection|0|||
105813977|NCT03127137|364977793|FG000|Overall Study|Post procedure testing could not be obtained|0|||
105813978|NCT03127137|364977794|FG001|Overall Study|Post procedure testing could not be obtained|1|||
105813979|NCT02460159|364977795|FG000|Overall Study|Adverse Event|4|||
105813980|NCT02460159|364977796|FG001|Overall Study|Adverse Event|1|||
105813981|NCT02460159|364977795|FG000|Overall Study|Withdrawal by Subject|2|||
105813982|NCT02460159|364977796|FG001|Overall Study|Withdrawal by Subject|0|||
105813983|NCT05518487|364977797|FG000|Overall Study|Withdrawal by Subject|3|||
105813984|NCT02194998|364977805|FG000|On-HCV Treatment|Did not pick up study medication|0|||
105813985|NCT02194998|364977806|FG001|On-HCV Treatment|Did not pick up study medication|1|||
105813986|NCT02194998|364977807|FG002|On-HCV Treatment|Did not pick up study medication|0|||
105813987|NCT02194998|364977808|FG003|On-HCV Treatment|Did not pick up study medication|0|||
105813988|NCT02194998|364977805|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
105813989|NCT02194998|364977806|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
105813990|NCT02194998|364977807|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
105813991|NCT02194998|364977808|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
105813992|NCT02236130|364977809|FG000|Overall Study|Lost to Follow-up|7|||
105813993|NCT02236130|364977810|FG001|Overall Study|Lost to Follow-up|12|||
105813994|NCT01626079|364977813|FG000|Overall Study|Death|167|||
105813995|NCT01626079|364977814|FG001|Overall Study|Death|192|||
105813996|NCT01626079|364977815|FG002|Overall Study|Death|39|||
105813997|NCT01626079|364977813|FG000|Overall Study|Withdrawal by Subject|23|||
105813998|NCT01626079|364977814|FG001|Overall Study|Withdrawal by Subject|37|||
105813999|NCT01626079|364977815|FG002|Overall Study|Withdrawal by Subject|5|||
105814000|NCT01626079|364977813|FG000|Overall Study|Lost to Follow-up|7|||
105814001|NCT01626079|364977814|FG001|Overall Study|Lost to Follow-up|4|||
105814002|NCT01626079|364977815|FG002|Overall Study|Lost to Follow-up|2|||
105814003|NCT01626079|364977813|FG000|Overall Study|Missed Visits|1|||
105814004|NCT01626079|364977814|FG001|Overall Study|Missed Visits|4|||
105814005|NCT01626079|364977815|FG002|Overall Study|Missed Visits|6|||
105814006|NCT01074554|364977816|FG000|Overall Study|Adverse Event|3|||
105814007|NCT01074554|364977817|FG001|Overall Study|Adverse Event|3|||
105814008|NCT01074554|364977816|FG000|Overall Study|Lost to Follow-up|0|||
105814009|NCT01074554|364977817|FG001|Overall Study|Lost to Follow-up|1|||
105814010|NCT05150964|364977818|FG000|Overall Study|Lost to Follow-up|2|||
105814011|NCT00661505|364977819|FG000|Overall Study|Adverse Event|3|||
105814012|NCT00661505|364977819|FG000|Overall Study|Protocol Violation|14|||
105814013|NCT00661505|364977819|FG000|Overall Study|Withdrawal by Subject|8|||
105814014|NCT00661505|364977819|FG000|Overall Study|Lost to Follow-up|3|||
105814015|NCT00661505|364977819|FG000|Overall Study|Other|2|||
105814016|NCT03561883|364977820|FG000|Overall Study|Adverse Event|10|||
105814017|NCT03561883|364977821|FG001|Overall Study|Adverse Event|13|||
105814018|NCT03561883|364977820|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105814019|NCT03561883|364977821|FG001|Overall Study|Non-Compliance With Study Drug|2|||
105814020|NCT03561883|364977820|FG000|Overall Study|Protocol Violation|2|||
105814021|NCT03561883|364977821|FG001|Overall Study|Protocol Violation|3|||
105814022|NCT03561883|364977820|FG000|Overall Study|Withdrawal by Subject|14|||
105486120|NCT00708201|363791409|FG000|Overall Study|Withdrawal by Subject|1|||
105486121|NCT00708201|363791410|FG001|Overall Study|Withdrawal by Subject|1|||
105486122|NCT00708201|363791409|FG000|Overall Study|Lost to Follow-up|2|||
105814023|NCT03561883|364977821|FG001|Overall Study|Withdrawal by Subject|6|||
105814024|NCT03561883|364977820|FG000|Overall Study|Lost to Follow-up|2|||
105814025|NCT03561883|364977821|FG001|Overall Study|Lost to Follow-up|6|||
105486123|NCT00708201|363791410|FG001|Overall Study|Lost to Follow-up|0|||
105814026|NCT03561883|364977820|FG000|Overall Study|Study Terminated by Sponsor|12|||
105814027|NCT03561883|364977821|FG001|Overall Study|Study Terminated by Sponsor|11|||
105814028|NCT03561883|364977820|FG000|Overall Study|Physician Decision|1|||
105814029|NCT03561883|364977821|FG001|Overall Study|Physician Decision|0|||
105486124|NCT00708201|363791409|FG000|Overall Study|Protocol Violation|0|||
105814030|NCT03561883|364977820|FG000|Overall Study|Randomized by Mistake|1|||
105814031|NCT03561883|364977821|FG001|Overall Study|Randomized by Mistake|0|||
105362016|NCT02326272|363330150|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
105362017|NCT02326272|363330151|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
105763565|NCT01906476|364787175|FG001|Overall Study|Lost to Follow-up|16|||
105763566|NCT01041404|364787180|FG000|Overall Study|Adverse Event|45|||
105763567|NCT01041404|364787181|FG001|Overall Study|Adverse Event|35|||
105763568|NCT01041404|364787180|FG000|Overall Study|Lack of Efficacy|200|||
105763569|NCT01041404|364787181|FG001|Overall Study|Lack of Efficacy|210|||
105763570|NCT01041404|364787180|FG000|Overall Study|Violation of Selection Criteria|0|||
105763571|NCT01041404|364787181|FG001|Overall Study|Violation of Selection Criteria|1|||
105763572|NCT01041404|364787180|FG000|Overall Study|Protocol Violation|4|||
105763573|NCT01041404|364787181|FG001|Overall Study|Protocol Violation|0|||
105763574|NCT01041404|364787180|FG000|Overall Study|Withdrawal by Subject|29|||
105763575|NCT01041404|364787181|FG001|Overall Study|Withdrawal by Subject|23|||
105763576|NCT01041404|364787180|FG000|Overall Study|Failure to Return|1|||
105763577|NCT01041404|364787181|FG001|Overall Study|Failure to Return|2|||
105763578|NCT01041404|364787180|FG000|Overall Study|Other|11|||
105763579|NCT01041404|364787181|FG001|Overall Study|Other|23|||
105763580|NCT01993667|364787182|FG000|Overall Study|Insufficient data to analyze|16|||
105763581|NCT01993667|364787183|FG001|Overall Study|Insufficient data to analyze|16|||
105763582|NCT01993667|364787182|FG000|Overall Study|Insufficient altitude reached|3|||
105763583|NCT01993667|364787183|FG001|Overall Study|Insufficient altitude reached|1|||
105763584|NCT01993667|364787182|FG000|Overall Study|Lost to Follow-up|2|||
105763585|NCT01993667|364787183|FG001|Overall Study|Lost to Follow-up|2|||
105763586|NCT02896192|364787184|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
105763587|NCT02896192|364787184|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
105763588|NCT02896192|364787184|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
105763589|NCT00383708|364787185|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
105763590|NCT00383708|364787185|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
105763591|NCT00383708|364787185|FG000|Run-in Period|Protocol Violation|4|||
105763592|NCT00383708|364787185|FG000|Run-in Period|Adverse Event|2|||
105763593|NCT00383708|364787185|FG000|Run-in Period|Claustrophobia|1|||
105763594|NCT00383708|364787185|FG000|Co-administration Period|Adverse Event|5|||
105763595|NCT00318370|364787186|FG000|Period 1|Lack of Efficacy|5|||
105763596|NCT00318370|364787187|FG001|Period 1|Lack of Efficacy|0|||
105763597|NCT00318370|364787188|FG002|Period 1|Lack of Efficacy|0|||
105763598|NCT00318370|364787186|FG000|Period 1|Physician Decision|1|||
105763599|NCT00318370|364787187|FG001|Period 1|Physician Decision|0|||
105763600|NCT00318370|364787188|FG002|Period 1|Physician Decision|0|||
105763601|NCT00318370|364787186|FG000|Period 1|Withdrawal by Subject|1|||
105763602|NCT00318370|364787187|FG001|Period 1|Withdrawal by Subject|0|||
105763603|NCT00318370|364787188|FG002|Period 1|Withdrawal by Subject|0|||
105763604|NCT00318370|364787186|FG000|Period 2|Adverse Event|0|||
105763605|NCT00318370|364787187|FG001|Period 2|Adverse Event|3|||
105763606|NCT00318370|364787188|FG002|Period 2|Adverse Event|0|||
105763607|NCT00318370|364787186|FG000|Period 2|Lack of Efficacy|0|||
105763608|NCT00318370|364787187|FG001|Period 2|Lack of Efficacy|5|||
105763609|NCT00318370|364787188|FG002|Period 2|Lack of Efficacy|0|||
105763610|NCT00318370|364787186|FG000|Period 2|Physician Decision|0|||
105763611|NCT00318370|364787187|FG001|Period 2|Physician Decision|1|||
105763612|NCT00318370|364787188|FG002|Period 2|Physician Decision|0|||
105763613|NCT00318370|364787186|FG000|Period 2|Withdrawal by Subject|0|||
105763614|NCT00318370|364787187|FG001|Period 2|Withdrawal by Subject|1|||
105763615|NCT00318370|364787188|FG002|Period 2|Withdrawal by Subject|0|||
105763616|NCT00318370|364787186|FG000|Period 2|Other|0|||
105763617|NCT00318370|364787187|FG001|Period 2|Other|1|||
105763618|NCT00318370|364787188|FG002|Period 2|Other|0|||
105763619|NCT00318370|364787186|FG000|Period 3|Adverse Event|0|||
105763620|NCT00318370|364787187|FG001|Period 3|Adverse Event|0|||
105763621|NCT00318370|364787188|FG002|Period 3|Adverse Event|1|||
105763622|NCT00318370|364787186|FG000|Period 3|Lack of Efficacy|0|||
105763623|NCT00318370|364787187|FG001|Period 3|Lack of Efficacy|0|||
105763624|NCT00318370|364787188|FG002|Period 3|Lack of Efficacy|24|||
105763625|NCT00318370|364787186|FG000|Period 3|Death|0|||
105763626|NCT00318370|364787187|FG001|Period 3|Death|0|||
105763627|NCT00318370|364787188|FG002|Period 3|Death|1|||
105763628|NCT00318370|364787186|FG000|Period 3|Physician Decision|0|||
105486125|NCT00708201|363791410|FG001|Overall Study|Protocol Violation|1|||
105814032|NCT03561883|364977820|FG000|Overall Study|Other, Not Specified|3|||
105814033|NCT03561883|364977821|FG001|Overall Study|Other, Not Specified|2|||
105814034|NCT06354270|364977822|FG000|Overall Study|Withdrawal by Subject|1|||
105814035|NCT06354270|364977823|FG001|Overall Study|Withdrawal by Subject|0|||
105814036|NCT00745095|364977825|FG000|Overall Study|Declined to participate|1|||
105814037|NCT00745095|364977826|FG001|Overall Study|Declined to participate|0|||
105814038|NCT00745095|364977827|FG002|Overall Study|Declined to participate|0|||
105814039|NCT00745095|364977828|FG003|Overall Study|Declined to participate|0|||
105814040|NCT00745095|364977829|FG004|Overall Study|Declined to participate|92|||
105814041|NCT00745095|364977830|FG005|Overall Study|Declined to participate|95|||
105814042|NCT00745095|364977825|FG000|Overall Study|Ineligible due to GFR criteria|0|||
105814043|NCT00745095|364977826|FG001|Overall Study|Ineligible due to GFR criteria|2|||
105814044|NCT00745095|364977827|FG002|Overall Study|Ineligible due to GFR criteria|3|||
105814045|NCT00745095|364977828|FG003|Overall Study|Ineligible due to GFR criteria|3|||
105814046|NCT00745095|364977829|FG004|Overall Study|Ineligible due to GFR criteria|30|||
105814047|NCT00745095|364977830|FG005|Overall Study|Ineligible due to GFR criteria|28|||
105814048|NCT00117949|364977835|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
105814049|NCT00117949|364977836|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
105814050|NCT00117949|364977837|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
105814051|NCT00117949|364977838|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
105814052|NCT00117949|364977835|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
105814053|NCT00117949|364977836|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
105814054|NCT00117949|364977837|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
105814055|NCT00117949|364977838|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
105814056|NCT00117949|364977835|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
105814057|NCT00117949|364977836|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
105814058|NCT00117949|364977837|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
105814059|NCT00117949|364977838|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
105814060|NCT00117949|364977835|FG000|Overall Study|PSA increase >=10ng/mL|0|||
105814061|NCT00117949|364977836|FG001|Overall Study|PSA increase >=10ng/mL|1|||
105814062|NCT00117949|364977837|FG002|Overall Study|PSA increase >=10ng/mL|1|||
105814063|NCT00117949|364977838|FG003|Overall Study|PSA increase >=10ng/mL|0|||
105814064|NCT00117949|364977835|FG000|Overall Study|PSA reduction <=50%|0|||
105814065|NCT00117949|364977836|FG001|Overall Study|PSA reduction <=50%|2|||
105814066|NCT00117949|364977837|FG002|Overall Study|PSA reduction <=50%|2|||
105814067|NCT00117949|364977838|FG003|Overall Study|PSA reduction <=50%|4|||
105814068|NCT00117949|364977835|FG000|Overall Study|Hepatic abnormalities|0|||
105814069|NCT00117949|364977836|FG001|Overall Study|Hepatic abnormalities|1|||
105814070|NCT00117949|364977837|FG002|Overall Study|Hepatic abnormalities|0|||
105814071|NCT00117949|364977838|FG003|Overall Study|Hepatic abnormalities|1|||
105814072|NCT01974141|364977842|FG000|Overall Study|Other Reasons|28|||
105814073|NCT01974141|364977843|FG001|Overall Study|Other Reasons|18|||
105814074|NCT01974141|364977842|FG000|Overall Study|Protocol Violation|2|||
105814075|NCT01974141|364977843|FG001|Overall Study|Protocol Violation|6|||
105814076|NCT01974141|364977842|FG000|Overall Study|Personal Reasons|21|||
105486126|NCT04761627|363791411|FG000|Run-in Period|Death|1|||
105486127|NCT04761627|363791412|FG001|Run-in Period|Death|0|||
105486128|NCT04761627|363791413|FG002|Run-in Period|Death|0|||
105486129|NCT04761627|363791411|FG000|Run-in Period|Required alternative therapy|2|||
105486130|NCT04761627|363791412|FG001|Run-in Period|Required alternative therapy|0|||
105486131|NCT04761627|363791413|FG002|Run-in Period|Required alternative therapy|0|||
105486132|NCT04761627|363791411|FG000|Run-in Period|Lost to Follow-up|2|||
105486133|NCT04761627|363791412|FG001|Run-in Period|Lost to Follow-up|0|||
105486134|NCT04761627|363791413|FG002|Run-in Period|Lost to Follow-up|0|||
105486135|NCT04761627|363791411|FG000|Run-in Period|Protocol Violation|3|||
105814077|NCT01974141|364977843|FG001|Overall Study|Personal Reasons|20|||
105814078|NCT01974141|364977842|FG000|Overall Study|Lost to Follow-up|38|||
105814079|NCT01974141|364977843|FG001|Overall Study|Lost to Follow-up|29|||
105814080|NCT01974141|364977842|FG000|Overall Study|Pregnancy|3|||
105814081|NCT01974141|364977843|FG001|Overall Study|Pregnancy|3|||
105814082|NCT01974141|364977842|FG000|Overall Study|Lack of Efficacy|0|||
105486136|NCT04761627|363791412|FG001|Run-in Period|Protocol Violation|0|||
105486137|NCT04761627|363791413|FG002|Run-in Period|Protocol Violation|0|||
105486138|NCT04761627|363791411|FG000|Run-in Period|Abnormal liver function|1|||
105486139|NCT04761627|363791412|FG001|Run-in Period|Abnormal liver function|0|||
105486140|NCT04761627|363791413|FG002|Run-in Period|Abnormal liver function|0|||
105763629|NCT00318370|364787187|FG001|Period 3|Physician Decision|0|||
105763630|NCT00318370|364787188|FG002|Period 3|Physician Decision|1|||
105763631|NCT00318370|364787186|FG000|Period 3|Withdrawal by Subject|0|||
105763632|NCT00318370|364787187|FG001|Period 3|Withdrawal by Subject|0|||
105763633|NCT00318370|364787188|FG002|Period 3|Withdrawal by Subject|3|||
105763634|NCT00318370|364787186|FG000|Period 3|Other|0|||
105763635|NCT00318370|364787187|FG001|Period 3|Other|0|||
105763636|NCT00318370|364787188|FG002|Period 3|Other|3|||
105763637|NCT01750840|364787192|FG000|Overall Study|Lost to Follow-up|4|||
105763638|NCT02820038|364787193|FG000|Overall Study|Lost to Follow-up|7|||
105763639|NCT02820038|364787194|FG001|Overall Study|Lost to Follow-up|11|||
105763640|NCT02820038|364787195|FG002|Overall Study|Lost to Follow-up|2|||
105763641|NCT02820038|364787196|FG003|Overall Study|Lost to Follow-up|9|||
105763642|NCT02820038|364787193|FG000|Overall Study|Withdrawal by Subject|3|||
105763643|NCT02820038|364787194|FG001|Overall Study|Withdrawal by Subject|14|||
105763644|NCT02820038|364787195|FG002|Overall Study|Withdrawal by Subject|3|||
105763645|NCT02820038|364787196|FG003|Overall Study|Withdrawal by Subject|13|||
105763646|NCT00479167|364787197|FG000|Overall Study|Withdrawal by Subject|1|||
105763647|NCT01997281|364787198|FG000|Overall Study|Withdrawal by Subject|1|||
105763648|NCT01997281|364787199|FG001|Overall Study|Withdrawal by Subject|0|||
105763649|NCT01570309|364787202|FG000|Overall Study|Withdrawal by Subject|3|||
105763650|NCT01570309|364787203|FG001|Overall Study|Withdrawal by Subject|3|||
105763651|NCT00560794|364787204|FG000|Overall Study|Adverse Event|2|||
105763652|NCT00560794|364787204|FG000|Overall Study|Patient was not Compliant|1|||
105763653|NCT00560794|364787204|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
105763654|NCT00560794|364787204|FG000|Overall Study|Hematological Relapse|1|||
105763655|NCT00560794|364787204|FG000|Overall Study|Received Bone Marrow Transplant|6|||
105763656|NCT03619837|364787205|FG000|Screening|received organs from HCV-negative donors|47|||
105763657|NCT03619837|364787205|FG000|Screening|died on the wait-list|2|||
105763658|NCT03619837|364787205|FG000|Screening|remained on the wait list|40|||
105763659|NCT03619837|364787205|FG000|Screening|didn't meet eligibility criteria|3|||
105763660|NCT03619837|364787205|FG000|Screening|withdrew consent|2|||
105763661|NCT03619837|364787205|FG000|Screening|never listed for HCV-viremic donor|1|||
105763662|NCT03619837|364787205|FG000|Screening|developed exclusion criteria|2|||
105763663|NCT03619837|364787205|FG000|Screening|excluded by the investigator due to non-compliance|1|||
105763664|NCT02290340|364787207|FG000|Overall Study|Lost to Follow-up|0|||
105763665|NCT02290340|364787208|FG001|Overall Study|Lost to Follow-up|0|||
105763666|NCT02290340|364787209|FG002|Overall Study|Lost to Follow-up|0|||
105763667|NCT02290340|364787210|FG003|Overall Study|Lost to Follow-up|1|||
105763668|NCT02290340|364787207|FG000|Overall Study|Withdrawal by Subject|1|||
105763669|NCT02290340|364787208|FG001|Overall Study|Withdrawal by Subject|0|||
105763670|NCT02290340|364787209|FG002|Overall Study|Withdrawal by Subject|0|||
105763671|NCT02290340|364787210|FG003|Overall Study|Withdrawal by Subject|0|||
105763672|NCT02290340|364787207|FG000|Overall Study|Other|1|||
105763673|NCT02290340|364787208|FG001|Overall Study|Other|0|||
105763674|NCT02290340|364787209|FG002|Overall Study|Other|0|||
105763675|NCT02290340|364787210|FG003|Overall Study|Other|1|||
105763676|NCT00651313|364787211|FG000|Overall Study|Adverse Event|0|||
105763677|NCT00651313|364787212|FG001|Overall Study|Adverse Event|1|||
105763678|NCT00651313|364787211|FG000|Overall Study|Withdrawal by Subject|3|||
105763679|NCT00651313|364787212|FG001|Overall Study|Withdrawal by Subject|1|||
105763680|NCT00651313|364787211|FG000|Overall Study|Lost to Follow-up|1|||
105763681|NCT00651313|364787212|FG001|Overall Study|Lost to Follow-up|1|||
105763682|NCT00651313|364787211|FG000|Overall Study|Adminstrative Discontinuation|2|||
105763683|NCT00651313|364787212|FG001|Overall Study|Adminstrative Discontinuation|3|||
105763684|NCT00643448|364787224|FG000|Overall Study|Lack of Efficacy|2|||
105763685|NCT00643448|364787225|FG001|Overall Study|Lack of Efficacy|0|||
105763686|NCT00643448|364787226|FG002|Overall Study|Lack of Efficacy|4|||
105763687|NCT00643448|364787224|FG000|Overall Study|Adverse Event|2|||
105763688|NCT00643448|364787225|FG001|Overall Study|Adverse Event|2|||
105763689|NCT00643448|364787226|FG002|Overall Study|Adverse Event|2|||
105763690|NCT00643448|364787224|FG000|Overall Study|QTcF>550 ms|0|||
105763691|NCT00643448|364787225|FG001|Overall Study|QTcF>550 ms|3|||
105763692|NCT00643448|364787226|FG002|Overall Study|QTcF>550 ms|0|||
105763693|NCT00089999|364787227|FG000|Overall Study|Adverse Event|4|||
105763694|NCT00089999|364787228|FG001|Overall Study|Adverse Event|7|||
105763695|NCT00089999|364787227|FG000|Overall Study|Withdrawal by Subject|0|||
105763696|NCT00089999|364787228|FG001|Overall Study|Withdrawal by Subject|4|||
105763697|NCT00089999|364787227|FG000|Overall Study|Lost to Follow-up|2|||
105763698|NCT00089999|364787228|FG001|Overall Study|Lost to Follow-up|1|||
105763699|NCT00089999|364787227|FG000|Overall Study|Radiological Progression of Cancer|52|||
105763700|NCT00089999|364787228|FG001|Overall Study|Radiological Progression of Cancer|44|||
105763701|NCT00089999|364787227|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
105763702|NCT00089999|364787228|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
105763703|NCT00089999|364787227|FG000|Overall Study|Death|3|||
105763704|NCT00089999|364787228|FG001|Overall Study|Death|3|||
105814083|NCT01974141|364977843|FG001|Overall Study|Lack of Efficacy|1|||
105814084|NCT01974141|364977842|FG000|Overall Study|Adverse Event|4|||
105814085|NCT01974141|364977843|FG001|Overall Study|Adverse Event|5|||
105814086|NCT02480764|364977848|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
105814087|NCT02480764|364977849|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
105814088|NCT02480764|364977850|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
105814089|NCT02480764|364977848|FG000|Overall Study|Major Protocol Deviation|1|||
105814090|NCT02480764|364977849|FG001|Overall Study|Major Protocol Deviation|4|||
105814091|NCT02480764|364977850|FG002|Overall Study|Major Protocol Deviation|3|||
105814092|NCT02480764|364977848|FG000|Overall Study|Lost to Follow-up|0|||
105814093|NCT02480764|364977849|FG001|Overall Study|Lost to Follow-up|1|||
105814094|NCT02480764|364977850|FG002|Overall Study|Lost to Follow-up|2|||
105814095|NCT02480764|364977848|FG000|Overall Study|Voluntary Withdrawal|6|||
105814096|NCT02480764|364977849|FG001|Overall Study|Voluntary Withdrawal|5|||
105814097|NCT02480764|364977850|FG002|Overall Study|Voluntary Withdrawal|10|||
105814098|NCT02480764|364977848|FG000|Overall Study|Lack of Efficacy|0|||
105814099|NCT02480764|364977849|FG001|Overall Study|Lack of Efficacy|3|||
105814100|NCT02480764|364977850|FG002|Overall Study|Lack of Efficacy|3|||
105814101|NCT02480764|364977848|FG000|Overall Study|Reason not Specified|0|||
105814102|NCT02480764|364977849|FG001|Overall Study|Reason not Specified|1|||
105814103|NCT02480764|364977850|FG002|Overall Study|Reason not Specified|0|||
105814104|NCT03629249|364977851|FG000|Overall Study|Study terminated by sponsor|197|||
105814105|NCT03629249|364977852|FG001|Overall Study|Study terminated by sponsor|197|||
105814106|NCT03629249|364977853|FG002|Overall Study|Study terminated by sponsor|194|||
105814107|NCT03629249|364977851|FG000|Overall Study|Protocol deviation|0|||
105814108|NCT03629249|364977852|FG001|Overall Study|Protocol deviation|2|||
105814109|NCT03629249|364977853|FG002|Overall Study|Protocol deviation|5|||
105814110|NCT03629249|364977851|FG000|Overall Study|Subject decision|1|||
105814111|NCT03629249|364977852|FG001|Overall Study|Subject decision|1|||
105814112|NCT03629249|364977853|FG002|Overall Study|Subject decision|3|||
105814113|NCT03629249|364977851|FG000|Overall Study|Adverse Event|1|||
105814114|NCT03629249|364977852|FG001|Overall Study|Adverse Event|1|||
105814115|NCT03629249|364977853|FG002|Overall Study|Adverse Event|0|||
105814116|NCT03629249|364977851|FG000|Overall Study|Death|1|||
105814117|NCT03629249|364977852|FG001|Overall Study|Death|0|||
105814118|NCT03629249|364977853|FG002|Overall Study|Death|0|||
105814119|NCT03629249|364977851|FG000|Overall Study|Physician Decision|1|||
105814120|NCT03629249|364977852|FG001|Overall Study|Physician Decision|0|||
105814121|NCT03629249|364977853|FG002|Overall Study|Physician Decision|0|||
105814122|NCT02079532|364977858|FG000|Overall Study|Adverse Event|7|||
105814123|NCT02079532|364977858|FG000|Overall Study|Additional or changed therapy|2|||
105814124|NCT02079532|364977858|FG000|Overall Study|Lack of Efficacy|9|||
105814125|NCT02079532|364977858|FG000|Overall Study|Protocol Violation|3|||
105814126|NCT02079532|364977858|FG000|Overall Study|Withdrawal by Subject|1|||
105814127|NCT02079532|364977858|FG000|Overall Study|Administrative problems|1|||
105814128|NCT02079532|364977858|FG000|Overall Study|Inclusion into ReFIRST|3|||
105814129|NCT02079532|364977858|FG000|Overall Study|Other|3|||
105814130|NCT00591630|364977859|FG000|Overall Study|Death|0|||
105814131|NCT00591630|364977860|FG001|Overall Study|Death|0|||
105814132|NCT00591630|364977861|FG002|Overall Study|Death|1|||
105814133|NCT00591630|364977862|FG003|Overall Study|Death|0|||
105814134|NCT00463606|364977863|FG000|Overall Study|Adverse Event|21|||
105814135|NCT00463606|364977864|FG001|Overall Study|Adverse Event|18|||
105814136|NCT00463606|364977865|FG002|Overall Study|Adverse Event|11|||
105814137|NCT00463606|364977863|FG000|Overall Study|Withdrawal by Subject|11|||
105814138|NCT00463606|364977864|FG001|Overall Study|Withdrawal by Subject|11|||
105814139|NCT00463606|364977865|FG002|Overall Study|Withdrawal by Subject|5|||
105814140|NCT00463606|364977863|FG000|Overall Study|Lost to Follow-up|2|||
105362018|NCT02326272|363330152|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105362019|NCT02326272|363330153|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105362020|NCT02326272|363330154|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105362021|NCT02326272|363330155|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105362022|NCT02326272|363330156|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105362023|NCT02326272|363330157|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105362024|NCT02326272|363330143|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105362025|NCT02326272|363330144|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105814141|NCT00463606|364977864|FG001|Overall Study|Lost to Follow-up|2|||
105814142|NCT00463606|364977865|FG002|Overall Study|Lost to Follow-up|3|||
105814143|NCT00463606|364977863|FG000|Overall Study|Subject noncompliance|1|||
105814144|NCT00463606|364977864|FG001|Overall Study|Subject noncompliance|1|||
105814145|NCT00463606|364977865|FG002|Overall Study|Subject noncompliance|0|||
105814146|NCT00463606|364977863|FG000|Overall Study|Subject moved out of town|1|||
105814147|NCT00463606|364977864|FG001|Overall Study|Subject moved out of town|0|||
105814148|NCT00463606|364977865|FG002|Overall Study|Subject moved out of town|0|||
105814149|NCT00463606|364977863|FG000|Overall Study|Physician Decision|0|||
105814150|NCT00463606|364977864|FG001|Overall Study|Physician Decision|1|||
105362026|NCT02326272|363330145|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105362027|NCT02326272|363330146|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105362028|NCT02326272|363330147|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105362029|NCT02326272|363330148|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
105362030|NCT02326272|363330149|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105362031|NCT02326272|363330150|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105571551|NCT00747123|364091238|FG003|Overall Study|Adverse Event|1|||
105763705|NCT00089999|364787227|FG000|Overall Study|Poor General Condition|1|||
105763706|NCT00089999|364787228|FG001|Overall Study|Poor General Condition|0|||
105763707|NCT00089999|364787227|FG000|Overall Study|Clinical Progression|1|||
105763708|NCT00089999|364787228|FG001|Overall Study|Clinical Progression|2|||
105763709|NCT00089999|364787227|FG000|Overall Study|Physician Decision|2|||
105763710|NCT00089999|364787228|FG001|Overall Study|Physician Decision|2|||
105763711|NCT00089999|364787227|FG000|Overall Study|Patient Underwent Surgery|2|||
105763712|NCT00089999|364787228|FG001|Overall Study|Patient Underwent Surgery|0|||
105763713|NCT00089999|364787227|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
105763714|NCT00089999|364787228|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
105763715|NCT01607073|364787229|FG000|Overall Study|Adverse Event|1|||
105763716|NCT03906136|364788849|FG000|Overall Study|Adverse Event|1|||
105763717|NCT03906136|364788850|FG001|Overall Study|Adverse Event|0|||
105763718|NCT03906136|364788849|FG000|Overall Study|Lost to Follow-up|7|||
105763719|NCT03906136|364788850|FG001|Overall Study|Lost to Follow-up|4|||
105763720|NCT03906136|364788849|FG000|Overall Study|Physician Decision|1|||
105763721|NCT03906136|364788850|FG001|Overall Study|Physician Decision|0|||
105763722|NCT03906136|364788849|FG000|Overall Study|Withdrawal by Subject|3|||
105763723|NCT03906136|364788850|FG001|Overall Study|Withdrawal by Subject|7|||
105763724|NCT01375647|364788851|FG000|Overall Study|Lost to Follow-up|3|||
105763725|NCT01375647|364788852|FG001|Overall Study|Lost to Follow-up|3|||
105763726|NCT01375647|364788853|FG002|Overall Study|Lost to Follow-up|7|||
105763727|NCT01375647|364788854|FG003|Overall Study|Lost to Follow-up|10|||
105763728|NCT01375647|364788851|FG000|Overall Study|Death|1|||
105763729|NCT01375647|364788852|FG001|Overall Study|Death|2|||
105763730|NCT01375647|364788853|FG002|Overall Study|Death|1|||
105763731|NCT01375647|364788854|FG003|Overall Study|Death|0|||
105763732|NCT01375647|364788851|FG000|Overall Study|Withdrawal by Subject|17|||
105763733|NCT01375647|364788852|FG001|Overall Study|Withdrawal by Subject|20|||
105763734|NCT01375647|364788853|FG002|Overall Study|Withdrawal by Subject|26|||
105763735|NCT01375647|364788854|FG003|Overall Study|Withdrawal by Subject|14|||
105763736|NCT01375647|364788851|FG000|Overall Study|Physician Decision|1|||
105763737|NCT01375647|364788852|FG001|Overall Study|Physician Decision|0|||
105763738|NCT01375647|364788853|FG002|Overall Study|Physician Decision|0|||
105763739|NCT01375647|364788854|FG003|Overall Study|Physician Decision|0|||
105763740|NCT03366844|364788855|FG000|Overall Study|Physician Decision|1|||
105763741|NCT03366844|364788855|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
105763742|NCT01826448|364788856|FG000|Overall Study|Adverse Event|1|||
105763743|NCT01826448|364788857|FG001|Overall Study|Adverse Event|3|||
105763744|NCT01826448|364788856|FG000|Overall Study|Disease progression|2|||
105763745|NCT01826448|364788857|FG001|Overall Study|Disease progression|4|||
105763746|NCT01826448|364788856|FG000|Overall Study|Withdrawal by Subject|1|||
105763747|NCT01826448|364788857|FG001|Overall Study|Withdrawal by Subject|0|||
105763748|NCT01826448|364788856|FG000|Overall Study|Physician Decision|0|||
105763749|NCT01826448|364788857|FG001|Overall Study|Physician Decision|1|||
105763750|NCT01826448|364788856|FG000|Overall Study|2 active cancers|0|||
105763751|NCT01826448|364788857|FG001|Overall Study|2 active cancers|1|||
105763752|NCT04038385|364788858|FG000|Overall Study|Completed baseline assessment only|7|||
105763753|NCT04038385|364788859|FG001|Overall Study|Completed baseline assessment only|4|||
105763754|NCT04038385|364788858|FG000|Overall Study|Moved out of area|4|||
105763755|NCT04038385|364788859|FG001|Overall Study|Moved out of area|2|||
105763756|NCT04038385|364788858|FG000|Overall Study|Discontinued study involvement|6|||
105763757|NCT04038385|364788859|FG001|Overall Study|Discontinued study involvement|1|||
105763758|NCT03424044|364788860|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763759|NCT03424044|364788861|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763760|NCT03424044|364788862|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
105763761|NCT03424044|364788863|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763762|NCT03424044|364788864|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763763|NCT03424044|364788865|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763764|NCT03424044|364788866|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763765|NCT03424044|364788867|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763766|NCT03424044|364788868|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763767|NCT03424044|364788860|FG000|First Intervention (76 Hours)|Adverse Event|0|||
105763768|NCT03424044|364788861|FG001|First Intervention (76 Hours)|Adverse Event|0|||
105814151|NCT00463606|364977865|FG002|Overall Study|Physician Decision|0|||
105814152|NCT00463606|364977863|FG000|Overall Study|Sponsor request|0|||
105814153|NCT00463606|364977864|FG001|Overall Study|Sponsor request|1|||
105814154|NCT00463606|364977865|FG002|Overall Study|Sponsor request|0|||
105814155|NCT00463606|364977863|FG000|Overall Study|Exclusion criteria violation|2|||
105814156|NCT00463606|364977864|FG001|Overall Study|Exclusion criteria violation|0|||
105814157|NCT00463606|364977865|FG002|Overall Study|Exclusion criteria violation|0|||
105814158|NCT00463606|364977863|FG000|Overall Study|Coordinator error|1|||
105814159|NCT00463606|364977864|FG001|Overall Study|Coordinator error|0|||
105814160|NCT00463606|364977865|FG002|Overall Study|Coordinator error|0|||
105814161|NCT00463606|364977863|FG000|Overall Study|Patient randomized in error|1|||
105814162|NCT00463606|364977864|FG001|Overall Study|Patient randomized in error|0|||
105814163|NCT00463606|364977865|FG002|Overall Study|Patient randomized in error|0|||
105814164|NCT00463606|364977863|FG000|Overall Study|Participation in another ABT-335 trial|1|||
105814165|NCT00463606|364977864|FG001|Overall Study|Participation in another ABT-335 trial|0|||
105814166|NCT00463606|364977865|FG002|Overall Study|Participation in another ABT-335 trial|0|||
105814167|NCT00463606|364977863|FG000|Overall Study|Protocol Violation|0|||
105814168|NCT00463606|364977864|FG001|Overall Study|Protocol Violation|0|||
105814169|NCT00463606|364977865|FG002|Overall Study|Protocol Violation|1|||
105814170|NCT01027143|364979206|FG000|Overall Study|Lost to Follow-up|9|||
105814171|NCT01027143|364979207|FG001|Overall Study|Lost to Follow-up|4|||
105814172|NCT02918877|364979208|FG000|Overall Study|Withdrawal by Subject|2|||
105814173|NCT02918877|364979209|FG001|Overall Study|Withdrawal by Subject|2|||
105814174|NCT02918877|364979208|FG000|Overall Study|Surgery cancelled|1|||
105814175|NCT02918877|364979209|FG001|Overall Study|Surgery cancelled|0|||
105814176|NCT02918877|364979208|FG000|Overall Study|Physician Decision|1|||
105814177|NCT02918877|364979209|FG001|Overall Study|Physician Decision|0|||
105814178|NCT02918877|364979208|FG000|Overall Study|Received intraoperative steroids|1|||
105814179|NCT02918877|364979209|FG001|Overall Study|Received intraoperative steroids|0|||
105814180|NCT02918877|364979208|FG000|Overall Study|Unable to obtain lab samples|1|||
105814181|NCT02918877|364979209|FG001|Overall Study|Unable to obtain lab samples|0|||
105814182|NCT02918877|364979208|FG000|Overall Study|Unsafe to perform BAL|0|||
105814183|NCT02918877|364979209|FG001|Overall Study|Unsafe to perform BAL|1|||
105814184|NCT04455633|364979210|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
105814185|NCT04455633|364979211|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
105814186|NCT04455633|364979212|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
105814187|NCT04455633|364979210|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
105814188|NCT04455633|364979211|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
105814189|NCT04455633|364979212|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
105814190|NCT04455633|364979210|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
105814191|NCT04455633|364979211|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
105814192|NCT04455633|364979212|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
105814193|NCT04455633|364979210|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
105814194|NCT04455633|364979211|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
105814195|NCT04455633|364979212|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
105814196|NCT02532764|364979213|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
105814197|NCT02532764|364979214|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
105814198|NCT02532764|364979215|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
105814199|NCT02532764|364979216|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
105814200|NCT02532764|364979217|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
105814201|NCT02532764|364979218|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
105814202|NCT02532764|364979219|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
105814203|NCT02532764|364979220|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
105814204|NCT02532764|364979221|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
105814205|NCT02532764|364979222|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
105814206|NCT01492361|364979223|FG000|Overall Study|Withdrawal by Subject|281|||
105814207|NCT01492361|364979224|FG001|Overall Study|Withdrawal by Subject|297|||
105814208|NCT01492361|364979223|FG000|Overall Study|Physician Decision|12|||
105814209|NCT01492361|364979224|FG001|Overall Study|Physician Decision|12|||
105814210|NCT01492361|364979223|FG000|Overall Study|Lost to Follow-up|6|||
105814211|NCT01492361|364979224|FG001|Overall Study|Lost to Follow-up|13|||
105571552|NCT01351025|364091242|FG000|Week 0 - 20|Lost to Follow-up|2|||
105814212|NCT01492361|364979223|FG000|Overall Study|Other than specified above|106|||
105814213|NCT01492361|364979224|FG001|Overall Study|Other than specified above|138|||
105814214|NCT03444038|364979227|FG000|Overall Study|Adverse Event|12|||
105814215|NCT03444038|364979227|FG000|Overall Study|Withdrawal by Subject|7|||
105814216|NCT03444038|364979227|FG000|Overall Study|Lost to Follow-up|1|||
105814217|NCT03444038|364979227|FG000|Overall Study|Physician Decision|2|||
105814218|NCT03444038|364979227|FG000|Overall Study|Lack of Efficacy|7|||
105814219|NCT01717976|364979228|FG000|Overall Study|Protocol Violation|0|||
105571553|NCT01351025|364091243|FG001|Week 0 - 20|Lost to Follow-up|1|||
105814220|NCT01717976|364979229|FG001|Overall Study|Protocol Violation|1|||
105814221|NCT01087970|364979230|FG000|Overall Study|Protocol Violation|2|||
105814222|NCT00755196|364979232|FG000|Overall Study|Lost to Follow-up|1|||
105814223|NCT00755196|364979232|FG000|Overall Study|Lack of Efficiency|1|||
105814224|NCT01604850|364979233|FG000|Overall Study|Enrolled but never treated|0|||
105814225|NCT01604850|364979234|FG001|Overall Study|Enrolled but never treated|1|||
105814226|NCT01604850|364979233|FG000|Overall Study|Efficacy Failure|50|||
105814227|NCT01604850|364979234|FG001|Overall Study|Efficacy Failure|29|||
105814228|NCT01604850|364979233|FG000|Overall Study|Lost to Follow-up|1|||
105814229|NCT01604850|364979234|FG001|Overall Study|Lost to Follow-up|0|||
105814230|NCT01604850|364979233|FG000|Overall Study|Subject withdrew consent|1|||
105814231|NCT01604850|364979234|FG001|Overall Study|Subject withdrew consent|0|||
105814232|NCT01703832|364979235|FG000|Overall Study|Withdrawal by Subject|1|||
105814233|NCT01703832|364979236|FG001|Overall Study|Withdrawal by Subject|0|||
105814234|NCT01991470|364979237|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
105814235|NCT01991470|364979237|FG000|Enlite 1 Period|Adverse Event|1|||
105814236|NCT01991470|364979237|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
105814237|NCT01991470|364979237|FG000|Enlite 3 Period|Lost to Follow-up|1|||
105814238|NCT01991470|364979237|FG000|Enlite 3 Period|Physician Decision|2|||
105814239|NCT01991470|364979237|FG000|Enlite 3 Period|Physician Decision|8|||
105814240|NCT01991470|364979237|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
105814241|NCT00543309|364979238|FG000|Overall Study|Physician Decision|0|||
105814242|NCT00543309|364979239|FG001|Overall Study|Physician Decision|1|||
105814243|NCT00543309|364979240|FG002|Overall Study|Physician Decision|0|||
105814244|NCT03552757|364979241|FG000|Overall Study|Withdrawal by Subject|10|||
105814245|NCT03552757|364979242|FG001|Overall Study|Withdrawal by Subject|5|||
105814246|NCT03552757|364979243|FG002|Overall Study|Withdrawal by Subject|12|||
105814247|NCT03552757|364979241|FG000|Overall Study|Lost to Follow-up|2|||
105814248|NCT03552757|364979242|FG001|Overall Study|Lost to Follow-up|7|||
105814249|NCT03552757|364979243|FG002|Overall Study|Lost to Follow-up|7|||
105814250|NCT03552757|364979241|FG000|Overall Study|Death|1|||
105814251|NCT03552757|364979242|FG001|Overall Study|Death|1|||
105814252|NCT03552757|364979243|FG002|Overall Study|Death|1|||
105814253|NCT00762086|364979244|FG000|Overall Study|Adverse Event|2|||
105814254|NCT00762086|364979245|FG001|Overall Study|Adverse Event|0|||
105814255|NCT00762086|364979244|FG000|Overall Study|Lost to Follow-up|0|||
105814256|NCT00762086|364979245|FG001|Overall Study|Lost to Follow-up|2|||
105814257|NCT00762086|364979244|FG000|Overall Study|Non compliance|1|||
105814258|NCT00762086|364979245|FG001|Overall Study|Non compliance|0|||
105814259|NCT00762086|364979244|FG000|Overall Study|Withdrawal by Subject|2|||
105814260|NCT00762086|364979245|FG001|Overall Study|Withdrawal by Subject|2|||
105814261|NCT00762086|364979244|FG000|Overall Study|Ineligible to participate in the study|1|||
105814262|NCT00762086|364979245|FG001|Overall Study|Ineligible to participate in the study|0|||
105814263|NCT01203878|364979248|FG000|Overall Study|Withdrawal by Subject|0|||
105362032|NCT02326272|363330151|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105362033|NCT02326272|363330152|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105362034|NCT02326272|363330153|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105814264|NCT01203878|364979249|FG001|Overall Study|Withdrawal by Subject|0|||
105814265|NCT01203878|364979250|FG002|Overall Study|Withdrawal by Subject|1|||
105814266|NCT01203878|364979248|FG000|Overall Study|Adverse Event|0|||
105814267|NCT01203878|364979249|FG001|Overall Study|Adverse Event|0|||
105814268|NCT01203878|364979250|FG002|Overall Study|Adverse Event|2|||
105814269|NCT03952143|364979251|FG000|Lead-In Period|Adverse Event|2|||
105814270|NCT03952143|364979252|FG001|Lead-In Period|Adverse Event|0|||
105814271|NCT03952143|364979253|FG002|Lead-In Period|Adverse Event|0|||
105814272|NCT03952143|364979251|FG000|Lead-In Period|Lack of Efficacy|2|||
105814273|NCT03952143|364979252|FG001|Lead-In Period|Lack of Efficacy|0|||
105814274|NCT03952143|364979253|FG002|Lead-In Period|Lack of Efficacy|0|||
105814275|NCT03952143|364979251|FG000|Lead-In Period|Physician Decision|5|||
105571554|NCT01351025|364091242|FG000|Week 0 - 20|Withdrawal by Subject|1|||
105814276|NCT03952143|364979252|FG001|Lead-In Period|Physician Decision|0|||
105814277|NCT03952143|364979253|FG002|Lead-In Period|Physician Decision|0|||
105814278|NCT03952143|364979251|FG000|Lead-In Period|Protocol Violation|5|||
105814279|NCT03952143|364979252|FG001|Lead-In Period|Protocol Violation|0|||
105814280|NCT03952143|364979253|FG002|Lead-In Period|Protocol Violation|0|||
105814281|NCT03952143|364979251|FG000|Lead-In Period|Withdrawal by Subject|19|||
105814282|NCT03952143|364979252|FG001|Lead-In Period|Withdrawal by Subject|0|||
105814283|NCT03952143|364979253|FG002|Lead-In Period|Withdrawal by Subject|0|||
105814284|NCT03952143|364979251|FG000|Treatment Period|Adverse Event|0|||
105814285|NCT03952143|364979252|FG001|Treatment Period|Adverse Event|0|||
105814286|NCT03952143|364979253|FG002|Treatment Period|Adverse Event|1|||
105814287|NCT03952143|364979251|FG000|Treatment Period|Lost to Follow-up|0|||
105814288|NCT03952143|364979252|FG001|Treatment Period|Lost to Follow-up|2|||
105814289|NCT03952143|364979253|FG002|Treatment Period|Lost to Follow-up|0|||
105814290|NCT03952143|364979251|FG000|Treatment Period|Physician Decision|0|||
105814291|NCT03952143|364979252|FG001|Treatment Period|Physician Decision|0|||
105814292|NCT03952143|364979253|FG002|Treatment Period|Physician Decision|2|||
105814293|NCT03952143|364979251|FG000|Treatment Period|Protocol Violation|0|||
105814294|NCT03952143|364979252|FG001|Treatment Period|Protocol Violation|0|||
105814295|NCT03952143|364979253|FG002|Treatment Period|Protocol Violation|1|||
105814296|NCT03952143|364979251|FG000|Treatment Period|Withdrawal by Subject|0|||
105814297|NCT03952143|364979252|FG001|Treatment Period|Withdrawal by Subject|5|||
105814298|NCT03952143|364979253|FG002|Treatment Period|Withdrawal by Subject|26|||
105814299|NCT03952143|364979251|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
105814300|NCT03952143|364979252|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
105814301|NCT03952143|364979253|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
105814302|NCT03952143|364979251|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
105814303|NCT03952143|364979252|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
105814304|NCT03952143|364979253|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
105814305|NCT01239121|364979254|FG000|Overall Study|Withdrawal by Subject|2|||
105814306|NCT01239121|364979255|FG001|Overall Study|Withdrawal by Subject|4|||
105814307|NCT01239121|364979256|FG002|Overall Study|Withdrawal by Subject|0|||
105814308|NCT00220337|364979257|FG000|Overall Study|Adverse Event|70|||
105814309|NCT00220337|364979257|FG000|Overall Study|Lack of Efficacy|17|||
105814310|NCT00220337|364979257|FG000|Overall Study|Withdrawal by Subject|68|||
105814311|NCT00220337|364979257|FG000|Overall Study|Protocol Violation|2|||
105814312|NCT00220337|364979257|FG000|Overall Study|Lost to Follow-up|5|||
105814313|NCT00220337|364979257|FG000|Overall Study|Other|12|||
105814314|NCT00220337|364979257|FG000|Overall Study|Unsatisfactory compliance|5|||
105814315|NCT03661528|364979258|FG000|Overall Study|Death|1|||
105814316|NCT03661528|364979259|FG001|Overall Study|Death|0|||
105814317|NCT03661528|364979258|FG000|Overall Study|Physician Decision|3|||
105814318|NCT03661528|364979259|FG001|Overall Study|Physician Decision|1|||
105814319|NCT03661528|364979258|FG000|Overall Study|Other than Specified|5|||
105814320|NCT03661528|364979259|FG001|Overall Study|Other than Specified|2|||
105814321|NCT03661528|364979258|FG000|Overall Study|Withdrawal by Subject|5|||
105814322|NCT03661528|364979259|FG001|Overall Study|Withdrawal by Subject|3|||
105814323|NCT03661528|364979258|FG000|Overall Study|Disease Progression|8|||
105814324|NCT03661528|364979259|FG001|Overall Study|Disease Progression|13|||
105814325|NCT03661528|364979258|FG000|Overall Study|Adverse Event|61|||
105814326|NCT03661528|364979259|FG001|Overall Study|Adverse Event|55|||
105814327|NCT01617668|364979260|FG000|Overall Study|Adverse Event|7|||
105814328|NCT01617668|364979261|FG001|Overall Study|Adverse Event|0|||
105814329|NCT01617668|364979262|FG002|Overall Study|Adverse Event|12|||
105814330|NCT01617668|364979263|FG003|Overall Study|Adverse Event|5|||
105814331|NCT01617668|364979260|FG000|Overall Study|Physician Decision|1|||
105814332|NCT01617668|364979261|FG001|Overall Study|Physician Decision|2|||
105814333|NCT01617668|364979262|FG002|Overall Study|Physician Decision|3|||
105814334|NCT01617668|364979263|FG003|Overall Study|Physician Decision|0|||
105814335|NCT01617668|364979260|FG000|Overall Study|Progressive Disease|4|||
105814336|NCT01617668|364979261|FG001|Overall Study|Progressive Disease|4|||
105814337|NCT01617668|364979262|FG002|Overall Study|Progressive Disease|6|||
105814338|NCT01617668|364979263|FG003|Overall Study|Progressive Disease|9|||
105814339|NCT01617668|364979260|FG000|Overall Study|Subject/guardian decision|1|||
105814340|NCT01617668|364979261|FG001|Overall Study|Subject/guardian decision|3|||
105814341|NCT01617668|364979262|FG002|Overall Study|Subject/guardian decision|2|||
105814342|NCT01617668|364979263|FG003|Overall Study|Subject/guardian decision|1|||
105814343|NCT01876706|364979264|FG000|Overall Study|BPH Intervention|9|||
105814344|NCT01876706|364979264|FG000|Overall Study|Lost to Follow-up|7|||
105571555|NCT01351025|364091243|FG001|Week 0 - 20|Withdrawal by Subject|0|||
105571556|NCT01351025|364091242|FG000|Week 24 - 44|Lost to Follow-up|0|||
105814345|NCT01876706|364979264|FG000|Overall Study|Withdrawals|6|||
105814346|NCT01876706|364979264|FG000|Overall Study|Death|3|||
105814347|NCT00659607|364979265|FG000|Overall Study|No blood pressure recorded|147|||
105814348|NCT00659607|364979265|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
105814349|NCT00659607|364979265|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
105814350|NCT00659607|364979265|FG000|Overall Study|No recorded efficacy data|15|||
105814351|NCT00659607|364979265|FG000|Overall Study|Inconsistent BP measuring date|2|||
105814352|NCT02073643|364979272|FG000|Overall Study|Lost to Follow-up|24|||
105814353|NCT01062256|364979273|FG000|Overall Study|Adverse Event|1|||
105814354|NCT01062256|364979274|FG001|Overall Study|Adverse Event|0|||
105814355|NCT01062256|364979275|FG002|Overall Study|Adverse Event|0|||
105362035|NCT02326272|363330154|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105362036|NCT02326272|363330155|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105571557|NCT01351025|364091243|FG001|Week 24 - 44|Lost to Follow-up|2|||
105571558|NCT01351025|364091242|FG000|Week 24 - 44|Site closed|0|||
105571559|NCT01351025|364091243|FG001|Week 24 - 44|Site closed|1|||
105814356|NCT01062256|364979273|FG000|Overall Study|Withdrawal by Subject|1|||
105814357|NCT01062256|364979274|FG001|Overall Study|Withdrawal by Subject|1|||
105814358|NCT01062256|364979275|FG002|Overall Study|Withdrawal by Subject|1|||
105814359|NCT01062256|364979273|FG000|Overall Study|Ineligible|1|||
105814360|NCT01062256|364979274|FG001|Overall Study|Ineligible|4|||
105814361|NCT01062256|364979275|FG002|Overall Study|Ineligible|3|||
105814362|NCT01062256|364979273|FG000|Overall Study|Administrative|0|||
105814363|NCT01062256|364979274|FG001|Overall Study|Administrative|2|||
105814364|NCT01062256|364979275|FG002|Overall Study|Administrative|0|||
105814365|NCT03752528|364979286|FG000|Part A|Lost to Follow-up|1|||
105814366|NCT03752528|364979286|FG000|Part A|Protocol Violation|1|||
105814367|NCT03752528|364979286|FG000|Part B|Protocol Violation|1|||
105814368|NCT03752528|364979286|FG000|Part B|Study terminated by sponsor|3|||
105814369|NCT04534283|364979288|FG000|Overall Study|Physician Decision|2|||
105814370|NCT04534283|364979288|FG000|Overall Study|Withdrawal by Subject|1|||
105814371|NCT04534283|364979288|FG000|Overall Study|Disease Progression|12|||
105814372|NCT04534283|364979288|FG000|Overall Study|Adverse Event|1|||
105814373|NCT01941030|364979293|FG000|Overall Study|Death|3|||
105814374|NCT01941030|364979294|FG001|Overall Study|Death|2|||
105814375|NCT01941030|364979293|FG000|Overall Study|Lost to Follow-up|6|||
105814376|NCT01941030|364979294|FG001|Overall Study|Lost to Follow-up|5|||
105814377|NCT01941030|364979293|FG000|Overall Study|Withdrawal by Subject|4|||
105814378|NCT01941030|364979294|FG001|Overall Study|Withdrawal by Subject|6|||
105814379|NCT02930005|364979301|FG000|Overall Study|Lost to Follow-up|1|||
105814380|NCT02930005|364979302|FG001|Overall Study|Lost to Follow-up|5|||
105814381|NCT02003183|364979305|FG000|Overall Study|Lost to Follow-up|0|||
105814382|NCT02003183|364979306|FG001|Overall Study|Lost to Follow-up|2|||
105814383|NCT00406848|364979307|FG000|Overall Study|Withdrawal by Subject|27|||
105814384|NCT00406848|364979308|FG001|Overall Study|Withdrawal by Subject|22|||
105814385|NCT00406848|364979307|FG000|Overall Study|Adverse Event|38|||
105814386|NCT00406848|364979308|FG001|Overall Study|Adverse Event|7|||
105814387|NCT00406848|364979307|FG000|Overall Study|Lack of Efficacy|9|||
105814388|NCT00406848|364979308|FG001|Overall Study|Lack of Efficacy|14|||
105814389|NCT00406848|364979307|FG000|Overall Study|Protocol Violation|10|||
105814390|NCT00406848|364979308|FG001|Overall Study|Protocol Violation|6|||
105814391|NCT00406848|364979307|FG000|Overall Study|Lost to Follow-up|6|||
105814392|NCT00406848|364979308|FG001|Overall Study|Lost to Follow-up|2|||
105814393|NCT00406848|364979307|FG000|Overall Study|Physician Decision|2|||
105814394|NCT00406848|364979308|FG001|Overall Study|Physician Decision|2|||
105814395|NCT00406848|364979307|FG000|Overall Study|Sponsor Decision|1|||
105814396|NCT00406848|364979308|FG001|Overall Study|Sponsor Decision|1|||
105814397|NCT03262012|364979326|FG000|Overall Study|Withdrawal by Subject|15|||
105814398|NCT03262012|364979327|FG001|Overall Study|Withdrawal by Subject|13|||
105814399|NCT03262012|364979328|FG002|Overall Study|Withdrawal by Subject|8|||
105814400|NCT03262012|364979329|FG003|Overall Study|Withdrawal by Subject|7|||
105814401|NCT03262012|364979326|FG000|Overall Study|Adverse Event|10|||
105814402|NCT03262012|364979327|FG001|Overall Study|Adverse Event|12|||
105814403|NCT03262012|364979328|FG002|Overall Study|Adverse Event|4|||
105814404|NCT03262012|364979329|FG003|Overall Study|Adverse Event|6|||
105814405|NCT03262012|364979326|FG000|Overall Study|Physician Decision|2|||
105814406|NCT03262012|364979327|FG001|Overall Study|Physician Decision|5|||
105814407|NCT03262012|364979328|FG002|Overall Study|Physician Decision|1|||
105814408|NCT03262012|364979329|FG003|Overall Study|Physician Decision|0|||
105814409|NCT03262012|364979326|FG000|Overall Study|Lack of Efficacy|0|||
105814410|NCT03262012|364979327|FG001|Overall Study|Lack of Efficacy|5|||
105814411|NCT03262012|364979328|FG002|Overall Study|Lack of Efficacy|1|||
105814412|NCT03262012|364979329|FG003|Overall Study|Lack of Efficacy|2|||
105814413|NCT03262012|364979326|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
105814414|NCT03262012|364979327|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
105814415|NCT03262012|364979328|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
105814416|NCT03262012|364979329|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
105814417|NCT00076102|364980673|FG000|Overall Study|Clinical progression|1|||
105814418|NCT00076102|364980673|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
105814419|NCT00076102|364980673|FG000|Overall Study|plexiform neurofibroma surgery|1|||
105814420|NCT00076102|364980673|FG000|Overall Study|refusal of further therapy|2|||
105814421|NCT00090857|364980675|FG000|Overall Study|Lost to Follow-up|0|||
105814422|NCT00090857|364980676|FG001|Overall Study|Lost to Follow-up|1|||
105814423|NCT00090857|364980675|FG000|Overall Study|Withdrawal by Subject|2|||
105814424|NCT00090857|364980676|FG001|Overall Study|Withdrawal by Subject|0|||
105814425|NCT00090857|364980675|FG000|Overall Study|Adverse Event|2|||
105814426|NCT00090857|364980676|FG001|Overall Study|Adverse Event|2|||
105814427|NCT05097326|364980677|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
105814428|NCT05097326|364980678|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
105814429|NCT01451762|364980679|FG000|Overall Study|Lost to Follow-up|3|||
105814430|NCT01451762|364980680|FG001|Overall Study|Lost to Follow-up|6|||
105814431|NCT01451762|364980681|FG002|Overall Study|Lost to Follow-up|6|||
105814432|NCT00630305|364980684|FG000|Overall Study|Withdrawal by Subject|1|||
105814433|NCT00630305|364980684|FG000|Overall Study|Inability to insert contact lens|1|||
105814434|NCT01494506|364980687|FG000|Overall Study|Lack of Efficacy|77|||
105814435|NCT01494506|364980688|FG001|Overall Study|Lack of Efficacy|83|||
105814436|NCT01494506|364980689|FG002|Overall Study|Lack of Efficacy|57|||
105814437|NCT01494506|364980687|FG000|Overall Study|Adverse Event|17|||
105814438|NCT01494506|364980688|FG001|Overall Study|Adverse Event|10|||
105814439|NCT01494506|364980689|FG002|Overall Study|Adverse Event|11|||
105814440|NCT01494506|364980687|FG000|Overall Study|Death|9|||
105814441|NCT01494506|364980688|FG001|Overall Study|Death|5|||
105814442|NCT01494506|364980689|FG002|Overall Study|Death|2|||
105814443|NCT01494506|364980687|FG000|Overall Study|Physician Decision|7|||
105814444|NCT01494506|364980688|FG001|Overall Study|Physician Decision|5|||
105814445|NCT01494506|364980689|FG002|Overall Study|Physician Decision|4|||
105814446|NCT01494506|364980687|FG000|Overall Study|Withdrawal by Subject|17|||
105362037|NCT02326272|363330156|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105362038|NCT02326272|363330157|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105362039|NCT02326272|363330143|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105814447|NCT01494506|364980688|FG001|Overall Study|Withdrawal by Subject|20|||
105814448|NCT01494506|364980689|FG002|Overall Study|Withdrawal by Subject|14|||
105814449|NCT01494506|364980687|FG000|Overall Study|Clinical Deterioration|21|||
105814450|NCT01494506|364980688|FG001|Overall Study|Clinical Deterioration|17|||
105814451|NCT01494506|364980689|FG002|Overall Study|Clinical Deterioration|13|||
105814452|NCT01494506|364980687|FG000|Overall Study|Sponsor Decision|0|||
105814453|NCT01494506|364980688|FG001|Overall Study|Sponsor Decision|0|||
105814454|NCT01494506|364980689|FG002|Overall Study|Sponsor Decision|1|||
105814455|NCT01494506|364980687|FG000|Overall Study|Other|0|||
105814456|NCT01494506|364980688|FG001|Overall Study|Other|3|||
105814457|NCT01494506|364980689|FG002|Overall Study|Other|1|||
105814458|NCT01882647|364980695|FG000|Overall Study|Lost to Follow-up|2|||
105814459|NCT01882647|364980696|FG001|Overall Study|Lost to Follow-up|2|||
105814460|NCT01882647|364980695|FG000|Overall Study|Withdrawal by Subject|0|||
105814461|NCT01882647|364980696|FG001|Overall Study|Withdrawal by Subject|4|||
105814462|NCT04720664|364980697|FG000|Overall Study|Adverse Event|2|||
105814463|NCT04720664|364980697|FG000|Overall Study|Lack of Efficacy|9|||
105814464|NCT01941095|364980698|FG000|Overall Study|Insufficient therapeutic response|13|||
105814465|NCT01941095|364980698|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
105814466|NCT01941095|364980698|FG000|Overall Study|Adverse Event|11|||
105814467|NCT01941095|364980698|FG000|Overall Study|Physician Decision|3|||
105814468|NCT01941095|364980698|FG000|Overall Study|Withdrawal by Subject|17|||
105814469|NCT01941095|364980698|FG000|Overall Study|Lost to Follow-up|10|||
105814470|NCT03311646|364980699|FG000|Overall Study|Physician Decision|1|||
105814471|NCT03311646|364980699|FG000|Overall Study|Withdrawal by Subject|5|||
105814472|NCT03311646|364980699|FG000|Overall Study|Lost to Follow-up|5|||
105814473|NCT03311646|364980699|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
105814474|NCT00883090|364980700|FG000|Overall Study|Sponsor's decision|1|||
105814475|NCT00883090|364980700|FG000|Overall Study|Withdrawal by Subject|1|||
105814476|NCT03527745|364980701|FG000|Overall Study|Lost to Follow-up|3|||
105814477|NCT03527745|364980702|FG001|Overall Study|Lost to Follow-up|6|||
105814478|NCT03527745|364980703|FG002|Overall Study|Lost to Follow-up|7|||
105814479|NCT03527745|364980704|FG003|Overall Study|Lost to Follow-up|9|||
105814480|NCT03527745|364980705|FG004|Overall Study|Lost to Follow-up|0|||
105814481|NCT03527745|364980706|FG005|Overall Study|Lost to Follow-up|2|||
105814482|NCT03527745|364980707|FG006|Overall Study|Lost to Follow-up|3|||
105814483|NCT03527745|364980708|FG007|Overall Study|Lost to Follow-up|2|||
105814484|NCT03527745|364980709|FG008|Overall Study|Lost to Follow-up|3|||
105814485|NCT03527745|364980710|FG009|Overall Study|Lost to Follow-up|2|||
105814486|NCT03527745|364980711|FG010|Overall Study|Lost to Follow-up|1|||
105814487|NCT03527745|364980712|FG011|Overall Study|Lost to Follow-up|1|||
105814488|NCT03527745|364980713|FG012|Overall Study|Lost to Follow-up|0|||
105814489|NCT03527745|364980714|FG013|Overall Study|Lost to Follow-up|0|||
105814490|NCT03527745|364980715|FG014|Overall Study|Lost to Follow-up|0|||
105814491|NCT03527745|364980716|FG015|Overall Study|Lost to Follow-up|0|||
105814492|NCT03527745|364980717|FG016|Overall Study|Lost to Follow-up|1|||
105814493|NCT03527745|364980718|FG017|Overall Study|Lost to Follow-up|0|||
105814494|NCT03527745|364980719|FG018|Overall Study|Lost to Follow-up|0|||
105814495|NCT03527745|364980720|FG019|Overall Study|Lost to Follow-up|1|||
105814496|NCT03527745|364980721|FG020|Overall Study|Lost to Follow-up|1|||
105814497|NCT03527745|364980722|FG021|Overall Study|Lost to Follow-up|5|||
105814498|NCT03527745|364980723|FG022|Overall Study|Lost to Follow-up|6|||
105814499|NCT03527745|364980724|FG023|Overall Study|Lost to Follow-up|8|||
105814500|NCT03527745|364980725|FG024|Overall Study|Lost to Follow-up|1|||
105814501|NCT03527745|364980726|FG025|Overall Study|Lost to Follow-up|3|||
105814502|NCT00728949|364980730|FG000|Overall Study|Adverse Event|8|||
105814503|NCT00728949|364980731|FG001|Overall Study|Adverse Event|0|||
105814504|NCT00728949|364980730|FG000|Overall Study|Withdrawal by Subject|2|||
105814505|NCT00728949|364980731|FG001|Overall Study|Withdrawal by Subject|2|||
105814506|NCT00728949|364980730|FG000|Overall Study|Abnormal Lab Results|0|||
105814507|NCT00728949|364980731|FG001|Overall Study|Abnormal Lab Results|2|||
105814508|NCT00728949|364980730|FG000|Overall Study|On treatment at cutoff date|1|||
105814509|NCT00728949|364980731|FG001|Overall Study|On treatment at cutoff date|0|||
105814510|NCT04015232|364980732|FG000|Overall Study|Withdrawal by Subject|7|||
105814511|NCT04015232|364980733|FG001|Overall Study|Withdrawal by Subject|4|||
105814512|NCT04015232|364980732|FG000|Overall Study|Protocol Violation|1|||
105814513|NCT04015232|364980733|FG001|Overall Study|Protocol Violation|0|||
105814514|NCT04015232|364980732|FG000|Overall Study|Medical Grounds|3|||
105814515|NCT04015232|364980733|FG001|Overall Study|Medical Grounds|3|||
105814516|NCT01996033|364980734|FG000|Overall Study|Death|1|||
105814517|NCT01996033|364980734|FG000|Overall Study|Physician Decision|1|||
105814518|NCT01996033|364980734|FG000|Overall Study|Withdrawal by Subject|4|||
105814519|NCT01996033|364980734|FG000|Overall Study|Lost to Follow-up|3|||
105814520|NCT01315249|364980735|FG000|Overall Study|Adverse Event|22|||
105814521|NCT01315249|364980736|FG001|Overall Study|Adverse Event|26|||
105814522|NCT01315249|364980735|FG000|Overall Study|Withdrawal by Subject|11|||
105814523|NCT01315249|364980736|FG001|Overall Study|Withdrawal by Subject|10|||
105814524|NCT01315249|364980735|FG000|Overall Study|Protocol Violation|8|||
105814525|NCT01315249|364980736|FG001|Overall Study|Protocol Violation|5|||
105814526|NCT01315249|364980735|FG000|Overall Study|Abnormal test results|1|||
105814527|NCT01315249|364980736|FG001|Overall Study|Abnormal test results|2|||
105486141|NCT04761627|363791411|FG000|Run-in Period|Adverse Event|6|||
105486142|NCT04761627|363791412|FG001|Run-in Period|Adverse Event|0|||
105486143|NCT04761627|363791413|FG002|Run-in Period|Adverse Event|0|||
105486144|NCT04761627|363791411|FG000|Run-in Period|Withdrawal by Subject|7|||
105814528|NCT01315249|364980735|FG000|Overall Study|Administrative problems|1|||
105814529|NCT01315249|364980736|FG001|Overall Study|Administrative problems|0|||
105814530|NCT01315249|364980735|FG000|Overall Study|inability to use device|1|||
105486145|NCT04761627|363791412|FG001|Run-in Period|Withdrawal by Subject|0|||
105814531|NCT01315249|364980736|FG001|Overall Study|inability to use device|0|||
105814532|NCT01315249|364980735|FG000|Overall Study|Lack of Efficacy|0|||
105814533|NCT01315249|364980736|FG001|Overall Study|Lack of Efficacy|1|||
105814534|NCT01315249|364980735|FG000|Overall Study|Lost to Follow-up|0|||
105814535|NCT01315249|364980736|FG001|Overall Study|Lost to Follow-up|2|||
105362040|NCT02326272|363330144|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105362041|NCT02326272|363330145|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105362042|NCT02326272|363330146|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105362043|NCT02326272|363330147|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105362044|NCT02326272|363330148|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105362045|NCT02326272|363330149|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
105362046|NCT02326272|363330150|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105362047|NCT02326272|363330151|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105362048|NCT02326272|363330152|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105362049|NCT02326272|363330153|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105814536|NCT01315249|364980735|FG000|Overall Study|Death|0|||
105814537|NCT01315249|364980736|FG001|Overall Study|Death|1|||
105814538|NCT03558828|364980739|FG000|Overall Study|Lost to Follow-up|4|||
105814539|NCT03558828|364980740|FG001|Overall Study|Lost to Follow-up|3|||
105814540|NCT03558828|364980741|FG002|Overall Study|Lost to Follow-up|3|||
105814541|NCT03558828|364980742|FG003|Overall Study|Lost to Follow-up|5|||
105814542|NCT03558828|364980743|FG004|Overall Study|Lost to Follow-up|2|||
105814543|NCT03558828|364980744|FG005|Overall Study|Lost to Follow-up|3|||
105814544|NCT03558828|364980739|FG000|Overall Study|dropped before the intervention|1|||
105814545|NCT03558828|364980740|FG001|Overall Study|dropped before the intervention|1|||
105814546|NCT03558828|364980741|FG002|Overall Study|dropped before the intervention|0|||
105814547|NCT03558828|364980742|FG003|Overall Study|dropped before the intervention|0|||
105814548|NCT03558828|364980743|FG004|Overall Study|dropped before the intervention|0|||
105814549|NCT03558828|364980744|FG005|Overall Study|dropped before the intervention|0|||
105814550|NCT00264797|364980747|FG000|Overall Study|Withdrawal by Subject|11|||
105814551|NCT00264797|364980748|FG001|Overall Study|Withdrawal by Subject|11|||
105814552|NCT00264797|364980747|FG000|Overall Study|Lost to Follow-up|9|||
105814553|NCT00264797|364980748|FG001|Overall Study|Lost to Follow-up|17|||
105814554|NCT00264797|364980747|FG000|Overall Study|Moved from area|3|||
105814555|NCT00264797|364980748|FG001|Overall Study|Moved from area|1|||
105814556|NCT00264797|364980747|FG000|Overall Study|Practical Problems|2|||
105814557|NCT00264797|364980748|FG001|Overall Study|Practical Problems|3|||
105814558|NCT00264797|364980747|FG000|Overall Study|Incarceration|4|||
105814559|NCT00264797|364980748|FG001|Overall Study|Incarceration|5|||
105814560|NCT00264797|364980747|FG000|Overall Study|Pressure/advice from Outsiders|1|||
105814561|NCT00264797|364980748|FG001|Overall Study|Pressure/advice from Outsiders|1|||
105814562|NCT00264797|364980747|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
105814563|NCT00264797|364980748|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
105814564|NCT00264797|364980747|FG000|Overall Study|Other|3|||
105814565|NCT00264797|364980748|FG001|Overall Study|Other|4|||
105814566|NCT03227445|364980749|FG000|Period 1 (28 Days)|Adverse Event|1|||
105814567|NCT03227445|364980750|FG001|Period 1 (28 Days)|Adverse Event|2|||
105814568|NCT03227445|364980751|FG002|Period 1 (28 Days)|Adverse Event|0|||
105814569|NCT03227445|364980752|FG003|Period 1 (28 Days)|Adverse Event|1|||
105814570|NCT03227445|364980749|FG000|Period 1 (28 Days)|Protocol Violation|1|||
105814571|NCT03227445|364980750|FG001|Period 1 (28 Days)|Protocol Violation|0|||
105814572|NCT03227445|364980751|FG002|Period 1 (28 Days)|Protocol Violation|0|||
105814573|NCT03227445|364980752|FG003|Period 1 (28 Days)|Protocol Violation|0|||
105814574|NCT03227445|364980749|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
105814575|NCT03227445|364980750|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
105814576|NCT03227445|364980751|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
105814577|NCT03227445|364980752|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
105814578|NCT03227445|364980749|FG000|Period 2 (28 Days)|Adverse Event|1|||
105814579|NCT03227445|364980750|FG001|Period 2 (28 Days)|Adverse Event|0|||
105814580|NCT03227445|364980751|FG002|Period 2 (28 Days)|Adverse Event|2|||
105814581|NCT03227445|364980752|FG003|Period 2 (28 Days)|Adverse Event|1|||
105814582|NCT03227445|364980749|FG000|Period 2 (28 Days)|Protocol Violation|0|||
105814583|NCT03227445|364980750|FG001|Period 2 (28 Days)|Protocol Violation|0|||
105814584|NCT03227445|364980751|FG002|Period 2 (28 Days)|Protocol Violation|0|||
105814585|NCT03227445|364980752|FG003|Period 2 (28 Days)|Protocol Violation|1|||
105814586|NCT03227445|364980749|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
105814587|NCT03227445|364980750|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
105814588|NCT03227445|364980751|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
105362050|NCT02326272|363330154|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105362051|NCT02326272|363330155|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105814589|NCT03227445|364980752|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
105814590|NCT02731157|364980755|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
105814591|NCT00623779|364980757|FG000|Overall Study|Adverse Event|1|||
105814592|NCT00623779|364980758|FG001|Overall Study|Adverse Event|3|||
105814593|NCT00623779|364980759|FG002|Overall Study|Adverse Event|0|||
105814594|NCT00623779|364980757|FG000|Overall Study|Criteria from CSR|2|||
105814595|NCT00623779|364980758|FG001|Overall Study|Criteria from CSR|0|||
105814596|NCT00623779|364980759|FG002|Overall Study|Criteria from CSR|1|||
105763769|NCT03424044|364788862|FG002|First Intervention (76 Hours)|Adverse Event|0|||
105763770|NCT03424044|364788863|FG003|First Intervention (76 Hours)|Adverse Event|0|||
105763771|NCT03424044|364788864|FG004|First Intervention (76 Hours)|Adverse Event|1|||
105763772|NCT03424044|364788865|FG005|First Intervention (76 Hours)|Adverse Event|0|||
105763773|NCT03424044|364788866|FG006|First Intervention (76 Hours)|Adverse Event|0|||
105763774|NCT03424044|364788867|FG007|First Intervention (76 Hours)|Adverse Event|0|||
105763775|NCT03424044|364788868|FG008|First Intervention (76 Hours)|Adverse Event|0|||
105763776|NCT03424044|364788860|FG000|First Intervention (76 Hours)|device issues|0|||
105763777|NCT03424044|364788861|FG001|First Intervention (76 Hours)|device issues|0|||
105763778|NCT03424044|364788862|FG002|First Intervention (76 Hours)|device issues|0|||
105763779|NCT03424044|364788863|FG003|First Intervention (76 Hours)|device issues|0|||
105763780|NCT03424044|364788864|FG004|First Intervention (76 Hours)|device issues|0|||
105763781|NCT03424044|364788865|FG005|First Intervention (76 Hours)|device issues|0|||
105763782|NCT03424044|364788866|FG006|First Intervention (76 Hours)|device issues|1|||
105763783|NCT03424044|364788867|FG007|First Intervention (76 Hours)|device issues|1|||
105763784|NCT03424044|364788868|FG008|First Intervention (76 Hours)|device issues|1|||
105763785|NCT03424044|364788860|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
105763786|NCT03424044|364788861|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
105763787|NCT03424044|364788862|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
105763788|NCT03424044|364788863|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
105763789|NCT03424044|364788864|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
105763790|NCT03424044|364788865|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
105763791|NCT03424044|364788866|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
105763792|NCT03424044|364788867|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
105763793|NCT03424044|364788868|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
105763794|NCT03424044|364788860|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763795|NCT03424044|364788861|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763796|NCT03424044|364788862|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763797|NCT03424044|364788863|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
105763798|NCT03424044|364788864|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763799|NCT03424044|364788865|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763800|NCT03424044|364788866|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763801|NCT03424044|364788867|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763802|NCT03424044|364788868|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763803|NCT02971007|364788869|FG000|Overall Study|Adverse Event|1|||
105763804|NCT02971007|364788870|FG001|Overall Study|Adverse Event|0|||
105763805|NCT02971007|364788871|FG002|Overall Study|Adverse Event|0|||
105763806|NCT02971007|364788869|FG000|Overall Study|Lost to Follow-up|0|||
105763807|NCT02971007|364788870|FG001|Overall Study|Lost to Follow-up|1|||
105763808|NCT02971007|364788871|FG002|Overall Study|Lost to Follow-up|1|||
105763809|NCT02971007|364788869|FG000|Overall Study|Withdrawal by Subject|0|||
105763810|NCT02971007|364788870|FG001|Overall Study|Withdrawal by Subject|1|||
105763811|NCT02971007|364788871|FG002|Overall Study|Withdrawal by Subject|0|||
105763812|NCT02971007|364788869|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
105763813|NCT02971007|364788870|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
105763814|NCT02971007|364788871|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
105763815|NCT02971007|364788869|FG000|Overall Study|Patient discontinued study drug|0|||
105763816|NCT02971007|364788870|FG001|Overall Study|Patient discontinued study drug|1|||
105763817|NCT02971007|364788871|FG002|Overall Study|Patient discontinued study drug|0|||
105763818|NCT01625611|364788873|FG000|Overall Study|No adlib drinks Lab 1|3|||
105763819|NCT01625611|364788874|FG001|Overall Study|No adlib drinks Lab 1|0|||
105763820|NCT01625611|364788873|FG000|Overall Study|Technical issues with PET|1|||
105763821|NCT01625611|364788874|FG001|Overall Study|Technical issues with PET|0|||
105763822|NCT01625611|364788873|FG000|Overall Study|Unable to complete study procedures|1|||
105763823|NCT01625611|364788874|FG001|Overall Study|Unable to complete study procedures|0|||
105763824|NCT01625611|364788873|FG000|Overall Study|Withdrawal by Subject|3|||
105763825|NCT01625611|364788874|FG001|Overall Study|Withdrawal by Subject|0|||
105763826|NCT02038790|364788875|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
105763827|NCT02038790|364788876|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
105763828|NCT00948194|364788877|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
105763829|NCT00948194|364788878|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
105763830|NCT05282121|364788880|FG000|Overall Study|Adverse Event|1|||
105763831|NCT05282121|364788881|FG001|Overall Study|Adverse Event|1|||
105763832|NCT05282121|364788882|FG002|Overall Study|Adverse Event|4|||
105763833|NCT05282121|364788883|FG003|Overall Study|Adverse Event|1|||
105763834|NCT05282121|364788880|FG000|Overall Study|Study Terminated by Sponsor|1|||
105763835|NCT05282121|364788881|FG001|Overall Study|Study Terminated by Sponsor|2|||
105814597|NCT00925769|364980762|FG000|Overall Study|Major toxicity|1|||
105814598|NCT00925769|364980763|FG001|Overall Study|Major toxicity|0|||
105814599|NCT00925769|364980764|FG002|Overall Study|Major toxicity|1|||
105814600|NCT00925769|364980765|FG003|Overall Study|Major toxicity|1|||
105814601|NCT00925769|364980766|FG004|Overall Study|Major toxicity|0|||
105814602|NCT00925769|364980767|FG005|Overall Study|Major toxicity|0|||
105814603|NCT00925769|364980762|FG000|Overall Study|Disease progression|4|||
105814604|NCT00925769|364980763|FG001|Overall Study|Disease progression|5|||
105814605|NCT00925769|364980764|FG002|Overall Study|Disease progression|3|||
105814606|NCT00925769|364980765|FG003|Overall Study|Disease progression|4|||
105814607|NCT00925769|364980766|FG004|Overall Study|Disease progression|2|||
105814608|NCT00925769|364980767|FG005|Overall Study|Disease progression|3|||
105814609|NCT00925769|364980762|FG000|Overall Study|Death|0|||
105814610|NCT00925769|364980763|FG001|Overall Study|Death|0|||
105814611|NCT00925769|364980764|FG002|Overall Study|Death|1|||
105814612|NCT00925769|364980765|FG003|Overall Study|Death|0|||
105814613|NCT00925769|364980766|FG004|Overall Study|Death|0|||
105814614|NCT00925769|364980767|FG005|Overall Study|Death|0|||
105814615|NCT00925769|364980762|FG000|Overall Study|Physician Decision|1|||
105814616|NCT00925769|364980763|FG001|Overall Study|Physician Decision|0|||
105814617|NCT00925769|364980764|FG002|Overall Study|Physician Decision|0|||
105814618|NCT00925769|364980765|FG003|Overall Study|Physician Decision|0|||
105814619|NCT00925769|364980766|FG004|Overall Study|Physician Decision|0|||
105814620|NCT00925769|364980767|FG005|Overall Study|Physician Decision|0|||
105362052|NCT02326272|363330156|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105362053|NCT02326272|363330157|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105362054|NCT02326272|363330143|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
105362055|NCT02326272|363330144|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
105763836|NCT05282121|364788882|FG002|Overall Study|Study Terminated by Sponsor|2|||
105763837|NCT05282121|364788883|FG003|Overall Study|Study Terminated by Sponsor|2|||
105763838|NCT05282121|364788880|FG000|Overall Study|Other than listed|0|||
105763839|NCT05282121|364788881|FG001|Overall Study|Other than listed|0|||
105763840|NCT05282121|364788882|FG002|Overall Study|Other than listed|1|||
105763841|NCT05282121|364788883|FG003|Overall Study|Other than listed|0|||
105763842|NCT05282121|364788880|FG000|Overall Study|No reason available|0|||
105763843|NCT05282121|364788881|FG001|Overall Study|No reason available|0|||
105763844|NCT05282121|364788882|FG002|Overall Study|No reason available|1|||
105763845|NCT05282121|364788883|FG003|Overall Study|No reason available|0|||
105763846|NCT03250624|364788891|FG000|Overall Study|Lack of Efficacy|1|||
105763847|NCT03250624|364788892|FG001|Overall Study|Lack of Efficacy|4|||
105763848|NCT03250624|364788891|FG000|Overall Study|Adverse Event|0|||
105763849|NCT03250624|364788892|FG001|Overall Study|Adverse Event|1|||
105763850|NCT03250624|364788891|FG000|Overall Study|Other|1|||
105763851|NCT03250624|364788892|FG001|Overall Study|Other|2|||
105763852|NCT00063986|364788894|FG000|Overall Study|Withdrawal by Subject|1|||
105763853|NCT00063986|364788894|FG000|Overall Study|Ineligible|1|||
105763854|NCT00063986|364788894|FG000|Overall Study|Intra-operatively ineligible|4|||
105763855|NCT00509028|364788895|FG000|Overall Study|Adverse Event|2|||
105814621|NCT00925769|364980762|FG000|Overall Study|Missing documentation|0|||
105814622|NCT00925769|364980763|FG001|Overall Study|Missing documentation|1|||
105814623|NCT00925769|364980764|FG002|Overall Study|Missing documentation|0|||
105814624|NCT00925769|364980765|FG003|Overall Study|Missing documentation|0|||
105814625|NCT00925769|364980766|FG004|Overall Study|Missing documentation|0|||
105814626|NCT00925769|364980767|FG005|Overall Study|Missing documentation|0|||
105763856|NCT00509028|364788896|FG001|Overall Study|Adverse Event|0|||
105571560|NCT01351025|364091242|FG000|Week 24 - 44|unable to get to clinic|1|||
105571561|NCT01351025|364091243|FG001|Week 24 - 44|unable to get to clinic|1|||
105763857|NCT00509028|364788895|FG000|Overall Study|Withdrawal by Subject|4|||
105763858|NCT00509028|364788896|FG001|Overall Study|Withdrawal by Subject|3|||
105763859|NCT00509028|364788895|FG000|Overall Study|Lost to Follow-up|0|||
105763860|NCT00509028|364788896|FG001|Overall Study|Lost to Follow-up|1|||
105763861|NCT00509028|364788895|FG000|Overall Study|Protocol Violation|4|||
105763862|NCT00509028|364788896|FG001|Overall Study|Protocol Violation|2|||
105763863|NCT00509028|364788895|FG000|Overall Study|Non-compliance|2|||
105763864|NCT00509028|364788896|FG001|Overall Study|Non-compliance|1|||
105763865|NCT02408484|364788900|FG000|Overall Study|Withdrawal by Subject|3|||
105763866|NCT02408484|364788900|FG000|Overall Study|Not treated during study period|1|||
105763867|NCT01510028|364788913|FG000|Overall Study|Lack of Efficacy|1|||
105763868|NCT01510028|364788914|FG001|Overall Study|Lack of Efficacy|0|||
105763869|NCT01510028|364788915|FG002|Overall Study|Lack of Efficacy|0|||
105763870|NCT01510028|364788916|FG003|Overall Study|Lack of Efficacy|0|||
105763871|NCT00633893|364788917|FG000|Overall Study|Death|1|||
105763872|NCT00633893|364788918|FG001|Overall Study|Death|3|||
105763873|NCT00633893|364788919|FG002|Overall Study|Death|9|||
105763874|NCT00633893|364788917|FG000|Overall Study|Adverse Event|65|||
105763875|NCT00633893|364788918|FG001|Overall Study|Adverse Event|58|||
105763876|NCT00633893|364788919|FG002|Overall Study|Adverse Event|126|||
105763877|NCT00633893|364788917|FG000|Overall Study|Withdrawal by Subject|7|||
105763878|NCT00633893|364788918|FG001|Overall Study|Withdrawal by Subject|12|||
105763879|NCT00633893|364788919|FG002|Overall Study|Withdrawal by Subject|6|||
105763880|NCT00633893|364788917|FG000|Overall Study|Lost to Follow-up|2|||
105763881|NCT00633893|364788918|FG001|Overall Study|Lost to Follow-up|4|||
105763882|NCT00633893|364788919|FG002|Overall Study|Lost to Follow-up|8|||
105763883|NCT00633893|364788917|FG000|Overall Study|Poor/non-compliance|5|||
105571562|NCT03734991|364091244|FG000|Overall Study|Adverse Event|4|||
105763884|NCT00633893|364788918|FG001|Overall Study|Poor/non-compliance|12|||
105763885|NCT00633893|364788919|FG002|Overall Study|Poor/non-compliance|3|||
105763886|NCT00633893|364788917|FG000|Overall Study|Pregnancy|2|||
105763887|NCT00633893|364788918|FG001|Overall Study|Pregnancy|1|||
105763888|NCT00633893|364788919|FG002|Overall Study|Pregnancy|1|||
105814627|NCT00925769|364980762|FG000|Overall Study|End of study visit not done|0|||
105814628|NCT00925769|364980763|FG001|Overall Study|End of study visit not done|0|||
105814629|NCT00925769|364980764|FG002|Overall Study|End of study visit not done|1|||
105814630|NCT00925769|364980765|FG003|Overall Study|End of study visit not done|0|||
105814631|NCT00925769|364980766|FG004|Overall Study|End of study visit not done|0|||
105814632|NCT00925769|364980767|FG005|Overall Study|End of study visit not done|0|||
105814633|NCT00925769|364980762|FG000|Overall Study|Participant is unable to swallow drug|0|||
105814634|NCT00925769|364980763|FG001|Overall Study|Participant is unable to swallow drug|0|||
105814635|NCT00925769|364980764|FG002|Overall Study|Participant is unable to swallow drug|0|||
105814636|NCT00925769|364980765|FG003|Overall Study|Participant is unable to swallow drug|1|||
105814637|NCT00925769|364980766|FG004|Overall Study|Participant is unable to swallow drug|0|||
105814638|NCT00925769|364980767|FG005|Overall Study|Participant is unable to swallow drug|0|||
105814639|NCT00925769|364980762|FG000|Overall Study|Adverse Event|0|||
105814640|NCT00925769|364980763|FG001|Overall Study|Adverse Event|0|||
105814641|NCT00925769|364980764|FG002|Overall Study|Adverse Event|0|||
105814642|NCT00925769|364980765|FG003|Overall Study|Adverse Event|0|||
105814643|NCT00925769|364980766|FG004|Overall Study|Adverse Event|1|||
105814644|NCT00925769|364980767|FG005|Overall Study|Adverse Event|0|||
105814645|NCT02017964|364980768|FG000|Overall Study|Patient deemed ineligible|1|||
105814646|NCT02732210|364980769|FG000|Overall Study|Site Closed|0|||
105814647|NCT02732210|364980770|FG001|Overall Study|Site Closed|11|||
105814648|NCT02732210|364980769|FG000|Overall Study|Study Ended|13|||
105814649|NCT02732210|364980770|FG001|Overall Study|Study Ended|13|||
105814650|NCT02732210|364980769|FG000|Overall Study|Withdrawal by Subject|28|||
105814651|NCT02732210|364980770|FG001|Overall Study|Withdrawal by Subject|87|||
105814652|NCT02732210|364980769|FG000|Overall Study|Lost to Follow-up|5|||
105814653|NCT02732210|364980770|FG001|Overall Study|Lost to Follow-up|57|||
105814654|NCT02732210|364980769|FG000|Overall Study|Death|4|||
105814655|NCT02732210|364980770|FG001|Overall Study|Death|15|||
105814656|NCT02732210|364980769|FG000|Overall Study|Other|35|||
105814657|NCT02732210|364980770|FG001|Overall Study|Other|103|||
105814658|NCT02732210|364980769|FG000|Overall Study|Missing|0|||
105814659|NCT02732210|364980770|FG001|Overall Study|Missing|8|||
105814660|NCT00686959|364980774|FG000|Overall Study|Participants censored (no death events)|124|||
105814661|NCT00686959|364980775|FG001|Overall Study|Participants censored (no death events)|117|||
105814662|NCT01038856|364980776|FG000|Overall Study|Adverse Event|2|||
105814663|NCT04638153|364980780|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105814664|NCT04638153|364980781|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105814665|NCT04638153|364980782|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105814666|NCT04638153|364980780|FG000|Overall Study|Study terminated by sponsor|4|||
105814667|NCT04638153|364980781|FG001|Overall Study|Study terminated by sponsor|2|||
105814668|NCT04638153|364980782|FG002|Overall Study|Study terminated by sponsor|14|||
105814669|NCT01434693|364980785|FG000|Overall Study|Adverse Event|1|||
105814670|NCT01434693|364980786|FG001|Overall Study|Adverse Event|0|||
105814671|NCT01434693|364980787|FG002|Overall Study|Adverse Event|0|||
105814672|NCT01434693|364980788|FG003|Overall Study|Adverse Event|0|||
105814673|NCT01434693|364980785|FG000|Overall Study|Withdrawal by Subject|1|||
105814674|NCT01434693|364980786|FG001|Overall Study|Withdrawal by Subject|0|||
105814675|NCT01434693|364980787|FG002|Overall Study|Withdrawal by Subject|1|||
105814676|NCT01434693|364980788|FG003|Overall Study|Withdrawal by Subject|1|||
105814677|NCT01434693|364980785|FG000|Overall Study|Lost to Follow-up|1|||
105814678|NCT01434693|364980786|FG001|Overall Study|Lost to Follow-up|0|||
105814679|NCT01434693|364980787|FG002|Overall Study|Lost to Follow-up|0|||
105814680|NCT01434693|364980788|FG003|Overall Study|Lost to Follow-up|0|||
105814681|NCT03912337|364980792|FG000|Overall Study|Withdrawal of Consent From Study|1|||
105814682|NCT03912337|364980793|FG001|Overall Study|Withdrawal of Consent From Study|0|||
105814683|NCT03912337|364980792|FG000|Overall Study|Lost to Follow-up|1|||
105814684|NCT03912337|364980793|FG001|Overall Study|Lost to Follow-up|1|||
105571563|NCT03734991|364091245|FG001|Overall Study|Adverse Event|0|||
105814685|NCT00537030|364980794|FG000|Overall Study|Physician Decision|2|||
105814686|NCT00537030|364980794|FG000|Overall Study|Withdrawal by Subject|2|||
105814687|NCT00537030|364980794|FG000|Overall Study|≥ Grade 2 allergy|7|||
105814688|NCT00537030|364980794|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
105814689|NCT00537030|364980794|FG000|Overall Study|Ineligible|2|||
105814690|NCT00537030|364980794|FG000|Overall Study|Inevaluable|2|||
105571564|NCT03734991|364091244|FG000|Overall Study|Lost to Follow-up|4|||
105814691|NCT02458469|364980795|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
105814692|NCT02458469|364980796|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
105814693|NCT02458469|364980797|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
105814694|NCT02458469|364980798|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
105814695|NCT02458469|364980799|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
105362056|NCT02326272|363330145|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
105362057|NCT02326272|363330146|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
105362058|NCT02326272|363330147|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
105362059|NCT02326272|363330148|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
105362060|NCT02326272|363330149|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
105362061|NCT02326272|363330150|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
105362062|NCT02326272|363330151|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
105763889|NCT00633893|364788917|FG000|Overall Study|Not meet/no longer meets criteria|4|||
105763890|NCT00633893|364788918|FG001|Overall Study|Not meet/no longer meets criteria|6|||
105763891|NCT00633893|364788919|FG002|Overall Study|Not meet/no longer meets criteria|4|||
105763892|NCT00633893|364788917|FG000|Overall Study|Other|28|||
105763893|NCT00633893|364788918|FG001|Overall Study|Other|33|||
105763894|NCT00633893|364788919|FG002|Overall Study|Other|31|||
105763895|NCT01675141|364788920|FG000|Overall Study|Lenalidomide outside NIH|3|||
105763896|NCT01675141|364788920|FG000|Overall Study|Withdrawal by Subject|3|||
105763897|NCT01675141|364788920|FG000|Overall Study|Physician Decision|4|||
105763898|NCT01675141|364788920|FG000|Overall Study|No treatment, per protocol|1|||
105763899|NCT01838213|364788923|FG000|Overall Study|Ineligible|166|||
105763900|NCT01838213|364788924|FG001|Overall Study|Ineligible|191|||
105763901|NCT02918318|364788925|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
105763902|NCT02918318|364788926|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
105763903|NCT02918318|364788927|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
105763904|NCT02918318|364788928|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
105763905|NCT02918318|364788929|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
105763906|NCT02918318|364788925|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
105763907|NCT02918318|364788926|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
105763908|NCT02918318|364788927|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
105763909|NCT02918318|364788928|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
105763910|NCT02918318|364788929|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
105763911|NCT02918318|364788925|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
105763912|NCT02918318|364788926|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
105763913|NCT02918318|364788927|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
105763914|NCT02918318|364788928|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
105763915|NCT02918318|364788929|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
105763916|NCT02918318|364788925|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
105763917|NCT02918318|364788926|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
105763918|NCT02918318|364788927|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
105763919|NCT02918318|364788928|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
105763920|NCT02918318|364788929|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
105763921|NCT02918318|364788925|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
105763922|NCT02918318|364788926|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
105763923|NCT02918318|364788927|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
105763924|NCT02918318|364788928|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
105763925|NCT02918318|364788929|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
105763926|NCT02918318|364788925|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
105763927|NCT02918318|364788926|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
105763928|NCT02918318|364788927|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
105763929|NCT02918318|364788928|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
105763930|NCT02918318|364788929|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
105362063|NCT02326272|363330152|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
105362064|NCT02326272|363330153|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
105571565|NCT03734991|364091245|FG001|Overall Study|Lost to Follow-up|0|||
105763931|NCT02918318|364788925|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
105763932|NCT02918318|364788926|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
105763933|NCT02918318|364788927|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
105571566|NCT03734991|364091244|FG000|Overall Study|Physician Decision|0|||
105571567|NCT03734991|364091245|FG001|Overall Study|Physician Decision|1|||
105763934|NCT02918318|364788928|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
105763935|NCT02918318|364788929|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
105763936|NCT02918318|364788925|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
105763937|NCT02918318|364788926|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
105763938|NCT02918318|364788927|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
105763939|NCT02918318|364788928|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
105763940|NCT02918318|364788929|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
105763941|NCT02918318|364788925|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
105763942|NCT02918318|364788926|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
105763943|NCT02918318|364788927|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
105763944|NCT02918318|364788928|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
105763945|NCT02918318|364788929|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
105763946|NCT02918318|364788925|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
105763947|NCT02918318|364788926|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
105763948|NCT02918318|364788927|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
105763949|NCT02918318|364788928|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
105763950|NCT02918318|364788929|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
105763951|NCT02918318|364788925|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
105763952|NCT02918318|364788926|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
105763953|NCT02918318|364788927|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
105763954|NCT02918318|364788928|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
105763955|NCT02918318|364788929|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
105763956|NCT02918318|364788925|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
105763957|NCT02918318|364788926|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
105763958|NCT02918318|364788927|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
105763959|NCT02918318|364788928|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
105763960|NCT02918318|364788929|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
105763961|NCT04685538|364788930|FG000|Overall Study|Adverse Event|0|||
105763962|NCT04685538|364788931|FG001|Overall Study|Adverse Event|1|||
105763963|NCT04685538|364788930|FG000|Overall Study|Lost to Follow-up|0|||
105763964|NCT04685538|364788931|FG001|Overall Study|Lost to Follow-up|2|||
105763965|NCT00770224|364788936|FG000|Step 1: Induction|Adverse Event|3|||
105763966|NCT00770224|364788937|FG001|Step 1: Induction|Adverse Event|0|||
105763967|NCT00770224|364788936|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
105763968|NCT00770224|364788937|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
105763969|NCT00770224|364788936|FG000|Step 1: Induction|Other reason not protocol specified|2|||
105763970|NCT00770224|364788937|FG001|Step 1: Induction|Other reason not protocol specified|0|||
105763971|NCT00770224|364788936|FG000|Step 1: Induction|Ineligible|2|||
105763972|NCT00770224|364788937|FG001|Step 1: Induction|Ineligible|0|||
105763973|NCT00770224|364788936|FG000|Step 1: Induction|No protocol treatment given|1|||
105763974|NCT00770224|364788937|FG001|Step 1: Induction|No protocol treatment given|0|||
105763975|NCT00770224|364788936|FG000|Step 2: Maintenance|Adverse Event|0|||
105763976|NCT00770224|364788937|FG001|Step 2: Maintenance|Adverse Event|10|||
105763977|NCT00770224|364788936|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
105763978|NCT00770224|364788937|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
105362065|NCT02326272|363330154|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
105814696|NCT02458469|364980800|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
105814697|NCT02458469|364980795|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
105814698|NCT02458469|364980796|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
105814699|NCT02458469|364980797|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
105814700|NCT02458469|364980798|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
105814701|NCT02458469|364980799|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
105814702|NCT02458469|364980800|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
105814703|NCT02458469|364980795|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
105814704|NCT02458469|364980796|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
105814705|NCT02458469|364980797|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
105814706|NCT02458469|364980798|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
105814707|NCT02458469|364980799|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
105814708|NCT02458469|364980800|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
105814709|NCT02849652|364980801|FG000|Overall Study|Lost to Follow-up|104|||
105814710|NCT02849652|364980802|FG001|Overall Study|Lost to Follow-up|35|||
105814711|NCT02849652|364980803|FG002|Overall Study|Lost to Follow-up|116|||
105814712|NCT02849652|364980804|FG003|Overall Study|Lost to Follow-up|22|||
105814713|NCT02849652|364980801|FG000|Overall Study|Withdrawal by Subject|10|||
105814714|NCT02849652|364980802|FG001|Overall Study|Withdrawal by Subject|2|||
105814715|NCT02849652|364980803|FG002|Overall Study|Withdrawal by Subject|8|||
105814716|NCT02849652|364980804|FG003|Overall Study|Withdrawal by Subject|4|||
105814717|NCT00472290|364980805|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
105814718|NCT00472290|364980805|FG000|Overall Study|Protocol Specified Criteria|7|||
105814719|NCT00472290|364980805|FG000|Overall Study|Administrative Decision|37|||
105814720|NCT00472290|364980805|FG000|Overall Study|Death|3|||
105814721|NCT00472290|364980805|FG000|Overall Study|Lost to Follow-up|1|||
105814722|NCT00472290|364980805|FG000|Overall Study|Lack of Efficacy|1|||
105362066|NCT02326272|363330155|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
105362067|NCT02326272|363330156|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
105362068|NCT02326272|363330157|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
105362069|NCT02326272|363330143|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105362070|NCT02326272|363330144|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105362071|NCT02326272|363330145|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105362072|NCT02326272|363330146|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105362073|NCT02326272|363330147|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105362074|NCT02326272|363330148|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105362075|NCT02326272|363330149|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105362076|NCT02326272|363330150|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105362077|NCT02326272|363330151|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105362078|NCT02326272|363330152|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105362079|NCT02326272|363330153|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
105362080|NCT02326272|363330154|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
105362081|NCT02326272|363330155|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
105362082|NCT02326272|363330156|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105362083|NCT02326272|363330157|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
105814723|NCT00472290|364980805|FG000|Overall Study|Disease Progression|4|||
105814724|NCT00472290|364980805|FG000|Overall Study|Withdrawal by Subject|5|||
105814725|NCT00472290|364980805|FG000|Overall Study|Adverse Event|6|||
105814726|NCT00472290|364980805|FG000|Overall Study|Requirement for alternative therapy|7|||
105814727|NCT00610363|364980812|FG000|Overall Study|Non-compliance with protocol|0|||
105814728|NCT00610363|364980813|FG001|Overall Study|Non-compliance with protocol|1|||
105814729|NCT00610363|364980812|FG000|Overall Study|Adverse Event|3|||
105814730|NCT00610363|364980813|FG001|Overall Study|Adverse Event|1|||
105362084|NCT02326272|363330143|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105486146|NCT04761627|363791413|FG002|Run-in Period|Withdrawal by Subject|0|||
105486147|NCT04761627|363791411|FG000|Run-in Period|Did not meet PASI 50|15|||
105814731|NCT00610363|364980812|FG000|Overall Study|Lack of Efficacy|2|||
105814732|NCT00610363|364980813|FG001|Overall Study|Lack of Efficacy|0|||
105814733|NCT00610363|364980812|FG000|Overall Study|Lost to Follow-up|4|||
105814734|NCT00610363|364980813|FG001|Overall Study|Lost to Follow-up|0|||
105814735|NCT00610363|364980812|FG000|Overall Study|Withdrawal by Subject|1|||
105814736|NCT00610363|364980813|FG001|Overall Study|Withdrawal by Subject|0|||
105814737|NCT00610363|364980812|FG000|Overall Study|Other than specified above|1|||
105814738|NCT00610363|364980813|FG001|Overall Study|Other than specified above|1|||
105814739|NCT00870870|364980816|FG000|Overall Study|Withdrawal by Subject|0|||
105814740|NCT00870870|364980817|FG001|Overall Study|Withdrawal by Subject|1|||
105814741|NCT00870870|364980818|FG002|Overall Study|Withdrawal by Subject|1|||
105814742|NCT00870870|364980819|FG003|Overall Study|Withdrawal by Subject|3|||
105814743|NCT00870870|364980816|FG000|Overall Study|Adverse Event|0|||
105814744|NCT00870870|364980817|FG001|Overall Study|Adverse Event|0|||
105814745|NCT00870870|364980818|FG002|Overall Study|Adverse Event|2|||
105814746|NCT00870870|364980819|FG003|Overall Study|Adverse Event|2|||
105814747|NCT00319735|364980826|FG000|Overall Study|Death|2|||
105814748|NCT00119379|364980827|FG000|Overall Study|Adverse Event|4|||
105814749|NCT00119379|364980828|FG001|Overall Study|Adverse Event|1|||
105814750|NCT00444145|364981872|FG000|Overall Study|Withdrawal by Subject|2|||
105814751|NCT00444145|364981872|FG000|Overall Study|Lost to Follow-up|1|||
105814752|NCT00444145|364981872|FG000|Overall Study|non-compliant|11|||
105814753|NCT00444145|364981872|FG000|Overall Study|Screen Failures|5|||
105814754|NCT01374919|364981873|FG000|Overall Study|Withdrawal by Subject|2|||
105814755|NCT03805438|364981874|FG000|Overall Study|Lack of Efficacy|1|||
105814756|NCT03805438|364981874|FG000|Overall Study|Protocol Violation|1|||
105814757|NCT00366899|364981875|FG000|Infant Series|Withdrawal by Subject|4|||
105814758|NCT00366899|364981876|FG001|Infant Series|Withdrawal by Subject|7|||
105814759|NCT00366899|364981875|FG000|Infant Series|Protocol Violation|2|||
105814760|NCT00366899|364981876|FG001|Infant Series|Protocol Violation|1|||
105814761|NCT00366899|364981875|FG000|Infant Series|Failed to return|1|||
105814762|NCT00366899|364981876|FG001|Infant Series|Failed to return|1|||
105814763|NCT00366899|364981875|FG000|Infant Series|Lost to Follow-up|0|||
105814764|NCT00366899|364981876|FG001|Infant Series|Lost to Follow-up|2|||
105814765|NCT00366899|364981875|FG000|Infant Series|Adverse Event|0|||
105814766|NCT00366899|364981876|FG001|Infant Series|Adverse Event|1|||
105814767|NCT00366899|364981875|FG000|Infant Series|Physician Decision|1|||
105814768|NCT00366899|364981876|FG001|Infant Series|Physician Decision|0|||
105814769|NCT00366899|364981875|FG000|Infant Series|Randomized but not consented|1|||
105814770|NCT00366899|364981876|FG001|Infant Series|Randomized but not consented|0|||
105814771|NCT00366899|364981875|FG000|After Infant Series|Lost to Follow-up|4|||
105814772|NCT00366899|364981876|FG001|After Infant Series|Lost to Follow-up|3|||
105814773|NCT00366899|364981875|FG000|After Infant Series|Withdrawal by Subject|1|||
105814774|NCT00366899|364981876|FG001|After Infant Series|Withdrawal by Subject|4|||
105814775|NCT00366899|364981875|FG000|After Infant Series|Adverse Event|1|||
105814776|NCT00366899|364981876|FG001|After Infant Series|Adverse Event|2|||
105814777|NCT00366899|364981875|FG000|After Infant Series|Protocol Violation|1|||
105814778|NCT00366899|364981876|FG001|After Infant Series|Protocol Violation|0|||
105814779|NCT00366899|364981875|FG000|Toddler Dose|Withdrawal by Subject|1|||
105814780|NCT00366899|364981876|FG001|Toddler Dose|Withdrawal by Subject|1|||
105814781|NCT00366899|364981875|FG000|Toddler Dose|Protocol Violation|1|||
105814782|NCT00366899|364981876|FG001|Toddler Dose|Protocol Violation|0|||
105814783|NCT00419770|364981878|FG000|Overall Study|Withdrawal by Subject|5|||
105814784|NCT00419770|364981879|FG001|Overall Study|Withdrawal by Subject|1|||
105814785|NCT02848326|364981881|FG000|Treatment Period|Adverse Event|5|||
105814786|NCT02848326|364981882|FG001|Treatment Period|Adverse Event|4|||
105814787|NCT02848326|364981883|FG002|Treatment Period|Adverse Event|11|||
105814788|NCT02848326|364981884|FG003|Treatment Period|Adverse Event|6|||
105814789|NCT02848326|364981885|FG004|Treatment Period|Adverse Event|5|||
105814790|NCT02848326|364981886|FG005|Treatment Period|Adverse Event|7|||
105814791|NCT02848326|364981881|FG000|Treatment Period|Withdrawal of Consent|20|||
105486148|NCT04761627|363791412|FG001|Run-in Period|Did not meet PASI 50|0|||
105486149|NCT04761627|363791413|FG002|Run-in Period|Did not meet PASI 50|0|||
105486150|NCT04761627|363791411|FG000|Run-in Period|Study site closure|2|||
105814792|NCT02848326|364981882|FG001|Treatment Period|Withdrawal of Consent|6|||
105814793|NCT02848326|364981883|FG002|Treatment Period|Withdrawal of Consent|9|||
105814794|NCT02848326|364981884|FG003|Treatment Period|Withdrawal of Consent|6|||
105814795|NCT02848326|364981885|FG004|Treatment Period|Withdrawal of Consent|9|||
105814796|NCT02848326|364981886|FG005|Treatment Period|Withdrawal of Consent|6|||
105814797|NCT02848326|364981881|FG000|Treatment Period|Lost to Follow-up|5|||
105814798|NCT02848326|364981882|FG001|Treatment Period|Lost to Follow-up|1|||
105814799|NCT02848326|364981883|FG002|Treatment Period|Lost to Follow-up|11|||
105814800|NCT02848326|364981884|FG003|Treatment Period|Lost to Follow-up|7|||
105814801|NCT02848326|364981885|FG004|Treatment Period|Lost to Follow-up|2|||
105814802|NCT02848326|364981886|FG005|Treatment Period|Lost to Follow-up|3|||
105814803|NCT02848326|364981881|FG000|Treatment Period|Pregnancy|0|||
105362085|NCT02326272|363330144|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105362086|NCT02326272|363330145|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105362087|NCT02326272|363330146|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105362088|NCT02326272|363330147|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105362089|NCT02326272|363330148|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105486151|NCT04761627|363791412|FG001|Run-in Period|Study site closure|0|||
105814804|NCT02848326|364981882|FG001|Treatment Period|Pregnancy|0|||
105814805|NCT02848326|364981883|FG002|Treatment Period|Pregnancy|1|||
105814806|NCT02848326|364981884|FG003|Treatment Period|Pregnancy|1|||
105814807|NCT02848326|364981885|FG004|Treatment Period|Pregnancy|0|||
105814808|NCT02848326|364981886|FG005|Treatment Period|Pregnancy|1|||
105814809|NCT02848326|364981881|FG000|Treatment Period|Protocol Violation|4|||
105814810|NCT02848326|364981882|FG001|Treatment Period|Protocol Violation|3|||
105814811|NCT02848326|364981883|FG002|Treatment Period|Protocol Violation|4|||
105814812|NCT02848326|364981884|FG003|Treatment Period|Protocol Violation|2|||
105814813|NCT02848326|364981885|FG004|Treatment Period|Protocol Violation|3|||
105814814|NCT02848326|364981886|FG005|Treatment Period|Protocol Violation|3|||
105814815|NCT02848326|364981881|FG000|Treatment Period|Non-compliance with Study Drug|4|||
105814816|NCT02848326|364981882|FG001|Treatment Period|Non-compliance with Study Drug|0|||
105814817|NCT02848326|364981883|FG002|Treatment Period|Non-compliance with Study Drug|0|||
105814818|NCT02848326|364981884|FG003|Treatment Period|Non-compliance with Study Drug|1|||
105814819|NCT02848326|364981885|FG004|Treatment Period|Non-compliance with Study Drug|0|||
105814820|NCT02848326|364981886|FG005|Treatment Period|Non-compliance with Study Drug|0|||
105814821|NCT02848326|364981881|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
105814822|NCT02848326|364981882|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
105814823|NCT02848326|364981883|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
105814824|NCT02848326|364981884|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
105814825|NCT02848326|364981885|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
105814826|NCT02848326|364981886|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
105814827|NCT02848326|364981881|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
105814828|NCT02848326|364981882|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
105814829|NCT02848326|364981883|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
105814830|NCT02848326|364981884|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
105814831|NCT02848326|364981885|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
105814832|NCT02848326|364981886|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
105814833|NCT00414466|364981887|FG000|Overall Study|Adverse Event|0|||
105814834|NCT00414466|364981888|FG001|Overall Study|Adverse Event|0|||
105814835|NCT00414466|364981889|FG002|Overall Study|Adverse Event|1|||
105814836|NCT00414466|364981890|FG003|Overall Study|Adverse Event|1|||
105814837|NCT00414466|364981887|FG000|Overall Study|Lack of Efficacy|1|||
105814838|NCT00414466|364981888|FG001|Overall Study|Lack of Efficacy|0|||
105814839|NCT00414466|364981889|FG002|Overall Study|Lack of Efficacy|0|||
105814840|NCT00414466|364981890|FG003|Overall Study|Lack of Efficacy|0|||
105814841|NCT00414466|364981887|FG000|Overall Study|Withdrawn by Sponsor|1|||
105814842|NCT00414466|364981888|FG001|Overall Study|Withdrawn by Sponsor|0|||
105814843|NCT00414466|364981889|FG002|Overall Study|Withdrawn by Sponsor|0|||
105814844|NCT00414466|364981890|FG003|Overall Study|Withdrawn by Sponsor|0|||
105814845|NCT04526210|364981896|FG000|Overall Study|Sponsor decision|7|||
105814846|NCT04526210|364981897|FG001|Overall Study|Sponsor decision|5|||
105814847|NCT04526210|364981896|FG000|Overall Study|Withdrawal by Subject|3|||
105814848|NCT04526210|364981897|FG001|Overall Study|Withdrawal by Subject|2|||
105814849|NCT01781637|364981898|FG000|Overall Study|Adverse Event|1|||
105814850|NCT01781637|364981899|FG001|Overall Study|Adverse Event|0|||
105814851|NCT01781637|364981898|FG000|Overall Study|Lack of Efficacy|2|||
105814852|NCT01781637|364981899|FG001|Overall Study|Lack of Efficacy|6|||
105814853|NCT01781637|364981898|FG000|Overall Study|Withdrawal by Subject|1|||
105814854|NCT01781637|364981899|FG001|Overall Study|Withdrawal by Subject|0|||
105814855|NCT02637232|364981900|FG000|Overall Study|Lost to Follow-up|42|||
105814856|NCT02637232|364981900|FG000|Overall Study|Adverse Event|11|||
105814857|NCT02637232|364981900|FG000|Overall Study|patient 's decision|2|||
105814858|NCT02999178|364981901|FG000|Overall Study|Adverse Event|85|||
105814859|NCT02999178|364981902|FG001|Overall Study|Adverse Event|62|||
105814860|NCT02999178|364981901|FG000|Overall Study|Protocol Violation|1|||
105814861|NCT02999178|364981902|FG001|Overall Study|Protocol Violation|2|||
105814862|NCT02999178|364981901|FG000|Overall Study|Lost to Follow-up|0|||
105814863|NCT02999178|364981902|FG001|Overall Study|Lost to Follow-up|2|||
105814864|NCT02999178|364981901|FG000|Overall Study|Withdrawal by Subject|21|||
105814865|NCT02999178|364981902|FG001|Overall Study|Withdrawal by Subject|21|||
105814866|NCT02999178|364981901|FG000|Overall Study|Other reason not defined above|7|||
105814867|NCT02999178|364981902|FG001|Overall Study|Other reason not defined above|13|||
105814868|NCT00433147|364981904|FG000|Overall Study|Adverse Event|0|||
105814869|NCT00433147|364981905|FG001|Overall Study|Adverse Event|1|||
105814870|NCT00433147|364981906|FG002|Overall Study|Adverse Event|0|||
105814871|NCT00433147|364981907|FG003|Overall Study|Adverse Event|0|||
105814872|NCT02937701|364981908|FG000|Day 1 to Week 22|Adverse Event|11|||
105814873|NCT02937701|364981909|FG001|Day 1 to Week 22|Adverse Event|14|||
105814874|NCT02937701|364981910|FG002|Day 1 to Week 22|Adverse Event|0|||
105814875|NCT02937701|364981911|FG003|Day 1 to Week 22|Adverse Event|0|||
105814876|NCT02937701|364981912|FG004|Day 1 to Week 22|Adverse Event|0|||
105814877|NCT02937701|364981908|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
105814878|NCT02937701|364981909|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
105814879|NCT02937701|364981910|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
105814880|NCT02937701|364981911|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
105814881|NCT02937701|364981912|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
105814882|NCT02937701|364981908|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
105814883|NCT02937701|364981909|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
105814884|NCT02937701|364981910|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
105814885|NCT02937701|364981911|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
105814886|NCT02937701|364981912|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
105814887|NCT02937701|364981908|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
105814888|NCT02937701|364981909|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
105814889|NCT02937701|364981910|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
105814890|NCT02937701|364981911|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
105814891|NCT02937701|364981912|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
105814892|NCT02937701|364981908|FG000|Day 1 to Week 22|Death|1|||
105814893|NCT02937701|364981909|FG001|Day 1 to Week 22|Death|1|||
105814894|NCT02937701|364981910|FG002|Day 1 to Week 22|Death|0|||
105814895|NCT02937701|364981911|FG003|Day 1 to Week 22|Death|0|||
105814896|NCT02937701|364981912|FG004|Day 1 to Week 22|Death|0|||
105814897|NCT02937701|364981908|FG000|Day 1 to Week 22|Protocol Violation|1|||
105814898|NCT02937701|364981909|FG001|Day 1 to Week 22|Protocol Violation|1|||
105814899|NCT02937701|364981910|FG002|Day 1 to Week 22|Protocol Violation|0|||
105814900|NCT02937701|364981911|FG003|Day 1 to Week 22|Protocol Violation|0|||
105814901|NCT02937701|364981912|FG004|Day 1 to Week 22|Protocol Violation|0|||
105814902|NCT02937701|364981908|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
105814903|NCT02937701|364981909|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
105814904|NCT02937701|364981910|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
105814905|NCT02937701|364981911|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
105814906|NCT02937701|364981912|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
105814907|NCT02937701|364981908|FG000|Day 1 to Week 22|Physician Decision|2|||
105814908|NCT02937701|364981909|FG001|Day 1 to Week 22|Physician Decision|0|||
105814909|NCT02937701|364981910|FG002|Day 1 to Week 22|Physician Decision|0|||
105814910|NCT02937701|364981911|FG003|Day 1 to Week 22|Physician Decision|0|||
105814911|NCT02937701|364981912|FG004|Day 1 to Week 22|Physician Decision|0|||
105814912|NCT02937701|364981908|FG000|Day 1 to Week 22|Other|1|||
105814913|NCT02937701|364981909|FG001|Day 1 to Week 22|Other|0|||
105814914|NCT02937701|364981910|FG002|Day 1 to Week 22|Other|0|||
105814915|NCT02937701|364981911|FG003|Day 1 to Week 22|Other|0|||
105814916|NCT02937701|364981912|FG004|Day 1 to Week 22|Other|0|||
105814917|NCT02937701|364981908|FG000|Week 22 to Week 50|Adverse Event|0|||
105814918|NCT02937701|364981909|FG001|Week 22 to Week 50|Adverse Event|0|||
105814919|NCT02937701|364981910|FG002|Week 22 to Week 50|Adverse Event|10|||
105814920|NCT02937701|364981911|FG003|Week 22 to Week 50|Adverse Event|3|||
105814921|NCT02937701|364981912|FG004|Week 22 to Week 50|Adverse Event|3|||
105814922|NCT02937701|364981908|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
105814923|NCT02937701|364981909|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
105814924|NCT02937701|364981910|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
105814925|NCT02937701|364981911|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
105814926|NCT02937701|364981912|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
105814927|NCT02937701|364981908|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
105814928|NCT02937701|364981909|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
105814929|NCT02937701|364981910|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
105814930|NCT02937701|364981911|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
105814931|NCT02937701|364981912|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
105814932|NCT02937701|364981908|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
105814933|NCT02937701|364981909|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
105814934|NCT02937701|364981910|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
105814935|NCT02937701|364981911|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
105814936|NCT02937701|364981912|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
105814937|NCT02937701|364981908|FG000|Week 22 to Week 50|Physician Decision|0|||
105814938|NCT02937701|364981909|FG001|Week 22 to Week 50|Physician Decision|0|||
105814939|NCT02937701|364981910|FG002|Week 22 to Week 50|Physician Decision|2|||
105814940|NCT02937701|364981911|FG003|Week 22 to Week 50|Physician Decision|0|||
105814941|NCT02937701|364981912|FG004|Week 22 to Week 50|Physician Decision|1|||
105814942|NCT02937701|364981908|FG000|Week 22 to Week 50|Other|0|||
105814943|NCT02937701|364981909|FG001|Week 22 to Week 50|Other|0|||
105814944|NCT02937701|364981910|FG002|Week 22 to Week 50|Other|0|||
105814945|NCT02937701|364981911|FG003|Week 22 to Week 50|Other|0|||
105814946|NCT02937701|364981912|FG004|Week 22 to Week 50|Other|1|||
105814947|NCT01153984|364981915|FG000|Overall Study|Withdrawal by Subject|1|||
105814948|NCT01153984|364981915|FG000|Overall Study|Adverse Event|1|||
105814949|NCT00243932|364981916|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
105814950|NCT00243932|364981917|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
105814951|NCT00243932|364981918|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
105814952|NCT00727571|364981922|FG000|Overall Study|Ineligibility determined|1|||
105486152|NCT04761627|363791413|FG002|Run-in Period|Study site closure|0|||
105486153|NCT04761627|363791411|FG000|Run-in Period|Pregnancy|2|||
105486154|NCT04761627|363791412|FG001|Run-in Period|Pregnancy|0|||
105486155|NCT04761627|363791413|FG002|Run-in Period|Pregnancy|0|||
105486156|NCT04761627|363791411|FG000|Post-randomization Period|Military service|0|||
105486157|NCT04761627|363791412|FG001|Post-randomization Period|Military service|1|||
105763979|NCT00770224|364788936|FG000|Step 2: Maintenance|Progression/relapse|0|||
105763980|NCT00770224|364788937|FG001|Step 2: Maintenance|Progression/relapse|1|||
105763981|NCT00770224|364788936|FG000|Step 2: Maintenance|Death|0|||
105763982|NCT00770224|364788937|FG001|Step 2: Maintenance|Death|2|||
105763983|NCT00770224|364788936|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
105763984|NCT00770224|364788937|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
105763985|NCT00770224|364788936|FG000|Step 2: Maintenance|Ineligible|0|||
105763986|NCT00770224|364788937|FG001|Step 2: Maintenance|Ineligible|2|||
105763987|NCT03371251|364788946|FG000|Overall Study|Withdrawal by Subject|1|||
105763988|NCT03371251|364788947|FG001|Overall Study|Withdrawal by Subject|0|||
105763989|NCT03371251|364788948|FG002|Overall Study|Withdrawal by Subject|1|||
105763990|NCT03371251|364788949|FG003|Overall Study|Withdrawal by Subject|0|||
105763991|NCT03371251|364788950|FG004|Overall Study|Withdrawal by Subject|2|||
105763992|NCT03371251|364788951|FG005|Overall Study|Withdrawal by Subject|2|||
105763993|NCT03371251|364788946|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
105763994|NCT03371251|364788947|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
105763995|NCT03371251|364788948|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
105763996|NCT03371251|364788949|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
105814953|NCT00727571|364981923|FG001|Overall Study|Ineligibility determined|1|||
105814954|NCT00727571|364981924|FG002|Overall Study|Ineligibility determined|1|||
105814955|NCT00727571|364981925|FG003|Overall Study|Ineligibility determined|0|||
105486158|NCT04761627|363791413|FG002|Post-randomization Period|Military service|0|||
105814956|NCT00727571|364981922|FG000|Overall Study|Death|0|||
105814957|NCT00727571|364981923|FG001|Overall Study|Death|19|||
105571568|NCT03734991|364091244|FG000|Overall Study|Pregnancy|1|||
105763997|NCT03371251|364788950|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
105763998|NCT03371251|364788951|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
105763999|NCT03371251|364788946|FG000|Overall Study|Adverse Event|0|||
105764000|NCT03371251|364788947|FG001|Overall Study|Adverse Event|0|||
105764001|NCT03371251|364788948|FG002|Overall Study|Adverse Event|0|||
105764002|NCT03371251|364788949|FG003|Overall Study|Adverse Event|0|||
105764003|NCT03371251|364788950|FG004|Overall Study|Adverse Event|1|||
105764004|NCT03371251|364788951|FG005|Overall Study|Adverse Event|0|||
105764005|NCT03371251|364788946|FG000|Overall Study|Decision by Sponsor|0|||
105764006|NCT03371251|364788947|FG001|Overall Study|Decision by Sponsor|0|||
105764007|NCT03371251|364788948|FG002|Overall Study|Decision by Sponsor|0|||
105764008|NCT03371251|364788949|FG003|Overall Study|Decision by Sponsor|0|||
105764009|NCT03371251|364788950|FG004|Overall Study|Decision by Sponsor|2|||
105764010|NCT03371251|364788951|FG005|Overall Study|Decision by Sponsor|0|||
105764011|NCT02017704|364788952|FG000|Overall Study|Withdrawal by Subject|2|||
105764012|NCT02017704|364788953|FG001|Overall Study|Withdrawal by Subject|0|||
105764013|NCT01641081|364788954|FG000|Period 1|Sponsor request (potential unblinding)|0|||
105764014|NCT01641081|364788955|FG001|Period 1|Sponsor request (potential unblinding)|0|||
105764015|NCT01641081|364788956|FG002|Period 1|Sponsor request (potential unblinding)|0|||
105764016|NCT01641081|364788957|FG003|Period 1|Sponsor request (potential unblinding)|0|||
105764017|NCT01641081|364788958|FG004|Period 1|Sponsor request (potential unblinding)|0|||
105764018|NCT01641081|364788959|FG005|Period 1|Sponsor request (potential unblinding)|0|||
105764019|NCT01641081|364788960|FG006|Period 1|Sponsor request (potential unblinding)|1|||
105764020|NCT01641081|364788961|FG007|Period 1|Sponsor request (potential unblinding)|0|||
105764021|NCT01641081|364788962|FG008|Period 1|Sponsor request (potential unblinding)|0|||
105764022|NCT01641081|364788963|FG009|Period 1|Sponsor request (potential unblinding)|0|||
105764023|NCT01641081|364788954|FG000|Period 1|Protocol Violation|0|||
105764024|NCT01641081|364788955|FG001|Period 1|Protocol Violation|0|||
105764025|NCT01641081|364788956|FG002|Period 1|Protocol Violation|0|||
105764026|NCT01641081|364788957|FG003|Period 1|Protocol Violation|0|||
105764027|NCT01641081|364788958|FG004|Period 1|Protocol Violation|1|||
105764028|NCT01641081|364788959|FG005|Period 1|Protocol Violation|0|||
105764029|NCT01641081|364788960|FG006|Period 1|Protocol Violation|0|||
105764030|NCT01641081|364788961|FG007|Period 1|Protocol Violation|1|||
105764031|NCT01641081|364788962|FG008|Period 1|Protocol Violation|0|||
105764032|NCT01641081|364788963|FG009|Period 1|Protocol Violation|0|||
105764033|NCT01641081|364788954|FG000|Period 1|Adverse Event|1|||
105764034|NCT01641081|364788955|FG001|Period 1|Adverse Event|0|||
105764035|NCT01641081|364788956|FG002|Period 1|Adverse Event|0|||
105764036|NCT01641081|364788957|FG003|Period 1|Adverse Event|0|||
105764037|NCT01641081|364788958|FG004|Period 1|Adverse Event|0|||
105764038|NCT01641081|364788959|FG005|Period 1|Adverse Event|0|||
105764039|NCT01641081|364788960|FG006|Period 1|Adverse Event|0|||
105764040|NCT01641081|364788961|FG007|Period 1|Adverse Event|2|||
105764041|NCT01641081|364788962|FG008|Period 1|Adverse Event|0|||
105764042|NCT01641081|364788963|FG009|Period 1|Adverse Event|0|||
105764043|NCT01641081|364788954|FG000|Period 2|Adverse Event|0|||
105764044|NCT01641081|364788955|FG001|Period 2|Adverse Event|0|||
105764045|NCT01641081|364788956|FG002|Period 2|Adverse Event|0|||
105764046|NCT01641081|364788957|FG003|Period 2|Adverse Event|0|||
105764047|NCT01641081|364788958|FG004|Period 2|Adverse Event|0|||
105764048|NCT01641081|364788959|FG005|Period 2|Adverse Event|1|||
105764049|NCT01641081|364788960|FG006|Period 2|Adverse Event|0|||
105764050|NCT01641081|364788961|FG007|Period 2|Adverse Event|0|||
105764051|NCT01641081|364788962|FG008|Period 2|Adverse Event|0|||
105764052|NCT01641081|364788963|FG009|Period 2|Adverse Event|0|||
105764053|NCT01641081|364788954|FG000|Period 2|Withdrawal by Subject|0|||
105764054|NCT01641081|364788955|FG001|Period 2|Withdrawal by Subject|0|||
105764055|NCT01641081|364788956|FG002|Period 2|Withdrawal by Subject|0|||
105764056|NCT01641081|364788957|FG003|Period 2|Withdrawal by Subject|1|||
105764057|NCT01641081|364788958|FG004|Period 2|Withdrawal by Subject|0|||
105764058|NCT01641081|364788959|FG005|Period 2|Withdrawal by Subject|0|||
105764059|NCT01641081|364788960|FG006|Period 2|Withdrawal by Subject|2|||
105764060|NCT01641081|364788961|FG007|Period 2|Withdrawal by Subject|0|||
105764061|NCT01641081|364788962|FG008|Period 2|Withdrawal by Subject|0|||
105764062|NCT01641081|364788963|FG009|Period 2|Withdrawal by Subject|0|||
105764063|NCT01641081|364788954|FG000|Period 2|Protocol Violation|1|||
105764064|NCT01641081|364788955|FG001|Period 2|Protocol Violation|0|||
105764065|NCT01641081|364788956|FG002|Period 2|Protocol Violation|0|||
105764066|NCT01641081|364788957|FG003|Period 2|Protocol Violation|0|||
105764067|NCT01641081|364788958|FG004|Period 2|Protocol Violation|0|||
105764068|NCT01641081|364788959|FG005|Period 2|Protocol Violation|0|||
105764069|NCT01641081|364788960|FG006|Period 2|Protocol Violation|0|||
105764070|NCT01641081|364788961|FG007|Period 2|Protocol Violation|0|||
105764071|NCT01641081|364788962|FG008|Period 2|Protocol Violation|0|||
105764072|NCT01641081|364788963|FG009|Period 2|Protocol Violation|0|||
105764073|NCT01641081|364788954|FG000|Period 3|Adverse Event|0|||
105764074|NCT01641081|364788955|FG001|Period 3|Adverse Event|0|||
105764075|NCT01641081|364788956|FG002|Period 3|Adverse Event|1|||
105814958|NCT00727571|364981924|FG002|Overall Study|Death|5|||
105814959|NCT00727571|364981925|FG003|Overall Study|Death|1|||
105814960|NCT00727571|364981922|FG000|Overall Study|Physician Decision|0|||
105814961|NCT00727571|364981923|FG001|Overall Study|Physician Decision|5|||
105362090|NCT02326272|363330149|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105362091|NCT02326272|363330150|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105362092|NCT02326272|363330151|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105362093|NCT02326272|363330152|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105814962|NCT00727571|364981924|FG002|Overall Study|Physician Decision|0|||
105814963|NCT00727571|364981925|FG003|Overall Study|Physician Decision|0|||
105814964|NCT00727571|364981922|FG000|Overall Study|Withdrawal by Subject|0|||
105814965|NCT00727571|364981923|FG001|Overall Study|Withdrawal by Subject|10|||
105814966|NCT00727571|364981924|FG002|Overall Study|Withdrawal by Subject|11|||
105814967|NCT00727571|364981925|FG003|Overall Study|Withdrawal by Subject|0|||
105814968|NCT00727571|364981922|FG000|Overall Study|Subject Non Compliance|0|||
105814969|NCT00727571|364981923|FG001|Overall Study|Subject Non Compliance|6|||
105814970|NCT00727571|364981924|FG002|Overall Study|Subject Non Compliance|0|||
105814971|NCT00727571|364981925|FG003|Overall Study|Subject Non Compliance|4|||
105814972|NCT00727571|364981922|FG000|Overall Study|Dismissed from nursing home|0|||
105814973|NCT00727571|364981923|FG001|Overall Study|Dismissed from nursing home|9|||
105814974|NCT00727571|364981924|FG002|Overall Study|Dismissed from nursing home|5|||
105814975|NCT00727571|364981925|FG003|Overall Study|Dismissed from nursing home|0|||
105814976|NCT00727571|364981922|FG000|Overall Study|Hospitalization|0|||
105814977|NCT00727571|364981923|FG001|Overall Study|Hospitalization|1|||
105362094|NCT02326272|363330153|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
105362095|NCT02326272|363330154|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105362096|NCT02326272|363330155|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
105362097|NCT02326272|363330156|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105362098|NCT02326272|363330157|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105362099|NCT02326272|363330143|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105486159|NCT04761627|363791411|FG000|Post-randomization Period|Adverse Event|0|||
105486160|NCT04761627|363791412|FG001|Post-randomization Period|Adverse Event|4|||
105814978|NCT00727571|364981924|FG002|Overall Study|Hospitalization|0|||
105362100|NCT02326272|363330144|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105486161|NCT04761627|363791413|FG002|Post-randomization Period|Adverse Event|2|||
105486162|NCT04761627|363791411|FG000|Post-randomization Period|Lost to Follow-up|0|||
105814979|NCT00727571|364981925|FG003|Overall Study|Hospitalization|1|||
105814980|NCT00727571|364981922|FG000|Overall Study|AE not leading to hospitalization|0|||
105571569|NCT03734991|364091245|FG001|Overall Study|Pregnancy|0|||
105571570|NCT03734991|364091244|FG000|Overall Study|Withdrawal by Subject|6|||
105764076|NCT01641081|364788957|FG003|Period 3|Adverse Event|0|||
105764077|NCT01641081|364788958|FG004|Period 3|Adverse Event|0|||
105764078|NCT01641081|364788959|FG005|Period 3|Adverse Event|0|||
105764079|NCT01641081|364788960|FG006|Period 3|Adverse Event|0|||
105764080|NCT01641081|364788961|FG007|Period 3|Adverse Event|0|||
105764081|NCT01641081|364788962|FG008|Period 3|Adverse Event|0|||
105764082|NCT01641081|364788963|FG009|Period 3|Adverse Event|0|||
105764083|NCT01641081|364788954|FG000|Period 3|Withdrawal by Subject|0|||
105764084|NCT01641081|364788955|FG001|Period 3|Withdrawal by Subject|0|||
105764085|NCT01641081|364788956|FG002|Period 3|Withdrawal by Subject|0|||
105764086|NCT01641081|364788957|FG003|Period 3|Withdrawal by Subject|0|||
105764087|NCT01641081|364788958|FG004|Period 3|Withdrawal by Subject|0|||
105764088|NCT01641081|364788959|FG005|Period 3|Withdrawal by Subject|0|||
105764089|NCT01641081|364788960|FG006|Period 3|Withdrawal by Subject|0|||
105764090|NCT01641081|364788961|FG007|Period 3|Withdrawal by Subject|0|||
105764091|NCT01641081|364788962|FG008|Period 3|Withdrawal by Subject|1|||
105764092|NCT01641081|364788963|FG009|Period 3|Withdrawal by Subject|0|||
105764093|NCT01641081|364788954|FG000|Period 4|Adverse Event|0|||
105764094|NCT01641081|364788955|FG001|Period 4|Adverse Event|1|||
105764095|NCT01641081|364788956|FG002|Period 4|Adverse Event|0|||
105764096|NCT01641081|364788957|FG003|Period 4|Adverse Event|1|||
105764097|NCT01641081|364788958|FG004|Period 4|Adverse Event|0|||
105764098|NCT01641081|364788959|FG005|Period 4|Adverse Event|0|||
105764099|NCT01641081|364788960|FG006|Period 4|Adverse Event|0|||
105764100|NCT01641081|364788961|FG007|Period 4|Adverse Event|0|||
105764101|NCT01641081|364788962|FG008|Period 4|Adverse Event|0|||
105764102|NCT01641081|364788963|FG009|Period 4|Adverse Event|0|||
105764103|NCT01641081|364788954|FG000|Period 5|Adverse Event|0|||
105764104|NCT01641081|364788955|FG001|Period 5|Adverse Event|0|||
105764105|NCT01641081|364788956|FG002|Period 5|Adverse Event|2|||
105764106|NCT01641081|364788957|FG003|Period 5|Adverse Event|0|||
105764107|NCT01641081|364788958|FG004|Period 5|Adverse Event|0|||
105764108|NCT01641081|364788959|FG005|Period 5|Adverse Event|0|||
105764109|NCT01641081|364788960|FG006|Period 5|Adverse Event|0|||
105764110|NCT01641081|364788961|FG007|Period 5|Adverse Event|0|||
105764111|NCT01641081|364788962|FG008|Period 5|Adverse Event|0|||
105764112|NCT01641081|364788963|FG009|Period 5|Adverse Event|0|||
105764113|NCT01451398|364788968|FG000|Overall Study|Adverse Event|7|||
105764114|NCT01451398|364788969|FG001|Overall Study|Adverse Event|9|||
105764115|NCT01451398|364788968|FG000|Overall Study|Protocol Violation|1|||
105764116|NCT01451398|364788969|FG001|Overall Study|Protocol Violation|2|||
105764117|NCT01451398|364788968|FG000|Overall Study|Physician Decision|1|||
105764118|NCT01451398|364788969|FG001|Overall Study|Physician Decision|1|||
105764119|NCT01451398|364788968|FG000|Overall Study|Withdrawal by Subject|10|||
105764120|NCT01451398|364788969|FG001|Overall Study|Withdrawal by Subject|14|||
105764121|NCT01451398|364788968|FG000|Overall Study|Lost to Follow-up|6|||
105764122|NCT01451398|364788969|FG001|Overall Study|Lost to Follow-up|4|||
105764123|NCT01451398|364788968|FG000|Overall Study|Non-compliance with study drug|1|||
105764124|NCT01451398|364788969|FG001|Overall Study|Non-compliance with study drug|3|||
105764125|NCT01451398|364788968|FG000|Overall Study|Non-compliance with protocol|1|||
105764126|NCT01451398|364788969|FG001|Overall Study|Non-compliance with protocol|1|||
105764127|NCT01451398|364788968|FG000|Overall Study|Moved out of country|0|||
105764128|NCT01451398|364788969|FG001|Overall Study|Moved out of country|1|||
105764129|NCT01451398|364788968|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
105764130|NCT01451398|364788969|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
105764131|NCT01451398|364788968|FG000|Overall Study|Lack of Efficacy|0|||
105764132|NCT01451398|364788969|FG001|Overall Study|Lack of Efficacy|1|||
105764133|NCT01000025|364788970|FG000|Overall Study|Adverse Event|43|||
105764134|NCT01000025|364788971|FG001|Overall Study|Adverse Event|2|||
105764135|NCT01000025|364788970|FG000|Overall Study|Withdrawal by Subject|13|||
105764136|NCT01000025|364788971|FG001|Overall Study|Withdrawal by Subject|8|||
105764137|NCT01000025|364788970|FG000|Overall Study|Death|23|||
105764138|NCT01000025|364788971|FG001|Overall Study|Death|13|||
105764139|NCT01000025|364788970|FG000|Overall Study|Lack of Efficacy|363|||
105764140|NCT01000025|364788971|FG001|Overall Study|Lack of Efficacy|208|||
105764141|NCT01000025|364788970|FG000|Overall Study|Intercurrent Illness|26|||
105764142|NCT01000025|364788971|FG001|Overall Study|Intercurrent Illness|7|||
105764143|NCT00842361|364788983|FG000|Overall Study|Protocol Violation|1|||
105764144|NCT00842361|364788984|FG001|Overall Study|Protocol Violation|0|||
105764145|NCT00842361|364788983|FG000|Overall Study|Unclassified|0|||
105764146|NCT00842361|364788984|FG001|Overall Study|Unclassified|2|||
105764147|NCT04285853|364788985|FG000|Overall Study|Withdrawal by Subject|1|||
105764148|NCT04285853|364788986|FG001|Overall Study|Withdrawal by Subject|0|||
105764149|NCT04285853|364788985|FG000|Overall Study|Lost to Follow-up|9|||
105764150|NCT04285853|364788986|FG001|Overall Study|Lost to Follow-up|5|||
105764151|NCT00587301|364788987|FG000|Overall Study|Screen Failure|9|||
105764152|NCT00587301|364788987|FG000|Overall Study|Lost to Follow-up|22|||
105764153|NCT00587301|364788987|FG000|Overall Study|Withdrawal by Subject|7|||
105764154|NCT00587301|364788987|FG000|Overall Study|Protocol Violation|7|||
105814981|NCT00727571|364981923|FG001|Overall Study|AE not leading to hospitalization|0|||
105814982|NCT00727571|364981924|FG002|Overall Study|AE not leading to hospitalization|2|||
105814983|NCT00727571|364981925|FG003|Overall Study|AE not leading to hospitalization|0|||
105814984|NCT00727571|364981922|FG000|Overall Study|Other|0|||
105814985|NCT00727571|364981923|FG001|Overall Study|Other|4|||
105814986|NCT00727571|364981924|FG002|Overall Study|Other|6|||
105814987|NCT00727571|364981925|FG003|Overall Study|Other|0|||
105814988|NCT04099888|364981929|FG000|Overall Study|Study terminated by sponsor|9|||
105814989|NCT04099888|364981930|FG001|Overall Study|Study terminated by sponsor|11|||
105814990|NCT04099888|364981929|FG000|Overall Study|Lost to Follow-up|1|||
105814991|NCT04099888|364981930|FG001|Overall Study|Lost to Follow-up|1|||
105814992|NCT04099888|364981929|FG000|Overall Study|Withdrawal by Subject|5|||
105814993|NCT04099888|364981930|FG001|Overall Study|Withdrawal by Subject|6|||
105814994|NCT04099888|364981929|FG000|Overall Study|Death|5|||
105814995|NCT04099888|364981930|FG001|Overall Study|Death|2|||
105814996|NCT04099888|364981929|FG000|Overall Study|Other|1|||
105814997|NCT04099888|364981930|FG001|Overall Study|Other|0|||
105814998|NCT04538170|364981931|FG000|Overall Study|Withdrawal by Subject|104|||
105814999|NCT04538170|364981932|FG001|Overall Study|Withdrawal by Subject|210|||
105815000|NCT03002077|364981934|FG000|Overall Study|Non-compliance with Study Drug|4|||
105815001|NCT03002077|364981934|FG000|Overall Study|Non-compliance w/Background ADT|1|||
105815002|NCT03002077|364981934|FG000|Overall Study|Study Terminated by Sponsor|257|||
105815003|NCT03002077|364981934|FG000|Overall Study|Site Terminated by Sponsor|5|||
105815004|NCT03002077|364981934|FG000|Overall Study|Miscellaneous Reasons|10|||
105815005|NCT03002077|364981934|FG000|Overall Study|Adverse Event|23|||
105815006|NCT03002077|364981934|FG000|Overall Study|Lack of Efficacy|20|||
105815007|NCT03002077|364981934|FG000|Overall Study|Withdrawal by Subject|72|||
105815008|NCT03002077|364981934|FG000|Overall Study|Lost to Follow-up|21|||
105815009|NCT03002077|364981934|FG000|Overall Study|Pregnancy|4|||
105815010|NCT03002077|364981934|FG000|Overall Study|Protocol Violation|21|||
105815011|NCT03370276|364981938|FG000|Overall Study|Death|0|||
105815012|NCT03370276|364981939|FG001|Overall Study|Death|2|||
105815013|NCT03370276|364981940|FG002|Overall Study|Death|5|||
105815014|NCT00777829|364981941|FG000|Overall Study|Withdrawal by Subject|0|||
105815015|NCT00777829|364981942|FG001|Overall Study|Withdrawal by Subject|2|||
105815016|NCT00854308|364981944|FG000|Overall Study|Disease progression|42|||
105815017|NCT00854308|364981945|FG001|Overall Study|Disease progression|50|||
105815018|NCT00854308|364981944|FG000|Overall Study|Adverse Event|8|||
105815019|NCT00854308|364981945|FG001|Overall Study|Adverse Event|3|||
105815020|NCT00854308|364981944|FG000|Overall Study|Death|2|||
105815021|NCT00854308|364981945|FG001|Overall Study|Death|5|||
105815022|NCT00854308|364981944|FG000|Overall Study|Physician Decision|6|||
105815023|NCT00854308|364981945|FG001|Overall Study|Physician Decision|6|||
105815024|NCT00854308|364981944|FG000|Overall Study|Withdrawal by Subject|4|||
105815025|NCT00854308|364981945|FG001|Overall Study|Withdrawal by Subject|2|||
105815026|NCT00854308|364981944|FG000|Overall Study|Sponsor's decision to terminate study|0|||
105815027|NCT00854308|364981945|FG001|Overall Study|Sponsor's decision to terminate study|1|||
105815028|NCT01390844|364981946|FG000|Treatment Phase|Adverse Event|12|||
105815029|NCT01390844|364981947|FG001|Treatment Phase|Adverse Event|2|||
105815030|NCT01390844|364981948|FG002|Treatment Phase|Adverse Event|3|||
105815031|NCT01390844|364981949|FG003|Treatment Phase|Adverse Event|2|||
105815032|NCT01390844|364981946|FG000|Treatment Phase|Treatment Failure|23|||
105815033|NCT01390844|364981947|FG001|Treatment Phase|Treatment Failure|25|||
105815034|NCT01390844|364981948|FG002|Treatment Phase|Treatment Failure|10|||
105815035|NCT01390844|364981949|FG003|Treatment Phase|Treatment Failure|13|||
105815036|NCT01390844|364981946|FG000|Treatment Phase|Non-Medical Reasons|5|||
105815037|NCT01390844|364981947|FG001|Treatment Phase|Non-Medical Reasons|1|||
105815038|NCT01390844|364981948|FG002|Treatment Phase|Non-Medical Reasons|8|||
105815039|NCT01390844|364981949|FG003|Treatment Phase|Non-Medical Reasons|1|||
105815040|NCT01390844|364981946|FG000|Treatment Phase|Non-GCP Compliant|0|||
105815041|NCT01390844|364981947|FG001|Treatment Phase|Non-GCP Compliant|0|||
105815042|NCT01390844|364981948|FG002|Treatment Phase|Non-GCP Compliant|10|||
105815043|NCT01390844|364981949|FG003|Treatment Phase|Non-GCP Compliant|3|||
105815044|NCT01390844|364981946|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
105815045|NCT01390844|364981947|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
105815046|NCT01390844|364981948|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
105815047|NCT01390844|364981949|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
105815048|NCT00958243|364981952|FG000|Overall Study|Withdrawal by Subject|0|||
105815049|NCT00958243|364981953|FG001|Overall Study|Withdrawal by Subject|1|||
105815050|NCT00958243|364981954|FG002|Overall Study|Withdrawal by Subject|3|||
105815051|NCT00958243|364981955|FG003|Overall Study|Withdrawal by Subject|1|||
105815052|NCT00958243|364981956|FG004|Overall Study|Withdrawal by Subject|1|||
105815053|NCT00958243|364981957|FG005|Overall Study|Withdrawal by Subject|5|||
105815054|NCT00958243|364981952|FG000|Overall Study|Lost to Follow-up|2|||
105815055|NCT00958243|364981953|FG001|Overall Study|Lost to Follow-up|5|||
105815056|NCT00958243|364981954|FG002|Overall Study|Lost to Follow-up|11|||
105815057|NCT00958243|364981955|FG003|Overall Study|Lost to Follow-up|2|||
105815058|NCT00958243|364981956|FG004|Overall Study|Lost to Follow-up|8|||
105815059|NCT00958243|364981957|FG005|Overall Study|Lost to Follow-up|5|||
105815060|NCT02016170|364981968|FG000|Overall Study|Adverse Event|1|||
105815061|NCT02016170|364981969|FG001|Overall Study|Adverse Event|1|||
105815062|NCT02016170|364981970|FG002|Overall Study|Adverse Event|0|||
105815063|NCT02016170|364981968|FG000|Overall Study|Protocol Violation|1|||
105815064|NCT02016170|364981969|FG001|Overall Study|Protocol Violation|0|||
105815065|NCT02016170|364981970|FG002|Overall Study|Protocol Violation|0|||
105815066|NCT00336479|364981972|FG000|Overall Study|Adverse Event|8|||
105815067|NCT00336479|364981973|FG001|Overall Study|Adverse Event|11|||
105815068|NCT00336479|364981974|FG002|Overall Study|Adverse Event|18|||
105815069|NCT00336479|364981975|FG003|Overall Study|Adverse Event|4|||
105815070|NCT00336479|364981972|FG000|Overall Study|Noncompliant|1|||
105815071|NCT00336479|364981973|FG001|Overall Study|Noncompliant|7|||
105815072|NCT00336479|364981974|FG002|Overall Study|Noncompliant|3|||
105815073|NCT00336479|364981975|FG003|Overall Study|Noncompliant|0|||
105815074|NCT00336479|364981972|FG000|Overall Study|Physician Decision|2|||
105815075|NCT00336479|364981973|FG001|Overall Study|Physician Decision|3|||
105815076|NCT00336479|364981974|FG002|Overall Study|Physician Decision|1|||
105815077|NCT00336479|364981975|FG003|Overall Study|Physician Decision|0|||
105815078|NCT00336479|364981972|FG000|Overall Study|Lost to Follow-up|3|||
105815079|NCT00336479|364981973|FG001|Overall Study|Lost to Follow-up|2|||
105815080|NCT00336479|364981974|FG002|Overall Study|Lost to Follow-up|0|||
105815081|NCT00336479|364981975|FG003|Overall Study|Lost to Follow-up|0|||
105815082|NCT00336479|364981972|FG000|Overall Study|Withdrawal by Subject|3|||
105815083|NCT00336479|364981973|FG001|Overall Study|Withdrawal by Subject|2|||
105815084|NCT00336479|364981974|FG002|Overall Study|Withdrawal by Subject|3|||
105815085|NCT00336479|364981975|FG003|Overall Study|Withdrawal by Subject|0|||
105815086|NCT00336479|364981972|FG000|Overall Study|Other|0|||
105815087|NCT00336479|364981973|FG001|Overall Study|Other|0|||
105815088|NCT00336479|364981974|FG002|Overall Study|Other|1|||
105815089|NCT00336479|364981975|FG003|Overall Study|Other|0|||
105815090|NCT00336479|364981972|FG000|Overall Study|Virologic Stopping Rule|20|||
105815091|NCT00336479|364981973|FG001|Overall Study|Virologic Stopping Rule|0|||
105815092|NCT00336479|364981974|FG002|Overall Study|Virologic Stopping Rule|0|||
105815093|NCT00336479|364981975|FG003|Overall Study|Virologic Stopping Rule|0|||
105815094|NCT01479439|364981980|FG000|Overall Study|Adverse Event|1|||
105815095|NCT01479439|364981981|FG001|Overall Study|Adverse Event|0|||
105815096|NCT01479439|364981982|FG002|Overall Study|Adverse Event|0|||
105815097|NCT01479439|364981980|FG000|Overall Study|Lost to Follow-up|0|||
105815098|NCT01479439|364981981|FG001|Overall Study|Lost to Follow-up|1|||
105815099|NCT01479439|364981982|FG002|Overall Study|Lost to Follow-up|0|||
105815100|NCT01479439|364981980|FG000|Overall Study|Protocol Violation|0|||
105815101|NCT01479439|364981981|FG001|Overall Study|Protocol Violation|0|||
105815102|NCT01479439|364981982|FG002|Overall Study|Protocol Violation|2|||
105815103|NCT02365207|364981983|FG000|Overall Study|Withdrawal by Subject|1|||
105815104|NCT02365207|364981983|FG000|Overall Study|Physician Decision|1|||
105815105|NCT01936948|364981984|FG000|Overall Study|no 30-day follow-up data|0|||
105815106|NCT01936948|364981985|FG001|Overall Study|no 30-day follow-up data|3|||
105815107|NCT01936948|364981986|FG002|Overall Study|no 30-day follow-up data|3|||
105815108|NCT01936948|364981987|FG003|Overall Study|no 30-day follow-up data|3|||
105815109|NCT01318499|364981988|FG000|Overall Study|Adverse Event|16|||
105815110|NCT01318499|364981989|FG001|Overall Study|Adverse Event|11|||
105815111|NCT01318499|364981990|FG002|Overall Study|Adverse Event|6|||
105815112|NCT01318499|364981988|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
105815113|NCT01318499|364981989|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
105815114|NCT01318499|364981990|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
105815115|NCT01318499|364981988|FG000|Overall Study|Noncompliance|2|||
105815116|NCT01318499|364981989|FG001|Overall Study|Noncompliance|3|||
105815117|NCT01318499|364981990|FG002|Overall Study|Noncompliance|0|||
105815118|NCT01318499|364981988|FG000|Overall Study|Treatment Failure|19|||
105815119|NCT01318499|364981989|FG001|Overall Study|Treatment Failure|19|||
105815120|NCT01318499|364981990|FG002|Overall Study|Treatment Failure|101|||
105815121|NCT01318499|364981988|FG000|Overall Study|Protocol Violation|2|||
105815122|NCT01318499|364981989|FG001|Overall Study|Protocol Violation|4|||
105815123|NCT01318499|364981990|FG002|Overall Study|Protocol Violation|2|||
105815124|NCT01318499|364981988|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
105815125|NCT01318499|364981989|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
105815126|NCT01318499|364981990|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
105815127|NCT01318499|364981988|FG000|Overall Study|Other|7|||
105815128|NCT01318499|364981989|FG001|Overall Study|Other|10|||
105815129|NCT01318499|364981990|FG002|Overall Study|Other|22|||
105815130|NCT01722877|364981991|FG000|Overall Study|Death|1|||
105815131|NCT01722877|364981991|FG000|Overall Study|Lost to Follow-up|1|||
105815132|NCT00822926|364981992|FG000|Second Injection Visit|Lost to Follow-up|1|||
105815133|NCT00822926|364981993|FG001|Second Injection Visit|Lost to Follow-up|0|||
105815134|NCT00822926|364981992|FG000|Second Injection Visit|Withdrawal by Subject|0|||
105815135|NCT00822926|364981993|FG001|Second Injection Visit|Withdrawal by Subject|1|||
105815136|NCT02719522|364982000|FG000|Overall Study|Implant Failure|4|||
105815137|NCT02719522|364982000|FG000|Overall Study|Death|2|||
105815138|NCT02719522|364982000|FG000|Overall Study|Lost to Follow-up|5|||
105815139|NCT01044732|364982009|FG000|Overall Study|Lost to Follow-up|2|||
105815140|NCT01044732|364982010|FG001|Overall Study|Lost to Follow-up|1|||
105815141|NCT01044732|364982009|FG000|Overall Study|Physician Decision|5|||
105815142|NCT01044732|364982010|FG001|Overall Study|Physician Decision|3|||
105815143|NCT01044732|364982009|FG000|Overall Study|Protocol Violation|11|||
105815144|NCT01044732|364982010|FG001|Overall Study|Protocol Violation|12|||
105815145|NCT01044732|364982009|FG000|Overall Study|Withdrawal by Subject|0|||
105815146|NCT01044732|364982010|FG001|Overall Study|Withdrawal by Subject|1|||
105815147|NCT01044732|364982009|FG000|Overall Study|Inadequate bowel preparation|11|||
105815148|NCT01044732|364982010|FG001|Overall Study|Inadequate bowel preparation|17|||
105815149|NCT01044732|364982009|FG000|Overall Study|Inability to reach cecum|5|||
105815150|NCT01044732|364982010|FG001|Overall Study|Inability to reach cecum|2|||
105815151|NCT01044732|364982009|FG000|Overall Study|Technical error or malfunction|15|||
105815152|NCT01044732|364982010|FG001|Overall Study|Technical error or malfunction|14|||
105815153|NCT00385684|364982015|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
105815154|NCT00385684|364982016|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
105815155|NCT00385684|364982015|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
105815156|NCT00385684|364982016|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
105815157|NCT00385684|364982015|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
105815158|NCT00385684|364982016|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
105815159|NCT00880568|364983428|FG000|Overall Study|Disease progression|3|||
105362101|NCT02326272|363330145|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105362102|NCT02326272|363330146|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105362103|NCT02326272|363330147|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105362104|NCT02326272|363330148|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105362105|NCT02326272|363330149|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105362106|NCT02326272|363330150|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105362107|NCT02326272|363330151|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105362108|NCT02326272|363330152|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105362109|NCT02326272|363330153|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105362110|NCT02326272|363330154|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
105362111|NCT02326272|363330155|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105362112|NCT02326272|363330156|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105362113|NCT02326272|363330157|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105362114|NCT02326272|363330143|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105362115|NCT02326272|363330144|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105362116|NCT02326272|363330145|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105362117|NCT02326272|363330146|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105362118|NCT02326272|363330147|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105362119|NCT02326272|363330148|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105362120|NCT02326272|363330149|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105362121|NCT02326272|363330150|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105362122|NCT02326272|363330151|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105362123|NCT02326272|363330152|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105362124|NCT02326272|363330153|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
105362125|NCT02326272|363330154|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105362126|NCT02326272|363330155|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
105362127|NCT02326272|363330156|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105815160|NCT00880568|364983429|FG001|Overall Study|Disease progression|3|||
105815161|NCT00880568|364983430|FG002|Overall Study|Disease progression|3|||
105815162|NCT00880568|364983431|FG003|Overall Study|Disease progression|1|||
105815163|NCT00880568|364983432|FG004|Overall Study|Disease progression|3|||
105815164|NCT00880568|364983433|FG005|Overall Study|Disease progression|3|||
105815165|NCT00880568|364983434|FG006|Overall Study|Disease progression|5|||
105815166|NCT00880568|364983435|FG007|Overall Study|Disease progression|0|||
105815167|NCT00880568|364983436|FG008|Overall Study|Disease progression|3|||
105815168|NCT00880568|364983428|FG000|Overall Study|Adverse Event|0|||
105815169|NCT00880568|364983429|FG001|Overall Study|Adverse Event|0|||
105815170|NCT00880568|364983430|FG002|Overall Study|Adverse Event|0|||
105815171|NCT00880568|364983431|FG003|Overall Study|Adverse Event|0|||
105815172|NCT00880568|364983432|FG004|Overall Study|Adverse Event|0|||
105815173|NCT00880568|364983433|FG005|Overall Study|Adverse Event|0|||
105815174|NCT00880568|364983434|FG006|Overall Study|Adverse Event|1|||
105815175|NCT00880568|364983435|FG007|Overall Study|Adverse Event|1|||
105815176|NCT00880568|364983436|FG008|Overall Study|Adverse Event|0|||
105815177|NCT00880568|364983428|FG000|Overall Study|Withdrawal by Subject|0|||
105815178|NCT00880568|364983429|FG001|Overall Study|Withdrawal by Subject|0|||
105815179|NCT00880568|364983430|FG002|Overall Study|Withdrawal by Subject|0|||
105815180|NCT00880568|364983431|FG003|Overall Study|Withdrawal by Subject|0|||
105815181|NCT00880568|364983432|FG004|Overall Study|Withdrawal by Subject|0|||
105815182|NCT00880568|364983433|FG005|Overall Study|Withdrawal by Subject|0|||
105815183|NCT00880568|364983434|FG006|Overall Study|Withdrawal by Subject|0|||
105815184|NCT00880568|364983435|FG007|Overall Study|Withdrawal by Subject|1|||
105815185|NCT00880568|364983436|FG008|Overall Study|Withdrawal by Subject|0|||
105815186|NCT02152566|364983439|FG000|Overall Study|Lost to Follow-up|1|||
105815187|NCT02152566|364983439|FG000|Overall Study|Withdrawal by Subject|2|||
105815188|NCT01866319|364983442|FG000|Overall Study|Adverse Event|12|||
105815189|NCT01866319|364983443|FG001|Overall Study|Adverse Event|5|||
105815190|NCT01866319|364983444|FG002|Overall Study|Adverse Event|9|||
105815191|NCT01866319|364983442|FG000|Overall Study|Clinical progression|3|||
105486163|NCT04761627|363791412|FG001|Post-randomization Period|Lost to Follow-up|6|||
105486164|NCT04761627|363791413|FG002|Post-randomization Period|Lost to Follow-up|6|||
105815192|NCT01866319|364983443|FG001|Overall Study|Clinical progression|2|||
105815193|NCT01866319|364983444|FG002|Overall Study|Clinical progression|2|||
105815194|NCT01866319|364983442|FG000|Overall Study|Death|153|||
105815195|NCT01866319|364983443|FG001|Overall Study|Death|154|||
105815196|NCT01866319|364983444|FG002|Overall Study|Death|147|||
105815197|NCT01866319|364983442|FG000|Overall Study|Lost to Follow-up|6|||
105815198|NCT01866319|364983443|FG001|Overall Study|Lost to Follow-up|3|||
105815199|NCT01866319|364983444|FG002|Overall Study|Lost to Follow-up|8|||
105815200|NCT01866319|364983442|FG000|Overall Study|Physician Decision|1|||
105815201|NCT01866319|364983443|FG001|Overall Study|Physician Decision|0|||
105815202|NCT01866319|364983444|FG002|Overall Study|Physician Decision|1|||
105815203|NCT01866319|364983442|FG000|Overall Study|Protocol Violation|0|||
105815204|NCT01866319|364983443|FG001|Overall Study|Protocol Violation|0|||
105815205|NCT01866319|364983444|FG002|Overall Study|Protocol Violation|1|||
105815206|NCT01866319|364983442|FG000|Overall Study|Withdrawal by Subject|32|||
105815207|NCT01866319|364983443|FG001|Overall Study|Withdrawal by Subject|14|||
105815208|NCT01866319|364983444|FG002|Overall Study|Withdrawal by Subject|12|||
105815209|NCT01328093|364983447|FG000|Double-Blind Phase|Adverse Event|78|||
105815210|NCT01328093|364983448|FG001|Double-Blind Phase|Adverse Event|15|||
105815211|NCT01328093|364983447|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
105815212|NCT01328093|364983448|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
105815213|NCT01328093|364983447|FG000|Double-Blind Phase|Lost to Follow-up|39|||
105815214|NCT01328093|364983448|FG001|Double-Blind Phase|Lost to Follow-up|14|||
105815215|NCT01328093|364983447|FG000|Double-Blind Phase|Protocol Violation|30|||
105815216|NCT01328093|364983448|FG001|Double-Blind Phase|Protocol Violation|10|||
105815217|NCT01328093|364983447|FG000|Double-Blind Phase|Lack of Efficacy|55|||
105815218|NCT01328093|364983448|FG001|Double-Blind Phase|Lack of Efficacy|13|||
105486165|NCT04761627|363791411|FG000|Post-randomization Period|Withdrawal by Subject|0|||
105815219|NCT01328093|364983447|FG000|Double-Blind Phase|Sponsor Decision|17|||
105815220|NCT01328093|364983448|FG001|Double-Blind Phase|Sponsor Decision|3|||
105815221|NCT01328093|364983447|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
105815222|NCT01328093|364983448|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
105815223|NCT01328093|364983447|FG000|Double-Blind Phase|Scheduling conflict|8|||
105815224|NCT01328093|364983448|FG001|Double-Blind Phase|Scheduling conflict|3|||
105815225|NCT01328093|364983447|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
105815226|NCT01328093|364983448|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
105815227|NCT01328093|364983447|FG000|Double-Blind Phase|Death|1|||
105815228|NCT01328093|364983448|FG001|Double-Blind Phase|Death|0|||
105815229|NCT01328093|364983447|FG000|Open-Label Phase|Sponsor Decision|98|||
105815230|NCT01328093|364983448|FG001|Open-Label Phase|Sponsor Decision|34|||
105815231|NCT01328093|364983447|FG000|Open-Label Phase|Protocol Violation|8|||
105815232|NCT01328093|364983448|FG001|Open-Label Phase|Protocol Violation|3|||
105815233|NCT01328093|364983447|FG000|Open-Label Phase|Lost to Follow-up|10|||
105815234|NCT01328093|364983448|FG001|Open-Label Phase|Lost to Follow-up|1|||
105486166|NCT04761627|363791412|FG001|Post-randomization Period|Withdrawal by Subject|7|||
105815235|NCT01328093|364983447|FG000|Open-Label Phase|Adverse Event|10|||
105815236|NCT01328093|364983448|FG001|Open-Label Phase|Adverse Event|4|||
105815237|NCT01328093|364983447|FG000|Open-Label Phase|Lack of Efficacy|5|||
105815238|NCT01328093|364983448|FG001|Open-Label Phase|Lack of Efficacy|6|||
105815239|NCT01328093|364983447|FG000|Open-Label Phase|Withdrawal by Subject|4|||
105815240|NCT01328093|364983448|FG001|Open-Label Phase|Withdrawal by Subject|1|||
105815241|NCT01328093|364983447|FG000|Open-Label Phase|Scheduling conflict|2|||
105815242|NCT01328093|364983448|FG001|Open-Label Phase|Scheduling conflict|1|||
105815243|NCT01328093|364983447|FG000|Open-Label Phase|Subject is moving or has moved|2|||
105815244|NCT01328093|364983448|FG001|Open-Label Phase|Subject is moving or has moved|0|||
105815245|NCT01328093|364983447|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
105815246|NCT01328093|364983448|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
105815247|NCT00760266|364983451|FG000|Overall Study|Adverse Event|13|||
105815248|NCT00760266|364983452|FG001|Overall Study|Adverse Event|7|||
105815249|NCT00760266|364983451|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105815250|NCT00760266|364983452|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105815251|NCT00760266|364983451|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105815252|NCT00760266|364983452|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105815253|NCT00760266|364983451|FG000|Overall Study|Lack of Efficacy|2|||
105815254|NCT00760266|364983452|FG001|Overall Study|Lack of Efficacy|2|||
105815255|NCT00760266|364983451|FG000|Overall Study|Protocol deviation|2|||
105815256|NCT00760266|364983452|FG001|Overall Study|Protocol deviation|4|||
105815257|NCT00760266|364983451|FG000|Overall Study|Patient withdrew consent|3|||
105815258|NCT00760266|364983452|FG001|Overall Study|Patient withdrew consent|3|||
105815259|NCT00760266|364983451|FG000|Overall Study|Lost to Follow-up|2|||
105815260|NCT00760266|364983452|FG001|Overall Study|Lost to Follow-up|1|||
105815261|NCT00760266|364983451|FG000|Overall Study|Administrative Problems|0|||
105815262|NCT00760266|364983452|FG001|Overall Study|Administrative Problems|1|||
105815263|NCT03340727|364983455|FG000|Overall Study|Death|1|||
105815264|NCT03340727|364983456|FG001|Overall Study|Death|0|||
105815265|NCT03340727|364983455|FG000|Overall Study|Lost to Follow-up|31|||
105815266|NCT03340727|364983456|FG001|Overall Study|Lost to Follow-up|35|||
105815267|NCT03340727|364983455|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
105815268|NCT03340727|364983456|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
105815269|NCT03340727|364983455|FG000|Overall Study|Transferred to another facility|10|||
105815270|NCT03340727|364983456|FG001|Overall Study|Transferred to another facility|7|||
105815271|NCT03340727|364983455|FG000|Overall Study|Withdrawal by Subject|28|||
105815272|NCT03340727|364983456|FG001|Overall Study|Withdrawal by Subject|17|||
105815273|NCT01572948|364983457|FG000|Overall Study|Lost to Follow-up|1|||
105815274|NCT01572948|364983458|FG001|Overall Study|Lost to Follow-up|0|||
105815275|NCT01572948|364983457|FG000|Overall Study|unable to contact|0|||
105815276|NCT01572948|364983458|FG001|Overall Study|unable to contact|1|||
105815277|NCT03603314|364983459|FG000|Overall Study|Lost to Follow-up|0|||
105815278|NCT03603314|364983460|FG001|Overall Study|Lost to Follow-up|3|||
105815279|NCT03603314|364983461|FG002|Overall Study|Lost to Follow-up|0|||
105815280|NCT03603314|364983459|FG000|Overall Study|Protocol Violation|0|||
105815281|NCT03603314|364983460|FG001|Overall Study|Protocol Violation|1|||
105815282|NCT03603314|364983461|FG002|Overall Study|Protocol Violation|0|||
105815283|NCT03603314|364983459|FG000|Overall Study|Adverse Event|2|||
105815284|NCT03603314|364983460|FG001|Overall Study|Adverse Event|0|||
105815285|NCT03603314|364983461|FG002|Overall Study|Adverse Event|0|||
105815286|NCT03603314|364983459|FG000|Overall Study|Physician Decision|1|||
105815287|NCT03603314|364983460|FG001|Overall Study|Physician Decision|1|||
105815288|NCT03603314|364983461|FG002|Overall Study|Physician Decision|0|||
105815289|NCT03603314|364983459|FG000|Overall Study|Withdrawal by Subject|4|||
105815290|NCT03603314|364983460|FG001|Overall Study|Withdrawal by Subject|5|||
105815291|NCT03603314|364983461|FG002|Overall Study|Withdrawal by Subject|3|||
105815292|NCT03603314|364983459|FG000|Overall Study|Other|0|||
105815293|NCT03603314|364983460|FG001|Overall Study|Other|1|||
105815294|NCT03603314|364983461|FG002|Overall Study|Other|0|||
105815295|NCT00050778|364983462|FG000|Overall Study|Adverse Event|13|||
105815296|NCT00050778|364983463|FG001|Overall Study|Adverse Event|3|||
105815297|NCT00050778|364983464|FG002|Overall Study|Adverse Event|2|||
105815298|NCT00050778|364983462|FG000|Overall Study|Death|0|||
105815299|NCT00050778|364983463|FG001|Overall Study|Death|1|||
105815300|NCT00050778|364983464|FG002|Overall Study|Death|1|||
105815301|NCT00050778|364983462|FG000|Overall Study|Lack of Efficacy|16|||
105362128|NCT02326272|363330157|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
105815302|NCT00050778|364983463|FG001|Overall Study|Lack of Efficacy|2|||
105815303|NCT00050778|364983464|FG002|Overall Study|Lack of Efficacy|2|||
105815304|NCT00050778|364983462|FG000|Overall Study|Lost to Follow-up|0|||
105815305|NCT00050778|364983463|FG001|Overall Study|Lost to Follow-up|2|||
105815306|NCT00050778|364983464|FG002|Overall Study|Lost to Follow-up|4|||
105815307|NCT00050778|364983462|FG000|Overall Study|Physician Decision|3|||
105815308|NCT00050778|364983463|FG001|Overall Study|Physician Decision|0|||
105815309|NCT00050778|364983464|FG002|Overall Study|Physician Decision|2|||
105815310|NCT00050778|364983462|FG000|Overall Study|Protocol Violation|2|||
105815311|NCT00050778|364983463|FG001|Overall Study|Protocol Violation|0|||
105815312|NCT00050778|364983464|FG002|Overall Study|Protocol Violation|1|||
105815313|NCT00050778|364983462|FG000|Overall Study|Withdrawal by Subject|6|||
105815314|NCT00050778|364983463|FG001|Overall Study|Withdrawal by Subject|8|||
105815315|NCT00050778|364983464|FG002|Overall Study|Withdrawal by Subject|4|||
105815316|NCT00050778|364983462|FG000|Overall Study|Randomized but not treated|4|||
105815317|NCT00050778|364983463|FG001|Overall Study|Randomized but not treated|5|||
105815318|NCT00050778|364983464|FG002|Overall Study|Randomized but not treated|2|||
105815319|NCT00050778|364983462|FG000|Overall Study|Familial and personal reasons|1|||
105815320|NCT00050778|364983463|FG001|Overall Study|Familial and personal reasons|0|||
105815321|NCT00050778|364983464|FG002|Overall Study|Familial and personal reasons|0|||
105815322|NCT02910037|364983467|FG000|Overall Study|Withdrawal by Subject|4|||
105815323|NCT02910037|364983467|FG000|Overall Study|Lost to Follow-up|6|||
105815324|NCT00813293|364983468|FG000|Overall Study|Intercurrent illness|1|||
105815325|NCT00813293|364983469|FG001|Overall Study|Intercurrent illness|0|||
105815326|NCT00813293|364983468|FG000|Overall Study|Adverse Event|0|||
105815327|NCT00813293|364983469|FG001|Overall Study|Adverse Event|1|||
105815328|NCT01544127|364983470|FG000|Overall Study|Lost to Follow-up|4|||
105815329|NCT01544127|364983471|FG001|Overall Study|Lost to Follow-up|2|||
105815330|NCT01544127|364983472|FG002|Overall Study|Lost to Follow-up|9|||
105815331|NCT01544127|364983470|FG000|Overall Study|Withdrawal by Subject|2|||
105815332|NCT01544127|364983471|FG001|Overall Study|Withdrawal by Subject|2|||
105815333|NCT01544127|364983472|FG002|Overall Study|Withdrawal by Subject|1|||
105815334|NCT01544127|364983470|FG000|Overall Study|Discharged out of catchment area|1|||
105815335|NCT01544127|364983471|FG001|Overall Study|Discharged out of catchment area|1|||
105815336|NCT01544127|364983472|FG002|Overall Study|Discharged out of catchment area|1|||
105815337|NCT01544127|364983470|FG000|Overall Study|Death|1|||
105815338|NCT01544127|364983471|FG001|Overall Study|Death|0|||
105815339|NCT01544127|364983472|FG002|Overall Study|Death|0|||
105815340|NCT01544127|364983470|FG000|Overall Study|Jail or Prison|1|||
105815341|NCT01544127|364983471|FG001|Overall Study|Jail or Prison|1|||
105815342|NCT01544127|364983472|FG002|Overall Study|Jail or Prison|2|||
105815343|NCT01544127|364983470|FG000|Overall Study|Became Psychotic|1|||
105815344|NCT01544127|364983471|FG001|Overall Study|Became Psychotic|0|||
105815345|NCT01544127|364983472|FG002|Overall Study|Became Psychotic|0|||
105815346|NCT01544127|364983470|FG000|Overall Study|Researcher withdrew|1|||
105815347|NCT01544127|364983471|FG001|Overall Study|Researcher withdrew|0|||
105815348|NCT01544127|364983472|FG002|Overall Study|Researcher withdrew|0|||
105815349|NCT01544127|364983470|FG000|Overall Study|Went active duty|0|||
105815350|NCT01544127|364983471|FG001|Overall Study|Went active duty|0|||
105815351|NCT01544127|364983472|FG002|Overall Study|Went active duty|1|||
105815352|NCT00615069|364983474|FG000|Overall Study|Death|10|||
105815353|NCT00615069|364983474|FG000|Overall Study|Physician Decision|2|||
105815354|NCT00615069|364983474|FG000|Overall Study|Withdrawal by Subject|4|||
105815355|NCT02914600|364983475|FG000|Overall Study|Adverse Event|298|||
105815356|NCT02914600|364983476|FG001|Overall Study|Adverse Event|35|||
105815357|NCT02914600|364983477|FG002|Overall Study|Adverse Event|25|||
105815358|NCT02914600|364983475|FG000|Overall Study|Sponsors decision|287|||
105815359|NCT02914600|364983476|FG001|Overall Study|Sponsors decision|41|||
105815360|NCT02914600|364983477|FG002|Overall Study|Sponsors decision|12|||
105815361|NCT02914600|364983475|FG000|Overall Study|Withdrawal by Subject|158|||
105815362|NCT02914600|364983476|FG001|Overall Study|Withdrawal by Subject|20|||
105815363|NCT02914600|364983477|FG002|Overall Study|Withdrawal by Subject|18|||
105815364|NCT02914600|364983475|FG000|Overall Study|Investigators discretion|169|||
105815365|NCT02914600|364983476|FG001|Overall Study|Investigators discretion|14|||
105815366|NCT02914600|364983477|FG002|Overall Study|Investigators discretion|13|||
105815367|NCT02914600|364983475|FG000|Overall Study|Lost to Follow-up|10|||
105815368|NCT02914600|364983476|FG001|Overall Study|Lost to Follow-up|4|||
105815369|NCT02914600|364983477|FG002|Overall Study|Lost to Follow-up|0|||
105815370|NCT02914600|364983475|FG000|Overall Study|Pregnancy|8|||
105815371|NCT02914600|364983476|FG001|Overall Study|Pregnancy|0|||
105815372|NCT02914600|364983477|FG002|Overall Study|Pregnancy|0|||
105815373|NCT02914600|364983475|FG000|Overall Study|Protocol Violation|5|||
105815374|NCT02914600|364983476|FG001|Overall Study|Protocol Violation|3|||
105815375|NCT02914600|364983477|FG002|Overall Study|Protocol Violation|0|||
105815376|NCT02914600|364983475|FG000|Overall Study|Non-compliance with study drug|6|||
105815377|NCT02914600|364983476|FG001|Overall Study|Non-compliance with study drug|1|||
105815378|NCT02914600|364983477|FG002|Overall Study|Non-compliance with study drug|0|||
105815379|NCT02914600|364983475|FG000|Overall Study|Death|3|||
105815380|NCT02914600|364983476|FG001|Overall Study|Death|1|||
105815381|NCT02914600|364983477|FG002|Overall Study|Death|1|||
105815382|NCT02914600|364983475|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
105815383|NCT02914600|364983476|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
105815384|NCT02914600|364983477|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
105815385|NCT02914600|364983475|FG000|Overall Study|Enrolled but not treated|1|||
105815386|NCT02914600|364983476|FG001|Overall Study|Enrolled but not treated|0|||
105815387|NCT02914600|364983477|FG002|Overall Study|Enrolled but not treated|0|||
105815388|NCT01395030|364983481|FG000|Overall Study|Did not complete FCH PET/CT|7|||
105815389|NCT02079766|364983482|FG000|Overall Study|Physician Decision|1|||
105815390|NCT02079766|364983483|FG001|Overall Study|Physician Decision|0|||
105815391|NCT02079766|364983482|FG000|Overall Study|Withdrawal by Subject|1|||
105815392|NCT02079766|364983483|FG001|Overall Study|Withdrawal by Subject|0|||
105815393|NCT02008565|364983488|FG000|Overall Study|Protocol Violation|1|||
105815394|NCT02008565|364983489|FG001|Overall Study|Protocol Violation|1|||
105815395|NCT02008565|364983490|FG002|Overall Study|Protocol Violation|2|||
105815396|NCT02008565|364983491|FG003|Overall Study|Protocol Violation|0|||
105815397|NCT02781727|364983492|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
105815398|NCT02781727|364983493|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
105815399|NCT02781727|364983492|FG000|Treatment Period|Withdrawal by Subject|1|||
105815400|NCT02781727|364983493|FG001|Treatment Period|Withdrawal by Subject|0|||
105815401|NCT02781727|364983492|FG000|Treatment Period|Lost to Follow-up|0|||
105815402|NCT02781727|364983493|FG001|Treatment Period|Lost to Follow-up|1|||
105815403|NCT02327130|364983494|FG000|Overall Study|Discharged in less than 5 days|5|||
105815404|NCT02327130|364983494|FG000|Overall Study|Physician Decision|2|||
105815405|NCT02327130|364983494|FG000|Overall Study|Unable to provide breath sample|1|||
105815406|NCT02327130|364983494|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
105815407|NCT02327130|364983494|FG000|Overall Study|Met exclusion criteria|3|||
105815408|NCT00857623|364983495|FG000|Overall Study|Adverse Event|5|||
105815409|NCT00857623|364983496|FG001|Overall Study|Adverse Event|2|||
105815410|NCT00857623|364983495|FG000|Overall Study|Study-specific discontinuation criteria|5|||
105815411|NCT00857623|364983496|FG001|Overall Study|Study-specific discontinuation criteria|3|||
105815412|NCT00857623|364983495|FG000|Overall Study|Withdrawal by Subject|2|||
105815413|NCT00857623|364983496|FG001|Overall Study|Withdrawal by Subject|1|||
105815414|NCT00857623|364983495|FG000|Overall Study|Lack of Efficacy|1|||
105815415|NCT00857623|364983496|FG001|Overall Study|Lack of Efficacy|1|||
105815416|NCT00857623|364983495|FG000|Overall Study|Severe non-compliance to protocol|1|||
105815417|NCT00857623|364983496|FG001|Overall Study|Severe non-compliance to protocol|1|||
105815418|NCT00857623|364983495|FG000|Overall Study|Intake of prohibited medication|0|||
105815419|NCT00857623|364983496|FG001|Overall Study|Intake of prohibited medication|1|||
105815420|NCT00857623|364983495|FG000|Overall Study|Positive for HEP C|0|||
105815421|NCT00857623|364983496|FG001|Overall Study|Positive for HEP C|1|||
105815422|NCT02193178|364983497|FG000|Overall Study|Lost to Follow-up|1|||
105815423|NCT02193178|364983497|FG000|Overall Study|Dry eyes|1|||
105815424|NCT03435081|364983498|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
105815425|NCT03435081|364983499|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
105815426|NCT03435081|364983500|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
105815427|NCT03435081|364983498|FG000|Week 0 to Week 16|Adverse Event|2|||
105815428|NCT03435081|364983499|FG001|Week 0 to Week 16|Adverse Event|2|||
105815429|NCT03435081|364983500|FG002|Week 0 to Week 16|Adverse Event|2|||
105815430|NCT03435081|364983498|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
105815431|NCT03435081|364983499|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
105815432|NCT03435081|364983500|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
105815433|NCT03435081|364983498|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
105815434|NCT03435081|364983499|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
105815435|NCT03435081|364983500|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
105815436|NCT03435081|364983498|FG000|Week 0 to Week 16|Pregnancy|1|||
105815437|NCT03435081|364983499|FG001|Week 0 to Week 16|Pregnancy|0|||
105815438|NCT03435081|364983500|FG002|Week 0 to Week 16|Pregnancy|0|||
105815439|NCT03435081|364983498|FG000|Week 0 to Week 16|Non-compliance|1|||
105815440|NCT03435081|364983499|FG001|Week 0 to Week 16|Non-compliance|0|||
105815441|NCT03435081|364983500|FG002|Week 0 to Week 16|Non-compliance|2|||
105815442|NCT03435081|364983498|FG000|Week 0 to Week 16|Inadequate Response|0|||
105815443|NCT03435081|364983499|FG001|Week 0 to Week 16|Inadequate Response|1|||
105815444|NCT03435081|364983500|FG002|Week 0 to Week 16|Inadequate Response|0|||
105815445|NCT03435081|364983498|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
105815446|NCT03435081|364983499|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
105815447|NCT03435081|364983500|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
105815448|NCT03435081|364983498|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
105815449|NCT03435081|364983499|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
105815450|NCT03435081|364983500|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
105815451|NCT03435081|364983498|FG000|Week 16 to Week 104|Adverse Event|1|||
105815452|NCT03435081|364983499|FG001|Week 16 to Week 104|Adverse Event|0|||
105815453|NCT03435081|364983500|FG002|Week 16 to Week 104|Adverse Event|2|||
105815454|NCT03435081|364983498|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
105815455|NCT03435081|364983499|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
105815456|NCT03435081|364983500|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
105815457|NCT03435081|364983498|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
105815458|NCT03435081|364983499|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
105815459|NCT03435081|364983500|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
105815460|NCT03435081|364983498|FG000|Week 16 to Week 104|Non--Compliance|0|||
105815461|NCT03435081|364983499|FG001|Week 16 to Week 104|Non--Compliance|0|||
105815462|NCT03435081|364983500|FG002|Week 16 to Week 104|Non--Compliance|1|||
105815463|NCT00420238|364983502|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
105815464|NCT00420238|364983503|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
105815465|NCT00420238|364983502|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
105815466|NCT00420238|364983503|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
105815467|NCT00420238|364983502|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
105815468|NCT00420238|364983503|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
105815469|NCT00420238|364983502|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
105815470|NCT00420238|364983503|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
105815471|NCT00420238|364983502|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
105815472|NCT00420238|364983503|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
105815473|NCT00420238|364983502|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
105815474|NCT00420238|364983503|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
105815475|NCT05214560|364983504|FG000|Overall Study|Screening Failure|1|||
105815476|NCT05214560|364983504|FG000|Overall Study|Physician Decision|4|||
105815477|NCT05214560|364983504|FG000|Overall Study|Withdrawal by Subject|1|||
105815478|NCT05214560|364983504|FG000|Overall Study|Lost to Follow-up|2|||
105815479|NCT05214560|364983504|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
105815480|NCT05214560|364983504|FG000|Overall Study|Study physician not available for the anesthesia|3|||
105815481|NCT05214560|364983504|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
105815482|NCT05214560|364983504|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
105815483|NCT05214560|364983504|FG000|Overall Study|Surgery not performed|3|||
105815484|NCT04510285|364983505|FG000|Overall Study|Death|1|||
105815485|NCT01417078|364983506|FG000|Overall Study|Withdrawal by Subject|1|||
105815486|NCT00626548|364983508|FG000|Overall Study|Adverse Event|164|||
105815487|NCT00626548|364983509|FG001|Overall Study|Adverse Event|44|||
105486167|NCT04761627|363791413|FG002|Post-randomization Period|Withdrawal by Subject|6|||
105486168|NCT04761627|363791411|FG000|Post-randomization Period|Pregnancy|0|||
105486169|NCT04761627|363791412|FG001|Post-randomization Period|Pregnancy|0|||
105815488|NCT00626548|364983508|FG000|Overall Study|Withdrawal by Subject|42|||
105815489|NCT00626548|364983509|FG001|Overall Study|Withdrawal by Subject|46|||
105815490|NCT00626548|364983508|FG000|Overall Study|Protocol Violation|4|||
105815491|NCT00626548|364983509|FG001|Overall Study|Protocol Violation|11|||
105815492|NCT00626548|364983508|FG000|Overall Study|Lost to Follow-up|2|||
105815493|NCT00626548|364983509|FG001|Overall Study|Lost to Follow-up|2|||
105815494|NCT00626548|364983508|FG000|Overall Study|Other termination reason|493|||
105815495|NCT00626548|364983509|FG001|Overall Study|Other termination reason|613|||
105764155|NCT00418717|364788989|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
105764156|NCT00418717|364788989|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
105764157|NCT02460978|364788991|FG000|Overall Study|Adverse Event|17|||
105764158|NCT02460978|364788992|FG001|Overall Study|Adverse Event|11|||
105764159|NCT02460978|364788993|FG002|Overall Study|Adverse Event|11|||
105764160|NCT02460978|364788991|FG000|Overall Study|Withdrawal by Subject|5|||
105764161|NCT02460978|364788992|FG001|Overall Study|Withdrawal by Subject|5|||
105764162|NCT02460978|364788993|FG002|Overall Study|Withdrawal by Subject|14|||
105764163|NCT02460978|364788991|FG000|Overall Study|Lost to Follow-up|2|||
105764164|NCT02460978|364788992|FG001|Overall Study|Lost to Follow-up|3|||
105764165|NCT02460978|364788993|FG002|Overall Study|Lost to Follow-up|1|||
105764166|NCT02460978|364788991|FG000|Overall Study|Protocol Violation|1|||
105764167|NCT02460978|364788992|FG001|Overall Study|Protocol Violation|1|||
105764168|NCT02460978|364788993|FG002|Overall Study|Protocol Violation|1|||
105764169|NCT02460978|364788991|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
105764170|NCT02460978|364788992|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
105764171|NCT02460978|364788993|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
105764172|NCT02460978|364788991|FG000|Overall Study|Pregnancy|0|||
105764173|NCT02460978|364788992|FG001|Overall Study|Pregnancy|0|||
105764174|NCT02460978|364788993|FG002|Overall Study|Pregnancy|2|||
105764175|NCT00994162|364788994|FG000|Overall Study|Withdrawal by Subject|1|||
105764176|NCT00994162|364788994|FG000|Overall Study|Lost to Follow-up|2|||
105764177|NCT00994162|364788994|FG000|Overall Study|Product Complaint|1|||
105764178|NCT00994162|364788994|FG000|Overall Study|Poor Compliance|5|||
105764179|NCT00994162|364788994|FG000|Overall Study|Lack of Response|3|||
105764180|NCT00994162|364788994|FG000|Overall Study|Discharged from Hospital|4|||
105764181|NCT00994162|364788994|FG000|Overall Study|Death|2|||
105764182|NCT00994162|364788994|FG000|Overall Study|Care Transferred to Another Physician|2|||
105764183|NCT00994162|364788994|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
105764184|NCT00994162|364788994|FG000|Overall Study|Physician Decision|2|||
105764185|NCT00994162|364788994|FG000|Overall Study|Surrounding Wound Erythematous|1|||
105764186|NCT00994162|364788994|FG000|Overall Study|Machine Losing Vaccum|1|||
105764187|NCT00994162|364788994|FG000|Overall Study|Patient Lived Too Far Away|1|||
105764188|NCT00994162|364788994|FG000|Overall Study|Above Knee Amputation|1|||
105764189|NCT00994162|364788994|FG000|Overall Study|Reason Not Reported By Site|1|||
105764190|NCT01814826|364788995|FG000|Overall Study|Other|3|||
105764191|NCT01814826|364788996|FG001|Overall Study|Other|5|||
105764192|NCT01814826|364788997|FG002|Overall Study|Other|0|||
105764193|NCT01814826|364788995|FG000|Overall Study|Death|29|||
105764194|NCT01814826|364788996|FG001|Overall Study|Death|24|||
105764195|NCT01814826|364788997|FG002|Overall Study|Death|3|||
105764196|NCT01042938|364789002|FG000|Overall Study|Withdrawal by Subject|1|||
105764197|NCT01042938|364789003|FG001|Overall Study|Withdrawal by Subject|1|||
105764198|NCT01042938|364789002|FG000|Overall Study|Protocol Violation|1|||
105764199|NCT01042938|364789003|FG001|Overall Study|Protocol Violation|1|||
105764200|NCT01042938|364789002|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
105764201|NCT01042938|364789003|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
105764202|NCT04095793|364789008|FG000|Overall Study|Adverse Event|3|||
105764203|NCT04095793|364789008|FG000|Overall Study|Study Terminated by Sponsor|103|||
105764204|NCT04095793|364789008|FG000|Overall Study|Withdrawal by Subject|4|||
105764205|NCT02384993|364789009|FG000|Overall Study|Adverse Event|0|||
105764206|NCT02384993|364789010|FG001|Overall Study|Adverse Event|1|||
105764207|NCT02571972|364789013|FG000|Overall Study|Protocol Violation|2|||
105486170|NCT04761627|363791413|FG002|Post-randomization Period|Pregnancy|1|||
105486171|NCT04761627|363791411|FG000|Post-randomization Period|Study site closure|0|||
105486172|NCT04761627|363791412|FG001|Post-randomization Period|Study site closure|0|||
105486173|NCT04761627|363791413|FG002|Post-randomization Period|Study site closure|1|||
105486174|NCT04761627|363791411|FG000|Post-randomization Period|Family planning|0|||
105486175|NCT04761627|363791412|FG001|Post-randomization Period|Family planning|1|||
105486176|NCT04761627|363791413|FG002|Post-randomization Period|Family planning|0|||
105486177|NCT01214174|363791414|FG000|Overall Study|Withdrawal by Subject|0|||
105486178|NCT01214174|363791415|FG001|Overall Study|Withdrawal by Subject|0|||
105486179|NCT01214174|363791416|FG002|Overall Study|Withdrawal by Subject|1|||
105486180|NCT01634178|363791417|FG000|Treatment Period 1|Adverse Event|0|||
105486181|NCT01634178|363791418|FG001|Treatment Period 1|Adverse Event|1|||
105486182|NCT01634178|363791417|FG000|Treatment Period 2|Adverse Event|1|||
105486183|NCT01634178|363791418|FG001|Treatment Period 2|Adverse Event|0|||
105486184|NCT01933789|363791419|FG000|Overall Study|Death|0|||
105486185|NCT01933789|363791420|FG001|Overall Study|Death|0|||
105486186|NCT01933789|363791421|FG002|Overall Study|Death|0|||
105486187|NCT01933789|363791422|FG003|Overall Study|Death|0|||
105486188|NCT01933789|363791423|FG004|Overall Study|Death|21|||
105486189|NCT01933789|363791424|FG005|Overall Study|Death|32|||
105486190|NCT01933789|363791425|FG006|Overall Study|Death|0|||
105486191|NCT01933789|363791426|FG007|Overall Study|Death|0|||
105486192|NCT01933789|363791427|FG008|Overall Study|Death|0|||
105486193|NCT01933789|363791419|FG000|Overall Study|Lost to Follow-up|0|||
105486194|NCT01933789|363791420|FG001|Overall Study|Lost to Follow-up|0|||
105486195|NCT01933789|363791421|FG002|Overall Study|Lost to Follow-up|0|||
105486196|NCT01933789|363791422|FG003|Overall Study|Lost to Follow-up|1|||
105486197|NCT01933789|363791423|FG004|Overall Study|Lost to Follow-up|8|||
105764208|NCT02571972|364789013|FG000|Overall Study|Withdrawal by Subject|2|||
105486198|NCT01933789|363791424|FG005|Overall Study|Lost to Follow-up|9|||
105486199|NCT01933789|363791425|FG006|Overall Study|Lost to Follow-up|1|||
105486200|NCT01933789|363791426|FG007|Overall Study|Lost to Follow-up|4|||
105764209|NCT00634751|364791633|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
105764210|NCT00634751|364791634|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
105764211|NCT00634751|364791635|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
105764212|NCT00634751|364791636|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
105764213|NCT00634751|364791633|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
105764214|NCT00634751|364791634|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
105764215|NCT00634751|364791635|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
105764216|NCT00634751|364791636|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
105764217|NCT00634751|364791633|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
105764218|NCT00634751|364791634|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
105764219|NCT00634751|364791635|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
105764220|NCT00634751|364791636|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
105764221|NCT00216086|364791646|FG000|Overall Study|Protocol Violation|1|||
105764222|NCT00216086|364791646|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
105764223|NCT00216086|364791646|FG000|Overall Study|Social Reasons|2|||
105764224|NCT00239356|364791649|FG000|Overall Study|Lack of Efficacy|1|||
105764225|NCT00239356|364791650|FG001|Overall Study|Lack of Efficacy|0|||
105764226|NCT00239356|364791649|FG000|Overall Study|Adverse Event|6|||
105764227|NCT00239356|364791650|FG001|Overall Study|Adverse Event|0|||
105764228|NCT00239356|364791649|FG000|Overall Study|Withdrawal by Subject|15|||
105764229|NCT00239356|364791650|FG001|Overall Study|Withdrawal by Subject|6|||
105764230|NCT00239356|364791649|FG000|Overall Study|Lost to Follow-up|3|||
105764231|NCT00239356|364791650|FG001|Overall Study|Lost to Follow-up|0|||
105764232|NCT00239356|364791649|FG000|Overall Study|poor/non-compliance|2|||
105764233|NCT00239356|364791650|FG001|Overall Study|poor/non-compliance|0|||
105764234|NCT00239356|364791649|FG000|Overall Study|Pregnancy|1|||
105764235|NCT00239356|364791650|FG001|Overall Study|Pregnancy|0|||
105764236|NCT00239356|364791649|FG000|Overall Study|Administrative reason|0|||
105764237|NCT00239356|364791650|FG001|Overall Study|Administrative reason|1|||
105764238|NCT00239356|364791649|FG000|Overall Study|Drug available on market|11|||
105764239|NCT00239356|364791650|FG001|Overall Study|Drug available on market|2|||
105764240|NCT01094808|364791651|FG000|Overall Study|Withdrawal by Subject|1|||
105764241|NCT01094808|364791652|FG001|Overall Study|Withdrawal by Subject|1|||
105764242|NCT01094808|364791653|FG002|Overall Study|Withdrawal by Subject|0|||
105764243|NCT00369278|364791654|FG000|Overall Study|Adverse Event|14|||
105764244|NCT00369278|364791655|FG001|Overall Study|Adverse Event|11|||
105764245|NCT00369278|364791654|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105764246|NCT00369278|364791655|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
105764247|NCT00369278|364791654|FG000|Overall Study|Protocol Violation|2|||
105764248|NCT00369278|364791655|FG001|Overall Study|Protocol Violation|1|||
105764249|NCT00369278|364791654|FG000|Overall Study|Withdrawal by Subject|2|||
105764250|NCT00369278|364791655|FG001|Overall Study|Withdrawal by Subject|2|||
105815496|NCT03338972|364983510|FG000|Overall Study|Death|1|||
105764251|NCT00369278|364791654|FG000|Overall Study|Lost to Follow-up|1|||
105764252|NCT00369278|364791655|FG001|Overall Study|Lost to Follow-up|0|||
105764253|NCT00369278|364791654|FG000|Overall Study|Graft loss|1|||
105486201|NCT01933789|363791427|FG008|Overall Study|Lost to Follow-up|0|||
105764254|NCT00369278|364791655|FG001|Overall Study|Graft loss|2|||
105764255|NCT00711412|364791658|FG000|Induction Treatment|Death|2|||
105764256|NCT00711412|364791658|FG000|Induction Treatment|Adverse Event|1|||
105764257|NCT00711412|364791658|FG000|Induction Treatment|Other|1|||
105764258|NCT00711412|364791658|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
105764259|NCT00711412|364791658|FG000|Evaluated for Combination Treatment|Death|1|||
105764260|NCT00711412|364791658|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
105764261|NCT00711412|364791658|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
105764262|NCT00711412|364791658|FG000|Combination Treatment|Progressive Disease|1|||
105764263|NCT00711412|364791658|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
105764264|NCT00711412|364791658|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
105764265|NCT00711412|364791658|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
105764266|NCT00711412|364791658|FG000|Evaluation for Response and Surgery|Death|1|||
105764267|NCT00711412|364791658|FG000|Survival Follow up Until Death|Other|12|||
105764268|NCT04179032|364791661|FG000|Part B (Up to Week 52)|Adverse Event|1|||
105764269|NCT04179032|364791661|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
105764270|NCT04179032|364791661|FG000|Access Extension Phase|Ongoing|11|||
105764271|NCT01998958|364791662|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764272|NCT01998958|364791663|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
105764273|NCT01998958|364791664|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764274|NCT01998958|364791665|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764275|NCT01998958|364791666|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764276|NCT01998958|364791667|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764277|NCT01998958|364791668|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764278|NCT01998958|364791669|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764279|NCT01998958|364791670|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764280|NCT01998958|364791671|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764281|NCT01998958|364791672|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764282|NCT01998958|364791673|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764283|NCT01998958|364791674|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764284|NCT01998958|364791675|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764285|NCT01998958|364791676|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764286|NCT01998958|364791677|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764287|NCT01998958|364791678|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764288|NCT01998958|364791679|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764289|NCT01998958|364791680|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764290|NCT01998958|364791681|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764291|NCT01998958|364791682|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764292|NCT01998958|364791683|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764293|NCT01998958|364791684|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764294|NCT01998958|364791685|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764295|NCT01998958|364791686|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764296|NCT01998958|364791687|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764297|NCT01998958|364791688|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764298|NCT01998958|364791689|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764299|NCT01998958|364791690|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764300|NCT01998958|364791691|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764301|NCT01998958|364791692|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764302|NCT01998958|364791693|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764303|NCT01998958|364791662|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764304|NCT01998958|364791663|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
105764305|NCT01998958|364791664|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764306|NCT01998958|364791665|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764307|NCT01998958|364791666|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764308|NCT01998958|364791667|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764309|NCT01998958|364791668|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764310|NCT01998958|364791669|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764311|NCT01998958|364791670|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764312|NCT01998958|364791671|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764313|NCT01998958|364791672|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764314|NCT01998958|364791673|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764315|NCT01998958|364791674|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764316|NCT01998958|364791675|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764317|NCT01998958|364791676|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764318|NCT01998958|364791677|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764319|NCT01998958|364791678|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764320|NCT01998958|364791679|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764321|NCT01998958|364791680|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764322|NCT01998958|364791681|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105571571|NCT03734991|364091245|FG001|Overall Study|Withdrawal by Subject|3|||
105571572|NCT03734991|364091244|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
105571573|NCT03734991|364091245|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
105571574|NCT03734991|364091244|FG000|Overall Study|Other|2|||
105571575|NCT03734991|364091245|FG001|Overall Study|Other|2|||
105571576|NCT02569710|364091256|FG000|Overall Study|Adverse Event|1|||
105571577|NCT02569710|364091257|FG001|Overall Study|Adverse Event|0|||
105571578|NCT02569710|364091258|FG002|Overall Study|Adverse Event|0|||
105571579|NCT02569710|364091259|FG003|Overall Study|Adverse Event|0|||
105571580|NCT02569710|364091260|FG004|Overall Study|Adverse Event|0|||
105571581|NCT02569710|364091261|FG005|Overall Study|Adverse Event|0|||
105571582|NCT02569710|364091262|FG006|Overall Study|Adverse Event|0|||
105571583|NCT02569710|364091263|FG007|Overall Study|Adverse Event|0|||
105571584|NCT02569710|364091264|FG008|Overall Study|Adverse Event|0|||
105571585|NCT02569710|364091265|FG009|Overall Study|Adverse Event|0|||
105571586|NCT02569710|364091256|FG000|Overall Study|Lost to Follow-up|0|||
105571587|NCT02569710|364091257|FG001|Overall Study|Lost to Follow-up|0|||
105571588|NCT02569710|364091258|FG002|Overall Study|Lost to Follow-up|0|||
105571589|NCT02569710|364091259|FG003|Overall Study|Lost to Follow-up|0|||
105571590|NCT02569710|364091260|FG004|Overall Study|Lost to Follow-up|0|||
105571591|NCT02569710|364091261|FG005|Overall Study|Lost to Follow-up|0|||
105571592|NCT02569710|364091262|FG006|Overall Study|Lost to Follow-up|1|||
105571593|NCT02569710|364091263|FG007|Overall Study|Lost to Follow-up|0|||
105571594|NCT02569710|364091264|FG008|Overall Study|Lost to Follow-up|1|||
105571595|NCT02569710|364091265|FG009|Overall Study|Lost to Follow-up|0|||
105764323|NCT01998958|364791682|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764324|NCT01998958|364791683|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764325|NCT01998958|364791684|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764326|NCT01998958|364791685|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764327|NCT01998958|364791686|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764328|NCT01998958|364791687|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764329|NCT01998958|364791688|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764330|NCT01998958|364791689|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764331|NCT01998958|364791690|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764332|NCT01998958|364791691|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764333|NCT01998958|364791692|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764334|NCT01998958|364791693|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764335|NCT01998958|364791662|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
105764336|NCT01998958|364791663|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
105764337|NCT01998958|364791664|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
105764338|NCT01998958|364791665|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
105764339|NCT01998958|364791666|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
105764340|NCT01998958|364791667|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
105764341|NCT01998958|364791668|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
105764342|NCT01998958|364791669|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
105764343|NCT01998958|364791670|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
105764344|NCT01998958|364791671|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
105764345|NCT01998958|364791672|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
105764346|NCT01998958|364791673|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
105764347|NCT01998958|364791674|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
105764348|NCT01998958|364791675|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
105764349|NCT01998958|364791676|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
105764350|NCT01998958|364791677|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
105764351|NCT01998958|364791678|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
105764352|NCT01998958|364791679|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
105764353|NCT01998958|364791680|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
105764354|NCT01998958|364791681|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
105764355|NCT01998958|364791682|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
105764356|NCT01998958|364791683|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
105764357|NCT01998958|364791684|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
105764358|NCT01998958|364791685|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
105764359|NCT01998958|364791686|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
105764360|NCT01998958|364791687|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
105764361|NCT01998958|364791688|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
105764362|NCT01998958|364791689|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
105764363|NCT01998958|364791690|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
105764364|NCT01998958|364791691|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
105571596|NCT02569710|364091256|FG000|Overall Study|Virologic failure|0|||
105571597|NCT02569710|364091257|FG001|Overall Study|Virologic failure|0|||
105571598|NCT02569710|364091258|FG002|Overall Study|Virologic failure|0|||
105571599|NCT02569710|364091259|FG003|Overall Study|Virologic failure|0|||
105571600|NCT02569710|364091260|FG004|Overall Study|Virologic failure|1|||
105571601|NCT02569710|364091261|FG005|Overall Study|Virologic failure|0|||
105764365|NCT01998958|364791692|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
105571602|NCT02569710|364091262|FG006|Overall Study|Virologic failure|1|||
105571603|NCT02569710|364091263|FG007|Overall Study|Virologic failure|0|||
105571604|NCT02569710|364091264|FG008|Overall Study|Virologic failure|0|||
105571605|NCT02569710|364091265|FG009|Overall Study|Virologic failure|0|||
105571606|NCT02569710|364091256|FG000|Overall Study|Withdrawal by Subject|0|||
105571607|NCT02569710|364091257|FG001|Overall Study|Withdrawal by Subject|0|||
105571608|NCT02569710|364091258|FG002|Overall Study|Withdrawal by Subject|0|||
105571609|NCT02569710|364091259|FG003|Overall Study|Withdrawal by Subject|0|||
105571610|NCT02569710|364091260|FG004|Overall Study|Withdrawal by Subject|0|||
105571611|NCT02569710|364091261|FG005|Overall Study|Withdrawal by Subject|1|||
105571612|NCT02569710|364091262|FG006|Overall Study|Withdrawal by Subject|0|||
105571613|NCT02569710|364091263|FG007|Overall Study|Withdrawal by Subject|0|||
105571614|NCT02569710|364091264|FG008|Overall Study|Withdrawal by Subject|0|||
105571615|NCT02569710|364091265|FG009|Overall Study|Withdrawal by Subject|0|||
105815497|NCT03338972|364983511|FG001|Overall Study|Death|1|||
105815498|NCT03338972|364983512|FG002|Overall Study|Death|0|||
105815499|NCT03338972|364983513|FG003|Overall Study|Death|0|||
105815500|NCT03338972|364983510|FG000|Overall Study|Withdrawal by Subject|1|||
105815501|NCT03338972|364983511|FG001|Overall Study|Withdrawal by Subject|0|||
105815502|NCT03338972|364983512|FG002|Overall Study|Withdrawal by Subject|0|||
105815503|NCT03338972|364983513|FG003|Overall Study|Withdrawal by Subject|0|||
105815504|NCT03991494|364983520|FG000|Overall Study|Progressive Disease|4|||
105815505|NCT03420300|364983522|FG000|Overall Study|Death|2|||
105815506|NCT02421952|364983527|FG000|Overall Study|Diary Not Returned|93|||
105815507|NCT02421952|364983527|FG000|Overall Study|Failed seriation task|13|||
105815508|NCT02421952|364983527|FG000|Overall Study|Subject uncooperative for baseline test|2|||
105815509|NCT02421952|364983527|FG000|Overall Study|Surgery cancelled|1|||
105815510|NCT01937390|364983530|FG000|Overall Study|Death|2|||
105815511|NCT01937390|364983530|FG000|Overall Study|Lost to Follow-up|7|||
105815512|NCT01937390|364983530|FG000|Overall Study|Withdrawal by Subject|5|||
105815513|NCT01937390|364983530|FG000|Overall Study|Fail to return|21|||
105815514|NCT01706536|364983535|FG000|Overall Study|Withdrawal by Subject|1|||
105815515|NCT01706536|364983536|FG001|Overall Study|Withdrawal by Subject|0|||
105815516|NCT01706536|364983537|FG002|Overall Study|Withdrawal by Subject|1|||
105815517|NCT01706536|364983538|FG003|Overall Study|Withdrawal by Subject|0|||
105815518|NCT01706536|364983539|FG004|Overall Study|Withdrawal by Subject|0|||
105815519|NCT01706536|364983535|FG000|Overall Study|Adverse Event|2|||
105815520|NCT01706536|364983536|FG001|Overall Study|Adverse Event|3|||
105815521|NCT01706536|364983537|FG002|Overall Study|Adverse Event|4|||
105815522|NCT01706536|364983538|FG003|Overall Study|Adverse Event|3|||
105815523|NCT01706536|364983539|FG004|Overall Study|Adverse Event|2|||
105815524|NCT01706536|364983535|FG000|Overall Study|Lack of Efficacy|1|||
105815525|NCT01706536|364983536|FG001|Overall Study|Lack of Efficacy|0|||
105815526|NCT01706536|364983537|FG002|Overall Study|Lack of Efficacy|0|||
105815527|NCT01706536|364983538|FG003|Overall Study|Lack of Efficacy|1|||
105815528|NCT01706536|364983539|FG004|Overall Study|Lack of Efficacy|0|||
105815529|NCT01706536|364983535|FG000|Overall Study|non compliance|0|||
105815530|NCT01706536|364983536|FG001|Overall Study|non compliance|1|||
105815531|NCT01706536|364983537|FG002|Overall Study|non compliance|0|||
105815532|NCT01706536|364983538|FG003|Overall Study|non compliance|0|||
105815533|NCT01706536|364983539|FG004|Overall Study|non compliance|0|||
105815534|NCT00824265|364983540|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
105815535|NCT00824265|364983541|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
105815536|NCT00824265|364983540|FG000|Treatment Phase|Protocol Violation|1|||
105815537|NCT00824265|364983541|FG001|Treatment Phase|Protocol Violation|0|||
105571616|NCT03203694|364091270|FG000|Overall Study|Withdrawal by Subject|2|||
105815538|NCT00824265|364983540|FG000|Treatment Phase|Lost to Follow-up|1|||
105815539|NCT00824265|364983541|FG001|Treatment Phase|Lost to Follow-up|1|||
105571617|NCT03203694|364091271|FG001|Overall Study|Withdrawal by Subject|0|||
105815540|NCT00824265|364983540|FG000|Treatment Phase|Physician Decision|6|||
105815541|NCT00824265|364983541|FG001|Treatment Phase|Physician Decision|12|||
105815542|NCT00824265|364983540|FG000|Treatment Phase|Withdrawal by Subject|6|||
105815543|NCT00824265|364983541|FG001|Treatment Phase|Withdrawal by Subject|15|||
105815544|NCT00824265|364983540|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
105815545|NCT00824265|364983541|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
105815546|NCT00824265|364983540|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
105815547|NCT00824265|364983541|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
105815548|NCT04149964|364983542|FG000|Overall Study|Lost to Follow-up|19|||
105571618|NCT03203694|364091272|FG002|Overall Study|Withdrawal by Subject|0|||
105815549|NCT04149964|364983543|FG001|Overall Study|Lost to Follow-up|18|||
105815550|NCT01402947|364983544|FG000|First Intervention|Adverse Event|0|||
105815551|NCT01402947|364983545|FG001|First Intervention|Adverse Event|1|||
105815552|NCT01223365|364983546|FG000|Open-label Titration Period|Enrolled but not treated|1|||
105815553|NCT01223365|364983546|FG000|Open-label Titration Period|Adverse Event|23|||
105815554|NCT01223365|364983546|FG000|Open-label Titration Period|Lack of Efficacy|3|||
105815555|NCT01223365|364983546|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
105815556|NCT01223365|364983546|FG000|Open-label Titration Period|Protocol Violation|1|||
105815557|NCT01223365|364983546|FG000|Open-label Titration Period|Lost to Follow-up|2|||
105815558|NCT01223365|364983546|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
105815559|NCT01223365|364983546|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
105815560|NCT01223365|364983546|FG000|Open-label Titration Period|Starting physical therapy|1|||
105815561|NCT01223365|364983546|FG000|Open-label Treatment Period|Adverse Event|39|||
105815562|NCT01223365|364983546|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
105815563|NCT01223365|364983546|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
105815564|NCT01223365|364983546|FG000|Open-label Treatment Period|Protocol Violation|15|||
105815565|NCT01223365|364983546|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
105815566|NCT01223365|364983546|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
105815567|NCT01223365|364983546|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
105815568|NCT01223365|364983546|FG000|Open-label Treatment Period|Moved out of area|2|||
105815569|NCT01223365|364983546|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
105815570|NCT01223365|364983546|FG000|Open-label Treatment Period|"Out of window"|1|||
105815571|NCT01223365|364983546|FG000|Open-label Treatment Period|Starting physical therapy|1|||
105815572|NCT01223365|364983546|FG000|Open-label Treatment Period|Physician Decision|2|||
105815573|NCT02682602|364983547|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
105815574|NCT02682602|364983548|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
105815575|NCT02682602|364983547|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
105815576|NCT02682602|364983548|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
105815577|NCT02140060|364983549|FG000|Overall Study|Adverse Event|0|||
105815578|NCT02140060|364983550|FG001|Overall Study|Adverse Event|0|||
105815579|NCT02140060|364983551|FG002|Overall Study|Adverse Event|0|||
105815580|NCT02140060|364983552|FG003|Overall Study|Adverse Event|1|||
105815581|NCT02140060|364983553|FG004|Overall Study|Adverse Event|1|||
105815582|NCT02140060|364983554|FG005|Overall Study|Adverse Event|1|||
105815583|NCT02140060|364983549|FG000|Overall Study|Lack of Efficacy|0|||
105815584|NCT02140060|364983550|FG001|Overall Study|Lack of Efficacy|0|||
105815585|NCT02140060|364983551|FG002|Overall Study|Lack of Efficacy|0|||
105815586|NCT02140060|364983552|FG003|Overall Study|Lack of Efficacy|1|||
105815587|NCT02140060|364983553|FG004|Overall Study|Lack of Efficacy|0|||
105815588|NCT02140060|364983554|FG005|Overall Study|Lack of Efficacy|0|||
105815589|NCT02039908|364983555|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
105815590|NCT02039908|364983556|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
105815591|NCT02039908|364983557|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
105815592|NCT02039908|364983558|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
105815593|NCT02039908|364983555|FG000|Phase 1-Summer|Protocol Violation|6|||
105815594|NCT02039908|364983556|FG001|Phase 1-Summer|Protocol Violation|0|||
105815595|NCT02039908|364983557|FG002|Phase 1-Summer|Protocol Violation|0|||
105815596|NCT02039908|364983558|FG003|Phase 1-Summer|Protocol Violation|0|||
105815597|NCT02039908|364983555|FG000|Phase 2-School Year|Lost to Follow-up|0|||
105815598|NCT02039908|364983556|FG001|Phase 2-School Year|Lost to Follow-up|0|||
105815599|NCT02039908|364983557|FG002|Phase 2-School Year|Lost to Follow-up|1|||
105815600|NCT02039908|364983558|FG003|Phase 2-School Year|Lost to Follow-up|3|||
105815601|NCT02039908|364983555|FG000|Phase 2-School Year|Protocol Violation|0|||
105815602|NCT02039908|364983556|FG001|Phase 2-School Year|Protocol Violation|0|||
105815603|NCT02039908|364983557|FG002|Phase 2-School Year|Protocol Violation|3|||
105815604|NCT02039908|364983558|FG003|Phase 2-School Year|Protocol Violation|0|||
105815605|NCT02039908|364983555|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
105815606|NCT02039908|364983556|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
105815607|NCT02039908|364983557|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
105815608|NCT02039908|364983558|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
105815609|NCT03471078|364985303|FG000|Overall Study|Withdrawal by Subject|9|||
105815610|NCT03471078|364985304|FG001|Overall Study|Withdrawal by Subject|1|||
105571619|NCT03203694|364091273|FG003|Overall Study|Withdrawal by Subject|0|||
105571620|NCT03203694|364091274|FG004|Overall Study|Withdrawal by Subject|0|||
105571621|NCT03203694|364091275|FG005|Overall Study|Withdrawal by Subject|0|||
105571622|NCT02049710|364091276|FG000|Overall Study|Lost to Follow-up|319|||
105571623|NCT02049710|364091277|FG001|Overall Study|Lost to Follow-up|324|||
105571624|NCT05200936|364091278|FG000|Overall Study|Withdrawal by Subject|2|||
105571625|NCT05200936|364091279|FG001|Overall Study|Withdrawal by Subject|2|||
105571626|NCT05200936|364091278|FG000|Overall Study|Lost to Follow-up|2|||
105571627|NCT05200936|364091279|FG001|Overall Study|Lost to Follow-up|0|||
105571628|NCT05200936|364091278|FG000|Overall Study|Pregnancy|0|||
105571629|NCT05200936|364091279|FG001|Overall Study|Pregnancy|1|||
105571630|NCT03713021|364091281|FG000|Overall Study|Did not have CT sim scan available|6|||
105571631|NCT03713021|364091281|FG000|Overall Study|Not eligible|4|||
105571632|NCT03713021|364091281|FG000|Overall Study|Issues with TraceIT markers|5|||
105571633|NCT03813147|364091282|FG000|Overall Study|Lack of Efficacy|4|||
105571634|NCT03813147|364091283|FG001|Overall Study|Lack of Efficacy|4|||
105571635|NCT03813147|364091282|FG000|Overall Study|Physician Decision|2|||
105764366|NCT01998958|364791693|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
105764367|NCT01998958|364791662|FG000|Period 1 (Panel A and B)|Other|1|||
105764368|NCT01998958|364791663|FG001|Period 1 (Panel A and B)|Other|0|||
105764369|NCT01998958|364791664|FG002|Period 1 (Panel A and B)|Other|0|||
105764370|NCT01998958|364791665|FG003|Period 1 (Panel A and B)|Other|0|||
105764371|NCT01998958|364791666|FG004|Period 1 (Panel A and B)|Other|0|||
105764372|NCT01998958|364791667|FG005|Period 1 (Panel A and B)|Other|0|||
105764373|NCT01998958|364791668|FG006|Period 1 (Panel A and B)|Other|0|||
105764374|NCT01998958|364791669|FG007|Period 1 (Panel A and B)|Other|0|||
105764375|NCT01998958|364791670|FG008|Period 1 (Panel A and B)|Other|0|||
105764376|NCT01998958|364791671|FG009|Period 1 (Panel A and B)|Other|0|||
105764377|NCT01998958|364791672|FG010|Period 1 (Panel A and B)|Other|0|||
105764378|NCT01998958|364791673|FG011|Period 1 (Panel A and B)|Other|0|||
105764379|NCT01998958|364791674|FG012|Period 1 (Panel A and B)|Other|0|||
105764380|NCT01998958|364791675|FG013|Period 1 (Panel A and B)|Other|0|||
105764381|NCT01998958|364791676|FG014|Period 1 (Panel A and B)|Other|0|||
105764382|NCT01998958|364791677|FG015|Period 1 (Panel A and B)|Other|0|||
105764383|NCT01998958|364791678|FG016|Period 1 (Panel A and B)|Other|0|||
105764384|NCT01998958|364791679|FG017|Period 1 (Panel A and B)|Other|0|||
105764385|NCT01998958|364791680|FG018|Period 1 (Panel A and B)|Other|0|||
105764386|NCT01998958|364791681|FG019|Period 1 (Panel A and B)|Other|0|||
105764387|NCT01998958|364791682|FG020|Period 1 (Panel A and B)|Other|0|||
105764388|NCT01998958|364791683|FG021|Period 1 (Panel A and B)|Other|0|||
105764389|NCT01998958|364791684|FG022|Period 1 (Panel A and B)|Other|0|||
105764390|NCT01998958|364791685|FG023|Period 1 (Panel A and B)|Other|0|||
105764391|NCT01998958|364791686|FG024|Period 1 (Panel A and B)|Other|0|||
105764392|NCT01998958|364791687|FG025|Period 1 (Panel A and B)|Other|0|||
105764393|NCT01998958|364791688|FG026|Period 1 (Panel A and B)|Other|0|||
105764394|NCT01998958|364791689|FG027|Period 1 (Panel A and B)|Other|0|||
105764395|NCT01998958|364791690|FG028|Period 1 (Panel A and B)|Other|0|||
105764396|NCT01998958|364791691|FG029|Period 1 (Panel A and B)|Other|0|||
105764397|NCT01998958|364791692|FG030|Period 1 (Panel A and B)|Other|0|||
105764398|NCT01998958|364791693|FG031|Period 1 (Panel A and B)|Other|0|||
105764399|NCT01998958|364791662|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
105764400|NCT01998958|364791663|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
105764401|NCT01998958|364791664|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
105764402|NCT01998958|364791665|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
105764403|NCT01998958|364791666|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
105764404|NCT01998958|364791667|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
105764405|NCT01998958|364791668|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
105764406|NCT01998958|364791669|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
105764407|NCT01998958|364791670|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
105764408|NCT01998958|364791671|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
105764409|NCT01998958|364791672|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
105571636|NCT03813147|364091283|FG001|Overall Study|Physician Decision|1|||
105571637|NCT02581930|364091284|FG000|Overall Study|Withdrawal by Subject|1|||
105764410|NCT01998958|364791673|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
105764411|NCT01998958|364791674|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
105764412|NCT01998958|364791675|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
105764413|NCT01998958|364791676|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
105764414|NCT01998958|364791677|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
105764415|NCT01998958|364791678|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
105815611|NCT03471078|364985303|FG000|Overall Study|Adverse Event|4|||
105815612|NCT03471078|364985304|FG001|Overall Study|Adverse Event|1|||
105815613|NCT03471078|364985303|FG000|Overall Study|Physician Decision|3|||
105815614|NCT03471078|364985304|FG001|Overall Study|Physician Decision|2|||
105815615|NCT03471078|364985303|FG000|Overall Study|Death|2|||
105815616|NCT03471078|364985304|FG001|Overall Study|Death|0|||
105815617|NCT03471078|364985303|FG000|Overall Study|Other|3|||
105815618|NCT03471078|364985304|FG001|Overall Study|Other|2|||
105815619|NCT01108094|364985306|FG000|Overall Study|Adverse Event|2|||
105815620|NCT01108094|364985307|FG001|Overall Study|Adverse Event|0|||
105815621|NCT01108094|364985308|FG002|Overall Study|Adverse Event|0|||
105815622|NCT01108094|364985309|FG003|Overall Study|Adverse Event|0|||
105815623|NCT01108094|364985306|FG000|Overall Study|Withdrawal by Subject|1|||
105815624|NCT01108094|364985307|FG001|Overall Study|Withdrawal by Subject|0|||
105815625|NCT01108094|364985308|FG002|Overall Study|Withdrawal by Subject|0|||
105815626|NCT01108094|364985309|FG003|Overall Study|Withdrawal by Subject|0|||
105815627|NCT02896361|364985334|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
105815628|NCT02896361|364985335|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
105815629|NCT02896361|364985336|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
105815630|NCT02896361|364985334|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
105815631|NCT02896361|364985335|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
105815632|NCT02896361|364985336|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
105815633|NCT03164772|364985338|FG000|Overall Study|Death|4|||
105815634|NCT03164772|364985339|FG001|Overall Study|Death|2|||
105815635|NCT03164772|364985338|FG000|Overall Study|Adverse Event|1|||
105815636|NCT03164772|364985339|FG001|Overall Study|Adverse Event|4|||
105815637|NCT03164772|364985338|FG000|Overall Study|Progressive Disease|11|||
105815638|NCT03164772|364985339|FG001|Overall Study|Progressive Disease|21|||
105815639|NCT03164772|364985338|FG000|Overall Study|Physician Decision|2|||
105815640|NCT03164772|364985339|FG001|Overall Study|Physician Decision|0|||
105815641|NCT03164772|364985338|FG000|Overall Study|Withdrawal by Subject|0|||
105815642|NCT03164772|364985339|FG001|Overall Study|Withdrawal by Subject|4|||
105815643|NCT01029353|364985340|FG000|Overall Study|Lost to Follow-up|4|||
105815644|NCT01029353|364985341|FG001|Overall Study|Lost to Follow-up|5|||
105815645|NCT01029353|364985342|FG002|Overall Study|Lost to Follow-up|5|||
105815646|NCT01029353|364985343|FG003|Overall Study|Lost to Follow-up|4|||
105815647|NCT01029353|364985340|FG000|Overall Study|Consent Withdrawn|2|||
105815648|NCT01029353|364985341|FG001|Overall Study|Consent Withdrawn|0|||
105815649|NCT01029353|364985342|FG002|Overall Study|Consent Withdrawn|0|||
105815650|NCT01029353|364985343|FG003|Overall Study|Consent Withdrawn|0|||
105815651|NCT01029353|364985340|FG000|Overall Study|Primary Outcome Indeterminate|1|||
105815652|NCT01029353|364985341|FG001|Overall Study|Primary Outcome Indeterminate|3|||
105815653|NCT01029353|364985342|FG002|Overall Study|Primary Outcome Indeterminate|2|||
105815654|NCT01029353|364985343|FG003|Overall Study|Primary Outcome Indeterminate|0|||
105815655|NCT01287013|364985345|FG000|Overall Study|Non-evaluable|3|||
105815656|NCT01287013|364985346|FG001|Overall Study|Non-evaluable|5|||
105815657|NCT01287013|364985347|FG002|Overall Study|Non-evaluable|21|||
105815658|NCT00051025|364985351|FG000|Overall Study|Progressive Disease|1|||
105815659|NCT00051025|364985352|FG001|Overall Study|Progressive Disease|1|||
105815660|NCT00051025|364985351|FG000|Overall Study|Adverse Event|1|||
105815661|NCT00051025|364985352|FG001|Overall Study|Adverse Event|1|||
105815662|NCT00051025|364985351|FG000|Overall Study|Withdrawal by Subject|0|||
105815663|NCT00051025|364985352|FG001|Overall Study|Withdrawal by Subject|1|||
105362129|NCT02326272|363330143|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105362130|NCT02326272|363330144|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105362131|NCT02326272|363330145|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105362132|NCT02326272|363330146|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105362133|NCT02326272|363330147|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105362134|NCT02326272|363330148|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105486202|NCT01933789|363791419|FG000|Overall Study|Withdrawal by Subject|2|||
105486203|NCT01933789|363791420|FG001|Overall Study|Withdrawal by Subject|1|||
105362135|NCT02326272|363330149|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105362136|NCT02326272|363330150|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105486204|NCT01933789|363791421|FG002|Overall Study|Withdrawal by Subject|0|||
105486205|NCT01933789|363791422|FG003|Overall Study|Withdrawal by Subject|0|||
105815664|NCT00051025|364985351|FG000|Overall Study|Death|0|||
105815665|NCT00051025|364985352|FG001|Overall Study|Death|1|||
105815666|NCT02189941|364985353|FG000|Overall Study|Non-compliance|0|||
105815667|NCT02189941|364985354|FG001|Overall Study|Non-compliance|0|||
105815668|NCT02189941|364985355|FG002|Overall Study|Non-compliance|1|||
105815669|NCT01682083|364985357|FG000|Overall Study|Lost to Follow-up|11|||
105815670|NCT01682083|364985358|FG001|Overall Study|Lost to Follow-up|18|||
105815671|NCT01682083|364985357|FG000|Overall Study|Withdrawal by Subject|31|||
105815672|NCT01682083|364985358|FG001|Overall Study|Withdrawal by Subject|40|||
105815673|NCT01682083|364985357|FG000|Overall Study|Death|60|||
105815674|NCT01682083|364985358|FG001|Overall Study|Death|93|||
105362137|NCT02326272|363330151|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105362138|NCT02326272|363330152|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105362139|NCT02326272|363330153|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105362140|NCT02326272|363330154|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
105362141|NCT02326272|363330155|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105362142|NCT02326272|363330156|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105362143|NCT02326272|363330157|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
105362144|NCT02326272|363330143|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105362145|NCT02326272|363330144|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105362146|NCT02326272|363330145|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105362147|NCT02326272|363330146|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105362148|NCT02326272|363330147|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105362149|NCT02326272|363330148|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105362150|NCT02326272|363330149|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105362151|NCT02326272|363330150|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105362152|NCT02326272|363330151|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105362153|NCT02326272|363330152|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105362154|NCT02326272|363330153|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105362155|NCT02326272|363330154|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
105362156|NCT02326272|363330155|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
105362157|NCT02326272|363330156|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105362158|NCT02326272|363330157|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
105362159|NCT02326272|363330143|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105362160|NCT02326272|363330144|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105362161|NCT02326272|363330145|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105362162|NCT02326272|363330146|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105362163|NCT02326272|363330147|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105362164|NCT02326272|363330148|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105362165|NCT02326272|363330149|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105362166|NCT02326272|363330150|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105362167|NCT02326272|363330151|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105362168|NCT02326272|363330152|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105362169|NCT02326272|363330153|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105362170|NCT02326272|363330154|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
105362171|NCT02326272|363330155|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105362172|NCT02326272|363330156|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105362173|NCT02326272|363330157|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105362174|NCT02326272|363330143|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105362175|NCT02326272|363330144|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105362176|NCT02326272|363330145|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105486206|NCT01933789|363791423|FG004|Overall Study|Withdrawal by Subject|17|||
105486207|NCT01933789|363791424|FG005|Overall Study|Withdrawal by Subject|16|||
105486208|NCT01933789|363791425|FG006|Overall Study|Withdrawal by Subject|1|||
105486209|NCT01933789|363791426|FG007|Overall Study|Withdrawal by Subject|4|||
105764416|NCT01998958|364791679|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
105764417|NCT01998958|364791680|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
105764418|NCT01998958|364791681|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
105764419|NCT01998958|364791682|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
105764420|NCT01998958|364791683|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
105764421|NCT01998958|364791684|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
105764422|NCT01998958|364791685|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
105764423|NCT01998958|364791686|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
105764424|NCT01998958|364791687|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
105764425|NCT01998958|364791688|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
105764426|NCT01998958|364791689|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
105764427|NCT01998958|364791690|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
105764428|NCT01998958|364791691|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
105764429|NCT01998958|364791692|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
105764430|NCT01998958|364791693|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
105764431|NCT01998958|364791662|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764432|NCT01998958|364791663|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764433|NCT01998958|364791664|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764434|NCT01998958|364791665|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764435|NCT01998958|364791666|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764436|NCT01998958|364791667|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764437|NCT01998958|364791668|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764438|NCT01998958|364791669|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105362177|NCT02326272|363330146|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105362178|NCT02326272|363330147|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105362179|NCT02326272|363330148|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105764439|NCT01998958|364791670|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764440|NCT01998958|364791671|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764441|NCT01998958|364791672|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764442|NCT01998958|364791673|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764443|NCT01998958|364791674|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764444|NCT01998958|364791675|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764445|NCT01998958|364791676|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
105764446|NCT01998958|364791677|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764447|NCT01998958|364791678|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764448|NCT01998958|364791679|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764449|NCT01998958|364791680|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
105764450|NCT01998958|364791681|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764451|NCT01998958|364791682|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764452|NCT01998958|364791683|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764453|NCT01998958|364791684|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764454|NCT01998958|364791685|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764455|NCT01998958|364791686|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764456|NCT01998958|364791687|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764457|NCT01998958|364791688|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764458|NCT01998958|364791689|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764459|NCT01998958|364791690|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764460|NCT01998958|364791691|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764461|NCT01998958|364791692|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764462|NCT01998958|364791693|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764463|NCT01998958|364791662|FG000|Open Label Phase (Optional)|Adverse Event|0|||
105764464|NCT01998958|364791663|FG001|Open Label Phase (Optional)|Adverse Event|0|||
105764465|NCT01998958|364791664|FG002|Open Label Phase (Optional)|Adverse Event|0|||
105764466|NCT01998958|364791665|FG003|Open Label Phase (Optional)|Adverse Event|0|||
105764467|NCT01998958|364791666|FG004|Open Label Phase (Optional)|Adverse Event|0|||
105764468|NCT01998958|364791667|FG005|Open Label Phase (Optional)|Adverse Event|0|||
105764469|NCT01998958|364791668|FG006|Open Label Phase (Optional)|Adverse Event|0|||
105764470|NCT01998958|364791669|FG007|Open Label Phase (Optional)|Adverse Event|0|||
105764471|NCT01998958|364791670|FG008|Open Label Phase (Optional)|Adverse Event|0|||
105764472|NCT01998958|364791671|FG009|Open Label Phase (Optional)|Adverse Event|0|||
105815675|NCT01682083|364985357|FG000|Overall Study|Physician Decision|5|||
105815676|NCT01682083|364985358|FG001|Overall Study|Physician Decision|4|||
105815677|NCT00445003|364985360|FG000|Overall Study|Death|1|||
105815678|NCT00445003|364985361|FG001|Overall Study|Death|2|||
105815679|NCT00445003|364985362|FG002|Overall Study|Death|1|||
105815680|NCT00445003|364985360|FG000|Overall Study|Missed Visit|3|||
105815681|NCT00445003|364985361|FG001|Overall Study|Missed Visit|5|||
105815682|NCT00445003|364985362|FG002|Overall Study|Missed Visit|1|||
105815683|NCT00445003|364985360|FG000|Overall Study|Dropped|1|||
105362180|NCT02326272|363330149|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105362181|NCT02326272|363330150|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105362182|NCT02326272|363330151|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105815684|NCT00445003|364985361|FG001|Overall Study|Dropped|3|||
105815685|NCT00445003|364985362|FG002|Overall Study|Dropped|2|||
105815686|NCT00528606|364985365|FG000|Overall Study|Withdrew consent|4|||
105815687|NCT00528606|364985366|FG001|Overall Study|Withdrew consent|3|||
105815688|NCT00528606|364985365|FG000|Overall Study|Lost to Follow-up|4|||
105815689|NCT00528606|364985366|FG001|Overall Study|Lost to Follow-up|1|||
105815690|NCT00528606|364985365|FG000|Overall Study|Adverse Event|3|||
105815691|NCT00528606|364985366|FG001|Overall Study|Adverse Event|0|||
105815692|NCT00528606|364985365|FG000|Overall Study|Other|2|||
105815693|NCT00528606|364985366|FG001|Overall Study|Other|0|||
105815694|NCT01471093|364985367|FG000|Overall Study|Adverse Event|1|||
105815695|NCT01471093|364985368|FG001|Overall Study|Adverse Event|0|||
105815696|NCT01471093|364985369|FG002|Overall Study|Adverse Event|0|||
105815697|NCT01471093|364985370|FG003|Overall Study|Adverse Event|0|||
105815698|NCT02475954|364985371|FG000|Overall Study|Withdrawal by Subject|2|||
105815699|NCT02475954|364985372|FG001|Overall Study|Withdrawal by Subject|2|||
105815700|NCT02475954|364985371|FG000|Overall Study|Lost to Follow-up|11|||
105815701|NCT02475954|364985372|FG001|Overall Study|Lost to Follow-up|9|||
105815702|NCT02475954|364985371|FG000|Overall Study|Death|1|||
105815703|NCT02475954|364985372|FG001|Overall Study|Death|1|||
105815704|NCT02932878|364985374|FG000|Overall Study|Due to Lab Results|2|||
105815705|NCT02932878|364985375|FG001|Overall Study|Due to Lab Results|1|||
105362183|NCT02326272|363330152|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105362184|NCT02326272|363330153|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105362185|NCT02326272|363330154|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105362186|NCT02326272|363330155|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
105362187|NCT02326272|363330156|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105362188|NCT02326272|363330157|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105362189|NCT00917124|363330161|FG000|Overall Study|Protocol Violation|4|||
105362190|NCT00917124|363330162|FG001|Overall Study|Protocol Violation|6|||
105362191|NCT01716663|363330175|FG000|Overall Study|Withdrawn prior to procedure|4|||
105362192|NCT01716663|363330175|FG000|Overall Study|Treated with non-study catheter|2|||
105362193|NCT01719380|363330187|FG000|Overall Study|Adverse Event|0|||
105362194|NCT01719380|363330188|FG001|Overall Study|Adverse Event|0|||
105362195|NCT01719380|363330189|FG002|Overall Study|Adverse Event|1|||
105362196|NCT01719380|363330190|FG003|Overall Study|Adverse Event|2|||
105362197|NCT01719380|363330191|FG004|Overall Study|Adverse Event|0|||
105362198|NCT01719380|363330192|FG005|Overall Study|Adverse Event|1|||
105362199|NCT01719380|363330193|FG006|Overall Study|Adverse Event|0|||
105815706|NCT01918397|364985376|FG000|Overall Study|Never started treatment|2|||
105815707|NCT01918397|364985377|FG001|Overall Study|Never started treatment|1|||
105815708|NCT01918397|364985378|FG002|Overall Study|Never started treatment|0|||
105362200|NCT01719380|363330194|FG007|Overall Study|Adverse Event|1|||
105362201|NCT01719380|363330195|FG008|Overall Study|Adverse Event|4|||
105362202|NCT01719380|363330196|FG009|Overall Study|Adverse Event|3|||
105362203|NCT01719380|363330187|FG000|Overall Study|Death|0|||
105362204|NCT01719380|363330188|FG001|Overall Study|Death|1|||
105362205|NCT01719380|363330189|FG002|Overall Study|Death|0|||
105362206|NCT01719380|363330190|FG003|Overall Study|Death|0|||
105362207|NCT01719380|363330191|FG004|Overall Study|Death|0|||
105362208|NCT01719380|363330192|FG005|Overall Study|Death|0|||
105362209|NCT01719380|363330193|FG006|Overall Study|Death|0|||
105362210|NCT01719380|363330194|FG007|Overall Study|Death|0|||
105362211|NCT01719380|363330195|FG008|Overall Study|Death|3|||
105815709|NCT01918397|364985379|FG003|Overall Study|Never started treatment|0|||
105815710|NCT01918397|364985376|FG000|Overall Study|Adverse Event|1|||
105815711|NCT01918397|364985377|FG001|Overall Study|Adverse Event|1|||
105362212|NCT01719380|363330196|FG009|Overall Study|Death|3|||
105362213|NCT01719380|363330187|FG000|Overall Study|Participant/Guardian Decision|0|||
105815712|NCT01918397|364985378|FG002|Overall Study|Adverse Event|1|||
105815713|NCT01918397|364985379|FG003|Overall Study|Adverse Event|0|||
105362214|NCT01719380|363330188|FG001|Overall Study|Participant/Guardian Decision|0|||
105362215|NCT01719380|363330189|FG002|Overall Study|Participant/Guardian Decision|1|||
105815714|NCT01918397|364985376|FG000|Overall Study|Lack of compliance|2|||
105815715|NCT01918397|364985377|FG001|Overall Study|Lack of compliance|2|||
105815716|NCT01918397|364985378|FG002|Overall Study|Lack of compliance|3|||
105815717|NCT01918397|364985379|FG003|Overall Study|Lack of compliance|0|||
105815718|NCT01918397|364985376|FG000|Overall Study|Pregnancy|0|||
105815719|NCT01918397|364985377|FG001|Overall Study|Pregnancy|1|||
105815720|NCT01918397|364985378|FG002|Overall Study|Pregnancy|0|||
105815721|NCT01918397|364985379|FG003|Overall Study|Pregnancy|0|||
105815722|NCT01918397|364985376|FG000|Overall Study|Rifampin susceptible|0|||
105815723|NCT01918397|364985377|FG001|Overall Study|Rifampin susceptible|0|||
105815724|NCT01918397|364985378|FG002|Overall Study|Rifampin susceptible|0|||
105815725|NCT01918397|364985379|FG003|Overall Study|Rifampin susceptible|2|||
105815726|NCT01918397|364985376|FG000|Overall Study|Treatment failure|0|||
105815727|NCT01918397|364985377|FG001|Overall Study|Treatment failure|0|||
105815728|NCT01918397|364985378|FG002|Overall Study|Treatment failure|0|||
105815729|NCT01918397|364985379|FG003|Overall Study|Treatment failure|1|||
105815730|NCT01918397|364985376|FG000|Overall Study|Withdrawal by Subject|3|||
105815731|NCT01918397|364985377|FG001|Overall Study|Withdrawal by Subject|2|||
105815732|NCT01918397|364985378|FG002|Overall Study|Withdrawal by Subject|1|||
105815733|NCT01918397|364985379|FG003|Overall Study|Withdrawal by Subject|1|||
105815734|NCT01918397|364985376|FG000|Overall Study|XDR at baseline|0|||
105815735|NCT01918397|364985377|FG001|Overall Study|XDR at baseline|0|||
105815736|NCT01918397|364985378|FG002|Overall Study|XDR at baseline|1|||
105815737|NCT01918397|364985379|FG003|Overall Study|XDR at baseline|0|||
105815738|NCT01918397|364985376|FG000|Overall Study|Lost to Follow-up|2|||
105815739|NCT01918397|364985377|FG001|Overall Study|Lost to Follow-up|1|||
105815740|NCT01918397|364985378|FG002|Overall Study|Lost to Follow-up|1|||
105815741|NCT01918397|364985379|FG003|Overall Study|Lost to Follow-up|1|||
105815742|NCT01918397|364985376|FG000|Overall Study|Increased QTc|1|||
105815743|NCT01918397|364985377|FG001|Overall Study|Increased QTc|0|||
105815744|NCT01918397|364985378|FG002|Overall Study|Increased QTc|0|||
105815745|NCT01918397|364985379|FG003|Overall Study|Increased QTc|1|||
105815746|NCT01918397|364985376|FG000|Overall Study|Death|0|||
105815747|NCT01918397|364985377|FG001|Overall Study|Death|0|||
105815748|NCT01918397|364985378|FG002|Overall Study|Death|1|||
105815749|NCT01918397|364985379|FG003|Overall Study|Death|0|||
105815750|NCT01918397|364985376|FG000|Overall Study|Involved in another investigative trial|0|||
105815751|NCT01918397|364985377|FG001|Overall Study|Involved in another investigative trial|0|||
105815752|NCT01918397|364985378|FG002|Overall Study|Involved in another investigative trial|0|||
105815753|NCT01918397|364985379|FG003|Overall Study|Involved in another investigative trial|1|||
105815754|NCT00849901|364985383|FG000|Acute Treatment Phase|Adverse Event|9|||
105815755|NCT00849901|364985384|FG001|Acute Treatment Phase|Adverse Event|1|||
105815756|NCT00849901|364985385|FG002|Acute Treatment Phase|Adverse Event|3|||
105815757|NCT00849901|364985383|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
105815758|NCT00849901|364985384|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
105815759|NCT00849901|364985385|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
105815760|NCT00849901|364985383|FG000|Acute Treatment Phase|Protocol Violation|0|||
105815761|NCT00849901|364985384|FG001|Acute Treatment Phase|Protocol Violation|2|||
105815762|NCT00849901|364985385|FG002|Acute Treatment Phase|Protocol Violation|1|||
105815763|NCT00849901|364985383|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
105815764|NCT00849901|364985384|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
105815765|NCT00849901|364985385|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
105815766|NCT00849901|364985383|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
105815767|NCT00849901|364985384|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
105815768|NCT00849901|364985385|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
105815769|NCT00849901|364985383|FG000|Acute Treatment Phase|Physician Decision|1|||
105815770|NCT00849901|364985384|FG001|Acute Treatment Phase|Physician Decision|1|||
105815771|NCT00849901|364985385|FG002|Acute Treatment Phase|Physician Decision|1|||
105815772|NCT00849901|364985383|FG000|Acute Treatment Phase|Sponsor Decision|1|||
105815773|NCT00849901|364985384|FG001|Acute Treatment Phase|Sponsor Decision|0|||
105815774|NCT00849901|364985385|FG002|Acute Treatment Phase|Sponsor Decision|0|||
105815775|NCT00849901|364985383|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
105815776|NCT00849901|364985384|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
105815777|NCT00849901|364985385|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
105815778|NCT00849901|364985383|FG000|Extension Phase|Adverse Event|2|||
105815779|NCT00849901|364985384|FG001|Extension Phase|Adverse Event|8|||
105815780|NCT00849901|364985385|FG002|Extension Phase|Adverse Event|4|||
105815781|NCT00849901|364985383|FG000|Extension Phase|Lost to Follow-up|3|||
105815782|NCT00849901|364985384|FG001|Extension Phase|Lost to Follow-up|0|||
105815783|NCT00849901|364985385|FG002|Extension Phase|Lost to Follow-up|1|||
105362216|NCT01719380|363330190|FG003|Overall Study|Participant/Guardian Decision|0|||
105362217|NCT01719380|363330191|FG004|Overall Study|Participant/Guardian Decision|0|||
105764473|NCT01998958|364791672|FG010|Open Label Phase (Optional)|Adverse Event|0|||
105764474|NCT01998958|364791673|FG011|Open Label Phase (Optional)|Adverse Event|0|||
105764475|NCT01998958|364791674|FG012|Open Label Phase (Optional)|Adverse Event|0|||
105764476|NCT01998958|364791675|FG013|Open Label Phase (Optional)|Adverse Event|0|||
105764477|NCT01998958|364791676|FG014|Open Label Phase (Optional)|Adverse Event|0|||
105764478|NCT01998958|364791677|FG015|Open Label Phase (Optional)|Adverse Event|0|||
105764479|NCT01998958|364791678|FG016|Open Label Phase (Optional)|Adverse Event|0|||
105764480|NCT01998958|364791679|FG017|Open Label Phase (Optional)|Adverse Event|0|||
105764481|NCT01998958|364791680|FG018|Open Label Phase (Optional)|Adverse Event|0|||
105764482|NCT01998958|364791681|FG019|Open Label Phase (Optional)|Adverse Event|0|||
105764483|NCT01998958|364791682|FG020|Open Label Phase (Optional)|Adverse Event|0|||
105764484|NCT01998958|364791683|FG021|Open Label Phase (Optional)|Adverse Event|0|||
105764485|NCT01998958|364791684|FG022|Open Label Phase (Optional)|Adverse Event|0|||
105764486|NCT01998958|364791685|FG023|Open Label Phase (Optional)|Adverse Event|1|||
105764487|NCT01998958|364791686|FG024|Open Label Phase (Optional)|Adverse Event|0|||
105764488|NCT01998958|364791687|FG025|Open Label Phase (Optional)|Adverse Event|0|||
105764489|NCT01998958|364791688|FG026|Open Label Phase (Optional)|Adverse Event|0|||
105764490|NCT01998958|364791689|FG027|Open Label Phase (Optional)|Adverse Event|0|||
105764491|NCT01998958|364791690|FG028|Open Label Phase (Optional)|Adverse Event|0|||
105764492|NCT01998958|364791691|FG029|Open Label Phase (Optional)|Adverse Event|0|||
105764493|NCT01998958|364791692|FG030|Open Label Phase (Optional)|Adverse Event|0|||
105764494|NCT01998958|364791693|FG031|Open Label Phase (Optional)|Adverse Event|0|||
105764495|NCT01998958|364791662|FG000|Open Label Phase (Optional)|Other|0|||
105764496|NCT01998958|364791663|FG001|Open Label Phase (Optional)|Other|0|||
105764497|NCT01998958|364791664|FG002|Open Label Phase (Optional)|Other|0|||
105764498|NCT01998958|364791665|FG003|Open Label Phase (Optional)|Other|0|||
105764499|NCT01998958|364791666|FG004|Open Label Phase (Optional)|Other|0|||
105764500|NCT01998958|364791667|FG005|Open Label Phase (Optional)|Other|0|||
105764501|NCT01998958|364791668|FG006|Open Label Phase (Optional)|Other|0|||
105764502|NCT01998958|364791669|FG007|Open Label Phase (Optional)|Other|0|||
105764503|NCT01998958|364791670|FG008|Open Label Phase (Optional)|Other|0|||
105764504|NCT01998958|364791671|FG009|Open Label Phase (Optional)|Other|0|||
105764505|NCT01998958|364791672|FG010|Open Label Phase (Optional)|Other|0|||
105764506|NCT01998958|364791673|FG011|Open Label Phase (Optional)|Other|0|||
105764507|NCT01998958|364791674|FG012|Open Label Phase (Optional)|Other|0|||
105764508|NCT01998958|364791675|FG013|Open Label Phase (Optional)|Other|0|||
105764509|NCT01998958|364791676|FG014|Open Label Phase (Optional)|Other|0|||
105764510|NCT01998958|364791677|FG015|Open Label Phase (Optional)|Other|0|||
105764511|NCT01998958|364791678|FG016|Open Label Phase (Optional)|Other|0|||
105764512|NCT01998958|364791679|FG017|Open Label Phase (Optional)|Other|0|||
105764513|NCT01998958|364791680|FG018|Open Label Phase (Optional)|Other|0|||
105764514|NCT01998958|364791681|FG019|Open Label Phase (Optional)|Other|0|||
105764515|NCT01998958|364791682|FG020|Open Label Phase (Optional)|Other|0|||
105764516|NCT01998958|364791683|FG021|Open Label Phase (Optional)|Other|0|||
105764517|NCT01998958|364791684|FG022|Open Label Phase (Optional)|Other|5|||
105764518|NCT01998958|364791685|FG023|Open Label Phase (Optional)|Other|1|||
105764519|NCT01998958|364791686|FG024|Open Label Phase (Optional)|Other|0|||
105764520|NCT01998958|364791687|FG025|Open Label Phase (Optional)|Other|0|||
105764521|NCT01998958|364791688|FG026|Open Label Phase (Optional)|Other|0|||
105764522|NCT01998958|364791689|FG027|Open Label Phase (Optional)|Other|0|||
105764523|NCT01998958|364791690|FG028|Open Label Phase (Optional)|Other|0|||
105764524|NCT01998958|364791691|FG029|Open Label Phase (Optional)|Other|0|||
105764525|NCT01998958|364791692|FG030|Open Label Phase (Optional)|Other|0|||
105764526|NCT01998958|364791693|FG031|Open Label Phase (Optional)|Other|0|||
105764527|NCT01998958|364791662|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764528|NCT01998958|364791663|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764529|NCT01998958|364791664|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764530|NCT01998958|364791665|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764531|NCT01998958|364791666|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764532|NCT01998958|364791667|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764533|NCT01998958|364791668|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764534|NCT01998958|364791669|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764535|NCT01998958|364791670|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764536|NCT01998958|364791671|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764537|NCT01998958|364791672|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764538|NCT01998958|364791673|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764539|NCT01998958|364791674|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764540|NCT01998958|364791675|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764541|NCT01998958|364791676|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764542|NCT01998958|364791677|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764543|NCT01998958|364791678|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764544|NCT01998958|364791679|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764545|NCT01998958|364791680|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764546|NCT01998958|364791681|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
105362218|NCT01719380|363330192|FG005|Overall Study|Participant/Guardian Decision|0|||
105362219|NCT01719380|363330193|FG006|Overall Study|Participant/Guardian Decision|0|||
105362220|NCT01719380|363330194|FG007|Overall Study|Participant/Guardian Decision|0|||
105362221|NCT01719380|363330195|FG008|Overall Study|Participant/Guardian Decision|2|||
105362222|NCT01719380|363330196|FG009|Overall Study|Participant/Guardian Decision|2|||
105362223|NCT01719380|363330187|FG000|Overall Study|Physician Decision|0|||
105362224|NCT01719380|363330188|FG001|Overall Study|Physician Decision|0|||
105362225|NCT01719380|363330189|FG002|Overall Study|Physician Decision|2|||
105362226|NCT01719380|363330190|FG003|Overall Study|Physician Decision|0|||
105362227|NCT01719380|363330191|FG004|Overall Study|Physician Decision|0|||
105362228|NCT01719380|363330192|FG005|Overall Study|Physician Decision|0|||
105362229|NCT01719380|363330193|FG006|Overall Study|Physician Decision|0|||
105362230|NCT01719380|363330194|FG007|Overall Study|Physician Decision|0|||
105362231|NCT01719380|363330195|FG008|Overall Study|Physician Decision|1|||
105362232|NCT01719380|363330196|FG009|Overall Study|Physician Decision|1|||
105362233|NCT01719380|363330187|FG000|Overall Study|Lack of Efficacy|2|||
105362234|NCT01719380|363330188|FG001|Overall Study|Lack of Efficacy|6|||
105362235|NCT01719380|363330189|FG002|Overall Study|Lack of Efficacy|5|||
105362236|NCT01719380|363330190|FG003|Overall Study|Lack of Efficacy|6|||
105362237|NCT01719380|363330191|FG004|Overall Study|Lack of Efficacy|3|||
105362238|NCT01719380|363330192|FG005|Overall Study|Lack of Efficacy|7|||
105362239|NCT01719380|363330193|FG006|Overall Study|Lack of Efficacy|10|||
105362240|NCT01719380|363330194|FG007|Overall Study|Lack of Efficacy|6|||
105362241|NCT01719380|363330195|FG008|Overall Study|Lack of Efficacy|39|||
105362242|NCT01719380|363330196|FG009|Overall Study|Lack of Efficacy|42|||
105362243|NCT01719380|363330187|FG000|Overall Study|Progressive Disease|0|||
105362244|NCT01719380|363330188|FG001|Overall Study|Progressive Disease|0|||
105362245|NCT01719380|363330189|FG002|Overall Study|Progressive Disease|0|||
105362246|NCT01719380|363330190|FG003|Overall Study|Progressive Disease|0|||
105362247|NCT01719380|363330191|FG004|Overall Study|Progressive Disease|0|||
105362248|NCT01719380|363330192|FG005|Overall Study|Progressive Disease|0|||
105362249|NCT01719380|363330193|FG006|Overall Study|Progressive Disease|0|||
105362250|NCT01719380|363330194|FG007|Overall Study|Progressive Disease|0|||
105362251|NCT01719380|363330195|FG008|Overall Study|Progressive Disease|1|||
105362252|NCT01719380|363330196|FG009|Overall Study|Progressive Disease|0|||
105362253|NCT00321906|363330199|FG000|Overall Study|Adverse Event|36|||
105362254|NCT00321906|363330200|FG001|Overall Study|Adverse Event|44|||
105362255|NCT00321906|363330199|FG000|Overall Study|Death|9|||
105362256|NCT00321906|363330200|FG001|Overall Study|Death|6|||
105362257|NCT00321906|363330199|FG000|Overall Study|Lost to Follow-up|1|||
105362258|NCT00321906|363330200|FG001|Overall Study|Lost to Follow-up|2|||
105362259|NCT00321906|363330199|FG000|Overall Study|Withdrawal by Subject|0|||
105362260|NCT00321906|363330200|FG001|Overall Study|Withdrawal by Subject|4|||
105362261|NCT02420119|363330201|FG000|Overall Study|insufficient laboratory data|5|||
105362262|NCT00810069|363330202|FG000|Lead-in Period I|Adverse Event|43|||
105362263|NCT00810069|363330203|FG001|Lead-in Period I|Adverse Event|0|||
105362264|NCT00810069|363330204|FG002|Lead-in Period I|Adverse Event|0|||
105362265|NCT00810069|363330202|FG000|Lead-in Period I|Lack of Efficacy|1|||
105362266|NCT00810069|363330203|FG001|Lead-in Period I|Lack of Efficacy|0|||
105362267|NCT00810069|363330204|FG002|Lead-in Period I|Lack of Efficacy|0|||
105362268|NCT00810069|363330202|FG000|Lead-in Period I|Lost to Follow-up|19|||
105362269|NCT00810069|363330203|FG001|Lead-in Period I|Lost to Follow-up|0|||
105362270|NCT00810069|363330204|FG002|Lead-in Period I|Lost to Follow-up|0|||
105362271|NCT00810069|363330202|FG000|Lead-in Period I|Physician Decision|1|||
105362272|NCT00810069|363330203|FG001|Lead-in Period I|Physician Decision|0|||
105362273|NCT00810069|363330204|FG002|Lead-in Period I|Physician Decision|0|||
105362274|NCT00810069|363330202|FG000|Lead-in Period I|Protocol Violation|1|||
105362275|NCT00810069|363330203|FG001|Lead-in Period I|Protocol Violation|0|||
105362276|NCT00810069|363330204|FG002|Lead-in Period I|Protocol Violation|0|||
105362277|NCT00810069|363330202|FG000|Lead-in Period I|Withdrawal by Subject|46|||
105362278|NCT00810069|363330203|FG001|Lead-in Period I|Withdrawal by Subject|0|||
105362279|NCT00810069|363330204|FG002|Lead-in Period I|Withdrawal by Subject|0|||
105362280|NCT00810069|363330202|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
105362281|NCT00810069|363330203|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
105362282|NCT00810069|363330204|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
105362283|NCT00810069|363330202|FG000|Lead-in Period I|Randomization criteria not met|158|||
105362284|NCT00810069|363330203|FG001|Lead-in Period I|Randomization criteria not met|0|||
105362285|NCT00810069|363330204|FG002|Lead-in Period I|Randomization criteria not met|0|||
105362286|NCT00810069|363330202|FG000|Double-Blind Period II|Adverse Event|0|||
105362287|NCT00810069|363330203|FG001|Double-Blind Period II|Adverse Event|9|||
105362288|NCT00810069|363330204|FG002|Double-Blind Period II|Adverse Event|8|||
105362289|NCT00810069|363330202|FG000|Double-Blind Period II|Lack of Efficacy|0|||
105362290|NCT00810069|363330203|FG001|Double-Blind Period II|Lack of Efficacy|7|||
105486210|NCT01933789|363791427|FG008|Overall Study|Withdrawal by Subject|0|||
105362291|NCT00810069|363330204|FG002|Double-Blind Period II|Lack of Efficacy|12|||
105486211|NCT01933789|363791419|FG000|Overall Study|Became Ineligible|4|||
105362292|NCT00810069|363330202|FG000|Double-Blind Period II|Lost to Follow-up|0|||
105362293|NCT00810069|363330203|FG001|Double-Blind Period II|Lost to Follow-up|9|||
105486212|NCT01933789|363791420|FG001|Overall Study|Became Ineligible|0|||
105486213|NCT01933789|363791421|FG002|Overall Study|Became Ineligible|0|||
105486214|NCT01933789|363791422|FG003|Overall Study|Became Ineligible|0|||
105815784|NCT00849901|364985383|FG000|Extension Phase|Protocol Violation|2|||
105815785|NCT00849901|364985384|FG001|Extension Phase|Protocol Violation|2|||
105815786|NCT00849901|364985385|FG002|Extension Phase|Protocol Violation|4|||
105815787|NCT00849901|364985383|FG000|Extension Phase|Withdrawal by Subject|7|||
105815788|NCT00849901|364985384|FG001|Extension Phase|Withdrawal by Subject|6|||
105815789|NCT00849901|364985385|FG002|Extension Phase|Withdrawal by Subject|3|||
105815790|NCT00849901|364985383|FG000|Extension Phase|Parent or Caregiver Decision|10|||
105815791|NCT00849901|364985384|FG001|Extension Phase|Parent or Caregiver Decision|4|||
105815792|NCT00849901|364985385|FG002|Extension Phase|Parent or Caregiver Decision|4|||
105815793|NCT00849901|364985383|FG000|Extension Phase|Physician Decision|1|||
105815794|NCT00849901|364985384|FG001|Extension Phase|Physician Decision|2|||
105815795|NCT00849901|364985385|FG002|Extension Phase|Physician Decision|0|||
105815796|NCT00849901|364985383|FG000|Extension Phase|Lack of Efficacy|2|||
105815797|NCT00849901|364985384|FG001|Extension Phase|Lack of Efficacy|4|||
105815798|NCT00849901|364985385|FG002|Extension Phase|Lack of Efficacy|1|||
105815799|NCT00437658|364985386|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
105815800|NCT00437658|364985387|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
105815801|NCT00437658|364985388|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
105815802|NCT00437658|364985386|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
105815803|NCT00437658|364985387|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
105815804|NCT00437658|364985388|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
105815805|NCT00437658|364985386|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
105815806|NCT00437658|364985387|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
105815807|NCT00437658|364985388|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
105815808|NCT00437658|364985386|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
105815809|NCT00437658|364985387|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
105815810|NCT00437658|364985388|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
105815811|NCT00437658|364985386|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
105815812|NCT00437658|364985387|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
105486215|NCT01933789|363791423|FG004|Overall Study|Became Ineligible|13|||
105815813|NCT00437658|364985388|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
105815814|NCT00437658|364985386|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
105815815|NCT00437658|364985387|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
105815816|NCT00437658|364985388|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
105815817|NCT00437658|364985386|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
105815818|NCT00437658|364985387|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
105815819|NCT00437658|364985388|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
105815820|NCT00437658|364985386|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
105815821|NCT00437658|364985387|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
105815822|NCT00437658|364985388|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
105815823|NCT00437658|364985386|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
105815824|NCT00437658|364985387|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
105815825|NCT00437658|364985388|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
105815826|NCT00437658|364985386|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
105815827|NCT00437658|364985387|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
105815828|NCT00437658|364985388|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
105815829|NCT00437658|364985386|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
105815830|NCT00437658|364985387|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
105815831|NCT00437658|364985388|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
105815832|NCT00437658|364985386|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
105815833|NCT00437658|364985387|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
105815834|NCT00437658|364985388|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
105815835|NCT02465567|364985389|FG000|Overall Study|Adverse Event|118|||
105815836|NCT02465567|364985390|FG001|Overall Study|Adverse Event|113|||
105486216|NCT01933789|363791424|FG005|Overall Study|Became Ineligible|10|||
105486217|NCT01933789|363791425|FG006|Overall Study|Became Ineligible|13|||
105486218|NCT01933789|363791426|FG007|Overall Study|Became Ineligible|6|||
105486219|NCT01933789|363791427|FG008|Overall Study|Became Ineligible|0|||
105486220|NCT02497976|363791430|FG000|Overall Study|Withdrawal by Subject|2|||
105815837|NCT02465567|364985391|FG002|Overall Study|Adverse Event|147|||
105486221|NCT02497976|363791431|FG001|Overall Study|Withdrawal by Subject|0|||
105815838|NCT02465567|364985392|FG003|Overall Study|Adverse Event|138|||
105815839|NCT02465567|364985389|FG000|Overall Study|Lack of Efficacy|103|||
105815840|NCT02465567|364985390|FG001|Overall Study|Lack of Efficacy|102|||
105815841|NCT02465567|364985391|FG002|Overall Study|Lack of Efficacy|171|||
105815842|NCT02465567|364985392|FG003|Overall Study|Lack of Efficacy|135|||
105486222|NCT02497976|363791430|FG000|Overall Study|Moved out of area|0|||
105486223|NCT02497976|363791431|FG001|Overall Study|Moved out of area|1|||
105486224|NCT05442775|363791432|FG000|Overall Study|Trial terminated|61|||
105486225|NCT05442775|363791432|FG000|Overall Study|Lack of Efficacy|4|||
105486226|NCT05442775|363791432|FG000|Overall Study|Withdrawal by Subject|4|||
105486227|NCT05442775|363791432|FG000|Overall Study|Death|1|||
105486228|NCT05442775|363791432|FG000|Overall Study|Participant removed at Sponsor request|1|||
105486229|NCT00584740|363791440|FG000|Overall Study|Adverse Event|1|||
105486230|NCT00584740|363791441|FG001|Overall Study|Adverse Event|1|||
105764547|NCT01998958|364791682|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764548|NCT01998958|364791683|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764549|NCT01998958|364791684|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
105764550|NCT01998958|364791685|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764551|NCT01998958|364791686|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764552|NCT01998958|364791687|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764553|NCT01998958|364791688|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764554|NCT01998958|364791689|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764555|NCT01998958|364791690|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764556|NCT01998958|364791691|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764557|NCT01998958|364791692|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764558|NCT01998958|364791693|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764559|NCT01998958|364791662|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764560|NCT01998958|364791663|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764561|NCT01998958|364791664|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764562|NCT01998958|364791665|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764563|NCT01998958|364791666|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764564|NCT01998958|364791667|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764565|NCT01998958|364791668|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764566|NCT01998958|364791669|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764567|NCT01998958|364791670|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764568|NCT01998958|364791671|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764569|NCT01998958|364791672|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764570|NCT01998958|364791673|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764571|NCT01998958|364791674|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764572|NCT01998958|364791675|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764573|NCT01998958|364791676|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764574|NCT01998958|364791677|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764575|NCT01998958|364791678|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764576|NCT01998958|364791679|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
105486231|NCT00584740|363791440|FG000|Overall Study|Lack of Efficacy|8|||
105815843|NCT02465567|364985389|FG000|Overall Study|Withdrawal by Subject|104|||
105815844|NCT02465567|364985390|FG001|Overall Study|Withdrawal by Subject|94|||
105486232|NCT00584740|363791441|FG001|Overall Study|Lack of Efficacy|2|||
105764577|NCT01998958|364791680|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764578|NCT01998958|364791681|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764579|NCT01998958|364791682|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764580|NCT01998958|364791683|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
105764581|NCT01998958|364791684|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
105764582|NCT01998958|364791685|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764583|NCT01998958|364791686|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764584|NCT01998958|364791687|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764585|NCT01998958|364791688|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764586|NCT01998958|364791689|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764587|NCT01998958|364791690|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764588|NCT01998958|364791691|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764589|NCT01998958|364791692|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764590|NCT01998958|364791693|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764591|NCT01998958|364791662|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764592|NCT01998958|364791663|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764593|NCT01998958|364791664|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764594|NCT01998958|364791665|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764595|NCT01998958|364791666|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764596|NCT01998958|364791667|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764597|NCT01998958|364791668|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764598|NCT01998958|364791669|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764599|NCT01998958|364791670|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764600|NCT01998958|364791671|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764601|NCT01998958|364791672|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764602|NCT01998958|364791673|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764603|NCT01998958|364791674|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764604|NCT01998958|364791675|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764605|NCT01998958|364791676|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764606|NCT01998958|364791677|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764607|NCT01998958|364791678|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764608|NCT01998958|364791679|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764609|NCT01998958|364791680|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764610|NCT01998958|364791681|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764611|NCT01998958|364791682|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105815845|NCT02465567|364985391|FG002|Overall Study|Withdrawal by Subject|123|||
105815846|NCT02465567|364985392|FG003|Overall Study|Withdrawal by Subject|130|||
105815847|NCT02465567|364985389|FG000|Overall Study|Physician Decision|23|||
105815848|NCT02465567|364985390|FG001|Overall Study|Physician Decision|33|||
105815849|NCT02465567|364985391|FG002|Overall Study|Physician Decision|38|||
105815850|NCT02465567|364985392|FG003|Overall Study|Physician Decision|28|||
105815851|NCT02465567|364985389|FG000|Overall Study|Major Protocol Deviation|24|||
105815852|NCT02465567|364985390|FG001|Overall Study|Major Protocol Deviation|26|||
105815853|NCT02465567|364985391|FG002|Overall Study|Major Protocol Deviation|22|||
105815854|NCT02465567|364985392|FG003|Overall Study|Major Protocol Deviation|25|||
105815855|NCT02465567|364985389|FG000|Overall Study|Lost to Follow-up|25|||
105815856|NCT02465567|364985390|FG001|Overall Study|Lost to Follow-up|21|||
105815857|NCT02465567|364985391|FG002|Overall Study|Lost to Follow-up|19|||
105815858|NCT02465567|364985392|FG003|Overall Study|Lost to Follow-up|15|||
105815859|NCT02465567|364985389|FG000|Overall Study|Protocol Specified Criteria|20|||
105815860|NCT02465567|364985390|FG001|Overall Study|Protocol Specified Criteria|10|||
105815861|NCT02465567|364985391|FG002|Overall Study|Protocol Specified Criteria|9|||
105815862|NCT02465567|364985392|FG003|Overall Study|Protocol Specified Criteria|12|||
105815863|NCT02465567|364985389|FG000|Overall Study|Administrative Reasons|12|||
105815864|NCT02465567|364985390|FG001|Overall Study|Administrative Reasons|9|||
105815865|NCT02465567|364985391|FG002|Overall Study|Administrative Reasons|11|||
105815866|NCT02465567|364985392|FG003|Overall Study|Administrative Reasons|5|||
105815867|NCT02465567|364985389|FG000|Overall Study|Randomized but not treated|1|||
105815868|NCT02465567|364985390|FG001|Overall Study|Randomized but not treated|5|||
105815869|NCT02465567|364985391|FG002|Overall Study|Randomized but not treated|4|||
105815870|NCT02465567|364985392|FG003|Overall Study|Randomized but not treated|5|||
105815871|NCT02465567|364985389|FG000|Overall Study|enrolled in >1 studies|18|||
105815872|NCT02465567|364985390|FG001|Overall Study|enrolled in >1 studies|11|||
105815873|NCT02465567|364985391|FG002|Overall Study|enrolled in >1 studies|19|||
105815874|NCT02465567|364985392|FG003|Overall Study|enrolled in >1 studies|15|||
105815875|NCT02465567|364985389|FG000|Overall Study|missing PI Signature|1|||
105815876|NCT02465567|364985390|FG001|Overall Study|missing PI Signature|0|||
105815877|NCT02465567|364985391|FG002|Overall Study|missing PI Signature|0|||
105815878|NCT02465567|364985392|FG003|Overall Study|missing PI Signature|0|||
105815879|NCT00832377|364985394|FG000|Overall Study|Protocol Violation|1|||
105815880|NCT00569374|364985396|FG000|Overall Study|Withdrawal by Subject|4|||
105815881|NCT01666730|364985397|FG000|Overall Study|Adverse Event|16|||
105815882|NCT01666730|364985397|FG000|Overall Study|Death|2|||
105815883|NCT01666730|364985397|FG000|Overall Study|Physician Decision|5|||
105815884|NCT01666730|364985397|FG000|Overall Study|Withdrawal by Subject|9|||
105815885|NCT01666730|364985397|FG000|Overall Study|Disease progression/relapse|18|||
105815886|NCT00912288|364985398|FG000|Overall Study|Death|0|||
105815887|NCT00912288|364985399|FG001|Overall Study|Death|1|||
105815888|NCT00912288|364985398|FG000|Overall Study|Adverse Event|1|||
105815889|NCT00912288|364985399|FG001|Overall Study|Adverse Event|1|||
105815890|NCT00912288|364985398|FG000|Overall Study|Lost to Follow-up|1|||
105815891|NCT00912288|364985399|FG001|Overall Study|Lost to Follow-up|0|||
105815892|NCT00912288|364985398|FG000|Overall Study|Protocol Violation|1|||
105815893|NCT00912288|364985399|FG001|Overall Study|Protocol Violation|0|||
105815894|NCT00912288|364985398|FG000|Overall Study|Withdrawal by Subject|3|||
105815895|NCT00912288|364985399|FG001|Overall Study|Withdrawal by Subject|3|||
105815896|NCT00912288|364985398|FG000|Overall Study|Study terminated by sponsor|34|||
105815897|NCT00912288|364985399|FG001|Overall Study|Study terminated by sponsor|35|||
105815898|NCT00912288|364985398|FG000|Overall Study|Other|1|||
105815899|NCT00912288|364985399|FG001|Overall Study|Other|0|||
105815900|NCT02087904|364985400|FG000|Overall Study|Did Not Receive Study Drug|0|||
105815901|NCT02087904|364985401|FG001|Overall Study|Did Not Receive Study Drug|0|||
105815902|NCT02087904|364985402|FG002|Overall Study|Did Not Receive Study Drug|2|||
105815903|NCT02087904|364985403|FG003|Overall Study|Did Not Receive Study Drug|1|||
105815904|NCT02087904|364985400|FG000|Overall Study|Adverse Event|8|||
105815905|NCT02087904|364985401|FG001|Overall Study|Adverse Event|4|||
105815906|NCT02087904|364985402|FG002|Overall Study|Adverse Event|4|||
105815907|NCT02087904|364985403|FG003|Overall Study|Adverse Event|12|||
105815908|NCT02087904|364985400|FG000|Overall Study|Lack of Efficacy|3|||
105815909|NCT02087904|364985401|FG001|Overall Study|Lack of Efficacy|6|||
105815910|NCT02087904|364985402|FG002|Overall Study|Lack of Efficacy|3|||
105815911|NCT02087904|364985403|FG003|Overall Study|Lack of Efficacy|2|||
105815912|NCT02087904|364985400|FG000|Overall Study|Other|6|||
105815913|NCT02087904|364985401|FG001|Overall Study|Other|2|||
105815914|NCT02087904|364985402|FG002|Overall Study|Other|4|||
105815915|NCT02087904|364985403|FG003|Overall Study|Other|4|||
105815916|NCT02087904|364985400|FG000|Overall Study|Withdrawal by Subject|8|||
105815917|NCT02087904|364985401|FG001|Overall Study|Withdrawal by Subject|3|||
105815918|NCT02087904|364985402|FG002|Overall Study|Withdrawal by Subject|7|||
105815919|NCT02087904|364985403|FG003|Overall Study|Withdrawal by Subject|4|||
105815920|NCT02087904|364985400|FG000|Overall Study|Lost to Follow-up|0|||
105815921|NCT02087904|364985401|FG001|Overall Study|Lost to Follow-up|4|||
105815922|NCT02087904|364985402|FG002|Overall Study|Lost to Follow-up|2|||
105815923|NCT02087904|364985403|FG003|Overall Study|Lost to Follow-up|2|||
105815924|NCT01735630|364985404|FG000|Overall Study|Adverse Event|8|||
105815925|NCT01735630|364985405|FG001|Overall Study|Adverse Event|7|||
105815926|NCT01735630|364985404|FG000|Overall Study|Lost to Follow-up|1|||
105815927|NCT01735630|364985405|FG001|Overall Study|Lost to Follow-up|0|||
105815928|NCT01735630|364985404|FG000|Overall Study|Physician Decision|0|||
105815929|NCT01735630|364985405|FG001|Overall Study|Physician Decision|1|||
105815930|NCT01735630|364985404|FG000|Overall Study|Sponsor Decision|2|||
105815931|NCT01735630|364985405|FG001|Overall Study|Sponsor Decision|1|||
105815932|NCT01735630|364985404|FG000|Overall Study|Withdrawal by Subject|7|||
105815933|NCT01735630|364985405|FG001|Overall Study|Withdrawal by Subject|9|||
105815934|NCT03099538|364985406|FG000|Overall Study|Lack of Efficacy|3|||
105815935|NCT01196052|364985407|FG000|Overall Study|Adverse Event|9|||
105815936|NCT01196052|364985407|FG000|Overall Study|Lost to Follow-up|1|||
105815937|NCT01196052|364985407|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
105815938|NCT01196052|364985407|FG000|Overall Study|Reason not Specified|5|||
105815939|NCT01196052|364985407|FG000|Overall Study|Withdrawal by Subject|6|||
105815940|NCT02178722|364985408|FG000|Overall Study|Withdrawal by Subject|0|||
105815941|NCT02178722|364985409|FG001|Overall Study|Withdrawal by Subject|0|||
105815942|NCT02178722|364985410|FG002|Overall Study|Withdrawal by Subject|0|||
105815943|NCT02178722|364985411|FG003|Overall Study|Withdrawal by Subject|2|||
105815944|NCT02178722|364985412|FG004|Overall Study|Withdrawal by Subject|33|||
105362294|NCT00810069|363330204|FG002|Double-Blind Period II|Lost to Follow-up|9|||
105362295|NCT00810069|363330202|FG000|Double-Blind Period II|Physician Decision|0|||
105362296|NCT00810069|363330203|FG001|Double-Blind Period II|Physician Decision|0|||
105362297|NCT00810069|363330204|FG002|Double-Blind Period II|Physician Decision|1|||
105362298|NCT00810069|363330202|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
105362299|NCT00810069|363330203|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
105362300|NCT00810069|363330204|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
105362301|NCT00810069|363330202|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
105362302|NCT00810069|363330203|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
105362303|NCT00810069|363330204|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
105362304|NCT00810069|363330202|FG000|Double-Blind Period II|Clinical relapse|0|||
105362305|NCT00810069|363330203|FG001|Double-Blind Period II|Clinical relapse|3|||
105362306|NCT00810069|363330204|FG002|Double-Blind Period II|Clinical relapse|0|||
105362307|NCT00810069|363330202|FG000|Double-Blind Period II|Protocol Violation|0|||
105362308|NCT00810069|363330203|FG001|Double-Blind Period II|Protocol Violation|7|||
105362309|NCT00810069|363330204|FG002|Double-Blind Period II|Protocol Violation|6|||
105362310|NCT01630135|363330206|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
105362311|NCT01630135|363330207|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
105362312|NCT02227784|363330211|FG000|Double-Blind Phase|Adverse Event|3|||
105362313|NCT02227784|363330212|FG001|Double-Blind Phase|Adverse Event|2|||
105362314|NCT02227784|363330213|FG002|Double-Blind Phase|Adverse Event|1|||
105362315|NCT02227784|363330214|FG003|Double-Blind Phase|Adverse Event|3|||
105815945|NCT02178722|364985408|FG000|Overall Study|Death|2|||
105815946|NCT02178722|364985409|FG001|Overall Study|Death|13|||
105815947|NCT02178722|364985410|FG002|Overall Study|Death|12|||
105815948|NCT02178722|364985411|FG003|Overall Study|Death|12|||
105815949|NCT02178722|364985412|FG004|Overall Study|Death|205|||
105815950|NCT02178722|364985408|FG000|Overall Study|Lost to Follow-up|0|||
105815951|NCT02178722|364985409|FG001|Overall Study|Lost to Follow-up|0|||
105815952|NCT02178722|364985410|FG002|Overall Study|Lost to Follow-up|0|||
105815953|NCT02178722|364985411|FG003|Overall Study|Lost to Follow-up|2|||
105815954|NCT02178722|364985412|FG004|Overall Study|Lost to Follow-up|11|||
105362316|NCT02227784|363330215|FG004|Double-Blind Phase|Adverse Event|0|||
105362317|NCT02227784|363330211|FG000|Double-Blind Phase|Physician Decision|1|||
105815955|NCT02178722|364985408|FG000|Overall Study|Study terminated by Sponsor|2|||
105815956|NCT02178722|364985409|FG001|Overall Study|Study terminated by Sponsor|7|||
105815957|NCT02178722|364985410|FG002|Overall Study|Study terminated by Sponsor|6|||
105815958|NCT02178722|364985411|FG003|Overall Study|Study terminated by Sponsor|4|||
105815959|NCT02178722|364985412|FG004|Overall Study|Study terminated by Sponsor|128|||
105815960|NCT02178722|364985408|FG000|Overall Study|Physician Decision|0|||
105815961|NCT02178722|364985409|FG001|Overall Study|Physician Decision|0|||
105815962|NCT02178722|364985410|FG002|Overall Study|Physician Decision|0|||
105815963|NCT02178722|364985411|FG003|Overall Study|Physician Decision|0|||
105815964|NCT02178722|364985412|FG004|Overall Study|Physician Decision|3|||
105815965|NCT02178722|364985408|FG000|Overall Study|Other|0|||
105815966|NCT02178722|364985409|FG001|Overall Study|Other|0|||
105815967|NCT02178722|364985410|FG002|Overall Study|Other|0|||
105815968|NCT02178722|364985411|FG003|Overall Study|Other|0|||
105815969|NCT02178722|364985412|FG004|Overall Study|Other|2|||
105815970|NCT00440557|364985413|FG000|Overall Study|Withdrawal by Subject|10|||
105815971|NCT00440557|364985414|FG001|Overall Study|Withdrawal by Subject|5|||
105815972|NCT00440557|364985415|FG002|Overall Study|Withdrawal by Subject|11|||
105815973|NCT00440557|364985413|FG000|Overall Study|Lost to Follow-up|1|||
105815974|NCT00440557|364985414|FG001|Overall Study|Lost to Follow-up|2|||
105815975|NCT00440557|364985415|FG002|Overall Study|Lost to Follow-up|6|||
105815976|NCT00440557|364985413|FG000|Overall Study|Adverse Event|3|||
105815977|NCT00440557|364985414|FG001|Overall Study|Adverse Event|3|||
105815978|NCT00440557|364985415|FG002|Overall Study|Adverse Event|5|||
105815979|NCT00440557|364985413|FG000|Overall Study|Death|2|||
105486233|NCT00584740|363791440|FG000|Overall Study|Withdrawal by Subject|3|||
105815980|NCT00440557|364985414|FG001|Overall Study|Death|6|||
105815981|NCT00440557|364985415|FG002|Overall Study|Death|3|||
105815982|NCT00440557|364985413|FG000|Overall Study|Began Dialysis|4|||
105815983|NCT00440557|364985414|FG001|Overall Study|Began Dialysis|1|||
105815984|NCT00440557|364985415|FG002|Overall Study|Began Dialysis|4|||
105815985|NCT00440557|364985413|FG000|Overall Study|Principal Investigator decision|0|||
105815986|NCT00440557|364985414|FG001|Overall Study|Principal Investigator decision|3|||
105815987|NCT00440557|364985415|FG002|Overall Study|Principal Investigator decision|1|||
105815988|NCT00440557|364985413|FG000|Overall Study|Patient moved|1|||
105815989|NCT00440557|364985414|FG001|Overall Study|Patient moved|2|||
105486234|NCT00584740|363791441|FG001|Overall Study|Withdrawal by Subject|2|||
105486235|NCT00584740|363791440|FG000|Overall Study|Lost to Follow-up|0|||
105486236|NCT00584740|363791441|FG001|Overall Study|Lost to Follow-up|1|||
105486237|NCT02483533|363791444|FG000|Overall Study|Lack of Efficacy|50|||
105486238|NCT02483533|363791445|FG001|Overall Study|Lack of Efficacy|50|||
105486239|NCT04966741|363791451|FG000|Overall Study|Lost to Follow-up|1|||
105486240|NCT04966741|363791452|FG001|Overall Study|Lost to Follow-up|0|||
105571638|NCT02581930|364091284|FG000|Overall Study|patient declined further treatment|1|||
105815990|NCT00440557|364985415|FG002|Overall Study|Patient moved|1|||
105815991|NCT00440557|364985413|FG000|Overall Study|Principal Investigator's office closed|3|||
105815992|NCT00440557|364985414|FG001|Overall Study|Principal Investigator's office closed|6|||
105815993|NCT00440557|364985415|FG002|Overall Study|Principal Investigator's office closed|4|||
105815994|NCT00440557|364985413|FG000|Overall Study|Patient transferred to nursing home|0|||
105815995|NCT00440557|364985414|FG001|Overall Study|Patient transferred to nursing home|1|||
105815996|NCT00440557|364985415|FG002|Overall Study|Patient transferred to nursing home|0|||
105815997|NCT00440557|364985413|FG000|Overall Study|Patient had surgery|1|||
105815998|NCT00440557|364985414|FG001|Overall Study|Patient had surgery|0|||
105486241|NCT02953509|363791454|FG000|Overall Study|Death|1|||
105815999|NCT00440557|364985415|FG002|Overall Study|Patient had surgery|0|||
105816000|NCT03553823|364985416|FG000|Overall Study|Physician Decision|0|||
105816001|NCT03553823|364985417|FG001|Overall Study|Physician Decision|1|||
105816002|NCT00893464|364985418|FG000|Overall Study|Did not complete therapy/experience PD|0|||
105816003|NCT00893464|364985419|FG001|Overall Study|Did not complete therapy/experience PD|0|||
105816004|NCT00893464|364985420|FG002|Overall Study|Did not complete therapy/experience PD|0|||
105816005|NCT00893464|364985421|FG003|Overall Study|Did not complete therapy/experience PD|0|||
105816006|NCT00893464|364985422|FG004|Overall Study|Did not complete therapy/experience PD|0|||
105816007|NCT00893464|364985423|FG005|Overall Study|Did not complete therapy/experience PD|0|||
105816008|NCT00893464|364985424|FG006|Overall Study|Did not complete therapy/experience PD|2|||
105816009|NCT00893464|364985425|FG007|Overall Study|Did not complete therapy/experience PD|2|||
105816010|NCT03450070|364985426|FG000|Overall Study|Withdrawal by Subject|8|||
105816011|NCT01035060|364985431|FG000|Overall Study|Lost to Follow-up|0|||
105816012|NCT01035060|364985432|FG001|Overall Study|Lost to Follow-up|7|||
105816013|NCT01035060|364985431|FG000|Overall Study|Did not quality after 2nd screening|14|||
105816014|NCT01035060|364985432|FG001|Overall Study|Did not quality after 2nd screening|1|||
105816015|NCT01035060|364985431|FG000|Overall Study|Withdrawal by Subject|8|||
105816016|NCT01035060|364985432|FG001|Overall Study|Withdrawal by Subject|6|||
105816017|NCT01035060|364985431|FG000|Overall Study|Physician Decision|2|||
105486242|NCT02953509|363791455|FG001|Overall Study|Death|3|||
105486243|NCT02953509|363791456|FG002|Overall Study|Death|3|||
105486244|NCT02953509|363791457|FG003|Overall Study|Death|4|||
105816018|NCT01035060|364985432|FG001|Overall Study|Physician Decision|0|||
105816019|NCT01126736|364985433|FG000|Overall Study|Death|2|||
105816020|NCT01126736|364985434|FG001|Overall Study|Death|2|||
105486245|NCT02953509|363791458|FG004|Overall Study|Death|12|||
105486246|NCT02953509|363791459|FG005|Overall Study|Death|3|||
105486247|NCT02953509|363791460|FG006|Overall Study|Death|25|||
105486248|NCT02953509|363791461|FG007|Overall Study|Death|10|||
105486249|NCT02953509|363791462|FG008|Overall Study|Death|21|||
105486250|NCT02953509|363791463|FG009|Overall Study|Death|20|||
105486251|NCT02953509|363791454|FG000|Overall Study|Reason Not Specified|0|||
105486252|NCT02953509|363791455|FG001|Overall Study|Reason Not Specified|2|||
105486253|NCT02953509|363791456|FG002|Overall Study|Reason Not Specified|8|||
105486254|NCT02953509|363791457|FG003|Overall Study|Reason Not Specified|2|||
105816021|NCT01126736|364985435|FG002|Overall Study|Death|1|||
105816022|NCT01126736|364985436|FG003|Overall Study|Death|19|||
105816023|NCT01126736|364985437|FG004|Overall Study|Death|19|||
105816024|NCT01126736|364985433|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
105816025|NCT01126736|364985434|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
105816026|NCT01126736|364985435|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
105816027|NCT01126736|364985436|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
105816028|NCT01126736|364985437|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
105816029|NCT01126736|364985433|FG000|Overall Study|Lost to Follow-up|0|||
105816030|NCT01126736|364985434|FG001|Overall Study|Lost to Follow-up|0|||
105816031|NCT01126736|364985435|FG002|Overall Study|Lost to Follow-up|0|||
105816032|NCT01126736|364985436|FG003|Overall Study|Lost to Follow-up|1|||
105816033|NCT01126736|364985437|FG004|Overall Study|Lost to Follow-up|1|||
105816034|NCT01126736|364985433|FG000|Overall Study|Administrative reasons|0|||
105816035|NCT01126736|364985434|FG001|Overall Study|Administrative reasons|0|||
105816036|NCT01126736|364985435|FG002|Overall Study|Administrative reasons|0|||
105816037|NCT01126736|364985436|FG003|Overall Study|Administrative reasons|0|||
105816038|NCT01126736|364985437|FG004|Overall Study|Administrative reasons|1|||
105816039|NCT01126736|364985433|FG000|Overall Study|Progressive disease|0|||
105816040|NCT01126736|364985434|FG001|Overall Study|Progressive disease|0|||
105816041|NCT01126736|364985435|FG002|Overall Study|Progressive disease|0|||
105816042|NCT01126736|364985436|FG003|Overall Study|Progressive disease|2|||
105816043|NCT01126736|364985437|FG004|Overall Study|Progressive disease|1|||
105816044|NCT01126736|364985433|FG000|Overall Study|Withdrawal by Subject|0|||
105816045|NCT01126736|364985434|FG001|Overall Study|Withdrawal by Subject|0|||
105816046|NCT01126736|364985435|FG002|Overall Study|Withdrawal by Subject|0|||
105816047|NCT01126736|364985436|FG003|Overall Study|Withdrawal by Subject|1|||
105816048|NCT01126736|364985437|FG004|Overall Study|Withdrawal by Subject|1|||
105816049|NCT01126736|364985433|FG000|Overall Study|Other|2|||
105486255|NCT02953509|363791458|FG004|Overall Study|Reason Not Specified|11|||
105486256|NCT02953509|363791459|FG005|Overall Study|Reason Not Specified|4|||
105486257|NCT02953509|363791460|FG006|Overall Study|Reason Not Specified|12|||
105816050|NCT01126736|364985434|FG001|Overall Study|Other|4|||
105486258|NCT02953509|363791461|FG007|Overall Study|Reason Not Specified|2|||
105486259|NCT02953509|363791462|FG008|Overall Study|Reason Not Specified|7|||
105816051|NCT01126736|364985435|FG002|Overall Study|Other|4|||
105816052|NCT01126736|364985436|FG003|Overall Study|Other|16|||
105816053|NCT01126736|364985437|FG004|Overall Study|Other|15|||
105816054|NCT00877032|364985443|FG000|Overall Study|Did not meet entrance criteria|0|||
105816055|NCT00877032|364985444|FG001|Overall Study|Did not meet entrance criteria|0|||
105486260|NCT02953509|363791463|FG009|Overall Study|Reason Not Specified|2|||
105816056|NCT00877032|364985445|FG002|Overall Study|Did not meet entrance criteria|0|||
105816057|NCT00877032|364985446|FG003|Overall Study|Did not meet entrance criteria|1|||
105816058|NCT00877032|364985447|FG004|Overall Study|Did not meet entrance criteria|0|||
105816059|NCT00877032|364985448|FG005|Overall Study|Did not meet entrance criteria|0|||
105486261|NCT02953509|363791454|FG000|Overall Study|Consent Withdrawn|1|||
105486262|NCT02953509|363791455|FG001|Overall Study|Consent Withdrawn|1|||
105486263|NCT02953509|363791456|FG002|Overall Study|Consent Withdrawn|2|||
105486264|NCT02953509|363791457|FG003|Overall Study|Consent Withdrawn|1|||
105571639|NCT00332332|364092714|FG000|Overall Study|Adverse Event|13|||
105571640|NCT00332332|364092714|FG000|Overall Study|Death|1|||
105816060|NCT00877032|364985449|FG006|Overall Study|Did not meet entrance criteria|2|||
105816061|NCT02107092|364985451|FG000|Overall Study|Miscellaneous|3|||
105816062|NCT02107092|364985451|FG000|Overall Study|Subject compliance|3|||
105816063|NCT02107092|364985451|FG000|Overall Study|Hypo-or hyperkalemia|2|||
105816064|NCT02107092|364985451|FG000|Overall Study|Met ECG withdrawal criteria|3|||
105816065|NCT02107092|364985451|FG000|Overall Study|Physician Decision|3|||
105816066|NCT02107092|364985451|FG000|Overall Study|Lost to Follow-up|2|||
105816067|NCT02107092|364985451|FG000|Overall Study|Withdrawal by Subject|9|||
105816068|NCT02107092|364985451|FG000|Overall Study|Adverse Event|7|||
105816069|NCT02107092|364985451|FG000|Overall Study|Expected progression of CKD|12|||
105816070|NCT03522675|364985453|FG000|Overall Study|Screen fail|1|||
105816071|NCT03522675|364985453|FG000|Overall Study|Non-reactive to histamine|1|||
105816072|NCT02076022|364985454|FG000|Overall Study|Withdrawal by Subject|2|||
105816073|NCT02076022|364985455|FG001|Overall Study|Withdrawal by Subject|0|||
105816074|NCT01536405|364985456|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
105816075|NCT01536405|364985457|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
105816076|NCT01536405|364985456|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
105816077|NCT01536405|364985457|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
105816078|NCT01536405|364985456|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
105816079|NCT01536405|364985457|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
105816080|NCT01536405|364985456|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
105816081|NCT01536405|364985457|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
105816082|NCT01536405|364985456|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
105816083|NCT01536405|364985457|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
105816084|NCT01536405|364985456|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
105816085|NCT01536405|364985457|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
105816086|NCT01536405|364985456|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
105816087|NCT01536405|364985457|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
105816088|NCT01536405|364985456|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
105816089|NCT01536405|364985457|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
105816090|NCT01536405|364985456|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
105816091|NCT01536405|364985457|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
105816092|NCT01536405|364985456|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
105816093|NCT01536405|364985457|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
105816094|NCT01536405|364985456|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
105816095|NCT01536405|364985457|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
105816096|NCT01536405|364985456|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
105816097|NCT01536405|364985457|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
105816098|NCT01536405|364985456|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
105816099|NCT01536405|364985457|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
105816100|NCT02549092|364985458|FG000|Treatment Period|Adverse Event|2|||
105816101|NCT02549092|364985459|FG001|Treatment Period|Adverse Event|2|||
105816102|NCT02549092|364985458|FG000|Treatment Period|Withdrawal by Subject|1|||
105816103|NCT02549092|364985459|FG001|Treatment Period|Withdrawal by Subject|3|||
105816104|NCT02549092|364985458|FG000|Treatment Period|Lack of Efficacy|0|||
105816105|NCT02549092|364985459|FG001|Treatment Period|Lack of Efficacy|2|||
105816106|NCT02549092|364985458|FG000|Extension/Transition Period|Adverse Event|1|||
105816107|NCT02549092|364985459|FG001|Extension/Transition Period|Adverse Event|1|||
105816108|NCT02549092|364985458|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
105816109|NCT02549092|364985459|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
105816110|NCT02549092|364985458|FG000|Extension/Transition Period|Other, Not Specified|4|||
105816111|NCT02549092|364985459|FG001|Extension/Transition Period|Other, Not Specified|2|||
105816112|NCT02511782|364985462|FG000|Overall Study|Withdrawal by Subject|1|||
105816113|NCT02511782|364985463|FG001|Overall Study|Withdrawal by Subject|0|||
105816114|NCT02511782|364985464|FG002|Overall Study|Withdrawal by Subject|0|||
105816115|NCT00450190|364985465|FG000|Overall Study|Withdrawal by Subject|2|||
105816116|NCT04625114|364985473|FG000|Overall Study|Adverse Event|3|||
105816117|NCT04625114|364985474|FG001|Overall Study|Adverse Event|1|||
105816118|NCT04625114|364985473|FG000|Overall Study|Withdrawal by Subject|2|||
105816119|NCT04625114|364985474|FG001|Overall Study|Withdrawal by Subject|0|||
105816120|NCT00565448|364985482|FG000|Overall Study|Adverse Event|1|||
105816121|NCT00565448|364985483|FG001|Overall Study|Adverse Event|2|||
105816122|NCT00565448|364985482|FG000|Overall Study|Disease progression|1|||
105816123|NCT00565448|364985483|FG001|Overall Study|Disease progression|0|||
105816124|NCT00565448|364985482|FG000|Overall Study|Withdrawal by Subject|1|||
105816125|NCT00565448|364985483|FG001|Overall Study|Withdrawal by Subject|0|||
105816126|NCT00193609|364985484|FG000|Overall Study|Lack of Efficacy|2|||
105816127|NCT00193609|364985484|FG000|Overall Study|Adverse Event|2|||
105816128|NCT03048500|364985485|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
105816129|NCT03048500|364985485|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
105816130|NCT03048500|364985485|FG000|Reached 1st Response/Continued Treatment|Death|1|||
105816131|NCT03048500|364985485|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
105816132|NCT03048500|364985485|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
105816133|NCT03048500|364985485|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
105816134|NCT03048500|364985485|FG000|Follow up for 3 Years|Death|12|||
105816135|NCT00048581|364985486|FG000|Double-Blind Period|Adverse Event|9|||
105816136|NCT00048581|364985487|FG001|Double-Blind Period|Adverse Event|5|||
105816137|NCT00048581|364985488|FG002|Double-Blind Period|Adverse Event|0|||
105816138|NCT00048581|364985486|FG000|Double-Blind Period|Lack of Efficacy|14|||
105816139|NCT00048581|364985487|FG001|Double-Blind Period|Lack of Efficacy|27|||
105816140|NCT00048581|364985488|FG002|Double-Blind Period|Lack of Efficacy|0|||
105816141|NCT00048581|364985486|FG000|Double-Blind Period|Lost to Follow-up|5|||
105816142|NCT00048581|364985487|FG001|Double-Blind Period|Lost to Follow-up|0|||
105816143|NCT00048581|364985488|FG002|Double-Blind Period|Lost to Follow-up|0|||
105816144|NCT00048581|364985486|FG000|Double-Blind Period|Withdrawal by Subject|5|||
105816145|NCT00048581|364985487|FG001|Double-Blind Period|Withdrawal by Subject|2|||
105816146|NCT00048581|364985488|FG002|Double-Blind Period|Withdrawal by Subject|0|||
105816147|NCT00048581|364985486|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
105816148|NCT00048581|364985487|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
105816149|NCT00048581|364985488|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
105816150|NCT00048581|364985486|FG000|Double-Blind Period|Investigator Decision|1|||
105816151|NCT00048581|364985487|FG001|Double-Blind Period|Investigator Decision|0|||
105816152|NCT00048581|364985488|FG002|Double-Blind Period|Investigator Decision|0|||
105816153|NCT00048581|364985486|FG000|Open-Label Period|Death|0|||
105571641|NCT00332332|364092714|FG000|Overall Study|Withdrawal by Subject|8|||
105764612|NCT01998958|364791683|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
105764613|NCT01998958|364791684|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
105764614|NCT01998958|364791685|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
105764615|NCT01998958|364791686|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764616|NCT01998958|364791687|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764617|NCT01998958|364791688|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764618|NCT01998958|364791689|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764619|NCT01998958|364791690|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764620|NCT01998958|364791691|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764621|NCT01998958|364791692|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764622|NCT01998958|364791693|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764623|NCT03551626|364791694|FG000|Overall Study|Adverse Event|88|||
105764624|NCT03551626|364791694|FG000|Overall Study|Disease relapse|18|||
105764625|NCT03551626|364791694|FG000|Overall Study|Withdrawal of informed consent|6|||
105764626|NCT03551626|364791694|FG000|Overall Study|Patient decision|5|||
105764627|NCT03551626|364791694|FG000|Overall Study|Physician Decision|4|||
105764628|NCT03551626|364791694|FG000|Overall Study|Lost to Follow-up|3|||
105764629|NCT03551626|364791694|FG000|Overall Study|Pregnancy|1|||
105816154|NCT00048581|364985487|FG001|Open-Label Period|Death|0|||
105816155|NCT00048581|364985488|FG002|Open-Label Period|Death|4|||
105816156|NCT00048581|364985486|FG000|Open-Label Period|Adverse Event|0|||
105816157|NCT00048581|364985487|FG001|Open-Label Period|Adverse Event|0|||
105816158|NCT00048581|364985488|FG002|Open-Label Period|Adverse Event|37|||
105764630|NCT03551626|364791694|FG000|Overall Study|Protocol deviation|1|||
105764631|NCT03551626|364791694|FG000|Overall Study|Technical problems|1|||
105816159|NCT00048581|364985486|FG000|Open-Label Period|Lack of Efficacy|0|||
105816160|NCT00048581|364985487|FG001|Open-Label Period|Lack of Efficacy|0|||
105816161|NCT00048581|364985488|FG002|Open-Label Period|Lack of Efficacy|69|||
105816162|NCT00048581|364985486|FG000|Open-Label Period|Lost to Follow-up|0|||
105816163|NCT00048581|364985487|FG001|Open-Label Period|Lost to Follow-up|0|||
105816164|NCT00048581|364985488|FG002|Open-Label Period|Lost to Follow-up|14|||
105816165|NCT00048581|364985486|FG000|Open-Label Period|Withdrawal by Subject|0|||
105816166|NCT00048581|364985487|FG001|Open-Label Period|Withdrawal by Subject|0|||
105816167|NCT00048581|364985488|FG002|Open-Label Period|Withdrawal by Subject|20|||
105816168|NCT00048581|364985486|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
105816169|NCT00048581|364985487|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
105816170|NCT00048581|364985488|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
105816171|NCT00048581|364985486|FG000|Open-Label Period|Poor/Non-compliance|0|||
105816172|NCT00048581|364985487|FG001|Open-Label Period|Poor/Non-compliance|0|||
105816173|NCT00048581|364985488|FG002|Open-Label Period|Poor/Non-compliance|5|||
105816174|NCT00048581|364985486|FG000|Open-Label Period|Pregnancy|0|||
105816175|NCT00048581|364985487|FG001|Open-Label Period|Pregnancy|0|||
105816176|NCT00048581|364985488|FG002|Open-Label Period|Pregnancy|7|||
105816177|NCT00048581|364985486|FG000|Open-Label Period|Study Site Closure|0|||
105816178|NCT00048581|364985487|FG001|Open-Label Period|Study Site Closure|0|||
105816179|NCT00048581|364985488|FG002|Open-Label Period|Study Site Closure|2|||
105816180|NCT00048581|364985486|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
105816181|NCT00048581|364985487|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
105816182|NCT00048581|364985488|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
105816183|NCT00048581|364985486|FG000|Open-Label Period|Problem With Transportation To Site|0|||
105816184|NCT00048581|364985487|FG001|Open-Label Period|Problem With Transportation To Site|0|||
105816185|NCT00048581|364985488|FG002|Open-Label Period|Problem With Transportation To Site|1|||
105816186|NCT00048581|364985486|FG000|Open-Label Period|Primary Investigator Retired|0|||
105816187|NCT00048581|364985487|FG001|Open-Label Period|Primary Investigator Retired|0|||
105816188|NCT00048581|364985488|FG002|Open-Label Period|Primary Investigator Retired|2|||
105816189|NCT00048581|364985486|FG000|Open-Label Period|Study Ended By Sponsor|0|||
105816190|NCT00048581|364985487|FG001|Open-Label Period|Study Ended By Sponsor|0|||
105816191|NCT00048581|364985488|FG002|Open-Label Period|Study Ended By Sponsor|1|||
105816192|NCT01406795|364985489|FG000|Overall Study|Withdrawal by Subject|1|||
105816193|NCT03897088|364985490|FG000|Overall Study|Withdrawal by Subject|12|||
105816194|NCT03897088|364985491|FG001|Overall Study|Withdrawal by Subject|12|||
105816195|NCT03897088|364985490|FG000|Overall Study|Lost to Follow-up|7|||
105816196|NCT03897088|364985491|FG001|Overall Study|Lost to Follow-up|15|||
105816197|NCT03897088|364985490|FG000|Overall Study|Sponsor Decision|1|||
105816198|NCT03897088|364985491|FG001|Overall Study|Sponsor Decision|2|||
105816199|NCT03897088|364985490|FG000|Overall Study|COVID-19|2|||
105816200|NCT03897088|364985491|FG001|Overall Study|COVID-19|0|||
105816201|NCT03897088|364985490|FG000|Overall Study|Other|3|||
105816202|NCT03897088|364985491|FG001|Overall Study|Other|0|||
105816203|NCT03897088|364985490|FG000|Overall Study|Non-compliance with Study Drug|1|||
105816204|NCT03897088|364985491|FG001|Overall Study|Non-compliance with Study Drug|1|||
105816205|NCT03897088|364985490|FG000|Overall Study|Pregnancy|0|||
105816206|NCT03897088|364985491|FG001|Overall Study|Pregnancy|1|||
105816207|NCT00385593|364985492|FG000|Overall Study|Adverse Event|3|||
105816208|NCT00385593|364985493|FG001|Overall Study|Adverse Event|2|||
105816209|NCT00385593|364985492|FG000|Overall Study|Withdrawal by Subject|17|||
105816210|NCT00385593|364985493|FG001|Overall Study|Withdrawal by Subject|7|||
105816211|NCT00385593|364985492|FG000|Overall Study|Lost to Follow-up|12|||
105816212|NCT00385593|364985493|FG001|Overall Study|Lost to Follow-up|8|||
105816213|NCT00385593|364985492|FG000|Overall Study|Protocol Violation|7|||
105816214|NCT00385593|364985493|FG001|Overall Study|Protocol Violation|4|||
105816215|NCT00385593|364985492|FG000|Overall Study|Several reasons|17|||
105816216|NCT00385593|364985493|FG001|Overall Study|Several reasons|15|||
105816217|NCT00385593|364985492|FG000|Overall Study|Incorrect inclusion|2|||
105816218|NCT00385593|364985493|FG001|Overall Study|Incorrect inclusion|0|||
105816219|NCT00385593|364985492|FG000|Overall Study|Incorrect randomization|0|||
105816220|NCT00385593|364985493|FG001|Overall Study|Incorrect randomization|1|||
105816221|NCT03725605|364985494|FG000|Overall Study|Unsuccessful TIL expansion|2|||
105816222|NCT01619800|364986807|FG000|Overall Study|study terminated|2|||
105816223|NCT01619800|364986808|FG001|Overall Study|study terminated|0|||
105816224|NCT00416520|364986815|FG000|Open-label Period|Adverse Event|28|||
105816225|NCT00416520|364986816|FG001|Open-label Period|Adverse Event|10|||
105816226|NCT00416520|364986817|FG002|Open-label Period|Adverse Event|0|||
105816227|NCT00416520|364986818|FG003|Open-label Period|Adverse Event|0|||
105816228|NCT00416520|364986815|FG000|Open-label Period|Death|2|||
105816229|NCT00416520|364986816|FG001|Open-label Period|Death|1|||
105816230|NCT00416520|364986817|FG002|Open-label Period|Death|0|||
105816231|NCT00416520|364986818|FG003|Open-label Period|Death|0|||
105816232|NCT00416520|364986815|FG000|Open-label Period|Lack of Efficacy|8|||
105816233|NCT00416520|364986816|FG001|Open-label Period|Lack of Efficacy|1|||
105816234|NCT00416520|364986817|FG002|Open-label Period|Lack of Efficacy|0|||
105816235|NCT00416520|364986818|FG003|Open-label Period|Lack of Efficacy|0|||
105816236|NCT00416520|364986815|FG000|Open-label Period|Protocol Violation|3|||
105816237|NCT00416520|364986816|FG001|Open-label Period|Protocol Violation|3|||
105816238|NCT00416520|364986817|FG002|Open-label Period|Protocol Violation|0|||
105816239|NCT00416520|364986818|FG003|Open-label Period|Protocol Violation|0|||
105816240|NCT00416520|364986815|FG000|Open-label Period|Withdrawal by Subject|16|||
105816241|NCT00416520|364986816|FG001|Open-label Period|Withdrawal by Subject|5|||
105816242|NCT00416520|364986817|FG002|Open-label Period|Withdrawal by Subject|0|||
105816243|NCT00416520|364986818|FG003|Open-label Period|Withdrawal by Subject|0|||
105816244|NCT00416520|364986815|FG000|Open-label Period|Other Reasons|3|||
105486265|NCT02953509|363791458|FG004|Overall Study|Consent Withdrawn|3|||
105486266|NCT02953509|363791459|FG005|Overall Study|Consent Withdrawn|0|||
105816245|NCT00416520|364986816|FG001|Open-label Period|Other Reasons|12|||
105816246|NCT00416520|364986817|FG002|Open-label Period|Other Reasons|0|||
105816247|NCT00416520|364986818|FG003|Open-label Period|Other Reasons|0|||
105816248|NCT00416520|364986815|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
105816249|NCT00416520|364986816|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
105816250|NCT00416520|364986817|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
105816251|NCT00416520|364986818|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
105816252|NCT00416520|364986815|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
105816253|NCT00416520|364986816|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
105816254|NCT00416520|364986817|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
105816255|NCT00416520|364986818|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
105816256|NCT00416520|364986815|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
105816257|NCT00416520|364986816|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
105816258|NCT00416520|364986817|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
105816259|NCT00416520|364986818|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
105816260|NCT03601637|364986819|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
105816261|NCT03601637|364986820|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
105816262|NCT03601637|364986819|FG000|Overall Study|Adverse Event|1|||
105816263|NCT03601637|364986820|FG001|Overall Study|Adverse Event|1|||
105816264|NCT03601637|364986819|FG000|Overall Study|Other|0|||
105816265|NCT03601637|364986820|FG001|Overall Study|Other|1|||
105816266|NCT01042522|364986825|FG000|Overall Study|Adverse Event|1|||
105816267|NCT01042522|364986826|FG001|Overall Study|Adverse Event|2|||
105816268|NCT01042522|364986825|FG000|Overall Study|Disease Progression|5|||
105816269|NCT01042522|364986826|FG001|Overall Study|Disease Progression|0|||
105816270|NCT01042522|364986825|FG000|Overall Study|Death|1|||
105816271|NCT01042522|364986826|FG001|Overall Study|Death|0|||
105816272|NCT01042522|364986825|FG000|Overall Study|Patient Refused|0|||
105816273|NCT01042522|364986826|FG001|Overall Study|Patient Refused|3|||
105816274|NCT01042522|364986825|FG000|Overall Study|Withdrawal by Subject|1|||
105816275|NCT01042522|364986826|FG001|Overall Study|Withdrawal by Subject|1|||
105816276|NCT00549718|364986827|FG000|Overall Study|Insufficient clinical response|20|||
105816277|NCT00549718|364986828|FG001|Overall Study|Insufficient clinical response|7|||
105816278|NCT00549718|364986829|FG002|Overall Study|Insufficient clinical response|18|||
105816279|NCT00549718|364986830|FG003|Overall Study|Insufficient clinical response|32|||
105816280|NCT00549718|364986827|FG000|Overall Study|Adverse Event|6|||
105816281|NCT00549718|364986828|FG001|Overall Study|Adverse Event|8|||
105816282|NCT00549718|364986829|FG002|Overall Study|Adverse Event|7|||
105816283|NCT00549718|364986830|FG003|Overall Study|Adverse Event|3|||
105816284|NCT00549718|364986827|FG000|Overall Study|Lost to Follow-up|4|||
105816285|NCT00549718|364986828|FG001|Overall Study|Lost to Follow-up|2|||
105816286|NCT00549718|364986829|FG002|Overall Study|Lost to Follow-up|0|||
105816287|NCT00549718|364986830|FG003|Overall Study|Lost to Follow-up|6|||
105816288|NCT00549718|364986827|FG000|Overall Study|Withdrawal by Subject|9|||
105816289|NCT00549718|364986828|FG001|Overall Study|Withdrawal by Subject|18|||
105816290|NCT00549718|364986829|FG002|Overall Study|Withdrawal by Subject|12|||
105816291|NCT00549718|364986830|FG003|Overall Study|Withdrawal by Subject|13|||
105816292|NCT00549718|364986827|FG000|Overall Study|Administrative|2|||
105816293|NCT00549718|364986828|FG001|Overall Study|Administrative|2|||
105816294|NCT00549718|364986829|FG002|Overall Study|Administrative|2|||
105816295|NCT00549718|364986830|FG003|Overall Study|Administrative|1|||
105816296|NCT03597256|364986831|FG000|Overall Study|Lost to Follow-up|3|||
105816297|NCT03597256|364986832|FG001|Overall Study|Lost to Follow-up|1|||
105816298|NCT03597256|364986831|FG000|Overall Study|Withdrawal by Subject|0|||
105816299|NCT03597256|364986832|FG001|Overall Study|Withdrawal by Subject|1|||
105816300|NCT03597256|364986831|FG000|Overall Study|Could not return for treatment|0|||
105816301|NCT03597256|364986832|FG001|Overall Study|Could not return for treatment|1|||
105816302|NCT03597256|364986831|FG000|Overall Study|Moved from location|0|||
105816303|NCT03597256|364986832|FG001|Overall Study|Moved from location|1|||
105816304|NCT03597256|364986831|FG000|Overall Study|Not accepted the treatment|0|||
105816305|NCT03597256|364986832|FG001|Overall Study|Not accepted the treatment|1|||
105816306|NCT01045096|364986833|FG000|Overall Study|Withdrawal by Subject|2|||
105816307|NCT01045096|364986834|FG001|Overall Study|Withdrawal by Subject|0|||
105816308|NCT01045096|364986835|FG002|Overall Study|Withdrawal by Subject|0|||
105816309|NCT01045096|364986833|FG000|Overall Study|Other|1|||
105816310|NCT01045096|364986834|FG001|Overall Study|Other|0|||
105816311|NCT01045096|364986835|FG002|Overall Study|Other|0|||
105816312|NCT02109042|364986837|FG000|Overall Study|Sponsor Decision|15|||
105816313|NCT01511939|364986838|FG000|Overall Study|Withdrawal by Subject|2|||
105362318|NCT02227784|363330212|FG001|Double-Blind Phase|Physician Decision|0|||
105816314|NCT01511939|364986839|FG001|Overall Study|Withdrawal by Subject|1|||
105816315|NCT01511939|364986840|FG002|Overall Study|Withdrawal by Subject|0|||
105816316|NCT04407806|364986844|FG000|Overall Study|Withdrawal by Subject|1|||
105816317|NCT04407806|364986845|FG001|Overall Study|Withdrawal by Subject|2|||
105816318|NCT01520909|364986846|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
105816319|NCT01520909|364986847|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
105816320|NCT01520909|364986848|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
105362319|NCT02227784|363330213|FG002|Double-Blind Phase|Physician Decision|0|||
105362320|NCT02227784|363330214|FG003|Double-Blind Phase|Physician Decision|1|||
105362321|NCT02227784|363330215|FG004|Double-Blind Phase|Physician Decision|0|||
105362322|NCT02227784|363330211|FG000|Double-Blind Phase|Protocol Violation|0|||
105362323|NCT02227784|363330212|FG001|Double-Blind Phase|Protocol Violation|0|||
105362324|NCT02227784|363330213|FG002|Double-Blind Phase|Protocol Violation|1|||
105362325|NCT02227784|363330214|FG003|Double-Blind Phase|Protocol Violation|1|||
105362326|NCT02227784|363330215|FG004|Double-Blind Phase|Protocol Violation|0|||
105362327|NCT02227784|363330211|FG000|Double-Blind Phase|Sponsor Decision|34|||
105362328|NCT02227784|363330212|FG001|Double-Blind Phase|Sponsor Decision|15|||
105362329|NCT02227784|363330213|FG002|Double-Blind Phase|Sponsor Decision|14|||
105362330|NCT02227784|363330214|FG003|Double-Blind Phase|Sponsor Decision|32|||
105362331|NCT02227784|363330215|FG004|Double-Blind Phase|Sponsor Decision|0|||
105362332|NCT02227784|363330211|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
105362333|NCT02227784|363330212|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
105362334|NCT02227784|363330213|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
105362335|NCT02227784|363330214|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
105362336|NCT02227784|363330215|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
105362337|NCT02227784|363330211|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
105362338|NCT02227784|363330212|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
105362339|NCT02227784|363330213|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
105362340|NCT02227784|363330214|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
105362341|NCT02227784|363330215|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
105362342|NCT02227784|363330211|FG000|Open-Label Extension Phase (OLE)|Death|0|||
105362343|NCT02227784|363330212|FG001|Open-Label Extension Phase (OLE)|Death|0|||
105362344|NCT02227784|363330213|FG002|Open-Label Extension Phase (OLE)|Death|0|||
105362345|NCT02227784|363330214|FG003|Open-Label Extension Phase (OLE)|Death|0|||
105362346|NCT02227784|363330215|FG004|Open-Label Extension Phase (OLE)|Death|1|||
105362347|NCT02227784|363330211|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
105362348|NCT02227784|363330212|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
105362349|NCT02227784|363330213|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
105362350|NCT02227784|363330214|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
105362351|NCT02227784|363330215|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
105764632|NCT02133001|364791695|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
105764633|NCT02133001|364791696|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
105764634|NCT02133001|364791695|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
105764635|NCT02133001|364791696|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
105764636|NCT02133001|364791695|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
105764637|NCT02133001|364791696|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
105764638|NCT02133001|364791695|FG000|Double Blind (Day 1-25)|Other|2|||
105764639|NCT02133001|364791696|FG001|Double Blind (Day 1-25)|Other|2|||
105764640|NCT02133001|364791695|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
105764641|NCT02133001|364791696|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
105764642|NCT02133001|364791695|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
105764643|NCT02133001|364791696|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
105764644|NCT02133001|364791695|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
105764645|NCT02133001|364791696|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
105764646|NCT02133001|364791695|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
105764647|NCT02133001|364791696|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
105764648|NCT02062827|364791699|FG000|Overall Study|Death|1|||
105764649|NCT02062827|364791700|FG001|Overall Study|Death|0|||
105764650|NCT02062827|364791701|FG002|Overall Study|Death|0|||
105764651|NCT02062827|364791702|FG003|Overall Study|Death|0|||
105764652|NCT02062827|364791703|FG004|Overall Study|Death|0|||
105764653|NCT02062827|364791704|FG005|Overall Study|Death|0|||
105764654|NCT02062827|364791705|FG006|Overall Study|Death|0|||
105764655|NCT02062827|364791706|FG007|Overall Study|Death|0|||
105764656|NCT02062827|364791699|FG000|Overall Study|Withdrawal by Subject|3|||
105764657|NCT02062827|364791700|FG001|Overall Study|Withdrawal by Subject|1|||
105764658|NCT02062827|364791701|FG002|Overall Study|Withdrawal by Subject|1|||
105764659|NCT02062827|364791702|FG003|Overall Study|Withdrawal by Subject|2|||
105764660|NCT02062827|364791703|FG004|Overall Study|Withdrawal by Subject|6|||
105764661|NCT02062827|364791704|FG005|Overall Study|Withdrawal by Subject|0|||
105816321|NCT01520909|364986846|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
105816322|NCT01520909|364986847|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
105362352|NCT02227784|363330211|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
105362353|NCT02227784|363330212|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
105362354|NCT02227784|363330213|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
105764662|NCT02062827|364791705|FG006|Overall Study|Withdrawal by Subject|5|||
105764663|NCT02062827|364791706|FG007|Overall Study|Withdrawal by Subject|0|||
105764664|NCT02062827|364791699|FG000|Overall Study|Screen Fail|0|||
105764665|NCT02062827|364791700|FG001|Overall Study|Screen Fail|0|||
105764666|NCT02062827|364791701|FG002|Overall Study|Screen Fail|0|||
105764667|NCT02062827|364791702|FG003|Overall Study|Screen Fail|0|||
105764668|NCT02062827|364791703|FG004|Overall Study|Screen Fail|0|||
105816323|NCT01520909|364986848|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
105816324|NCT01520909|364986846|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
105816325|NCT01520909|364986847|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
105816326|NCT01520909|364986848|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
105816327|NCT01520909|364986846|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
105816328|NCT01520909|364986847|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
105816329|NCT01520909|364986848|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
105816330|NCT01882257|364986851|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
105816331|NCT01882257|364986852|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
105816332|NCT01882257|364986853|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
105816333|NCT01882257|364986851|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
105816334|NCT01882257|364986852|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
105816335|NCT01882257|364986853|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
105816336|NCT03478397|364986856|FG000|Overall Study|Refused to participate|31|||
105816337|NCT03478397|364986857|FG001|Overall Study|Refused to participate|7|||
105816338|NCT02942264|364986858|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
105816339|NCT02942264|364986859|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
105816340|NCT02942264|364986860|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
105816341|NCT02942264|364986861|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
105816342|NCT02942264|364986862|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
105816343|NCT02942264|364986863|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
105816344|NCT02942264|364986864|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
105816345|NCT02942264|364986865|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
105362355|NCT02227784|363330214|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
105362356|NCT02227784|363330215|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
105362357|NCT00992017|363330217|FG000|Overall Study|Lost to Follow-up|2|||
105362358|NCT00992017|363330217|FG000|Overall Study|Withdrawal by Subject|2|||
105362359|NCT00992017|363330217|FG000|Overall Study|Unable to get to clinic|5|||
105362360|NCT00992017|363330217|FG000|Overall Study|Not adhere to study requirements|1|||
105362361|NCT01827592|363330220|FG000|Overall Study|Adverse Event|11|||
105362362|NCT01827592|363330221|FG001|Overall Study|Adverse Event|9|||
105362363|NCT01827592|363330222|FG002|Overall Study|Adverse Event|2|||
105362364|NCT01827592|363330220|FG000|Overall Study|Physician Decision|0|||
105362365|NCT01827592|363330221|FG001|Overall Study|Physician Decision|2|||
105362366|NCT01827592|363330222|FG002|Overall Study|Physician Decision|1|||
105362367|NCT01827592|363330220|FG000|Overall Study|Protocol Violation|2|||
105362368|NCT01827592|363330221|FG001|Overall Study|Protocol Violation|1|||
105362369|NCT01827592|363330222|FG002|Overall Study|Protocol Violation|0|||
105486267|NCT02953509|363791460|FG006|Overall Study|Consent Withdrawn|4|||
105362370|NCT01827592|363330220|FG000|Overall Study|Lost to Follow-up|1|||
105362371|NCT01827592|363330221|FG001|Overall Study|Lost to Follow-up|2|||
105362372|NCT01827592|363330222|FG002|Overall Study|Lost to Follow-up|2|||
105816346|NCT02942264|364986866|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
105816347|NCT02942264|364986858|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816348|NCT02942264|364986859|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816349|NCT02942264|364986860|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816350|NCT02942264|364986861|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816351|NCT02942264|364986862|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816352|NCT02942264|364986863|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816353|NCT02942264|364986864|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816354|NCT02942264|364986865|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816355|NCT02942264|364986866|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
105816356|NCT02188303|364986867|FG000|Overall Study|Adverse Event|0|||
105816357|NCT02188303|364986868|FG001|Overall Study|Adverse Event|0|||
105816358|NCT02188303|364986869|FG002|Overall Study|Adverse Event|0|||
105816359|NCT02188303|364986870|FG003|Overall Study|Adverse Event|0|||
105816360|NCT02188303|364986871|FG004|Overall Study|Adverse Event|0|||
105816361|NCT02188303|364986872|FG005|Overall Study|Adverse Event|2|||
105816362|NCT02188303|364986873|FG006|Overall Study|Adverse Event|0|||
105816363|NCT02188303|364986874|FG007|Overall Study|Adverse Event|2|||
105764669|NCT02062827|364791704|FG005|Overall Study|Screen Fail|0|||
105764670|NCT02062827|364791705|FG006|Overall Study|Screen Fail|0|||
105764671|NCT02062827|364791706|FG007|Overall Study|Screen Fail|8|||
105764672|NCT02498392|364791707|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
105764673|NCT02498392|364791708|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
105764674|NCT02498392|364791707|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
105764675|NCT02498392|364791708|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
105764676|NCT02498392|364791707|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
105764677|NCT02498392|364791708|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
105764678|NCT02498392|364791707|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
105764679|NCT02498392|364791708|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
105764680|NCT02498392|364791707|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
105764681|NCT02498392|364791708|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
105764682|NCT02498392|364791707|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
105764683|NCT02498392|364791708|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
105764684|NCT03135262|364791710|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
105764685|NCT03135262|364791711|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
105764686|NCT03135262|364791712|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
105764687|NCT03135262|364791713|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
105764688|NCT03135262|364791714|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
105764689|NCT03135262|364791710|FG000|Overall Study|Progression of disease|0|||
105764690|NCT03135262|364791711|FG001|Overall Study|Progression of disease|0|||
105764691|NCT03135262|364791712|FG002|Overall Study|Progression of disease|0|||
105764692|NCT03135262|364791713|FG003|Overall Study|Progression of disease|1|||
105764693|NCT03135262|364791714|FG004|Overall Study|Progression of disease|0|||
105764694|NCT03135262|364791710|FG000|Overall Study|Death|6|||
105764695|NCT03135262|364791711|FG001|Overall Study|Death|2|||
105764696|NCT03135262|364791712|FG002|Overall Study|Death|2|||
105764697|NCT03135262|364791713|FG003|Overall Study|Death|2|||
105764698|NCT03135262|364791714|FG004|Overall Study|Death|0|||
105764699|NCT03135262|364791710|FG000|Overall Study|Withdrawal by Subject|0|||
105764700|NCT03135262|364791711|FG001|Overall Study|Withdrawal by Subject|0|||
105764701|NCT03135262|364791712|FG002|Overall Study|Withdrawal by Subject|1|||
105764702|NCT03135262|364791713|FG003|Overall Study|Withdrawal by Subject|0|||
105764703|NCT03135262|364791714|FG004|Overall Study|Withdrawal by Subject|1|||
105764704|NCT03135262|364791710|FG000|Overall Study|Study terminated by sponsor|2|||
105764705|NCT03135262|364791711|FG001|Overall Study|Study terminated by sponsor|4|||
105764706|NCT03135262|364791712|FG002|Overall Study|Study terminated by sponsor|4|||
105764707|NCT03135262|364791713|FG003|Overall Study|Study terminated by sponsor|3|||
105764708|NCT03135262|364791714|FG004|Overall Study|Study terminated by sponsor|0|||
105764709|NCT01266070|364791718|FG000|Overall Study|Adverse Event|3|||
105764710|NCT01266070|364791718|FG000|Overall Study|Protocol Violation|1|||
105764711|NCT03006926|364791719|FG000|Overall Study|Adverse Event|0|||
105764712|NCT03006926|364791720|FG001|Overall Study|Adverse Event|27|||
105764713|NCT03006926|364791719|FG000|Overall Study|Withdrawal by Subject|0|||
105764714|NCT03006926|364791720|FG001|Overall Study|Withdrawal by Subject|1|||
105764715|NCT03006926|364791719|FG000|Overall Study|Radiological Disease Progression|0|||
105486268|NCT02953509|363791461|FG007|Overall Study|Consent Withdrawn|1|||
105816364|NCT02188303|364986867|FG000|Overall Study|Dose Termination Criteria Met|0|||
105816365|NCT02188303|364986868|FG001|Overall Study|Dose Termination Criteria Met|0|||
105816366|NCT02188303|364986869|FG002|Overall Study|Dose Termination Criteria Met|0|||
105816367|NCT02188303|364986870|FG003|Overall Study|Dose Termination Criteria Met|0|||
105816368|NCT02188303|364986871|FG004|Overall Study|Dose Termination Criteria Met|0|||
105816369|NCT02188303|364986872|FG005|Overall Study|Dose Termination Criteria Met|0|||
105816370|NCT02188303|364986873|FG006|Overall Study|Dose Termination Criteria Met|2|||
105816371|NCT02188303|364986874|FG007|Overall Study|Dose Termination Criteria Met|4|||
105816372|NCT00856388|364986875|FG000|Overall Study|Other|1|||
105816373|NCT04091971|364986878|FG000|Overall Study|Withdrawal by Subject|1|||
105816374|NCT04091971|364986878|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
105816375|NCT04091971|364986878|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
105816376|NCT01720264|364986881|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
105816377|NCT01720264|364986881|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
105816378|NCT01720264|364986881|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
105816379|NCT04869787|364986882|FG000|Screening|Physician Decision|1|||
105816380|NCT04869787|364986882|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
105816381|NCT01387022|364986883|FG000|Overall Study|Death|1|||
105816382|NCT01387022|364986884|FG001|Overall Study|Death|1|||
105816383|NCT01387022|364986883|FG000|Overall Study|Lost to Follow-up|0|||
105816384|NCT01387022|364986884|FG001|Overall Study|Lost to Follow-up|3|||
105816385|NCT01496183|364986886|FG000|Overall Study|Physician Decision|3|||
105816386|NCT01496183|364986887|FG001|Overall Study|Physician Decision|1|||
105816387|NCT01496183|364986886|FG000|Overall Study|Withdrawal by Subject|0|||
105816388|NCT01496183|364986887|FG001|Overall Study|Withdrawal by Subject|1|||
105816389|NCT01376167|364986888|FG000|Overall Study|Lost to Follow-up|2|||
105816390|NCT01376167|364986889|FG001|Overall Study|Lost to Follow-up|4|||
105816391|NCT01376167|364986890|FG002|Overall Study|Lost to Follow-up|2|||
105816392|NCT01376167|364986888|FG000|Overall Study|Physician Decision|1|||
105816393|NCT01376167|364986889|FG001|Overall Study|Physician Decision|1|||
105816394|NCT01376167|364986890|FG002|Overall Study|Physician Decision|0|||
105816395|NCT01376167|364986888|FG000|Overall Study|Withdrawal by Subject|1|||
105816396|NCT01376167|364986889|FG001|Overall Study|Withdrawal by Subject|5|||
105816397|NCT01376167|364986890|FG002|Overall Study|Withdrawal by Subject|4|||
105816398|NCT04786184|364986891|FG000|Overall Study|Adverse Event|4|||
105816399|NCT04786184|364986892|FG001|Overall Study|Adverse Event|0|||
105816400|NCT04786184|364986891|FG000|Overall Study|Withdrawal by Subject|3|||
105816401|NCT04786184|364986892|FG001|Overall Study|Withdrawal by Subject|1|||
105816402|NCT04786184|364986891|FG000|Overall Study|Lost to Follow-up|4|||
105816403|NCT04786184|364986892|FG001|Overall Study|Lost to Follow-up|2|||
105816404|NCT03693430|364986895|FG000|Overall Study|Lost to Follow-up|3|||
105816405|NCT03693430|364986896|FG001|Overall Study|Lost to Follow-up|14|||
105816406|NCT03693430|364986895|FG000|Overall Study|Death|1|||
105816407|NCT03693430|364986896|FG001|Overall Study|Death|0|||
105816408|NCT03693430|364986895|FG000|Overall Study|Withdrawal by Subject|0|||
105816409|NCT03693430|364986896|FG001|Overall Study|Withdrawal by Subject|4|||
105816410|NCT00585689|364986897|FG000|Overall Study|Received different ABI-007 schedule|3|||
105816411|NCT00585689|364986897|FG000|Overall Study|Adverse Event|1|||
105816412|NCT00585689|364986897|FG000|Overall Study|Patient Declined Surgery|1|||
105816413|NCT00585689|364986897|FG000|Overall Study|Patient had unresectable disease|1|||
105816414|NCT00585689|364986897|FG000|Overall Study|Death|1|||
105816415|NCT02373098|364986898|FG000|Overall Study|Lost to Follow-up|1|||
105816416|NCT02373098|364986899|FG001|Overall Study|Lost to Follow-up|0|||
105816417|NCT02373098|364986898|FG000|Overall Study|Protocol Violation|3|||
105816418|NCT02373098|364986899|FG001|Overall Study|Protocol Violation|0|||
105816419|NCT02373098|364986898|FG000|Overall Study|Withdrawal by Subject|5|||
105816420|NCT02373098|364986899|FG001|Overall Study|Withdrawal by Subject|0|||
105816421|NCT02373098|364986898|FG000|Overall Study|Adverse Event|3|||
105816422|NCT02373098|364986899|FG001|Overall Study|Adverse Event|0|||
105816423|NCT05067647|364986903|FG000|Overall Study|Lost to Follow-up|1|||
105816424|NCT04185909|364986905|FG000|Overall Study|Lost to Follow-up|1|||
105816425|NCT01059903|364986906|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
105816426|NCT01059903|364986907|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
105816427|NCT03639311|364986908|FG000|Maintenance Phase|Lost to Follow-up|1|||
105816428|NCT03639311|364986909|FG001|Maintenance Phase|Lost to Follow-up|0|||
105816429|NCT03639311|364986910|FG002|Maintenance Phase|Lost to Follow-up|0|||
105816430|NCT03639311|364986908|FG000|Maintenance Phase|Adverse Event|1|||
105816431|NCT03639311|364986909|FG001|Maintenance Phase|Adverse Event|0|||
105816432|NCT03639311|364986910|FG002|Maintenance Phase|Adverse Event|0|||
105816433|NCT03639311|364986908|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
105816434|NCT03639311|364986909|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
105816435|NCT03639311|364986910|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
105816436|NCT03639311|364986908|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
105816437|NCT03639311|364986909|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
105816438|NCT03639311|364986910|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
105816439|NCT03639311|364986908|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
105816440|NCT03639311|364986909|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
105816441|NCT03639311|364986910|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
105816442|NCT03639311|364986908|FG000|Maintenance Phase|Lack of Efficacy|1|||
105816443|NCT03639311|364986909|FG001|Maintenance Phase|Lack of Efficacy|0|||
105816444|NCT03639311|364986910|FG002|Maintenance Phase|Lack of Efficacy|0|||
105816445|NCT04320849|364986913|FG000|Overall Study|Withdrawal by Subject|4|||
105816446|NCT04320849|364986913|FG000|Overall Study|Imaging data unavailable|2|||
105816447|NCT04320849|364986913|FG000|Overall Study|Incomplete imaging|2|||
105816448|NCT00214422|364986915|FG000|Overall Study|Physician Decision|2|||
105816449|NCT00214422|364986916|FG001|Overall Study|Physician Decision|0|||
105816450|NCT00214422|364986917|FG002|Overall Study|Physician Decision|0|||
105816451|NCT00214422|364986915|FG000|Overall Study|Developed esophageal ca|1|||
105816452|NCT00214422|364986916|FG001|Overall Study|Developed esophageal ca|0|||
105816453|NCT00214422|364986917|FG002|Overall Study|Developed esophageal ca|0|||
105816454|NCT00214422|364986915|FG000|Overall Study|Pt taken off study|1|||
105816455|NCT00214422|364986916|FG001|Overall Study|Pt taken off study|1|||
105816456|NCT00214422|364986917|FG002|Overall Study|Pt taken off study|0|||
105816457|NCT00214422|364986915|FG000|Overall Study|Disease progression on study|1|||
105816458|NCT00214422|364986916|FG001|Overall Study|Disease progression on study|0|||
105816459|NCT00214422|364986917|FG002|Overall Study|Disease progression on study|0|||
105816460|NCT00214422|364986915|FG000|Overall Study|Unable to make a radiation treatment|0|||
105816461|NCT00214422|364986916|FG001|Overall Study|Unable to make a radiation treatment|0|||
105816462|NCT00214422|364986917|FG002|Overall Study|Unable to make a radiation treatment|1|||
105816463|NCT00854100|364986918|FG000|Overall Study|Inability to complete the study visits|0|||
105816464|NCT00854100|364986919|FG001|Overall Study|Inability to complete the study visits|0|||
105816465|NCT00854100|364986920|FG002|Overall Study|Inability to complete the study visits|1|||
105816466|NCT00854100|364986918|FG000|Overall Study|Lost to Follow-up|2|||
105816467|NCT00854100|364986919|FG001|Overall Study|Lost to Follow-up|0|||
105816468|NCT00854100|364986920|FG002|Overall Study|Lost to Follow-up|3|||
105816469|NCT00854100|364986918|FG000|Overall Study|Withdrawal by Subject|3|||
105816470|NCT00854100|364986919|FG001|Overall Study|Withdrawal by Subject|1|||
105816471|NCT00854100|364986920|FG002|Overall Study|Withdrawal by Subject|2|||
105816472|NCT00854100|364986918|FG000|Overall Study|Protocol Violation|2|||
105816473|NCT00854100|364986919|FG001|Overall Study|Protocol Violation|4|||
105816474|NCT00854100|364986920|FG002|Overall Study|Protocol Violation|3|||
105816475|NCT00854100|364986918|FG000|Overall Study|Adverse Event|2|||
105816476|NCT00854100|364986919|FG001|Overall Study|Adverse Event|1|||
105816477|NCT00854100|364986920|FG002|Overall Study|Adverse Event|2|||
105816478|NCT00389064|364986921|FG000|Overall Study|Adverse Event|11|||
105816479|NCT00389064|364986922|FG001|Overall Study|Adverse Event|3|||
105816480|NCT00389064|364986921|FG000|Overall Study|Lack of Efficacy|3|||
105816481|NCT00389064|364986922|FG001|Overall Study|Lack of Efficacy|14|||
105816482|NCT00389064|364986921|FG000|Overall Study|Withdrawal by Subject|17|||
105816483|NCT00389064|364986922|FG001|Overall Study|Withdrawal by Subject|27|||
105816484|NCT00389064|364986921|FG000|Overall Study|Physician Decision|2|||
105816485|NCT00389064|364986922|FG001|Overall Study|Physician Decision|2|||
105816486|NCT00389064|364986921|FG000|Overall Study|Lost to Follow-up|1|||
105816487|NCT00389064|364986922|FG001|Overall Study|Lost to Follow-up|2|||
105816488|NCT00389064|364986921|FG000|Overall Study|Protocol Violation|2|||
105816489|NCT00389064|364986922|FG001|Overall Study|Protocol Violation|0|||
105816490|NCT00389064|364986921|FG000|Overall Study|Multiple Reasons|9|||
105816491|NCT00389064|364986922|FG001|Overall Study|Multiple Reasons|11|||
105816492|NCT04753437|364986927|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
105816493|NCT04753437|364986928|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
105816494|NCT04753437|364986927|FG000|Overall Study|Liver Function Test Abnormalities|2|||
105816495|NCT04753437|364986928|FG001|Overall Study|Liver Function Test Abnormalities|4|||
105816496|NCT02920996|364986929|FG000|Overall Study|Adverse Event|8|||
105816497|NCT02920996|364986930|FG001|Overall Study|Adverse Event|0|||
105816498|NCT02920996|364986929|FG000|Overall Study|Physician Decision|1|||
105816499|NCT02920996|364986930|FG001|Overall Study|Physician Decision|0|||
105816500|NCT02920996|364986929|FG000|Overall Study|Death|1|||
105816501|NCT02920996|364986930|FG001|Overall Study|Death|0|||
105816502|NCT02920996|364986929|FG000|Overall Study|Missing|1|||
105816503|NCT02920996|364986930|FG001|Overall Study|Missing|0|||
105816504|NCT02920996|364986929|FG000|Overall Study|Subject Non-Compliance|1|||
105816505|NCT02920996|364986930|FG001|Overall Study|Subject Non-Compliance|0|||
105816506|NCT02272777|364986931|FG000|Overall Study|Adverse Event|0|||
105816507|NCT02272777|364986932|FG001|Overall Study|Adverse Event|1|||
105816508|NCT02272777|364986931|FG000|Overall Study|Withdrawal by Subject|0|||
105816509|NCT02272777|364986932|FG001|Overall Study|Withdrawal by Subject|3|||
105816510|NCT02272777|364986931|FG000|Overall Study|Lost to Follow-up|2|||
105816511|NCT02272777|364986932|FG001|Overall Study|Lost to Follow-up|0|||
105816512|NCT02272777|364986931|FG000|Overall Study|Other|2|||
105816513|NCT02272777|364986932|FG001|Overall Study|Other|0|||
105816514|NCT02066922|364986933|FG000|Overall Study|Adverse Event|1|||
105816515|NCT00440297|364986935|FG000|Overall Study|Adverse Event|8|||
105816516|NCT00440297|364986936|FG001|Overall Study|Adverse Event|5|||
105816517|NCT00440297|364986935|FG000|Overall Study|Lost to Follow-up|1|||
105816518|NCT00440297|364986936|FG001|Overall Study|Lost to Follow-up|0|||
105816519|NCT00440297|364986935|FG000|Overall Study|Physician Decision|1|||
105816520|NCT00440297|364986936|FG001|Overall Study|Physician Decision|0|||
105816521|NCT00440297|364986935|FG000|Overall Study|Protocol Violation|11|||
105816522|NCT00440297|364986936|FG001|Overall Study|Protocol Violation|7|||
105816523|NCT00440297|364986935|FG000|Overall Study|Withdrawal by Subject|1|||
105816524|NCT00440297|364986936|FG001|Overall Study|Withdrawal by Subject|6|||
105816525|NCT00440297|364986935|FG000|Overall Study|Randomized by mistake|1|||
105816526|NCT00440297|364986936|FG001|Overall Study|Randomized by mistake|0|||
105816527|NCT03567174|364986937|FG000|Overall Study|Death|24|||
105816528|NCT03567174|364986938|FG001|Overall Study|Death|31|||
105816529|NCT03567174|364986937|FG000|Overall Study|Lost to Follow-up|165|||
105816530|NCT03567174|364986938|FG001|Overall Study|Lost to Follow-up|174|||
105816531|NCT03243630|364986939|FG000|Overall Study|Protocol Violation|1|||
105816532|NCT03243630|364986939|FG000|Overall Study|Physician Decision|1|||
105816533|NCT03707912|364986940|FG000|Overall Study|Violation of inclusion criteria|1|||
105816534|NCT03707912|364986941|FG001|Overall Study|Violation of inclusion criteria|0|||
105816535|NCT01085045|364988236|FG000|Part A|Withdrawal by Subject|4|||
105816536|NCT01085045|364988236|FG000|Part A|Adverse Event|6|||
105816537|NCT01085045|364988236|FG000|Part A|Protocol Violation|1|||
105816538|NCT01085045|364988236|FG000|Part A|Protocol Specified Criteria|7|||
105816539|NCT01085045|364988236|FG000|Part B|Withdrawal by Subject|2|||
105816540|NCT01085045|364988236|FG000|Part B|Protocol Specified Criteria|6|||
105816541|NCT01085045|364988236|FG000|Part B|Lost to Follow-up|1|||
105816542|NCT01085045|364988236|FG000|Part B|Adverse Event|6|||
105816543|NCT01248247|364988237|FG000|Overall Study|Adverse Event|2|||
105816544|NCT01248247|364988238|FG001|Overall Study|Adverse Event|4|||
105816545|NCT01248247|364988239|FG002|Overall Study|Adverse Event|4|||
105816546|NCT01248247|364988240|FG003|Overall Study|Adverse Event|2|||
105816547|NCT01248247|364988237|FG000|Overall Study|Death|0|||
105816548|NCT01248247|364988238|FG001|Overall Study|Death|1|||
105816549|NCT01248247|364988239|FG002|Overall Study|Death|4|||
105816550|NCT01248247|364988240|FG003|Overall Study|Death|7|||
105816551|NCT01248247|364988237|FG000|Overall Study|Lost to Follow-up|0|||
105486269|NCT02953509|363791462|FG008|Overall Study|Consent Withdrawn|1|||
105486270|NCT02953509|363791463|FG009|Overall Study|Consent Withdrawn|4|||
105816552|NCT01248247|364988238|FG001|Overall Study|Lost to Follow-up|1|||
105816553|NCT01248247|364988239|FG002|Overall Study|Lost to Follow-up|1|||
105816554|NCT01248247|364988240|FG003|Overall Study|Lost to Follow-up|0|||
105816555|NCT01248247|364988237|FG000|Overall Study|Alternative treatment|0|||
105816556|NCT01248247|364988238|FG001|Overall Study|Alternative treatment|1|||
105816557|NCT01248247|364988239|FG002|Overall Study|Alternative treatment|0|||
105816558|NCT01248247|364988240|FG003|Overall Study|Alternative treatment|0|||
105816559|NCT01248247|364988237|FG000|Overall Study|Other|2|||
105816560|NCT01248247|364988238|FG001|Overall Study|Other|8|||
105816561|NCT01248247|364988239|FG002|Overall Study|Other|8|||
105816562|NCT01248247|364988240|FG003|Overall Study|Other|5|||
105816563|NCT01248247|364988237|FG000|Overall Study|Progression|18|||
105816564|NCT01248247|364988238|FG001|Overall Study|Progression|27|||
105816565|NCT01248247|364988239|FG002|Overall Study|Progression|56|||
105816566|NCT01248247|364988240|FG003|Overall Study|Progression|44|||
105816567|NCT01248247|364988237|FG000|Overall Study|Refuse further treatment|0|||
105816568|NCT01248247|364988238|FG001|Overall Study|Refuse further treatment|0|||
105816569|NCT01248247|364988239|FG002|Overall Study|Refuse further treatment|1|||
105816570|NCT01248247|364988240|FG003|Overall Study|Refuse further treatment|2|||
105816571|NCT01248247|364988237|FG000|Overall Study|Complicating disease|0|||
105816572|NCT01248247|364988238|FG001|Overall Study|Complicating disease|0|||
105816573|NCT01248247|364988239|FG002|Overall Study|Complicating disease|1|||
105816574|NCT01248247|364988240|FG003|Overall Study|Complicating disease|1|||
105816575|NCT02817841|364988244|FG000|Overall Study|Lost to Follow-up|287|||
105816576|NCT02817841|364988244|FG000|Overall Study|Withdrawal by Subject|183|||
105816577|NCT02817841|364988244|FG000|Overall Study|Adverse event not related to bleeding|131|||
105816578|NCT02817841|364988244|FG000|Overall Study|Adverse event related to bleeding|51|||
105816579|NCT02817841|364988244|FG000|Overall Study|Pregnancy|32|||
105816580|NCT02817841|364988244|FG000|Overall Study|Pregnancy wish|17|||
105816581|NCT02817841|364988244|FG000|Overall Study|Other reasons|53|||
105816582|NCT02817841|364988244|FG000|Overall Study|Protocol Violation|94|||
105816583|NCT04349917|364988247|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
105816584|NCT04349917|364988248|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
105816585|NCT04349917|364988247|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
105816586|NCT04349917|364988248|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
105816587|NCT00705536|364988249|FG000|Start Period 1|Withdrawal by Subject|0|||
105816588|NCT00705536|364988250|FG001|Start Period 1|Withdrawal by Subject|0|||
105816589|NCT00705536|364988251|FG002|Start Period 1|Withdrawal by Subject|0|||
105816590|NCT00705536|364988252|FG003|Start Period 1|Withdrawal by Subject|1|||
105816591|NCT04188106|364988253|FG000|Overall Study|Lost to Follow-up|5|||
105816592|NCT04188106|364988253|FG000|Overall Study|Non-Compliance|1|||
105816593|NCT00441467|364988259|FG000|Overall Study|Adverse Event|6|||
105816594|NCT00441467|364988259|FG000|Overall Study|Withdrawal by Subject|3|||
105816595|NCT00441467|364988259|FG000|Overall Study|Progressive disease|9|||
105816596|NCT00420303|364988260|FG000|Overall Study|Serious Adverse Event|1|||
105816597|NCT00420303|364988261|FG001|Overall Study|Serious Adverse Event|0|||
105816598|NCT00420303|364988260|FG000|Overall Study|Lack of Efficacy|0|||
105816599|NCT00420303|364988261|FG001|Overall Study|Lack of Efficacy|3|||
105816600|NCT00420303|364988260|FG000|Overall Study|Physician Decision|0|||
105816601|NCT00420303|364988261|FG001|Overall Study|Physician Decision|1|||
105816602|NCT01948258|364988262|FG000|Overall Study|Pregnancy|41|||
105816603|NCT01948258|364988262|FG000|Overall Study|Did not complete by cut-off date|35|||
105816604|NCT01948258|364988262|FG000|Overall Study|Lost to Follow-up|27|||
105816605|NCT01948258|364988262|FG000|Overall Study|Withdrawal by SPD|8|||
105816606|NCT01948258|364988262|FG000|Overall Study|Withdrawal by Subject|6|||
105816607|NCT01948258|364988262|FG000|Overall Study|Health Care Professional|43|||
105816608|NCT01948258|364988262|FG000|Overall Study|Removed from statistical analysis|2|||
105816609|NCT04657770|364988266|FG000|Overall Study|Withdrawal by Subject|3|||
105816610|NCT04657770|364988266|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
105816611|NCT00088829|364988267|FG000|Overall Study|PI left institution and study was close|22|||
105816612|NCT00365300|364988271|FG000|Open-label Phase|Adverse Event|4|||
105816613|NCT00365300|364988272|FG001|Open-label Phase|Adverse Event|0|||
105816614|NCT00365300|364988271|FG000|Open-label Phase|Failed to Return|1|||
105816615|NCT00365300|364988272|FG001|Open-label Phase|Failed to Return|0|||
105816616|NCT00365300|364988271|FG000|Open-label Phase|Physician Decision|1|||
105816617|NCT00365300|364988272|FG001|Open-label Phase|Physician Decision|0|||
105816618|NCT00365300|364988271|FG000|Open-label Phase|Noncompliance|9|||
105816619|NCT00365300|364988272|FG001|Open-label Phase|Noncompliance|0|||
105816620|NCT00365300|364988271|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
105362373|NCT01827592|363330220|FG000|Overall Study|Withdrawal by Subject|12|||
105816621|NCT00365300|364988272|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
105816622|NCT00365300|364988271|FG000|Open-label Phase|Protocol Violation|1|||
105816623|NCT00365300|364988272|FG001|Open-label Phase|Protocol Violation|0|||
105816624|NCT00365300|364988271|FG000|Open-label Phase|Lack of Efficacy|1|||
105362374|NCT01827592|363330221|FG001|Overall Study|Withdrawal by Subject|11|||
105816625|NCT00365300|364988272|FG001|Open-label Phase|Lack of Efficacy|0|||
105816626|NCT00365300|364988271|FG000|Open-label Phase|Patient skipped open label phase|1|||
105362375|NCT01827592|363330222|FG002|Overall Study|Withdrawal by Subject|11|||
105362376|NCT01827592|363330220|FG000|Overall Study|Patient's substantial non-compliance|1|||
105362377|NCT01827592|363330221|FG001|Overall Study|Patient's substantial non-compliance|1|||
105362378|NCT01827592|363330222|FG002|Overall Study|Patient's substantial non-compliance|6|||
105362379|NCT01827592|363330220|FG000|Overall Study|Trial terminated by Sponsor|47|||
105816627|NCT00365300|364988272|FG001|Open-label Phase|Patient skipped open label phase|0|||
105816628|NCT00365300|364988271|FG000|Double-blind Phase|Failed to return|1|||
105816629|NCT00365300|364988272|FG001|Double-blind Phase|Failed to return|0|||
105764716|NCT03006926|364791720|FG001|Overall Study|Radiological Disease Progression|52|||
105764717|NCT03006926|364791719|FG000|Overall Study|Clinical Disease Progression|0|||
105764718|NCT03006926|364791720|FG001|Overall Study|Clinical Disease Progression|10|||
105764719|NCT03006926|364791719|FG000|Overall Study|Other|0|||
105764720|NCT03006926|364791720|FG001|Overall Study|Other|8|||
105764721|NCT04882072|364791721|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
105764722|NCT04882072|364791722|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
105764723|NCT04882072|364791721|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
105764724|NCT04882072|364791722|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
105764725|NCT04882072|364791721|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
105764726|NCT04882072|364791722|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
105764727|NCT03185819|364791727|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
105764728|NCT03185819|364791728|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
105764729|NCT03185819|364791729|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
105764730|NCT03185819|364791730|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
105764731|NCT03185819|364791727|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
105764732|NCT03185819|364791728|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
105764733|NCT03185819|364791729|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
105764734|NCT03185819|364791730|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
105764735|NCT03185819|364791727|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
105764736|NCT03185819|364791728|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
105764737|NCT03185819|364791729|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
105764738|NCT03185819|364791730|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
105764739|NCT03185819|364791727|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
105764740|NCT03185819|364791728|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
105764741|NCT03185819|364791729|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
105764742|NCT03185819|364791730|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
105764743|NCT03185819|364791727|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
105764744|NCT03185819|364791728|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
105764745|NCT03185819|364791729|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
105764746|NCT03185819|364791730|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
105764747|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
105764748|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
105764749|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
105764750|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
105764751|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
105764752|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
105764753|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
105764754|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
105764755|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
105764756|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
105764757|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
105764758|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
105764759|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
105764760|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
105764761|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
105764762|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
105764763|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
105764764|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
105764765|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
105764766|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
105764767|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
105764768|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
105764769|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
105764770|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
105764771|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
105764772|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
105764773|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
105764774|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
105764775|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
105816630|NCT00365300|364988271|FG000|Double-blind Phase|Noncompliance|1|||
105816631|NCT00365300|364988272|FG001|Double-blind Phase|Noncompliance|1|||
105816632|NCT00365300|364988271|FG000|Double-blind Phase|Withdrawal by Subject|0|||
105816633|NCT00365300|364988272|FG001|Double-blind Phase|Withdrawal by Subject|1|||
105816634|NCT00365300|364988271|FG000|Double-blind Phase|Protocol Violation|3|||
105816635|NCT00365300|364988272|FG001|Double-blind Phase|Protocol Violation|1|||
105816636|NCT00365300|364988271|FG000|Double-blind Phase|Lack of Efficacy|6|||
105816637|NCT00365300|364988272|FG001|Double-blind Phase|Lack of Efficacy|6|||
105816638|NCT00274937|364988273|FG000|Overall Study|Physician Decision|10|||
105816639|NCT00274937|364988273|FG000|Overall Study|Withdrawal by Subject|6|||
105816640|NCT00274937|364988273|FG000|Overall Study|Progressive Disease|4|||
105816641|NCT01367457|364988275|FG000|Overall Study|Death|2|||
105816642|NCT01367457|364988276|FG001|Overall Study|Death|0|||
105816643|NCT01367457|364988277|FG002|Overall Study|Death|0|||
105816644|NCT01367457|364988275|FG000|Overall Study|Investigator's decision|2|||
105816645|NCT01367457|364988276|FG001|Overall Study|Investigator's decision|0|||
105816646|NCT01367457|364988277|FG002|Overall Study|Investigator's decision|0|||
105816647|NCT01367457|364988275|FG000|Overall Study|Clinical decline (CD)|2|||
105816648|NCT01367457|364988276|FG001|Overall Study|Clinical decline (CD)|0|||
105816649|NCT01367457|364988277|FG002|Overall Study|Clinical decline (CD)|0|||
105816650|NCT01367457|364988275|FG000|Overall Study|Progression and death|8|||
105816651|NCT01367457|364988276|FG001|Overall Study|Progression and death|0|||
105816652|NCT01367457|364988277|FG002|Overall Study|Progression and death|0|||
105816653|NCT01367457|364988275|FG000|Overall Study|Toxicity|16|||
105816654|NCT01367457|364988276|FG001|Overall Study|Toxicity|0|||
105816655|NCT01367457|364988277|FG002|Overall Study|Toxicity|0|||
105816656|NCT01367457|364988275|FG000|Overall Study|Progression|137|||
105816657|NCT01367457|364988276|FG001|Overall Study|Progression|0|||
105816658|NCT01367457|364988277|FG002|Overall Study|Progression|0|||
105816659|NCT01367457|364988275|FG000|Overall Study|Patient asks for rest + slow progression|1|||
105816660|NCT01367457|364988276|FG001|Overall Study|Patient asks for rest + slow progression|0|||
105816661|NCT01367457|364988277|FG002|Overall Study|Patient asks for rest + slow progression|0|||
105816662|NCT01367457|364988275|FG000|Overall Study|Investigator's opinion, stable disease|1|||
105816663|NCT01367457|364988276|FG001|Overall Study|Investigator's opinion, stable disease|0|||
105816664|NCT01367457|364988277|FG002|Overall Study|Investigator's opinion, stable disease|0|||
105816665|NCT01367457|364988275|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
105816666|NCT01367457|364988276|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
105816667|NCT01367457|364988277|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
105816668|NCT01367457|364988275|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
105816669|NCT01367457|364988276|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
105816670|NCT01367457|364988277|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
105816671|NCT01367457|364988275|FG000|Overall Study|low grade toxicities + stable disease|1|||
105816672|NCT01367457|364988276|FG001|Overall Study|low grade toxicities + stable disease|0|||
105816673|NCT01367457|364988277|FG002|Overall Study|low grade toxicities + stable disease|0|||
105816674|NCT01367457|364988275|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
105816675|NCT01367457|364988276|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
105816676|NCT01367457|364988277|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
105816677|NCT01367457|364988275|FG000|Overall Study|Withdrawal by Subject|1|||
105816678|NCT01367457|364988276|FG001|Overall Study|Withdrawal by Subject|0|||
105816679|NCT01367457|364988277|FG002|Overall Study|Withdrawal by Subject|0|||
105816680|NCT01367457|364988275|FG000|Overall Study|CD, associated leukaemia|1|||
105816681|NCT01367457|364988276|FG001|Overall Study|CD, associated leukaemia|0|||
105816682|NCT01367457|364988277|FG002|Overall Study|CD, associated leukaemia|0|||
105816683|NCT01367457|364988275|FG000|Overall Study|Uncontrolled pain|1|||
105816684|NCT01367457|364988276|FG001|Overall Study|Uncontrolled pain|0|||
105816685|NCT01367457|364988277|FG002|Overall Study|Uncontrolled pain|0|||
105816686|NCT01367457|364988275|FG000|Overall Study|Overall status worsens to grade 4|1|||
105816687|NCT01367457|364988276|FG001|Overall Study|Overall status worsens to grade 4|0|||
105816688|NCT01367457|364988277|FG002|Overall Study|Overall status worsens to grade 4|0|||
105816689|NCT01367457|364988275|FG000|Overall Study|Stabilisation + frequent infections|1|||
105816690|NCT01367457|364988276|FG001|Overall Study|Stabilisation + frequent infections|0|||
105816691|NCT01367457|364988277|FG002|Overall Study|Stabilisation + frequent infections|0|||
105816692|NCT01367457|364988275|FG000|Overall Study|No clinical benefit|1|||
105816693|NCT01367457|364988276|FG001|Overall Study|No clinical benefit|0|||
105816694|NCT01367457|364988277|FG002|Overall Study|No clinical benefit|0|||
105816695|NCT01367457|364988275|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
105816696|NCT01367457|364988276|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
105486271|NCT02953509|363791454|FG000|Overall Study|Lost to Follow-up|0|||
105816697|NCT01367457|364988277|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
105816698|NCT01367457|364988275|FG000|Overall Study|Overall decline|1|||
105816699|NCT01367457|364988276|FG001|Overall Study|Overall decline|0|||
105816700|NCT01367457|364988277|FG002|Overall Study|Overall decline|0|||
105486272|NCT02953509|363791455|FG001|Overall Study|Lost to Follow-up|0|||
105486273|NCT02953509|363791456|FG002|Overall Study|Lost to Follow-up|0|||
105816701|NCT01367457|364988275|FG000|Overall Study|Rejection of treatment|1|||
105816702|NCT01367457|364988276|FG001|Overall Study|Rejection of treatment|0|||
105816703|NCT01367457|364988277|FG002|Overall Study|Rejection of treatment|0|||
105816704|NCT01367457|364988275|FG000|Overall Study|Lost to Follow-up|1|||
105816705|NCT01367457|364988276|FG001|Overall Study|Lost to Follow-up|0|||
105816706|NCT01367457|364988277|FG002|Overall Study|Lost to Follow-up|0|||
105816707|NCT01367457|364988275|FG000|Overall Study|Death from septic shock|1|||
105816708|NCT01367457|364988276|FG001|Overall Study|Death from septic shock|0|||
105816709|NCT01367457|364988277|FG002|Overall Study|Death from septic shock|0|||
105816710|NCT01367457|364988275|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
105816711|NCT01367457|364988276|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
105816712|NCT01367457|364988277|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
105816713|NCT01367457|364988275|FG000|Overall Study|Patient's Wish|1|||
105816714|NCT01367457|364988276|FG001|Overall Study|Patient's Wish|0|||
105816715|NCT01367457|364988277|FG002|Overall Study|Patient's Wish|0|||
105816716|NCT01367457|364988275|FG000|Overall Study|Palliative. Overall decline|1|||
105816717|NCT01367457|364988276|FG001|Overall Study|Palliative. Overall decline|0|||
105816718|NCT01367457|364988277|FG002|Overall Study|Palliative. Overall decline|0|||
105816719|NCT01367457|364988275|FG000|Overall Study|Suspected DP/suspected active infection|1|||
105816720|NCT01367457|364988276|FG001|Overall Study|Suspected DP/suspected active infection|0|||
105816721|NCT01367457|364988277|FG002|Overall Study|Suspected DP/suspected active infection|0|||
105816722|NCT02058498|364988278|FG000|Overall Study|Withdrawal by Subject|4|||
105816723|NCT01449630|364988281|FG000|Period 1|Physician Decision|1|||
105816724|NCT01449630|364988282|FG001|Period 1|Physician Decision|0|||
105816725|NCT01449630|364988283|FG002|Period 1|Physician Decision|0|||
105816726|NCT01449630|364988284|FG003|Period 1|Physician Decision|1|||
105816727|NCT01449630|364988285|FG004|Period 1|Physician Decision|0|||
105816728|NCT01449630|364988286|FG005|Period 1|Physician Decision|0|||
105816729|NCT01449630|364988287|FG006|Period 1|Physician Decision|0|||
105816730|NCT01449630|364988288|FG007|Period 1|Physician Decision|0|||
105816731|NCT01449630|364988289|FG008|Period 1|Physician Decision|0|||
105816732|NCT01449630|364988281|FG000|Period 1|Sponsor Decision|0|||
105816733|NCT01449630|364988282|FG001|Period 1|Sponsor Decision|0|||
105816734|NCT01449630|364988283|FG002|Period 1|Sponsor Decision|0|||
105816735|NCT01449630|364988284|FG003|Period 1|Sponsor Decision|0|||
105816736|NCT01449630|364988285|FG004|Period 1|Sponsor Decision|0|||
105816737|NCT01449630|364988286|FG005|Period 1|Sponsor Decision|1|||
105816738|NCT01449630|364988287|FG006|Period 1|Sponsor Decision|0|||
105816739|NCT01449630|364988288|FG007|Period 1|Sponsor Decision|0|||
105816740|NCT01449630|364988289|FG008|Period 1|Sponsor Decision|0|||
105816741|NCT01449630|364988281|FG000|Period 2|Sponsor Decision|0|||
105816742|NCT01449630|364988282|FG001|Period 2|Sponsor Decision|0|||
105816743|NCT01449630|364988283|FG002|Period 2|Sponsor Decision|0|||
105816744|NCT01449630|364988284|FG003|Period 2|Sponsor Decision|0|||
105816745|NCT01449630|364988285|FG004|Period 2|Sponsor Decision|0|||
105816746|NCT01449630|364988286|FG005|Period 2|Sponsor Decision|0|||
105816747|NCT01449630|364988287|FG006|Period 2|Sponsor Decision|1|||
105816748|NCT01449630|364988288|FG007|Period 2|Sponsor Decision|0|||
105816749|NCT01449630|364988289|FG008|Period 2|Sponsor Decision|0|||
105816750|NCT01389102|364988290|FG000|Overall Study|Adverse Event|1|||
105816751|NCT01389102|364988291|FG001|Overall Study|Adverse Event|3|||
105816752|NCT01389102|364988292|FG002|Overall Study|Adverse Event|2|||
105816753|NCT01389102|364988293|FG003|Overall Study|Adverse Event|2|||
105816754|NCT01389102|364988294|FG004|Overall Study|Adverse Event|2|||
105816755|NCT01389102|364988295|FG005|Overall Study|Adverse Event|2|||
105816756|NCT01389102|364988290|FG000|Overall Study|Hurricane Katrina|4|||
105816757|NCT01389102|364988291|FG001|Overall Study|Hurricane Katrina|2|||
105816758|NCT01389102|364988292|FG002|Overall Study|Hurricane Katrina|3|||
105816759|NCT01389102|364988293|FG003|Overall Study|Hurricane Katrina|0|||
105816760|NCT01389102|364988294|FG004|Overall Study|Hurricane Katrina|3|||
105816761|NCT01389102|364988295|FG005|Overall Study|Hurricane Katrina|1|||
105816762|NCT01389102|364988290|FG000|Overall Study|Lost to Follow-up|4|||
105816763|NCT01389102|364988291|FG001|Overall Study|Lost to Follow-up|1|||
105816764|NCT01389102|364988292|FG002|Overall Study|Lost to Follow-up|1|||
105816765|NCT01389102|364988293|FG003|Overall Study|Lost to Follow-up|2|||
105816766|NCT01389102|364988294|FG004|Overall Study|Lost to Follow-up|4|||
105816767|NCT01389102|364988295|FG005|Overall Study|Lost to Follow-up|1|||
105816768|NCT01389102|364988290|FG000|Overall Study|Protocol Violation|0|||
105816769|NCT01389102|364988291|FG001|Overall Study|Protocol Violation|0|||
105816770|NCT01389102|364988292|FG002|Overall Study|Protocol Violation|3|||
105816771|NCT01389102|364988293|FG003|Overall Study|Protocol Violation|0|||
105816772|NCT01389102|364988294|FG004|Overall Study|Protocol Violation|1|||
105816773|NCT01389102|364988295|FG005|Overall Study|Protocol Violation|1|||
105816774|NCT01389102|364988290|FG000|Overall Study|Withdrawal by Subject|7|||
105816775|NCT01389102|364988291|FG001|Overall Study|Withdrawal by Subject|4|||
105816776|NCT01389102|364988292|FG002|Overall Study|Withdrawal by Subject|9|||
105816777|NCT01389102|364988293|FG003|Overall Study|Withdrawal by Subject|2|||
105816778|NCT01389102|364988294|FG004|Overall Study|Withdrawal by Subject|3|||
105816779|NCT01389102|364988295|FG005|Overall Study|Withdrawal by Subject|3|||
105816780|NCT01389102|364988290|FG000|Overall Study|Subject Traveling Out of Country|0|||
105816781|NCT01389102|364988291|FG001|Overall Study|Subject Traveling Out of Country|0|||
105816782|NCT01389102|364988292|FG002|Overall Study|Subject Traveling Out of Country|0|||
105816783|NCT01389102|364988293|FG003|Overall Study|Subject Traveling Out of Country|1|||
105816784|NCT01389102|364988294|FG004|Overall Study|Subject Traveling Out of Country|0|||
105816785|NCT01389102|364988295|FG005|Overall Study|Subject Traveling Out of Country|0|||
105816786|NCT01389102|364988290|FG000|Overall Study|Subject Moved|2|||
105816787|NCT01389102|364988291|FG001|Overall Study|Subject Moved|0|||
105816788|NCT01389102|364988292|FG002|Overall Study|Subject Moved|1|||
105816789|NCT01389102|364988293|FG003|Overall Study|Subject Moved|0|||
105816790|NCT01389102|364988294|FG004|Overall Study|Subject Moved|0|||
105816791|NCT01389102|364988295|FG005|Overall Study|Subject Moved|0|||
105816792|NCT01389102|364988290|FG000|Overall Study|Unavailable due to husband's illness|0|||
105816793|NCT01389102|364988291|FG001|Overall Study|Unavailable due to husband's illness|1|||
105816794|NCT01389102|364988292|FG002|Overall Study|Unavailable due to husband's illness|0|||
105816795|NCT01389102|364988293|FG003|Overall Study|Unavailable due to husband's illness|0|||
105816796|NCT01389102|364988294|FG004|Overall Study|Unavailable due to husband's illness|0|||
105816797|NCT01389102|364988295|FG005|Overall Study|Unavailable due to husband's illness|0|||
105816798|NCT01389102|364988290|FG000|Overall Study|Investigator Judgement|0|||
105816799|NCT01389102|364988291|FG001|Overall Study|Investigator Judgement|1|||
105816800|NCT01389102|364988292|FG002|Overall Study|Investigator Judgement|0|||
105816801|NCT01389102|364988293|FG003|Overall Study|Investigator Judgement|0|||
105816802|NCT01389102|364988294|FG004|Overall Study|Investigator Judgement|0|||
105816803|NCT01389102|364988295|FG005|Overall Study|Investigator Judgement|0|||
105816804|NCT00553280|364988299|FG000|Overall Study|Adverse Event|19|||
105816805|NCT00553280|364988299|FG000|Overall Study|Lack of Efficacy|3|||
105816806|NCT00553280|364988299|FG000|Overall Study|Withdrawal by Subject|3|||
105816807|NCT00553280|364988299|FG000|Overall Study|Physician Decision|1|||
105816808|NCT01182415|364988300|FG000|Overall Study|Lost to Follow-up|1|||
105816809|NCT00454909|364988301|FG000|Overall Study|Withdrawal by Subject|1|||
105816810|NCT00454909|364988302|FG001|Overall Study|Withdrawal by Subject|0|||
105816811|NCT00454909|364988303|FG002|Overall Study|Withdrawal by Subject|0|||
105816812|NCT00454909|364988301|FG000|Overall Study|Migrated/moved from study area|0|||
105816813|NCT00454909|364988302|FG001|Overall Study|Migrated/moved from study area|0|||
105816814|NCT00454909|364988303|FG002|Overall Study|Migrated/moved from study area|1|||
105816815|NCT00454909|364988301|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
105816816|NCT00454909|364988302|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
105816817|NCT00454909|364988303|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
105816818|NCT00454909|364988301|FG000|Overall Study|Others|1|||
105816819|NCT00454909|364988302|FG001|Overall Study|Others|0|||
105816820|NCT00454909|364988303|FG002|Overall Study|Others|0|||
105816821|NCT02996682|364988304|FG000|Overall Study|Death|0|||
105816822|NCT02996682|364988305|FG001|Overall Study|Death|3|||
105816823|NCT02457520|364988306|FG000|Active Treatment Phase|Adverse Event|10|||
105816824|NCT02457520|364988306|FG000|Active Treatment Phase|Lost to Follow-up|8|||
105816825|NCT02457520|364988306|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
105816826|NCT02457520|364988306|FG000|Active Treatment Phase|other|4|||
105816827|NCT02457520|364988306|FG000|Active Treatment Phase|Physician Decision|1|||
105816828|NCT02457520|364988306|FG000|Active Treatment Phase|Protocol Violation|1|||
105816829|NCT02457520|364988306|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
105816830|NCT02457520|364988306|FG000|Post-treatment Period|Other: Retreatment Required|7|||
105816831|NCT02457520|364988306|FG000|Post-treatment Period|Lost to Follow-up|23|||
105816832|NCT02457520|364988306|FG000|Post-treatment Period|Other|3|||
105816833|NCT02457520|364988306|FG000|Post-treatment Period|Physician Decision|1|||
105816834|NCT02457520|364988306|FG000|Post-treatment Period|Withdrawal by Subject|14|||
105816835|NCT02587962|364988307|FG000|Overall Study|Adverse Event|0|||
105816836|NCT02587962|364988308|FG001|Overall Study|Adverse Event|0|||
105816837|NCT02587962|364988309|FG002|Overall Study|Adverse Event|1|||
105816838|NCT02587962|364988310|FG003|Overall Study|Adverse Event|0|||
105571642|NCT00332332|364092714|FG000|Overall Study|Physician Decision|1|||
105816839|NCT02587962|364988311|FG004|Overall Study|Adverse Event|0|||
105816840|NCT02587962|364988307|FG000|Overall Study|Withdrawal by Subject|0|||
105816841|NCT02587962|364988308|FG001|Overall Study|Withdrawal by Subject|0|||
105816842|NCT02587962|364988309|FG002|Overall Study|Withdrawal by Subject|1|||
105816843|NCT02587962|364988310|FG003|Overall Study|Withdrawal by Subject|1|||
105816844|NCT02587962|364988311|FG004|Overall Study|Withdrawal by Subject|4|||
105816845|NCT02587962|364988307|FG000|Overall Study|Radiological progression|2|||
105816846|NCT02587962|364988308|FG001|Overall Study|Radiological progression|2|||
105816847|NCT02587962|364988309|FG002|Overall Study|Radiological progression|2|||
105816848|NCT02587962|364988310|FG003|Overall Study|Radiological progression|5|||
105764776|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
105764777|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
105764778|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
105764779|NCT03321526|364791731|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
105764780|NCT03321526|364791732|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
105764781|NCT03321526|364791731|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
105764782|NCT03321526|364791732|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
105764783|NCT03321526|364791731|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
105764784|NCT03321526|364791732|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
105764785|NCT03321526|364791731|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
105764786|NCT03321526|364791732|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
105764787|NCT03321526|364791731|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
105764788|NCT03321526|364791732|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
105764789|NCT03321526|364791731|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
105764790|NCT03321526|364791732|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
105764791|NCT03321526|364791731|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
105764792|NCT03321526|364791732|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
105764793|NCT03321526|364791731|FG000|Follow-up Phase (2 Weeks)|Other|24|||
105764794|NCT03321526|364791732|FG001|Follow-up Phase (2 Weeks)|Other|24|||
105764795|NCT04583969|364791733|FG000|Overall Study|Death|31|||
105764796|NCT04583969|364791734|FG001|Overall Study|Death|38|||
105764797|NCT04583969|364791733|FG000|Overall Study|Lost to Follow-up|16|||
105764798|NCT04583969|364791734|FG001|Overall Study|Lost to Follow-up|13|||
105764799|NCT04583969|364791733|FG000|Overall Study|Protocol Violation|1|||
105764800|NCT04583969|364791734|FG001|Overall Study|Protocol Violation|0|||
105764801|NCT04583969|364791733|FG000|Overall Study|Withdrawal by Subject|3|||
105764802|NCT04583969|364791734|FG001|Overall Study|Withdrawal by Subject|3|||
105764803|NCT04583969|364791733|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
105764804|NCT04583969|364791734|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
105764805|NCT04583969|364791733|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
105764806|NCT04583969|364791734|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
105764807|NCT04583969|364791733|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
105764808|NCT04583969|364791734|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
105764809|NCT04583969|364791733|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
105764810|NCT04583969|364791734|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
105764811|NCT04583969|364791733|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
105764812|NCT04583969|364791734|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
105764813|NCT02873208|364791737|FG000|Overall Study|Withdrawal by Subject|36|||
105764814|NCT02873208|364791737|FG000|Overall Study|Lost to Follow-up|22|||
105764815|NCT02873208|364791737|FG000|Overall Study|Adverse Event|15|||
105764816|NCT02873208|364791737|FG000|Overall Study|Non-compliance with study drug|12|||
105764817|NCT02873208|364791737|FG000|Overall Study|Protocol Violation|8|||
105764818|NCT02873208|364791737|FG000|Overall Study|Pregnancy|2|||
105764819|NCT02873208|364791737|FG000|Overall Study|Incarceration|1|||
105764820|NCT02873208|364791737|FG000|Overall Study|Lack of Efficacy|1|||
105486274|NCT02953509|363791457|FG003|Overall Study|Lost to Follow-up|0|||
105764821|NCT02873208|364791737|FG000|Overall Study|Physician Decision|1|||
105764822|NCT02910089|364791738|FG000|Overall Study|Lost insurance eligibility|22|||
105764823|NCT02910089|364791739|FG001|Overall Study|Lost insurance eligibility|16|||
105764824|NCT01057862|364791740|FG000|Overall Study|Withdrawal by Subject|1|||
105764825|NCT01057862|364791741|FG001|Overall Study|Withdrawal by Subject|2|||
105764826|NCT04080752|364791742|FG000|Overall Study|Adverse Event|2|||
105764827|NCT04080752|364791743|FG001|Overall Study|Adverse Event|3|||
105764828|NCT04080752|364791742|FG000|Overall Study|Lack of Efficacy|1|||
105764829|NCT04080752|364791743|FG001|Overall Study|Lack of Efficacy|0|||
105764830|NCT04080752|364791742|FG000|Overall Study|Lost to Follow-up|1|||
105764831|NCT04080752|364791743|FG001|Overall Study|Lost to Follow-up|0|||
105764832|NCT04080752|364791742|FG000|Overall Study|Pregnancy|0|||
105764833|NCT04080752|364791743|FG001|Overall Study|Pregnancy|1|||
105764834|NCT04080752|364791742|FG000|Overall Study|Withdrawal by Subject|7|||
105764835|NCT04080752|364791743|FG001|Overall Study|Withdrawal by Subject|0|||
105764836|NCT04080752|364791742|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105764837|NCT04080752|364791743|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105764838|NCT04080752|364791742|FG000|Overall Study|Other|2|||
105764839|NCT04080752|364791743|FG001|Overall Study|Other|1|||
105764840|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
105764841|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
105764842|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
105764843|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
105764844|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
105764845|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
105764846|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
105764847|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
105764848|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
105764849|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
105764850|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
105764851|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
105764852|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
105764853|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
105764854|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
105764855|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
105764856|NCT03434041|364791744|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
105764857|NCT03434041|364791745|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
105764858|NCT03434041|364791744|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
105764859|NCT03434041|364791745|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
105764860|NCT03434041|364791744|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
105764861|NCT03434041|364791745|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
105764862|NCT03363165|364791746|FG000|3-month Follow-up|Death|0|||
105764863|NCT03363165|364791747|FG001|3-month Follow-up|Death|1|||
105764864|NCT03363165|364791746|FG000|6-month Follow-up|Death|0|||
105764865|NCT03363165|364791747|FG001|6-month Follow-up|Death|1|||
105764866|NCT03363165|364791746|FG000|6-month Follow-up|Withdrawal by Subject|1|||
105764867|NCT03363165|364791747|FG001|6-month Follow-up|Withdrawal by Subject|1|||
105764868|NCT03363165|364791746|FG000|12-month Follow-up|Death|1|||
105764869|NCT03363165|364791747|FG001|12-month Follow-up|Death|1|||
105764870|NCT03363165|364791746|FG000|12-month Follow-up|Withdrawal by Subject|1|||
105764871|NCT03363165|364791747|FG001|12-month Follow-up|Withdrawal by Subject|1|||
105764872|NCT01585168|364791748|FG000|Overall Study|Lost to Follow-up|3|||
105764873|NCT01585168|364791749|FG001|Overall Study|Lost to Follow-up|1|||
105764874|NCT01585168|364791750|FG002|Overall Study|Lost to Follow-up|1|||
105764875|NCT01585168|364791751|FG003|Overall Study|Lost to Follow-up|1|||
105764876|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
105764877|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
105764878|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
105764879|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
105764880|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
105764881|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
105764882|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
105764883|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
105764884|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
105764885|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
105764886|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
105764887|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
105764888|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
105764889|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
105764890|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
105764891|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
105486275|NCT02953509|363791458|FG004|Overall Study|Lost to Follow-up|0|||
105816849|NCT02587962|364988311|FG004|Overall Study|Radiological progression|10|||
105816850|NCT02587962|364988307|FG000|Overall Study|Clinical progression|0|||
105816851|NCT02587962|364988308|FG001|Overall Study|Clinical progression|1|||
105816852|NCT02587962|364988309|FG002|Overall Study|Clinical progression|2|||
105816853|NCT02587962|364988310|FG003|Overall Study|Clinical progression|0|||
105816854|NCT02587962|364988311|FG004|Overall Study|Clinical progression|1|||
105816855|NCT00282048|364988312|FG000|Overall Study|Lack of Efficacy|30|||
105816856|NCT00282048|364988312|FG000|Overall Study|Adverse Event|22|||
105816857|NCT00282048|364988312|FG000|Overall Study|Withdrawal by Subject|1|||
105816858|NCT00282048|364988312|FG000|Overall Study|Other|8|||
105816859|NCT00282048|364988312|FG000|Overall Study|Ongoing|1|||
105816860|NCT00259012|364988313|FG000|Overall Study|Adverse Event|0|||
105816861|NCT00259012|364988314|FG001|Overall Study|Adverse Event|1|||
105816862|NCT00259012|364988313|FG000|Overall Study|Withdrawal by Subject|1|||
105816863|NCT00259012|364988314|FG001|Overall Study|Withdrawal by Subject|0|||
105816864|NCT00259012|364988313|FG000|Overall Study|Physician Decision|0|||
105816865|NCT00259012|364988314|FG001|Overall Study|Physician Decision|1|||
105816866|NCT00259012|364988313|FG000|Overall Study|Lost to Follow-up|0|||
105816867|NCT00259012|364988314|FG001|Overall Study|Lost to Follow-up|1|||
105816868|NCT00259012|364988313|FG000|Overall Study|Protocol Violation|1|||
105816869|NCT00259012|364988314|FG001|Overall Study|Protocol Violation|1|||
105816870|NCT00312663|364988315|FG000|Immunization Phase|Adverse Event|0|||
105816871|NCT00312663|364988316|FG001|Immunization Phase|Adverse Event|1|||
105816872|NCT00312663|364988317|FG002|Immunization Phase|Adverse Event|0|||
105816873|NCT00376623|364988318|FG000|Overall Study|Progressive disease|35|||
105816874|NCT00376623|364988319|FG001|Overall Study|Progressive disease|22|||
105816875|NCT00376623|364988320|FG002|Overall Study|Progressive disease|17|||
105816876|NCT00376623|364988318|FG000|Overall Study|Lost to Follow-up|0|||
105816877|NCT00376623|364988319|FG001|Overall Study|Lost to Follow-up|1|||
105816878|NCT00376623|364988320|FG002|Overall Study|Lost to Follow-up|0|||
105816879|NCT00376623|364988318|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
105816880|NCT00376623|364988319|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
105816881|NCT00376623|364988320|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
105816882|NCT00376623|364988318|FG000|Overall Study|Not treated with BI 2536|1|||
105816883|NCT00376623|364988319|FG001|Overall Study|Not treated with BI 2536|0|||
105816884|NCT00376623|364988320|FG002|Overall Study|Not treated with BI 2536|0|||
105816885|NCT00376623|364988318|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
105816886|NCT00376623|364988319|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
105816887|NCT00376623|364988320|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
105816888|NCT00376623|364988318|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
105816889|NCT00376623|364988319|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
105816890|NCT00376623|364988320|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
105816891|NCT00376623|364988318|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
105816892|NCT00376623|364988319|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
105816893|NCT00376623|364988320|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
105816894|NCT00376623|364988318|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
105816895|NCT00376623|364988319|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
105816896|NCT00376623|364988320|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
105816897|NCT00376623|364988318|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
105816898|NCT00376623|364988319|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
105816899|NCT00376623|364988320|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
105816900|NCT00376623|364988318|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
105816901|NCT00376623|364988319|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
105816902|NCT00376623|364988320|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
105816903|NCT00376623|364988318|FG000|Overall Study|Increase of tumour markers|0|||
105816904|NCT00376623|364988319|FG001|Overall Study|Increase of tumour markers|1|||
105816905|NCT00376623|364988320|FG002|Overall Study|Increase of tumour markers|0|||
105816906|NCT00376623|364988318|FG000|Overall Study|Bone metastasis|1|||
105816907|NCT00376623|364988319|FG001|Overall Study|Bone metastasis|0|||
105816908|NCT00376623|364988320|FG002|Overall Study|Bone metastasis|0|||
105816909|NCT00286754|364988327|FG000|Overall Study|Adverse Event|2|||
105816910|NCT00286754|364988328|FG001|Overall Study|Adverse Event|2|||
105816911|NCT00286754|364988329|FG002|Overall Study|Adverse Event|3|||
105486276|NCT02953509|363791459|FG005|Overall Study|Lost to Follow-up|0|||
105764892|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
105764893|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
105764894|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
105764895|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
105764896|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
105764897|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
105764898|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
105764899|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
105764900|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Other|0|||
105764901|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Other|1|||
105764902|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Other|0|||
105764903|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Other|0|||
105764904|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
105764905|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
105764906|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
105764907|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
105764908|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
105764909|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
105764910|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
105816912|NCT00286754|364988327|FG000|Overall Study|Withdrawal by Subject|6|||
105816913|NCT00286754|364988328|FG001|Overall Study|Withdrawal by Subject|2|||
105816914|NCT00286754|364988329|FG002|Overall Study|Withdrawal by Subject|0|||
105816915|NCT00286754|364988327|FG000|Overall Study|Lost to Follow-up|12|||
105816916|NCT00286754|364988328|FG001|Overall Study|Lost to Follow-up|14|||
105816917|NCT00286754|364988329|FG002|Overall Study|Lost to Follow-up|6|||
105571643|NCT00332332|364092714|FG000|Overall Study|Lost to Follow-up|3|||
105571644|NCT00332332|364092714|FG000|Overall Study|Protocol deviation|4|||
105764911|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
105764912|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Death|0|||
105764913|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Death|1|||
105764914|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Death|0|||
105764915|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Death|0|||
105764916|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
105764917|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
105764918|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
105764919|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
105764920|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
105764921|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
105764922|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
105764923|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
105764924|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
105764925|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
105764926|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
105764927|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
105764928|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
105764929|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
105764930|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
105764931|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
105764932|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
105764933|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
105764934|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
105764935|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
105764936|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
105764937|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
105764938|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
105764939|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
105764940|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Other|2|||
105764941|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Other|1|||
105764942|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Other|0|||
105764943|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Other|0|||
105764944|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
105764945|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
105764946|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
105764947|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
105764948|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
105764949|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
105764950|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
105764951|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
105764952|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
105764953|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
105764954|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
105816918|NCT00286754|364988327|FG000|Overall Study|Moved out of state|0|||
105362380|NCT01827592|363330221|FG001|Overall Study|Trial terminated by Sponsor|53|||
105362381|NCT01827592|363330222|FG002|Overall Study|Trial terminated by Sponsor|51|||
105362382|NCT01827592|363330220|FG000|Overall Study|Others|0|||
105362383|NCT01827592|363330221|FG001|Overall Study|Others|1|||
105362384|NCT01827592|363330222|FG002|Overall Study|Others|3|||
105362385|NCT02998151|363330223|FG000|Overall Study|Withdrawal by Subject|3|||
105362386|NCT02998151|363330223|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
105362387|NCT02998151|363330223|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
105362388|NCT00325819|363330228|FG000|Overall Study|Study product lost in mail|2|||
105362389|NCT00325819|363330229|FG001|Overall Study|Study product lost in mail|1|||
105362390|NCT00325819|363330228|FG000|Overall Study|Did not take a dose of study product|4|||
105362391|NCT00325819|363330229|FG001|Overall Study|Did not take a dose of study product|9|||
105362392|NCT00325819|363330228|FG000|Overall Study|Lost to Follow-up|3|||
105764955|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
105764956|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Death|1|||
105764957|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Death|2|||
105764958|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Death|0|||
105764959|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Death|2|||
105764960|NCT04737759|364791759|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
105764961|NCT04737759|364791760|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
105764962|NCT04737759|364791759|FG000|Overall Study|Death|2|||
105764963|NCT04737759|364791760|FG001|Overall Study|Death|0|||
105764964|NCT04737759|364791759|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
105764965|NCT04737759|364791760|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
105764966|NCT04737759|364791759|FG000|Overall Study|Lost to Follow-up|4|||
105764967|NCT04737759|364791760|FG001|Overall Study|Lost to Follow-up|12|||
105764968|NCT02260388|364791765|FG000|Overall Study|Lost to Follow-up|2|||
105764969|NCT02260388|364791766|FG001|Overall Study|Lost to Follow-up|8|||
105764970|NCT02260388|364791767|FG002|Overall Study|Lost to Follow-up|3|||
105764971|NCT02260388|364791768|FG003|Overall Study|Lost to Follow-up|4|||
105764972|NCT00422669|364791773|FG000|Overall Study|The study was terminated early.|98|||
105764973|NCT00422669|364791774|FG001|Overall Study|The study was terminated early.|100|||
105764974|NCT00422669|364791775|FG002|Overall Study|The study was terminated early.|7|||
105764975|NCT02738580|364791776|FG000|Overall Study|Adverse Event|1|||
105764976|NCT02738580|364791777|FG001|Overall Study|Adverse Event|0|||
105764977|NCT02738580|364791776|FG000|Overall Study|Lack of Efficacy|3|||
105764978|NCT02738580|364791777|FG001|Overall Study|Lack of Efficacy|2|||
105764979|NCT02738580|364791776|FG000|Overall Study|Withdrawal by Subject|0|||
105764980|NCT02738580|364791777|FG001|Overall Study|Withdrawal by Subject|1|||
105764981|NCT02738580|364791776|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
105764982|NCT02738580|364791777|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
105764983|NCT00996593|364791778|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
105764984|NCT00996593|364791778|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
105764985|NCT00996593|364791778|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
105764986|NCT00996593|364791778|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
105764987|NCT00996593|364791778|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
105764988|NCT00996593|364791778|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
105764989|NCT00996593|364791778|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
105764990|NCT00996593|364791778|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
105764991|NCT00996593|364791778|FG000|Long-Term Follow-Up|Site Closed|1|||
105764992|NCT00741260|364791779|FG000|Overall Study|Disease Progression|3|||
105764993|NCT00741260|364791780|FG001|Overall Study|Disease Progression|5|||
105764994|NCT00741260|364791781|FG002|Overall Study|Disease Progression|3|||
105764995|NCT00741260|364791782|FG003|Overall Study|Disease Progression|3|||
105764996|NCT00741260|364791783|FG004|Overall Study|Disease Progression|5|||
105764997|NCT00741260|364791784|FG005|Overall Study|Disease Progression|37|||
105764998|NCT00741260|364791785|FG006|Overall Study|Disease Progression|4|||
105764999|NCT00741260|364791779|FG000|Overall Study|Death|0|||
105765000|NCT00741260|364791780|FG001|Overall Study|Death|1|||
105765001|NCT00741260|364791781|FG002|Overall Study|Death|0|||
105765002|NCT00741260|364791782|FG003|Overall Study|Death|1|||
105765003|NCT00741260|364791783|FG004|Overall Study|Death|2|||
105765004|NCT00741260|364791784|FG005|Overall Study|Death|2|||
105765005|NCT00741260|364791785|FG006|Overall Study|Death|1|||
105765006|NCT00741260|364791779|FG000|Overall Study|Withdrawal by Subject|0|||
105765007|NCT00741260|364791780|FG001|Overall Study|Withdrawal by Subject|0|||
105765008|NCT00741260|364791781|FG002|Overall Study|Withdrawal by Subject|0|||
105765009|NCT00741260|364791782|FG003|Overall Study|Withdrawal by Subject|0|||
105765010|NCT00741260|364791783|FG004|Overall Study|Withdrawal by Subject|1|||
105765011|NCT00741260|364791784|FG005|Overall Study|Withdrawal by Subject|3|||
105765012|NCT00741260|364791785|FG006|Overall Study|Withdrawal by Subject|1|||
105765013|NCT00741260|364791779|FG000|Overall Study|Physician Decision|1|||
105765014|NCT00741260|364791780|FG001|Overall Study|Physician Decision|1|||
105765015|NCT00741260|364791781|FG002|Overall Study|Physician Decision|0|||
105765016|NCT00741260|364791782|FG003|Overall Study|Physician Decision|0|||
105765017|NCT00741260|364791783|FG004|Overall Study|Physician Decision|0|||
105765018|NCT00741260|364791784|FG005|Overall Study|Physician Decision|0|||
105765019|NCT00741260|364791785|FG006|Overall Study|Physician Decision|0|||
105765020|NCT00741260|364791779|FG000|Overall Study|Other|2|||
105765021|NCT00741260|364791780|FG001|Overall Study|Other|1|||
105765022|NCT00741260|364791781|FG002|Overall Study|Other|1|||
105765023|NCT00741260|364791782|FG003|Overall Study|Other|2|||
105765024|NCT00741260|364791783|FG004|Overall Study|Other|1|||
105765025|NCT00741260|364791784|FG005|Overall Study|Other|3|||
105765026|NCT00741260|364791785|FG006|Overall Study|Other|1|||
105765027|NCT03094611|364791790|FG000|Overall Study|Lack of Efficacy|1|||
105765028|NCT03094611|364791790|FG000|Overall Study|Stem Cell Transplant|1|||
105765029|NCT01614795|364791793|FG000|Overall Study|Adverse Event|0|||
105765030|NCT01614795|364791794|FG001|Overall Study|Adverse Event|0|||
105765031|NCT01614795|364791795|FG002|Overall Study|Adverse Event|1|||
105765032|NCT01614795|364791796|FG003|Overall Study|Adverse Event|1|||
105765033|NCT01614795|364791793|FG000|Overall Study|Lack of Efficacy|10|||
105765034|NCT01614795|364791794|FG001|Overall Study|Lack of Efficacy|10|||
105765035|NCT01614795|364791795|FG002|Overall Study|Lack of Efficacy|9|||
105765036|NCT01614795|364791796|FG003|Overall Study|Lack of Efficacy|8|||
105765037|NCT01614795|364791793|FG000|Overall Study|Physician Decision|1|||
105765038|NCT01614795|364791794|FG001|Overall Study|Physician Decision|0|||
105765039|NCT01614795|364791795|FG002|Overall Study|Physician Decision|1|||
105765040|NCT01614795|364791796|FG003|Overall Study|Physician Decision|1|||
105765041|NCT01614795|364791793|FG000|Overall Study|Withdrawal by Subject|0|||
105765042|NCT01614795|364791794|FG001|Overall Study|Withdrawal by Subject|1|||
105765043|NCT01614795|364791795|FG002|Overall Study|Withdrawal by Subject|0|||
105765044|NCT01614795|364791796|FG003|Overall Study|Withdrawal by Subject|2|||
105765045|NCT01614795|364791793|FG000|Overall Study|Ineligible|0|||
105765046|NCT01614795|364791794|FG001|Overall Study|Ineligible|1|||
105765047|NCT01614795|364791795|FG002|Overall Study|Ineligible|0|||
105765048|NCT01614795|364791796|FG003|Overall Study|Ineligible|0|||
105765049|NCT01929707|364791800|FG000|Intervention Period 1|Lost to Follow-up|0|||
105765050|NCT01929707|364791801|FG001|Intervention Period 1|Lost to Follow-up|0|||
105765051|NCT01929707|364791802|FG002|Intervention Period 1|Lost to Follow-up|0|||
105765052|NCT01929707|364791803|FG003|Intervention Period 1|Lost to Follow-up|1|||
105765053|NCT01929707|364791804|FG004|Intervention Period 1|Lost to Follow-up|0|||
105765054|NCT01929707|364791805|FG005|Intervention Period 1|Lost to Follow-up|0|||
105765055|NCT01929707|364791806|FG006|Intervention Period 1|Lost to Follow-up|0|||
105765056|NCT01929707|364791807|FG007|Intervention Period 1|Lost to Follow-up|0|||
105765057|NCT01929707|364791800|FG000|Intervention Period 1|Withdrawal by Subject|0|||
105765058|NCT01929707|364791801|FG001|Intervention Period 1|Withdrawal by Subject|0|||
105765059|NCT01929707|364791802|FG002|Intervention Period 1|Withdrawal by Subject|0|||
105765060|NCT01929707|364791803|FG003|Intervention Period 1|Withdrawal by Subject|2|||
105765061|NCT01929707|364791804|FG004|Intervention Period 1|Withdrawal by Subject|0|||
105765062|NCT01929707|364791805|FG005|Intervention Period 1|Withdrawal by Subject|0|||
105765063|NCT01929707|364791806|FG006|Intervention Period 1|Withdrawal by Subject|0|||
105765064|NCT01929707|364791807|FG007|Intervention Period 1|Withdrawal by Subject|0|||
105765065|NCT01929707|364791800|FG000|Intervention Period 2|Withdrawal by Subject|0|||
105765066|NCT01929707|364791801|FG001|Intervention Period 2|Withdrawal by Subject|0|||
105765067|NCT01929707|364791802|FG002|Intervention Period 2|Withdrawal by Subject|0|||
105765068|NCT01929707|364791803|FG003|Intervention Period 2|Withdrawal by Subject|0|||
105765069|NCT01929707|364791804|FG004|Intervention Period 2|Withdrawal by Subject|0|||
105765070|NCT01929707|364791805|FG005|Intervention Period 2|Withdrawal by Subject|2|||
105765071|NCT01929707|364791806|FG006|Intervention Period 2|Withdrawal by Subject|0|||
105765072|NCT01929707|364791807|FG007|Intervention Period 2|Withdrawal by Subject|0|||
105765073|NCT02566109|364791808|FG000|Overall Study|Withdrawal by Subject|1|||
105765074|NCT01685203|364791814|FG000|Overall Study|Lost to Follow-up|3|||
105765075|NCT01685203|364791815|FG001|Overall Study|Lost to Follow-up|3|||
105765076|NCT01685203|364791816|FG002|Overall Study|Lost to Follow-up|0|||
105765077|NCT01685203|364791817|FG003|Overall Study|Lost to Follow-up|1|||
105765078|NCT01685203|364791818|FG004|Overall Study|Lost to Follow-up|0|||
105362393|NCT00325819|363330229|FG001|Overall Study|Lost to Follow-up|3|||
105765079|NCT01685203|364791819|FG005|Overall Study|Lost to Follow-up|0|||
105765080|NCT01685203|364791820|FG006|Overall Study|Lost to Follow-up|0|||
105765081|NCT01685203|364791814|FG000|Overall Study|Adverse Event|0|||
105765082|NCT01685203|364791815|FG001|Overall Study|Adverse Event|0|||
105362394|NCT00452439|363332560|FG000|Overall Study|Lost to Follow-up|1|||
105362395|NCT00452439|363332561|FG001|Overall Study|Lost to Follow-up|1|||
105765083|NCT01685203|364791816|FG002|Overall Study|Adverse Event|0|||
105765084|NCT01685203|364791817|FG003|Overall Study|Adverse Event|0|||
105765085|NCT01685203|364791818|FG004|Overall Study|Adverse Event|0|||
105765086|NCT01685203|364791819|FG005|Overall Study|Adverse Event|2|||
105765087|NCT01685203|364791820|FG006|Overall Study|Adverse Event|0|||
105765088|NCT01685203|364791814|FG000|Overall Study|Adverse event and withdrew consent|1|||
105765089|NCT01685203|364791815|FG001|Overall Study|Adverse event and withdrew consent|0|||
105362396|NCT00452439|363332560|FG000|Overall Study|Refused Treatment|4|||
105816919|NCT00286754|364988328|FG001|Overall Study|Moved out of state|0|||
105816920|NCT00286754|364988329|FG002|Overall Study|Moved out of state|1|||
105816921|NCT01173692|364988332|FG000|Overall Study|Adverse Event|1|||
105816922|NCT01173692|364988333|FG001|Overall Study|Adverse Event|2|||
105816923|NCT01173692|364988332|FG000|Overall Study|Withdrawal by Subject|1|||
105816924|NCT01173692|364988333|FG001|Overall Study|Withdrawal by Subject|3|||
105816925|NCT00579670|364988334|FG000|Overall Study|Death|1|||
105816926|NCT00579670|364988335|FG001|Overall Study|Death|0|||
105816927|NCT00579670|364988336|FG002|Overall Study|Death|0|||
105816928|NCT00579670|364988337|FG003|Overall Study|Death|0|||
105816929|NCT00579670|364988338|FG004|Overall Study|Death|0|||
105816930|NCT00579670|364988334|FG000|Overall Study|Adverse Event|1|||
105816931|NCT00579670|364988335|FG001|Overall Study|Adverse Event|0|||
105816932|NCT00579670|364988336|FG002|Overall Study|Adverse Event|1|||
105816933|NCT00579670|364988337|FG003|Overall Study|Adverse Event|2|||
105816934|NCT00579670|364988338|FG004|Overall Study|Adverse Event|0|||
105816935|NCT00579670|364988334|FG000|Overall Study|Lack of Efficacy|0|||
105816936|NCT00579670|364988335|FG001|Overall Study|Lack of Efficacy|0|||
105816937|NCT00579670|364988336|FG002|Overall Study|Lack of Efficacy|1|||
105816938|NCT00579670|364988337|FG003|Overall Study|Lack of Efficacy|14|||
105816939|NCT00579670|364988338|FG004|Overall Study|Lack of Efficacy|0|||
105816940|NCT00579670|364988334|FG000|Overall Study|Lost to Follow-up|0|||
105816941|NCT00579670|364988335|FG001|Overall Study|Lost to Follow-up|1|||
105816942|NCT00579670|364988336|FG002|Overall Study|Lost to Follow-up|0|||
105816943|NCT00579670|364988337|FG003|Overall Study|Lost to Follow-up|4|||
105816944|NCT00579670|364988338|FG004|Overall Study|Lost to Follow-up|0|||
105816945|NCT00579670|364988334|FG000|Overall Study|Other|0|||
105816946|NCT00579670|364988335|FG001|Overall Study|Other|0|||
105816947|NCT00579670|364988336|FG002|Overall Study|Other|1|||
105816948|NCT00579670|364988337|FG003|Overall Study|Other|2|||
105816949|NCT00579670|364988338|FG004|Overall Study|Other|0|||
105816950|NCT00579670|364988334|FG000|Overall Study|Withdrawal by Subject|0|||
105816951|NCT00579670|364988335|FG001|Overall Study|Withdrawal by Subject|0|||
105816952|NCT00579670|364988336|FG002|Overall Study|Withdrawal by Subject|1|||
105816953|NCT00579670|364988337|FG003|Overall Study|Withdrawal by Subject|0|||
105816954|NCT00579670|364988338|FG004|Overall Study|Withdrawal by Subject|0|||
105816955|NCT03361228|364988340|FG000|Overall Study|Other|1|||
105816956|NCT03361228|364988341|FG001|Overall Study|Other|1|||
105816957|NCT03361228|364988340|FG000|Overall Study|Death|3|||
105816958|NCT03361228|364988341|FG001|Overall Study|Death|0|||
105816959|NCT00302952|364988342|FG000|Overall Study|Physician Decision|1|||
105816960|NCT00302952|364988343|FG001|Overall Study|Physician Decision|1|||
105816961|NCT00302952|364988342|FG000|Overall Study|Withdrawal by Subject|2|||
105816962|NCT00302952|364988343|FG001|Overall Study|Withdrawal by Subject|3|||
105816963|NCT00302952|364988342|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
105816964|NCT00302952|364988343|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
105816965|NCT02979353|364988348|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
105816966|NCT02979353|364988349|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
105816967|NCT02979353|364988348|FG000|Overall Study|Withdrawal by Subject|16|||
105816968|NCT02979353|364988349|FG001|Overall Study|Withdrawal by Subject|12|||
105816969|NCT02979353|364988348|FG000|Overall Study|Death|10|||
105816970|NCT02979353|364988349|FG001|Overall Study|Death|11|||
105816971|NCT02979353|364988348|FG000|Overall Study|Transfer to Hospice Care|19|||
105816972|NCT02979353|364988349|FG001|Overall Study|Transfer to Hospice Care|14|||
105816973|NCT02979353|364988348|FG000|Overall Study|Lost to Follow-up|1|||
105816974|NCT02979353|364988349|FG001|Overall Study|Lost to Follow-up|5|||
105816975|NCT03018249|364988352|FG000|Overall Study|Withdrawal by Subject|2|||
105816976|NCT03018249|364988353|FG001|Overall Study|Withdrawal by Subject|2|||
105816977|NCT02924038|364990430|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
105816978|NCT02924038|364990431|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
105816979|NCT02289963|364990445|FG000|Overall Study|Adverse Event|1|||
105816980|NCT02289963|364990446|FG001|Overall Study|Adverse Event|2|||
105816981|NCT02289963|364990445|FG000|Overall Study|Poor compliance to protocol|1|||
105816982|NCT02289963|364990446|FG001|Overall Study|Poor compliance to protocol|0|||
105816983|NCT02289963|364990445|FG000|Overall Study|Withdrawal by Subject|1|||
105816984|NCT02289963|364990446|FG001|Overall Study|Withdrawal by Subject|0|||
105816985|NCT02289963|364990445|FG000|Overall Study|Last injection missed|2|||
105816986|NCT02289963|364990446|FG001|Overall Study|Last injection missed|2|||
105816987|NCT02289963|364990445|FG000|Overall Study|End treatment visit outside visit window|0|||
105816988|NCT02289963|364990446|FG001|Overall Study|End treatment visit outside visit window|4|||
105816989|NCT02289963|364990445|FG000|Overall Study|Other than specified above|0|||
105816990|NCT02289963|364990446|FG001|Overall Study|Other than specified above|2|||
105816991|NCT00485472|364990447|FG000|Overall Study|Adverse Event|8|||
105816992|NCT00485472|364990448|FG001|Overall Study|Adverse Event|5|||
105816993|NCT00485472|364990447|FG000|Overall Study|Lack of Efficacy|5|||
105816994|NCT00485472|364990448|FG001|Overall Study|Lack of Efficacy|4|||
105816995|NCT00485472|364990447|FG000|Overall Study|Withdrawal by Subject|1|||
105816996|NCT00485472|364990448|FG001|Overall Study|Withdrawal by Subject|0|||
105362397|NCT00452439|363332561|FG001|Overall Study|Refused Treatment|3|||
105765090|NCT01685203|364791816|FG002|Overall Study|Adverse event and withdrew consent|0|||
105765091|NCT01685203|364791817|FG003|Overall Study|Adverse event and withdrew consent|0|||
105765092|NCT01685203|364791818|FG004|Overall Study|Adverse event and withdrew consent|0|||
105765093|NCT01685203|364791819|FG005|Overall Study|Adverse event and withdrew consent|0|||
105765094|NCT01685203|364791820|FG006|Overall Study|Adverse event and withdrew consent|0|||
105765095|NCT01685203|364791814|FG000|Overall Study|Patient's decision|0|||
105765096|NCT01685203|364791815|FG001|Overall Study|Patient's decision|0|||
105765097|NCT01685203|364791816|FG002|Overall Study|Patient's decision|0|||
105765098|NCT01685203|364791817|FG003|Overall Study|Patient's decision|0|||
105765099|NCT01685203|364791818|FG004|Overall Study|Patient's decision|0|||
105765100|NCT01685203|364791819|FG005|Overall Study|Patient's decision|1|||
105765101|NCT01685203|364791820|FG006|Overall Study|Patient's decision|0|||
105765102|NCT03215667|364791827|FG000|Overall Study|Physician Decision|4|||
105765103|NCT04857892|364791828|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
105765104|NCT04857892|364791829|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
105765105|NCT04857892|364791830|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
105765106|NCT04857892|364791831|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
105765107|NCT04857892|364791832|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
105765108|NCT04857892|364791828|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
105765109|NCT04857892|364791829|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
105765110|NCT04857892|364791830|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
105765111|NCT04857892|364791831|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
105765112|NCT04857892|364791832|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
105765113|NCT04857892|364791828|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
105765114|NCT04857892|364791829|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
105765115|NCT04857892|364791830|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
105765116|NCT04857892|364791831|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
105765117|NCT04857892|364791832|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
105765118|NCT01390038|364791833|FG000|Overall Study|Death|1|||
105765119|NCT01390038|364791833|FG000|Overall Study|Lost to Follow-up|1|||
105765120|NCT01390038|364791833|FG000|Overall Study|Withdrawal by Subject|4|||
105765121|NCT01390038|364791833|FG000|Overall Study|Simpliciti System Removal|2|||
105765122|NCT00368472|364791836|FG000|Overall Study|Adverse Event|22|||
105765123|NCT00368472|364791836|FG000|Overall Study|Medication non-compliance|4|||
105765124|NCT00368472|364791836|FG000|Overall Study|Protocol Violation|2|||
105765125|NCT00368472|364791836|FG000|Overall Study|Request of Investigator or Sponsor|3|||
105765126|NCT00368472|364791836|FG000|Overall Study|Withdrawal by Subject|40|||
105765127|NCT00368472|364791836|FG000|Overall Study|Diary non-compliance|1|||
105765128|NCT00368472|364791836|FG000|Overall Study|Other|32|||
105765129|NCT00368472|364791836|FG000|Overall Study|Missing Final Disposition Date|1|||
105765130|NCT00251589|364791845|FG000|Overall Study|Adverse Event|5|||
105765131|NCT00251589|364791846|FG001|Overall Study|Adverse Event|1|||
105765132|NCT00251589|364791847|FG002|Overall Study|Adverse Event|2|||
105765133|NCT00251589|364791848|FG003|Overall Study|Adverse Event|1|||
105765134|NCT00251589|364791845|FG000|Overall Study|Withdrawal by Subject|1|||
105765135|NCT00251589|364791846|FG001|Overall Study|Withdrawal by Subject|1|||
105765136|NCT00251589|364791847|FG002|Overall Study|Withdrawal by Subject|0|||
105765137|NCT00251589|364791848|FG003|Overall Study|Withdrawal by Subject|0|||
105765138|NCT00251589|364791845|FG000|Overall Study|Discontinued due to progressive disease|9|||
105765139|NCT00251589|364791846|FG001|Overall Study|Discontinued due to progressive disease|1|||
105765140|NCT00251589|364791847|FG002|Overall Study|Discontinued due to progressive disease|0|||
105765141|NCT00251589|364791848|FG003|Overall Study|Discontinued due to progressive disease|1|||
105765142|NCT03039192|364791849|FG000|Overall Study|Lost to Follow-up|4|||
105765143|NCT03039192|364791850|FG001|Overall Study|Lost to Follow-up|4|||
105765144|NCT03039192|364791849|FG000|Overall Study|Adverse event, serious fatal|0|||
105765145|NCT03039192|364791850|FG001|Overall Study|Adverse event, serious fatal|1|||
105765146|NCT03039192|364791849|FG000|Overall Study|Adverse event, non-fatal|0|||
105765147|NCT03039192|364791850|FG001|Overall Study|Adverse event, non-fatal|2|||
105765148|NCT03039192|364791849|FG000|Overall Study|Withdrawal by Subject|6|||
105765149|NCT03039192|364791850|FG001|Overall Study|Withdrawal by Subject|9|||
105765150|NCT03039192|364791849|FG000|Overall Study|Discontinued from treatment phase|19|||
105765151|NCT03039192|364791850|FG001|Overall Study|Discontinued from treatment phase|12|||
105765152|NCT03039192|364791849|FG000|Overall Study|Other|3|||
105765153|NCT03039192|364791850|FG001|Overall Study|Other|2|||
105765154|NCT02407236|364791851|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
105765155|NCT02407236|364791852|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
105765156|NCT02407236|364791853|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
105765157|NCT02407236|364791854|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
105765158|NCT02407236|364791855|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
105765159|NCT02407236|364791856|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
105765160|NCT02407236|364791857|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
105765161|NCT02407236|364791858|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
105816997|NCT00485472|364990447|FG000|Overall Study|Protocol Violation|0|||
105816998|NCT00485472|364990448|FG001|Overall Study|Protocol Violation|1|||
105816999|NCT00485472|364990447|FG000|Overall Study|Other|2|||
105817000|NCT00485472|364990448|FG001|Overall Study|Other|1|||
105817001|NCT00485472|364990447|FG000|Overall Study|Lost to Follow-up|0|||
105817002|NCT00485472|364990448|FG001|Overall Study|Lost to Follow-up|1|||
105817003|NCT00746798|364990449|FG000|Overall Study|Protocol Violation|0|||
105817004|NCT00746798|364990450|FG001|Overall Study|Protocol Violation|1|||
105817005|NCT00746798|364990451|FG002|Overall Study|Protocol Violation|0|||
105817006|NCT00746798|364990452|FG003|Overall Study|Protocol Violation|0|||
105817007|NCT00746798|364990449|FG000|Overall Study|Withdrawal by Subject|0|||
105817008|NCT00746798|364990450|FG001|Overall Study|Withdrawal by Subject|1|||
105817009|NCT00746798|364990451|FG002|Overall Study|Withdrawal by Subject|1|||
105817010|NCT00746798|364990452|FG003|Overall Study|Withdrawal by Subject|0|||
105817011|NCT00746798|364990449|FG000|Overall Study|Death|0|||
105817012|NCT00746798|364990450|FG001|Overall Study|Death|0|||
105817013|NCT00746798|364990451|FG002|Overall Study|Death|2|||
105817014|NCT00746798|364990452|FG003|Overall Study|Death|0|||
105817015|NCT00746798|364990449|FG000|Overall Study|Participant unable to return for visit|1|||
105817016|NCT00746798|364990450|FG001|Overall Study|Participant unable to return for visit|0|||
105817017|NCT00746798|364990451|FG002|Overall Study|Participant unable to return for visit|0|||
105817018|NCT00746798|364990452|FG003|Overall Study|Participant unable to return for visit|0|||
105817019|NCT02262377|364990453|FG000|Overall Study|Lost to Follow-up|5|||
105817020|NCT02262377|364990454|FG001|Overall Study|Lost to Follow-up|6|||
105817021|NCT02262377|364990453|FG000|Overall Study|Found ineligible after enrollment|3|||
105817022|NCT02262377|364990454|FG001|Overall Study|Found ineligible after enrollment|0|||
105817023|NCT02262377|364990453|FG000|Overall Study|Withdrawal by Subject|4|||
105817024|NCT02262377|364990454|FG001|Overall Study|Withdrawal by Subject|0|||
105817025|NCT01900730|364990460|FG000|Overall Study|Withdrawal by Subject|1|||
105817026|NCT01900730|364990461|FG001|Overall Study|Withdrawal by Subject|0|||
105817027|NCT01900730|364990460|FG000|Overall Study|Screen Failure|1|||
105817028|NCT01900730|364990461|FG001|Overall Study|Screen Failure|0|||
105817029|NCT01179048|364990462|FG000|Overall Study|Withdrawn - does not allow contact|4|||
105817030|NCT01179048|364990463|FG001|Overall Study|Withdrawn - does not allow contact|8|||
105817031|NCT01179048|364990462|FG000|Overall Study|Lost to Follow-up|8|||
105817032|NCT01179048|364990463|FG001|Overall Study|Lost to Follow-up|9|||
105817033|NCT01179048|364990462|FG000|Overall Study|Alive|127|||
105817034|NCT01179048|364990463|FG001|Overall Study|Alive|142|||
105817035|NCT03203447|364990468|FG000|Overall Study|Withdrawal by Subject|2|||
105817036|NCT03203447|364990469|FG001|Overall Study|Withdrawal by Subject|1|||
105817037|NCT03203447|364990468|FG000|Overall Study|Lost to Follow-up|1|||
105817038|NCT03203447|364990469|FG001|Overall Study|Lost to Follow-up|10|||
105817039|NCT03203447|364990468|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
105817040|NCT03203447|364990469|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
105817041|NCT00324168|364990470|FG000|Overall Study|Lost to Follow-up|19|||
105817042|NCT00324168|364990471|FG001|Overall Study|Lost to Follow-up|18|||
105817043|NCT00324168|364990470|FG000|Overall Study|Death|3|||
105817044|NCT00324168|364990471|FG001|Overall Study|Death|3|||
105362398|NCT00452439|363332560|FG000|Overall Study|Death|3|||
105362399|NCT00452439|363332561|FG001|Overall Study|Death|1|||
105362400|NCT00452439|363332560|FG000|Overall Study|Bone Marrow Transplant|0|||
105362401|NCT00452439|363332561|FG001|Overall Study|Bone Marrow Transplant|1|||
105362402|NCT00452439|363332560|FG000|Overall Study|Too Ill to Continue|0|||
105362403|NCT00452439|363332561|FG001|Overall Study|Too Ill to Continue|1|||
105362404|NCT00452439|363332560|FG000|Overall Study|Failed to achieve complete response|2|||
105362405|NCT00452439|363332561|FG001|Overall Study|Failed to achieve complete response|0|||
105362406|NCT00452439|363332560|FG000|Overall Study|Relapse|3|||
105362407|NCT00452439|363332561|FG001|Overall Study|Relapse|0|||
105362408|NCT00452439|363332560|FG000|Overall Study|Fracture|1|||
105362409|NCT00452439|363332561|FG001|Overall Study|Fracture|0|||
105362410|NCT01212094|363332562|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
105362411|NCT01212094|363332563|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
105362412|NCT01212094|363332564|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
105362413|NCT01212094|363332562|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
105362414|NCT01212094|363332563|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
105362415|NCT01212094|363332564|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
105362416|NCT01212094|363332562|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
105362417|NCT01212094|363332563|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
105362418|NCT01212094|363332564|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
105362419|NCT01212094|363332562|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
105362420|NCT01212094|363332563|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
105362421|NCT01212094|363332564|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
105362422|NCT01212094|363332562|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
105362423|NCT01212094|363332563|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
105362424|NCT01212094|363332564|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
105362425|NCT01212094|363332562|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
105362426|NCT01212094|363332563|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
105362427|NCT01212094|363332564|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
105362428|NCT03512353|363332565|FG000|Overall Study|Sponsor Decision|3|||
105362429|NCT03512353|363332565|FG000|Overall Study|Death|1|||
105362430|NCT03569098|363332566|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
105362431|NCT03569098|363332567|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
105362432|NCT03569098|363332568|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
105362433|NCT03569098|363332566|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
105362434|NCT03569098|363332567|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
105362435|NCT03569098|363332568|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
105362436|NCT03569098|363332566|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
105362437|NCT03569098|363332567|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
105362438|NCT03569098|363332568|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
105362439|NCT03569098|363332566|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
105362440|NCT03569098|363332567|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
105362441|NCT03569098|363332568|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
105362442|NCT03569098|363332566|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
105362443|NCT03569098|363332567|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
105362444|NCT03569098|363332568|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
105362445|NCT03569098|363332566|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
105817045|NCT00324168|364990470|FG000|Overall Study|Patient did not visit in f/u window|6|||
105362446|NCT03569098|363332567|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
105362447|NCT03569098|363332568|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
105362448|NCT03569098|363332566|FG000|Double-Blind Treatment Cycle 1|Other|1|||
105362449|NCT03569098|363332567|FG001|Double-Blind Treatment Cycle 1|Other|0|||
105817046|NCT00324168|364990471|FG001|Overall Study|Patient did not visit in f/u window|9|||
105817047|NCT01591785|364990475|FG000|Overall Study|worsening condition|1|||
105817048|NCT01591785|364990476|FG001|Overall Study|worsening condition|2|||
105817049|NCT01591785|364990475|FG000|Overall Study|Protocol Violation|2|||
105817050|NCT01591785|364990476|FG001|Overall Study|Protocol Violation|0|||
105817051|NCT01591785|364990475|FG000|Overall Study|Lost to Follow-up|1|||
105817052|NCT01591785|364990476|FG001|Overall Study|Lost to Follow-up|0|||
105817053|NCT00358449|364990477|FG000|Overall Study|Adverse Event|1|||
105817054|NCT00358449|364990478|FG001|Overall Study|Adverse Event|0|||
105817055|NCT00358449|364990479|FG002|Overall Study|Adverse Event|1|||
105817056|NCT00358449|364990477|FG000|Overall Study|Lost to Follow-up|1|||
105817057|NCT00358449|364990478|FG001|Overall Study|Lost to Follow-up|0|||
105817058|NCT00358449|364990479|FG002|Overall Study|Lost to Follow-up|0|||
105817059|NCT00358449|364990477|FG000|Overall Study|Withdrawal by Subject|2|||
105817060|NCT00358449|364990478|FG001|Overall Study|Withdrawal by Subject|0|||
105817061|NCT00358449|364990479|FG002|Overall Study|Withdrawal by Subject|0|||
105817062|NCT00358449|364990477|FG000|Overall Study|Lack of Efficacy|0|||
105817063|NCT00358449|364990478|FG001|Overall Study|Lack of Efficacy|1|||
105817064|NCT00358449|364990479|FG002|Overall Study|Lack of Efficacy|0|||
105817065|NCT00358449|364990477|FG000|Overall Study|Steriod Inhaler was Increased|0|||
105817066|NCT00358449|364990478|FG001|Overall Study|Steriod Inhaler was Increased|0|||
105817067|NCT00358449|364990479|FG002|Overall Study|Steriod Inhaler was Increased|1|||
105817068|NCT00496964|364990483|FG000|Overall Study|Withdrawal by Subject|0|||
105817069|NCT00496964|364990484|FG001|Overall Study|Withdrawal by Subject|1|||
105817070|NCT05327491|364990485|FG000|Periods 1 & 2|Miscellaneous|0|||
105817071|NCT05327491|364990486|FG001|Periods 1 & 2|Miscellaneous|1|||
105817072|NCT05327491|364990487|FG002|Periods 1 & 2|Miscellaneous|0|||
105817073|NCT05327491|364990488|FG003|Periods 1 & 2|Miscellaneous|0|||
105817074|NCT05327491|364990485|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
105817075|NCT05327491|364990486|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
105817076|NCT05327491|364990487|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
105817077|NCT05327491|364990488|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
105817078|NCT02334722|364990489|FG000|Overall Study|Lost to Follow-up|4|||
105817079|NCT02334722|364990490|FG001|Overall Study|Lost to Follow-up|0|||
105817080|NCT02334722|364990489|FG000|Overall Study|6 week questionnaire not completed|2|||
105817081|NCT02334722|364990490|FG001|Overall Study|6 week questionnaire not completed|0|||
105817082|NCT02334722|364990489|FG000|Overall Study|Unable to obtain medication|1|||
105817083|NCT02334722|364990490|FG001|Overall Study|Unable to obtain medication|1|||
105817084|NCT02334722|364990489|FG000|Overall Study|Withdrawal by Subject|0|||
105817085|NCT02334722|364990490|FG001|Overall Study|Withdrawal by Subject|3|||
105817086|NCT02334722|364990489|FG000|Overall Study|Adverse Event|0|||
105817087|NCT02334722|364990490|FG001|Overall Study|Adverse Event|2|||
105817088|NCT02334722|364990489|FG000|Overall Study|Physician Decision|0|||
105817089|NCT02334722|364990490|FG001|Overall Study|Physician Decision|1|||
105817090|NCT04088760|364990491|FG000|Overall Study|Physician Decision|1|||
105817091|NCT01391793|364990494|FG000|Overall Study|Ineligible|3|||
105817092|NCT01391793|364990495|FG001|Overall Study|Ineligible|0|||
105817093|NCT01391793|364990494|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
105817094|NCT01391793|364990495|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
105817095|NCT01391793|364990494|FG000|Overall Study|No DMSA|73|||
105817096|NCT01391793|364990495|FG001|Overall Study|No DMSA|57|||
105817097|NCT00436553|364990496|FG000|Overall Study|Adverse Event|4|||
105817098|NCT00436553|364990497|FG001|Overall Study|Adverse Event|3|||
105817099|NCT00436553|364990498|FG002|Overall Study|Adverse Event|4|||
105817100|NCT00436553|364990496|FG000|Overall Study|Death|3|||
105817101|NCT00436553|364990497|FG001|Overall Study|Death|1|||
105817102|NCT00436553|364990498|FG002|Overall Study|Death|3|||
105817103|NCT00436553|364990496|FG000|Overall Study|Lost to Follow-up|0|||
105817104|NCT00436553|364990497|FG001|Overall Study|Lost to Follow-up|2|||
105817105|NCT00436553|364990498|FG002|Overall Study|Lost to Follow-up|0|||
105362450|NCT03569098|363332568|FG002|Double-Blind Treatment Cycle 1|Other|1|||
105362451|NCT03569098|363332566|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
105362452|NCT03569098|363332567|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
105362453|NCT03569098|363332568|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
105362454|NCT03569098|363332566|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
105362455|NCT03569098|363332567|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
105362456|NCT03569098|363332568|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
105362457|NCT03569098|363332566|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
105362458|NCT03569098|363332567|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
105362459|NCT03569098|363332568|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
105362460|NCT03569098|363332566|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
105362461|NCT03569098|363332567|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
105362462|NCT03569098|363332568|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
105362463|NCT03569098|363332566|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
105486277|NCT02953509|363791460|FG006|Overall Study|Lost to Follow-up|1|||
105817106|NCT00436553|364990496|FG000|Overall Study|Protocol Violation|1|||
105817107|NCT00436553|364990497|FG001|Overall Study|Protocol Violation|0|||
105817108|NCT00436553|364990498|FG002|Overall Study|Protocol Violation|0|||
105817109|NCT00436553|364990496|FG000|Overall Study|Withdrawal by Subject|5|||
105817110|NCT00436553|364990497|FG001|Overall Study|Withdrawal by Subject|6|||
105817111|NCT00436553|364990498|FG002|Overall Study|Withdrawal by Subject|3|||
105817112|NCT00064753|364990499|FG000|Overall Study|Death|251|||
105817113|NCT00064753|364990500|FG001|Overall Study|Death|242|||
105817114|NCT00064753|364990499|FG000|Overall Study|Withdrawal by Subject|198|||
105817115|NCT00064753|364990500|FG001|Overall Study|Withdrawal by Subject|171|||
105817116|NCT00064753|364990499|FG000|Overall Study|Lost to Follow-up|225|||
105817117|NCT00064753|364990500|FG001|Overall Study|Lost to Follow-up|235|||
105817118|NCT00533273|364990510|FG000|Double-blind|Withdrew consent|0|||
105817119|NCT00533273|364990511|FG001|Double-blind|Withdrew consent|2|||
105817120|NCT00533273|364990510|FG000|Open-label|Withdrawal by Subject|6|||
105817121|NCT00533273|364990511|FG001|Open-label|Withdrawal by Subject|0|||
105817122|NCT00669942|364990513|FG000|Parts 2 and 3|Adverse Event|0|||
105817123|NCT00669942|364990514|FG001|Parts 2 and 3|Adverse Event|0|||
105817124|NCT00669942|364990515|FG002|Parts 2 and 3|Adverse Event|0|||
105817125|NCT00669942|364990516|FG003|Parts 2 and 3|Adverse Event|0|||
105817126|NCT00669942|364990517|FG004|Parts 2 and 3|Adverse Event|0|||
105817127|NCT00669942|364990518|FG005|Parts 2 and 3|Adverse Event|0|||
105817128|NCT00669942|364990519|FG006|Parts 2 and 3|Adverse Event|0|||
105817129|NCT00669942|364990520|FG007|Parts 2 and 3|Adverse Event|2|||
105817130|NCT00669942|364990521|FG008|Parts 2 and 3|Adverse Event|1|||
105817131|NCT00669942|364990522|FG009|Parts 2 and 3|Adverse Event|0|||
105817132|NCT00669942|364990523|FG010|Parts 2 and 3|Adverse Event|0|||
105817133|NCT00669942|364990524|FG011|Parts 2 and 3|Adverse Event|0|||
105817134|NCT00669942|364990513|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
105817135|NCT00669942|364990514|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
105817136|NCT00669942|364990515|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
105817137|NCT00669942|364990516|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
105817138|NCT00669942|364990517|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
105817139|NCT00669942|364990518|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
105817140|NCT00669942|364990519|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
105817141|NCT00669942|364990520|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
105817142|NCT00669942|364990521|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
105817143|NCT00669942|364990522|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
105817144|NCT00669942|364990523|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
105817145|NCT00669942|364990524|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
105817146|NCT00669942|364990513|FG000|Parts 2 and 3|Protocol Violation|0|||
105817147|NCT00669942|364990514|FG001|Parts 2 and 3|Protocol Violation|0|||
105817148|NCT00669942|364990515|FG002|Parts 2 and 3|Protocol Violation|0|||
105817149|NCT00669942|364990516|FG003|Parts 2 and 3|Protocol Violation|0|||
105817150|NCT00669942|364990517|FG004|Parts 2 and 3|Protocol Violation|0|||
105817151|NCT00669942|364990518|FG005|Parts 2 and 3|Protocol Violation|1|||
105817152|NCT00669942|364990519|FG006|Parts 2 and 3|Protocol Violation|0|||
105817153|NCT00669942|364990520|FG007|Parts 2 and 3|Protocol Violation|0|||
105817154|NCT00669942|364990521|FG008|Parts 2 and 3|Protocol Violation|0|||
105817155|NCT00669942|364990522|FG009|Parts 2 and 3|Protocol Violation|0|||
105817156|NCT00669942|364990523|FG010|Parts 2 and 3|Protocol Violation|0|||
105817157|NCT00669942|364990524|FG011|Parts 2 and 3|Protocol Violation|0|||
105817158|NCT04213326|364990530|FG000|Overall Study|Consent withdrawn|51|||
105817159|NCT04213326|364990531|FG001|Overall Study|Consent withdrawn|241|||
105817160|NCT04213326|364990530|FG000|Overall Study|Lost to Follow-up|50|||
105817161|NCT04213326|364990531|FG001|Overall Study|Lost to Follow-up|902|||
105817162|NCT04213326|364990530|FG000|Overall Study|Protocol Violation|3|||
105817163|NCT04213326|364990531|FG001|Overall Study|Protocol Violation|25|||
105817164|NCT04213326|364990530|FG000|Overall Study|Participant eligibility changed|106|||
105817165|NCT04213326|364990531|FG001|Overall Study|Participant eligibility changed|19|||
105817166|NCT04213326|364990530|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
105817167|NCT04213326|364990531|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
105817168|NCT04213326|364990530|FG000|Overall Study|Incomplete study visit|0|||
105817169|NCT04213326|364990531|FG001|Overall Study|Incomplete study visit|367|||
105817170|NCT02865850|364990536|FG000|Overall Study|Death|15|||
105571645|NCT00332332|364092714|FG000|Overall Study|Noncompliance|2|||
105571646|NCT00332332|364092714|FG000|Overall Study|Disease progression|2|||
105817171|NCT02865850|364990537|FG001|Overall Study|Death|19|||
105817172|NCT02865850|364990536|FG000|Overall Study|Withdrawal by Subject|3|||
105817173|NCT02865850|364990537|FG001|Overall Study|Withdrawal by Subject|2|||
105817174|NCT02865850|364990536|FG000|Overall Study|Lost to Follow-up|3|||
105571647|NCT00332332|364092714|FG000|Overall Study|Other|18|||
105571648|NCT00332332|364092714|FG000|Overall Study|Did not receive study treatment|16|||
105817175|NCT02865850|364990537|FG001|Overall Study|Lost to Follow-up|2|||
105817176|NCT02726581|364990538|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
105817177|NCT02726581|364990539|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
105817178|NCT02726581|364990540|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
105817179|NCT02726581|364990538|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
105817180|NCT02726581|364990539|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
105817181|NCT02726581|364990540|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
105817182|NCT02726581|364990538|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
105571649|NCT02746575|364092715|FG000|Overall Study|Surgery cancelled or time chaned|13|||
105817183|NCT02726581|364990539|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105817184|NCT02726581|364990540|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105817185|NCT02726581|364990538|FG000|Treatment Period|Disease progression|47|||
105817186|NCT02726581|364990539|FG001|Treatment Period|Disease progression|50|||
105817187|NCT02726581|364990540|FG002|Treatment Period|Disease progression|16|||
105817188|NCT02726581|364990538|FG000|Treatment Period|Other reasons|9|||
105817189|NCT02726581|364990539|FG001|Treatment Period|Other reasons|8|||
105817190|NCT02726581|364990540|FG002|Treatment Period|Other reasons|2|||
105817191|NCT02726581|364990538|FG000|Treatment Period|Study drug toxicity|6|||
105817192|NCT02726581|364990539|FG001|Treatment Period|Study drug toxicity|3|||
105817193|NCT02726581|364990540|FG002|Treatment Period|Study drug toxicity|2|||
105817194|NCT02726581|364990538|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
105817195|NCT02726581|364990539|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
105817196|NCT02726581|364990540|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
105817197|NCT02726581|364990538|FG000|Treatment Period|Participant withdrew consent|3|||
105817198|NCT02726581|364990539|FG001|Treatment Period|Participant withdrew consent|1|||
105817199|NCT02726581|364990540|FG002|Treatment Period|Participant withdrew consent|1|||
105817200|NCT02726581|364990538|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
105817201|NCT02726581|364990539|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
105817202|NCT02726581|364990540|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
105817203|NCT02726581|364990538|FG000|Treatment Period|Maximum clinical benefit|0|||
105817204|NCT02726581|364990539|FG001|Treatment Period|Maximum clinical benefit|2|||
105817205|NCT02726581|364990540|FG002|Treatment Period|Maximum clinical benefit|0|||
105817206|NCT02726581|364990538|FG000|Treatment Period|Death|1|||
105817207|NCT02726581|364990539|FG001|Treatment Period|Death|0|||
105817208|NCT02726581|364990540|FG002|Treatment Period|Death|0|||
105817209|NCT02726581|364990538|FG000|Treatment Period|Poor/non-compliance|1|||
105817210|NCT02726581|364990539|FG001|Treatment Period|Poor/non-compliance|0|||
105817211|NCT02726581|364990540|FG002|Treatment Period|Poor/non-compliance|0|||
105817212|NCT02726581|364990538|FG000|Treatment Period|Participant no longer meets study criteria|0|||
105817213|NCT02726581|364990539|FG001|Treatment Period|Participant no longer meets study criteria|1|||
105817214|NCT02726581|364990540|FG002|Treatment Period|Participant no longer meets study criteria|0|||
105817215|NCT01772537|364990545|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
105817216|NCT01772537|364990546|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
105817217|NCT01772537|364990547|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
105817218|NCT03195491|364990548|FG000|Overall Study|Study drug toxicity|25|||
105817219|NCT03195491|364990549|FG001|Overall Study|Study drug toxicity|3|||
105817220|NCT03195491|364990548|FG000|Overall Study|Maximum clinical benefit|5|||
105817221|NCT03195491|364990549|FG001|Overall Study|Maximum clinical benefit|0|||
105817222|NCT03195491|364990548|FG000|Overall Study|Lost to Follow-up|1|||
105817223|NCT03195491|364990549|FG001|Overall Study|Lost to Follow-up|0|||
105817224|NCT03195491|364990548|FG000|Overall Study|Death|3|||
105817225|NCT03195491|364990549|FG001|Overall Study|Death|0|||
105817226|NCT03195491|364990548|FG000|Overall Study|Adverse event unrelated to study drug|19|||
105817227|NCT03195491|364990549|FG001|Overall Study|Adverse event unrelated to study drug|2|||
105817228|NCT03195491|364990548|FG000|Overall Study|Disease progression|266|||
105817229|NCT03195491|364990549|FG001|Overall Study|Disease progression|8|||
105817230|NCT03195491|364990548|FG000|Overall Study|Other reasons|10|||
105817231|NCT03195491|364990549|FG001|Overall Study|Other reasons|0|||
105817232|NCT03195491|364990548|FG000|Overall Study|Participant withdrew consent|8|||
105817233|NCT03195491|364990549|FG001|Overall Study|Participant withdrew consent|1|||
105817234|NCT03195491|364990548|FG000|Overall Study|Participant no longer meets study criteria|0|||
105817235|NCT03195491|364990549|FG001|Overall Study|Participant no longer meets study criteria|1|||
105817236|NCT03195491|364990548|FG000|Overall Study|Participant request to discontinue study treatment|10|||
105817237|NCT03195491|364990549|FG001|Overall Study|Participant request to discontinue study treatment|0|||
105817238|NCT01263704|364990550|FG000|Overall Study|Progressive disease|18|||
105817239|NCT01263704|364990550|FG000|Overall Study|Adverse Event|3|||
105817240|NCT01263704|364990550|FG000|Overall Study|Death|2|||
105817241|NCT01263704|364990550|FG000|Overall Study|Patient withdrew consent|2|||
105817242|NCT01263704|364990550|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
105817243|NCT01263704|364990550|FG000|Overall Study|Lost to Follow-up|1|||
105817244|NCT01263704|364990550|FG000|Overall Study|Colon metastases|1|||
105817245|NCT01263704|364990550|FG000|Overall Study|Principal Investigator (PI) decision|1|||
105817246|NCT00112463|364990567|FG000|Overall Study|Physician Decision|1|||
105817247|NCT00112463|364990567|FG000|Overall Study|Progression|30|||
105817248|NCT00112463|364990567|FG000|Overall Study|Second Primary|1|||
105817249|NCT00112463|364990567|FG000|Overall Study|Toxicity|3|||
105817250|NCT00112463|364990567|FG000|Overall Study|Withdrawal by Subject|2|||
105817251|NCT00112463|364990567|FG000|Overall Study|Never started treatment|2|||
105817252|NCT01185821|364990577|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105817253|NCT01185821|364990578|FG001|Overall Study|Abnormal laboratory value(s)|2|||
105817254|NCT01185821|364990579|FG002|Overall Study|Abnormal laboratory value(s)|1|||
105817255|NCT01185821|364990580|FG003|Overall Study|Abnormal laboratory value(s)|0|||
105817256|NCT01185821|364990581|FG004|Overall Study|Abnormal laboratory value(s)|0|||
105817257|NCT01185821|364990577|FG000|Overall Study|Protocol Violation|0|||
105817258|NCT01185821|364990578|FG001|Overall Study|Protocol Violation|0|||
105817259|NCT01185821|364990579|FG002|Overall Study|Protocol Violation|0|||
105817260|NCT01185821|364990580|FG003|Overall Study|Protocol Violation|1|||
105817261|NCT01185821|364990581|FG004|Overall Study|Protocol Violation|1|||
105817262|NCT01185821|364990577|FG000|Overall Study|Abnormal test procedure result|0|||
105817263|NCT01185821|364990578|FG001|Overall Study|Abnormal test procedure result|0|||
105817264|NCT01185821|364990579|FG002|Overall Study|Abnormal test procedure result|0|||
105817265|NCT01185821|364990580|FG003|Overall Study|Abnormal test procedure result|0|||
105817266|NCT01185821|364990581|FG004|Overall Study|Abnormal test procedure result|1|||
105817267|NCT01185821|364990577|FG000|Overall Study|Death|0|||
105817268|NCT01185821|364990578|FG001|Overall Study|Death|1|||
105817269|NCT01185821|364990579|FG002|Overall Study|Death|0|||
105817270|NCT01185821|364990580|FG003|Overall Study|Death|0|||
105817271|NCT01185821|364990581|FG004|Overall Study|Death|0|||
105817272|NCT01185821|364990577|FG000|Overall Study|Condition no longer required study drug|0|||
105817273|NCT01185821|364990578|FG001|Overall Study|Condition no longer required study drug|0|||
105817274|NCT01185821|364990579|FG002|Overall Study|Condition no longer required study drug|0|||
105817275|NCT01185821|364990580|FG003|Overall Study|Condition no longer required study drug|0|||
105817276|NCT01185821|364990581|FG004|Overall Study|Condition no longer required study drug|1|||
105817277|NCT01185821|364990577|FG000|Overall Study|Adverse Event|2|||
105817278|NCT01185821|364990578|FG001|Overall Study|Adverse Event|3|||
105817279|NCT01185821|364990579|FG002|Overall Study|Adverse Event|1|||
105486278|NCT02953509|363791461|FG007|Overall Study|Lost to Follow-up|1|||
105486279|NCT02953509|363791462|FG008|Overall Study|Lost to Follow-up|1|||
105765162|NCT02407236|364791859|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
105765163|NCT02407236|364791860|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
105765164|NCT02407236|364791861|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
105765165|NCT02407236|364791862|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
105765166|NCT02407236|364791863|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
105765167|NCT02407236|364791851|FG000|Induction Study (8 Weeks)|Death|0|||
105765168|NCT02407236|364791852|FG001|Induction Study (8 Weeks)|Death|0|||
105765169|NCT02407236|364791853|FG002|Induction Study (8 Weeks)|Death|1|||
105765170|NCT02407236|364791854|FG003|Induction Study (8 Weeks)|Death|0|||
105765171|NCT02407236|364791855|FG004|Induction Study (8 Weeks)|Death|0|||
105765172|NCT02407236|364791856|FG005|Induction Study (8 Weeks)|Death|0|||
105765173|NCT02407236|364791857|FG006|Induction Study (8 Weeks)|Death|0|||
105765174|NCT02407236|364791858|FG007|Induction Study (8 Weeks)|Death|0|||
105765175|NCT02407236|364791859|FG008|Induction Study (8 Weeks)|Death|0|||
105765176|NCT02407236|364791860|FG009|Induction Study (8 Weeks)|Death|0|||
105765177|NCT02407236|364791861|FG010|Induction Study (8 Weeks)|Death|0|||
105765178|NCT02407236|364791862|FG011|Induction Study (8 Weeks)|Death|0|||
105765179|NCT02407236|364791863|FG012|Induction Study (8 Weeks)|Death|0|||
105765180|NCT02407236|364791851|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
105765181|NCT02407236|364791852|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
105765182|NCT02407236|364791853|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
105765183|NCT02407236|364791854|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765184|NCT02407236|364791855|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765185|NCT02407236|364791856|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765186|NCT02407236|364791857|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765187|NCT02407236|364791858|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765188|NCT02407236|364791859|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765189|NCT02407236|364791860|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765190|NCT02407236|364791861|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765191|NCT02407236|364791862|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765192|NCT02407236|364791863|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765193|NCT02407236|364791851|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765194|NCT02407236|364791852|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105817280|NCT01185821|364990580|FG003|Overall Study|Adverse Event|2|||
105486280|NCT02953509|363791463|FG009|Overall Study|Lost to Follow-up|1|||
105486281|NCT02953509|363791454|FG000|Overall Study|Study terminated by sponsor|1|||
105817281|NCT01185821|364990581|FG004|Overall Study|Adverse Event|5|||
105817282|NCT01185821|364990577|FG000|Overall Study|Lack of Efficacy|0|||
105765195|NCT02407236|364791853|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
105765196|NCT02407236|364791854|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765197|NCT02407236|364791855|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765198|NCT02407236|364791856|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765199|NCT02407236|364791857|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765200|NCT02407236|364791858|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765201|NCT02407236|364791859|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765202|NCT02407236|364791860|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765203|NCT02407236|364791861|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765204|NCT02407236|364791862|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765205|NCT02407236|364791863|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765206|NCT02407236|364791851|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
105765207|NCT02407236|364791852|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
105765208|NCT02407236|364791853|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
105765209|NCT02407236|364791854|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
105765210|NCT02407236|364791855|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
105765211|NCT02407236|364791856|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
105765212|NCT02407236|364791857|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
105765213|NCT02407236|364791858|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
105765214|NCT02407236|364791859|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
105765215|NCT02407236|364791860|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
105765216|NCT02407236|364791861|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
105765217|NCT02407236|364791862|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
105765218|NCT02407236|364791863|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
105765219|NCT02407236|364791851|FG000|Induction Study (8 Weeks)|Other|2|||
105765220|NCT02407236|364791852|FG001|Induction Study (8 Weeks)|Other|1|||
105765221|NCT02407236|364791853|FG002|Induction Study (8 Weeks)|Other|5|||
105765222|NCT02407236|364791854|FG003|Induction Study (8 Weeks)|Other|0|||
105765223|NCT02407236|364791855|FG004|Induction Study (8 Weeks)|Other|0|||
105765224|NCT02407236|364791856|FG005|Induction Study (8 Weeks)|Other|0|||
105765225|NCT02407236|364791857|FG006|Induction Study (8 Weeks)|Other|0|||
105765226|NCT02407236|364791858|FG007|Induction Study (8 Weeks)|Other|0|||
105765227|NCT02407236|364791859|FG008|Induction Study (8 Weeks)|Other|0|||
105765228|NCT02407236|364791860|FG009|Induction Study (8 Weeks)|Other|0|||
105765229|NCT02407236|364791861|FG010|Induction Study (8 Weeks)|Other|0|||
105765230|NCT02407236|364791862|FG011|Induction Study (8 Weeks)|Other|0|||
105765231|NCT02407236|364791863|FG012|Induction Study (8 Weeks)|Other|0|||
105765232|NCT02407236|364791851|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765233|NCT02407236|364791852|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765234|NCT02407236|364791853|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765235|NCT02407236|364791854|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
105765236|NCT02407236|364791855|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
105765237|NCT02407236|364791856|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
105765238|NCT02407236|364791857|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
105765239|NCT02407236|364791858|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
105765240|NCT02407236|364791859|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765241|NCT02407236|364791860|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765242|NCT02407236|364791861|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765243|NCT02407236|364791862|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765244|NCT02407236|364791863|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765245|NCT02407236|364791851|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765246|NCT02407236|364791852|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765247|NCT02407236|364791853|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765248|NCT02407236|364791854|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
105765249|NCT02407236|364791855|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
105765250|NCT02407236|364791856|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
105765251|NCT02407236|364791857|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
105765252|NCT02407236|364791858|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
105765253|NCT02407236|364791859|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765254|NCT02407236|364791860|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765255|NCT02407236|364791861|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765256|NCT02407236|364791862|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765257|NCT02407236|364791863|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765258|NCT02407236|364791851|FG000|Maintenance Study (44 Weeks)|Other|0|||
105765259|NCT02407236|364791852|FG001|Maintenance Study (44 Weeks)|Other|0|||
105765260|NCT02407236|364791853|FG002|Maintenance Study (44 Weeks)|Other|0|||
105765261|NCT02407236|364791854|FG003|Maintenance Study (44 Weeks)|Other|5|||
105765262|NCT02407236|364791855|FG004|Maintenance Study (44 Weeks)|Other|7|||
105765263|NCT02407236|364791856|FG005|Maintenance Study (44 Weeks)|Other|8|||
105765264|NCT02407236|364791857|FG006|Maintenance Study (44 Weeks)|Other|4|||
105765265|NCT02407236|364791858|FG007|Maintenance Study (44 Weeks)|Other|6|||
105765266|NCT02407236|364791859|FG008|Maintenance Study (44 Weeks)|Other|0|||
105765267|NCT02407236|364791860|FG009|Maintenance Study (44 Weeks)|Other|0|||
105765268|NCT02407236|364791861|FG010|Maintenance Study (44 Weeks)|Other|0|||
105765269|NCT02407236|364791862|FG011|Maintenance Study (44 Weeks)|Other|0|||
105765270|NCT02407236|364791863|FG012|Maintenance Study (44 Weeks)|Other|0|||
105765271|NCT02407236|364791851|FG000|Maintenance Study (44 Weeks)|Death|0|||
105765272|NCT02407236|364791852|FG001|Maintenance Study (44 Weeks)|Death|0|||
105765273|NCT02407236|364791853|FG002|Maintenance Study (44 Weeks)|Death|0|||
105765274|NCT02407236|364791854|FG003|Maintenance Study (44 Weeks)|Death|0|||
105765275|NCT02407236|364791855|FG004|Maintenance Study (44 Weeks)|Death|0|||
105765276|NCT02407236|364791856|FG005|Maintenance Study (44 Weeks)|Death|0|||
105765277|NCT02407236|364791857|FG006|Maintenance Study (44 Weeks)|Death|0|||
105765278|NCT02407236|364791858|FG007|Maintenance Study (44 Weeks)|Death|1|||
105765279|NCT02407236|364791859|FG008|Maintenance Study (44 Weeks)|Death|0|||
105765280|NCT02407236|364791860|FG009|Maintenance Study (44 Weeks)|Death|0|||
105765281|NCT02407236|364791861|FG010|Maintenance Study (44 Weeks)|Death|0|||
105765282|NCT02407236|364791862|FG011|Maintenance Study (44 Weeks)|Death|0|||
105765283|NCT02407236|364791863|FG012|Maintenance Study (44 Weeks)|Death|0|||
105765284|NCT02407236|364791851|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765285|NCT02407236|364791852|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765286|NCT02407236|364791853|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765287|NCT02407236|364791854|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765288|NCT02407236|364791855|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765289|NCT02407236|364791856|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765290|NCT02407236|364791857|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765291|NCT02407236|364791858|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765292|NCT02407236|364791859|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
105765293|NCT02407236|364791860|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
105765294|NCT02407236|364791861|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
105765295|NCT02407236|364791862|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
105765296|NCT02407236|364791863|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
105765297|NCT02407236|364791851|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765298|NCT02407236|364791852|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765299|NCT02407236|364791853|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765300|NCT02407236|364791854|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765301|NCT02407236|364791855|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765302|NCT02407236|364791856|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765303|NCT02407236|364791857|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765304|NCT02407236|364791858|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765305|NCT02407236|364791859|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765306|NCT02407236|364791860|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765307|NCT02407236|364791861|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
105765308|NCT02407236|364791862|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765309|NCT02407236|364791863|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765310|NCT02407236|364791851|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765311|NCT02407236|364791852|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765312|NCT02407236|364791853|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765313|NCT02407236|364791854|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765314|NCT02407236|364791855|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765315|NCT02407236|364791856|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765316|NCT02407236|364791857|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765317|NCT02407236|364791858|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765318|NCT02407236|364791859|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
105765319|NCT02407236|364791860|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
105765320|NCT02407236|364791861|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
105765321|NCT02407236|364791862|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
105765322|NCT02407236|364791863|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
105765323|NCT02407236|364791851|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
105765324|NCT02407236|364791852|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
105765325|NCT02407236|364791853|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
105765326|NCT02407236|364791854|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
105765327|NCT02407236|364791855|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
105765328|NCT02407236|364791856|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
105765329|NCT02407236|364791857|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
105765330|NCT02407236|364791858|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
105765331|NCT02407236|364791859|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
105765332|NCT02407236|364791860|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
105765333|NCT02407236|364791861|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
105765334|NCT02407236|364791862|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
105817283|NCT01185821|364990578|FG001|Overall Study|Lack of Efficacy|0|||
105817284|NCT01185821|364990579|FG002|Overall Study|Lack of Efficacy|3|||
105817285|NCT01185821|364990580|FG003|Overall Study|Lack of Efficacy|0|||
105817286|NCT01185821|364990581|FG004|Overall Study|Lack of Efficacy|9|||
105817287|NCT01185821|364990577|FG000|Overall Study|Withdrawal by Subject|3|||
105817288|NCT01185821|364990578|FG001|Overall Study|Withdrawal by Subject|2|||
105817289|NCT01185821|364990579|FG002|Overall Study|Withdrawal by Subject|2|||
105817290|NCT01185821|364990580|FG003|Overall Study|Withdrawal by Subject|1|||
105817291|NCT01185821|364990581|FG004|Overall Study|Withdrawal by Subject|3|||
105817292|NCT01185821|364990577|FG000|Overall Study|Lost to Follow-up|1|||
105817293|NCT01185821|364990578|FG001|Overall Study|Lost to Follow-up|1|||
105817294|NCT01185821|364990579|FG002|Overall Study|Lost to Follow-up|2|||
105817295|NCT01185821|364990580|FG003|Overall Study|Lost to Follow-up|1|||
105817296|NCT01185821|364990581|FG004|Overall Study|Lost to Follow-up|2|||
105817297|NCT01185821|364990577|FG000|Overall Study|Administrative problems|0|||
105817298|NCT01185821|364990578|FG001|Overall Study|Administrative problems|0|||
105817299|NCT01185821|364990579|FG002|Overall Study|Administrative problems|1|||
105817300|NCT01185821|364990580|FG003|Overall Study|Administrative problems|1|||
105817301|NCT01185821|364990581|FG004|Overall Study|Administrative problems|2|||
105817302|NCT01546545|364990583|FG000|Overall Study|Withdrawal by Subject|1|||
105817303|NCT00296647|364990584|FG000|Overall Study|Death|4|||
105817304|NCT00296647|364990585|FG001|Overall Study|Death|1|||
105817305|NCT00296647|364990586|FG002|Overall Study|Death|2|||
105817306|NCT00296647|364990587|FG003|Overall Study|Death|1|||
105817307|NCT00296647|364990588|FG004|Overall Study|Death|1|||
105817308|NCT00296647|364990584|FG000|Overall Study|Withdrawal by Subject|28|||
105817309|NCT00296647|364990585|FG001|Overall Study|Withdrawal by Subject|27|||
105817310|NCT00296647|364990586|FG002|Overall Study|Withdrawal by Subject|32|||
105817311|NCT00296647|364990587|FG003|Overall Study|Withdrawal by Subject|16|||
105817312|NCT00296647|364990588|FG004|Overall Study|Withdrawal by Subject|19|||
105817313|NCT01001208|364990597|FG000|Overall Study|Adverse Event|10|||
105817314|NCT01001208|364990598|FG001|Overall Study|Adverse Event|5|||
105817315|NCT01001208|364990597|FG000|Overall Study|Lost to Follow-up|5|||
105817316|NCT01001208|364990598|FG001|Overall Study|Lost to Follow-up|9|||
105817317|NCT01001208|364990597|FG000|Overall Study|Physician Decision|1|||
105817318|NCT01001208|364990598|FG001|Overall Study|Physician Decision|0|||
105817319|NCT01001208|364990597|FG000|Overall Study|Withdrawal by Subject|4|||
105817320|NCT01001208|364990598|FG001|Overall Study|Withdrawal by Subject|5|||
105817321|NCT01001208|364990597|FG000|Overall Study|Ineligibility Determined|4|||
105817322|NCT01001208|364990598|FG001|Overall Study|Ineligibility Determined|2|||
105817323|NCT01001208|364990597|FG000|Overall Study|Noncompliance|4|||
105817324|NCT01001208|364990598|FG001|Overall Study|Noncompliance|7|||
105817325|NCT01001208|364990597|FG000|Overall Study|Disease Progression|0|||
105817326|NCT01001208|364990598|FG001|Overall Study|Disease Progression|3|||
105817327|NCT01001208|364990597|FG000|Overall Study|Other|0|||
105817328|NCT01001208|364990598|FG001|Overall Study|Other|2|||
105817329|NCT00855738|364990599|FG000|Overall Study|Lost to Follow-up|2|||
105817330|NCT00855738|364990599|FG000|Overall Study|Adverse Event|1|||
105817331|NCT00855738|364990599|FG000|Overall Study|Subject Defaulted|1|||
105817332|NCT00855738|364990599|FG000|Overall Study|Death|1|||
105817333|NCT02100228|364990602|FG000|Overall Study|Other|19|||
105817334|NCT02100228|364990603|FG001|Overall Study|Other|19|||
105817335|NCT02100228|364990602|FG000|Overall Study|Administrative reason|0|||
105817336|NCT02100228|364990603|FG001|Overall Study|Administrative reason|1|||
105817337|NCT02100228|364990602|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
105765335|NCT02407236|364791863|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
105765336|NCT02177812|364791866|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
105765337|NCT02177812|364791867|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
105765338|NCT02177812|364791868|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
105765339|NCT02177812|364791869|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
105765340|NCT02177812|364791870|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
105765341|NCT02177812|364791871|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
105765342|NCT02177812|364791872|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
105765343|NCT02177812|364791873|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
105765344|NCT02177812|364791874|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
105817338|NCT02100228|364990603|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
105817339|NCT02100228|364990602|FG000|Overall Study|Non-compliance|0|||
105817340|NCT02100228|364990603|FG001|Overall Study|Non-compliance|3|||
105817341|NCT02100228|364990602|FG000|Overall Study|Lost to Follow-up|0|||
105817342|NCT02100228|364990603|FG001|Overall Study|Lost to Follow-up|1|||
105817343|NCT02100228|364990602|FG000|Overall Study|Withdrawal by Subject|27|||
105817344|NCT02100228|364990603|FG001|Overall Study|Withdrawal by Subject|37|||
105817345|NCT02100228|364990602|FG000|Overall Study|Adverse Event|16|||
105817346|NCT02100228|364990603|FG001|Overall Study|Adverse Event|12|||
105817347|NCT02100228|364990602|FG000|Overall Study|Death|1|||
105817348|NCT02100228|364990603|FG001|Overall Study|Death|1|||
105765345|NCT02177812|364791866|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
105765346|NCT02177812|364791867|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
105765347|NCT02177812|364791868|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
105765348|NCT02177812|364791869|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
105765349|NCT02177812|364791870|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
105765350|NCT02177812|364791871|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
105765351|NCT02177812|364791872|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
105765352|NCT02177812|364791873|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
105765353|NCT02177812|364791874|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
105765354|NCT02177812|364791866|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
105765355|NCT02177812|364791867|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
105765356|NCT02177812|364791868|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
105765357|NCT02177812|364791869|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
105765358|NCT02177812|364791870|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
105765359|NCT02177812|364791871|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
105765360|NCT02177812|364791872|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
105765361|NCT02177812|364791873|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
105765362|NCT02177812|364791874|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
105765363|NCT02000219|364793661|FG000|14-Week Study Period|Physician Decision|1|||
105765364|NCT02000219|364793661|FG000|14-Week Study Period|Adverse Event|1|||
105765365|NCT02000219|364793661|FG000|14-Week Study Period|Underwent transplantation|1|||
105765366|NCT02000219|364793661|FG000|Continuation Period|Withdrawal by Subject|1|||
105765367|NCT02000219|364793661|FG000|Continuation Period|Had liver transplant|2|||
105765368|NCT02000219|364793661|FG000|Continuation Period|Non-compliance with study drug|2|||
105765369|NCT00784459|364793667|FG000|Overall Study|Adverse Event|0|||
105765370|NCT00784459|364793668|FG001|Overall Study|Adverse Event|2|||
105765371|NCT02431702|364793669|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
105765372|NCT02431702|364793670|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
105765373|NCT02431702|364793671|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
105765374|NCT02431702|364793672|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
105765375|NCT02431702|364793673|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
105765376|NCT02431702|364793674|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
105765377|NCT02431702|364793675|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
105765378|NCT02431702|364793669|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
105765379|NCT02431702|364793670|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
105765380|NCT02431702|364793671|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
105765381|NCT02431702|364793672|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
105765382|NCT02431702|364793673|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
105765383|NCT02431702|364793674|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
105765384|NCT02431702|364793675|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
105765385|NCT02431702|364793669|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
105765386|NCT02431702|364793670|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
105765387|NCT02431702|364793671|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
105765388|NCT02431702|364793672|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
105765389|NCT02431702|364793673|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
105765390|NCT02431702|364793674|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
105765391|NCT02431702|364793675|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
105765392|NCT02431702|364793669|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
105765393|NCT02431702|364793670|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
105765394|NCT02431702|364793671|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
105765395|NCT02431702|364793672|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
105765396|NCT02431702|364793673|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
105765397|NCT02431702|364793674|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
105765398|NCT02431702|364793675|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
105765399|NCT02431702|364793669|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
105765400|NCT02431702|364793670|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
105765401|NCT02431702|364793671|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
105765402|NCT02431702|364793672|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
105765403|NCT02431702|364793673|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
105765404|NCT02431702|364793674|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
105765405|NCT02431702|364793675|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
105765406|NCT02431702|364793669|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
105765407|NCT02431702|364793670|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
105765408|NCT02431702|364793671|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
105765409|NCT02431702|364793672|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
105765410|NCT02431702|364793673|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
105765411|NCT02431702|364793674|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
105817349|NCT03929393|364990606|FG000|Overall Study|Death|1|||
105817350|NCT03929393|364990607|FG001|Overall Study|Death|0|||
105817351|NCT03929393|364990606|FG000|Overall Study|Time Commitment|2|||
105817352|NCT03929393|364990607|FG001|Overall Study|Time Commitment|5|||
105817353|NCT03929393|364990606|FG000|Overall Study|Motor Vehicle Accident|0|||
105817354|NCT03929393|364990607|FG001|Overall Study|Motor Vehicle Accident|1|||
105817355|NCT03929393|364990606|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
105817356|NCT03929393|364990607|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
105817357|NCT03929393|364990606|FG000|Overall Study|Other|1|||
105817358|NCT03929393|364990607|FG001|Overall Study|Other|3|||
105817359|NCT03500692|364990629|FG000|Overall Study|Death|163|||
105817360|NCT03500692|364990629|FG000|Overall Study|Lost to Follow-up|75|||
105817361|NCT03500692|364990629|FG000|Overall Study|Termination Reasons|3|||
105817362|NCT05593965|364990630|FG000|1st Intervention (1 Day)|Technical error|1|||
105817363|NCT05593965|364990631|FG001|1st Intervention (1 Day)|Technical error|0|||
105817364|NCT01387737|364992311|FG000|Overall Study|Adverse Event|20|||
105817365|NCT01387737|364992312|FG001|Overall Study|Adverse Event|30|||
105817366|NCT01387737|364992311|FG000|Overall Study|Lack of Efficacy|1|||
105817367|NCT01387737|364992312|FG001|Overall Study|Lack of Efficacy|0|||
105817368|NCT01387737|364992311|FG000|Overall Study|Physician Decision|3|||
105817369|NCT01387737|364992312|FG001|Overall Study|Physician Decision|10|||
105817370|NCT01387737|364992311|FG000|Overall Study|Withdrawal by Subject|27|||
105817371|NCT01387737|364992312|FG001|Overall Study|Withdrawal by Subject|31|||
105817372|NCT01387737|364992311|FG000|Overall Study|Clearly not eligible for the study|1|||
105817373|NCT01387737|364992312|FG001|Overall Study|Clearly not eligible for the study|3|||
105817374|NCT01746017|364992315|FG000|Period 1|Withdrawal by Subject|0|||
105817375|NCT01746017|364992316|FG001|Period 1|Withdrawal by Subject|0|||
105817376|NCT01746017|364992317|FG002|Period 1|Withdrawal by Subject|0|||
105817377|NCT01746017|364992318|FG003|Period 1|Withdrawal by Subject|0|||
105817378|NCT01746017|364992319|FG004|Period 1|Withdrawal by Subject|0|||
105817379|NCT01746017|364992320|FG005|Period 1|Withdrawal by Subject|0|||
105817380|NCT01746017|364992321|FG006|Period 1|Withdrawal by Subject|1|||
105817381|NCT01746017|364992322|FG007|Period 1|Withdrawal by Subject|0|||
105817382|NCT01746017|364992323|FG008|Period 1|Withdrawal by Subject|0|||
105817383|NCT01746017|364992324|FG009|Period 1|Withdrawal by Subject|0|||
105817384|NCT01746017|364992325|FG010|Period 1|Withdrawal by Subject|0|||
105817385|NCT01746017|364992315|FG000|Period 3|Withdrawal by Subject|0|||
105817386|NCT01746017|364992316|FG001|Period 3|Withdrawal by Subject|0|||
105817387|NCT01746017|364992317|FG002|Period 3|Withdrawal by Subject|0|||
105817388|NCT01746017|364992318|FG003|Period 3|Withdrawal by Subject|0|||
105817389|NCT01746017|364992319|FG004|Period 3|Withdrawal by Subject|0|||
105817390|NCT01746017|364992320|FG005|Period 3|Withdrawal by Subject|1|||
105817391|NCT01746017|364992321|FG006|Period 3|Withdrawal by Subject|0|||
105817392|NCT01746017|364992322|FG007|Period 3|Withdrawal by Subject|0|||
105817393|NCT01746017|364992323|FG008|Period 3|Withdrawal by Subject|0|||
105817394|NCT01746017|364992324|FG009|Period 3|Withdrawal by Subject|0|||
105817395|NCT01746017|364992325|FG010|Period 3|Withdrawal by Subject|0|||
105486282|NCT02953509|363791455|FG001|Overall Study|Study terminated by sponsor|0|||
105486283|NCT02953509|363791456|FG002|Overall Study|Study terminated by sponsor|0|||
105817396|NCT00397488|364992326|FG000|Overall Study|Withdrawal by Subject|3|||
105817397|NCT00397488|364992326|FG000|Overall Study|Adverse Event|3|||
105817398|NCT00397488|364992326|FG000|Overall Study|Death|1|||
105817399|NCT02424097|364992329|FG000|Overall Study|Lost to Follow-up|1|||
105817400|NCT02424097|364992330|FG001|Overall Study|Lost to Follow-up|2|||
105817401|NCT01215981|364992333|FG000|Overall Study|Physician Decision|0|||
105817402|NCT01215981|364992334|FG001|Overall Study|Physician Decision|1|||
105817403|NCT01215981|364992333|FG000|Overall Study|Protocol Violation|1|||
105817404|NCT01215981|364992334|FG001|Overall Study|Protocol Violation|0|||
105817405|NCT01215981|364992333|FG000|Overall Study|Withdrawal by Subject|1|||
105817406|NCT01215981|364992334|FG001|Overall Study|Withdrawal by Subject|0|||
105817407|NCT01507051|364992335|FG000|Overall Study|Withdrawal by Subject|1|||
105817408|NCT01507051|364992336|FG001|Overall Study|Withdrawal by Subject|3|||
105817409|NCT01507051|364992337|FG002|Overall Study|Withdrawal by Subject|1|||
105817410|NCT01507051|364992338|FG003|Overall Study|Withdrawal by Subject|6|||
105817411|NCT01507051|364992335|FG000|Overall Study|Physician Decision|0|||
105817412|NCT01507051|364992336|FG001|Overall Study|Physician Decision|0|||
105817413|NCT01507051|364992337|FG002|Overall Study|Physician Decision|0|||
105817414|NCT01507051|364992338|FG003|Overall Study|Physician Decision|1|||
105817415|NCT01507051|364992335|FG000|Overall Study|Adverse Event|1|||
105817416|NCT01507051|364992336|FG001|Overall Study|Adverse Event|0|||
105817417|NCT01507051|364992337|FG002|Overall Study|Adverse Event|0|||
105817418|NCT01507051|364992338|FG003|Overall Study|Adverse Event|0|||
105817419|NCT01675622|364992339|FG000|Overall Study|Withdrawal by Subject|2|||
105817420|NCT01675622|364992340|FG001|Overall Study|Withdrawal by Subject|2|||
105817421|NCT01675622|364992339|FG000|Overall Study|Adverse Event|12|||
105817422|NCT01675622|364992340|FG001|Overall Study|Adverse Event|10|||
105817423|NCT01675622|364992339|FG000|Overall Study|Protocol Violation|4|||
105817424|NCT01675622|364992340|FG001|Overall Study|Protocol Violation|1|||
105817425|NCT01675622|364992339|FG000|Overall Study|Lack of Efficacy|2|||
105765412|NCT02431702|364793675|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
105765413|NCT02431702|364793669|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
105765414|NCT02431702|364793670|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
105765415|NCT02431702|364793671|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
105765416|NCT02431702|364793672|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
105765417|NCT02431702|364793673|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
105765418|NCT02431702|364793674|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
105765419|NCT02431702|364793675|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
105765420|NCT02431702|364793669|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
105765421|NCT02431702|364793670|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
105765422|NCT02431702|364793671|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
105765423|NCT02431702|364793672|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
105765424|NCT02431702|364793673|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
105765425|NCT02431702|364793674|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
105765426|NCT02431702|364793675|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
105765427|NCT02431702|364793669|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
105765428|NCT02431702|364793670|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
105765429|NCT02431702|364793671|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
105765430|NCT02431702|364793672|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
105765431|NCT02431702|364793673|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
105765432|NCT02431702|364793674|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
105765433|NCT02431702|364793675|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
105765434|NCT02431702|364793669|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
105765435|NCT02431702|364793670|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
105765436|NCT02431702|364793671|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
105765437|NCT02431702|364793672|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
105765438|NCT02431702|364793673|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
105765439|NCT02431702|364793674|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
105765440|NCT02431702|364793675|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
105765441|NCT02431702|364793669|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
105817426|NCT01675622|364992340|FG001|Overall Study|Lack of Efficacy|4|||
105817427|NCT01675622|364992339|FG000|Overall Study|Lost to Follow-up|1|||
105817428|NCT01675622|364992340|FG001|Overall Study|Lost to Follow-up|3|||
105817429|NCT01675622|364992339|FG000|Overall Study|Other|5|||
105817430|NCT01675622|364992340|FG001|Overall Study|Other|4|||
105817431|NCT04032977|364992341|FG000|Overall Study|Withdrawal by Subject|6|||
105362464|NCT03569098|363332567|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
105362465|NCT03569098|363332568|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
105362466|NCT03569098|363332566|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
105362467|NCT03569098|363332567|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
105362468|NCT03569098|363332568|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
105362469|NCT02581488|363332569|FG000|Overall Study|Adverse Event|6|||
105362470|NCT02581488|363332570|FG001|Overall Study|Adverse Event|7|||
105362471|NCT02581488|363332569|FG000|Overall Study|Lost to Follow-up|1|||
105362472|NCT02581488|363332570|FG001|Overall Study|Lost to Follow-up|0|||
105362473|NCT02581488|363332569|FG000|Overall Study|Withdrawal by Subject|1|||
105362474|NCT02581488|363332570|FG001|Overall Study|Withdrawal by Subject|0|||
105362475|NCT02581488|363332569|FG000|Overall Study|Non-Compliance|1|||
105817432|NCT04032977|364992342|FG001|Overall Study|Withdrawal by Subject|1|||
105817433|NCT04032977|364992341|FG000|Overall Study|Lost to Follow-up|2|||
105362476|NCT02581488|363332570|FG001|Overall Study|Non-Compliance|0|||
105362477|NCT02581488|363332569|FG000|Overall Study|Protocol Violation|0|||
105362478|NCT02581488|363332570|FG001|Overall Study|Protocol Violation|4|||
105362479|NCT02019550|363332572|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
105362480|NCT02019550|363332573|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
105362481|NCT01307891|363332574|FG000|Overall Study|Progressive Disease|3|||
105362482|NCT01307891|363332575|FG001|Overall Study|Progressive Disease|1|||
105362483|NCT03365934|363332576|FG000|Overall Study|Adverse Event|1|||
105362484|NCT03365934|363332576|FG000|Overall Study|Withdrawal by Subject|1|||
105362485|NCT04194489|363332577|FG000|Overall Study|Withdrawal by Subject|5|||
105362486|NCT04194489|363332577|FG000|Overall Study|Lost to Follow-up|48|||
105362487|NCT04771013|363332579|FG000|Overall Study|Withdrawal by Subject|2|||
105362488|NCT04771013|363332580|FG001|Overall Study|Withdrawal by Subject|0|||
105362489|NCT04771013|363332579|FG000|Overall Study|Death|0|||
105362490|NCT04771013|363332580|FG001|Overall Study|Death|5|||
105362491|NCT04771013|363332579|FG000|Overall Study|Referred to another hospital before day 20|0|||
105362492|NCT04771013|363332580|FG001|Overall Study|Referred to another hospital before day 20|1|||
105362493|NCT01255904|363332581|FG000|Overall Study|Physician Decision|1|||
105817434|NCT04032977|364992342|FG001|Overall Study|Lost to Follow-up|7|||
105817435|NCT04032977|364992341|FG000|Overall Study|Pregnancy|1|||
105817436|NCT04032977|364992342|FG001|Overall Study|Pregnancy|0|||
105817437|NCT01101022|364992344|FG000|Overall Study|Adverse Event|6|||
105817438|NCT01101022|364992345|FG001|Overall Study|Adverse Event|2|||
105817439|NCT01101022|364992344|FG000|Overall Study|Protocol Violation|4|||
105817440|NCT01101022|364992345|FG001|Overall Study|Protocol Violation|3|||
105817441|NCT01101022|364992344|FG000|Overall Study|Withdrawal by Subject|3|||
105362494|NCT01255904|363332582|FG001|Overall Study|Physician Decision|4|||
105362495|NCT00377637|363332584|FG000|Induction Phase|Adverse Event|12|||
105362496|NCT00377637|363332585|FG001|Induction Phase|Adverse Event|21|||
105362497|NCT00377637|363332586|FG002|Induction Phase|Adverse Event|0|||
105362498|NCT00377637|363332587|FG003|Induction Phase|Adverse Event|0|||
105362499|NCT00377637|363332584|FG000|Induction Phase|Deterioration/serum creatinine|2|||
105362500|NCT00377637|363332585|FG001|Induction Phase|Deterioration/serum creatinine|0|||
105571650|NCT02746575|364092715|FG000|Overall Study|Received epidural|10|||
105817442|NCT01101022|364992345|FG001|Overall Study|Withdrawal by Subject|8|||
105817443|NCT01101022|364992344|FG000|Overall Study|Lost to Follow-up|1|||
105817444|NCT01101022|364992345|FG001|Overall Study|Lost to Follow-up|4|||
105817445|NCT01101022|364992344|FG000|Overall Study|Lack of Efficacy|0|||
105817446|NCT01101022|364992345|FG001|Overall Study|Lack of Efficacy|7|||
105817447|NCT01101022|364992344|FG000|Overall Study|Sponsor decision|1|||
105817448|NCT01101022|364992345|FG001|Overall Study|Sponsor decision|1|||
105817449|NCT01101022|364992344|FG000|Overall Study|Non-compliance|1|||
105817450|NCT01101022|364992345|FG001|Overall Study|Non-compliance|0|||
105817451|NCT01101022|364992344|FG000|Overall Study|Work schedule|1|||
105817452|NCT01101022|364992345|FG001|Overall Study|Work schedule|1|||
105817453|NCT01101022|364992344|FG000|Overall Study|Vacation|0|||
105817454|NCT01101022|364992345|FG001|Overall Study|Vacation|1|||
105362501|NCT00377637|363332586|FG002|Induction Phase|Deterioration/serum creatinine|0|||
105362502|NCT00377637|363332587|FG003|Induction Phase|Deterioration/serum creatinine|0|||
105362503|NCT00377637|363332584|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
105362504|NCT00377637|363332585|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
105362505|NCT00377637|363332586|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
105362506|NCT00377637|363332587|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
105362507|NCT00377637|363332584|FG000|Induction Phase|Lost to Follow-up|2|||
105362508|NCT00377637|363332585|FG001|Induction Phase|Lost to Follow-up|1|||
105362509|NCT00377637|363332586|FG002|Induction Phase|Lost to Follow-up|0|||
105817455|NCT01519661|364992346|FG000|Overall Study|Protocol deviation|6|||
105817456|NCT01519661|364992346|FG000|Overall Study|Lost to Follow-up|3|||
105817457|NCT01519661|364992346|FG000|Overall Study|Withdrawal by Subject|17|||
105817458|NCT01519661|364992346|FG000|Overall Study|Lack of Efficacy|6|||
105817459|NCT01519661|364992346|FG000|Overall Study|Adverse Event|29|||
105817460|NCT03075761|364992347|FG000|Overall Study|Lost to Follow-up|1|||
105817461|NCT03075761|364992348|FG001|Overall Study|Lost to Follow-up|6|||
105817462|NCT02880761|364992349|FG000|Overall Study|Death|6|||
105362510|NCT00377637|363332587|FG003|Induction Phase|Lost to Follow-up|0|||
105362511|NCT00377637|363332584|FG000|Induction Phase|Death|1|||
105362512|NCT00377637|363332585|FG001|Induction Phase|Death|3|||
105362513|NCT00377637|363332586|FG002|Induction Phase|Death|0|||
105362514|NCT00377637|363332587|FG003|Induction Phase|Death|0|||
105362515|NCT00377637|363332584|FG000|Induction Phase|Withdrawal by Subject|5|||
105362516|NCT00377637|363332585|FG001|Induction Phase|Withdrawal by Subject|6|||
105817463|NCT02880761|364992350|FG001|Overall Study|Death|8|||
105817464|NCT02880761|364992349|FG000|Overall Study|Withdrawal by Subject|3|||
105817465|NCT02880761|364992350|FG001|Overall Study|Withdrawal by Subject|6|||
105817466|NCT02880761|364992349|FG000|Overall Study|Protocol Violation|4|||
105817467|NCT02880761|364992350|FG001|Overall Study|Protocol Violation|3|||
105817468|NCT02880761|364992349|FG000|Overall Study|Lost to Follow-up|3|||
105817469|NCT02880761|364992350|FG001|Overall Study|Lost to Follow-up|4|||
105817470|NCT01139047|364992351|FG000|Overall Study|Withdrawal by Subject|1|||
105817471|NCT02106156|364992352|FG000|Overall Study|Patient Died|19|||
105817472|NCT02106156|364992353|FG001|Overall Study|Patient Died|0|||
105817473|NCT02106156|364992354|FG002|Overall Study|Patient Died|0|||
105817474|NCT02106156|364992352|FG000|Overall Study|Lack of Tolerability|305|||
105817475|NCT02106156|364992353|FG001|Overall Study|Lack of Tolerability|3|||
105817476|NCT02106156|364992354|FG002|Overall Study|Lack of Tolerability|0|||
105817477|NCT02106156|364992352|FG000|Overall Study|Lack of Virological Response|1044|||
105817478|NCT02106156|364992353|FG001|Overall Study|Lack of Virological Response|8|||
105817479|NCT02106156|364992354|FG002|Overall Study|Lack of Virological Response|0|||
105817480|NCT02106156|364992352|FG000|Overall Study|Concomitant Disease|74|||
105817481|NCT02106156|364992353|FG001|Overall Study|Concomitant Disease|2|||
105817482|NCT02106156|364992354|FG002|Overall Study|Concomitant Disease|0|||
105817483|NCT02106156|364992352|FG000|Overall Study|Lack of Compliance|211|||
105817484|NCT02106156|364992353|FG001|Overall Study|Lack of Compliance|7|||
105817485|NCT02106156|364992354|FG002|Overall Study|Lack of Compliance|0|||
105817486|NCT02106156|364992352|FG000|Overall Study|Patients Request|307|||
105817487|NCT02106156|364992353|FG001|Overall Study|Patients Request|9|||
105817488|NCT02106156|364992354|FG002|Overall Study|Patients Request|0|||
105817489|NCT02106156|364992352|FG000|Overall Study|Lost to Follow-up|451|||
105817490|NCT02106156|364992353|FG001|Overall Study|Lost to Follow-up|8|||
105817491|NCT02106156|364992354|FG002|Overall Study|Lost to Follow-up|0|||
105817492|NCT02106156|364992352|FG000|Overall Study|Unplanned Event|82|||
105817493|NCT02106156|364992353|FG001|Overall Study|Unplanned Event|2|||
105817494|NCT02106156|364992354|FG002|Overall Study|Unplanned Event|0|||
105817495|NCT02106156|364992352|FG000|Overall Study|Change of Laboratory Parameter|10|||
105817496|NCT02106156|364992353|FG001|Overall Study|Change of Laboratory Parameter|0|||
105817497|NCT02106156|364992354|FG002|Overall Study|Change of Laboratory Parameter|0|||
105817498|NCT02106156|364992352|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
105817499|NCT02106156|364992353|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
105817500|NCT02106156|364992354|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
105817501|NCT02106156|364992352|FG000|Overall Study|Relocation/Change of Physician|40|||
105817502|NCT02106156|364992353|FG001|Overall Study|Relocation/Change of Physician|1|||
105817503|NCT02106156|364992354|FG002|Overall Study|Relocation/Change of Physician|0|||
105817504|NCT02943447|364992355|FG000|Blinded Study Phase|Withdrew Consent|1|||
105817505|NCT02943447|364992356|FG001|Blinded Study Phase|Withdrew Consent|2|||
105817506|NCT02943447|364992357|FG002|Blinded Study Phase|Withdrew Consent|1|||
105817507|NCT02943447|364992355|FG000|Blinded Study Phase|Adverse Event|3|||
105817508|NCT02943447|364992356|FG001|Blinded Study Phase|Adverse Event|0|||
105362517|NCT00377637|363332586|FG002|Induction Phase|Withdrawal by Subject|0|||
105362518|NCT00377637|363332587|FG003|Induction Phase|Withdrawal by Subject|0|||
105362519|NCT00377637|363332584|FG000|Induction Phase|Physician Decision|3|||
105362520|NCT00377637|363332585|FG001|Induction Phase|Physician Decision|1|||
105362521|NCT00377637|363332586|FG002|Induction Phase|Physician Decision|0|||
105362522|NCT00377637|363332587|FG003|Induction Phase|Physician Decision|0|||
105362523|NCT00377637|363332584|FG000|Induction Phase|Sponsor decision|1|||
105362524|NCT00377637|363332585|FG001|Induction Phase|Sponsor decision|2|||
105362525|NCT00377637|363332586|FG002|Induction Phase|Sponsor decision|0|||
105817509|NCT02943447|364992357|FG002|Blinded Study Phase|Adverse Event|0|||
105817510|NCT02943447|364992355|FG000|Blinded Study Phase|Investigator's discretion|1|||
105817511|NCT02943447|364992356|FG001|Blinded Study Phase|Investigator's discretion|0|||
105817512|NCT02943447|364992357|FG002|Blinded Study Phase|Investigator's discretion|0|||
105817513|NCT02943447|364992355|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
105817514|NCT02943447|364992356|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
105817515|NCT02943447|364992357|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
105817516|NCT02943447|364992355|FG000|Open-Label Extension Phase|Adverse Event|4|||
105362526|NCT00377637|363332587|FG003|Induction Phase|Sponsor decision|0|||
105362527|NCT00377637|363332584|FG000|Induction Phase|Non-Compliance|1|||
105817517|NCT02943447|364992356|FG001|Open-Label Extension Phase|Adverse Event|7|||
105817518|NCT02943447|364992357|FG002|Open-Label Extension Phase|Adverse Event|3|||
105817519|NCT02943447|364992355|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
105817520|NCT02943447|364992356|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
105362528|NCT00377637|363332585|FG001|Induction Phase|Non-Compliance|0|||
105362529|NCT00377637|363332586|FG002|Induction Phase|Non-Compliance|0|||
105362530|NCT00377637|363332587|FG003|Induction Phase|Non-Compliance|0|||
105362531|NCT00377637|363332584|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
105362532|NCT00377637|363332585|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
105362533|NCT00377637|363332586|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
105362534|NCT00377637|363332587|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
105362535|NCT00377637|363332584|FG000|Maintenance Phase|Adverse Event|0|||
105362536|NCT00377637|363332585|FG001|Maintenance Phase|Adverse Event|0|||
105362537|NCT00377637|363332586|FG002|Maintenance Phase|Adverse Event|29|||
105362538|NCT00377637|363332587|FG003|Maintenance Phase|Adverse Event|43|||
105362539|NCT00377637|363332584|FG000|Maintenance Phase|Physician Decision|0|||
105362540|NCT00377637|363332585|FG001|Maintenance Phase|Physician Decision|0|||
105362541|NCT00377637|363332586|FG002|Maintenance Phase|Physician Decision|5|||
105362542|NCT00377637|363332587|FG003|Maintenance Phase|Physician Decision|4|||
105362543|NCT00377637|363332584|FG000|Maintenance Phase|Lost to Follow-up|0|||
105362544|NCT00377637|363332585|FG001|Maintenance Phase|Lost to Follow-up|0|||
105362545|NCT00377637|363332586|FG002|Maintenance Phase|Lost to Follow-up|3|||
105362546|NCT00377637|363332587|FG003|Maintenance Phase|Lost to Follow-up|1|||
105362547|NCT00377637|363332584|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105362548|NCT00377637|363332585|FG001|Maintenance Phase|Withdrawal by Subject|0|||
105362549|NCT00377637|363332586|FG002|Maintenance Phase|Withdrawal by Subject|3|||
105362550|NCT00377637|363332587|FG003|Maintenance Phase|Withdrawal by Subject|3|||
105362551|NCT00377637|363332584|FG000|Maintenance Phase|Sponsor decision|0|||
105362552|NCT00377637|363332585|FG001|Maintenance Phase|Sponsor decision|0|||
105362553|NCT00377637|363332586|FG002|Maintenance Phase|Sponsor decision|2|||
105362554|NCT00377637|363332587|FG003|Maintenance Phase|Sponsor decision|3|||
105362555|NCT00377637|363332584|FG000|Maintenance Phase|Non-compliance|0|||
105362556|NCT00377637|363332585|FG001|Maintenance Phase|Non-compliance|0|||
105362557|NCT00377637|363332586|FG002|Maintenance Phase|Non-compliance|1|||
105362558|NCT00377637|363332587|FG003|Maintenance Phase|Non-compliance|1|||
105362559|NCT00377637|363332584|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
105362560|NCT00377637|363332585|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
105362561|NCT00377637|363332586|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
105362562|NCT00377637|363332587|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
105362563|NCT00377637|363332584|FG000|Maintenance Phase|Death|0|||
105362564|NCT00377637|363332585|FG001|Maintenance Phase|Death|0|||
105362565|NCT00377637|363332586|FG002|Maintenance Phase|Death|0|||
105362566|NCT00377637|363332587|FG003|Maintenance Phase|Death|1|||
105362567|NCT00974311|363332588|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
105362568|NCT00974311|363332589|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
105362569|NCT00974311|363332588|FG000|DB Phase (up to 24 Months)|Death|561|||
105362570|NCT00974311|363332589|FG001|DB Phase (up to 24 Months)|Death|298|||
105362571|NCT00974311|363332588|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
105362572|NCT00974311|363332589|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
105362573|NCT00974311|363332588|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
105362574|NCT00974311|363332589|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
105362575|NCT00974311|363332588|FG000|DB Phase (up to 24 Months)|Other|1|||
105362576|NCT00974311|363332589|FG001|DB Phase (up to 24 Months)|Other|0|||
105362577|NCT00974311|363332588|FG000|OLE Phase (up to 77 Months)|Death|14|||
105362578|NCT00974311|363332589|FG001|OLE Phase (up to 77 Months)|Death|21|||
105362579|NCT00974311|363332588|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
105362580|NCT00974311|363332589|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
105362581|NCT00974311|363332588|FG000|OLE Phase (up to 77 Months)|Other|15|||
105362582|NCT00974311|363332589|FG001|OLE Phase (up to 77 Months)|Other|2|||
105362583|NCT00974311|363332588|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
105362584|NCT00974311|363332589|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
105362585|NCT00165503|363332592|FG000|Overall Study|Death|1|||
105362586|NCT00165503|363332592|FG000|Overall Study|Lost to Follow-up|12|||
105362587|NCT00165503|363332592|FG000|Overall Study|Unresectable|3|||
105362588|NCT02254772|363332593|FG000|Overall Study|Ineligible|1|||
105362589|NCT02254772|363332593|FG000|Overall Study|Withdrawal by Subject|1|||
105362590|NCT02346708|363332594|FG000|Overall Study|Adverse Event|2|||
105362591|NCT02346708|363332595|FG001|Overall Study|Adverse Event|0|||
105362592|NCT02346708|363332594|FG000|Overall Study|Protocol Violation|0|||
105362593|NCT02346708|363332595|FG001|Overall Study|Protocol Violation|1|||
105362594|NCT00928434|363332598|FG000|Overall Study|Adverse Event|14|||
105362595|NCT00928434|363332599|FG001|Overall Study|Adverse Event|5|||
105362596|NCT00928434|363332600|FG002|Overall Study|Adverse Event|18|||
105362597|NCT00928434|363332598|FG000|Overall Study|Protocol Violation|5|||
105362598|NCT00928434|363332599|FG001|Overall Study|Protocol Violation|0|||
105362599|NCT00928434|363332600|FG002|Overall Study|Protocol Violation|8|||
105362600|NCT00928434|363332598|FG000|Overall Study|Physician Decision|2|||
105362601|NCT00928434|363332599|FG001|Overall Study|Physician Decision|0|||
105362602|NCT00928434|363332600|FG002|Overall Study|Physician Decision|3|||
105362603|NCT00928434|363332598|FG000|Overall Study|Lost to Follow-up|1|||
105486284|NCT02953509|363791457|FG003|Overall Study|Study terminated by sponsor|0|||
105486285|NCT02953509|363791458|FG004|Overall Study|Study terminated by sponsor|0|||
105486286|NCT02953509|363791459|FG005|Overall Study|Study terminated by sponsor|0|||
105486287|NCT02953509|363791460|FG006|Overall Study|Study terminated by sponsor|1|||
105486288|NCT02953509|363791461|FG007|Overall Study|Study terminated by sponsor|0|||
105486289|NCT02953509|363791462|FG008|Overall Study|Study terminated by sponsor|1|||
105486290|NCT02953509|363791463|FG009|Overall Study|Study terminated by sponsor|1|||
105486291|NCT00509262|363791464|FG000|Overall Study|Adverse Event|16|||
105486292|NCT00509262|363791465|FG001|Overall Study|Adverse Event|18|||
105486293|NCT00509262|363791464|FG000|Overall Study|Other|2|||
105571651|NCT02746575|364092715|FG000|Overall Study|Withdrawal by Subject|3|||
105571652|NCT02746575|364092715|FG000|Overall Study|Bradycardia/hypotension|9|||
105571653|NCT02746575|364092715|FG000|Overall Study|Study paused|8|||
105571654|NCT02746575|364092715|FG000|Overall Study|put on beta-blocker|3|||
105571655|NCT02746575|364092715|FG000|Overall Study|type of surgery|1|||
105765442|NCT02431702|364793670|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
105765443|NCT02431702|364793671|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
105817521|NCT02943447|364992357|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
105817522|NCT02943447|364992355|FG000|Open-Label Extension Phase|Withdrew consent|1|||
105817523|NCT02943447|364992356|FG001|Open-Label Extension Phase|Withdrew consent|1|||
105817524|NCT02943447|364992357|FG002|Open-Label Extension Phase|Withdrew consent|1|||
105817525|NCT02943447|364992355|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
105817526|NCT02943447|364992356|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
105817527|NCT02943447|364992357|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
105817528|NCT00840632|364992367|FG000|First Intervention|Withdrawal by Subject|0|||
105817529|NCT00840632|364992368|FG001|First Intervention|Withdrawal by Subject|1|||
105817530|NCT00840632|364992367|FG000|Washout|Withdrawal by Subject|1|||
105486294|NCT00509262|363791465|FG001|Overall Study|Other|2|||
105765444|NCT02431702|364793672|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
105765445|NCT02431702|364793673|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
105765446|NCT02431702|364793674|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
105765447|NCT02431702|364793675|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
105765448|NCT02431702|364793669|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
105765449|NCT02431702|364793670|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
105765450|NCT02431702|364793671|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
105765451|NCT02431702|364793672|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
105765452|NCT02431702|364793673|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
105765453|NCT02431702|364793674|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
105765454|NCT02431702|364793675|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
105765455|NCT02431702|364793669|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
105817531|NCT00840632|364992368|FG001|Washout|Withdrawal by Subject|1|||
105817532|NCT05017480|364992369|FG000|Stage 1 Study|Withdrawal by Subject|8|||
105817533|NCT05017480|364992370|FG001|Stage 1 Study|Withdrawal by Subject|6|||
105817534|NCT05017480|364992371|FG002|Stage 1 Study|Withdrawal by Subject|0|||
105817535|NCT05017480|364992372|FG003|Stage 1 Study|Withdrawal by Subject|0|||
105486295|NCT00509262|363791464|FG000|Overall Study|Lack of Efficacy|1|||
105486296|NCT00509262|363791465|FG001|Overall Study|Lack of Efficacy|0|||
105571656|NCT02746575|364092715|FG000|Overall Study|typ of surgery|1|||
105571657|NCT02746575|364092715|FG000|Overall Study|PI unavailable|1|||
105765456|NCT02431702|364793670|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
105765457|NCT02431702|364793671|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
105765458|NCT02431702|364793672|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
105765459|NCT02431702|364793673|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
105765460|NCT02431702|364793674|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
105765461|NCT02431702|364793675|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
105765462|NCT02431702|364793669|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
105765463|NCT02431702|364793670|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
105765464|NCT02431702|364793671|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
105765465|NCT02431702|364793672|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
105765466|NCT02431702|364793673|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
105765467|NCT02431702|364793674|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
105765468|NCT02431702|364793675|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
105765469|NCT02431702|364793669|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
105765470|NCT02431702|364793670|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
105765471|NCT02431702|364793671|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
105765472|NCT02431702|364793672|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
105765473|NCT02431702|364793673|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
105765474|NCT02431702|364793674|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
105765475|NCT02431702|364793675|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
105765476|NCT04984876|364793676|FG000|Overall Study|Subject decision|2|||
105765477|NCT04984876|364793677|FG001|Overall Study|Subject decision|10|||
105765478|NCT04984876|364793678|FG002|Overall Study|Subject decision|3|||
105765479|NCT04984876|364793679|FG003|Overall Study|Subject decision|3|||
105765480|NCT04984876|364793680|FG004|Overall Study|Subject decision|3|||
105765481|NCT04984876|364793681|FG005|Overall Study|Subject decision|0|||
105765482|NCT04984876|364793676|FG000|Overall Study|Guardian decision|0|||
105765483|NCT04984876|364793677|FG001|Overall Study|Guardian decision|1|||
105765484|NCT04984876|364793678|FG002|Overall Study|Guardian decision|0|||
105765485|NCT04984876|364793679|FG003|Overall Study|Guardian decision|2|||
105765486|NCT04984876|364793680|FG004|Overall Study|Guardian decision|0|||
105765487|NCT04984876|364793681|FG005|Overall Study|Guardian decision|1|||
105765488|NCT04984876|364793676|FG000|Overall Study|Lost to Follow-up|0|||
105765489|NCT04984876|364793677|FG001|Overall Study|Lost to Follow-up|0|||
105765490|NCT04984876|364793678|FG002|Overall Study|Lost to Follow-up|1|||
105765491|NCT04984876|364793679|FG003|Overall Study|Lost to Follow-up|1|||
105765492|NCT04984876|364793680|FG004|Overall Study|Lost to Follow-up|0|||
105765493|NCT04984876|364793681|FG005|Overall Study|Lost to Follow-up|0|||
105765494|NCT04984876|364793676|FG000|Overall Study|Physician Decision|1|||
105765495|NCT04984876|364793677|FG001|Overall Study|Physician Decision|0|||
105765496|NCT04984876|364793678|FG002|Overall Study|Physician Decision|0|||
105765497|NCT04984876|364793679|FG003|Overall Study|Physician Decision|1|||
105765498|NCT04984876|364793680|FG004|Overall Study|Physician Decision|0|||
105765499|NCT04984876|364793681|FG005|Overall Study|Physician Decision|0|||
105765500|NCT04984876|364793676|FG000|Overall Study|Adverse Event|0|||
105765501|NCT04984876|364793677|FG001|Overall Study|Adverse Event|0|||
105486297|NCT00509262|363791464|FG000|Overall Study|Lost to Follow-up|1|||
105765502|NCT04984876|364793678|FG002|Overall Study|Adverse Event|1|||
105765503|NCT04984876|364793679|FG003|Overall Study|Adverse Event|0|||
105765504|NCT04984876|364793680|FG004|Overall Study|Adverse Event|0|||
105765505|NCT04984876|364793681|FG005|Overall Study|Adverse Event|0|||
105765506|NCT02204410|364793682|FG000|Overall Study|Lost to Follow-up|5|||
105765507|NCT02204410|364793682|FG000|Overall Study|Physician Decision|2|||
105765508|NCT02204410|364793682|FG000|Overall Study|Protocol Violation|1|||
105486298|NCT00509262|363791465|FG001|Overall Study|Lost to Follow-up|6|||
105817536|NCT05017480|364992373|FG004|Stage 1 Study|Withdrawal by Subject|0|||
105817537|NCT05017480|364992369|FG000|Stage 1 Study|Adverse Event|1|||
105817538|NCT05017480|364992370|FG001|Stage 1 Study|Adverse Event|1|||
105817539|NCT05017480|364992371|FG002|Stage 1 Study|Adverse Event|0|||
105817540|NCT05017480|364992372|FG003|Stage 1 Study|Adverse Event|0|||
105817541|NCT05017480|364992373|FG004|Stage 1 Study|Adverse Event|0|||
105817542|NCT05017480|364992369|FG000|Stage 1 Study|Poor Compliance|1|||
105817543|NCT05017480|364992370|FG001|Stage 1 Study|Poor Compliance|1|||
105817544|NCT05017480|364992371|FG002|Stage 1 Study|Poor Compliance|0|||
105817545|NCT05017480|364992372|FG003|Stage 1 Study|Poor Compliance|0|||
105817546|NCT05017480|364992373|FG004|Stage 1 Study|Poor Compliance|0|||
105817547|NCT05017480|364992369|FG000|Stage 1 Study|Physician Decision|0|||
105817548|NCT05017480|364992370|FG001|Stage 1 Study|Physician Decision|1|||
105817549|NCT05017480|364992371|FG002|Stage 1 Study|Physician Decision|0|||
105817550|NCT05017480|364992372|FG003|Stage 1 Study|Physician Decision|0|||
105817551|NCT05017480|364992373|FG004|Stage 1 Study|Physician Decision|0|||
105817552|NCT05017480|364992369|FG000|Stage 2 Study|Withdrawal by Subject|0|||
105817553|NCT05017480|364992370|FG001|Stage 2 Study|Withdrawal by Subject|0|||
105817554|NCT05017480|364992371|FG002|Stage 2 Study|Withdrawal by Subject|6|||
105817555|NCT05017480|364992372|FG003|Stage 2 Study|Withdrawal by Subject|9|||
105817556|NCT05017480|364992373|FG004|Stage 2 Study|Withdrawal by Subject|11|||
105817557|NCT05017480|364992369|FG000|Stage 2 Study|Lost to Follow-up|0|||
105817558|NCT05017480|364992370|FG001|Stage 2 Study|Lost to Follow-up|0|||
105817559|NCT05017480|364992371|FG002|Stage 2 Study|Lost to Follow-up|0|||
105817560|NCT05017480|364992372|FG003|Stage 2 Study|Lost to Follow-up|2|||
105817561|NCT05017480|364992373|FG004|Stage 2 Study|Lost to Follow-up|1|||
105817562|NCT05017480|364992369|FG000|Stage 2 Study|Adverse Event|0|||
105817563|NCT05017480|364992370|FG001|Stage 2 Study|Adverse Event|0|||
105817564|NCT05017480|364992371|FG002|Stage 2 Study|Adverse Event|0|||
105817565|NCT05017480|364992372|FG003|Stage 2 Study|Adverse Event|1|||
105817566|NCT05017480|364992373|FG004|Stage 2 Study|Adverse Event|0|||
105817567|NCT05017480|364992369|FG000|Stage 2 Study|COVID-19|0|||
105817568|NCT05017480|364992370|FG001|Stage 2 Study|COVID-19|0|||
105817569|NCT05017480|364992371|FG002|Stage 2 Study|COVID-19|0|||
105817570|NCT05017480|364992372|FG003|Stage 2 Study|COVID-19|1|||
105817571|NCT05017480|364992373|FG004|Stage 2 Study|COVID-19|0|||
105817572|NCT05017480|364992369|FG000|Stage 2 Study|Pregnancy|0|||
105817573|NCT05017480|364992370|FG001|Stage 2 Study|Pregnancy|0|||
105817574|NCT05017480|364992371|FG002|Stage 2 Study|Pregnancy|0|||
105817575|NCT05017480|364992372|FG003|Stage 2 Study|Pregnancy|0|||
105817576|NCT05017480|364992373|FG004|Stage 2 Study|Pregnancy|1|||
105817577|NCT01136382|364992374|FG000|Overall Study|Other|8|||
105817578|NCT01136382|364992375|FG001|Overall Study|Other|3|||
105817579|NCT01136382|364992374|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
105817580|NCT01136382|364992375|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
105817581|NCT01136382|364992374|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
105817582|NCT01136382|364992375|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
105817583|NCT01136382|364992374|FG000|Overall Study|Withdrawal by Subject|4|||
105817584|NCT01136382|364992375|FG001|Overall Study|Withdrawal by Subject|1|||
105817585|NCT02311361|364992382|FG000|Overall Study|Did not receive treatment|0|||
105817586|NCT02311361|364992383|FG001|Overall Study|Did not receive treatment|1|||
105817587|NCT02311361|364992384|FG002|Overall Study|Did not receive treatment|0|||
105817588|NCT02311361|364992385|FG003|Overall Study|Did not receive treatment|1|||
105817589|NCT01725529|364992386|FG000|Overall Study|Adverse Event|1|||
105817590|NCT01725529|364992387|FG001|Overall Study|Adverse Event|0|||
105817591|NCT01725529|364992388|FG002|Overall Study|Adverse Event|0|||
105362604|NCT00928434|363332599|FG001|Overall Study|Lost to Follow-up|0|||
105362605|NCT00928434|363332600|FG002|Overall Study|Lost to Follow-up|3|||
105362606|NCT00928434|363332598|FG000|Overall Study|Withdrawal by Subject|5|||
105817592|NCT01725529|364992386|FG000|Overall Study|Lost to Follow-up|2|||
105362607|NCT00928434|363332599|FG001|Overall Study|Withdrawal by Subject|3|||
105817593|NCT01725529|364992387|FG001|Overall Study|Lost to Follow-up|1|||
105817594|NCT01725529|364992388|FG002|Overall Study|Lost to Follow-up|1|||
105817595|NCT01725529|364992386|FG000|Overall Study|Protocol Violation|0|||
105817596|NCT01725529|364992387|FG001|Overall Study|Protocol Violation|1|||
105817597|NCT01725529|364992388|FG002|Overall Study|Protocol Violation|1|||
105817598|NCT01725529|364992386|FG000|Overall Study|Withdrawal by Subject|12|||
105817599|NCT01725529|364992387|FG001|Overall Study|Withdrawal by Subject|14|||
105817600|NCT01725529|364992388|FG002|Overall Study|Withdrawal by Subject|8|||
105817601|NCT00633594|364992395|FG000|Overall Study|Adverse Event|0|||
105817602|NCT00633594|364992396|FG001|Overall Study|Adverse Event|4|||
105817603|NCT00633594|364992397|FG002|Overall Study|Adverse Event|7|||
105817604|NCT00633594|364992395|FG000|Overall Study|Death|0|||
105817605|NCT00633594|364992396|FG001|Overall Study|Death|1|||
105817606|NCT00633594|364992397|FG002|Overall Study|Death|2|||
105817607|NCT00633594|364992395|FG000|Overall Study|Disease Progression|0|||
105486299|NCT00509262|363791464|FG000|Overall Study|Physician Decision|1|||
105817608|NCT00633594|364992396|FG001|Overall Study|Disease Progression|0|||
105817609|NCT00633594|364992397|FG002|Overall Study|Disease Progression|1|||
105817610|NCT00864097|364992398|FG000|Overall Study|Death|0|||
105817611|NCT00864097|364992399|FG001|Overall Study|Death|1|||
105817612|NCT00864097|364992400|FG002|Overall Study|Death|0|||
105817613|NCT00864097|364992401|FG003|Overall Study|Death|0|||
105817614|NCT00864097|364992398|FG000|Overall Study|Adverse Event|6|||
105817615|NCT00864097|364992399|FG001|Overall Study|Adverse Event|8|||
105817616|NCT00864097|364992400|FG002|Overall Study|Adverse Event|11|||
105817617|NCT00864097|364992401|FG003|Overall Study|Adverse Event|9|||
105817618|NCT00864097|364992398|FG000|Overall Study|Lack of Efficacy|9|||
105817619|NCT00864097|364992399|FG001|Overall Study|Lack of Efficacy|3|||
105817620|NCT00864097|364992400|FG002|Overall Study|Lack of Efficacy|7|||
105817621|NCT00864097|364992401|FG003|Overall Study|Lack of Efficacy|2|||
105817622|NCT00864097|364992398|FG000|Overall Study|Lost to Follow-up|0|||
105817623|NCT00864097|364992399|FG001|Overall Study|Lost to Follow-up|1|||
105817624|NCT00864097|364992400|FG002|Overall Study|Lost to Follow-up|0|||
105817625|NCT00864097|364992401|FG003|Overall Study|Lost to Follow-up|1|||
105817626|NCT00864097|364992398|FG000|Overall Study|Withdrawal by Subject|15|||
105817627|NCT00864097|364992399|FG001|Overall Study|Withdrawal by Subject|11|||
105817628|NCT00864097|364992400|FG002|Overall Study|Withdrawal by Subject|11|||
105817629|NCT00864097|364992401|FG003|Overall Study|Withdrawal by Subject|12|||
105817630|NCT00864097|364992398|FG000|Overall Study|Protocol Violation|2|||
105817631|NCT00864097|364992399|FG001|Overall Study|Protocol Violation|1|||
105817632|NCT00864097|364992400|FG002|Overall Study|Protocol Violation|0|||
105817633|NCT00864097|364992401|FG003|Overall Study|Protocol Violation|1|||
105817634|NCT00864097|364992398|FG000|Overall Study|Terminated by sponsor|105|||
105817635|NCT00864097|364992399|FG001|Overall Study|Terminated by sponsor|112|||
105817636|NCT00864097|364992400|FG002|Overall Study|Terminated by sponsor|102|||
105817637|NCT00864097|364992401|FG003|Overall Study|Terminated by sponsor|99|||
105817638|NCT00864097|364992398|FG000|Overall Study|Randomized but not treated|2|||
105817639|NCT00864097|364992399|FG001|Overall Study|Randomized but not treated|0|||
105817640|NCT00864097|364992400|FG002|Overall Study|Randomized but not treated|1|||
105817641|NCT00864097|364992401|FG003|Overall Study|Randomized but not treated|0|||
105817642|NCT00864097|364992398|FG000|Overall Study|Other|0|||
105817643|NCT00864097|364992399|FG001|Overall Study|Other|0|||
105817644|NCT00864097|364992400|FG002|Overall Study|Other|0|||
105817645|NCT00864097|364992401|FG003|Overall Study|Other|1|||
105817646|NCT00620022|364992402|FG000|Treatment Period 1|Adverse Event|4|||
105817647|NCT00620022|364992403|FG001|Treatment Period 1|Adverse Event|6|||
105817648|NCT00620022|364992402|FG000|Treatment Period 1|Subject withdrew consent|1|||
105817649|NCT00620022|364992403|FG001|Treatment Period 1|Subject withdrew consent|0|||
105817650|NCT00620022|364992402|FG000|Treatment Period 2|Adverse Event|2|||
105817651|NCT00620022|364992403|FG001|Treatment Period 2|Adverse Event|2|||
105817652|NCT00262223|364992404|FG000|Treatment Phase|Withdrawal by Subject|3|||
105817653|NCT00262223|364992405|FG001|Treatment Phase|Withdrawal by Subject|6|||
105817654|NCT00262223|364992404|FG000|Treatment Phase|Adverse Event|1|||
105817655|NCT00262223|364992405|FG001|Treatment Phase|Adverse Event|2|||
105817656|NCT00262223|364992404|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
105817657|NCT00262223|364992405|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
105817658|NCT00262223|364992404|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
105817659|NCT00262223|364992405|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
105817660|NCT00262223|364992404|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
105817661|NCT00262223|364992405|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
105817662|NCT01804270|364992406|FG000|Overall Study|Withdrawal by Subject|1|||
105817663|NCT01804270|364992407|FG001|Overall Study|Withdrawal by Subject|1|||
105817664|NCT05038293|364992412|FG000|Overall Study|device was not operating properly for one subject.|1|||
105817665|NCT05038293|364992413|FG001|Overall Study|device was not operating properly for one subject.|0|||
105817666|NCT05038293|364992412|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
105817667|NCT05038293|364992413|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
105817668|NCT00418184|364992414|FG000|Double-blind Phase|Withdrawal by Subject|22|||
105817669|NCT00418184|364992415|FG001|Double-blind Phase|Withdrawal by Subject|9|||
105817670|NCT00418184|364992414|FG000|Double-blind Phase|Adverse Event|2|||
105362608|NCT00928434|363332600|FG002|Overall Study|Withdrawal by Subject|2|||
105362609|NCT00928434|363332598|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
105817671|NCT00418184|364992415|FG001|Double-blind Phase|Adverse Event|1|||
105817672|NCT00418184|364992414|FG000|Double-blind Phase|Poor compliance|3|||
105817673|NCT00418184|364992415|FG001|Double-blind Phase|Poor compliance|1|||
105817674|NCT00150462|364992417|FG000|Overall Study|Disease Progression or Relapse|3|||
105817675|NCT00150462|364992418|FG001|Overall Study|Disease Progression or Relapse|1|||
105817676|NCT00150462|364992419|FG002|Overall Study|Disease Progression or Relapse|2|||
105817677|NCT00150462|364992420|FG003|Overall Study|Disease Progression or Relapse|1|||
105817678|NCT00150462|364992421|FG004|Overall Study|Disease Progression or Relapse|2|||
105817679|NCT00150462|364992422|FG005|Overall Study|Disease Progression or Relapse|2|||
105817680|NCT00150462|364992423|FG006|Overall Study|Disease Progression or Relapse|3|||
105817681|NCT00150462|364992424|FG007|Overall Study|Disease Progression or Relapse|5|||
105817682|NCT00150462|364992425|FG008|Overall Study|Disease Progression or Relapse|5|||
105817683|NCT00150462|364992426|FG009|Overall Study|Disease Progression or Relapse|3|||
105362610|NCT00928434|363332599|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
105817684|NCT00150462|364992427|FG010|Overall Study|Disease Progression or Relapse|2|||
105817685|NCT00150462|364992417|FG000|Overall Study|Withdrawal by Subject|0|||
105817686|NCT00150462|364992418|FG001|Overall Study|Withdrawal by Subject|1|||
105817687|NCT00150462|364992419|FG002|Overall Study|Withdrawal by Subject|1|||
105817688|NCT00150462|364992420|FG003|Overall Study|Withdrawal by Subject|0|||
105817689|NCT00150462|364992421|FG004|Overall Study|Withdrawal by Subject|1|||
105817690|NCT00150462|364992422|FG005|Overall Study|Withdrawal by Subject|2|||
105817691|NCT00150462|364992423|FG006|Overall Study|Withdrawal by Subject|0|||
105817692|NCT00150462|364992424|FG007|Overall Study|Withdrawal by Subject|1|||
105817693|NCT00150462|364992425|FG008|Overall Study|Withdrawal by Subject|0|||
105817694|NCT00150462|364992426|FG009|Overall Study|Withdrawal by Subject|1|||
105817695|NCT00150462|364992427|FG010|Overall Study|Withdrawal by Subject|0|||
105817696|NCT00150462|364992417|FG000|Overall Study|Death|0|||
105817697|NCT00150462|364992418|FG001|Overall Study|Death|1|||
105817698|NCT00150462|364992419|FG002|Overall Study|Death|0|||
105817699|NCT00150462|364992420|FG003|Overall Study|Death|0|||
105817700|NCT00150462|364992421|FG004|Overall Study|Death|0|||
105817701|NCT00150462|364992422|FG005|Overall Study|Death|0|||
105817702|NCT00150462|364992423|FG006|Overall Study|Death|0|||
105817703|NCT00150462|364992424|FG007|Overall Study|Death|0|||
105817704|NCT00150462|364992425|FG008|Overall Study|Death|1|||
105817705|NCT00150462|364992426|FG009|Overall Study|Death|0|||
105817706|NCT00150462|364992427|FG010|Overall Study|Death|0|||
105817707|NCT00150462|364992417|FG000|Overall Study|Adverse Event|0|||
105817708|NCT00150462|364992418|FG001|Overall Study|Adverse Event|0|||
105817709|NCT00150462|364992419|FG002|Overall Study|Adverse Event|0|||
105817710|NCT00150462|364992420|FG003|Overall Study|Adverse Event|1|||
105817711|NCT00150462|364992421|FG004|Overall Study|Adverse Event|0|||
105817712|NCT00150462|364992422|FG005|Overall Study|Adverse Event|0|||
105817713|NCT00150462|364992423|FG006|Overall Study|Adverse Event|0|||
105817714|NCT00150462|364992424|FG007|Overall Study|Adverse Event|2|||
105817715|NCT00150462|364992425|FG008|Overall Study|Adverse Event|0|||
105817716|NCT00150462|364992426|FG009|Overall Study|Adverse Event|1|||
105817717|NCT00150462|364992427|FG010|Overall Study|Adverse Event|0|||
105817718|NCT00150462|364992417|FG000|Overall Study|Physician Decision|0|||
105817719|NCT00150462|364992418|FG001|Overall Study|Physician Decision|0|||
105817720|NCT00150462|364992419|FG002|Overall Study|Physician Decision|1|||
105817721|NCT00150462|364992420|FG003|Overall Study|Physician Decision|1|||
105817722|NCT00150462|364992421|FG004|Overall Study|Physician Decision|0|||
105817723|NCT00150462|364992422|FG005|Overall Study|Physician Decision|0|||
105817724|NCT00150462|364992423|FG006|Overall Study|Physician Decision|0|||
105817725|NCT00150462|364992424|FG007|Overall Study|Physician Decision|0|||
105817726|NCT00150462|364992425|FG008|Overall Study|Physician Decision|0|||
105817727|NCT00150462|364992426|FG009|Overall Study|Physician Decision|0|||
105817728|NCT00150462|364992427|FG010|Overall Study|Physician Decision|0|||
105817729|NCT00150462|364992417|FG000|Overall Study|Other|0|||
105817730|NCT00150462|364992418|FG001|Overall Study|Other|0|||
105817731|NCT00150462|364992419|FG002|Overall Study|Other|0|||
105817732|NCT00150462|364992420|FG003|Overall Study|Other|0|||
105817733|NCT00150462|364992421|FG004|Overall Study|Other|0|||
105817734|NCT00150462|364992422|FG005|Overall Study|Other|0|||
105817735|NCT00150462|364992423|FG006|Overall Study|Other|0|||
105817736|NCT00150462|364992424|FG007|Overall Study|Other|0|||
105817737|NCT00150462|364992425|FG008|Overall Study|Other|0|||
105817738|NCT00150462|364992426|FG009|Overall Study|Other|1|||
105817739|NCT00150462|364992427|FG010|Overall Study|Other|1|||
105817740|NCT00625443|364992428|FG000|Overall Study|Adverse Event|1|||
105817741|NCT00625443|364992429|FG001|Overall Study|Adverse Event|4|||
105817742|NCT00625443|364992430|FG002|Overall Study|Adverse Event|0|||
105817743|NCT00625443|364992428|FG000|Overall Study|Non-compliance with protocol|0|||
105817744|NCT00625443|364992429|FG001|Overall Study|Non-compliance with protocol|1|||
105817745|NCT00625443|364992430|FG002|Overall Study|Non-compliance with protocol|0|||
105817746|NCT00625443|364992428|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
105817747|NCT00625443|364992429|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
105817748|NCT00625443|364992430|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
105817749|NCT00625443|364992428|FG000|Overall Study|Withdrawal by Subject|0|||
105817750|NCT00625443|364992429|FG001|Overall Study|Withdrawal by Subject|1|||
105817751|NCT00625443|364992430|FG002|Overall Study|Withdrawal by Subject|2|||
105817752|NCT00625443|364992428|FG000|Overall Study|Physician Decision|0|||
105817753|NCT00625443|364992429|FG001|Overall Study|Physician Decision|4|||
105817754|NCT00625443|364992430|FG002|Overall Study|Physician Decision|2|||
105817755|NCT00625443|364992428|FG000|Overall Study|Other|0|||
105817756|NCT00625443|364992429|FG001|Overall Study|Other|1|||
105817757|NCT00625443|364992430|FG002|Overall Study|Other|1|||
105817758|NCT02015390|364992432|FG000|Overall Study|Lost to Follow-up|1|||
105817759|NCT02015390|364992433|FG001|Overall Study|Lost to Follow-up|0|||
105817760|NCT02015390|364992432|FG000|Overall Study|Adverse Event|0|||
105817761|NCT02015390|364992433|FG001|Overall Study|Adverse Event|3|||
105817762|NCT02015390|364992432|FG000|Overall Study|Physician Decision|0|||
105817763|NCT02015390|364992433|FG001|Overall Study|Physician Decision|1|||
105817764|NCT00184600|364992439|FG000|Overall Study|Adverse Event|9|||
105817765|NCT00184600|364992440|FG001|Overall Study|Adverse Event|0|||
105817766|NCT00184600|364992441|FG002|Overall Study|Adverse Event|5|||
105817767|NCT00184600|364992439|FG000|Overall Study|Death|3|||
105817768|NCT00184600|364992440|FG001|Overall Study|Death|9|||
105817769|NCT00184600|364992441|FG002|Overall Study|Death|7|||
105817770|NCT00184600|364992439|FG000|Overall Study|Lack of Efficacy|3|||
105817771|NCT00184600|364992440|FG001|Overall Study|Lack of Efficacy|1|||
105817772|NCT00184600|364992441|FG002|Overall Study|Lack of Efficacy|3|||
105817773|NCT00184600|364992439|FG000|Overall Study|Lost to Follow-up|4|||
105817774|NCT00184600|364992440|FG001|Overall Study|Lost to Follow-up|6|||
105817775|NCT00184600|364992441|FG002|Overall Study|Lost to Follow-up|1|||
105817776|NCT00184600|364992439|FG000|Overall Study|Protocol Violation|2|||
105817777|NCT00184600|364992440|FG001|Overall Study|Protocol Violation|2|||
105817778|NCT00184600|364992441|FG002|Overall Study|Protocol Violation|3|||
105817779|NCT00184600|364992439|FG000|Overall Study|Withdrawal by Subject|20|||
105817780|NCT00184600|364992440|FG001|Overall Study|Withdrawal by Subject|28|||
105817781|NCT00184600|364992441|FG002|Overall Study|Withdrawal by Subject|12|||
105817782|NCT00184600|364992439|FG000|Overall Study|Unclassified|4|||
105817783|NCT00184600|364992440|FG001|Overall Study|Unclassified|5|||
105817784|NCT00184600|364992441|FG002|Overall Study|Unclassified|3|||
105817785|NCT00707161|364992442|FG000|Overall Study|Physician Decision|6|||
105817786|NCT00624065|364992443|FG000|Overall Study|Adverse Event|5|||
105817787|NCT00624065|364992444|FG001|Overall Study|Adverse Event|6|||
105817788|NCT00624065|364992443|FG000|Overall Study|Lost to Follow-up|4|||
105817789|NCT00624065|364992444|FG001|Overall Study|Lost to Follow-up|1|||
105817790|NCT00624065|364992443|FG000|Overall Study|Consent withdrawn|6|||
105817791|NCT00624065|364992444|FG001|Overall Study|Consent withdrawn|5|||
105817792|NCT00624065|364992443|FG000|Overall Study|Lack of Efficacy|0|||
105817793|NCT00624065|364992444|FG001|Overall Study|Lack of Efficacy|3|||
105817794|NCT00624065|364992443|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
105817795|NCT00624065|364992444|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
105817796|NCT02661295|364992446|FG000|Overall Study|Death|1|||
105817797|NCT02661295|364992446|FG000|Overall Study|Transferred Out|1|||
105817798|NCT02661295|364992446|FG000|Overall Study|Kidney Transplant|1|||
105817799|NCT02661295|364992446|FG000|Overall Study|Withdrawn due to side effects|8|||
105817800|NCT02661295|364992446|FG000|Overall Study|Withdrawn due to access type|1|||
105817801|NCT02661295|364992446|FG000|Overall Study|Withdrawn due to allergies|1|||
105817802|NCT02661295|364992446|FG000|Overall Study|Withdrawn due to non-compliance|1|||
105817803|NCT02661295|364992446|FG000|Overall Study|Withdrawal by Subject|3|||
105817804|NCT02661295|364992446|FG000|Overall Study|Failed screening|2|||
105817805|NCT00301366|364992447|FG000|Overall Study|Adverse Event|1|||
105817806|NCT01079988|364992448|FG000|Overall Study|Lost to Follow-up|0|||
105817807|NCT01079988|364992449|FG001|Overall Study|Lost to Follow-up|0|||
105817808|NCT01079988|364992450|FG002|Overall Study|Lost to Follow-up|0|||
105817809|NCT01079988|364992451|FG003|Overall Study|Lost to Follow-up|1|||
105817810|NCT01079988|364992452|FG004|Overall Study|Lost to Follow-up|0|||
105817811|NCT01079988|364992448|FG000|Overall Study|Lack of Efficacy|1|||
105817812|NCT01079988|364992449|FG001|Overall Study|Lack of Efficacy|0|||
105817813|NCT01079988|364992450|FG002|Overall Study|Lack of Efficacy|0|||
105817814|NCT01079988|364992451|FG003|Overall Study|Lack of Efficacy|0|||
105817815|NCT01079988|364992452|FG004|Overall Study|Lack of Efficacy|0|||
105817816|NCT01079988|364992448|FG000|Overall Study|Other|0|||
105817817|NCT01079988|364992449|FG001|Overall Study|Other|0|||
105817818|NCT01079988|364992450|FG002|Overall Study|Other|0|||
105817819|NCT01079988|364992451|FG003|Overall Study|Other|2|||
105817820|NCT01079988|364992452|FG004|Overall Study|Other|1|||
105817821|NCT00304083|364992457|FG000|Overall Study|Withdrawal by Subject|4|||
105817822|NCT00304083|364992458|FG001|Overall Study|Withdrawal by Subject|2|||
105817823|NCT00304083|364992457|FG000|Overall Study|Physician Decision|8|||
105817824|NCT00304083|364992458|FG001|Overall Study|Physician Decision|3|||
105817825|NCT00304083|364992457|FG000|Overall Study|Disease Progression|5|||
105817826|NCT00304083|364992458|FG001|Overall Study|Disease Progression|1|||
105817827|NCT00304083|364992457|FG000|Overall Study|Other|5|||
105817828|NCT00304083|364992458|FG001|Overall Study|Other|2|||
105817829|NCT04419311|364992459|FG000|Overall Study|Lost to Follow-up|1|||
105817830|NCT04419311|364992460|FG001|Overall Study|Lost to Follow-up|0|||
105817831|NCT03555305|364992461|FG000|Period 1|Physician Decision|0|||
105817832|NCT03555305|364992462|FG001|Period 1|Physician Decision|1|||
105817833|NCT03555305|364992461|FG000|Period 1|Adverse Event|0|||
105817834|NCT03555305|364992462|FG001|Period 1|Adverse Event|1|||
105817835|NCT03966365|364992463|FG000|Overall Study|Protocol Violation|1|||
105817836|NCT03966365|364992464|FG001|Overall Study|Protocol Violation|0|||
105817837|NCT00095212|364992465|FG000|Overall Study|Withdrawal by Subject|1|||
105817838|NCT00095212|364992466|FG001|Overall Study|Withdrawal by Subject|3|||
105817839|NCT02216071|364992467|FG000|Overall Study|Withdrawal by Subject|7|||
105817840|NCT02216071|364992468|FG001|Overall Study|Withdrawal by Subject|2|||
105817841|NCT02216071|364992467|FG000|Overall Study|Lost to Follow-up|3|||
105817842|NCT02216071|364992468|FG001|Overall Study|Lost to Follow-up|3|||
105817843|NCT02216071|364992467|FG000|Overall Study|Protocol Violation|3|||
105817844|NCT02216071|364992468|FG001|Overall Study|Protocol Violation|5|||
105817845|NCT02216071|364992467|FG000|Overall Study|Other|2|||
105817846|NCT02216071|364992468|FG001|Overall Study|Other|2|||
105817847|NCT02335658|364992469|FG000|Overall Study|Adverse Event|18|||
105817848|NCT02335658|364992470|FG001|Overall Study|Adverse Event|12|||
105817849|NCT02335658|364992469|FG000|Overall Study|Lack of Efficacy|4|||
105817850|NCT02335658|364992470|FG001|Overall Study|Lack of Efficacy|5|||
105817851|NCT02335658|364992469|FG000|Overall Study|Pregnancy|1|||
105817852|NCT02335658|364992470|FG001|Overall Study|Pregnancy|0|||
105817853|NCT02335658|364992469|FG000|Overall Study|Withdrawal by Subject|13|||
105817854|NCT02335658|364992470|FG001|Overall Study|Withdrawal by Subject|21|||
105817855|NCT02335658|364992469|FG000|Overall Study|non-compliance|2|||
105817856|NCT02335658|364992470|FG001|Overall Study|non-compliance|3|||
105817857|NCT02335658|364992469|FG000|Overall Study|other reason|2|||
105817858|NCT02335658|364992470|FG001|Overall Study|other reason|3|||
105817859|NCT05341622|364992471|FG000|Overall Study|Death|0|||
105817860|NCT05341622|364992472|FG001|Overall Study|Death|0|||
105817861|NCT05341622|364992473|FG002|Overall Study|Death|0|||
105817862|NCT05341622|364992474|FG003|Overall Study|Death|0|||
105817863|NCT05341622|364992475|FG004|Overall Study|Death|1|||
105817864|NCT05341622|364992476|FG005|Overall Study|Death|0|||
105817865|NCT05341622|364992477|FG006|Overall Study|Death|0|||
105817866|NCT05341622|364992478|FG007|Overall Study|Death|1|||
105817867|NCT05341622|364992471|FG000|Overall Study|Invalid Address|0|||
105817868|NCT05341622|364992472|FG001|Overall Study|Invalid Address|1|||
105817869|NCT05341622|364992473|FG002|Overall Study|Invalid Address|0|||
105817870|NCT05341622|364992474|FG003|Overall Study|Invalid Address|0|||
105817871|NCT05341622|364992475|FG004|Overall Study|Invalid Address|0|||
105817872|NCT05341622|364992476|FG005|Overall Study|Invalid Address|0|||
105817873|NCT05341622|364992477|FG006|Overall Study|Invalid Address|0|||
105817874|NCT05341622|364992478|FG007|Overall Study|Invalid Address|0|||
105817875|NCT05341622|364992471|FG000|Overall Study|Ineligible|26|||
105817876|NCT05341622|364992472|FG001|Overall Study|Ineligible|21|||
105817877|NCT05341622|364992473|FG002|Overall Study|Ineligible|28|||
105817878|NCT05341622|364992474|FG003|Overall Study|Ineligible|24|||
105817879|NCT05341622|364992475|FG004|Overall Study|Ineligible|29|||
105817880|NCT05341622|364992476|FG005|Overall Study|Ineligible|31|||
105817881|NCT05341622|364992477|FG006|Overall Study|Ineligible|28|||
105817882|NCT05341622|364992478|FG007|Overall Study|Ineligible|26|||
105817883|NCT02658084|364992479|FG000|Overall Study|Withdrawal by Subject|1|||
105817884|NCT02658084|364992480|FG001|Overall Study|Withdrawal by Subject|0|||
105817885|NCT02658084|364992479|FG000|Overall Study|Study Termination|1|||
105817886|NCT02658084|364992480|FG001|Overall Study|Study Termination|0|||
105817887|NCT01880593|364992483|FG000|Overall Study|Adverse Event|1|||
105817888|NCT01880593|364992484|FG001|Overall Study|Adverse Event|0|||
105817889|NCT01880593|364992483|FG000|Overall Study|Lack of Efficacy|1|||
105817890|NCT01880593|364992484|FG001|Overall Study|Lack of Efficacy|5|||
105817891|NCT01880593|364992483|FG000|Overall Study|Withdrawal by Subject|6|||
105817892|NCT01880593|364992484|FG001|Overall Study|Withdrawal by Subject|1|||
105817893|NCT05275205|364992492|FG000|Overall Study|Adverse Event|1|||
105817894|NCT05275205|364992493|FG001|Overall Study|Adverse Event|2|||
105817895|NCT05275205|364992492|FG000|Overall Study|Physician Decision|1|||
105817896|NCT05275205|364992493|FG001|Overall Study|Physician Decision|1|||
105817897|NCT05275205|364992492|FG000|Overall Study|Withdrawal by Subject|2|||
105817898|NCT05275205|364992493|FG001|Overall Study|Withdrawal by Subject|3|||
105817899|NCT05275205|364992492|FG000|Overall Study|Death|1|||
105817900|NCT05275205|364992493|FG001|Overall Study|Death|0|||
105817901|NCT05275205|364992492|FG000|Overall Study|Patient unable to attend visits|1|||
105817902|NCT05275205|364992493|FG001|Overall Study|Patient unable to attend visits|0|||
105817903|NCT02024932|364992494|FG000|Overall Study|Adverse Event|2|||
105817904|NCT02024932|364992495|FG001|Overall Study|Adverse Event|3|||
105817905|NCT02024932|364992496|FG002|Overall Study|Adverse Event|0|||
105817906|NCT02024932|364992497|FG003|Overall Study|Adverse Event|0|||
105817907|NCT02024932|364992498|FG004|Overall Study|Adverse Event|2|||
105817908|NCT02024932|364992499|FG005|Overall Study|Adverse Event|0|||
105817909|NCT02024932|364992494|FG000|Overall Study|Abnormal laboratory value|0|||
105817910|NCT02024932|364992495|FG001|Overall Study|Abnormal laboratory value|0|||
105817911|NCT02024932|364992496|FG002|Overall Study|Abnormal laboratory value|0|||
105817912|NCT02024932|364992497|FG003|Overall Study|Abnormal laboratory value|2|||
105817913|NCT02024932|364992498|FG004|Overall Study|Abnormal laboratory value|0|||
105817914|NCT02024932|364992499|FG005|Overall Study|Abnormal laboratory value|0|||
105817915|NCT03020641|364992500|FG000|Overall Study|Lost to Follow-up|0|||
105817916|NCT03020641|364992501|FG001|Overall Study|Lost to Follow-up|1|||
105817917|NCT03020641|364992500|FG000|Overall Study|Converted to open surgery|2|||
105817918|NCT03020641|364992501|FG001|Overall Study|Converted to open surgery|1|||
105817919|NCT03020641|364992500|FG000|Overall Study|for surgery not performed|0|||
105817920|NCT03020641|364992501|FG001|Overall Study|for surgery not performed|1|||
105817921|NCT02653664|364994224|FG000|Post-Treatment|Withdrawal by Subject|6|||
105817922|NCT02653664|364994225|FG001|Post-Treatment|Withdrawal by Subject|5|||
105817923|NCT02653664|364994226|FG002|Post-Treatment|Withdrawal by Subject|7|||
105817924|NCT02653664|364994224|FG000|Post-Treatment|Lost to Follow-up|8|||
105817925|NCT02653664|364994225|FG001|Post-Treatment|Lost to Follow-up|1|||
105817926|NCT02653664|364994226|FG002|Post-Treatment|Lost to Follow-up|7|||
105817927|NCT02653664|364994224|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
105817928|NCT02653664|364994225|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
105817929|NCT02653664|364994226|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
105817930|NCT02653664|364994224|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
105817931|NCT02653664|364994225|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
105817932|NCT02653664|364994226|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
105817933|NCT02653664|364994224|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
105817934|NCT02653664|364994225|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
105817935|NCT02653664|364994226|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
105817936|NCT02653664|364994224|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
105817937|NCT02653664|364994225|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
105817938|NCT02653664|364994226|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
105817939|NCT02653664|364994224|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
105817940|NCT02653664|364994225|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
105817941|NCT02653664|364994226|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
105817942|NCT02653664|364994224|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
105817943|NCT02653664|364994225|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
105817944|NCT02653664|364994226|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
105817945|NCT02653664|364994224|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
105817946|NCT02653664|364994225|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
105817947|NCT02653664|364994226|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
105817948|NCT02653664|364994224|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
105817949|NCT02653664|364994225|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
105817950|NCT02653664|364994226|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
105817951|NCT03655106|364994227|FG000|Overall Study|Withdrawal by Subject|3|||
105817952|NCT03655106|364994228|FG001|Overall Study|Withdrawal by Subject|2|||
105817953|NCT03655106|364994227|FG000|Overall Study|Lost to Follow-up|2|||
105817954|NCT03655106|364994228|FG001|Overall Study|Lost to Follow-up|1|||
105817955|NCT03655106|364994227|FG000|Overall Study|Duplicate Enrollment|1|||
105817956|NCT03655106|364994228|FG001|Overall Study|Duplicate Enrollment|1|||
105486300|NCT00509262|363791465|FG001|Overall Study|Physician Decision|3|||
105817957|NCT03655106|364994227|FG000|Overall Study|Protocol Violation|3|||
105817958|NCT03655106|364994228|FG001|Overall Study|Protocol Violation|0|||
105817959|NCT03497897|364994231|FG000|Overall Study|Adverse Event|1|||
105817960|NCT03497897|364994232|FG001|Overall Study|Adverse Event|1|||
105817961|NCT03497897|364994233|FG002|Overall Study|Adverse Event|1|||
105817962|NCT03497897|364994231|FG000|Overall Study|Lost to Follow-up|2|||
105817963|NCT03497897|364994232|FG001|Overall Study|Lost to Follow-up|0|||
105817964|NCT03497897|364994233|FG002|Overall Study|Lost to Follow-up|2|||
105817965|NCT03497897|364994231|FG000|Overall Study|Physician Decision|1|||
105817966|NCT03497897|364994232|FG001|Overall Study|Physician Decision|0|||
105817967|NCT03497897|364994233|FG002|Overall Study|Physician Decision|0|||
105817968|NCT03497897|364994231|FG000|Overall Study|Subject/Guardian Decision|2|||
105817969|NCT03497897|364994232|FG001|Overall Study|Subject/Guardian Decision|1|||
105817970|NCT03497897|364994233|FG002|Overall Study|Subject/Guardian Decision|3|||
105817971|NCT00723528|364994236|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
105817972|NCT00723528|364994237|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
105817973|NCT00723528|364994238|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
105817974|NCT00723528|364994239|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
105817975|NCT00723528|364994240|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
105817976|NCT00723528|364994241|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
105817977|NCT00723528|364994242|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
105817978|NCT00723528|364994236|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
105817979|NCT00723528|364994237|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
105817980|NCT00723528|364994238|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
105817981|NCT00723528|364994239|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
105817982|NCT00723528|364994240|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
105817983|NCT00723528|364994241|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
105817984|NCT00723528|364994242|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
105817985|NCT00723528|364994236|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
105362611|NCT00928434|363332600|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
105362612|NCT00928434|363332598|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
105362613|NCT00928434|363332599|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
105817986|NCT00723528|364994237|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
105817987|NCT00723528|364994238|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
105817988|NCT00723528|364994239|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
105817989|NCT00723528|364994240|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
105817990|NCT00723528|364994241|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
105362614|NCT00928434|363332600|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
105817991|NCT00723528|364994242|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
105817992|NCT00723528|364994236|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
105817993|NCT00723528|364994237|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
105817994|NCT00723528|364994238|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
105817995|NCT00723528|364994239|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
105817996|NCT00723528|364994240|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
105817997|NCT00723528|364994241|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
105817998|NCT00723528|364994242|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
105817999|NCT00723528|364994236|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
105818000|NCT00723528|364994237|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
105818001|NCT00723528|364994238|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
105818002|NCT00723528|364994239|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
105818003|NCT00723528|364994240|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
105818004|NCT00723528|364994241|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
105818005|NCT00723528|364994242|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
105818006|NCT00723528|364994236|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
105818007|NCT00723528|364994237|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
105818008|NCT00723528|364994238|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
105818009|NCT00723528|364994239|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
105818010|NCT00723528|364994240|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
105818011|NCT00723528|364994241|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
105818012|NCT00723528|364994242|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
105818013|NCT00723528|364994236|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
105818014|NCT00723528|364994237|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
105818015|NCT00723528|364994238|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
105818016|NCT00723528|364994239|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
105818017|NCT00723528|364994240|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
105818018|NCT00723528|364994241|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
105818019|NCT00723528|364994242|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
105818020|NCT00723528|364994236|FG000|Period 2: After Controlled Period|Other|0|||
105818021|NCT00723528|364994237|FG001|Period 2: After Controlled Period|Other|0|||
105818022|NCT00723528|364994238|FG002|Period 2: After Controlled Period|Other|0|||
105818023|NCT00723528|364994239|FG003|Period 2: After Controlled Period|Other|0|||
105818024|NCT00723528|364994240|FG004|Period 2: After Controlled Period|Other|1|||
105818025|NCT00723528|364994241|FG005|Period 2: After Controlled Period|Other|4|||
105818026|NCT00723528|364994242|FG006|Period 2: After Controlled Period|Other|0|||
105818027|NCT00723528|364994236|FG000|Period 2: After Controlled Period|Adverse Event|0|||
105818028|NCT00723528|364994237|FG001|Period 2: After Controlled Period|Adverse Event|0|||
105818029|NCT00723528|364994238|FG002|Period 2: After Controlled Period|Adverse Event|0|||
105818030|NCT00723528|364994239|FG003|Period 2: After Controlled Period|Adverse Event|0|||
105818031|NCT00723528|364994240|FG004|Period 2: After Controlled Period|Adverse Event|1|||
105818032|NCT00723528|364994241|FG005|Period 2: After Controlled Period|Adverse Event|0|||
105818033|NCT00723528|364994242|FG006|Period 2: After Controlled Period|Adverse Event|1|||
105818034|NCT00723528|364994236|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
105818035|NCT00723528|364994237|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
105818036|NCT00723528|364994238|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
105818037|NCT00723528|364994239|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
105818038|NCT00723528|364994240|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
105818039|NCT00723528|364994241|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
105818040|NCT00723528|364994242|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
105362615|NCT00928434|363332598|FG000|Overall Study|Other (not meeting above criteria)|5|||
105362616|NCT00928434|363332599|FG001|Overall Study|Other (not meeting above criteria)|1|||
105818041|NCT00723528|364994236|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
105818042|NCT00723528|364994237|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
105818043|NCT00723528|364994238|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
105818044|NCT00723528|364994239|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
105818045|NCT00723528|364994240|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
105818046|NCT00723528|364994241|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
105818047|NCT00723528|364994242|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
105818048|NCT03785548|364994243|FG000|Overall Study|age > 80|1|||
105818049|NCT03785548|364994244|FG001|Overall Study|age > 80|0|||
105818050|NCT03785548|364994243|FG000|Overall Study|no Postop queries|1|||
105362617|NCT00928434|363332600|FG002|Overall Study|Other (not meeting above criteria)|2|||
105362618|NCT01781962|363332601|FG000|Overall Study|Other Miscellaneous Reasons|5|||
105818051|NCT03785548|364994244|FG001|Overall Study|no Postop queries|0|||
105818052|NCT01710657|364994247|FG000|Overall Study|Lost to Follow-up|2|||
105818053|NCT01710657|364994248|FG001|Overall Study|Lost to Follow-up|0|||
105818054|NCT01710657|364994249|FG002|Overall Study|Lost to Follow-up|1|||
105818055|NCT01710657|364994247|FG000|Overall Study|Protocol Violation|2|||
105818056|NCT01710657|364994248|FG001|Overall Study|Protocol Violation|2|||
105818057|NCT01710657|364994249|FG002|Overall Study|Protocol Violation|0|||
105818058|NCT01710657|364994247|FG000|Overall Study|Adverse Event|14|||
105818059|NCT01710657|364994248|FG001|Overall Study|Adverse Event|8|||
105818060|NCT01710657|364994249|FG002|Overall Study|Adverse Event|28|||
105818061|NCT01710657|364994247|FG000|Overall Study|Withdrawal by Subject|0|||
105818062|NCT01710657|364994248|FG001|Overall Study|Withdrawal by Subject|1|||
105818063|NCT01710657|364994249|FG002|Overall Study|Withdrawal by Subject|2|||
105818064|NCT01710657|364994247|FG000|Overall Study|Lack of Efficacy|0|||
105818065|NCT01710657|364994248|FG001|Overall Study|Lack of Efficacy|1|||
105818066|NCT01710657|364994249|FG002|Overall Study|Lack of Efficacy|1|||
105818067|NCT00905346|364994261|FG000|Period 1|Withdrawal by Subject|1|||
105818068|NCT00905346|364994262|FG001|Period 1|Withdrawal by Subject|0|||
105818069|NCT04605094|364994263|FG000|Overall Study|Adverse Event|2|||
105818070|NCT04605094|364994264|FG001|Overall Study|Adverse Event|2|||
105818071|NCT04605094|364994263|FG000|Overall Study|Lost to Follow-up|1|||
105818072|NCT04605094|364994264|FG001|Overall Study|Lost to Follow-up|4|||
105818073|NCT04605094|364994263|FG000|Overall Study|Physician Decision|2|||
105818074|NCT04605094|364994264|FG001|Overall Study|Physician Decision|2|||
105818075|NCT04605094|364994263|FG000|Overall Study|Study terminated by Sponsor|31|||
105818076|NCT04605094|364994264|FG001|Overall Study|Study terminated by Sponsor|33|||
105818077|NCT04605094|364994263|FG000|Overall Study|Withdrawal by Subject|22|||
105818078|NCT04605094|364994264|FG001|Overall Study|Withdrawal by Subject|19|||
105818079|NCT04605094|364994263|FG000|Overall Study|Other|1|||
105818080|NCT04605094|364994264|FG001|Overall Study|Other|1|||
105818081|NCT01149473|364994265|FG000|First Intervention|Adverse Event|1|||
105818082|NCT01149473|364994266|FG001|First Intervention|Adverse Event|1|||
105818083|NCT01149473|364994265|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
105818084|NCT01149473|364994266|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
105818085|NCT00469417|364994267|FG000|Overall Study|Treatment failure all lesions|18|||
105818086|NCT00469417|364994268|FG001|Overall Study|Treatment failure all lesions|11|||
105818087|NCT00469417|364994267|FG000|Overall Study|Consent withdrawn|1|||
105818088|NCT00469417|364994268|FG001|Overall Study|Consent withdrawn|1|||
105818089|NCT00469417|364994267|FG000|Overall Study|Adverse Event|8|||
105818090|NCT00469417|364994268|FG001|Overall Study|Adverse Event|2|||
105818091|NCT00469417|364994267|FG000|Overall Study|Lost to Follow-up|1|||
105818092|NCT00469417|364994268|FG001|Overall Study|Lost to Follow-up|2|||
105818093|NCT00469417|364994267|FG000|Overall Study|Intercurrent disease|0|||
105818094|NCT00469417|364994268|FG001|Overall Study|Intercurrent disease|1|||
105818095|NCT00469417|364994267|FG000|Overall Study|Randomized but not treated|2|||
105818096|NCT00469417|364994268|FG001|Overall Study|Randomized but not treated|0|||
105818097|NCT04206332|364994274|FG000|Part A|Lost to Follow-up|0|||
105818098|NCT04206332|364994275|FG001|Part A|Lost to Follow-up|1|||
105818099|NCT04206332|364994276|FG002|Part A|Lost to Follow-up|0|||
105818100|NCT04206332|364994277|FG003|Part A|Lost to Follow-up|0|||
105818101|NCT04206332|364994278|FG004|Part A|Lost to Follow-up|0|||
105818102|NCT04206332|364994279|FG005|Part A|Lost to Follow-up|0|||
105818103|NCT04206332|364994280|FG006|Part A|Lost to Follow-up|0|||
105818104|NCT04206332|364994281|FG007|Part A|Lost to Follow-up|0|||
105818105|NCT04206332|364994282|FG008|Part A|Lost to Follow-up|0|||
105818106|NCT04206332|364994283|FG009|Part A|Lost to Follow-up|0|||
105818107|NCT04206332|364994284|FG010|Part A|Lost to Follow-up|0|||
105818108|NCT04206332|364994285|FG011|Part A|Lost to Follow-up|0|||
105362619|NCT03006562|363332602|FG000|Overall Study|Lost to Follow-up|0|||
105362620|NCT03006562|363332603|FG001|Overall Study|Lost to Follow-up|1|||
105362621|NCT01001910|363332604|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
105818109|NCT04206332|364994286|FG012|Part A|Lost to Follow-up|0|||
105818110|NCT04206332|364994287|FG013|Part A|Lost to Follow-up|0|||
105818111|NCT04206332|364994288|FG014|Part A|Lost to Follow-up|0|||
105818112|NCT04206332|364994289|FG015|Part A|Lost to Follow-up|0|||
105818113|NCT04206332|364994290|FG016|Part A|Lost to Follow-up|0|||
105818114|NCT04206332|364994274|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818115|NCT04206332|364994275|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818116|NCT04206332|364994276|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818117|NCT04206332|364994277|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105362622|NCT00614874|363332605|FG000|Overall Study|Protocol Violation|1|||
105818118|NCT04206332|364994278|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105362623|NCT00614874|363332605|FG000|Overall Study|Withdrawal by Subject|1|||
105818119|NCT04206332|364994279|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
105818120|NCT04206332|364994280|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818121|NCT04206332|364994281|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105765509|NCT02204410|364793682|FG000|Overall Study|Withdrawal by Subject|3|||
105362624|NCT00716456|363332609|FG000|Overall Study|Adverse Event|0|||
105765510|NCT00209092|364793687|FG000|Overall Study|Progression of disease|7|||
105765511|NCT00209092|364793688|FG001|Overall Study|Progression of disease|1|||
105765512|NCT00209092|364793687|FG000|Overall Study|Adverse Event|0|||
105765513|NCT00209092|364793688|FG001|Overall Study|Adverse Event|1|||
105765514|NCT00209092|364793687|FG000|Overall Study|Withdrawal by Subject|1|||
105765515|NCT00209092|364793688|FG001|Overall Study|Withdrawal by Subject|0|||
105765516|NCT02853123|364793690|FG000|Treatment Period 1|Adverse Event|0|||
105765517|NCT02853123|364793691|FG001|Treatment Period 1|Adverse Event|3|||
105765518|NCT02853123|364793690|FG000|Washout Period|Worsening of COPD|0|||
105765519|NCT02853123|364793691|FG001|Washout Period|Worsening of COPD|3|||
105765520|NCT02853123|364793690|FG000|Washout Period|Adverse Event|1|||
105765521|NCT02853123|364793691|FG001|Washout Period|Adverse Event|0|||
105765522|NCT01235338|364793692|FG000|Overall Study|Adverse Event|3|||
105765523|NCT01235338|364793693|FG001|Overall Study|Adverse Event|2|||
105765524|NCT01235338|364793692|FG000|Overall Study|Protocol Violation|1|||
105765525|NCT01235338|364793693|FG001|Overall Study|Protocol Violation|1|||
105765526|NCT01235338|364793692|FG000|Overall Study|Withdrawal by Subject|5|||
105765527|NCT01235338|364793693|FG001|Overall Study|Withdrawal by Subject|0|||
105765528|NCT01235338|364793692|FG000|Overall Study|Exclusion criteria violations|1|||
105765529|NCT01235338|364793693|FG001|Overall Study|Exclusion criteria violations|1|||
105765530|NCT01235338|364793692|FG000|Overall Study|Positive drug screen|0|||
105765531|NCT01235338|364793693|FG001|Overall Study|Positive drug screen|1|||
105765532|NCT01235338|364793692|FG000|Overall Study|Prohibited meds|1|||
105765533|NCT01235338|364793693|FG001|Overall Study|Prohibited meds|0|||
105765534|NCT02809118|364793696|FG000|Overall Study|Withdrawal by Subject|0|||
105765535|NCT02809118|364793697|FG001|Overall Study|Withdrawal by Subject|1|||
105765536|NCT02809118|364793698|FG002|Overall Study|Withdrawal by Subject|1|||
105765537|NCT01495689|364793703|FG000|Overall Study|Death|0|||
105765538|NCT01495689|364793704|FG001|Overall Study|Death|1|||
105765539|NCT01495689|364793703|FG000|Overall Study|Withdrawal by Subject|3|||
105765540|NCT01495689|364793704|FG001|Overall Study|Withdrawal by Subject|0|||
105765541|NCT01495689|364793703|FG000|Overall Study|Lost to Follow-up|7|||
105765542|NCT01495689|364793704|FG001|Overall Study|Lost to Follow-up|6|||
105765543|NCT01843205|364793705|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
105765544|NCT01843205|364793706|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
105765545|NCT00517413|364793707|FG000|Overall Study|Adverse Event|7|||
105765546|NCT00517413|364793707|FG000|Overall Study|Death|13|||
105765547|NCT00517413|364793707|FG000|Overall Study|Protocol Violation|15|||
105765548|NCT00517413|364793707|FG000|Overall Study|Withdrawal by Subject|2|||
105765549|NCT00517413|364793707|FG000|Overall Study|Failure to return|1|||
105765550|NCT00517413|364793707|FG000|Overall Study|Other-Reasons|23|||
105765551|NCT01355497|364793708|FG000|Overall Study|Death|19|||
105765552|NCT01355497|364793709|FG001|Overall Study|Death|18|||
105765553|NCT01355497|364793708|FG000|Overall Study|Lost to Follow-up|3|||
105765554|NCT01355497|364793709|FG001|Overall Study|Lost to Follow-up|0|||
105765555|NCT01355497|364793708|FG000|Overall Study|Protocol Violation|0|||
105765556|NCT01355497|364793709|FG001|Overall Study|Protocol Violation|1|||
105765557|NCT01355497|364793708|FG000|Overall Study|other-not provided|9|||
105765558|NCT01355497|364793709|FG001|Overall Study|other-not provided|4|||
105765559|NCT01355497|364793708|FG000|Overall Study|Withdrawal by Subject|12|||
105765560|NCT01355497|364793709|FG001|Overall Study|Withdrawal by Subject|20|||
105765561|NCT01355497|364793708|FG000|Overall Study|noncompliance|1|||
105765562|NCT01355497|364793709|FG001|Overall Study|noncompliance|2|||
105765563|NCT01355497|364793708|FG000|Overall Study|progressive disease|11|||
105765564|NCT01355497|364793709|FG001|Overall Study|progressive disease|8|||
105765565|NCT01355497|364793708|FG000|Overall Study|Adverse Event|11|||
105765566|NCT01355497|364793709|FG001|Overall Study|Adverse Event|10|||
105765567|NCT02741310|364793710|FG000|Overall Study|Sponsor Decision|2|||
105765568|NCT02741310|364793711|FG001|Overall Study|Sponsor Decision|2|||
105765569|NCT01784211|364793715|FG000|Part A (Days 1-15)|Adverse Event|1|||
105765570|NCT01784211|364793716|FG001|Part A (Days 1-15)|Adverse Event|1|||
105765571|NCT01784211|364793717|FG002|Part A (Days 1-15)|Adverse Event|0|||
105818122|NCT04206332|364994282|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818123|NCT04206332|364994283|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818124|NCT04206332|364994284|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818125|NCT04206332|364994285|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818126|NCT04206332|364994286|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818127|NCT04206332|364994287|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818128|NCT04206332|364994288|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818129|NCT04206332|364994289|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818130|NCT04206332|364994290|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818131|NCT04206332|364994274|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818132|NCT04206332|364994275|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818133|NCT04206332|364994276|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818134|NCT04206332|364994277|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818135|NCT04206332|364994278|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818136|NCT04206332|364994279|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818137|NCT04206332|364994280|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818138|NCT04206332|364994281|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
105818139|NCT04206332|364994282|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818140|NCT04206332|364994283|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818141|NCT04206332|364994284|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
105818142|NCT04206332|364994285|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818143|NCT04206332|364994286|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818144|NCT04206332|364994287|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818145|NCT04206332|364994288|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818146|NCT04206332|364994289|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818147|NCT04206332|364994290|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818148|NCT04206332|364994274|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818149|NCT04206332|364994275|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818150|NCT04206332|364994276|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818151|NCT04206332|364994277|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818152|NCT04206332|364994278|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818153|NCT04206332|364994279|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818154|NCT04206332|364994280|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818155|NCT04206332|364994281|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818156|NCT04206332|364994282|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818157|NCT04206332|364994283|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818158|NCT04206332|364994284|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818159|NCT04206332|364994285|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818160|NCT04206332|364994286|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818161|NCT04206332|364994287|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818162|NCT04206332|364994288|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818163|NCT04206332|364994289|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818164|NCT04206332|364994290|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
105818165|NCT04206332|364994274|FG000|Part C|Withdrawal by Subject|0|||
105818166|NCT04206332|364994275|FG001|Part C|Withdrawal by Subject|0|||
105818167|NCT04206332|364994276|FG002|Part C|Withdrawal by Subject|0|||
105818168|NCT04206332|364994277|FG003|Part C|Withdrawal by Subject|0|||
105818169|NCT04206332|364994278|FG004|Part C|Withdrawal by Subject|0|||
105818170|NCT04206332|364994279|FG005|Part C|Withdrawal by Subject|0|||
105818171|NCT04206332|364994280|FG006|Part C|Withdrawal by Subject|0|||
105818172|NCT04206332|364994281|FG007|Part C|Withdrawal by Subject|0|||
105818173|NCT04206332|364994282|FG008|Part C|Withdrawal by Subject|0|||
105818174|NCT04206332|364994283|FG009|Part C|Withdrawal by Subject|0|||
105818175|NCT04206332|364994284|FG010|Part C|Withdrawal by Subject|0|||
105818176|NCT04206332|364994285|FG011|Part C|Withdrawal by Subject|0|||
105818177|NCT04206332|364994286|FG012|Part C|Withdrawal by Subject|0|||
105818178|NCT04206332|364994287|FG013|Part C|Withdrawal by Subject|0|||
105818179|NCT04206332|364994288|FG014|Part C|Withdrawal by Subject|2|||
105818180|NCT04206332|364994289|FG015|Part C|Withdrawal by Subject|0|||
105818181|NCT04206332|364994290|FG016|Part C|Withdrawal by Subject|0|||
105818182|NCT04567186|364994300|FG000|Period 1|COVID-19 related|1|||
105818183|NCT04567186|364994301|FG001|Period 1|COVID-19 related|0|||
105818184|NCT04567186|364994300|FG000|Period 1|Protocol Violation|0|||
105818185|NCT04567186|364994301|FG001|Period 1|Protocol Violation|1|||
105818186|NCT04567186|364994300|FG000|Period 1|Adverse Event|0|||
105818187|NCT04567186|364994301|FG001|Period 1|Adverse Event|2|||
105818188|NCT04567186|364994300|FG000|Period 2|COVID-19 Related|0|||
105818189|NCT04567186|364994301|FG001|Period 2|COVID-19 Related|1|||
105818190|NCT04567186|364994300|FG000|Period 2|Protocol Violation|0|||
105818191|NCT04567186|364994301|FG001|Period 2|Protocol Violation|1|||
105818192|NCT04567186|364994300|FG000|Period 2|Lost to Follow-up|0|||
105818193|NCT04567186|364994301|FG001|Period 2|Lost to Follow-up|1|||
105818194|NCT04567186|364994300|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
105818195|NCT04567186|364994301|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
105818196|NCT02193880|364994302|FG000|Overall Study|patients did not collect enough HPC|3|||
105818197|NCT03136380|364994303|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
105818198|NCT03136380|364994304|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
105818199|NCT03136380|364994305|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
105818200|NCT03136380|364994306|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
105818201|NCT03136380|364994307|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
105818202|NCT02728102|364994308|FG000|Overall Study|Death|3|||
105818203|NCT02728102|364994309|FG001|Overall Study|Death|0|||
105818204|NCT02728102|364994310|FG002|Overall Study|Death|1|||
105818205|NCT02728102|364994308|FG000|Overall Study|Withdrawal by Subject|0|||
105818206|NCT02728102|364994309|FG001|Overall Study|Withdrawal by Subject|2|||
105818207|NCT02728102|364994310|FG002|Overall Study|Withdrawal by Subject|3|||
105818208|NCT02728102|364994308|FG000|Overall Study|Physician Decision|1|||
105818209|NCT02728102|364994309|FG001|Overall Study|Physician Decision|1|||
105818210|NCT02728102|364994310|FG002|Overall Study|Physician Decision|0|||
105818211|NCT02728102|364994308|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
105818212|NCT02728102|364994309|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
105818213|NCT02728102|364994310|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
105818214|NCT02728102|364994308|FG000|Overall Study|Covid|0|||
105818215|NCT02728102|364994309|FG001|Overall Study|Covid|0|||
105818216|NCT02728102|364994310|FG002|Overall Study|Covid|1|||
105818217|NCT02419937|364994313|FG000|Overall Study|Lost to Follow-up|1|||
105818218|NCT02419937|364994314|FG001|Overall Study|Lost to Follow-up|0|||
105818219|NCT02924883|364994315|FG000|Overall Study|Death|39|||
105818220|NCT02924883|364994316|FG001|Overall Study|Death|20|||
105818221|NCT02924883|364994315|FG000|Overall Study|Lost to Follow-up|1|||
105818222|NCT02924883|364994316|FG001|Overall Study|Lost to Follow-up|0|||
105818223|NCT02924883|364994315|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
105818224|NCT02924883|364994316|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
105818225|NCT02924883|364994315|FG000|Overall Study|Protocol Violation|1|||
105818226|NCT02924883|364994316|FG001|Overall Study|Protocol Violation|0|||
105818227|NCT02924883|364994315|FG000|Overall Study|Withdrawal by Subject|22|||
105818228|NCT02924883|364994316|FG001|Overall Study|Withdrawal by Subject|16|||
105818229|NCT02924883|364994315|FG000|Overall Study|Progressive Disease|1|||
105818230|NCT02924883|364994316|FG001|Overall Study|Progressive Disease|0|||
105818231|NCT02924883|364994315|FG000|Overall Study|Study Terminated by Sponsor|69|||
105818232|NCT02924883|364994316|FG001|Overall Study|Study Terminated by Sponsor|32|||
105818233|NCT02794974|364994321|FG000|Overall Study|Physician Decision|0|||
105818234|NCT02794974|364994322|FG001|Overall Study|Physician Decision|1|||
105818235|NCT03699020|364994323|FG000|Overall Study|Withdrawal by Subject|3|||
105818236|NCT03699020|364994324|FG001|Overall Study|Withdrawal by Subject|2|||
105818237|NCT01873586|364994325|FG000|Overall Study|Lost to Follow-up|3|||
105818238|NCT01256684|364994326|FG000|Overall Study|Adverse Event|1|||
105818239|NCT01256684|364994327|FG001|Overall Study|Adverse Event|4|||
105818240|NCT01256684|364994328|FG002|Overall Study|Adverse Event|2|||
105818241|NCT01256684|364994326|FG000|Overall Study|Withdrawal by Subject|4|||
105818242|NCT01256684|364994327|FG001|Overall Study|Withdrawal by Subject|0|||
105818243|NCT01256684|364994328|FG002|Overall Study|Withdrawal by Subject|2|||
105818244|NCT01256684|364994326|FG000|Overall Study|Physician Decision|0|||
105818245|NCT01256684|364994327|FG001|Overall Study|Physician Decision|1|||
105818246|NCT01256684|364994328|FG002|Overall Study|Physician Decision|0|||
105818247|NCT01256684|364994326|FG000|Overall Study|Lack of Efficacy|0|||
105818248|NCT01256684|364994327|FG001|Overall Study|Lack of Efficacy|1|||
105818249|NCT01256684|364994328|FG002|Overall Study|Lack of Efficacy|1|||
105818250|NCT01256684|364994326|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
105818251|NCT01256684|364994327|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
105818252|NCT01256684|364994328|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
105818253|NCT01981720|364994329|FG000|Overall Study|Adverse Event|1|||
105818254|NCT01981720|364994329|FG000|Overall Study|Withdrawal by Subject|3|||
105818255|NCT01981720|364994329|FG000|Overall Study|Pregnancy|1|||
105818256|NCT02246920|364994330|FG000|Overall Study|Adverse Event|3|||
105818257|NCT02246920|364994331|FG001|Overall Study|Adverse Event|1|||
105818258|NCT02246920|364994332|FG002|Overall Study|Adverse Event|1|||
105818259|NCT02246920|364994330|FG000|Overall Study|Lost to Follow-up|2|||
105818260|NCT02246920|364994331|FG001|Overall Study|Lost to Follow-up|1|||
105818261|NCT02246920|364994332|FG002|Overall Study|Lost to Follow-up|0|||
105818262|NCT02246920|364994330|FG000|Overall Study|Protocol Violation|2|||
105818263|NCT02246920|364994331|FG001|Overall Study|Protocol Violation|5|||
105818264|NCT02246920|364994332|FG002|Overall Study|Protocol Violation|1|||
105818265|NCT02246920|364994330|FG000|Overall Study|Withdrawal by Subject|0|||
105818266|NCT02246920|364994331|FG001|Overall Study|Withdrawal by Subject|0|||
105818267|NCT02246920|364994332|FG002|Overall Study|Withdrawal by Subject|1|||
105818268|NCT01185548|364994333|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
105818269|NCT02678286|364994334|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
105818270|NCT02678286|364994335|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
105818271|NCT02678286|364994334|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
105818272|NCT02678286|364994335|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
105818273|NCT02678286|364994334|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
105818274|NCT02678286|364994335|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
105818275|NCT02678286|364994334|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
105818276|NCT02678286|364994335|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
105818277|NCT02678286|364994334|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
105818278|NCT02678286|364994335|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
105818279|NCT00086996|364994337|FG000|Overall Study|Adverse Event|29|||
105818280|NCT00086996|364994337|FG000|Overall Study|Death|4|||
105818281|NCT00086996|364994337|FG000|Overall Study|progression/relapse|7|||
105818282|NCT00086996|364994337|FG000|Overall Study|Withdrawal by Subject|13|||
105818283|NCT00086996|364994337|FG000|Overall Study|Other|6|||
105818284|NCT00086996|364994337|FG000|Overall Study|not eligible|5|||
105818285|NCT01422538|364994340|FG000|Overall Study|Lost to Follow-up|0|||
105818286|NCT01422538|364994341|FG001|Overall Study|Lost to Follow-up|1|||
105818287|NCT01422538|364994342|FG002|Overall Study|Lost to Follow-up|1|||
105818288|NCT01422538|364994340|FG000|Overall Study|Missed visit|0|||
105818289|NCT01422538|364994341|FG001|Overall Study|Missed visit|1|||
105818290|NCT01422538|364994342|FG002|Overall Study|Missed visit|1|||
105818291|NCT02674477|364994343|FG000|Overall Study|Protocol Violation|8|||
105818292|NCT02674477|364994344|FG001|Overall Study|Protocol Violation|2|||
105818293|NCT00004562|364994345|FG000|Overall Study|Lost to Follow-up|102|||
105818294|NCT00004562|364994346|FG001|Overall Study|Lost to Follow-up|91|||
105818295|NCT02770820|364994347|FG000|Overall Study|Death|1|||
105818296|NCT02770820|364994347|FG000|Overall Study|Physician Decision|2|||
105818297|NCT00696020|364994348|FG000|Overall Study|Adverse Event|3|||
105818298|NCT00696020|364994349|FG001|Overall Study|Adverse Event|1|||
105818299|NCT00696020|364994350|FG002|Overall Study|Adverse Event|2|||
105818300|NCT00696020|364994351|FG003|Overall Study|Adverse Event|1|||
105818301|NCT00696020|364994348|FG000|Overall Study|Lack of Efficacy|1|||
105818302|NCT00696020|364994349|FG001|Overall Study|Lack of Efficacy|0|||
105818303|NCT00696020|364994350|FG002|Overall Study|Lack of Efficacy|0|||
105818304|NCT00696020|364994351|FG003|Overall Study|Lack of Efficacy|0|||
105818305|NCT00696020|364994348|FG000|Overall Study|Protocol Violation|0|||
105818306|NCT00696020|364994349|FG001|Overall Study|Protocol Violation|0|||
105818307|NCT00696020|364994350|FG002|Overall Study|Protocol Violation|0|||
105818308|NCT00696020|364994351|FG003|Overall Study|Protocol Violation|1|||
105818309|NCT00696020|364994348|FG000|Overall Study|Withdrawal by Subject|0|||
105818310|NCT00696020|364994349|FG001|Overall Study|Withdrawal by Subject|1|||
105818311|NCT00696020|364994350|FG002|Overall Study|Withdrawal by Subject|0|||
105818312|NCT00696020|364994351|FG003|Overall Study|Withdrawal by Subject|1|||
105818313|NCT00696020|364994348|FG000|Overall Study|Other not stated above|0|||
105818314|NCT00696020|364994349|FG001|Overall Study|Other not stated above|0|||
105818315|NCT00696020|364994350|FG002|Overall Study|Other not stated above|1|||
105818316|NCT00696020|364994351|FG003|Overall Study|Other not stated above|1|||
105818317|NCT04274686|364994355|FG000|Overall Study|Physician Decision|1|||
105818318|NCT04274686|364994356|FG001|Overall Study|Physician Decision|0|||
105818319|NCT02331394|364994357|FG000|Overall Study|Disease progression|1|||
105818320|NCT02336165|364994358|FG000|Overall Study|Death|3|||
105818321|NCT02336165|364994359|FG001|Overall Study|Death|0|||
105818322|NCT02336165|364994360|FG002|Overall Study|Death|0|||
105818323|NCT02336165|364994361|FG003|Overall Study|Death|0|||
105818324|NCT02336165|364994362|FG004|Overall Study|Death|1|||
105818325|NCT02336165|364994358|FG000|Overall Study|Physician Decision|2|||
105818326|NCT02336165|364994359|FG001|Overall Study|Physician Decision|2|||
105818327|NCT02336165|364994360|FG002|Overall Study|Physician Decision|1|||
105818328|NCT02336165|364994361|FG003|Overall Study|Physician Decision|1|||
105818329|NCT02336165|364994362|FG004|Overall Study|Physician Decision|0|||
105818330|NCT02336165|364994358|FG000|Overall Study|Withdrawal by Subject|0|||
105818331|NCT02336165|364994359|FG001|Overall Study|Withdrawal by Subject|0|||
105818332|NCT02336165|364994360|FG002|Overall Study|Withdrawal by Subject|1|||
105818333|NCT02336165|364994361|FG003|Overall Study|Withdrawal by Subject|0|||
105818334|NCT02336165|364994362|FG004|Overall Study|Withdrawal by Subject|1|||
105818335|NCT02336165|364994358|FG000|Overall Study|Adverse Event|4|||
105818336|NCT02336165|364994359|FG001|Overall Study|Adverse Event|1|||
105818337|NCT02336165|364994360|FG002|Overall Study|Adverse Event|2|||
105818338|NCT02336165|364994361|FG003|Overall Study|Adverse Event|4|||
105818339|NCT02336165|364994362|FG004|Overall Study|Adverse Event|1|||
105818340|NCT02336165|364994358|FG000|Overall Study|Progressive disease|23|||
105818341|NCT02336165|364994359|FG001|Overall Study|Progressive disease|22|||
105818342|NCT02336165|364994360|FG002|Overall Study|Progressive disease|27|||
105818343|NCT02336165|364994361|FG003|Overall Study|Progressive disease|24|||
105818344|NCT02336165|364994362|FG004|Overall Study|Progressive disease|19|||
105818345|NCT02336165|364994358|FG000|Overall Study|Non-compliance|1|||
105818346|NCT02336165|364994359|FG001|Overall Study|Non-compliance|0|||
105818347|NCT02336165|364994360|FG002|Overall Study|Non-compliance|0|||
105818348|NCT02336165|364994361|FG003|Overall Study|Non-compliance|1|||
105818349|NCT02336165|364994362|FG004|Overall Study|Non-compliance|0|||
105362625|NCT00716456|363332610|FG001|Overall Study|Adverse Event|2|||
105765572|NCT01784211|364793718|FG003|Part A (Days 1-15)|Adverse Event|0|||
105765573|NCT01784211|364793719|FG004|Part A (Days 1-15)|Adverse Event|0|||
105765574|NCT01784211|364793720|FG005|Part A (Days 1-15)|Adverse Event|0|||
105765575|NCT01784211|364793715|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
105765576|NCT01784211|364793716|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
105765577|NCT01784211|364793717|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
105765578|NCT01784211|364793718|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
105765579|NCT01784211|364793719|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
105765580|NCT01784211|364793720|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
105765581|NCT00441727|364793721|FG000|Overall Study|Protocol Violation|19|||
105765582|NCT00441727|364793722|FG001|Overall Study|Protocol Violation|28|||
105765583|NCT00441727|364793723|FG002|Overall Study|Protocol Violation|32|||
105765584|NCT00441727|364793721|FG000|Overall Study|Adverse Event|26|||
105765585|NCT00441727|364793722|FG001|Overall Study|Adverse Event|33|||
105765586|NCT00441727|364793723|FG002|Overall Study|Adverse Event|28|||
105765587|NCT00441727|364793721|FG000|Overall Study|Lack of Efficacy|7|||
105765588|NCT00441727|364793722|FG001|Overall Study|Lack of Efficacy|8|||
105765589|NCT00441727|364793723|FG002|Overall Study|Lack of Efficacy|48|||
105765590|NCT00441727|364793721|FG000|Overall Study|Withdrawal by Subject|40|||
105765591|NCT00441727|364793722|FG001|Overall Study|Withdrawal by Subject|34|||
105765592|NCT00441727|364793723|FG002|Overall Study|Withdrawal by Subject|47|||
105765593|NCT00441727|364793721|FG000|Overall Study|Lost to Follow-up|5|||
105765594|NCT00441727|364793722|FG001|Overall Study|Lost to Follow-up|6|||
105765595|NCT00441727|364793723|FG002|Overall Study|Lost to Follow-up|5|||
105765596|NCT00441727|364793721|FG000|Overall Study|Safety Reasons|3|||
105765597|NCT00441727|364793722|FG001|Overall Study|Safety Reasons|1|||
105765598|NCT00441727|364793723|FG002|Overall Study|Safety Reasons|3|||
105765599|NCT00441727|364793721|FG000|Overall Study|Various reason specified|6|||
105765600|NCT00441727|364793722|FG001|Overall Study|Various reason specified|8|||
105765601|NCT00441727|364793723|FG002|Overall Study|Various reason specified|5|||
105765602|NCT00364832|364793724|FG000|Core Period|Early Withdrawals|2|||
105765603|NCT00364832|364793725|FG001|Core Period|Early Withdrawals|2|||
105765604|NCT00364832|364793726|FG002|Core Period|Early Withdrawals|1|||
105765605|NCT00364832|364793727|FG003|Core Period|Early Withdrawals|1|||
105765606|NCT00364832|364793728|FG004|Core Period|Early Withdrawals|0|||
105765607|NCT00364832|364793729|FG005|Core Period|Early Withdrawals|0|||
105765608|NCT00364832|364793730|FG006|Core Period|Early Withdrawals|4|||
105765609|NCT00364832|364793731|FG007|Core Period|Early Withdrawals|1|||
105765610|NCT00364832|364793732|FG008|Core Period|Early Withdrawals|0|||
105765611|NCT00364832|364793733|FG009|Core Period|Early Withdrawals|0|||
105765612|NCT00364832|364793734|FG010|Core Period|Early Withdrawals|0|||
105765613|NCT00364832|364793735|FG011|Core Period|Early Withdrawals|0|||
105765614|NCT00364832|364793724|FG000|Extension Year 1|Early Withdrawals|0|||
105765615|NCT00364832|364793725|FG001|Extension Year 1|Early Withdrawals|0|||
105765616|NCT00364832|364793726|FG002|Extension Year 1|Early Withdrawals|0|||
105765617|NCT00364832|364793727|FG003|Extension Year 1|Early Withdrawals|0|||
105765618|NCT00364832|364793728|FG004|Extension Year 1|Early Withdrawals|0|||
105765619|NCT00364832|364793729|FG005|Extension Year 1|Early Withdrawals|0|||
105765620|NCT00364832|364793730|FG006|Extension Year 1|Early Withdrawals|0|||
105765621|NCT00364832|364793731|FG007|Extension Year 1|Early Withdrawals|0|||
105765622|NCT00364832|364793732|FG008|Extension Year 1|Early Withdrawals|0|||
105765623|NCT00364832|364793733|FG009|Extension Year 1|Early Withdrawals|4|||
105765624|NCT00364832|364793734|FG010|Extension Year 1|Early Withdrawals|2|||
105765625|NCT00364832|364793735|FG011|Extension Year 1|Early Withdrawals|10|||
105765626|NCT00364832|364793724|FG000|Extension Year 2|Early Withdrawals|0|||
105765627|NCT00364832|364793725|FG001|Extension Year 2|Early Withdrawals|0|||
105765628|NCT00364832|364793726|FG002|Extension Year 2|Early Withdrawals|0|||
105765629|NCT00364832|364793727|FG003|Extension Year 2|Early Withdrawals|0|||
105765630|NCT00364832|364793728|FG004|Extension Year 2|Early Withdrawals|0|||
105765631|NCT00364832|364793729|FG005|Extension Year 2|Early Withdrawals|0|||
105765632|NCT00364832|364793730|FG006|Extension Year 2|Early Withdrawals|0|||
105765633|NCT00364832|364793731|FG007|Extension Year 2|Early Withdrawals|0|||
105765634|NCT00364832|364793732|FG008|Extension Year 2|Early Withdrawals|0|||
105765635|NCT00364832|364793733|FG009|Extension Year 2|Early Withdrawals|5|||
105765636|NCT00364832|364793734|FG010|Extension Year 2|Early Withdrawals|5|||
105765637|NCT00364832|364793735|FG011|Extension Year 2|Early Withdrawals|3|||
105765638|NCT02954952|364793738|FG000|Overall Study|Withdrawal by Subject|1|||
105765639|NCT02954952|364793739|FG001|Overall Study|Withdrawal by Subject|0|||
105765640|NCT02954952|364793740|FG002|Overall Study|Withdrawal by Subject|0|||
105765641|NCT02954952|364793738|FG000|Overall Study|No data collected|0|||
105765642|NCT02954952|364793739|FG001|Overall Study|No data collected|1|||
105765643|NCT02954952|364793740|FG002|Overall Study|No data collected|0|||
105765644|NCT02432703|364793741|FG000|Overall Study|Adverse Event|1|||
105765645|NCT02432703|364793742|FG001|Overall Study|Adverse Event|4|||
105765646|NCT02432703|364793741|FG000|Overall Study|Lack of Efficacy|1|||
105765647|NCT02432703|364793742|FG001|Overall Study|Lack of Efficacy|0|||
105765648|NCT02432703|364793741|FG000|Overall Study|Lost to Follow-up|5|||
105818350|NCT02336165|364994358|FG000|Overall Study|Other|1|||
105818351|NCT02336165|364994359|FG001|Overall Study|Other|0|||
105818352|NCT02336165|364994360|FG002|Overall Study|Other|0|||
105818353|NCT02336165|364994361|FG003|Overall Study|Other|1|||
105818354|NCT02336165|364994362|FG004|Overall Study|Other|0|||
105818355|NCT00910663|364994365|FG000|Period 1|Withdrawal by Subject|0|||
105818356|NCT00910663|364994366|FG001|Period 1|Withdrawal by Subject|1|||
105818357|NCT00552669|364994367|FG000|Overall Study|Death|3|||
105818358|NCT00552669|364994368|FG001|Overall Study|Death|7|||
105818359|NCT03687736|364994369|FG000|Overall Study|Lost to Follow-up|7|||
105818360|NCT03687736|364994369|FG000|Overall Study|Withdrawal by Subject|3|||
105818361|NCT01844375|364994370|FG000|Overall Study|Protocol Violation|1|||
105818362|NCT01844375|364994371|FG001|Overall Study|Protocol Violation|1|||
105818363|NCT02098876|364994374|FG000|Overall Study|Withdrawal by Subject|5|||
105818364|NCT02098876|364994375|FG001|Overall Study|Withdrawal by Subject|5|||
105818365|NCT03627091|364994376|FG000|Overall Study|Adverse Event|0|||
105818366|NCT03627091|364994377|FG001|Overall Study|Adverse Event|0|||
105818367|NCT03627091|364994378|FG002|Overall Study|Adverse Event|2|||
105818368|NCT03627091|364994376|FG000|Overall Study|Withdrawal by Subject|2|||
105818369|NCT03627091|364994377|FG001|Overall Study|Withdrawal by Subject|0|||
105818370|NCT03627091|364994378|FG002|Overall Study|Withdrawal by Subject|2|||
105818371|NCT03627091|364994376|FG000|Overall Study|Physician Decision|2|||
105818372|NCT03627091|364994377|FG001|Overall Study|Physician Decision|0|||
105818373|NCT03627091|364994378|FG002|Overall Study|Physician Decision|0|||
105818374|NCT03627091|364994376|FG000|Overall Study|Site terminated by sponsor|0|||
105818375|NCT03627091|364994377|FG001|Overall Study|Site terminated by sponsor|1|||
105818376|NCT03627091|364994378|FG002|Overall Study|Site terminated by sponsor|0|||
105818377|NCT03627091|364994376|FG000|Overall Study|Disease relapse|7|||
105818378|NCT03627091|364994377|FG001|Overall Study|Disease relapse|5|||
105362626|NCT00716456|363332611|FG002|Overall Study|Adverse Event|0|||
105362627|NCT01619852|363332612|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
105362628|NCT01619852|363332613|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
105362629|NCT01619852|363332612|FG000|3 Month Follow up|Lost to Follow-up|31|||
105362630|NCT01619852|363332613|FG001|3 Month Follow up|Lost to Follow-up|34|||
105362631|NCT00970489|363332614|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
105362632|NCT00970489|363332615|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
105818379|NCT03627091|364994378|FG002|Overall Study|Disease relapse|1|||
105818380|NCT03627091|364994376|FG000|Overall Study|Other|1|||
105818381|NCT03627091|364994377|FG001|Overall Study|Other|0|||
105818382|NCT03627091|364994378|FG002|Overall Study|Other|0|||
105818383|NCT01061866|364994379|FG000|Overall Study|Adverse Event|2|||
105818384|NCT01270503|364994380|FG000|Overall Study|Lost to Follow-up|1|||
105818385|NCT03020615|364994381|FG000|Overall Study|Physician Decision|3|||
105818386|NCT03020615|364994382|FG001|Overall Study|Physician Decision|1|||
105818387|NCT03020615|364994383|FG002|Overall Study|Physician Decision|2|||
105818388|NCT03020615|364994381|FG000|Overall Study|Parent/guardian/patient choice|3|||
105818389|NCT03020615|364994382|FG001|Overall Study|Parent/guardian/patient choice|0|||
105818390|NCT03020615|364994383|FG002|Overall Study|Parent/guardian/patient choice|4|||
105818391|NCT03020615|364994381|FG000|Overall Study|Screen failure|0|||
105818392|NCT03020615|364994382|FG001|Overall Study|Screen failure|0|||
105818393|NCT03020615|364994383|FG002|Overall Study|Screen failure|1|||
105818394|NCT03020615|364994381|FG000|Overall Study|Death|1|||
105818395|NCT03020615|364994382|FG001|Overall Study|Death|0|||
105362633|NCT02087774|363332616|FG000|Overall Study|Were absent day of data collection|8|||
105362634|NCT02087774|363332617|FG001|Overall Study|Were absent day of data collection|20|||
105362635|NCT01723072|363332618|FG000|Overall Study|Withdrawal by Subject|7|||
105362636|NCT01723072|363332619|FG001|Overall Study|Withdrawal by Subject|13|||
105362637|NCT01723072|363332618|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
105362638|NCT01723072|363332619|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
105362639|NCT01723072|363332618|FG000|Overall Study|Other|4|||
105362640|NCT01723072|363332619|FG001|Overall Study|Other|3|||
105362641|NCT03428100|363332620|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
105362642|NCT03428100|363332621|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105818396|NCT03020615|364994383|FG002|Overall Study|Death|0|||
105818397|NCT03020615|364994381|FG000|Overall Study|Lost to Follow-up|0|||
105818398|NCT03020615|364994382|FG001|Overall Study|Lost to Follow-up|1|||
105818399|NCT03020615|364994383|FG002|Overall Study|Lost to Follow-up|0|||
105818400|NCT01536574|364994385|FG000|Overall Study|Adverse Event|4|||
105818401|NCT01536574|364994386|FG001|Overall Study|Adverse Event|5|||
105818402|NCT01536574|364994385|FG000|Overall Study|Withdrawal by Subject|1|||
105818403|NCT01536574|364994386|FG001|Overall Study|Withdrawal by Subject|2|||
105362643|NCT03428100|363332622|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
105362644|NCT03428100|363332623|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
105818404|NCT01536574|364994385|FG000|Overall Study|Lack of Efficacy|1|||
105818405|NCT01536574|364994386|FG001|Overall Study|Lack of Efficacy|0|||
105818406|NCT02481830|364994387|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
105818407|NCT02481830|364994388|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
105818408|NCT02481830|364994387|FG000|Pre-treatment|Withdrawal by Subject|0|||
105486301|NCT00509262|363791464|FG000|Overall Study|Protocol Violation|2|||
105486302|NCT00509262|363791465|FG001|Overall Study|Protocol Violation|2|||
105486303|NCT00509262|363791464|FG000|Overall Study|Withdrawal by Subject|24|||
105486304|NCT00509262|363791465|FG001|Overall Study|Withdrawal by Subject|11|||
105486305|NCT01101191|363791466|FG000|Period 1|Withdrawal by Subject|1|||
105486306|NCT01101191|363791467|FG001|Period 1|Withdrawal by Subject|0|||
105486307|NCT01101191|363791466|FG000|Period 1|Adverse Event|1|||
105486308|NCT01101191|363791467|FG001|Period 1|Adverse Event|2|||
105486309|NCT01092832|363791469|FG000|Overall Study|Other|1|||
105486310|NCT01092832|363791470|FG001|Overall Study|Other|0|||
105486311|NCT00718237|363791475|FG000|Overall Study|Adverse Event|1|||
105818409|NCT02481830|364994388|FG001|Pre-treatment|Withdrawal by Subject|10|||
105818410|NCT02481830|364994387|FG000|Pre-treatment|Disease Progression|1|||
105818411|NCT02481830|364994388|FG001|Pre-treatment|Disease Progression|1|||
105818412|NCT02481830|364994387|FG000|Pre-treatment|Other reasons|0|||
105818413|NCT02481830|364994388|FG001|Pre-treatment|Other reasons|1|||
105818414|NCT02481830|364994387|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
105818415|NCT02481830|364994388|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
105818416|NCT02481830|364994387|FG000|Treatment|Disease Progression|233|||
105818417|NCT02481830|364994388|FG001|Treatment|Disease Progression|171|||
105818418|NCT02481830|364994387|FG000|Treatment|Study drug toxicity|18|||
105818419|NCT02481830|364994388|FG001|Treatment|Study drug toxicity|38|||
105818420|NCT02481830|364994387|FG000|Treatment|Death|1|||
105818421|NCT02481830|364994388|FG001|Treatment|Death|1|||
105818422|NCT02481830|364994387|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
105818423|NCT02481830|364994388|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
105818424|NCT02481830|364994387|FG000|Treatment|Participants request to discontinue Study treatment|6|||
105818425|NCT02481830|364994388|FG001|Treatment|Participants request to discontinue Study treatment|34|||
105818426|NCT02481830|364994387|FG000|Treatment|Withdrawal by Subject|2|||
105818427|NCT02481830|364994388|FG001|Treatment|Withdrawal by Subject|3|||
105818428|NCT02481830|364994387|FG000|Treatment|Lost to Follow-up|1|||
105818429|NCT02481830|364994388|FG001|Treatment|Lost to Follow-up|0|||
105818430|NCT02481830|364994387|FG000|Treatment|Maximum Clinical Benefit|0|||
105818431|NCT02481830|364994388|FG001|Treatment|Maximum Clinical Benefit|5|||
105818432|NCT02481830|364994387|FG000|Treatment|Administrative reason by sponsor|1|||
105818433|NCT02481830|364994388|FG001|Treatment|Administrative reason by sponsor|1|||
105818434|NCT02481830|364994387|FG000|Treatment|Other reasons|6|||
105818435|NCT02481830|364994388|FG001|Treatment|Other reasons|1|||
105818436|NCT00102440|364994389|FG000|Overall Study|Lost to Follow-up|25|||
105818437|NCT00102440|364994390|FG001|Overall Study|Lost to Follow-up|18|||
105818438|NCT00102440|364994391|FG002|Overall Study|Lost to Follow-up|21|||
105818439|NCT00102440|364994389|FG000|Overall Study|Adverse Event|16|||
105818440|NCT00102440|364994390|FG001|Overall Study|Adverse Event|23|||
105818441|NCT00102440|364994391|FG002|Overall Study|Adverse Event|8|||
105818442|NCT00102440|364994389|FG000|Overall Study|Gout Flare|10|||
105818443|NCT00102440|364994390|FG001|Overall Study|Gout Flare|28|||
105818444|NCT00102440|364994391|FG002|Overall Study|Gout Flare|9|||
105818445|NCT00102440|364994389|FG000|Overall Study|Personal Reason(s)|19|||
105818446|NCT00102440|364994390|FG001|Overall Study|Personal Reason(s)|13|||
105818447|NCT00102440|364994391|FG002|Overall Study|Personal Reason(s)|13|||
105818448|NCT00102440|364994389|FG000|Overall Study|Other|11|||
105818449|NCT00102440|364994390|FG001|Overall Study|Other|14|||
105818450|NCT00102440|364994391|FG002|Overall Study|Other|14|||
105818451|NCT00102440|364994389|FG000|Overall Study|Protocol Violation|7|||
105818452|NCT00102440|364994390|FG001|Overall Study|Protocol Violation|2|||
105818453|NCT00102440|364994391|FG002|Overall Study|Protocol Violation|1|||
105818454|NCT01745120|364994397|FG000|Overall Study|Investigator decision|1|||
105818455|NCT01745120|364994398|FG001|Overall Study|Investigator decision|0|||
105818456|NCT02902211|364994404|FG000|First Three Months|Withdrawal by Subject|7|||
105818457|NCT02902211|364994405|FG001|First Three Months|Withdrawal by Subject|3|||
105818458|NCT00909610|364995869|FG000|Period: First Intervention|Adverse Event|0|||
105486312|NCT00718237|363791476|FG001|Overall Study|Adverse Event|3|||
105486313|NCT00718237|363791475|FG000|Overall Study|Lost to Follow-up|2|||
105486314|NCT00718237|363791476|FG001|Overall Study|Lost to Follow-up|2|||
105818459|NCT00909610|364995870|FG001|Period: First Intervention|Adverse Event|1|||
105818460|NCT00909610|364995869|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
105818461|NCT00909610|364995870|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
105818462|NCT00909610|364995869|FG000|Period: Second Intervention|Adverse Event|1|||
105818463|NCT00909610|364995870|FG001|Period: Second Intervention|Adverse Event|0|||
105818464|NCT01034358|364995876|FG000|Overall Study|Withdrawal by Subject|1|||
105818465|NCT01034358|364995876|FG000|Overall Study|Protocol Violation|1|||
105818466|NCT00829790|364995877|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
105818467|NCT00829790|364995878|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
105818468|NCT00834743|364995879|FG000|Second Intervention|Withdrawal by Subject|1|||
105818469|NCT00834743|364995880|FG001|Second Intervention|Withdrawal by Subject|0|||
105818470|NCT00829530|364995883|FG000|First Intervention|Adverse Event|0|||
105818471|NCT00829530|364995884|FG001|First Intervention|Adverse Event|1|||
105818472|NCT00829530|364995883|FG000|First Intervention|Intolerance to Venopuncture|0|||
105818473|NCT00829530|364995884|FG001|First Intervention|Intolerance to Venopuncture|1|||
105818474|NCT00829530|364995883|FG000|Second Intervention|Intolerance to Venopuncture|1|||
105818475|NCT00829530|364995884|FG001|Second Intervention|Intolerance to Venopuncture|0|||
105818476|NCT04466111|364995885|FG000|Prior to Trial Phase|Physician Decision|1|||
105818477|NCT00105196|364995887|FG000|Overall Study|Lack of Efficacy|2|||
105818478|NCT00105196|364995888|FG001|Overall Study|Lack of Efficacy|3|||
105818479|NCT00105196|364995887|FG000|Overall Study|Adverse Event|11|||
105818480|NCT00105196|364995888|FG001|Overall Study|Adverse Event|3|||
105818481|NCT00105196|364995887|FG000|Overall Study|Withdrawal by Subject|6|||
105818482|NCT00105196|364995888|FG001|Overall Study|Withdrawal by Subject|6|||
105818483|NCT00105196|364995887|FG000|Overall Study|Lost to Follow-up|3|||
105818484|NCT00105196|364995888|FG001|Overall Study|Lost to Follow-up|2|||
105818485|NCT00105196|364995887|FG000|Overall Study|Poor/noncompliance|3|||
105818486|NCT00105196|364995888|FG001|Overall Study|Poor/noncompliance|4|||
105818487|NCT00105196|364995887|FG000|Overall Study|Protocol Violation|5|||
105818488|NCT00105196|364995888|FG001|Overall Study|Protocol Violation|2|||
105818489|NCT00105196|364995887|FG000|Overall Study|pending surgery|0|||
105818490|NCT00105196|364995888|FG001|Overall Study|pending surgery|1|||
105818491|NCT00105196|364995887|FG000|Overall Study|marijuana use|0|||
105818492|NCT00105196|364995888|FG001|Overall Study|marijuana use|1|||
105818493|NCT00105196|364995887|FG000|Overall Study|Subject became unblinded|0|||
105818494|NCT00105196|364995888|FG001|Overall Study|Subject became unblinded|1|||
105818495|NCT03025880|364995889|FG000|Overall Study|Adverse Event|1|||
105818496|NCT03025880|364995890|FG001|Overall Study|Adverse Event|0|||
105818497|NCT03025880|364995889|FG000|Overall Study|Death|1|||
105818498|NCT03025880|364995890|FG001|Overall Study|Death|1|||
105818499|NCT03025880|364995889|FG000|Overall Study|Withdrawal by Subject|0|||
105818500|NCT03025880|364995890|FG001|Overall Study|Withdrawal by Subject|1|||
105818501|NCT03025880|364995889|FG000|Overall Study|Physician Decision|0|||
105818502|NCT03025880|364995890|FG001|Overall Study|Physician Decision|1|||
105818503|NCT03025880|364995889|FG000|Overall Study|Progressive Disease|12|||
105818504|NCT03025880|364995890|FG001|Overall Study|Progressive Disease|19|||
105818505|NCT01661686|364995895|FG000|Overall Study|Lost to Follow-up|2|||
105818506|NCT01661686|364995896|FG001|Overall Study|Lost to Follow-up|1|||
105818507|NCT01661686|364995895|FG000|Overall Study|did not receive allocated intervention|0|||
105818508|NCT01661686|364995896|FG001|Overall Study|did not receive allocated intervention|1|||
105818509|NCT02202850|364995899|FG000|Overall Study|Other|2|||
105818510|NCT02202850|364995900|FG001|Overall Study|Other|2|||
105818511|NCT02202850|364995899|FG000|Overall Study|Enbrel treatment discontinued|15|||
105818512|NCT02202850|364995900|FG001|Overall Study|Enbrel treatment discontinued|3|||
105818513|NCT02202850|364995899|FG000|Overall Study|Lost to Follow-up|7|||
105818514|NCT02202850|364995900|FG001|Overall Study|Lost to Follow-up|1|||
105818515|NCT00772941|364995904|FG000|Overall Study|CRFs not available|195|||
105818516|NCT00772941|364995904|FG000|Overall Study|Study not completed|16|||
105818517|NCT00772941|364995904|FG000|Overall Study|Missed Visits|374|||
105818518|NCT00772941|364995904|FG000|Overall Study|Poor Compliance|7|||
105818519|NCT00772941|364995904|FG000|Overall Study|GPSP Violation|90|||
105818520|NCT04627038|364995905|FG000|Overall Study|Adverse Event|36|||
105818521|NCT04627038|364995906|FG001|Overall Study|Adverse Event|8|||
105818522|NCT04627038|364995905|FG000|Overall Study|Lost to Follow-up|1|||
105818523|NCT04627038|364995906|FG001|Overall Study|Lost to Follow-up|0|||
105818524|NCT04627038|364995905|FG000|Overall Study|Physician Decision|0|||
105818525|NCT04627038|364995906|FG001|Overall Study|Physician Decision|1|||
105362645|NCT03428100|363332624|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105362646|NCT03428100|363332625|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105362647|NCT03428100|363332626|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105362648|NCT03428100|363332627|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105362649|NCT03428100|363332628|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105362650|NCT03428100|363332629|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105571658|NCT02746575|364092715|FG000|Overall Study|Unknown history of CVA|1|||
105818526|NCT04627038|364995905|FG000|Overall Study|Protocol Violation|3|||
105818527|NCT04627038|364995906|FG001|Overall Study|Protocol Violation|1|||
105818528|NCT04627038|364995905|FG000|Overall Study|Withdrawal by Subject|13|||
105818529|NCT04627038|364995906|FG001|Overall Study|Withdrawal by Subject|3|||
105818530|NCT04627038|364995905|FG000|Overall Study|Non-compliance with study drug|0|||
105818531|NCT04627038|364995906|FG001|Overall Study|Non-compliance with study drug|1|||
105818532|NCT04627038|364995905|FG000|Overall Study|Prohibited Concomitant Medication|1|||
105818533|NCT04627038|364995906|FG001|Overall Study|Prohibited Concomitant Medication|0|||
105818534|NCT00834756|364995907|FG000|First Intervention|Adverse Event|1|||
105818535|NCT00834756|364995908|FG001|First Intervention|Adverse Event|0|||
105818536|NCT00834756|364995907|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
105818537|NCT00834756|364995908|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
105818538|NCT02193165|364995909|FG000|4 Week Product Use|Lost to Follow-up|1|||
105818539|NCT02193165|364995910|FG001|4 Week Product Use|Lost to Follow-up|1|||
105818540|NCT02193165|364995911|FG002|4 Week Product Use|Lost to Follow-up|1|||
105818541|NCT02193165|364995909|FG000|6 Week Product Use|Lost to Follow-up|0|||
105818542|NCT02193165|364995910|FG001|6 Week Product Use|Lost to Follow-up|1|||
105362651|NCT03428100|363332630|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105362652|NCT03428100|363332631|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105362653|NCT03428100|363332632|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105362654|NCT03428100|363332633|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105362655|NCT03428100|363332634|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105362656|NCT03428100|363332635|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105362657|NCT03428100|363332636|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105362658|NCT03428100|363332637|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105362659|NCT03428100|363332638|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105362660|NCT03428100|363332620|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
105362661|NCT03428100|363332621|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
105362662|NCT03428100|363332622|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
105362663|NCT03428100|363332623|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
105362664|NCT03428100|363332624|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105362665|NCT03428100|363332625|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105362666|NCT03428100|363332626|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105362667|NCT03428100|363332627|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105362668|NCT03428100|363332628|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105362669|NCT03428100|363332629|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105362670|NCT03428100|363332630|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105362671|NCT03428100|363332631|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105362672|NCT03428100|363332632|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105362673|NCT03428100|363332633|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105362674|NCT03428100|363332634|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105362675|NCT03428100|363332635|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105362676|NCT03428100|363332636|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105362677|NCT03428100|363332637|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105362678|NCT03428100|363332638|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105362679|NCT03428100|363332620|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105362680|NCT03428100|363332621|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
105362681|NCT03428100|363332622|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
105362682|NCT03428100|363332623|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105362683|NCT03428100|363332624|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105362684|NCT03428100|363332625|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105362685|NCT03428100|363332626|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105362686|NCT03428100|363332627|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105362687|NCT03428100|363332628|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105818543|NCT02193165|364995911|FG002|6 Week Product Use|Lost to Follow-up|0|||
105818544|NCT02514122|364995912|FG000|Overall Study|Withdrawal by Subject|2|||
105818545|NCT02514122|364995913|FG001|Overall Study|Withdrawal by Subject|0|||
105818546|NCT04239872|364995914|FG000|Overall Study|Lost to Follow-up|0|||
105818547|NCT04239872|364995915|FG001|Overall Study|Lost to Follow-up|1|||
105818548|NCT01498120|364995920|FG000|Overall Study|Lost to Follow-up|1|||
105818549|NCT01498120|364995920|FG000|Overall Study|Withdrawal by Subject|5|||
105818550|NCT01498120|364995920|FG000|Overall Study|AE, non-serious non-fatal|3|||
105818551|NCT01498120|364995920|FG000|Overall Study|Other|4|||
105818552|NCT00850174|364995923|FG000|Washout: One Week|Withdrawal by Subject|0|||
105818553|NCT00850174|364995924|FG001|Washout: One Week|Withdrawal by Subject|2|||
105818554|NCT00850174|364995923|FG000|Second Intervention|Withdrawal by Subject|1|||
105818555|NCT00850174|364995924|FG001|Second Intervention|Withdrawal by Subject|0|||
105818556|NCT01513174|364995925|FG000|Overall Study|Inclusion Error|1|||
105818557|NCT01513174|364995926|FG001|Overall Study|Inclusion Error|7|||
105818558|NCT01513174|364995925|FG000|Overall Study|Not receive study treatment|3|||
105818559|NCT01513174|364995926|FG001|Overall Study|Not receive study treatment|1|||
105818560|NCT00635492|364995927|FG000|Overall Study|Death|12|||
105818561|NCT00635492|364995928|FG001|Overall Study|Death|40|||
105818562|NCT00635492|364995927|FG000|Overall Study|Lost to Follow-up|151|||
105362688|NCT03428100|363332629|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105486315|NCT00718237|363791475|FG000|Overall Study|Physician Decision|1|||
105486316|NCT00718237|363791476|FG001|Overall Study|Physician Decision|0|||
105486317|NCT00718237|363791475|FG000|Overall Study|Withdrawal by Subject|9|||
105818563|NCT00635492|364995928|FG001|Overall Study|Lost to Follow-up|172|||
105818564|NCT00635492|364995927|FG000|Overall Study|Physician Decision|32|||
105818565|NCT00635492|364995928|FG001|Overall Study|Physician Decision|22|||
105818566|NCT00635492|364995927|FG000|Overall Study|Sponsor decision|2|||
105818567|NCT00635492|364995928|FG001|Overall Study|Sponsor decision|3|||
105362689|NCT03428100|363332630|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105362690|NCT03428100|363332631|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105362691|NCT03428100|363332632|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105818568|NCT00635492|364995927|FG000|Overall Study|Withdrawal by Subject|82|||
105818569|NCT00635492|364995928|FG001|Overall Study|Withdrawal by Subject|45|||
105818570|NCT01900626|364995929|FG000|Overall Study|study was closed due to low enrollment|1|||
105818571|NCT01900626|364995930|FG001|Overall Study|study was closed due to low enrollment|1|||
105818572|NCT01702987|364995931|FG000|Overall Study|Withdrawal by Subject|1|||
105818573|NCT01702987|364995932|FG001|Overall Study|Withdrawal by Subject|0|||
105818574|NCT04263649|364995933|FG000|Overall Study|Adverse Event|53|||
105818575|NCT04263649|364995933|FG000|Overall Study|Lost to Follow-up|3|||
105818576|NCT04263649|364995933|FG000|Overall Study|Death|29|||
105818577|NCT04263649|364995933|FG000|Overall Study|Device deficiency|19|||
105818578|NCT04263649|364995933|FG000|Overall Study|other reasons|11|||
105818579|NCT02057458|364995934|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
105818580|NCT02057458|364995935|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
105818581|NCT02057458|364995936|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
105818582|NCT02057458|364995934|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
105818583|NCT02057458|364995935|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
105818584|NCT02057458|364995936|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
105818585|NCT02057458|364995934|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
105818586|NCT02057458|364995935|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
105818587|NCT02057458|364995936|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
105818588|NCT01629381|364995937|FG000|Overall Study|Withdrawal by Subject|2|||
105818589|NCT01629381|364995938|FG001|Overall Study|Withdrawal by Subject|5|||
105818590|NCT01534520|364995939|FG000|Overall Study|Adverse Event|0|||
105818591|NCT01534520|364995940|FG001|Overall Study|Adverse Event|1|||
105818592|NCT01214850|364995943|FG000|Overall Study|Withdrawal by Subject|38|||
105818593|NCT01214850|364995944|FG001|Overall Study|Withdrawal by Subject|31|||
105818594|NCT01214850|364995945|FG002|Overall Study|Withdrawal by Subject|28|||
105818595|NCT01214850|364995943|FG000|Overall Study|Lost to Follow-up|124|||
105818596|NCT01214850|364995944|FG001|Overall Study|Lost to Follow-up|98|||
105818597|NCT01214850|364995945|FG002|Overall Study|Lost to Follow-up|123|||
105818598|NCT01214850|364995943|FG000|Overall Study|Protocol Violation|5|||
105818599|NCT01214850|364995944|FG001|Overall Study|Protocol Violation|5|||
105818600|NCT01214850|364995945|FG002|Overall Study|Protocol Violation|6|||
105818601|NCT01214850|364995943|FG000|Overall Study|Adverse event or death|11|||
105818602|NCT01214850|364995944|FG001|Overall Study|Adverse event or death|8|||
105818603|NCT01214850|364995945|FG002|Overall Study|Adverse event or death|3|||
105818604|NCT01214850|364995943|FG000|Overall Study|Inappropriate enrollment|2|||
105818605|NCT01214850|364995944|FG001|Overall Study|Inappropriate enrollment|1|||
105818606|NCT01214850|364995945|FG002|Overall Study|Inappropriate enrollment|0|||
105818607|NCT01214850|364995943|FG000|Overall Study|Administrative reason|1|||
105818608|NCT01214850|364995944|FG001|Overall Study|Administrative reason|0|||
105818609|NCT01214850|364995945|FG002|Overall Study|Administrative reason|0|||
105818610|NCT01214850|364995943|FG000|Overall Study|Unable to classify|2|||
105818611|NCT01214850|364995944|FG001|Overall Study|Unable to classify|1|||
105818612|NCT01214850|364995945|FG002|Overall Study|Unable to classify|1|||
105818613|NCT01863745|364995951|FG000|Overall Study|Disease Progression|9|||
105818614|NCT01863745|364995951|FG000|Overall Study|Adverse Event|2|||
105818615|NCT01863745|364995951|FG000|Overall Study|Death|1|||
105818616|NCT01863745|364995951|FG000|Overall Study|Withdrawal by Subject|1|||
105818617|NCT00735904|364995952|FG000|Overall Study|Adverse Event|3|||
105818618|NCT00735904|364995952|FG000|Overall Study|Death|20|||
105818619|NCT00735904|364995952|FG000|Overall Study|Protocol Violation|1|||
105818620|NCT00735904|364995952|FG000|Overall Study|Withdrawal by Subject|1|||
105818621|NCT00735904|364995952|FG000|Overall Study|Study Terminated by Sponsor|5|||
105818622|NCT00735904|364995952|FG000|Overall Study|Other|8|||
105818623|NCT03204539|364995953|FG000|Overall Study|Loss of funding|0|||
105818624|NCT03204539|364995954|FG001|Overall Study|Loss of funding|1|||
105818625|NCT01171963|364995957|FG000|Overall Study|Adverse Event|10|||
105818626|NCT01171963|364995958|FG001|Overall Study|Adverse Event|15|||
105818627|NCT01171963|364995957|FG000|Overall Study|Lost to Follow-up|23|||
105818628|NCT01171963|364995958|FG001|Overall Study|Lost to Follow-up|24|||
105818629|NCT01171963|364995957|FG000|Overall Study|Other - diarrhoea|1|||
105818630|NCT01171963|364995958|FG001|Overall Study|Other - diarrhoea|0|||
105818631|NCT01171963|364995957|FG000|Overall Study|Withdrawal by Subject|114|||
105818632|NCT01171963|364995958|FG001|Overall Study|Withdrawal by Subject|129|||
105818633|NCT05093205|364995959|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
105818634|NCT05093205|364995960|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
105818635|NCT05093205|364995961|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
105818636|NCT05093205|364995962|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
105818637|NCT05093205|364995963|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
105818638|NCT05093205|364995964|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
105362692|NCT03428100|363332633|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105362693|NCT03428100|363332634|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105486318|NCT00718237|363791476|FG001|Overall Study|Withdrawal by Subject|10|||
105818639|NCT05093205|364995965|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
105818640|NCT05093205|364995966|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
105818641|NCT05093205|364995967|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
105818642|NCT05093205|364995968|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
105818643|NCT05093205|364995969|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
105818644|NCT05093205|364995970|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
105818645|NCT05093205|364995971|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
105818646|NCT05093205|364995959|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818647|NCT05093205|364995960|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818648|NCT05093205|364995961|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
105818649|NCT05093205|364995962|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818650|NCT05093205|364995963|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818651|NCT05093205|364995964|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818652|NCT05093205|364995965|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818653|NCT05093205|364995966|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818654|NCT05093205|364995967|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818655|NCT05093205|364995968|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818656|NCT05093205|364995969|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818657|NCT05093205|364995970|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818658|NCT05093205|364995971|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818659|NCT05093205|364995959|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
105818660|NCT05093205|364995960|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
105818661|NCT05093205|364995961|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
105818662|NCT05093205|364995962|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
105818663|NCT05093205|364995963|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
105818664|NCT05093205|364995964|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
105818665|NCT05093205|364995965|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
105818666|NCT05093205|364995966|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
105818667|NCT05093205|364995967|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
105818668|NCT05093205|364995968|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
105818669|NCT05093205|364995969|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
105818670|NCT05093205|364995970|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
105818671|NCT05093205|364995971|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
105818672|NCT05093205|364995959|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
105818673|NCT05093205|364995960|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
105818674|NCT05093205|364995961|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
105818675|NCT05093205|364995962|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
105818676|NCT05093205|364995963|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
105818677|NCT05093205|364995964|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
105818678|NCT05093205|364995965|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
105818679|NCT05093205|364995966|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
105818680|NCT05093205|364995967|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
105818681|NCT05093205|364995968|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
105818682|NCT05093205|364995969|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
105818683|NCT05093205|364995970|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
105818684|NCT05093205|364995971|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
105818685|NCT05093205|364995959|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
105818686|NCT05093205|364995960|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
105818687|NCT05093205|364995961|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
105818688|NCT05093205|364995962|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
105818689|NCT05093205|364995963|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
105818690|NCT05093205|364995964|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
105818691|NCT05093205|364995965|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
105818692|NCT05093205|364995966|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
105818693|NCT05093205|364995967|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
105818694|NCT05093205|364995968|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
105818695|NCT05093205|364995969|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
105818696|NCT05093205|364995970|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
105818697|NCT05093205|364995971|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
105818698|NCT05093205|364995959|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
105818699|NCT05093205|364995960|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
105818700|NCT05093205|364995961|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
105818701|NCT05093205|364995962|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
105818702|NCT05093205|364995963|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
105818703|NCT05093205|364995964|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
105818704|NCT05093205|364995965|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
105818705|NCT05093205|364995966|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
105818706|NCT05093205|364995967|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
105818707|NCT05093205|364995968|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
105818708|NCT05093205|364995969|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
105818709|NCT05093205|364995970|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
105818710|NCT05093205|364995971|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
105818711|NCT05093205|364995959|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
105818712|NCT05093205|364995960|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
105818713|NCT05093205|364995961|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
105818714|NCT05093205|364995962|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
105818715|NCT05093205|364995963|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
105818716|NCT05093205|364995964|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
105818717|NCT05093205|364995965|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
105818718|NCT05093205|364995966|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
105818719|NCT05093205|364995967|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
105818720|NCT05093205|364995968|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
105818721|NCT05093205|364995969|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
105818722|NCT05093205|364995970|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
105818723|NCT05093205|364995971|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
105818724|NCT05093205|364995959|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
105818725|NCT05093205|364995960|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
105818726|NCT05093205|364995961|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
105818727|NCT05093205|364995962|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
105818728|NCT05093205|364995963|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
105818729|NCT05093205|364995964|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
105818730|NCT05093205|364995965|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
105818731|NCT05093205|364995966|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
105818732|NCT05093205|364995967|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
105818733|NCT05093205|364995968|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
105818734|NCT05093205|364995969|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
105818735|NCT05093205|364995970|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
105818736|NCT05093205|364995971|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
105818737|NCT05093205|364995959|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818738|NCT05093205|364995960|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818739|NCT05093205|364995961|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818740|NCT05093205|364995962|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818741|NCT05093205|364995963|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818742|NCT05093205|364995964|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818743|NCT05093205|364995965|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818744|NCT05093205|364995966|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818745|NCT05093205|364995967|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818746|NCT05093205|364995968|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
105818747|NCT05093205|364995969|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818748|NCT05093205|364995970|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818749|NCT05093205|364995971|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818750|NCT05093205|364995959|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
105818751|NCT05093205|364995960|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
105818752|NCT05093205|364995961|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
105818753|NCT05093205|364995962|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
105818754|NCT05093205|364995963|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
105818755|NCT05093205|364995964|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
105818756|NCT05093205|364995965|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
105818757|NCT05093205|364995966|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
105818758|NCT05093205|364995967|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
105818759|NCT05093205|364995968|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
105818760|NCT05093205|364995969|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
105818761|NCT05093205|364995970|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
105818762|NCT05093205|364995971|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
105818763|NCT05093205|364995959|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818764|NCT05093205|364995960|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818765|NCT05093205|364995961|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818766|NCT05093205|364995962|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818767|NCT05093205|364995963|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818768|NCT05093205|364995964|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818769|NCT05093205|364995965|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818770|NCT05093205|364995966|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818771|NCT05093205|364995967|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818772|NCT05093205|364995968|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818773|NCT05093205|364995969|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
105818774|NCT05093205|364995970|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818775|NCT05093205|364995971|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818776|NCT05093205|364995959|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818777|NCT05093205|364995960|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818778|NCT05093205|364995961|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818779|NCT05093205|364995962|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818780|NCT05093205|364995963|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818781|NCT05093205|364995964|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818782|NCT05093205|364995965|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818783|NCT05093205|364995966|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818784|NCT05093205|364995967|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818785|NCT05093205|364995968|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818786|NCT05093205|364995969|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818787|NCT05093205|364995970|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
105818788|NCT05093205|364995971|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818789|NCT05093205|364995959|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
105818790|NCT05093205|364995960|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
105818791|NCT05093205|364995961|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
105818792|NCT05093205|364995962|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
105818793|NCT05093205|364995963|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
105818794|NCT05093205|364995964|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
105818795|NCT05093205|364995965|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
105818796|NCT05093205|364995966|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
105818797|NCT05093205|364995967|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
105818798|NCT05093205|364995968|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
105818799|NCT05093205|364995969|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
105818800|NCT05093205|364995970|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
105818801|NCT05093205|364995971|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
105818802|NCT05093205|364995959|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818803|NCT05093205|364995960|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818804|NCT05093205|364995961|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818805|NCT05093205|364995962|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818806|NCT05093205|364995963|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818807|NCT05093205|364995964|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818808|NCT05093205|364995965|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818809|NCT05093205|364995966|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818810|NCT05093205|364995967|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818811|NCT05093205|364995968|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818812|NCT05093205|364995969|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818813|NCT05093205|364995970|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
105818814|NCT05093205|364995971|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818815|NCT00846495|364995977|FG000|Overall Study|Lost to Follow-up|1|||
105818816|NCT00846495|364995978|FG001|Overall Study|Lost to Follow-up|0|||
105818817|NCT00846495|364995977|FG000|Overall Study|Adverse Event|5|||
105818818|NCT00846495|364995978|FG001|Overall Study|Adverse Event|1|||
105818819|NCT00846495|364995977|FG000|Overall Study|Lack of Efficacy|1|||
105818820|NCT00846495|364995978|FG001|Overall Study|Lack of Efficacy|2|||
105818821|NCT00846495|364995977|FG000|Overall Study|Physician Decision|1|||
105818822|NCT00846495|364995978|FG001|Overall Study|Physician Decision|0|||
105818823|NCT00984126|364995979|FG000|Overall Study|Protocol Violation|0|||
105818824|NCT00984126|364995980|FG001|Overall Study|Protocol Violation|0|||
105818825|NCT00984126|364995981|FG002|Overall Study|Protocol Violation|1|||
105818826|NCT00984126|364995982|FG003|Overall Study|Protocol Violation|2|||
105818827|NCT00984126|364995979|FG000|Overall Study|Adverse Event|0|||
105818828|NCT00984126|364995980|FG001|Overall Study|Adverse Event|0|||
105818829|NCT00984126|364995981|FG002|Overall Study|Adverse Event|0|||
105818830|NCT00984126|364995982|FG003|Overall Study|Adverse Event|2|||
105818831|NCT00984126|364995979|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
105818832|NCT00984126|364995980|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
105818833|NCT00984126|364995981|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
105818834|NCT00984126|364995982|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
105818835|NCT00984126|364995979|FG000|Overall Study|Withdrawal criteria|0|||
105818836|NCT00984126|364995980|FG001|Overall Study|Withdrawal criteria|1|||
105818837|NCT00984126|364995981|FG002|Overall Study|Withdrawal criteria|3|||
105818838|NCT00984126|364995982|FG003|Overall Study|Withdrawal criteria|9|||
105818839|NCT03459807|364995985|FG000|Overall Study|Withdrawal due to transplant|0|||
105818840|NCT03459807|364995986|FG001|Overall Study|Withdrawal due to transplant|1|||
105818841|NCT00359281|364995987|FG000|Overall Study|Adverse Event|1|||
105818842|NCT00359281|364995988|FG001|Overall Study|Adverse Event|0|||
105818843|NCT00359281|364995989|FG002|Overall Study|Adverse Event|0|||
105818844|NCT00359281|364995990|FG003|Overall Study|Adverse Event|0|||
105818845|NCT00359281|364995991|FG004|Overall Study|Adverse Event|0|||
105818846|NCT00359281|364995992|FG005|Overall Study|Adverse Event|0|||
105818847|NCT00359281|364995993|FG006|Overall Study|Adverse Event|1|||
105818848|NCT00359281|364995994|FG007|Overall Study|Adverse Event|0|||
105818849|NCT00359281|364995995|FG008|Overall Study|Adverse Event|0|||
105818850|NCT00359281|364995987|FG000|Overall Study|Withdrawal by Subject|0|||
105818851|NCT00359281|364995988|FG001|Overall Study|Withdrawal by Subject|0|||
105818852|NCT00359281|364995989|FG002|Overall Study|Withdrawal by Subject|0|||
105818853|NCT00359281|364995990|FG003|Overall Study|Withdrawal by Subject|0|||
105818854|NCT00359281|364995991|FG004|Overall Study|Withdrawal by Subject|0|||
105818855|NCT00359281|364995992|FG005|Overall Study|Withdrawal by Subject|0|||
105818856|NCT00359281|364995993|FG006|Overall Study|Withdrawal by Subject|1|||
105818857|NCT00359281|364995994|FG007|Overall Study|Withdrawal by Subject|0|||
105818858|NCT00359281|364995995|FG008|Overall Study|Withdrawal by Subject|0|||
105818859|NCT02392000|364995996|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
105362694|NCT03428100|363332635|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105362695|NCT03428100|363332636|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105362696|NCT03428100|363332637|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105362697|NCT03428100|363332638|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105362698|NCT03428100|363332620|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
105362699|NCT03428100|363332621|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362700|NCT03428100|363332622|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362701|NCT03428100|363332623|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362702|NCT03428100|363332624|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362703|NCT03428100|363332625|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362704|NCT03428100|363332626|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362705|NCT03428100|363332627|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362706|NCT03428100|363332628|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362707|NCT03428100|363332629|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362708|NCT03428100|363332630|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362709|NCT03428100|363332631|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362710|NCT03428100|363332632|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362711|NCT03428100|363332633|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362712|NCT03428100|363332634|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362713|NCT03428100|363332635|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362714|NCT03428100|363332636|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105818860|NCT02392000|364995996|FG000|Overall Study|Withdrawal by Subject|1|||
105818861|NCT02392000|364995996|FG000|Overall Study|Lost to Follow-up|8|||
105362715|NCT03428100|363332637|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105362716|NCT03428100|363332638|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105818862|NCT04384978|364995998|FG000|Overall Study|Withdrawal by Subject|4|||
105818863|NCT04384978|364995999|FG001|Overall Study|Withdrawal by Subject|0|||
105818864|NCT02612337|364996002|FG000|Overall Study|Lack of Efficacy|1|||
105818865|NCT02612337|364996003|FG001|Overall Study|Lack of Efficacy|0|||
105818866|NCT02612337|364996002|FG000|Overall Study|Withdrawal by Subject|2|||
105818867|NCT02612337|364996003|FG001|Overall Study|Withdrawal by Subject|2|||
105818868|NCT02612337|364996002|FG000|Overall Study|Did not receive study drug|0|||
105818869|NCT02612337|364996003|FG001|Overall Study|Did not receive study drug|1|||
105818870|NCT02089997|364996006|FG000|Overall Study|Case report forms uncollected|99|||
105818871|NCT02089997|364996006|FG000|Overall Study|Protocol Violation|147|||
105818872|NCT02441309|364996007|FG000|Overall Study|Disease progression|2|||
105818873|NCT02441309|364996008|FG001|Overall Study|Disease progression|1|||
105818874|NCT02441309|364996009|FG002|Overall Study|Disease progression|2|||
105818875|NCT02441309|364996007|FG000|Overall Study|Adverse Event|0|||
105818876|NCT02441309|364996008|FG001|Overall Study|Adverse Event|1|||
105818877|NCT02441309|364996009|FG002|Overall Study|Adverse Event|0|||
105818878|NCT02441309|364996007|FG000|Overall Study|Withdrawal by Subject|1|||
105818879|NCT02441309|364996008|FG001|Overall Study|Withdrawal by Subject|0|||
105818880|NCT02441309|364996009|FG002|Overall Study|Withdrawal by Subject|1|||
105818881|NCT00415363|364996010|FG000|Overall Study|Withdrawal by Subject|4|||
105818882|NCT00415363|364996011|FG001|Overall Study|Withdrawal by Subject|4|||
105818883|NCT00415363|364996010|FG000|Overall Study|Adverse Event|4|||
105818884|NCT00415363|364996011|FG001|Overall Study|Adverse Event|4|||
105818885|NCT00415363|364996010|FG000|Overall Study|Lost to Follow-up|2|||
105818886|NCT00415363|364996011|FG001|Overall Study|Lost to Follow-up|1|||
105818887|NCT00415363|364996010|FG000|Overall Study|Physician Decision|3|||
105818888|NCT00415363|364996011|FG001|Overall Study|Physician Decision|1|||
105818889|NCT00415363|364996010|FG000|Overall Study|Death|16|||
105818890|NCT00415363|364996011|FG001|Overall Study|Death|12|||
105818891|NCT00415363|364996010|FG000|Overall Study|Progressive disease|26|||
105818892|NCT00415363|364996011|FG001|Overall Study|Progressive disease|32|||
105818893|NCT02374853|364996015|FG000|Overall Study|Surgery Cancelled|5|||
105818894|NCT02374853|364996016|FG001|Overall Study|Surgery Cancelled|11|||
105818895|NCT00819741|364996021|FG000|Overall Study|Adverse Event|5|||
105818896|NCT00819741|364996022|FG001|Overall Study|Adverse Event|2|||
105818897|NCT00819741|364996021|FG000|Overall Study|Lack of Efficacy|0|||
105818898|NCT00819741|364996022|FG001|Overall Study|Lack of Efficacy|2|||
105818899|NCT00819741|364996021|FG000|Overall Study|Lost to Follow-up|3|||
105818900|NCT00819741|364996022|FG001|Overall Study|Lost to Follow-up|1|||
105818901|NCT00819741|364996021|FG000|Overall Study|Protocol Violation|3|||
105818902|NCT00819741|364996022|FG001|Overall Study|Protocol Violation|4|||
105818903|NCT00819741|364996021|FG000|Overall Study|Withdrawal by Subject|2|||
105818904|NCT00819741|364996022|FG001|Overall Study|Withdrawal by Subject|2|||
105818905|NCT00819741|364996021|FG000|Overall Study|Unclassified|6|||
105818906|NCT00819741|364996022|FG001|Overall Study|Unclassified|0|||
105818907|NCT00819741|364996021|FG000|Overall Study|Reasons unknown|3|||
105818908|NCT00819741|364996022|FG001|Overall Study|Reasons unknown|3|||
105818909|NCT00396279|364997228|FG000|Overall Study|Ongoing in study|26|||
105818910|NCT00396279|364997228|FG000|Overall Study|Disease progression|2|||
105818911|NCT00396279|364997228|FG000|Overall Study|Withdrawal by Subject|1|||
105818912|NCT00396279|364997228|FG000|Overall Study|Physician Decision|1|||
105818913|NCT00667095|364997229|FG000|Overall Study|Withdrawal by Subject|0|||
105818914|NCT00667095|364997230|FG001|Overall Study|Withdrawal by Subject|1|||
105818915|NCT03447262|364997231|FG000|Overall Study|Adverse Event|7|||
105818916|NCT03447262|364997231|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
105818917|NCT03447262|364997231|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
105818918|NCT03447262|364997231|FG000|Overall Study|Death|2|||
105818919|NCT03447262|364997231|FG000|Overall Study|Study Termination by Sponsor|455|||
105818920|NCT03447262|364997231|FG000|Overall Study|Other|4|||
105818921|NCT00830206|364997232|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
105818922|NCT00830206|364997233|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
105818923|NCT03351335|364997236|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
105818924|NCT03351335|364997237|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
105818925|NCT03351335|364997238|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
105818926|NCT04000815|364997240|FG000|Overall Study|Lost to Follow-up|9|||
105818927|NCT04000815|364997241|FG001|Overall Study|Lost to Follow-up|2|||
105818928|NCT04000815|364997242|FG002|Overall Study|Lost to Follow-up|3|||
105818929|NCT04000815|364997240|FG000|Overall Study|Withdrawal by Subject|4|||
105818930|NCT04000815|364997241|FG001|Overall Study|Withdrawal by Subject|3|||
105818931|NCT04000815|364997242|FG002|Overall Study|Withdrawal by Subject|2|||
105818932|NCT04000815|364997240|FG000|Overall Study|Right ovarian cyst occured|1|||
105818933|NCT04000815|364997241|FG001|Overall Study|Right ovarian cyst occured|0|||
105818934|NCT04000815|364997242|FG002|Overall Study|Right ovarian cyst occured|0|||
105362717|NCT03428100|363332620|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362718|NCT03428100|363332621|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
105818935|NCT04000815|364997240|FG000|Overall Study|Hypertension occured on follow up|0|||
105818936|NCT04000815|364997241|FG001|Overall Study|Hypertension occured on follow up|0|||
105818937|NCT04000815|364997242|FG002|Overall Study|Hypertension occured on follow up|2|||
105818938|NCT00620074|364997243|FG000|Overall Study|Adverse Event|1|||
105818939|NCT02246166|364997245|FG000|Overall Study|Protocol Violation|1|||
105818940|NCT02246166|364997246|FG001|Overall Study|Protocol Violation|0|||
105818941|NCT02472366|364997247|FG000|Overall Study|Lost to Follow-up|1|||
105818942|NCT02472366|364997248|FG001|Overall Study|Lost to Follow-up|0|||
105818943|NCT00252720|364997252|FG000|Overall Study|Withdrawal by Subject|95|||
105818944|NCT00252720|364997253|FG001|Overall Study|Withdrawal by Subject|97|||
105818945|NCT00252720|364997252|FG000|Overall Study|Death|7|||
105818946|NCT00252720|364997253|FG001|Overall Study|Death|8|||
105818947|NCT00252720|364997252|FG000|Overall Study|Moving|23|||
105818948|NCT00252720|364997253|FG001|Overall Study|Moving|42|||
105818949|NCT00252720|364997252|FG000|Overall Study|Mainly patients lost to follow-up|7|||
105818950|NCT00252720|364997253|FG001|Overall Study|Mainly patients lost to follow-up|18|||
105818951|NCT02255097|364997254|FG000|Overall Study|Death|151|||
105818952|NCT02255097|364997254|FG000|Overall Study|Lost to Follow-up|5|||
105818953|NCT02255097|364997254|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
105818954|NCT02255097|364997254|FG000|Overall Study|Withdrawal by Subject|7|||
105818955|NCT02255097|364997254|FG000|Overall Study|Allocated but not treated|1|||
105818956|NCT01118312|364997261|FG000|Overall Study|Lost to Follow-up|33|||
105818957|NCT01118312|364997262|FG001|Overall Study|Lost to Follow-up|32|||
105818958|NCT01118312|364997261|FG000|Overall Study|Withdrawal by Subject|1|||
105818959|NCT01118312|364997262|FG001|Overall Study|Withdrawal by Subject|3|||
105818960|NCT02017223|364997263|FG000|Overall Study|Algorithm problems|2|||
105818961|NCT00678639|364997264|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
105818962|NCT00678639|364997265|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
105818963|NCT04060147|364997267|FG000|Overall Study|Withdrew consent|1|||
105818964|NCT00986245|364997268|FG000|First Intervention|Poor compliance|8|||
105818965|NCT00986245|364997269|FG001|First Intervention|Poor compliance|4|||
105818966|NCT00986245|364997268|FG000|First Intervention|Lack of Efficacy|1|||
105818967|NCT00986245|364997269|FG001|First Intervention|Lack of Efficacy|2|||
105818968|NCT00986245|364997268|FG000|First Intervention|Withdrawal by Subject|0|||
105818969|NCT00986245|364997269|FG001|First Intervention|Withdrawal by Subject|1|||
105818970|NCT00986245|364997268|FG000|First Intervention|Protocol Violation|0|||
105818971|NCT00986245|364997269|FG001|First Intervention|Protocol Violation|1|||
105818972|NCT00986245|364997268|FG000|First Intervention|Out of indication|1|||
105818973|NCT00986245|364997269|FG001|First Intervention|Out of indication|0|||
105818974|NCT00986245|364997268|FG000|Second Intervention|Poor compliance|1|||
105818975|NCT00986245|364997269|FG001|Second Intervention|Poor compliance|0|||
105818976|NCT00986245|364997268|FG000|Second Intervention|Lost to Follow-up|1|||
105818977|NCT00986245|364997269|FG001|Second Intervention|Lost to Follow-up|0|||
105818978|NCT00986245|364997268|FG000|Second Intervention|Protocol Violation|0|||
105818979|NCT00986245|364997269|FG001|Second Intervention|Protocol Violation|1|||
105818980|NCT05169710|364997270|FG000|Overall Study|Adverse Event|1|||
105818981|NCT05169710|364997271|FG001|Overall Study|Adverse Event|2|||
105818982|NCT05169710|364997272|FG002|Overall Study|Adverse Event|2|||
105818983|NCT05169710|364997270|FG000|Overall Study|Lost to Follow-up|0|||
105818984|NCT05169710|364997271|FG001|Overall Study|Lost to Follow-up|0|||
105818985|NCT05169710|364997272|FG002|Overall Study|Lost to Follow-up|1|||
105362719|NCT03428100|363332622|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362720|NCT03428100|363332623|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362721|NCT03428100|363332624|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362722|NCT03428100|363332625|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362723|NCT03428100|363332626|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362724|NCT03428100|363332627|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362725|NCT03428100|363332628|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105765649|NCT02432703|364793742|FG001|Overall Study|Lost to Follow-up|3|||
105765650|NCT02432703|364793741|FG000|Overall Study|Withdrawal by Subject|9|||
105765651|NCT02432703|364793742|FG001|Overall Study|Withdrawal by Subject|6|||
105765652|NCT02432703|364793741|FG000|Overall Study|Other|6|||
105765653|NCT02432703|364793742|FG001|Overall Study|Other|5|||
105765654|NCT00415584|364793743|FG000|Overall Study|Withdrawal by Subject|1|||
105765655|NCT02640755|364793746|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
105765656|NCT02640755|364793747|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
105765657|NCT02640755|364793746|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
105765658|NCT02640755|364793747|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
105765659|NCT02640755|364793746|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
105765660|NCT02640755|364793747|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
105765661|NCT02255760|364793748|FG000|Overall Study|Lost to Follow-up|0|||
105765662|NCT02255760|364793749|FG001|Overall Study|Lost to Follow-up|1|||
105765663|NCT02255760|364793750|FG002|Overall Study|Lost to Follow-up|0|||
105765664|NCT02255760|364793751|FG003|Overall Study|Lost to Follow-up|0|||
105765665|NCT02255760|364793752|FG004|Overall Study|Lost to Follow-up|0|||
105765666|NCT00003838|364793753|FG000|Overall Study|Death|0|||
105765667|NCT00003838|364793754|FG001|Overall Study|Death|12|||
105765668|NCT00003838|364793755|FG002|Overall Study|Death|7|||
105765669|NCT00003838|364793753|FG000|Overall Study|Lost to Follow-up|0|||
105765670|NCT00003838|364793754|FG001|Overall Study|Lost to Follow-up|1|||
105765671|NCT00003838|364793755|FG002|Overall Study|Lost to Follow-up|1|||
105765672|NCT00003838|364793753|FG000|Overall Study|Disease Progression|0|||
105765673|NCT00003838|364793754|FG001|Overall Study|Disease Progression|12|||
105765674|NCT00003838|364793755|FG002|Overall Study|Disease Progression|0|||
105765675|NCT00618813|364793756|FG000|Overall Study|Lack of Efficacy|1|||
105765676|NCT00618813|364793756|FG000|Overall Study|Physician Decision|2|||
105818986|NCT05169710|364997270|FG000|Overall Study|Withdrawal by Subject|2|||
105818987|NCT05169710|364997271|FG001|Overall Study|Withdrawal by Subject|1|||
105818988|NCT05169710|364997272|FG002|Overall Study|Withdrawal by Subject|0|||
105818989|NCT05169710|364997270|FG000|Overall Study|Other Study Discontinuation Reason|0|||
105818990|NCT05169710|364997271|FG001|Overall Study|Other Study Discontinuation Reason|2|||
105818991|NCT05169710|364997272|FG002|Overall Study|Other Study Discontinuation Reason|0|||
105818992|NCT04400890|364997273|FG000|Overall Study|Withdrawal by Subject|3|||
105818993|NCT04400890|364997274|FG001|Overall Study|Withdrawal by Subject|2|||
105818994|NCT00836056|364997287|FG000|First Intervention|Adverse Event|1|||
105818995|NCT00836056|364997288|FG001|First Intervention|Adverse Event|0|||
105818996|NCT01686438|364997289|FG000|Overall Study|Lost to Follow-up|8|||
105818997|NCT01686438|364997290|FG001|Overall Study|Lost to Follow-up|9|||
105818998|NCT01686438|364997291|FG002|Overall Study|Lost to Follow-up|10|||
105818999|NCT01686438|364997289|FG000|Overall Study|Adverse Event|0|||
105819000|NCT01686438|364997290|FG001|Overall Study|Adverse Event|0|||
105819001|NCT01686438|364997291|FG002|Overall Study|Adverse Event|1|||
105819002|NCT01686438|364997289|FG000|Overall Study|Protocol Violation|0|||
105819003|NCT01686438|364997290|FG001|Overall Study|Protocol Violation|0|||
105819004|NCT01686438|364997291|FG002|Overall Study|Protocol Violation|1|||
105819005|NCT01686438|364997289|FG000|Overall Study|Withdrawal by Subject|0|||
105819006|NCT01686438|364997290|FG001|Overall Study|Withdrawal by Subject|0|||
105819007|NCT01686438|364997291|FG002|Overall Study|Withdrawal by Subject|1|||
105819008|NCT00550537|364997292|FG000|Overall Study|Death|18|||
105819009|NCT00550537|364997292|FG000|Overall Study|Adverse Event|20|||
105819010|NCT00550537|364997292|FG000|Overall Study|Disease progression before|46|||
105819011|NCT00550537|364997292|FG000|Overall Study|Withdrawal by Subject|7|||
105819012|NCT00550537|364997292|FG000|Overall Study|Change in treatment plan|4|||
105819013|NCT00550537|364997292|FG000|Overall Study|Other complicating ilness|3|||
105819014|NCT00550537|364997292|FG000|Overall Study|Declining performance status|2|||
105819015|NCT00550537|364997292|FG000|Overall Study|Treated closer to home|4|||
105819016|NCT01029340|364997294|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
105819017|NCT01029340|364997295|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
105819018|NCT01029340|364997296|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
105819019|NCT01029340|364997297|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
105819020|NCT01029340|364997298|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
105819021|NCT01029340|364997299|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
105819022|NCT01029340|364997294|FG000|Part B Treatment Period|Protocol Violation|0|||
105819023|NCT01029340|364997295|FG001|Part B Treatment Period|Protocol Violation|0|||
105819024|NCT01029340|364997296|FG002|Part B Treatment Period|Protocol Violation|1|||
105819025|NCT01029340|364997297|FG003|Part B Treatment Period|Protocol Violation|0|||
105819026|NCT01029340|364997298|FG004|Part B Treatment Period|Protocol Violation|0|||
105819027|NCT01029340|364997299|FG005|Part B Treatment Period|Protocol Violation|0|||
105819028|NCT01029340|364997294|FG000|Extension Period|Adverse Event|0|||
105819029|NCT01029340|364997295|FG001|Extension Period|Adverse Event|0|||
105819030|NCT01029340|364997296|FG002|Extension Period|Adverse Event|0|||
105819031|NCT01029340|364997297|FG003|Extension Period|Adverse Event|0|||
105819032|NCT01029340|364997298|FG004|Extension Period|Adverse Event|0|||
105819033|NCT01029340|364997299|FG005|Extension Period|Adverse Event|1|||
105819034|NCT01029340|364997294|FG000|Extension Period|starting another study|0|||
105819035|NCT01029340|364997295|FG001|Extension Period|starting another study|0|||
105819036|NCT01029340|364997296|FG002|Extension Period|starting another study|0|||
105819037|NCT01029340|364997297|FG003|Extension Period|starting another study|0|||
105819038|NCT01029340|364997298|FG004|Extension Period|starting another study|0|||
105819039|NCT01029340|364997299|FG005|Extension Period|starting another study|8|||
105819040|NCT01029340|364997294|FG000|Extension Period|non-compliance|0|||
105819041|NCT01029340|364997295|FG001|Extension Period|non-compliance|0|||
105819042|NCT01029340|364997296|FG002|Extension Period|non-compliance|0|||
105819043|NCT01029340|364997297|FG003|Extension Period|non-compliance|0|||
105819044|NCT01029340|364997298|FG004|Extension Period|non-compliance|0|||
105819045|NCT01029340|364997299|FG005|Extension Period|non-compliance|1|||
105819046|NCT01029340|364997294|FG000|Extension Period|Withdrawal by Subject|0|||
105819047|NCT01029340|364997295|FG001|Extension Period|Withdrawal by Subject|0|||
105819048|NCT01029340|364997296|FG002|Extension Period|Withdrawal by Subject|0|||
105819049|NCT01029340|364997297|FG003|Extension Period|Withdrawal by Subject|0|||
105819050|NCT01029340|364997298|FG004|Extension Period|Withdrawal by Subject|0|||
105819051|NCT01029340|364997299|FG005|Extension Period|Withdrawal by Subject|1|||
105819052|NCT01029340|364997294|FG000|Extension Period|Physician Decision|0|||
105819053|NCT01029340|364997295|FG001|Extension Period|Physician Decision|0|||
105819054|NCT01029340|364997296|FG002|Extension Period|Physician Decision|0|||
105819055|NCT01029340|364997297|FG003|Extension Period|Physician Decision|0|||
105819056|NCT01029340|364997298|FG004|Extension Period|Physician Decision|0|||
105819057|NCT01029340|364997299|FG005|Extension Period|Physician Decision|1|||
105819058|NCT00268905|364997300|FG000|Overall Study|Adverse Event|3|||
105819059|NCT00268905|364997301|FG001|Overall Study|Adverse Event|0|||
105819060|NCT00268905|364997302|FG002|Overall Study|Adverse Event|4|||
105819061|NCT00268905|364997300|FG000|Overall Study|Lost to Follow-up|0|||
105819062|NCT00268905|364997301|FG001|Overall Study|Lost to Follow-up|1|||
105819063|NCT00268905|364997302|FG002|Overall Study|Lost to Follow-up|0|||
105819064|NCT00268905|364997300|FG000|Overall Study|Withdrawal by Subject|0|||
105819065|NCT00268905|364997301|FG001|Overall Study|Withdrawal by Subject|0|||
105819066|NCT00268905|364997302|FG002|Overall Study|Withdrawal by Subject|3|||
105819067|NCT00268905|364997300|FG000|Overall Study|Progressive Disease|28|||
105819068|NCT00268905|364997301|FG001|Overall Study|Progressive Disease|4|||
105819069|NCT00268905|364997302|FG002|Overall Study|Progressive Disease|3|||
105819070|NCT00268905|364997300|FG000|Overall Study|Physician Decision|3|||
105819071|NCT00268905|364997301|FG001|Overall Study|Physician Decision|0|||
105819072|NCT00268905|364997302|FG002|Overall Study|Physician Decision|1|||
105819073|NCT00268905|364997300|FG000|Overall Study|Clinical Progression|9|||
105819074|NCT00268905|364997301|FG001|Overall Study|Clinical Progression|4|||
105819075|NCT00268905|364997302|FG002|Overall Study|Clinical Progression|1|||
105819076|NCT01864174|364997303|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
105819077|NCT01864174|364997304|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
105819078|NCT01864174|364997303|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
105819079|NCT01864174|364997304|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
105819080|NCT01864174|364997303|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
105819081|NCT01864174|364997304|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
105819082|NCT01864174|364997303|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
105819083|NCT01864174|364997304|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
105819084|NCT01864174|364997303|FG000|Double Blind - Compliant Randomized|Death|1|||
105362726|NCT03428100|363332629|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362727|NCT03428100|363332630|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362728|NCT03428100|363332631|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362729|NCT03428100|363332632|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362730|NCT03428100|363332633|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105486319|NCT02068768|363791477|FG000|Overall Study|Lost to Follow-up|5|||
105486320|NCT02068768|363791477|FG000|Overall Study|Early Termination by Sponsor|2|||
105819085|NCT01864174|364997304|FG001|Double Blind - Compliant Randomized|Death|0|||
105819086|NCT01864174|364997303|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
105819087|NCT01864174|364997304|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
105819088|NCT01864174|364997303|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
105819089|NCT01864174|364997304|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
105819090|NCT01864174|364997303|FG000|Double Blind - Compliant Randomized|Other|6|||
105819091|NCT01864174|364997304|FG001|Double Blind - Compliant Randomized|Other|10|||
105819092|NCT01864174|364997303|FG000|Off Treatment Follow-Up|Other|2|||
105819093|NCT01864174|364997304|FG001|Off Treatment Follow-Up|Other|0|||
105819094|NCT01864174|364997303|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
105819095|NCT01864174|364997304|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
105819096|NCT02648347|364997308|FG000|Overall Study|Death|174|||
105819097|NCT02648347|364997309|FG001|Overall Study|Death|167|||
105819098|NCT02648347|364997308|FG000|Overall Study|Withdrawal by Subject|16|||
105819099|NCT02648347|364997309|FG001|Overall Study|Withdrawal by Subject|9|||
105819100|NCT02648347|364997308|FG000|Overall Study|Lost to Follow-up|18|||
105819101|NCT02648347|364997309|FG001|Overall Study|Lost to Follow-up|21|||
105819102|NCT02648347|364997308|FG000|Overall Study|Missing|1|||
105819103|NCT02648347|364997309|FG001|Overall Study|Missing|0|||
105819104|NCT03546842|364997310|FG000|Overall Study|Protocol Violation|1|||
105819105|NCT03546842|364997310|FG000|Overall Study|Withdrawal by Subject|2|||
105819106|NCT02739997|364997314|FG000|Overall Study|Death|1|||
105819107|NCT02739997|364997314|FG000|Overall Study|Withdrawal by Subject|1|||
105819108|NCT00617305|364997318|FG000|Overall Study|Adverse Event|4|||
105819109|NCT00617305|364997319|FG001|Overall Study|Adverse Event|0|||
105819110|NCT00617305|364997320|FG002|Overall Study|Adverse Event|0|||
105819111|NCT00617305|364997318|FG000|Overall Study|Death|1|||
105819112|NCT00617305|364997319|FG001|Overall Study|Death|0|||
105819113|NCT00617305|364997320|FG002|Overall Study|Death|0|||
105819114|NCT00617305|364997318|FG000|Overall Study|Physician Decision|1|||
105819115|NCT00617305|364997319|FG001|Overall Study|Physician Decision|0|||
105819116|NCT00617305|364997320|FG002|Overall Study|Physician Decision|0|||
105819117|NCT00617305|364997318|FG000|Overall Study|Protocol Violation|1|||
105819118|NCT00617305|364997319|FG001|Overall Study|Protocol Violation|0|||
105819119|NCT00617305|364997320|FG002|Overall Study|Protocol Violation|1|||
105819120|NCT00617305|364997318|FG000|Overall Study|Withdrawal by Subject|1|||
105819121|NCT00617305|364997319|FG001|Overall Study|Withdrawal by Subject|0|||
105819122|NCT00617305|364997320|FG002|Overall Study|Withdrawal by Subject|0|||
105819123|NCT02158663|364997322|FG000|Overall Study|Withdrawal by Subject|5|||
105819124|NCT02158663|364997323|FG001|Overall Study|Withdrawal by Subject|4|||
105819125|NCT01265056|364997324|FG000|Initial Study Period|Withdrawal by Subject|1|||
105819126|NCT01265056|364997325|FG001|Initial Study Period|Withdrawal by Subject|1|||
105819127|NCT01265056|364997324|FG000|Initial Study Period|Withdrawal by Subject|1|||
105819128|NCT01265056|364997325|FG001|Initial Study Period|Withdrawal by Subject|1|||
105819129|NCT01265056|364997324|FG000|Follow up|Lost to Follow-up|7|||
105819130|NCT01265056|364997325|FG001|Follow up|Lost to Follow-up|3|||
105819131|NCT02453386|364997329|FG000|Overall Study|Adverse Event|22|||
105819132|NCT02453386|364997330|FG001|Overall Study|Adverse Event|30|||
105819133|NCT02453386|364997331|FG002|Overall Study|Adverse Event|15|||
105819134|NCT02453386|364997329|FG000|Overall Study|Protocol Violation|1|||
105819135|NCT02453386|364997330|FG001|Overall Study|Protocol Violation|0|||
105571659|NCT01161472|364092716|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
105571660|NCT01161472|364092717|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
105571661|NCT01161472|364092718|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
105819136|NCT02453386|364997331|FG002|Overall Study|Protocol Violation|1|||
105819137|NCT02453386|364997329|FG000|Overall Study|Withdrawal by Subject|10|||
105819138|NCT02453386|364997330|FG001|Overall Study|Withdrawal by Subject|9|||
105819139|NCT02453386|364997331|FG002|Overall Study|Withdrawal by Subject|9|||
105819140|NCT02453386|364997329|FG000|Overall Study|Sponsor Terminated Study|14|||
105819141|NCT02453386|364997330|FG001|Overall Study|Sponsor Terminated Study|8|||
105819142|NCT02453386|364997331|FG002|Overall Study|Sponsor Terminated Study|11|||
105819143|NCT02453386|364997329|FG000|Overall Study|Subject Terminated by Sponsor|1|||
105819144|NCT02453386|364997330|FG001|Overall Study|Subject Terminated by Sponsor|1|||
105819145|NCT02453386|364997331|FG002|Overall Study|Subject Terminated by Sponsor|1|||
105765677|NCT00618813|364793756|FG000|Overall Study|Withdrawal by Subject|1|||
105765678|NCT01192100|364793757|FG000|Overall Study|Withdrawal by Subject|0|||
105765679|NCT01192100|364793758|FG001|Overall Study|Withdrawal by Subject|0|||
105765680|NCT01192100|364793759|FG002|Overall Study|Withdrawal by Subject|0|||
105765681|NCT01192100|364793760|FG003|Overall Study|Withdrawal by Subject|0|||
105765682|NCT01192100|364793761|FG004|Overall Study|Withdrawal by Subject|1|||
105765683|NCT01192100|364793762|FG005|Overall Study|Withdrawal by Subject|0|||
105765684|NCT01192100|364793757|FG000|Overall Study|Protocol Violation|0|||
105765685|NCT01192100|364793758|FG001|Overall Study|Protocol Violation|0|||
105765686|NCT01192100|364793759|FG002|Overall Study|Protocol Violation|0|||
105765687|NCT01192100|364793760|FG003|Overall Study|Protocol Violation|1|||
105765688|NCT01192100|364793761|FG004|Overall Study|Protocol Violation|0|||
105765689|NCT01192100|364793762|FG005|Overall Study|Protocol Violation|0|||
105765690|NCT01235507|364793768|FG000|Overall Study|Adverse Event|1|||
105765691|NCT01235507|364793768|FG000|Overall Study|Withdrawal by Subject|1|||
105765692|NCT00918346|364793772|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
105765693|NCT00918346|364793773|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
105765694|NCT01421069|364793774|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
105765695|NCT01421069|364793774|FG000|Parent Study|Failed to return|3|||
105765696|NCT01421069|364793774|FG000|Parent Study|Withdrawal by Subject|1|||
105765697|NCT01421069|364793774|FG000|Parent Study|Lost to Follow-up|2|||
105765698|NCT01421069|364793774|FG000|Parent Study|Lack of Efficacy|1|||
105765699|NCT01421069|364793774|FG000|Overall Period for Extension Study|Other|2|||
105765700|NCT01421069|364793774|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
105765701|NCT01421069|364793774|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
105765702|NCT01421069|364793774|FG000|Overall Period for Extension Study|Pregnancy|1|||
105765703|NCT01421069|364793774|FG000|Overall Period for Extension Study|Adverse Event|1|||
105765704|NCT01421069|364793774|FG000|Overall Period for Extension Study|Protocol Violation|1|||
105765705|NCT01421069|364793774|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
105765706|NCT01421069|364793774|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
105765707|NCT01421069|364793774|FG000|Active Treatment Period|Other|1|||
105765708|NCT01421069|364793774|FG000|Active Treatment Period|No longer willing to participate in study|8|||
105765709|NCT01421069|364793774|FG000|Active Treatment Period|Insufficient clinical response|1|||
105765710|NCT01421069|364793774|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
105765711|NCT01421069|364793774|FG000|Active Treatment Period|Pregnancy|1|||
105765712|NCT01421069|364793774|FG000|Active Treatment Period|Adverse Event|1|||
105765713|NCT01421069|364793774|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
105765714|NCT01421069|364793774|FG000|Active Treatment Period|Enrolled in observational period|29|||
105765715|NCT01421069|364793774|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
105765716|NCT01421069|364793774|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
105765717|NCT01421069|364793774|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
105765718|NCT01421069|364793774|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
105765719|NCT01421069|364793774|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
105765720|NCT01421069|364793774|FG000|2b. Retreatment Period|Protocol Violation|1|||
105765721|NCT01421069|364793774|FG000|Observational Period|Other|1|||
105765722|NCT01421069|364793774|FG000|Observational Period|No longer willing to participate in study|4|||
105765723|NCT01421069|364793774|FG000|Observational Period|Lost to Follow-up|3|||
105765724|NCT01095666|364793775|FG000|Overall Study|Lack of Efficacy|0|||
105765725|NCT01095666|364793776|FG001|Overall Study|Lack of Efficacy|0|||
105765726|NCT01095666|364793777|FG002|Overall Study|Lack of Efficacy|1|||
105765727|NCT01095666|364793775|FG000|Overall Study|Adverse Event|2|||
105765728|NCT01095666|364793776|FG001|Overall Study|Adverse Event|1|||
105765729|NCT01095666|364793777|FG002|Overall Study|Adverse Event|3|||
105765730|NCT01095666|364793775|FG000|Overall Study|Lost to Follow-up|2|||
105765731|NCT01095666|364793776|FG001|Overall Study|Lost to Follow-up|2|||
105765732|NCT01095666|364793777|FG002|Overall Study|Lost to Follow-up|0|||
105765733|NCT01095666|364793775|FG000|Overall Study|Withdrawal by Subject|6|||
105765734|NCT01095666|364793776|FG001|Overall Study|Withdrawal by Subject|6|||
105765735|NCT01095666|364793777|FG002|Overall Study|Withdrawal by Subject|1|||
105765736|NCT01095666|364793775|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
105765737|NCT01095666|364793776|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
105765738|NCT01095666|364793777|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
105765739|NCT01749800|364793781|FG000|Overall Study|not meeting inclusion criteria|3|||
105765740|NCT01749800|364793782|FG001|Overall Study|not meeting inclusion criteria|0|||
105765741|NCT01749800|364793783|FG002|Overall Study|not meeting inclusion criteria|0|||
105765742|NCT01749800|364793781|FG000|Overall Study|Withdrawal by Subject|0|||
105765743|NCT01749800|364793782|FG001|Overall Study|Withdrawal by Subject|1|||
105765744|NCT01749800|364793783|FG002|Overall Study|Withdrawal by Subject|0|||
105765745|NCT03074318|364793784|FG000|Overall Study|Adverse Event|0|||
105765746|NCT03074318|364793785|FG001|Overall Study|Adverse Event|1|||
105765747|NCT03074318|364793786|FG002|Overall Study|Adverse Event|1|||
105765748|NCT03074318|364793787|FG003|Overall Study|Adverse Event|1|||
105765749|NCT03074318|364793784|FG000|Overall Study|Death|1|||
105571662|NCT01161472|364092719|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
105571663|NCT00798174|364092720|FG000|Overall Study|inability to implant azygos coil|3|||
105571664|NCT00798174|364092721|FG001|Overall Study|inability to implant azygos coil|3|||
105819146|NCT02453386|364997329|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
105819147|NCT02453386|364997330|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
105819148|NCT02453386|364997331|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
105819149|NCT02453386|364997329|FG000|Overall Study|Lost to Follow-up|0|||
105819150|NCT02453386|364997330|FG001|Overall Study|Lost to Follow-up|0|||
105819151|NCT02453386|364997331|FG002|Overall Study|Lost to Follow-up|1|||
105819152|NCT02453386|364997329|FG000|Overall Study|Other|1|||
105819153|NCT02453386|364997330|FG001|Overall Study|Other|0|||
105819154|NCT02453386|364997331|FG002|Overall Study|Other|1|||
105819155|NCT00465270|364997341|FG000|Overall Study|Death|7|||
105819156|NCT00465270|364997342|FG001|Overall Study|Death|11|||
105819157|NCT00465270|364997341|FG000|Overall Study|Withdrawal by Subject|34|||
105819158|NCT00465270|364997342|FG001|Overall Study|Withdrawal by Subject|78|||
105819159|NCT00465270|364997341|FG000|Overall Study|Lost to Follow-up|60|||
105819160|NCT00465270|364997342|FG001|Overall Study|Lost to Follow-up|67|||
105819161|NCT00465270|364997341|FG000|Overall Study|Investigator request|3|||
105819162|NCT00465270|364997342|FG001|Overall Study|Investigator request|4|||
105819163|NCT01576042|364997343|FG000|Overall Study|Physician Decision|2|||
105819164|NCT01576042|364997344|FG001|Overall Study|Physician Decision|0|||
105819165|NCT03586726|364997345|FG000|Overall Study|Withdrawal by Subject|1|||
105819166|NCT03197883|364997346|FG000|Overall Study|Adverse Event|1|||
105819167|NCT03197883|364997347|FG001|Overall Study|Adverse Event|1|||
105819168|NCT03197883|364997346|FG000|Overall Study|Lost to Follow-up|1|||
105819169|NCT03197883|364997347|FG001|Overall Study|Lost to Follow-up|0|||
105819170|NCT03197883|364997346|FG000|Overall Study|Protocol Violation|1|||
105819171|NCT03197883|364997347|FG001|Overall Study|Protocol Violation|0|||
105819172|NCT03197883|364997346|FG000|Overall Study|Other (Not Specified)|0|||
105819173|NCT03197883|364997347|FG001|Overall Study|Other (Not Specified)|5|||
105819174|NCT02605928|364997350|FG000|Overall Study|Model tuning phase|28|||
105819175|NCT02605928|364997350|FG000|Overall Study|Lack of Efficacy|5|||
105819176|NCT01697696|364997354|FG000|Overall Study|Study terminated by sponsor|0|||
105819177|NCT01697696|364997355|FG001|Overall Study|Study terminated by sponsor|3|||
105819178|NCT01697696|364997354|FG000|Overall Study|Protocol deviation|1|||
105819179|NCT01697696|364997355|FG001|Overall Study|Protocol deviation|0|||
105819180|NCT01697696|364997354|FG000|Overall Study|Physician Decision|1|||
105819181|NCT01697696|364997355|FG001|Overall Study|Physician Decision|0|||
105819182|NCT01697696|364997354|FG000|Overall Study|Death|4|||
105819183|NCT01697696|364997355|FG001|Overall Study|Death|2|||
105819184|NCT01697696|364997354|FG000|Overall Study|Lost to Follow-up|10|||
105819185|NCT01697696|364997355|FG001|Overall Study|Lost to Follow-up|7|||
105819186|NCT01697696|364997354|FG000|Overall Study|Subject/guardian decision|31|||
105819187|NCT01697696|364997355|FG001|Overall Study|Subject/guardian decision|35|||
105819188|NCT01424644|364997356|FG000|Overall Study|Adverse Event|2|||
105819189|NCT01424644|364997357|FG001|Overall Study|Adverse Event|0|||
105819190|NCT01424644|364997356|FG000|Overall Study|Withdrawal by Subject|9|||
105819191|NCT01424644|364997357|FG001|Overall Study|Withdrawal by Subject|12|||
105819192|NCT01424644|364997356|FG000|Overall Study|Lost to Follow-up|16|||
105819193|NCT01424644|364997357|FG001|Overall Study|Lost to Follow-up|12|||
105819194|NCT01424644|364997356|FG000|Overall Study|Protocol Violation|4|||
105819195|NCT01424644|364997357|FG001|Overall Study|Protocol Violation|3|||
105819196|NCT01424644|364997356|FG000|Overall Study|Administrative Reason|1|||
105819197|NCT01424644|364997357|FG001|Overall Study|Administrative Reason|0|||
105819198|NCT01424644|364997356|FG000|Overall Study|Unable to Classify|1|||
105819199|NCT01424644|364997357|FG001|Overall Study|Unable to Classify|0|||
105819200|NCT00939003|364997361|FG000|Double-blind Treatment Period|Adverse Event|1|||
105819201|NCT00939003|364997362|FG001|Double-blind Treatment Period|Adverse Event|1|||
105819202|NCT00939003|364997361|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
105819203|NCT00939003|364997362|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
105819204|NCT00939003|364997361|FG000|Double-blind Treatment Period|Pregnancy|0|||
105819205|NCT00939003|364997362|FG001|Double-blind Treatment Period|Pregnancy|1|||
105819206|NCT00939003|364997361|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
105819207|NCT00939003|364997362|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
105819208|NCT00939003|364997361|FG000|Open-label Treatment Period|Adverse Event|4|||
105819209|NCT00939003|364997362|FG001|Open-label Treatment Period|Adverse Event|8|||
105819210|NCT00939003|364997361|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
105819211|NCT00939003|364997362|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
105819212|NCT00939003|364997361|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
105819213|NCT00939003|364997362|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
105819214|NCT00939003|364997361|FG000|Open-label Treatment Period|Pregnancy|1|||
105819215|NCT00939003|364997362|FG001|Open-label Treatment Period|Pregnancy|1|||
105819216|NCT00939003|364997361|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
105819217|NCT00939003|364997362|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
105819218|NCT00939003|364997361|FG000|Open-label Treatment Period|Site Closure|3|||
105819219|NCT00939003|364997362|FG001|Open-label Treatment Period|Site Closure|4|||
105819220|NCT04611789|364997363|FG000|Overall Study|Lost to Follow-up|1|||
105819221|NCT04611789|364997364|FG001|Overall Study|Lost to Follow-up|0|||
105819222|NCT04611789|364997365|FG002|Overall Study|Lost to Follow-up|0|||
105362731|NCT03428100|363332634|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362732|NCT03428100|363332635|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362733|NCT03428100|363332636|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362734|NCT03428100|363332637|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362735|NCT03428100|363332638|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105362736|NCT03428100|363332620|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105362737|NCT03428100|363332621|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105362738|NCT03428100|363332622|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105362739|NCT03428100|363332623|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105362740|NCT03428100|363332624|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105362741|NCT03428100|363332625|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
105362742|NCT03428100|363332626|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
105362743|NCT03428100|363332627|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
105362744|NCT03428100|363332628|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
105362745|NCT03428100|363332629|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105362746|NCT03428100|363332630|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
105362747|NCT03428100|363332631|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105362748|NCT03428100|363332632|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
105362749|NCT03428100|363332633|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
105362750|NCT03428100|363332634|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
105362751|NCT03428100|363332635|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
105362752|NCT03428100|363332636|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
105362753|NCT03428100|363332637|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105362754|NCT03428100|363332638|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105362755|NCT03428100|363332620|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
105362756|NCT03428100|363332621|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
105362757|NCT03428100|363332622|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
105362758|NCT03428100|363332623|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
105362759|NCT03428100|363332624|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
105362760|NCT03428100|363332625|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
105362761|NCT03428100|363332626|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
105486321|NCT03761797|363791478|FG000|Overall Study|Changing hospital|11|||
105819223|NCT02131129|364997366|FG000|Overall Study|Withdrawal by Subject|1|||
105819224|NCT02131129|364997367|FG001|Overall Study|Withdrawal by Subject|0|||
105819225|NCT00727961|364997368|FG000|Overall Study|Lost to Follow-up|1|||
105819226|NCT00727961|364997368|FG000|Overall Study|Adverse Event|4|||
105819227|NCT00727961|364997368|FG000|Overall Study|Patient's refusal|2|||
105819228|NCT00727961|364997368|FG000|Overall Study|Progression|30|||
105819229|NCT02865122|364997369|FG000|Overall Study|Adverse Event|1|||
105819230|NCT02865122|364997370|FG001|Overall Study|Adverse Event|0|||
105819231|NCT02865122|364997371|FG002|Overall Study|Adverse Event|0|||
105819232|NCT00837486|364997374|FG000|Blinded-treatment Phase|Physician Decision|1|||
105819233|NCT00837486|364997375|FG001|Blinded-treatment Phase|Physician Decision|0|||
105819234|NCT00837486|364997374|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
105819235|NCT00837486|364997375|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
105819236|NCT00837486|364997374|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
105819237|NCT00837486|364997375|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
105819238|NCT00837486|364997374|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
105819239|NCT00837486|364997375|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
105819240|NCT01313780|364997376|FG000|Overall Study|Lack of Efficacy|4|||
105819241|NCT01313780|364997377|FG001|Overall Study|Lack of Efficacy|2|||
105819242|NCT01313780|364997376|FG000|Overall Study|Adverse Event|6|||
105819243|NCT01313780|364997377|FG001|Overall Study|Adverse Event|11|||
105819244|NCT01313780|364997376|FG000|Overall Study|Withdrawal by Subject|2|||
105819245|NCT01313780|364997377|FG001|Overall Study|Withdrawal by Subject|8|||
105486322|NCT03761797|363791478|FG000|Overall Study|Improvement/remission|6|||
105819246|NCT01313780|364997376|FG000|Overall Study|Protocol Violation|10|||
105819247|NCT01313780|364997377|FG001|Overall Study|Protocol Violation|4|||
105819248|NCT01313780|364997376|FG000|Overall Study|missing data|3|||
105819249|NCT01313780|364997377|FG001|Overall Study|missing data|3|||
105819250|NCT01294787|364999161|FG000|Period 1|Adverse Event|0|||
105819251|NCT01294787|364999162|FG001|Period 1|Adverse Event|0|||
105819252|NCT01294787|364999163|FG002|Period 1|Adverse Event|0|||
105819253|NCT01294787|364999164|FG003|Period 1|Adverse Event|0|||
105362762|NCT03428100|363332627|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
105362763|NCT03428100|363332628|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
105486323|NCT03761797|363791478|FG000|Overall Study|Withdrawal by Subject|19|||
105819254|NCT01294787|364999165|FG004|Period 1|Adverse Event|1|||
105819255|NCT01294787|364999166|FG005|Period 1|Adverse Event|0|||
105819256|NCT01294787|364999161|FG000|Period 1|Withdrawal by Subject|0|||
105819257|NCT01294787|364999162|FG001|Period 1|Withdrawal by Subject|0|||
105819258|NCT01294787|364999163|FG002|Period 1|Withdrawal by Subject|0|||
105819259|NCT01294787|364999164|FG003|Period 1|Withdrawal by Subject|1|||
105819260|NCT01294787|364999165|FG004|Period 1|Withdrawal by Subject|1|||
105819261|NCT01294787|364999166|FG005|Period 1|Withdrawal by Subject|1|||
105819262|NCT01294787|364999161|FG000|Period 1|Administrative problem|0|||
105819263|NCT01294787|364999162|FG001|Period 1|Administrative problem|0|||
105819264|NCT01294787|364999163|FG002|Period 1|Administrative problem|1|||
105819265|NCT01294787|364999164|FG003|Period 1|Administrative problem|0|||
105819266|NCT01294787|364999165|FG004|Period 1|Administrative problem|0|||
105819267|NCT01294787|364999166|FG005|Period 1|Administrative problem|1|||
105819268|NCT01294787|364999161|FG000|Period 2|Adverse Event|0|||
105819269|NCT01294787|364999162|FG001|Period 2|Adverse Event|3|||
105819270|NCT01294787|364999163|FG002|Period 2|Adverse Event|0|||
105819271|NCT01294787|364999164|FG003|Period 2|Adverse Event|1|||
105819272|NCT01294787|364999165|FG004|Period 2|Adverse Event|0|||
105819273|NCT01294787|364999166|FG005|Period 2|Adverse Event|0|||
105819274|NCT01294787|364999161|FG000|Period 2|No longer needs study drug|0|||
105819275|NCT01294787|364999162|FG001|Period 2|No longer needs study drug|0|||
105819276|NCT01294787|364999163|FG002|Period 2|No longer needs study drug|0|||
105819277|NCT01294787|364999164|FG003|Period 2|No longer needs study drug|1|||
105819278|NCT01294787|364999165|FG004|Period 2|No longer needs study drug|0|||
105819279|NCT01294787|364999166|FG005|Period 2|No longer needs study drug|0|||
105819280|NCT01294787|364999161|FG000|Period 3|Adverse Event|0|||
105819281|NCT01294787|364999162|FG001|Period 3|Adverse Event|0|||
105819282|NCT01294787|364999163|FG002|Period 3|Adverse Event|0|||
105819283|NCT01294787|364999164|FG003|Period 3|Adverse Event|0|||
105819284|NCT01294787|364999165|FG004|Period 3|Adverse Event|1|||
105819285|NCT01294787|364999166|FG005|Period 3|Adverse Event|0|||
105819286|NCT00942968|364999167|FG000|Overall Study|Adverse Event|60|||
105819287|NCT00942968|364999167|FG000|Overall Study|Death|76|||
105819288|NCT00942968|364999167|FG000|Overall Study|Protocol Violation|9|||
105819289|NCT00942968|364999167|FG000|Overall Study|Lost to Follow-up|4|||
105819290|NCT00942968|364999167|FG000|Overall Study|Withdrawal by Subject|44|||
105819291|NCT00942968|364999167|FG000|Overall Study|Sponsor request|5|||
105819292|NCT00942968|364999167|FG000|Overall Study|Physician Decision|11|||
105819293|NCT00942968|364999167|FG000|Overall Study|Progression of disease|12|||
105819294|NCT00942968|364999167|FG000|Overall Study|Inferior vena cava filter placement|4|||
105819295|NCT00942968|364999167|FG000|Overall Study|Pulmonary embolism (PE)|1|||
105819296|NCT00942968|364999167|FG000|Overall Study|Participant required pancreatic biopsy|1|||
105819297|NCT00942968|364999167|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
105819298|NCT00745420|364999168|FG000|Overall Study|Ineligible|1|||
105819299|NCT01993030|364999169|FG000|Overall Study|Adverse Event|0|||
105819300|NCT01993030|364999170|FG001|Overall Study|Adverse Event|4|||
105819301|NCT03874715|364999172|FG000|Overall Study|Adverse Event|2|||
105819302|NCT03874715|364999173|FG001|Overall Study|Adverse Event|0|||
105819303|NCT03874715|364999172|FG000|Overall Study|Poor compliance to protocol|5|||
105819304|NCT03874715|364999173|FG001|Overall Study|Poor compliance to protocol|1|||
105819305|NCT03874715|364999172|FG000|Overall Study|Withdrawal by Subject|1|||
105819306|NCT03874715|364999173|FG001|Overall Study|Withdrawal by Subject|0|||
105819307|NCT03874715|364999172|FG000|Overall Study|Other-unspecified|1|||
105819308|NCT03874715|364999173|FG001|Overall Study|Other-unspecified|0|||
105819309|NCT01802320|364999176|FG000|Overall Study|Death|1|||
105819310|NCT01802320|364999176|FG000|Overall Study|Withdrawal by Subject|1|||
105819311|NCT04123548|364999177|FG000|Overall Study|Withdrawal by Subject|1|||
105819312|NCT04123548|364999177|FG000|Overall Study|Lost to Follow-up|8|||
105819313|NCT04123548|364999177|FG000|Overall Study|Death|4|||
105819314|NCT04123548|364999177|FG000|Overall Study|Reason Not Specified|1|||
105819315|NCT00328926|364999178|FG000|Overall Study|Pregnancy|2|||
105819316|NCT00328926|364999179|FG001|Overall Study|Pregnancy|1|||
105819317|NCT00328926|364999180|FG002|Overall Study|Pregnancy|0|||
105819318|NCT00328926|364999178|FG000|Overall Study|Lost to Follow-up|0|||
105819319|NCT00328926|364999179|FG001|Overall Study|Lost to Follow-up|1|||
105819320|NCT00328926|364999180|FG002|Overall Study|Lost to Follow-up|0|||
105819321|NCT00328926|364999178|FG000|Overall Study|Death|0|||
105819322|NCT00328926|364999179|FG001|Overall Study|Death|0|||
105486324|NCT03761797|363791478|FG000|Overall Study|Lost to Follow-up|33|||
105486325|NCT03761797|363791478|FG000|Overall Study|Adverse Event|37|||
105486326|NCT03761797|363791478|FG000|Overall Study|Case report form (CRF) not collected|5|||
105819323|NCT00328926|364999180|FG002|Overall Study|Death|1|||
105819324|NCT00328926|364999178|FG000|Overall Study|In vitro fertilization treatment|0|||
105819325|NCT00328926|364999179|FG001|Overall Study|In vitro fertilization treatment|0|||
105486327|NCT03761797|363791478|FG000|Overall Study|No patient visit after entry|13|||
105819326|NCT00328926|364999180|FG002|Overall Study|In vitro fertilization treatment|1|||
105819327|NCT00328926|364999178|FG000|Overall Study|Lack of ovarian response|0|||
105819328|NCT00328926|364999179|FG001|Overall Study|Lack of ovarian response|1|||
105819329|NCT00328926|364999180|FG002|Overall Study|Lack of ovarian response|0|||
105819330|NCT02269657|364999181|FG000|Overall Study|Protocol Violation|3|||
105819331|NCT01171989|364999187|FG000|Overall Study|Lost to Follow-up|0|||
105819332|NCT01171989|364999188|FG001|Overall Study|Lost to Follow-up|0|||
105819333|NCT01171989|364999189|FG002|Overall Study|Lost to Follow-up|1|||
105819334|NCT02440711|364999191|FG000|Second Intervention|Lost to Follow-up|1|||
105819335|NCT02440711|364999192|FG001|Second Intervention|Lost to Follow-up|0|||
105819336|NCT03450057|364999194|FG000|Overall Study|Death|17|||
105819337|NCT03450057|364999194|FG000|Overall Study|ICF withdrawal|4|||
105819338|NCT03450057|364999194|FG000|Overall Study|Lost to Follow-up|2|||
105819339|NCT02146105|364999195|FG000|Overall Study|Adverse Event|1|||
105819340|NCT02146105|364999195|FG000|Overall Study|Withdrawal by Subject|5|||
105819341|NCT05755282|364999196|FG000|Overall Study|Protocol Violation|0|||
105819342|NCT05755282|364999197|FG001|Overall Study|Protocol Violation|1|||
105819343|NCT04129346|364999198|FG000|Overall Study|Death|1|||
105819344|NCT04129346|364999199|FG001|Overall Study|Death|0|||
105819345|NCT00573066|364999200|FG000|Overall Study|Exclusion criteria|18|||
105819346|NCT00573066|364999200|FG000|Overall Study|IV malfunction|1|||
105819347|NCT00573066|364999200|FG000|Overall Study|Postoperative bleeding|1|||
105819348|NCT01838941|364999202|FG000|Overall Study|Adverse Event|1|||
105819349|NCT01838941|364999202|FG000|Overall Study|Withdrawal by Subject|1|||
105819350|NCT02822235|364999203|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
105819351|NCT02822235|364999204|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
105819352|NCT02822235|364999203|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
105819353|NCT02822235|364999204|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
105819354|NCT02822235|364999203|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
105819355|NCT02822235|364999204|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
105819356|NCT02822235|364999203|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
105819357|NCT02822235|364999204|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
105819358|NCT02822235|364999203|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
105819359|NCT02822235|364999204|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
105819360|NCT02822235|364999203|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
105819361|NCT02822235|364999204|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
105819362|NCT03375463|364999207|FG000|Period 1|Lost to Follow-up|0|||
105819363|NCT03375463|364999208|FG001|Period 1|Lost to Follow-up|0|||
105819364|NCT03375463|364999209|FG002|Period 1|Lost to Follow-up|1|||
105819365|NCT03375463|364999210|FG003|Period 1|Lost to Follow-up|0|||
105819366|NCT03375463|364999211|FG004|Period 1|Lost to Follow-up|0|||
105819367|NCT03375463|364999212|FG005|Period 1|Lost to Follow-up|0|||
105819368|NCT03375463|364999207|FG000|Period 1|Adverse Event|0|||
105819369|NCT03375463|364999208|FG001|Period 1|Adverse Event|0|||
105819370|NCT03375463|364999209|FG002|Period 1|Adverse Event|0|||
105819371|NCT03375463|364999210|FG003|Period 1|Adverse Event|0|||
105819372|NCT03375463|364999211|FG004|Period 1|Adverse Event|1|||
105819373|NCT03375463|364999212|FG005|Period 1|Adverse Event|0|||
105819374|NCT03375463|364999207|FG000|Period 2|Lost to Follow-up|1|||
105819375|NCT03375463|364999208|FG001|Period 2|Lost to Follow-up|1|||
105819376|NCT03375463|364999209|FG002|Period 2|Lost to Follow-up|0|||
105819377|NCT03375463|364999210|FG003|Period 2|Lost to Follow-up|0|||
105819378|NCT03375463|364999211|FG004|Period 2|Lost to Follow-up|0|||
105819379|NCT03375463|364999212|FG005|Period 2|Lost to Follow-up|0|||
105819380|NCT03138967|364999213|FG000|Overall Study|Death|0|||
105819381|NCT03138967|364999214|FG001|Overall Study|Death|1|||
105819382|NCT03138967|364999213|FG000|Overall Study|Physician Decision|1|||
105819383|NCT03138967|364999214|FG001|Overall Study|Physician Decision|3|||
105819384|NCT02258074|364999215|FG000|Overall Study|Withdrawal by Subject|1|||
105819385|NCT02258074|364999216|FG001|Overall Study|Withdrawal by Subject|0|||
105819386|NCT02258074|364999217|FG002|Overall Study|Withdrawal by Subject|0|||
105819387|NCT02258074|364999218|FG003|Overall Study|Withdrawal by Subject|0|||
105819388|NCT00468286|364999219|FG000|Overall Study|Adverse Event|1|||
105819389|NCT00468286|364999220|FG001|Overall Study|Adverse Event|6|||
105819390|NCT00468286|364999219|FG000|Overall Study|Protocol Violation|2|||
105819391|NCT00468286|364999220|FG001|Overall Study|Protocol Violation|2|||
105819392|NCT00468286|364999219|FG000|Overall Study|Withdrawal by Subject|4|||
105819393|NCT00468286|364999220|FG001|Overall Study|Withdrawal by Subject|3|||
105819394|NCT00468286|364999219|FG000|Overall Study|Physician Decision|0|||
105819395|NCT00468286|364999220|FG001|Overall Study|Physician Decision|1|||
105819396|NCT02196675|364999223|FG000|Overall Study|Withdrawal by Subject|1|||
105571665|NCT00798174|364092720|FG000|Overall Study|Inability to sedate for DFT testing|1|||
105571666|NCT00798174|364092721|FG001|Overall Study|Inability to sedate for DFT testing|0|||
105819397|NCT02196675|364999224|FG001|Overall Study|Withdrawal by Subject|0|||
105819398|NCT02196675|364999225|FG002|Overall Study|Withdrawal by Subject|0|||
105819399|NCT02196675|364999223|FG000|Overall Study|Intra-operative surgical exclusion|1|||
105819400|NCT02196675|364999224|FG001|Overall Study|Intra-operative surgical exclusion|1|||
105819401|NCT02196675|364999225|FG002|Overall Study|Intra-operative surgical exclusion|0|||
105819402|NCT02196675|364999223|FG000|Overall Study|Protocol Violation|0|||
105819403|NCT02196675|364999224|FG001|Overall Study|Protocol Violation|1|||
105819404|NCT02196675|364999225|FG002|Overall Study|Protocol Violation|0|||
105819405|NCT02196675|364999223|FG000|Overall Study|Death|0|||
105819406|NCT02196675|364999224|FG001|Overall Study|Death|0|||
105819407|NCT02196675|364999225|FG002|Overall Study|Death|1|||
105819408|NCT02711852|364999227|FG000|Overall Study|Death|5|||
105819409|NCT02711852|364999227|FG000|Overall Study|Lost to Follow-up|1|||
105819410|NCT02711852|364999227|FG000|Overall Study|Completed follow-up|3|||
105819411|NCT02711852|364999227|FG000|Overall Study|Withdrawal by Subject|1|||
105819412|NCT00537979|364999229|FG000|Overall Study|Adverse Event|2|||
105819413|NCT00537979|364999230|FG001|Overall Study|Adverse Event|2|||
105819414|NCT00537979|364999229|FG000|Overall Study|Withdrawal by Subject|1|||
105819415|NCT00537979|364999230|FG001|Overall Study|Withdrawal by Subject|4|||
105819416|NCT00537979|364999229|FG000|Overall Study|Lost to Follow-up|1|||
105819417|NCT00537979|364999230|FG001|Overall Study|Lost to Follow-up|4|||
105819418|NCT00537979|364999229|FG000|Overall Study|Lack of Efficacy|0|||
105819419|NCT00537979|364999230|FG001|Overall Study|Lack of Efficacy|1|||
105819420|NCT00537979|364999229|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
105819421|NCT00537979|364999230|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
105819422|NCT00537979|364999229|FG000|Overall Study|Death|0|||
105819423|NCT00537979|364999230|FG001|Overall Study|Death|3|||
105819424|NCT00537979|364999229|FG000|Overall Study|Kidney transplant|0|||
105819425|NCT00537979|364999230|FG001|Overall Study|Kidney transplant|3|||
105819426|NCT00537979|364999229|FG000|Overall Study|Heart failure|0|||
105819427|NCT00537979|364999230|FG001|Overall Study|Heart failure|1|||
105819428|NCT02601560|364999233|FG000|Overall Study|Other|0|||
105819429|NCT02601560|364999234|FG001|Overall Study|Other|0|||
105819430|NCT02601560|364999235|FG002|Overall Study|Other|0|||
105819431|NCT02601560|364999236|FG003|Overall Study|Other|0|||
105819432|NCT02601560|364999237|FG004|Overall Study|Other|0|||
105819433|NCT02601560|364999238|FG005|Overall Study|Other|0|||
105819434|NCT02601560|364999239|FG006|Overall Study|Other|1|||
105819435|NCT02601560|364999240|FG007|Overall Study|Other|0|||
105819436|NCT02009163|364999245|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
105819437|NCT02009163|364999246|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
105819438|NCT02009163|364999247|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
105819439|NCT02009163|364999245|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
105819440|NCT02009163|364999246|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
105819441|NCT02009163|364999247|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
105819442|NCT02009163|364999245|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
105819443|NCT02009163|364999246|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
105819444|NCT02009163|364999247|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
105819445|NCT02009163|364999245|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
105819446|NCT02009163|364999246|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
105819447|NCT02009163|364999247|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
105819448|NCT02009163|364999245|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
105819449|NCT02009163|364999246|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
105819450|NCT02009163|364999247|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
105819451|NCT02009163|364999245|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
105819452|NCT02009163|364999246|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
105819453|NCT02009163|364999247|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
105819454|NCT02009163|364999245|FG000|Open-label Period (Non-randomized)|Other|13|||
105819455|NCT02009163|364999246|FG001|Open-label Period (Non-randomized)|Other|0|||
105819456|NCT02009163|364999247|FG002|Open-label Period (Non-randomized)|Other|0|||
105819457|NCT02009163|364999245|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
105819458|NCT02009163|364999246|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
105819459|NCT02009163|364999247|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
105819460|NCT02009163|364999245|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
105819461|NCT02009163|364999246|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
105819462|NCT02009163|364999247|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
105819463|NCT02009163|364999245|FG000|Randomized-withdrawal Period|Adverse Event|0|||
105819464|NCT02009163|364999246|FG001|Randomized-withdrawal Period|Adverse Event|0|||
105819465|NCT02009163|364999247|FG002|Randomized-withdrawal Period|Adverse Event|6|||
105819466|NCT02009163|364999245|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
105819467|NCT02009163|364999246|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
105819468|NCT02009163|364999247|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
105819469|NCT02009163|364999245|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
105819470|NCT02009163|364999246|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
105819471|NCT02009163|364999247|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
105819472|NCT02009163|364999245|FG000|Randomized-withdrawal Period|Pregnancy|0|||
105819473|NCT02009163|364999246|FG001|Randomized-withdrawal Period|Pregnancy|0|||
105819474|NCT02009163|364999247|FG002|Randomized-withdrawal Period|Pregnancy|2|||
105819475|NCT02009163|364999245|FG000|Randomized-withdrawal Period|Other|0|||
105819476|NCT02009163|364999246|FG001|Randomized-withdrawal Period|Other|9|||
105819477|NCT02009163|364999247|FG002|Randomized-withdrawal Period|Other|5|||
105819478|NCT02414152|364999250|FG000|Overall Study|Withdrawal by Subject|1|||
105819479|NCT02414152|364999250|FG000|Overall Study|Lack of Efficacy|1|||
105819480|NCT01474551|364999252|FG000|Overall Study|Death|1|||
105819481|NCT00833937|364999253|FG000|Washout|Withdrawal by Subject|1|||
105819482|NCT00833937|364999254|FG001|Washout|Withdrawal by Subject|0|||
105819483|NCT02388191|364999270|FG000|Overall Study|Patient did not receive IUD|1|||
105819484|NCT02388191|364999271|FG001|Overall Study|Patient did not receive IUD|0|||
105819485|NCT03135834|364999272|FG000|Stage 1|Adverse Event|1|||
105819486|NCT03135834|364999273|FG001|Stage 1|Adverse Event|2|||
105819487|NCT03135834|364999274|FG002|Stage 1|Adverse Event|2|||
105819488|NCT03135834|364999275|FG003|Stage 1|Adverse Event|1|||
105819489|NCT03135834|364999272|FG000|Stage 1|Death|1|||
105819490|NCT03135834|364999273|FG001|Stage 1|Death|0|||
105819491|NCT03135834|364999274|FG002|Stage 1|Death|0|||
105819492|NCT03135834|364999275|FG003|Stage 1|Death|0|||
105819493|NCT03135834|364999272|FG000|Stage 1|Lost to Follow-up|17|||
105819494|NCT03135834|364999273|FG001|Stage 1|Lost to Follow-up|24|||
105819495|NCT03135834|364999274|FG002|Stage 1|Lost to Follow-up|21|||
105819496|NCT03135834|364999275|FG003|Stage 1|Lost to Follow-up|38|||
105819497|NCT03135834|364999272|FG000|Stage 1|No longer met eligibility criteria|1|||
105819498|NCT03135834|364999273|FG001|Stage 1|No longer met eligibility criteria|6|||
105819499|NCT03135834|364999274|FG002|Stage 1|No longer met eligibility criteria|2|||
105819500|NCT03135834|364999275|FG003|Stage 1|No longer met eligibility criteria|5|||
105819501|NCT03135834|364999272|FG000|Stage 1|Other|0|||
105819502|NCT03135834|364999273|FG001|Stage 1|Other|2|||
105819503|NCT03135834|364999274|FG002|Stage 1|Other|1|||
105819504|NCT03135834|364999275|FG003|Stage 1|Other|0|||
105819505|NCT03135834|364999272|FG000|Stage 1|Physician Decision|0|||
105819506|NCT03135834|364999273|FG001|Stage 1|Physician Decision|1|||
105819507|NCT03135834|364999274|FG002|Stage 1|Physician Decision|0|||
105819508|NCT03135834|364999275|FG003|Stage 1|Physician Decision|0|||
105819509|NCT03135834|364999272|FG000|Stage 1|Pregnancy|0|||
105819510|NCT03135834|364999273|FG001|Stage 1|Pregnancy|4|||
105819511|NCT03135834|364999274|FG002|Stage 1|Pregnancy|2|||
105819512|NCT03135834|364999275|FG003|Stage 1|Pregnancy|4|||
105819513|NCT03135834|364999272|FG000|Stage 1|Protocol Violation|1|||
105819514|NCT03135834|364999273|FG001|Stage 1|Protocol Violation|1|||
105819515|NCT03135834|364999274|FG002|Stage 1|Protocol Violation|2|||
105819516|NCT03135834|364999275|FG003|Stage 1|Protocol Violation|1|||
105819517|NCT03135834|364999272|FG000|Stage 1|Withdrawal by parent/guardian|2|||
105819518|NCT03135834|364999273|FG001|Stage 1|Withdrawal by parent/guardian|10|||
105819519|NCT03135834|364999274|FG002|Stage 1|Withdrawal by parent/guardian|2|||
105819520|NCT03135834|364999275|FG003|Stage 1|Withdrawal by parent/guardian|1|||
105819521|NCT03135834|364999272|FG000|Stage 1|Withdrawal by Subject|16|||
105819522|NCT03135834|364999273|FG001|Stage 1|Withdrawal by Subject|22|||
105819523|NCT03135834|364999274|FG002|Stage 1|Withdrawal by Subject|7|||
105819524|NCT03135834|364999275|FG003|Stage 1|Withdrawal by Subject|10|||
105819525|NCT03135834|364999272|FG000|Stage 1|Randomized but not Vaccinated|0|||
105819526|NCT03135834|364999273|FG001|Stage 1|Randomized but not Vaccinated|3|||
105819527|NCT03135834|364999274|FG002|Stage 1|Randomized but not Vaccinated|1|||
105819528|NCT03135834|364999275|FG003|Stage 1|Randomized but not Vaccinated|6|||
105819529|NCT03135834|364999272|FG000|Stage 2|Lost to Follow-up|0|||
105819530|NCT03135834|364999273|FG001|Stage 2|Lost to Follow-up|1|||
105819531|NCT03135834|364999274|FG002|Stage 2|Lost to Follow-up|0|||
105819532|NCT03135834|364999275|FG003|Stage 2|Lost to Follow-up|0|||
105819533|NCT03135834|364999272|FG000|Stage 2|Withdrawal by Subject|0|||
105819534|NCT03135834|364999273|FG001|Stage 2|Withdrawal by Subject|1|||
105819535|NCT03135834|364999274|FG002|Stage 2|Withdrawal by Subject|0|||
105819536|NCT03135834|364999275|FG003|Stage 2|Withdrawal by Subject|0|||
105819537|NCT03135834|364999272|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
105819538|NCT03135834|364999273|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
105819539|NCT03135834|364999274|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
105819540|NCT03135834|364999275|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
105819541|NCT03135834|364999272|FG000|Stage 2|Did not receive Booster Vaccination|1|||
105819542|NCT03135834|364999273|FG001|Stage 2|Did not receive Booster Vaccination|1|||
105819543|NCT03135834|364999274|FG002|Stage 2|Did not receive Booster Vaccination|0|||
105819544|NCT03135834|364999275|FG003|Stage 2|Did not receive Booster Vaccination|0|||
105819545|NCT00965185|364999276|FG000|Overall Study|Lost to Follow-up|2|||
105819546|NCT00965185|364999277|FG001|Overall Study|Lost to Follow-up|0|||
105819547|NCT00965185|364999276|FG000|Overall Study|Withdrawal by Subject|0|||
105819548|NCT00965185|364999277|FG001|Overall Study|Withdrawal by Subject|1|||
105819549|NCT01854047|364999278|FG000|Overall Study|Lack of Efficacy|1|||
105819550|NCT01854047|364999279|FG001|Overall Study|Lack of Efficacy|0|||
105819551|NCT01854047|364999280|FG002|Overall Study|Lack of Efficacy|0|||
105819552|NCT01854047|364999281|FG003|Overall Study|Lack of Efficacy|0|||
105819553|NCT01854047|364999282|FG004|Overall Study|Lack of Efficacy|0|||
105819554|NCT01854047|364999278|FG000|Overall Study|Poor compliance to protocol|3|||
105819555|NCT01854047|364999279|FG001|Overall Study|Poor compliance to protocol|0|||
105819556|NCT01854047|364999280|FG002|Overall Study|Poor compliance to protocol|2|||
105819557|NCT01854047|364999281|FG003|Overall Study|Poor compliance to protocol|0|||
105819558|NCT01854047|364999282|FG004|Overall Study|Poor compliance to protocol|0|||
105819559|NCT01854047|364999278|FG000|Overall Study|Adverse Event|5|||
105819560|NCT01854047|364999279|FG001|Overall Study|Adverse Event|4|||
105819561|NCT01854047|364999280|FG002|Overall Study|Adverse Event|6|||
105819562|NCT01854047|364999281|FG003|Overall Study|Adverse Event|10|||
105819563|NCT01854047|364999282|FG004|Overall Study|Adverse Event|7|||
105819564|NCT01854047|364999278|FG000|Overall Study|Randomized but not treated|0|||
105819565|NCT01854047|364999279|FG001|Overall Study|Randomized but not treated|1|||
105819566|NCT01854047|364999280|FG002|Overall Study|Randomized but not treated|2|||
105819567|NCT01854047|364999281|FG003|Overall Study|Randomized but not treated|0|||
105819568|NCT01854047|364999282|FG004|Overall Study|Randomized but not treated|4|||
105819569|NCT01854047|364999278|FG000|Overall Study|Other than specified above|3|||
105819570|NCT01854047|364999279|FG001|Overall Study|Other than specified above|3|||
105819571|NCT01854047|364999280|FG002|Overall Study|Other than specified above|3|||
105819572|NCT01854047|364999281|FG003|Overall Study|Other than specified above|5|||
105819573|NCT01854047|364999282|FG004|Overall Study|Other than specified above|8|||
105819574|NCT01045161|364999283|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
105819575|NCT01045161|364999284|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
105819576|NCT01045161|364999285|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
105819577|NCT01045161|364999283|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
105819578|NCT01045161|364999284|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
105819579|NCT01045161|364999285|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
105819580|NCT01045161|364999283|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
105819581|NCT01045161|364999284|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
105819582|NCT01045161|364999285|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
105819583|NCT01045161|364999283|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
105819584|NCT01045161|364999284|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
105819585|NCT01045161|364999285|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
105819586|NCT01045161|364999283|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
105819587|NCT01045161|364999284|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
105819588|NCT01045161|364999285|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
105819589|NCT01045161|364999283|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
105819590|NCT01045161|364999284|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
105819591|NCT01045161|364999285|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
105819592|NCT01045161|364999283|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
105819593|NCT01045161|364999284|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
105819594|NCT01045161|364999285|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
105819595|NCT01045161|364999283|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
105819596|NCT01045161|364999284|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
105819597|NCT01045161|364999285|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
105819598|NCT01045161|364999283|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
105819599|NCT01045161|364999284|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
105819600|NCT01045161|364999285|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
105819601|NCT01045161|364999283|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
105819602|NCT01045161|364999284|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
105819603|NCT01045161|364999285|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
105819604|NCT01045161|364999283|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
105819605|NCT01045161|364999284|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
105819606|NCT01045161|364999285|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
105819607|NCT01045161|364999283|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
105819608|NCT01045161|364999284|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
105819609|NCT01045161|364999285|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
105819610|NCT01045161|364999283|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
105819611|NCT01045161|364999284|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
105765750|NCT03074318|364793785|FG001|Overall Study|Death|0|||
105765751|NCT03074318|364793786|FG002|Overall Study|Death|0|||
105765752|NCT03074318|364793787|FG003|Overall Study|Death|0|||
105765753|NCT03074318|364793784|FG000|Overall Study|Withdrawal by Subject|1|||
105765754|NCT03074318|364793785|FG001|Overall Study|Withdrawal by Subject|2|||
105765755|NCT03074318|364793786|FG002|Overall Study|Withdrawal by Subject|2|||
105765756|NCT03074318|364793787|FG003|Overall Study|Withdrawal by Subject|4|||
105765757|NCT03074318|364793784|FG000|Overall Study|Trial Closure|2|||
105765758|NCT03074318|364793785|FG001|Overall Study|Trial Closure|2|||
105765759|NCT03074318|364793786|FG002|Overall Study|Trial Closure|3|||
105765760|NCT03074318|364793787|FG003|Overall Study|Trial Closure|11|||
105765761|NCT03549429|364793796|FG000|Overall Study|Protocol Violation|5|||
105765762|NCT03549429|364793797|FG001|Overall Study|Protocol Violation|3|||
105765763|NCT00924729|364793798|FG000|Overall Study|insufficient volume for analysis|1|||
105765764|NCT00924729|364793799|FG001|Overall Study|insufficient volume for analysis|0|||
105765765|NCT00924729|364793798|FG000|Overall Study|Protocol Violation|1|||
105765766|NCT00924729|364793799|FG001|Overall Study|Protocol Violation|0|||
105765767|NCT00588523|364793803|FG000|Overall Study|Not treated|3|||
105765768|NCT04449276|364793804|FG000|Overall Study|Adverse Event|1|||
105765769|NCT04449276|364793805|FG001|Overall Study|Adverse Event|2|||
105486328|NCT03761797|363791478|FG000|Overall Study|Switch to other diabetes medication|10|||
105765770|NCT04449276|364793806|FG002|Overall Study|Adverse Event|0|||
105765771|NCT04449276|364793807|FG003|Overall Study|Adverse Event|0|||
105765772|NCT04449276|364793808|FG004|Overall Study|Adverse Event|2|||
105765773|NCT04449276|364793809|FG005|Overall Study|Adverse Event|0|||
105765774|NCT04449276|364793810|FG006|Overall Study|Adverse Event|0|||
105765775|NCT04449276|364793811|FG007|Overall Study|Adverse Event|1|||
105765776|NCT04449276|364793804|FG000|Overall Study|Withdrawal by Subject|2|||
105765777|NCT04449276|364793805|FG001|Overall Study|Withdrawal by Subject|0|||
105765778|NCT04449276|364793806|FG002|Overall Study|Withdrawal by Subject|0|||
105765779|NCT04449276|364793807|FG003|Overall Study|Withdrawal by Subject|1|||
105765780|NCT04449276|364793808|FG004|Overall Study|Withdrawal by Subject|0|||
105765781|NCT04449276|364793809|FG005|Overall Study|Withdrawal by Subject|0|||
105765782|NCT04449276|364793810|FG006|Overall Study|Withdrawal by Subject|0|||
105765783|NCT04449276|364793811|FG007|Overall Study|Withdrawal by Subject|0|||
105765784|NCT04449276|364793804|FG000|Overall Study|Other|0|||
105765785|NCT04449276|364793805|FG001|Overall Study|Other|2|||
105765786|NCT04449276|364793806|FG002|Overall Study|Other|3|||
105765787|NCT04449276|364793807|FG003|Overall Study|Other|2|||
105765788|NCT04449276|364793808|FG004|Overall Study|Other|0|||
105765789|NCT04449276|364793809|FG005|Overall Study|Other|0|||
105765790|NCT04449276|364793810|FG006|Overall Study|Other|0|||
105765791|NCT04449276|364793811|FG007|Overall Study|Other|1|||
105765792|NCT02023112|364793816|FG000|Overall Study|Withdrawal by Subject|2|||
105765793|NCT02023112|364793817|FG001|Overall Study|Withdrawal by Subject|1|||
105765794|NCT03034057|364793820|FG000|Overall Study|Withdrawal by Subject|10|||
105765795|NCT03034057|364793820|FG000|Overall Study|Protocol Violation|1|||
105765796|NCT03034057|364793820|FG000|Overall Study|Not defined|2|||
105765797|NCT03034057|364793820|FG000|Overall Study|Lost to Follow-up|19|||
105765798|NCT03034057|364793820|FG000|Overall Study|Adverse Event|22|||
105765799|NCT03034057|364793820|FG000|Overall Study|Medication error without associated AE|1|||
105765800|NCT02917629|364793821|FG000|Overall Study|Withdrawal by Subject|0|||
105765801|NCT02917629|364793822|FG001|Overall Study|Withdrawal by Subject|1|||
105765802|NCT03339401|364793823|FG000|Overall Study|Death|2|||
105765803|NCT03339401|364793824|FG001|Overall Study|Death|1|||
105765804|NCT03339401|364793823|FG000|Overall Study|Withdrawal by Subject|2|||
105765805|NCT03339401|364793824|FG001|Overall Study|Withdrawal by Subject|0|||
105765806|NCT03339401|364793823|FG000|Overall Study|Study terminated|4|||
105765807|NCT03339401|364793824|FG001|Overall Study|Study terminated|3|||
105765808|NCT03339401|364793823|FG000|Overall Study|Investigator Decision|1|||
105765809|NCT03339401|364793824|FG001|Overall Study|Investigator Decision|0|||
105765810|NCT00701103|364793825|FG000|Overall Study|Adverse Event|0|||
105765811|NCT00701103|364793826|FG001|Overall Study|Adverse Event|0|||
105765812|NCT00701103|364793827|FG002|Overall Study|Adverse Event|1|||
105765813|NCT00701103|364793828|FG003|Overall Study|Adverse Event|1|||
105765814|NCT00701103|364793829|FG004|Overall Study|Adverse Event|0|||
105765815|NCT00701103|364793830|FG005|Overall Study|Adverse Event|1|||
105765816|NCT00701103|364793831|FG006|Overall Study|Adverse Event|1|||
105765817|NCT00701103|364793832|FG007|Overall Study|Adverse Event|0|||
105765818|NCT00701103|364793833|FG008|Overall Study|Adverse Event|0|||
105765819|NCT00701103|364793834|FG009|Overall Study|Adverse Event|2|||
105765820|NCT00701103|364793835|FG010|Overall Study|Adverse Event|0|||
105765821|NCT00701103|364793825|FG000|Overall Study|Progressive Disease|5|||
105765822|NCT00701103|364793826|FG001|Overall Study|Progressive Disease|2|||
105765823|NCT00701103|364793827|FG002|Overall Study|Progressive Disease|6|||
105765824|NCT00701103|364793828|FG003|Overall Study|Progressive Disease|5|||
105765825|NCT00701103|364793829|FG004|Overall Study|Progressive Disease|6|||
105765826|NCT00701103|364793830|FG005|Overall Study|Progressive Disease|5|||
105765827|NCT00701103|364793831|FG006|Overall Study|Progressive Disease|7|||
105765828|NCT00701103|364793832|FG007|Overall Study|Progressive Disease|7|||
105765829|NCT00701103|364793833|FG008|Overall Study|Progressive Disease|8|||
105765830|NCT00701103|364793834|FG009|Overall Study|Progressive Disease|8|||
105765831|NCT00701103|364793835|FG010|Overall Study|Progressive Disease|11|||
105765832|NCT00701103|364793825|FG000|Overall Study|Withdrawal by Subject|0|||
105765833|NCT00701103|364793826|FG001|Overall Study|Withdrawal by Subject|1|||
105765834|NCT00701103|364793827|FG002|Overall Study|Withdrawal by Subject|1|||
105765835|NCT00701103|364793828|FG003|Overall Study|Withdrawal by Subject|0|||
105765836|NCT00701103|364793829|FG004|Overall Study|Withdrawal by Subject|0|||
105765837|NCT00701103|364793830|FG005|Overall Study|Withdrawal by Subject|0|||
105765838|NCT00701103|364793831|FG006|Overall Study|Withdrawal by Subject|0|||
105819612|NCT01045161|364999285|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
105819613|NCT01045161|364999283|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
105819614|NCT01045161|364999284|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
105819615|NCT01045161|364999285|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
105819616|NCT01353664|364999287|FG000|Overall Study|Other|3|||
105819617|NCT01353664|364999287|FG000|Overall Study|Disease Progression|16|||
105819618|NCT01110005|364999288|FG000|Overall Study|ineligible|1|||
105819619|NCT01110005|364999289|FG001|Overall Study|ineligible|2|||
105819620|NCT01110005|364999288|FG000|Overall Study|missing consent|3|||
105819621|NCT01110005|364999289|FG001|Overall Study|missing consent|2|||
105819622|NCT01110005|364999288|FG000|Overall Study|Withdrawal by Subject|0|||
105819623|NCT01110005|364999289|FG001|Overall Study|Withdrawal by Subject|1|||
105819624|NCT02242201|364999296|FG000|Overall Study|preoperative identified neuropathy|2|||
105819625|NCT02242201|364999297|FG001|Overall Study|preoperative identified neuropathy|0|||
105819626|NCT02242201|364999298|FG002|Overall Study|preoperative identified neuropathy|0|||
105819627|NCT02242201|364999296|FG000|Overall Study|planned post-op anticoagulation|1|||
105819628|NCT02242201|364999297|FG001|Overall Study|planned post-op anticoagulation|0|||
105819629|NCT02242201|364999298|FG002|Overall Study|planned post-op anticoagulation|0|||
105819630|NCT02242201|364999296|FG000|Overall Study|changed surgical procedure|1|||
105819631|NCT02242201|364999297|FG001|Overall Study|changed surgical procedure|0|||
105819632|NCT02242201|364999298|FG002|Overall Study|changed surgical procedure|0|||
105819633|NCT02242201|364999296|FG000|Overall Study|postponed surgery|0|||
105819634|NCT02242201|364999297|FG001|Overall Study|postponed surgery|0|||
105819635|NCT02242201|364999298|FG002|Overall Study|postponed surgery|1|||
105819636|NCT02242201|364999296|FG000|Overall Study|preoperative opioid consumption|0|||
105819637|NCT02242201|364999297|FG001|Overall Study|preoperative opioid consumption|1|||
105819638|NCT02242201|364999298|FG002|Overall Study|preoperative opioid consumption|0|||
105819639|NCT03616106|364999312|FG000|Overall Study|Removed by PI|6|||
105819640|NCT03616106|364999313|FG001|Overall Study|Removed by PI|0|||
105819641|NCT03616106|364999312|FG000|Overall Study|Withdrawal by Subject|1|||
105819642|NCT03616106|364999313|FG001|Overall Study|Withdrawal by Subject|1|||
105819643|NCT03616106|364999312|FG000|Overall Study|Lost to Follow-up|7|||
105819644|NCT03616106|364999313|FG001|Overall Study|Lost to Follow-up|0|||
105819645|NCT03041025|364999314|FG000|Overall Study|Adverse Event|0|||
105819646|NCT03041025|364999315|FG001|Overall Study|Adverse Event|0|||
105819647|NCT03041025|364999316|FG002|Overall Study|Adverse Event|1|||
105819648|NCT03041025|364999314|FG000|Overall Study|Lost to Follow-up|1|||
105819649|NCT03041025|364999315|FG001|Overall Study|Lost to Follow-up|0|||
105819650|NCT03041025|364999316|FG002|Overall Study|Lost to Follow-up|0|||
105819651|NCT03041025|364999314|FG000|Overall Study|Withdrawal by Subject|0|||
105819652|NCT03041025|364999315|FG001|Overall Study|Withdrawal by Subject|0|||
105819653|NCT03041025|364999316|FG002|Overall Study|Withdrawal by Subject|1|||
105819654|NCT00119015|364999317|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
105819655|NCT00119015|364999318|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
105819656|NCT00119015|364999319|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
105819657|NCT01811953|365000715|FG000|Overall Study|Adverse Event|0|||
105819658|NCT01811953|365000716|FG001|Overall Study|Adverse Event|0|||
105819659|NCT01811953|365000717|FG002|Overall Study|Adverse Event|0|||
105819660|NCT01811953|365000718|FG003|Overall Study|Adverse Event|1|||
105819661|NCT01811953|365000719|FG004|Overall Study|Adverse Event|0|||
105819662|NCT01811953|365000720|FG005|Overall Study|Adverse Event|1|||
105819663|NCT01811953|365000715|FG000|Overall Study|Protocol Violation|0|||
105819664|NCT01811953|365000716|FG001|Overall Study|Protocol Violation|0|||
105819665|NCT01811953|365000717|FG002|Overall Study|Protocol Violation|0|||
105819666|NCT01811953|365000718|FG003|Overall Study|Protocol Violation|0|||
105819667|NCT01811953|365000719|FG004|Overall Study|Protocol Violation|1|||
105819668|NCT01811953|365000720|FG005|Overall Study|Protocol Violation|0|||
105819669|NCT01049334|365000723|FG000|Overall Study|Withdrawal by Subject|5|||
105819670|NCT01049334|365000724|FG001|Overall Study|Withdrawal by Subject|3|||
105819671|NCT01049334|365000723|FG000|Overall Study|Adverse Event|2|||
105819672|NCT01049334|365000724|FG001|Overall Study|Adverse Event|3|||
105819673|NCT01049334|365000723|FG000|Overall Study|Physician Decision|2|||
105819674|NCT01049334|365000724|FG001|Overall Study|Physician Decision|0|||
105819675|NCT01049334|365000723|FG000|Overall Study|Protocol Violation|0|||
105819676|NCT01049334|365000724|FG001|Overall Study|Protocol Violation|1|||
105819677|NCT02495857|365000725|FG000|Overall Study|Adverse Event|5|||
105819678|NCT02495857|365000726|FG001|Overall Study|Adverse Event|0|||
105819679|NCT02495857|365000727|FG002|Overall Study|Adverse Event|1|||
105819680|NCT02495857|365000725|FG000|Overall Study|Withdrawal by Subject|9|||
105819681|NCT02495857|365000726|FG001|Overall Study|Withdrawal by Subject|6|||
105819682|NCT02495857|365000727|FG002|Overall Study|Withdrawal by Subject|10|||
105819683|NCT02495857|365000725|FG000|Overall Study|Physician Decision|0|||
105819684|NCT02495857|365000726|FG001|Overall Study|Physician Decision|1|||
105819685|NCT02495857|365000727|FG002|Overall Study|Physician Decision|0|||
105819686|NCT02495857|365000725|FG000|Overall Study|Protocol Violation|1|||
105819687|NCT02495857|365000726|FG001|Overall Study|Protocol Violation|1|||
105819688|NCT02495857|365000727|FG002|Overall Study|Protocol Violation|2|||
105819689|NCT02495857|365000725|FG000|Overall Study|Lost to Follow-up|4|||
105819690|NCT02495857|365000726|FG001|Overall Study|Lost to Follow-up|5|||
105819691|NCT02495857|365000727|FG002|Overall Study|Lost to Follow-up|3|||
105819692|NCT02495857|365000725|FG000|Overall Study|Other|3|||
105819693|NCT02495857|365000726|FG001|Overall Study|Other|3|||
105819694|NCT02495857|365000727|FG002|Overall Study|Other|2|||
105819695|NCT02883452|365000728|FG000|Overall Study|Withdrawal by Subject|1|||
105819696|NCT02883452|365000729|FG001|Overall Study|Withdrawal by Subject|1|||
105819697|NCT02883452|365000730|FG002|Overall Study|Withdrawal by Subject|3|||
105819698|NCT02883452|365000731|FG003|Overall Study|Withdrawal by Subject|0|||
105819699|NCT02883452|365000732|FG004|Overall Study|Withdrawal by Subject|2|||
105819700|NCT02883452|365000733|FG005|Overall Study|Withdrawal by Subject|5|||
105819701|NCT02883452|365000728|FG000|Overall Study|Disease progression|1|||
105819702|NCT02883452|365000729|FG001|Overall Study|Disease progression|0|||
105819703|NCT02883452|365000730|FG002|Overall Study|Disease progression|0|||
105819704|NCT02883452|365000731|FG003|Overall Study|Disease progression|1|||
105819705|NCT02883452|365000732|FG004|Overall Study|Disease progression|4|||
105819706|NCT02883452|365000733|FG005|Overall Study|Disease progression|5|||
105819707|NCT02883452|365000728|FG000|Overall Study|Adverse Event|2|||
105819708|NCT02883452|365000729|FG001|Overall Study|Adverse Event|1|||
105819709|NCT02883452|365000730|FG002|Overall Study|Adverse Event|1|||
105819710|NCT02883452|365000731|FG003|Overall Study|Adverse Event|1|||
105819711|NCT02883452|365000732|FG004|Overall Study|Adverse Event|1|||
105819712|NCT02883452|365000733|FG005|Overall Study|Adverse Event|3|||
105819713|NCT02883452|365000728|FG000|Overall Study|Physician Decision|0|||
105819714|NCT02883452|365000729|FG001|Overall Study|Physician Decision|0|||
105819715|NCT02883452|365000730|FG002|Overall Study|Physician Decision|0|||
105819716|NCT02883452|365000731|FG003|Overall Study|Physician Decision|0|||
105819717|NCT02883452|365000732|FG004|Overall Study|Physician Decision|4|||
105819718|NCT02883452|365000733|FG005|Overall Study|Physician Decision|1|||
105819719|NCT02883452|365000728|FG000|Overall Study|Death|1|||
105819720|NCT02883452|365000729|FG001|Overall Study|Death|0|||
105819721|NCT02883452|365000730|FG002|Overall Study|Death|1|||
105819722|NCT02883452|365000731|FG003|Overall Study|Death|0|||
105819723|NCT02883452|365000732|FG004|Overall Study|Death|0|||
105819724|NCT02883452|365000733|FG005|Overall Study|Death|0|||
105819725|NCT02883452|365000728|FG000|Overall Study|Other|0|||
105819726|NCT02883452|365000729|FG001|Overall Study|Other|0|||
105819727|NCT02883452|365000730|FG002|Overall Study|Other|0|||
105819728|NCT02883452|365000731|FG003|Overall Study|Other|0|||
105819729|NCT02883452|365000732|FG004|Overall Study|Other|0|||
105819730|NCT02883452|365000733|FG005|Overall Study|Other|1|||
105819731|NCT00834522|365000735|FG000|Washout|Adverse Event|1|||
105819732|NCT00834522|365000736|FG001|Washout|Adverse Event|0|||
105819733|NCT00834522|365000735|FG000|Washout|Withdrawal by Subject|2|||
105819734|NCT00834522|365000736|FG001|Washout|Withdrawal by Subject|1|||
105819735|NCT01313273|365000749|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
105819736|NCT01313273|365000750|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
105819737|NCT01313273|365000749|FG000|Overall Study|Withdrawal by Subject|1|||
105819738|NCT01313273|365000750|FG001|Overall Study|Withdrawal by Subject|0|||
105819739|NCT01313273|365000749|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
105819740|NCT01313273|365000750|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
105819741|NCT01602419|365000751|FG000|Overall Study|Not treated with Wilate|9|||
105819742|NCT01602419|365000751|FG000|Overall Study|Adverse Drug Reaction|4|||
105819743|NCT01602419|365000751|FG000|Overall Study|Insurance issues|3|||
105819744|NCT01602419|365000751|FG000|Overall Study|Changed treatment centre|1|||
105819745|NCT01602419|365000751|FG000|Overall Study|Treatment centre closed|1|||
105819746|NCT01602419|365000751|FG000|Overall Study|Withdrawal by Subject|5|||
105819747|NCT01602419|365000751|FG000|Overall Study|Lost to Follow-up|6|||
105819748|NCT01010542|365000752|FG000|Overall Study|Adverse Event|0|||
105819749|NCT01010542|365000753|FG001|Overall Study|Adverse Event|1|||
105571667|NCT02887989|364092725|FG000|Overall Study|Withdrawal by Subject|8|||
105571668|NCT02887989|364092726|FG001|Overall Study|Withdrawal by Subject|11|||
105819750|NCT01010542|365000754|FG002|Overall Study|Adverse Event|0|||
105819751|NCT01010542|365000752|FG000|Overall Study|Lost to Follow-up|0|||
105819752|NCT01010542|365000753|FG001|Overall Study|Lost to Follow-up|1|||
105819753|NCT01010542|365000754|FG002|Overall Study|Lost to Follow-up|0|||
105819754|NCT01010542|365000752|FG000|Overall Study|Withdrawal by Subject|0|||
105819755|NCT01010542|365000753|FG001|Overall Study|Withdrawal by Subject|3|||
105819756|NCT01010542|365000754|FG002|Overall Study|Withdrawal by Subject|2|||
105819757|NCT03956862|365000755|FG000|Overall Study|Lost to Follow-up|1|||
105819758|NCT03956862|365000756|FG001|Overall Study|Lost to Follow-up|1|||
105819759|NCT03956862|365000755|FG000|Overall Study|Withdrawal by Subject|1|||
105819760|NCT03956862|365000756|FG001|Overall Study|Withdrawal by Subject|1|||
105819761|NCT01472341|365000757|FG000|Overall Study|Started insulin therapy|55|||
105819762|NCT01472341|365000757|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
105819763|NCT01472341|365000757|FG000|Overall Study|Withdrawal by Subject|39|||
105819764|NCT01472341|365000757|FG000|Overall Study|Lost to Follow-up|52|||
105819765|NCT01472341|365000757|FG000|Overall Study|Laboratory parameters unavailable|25|||
105819766|NCT01472341|365000757|FG000|Overall Study|Death|9|||
105819767|NCT01363765|365000760|FG000|Overall Study|non-diagnostic|2621|||
105819768|NCT01363765|365000761|FG001|Overall Study|non-diagnostic|1124|||
105819769|NCT01363765|365000760|FG000|Overall Study|duplicate records|736|||
105819770|NCT01363765|365000761|FG001|Overall Study|duplicate records|3177|||
105819771|NCT01363765|365000760|FG000|Overall Study|non-resident|156|||
105819772|NCT01363765|365000761|FG001|Overall Study|non-resident|76|||
105819773|NCT01363765|365000760|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
105819774|NCT01363765|365000761|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
105819775|NCT01363765|365000760|FG000|Overall Study|smear during intervention|2170|||
105819776|NCT01363765|365000761|FG001|Overall Study|smear during intervention|0|||
105819777|NCT01975948|365000763|FG000|Overall Study|Withdrawal by Subject|17|||
105819778|NCT01975948|365000764|FG001|Overall Study|Withdrawal by Subject|21|||
105819779|NCT01975948|365000765|FG002|Overall Study|Withdrawal by Subject|7|||
105819780|NCT01975948|365000766|FG003|Overall Study|Withdrawal by Subject|6|||
105819781|NCT01200810|365000768|FG000|Overall Study|Physician Decision|1|||
105819782|NCT01200810|365000769|FG001|Overall Study|Physician Decision|0|||
105819783|NCT01200810|365000768|FG000|Overall Study|Withdrawal by Subject|1|||
105819784|NCT01200810|365000769|FG001|Overall Study|Withdrawal by Subject|2|||
105819785|NCT01200810|365000768|FG000|Overall Study|Sponsor stopped making study drug|3|||
105819786|NCT01200810|365000769|FG001|Overall Study|Sponsor stopped making study drug|3|||
105819787|NCT00365846|365000770|FG000|Overall Study|Lost to Follow-up|1|||
105819788|NCT03925532|365000776|FG000|Overall Study|Lost to Follow-up|1|||
105819789|NCT04499963|365000777|FG000|Overall Study|Adverse Event|3|||
105819790|NCT04499963|365000778|FG001|Overall Study|Adverse Event|0|||
105819791|NCT04499963|365000777|FG000|Overall Study|Death|3|||
105819792|NCT04499963|365000778|FG001|Overall Study|Death|0|||
105819793|NCT04499963|365000777|FG000|Overall Study|Lack of Efficacy|7|||
105819794|NCT04499963|365000778|FG001|Overall Study|Lack of Efficacy|0|||
105819795|NCT04499963|365000777|FG000|Overall Study|Lost to Follow-up|2|||
105819796|NCT04499963|365000778|FG001|Overall Study|Lost to Follow-up|0|||
105819797|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Adverse Event|11|||
105819798|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Adverse Event|23|||
105819799|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Adverse Event|29|||
105819800|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Adverse Event|2|||
105819801|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Adverse Event|8|||
105819802|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
105819803|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
105819804|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
105819805|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
105819806|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
105819807|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
105819808|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
105819809|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
105819810|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
105819811|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
105819812|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
105819813|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
105362764|NCT03428100|363332629|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
105362765|NCT03428100|363332630|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
105362766|NCT03428100|363332631|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
105362767|NCT03428100|363332632|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
105362768|NCT03428100|363332633|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
105362769|NCT03428100|363332634|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
105362770|NCT03428100|363332635|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
105362771|NCT03428100|363332636|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
105362772|NCT03428100|363332637|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
105362773|NCT03428100|363332638|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
105362774|NCT03428100|363332620|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
105362775|NCT03428100|363332621|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
105362776|NCT03428100|363332622|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
105765839|NCT00701103|364793832|FG007|Overall Study|Withdrawal by Subject|0|||
105765840|NCT00701103|364793833|FG008|Overall Study|Withdrawal by Subject|0|||
105765841|NCT00701103|364793834|FG009|Overall Study|Withdrawal by Subject|0|||
105765842|NCT00701103|364793835|FG010|Overall Study|Withdrawal by Subject|0|||
105765843|NCT00701103|364793825|FG000|Overall Study|Other|0|||
105765844|NCT00701103|364793826|FG001|Overall Study|Other|0|||
105765845|NCT00701103|364793827|FG002|Overall Study|Other|0|||
105765846|NCT00701103|364793828|FG003|Overall Study|Other|0|||
105765847|NCT00701103|364793829|FG004|Overall Study|Other|0|||
105765848|NCT00701103|364793830|FG005|Overall Study|Other|0|||
105765849|NCT00701103|364793831|FG006|Overall Study|Other|0|||
105765850|NCT00701103|364793832|FG007|Overall Study|Other|0|||
105765851|NCT00701103|364793833|FG008|Overall Study|Other|1|||
105765852|NCT00701103|364793834|FG009|Overall Study|Other|1|||
105765853|NCT00701103|364793835|FG010|Overall Study|Other|0|||
105765854|NCT03271307|364793836|FG000|Overall Study|Lost to Follow-up|0|||
105765855|NCT03271307|364793837|FG001|Overall Study|Lost to Follow-up|0|||
105765856|NCT03271307|364793838|FG002|Overall Study|Lost to Follow-up|0|||
105765857|NCT03271307|364793839|FG003|Overall Study|Lost to Follow-up|28|||
105765858|NCT03271307|364793840|FG004|Overall Study|Lost to Follow-up|91|||
105765859|NCT01449955|364793841|FG000|Overall Study|Withdrawal by Subject|1|||
105765860|NCT01449955|364793842|FG001|Overall Study|Withdrawal by Subject|2|||
105765861|NCT02067533|364793849|FG000|Overall Study|Lost to Follow-up|4|||
105765862|NCT02067533|364793850|FG001|Overall Study|Lost to Follow-up|2|||
105765863|NCT01176240|364793851|FG000|Study 306A|Lack of Efficacy|2|||
105765864|NCT01176240|364793852|FG001|Study 306A|Lack of Efficacy|1|||
105765865|NCT01176240|364793851|FG000|Study 306A|Protocol Violation|0|||
105765866|NCT01176240|364793852|FG001|Study 306A|Protocol Violation|1|||
105765867|NCT01176240|364793851|FG000|Study 306A|Withdrawal by Subject|0|||
105765868|NCT01176240|364793852|FG001|Study 306A|Withdrawal by Subject|1|||
105765869|NCT01176240|364793851|FG000|Study 306A|Stop due to diverse problems|1|||
105765870|NCT01176240|364793852|FG001|Study 306A|Stop due to diverse problems|0|||
105765871|NCT01176240|364793851|FG000|Study 306B|Lack of Efficacy|5|||
105765872|NCT01176240|364793852|FG001|Study 306B|Lack of Efficacy|3|||
105765873|NCT01176240|364793851|FG000|Study 306B|Adverse Event|10|||
105765874|NCT01176240|364793852|FG001|Study 306B|Adverse Event|5|||
105765875|NCT01176240|364793851|FG000|Study 306B|Protocol Violation|2|||
105765876|NCT01176240|364793852|FG001|Study 306B|Protocol Violation|3|||
105765877|NCT01176240|364793851|FG000|Study 306B|Withdrawal by Subject|4|||
105765878|NCT01176240|364793852|FG001|Study 306B|Withdrawal by Subject|1|||
105765879|NCT01176240|364793851|FG000|Study 306B|Physician Decision|2|||
105765880|NCT01176240|364793852|FG001|Study 306B|Physician Decision|1|||
105765881|NCT01176240|364793851|FG000|Study 306B|Supine Hypertension|1|||
105765882|NCT01176240|364793852|FG001|Study 306B|Supine Hypertension|2|||
105765883|NCT01176240|364793851|FG000|Study 306B|Lost to Follow-up|0|||
105765884|NCT01176240|364793852|FG001|Study 306B|Lost to Follow-up|1|||
105765885|NCT01176240|364793851|FG000|Study 306B|withdrew prior to dosing|2|||
105765886|NCT01176240|364793852|FG001|Study 306B|withdrew prior to dosing|1|||
105765887|NCT01931150|364793853|FG000|Overall Study|Withdrawal by Subject|1|||
105765888|NCT01931150|364793854|FG001|Overall Study|Withdrawal by Subject|2|||
105765889|NCT04968353|364793855|FG000|Overall Study|Non-compliance|1|||
105765890|NCT04968353|364793856|FG001|Overall Study|Non-compliance|0|||
105765891|NCT04968353|364793857|FG002|Overall Study|Non-compliance|2|||
105765892|NCT04968353|364793858|FG003|Overall Study|Non-compliance|0|||
105765893|NCT02967692|364795917|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
105765894|NCT02967692|364795918|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
105571669|NCT02887989|364092725|FG000|Overall Study|Death|1|||
105765895|NCT02967692|364795919|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
105765896|NCT02967692|364795920|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
105765897|NCT02967692|364795917|FG000|Overall Study|Progressive disease|3|||
105765898|NCT02967692|364795918|FG001|Overall Study|Progressive disease|15|||
105765899|NCT02967692|364795919|FG002|Overall Study|Progressive disease|99|||
105765900|NCT02967692|364795920|FG003|Overall Study|Progressive disease|128|||
105765901|NCT02967692|364795917|FG000|Overall Study|Subject/guardian decision|1|||
105819814|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
105819815|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
105819816|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
105819817|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
105819818|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
105819819|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
105819820|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
105819821|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
105819822|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
105819823|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
105819824|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
105819825|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
105819826|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
105819827|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
105819828|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
105819829|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
105819830|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
105819831|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
105819832|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Move|0|||
105819833|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Move|1|||
105819834|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Move|0|||
105819835|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Move|0|||
105819836|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Move|0|||
105819837|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
105819838|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
105819839|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
105819840|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
105819841|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
105819842|NCT00318461|365000781|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
105819843|NCT00318461|365000782|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
105819844|NCT00318461|365000783|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
105819845|NCT00318461|365000784|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
105819846|NCT00318461|365000785|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
105819847|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Work commitment|0|||
105819848|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Work commitment|0|||
105819849|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Work commitment|0|||
105819850|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Work commitment|0|||
105819851|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Work commitment|1|||
105819852|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Investigator decision|0|||
105819853|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Investigator decision|0|||
105819854|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Investigator decision|0|||
105819855|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Investigator decision|0|||
105819856|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Investigator decision|1|||
105819857|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Lack of time|1|||
105819858|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Lack of time|0|||
105819859|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Lack of time|0|||
105819860|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Lack of time|0|||
105819861|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Lack of time|0|||
105819862|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
105819863|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
105819864|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
105819865|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
105819866|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
105819867|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
105819868|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
105819869|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
105819870|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
105819871|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
105819872|NCT00318461|365000781|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
105819873|NCT00318461|365000782|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
105819874|NCT00318461|365000783|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
105819875|NCT00318461|365000784|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
105819876|NCT00318461|365000785|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
105819877|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
105819878|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
105819879|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
105819880|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
105819881|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
105819882|NCT00318461|365000781|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
105819883|NCT00318461|365000782|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
105819884|NCT00318461|365000783|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
105819885|NCT00318461|365000784|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
105819886|NCT00318461|365000785|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
105819887|NCT00318461|365000781|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
105819888|NCT00318461|365000782|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
105819889|NCT00318461|365000783|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
105819890|NCT00318461|365000784|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
105819891|NCT00318461|365000785|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
105819892|NCT00318461|365000781|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
105819893|NCT00318461|365000782|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
105819894|NCT00318461|365000783|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
105819895|NCT00318461|365000784|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
105819896|NCT00318461|365000785|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
105819897|NCT00318461|365000781|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
105819898|NCT00318461|365000782|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
105819899|NCT00318461|365000783|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
105819900|NCT00318461|365000784|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
105819901|NCT00318461|365000785|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
105819902|NCT01723397|365000786|FG000|Study Period 1|Protocol Violation|0|||
105819903|NCT01723397|365000787|FG001|Study Period 1|Protocol Violation|1|||
105819904|NCT01723397|365000786|FG000|Study Period 2|Protocol Violation|0|||
105819905|NCT01723397|365000787|FG001|Study Period 2|Protocol Violation|1|||
105819906|NCT00838279|365000792|FG000|Washout|Protocol Violation|1|||
105819907|NCT00838279|365000793|FG001|Washout|Protocol Violation|0|||
105819908|NCT00838279|365000792|FG000|Washout|Withdrawal by Subject|0|||
105819909|NCT00838279|365000793|FG001|Washout|Withdrawal by Subject|1|||
105819910|NCT03233724|365000798|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
105819911|NCT03233724|365000799|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
105819912|NCT03233724|365000800|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
105819913|NCT03233724|365000801|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
105819914|NCT03233724|365000802|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
105819915|NCT03233724|365000798|FG000|Phase I Dose Escalation|Best interest of participant|1|||
105819916|NCT03233724|365000799|FG001|Phase I Dose Escalation|Best interest of participant|1|||
105819917|NCT03233724|365000800|FG002|Phase I Dose Escalation|Best interest of participant|1|||
105819918|NCT03233724|365000801|FG003|Phase I Dose Escalation|Best interest of participant|0|||
105819919|NCT03233724|365000802|FG004|Phase I Dose Escalation|Best interest of participant|0|||
105819920|NCT03233724|365000798|FG000|Phase I Dose Escalation|Physician Decision|0|||
105819921|NCT03233724|365000799|FG001|Phase I Dose Escalation|Physician Decision|0|||
105819922|NCT03233724|365000800|FG002|Phase I Dose Escalation|Physician Decision|1|||
105819923|NCT03233724|365000801|FG003|Phase I Dose Escalation|Physician Decision|0|||
105819924|NCT03233724|365000802|FG004|Phase I Dose Escalation|Physician Decision|0|||
105819925|NCT03233724|365000798|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
105819926|NCT03233724|365000799|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
105819927|NCT03233724|365000800|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
105819928|NCT03233724|365000801|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
105819929|NCT03233724|365000802|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
105819930|NCT03482882|365000803|FG000|Overall Study|Adverse Event|3|||
105486329|NCT03761797|363791478|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
105486330|NCT03761797|363791478|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
105486331|NCT03761797|363791478|FG000|Overall Study|Insufficient effectives|2|||
105486332|NCT03761797|363791478|FG000|Overall Study|Excessive alcohol intake|1|||
105819931|NCT03482882|365000803|FG000|Overall Study|Lost to Follow-up|1|||
105819932|NCT03482882|365000803|FG000|Overall Study|Protocol Violation|2|||
105819933|NCT03482882|365000803|FG000|Overall Study|Not further specified|1|||
105819934|NCT04646213|365000804|FG000|Overall Study|Physician Decision|3|||
105819935|NCT04646213|365000804|FG000|Overall Study|Withdrawal by Subject|2|||
105819936|NCT02281084|365000806|FG000|Overall Study|Death|21|||
105819937|NCT02281084|365000807|FG001|Overall Study|Death|18|||
105819938|NCT02281084|365000808|FG002|Overall Study|Death|3|||
105819939|NCT02281084|365000809|FG003|Overall Study|Death|5|||
105819940|NCT02281084|365000806|FG000|Overall Study|Adverse Event|1|||
105819941|NCT02281084|365000807|FG001|Overall Study|Adverse Event|0|||
105819942|NCT02281084|365000808|FG002|Overall Study|Adverse Event|0|||
105819943|NCT02281084|365000809|FG003|Overall Study|Adverse Event|0|||
105819944|NCT02281084|365000806|FG000|Overall Study|Withdrawal by Subject|2|||
105819945|NCT02281084|365000807|FG001|Overall Study|Withdrawal by Subject|2|||
105819946|NCT02281084|365000808|FG002|Overall Study|Withdrawal by Subject|0|||
105819947|NCT02281084|365000809|FG003|Overall Study|Withdrawal by Subject|0|||
105819948|NCT02281084|365000806|FG000|Overall Study|Site Closure by Sponsor|5|||
105819949|NCT02281084|365000807|FG001|Overall Study|Site Closure by Sponsor|1|||
105819950|NCT02281084|365000808|FG002|Overall Study|Site Closure by Sponsor|2|||
105819951|NCT02281084|365000809|FG003|Overall Study|Site Closure by Sponsor|0|||
105819952|NCT01686477|365000810|FG000|Feeding Intervention|Death|1|||
105819953|NCT01686477|365000811|FG001|Feeding Intervention|Death|0|||
105819954|NCT01686477|365000812|FG002|Feeding Intervention|Death|1|||
105819955|NCT01686477|365000810|FG000|Feeding Intervention|Withdrawal by Subject|0|||
105819956|NCT01686477|365000811|FG001|Feeding Intervention|Withdrawal by Subject|6|||
105819957|NCT01686477|365000812|FG002|Feeding Intervention|Withdrawal by Subject|0|||
105819958|NCT01686477|365000810|FG000|Feeding Intervention|Physician Decision|1|||
105819959|NCT01686477|365000811|FG001|Feeding Intervention|Physician Decision|2|||
105819960|NCT01686477|365000812|FG002|Feeding Intervention|Physician Decision|0|||
105819961|NCT01686477|365000810|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
105819962|NCT01686477|365000811|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
105819963|NCT01686477|365000812|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
105819964|NCT01686477|365000810|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
105819965|NCT01686477|365000811|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
105819966|NCT01686477|365000812|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
105819967|NCT01686477|365000810|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
105819968|NCT01686477|365000811|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
105819969|NCT01686477|365000812|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
105819970|NCT01686477|365000810|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
105819971|NCT01686477|365000811|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
105819972|NCT01686477|365000812|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
105819973|NCT01686477|365000810|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
105819974|NCT01686477|365000811|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
105819975|NCT01686477|365000812|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
105819976|NCT01686477|365000810|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
105819977|NCT01686477|365000811|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
105819978|NCT01686477|365000812|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
105819979|NCT01686477|365000810|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
105819980|NCT01686477|365000811|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
105819981|NCT01686477|365000812|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
105819982|NCT02305758|365000813|FG000|Overall Study|Death|27|||
105819983|NCT02305758|365000814|FG001|Overall Study|Death|27|||
105819984|NCT02305758|365000813|FG000|Overall Study|Withdrew consent|9|||
105819985|NCT02305758|365000814|FG001|Overall Study|Withdrew consent|2|||
105819986|NCT02305758|365000813|FG000|Overall Study|Lost to Follow-up|6|||
105819987|NCT02305758|365000814|FG001|Overall Study|Lost to Follow-up|1|||
105819988|NCT02305758|365000813|FG000|Overall Study|Study Terminated by Sponsor|21|||
105819989|NCT02305758|365000814|FG001|Overall Study|Study Terminated by Sponsor|34|||
105819990|NCT02305758|365000813|FG000|Overall Study|Other, not specified|2|||
105819991|NCT02305758|365000814|FG001|Overall Study|Other, not specified|1|||
105819992|NCT02032888|365000815|FG000|Treatment Period|Poor compliance/noncompliance|1|||
105819993|NCT02032888|365000816|FG001|Treatment Period|Poor compliance/noncompliance|1|||
105819994|NCT02032888|365000817|FG002|Treatment Period|Poor compliance/noncompliance|0|||
105819995|NCT02032888|365000815|FG000|Treatment Period|Other|1|||
105819996|NCT02032888|365000816|FG001|Treatment Period|Other|1|||
105819997|NCT02032888|365000817|FG002|Treatment Period|Other|0|||
105819998|NCT02032888|365000815|FG000|Follow-up Period|Lost to Follow-up|1|||
105819999|NCT02032888|365000816|FG001|Follow-up Period|Lost to Follow-up|1|||
105820000|NCT02032888|365000817|FG002|Follow-up Period|Lost to Follow-up|0|||
105820001|NCT02032888|365000815|FG000|Follow-up Period|Death|1|||
105820002|NCT02032888|365000816|FG001|Follow-up Period|Death|1|||
105820003|NCT02032888|365000817|FG002|Follow-up Period|Death|0|||
105820004|NCT02032888|365000815|FG000|Follow-up Period|Other|1|||
105486333|NCT02380690|363791481|FG000|Overall Study|Lost to Follow-up|14|||
105765902|NCT02967692|364795918|FG001|Overall Study|Subject/guardian decision|1|||
105765903|NCT02967692|364795919|FG002|Overall Study|Subject/guardian decision|6|||
105765904|NCT02967692|364795920|FG003|Overall Study|Subject/guardian decision|13|||
105765905|NCT02967692|364795917|FG000|Overall Study|Death|0|||
105765906|NCT02967692|364795918|FG001|Overall Study|Death|1|||
105765907|NCT02967692|364795919|FG002|Overall Study|Death|10|||
105765908|NCT02967692|364795920|FG003|Overall Study|Death|9|||
105765909|NCT02967692|364795917|FG000|Overall Study|Protocol deviation|1|||
105765910|NCT02967692|364795918|FG001|Overall Study|Protocol deviation|0|||
105765911|NCT02967692|364795919|FG002|Overall Study|Protocol deviation|1|||
105765912|NCT02967692|364795920|FG003|Overall Study|Protocol deviation|1|||
105765913|NCT02967692|364795917|FG000|Overall Study|Lost to Follow-up|0|||
105765914|NCT02967692|364795918|FG001|Overall Study|Lost to Follow-up|0|||
105765915|NCT02967692|364795919|FG002|Overall Study|Lost to Follow-up|1|||
105765916|NCT02967692|364795920|FG003|Overall Study|Lost to Follow-up|0|||
105765917|NCT02967692|364795917|FG000|Overall Study|Physician Decision|0|||
105765918|NCT02967692|364795918|FG001|Overall Study|Physician Decision|0|||
105765919|NCT02967692|364795919|FG002|Overall Study|Physician Decision|13|||
105765920|NCT02967692|364795920|FG003|Overall Study|Physician Decision|9|||
105765921|NCT02967692|364795917|FG000|Overall Study|Adverse Event|1|||
105765922|NCT02967692|364795918|FG001|Overall Study|Adverse Event|9|||
105765923|NCT02967692|364795919|FG002|Overall Study|Adverse Event|51|||
105765924|NCT02967692|364795920|FG003|Overall Study|Adverse Event|23|||
105765925|NCT03038672|364795921|FG000|Initial Treatment|Unacceptable chemistry|0|||
105765926|NCT03038672|364795922|FG001|Initial Treatment|Unacceptable chemistry|1|||
105765927|NCT03038672|364795921|FG000|Initial Treatment|Progression prior to treatment|1|||
105765928|NCT03038672|364795922|FG001|Initial Treatment|Progression prior to treatment|0|||
105765929|NCT03038672|364795921|FG000|Initial Treatment|No treatment per protocol|1|||
105765930|NCT03038672|364795922|FG001|Initial Treatment|No treatment per protocol|0|||
105765931|NCT01731990|364795923|FG000|Overall Study|Adverse Event|1|||
105765932|NCT01731990|364795924|FG001|Overall Study|Adverse Event|5|||
105765933|NCT01731990|364795923|FG000|Overall Study|Withdrawal by Subject|1|||
105765934|NCT01731990|364795924|FG001|Overall Study|Withdrawal by Subject|1|||
105765935|NCT01731990|364795923|FG000|Overall Study|Protocol deviation|1|||
105765936|NCT01731990|364795924|FG001|Overall Study|Protocol deviation|2|||
105765937|NCT01731990|364795923|FG000|Overall Study|Death|1|||
105765938|NCT01731990|364795924|FG001|Overall Study|Death|0|||
105765939|NCT01280812|364795925|FG000|Overall Study|Withdrawal by Subject|2|||
105765940|NCT01280812|364795926|FG001|Overall Study|Withdrawal by Subject|1|||
105765941|NCT01280812|364795927|FG002|Overall Study|Withdrawal by Subject|0|||
105765942|NCT01280812|364795925|FG000|Overall Study|Lost to Follow-up|1|||
105765943|NCT01280812|364795926|FG001|Overall Study|Lost to Follow-up|1|||
105765944|NCT01280812|364795927|FG002|Overall Study|Lost to Follow-up|1|||
105765945|NCT04483544|364795928|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
105765946|NCT04483544|364795928|FG000|Post-Treatment|Admitted to hospice|2|||
105765947|NCT04483544|364795928|FG000|Post-Treatment|Study terminated|3|||
105765948|NCT01131078|364795931|FG000|Overall Study|Adverse Event|22|||
105765949|NCT01131078|364795932|FG001|Overall Study|Adverse Event|12|||
105765950|NCT01131078|364795933|FG002|Overall Study|Adverse Event|17|||
105765951|NCT01131078|364795931|FG000|Overall Study|Progressive Disease|58|||
105765952|NCT01131078|364795932|FG001|Overall Study|Progressive Disease|77|||
105765953|NCT01131078|364795933|FG002|Overall Study|Progressive Disease|71|||
105765954|NCT01131078|364795931|FG000|Overall Study|Protocol Violation|1|||
105765955|NCT01131078|364795932|FG001|Overall Study|Protocol Violation|0|||
105765956|NCT01131078|364795933|FG002|Overall Study|Protocol Violation|0|||
105765957|NCT01131078|364795931|FG000|Overall Study|Lost to Follow-up|1|||
105765958|NCT01131078|364795932|FG001|Overall Study|Lost to Follow-up|1|||
105765959|NCT01131078|364795933|FG002|Overall Study|Lost to Follow-up|1|||
105765960|NCT01131078|364795931|FG000|Overall Study|Withdrawal by Subject|2|||
105765961|NCT01131078|364795932|FG001|Overall Study|Withdrawal by Subject|4|||
105765962|NCT01131078|364795933|FG002|Overall Study|Withdrawal by Subject|3|||
105765963|NCT01131078|364795931|FG000|Overall Study|Non-compliance|3|||
105765964|NCT01131078|364795932|FG001|Overall Study|Non-compliance|0|||
105765965|NCT01131078|364795933|FG002|Overall Study|Non-compliance|0|||
105820005|NCT02032888|365000816|FG001|Follow-up Period|Other|0|||
105820006|NCT02032888|365000817|FG002|Follow-up Period|Other|0|||
105820007|NCT02445339|365000818|FG000|Overall Study|Physician Decision|1|||
105820008|NCT02445339|365000819|FG001|Overall Study|Physician Decision|0|||
105765966|NCT01131078|364795931|FG000|Overall Study|Physician Decision|10|||
105820009|NCT02445339|365000818|FG000|Overall Study|Lost to Follow-up|11|||
105820010|NCT02445339|365000819|FG001|Overall Study|Lost to Follow-up|15|||
105765967|NCT01131078|364795932|FG001|Overall Study|Physician Decision|6|||
105765968|NCT01131078|364795933|FG002|Overall Study|Physician Decision|8|||
105765969|NCT01131078|364795931|FG000|Overall Study|Death|4|||
105765970|NCT01131078|364795932|FG001|Overall Study|Death|0|||
105820011|NCT03161405|365000820|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
105765971|NCT01131078|364795933|FG002|Overall Study|Death|2|||
105765972|NCT01131078|364795931|FG000|Overall Study|Other|0|||
105765973|NCT01131078|364795932|FG001|Overall Study|Other|1|||
105820012|NCT02186821|365000821|FG000|Overall Study|Adverse Event|9|||
105820013|NCT02186821|365000821|FG000|Overall Study|Death|2|||
105820014|NCT02186821|365000821|FG000|Overall Study|Disease progression|32|||
105820015|NCT02186821|365000821|FG000|Overall Study|Protocol Violation|1|||
105820016|NCT02186821|365000821|FG000|Overall Study|Physician Decision|1|||
105820017|NCT02186821|365000821|FG000|Overall Study|Study terminated by sponsor|2|||
105820018|NCT02820350|365000822|FG000|Overall Study|Withdrawal by Subject|3|||
105820019|NCT02820350|365000822|FG000|Overall Study|Death|4|||
105820020|NCT03649477|365000823|FG000|Overall Study|Adverse Event|2|||
105820021|NCT03649477|365000824|FG001|Overall Study|Adverse Event|0|||
105820022|NCT03649477|365000825|FG002|Overall Study|Adverse Event|0|||
105820023|NCT00787254|365000826|FG000|Overall Study|Adverse Event|24|||
105820024|NCT00787254|365000827|FG001|Overall Study|Adverse Event|23|||
105820025|NCT00787254|365000826|FG000|Overall Study|Protocol Violation|26|||
105820026|NCT00787254|365000827|FG001|Overall Study|Protocol Violation|23|||
105820027|NCT00787254|365000826|FG000|Overall Study|Withdrawal by Subject|16|||
105820028|NCT00787254|365000827|FG001|Overall Study|Withdrawal by Subject|11|||
105820029|NCT00787254|365000826|FG000|Overall Study|Lack of Efficacy|4|||
105820030|NCT00787254|365000827|FG001|Overall Study|Lack of Efficacy|15|||
105820031|NCT00787254|365000826|FG000|Overall Study|NSAIDs discontinuation|1|||
105820032|NCT00787254|365000827|FG001|Overall Study|NSAIDs discontinuation|2|||
105820033|NCT00787254|365000826|FG000|Overall Study|Institution closed|1|||
105820034|NCT00787254|365000827|FG001|Overall Study|Institution closed|0|||
105820035|NCT00787254|365000826|FG000|Overall Study|Physician Decision|4|||
105820036|NCT00787254|365000827|FG001|Overall Study|Physician Decision|8|||
105820037|NCT00731783|365000835|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
105820038|NCT00731783|365000836|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
105820039|NCT00731783|365000835|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
105820040|NCT00731783|365000836|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
105820041|NCT00731783|365000835|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
105820042|NCT00731783|365000836|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
105820043|NCT00731783|365000835|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
105820044|NCT00731783|365000836|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
105820045|NCT00316186|365000840|FG000|Overall Study|Adverse Event|6|||
105820046|NCT00316186|365000840|FG000|Overall Study|Disease Progression|4|||
105820047|NCT00316186|365000840|FG000|Overall Study|Lost to Follow-up|1|||
105820048|NCT00316186|365000840|FG000|Overall Study|Other|1|||
105820049|NCT00859430|365000841|FG000|First Intervention|Withdrawal by Subject|0|||
105820050|NCT00859430|365000842|FG001|First Intervention|Withdrawal by Subject|1|||
105820051|NCT03235739|365002555|FG000|Overall Study|Withdrawal by Subject|2|||
105820052|NCT03235739|365002556|FG001|Overall Study|Withdrawal by Subject|2|||
105820053|NCT03235739|365002555|FG000|Overall Study|Physician Decision|0|||
105820054|NCT03235739|365002556|FG001|Overall Study|Physician Decision|1|||
105820055|NCT01066143|365002558|FG000|Overall Study|ineligible for the study|8|||
105820056|NCT02847650|365002559|FG000|Overall Study|Adverse Event|2|||
105820057|NCT02847650|365002560|FG001|Overall Study|Adverse Event|4|||
105820058|NCT02847650|365002559|FG000|Overall Study|Lost to Follow-up|1|||
105820059|NCT02847650|365002560|FG001|Overall Study|Lost to Follow-up|0|||
105820060|NCT02847650|365002559|FG000|Overall Study|Protocol Violation|0|||
105820061|NCT02847650|365002560|FG001|Overall Study|Protocol Violation|1|||
105820062|NCT02847650|365002559|FG000|Overall Study|Withdrawal by Subject|1|||
105820063|NCT02847650|365002560|FG001|Overall Study|Withdrawal by Subject|1|||
105820064|NCT03772522|365002561|FG000|Pre-intervention|Withdrawal by Subject|3|||
105820065|NCT03772522|365002562|FG001|Pre-intervention|Withdrawal by Subject|4|||
105820066|NCT03772522|365002561|FG000|Intervention|Withdrawal by Subject|1|||
105820067|NCT03772522|365002562|FG001|Intervention|Withdrawal by Subject|0|||
105820068|NCT03772522|365002561|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
105820069|NCT03772522|365002562|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
105820070|NCT05376319|365002563|FG000|Overall Study|Funding termination|2|||
105820071|NCT05376319|365002564|FG001|Overall Study|Funding termination|4|||
105820072|NCT00218257|365002567|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
105820073|NCT00218257|365002568|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
105820074|NCT00579345|365002569|FG000|Overall Study|Withdrawal by Subject|2|||
105820075|NCT00579345|365002570|FG001|Overall Study|Withdrawal by Subject|0|||
105820076|NCT00579345|365002571|FG002|Overall Study|Withdrawal by Subject|0|||
105820077|NCT00579345|365002572|FG003|Overall Study|Withdrawal by Subject|0|||
105820078|NCT00579345|365002573|FG004|Overall Study|Withdrawal by Subject|0|||
105820079|NCT00579345|365002574|FG005|Overall Study|Withdrawal by Subject|0|||
105820080|NCT00579345|365002575|FG006|Overall Study|Withdrawal by Subject|0|||
105820081|NCT00579345|365002576|FG007|Overall Study|Withdrawal by Subject|1|||
105362777|NCT03428100|363332623|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
105362778|NCT03428100|363332624|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
105820082|NCT00579345|365002569|FG000|Overall Study|Lost to Follow-up|1|||
105820083|NCT00579345|365002570|FG001|Overall Study|Lost to Follow-up|0|||
105820084|NCT00579345|365002571|FG002|Overall Study|Lost to Follow-up|0|||
105820085|NCT00579345|365002572|FG003|Overall Study|Lost to Follow-up|0|||
105820086|NCT00579345|365002573|FG004|Overall Study|Lost to Follow-up|0|||
105820087|NCT00579345|365002574|FG005|Overall Study|Lost to Follow-up|0|||
105820088|NCT00579345|365002575|FG006|Overall Study|Lost to Follow-up|0|||
105820089|NCT00579345|365002576|FG007|Overall Study|Lost to Follow-up|0|||
105820090|NCT00579345|365002569|FG000|Overall Study|Adverse Event|0|||
105820091|NCT00579345|365002570|FG001|Overall Study|Adverse Event|0|||
105820092|NCT00579345|365002571|FG002|Overall Study|Adverse Event|1|||
105820093|NCT00579345|365002572|FG003|Overall Study|Adverse Event|0|||
105820094|NCT00579345|365002573|FG004|Overall Study|Adverse Event|0|||
105820095|NCT00579345|365002574|FG005|Overall Study|Adverse Event|0|||
105820096|NCT00579345|365002575|FG006|Overall Study|Adverse Event|0|||
105820097|NCT00579345|365002576|FG007|Overall Study|Adverse Event|0|||
105820098|NCT00579345|365002569|FG000|Overall Study|Protocol Violation|1|||
105820099|NCT00579345|365002570|FG001|Overall Study|Protocol Violation|0|||
105820100|NCT00579345|365002571|FG002|Overall Study|Protocol Violation|0|||
105820101|NCT00579345|365002572|FG003|Overall Study|Protocol Violation|0|||
105820102|NCT00579345|365002573|FG004|Overall Study|Protocol Violation|0|||
105820103|NCT00579345|365002574|FG005|Overall Study|Protocol Violation|0|||
105820104|NCT00579345|365002575|FG006|Overall Study|Protocol Violation|0|||
105820105|NCT00579345|365002576|FG007|Overall Study|Protocol Violation|1|||
105820106|NCT00579345|365002569|FG000|Overall Study|Death|1|||
105820107|NCT00579345|365002570|FG001|Overall Study|Death|1|||
105820108|NCT00579345|365002571|FG002|Overall Study|Death|1|||
105820109|NCT00579345|365002572|FG003|Overall Study|Death|1|||
105820110|NCT00579345|365002573|FG004|Overall Study|Death|0|||
105820111|NCT00579345|365002574|FG005|Overall Study|Death|0|||
105820112|NCT00579345|365002575|FG006|Overall Study|Death|0|||
105820113|NCT00579345|365002576|FG007|Overall Study|Death|0|||
105820114|NCT01466166|365002577|FG000|Overall Study|Death|1|||
105820115|NCT01466166|365002577|FG000|Overall Study|Lost to Follow-up|7|||
105820116|NCT01466166|365002577|FG000|Overall Study|Infusion Reaction (IR)|27|||
105820117|NCT01466166|365002577|FG000|Overall Study|Adverse Event (Other than IR)|11|||
105820118|NCT01466166|365002577|FG000|Overall Study|Elevated Serum Uric Acid|78|||
105820119|NCT01466166|365002577|FG000|Overall Study|Withdrawal by Subject|13|||
105820120|NCT01466166|365002577|FG000|Overall Study|Sponsor Decision|4|||
105820121|NCT01466166|365002577|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
105820122|NCT01466166|365002577|FG000|Overall Study|Other|20|||
105820123|NCT02175095|365002580|FG000|Overall Study|Withdrawal by Subject|3|||
105820124|NCT01340495|365002581|FG000|Overall Study|Withdrawal by Subject|1|||
105820125|NCT00667862|365002582|FG000|Overall Study|Adverse Event|9|||
105820126|NCT00667862|365002582|FG000|Overall Study|Death|1|||
105820127|NCT00667862|365002582|FG000|Overall Study|Disease Progression|22|||
105820128|NCT00667862|365002582|FG000|Overall Study|Withdrawal by Subject|3|||
105820129|NCT01954394|365002585|FG000|Overall Study|Enrolled but not treated|1|||
105820130|NCT01954394|365002586|FG001|Overall Study|Enrolled but not treated|0|||
105820131|NCT01954394|365002585|FG000|Overall Study|Adverse Event|10|||
105820132|NCT01954394|365002586|FG001|Overall Study|Adverse Event|23|||
105820133|NCT01954394|365002585|FG000|Overall Study|Poor compliance to protocol|7|||
105820134|NCT01954394|365002586|FG001|Overall Study|Poor compliance to protocol|7|||
105820135|NCT01954394|365002585|FG000|Overall Study|Participant Moved|0|||
105820136|NCT01954394|365002586|FG001|Overall Study|Participant Moved|4|||
105820137|NCT01954394|365002585|FG000|Overall Study|Related to Study Drug administration|2|||
105820138|NCT01954394|365002586|FG001|Overall Study|Related to Study Drug administration|2|||
105820139|NCT01954394|365002585|FG000|Overall Study|Other than specified above|10|||
105820140|NCT01954394|365002586|FG001|Overall Study|Other than specified above|21|||
105820141|NCT05612724|365002588|FG000|Overall Study|Lost to Follow-up|4|||
105820142|NCT02128997|365002590|FG000|Overall Study|Lost to Follow-up|6|||
105820143|NCT02128997|365002591|FG001|Overall Study|Lost to Follow-up|11|||
105820144|NCT00239577|365002594|FG000|Primary Phase|Adverse Event|0|||
105820145|NCT00239577|365002595|FG001|Primary Phase|Adverse Event|0|||
105820146|NCT00239577|365002596|FG002|Primary Phase|Adverse Event|1|||
105820147|NCT00239577|365002597|FG003|Primary Phase|Adverse Event|0|||
105820148|NCT00239577|365002594|FG000|Primary Phase|Other|5|||
105820149|NCT00239577|365002595|FG001|Primary Phase|Other|3|||
105820150|NCT00239577|365002596|FG002|Primary Phase|Other|2|||
105820151|NCT00239577|365002597|FG003|Primary Phase|Other|0|||
105820152|NCT03988803|365002598|FG000|Period 2|Prematurely discontinued from medication|2|||
105362779|NCT03428100|363332625|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
105820153|NCT03988803|365002598|FG000|Period 2|Adverse Event|1|||
105820154|NCT03021018|365002601|FG000|Overall Study|Adverse Event|1|||
105820155|NCT03021018|365002602|FG001|Overall Study|Adverse Event|0|||
105820156|NCT03021018|365002603|FG002|Overall Study|Adverse Event|0|||
105820157|NCT03021018|365002601|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
105820158|NCT03021018|365002602|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
105765974|NCT01131078|364795933|FG002|Overall Study|Other|0|||
105765975|NCT00959894|364795936|FG000|Overall Study|Lost to Follow-up|10|||
105765976|NCT00959894|364795936|FG000|Overall Study|Adverse Event|3|||
105765977|NCT00959894|364795936|FG000|Overall Study|Withdrawal by Subject|1|||
105765978|NCT00959894|364795936|FG000|Overall Study|Need for contraindicated medication|1|||
105765979|NCT00959894|364795936|FG000|Overall Study|Subject moved out of town|1|||
105765980|NCT00922974|364795937|FG000|Phase II Component|Protocol Violation|2|||
105765981|NCT00922974|364795938|FG001|Phase II Component|Protocol Violation|0|||
105765982|NCT00922974|364795937|FG000|Phase II Component|Not evaluable for treatment review|5|||
105765983|NCT00922974|364795938|FG001|Phase II Component|Not evaluable for treatment review|0|||
105765984|NCT00922974|364795937|FG000|Phase III Component|Protocol Violation|8|||
105765985|NCT00922974|364795938|FG001|Phase III Component|Protocol Violation|6|||
105765986|NCT00653068|364795939|FG000|Overall Study|Death|9|||
105765987|NCT00653068|364795939|FG000|Overall Study|Lack of Efficacy|34|||
105765988|NCT00653068|364795939|FG000|Overall Study|Physician Decision|4|||
105765989|NCT00653068|364795939|FG000|Overall Study|Withdrawal by Subject|1|||
105765990|NCT00653068|364795939|FG000|Overall Study|Ineligible|2|||
105765991|NCT03950440|364795940|FG000|Overall Study|Death|8|||
105765992|NCT03950440|364795941|FG001|Overall Study|Death|2|||
105765993|NCT03950440|364795942|FG002|Overall Study|Death|1|||
105765994|NCT02043509|364795943|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
105765995|NCT02043509|364795944|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
105765996|NCT02043509|364795943|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
105765997|NCT02043509|364795944|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
105765998|NCT02043509|364795943|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
105765999|NCT02043509|364795944|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
105766000|NCT02043509|364795943|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
105766001|NCT02043509|364795944|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
105766002|NCT00608244|364795945|FG000|Overall Study|Adverse Event|1|||
105766003|NCT00608244|364795945|FG000|Overall Study|Low trough levels|1|||
105766004|NCT01957215|364795950|FG000|Overall Study|Adverse Event|2|||
105766005|NCT01957215|364795951|FG001|Overall Study|Adverse Event|2|||
105766006|NCT01957215|364795950|FG000|Overall Study|Lost to Follow-up|3|||
105766007|NCT01957215|364795951|FG001|Overall Study|Lost to Follow-up|3|||
105766008|NCT01957215|364795950|FG000|Overall Study|Protocol Violation|1|||
105766009|NCT01957215|364795951|FG001|Overall Study|Protocol Violation|2|||
105766010|NCT01957215|364795950|FG000|Overall Study|Withdrawal by Subject|7|||
105766011|NCT01957215|364795951|FG001|Overall Study|Withdrawal by Subject|5|||
105766012|NCT03597503|364795952|FG000|Overall Study|Withdrawal by Subject|0|||
105766013|NCT03597503|364795953|FG001|Overall Study|Withdrawal by Subject|2|||
105766014|NCT03597503|364795952|FG000|Overall Study|Lost to Follow-up|1|||
105766015|NCT03597503|364795953|FG001|Overall Study|Lost to Follow-up|2|||
105766016|NCT03597503|364795952|FG000|Overall Study|Protocol Violation|1|||
105766017|NCT03597503|364795953|FG001|Overall Study|Protocol Violation|0|||
105766018|NCT00323310|364795954|FG000|Overall Study|Withdrawal by Subject|1|||
105766019|NCT00323310|364795954|FG000|Overall Study|a parent refused blood draw|1|||
105766020|NCT00323310|364795954|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
105766021|NCT02443155|364795962|FG000|Overall Study|Adverse Event|3|||
105766022|NCT02443155|364795963|FG001|Overall Study|Adverse Event|4|||
105766023|NCT02443155|364795964|FG002|Overall Study|Adverse Event|1|||
105766024|NCT02443155|364795965|FG003|Overall Study|Adverse Event|2|||
105766025|NCT02443155|364795962|FG000|Overall Study|Unclassified|0|||
105766026|NCT02443155|364795963|FG001|Overall Study|Unclassified|0|||
105766027|NCT02443155|364795964|FG002|Overall Study|Unclassified|2|||
105766028|NCT02443155|364795965|FG003|Overall Study|Unclassified|1|||
105766029|NCT02443155|364795962|FG000|Overall Study|Withdrawal by Subject|4|||
105766030|NCT02443155|364795963|FG001|Overall Study|Withdrawal by Subject|7|||
105766031|NCT02443155|364795964|FG002|Overall Study|Withdrawal by Subject|3|||
105766032|NCT02443155|364795965|FG003|Overall Study|Withdrawal by Subject|9|||
105766033|NCT02443155|364795962|FG000|Overall Study|Pregnancy|3|||
105766034|NCT02443155|364795963|FG001|Overall Study|Pregnancy|1|||
105766035|NCT02443155|364795964|FG002|Overall Study|Pregnancy|1|||
105766036|NCT02443155|364795965|FG003|Overall Study|Pregnancy|2|||
105766037|NCT02443155|364795962|FG000|Overall Study|Lost to Follow-up|1|||
105766038|NCT02443155|364795963|FG001|Overall Study|Lost to Follow-up|2|||
105766039|NCT02443155|364795964|FG002|Overall Study|Lost to Follow-up|0|||
105766040|NCT02443155|364795965|FG003|Overall Study|Lost to Follow-up|1|||
105766041|NCT02443155|364795962|FG000|Overall Study|Protocol Violation|1|||
105766042|NCT02443155|364795963|FG001|Overall Study|Protocol Violation|0|||
105766043|NCT02443155|364795964|FG002|Overall Study|Protocol Violation|1|||
105766044|NCT02443155|364795965|FG003|Overall Study|Protocol Violation|1|||
105766045|NCT02443155|364795962|FG000|Overall Study|Death|0|||
105766046|NCT02443155|364795963|FG001|Overall Study|Death|0|||
105766047|NCT02443155|364795964|FG002|Overall Study|Death|1|||
105766048|NCT02443155|364795965|FG003|Overall Study|Death|0|||
105766049|NCT00405275|364795967|FG000|Overall Study|Death|1|||
105766050|NCT00405275|364795968|FG001|Overall Study|Death|0|||
105766051|NCT00405275|364795967|FG000|Overall Study|Lost to Follow-up|5|||
105766052|NCT00405275|364795968|FG001|Overall Study|Lost to Follow-up|1|||
105820159|NCT03021018|365002603|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
105820160|NCT01439880|365002613|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
105820161|NCT01439880|365002614|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
105820162|NCT01439880|365002613|FG000|SOC-controlled Period (Year 1)|Death|2|||
105820163|NCT01439880|365002614|FG001|SOC-controlled Period (Year 1)|Death|1|||
105820164|NCT01439880|365002613|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
105820165|NCT01439880|365002614|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
105820166|NCT01439880|365002613|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
105820167|NCT01439880|365002614|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
105820168|NCT01439880|365002613|FG000|SOC-controlled Period (Year 1)|Other|8|||
105820169|NCT01439880|365002614|FG001|SOC-controlled Period (Year 1)|Other|13|||
105820170|NCT01439880|365002613|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
105820171|NCT01439880|365002614|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
105820172|NCT01439880|365002613|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
105820173|NCT01439880|365002614|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
105820174|NCT01439880|365002613|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
105820175|NCT01439880|365002614|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
105820176|NCT01439880|365002613|FG000|All-IP Period (Years 2 to 5)|Death|3|||
105820177|NCT01439880|365002614|FG001|All-IP Period (Years 2 to 5)|Death|13|||
105820178|NCT01439880|365002613|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
105820179|NCT01439880|365002614|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
105820180|NCT01439880|365002613|FG000|All-IP Period (Years 2 to 5)|Other|14|||
105820181|NCT01439880|365002614|FG001|All-IP Period (Years 2 to 5)|Other|31|||
105820182|NCT01439880|365002613|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
105820183|NCT01439880|365002614|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
105820184|NCT02956460|365002617|FG000|Lens 1|Lost to Follow-up|1|||
105820185|NCT02956460|365002618|FG001|Lens 1|Lost to Follow-up|0|||
105820186|NCT00834249|365002619|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
105820187|NCT00834249|365002620|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
105820188|NCT00834249|365002619|FG000|Second Intervention|Adverse Event|1|||
105820189|NCT00834249|365002620|FG001|Second Intervention|Adverse Event|0|||
105820190|NCT00851877|365002621|FG000|Phase I-1|Death|1|||
105820191|NCT00851877|365002622|FG001|Phase I-1|Death|0|||
105820192|NCT00851877|365002623|FG002|Phase I-1|Death|0|||
105820193|NCT00851877|365002621|FG000|Phase II|Withdrawal by Subject|0|||
105820194|NCT00851877|365002622|FG001|Phase II|Withdrawal by Subject|0|||
105820195|NCT00851877|365002623|FG002|Phase II|Withdrawal by Subject|3|||
105820196|NCT00834067|365002626|FG000|Washout of 21 Days|Protocol Violation|0|||
105820197|NCT00834067|365002627|FG001|Washout of 21 Days|Protocol Violation|1|||
105820198|NCT01247701|365002628|FG000|Overall Study|Death|2|||
105820199|NCT01247701|365002628|FG000|Overall Study|Relapsed|8|||
105820200|NCT04166630|365002629|FG000|Overall Study|Withdrawal by Subject|0|||
105820201|NCT04166630|365002630|FG001|Overall Study|Withdrawal by Subject|1|||
105820202|NCT00272779|365002631|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
105820203|NCT00272779|365002632|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
105820204|NCT00272779|365002631|FG000|Baseline Through Week 48|Death before Week 48|4|||
105820205|NCT00272779|365002632|FG001|Baseline Through Week 48|Death before Week 48|4|||
105820206|NCT00272779|365002631|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
105820207|NCT00272779|365002632|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
105820208|NCT00272779|365002631|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
105820209|NCT00272779|365002632|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
105820210|NCT00272779|365002631|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
105820211|NCT00272779|365002632|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
105820212|NCT00272779|365002631|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
105820213|NCT00272779|365002632|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
105820214|NCT00272779|365002631|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
105820215|NCT00272779|365002632|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
105820216|NCT00272779|365002631|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
105820217|NCT00272779|365002632|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
105820218|NCT00272779|365002631|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
105820219|NCT00272779|365002632|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
105820220|NCT00272779|365002631|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
105820221|NCT00272779|365002632|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
105820222|NCT00272779|365002631|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
105820223|NCT00272779|365002632|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
105820224|NCT00272779|365002631|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
105820225|NCT00272779|365002632|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
105820226|NCT00272779|365002631|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
105820227|NCT00272779|365002632|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
105362780|NCT03428100|363332626|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
105820228|NCT00272779|365002631|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
105820229|NCT00272779|365002632|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
105820230|NCT00272779|365002631|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
105820231|NCT00272779|365002632|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
105820232|NCT00272779|365002631|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
105820233|NCT00272779|365002632|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
105820234|NCT00272779|365002631|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
105820235|NCT00272779|365002632|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
105820236|NCT00272779|365002631|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
105820237|NCT00272779|365002632|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
105820238|NCT00272779|365002631|FG000|Baseline Through Week 48|Continuing treatment|385|||
105820239|NCT00272779|365002632|FG001|Baseline Through Week 48|Continuing treatment|368|||
105820240|NCT00272779|365002631|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
105820241|NCT00272779|365002632|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
105820242|NCT00272779|365002631|FG000|Baseline Through Week 48|Never treated|2|||
105820243|NCT00272779|365002632|FG001|Baseline Through Week 48|Never treated|3|||
105820244|NCT00272779|365002631|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
105820245|NCT00272779|365002632|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
105820246|NCT00272779|365002631|FG000|Baseline Through Week 96|Death before Week 96|6|||
105820247|NCT00272779|365002632|FG001|Baseline Through Week 96|Death before Week 96|5|||
105820248|NCT00272779|365002631|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
105820249|NCT00272779|365002632|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
105820250|NCT00272779|365002631|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
105820251|NCT00272779|365002632|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
105820252|NCT00272779|365002631|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
105820253|NCT00272779|365002632|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
105820254|NCT00272779|365002631|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
105820255|NCT00272779|365002632|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
105820256|NCT00272779|365002631|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
105820257|NCT00272779|365002632|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
105820258|NCT00272779|365002631|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
105820259|NCT00272779|365002632|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
105820260|NCT00272779|365002631|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
105820261|NCT00272779|365002632|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
105820262|NCT00272779|365002631|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
105820263|NCT00272779|365002632|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
105820264|NCT00272779|365002631|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
105820265|NCT00272779|365002632|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
105820266|NCT00272779|365002631|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
105820267|NCT00272779|365002632|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
105820268|NCT00272779|365002631|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
105820269|NCT00272779|365002632|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
105820270|NCT00272779|365002631|FG000|Baseline Through Week 96|Never treated|2|||
105820271|NCT00272779|365002632|FG001|Baseline Through Week 96|Never treated|3|||
105820272|NCT00272779|365002631|FG000|Baseline Through Week 96|Continuing on treatment|61|||
105820273|NCT00272779|365002632|FG001|Baseline Through Week 96|Continuing on treatment|38|||
105820274|NCT00561015|365002633|FG000|Overall Study|Adverse Event|0|||
105820275|NCT00561015|365002634|FG001|Overall Study|Adverse Event|0|||
105820276|NCT00561015|365002635|FG002|Overall Study|Adverse Event|0|||
105820277|NCT00561015|365002636|FG003|Overall Study|Adverse Event|0|||
105820278|NCT00561015|365002637|FG004|Overall Study|Adverse Event|1|||
105820279|NCT00561015|365002638|FG005|Overall Study|Adverse Event|0|||
105820280|NCT00561015|365002633|FG000|Overall Study|Lost to Follow-up|2|||
105820281|NCT00561015|365002634|FG001|Overall Study|Lost to Follow-up|0|||
105820282|NCT00561015|365002635|FG002|Overall Study|Lost to Follow-up|0|||
105820283|NCT00561015|365002636|FG003|Overall Study|Lost to Follow-up|1|||
105820284|NCT00561015|365002637|FG004|Overall Study|Lost to Follow-up|0|||
105820285|NCT00561015|365002638|FG005|Overall Study|Lost to Follow-up|3|||
105820286|NCT00561015|365002633|FG000|Overall Study|Participant non-compliance|2|||
105820287|NCT00561015|365002634|FG001|Overall Study|Participant non-compliance|0|||
105362781|NCT03428100|363332627|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
105486334|NCT02380690|363791482|FG001|Overall Study|Lost to Follow-up|4|||
105820288|NCT00561015|365002635|FG002|Overall Study|Participant non-compliance|0|||
105820289|NCT00561015|365002636|FG003|Overall Study|Participant non-compliance|0|||
105820290|NCT00561015|365002637|FG004|Overall Study|Participant non-compliance|0|||
105820291|NCT00561015|365002638|FG005|Overall Study|Participant non-compliance|0|||
105820292|NCT00096447|365002641|FG000|Overall Study|Never treated|1|||
105820293|NCT00163657|365002642|FG000|Overall Study|Death|12|||
105820294|NCT00163657|365002643|FG001|Overall Study|Death|14|||
105820295|NCT00163657|365002644|FG002|Overall Study|Death|19|||
105820296|NCT00163657|365002642|FG000|Overall Study|graft loss|4|||
105820297|NCT00163657|365002643|FG001|Overall Study|graft loss|1|||
105820298|NCT00163657|365002644|FG002|Overall Study|graft loss|2|||
105820299|NCT00163657|365002642|FG000|Overall Study|Withdrawal by Subject|2|||
105820300|NCT00163657|365002643|FG001|Overall Study|Withdrawal by Subject|3|||
105820301|NCT00163657|365002644|FG002|Overall Study|Withdrawal by Subject|2|||
105820302|NCT00163657|365002642|FG000|Overall Study|Physician Decision|0|||
105820303|NCT00163657|365002643|FG001|Overall Study|Physician Decision|1|||
105820304|NCT00163657|365002644|FG002|Overall Study|Physician Decision|1|||
105820305|NCT00163657|365002642|FG000|Overall Study|Non Compliance|1|||
105820306|NCT00163657|365002643|FG001|Overall Study|Non Compliance|0|||
105820307|NCT00163657|365002644|FG002|Overall Study|Non Compliance|0|||
105820308|NCT00163657|365002642|FG000|Overall Study|Lost to Follow-up|1|||
105820309|NCT00163657|365002643|FG001|Overall Study|Lost to Follow-up|3|||
105820310|NCT00163657|365002644|FG002|Overall Study|Lost to Follow-up|10|||
105820311|NCT00163657|365002642|FG000|Overall Study|Other reason|0|||
105820312|NCT00163657|365002643|FG001|Overall Study|Other reason|1|||
105820313|NCT00163657|365002644|FG002|Overall Study|Other reason|3|||
105820314|NCT03214952|365002647|FG000|Overall Study|Protocol Deviation|45|||
105820315|NCT03214952|365002647|FG000|Overall Study|Case Report Forms Uncollected|13|||
105820316|NCT03769896|365002648|FG000|Open-label Phase|Lack of Efficacy|5|||
105820317|NCT03769896|365002649|FG001|Open-label Phase|Lack of Efficacy|0|||
105820318|NCT03769896|365002648|FG000|Open-label Phase|Adverse Event|3|||
105820319|NCT03769896|365002649|FG001|Open-label Phase|Adverse Event|0|||
105820320|NCT03769896|365002648|FG000|Open-label Phase|Withdrawal by Subject|1|||
105820321|NCT03769896|365002649|FG001|Open-label Phase|Withdrawal by Subject|0|||
105820322|NCT02300103|365002657|FG000|Overall Study|Lack of Efficacy|3|||
105820323|NCT02300103|365002657|FG000|Overall Study|Protocol Violation|1|||
105820324|NCT02300103|365002657|FG000|Overall Study|Withdrew Consent|2|||
105820325|NCT01015625|365002658|FG000|Overall Study|Lost to Follow-up|3|||
105820326|NCT01015625|365002659|FG001|Overall Study|Lost to Follow-up|1|||
105820327|NCT01015625|365002658|FG000|Overall Study|Withdrawal by Subject|2|||
105820328|NCT01015625|365002659|FG001|Overall Study|Withdrawal by Subject|3|||
105820329|NCT01015625|365002658|FG000|Overall Study|Physician Decision|2|||
105820330|NCT01015625|365002659|FG001|Overall Study|Physician Decision|0|||
105820331|NCT01015625|365002658|FG000|Overall Study|Death|30|||
105820332|NCT01015625|365002659|FG001|Overall Study|Death|22|||
105820333|NCT04112823|365002660|FG000|Overall Study|Lost to Follow-up|2|||
105820334|NCT04112823|365002661|FG001|Overall Study|Lost to Follow-up|3|||
105820335|NCT02682784|365002664|FG000|Overall Study|Withdrawal by Subject|0|||
105820336|NCT02682784|365002665|FG001|Overall Study|Withdrawal by Subject|2|||
105820337|NCT02682784|365002666|FG002|Overall Study|Withdrawal by Subject|1|||
105820338|NCT02682784|365002667|FG003|Overall Study|Withdrawal by Subject|2|||
105820339|NCT02682784|365002664|FG000|Overall Study|Physician Decision|1|||
105820340|NCT02682784|365002665|FG001|Overall Study|Physician Decision|0|||
105820341|NCT02682784|365002666|FG002|Overall Study|Physician Decision|1|||
105486335|NCT02380690|363791481|FG000|Overall Study|Withdrawal by Subject|20|||
105486336|NCT02380690|363791482|FG001|Overall Study|Withdrawal by Subject|8|||
105486337|NCT01958827|363791483|FG000|Overall Study|Adverse Event|3|||
105486338|NCT01958827|363791483|FG000|Overall Study|Lack of Efficacy|6|||
105766053|NCT00405275|364795967|FG000|Overall Study|Withdrawal by Subject|7|||
105766054|NCT00405275|364795968|FG001|Overall Study|Withdrawal by Subject|9|||
105766055|NCT00405275|364795967|FG000|Overall Study|Unwilling to continue|10|||
105766056|NCT00405275|364795968|FG001|Overall Study|Unwilling to continue|9|||
105766057|NCT01376388|364795972|FG000|Overall Study|Adverse Event|13|||
105766058|NCT01376388|364795972|FG000|Overall Study|Lack of Efficacy|2|||
105766059|NCT01376388|364795972|FG000|Overall Study|Withdrawal by Subject|3|||
105766060|NCT00136357|364795984|FG000|Overall Study|Withdrawal by Subject|3|||
105766061|NCT00136357|364795985|FG001|Overall Study|Withdrawal by Subject|2|||
105766062|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
105766063|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
105766064|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
105766065|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
105766066|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
105766067|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
105766068|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
105766069|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
105766070|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
105766071|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
105766072|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
105766073|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
105766074|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
105766075|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
105820342|NCT02682784|365002667|FG003|Overall Study|Physician Decision|1|||
105820343|NCT00467363|365002668|FG000|Overall Study|Lost to Follow-up|80|||
105820344|NCT00467363|365002669|FG001|Overall Study|Lost to Follow-up|70|||
105820345|NCT01401647|365002673|FG000|Overall Study|Withdrawal by Subject|1|||
105820346|NCT01401647|365002674|FG001|Overall Study|Withdrawal by Subject|5|||
105820347|NCT01401647|365002675|FG002|Overall Study|Withdrawal by Subject|2|||
105820348|NCT01401647|365002673|FG000|Overall Study|Lost to Follow-up|3|||
105820349|NCT01401647|365002674|FG001|Overall Study|Lost to Follow-up|3|||
105820350|NCT01401647|365002675|FG002|Overall Study|Lost to Follow-up|1|||
105820351|NCT01527006|365002679|FG000|Core Study|Adverse Event|0|||
105820352|NCT01527006|365002680|FG001|Core Study|Adverse Event|2|||
105820353|NCT01527006|365002679|FG000|Core Study|Lost to Follow-up|0|||
105820354|NCT01527006|365002680|FG001|Core Study|Lost to Follow-up|1|||
105820355|NCT01527006|365002679|FG000|Core Study|Subject Choice|1|||
105820356|NCT01527006|365002680|FG001|Core Study|Subject Choice|0|||
105820357|NCT01527006|365002679|FG000|Core Study|Inadequate Therapeutic Effect|1|||
105820358|NCT01527006|365002680|FG001|Core Study|Inadequate Therapeutic Effect|0|||
105820359|NCT01527006|365002679|FG000|Core Study|Withdrawal by Subject|0|||
105820360|NCT01527006|365002680|FG001|Core Study|Withdrawal by Subject|1|||
105820361|NCT01527006|365002679|FG000|Core Study|Other|0|||
105820362|NCT01527006|365002680|FG001|Core Study|Other|2|||
105820363|NCT01527006|365002679|FG000|Extension Phase|Adverse Event|4|||
105820364|NCT01527006|365002680|FG001|Extension Phase|Adverse Event|2|||
105820365|NCT01527006|365002679|FG000|Extension Phase|Lost to Follow-up|0|||
105820366|NCT01527006|365002680|FG001|Extension Phase|Lost to Follow-up|1|||
105820367|NCT01527006|365002679|FG000|Extension Phase|Subject Choice|1|||
105820368|NCT01527006|365002680|FG001|Extension Phase|Subject Choice|1|||
105820369|NCT01527006|365002679|FG000|Extension Phase|Inadequate therapeutic effect|1|||
105820370|NCT01527006|365002680|FG001|Extension Phase|Inadequate therapeutic effect|1|||
105820371|NCT01527006|365002679|FG000|Extension Phase|Other|0|||
105820372|NCT01527006|365002680|FG001|Extension Phase|Other|3|||
105820373|NCT00904215|365002681|FG000|Overall Study|Adverse Event|25|||
105820374|NCT00904215|365002681|FG000|Overall Study|Protocol Violation|10|||
105820375|NCT00904215|365002681|FG000|Overall Study|Lost to Follow-up|63|||
105820376|NCT00904215|365002681|FG000|Overall Study|Withdrawal by Subject|9|||
105820377|NCT00904215|365002681|FG000|Overall Study|Other|28|||
105820378|NCT00838630|365002683|FG000|First Intervention|Adverse Event|1|||
105820379|NCT00838630|365002684|FG001|First Intervention|Adverse Event|0|||
105820380|NCT00838630|365002683|FG000|Washout: 7 Days|Protocol Violation|1|||
105820381|NCT00838630|365002684|FG001|Washout: 7 Days|Protocol Violation|0|||
105820382|NCT02159183|365002693|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
105820383|NCT02159183|365002694|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
105820384|NCT02159183|365002693|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
105820385|NCT02159183|365002694|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
105820386|NCT02159183|365002693|FG000|Analysis After the 36 Months Follow-up|Death|0|||
105820387|NCT02159183|365002694|FG001|Analysis After the 36 Months Follow-up|Death|1|||
105820388|NCT02159183|365002693|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
105820389|NCT02159183|365002694|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
105820390|NCT02159183|365002693|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
105820391|NCT02159183|365002694|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
105820392|NCT03017885|365002695|FG000|Overall Study|Adverse Event|2|||
105820393|NCT03017885|365002696|FG001|Overall Study|Adverse Event|0|||
105820394|NCT03017885|365002697|FG002|Overall Study|Adverse Event|0|||
105820395|NCT03017885|365002698|FG003|Overall Study|Adverse Event|0|||
105820396|NCT03017885|365002699|FG004|Overall Study|Adverse Event|0|||
105820397|NCT03017885|365002700|FG005|Overall Study|Adverse Event|0|||
105820398|NCT03017885|365002695|FG000|Overall Study|Progression of disease|4|||
105820399|NCT03017885|365002696|FG001|Overall Study|Progression of disease|3|||
105820400|NCT03017885|365002697|FG002|Overall Study|Progression of disease|4|||
105820401|NCT03017885|365002698|FG003|Overall Study|Progression of disease|0|||
105820402|NCT03017885|365002699|FG004|Overall Study|Progression of disease|0|||
105820403|NCT03017885|365002700|FG005|Overall Study|Progression of disease|0|||
105820404|NCT03017885|365002695|FG000|Overall Study|Other than listed|1|||
105820405|NCT03017885|365002696|FG001|Overall Study|Other than listed|2|||
105820406|NCT03017885|365002697|FG002|Overall Study|Other than listed|1|||
105820407|NCT03017885|365002698|FG003|Overall Study|Other than listed|0|||
105820408|NCT03017885|365002699|FG004|Overall Study|Other than listed|0|||
105820409|NCT03017885|365002700|FG005|Overall Study|Other than listed|0|||
105820410|NCT03017885|365002695|FG000|Overall Study|Lost to Follow-up|2|||
105820411|NCT03017885|365002696|FG001|Overall Study|Lost to Follow-up|0|||
105820412|NCT03017885|365002697|FG002|Overall Study|Lost to Follow-up|3|||
105820413|NCT03017885|365002698|FG003|Overall Study|Lost to Follow-up|0|||
105820414|NCT03017885|365002699|FG004|Overall Study|Lost to Follow-up|0|||
105820415|NCT03017885|365002700|FG005|Overall Study|Lost to Follow-up|0|||
105820416|NCT03017885|365002695|FG000|Overall Study|Change to other anti-cancer therapy|0|||
105820417|NCT03017885|365002696|FG001|Overall Study|Change to other anti-cancer therapy|0|||
105820418|NCT03017885|365002697|FG002|Overall Study|Change to other anti-cancer therapy|1|||
105820419|NCT03017885|365002698|FG003|Overall Study|Change to other anti-cancer therapy|0|||
105820420|NCT03017885|365002699|FG004|Overall Study|Change to other anti-cancer therapy|0|||
105820421|NCT03017885|365002700|FG005|Overall Study|Change to other anti-cancer therapy|0|||
105820422|NCT00723710|365002705|FG000|Overall Study|Disease progression|48|||
105820423|NCT00723710|365002705|FG000|Overall Study|Adverse Event|88|||
105820424|NCT00723710|365002705|FG000|Overall Study|Withdrawal by Subject|36|||
105820425|NCT00723710|365002705|FG000|Overall Study|Physician Decision|2|||
105820426|NCT04405570|365002706|FG000|Overall Study|Adverse Event|0|||
105820427|NCT04405570|365002707|FG001|Overall Study|Adverse Event|1|||
105820428|NCT04405570|365002708|FG002|Overall Study|Adverse Event|1|||
105820429|NCT04405570|365002709|FG003|Overall Study|Adverse Event|1|||
105820430|NCT04405570|365002706|FG000|Overall Study|Lost to Follow-up|0|||
105820431|NCT04405570|365002707|FG001|Overall Study|Lost to Follow-up|1|||
105820432|NCT04405570|365002708|FG002|Overall Study|Lost to Follow-up|0|||
105820433|NCT04405570|365002709|FG003|Overall Study|Lost to Follow-up|0|||
105820434|NCT04405570|365002706|FG000|Overall Study|Physician Decision|0|||
105820435|NCT04405570|365002707|FG001|Overall Study|Physician Decision|0|||
105820436|NCT04405570|365002708|FG002|Overall Study|Physician Decision|1|||
105820437|NCT04405570|365002709|FG003|Overall Study|Physician Decision|0|||
105820438|NCT04405570|365002706|FG000|Overall Study|Withdrawal by Subject|0|||
105820439|NCT04405570|365002707|FG001|Overall Study|Withdrawal by Subject|1|||
105820440|NCT04405570|365002708|FG002|Overall Study|Withdrawal by Subject|1|||
105820441|NCT04405570|365002709|FG003|Overall Study|Withdrawal by Subject|0|||
105820442|NCT04405570|365002706|FG000|Overall Study|Randomized not dosed|0|||
105820443|NCT04405570|365002707|FG001|Overall Study|Randomized not dosed|2|||
105820444|NCT04405570|365002708|FG002|Overall Study|Randomized not dosed|0|||
105820445|NCT04405570|365002709|FG003|Overall Study|Randomized not dosed|0|||
105820446|NCT00858845|365002711|FG000|Overall Study|Patient underwent heart transplant.|0|||
105820447|NCT00858845|365002712|FG001|Overall Study|Patient underwent heart transplant.|1|||
105820448|NCT03880266|365002714|FG000|Overall Study|Withdrawal by Subject|0|||
105820449|NCT03880266|365002715|FG001|Overall Study|Withdrawal by Subject|1|||
105820450|NCT03880266|365002716|FG002|Overall Study|Withdrawal by Subject|1|||
105820451|NCT03880266|365002717|FG003|Overall Study|Withdrawal by Subject|0|||
105820452|NCT03880266|365002718|FG004|Overall Study|Withdrawal by Subject|0|||
105820453|NCT03880266|365002719|FG005|Overall Study|Withdrawal by Subject|0|||
105820454|NCT03880266|365002720|FG006|Overall Study|Withdrawal by Subject|0|||
105820455|NCT03880266|365002721|FG007|Overall Study|Withdrawal by Subject|0|||
105820456|NCT01796171|365004368|FG000|Enrolled|Death|0|||
105820457|NCT01796171|365004369|FG001|Enrolled|Death|0|||
105820458|NCT01796171|365004370|FG002|Enrolled|Death|0|||
105820459|NCT01796171|365004371|FG003|Enrolled|Death|0|||
105820460|NCT01796171|365004372|FG004|Enrolled|Death|0|||
105820461|NCT01796171|365004373|FG005|Enrolled|Death|0|||
105820462|NCT01796171|365004374|FG006|Enrolled|Death|0|||
105820463|NCT01796171|365004375|FG007|Enrolled|Death|0|||
105820464|NCT01796171|365004376|FG008|Enrolled|Death|0|||
105820465|NCT01796171|365004377|FG009|Enrolled|Death|0|||
105820466|NCT01796171|365004378|FG010|Enrolled|Death|0|||
105820467|NCT01796171|365004379|FG011|Enrolled|Death|0|||
105820468|NCT01796171|365004380|FG012|Enrolled|Death|0|||
105820469|NCT01796171|365004381|FG013|Enrolled|Death|0|||
105820470|NCT01796171|365004382|FG014|Enrolled|Death|1|||
105820471|NCT01796171|365004368|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
105820472|NCT01796171|365004369|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
105820473|NCT01796171|365004370|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
105820474|NCT01796171|365004371|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
105820475|NCT01796171|365004372|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
105766076|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
105766077|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
105766078|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
105766079|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
105766080|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
105766081|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
105766082|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
105766083|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
105766084|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
105766085|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
105766086|NCT01001572|364795989|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
105766087|NCT01001572|364795990|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
105766088|NCT01001572|364795991|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
105820476|NCT01796171|365004373|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
105820477|NCT01796171|365004374|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
105820478|NCT01796171|365004375|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
105820479|NCT01796171|365004376|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
105820480|NCT01796171|365004377|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
105820481|NCT01796171|365004378|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
105820482|NCT01796171|365004379|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
105820483|NCT01796171|365004380|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
105820484|NCT01796171|365004381|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
105820485|NCT01796171|365004382|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
105820486|NCT01796171|365004368|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820487|NCT01796171|365004369|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820488|NCT01796171|365004370|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820489|NCT01796171|365004371|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820490|NCT01796171|365004372|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820491|NCT01796171|365004373|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820492|NCT01796171|365004374|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820493|NCT01796171|365004375|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820494|NCT01796171|365004376|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820495|NCT01796171|365004377|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820496|NCT01796171|365004378|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820497|NCT01796171|365004379|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820498|NCT01796171|365004380|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820499|NCT01796171|365004381|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
105820500|NCT01796171|365004382|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820501|NCT01796171|365004368|FG000|Treatment Period With Betalutin|Progressive disease|0|||
105820502|NCT01796171|365004369|FG001|Treatment Period With Betalutin|Progressive disease|1|||
105820503|NCT01796171|365004370|FG002|Treatment Period With Betalutin|Progressive disease|0|||
105820504|NCT01796171|365004371|FG003|Treatment Period With Betalutin|Progressive disease|0|||
105820505|NCT01796171|365004372|FG004|Treatment Period With Betalutin|Progressive disease|0|||
105820506|NCT01796171|365004373|FG005|Treatment Period With Betalutin|Progressive disease|0|||
105820507|NCT01796171|365004374|FG006|Treatment Period With Betalutin|Progressive disease|0|||
105820508|NCT01796171|365004375|FG007|Treatment Period With Betalutin|Progressive disease|0|||
105820509|NCT01796171|365004376|FG008|Treatment Period With Betalutin|Progressive disease|0|||
105820510|NCT01796171|365004377|FG009|Treatment Period With Betalutin|Progressive disease|0|||
105820511|NCT01796171|365004378|FG010|Treatment Period With Betalutin|Progressive disease|0|||
105820512|NCT01796171|365004379|FG011|Treatment Period With Betalutin|Progressive disease|0|||
105820513|NCT01796171|365004380|FG012|Treatment Period With Betalutin|Progressive disease|0|||
105820514|NCT01796171|365004381|FG013|Treatment Period With Betalutin|Progressive disease|0|||
105820515|NCT01796171|365004382|FG014|Treatment Period With Betalutin|Progressive disease|0|||
105820516|NCT01796171|365004368|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820517|NCT01796171|365004369|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105362782|NCT03428100|363332628|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
105820518|NCT01796171|365004370|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820519|NCT01796171|365004371|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820520|NCT01796171|365004372|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820521|NCT01796171|365004373|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820522|NCT01796171|365004374|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820523|NCT01796171|365004375|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820524|NCT01796171|365004376|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
105820525|NCT01796171|365004377|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820526|NCT01796171|365004378|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
105820527|NCT01796171|365004379|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
105820528|NCT01796171|365004380|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820529|NCT01796171|365004381|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820530|NCT01796171|365004382|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820531|NCT01796171|365004368|FG000|Treatment Period With Betalutin|Physician Decision|0|||
105820532|NCT01796171|365004369|FG001|Treatment Period With Betalutin|Physician Decision|0|||
105820533|NCT01796171|365004370|FG002|Treatment Period With Betalutin|Physician Decision|0|||
105820534|NCT01796171|365004371|FG003|Treatment Period With Betalutin|Physician Decision|0|||
105362783|NCT03428100|363332629|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
105362784|NCT03428100|363332630|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
105362785|NCT03428100|363332631|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
105362786|NCT03428100|363332632|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
105766089|NCT01001572|364795989|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
105766090|NCT01001572|364795990|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
105766091|NCT01001572|364795991|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
105766092|NCT01001572|364795989|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
105766093|NCT01001572|364795990|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
105766094|NCT01001572|364795991|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
105820535|NCT01796171|365004372|FG004|Treatment Period With Betalutin|Physician Decision|0|||
105820536|NCT01796171|365004373|FG005|Treatment Period With Betalutin|Physician Decision|0|||
105820537|NCT01796171|365004374|FG006|Treatment Period With Betalutin|Physician Decision|0|||
105571670|NCT02887989|364092726|FG001|Overall Study|Death|0|||
105820538|NCT01796171|365004375|FG007|Treatment Period With Betalutin|Physician Decision|0|||
105820539|NCT01796171|365004376|FG008|Treatment Period With Betalutin|Physician Decision|0|||
105820540|NCT01796171|365004377|FG009|Treatment Period With Betalutin|Physician Decision|0|||
105820541|NCT01796171|365004378|FG010|Treatment Period With Betalutin|Physician Decision|5|||
105820542|NCT01796171|365004379|FG011|Treatment Period With Betalutin|Physician Decision|1|||
105820543|NCT01796171|365004380|FG012|Treatment Period With Betalutin|Physician Decision|1|||
105820544|NCT01796171|365004381|FG013|Treatment Period With Betalutin|Physician Decision|0|||
105820545|NCT01796171|365004382|FG014|Treatment Period With Betalutin|Physician Decision|0|||
105820546|NCT01796171|365004368|FG000|Treatment Period With Betalutin|Death|0|||
105820547|NCT01796171|365004369|FG001|Treatment Period With Betalutin|Death|0|||
105820548|NCT01796171|365004370|FG002|Treatment Period With Betalutin|Death|0|||
105820549|NCT01796171|365004371|FG003|Treatment Period With Betalutin|Death|0|||
105820550|NCT01796171|365004372|FG004|Treatment Period With Betalutin|Death|0|||
105820551|NCT01796171|365004373|FG005|Treatment Period With Betalutin|Death|0|||
105820552|NCT01796171|365004374|FG006|Treatment Period With Betalutin|Death|0|||
105820553|NCT01796171|365004375|FG007|Treatment Period With Betalutin|Death|0|||
105820554|NCT01796171|365004376|FG008|Treatment Period With Betalutin|Death|0|||
105820555|NCT01796171|365004377|FG009|Treatment Period With Betalutin|Death|0|||
105820556|NCT01796171|365004378|FG010|Treatment Period With Betalutin|Death|2|||
105820557|NCT01796171|365004379|FG011|Treatment Period With Betalutin|Death|0|||
105820558|NCT01796171|365004380|FG012|Treatment Period With Betalutin|Death|0|||
105820559|NCT01796171|365004381|FG013|Treatment Period With Betalutin|Death|0|||
105820560|NCT01796171|365004382|FG014|Treatment Period With Betalutin|Death|0|||
105820561|NCT01796171|365004368|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
105820562|NCT01796171|365004369|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
105820563|NCT01796171|365004370|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
105820564|NCT01796171|365004371|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
105820565|NCT01796171|365004372|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
105820566|NCT01796171|365004373|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
105820567|NCT01796171|365004374|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
105820568|NCT01796171|365004375|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
105820569|NCT01796171|365004376|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
105820570|NCT01796171|365004377|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
105820571|NCT01796171|365004378|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
105820572|NCT01796171|365004379|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
105820573|NCT01796171|365004380|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
105820574|NCT01796171|365004381|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
105820575|NCT01796171|365004382|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
105820576|NCT01796171|365004368|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820577|NCT01796171|365004369|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820578|NCT01796171|365004370|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820579|NCT01796171|365004371|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820580|NCT01796171|365004372|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820581|NCT01796171|365004373|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820582|NCT01796171|365004374|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820583|NCT01796171|365004375|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820584|NCT01796171|365004376|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820585|NCT01796171|365004377|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820586|NCT01796171|365004378|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
105820587|NCT01796171|365004379|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
105820588|NCT01796171|365004380|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820589|NCT01796171|365004381|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820590|NCT01796171|365004382|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820591|NCT01796171|365004368|FG000|Follow-up Period|Start of further anticancer therapy|4|||
105820592|NCT01796171|365004369|FG001|Follow-up Period|Start of further anticancer therapy|25|||
105820593|NCT01796171|365004370|FG002|Follow-up Period|Start of further anticancer therapy|2|||
105820594|NCT01796171|365004371|FG003|Follow-up Period|Start of further anticancer therapy|1|||
105820595|NCT01796171|365004372|FG004|Follow-up Period|Start of further anticancer therapy|2|||
105820596|NCT01796171|365004373|FG005|Follow-up Period|Start of further anticancer therapy|2|||
105820597|NCT01796171|365004374|FG006|Follow-up Period|Start of further anticancer therapy|1|||
105820598|NCT01796171|365004375|FG007|Follow-up Period|Start of further anticancer therapy|15|||
105820599|NCT01796171|365004376|FG008|Follow-up Period|Start of further anticancer therapy|2|||
105820600|NCT01796171|365004377|FG009|Follow-up Period|Start of further anticancer therapy|0|||
105820601|NCT01796171|365004378|FG010|Follow-up Period|Start of further anticancer therapy|0|||
105820602|NCT01796171|365004379|FG011|Follow-up Period|Start of further anticancer therapy|0|||
105820603|NCT01796171|365004380|FG012|Follow-up Period|Start of further anticancer therapy|0|||
105820604|NCT01796171|365004381|FG013|Follow-up Period|Start of further anticancer therapy|0|||
105820605|NCT01796171|365004382|FG014|Follow-up Period|Start of further anticancer therapy|0|||
105820606|NCT01796171|365004368|FG000|Follow-up Period|Progressive disease|0|||
105820607|NCT01796171|365004369|FG001|Follow-up Period|Progressive disease|1|||
105820608|NCT01796171|365004370|FG002|Follow-up Period|Progressive disease|0|||
105820609|NCT01796171|365004371|FG003|Follow-up Period|Progressive disease|0|||
105820610|NCT01796171|365004372|FG004|Follow-up Period|Progressive disease|0|||
105820611|NCT01796171|365004373|FG005|Follow-up Period|Progressive disease|0|||
105820612|NCT01796171|365004374|FG006|Follow-up Period|Progressive disease|0|||
105820613|NCT01796171|365004375|FG007|Follow-up Period|Progressive disease|3|||
105820614|NCT01796171|365004376|FG008|Follow-up Period|Progressive disease|0|||
105820615|NCT01796171|365004377|FG009|Follow-up Period|Progressive disease|0|||
105820616|NCT01796171|365004378|FG010|Follow-up Period|Progressive disease|0|||
105820617|NCT01796171|365004379|FG011|Follow-up Period|Progressive disease|0|||
105820618|NCT01796171|365004380|FG012|Follow-up Period|Progressive disease|0|||
105820619|NCT01796171|365004381|FG013|Follow-up Period|Progressive disease|0|||
105820620|NCT01796171|365004382|FG014|Follow-up Period|Progressive disease|0|||
105820621|NCT01796171|365004368|FG000|Follow-up Period|Physician Decision|0|||
105820622|NCT01796171|365004369|FG001|Follow-up Period|Physician Decision|2|||
105820623|NCT01796171|365004370|FG002|Follow-up Period|Physician Decision|0|||
105820624|NCT01796171|365004371|FG003|Follow-up Period|Physician Decision|0|||
105820625|NCT01796171|365004372|FG004|Follow-up Period|Physician Decision|0|||
105820626|NCT01796171|365004373|FG005|Follow-up Period|Physician Decision|0|||
105820627|NCT01796171|365004374|FG006|Follow-up Period|Physician Decision|0|||
105820628|NCT01796171|365004375|FG007|Follow-up Period|Physician Decision|0|||
105820629|NCT01796171|365004376|FG008|Follow-up Period|Physician Decision|0|||
105820630|NCT01796171|365004377|FG009|Follow-up Period|Physician Decision|0|||
105820631|NCT01796171|365004378|FG010|Follow-up Period|Physician Decision|5|||
105820632|NCT01796171|365004379|FG011|Follow-up Period|Physician Decision|0|||
105820633|NCT01796171|365004380|FG012|Follow-up Period|Physician Decision|0|||
105820634|NCT01796171|365004381|FG013|Follow-up Period|Physician Decision|0|||
105820635|NCT01796171|365004382|FG014|Follow-up Period|Physician Decision|0|||
105820636|NCT01796171|365004368|FG000|Follow-up Period|Withdrawal by Subject|0|||
105820637|NCT01796171|365004369|FG001|Follow-up Period|Withdrawal by Subject|1|||
105820638|NCT01796171|365004370|FG002|Follow-up Period|Withdrawal by Subject|0|||
105820639|NCT01796171|365004371|FG003|Follow-up Period|Withdrawal by Subject|0|||
105820640|NCT01796171|365004372|FG004|Follow-up Period|Withdrawal by Subject|0|||
105820641|NCT01796171|365004373|FG005|Follow-up Period|Withdrawal by Subject|1|||
105820642|NCT01796171|365004374|FG006|Follow-up Period|Withdrawal by Subject|0|||
105820643|NCT01796171|365004375|FG007|Follow-up Period|Withdrawal by Subject|0|||
105820644|NCT01796171|365004376|FG008|Follow-up Period|Withdrawal by Subject|0|||
105820645|NCT01796171|365004377|FG009|Follow-up Period|Withdrawal by Subject|0|||
105820646|NCT01796171|365004378|FG010|Follow-up Period|Withdrawal by Subject|3|||
105820647|NCT01796171|365004379|FG011|Follow-up Period|Withdrawal by Subject|1|||
105362787|NCT03428100|363332633|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
105362788|NCT03428100|363332634|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
105362789|NCT03428100|363332635|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
105362790|NCT03428100|363332636|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
105362791|NCT03428100|363332637|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
105486339|NCT01958827|363791483|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
105486340|NCT00356122|363791484|FG000|TREATMENT|Lack of Efficacy|26|||
105486341|NCT00356122|363791484|FG000|TREATMENT|Adverse Event|10|||
105486342|NCT00356122|363791484|FG000|TREATMENT|Subject's request|4|||
105486343|NCT00356122|363791484|FG000|TREATMENT|Other|4|||
105486344|NCT00356122|363791484|FG000|TREATMENT|Did not receive study medication|1|||
105486345|NCT00356122|363791484|FG000|FOLLOW-UP|Death|37|||
105486346|NCT00356122|363791484|FG000|FOLLOW-UP|Lost to Follow-up|2|||
105486347|NCT00356122|363791484|FG000|FOLLOW-UP|Other|2|||
105486348|NCT02361346|363791485|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
105486349|NCT02361346|363791486|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
105486350|NCT02361346|363791487|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
105486351|NCT02361346|363791488|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
105486352|NCT02361346|363791489|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
105486353|NCT02361346|363791490|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
105486354|NCT02361346|363791491|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
105486355|NCT02361346|363791492|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
105486356|NCT02361346|363791493|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
105486357|NCT02361346|363791485|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
105486358|NCT02361346|363791486|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
105486359|NCT02361346|363791487|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
105486360|NCT02361346|363791488|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
105486361|NCT02361346|363791489|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
105486362|NCT02361346|363791490|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
105486363|NCT02361346|363791491|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
105486364|NCT02361346|363791492|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
105486365|NCT02361346|363791493|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
105486366|NCT02361346|363791485|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
105486367|NCT02361346|363791486|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
105486368|NCT02361346|363791487|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
105486369|NCT02361346|363791488|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
105486370|NCT02361346|363791489|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
105486371|NCT02361346|363791490|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
105820648|NCT01796171|365004380|FG012|Follow-up Period|Withdrawal by Subject|0|||
105820649|NCT01796171|365004381|FG013|Follow-up Period|Withdrawal by Subject|0|||
105820650|NCT01796171|365004382|FG014|Follow-up Period|Withdrawal by Subject|0|||
105820651|NCT01796171|365004368|FG000|Follow-up Period|Death|0|||
105486372|NCT02361346|363791491|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
105486373|NCT02361346|363791492|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
105486374|NCT02361346|363791493|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
105486375|NCT02361346|363791485|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
105486376|NCT02361346|363791486|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
105820652|NCT01796171|365004369|FG001|Follow-up Period|Death|0|||
105820653|NCT01796171|365004370|FG002|Follow-up Period|Death|0|||
105820654|NCT01796171|365004371|FG003|Follow-up Period|Death|0|||
105820655|NCT01796171|365004372|FG004|Follow-up Period|Death|0|||
105820656|NCT01796171|365004373|FG005|Follow-up Period|Death|0|||
105820657|NCT01796171|365004374|FG006|Follow-up Period|Death|1|||
105820658|NCT01796171|365004375|FG007|Follow-up Period|Death|0|||
105820659|NCT01796171|365004376|FG008|Follow-up Period|Death|0|||
105820660|NCT01796171|365004377|FG009|Follow-up Period|Death|0|||
105820661|NCT01796171|365004378|FG010|Follow-up Period|Death|17|||
105820662|NCT01796171|365004379|FG011|Follow-up Period|Death|9|||
105820663|NCT01796171|365004380|FG012|Follow-up Period|Death|1|||
105820664|NCT01796171|365004381|FG013|Follow-up Period|Death|0|||
105820665|NCT01796171|365004382|FG014|Follow-up Period|Death|0|||
105820666|NCT01796171|365004368|FG000|Follow-up Period|Patient transferred to other hospital|0|||
105820667|NCT01796171|365004369|FG001|Follow-up Period|Patient transferred to other hospital|1|||
105820668|NCT01796171|365004370|FG002|Follow-up Period|Patient transferred to other hospital|0|||
105820669|NCT01796171|365004371|FG003|Follow-up Period|Patient transferred to other hospital|0|||
105486377|NCT02361346|363791487|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
105820670|NCT01796171|365004372|FG004|Follow-up Period|Patient transferred to other hospital|0|||
105486378|NCT02361346|363791488|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
105486379|NCT02361346|363791489|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
105486380|NCT02361346|363791490|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
105571671|NCT00674323|364092727|FG000|Overall Study|Adverse Event|0|||
105820671|NCT01796171|365004373|FG005|Follow-up Period|Patient transferred to other hospital|0|||
105820672|NCT01796171|365004374|FG006|Follow-up Period|Patient transferred to other hospital|0|||
105820673|NCT01796171|365004375|FG007|Follow-up Period|Patient transferred to other hospital|0|||
105820674|NCT01796171|365004376|FG008|Follow-up Period|Patient transferred to other hospital|0|||
105820675|NCT01796171|365004377|FG009|Follow-up Period|Patient transferred to other hospital|0|||
105820676|NCT01796171|365004378|FG010|Follow-up Period|Patient transferred to other hospital|0|||
105820677|NCT01796171|365004379|FG011|Follow-up Period|Patient transferred to other hospital|0|||
105820678|NCT01796171|365004380|FG012|Follow-up Period|Patient transferred to other hospital|0|||
105820679|NCT01796171|365004381|FG013|Follow-up Period|Patient transferred to other hospital|0|||
105820680|NCT01796171|365004382|FG014|Follow-up Period|Patient transferred to other hospital|0|||
105820681|NCT01796171|365004368|FG000|Follow-up Period|Sponsor Decision|0|||
105820682|NCT01796171|365004369|FG001|Follow-up Period|Sponsor Decision|0|||
105820683|NCT01796171|365004370|FG002|Follow-up Period|Sponsor Decision|0|||
105820684|NCT01796171|365004371|FG003|Follow-up Period|Sponsor Decision|0|||
105820685|NCT01796171|365004372|FG004|Follow-up Period|Sponsor Decision|0|||
105820686|NCT01796171|365004373|FG005|Follow-up Period|Sponsor Decision|0|||
105820687|NCT01796171|365004374|FG006|Follow-up Period|Sponsor Decision|0|||
105820688|NCT01796171|365004375|FG007|Follow-up Period|Sponsor Decision|0|||
105820689|NCT01796171|365004376|FG008|Follow-up Period|Sponsor Decision|0|||
105820690|NCT01796171|365004377|FG009|Follow-up Period|Sponsor Decision|0|||
105820691|NCT01796171|365004378|FG010|Follow-up Period|Sponsor Decision|40|||
105820692|NCT01796171|365004379|FG011|Follow-up Period|Sponsor Decision|15|||
105820693|NCT01796171|365004380|FG012|Follow-up Period|Sponsor Decision|7|||
105820694|NCT01796171|365004381|FG013|Follow-up Period|Sponsor Decision|0|||
105820695|NCT01796171|365004382|FG014|Follow-up Period|Sponsor Decision|0|||
105820696|NCT01083693|365004385|FG000|Overall Study|Adverse Event|1|||
105820697|NCT01083693|365004386|FG001|Overall Study|Adverse Event|1|||
105820698|NCT01083693|365004387|FG002|Overall Study|Adverse Event|0|||
105820699|NCT01083693|365004385|FG000|Overall Study|Lost to Follow-up|2|||
105820700|NCT01083693|365004386|FG001|Overall Study|Lost to Follow-up|0|||
105820701|NCT01083693|365004387|FG002|Overall Study|Lost to Follow-up|2|||
105820702|NCT01083693|365004385|FG000|Overall Study|Lack of effectiveness|13|||
105820703|NCT01083693|365004386|FG001|Overall Study|Lack of effectiveness|2|||
105362792|NCT03428100|363332638|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
105362793|NCT03428100|363332620|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105362794|NCT03428100|363332621|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105362795|NCT03428100|363332622|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105362796|NCT03428100|363332623|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105362797|NCT03428100|363332624|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105362798|NCT03428100|363332625|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105362799|NCT03428100|363332626|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105362800|NCT03428100|363332627|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
105362801|NCT03428100|363332628|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105362802|NCT03428100|363332629|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105362803|NCT03428100|363332630|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105362804|NCT03428100|363332631|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
105362805|NCT03428100|363332632|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
105362806|NCT03428100|363332633|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105486381|NCT02361346|363791491|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
105362807|NCT03428100|363332634|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
105820704|NCT01083693|365004387|FG002|Overall Study|Lack of effectiveness|2|||
105820705|NCT01083693|365004385|FG000|Overall Study|Patient Moved|0|||
105820706|NCT01083693|365004386|FG001|Overall Study|Patient Moved|1|||
105486382|NCT02361346|363791492|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
105820707|NCT01083693|365004387|FG002|Overall Study|Patient Moved|0|||
105820708|NCT01083693|365004385|FG000|Overall Study|Complete remission|0|||
105820709|NCT01083693|365004386|FG001|Overall Study|Complete remission|1|||
105820710|NCT01083693|365004387|FG002|Overall Study|Complete remission|0|||
105820711|NCT01083693|365004385|FG000|Overall Study|Other medical condition/surgery|1|||
105820712|NCT01083693|365004386|FG001|Overall Study|Other medical condition/surgery|1|||
105820713|NCT01083693|365004387|FG002|Overall Study|Other medical condition/surgery|0|||
105820714|NCT01083693|365004385|FG000|Overall Study|Withdrawal by Subject|3|||
105820715|NCT01083693|365004386|FG001|Overall Study|Withdrawal by Subject|0|||
105820716|NCT01083693|365004387|FG002|Overall Study|Withdrawal by Subject|2|||
105820717|NCT01083693|365004385|FG000|Overall Study|Reason unknown|0|||
105820718|NCT01083693|365004386|FG001|Overall Study|Reason unknown|0|||
105820719|NCT01083693|365004387|FG002|Overall Study|Reason unknown|1|||
105820720|NCT00905840|365004390|FG000|Overall Study|Lost to Follow-up|11|||
105820721|NCT00905840|365004390|FG000|Overall Study|Death|3|||
105820722|NCT00905840|365004390|FG000|Overall Study|Withdrawal by Subject|1|||
105820723|NCT00905840|365004390|FG000|Overall Study|Adverse Event|1|||
105820724|NCT02459951|365004391|FG000|Overall Study|Unable to meet holding requirement|1|||
105820725|NCT03620747|365004395|FG000|Overall Study|Participant decision|7|||
105820726|NCT03620747|365004395|FG000|Overall Study|Adverse Event|6|||
105820727|NCT03620747|365004395|FG000|Overall Study|Lack of Efficacy|1|||
105820728|NCT03620747|365004395|FG000|Overall Study|Poor compliance to protocol|2|||
105820729|NCT03620747|365004395|FG000|Overall Study|Other-unspecified|3|||
105820730|NCT02714062|365004396|FG000|Overall Study|Adverse Event|0|||
105820731|NCT02714062|365004397|FG001|Overall Study|Adverse Event|0|||
105820732|NCT02714062|365004398|FG002|Overall Study|Adverse Event|2|||
105820733|NCT02714062|365004396|FG000|Overall Study|Withdrawal by Subject|1|||
105820734|NCT02714062|365004397|FG001|Overall Study|Withdrawal by Subject|0|||
105820735|NCT02714062|365004398|FG002|Overall Study|Withdrawal by Subject|1|||
105820736|NCT02714062|365004396|FG000|Overall Study|Protocol Violation|0|||
105820737|NCT02714062|365004397|FG001|Overall Study|Protocol Violation|1|||
105820738|NCT02714062|365004398|FG002|Overall Study|Protocol Violation|0|||
105820739|NCT04533594|365004404|FG000|Overall Study|Death|26|||
105820740|NCT00473330|365004405|FG000|Core Study|Adverse Event|4|||
105820741|NCT00473330|365004406|FG001|Core Study|Adverse Event|4|||
105820742|NCT00473330|365004407|FG002|Core Study|Adverse Event|1|||
105820743|NCT00473330|365004405|FG000|Core Study|Death|6|||
105820744|NCT00473330|365004406|FG001|Core Study|Death|4|||
105820745|NCT00473330|365004407|FG002|Core Study|Death|4|||
105820746|NCT00473330|365004405|FG000|Core Study|Lost to Follow-up|5|||
105820747|NCT00473330|365004406|FG001|Core Study|Lost to Follow-up|5|||
105820748|NCT00473330|365004407|FG002|Core Study|Lost to Follow-up|10|||
105820749|NCT00473330|365004405|FG000|Core Study|Physician Decision|2|||
105820750|NCT00473330|365004406|FG001|Core Study|Physician Decision|1|||
105820751|NCT00473330|365004407|FG002|Core Study|Physician Decision|3|||
105820752|NCT00473330|365004405|FG000|Core Study|Subject Non-compliance|1|||
105820753|NCT00473330|365004406|FG001|Core Study|Subject Non-compliance|2|||
105820754|NCT00473330|365004407|FG002|Core Study|Subject Non-compliance|1|||
105820755|NCT00473330|365004405|FG000|Core Study|Subject Required Other Therapy|0|||
105820756|NCT00473330|365004406|FG001|Core Study|Subject Required Other Therapy|1|||
105820757|NCT00473330|365004407|FG002|Core Study|Subject Required Other Therapy|3|||
105820758|NCT00473330|365004405|FG000|Core Study|Subject's Decision|9|||
105820759|NCT00473330|365004406|FG001|Core Study|Subject's Decision|8|||
105820760|NCT00473330|365004407|FG002|Core Study|Subject's Decision|19|||
105820761|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
105820762|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
105820763|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
105820764|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Death|2|||
105820765|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Death|0|||
105820766|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Death|0|||
105486383|NCT02361346|363791493|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
105486384|NCT02361346|363791485|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
105820767|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
105820768|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
105486385|NCT02361346|363791486|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
105486386|NCT02361346|363791487|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
105486387|NCT02361346|363791488|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
105486388|NCT02361346|363791489|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
105486389|NCT02361346|363791490|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
105486390|NCT02361346|363791491|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
105820769|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
105820770|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
105820771|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
105820772|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
105820773|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
105820774|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
105820775|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
105820776|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
105820777|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
105820778|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
105820779|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
105362808|NCT03428100|363332635|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105362809|NCT03428100|363332636|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105766095|NCT01001572|364795989|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
105766096|NCT01001572|364795990|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
105766097|NCT01001572|364795991|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
105766098|NCT01001572|364795989|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
105766099|NCT01001572|364795990|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
105766100|NCT01001572|364795991|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
105766101|NCT01001572|364795989|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105766102|NCT01001572|364795990|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105766103|NCT01001572|364795991|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
105766104|NCT01224106|364795992|FG000|Double-Blind Treatment Phase|Death|3|||
105766105|NCT01224106|364795993|FG001|Double-Blind Treatment Phase|Death|0|||
105766106|NCT01224106|364795994|FG002|Double-Blind Treatment Phase|Death|0|||
105766107|NCT01224106|364795995|FG003|Double-Blind Treatment Phase|Death|0|||
105766108|NCT01224106|364795996|FG004|Double-Blind Treatment Phase|Death|0|||
105766109|NCT01224106|364795992|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
105766110|NCT01224106|364795993|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
105766111|NCT01224106|364795994|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
105766112|NCT01224106|364795995|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
105766113|NCT01224106|364795996|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
105766114|NCT01224106|364795992|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
105766115|NCT01224106|364795993|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
105766116|NCT01224106|364795994|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
105766117|NCT01224106|364795995|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
105766118|NCT01224106|364795996|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
105766119|NCT01224106|364795992|FG000|Double-Blind Treatment Phase|Other|0|||
105766120|NCT01224106|364795993|FG001|Double-Blind Treatment Phase|Other|0|||
105766121|NCT01224106|364795994|FG002|Double-Blind Treatment Phase|Other|1|||
105766122|NCT01224106|364795995|FG003|Double-Blind Treatment Phase|Other|0|||
105766123|NCT01224106|364795996|FG004|Double-Blind Treatment Phase|Other|0|||
105766124|NCT01224106|364795992|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
105766125|NCT01224106|364795993|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
105766126|NCT01224106|364795994|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
105766127|NCT01224106|364795995|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
105766128|NCT01224106|364795996|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
105766129|NCT01224106|364795992|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
105766130|NCT01224106|364795993|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
105766131|NCT01224106|364795994|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
105766132|NCT01224106|364795995|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
105766133|NCT01224106|364795996|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
105766134|NCT01224106|364795992|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
105766135|NCT01224106|364795993|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105766136|NCT01224106|364795994|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
105766137|NCT01224106|364795995|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105766138|NCT01224106|364795996|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105766139|NCT01224106|364795992|FG000|Open-Label Extension (OLE) Phase|Death|0|||
105766140|NCT01224106|364795993|FG001|Open-Label Extension (OLE) Phase|Death|0|||
105766141|NCT01224106|364795994|FG002|Open-Label Extension (OLE) Phase|Death|0|||
105766142|NCT01224106|364795995|FG003|Open-Label Extension (OLE) Phase|Death|1|||
105766143|NCT01224106|364795996|FG004|Open-Label Extension (OLE) Phase|Death|3|||
105766144|NCT01224106|364795992|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
105766145|NCT01224106|364795993|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
105766146|NCT01224106|364795994|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
105766147|NCT01224106|364795995|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
105766148|NCT01224106|364795996|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
105766149|NCT01224106|364795992|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
105766150|NCT01224106|364795993|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
105766151|NCT01224106|364795994|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
105766152|NCT01224106|364795995|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
105766153|NCT01224106|364795996|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
105766154|NCT01224106|364795992|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
105766155|NCT01224106|364795993|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
105820780|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
105820781|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
105820782|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
105820783|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
105820784|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
105820785|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
105820786|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
105820787|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
105820788|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Death|2|||
105820789|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Death|2|||
105820790|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Death|1|||
105820791|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
105820792|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
105820793|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
105820794|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
105820795|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
105820796|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
105820797|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
105820798|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
105820799|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
105820800|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
105820801|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
105820802|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
105820803|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
105820804|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
105820805|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
105820806|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
105820807|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
105820808|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
105820809|NCT00960297|365004410|FG000|Overall Study|Physician Decision|1|||
105820810|NCT00960297|365004410|FG000|Overall Study|Venous port infection|1|||
105820811|NCT00960297|365004410|FG000|Overall Study|Disease progression|1|||
105820812|NCT03965091|365004416|FG000|Overall Study|Adverse Event|0|||
105820813|NCT03965091|365004417|FG001|Overall Study|Adverse Event|2|||
105820814|NCT03965091|365004418|FG002|Overall Study|Adverse Event|3|||
105820815|NCT03965091|365004416|FG000|Overall Study|Withdrawal by Subject|11|||
105820816|NCT03965091|365004417|FG001|Overall Study|Withdrawal by Subject|3|||
105820817|NCT03965091|365004418|FG002|Overall Study|Withdrawal by Subject|5|||
105820818|NCT03965091|365004416|FG000|Overall Study|Non-compliance with study drug|0|||
105820819|NCT03965091|365004417|FG001|Overall Study|Non-compliance with study drug|0|||
105820820|NCT03965091|365004418|FG002|Overall Study|Non-compliance with study drug|1|||
105820821|NCT03965091|365004416|FG000|Overall Study|Lost to Follow-up|1|||
105820822|NCT03965091|365004417|FG001|Overall Study|Lost to Follow-up|1|||
105820823|NCT03965091|365004418|FG002|Overall Study|Lost to Follow-up|1|||
105820824|NCT03965091|365004416|FG000|Overall Study|Lack of Efficacy|2|||
105820825|NCT03965091|365004417|FG001|Overall Study|Lack of Efficacy|0|||
105820826|NCT03965091|365004418|FG002|Overall Study|Lack of Efficacy|0|||
105820827|NCT03965091|365004416|FG000|Overall Study|Other than specified|9|||
105820828|NCT03965091|365004417|FG001|Overall Study|Other than specified|11|||
105820829|NCT03965091|365004418|FG002|Overall Study|Other than specified|8|||
105820830|NCT03500341|365004419|FG000|Overall Study|Withdrawn prior to Completion|2|||
105820831|NCT02576938|365004420|FG000|Overall Study|Adverse Event|5|||
105820832|NCT02576938|365004421|FG001|Overall Study|Adverse Event|3|||
105820833|NCT02576938|365004422|FG002|Overall Study|Adverse Event|6|||
105820834|NCT02576938|365004420|FG000|Overall Study|Protocol Violation|1|||
105820835|NCT02576938|365004421|FG001|Overall Study|Protocol Violation|1|||
105571672|NCT00674323|364092728|FG001|Overall Study|Adverse Event|1|||
105571673|NCT00674323|364092729|FG002|Overall Study|Adverse Event|0|||
105820836|NCT02576938|365004422|FG002|Overall Study|Protocol Violation|1|||
105820837|NCT02576938|365004420|FG000|Overall Study|Withdrawal by Subject|3|||
105820838|NCT02576938|365004421|FG001|Overall Study|Withdrawal by Subject|2|||
105820839|NCT02576938|365004422|FG002|Overall Study|Withdrawal by Subject|4|||
105820840|NCT02576938|365004420|FG000|Overall Study|Lack of Efficacy|9|||
105820841|NCT02576938|365004421|FG001|Overall Study|Lack of Efficacy|4|||
105820842|NCT02576938|365004422|FG002|Overall Study|Lack of Efficacy|0|||
105820843|NCT02576938|365004420|FG000|Overall Study|Lost to Follow-up|2|||
105820844|NCT02576938|365004421|FG001|Overall Study|Lost to Follow-up|0|||
105820845|NCT02576938|365004422|FG002|Overall Study|Lost to Follow-up|1|||
105820846|NCT02576938|365004420|FG000|Overall Study|Physician Decision|0|||
105820847|NCT02576938|365004421|FG001|Overall Study|Physician Decision|1|||
105820848|NCT02576938|365004422|FG002|Overall Study|Physician Decision|0|||
105820849|NCT02576938|365004420|FG000|Overall Study|Met Exclusion Criteria|0|||
105820850|NCT02576938|365004421|FG001|Overall Study|Met Exclusion Criteria|1|||
105820851|NCT02576938|365004422|FG002|Overall Study|Met Exclusion Criteria|0|||
105820852|NCT00123734|365004423|FG000|Overall Study|Death|3|||
105820853|NCT00123734|365004423|FG000|Overall Study|Lost to Follow-up|3|||
105820854|NCT00123734|365004423|FG000|Overall Study|Dropout|1|||
105820855|NCT00123734|365004423|FG000|Overall Study|Withdrawal by Subject|1|||
105820856|NCT00834340|365004424|FG000|Washout|Adverse Event|1|||
105820857|NCT00834340|365004425|FG001|Washout|Adverse Event|0|||
105820858|NCT00834340|365004424|FG000|Washout|Withdrawal by Subject|1|||
105820859|NCT00834340|365004425|FG001|Washout|Withdrawal by Subject|0|||
105820860|NCT00448591|365004426|FG000|Overall Study|Withdrawal by Subject|178|||
105820861|NCT00448591|365004426|FG000|Overall Study|Progressive Disease|1382|||
105820862|NCT00448591|365004426|FG000|Overall Study|Adverse Event|382|||
105820863|NCT00448591|365004426|FG000|Overall Study|Protocol Violation|41|||
105820864|NCT00448591|365004426|FG000|Overall Study|Lost to Follow-up|19|||
105820865|NCT00448591|365004426|FG000|Overall Study|Treatment Regimen Completed|70|||
105820866|NCT00448591|365004426|FG000|Overall Study|Other|154|||
105820867|NCT00448591|365004426|FG000|Overall Study|Termination of Study|70|||
105820868|NCT02937870|365004429|FG000|Overall Study|Adverse Event|1|||
105820869|NCT02937870|365004429|FG000|Overall Study|Protocol Deviation|2|||
105820870|NCT00609674|365004430|FG000|Overall Study|Adverse Event|1|||
105820871|NCT00609674|365004431|FG001|Overall Study|Adverse Event|1|||
105820872|NCT00609674|365004430|FG000|Overall Study|Protocol Violation|3|||
105820873|NCT00609674|365004431|FG001|Overall Study|Protocol Violation|5|||
105820874|NCT00609674|365004430|FG000|Overall Study|Lost to Follow-up|1|||
105820875|NCT00609674|365004431|FG001|Overall Study|Lost to Follow-up|0|||
105820876|NCT00609674|365004430|FG000|Overall Study|Withdrew consent|2|||
105820877|NCT00609674|365004431|FG001|Overall Study|Withdrew consent|1|||
105820878|NCT04408794|365004433|FG000|Overall Study|Adverse Event|43|||
105820879|NCT04408794|365004433|FG000|Overall Study|Infrequent study drug usage|43|||
105820880|NCT04408794|365004433|FG000|Overall Study|Lack of Efficacy|61|||
105820881|NCT04408794|365004433|FG000|Overall Study|Lost to Follow-up|33|||
105820882|NCT04408794|365004433|FG000|Overall Study|Non-compliance|6|||
105820883|NCT04408794|365004433|FG000|Overall Study|Physician Decision|1|||
105820884|NCT04408794|365004433|FG000|Overall Study|Pregnancy|6|||
105820885|NCT04408794|365004433|FG000|Overall Study|Protocol Deviation|9|||
105820886|NCT04408794|365004433|FG000|Overall Study|Sheehan-STS Result|1|||
105820887|NCT04408794|365004433|FG000|Overall Study|Withdrawal by Subject|57|||
105820888|NCT04408794|365004433|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
105820889|NCT04408794|365004433|FG000|Overall Study|Never Treated Migraine|5|||
105820890|NCT00571064|365004436|FG000|Overall Study|Adverse Event|13|||
105820891|NCT00571064|365004436|FG000|Overall Study|Protocol Violation|4|||
105820892|NCT00571064|365004436|FG000|Overall Study|Withdrawal by Subject|2|||
105820893|NCT00571064|365004436|FG000|Overall Study|Other|2|||
105820894|NCT04238754|365004437|FG000|Washout - 1 Week|Lost to Follow-up|1|||
105820895|NCT04238754|365004438|FG001|Washout - 1 Week|Lost to Follow-up|0|||
105820896|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
105820897|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
105820898|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
105820899|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
105820900|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
105820901|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
105820902|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
105820903|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
105820904|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
105820905|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
105820906|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
105820907|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
105820908|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
105571674|NCT00674323|364092727|FG000|Overall Study|Protocol Violation|1|||
105571675|NCT00674323|364092728|FG001|Overall Study|Protocol Violation|0|||
105571676|NCT00674323|364092729|FG002|Overall Study|Protocol Violation|0|||
105571677|NCT00041756|364092734|FG000|Overall Study|Adverse Event|4|||
105571678|NCT00041756|364092735|FG001|Overall Study|Adverse Event|10|||
105571679|NCT00041756|364092736|FG002|Overall Study|Adverse Event|6|||
105571680|NCT00041756|364092737|FG003|Overall Study|Adverse Event|11|||
105571681|NCT00041756|364092738|FG004|Overall Study|Adverse Event|34|||
105571682|NCT00041756|364092734|FG000|Overall Study|Protocol Violation|1|||
105820909|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
105820910|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
105820911|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
105820912|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
105820913|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
105820914|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
105820915|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
105820916|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
105820917|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
105820918|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
105820919|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
105820920|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
105820921|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
105820922|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
105820923|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
105820924|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
105820925|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
105820926|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
105820927|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
105820928|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
105820929|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
105820930|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
105820931|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
105820932|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
105820933|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
105820934|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
105820935|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
105820936|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
105820937|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
105820938|NCT02159950|365004443|FG000|Overall Study|Adverse Event|0|||
105820939|NCT02159950|365004444|FG001|Overall Study|Adverse Event|1|||
105820940|NCT02159950|365004443|FG000|Overall Study|Progression|0|||
105820941|NCT02159950|365004444|FG001|Overall Study|Progression|1|||
105820942|NCT03285594|365004447|FG000|Overall Study|At the Participant's Own Request|10|||
105820943|NCT03285594|365004448|FG001|Overall Study|At the Participant's Own Request|5|||
105820944|NCT03285594|365004449|FG002|Overall Study|At the Participant's Own Request|21|||
105820945|NCT03285594|365004447|FG000|Overall Study|Adverse Event|2|||
105820946|NCT03285594|365004448|FG001|Overall Study|Adverse Event|2|||
105820947|NCT03285594|365004449|FG002|Overall Study|Adverse Event|6|||
105820948|NCT03285594|365004447|FG000|Overall Study|Poor Compliance to Protocol|0|||
105820949|NCT03285594|365004448|FG001|Overall Study|Poor Compliance to Protocol|0|||
105820950|NCT03285594|365004449|FG002|Overall Study|Poor Compliance to Protocol|1|||
105820951|NCT03285594|365004447|FG000|Overall Study|Lost to Follow-up|0|||
105820952|NCT03285594|365004448|FG001|Overall Study|Lost to Follow-up|0|||
105820953|NCT03285594|365004449|FG002|Overall Study|Lost to Follow-up|1|||
105820954|NCT03285594|365004447|FG000|Overall Study|Reason Not Specified|3|||
105820955|NCT03285594|365004448|FG001|Overall Study|Reason Not Specified|4|||
105820956|NCT03285594|365004449|FG002|Overall Study|Reason Not Specified|8|||
105820957|NCT00556322|365004452|FG000|Overall Study|Insufficient therapeutic response|158|||
105820958|NCT00556322|365004453|FG001|Overall Study|Insufficient therapeutic response|168|||
105820959|NCT00556322|365004452|FG000|Overall Study|Adverse Event|7|||
105820960|NCT00556322|365004453|FG001|Overall Study|Adverse Event|4|||
105820961|NCT00556322|365004452|FG000|Overall Study|Other|4|||
105820962|NCT00556322|365004453|FG001|Overall Study|Other|1|||
105820963|NCT00556322|365004452|FG000|Overall Study|Lost to Follow-up|5|||
105820964|NCT00556322|365004453|FG001|Overall Study|Lost to Follow-up|3|||
105486391|NCT02361346|363791492|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
105820965|NCT00556322|365004452|FG000|Overall Study|Withdrawal by Subject|19|||
105820966|NCT00556322|365004453|FG001|Overall Study|Withdrawal by Subject|7|||
105820967|NCT00556322|365004452|FG000|Overall Study|Protocol Violation|5|||
105820968|NCT00556322|365004453|FG001|Overall Study|Protocol Violation|1|||
105820969|NCT00556322|365004452|FG000|Overall Study|Ongoing at data cutoff|3|||
105486392|NCT02361346|363791493|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
105486393|NCT02361346|363791485|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
105571683|NCT00041756|364092735|FG001|Overall Study|Protocol Violation|1|||
105820970|NCT00556322|365004453|FG001|Overall Study|Ongoing at data cutoff|5|||
105820971|NCT00556322|365004452|FG000|Overall Study|Death|20|||
105820972|NCT00556322|365004453|FG001|Overall Study|Death|14|||
105820973|NCT03733444|365004454|FG000|Overall Study|Adverse Event|8|||
105820974|NCT03733444|365004455|FG001|Overall Study|Adverse Event|10|||
105820975|NCT03733444|365004456|FG002|Overall Study|Adverse Event|5|||
105820976|NCT03733444|365004454|FG000|Overall Study|Death|20|||
105820977|NCT03733444|365004455|FG001|Overall Study|Death|19|||
105820978|NCT03733444|365004456|FG002|Overall Study|Death|11|||
105820979|NCT03733444|365004454|FG000|Overall Study|Lost to Follow-up|3|||
105820980|NCT03733444|365004455|FG001|Overall Study|Lost to Follow-up|0|||
105820981|NCT03733444|365004456|FG002|Overall Study|Lost to Follow-up|1|||
105820982|NCT03733444|365004454|FG000|Overall Study|Lack of Efficacy|0|||
105820983|NCT03733444|365004455|FG001|Overall Study|Lack of Efficacy|1|||
105820984|NCT03733444|365004456|FG002|Overall Study|Lack of Efficacy|1|||
105820985|NCT03733444|365004454|FG000|Overall Study|Physician Decision|2|||
105486394|NCT02361346|363791486|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
105486395|NCT02361346|363791487|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
105486396|NCT02361346|363791488|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
105486397|NCT02361346|363791489|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
105486398|NCT02361346|363791490|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
105486399|NCT02361346|363791491|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
105486400|NCT02361346|363791492|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
105486401|NCT02361346|363791493|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
105486402|NCT03670836|363791501|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
105486403|NCT03670836|363791502|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
105486404|NCT03670836|363791501|FG000|Per Protocol Population (PP)|Physician Decision|9|||
105486405|NCT03670836|363791502|FG001|Per Protocol Population (PP)|Physician Decision|10|||
105486406|NCT03670836|363791501|FG000|Per Protocol Population (PP)|Physician Decision|4|||
105486407|NCT03670836|363791502|FG001|Per Protocol Population (PP)|Physician Decision|6|||
105486408|NCT03670836|363791501|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
105486409|NCT03670836|363791502|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
105486410|NCT02278471|363793307|FG000|Overall Study|Lost to Follow-up|6|||
105486411|NCT02278471|363793308|FG001|Overall Study|Lost to Follow-up|15|||
105486412|NCT02278471|363793307|FG000|Overall Study|Death|2|||
105486413|NCT02278471|363793308|FG001|Overall Study|Death|2|||
105486414|NCT02278471|363793307|FG000|Overall Study|Withdrawal by Subject|0|||
105486415|NCT02278471|363793308|FG001|Overall Study|Withdrawal by Subject|3|||
105486416|NCT00640835|363793310|FG000|Overall Study|Adverse Event|5|||
105486417|NCT00640835|363793311|FG001|Overall Study|Adverse Event|3|||
105571684|NCT00041756|364092736|FG002|Overall Study|Protocol Violation|2|||
105766156|NCT01224106|364795994|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
105766157|NCT01224106|364795995|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
105766158|NCT01224106|364795996|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
105766159|NCT01224106|364795992|FG000|Open-Label Extension (OLE) Phase|Other|0|||
105766160|NCT01224106|364795993|FG001|Open-Label Extension (OLE) Phase|Other|0|||
105766161|NCT01224106|364795994|FG002|Open-Label Extension (OLE) Phase|Other|0|||
105766162|NCT01224106|364795995|FG003|Open-Label Extension (OLE) Phase|Other|5|||
105766163|NCT01224106|364795996|FG004|Open-Label Extension (OLE) Phase|Other|3|||
105766164|NCT00446797|364795997|FG000|Overall Study|Lack of Efficacy|0|||
105766165|NCT00446797|364795998|FG001|Overall Study|Lack of Efficacy|2|||
105766166|NCT00446797|364795997|FG000|Overall Study|Lost to Follow-up|5|||
105766167|NCT00446797|364795998|FG001|Overall Study|Lost to Follow-up|3|||
105766168|NCT00446797|364795997|FG000|Overall Study|Withdrawal by Subject|2|||
105766169|NCT00446797|364795998|FG001|Overall Study|Withdrawal by Subject|2|||
105766170|NCT00446797|364795997|FG000|Overall Study|Protocol Violation|1|||
105766171|NCT00446797|364795998|FG001|Overall Study|Protocol Violation|3|||
105820986|NCT03733444|365004455|FG001|Overall Study|Physician Decision|1|||
105820987|NCT03733444|365004456|FG002|Overall Study|Physician Decision|0|||
105820988|NCT03733444|365004454|FG000|Overall Study|Protocol Violation|2|||
105486418|NCT00640835|363793310|FG000|Overall Study|Withdrawal by Subject|12|||
105486419|NCT00640835|363793311|FG001|Overall Study|Withdrawal by Subject|14|||
105486420|NCT00640835|363793310|FG000|Overall Study|Physician Decision|10|||
105486421|NCT00640835|363793311|FG001|Overall Study|Physician Decision|14|||
105486422|NCT00640835|363793310|FG000|Overall Study|Sponsor's Decision|11|||
105486423|NCT00640835|363793311|FG001|Overall Study|Sponsor's Decision|7|||
105486424|NCT00640835|363793310|FG000|Overall Study|Protocol Violation|2|||
105486425|NCT00640835|363793311|FG001|Overall Study|Protocol Violation|2|||
105820989|NCT03733444|365004455|FG001|Overall Study|Protocol Violation|1|||
105820990|NCT03733444|365004456|FG002|Overall Study|Protocol Violation|0|||
105820991|NCT03733444|365004454|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
105820992|NCT03733444|365004455|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
105820993|NCT03733444|365004456|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
105820994|NCT03733444|365004454|FG000|Overall Study|Study Terminated by Sponsor|203|||
105820995|NCT03733444|365004455|FG001|Overall Study|Study Terminated by Sponsor|209|||
105820996|NCT03733444|365004456|FG002|Overall Study|Study Terminated by Sponsor|221|||
105820997|NCT03733444|365004454|FG000|Overall Study|Withdrawal by Subject|19|||
105820998|NCT03733444|365004455|FG001|Overall Study|Withdrawal by Subject|18|||
105820999|NCT03733444|365004456|FG002|Overall Study|Withdrawal by Subject|16|||
105821000|NCT03733444|365004454|FG000|Overall Study|Miscellaneous|1|||
105821001|NCT03733444|365004455|FG001|Overall Study|Miscellaneous|0|||
105821002|NCT03733444|365004456|FG002|Overall Study|Miscellaneous|1|||
105821003|NCT03733444|365004454|FG000|Overall Study|Not Treated|1|||
105821004|NCT03733444|365004455|FG001|Overall Study|Not Treated|2|||
105821005|NCT03733444|365004456|FG002|Overall Study|Not Treated|1|||
105821006|NCT03663179|365004457|FG000|Overall Study|Withdrawal by Subject|2|||
105821007|NCT03663179|365004458|FG001|Overall Study|Withdrawal by Subject|0|||
105821008|NCT03663179|365004457|FG000|Overall Study|Lost to Follow-up|1|||
105821009|NCT03663179|365004458|FG001|Overall Study|Lost to Follow-up|1|||
105821010|NCT03663179|365004457|FG000|Overall Study|Revealed exclusionary condition|1|||
105821011|NCT03663179|365004458|FG001|Overall Study|Revealed exclusionary condition|0|||
105821012|NCT00651820|365004461|FG000|Overall Study|Lost to Follow-up|2|||
105821013|NCT00576056|365004462|FG000|Overall Study|Adverse Event|1|||
105821014|NCT00576056|365004462|FG000|Overall Study|Death|1|||
105821015|NCT00576056|365004462|FG000|Overall Study|Lack of Efficacy|1|||
105821016|NCT00576056|365004462|FG000|Overall Study|Withdrawal by Subject|2|||
105821017|NCT00576056|365004462|FG000|Overall Study|did not meet eligibility criteria|8|||
105821018|NCT00576056|365004462|FG000|Overall Study|Physician Decision|1|||
105821019|NCT03686033|365004463|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
105821020|NCT03686033|365004464|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
105821021|NCT03686033|365004465|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
105821022|NCT03686033|365004466|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
105821023|NCT03686033|365004467|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
105821024|NCT03686033|365004468|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
105821025|NCT00657553|365004475|FG000|Overall Study|low accrual, no analysis run|5|||
105821026|NCT00657553|365004476|FG001|Overall Study|low accrual, no analysis run|5|||
105821027|NCT03031847|365004477|FG000|Overall Study|Death|1|||
105821028|NCT03031847|365004478|FG001|Overall Study|Death|1|||
105821029|NCT03031847|365004479|FG002|Overall Study|Death|2|||
105821030|NCT03031847|365004480|FG003|Overall Study|Death|3|||
105821031|NCT03031847|365004477|FG000|Overall Study|Lost to Follow-up|1|||
105821032|NCT03031847|365004478|FG001|Overall Study|Lost to Follow-up|1|||
105821033|NCT03031847|365004479|FG002|Overall Study|Lost to Follow-up|2|||
105821034|NCT03031847|365004480|FG003|Overall Study|Lost to Follow-up|3|||
105362810|NCT03428100|363332637|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
105362811|NCT03428100|363332638|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105362812|NCT03428100|363332620|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
105362813|NCT03428100|363332621|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
105821035|NCT03173547|365004481|FG000|Overall Study|Adverse Event|2|||
105821036|NCT03173547|365004482|FG001|Overall Study|Adverse Event|0|||
105821037|NCT03173547|365004481|FG000|Overall Study|Withdrawal by Subject|2|||
105821038|NCT03173547|365004482|FG001|Overall Study|Withdrawal by Subject|2|||
105821039|NCT00446563|365004483|FG000|Overall Study|Adverse Event|4|||
105821040|NCT00446563|365004484|FG001|Overall Study|Adverse Event|3|||
105821041|NCT00446563|365004483|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105821042|NCT00446563|365004484|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105821043|NCT00446563|365004483|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105821044|NCT00446563|365004484|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105821045|NCT00446563|365004483|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105821046|NCT00446563|365004484|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105821047|NCT00446563|365004483|FG000|Overall Study|Withdrawal by Subject|2|||
105821048|NCT00446563|365004484|FG001|Overall Study|Withdrawal by Subject|1|||
105821049|NCT00446563|365004483|FG000|Overall Study|Administrative problems|0|||
105821050|NCT00446563|365004484|FG001|Overall Study|Administrative problems|1|||
105821051|NCT03769025|365004485|FG000|Overall Study|Withdrawal by Subject|1|||
105821052|NCT03769025|365004486|FG001|Overall Study|Withdrawal by Subject|1|||
105821053|NCT03769025|365004485|FG000|Overall Study|Lost to Follow-up|4|||
105821054|NCT03769025|365004486|FG001|Overall Study|Lost to Follow-up|3|||
105821055|NCT01302548|365004487|FG000|Overall Study|Lost to Follow-up|2|||
105821056|NCT01302548|365004488|FG001|Overall Study|Lost to Follow-up|1|||
105821057|NCT03600376|365004489|FG000|Overall Study|Adverse Event|1|||
105821058|NCT03600376|365004490|FG001|Overall Study|Adverse Event|1|||
105821059|NCT03600376|365004489|FG000|Overall Study|Transferred to other facility|1|||
105821060|NCT03600376|365004490|FG001|Overall Study|Transferred to other facility|0|||
105821061|NCT03600376|365004489|FG000|Overall Study|Investigator Decision|0|||
105821062|NCT03600376|365004490|FG001|Overall Study|Investigator Decision|4|||
105821063|NCT03600376|365004489|FG000|Overall Study|Determined to be ineligible for study|0|||
105821064|NCT03600376|365004490|FG001|Overall Study|Determined to be ineligible for study|1|||
105821065|NCT03290781|365004493|FG000|Overall Study|Adverse Event|5|||
105821066|NCT03290781|365004494|FG001|Overall Study|Adverse Event|7|||
105821067|NCT03290781|365004495|FG002|Overall Study|Adverse Event|4|||
105821068|NCT03290781|365004496|FG003|Overall Study|Adverse Event|1|||
105821069|NCT03290781|365004497|FG004|Overall Study|Adverse Event|0|||
105821070|NCT03290781|365004498|FG005|Overall Study|Adverse Event|0|||
105821071|NCT03290781|365004499|FG006|Overall Study|Adverse Event|0|||
105821072|NCT03290781|365004493|FG000|Overall Study|Death|0|||
105821073|NCT03290781|365004494|FG001|Overall Study|Death|0|||
105821074|NCT03290781|365004495|FG002|Overall Study|Death|1|||
105821075|NCT03290781|365004496|FG003|Overall Study|Death|0|||
105821076|NCT03290781|365004497|FG004|Overall Study|Death|1|||
105821077|NCT03290781|365004498|FG005|Overall Study|Death|0|||
105821078|NCT03290781|365004499|FG006|Overall Study|Death|0|||
105821079|NCT03290781|365004493|FG000|Overall Study|Withdrawal by Subject|6|||
105821080|NCT03290781|365004494|FG001|Overall Study|Withdrawal by Subject|5|||
105821081|NCT03290781|365004495|FG002|Overall Study|Withdrawal by Subject|9|||
105821082|NCT03290781|365004496|FG003|Overall Study|Withdrawal by Subject|10|||
105821083|NCT03290781|365004497|FG004|Overall Study|Withdrawal by Subject|1|||
105821084|NCT03290781|365004498|FG005|Overall Study|Withdrawal by Subject|2|||
105821085|NCT03290781|365004499|FG006|Overall Study|Withdrawal by Subject|0|||
105821086|NCT03290781|365004493|FG000|Overall Study|Physician Decision|0|||
105821087|NCT03290781|365004494|FG001|Overall Study|Physician Decision|1|||
105821088|NCT03290781|365004495|FG002|Overall Study|Physician Decision|0|||
105821089|NCT03290781|365004496|FG003|Overall Study|Physician Decision|0|||
105821090|NCT03290781|365004497|FG004|Overall Study|Physician Decision|0|||
105821091|NCT03290781|365004498|FG005|Overall Study|Physician Decision|0|||
105821092|NCT03290781|365004499|FG006|Overall Study|Physician Decision|0|||
105821093|NCT03290781|365004493|FG000|Overall Study|Site Terminated by Sponsor|1|||
105821094|NCT03290781|365004494|FG001|Overall Study|Site Terminated by Sponsor|0|||
105821095|NCT03290781|365004495|FG002|Overall Study|Site Terminated by Sponsor|2|||
105821096|NCT03290781|365004496|FG003|Overall Study|Site Terminated by Sponsor|1|||
105821097|NCT03290781|365004497|FG004|Overall Study|Site Terminated by Sponsor|0|||
105821098|NCT03290781|365004498|FG005|Overall Study|Site Terminated by Sponsor|0|||
105821099|NCT03290781|365004499|FG006|Overall Study|Site Terminated by Sponsor|0|||
105821100|NCT03290781|365004493|FG000|Overall Study|Lost to Follow-up|0|||
105821101|NCT03290781|365004494|FG001|Overall Study|Lost to Follow-up|0|||
105821102|NCT03290781|365004495|FG002|Overall Study|Lost to Follow-up|0|||
105821103|NCT03290781|365004496|FG003|Overall Study|Lost to Follow-up|1|||
105821104|NCT03290781|365004497|FG004|Overall Study|Lost to Follow-up|0|||
105821105|NCT03290781|365004498|FG005|Overall Study|Lost to Follow-up|0|||
105821106|NCT03290781|365004499|FG006|Overall Study|Lost to Follow-up|0|||
105821107|NCT03290781|365004493|FG000|Overall Study|Protocol Deviation|2|||
105821108|NCT03290781|365004494|FG001|Overall Study|Protocol Deviation|0|||
105821109|NCT03290781|365004495|FG002|Overall Study|Protocol Deviation|0|||
105821110|NCT03290781|365004496|FG003|Overall Study|Protocol Deviation|1|||
105821111|NCT03290781|365004497|FG004|Overall Study|Protocol Deviation|0|||
105362814|NCT03428100|363332622|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
105362815|NCT03428100|363332623|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
105362816|NCT03428100|363332624|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
105362817|NCT03428100|363332625|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
105362818|NCT03428100|363332626|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
105362819|NCT03428100|363332627|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
105362820|NCT03428100|363332628|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
105362821|NCT03428100|363332629|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
105362822|NCT03428100|363332630|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
105362823|NCT03428100|363332631|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
105486426|NCT00640835|363793310|FG000|Overall Study|Lost to Follow-up|17|||
105821112|NCT03290781|365004498|FG005|Overall Study|Protocol Deviation|0|||
105821113|NCT03290781|365004499|FG006|Overall Study|Protocol Deviation|0|||
105821114|NCT03290781|365004493|FG000|Overall Study|Disease Relapse|32|||
105821115|NCT03290781|365004494|FG001|Overall Study|Disease Relapse|5|||
105821116|NCT03290781|365004495|FG002|Overall Study|Disease Relapse|38|||
105821117|NCT03290781|365004496|FG003|Overall Study|Disease Relapse|7|||
105821118|NCT03290781|365004497|FG004|Overall Study|Disease Relapse|3|||
105821119|NCT03290781|365004498|FG005|Overall Study|Disease Relapse|1|||
105362824|NCT03428100|363332632|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
105362825|NCT03428100|363332633|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
105821120|NCT03290781|365004499|FG006|Overall Study|Disease Relapse|4|||
105821121|NCT03290781|365004493|FG000|Overall Study|Other|3|||
105821122|NCT03290781|365004494|FG001|Overall Study|Other|0|||
105821123|NCT03290781|365004495|FG002|Overall Study|Other|2|||
105821124|NCT03290781|365004496|FG003|Overall Study|Other|2|||
105821125|NCT03290781|365004497|FG004|Overall Study|Other|0|||
105821126|NCT03290781|365004498|FG005|Overall Study|Other|0|||
105821127|NCT03290781|365004499|FG006|Overall Study|Other|0|||
105821128|NCT03238781|365004500|FG000|Overall Study|Adverse Event|1|||
105821129|NCT03238781|365004501|FG001|Overall Study|Adverse Event|1|||
105821130|NCT03238781|365004502|FG002|Overall Study|Adverse Event|2|||
105821131|NCT03238781|365004500|FG000|Overall Study|Lost to Follow-up|2|||
105821132|NCT03238781|365004501|FG001|Overall Study|Lost to Follow-up|1|||
105821133|NCT03238781|365004502|FG002|Overall Study|Lost to Follow-up|2|||
105821134|NCT03238781|365004500|FG000|Overall Study|Withdrawal by Subject|23|||
105821135|NCT03238781|365004501|FG001|Overall Study|Withdrawal by Subject|14|||
105821136|NCT03238781|365004502|FG002|Overall Study|Withdrawal by Subject|16|||
105821137|NCT03238781|365004500|FG000|Overall Study|Decision by sponsor|0|||
105821138|NCT03238781|365004501|FG001|Overall Study|Decision by sponsor|1|||
105821139|NCT03238781|365004502|FG002|Overall Study|Decision by sponsor|0|||
105821140|NCT01577381|365004505|FG000|Overall Study|Discontinued|2|||
105821141|NCT01577381|365004506|FG001|Overall Study|Discontinued|1|||
105821142|NCT01577381|365004507|FG002|Overall Study|Discontinued|2|||
105821143|NCT01577381|365004508|FG003|Overall Study|Discontinued|2|||
105821144|NCT01577381|365004505|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
105821145|NCT01577381|365004506|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
105821146|NCT01577381|365004507|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
105821147|NCT01577381|365004508|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
105821148|NCT01421277|365004511|FG000|Overall Study|Lack of qualifying event|0|||
105821149|NCT01421277|365004512|FG001|Overall Study|Lack of qualifying event|61|||
105821150|NCT01421277|365004511|FG000|Overall Study|Incomplete baseline data|0|||
105821151|NCT01421277|365004512|FG001|Overall Study|Incomplete baseline data|31|||
105821152|NCT00813592|365004513|FG000|Overall Study|Disease assessment was not completed per|2|||
105821153|NCT01097577|365004514|FG000|Overall Study|Adverse Event|0|||
105821154|NCT01097577|365004515|FG001|Overall Study|Adverse Event|1|||
105821155|NCT00467896|365006498|FG000|Overall Study|Consent Withdrawal|18|||
105821156|NCT00467896|365006498|FG000|Overall Study|Adverse Event|7|||
105821157|NCT00467896|365006498|FG000|Overall Study|Serious Adverse Event|13|||
105821158|NCT00467896|365006498|FG000|Overall Study|Non-compliance|3|||
105821159|NCT00467896|365006498|FG000|Overall Study|Changed therapy|2|||
105821160|NCT00467896|365006498|FG000|Overall Study|Patient received transplant|2|||
105821161|NCT00467896|365006498|FG000|Overall Study|Patient had atrial septostomy|1|||
105821162|NCT00467896|365006498|FG000|Overall Study|Patient weaned off iloprost|1|||
105821163|NCT00467896|365006498|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
105821164|NCT00467896|365006498|FG000|Overall Study|Started intravenous prostacyclin|1|||
105821165|NCT00467896|365006498|FG000|Overall Study|Started inhaled Remodulin|1|||
105821166|NCT00467896|365006498|FG000|Overall Study|Patient had no improvement|1|||
105821167|NCT01124175|365006499|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
105821168|NCT01124175|365006500|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
105821169|NCT00462345|365006512|FG000|Overall Study|Withdrawal by Subject|2|||
105821170|NCT00462345|365006512|FG000|Overall Study|Did not complete second course|1|||
105821171|NCT00070291|365006515|FG000|Step 1|Withdrawal by Subject|1|||
105821172|NCT00070291|365006515|FG000|Step 1|Adverse Event|1|||
105821173|NCT00070291|365006515|FG000|Step 2|Adverse Event|1|||
105821174|NCT02028715|365006518|FG000|Overall Study|Adverse Event|2|||
105821175|NCT02028715|365006519|FG001|Overall Study|Adverse Event|2|||
105821176|NCT02028715|365006518|FG000|Overall Study|Physician Decision|1|||
105821177|NCT02028715|365006519|FG001|Overall Study|Physician Decision|0|||
105362826|NCT03428100|363332634|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
105362827|NCT03428100|363332635|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
105362828|NCT03428100|363332636|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
105362829|NCT03428100|363332637|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
105362830|NCT03428100|363332638|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
105362831|NCT03428100|363332620|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105362832|NCT03428100|363332621|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105362833|NCT03428100|363332622|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105821178|NCT02028715|365006518|FG000|Overall Study|Did not complete satisfaction surveys|2|||
105821179|NCT02028715|365006519|FG001|Overall Study|Did not complete satisfaction surveys|2|||
105821180|NCT00520130|365006522|FG000|Overall Study|Disease progression on study|4|||
105821181|NCT00520130|365006523|FG001|Overall Study|Disease progression on study|0|||
105821182|NCT00520130|365006522|FG000|Overall Study|Physician Decision|1|||
105821183|NCT00520130|365006523|FG001|Overall Study|Physician Decision|1|||
105821184|NCT00371839|365006524|FG000|Overall Study|Death|4|||
105821185|NCT00371839|365006525|FG001|Overall Study|Death|0|||
105821186|NCT00371839|365006526|FG002|Overall Study|Death|0|||
105821187|NCT00371839|365006524|FG000|Overall Study|Withdrawal by Subject|7|||
105362834|NCT03428100|363332623|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105486427|NCT00640835|363793311|FG001|Overall Study|Lost to Follow-up|13|||
105821188|NCT00371839|365006525|FG001|Overall Study|Withdrawal by Subject|4|||
105821189|NCT00371839|365006526|FG002|Overall Study|Withdrawal by Subject|0|||
105821190|NCT00371839|365006524|FG000|Overall Study|Lost to Follow-up|6|||
105821191|NCT00371839|365006525|FG001|Overall Study|Lost to Follow-up|3|||
105821192|NCT00371839|365006526|FG002|Overall Study|Lost to Follow-up|2|||
105821193|NCT02724462|365006527|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
105821194|NCT02724462|365006528|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
105821195|NCT02724462|365006527|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
105821196|NCT02724462|365006528|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
105821197|NCT02724462|365006527|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
105362835|NCT03428100|363332624|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105362836|NCT03428100|363332625|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105362837|NCT03428100|363332626|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
105362838|NCT03428100|363332627|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105362839|NCT03428100|363332628|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105362840|NCT03428100|363332629|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105362841|NCT03428100|363332630|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105362842|NCT03428100|363332631|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105362843|NCT03428100|363332632|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105362844|NCT03428100|363332633|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105362845|NCT03428100|363332634|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105362846|NCT03428100|363332635|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105362847|NCT03428100|363332636|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105362848|NCT03428100|363332637|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105362849|NCT03428100|363332638|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
105362850|NCT03428100|363332620|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
105362851|NCT03428100|363332621|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
105362852|NCT03428100|363332622|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
105362853|NCT03428100|363332623|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
105362854|NCT03428100|363332624|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
105362855|NCT03428100|363332625|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
105362856|NCT03428100|363332626|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
105362857|NCT03428100|363332627|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
105362858|NCT03428100|363332628|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
105362859|NCT03428100|363332629|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
105362860|NCT03428100|363332630|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
105362861|NCT03428100|363332631|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
105362862|NCT03428100|363332632|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
105362863|NCT03428100|363332633|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
105362864|NCT03428100|363332634|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
105362865|NCT03428100|363332635|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
105362866|NCT03428100|363332636|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
105362867|NCT03428100|363332637|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
105362868|NCT03428100|363332638|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
105362869|NCT03428100|363332620|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105362870|NCT03428100|363332621|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105362871|NCT03428100|363332622|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105362872|NCT03428100|363332623|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105362873|NCT03428100|363332624|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
105362874|NCT03428100|363332625|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105362875|NCT03428100|363332626|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
105362876|NCT03428100|363332627|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
105362877|NCT03428100|363332628|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105362878|NCT03428100|363332629|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
105362879|NCT03428100|363332630|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
105362880|NCT03428100|363332631|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
105362881|NCT03428100|363332632|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
105362882|NCT03428100|363332633|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
105362883|NCT03428100|363332634|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
105362884|NCT03428100|363332635|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105362885|NCT03428100|363332636|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
105362886|NCT03428100|363332637|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
105362887|NCT03428100|363332638|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105362888|NCT02168491|363332642|FG000|Overall Study|Withdrawal by Subject|1|||
105362889|NCT00676403|363332643|FG000|Overall Study|Adverse Event|1|||
105821198|NCT02724462|365006528|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
105821199|NCT02724462|365006527|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
105821200|NCT02724462|365006528|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
105821201|NCT02724462|365006527|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
105821202|NCT02724462|365006528|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
105821203|NCT02724462|365006527|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
105821204|NCT02724462|365006528|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
105821205|NCT01900691|365006529|FG000|Overall Study|Death|7|||
105821206|NCT01900691|365006529|FG000|Overall Study|Lost to Follow-up|4|||
105821207|NCT01900691|365006529|FG000|Overall Study|Study Device Not Placed|3|||
105821208|NCT01900691|365006529|FG000|Overall Study|Non study stent placed|2|||
105821209|NCT01900691|365006529|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
105821210|NCT01900691|365006529|FG000|Overall Study|Complete stent migration through digestive tract|1|||
105821211|NCT04089735|365006530|FG000|Overall Study|Adverse Event|1|||
105821212|NCT04089735|365006531|FG001|Overall Study|Adverse Event|0|||
105821213|NCT04089735|365006532|FG002|Overall Study|Adverse Event|1|||
105821214|NCT04089735|365006533|FG003|Overall Study|Adverse Event|1|||
105821215|NCT04089735|365006534|FG004|Overall Study|Adverse Event|0|||
105821216|NCT04089735|365006535|FG005|Overall Study|Adverse Event|0|||
105821217|NCT04089735|365006530|FG000|Overall Study|Physician Decision|0|||
105821218|NCT04089735|365006531|FG001|Overall Study|Physician Decision|3|||
105821219|NCT04089735|365006532|FG002|Overall Study|Physician Decision|0|||
105821220|NCT04089735|365006533|FG003|Overall Study|Physician Decision|0|||
105821221|NCT04089735|365006534|FG004|Overall Study|Physician Decision|0|||
105821222|NCT04089735|365006535|FG005|Overall Study|Physician Decision|0|||
105821223|NCT04089735|365006530|FG000|Overall Study|Withdrawal by Subject|0|||
105821224|NCT04089735|365006531|FG001|Overall Study|Withdrawal by Subject|0|||
105821225|NCT04089735|365006532|FG002|Overall Study|Withdrawal by Subject|1|||
105821226|NCT04089735|365006533|FG003|Overall Study|Withdrawal by Subject|0|||
105821227|NCT04089735|365006534|FG004|Overall Study|Withdrawal by Subject|0|||
105821228|NCT04089735|365006535|FG005|Overall Study|Withdrawal by Subject|0|||
105821229|NCT04089735|365006530|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
105821230|NCT04089735|365006531|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
105821231|NCT04089735|365006532|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
105821232|NCT04089735|365006533|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
105821233|NCT04089735|365006534|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
105821234|NCT04089735|365006535|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
105821235|NCT02736721|365006540|FG000|Overall Study|Adverse Event|8|||
105821236|NCT02736721|365006540|FG000|Overall Study|Lost to Follow-up|3|||
105821237|NCT02736721|365006540|FG000|Overall Study|Other|5|||
105821238|NCT02422264|365006541|FG000|Overall Study|Serious Adverse Event|1|||
105821239|NCT02422264|365006542|FG001|Overall Study|Serious Adverse Event|0|||
105821240|NCT02422264|365006541|FG000|Overall Study|Withdrawal by Subject|1|||
105821241|NCT02422264|365006542|FG001|Overall Study|Withdrawal by Subject|2|||
105821242|NCT02422264|365006541|FG000|Overall Study|Migrated/moved from study area|3|||
105821243|NCT02422264|365006542|FG001|Overall Study|Migrated/moved from study area|1|||
105821244|NCT02422264|365006541|FG000|Overall Study|Subject vaccinated outside of the study|0|||
105362890|NCT00676403|363332644|FG001|Overall Study|Adverse Event|2|||
105362891|NCT00676403|363332645|FG002|Overall Study|Adverse Event|0|||
105362892|NCT00676403|363332646|FG003|Overall Study|Adverse Event|5|||
105362893|NCT00676403|363332647|FG004|Overall Study|Adverse Event|1|||
105362894|NCT00676403|363332648|FG005|Overall Study|Adverse Event|2|||
105362895|NCT00676403|363332643|FG000|Overall Study|Lost to Follow-up|0|||
105362896|NCT00676403|363332644|FG001|Overall Study|Lost to Follow-up|0|||
105362897|NCT00676403|363332645|FG002|Overall Study|Lost to Follow-up|0|||
105362898|NCT00676403|363332646|FG003|Overall Study|Lost to Follow-up|0|||
105362899|NCT00676403|363332647|FG004|Overall Study|Lost to Follow-up|0|||
105362900|NCT00676403|363332648|FG005|Overall Study|Lost to Follow-up|1|||
105362901|NCT00676403|363332643|FG000|Overall Study|Reason Unspecified|1|||
105821245|NCT02422264|365006542|FG001|Overall Study|Subject vaccinated outside of the study|1|||
105821246|NCT00934050|365006547|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
105821247|NCT00934050|365006548|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
105821248|NCT00934050|365006549|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
105821249|NCT00934050|365006550|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
105362902|NCT00676403|363332644|FG001|Overall Study|Reason Unspecified|0|||
105821250|NCT00934050|365006551|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
105821251|NCT00934050|365006552|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
105362903|NCT00676403|363332645|FG002|Overall Study|Reason Unspecified|1|||
105362904|NCT00676403|363332646|FG003|Overall Study|Reason Unspecified|0|||
105362905|NCT00676403|363332647|FG004|Overall Study|Reason Unspecified|0|||
105362906|NCT00676403|363332648|FG005|Overall Study|Reason Unspecified|1|||
105362907|NCT00676403|363332643|FG000|Overall Study|Withdrawal by Subject|0|||
105821252|NCT00934050|365006547|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
105821253|NCT00934050|365006548|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
105821254|NCT00934050|365006549|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
105821255|NCT00934050|365006550|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
105821256|NCT00934050|365006551|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
105821257|NCT00934050|365006552|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
105821258|NCT00934050|365006547|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
105821259|NCT00934050|365006548|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
105821260|NCT00934050|365006549|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
105821261|NCT00934050|365006550|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
105821262|NCT00934050|365006551|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
105821263|NCT00934050|365006552|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
105821264|NCT00934050|365006547|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
105821265|NCT00934050|365006548|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
105821266|NCT00934050|365006549|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
105821267|NCT00934050|365006550|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
105821268|NCT00934050|365006551|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
105821269|NCT00934050|365006552|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
105821270|NCT00934050|365006547|FG000|Enrolled After 15 Dec 2009|Death|0|||
105821271|NCT00934050|365006548|FG001|Enrolled After 15 Dec 2009|Death|0|||
105821272|NCT00934050|365006549|FG002|Enrolled After 15 Dec 2009|Death|0|||
105821273|NCT00934050|365006550|FG003|Enrolled After 15 Dec 2009|Death|0|||
105821274|NCT00934050|365006551|FG004|Enrolled After 15 Dec 2009|Death|0|||
105821275|NCT00934050|365006552|FG005|Enrolled After 15 Dec 2009|Death|1|||
105821276|NCT00934050|365006547|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
105821277|NCT00934050|365006548|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
105821278|NCT00934050|365006549|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
105362908|NCT00676403|363332644|FG001|Overall Study|Withdrawal by Subject|0|||
105821279|NCT00934050|365006550|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
105821280|NCT00934050|365006551|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
105821281|NCT00934050|365006552|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
105821282|NCT00934050|365006547|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
105821283|NCT00934050|365006548|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
105821284|NCT00934050|365006549|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
105821285|NCT00934050|365006550|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
105821286|NCT00934050|365006551|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
105821287|NCT00934050|365006552|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
105821288|NCT00461786|365006553|FG000|Overall Study|Entry Criteria Not Met|2|||
105821289|NCT00461786|365006553|FG000|Overall Study|Inevaluable (Never Treated)|1|||
105821290|NCT00835991|365006554|FG000|First Intervention|Adverse Event|0|||
105821291|NCT00835991|365006555|FG001|First Intervention|Adverse Event|1|||
105821292|NCT00835991|365006554|FG000|Washout|Protocol Violation|0|||
105821293|NCT00835991|365006555|FG001|Washout|Protocol Violation|2|||
105821294|NCT00835991|365006554|FG000|Washout|Withdrawal by Subject|3|||
105821295|NCT00835991|365006555|FG001|Washout|Withdrawal by Subject|1|||
105821296|NCT02149420|365006556|FG000|Core Study|Administrative problems|0|||
105821297|NCT02149420|365006557|FG001|Core Study|Administrative problems|1|||
105821298|NCT02149420|365006558|FG002|Core Study|Administrative problems|2|||
105821299|NCT02149420|365006556|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
105821300|NCT02149420|365006557|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
105821301|NCT02149420|365006558|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
105821302|NCT00829673|365006559|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
105821303|NCT00829673|365006560|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
105821304|NCT02378935|365006561|FG000|Overall Study|Lack of Efficacy|10|||
105821305|NCT02378935|365006562|FG001|Overall Study|Lack of Efficacy|0|||
105821306|NCT02378935|365006563|FG002|Overall Study|Lack of Efficacy|2|||
105821307|NCT02378935|365006564|FG003|Overall Study|Lack of Efficacy|6|||
105821308|NCT02378935|365006565|FG004|Overall Study|Lack of Efficacy|0|||
105821309|NCT02378935|365006566|FG005|Overall Study|Lack of Efficacy|0|||
105821310|NCT02378935|365006567|FG006|Overall Study|Lack of Efficacy|0|||
105821311|NCT02378935|365006561|FG000|Overall Study|Death|0|||
105821312|NCT02378935|365006562|FG001|Overall Study|Death|0|||
105821313|NCT02378935|365006563|FG002|Overall Study|Death|1|||
105821314|NCT02378935|365006564|FG003|Overall Study|Death|0|||
105821315|NCT02378935|365006565|FG004|Overall Study|Death|0|||
105821316|NCT02378935|365006566|FG005|Overall Study|Death|0|||
105821317|NCT02378935|365006567|FG006|Overall Study|Death|0|||
105821318|NCT01015703|365006570|FG000|Overall Study|Withdrawal by Subject|0|||
105821319|NCT01015703|365006571|FG001|Overall Study|Withdrawal by Subject|1|||
105821320|NCT01015703|365006572|FG002|Overall Study|Withdrawal by Subject|0|||
105821321|NCT01015703|365006573|FG003|Overall Study|Withdrawal by Subject|0|||
105821322|NCT01015703|365006574|FG004|Overall Study|Withdrawal by Subject|0|||
105821323|NCT01015703|365006570|FG000|Overall Study|Adverse Event|1|||
105821324|NCT01015703|365006571|FG001|Overall Study|Adverse Event|0|||
105821325|NCT01015703|365006572|FG002|Overall Study|Adverse Event|0|||
105821326|NCT01015703|365006573|FG003|Overall Study|Adverse Event|0|||
105821327|NCT01015703|365006574|FG004|Overall Study|Adverse Event|0|||
105821328|NCT01015703|365006570|FG000|Overall Study|Protocol Violation|1|||
105821329|NCT01015703|365006571|FG001|Overall Study|Protocol Violation|0|||
105821330|NCT01015703|365006572|FG002|Overall Study|Protocol Violation|0|||
105821331|NCT01015703|365006573|FG003|Overall Study|Protocol Violation|0|||
105821332|NCT01015703|365006574|FG004|Overall Study|Protocol Violation|0|||
105821333|NCT00627016|365006575|FG000|Overall Study|Adverse Event|1|||
105821334|NCT00627016|365006576|FG001|Overall Study|Adverse Event|1|||
105821335|NCT00627016|365006575|FG000|Overall Study|Protocol Violation|0|||
105821336|NCT00627016|365006576|FG001|Overall Study|Protocol Violation|2|||
105821337|NCT00627016|365006575|FG000|Overall Study|Lost to Follow-up|0|||
105821338|NCT00627016|365006576|FG001|Overall Study|Lost to Follow-up|1|||
105821339|NCT00627016|365006575|FG000|Overall Study|Withdrawal by Subject|2|||
105821340|NCT00627016|365006576|FG001|Overall Study|Withdrawal by Subject|1|||
105821341|NCT00627016|365006575|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
105821342|NCT00627016|365006576|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
105821343|NCT00627016|365006575|FG000|Overall Study|Lack of Efficacy|1|||
105821344|NCT00627016|365006576|FG001|Overall Study|Lack of Efficacy|0|||
105821345|NCT00627016|365006575|FG000|Overall Study|Placed on Excluded Drugs|1|||
105821346|NCT00627016|365006576|FG001|Overall Study|Placed on Excluded Drugs|0|||
105821347|NCT00627016|365006575|FG000|Overall Study|Pregnancy|1|||
105821348|NCT00627016|365006576|FG001|Overall Study|Pregnancy|0|||
105821349|NCT01534663|365006577|FG000|Overall Study|Lost to Follow-up|0|||
105821350|NCT01534663|365006578|FG001|Overall Study|Lost to Follow-up|2|||
105821351|NCT01534663|365006577|FG000|Overall Study|Adverse Event|2|||
105821352|NCT01534663|365006578|FG001|Overall Study|Adverse Event|1|||
105821353|NCT02718326|365006579|FG000|Overall Study|Adverse Event|4|||
105821354|NCT02718326|365006580|FG001|Overall Study|Adverse Event|9|||
105821355|NCT02718326|365006581|FG002|Overall Study|Adverse Event|0|||
105821356|NCT02718326|365006579|FG000|Overall Study|Death|8|||
105821357|NCT02718326|365006580|FG001|Overall Study|Death|1|||
105821358|NCT02718326|365006581|FG002|Overall Study|Death|2|||
105362909|NCT00676403|363332645|FG002|Overall Study|Withdrawal by Subject|0|||
105362910|NCT00676403|363332646|FG003|Overall Study|Withdrawal by Subject|0|||
105362911|NCT00676403|363332647|FG004|Overall Study|Withdrawal by Subject|0|||
105362912|NCT00676403|363332648|FG005|Overall Study|Withdrawal by Subject|1|||
105362913|NCT01610037|363332649|FG000|All Patients|Adverse Event|27|||
105362914|NCT01610037|363332650|FG001|All Patients|Adverse Event|22|||
105362915|NCT01610037|363332651|FG002|All Patients|Adverse Event|26|||
105362916|NCT01610037|363332649|FG000|All Patients|Withdrawal by Subject|12|||
105362917|NCT01610037|363332650|FG001|All Patients|Withdrawal by Subject|10|||
105362918|NCT01610037|363332651|FG002|All Patients|Withdrawal by Subject|20|||
105362919|NCT01610037|363332649|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
105362920|NCT01610037|363332650|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
105362921|NCT01610037|363332651|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
105362922|NCT01610037|363332649|FG000|All Patients|Death|4|||
105362923|NCT01610037|363332650|FG001|All Patients|Death|2|||
105362924|NCT01610037|363332651|FG002|All Patients|Death|1|||
105362925|NCT01610037|363332649|FG000|All Patients|Protocol deviation|4|||
105362926|NCT01610037|363332650|FG001|All Patients|Protocol deviation|3|||
105362927|NCT01610037|363332651|FG002|All Patients|Protocol deviation|3|||
105362928|NCT01610037|363332649|FG000|All Patients|Abnormal laboratory value|1|||
105362929|NCT01610037|363332650|FG001|All Patients|Abnormal laboratory value|1|||
105362930|NCT01610037|363332651|FG002|All Patients|Abnormal laboratory value|0|||
105362931|NCT01610037|363332649|FG000|All Patients|Administrative problems|1|||
105362932|NCT01610037|363332650|FG001|All Patients|Administrative problems|4|||
105362933|NCT01610037|363332651|FG002|All Patients|Administrative problems|4|||
105362934|NCT01610037|363332649|FG000|All Patients|Lost to Follow-up|1|||
105362935|NCT01610037|363332650|FG001|All Patients|Lost to Follow-up|0|||
105362936|NCT01610037|363332651|FG002|All Patients|Lost to Follow-up|0|||
105362937|NCT01610037|363332649|FG000|All Patients|Abnormal test procedure result(s)|0|||
105362938|NCT01610037|363332650|FG001|All Patients|Abnormal test procedure result(s)|1|||
105362939|NCT01610037|363332651|FG002|All Patients|Abnormal test procedure result(s)|3|||
105362940|NCT01610037|363332649|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
105362941|NCT01610037|363332650|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
105362942|NCT01610037|363332651|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
105362943|NCT01610037|363332649|FG000|Treatment and Follow up Period|Death|10|||
105362944|NCT01610037|363332650|FG001|Treatment and Follow up Period|Death|5|||
105362945|NCT01610037|363332651|FG002|Treatment and Follow up Period|Death|4|||
105362946|NCT01610037|363332649|FG000|Treatment and Follow up Period|Administrative problems|1|||
105362947|NCT01610037|363332650|FG001|Treatment and Follow up Period|Administrative problems|3|||
105362948|NCT01610037|363332651|FG002|Treatment and Follow up Period|Administrative problems|2|||
105362949|NCT01610037|363332649|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
105362950|NCT01610037|363332650|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
105362951|NCT01610037|363332651|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
105362952|NCT06400238|363332652|FG000|Overall Study|Started Protocol Therapy|2|||
105362953|NCT06400238|363332652|FG000|Overall Study|Adverse Event|1|||
105362954|NCT06400238|363332652|FG000|Overall Study|Death|1|||
105362955|NCT06400238|363332652|FG000|Overall Study|Disease Progression|27|||
105362956|NCT06400238|363332652|FG000|Overall Study|Withdrawal by Subject|2|||
105362957|NCT06400238|363332652|FG000|Overall Study|Physician Decision|2|||
105821359|NCT02718326|365006579|FG000|Overall Study|Withdrawal by Subject|4|||
105821360|NCT02718326|365006580|FG001|Overall Study|Withdrawal by Subject|9|||
105821361|NCT02718326|365006581|FG002|Overall Study|Withdrawal by Subject|6|||
105821362|NCT02718326|365006579|FG000|Overall Study|Lost to Follow-up|18|||
105821363|NCT02718326|365006580|FG001|Overall Study|Lost to Follow-up|5|||
105821364|NCT02718326|365006581|FG002|Overall Study|Lost to Follow-up|14|||
105821365|NCT02718326|365006579|FG000|Overall Study|Protocol Deviation|1|||
105821366|NCT02718326|365006580|FG001|Overall Study|Protocol Deviation|0|||
105821367|NCT02718326|365006581|FG002|Overall Study|Protocol Deviation|0|||
105362958|NCT05209880|363332653|FG000|1-Month Follow-up|Spoke with Doctor|5|||
105821368|NCT02718326|365006579|FG000|Overall Study|Pregnancy|1|||
105821369|NCT02718326|365006580|FG001|Overall Study|Pregnancy|0|||
105821370|NCT02718326|365006581|FG002|Overall Study|Pregnancy|0|||
105821371|NCT00377260|365006583|FG000|Overall Study|Lost to Follow-up|0|||
105821372|NCT00377260|365006584|FG001|Overall Study|Lost to Follow-up|1|||
105362959|NCT05209880|363332654|FG001|1-Month Follow-up|Spoke with Doctor|5|||
105821373|NCT00377260|365006583|FG000|Overall Study|Withdrawal by Subject|2|||
105362960|NCT05209880|363332653|FG000|1-Month Follow-up|Lost to Follow-up|7|||
105362961|NCT05209880|363332654|FG001|1-Month Follow-up|Lost to Follow-up|9|||
105362962|NCT05209880|363332653|FG000|1-Month Follow-up|Discontinued|0|||
105362963|NCT05209880|363332654|FG001|1-Month Follow-up|Discontinued|1|||
105362964|NCT05209880|363332653|FG000|3-Month Follow-up|Spoke with Doctor|17|||
105362965|NCT05209880|363332654|FG001|3-Month Follow-up|Spoke with Doctor|7|||
105821374|NCT00377260|365006584|FG001|Overall Study|Withdrawal by Subject|4|||
105821375|NCT03154047|365006585|FG000|Overall Study|Death|1|||
105821376|NCT03154047|365006585|FG000|Overall Study|Study terminated by sponsor|76|||
105821377|NCT03154047|365006585|FG000|Overall Study|Withdrawal by Subject|3|||
105821378|NCT02436005|365006586|FG000|Second Intervention|Adverse Event|0|||
105821379|NCT02436005|365006587|FG001|Second Intervention|Adverse Event|1|||
105821380|NCT01558635|365006588|FG000|Overall Study|Death|1|||
105821381|NCT01558635|365006588|FG000|Overall Study|Withdrawal by Subject|2|||
105362966|NCT05209880|363332653|FG000|3-Month Follow-up|Lost to Follow-up|8|||
105362967|NCT05209880|363332654|FG001|3-Month Follow-up|Lost to Follow-up|10|||
105362968|NCT05209880|363332653|FG000|3-Month Follow-up|Discontinued|1|||
105362969|NCT05209880|363332654|FG001|3-Month Follow-up|Discontinued|3|||
105362970|NCT05209880|363332653|FG000|6-Month Follow-up|Spoke with Doctor|25|||
105362971|NCT05209880|363332654|FG001|6-Month Follow-up|Spoke with Doctor|14|||
105362972|NCT05209880|363332653|FG000|6-Month Follow-up|Lost to Follow-up|9|||
105362973|NCT05209880|363332654|FG001|6-Month Follow-up|Lost to Follow-up|14|||
105362974|NCT05209880|363332653|FG000|6-Month Follow-up|Discontinued|1|||
105362975|NCT05209880|363332654|FG001|6-Month Follow-up|Discontinued|3|||
105362976|NCT01411852|363332655|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
105362977|NCT01411852|363332656|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
105362978|NCT01411852|363332655|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
105362979|NCT01411852|363332656|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
105362980|NCT01411852|363332655|FG000|Prehospital Intervention Phase|Found to be under age|0|||
105362981|NCT01411852|363332656|FG001|Prehospital Intervention Phase|Found to be under age|1|||
105362982|NCT01411852|363332655|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
105362983|NCT01411852|363332656|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
105362984|NCT01411852|363332655|FG000|Hospital Intervention Phase|Severe head injury|5|||
105362985|NCT01411852|363332656|FG001|Hospital Intervention Phase|Severe head injury|4|||
105362986|NCT01411852|363332655|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
105362987|NCT01411852|363332656|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
105362988|NCT01411852|363332655|FG000|Hospital Intervention Phase|Miscommunication error|1|||
105362989|NCT01411852|363332656|FG001|Hospital Intervention Phase|Miscommunication error|2|||
105362990|NCT01411852|363332655|FG000|Hospital Intervention Phase|CPR administered|3|||
105362991|NCT01411852|363332656|FG001|Hospital Intervention Phase|CPR administered|1|||
105362992|NCT01411852|363332655|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
105362993|NCT01411852|363332656|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
105362994|NCT01411852|363332655|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
105362995|NCT01411852|363332656|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
105362996|NCT01411852|363332655|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
105362997|NCT01411852|363332656|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
105362998|NCT01411852|363332655|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
105362999|NCT01411852|363332656|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
105363000|NCT01411852|363332655|FG000|Hospital Intervention Phase|Other ineligible|2|||
105363001|NCT01411852|363332656|FG001|Hospital Intervention Phase|Other ineligible|2|||
105363002|NCT01411852|363332655|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
105363003|NCT01411852|363332656|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
105363004|NCT01411852|363332655|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
105363005|NCT01411852|363332656|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
105363006|NCT01411852|363332655|FG000|Hospital Intervention Phase|Vascular access failed|1|||
105363007|NCT01411852|363332656|FG001|Hospital Intervention Phase|Vascular access failed|0|||
105363008|NCT03743025|363332657|FG000|Overall Study|Surgery was cancelled|2|||
105363009|NCT03743025|363332658|FG001|Overall Study|Surgery was cancelled|1|||
105363010|NCT00807885|363332660|FG000|Overall Study|Lost to Follow-up|0|||
105363011|NCT00807885|363332661|FG001|Overall Study|Lost to Follow-up|0|||
105363012|NCT00807885|363332662|FG002|Overall Study|Lost to Follow-up|0|||
105363013|NCT00807885|363332663|FG003|Overall Study|Lost to Follow-up|0|||
105363014|NCT00807885|363332664|FG004|Overall Study|Lost to Follow-up|0|||
105363015|NCT00807885|363332665|FG005|Overall Study|Lost to Follow-up|1|||
105363016|NCT00807885|363332666|FG006|Overall Study|Lost to Follow-up|0|||
105363017|NCT00807885|363332667|FG007|Overall Study|Lost to Follow-up|0|||
105363018|NCT00807885|363332668|FG008|Overall Study|Lost to Follow-up|0|||
105363019|NCT03489343|363332672|FG000|Overall Study|Documented progressive disease|1|||
105486428|NCT00640835|363793310|FG000|Overall Study|Other Reason|19|||
105486429|NCT00640835|363793311|FG001|Overall Study|Other Reason|4|||
105363020|NCT03489343|363332673|FG001|Overall Study|Documented progressive disease|0|||
105363021|NCT03489343|363332674|FG002|Overall Study|Documented progressive disease|3|||
105363022|NCT03489343|363332675|FG003|Overall Study|Documented progressive disease|1|||
105363023|NCT03489343|363332676|FG004|Overall Study|Documented progressive disease|3|||
105363024|NCT03489343|363332677|FG005|Overall Study|Documented progressive disease|5|||
105363025|NCT03489343|363332678|FG006|Overall Study|Documented progressive disease|4|||
105363026|NCT03489343|363332672|FG000|Overall Study|Adverse Event|0|||
105363027|NCT03489343|363332673|FG001|Overall Study|Adverse Event|1|||
105363028|NCT03489343|363332674|FG002|Overall Study|Adverse Event|0|||
105363029|NCT03489343|363332675|FG003|Overall Study|Adverse Event|0|||
105486430|NCT01741012|363793312|FG000|Overall Study|Lost to Follow-up|1|||
105821382|NCT01558635|365006588|FG000|Overall Study|Physician Decision|1|||
105363030|NCT03489343|363332676|FG004|Overall Study|Adverse Event|0|||
105363031|NCT03489343|363332677|FG005|Overall Study|Adverse Event|1|||
105363032|NCT03489343|363332678|FG006|Overall Study|Adverse Event|0|||
105363033|NCT03489343|363332672|FG000|Overall Study|Withdrawal by Subject|0|||
105363034|NCT03489343|363332673|FG001|Overall Study|Withdrawal by Subject|0|||
105363035|NCT03489343|363332674|FG002|Overall Study|Withdrawal by Subject|0|||
105363036|NCT03489343|363332675|FG003|Overall Study|Withdrawal by Subject|1|||
105363037|NCT03489343|363332676|FG004|Overall Study|Withdrawal by Subject|0|||
105363038|NCT03489343|363332677|FG005|Overall Study|Withdrawal by Subject|1|||
105363039|NCT03489343|363332678|FG006|Overall Study|Withdrawal by Subject|1|||
105363040|NCT03489343|363332672|FG000|Overall Study|Clinical progression|0|||
105363041|NCT03489343|363332673|FG001|Overall Study|Clinical progression|0|||
105363042|NCT03489343|363332674|FG002|Overall Study|Clinical progression|0|||
105363043|NCT03489343|363332675|FG003|Overall Study|Clinical progression|1|||
105363044|NCT03489343|363332676|FG004|Overall Study|Clinical progression|0|||
105363045|NCT03489343|363332677|FG005|Overall Study|Clinical progression|0|||
105363046|NCT03489343|363332678|FG006|Overall Study|Clinical progression|1|||
105363047|NCT00327717|363332679|FG000|Overall Study|Adverse Event|6|||
105363048|NCT00327717|363332680|FG001|Overall Study|Adverse Event|6|||
105363049|NCT00327717|363332679|FG000|Overall Study|Lack of Efficacy|0|||
105363050|NCT00327717|363332680|FG001|Overall Study|Lack of Efficacy|1|||
105363051|NCT00327717|363332679|FG000|Overall Study|Withdrawal by Subject|3|||
105363052|NCT00327717|363332680|FG001|Overall Study|Withdrawal by Subject|7|||
105363053|NCT01158261|363332681|FG000|Overall Study|Lost to Follow-up|9|||
105363054|NCT01158261|363332681|FG000|Overall Study|Death|7|||
105363055|NCT01158261|363332681|FG000|Overall Study|Withdrawal by Subject|1|||
105363056|NCT03143101|363332682|FG000|Overall Study|Withdrawal by Subject|0|||
105363057|NCT03143101|363332683|FG001|Overall Study|Withdrawal by Subject|1|||
105363058|NCT03143101|363332684|FG002|Overall Study|Withdrawal by Subject|0|||
105363059|NCT03143101|363332682|FG000|Overall Study|Lost to Follow-up|2|||
105363060|NCT03143101|363332683|FG001|Overall Study|Lost to Follow-up|2|||
105363061|NCT03143101|363332684|FG002|Overall Study|Lost to Follow-up|0|||
105363062|NCT02899065|363332685|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
105486431|NCT01741012|363793312|FG000|Overall Study|Withdrawal by Subject|2|||
105821383|NCT01558635|365006588|FG000|Overall Study|Subject received other treatment|1|||
105363063|NCT02899065|363332686|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
105363064|NCT02899065|363332685|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
105363065|NCT02899065|363332686|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
105363066|NCT02899065|363332685|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
105363067|NCT02899065|363332686|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
105363068|NCT00593918|363332689|FG000|Overall Study|Withdrawal by Subject|5|||
105363069|NCT00593918|363332690|FG001|Overall Study|Withdrawal by Subject|24|||
105363070|NCT01601496|363332691|FG000|Overall Study|Physician Decision|1|||
105363071|NCT01601496|363332691|FG000|Overall Study|Withdrawal by Subject|1|||
105363072|NCT01601496|363332691|FG000|Overall Study|Lost to Follow-up|6|||
105363073|NCT01601496|363332691|FG000|Overall Study|Death|4|||
105363074|NCT01601496|363332691|FG000|Overall Study|Other: patient refusal to continue|3|||
105363075|NCT01585246|363332693|FG000|Overall Study|Lost to Follow-up|0|||
105363076|NCT01585246|363332694|FG001|Overall Study|Lost to Follow-up|0|||
105363077|NCT01585246|363332695|FG002|Overall Study|Lost to Follow-up|2|||
105363078|NCT01585246|363332696|FG003|Overall Study|Lost to Follow-up|1|||
105363079|NCT01585246|363332697|FG004|Overall Study|Lost to Follow-up|0|||
105363080|NCT01585246|363332693|FG000|Overall Study|Protocol Violation|0|||
105363081|NCT01585246|363332694|FG001|Overall Study|Protocol Violation|0|||
105363082|NCT01585246|363332695|FG002|Overall Study|Protocol Violation|0|||
105363083|NCT01585246|363332696|FG003|Overall Study|Protocol Violation|0|||
105363084|NCT01585246|363332697|FG004|Overall Study|Protocol Violation|1|||
105363085|NCT01585246|363332693|FG000|Overall Study|Withdrawal by Subject|0|||
105363086|NCT01585246|363332694|FG001|Overall Study|Withdrawal by Subject|0|||
105821384|NCT01558635|365006588|FG000|Overall Study|Reveal XT was explanted|1|||
105821385|NCT00448019|365006594|FG000|Overall Study|Withdrawal by Subject|3|||
105821386|NCT00448019|365006594|FG000|Overall Study|Disease progression|1|||
105363087|NCT01585246|363332695|FG002|Overall Study|Withdrawal by Subject|1|||
105363088|NCT01585246|363332696|FG003|Overall Study|Withdrawal by Subject|2|||
105363089|NCT01585246|363332697|FG004|Overall Study|Withdrawal by Subject|1|||
105363090|NCT01585246|363332693|FG000|Overall Study|Other|0|||
105363091|NCT01585246|363332694|FG001|Overall Study|Other|1|||
105363092|NCT01585246|363332695|FG002|Overall Study|Other|1|||
105363093|NCT01585246|363332696|FG003|Overall Study|Other|1|||
105363094|NCT01585246|363332697|FG004|Overall Study|Other|0|||
105363095|NCT03113968|363332700|FG000|Overall Study|Withdrawal by Subject|31|||
105363096|NCT03113968|363332701|FG001|Overall Study|Withdrawal by Subject|4|||
105363097|NCT02111174|363332702|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
105363098|NCT02111174|363332703|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
105486432|NCT01249118|363793313|FG000|First Washout Period|Physician Decision|0|||
105486433|NCT01249118|363793314|FG001|First Washout Period|Physician Decision|1|||
105363099|NCT02111174|363332702|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
105363100|NCT02111174|363332703|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
105363101|NCT02111174|363332702|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
105363102|NCT02111174|363332703|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
105363103|NCT02111174|363332702|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
105363104|NCT02111174|363332703|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
105363105|NCT01657162|363332704|FG000|Overall Study|Adverse Event|26|||
105363106|NCT01657162|363332705|FG001|Overall Study|Adverse Event|36|||
105363107|NCT01657162|363332704|FG000|Overall Study|Withdrawal by Subject|13|||
105363108|NCT01657162|363332705|FG001|Overall Study|Withdrawal by Subject|13|||
105363109|NCT01657162|363332704|FG000|Overall Study|Continuing Significant Deterioration|9|||
105363110|NCT01657162|363332705|FG001|Overall Study|Continuing Significant Deterioration|3|||
105363111|NCT01657162|363332704|FG000|Overall Study|Refusal of Treatment|4|||
105363112|NCT01657162|363332705|FG001|Overall Study|Refusal of Treatment|6|||
105363113|NCT01657162|363332704|FG000|Overall Study|Lost to Follow-up|3|||
105363114|NCT01657162|363332705|FG001|Overall Study|Lost to Follow-up|4|||
105363115|NCT01657162|363332704|FG000|Overall Study|Death|2|||
105363116|NCT01657162|363332705|FG001|Overall Study|Death|3|||
105363117|NCT01657162|363332704|FG000|Overall Study|Inability to Complete Study Procedures|1|||
105363118|NCT01657162|363332705|FG001|Overall Study|Inability to Complete Study Procedures|7|||
105363119|NCT01657162|363332704|FG000|Overall Study|Protocol Violation|1|||
105363120|NCT01657162|363332705|FG001|Overall Study|Protocol Violation|0|||
105363121|NCT01657162|363332704|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
105363122|NCT01657162|363332705|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
105363123|NCT01657162|363332704|FG000|Overall Study|Other than Specified|0|||
105363124|NCT01657162|363332705|FG001|Overall Study|Other than Specified|2|||
105363125|NCT00871234|363332706|FG000|Overall Study|Adverse Event|2|||
105363126|NCT00871234|363332706|FG000|Overall Study|Lost to Follow-up|3|||
105363127|NCT03380377|363332707|FG000|Overall Study|Physician Decision|1|||
105363128|NCT03380377|363332707|FG000|Overall Study|Withdrawal by Subject|1|||
105363129|NCT00128661|363332708|FG000|Overall Study|Adverse Event|14|||
105363130|NCT00128661|363332709|FG001|Overall Study|Adverse Event|11|||
105363131|NCT00128661|363332708|FG000|Overall Study|Lost to Follow-up|10|||
105363132|NCT00128661|363332709|FG001|Overall Study|Lost to Follow-up|7|||
105363133|NCT00128661|363332708|FG000|Overall Study|Withdrawal by Subject|243|||
105363134|NCT00128661|363332709|FG001|Overall Study|Withdrawal by Subject|232|||
105363135|NCT00128661|363332708|FG000|Overall Study|Other|7|||
105363136|NCT00128661|363332709|FG001|Overall Study|Other|8|||
105363137|NCT03421379|363332711|FG000|Period 1|Withdrawal by Subject|0|||
105363138|NCT03421379|363332712|FG001|Period 1|Withdrawal by Subject|1|||
105363139|NCT03421379|363332711|FG000|Period 1|Physician Decision|1|||
105363140|NCT03421379|363332712|FG001|Period 1|Physician Decision|1|||
105363141|NCT03421379|363332711|FG000|Period 1|Did not receive treatment|1|||
105363142|NCT03421379|363332712|FG001|Period 1|Did not receive treatment|2|||
105363143|NCT02782741|363332713|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
105363144|NCT02782741|363332714|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
105363145|NCT02782741|363332715|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
105571685|NCT00041756|364092737|FG003|Overall Study|Protocol Violation|2|||
105363146|NCT02782741|363332713|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
105363147|NCT02782741|363332714|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
105363148|NCT02782741|363332715|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
105363149|NCT02782741|363332713|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
105363150|NCT02782741|363332714|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
105363151|NCT02782741|363332715|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
105363152|NCT02782741|363332713|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
105363153|NCT02782741|363332714|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
105363154|NCT02782741|363332715|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
105363155|NCT02782741|363332713|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
105766172|NCT00446797|364795997|FG000|Overall Study|subject entered at another site|0|||
105766173|NCT00446797|364795998|FG001|Overall Study|subject entered at another site|1|||
105766174|NCT00446797|364795997|FG000|Overall Study|did not meet entrance criteria|0|||
105766175|NCT00446797|364795998|FG001|Overall Study|did not meet entrance criteria|1|||
105766176|NCT00511108|364795999|FG000|Overall Study|Adverse Event|2|||
105766177|NCT00511108|364796000|FG001|Overall Study|Adverse Event|0|||
105766178|NCT00511108|364796001|FG002|Overall Study|Adverse Event|1|||
105766179|NCT00511108|364796002|FG003|Overall Study|Adverse Event|2|||
105766180|NCT00511108|364795999|FG000|Overall Study|Lost to Follow-up|0|||
105766181|NCT00511108|364796000|FG001|Overall Study|Lost to Follow-up|2|||
105766182|NCT00511108|364796001|FG002|Overall Study|Lost to Follow-up|1|||
105766183|NCT00511108|364796002|FG003|Overall Study|Lost to Follow-up|0|||
105766184|NCT00511108|364795999|FG000|Overall Study|Physician Decision|0|||
105766185|NCT00511108|364796000|FG001|Overall Study|Physician Decision|0|||
105766186|NCT00511108|364796001|FG002|Overall Study|Physician Decision|0|||
105766187|NCT00511108|364796002|FG003|Overall Study|Physician Decision|1|||
105766188|NCT00511108|364795999|FG000|Overall Study|Withdrawal by Subject|4|||
105766189|NCT00511108|364796000|FG001|Overall Study|Withdrawal by Subject|0|||
105766190|NCT00511108|364796001|FG002|Overall Study|Withdrawal by Subject|3|||
105766191|NCT00511108|364796002|FG003|Overall Study|Withdrawal by Subject|2|||
105766192|NCT02044822|364796003|FG000|Overall Study|Study Terminated by Sponsor|77|||
105766193|NCT02044822|364796003|FG000|Overall Study|Investigator's Discretion|10|||
105766194|NCT02044822|364796003|FG000|Overall Study|Withdrew Consent|3|||
105766195|NCT02044822|364796003|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
105766196|NCT02044822|364796003|FG000|Overall Study|Lost to Follow-up|1|||
105766197|NCT02147691|364796004|FG000|Overall Study|Withdrawal by Subject|2|||
105766198|NCT02147691|364796005|FG001|Overall Study|Withdrawal by Subject|0|||
105766199|NCT02147691|364796004|FG000|Overall Study|Adverse Event|2|||
105766200|NCT02147691|364796005|FG001|Overall Study|Adverse Event|0|||
105766201|NCT02147691|364796004|FG000|Overall Study|Lost to Follow-up|0|||
105766202|NCT02147691|364796005|FG001|Overall Study|Lost to Follow-up|1|||
105766203|NCT02025530|364796008|FG000|Overall Study|No longer met elligibility criteria|5|||
105766204|NCT02025530|364796009|FG001|Overall Study|No longer met elligibility criteria|1|||
105766205|NCT03417505|364796010|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
105766206|NCT03417505|364796011|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
105766207|NCT04211961|364796018|FG000|Overall Study|Death|0|||
105766208|NCT04211961|364796019|FG001|Overall Study|Death|1|||
105766209|NCT04211961|364796018|FG000|Overall Study|Lost to Follow-up|0|||
105766210|NCT04211961|364796019|FG001|Overall Study|Lost to Follow-up|1|||
105766211|NCT04211961|364796018|FG000|Overall Study|Withdrawal by Subject|0|||
105766212|NCT04211961|364796019|FG001|Overall Study|Withdrawal by Subject|1|||
105766213|NCT00420342|364796020|FG000|Overall Study|Lost to Follow-up|1|||
105766214|NCT00420342|364796021|FG001|Overall Study|Lost to Follow-up|0|||
105766215|NCT00420342|364796022|FG002|Overall Study|Lost to Follow-up|1|||
105766216|NCT00420342|364796020|FG000|Overall Study|Withdrawal by Subject|0|||
105766217|NCT00420342|364796021|FG001|Overall Study|Withdrawal by Subject|2|||
105766218|NCT00420342|364796022|FG002|Overall Study|Withdrawal by Subject|0|||
105766219|NCT01237223|364796029|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
105766220|NCT01237223|364796030|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
105766221|NCT01237223|364796031|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
105766222|NCT01237223|364796032|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
105766223|NCT01237223|364796033|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
105766224|NCT01237223|364796034|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
105766225|NCT01237223|364796029|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
105766226|NCT01237223|364796030|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
105766227|NCT01237223|364796031|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
105766228|NCT01237223|364796032|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
105766229|NCT01237223|364796033|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
105766230|NCT01237223|364796034|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
105766231|NCT01237223|364796029|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
105766232|NCT01237223|364796030|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
105766233|NCT01237223|364796031|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
105766234|NCT01237223|364796032|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
105766235|NCT01237223|364796033|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
105766236|NCT01237223|364796034|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
105766237|NCT01237223|364796029|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
105766238|NCT01237223|364796030|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
105821387|NCT00448019|365006594|FG000|Overall Study|Death|2|||
105821388|NCT00448019|365006594|FG000|Overall Study|Insurance Issues|1|||
105821389|NCT02543203|365006595|FG000|Overall Study|Unpalatable Fragrance|2|||
105821390|NCT02543203|365006596|FG001|Overall Study|Unpalatable Fragrance|2|||
105821391|NCT02543203|365006595|FG000|Overall Study|Lost to Follow-up|1|||
105821392|NCT02543203|365006596|FG001|Overall Study|Lost to Follow-up|0|||
105821393|NCT02543203|365006595|FG000|Overall Study|Increased Irritability|1|||
105821394|NCT02543203|365006596|FG001|Overall Study|Increased Irritability|0|||
105821395|NCT02543203|365006595|FG000|Overall Study|Family|1|||
105821396|NCT02543203|365006596|FG001|Overall Study|Family|2|||
105821397|NCT02543203|365006595|FG000|Overall Study|Negative Behavior|1|||
105821398|NCT02543203|365006596|FG001|Overall Study|Negative Behavior|0|||
105821399|NCT02543203|365006595|FG000|Overall Study|Withdrawal by Subject|0|||
105821400|NCT02543203|365006596|FG001|Overall Study|Withdrawal by Subject|1|||
105821401|NCT00089661|365006597|FG000|Overall Study|Adverse Event|0|||
105821402|NCT00089661|365006598|FG001|Overall Study|Adverse Event|2|||
105821403|NCT00089661|365006597|FG000|Overall Study|Death|1|||
105821404|NCT00089661|365006598|FG001|Overall Study|Death|0|||
105821405|NCT00089661|365006597|FG000|Overall Study|Lost to Follow-up|0|||
105821406|NCT00089661|365006598|FG001|Overall Study|Lost to Follow-up|3|||
105821407|NCT00089661|365006597|FG000|Overall Study|Withdrawal by Subject|11|||
105363156|NCT02782741|363332714|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
105363157|NCT02782741|363332715|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
105363158|NCT04157088|363332717|FG000|Overall Study|Study terminated by sponsor|23|||
105363159|NCT04157088|363332717|FG000|Overall Study|Withdrawal by Subject|4|||
105363160|NCT04157088|363332717|FG000|Overall Study|Lost to Follow-up|2|||
105363161|NCT04157088|363332717|FG000|Overall Study|Death|1|||
105363162|NCT04058028|363332721|FG000|Overall Study|Withdrawal of Consent from Study|12|||
105363163|NCT04058028|363332722|FG001|Overall Study|Withdrawal of Consent from Study|8|||
105821408|NCT00089661|365006598|FG001|Overall Study|Withdrawal by Subject|9|||
105821409|NCT00089661|365006597|FG000|Overall Study|Disease progression|1|||
105821410|NCT00089661|365006598|FG001|Overall Study|Disease progression|3|||
105821411|NCT00089661|365006597|FG000|Overall Study|Ineligibility determined|4|||
105821412|NCT00089661|365006598|FG001|Overall Study|Ineligibility determined|4|||
105363164|NCT04058028|363332723|FG002|Overall Study|Withdrawal of Consent from Study|6|||
105363165|NCT04058028|363332724|FG003|Overall Study|Withdrawal of Consent from Study|7|||
105363166|NCT04058028|363332721|FG000|Overall Study|Decision by Sponsor|13|||
105363167|NCT04058028|363332722|FG001|Overall Study|Decision by Sponsor|4|||
105363168|NCT04058028|363332723|FG002|Overall Study|Decision by Sponsor|1|||
105363169|NCT04058028|363332724|FG003|Overall Study|Decision by Sponsor|35|||
105363170|NCT04058028|363332721|FG000|Overall Study|Lost to Follow-up|1|||
105363171|NCT04058028|363332722|FG001|Overall Study|Lost to Follow-up|1|||
105363172|NCT04058028|363332723|FG002|Overall Study|Lost to Follow-up|1|||
105363173|NCT04058028|363332724|FG003|Overall Study|Lost to Follow-up|0|||
105363174|NCT04058028|363332721|FG000|Overall Study|Death|0|||
105363175|NCT04058028|363332722|FG001|Overall Study|Death|1|||
105363176|NCT04058028|363332723|FG002|Overall Study|Death|0|||
105363177|NCT04058028|363332724|FG003|Overall Study|Death|0|||
105363178|NCT01598610|363332727|FG000|Overall Study|Adverse Event|1|||
105363179|NCT04622969|363332728|FG000|Overall Study|Withdrawal by Subject|2|||
105363180|NCT04622969|363332729|FG001|Overall Study|Withdrawal by Subject|3|||
105363181|NCT00810199|363332737|FG000|Overall Study|Adverse Event|24|||
105363182|NCT00810199|363332738|FG001|Overall Study|Adverse Event|26|||
105363183|NCT00810199|363332737|FG000|Overall Study|Death|4|||
105363184|NCT00810199|363332738|FG001|Overall Study|Death|6|||
105363185|NCT00810199|363332737|FG000|Overall Study|Withdrew consent|9|||
105363186|NCT00810199|363332738|FG001|Overall Study|Withdrew consent|12|||
105363187|NCT00810199|363332737|FG000|Overall Study|Insufficient therapeutic response|5|||
105363188|NCT00810199|363332738|FG001|Overall Study|Insufficient therapeutic response|14|||
105363189|NCT00810199|363332737|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
105363190|NCT00810199|363332738|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
105363191|NCT00810199|363332737|FG000|Overall Study|Administrative/Other|5|||
105363192|NCT00810199|363332738|FG001|Overall Study|Administrative/Other|6|||
105363193|NCT00810199|363332737|FG000|Overall Study|Protocol Violation|2|||
105821413|NCT00089661|365006597|FG000|Overall Study|Noncompliance|2|||
105821414|NCT00089661|365006598|FG001|Overall Study|Noncompliance|4|||
105363194|NCT00810199|363332738|FG001|Overall Study|Protocol Violation|6|||
105363195|NCT00810199|363332737|FG000|Overall Study|Failure to return|1|||
105363196|NCT00810199|363332738|FG001|Overall Study|Failure to return|4|||
105363197|NCT00810199|363332737|FG000|Overall Study|Did not receive study drug|2|||
105363198|NCT00810199|363332738|FG001|Overall Study|Did not receive study drug|1|||
105363199|NCT00181883|363332747|FG000|Overall Study|Lack of Efficacy|2|||
105363200|NCT00181883|363332747|FG000|Overall Study|Treatment Limiting AEs|3|||
105363201|NCT00181883|363332747|FG000|Overall Study|Withdrawal by Subject|4|||
105363202|NCT00181883|363332747|FG000|Overall Study|Lost to Follow-up|1|||
105363203|NCT04001803|363332749|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
105363204|NCT04001803|363332749|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
105821415|NCT00089661|365006597|FG000|Overall Study|Other|2|||
105821416|NCT00089661|365006598|FG001|Overall Study|Other|1|||
105821417|NCT01273805|365006603|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
105821418|NCT01273805|365006604|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
105821419|NCT02647944|365006605|FG000|Overall Study|Withdrawal by Subject|0|||
105821420|NCT02647944|365006606|FG001|Overall Study|Withdrawal by Subject|3|||
105821421|NCT02647944|365006605|FG000|Overall Study|Adverse Event|2|||
105821422|NCT02647944|365006606|FG001|Overall Study|Adverse Event|0|||
105821423|NCT02077465|365006607|FG000|Overall Study|Withdrew Consent|0|||
105821424|NCT02077465|365006608|FG001|Overall Study|Withdrew Consent|1|||
105821425|NCT02077465|365006607|FG000|Overall Study|Lost to Follow-up|1|||
105821426|NCT02077465|365006608|FG001|Overall Study|Lost to Follow-up|0|||
105821427|NCT02760368|365006610|FG000|Overall Study|Withdrawal by Subject|8|||
105821428|NCT02760368|365006611|FG001|Overall Study|Withdrawal by Subject|12|||
105821429|NCT02760368|365006612|FG002|Overall Study|Withdrawal by Subject|9|||
105821430|NCT02760368|365006610|FG000|Overall Study|Screen Failure|0|||
105821431|NCT02760368|365006611|FG001|Overall Study|Screen Failure|0|||
105821432|NCT02760368|365006612|FG002|Overall Study|Screen Failure|1|||
105821433|NCT02760368|365006610|FG000|Overall Study|Death|0|||
105821434|NCT02760368|365006611|FG001|Overall Study|Death|1|||
105821435|NCT02760368|365006612|FG002|Overall Study|Death|0|||
105363205|NCT04001803|363332749|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
105363206|NCT04001803|363332749|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
105363207|NCT04001803|363332749|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
105363208|NCT04001803|363332749|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
105486434|NCT01249118|363793315|FG002|First Washout Period|Physician Decision|0|||
105363209|NCT04001803|363332749|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
105363210|NCT04001803|363332749|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
105363211|NCT04001803|363332749|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
105363212|NCT04001803|363332749|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
105821436|NCT02760368|365006610|FG000|Overall Study|Withdrawal by Sponsor|0|||
105821437|NCT02760368|365006611|FG001|Overall Study|Withdrawal by Sponsor|0|||
105821438|NCT02760368|365006612|FG002|Overall Study|Withdrawal by Sponsor|1|||
105486435|NCT00737464|363793322|FG000|Overall Study|Adverse Event|1|||
105821439|NCT01827163|365006613|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
105821440|NCT01827163|365006613|FG000|Overall Study|Adverse Event|9|||
105821441|NCT01037114|365006614|FG000|Year 20|Others|1|||
105821442|NCT01792635|365006619|FG000|Part B|Adverse Event|0|||
105821443|NCT01792635|365006620|FG001|Part B|Adverse Event|0|||
105821444|NCT01792635|365006621|FG002|Part B|Adverse Event|1|||
105821445|NCT01792635|365006619|FG000|Part B|Study terminated|0|||
105821446|NCT01792635|365006620|FG001|Part B|Study terminated|4|||
105821447|NCT01792635|365006621|FG002|Part B|Study terminated|3|||
105821448|NCT02294604|365006624|FG000|Overall Study|Did not provide samples for culture|0|||
105821449|NCT02294604|365006625|FG001|Overall Study|Did not provide samples for culture|1|||
105821450|NCT02294604|365006626|FG002|Overall Study|Did not provide samples for culture|0|||
105821451|NCT02294604|365006624|FG000|Overall Study|Culture contamination|1|||
105821452|NCT02294604|365006625|FG001|Overall Study|Culture contamination|2|||
105821453|NCT02294604|365006626|FG002|Overall Study|Culture contamination|0|||
105821454|NCT00968812|365006630|FG000|Overall Study|Adverse Event|30|||
105821455|NCT00968812|365006631|FG001|Overall Study|Adverse Event|46|||
105821456|NCT00968812|365006632|FG002|Overall Study|Adverse Event|33|||
105821457|NCT00968812|365006630|FG000|Overall Study|Death|2|||
105821458|NCT00968812|365006631|FG001|Overall Study|Death|2|||
105821459|NCT00968812|365006632|FG002|Overall Study|Death|1|||
105821460|NCT00968812|365006630|FG000|Overall Study|Lack of Efficacy|9|||
105821461|NCT00968812|365006631|FG001|Overall Study|Lack of Efficacy|7|||
105821462|NCT00968812|365006632|FG002|Overall Study|Lack of Efficacy|16|||
105821463|NCT00968812|365006630|FG000|Overall Study|Lost to Follow-up|17|||
105821464|NCT00968812|365006631|FG001|Overall Study|Lost to Follow-up|12|||
105821465|NCT00968812|365006632|FG002|Overall Study|Lost to Follow-up|11|||
105821466|NCT00968812|365006630|FG000|Overall Study|Physician Decision|8|||
105821467|NCT00968812|365006631|FG001|Overall Study|Physician Decision|5|||
105821468|NCT00968812|365006632|FG002|Overall Study|Physician Decision|9|||
105821469|NCT00968812|365006630|FG000|Overall Study|Protocol Violation|7|||
105821470|NCT00968812|365006631|FG001|Overall Study|Protocol Violation|4|||
105821471|NCT00968812|365006632|FG002|Overall Study|Protocol Violation|3|||
105821472|NCT00968812|365006630|FG000|Overall Study|Withdrawal by Subject|17|||
105821473|NCT00968812|365006631|FG001|Overall Study|Withdrawal by Subject|23|||
105821474|NCT00968812|365006632|FG002|Overall Study|Withdrawal by Subject|25|||
105821475|NCT00968812|365006630|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
105821476|NCT00968812|365006631|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
105821477|NCT00968812|365006632|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
105821478|NCT00968812|365006630|FG000|Overall Study|Noncompliance with study drug|4|||
105821479|NCT00968812|365006631|FG001|Overall Study|Noncompliance with study drug|1|||
105821480|NCT00968812|365006632|FG002|Overall Study|Noncompliance with study drug|6|||
105821481|NCT00968812|365006630|FG000|Overall Study|Unable to take rescue therapy|12|||
105821482|NCT00968812|365006631|FG001|Overall Study|Unable to take rescue therapy|12|||
105821483|NCT00968812|365006632|FG002|Overall Study|Unable to take rescue therapy|17|||
105821484|NCT00968812|365006630|FG000|Overall Study|Other|25|||
105821485|NCT00968812|365006631|FG001|Overall Study|Other|37|||
105821486|NCT00968812|365006632|FG002|Overall Study|Other|40|||
105821487|NCT03098394|365006636|FG000|Overall Study|Pregnancy|0|||
105821488|NCT03098394|365006637|FG001|Overall Study|Pregnancy|1|||
105821489|NCT01294917|365006644|FG000|Overall Study|Relocation|5|||
105821490|NCT01294917|365006644|FG000|Overall Study|Inconvenience|1|||
105821491|NCT01208337|365006649|FG000|Overall Study|Death|3|||
105821492|NCT02645409|365006650|FG000|Overall Study|Withdrawal by Subject|3|||
105821493|NCT02645409|365006651|FG001|Overall Study|Withdrawal by Subject|0|||
105821494|NCT02645409|365006650|FG000|Overall Study|Physician Decision|1|||
105821495|NCT02645409|365006651|FG001|Overall Study|Physician Decision|0|||
105821496|NCT03084471|365006654|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
105821497|NCT03084471|365006654|FG000|Overall Study|Condition under investigation worsened|84|||
105821498|NCT03084471|365006654|FG000|Overall Study|Lack of therapeutic response|2|||
105821499|NCT03084471|365006654|FG000|Overall Study|Protocol Violation|1|||
105821500|NCT03084471|365006654|FG000|Overall Study|Adverse Event|73|||
105821501|NCT03084471|365006654|FG000|Overall Study|Withdrawal by Subject|12|||
105821502|NCT03084471|365006654|FG000|Overall Study|Disease relapse|181|||
105821503|NCT03084471|365006654|FG000|Overall Study|Subjective disease progression|359|||
105363213|NCT01945944|363332752|FG000|Overall Study|Adverse Event|0|||
105363214|NCT01945944|363332753|FG001|Overall Study|Adverse Event|2|||
105363215|NCT01945944|363332752|FG000|Overall Study|Physician Decision|1|||
105363216|NCT01945944|363332753|FG001|Overall Study|Physician Decision|0|||
105363217|NCT01945944|363332752|FG000|Overall Study|Withdrawal by Subject|0|||
105363218|NCT01945944|363332753|FG001|Overall Study|Withdrawal by Subject|1|||
105363219|NCT01817075|363332754|FG000|Overall Study|Adverse Event|7|||
105363220|NCT01817075|363332755|FG001|Overall Study|Adverse Event|5|||
105363221|NCT01817075|363332754|FG000|Overall Study|Physician Decision|9|||
105363222|NCT01817075|363332755|FG001|Overall Study|Physician Decision|12|||
105363223|NCT01817075|363332754|FG000|Overall Study|Withdrawal by Subject|31|||
105363224|NCT01817075|363332755|FG001|Overall Study|Withdrawal by Subject|15|||
105363225|NCT01817075|363332754|FG000|Overall Study|Received Sorafenib after enrollment|0|||
105363226|NCT01817075|363332755|FG001|Overall Study|Received Sorafenib after enrollment|1|||
105363227|NCT01817075|363332754|FG000|Overall Study|Ineligible|0|||
105363228|NCT01817075|363332755|FG001|Overall Study|Ineligible|2|||
105363229|NCT01519817|363334345|FG000|Overall Study|Withdrawal by Subject|1|||
105486436|NCT00737464|363793322|FG000|Overall Study|Death|6|||
105486437|NCT00737464|363793322|FG000|Overall Study|Other - Failure to Return|1|||
105486438|NCT00737464|363793322|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
105766239|NCT01237223|364796031|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
105766240|NCT01237223|364796032|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
105821504|NCT03084471|365006654|FG000|Overall Study|Other (as recorded)|33|||
105821505|NCT03084471|365006654|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
105821506|NCT00505622|365006655|FG000|Overall Study|Adverse Event|5|||
105821507|NCT00505622|365006656|FG001|Overall Study|Adverse Event|6|||
105821508|NCT00505622|365006657|FG002|Overall Study|Adverse Event|4|||
105821509|NCT00505622|365006655|FG000|Overall Study|Protocol Violation|1|||
105821510|NCT00505622|365006656|FG001|Overall Study|Protocol Violation|1|||
105821511|NCT00505622|365006657|FG002|Overall Study|Protocol Violation|0|||
105821512|NCT00505622|365006655|FG000|Overall Study|Withdrawal by Subject|0|||
105821513|NCT00505622|365006656|FG001|Overall Study|Withdrawal by Subject|3|||
105821514|NCT00505622|365006657|FG002|Overall Study|Withdrawal by Subject|2|||
105821515|NCT00505622|365006655|FG000|Overall Study|Study termination by sponsor|115|||
105821516|NCT00505622|365006656|FG001|Overall Study|Study termination by sponsor|98|||
105821517|NCT00505622|365006657|FG002|Overall Study|Study termination by sponsor|90|||
105821518|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
105821519|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
105821520|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
105821521|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
105821522|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
105821523|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
105821524|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
105821525|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
105821526|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
105766241|NCT01237223|364796033|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
105766242|NCT01237223|364796034|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
105766243|NCT01237223|364796029|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
105766244|NCT01237223|364796030|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
105766245|NCT01237223|364796031|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
105766246|NCT01237223|364796032|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
105766247|NCT01237223|364796033|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
105766248|NCT01237223|364796034|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
105766249|NCT01237223|364796029|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
105766250|NCT01237223|364796030|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
105766251|NCT01237223|364796031|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
105766252|NCT01237223|364796032|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
105821527|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
105821528|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
105363230|NCT01519817|363334346|FG001|Overall Study|Withdrawal by Subject|0|||
105363231|NCT01519817|363334347|FG002|Overall Study|Withdrawal by Subject|0|||
105363232|NCT01519817|363334348|FG003|Overall Study|Withdrawal by Subject|0|||
105363233|NCT01519817|363334345|FG000|Overall Study|Off study due to infection|0|||
105363234|NCT01519817|363334346|FG001|Overall Study|Off study due to infection|0|||
105821529|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
105363235|NCT01519817|363334347|FG002|Overall Study|Off study due to infection|0|||
105486439|NCT00737464|363793322|FG000|Overall Study|Other reasons|4|||
105486440|NCT00290407|363793324|FG000|Overall Study|Physician Decision|2|||
105363236|NCT01519817|363334348|FG003|Overall Study|Off study due to infection|1|||
105363237|NCT02922153|363334349|FG000|Overall Study|Death|8|||
105363238|NCT02922153|363334350|FG001|Overall Study|Death|1|||
105363239|NCT02922153|363334349|FG000|Overall Study|Lost to Follow-up|1|||
105363240|NCT02922153|363334350|FG001|Overall Study|Lost to Follow-up|0|||
105363241|NCT02922153|363334349|FG000|Overall Study|Physician Decision|1|||
105363242|NCT02922153|363334350|FG001|Overall Study|Physician Decision|1|||
105363243|NCT04085601|363334353|FG000|Overall Study|Lost to Follow-up|1|||
105363244|NCT04085601|363334354|FG001|Overall Study|Lost to Follow-up|0|||
105363245|NCT04085601|363334353|FG000|Overall Study|Death|1|||
105363246|NCT04085601|363334354|FG001|Overall Study|Death|1|||
105363247|NCT04534517|363334357|FG000|Overall Study|Adverse Event|1|||
105363248|NCT04534517|363334357|FG000|Overall Study|Withdrawal by Subject|1|||
105363249|NCT04534517|363334357|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
105821530|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
105821531|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
105821532|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
105821533|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
105821534|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
105821535|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
105821536|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
105821537|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
105821538|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Death|0|||
105821539|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Death|1|||
105821540|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Death|0|||
105821541|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Death|0|||
105821542|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
105821543|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
105821544|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
105821545|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
105821546|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
105821547|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
105821548|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
105821549|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
105821550|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
105821551|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
105821552|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
105821553|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
105821554|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
105821555|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
105821556|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
105821557|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
105821558|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
105821559|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
105821560|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
105821561|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
105821562|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
105821563|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
105363250|NCT04534517|363334357|FG000|Overall Study|COVID-19 Related|1|||
105363251|NCT01716806|363334358|FG000|Overall Study|Patient withdrawal of consent|4|||
105821564|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
105363252|NCT01716806|363334359|FG001|Overall Study|Patient withdrawal of consent|2|||
105486441|NCT01082640|363793335|FG000|Overall Study|Adverse Event|9|||
105821565|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
105821566|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
105821567|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
105821568|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
105821569|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
105821570|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
105821571|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
105821572|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
105821573|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
105821574|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
105821575|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
105821576|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
105821577|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
105821578|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
105821579|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
105821580|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
105821581|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
105821582|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
105821583|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
105821584|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
105821585|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
105821586|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
105821587|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
105821588|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
105821589|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
105821590|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
105821591|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
105821592|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
105821593|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
105821594|NCT03552393|365006662|FG000|Core Period|Kidney Transplant|1|||
105821595|NCT03552393|365006662|FG000|Core Period|Prohibited Medication|1|||
105821596|NCT03552393|365006662|FG000|Safety Extension Period|Kidney Transplant|4|||
105821597|NCT02601625|365006663|FG000|Overall Study|Lost to Follow-up|0|||
105821598|NCT02601625|365006664|FG001|Overall Study|Lost to Follow-up|0|||
105821599|NCT02601625|365006665|FG002|Overall Study|Lost to Follow-up|1|||
105821600|NCT02601625|365006666|FG003|Overall Study|Lost to Follow-up|1|||
105821601|NCT01289262|365006669|FG000|Overall Study|Lost to Follow-up|29|||
105821602|NCT01289262|365006670|FG001|Overall Study|Lost to Follow-up|16|||
105821603|NCT01289262|365006669|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
105821604|NCT01289262|365006670|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
105821605|NCT04887415|365006671|FG000|Overall Study|Lost to Follow-up|2|||
105821606|NCT01250912|365006672|FG000|Overall Study|Lost to Follow-up|1|||
105821607|NCT01218867|365006673|FG000|Overall Study|Death during treatment|0|||
105821608|NCT01218867|365006674|FG001|Overall Study|Death during treatment|0|||
105821609|NCT01218867|365006675|FG002|Overall Study|Death during treatment|0|||
105821610|NCT01218867|365006676|FG003|Overall Study|Death during treatment|0|||
105821611|NCT01218867|365006677|FG004|Overall Study|Death during treatment|0|||
105821612|NCT01218867|365006678|FG005|Overall Study|Death during treatment|0|||
105821613|NCT01218867|365006679|FG006|Overall Study|Death during treatment|1|||
105821614|NCT01218867|365006680|FG007|Overall Study|Death during treatment|0|||
105821615|NCT01218867|365006681|FG008|Overall Study|Death during treatment|0|||
105821616|NCT01218867|365006682|FG009|Overall Study|Death during treatment|0|||
105821617|NCT01218867|365006683|FG010|Overall Study|Death during treatment|0|||
105821618|NCT03681470|365006686|FG000|Overall Study|Lack of Efficacy|3|||
105821619|NCT03681470|365006686|FG000|Overall Study|Lost to Follow-up|1|||
105821620|NCT03681470|365006686|FG000|Overall Study|Protocol Violation|3|||
105821621|NCT03681470|365006686|FG000|Overall Study|Withdrawal by Subject|1|||
105821622|NCT03206177|365006688|FG000|Overall Study|Withdrawal by Subject|1|||
105821623|NCT02963259|365006689|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
105821624|NCT02963259|365006689|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
105821625|NCT02963259|365006689|FG000|Overall Study|Death|1|||
105821626|NCT02963259|365006689|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
105821627|NCT01136174|365006690|FG000|Overall Study|Adverse Event|0|||
105486442|NCT01082640|363793336|FG001|Overall Study|Adverse Event|5|||
105821628|NCT01136174|365006691|FG001|Overall Study|Adverse Event|0|||
105821629|NCT01136174|365006692|FG002|Overall Study|Adverse Event|0|||
105821630|NCT01136174|365006693|FG003|Overall Study|Adverse Event|4|||
105821631|NCT02655679|365006694|FG000|Overall Study|Adverse Event|0|||
105821632|NCT02655679|365006695|FG001|Overall Study|Adverse Event|1|||
105821633|NCT02655679|365006696|FG002|Overall Study|Adverse Event|0|||
105821634|NCT02655679|365006697|FG003|Overall Study|Adverse Event|0|||
105821635|NCT02655679|365006698|FG004|Overall Study|Adverse Event|0|||
105821636|NCT02655679|365006694|FG000|Overall Study|Withdrawal by Subject|1|||
105821637|NCT02655679|365006695|FG001|Overall Study|Withdrawal by Subject|1|||
105821638|NCT02655679|365006696|FG002|Overall Study|Withdrawal by Subject|0|||
105821639|NCT02655679|365006697|FG003|Overall Study|Withdrawal by Subject|3|||
105821640|NCT02655679|365006698|FG004|Overall Study|Withdrawal by Subject|1|||
105821641|NCT02655679|365006694|FG000|Overall Study|Inability to Comply with the Protocol|1|||
105821642|NCT02655679|365006695|FG001|Overall Study|Inability to Comply with the Protocol|0|||
105821643|NCT02655679|365006696|FG002|Overall Study|Inability to Comply with the Protocol|0|||
105821644|NCT02655679|365006697|FG003|Overall Study|Inability to Comply with the Protocol|0|||
105821645|NCT02655679|365006698|FG004|Overall Study|Inability to Comply with the Protocol|0|||
105821646|NCT02655679|365006694|FG000|Overall Study|Lost to Follow-up|0|||
105821647|NCT02655679|365006695|FG001|Overall Study|Lost to Follow-up|1|||
105821648|NCT02655679|365006696|FG002|Overall Study|Lost to Follow-up|1|||
105821649|NCT02655679|365006697|FG003|Overall Study|Lost to Follow-up|1|||
105821650|NCT02655679|365006698|FG004|Overall Study|Lost to Follow-up|0|||
105821651|NCT02655679|365006694|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105821652|NCT02655679|365006695|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105821653|NCT02655679|365006696|FG002|Overall Study|Other Miscellaneous Reasons|0|||
105821654|NCT02655679|365006697|FG003|Overall Study|Other Miscellaneous Reasons|0|||
105821655|NCT02655679|365006698|FG004|Overall Study|Other Miscellaneous Reasons|0|||
105821656|NCT02178787|365006699|FG000|Overall Study|Lost to Follow-up|1|||
105821657|NCT02178787|365006700|FG001|Overall Study|Lost to Follow-up|0|||
105821658|NCT02178787|365006699|FG000|Overall Study|Withdrawal by Subject|0|||
105821659|NCT02178787|365006700|FG001|Overall Study|Withdrawal by Subject|2|||
105821660|NCT02178787|365006699|FG000|Overall Study|No TCD window|3|||
105821661|NCT02178787|365006700|FG001|Overall Study|No TCD window|7|||
105821662|NCT02178787|365006699|FG000|Overall Study|Physician Decision|1|||
105821663|NCT02178787|365006700|FG001|Overall Study|Physician Decision|0|||
105821664|NCT03873272|365006701|FG000|Overall Study|Withdrawal by Subject|2|||
105821665|NCT03873272|365006702|FG001|Overall Study|Withdrawal by Subject|0|||
105821666|NCT03873272|365006703|FG002|Overall Study|Withdrawal by Subject|1|||
105821667|NCT03873272|365006701|FG000|Overall Study|Death|0|||
105821668|NCT03873272|365006702|FG001|Overall Study|Death|2|||
105821669|NCT03873272|365006703|FG002|Overall Study|Death|1|||
105821670|NCT01597245|365006706|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
105821671|NCT01597245|365006707|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
105821672|NCT01597245|365006708|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
105821673|NCT01597245|365006709|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
105821674|NCT01597245|365006710|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821675|NCT01597245|365006711|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821676|NCT01597245|365006712|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821677|NCT01597245|365006713|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821678|NCT01597245|365006714|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821679|NCT01597245|365006715|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821680|NCT01597245|365006716|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821681|NCT01597245|365006717|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821682|NCT01597245|365006718|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821683|NCT01597245|365006719|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821684|NCT01597245|365006720|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821685|NCT01597245|365006721|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821686|NCT01597245|365006722|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821687|NCT01597245|365006723|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821688|NCT01597245|365006724|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821689|NCT01597245|365006725|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821690|NCT01597245|365006726|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821691|NCT01597245|365006706|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
105821692|NCT01597245|365006707|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
105821693|NCT01597245|365006708|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
105821694|NCT01597245|365006709|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
105821695|NCT01597245|365006710|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821696|NCT01597245|365006711|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821697|NCT01597245|365006712|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821698|NCT01597245|365006713|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821699|NCT01597245|365006714|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821700|NCT01597245|365006715|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821701|NCT01597245|365006716|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821702|NCT01597245|365006717|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821703|NCT01597245|365006718|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821704|NCT01597245|365006719|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105363253|NCT01716806|363334360|FG002|Overall Study|Patient withdrawal of consent|4|||
105766253|NCT01237223|364796033|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
105766254|NCT01237223|364796034|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
105766255|NCT01237223|364796029|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
105766256|NCT01237223|364796030|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
105766257|NCT01237223|364796031|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
105766258|NCT01237223|364796032|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
105766259|NCT01237223|364796033|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
105766260|NCT01237223|364796034|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
105766261|NCT01237223|364796029|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
105766262|NCT01237223|364796030|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
105766263|NCT01237223|364796031|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
105766264|NCT01237223|364796032|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
105766265|NCT01237223|364796033|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
105766266|NCT01237223|364796034|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
105766267|NCT01237223|364796029|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
105766268|NCT01237223|364796030|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
105766269|NCT01237223|364796031|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
105766270|NCT01237223|364796032|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
105766271|NCT01237223|364796033|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
105766272|NCT01237223|364796034|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
105766273|NCT01237223|364796029|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
105766274|NCT01237223|364796030|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
105766275|NCT01237223|364796031|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
105766276|NCT01237223|364796032|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
105766277|NCT01237223|364796033|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
105766278|NCT01237223|364796034|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
105766279|NCT00839436|364796035|FG000|Overall Study|Developed exclusionary condition|1|||
105766280|NCT00839436|364796036|FG001|Overall Study|Developed exclusionary condition|0|||
105766281|NCT00839436|364796037|FG002|Overall Study|Developed exclusionary condition|0|||
105766282|NCT00839436|364796035|FG000|Overall Study|Withdrawal by Subject|0|||
105766283|NCT00839436|364796036|FG001|Overall Study|Withdrawal by Subject|1|||
105766284|NCT00839436|364796037|FG002|Overall Study|Withdrawal by Subject|0|||
105766285|NCT00839436|364796035|FG000|Overall Study|Study drug no longer available|0|||
105766286|NCT00839436|364796036|FG001|Overall Study|Study drug no longer available|0|||
105766287|NCT00839436|364796037|FG002|Overall Study|Study drug no longer available|1|||
105766288|NCT05784129|364796038|FG000|Overall Study|Study terminated by sponsor|2|||
105766289|NCT05784129|364796039|FG001|Overall Study|Study terminated by sponsor|2|||
105766290|NCT01156363|364796042|FG000|Overall Study|Adverse Event|6|||
105766291|NCT01156363|364796042|FG000|Overall Study|Insufficient Therapeutic Response|5|||
105766292|NCT01156363|364796042|FG000|Overall Study|Failure to Return|1|||
105766293|NCT01156363|364796042|FG000|Overall Study|Refused Treatment|4|||
105766294|NCT01156363|364796042|FG000|Overall Study|Other|6|||
105766295|NCT00047008|364796051|FG000|Overall Study|Withdrawn consent|2|||
105766296|NCT00047008|364796052|FG001|Overall Study|Withdrawn consent|3|||
105766297|NCT00047008|364796051|FG000|Overall Study|Ineligible|9|||
105766298|NCT00047008|364796052|FG001|Overall Study|Ineligible|8|||
105766299|NCT00429572|364796053|FG000|Overall Study|Disease progression|1|||
105766300|NCT01782885|364796056|FG000|Overall Study|Lost to Follow-up|4|||
105766301|NCT01782885|364796057|FG001|Overall Study|Lost to Follow-up|6|||
105766302|NCT01587274|364796058|FG000|Overall Study|Lost to Follow-up|4|||
105766303|NCT01587274|364796059|FG001|Overall Study|Lost to Follow-up|5|||
105766304|NCT01587274|364796060|FG002|Overall Study|Lost to Follow-up|3|||
105766305|NCT00361218|364796064|FG000|Overall Study|Lost to Follow-up|11|||
105766306|NCT00361218|364796064|FG000|Overall Study|Personal Reasons|7|||
105766307|NCT00361218|364796064|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
105766308|NCT00608842|364796070|FG000|Overall Study|Participant's Request|0|||
105766309|NCT00608842|364796071|FG001|Overall Study|Participant's Request|1|||
105766310|NCT00608842|364796072|FG002|Overall Study|Participant's Request|2|||
105766311|NCT00608842|364796073|FG003|Overall Study|Participant's Request|1|||
105766312|NCT00608842|364796070|FG000|Overall Study|Lost to Follow-up|1|||
105766313|NCT00608842|364796071|FG001|Overall Study|Lost to Follow-up|0|||
105766314|NCT00608842|364796072|FG002|Overall Study|Lost to Follow-up|0|||
105821705|NCT01597245|365006720|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821706|NCT01597245|365006721|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821707|NCT01597245|365006722|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821708|NCT01597245|365006723|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821709|NCT01597245|365006724|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821710|NCT01597245|365006725|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821711|NCT01597245|365006726|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821712|NCT01597245|365006706|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
105821713|NCT01597245|365006707|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
105821714|NCT01597245|365006708|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
105821715|NCT01597245|365006709|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
105821716|NCT01597245|365006710|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821717|NCT01597245|365006711|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821718|NCT01597245|365006712|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821719|NCT01597245|365006713|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821720|NCT01597245|365006714|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821721|NCT01597245|365006715|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821722|NCT01597245|365006716|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821723|NCT01597245|365006717|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821724|NCT01597245|365006718|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821725|NCT01597245|365006719|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821726|NCT01597245|365006720|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821727|NCT01597245|365006721|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821728|NCT01597245|365006722|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821729|NCT01597245|365006723|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821730|NCT01597245|365006724|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821731|NCT01597245|365006725|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821732|NCT01597245|365006726|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821733|NCT01597245|365006706|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
105821734|NCT01597245|365006707|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
105821735|NCT01597245|365006708|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
105821736|NCT01597245|365006709|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821737|NCT01597245|365006710|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821738|NCT01597245|365006711|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821739|NCT01597245|365006712|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821740|NCT01597245|365006713|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821741|NCT01597245|365006714|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105363254|NCT01716806|363334361|FG003|Overall Study|Patient withdrawal of consent|3|||
105363255|NCT01716806|363334362|FG004|Overall Study|Patient withdrawal of consent|2|||
105821742|NCT01597245|365006715|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821743|NCT01597245|365006716|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821744|NCT01597245|365006717|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821745|NCT01597245|365006718|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821746|NCT01597245|365006719|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821747|NCT01597245|365006720|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821748|NCT01597245|365006721|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821749|NCT01597245|365006722|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821750|NCT01597245|365006723|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821751|NCT01597245|365006724|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821752|NCT01597245|365006725|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821753|NCT01597245|365006726|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821754|NCT01597245|365006706|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
105821755|NCT01597245|365006707|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821756|NCT01597245|365006708|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821757|NCT01597245|365006709|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
105821758|NCT01597245|365006710|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821759|NCT01597245|365006711|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821760|NCT01597245|365006712|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821761|NCT01597245|365006713|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821762|NCT01597245|365006714|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105363256|NCT01716806|363334363|FG005|Overall Study|Patient withdrawal of consent|0|||
105363257|NCT01716806|363334358|FG000|Overall Study|Lost to Follow-up|3|||
105363258|NCT01716806|363334359|FG001|Overall Study|Lost to Follow-up|3|||
105363259|NCT01716806|363334360|FG002|Overall Study|Lost to Follow-up|0|||
105363260|NCT01716806|363334361|FG003|Overall Study|Lost to Follow-up|2|||
105486443|NCT01082640|363793337|FG002|Overall Study|Adverse Event|3|||
105571686|NCT00041756|364092738|FG004|Overall Study|Protocol Violation|1|||
105766315|NCT00608842|364796073|FG003|Overall Study|Lost to Follow-up|0|||
105766316|NCT00412113|364796078|FG000|Overall Study|Adverse Event|11|||
105766317|NCT00412113|364796079|FG001|Overall Study|Adverse Event|15|||
105766318|NCT00412113|364796078|FG000|Overall Study|did not receive treatment|1|||
105766319|NCT00412113|364796079|FG001|Overall Study|did not receive treatment|0|||
105766320|NCT01190020|364796080|FG000|Overall Study|Adverse Event|2|||
105766321|NCT01190020|364796081|FG001|Overall Study|Adverse Event|0|||
105766322|NCT01190020|364796080|FG000|Overall Study|Lost to Follow-up|2|||
105766323|NCT01190020|364796081|FG001|Overall Study|Lost to Follow-up|0|||
105766324|NCT01190020|364796080|FG000|Overall Study|Withdrawal by Subject|3|||
105766325|NCT01190020|364796081|FG001|Overall Study|Withdrawal by Subject|0|||
105766326|NCT02493868|364796082|FG000|Induction Phase: DE Participants|Adverse Event|22|||
105766327|NCT02493868|364796083|FG001|Induction Phase: DE Participants|Adverse Event|0|||
105766328|NCT02493868|364796082|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
105766329|NCT02493868|364796083|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
105766330|NCT02493868|364796082|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
105486444|NCT01082640|363793335|FG000|Overall Study|Withdrawal by Subject|3|||
105363261|NCT01716806|363334362|FG004|Overall Study|Lost to Follow-up|1|||
105363262|NCT01716806|363334363|FG005|Overall Study|Lost to Follow-up|0|||
105363263|NCT01716806|363334358|FG000|Overall Study|Death|13|||
105363264|NCT01716806|363334359|FG001|Overall Study|Death|9|||
105363265|NCT01716806|363334360|FG002|Overall Study|Death|12|||
105363266|NCT01716806|363334361|FG003|Overall Study|Death|4|||
105363267|NCT01716806|363334362|FG004|Overall Study|Death|10|||
105363268|NCT01716806|363334363|FG005|Overall Study|Death|5|||
105363269|NCT01716806|363334358|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
105363270|NCT01716806|363334359|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
105363271|NCT01716806|363334360|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
105363272|NCT01716806|363334361|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
105363273|NCT01716806|363334362|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
105363274|NCT01716806|363334363|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
105363275|NCT01716806|363334358|FG000|Overall Study|PI decision|0|||
105363276|NCT01716806|363334359|FG001|Overall Study|PI decision|0|||
105363277|NCT01716806|363334360|FG002|Overall Study|PI decision|0|||
105363278|NCT01716806|363334361|FG003|Overall Study|PI decision|0|||
105363279|NCT01716806|363334362|FG004|Overall Study|PI decision|1|||
105363280|NCT01716806|363334363|FG005|Overall Study|PI decision|0|||
105363281|NCT01716806|363334358|FG000|Overall Study|Change in performance status|1|||
105363282|NCT01716806|363334359|FG001|Overall Study|Change in performance status|0|||
105363283|NCT01716806|363334360|FG002|Overall Study|Change in performance status|0|||
105363284|NCT01716806|363334361|FG003|Overall Study|Change in performance status|0|||
105821763|NCT01597245|365006715|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821764|NCT01597245|365006716|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821765|NCT01597245|365006717|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821766|NCT01597245|365006718|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821767|NCT01597245|365006719|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821768|NCT01597245|365006720|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821769|NCT01597245|365006721|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821770|NCT01597245|365006722|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821771|NCT01597245|365006723|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821772|NCT01597245|365006724|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821773|NCT01597245|365006725|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821774|NCT01597245|365006726|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821775|NCT01597245|365006706|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
105821776|NCT01597245|365006707|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
105821777|NCT01597245|365006708|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
105363285|NCT01716806|363334362|FG004|Overall Study|Change in performance status|0|||
105363286|NCT01716806|363334363|FG005|Overall Study|Change in performance status|0|||
105363287|NCT01716806|363334358|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
105363288|NCT01716806|363334359|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
105363289|NCT01716806|363334360|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
105363290|NCT01716806|363334361|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
105363291|NCT01716806|363334362|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
105363292|NCT01716806|363334363|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
105363293|NCT01716806|363334358|FG000|Overall Study|Sponsor direction|7|||
105363294|NCT01716806|363334359|FG001|Overall Study|Sponsor direction|8|||
105363295|NCT01716806|363334360|FG002|Overall Study|Sponsor direction|5|||
105363296|NCT01716806|363334361|FG003|Overall Study|Sponsor direction|12|||
105363297|NCT01716806|363334362|FG004|Overall Study|Sponsor direction|16|||
105363298|NCT01716806|363334363|FG005|Overall Study|Sponsor direction|1|||
105363299|NCT02692586|363334364|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
105363300|NCT02692586|363334364|FG000|Overall Study|Received adjunctive thrombolytics|2|||
105363301|NCT03506438|363334366|FG000|Overall Study|Lost to Follow-up|8|||
105363302|NCT03506438|363334367|FG001|Overall Study|Lost to Follow-up|7|||
105363303|NCT03506438|363334368|FG002|Overall Study|Lost to Follow-up|8|||
105363304|NCT03506438|363334369|FG003|Overall Study|Lost to Follow-up|7|||
105363305|NCT03506438|363334370|FG004|Overall Study|Lost to Follow-up|0|||
105363306|NCT03506438|363334371|FG005|Overall Study|Lost to Follow-up|0|||
105363307|NCT01128296|363334372|FG000|Overall Study|Physician Decision|0|||
105363308|NCT01128296|363334373|FG001|Overall Study|Physician Decision|0|||
105363309|NCT01128296|363334374|FG002|Overall Study|Physician Decision|0|||
105363310|NCT01128296|363334375|FG003|Overall Study|Physician Decision|0|||
105363311|NCT01128296|363334376|FG004|Overall Study|Physician Decision|0|||
105363312|NCT01128296|363334377|FG005|Overall Study|Physician Decision|3|||
105363313|NCT01128296|363334372|FG000|Overall Study|Withdrawal by Subject|0|||
105821778|NCT01597245|365006709|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821779|NCT01597245|365006710|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821780|NCT01597245|365006711|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821781|NCT01597245|365006712|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105363314|NCT01128296|363334373|FG001|Overall Study|Withdrawal by Subject|0|||
105363315|NCT01128296|363334374|FG002|Overall Study|Withdrawal by Subject|0|||
105821782|NCT01597245|365006713|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821783|NCT01597245|365006714|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821784|NCT01597245|365006715|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821785|NCT01597245|365006716|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821786|NCT01597245|365006717|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821787|NCT01597245|365006718|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821788|NCT01597245|365006719|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821789|NCT01597245|365006720|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821790|NCT01597245|365006721|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821791|NCT01597245|365006722|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821792|NCT01597245|365006723|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821793|NCT01597245|365006724|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821794|NCT01597245|365006725|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821795|NCT01597245|365006726|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821796|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821797|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821798|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105363316|NCT01128296|363334375|FG003|Overall Study|Withdrawal by Subject|0|||
105363317|NCT01128296|363334376|FG004|Overall Study|Withdrawal by Subject|0|||
105363318|NCT01128296|363334377|FG005|Overall Study|Withdrawal by Subject|2|||
105363319|NCT00823264|363334378|FG000|Overall Study|Protocol Violation|2|||
105363320|NCT00823264|363334379|FG001|Overall Study|Protocol Violation|0|||
105363321|NCT04155463|363334380|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
105363322|NCT04155463|363334381|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
105363323|NCT01914393|363334388|FG000|Overall Study|Protocol Violation|11|||
105363324|NCT01914393|363334389|FG001|Overall Study|Protocol Violation|3|||
105363325|NCT01914393|363334390|FG002|Overall Study|Protocol Violation|19|||
105363326|NCT01914393|363334388|FG000|Overall Study|Lack of Efficacy|11|||
105363327|NCT01914393|363334389|FG001|Overall Study|Lack of Efficacy|16|||
105363328|NCT01914393|363334390|FG002|Overall Study|Lack of Efficacy|5|||
105363329|NCT01914393|363334388|FG000|Overall Study|no reason given|14|||
105363330|NCT01914393|363334389|FG001|Overall Study|no reason given|8|||
105363331|NCT01914393|363334390|FG002|Overall Study|no reason given|16|||
105363332|NCT01914393|363334388|FG000|Overall Study|Adverse Event|29|||
105363333|NCT01914393|363334389|FG001|Overall Study|Adverse Event|18|||
105363334|NCT01914393|363334390|FG002|Overall Study|Adverse Event|31|||
105363335|NCT01914393|363334388|FG000|Overall Study|Withdrawal by Subject|38|||
105363336|NCT01914393|363334389|FG001|Overall Study|Withdrawal by Subject|20|||
105363337|NCT01914393|363334390|FG002|Overall Study|Withdrawal by Subject|47|||
105363338|NCT01914393|363334388|FG000|Overall Study|Lost to Follow-up|12|||
105363339|NCT01914393|363334389|FG001|Overall Study|Lost to Follow-up|6|||
105363340|NCT01914393|363334390|FG002|Overall Study|Lost to Follow-up|19|||
105363341|NCT01914393|363334388|FG000|Overall Study|subject never dosed|0|||
105363342|NCT01914393|363334389|FG001|Overall Study|subject never dosed|0|||
105363343|NCT01914393|363334390|FG002|Overall Study|subject never dosed|1|||
105363344|NCT05137717|363334392|FG000|Overall Study|Death|2|||
105363345|NCT05137717|363334392|FG000|Overall Study|Withdrawal by Subject|6|||
105363346|NCT00737100|363334398|FG000|Overall Study|Adverse Event|6|||
105363347|NCT00737100|363334399|FG001|Overall Study|Adverse Event|5|||
105363348|NCT00737100|363334400|FG002|Overall Study|Adverse Event|3|||
105363349|NCT00737100|363334398|FG000|Overall Study|Lost to Follow-up|0|||
105363350|NCT00737100|363334399|FG001|Overall Study|Lost to Follow-up|1|||
105363351|NCT00737100|363334400|FG002|Overall Study|Lost to Follow-up|0|||
105363352|NCT00737100|363334398|FG000|Overall Study|Withdrawal by Subject|0|||
105363353|NCT00737100|363334399|FG001|Overall Study|Withdrawal by Subject|0|||
105363354|NCT00737100|363334400|FG002|Overall Study|Withdrawal by Subject|3|||
105363355|NCT00737100|363334398|FG000|Overall Study|Reason discontinued not explained above|1|||
105363356|NCT00737100|363334399|FG001|Overall Study|Reason discontinued not explained above|1|||
105363357|NCT00737100|363334400|FG002|Overall Study|Reason discontinued not explained above|1|||
105363358|NCT01265394|363334401|FG000|Overall Study|Subjects withdrawn|37|||
105363359|NCT00115778|363334404|FG000|Overall Study|Withdrawal by Subject|0|||
105363360|NCT00115778|363334405|FG001|Overall Study|Withdrawal by Subject|1|||
105363361|NCT00268983|363334406|FG000|Overall Study|Death|3|||
105363362|NCT00268983|363334407|FG001|Overall Study|Death|0|||
105363363|NCT03713684|363334410|FG000|Overall Study|Adverse Event|1|||
105363364|NCT03713684|363334411|FG001|Overall Study|Adverse Event|3|||
105363365|NCT03713684|363334412|FG002|Overall Study|Adverse Event|1|||
105363366|NCT03713684|363334413|FG003|Overall Study|Adverse Event|0|||
105363367|NCT03713684|363334410|FG000|Overall Study|Poor compliance to protocol|2|||
105363368|NCT03713684|363334411|FG001|Overall Study|Poor compliance to protocol|1|||
105363369|NCT03713684|363334412|FG002|Overall Study|Poor compliance to protocol|0|||
105363370|NCT03713684|363334413|FG003|Overall Study|Poor compliance to protocol|1|||
105486445|NCT01082640|363793336|FG001|Overall Study|Withdrawal by Subject|3|||
105766331|NCT02493868|364796083|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
105766332|NCT02493868|364796082|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
105766333|NCT02493868|364796083|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
105766334|NCT02493868|364796082|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
105766335|NCT02493868|364796083|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
105766336|NCT02493868|364796082|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
105766337|NCT02493868|364796083|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
105363371|NCT03713684|363334410|FG000|Overall Study|Withdrawal by Subject|14|||
105363372|NCT03713684|363334411|FG001|Overall Study|Withdrawal by Subject|6|||
105363373|NCT03713684|363334412|FG002|Overall Study|Withdrawal by Subject|14|||
105363374|NCT03713684|363334413|FG003|Overall Study|Withdrawal by Subject|16|||
105363375|NCT03713684|363334410|FG000|Overall Study|Other than specified|69|||
105363376|NCT03713684|363334411|FG001|Overall Study|Other than specified|77|||
105363377|NCT03713684|363334412|FG002|Overall Study|Other than specified|73|||
105363378|NCT03713684|363334413|FG003|Overall Study|Other than specified|70|||
105363379|NCT00249873|363334414|FG000|Overall Study|Not treated|7|||
105766338|NCT02493868|364796082|FG000|Induction Phase: DE Participants|Other|8|||
105363380|NCT00249873|363334415|FG001|Overall Study|Not treated|8|||
105363381|NCT00249873|363334414|FG000|Overall Study|Significant thrombocytopenia|9|||
105363382|NCT00249873|363334415|FG001|Overall Study|Significant thrombocytopenia|8|||
105363383|NCT00249873|363334414|FG000|Overall Study|Severe allergic reaction|8|||
105766339|NCT02493868|364796083|FG001|Induction Phase: DE Participants|Other|0|||
105766340|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
105766341|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
105766342|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
105766343|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
105766344|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
105766345|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
105766346|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
105766347|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
105766348|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
105766349|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
105766350|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
105766351|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
105766352|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
105766353|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
105766354|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|Other|10|||
105766355|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|Other|2|||
105766356|NCT02493868|364796082|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
105821799|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821800|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821801|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
105821802|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
105821803|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821804|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821805|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821806|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821807|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821808|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821809|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821810|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821811|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821812|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821813|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821814|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821815|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821816|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821817|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821818|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821819|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821820|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821821|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
105821822|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
105821823|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
105821824|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
105821825|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821826|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
105821827|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821828|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821829|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821830|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821831|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821832|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821833|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821834|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821835|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821836|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821837|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821838|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821839|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821840|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821841|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821842|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821843|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
105821844|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821845|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821846|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
105821847|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821848|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
105821849|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
105821850|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
105821851|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821852|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821853|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821854|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821855|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821856|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821857|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821858|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821859|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821860|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821861|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105363384|NCT00249873|363334415|FG001|Overall Study|Severe allergic reaction|1|||
105821862|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821863|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
105363385|NCT00249873|363334414|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
105363386|NCT00249873|363334415|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
105363387|NCT00249873|363334414|FG000|Overall Study|Other Serious Adverse Event|86|||
105363388|NCT00249873|363334415|FG001|Overall Study|Other Serious Adverse Event|97|||
105363389|NCT00249873|363334414|FG000|Overall Study|Qualifying condition not present|20|||
105363390|NCT00249873|363334415|FG001|Overall Study|Qualifying condition not present|23|||
105363391|NCT00249873|363334414|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
105363392|NCT00249873|363334415|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
105363393|NCT00249873|363334414|FG000|Overall Study|Withdrawal by Subject|504|||
105363394|NCT00249873|363334415|FG001|Overall Study|Withdrawal by Subject|466|||
105363395|NCT00249873|363334414|FG000|Overall Study|Lost to Follow-up|4|||
105363396|NCT00249873|363334415|FG001|Overall Study|Lost to Follow-up|7|||
105363397|NCT00249873|363334414|FG000|Overall Study|Minor bleeding|99|||
105363398|NCT00249873|363334415|FG001|Overall Study|Minor bleeding|37|||
105363399|NCT00249873|363334414|FG000|Overall Study|Non-compliance|41|||
105363400|NCT00249873|363334415|FG001|Overall Study|Non-compliance|46|||
105363401|NCT00249873|363334414|FG000|Overall Study|Other non serious Adverse Event|112|||
105363402|NCT00249873|363334415|FG001|Overall Study|Other non serious Adverse Event|108|||
105363403|NCT00249873|363334414|FG000|Overall Study|Other contraindicated medication|1|||
105363404|NCT00249873|363334415|FG001|Overall Study|Other contraindicated medication|0|||
105363405|NCT00249873|363334414|FG000|Overall Study|Patient not wish to continue after May08|3|||
105363406|NCT00249873|363334415|FG001|Overall Study|Patient not wish to continue after May08|4|||
105363407|NCT00249873|363334414|FG000|Overall Study|Physician withdrew consent|59|||
105363408|NCT00249873|363334415|FG001|Overall Study|Physician withdrew consent|60|||
105363409|NCT00249873|363334414|FG000|Overall Study|Open label clopidogrel required|31|||
105363410|NCT00249873|363334415|FG001|Overall Study|Open label clopidogrel required|42|||
105363411|NCT00249873|363334414|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
105363412|NCT00249873|363334415|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
105363413|NCT00249873|363334414|FG000|Overall Study|Oral anticoagulant required|159|||
105363414|NCT00249873|363334415|FG001|Overall Study|Oral anticoagulant required|157|||
105363415|NCT00249873|363334414|FG000|Overall Study|Study drug intolerance|5|||
105363416|NCT00249873|363334415|FG001|Overall Study|Study drug intolerance|0|||
105363417|NCT00249873|363334414|FG000|Overall Study|Surgery/ procedure|9|||
105363418|NCT00249873|363334415|FG001|Overall Study|Surgery/ procedure|9|||
105363419|NCT00249873|363334414|FG000|Overall Study|Event related to cardiac condition|12|||
105363420|NCT00249873|363334415|FG001|Overall Study|Event related to cardiac condition|21|||
105363421|NCT00249873|363334414|FG000|Overall Study|Thromboembolic/outcome event|82|||
105363422|NCT00249873|363334415|FG001|Overall Study|Thromboembolic/outcome event|122|||
105363423|NCT02595502|363334418|FG000|Period 1|Adverse Event|0|||
105363424|NCT02595502|363334419|FG001|Period 1|Adverse Event|1|||
105363425|NCT02595502|363334418|FG000|Period 1|Withdrawal by Subject|1|||
105363426|NCT02595502|363334419|FG001|Period 1|Withdrawal by Subject|0|||
105363427|NCT02595502|363334418|FG000|Period 1|Lost to Follow-up|0|||
105363428|NCT02595502|363334419|FG001|Period 1|Lost to Follow-up|1|||
105363429|NCT02595502|363334418|FG000|Period 2|Adverse Event|1|||
105363430|NCT02595502|363334419|FG001|Period 2|Adverse Event|1|||
105766357|NCT02493868|364796083|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
105766358|NCT02493868|364796082|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
105766359|NCT02493868|364796083|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
105766360|NCT02493868|364796082|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
105766361|NCT02493868|364796083|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
105766362|NCT02493868|364796082|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
105766363|NCT02493868|364796083|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
105766364|NCT02493868|364796082|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
105363431|NCT02595502|363334418|FG000|Period 2|Received incorrect lens at Period 1|0|||
105363432|NCT02595502|363334419|FG001|Period 2|Received incorrect lens at Period 1|1|||
105363433|NCT02595502|363334418|FG000|Period 3|Protocol Violation|0|||
105363434|NCT02595502|363334419|FG001|Period 3|Protocol Violation|1|||
105766365|NCT02493868|364796083|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
105821864|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
105363435|NCT02595502|363334418|FG000|Period 3|Lost to Follow-up|1|||
105363436|NCT02595502|363334419|FG001|Period 3|Lost to Follow-up|0|||
105363437|NCT02595502|363334418|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
105363438|NCT02595502|363334419|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
105363439|NCT05556148|363334420|FG000|Overall Study|Early Termination|29|||
105363440|NCT05556148|363334420|FG000|Overall Study|Baseline Tasks Expired|4|||
105363441|NCT05556148|363334420|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
105821865|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
105821866|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
105821867|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
105821868|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
105821869|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
105821870|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
105821871|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
105821872|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821873|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821874|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821875|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821876|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821877|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821878|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821879|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821880|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821881|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821882|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821883|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821884|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
105821885|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
105821886|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
105821887|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821888|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
105821889|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
105821890|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
105821891|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
105821892|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
105821893|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821894|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821895|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821896|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821897|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821898|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821899|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821900|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821901|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821902|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821903|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821904|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821905|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
105821906|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821907|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821908|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821909|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
105821910|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
105821911|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
105821912|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821913|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
105821914|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821915|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821916|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821917|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821918|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821919|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821920|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821921|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821922|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821923|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105486446|NCT01082640|363793337|FG002|Overall Study|Withdrawal by Subject|2|||
105486447|NCT01082640|363793335|FG000|Overall Study|Major protocol deviation|3|||
105486448|NCT01082640|363793336|FG001|Overall Study|Major protocol deviation|3|||
105486449|NCT01082640|363793337|FG002|Overall Study|Major protocol deviation|0|||
105486450|NCT01082640|363793335|FG000|Overall Study|Lost to Follow-up|0|||
105486451|NCT01082640|363793336|FG001|Overall Study|Lost to Follow-up|3|||
105486452|NCT01082640|363793337|FG002|Overall Study|Lost to Follow-up|0|||
105486453|NCT01082640|363793335|FG000|Overall Study|Other|2|||
105486454|NCT01082640|363793336|FG001|Overall Study|Other|1|||
105486455|NCT01082640|363793337|FG002|Overall Study|Other|3|||
105486456|NCT01721577|363793338|FG000|Overall Study|Lack of Efficacy|1|||
105571687|NCT00041756|364092734|FG000|Overall Study|Withdrawal by Subject|3|||
105571688|NCT00041756|364092735|FG001|Overall Study|Withdrawal by Subject|3|||
105821924|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821925|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821926|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
105821927|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
105821928|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
105821929|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821930|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
105821931|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
105821932|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
105821933|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
105821934|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
105821935|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821936|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821937|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821938|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821939|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821940|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821941|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821942|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821943|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821944|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821945|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821946|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821947|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821948|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
105821949|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105486457|NCT01721577|363793339|FG001|Overall Study|Lack of Efficacy|0|||
105486458|NCT01721577|363793338|FG000|Overall Study|Death|1|||
105486459|NCT01721577|363793339|FG001|Overall Study|Death|0|||
105486460|NCT01721577|363793338|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
105486461|NCT01721577|363793339|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
105766366|NCT02493868|364796082|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
105766367|NCT02493868|364796083|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
105766368|NCT02493868|364796082|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
105766369|NCT02493868|364796083|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
105766370|NCT02493868|364796082|FG000|Follow-up Phase|Lost to Follow-up|1|||
105766371|NCT02493868|364796083|FG001|Follow-up Phase|Lost to Follow-up|0|||
105766372|NCT02493868|364796082|FG000|Follow-up Phase|Withdrawal by Subject|3|||
105766373|NCT02493868|364796083|FG001|Follow-up Phase|Withdrawal by Subject|0|||
105766374|NCT02493868|364796082|FG000|Follow-up Phase|Investigator Decision|5|||
105766375|NCT02493868|364796083|FG001|Follow-up Phase|Investigator Decision|1|||
105766376|NCT02493868|364796082|FG000|Follow-up Phase|Other|2|||
105766377|NCT02493868|364796083|FG001|Follow-up Phase|Other|1|||
105766378|NCT00430027|364798188|FG000|Overall Study|Study terminated|8|||
105766379|NCT01685060|364798194|FG000|Overall Study|Rollover patients|16|||
105766380|NCT01685060|364798194|FG000|Overall Study|Adverse Event|12|||
105766381|NCT01685060|364798194|FG000|Overall Study|Progressive disease|69|||
105363442|NCT05556148|363334420|FG000|Overall Study|No Longer Wished to Participate|1|||
105766382|NCT01685060|364798194|FG000|Overall Study|Physician Decision|14|||
105821950|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821951|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
105821952|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
105821953|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
105821954|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
105821955|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821956|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821957|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821958|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821959|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821960|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821961|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821962|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821963|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821964|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821965|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821966|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821967|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821968|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821969|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821970|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821971|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821972|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821973|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821974|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
105821975|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821976|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821977|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821978|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821979|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821980|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821981|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821982|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821983|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821984|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821985|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821986|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821987|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821988|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821989|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821990|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821991|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821992|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821993|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821994|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821995|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821996|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105363443|NCT05556148|363334420|FG000|Overall Study|Bacterial Conjunctivitis|1|||
105363444|NCT00458003|363334421|FG000|Overall Study|Non protocol spinal anesthesia|1|||
105363445|NCT00458003|363334422|FG001|Overall Study|Non protocol spinal anesthesia|1|||
105363446|NCT00875563|363334429|FG000|Overall Study|Death|4|||
105363447|NCT00875563|363334429|FG000|Overall Study|Withdrawal by Subject|7|||
105363448|NCT00875563|363334429|FG000|Overall Study|No long-term (3-5 year) consent|6|||
105363449|NCT00875563|363334429|FG000|Overall Study|Still be eligible for follow-up|7|||
105363450|NCT00511810|363334432|FG000|Overall Study|Lost to Follow-up|1|||
105363451|NCT00511810|363334433|FG001|Overall Study|Lost to Follow-up|2|||
105363452|NCT00511810|363334432|FG000|Overall Study|Lack of Efficacy|0|||
105363453|NCT00511810|363334433|FG001|Overall Study|Lack of Efficacy|2|||
105363454|NCT00511810|363334432|FG000|Overall Study|Refused second scn|0|||
105486462|NCT01721577|363793338|FG000|Overall Study|Adverse Event|0|||
105486463|NCT01721577|363793339|FG001|Overall Study|Adverse Event|2|||
105486464|NCT02496676|363793340|FG000|Phase 1 - Period 1|Adverse Event|0|||
105486465|NCT02496676|363793341|FG001|Phase 1 - Period 1|Adverse Event|1|||
105486466|NCT02496676|363793340|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
105363455|NCT00511810|363334433|FG001|Overall Study|Refused second scn|1|||
105363456|NCT00313846|363334434|FG000|Overall Study|Withdrawal by Subject|2|||
105486467|NCT02496676|363793341|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
105486468|NCT03823378|363793343|FG000|Overall Study|Adverse Event|2|||
105363457|NCT00313846|363334435|FG001|Overall Study|Withdrawal by Subject|0|||
105363458|NCT00313846|363334434|FG000|Overall Study|Adverse Event|1|||
105363459|NCT00313846|363334435|FG001|Overall Study|Adverse Event|8|||
105363460|NCT00313846|363334434|FG000|Overall Study|Administrative|2|||
105363461|NCT00313846|363334435|FG001|Overall Study|Administrative|3|||
105363462|NCT03257436|363334436|FG000|Overall Study|Withdrawal by Subject|76|||
105363463|NCT03257436|363334436|FG000|Overall Study|Death|19|||
105363464|NCT02659943|363334437|FG000|Overall Study|Switched to alternative treatment|1|||
105363465|NCT02659943|363334438|FG001|Overall Study|Switched to alternative treatment|1|||
105363466|NCT02659943|363334439|FG002|Overall Study|Switched to alternative treatment|0|||
105363467|NCT02659943|363334440|FG003|Overall Study|Switched to alternative treatment|2|||
105363468|NCT02659943|363334441|FG004|Overall Study|Switched to alternative treatment|1|||
105363469|NCT02659943|363334442|FG005|Overall Study|Switched to alternative treatment|0|||
105363470|NCT02659943|363334443|FG006|Overall Study|Switched to alternative treatment|1|||
105363471|NCT02659943|363334437|FG000|Overall Study|Disease progression on study|0|||
105486469|NCT03823378|363793344|FG001|Overall Study|Adverse Event|2|||
105486470|NCT03823378|363793345|FG002|Overall Study|Adverse Event|0|||
105486471|NCT03823378|363793346|FG003|Overall Study|Adverse Event|0|||
105486472|NCT03823378|363793347|FG004|Overall Study|Adverse Event|0|||
105766383|NCT01685060|364798194|FG000|Overall Study|Subject/guardian decision|20|||
105766384|NCT01685060|364798194|FG000|Overall Study|Lost to Follow-up|1|||
105766385|NCT01685060|364798194|FG000|Overall Study|Death|8|||
105766386|NCT02944513|364798195|FG000|Overall Study|Withdrawal by Subject|4|||
105486473|NCT03823378|363793348|FG005|Overall Study|Adverse Event|0|||
105486474|NCT03823378|363793343|FG000|Overall Study|Lost to Follow-up|0|||
105486475|NCT03823378|363793344|FG001|Overall Study|Lost to Follow-up|1|||
105766387|NCT02944513|364798196|FG001|Overall Study|Withdrawal by Subject|1|||
105766388|NCT00937326|364798197|FG000|Overall Study|Adverse Event|0|||
105766389|NCT00937326|364798198|FG001|Overall Study|Adverse Event|3|||
105766390|NCT00937326|364798199|FG002|Overall Study|Adverse Event|1|||
105766391|NCT00937326|364798200|FG003|Overall Study|Adverse Event|1|||
105766392|NCT00937326|364798201|FG004|Overall Study|Adverse Event|2|||
105766393|NCT00937326|364798197|FG000|Overall Study|Death|0|||
105766394|NCT00937326|364798198|FG001|Overall Study|Death|0|||
105766395|NCT00937326|364798199|FG002|Overall Study|Death|1|||
105766396|NCT00937326|364798200|FG003|Overall Study|Death|0|||
105766397|NCT00937326|364798201|FG004|Overall Study|Death|0|||
105766398|NCT00937326|364798197|FG000|Overall Study|Withdrawal by Subject|3|||
105766399|NCT00937326|364798198|FG001|Overall Study|Withdrawal by Subject|4|||
105766400|NCT00937326|364798199|FG002|Overall Study|Withdrawal by Subject|1|||
105766401|NCT00937326|364798200|FG003|Overall Study|Withdrawal by Subject|4|||
105766402|NCT00937326|364798201|FG004|Overall Study|Withdrawal by Subject|3|||
105766403|NCT00937326|364798197|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
105766404|NCT00937326|364798198|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
105766405|NCT00937326|364798199|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
105766406|NCT00937326|364798200|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
105766407|NCT00937326|364798201|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
105766408|NCT02578992|364798202|FG000|Overall Study|equipment not available or malfunction|3|||
105766409|NCT02578992|364798203|FG001|Overall Study|equipment not available or malfunction|3|||
105766410|NCT00790218|364798206|FG000|Overall Study|Death|1|||
105766411|NCT00790218|364798207|FG001|Overall Study|Death|0|||
105766412|NCT00790218|364798208|FG002|Overall Study|Death|0|||
105766413|NCT00086385|364798209|FG000|Overall Study|Death|2|||
105766414|NCT00086385|364798210|FG001|Overall Study|Death|2|||
105766415|NCT00086385|364798211|FG002|Overall Study|Death|1|||
105766416|NCT00086385|364798212|FG003|Overall Study|Death|1|||
105766417|NCT00880100|364798215|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
105766418|NCT00880100|364798215|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
105486476|NCT03823378|363793345|FG002|Overall Study|Lost to Follow-up|0|||
105486477|NCT03823378|363793346|FG003|Overall Study|Lost to Follow-up|0|||
105486478|NCT03823378|363793347|FG004|Overall Study|Lost to Follow-up|1|||
105766419|NCT00880100|364798215|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
105766420|NCT01431521|364798216|FG000|Overall Study|Withdrawal by Subject|0|||
105766421|NCT01431521|364798217|FG001|Overall Study|Withdrawal by Subject|0|||
105766422|NCT01431521|364798218|FG002|Overall Study|Withdrawal by Subject|1|||
105766423|NCT01431521|364798219|FG003|Overall Study|Withdrawal by Subject|0|||
105766424|NCT00731666|364798220|FG000|Overall Study|Adverse Event|2|||
105766425|NCT00731666|364798220|FG000|Overall Study|Lost to Follow-up|8|||
105486479|NCT03823378|363793348|FG005|Overall Study|Lost to Follow-up|0|||
105486480|NCT03823378|363793343|FG000|Overall Study|Withdrawal by Subject|0|||
105486481|NCT03823378|363793344|FG001|Overall Study|Withdrawal by Subject|1|||
105766426|NCT00731666|364798220|FG000|Overall Study|Withdrawal by Subject|2|||
105766427|NCT00608894|364798221|FG000|Overall Study|Withdrawal by Subject|0|||
105486482|NCT03823378|363793345|FG002|Overall Study|Withdrawal by Subject|4|||
105486483|NCT03823378|363793346|FG003|Overall Study|Withdrawal by Subject|2|||
105766428|NCT00608894|364798222|FG001|Overall Study|Withdrawal by Subject|2|||
105766429|NCT03654560|364798223|FG000|Overall Study|Death|3|||
105363472|NCT02659943|363334438|FG001|Overall Study|Disease progression on study|1|||
105363473|NCT02659943|363334439|FG002|Overall Study|Disease progression on study|1|||
105363474|NCT02659943|363334440|FG003|Overall Study|Disease progression on study|1|||
105363475|NCT02659943|363334441|FG004|Overall Study|Disease progression on study|1|||
105363476|NCT02659943|363334442|FG005|Overall Study|Disease progression on study|4|||
105363477|NCT02659943|363334443|FG006|Overall Study|Disease progression on study|0|||
105363478|NCT02659943|363334437|FG000|Overall Study|Patient's condition per principal investigator|0|||
105363479|NCT02659943|363334438|FG001|Overall Study|Patient's condition per principal investigator|0|||
105363480|NCT02659943|363334439|FG002|Overall Study|Patient's condition per principal investigator|0|||
105363481|NCT02659943|363334440|FG003|Overall Study|Patient's condition per principal investigator|0|||
105363482|NCT02659943|363334441|FG004|Overall Study|Patient's condition per principal investigator|0|||
105363483|NCT02659943|363334442|FG005|Overall Study|Patient's condition per principal investigator|1|||
105363484|NCT02659943|363334443|FG006|Overall Study|Patient's condition per principal investigator|0|||
105363485|NCT02659943|363334437|FG000|Overall Study|Ineligible|0|||
105363486|NCT02659943|363334438|FG001|Overall Study|Ineligible|0|||
105363487|NCT02659943|363334439|FG002|Overall Study|Ineligible|0|||
105363488|NCT02659943|363334440|FG003|Overall Study|Ineligible|0|||
105363489|NCT02659943|363334441|FG004|Overall Study|Ineligible|0|||
105363490|NCT02659943|363334442|FG005|Overall Study|Ineligible|0|||
105363491|NCT02659943|363334443|FG006|Overall Study|Ineligible|1|||
105363492|NCT02659943|363334437|FG000|Overall Study|No longer meets eligibility|0|||
105363493|NCT02659943|363334438|FG001|Overall Study|No longer meets eligibility|0|||
105363494|NCT02659943|363334439|FG002|Overall Study|No longer meets eligibility|0|||
105363495|NCT02659943|363334440|FG003|Overall Study|No longer meets eligibility|0|||
105363496|NCT02659943|363334441|FG004|Overall Study|No longer meets eligibility|0|||
105363497|NCT02659943|363334442|FG005|Overall Study|No longer meets eligibility|0|||
105363498|NCT02659943|363334443|FG006|Overall Study|No longer meets eligibility|1|||
105363499|NCT02659943|363334437|FG000|Overall Study|No treatment, per protocol|0|||
105363500|NCT02659943|363334438|FG001|Overall Study|No treatment, per protocol|0|||
105766430|NCT03654560|364798224|FG001|Overall Study|Death|1|||
105766431|NCT03654560|364798223|FG000|Overall Study|Lost to Follow-up|1|||
105766432|NCT03654560|364798224|FG001|Overall Study|Lost to Follow-up|0|||
105766433|NCT01473355|364798225|FG000|Overall Study|Protocol Violation|2|||
105766434|NCT01473355|364798225|FG000|Overall Study|Adverse Event|2|||
105766435|NCT01473355|364798225|FG000|Overall Study|Lost to Follow-up|2|||
105766436|NCT00106249|364798226|FG000|Overall Study|Lost to Follow-up|3|||
105766437|NCT00106249|364798227|FG001|Overall Study|Lost to Follow-up|2|||
105766438|NCT01462045|364798230|FG000|Overall Study|Family matter|0|||
105766439|NCT01462045|364798231|FG001|Overall Study|Family matter|1|||
105766440|NCT01462045|364798232|FG002|Overall Study|Family matter|0|||
105766441|NCT02471586|364798233|FG000|Overall Study|Lost to Follow-up|3|||
105766442|NCT02471586|364798234|FG001|Overall Study|Lost to Follow-up|8|||
105766443|NCT02471586|364798235|FG002|Overall Study|Lost to Follow-up|4|||
105766444|NCT02471586|364798233|FG000|Overall Study|Death|2|||
105766445|NCT02471586|364798234|FG001|Overall Study|Death|2|||
105766446|NCT02471586|364798235|FG002|Overall Study|Death|0|||
105766447|NCT01117181|364798237|FG000|Overall Study|Lost to Follow-up|1|||
105766448|NCT01117181|364798238|FG001|Overall Study|Lost to Follow-up|0|||
105766449|NCT01117181|364798237|FG000|Overall Study|Withdrawal by Subject|0|||
105766450|NCT01117181|364798238|FG001|Overall Study|Withdrawal by Subject|2|||
105766451|NCT01119963|364798239|FG000|Overall Study|Lost to Follow-up|1|||
105766452|NCT01119963|364798240|FG001|Overall Study|Lost to Follow-up|1|||
105766453|NCT03938636|364798241|FG000|Overall Study|Protocol Violation|0|||
105766454|NCT03938636|364798242|FG001|Overall Study|Protocol Violation|1|||
105766455|NCT03938636|364798243|FG002|Overall Study|Protocol Violation|1|||
105766456|NCT03938636|364798241|FG000|Overall Study|Subject withdrew due to death in family|0|||
105766457|NCT03938636|364798242|FG001|Overall Study|Subject withdrew due to death in family|1|||
105766458|NCT03938636|364798243|FG002|Overall Study|Subject withdrew due to death in family|0|||
105766459|NCT03938636|364798241|FG000|Overall Study|Missed visit|0|||
105766460|NCT03938636|364798242|FG001|Overall Study|Missed visit|1|||
105766461|NCT03938636|364798243|FG002|Overall Study|Missed visit|0|||
105766462|NCT03938636|364798241|FG000|Overall Study|Adverse Event|0|||
105766463|NCT03938636|364798242|FG001|Overall Study|Adverse Event|0|||
105766464|NCT03938636|364798243|FG002|Overall Study|Adverse Event|1|||
105766465|NCT03938636|364798241|FG000|Overall Study|Lost to Follow-up|0|||
105766466|NCT03938636|364798242|FG001|Overall Study|Lost to Follow-up|0|||
105766467|NCT03938636|364798243|FG002|Overall Study|Lost to Follow-up|1|||
105766468|NCT00606177|364798244|FG000|Overall Study|Adverse Event|9|||
105766469|NCT00606177|364798245|FG001|Overall Study|Adverse Event|5|||
105766470|NCT00606177|364798244|FG000|Overall Study|Lack of Efficacy|3|||
105766471|NCT00606177|364798245|FG001|Overall Study|Lack of Efficacy|7|||
105766472|NCT00606177|364798244|FG000|Overall Study|Physician Decision|1|||
105766473|NCT00606177|364798245|FG001|Overall Study|Physician Decision|0|||
105766474|NCT00606177|364798244|FG000|Overall Study|Protocol Violation|1|||
105766475|NCT00606177|364798245|FG001|Overall Study|Protocol Violation|4|||
105766476|NCT00606177|364798244|FG000|Overall Study|Withdrawal by Subject|5|||
105766477|NCT00606177|364798245|FG001|Overall Study|Withdrawal by Subject|6|||
105821997|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821998|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
105821999|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
105822000|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
105822001|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105822002|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105822003|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105822004|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105822005|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105822006|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822007|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822008|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822009|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822010|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822011|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822012|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822013|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822014|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822015|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822016|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822017|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822018|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822019|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
105822020|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
105822021|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
105822022|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822023|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822024|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822025|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822026|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822027|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822028|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822029|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822030|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822031|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822032|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822033|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822034|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822035|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822036|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822037|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822038|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822039|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822040|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822041|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
105822042|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
105822043|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822044|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822045|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822046|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822047|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822048|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822049|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822050|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822051|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822052|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822053|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822054|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822055|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822056|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105486484|NCT03823378|363793347|FG004|Overall Study|Withdrawal by Subject|0|||
105486485|NCT03823378|363793348|FG005|Overall Study|Withdrawal by Subject|1|||
105486486|NCT03823378|363793343|FG000|Overall Study|Other, not specified|19|||
105822057|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822058|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822059|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822060|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822061|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822062|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
105822063|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
105822064|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822065|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822066|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822067|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822068|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822069|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822070|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822071|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822072|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822073|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822074|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822075|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822076|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822077|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822078|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822079|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822080|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822081|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822082|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
105822083|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
105363501|NCT02659943|363334439|FG002|Overall Study|No treatment, per protocol|0|||
105363502|NCT02659943|363334440|FG003|Overall Study|No treatment, per protocol|0|||
105363503|NCT02659943|363334441|FG004|Overall Study|No treatment, per protocol|0|||
105363504|NCT02659943|363334442|FG005|Overall Study|No treatment, per protocol|0|||
105363505|NCT02659943|363334443|FG006|Overall Study|No treatment, per protocol|3|||
105363506|NCT03990051|363334446|FG000|Masked Period|Lost to Follow-up|1|||
105363507|NCT03990051|363334447|FG001|Masked Period|Lost to Follow-up|0|||
105363508|NCT03990051|363334446|FG000|Long Term Period|Death|1|||
105363509|NCT03990051|363334447|FG001|Long Term Period|Death|1|||
105363510|NCT03990051|363334446|FG000|Long Term Period|Lost to Follow-up|7|||
105363511|NCT03990051|363334447|FG001|Long Term Period|Lost to Follow-up|2|||
105363512|NCT03193047|363334448|FG000|Overall Study|Physician Decision|1|||
105363513|NCT03193047|363334449|FG001|Overall Study|Physician Decision|0|||
105363514|NCT03193047|363334448|FG000|Overall Study|Participant Left State|1|||
105363515|NCT03193047|363334449|FG001|Overall Study|Participant Left State|0|||
105363516|NCT05200845|363334450|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
105363517|NCT05200845|363334451|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
105363518|NCT05200845|363334452|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
105363519|NCT05200845|363334453|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
105363520|NCT05200845|363334450|FG000|Overall Study|Withdrawal by Subject|0|||
105363521|NCT05200845|363334451|FG001|Overall Study|Withdrawal by Subject|1|||
105363522|NCT05200845|363334452|FG002|Overall Study|Withdrawal by Subject|1|||
105363523|NCT05200845|363334453|FG003|Overall Study|Withdrawal by Subject|0|||
105822084|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
105822085|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822086|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822087|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105363524|NCT01272908|363334454|FG000|Initial Treatment Period|Adverse Event|1|||
105822088|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105363525|NCT01272908|363334454|FG000|Initial Treatment Period|Lack of Efficacy|5|||
105363526|NCT01272908|363334454|FG000|Initial Treatment Period|Protocol Violation|1|||
105363527|NCT01272908|363334454|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
105571689|NCT00041756|364092736|FG002|Overall Study|Withdrawal by Subject|4|||
105822089|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105363528|NCT01272908|363334454|FG000|Re-Treatment Period|Adverse Event|2|||
105571690|NCT00041756|364092737|FG003|Overall Study|Withdrawal by Subject|2|||
105363529|NCT01272908|363334454|FG000|Re-Treatment Period|Lack of Efficacy|3|||
105363530|NCT01272908|363334454|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
105363531|NCT02221648|363334455|FG000|Overall Study|Withdrawal by Subject|3|||
105363532|NCT02221648|363334456|FG001|Overall Study|Withdrawal by Subject|3|||
105363533|NCT00149396|363334460|FG000|Overall Study|Death|15|||
105363534|NCT00149396|363334460|FG000|Overall Study|Withdrawal by Subject|1|||
105363535|NCT00149396|363334460|FG000|Overall Study|Subject noncompliance|2|||
105363536|NCT00149396|363334460|FG000|Overall Study|other treatment|5|||
105363537|NCT02364388|363334461|FG000|Overall Study|Protocol Violation|1|||
105363538|NCT02364388|363334461|FG000|Overall Study|Technical Failure|3|||
105363539|NCT02364388|363334461|FG000|Overall Study|No OA/US data|2|||
105363540|NCT02364388|363334461|FG000|Overall Study|No Biopsy|2|||
105363541|NCT05227118|363334463|FG000|Overall Study|Adverse Event|0|||
105363542|NCT05227118|363334464|FG001|Overall Study|Adverse Event|0|||
105363543|NCT05227118|363334465|FG002|Overall Study|Adverse Event|1|||
105363544|NCT05227118|363334466|FG003|Overall Study|Adverse Event|0|||
105363545|NCT05227118|363334463|FG000|Overall Study|Withdrawal by Subject|0|||
105363546|NCT05227118|363334464|FG001|Overall Study|Withdrawal by Subject|0|||
105363547|NCT05227118|363334465|FG002|Overall Study|Withdrawal by Subject|2|||
105363548|NCT05227118|363334466|FG003|Overall Study|Withdrawal by Subject|0|||
105363549|NCT02689804|363334467|FG000|Overall Study|Withdrawal by Subject|2|||
105363550|NCT02689804|363334468|FG001|Overall Study|Withdrawal by Subject|0|||
105363551|NCT00901342|363334472|FG000|Overall Study|Adverse Event|1|||
105363552|NCT00901342|363334472|FG000|Overall Study|Death|4|||
105363553|NCT00901342|363334472|FG000|Overall Study|Disease progression|1|||
105363554|NCT00901342|363334472|FG000|Overall Study|Withdrawal by Subject|9|||
105363555|NCT00838097|363334473|FG000|Overall Study|Ineligibility determined|6|||
105363556|NCT00838097|363334473|FG000|Overall Study|Adverse Event|2|||
105363557|NCT00838097|363334473|FG000|Overall Study|Withdrawal by Subject|3|||
105363558|NCT00838097|363334473|FG000|Overall Study|Requirement for alternative therapy|2|||
105363559|NCT00838097|363334473|FG000|Overall Study|Physician Decision|4|||
105363560|NCT00838097|363334473|FG000|Overall Study|Lost to Follow-up|11|||
105363561|NCT00838097|363334473|FG000|Overall Study|Death|6|||
105363562|NCT00838097|363334473|FG000|Overall Study|Protocol-specified criteria|142|||
105363563|NCT02421419|363334478|FG000|Overall Study|Physician Decision|0|||
105363564|NCT02421419|363334479|FG001|Overall Study|Physician Decision|0|||
105363565|NCT02421419|363334480|FG002|Overall Study|Physician Decision|1|||
105363566|NCT04863872|363334483|FG000|Overall Study|Withdrawal by Subject|4|||
105363567|NCT04863872|363334484|FG001|Overall Study|Withdrawal by Subject|15|||
105363568|NCT04863872|363334483|FG000|Overall Study|Death|5|||
105363569|NCT04863872|363334484|FG001|Overall Study|Death|2|||
105363570|NCT04863872|363334483|FG000|Overall Study|Lost to Follow-up|2|||
105363571|NCT04863872|363334484|FG001|Overall Study|Lost to Follow-up|1|||
105363572|NCT02039778|363334487|FG000|Overall Study|Death|2|||
105363573|NCT02039778|363334487|FG000|Overall Study|Withdrawal by Subject|1|||
105363574|NCT02039778|363334487|FG000|Overall Study|Never started the protocol treatment|1|||
105363575|NCT04391842|363334488|FG000|Overall Study|Withdrawal by Subject|2|||
105363576|NCT02864407|363334491|FG000|Overall Study|Protocol Violation|3|||
105363577|NCT02864407|363334491|FG000|Overall Study|Lost to Follow-up|115|||
105363578|NCT02864407|363334491|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
105363579|NCT02864407|363334491|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
105363580|NCT02864407|363334491|FG000|Overall Study|Consent prior to the contract date|1|||
105363581|NCT01691378|363334492|FG000|Overall Study|Withdrawal by Subject|2|||
105363582|NCT01691378|363334493|FG001|Overall Study|Withdrawal by Subject|0|||
105363583|NCT01691378|363334492|FG000|Overall Study|Lost to Follow-up|5|||
105363584|NCT01691378|363334493|FG001|Overall Study|Lost to Follow-up|2|||
105363585|NCT02849080|363334494|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
105363586|NCT02849080|363334495|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
105363587|NCT02849080|363334496|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
105363588|NCT02849080|363334497|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
105363589|NCT02849080|363334494|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
105363590|NCT02849080|363334495|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
105363591|NCT02849080|363334496|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
105363592|NCT02849080|363334497|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
105363593|NCT02849080|363334494|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
105363594|NCT02849080|363334495|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
105363595|NCT02849080|363334496|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
105363596|NCT02849080|363334497|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
105363597|NCT02849080|363334494|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
105363598|NCT02849080|363334495|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
105363599|NCT02849080|363334496|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
105363600|NCT02849080|363334497|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
105363601|NCT02849080|363334494|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
105363602|NCT02849080|363334495|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
105363603|NCT02849080|363334496|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
105363604|NCT02849080|363334497|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
105822090|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822091|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822092|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822093|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822094|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822095|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822096|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822097|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822098|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822099|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822100|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822101|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822102|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822103|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822104|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
105822105|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
105822106|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822107|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822108|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822109|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822110|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822111|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822112|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822113|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822114|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822115|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822116|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822117|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822118|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822119|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822120|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822121|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822122|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822123|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822124|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822125|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
105822126|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
105822127|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822128|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822129|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822130|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822131|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822132|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822133|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822134|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822135|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822136|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822137|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822138|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822139|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822140|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822141|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822142|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822143|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822144|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822145|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822146|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
105822147|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
105822148|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822149|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822150|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822151|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822152|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822153|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105486487|NCT03823378|363793344|FG001|Overall Study|Other, not specified|12|||
105486488|NCT03823378|363793345|FG002|Overall Study|Other, not specified|6|||
105486489|NCT03823378|363793346|FG003|Overall Study|Other, not specified|8|||
105822154|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822155|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822156|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822157|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822158|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822159|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822160|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822161|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822162|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822163|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822164|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822165|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822166|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822167|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
105822168|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
105822169|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822170|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822171|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822172|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105766478|NCT00606177|364798244|FG000|Overall Study|Progression to depressive phase|6|||
105766479|NCT00606177|364798245|FG001|Overall Study|Progression to depressive phase|1|||
105766480|NCT00606177|364798244|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
105766481|NCT00606177|364798245|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
105766482|NCT00606177|364798244|FG000|Overall Study|Change of residence or other commitments|1|||
105766483|NCT00606177|364798245|FG001|Overall Study|Change of residence or other commitments|1|||
105766484|NCT02473289|364798248|FG000|Overall Study|Adverse Event|2|||
105766485|NCT02473289|364798249|FG001|Overall Study|Adverse Event|3|||
105766486|NCT02473289|364798248|FG000|Overall Study|Lost to Follow-up|1|||
105766487|NCT02473289|364798249|FG001|Overall Study|Lost to Follow-up|1|||
105766488|NCT02473289|364798248|FG000|Overall Study|Protocol Violation|0|||
105766489|NCT02473289|364798249|FG001|Overall Study|Protocol Violation|1|||
105766490|NCT02473289|364798248|FG000|Overall Study|Withdrawal of consent|6|||
105766491|NCT02473289|364798249|FG001|Overall Study|Withdrawal of consent|7|||
105766492|NCT02473289|364798248|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
105766493|NCT02473289|364798249|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
105766494|NCT02473289|364798248|FG000|Overall Study|Other|2|||
105766495|NCT02473289|364798249|FG001|Overall Study|Other|0|||
105766496|NCT03277105|364798252|FG000|Overall Study|Death|129|||
105486490|NCT03823378|363793347|FG004|Overall Study|Other, not specified|17|||
105486491|NCT03823378|363793348|FG005|Overall Study|Other, not specified|7|||
105363605|NCT02849080|363334494|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
105363606|NCT02849080|363334495|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
105363607|NCT02849080|363334496|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
105363608|NCT02849080|363334497|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
105363609|NCT01819727|363334498|FG000|Overall Study|Adverse Event|8|||
105363610|NCT01819727|363334499|FG001|Overall Study|Adverse Event|9|||
105363611|NCT01819727|363334498|FG000|Overall Study|Death|1|||
105363612|NCT01819727|363334499|FG001|Overall Study|Death|0|||
105363613|NCT01819727|363334498|FG000|Overall Study|Lost to Follow-up|1|||
105363614|NCT01819727|363334499|FG001|Overall Study|Lost to Follow-up|1|||
105363615|NCT01819727|363334498|FG000|Overall Study|Physician Decision|3|||
105363616|NCT01819727|363334499|FG001|Overall Study|Physician Decision|2|||
105363617|NCT01819727|363334498|FG000|Overall Study|Pregnancy|1|||
105363618|NCT01819727|363334499|FG001|Overall Study|Pregnancy|0|||
105363619|NCT01819727|363334498|FG000|Overall Study|Protocol Violation|0|||
105363620|NCT01819727|363334499|FG001|Overall Study|Protocol Violation|2|||
105363621|NCT01819727|363334498|FG000|Overall Study|Study Terminated by Sponsor|0|||
105363622|NCT01819727|363334499|FG001|Overall Study|Study Terminated by Sponsor|1|||
105363623|NCT01819727|363334498|FG000|Overall Study|Withdrawal by Subject|6|||
105363624|NCT01819727|363334499|FG001|Overall Study|Withdrawal by Subject|11|||
105363625|NCT01819727|363334498|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
105363626|NCT01819727|363334499|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
105363627|NCT01819727|363334498|FG000|Overall Study|Quit due to lack of health benifits|0|||
105766497|NCT03277105|364798253|FG001|Overall Study|Death|124|||
105766498|NCT03277105|364798252|FG000|Overall Study|Lost to Follow-up|2|||
105766499|NCT03277105|364798253|FG001|Overall Study|Lost to Follow-up|4|||
105766500|NCT03277105|364798252|FG000|Overall Study|Withdrawal by Subject|10|||
105766501|NCT03277105|364798253|FG001|Overall Study|Withdrawal by Subject|10|||
105766502|NCT03277105|364798252|FG000|Overall Study|Other|118|||
105766503|NCT03277105|364798253|FG001|Overall Study|Other|125|||
105766504|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
105766505|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
105766506|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
105766507|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
105766508|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
105766509|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
105766510|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
105766511|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
105766512|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
105363628|NCT01819727|363334499|FG001|Overall Study|Quit due to lack of health benifits|1|||
105766513|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
105766514|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
105766515|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
105766516|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
105766517|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
105766518|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
105363629|NCT03839394|363334505|FG000|Overall Study|Lost to Follow-up|6|||
105363630|NCT03839394|363334506|FG001|Overall Study|Lost to Follow-up|8|||
105363631|NCT03839394|363334505|FG000|Overall Study|Withdrawal by Subject|0|||
105363632|NCT03839394|363334506|FG001|Overall Study|Withdrawal by Subject|2|||
105363633|NCT01367249|363334507|FG000|Overall Study|Withdrawal by Subject|6|||
105363634|NCT01367249|363334508|FG001|Overall Study|Withdrawal by Subject|6|||
105363635|NCT01367249|363334507|FG000|Overall Study|Other|3|||
105363636|NCT01367249|363334508|FG001|Overall Study|Other|10|||
105363637|NCT00823134|363336208|FG000|Overall Study|Invalid measurement|1|||
105363638|NCT04110314|363336209|FG000|Overall Study|Did not meet inclusion criteria|35255|||
105363639|NCT04110314|363336210|FG001|Overall Study|Did not meet inclusion criteria|35104|||
105363640|NCT04110314|363336211|FG002|Overall Study|Did not meet inclusion criteria|35636|||
105363641|NCT04110314|363336212|FG003|Overall Study|Did not meet inclusion criteria|35135|||
105363642|NCT04110314|363336213|FG004|Overall Study|Did not meet inclusion criteria|35247|||
105363643|NCT04110314|363336214|FG005|Overall Study|Did not meet inclusion criteria|35727|||
105363644|NCT00468585|363336221|FG000|Overall Study|Patient not treated|1|||
105363645|NCT00468585|363336222|FG001|Overall Study|Patient not treated|0|||
105363646|NCT00468585|363336223|FG002|Overall Study|Patient not treated|1|||
105363647|NCT00468585|363336224|FG003|Overall Study|Patient not treated|0|||
105363648|NCT00468585|363336221|FG000|Overall Study|Patient found to be ineligible|0|||
105363649|NCT00468585|363336222|FG001|Overall Study|Patient found to be ineligible|0|||
105363650|NCT00468585|363336223|FG002|Overall Study|Patient found to be ineligible|1|||
105363651|NCT00468585|363336224|FG003|Overall Study|Patient found to be ineligible|0|||
105363652|NCT00468585|363336221|FG000|Overall Study|Adverse Event|0|||
105363653|NCT00468585|363336222|FG001|Overall Study|Adverse Event|0|||
105363654|NCT00468585|363336223|FG002|Overall Study|Adverse Event|1|||
105363655|NCT00468585|363336224|FG003|Overall Study|Adverse Event|0|||
105363656|NCT00468585|363336221|FG000|Overall Study|Withdrawal by Subject|0|||
105363657|NCT00468585|363336222|FG001|Overall Study|Withdrawal by Subject|0|||
105363658|NCT00468585|363336223|FG002|Overall Study|Withdrawal by Subject|2|||
105363659|NCT00468585|363336224|FG003|Overall Study|Withdrawal by Subject|1|||
105363660|NCT02048722|363336229|FG000|2 Cycles of Treatment|Adverse Event|2|||
105363661|NCT02048722|363336229|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
105363662|NCT02048722|363336229|FG000|2 Cycles of Treatment|Progressive Disease|2|||
105363663|NCT02048722|363336229|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
105363664|NCT02048722|363336229|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
105363665|NCT02048722|363336229|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
105363666|NCT01529606|363336232|FG000|Overall Study|Lost to Follow-up|21|||
105363667|NCT01529606|363336233|FG001|Overall Study|Lost to Follow-up|18|||
105363668|NCT04073303|363336237|FG000|Overall Study|Adverse Event|0|||
105486492|NCT00058539|363793349|FG000|Overall Study|Disease progression|24|||
105486493|NCT00058539|363793349|FG000|Overall Study|Adverse Event|3|||
105486494|NCT00058539|363793349|FG000|Overall Study|Withdrawal by Subject|5|||
105363669|NCT04073303|363336238|FG001|Overall Study|Adverse Event|2|||
105363670|NCT04073303|363336237|FG000|Overall Study|Withdrawal by Subject|16|||
105363671|NCT04073303|363336238|FG001|Overall Study|Withdrawal by Subject|36|||
105363672|NCT04073303|363336237|FG000|Overall Study|Lost to Follow-up|6|||
105363673|NCT04073303|363336238|FG001|Overall Study|Lost to Follow-up|1|||
105363674|NCT04073303|363336237|FG000|Overall Study|Protocol Deviation|0|||
105486495|NCT00058539|363793349|FG000|Overall Study|Physician Decision|9|||
105486496|NCT00058539|363793349|FG000|Overall Study|Death|1|||
105363675|NCT04073303|363336238|FG001|Overall Study|Protocol Deviation|4|||
105363676|NCT04073303|363336237|FG000|Overall Study|Other|1|||
105363677|NCT04073303|363336238|FG001|Overall Study|Other|1|||
105363678|NCT04144322|363336239|FG000|Overall Study|Lack of Efficacy|2|||
105363679|NCT04144322|363336240|FG001|Overall Study|Lack of Efficacy|2|||
105363680|NCT04795466|363336241|FG000|Overall Study|Adverse Event|3|||
105363681|NCT04795466|363336242|FG001|Overall Study|Adverse Event|1|||
105363682|NCT04795466|363336241|FG000|Overall Study|Physician Decision|1|||
105363683|NCT04795466|363336242|FG001|Overall Study|Physician Decision|0|||
105363684|NCT04795466|363336241|FG000|Overall Study|Withdrawal by Subject|2|||
105363685|NCT04795466|363336242|FG001|Overall Study|Withdrawal by Subject|1|||
105363686|NCT02131064|363336244|FG000|Overall Study|Death|5|||
105363687|NCT02131064|363336245|FG001|Overall Study|Death|6|||
105363688|NCT02131064|363336244|FG000|Overall Study|Lost to Follow-up|4|||
105363689|NCT02131064|363336245|FG001|Overall Study|Lost to Follow-up|8|||
105363690|NCT02131064|363336244|FG000|Overall Study|Withdrawal by Subject|14|||
105363691|NCT02131064|363336245|FG001|Overall Study|Withdrawal by Subject|18|||
105363692|NCT02131064|363336244|FG000|Overall Study|Other|2|||
105363693|NCT02131064|363336245|FG001|Overall Study|Other|2|||
105363694|NCT01534273|363336250|FG000|Period 1|Physician Decision|0|||
105363695|NCT01534273|363336251|FG001|Period 1|Physician Decision|0|||
105363696|NCT01534273|363336252|FG002|Period 1|Physician Decision|0|||
105363697|NCT01534273|363336253|FG003|Period 1|Physician Decision|1|||
105363698|NCT01534273|363336254|FG004|Period 1|Physician Decision|0|||
105363699|NCT01534273|363336255|FG005|Period 1|Physician Decision|0|||
105363700|NCT01534273|363336256|FG006|Period 1|Physician Decision|0|||
105363701|NCT01619865|363336259|FG000|Overall Study|Adverse Event|1|||
105363702|NCT01619865|363336259|FG000|Overall Study|Death|2|||
105363703|NCT01619865|363336259|FG000|Overall Study|subject not able to comply|1|||
105363704|NCT03586050|363336260|FG000|Overall Study|Death|3|||
105363705|NCT03586050|363336260|FG000|Overall Study|Withdrawal by Subject|2|||
105363706|NCT04767373|363336261|FG000|Overall Study|Death|6|||
105363707|NCT04767373|363336262|FG001|Overall Study|Death|3|||
105363708|NCT04767373|363336261|FG000|Overall Study|Lost to Follow-up|67|||
105363709|NCT04767373|363336262|FG001|Overall Study|Lost to Follow-up|35|||
105363710|NCT04767373|363336261|FG000|Overall Study|Physician Decision|15|||
105363711|NCT04767373|363336262|FG001|Overall Study|Physician Decision|4|||
105363712|NCT04767373|363336261|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105363713|NCT04767373|363336262|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
105363714|NCT04767373|363336261|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
105363715|NCT04767373|363336262|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
105363716|NCT04767373|363336261|FG000|Overall Study|Other|1|||
105363717|NCT04767373|363336262|FG001|Overall Study|Other|2|||
105363718|NCT02658669|363336263|FG000|Overall Study|Lost to Follow-up|7|||
105363719|NCT02658669|363336264|FG001|Overall Study|Lost to Follow-up|5|||
105363720|NCT01435759|363336265|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
105363721|NCT01435759|363336266|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
105363722|NCT01435759|363336267|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
105363723|NCT01435759|363336268|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
105363724|NCT01435759|363336269|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
105363725|NCT01435759|363336270|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
105363726|NCT01435759|363336265|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
105363727|NCT01435759|363336266|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
105363728|NCT01435759|363336267|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
105363729|NCT01435759|363336268|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
105363730|NCT01435759|363336269|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
105363731|NCT01435759|363336270|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
105363732|NCT01435759|363336265|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
105363733|NCT01435759|363336266|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
105363734|NCT01435759|363336267|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
105363735|NCT01435759|363336268|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
105363736|NCT01435759|363336269|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
105363737|NCT01435759|363336270|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
105363738|NCT01435759|363336265|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
105363739|NCT01435759|363336266|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
105363740|NCT01435759|363336267|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
105363741|NCT01435759|363336268|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
105363742|NCT01435759|363336269|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
105363743|NCT01435759|363336270|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
105363744|NCT01435759|363336265|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
105363745|NCT01435759|363336266|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
105363746|NCT01435759|363336267|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
105363747|NCT01435759|363336268|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
105363748|NCT01435759|363336269|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
105486497|NCT00930982|363793352|FG000|Overall Study|Adverse Event|19|||
105822173|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822174|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822175|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822176|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105363749|NCT01435759|363336270|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
105363750|NCT01435759|363336265|FG000|Antidepressant Lead-in Phase|Other|119|||
105363751|NCT01435759|363336266|FG001|Antidepressant Lead-in Phase|Other|0|||
105363752|NCT01435759|363336267|FG002|Antidepressant Lead-in Phase|Other|0|||
105363753|NCT01435759|363336268|FG003|Antidepressant Lead-in Phase|Other|0|||
105363754|NCT01435759|363336269|FG004|Antidepressant Lead-in Phase|Other|0|||
105363755|NCT01435759|363336270|FG005|Antidepressant Lead-in Phase|Other|0|||
105363756|NCT01435759|363336265|FG000|Double-blind Phase|Adverse Event|7|||
105363757|NCT01435759|363336266|FG001|Double-blind Phase|Adverse Event|0|||
105363758|NCT01435759|363336267|FG002|Double-blind Phase|Adverse Event|1|||
105363759|NCT01435759|363336268|FG003|Double-blind Phase|Adverse Event|1|||
105822177|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822178|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822179|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822180|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105363760|NCT01435759|363336269|FG004|Double-blind Phase|Adverse Event|1|||
105363761|NCT01435759|363336270|FG005|Double-blind Phase|Adverse Event|3|||
105363762|NCT01435759|363336265|FG000|Double-blind Phase|Protocol Violation|2|||
105363763|NCT01435759|363336266|FG001|Double-blind Phase|Protocol Violation|0|||
105363764|NCT01435759|363336267|FG002|Double-blind Phase|Protocol Violation|1|||
105363765|NCT01435759|363336268|FG003|Double-blind Phase|Protocol Violation|2|||
105822181|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822182|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822183|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822184|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822185|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822186|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822187|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
105822188|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822189|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822190|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822191|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822192|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822193|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822194|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822195|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822196|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822197|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822198|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822199|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822200|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822201|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822202|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822203|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822204|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822205|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822206|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822207|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822208|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105363766|NCT01435759|363336269|FG004|Double-blind Phase|Protocol Violation|0|||
105363767|NCT01435759|363336270|FG005|Double-blind Phase|Protocol Violation|1|||
105363768|NCT01435759|363336265|FG000|Double-blind Phase|Withdrawal by Subject|17|||
105363769|NCT01435759|363336266|FG001|Double-blind Phase|Withdrawal by Subject|4|||
105363770|NCT01435759|363336267|FG002|Double-blind Phase|Withdrawal by Subject|3|||
105363771|NCT01435759|363336268|FG003|Double-blind Phase|Withdrawal by Subject|4|||
105363772|NCT01435759|363336269|FG004|Double-blind Phase|Withdrawal by Subject|2|||
105363773|NCT01435759|363336270|FG005|Double-blind Phase|Withdrawal by Subject|2|||
105363774|NCT01435759|363336265|FG000|Double-blind Phase|Lost to Follow-up|31|||
105363775|NCT01435759|363336266|FG001|Double-blind Phase|Lost to Follow-up|1|||
105363776|NCT01435759|363336267|FG002|Double-blind Phase|Lost to Follow-up|2|||
105363777|NCT01435759|363336268|FG003|Double-blind Phase|Lost to Follow-up|0|||
105363778|NCT01435759|363336269|FG004|Double-blind Phase|Lost to Follow-up|3|||
105363779|NCT01435759|363336270|FG005|Double-blind Phase|Lost to Follow-up|3|||
105363780|NCT01435759|363336265|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
105363781|NCT01435759|363336266|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
105363782|NCT01435759|363336267|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
105363783|NCT01435759|363336268|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
105363784|NCT01435759|363336269|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
105363785|NCT01435759|363336270|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
105822209|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822210|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105363786|NCT01435759|363336265|FG000|Double-blind Phase|Other|8|||
105363787|NCT01435759|363336266|FG001|Double-blind Phase|Other|2|||
105363788|NCT01435759|363336267|FG002|Double-blind Phase|Other|0|||
105822211|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
105822212|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
105822213|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
105822214|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
105822215|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
105822216|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822217|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822218|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822219|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822220|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822221|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822222|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822223|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822224|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822225|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822226|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822227|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822228|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822229|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822230|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822231|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822232|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822233|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
105822234|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
105822235|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
105822236|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
105822237|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822238|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822239|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822240|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822241|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822242|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822243|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822244|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822245|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822246|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822247|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105363789|NCT01435759|363336268|FG003|Double-blind Phase|Other|2|||
105363790|NCT01435759|363336269|FG004|Double-blind Phase|Other|0|||
105363791|NCT01435759|363336270|FG005|Double-blind Phase|Other|0|||
105363792|NCT03727841|363336273|FG000|Overall Study|Physician Decision|3|||
105363793|NCT03727841|363336274|FG001|Overall Study|Physician Decision|1|||
105363794|NCT03126786|363336275|FG000|Overall Study|Adverse Event|3|||
105363795|NCT03126786|363336276|FG001|Overall Study|Adverse Event|0|||
105363796|NCT03126786|363336275|FG000|Overall Study|Lost to Follow-up|0|||
105363797|NCT03126786|363336276|FG001|Overall Study|Lost to Follow-up|1|||
105363798|NCT03126786|363336275|FG000|Overall Study|Withdrawal by Subject|3|||
105363799|NCT03126786|363336276|FG001|Overall Study|Withdrawal by Subject|1|||
105363800|NCT01211145|363336277|FG000|Overall Study|Reason not specified|3|||
105363801|NCT01211145|363336278|FG001|Overall Study|Reason not specified|2|||
105363802|NCT01211145|363336279|FG002|Overall Study|Reason not specified|2|||
105363803|NCT01211145|363336280|FG003|Overall Study|Reason not specified|1|||
105822248|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822249|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822250|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105363804|NCT01211145|363336277|FG000|Overall Study|Lost to Follow-up|3|||
105363805|NCT01211145|363336278|FG001|Overall Study|Lost to Follow-up|2|||
105363806|NCT01211145|363336279|FG002|Overall Study|Lost to Follow-up|1|||
105363807|NCT01211145|363336280|FG003|Overall Study|Lost to Follow-up|2|||
105363808|NCT01211145|363336277|FG000|Overall Study|Study-specific withdrawal criteria|1|||
105363809|NCT01211145|363336278|FG001|Overall Study|Study-specific withdrawal criteria|0|||
105363810|NCT01211145|363336279|FG002|Overall Study|Study-specific withdrawal criteria|0|||
105363811|NCT01211145|363336280|FG003|Overall Study|Study-specific withdrawal criteria|0|||
105363812|NCT01211145|363336277|FG000|Overall Study|Severe noncompliance to protocol|1|||
105363813|NCT01211145|363336278|FG001|Overall Study|Severe noncompliance to protocol|0|||
105363814|NCT01211145|363336279|FG002|Overall Study|Severe noncompliance to protocol|0|||
105363815|NCT01211145|363336280|FG003|Overall Study|Severe noncompliance to protocol|0|||
105363816|NCT01211145|363336277|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
105363817|NCT01211145|363336278|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
105363818|NCT01211145|363336279|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
105363819|NCT01211145|363336280|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
105363820|NCT01211145|363336277|FG000|Overall Study|Patient decision|2|||
105363821|NCT01211145|363336278|FG001|Overall Study|Patient decision|1|||
105363822|NCT01211145|363336279|FG002|Overall Study|Patient decision|0|||
105363823|NCT01211145|363336280|FG003|Overall Study|Patient decision|2|||
105486498|NCT00930982|363793353|FG001|Overall Study|Adverse Event|23|||
105486499|NCT00930982|363793352|FG000|Overall Study|Protocol Violation|1|||
105822251|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822252|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822253|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
105822254|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822255|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822256|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
105822257|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
105822258|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822259|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822260|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822261|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822262|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822263|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822264|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822265|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822266|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822267|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822268|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822269|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822270|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822271|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822272|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105363824|NCT04396626|363336281|FG000|Overall Study|Premature termination of study|975|||
105363825|NCT02417753|363336282|FG000|Overall Study|Death|1|||
105363826|NCT04805671|363336283|FG000|Overall Study|Death|2|||
105486500|NCT00930982|363793353|FG001|Overall Study|Protocol Violation|5|||
105363827|NCT04805671|363336284|FG001|Overall Study|Death|7|||
105363828|NCT04805671|363336283|FG000|Overall Study|Lost to Follow-up|1|||
105363829|NCT04805671|363336284|FG001|Overall Study|Lost to Follow-up|0|||
105363830|NCT04805671|363336283|FG000|Overall Study|Withdrawal by Subject|9|||
105486501|NCT00930982|363793352|FG000|Overall Study|Withdrawal by Subject|1|||
105363831|NCT04805671|363336284|FG001|Overall Study|Withdrawal by Subject|7|||
105363832|NCT04805671|363336283|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
105363833|NCT04805671|363336284|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
105363834|NCT00385918|363336298|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
105363835|NCT00385918|363336299|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
105363836|NCT00385918|363336300|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
105363837|NCT00385918|363336298|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
105363838|NCT00385918|363336299|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
105363839|NCT00385918|363336300|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
105363840|NCT00385918|363336298|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
105363841|NCT00385918|363336299|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
105363842|NCT00385918|363336300|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
105363843|NCT00385918|363336298|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
105363844|NCT00385918|363336299|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
105363845|NCT00385918|363336300|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
105363846|NCT00385918|363336298|FG000|Intervention Phase After Randomization|Physician Decision|1|||
105363847|NCT00385918|363336299|FG001|Intervention Phase After Randomization|Physician Decision|0|||
105363848|NCT00385918|363336300|FG002|Intervention Phase After Randomization|Physician Decision|0|||
105363849|NCT00385918|363336298|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
105363850|NCT00385918|363336299|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
105363851|NCT00385918|363336300|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
105822273|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822274|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822275|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822276|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
105822277|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
105822278|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
105822279|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822280|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822281|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822282|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822283|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822284|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822285|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822286|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822287|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822288|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822289|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822290|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822291|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822292|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822293|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822294|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822295|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
105822296|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822297|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822298|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
105822299|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
105822300|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822301|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822302|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822303|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822304|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822305|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822306|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822307|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822308|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822309|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822310|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822311|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822312|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105766519|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
105766520|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
105766521|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
105766522|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
105766523|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
105766524|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
105766525|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
105766526|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
105766527|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
105766528|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
105766529|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
105766530|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
105766531|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
105766532|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
105766533|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
105766534|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
105766535|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
105766536|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
105766537|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
105766538|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
105766539|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
105766540|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
105766541|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
105766542|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
105766543|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
105766544|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
105766545|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
105766546|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
105766547|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
105766548|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
105766549|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
105766550|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
105766551|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
105766552|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
105766553|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
105766554|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
105766555|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
105766556|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
105766557|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
105766558|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
105766559|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
105766560|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
105766561|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
105766562|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
105766563|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
105766564|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
105766565|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
105766566|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
105766567|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
105766568|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
105766569|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
105766570|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
105766571|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
105766572|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
105766573|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
105766574|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
105766575|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
105766576|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
105766577|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
105766578|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
105766579|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
105766580|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
105822313|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822314|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822315|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822316|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
105822317|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822318|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822319|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
105822320|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
105822321|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822322|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822323|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822324|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822325|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105766581|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
105766582|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
105766583|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
105766584|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
105766585|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
105766586|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
105766587|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
105766588|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
105766589|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
105766590|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
105766591|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
105766592|NCT02057068|364798258|FG000|Overall Study|Withdrawal by Subject|2|||
105766593|NCT02057068|364798259|FG001|Overall Study|Withdrawal by Subject|2|||
105766594|NCT02057068|364798258|FG000|Overall Study|Caregiver (CG) Health|0|||
105766595|NCT02057068|364798259|FG001|Overall Study|Caregiver (CG) Health|2|||
105766596|NCT02057068|364798258|FG000|Overall Study|Carepartner (CP) Health|4|||
105822326|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822327|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105766597|NCT02057068|364798259|FG001|Overall Study|Carepartner (CP) Health|2|||
105766598|NCT02057068|364798258|FG000|Overall Study|Lost to Follow-up|2|||
105766599|NCT02057068|364798259|FG001|Overall Study|Lost to Follow-up|2|||
105766600|NCT00633360|364798260|FG000|Overall Study|Lost to Follow-up|1|||
105766601|NCT00633360|364798261|FG001|Overall Study|Lost to Follow-up|1|||
105766602|NCT00633360|364798260|FG000|Overall Study|Adverse Event|3|||
105766603|NCT00633360|364798261|FG001|Overall Study|Adverse Event|1|||
105766604|NCT00633360|364798260|FG000|Overall Study|Protocol Violation|0|||
105822328|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822329|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822330|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822331|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822332|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822333|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822334|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822335|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822336|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105571691|NCT00041756|364092738|FG004|Overall Study|Withdrawal by Subject|3|||
105571692|NCT00041756|364092734|FG000|Overall Study|Lost to Follow-up|0|||
105571693|NCT00041756|364092735|FG001|Overall Study|Lost to Follow-up|1|||
105571694|NCT00041756|364092736|FG002|Overall Study|Lost to Follow-up|0|||
105571695|NCT00041756|364092737|FG003|Overall Study|Lost to Follow-up|1|||
105571696|NCT00041756|364092738|FG004|Overall Study|Lost to Follow-up|0|||
105571697|NCT00041756|364092734|FG000|Overall Study|Unable to meet protocol criteria|0|||
105571698|NCT00041756|364092735|FG001|Overall Study|Unable to meet protocol criteria|0|||
105571699|NCT00041756|364092736|FG002|Overall Study|Unable to meet protocol criteria|1|||
105571700|NCT00041756|364092737|FG003|Overall Study|Unable to meet protocol criteria|0|||
105571701|NCT00041756|364092738|FG004|Overall Study|Unable to meet protocol criteria|1|||
105766605|NCT00633360|364798261|FG001|Overall Study|Protocol Violation|1|||
105766606|NCT01505114|364798262|FG000|Overall Study|Withdrawal by Subject|5|||
105766607|NCT01505114|364798263|FG001|Overall Study|Withdrawal by Subject|4|||
105766608|NCT01505114|364798264|FG002|Overall Study|Withdrawal by Subject|4|||
105766609|NCT01505114|364798265|FG003|Overall Study|Withdrawal by Subject|7|||
105766610|NCT01505114|364798262|FG000|Overall Study|Death|1|||
105766611|NCT01505114|364798263|FG001|Overall Study|Death|0|||
105766612|NCT01505114|364798264|FG002|Overall Study|Death|0|||
105766613|NCT01505114|364798265|FG003|Overall Study|Death|1|||
105363852|NCT02256839|363336301|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
105363853|NCT02256839|363336302|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
105363854|NCT04202497|363336303|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
105363855|NCT04202497|363336304|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
105363856|NCT04202497|363336305|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
105363857|NCT04202497|363336306|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
105363858|NCT01261390|363336308|FG000|Overall Study|Significant Concurrent Illness|1|||
105363859|NCT01261390|363336309|FG001|Overall Study|Significant Concurrent Illness|0|||
105363860|NCT01261390|363336310|FG002|Overall Study|Significant Concurrent Illness|1|||
105363861|NCT01261390|363336311|FG003|Overall Study|Significant Concurrent Illness|0|||
105363862|NCT01261390|363336308|FG000|Overall Study|Dissatisfaction with Treatment|2|||
105363863|NCT01261390|363336309|FG001|Overall Study|Dissatisfaction with Treatment|1|||
105363864|NCT01261390|363336310|FG002|Overall Study|Dissatisfaction with Treatment|1|||
105363865|NCT01261390|363336311|FG003|Overall Study|Dissatisfaction with Treatment|2|||
105363866|NCT01261390|363336308|FG000|Overall Study|Relocation|0|||
105363867|NCT01261390|363336309|FG001|Overall Study|Relocation|1|||
105363868|NCT01261390|363336310|FG002|Overall Study|Relocation|0|||
105766614|NCT01505114|364798262|FG000|Overall Study|unable to adhere to visit schedule|3|||
105766615|NCT01505114|364798263|FG001|Overall Study|unable to adhere to visit schedule|2|||
105766616|NCT01505114|364798264|FG002|Overall Study|unable to adhere to visit schedule|3|||
105766617|NCT01505114|364798265|FG003|Overall Study|unable to adhere to visit schedule|3|||
105766618|NCT01505114|364798262|FG000|Overall Study|Lost to Follow-up|11|||
105766619|NCT01505114|364798263|FG001|Overall Study|Lost to Follow-up|5|||
105766620|NCT01505114|364798264|FG002|Overall Study|Lost to Follow-up|8|||
105766621|NCT01505114|364798265|FG003|Overall Study|Lost to Follow-up|7|||
105766622|NCT01505114|364798262|FG000|Overall Study|relocated|4|||
105766623|NCT01505114|364798263|FG001|Overall Study|relocated|2|||
105766624|NCT01505114|364798264|FG002|Overall Study|relocated|2|||
105766625|NCT01505114|364798265|FG003|Overall Study|relocated|3|||
105766626|NCT01505114|364798262|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
105766627|NCT01505114|364798263|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
105766628|NCT01505114|364798264|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
105766629|NCT01505114|364798265|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
105766630|NCT01505114|364798262|FG000|Overall Study|staff safety concerns|0|||
105766631|NCT01505114|364798263|FG001|Overall Study|staff safety concerns|0|||
105766632|NCT01505114|364798264|FG002|Overall Study|staff safety concerns|0|||
105766633|NCT01505114|364798265|FG003|Overall Study|staff safety concerns|1|||
105766634|NCT01505114|364798262|FG000|Overall Study|investigator decision|1|||
105766635|NCT01505114|364798263|FG001|Overall Study|investigator decision|0|||
105766636|NCT01505114|364798264|FG002|Overall Study|investigator decision|1|||
105766637|NCT01505114|364798265|FG003|Overall Study|investigator decision|0|||
105766638|NCT00910728|364798266|FG000|Overall Study|Lack of Efficacy|2|||
105766639|NCT00910728|364798267|FG001|Overall Study|Lack of Efficacy|3|||
105766640|NCT00910728|364798268|FG002|Overall Study|Lack of Efficacy|1|||
105766641|NCT00910728|364798269|FG003|Overall Study|Lack of Efficacy|2|||
105766642|NCT00910728|364798270|FG004|Overall Study|Lack of Efficacy|1|||
105766643|NCT00910728|364798271|FG005|Overall Study|Lack of Efficacy|0|||
105766644|NCT00910728|364798272|FG006|Overall Study|Lack of Efficacy|2|||
105766645|NCT00910728|364798273|FG007|Overall Study|Lack of Efficacy|2|||
105766646|NCT00910728|364798274|FG008|Overall Study|Lack of Efficacy|2|||
105766647|NCT00910728|364798266|FG000|Overall Study|Withdrawal by Subject|0|||
105766648|NCT00910728|364798267|FG001|Overall Study|Withdrawal by Subject|0|||
105822337|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
105822338|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822339|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822340|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
105822341|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822342|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822343|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822344|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105766649|NCT00910728|364798268|FG002|Overall Study|Withdrawal by Subject|0|||
105822345|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822346|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822347|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822348|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822349|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822350|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105766650|NCT00910728|364798269|FG003|Overall Study|Withdrawal by Subject|0|||
105766651|NCT00910728|364798270|FG004|Overall Study|Withdrawal by Subject|3|||
105766652|NCT00910728|364798271|FG005|Overall Study|Withdrawal by Subject|1|||
105363869|NCT01261390|363336311|FG003|Overall Study|Relocation|0|||
105766653|NCT00910728|364798272|FG006|Overall Study|Withdrawal by Subject|2|||
105822351|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105766654|NCT00910728|364798273|FG007|Overall Study|Withdrawal by Subject|0|||
105766655|NCT00910728|364798274|FG008|Overall Study|Withdrawal by Subject|0|||
105766656|NCT00910728|364798266|FG000|Overall Study|(not specified)|2|||
105766657|NCT00910728|364798267|FG001|Overall Study|(not specified)|0|||
105766658|NCT00910728|364798268|FG002|Overall Study|(not specified)|1|||
105766659|NCT00910728|364798269|FG003|Overall Study|(not specified)|0|||
105766660|NCT00910728|364798270|FG004|Overall Study|(not specified)|1|||
105363870|NCT01261390|363336308|FG000|Overall Study|Loss of Interest in the Study|3|||
105363871|NCT01261390|363336309|FG001|Overall Study|Loss of Interest in the Study|1|||
105363872|NCT01261390|363336310|FG002|Overall Study|Loss of Interest in the Study|0|||
105363873|NCT01261390|363336311|FG003|Overall Study|Loss of Interest in the Study|0|||
105363874|NCT01261390|363336308|FG000|Overall Study|Lost to Follow-up|1|||
105363875|NCT01261390|363336309|FG001|Overall Study|Lost to Follow-up|6|||
105363876|NCT01261390|363336310|FG002|Overall Study|Lost to Follow-up|5|||
105363877|NCT01261390|363336311|FG003|Overall Study|Lost to Follow-up|6|||
105363878|NCT01951417|363336327|FG000|Overall Study|Withdrawal by Subject|1|||
105363879|NCT01951417|363336327|FG000|Overall Study|Protocol Violation|2|||
105363880|NCT01951417|363336327|FG000|Overall Study|Lost to Follow-up|6|||
105363881|NCT00196105|363336328|FG000|Overall Study|Lost to Follow-up|4|||
105363882|NCT00196105|363336329|FG001|Overall Study|Lost to Follow-up|5|||
105363883|NCT00196105|363336330|FG002|Overall Study|Lost to Follow-up|7|||
105363884|NCT04346199|363336333|FG000|Overall Study|Death|8|||
105363885|NCT04346199|363336334|FG001|Overall Study|Death|9|||
105766661|NCT00910728|364798271|FG005|Overall Study|(not specified)|0|||
105766662|NCT00910728|364798272|FG006|Overall Study|(not specified)|0|||
105766663|NCT00910728|364798273|FG007|Overall Study|(not specified)|0|||
105766664|NCT00910728|364798274|FG008|Overall Study|(not specified)|0|||
105766665|NCT00910728|364798266|FG000|Overall Study|Adverse Event|2|||
105766666|NCT00910728|364798267|FG001|Overall Study|Adverse Event|0|||
105766667|NCT00910728|364798268|FG002|Overall Study|Adverse Event|1|||
105766668|NCT00910728|364798269|FG003|Overall Study|Adverse Event|1|||
105766669|NCT00910728|364798270|FG004|Overall Study|Adverse Event|0|||
105766670|NCT00910728|364798271|FG005|Overall Study|Adverse Event|0|||
105766671|NCT00910728|364798272|FG006|Overall Study|Adverse Event|2|||
105766672|NCT00910728|364798273|FG007|Overall Study|Adverse Event|1|||
105766673|NCT00910728|364798274|FG008|Overall Study|Adverse Event|1|||
105766674|NCT03997760|364798275|FG000|Overall Study|Protocol Deviation|0|||
105766675|NCT03997760|364798276|FG001|Overall Study|Protocol Deviation|1|||
105766676|NCT03997760|364798277|FG002|Overall Study|Protocol Deviation|0|||
105766677|NCT03997760|364798278|FG003|Overall Study|Protocol Deviation|0|||
105766678|NCT00431496|364798279|FG000|Overall Study|Adverse Event|3|||
105766679|NCT00431496|364798279|FG000|Overall Study|Lost to Follow-up|1|||
105766680|NCT00431496|364798279|FG000|Overall Study|Withdrawal by Subject|2|||
105766681|NCT00431496|364798279|FG000|Overall Study|Protocol-specified criteria|5|||
105766682|NCT00565812|364798280|FG000|Overall Study|Death|2|||
105766683|NCT00565812|364798281|FG001|Overall Study|Death|1|||
105766684|NCT00565812|364798282|FG002|Overall Study|Death|3|||
105766685|NCT00565812|364798280|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
105766686|NCT00565812|364798281|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
105766687|NCT00565812|364798282|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
105766688|NCT00565812|364798280|FG000|Overall Study|Lost to Follow-up|10|||
105766689|NCT00565812|364798281|FG001|Overall Study|Lost to Follow-up|8|||
105766690|NCT00565812|364798282|FG002|Overall Study|Lost to Follow-up|8|||
105766691|NCT00565812|364798280|FG000|Overall Study|Withdrawal by Subject|58|||
105766692|NCT00565812|364798281|FG001|Overall Study|Withdrawal by Subject|47|||
105363886|NCT04346199|363336333|FG000|Overall Study|Lost to Follow-up|0|||
105363887|NCT04346199|363336334|FG001|Overall Study|Lost to Follow-up|1|||
105363888|NCT04346199|363336333|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
105766693|NCT00565812|364798282|FG002|Overall Study|Withdrawal by Subject|48|||
105766694|NCT00565812|364798280|FG000|Overall Study|Work Schedule|5|||
105766695|NCT00565812|364798281|FG001|Overall Study|Work Schedule|3|||
105766696|NCT00565812|364798282|FG002|Overall Study|Work Schedule|1|||
105766697|NCT00565812|364798280|FG000|Overall Study|Protocol Violation|2|||
105766698|NCT00565812|364798281|FG001|Overall Study|Protocol Violation|6|||
105822352|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105766699|NCT00565812|364798282|FG002|Overall Study|Protocol Violation|4|||
105363889|NCT04346199|363336334|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
105363890|NCT04346199|363336333|FG000|Overall Study|Withdrawal by Subject|5|||
105363891|NCT04346199|363336334|FG001|Overall Study|Withdrawal by Subject|1|||
105363892|NCT01026948|363336335|FG000|Overall Study|Physician Decision|8|||
105766700|NCT00565812|364798280|FG000|Overall Study|Adverse Event|41|||
105766701|NCT00565812|364798281|FG001|Overall Study|Adverse Event|54|||
105766702|NCT00565812|364798282|FG002|Overall Study|Adverse Event|40|||
105766703|NCT00565812|364798280|FG000|Overall Study|Jury Duty|1|||
105766704|NCT00565812|364798281|FG001|Overall Study|Jury Duty|0|||
105766705|NCT00565812|364798282|FG002|Overall Study|Jury Duty|0|||
105766706|NCT00565812|364798280|FG000|Overall Study|Relocated Out of Area|5|||
105822353|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822354|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822355|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822356|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822357|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822358|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
105822359|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105766707|NCT00565812|364798281|FG001|Overall Study|Relocated Out of Area|8|||
105766708|NCT00565812|364798282|FG002|Overall Study|Relocated Out of Area|9|||
105766709|NCT00565812|364798280|FG000|Overall Study|Sponsor Decision|1|||
105766710|NCT00565812|364798281|FG001|Overall Study|Sponsor Decision|5|||
105766711|NCT00565812|364798282|FG002|Overall Study|Sponsor Decision|1|||
105766712|NCT00565812|364798280|FG000|Overall Study|Domestic Reasons|7|||
105766713|NCT00565812|364798281|FG001|Overall Study|Domestic Reasons|1|||
105766714|NCT00565812|364798282|FG002|Overall Study|Domestic Reasons|3|||
105766715|NCT00565812|364798280|FG000|Overall Study|Research Site Closure|6|||
105766716|NCT00565812|364798281|FG001|Overall Study|Research Site Closure|1|||
105766717|NCT00565812|364798282|FG002|Overall Study|Research Site Closure|8|||
105766718|NCT00565812|364798280|FG000|Overall Study|Surgical Intervention|0|||
105766719|NCT00565812|364798281|FG001|Overall Study|Surgical Intervention|1|||
105766720|NCT00565812|364798282|FG002|Overall Study|Surgical Intervention|2|||
105822360|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822361|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
105822362|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822363|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822364|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822365|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822366|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822367|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822368|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822369|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822370|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822371|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822372|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822373|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822374|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822375|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822376|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822377|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822378|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822379|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822380|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822381|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822382|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
105822383|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822384|NCT00857454|365008719|FG000|Overall Study|Withdrawal by Subject|2|||
105822385|NCT00857454|365008719|FG000|Overall Study|Lost to Follow-up|1|||
105822386|NCT00857454|365008719|FG000|Overall Study|Adverse Event|2|||
105822387|NCT00857454|365008719|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
105822388|NCT00857454|365008719|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
105822389|NCT00857454|365008719|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
105822390|NCT00583453|365008720|FG000|Overall Study|discontinued intervention|0|||
105822391|NCT00583453|365008721|FG001|Overall Study|discontinued intervention|2|||
105822392|NCT00365365|365008722|FG000|Overall Study|Randomized but not treated|0|||
105822393|NCT00365365|365008723|FG001|Overall Study|Randomized but not treated|2|||
105822394|NCT00365365|365008724|FG002|Overall Study|Randomized but not treated|0|||
105822395|NCT00365365|365008722|FG000|Overall Study|Poor compliance to protocol|0|||
105822396|NCT00365365|365008723|FG001|Overall Study|Poor compliance to protocol|1|||
105822397|NCT00365365|365008724|FG002|Overall Study|Poor compliance to protocol|0|||
105363893|NCT01705977|363336336|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
105822398|NCT00365365|365008722|FG000|Overall Study|Lost to Follow-up|3|||
105822399|NCT00365365|365008723|FG001|Overall Study|Lost to Follow-up|3|||
105822400|NCT00365365|365008724|FG002|Overall Study|Lost to Follow-up|3|||
105363894|NCT01705977|363336337|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
105363895|NCT01705977|363336336|FG000|Treatment Period (Year 1)|Adverse Event|57|||
105363896|NCT01705977|363336337|FG001|Treatment Period (Year 1)|Adverse Event|49|||
105766721|NCT00565812|364798280|FG000|Overall Study|Low Compliance|1|||
105766722|NCT00565812|364798281|FG001|Overall Study|Low Compliance|0|||
105766723|NCT00565812|364798282|FG002|Overall Study|Low Compliance|1|||
105363897|NCT01705977|363336336|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
105766724|NCT00565812|364798280|FG000|Overall Study|Follow-up Visit Not Completed|2|||
105766725|NCT00565812|364798281|FG001|Overall Study|Follow-up Visit Not Completed|0|||
105766726|NCT00565812|364798282|FG002|Overall Study|Follow-up Visit Not Completed|1|||
105766727|NCT00565812|364798280|FG000|Overall Study|Physician Decision|2|||
105766728|NCT00565812|364798281|FG001|Overall Study|Physician Decision|0|||
105766729|NCT00565812|364798282|FG002|Overall Study|Physician Decision|0|||
105766730|NCT01448707|364798283|FG000|Overall Study|Adverse Event|3|||
105766731|NCT01448707|364798284|FG001|Overall Study|Adverse Event|1|||
105766732|NCT01448707|364798283|FG000|Overall Study|Lost to Follow-up|2|||
105766733|NCT01448707|364798284|FG001|Overall Study|Lost to Follow-up|6|||
105766734|NCT01448707|364798283|FG000|Overall Study|Withdrawal by Subject|6|||
105766735|NCT01448707|364798284|FG001|Overall Study|Withdrawal by Subject|7|||
105766736|NCT01448707|364798283|FG000|Overall Study|Other|7|||
105766737|NCT01448707|364798284|FG001|Overall Study|Other|4|||
105766738|NCT00845845|364798285|FG000|Overall Study|Lost to Follow-up|0|||
105766739|NCT00845845|364798286|FG001|Overall Study|Lost to Follow-up|4|||
105766740|NCT02033850|364798289|FG000|Overall Study|Death|1|||
105766741|NCT02033850|364798290|FG001|Overall Study|Death|0|||
105766742|NCT02033850|364798289|FG000|Overall Study|unrelated medical reason|1|||
105766743|NCT02033850|364798290|FG001|Overall Study|unrelated medical reason|1|||
105766744|NCT02623699|364798294|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766745|NCT02623699|364798295|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
105766746|NCT02623699|364798296|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766747|NCT02623699|364798297|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766748|NCT02623699|364798298|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766749|NCT02623699|364798299|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766750|NCT02623699|364798300|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766751|NCT02623699|364798301|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766752|NCT02623699|364798302|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766753|NCT02623699|364798303|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766754|NCT02623699|364798304|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766755|NCT02623699|364798305|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766756|NCT02623699|364798294|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766757|NCT02623699|364798295|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766758|NCT02623699|364798296|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766759|NCT02623699|364798297|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766760|NCT02623699|364798298|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766761|NCT02623699|364798299|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766762|NCT02623699|364798300|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
105766763|NCT02623699|364798301|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766764|NCT02623699|364798302|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766765|NCT02623699|364798303|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766766|NCT02623699|364798304|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766767|NCT02623699|364798305|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766768|NCT02623699|364798294|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766769|NCT02623699|364798295|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766770|NCT02623699|364798296|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766771|NCT02623699|364798297|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766772|NCT02623699|364798298|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766773|NCT02623699|364798299|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
105766774|NCT02623699|364798300|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766775|NCT02623699|364798301|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766776|NCT02623699|364798302|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766777|NCT02623699|364798303|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105363898|NCT01705977|363336337|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
105766778|NCT02623699|364798304|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766779|NCT02623699|364798305|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766780|NCT02623699|364798294|FG000|Part B (Up to 289 Days)|Death|0|||
105766781|NCT02623699|364798295|FG001|Part B (Up to 289 Days)|Death|0|||
105766782|NCT02623699|364798296|FG002|Part B (Up to 289 Days)|Death|0|||
105766783|NCT02623699|364798297|FG003|Part B (Up to 289 Days)|Death|0|||
105766784|NCT02623699|364798298|FG004|Part B (Up to 289 Days)|Death|0|||
105766785|NCT02623699|364798299|FG005|Part B (Up to 289 Days)|Death|1|||
105766786|NCT02623699|364798300|FG006|Part B (Up to 289 Days)|Death|1|||
105822401|NCT00365365|365008722|FG000|Overall Study|Death|1|||
105822402|NCT00365365|365008723|FG001|Overall Study|Death|3|||
105822403|NCT00365365|365008724|FG002|Overall Study|Death|0|||
105822404|NCT00365365|365008722|FG000|Overall Study|Subject's request|11|||
105822405|NCT00365365|365008723|FG001|Overall Study|Subject's request|13|||
105822406|NCT00365365|365008724|FG002|Overall Study|Subject's request|1|||
105822407|NCT00365365|365008722|FG000|Overall Study|Disease progression/relapse|9|||
105822408|NCT00365365|365008723|FG001|Overall Study|Disease progression/relapse|6|||
105822409|NCT00365365|365008724|FG002|Overall Study|Disease progression/relapse|7|||
105822410|NCT00365365|365008722|FG000|Overall Study|Adverse Event|6|||
105822411|NCT00365365|365008723|FG001|Overall Study|Adverse Event|6|||
105822412|NCT00365365|365008724|FG002|Overall Study|Adverse Event|3|||
105822413|NCT00365365|365008722|FG000|Overall Study|Moved|2|||
105822414|NCT00365365|365008723|FG001|Overall Study|Moved|0|||
105822415|NCT00365365|365008724|FG002|Overall Study|Moved|0|||
105822416|NCT00365365|365008722|FG000|Overall Study|New cancer|1|||
105822417|NCT00365365|365008723|FG001|Overall Study|New cancer|0|||
105822418|NCT00365365|365008724|FG002|Overall Study|New cancer|0|||
105822419|NCT00365365|365008722|FG000|Overall Study|Withdrew consent|1|||
105822420|NCT00365365|365008723|FG001|Overall Study|Withdrew consent|1|||
105822421|NCT00365365|365008724|FG002|Overall Study|Withdrew consent|0|||
105822422|NCT00365365|365008722|FG000|Overall Study|Second malignancy|0|||
105822423|NCT00365365|365008723|FG001|Overall Study|Second malignancy|1|||
105822424|NCT00365365|365008724|FG002|Overall Study|Second malignancy|0|||
105822425|NCT00365365|365008722|FG000|Overall Study|Patient/physician decision|0|||
105822426|NCT00365365|365008723|FG001|Overall Study|Patient/physician decision|0|||
105822427|NCT00365365|365008724|FG002|Overall Study|Patient/physician decision|1|||
105822428|NCT00984022|365008725|FG000|Overall Study|Lost to Follow-up|10|||
105822429|NCT00984022|365008726|FG001|Overall Study|Lost to Follow-up|14|||
105822430|NCT00573443|365008727|FG000|Double-Blind Phase|Lost to Follow-up|1|||
105822431|NCT00573443|365008728|FG001|Double-Blind Phase|Lost to Follow-up|3|||
105822432|NCT00573443|365008729|FG002|Double-Blind Phase|Lost to Follow-up|2|||
105822433|NCT00573443|365008727|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
105822434|NCT00573443|365008728|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
105822435|NCT00573443|365008729|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
105822436|NCT00573443|365008727|FG000|Double-Blind Phase|Adverse Event|1|||
105822437|NCT00573443|365008728|FG001|Double-Blind Phase|Adverse Event|5|||
105822438|NCT00573443|365008729|FG002|Double-Blind Phase|Adverse Event|0|||
105822439|NCT00573443|365008727|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
105822440|NCT00573443|365008728|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
105822441|NCT00573443|365008729|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
105822442|NCT00573443|365008727|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
105822443|NCT00573443|365008728|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
105822444|NCT00573443|365008729|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
105822445|NCT00573443|365008727|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
105822446|NCT00573443|365008728|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
105822447|NCT00573443|365008729|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
105822448|NCT00573443|365008727|FG000|Double-Blind Phase|Protocol Violation|0|||
105822449|NCT00573443|365008728|FG001|Double-Blind Phase|Protocol Violation|2|||
105363899|NCT01705977|363336336|FG000|Treatment Period (Year 1)|Site closure|3|||
105363900|NCT01705977|363336337|FG001|Treatment Period (Year 1)|Site closure|2|||
105363901|NCT01705977|363336336|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
105363902|NCT01705977|363336337|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
105822450|NCT00573443|365008729|FG002|Double-Blind Phase|Protocol Violation|1|||
105822451|NCT00573443|365008727|FG000|Double-Blind Phase|Other|0|||
105822452|NCT00573443|365008728|FG001|Double-Blind Phase|Other|2|||
105822453|NCT00573443|365008729|FG002|Double-Blind Phase|Other|3|||
105822454|NCT00573443|365008727|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
105822455|NCT00573443|365008728|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
105822456|NCT00573443|365008729|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
105822457|NCT00573443|365008727|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
105822458|NCT00573443|365008728|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
105822459|NCT00573443|365008729|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
105822460|NCT00573443|365008727|FG000|Open-Label Extension Phase|Adverse Event|3|||
105363903|NCT01705977|363336336|FG000|Treatment Period (Year 1)|Physician Decision|48|||
105822461|NCT00573443|365008728|FG001|Open-Label Extension Phase|Adverse Event|0|||
105363904|NCT01705977|363336337|FG001|Treatment Period (Year 1)|Physician Decision|38|||
105363905|NCT01705977|363336336|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
105822462|NCT00573443|365008729|FG002|Open-Label Extension Phase|Adverse Event|0|||
105822463|NCT00573443|365008727|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
105822464|NCT00573443|365008728|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
105363906|NCT01705977|363336337|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
105822465|NCT00573443|365008729|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
105822466|NCT00573443|365008727|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
105822467|NCT00573443|365008728|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
105822468|NCT00573443|365008729|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
105363907|NCT01705977|363336336|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
105363908|NCT01705977|363336337|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
105363909|NCT01705977|363336336|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
105363910|NCT01705977|363336337|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
105363911|NCT01705977|363336336|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
105363912|NCT01705977|363336337|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
105363913|NCT01705977|363336336|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
105363914|NCT01705977|363336337|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
105363915|NCT01705977|363336336|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
105363916|NCT01705977|363336337|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
105363917|NCT03066830|363336338|FG000|Overall Study|At the Participant's own Request|16|||
105363918|NCT03066830|363336339|FG001|Overall Study|At the Participant's own Request|17|||
105363919|NCT03066830|363336338|FG000|Overall Study|Other|3|||
105363920|NCT03066830|363336339|FG001|Overall Study|Other|0|||
105363921|NCT03066830|363336338|FG000|Overall Study|Poor Compliance to Protocol|1|||
105363922|NCT03066830|363336339|FG001|Overall Study|Poor Compliance to Protocol|0|||
105363923|NCT03066830|363336338|FG000|Overall Study|Adverse Event|2|||
105363924|NCT03066830|363336339|FG001|Overall Study|Adverse Event|2|||
105363925|NCT03066830|363336338|FG000|Overall Study|Lost to Follow-up|11|||
105363926|NCT03066830|363336339|FG001|Overall Study|Lost to Follow-up|3|||
105363927|NCT00828113|363336340|FG000|Overall Study|Withdrawal by Subject|27|||
105363928|NCT00828113|363336341|FG001|Overall Study|Withdrawal by Subject|26|||
105363929|NCT00828113|363336340|FG000|Overall Study|Lost to Follow-up|3|||
105363930|NCT00828113|363336341|FG001|Overall Study|Lost to Follow-up|5|||
105363931|NCT03014206|363336345|FG000|Overall Study|Registration Violation|12|||
105363932|NCT00003471|363336360|FG000|Overall Study|Not evaluable|4|||
105363933|NCT04877990|363336361|FG000|Treatment|Other reasons|3|||
105363934|NCT04877990|363336362|FG001|Treatment|Other reasons|1|||
105363935|NCT04877990|363336361|FG000|Treatment|Administrative reasons by sponsor|17|||
105363936|NCT04877990|363336362|FG001|Treatment|Administrative reasons by sponsor|33|||
105363937|NCT04877990|363336361|FG000|Treatment|Withdrawal by Subject|2|||
105363938|NCT04877990|363336362|FG001|Treatment|Withdrawal by Subject|6|||
105363939|NCT04877990|363336361|FG000|Treatment|Adverse Event|2|||
105363940|NCT04877990|363336362|FG001|Treatment|Adverse Event|1|||
105363941|NCT03718429|363336366|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
105363942|NCT03718429|363336367|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
105363943|NCT03718429|363336368|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
105363944|NCT03718429|363336369|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
105363945|NCT01190813|363336370|FG000|Overall Study|Lost to Follow-up|1|||
105363946|NCT01190813|363336371|FG001|Overall Study|Lost to Follow-up|2|||
105363947|NCT01190813|363336370|FG000|Overall Study|Withdrawal by Subject|2|||
105363948|NCT01190813|363336371|FG001|Overall Study|Withdrawal by Subject|1|||
105363949|NCT01190813|363336370|FG000|Overall Study|Refused study treatment after randomized|1|||
105363950|NCT01190813|363336371|FG001|Overall Study|Refused study treatment after randomized|0|||
105363951|NCT01190813|363336370|FG000|Overall Study|Adverse Event|0|||
105363952|NCT01190813|363336371|FG001|Overall Study|Adverse Event|1|||
105363953|NCT05212168|363336374|FG000|Overall Study|Lost to Follow-up|0|||
105363954|NCT05212168|363336375|FG001|Overall Study|Lost to Follow-up|3|||
105363955|NCT05212168|363336374|FG000|Overall Study|Study terminated by sponsor|30|||
105363956|NCT05212168|363336375|FG001|Overall Study|Study terminated by sponsor|27|||
105363957|NCT05212168|363336374|FG000|Overall Study|Other|4|||
105363958|NCT05212168|363336375|FG001|Overall Study|Other|7|||
105363959|NCT04614324|363336376|FG000|Overall Study|Lost to Follow-up|3|||
105363960|NCT04614324|363336376|FG000|Overall Study|Physician Decision|1|||
105363961|NCT04614324|363336376|FG000|Overall Study|Withdrawal by Subject|2|||
105363962|NCT04614324|363336376|FG000|Overall Study|Remaining in Follow up|123|||
105439842|NCT00965419|363615087|FG000|Follow-up Phase|Protocol Violation|4|||
105439843|NCT00965419|363615087|FG000|Follow-up Phase|Withdrawal by Subject|8|||
105439844|NCT00965419|363615087|FG000|Follow-up Phase|Physician Decision|4|||
105439845|NCT00965419|363615087|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
105439846|NCT00965419|363615087|FG000|Follow-up Phase|Lack of Efficacy|28|||
105439847|NCT02476006|363615095|FG000|Overall Study|Death|4|||
105439848|NCT02476006|363615095|FG000|Overall Study|Lack of treatment efficacy|2|||
105439849|NCT02476006|363615095|FG000|Overall Study|Pregnancy|1|||
105439850|NCT02476006|363615095|FG000|Overall Study|Participant did not wish to continue|39|||
105439851|NCT02476006|363615095|FG000|Overall Study|Adverse Event|41|||
105439852|NCT02476006|363615095|FG000|Overall Study|Poor compliance to study protocol|3|||
105439853|NCT02476006|363615095|FG000|Overall Study|Sponsor decision|6|||
105439854|NCT02476006|363615095|FG000|Overall Study|Lost to Follow-up|5|||
105439855|NCT02476006|363615095|FG000|Overall Study|Physician Decision|5|||
105439856|NCT02476006|363615095|FG000|Overall Study|Study ended treatment not available|4|||
105439857|NCT02476006|363615095|FG000|Overall Study|Switched to commercial drug|4|||
105439858|NCT02476006|363615095|FG000|Overall Study|Excluded from study|1|||
105439859|NCT02476006|363615095|FG000|Overall Study|Protocol Violation|1|||
105486502|NCT00930982|363793353|FG001|Overall Study|Withdrawal by Subject|1|||
105822469|NCT00573443|365008727|FG000|Open-Label Extension Phase|Protocol Violation|2|||
105822470|NCT00573443|365008728|FG001|Open-Label Extension Phase|Protocol Violation|0|||
105822471|NCT00573443|365008729|FG002|Open-Label Extension Phase|Protocol Violation|0|||
105822472|NCT00573443|365008727|FG000|Open-Label Extension Phase|Other|2|||
105822473|NCT00573443|365008728|FG001|Open-Label Extension Phase|Other|0|||
105822474|NCT00573443|365008729|FG002|Open-Label Extension Phase|Other|0|||
105822475|NCT00418561|365008732|FG000|Overall Study|Participant's (guardian's) decision|0|||
105822476|NCT00418561|365008733|FG001|Overall Study|Participant's (guardian's) decision|1|||
105822477|NCT00418561|365008734|FG002|Overall Study|Participant's (guardian's) decision|0|||
105822478|NCT01693523|365008739|FG000|Overall Study|Adverse Event|2|||
105822479|NCT01693523|365008740|FG001|Overall Study|Adverse Event|1|||
105822480|NCT01693523|365008741|FG002|Overall Study|Adverse Event|0|||
105822481|NCT01693523|365008739|FG000|Overall Study|Death|0|||
105822482|NCT01693523|365008740|FG001|Overall Study|Death|1|||
105822483|NCT01693523|365008741|FG002|Overall Study|Death|1|||
105822484|NCT01693523|365008739|FG000|Overall Study|Lost to Follow-up|0|||
105822485|NCT01693523|365008740|FG001|Overall Study|Lost to Follow-up|0|||
105822486|NCT01693523|365008741|FG002|Overall Study|Lost to Follow-up|4|||
105822487|NCT01693523|365008739|FG000|Overall Study|Physician Decision|0|||
105822488|NCT01693523|365008740|FG001|Overall Study|Physician Decision|0|||
105363963|NCT02317991|363338407|FG000|Overall Study|Adverse Event|12|||
105363964|NCT02317991|363338407|FG000|Overall Study|Death|4|||
105363965|NCT02317991|363338407|FG000|Overall Study|Withdrawal by Subject|8|||
105363966|NCT02317991|363338407|FG000|Overall Study|Progressive Disease|41|||
105363967|NCT02291029|363338413|FG000|Overall Study|Withdrawal by Subject|0|||
105363968|NCT02291029|363338414|FG001|Overall Study|Withdrawal by Subject|0|||
105363969|NCT02291029|363338415|FG002|Overall Study|Withdrawal by Subject|1|||
105363970|NCT02291029|363338416|FG003|Overall Study|Withdrawal by Subject|0|||
105363971|NCT02291029|363338417|FG004|Overall Study|Withdrawal by Subject|0|||
105363972|NCT02291029|363338418|FG005|Overall Study|Withdrawal by Subject|0|||
105363973|NCT02291029|363338413|FG000|Overall Study|Adverse Event|0|||
105363974|NCT02291029|363338414|FG001|Overall Study|Adverse Event|1|||
105363975|NCT02291029|363338415|FG002|Overall Study|Adverse Event|0|||
105363976|NCT02291029|363338416|FG003|Overall Study|Adverse Event|0|||
105363977|NCT02291029|363338417|FG004|Overall Study|Adverse Event|0|||
105363978|NCT02291029|363338418|FG005|Overall Study|Adverse Event|0|||
105363979|NCT00379834|363338420|FG000|Overall Study|Time constraints|2|||
105363980|NCT01325350|363338423|FG000|Overall Study|Adverse Event|3|||
105363981|NCT01325350|363338424|FG001|Overall Study|Adverse Event|3|||
105363982|NCT01325350|363338425|FG002|Overall Study|Adverse Event|3|||
105363983|NCT01325350|363338426|FG003|Overall Study|Adverse Event|1|||
105363984|NCT01325350|363338427|FG004|Overall Study|Adverse Event|2|||
105363985|NCT01325350|363338423|FG000|Overall Study|Pregnancy|0|||
105363986|NCT01325350|363338424|FG001|Overall Study|Pregnancy|0|||
105363987|NCT01325350|363338425|FG002|Overall Study|Pregnancy|1|||
105363988|NCT01325350|363338426|FG003|Overall Study|Pregnancy|0|||
105363989|NCT01325350|363338427|FG004|Overall Study|Pregnancy|1|||
105363990|NCT01325350|363338423|FG000|Overall Study|Lost to Follow-up|1|||
105363991|NCT01325350|363338424|FG001|Overall Study|Lost to Follow-up|0|||
105363992|NCT01325350|363338425|FG002|Overall Study|Lost to Follow-up|5|||
105363993|NCT01325350|363338426|FG003|Overall Study|Lost to Follow-up|1|||
105822489|NCT01693523|365008741|FG002|Overall Study|Physician Decision|1|||
105822490|NCT01693523|365008739|FG000|Overall Study|Withdrawal by Subject|1|||
105822491|NCT01693523|365008740|FG001|Overall Study|Withdrawal by Subject|2|||
105822492|NCT01693523|365008741|FG002|Overall Study|Withdrawal by Subject|2|||
105822493|NCT01693523|365008739|FG000|Overall Study|Lack of compliance study medication|1|||
105822494|NCT01693523|365008740|FG001|Overall Study|Lack of compliance study medication|2|||
105822495|NCT01693523|365008741|FG002|Overall Study|Lack of compliance study medication|0|||
105363994|NCT01325350|363338427|FG004|Overall Study|Lost to Follow-up|5|||
105363995|NCT01325350|363338423|FG000|Overall Study|Personal Reasons|2|||
105363996|NCT01325350|363338424|FG001|Overall Study|Personal Reasons|1|||
105363997|NCT01325350|363338425|FG002|Overall Study|Personal Reasons|6|||
105363998|NCT01325350|363338426|FG003|Overall Study|Personal Reasons|5|||
105822496|NCT01693523|365008739|FG000|Overall Study|Chemotherapy was held|1|||
105822497|NCT01693523|365008740|FG001|Overall Study|Chemotherapy was held|2|||
105822498|NCT01693523|365008741|FG002|Overall Study|Chemotherapy was held|0|||
105822499|NCT03343535|365008742|FG000|Overall Study|Lost to Follow-up|1|||
105822500|NCT03343535|365008742|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
105822501|NCT03343535|365008742|FG000|Overall Study|Death|12|||
105822502|NCT03181594|365008743|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
105822503|NCT03181594|365008743|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
105822504|NCT03181594|365008743|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
105822505|NCT03181594|365008743|FG000|Initial Study Protocol (12-month FU)|Death|1|||
105822506|NCT03181594|365008743|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
105822507|NCT03181594|365008743|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
105822508|NCT01675765|365008744|FG000|Overall Study|Progressive disease|4|||
105822509|NCT01675765|365008745|FG001|Overall Study|Progressive disease|4|||
105822510|NCT01675765|365008744|FG000|Overall Study|Adverse Event|1|||
105822511|NCT01675765|365008745|FG001|Overall Study|Adverse Event|2|||
105822512|NCT01675765|365008744|FG000|Overall Study|Withdrawal by Subject|2|||
105822513|NCT01675765|365008745|FG001|Overall Study|Withdrawal by Subject|0|||
105822514|NCT01675765|365008744|FG000|Overall Study|Death|1|||
105822515|NCT01675765|365008745|FG001|Overall Study|Death|0|||
105822516|NCT01675765|365008744|FG000|Overall Study|Clinical progression|3|||
105822517|NCT01675765|365008745|FG001|Overall Study|Clinical progression|2|||
105822518|NCT00113386|365008757|FG000|Overall Study|Withdrawal by Subject|1|||
105822519|NCT00113386|365008758|FG001|Overall Study|Withdrawal by Subject|0|||
105822520|NCT00113386|365008757|FG000|Overall Study|Physician Decision|0|||
105822521|NCT00113386|365008758|FG001|Overall Study|Physician Decision|1|||
105822522|NCT00113386|365008757|FG000|Overall Study|Toxicity|3|||
105822523|NCT00113386|365008758|FG001|Overall Study|Toxicity|0|||
105822524|NCT00113386|365008757|FG000|Overall Study|Ineligible|1|||
105822525|NCT00113386|365008758|FG001|Overall Study|Ineligible|2|||
105822526|NCT00113386|365008757|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
105822527|NCT00113386|365008758|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
105822528|NCT00640562|365008759|FG000|Overall Study|Adverse Event|8|||
105822529|NCT00640562|365008760|FG001|Overall Study|Adverse Event|5|||
105822530|NCT00640562|365008759|FG000|Overall Study|Lack of Efficacy|1|||
105822531|NCT00640562|365008760|FG001|Overall Study|Lack of Efficacy|4|||
105822532|NCT00640562|365008759|FG000|Overall Study|Protocol Violation|2|||
105822533|NCT00640562|365008760|FG001|Overall Study|Protocol Violation|4|||
105822534|NCT00640562|365008759|FG000|Overall Study|Withdrawal by Subject|6|||
105822535|NCT00640562|365008760|FG001|Overall Study|Withdrawal by Subject|10|||
105822536|NCT00640562|365008759|FG000|Overall Study|Known risperidone intolerance|0|||
105822537|NCT00640562|365008760|FG001|Overall Study|Known risperidone intolerance|1|||
105822538|NCT00640562|365008759|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
105822539|NCT00640562|365008760|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
105822540|NCT00640562|365008759|FG000|Overall Study|Low study drug dose|0|||
105822541|NCT00640562|365008760|FG001|Overall Study|Low study drug dose|1|||
105822542|NCT00640562|365008759|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
105822543|NCT00640562|365008760|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
105822544|NCT02849457|365008761|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
105822545|NCT02849457|365008762|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
105486503|NCT02129777|363793354|FG000|Double-Blind Period|Adverse Event|0|||
105822546|NCT02849457|365008763|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
105822547|NCT02849457|365008764|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
105822548|NCT03673670|365008766|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
105822549|NCT03673670|365008767|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
105822550|NCT03673670|365008768|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
105822551|NCT03673670|365008769|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
105486504|NCT02129777|363793355|FG001|Double-Blind Period|Adverse Event|0|||
105486505|NCT02129777|363793356|FG002|Double-Blind Period|Adverse Event|0|||
105822552|NCT03673670|365008770|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
105822553|NCT03673670|365008771|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
105822554|NCT03673670|365008766|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
105822555|NCT03673670|365008767|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
105822556|NCT03673670|365008768|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
105822557|NCT03673670|365008769|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
105822558|NCT03673670|365008770|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
105822559|NCT03673670|365008771|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
105822560|NCT03673670|365008766|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
105822561|NCT03673670|365008767|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
105822562|NCT03673670|365008768|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
105822563|NCT03673670|365008769|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
105822564|NCT03673670|365008770|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
105822565|NCT03673670|365008771|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
105822566|NCT03673670|365008766|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
105822567|NCT03673670|365008767|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
105822568|NCT03673670|365008768|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
105822569|NCT03673670|365008769|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
105822570|NCT03673670|365008770|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
105822571|NCT03673670|365008771|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
105822572|NCT03673670|365008766|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
105822573|NCT03673670|365008767|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
105822574|NCT03673670|365008768|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
105822575|NCT03673670|365008769|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
105822576|NCT03673670|365008770|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
105486506|NCT02129777|363793357|FG003|Double-Blind Period|Adverse Event|0|||
105486507|NCT02129777|363793358|FG004|Double-Blind Period|Adverse Event|1|||
105486508|NCT02129777|363793359|FG005|Double-Blind Period|Adverse Event|0|||
105486509|NCT02129777|363793360|FG006|Double-Blind Period|Adverse Event|0|||
105486510|NCT02129777|363793354|FG000|Double-Blind Period|Lost to Follow-up|1|||
105486511|NCT02129777|363793355|FG001|Double-Blind Period|Lost to Follow-up|1|||
105486512|NCT02129777|363793356|FG002|Double-Blind Period|Lost to Follow-up|1|||
105486513|NCT02129777|363793357|FG003|Double-Blind Period|Lost to Follow-up|2|||
105486514|NCT02129777|363793358|FG004|Double-Blind Period|Lost to Follow-up|0|||
105486515|NCT02129777|363793359|FG005|Double-Blind Period|Lost to Follow-up|0|||
105486516|NCT02129777|363793360|FG006|Double-Blind Period|Lost to Follow-up|0|||
105486517|NCT02129777|363793354|FG000|Double-Blind Period|Withdrawal by Subject|2|||
105486518|NCT02129777|363793355|FG001|Double-Blind Period|Withdrawal by Subject|4|||
105486519|NCT02129777|363793356|FG002|Double-Blind Period|Withdrawal by Subject|3|||
105486520|NCT02129777|363793357|FG003|Double-Blind Period|Withdrawal by Subject|2|||
105486521|NCT02129777|363793358|FG004|Double-Blind Period|Withdrawal by Subject|3|||
105486522|NCT02129777|363793359|FG005|Double-Blind Period|Withdrawal by Subject|0|||
105486523|NCT02129777|363793360|FG006|Double-Blind Period|Withdrawal by Subject|0|||
105486524|NCT02129777|363793354|FG000|Double-Blind Period|Pregnancy|0|||
105486525|NCT02129777|363793355|FG001|Double-Blind Period|Pregnancy|0|||
105486526|NCT02129777|363793356|FG002|Double-Blind Period|Pregnancy|0|||
105486527|NCT02129777|363793357|FG003|Double-Blind Period|Pregnancy|0|||
105486528|NCT02129777|363793358|FG004|Double-Blind Period|Pregnancy|1|||
105486529|NCT02129777|363793359|FG005|Double-Blind Period|Pregnancy|0|||
105486530|NCT02129777|363793360|FG006|Double-Blind Period|Pregnancy|0|||
105486531|NCT02129777|363793354|FG000|Double-Blind Period|Lack of Efficacy|3|||
105486532|NCT02129777|363793355|FG001|Double-Blind Period|Lack of Efficacy|1|||
105486533|NCT02129777|363793356|FG002|Double-Blind Period|Lack of Efficacy|0|||
105486534|NCT02129777|363793357|FG003|Double-Blind Period|Lack of Efficacy|3|||
105486535|NCT02129777|363793358|FG004|Double-Blind Period|Lack of Efficacy|2|||
105486536|NCT02129777|363793359|FG005|Double-Blind Period|Lack of Efficacy|0|||
105486537|NCT02129777|363793360|FG006|Double-Blind Period|Lack of Efficacy|0|||
105486538|NCT02129777|363793354|FG000|Double-Blind Period|Other|1|||
105486539|NCT02129777|363793355|FG001|Double-Blind Period|Other|2|||
105486540|NCT02129777|363793356|FG002|Double-Blind Period|Other|0|||
105486541|NCT02129777|363793357|FG003|Double-Blind Period|Other|0|||
105486542|NCT02129777|363793358|FG004|Double-Blind Period|Other|0|||
105486543|NCT02129777|363793359|FG005|Double-Blind Period|Other|0|||
105486544|NCT02129777|363793360|FG006|Double-Blind Period|Other|0|||
105571702|NCT00041756|364092734|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
105571703|NCT00041756|364092735|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
105571704|NCT00041756|364092736|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
105486545|NCT02129777|363793354|FG000|Open-Label Period|Lack of Efficacy|0|||
105486546|NCT02129777|363793355|FG001|Open-Label Period|Lack of Efficacy|0|||
105486547|NCT02129777|363793356|FG002|Open-Label Period|Lack of Efficacy|0|||
105486548|NCT02129777|363793357|FG003|Open-Label Period|Lack of Efficacy|0|||
105486549|NCT02129777|363793358|FG004|Open-Label Period|Lack of Efficacy|0|||
105486550|NCT02129777|363793359|FG005|Open-Label Period|Lack of Efficacy|0|||
105486551|NCT02129777|363793360|FG006|Open-Label Period|Lack of Efficacy|5|||
105486552|NCT02129777|363793354|FG000|Open-Label Period|Lost to Follow-up|0|||
105571705|NCT00041756|364092737|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
105571706|NCT00041756|364092738|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
105766787|NCT02623699|364798301|FG007|Part B (Up to 289 Days)|Death|0|||
105766788|NCT02623699|364798302|FG008|Part B (Up to 289 Days)|Death|1|||
105766789|NCT02623699|364798303|FG009|Part B (Up to 289 Days)|Death|0|||
105766790|NCT02623699|364798304|FG010|Part B (Up to 289 Days)|Death|0|||
105766791|NCT02623699|364798305|FG011|Part B (Up to 289 Days)|Death|0|||
105766792|NCT02623699|364798294|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
105766793|NCT02623699|364798295|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
105766794|NCT02623699|364798296|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
105766795|NCT02623699|364798297|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
105766796|NCT02623699|364798298|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
105766797|NCT02623699|364798299|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
105766798|NCT02623699|364798300|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
105766799|NCT02623699|364798301|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
105766800|NCT02623699|364798302|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
105766801|NCT02623699|364798303|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
105766802|NCT02623699|364798304|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
105766803|NCT02623699|364798305|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
105766804|NCT02623699|364798294|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766805|NCT02623699|364798295|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766806|NCT02623699|364798296|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766807|NCT02623699|364798297|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766808|NCT02623699|364798298|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766809|NCT02623699|364798299|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766810|NCT02623699|364798300|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766811|NCT02623699|364798301|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766812|NCT02623699|364798302|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766813|NCT02623699|364798303|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766814|NCT02623699|364798304|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
105766815|NCT02623699|364798305|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
105766816|NCT02623699|364798294|FG000|Part C (Up to 236 Days)|Death|0|||
105766817|NCT02623699|364798295|FG001|Part C (Up to 236 Days)|Death|0|||
105766818|NCT02623699|364798296|FG002|Part C (Up to 236 Days)|Death|0|||
105766819|NCT02623699|364798297|FG003|Part C (Up to 236 Days)|Death|0|||
105766820|NCT02623699|364798298|FG004|Part C (Up to 236 Days)|Death|0|||
105822577|NCT03673670|365008771|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
105766821|NCT02623699|364798299|FG005|Part C (Up to 236 Days)|Death|0|||
105766822|NCT02623699|364798300|FG006|Part C (Up to 236 Days)|Death|0|||
105822578|NCT03673670|365008766|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
105363999|NCT01325350|363338427|FG004|Overall Study|Personal Reasons|3|||
105364000|NCT01325350|363338423|FG000|Overall Study|Protocol Violation|0|||
105571707|NCT03980184|364092739|FG000|Overall Study|Dropped out before treatment|2|||
105571708|NCT03980184|364092740|FG001|Overall Study|Dropped out before treatment|2|||
105571709|NCT03980184|364092739|FG000|Overall Study|Lost to Follow-up|11|||
105571710|NCT03980184|364092740|FG001|Overall Study|Lost to Follow-up|13|||
105571711|NCT01112514|364092744|FG000|Overall Study|Lost to Follow-up|1|||
105766823|NCT02623699|364798301|FG007|Part C (Up to 236 Days)|Death|0|||
105766824|NCT02623699|364798302|FG008|Part C (Up to 236 Days)|Death|0|||
105766825|NCT02623699|364798303|FG009|Part C (Up to 236 Days)|Death|0|||
105766826|NCT02623699|364798304|FG010|Part C (Up to 236 Days)|Death|0|||
105766827|NCT02623699|364798305|FG011|Part C (Up to 236 Days)|Death|1|||
105766828|NCT02623699|364798294|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
105766829|NCT02623699|364798295|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
105766830|NCT02623699|364798296|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
105766831|NCT02623699|364798297|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
105766832|NCT02623699|364798298|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
105766833|NCT02623699|364798299|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
105766834|NCT02623699|364798300|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
105766835|NCT02623699|364798301|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
105766836|NCT02623699|364798302|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
105766837|NCT02623699|364798303|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
105766838|NCT02623699|364798304|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
105766839|NCT02623699|364798305|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
105766840|NCT00899678|364798306|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
105766841|NCT00899678|364798307|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
105766842|NCT00899678|364798308|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
105766843|NCT00899678|364798306|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
105766844|NCT00899678|364798307|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
105766845|NCT00899678|364798308|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
105766846|NCT00899678|364798306|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
105766847|NCT00899678|364798307|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
105766848|NCT00899678|364798308|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
105766849|NCT00899678|364798306|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
105766850|NCT00899678|364798307|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
105766851|NCT00899678|364798308|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
105766852|NCT00899678|364798306|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
105766853|NCT00899678|364798307|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
105766854|NCT00899678|364798308|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
105766855|NCT00899678|364798306|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
105766856|NCT00899678|364798307|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
105766857|NCT00899678|364798308|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
105766858|NCT00899678|364798306|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
105766859|NCT00899678|364798307|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
105766860|NCT00899678|364798308|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
105766861|NCT00899678|364798306|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
105766862|NCT00899678|364798307|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
105766863|NCT00899678|364798308|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
105766864|NCT00899678|364798306|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
105766865|NCT00899678|364798307|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
105766866|NCT00899678|364798308|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
105766867|NCT02699125|364798309|FG000|Placebo|Lost to Follow-up|2|||
105766868|NCT02699125|364798310|FG001|Placebo|Lost to Follow-up|0|||
105766869|NCT02699125|364798309|FG000|Placebo|Protocol Violation|1|||
105766870|NCT02699125|364798310|FG001|Placebo|Protocol Violation|0|||
105766871|NCT02699125|364798309|FG000|Placebo|Withdrawal by Subject|0|||
105766872|NCT02699125|364798310|FG001|Placebo|Withdrawal by Subject|4|||
105766873|NCT02699125|364798309|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
105766874|NCT02699125|364798310|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
105766875|NCT03148795|364798315|FG000|Overall Study|Progressive Disease|1|||
105766876|NCT02963766|364798316|FG000|Double-Blind Period|Adverse Event|1|||
105766877|NCT02963766|364798317|FG001|Double-Blind Period|Adverse Event|0|||
105766878|NCT02963766|364798318|FG002|Double-Blind Period|Adverse Event|1|||
105766879|NCT02963766|364798316|FG000|Double-Blind Period|Physician Decision|1|||
105766880|NCT02963766|364798317|FG001|Double-Blind Period|Physician Decision|0|||
105766881|NCT02963766|364798318|FG002|Double-Blind Period|Physician Decision|0|||
105766882|NCT02963766|364798316|FG000|Double-Blind Period|Withdrawal by Subject|1|||
105766883|NCT02963766|364798317|FG001|Double-Blind Period|Withdrawal by Subject|1|||
105766884|NCT02963766|364798318|FG002|Double-Blind Period|Withdrawal by Subject|0|||
105766885|NCT02963766|364798316|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
105766886|NCT02963766|364798317|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
105766887|NCT02963766|364798318|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
105766888|NCT02963766|364798316|FG000|Double-Blind Period|Protocol Violation|1|||
105766889|NCT02963766|364798317|FG001|Double-Blind Period|Protocol Violation|0|||
105766890|NCT02963766|364798318|FG002|Double-Blind Period|Protocol Violation|0|||
105766891|NCT02963766|364798316|FG000|Double-Blind Period|Lost to Follow-up|0|||
105766892|NCT02963766|364798317|FG001|Double-Blind Period|Lost to Follow-up|1|||
105766893|NCT02963766|364798318|FG002|Double-Blind Period|Lost to Follow-up|0|||
105766894|NCT02963766|364798316|FG000|Open Label Extension (OLE)|Physician Decision|1|||
105766895|NCT02963766|364798317|FG001|Open Label Extension (OLE)|Physician Decision|2|||
105766896|NCT02963766|364798318|FG002|Open Label Extension (OLE)|Physician Decision|2|||
105766897|NCT02963766|364798316|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
105766898|NCT02963766|364798317|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
105766899|NCT02963766|364798318|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
105766900|NCT00398138|364798319|FG000|Overall Study|Adverse Event|2|||
105766901|NCT02224274|364798320|FG000|Overall Study|Death|1|||
105766902|NCT02224274|364798321|FG001|Overall Study|Death|0|||
105766903|NCT00499460|364798322|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
105766904|NCT00499460|364798323|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
105766905|NCT00499460|364798322|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
105766906|NCT00499460|364798323|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
105766907|NCT00499460|364798322|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
105766908|NCT00499460|364798323|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
105766909|NCT03418376|364798324|FG000|Overall Study|Musculoskeletal injury|1|||
105766910|NCT03418376|364798325|FG001|Overall Study|Musculoskeletal injury|2|||
105766911|NCT03418376|364798326|FG002|Overall Study|Musculoskeletal injury|1|||
105766912|NCT03418376|364798327|FG003|Overall Study|Musculoskeletal injury|0|||
105766913|NCT03418376|364798324|FG000|Overall Study|Personal reasons|0|||
105766914|NCT03418376|364798325|FG001|Overall Study|Personal reasons|2|||
105766915|NCT03418376|364798326|FG002|Overall Study|Personal reasons|2|||
105766916|NCT03418376|364798327|FG003|Overall Study|Personal reasons|1|||
105766917|NCT03418376|364798324|FG000|Overall Study|Exacerbation|0|||
105766918|NCT03418376|364798325|FG001|Overall Study|Exacerbation|1|||
105766919|NCT03418376|364798326|FG002|Overall Study|Exacerbation|0|||
105766920|NCT03418376|364798327|FG003|Overall Study|Exacerbation|0|||
105766921|NCT00807014|364798328|FG000|Overall Study|Participant Considered Disease Cured|13|||
105766922|NCT00807014|364798329|FG001|Overall Study|Participant Considered Disease Cured|2|||
105766923|NCT00807014|364798328|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
105766924|NCT00807014|364798329|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
105766925|NCT00807014|364798328|FG000|Overall Study|Protocol Violation|2|||
105766926|NCT00807014|364798329|FG001|Overall Study|Protocol Violation|8|||
105766927|NCT00807014|364798328|FG000|Overall Study|Adverse Event|0|||
105766928|NCT00807014|364798329|FG001|Overall Study|Adverse Event|2|||
105766929|NCT00807014|364798328|FG000|Overall Study|Lost to Follow-up|9|||
105766930|NCT00807014|364798329|FG001|Overall Study|Lost to Follow-up|7|||
105766931|NCT00807014|364798328|FG000|Overall Study|Recovery|1|||
105766932|NCT00807014|364798329|FG001|Overall Study|Recovery|0|||
105766933|NCT00807014|364798328|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
105766934|NCT00807014|364798329|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
105766935|NCT00814307|364798337|FG000|Overall Study|Randomized but not treated|1|||
105766936|NCT00814307|364798338|FG001|Overall Study|Randomized but not treated|0|||
105766937|NCT00814307|364798339|FG002|Overall Study|Randomized but not treated|0|||
105766938|NCT00814307|364798340|FG003|Overall Study|Randomized but not treated|0|||
105766939|NCT00814307|364798337|FG000|Overall Study|Adverse Event|3|||
105766940|NCT00814307|364798338|FG001|Overall Study|Adverse Event|9|||
105766941|NCT00814307|364798339|FG002|Overall Study|Adverse Event|3|||
105766942|NCT00814307|364798340|FG003|Overall Study|Adverse Event|2|||
105766943|NCT00814307|364798337|FG000|Overall Study|Lack of Efficacy|1|||
105766944|NCT00814307|364798338|FG001|Overall Study|Lack of Efficacy|1|||
105766945|NCT00814307|364798339|FG002|Overall Study|Lack of Efficacy|3|||
105766946|NCT00814307|364798340|FG003|Overall Study|Lack of Efficacy|4|||
105766947|NCT00814307|364798337|FG000|Overall Study|Other|1|||
105766948|NCT00814307|364798338|FG001|Overall Study|Other|2|||
105766949|NCT00814307|364798339|FG002|Overall Study|Other|0|||
105766950|NCT00814307|364798340|FG003|Overall Study|Other|1|||
105766951|NCT00814307|364798337|FG000|Overall Study|Protocol Violation|2|||
105766952|NCT00814307|364798338|FG001|Overall Study|Protocol Violation|8|||
105822579|NCT03673670|365008767|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
105822580|NCT03673670|365008768|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
105822581|NCT03673670|365008769|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
105822582|NCT03673670|365008770|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
105822583|NCT03673670|365008771|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
105822584|NCT03673670|365008766|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
105822585|NCT03673670|365008767|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
105822586|NCT03673670|365008768|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
105822587|NCT03673670|365008769|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
105822588|NCT03673670|365008770|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
105822589|NCT03673670|365008771|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
105822590|NCT00244764|365008772|FG000|Overall Study|Adverse Event|37|||
105822591|NCT00244764|365008772|FG000|Overall Study|Lost to Follow-up|23|||
105766953|NCT00814307|364798339|FG002|Overall Study|Protocol Violation|1|||
105766954|NCT00814307|364798340|FG003|Overall Study|Protocol Violation|1|||
105766955|NCT00814307|364798337|FG000|Overall Study|Withdrawal by Subject|4|||
105766956|NCT00814307|364798338|FG001|Overall Study|Withdrawal by Subject|6|||
105766957|NCT00814307|364798339|FG002|Overall Study|Withdrawal by Subject|0|||
105766958|NCT00814307|364798340|FG003|Overall Study|Withdrawal by Subject|2|||
105766959|NCT00814307|364798337|FG000|Overall Study|Death|0|||
105766960|NCT00814307|364798338|FG001|Overall Study|Death|1|||
105766961|NCT00814307|364798339|FG002|Overall Study|Death|0|||
105766962|NCT00814307|364798340|FG003|Overall Study|Death|0|||
105766963|NCT03209362|364798349|FG000|Overall Study|Adverse Event|0|||
105766964|NCT03209362|364798350|FG001|Overall Study|Adverse Event|1|||
105822592|NCT00244764|365008772|FG000|Overall Study|Withdrawal by Subject|12|||
105822593|NCT00244764|365008772|FG000|Overall Study|Disease Progression|13|||
105822594|NCT00244764|365008772|FG000|Overall Study|Protocol Violation|2|||
105822595|NCT00244764|365008772|FG000|Overall Study|Death|1|||
105822596|NCT00244764|365008772|FG000|Overall Study|Off Study Medication for >21 Days|1|||
105822597|NCT00244764|365008772|FG000|Overall Study|Declining Performance Status|1|||
105822598|NCT00244764|365008772|FG000|Overall Study|Participant was Hospitalized until Death|1|||
105822599|NCT00244764|365008772|FG000|Overall Study|Primary Investigator Discretion|2|||
105822600|NCT00244764|365008772|FG000|Overall Study|Sponsor Terminated Study|2|||
105822601|NCT00244764|365008772|FG000|Overall Study|Developed Secondary Malignancy|1|||
105822602|NCT02911792|365008775|FG000|Overall Study|Lost to Follow-up|3|||
105822603|NCT02911792|365008776|FG001|Overall Study|Lost to Follow-up|3|||
105822604|NCT02911792|365008777|FG002|Overall Study|Lost to Follow-up|3|||
105364001|NCT01325350|363338424|FG001|Overall Study|Protocol Violation|0|||
105364002|NCT01325350|363338425|FG002|Overall Study|Protocol Violation|0|||
105766965|NCT03209362|364798349|FG000|Overall Study|Lost to Follow-up|0|||
105766966|NCT03209362|364798350|FG001|Overall Study|Lost to Follow-up|1|||
105822605|NCT02911792|365008778|FG003|Overall Study|Lost to Follow-up|3|||
105822606|NCT01244620|365008779|FG000|Overall Study|Study terminated|4|||
105822607|NCT01244620|365008780|FG001|Overall Study|Study terminated|4|||
105766967|NCT03209362|364798349|FG000|Overall Study|Withdrawal by Subject|2|||
105364003|NCT01325350|363338426|FG003|Overall Study|Protocol Violation|1|||
105364004|NCT01325350|363338427|FG004|Overall Study|Protocol Violation|0|||
105364005|NCT01325350|363338423|FG000|Overall Study|Withdrawal by Subject|0|||
105364006|NCT01325350|363338424|FG001|Overall Study|Withdrawal by Subject|0|||
105364007|NCT01325350|363338425|FG002|Overall Study|Withdrawal by Subject|1|||
105364008|NCT01325350|363338426|FG003|Overall Study|Withdrawal by Subject|1|||
105364009|NCT01325350|363338427|FG004|Overall Study|Withdrawal by Subject|0|||
105364010|NCT01325350|363338423|FG000|Overall Study|Did Not Receive Treatment|0|||
105364011|NCT01325350|363338424|FG001|Overall Study|Did Not Receive Treatment|1|||
105364012|NCT01325350|363338425|FG002|Overall Study|Did Not Receive Treatment|1|||
105364013|NCT01325350|363338426|FG003|Overall Study|Did Not Receive Treatment|0|||
105364014|NCT01325350|363338427|FG004|Overall Study|Did Not Receive Treatment|1|||
105364015|NCT01063855|363338428|FG000|Overall Study|Adverse Event|4|||
105364016|NCT01063855|363338429|FG001|Overall Study|Adverse Event|4|||
105364017|NCT01063855|363338428|FG000|Overall Study|Death|0|||
105364018|NCT01063855|363338429|FG001|Overall Study|Death|1|||
105364019|NCT01063855|363338428|FG000|Overall Study|Lost to Follow-up|8|||
105364020|NCT01063855|363338429|FG001|Overall Study|Lost to Follow-up|4|||
105364021|NCT01063855|363338428|FG000|Overall Study|Pregnancy|1|||
105364022|NCT01063855|363338429|FG001|Overall Study|Pregnancy|0|||
105364023|NCT01063855|363338428|FG000|Overall Study|Lack of Efficacy|0|||
105364024|NCT01063855|363338429|FG001|Overall Study|Lack of Efficacy|1|||
105364025|NCT01063855|363338428|FG000|Overall Study|Withdrawal by Subject|11|||
105364026|NCT01063855|363338429|FG001|Overall Study|Withdrawal by Subject|8|||
105364027|NCT01063855|363338428|FG000|Overall Study|Reason not specified|13|||
105364028|NCT01063855|363338429|FG001|Overall Study|Reason not specified|11|||
105364029|NCT02806713|363338430|FG000|Overall Study|Urethral injury during procedure|1|||
105364030|NCT02806713|363338431|FG001|Overall Study|Urethral injury during procedure|0|||
105364031|NCT02806713|363338430|FG000|Overall Study|cancelled surgery|1|||
105364032|NCT02806713|363338431|FG001|Overall Study|cancelled surgery|2|||
105364033|NCT01165307|363338432|FG000|Overall Study|Lost to Follow-up|11|||
105364034|NCT01165307|363338433|FG001|Overall Study|Lost to Follow-up|3|||
105364035|NCT01165307|363338432|FG000|Overall Study|Withdrawal by Subject|2|||
105364036|NCT01165307|363338433|FG001|Overall Study|Withdrawal by Subject|0|||
105364037|NCT01165307|363338432|FG000|Overall Study|Subject not available for contact|1|||
105364038|NCT01165307|363338433|FG001|Overall Study|Subject not available for contact|0|||
105364039|NCT03234036|363338436|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
105364040|NCT03234036|363338437|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
105364041|NCT03234036|363338438|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
105364042|NCT03234036|363338439|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
105364043|NCT02999789|363338440|FG000|Overall Study|Withdrawal by Subject|0|||
105364044|NCT02999789|363338441|FG001|Overall Study|Withdrawal by Subject|1|||
105364045|NCT02999789|363338440|FG000|Overall Study|Became ineligible|1|||
105364046|NCT02999789|363338441|FG001|Overall Study|Became ineligible|2|||
105364047|NCT00521365|363338444|FG000|Overall Study|Adverse Event|3|||
105364048|NCT00521365|363338444|FG000|Overall Study|Lost to Follow-up|6|||
105364049|NCT00521365|363338444|FG000|Overall Study|Protocol deviation|2|||
105364050|NCT00521365|363338444|FG000|Overall Study|Drug compliance|3|||
105364051|NCT00521365|363338444|FG000|Overall Study|Usage of not allowed drugs|6|||
105364052|NCT03627832|363338445|FG000|Overall Study|Withdrawal by Subject|10|||
105364053|NCT03627832|363338446|FG001|Overall Study|Withdrawal by Subject|1|||
105364054|NCT01718483|363338447|FG000|Overall Study|Withdrawal by Subject|14|||
105364055|NCT01718483|363338448|FG001|Overall Study|Withdrawal by Subject|12|||
105364056|NCT01718483|363338447|FG000|Overall Study|Adverse Event|5|||
105364057|NCT01718483|363338448|FG001|Overall Study|Adverse Event|12|||
105364058|NCT01718483|363338447|FG000|Overall Study|Lost to Follow-up|8|||
105364059|NCT01718483|363338448|FG001|Overall Study|Lost to Follow-up|3|||
105364060|NCT01718483|363338447|FG000|Overall Study|Protocol Violation|4|||
105364061|NCT01718483|363338448|FG001|Overall Study|Protocol Violation|2|||
105364062|NCT01718483|363338447|FG000|Overall Study|Other|1|||
105364063|NCT01718483|363338448|FG001|Overall Study|Other|4|||
105364064|NCT01718483|363338447|FG000|Overall Study|Pregnancy|1|||
105364065|NCT01718483|363338448|FG001|Overall Study|Pregnancy|1|||
105486553|NCT02129777|363793355|FG001|Open-Label Period|Lost to Follow-up|0|||
105364066|NCT01718483|363338447|FG000|Overall Study|Lack of Efficacy|1|||
105364067|NCT01718483|363338448|FG001|Overall Study|Lack of Efficacy|0|||
105364068|NCT00048035|363338449|FG000|Core Period|Early Withdrawals|4|||
105364069|NCT00048035|363338450|FG001|Core Period|Early Withdrawals|2|||
105486554|NCT02129777|363793356|FG002|Open-Label Period|Lost to Follow-up|0|||
105822608|NCT01244620|365008781|FG002|Overall Study|Study terminated|4|||
105822609|NCT01244620|365008782|FG003|Overall Study|Study terminated|4|||
105822610|NCT03872128|365008783|FG000|Overall Study|Dropped out before treatment|1|||
105822611|NCT03872128|365008784|FG001|Overall Study|Dropped out before treatment|0|||
105822612|NCT03872128|365008785|FG002|Overall Study|Dropped out before treatment|4|||
105822613|NCT03872128|365008783|FG000|Overall Study|Lost to Follow-up|2|||
105822614|NCT03872128|365008784|FG001|Overall Study|Lost to Follow-up|5|||
105822615|NCT03872128|365008785|FG002|Overall Study|Lost to Follow-up|8|||
105822616|NCT00840073|365008786|FG000|Second Intervention|Missed 72 hour blood draw|1|||
105822617|NCT00840073|365008787|FG001|Second Intervention|Missed 72 hour blood draw|1|||
105822618|NCT03637764|365008788|FG000|Overall Study|Adverse Event|2|||
105364070|NCT00048035|363338451|FG002|Core Period|Early Withdrawals|1|||
105364071|NCT00048035|363338452|FG003|Core Period|Early Withdrawals|1|||
105364072|NCT00048035|363338453|FG004|Core Period|Early Withdrawals|1|||
105364073|NCT00048035|363338454|FG005|Core Period|Early Withdrawals|1|||
105364074|NCT00048035|363338455|FG006|Core Period|Early Withdrawals|0|||
105364075|NCT00048035|363338456|FG007|Core Period|Early Withdrawals|0|||
105364076|NCT00048035|363338449|FG000|Extension Year 1|Early Withdrawals|0|||
105364077|NCT00048035|363338450|FG001|Extension Year 1|Early Withdrawals|0|||
105364078|NCT00048035|363338451|FG002|Extension Year 1|Early Withdrawals|0|||
105364079|NCT00048035|363338452|FG003|Extension Year 1|Early Withdrawals|0|||
105364080|NCT00048035|363338453|FG004|Extension Year 1|Early Withdrawals|0|||
105364081|NCT00048035|363338454|FG005|Extension Year 1|Early Withdrawals|0|||
105364082|NCT00048035|363338455|FG006|Extension Year 1|Early Withdrawals|11|||
105364083|NCT00048035|363338456|FG007|Extension Year 1|Early Withdrawals|11|||
105364084|NCT00048035|363338449|FG000|Extension Year 2|Early Withdrawals|0|||
105364085|NCT00048035|363338450|FG001|Extension Year 2|Early Withdrawals|0|||
105364086|NCT00048035|363338451|FG002|Extension Year 2|Early Withdrawals|0|||
105364087|NCT00048035|363338452|FG003|Extension Year 2|Early Withdrawals|0|||
105364088|NCT00048035|363338453|FG004|Extension Year 2|Early Withdrawals|0|||
105364089|NCT00048035|363338454|FG005|Extension Year 2|Early Withdrawals|0|||
105364090|NCT00048035|363338455|FG006|Extension Year 2|Early Withdrawals|3|||
105364091|NCT00048035|363338456|FG007|Extension Year 2|Early Withdrawals|3|||
105364092|NCT00509899|363338457|FG000|Overall Study|Progressive disease|1|||
105364093|NCT00509899|363338458|FG001|Overall Study|Progressive disease|3|||
105364094|NCT00509899|363338459|FG002|Overall Study|Progressive disease|5|||
105364095|NCT00509899|363338460|FG003|Overall Study|Progressive disease|1|||
105364096|NCT00509899|363338461|FG004|Overall Study|Progressive disease|0|||
105364097|NCT00509899|363338462|FG005|Overall Study|Progressive disease|1|||
105364098|NCT00509899|363338463|FG006|Overall Study|Progressive disease|0|||
105364099|NCT00509899|363338464|FG007|Overall Study|Progressive disease|0|||
105364100|NCT00509899|363338457|FG000|Overall Study|Unacceptable Toxicity|1|||
105364101|NCT00509899|363338458|FG001|Overall Study|Unacceptable Toxicity|0|||
105364102|NCT00509899|363338459|FG002|Overall Study|Unacceptable Toxicity|0|||
105364103|NCT00509899|363338460|FG003|Overall Study|Unacceptable Toxicity|2|||
105364104|NCT00509899|363338461|FG004|Overall Study|Unacceptable Toxicity|0|||
105364105|NCT00509899|363338462|FG005|Overall Study|Unacceptable Toxicity|0|||
105364106|NCT00509899|363338463|FG006|Overall Study|Unacceptable Toxicity|0|||
105364107|NCT00509899|363338464|FG007|Overall Study|Unacceptable Toxicity|0|||
105364108|NCT00509899|363338457|FG000|Overall Study|Withdrawal by Subject|6|||
105364109|NCT00509899|363338458|FG001|Overall Study|Withdrawal by Subject|2|||
105364110|NCT00509899|363338459|FG002|Overall Study|Withdrawal by Subject|3|||
105364111|NCT00509899|363338460|FG003|Overall Study|Withdrawal by Subject|0|||
105364112|NCT00509899|363338461|FG004|Overall Study|Withdrawal by Subject|3|||
105822619|NCT03637764|365008789|FG001|Overall Study|Adverse Event|0|||
105822620|NCT03637764|365008790|FG002|Overall Study|Adverse Event|0|||
105822621|NCT03637764|365008791|FG003|Overall Study|Adverse Event|1|||
105822622|NCT03637764|365008788|FG000|Overall Study|Progressive Disease|23|||
105822623|NCT03637764|365008789|FG001|Overall Study|Progressive Disease|23|||
105822624|NCT03637764|365008790|FG002|Overall Study|Progressive Disease|18|||
105822625|NCT03637764|365008791|FG003|Overall Study|Progressive Disease|31|||
105822626|NCT03637764|365008788|FG000|Overall Study|Withdrawal by Subject|1|||
105822627|NCT03637764|365008789|FG001|Overall Study|Withdrawal by Subject|3|||
105822628|NCT03637764|365008790|FG002|Overall Study|Withdrawal by Subject|0|||
105571712|NCT02176421|364092745|FG000|Overall Study|Lost to Follow-up|4|||
105571713|NCT02176421|364092745|FG000|Overall Study|Adverse Event|1|||
105822629|NCT03637764|365008791|FG003|Overall Study|Withdrawal by Subject|1|||
105822630|NCT02648438|365008792|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105822631|NCT02648438|365008793|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
105822632|NCT02648438|365008794|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
105822633|NCT02648438|365008792|FG000|Overall Study|Protocol Violation|2|||
105364113|NCT00509899|363338462|FG005|Overall Study|Withdrawal by Subject|2|||
105364114|NCT00509899|363338463|FG006|Overall Study|Withdrawal by Subject|0|||
105364115|NCT00509899|363338464|FG007|Overall Study|Withdrawal by Subject|0|||
105364116|NCT00509899|363338457|FG000|Overall Study|Physician Decision|4|||
105364117|NCT00509899|363338458|FG001|Overall Study|Physician Decision|2|||
105364118|NCT00509899|363338459|FG002|Overall Study|Physician Decision|7|||
105364119|NCT00509899|363338460|FG003|Overall Study|Physician Decision|0|||
105364120|NCT00509899|363338461|FG004|Overall Study|Physician Decision|1|||
105364121|NCT00509899|363338462|FG005|Overall Study|Physician Decision|4|||
105364122|NCT00509899|363338463|FG006|Overall Study|Physician Decision|0|||
105364123|NCT00509899|363338464|FG007|Overall Study|Physician Decision|0|||
105364124|NCT00509899|363338457|FG000|Overall Study|Intercurrent Illness|1|||
105364125|NCT00509899|363338458|FG001|Overall Study|Intercurrent Illness|0|||
105364126|NCT00509899|363338459|FG002|Overall Study|Intercurrent Illness|0|||
105364127|NCT00509899|363338460|FG003|Overall Study|Intercurrent Illness|1|||
105364128|NCT00509899|363338461|FG004|Overall Study|Intercurrent Illness|0|||
105364129|NCT00509899|363338462|FG005|Overall Study|Intercurrent Illness|1|||
105822634|NCT02648438|365008793|FG001|Overall Study|Protocol Violation|0|||
105822635|NCT02648438|365008794|FG002|Overall Study|Protocol Violation|0|||
105822636|NCT02648438|365008792|FG000|Overall Study|Withdrawal by Subject|1|||
105822637|NCT02648438|365008793|FG001|Overall Study|Withdrawal by Subject|1|||
105822638|NCT02648438|365008794|FG002|Overall Study|Withdrawal by Subject|0|||
105822639|NCT02760927|365008795|FG000|Overall Study|Tube Slippage from Device|1|||
105822640|NCT02105272|365008796|FG000|Overall Study|Adverse Event|1|||
105766968|NCT03209362|364798350|FG001|Overall Study|Withdrawal by Subject|0|||
105822641|NCT02105272|365008797|FG001|Overall Study|Adverse Event|2|||
105822642|NCT02105272|365008796|FG000|Overall Study|Physician Decision|0|||
105822643|NCT02105272|365008797|FG001|Overall Study|Physician Decision|1|||
105822644|NCT02105272|365008796|FG000|Overall Study|Protocol Violation|2|||
105766969|NCT03209362|364798349|FG000|Overall Study|Other|0|||
105766970|NCT03209362|364798350|FG001|Overall Study|Other|1|||
105766971|NCT00796224|364798351|FG000|Overall Study|Adverse Event|1|||
105766972|NCT00796224|364798352|FG001|Overall Study|Adverse Event|0|||
105766973|NCT00796224|364798351|FG000|Overall Study|Protocol Violation|0|||
105766974|NCT00796224|364798352|FG001|Overall Study|Protocol Violation|1|||
105766975|NCT02569398|364798353|FG000|Overall Study|Adverse Event|0|||
105766976|NCT02569398|364798354|FG001|Overall Study|Adverse Event|1|||
105766977|NCT02569398|364798355|FG002|Overall Study|Adverse Event|6|||
105766978|NCT02569398|364798353|FG000|Overall Study|Withdrawal by Subject|43|||
105766979|NCT02569398|364798354|FG001|Overall Study|Withdrawal by Subject|43|||
105766980|NCT02569398|364798355|FG002|Overall Study|Withdrawal by Subject|30|||
105766981|NCT02569398|364798353|FG000|Overall Study|Study terminated by sponsor|130|||
105766982|NCT02569398|364798354|FG001|Overall Study|Study terminated by sponsor|131|||
105766983|NCT02569398|364798355|FG002|Overall Study|Study terminated by sponsor|134|||
105766984|NCT02569398|364798353|FG000|Overall Study|Other|12|||
105766985|NCT02569398|364798354|FG001|Overall Study|Other|14|||
105766986|NCT02569398|364798355|FG002|Overall Study|Other|13|||
105766987|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
105766988|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
105766989|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Death|0|||
105766990|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Death|4|||
105766991|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
105766992|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
105766993|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
105766994|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
105766995|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
105766996|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
105766997|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
105766998|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
105766999|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
105767000|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
105767001|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Other|4|||
105822645|NCT02105272|365008797|FG001|Overall Study|Protocol Violation|0|||
105822646|NCT02105272|365008796|FG000|Overall Study|Withdrawal by Subject|2|||
105767002|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Other|3|||
105767003|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
105767004|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
105767005|NCT03517722|364798356|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
105767006|NCT03517722|364798357|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
105767007|NCT03517722|364798356|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
105767008|NCT03517722|364798357|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
105767009|NCT03517722|364798356|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
105767010|NCT03517722|364798357|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
105767011|NCT03517722|364798356|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
105767012|NCT03517722|364798357|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
105767013|NCT02371980|364800366|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
105767014|NCT02371980|364800367|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
105364130|NCT00509899|363338463|FG006|Overall Study|Intercurrent Illness|0|||
105364131|NCT00509899|363338464|FG007|Overall Study|Intercurrent Illness|0|||
105364132|NCT00509899|363338457|FG000|Overall Study|Death|2|||
105364133|NCT00509899|363338458|FG001|Overall Study|Death|2|||
105364134|NCT00509899|363338459|FG002|Overall Study|Death|3|||
105364135|NCT00509899|363338460|FG003|Overall Study|Death|0|||
105364136|NCT00509899|363338461|FG004|Overall Study|Death|1|||
105767015|NCT02371980|364800368|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
105767016|NCT02371980|364800369|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
105767017|NCT02371980|364800370|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
105767018|NCT02371980|364800366|FG000|Open-label Period|Significant Protocol Deviation|19|||
105767019|NCT02371980|364800367|FG001|Open-label Period|Significant Protocol Deviation|0|||
105767020|NCT02371980|364800368|FG002|Open-label Period|Significant Protocol Deviation|0|||
105767021|NCT02371980|364800369|FG003|Open-label Period|Significant Protocol Deviation|0|||
105767022|NCT02371980|364800370|FG004|Open-label Period|Significant Protocol Deviation|0|||
105767023|NCT02371980|364800366|FG000|Open-label Period|Noncompliance with Study Drug|10|||
105767024|NCT02371980|364800367|FG001|Open-label Period|Noncompliance with Study Drug|0|||
105767025|NCT02371980|364800368|FG002|Open-label Period|Noncompliance with Study Drug|0|||
105364137|NCT00509899|363338462|FG005|Overall Study|Death|1|||
105364138|NCT00509899|363338463|FG006|Overall Study|Death|1|||
105767026|NCT02371980|364800369|FG003|Open-label Period|Noncompliance with Study Drug|0|||
105767027|NCT02371980|364800370|FG004|Open-label Period|Noncompliance with Study Drug|0|||
105364139|NCT00509899|363338464|FG007|Overall Study|Death|1|||
105364140|NCT00509899|363338457|FG000|Overall Study|Lack of Efficacy|1|||
105364141|NCT00509899|363338458|FG001|Overall Study|Lack of Efficacy|0|||
105364142|NCT00509899|363338459|FG002|Overall Study|Lack of Efficacy|2|||
105364143|NCT00509899|363338460|FG003|Overall Study|Lack of Efficacy|0|||
105364144|NCT00509899|363338461|FG004|Overall Study|Lack of Efficacy|0|||
105364145|NCT00509899|363338462|FG005|Overall Study|Lack of Efficacy|1|||
105364146|NCT00509899|363338463|FG006|Overall Study|Lack of Efficacy|0|||
105364147|NCT00509899|363338464|FG007|Overall Study|Lack of Efficacy|0|||
105364148|NCT02771275|363338465|FG000|Overall Study|Reoperation|3|||
105364149|NCT02771275|363338465|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
105364150|NCT02185417|363338466|FG000|Overall Study|Death|448|||
105364151|NCT02185417|363338467|FG001|Overall Study|Death|446|||
105364152|NCT02185417|363338468|FG002|Overall Study|Death|0|||
105364153|NCT02185417|363338466|FG000|Overall Study|Withdrawal by Subject|7|||
105364154|NCT02185417|363338467|FG001|Overall Study|Withdrawal by Subject|12|||
105364155|NCT02185417|363338468|FG002|Overall Study|Withdrawal by Subject|0|||
105364156|NCT02154139|363338469|FG000|Overall Study|Injection not administered|2|||
105364157|NCT02154139|363338469|FG000|Overall Study|Other|2|||
105364158|NCT02154139|363338469|FG000|Overall Study|Investigator transferred|3|||
105364159|NCT01290718|363338470|FG000|Overall Study|Early termination of the study|4|||
105364160|NCT02157519|363338480|FG000|Overall Study|Death|3|||
105364161|NCT02157519|363338481|FG001|Overall Study|Death|1|||
105364162|NCT02157519|363338480|FG000|Overall Study|Withdrawal by Subject|7|||
105364163|NCT02157519|363338481|FG001|Overall Study|Withdrawal by Subject|0|||
105364164|NCT02157519|363338480|FG000|Overall Study|Lost to Follow-up|1|||
105364165|NCT02157519|363338481|FG001|Overall Study|Lost to Follow-up|0|||
105767028|NCT02371980|364800366|FG000|Open-label Period|Lost to Follow-up|55|||
105767029|NCT02371980|364800367|FG001|Open-label Period|Lost to Follow-up|0|||
105767030|NCT02371980|364800368|FG002|Open-label Period|Lost to Follow-up|0|||
105364166|NCT03075267|363338482|FG000|Overall Study|Protocol Violation|1|||
105364167|NCT03075267|363338483|FG001|Overall Study|Protocol Violation|0|||
105364168|NCT03075267|363338484|FG002|Overall Study|Protocol Violation|0|||
105364169|NCT00809445|363338485|FG000|1 Month Follow-up|Lost contact|1|||
105364170|NCT00809445|363338486|FG001|1 Month Follow-up|Lost contact|2|||
105364171|NCT00809445|363338487|FG002|1 Month Follow-up|Lost contact|1|||
105364172|NCT00809445|363338485|FG000|1 Month Follow-up|Withdrew consent|1|||
105364173|NCT00809445|363338486|FG001|1 Month Follow-up|Withdrew consent|1|||
105364174|NCT00809445|363338487|FG002|1 Month Follow-up|Withdrew consent|1|||
105364175|NCT00809445|363338485|FG000|1 Month Follow-up|Death|0|||
105364176|NCT00809445|363338486|FG001|1 Month Follow-up|Death|1|||
105364177|NCT00809445|363338487|FG002|1 Month Follow-up|Death|1|||
105767031|NCT02371980|364800369|FG003|Open-label Period|Lost to Follow-up|0|||
105767032|NCT02371980|364800370|FG004|Open-label Period|Lost to Follow-up|0|||
105822647|NCT02105272|365008797|FG001|Overall Study|Withdrawal by Subject|0|||
105822648|NCT02964039|365008798|FG000|Overall Study|Medical reason unrelated to study participation|1|||
105822649|NCT02964039|365008799|FG001|Overall Study|Medical reason unrelated to study participation|0|||
105822650|NCT02964039|365008800|FG002|Overall Study|Medical reason unrelated to study participation|3|||
105822651|NCT02964039|365008798|FG000|Overall Study|Research shutdown due to pandemic|2|||
105822652|NCT02964039|365008799|FG001|Overall Study|Research shutdown due to pandemic|0|||
105822653|NCT02964039|365008800|FG002|Overall Study|Research shutdown due to pandemic|1|||
105822654|NCT02964039|365008798|FG000|Overall Study|Withdrawal by Subject|0|||
105822655|NCT02964039|365008799|FG001|Overall Study|Withdrawal by Subject|1|||
105822656|NCT02964039|365008800|FG002|Overall Study|Withdrawal by Subject|0|||
105822657|NCT02964039|365008798|FG000|Overall Study|Lost to Follow-up|1|||
105822658|NCT02964039|365008799|FG001|Overall Study|Lost to Follow-up|0|||
105822659|NCT02964039|365008800|FG002|Overall Study|Lost to Follow-up|1|||
105822660|NCT01103713|365008801|FG000|Overall Study|Lost to Follow-up|2|||
105822661|NCT01103713|365008801|FG000|Overall Study|Withdrawal by Subject|8|||
105822662|NCT01103713|365008801|FG000|Overall Study|Study terminated by sponsor|2|||
105822663|NCT01103713|365008801|FG000|Overall Study|Other|1|||
105822664|NCT01615198|365008802|FG000|Overall Study|Withdrawal by Subject|5|||
105822665|NCT01615198|365008803|FG001|Overall Study|Withdrawal by Subject|5|||
105822666|NCT01615198|365008802|FG000|Overall Study|Protocol deviation|1|||
105822667|NCT01615198|365008803|FG001|Overall Study|Protocol deviation|1|||
105822668|NCT01615198|365008802|FG000|Overall Study|Physician Decision|5|||
105822669|NCT01615198|365008803|FG001|Overall Study|Physician Decision|1|||
105822670|NCT01615198|365008802|FG000|Overall Study|Lost to Follow-up|1|||
105767033|NCT02371980|364800366|FG000|Open-label Period|Voluntary Withdrawal|91|||
105767034|NCT02371980|364800367|FG001|Open-label Period|Voluntary Withdrawal|0|||
105767035|NCT02371980|364800368|FG002|Open-label Period|Voluntary Withdrawal|0|||
105767036|NCT02371980|364800369|FG003|Open-label Period|Voluntary Withdrawal|0|||
105767037|NCT02371980|364800370|FG004|Open-label Period|Voluntary Withdrawal|0|||
105767038|NCT02371980|364800366|FG000|Open-label Period|Pregnancy|1|||
105767039|NCT02371980|364800367|FG001|Open-label Period|Pregnancy|0|||
105767040|NCT02371980|364800368|FG002|Open-label Period|Pregnancy|0|||
105767041|NCT02371980|364800369|FG003|Open-label Period|Pregnancy|0|||
105767042|NCT02371980|364800370|FG004|Open-label Period|Pregnancy|0|||
105822671|NCT01615198|365008803|FG001|Overall Study|Lost to Follow-up|1|||
105822672|NCT01615198|365008802|FG000|Overall Study|Lack of Efficacy|1|||
105822673|NCT01615198|365008803|FG001|Overall Study|Lack of Efficacy|6|||
105822674|NCT01615198|365008802|FG000|Overall Study|Adverse Event|11|||
105822675|NCT01615198|365008803|FG001|Overall Study|Adverse Event|5|||
105822676|NCT02089685|365008804|FG000|Overall Study|Adverse Event|1|||
105822677|NCT02089685|365008805|FG001|Overall Study|Adverse Event|0|||
105822678|NCT02089685|365008806|FG002|Overall Study|Adverse Event|0|||
105822679|NCT02089685|365008807|FG003|Overall Study|Adverse Event|0|||
105822680|NCT02089685|365008808|FG004|Overall Study|Adverse Event|1|||
105822681|NCT02089685|365008809|FG005|Overall Study|Adverse Event|0|||
105822682|NCT02089685|365008804|FG000|Overall Study|Clinical Progression|4|||
105822683|NCT02089685|365008805|FG001|Overall Study|Clinical Progression|0|||
105822684|NCT02089685|365008806|FG002|Overall Study|Clinical Progression|0|||
105822685|NCT02089685|365008807|FG003|Overall Study|Clinical Progression|5|||
105822686|NCT02089685|365008808|FG004|Overall Study|Clinical Progression|1|||
105822687|NCT02089685|365008809|FG005|Overall Study|Clinical Progression|2|||
105822688|NCT02089685|365008804|FG000|Overall Study|Excluded Medication|1|||
105822689|NCT02089685|365008805|FG001|Overall Study|Excluded Medication|0|||
105822690|NCT02089685|365008806|FG002|Overall Study|Excluded Medication|0|||
105767043|NCT02371980|364800366|FG000|Open-label Period|Lack of Efficacy|116|||
105767044|NCT02371980|364800367|FG001|Open-label Period|Lack of Efficacy|0|||
105767045|NCT02371980|364800368|FG002|Open-label Period|Lack of Efficacy|0|||
105364178|NCT00809445|363338485|FG000|1 Month Follow-up|Incarcerated|0|||
105364179|NCT00809445|363338486|FG001|1 Month Follow-up|Incarcerated|0|||
105364180|NCT00809445|363338487|FG002|1 Month Follow-up|Incarcerated|1|||
105364181|NCT00809445|363338485|FG000|6 Month Follow-up|Lost contact|16|||
105364182|NCT00809445|363338486|FG001|6 Month Follow-up|Lost contact|14|||
105364183|NCT00809445|363338487|FG002|6 Month Follow-up|Lost contact|14|||
105364184|NCT00809445|363338485|FG000|6 Month Follow-up|Death|2|||
105364185|NCT00809445|363338486|FG001|6 Month Follow-up|Death|1|||
105364186|NCT00809445|363338487|FG002|6 Month Follow-up|Death|1|||
105364187|NCT00809445|363338485|FG000|6 Month Follow-up|Incarcerated|6|||
105364188|NCT00809445|363338486|FG001|6 Month Follow-up|Incarcerated|8|||
105364189|NCT00809445|363338487|FG002|6 Month Follow-up|Incarcerated|8|||
105364190|NCT00809445|363338485|FG000|6 Month Follow-up|Withdrew consent|0|||
105364191|NCT00809445|363338486|FG001|6 Month Follow-up|Withdrew consent|0|||
105364192|NCT00809445|363338487|FG002|6 Month Follow-up|Withdrew consent|1|||
105364193|NCT01825200|363338492|FG000|Overall Study|Lost to Follow-up|5|||
105364194|NCT01825200|363338493|FG001|Overall Study|Lost to Follow-up|6|||
105364195|NCT01825200|363338492|FG000|Overall Study|Withdrawal by Subject|0|||
105364196|NCT01825200|363338493|FG001|Overall Study|Withdrawal by Subject|1|||
105364197|NCT00490035|363338494|FG000|Overall Study|AE, non-serious non-fatal|3|||
105364198|NCT00490035|363338495|FG001|Overall Study|AE, non-serious non-fatal|4|||
105364199|NCT00490035|363338496|FG002|Overall Study|AE, non-serious non-fatal|4|||
105364200|NCT00490035|363338497|FG003|Overall Study|AE, non-serious non-fatal|5|||
105364201|NCT00490035|363338494|FG000|Overall Study|Lost to Follow-up|2|||
105364202|NCT00490035|363338495|FG001|Overall Study|Lost to Follow-up|0|||
105364203|NCT00490035|363338496|FG002|Overall Study|Lost to Follow-up|1|||
105364204|NCT00490035|363338497|FG003|Overall Study|Lost to Follow-up|0|||
105364205|NCT00490035|363338494|FG000|Overall Study|Withdrawal by Subject|2|||
105364206|NCT00490035|363338495|FG001|Overall Study|Withdrawal by Subject|1|||
105364207|NCT00490035|363338496|FG002|Overall Study|Withdrawal by Subject|1|||
105364208|NCT00490035|363338497|FG003|Overall Study|Withdrawal by Subject|0|||
105364209|NCT00490035|363338494|FG000|Overall Study|Other reason|0|||
105364210|NCT00490035|363338495|FG001|Overall Study|Other reason|1|||
105364211|NCT00490035|363338496|FG002|Overall Study|Other reason|3|||
105364212|NCT00490035|363338497|FG003|Overall Study|Other reason|1|||
105364213|NCT00490035|363338494|FG000|Overall Study|AE, serious fatal|1|||
105364214|NCT00490035|363338495|FG001|Overall Study|AE, serious fatal|0|||
105364215|NCT00490035|363338496|FG002|Overall Study|AE, serious fatal|0|||
105364216|NCT00490035|363338497|FG003|Overall Study|AE, serious fatal|0|||
105364217|NCT00490035|363338494|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
105364218|NCT00490035|363338495|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
105364219|NCT00490035|363338496|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
105364220|NCT00490035|363338497|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
105364221|NCT00490035|363338494|FG000|Overall Study|AE of unknown type|0|||
105364222|NCT00490035|363338495|FG001|Overall Study|AE of unknown type|0|||
105486555|NCT02129777|363793357|FG003|Open-Label Period|Lost to Follow-up|0|||
105486556|NCT02129777|363793358|FG004|Open-Label Period|Lost to Follow-up|0|||
105486557|NCT02129777|363793359|FG005|Open-Label Period|Lost to Follow-up|1|||
105486558|NCT02129777|363793360|FG006|Open-Label Period|Lost to Follow-up|1|||
105486559|NCT02129777|363793354|FG000|Open-Label Period|Withdrawal by Subject|0|||
105486560|NCT02129777|363793355|FG001|Open-Label Period|Withdrawal by Subject|0|||
105486561|NCT02129777|363793356|FG002|Open-Label Period|Withdrawal by Subject|0|||
105486562|NCT02129777|363793357|FG003|Open-Label Period|Withdrawal by Subject|0|||
105767046|NCT02371980|364800369|FG003|Open-label Period|Lack of Efficacy|0|||
105767047|NCT02371980|364800370|FG004|Open-label Period|Lack of Efficacy|0|||
105767048|NCT02371980|364800366|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
105767049|NCT02371980|364800367|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
105767050|NCT02371980|364800368|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
105767051|NCT02371980|364800369|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
105767052|NCT02371980|364800370|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
105767053|NCT02371980|364800366|FG000|Open-label Period|Reason not Specified|9|||
105767054|NCT02371980|364800367|FG001|Open-label Period|Reason not Specified|0|||
105767055|NCT02371980|364800368|FG002|Open-label Period|Reason not Specified|0|||
105767056|NCT02371980|364800369|FG003|Open-label Period|Reason not Specified|0|||
105767057|NCT02371980|364800370|FG004|Open-label Period|Reason not Specified|0|||
105767058|NCT02371980|364800366|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
105767059|NCT02371980|364800367|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
105767060|NCT02371980|364800368|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
105767061|NCT02371980|364800369|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
105767062|NCT02371980|364800370|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
105822691|NCT02089685|365008807|FG003|Overall Study|Excluded Medication|11|||
105364223|NCT00490035|363338496|FG002|Overall Study|AE of unknown type|2|||
105364224|NCT00490035|363338497|FG003|Overall Study|AE of unknown type|0|||
105364225|NCT05358821|363338498|FG000|Overall Study|Withdrawal by Subject|0|||
105486563|NCT02129777|363793358|FG004|Open-Label Period|Withdrawal by Subject|0|||
105486564|NCT02129777|363793359|FG005|Open-Label Period|Withdrawal by Subject|1|||
105364226|NCT05358821|363338499|FG001|Overall Study|Withdrawal by Subject|1|||
105364227|NCT05358821|363338500|FG002|Overall Study|Withdrawal by Subject|0|||
105364228|NCT05358821|363338498|FG000|Overall Study|Withdrawal of Consent|0|||
105364229|NCT05358821|363338499|FG001|Overall Study|Withdrawal of Consent|0|||
105364230|NCT05358821|363338500|FG002|Overall Study|Withdrawal of Consent|1|||
105364231|NCT04613518|363338510|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
105364232|NCT04613518|363338511|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
105364233|NCT04613518|363338512|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
105364234|NCT04613518|363338510|FG000|Double-Blind Treatment Period|Adverse Event|2|||
105822692|NCT02089685|365008808|FG004|Overall Study|Excluded Medication|2|||
105822693|NCT02089685|365008809|FG005|Overall Study|Excluded Medication|1|||
105822694|NCT02089685|365008804|FG000|Overall Study|Progressive disease|13|||
105822695|NCT02089685|365008805|FG001|Overall Study|Progressive disease|10|||
105822696|NCT02089685|365008806|FG002|Overall Study|Progressive disease|3|||
105822697|NCT02089685|365008807|FG003|Overall Study|Progressive disease|51|||
105822698|NCT02089685|365008808|FG004|Overall Study|Progressive disease|17|||
105822699|NCT02089685|365008809|FG005|Overall Study|Progressive disease|12|||
105822700|NCT02089685|365008804|FG000|Overall Study|Follow up ended by sponsor|2|||
105822701|NCT02089685|365008805|FG001|Overall Study|Follow up ended by sponsor|2|||
105822702|NCT02089685|365008806|FG002|Overall Study|Follow up ended by sponsor|0|||
105822703|NCT02089685|365008807|FG003|Overall Study|Follow up ended by sponsor|70|||
105364235|NCT04613518|363338511|FG001|Double-Blind Treatment Period|Adverse Event|0|||
105364236|NCT04613518|363338512|FG002|Double-Blind Treatment Period|Adverse Event|1|||
105364237|NCT04613518|363338510|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
105364238|NCT04613518|363338511|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
105364239|NCT04613518|363338512|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
105364240|NCT04613518|363338510|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
105364241|NCT04613518|363338511|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
105364242|NCT04613518|363338512|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
105364243|NCT04613518|363338510|FG000|Double-Blind Treatment Period|Other Reasons|2|||
105364244|NCT04613518|363338511|FG001|Double-Blind Treatment Period|Other Reasons|0|||
105364245|NCT04613518|363338512|FG002|Double-Blind Treatment Period|Other Reasons|0|||
105364246|NCT04613518|363338510|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
105364247|NCT04613518|363338511|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
105364248|NCT04613518|363338512|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
105364249|NCT04613518|363338510|FG000|Open-Label Treatment Period|Adverse Event|1|||
105364250|NCT04613518|363338511|FG001|Open-Label Treatment Period|Adverse Event|0|||
105364251|NCT04613518|363338512|FG002|Open-Label Treatment Period|Adverse Event|3|||
105364252|NCT04613518|363338510|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
105364253|NCT04613518|363338511|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
105364254|NCT04613518|363338512|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
105364255|NCT04613518|363338510|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
105364256|NCT04613518|363338511|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
105364257|NCT04613518|363338512|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
105822704|NCT02089685|365008808|FG004|Overall Study|Follow up ended by sponsor|26|||
105822705|NCT02089685|365008809|FG005|Overall Study|Follow up ended by sponsor|26|||
105822706|NCT02089685|365008804|FG000|Overall Study|Withdrawal by Subject|0|||
105822707|NCT02089685|365008805|FG001|Overall Study|Withdrawal by Subject|2|||
105822708|NCT02089685|365008806|FG002|Overall Study|Withdrawal by Subject|0|||
105822709|NCT02089685|365008807|FG003|Overall Study|Withdrawal by Subject|8|||
105364258|NCT04613518|363338510|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
105364259|NCT04613518|363338511|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
105822710|NCT02089685|365008808|FG004|Overall Study|Withdrawal by Subject|1|||
105822711|NCT02089685|365008809|FG005|Overall Study|Withdrawal by Subject|1|||
105822712|NCT02089685|365008804|FG000|Overall Study|Status not recorded|1|||
105822713|NCT02089685|365008805|FG001|Overall Study|Status not recorded|0|||
105364260|NCT04613518|363338512|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
105364261|NCT04613518|363338510|FG000|Open-Label Treatment Period|Other reasons|1|||
105364262|NCT04613518|363338511|FG001|Open-Label Treatment Period|Other reasons|0|||
105364263|NCT04613518|363338512|FG002|Open-Label Treatment Period|Other reasons|0|||
105364264|NCT03589807|363338513|FG000|Overall Study|Lost to Follow-up|0|||
105364265|NCT03589807|363338514|FG001|Overall Study|Lost to Follow-up|2|||
105364266|NCT03589807|363338515|FG002|Overall Study|Lost to Follow-up|2|||
105364267|NCT03589807|363338516|FG003|Overall Study|Lost to Follow-up|3|||
105364268|NCT03589807|363338517|FG004|Overall Study|Lost to Follow-up|1|||
105364269|NCT03589807|363338518|FG005|Overall Study|Lost to Follow-up|1|||
105364270|NCT03589807|363338513|FG000|Overall Study|Withdrawal by Subject|0|||
105822714|NCT02089685|365008806|FG002|Overall Study|Status not recorded|0|||
105822715|NCT02089685|365008807|FG003|Overall Study|Status not recorded|0|||
105822716|NCT02089685|365008808|FG004|Overall Study|Status not recorded|1|||
105822717|NCT02089685|365008809|FG005|Overall Study|Status not recorded|0|||
105822718|NCT02089685|365008804|FG000|Overall Study|Death|0|||
105364271|NCT03589807|363338514|FG001|Overall Study|Withdrawal by Subject|5|||
105364272|NCT03589807|363338515|FG002|Overall Study|Withdrawal by Subject|0|||
105364273|NCT03589807|363338516|FG003|Overall Study|Withdrawal by Subject|0|||
105364274|NCT03589807|363338517|FG004|Overall Study|Withdrawal by Subject|0|||
105364275|NCT03589807|363338518|FG005|Overall Study|Withdrawal by Subject|0|||
105364276|NCT03589807|363338513|FG000|Overall Study|Protocol Violation|0|||
105364277|NCT03589807|363338514|FG001|Overall Study|Protocol Violation|0|||
105364278|NCT03589807|363338515|FG002|Overall Study|Protocol Violation|0|||
105364279|NCT03589807|363338516|FG003|Overall Study|Protocol Violation|1|||
105364280|NCT03589807|363338517|FG004|Overall Study|Protocol Violation|0|||
105364281|NCT03589807|363338518|FG005|Overall Study|Protocol Violation|0|||
105822719|NCT02089685|365008805|FG001|Overall Study|Death|0|||
105822720|NCT02089685|365008806|FG002|Overall Study|Death|0|||
105822721|NCT02089685|365008807|FG003|Overall Study|Death|7|||
105822722|NCT02089685|365008808|FG004|Overall Study|Death|2|||
105822723|NCT02089685|365008809|FG005|Overall Study|Death|5|||
105822724|NCT02089685|365008804|FG000|Overall Study|Lost to Follow-up|0|||
105822725|NCT02089685|365008805|FG001|Overall Study|Lost to Follow-up|0|||
105822726|NCT02089685|365008806|FG002|Overall Study|Lost to Follow-up|0|||
105822727|NCT02089685|365008807|FG003|Overall Study|Lost to Follow-up|1|||
105822728|NCT02089685|365008808|FG004|Overall Study|Lost to Follow-up|0|||
105822729|NCT02089685|365008809|FG005|Overall Study|Lost to Follow-up|0|||
105822730|NCT02089685|365008804|FG000|Overall Study|Physician Decision|0|||
105822731|NCT02089685|365008805|FG001|Overall Study|Physician Decision|0|||
105822732|NCT02089685|365008806|FG002|Overall Study|Physician Decision|0|||
105364282|NCT03589807|363338513|FG000|Overall Study|Enrolled but treatment not administered|0|||
105364283|NCT03589807|363338514|FG001|Overall Study|Enrolled but treatment not administered|0|||
105364284|NCT03589807|363338515|FG002|Overall Study|Enrolled but treatment not administered|0|||
105822733|NCT02089685|365008807|FG003|Overall Study|Physician Decision|0|||
105822734|NCT02089685|365008808|FG004|Overall Study|Physician Decision|0|||
105822735|NCT02089685|365008809|FG005|Overall Study|Physician Decision|4|||
105822736|NCT02089685|365008804|FG000|Overall Study|Screen failure|1|||
105822737|NCT02089685|365008805|FG001|Overall Study|Screen failure|0|||
105822738|NCT02089685|365008806|FG002|Overall Study|Screen failure|0|||
105822739|NCT02089685|365008807|FG003|Overall Study|Screen failure|0|||
105822740|NCT02089685|365008808|FG004|Overall Study|Screen failure|0|||
105822741|NCT02089685|365008809|FG005|Overall Study|Screen failure|0|||
105822742|NCT01848938|365008814|FG000|Overall Study|Lost to Follow-up|1|||
105822743|NCT01848938|365008815|FG001|Overall Study|Lost to Follow-up|1|||
105822744|NCT01757392|365008816|FG000|Overall Study|Withdrawal by Subject|1|||
105822745|NCT01757392|365008816|FG000|Overall Study|Screen Fail|3|||
105822746|NCT04608188|365008821|FG000|Overall Study|Withdrawal by Subject|4|||
105822747|NCT04608188|365008822|FG001|Overall Study|Withdrawal by Subject|8|||
105822748|NCT00463684|365008826|FG000|Overall Study|Withdrawal by Subject|1|||
105822749|NCT00463684|365008826|FG000|Overall Study|Lost to Follow-up|3|||
105822750|NCT01929863|365008827|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
105822751|NCT01929863|365008828|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
105822752|NCT01929863|365008827|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
105822753|NCT01929863|365008828|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
105822754|NCT01929863|365008827|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
105822755|NCT01929863|365008828|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
105822756|NCT03792477|365008829|FG000|Overall Study|Adverse Event|0|||
105822757|NCT03792477|365008830|FG001|Overall Study|Adverse Event|0|||
105822758|NCT03792477|365008831|FG002|Overall Study|Adverse Event|0|||
105822759|NCT03792477|365008832|FG003|Overall Study|Adverse Event|1|||
105364285|NCT03589807|363338516|FG003|Overall Study|Enrolled but treatment not administered|0|||
105364286|NCT03589807|363338517|FG004|Overall Study|Enrolled but treatment not administered|1|||
105364287|NCT03589807|363338518|FG005|Overall Study|Enrolled but treatment not administered|0|||
105364288|NCT00248651|363338522|FG000|Overall Study|Withdrawal by Subject|28|||
105364289|NCT00248651|363338523|FG001|Overall Study|Withdrawal by Subject|40|||
105364290|NCT00248651|363338524|FG002|Overall Study|Withdrawal by Subject|32|||
105364291|NCT01365130|363338527|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
105364292|NCT05607576|363338531|FG000|Overall Study|immediate sensor error|2|||
105822760|NCT03792477|365008833|FG004|Overall Study|Adverse Event|0|||
105822761|NCT03792477|365008829|FG000|Overall Study|Lost to Follow-up|0|||
105822762|NCT03792477|365008830|FG001|Overall Study|Lost to Follow-up|0|||
105364293|NCT05607576|363338531|FG000|Overall Study|Physician Decision|2|||
105364294|NCT01091246|363338539|FG000|Overall Study|Lost to Follow-up|23|||
105822763|NCT03792477|365008831|FG002|Overall Study|Lost to Follow-up|2|||
105822764|NCT03792477|365008832|FG003|Overall Study|Lost to Follow-up|0|||
105822765|NCT03792477|365008833|FG004|Overall Study|Lost to Follow-up|0|||
105822766|NCT03792477|365008829|FG000|Overall Study|Other|0|||
105822767|NCT03792477|365008830|FG001|Overall Study|Other|0|||
105822768|NCT03792477|365008831|FG002|Overall Study|Other|0|||
105822769|NCT03792477|365008832|FG003|Overall Study|Other|0|||
105822770|NCT03792477|365008833|FG004|Overall Study|Other|1|||
105822771|NCT00840411|365008834|FG000|First Intervention|Adverse Event|1|||
105822772|NCT00840411|365008835|FG001|First Intervention|Adverse Event|0|||
105822773|NCT00840411|365008834|FG000|Washout|Withdrawal by Subject|1|||
105822774|NCT00840411|365008835|FG001|Washout|Withdrawal by Subject|0|||
105822775|NCT03122457|365008836|FG000|Overall Study|Withdrawal by Subject|6|||
105822776|NCT01921062|365008837|FG000|Overall Study|Withdrawal by Subject|0|||
105822777|NCT01921062|365008838|FG001|Overall Study|Withdrawal by Subject|7|||
105822778|NCT01921062|365008837|FG000|Overall Study|Adverse Event|5|||
105822779|NCT01921062|365008838|FG001|Overall Study|Adverse Event|6|||
105822780|NCT01921062|365008837|FG000|Overall Study|Protocol Violation|0|||
105822781|NCT01921062|365008838|FG001|Overall Study|Protocol Violation|1|||
105822782|NCT01921062|365008837|FG000|Overall Study|VMIQ score > 72|4|||
105822783|NCT01921062|365008838|FG001|Overall Study|VMIQ score > 72|1|||
105822784|NCT01921062|365008837|FG000|Overall Study|Logistic error|0|||
105822785|NCT01921062|365008838|FG001|Overall Study|Logistic error|1|||
105822786|NCT01878292|365008839|FG000|Randomized|Protocol Violation|1|||
105822787|NCT01878292|365008840|FG001|Randomized|Protocol Violation|0|||
105822788|NCT01878292|365008841|FG002|Randomized|Protocol Violation|0|||
105822789|NCT01878292|365008839|FG000|Randomized|Lost to Follow-up|1|||
105822790|NCT01878292|365008840|FG001|Randomized|Lost to Follow-up|0|||
105822791|NCT01878292|365008841|FG002|Randomized|Lost to Follow-up|0|||
105822792|NCT01878292|365008839|FG000|Randomized|Adverse Event|1|||
105822793|NCT01878292|365008840|FG001|Randomized|Adverse Event|0|||
105822794|NCT01878292|365008841|FG002|Randomized|Adverse Event|0|||
105822795|NCT01878292|365008839|FG000|Double-blind Treatment Period|Other Reasons|2|||
105822796|NCT01878292|365008840|FG001|Double-blind Treatment Period|Other Reasons|0|||
105822797|NCT01878292|365008841|FG002|Double-blind Treatment Period|Other Reasons|0|||
105822798|NCT01878292|365008839|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
105822799|NCT01878292|365008840|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
105822800|NCT01878292|365008841|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
105822801|NCT01878292|365008839|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
105822802|NCT01878292|365008840|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
105822803|NCT01878292|365008841|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
105822804|NCT01878292|365008839|FG000|Double-blind Treatment Period|Protocol Violation|3|||
105822805|NCT01878292|365008840|FG001|Double-blind Treatment Period|Protocol Violation|4|||
105822806|NCT01878292|365008841|FG002|Double-blind Treatment Period|Protocol Violation|2|||
105822807|NCT01878292|365008839|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
105822808|NCT01878292|365008840|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
105822809|NCT01878292|365008841|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
105822810|NCT01878292|365008839|FG000|Double-blind Treatment Period|Adverse Event|4|||
105822811|NCT01878292|365008840|FG001|Double-blind Treatment Period|Adverse Event|9|||
105822812|NCT01878292|365008841|FG002|Double-blind Treatment Period|Adverse Event|8|||
105364295|NCT01091246|363338540|FG001|Overall Study|Lost to Follow-up|11|||
105364296|NCT01091246|363338541|FG002|Overall Study|Lost to Follow-up|7|||
105364297|NCT01091246|363338539|FG000|Overall Study|Adverse Event|1|||
105364298|NCT01091246|363338540|FG001|Overall Study|Adverse Event|0|||
105364299|NCT01091246|363338541|FG002|Overall Study|Adverse Event|1|||
105364300|NCT01091246|363338539|FG000|Overall Study|Withdrawal by Subject|9|||
105364301|NCT01091246|363338540|FG001|Overall Study|Withdrawal by Subject|5|||
105364302|NCT01091246|363338541|FG002|Overall Study|Withdrawal by Subject|4|||
105364303|NCT01091246|363338539|FG000|Overall Study|Subject not dosed|2|||
105364304|NCT01091246|363338540|FG001|Overall Study|Subject not dosed|0|||
105364305|NCT01091246|363338541|FG002|Overall Study|Subject not dosed|1|||
105364306|NCT02573259|363338547|FG000|Overall Study|Death|1|||
105364307|NCT02573259|363338548|FG001|Overall Study|Death|6|||
105364308|NCT02573259|363338549|FG002|Overall Study|Death|5|||
105364309|NCT02573259|363338550|FG003|Overall Study|Death|6|||
105486565|NCT02129777|363793360|FG006|Open-Label Period|Withdrawal by Subject|3|||
105486566|NCT02129777|363793354|FG000|Open-Label Period|Study Termination|0|||
105486567|NCT02129777|363793355|FG001|Open-Label Period|Study Termination|0|||
105486568|NCT02129777|363793356|FG002|Open-Label Period|Study Termination|0|||
105486569|NCT02129777|363793357|FG003|Open-Label Period|Study Termination|0|||
105822813|NCT01878292|365008839|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
105822814|NCT01878292|365008840|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
105822815|NCT01878292|365008841|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
105822816|NCT00773253|365008842|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
105822817|NCT00773253|365008843|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
105364310|NCT02573259|363338551|FG004|Overall Study|Death|9|||
105364311|NCT02573259|363338552|FG005|Overall Study|Death|32|||
105486570|NCT02129777|363793358|FG004|Open-Label Period|Study Termination|0|||
105822818|NCT00323882|365008844|FG000|Overall Study|Adverse Event|2|||
105822819|NCT00323882|365008845|FG001|Overall Study|Adverse Event|1|||
105822820|NCT00323882|365008846|FG002|Overall Study|Adverse Event|1|||
105822821|NCT00323882|365008847|FG003|Overall Study|Adverse Event|1|||
105822822|NCT00323882|365008848|FG004|Overall Study|Adverse Event|3|||
105364312|NCT02573259|363338553|FG006|Overall Study|Death|21|||
105364313|NCT02573259|363338547|FG000|Overall Study|Lost to Follow-up|0|||
105364314|NCT02573259|363338548|FG001|Overall Study|Lost to Follow-up|0|||
105486571|NCT02129777|363793359|FG005|Open-Label Period|Study Termination|10|||
105364315|NCT02573259|363338549|FG002|Overall Study|Lost to Follow-up|0|||
105364316|NCT02573259|363338550|FG003|Overall Study|Lost to Follow-up|0|||
105767063|NCT02371980|364800366|FG000|Double-blind Period|Significant Protocol Deviation|0|||
105767064|NCT02371980|364800367|FG001|Double-blind Period|Significant Protocol Deviation|2|||
105767065|NCT02371980|364800368|FG002|Double-blind Period|Significant Protocol Deviation|7|||
105767066|NCT02371980|364800369|FG003|Double-blind Period|Significant Protocol Deviation|3|||
105767067|NCT02371980|364800370|FG004|Double-blind Period|Significant Protocol Deviation|3|||
105767068|NCT02371980|364800366|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
105767069|NCT02371980|364800367|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
105767070|NCT02371980|364800368|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
105767071|NCT02371980|364800369|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
105767072|NCT02371980|364800370|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
105767073|NCT02371980|364800366|FG000|Double-blind Period|Lost to Follow-up|0|||
105767074|NCT02371980|364800367|FG001|Double-blind Period|Lost to Follow-up|8|||
105767075|NCT02371980|364800368|FG002|Double-blind Period|Lost to Follow-up|8|||
105767076|NCT02371980|364800369|FG003|Double-blind Period|Lost to Follow-up|6|||
105767077|NCT02371980|364800370|FG004|Double-blind Period|Lost to Follow-up|5|||
105767078|NCT02371980|364800366|FG000|Double-blind Period|Voluntary Withdrawal|0|||
105767079|NCT02371980|364800367|FG001|Double-blind Period|Voluntary Withdrawal|12|||
105767080|NCT02371980|364800368|FG002|Double-blind Period|Voluntary Withdrawal|8|||
105767081|NCT02371980|364800369|FG003|Double-blind Period|Voluntary Withdrawal|9|||
105767082|NCT02371980|364800370|FG004|Double-blind Period|Voluntary Withdrawal|11|||
105767083|NCT02371980|364800366|FG000|Double-blind Period|Relapse|0|||
105767084|NCT02371980|364800367|FG001|Double-blind Period|Relapse|50|||
105767085|NCT02371980|364800368|FG002|Double-blind Period|Relapse|25|||
105767086|NCT02371980|364800369|FG003|Double-blind Period|Relapse|25|||
105767087|NCT02371980|364800370|FG004|Double-blind Period|Relapse|26|||
105767088|NCT02371980|364800366|FG000|Double-blind Period|Reason not Specified|0|||
105767089|NCT02371980|364800367|FG001|Double-blind Period|Reason not Specified|3|||
105767090|NCT02371980|364800368|FG002|Double-blind Period|Reason not Specified|3|||
105767091|NCT02371980|364800369|FG003|Double-blind Period|Reason not Specified|2|||
105767092|NCT02371980|364800370|FG004|Double-blind Period|Reason not Specified|1|||
105767093|NCT02371980|364800366|FG000|Double-blind Period|Missing|0|||
105767094|NCT02371980|364800367|FG001|Double-blind Period|Missing|1|||
105767095|NCT02371980|364800368|FG002|Double-blind Period|Missing|0|||
105767096|NCT02371980|364800369|FG003|Double-blind Period|Missing|0|||
105767097|NCT02371980|364800370|FG004|Double-blind Period|Missing|0|||
105767098|NCT05569421|364800377|FG000|Overall Study|Withdrawal by Subject|1|||
105767099|NCT05569421|364800378|FG001|Overall Study|Withdrawal by Subject|0|||
105767100|NCT05569421|364800379|FG002|Overall Study|Withdrawal by Subject|0|||
105767101|NCT02158728|364800380|FG000|Overall Study|no procedure according to CIP done|3|||
105822823|NCT00323882|365008844|FG000|Overall Study|Disease Progression|6|||
105571714|NCT02948959|364092748|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
105767102|NCT02158728|364800380|FG000|Overall Study|no qualified dataset|24|||
105364317|NCT02573259|363338551|FG004|Overall Study|Lost to Follow-up|0|||
105767103|NCT00524043|364800381|FG000|Overall Study|Lack of Efficacy|15|||
105364318|NCT02573259|363338552|FG005|Overall Study|Lost to Follow-up|2|||
105364319|NCT02573259|363338553|FG006|Overall Study|Lost to Follow-up|1|||
105364320|NCT02573259|363338547|FG000|Overall Study|Participant refused further follow-up|0|||
105364321|NCT02573259|363338548|FG001|Overall Study|Participant refused further follow-up|2|||
105364322|NCT02573259|363338549|FG002|Overall Study|Participant refused further follow-up|1|||
105364323|NCT02573259|363338550|FG003|Overall Study|Participant refused further follow-up|0|||
105364324|NCT02573259|363338551|FG004|Overall Study|Participant refused further follow-up|3|||
105364325|NCT02573259|363338552|FG005|Overall Study|Participant refused further follow-up|20|||
105364326|NCT02573259|363338553|FG006|Overall Study|Participant refused further follow-up|7|||
105364327|NCT02573259|363338547|FG000|Overall Study|Other|0|||
105364328|NCT02573259|363338548|FG001|Overall Study|Other|0|||
105364329|NCT02573259|363338549|FG002|Overall Study|Other|0|||
105364330|NCT02573259|363338550|FG003|Overall Study|Other|0|||
105364331|NCT02573259|363338551|FG004|Overall Study|Other|1|||
105364332|NCT02573259|363338552|FG005|Overall Study|Other|4|||
105364333|NCT02573259|363338553|FG006|Overall Study|Other|5|||
105364334|NCT00751140|363338554|FG000|Overall Study|benign angioma excluded from analysis|1|||
105364335|NCT02667301|363338555|FG000|Overall Study|Adverse Event|1|||
105364336|NCT02667301|363338555|FG000|Overall Study|Lack of Efficacy|1|||
105364337|NCT03528551|363338559|FG000|Overall Study|Lost to Follow-up|0|||
105364338|NCT03528551|363338560|FG001|Overall Study|Lost to Follow-up|1|||
105364339|NCT03528551|363338561|FG002|Overall Study|Lost to Follow-up|0|||
105364340|NCT03528551|363338559|FG000|Overall Study|Transferred to other arm/group|2|||
105364341|NCT03528551|363338560|FG001|Overall Study|Transferred to other arm/group|3|||
105364342|NCT03528551|363338561|FG002|Overall Study|Transferred to other arm/group|0|||
105364343|NCT03528551|363338559|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105364344|NCT03528551|363338560|FG001|Overall Study|Withdrawal by parent/guardian|5|||
105364345|NCT03528551|363338561|FG002|Overall Study|Withdrawal by parent/guardian|0|||
105364346|NCT03528551|363338559|FG000|Overall Study|Protocol Violation|0|||
105364347|NCT03528551|363338560|FG001|Overall Study|Protocol Violation|3|||
105571715|NCT02948959|364092749|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
105571716|NCT02948959|364092748|FG000|52 Weeks Treatment Period|Adverse Event|2|||
105571717|NCT02948959|364092749|FG001|52 Weeks Treatment Period|Adverse Event|5|||
105571718|NCT02948959|364092748|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
105767104|NCT00524043|364800382|FG001|Overall Study|Lack of Efficacy|13|||
105767105|NCT00524043|364800383|FG002|Overall Study|Lack of Efficacy|14|||
105767106|NCT00524043|364800381|FG000|Overall Study|Withdrawal by Subject|5|||
105767107|NCT00524043|364800382|FG001|Overall Study|Withdrawal by Subject|7|||
105767108|NCT00524043|364800383|FG002|Overall Study|Withdrawal by Subject|7|||
105767109|NCT00524043|364800381|FG000|Overall Study|Adverse Event|5|||
105767110|NCT00524043|364800382|FG001|Overall Study|Adverse Event|2|||
105767111|NCT00524043|364800383|FG002|Overall Study|Adverse Event|7|||
105767112|NCT00524043|364800381|FG000|Overall Study|Lost to Follow-up|3|||
105767113|NCT00524043|364800382|FG001|Overall Study|Lost to Follow-up|5|||
105767114|NCT00524043|364800383|FG002|Overall Study|Lost to Follow-up|3|||
105767115|NCT00524043|364800381|FG000|Overall Study|Various (eg, incarceration)|2|||
105767116|NCT00524043|364800382|FG001|Overall Study|Various (eg, incarceration)|1|||
105767117|NCT00524043|364800383|FG002|Overall Study|Various (eg, incarceration)|0|||
105767118|NCT03933215|364800397|FG000|Overall Study|Other|6|||
105767119|NCT03933215|364800397|FG000|Overall Study|Sponsor decision|5|||
105767120|NCT03933215|364800397|FG000|Overall Study|Protocol Violation|5|||
105767121|NCT03933215|364800397|FG000|Overall Study|Withdrawal by Subject|6|||
105767122|NCT03933215|364800397|FG000|Overall Study|Lost to Follow-up|6|||
105767123|NCT03933215|364800397|FG000|Overall Study|Enrolled but not treated|38|||
105767124|NCT04222673|364800398|FG000|Overall Study|Lost to Follow-up|5|||
105767125|NCT04097028|364800399|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
105767126|NCT04097028|364800399|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
105767127|NCT04097028|364800399|FG000|Overall Study|Disease Progression prior to Surgery|2|||
105767128|NCT04097028|364800399|FG000|Overall Study|Adverse Event prior to Surgery|1|||
105767129|NCT04072575|364800400|FG000|Overall Study|Physician Decision|1|||
105767130|NCT04072575|364800400|FG000|Overall Study|Adverse Event|7|||
105767131|NCT04072575|364800400|FG000|Overall Study|Withdrawal by Subject|14|||
105767132|NCT04072575|364800400|FG000|Overall Study|Other|2|||
105767133|NCT02244619|364800401|FG000|Overall Study|Did not receive study intervention|8|||
105767134|NCT02244619|364800402|FG001|Overall Study|Did not receive study intervention|21|||
105767135|NCT03285490|364800403|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
105767136|NCT03285490|364800404|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
105767137|NCT03285490|364800403|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
105364348|NCT03528551|363338561|FG002|Overall Study|Protocol Violation|0|||
105364349|NCT03528551|363338559|FG000|Overall Study|Withdrawal by Subject|0|||
105364350|NCT03528551|363338560|FG001|Overall Study|Withdrawal by Subject|7|||
105571719|NCT02948959|364092749|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
105767138|NCT03285490|364800404|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
105364351|NCT03528551|363338561|FG002|Overall Study|Withdrawal by Subject|0|||
105364352|NCT00808067|363338562|FG000|Overall Study|Major/minor bleed|30|||
105364353|NCT00808067|363338563|FG001|Overall Study|Major/minor bleed|44|||
105364354|NCT00808067|363338562|FG000|Overall Study|Outcome event - other|33|||
105364355|NCT00808067|363338563|FG001|Overall Study|Outcome event - other|25|||
105364356|NCT00808067|363338562|FG000|Overall Study|Adverse Event|111|||
105364357|NCT00808067|363338563|FG001|Overall Study|Adverse Event|121|||
105364358|NCT00808067|363338562|FG000|Overall Study|Hospitalization (not including surgery)|18|||
105364359|NCT00808067|363338563|FG001|Overall Study|Hospitalization (not including surgery)|17|||
105364360|NCT00808067|363338562|FG000|Overall Study|Hospitalization due to surgery|37|||
105364361|NCT00808067|363338563|FG001|Overall Study|Hospitalization due to surgery|40|||
105364362|NCT00808067|363338562|FG000|Overall Study|Reduced creatinine clearance|53|||
105571720|NCT02948959|364092748|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
105571721|NCT02948959|364092749|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
105571722|NCT02948959|364092748|FG000|52 Weeks Treatment Period|Randomized by error|0|||
105571723|NCT02948959|364092749|FG001|52 Weeks Treatment Period|Randomized by error|5|||
105571724|NCT02948959|364092748|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
105571725|NCT02948959|364092749|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
105767139|NCT03745989|364800405|FG000|Overall Study|Death|3|||
105767140|NCT03745989|364800406|FG001|Overall Study|Death|7|||
105767141|NCT03745989|364800407|FG002|Overall Study|Death|4|||
105767142|NCT03745989|364800405|FG000|Overall Study|Lost to Follow-up|0|||
105767143|NCT03745989|364800406|FG001|Overall Study|Lost to Follow-up|2|||
105767144|NCT03745989|364800407|FG002|Overall Study|Lost to Follow-up|0|||
105767145|NCT03745989|364800405|FG000|Overall Study|Sponsor Decision|0|||
105767146|NCT03745989|364800406|FG001|Overall Study|Sponsor Decision|2|||
105767147|NCT03745989|364800407|FG002|Overall Study|Sponsor Decision|8|||
105767148|NCT03745989|364800405|FG000|Overall Study|Withdrawal by Subject|0|||
105767149|NCT03745989|364800406|FG001|Overall Study|Withdrawal by Subject|1|||
105767150|NCT03745989|364800407|FG002|Overall Study|Withdrawal by Subject|3|||
105767151|NCT02728206|364800408|FG000|Overall Study|Death|1|||
105767152|NCT02773368|364800412|FG000|Overall Study|Lost to Follow-up|4|||
105767153|NCT02773368|364800413|FG001|Overall Study|Lost to Follow-up|1|||
105767154|NCT02773368|364800412|FG000|Overall Study|Withdrawal by Subject|5|||
105767155|NCT02773368|364800413|FG001|Overall Study|Withdrawal by Subject|1|||
105767156|NCT02773368|364800412|FG000|Overall Study|Unclassified|1|||
105767157|NCT02773368|364800413|FG001|Overall Study|Unclassified|1|||
105767158|NCT02773368|364800412|FG000|Overall Study|Missing|0|||
105767159|NCT02773368|364800413|FG001|Overall Study|Missing|1|||
105767160|NCT01366534|364800415|FG000|Overall Study|Lost to Follow-up|1|||
105767161|NCT01366534|364800416|FG001|Overall Study|Lost to Follow-up|0|||
105767162|NCT01366534|364800417|FG002|Overall Study|Lost to Follow-up|0|||
105767163|NCT01366534|364800415|FG000|Overall Study|Migrated|1|||
105767164|NCT01366534|364800416|FG001|Overall Study|Migrated|1|||
105767165|NCT01366534|364800417|FG002|Overall Study|Migrated|0|||
105767166|NCT01366534|364800415|FG000|Overall Study|Declined challenged|0|||
105767167|NCT01366534|364800416|FG001|Overall Study|Declined challenged|1|||
105767168|NCT01366534|364800417|FG002|Overall Study|Declined challenged|0|||
105767169|NCT01929018|364800418|FG000|Overall Study|Lost to Follow-up|1|||
105767170|NCT01929018|364800419|FG001|Overall Study|Lost to Follow-up|0|||
105767171|NCT01929018|364800418|FG000|Overall Study|Hospitalization|0|||
105767172|NCT01929018|364800419|FG001|Overall Study|Hospitalization|1|||
105767173|NCT01047436|364800421|FG000|Overall Study|Protocol Violation|1|||
105767174|NCT01047436|364800422|FG001|Overall Study|Protocol Violation|0|||
105767175|NCT01678313|364800426|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
105767176|NCT01678313|364800427|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
105767177|NCT01678313|364800426|FG000|Completed the 3-month Therapy|Physician Decision|3|||
105767178|NCT01678313|364800427|FG001|Completed the 3-month Therapy|Physician Decision|4|||
105767179|NCT01678313|364800426|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
105767180|NCT01678313|364800427|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
105767181|NCT01678313|364800426|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
105767182|NCT01678313|364800427|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
105767183|NCT02635867|364800429|FG000|Overall Study|Lost to Follow-up|4|||
105767184|NCT02635867|364800430|FG001|Overall Study|Lost to Follow-up|3|||
105767185|NCT02635867|364800431|FG002|Overall Study|Lost to Follow-up|3|||
105767186|NCT02635867|364800432|FG003|Overall Study|Lost to Follow-up|4|||
105767187|NCT02635867|364800433|FG004|Overall Study|Lost to Follow-up|1|||
105767188|NCT02565576|364800434|FG000|Overall Study|abnormal lab value|2|||
105767189|NCT02565576|364800435|FG001|Overall Study|abnormal lab value|0|||
105364363|NCT00808067|363338563|FG001|Overall Study|Reduced creatinine clearance|55|||
105364364|NCT00808067|363338562|FG000|Overall Study|Elevated LFT results|7|||
105767190|NCT02565576|364800434|FG000|Overall Study|subject / guardian decision|1|||
105767191|NCT02565576|364800435|FG001|Overall Study|subject / guardian decision|3|||
105767192|NCT02565576|364800434|FG000|Overall Study|Lost to Follow-up|1|||
105767193|NCT02565576|364800435|FG001|Overall Study|Lost to Follow-up|0|||
105767194|NCT02565576|364800434|FG000|Overall Study|Death|0|||
105767195|NCT02565576|364800435|FG001|Overall Study|Death|2|||
105767196|NCT02565576|364800434|FG000|Overall Study|Adverse Event|1|||
105767197|NCT02565576|364800435|FG001|Overall Study|Adverse Event|0|||
105822824|NCT00323882|365008845|FG001|Overall Study|Disease Progression|4|||
105822825|NCT00323882|365008846|FG002|Overall Study|Disease Progression|10|||
105822826|NCT00323882|365008847|FG003|Overall Study|Disease Progression|5|||
105822827|NCT00323882|365008848|FG004|Overall Study|Disease Progression|22|||
105822828|NCT00323882|365008844|FG000|Overall Study|Death|0|||
105822829|NCT00323882|365008845|FG001|Overall Study|Death|1|||
105822830|NCT00323882|365008846|FG002|Overall Study|Death|1|||
105822831|NCT00323882|365008847|FG003|Overall Study|Death|0|||
105822832|NCT00323882|365008848|FG004|Overall Study|Death|5|||
105822833|NCT00323882|365008844|FG000|Overall Study|Lost to Follow-up|0|||
105822834|NCT00323882|365008845|FG001|Overall Study|Lost to Follow-up|0|||
105822835|NCT00323882|365008846|FG002|Overall Study|Lost to Follow-up|1|||
105822836|NCT00323882|365008847|FG003|Overall Study|Lost to Follow-up|0|||
105822837|NCT00323882|365008848|FG004|Overall Study|Lost to Follow-up|1|||
105822838|NCT00323882|365008844|FG000|Overall Study|Other|0|||
105822839|NCT00323882|365008845|FG001|Overall Study|Other|0|||
105822840|NCT00323882|365008846|FG002|Overall Study|Other|0|||
105767198|NCT00424099|364800436|FG000|Overall Study|Adverse Event|0|||
105767199|NCT00424099|364800437|FG001|Overall Study|Adverse Event|1|||
105767200|NCT00424099|364800438|FG002|Overall Study|Adverse Event|1|||
105767201|NCT00424099|364800439|FG003|Overall Study|Adverse Event|0|||
105767202|NCT00424099|364800436|FG000|Overall Study|Death|0|||
105767203|NCT00424099|364800437|FG001|Overall Study|Death|1|||
105767204|NCT00424099|364800438|FG002|Overall Study|Death|0|||
105767205|NCT00424099|364800439|FG003|Overall Study|Death|0|||
105767206|NCT00424099|364800436|FG000|Overall Study|Illness|2|||
105767207|NCT00424099|364800437|FG001|Overall Study|Illness|0|||
105767208|NCT00424099|364800438|FG002|Overall Study|Illness|1|||
105767209|NCT00424099|364800439|FG003|Overall Study|Illness|4|||
105767210|NCT00424099|364800436|FG000|Overall Study|Lost to Follow-up|0|||
105767211|NCT00424099|364800437|FG001|Overall Study|Lost to Follow-up|0|||
105767212|NCT00424099|364800438|FG002|Overall Study|Lost to Follow-up|3|||
105767213|NCT00424099|364800439|FG003|Overall Study|Lost to Follow-up|0|||
105767214|NCT00424099|364800436|FG000|Overall Study|Hospitalized|1|||
105767215|NCT00424099|364800437|FG001|Overall Study|Hospitalized|2|||
105767216|NCT00424099|364800438|FG002|Overall Study|Hospitalized|1|||
105767217|NCT00424099|364800439|FG003|Overall Study|Hospitalized|3|||
105767218|NCT00424099|364800436|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
105767219|NCT00424099|364800437|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
105767220|NCT00424099|364800438|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
105767221|NCT00424099|364800439|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
105767222|NCT00424099|364800436|FG000|Overall Study|Withdrawal by Subject|1|||
105767223|NCT00424099|364800437|FG001|Overall Study|Withdrawal by Subject|9|||
105767224|NCT00424099|364800438|FG002|Overall Study|Withdrawal by Subject|4|||
105767225|NCT00424099|364800439|FG003|Overall Study|Withdrawal by Subject|6|||
105767226|NCT00424099|364800436|FG000|Overall Study|Physician Decision|0|||
105767227|NCT00424099|364800437|FG001|Overall Study|Physician Decision|0|||
105767228|NCT00424099|364800438|FG002|Overall Study|Physician Decision|1|||
105767229|NCT00424099|364800439|FG003|Overall Study|Physician Decision|0|||
105767230|NCT00424099|364800436|FG000|Overall Study|Missing|0|||
105767231|NCT00424099|364800437|FG001|Overall Study|Missing|0|||
105767232|NCT00424099|364800438|FG002|Overall Study|Missing|1|||
105767233|NCT00424099|364800439|FG003|Overall Study|Missing|0|||
105767234|NCT00796003|364800440|FG000|Overall Study|Disease Progression|2|||
105767235|NCT00796003|364800441|FG001|Overall Study|Disease Progression|13|||
105767236|NCT00796003|364800440|FG000|Overall Study|Adverse Event|1|||
105767237|NCT00796003|364800441|FG001|Overall Study|Adverse Event|7|||
105767238|NCT00796003|364800440|FG000|Overall Study|Specified organ function not met|0|||
105822841|NCT00323882|365008847|FG003|Overall Study|Other|1|||
105767239|NCT00796003|364800441|FG001|Overall Study|Specified organ function not met|1|||
105767240|NCT00796003|364800440|FG000|Overall Study|Physician Decision|0|||
105767241|NCT00796003|364800441|FG001|Overall Study|Physician Decision|4|||
105767242|NCT00796003|364800440|FG000|Overall Study|Withdrawal by Subject|0|||
105767243|NCT00796003|364800441|FG001|Overall Study|Withdrawal by Subject|1|||
105767244|NCT00796003|364800440|FG000|Overall Study|Other|0|||
105767245|NCT00796003|364800441|FG001|Overall Study|Other|1|||
105767246|NCT00796003|364800440|FG000|Overall Study|Participants Not treated|0|||
105822842|NCT00323882|365008848|FG004|Overall Study|Other|1|||
105822843|NCT00835536|365008849|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
105767247|NCT00796003|364800441|FG001|Overall Study|Participants Not treated|2|||
105822844|NCT00835536|365008850|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
105822845|NCT02911701|365008853|FG000|Overall Study|Withdrawal by Subject|2|||
105822846|NCT02911701|365008854|FG001|Overall Study|Withdrawal by Subject|4|||
105767248|NCT05179057|364800442|FG000|Overall Study|Adverse Event|3|||
105767249|NCT05179057|364800443|FG001|Overall Study|Adverse Event|2|||
105767250|NCT05179057|364800442|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
105767251|NCT05179057|364800443|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
105767252|NCT05179057|364800442|FG000|Overall Study|Study terminated|13|||
105822847|NCT02911701|365008853|FG000|Overall Study|Adverse Event|1|||
105364365|NCT00808067|363338563|FG001|Overall Study|Elevated LFT results|3|||
105364366|NCT00808067|363338562|FG000|Overall Study|Patient refused to take study medication|65|||
105364367|NCT00808067|363338563|FG001|Overall Study|Patient refused to take study medication|76|||
105364368|NCT00808067|363338562|FG000|Overall Study|Missing|1|||
105364369|NCT00808067|363338563|FG001|Overall Study|Missing|0|||
105364370|NCT00808067|363338562|FG000|Overall Study|Death|1|||
105364371|NCT00808067|363338563|FG001|Overall Study|Death|1|||
105364372|NCT00808067|363338562|FG000|Overall Study|Procedure|6|||
105364373|NCT00808067|363338563|FG001|Overall Study|Procedure|7|||
105364374|NCT00808067|363338562|FG000|Overall Study|Withdrawal by Subject|21|||
105364375|NCT00808067|363338563|FG001|Overall Study|Withdrawal by Subject|25|||
105364376|NCT00808067|363338562|FG000|Overall Study|Site closed|4|||
105364377|NCT00808067|363338563|FG001|Overall Study|Site closed|3|||
105364378|NCT00808067|363338562|FG000|Overall Study|Physician Decision|47|||
105364379|NCT00808067|363338563|FG001|Overall Study|Physician Decision|38|||
105364380|NCT00808067|363338562|FG000|Overall Study|Protocol Violation|3|||
105364381|NCT00808067|363338563|FG001|Overall Study|Protocol Violation|11|||
105364382|NCT00808067|363338562|FG000|Overall Study|Patient elected|7|||
105364383|NCT00808067|363338563|FG001|Overall Study|Patient elected|9|||
105364384|NCT00808067|363338562|FG000|Overall Study|Site closed for cause|19|||
105364385|NCT00808067|363338563|FG001|Overall Study|Site closed for cause|19|||
105364386|NCT00808067|363338562|FG000|Overall Study|Other reason not defined above|5|||
105364387|NCT00808067|363338563|FG001|Overall Study|Other reason not defined above|5|||
105364388|NCT00808067|363338562|FG000|Overall Study|Excluded from analysis|13|||
105364389|NCT00808067|363338563|FG001|Overall Study|Excluded from analysis|19|||
105364390|NCT02104895|363338564|FG000|Overall Study|Withdrawal by Subject|0|||
105364391|NCT02104895|363338565|FG001|Overall Study|Withdrawal by Subject|14|||
105364392|NCT04632225|363338566|FG000|Overall Study|Withdrawal by Subject|2|||
105364393|NCT04632225|363338567|FG001|Overall Study|Withdrawal by Subject|2|||
105364394|NCT00919633|363338568|FG000|Overall Study|Adverse Event|1|||
105364395|NCT00919633|363338569|FG001|Overall Study|Adverse Event|9|||
105364396|NCT00919633|363338570|FG002|Overall Study|Adverse Event|12|||
105364397|NCT00919633|363338571|FG003|Overall Study|Adverse Event|10|||
105364398|NCT00919633|363338568|FG000|Overall Study|Death|0|||
105364399|NCT00919633|363338569|FG001|Overall Study|Death|0|||
105364400|NCT00919633|363338570|FG002|Overall Study|Death|2|||
105364401|NCT00919633|363338571|FG003|Overall Study|Death|0|||
105364402|NCT00919633|363338568|FG000|Overall Study|Lack of Efficacy|17|||
105364403|NCT00919633|363338569|FG001|Overall Study|Lack of Efficacy|3|||
105364404|NCT00919633|363338570|FG002|Overall Study|Lack of Efficacy|2|||
105364405|NCT00919633|363338571|FG003|Overall Study|Lack of Efficacy|3|||
105364406|NCT00919633|363338568|FG000|Overall Study|Withdrawal by Subject|1|||
105364407|NCT00919633|363338569|FG001|Overall Study|Withdrawal by Subject|2|||
105364408|NCT00919633|363338570|FG002|Overall Study|Withdrawal by Subject|4|||
105364409|NCT00919633|363338571|FG003|Overall Study|Withdrawal by Subject|3|||
105364410|NCT00919633|363338568|FG000|Overall Study|Lost to Follow-up|3|||
105364411|NCT00919633|363338569|FG001|Overall Study|Lost to Follow-up|1|||
105364412|NCT00919633|363338570|FG002|Overall Study|Lost to Follow-up|0|||
105364413|NCT00919633|363338571|FG003|Overall Study|Lost to Follow-up|2|||
105364414|NCT00919633|363338568|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
105364415|NCT00919633|363338569|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
105364416|NCT00919633|363338570|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
105364417|NCT00919633|363338571|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
105364418|NCT00919633|363338568|FG000|Overall Study|Protocol Violation|0|||
105364419|NCT00919633|363338569|FG001|Overall Study|Protocol Violation|0|||
105364420|NCT00919633|363338570|FG002|Overall Study|Protocol Violation|0|||
105364421|NCT00919633|363338571|FG003|Overall Study|Protocol Violation|1|||
105364422|NCT00919633|363338568|FG000|Overall Study|Physician Decision|0|||
105364423|NCT00919633|363338569|FG001|Overall Study|Physician Decision|0|||
105364424|NCT00919633|363338570|FG002|Overall Study|Physician Decision|0|||
105364425|NCT00919633|363338571|FG003|Overall Study|Physician Decision|1|||
105364426|NCT00919633|363338568|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
105364427|NCT00919633|363338569|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
105364428|NCT00919633|363338570|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
105364429|NCT00919633|363338571|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
105364430|NCT00919633|363338568|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
105364431|NCT00919633|363338569|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
105364432|NCT00919633|363338570|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
105364433|NCT00919633|363338571|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
105364434|NCT00490919|363338572|FG000|Open-label Run-in Period|Adverse Event|239|||
105767253|NCT05179057|364800443|FG001|Overall Study|Study terminated|7|||
105364435|NCT00490919|363338573|FG001|Open-label Run-in Period|Adverse Event|0|||
105364436|NCT00490919|363338574|FG002|Open-label Run-in Period|Adverse Event|0|||
105364437|NCT00490919|363338572|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
105364438|NCT00490919|363338573|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
105364439|NCT00490919|363338574|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
105822848|NCT02911701|365008854|FG001|Overall Study|Adverse Event|0|||
105767254|NCT05179057|364800442|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
105767255|NCT05179057|364800443|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
105767256|NCT05179057|364800442|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
105767257|NCT05179057|364800443|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
105767258|NCT02417064|364800444|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
105767259|NCT02417064|364800445|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
105767260|NCT02417064|364800446|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
105767261|NCT02417064|364800444|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
105767262|NCT02417064|364800445|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
105767263|NCT02417064|364800446|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
105767264|NCT02417064|364800444|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
105767265|NCT02417064|364800445|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
105767266|NCT02417064|364800446|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
105767267|NCT02417064|364800444|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
105767268|NCT02417064|364800445|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
105767269|NCT02417064|364800446|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
105767270|NCT02417064|364800444|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
105767271|NCT02417064|364800445|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
105767272|NCT02417064|364800446|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
105767273|NCT02417064|364800444|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
105767274|NCT02417064|364800445|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
105364440|NCT00490919|363338572|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
105364441|NCT00490919|363338573|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
105364442|NCT00490919|363338574|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
105364443|NCT00490919|363338572|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
105364444|NCT00490919|363338573|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
105364445|NCT00490919|363338574|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
105364446|NCT00490919|363338572|FG000|Open-label Run-in Period|Administrative|40|||
105364447|NCT00490919|363338573|FG001|Open-label Run-in Period|Administrative|0|||
105364448|NCT00490919|363338574|FG002|Open-label Run-in Period|Administrative|0|||
105364449|NCT00490919|363338572|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
105364450|NCT00490919|363338573|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
105364451|NCT00490919|363338574|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
105364452|NCT00490919|363338572|FG000|Double-blind Phase|Adverse Event|0|||
105364453|NCT00490919|363338573|FG001|Double-blind Phase|Adverse Event|40|||
105486572|NCT02129777|363793360|FG006|Open-Label Period|Study Termination|39|||
105486573|NCT02376829|363793363|FG000|Overall Study|Withdrawal by Subject|27|||
105486574|NCT02376829|363793364|FG001|Overall Study|Withdrawal by Subject|44|||
105486575|NCT01439347|363793365|FG000|Overall Study|Death|10|||
105486576|NCT01439347|363793366|FG001|Overall Study|Death|9|||
105486577|NCT01439347|363793365|FG000|Overall Study|Withdrawal by Subject|0|||
105486578|NCT01439347|363793366|FG001|Overall Study|Withdrawal by Subject|1|||
105486579|NCT01439347|363793365|FG000|Overall Study|Physician Decision|1|||
105486580|NCT01439347|363793366|FG001|Overall Study|Physician Decision|0|||
105486581|NCT01439347|363793365|FG000|Overall Study|Sponsor Terminated Study|2|||
105486582|NCT01439347|363793366|FG001|Overall Study|Sponsor Terminated Study|3|||
105486583|NCT01582854|363793370|FG000|Overall Study|Death|8|||
105486584|NCT01582854|363793371|FG001|Overall Study|Death|5|||
105486585|NCT01582854|363793370|FG000|Overall Study|Adverse Event|2|||
105486586|NCT01582854|363793371|FG001|Overall Study|Adverse Event|3|||
105486587|NCT01582854|363793370|FG000|Overall Study|Withdrawal by Participant|8|||
105486588|NCT01582854|363793371|FG001|Overall Study|Withdrawal by Participant|11|||
105486589|NCT01582854|363793370|FG000|Overall Study|Lost to Follow-up|1|||
105486590|NCT01582854|363793371|FG001|Overall Study|Lost to Follow-up|2|||
105486591|NCT01582854|363793370|FG000|Overall Study|Physician Decision|0|||
105486592|NCT01582854|363793371|FG001|Overall Study|Physician Decision|1|||
105486593|NCT01582854|363793370|FG000|Overall Study|Recurrent Stroke|13|||
105486594|NCT01582854|363793371|FG001|Overall Study|Recurrent Stroke|8|||
105486595|NCT01582854|363793370|FG000|Overall Study|Disallowed Concomitant Medication|3|||
105486596|NCT01582854|363793371|FG001|Overall Study|Disallowed Concomitant Medication|2|||
105486597|NCT01582854|363793370|FG000|Overall Study|Carotid or Neurosurgery|0|||
105486598|NCT01582854|363793371|FG001|Overall Study|Carotid or Neurosurgery|1|||
105486599|NCT01582854|363793370|FG000|Overall Study|General Anaesthesia|0|||
105486600|NCT01582854|363793371|FG001|Overall Study|General Anaesthesia|1|||
105364454|NCT00490919|363338574|FG002|Double-blind Phase|Adverse Event|20|||
105364455|NCT00490919|363338572|FG000|Double-blind Phase|Withdrawal by Subject|0|||
105364456|NCT00490919|363338573|FG001|Double-blind Phase|Withdrawal by Subject|10|||
105364457|NCT00490919|363338574|FG002|Double-blind Phase|Withdrawal by Subject|11|||
105364458|NCT00490919|363338572|FG000|Double-blind Phase|Lost to Follow-up|0|||
105486601|NCT01582854|363793370|FG000|Overall Study|Other Miscellaneous Reason|1|||
105486602|NCT01582854|363793371|FG001|Overall Study|Other Miscellaneous Reason|0|||
105486603|NCT04068896|363793372|FG000|Overall Study|Adverse Event|2|||
105486604|NCT04068896|363793373|FG001|Overall Study|Adverse Event|0|||
105486605|NCT04068896|363793374|FG002|Overall Study|Adverse Event|1|||
105486606|NCT04068896|363793375|FG003|Overall Study|Adverse Event|0|||
105486607|NCT04068896|363793376|FG004|Overall Study|Adverse Event|0|||
105486608|NCT04068896|363793377|FG005|Overall Study|Adverse Event|0|||
105486609|NCT04068896|363793372|FG000|Overall Study|Death|3|||
105486610|NCT04068896|363793373|FG001|Overall Study|Death|1|||
105486611|NCT04068896|363793374|FG002|Overall Study|Death|3|||
105486612|NCT04068896|363793375|FG003|Overall Study|Death|19|||
105486613|NCT04068896|363793376|FG004|Overall Study|Death|17|||
105364459|NCT00490919|363338573|FG001|Double-blind Phase|Lost to Follow-up|8|||
105364460|NCT00490919|363338574|FG002|Double-blind Phase|Lost to Follow-up|11|||
105364461|NCT00490919|363338572|FG000|Double-blind Phase|Lack of Efficacy|0|||
105364462|NCT00490919|363338573|FG001|Double-blind Phase|Lack of Efficacy|22|||
105364463|NCT00490919|363338574|FG002|Double-blind Phase|Lack of Efficacy|36|||
105364464|NCT00490919|363338572|FG000|Double-blind Phase|Administrative|0|||
105364465|NCT00490919|363338573|FG001|Double-blind Phase|Administrative|6|||
105364466|NCT00490919|363338574|FG002|Double-blind Phase|Administrative|6|||
105364467|NCT00419757|363340293|FG000|Overall Study|Adverse Event|1|||
105364468|NCT00419757|363340294|FG001|Overall Study|Adverse Event|4|||
105364469|NCT00419757|363340293|FG000|Overall Study|Lost to Follow-up|1|||
105364470|NCT00419757|363340294|FG001|Overall Study|Lost to Follow-up|4|||
105364471|NCT00419757|363340293|FG000|Overall Study|Withdrawal by Subject|7|||
105364472|NCT00419757|363340294|FG001|Overall Study|Withdrawal by Subject|1|||
105364473|NCT00419757|363340293|FG000|Overall Study|Protocol Violation|2|||
105364474|NCT00419757|363340294|FG001|Overall Study|Protocol Violation|3|||
105364475|NCT00419757|363340293|FG000|Overall Study|Study specific discontinuation criteria|4|||
105364476|NCT00419757|363340294|FG001|Overall Study|Study specific discontinuation criteria|8|||
105364477|NCT00419757|363340293|FG000|Overall Study|Multiple reasons|3|||
105364478|NCT00419757|363340294|FG001|Overall Study|Multiple reasons|1|||
105364479|NCT01298700|363340302|FG000|Overall Study|Adverse Event|50|||
105364480|NCT01298700|363340303|FG001|Overall Study|Adverse Event|51|||
105364481|NCT01298700|363340302|FG000|Overall Study|Lack of Efficacy|9|||
105364482|NCT01298700|363340303|FG001|Overall Study|Lack of Efficacy|14|||
105364483|NCT01298700|363340302|FG000|Overall Study|Lost to Follow-up|5|||
105364484|NCT01298700|363340303|FG001|Overall Study|Lost to Follow-up|2|||
105364485|NCT01298700|363340302|FG000|Overall Study|Withdrawal by Subject|12|||
105364486|NCT01298700|363340303|FG001|Overall Study|Withdrawal by Subject|9|||
105364487|NCT01298700|363340302|FG000|Overall Study|Protocol Violation|6|||
105364488|NCT01298700|363340303|FG001|Overall Study|Protocol Violation|4|||
105364489|NCT01298700|363340302|FG000|Overall Study|Other Miscellaneous Reasons|16|||
105364490|NCT01298700|363340303|FG001|Overall Study|Other Miscellaneous Reasons|15|||
105364491|NCT01298700|363340302|FG000|Overall Study|Did not Receive Study Drug|3|||
105364492|NCT01298700|363340303|FG001|Overall Study|Did not Receive Study Drug|5|||
105364493|NCT00956839|363340306|FG000|Overall Study|Lost to Follow-up|3|||
105364494|NCT00956839|363340307|FG001|Overall Study|Lost to Follow-up|0|||
105364495|NCT00956839|363340308|FG002|Overall Study|Lost to Follow-up|3|||
105364496|NCT03934216|363340309|FG000|Overall Study|Other Reasons|5|||
105364497|NCT03934216|363340310|FG001|Overall Study|Other Reasons|5|||
105364498|NCT03934216|363340309|FG000|Overall Study|Adverse Event|22|||
105364499|NCT03934216|363340310|FG001|Overall Study|Adverse Event|11|||
105364500|NCT03934216|363340309|FG000|Overall Study|Lack of Efficacy|8|||
105364501|NCT03934216|363340310|FG001|Overall Study|Lack of Efficacy|7|||
105364502|NCT03934216|363340309|FG000|Overall Study|Lost to Follow-up|2|||
105364503|NCT03934216|363340310|FG001|Overall Study|Lost to Follow-up|0|||
105364504|NCT03934216|363340309|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105486614|NCT04068896|363793377|FG005|Overall Study|Death|0|||
105486615|NCT04068896|363793372|FG000|Overall Study|Physician Decision|0|||
105486616|NCT04068896|363793373|FG001|Overall Study|Physician Decision|0|||
105486617|NCT04068896|363793374|FG002|Overall Study|Physician Decision|0|||
105486618|NCT04068896|363793375|FG003|Overall Study|Physician Decision|1|||
105486619|NCT04068896|363793376|FG004|Overall Study|Physician Decision|0|||
105486620|NCT04068896|363793377|FG005|Overall Study|Physician Decision|0|||
105486621|NCT04068896|363793372|FG000|Overall Study|progressive disease|3|||
105486622|NCT04068896|363793373|FG001|Overall Study|progressive disease|5|||
105486623|NCT04068896|363793374|FG002|Overall Study|progressive disease|3|||
105486624|NCT04068896|363793375|FG003|Overall Study|progressive disease|2|||
105486625|NCT04068896|363793376|FG004|Overall Study|progressive disease|1|||
105486626|NCT04068896|363793377|FG005|Overall Study|progressive disease|2|||
105486627|NCT04068896|363793372|FG000|Overall Study|Study terminated by sponsor|0|||
105486628|NCT04068896|363793373|FG001|Overall Study|Study terminated by sponsor|0|||
105486629|NCT04068896|363793374|FG002|Overall Study|Study terminated by sponsor|1|||
105486630|NCT04068896|363793375|FG003|Overall Study|Study terminated by sponsor|2|||
105486631|NCT04068896|363793376|FG004|Overall Study|Study terminated by sponsor|1|||
105486632|NCT04068896|363793377|FG005|Overall Study|Study terminated by sponsor|4|||
105486633|NCT04068896|363793372|FG000|Overall Study|Protocol Violation|0|||
105486634|NCT04068896|363793373|FG001|Overall Study|Protocol Violation|0|||
105486635|NCT04068896|363793374|FG002|Overall Study|Protocol Violation|0|||
105486636|NCT04068896|363793375|FG003|Overall Study|Protocol Violation|1|||
105767275|NCT02417064|364800446|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
105767276|NCT02417064|364800444|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
105767277|NCT02417064|364800445|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
105767278|NCT02417064|364800446|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
105767279|NCT02417064|364800444|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
105767280|NCT02417064|364800445|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
105767281|NCT02417064|364800446|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
105767282|NCT02417064|364800444|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
105767283|NCT02417064|364800445|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
105767284|NCT02417064|364800446|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
105767285|NCT02417064|364800444|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
105767286|NCT02417064|364800445|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
105767287|NCT02417064|364800446|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
105767288|NCT02417064|364800444|FG000|Follow-up Phase (24 Weeks)|Other|2|||
105767289|NCT02417064|364800445|FG001|Follow-up Phase (24 Weeks)|Other|2|||
105767290|NCT02417064|364800446|FG002|Follow-up Phase (24 Weeks)|Other|3|||
105767291|NCT02136134|364800447|FG000|Overall Study|Death|170|||
105767292|NCT02136134|364800448|FG001|Overall Study|Death|148|||
105767293|NCT02136134|364800447|FG000|Overall Study|Withdrawal by Subject|19|||
105767294|NCT02136134|364800448|FG001|Overall Study|Withdrawal by Subject|10|||
105767295|NCT02136134|364800447|FG000|Overall Study|Lost to Follow-up|3|||
105767296|NCT02136134|364800448|FG001|Overall Study|Lost to Follow-up|3|||
105767297|NCT02136134|364800447|FG000|Overall Study|Uspecified|55|||
105767298|NCT02136134|364800448|FG001|Overall Study|Uspecified|90|||
105767299|NCT03345342|364800449|FG000|Open-Label Phase|Adverse Event|30|||
105767300|NCT03345342|364800450|FG001|Open-Label Phase|Adverse Event|0|||
105767301|NCT03345342|364800451|FG002|Open-Label Phase|Adverse Event|0|||
105767302|NCT03345342|364800452|FG003|Open-Label Phase|Adverse Event|0|||
105767303|NCT03345342|364800453|FG004|Open-Label Phase|Adverse Event|0|||
105767304|NCT03345342|364800449|FG000|Open-Label Phase|Death|1|||
105767305|NCT03345342|364800450|FG001|Open-Label Phase|Death|0|||
105364505|NCT03934216|363340310|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105364506|NCT03934216|363340309|FG000|Overall Study|Pregnancy|1|||
105364507|NCT03934216|363340310|FG001|Overall Study|Pregnancy|0|||
105364508|NCT03934216|363340309|FG000|Overall Study|Withdrawal by Subject|18|||
105364509|NCT03934216|363340310|FG001|Overall Study|Withdrawal by Subject|6|||
105364510|NCT03934216|363340309|FG000|Overall Study|Randomized but not treated|1|||
105364511|NCT03934216|363340310|FG001|Overall Study|Randomized but not treated|1|||
105364512|NCT02063672|363340311|FG000|Overall Study|Ongoing Follow-up|27|||
105767306|NCT03345342|364800451|FG002|Open-Label Phase|Death|0|||
105364513|NCT02063672|363340312|FG001|Overall Study|Ongoing Follow-up|14|||
105767307|NCT03345342|364800452|FG003|Open-Label Phase|Death|0|||
105767308|NCT03345342|364800453|FG004|Open-Label Phase|Death|0|||
105364514|NCT02063672|363340311|FG000|Overall Study|Death|5|||
105364515|NCT02063672|363340312|FG001|Overall Study|Death|3|||
105364516|NCT02063672|363340311|FG000|Overall Study|Lost to Follow-up|1|||
105767309|NCT03345342|364800449|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
105364517|NCT02063672|363340312|FG001|Overall Study|Lost to Follow-up|3|||
105364518|NCT02063672|363340311|FG000|Overall Study|Withdrawal by Subject|2|||
105364519|NCT02063672|363340312|FG001|Overall Study|Withdrawal by Subject|2|||
105364520|NCT01396083|363340315|FG000|Overall Study|Adverse Event|2|||
105364521|NCT01396083|363340316|FG001|Overall Study|Adverse Event|28|||
105364522|NCT01396083|363340315|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105364523|NCT01396083|363340316|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
105364524|NCT01396083|363340315|FG000|Overall Study|Consent withdrawn|4|||
105364525|NCT01396083|363340316|FG001|Overall Study|Consent withdrawn|5|||
105364526|NCT01396083|363340315|FG000|Overall Study|Protocol deviation(s)|0|||
105364527|NCT01396083|363340316|FG001|Overall Study|Protocol deviation(s)|1|||
105364528|NCT01396083|363340315|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105364529|NCT01396083|363340316|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105364530|NCT01396083|363340315|FG000|Overall Study|Administrative problems|1|||
105364531|NCT01396083|363340316|FG001|Overall Study|Administrative problems|0|||
105364532|NCT01396083|363340315|FG000|Overall Study|Lost to Follow-up|1|||
105364533|NCT01396083|363340316|FG001|Overall Study|Lost to Follow-up|0|||
105364534|NCT02163395|363340317|FG000|Overall Study|Withdrawal by Subject|1|||
105364535|NCT02163395|363340317|FG000|Overall Study|Lost to Follow-up|3|||
105364536|NCT02163395|363340317|FG000|Overall Study|Adverse Event|1|||
105364537|NCT00104052|363340318|FG000|Overall Study|Adverse Event|1|||
105364538|NCT00104052|363340318|FG000|Overall Study|Lack of Efficacy|26|||
105364539|NCT00104052|363340318|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
105364540|NCT03150082|363340335|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
105364541|NCT03150082|363340336|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
105364542|NCT00003537|363340338|FG000|Overall Study|Not evalauable|1|||
105364543|NCT01249417|363340339|FG000|Randomised Population|Study treatment not received|0|||
105364544|NCT01249417|363340340|FG001|Randomised Population|Study treatment not received|0|||
105364545|NCT01249417|363340341|FG002|Randomised Population|Study treatment not received|2|||
105364546|NCT01249417|363340339|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
105364547|NCT01249417|363340340|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
105364548|NCT01249417|363340341|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
105364549|NCT01249417|363340339|FG000|Treatment Phase - ITT Population|Other|0|||
105364550|NCT01249417|363340340|FG001|Treatment Phase - ITT Population|Other|0|||
105364551|NCT01249417|363340341|FG002|Treatment Phase - ITT Population|Other|1|||
105364552|NCT01249417|363340339|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
105364553|NCT01249417|363340340|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
105364554|NCT01249417|363340341|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
105364555|NCT01249417|363340339|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
105364556|NCT01249417|363340340|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
105364557|NCT01249417|363340341|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
105364558|NCT01249417|363340339|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
105364559|NCT01249417|363340340|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
105364560|NCT01249417|363340341|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
105364561|NCT02619617|363340342|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
105364562|NCT02619617|363340343|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
105364563|NCT02619617|363340342|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
105364564|NCT02619617|363340343|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
105364565|NCT02735980|363340344|FG000|Overall Study|Adverse Event|0|||
105364566|NCT02735980|363340345|FG001|Overall Study|Adverse Event|4|||
105364567|NCT02735980|363340346|FG002|Overall Study|Adverse Event|1|||
105364568|NCT02735980|363340344|FG000|Overall Study|Death|5|||
105364569|NCT02735980|363340345|FG001|Overall Study|Death|4|||
105364570|NCT02735980|363340346|FG002|Overall Study|Death|0|||
105364571|NCT02735980|363340344|FG000|Overall Study|Physician Decision|3|||
105364572|NCT02735980|363340345|FG001|Overall Study|Physician Decision|1|||
105364573|NCT02735980|363340346|FG002|Overall Study|Physician Decision|0|||
105364574|NCT02735980|363340344|FG000|Overall Study|Screen failure|1|||
105364575|NCT02735980|363340345|FG001|Overall Study|Screen failure|0|||
105364576|NCT02735980|363340346|FG002|Overall Study|Screen failure|0|||
105364577|NCT02735980|363340344|FG000|Overall Study|Withdrawal by Subject|1|||
105364578|NCT02735980|363340345|FG001|Overall Study|Withdrawal by Subject|2|||
105364579|NCT02735980|363340346|FG002|Overall Study|Withdrawal by Subject|0|||
105364580|NCT01447407|363340347|FG000|Overall Study|Withdrawal by Subject|2|||
105364581|NCT01447407|363340348|FG001|Overall Study|Withdrawal by Subject|0|||
105364582|NCT01447407|363340349|FG002|Overall Study|Withdrawal by Subject|0|||
105364583|NCT01447407|363340350|FG003|Overall Study|Withdrawal by Subject|1|||
105364584|NCT01447407|363340347|FG000|Overall Study|Physician Decision|0|||
105364585|NCT01447407|363340348|FG001|Overall Study|Physician Decision|0|||
105364586|NCT01447407|363340349|FG002|Overall Study|Physician Decision|1|||
105364587|NCT01447407|363340350|FG003|Overall Study|Physician Decision|1|||
105364588|NCT00528424|363340353|FG000|Overall Study|Lost to Follow-up|13|||
105364589|NCT00528424|363340353|FG000|Overall Study|Withdrew consent|2|||
105486637|NCT04068896|363793376|FG004|Overall Study|Protocol Violation|0|||
105486638|NCT04068896|363793377|FG005|Overall Study|Protocol Violation|0|||
105822849|NCT00830024|365008855|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
105822850|NCT00830024|365008856|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
105822851|NCT03134222|365008857|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
105822852|NCT03134222|365008858|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
105822853|NCT03134222|365008859|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
105822854|NCT03134222|365008860|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
105822855|NCT03134222|365008861|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
105822856|NCT03134222|365008857|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
105822857|NCT03134222|365008858|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
105822858|NCT03134222|365008859|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
105822859|NCT03134222|365008860|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
105364590|NCT00528424|363340353|FG000|Overall Study|Administrative reason|2|||
105364591|NCT00528424|363340353|FG000|Overall Study|Other|12|||
105364592|NCT02515630|363340354|FG000|Overall Study|Withdrawal by Subject|5|||
105364593|NCT02515630|363340354|FG000|Overall Study|Adverse Event|4|||
105571726|NCT02948959|364092748|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
105571727|NCT02948959|364092749|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
105822860|NCT03134222|365008861|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
105822861|NCT03134222|365008857|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
105364594|NCT02515630|363340354|FG000|Overall Study|Physician Decision|4|||
105364595|NCT02515630|363340354|FG000|Overall Study|Death|2|||
105364596|NCT02515630|363340354|FG000|Overall Study|Disease Progression|1|||
105364597|NCT00643201|363340355|FG000|Randomized, Completed 6 Months of Study|Death|20|||
105364598|NCT00643201|363340356|FG001|Randomized, Completed 6 Months of Study|Death|26|||
105364599|NCT00643201|363340355|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
105364600|NCT00643201|363340356|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
105364601|NCT00643201|363340355|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
105364602|NCT00643201|363340356|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
105486639|NCT04068896|363793372|FG000|Overall Study|Withdrawal by Subject|0|||
105486640|NCT04068896|363793373|FG001|Overall Study|Withdrawal by Subject|3|||
105486641|NCT04068896|363793374|FG002|Overall Study|Withdrawal by Subject|0|||
105486642|NCT04068896|363793375|FG003|Overall Study|Withdrawal by Subject|2|||
105486643|NCT04068896|363793376|FG004|Overall Study|Withdrawal by Subject|1|||
105486644|NCT04068896|363793377|FG005|Overall Study|Withdrawal by Subject|0|||
105486645|NCT04068896|363793372|FG000|Overall Study|Symptomatic deterioration|2|||
105486646|NCT04068896|363793373|FG001|Overall Study|Symptomatic deterioration|0|||
105486647|NCT04068896|363793374|FG002|Overall Study|Symptomatic deterioration|0|||
105486648|NCT04068896|363793375|FG003|Overall Study|Symptomatic deterioration|0|||
105486649|NCT04068896|363793376|FG004|Overall Study|Symptomatic deterioration|0|||
105486650|NCT04068896|363793377|FG005|Overall Study|Symptomatic deterioration|0|||
105486651|NCT02522871|363793378|FG000|Overall Study|Protocol Violation|1|||
105486652|NCT02522871|363793379|FG001|Overall Study|Protocol Violation|4|||
105486653|NCT02522871|363793378|FG000|Overall Study|Treated without randomization|1|||
105486654|NCT02522871|363793379|FG001|Overall Study|Treated without randomization|0|||
105486655|NCT02522871|363793378|FG000|Overall Study|Death|9|||
105486656|NCT02522871|363793379|FG001|Overall Study|Death|9|||
105486657|NCT02522871|363793378|FG000|Overall Study|Died in operating room prior to transplant|0|||
105486658|NCT02522871|363793379|FG001|Overall Study|Died in operating room prior to transplant|1|||
105486659|NCT00722371|363793385|FG000|Overall Study|Adverse Event|6|||
105486660|NCT00722371|363793386|FG001|Overall Study|Adverse Event|13|||
105486661|NCT00722371|363793387|FG002|Overall Study|Adverse Event|9|||
105486662|NCT00722371|363793388|FG003|Overall Study|Adverse Event|10|||
105486663|NCT00722371|363793389|FG004|Overall Study|Adverse Event|6|||
105486664|NCT00722371|363793390|FG005|Overall Study|Adverse Event|8|||
105486665|NCT00722371|363793391|FG006|Overall Study|Adverse Event|4|||
105486666|NCT00722371|363793385|FG000|Overall Study|Contraindication|0|||
105486667|NCT00722371|363793386|FG001|Overall Study|Contraindication|0|||
105486668|NCT00722371|363793387|FG002|Overall Study|Contraindication|1|||
105486669|NCT00722371|363793388|FG003|Overall Study|Contraindication|0|||
105486670|NCT00722371|363793389|FG004|Overall Study|Contraindication|0|||
105486671|NCT00722371|363793390|FG005|Overall Study|Contraindication|0|||
105486672|NCT00722371|363793391|FG006|Overall Study|Contraindication|0|||
105486673|NCT00722371|363793385|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
105486674|NCT00722371|363793386|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
105486675|NCT00722371|363793387|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
105486676|NCT00722371|363793388|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
105486677|NCT00722371|363793389|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
105486678|NCT00722371|363793390|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
105486679|NCT00722371|363793391|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
105486680|NCT00722371|363793385|FG000|Overall Study|Excluded medication|0|||
105486681|NCT00722371|363793386|FG001|Overall Study|Excluded medication|1|||
105486682|NCT00722371|363793387|FG002|Overall Study|Excluded medication|1|||
105486683|NCT00722371|363793388|FG003|Overall Study|Excluded medication|0|||
105486684|NCT00722371|363793389|FG004|Overall Study|Excluded medication|0|||
105364603|NCT00643201|363340355|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
105364604|NCT00643201|363340356|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
105364605|NCT00643201|363340355|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
105364606|NCT00643201|363340356|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
105364607|NCT00643201|363340355|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
105364608|NCT00643201|363340356|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
105364609|NCT00643201|363340355|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
105364610|NCT00643201|363340356|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
105364611|NCT00643201|363340355|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
105364612|NCT00643201|363340356|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
105364613|NCT00643201|363340355|FG000|Randomized, Completed 6 Months of Study|Other|107|||
105364614|NCT00643201|363340356|FG001|Randomized, Completed 6 Months of Study|Other|107|||
105364615|NCT00643201|363340355|FG000|Completed Study Follow Up|Death|28|||
105364616|NCT00643201|363340356|FG001|Completed Study Follow Up|Death|34|||
105364617|NCT00643201|363340355|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
105364618|NCT00643201|363340356|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
105364619|NCT00643201|363340355|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
105364620|NCT00643201|363340356|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
105364621|NCT00643201|363340355|FG000|Completed Study Follow Up|non-specified|1|||
105364622|NCT00643201|363340356|FG001|Completed Study Follow Up|non-specified|0|||
105364623|NCT00483652|363340357|FG000|Double-blind Treatment Period|Protocol Violation|2|||
105364624|NCT00483652|363340358|FG001|Double-blind Treatment Period|Protocol Violation|1|||
105364625|NCT00483652|363340357|FG000|Double-blind Treatment Period|Adverse Event|3|||
105364626|NCT00483652|363340358|FG001|Double-blind Treatment Period|Adverse Event|4|||
105364627|NCT00483652|363340357|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
105364628|NCT00483652|363340358|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
105364629|NCT00483652|363340357|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
105364630|NCT00483652|363340358|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
105364631|NCT00971867|363340359|FG000|Overall Study|Adverse Event|4|||
105364632|NCT00971867|363340359|FG000|Overall Study|Participant Withdrew Consent|1|||
105364633|NCT00971867|363340359|FG000|Overall Study|Disease Progression|6|||
105364634|NCT01676701|363340367|FG000|Overall Study|Protocol Violation|1|||
105364635|NCT01676701|363340368|FG001|Overall Study|Protocol Violation|0|||
105364636|NCT01676701|363340367|FG000|Overall Study|Sponsor Decision|3|||
105364637|NCT01676701|363340368|FG001|Overall Study|Sponsor Decision|4|||
105364638|NCT02115607|363340371|FG000|Overall Study|Withdrawal by Subject|1|||
105364639|NCT05490771|363340373|FG000|Overall Study|Disease progression|18|||
105364640|NCT05490771|363340373|FG000|Overall Study|Adverse Event|3|||
105364641|NCT05490771|363340373|FG000|Overall Study|Other complicating disease|1|||
105364642|NCT05490771|363340373|FG000|Overall Study|Withdrawal by Subject|3|||
105364643|NCT05490771|363340373|FG000|Overall Study|Physician Decision|1|||
105364644|NCT05490771|363340373|FG000|Overall Study|Still on treatment|2|||
105364645|NCT05490771|363340373|FG000|Overall Study|Never start protocol therapy|5|||
105364646|NCT05490771|363340373|FG000|Overall Study|Ineligible|2|||
105364647|NCT00549549|363340374|FG000|Overall Study|Adverse Event|5|||
105364648|NCT00549549|363340375|FG001|Overall Study|Adverse Event|3|||
105364649|NCT00549549|363340376|FG002|Overall Study|Adverse Event|1|||
105364650|NCT00549549|363340377|FG003|Overall Study|Adverse Event|9|||
105364651|NCT00549549|363340374|FG000|Overall Study|Lack of Efficacy|9|||
105364652|NCT00549549|363340375|FG001|Overall Study|Lack of Efficacy|6|||
105364653|NCT00549549|363340376|FG002|Overall Study|Lack of Efficacy|4|||
105364654|NCT00549549|363340377|FG003|Overall Study|Lack of Efficacy|2|||
105364655|NCT00549549|363340374|FG000|Overall Study|Lost to Follow-up|1|||
105364656|NCT00549549|363340375|FG001|Overall Study|Lost to Follow-up|0|||
105364657|NCT00549549|363340376|FG002|Overall Study|Lost to Follow-up|1|||
105364658|NCT00549549|363340377|FG003|Overall Study|Lost to Follow-up|2|||
105364659|NCT00549549|363340374|FG000|Overall Study|Withdrawal by Subject|0|||
105364660|NCT00549549|363340375|FG001|Overall Study|Withdrawal by Subject|4|||
105822862|NCT03134222|365008858|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
105822863|NCT03134222|365008859|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
105364661|NCT00549549|363340376|FG002|Overall Study|Withdrawal by Subject|1|||
105364662|NCT00549549|363340377|FG003|Overall Study|Withdrawal by Subject|0|||
105364663|NCT00549549|363340374|FG000|Overall Study|Other|9|||
105364664|NCT00549549|363340375|FG001|Overall Study|Other|9|||
105364665|NCT00549549|363340376|FG002|Overall Study|Other|9|||
105364666|NCT00549549|363340377|FG003|Overall Study|Other|11|||
105822864|NCT03134222|365008860|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
105822865|NCT03134222|365008861|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
105364667|NCT00549549|363340374|FG000|Overall Study|Randomized but not treated|0|||
105364668|NCT00549549|363340375|FG001|Overall Study|Randomized but not treated|0|||
105364669|NCT00549549|363340376|FG002|Overall Study|Randomized but not treated|1|||
105364670|NCT00549549|363340377|FG003|Overall Study|Randomized but not treated|1|||
105364671|NCT03771963|363340378|FG000|Overall Study|Lost to Follow-up|22|||
105571728|NCT02948959|364092748|FG000|52 Weeks Treatment Period|Change of residence location|0|||
105364672|NCT03771963|363340378|FG000|Overall Study|Withdrawal of Consent|10|||
105364673|NCT00485069|363340379|FG000|Overall Study|Adverse Event|10|||
105364674|NCT00485069|363340380|FG001|Overall Study|Adverse Event|4|||
105364675|NCT00485069|363340379|FG000|Overall Study|Lack of Efficacy|2|||
105364676|NCT00485069|363340380|FG001|Overall Study|Lack of Efficacy|1|||
105364677|NCT00485069|363340379|FG000|Overall Study|Protocol Violation|0|||
105364678|NCT00485069|363340380|FG001|Overall Study|Protocol Violation|1|||
105364679|NCT00485069|363340379|FG000|Overall Study|Withdrawal by Subject|6|||
105364680|NCT00485069|363340380|FG001|Overall Study|Withdrawal by Subject|6|||
105364681|NCT00102596|363340381|FG000|Part A|Screen failures|6|||
105364682|NCT00102596|363340382|FG001|Part A|Screen failures|0|||
105364683|NCT00102596|363340381|FG000|Part A|Adverse Event|1|||
105364684|NCT00102596|363340382|FG001|Part A|Adverse Event|0|||
105364685|NCT02989402|363340383|FG000|Overall Study|Adverse event, or serious adverse event|4|||
105364686|NCT02989402|363340383|FG000|Overall Study|Death|2|||
105364687|NCT02989402|363340383|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
105364688|NCT02989402|363340383|FG000|Overall Study|Lost to Follow-up|8|||
105364689|NCT02989402|363340383|FG000|Overall Study|Patient no longer on monotherapy|1|||
105364690|NCT02989402|363340383|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
105364691|NCT02989402|363340383|FG000|Overall Study|Withdrawal by Subject|7|||
105364692|NCT02989402|363340383|FG000|Overall Study|Other|2|||
105364693|NCT02688933|363340386|FG000|Overall Study|Adverse Event|3|||
105364694|NCT02688933|363340387|FG001|Overall Study|Adverse Event|1|||
105364695|NCT02688933|363340386|FG000|Overall Study|Lack of Efficacy|2|||
105364696|NCT02688933|363340387|FG001|Overall Study|Lack of Efficacy|2|||
105364697|NCT02688933|363340386|FG000|Overall Study|Poor compliance to protocol|7|||
105364698|NCT02688933|363340387|FG001|Overall Study|Poor compliance to protocol|4|||
105364699|NCT02688933|363340386|FG000|Overall Study|Hypoglycemia|2|||
105364700|NCT02688933|363340387|FG001|Overall Study|Hypoglycemia|0|||
105364701|NCT02688933|363340386|FG000|Overall Study|Other than Specified|14|||
105364702|NCT02688933|363340387|FG001|Overall Study|Other than Specified|25|||
105767310|NCT03345342|364800450|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
105767311|NCT03345342|364800451|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
105767312|NCT03345342|364800452|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
105767313|NCT03345342|364800453|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
105767314|NCT03345342|364800449|FG000|Open-Label Phase|Lack of Efficacy|6|||
105767315|NCT03345342|364800450|FG001|Open-Label Phase|Lack of Efficacy|0|||
105767316|NCT03345342|364800451|FG002|Open-Label Phase|Lack of Efficacy|0|||
105767317|NCT03345342|364800452|FG003|Open-Label Phase|Lack of Efficacy|0|||
105767318|NCT03345342|364800453|FG004|Open-Label Phase|Lack of Efficacy|0|||
105767319|NCT03345342|364800449|FG000|Open-Label Phase|Lost to Follow-up|9|||
105767320|NCT03345342|364800450|FG001|Open-Label Phase|Lost to Follow-up|0|||
105767321|NCT03345342|364800451|FG002|Open-Label Phase|Lost to Follow-up|0|||
105767322|NCT03345342|364800452|FG003|Open-Label Phase|Lost to Follow-up|0|||
105767323|NCT03345342|364800453|FG004|Open-Label Phase|Lost to Follow-up|0|||
105767324|NCT03345342|364800449|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
105767325|NCT03345342|364800450|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
105767326|NCT03345342|364800451|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
105767327|NCT03345342|364800452|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
105767328|NCT03345342|364800453|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
105767329|NCT03345342|364800449|FG000|Open-Label Phase|Physician Decision|4|||
105767330|NCT03345342|364800450|FG001|Open-Label Phase|Physician Decision|0|||
105767331|NCT03345342|364800451|FG002|Open-Label Phase|Physician Decision|0|||
105767332|NCT03345342|364800452|FG003|Open-Label Phase|Physician Decision|0|||
105767333|NCT03345342|364800453|FG004|Open-Label Phase|Physician Decision|0|||
105767334|NCT03345342|364800449|FG000|Open-Label Phase|Protocol Violation|8|||
105767335|NCT03345342|364800450|FG001|Open-Label Phase|Protocol Violation|0|||
105767336|NCT03345342|364800451|FG002|Open-Label Phase|Protocol Violation|0|||
105767337|NCT03345342|364800452|FG003|Open-Label Phase|Protocol Violation|0|||
105767338|NCT03345342|364800453|FG004|Open-Label Phase|Protocol Violation|0|||
105767339|NCT03345342|364800449|FG000|Open-Label Phase|Withdrawal by Subject|57|||
105767340|NCT03345342|364800450|FG001|Open-Label Phase|Withdrawal by Subject|0|||
105767341|NCT03345342|364800451|FG002|Open-Label Phase|Withdrawal by Subject|0|||
105767342|NCT03345342|364800452|FG003|Open-Label Phase|Withdrawal by Subject|0|||
105767343|NCT03345342|364800453|FG004|Open-Label Phase|Withdrawal by Subject|0|||
105767344|NCT03345342|364800449|FG000|Open-Label Phase|Other|15|||
105767345|NCT03345342|364800450|FG001|Open-Label Phase|Other|0|||
105767346|NCT03345342|364800451|FG002|Open-Label Phase|Other|0|||
105767347|NCT03345342|364800452|FG003|Open-Label Phase|Other|0|||
105822866|NCT03134222|365008857|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
105364703|NCT02688933|363340386|FG000|Overall Study|Lost to Follow-up|1|||
105486685|NCT00722371|363793390|FG005|Overall Study|Excluded medication|0|||
105486686|NCT00722371|363793391|FG006|Overall Study|Excluded medication|1|||
105486687|NCT00722371|363793385|FG000|Overall Study|Hyperglycemia|2|||
105364704|NCT02688933|363340387|FG001|Overall Study|Lost to Follow-up|5|||
105364705|NCT05067972|363340389|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
105486688|NCT00722371|363793386|FG001|Overall Study|Hyperglycemia|6|||
105822867|NCT03134222|365008858|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
105822868|NCT03134222|365008859|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
105822869|NCT03134222|365008860|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
105822870|NCT03134222|365008861|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
105822871|NCT03134222|365008857|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
105822872|NCT03134222|365008858|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
105822873|NCT03134222|365008859|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
105822874|NCT03134222|365008860|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
105822875|NCT03134222|365008861|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
105364706|NCT05067972|363340390|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
105364707|NCT05067972|363340391|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
105364708|NCT05067972|363340392|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
105364709|NCT05067972|363340393|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
105364710|NCT05067972|363340394|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
105364711|NCT05067972|363340395|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
105364712|NCT05067972|363340389|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
105364713|NCT05067972|363340390|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
105364714|NCT05067972|363340391|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
105364715|NCT05067972|363340392|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
105364716|NCT05067972|363340393|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
105364717|NCT05067972|363340394|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
105364718|NCT05067972|363340395|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
105364719|NCT05067972|363340389|FG000|Part 1: Treatment|Progressive Disease|3|||
105364720|NCT05067972|363340390|FG001|Part 1: Treatment|Progressive Disease|3|||
105364721|NCT05067972|363340391|FG002|Part 1: Treatment|Progressive Disease|4|||
105364722|NCT05067972|363340392|FG003|Part 1: Treatment|Progressive Disease|2|||
105364723|NCT05067972|363340393|FG004|Part 1: Treatment|Progressive Disease|3|||
105364724|NCT05067972|363340394|FG005|Part 1: Treatment|Progressive Disease|0|||
105364725|NCT05067972|363340395|FG006|Part 1: Treatment|Progressive Disease|2|||
105364726|NCT05067972|363340389|FG000|Part 1: Treatment|Physician Decision|0|||
105364727|NCT05067972|363340390|FG001|Part 1: Treatment|Physician Decision|0|||
105364728|NCT05067972|363340391|FG002|Part 1: Treatment|Physician Decision|0|||
105364729|NCT05067972|363340392|FG003|Part 1: Treatment|Physician Decision|1|||
105364730|NCT05067972|363340393|FG004|Part 1: Treatment|Physician Decision|0|||
105364731|NCT05067972|363340394|FG005|Part 1: Treatment|Physician Decision|0|||
105364732|NCT05067972|363340395|FG006|Part 1: Treatment|Physician Decision|0|||
105364733|NCT05067972|363340389|FG000|Part 1: Treatment|Death|0|||
105364734|NCT05067972|363340390|FG001|Part 1: Treatment|Death|0|||
105364735|NCT05067972|363340391|FG002|Part 1: Treatment|Death|0|||
105364736|NCT05067972|363340392|FG003|Part 1: Treatment|Death|2|||
105364737|NCT05067972|363340393|FG004|Part 1: Treatment|Death|0|||
105364738|NCT05067972|363340394|FG005|Part 1: Treatment|Death|0|||
105364739|NCT05067972|363340395|FG006|Part 1: Treatment|Death|0|||
105364740|NCT05067972|363340389|FG000|Part 1: Treatment|Adverse Event|0|||
105364741|NCT05067972|363340390|FG001|Part 1: Treatment|Adverse Event|0|||
105364742|NCT05067972|363340391|FG002|Part 1: Treatment|Adverse Event|0|||
105486689|NCT00722371|363793387|FG002|Overall Study|Hyperglycemia|4|||
105486690|NCT00722371|363793388|FG003|Overall Study|Hyperglycemia|2|||
105486691|NCT00722371|363793389|FG004|Overall Study|Hyperglycemia|5|||
105486692|NCT00722371|363793390|FG005|Overall Study|Hyperglycemia|1|||
105486693|NCT00722371|363793391|FG006|Overall Study|Hyperglycemia|1|||
105486694|NCT00722371|363793385|FG000|Overall Study|Hypoglycemia|1|||
105486695|NCT00722371|363793386|FG001|Overall Study|Hypoglycemia|0|||
105486696|NCT00722371|363793387|FG002|Overall Study|Hypoglycemia|0|||
105486697|NCT00722371|363793388|FG003|Overall Study|Hypoglycemia|0|||
105486698|NCT00722371|363793389|FG004|Overall Study|Hypoglycemia|0|||
105486699|NCT00722371|363793390|FG005|Overall Study|Hypoglycemia|0|||
105486700|NCT00722371|363793391|FG006|Overall Study|Hypoglycemia|0|||
105486701|NCT00722371|363793385|FG000|Overall Study|Lack of Efficacy|4|||
105486702|NCT00722371|363793386|FG001|Overall Study|Lack of Efficacy|6|||
105486703|NCT00722371|363793387|FG002|Overall Study|Lack of Efficacy|6|||
105486704|NCT00722371|363793388|FG003|Overall Study|Lack of Efficacy|6|||
105486705|NCT00722371|363793389|FG004|Overall Study|Lack of Efficacy|2|||
105767348|NCT03345342|364800453|FG004|Open-Label Phase|Other|0|||
105767349|NCT03345342|364800449|FG000|Double-Blind Phase|Adverse Event|0|||
105767350|NCT03345342|364800450|FG001|Double-Blind Phase|Adverse Event|1|||
105364743|NCT05067972|363340392|FG003|Part 1: Treatment|Adverse Event|0|||
105486706|NCT00722371|363793390|FG005|Overall Study|Lack of Efficacy|3|||
105486707|NCT00722371|363793391|FG006|Overall Study|Lack of Efficacy|0|||
105767351|NCT03345342|364800451|FG002|Double-Blind Phase|Adverse Event|6|||
105767352|NCT03345342|364800452|FG003|Double-Blind Phase|Adverse Event|0|||
105767353|NCT03345342|364800453|FG004|Double-Blind Phase|Adverse Event|0|||
105767354|NCT03345342|364800449|FG000|Double-Blind Phase|Death|0|||
105767355|NCT03345342|364800450|FG001|Double-Blind Phase|Death|2|||
105767356|NCT03345342|364800451|FG002|Double-Blind Phase|Death|1|||
105767357|NCT03345342|364800452|FG003|Double-Blind Phase|Death|0|||
105767358|NCT03345342|364800453|FG004|Double-Blind Phase|Death|0|||
105767359|NCT03345342|364800449|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
105767360|NCT03345342|364800450|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
105767361|NCT03345342|364800451|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
105767362|NCT03345342|364800452|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
105767363|NCT03345342|364800453|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
105767364|NCT03345342|364800449|FG000|Double-Blind Phase|Lost to Follow-up|0|||
105767365|NCT03345342|364800450|FG001|Double-Blind Phase|Lost to Follow-up|1|||
105767366|NCT03345342|364800451|FG002|Double-Blind Phase|Lost to Follow-up|7|||
105767367|NCT03345342|364800452|FG003|Double-Blind Phase|Lost to Follow-up|0|||
105767368|NCT03345342|364800453|FG004|Double-Blind Phase|Lost to Follow-up|0|||
105767369|NCT03345342|364800449|FG000|Double-Blind Phase|Physician Decision|0|||
105767370|NCT03345342|364800450|FG001|Double-Blind Phase|Physician Decision|1|||
105767371|NCT03345342|364800451|FG002|Double-Blind Phase|Physician Decision|4|||
105767372|NCT03345342|364800452|FG003|Double-Blind Phase|Physician Decision|0|||
105767373|NCT03345342|364800453|FG004|Double-Blind Phase|Physician Decision|0|||
105767374|NCT03345342|364800449|FG000|Double-Blind Phase|Protocol Violation|0|||
105767375|NCT03345342|364800450|FG001|Double-Blind Phase|Protocol Violation|0|||
105767376|NCT03345342|364800451|FG002|Double-Blind Phase|Protocol Violation|1|||
105767377|NCT03345342|364800452|FG003|Double-Blind Phase|Protocol Violation|0|||
105767378|NCT03345342|364800453|FG004|Double-Blind Phase|Protocol Violation|0|||
105767379|NCT03345342|364800449|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
105767380|NCT03345342|364800450|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
105767381|NCT03345342|364800451|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
105767382|NCT03345342|364800452|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
105767383|NCT03345342|364800453|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
105486708|NCT00722371|363793385|FG000|Overall Study|Lost to Follow-up|11|||
105486709|NCT00722371|363793386|FG001|Overall Study|Lost to Follow-up|14|||
105486710|NCT00722371|363793387|FG002|Overall Study|Lost to Follow-up|21|||
105486711|NCT00722371|363793388|FG003|Overall Study|Lost to Follow-up|13|||
105767384|NCT03345342|364800449|FG000|Double-Blind Phase|Other|0|||
105822876|NCT03134222|365008857|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
105822877|NCT03134222|365008858|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
105822878|NCT03134222|365008859|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
105822879|NCT03134222|365008860|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
105822880|NCT03134222|365008861|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
105822881|NCT03134222|365008857|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
105822882|NCT03134222|365008858|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
105822883|NCT03134222|365008859|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
105822884|NCT03134222|365008860|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
105822885|NCT03134222|365008861|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
105822886|NCT03134222|365008857|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
105822887|NCT03134222|365008858|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
105822888|NCT03134222|365008859|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
105822889|NCT03134222|365008860|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
105822890|NCT03134222|365008861|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
105822891|NCT00950989|365008862|FG000|Overall Study|Death|0|||
105822892|NCT00950989|365008863|FG001|Overall Study|Death|0|||
105822893|NCT00950989|365008864|FG002|Overall Study|Death|1|||
105822894|NCT00950989|365008865|FG003|Overall Study|Death|0|||
105822895|NCT00950989|365008862|FG000|Overall Study|Administrative Decision|0|||
105822896|NCT00950989|365008863|FG001|Overall Study|Administrative Decision|1|||
105822897|NCT00950989|365008864|FG002|Overall Study|Administrative Decision|0|||
105822898|NCT00950989|365008865|FG003|Overall Study|Administrative Decision|0|||
105822899|NCT00950989|365008862|FG000|Overall Study|Disease Progression|0|||
105822900|NCT00950989|365008863|FG001|Overall Study|Disease Progression|0|||
105822901|NCT00950989|365008864|FG002|Overall Study|Disease Progression|1|||
105364744|NCT05067972|363340393|FG004|Part 1: Treatment|Adverse Event|0|||
105822902|NCT00950989|365008865|FG003|Overall Study|Disease Progression|0|||
105822903|NCT00950989|365008862|FG000|Overall Study|Withdrawal by Subject|2|||
105822904|NCT00950989|365008863|FG001|Overall Study|Withdrawal by Subject|1|||
105822905|NCT00950989|365008864|FG002|Overall Study|Withdrawal by Subject|0|||
105822906|NCT00950989|365008865|FG003|Overall Study|Withdrawal by Subject|0|||
105822907|NCT00950989|365008862|FG000|Overall Study|Adverse Event|2|||
105822908|NCT00950989|365008863|FG001|Overall Study|Adverse Event|1|||
105822909|NCT00950989|365008864|FG002|Overall Study|Adverse Event|1|||
105822910|NCT00950989|365008865|FG003|Overall Study|Adverse Event|0|||
105822911|NCT01841554|365008870|FG000|Overall Study|Death|7|||
105822912|NCT01841554|365008870|FG000|Overall Study|No Implantation|1|||
105822913|NCT01841554|365008870|FG000|Overall Study|Discontinued Follow Up|5|||
105822914|NCT01841554|365008870|FG000|Overall Study|Study exit due to secondary intervention|6|||
105822915|NCT03804983|365008874|FG000|Overall Study|Adverse Event|0|||
105822916|NCT03804983|365008875|FG001|Overall Study|Adverse Event|1|||
105822917|NCT03804983|365008874|FG000|Overall Study|Family Obligation|1|||
105822918|NCT03804983|365008875|FG001|Overall Study|Family Obligation|0|||
105822919|NCT02152163|365008876|FG000|Overall Study|Physician Decision|12|||
105822920|NCT02152163|365008877|FG001|Overall Study|Physician Decision|13|||
105822921|NCT03123471|365008880|FG000|Placebo-controlled Phase|Adverse Event|3|||
105822922|NCT03123471|365008881|FG001|Placebo-controlled Phase|Adverse Event|8|||
105822923|NCT03123471|365008880|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
105822924|NCT03123471|365008881|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
105822925|NCT03123471|365008880|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
105822926|NCT03123471|365008881|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
105822927|NCT03123471|365008880|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
105822928|NCT03123471|365008881|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
105486712|NCT00722371|363793389|FG004|Overall Study|Lost to Follow-up|8|||
105822929|NCT03123471|365008880|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
105822930|NCT03123471|365008881|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
105822931|NCT03123471|365008880|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
105822932|NCT03123471|365008881|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
105486713|NCT00722371|363793390|FG005|Overall Study|Lost to Follow-up|16|||
105486714|NCT00722371|363793391|FG006|Overall Study|Lost to Follow-up|13|||
105822933|NCT03123471|365008880|FG000|Placebo-controlled Phase|Miscellaneous|0|||
105822934|NCT03123471|365008881|FG001|Placebo-controlled Phase|Miscellaneous|1|||
105822935|NCT03123471|365008880|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
105822936|NCT03123471|365008881|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
105822937|NCT03123471|365008880|FG000|Apremilast Extension Phase|Adverse Event|1|||
105822938|NCT03123471|365008881|FG001|Apremilast Extension Phase|Adverse Event|5|||
105822939|NCT03123471|365008880|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
105822940|NCT03123471|365008881|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
105822941|NCT03123471|365008880|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
105822942|NCT03123471|365008881|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
105822943|NCT00424047|365008882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
105822944|NCT00424047|365008883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
105822945|NCT00424047|365008882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
105822946|NCT00424047|365008883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
105822947|NCT00424047|365008882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
105822948|NCT00424047|365008883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
105822949|NCT00424047|365008882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
105822950|NCT00424047|365008883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
105822951|NCT00424047|365008882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
105364745|NCT05067972|363340394|FG005|Part 1: Treatment|Adverse Event|2|||
105364746|NCT05067972|363340395|FG006|Part 1: Treatment|Adverse Event|1|||
105364747|NCT05067972|363340389|FG000|Part 1: Follow-up|Adverse Event|0|||
105364748|NCT05067972|363340390|FG001|Part 1: Follow-up|Adverse Event|0|||
105364749|NCT05067972|363340391|FG002|Part 1: Follow-up|Adverse Event|0|||
105364750|NCT05067972|363340392|FG003|Part 1: Follow-up|Adverse Event|0|||
105364751|NCT05067972|363340393|FG004|Part 1: Follow-up|Adverse Event|0|||
105364752|NCT05067972|363340394|FG005|Part 1: Follow-up|Adverse Event|1|||
105364753|NCT05067972|363340395|FG006|Part 1: Follow-up|Adverse Event|0|||
105364754|NCT05067972|363340389|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
105364755|NCT05067972|363340390|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
105364756|NCT05067972|363340391|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
105364757|NCT05067972|363340392|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
105364758|NCT05067972|363340393|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
105364759|NCT05067972|363340394|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
105364760|NCT05067972|363340395|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
105364761|NCT05067972|363340389|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
105364762|NCT05067972|363340390|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
105364763|NCT05067972|363340391|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
105364764|NCT05067972|363340392|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
105364765|NCT05067972|363340393|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
105364766|NCT05067972|363340394|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
105364767|NCT05067972|363340395|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
105364768|NCT05067972|363340389|FG000|Part 1: Follow-up|Physician Decision|0|||
105364769|NCT05067972|363340390|FG001|Part 1: Follow-up|Physician Decision|0|||
105364770|NCT05067972|363340391|FG002|Part 1: Follow-up|Physician Decision|0|||
105364771|NCT05067972|363340392|FG003|Part 1: Follow-up|Physician Decision|1|||
105364772|NCT05067972|363340393|FG004|Part 1: Follow-up|Physician Decision|0|||
105364773|NCT05067972|363340394|FG005|Part 1: Follow-up|Physician Decision|0|||
105364774|NCT05067972|363340395|FG006|Part 1: Follow-up|Physician Decision|0|||
105364775|NCT05067972|363340389|FG000|Part 1: Follow-up|Death|1|||
105364776|NCT05067972|363340390|FG001|Part 1: Follow-up|Death|2|||
105364777|NCT05067972|363340391|FG002|Part 1: Follow-up|Death|1|||
105364778|NCT05067972|363340392|FG003|Part 1: Follow-up|Death|0|||
105364779|NCT05067972|363340393|FG004|Part 1: Follow-up|Death|1|||
105364780|NCT05067972|363340394|FG005|Part 1: Follow-up|Death|0|||
105364781|NCT05067972|363340395|FG006|Part 1: Follow-up|Death|1|||
105364782|NCT04577794|363340397|FG000|Overall Study|Adverse Event|1|||
105364783|NCT04577794|363340398|FG001|Overall Study|Adverse Event|1|||
105364784|NCT00689338|363340403|FG000|Overall Study|Death|65|||
105364785|NCT00689338|363340403|FG000|Overall Study|Adverse Event|13|||
105364786|NCT00689338|363340403|FG000|Overall Study|Insufficient Clinical Response|1|||
105364787|NCT00689338|363340403|FG000|Overall Study|Lack of Efficacy|6|||
105364788|NCT00689338|363340403|FG000|Overall Study|Other|8|||
105364789|NCT00689338|363340403|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
105364790|NCT00689338|363340403|FG000|Overall Study|Lost to Follow-up|5|||
105364791|NCT00689338|363340403|FG000|Overall Study|Withdrawal by Subject|3|||
105364792|NCT00689338|363340403|FG000|Overall Study|Protocol Violation|15|||
105364793|NCT02700048|363340404|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
105364794|NCT02700048|363340405|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
105364795|NCT02175225|363340406|FG000|Overall Study|Withdrawal by Subject|1|||
105364796|NCT02175225|363340407|FG001|Overall Study|Withdrawal by Subject|2|||
105364797|NCT02175225|363340406|FG000|Overall Study|Lost to Follow-up|6|||
105364798|NCT02175225|363340407|FG001|Overall Study|Lost to Follow-up|7|||
105822952|NCT00424047|365008883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
105822953|NCT00424047|365008882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
105364799|NCT02175225|363340406|FG000|Overall Study|Study drug not administered|1|||
105364800|NCT02175225|363340407|FG001|Overall Study|Study drug not administered|2|||
105364801|NCT02340000|363340408|FG000|Time Period 1|Withdrawal by Subject|6|||
105364802|NCT02340000|363340409|FG001|Time Period 1|Withdrawal by Subject|8|||
105364803|NCT02340000|363340408|FG000|Time Period 1|Lost to Follow-up|6|||
105364804|NCT02340000|363340409|FG001|Time Period 1|Lost to Follow-up|7|||
105364805|NCT02340000|363340408|FG000|Time Period 2|Withdrawal by Subject|9|||
105364806|NCT02340000|363340409|FG001|Time Period 2|Withdrawal by Subject|7|||
105364807|NCT02340000|363340408|FG000|Time Period 2|Lost to Follow-up|10|||
105364808|NCT02340000|363340409|FG001|Time Period 2|Lost to Follow-up|8|||
105364809|NCT01107925|363340410|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
105364810|NCT01107925|363340411|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
105364811|NCT01107925|363340412|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
105364812|NCT01107925|363340413|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
105364813|NCT01107925|363340414|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
105364814|NCT01107925|363340415|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
105364815|NCT01107925|363340410|FG000|Period 2|Withdrawal by Subject|0|||
105364816|NCT01107925|363340411|FG001|Period 2|Withdrawal by Subject|1|||
105364817|NCT01107925|363340412|FG002|Period 2|Withdrawal by Subject|0|||
105364818|NCT01107925|363340413|FG003|Period 2|Withdrawal by Subject|0|||
105364819|NCT01107925|363340414|FG004|Period 2|Withdrawal by Subject|0|||
105364820|NCT01107925|363340415|FG005|Period 2|Withdrawal by Subject|1|||
105364821|NCT01619878|363340417|FG000|6 Week Follow-up Phase|Adverse Event|1|||
105364822|NCT01619878|363340417|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
105364823|NCT01619878|363340417|FG000|Follow-up at 12 Months of Age|Death|2|||
105364824|NCT00369343|363340418|FG000|Double-blind Phase|Adverse Event|19|||
105364825|NCT00369343|363340419|FG001|Double-blind Phase|Adverse Event|4|||
105364826|NCT00369343|363340418|FG000|Double-blind Phase|Failed to return|2|||
105364827|NCT00369343|363340419|FG001|Double-blind Phase|Failed to return|0|||
105364828|NCT00369343|363340418|FG000|Double-blind Phase|Lost to Follow-up|9|||
105364829|NCT00369343|363340419|FG001|Double-blind Phase|Lost to Follow-up|2|||
105364830|NCT00369343|363340418|FG000|Double-blind Phase|Protocol Violation|2|||
105767385|NCT03345342|364800450|FG001|Double-Blind Phase|Other|1|||
105767386|NCT03345342|364800451|FG002|Double-Blind Phase|Other|3|||
105767387|NCT03345342|364800452|FG003|Double-Blind Phase|Other|0|||
105767388|NCT03345342|364800453|FG004|Double-Blind Phase|Other|0|||
105767389|NCT03345342|364800449|FG000|Follow-Up Phase|Adverse Event|0|||
105767390|NCT03345342|364800450|FG001|Follow-Up Phase|Adverse Event|0|||
105767391|NCT03345342|364800451|FG002|Follow-Up Phase|Adverse Event|0|||
105767392|NCT03345342|364800452|FG003|Follow-Up Phase|Adverse Event|0|||
105767393|NCT03345342|364800453|FG004|Follow-Up Phase|Adverse Event|4|||
105767394|NCT03345342|364800449|FG000|Follow-Up Phase|Lost to Follow-up|0|||
105364831|NCT00369343|363340419|FG001|Double-blind Phase|Protocol Violation|0|||
105767395|NCT03345342|364800450|FG001|Follow-Up Phase|Lost to Follow-up|0|||
105767396|NCT03345342|364800451|FG002|Follow-Up Phase|Lost to Follow-up|0|||
105767397|NCT03345342|364800452|FG003|Follow-Up Phase|Lost to Follow-up|0|||
105767398|NCT03345342|364800453|FG004|Follow-Up Phase|Lost to Follow-up|6|||
105364832|NCT00369343|363340418|FG000|Double-blind Phase|Withdrawal by Subject|8|||
105364833|NCT00369343|363340419|FG001|Double-blind Phase|Withdrawal by Subject|6|||
105364834|NCT00369343|363340418|FG000|Double-blind Phase|Lack of Efficacy|0|||
105364835|NCT00369343|363340419|FG001|Double-blind Phase|Lack of Efficacy|4|||
105364836|NCT00369343|363340418|FG000|Double-blind Phase|Protocol deviation|4|||
105364837|NCT00369343|363340419|FG001|Double-blind Phase|Protocol deviation|0|||
105364838|NCT00369343|363340418|FG000|Open-label Phase|Adverse Event|19|||
105364839|NCT00369343|363340419|FG001|Open-label Phase|Adverse Event|7|||
105364840|NCT00369343|363340418|FG000|Open-label Phase|Failed to return|4|||
105364841|NCT00369343|363340419|FG001|Open-label Phase|Failed to return|0|||
105364842|NCT00369343|363340418|FG000|Open-label Phase|Physician Decision|2|||
105364843|NCT00369343|363340419|FG001|Open-label Phase|Physician Decision|0|||
105364844|NCT00369343|363340418|FG000|Open-label Phase|Lost to Follow-up|5|||
105364845|NCT00369343|363340419|FG001|Open-label Phase|Lost to Follow-up|3|||
105364846|NCT00369343|363340418|FG000|Open-label Phase|inadvertently reported study completers|3|||
105364847|NCT00369343|363340419|FG001|Open-label Phase|inadvertently reported study completers|2|||
105364848|NCT00369343|363340418|FG000|Open-label Phase|Protocol Violation|1|||
105364849|NCT00369343|363340419|FG001|Open-label Phase|Protocol Violation|3|||
105364850|NCT00369343|363340418|FG000|Open-label Phase|Withdrawal by Subject|15|||
105364851|NCT00369343|363340419|FG001|Open-label Phase|Withdrawal by Subject|6|||
105364852|NCT00369343|363340418|FG000|Open-label Phase|Lack of Efficacy|4|||
105364853|NCT00369343|363340419|FG001|Open-label Phase|Lack of Efficacy|3|||
105364854|NCT00369343|363340418|FG000|Open-label Phase|Lack of continuance tolerability|3|||
105364855|NCT00369343|363340419|FG001|Open-label Phase|Lack of continuance tolerability|4|||
105364856|NCT00369343|363340418|FG000|Open-label Phase|did not take study drug|1|||
105364857|NCT00369343|363340419|FG001|Open-label Phase|did not take study drug|2|||
105364858|NCT02895295|363340422|FG000|Overall Study|Survey Non-response|71|||
105364859|NCT02895295|363340423|FG001|Overall Study|Survey Non-response|94|||
105364860|NCT02895295|363340424|FG002|Overall Study|Survey Non-response|92|||
105364861|NCT02493517|363340425|FG000|Overall Study|Protocol Violation|1|||
105364862|NCT02493517|363340426|FG001|Overall Study|Protocol Violation|2|||
105822954|NCT00424047|365008883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
105822955|NCT00424047|365008882|FG000|On Study at Time of Unblinding|Adverse Event|22|||
105822956|NCT00424047|365008883|FG001|On Study at Time of Unblinding|Adverse Event|12|||
105822957|NCT00424047|365008882|FG000|On Study at Time of Unblinding|Progression of disease|92|||
105822958|NCT00424047|365008883|FG001|On Study at Time of Unblinding|Progression of disease|128|||
105822959|NCT00424047|365008882|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
105822960|NCT00424047|365008883|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
105822961|NCT00424047|365008882|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
105822962|NCT00424047|365008883|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
105822963|NCT00424047|365008882|FG000|On Study at Time of Unblinding|Death|11|||
105822964|NCT00424047|365008883|FG001|On Study at Time of Unblinding|Death|11|||
105822965|NCT00424047|365008882|FG000|On Study at Time of Unblinding|Other|5|||
105822966|NCT00424047|365008883|FG001|On Study at Time of Unblinding|Other|4|||
105822967|NCT00424047|365008882|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
105822968|NCT00424047|365008883|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
105822969|NCT00424047|365008882|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
105822970|NCT00424047|365008883|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
105822971|NCT00424047|365008882|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
105822972|NCT00424047|365008883|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
105822973|NCT00424047|365008882|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
105822974|NCT00424047|365008883|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
105822975|NCT00424047|365008882|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
105822976|NCT00424047|365008883|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
105822977|NCT00312897|365008884|FG000|Overall Study|Adverse Event|1|||
105822978|NCT00312897|365008885|FG001|Overall Study|Adverse Event|0|||
105822979|NCT00312897|365008884|FG000|Overall Study|Lost to Follow-up|2|||
105822980|NCT00312897|365008885|FG001|Overall Study|Lost to Follow-up|0|||
105822981|NCT00312897|365008884|FG000|Overall Study|Physician Decision|1|||
105822982|NCT00312897|365008885|FG001|Overall Study|Physician Decision|0|||
105822983|NCT00312897|365008884|FG000|Overall Study|Withdrawal by Subject|1|||
105822984|NCT00312897|365008885|FG001|Overall Study|Withdrawal by Subject|3|||
105822985|NCT00312897|365008884|FG000|Overall Study|Pregnancy|1|||
105822986|NCT00312897|365008885|FG001|Overall Study|Pregnancy|0|||
105364863|NCT02493517|363340425|FG000|Overall Study|Withdrawal by Subject|1|||
105364864|NCT02493517|363340426|FG001|Overall Study|Withdrawal by Subject|2|||
105364865|NCT02493517|363340425|FG000|Overall Study|Adverse Event|0|||
105822987|NCT00312897|365008884|FG000|Overall Study|discontinued prior to getting treatment|0|||
105822988|NCT00312897|365008885|FG001|Overall Study|discontinued prior to getting treatment|3|||
105822989|NCT01473953|365008888|FG000|Overall Study|Other|1|||
105364866|NCT02493517|363340426|FG001|Overall Study|Adverse Event|2|||
105364867|NCT02493517|363340425|FG000|Overall Study|Missed study visit|0|||
105364868|NCT02493517|363340426|FG001|Overall Study|Missed study visit|1|||
105364869|NCT02370511|363340437|FG000|Overall Study|Death|10|||
105364870|NCT02370511|363340438|FG001|Overall Study|Death|7|||
105364871|NCT02370511|363340439|FG002|Overall Study|Death|1|||
105364872|NCT02370511|363340437|FG000|Overall Study|Withdrawal by Subject|2|||
105364873|NCT02370511|363340438|FG001|Overall Study|Withdrawal by Subject|0|||
105364874|NCT02370511|363340439|FG002|Overall Study|Withdrawal by Subject|0|||
105364875|NCT02370511|363340437|FG000|Overall Study|Lost to Follow-up|0|||
105364876|NCT02370511|363340438|FG001|Overall Study|Lost to Follow-up|4|||
105364877|NCT02370511|363340439|FG002|Overall Study|Lost to Follow-up|0|||
105364878|NCT00807365|363340444|FG000|Overall Study|Study Terminated|5|||
105364879|NCT03811821|363340450|FG000|Overall Study|Adverse Event|1|||
105364880|NCT03811821|363340451|FG001|Overall Study|Adverse Event|1|||
105364881|NCT03811821|363340450|FG000|Overall Study|Withdrawal by Subject|5|||
105364882|NCT03811821|363340451|FG001|Overall Study|Withdrawal by Subject|4|||
105364883|NCT03811821|363340450|FG000|Overall Study|Lost to Follow-up|2|||
105364884|NCT03811821|363340451|FG001|Overall Study|Lost to Follow-up|2|||
105364885|NCT03811821|363340450|FG000|Overall Study|Contraindication for treatment|0|||
105364886|NCT03811821|363340451|FG001|Overall Study|Contraindication for treatment|1|||
105364887|NCT03811821|363340450|FG000|Overall Study|Tolerability|0|||
105364888|NCT03811821|363340451|FG001|Overall Study|Tolerability|3|||
105364889|NCT03811821|363340450|FG000|Overall Study|Comorbidities|0|||
105364890|NCT03811821|363340451|FG001|Overall Study|Comorbidities|2|||
105364891|NCT04809974|363342654|FG000|Lead-in Phase|Withdrawal by Subject|3|||
105364892|NCT04809974|363342655|FG001|Lead-in Phase|Withdrawal by Subject|0|||
105364893|NCT04809974|363342656|FG002|Lead-in Phase|Withdrawal by Subject|0|||
105364894|NCT04809974|363342654|FG000|Lead-in Phase|No longer eligible|11|||
105364895|NCT04809974|363342655|FG001|Lead-in Phase|No longer eligible|0|||
105822990|NCT01473953|365008889|FG001|Overall Study|Other|0|||
105822991|NCT01473953|365008890|FG002|Overall Study|Other|0|||
105822992|NCT01473953|365008891|FG003|Overall Study|Other|0|||
105822993|NCT01473953|365008892|FG004|Overall Study|Other|0|||
105822994|NCT01279486|365008893|FG000|Overall Study|Lost to Follow-up|1|||
105364896|NCT04809974|363342656|FG002|Lead-in Phase|No longer eligible|0|||
105364897|NCT04809974|363342654|FG000|Randomized Phase|Lost to Follow-up|0|||
105364898|NCT04809974|363342655|FG001|Randomized Phase|Lost to Follow-up|1|||
105364899|NCT04809974|363342656|FG002|Randomized Phase|Lost to Follow-up|5|||
105364900|NCT04809974|363342654|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
105364901|NCT04809974|363342655|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
105364902|NCT04809974|363342656|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
105364903|NCT04809974|363342654|FG000|Randomized Phase|Adverse Event|0|||
105364904|NCT04809974|363342655|FG001|Randomized Phase|Adverse Event|1|||
105364905|NCT04809974|363342656|FG002|Randomized Phase|Adverse Event|4|||
105364906|NCT04809974|363342654|FG000|Randomized Phase|Withdrawal by Subject|0|||
105364907|NCT04809974|363342655|FG001|Randomized Phase|Withdrawal by Subject|0|||
105364908|NCT04809974|363342656|FG002|Randomized Phase|Withdrawal by Subject|5|||
105364909|NCT03246347|363342657|FG000|Overall Study|On Study|23|||
105364910|NCT05664581|363342658|FG000|Overall Study|Withdrawal by Subject|2|||
105364911|NCT03163446|363342663|FG000|Overall Study|Unable to return for Day 180 visit|2|||
105364912|NCT03163446|363342664|FG001|Overall Study|Unable to return for Day 180 visit|0|||
105364913|NCT03163446|363342663|FG000|Overall Study|Withdrawal by Subject|2|||
105364914|NCT03163446|363342664|FG001|Overall Study|Withdrawal by Subject|6|||
105364915|NCT03163446|363342663|FG000|Overall Study|Death|16|||
105364916|NCT03163446|363342664|FG001|Overall Study|Death|5|||
105364917|NCT03163446|363342663|FG000|Overall Study|Lost to Follow-up|6|||
105364918|NCT03163446|363342664|FG001|Overall Study|Lost to Follow-up|5|||
105364919|NCT03163446|363342663|FG000|Overall Study|Physician Decision|1|||
105364920|NCT03163446|363342664|FG001|Overall Study|Physician Decision|1|||
105364921|NCT03163446|363342663|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
105364922|NCT03163446|363342664|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
105364923|NCT01317940|363342667|FG000|Overall Study|Death|1|||
105822995|NCT01404988|365008900|FG000|Overall Study|Death|2|||
105822996|NCT01404988|365008901|FG001|Overall Study|Death|0|||
105822997|NCT01404988|365008902|FG002|Overall Study|Death|2|||
105364924|NCT01317940|363342668|FG001|Overall Study|Death|0|||
105364925|NCT01317940|363342669|FG002|Overall Study|Death|1|||
105364926|NCT01317940|363342670|FG003|Overall Study|Death|0|||
105364927|NCT01317940|363342671|FG004|Overall Study|Death|0|||
105364928|NCT01317940|363342672|FG005|Overall Study|Death|0|||
105364929|NCT01317940|363342667|FG000|Overall Study|Lost to Follow-up|0|||
105822998|NCT01404988|365008900|FG000|Overall Study|Adverse Event|1|||
105486715|NCT00722371|363793385|FG000|Overall Study|Physician Decision|5|||
105364930|NCT01317940|363342668|FG001|Overall Study|Lost to Follow-up|0|||
105364931|NCT01317940|363342669|FG002|Overall Study|Lost to Follow-up|1|||
105822999|NCT01404988|365008901|FG001|Overall Study|Adverse Event|0|||
105823000|NCT01404988|365008902|FG002|Overall Study|Adverse Event|0|||
105364932|NCT01317940|363342670|FG003|Overall Study|Lost to Follow-up|1|||
105486716|NCT00722371|363793386|FG001|Overall Study|Physician Decision|2|||
105486717|NCT00722371|363793387|FG002|Overall Study|Physician Decision|2|||
105364933|NCT01317940|363342671|FG004|Overall Study|Lost to Follow-up|1|||
105767399|NCT03345342|364800449|FG000|Follow-Up Phase|Physician Decision|0|||
105767400|NCT03345342|364800450|FG001|Follow-Up Phase|Physician Decision|0|||
105767401|NCT03345342|364800451|FG002|Follow-Up Phase|Physician Decision|0|||
105364934|NCT01317940|363342672|FG005|Overall Study|Lost to Follow-up|0|||
105486718|NCT00722371|363793388|FG003|Overall Study|Physician Decision|5|||
105486719|NCT00722371|363793389|FG004|Overall Study|Physician Decision|2|||
105767402|NCT03345342|364800452|FG003|Follow-Up Phase|Physician Decision|0|||
105767403|NCT03345342|364800453|FG004|Follow-Up Phase|Physician Decision|5|||
105767404|NCT03345342|364800449|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
105767405|NCT03345342|364800450|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
105767406|NCT03345342|364800451|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
105767407|NCT03345342|364800452|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
105767408|NCT03345342|364800453|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
105767409|NCT03345342|364800449|FG000|Follow-Up Phase|Other|0|||
105767410|NCT03345342|364800450|FG001|Follow-Up Phase|Other|0|||
105767411|NCT03345342|364800451|FG002|Follow-Up Phase|Other|0|||
105767412|NCT03345342|364800452|FG003|Follow-Up Phase|Other|3|||
105767413|NCT03345342|364800453|FG004|Follow-Up Phase|Other|1|||
105767414|NCT02437162|364800454|FG000|Overall Study|Protocol Violation|0|||
105767415|NCT02437162|364800455|FG001|Overall Study|Protocol Violation|1|||
105767416|NCT02437162|364800456|FG002|Overall Study|Protocol Violation|0|||
105767417|NCT02437162|364800454|FG000|Overall Study|Randomized but not treated|0|||
105767418|NCT02437162|364800455|FG001|Overall Study|Randomized but not treated|0|||
105767419|NCT02437162|364800456|FG002|Overall Study|Randomized but not treated|1|||
105767420|NCT02437162|364800454|FG000|Overall Study|Study discontinued by Sponsor|93|||
105767421|NCT02437162|364800455|FG001|Overall Study|Study discontinued by Sponsor|98|||
105767422|NCT02437162|364800456|FG002|Overall Study|Study discontinued by Sponsor|97|||
105767423|NCT02437162|364800454|FG000|Overall Study|Withdrawal by Subject|13|||
105767424|NCT02437162|364800455|FG001|Overall Study|Withdrawal by Subject|7|||
105767425|NCT02437162|364800456|FG002|Overall Study|Withdrawal by Subject|9|||
105767426|NCT02437162|364800454|FG000|Overall Study|Adverse Event|0|||
105767427|NCT02437162|364800455|FG001|Overall Study|Adverse Event|1|||
105767428|NCT02437162|364800456|FG002|Overall Study|Adverse Event|0|||
105767429|NCT02437162|364800454|FG000|Overall Study|Lost to Follow-up|1|||
105767430|NCT02437162|364800455|FG001|Overall Study|Lost to Follow-up|0|||
105767431|NCT02437162|364800456|FG002|Overall Study|Lost to Follow-up|1|||
105767432|NCT02437162|364800454|FG000|Overall Study|Death|0|||
105767433|NCT02437162|364800455|FG001|Overall Study|Death|1|||
105767434|NCT02437162|364800456|FG002|Overall Study|Death|0|||
105767435|NCT02437162|364800454|FG000|Overall Study|Other|0|||
105767436|NCT02437162|364800455|FG001|Overall Study|Other|0|||
105767437|NCT02437162|364800456|FG002|Overall Study|Other|1|||
105767438|NCT03981744|364800457|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
105767439|NCT03981744|364800458|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
105486720|NCT00722371|363793390|FG005|Overall Study|Physician Decision|3|||
105767440|NCT03981744|364800459|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
105767441|NCT03981744|364800460|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
105767442|NCT03981744|364800457|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
105767443|NCT03981744|364800458|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
105767444|NCT03981744|364800459|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
105767445|NCT03981744|364800460|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
105767446|NCT03981744|364800457|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
105364935|NCT01317940|363342667|FG000|Overall Study|Change in therapy plan|0|||
105364936|NCT01317940|363342668|FG001|Overall Study|Change in therapy plan|0|||
105364937|NCT01317940|363342669|FG002|Overall Study|Change in therapy plan|3|||
105364938|NCT01317940|363342670|FG003|Overall Study|Change in therapy plan|0|||
105364939|NCT01317940|363342671|FG004|Overall Study|Change in therapy plan|0|||
105364940|NCT01317940|363342672|FG005|Overall Study|Change in therapy plan|0|||
105364941|NCT04152200|363342674|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
105364942|NCT04152200|363342675|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
105364943|NCT02699996|363342676|FG000|Overall Study|Withdrawal by Subject|5|||
105364944|NCT02699996|363342677|FG001|Overall Study|Withdrawal by Subject|2|||
105364945|NCT01921517|363342678|FG000|Overall Study|Lost to Follow-up|5|||
105364946|NCT01921517|363342679|FG001|Overall Study|Lost to Follow-up|0|||
105364947|NCT01921517|363342678|FG000|Overall Study|Newly diagnosed health concern|2|||
105364948|NCT01921517|363342679|FG001|Overall Study|Newly diagnosed health concern|0|||
105364949|NCT01921517|363342678|FG000|Overall Study|Physician Decision|0|||
105364950|NCT01921517|363342679|FG001|Overall Study|Physician Decision|2|||
105364951|NCT01921517|363342678|FG000|Overall Study|Withdrawal by Subject|7|||
105364952|NCT01921517|363342679|FG001|Overall Study|Withdrawal by Subject|3|||
105364953|NCT01921517|363342678|FG000|Overall Study|Subject missed final imaging|1|||
105364954|NCT01921517|363342679|FG001|Overall Study|Subject missed final imaging|4|||
105823001|NCT01404988|365008900|FG000|Overall Study|Withdrawal by Subject|2|||
105823002|NCT01404988|365008901|FG001|Overall Study|Withdrawal by Subject|2|||
105823003|NCT01404988|365008902|FG002|Overall Study|Withdrawal by Subject|0|||
105823004|NCT01404988|365008900|FG000|Overall Study|Lost to Follow-up|1|||
105823005|NCT01404988|365008901|FG001|Overall Study|Lost to Follow-up|2|||
105823006|NCT01404988|365008902|FG002|Overall Study|Lost to Follow-up|1|||
105823007|NCT01963728|365008907|FG000|Overall Study|Study terminated early|0|||
105823008|NCT01963728|365008908|FG001|Overall Study|Study terminated early|1|||
105823009|NCT04852978|365008911|FG000|Overall Study|Physician Decision|0|||
105364955|NCT04069715|363342682|FG000|Overall Study|Lost to Follow-up|1|||
105823010|NCT04852978|365008912|FG001|Overall Study|Physician Decision|1|||
105823011|NCT04852978|365008913|FG002|Overall Study|Physician Decision|0|||
105364956|NCT04069715|363342683|FG001|Overall Study|Lost to Follow-up|1|||
105364957|NCT04069715|363342682|FG000|Overall Study|Physician Decision|1|||
105364958|NCT04069715|363342683|FG001|Overall Study|Physician Decision|1|||
105364959|NCT04069715|363342682|FG000|Overall Study|Withdrawal by Subject|3|||
105364960|NCT04069715|363342683|FG001|Overall Study|Withdrawal by Subject|3|||
105364961|NCT01095835|363342686|FG000|Overall Study|Adverse Event|8|||
105364962|NCT01095835|363342687|FG001|Overall Study|Adverse Event|6|||
105364963|NCT01095835|363342688|FG002|Overall Study|Adverse Event|6|||
105486721|NCT00722371|363793391|FG006|Overall Study|Physician Decision|4|||
105486722|NCT00722371|363793385|FG000|Overall Study|Pregnancy|1|||
105823012|NCT04852978|365008914|FG003|Overall Study|Physician Decision|0|||
105823013|NCT04852978|365008915|FG004|Overall Study|Physician Decision|0|||
105823014|NCT04852978|365008916|FG005|Overall Study|Physician Decision|0|||
105823015|NCT04852978|365008917|FG006|Overall Study|Physician Decision|0|||
105823016|NCT04852978|365008918|FG007|Overall Study|Physician Decision|2|||
105823017|NCT04852978|365008919|FG008|Overall Study|Physician Decision|0|||
105823018|NCT04852978|365008911|FG000|Overall Study|Sponsor request|0|||
105364964|NCT01095835|363342686|FG000|Overall Study|Lack of Efficacy|0|||
105364965|NCT01095835|363342687|FG001|Overall Study|Lack of Efficacy|1|||
105364966|NCT01095835|363342688|FG002|Overall Study|Lack of Efficacy|0|||
105364967|NCT01095835|363342686|FG000|Overall Study|Physician Decision|0|||
105486723|NCT00722371|363793386|FG001|Overall Study|Pregnancy|1|||
105486724|NCT00722371|363793387|FG002|Overall Study|Pregnancy|0|||
105486725|NCT00722371|363793388|FG003|Overall Study|Pregnancy|0|||
105486726|NCT00722371|363793389|FG004|Overall Study|Pregnancy|0|||
105486727|NCT00722371|363793390|FG005|Overall Study|Pregnancy|1|||
105823019|NCT04852978|365008912|FG001|Overall Study|Sponsor request|0|||
105823020|NCT04852978|365008913|FG002|Overall Study|Sponsor request|1|||
105823021|NCT04852978|365008914|FG003|Overall Study|Sponsor request|0|||
105823022|NCT04852978|365008915|FG004|Overall Study|Sponsor request|0|||
105823023|NCT04852978|365008916|FG005|Overall Study|Sponsor request|0|||
105823024|NCT04852978|365008917|FG006|Overall Study|Sponsor request|0|||
105823025|NCT04852978|365008918|FG007|Overall Study|Sponsor request|0|||
105823026|NCT04852978|365008919|FG008|Overall Study|Sponsor request|0|||
105823027|NCT04852978|365008911|FG000|Overall Study|Death|0|||
105823028|NCT04852978|365008912|FG001|Overall Study|Death|0|||
105823029|NCT04852978|365008913|FG002|Overall Study|Death|0|||
105823030|NCT04852978|365008914|FG003|Overall Study|Death|0|||
105823031|NCT04852978|365008915|FG004|Overall Study|Death|0|||
105823032|NCT04852978|365008916|FG005|Overall Study|Death|0|||
105823033|NCT04852978|365008917|FG006|Overall Study|Death|1|||
105823034|NCT04852978|365008918|FG007|Overall Study|Death|0|||
105823035|NCT04852978|365008919|FG008|Overall Study|Death|0|||
105823036|NCT04852978|365008911|FG000|Overall Study|Lost to Follow-up|3|||
105823037|NCT04852978|365008912|FG001|Overall Study|Lost to Follow-up|2|||
105823038|NCT04852978|365008913|FG002|Overall Study|Lost to Follow-up|2|||
105823039|NCT04852978|365008914|FG003|Overall Study|Lost to Follow-up|0|||
105823040|NCT04852978|365008915|FG004|Overall Study|Lost to Follow-up|2|||
105823041|NCT04852978|365008916|FG005|Overall Study|Lost to Follow-up|4|||
105767447|NCT03981744|364800458|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
105767448|NCT03981744|364800459|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
105767449|NCT03981744|364800460|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
105767450|NCT02782104|364800461|FG000|Overall Study|Other|215|||
105823042|NCT04852978|365008917|FG006|Overall Study|Lost to Follow-up|1|||
105823043|NCT04852978|365008918|FG007|Overall Study|Lost to Follow-up|2|||
105823044|NCT04852978|365008919|FG008|Overall Study|Lost to Follow-up|2|||
105823045|NCT04852978|365008911|FG000|Overall Study|Withdrawal by Subject|4|||
105823046|NCT04852978|365008912|FG001|Overall Study|Withdrawal by Subject|2|||
105823047|NCT04852978|365008913|FG002|Overall Study|Withdrawal by Subject|2|||
105823048|NCT04852978|365008914|FG003|Overall Study|Withdrawal by Subject|1|||
105823049|NCT04852978|365008915|FG004|Overall Study|Withdrawal by Subject|5|||
105823050|NCT04852978|365008916|FG005|Overall Study|Withdrawal by Subject|3|||
105823051|NCT04852978|365008917|FG006|Overall Study|Withdrawal by Subject|2|||
105823052|NCT04852978|365008918|FG007|Overall Study|Withdrawal by Subject|2|||
105823053|NCT04852978|365008919|FG008|Overall Study|Withdrawal by Subject|1|||
105823054|NCT02068794|365010404|FG000|Overall Study|Withdrawal by Subject|0|||
105823055|NCT02068794|365010405|FG001|Overall Study|Withdrawal by Subject|1|||
105823056|NCT02068794|365010406|FG002|Overall Study|Withdrawal by Subject|2|||
105823057|NCT02068794|365010404|FG000|Overall Study|Early Progression|1|||
105823058|NCT02068794|365010405|FG001|Overall Study|Early Progression|0|||
105823059|NCT02068794|365010406|FG002|Overall Study|Early Progression|1|||
105823060|NCT02068794|365010404|FG000|Overall Study|Ineligible|0|||
105823061|NCT02068794|365010405|FG001|Overall Study|Ineligible|0|||
105823062|NCT02068794|365010406|FG002|Overall Study|Ineligible|1|||
105823063|NCT04115293|365010407|FG000|Overall Study|Adverse Event|0|||
105767451|NCT02782104|364800461|FG000|Overall Study|Induction Day 28 Non Responder|9|||
105767452|NCT02782104|364800461|FG000|Overall Study|Non-Compliance with Study Drug|2|||
105767453|NCT02782104|364800461|FG000|Overall Study|Death|8|||
105767454|NCT02782104|364800461|FG000|Overall Study|Pregnancy|6|||
105767455|NCT02782104|364800461|FG000|Overall Study|Withdrawal by Subject|63|||
105767456|NCT02782104|364800461|FG000|Overall Study|Protocol Violation|7|||
105767457|NCT02782104|364800461|FG000|Overall Study|Lack of Efficacy|61|||
105767458|NCT02782104|364800461|FG000|Overall Study|Lost to Follow-up|23|||
105767459|NCT02782104|364800461|FG000|Overall Study|Adverse Event|74|||
105767460|NCT03464136|364800462|FG000|Overall Study|Lost to Follow-up|5|||
105767461|NCT03464136|364800463|FG001|Overall Study|Lost to Follow-up|8|||
105767462|NCT03464136|364800462|FG000|Overall Study|Withdrawal by Subject|16|||
105767463|NCT03464136|364800463|FG001|Overall Study|Withdrawal by Subject|13|||
105767464|NCT03464136|364800462|FG000|Overall Study|Death|1|||
105767465|NCT03464136|364800463|FG001|Overall Study|Death|0|||
105767466|NCT03464136|364800462|FG000|Overall Study|Other|8|||
105767467|NCT03464136|364800463|FG001|Overall Study|Other|4|||
105767468|NCT04338321|364800464|FG000|Overall Study|Adverse Event|4|||
105767469|NCT04338321|364800465|FG001|Overall Study|Adverse Event|10|||
105767470|NCT04338321|364800464|FG000|Overall Study|Death|1|||
105767471|NCT04338321|364800465|FG001|Overall Study|Death|1|||
105767472|NCT04338321|364800464|FG000|Overall Study|Lost to Follow-up|4|||
105767473|NCT04338321|364800465|FG001|Overall Study|Lost to Follow-up|9|||
105767474|NCT04338321|364800464|FG000|Overall Study|Withdrawal by Subject|45|||
105823064|NCT04115293|365010408|FG001|Overall Study|Adverse Event|2|||
105823065|NCT04115293|365010407|FG000|Overall Study|Withdrawal by Subject|2|||
105823066|NCT04115293|365010408|FG001|Overall Study|Withdrawal by Subject|1|||
105823067|NCT04115293|365010407|FG000|Overall Study|Physician Decision|1|||
105823068|NCT04115293|365010408|FG001|Overall Study|Physician Decision|0|||
105823069|NCT04115293|365010407|FG000|Overall Study|Death|1|||
105823070|NCT04115293|365010408|FG001|Overall Study|Death|1|||
105823071|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
105823072|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
105364968|NCT01095835|363342687|FG001|Overall Study|Physician Decision|0|||
105364969|NCT01095835|363342688|FG002|Overall Study|Physician Decision|1|||
105364970|NCT01095835|363342686|FG000|Overall Study|Withdrawal by Subject|1|||
105364971|NCT01095835|363342687|FG001|Overall Study|Withdrawal by Subject|3|||
105364972|NCT01095835|363342688|FG002|Overall Study|Withdrawal by Subject|0|||
105364973|NCT01095835|363342686|FG000|Overall Study|Non study compliance|0|||
105364974|NCT01095835|363342687|FG001|Overall Study|Non study compliance|0|||
105364975|NCT01095835|363342688|FG002|Overall Study|Non study compliance|1|||
105364976|NCT01095835|363342686|FG000|Overall Study|Protocol Violation|1|||
105364977|NCT01095835|363342687|FG001|Overall Study|Protocol Violation|2|||
105364978|NCT01095835|363342688|FG002|Overall Study|Protocol Violation|0|||
105364979|NCT00327340|363342693|FG000|Overall Study|Withdrawal by Subject|1|||
105364980|NCT00327340|363342694|FG001|Overall Study|Withdrawal by Subject|5|||
105364981|NCT00327340|363342693|FG000|Overall Study|Physician Decision|1|||
105364982|NCT00327340|363342694|FG001|Overall Study|Physician Decision|1|||
105364983|NCT00327340|363342693|FG000|Overall Study|Disease Progression|10|||
105364984|NCT00327340|363342694|FG001|Overall Study|Disease Progression|19|||
105364985|NCT00327340|363342693|FG000|Overall Study|Symptomatic Disease|0|||
105364986|NCT00327340|363342694|FG001|Overall Study|Symptomatic Disease|2|||
105364987|NCT00327340|363342693|FG000|Overall Study|Adverse Event|3|||
105364988|NCT00327340|363342694|FG001|Overall Study|Adverse Event|3|||
105364989|NCT03527277|363342695|FG000|Overall Study|Withdrawal by Subject|5|||
105364990|NCT03527277|363342696|FG001|Overall Study|Withdrawal by Subject|0|||
105364991|NCT03527277|363342695|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
105364992|NCT03527277|363342696|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
105364993|NCT03527277|363342695|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
105364994|NCT03527277|363342696|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
105364995|NCT03316586|363342697|FG000|Overall Study|Adverse Event|2|||
105364996|NCT03316586|363342697|FG000|Overall Study|Physician Decision|3|||
105364997|NCT03316586|363342697|FG000|Overall Study|Lack of Efficacy|10|||
105364998|NCT03316586|363342697|FG000|Overall Study|still on treatment|1|||
105364999|NCT03316586|363342697|FG000|Overall Study|Patient needed radiation therapy|1|||
105365000|NCT03316586|363342697|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
105365001|NCT00643760|363342700|FG000|Overall Study|Adverse Event|11|||
105365002|NCT00643760|363342701|FG001|Overall Study|Adverse Event|5|||
105365003|NCT00643760|363342702|FG002|Overall Study|Adverse Event|12|||
105365004|NCT00643760|363342703|FG003|Overall Study|Adverse Event|21|||
105365005|NCT00643760|363342704|FG004|Overall Study|Adverse Event|6|||
105365006|NCT00643760|363342700|FG000|Overall Study|Lack of Efficacy|3|||
105365007|NCT00643760|363342701|FG001|Overall Study|Lack of Efficacy|1|||
105365008|NCT00643760|363342702|FG002|Overall Study|Lack of Efficacy|0|||
105486728|NCT00722371|363793391|FG006|Overall Study|Pregnancy|0|||
105365009|NCT00643760|363342703|FG003|Overall Study|Lack of Efficacy|4|||
105365010|NCT00643760|363342704|FG004|Overall Study|Lack of Efficacy|3|||
105365011|NCT00643760|363342700|FG000|Overall Study|Protocol Violation|7|||
105365012|NCT00643760|363342701|FG001|Overall Study|Protocol Violation|6|||
105365013|NCT00643760|363342702|FG002|Overall Study|Protocol Violation|4|||
105365014|NCT00643760|363342703|FG003|Overall Study|Protocol Violation|4|||
105767475|NCT04338321|364800465|FG001|Overall Study|Withdrawal by Subject|69|||
105767476|NCT04338321|364800464|FG000|Overall Study|Physician Decision|5|||
105767477|NCT04338321|364800465|FG001|Overall Study|Physician Decision|9|||
105767478|NCT04338321|364800464|FG000|Overall Study|Other|3|||
105767479|NCT04338321|364800465|FG001|Overall Study|Other|10|||
105767480|NCT02438787|364800466|FG000|Overall Study|Adverse Event|1|||
105767481|NCT02438787|364800467|FG001|Overall Study|Adverse Event|0|||
105767482|NCT02438787|364800468|FG002|Overall Study|Adverse Event|2|||
105767483|NCT02438787|364800466|FG000|Overall Study|Lack of Efficacy|1|||
105767484|NCT02438787|364800467|FG001|Overall Study|Lack of Efficacy|2|||
105767485|NCT02438787|364800468|FG002|Overall Study|Lack of Efficacy|0|||
105767486|NCT02438787|364800466|FG000|Overall Study|Lost to Follow-up|0|||
105767487|NCT02438787|364800467|FG001|Overall Study|Lost to Follow-up|1|||
105767488|NCT02438787|364800468|FG002|Overall Study|Lost to Follow-up|0|||
105767489|NCT02438787|364800466|FG000|Overall Study|Protocol Violation|0|||
105767490|NCT02438787|364800467|FG001|Overall Study|Protocol Violation|0|||
105767491|NCT02438787|364800468|FG002|Overall Study|Protocol Violation|1|||
105767492|NCT02438787|364800466|FG000|Overall Study|Withdrawal by Subject|15|||
105767493|NCT02438787|364800467|FG001|Overall Study|Withdrawal by Subject|7|||
105767494|NCT02438787|364800468|FG002|Overall Study|Withdrawal by Subject|10|||
105767495|NCT02438787|364800466|FG000|Overall Study|Study discontinued by sponsor|64|||
105767496|NCT02438787|364800467|FG001|Overall Study|Study discontinued by sponsor|72|||
105767497|NCT02438787|364800468|FG002|Overall Study|Study discontinued by sponsor|69|||
105767498|NCT02438787|364800466|FG000|Overall Study|Other|0|||
105767499|NCT02438787|364800467|FG001|Overall Study|Other|1|||
105767500|NCT02438787|364800468|FG002|Overall Study|Other|0|||
105767501|NCT02438787|364800466|FG000|Overall Study|Site terminated by sponsor|0|||
105767502|NCT02438787|364800467|FG001|Overall Study|Site terminated by sponsor|0|||
105767503|NCT02438787|364800468|FG002|Overall Study|Site terminated by sponsor|1|||
105767504|NCT03412565|364800469|FG000|Overall Study|Lost to Follow-up|0|||
105767505|NCT03412565|364800470|FG001|Overall Study|Lost to Follow-up|0|||
105767506|NCT03412565|364800471|FG002|Overall Study|Lost to Follow-up|1|||
105767507|NCT03412565|364800472|FG003|Overall Study|Lost to Follow-up|0|||
105767508|NCT03412565|364800469|FG000|Overall Study|Physician Decision|0|||
105767509|NCT03412565|364800470|FG001|Overall Study|Physician Decision|0|||
105767510|NCT03412565|364800471|FG002|Overall Study|Physician Decision|0|||
105767511|NCT03412565|364800472|FG003|Overall Study|Physician Decision|1|||
105767512|NCT03412565|364800469|FG000|Overall Study|Withdrawal by Subject|0|||
105767513|NCT03412565|364800470|FG001|Overall Study|Withdrawal by Subject|4|||
105767514|NCT03412565|364800471|FG002|Overall Study|Withdrawal by Subject|5|||
105767515|NCT03412565|364800472|FG003|Overall Study|Withdrawal by Subject|5|||
105767516|NCT03412565|364800469|FG000|Overall Study|Death|1|||
105767517|NCT03412565|364800470|FG001|Overall Study|Death|3|||
105767518|NCT03412565|364800471|FG002|Overall Study|Death|4|||
105767519|NCT03412565|364800472|FG003|Overall Study|Death|5|||
105767520|NCT03412565|364800469|FG000|Overall Study|Data collection ended|0|||
105767521|NCT03412565|364800470|FG001|Overall Study|Data collection ended|41|||
105767522|NCT03412565|364800471|FG002|Overall Study|Data collection ended|41|||
105767523|NCT03412565|364800472|FG003|Overall Study|Data collection ended|40|||
105767524|NCT03107793|364800473|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
105767525|NCT03107793|364800474|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
105767526|NCT03107793|364800475|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
105767527|NCT03107793|364800476|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
105767528|NCT03107793|364800477|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
105767529|NCT03107793|364800473|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
105767530|NCT03107793|364800474|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
105767531|NCT03107793|364800475|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
105767532|NCT03107793|364800476|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
105767533|NCT03107793|364800477|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
105767534|NCT03107793|364800473|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
105767535|NCT03107793|364800474|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
105767536|NCT03107793|364800475|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
105767537|NCT03107793|364800476|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
105767538|NCT03107793|364800477|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
105767539|NCT03107793|364800473|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
105767540|NCT03107793|364800474|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105767541|NCT03107793|364800475|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105767542|NCT03107793|364800476|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105571729|NCT02948959|364092749|FG001|52 Weeks Treatment Period|Change of residence location|1|||
105767543|NCT03107793|364800477|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105767544|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
105767545|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
105571730|NCT02948959|364092748|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
105571731|NCT02948959|364092749|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
105571732|NCT02948959|364092748|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
105571733|NCT02948959|364092749|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
105571734|NCT02948959|364092748|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
105571735|NCT02948959|364092749|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
105571736|NCT02948959|364092748|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
105571737|NCT02948959|364092749|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
105571738|NCT02948959|364092748|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
105571739|NCT02948959|364092749|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
105571740|NCT02948959|364092748|FG000|12 Weeks Follow-up Period|Study site closure|1|||
105571741|NCT02948959|364092749|FG001|12 Weeks Follow-up Period|Study site closure|0|||
105571742|NCT00409786|364092750|FG000|Overall Study|Withdrawal by Subject|3|||
105571743|NCT00301080|364092758|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
105571744|NCT00301080|364092759|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
105571745|NCT00301080|364092760|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
105571746|NCT00301080|364092761|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
105571747|NCT00301080|364092762|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
105571748|NCT03560258|364092765|FG000|Overall Study|Lost to Follow-up|3|||
105571749|NCT03560258|364092766|FG001|Overall Study|Lost to Follow-up|0|||
105571750|NCT03560258|364092767|FG002|Overall Study|Lost to Follow-up|0|||
105571751|NCT03560258|364092765|FG000|Overall Study|Protocol Violation|0|||
105571752|NCT03560258|364092766|FG001|Overall Study|Protocol Violation|1|||
105571753|NCT03560258|364092767|FG002|Overall Study|Protocol Violation|0|||
105571754|NCT03560258|364092765|FG000|Overall Study|Withdrawal by Subject|0|||
105571755|NCT03560258|364092766|FG001|Overall Study|Withdrawal by Subject|0|||
105767546|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
105767547|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
105767548|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
105767549|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
105767550|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
105767551|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
105767552|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
105823073|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
105767553|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
105767554|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
105767555|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
105767556|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
105767557|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
105767558|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
105571756|NCT03560258|364092767|FG002|Overall Study|Withdrawal by Subject|1|||
105571757|NCT01872910|364092768|FG000|Overall Study|Lost to Follow-up|2|||
105571758|NCT01872910|364092769|FG001|Overall Study|Lost to Follow-up|0|||
105767559|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
105767560|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
105767561|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
105767562|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
105767563|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
105767564|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
105365015|NCT00643760|363342704|FG004|Overall Study|Protocol Violation|6|||
105365016|NCT00643760|363342700|FG000|Overall Study|Lost to Follow-up|6|||
105365017|NCT00643760|363342701|FG001|Overall Study|Lost to Follow-up|2|||
105365018|NCT00643760|363342702|FG002|Overall Study|Lost to Follow-up|1|||
105365019|NCT00643760|363342703|FG003|Overall Study|Lost to Follow-up|3|||
105365020|NCT00643760|363342704|FG004|Overall Study|Lost to Follow-up|3|||
105365021|NCT00643760|363342700|FG000|Overall Study|Investigator Discretion|0|||
105365022|NCT00643760|363342701|FG001|Overall Study|Investigator Discretion|0|||
105365023|NCT00643760|363342702|FG002|Overall Study|Investigator Discretion|0|||
105365024|NCT00643760|363342703|FG003|Overall Study|Investigator Discretion|2|||
105365025|NCT00643760|363342704|FG004|Overall Study|Investigator Discretion|0|||
105365026|NCT00643760|363342700|FG000|Overall Study|Withdrawal by Subject|3|||
105365027|NCT00643760|363342701|FG001|Overall Study|Withdrawal by Subject|1|||
105365028|NCT00643760|363342702|FG002|Overall Study|Withdrawal by Subject|2|||
105365029|NCT00643760|363342703|FG003|Overall Study|Withdrawal by Subject|4|||
105365030|NCT00643760|363342704|FG004|Overall Study|Withdrawal by Subject|1|||
105365031|NCT00735709|363342705|FG000|Overall Study|Adverse Event|2|||
105365032|NCT00735709|363342706|FG001|Overall Study|Adverse Event|3|||
105365033|NCT00735709|363342707|FG002|Overall Study|Adverse Event|1|||
105365034|NCT00735709|363342708|FG003|Overall Study|Adverse Event|5|||
105365035|NCT00735709|363342705|FG000|Overall Study|Lack of Efficacy|8|||
105365036|NCT00735709|363342706|FG001|Overall Study|Lack of Efficacy|4|||
105767565|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
105767566|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
105767567|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
105767568|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
105767569|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
105767570|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
105767571|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
105767572|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
105767573|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
105767574|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105365037|NCT00735709|363342707|FG002|Overall Study|Lack of Efficacy|2|||
105486729|NCT00722371|363793385|FG000|Overall Study|Protocol Violation|6|||
105486730|NCT00722371|363793386|FG001|Overall Study|Protocol Violation|1|||
105486731|NCT00722371|363793387|FG002|Overall Study|Protocol Violation|0|||
105486732|NCT00722371|363793388|FG003|Overall Study|Protocol Violation|1|||
105486733|NCT00722371|363793389|FG004|Overall Study|Protocol Violation|4|||
105486734|NCT00722371|363793390|FG005|Overall Study|Protocol Violation|2|||
105486735|NCT00722371|363793391|FG006|Overall Study|Protocol Violation|1|||
105486736|NCT00722371|363793385|FG000|Overall Study|Withdrawal by Subject|18|||
105486737|NCT00722371|363793386|FG001|Overall Study|Withdrawal by Subject|27|||
105486738|NCT00722371|363793387|FG002|Overall Study|Withdrawal by Subject|19|||
105486739|NCT00722371|363793388|FG003|Overall Study|Withdrawal by Subject|23|||
105486740|NCT00722371|363793389|FG004|Overall Study|Withdrawal by Subject|19|||
105486741|NCT00722371|363793390|FG005|Overall Study|Withdrawal by Subject|18|||
105486742|NCT00722371|363793391|FG006|Overall Study|Withdrawal by Subject|26|||
105486743|NCT00378079|363793392|FG000|Overall Study|Lost to Follow-up|6|||
105486744|NCT00378079|363793393|FG001|Overall Study|Lost to Follow-up|1|||
105486745|NCT00378079|363793394|FG002|Overall Study|Lost to Follow-up|0|||
105486746|NCT03021564|363793395|FG000|Overall Study|Death|84|||
105486747|NCT03021564|363793396|FG001|Overall Study|Death|466|||
105486748|NCT03021564|363793395|FG000|Overall Study|Lost to Follow-up|0|||
105486749|NCT03021564|363793396|FG001|Overall Study|Lost to Follow-up|2|||
105486750|NCT00745615|363793407|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
105486751|NCT00745615|363793408|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
105486752|NCT00745615|363793409|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
105486753|NCT00745615|363793410|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
105486754|NCT00745615|363793411|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
105486755|NCT00745615|363793412|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
105486756|NCT00745615|363793407|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
105486757|NCT00745615|363793408|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
105486758|NCT00745615|363793409|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
105486759|NCT00745615|363793410|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
105486760|NCT00745615|363793411|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
105486761|NCT00745615|363793412|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
105571759|NCT01872910|364092770|FG002|Overall Study|Lost to Follow-up|2|||
105365038|NCT00735709|363342708|FG003|Overall Study|Lack of Efficacy|3|||
105365039|NCT00735709|363342705|FG000|Overall Study|Noncompliance|0|||
105365040|NCT00735709|363342706|FG001|Overall Study|Noncompliance|0|||
105365041|NCT00735709|363342707|FG002|Overall Study|Noncompliance|1|||
105486762|NCT00745615|363793407|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
105486763|NCT00745615|363793408|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
105486764|NCT00745615|363793409|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
105486765|NCT00745615|363793410|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
105767575|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
105767576|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105767577|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105767578|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105767579|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
105767580|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
105767581|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
105767582|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
105767583|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
105767584|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
105767585|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
105767586|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
105767587|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
105767588|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
105767589|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
105767590|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
105767591|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
105767592|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
105767593|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
105767594|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
105767595|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
105767596|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
105767597|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
105767598|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
105823074|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105823075|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105823076|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105823077|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105823078|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105823079|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
105823080|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
105823081|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105823082|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105823083|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105365042|NCT00735709|363342708|FG003|Overall Study|Noncompliance|0|||
105486766|NCT00745615|363793411|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
105486767|NCT00745615|363793412|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
105486768|NCT00745615|363793407|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
105486769|NCT00745615|363793408|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
105486770|NCT00745615|363793409|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
105486771|NCT00745615|363793410|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
105486772|NCT00745615|363793411|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
105486773|NCT00745615|363793412|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
105486774|NCT00745615|363793407|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
105486775|NCT00745615|363793408|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
105486776|NCT00745615|363793409|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
105486777|NCT00745615|363793410|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
105486778|NCT00745615|363793411|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
105486779|NCT00745615|363793412|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
105486780|NCT00745615|363793407|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
105486781|NCT00745615|363793408|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
105486782|NCT00745615|363793409|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
105486783|NCT00745615|363793410|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
105486784|NCT00745615|363793411|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
105486785|NCT00745615|363793412|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
105486786|NCT00745615|363793407|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
105486787|NCT00745615|363793408|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
105486788|NCT00745615|363793409|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
105486789|NCT00745615|363793410|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
105486790|NCT00745615|363793411|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
105486791|NCT00745615|363793412|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
105486792|NCT00745615|363793407|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
105486793|NCT00745615|363793408|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
105486794|NCT00745615|363793409|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
105486795|NCT00745615|363793410|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
105571760|NCT01872910|364092771|FG003|Overall Study|Lost to Follow-up|0|||
105571761|NCT01872910|364092772|FG004|Overall Study|Lost to Follow-up|0|||
105571762|NCT01872910|364092773|FG005|Overall Study|Lost to Follow-up|0|||
105571763|NCT00100932|364092774|FG000|Overall Study|Adverse Event|11|||
105571764|NCT00100932|364092775|FG001|Overall Study|Adverse Event|2|||
105571765|NCT00100932|364092774|FG000|Overall Study|Withdrawal by Subject|6|||
105571766|NCT00100932|364092775|FG001|Overall Study|Withdrawal by Subject|0|||
105571767|NCT00100932|364092774|FG000|Overall Study|Progressive Disease|44|||
105571768|NCT00100932|364092775|FG001|Overall Study|Progressive Disease|18|||
105571769|NCT00100932|364092774|FG000|Overall Study|Physician Decision|7|||
105571770|NCT00100932|364092775|FG001|Overall Study|Physician Decision|5|||
105571771|NCT00100932|364092774|FG000|Overall Study|Other|5|||
105571772|NCT00100932|364092775|FG001|Overall Study|Other|2|||
105571773|NCT01616771|364092776|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
105571774|NCT00744328|364092777|FG000|Overall Study|Lost to Follow-up|2|||
105571775|NCT00744328|364092778|FG001|Overall Study|Lost to Follow-up|5|||
105571776|NCT00744328|364092779|FG002|Overall Study|Lost to Follow-up|3|||
105571777|NCT00744328|364092777|FG000|Overall Study|Withdrawal by Subject|5|||
105571778|NCT00744328|364092778|FG001|Overall Study|Withdrawal by Subject|3|||
105571779|NCT00744328|364092779|FG002|Overall Study|Withdrawal by Subject|4|||
105571780|NCT00744328|364092777|FG000|Overall Study|Found ineligible after randomization|0|||
105571781|NCT00744328|364092778|FG001|Overall Study|Found ineligible after randomization|0|||
105571782|NCT00744328|364092779|FG002|Overall Study|Found ineligible after randomization|1|||
105571783|NCT01678820|364092785|FG000|Overall Study|Study Terminated by Sponsor|45|||
105571784|NCT01678820|364092786|FG001|Overall Study|Study Terminated by Sponsor|43|||
105571785|NCT01678820|364092787|FG002|Overall Study|Study Terminated by Sponsor|43|||
105571786|NCT01678820|364092785|FG000|Overall Study|Withdrawal by Subject|2|||
105571787|NCT01678820|364092786|FG001|Overall Study|Withdrawal by Subject|5|||
105571788|NCT01678820|364092787|FG002|Overall Study|Withdrawal by Subject|2|||
105571789|NCT01678820|364092785|FG000|Overall Study|Protocol Specified Criteria|2|||
105571790|NCT01678820|364092786|FG001|Overall Study|Protocol Specified Criteria|3|||
105571791|NCT01678820|364092787|FG002|Overall Study|Protocol Specified Criteria|1|||
105571792|NCT01678820|364092785|FG000|Overall Study|Adverse Event|2|||
105571793|NCT01678820|364092786|FG001|Overall Study|Adverse Event|2|||
105571794|NCT01678820|364092787|FG002|Overall Study|Adverse Event|2|||
105571795|NCT01678820|364092785|FG000|Overall Study|Lost to Follow-up|7|||
105571796|NCT01678820|364092786|FG001|Overall Study|Lost to Follow-up|2|||
105571797|NCT01678820|364092787|FG002|Overall Study|Lost to Follow-up|2|||
105571798|NCT01678820|364092785|FG000|Overall Study|Non-compliance with study drug|0|||
105571799|NCT01678820|364092786|FG001|Overall Study|Non-compliance with study drug|1|||
105571800|NCT01678820|364092787|FG002|Overall Study|Non-compliance with study drug|0|||
105571801|NCT01678820|364092785|FG000|Overall Study|Physician Decision|0|||
105571802|NCT01678820|364092786|FG001|Overall Study|Physician Decision|0|||
105571803|NCT01678820|364092787|FG002|Overall Study|Physician Decision|1|||
105571804|NCT01678820|364092785|FG000|Overall Study|Protocol Violation|4|||
105571805|NCT01678820|364092786|FG001|Overall Study|Protocol Violation|5|||
105571806|NCT01678820|364092787|FG002|Overall Study|Protocol Violation|4|||
105571807|NCT01678820|364092785|FG000|Overall Study|Not treated with double-blind study drug|0|||
105571808|NCT01678820|364092786|FG001|Overall Study|Not treated with double-blind study drug|2|||
105571809|NCT01678820|364092787|FG002|Overall Study|Not treated with double-blind study drug|2|||
105571810|NCT02247804|364092788|FG000|Treatment Period 1|Adverse Event|9|||
105571811|NCT02247804|364092789|FG001|Treatment Period 1|Adverse Event|2|||
105571812|NCT02247804|364092790|FG002|Treatment Period 1|Adverse Event|0|||
105571813|NCT02247804|364092788|FG000|Treatment Period 1|Lack of Efficacy|0|||
105571814|NCT02247804|364092789|FG001|Treatment Period 1|Lack of Efficacy|0|||
105571815|NCT02247804|364092790|FG002|Treatment Period 1|Lack of Efficacy|2|||
105571816|NCT02247804|364092788|FG000|Treatment Period 1|Lost to Follow-up|1|||
105571817|NCT02247804|364092789|FG001|Treatment Period 1|Lost to Follow-up|0|||
105571818|NCT02247804|364092790|FG002|Treatment Period 1|Lost to Follow-up|2|||
105571819|NCT02247804|364092788|FG000|Treatment Period 1|Personal Reasons|7|||
105571820|NCT02247804|364092789|FG001|Treatment Period 1|Personal Reasons|1|||
105571821|NCT02247804|364092790|FG002|Treatment Period 1|Personal Reasons|2|||
105571822|NCT02247804|364092788|FG000|Treatment Period 1|Protocol Deviation|0|||
105571823|NCT02247804|364092789|FG001|Treatment Period 1|Protocol Deviation|0|||
105571824|NCT02247804|364092790|FG002|Treatment Period 1|Protocol Deviation|1|||
105823084|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105823085|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
105571825|NCT02247804|364092788|FG000|Treatment Period 1|Randomized but not Treated|5|||
105571826|NCT02247804|364092789|FG001|Treatment Period 1|Randomized but not Treated|1|||
105571827|NCT02247804|364092790|FG002|Treatment Period 1|Randomized but not Treated|1|||
105571828|NCT02247804|364092788|FG000|Treatment Period 2|Adverse Event|6|||
105571829|NCT02247804|364092789|FG001|Treatment Period 2|Adverse Event|3|||
105571830|NCT02247804|364092790|FG002|Treatment Period 2|Adverse Event|3|||
105571831|NCT02247804|364092788|FG000|Treatment Period 2|Lack of Efficacy|0|||
105823086|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
105571832|NCT02247804|364092789|FG001|Treatment Period 2|Lack of Efficacy|0|||
105571833|NCT02247804|364092790|FG002|Treatment Period 2|Lack of Efficacy|1|||
105571834|NCT02247804|364092788|FG000|Treatment Period 2|Lost to Follow-up|0|||
105571835|NCT02247804|364092789|FG001|Treatment Period 2|Lost to Follow-up|1|||
105571836|NCT02247804|364092790|FG002|Treatment Period 2|Lost to Follow-up|1|||
105571837|NCT02247804|364092788|FG000|Treatment Period 2|Personal Reasons|2|||
105571838|NCT02247804|364092789|FG001|Treatment Period 2|Personal Reasons|1|||
105571839|NCT02247804|364092790|FG002|Treatment Period 2|Personal Reasons|1|||
105571840|NCT02247804|364092788|FG000|Treatment Period 2|Reason not Specified|0|||
105571841|NCT02247804|364092789|FG001|Treatment Period 2|Reason not Specified|0|||
105571842|NCT02247804|364092790|FG002|Treatment Period 2|Reason not Specified|2|||
105571843|NCT02247804|364092788|FG000|Treatment Period 3|Adverse Event|4|||
105571844|NCT02247804|364092789|FG001|Treatment Period 3|Adverse Event|3|||
105571845|NCT02247804|364092790|FG002|Treatment Period 3|Adverse Event|3|||
105571846|NCT02247804|364092788|FG000|Treatment Period 3|Lack of Efficacy|0|||
105571847|NCT02247804|364092789|FG001|Treatment Period 3|Lack of Efficacy|1|||
105571848|NCT02247804|364092790|FG002|Treatment Period 3|Lack of Efficacy|0|||
105571849|NCT02247804|364092788|FG000|Treatment Period 3|Lost to Follow-up|1|||
105571850|NCT02247804|364092789|FG001|Treatment Period 3|Lost to Follow-up|2|||
105571851|NCT02247804|364092790|FG002|Treatment Period 3|Lost to Follow-up|2|||
105571852|NCT02247804|364092788|FG000|Treatment Period 3|Personal Reasons|4|||
105571853|NCT02247804|364092789|FG001|Treatment Period 3|Personal Reasons|3|||
105571854|NCT02247804|364092790|FG002|Treatment Period 3|Personal Reasons|2|||
105571855|NCT02247804|364092788|FG000|Treatment Period 3|Reason not Specified|2|||
105571856|NCT02247804|364092789|FG001|Treatment Period 3|Reason not Specified|1|||
105571857|NCT02247804|364092790|FG002|Treatment Period 3|Reason not Specified|3|||
105571858|NCT00684762|364092800|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
105571859|NCT00684762|364092801|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
105571860|NCT00245856|364092802|FG000|Period Two|Withdrawal by Subject|0|||
105571861|NCT00245856|364092803|FG001|Period Two|Withdrawal by Subject|1|||
105571862|NCT01539863|364092804|FG000|Overall Study|Lost to Follow-up|5|||
105571863|NCT01539863|364092805|FG001|Overall Study|Lost to Follow-up|4|||
105571864|NCT00557622|364092806|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
105571865|NCT00557622|364092807|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
105571866|NCT00557622|364092806|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
105571867|NCT00557622|364092807|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
105571868|NCT00557622|364092806|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
105571869|NCT00557622|364092807|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
105571870|NCT00879996|364092808|FG000|Overall Study|Lost to Follow-up|7|||
105571871|NCT00879996|364092809|FG001|Overall Study|Lost to Follow-up|6|||
105571872|NCT00879996|364092808|FG000|Overall Study|non-compliance|6|||
105571873|NCT00879996|364092809|FG001|Overall Study|non-compliance|4|||
105571874|NCT00879996|364092808|FG000|Overall Study|Physician Decision|1|||
105571875|NCT00879996|364092809|FG001|Overall Study|Physician Decision|2|||
105571876|NCT00879996|364092808|FG000|Overall Study|psychiatric problem|0|||
105571877|NCT00879996|364092809|FG001|Overall Study|psychiatric problem|1|||
105571878|NCT00879996|364092808|FG000|Overall Study|put on parole|1|||
105571879|NCT00879996|364092809|FG001|Overall Study|put on parole|0|||
105571880|NCT00572624|364092810|FG000|Overall Study|Lost to Follow-up|10|||
105571881|NCT00572624|364092811|FG001|Overall Study|Lost to Follow-up|4|||
105571882|NCT00572624|364092810|FG000|Overall Study|Wanted to do a different diet program|1|||
105571883|NCT00572624|364092811|FG001|Overall Study|Wanted to do a different diet program|0|||
105571884|NCT00572624|364092810|FG000|Overall Study|Medication change|1|||
105571885|NCT00572624|364092811|FG001|Overall Study|Medication change|0|||
105571886|NCT00572624|364092810|FG000|Overall Study|Started a new job-- no time for study|1|||
105571887|NCT00572624|364092811|FG001|Overall Study|Started a new job-- no time for study|0|||
105571888|NCT00572624|364092810|FG000|Overall Study|Admitted to being a smoker|1|||
105571889|NCT00572624|364092811|FG001|Overall Study|Admitted to being a smoker|0|||
105571890|NCT00572624|364092810|FG000|Overall Study|Refused to do the stress test|1|||
105571891|NCT00572624|364092811|FG001|Overall Study|Refused to do the stress test|0|||
105571892|NCT00572624|364092810|FG000|Overall Study|Problem with vascular access|1|||
105571893|NCT00572624|364092811|FG001|Overall Study|Problem with vascular access|0|||
105571894|NCT00572624|364092810|FG000|Overall Study|Health issues unrelated to the study|1|||
105571895|NCT00572624|364092811|FG001|Overall Study|Health issues unrelated to the study|0|||
105571896|NCT02597933|364092812|FG000|Overall Study|Withdrawal by Subject|7|||
105571897|NCT02597933|364092813|FG001|Overall Study|Withdrawal by Subject|5|||
105571898|NCT02597933|364092812|FG000|Overall Study|Protocol Violation|2|||
105571899|NCT02597933|364092813|FG001|Overall Study|Protocol Violation|2|||
105571900|NCT02597933|364092812|FG000|Overall Study|Adverse Event|20|||
105571901|NCT02597933|364092813|FG001|Overall Study|Adverse Event|28|||
105571902|NCT02597933|364092812|FG000|Overall Study|Not treated|2|||
105571903|NCT02597933|364092813|FG001|Overall Study|Not treated|2|||
105571904|NCT02597933|364092812|FG000|Overall Study|Other than stated above|7|||
105571905|NCT02597933|364092813|FG001|Overall Study|Other than stated above|14|||
105571906|NCT00211237|364092818|FG000|Baseline|Withdrew|1|||
105571907|NCT00211237|364092819|FG001|Baseline|Withdrew|3|||
105571908|NCT00211237|364092820|FG002|Baseline|Withdrew|0|||
105365043|NCT00735709|363342705|FG000|Overall Study|Protocol deviations|1|||
105365044|NCT00735709|363342706|FG001|Overall Study|Protocol deviations|2|||
105365045|NCT00735709|363342707|FG002|Overall Study|Protocol deviations|1|||
105365046|NCT00735709|363342708|FG003|Overall Study|Protocol deviations|1|||
105365047|NCT00735709|363342705|FG000|Overall Study|Voluntary Withdrawal|1|||
105365048|NCT00735709|363342706|FG001|Overall Study|Voluntary Withdrawal|3|||
105365049|NCT00735709|363342707|FG002|Overall Study|Voluntary Withdrawal|5|||
105365050|NCT00735709|363342708|FG003|Overall Study|Voluntary Withdrawal|7|||
105365051|NCT00735709|363342705|FG000|Overall Study|Lost to Follow-up|0|||
105365052|NCT00735709|363342706|FG001|Overall Study|Lost to Follow-up|1|||
105365053|NCT00735709|363342707|FG002|Overall Study|Lost to Follow-up|1|||
105365054|NCT00735709|363342708|FG003|Overall Study|Lost to Follow-up|1|||
105365055|NCT00735709|363342705|FG000|Overall Study|Excluded medication|1|||
105365056|NCT00735709|363342706|FG001|Overall Study|Excluded medication|0|||
105365057|NCT00735709|363342707|FG002|Overall Study|Excluded medication|0|||
105365058|NCT00735709|363342708|FG003|Overall Study|Excluded medication|1|||
105365059|NCT00126594|363342712|FG000|Overall Study|Ineligible|2|||
105365060|NCT00126594|363342713|FG001|Overall Study|Ineligible|0|||
105365061|NCT00126594|363342712|FG000|Overall Study|Withdrawal by Subject|0|||
105365062|NCT00126594|363342713|FG001|Overall Study|Withdrawal by Subject|4|||
105365063|NCT00126594|363342712|FG000|Overall Study|Physician Decision|1|||
105365064|NCT00126594|363342713|FG001|Overall Study|Physician Decision|3|||
105365065|NCT00126594|363342712|FG000|Overall Study|Adverse Event|7|||
105365066|NCT00126594|363342713|FG001|Overall Study|Adverse Event|5|||
105365067|NCT00126594|363342712|FG000|Overall Study|Non-compliance|0|||
105365068|NCT00126594|363342713|FG001|Overall Study|Non-compliance|1|||
105365069|NCT00126594|363342712|FG000|Overall Study|Disease Progression|29|||
105365070|NCT00126594|363342713|FG001|Overall Study|Disease Progression|24|||
105365071|NCT01232790|363342714|FG000|Randomization|Withdrawal by Subject|2|||
105365072|NCT01232790|363342715|FG001|Randomization|Withdrawal by Subject|0|||
105365073|NCT01232790|363342714|FG000|Randomization|Protocol Violation|0|||
105486796|NCT00745615|363793411|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
105486797|NCT00745615|363793412|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
105486798|NCT00745615|363793407|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
105486799|NCT00745615|363793408|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
105486800|NCT00745615|363793409|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
105486801|NCT00745615|363793410|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
105486802|NCT00745615|363793411|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
105486803|NCT00745615|363793412|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
105486804|NCT00745615|363793407|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
105486805|NCT00745615|363793408|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
105486806|NCT00745615|363793409|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
105486807|NCT00745615|363793410|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
105486808|NCT00745615|363793411|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
105486809|NCT00745615|363793412|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
105486810|NCT00745615|363793407|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
105486811|NCT00745615|363793408|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
105486812|NCT00745615|363793409|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
105486813|NCT00745615|363793410|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
105486814|NCT00745615|363793411|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
105486815|NCT00745615|363793412|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
105486816|NCT00745615|363793407|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
105486817|NCT00745615|363793408|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
105486818|NCT00745615|363793409|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
105486819|NCT00745615|363793410|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
105486820|NCT00745615|363793411|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
105486821|NCT00745615|363793412|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
105486822|NCT00745615|363793407|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
105486823|NCT00745615|363793408|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
105486824|NCT00745615|363793409|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
105486825|NCT00745615|363793410|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
105486826|NCT00745615|363793411|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
105486827|NCT00745615|363793412|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
105486828|NCT00745615|363793407|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
105486829|NCT00745615|363793408|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
105365074|NCT01232790|363342715|FG001|Randomization|Protocol Violation|1|||
105365075|NCT01232790|363342714|FG000|Randomization|Physician Decision|0|||
105365076|NCT01232790|363342715|FG001|Randomization|Physician Decision|1|||
105365077|NCT01232790|363342714|FG000|Initial Assessment|Withdrawal by Subject|0|||
105365078|NCT01232790|363342715|FG001|Initial Assessment|Withdrawal by Subject|1|||
105365079|NCT01232790|363342714|FG000|First Crossover|Withdrawal by Subject|1|||
105365080|NCT01232790|363342715|FG001|First Crossover|Withdrawal by Subject|0|||
105365081|NCT01232790|363342714|FG000|Second Crossover|Withdrawal by Subject|1|||
105571909|NCT00211237|364092818|FG000|Baseline|Refused random assignment|1|||
105571910|NCT00211237|364092819|FG001|Baseline|Refused random assignment|0|||
105571911|NCT00211237|364092820|FG002|Baseline|Refused random assignment|0|||
105571912|NCT00211237|364092818|FG000|1 Month|Death|2|||
105571913|NCT00211237|364092819|FG001|1 Month|Death|1|||
105571914|NCT00211237|364092820|FG002|1 Month|Death|0|||
105571915|NCT00211237|364092818|FG000|1 Month|Lost to Follow-up|0|||
105571916|NCT00211237|364092819|FG001|1 Month|Lost to Follow-up|2|||
105571917|NCT00211237|364092820|FG002|1 Month|Lost to Follow-up|0|||
105571918|NCT00211237|364092818|FG000|1 Month|Withdrew|0|||
105571919|NCT00211237|364092819|FG001|1 Month|Withdrew|4|||
105571920|NCT00211237|364092820|FG002|1 Month|Withdrew|0|||
105571921|NCT00211237|364092818|FG000|1 Month|Additional surgery needed|1|||
105571922|NCT00211237|364092819|FG001|1 Month|Additional surgery needed|0|||
105571923|NCT00211237|364092820|FG002|1 Month|Additional surgery needed|0|||
105571924|NCT00211237|364092818|FG000|1 Month|Non-medical problem|0|||
105571925|NCT00211237|364092819|FG001|1 Month|Non-medical problem|2|||
105571926|NCT00211237|364092820|FG002|1 Month|Non-medical problem|0|||
105571927|NCT00211237|364092818|FG000|3 Months|Death|7|||
105571928|NCT00211237|364092819|FG001|3 Months|Death|3|||
105571929|NCT00211237|364092820|FG002|3 Months|Death|0|||
105571930|NCT00211237|364092818|FG000|3 Months|Could not comply with protocol|1|||
105571931|NCT00211237|364092819|FG001|3 Months|Could not comply with protocol|0|||
105571932|NCT00211237|364092820|FG002|3 Months|Could not comply with protocol|0|||
105767599|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
105767600|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
105767601|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
105365082|NCT01232790|363342715|FG001|Second Crossover|Withdrawal by Subject|2|||
105365083|NCT01249131|363342725|FG000|Washout Period of 10 Days|Adverse Event|0|||
105767602|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
105767603|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
105767604|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
105365084|NCT01249131|363342726|FG001|Washout Period of 10 Days|Adverse Event|0|||
105571933|NCT00211237|364092818|FG000|3 Months|Withdrew|0|||
105365085|NCT01249131|363342727|FG002|Washout Period of 10 Days|Adverse Event|0|||
105571934|NCT00211237|364092819|FG001|3 Months|Withdrew|1|||
105571935|NCT00211237|364092820|FG002|3 Months|Withdrew|0|||
105571936|NCT00211237|364092818|FG000|3 Months|Non-medical problem|0|||
105571937|NCT00211237|364092819|FG001|3 Months|Non-medical problem|0|||
105571938|NCT00211237|364092820|FG002|3 Months|Non-medical problem|1|||
105767605|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
105767606|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
105571939|NCT00211237|364092818|FG000|6 Months|Death|6|||
105571940|NCT00211237|364092819|FG001|6 Months|Death|0|||
105571941|NCT00211237|364092820|FG002|6 Months|Death|3|||
105571942|NCT00211237|364092818|FG000|6 Months|Lost to Follow-up|2|||
105571943|NCT00211237|364092819|FG001|6 Months|Lost to Follow-up|0|||
105571944|NCT00211237|364092820|FG002|6 Months|Lost to Follow-up|0|||
105571945|NCT00211237|364092818|FG000|6 Months|Could not comply with protocol|0|||
105571946|NCT00211237|364092819|FG001|6 Months|Could not comply with protocol|2|||
105571947|NCT00211237|364092820|FG002|6 Months|Could not comply with protocol|0|||
105571948|NCT00211237|364092818|FG000|12 Months|Death|8|||
105571949|NCT00211237|364092819|FG001|12 Months|Death|2|||
105571950|NCT00211237|364092820|FG002|12 Months|Death|3|||
105571951|NCT00211237|364092818|FG000|12 Months|Lost to Follow-up|1|||
105571952|NCT00211237|364092819|FG001|12 Months|Lost to Follow-up|0|||
105571953|NCT00211237|364092820|FG002|12 Months|Lost to Follow-up|1|||
105571954|NCT00211237|364092818|FG000|12 Months|Withdrew|0|||
105571955|NCT00211237|364092819|FG001|12 Months|Withdrew|0|||
105571956|NCT00211237|364092820|FG002|12 Months|Withdrew|1|||
105571957|NCT00211237|364092818|FG000|12 Months|unrelated medical problem|0|||
105571958|NCT00211237|364092819|FG001|12 Months|unrelated medical problem|0|||
105571959|NCT00211237|364092820|FG002|12 Months|unrelated medical problem|1|||
105571960|NCT00453102|364092823|FG000|Overall Study|Withdrawal by Subject|2|||
105571961|NCT02667886|364092826|FG000|Dose Escalation (Part A)|Adverse Event|1|||
105571962|NCT02667886|364092827|FG001|Dose Escalation (Part A)|Adverse Event|3|||
105571963|NCT02667886|364092828|FG002|Dose Escalation (Part A)|Adverse Event|1|||
105571964|NCT02667886|364092829|FG003|Dose Escalation (Part A)|Adverse Event|0|||
105571965|NCT02667886|364092830|FG004|Dose Escalation (Part A)|Adverse Event|0|||
105571966|NCT02667886|364092826|FG000|Dose Escalation (Part A)|Disease Progression|1|||
105571967|NCT02667886|364092827|FG001|Dose Escalation (Part A)|Disease Progression|4|||
105571968|NCT02667886|364092828|FG002|Dose Escalation (Part A)|Disease Progression|3|||
105571969|NCT02667886|364092829|FG003|Dose Escalation (Part A)|Disease Progression|0|||
105571970|NCT02667886|364092830|FG004|Dose Escalation (Part A)|Disease Progression|0|||
105571971|NCT02667886|364092826|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
105571972|NCT02667886|364092827|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
105767607|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
105767608|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
105767609|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Death|0|||
105767610|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Death|0|||
105767611|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Death|0|||
105767612|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Death|0|||
105767613|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Death|1|||
105767614|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
105767615|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
105767616|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
105767617|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
105767618|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
105767619|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
105767620|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
105767621|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
105767622|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
105767623|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
105767624|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
105571973|NCT02667886|364092828|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
105571974|NCT02667886|364092829|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
105571975|NCT02667886|364092830|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
105571976|NCT02667886|364092826|FG000|Dose Expansion (Part B)|Adverse Event|0|||
105823087|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
105571977|NCT02667886|364092827|FG001|Dose Expansion (Part B)|Adverse Event|0|||
105571978|NCT02667886|364092828|FG002|Dose Expansion (Part B)|Adverse Event|0|||
105571979|NCT02667886|364092829|FG003|Dose Expansion (Part B)|Adverse Event|9|||
105571980|NCT02667886|364092830|FG004|Dose Expansion (Part B)|Adverse Event|0|||
105365086|NCT01249131|363342728|FG003|Washout Period of 10 Days|Adverse Event|0|||
105365087|NCT01249131|363342729|FG004|Washout Period of 10 Days|Adverse Event|1|||
105365088|NCT01249131|363342730|FG005|Washout Period of 10 Days|Adverse Event|0|||
105365089|NCT02456727|363342731|FG000|Overall Study|Lost to Follow-up|63|||
105365090|NCT02456727|363342732|FG001|Overall Study|Lost to Follow-up|65|||
105365091|NCT02456727|363342731|FG000|Overall Study|Death|2|||
105365092|NCT02456727|363342732|FG001|Overall Study|Death|1|||
105365093|NCT02456727|363342731|FG000|Overall Study|Withdrawal by Subject|1|||
105365094|NCT02456727|363342732|FG001|Overall Study|Withdrawal by Subject|10|||
105365095|NCT02456727|363342731|FG000|Overall Study|Never Initiated Treatment|43|||
105365096|NCT02456727|363342732|FG001|Overall Study|Never Initiated Treatment|30|||
105365097|NCT05081388|363342733|FG000|Overall Study|Adverse Event|1|||
105365098|NCT05081388|363342734|FG001|Overall Study|Adverse Event|0|||
105365099|NCT05081388|363342735|FG002|Overall Study|Adverse Event|0|||
105365100|NCT05081388|363342736|FG003|Overall Study|Adverse Event|0|||
105365101|NCT05081388|363342737|FG004|Overall Study|Adverse Event|0|||
105767625|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
105767626|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
105767627|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
105767628|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
105767629|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
105767630|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
105767631|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
105767632|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
105767633|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
105767634|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
105767635|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
105767636|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
105767637|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
105767638|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
105767639|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Other|0|||
105767640|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Other|0|||
105767641|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Other|0|||
105767642|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Other|1|||
105767643|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Other|3|||
105767644|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
105767645|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
105767646|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
105767647|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
105767648|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
105767649|NCT03097133|364800478|FG000|Overall Study|Lost to Follow-up|3|||
105767650|NCT03097133|364800479|FG001|Overall Study|Lost to Follow-up|2|||
105767651|NCT03097133|364800478|FG000|Overall Study|Withdrawal by Subject|2|||
105767652|NCT03097133|364800479|FG001|Overall Study|Withdrawal by Subject|5|||
105767653|NCT03097133|364800478|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
105767654|NCT03097133|364800479|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
105767655|NCT03097133|364800478|FG000|Overall Study|Other|3|||
105767656|NCT03097133|364800479|FG001|Overall Study|Other|2|||
105767657|NCT03097133|364800478|FG000|Overall Study|Adverse Event|1|||
105767658|NCT03097133|364800479|FG001|Overall Study|Adverse Event|0|||
105767659|NCT01989572|364800483|FG000|Overall Study|Lack of Efficacy|35|||
105767660|NCT01989572|364800484|FG001|Overall Study|Lack of Efficacy|48|||
105767661|NCT01989572|364800485|FG002|Overall Study|Lack of Efficacy|48|||
105767662|NCT01989572|364800486|FG003|Overall Study|Lack of Efficacy|43|||
105767663|NCT01989572|364800487|FG004|Overall Study|Lack of Efficacy|71|||
105767664|NCT01989572|364800488|FG005|Overall Study|Lack of Efficacy|79|||
105767665|NCT01989572|364800483|FG000|Overall Study|Adverse Event|2|||
105767666|NCT01989572|364800484|FG001|Overall Study|Adverse Event|1|||
105767667|NCT01989572|364800485|FG002|Overall Study|Adverse Event|3|||
105365102|NCT05081388|363342733|FG000|Overall Study|Lost to Follow-up|0|||
105365103|NCT05081388|363342734|FG001|Overall Study|Lost to Follow-up|1|||
105365104|NCT05081388|363342735|FG002|Overall Study|Lost to Follow-up|0|||
105365105|NCT05081388|363342736|FG003|Overall Study|Lost to Follow-up|0|||
105365106|NCT05081388|363342737|FG004|Overall Study|Lost to Follow-up|0|||
105365107|NCT05081388|363342733|FG000|Overall Study|Subject decision|0|||
105365108|NCT05081388|363342734|FG001|Overall Study|Subject decision|0|||
105365109|NCT05081388|363342735|FG002|Overall Study|Subject decision|0|||
105365110|NCT05081388|363342736|FG003|Overall Study|Subject decision|1|||
105365111|NCT05081388|363342737|FG004|Overall Study|Subject decision|0|||
105365112|NCT00243919|363342738|FG000|Overall Study|Death|3|||
105365113|NCT00243919|363342739|FG001|Overall Study|Death|4|||
105365114|NCT00243919|363342740|FG002|Overall Study|Death|6|||
105365115|NCT00243919|363342738|FG000|Overall Study|Withdrawal by Subject|6|||
105571981|NCT02667886|364092826|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
105571982|NCT02667886|364092827|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
105571983|NCT02667886|364092828|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
105571984|NCT02667886|364092829|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
105571985|NCT02667886|364092830|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
105571986|NCT02667886|364092826|FG000|Dose Expansion (Part B)|Disease Progression|0|||
105571987|NCT02667886|364092827|FG001|Dose Expansion (Part B)|Disease Progression|0|||
105571988|NCT02667886|364092828|FG002|Dose Expansion (Part B)|Disease Progression|0|||
105571989|NCT02667886|364092829|FG003|Dose Expansion (Part B)|Disease Progression|38|||
105571990|NCT02667886|364092830|FG004|Dose Expansion (Part B)|Disease Progression|0|||
105571991|NCT02667886|364092826|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
105571992|NCT02667886|364092827|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
105571993|NCT02667886|364092828|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
105571994|NCT02667886|364092829|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
105571995|NCT02667886|364092830|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
105571996|NCT02667886|364092826|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
105571997|NCT02667886|364092827|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
105571998|NCT02667886|364092828|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
105571999|NCT02667886|364092829|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
105572000|NCT02667886|364092830|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
105572001|NCT02667886|364092826|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
105572002|NCT02667886|364092827|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
105572003|NCT02667886|364092828|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
105572004|NCT02667886|364092829|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
105572005|NCT02667886|364092830|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
105572006|NCT05778526|364092832|FG000|Overall Study|Lost to Follow-up|0|||
105572007|NCT05778526|364092833|FG001|Overall Study|Lost to Follow-up|1|||
105572008|NCT05778526|364092834|FG002|Overall Study|Lost to Follow-up|3|||
105572009|NCT05778526|364092832|FG000|Overall Study|Protocol Violation|0|||
105572010|NCT05778526|364092833|FG001|Overall Study|Protocol Violation|0|||
105572011|NCT05778526|364092834|FG002|Overall Study|Protocol Violation|8|||
105572012|NCT01861522|364092835|FG000|Overall Study|Adverse Event|1|||
105572013|NCT01861522|364092836|FG001|Overall Study|Adverse Event|0|||
105572014|NCT01861522|364092835|FG000|Overall Study|Withdrawal by Subject|2|||
105572015|NCT01861522|364092836|FG001|Overall Study|Withdrawal by Subject|0|||
105572016|NCT01555164|364092837|FG000|Overall Study|Adverse Event|5|||
105572017|NCT01555164|364092838|FG001|Overall Study|Adverse Event|7|||
105572018|NCT01555164|364092837|FG000|Overall Study|Hyperglycemia|0|||
105572019|NCT01555164|364092838|FG001|Overall Study|Hyperglycemia|1|||
105572020|NCT01555164|364092837|FG000|Overall Study|Investigator's Discretion|2|||
105572021|NCT01555164|364092838|FG001|Overall Study|Investigator's Discretion|2|||
105572022|NCT01555164|364092837|FG000|Overall Study|Lost to Follow-up|4|||
105572023|NCT01555164|364092838|FG001|Overall Study|Lost to Follow-up|3|||
105572024|NCT01555164|364092837|FG000|Overall Study|Protocol Violation|9|||
105572025|NCT01555164|364092838|FG001|Overall Study|Protocol Violation|5|||
105572026|NCT01555164|364092837|FG000|Overall Study|Subject Non-compliance|14|||
105572027|NCT01555164|364092838|FG001|Overall Study|Subject Non-compliance|6|||
105572028|NCT01555164|364092837|FG000|Overall Study|Subject Withdrew Consent|6|||
105572029|NCT01555164|364092838|FG001|Overall Study|Subject Withdrew Consent|11|||
105572030|NCT00886639|364092839|FG000|Overall Study|acute exacerbation|14|||
105572031|NCT00886639|364092839|FG000|Overall Study|non-compliance|2|||
105572032|NCT01103960|364092840|FG000|Overall Study|Adverse Event|2|||
105572033|NCT01103960|364092841|FG001|Overall Study|Adverse Event|1|||
105767668|NCT01989572|364800486|FG003|Overall Study|Adverse Event|0|||
105767669|NCT01989572|364800487|FG004|Overall Study|Adverse Event|3|||
105767670|NCT01989572|364800488|FG005|Overall Study|Adverse Event|0|||
105767671|NCT01989572|364800483|FG000|Overall Study|Death|0|||
105767672|NCT01989572|364800484|FG001|Overall Study|Death|0|||
105767673|NCT01989572|364800485|FG002|Overall Study|Death|0|||
105767674|NCT01989572|364800486|FG003|Overall Study|Death|0|||
105767675|NCT01989572|364800487|FG004|Overall Study|Death|1|||
105767676|NCT01989572|364800488|FG005|Overall Study|Death|0|||
105823088|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105823089|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105486830|NCT00745615|363793409|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
105486831|NCT00745615|363793410|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
105486832|NCT00745615|363793411|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
105486833|NCT00745615|363793412|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
105486834|NCT03224546|363793415|FG000|Overall Study|Lost to Follow-up|9|||
105486835|NCT03224546|363793416|FG001|Overall Study|Lost to Follow-up|8|||
105486836|NCT03224546|363793417|FG002|Overall Study|Lost to Follow-up|3|||
105486837|NCT03224546|363793415|FG000|Overall Study|Withdrawal by Subject|7|||
105486838|NCT03224546|363793416|FG001|Overall Study|Withdrawal by Subject|14|||
105486839|NCT03224546|363793417|FG002|Overall Study|Withdrawal by Subject|12|||
105486840|NCT01163032|363793421|FG000|Randomization Phase|Withdrawal by Subject|2|||
105486841|NCT01163032|363793422|FG001|Randomization Phase|Withdrawal by Subject|3|||
105486842|NCT01163032|363793423|FG002|Randomization Phase|Withdrawal by Subject|0|||
105486843|NCT01163032|363793421|FG000|Randomization Phase|Adverse Event|3|||
105486844|NCT01163032|363793422|FG001|Randomization Phase|Adverse Event|3|||
105486845|NCT01163032|363793423|FG002|Randomization Phase|Adverse Event|0|||
105486846|NCT01163032|363793421|FG000|Randomization Phase|Protocol Violation|0|||
105486847|NCT01163032|363793422|FG001|Randomization Phase|Protocol Violation|1|||
105486848|NCT01163032|363793423|FG002|Randomization Phase|Protocol Violation|0|||
105486849|NCT01163032|363793421|FG000|Randomization Phase|Various*|5|||
105486850|NCT01163032|363793422|FG001|Randomization Phase|Various*|4|||
105486851|NCT01163032|363793423|FG002|Randomization Phase|Various*|0|||
105486852|NCT01163032|363793421|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
105486853|NCT01163032|363793422|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
105486854|NCT01163032|363793423|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
105486855|NCT01163032|363793421|FG000|Open Label Extension Phase|Adverse Event|0|||
105486856|NCT01163032|363793422|FG001|Open Label Extension Phase|Adverse Event|0|||
105486857|NCT01163032|363793423|FG002|Open Label Extension Phase|Adverse Event|3|||
105486858|NCT01163032|363793421|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
105486859|NCT01163032|363793422|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
105486860|NCT01163032|363793423|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
105486861|NCT01163032|363793421|FG000|Open Label Extension Phase|Protocol Violation|0|||
105486862|NCT01163032|363793422|FG001|Open Label Extension Phase|Protocol Violation|0|||
105486863|NCT01163032|363793423|FG002|Open Label Extension Phase|Protocol Violation|1|||
105486864|NCT01163032|363793421|FG000|Open Label Extension Phase|Study Termination|0|||
105486865|NCT01163032|363793422|FG001|Open Label Extension Phase|Study Termination|0|||
105486866|NCT01163032|363793423|FG002|Open Label Extension Phase|Study Termination|7|||
105486867|NCT01163032|363793421|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
105486868|NCT01163032|363793422|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
105486869|NCT01163032|363793423|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
105486870|NCT02751931|363793426|FG000|Overall Study|Adverse Event|3|||
105486871|NCT02751931|363793427|FG001|Overall Study|Adverse Event|0|||
105486872|NCT02751931|363793426|FG000|Overall Study|Other: Miscelleneous|10|||
105486873|NCT02751931|363793427|FG001|Overall Study|Other: Miscelleneous|8|||
105486874|NCT05080660|363793428|FG000|Overall Study|Adverse Event|4|||
105486875|NCT05080660|363793429|FG001|Overall Study|Adverse Event|0|||
105486876|NCT05080660|363793428|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
105486877|NCT05080660|363793429|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
105486878|NCT05080660|363793428|FG000|Overall Study|Physician Decision|1|||
105486879|NCT05080660|363793429|FG001|Overall Study|Physician Decision|0|||
105486880|NCT05080660|363793428|FG000|Overall Study|Protocol Deviation|2|||
105486881|NCT05080660|363793429|FG001|Overall Study|Protocol Deviation|0|||
105486882|NCT05080660|363793428|FG000|Overall Study|Withdrawal by Subject|5|||
105486883|NCT05080660|363793429|FG001|Overall Study|Withdrawal by Subject|2|||
105486884|NCT00937391|363793430|FG000|Stage 2|Withdrawal by Subject|1|||
105486885|NCT01307020|363793431|FG000|Overall Study|Lost to Follow-up|0|||
105486886|NCT01307020|363793432|FG001|Overall Study|Lost to Follow-up|0|||
105486887|NCT01307020|363793433|FG002|Overall Study|Lost to Follow-up|1|||
105486888|NCT01307020|363793434|FG003|Overall Study|Lost to Follow-up|1|||
105486889|NCT01307020|363793435|FG004|Overall Study|Lost to Follow-up|0|||
105486890|NCT01307020|363793436|FG005|Overall Study|Lost to Follow-up|0|||
105486891|NCT01307020|363793437|FG006|Overall Study|Lost to Follow-up|1|||
105767677|NCT01989572|364800483|FG000|Overall Study|Withdrawal by Subject|4|||
105767678|NCT01989572|364800484|FG001|Overall Study|Withdrawal by Subject|1|||
105767679|NCT01989572|364800485|FG002|Overall Study|Withdrawal by Subject|5|||
105572034|NCT01103960|364092840|FG000|Overall Study|Withdrawal by Subject|2|||
105572035|NCT01103960|364092841|FG001|Overall Study|Withdrawal by Subject|1|||
105572036|NCT01103960|364092840|FG000|Overall Study|Other|1|||
105572037|NCT01103960|364092841|FG001|Overall Study|Other|0|||
105572038|NCT00876460|364092844|FG000|Combination Therapy Phase|Progressive disease|2|||
105572039|NCT00876460|364092845|FG001|Combination Therapy Phase|Progressive disease|3|||
105572040|NCT00876460|364092846|FG002|Combination Therapy Phase|Progressive disease|3|||
105572041|NCT00876460|364092847|FG003|Combination Therapy Phase|Progressive disease|3|||
105572042|NCT00876460|364092848|FG004|Combination Therapy Phase|Progressive disease|3|||
105572043|NCT00876460|364092849|FG005|Combination Therapy Phase|Progressive disease|1|||
105572044|NCT00876460|364092850|FG006|Combination Therapy Phase|Progressive disease|1|||
105572045|NCT00876460|364092851|FG007|Combination Therapy Phase|Progressive disease|1|||
105572046|NCT00876460|364092844|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
105572047|NCT00876460|364092845|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
105572048|NCT00876460|364092846|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
105572049|NCT00876460|364092847|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
105572050|NCT00876460|364092848|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
105572051|NCT00876460|364092849|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
105572052|NCT00876460|364092850|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
105572053|NCT00876460|364092851|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
105572054|NCT00876460|364092844|FG000|Combination Therapy Phase|Adverse Event|0|||
105572055|NCT00876460|364092845|FG001|Combination Therapy Phase|Adverse Event|2|||
105572056|NCT00876460|364092846|FG002|Combination Therapy Phase|Adverse Event|0|||
105572057|NCT00876460|364092847|FG003|Combination Therapy Phase|Adverse Event|2|||
105572058|NCT00876460|364092848|FG004|Combination Therapy Phase|Adverse Event|2|||
105572059|NCT00876460|364092849|FG005|Combination Therapy Phase|Adverse Event|0|||
105572060|NCT00876460|364092850|FG006|Combination Therapy Phase|Adverse Event|3|||
105572061|NCT00876460|364092851|FG007|Combination Therapy Phase|Adverse Event|2|||
105572062|NCT00876460|364092844|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
105572063|NCT00876460|364092845|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
105572064|NCT00876460|364092846|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
105572065|NCT00876460|364092847|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
105572066|NCT00876460|364092848|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
105572067|NCT00876460|364092849|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
105572068|NCT00876460|364092850|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
105572069|NCT00876460|364092851|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
105572070|NCT00876460|364092844|FG000|Combination Therapy Phase|Other reason not defined above|0|||
105572071|NCT00876460|364092845|FG001|Combination Therapy Phase|Other reason not defined above|0|||
105572072|NCT00876460|364092846|FG002|Combination Therapy Phase|Other reason not defined above|0|||
105572073|NCT00876460|364092847|FG003|Combination Therapy Phase|Other reason not defined above|0|||
105572074|NCT00876460|364092848|FG004|Combination Therapy Phase|Other reason not defined above|0|||
105572075|NCT00876460|364092849|FG005|Combination Therapy Phase|Other reason not defined above|0|||
105572076|NCT00876460|364092850|FG006|Combination Therapy Phase|Other reason not defined above|1|||
105572077|NCT00876460|364092851|FG007|Combination Therapy Phase|Other reason not defined above|2|||
105572078|NCT00876460|364092844|FG000|Combination Therapy Phase|Not treated|0|||
105572079|NCT00876460|364092845|FG001|Combination Therapy Phase|Not treated|0|||
105572080|NCT00876460|364092846|FG002|Combination Therapy Phase|Not treated|0|||
105572081|NCT00876460|364092847|FG003|Combination Therapy Phase|Not treated|0|||
105572082|NCT00876460|364092848|FG004|Combination Therapy Phase|Not treated|0|||
105572083|NCT00876460|364092849|FG005|Combination Therapy Phase|Not treated|0|||
105572084|NCT00876460|364092850|FG006|Combination Therapy Phase|Not treated|1|||
105572085|NCT00876460|364092851|FG007|Combination Therapy Phase|Not treated|0|||
105572086|NCT00876460|364092844|FG000|Mono Therapy Phase|Progressive disease|0|||
105572087|NCT00876460|364092845|FG001|Mono Therapy Phase|Progressive disease|0|||
105572088|NCT00876460|364092846|FG002|Mono Therapy Phase|Progressive disease|0|||
105572089|NCT00876460|364092847|FG003|Mono Therapy Phase|Progressive disease|0|||
105767680|NCT01989572|364800486|FG003|Overall Study|Withdrawal by Subject|1|||
105767681|NCT01989572|364800487|FG004|Overall Study|Withdrawal by Subject|12|||
105767682|NCT01989572|364800488|FG005|Overall Study|Withdrawal by Subject|4|||
105767683|NCT01989572|364800483|FG000|Overall Study|complicating disease|1|||
105767684|NCT01989572|364800484|FG001|Overall Study|complicating disease|1|||
105767685|NCT01989572|364800485|FG002|Overall Study|complicating disease|2|||
105767686|NCT01989572|364800486|FG003|Overall Study|complicating disease|0|||
105767687|NCT01989572|364800487|FG004|Overall Study|complicating disease|1|||
105767688|NCT01989572|364800488|FG005|Overall Study|complicating disease|0|||
105767689|NCT01989572|364800483|FG000|Overall Study|error|2|||
105767690|NCT01989572|364800484|FG001|Overall Study|error|1|||
105767691|NCT01989572|364800485|FG002|Overall Study|error|1|||
105767692|NCT01989572|364800486|FG003|Overall Study|error|1|||
105767693|NCT01989572|364800487|FG004|Overall Study|error|1|||
105767694|NCT01989572|364800488|FG005|Overall Study|error|1|||
105767695|NCT01989572|364800483|FG000|Overall Study|maximum dose reached|0|||
105572090|NCT00876460|364092848|FG004|Mono Therapy Phase|Progressive disease|2|||
105572091|NCT00876460|364092849|FG005|Mono Therapy Phase|Progressive disease|0|||
105572092|NCT00876460|364092850|FG006|Mono Therapy Phase|Progressive disease|1|||
105572093|NCT00876460|364092851|FG007|Mono Therapy Phase|Progressive disease|3|||
105572094|NCT00876460|364092844|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
105572095|NCT00876460|364092845|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
105572096|NCT00876460|364092846|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
105572097|NCT00876460|364092847|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
105572098|NCT00876460|364092848|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
105572099|NCT00876460|364092849|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
105572100|NCT00876460|364092850|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
105572101|NCT00876460|364092851|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
105572102|NCT00876460|364092844|FG000|Mono Therapy Phase|Adverse Event|0|||
105365116|NCT00243919|363342739|FG001|Overall Study|Withdrawal by Subject|6|||
105365117|NCT00243919|363342740|FG002|Overall Study|Withdrawal by Subject|2|||
105365118|NCT00243919|363342738|FG000|Overall Study|Lost to Follow-up|6|||
105365119|NCT00243919|363342739|FG001|Overall Study|Lost to Follow-up|7|||
105365120|NCT00243919|363342740|FG002|Overall Study|Lost to Follow-up|3|||
105486892|NCT01307020|363793438|FG007|Overall Study|Lost to Follow-up|0|||
105486893|NCT01307020|363793439|FG008|Overall Study|Lost to Follow-up|0|||
105486894|NCT01307020|363793440|FG009|Overall Study|Lost to Follow-up|0|||
105486895|NCT01307020|363793431|FG000|Overall Study|Electronic data capture failure|0|||
105486896|NCT01307020|363793432|FG001|Overall Study|Electronic data capture failure|1|||
105486897|NCT01307020|363793433|FG002|Overall Study|Electronic data capture failure|0|||
105486898|NCT01307020|363793434|FG003|Overall Study|Electronic data capture failure|0|||
105486899|NCT01307020|363793435|FG004|Overall Study|Electronic data capture failure|0|||
105486900|NCT01307020|363793436|FG005|Overall Study|Electronic data capture failure|0|||
105486901|NCT01307020|363793437|FG006|Overall Study|Electronic data capture failure|0|||
105486902|NCT01307020|363793438|FG007|Overall Study|Electronic data capture failure|0|||
105486903|NCT01307020|363793439|FG008|Overall Study|Electronic data capture failure|0|||
105486904|NCT01307020|363793440|FG009|Overall Study|Electronic data capture failure|0|||
105486905|NCT00727532|363793441|FG000|Overall Study|Adverse Event|1|||
105486906|NCT00727532|363793441|FG000|Overall Study|Withdrawal by Subject|1|||
105486907|NCT01986933|363793442|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
105486908|NCT01986933|363793443|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
105486909|NCT01986933|363793444|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
105486910|NCT01986933|363793445|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
105486911|NCT01986933|363793446|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
105486912|NCT01986933|363793442|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
105486913|NCT01986933|363793443|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
105486914|NCT01986933|363793444|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
105486915|NCT01986933|363793445|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
105486916|NCT01986933|363793446|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
105486917|NCT01986933|363793442|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
105486918|NCT01986933|363793443|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
105486919|NCT01986933|363793444|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
105486920|NCT01986933|363793445|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
105486921|NCT01986933|363793446|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
105486922|NCT01986933|363793442|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
105486923|NCT01986933|363793443|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
105486924|NCT01986933|363793444|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
105486925|NCT01986933|363793445|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
105486926|NCT01986933|363793446|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
105486927|NCT01986933|363793442|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
105486928|NCT01986933|363793443|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
105486929|NCT01986933|363793444|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
105486930|NCT01986933|363793445|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
105486931|NCT01986933|363793446|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
105486932|NCT01986933|363793442|FG000|Active-to-active (Part B)|Adverse Event|0|||
105486933|NCT01986933|363793443|FG001|Active-to-active (Part B)|Adverse Event|2|||
105486934|NCT01986933|363793444|FG002|Active-to-active (Part B)|Adverse Event|0|||
105486935|NCT01986933|363793445|FG003|Active-to-active (Part B)|Adverse Event|1|||
105486936|NCT01986933|363793446|FG004|Active-to-active (Part B)|Adverse Event|3|||
105486937|NCT01986933|363793442|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
105486938|NCT01986933|363793443|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
105486939|NCT01986933|363793444|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
105486940|NCT01986933|363793445|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
105486941|NCT01986933|363793446|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
105486942|NCT01986933|363793442|FG000|Active-to-active (Part B)|Pregnancy|0|||
105486943|NCT01986933|363793443|FG001|Active-to-active (Part B)|Pregnancy|0|||
105365121|NCT00243919|363342738|FG000|Overall Study|Administrative Error|1|||
105486944|NCT01986933|363793444|FG002|Active-to-active (Part B)|Pregnancy|0|||
105767696|NCT01989572|364800484|FG001|Overall Study|maximum dose reached|1|||
105767697|NCT01989572|364800485|FG002|Overall Study|maximum dose reached|0|||
105767698|NCT01989572|364800486|FG003|Overall Study|maximum dose reached|0|||
105767699|NCT01989572|364800487|FG004|Overall Study|maximum dose reached|1|||
105767700|NCT01989572|364800488|FG005|Overall Study|maximum dose reached|0|||
105767701|NCT01989572|364800483|FG000|Overall Study|unknown/not specify|3|||
105767702|NCT01989572|364800484|FG001|Overall Study|unknown/not specify|4|||
105365122|NCT00243919|363342739|FG001|Overall Study|Administrative Error|0|||
105767703|NCT01989572|364800485|FG002|Overall Study|unknown/not specify|1|||
105767704|NCT01989572|364800486|FG003|Overall Study|unknown/not specify|3|||
105767705|NCT01989572|364800487|FG004|Overall Study|unknown/not specify|3|||
105767706|NCT01989572|364800488|FG005|Overall Study|unknown/not specify|5|||
105767707|NCT01989572|364800483|FG000|Overall Study|not start protocol therapy|5|||
105767708|NCT01989572|364800484|FG001|Overall Study|not start protocol therapy|1|||
105767709|NCT01989572|364800485|FG002|Overall Study|not start protocol therapy|2|||
105767710|NCT01989572|364800486|FG003|Overall Study|not start protocol therapy|3|||
105767711|NCT01989572|364800487|FG004|Overall Study|not start protocol therapy|4|||
105767712|NCT01989572|364800488|FG005|Overall Study|not start protocol therapy|18|||
105767713|NCT01989572|364800483|FG000|Overall Study|alternative therapy|3|||
105767714|NCT01989572|364800484|FG001|Overall Study|alternative therapy|0|||
105767715|NCT01989572|364800485|FG002|Overall Study|alternative therapy|0|||
105767716|NCT01989572|364800486|FG003|Overall Study|alternative therapy|0|||
105767717|NCT01989572|364800487|FG004|Overall Study|alternative therapy|1|||
105767718|NCT01989572|364800488|FG005|Overall Study|alternative therapy|3|||
105767719|NCT00732641|364800493|FG000|Overall Study|Relapse or Progressive Disease|65|||
105767720|NCT00732641|364800494|FG001|Overall Study|Relapse or Progressive Disease|101|||
105767721|NCT00732641|364800493|FG000|Overall Study|Serious Adverse Events|12|||
105767722|NCT00732641|364800494|FG001|Overall Study|Serious Adverse Events|3|||
105767723|NCT00732641|364800493|FG000|Overall Study|Physician Decision|6|||
105767724|NCT00732641|364800494|FG001|Overall Study|Physician Decision|0|||
105767725|NCT00732641|364800493|FG000|Overall Study|Withdrawal by Subject|4|||
105767726|NCT00732641|364800494|FG001|Overall Study|Withdrawal by Subject|2|||
105767727|NCT00732641|364800493|FG000|Overall Study|Unable to Complete|1|||
105767728|NCT00732641|364800494|FG001|Overall Study|Unable to Complete|1|||
105767729|NCT00732641|364800493|FG000|Overall Study|Other|18|||
105365123|NCT00243919|363342740|FG002|Overall Study|Administrative Error|0|||
105365124|NCT00243919|363342738|FG000|Overall Study|Physician Decision|1|||
105486945|NCT01986933|363793445|FG003|Active-to-active (Part B)|Pregnancy|0|||
105486946|NCT01986933|363793446|FG004|Active-to-active (Part B)|Pregnancy|1|||
105486947|NCT01986933|363793442|FG000|Active-to-active (Part B)|Physician Decision|0|||
105486948|NCT01986933|363793443|FG001|Active-to-active (Part B)|Physician Decision|0|||
105486949|NCT01986933|363793444|FG002|Active-to-active (Part B)|Physician Decision|1|||
105486950|NCT01986933|363793445|FG003|Active-to-active (Part B)|Physician Decision|1|||
105486951|NCT01986933|363793446|FG004|Active-to-active (Part B)|Physician Decision|0|||
105486952|NCT01986933|363793442|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
105486953|NCT01986933|363793443|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
105486954|NCT01986933|363793444|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
105486955|NCT01986933|363793445|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
105486956|NCT01986933|363793446|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
105486957|NCT01986933|363793442|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
105486958|NCT01986933|363793443|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
105486959|NCT01986933|363793444|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
105486960|NCT01986933|363793445|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
105486961|NCT01986933|363793446|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
105486962|NCT01986933|363793442|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
105486963|NCT01986933|363793443|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
105486964|NCT01986933|363793444|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
105486965|NCT01986933|363793445|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
105486966|NCT01986933|363793446|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
105486967|NCT01986933|363793442|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
105486968|NCT01986933|363793443|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
105486969|NCT01986933|363793444|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
105486970|NCT01986933|363793445|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
105486971|NCT01986933|363793446|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
105486972|NCT01986933|363793442|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
105486973|NCT01986933|363793443|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
105486974|NCT01986933|363793444|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
105486975|NCT01986933|363793445|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
105486976|NCT01986933|363793446|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
105486977|NCT01986933|363793442|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
105486978|NCT01986933|363793443|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
105486979|NCT01986933|363793444|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
105572103|NCT00876460|364092845|FG001|Mono Therapy Phase|Adverse Event|0|||
105767730|NCT00732641|364800494|FG001|Overall Study|Other|5|||
105767731|NCT00732238|364800495|FG000|Overall Study|Bacteremia|4|||
105767732|NCT00732238|364800496|FG001|Overall Study|Bacteremia|1|||
105767733|NCT00732238|364800495|FG000|Overall Study|Asymptomatic bacteriuria|1|||
105767734|NCT00732238|364800496|FG001|Overall Study|Asymptomatic bacteriuria|0|||
105767735|NCT02280096|364800497|FG000|Overall Study|Pregnancy|1|||
105767736|NCT02280096|364800498|FG001|Overall Study|Pregnancy|0|||
105767737|NCT02280096|364800497|FG000|Overall Study|Functional neurological disorder|1|||
105767738|NCT02280096|364800498|FG001|Overall Study|Functional neurological disorder|0|||
105767739|NCT02280096|364800497|FG000|Overall Study|Lack of attachment|0|||
105767740|NCT02280096|364800498|FG001|Overall Study|Lack of attachment|1|||
105767741|NCT04661150|364800499|FG000|Overall Study|Ongoing in study|19|||
105767742|NCT04661150|364800500|FG001|Overall Study|Ongoing in study|20|||
105767743|NCT04661150|364800499|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
105767744|NCT04661150|364800500|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
105767745|NCT04661150|364800499|FG000|Overall Study|Death|2|||
105767746|NCT04661150|364800500|FG001|Overall Study|Death|0|||
105767747|NCT02939976|364800503|FG000|Overall Study|Lost to Follow-up|7|||
105767748|NCT02939976|364800504|FG001|Overall Study|Lost to Follow-up|1|||
105767749|NCT02939976|364800505|FG002|Overall Study|Lost to Follow-up|1|||
105767750|NCT02939976|364800506|FG003|Overall Study|Lost to Follow-up|2|||
105767751|NCT02939976|364800503|FG000|Overall Study|Withdrawal by Subject|4|||
105767752|NCT02939976|364800504|FG001|Overall Study|Withdrawal by Subject|0|||
105767753|NCT02939976|364800505|FG002|Overall Study|Withdrawal by Subject|2|||
105767754|NCT02939976|364800506|FG003|Overall Study|Withdrawal by Subject|4|||
105767755|NCT02939976|364800503|FG000|Overall Study|Due to early study closure|4|||
105767756|NCT02939976|364800504|FG001|Overall Study|Due to early study closure|3|||
105767757|NCT02939976|364800505|FG002|Overall Study|Due to early study closure|2|||
105767758|NCT02939976|364800506|FG003|Overall Study|Due to early study closure|3|||
105767759|NCT00246376|364800507|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
105767760|NCT00246376|364800508|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
105767761|NCT00246376|364800509|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
105767762|NCT00246376|364800510|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
105767763|NCT00246376|364800511|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
105823090|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105823091|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105823092|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
105823093|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
105823094|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
105823095|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105823096|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105823097|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105823098|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105823099|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
105823100|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
105823101|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
105823102|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
105486980|NCT01986933|363793445|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
105486981|NCT01986933|363793446|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
105486982|NCT01986933|363793442|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
105486983|NCT01986933|363793443|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
105486984|NCT01986933|363793444|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
105767764|NCT00246376|364800507|FG000|Overall Study|Adverse Event|2|||
105767765|NCT00246376|364800508|FG001|Overall Study|Adverse Event|3|||
105767766|NCT00246376|364800509|FG002|Overall Study|Adverse Event|1|||
105767767|NCT00246376|364800510|FG003|Overall Study|Adverse Event|3|||
105767768|NCT00246376|364800511|FG004|Overall Study|Adverse Event|1|||
105767769|NCT00246376|364800507|FG000|Overall Study|Lost to Follow-up|2|||
105767770|NCT00246376|364800508|FG001|Overall Study|Lost to Follow-up|11|||
105767771|NCT00246376|364800509|FG002|Overall Study|Lost to Follow-up|11|||
105767772|NCT00246376|364800510|FG003|Overall Study|Lost to Follow-up|16|||
105767773|NCT00246376|364800511|FG004|Overall Study|Lost to Follow-up|13|||
105767774|NCT01872897|364800512|FG000|Overall Study|Withdrawal by Subject|1|||
105767775|NCT01872897|364800513|FG001|Overall Study|Withdrawal by Subject|0|||
105767776|NCT01116648|364800514|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
105767777|NCT01116648|364800515|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
105767778|NCT01116648|364800516|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
105767779|NCT01116648|364800517|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
105767780|NCT01116648|364800518|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
105767781|NCT01116648|364800519|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
105767782|NCT01116648|364800520|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
105767783|NCT01116648|364800521|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
105767784|NCT01116648|364800522|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
105823103|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
105823104|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
105823105|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
105823106|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
105823107|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
105823108|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
105823109|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
105823110|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
105823111|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
105823112|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
105823113|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
105823114|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
105823115|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
105823116|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
105823117|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
105823118|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
105365125|NCT00243919|363342739|FG001|Overall Study|Physician Decision|1|||
105365126|NCT00243919|363342740|FG002|Overall Study|Physician Decision|0|||
105365127|NCT00192114|363342741|FG000|Overall Study|Objective Tumor Progression|19|||
105365128|NCT00192114|363342741|FG000|Overall Study|Adverse Event|2|||
105365129|NCT00192114|363342741|FG000|Overall Study|Clinical Progression|2|||
105365130|NCT00192114|363342741|FG000|Overall Study|Death|1|||
105365131|NCT01656395|363342751|FG000|Overall Study|Adverse Event|1|||
105486985|NCT01986933|363793445|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
105486986|NCT01986933|363793446|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
105486987|NCT01986933|363793442|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
105486988|NCT01986933|363793443|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
105486989|NCT01986933|363793444|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
105486990|NCT01986933|363793445|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
105486991|NCT01986933|363793446|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
105486992|NCT03119701|363793447|FG000|6-day Dosing|Death|4|||
105486993|NCT03119701|363793448|FG001|6-day Dosing|Death|1|||
105486994|NCT03119701|363793447|FG000|6-day Dosing|Adverse Event|3|||
105486995|NCT03119701|363793448|FG001|6-day Dosing|Adverse Event|0|||
105486996|NCT03119701|363793447|FG000|6-day Dosing|Physician Decision|0|||
105486997|NCT03119701|363793448|FG001|6-day Dosing|Physician Decision|1|||
105486998|NCT03119701|363793447|FG000|6-day Dosing|Withdrawal by Subject|0|||
105486999|NCT03119701|363793448|FG001|6-day Dosing|Withdrawal by Subject|1|||
105487000|NCT03119701|363793447|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
105487001|NCT03119701|363793448|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
105487002|NCT00596362|363793449|FG000|Overall Study|Progressive Disease|1|||
105487003|NCT00817479|363793450|FG000|Overall Study|Physician Decision|1|||
105487004|NCT00817479|363793451|FG001|Overall Study|Physician Decision|1|||
105487005|NCT03640559|363793454|FG000|Overall Study|Physician Decision|1|||
105487006|NCT03640559|363793455|FG001|Overall Study|Physician Decision|1|||
105487007|NCT03640559|363793454|FG000|Overall Study|Withdrawal by Subject|1|||
105487008|NCT03640559|363793455|FG001|Overall Study|Withdrawal by Subject|0|||
105487009|NCT02125604|363793456|FG000|Overall Study|Other|4|||
105487010|NCT02125604|363793456|FG000|Overall Study|Investigator Decision|1|||
105487011|NCT02125604|363793456|FG000|Overall Study|Lost to Follow-up|2|||
105487012|NCT02125604|363793456|FG000|Overall Study|Consent Withdrawn|4|||
105487013|NCT02125604|363793456|FG000|Overall Study|Adverse Event|20|||
105487014|NCT03442764|363794876|FG000|Overall Study|Adverse Event|1|||
105487015|NCT03442764|363794877|FG001|Overall Study|Adverse Event|0|||
105487016|NCT03442764|363794878|FG002|Overall Study|Adverse Event|0|||
105487017|NCT03269552|363794879|FG000|Overall Study|Adverse Event|2|||
105487018|NCT02448680|363794880|FG000|Overall Study|Physician Decision|1|||
105487019|NCT02448680|363794881|FG001|Overall Study|Physician Decision|1|||
105487020|NCT02448680|363794880|FG000|Overall Study|Withdrawal by Subject|0|||
105487021|NCT02448680|363794881|FG001|Overall Study|Withdrawal by Subject|2|||
105487022|NCT00815516|363794882|FG000|Overall Study|Death|3|||
105365132|NCT01656395|363342752|FG001|Overall Study|Adverse Event|14|||
105487023|NCT00815516|363794883|FG001|Overall Study|Death|1|||
105487024|NCT00815516|363794882|FG000|Overall Study|Physician Decision|1|||
105487025|NCT00815516|363794883|FG001|Overall Study|Physician Decision|0|||
105487026|NCT03410823|363794896|FG000|Overall Study|Death|1|||
105487027|NCT03410823|363794896|FG000|Overall Study|Withdrawal by Subject|2|||
105487028|NCT03410823|363794896|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
105487029|NCT01142128|363794897|FG000|Overall Study|Physician Decision|1|||
105487030|NCT01142128|363794897|FG000|Overall Study|Lost to Follow-up|1|||
105487031|NCT01142128|363794897|FG000|Overall Study|Withdrawal by Subject|2|||
105487032|NCT03355664|363794898|FG000|Overall Study|Adverse Event|1|||
105487033|NCT03355664|363794899|FG001|Overall Study|Adverse Event|2|||
105767785|NCT01116648|364800523|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
105767786|NCT01116648|364800524|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
105767787|NCT01116648|364800525|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
105767788|NCT01116648|364800526|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
105767789|NCT01116648|364800527|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
105767790|NCT01116648|364800528|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
105767791|NCT04159701|364800529|FG000|Period 1: Treatment Period|Pregnancy|1|||
105767792|NCT04159701|364800530|FG001|Period 1: Treatment Period|Pregnancy|0|||
105767793|NCT04159701|364800529|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
105767794|NCT04159701|364800530|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
105767795|NCT04159701|364800529|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
105767796|NCT04159701|364800530|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
105767797|NCT04159701|364800529|FG000|Washout Period|site terminated by sponsor|0|||
105767798|NCT04159701|364800530|FG001|Washout Period|site terminated by sponsor|1|||
105767799|NCT04159701|364800529|FG000|Washout Period|study terminated by sponsor|10|||
105767800|NCT04159701|364800530|FG001|Washout Period|study terminated by sponsor|3|||
105767801|NCT04159701|364800529|FG000|Washout Period|Withdrawal by Subject|1|||
105767802|NCT04159701|364800530|FG001|Washout Period|Withdrawal by Subject|0|||
105767803|NCT04159701|364800529|FG000|Washout Period|Inadvertent Enrollment|1|||
105767804|NCT04159701|364800530|FG001|Washout Period|Inadvertent Enrollment|0|||
105767805|NCT04159701|364800529|FG000|Washout Period|Miscellaneous|1|||
105767806|NCT04159701|364800530|FG001|Washout Period|Miscellaneous|0|||
105767807|NCT04159701|364800529|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
105767808|NCT04159701|364800530|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
105767809|NCT04159701|364800529|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
105767810|NCT04159701|364800530|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
105767811|NCT04159701|364800529|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
105767812|NCT04159701|364800530|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
105767813|NCT04159701|364800529|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
105767814|NCT04159701|364800530|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
105767815|NCT04159701|364800529|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
105767816|NCT04159701|364800530|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
105767817|NCT00865046|364800531|FG000|Overall Study|Lost to Follow-up|1|||
105767818|NCT00865046|364800532|FG001|Overall Study|Lost to Follow-up|4|||
105767819|NCT00865046|364800533|FG002|Overall Study|Lost to Follow-up|0|||
105767820|NCT00865046|364800531|FG000|Overall Study|Death|0|||
105767821|NCT00865046|364800532|FG001|Overall Study|Death|1|||
105767822|NCT00865046|364800533|FG002|Overall Study|Death|1|||
105767823|NCT00865046|364800531|FG000|Overall Study|Withdrawal by Subject|5|||
105767824|NCT00865046|364800532|FG001|Overall Study|Withdrawal by Subject|0|||
105767825|NCT00865046|364800533|FG002|Overall Study|Withdrawal by Subject|0|||
105767826|NCT03447821|364800534|FG000|Overall Study|Withdrawal by Subject|1|||
105767827|NCT03447821|364800535|FG001|Overall Study|Withdrawal by Subject|1|||
105767828|NCT03447821|364800536|FG002|Overall Study|Withdrawal by Subject|0|||
105767829|NCT03447821|364800534|FG000|Overall Study|Lost to Follow-up|0|||
105767830|NCT03447821|364800535|FG001|Overall Study|Lost to Follow-up|0|||
105572104|NCT00876460|364092846|FG002|Mono Therapy Phase|Adverse Event|0|||
105572105|NCT00876460|364092847|FG003|Mono Therapy Phase|Adverse Event|1|||
105572106|NCT00876460|364092848|FG004|Mono Therapy Phase|Adverse Event|0|||
105572107|NCT00876460|364092849|FG005|Mono Therapy Phase|Adverse Event|0|||
105572108|NCT00876460|364092850|FG006|Mono Therapy Phase|Adverse Event|0|||
105572109|NCT00876460|364092851|FG007|Mono Therapy Phase|Adverse Event|0|||
105572110|NCT03443713|364092854|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
105572111|NCT03443713|364092855|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
105572112|NCT03443713|364092856|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
105572113|NCT00874432|364092858|FG000|Overall Study|Withdrawal by Subject|1|||
105572114|NCT00874432|364092859|FG001|Overall Study|Withdrawal by Subject|0|||
105572115|NCT00874432|364092860|FG002|Overall Study|Withdrawal by Subject|0|||
105572116|NCT00874432|364092861|FG003|Overall Study|Withdrawal by Subject|0|||
105572117|NCT00874432|364092858|FG000|Overall Study|Physician Decision|1|||
105572118|NCT00874432|364092859|FG001|Overall Study|Physician Decision|0|||
105572119|NCT00874432|364092860|FG002|Overall Study|Physician Decision|0|||
105572120|NCT00874432|364092861|FG003|Overall Study|Physician Decision|0|||
105572121|NCT00874432|364092858|FG000|Overall Study|Other|1|||
105572122|NCT00874432|364092859|FG001|Overall Study|Other|2|||
105572123|NCT00874432|364092860|FG002|Overall Study|Other|8|||
105572124|NCT00874432|364092861|FG003|Overall Study|Other|3|||
105572125|NCT01672853|364092862|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
105572126|NCT01672853|364092863|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
105572127|NCT01672853|364092864|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
105572128|NCT01672853|364092862|FG000|Overall Study|Pregnancy|0|||
105572129|NCT01672853|364092863|FG001|Overall Study|Pregnancy|1|||
105572130|NCT01672853|364092864|FG002|Overall Study|Pregnancy|0|||
105572131|NCT01672853|364092862|FG000|Overall Study|Investigator's Discretion|1|||
105572132|NCT01672853|364092863|FG001|Overall Study|Investigator's Discretion|0|||
105572133|NCT01672853|364092864|FG002|Overall Study|Investigator's Discretion|0|||
105572134|NCT01672853|364092862|FG000|Overall Study|Withdrew Consent|5|||
105572135|NCT01672853|364092863|FG001|Overall Study|Withdrew Consent|5|||
105572136|NCT01672853|364092864|FG002|Overall Study|Withdrew Consent|5|||
105572137|NCT01672853|364092862|FG000|Overall Study|Adverse Event|4|||
105572138|NCT01672853|364092863|FG001|Overall Study|Adverse Event|6|||
105572139|NCT01672853|364092864|FG002|Overall Study|Adverse Event|8|||
105572140|NCT01672853|364092862|FG000|Overall Study|Lost to Follow-up|0|||
105572141|NCT01672853|364092863|FG001|Overall Study|Lost to Follow-up|1|||
105572142|NCT01672853|364092864|FG002|Overall Study|Lost to Follow-up|0|||
105572143|NCT01672853|364092862|FG000|Overall Study|Randomized but Never Treated|0|||
105572144|NCT01672853|364092863|FG001|Overall Study|Randomized but Never Treated|0|||
105572145|NCT01672853|364092864|FG002|Overall Study|Randomized but Never Treated|1|||
105572146|NCT02944656|364092865|FG000|Overall Study|No longer eligible|3|||
105572147|NCT02944656|364092866|FG001|Overall Study|No longer eligible|0|||
105572148|NCT02944656|364092865|FG000|Overall Study|Lost to Follow-up|7|||
105572149|NCT02944656|364092866|FG001|Overall Study|Lost to Follow-up|10|||
105572150|NCT02714205|364092868|FG000|Overall Study|Cannot tolerate medication|1|||
105572151|NCT02714205|364092869|FG001|Overall Study|Cannot tolerate medication|0|||
105572152|NCT02714205|364092868|FG000|Overall Study|Adverse Event|2|||
105572153|NCT02714205|364092869|FG001|Overall Study|Adverse Event|0|||
105572154|NCT02714205|364092868|FG000|Overall Study|Too busy|1|||
105572155|NCT02714205|364092869|FG001|Overall Study|Too busy|0|||
105572156|NCT02714205|364092868|FG000|Overall Study|Incomplete outcome data|0|||
105572157|NCT02714205|364092869|FG001|Overall Study|Incomplete outcome data|1|||
105767831|NCT03447821|364800536|FG002|Overall Study|Lost to Follow-up|1|||
105767832|NCT00329784|364800537|FG000|Overall Study|Lost to Follow-up|0|||
105767833|NCT00329784|364800538|FG001|Overall Study|Lost to Follow-up|1|||
105767834|NCT00329784|364800539|FG002|Overall Study|Lost to Follow-up|0|||
105767835|NCT00329784|364800540|FG003|Overall Study|Lost to Follow-up|0|||
105767836|NCT00329784|364800537|FG000|Overall Study|Withdrawal by Subject|4|||
105767837|NCT00329784|364800538|FG001|Overall Study|Withdrawal by Subject|2|||
105767838|NCT00329784|364800539|FG002|Overall Study|Withdrawal by Subject|0|||
105767839|NCT00329784|364800540|FG003|Overall Study|Withdrawal by Subject|0|||
105767840|NCT00329784|364800537|FG000|Overall Study|Other|1|||
105767841|NCT00329784|364800538|FG001|Overall Study|Other|2|||
105767842|NCT00329784|364800539|FG002|Overall Study|Other|0|||
105767843|NCT00329784|364800540|FG003|Overall Study|Other|0|||
105767844|NCT04362189|364800541|FG000|Overall Study|Lost to Follow-up|0|||
105572158|NCT05879198|364092872|FG000|Overall Study|Lost to Follow-up|1|||
105572159|NCT01598298|364092873|FG000|Overall Study|Not eligible|5|||
105572160|NCT01598298|364092874|FG001|Overall Study|Not eligible|5|||
105572161|NCT01598298|364092873|FG000|Overall Study|Adverse Event|21|||
105572162|NCT01598298|364092874|FG001|Overall Study|Adverse Event|19|||
105572163|NCT01598298|364092873|FG000|Overall Study|Progression/relapse|0|||
105572164|NCT01598298|364092874|FG001|Overall Study|Progression/relapse|2|||
105572165|NCT01598298|364092873|FG000|Overall Study|Withdrawal by Subject|10|||
105572166|NCT01598298|364092874|FG001|Overall Study|Withdrawal by Subject|15|||
105767845|NCT04362189|364800542|FG001|Overall Study|Lost to Follow-up|1|||
105767846|NCT04362189|364800541|FG000|Overall Study|Withdrawal by Subject|1|||
105365133|NCT01656395|363342753|FG002|Overall Study|Adverse Event|5|||
105365134|NCT01656395|363342754|FG003|Overall Study|Adverse Event|4|||
105365135|NCT01656395|363342755|FG004|Overall Study|Adverse Event|5|||
105365136|NCT01656395|363342756|FG005|Overall Study|Adverse Event|7|||
105365137|NCT01656395|363342757|FG006|Overall Study|Adverse Event|0|||
105365138|NCT01656395|363342758|FG007|Overall Study|Adverse Event|0|||
105365139|NCT01656395|363342751|FG000|Overall Study|Lack of Efficacy|1|||
105365140|NCT01656395|363342752|FG001|Overall Study|Lack of Efficacy|8|||
105365141|NCT01656395|363342753|FG002|Overall Study|Lack of Efficacy|6|||
105365142|NCT01656395|363342754|FG003|Overall Study|Lack of Efficacy|1|||
105365143|NCT01656395|363342755|FG004|Overall Study|Lack of Efficacy|1|||
105365144|NCT01656395|363342756|FG005|Overall Study|Lack of Efficacy|6|||
105365145|NCT01656395|363342757|FG006|Overall Study|Lack of Efficacy|0|||
105365146|NCT01656395|363342758|FG007|Overall Study|Lack of Efficacy|0|||
105365147|NCT01656395|363342751|FG000|Overall Study|Lost to Follow-up|1|||
105365148|NCT01656395|363342752|FG001|Overall Study|Lost to Follow-up|0|||
105365149|NCT01656395|363342753|FG002|Overall Study|Lost to Follow-up|0|||
105365150|NCT01656395|363342754|FG003|Overall Study|Lost to Follow-up|0|||
105365151|NCT01656395|363342755|FG004|Overall Study|Lost to Follow-up|0|||
105365152|NCT01656395|363342756|FG005|Overall Study|Lost to Follow-up|0|||
105365153|NCT01656395|363342757|FG006|Overall Study|Lost to Follow-up|0|||
105365154|NCT01656395|363342758|FG007|Overall Study|Lost to Follow-up|0|||
105365155|NCT01656395|363342751|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105365156|NCT01656395|363342752|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105365157|NCT01656395|363342753|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105365158|NCT01656395|363342754|FG003|Overall Study|Non-Compliance with Study Drug|0|||
105365159|NCT01656395|363342755|FG004|Overall Study|Non-Compliance with Study Drug|1|||
105572167|NCT01598298|364092873|FG000|Overall Study|Other reason (not protocol specified)|4|||
105572168|NCT01598298|364092874|FG001|Overall Study|Other reason (not protocol specified)|0|||
105572169|NCT01816763|364094430|FG000|Overall Study|The main reason for an incomplete survey|4|||
105572170|NCT01816763|364094431|FG001|Overall Study|The main reason for an incomplete survey|15|||
105823119|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
105823120|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105365160|NCT01656395|363342756|FG005|Overall Study|Non-Compliance with Study Drug|1|||
105365161|NCT01656395|363342757|FG006|Overall Study|Non-Compliance with Study Drug|0|||
105365162|NCT01656395|363342758|FG007|Overall Study|Non-Compliance with Study Drug|0|||
105365163|NCT01656395|363342751|FG000|Overall Study|Other|0|||
105487034|NCT03355664|363794898|FG000|Overall Study|Lost to Follow-up|11|||
105487035|NCT03355664|363794899|FG001|Overall Study|Lost to Follow-up|7|||
105487036|NCT03355664|363794898|FG000|Overall Study|Protocol Violation|1|||
105487037|NCT03355664|363794899|FG001|Overall Study|Protocol Violation|2|||
105487038|NCT03355664|363794898|FG000|Overall Study|Withdrawal by Subject|2|||
105487039|NCT03355664|363794899|FG001|Overall Study|Withdrawal by Subject|1|||
105487040|NCT00442468|363794900|FG000|Overall Study|Adverse Event|4|||
105487041|NCT00442468|363794900|FG000|Overall Study|Withdrawal by Subject|91|||
105487042|NCT00442468|363794900|FG000|Overall Study|Did not complete all study procedures|88|||
105487043|NCT02821910|363794906|FG000|Overall Study|Withdrawal by Subject|0|||
105487044|NCT02821910|363794907|FG001|Overall Study|Withdrawal by Subject|0|||
105487045|NCT02821910|363794908|FG002|Overall Study|Withdrawal by Subject|1|||
105487046|NCT02821910|363794909|FG003|Overall Study|Withdrawal by Subject|0|||
105487047|NCT02821910|363794910|FG004|Overall Study|Withdrawal by Subject|0|||
105487048|NCT02821910|363794911|FG005|Overall Study|Withdrawal by Subject|1|||
105487049|NCT02821910|363794906|FG000|Overall Study|Other than specified|1|||
105487050|NCT02821910|363794907|FG001|Overall Study|Other than specified|0|||
105487051|NCT02821910|363794908|FG002|Overall Study|Other than specified|1|||
105487052|NCT02821910|363794909|FG003|Overall Study|Other than specified|0|||
105487053|NCT02821910|363794910|FG004|Overall Study|Other than specified|0|||
105487054|NCT02821910|363794911|FG005|Overall Study|Other than specified|0|||
105487055|NCT00470184|363794914|FG000|Overall Study|Not Treated(became ineligible)|4|||
105487056|NCT00470184|363794914|FG000|Overall Study|Not treated (other)|1|||
105487057|NCT00470184|363794914|FG000|Overall Study|disease Progression|4|||
105572171|NCT01816763|364094432|FG002|Overall Study|The main reason for an incomplete survey|11|||
105572172|NCT00429494|364094433|FG000|Overall Study|Withdrawal by Subject|9|||
105823121|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
105365164|NCT01656395|363342752|FG001|Overall Study|Other|0|||
105365165|NCT01656395|363342753|FG002|Overall Study|Other|1|||
105365166|NCT01656395|363342754|FG003|Overall Study|Other|0|||
105365167|NCT01656395|363342755|FG004|Overall Study|Other|0|||
105365168|NCT01656395|363342756|FG005|Overall Study|Other|1|||
105365169|NCT01656395|363342757|FG006|Overall Study|Other|0|||
105365170|NCT01656395|363342758|FG007|Overall Study|Other|0|||
105487058|NCT00470184|363794914|FG000|Overall Study|Adverse Event|3|||
105487059|NCT00470184|363794914|FG000|Overall Study|Withdrawal by Subject|4|||
105487060|NCT00470184|363794914|FG000|Overall Study|other|5|||
105487061|NCT00470184|363794914|FG000|Overall Study|recurrence|1|||
105487062|NCT01966432|363794915|FG000|Overall Study|Lost to Follow-up|3|||
105487063|NCT01966432|363794916|FG001|Overall Study|Lost to Follow-up|2|||
105365171|NCT01656395|363342751|FG000|Overall Study|Physician Decision|2|||
105365172|NCT01656395|363342752|FG001|Overall Study|Physician Decision|3|||
105487064|NCT01966432|363794917|FG002|Overall Study|Lost to Follow-up|5|||
105487065|NCT01966432|363794915|FG000|Overall Study|Withdrawal by Subject|1|||
105487066|NCT01966432|363794916|FG001|Overall Study|Withdrawal by Subject|3|||
105487067|NCT01966432|363794917|FG002|Overall Study|Withdrawal by Subject|0|||
105487068|NCT01966432|363794915|FG000|Overall Study|Subject Incarcerated|0|||
105487069|NCT01966432|363794916|FG001|Overall Study|Subject Incarcerated|0|||
105487070|NCT01966432|363794917|FG002|Overall Study|Subject Incarcerated|1|||
105487071|NCT01966432|363794915|FG000|Overall Study|SBIRT program ended|1|||
105572173|NCT00429494|364094433|FG000|Overall Study|Death|6|||
105572174|NCT01992549|364094436|FG000|Overall Study|Lost to Follow-up|2|||
105572175|NCT01992549|364094436|FG000|Overall Study|Serious Adverse Event|1|||
105572176|NCT01992549|364094436|FG000|Overall Study|Product Switch to Extend Half Life|1|||
105572177|NCT01590771|364094437|FG000|Overall Study|Other Protocol Specified Criteria|5|||
105572178|NCT01590771|364094438|FG001|Overall Study|Other Protocol Specified Criteria|14|||
105572179|NCT01590771|364094437|FG000|Overall Study|Withdrawal by Subject|8|||
105572180|NCT01590771|364094438|FG001|Overall Study|Withdrawal by Subject|15|||
105572181|NCT01590771|364094437|FG000|Overall Study|Protocol Violation|1|||
105572182|NCT01590771|364094438|FG001|Overall Study|Protocol Violation|2|||
105767847|NCT04362189|364800542|FG001|Overall Study|Withdrawal by Subject|0|||
105767848|NCT04362189|364800541|FG000|Overall Study|FDA Clinical Hold|7|||
105767849|NCT04362189|364800542|FG001|Overall Study|FDA Clinical Hold|2|||
105767850|NCT04362189|364800541|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
105767851|NCT04362189|364800542|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
105767852|NCT04362189|364800541|FG000|Overall Study|Adverse Event|0|||
105767853|NCT04362189|364800542|FG001|Overall Study|Adverse Event|2|||
105767854|NCT04362189|364800541|FG000|Overall Study|Death|4|||
105767855|NCT04362189|364800542|FG001|Overall Study|Death|1|||
105767856|NCT00841672|364800547|FG000|Overall Study|Adverse Event|7|||
105767857|NCT00841672|364800548|FG001|Overall Study|Adverse Event|16|||
105767858|NCT00841672|364800547|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105767859|NCT00841672|364800548|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105767860|NCT00841672|364800547|FG000|Overall Study|Subject withdrew consent|2|||
105767861|NCT00841672|364800548|FG001|Overall Study|Subject withdrew consent|4|||
105767862|NCT00841672|364800547|FG000|Overall Study|Lost to Follow-up|1|||
105767863|NCT00841672|364800548|FG001|Overall Study|Lost to Follow-up|1|||
105767864|NCT00841672|364800547|FG000|Overall Study|Administrative problems|9|||
105767865|NCT00841672|364800548|FG001|Overall Study|Administrative problems|9|||
105767866|NCT00841672|364800547|FG000|Overall Study|Misrandomized|1|||
105767867|NCT00841672|364800548|FG001|Overall Study|Misrandomized|0|||
105767868|NCT00841672|364800547|FG000|Overall Study|Protocol Deviation|0|||
105767869|NCT00841672|364800548|FG001|Overall Study|Protocol Deviation|1|||
105767870|NCT01927068|364800549|FG000|Overall Study|Death|37|||
105767871|NCT01927068|364800550|FG001|Overall Study|Death|3|||
105767872|NCT01927068|364800549|FG000|Overall Study|Withdrawal by Subject|50|||
105767873|NCT01927068|364800550|FG001|Overall Study|Withdrawal by Subject|3|||
105767874|NCT01927068|364800549|FG000|Overall Study|Lost to Follow-up|10|||
105767875|NCT01927068|364800550|FG001|Overall Study|Lost to Follow-up|2|||
105767876|NCT01927068|364800549|FG000|Overall Study|Physician Decision|9|||
105767877|NCT01927068|364800550|FG001|Overall Study|Physician Decision|0|||
105767878|NCT01927068|364800549|FG000|Overall Study|Missed last follow-up visit|2|||
105767879|NCT01927068|364800550|FG001|Overall Study|Missed last follow-up visit|0|||
105767880|NCT00880607|364800551|FG000|Overall Study|Physician Decision|2|||
105823122|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
105823123|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105767881|NCT00880607|364800552|FG001|Overall Study|Physician Decision|2|||
105767882|NCT00880607|364800551|FG000|Overall Study|Protocol Violation|2|||
105767883|NCT00880607|364800552|FG001|Overall Study|Protocol Violation|1|||
105487072|NCT01966432|363794916|FG001|Overall Study|SBIRT program ended|8|||
105487073|NCT01966432|363794917|FG002|Overall Study|SBIRT program ended|20|||
105572183|NCT01590771|364094437|FG000|Overall Study|Lost to Follow-up|1|||
105572184|NCT01590771|364094438|FG001|Overall Study|Lost to Follow-up|1|||
105572185|NCT01590771|364094437|FG000|Overall Study|Lack of Efficacy|1|||
105572186|NCT01590771|364094438|FG001|Overall Study|Lack of Efficacy|0|||
105572187|NCT01590771|364094437|FG000|Overall Study|Adverse Event|3|||
105572188|NCT01590771|364094438|FG001|Overall Study|Adverse Event|7|||
105572189|NCT01785628|364094439|FG000|Overall Study|Lost to Follow-up|2|||
105572190|NCT01785628|364094440|FG001|Overall Study|Lost to Follow-up|3|||
105572191|NCT02936037|364094448|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
105572192|NCT02936037|364094449|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
105572193|NCT02936037|364094448|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
105572194|NCT02936037|364094449|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
105572195|NCT02936037|364094448|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
105572196|NCT02936037|364094449|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
105572197|NCT02936037|364094448|FG000|Double-Blind Treatment Period|Death|0|||
105572198|NCT02936037|364094449|FG001|Double-Blind Treatment Period|Death|1|||
105572199|NCT02936037|364094448|FG000|Double-Blind Treatment Period|Adverse Event|11|||
105572200|NCT02936037|364094449|FG001|Double-Blind Treatment Period|Adverse Event|11|||
105572201|NCT02936037|364094448|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
105572202|NCT02936037|364094449|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
105572203|NCT02936037|364094448|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105572204|NCT02936037|364094449|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
105572205|NCT02936037|364094448|FG000|Open Label Extension|Adverse Event|0|||
105572206|NCT02936037|364094449|FG001|Open Label Extension|Adverse Event|3|||
105572207|NCT02936037|364094448|FG000|Open Label Extension|Other|0|||
105572208|NCT02936037|364094449|FG001|Open Label Extension|Other|3|||
105572209|NCT02936037|364094448|FG000|Open Label Extension|Withdrawal by Subject|0|||
105572210|NCT02936037|364094449|FG001|Open Label Extension|Withdrawal by Subject|4|||
105572211|NCT00453310|364094453|FG000|Overall Study|Progression of Disease|10|||
105572212|NCT01806740|364094454|FG000|Overall Study|Withdrawal by Subject|4|||
105572213|NCT01806740|364094454|FG000|Overall Study|Physician Decision|1|||
105572214|NCT01806740|364094454|FG000|Overall Study|Patient's refusal of treatment|1|||
105572215|NCT04567693|364094455|FG000|Overall Study|Death|0|||
105572216|NCT04567693|364094456|FG001|Overall Study|Death|0|||
105572217|NCT04567693|364094457|FG002|Overall Study|Death|2|||
105572218|NCT04567693|364094455|FG000|Overall Study|Lost to Follow-up|1|||
105572219|NCT04567693|364094456|FG001|Overall Study|Lost to Follow-up|0|||
105572220|NCT04567693|364094457|FG002|Overall Study|Lost to Follow-up|2|||
105572221|NCT04567693|364094455|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
105572222|NCT04567693|364094456|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
105572223|NCT04567693|364094457|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
105572224|NCT00244374|364094462|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
105572225|NCT00244374|364094463|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
105572226|NCT00244374|364094464|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
105572227|NCT00244374|364094465|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
105572228|NCT00244374|364094466|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
105572229|NCT00244374|364094462|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
105572230|NCT00244374|364094463|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
105572231|NCT00244374|364094464|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
105572232|NCT00244374|364094465|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
105572233|NCT00244374|364094466|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
105823124|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105572234|NCT00244374|364094462|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
105572235|NCT00244374|364094463|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
105572236|NCT00244374|364094464|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
105572237|NCT00244374|364094465|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
105572238|NCT00244374|364094466|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
105572239|NCT00244374|364094462|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
105572240|NCT00244374|364094463|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
105626666|NCT04167553|364298144|FG004|Overall Study|Withdrawal by Subject|1|||
105572241|NCT00244374|364094464|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
105572242|NCT00244374|364094465|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
105572243|NCT00244374|364094466|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
105572244|NCT00244374|364094462|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
105572245|NCT00244374|364094463|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
105572246|NCT00244374|364094464|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
105572247|NCT00244374|364094465|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
105572248|NCT00244374|364094466|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
105572249|NCT00244374|364094462|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
105572250|NCT00244374|364094463|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
105572251|NCT00244374|364094464|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
105572252|NCT00244374|364094465|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
105572253|NCT00244374|364094466|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
105572254|NCT00244374|364094462|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
105572255|NCT00244374|364094463|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
105572256|NCT00244374|364094464|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
105572257|NCT00244374|364094465|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
105572258|NCT00244374|364094466|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
105572259|NCT00244374|364094462|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
105572260|NCT00244374|364094463|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
105572261|NCT00244374|364094464|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
105572262|NCT00244374|364094465|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
105572263|NCT00244374|364094466|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
105572264|NCT00244374|364094462|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
105572265|NCT00244374|364094463|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
105572266|NCT00244374|364094464|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
105572267|NCT00244374|364094465|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
105572268|NCT00244374|364094466|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
105572269|NCT00976482|364094467|FG000|Overall Study|Death|208|||
105572270|NCT00976482|364094467|FG000|Overall Study|Withdrawal by Subject|45|||
105572271|NCT00976482|364094467|FG000|Overall Study|Center terminated|1|||
105572272|NCT00976482|364094467|FG000|Overall Study|Protocol Violation|5|||
105572273|NCT05340751|364094475|FG000|Overall Study|Physician Decision|3|||
105572274|NCT01014975|364094477|FG000|Overall Study|Withdrawal by Subject|1|||
105572275|NCT01014975|364094478|FG001|Overall Study|Withdrawal by Subject|0|||
105572276|NCT01014975|364094479|FG002|Overall Study|Withdrawal by Subject|1|||
105572277|NCT01014975|364094477|FG000|Overall Study|Death|3|||
105572278|NCT01014975|364094478|FG001|Overall Study|Death|3|||
105572279|NCT01014975|364094479|FG002|Overall Study|Death|4|||
105572280|NCT01014975|364094477|FG000|Overall Study|Lost to Follow-up|0|||
105572281|NCT01014975|364094478|FG001|Overall Study|Lost to Follow-up|0|||
105572282|NCT01014975|364094479|FG002|Overall Study|Lost to Follow-up|1|||
105572283|NCT00633932|364094480|FG000|Overall Study|Adverse Event|1|||
105572284|NCT00633932|364094481|FG001|Overall Study|Adverse Event|3|||
105572285|NCT00633932|364094482|FG002|Overall Study|Adverse Event|4|||
105572286|NCT00633932|364094480|FG000|Overall Study|Withdrawal by Subject|3|||
105572287|NCT00633932|364094481|FG001|Overall Study|Withdrawal by Subject|9|||
105572288|NCT00633932|364094482|FG002|Overall Study|Withdrawal by Subject|1|||
105572289|NCT00633932|364094480|FG000|Overall Study|Lost to Follow-up|1|||
105572290|NCT00633932|364094481|FG001|Overall Study|Lost to Follow-up|0|||
105572291|NCT00633932|364094482|FG002|Overall Study|Lost to Follow-up|2|||
105572292|NCT00633932|364094480|FG000|Overall Study|Protocol Violation|5|||
105572293|NCT00633932|364094481|FG001|Overall Study|Protocol Violation|2|||
105572294|NCT00633932|364094482|FG002|Overall Study|Protocol Violation|3|||
105572295|NCT00633932|364094480|FG000|Overall Study|Physician Decision|0|||
105572296|NCT00633932|364094481|FG001|Overall Study|Physician Decision|0|||
105572297|NCT00633932|364094482|FG002|Overall Study|Physician Decision|1|||
105572298|NCT00633932|364094480|FG000|Overall Study|Doctor's judgement|1|||
105572299|NCT00633932|364094481|FG001|Overall Study|Doctor's judgement|0|||
105572300|NCT00633932|364094482|FG002|Overall Study|Doctor's judgement|0|||
105572301|NCT00633932|364094480|FG000|Overall Study|Moved Away|1|||
105572302|NCT00633932|364094481|FG001|Overall Study|Moved Away|0|||
105767884|NCT00880607|364800551|FG000|Overall Study|surgery did not extend past L1 level|3|||
105767885|NCT00880607|364800552|FG001|Overall Study|surgery did not extend past L1 level|0|||
105572303|NCT00633932|364094482|FG002|Overall Study|Moved Away|0|||
105572304|NCT00482274|364094483|FG000|Overall Study|Adverse Event|1|||
105572305|NCT01932294|364094484|FG000|Overall Study|Death|43|||
105767886|NCT02725268|364800553|FG000|Overall Study|Death|58|||
105487074|NCT01055496|363794918|FG000|Overall Study|Withdrawal by Subject|2|||
105487075|NCT01055496|363794919|FG001|Overall Study|Withdrawal by Subject|4|||
105487076|NCT01055496|363794918|FG000|Overall Study|Death|13|||
105487077|NCT01055496|363794919|FG001|Overall Study|Death|23|||
105487078|NCT01055496|363794918|FG000|Overall Study|Lost to Follow-up|0|||
105487079|NCT01055496|363794919|FG001|Overall Study|Lost to Follow-up|2|||
105487080|NCT01055496|363794918|FG000|Overall Study|Other - Unspecified|0|||
105487081|NCT01055496|363794919|FG001|Overall Study|Other - Unspecified|1|||
105487082|NCT04365257|363794925|FG000|Overall Study|Physician Decision|1|||
105487083|NCT04365257|363794926|FG001|Overall Study|Physician Decision|0|||
105487084|NCT04365257|363794925|FG000|Overall Study|Patient Noncompliance|1|||
105487085|NCT04365257|363794926|FG001|Overall Study|Patient Noncompliance|0|||
105487086|NCT04365257|363794925|FG000|Overall Study|Withdrawal by Subject|0|||
105487087|NCT04365257|363794926|FG001|Overall Study|Withdrawal by Subject|1|||
105487088|NCT03452527|363794927|FG000|Overall Study|Withdrawal by Subject|1|||
105487089|NCT03452527|363794928|FG001|Overall Study|Withdrawal by Subject|1|||
105487090|NCT03452527|363794927|FG000|Overall Study|Study Terminated|2|||
105487091|NCT03452527|363794928|FG001|Overall Study|Study Terminated|3|||
105487092|NCT01001299|363794933|FG000|Overall Study|Insufficient Therapeutic Response|20|||
105487093|NCT01001299|363794933|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
105487094|NCT01001299|363794933|FG000|Overall Study|Death|1|||
105487095|NCT01001299|363794933|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
105487096|NCT01001299|363794933|FG000|Overall Study|Withdrew Consent|1|||
105487097|NCT01323920|363794934|FG000|Overall Study|Death|5|||
105487098|NCT01323920|363794934|FG000|Overall Study|Withdrawal by Subject|1|||
105487099|NCT02117414|363794935|FG000|Overall Study|Death|5|||
105487100|NCT02117414|363794936|FG001|Overall Study|Death|2|||
105487101|NCT02117414|363794935|FG000|Overall Study|Withdrawal by Subject|10|||
105487102|NCT02117414|363794936|FG001|Overall Study|Withdrawal by Subject|4|||
105487103|NCT03101267|363794939|FG000|Primary Study Period|Withdrawal by Subject|1|||
105487104|NCT03101267|363794940|FG001|Primary Study Period|Withdrawal by Subject|2|||
105487105|NCT03101267|363794941|FG002|Primary Study Period|Withdrawal by Subject|3|||
105487106|NCT03101267|363794939|FG000|Primary Study Period|Miscellaneous|2|||
105487107|NCT03101267|363794940|FG001|Primary Study Period|Miscellaneous|0|||
105487108|NCT03101267|363794941|FG002|Primary Study Period|Miscellaneous|0|||
105487109|NCT00459056|363794942|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
105487110|NCT00459056|363794943|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
105487111|NCT02283177|363794944|FG000|Overall Study|Withdrawal by Subject|1|||
105487112|NCT02283177|363794945|FG001|Overall Study|Withdrawal by Subject|1|||
105487113|NCT01185834|363794949|FG000|Overall Study|Lost to Follow-up|2|||
105572306|NCT01932294|364094484|FG000|Overall Study|Lost to Follow-up|8|||
105365173|NCT01656395|363342753|FG002|Overall Study|Physician Decision|3|||
105365174|NCT01656395|363342754|FG003|Overall Study|Physician Decision|2|||
105365175|NCT01656395|363342755|FG004|Overall Study|Physician Decision|3|||
105487114|NCT01185834|363794949|FG000|Overall Study|Discomfort|4|||
105487115|NCT01185834|363794949|FG000|Overall Study|Biomicroscopy|4|||
105487116|NCT01185834|363794949|FG000|Overall Study|Time/Job Conflict|2|||
105487117|NCT01185834|363794949|FG000|Overall Study|Early exit - Site error|2|||
105487118|NCT02635646|363794950|FG000|Overall Study|Lost to Follow-up|24|||
105487119|NCT02635646|363794951|FG001|Overall Study|Lost to Follow-up|25|||
105487120|NCT02635646|363794950|FG000|Overall Study|Pregnancy|1|||
105487121|NCT02635646|363794951|FG001|Overall Study|Pregnancy|1|||
105487122|NCT02694718|363794964|FG000|Overall Study|Death|1|||
105487123|NCT02694718|363794964|FG000|Overall Study|Withdrawal by Subject|1|||
105487124|NCT02925793|363794965|FG000|Overall Study|Adverse Event|3|||
105487125|NCT02925793|363794966|FG001|Overall Study|Adverse Event|3|||
105365176|NCT01656395|363342756|FG005|Overall Study|Physician Decision|3|||
105365177|NCT01656395|363342757|FG006|Overall Study|Physician Decision|0|||
105365178|NCT01656395|363342758|FG007|Overall Study|Physician Decision|0|||
105365179|NCT01656395|363342751|FG000|Overall Study|Pregnancy|0|||
105365180|NCT01656395|363342752|FG001|Overall Study|Pregnancy|0|||
105365181|NCT01656395|363342753|FG002|Overall Study|Pregnancy|1|||
105365182|NCT01656395|363342754|FG003|Overall Study|Pregnancy|0|||
105365183|NCT01656395|363342755|FG004|Overall Study|Pregnancy|0|||
105365184|NCT01656395|363342756|FG005|Overall Study|Pregnancy|0|||
105487126|NCT02925793|363794967|FG002|Overall Study|Adverse Event|6|||
105487127|NCT02925793|363794965|FG000|Overall Study|Withdrawal by Subject|16|||
105487128|NCT02925793|363794966|FG001|Overall Study|Withdrawal by Subject|15|||
105487129|NCT02925793|363794967|FG002|Overall Study|Withdrawal by Subject|13|||
105365185|NCT01656395|363342757|FG006|Overall Study|Pregnancy|0|||
105365186|NCT01656395|363342758|FG007|Overall Study|Pregnancy|0|||
105365187|NCT01656395|363342751|FG000|Overall Study|Progressive Disease|0|||
105365188|NCT01656395|363342752|FG001|Overall Study|Progressive Disease|0|||
105487130|NCT02925793|363794965|FG000|Overall Study|Investigator Discretion|0|||
105487131|NCT02925793|363794966|FG001|Overall Study|Investigator Discretion|1|||
105487132|NCT02925793|363794967|FG002|Overall Study|Investigator Discretion|1|||
105487133|NCT02925793|363794965|FG000|Overall Study|Lost to Follow-up|2|||
105365189|NCT01656395|363342753|FG002|Overall Study|Progressive Disease|0|||
105365190|NCT01656395|363342754|FG003|Overall Study|Progressive Disease|0|||
105365191|NCT01656395|363342755|FG004|Overall Study|Progressive Disease|0|||
105365192|NCT01656395|363342756|FG005|Overall Study|Progressive Disease|1|||
105572307|NCT01932294|364094484|FG000|Overall Study|VAD Implantation|20|||
105365193|NCT01656395|363342757|FG006|Overall Study|Progressive Disease|0|||
105365194|NCT01656395|363342758|FG007|Overall Study|Progressive Disease|0|||
105572308|NCT01932294|364094484|FG000|Overall Study|Heart Transplantation|16|||
105572309|NCT01932294|364094484|FG000|Overall Study|Transferred to other hospitals|12|||
105572310|NCT02145078|364094486|FG000|Overall Study|Death|1|||
105365195|NCT01656395|363342751|FG000|Overall Study|Protocol Violation|6|||
105365196|NCT01656395|363342752|FG001|Overall Study|Protocol Violation|6|||
105365197|NCT01656395|363342753|FG002|Overall Study|Protocol Violation|9|||
105365198|NCT01656395|363342754|FG003|Overall Study|Protocol Violation|2|||
105365199|NCT01656395|363342755|FG004|Overall Study|Protocol Violation|4|||
105365200|NCT01656395|363342756|FG005|Overall Study|Protocol Violation|10|||
105365201|NCT01656395|363342757|FG006|Overall Study|Protocol Violation|0|||
105365202|NCT01656395|363342758|FG007|Overall Study|Protocol Violation|0|||
105365203|NCT01656395|363342751|FG000|Overall Study|Screen Failure|2|||
105365204|NCT01656395|363342752|FG001|Overall Study|Screen Failure|1|||
105572311|NCT02145078|364094486|FG000|Overall Study|Reason not given|3|||
105572312|NCT00597714|364094489|FG000|Overall Study|Death|56|||
105572313|NCT00597714|364094490|FG001|Overall Study|Death|46|||
105572314|NCT00597714|364094491|FG002|Overall Study|Death|0|||
105572315|NCT00597714|364094489|FG000|Overall Study|Recipient death|0|||
105572316|NCT00597714|364094490|FG001|Overall Study|Recipient death|0|||
105572317|NCT00597714|364094491|FG002|Overall Study|Recipient death|10|||
105572318|NCT03327402|364094492|FG000|Overall Study|Withdrawal by Subject|1|||
105572319|NCT03327402|364094492|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
105572320|NCT01588990|364094493|FG000|Phase A|Withdrawal by Subject|5|||
105572321|NCT01588990|364094493|FG000|Phase A|Physician Decision|11|||
105572322|NCT01588990|364094493|FG000|Phase A|Other|14|||
105572323|NCT01588990|364094493|FG000|Phase A|Lost to Follow-up|1|||
105572324|NCT01588990|364094493|FG000|Phase A|Death|5|||
105572325|NCT01588990|364094493|FG000|Phase A|Adverse Event|28|||
105572326|NCT01588990|364094493|FG000|Phase A|Still on therapy at end of study|6|||
105572327|NCT01588990|364094493|FG000|Phase B|Adverse Event|2|||
105572328|NCT01588990|364094493|FG000|Phase B|Still on therapy at end of study|5|||
105572329|NCT01588990|364094493|FG000|Phase B|Withdrawal by Subject|3|||
105365205|NCT01656395|363342753|FG002|Overall Study|Screen Failure|7|||
105365206|NCT01656395|363342754|FG003|Overall Study|Screen Failure|1|||
105572330|NCT01588990|364094493|FG000|Phase B|Physician Decision|4|||
105572331|NCT01588990|364094493|FG000|Phase B|Other|2|||
105572332|NCT02440594|364094499|FG000|Overall Study|Lost to Follow-up|34|||
105572333|NCT02440594|364094500|FG001|Overall Study|Lost to Follow-up|33|||
105572334|NCT02440594|364094501|FG002|Overall Study|Lost to Follow-up|54|||
105572335|NCT02440594|364094502|FG003|Overall Study|Lost to Follow-up|47|||
105572336|NCT02440594|364094503|FG004|Overall Study|Lost to Follow-up|5|||
105572337|NCT02440594|364094504|FG005|Overall Study|Lost to Follow-up|4|||
105365207|NCT01656395|363342755|FG004|Overall Study|Screen Failure|0|||
105767887|NCT02725268|364800554|FG001|Overall Study|Death|59|||
105767888|NCT02725268|364800555|FG002|Overall Study|Death|30|||
105767889|NCT02725268|364800556|FG003|Overall Study|Death|16|||
105365208|NCT01656395|363342756|FG005|Overall Study|Screen Failure|8|||
105365209|NCT01656395|363342757|FG006|Overall Study|Screen Failure|0|||
105365210|NCT01656395|363342758|FG007|Overall Study|Screen Failure|0|||
105365211|NCT01656395|363342751|FG000|Overall Study|Withdrawal by Subject|3|||
105365212|NCT01656395|363342752|FG001|Overall Study|Withdrawal by Subject|1|||
105365213|NCT01656395|363342753|FG002|Overall Study|Withdrawal by Subject|4|||
105365214|NCT01656395|363342754|FG003|Overall Study|Withdrawal by Subject|2|||
105365215|NCT01656395|363342755|FG004|Overall Study|Withdrawal by Subject|0|||
105365216|NCT01656395|363342756|FG005|Overall Study|Withdrawal by Subject|3|||
105365217|NCT01656395|363342757|FG006|Overall Study|Withdrawal by Subject|0|||
105365218|NCT01656395|363342758|FG007|Overall Study|Withdrawal by Subject|0|||
105365219|NCT03669549|363342760|FG000|Overall Study|Adverse Event|4|||
105365220|NCT03669549|363342760|FG000|Overall Study|Withdrawal by Subject|1|||
105365221|NCT03669549|363342760|FG000|Overall Study|Study terminated by the Sponsor|1|||
105365222|NCT02219685|363342761|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
105365223|NCT02219685|363342762|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
105365224|NCT02219685|363342761|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
105365225|NCT02219685|363342762|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
105767890|NCT02725268|364800553|FG000|Overall Study|Lost to Follow-up|4|||
105365226|NCT02974868|363342763|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
105365227|NCT02974868|363342764|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
105365228|NCT02974868|363342765|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
105365229|NCT02974868|363342766|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
105365230|NCT02974868|363342763|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
105572338|NCT02440594|364094505|FG006|Overall Study|Lost to Follow-up|28|||
105572339|NCT02440594|364094506|FG007|Overall Study|Lost to Follow-up|48|||
105767891|NCT02725268|364800554|FG001|Overall Study|Lost to Follow-up|3|||
105572340|NCT02440594|364094499|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
105572341|NCT02440594|364094500|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
105572342|NCT02440594|364094501|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
105572343|NCT02440594|364094502|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
105572344|NCT02440594|364094503|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
105823125|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105823126|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105823127|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
105823128|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
105823129|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
105823130|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
105823131|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
105823132|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
105823133|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
105823134|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
105823135|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
105823136|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
105823137|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
105823138|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
105823139|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
105823140|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
105823141|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105823142|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105823143|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105823144|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
105823145|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
105823146|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
105823147|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
105823148|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
105823149|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
105823150|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
105823151|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
105823152|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
105823153|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
105823154|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
105823155|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
105823156|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
105823157|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
105823158|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
105823159|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
105487134|NCT02925793|363794966|FG001|Overall Study|Lost to Follow-up|3|||
105487135|NCT02925793|363794967|FG002|Overall Study|Lost to Follow-up|1|||
105487136|NCT02925793|363794965|FG000|Overall Study|Lack of Efficacy|2|||
105487137|NCT02925793|363794966|FG001|Overall Study|Lack of Efficacy|6|||
105487138|NCT02925793|363794967|FG002|Overall Study|Lack of Efficacy|4|||
105487139|NCT02925793|363794965|FG000|Overall Study|Other:|2|||
105487140|NCT02925793|363794966|FG001|Overall Study|Other:|1|||
105487141|NCT02925793|363794967|FG002|Overall Study|Other:|3|||
105487142|NCT00879879|363794968|FG000|Overall Study|Death|1|||
105487143|NCT00879879|363794968|FG000|Overall Study|Withdrawal by Subject|1|||
105487144|NCT00879879|363794968|FG000|Overall Study|Physician Decision|1|||
105487145|NCT00645788|363794971|FG000|Overall Study|Did not receive study drug|1|||
105487146|NCT00645788|363794972|FG001|Overall Study|Did not receive study drug|1|||
105487147|NCT00645788|363794973|FG002|Overall Study|Did not receive study drug|0|||
105487148|NCT00645788|363794974|FG003|Overall Study|Did not receive study drug|0|||
105487149|NCT00645788|363794971|FG000|Overall Study|Adverse Event|4|||
105487150|NCT00645788|363794972|FG001|Overall Study|Adverse Event|9|||
105487151|NCT00645788|363794973|FG002|Overall Study|Adverse Event|5|||
105487152|NCT00645788|363794974|FG003|Overall Study|Adverse Event|3|||
105487153|NCT00645788|363794971|FG000|Overall Study|Lost to Follow-up|1|||
105487154|NCT00645788|363794972|FG001|Overall Study|Lost to Follow-up|0|||
105487155|NCT00645788|363794973|FG002|Overall Study|Lost to Follow-up|0|||
105487156|NCT00645788|363794974|FG003|Overall Study|Lost to Follow-up|0|||
105487157|NCT00645788|363794971|FG000|Overall Study|Protocol Violation|1|||
105487158|NCT00645788|363794972|FG001|Overall Study|Protocol Violation|0|||
105487159|NCT00645788|363794973|FG002|Overall Study|Protocol Violation|2|||
105487160|NCT00645788|363794974|FG003|Overall Study|Protocol Violation|0|||
105487161|NCT00645788|363794971|FG000|Overall Study|Withdrawal by Subject|0|||
105487162|NCT00645788|363794972|FG001|Overall Study|Withdrawal by Subject|1|||
105487163|NCT00645788|363794973|FG002|Overall Study|Withdrawal by Subject|0|||
105487164|NCT00645788|363794974|FG003|Overall Study|Withdrawal by Subject|2|||
105487165|NCT00645788|363794971|FG000|Overall Study|Pulmonary exacerbation|13|||
105487166|NCT00645788|363794972|FG001|Overall Study|Pulmonary exacerbation|16|||
105487167|NCT00645788|363794973|FG002|Overall Study|Pulmonary exacerbation|11|||
105365231|NCT02974868|363342764|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
105365232|NCT02974868|363342765|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
105365233|NCT02974868|363342766|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
105365234|NCT02974868|363342763|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
105365235|NCT02974868|363342764|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
105365236|NCT02974868|363342765|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
105365237|NCT02974868|363342766|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
105365238|NCT02974868|363342763|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
105365239|NCT02974868|363342764|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
105365240|NCT02974868|363342765|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
105365241|NCT02974868|363342766|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
105365242|NCT02869789|363342767|FG000|Overall Study|Disease progression|184|||
105365243|NCT02869789|363342768|FG001|Overall Study|Disease progression|109|||
105365244|NCT02869789|363342769|FG002|Overall Study|Disease progression|260|||
105365245|NCT02869789|363342770|FG003|Overall Study|Disease progression|19|||
105365246|NCT02869789|363342767|FG000|Overall Study|Study drug toxicity|90|||
105365247|NCT02869789|363342768|FG001|Overall Study|Study drug toxicity|32|||
105365248|NCT02869789|363342769|FG002|Overall Study|Study drug toxicity|55|||
105365249|NCT02869789|363342770|FG003|Overall Study|Study drug toxicity|14|||
105365250|NCT02869789|363342767|FG000|Overall Study|Death|7|||
105365251|NCT02869789|363342768|FG001|Overall Study|Death|3|||
105365252|NCT02869789|363342769|FG002|Overall Study|Death|5|||
105365253|NCT02869789|363342770|FG003|Overall Study|Death|1|||
105365254|NCT02869789|363342767|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
105365255|NCT02869789|363342768|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
105365256|NCT02869789|363342769|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
105365257|NCT02869789|363342770|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
105365258|NCT02869789|363342767|FG000|Overall Study|Participant request to discontinue study treatment|10|||
105365259|NCT02869789|363342768|FG001|Overall Study|Participant request to discontinue study treatment|5|||
105365260|NCT02869789|363342769|FG002|Overall Study|Participant request to discontinue study treatment|5|||
105365261|NCT02869789|363342770|FG003|Overall Study|Participant request to discontinue study treatment|3|||
105365262|NCT02869789|363342767|FG000|Overall Study|Withdrawal by Subject|5|||
105365263|NCT02869789|363342768|FG001|Overall Study|Withdrawal by Subject|2|||
105365264|NCT02869789|363342769|FG002|Overall Study|Withdrawal by Subject|7|||
105365265|NCT02869789|363342770|FG003|Overall Study|Withdrawal by Subject|2|||
105365266|NCT02869789|363342767|FG000|Overall Study|Lost to Follow-up|0|||
105365267|NCT02869789|363342768|FG001|Overall Study|Lost to Follow-up|0|||
105365268|NCT02869789|363342769|FG002|Overall Study|Lost to Follow-up|2|||
105365269|NCT02869789|363342770|FG003|Overall Study|Lost to Follow-up|0|||
105365270|NCT02869789|363342767|FG000|Overall Study|Maximum clinical benefit|5|||
105365271|NCT02869789|363342768|FG001|Overall Study|Maximum clinical benefit|2|||
105365272|NCT02869789|363342769|FG002|Overall Study|Maximum clinical benefit|1|||
105365273|NCT02869789|363342770|FG003|Overall Study|Maximum clinical benefit|0|||
105365274|NCT02869789|363342767|FG000|Overall Study|Poor/Non-compliance|0|||
105365275|NCT02869789|363342768|FG001|Overall Study|Poor/Non-compliance|2|||
105365276|NCT02869789|363342769|FG002|Overall Study|Poor/Non-compliance|1|||
105365277|NCT02869789|363342770|FG003|Overall Study|Poor/Non-compliance|0|||
105365278|NCT02869789|363342767|FG000|Overall Study|Participant no longer meets study criteria|0|||
105365279|NCT02869789|363342768|FG001|Overall Study|Participant no longer meets study criteria|1|||
105365280|NCT02869789|363342769|FG002|Overall Study|Participant no longer meets study criteria|1|||
105365281|NCT02869789|363342770|FG003|Overall Study|Participant no longer meets study criteria|0|||
105365282|NCT02869789|363342767|FG000|Overall Study|Administrative reason by sponsor|0|||
105365283|NCT02869789|363342768|FG001|Overall Study|Administrative reason by sponsor|0|||
105365284|NCT02869789|363342769|FG002|Overall Study|Administrative reason by sponsor|1|||
105365285|NCT02869789|363342770|FG003|Overall Study|Administrative reason by sponsor|0|||
105365286|NCT02869789|363342767|FG000|Overall Study|Other reasons|4|||
105365287|NCT02869789|363342768|FG001|Overall Study|Other reasons|8|||
105365288|NCT02869789|363342769|FG002|Overall Study|Other reasons|6|||
105365289|NCT02869789|363342770|FG003|Overall Study|Other reasons|0|||
105365290|NCT04817332|363342787|FG000|Overall Study|Lost to Follow-up|3|||
105365291|NCT04817332|363342788|FG001|Overall Study|Lost to Follow-up|3|||
105365292|NCT04817332|363342787|FG000|Overall Study|Protocol Violation|2|||
105365293|NCT04817332|363342788|FG001|Overall Study|Protocol Violation|0|||
105365294|NCT05635045|363342792|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
105767892|NCT02725268|364800555|FG002|Overall Study|Lost to Follow-up|0|||
105767893|NCT02725268|364800556|FG003|Overall Study|Lost to Follow-up|1|||
105767894|NCT02725268|364800553|FG000|Overall Study|Site Terminated by Sponsor|0|||
105767895|NCT02725268|364800554|FG001|Overall Study|Site Terminated by Sponsor|1|||
105767896|NCT02725268|364800555|FG002|Overall Study|Site Terminated by Sponsor|0|||
105365295|NCT05635045|363342793|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
105365296|NCT05635045|363342794|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
105767897|NCT02725268|364800556|FG003|Overall Study|Site Terminated by Sponsor|0|||
105487168|NCT00645788|363794974|FG003|Overall Study|Pulmonary exacerbation|9|||
105487169|NCT03149848|363794975|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
105487170|NCT03149848|363794975|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
105487171|NCT01390220|363794982|FG000|Test Dose Phase|Adverse Event|17|||
105487172|NCT01390220|363794983|FG001|Test Dose Phase|Adverse Event|0|||
105487173|NCT01390220|363794984|FG002|Test Dose Phase|Adverse Event|0|||
105823160|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
105823161|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
105487174|NCT01390220|363794982|FG000|Test Dose Phase|Withdrawal by Subject|8|||
105487175|NCT01390220|363794983|FG001|Test Dose Phase|Withdrawal by Subject|0|||
105487176|NCT01390220|363794984|FG002|Test Dose Phase|Withdrawal by Subject|0|||
105767898|NCT02725268|364800553|FG000|Overall Study|Withdrawal by Subject|8|||
105767899|NCT02725268|364800554|FG001|Overall Study|Withdrawal by Subject|6|||
105767900|NCT02725268|364800555|FG002|Overall Study|Withdrawal by Subject|8|||
105767901|NCT02725268|364800556|FG003|Overall Study|Withdrawal by Subject|1|||
105767902|NCT02725268|364800553|FG000|Overall Study|Reason not Specified|2|||
105823162|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
105823163|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
105823164|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
105823165|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
105823166|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
105823167|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
105823168|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
105767903|NCT02725268|364800554|FG001|Overall Study|Reason not Specified|1|||
105767904|NCT02725268|364800555|FG002|Overall Study|Reason not Specified|0|||
105767905|NCT02725268|364800556|FG003|Overall Study|Reason not Specified|0|||
105767906|NCT04228445|364800557|FG000|Overall Study|Lost to Follow-up|1|||
105767907|NCT04228445|364800558|FG001|Overall Study|Lost to Follow-up|1|||
105767908|NCT04228445|364800557|FG000|Overall Study|Physician Decision|1|||
105767909|NCT04228445|364800558|FG001|Overall Study|Physician Decision|2|||
105767910|NCT04228445|364800557|FG000|Overall Study|Withdrawal by Subject|0|||
105767911|NCT04228445|364800558|FG001|Overall Study|Withdrawal by Subject|1|||
105767912|NCT04228445|364800557|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
105767913|NCT04228445|364800558|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
105487177|NCT01390220|363794982|FG000|Test Dose Phase|Lost to Follow-up|2|||
105487178|NCT01390220|363794983|FG001|Test Dose Phase|Lost to Follow-up|0|||
105767914|NCT01167153|364800559|FG000|Overall Study|Non-effective therapy|1|||
105767915|NCT01167153|364800560|FG001|Overall Study|Non-effective therapy|4|||
105767916|NCT01167153|364800559|FG000|Overall Study|AE including clinical laboratory AE|2|||
105767917|NCT01167153|364800560|FG001|Overall Study|AE including clinical laboratory AE|8|||
105767918|NCT01167153|364800559|FG000|Overall Study|Hypotension|1|||
105767919|NCT01167153|364800560|FG001|Overall Study|Hypotension|0|||
105767920|NCT01167153|364800559|FG000|Overall Study|Lost to Follow-up|7|||
105767921|NCT01167153|364800560|FG001|Overall Study|Lost to Follow-up|9|||
105767922|NCT01167153|364800559|FG000|Overall Study|Non-compliance to concomitant medication|0|||
105767923|NCT01167153|364800560|FG001|Overall Study|Non-compliance to concomitant medication|2|||
105767924|NCT01167153|364800559|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
105767925|NCT01167153|364800560|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
105767926|NCT01167153|364800559|FG000|Overall Study|Withdrawal consent|1|||
105767927|NCT01167153|364800560|FG001|Overall Study|Withdrawal consent|1|||
105767928|NCT01167153|364800559|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
105767929|NCT01167153|364800560|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
105767930|NCT01696396|364802555|FG000|Overall Study|Withdrawal by Subject|19|||
105767931|NCT01696396|364802556|FG001|Overall Study|Withdrawal by Subject|5|||
105767932|NCT01696396|364802557|FG002|Overall Study|Withdrawal by Subject|19|||
105767933|NCT01696396|364802558|FG003|Overall Study|Withdrawal by Subject|11|||
105767934|NCT01696396|364802555|FG000|Overall Study|Decision by Sponsor|3|||
105767935|NCT01696396|364802556|FG001|Overall Study|Decision by Sponsor|1|||
105767936|NCT01696396|364802557|FG002|Overall Study|Decision by Sponsor|2|||
105767937|NCT01696396|364802558|FG003|Overall Study|Decision by Sponsor|2|||
105767938|NCT01696396|364802555|FG000|Overall Study|Lost to Follow-up|9|||
105767939|NCT01696396|364802556|FG001|Overall Study|Lost to Follow-up|1|||
105767940|NCT01696396|364802557|FG002|Overall Study|Lost to Follow-up|4|||
105767941|NCT01696396|364802558|FG003|Overall Study|Lost to Follow-up|1|||
105767942|NCT01696396|364802555|FG000|Overall Study|Death|0|||
105767943|NCT01696396|364802556|FG001|Overall Study|Death|0|||
105767944|NCT01696396|364802557|FG002|Overall Study|Death|1|||
105767945|NCT01696396|364802558|FG003|Overall Study|Death|0|||
105767946|NCT02712008|364802565|FG000|Baseline (Day 1) up to Week 12|Death|3|||
105767947|NCT02712008|364802566|FG001|Baseline (Day 1) up to Week 12|Death|0|||
105767948|NCT02712008|364802567|FG002|Baseline (Day 1) up to Week 12|Death|0|||
105767949|NCT02712008|364802568|FG003|Baseline (Day 1) up to Week 12|Death|0|||
105767950|NCT02712008|364802569|FG004|Baseline (Day 1) up to Week 12|Death|0|||
105767951|NCT02712008|364802570|FG005|Baseline (Day 1) up to Week 12|Death|0|||
105767952|NCT02712008|364802571|FG006|Baseline (Day 1) up to Week 12|Death|0|||
105767953|NCT02712008|364802572|FG007|Baseline (Day 1) up to Week 12|Death|0|||
105767954|NCT02712008|364802565|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105767955|NCT02712008|364802566|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
105767956|NCT02712008|364802567|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
105767957|NCT02712008|364802568|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105767958|NCT02712008|364802569|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105767959|NCT02712008|364802570|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105767960|NCT02712008|364802571|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105767961|NCT02712008|364802572|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105767962|NCT02712008|364802565|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
105767963|NCT02712008|364802566|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105767964|NCT02712008|364802567|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
105767965|NCT02712008|364802568|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105767966|NCT02712008|364802569|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105767967|NCT02712008|364802570|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105767968|NCT02712008|364802571|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105767969|NCT02712008|364802572|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105767970|NCT02712008|364802565|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
105767971|NCT02712008|364802566|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
105767972|NCT02712008|364802567|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
105767973|NCT02712008|364802568|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
105767974|NCT02712008|364802569|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
105767975|NCT02712008|364802570|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
105767976|NCT02712008|364802571|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
105767977|NCT02712008|364802572|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
105767978|NCT02712008|364802565|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
105767979|NCT02712008|364802566|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
105767980|NCT02712008|364802567|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
105767981|NCT02712008|364802568|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
105767982|NCT02712008|364802569|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
105767983|NCT02712008|364802570|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
105767984|NCT02712008|364802571|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
105767985|NCT02712008|364802572|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
105767986|NCT02712008|364802565|FG000|From Week 12 up to Week 36|Adverse Event|0|||
105767987|NCT02712008|364802566|FG001|From Week 12 up to Week 36|Adverse Event|0|||
105767988|NCT02712008|364802567|FG002|From Week 12 up to Week 36|Adverse Event|0|||
105767989|NCT02712008|364802568|FG003|From Week 12 up to Week 36|Adverse Event|0|||
105767990|NCT02712008|364802569|FG004|From Week 12 up to Week 36|Adverse Event|1|||
105767991|NCT02712008|364802570|FG005|From Week 12 up to Week 36|Adverse Event|0|||
105767992|NCT02712008|364802571|FG006|From Week 12 up to Week 36|Adverse Event|0|||
105767993|NCT02712008|364802572|FG007|From Week 12 up to Week 36|Adverse Event|2|||
105767994|NCT02712008|364802565|FG000|From Week 12 up to Week 36|Death|1|||
105767995|NCT02712008|364802566|FG001|From Week 12 up to Week 36|Death|0|||
105767996|NCT02712008|364802567|FG002|From Week 12 up to Week 36|Death|0|||
105767997|NCT02712008|364802568|FG003|From Week 12 up to Week 36|Death|0|||
105767998|NCT02712008|364802569|FG004|From Week 12 up to Week 36|Death|0|||
105767999|NCT02712008|364802570|FG005|From Week 12 up to Week 36|Death|0|||
105768000|NCT02712008|364802571|FG006|From Week 12 up to Week 36|Death|1|||
105768001|NCT02712008|364802572|FG007|From Week 12 up to Week 36|Death|0|||
105768002|NCT02712008|364802565|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
105823169|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
105823170|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
105823171|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
105823172|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
105823173|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
105823174|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
105823175|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
105768003|NCT02712008|364802566|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
105768004|NCT02712008|364802567|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
105768005|NCT02712008|364802568|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
105768006|NCT02712008|364802569|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
105768007|NCT02712008|364802570|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
105768008|NCT02712008|364802571|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
105768009|NCT02712008|364802572|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
105768010|NCT02712008|364802565|FG000|From Week 12 up to Week 36|Physician Decision|0|||
105768011|NCT02712008|364802566|FG001|From Week 12 up to Week 36|Physician Decision|0|||
105768012|NCT02712008|364802567|FG002|From Week 12 up to Week 36|Physician Decision|0|||
105768013|NCT02712008|364802568|FG003|From Week 12 up to Week 36|Physician Decision|1|||
105768014|NCT02712008|364802569|FG004|From Week 12 up to Week 36|Physician Decision|1|||
105768015|NCT02712008|364802570|FG005|From Week 12 up to Week 36|Physician Decision|0|||
105768016|NCT02712008|364802571|FG006|From Week 12 up to Week 36|Physician Decision|0|||
105823176|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
105823177|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
105823178|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
105823179|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
105823180|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
105823181|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
105823182|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
105823183|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
105823184|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
105823185|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
105823186|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
105823187|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
105823188|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
105823189|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
105487179|NCT01390220|363794984|FG002|Test Dose Phase|Lost to Follow-up|0|||
105487180|NCT01390220|363794982|FG000|Test Dose Phase|Protocol Violation|8|||
105768017|NCT02712008|364802572|FG007|From Week 12 up to Week 36|Physician Decision|0|||
105768018|NCT02712008|364802565|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
105768019|NCT02712008|364802566|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
105768020|NCT02712008|364802567|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
105768021|NCT02712008|364802568|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
105768022|NCT02712008|364802569|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
105823190|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
105823191|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
105823192|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
105823193|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
105823194|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
105823195|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
105823196|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
105823197|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
105823198|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
105823199|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
105823200|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
105823201|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
105823202|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
105823203|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
105823204|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
105823205|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
105823206|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
105823207|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
105823208|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
105823209|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
105823210|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
105823211|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
105823212|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
105823213|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
105823214|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
105823215|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
105823216|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
105823217|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
105823218|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
105823219|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
105768023|NCT02712008|364802570|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
105768024|NCT02712008|364802571|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
105768025|NCT02712008|364802572|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
105768026|NCT00777257|364802573|FG000|Overall Study|Adverse Event|3|||
105768027|NCT00777257|364802574|FG001|Overall Study|Adverse Event|1|||
105768028|NCT00777257|364802575|FG002|Overall Study|Adverse Event|0|||
105768029|NCT00777257|364802573|FG000|Overall Study|Lost to Follow-up|3|||
105768030|NCT00777257|364802574|FG001|Overall Study|Lost to Follow-up|3|||
105768031|NCT00777257|364802575|FG002|Overall Study|Lost to Follow-up|2|||
105768032|NCT00777257|364802573|FG000|Overall Study|Protocol Violation|2|||
105768033|NCT00777257|364802574|FG001|Overall Study|Protocol Violation|2|||
105768034|NCT00777257|364802575|FG002|Overall Study|Protocol Violation|2|||
105768035|NCT00777257|364802573|FG000|Overall Study|Withdrawal by Subject|3|||
105768036|NCT00777257|364802574|FG001|Overall Study|Withdrawal by Subject|6|||
105768037|NCT00777257|364802575|FG002|Overall Study|Withdrawal by Subject|5|||
105768038|NCT01199198|364802576|FG000|Overall Study|Adverse Event|3|||
105768039|NCT01199198|364802577|FG001|Overall Study|Adverse Event|0|||
105768040|NCT01199198|364802576|FG000|Overall Study|Lost to Follow-up|1|||
105768041|NCT01199198|364802577|FG001|Overall Study|Lost to Follow-up|5|||
105823220|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
105823221|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
105823222|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
105823223|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
105823224|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
105487181|NCT01390220|363794983|FG001|Test Dose Phase|Protocol Violation|0|||
105487182|NCT01390220|363794984|FG002|Test Dose Phase|Protocol Violation|0|||
105768042|NCT01199198|364802576|FG000|Overall Study|Withdrawal by Subject|1|||
105768043|NCT01199198|364802577|FG001|Overall Study|Withdrawal by Subject|2|||
105768044|NCT01199198|364802576|FG000|Overall Study|ICU Transfer|1|||
105768045|NCT01199198|364802577|FG001|Overall Study|ICU Transfer|2|||
105572345|NCT02440594|364094504|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
105572346|NCT02440594|364094505|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
105768046|NCT01199198|364802576|FG000|Overall Study|Hospice-care transfer|1|||
105768047|NCT01199198|364802577|FG001|Overall Study|Hospice-care transfer|2|||
105768048|NCT04315298|364802578|FG000|Overall Study|Withdrawal by Subject|0|||
105768049|NCT04315298|364802579|FG001|Overall Study|Withdrawal by Subject|0|||
105768050|NCT04315298|364802580|FG002|Overall Study|Withdrawal by Subject|0|||
105768051|NCT04315298|364802581|FG003|Overall Study|Withdrawal by Subject|2|||
105768052|NCT04315298|364802582|FG004|Overall Study|Withdrawal by Subject|2|||
105768053|NCT04315298|364802583|FG005|Overall Study|Withdrawal by Subject|2|||
105768054|NCT04315298|364802584|FG006|Overall Study|Withdrawal by Subject|0|||
105768055|NCT04315298|364802585|FG007|Overall Study|Withdrawal by Subject|1|||
105768056|NCT04315298|364802586|FG008|Overall Study|Withdrawal by Subject|1|||
105768057|NCT04315298|364802587|FG009|Overall Study|Withdrawal by Subject|1|||
105768058|NCT04315298|364802588|FG010|Overall Study|Withdrawal by Subject|0|||
105768059|NCT04315298|364802589|FG011|Overall Study|Withdrawal by Subject|0|||
105768060|NCT04315298|364802590|FG012|Overall Study|Withdrawal by Subject|0|||
105768061|NCT04315298|364802591|FG013|Overall Study|Withdrawal by Subject|0|||
105768062|NCT04315298|364802592|FG014|Overall Study|Withdrawal by Subject|0|||
105768063|NCT04315298|364802593|FG015|Overall Study|Withdrawal by Subject|0|||
105768064|NCT04315298|364802594|FG016|Overall Study|Withdrawal by Subject|0|||
105768065|NCT04315298|364802595|FG017|Overall Study|Withdrawal by Subject|0|||
105768066|NCT04315298|364802596|FG018|Overall Study|Withdrawal by Subject|0|||
105768067|NCT04315298|364802578|FG000|Overall Study|Physician Decision|0|||
105768068|NCT04315298|364802579|FG001|Overall Study|Physician Decision|0|||
105768069|NCT04315298|364802580|FG002|Overall Study|Physician Decision|0|||
105768070|NCT04315298|364802581|FG003|Overall Study|Physician Decision|0|||
105768071|NCT04315298|364802582|FG004|Overall Study|Physician Decision|1|||
105768072|NCT04315298|364802583|FG005|Overall Study|Physician Decision|0|||
105768073|NCT04315298|364802584|FG006|Overall Study|Physician Decision|0|||
105768074|NCT04315298|364802585|FG007|Overall Study|Physician Decision|0|||
105768075|NCT04315298|364802586|FG008|Overall Study|Physician Decision|0|||
105768076|NCT04315298|364802587|FG009|Overall Study|Physician Decision|0|||
105768077|NCT04315298|364802588|FG010|Overall Study|Physician Decision|0|||
105768078|NCT04315298|364802589|FG011|Overall Study|Physician Decision|0|||
105768079|NCT04315298|364802590|FG012|Overall Study|Physician Decision|0|||
105768080|NCT04315298|364802591|FG013|Overall Study|Physician Decision|0|||
105768081|NCT04315298|364802592|FG014|Overall Study|Physician Decision|0|||
105768082|NCT04315298|364802593|FG015|Overall Study|Physician Decision|0|||
105768083|NCT04315298|364802594|FG016|Overall Study|Physician Decision|0|||
105768084|NCT04315298|364802595|FG017|Overall Study|Physician Decision|0|||
105768085|NCT04315298|364802596|FG018|Overall Study|Physician Decision|0|||
105768086|NCT04315298|364802578|FG000|Overall Study|Lost to Follow-up|5|||
105768087|NCT04315298|364802579|FG001|Overall Study|Lost to Follow-up|10|||
105768088|NCT04315298|364802580|FG002|Overall Study|Lost to Follow-up|6|||
105768089|NCT04315298|364802581|FG003|Overall Study|Lost to Follow-up|8|||
105768090|NCT04315298|364802582|FG004|Overall Study|Lost to Follow-up|12|||
105768091|NCT04315298|364802583|FG005|Overall Study|Lost to Follow-up|13|||
105768092|NCT04315298|364802584|FG006|Overall Study|Lost to Follow-up|9|||
105768093|NCT04315298|364802585|FG007|Overall Study|Lost to Follow-up|16|||
105768094|NCT04315298|364802586|FG008|Overall Study|Lost to Follow-up|14|||
105768095|NCT04315298|364802587|FG009|Overall Study|Lost to Follow-up|0|||
105823225|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
105823226|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
105823227|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
105823228|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
105823229|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
105823230|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
105823231|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
105823232|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
105823233|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
105823234|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
105768096|NCT04315298|364802588|FG010|Overall Study|Lost to Follow-up|2|||
105768097|NCT04315298|364802589|FG011|Overall Study|Lost to Follow-up|1|||
105768098|NCT04315298|364802590|FG012|Overall Study|Lost to Follow-up|0|||
105768099|NCT04315298|364802591|FG013|Overall Study|Lost to Follow-up|0|||
105768100|NCT04315298|364802592|FG014|Overall Study|Lost to Follow-up|0|||
105768101|NCT04315298|364802593|FG015|Overall Study|Lost to Follow-up|2|||
105768102|NCT04315298|364802594|FG016|Overall Study|Lost to Follow-up|0|||
105768103|NCT04315298|364802595|FG017|Overall Study|Lost to Follow-up|0|||
105768104|NCT04315298|364802596|FG018|Overall Study|Lost to Follow-up|0|||
105768105|NCT04315298|364802578|FG000|Overall Study|Death|24|||
105768106|NCT04315298|364802579|FG001|Overall Study|Death|60|||
105768107|NCT04315298|364802580|FG002|Overall Study|Death|49|||
105768108|NCT04315298|364802581|FG003|Overall Study|Death|59|||
105768109|NCT04315298|364802582|FG004|Overall Study|Death|70|||
105768110|NCT04315298|364802583|FG005|Overall Study|Death|114|||
105768111|NCT04315298|364802584|FG006|Overall Study|Death|9|||
105768112|NCT04315298|364802585|FG007|Overall Study|Death|12|||
105768113|NCT04315298|364802586|FG008|Overall Study|Death|21|||
105768114|NCT04315298|364802587|FG009|Overall Study|Death|16|||
105768115|NCT04315298|364802588|FG010|Overall Study|Death|40|||
105768116|NCT04315298|364802589|FG011|Overall Study|Death|40|||
105768117|NCT04315298|364802590|FG012|Overall Study|Death|3|||
105768118|NCT04315298|364802591|FG013|Overall Study|Death|4|||
105768119|NCT04315298|364802592|FG014|Overall Study|Death|6|||
105768120|NCT04315298|364802593|FG015|Overall Study|Death|4|||
105768121|NCT04315298|364802594|FG016|Overall Study|Death|3|||
105768122|NCT04315298|364802595|FG017|Overall Study|Death|1|||
105768123|NCT04315298|364802596|FG018|Overall Study|Death|0|||
105768124|NCT01183104|364802597|FG000|Overall Study|Adverse Event|8|||
105768125|NCT01183104|364802598|FG001|Overall Study|Adverse Event|6|||
105768126|NCT01183104|364802597|FG000|Overall Study|Death|0|||
105768127|NCT01183104|364802598|FG001|Overall Study|Death|1|||
105768128|NCT01183104|364802597|FG000|Overall Study|Lost to Follow-up|14|||
105768129|NCT01183104|364802598|FG001|Overall Study|Lost to Follow-up|7|||
105768130|NCT01183104|364802597|FG000|Overall Study|Physician Decision|5|||
105768131|NCT01183104|364802598|FG001|Overall Study|Physician Decision|8|||
105768132|NCT01183104|364802597|FG000|Overall Study|Withdrawal by Subject|6|||
105768133|NCT01183104|364802598|FG001|Overall Study|Withdrawal by Subject|11|||
105768134|NCT01183104|364802597|FG000|Overall Study|Nonparticipation in Extension Study|39|||
105768135|NCT01183104|364802598|FG001|Overall Study|Nonparticipation in Extension Study|50|||
105768136|NCT01183104|364802597|FG000|Overall Study|Did not receive study drug|5|||
105487183|NCT01390220|363794982|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
105487184|NCT01390220|363794983|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
105487185|NCT01390220|363794984|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
105487186|NCT01390220|363794982|FG000|Test Dose Phase|Study/Site closure|6|||
105487187|NCT01390220|363794983|FG001|Test Dose Phase|Study/Site closure|0|||
105487188|NCT01390220|363794984|FG002|Test Dose Phase|Study/Site closure|0|||
105487189|NCT01390220|363794982|FG000|Test Dose Phase|Caregiver no longer available|5|||
105487190|NCT01390220|363794983|FG001|Test Dose Phase|Caregiver no longer available|0|||
105487191|NCT01390220|363794984|FG002|Test Dose Phase|Caregiver no longer available|0|||
105487192|NCT01390220|363794982|FG000|Test Dose Phase|Noncompliance|2|||
105487193|NCT01390220|363794983|FG001|Test Dose Phase|Noncompliance|0|||
105487194|NCT01390220|363794984|FG002|Test Dose Phase|Noncompliance|0|||
105487195|NCT01390220|363794982|FG000|Test Dose Phase|Logistical|6|||
105572347|NCT02440594|364094506|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
105572348|NCT02440594|364094499|FG000|Overall Study|Withdrawal by Subject|81|||
105572349|NCT02440594|364094500|FG001|Overall Study|Withdrawal by Subject|67|||
105572350|NCT02440594|364094501|FG002|Overall Study|Withdrawal by Subject|59|||
105572351|NCT02440594|364094502|FG003|Overall Study|Withdrawal by Subject|38|||
105572352|NCT02440594|364094503|FG004|Overall Study|Withdrawal by Subject|2|||
105572353|NCT02440594|364094504|FG005|Overall Study|Withdrawal by Subject|2|||
105572354|NCT02440594|364094505|FG006|Overall Study|Withdrawal by Subject|7|||
105572355|NCT02440594|364094506|FG007|Overall Study|Withdrawal by Subject|7|||
105572356|NCT02440594|364094499|FG000|Overall Study|Administratively w/drawn|3|||
105572357|NCT02440594|364094500|FG001|Overall Study|Administratively w/drawn|2|||
105572358|NCT02440594|364094501|FG002|Overall Study|Administratively w/drawn|0|||
105572359|NCT02440594|364094502|FG003|Overall Study|Administratively w/drawn|0|||
105572360|NCT02440594|364094503|FG004|Overall Study|Administratively w/drawn|0|||
105572361|NCT02440594|364094504|FG005|Overall Study|Administratively w/drawn|0|||
105572362|NCT02440594|364094505|FG006|Overall Study|Administratively w/drawn|2|||
105572363|NCT02440594|364094506|FG007|Overall Study|Administratively w/drawn|1|||
105572364|NCT00569803|364094507|FG000|Overall Study|Lost to Follow-up|1|||
105572365|NCT00569803|364094508|FG001|Overall Study|Lost to Follow-up|0|||
105572366|NCT00569803|364094509|FG002|Overall Study|Lost to Follow-up|0|||
105572367|NCT00569803|364094510|FG003|Overall Study|Lost to Follow-up|0|||
105572368|NCT00569803|364094511|FG004|Overall Study|Lost to Follow-up|0|||
105572369|NCT00569803|364094512|FG005|Overall Study|Lost to Follow-up|0|||
105572370|NCT00569803|364094513|FG006|Overall Study|Lost to Follow-up|0|||
105572371|NCT00569803|364094514|FG007|Overall Study|Lost to Follow-up|0|||
105572372|NCT00569803|364094507|FG000|Overall Study|injection syringe leaked during dosing|0|||
105572373|NCT00569803|364094508|FG001|Overall Study|injection syringe leaked during dosing|0|||
105572374|NCT00569803|364094509|FG002|Overall Study|injection syringe leaked during dosing|0|||
105487196|NCT01390220|363794983|FG001|Test Dose Phase|Logistical|0|||
105768137|NCT01183104|364802598|FG001|Overall Study|Did not receive study drug|9|||
105768138|NCT03050307|364802599|FG000|Overall Study|Adverse Event|4|||
105768139|NCT03050307|364802600|FG001|Overall Study|Adverse Event|2|||
105768140|NCT03050307|364802599|FG000|Overall Study|Significant Protocol Deviation|0|||
105768141|NCT03050307|364802600|FG001|Overall Study|Significant Protocol Deviation|1|||
105768142|NCT03050307|364802599|FG000|Overall Study|Lost to Follow-up|0|||
105768143|NCT03050307|364802600|FG001|Overall Study|Lost to Follow-up|1|||
105768144|NCT03050307|364802599|FG000|Overall Study|Voluntary Withdrawal|3|||
105768145|NCT03050307|364802600|FG001|Overall Study|Voluntary Withdrawal|4|||
105768146|NCT03050307|364802599|FG000|Overall Study|Reason not Specified|1|||
105768147|NCT03050307|364802600|FG001|Overall Study|Reason not Specified|1|||
105768148|NCT02177786|364802601|FG000|Overall Study|Withdrew Consent|2|||
105768149|NCT02177786|364802602|FG001|Overall Study|Withdrew Consent|6|||
105768150|NCT02177786|364802603|FG002|Overall Study|Withdrew Consent|9|||
105768151|NCT02177786|364802604|FG003|Overall Study|Withdrew Consent|5|||
105768152|NCT02177786|364802601|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
105768153|NCT02177786|364802602|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
105768154|NCT02177786|364802603|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
105768155|NCT02177786|364802604|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
105768156|NCT02177786|364802601|FG000|Overall Study|Adverse Event|1|||
105768157|NCT02177786|364802602|FG001|Overall Study|Adverse Event|1|||
105768158|NCT02177786|364802603|FG002|Overall Study|Adverse Event|2|||
105768159|NCT02177786|364802604|FG003|Overall Study|Adverse Event|3|||
105768160|NCT02177786|364802601|FG000|Overall Study|Death|1|||
105768161|NCT02177786|364802602|FG001|Overall Study|Death|1|||
105768162|NCT02177786|364802603|FG002|Overall Study|Death|1|||
105768163|NCT02177786|364802604|FG003|Overall Study|Death|1|||
105768164|NCT02177786|364802601|FG000|Overall Study|Lost to Follow-up|0|||
105768165|NCT02177786|364802602|FG001|Overall Study|Lost to Follow-up|0|||
105768166|NCT02177786|364802603|FG002|Overall Study|Lost to Follow-up|2|||
105768167|NCT02177786|364802604|FG003|Overall Study|Lost to Follow-up|2|||
105768168|NCT02177786|364802601|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105768169|NCT02177786|364802602|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105768170|NCT02177786|364802603|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105768171|NCT02177786|364802604|FG003|Overall Study|Non-Compliance with Study Drug|1|||
105768172|NCT02177786|364802601|FG000|Overall Study|Protocol Violation|0|||
105768173|NCT02177786|364802602|FG001|Overall Study|Protocol Violation|0|||
105768174|NCT02177786|364802603|FG002|Overall Study|Protocol Violation|2|||
105768175|NCT02177786|364802604|FG003|Overall Study|Protocol Violation|0|||
105768176|NCT02177786|364802601|FG000|Overall Study|Progressive Disease|0|||
105768177|NCT02177786|364802602|FG001|Overall Study|Progressive Disease|1|||
105768178|NCT02177786|364802603|FG002|Overall Study|Progressive Disease|0|||
105768179|NCT02177786|364802604|FG003|Overall Study|Progressive Disease|0|||
105768180|NCT02177786|364802601|FG000|Overall Study|Missing study completion status|0|||
105768181|NCT02177786|364802602|FG001|Overall Study|Missing study completion status|1|||
105768182|NCT02177786|364802603|FG002|Overall Study|Missing study completion status|0|||
105768183|NCT02177786|364802604|FG003|Overall Study|Missing study completion status|0|||
105768184|NCT01305941|364802605|FG000|Overall Study|Adverse Event|6|||
105768185|NCT01305941|364802605|FG000|Overall Study|Clinical decline|2|||
105768186|NCT01305941|364802605|FG000|Overall Study|Withdrawal by Subject|1|||
105768187|NCT01305941|364802605|FG000|Overall Study|Death|1|||
105768188|NCT02892734|364802606|FG000|Treatment on Study|Progressive Disease|2|||
105768189|NCT02892734|364802606|FG000|Follow up for 2 Years|Death|2|||
105768190|NCT02892734|364802606|FG000|Follow up for 2 Years|Study closed early|1|||
105768191|NCT00688623|364802607|FG000|Overall Study|Adverse Event|22|||
105768192|NCT00688623|364802607|FG000|Overall Study|abnormal lab value|1|||
105768193|NCT00688623|364802607|FG000|Overall Study|Withdrawal by Subject|4|||
105768194|NCT00688623|364802607|FG000|Overall Study|Death|3|||
105768195|NCT00688623|364802607|FG000|Overall Study|disease progression|23|||
105768196|NCT00688623|364802607|FG000|Overall Study|Protocol Violation|2|||
105768197|NCT04402385|364802613|FG000|Overall Study|Withdrawal by Subject|4|||
105768198|NCT04402385|364802614|FG001|Overall Study|Withdrawal by Subject|4|||
105768199|NCT04402385|364802613|FG000|Overall Study|Lost to Follow-up|1|||
105768200|NCT04402385|364802614|FG001|Overall Study|Lost to Follow-up|1|||
105768201|NCT04402385|364802613|FG000|Overall Study|Physician Decision|0|||
105487197|NCT01390220|363794984|FG002|Test Dose Phase|Logistical|0|||
105768202|NCT04402385|364802614|FG001|Overall Study|Physician Decision|1|||
105768203|NCT00088595|364802615|FG000|Overall Study|Adverse Event|11|||
105768204|NCT00088595|364802615|FG000|Overall Study|Withdrawal by Subject|8|||
105487198|NCT01390220|363794982|FG000|Comparative Phase|Withdrawal by Subject|0|||
105768205|NCT00088595|364802615|FG000|Overall Study|Ongoing (After Core)|7|||
105768206|NCT00088595|364802615|FG000|Overall Study|New Cancer Therapy|2|||
105768207|NCT01308853|364802623|FG000|Overall Study|Adverse Event|1|||
105768208|NCT01308853|364802623|FG000|Overall Study|Lost to Follow-up|2|||
105768209|NCT01308853|364802623|FG000|Overall Study|Insertion of permanent implants|1|||
105768210|NCT05283499|364802626|FG000|Overall Study|Did not receive intervention|1|||
105768211|NCT05283499|364802627|FG001|Overall Study|Did not receive intervention|2|||
105768212|NCT02828644|364802630|FG000|Overall Study|Lost to Follow-up|23|||
105768213|NCT02828644|364802631|FG001|Overall Study|Lost to Follow-up|22|||
105768214|NCT02436915|364802632|FG000|Overall Study|Withdrawal by Subject|0|||
105768215|NCT02436915|364802633|FG001|Overall Study|Withdrawal by Subject|1|||
105768216|NCT02603172|364802636|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
105768217|NCT02603172|364802637|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
105768218|NCT02603172|364802638|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
105768219|NCT02603172|364802639|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
105768220|NCT02603172|364802640|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
105768221|NCT02603172|364802641|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
105768222|NCT02603172|364802642|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
105768223|NCT02603172|364802643|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
105768224|NCT02418585|364802644|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
105768225|NCT02418585|364802645|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
105823235|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
105823236|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
105823237|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
105823238|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
105823239|NCT03071575|365010417|FG000|Overall Study|Death|0|||
105823240|NCT03071575|365010418|FG001|Overall Study|Death|1|||
105823241|NCT03071575|365010417|FG000|Overall Study|Lost to Follow-up|5|||
105823242|NCT03071575|365010418|FG001|Overall Study|Lost to Follow-up|11|||
105823243|NCT03071575|365010417|FG000|Overall Study|Withdrawal by Subject|4|||
105823244|NCT03071575|365010418|FG001|Overall Study|Withdrawal by Subject|2|||
105823245|NCT00834795|365010423|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
105823246|NCT00834795|365010424|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
105823247|NCT00834795|365010423|FG000|Second Intervention|Adverse Event|1|||
105823248|NCT00834795|365010424|FG001|Second Intervention|Adverse Event|0|||
105823249|NCT03818581|365010425|FG000|Overall Study|Adverse Event|1|||
105823250|NCT03818581|365010426|FG001|Overall Study|Adverse Event|0|||
105823251|NCT03818581|365010427|FG002|Overall Study|Adverse Event|0|||
105823252|NCT03818581|365010428|FG003|Overall Study|Adverse Event|0|||
105823253|NCT03818581|365010429|FG004|Overall Study|Adverse Event|0|||
105823254|NCT03818581|365010425|FG000|Overall Study|Covid-19|2|||
105823255|NCT03818581|365010426|FG001|Overall Study|Covid-19|0|||
105823256|NCT03818581|365010427|FG002|Overall Study|Covid-19|0|||
105823257|NCT03818581|365010428|FG003|Overall Study|Covid-19|0|||
105823258|NCT03818581|365010429|FG004|Overall Study|Covid-19|1|||
105823259|NCT03818581|365010425|FG000|Overall Study|Withdrawal by Subject|0|||
105823260|NCT03818581|365010426|FG001|Overall Study|Withdrawal by Subject|0|||
105823261|NCT03818581|365010427|FG002|Overall Study|Withdrawal by Subject|0|||
105823262|NCT03818581|365010428|FG003|Overall Study|Withdrawal by Subject|0|||
105823263|NCT03818581|365010429|FG004|Overall Study|Withdrawal by Subject|1|||
105823264|NCT03818581|365010425|FG000|Overall Study|No longer met study criteria|0|||
105823265|NCT03818581|365010426|FG001|Overall Study|No longer met study criteria|0|||
105823266|NCT03818581|365010427|FG002|Overall Study|No longer met study criteria|0|||
105823267|NCT03818581|365010428|FG003|Overall Study|No longer met study criteria|0|||
105487199|NCT01390220|363794983|FG001|Comparative Phase|Withdrawal by Subject|1|||
105768226|NCT02418585|364802644|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
105823268|NCT03818581|365010429|FG004|Overall Study|No longer met study criteria|1|||
105823269|NCT03255733|365010433|FG000|Overall Study|Lost to Follow-up|4|||
105823270|NCT01435265|365010434|FG000|Overall Study|Lost to Follow-up|0|||
105768227|NCT02418585|364802645|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
105768228|NCT02418585|364802644|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
105768229|NCT02418585|364802645|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
105768230|NCT02418585|364802644|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
105365297|NCT05635045|363342795|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
105365298|NCT02053493|363342797|FG000|Overall Study|Withdrawal by Subject|1|||
105365299|NCT02053493|363342798|FG001|Overall Study|Withdrawal by Subject|1|||
105365300|NCT01076543|363342799|FG000|Overall Study|Withdrawal by Subject|2|||
105365301|NCT01076543|363342800|FG001|Overall Study|Withdrawal by Subject|0|||
105365302|NCT01076543|363342801|FG002|Overall Study|Withdrawal by Subject|0|||
105768231|NCT02418585|364802645|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
105768232|NCT02418585|364802644|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
105768233|NCT02418585|364802645|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
105768234|NCT02418585|364802644|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
105768235|NCT02418585|364802645|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
105768236|NCT02418585|364802644|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
105768237|NCT02418585|364802645|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
105768238|NCT02418585|364802644|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
105768239|NCT02418585|364802645|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
105768240|NCT02418585|364802644|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
105768241|NCT02418585|364802645|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
105768242|NCT02418585|364802644|FG000|Follow-up Phase (24 Weeks)|Other|3|||
105768243|NCT02418585|364802645|FG001|Follow-up Phase (24 Weeks)|Other|2|||
105768244|NCT04075396|364802646|FG000|Overall Study|Death|11|||
105768245|NCT04075396|364802647|FG001|Overall Study|Death|9|||
105768246|NCT04075396|364802646|FG000|Overall Study|Withdrawal by Subject|1|||
105768247|NCT04075396|364802647|FG001|Overall Study|Withdrawal by Subject|2|||
105768248|NCT04075396|364802646|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
105768249|NCT04075396|364802647|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
105768250|NCT04075396|364802646|FG000|Overall Study|Enrolled but not-treated|0|||
105768251|NCT04075396|364802647|FG001|Overall Study|Enrolled but not-treated|1|||
105768252|NCT00693693|364802650|FG000|Overall Study|Lost to Follow-up|1|||
105768253|NCT00693693|364802651|FG001|Overall Study|Lost to Follow-up|1|||
105768254|NCT00693693|364802652|FG002|Overall Study|Lost to Follow-up|2|||
105768255|NCT01690988|364802658|FG000|Overall Study|Withdrawal by Subject|2|||
105768256|NCT01690988|364802659|FG001|Overall Study|Withdrawal by Subject|2|||
105768257|NCT01690988|364802660|FG002|Overall Study|Withdrawal by Subject|3|||
105768258|NCT01690988|364802658|FG000|Overall Study|Physician Decision|0|||
105768259|NCT01690988|364802659|FG001|Overall Study|Physician Decision|0|||
105768260|NCT01690988|364802660|FG002|Overall Study|Physician Decision|1|||
105768261|NCT01690988|364802658|FG000|Overall Study|Operation Cancelled|1|||
105768262|NCT01690988|364802659|FG001|Overall Study|Operation Cancelled|1|||
105768263|NCT01690988|364802660|FG002|Overall Study|Operation Cancelled|0|||
105768264|NCT01690988|364802658|FG000|Overall Study|Determined ineligible|1|||
105768265|NCT01690988|364802659|FG001|Overall Study|Determined ineligible|0|||
105768266|NCT01690988|364802660|FG002|Overall Study|Determined ineligible|0|||
105768267|NCT01690988|364802658|FG000|Overall Study|Death|1|||
105768268|NCT01690988|364802659|FG001|Overall Study|Death|1|||
105768269|NCT01690988|364802660|FG002|Overall Study|Death|1|||
105768270|NCT01690988|364802658|FG000|Overall Study|Sedated|1|||
105768271|NCT01690988|364802659|FG001|Overall Study|Sedated|1|||
105768272|NCT01690988|364802660|FG002|Overall Study|Sedated|2|||
105768273|NCT00372489|364802663|FG000|Overall Study|Adverse Event|18|||
105768274|NCT00372489|364802663|FG000|Overall Study|Lack of Efficacy|1|||
105768275|NCT00372489|364802663|FG000|Overall Study|Lost to Follow-up|3|||
105768276|NCT00372489|364802663|FG000|Overall Study|Physician Decision|3|||
105768277|NCT00372489|364802663|FG000|Overall Study|Withdrawal by Subject|5|||
105768278|NCT00372489|364802663|FG000|Overall Study|Patient Relocation|2|||
105768279|NCT00372489|364802663|FG000|Overall Study|Renal transplant|6|||
105768280|NCT00372489|364802663|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
105768281|NCT00552344|364802669|FG000|Overall Study|Lack of Efficacy|55|||
105768282|NCT00552344|364802669|FG000|Overall Study|Loss of efficacy|75|||
105768283|NCT00552344|364802669|FG000|Overall Study|Lost to Follow-up|8|||
105768284|NCT00552344|364802669|FG000|Overall Study|Withdrawal by Subject|48|||
105768285|NCT00552344|364802669|FG000|Overall Study|SAE, non-fatal|6|||
105768286|NCT00552344|364802669|FG000|Overall Study|AE, non-serious non-fatal|38|||
105768287|NCT00552344|364802669|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
105768288|NCT00552344|364802669|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
105768289|NCT00552344|364802669|FG000|Overall Study|Other Reason|22|||
105768290|NCT00471276|364802670|FG000|Overall Study|Death|2|||
105768291|NCT00471276|364802670|FG000|Overall Study|Adverse Event|16|||
105768292|NCT00471276|364802670|FG000|Overall Study|Protocol Violation|1|||
105768293|NCT00471276|364802670|FG000|Overall Study|Objective progression or relapse|54|||
105823271|NCT01435265|365010435|FG001|Overall Study|Lost to Follow-up|1|||
105768294|NCT00471276|364802670|FG000|Overall Study|Global deterioration of health status|1|||
105768295|NCT00471276|364802670|FG000|Overall Study|Other|3|||
105768296|NCT00471276|364802670|FG000|Overall Study|Refused treatment|6|||
105768297|NCT01594411|364802671|FG000|Overall Study|Lost to Follow-up|2|||
105768298|NCT04731922|364802672|FG000|Overall Study|Adverse Event|0|||
105768299|NCT04731922|364802673|FG001|Overall Study|Adverse Event|0|||
105768300|NCT04731922|364802674|FG002|Overall Study|Adverse Event|0|||
105768301|NCT04731922|364802675|FG003|Overall Study|Adverse Event|0|||
105768302|NCT04731922|364802676|FG004|Overall Study|Adverse Event|0|||
105768303|NCT04731922|364802677|FG005|Overall Study|Adverse Event|0|||
105768304|NCT04731922|364802678|FG006|Overall Study|Adverse Event|0|||
105768305|NCT04731922|364802679|FG007|Overall Study|Adverse Event|0|||
105768306|NCT04731922|364802680|FG008|Overall Study|Adverse Event|0|||
105768307|NCT04731922|364802681|FG009|Overall Study|Adverse Event|0|||
105768308|NCT04731922|364802682|FG010|Overall Study|Adverse Event|1|||
105768309|NCT04731922|364802683|FG011|Overall Study|Adverse Event|0|||
105768310|NCT04731922|364802684|FG012|Overall Study|Adverse Event|0|||
105768311|NCT04731922|364802685|FG013|Overall Study|Adverse Event|0|||
105768312|NCT04731922|364802686|FG014|Overall Study|Adverse Event|0|||
105768313|NCT04731922|364802687|FG015|Overall Study|Adverse Event|0|||
105768314|NCT04731922|364802688|FG016|Overall Study|Adverse Event|0|||
105768315|NCT04731922|364802672|FG000|Overall Study|Lost to Follow-up|0|||
105768316|NCT04731922|364802673|FG001|Overall Study|Lost to Follow-up|0|||
105768317|NCT04731922|364802674|FG002|Overall Study|Lost to Follow-up|0|||
105768318|NCT04731922|364802675|FG003|Overall Study|Lost to Follow-up|1|||
105768319|NCT04731922|364802676|FG004|Overall Study|Lost to Follow-up|0|||
105768320|NCT04731922|364802677|FG005|Overall Study|Lost to Follow-up|1|||
105768321|NCT04731922|364802678|FG006|Overall Study|Lost to Follow-up|0|||
105768322|NCT04731922|364802679|FG007|Overall Study|Lost to Follow-up|0|||
105768323|NCT04731922|364802680|FG008|Overall Study|Lost to Follow-up|0|||
105768324|NCT04731922|364802681|FG009|Overall Study|Lost to Follow-up|0|||
105768325|NCT04731922|364802682|FG010|Overall Study|Lost to Follow-up|0|||
105768326|NCT04731922|364802683|FG011|Overall Study|Lost to Follow-up|0|||
105768327|NCT04731922|364802684|FG012|Overall Study|Lost to Follow-up|0|||
105768328|NCT04731922|364802685|FG013|Overall Study|Lost to Follow-up|0|||
105768329|NCT04731922|364802686|FG014|Overall Study|Lost to Follow-up|0|||
105768330|NCT04731922|364802687|FG015|Overall Study|Lost to Follow-up|0|||
105768331|NCT04731922|364802688|FG016|Overall Study|Lost to Follow-up|0|||
105768332|NCT04731922|364802672|FG000|Overall Study|Withdrawal by Subject|1|||
105768333|NCT04731922|364802673|FG001|Overall Study|Withdrawal by Subject|0|||
105768334|NCT04731922|364802674|FG002|Overall Study|Withdrawal by Subject|0|||
105768335|NCT04731922|364802675|FG003|Overall Study|Withdrawal by Subject|0|||
105768336|NCT04731922|364802676|FG004|Overall Study|Withdrawal by Subject|1|||
105768337|NCT04731922|364802677|FG005|Overall Study|Withdrawal by Subject|0|||
105768338|NCT04731922|364802678|FG006|Overall Study|Withdrawal by Subject|1|||
105768339|NCT04731922|364802679|FG007|Overall Study|Withdrawal by Subject|0|||
105768340|NCT04731922|364802680|FG008|Overall Study|Withdrawal by Subject|0|||
105768341|NCT04731922|364802681|FG009|Overall Study|Withdrawal by Subject|0|||
105768342|NCT04731922|364802682|FG010|Overall Study|Withdrawal by Subject|0|||
105768343|NCT04731922|364802683|FG011|Overall Study|Withdrawal by Subject|0|||
105768344|NCT04731922|364802684|FG012|Overall Study|Withdrawal by Subject|0|||
105768345|NCT04731922|364802685|FG013|Overall Study|Withdrawal by Subject|1|||
105768346|NCT04731922|364802686|FG014|Overall Study|Withdrawal by Subject|0|||
105768347|NCT04731922|364802687|FG015|Overall Study|Withdrawal by Subject|0|||
105768348|NCT04731922|364802688|FG016|Overall Study|Withdrawal by Subject|0|||
105768349|NCT04731922|364802672|FG000|Overall Study|Other|0|||
105768350|NCT04731922|364802673|FG001|Overall Study|Other|0|||
105768351|NCT04731922|364802674|FG002|Overall Study|Other|0|||
105768352|NCT04731922|364802675|FG003|Overall Study|Other|0|||
105768353|NCT04731922|364802676|FG004|Overall Study|Other|0|||
105768354|NCT04731922|364802677|FG005|Overall Study|Other|0|||
105487200|NCT01390220|363794984|FG002|Comparative Phase|Withdrawal by Subject|0|||
105768355|NCT04731922|364802678|FG006|Overall Study|Other|1|||
105768356|NCT04731922|364802679|FG007|Overall Study|Other|0|||
105823272|NCT01111461|365010439|FG000|Overall Study|Adverse Event|32|||
105823273|NCT01111461|365010439|FG000|Overall Study|Participant choice|11|||
105823274|NCT01111461|365010439|FG000|Overall Study|Lost to Follow-up|1|||
105823275|NCT01111461|365010439|FG000|Overall Study|Withdrawal by Subject|1|||
105823276|NCT01111461|365010439|FG000|Overall Study|Other|6|||
105823277|NCT04278560|365010440|FG000|Overall Study|Adverse Event|1|||
105823278|NCT04278560|365010441|FG001|Overall Study|Adverse Event|2|||
105823279|NCT04278560|365010440|FG000|Overall Study|Withdrawal by Subject|0|||
105823280|NCT04278560|365010441|FG001|Overall Study|Withdrawal by Subject|1|||
105823281|NCT03616535|365010442|FG000|Overall Study|Death|2|||
105823282|NCT03616535|365010443|FG001|Overall Study|Death|0|||
105823283|NCT03616535|365010444|FG002|Overall Study|Death|0|||
105823284|NCT03616535|365010445|FG003|Overall Study|Death|1|||
105823285|NCT03616535|365010442|FG000|Overall Study|Lost to Follow-up|2|||
105823286|NCT03616535|365010443|FG001|Overall Study|Lost to Follow-up|1|||
105823287|NCT03616535|365010444|FG002|Overall Study|Lost to Follow-up|0|||
105823288|NCT03616535|365010445|FG003|Overall Study|Lost to Follow-up|2|||
105823289|NCT03616535|365010442|FG000|Overall Study|Withdrawal by Subject|1|||
105823290|NCT03616535|365010443|FG001|Overall Study|Withdrawal by Subject|2|||
105823291|NCT03616535|365010444|FG002|Overall Study|Withdrawal by Subject|5|||
105823292|NCT03616535|365010445|FG003|Overall Study|Withdrawal by Subject|1|||
105823293|NCT03616535|365010442|FG000|Overall Study|Not specified or change in eligibility|2|||
105823294|NCT03616535|365010443|FG001|Overall Study|Not specified or change in eligibility|3|||
105823295|NCT03616535|365010444|FG002|Overall Study|Not specified or change in eligibility|3|||
105823296|NCT03616535|365010445|FG003|Overall Study|Not specified or change in eligibility|1|||
105823297|NCT03935880|365010448|FG000|Overall Study|Lost to Follow-up|0|||
105823298|NCT03935880|365010449|FG001|Overall Study|Lost to Follow-up|1|||
105823299|NCT02476994|365010450|FG000|Overall Study|Based on feedback from FDA|1|||
105823300|NCT02476994|365010451|FG001|Overall Study|Based on feedback from FDA|0|||
105823301|NCT05618808|365010452|FG000|Overall Study|Withdrawal by Subject|3|||
105823302|NCT05618808|365010453|FG001|Overall Study|Withdrawal by Subject|1|||
105823303|NCT05618808|365010454|FG002|Overall Study|Withdrawal by Subject|3|||
105823304|NCT02646124|365010455|FG000|Overall Study|Lost to Follow-up|0|||
105823305|NCT02646124|365010456|FG001|Overall Study|Lost to Follow-up|2|||
105823306|NCT00905606|365010459|FG000|Period 1|Adverse Event|0|||
105823307|NCT00905606|365010460|FG001|Period 1|Adverse Event|1|||
105823308|NCT00905606|365010459|FG000|Washout|Withdrawal by Subject|1|||
105823309|NCT00905606|365010460|FG001|Washout|Withdrawal by Subject|0|||
105823310|NCT03635320|365010461|FG000|Overall Study|not implanted the device|1|||
105823311|NCT03635320|365010462|FG001|Overall Study|not implanted the device|2|||
105823312|NCT03635320|365010461|FG000|Overall Study|Withdrawal by Subject|11|||
105823313|NCT03635320|365010462|FG001|Overall Study|Withdrawal by Subject|6|||
105823314|NCT00804856|365010463|FG000|Overall Study|Progressive Disease|3|||
105823315|NCT00804856|365010464|FG001|Overall Study|Progressive Disease|2|||
105823316|NCT00804856|365010465|FG002|Overall Study|Progressive Disease|4|||
105823317|NCT00804856|365010466|FG003|Overall Study|Progressive Disease|6|||
105487201|NCT02045303|363794985|FG000|Overall Study|Protocol Violation|2|||
105823318|NCT00804856|365010467|FG004|Overall Study|Progressive Disease|4|||
105823319|NCT00804856|365010468|FG005|Overall Study|Progressive Disease|1|||
105823320|NCT00804856|365010469|FG006|Overall Study|Progressive Disease|8|||
105487202|NCT02045303|363794986|FG001|Overall Study|Protocol Violation|1|||
105823321|NCT00804856|365010470|FG007|Overall Study|Progressive Disease|2|||
105823322|NCT00804856|365010471|FG008|Overall Study|Progressive Disease|4|||
105823323|NCT00804856|365010472|FG009|Overall Study|Progressive Disease|5|||
105823324|NCT00804856|365010473|FG010|Overall Study|Progressive Disease|12|||
105823325|NCT00804856|365010474|FG011|Overall Study|Progressive Disease|2|||
105823326|NCT00804856|365010475|FG012|Overall Study|Progressive Disease|2|||
105823327|NCT00804856|365010476|FG013|Overall Study|Progressive Disease|26|||
105823328|NCT00804856|365010477|FG014|Overall Study|Progressive Disease|20|||
105823329|NCT00804856|365010463|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823330|NCT00804856|365010464|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823331|NCT00804856|365010465|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823332|NCT00804856|365010466|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823333|NCT00804856|365010467|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
105823334|NCT00804856|365010468|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823335|NCT00804856|365010469|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823336|NCT00804856|365010470|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823337|NCT00804856|365010471|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823338|NCT00804856|365010472|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823339|NCT00804856|365010473|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823340|NCT00804856|365010474|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823341|NCT00804856|365010475|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823342|NCT00804856|365010476|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823343|NCT00804856|365010477|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
105823344|NCT00804856|365010463|FG000|Overall Study|Other Adverse Event|1|||
105823345|NCT00804856|365010464|FG001|Overall Study|Other Adverse Event|1|||
105823346|NCT00804856|365010465|FG002|Overall Study|Other Adverse Event|1|||
105823347|NCT00804856|365010466|FG003|Overall Study|Other Adverse Event|2|||
105823348|NCT00804856|365010467|FG004|Overall Study|Other Adverse Event|2|||
105823349|NCT00804856|365010468|FG005|Overall Study|Other Adverse Event|1|||
105823350|NCT00804856|365010469|FG006|Overall Study|Other Adverse Event|3|||
105823351|NCT00804856|365010470|FG007|Overall Study|Other Adverse Event|0|||
105823352|NCT00804856|365010471|FG008|Overall Study|Other Adverse Event|0|||
105823353|NCT00804856|365010472|FG009|Overall Study|Other Adverse Event|1|||
105823354|NCT00804856|365010473|FG010|Overall Study|Other Adverse Event|5|||
105823355|NCT00804856|365010474|FG011|Overall Study|Other Adverse Event|2|||
105823356|NCT00804856|365010475|FG012|Overall Study|Other Adverse Event|0|||
105823357|NCT00804856|365010476|FG013|Overall Study|Other Adverse Event|6|||
105823358|NCT00804856|365010477|FG014|Overall Study|Other Adverse Event|13|||
105823359|NCT00804856|365010463|FG000|Overall Study|Non compliance with protocol|0|||
105823360|NCT00804856|365010464|FG001|Overall Study|Non compliance with protocol|0|||
105823361|NCT00804856|365010465|FG002|Overall Study|Non compliance with protocol|0|||
105823362|NCT00804856|365010466|FG003|Overall Study|Non compliance with protocol|0|||
105823363|NCT00804856|365010467|FG004|Overall Study|Non compliance with protocol|0|||
105823364|NCT00804856|365010468|FG005|Overall Study|Non compliance with protocol|0|||
105823365|NCT00804856|365010469|FG006|Overall Study|Non compliance with protocol|0|||
105823366|NCT00804856|365010470|FG007|Overall Study|Non compliance with protocol|0|||
105823367|NCT00804856|365010471|FG008|Overall Study|Non compliance with protocol|0|||
105823368|NCT00804856|365010472|FG009|Overall Study|Non compliance with protocol|0|||
105823369|NCT00804856|365010473|FG010|Overall Study|Non compliance with protocol|0|||
105823370|NCT00804856|365010474|FG011|Overall Study|Non compliance with protocol|0|||
105823371|NCT00804856|365010475|FG012|Overall Study|Non compliance with protocol|0|||
105823372|NCT00804856|365010476|FG013|Overall Study|Non compliance with protocol|2|||
105823373|NCT00804856|365010477|FG014|Overall Study|Non compliance with protocol|0|||
105823374|NCT00804856|365010463|FG000|Overall Study|Refused to continue medication|0|||
105823375|NCT00804856|365010464|FG001|Overall Study|Refused to continue medication|0|||
105823376|NCT00804856|365010465|FG002|Overall Study|Refused to continue medication|0|||
105823377|NCT00804856|365010466|FG003|Overall Study|Refused to continue medication|1|||
105823378|NCT00804856|365010467|FG004|Overall Study|Refused to continue medication|1|||
105823379|NCT00804856|365010468|FG005|Overall Study|Refused to continue medication|0|||
105823380|NCT00804856|365010469|FG006|Overall Study|Refused to continue medication|0|||
105823381|NCT00804856|365010470|FG007|Overall Study|Refused to continue medication|0|||
105823382|NCT00804856|365010471|FG008|Overall Study|Refused to continue medication|0|||
105823383|NCT00804856|365010472|FG009|Overall Study|Refused to continue medication|0|||
105823384|NCT00804856|365010473|FG010|Overall Study|Refused to continue medication|3|||
105823385|NCT00804856|365010474|FG011|Overall Study|Refused to continue medication|0|||
105823386|NCT00804856|365010475|FG012|Overall Study|Refused to continue medication|1|||
105823387|NCT00804856|365010476|FG013|Overall Study|Refused to continue medication|1|||
105823388|NCT00804856|365010477|FG014|Overall Study|Refused to continue medication|5|||
105823389|NCT00804856|365010463|FG000|Overall Study|Other reason than listed above|0|||
105823390|NCT00804856|365010464|FG001|Overall Study|Other reason than listed above|0|||
105823391|NCT00804856|365010465|FG002|Overall Study|Other reason than listed above|0|||
105823392|NCT00804856|365010466|FG003|Overall Study|Other reason than listed above|0|||
105823393|NCT00804856|365010467|FG004|Overall Study|Other reason than listed above|0|||
105823394|NCT00804856|365010468|FG005|Overall Study|Other reason than listed above|1|||
105823395|NCT00804856|365010469|FG006|Overall Study|Other reason than listed above|0|||
105823396|NCT00804856|365010470|FG007|Overall Study|Other reason than listed above|0|||
105823397|NCT00804856|365010471|FG008|Overall Study|Other reason than listed above|1|||
105823398|NCT00804856|365010472|FG009|Overall Study|Other reason than listed above|0|||
105823399|NCT00804856|365010473|FG010|Overall Study|Other reason than listed above|3|||
105823400|NCT00804856|365010474|FG011|Overall Study|Other reason than listed above|1|||
105823401|NCT00804856|365010475|FG012|Overall Study|Other reason than listed above|1|||
105823402|NCT00804856|365010476|FG013|Overall Study|Other reason than listed above|10|||
105823403|NCT00804856|365010477|FG014|Overall Study|Other reason than listed above|3|||
105823404|NCT00829309|365010478|FG000|Washout: 7 Days|Protocol Violation|1|||
105823405|NCT00829309|365010479|FG001|Washout: 7 Days|Protocol Violation|0|||
105823406|NCT03107091|365010480|FG000|Overall Study|Physician Decision|1|||
105823407|NCT00455312|365010481|FG000|Overall Study|Death|0|||
105823408|NCT00455312|365010482|FG001|Overall Study|Death|1|||
105823409|NCT00834418|365010483|FG000|Overall Study|Adverse Event|0|||
105823410|NCT00834418|365010484|FG001|Overall Study|Adverse Event|2|||
105823411|NCT01705574|365010485|FG000|Double-Blind Phase|Lost to Follow-up|12|||
105823412|NCT01705574|365010486|FG001|Double-Blind Phase|Lost to Follow-up|16|||
105823413|NCT01705574|365010487|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105823414|NCT01705574|365010488|FG003|Double-Blind Phase|Lost to Follow-up|0|||
105823415|NCT01705574|365010485|FG000|Double-Blind Phase|Adverse Event|3|||
105823416|NCT01705574|365010486|FG001|Double-Blind Phase|Adverse Event|10|||
105823417|NCT01705574|365010487|FG002|Double-Blind Phase|Adverse Event|0|||
105823418|NCT01705574|365010488|FG003|Double-Blind Phase|Adverse Event|0|||
105823419|NCT01705574|365010485|FG000|Double-Blind Phase|Withdrew Consent|8|||
105823420|NCT01705574|365010486|FG001|Double-Blind Phase|Withdrew Consent|5|||
105823421|NCT01705574|365010487|FG002|Double-Blind Phase|Withdrew Consent|0|||
105823422|NCT01705574|365010488|FG003|Double-Blind Phase|Withdrew Consent|0|||
105823423|NCT01705574|365010485|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
105823424|NCT01705574|365010486|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
105823425|NCT01705574|365010487|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
105823426|NCT01705574|365010488|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
105823427|NCT01705574|365010485|FG000|Double-Blind Phase|Pregnancy|1|||
105823428|NCT01705574|365010486|FG001|Double-Blind Phase|Pregnancy|1|||
105823429|NCT01705574|365010487|FG002|Double-Blind Phase|Pregnancy|0|||
105823430|NCT01705574|365010488|FG003|Double-Blind Phase|Pregnancy|0|||
105823431|NCT01705574|365010485|FG000|Double-Blind Phase|Protocol Violation|1|||
105823432|NCT01705574|365010486|FG001|Double-Blind Phase|Protocol Violation|0|||
105823433|NCT01705574|365010487|FG002|Double-Blind Phase|Protocol Violation|0|||
105823434|NCT01705574|365010488|FG003|Double-Blind Phase|Protocol Violation|0|||
105823435|NCT01705574|365010485|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
105823436|NCT01705574|365010486|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
105823437|NCT01705574|365010487|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
105823438|NCT01705574|365010488|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
105823439|NCT01705574|365010485|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
105823440|NCT01705574|365010486|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
105823441|NCT01705574|365010487|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
105823442|NCT01705574|365010488|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
105823443|NCT01705574|365010485|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
105823444|NCT01705574|365010486|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
105823445|NCT01705574|365010487|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
105823446|NCT01705574|365010488|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
105823447|NCT01705574|365010485|FG000|Open-Label Extension Phase|Adverse Event|3|||
105823448|NCT01705574|365010486|FG001|Open-Label Extension Phase|Adverse Event|0|||
105823449|NCT01705574|365010487|FG002|Open-Label Extension Phase|Adverse Event|0|||
105823450|NCT01705574|365010488|FG003|Open-Label Extension Phase|Adverse Event|1|||
105823451|NCT01705574|365010485|FG000|Open-Label Extension Phase|Death|2|||
105823452|NCT01705574|365010486|FG001|Open-Label Extension Phase|Death|0|||
105823453|NCT01705574|365010487|FG002|Open-Label Extension Phase|Death|1|||
105823454|NCT01705574|365010488|FG003|Open-Label Extension Phase|Death|0|||
105823455|NCT01705574|365010485|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
105487203|NCT02045303|363794987|FG002|Overall Study|Protocol Violation|0|||
105823456|NCT01705574|365010486|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
105823457|NCT01705574|365010487|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
105823458|NCT01705574|365010488|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
105823459|NCT01705574|365010485|FG000|Open-Label Extension Phase|Physician Decision|0|||
105487204|NCT02045303|363794985|FG000|Overall Study|Withdrawal by Subject|0|||
105823460|NCT01705574|365010486|FG001|Open-Label Extension Phase|Physician Decision|0|||
105823461|NCT01705574|365010487|FG002|Open-Label Extension Phase|Physician Decision|2|||
105365303|NCT01076543|363342802|FG003|Overall Study|Withdrawal by Subject|0|||
105365304|NCT01076543|363342803|FG004|Overall Study|Withdrawal by Subject|0|||
105365305|NCT01076543|363342804|FG005|Overall Study|Withdrawal by Subject|0|||
105365306|NCT02983045|363342805|FG000|Overall Study|Withdrawal by Subject|0|||
105365307|NCT02983045|363342806|FG001|Overall Study|Withdrawal by Subject|1|||
105365308|NCT02983045|363342807|FG002|Overall Study|Withdrawal by Subject|0|||
105365309|NCT02983045|363342808|FG003|Overall Study|Withdrawal by Subject|5|||
105365310|NCT02983045|363342809|FG004|Overall Study|Withdrawal by Subject|0|||
105365311|NCT02983045|363342810|FG005|Overall Study|Withdrawal by Subject|72|||
105365312|NCT02983045|363342811|FG006|Overall Study|Withdrawal by Subject|0|||
105365313|NCT02983045|363342812|FG007|Overall Study|Withdrawal by Subject|0|||
105365314|NCT02983045|363342813|FG008|Overall Study|Withdrawal by Subject|0|||
105365315|NCT02983045|363342814|FG009|Overall Study|Withdrawal by Subject|2|||
105365316|NCT02983045|363342805|FG000|Overall Study|Lost to Follow-up|0|||
105365317|NCT02983045|363342806|FG001|Overall Study|Lost to Follow-up|0|||
105823462|NCT01705574|365010488|FG003|Open-Label Extension Phase|Physician Decision|0|||
105823463|NCT01705574|365010485|FG000|Open-Label Extension Phase|Pregnancy|0|||
105823464|NCT01705574|365010486|FG001|Open-Label Extension Phase|Pregnancy|0|||
105823465|NCT01705574|365010487|FG002|Open-Label Extension Phase|Pregnancy|1|||
105823466|NCT01705574|365010488|FG003|Open-Label Extension Phase|Pregnancy|1|||
105823467|NCT00777023|365010489|FG000|Overall Study|Adverse Event|15|||
105823468|NCT00777023|365010490|FG001|Overall Study|Adverse Event|21|||
105823469|NCT00777023|365010491|FG002|Overall Study|Adverse Event|8|||
105823470|NCT00777023|365010489|FG000|Overall Study|Lack of Efficacy|1|||
105823471|NCT00777023|365010490|FG001|Overall Study|Lack of Efficacy|0|||
105823472|NCT00777023|365010491|FG002|Overall Study|Lack of Efficacy|14|||
105823473|NCT00777023|365010489|FG000|Overall Study|Protocol Violation|2|||
105823474|NCT00777023|365010490|FG001|Overall Study|Protocol Violation|1|||
105823475|NCT00777023|365010491|FG002|Overall Study|Protocol Violation|1|||
105823476|NCT00777023|365010489|FG000|Overall Study|Lost to Follow-up|2|||
105823477|NCT00777023|365010490|FG001|Overall Study|Lost to Follow-up|3|||
105823478|NCT00777023|365010491|FG002|Overall Study|Lost to Follow-up|3|||
105823479|NCT00777023|365010489|FG000|Overall Study|Death|0|||
105823480|NCT00777023|365010490|FG001|Overall Study|Death|1|||
105823481|NCT00777023|365010491|FG002|Overall Study|Death|0|||
105823482|NCT00777023|365010489|FG000|Overall Study|Withdrawal by Subject|7|||
105823483|NCT00777023|365010490|FG001|Overall Study|Withdrawal by Subject|7|||
105823484|NCT00777023|365010491|FG002|Overall Study|Withdrawal by Subject|8|||
105823485|NCT00777023|365010489|FG000|Overall Study|Missing data|1|||
105823486|NCT00777023|365010490|FG001|Overall Study|Missing data|1|||
105823487|NCT00777023|365010491|FG002|Overall Study|Missing data|0|||
105823488|NCT00777023|365010489|FG000|Overall Study|Reasons not specified|4|||
105823489|NCT00777023|365010490|FG001|Overall Study|Reasons not specified|4|||
105823490|NCT00777023|365010491|FG002|Overall Study|Reasons not specified|2|||
105823491|NCT00777023|365010489|FG000|Overall Study|Last dose date unknown|3|||
105823492|NCT00777023|365010490|FG001|Overall Study|Last dose date unknown|3|||
105823493|NCT00777023|365010491|FG002|Overall Study|Last dose date unknown|1|||
105823494|NCT03049748|365010492|FG000|Overall Study|Lost to Follow-up|1|||
105823495|NCT03049748|365010493|FG001|Overall Study|Lost to Follow-up|0|||
105823496|NCT03049748|365010492|FG000|Overall Study|Death|3|||
105823497|NCT03049748|365010493|FG001|Overall Study|Death|0|||
105823498|NCT03049748|365010492|FG000|Overall Study|Withdrawal by Subject|0|||
105823499|NCT03049748|365010493|FG001|Overall Study|Withdrawal by Subject|3|||
105823500|NCT03049748|365010492|FG000|Overall Study|Protocol Violation|0|||
105823501|NCT03049748|365010493|FG001|Overall Study|Protocol Violation|2|||
105823502|NCT03049748|365010492|FG000|Overall Study|Moved out of state (relocation)|0|||
105823503|NCT03049748|365010493|FG001|Overall Study|Moved out of state (relocation)|1|||
105823504|NCT02659150|365010494|FG000|Subject Enrollment|Physician Decision|3|||
105823505|NCT02659150|365010494|FG000|Subject Enrollment|Withdrawal by Subject|2|||
105823506|NCT02659150|365010494|FG000|Baseline Imaging|Withdrawal by Subject|1|||
105823507|NCT02659150|365010494|FG000|Baseline Imaging|Physician Decision|1|||
105823508|NCT02659150|365010494|FG000|Study Drug Dosing|Adverse Event|1|||
105823509|NCT03315455|365010495|FG000|Overall Study|Ongoing in the Study|13|||
105823510|NCT03315455|365010496|FG001|Overall Study|Ongoing in the Study|24|||
105823511|NCT03315455|365010497|FG002|Overall Study|Ongoing in the Study|17|||
105823512|NCT03315455|365010498|FG003|Overall Study|Ongoing in the Study|15|||
105823513|NCT03315455|365010495|FG000|Overall Study|Withdrawal by Subject|0|||
105823514|NCT03315455|365010496|FG001|Overall Study|Withdrawal by Subject|1|||
105823515|NCT03315455|365010497|FG002|Overall Study|Withdrawal by Subject|0|||
105823516|NCT03315455|365010498|FG003|Overall Study|Withdrawal by Subject|0|||
105365318|NCT02983045|363342807|FG002|Overall Study|Lost to Follow-up|0|||
105365319|NCT02983045|363342808|FG003|Overall Study|Lost to Follow-up|0|||
105823517|NCT00794963|365010501|FG000|Overall Study|Withdrawal by Subject|1|||
105823518|NCT00794963|365010502|FG001|Overall Study|Withdrawal by Subject|4|||
105823519|NCT01370317|365010508|FG000|Overall Study|Participant withdrew consent|1|||
105823520|NCT01370317|365010509|FG001|Overall Study|Participant withdrew consent|0|||
105823521|NCT01370317|365010508|FG000|Overall Study|Protocol deviation|0|||
105572375|NCT00569803|364094510|FG003|Overall Study|injection syringe leaked during dosing|1|||
105572376|NCT00569803|364094511|FG004|Overall Study|injection syringe leaked during dosing|0|||
105572377|NCT00569803|364094512|FG005|Overall Study|injection syringe leaked during dosing|0|||
105572378|NCT00569803|364094513|FG006|Overall Study|injection syringe leaked during dosing|0|||
105768357|NCT04731922|364802680|FG008|Overall Study|Other|0|||
105768358|NCT04731922|364802681|FG009|Overall Study|Other|0|||
105768359|NCT04731922|364802682|FG010|Overall Study|Other|0|||
105768360|NCT04731922|364802683|FG011|Overall Study|Other|0|||
105768361|NCT04731922|364802684|FG012|Overall Study|Other|0|||
105768362|NCT04731922|364802685|FG013|Overall Study|Other|0|||
105768363|NCT04731922|364802686|FG014|Overall Study|Other|0|||
105768364|NCT04731922|364802687|FG015|Overall Study|Other|0|||
105768365|NCT04731922|364802688|FG016|Overall Study|Other|0|||
105768366|NCT00422903|364802691|FG000|Overall Study|Disease Progression|3|||
105768367|NCT00422903|364802692|FG001|Overall Study|Disease Progression|1|||
105768368|NCT00422903|364802691|FG000|Overall Study|Adverse Event|0|||
105768369|NCT00422903|364802692|FG001|Overall Study|Adverse Event|2|||
105768370|NCT00422903|364802691|FG000|Overall Study|Informed Consent Withdrawn|1|||
105768371|NCT00422903|364802692|FG001|Overall Study|Informed Consent Withdrawn|2|||
105768372|NCT02092324|364802693|FG000|Overall Study|Adverse Event|1|||
105768373|NCT02092324|364802693|FG000|Overall Study|Lack of Efficacy|6|||
105768374|NCT02092324|364802693|FG000|Overall Study|Proceed to Transplant|3|||
105768375|NCT02092324|364802693|FG000|Overall Study|Physician Decision|7|||
105768376|NCT02092324|364802693|FG000|Overall Study|Misdiagnosis|2|||
105768377|NCT00981682|364802694|FG000|Overall Study|Adverse Event|48|||
105768378|NCT00981682|364802694|FG000|Overall Study|Withdrawal by Subject|52|||
105768379|NCT00981682|364802694|FG000|Overall Study|Lost to Follow-up|14|||
105768380|NCT00981682|364802694|FG000|Overall Study|Lack of Efficacy|13|||
105768381|NCT00981682|364802694|FG000|Overall Study|Protocol Violation|6|||
105768382|NCT00981682|364802694|FG000|Overall Study|administrative|9|||
105768383|NCT00044213|364802695|FG000|Overall Study|Withdrawal by Subject|50|||
105768384|NCT00044213|364802696|FG001|Overall Study|Withdrawal by Subject|65|||
105768385|NCT00044213|364802697|FG002|Overall Study|Withdrawal by Subject|91|||
105768386|NCT00044213|364802698|FG003|Overall Study|Withdrawal by Subject|83|||
105768387|NCT00044213|364802695|FG000|Overall Study|Death|42|||
105768388|NCT00044213|364802696|FG001|Overall Study|Death|42|||
105768389|NCT00044213|364802697|FG002|Overall Study|Death|42|||
105768390|NCT00044213|364802698|FG003|Overall Study|Death|49|||
105768391|NCT00044213|364802695|FG000|Overall Study|Lost to Follow-up|8|||
105768392|NCT00044213|364802696|FG001|Overall Study|Lost to Follow-up|5|||
105768393|NCT00044213|364802697|FG002|Overall Study|Lost to Follow-up|5|||
105768394|NCT00044213|364802698|FG003|Overall Study|Lost to Follow-up|4|||
105823522|NCT01370317|365010509|FG001|Overall Study|Protocol deviation|1|||
105823523|NCT02909907|365010512|FG000|Overall Study|Withdrawal by Subject|0|||
105823524|NCT02909907|365010513|FG001|Overall Study|Withdrawal by Subject|1|||
105823525|NCT03247972|365010518|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
105823526|NCT03247972|365010518|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
105823527|NCT01175018|365010519|FG000|Overall Study|Adverse Event|3|||
105823528|NCT01175018|365010520|FG001|Overall Study|Adverse Event|1|||
105823529|NCT01415986|365010528|FG000|Overall Study|Lost to Follow-up|1|||
105823530|NCT04078022|365010529|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
105823531|NCT04078022|365010530|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
105823532|NCT01316055|365010536|FG000|Overall Study|Lost to Follow-up|1|||
105823533|NCT01316055|365010537|FG001|Overall Study|Lost to Follow-up|0|||
105823534|NCT01316055|365010538|FG002|Overall Study|Lost to Follow-up|0|||
105823535|NCT00003470|365010539|FG000|Overall Study|Not evaluable|6|||
105823536|NCT00251979|365010540|FG000|Overall Study|Protocol Violation|3|||
105823537|NCT00251979|365010541|FG001|Overall Study|Protocol Violation|5|||
105823538|NCT00251979|365010540|FG000|Overall Study|Adverse Event|11|||
105823539|NCT00251979|365010541|FG001|Overall Study|Adverse Event|17|||
105823540|NCT00251979|365010540|FG000|Overall Study|Withdrawal by Subject|13|||
105823541|NCT00251979|365010541|FG001|Overall Study|Withdrawal by Subject|7|||
105823542|NCT00251979|365010540|FG000|Overall Study|Lost to Follow-up|8|||
105823543|NCT00251979|365010541|FG001|Overall Study|Lost to Follow-up|6|||
105823544|NCT00251979|365010540|FG000|Overall Study|Death|3|||
105823545|NCT00251979|365010541|FG001|Overall Study|Death|5|||
105823546|NCT03273153|365010544|FG000|Overall Study|Adverse Event|1|||
105823547|NCT03273153|365010545|FG001|Overall Study|Adverse Event|2|||
105823548|NCT03273153|365010544|FG000|Overall Study|Missing|0|||
105823549|NCT03273153|365010545|FG001|Overall Study|Missing|2|||
105823550|NCT03273153|365010544|FG000|Overall Study|Other|3|||
105823551|NCT03273153|365010545|FG001|Overall Study|Other|2|||
105823552|NCT03273153|365010544|FG000|Overall Study|Symptomatic Deterioration|0|||
105823553|NCT03273153|365010545|FG001|Overall Study|Symptomatic Deterioration|1|||
105823554|NCT03273153|365010544|FG000|Overall Study|Progressive Disease|6|||
105823555|NCT03273153|365010545|FG001|Overall Study|Progressive Disease|5|||
105823556|NCT03273153|365010544|FG000|Overall Study|Physician Decision|1|||
105823557|NCT03273153|365010545|FG001|Overall Study|Physician Decision|3|||
105823558|NCT03273153|365010544|FG000|Overall Study|Study Terminated by Sponsor|112|||
105823559|NCT03273153|365010545|FG001|Overall Study|Study Terminated by Sponsor|102|||
105823560|NCT03273153|365010544|FG000|Overall Study|Withdrawal by Subject|26|||
105823561|NCT03273153|365010545|FG001|Overall Study|Withdrawal by Subject|25|||
105823562|NCT03273153|365010544|FG000|Overall Study|Protocol Deviation|3|||
105823563|NCT03273153|365010545|FG001|Overall Study|Protocol Deviation|0|||
105823564|NCT03273153|365010544|FG000|Overall Study|Lost to Follow-up|6|||
105823565|NCT03273153|365010545|FG001|Overall Study|Lost to Follow-up|11|||
105823566|NCT03273153|365010544|FG000|Overall Study|Death|66|||
105823567|NCT03273153|365010545|FG001|Overall Study|Death|69|||
105823568|NCT00268203|365010546|FG000|Overall Study|Lost to Follow-up|92|||
105823569|NCT00268203|365010546|FG000|Overall Study|Withdrawal by Subject|9|||
105823570|NCT00268203|365010546|FG000|Overall Study|Received Other NHL Therapy|7|||
105823571|NCT00268203|365010546|FG000|Overall Study|Progressive Disease|359|||
105823572|NCT00268203|365010546|FG000|Overall Study|Death|84|||
105823573|NCT00268203|365010546|FG000|Overall Study|Reason Not Specified|34|||
105823574|NCT00268203|365010546|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
105823575|NCT00796562|365010550|FG000|Overall Study|Death|49|||
105823576|NCT02957942|365010551|FG000|Overall Study|Withdrawal by Subject|0|||
105823577|NCT02957942|365010552|FG001|Overall Study|Withdrawal by Subject|1|||
105823578|NCT02957942|365010551|FG000|Overall Study|Practicing experiment protocol|0|||
105823579|NCT02957942|365010552|FG001|Overall Study|Practicing experiment protocol|6|||
105823580|NCT02316548|365012006|FG000|Overall Study|Protocol Violation|0|||
105823581|NCT02316548|365012007|FG001|Overall Study|Protocol Violation|1|||
105823582|NCT02571907|365012008|FG000|Overall Study|Death|4|||
105823583|NCT02571907|365012008|FG000|Overall Study|Lost to Follow-up|3|||
105823584|NCT02571907|365012008|FG000|Overall Study|Withdrawal by Subject|3|||
105823585|NCT06358820|365012009|FG000|Overall Study|Adverse Event|11|||
105823586|NCT06358820|365012009|FG000|Overall Study|kidney transplantation|3|||
105823587|NCT06358820|365012009|FG000|Overall Study|patient voluntary withdrawal|6|||
105823588|NCT06358820|365012009|FG000|Overall Study|Physician Decision|1|||
105823589|NCT04247282|365012012|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
105823590|NCT04247282|365012013|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
105823591|NCT04247282|365012014|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
105823592|NCT04247282|365012015|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
105823593|NCT04247282|365012012|FG000|Overall Study|Refused further treatment|0|||
105823594|NCT04247282|365012013|FG001|Overall Study|Refused further treatment|1|||
105823595|NCT04247282|365012014|FG002|Overall Study|Refused further treatment|0|||
105823596|NCT04247282|365012015|FG003|Overall Study|Refused further treatment|0|||
105823597|NCT02519348|365012016|FG000|Overall Study|Death|31|||
105823598|NCT02519348|365012017|FG001|Overall Study|Death|74|||
105365320|NCT02983045|363342809|FG004|Overall Study|Lost to Follow-up|0|||
105365321|NCT02983045|363342810|FG005|Overall Study|Lost to Follow-up|10|||
105365322|NCT02983045|363342811|FG006|Overall Study|Lost to Follow-up|0|||
105365323|NCT02983045|363342812|FG007|Overall Study|Lost to Follow-up|0|||
105365324|NCT02983045|363342813|FG008|Overall Study|Lost to Follow-up|0|||
105365325|NCT02983045|363342814|FG009|Overall Study|Lost to Follow-up|0|||
105365326|NCT02616783|363342817|FG000|Overall Study|Randomized but Not Treated|1|||
105365327|NCT02616783|363342818|FG001|Overall Study|Randomized but Not Treated|0|||
105365328|NCT02616783|363342817|FG000|Overall Study|Adverse Event|1|||
105365329|NCT02616783|363342818|FG001|Overall Study|Adverse Event|0|||
105365330|NCT02616783|363342817|FG000|Overall Study|Death|1|||
105365331|NCT02616783|363342818|FG001|Overall Study|Death|0|||
105365332|NCT02616783|363342817|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105365333|NCT02616783|363342818|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105365334|NCT02616783|363342817|FG000|Overall Study|Protocol Violation|1|||
105365335|NCT02616783|363342818|FG001|Overall Study|Protocol Violation|1|||
105365336|NCT02616783|363342817|FG000|Overall Study|Withdrew Consent|1|||
105365337|NCT02616783|363342818|FG001|Overall Study|Withdrew Consent|1|||
105365338|NCT02155699|363342830|FG000|Overall Study|Withdrawal by Subject|0|||
105365339|NCT02155699|363342831|FG001|Overall Study|Withdrawal by Subject|3|||
105365340|NCT02155699|363342832|FG002|Overall Study|Withdrawal by Subject|6|||
105365341|NCT02155699|363342833|FG003|Overall Study|Withdrawal by Subject|1|||
105365342|NCT02155699|363342830|FG000|Overall Study|Lost to Follow-up|0|||
105365343|NCT02155699|363342831|FG001|Overall Study|Lost to Follow-up|0|||
105365344|NCT02155699|363342832|FG002|Overall Study|Lost to Follow-up|0|||
105365345|NCT02155699|363342833|FG003|Overall Study|Lost to Follow-up|3|||
105365346|NCT02155699|363342830|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
105365347|NCT02155699|363342831|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
105365348|NCT02155699|363342832|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
105365349|NCT02155699|363342833|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
105365350|NCT01275144|363342834|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
105365351|NCT01275144|363342835|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
105365352|NCT04467515|363342836|FG000|Overall Study|Lost to Follow-up|1|||
105365353|NCT04467515|363342837|FG001|Overall Study|Lost to Follow-up|0|||
105365354|NCT04467515|363342838|FG002|Overall Study|Lost to Follow-up|0|||
105365355|NCT04467515|363342836|FG000|Overall Study|Withdrawal by Subject|1|||
105365356|NCT04467515|363342837|FG001|Overall Study|Withdrawal by Subject|0|||
105365357|NCT04467515|363342838|FG002|Overall Study|Withdrawal by Subject|1|||
105365358|NCT04467515|363342836|FG000|Overall Study|Progressive Disease|0|||
105365359|NCT04467515|363342837|FG001|Overall Study|Progressive Disease|1|||
105365360|NCT04467515|363342838|FG002|Overall Study|Progressive Disease|3|||
105365361|NCT04467515|363342836|FG000|Overall Study|Death|0|||
105365362|NCT04467515|363342837|FG001|Overall Study|Death|1|||
105365363|NCT04467515|363342838|FG002|Overall Study|Death|0|||
105365364|NCT01676012|363342841|FG000|Overall Study|Adverse Event|2|||
105365365|NCT01676012|363342841|FG000|Overall Study|incomplete set of videos|1|||
105365366|NCT01628848|363342844|FG000|Overall Study|Adverse Event|9|||
105365367|NCT01628848|363342845|FG001|Overall Study|Adverse Event|7|||
105365368|NCT01628848|363342844|FG000|Overall Study|Lack of Efficacy|0|||
105365369|NCT01628848|363342845|FG001|Overall Study|Lack of Efficacy|4|||
105365370|NCT01628848|363342844|FG000|Overall Study|Withdrawal by Subject|0|||
105823599|NCT02519348|365012018|FG002|Overall Study|Death|47|||
105823600|NCT02519348|365012019|FG003|Overall Study|Death|54|||
105823601|NCT02519348|365012020|FG004|Overall Study|Death|63|||
105823602|NCT02519348|365012021|FG005|Overall Study|Death|18|||
105823603|NCT02519348|365012022|FG006|Overall Study|Death|2|||
105823604|NCT02519348|365012023|FG007|Overall Study|Death|5|||
105823605|NCT02519348|365012024|FG008|Overall Study|Death|5|||
105823606|NCT02519348|365012016|FG000|Overall Study|Withdrawal by Subject|4|||
105365371|NCT01628848|363342845|FG001|Overall Study|Withdrawal by Subject|2|||
105365372|NCT01628848|363342844|FG000|Overall Study|Physician Decision|3|||
105365373|NCT01628848|363342845|FG001|Overall Study|Physician Decision|1|||
105365374|NCT01526785|363342846|FG000|Overall Study|Study Terminated by Sponsor|8|||
105365375|NCT01526785|363342846|FG000|Overall Study|Death|2|||
105365376|NCT01526785|363342846|FG000|Overall Study|Physician Decision|1|||
105365377|NCT01526785|363342846|FG000|Overall Study|Withdrawal by Subject|2|||
105365378|NCT00960804|363342849|FG000|Overall Study|Adverse Event|1|||
105487205|NCT02045303|363794986|FG001|Overall Study|Withdrawal by Subject|2|||
105487206|NCT02045303|363794987|FG002|Overall Study|Withdrawal by Subject|0|||
105823607|NCT02519348|365012017|FG001|Overall Study|Withdrawal by Subject|7|||
105823608|NCT02519348|365012018|FG002|Overall Study|Withdrawal by Subject|4|||
105365379|NCT00960804|363342850|FG001|Overall Study|Adverse Event|0|||
105365380|NCT00960804|363342851|FG002|Overall Study|Adverse Event|0|||
105365381|NCT00960804|363342849|FG000|Overall Study|Withdrawal by Subject|1|||
105365382|NCT00960804|363342850|FG001|Overall Study|Withdrawal by Subject|0|||
105365383|NCT00960804|363342851|FG002|Overall Study|Withdrawal by Subject|0|||
105823609|NCT02519348|365012019|FG003|Overall Study|Withdrawal by Subject|3|||
105823610|NCT02519348|365012020|FG004|Overall Study|Withdrawal by Subject|3|||
105823611|NCT02519348|365012021|FG005|Overall Study|Withdrawal by Subject|2|||
105823612|NCT02519348|365012022|FG006|Overall Study|Withdrawal by Subject|0|||
105823613|NCT02519348|365012023|FG007|Overall Study|Withdrawal by Subject|0|||
105823614|NCT02519348|365012024|FG008|Overall Study|Withdrawal by Subject|1|||
105823615|NCT02519348|365012016|FG000|Overall Study|Lost to Follow-up|0|||
105823616|NCT02519348|365012017|FG001|Overall Study|Lost to Follow-up|0|||
105823617|NCT02519348|365012018|FG002|Overall Study|Lost to Follow-up|1|||
105823618|NCT02519348|365012019|FG003|Overall Study|Lost to Follow-up|0|||
105823619|NCT02519348|365012020|FG004|Overall Study|Lost to Follow-up|2|||
105823620|NCT02519348|365012021|FG005|Overall Study|Lost to Follow-up|1|||
105823621|NCT02519348|365012022|FG006|Overall Study|Lost to Follow-up|1|||
105823622|NCT02519348|365012023|FG007|Overall Study|Lost to Follow-up|0|||
105823623|NCT02519348|365012024|FG008|Overall Study|Lost to Follow-up|0|||
105823624|NCT02519348|365012016|FG000|Overall Study|Other|0|||
105823625|NCT02519348|365012017|FG001|Overall Study|Other|3|||
105823626|NCT02519348|365012018|FG002|Overall Study|Other|0|||
105823627|NCT02519348|365012019|FG003|Overall Study|Other|0|||
105823628|NCT02519348|365012020|FG004|Overall Study|Other|1|||
105823629|NCT02519348|365012021|FG005|Overall Study|Other|0|||
105823630|NCT02519348|365012022|FG006|Overall Study|Other|0|||
105823631|NCT02519348|365012023|FG007|Overall Study|Other|0|||
105823632|NCT02519348|365012024|FG008|Overall Study|Other|0|||
105823633|NCT02519348|365012016|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
105823634|NCT02519348|365012017|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
105823635|NCT02519348|365012018|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
105823636|NCT02519348|365012019|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
105823637|NCT02519348|365012020|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
105823638|NCT02519348|365012021|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
105823639|NCT02519348|365012022|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
105823640|NCT02519348|365012023|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
105823641|NCT02519348|365012024|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
105823642|NCT00207090|365012029|FG000|Overall Study|Study drug toxicity|3|||
105823643|NCT00207090|365012029|FG000|Overall Study|Chest wall mass larger|1|||
105823644|NCT00207090|365012029|FG000|Overall Study|Disease progression/relapse|2|||
105823645|NCT00207090|365012029|FG000|Overall Study|Physician Decision|1|||
105823646|NCT00841698|365012032|FG000|First Intervention|Withdrawal by Subject|1|||
105823647|NCT00841698|365012033|FG001|First Intervention|Withdrawal by Subject|0|||
105823648|NCT00906399|365012038|FG000|Year 1|Randomized But Not Treated|0|||
105823649|NCT00906399|365012039|FG001|Year 1|Randomized But Not Treated|1|||
105823650|NCT00906399|365012040|FG002|Year 1|Randomized But Not Treated|3|||
105823651|NCT00906399|365012041|FG003|Year 1|Randomized But Not Treated|0|||
105823652|NCT00906399|365012042|FG004|Year 1|Randomized But Not Treated|0|||
105823653|NCT00906399|365012043|FG005|Year 1|Randomized But Not Treated|0|||
105823654|NCT00906399|365012044|FG006|Year 1|Randomized But Not Treated|0|||
105823655|NCT00906399|365012038|FG000|Year 1|Adverse Event|4|||
105823656|NCT00906399|365012039|FG001|Year 1|Adverse Event|22|||
105823657|NCT00906399|365012040|FG002|Year 1|Adverse Event|24|||
105823658|NCT00906399|365012041|FG003|Year 1|Adverse Event|0|||
105823659|NCT00906399|365012042|FG004|Year 1|Adverse Event|0|||
105823660|NCT00906399|365012043|FG005|Year 1|Adverse Event|0|||
105823661|NCT00906399|365012044|FG006|Year 1|Adverse Event|0|||
105823662|NCT00906399|365012038|FG000|Year 1|Lost to Follow-up|4|||
105823663|NCT00906399|365012039|FG001|Year 1|Lost to Follow-up|4|||
105823664|NCT00906399|365012040|FG002|Year 1|Lost to Follow-up|2|||
105823665|NCT00906399|365012041|FG003|Year 1|Lost to Follow-up|0|||
105823666|NCT00906399|365012042|FG004|Year 1|Lost to Follow-up|0|||
105823667|NCT00906399|365012043|FG005|Year 1|Lost to Follow-up|0|||
105823668|NCT00906399|365012044|FG006|Year 1|Lost to Follow-up|0|||
105823669|NCT00906399|365012038|FG000|Year 1|Withdrawal by Subject|30|||
105823670|NCT00906399|365012039|FG001|Year 1|Withdrawal by Subject|32|||
105823671|NCT00906399|365012040|FG002|Year 1|Withdrawal by Subject|36|||
105823672|NCT00906399|365012041|FG003|Year 1|Withdrawal by Subject|0|||
105823673|NCT00906399|365012042|FG004|Year 1|Withdrawal by Subject|0|||
105823674|NCT00906399|365012043|FG005|Year 1|Withdrawal by Subject|0|||
105823675|NCT00906399|365012044|FG006|Year 1|Withdrawal by Subject|0|||
105823676|NCT00906399|365012038|FG000|Year 1|Physician Decision|0|||
105823677|NCT00906399|365012039|FG001|Year 1|Physician Decision|1|||
105823678|NCT00906399|365012040|FG002|Year 1|Physician Decision|3|||
105823679|NCT00906399|365012041|FG003|Year 1|Physician Decision|0|||
105823680|NCT00906399|365012042|FG004|Year 1|Physician Decision|0|||
105823681|NCT00906399|365012043|FG005|Year 1|Physician Decision|0|||
105823682|NCT00906399|365012044|FG006|Year 1|Physician Decision|0|||
105823683|NCT00906399|365012038|FG000|Year 1|Death|2|||
105823684|NCT00906399|365012039|FG001|Year 1|Death|1|||
105823685|NCT00906399|365012040|FG002|Year 1|Death|1|||
105823686|NCT00906399|365012041|FG003|Year 1|Death|0|||
105823687|NCT00906399|365012042|FG004|Year 1|Death|0|||
105823688|NCT00906399|365012043|FG005|Year 1|Death|0|||
105823689|NCT00906399|365012044|FG006|Year 1|Death|0|||
105823690|NCT00906399|365012038|FG000|Year 1|Other|4|||
105823691|NCT00906399|365012039|FG001|Year 1|Other|2|||
105823692|NCT00906399|365012040|FG002|Year 1|Other|7|||
105823693|NCT00906399|365012041|FG003|Year 1|Other|0|||
105823694|NCT00906399|365012042|FG004|Year 1|Other|0|||
105823695|NCT00906399|365012043|FG005|Year 1|Other|0|||
105823696|NCT00906399|365012044|FG006|Year 1|Other|0|||
105823697|NCT00906399|365012038|FG000|Year 2|Adverse Event|0|||
105823698|NCT00906399|365012039|FG001|Year 2|Adverse Event|0|||
105823699|NCT00906399|365012040|FG002|Year 2|Adverse Event|0|||
105823700|NCT00906399|365012041|FG003|Year 2|Adverse Event|9|||
105823701|NCT00906399|365012042|FG004|Year 2|Adverse Event|8|||
105823702|NCT00906399|365012043|FG005|Year 2|Adverse Event|11|||
105823703|NCT00906399|365012044|FG006|Year 2|Adverse Event|6|||
105823704|NCT00906399|365012038|FG000|Year 2|Lost to Follow-up|0|||
105823705|NCT00906399|365012039|FG001|Year 2|Lost to Follow-up|0|||
105823706|NCT00906399|365012040|FG002|Year 2|Lost to Follow-up|0|||
105823707|NCT00906399|365012041|FG003|Year 2|Lost to Follow-up|1|||
105823708|NCT00906399|365012042|FG004|Year 2|Lost to Follow-up|4|||
105823709|NCT00906399|365012043|FG005|Year 2|Lost to Follow-up|2|||
105823710|NCT00906399|365012044|FG006|Year 2|Lost to Follow-up|4|||
105823711|NCT00906399|365012038|FG000|Year 2|Withdrawal by Subject|0|||
105823712|NCT00906399|365012039|FG001|Year 2|Withdrawal by Subject|0|||
105823713|NCT00906399|365012040|FG002|Year 2|Withdrawal by Subject|0|||
105823714|NCT00906399|365012041|FG003|Year 2|Withdrawal by Subject|17|||
105823715|NCT00906399|365012042|FG004|Year 2|Withdrawal by Subject|18|||
105823716|NCT00906399|365012043|FG005|Year 2|Withdrawal by Subject|27|||
105823717|NCT00906399|365012044|FG006|Year 2|Withdrawal by Subject|13|||
105823718|NCT00906399|365012038|FG000|Year 2|Physician Decision|0|||
105823719|NCT00906399|365012039|FG001|Year 2|Physician Decision|0|||
105823720|NCT00906399|365012040|FG002|Year 2|Physician Decision|0|||
105823721|NCT00906399|365012041|FG003|Year 2|Physician Decision|0|||
105823722|NCT00906399|365012042|FG004|Year 2|Physician Decision|2|||
105823723|NCT00906399|365012043|FG005|Year 2|Physician Decision|6|||
105823724|NCT00906399|365012044|FG006|Year 2|Physician Decision|3|||
105823725|NCT00906399|365012038|FG000|Year 2|Death|0|||
105823726|NCT00906399|365012039|FG001|Year 2|Death|0|||
105823727|NCT00906399|365012040|FG002|Year 2|Death|0|||
105823728|NCT00906399|365012041|FG003|Year 2|Death|1|||
105823729|NCT00906399|365012042|FG004|Year 2|Death|0|||
105823730|NCT00906399|365012043|FG005|Year 2|Death|0|||
105823731|NCT00906399|365012044|FG006|Year 2|Death|3|||
105823732|NCT00906399|365012038|FG000|Year 2|Other|0|||
105823733|NCT00906399|365012039|FG001|Year 2|Other|0|||
105823734|NCT00906399|365012040|FG002|Year 2|Other|0|||
105823735|NCT00906399|365012041|FG003|Year 2|Other|2|||
105823736|NCT00906399|365012042|FG004|Year 2|Other|3|||
105823737|NCT00906399|365012043|FG005|Year 2|Other|1|||
105823738|NCT00906399|365012044|FG006|Year 2|Other|0|||
105823739|NCT00185458|365012045|FG000|Contraception Phase|Adverse Event|37|||
105823740|NCT00185458|365012045|FG000|Contraception Phase|Lost to Follow-up|10|||
105823741|NCT00185458|365012045|FG000|Contraception Phase|Protocol Violation|2|||
105823742|NCT00185458|365012045|FG000|Contraception Phase|Physician Decision|2|||
105823743|NCT00185458|365012045|FG000|Contraception Phase|Withdrawal by Subject|7|||
105823744|NCT00185458|365012045|FG000|HRT Phase|Adverse Event|18|||
105365384|NCT00960804|363342849|FG000|Overall Study|Study terminated by the sponsor|5|||
105365385|NCT00960804|363342850|FG001|Overall Study|Study terminated by the sponsor|4|||
105365386|NCT00960804|363342851|FG002|Overall Study|Study terminated by the sponsor|10|||
105365387|NCT01121263|363342852|FG000|Overall Study|Death|3|||
105365388|NCT01121263|363342853|FG001|Overall Study|Death|2|||
105365389|NCT01121263|363342852|FG000|Overall Study|Lost to Follow-up|22|||
105365390|NCT01121263|363342853|FG001|Overall Study|Lost to Follow-up|12|||
105365391|NCT01121263|363342852|FG000|Overall Study|Withdrawal by Subject|0|||
105365392|NCT01121263|363342853|FG001|Overall Study|Withdrawal by Subject|1|||
105365393|NCT02007720|363342854|FG000|Overall Study|Withdrawal by Subject|9|||
105365394|NCT02007720|363342855|FG001|Overall Study|Withdrawal by Subject|11|||
105365395|NCT02007720|363342854|FG000|Overall Study|study terminated by sponsor|58|||
105365396|NCT02007720|363342855|FG001|Overall Study|study terminated by sponsor|54|||
105365397|NCT02007720|363342854|FG000|Overall Study|technical problem|4|||
105823745|NCT00185458|365012045|FG000|HRT Phase|Lost to Follow-up|4|||
105823746|NCT00185458|365012045|FG000|HRT Phase|Protocol Violation|2|||
105823747|NCT00185458|365012045|FG000|HRT Phase|Withdrawal by Subject|3|||
105823748|NCT01911676|365012046|FG000|Period 1 of Study|Withdrawal by Subject|4|||
105823749|NCT01911676|365012047|FG001|Period 1 of Study|Withdrawal by Subject|2|||
105365398|NCT02007720|363342855|FG001|Overall Study|technical problem|2|||
105768395|NCT00422240|364802701|FG000|Overall Study|Lack of Efficacy|1|||
105768396|NCT00422240|364802702|FG001|Overall Study|Lack of Efficacy|2|||
105768397|NCT00422240|364802703|FG002|Overall Study|Lack of Efficacy|0|||
105768398|NCT00422240|364802704|FG003|Overall Study|Lack of Efficacy|1|||
105768399|NCT00422240|364802701|FG000|Overall Study|Adverse Event|11|||
105768400|NCT00422240|364802702|FG001|Overall Study|Adverse Event|4|||
105768401|NCT00422240|364802703|FG002|Overall Study|Adverse Event|5|||
105768402|NCT00422240|364802704|FG003|Overall Study|Adverse Event|2|||
105768403|NCT00422240|364802701|FG000|Overall Study|Subject request|21|||
105768404|NCT00422240|364802702|FG001|Overall Study|Subject request|17|||
105768405|NCT00422240|364802703|FG002|Overall Study|Subject request|18|||
105768406|NCT00422240|364802704|FG003|Overall Study|Subject request|30|||
105768407|NCT00422240|364802701|FG000|Overall Study|Protocol Violation|0|||
105823750|NCT01911676|365012048|FG002|Period 1 of Study|Withdrawal by Subject|1|||
105823751|NCT01911676|365012049|FG003|Period 1 of Study|Withdrawal by Subject|2|||
105823752|NCT01911676|365012046|FG000|Period 1 of Study|Physician Decision|2|||
105823753|NCT01911676|365012047|FG001|Period 1 of Study|Physician Decision|0|||
105823754|NCT01911676|365012048|FG002|Period 1 of Study|Physician Decision|0|||
105823755|NCT01911676|365012049|FG003|Period 1 of Study|Physician Decision|1|||
105823756|NCT01911676|365012046|FG000|Period 2 of Study|Physician Decision|2|||
105823757|NCT01911676|365012047|FG001|Period 2 of Study|Physician Decision|0|||
105823758|NCT01911676|365012048|FG002|Period 2 of Study|Physician Decision|0|||
105823759|NCT01911676|365012049|FG003|Period 2 of Study|Physician Decision|1|||
105823760|NCT01911676|365012046|FG000|Period 2 of Study|Lost to Follow-up|0|||
105823761|NCT01911676|365012047|FG001|Period 2 of Study|Lost to Follow-up|0|||
105823762|NCT01911676|365012048|FG002|Period 2 of Study|Lost to Follow-up|0|||
105823763|NCT01911676|365012049|FG003|Period 2 of Study|Lost to Follow-up|1|||
105823764|NCT01348789|365012050|FG000|Overall Study|Protocol Violation|2|||
105823765|NCT01348789|365012050|FG000|Overall Study|Withdrawal by Subject|2|||
105823766|NCT01566721|365012060|FG000|Treatment Period|Withdrawal by Subject|35|||
105823767|NCT01566721|365012061|FG001|Treatment Period|Withdrawal by Subject|9|||
105823768|NCT01566721|365012060|FG000|Treatment Period|Disease Progression/Recurrence|37|||
105823769|NCT01566721|365012061|FG001|Treatment Period|Disease Progression/Recurrence|13|||
105823770|NCT01566721|365012060|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
105823771|NCT01566721|365012061|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
105823772|NCT01566721|365012060|FG000|Treatment Period|Other|13|||
105823773|NCT01566721|365012061|FG001|Treatment Period|Other|2|||
105823774|NCT01566721|365012060|FG000|Treatment Period|Lack of Compliance|5|||
105823775|NCT01566721|365012061|FG001|Treatment Period|Lack of Compliance|1|||
105823776|NCT01566721|365012060|FG000|Treatment Period|Adverse Event|100|||
105823777|NCT01566721|365012061|FG001|Treatment Period|Adverse Event|30|||
105823778|NCT01566721|365012060|FG000|Treatment Period|Pregnancy|1|||
105823779|NCT01566721|365012061|FG001|Treatment Period|Pregnancy|0|||
105823780|NCT01566721|365012060|FG000|Safety Follow-up|Physician Decision|6|||
105823781|NCT01566721|365012061|FG001|Safety Follow-up|Physician Decision|4|||
105823782|NCT01566721|365012060|FG000|Safety Follow-up|Lost to Follow-up|101|||
105823783|NCT01566721|365012061|FG001|Safety Follow-up|Lost to Follow-up|48|||
105823784|NCT01566721|365012060|FG000|Safety Follow-up|Withdrawal by Subject|155|||
105823785|NCT01566721|365012061|FG001|Safety Follow-up|Withdrawal by Subject|49|||
105823786|NCT01566721|365012060|FG000|Safety Follow-up|Death|28|||
105823787|NCT01566721|365012061|FG001|Safety Follow-up|Death|4|||
105823788|NCT01566721|365012060|FG000|Safety Follow-up|Non-compliance|7|||
105823789|NCT01566721|365012061|FG001|Safety Follow-up|Non-compliance|3|||
105823790|NCT01566721|365012060|FG000|Safety Follow-up|Protocol Violation|7|||
105823791|NCT01566721|365012061|FG001|Safety Follow-up|Protocol Violation|0|||
105823792|NCT01566721|365012060|FG000|Safety Follow-up|Site closure|2|||
105823793|NCT01566721|365012061|FG001|Safety Follow-up|Site closure|3|||
105823794|NCT01566721|365012060|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
105823795|NCT01566721|365012061|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
105823796|NCT01566721|365012060|FG000|Safety Follow-up|Missing|7|||
105823797|NCT01566721|365012061|FG001|Safety Follow-up|Missing|2|||
105823798|NCT01566721|365012060|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
105823799|NCT01566721|365012061|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
105823800|NCT01566721|365012060|FG000|Safety Follow-up|Sponsor decision|1|||
105823801|NCT01566721|365012061|FG001|Safety Follow-up|Sponsor decision|0|||
105823802|NCT01566721|365012060|FG000|Safety Follow-up|Adverse Event|8|||
105823803|NCT01566721|365012061|FG001|Safety Follow-up|Adverse Event|4|||
105823804|NCT01794845|365012063|FG000|Overall Study|Withdrawal by Subject|1|||
105823805|NCT01169558|365012066|FG000|Overall Study|Disease progression|98|||
105823806|NCT01169558|365012066|FG000|Overall Study|Adverse Event|25|||
105823807|NCT01169558|365012066|FG000|Overall Study|Withdrawal of Consent|8|||
105823808|NCT01169558|365012066|FG000|Overall Study|Medical Decision|7|||
105823809|NCT01169558|365012066|FG000|Overall Study|Stable Disease|4|||
105823810|NCT01169558|365012066|FG000|Overall Study|Lost to Follow-up|4|||
105823811|NCT01169558|365012066|FG000|Overall Study|Need for Surgery|4|||
105823812|NCT01169558|365012066|FG000|Overall Study|Non-compliance|2|||
105823813|NCT01169558|365012066|FG000|Overall Study|Protocol Violation|2|||
105823814|NCT01169558|365012066|FG000|Overall Study|Partial response|2|||
105823815|NCT00429416|365012069|FG000|Overall Study|Death|1|||
105823816|NCT01456221|365012073|FG000|Overall Study|Withdrawal by Subject|56|||
105823817|NCT01456221|365012074|FG001|Overall Study|Withdrawal by Subject|49|||
105823818|NCT01456221|365012073|FG000|Overall Study|Lost to Follow-up|1|||
105823819|NCT01456221|365012074|FG001|Overall Study|Lost to Follow-up|4|||
105823820|NCT01456221|365012073|FG000|Overall Study|Received medication|3|||
105823821|NCT01456221|365012074|FG001|Overall Study|Received medication|2|||
105823822|NCT01456221|365012073|FG000|Overall Study|Incomplete data|4|||
105823823|NCT01456221|365012074|FG001|Overall Study|Incomplete data|2|||
105823824|NCT02530905|365012079|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
105823825|NCT02530905|365012080|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
105823826|NCT02530905|365012081|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
105365399|NCT02007720|363342854|FG000|Overall Study|patient followd less than 165 days|11|||
105365400|NCT02007720|363342855|FG001|Overall Study|patient followd less than 165 days|5|||
105365401|NCT03810456|363342856|FG000|Treatment|Urgent Family Matters|3|||
105365402|NCT03810456|363342857|FG001|Treatment|Urgent Family Matters|0|||
105365403|NCT03810456|363342858|FG002|Treatment|Urgent Family Matters|0|||
105365404|NCT03810456|363342856|FG000|Treatment|Scheduling Conflicts|0|||
105365405|NCT03810456|363342857|FG001|Treatment|Scheduling Conflicts|11|||
105365406|NCT03810456|363342858|FG002|Treatment|Scheduling Conflicts|0|||
105365407|NCT03810456|363342856|FG000|Treatment|No Longer Interested|0|||
105365408|NCT03810456|363342857|FG001|Treatment|No Longer Interested|12|||
105365409|NCT03810456|363342858|FG002|Treatment|No Longer Interested|0|||
105365410|NCT03810456|363342856|FG000|Treatment|Transportation Issues|0|||
105365411|NCT03810456|363342857|FG001|Treatment|Transportation Issues|1|||
105365412|NCT03810456|363342858|FG002|Treatment|Transportation Issues|0|||
105365413|NCT03810456|363342856|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
105365414|NCT03810456|363342857|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
105365415|NCT03810456|363342858|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
105365416|NCT03810456|363342856|FG000|1 Month Follow-Up|Relocated to Different State|1|||
105365417|NCT03810456|363342857|FG001|1 Month Follow-Up|Relocated to Different State|0|||
105365418|NCT03810456|363342858|FG002|1 Month Follow-Up|Relocated to Different State|1|||
105365419|NCT03810456|363342856|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
105365420|NCT03810456|363342857|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
105365421|NCT03810456|363342858|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
105365422|NCT03810456|363342856|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
105365423|NCT03810456|363342857|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
105365424|NCT03810456|363342858|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
105365425|NCT03810456|363342856|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
105365426|NCT03810456|363342857|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
105365427|NCT03810456|363342858|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
105365428|NCT03810456|363342856|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
105365429|NCT03810456|363342857|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
105365430|NCT03810456|363342858|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
105487207|NCT03533686|363794988|FG000|Overall Study|Withdrawal by Subject|1|||
105823827|NCT06999265|365012082|FG000|Overall Study|Lost to Follow-up|1|||
105823828|NCT06999265|365012083|FG001|Overall Study|Lost to Follow-up|1|||
105823829|NCT00811655|365012085|FG000|Overall Study|Physician Decision|1|||
105823830|NCT03043872|365012086|FG000|Overall Study|Withdrawal by Subject|6|||
105823831|NCT03043872|365012087|FG001|Overall Study|Withdrawal by Subject|6|||
105823832|NCT03043872|365012088|FG002|Overall Study|Withdrawal by Subject|15|||
105823833|NCT03043872|365012086|FG000|Overall Study|Lost to Follow-up|2|||
105823834|NCT03043872|365012087|FG001|Overall Study|Lost to Follow-up|1|||
105823835|NCT03043872|365012088|FG002|Overall Study|Lost to Follow-up|1|||
105823836|NCT03043872|365012086|FG000|Overall Study|Death|270|||
105823837|NCT03043872|365012087|FG001|Overall Study|Death|269|||
105823838|NCT03043872|365012088|FG002|Overall Study|Death|296|||
105823839|NCT02430480|365012089|FG000|Overall Study|Death|1|||
105823840|NCT02430480|365012089|FG000|Overall Study|Anesthesia concerns|1|||
105823841|NCT02430480|365012089|FG000|Overall Study|Progressed on treatment|1|||
105823842|NCT04493684|365012091|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
105823843|NCT04493684|365012092|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823844|NCT04493684|365012093|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
105823845|NCT04493684|365012094|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823846|NCT04493684|365012095|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823847|NCT04493684|365012096|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
105823848|NCT04493684|365012097|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823849|NCT04493684|365012098|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823850|NCT04493684|365012099|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823851|NCT04493684|365012100|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823852|NCT04493684|365012101|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823853|NCT04493684|365012102|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823854|NCT04493684|365012103|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823855|NCT04493684|365012104|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823856|NCT04493684|365012105|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823857|NCT04493684|365012106|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823858|NCT04493684|365012107|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823859|NCT04493684|365012091|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
105823860|NCT04493684|365012092|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823861|NCT04493684|365012093|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823862|NCT04493684|365012094|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105365431|NCT03810456|363342856|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
105365432|NCT03810456|363342857|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
105365433|NCT03810456|363342858|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
105365434|NCT01419535|363342859|FG000|Overall Study|could not maintain iv line|1|||
105365435|NCT01419535|363342860|FG001|Overall Study|could not maintain iv line|1|||
105365436|NCT01419535|363342859|FG000|Overall Study|Withdrawal by Subject|0|||
105572379|NCT00569803|364094514|FG007|Overall Study|injection syringe leaked during dosing|0|||
105572380|NCT00569803|364094507|FG000|Overall Study|Withdrawal by Subject|0|||
105823863|NCT04493684|365012095|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823864|NCT04493684|365012096|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823865|NCT04493684|365012097|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823866|NCT04493684|365012098|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823867|NCT04493684|365012099|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823868|NCT04493684|365012100|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823869|NCT04493684|365012101|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823870|NCT04493684|365012102|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823871|NCT04493684|365012103|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823872|NCT04493684|365012104|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823873|NCT04493684|365012105|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823874|NCT04493684|365012106|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823875|NCT04493684|365012107|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823876|NCT04493684|365012091|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823877|NCT04493684|365012092|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823878|NCT04493684|365012093|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823879|NCT04493684|365012094|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823880|NCT04493684|365012095|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823881|NCT04493684|365012096|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823882|NCT04493684|365012097|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
105823883|NCT04493684|365012098|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823884|NCT04493684|365012099|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823885|NCT04493684|365012100|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823886|NCT04493684|365012101|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823887|NCT04493684|365012102|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823888|NCT04493684|365012103|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823889|NCT04493684|365012104|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105768408|NCT00422240|364802702|FG001|Overall Study|Protocol Violation|1|||
105768409|NCT00422240|364802703|FG002|Overall Study|Protocol Violation|0|||
105768410|NCT00422240|364802704|FG003|Overall Study|Protocol Violation|1|||
105768411|NCT00422240|364802701|FG000|Overall Study|Lost to Follow-up|31|||
105768412|NCT00422240|364802702|FG001|Overall Study|Lost to Follow-up|32|||
105768413|NCT00422240|364802703|FG002|Overall Study|Lost to Follow-up|19|||
105768414|NCT00422240|364802704|FG003|Overall Study|Lost to Follow-up|34|||
105768415|NCT00422240|364802701|FG000|Overall Study|Other|1|||
105768416|NCT00422240|364802702|FG001|Overall Study|Other|0|||
105768417|NCT00422240|364802703|FG002|Overall Study|Other|0|||
105768418|NCT00422240|364802704|FG003|Overall Study|Other|1|||
105768419|NCT00422240|364802701|FG000|Overall Study|Pregnancy|3|||
105768420|NCT00422240|364802702|FG001|Overall Study|Pregnancy|1|||
105768421|NCT00422240|364802703|FG002|Overall Study|Pregnancy|1|||
105768422|NCT00422240|364802704|FG003|Overall Study|Pregnancy|2|||
105768423|NCT00441012|364802705|FG000|Overall Study|Adverse Event|0|||
105768424|NCT00441012|364802706|FG001|Overall Study|Adverse Event|1|||
105768425|NCT00441012|364802705|FG000|Overall Study|Lost to Follow-up|3|||
105768426|NCT00441012|364802706|FG001|Overall Study|Lost to Follow-up|3|||
105768427|NCT00441012|364802705|FG000|Overall Study|Protocol Violation|10|||
105768428|NCT00441012|364802706|FG001|Overall Study|Protocol Violation|9|||
105768429|NCT00441012|364802705|FG000|Overall Study|Withdrawal by Subject|4|||
105768430|NCT00441012|364802706|FG001|Overall Study|Withdrawal by Subject|0|||
105823890|NCT04493684|365012105|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823891|NCT04493684|365012106|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823892|NCT04493684|365012107|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823893|NCT04493684|365012091|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
105823894|NCT04493684|365012092|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823895|NCT04493684|365012093|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823896|NCT04493684|365012094|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823897|NCT04493684|365012095|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823898|NCT04493684|365012096|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823899|NCT04493684|365012097|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823900|NCT04493684|365012098|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823901|NCT04493684|365012099|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823902|NCT04493684|365012100|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823903|NCT04493684|365012101|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823904|NCT04493684|365012102|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823905|NCT04493684|365012103|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823906|NCT04493684|365012104|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823907|NCT04493684|365012105|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823908|NCT04493684|365012106|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823909|NCT04493684|365012107|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823910|NCT04493684|365012091|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823911|NCT04493684|365012092|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823912|NCT04493684|365012093|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823913|NCT04493684|365012094|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823914|NCT04493684|365012095|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823915|NCT04493684|365012096|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
105823916|NCT04493684|365012097|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823917|NCT04493684|365012098|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823918|NCT04493684|365012099|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823919|NCT04493684|365012100|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823920|NCT04493684|365012101|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105365437|NCT01419535|363342860|FG001|Overall Study|Withdrawal by Subject|1|||
105365438|NCT02358031|363343793|FG000|Overall Study|Death|253|||
105365439|NCT02358031|363343794|FG001|Overall Study|Death|237|||
105365440|NCT02358031|363343795|FG002|Overall Study|Death|266|||
105365441|NCT02358031|363343793|FG000|Overall Study|Lost to Follow-up|1|||
105365442|NCT02358031|363343794|FG001|Overall Study|Lost to Follow-up|1|||
105365443|NCT02358031|363343795|FG002|Overall Study|Lost to Follow-up|0|||
105365444|NCT02358031|363343793|FG000|Overall Study|Withdrawal by Subject|19|||
105365445|NCT02358031|363343794|FG001|Overall Study|Withdrawal by Subject|14|||
105365446|NCT02358031|363343795|FG002|Overall Study|Withdrawal by Subject|18|||
105365447|NCT02358031|363343793|FG000|Overall Study|Sponsor Decision|26|||
105365448|NCT02358031|363343794|FG001|Overall Study|Sponsor Decision|28|||
105365449|NCT02358031|363343795|FG002|Overall Study|Sponsor Decision|16|||
105365450|NCT03101150|363343796|FG000|Overall Study|Lost to Follow-up|2|||
105365451|NCT03101150|363343797|FG001|Overall Study|Lost to Follow-up|4|||
105365452|NCT03101150|363343796|FG000|Overall Study|Miscarriage|3|||
105365453|NCT03101150|363343797|FG001|Overall Study|Miscarriage|6|||
105365454|NCT01022203|363343800|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
105365455|NCT01022203|363343801|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
105365456|NCT01022203|363343800|FG000|Post Treatment Assessment|Physician Decision|2|||
105365457|NCT01022203|363343801|FG001|Post Treatment Assessment|Physician Decision|0|||
105365458|NCT01022203|363343800|FG000|Post Treatment Assessment|Adverse Event|0|||
105365459|NCT01022203|363343801|FG001|Post Treatment Assessment|Adverse Event|2|||
105365460|NCT01022203|363343800|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
105365461|NCT01022203|363343801|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
105365462|NCT03225170|363343802|FG000|Overall Study|Lost to Follow-up|4|||
105365463|NCT03225170|363343803|FG001|Overall Study|Lost to Follow-up|4|||
105365464|NCT03225170|363343804|FG002|Overall Study|Lost to Follow-up|0|||
105365465|NCT03225170|363343802|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
105365466|NCT03225170|363343803|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
105365467|NCT03225170|363343804|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
105365468|NCT01746862|363343817|FG000|Overall Study|Withdrawal by Subject|1|||
105365469|NCT01746862|363343818|FG001|Overall Study|Withdrawal by Subject|1|||
105365470|NCT01746862|363343817|FG000|Overall Study|Protocol Violation|1|||
105365471|NCT01746862|363343818|FG001|Overall Study|Protocol Violation|0|||
105365472|NCT01746862|363343817|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
105487208|NCT03533686|363794989|FG001|Overall Study|Withdrawal by Subject|0|||
105365473|NCT01746862|363343818|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
105823921|NCT04493684|365012102|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823922|NCT04493684|365012103|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823923|NCT04493684|365012104|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823924|NCT04493684|365012105|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823925|NCT04493684|365012106|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823926|NCT04493684|365012107|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823927|NCT04493684|365012091|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823928|NCT04493684|365012092|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823929|NCT04493684|365012093|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823930|NCT04493684|365012094|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823931|NCT04493684|365012095|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823932|NCT04493684|365012096|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823933|NCT04493684|365012097|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823934|NCT04493684|365012098|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823935|NCT04493684|365012099|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823936|NCT04493684|365012100|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823937|NCT04493684|365012101|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823938|NCT04493684|365012102|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
105823939|NCT04493684|365012103|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823940|NCT04493684|365012104|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823941|NCT04493684|365012105|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105487209|NCT03533686|363794990|FG002|Overall Study|Withdrawal by Subject|0|||
105487210|NCT03533686|363794991|FG003|Overall Study|Withdrawal by Subject|3|||
105823942|NCT04493684|365012106|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823943|NCT04493684|365012107|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823944|NCT04493684|365012091|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823945|NCT04493684|365012092|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823946|NCT04493684|365012093|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823947|NCT04493684|365012094|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823948|NCT04493684|365012095|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823949|NCT04493684|365012096|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823950|NCT04493684|365012097|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823951|NCT04493684|365012098|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823952|NCT04493684|365012099|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823953|NCT04493684|365012100|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823954|NCT04493684|365012101|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823955|NCT04493684|365012102|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823956|NCT04493684|365012103|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823957|NCT04493684|365012104|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823958|NCT04493684|365012105|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823959|NCT04493684|365012106|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
105823960|NCT04493684|365012107|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823961|NCT04493684|365012091|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823962|NCT04493684|365012092|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823963|NCT04493684|365012093|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823964|NCT04493684|365012094|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823965|NCT04493684|365012095|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823966|NCT04493684|365012096|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823967|NCT04493684|365012097|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823968|NCT04493684|365012098|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823969|NCT04493684|365012099|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823970|NCT04493684|365012100|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823971|NCT04493684|365012101|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823972|NCT04493684|365012102|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823973|NCT04493684|365012103|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823974|NCT04493684|365012104|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823975|NCT04493684|365012105|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823976|NCT04493684|365012106|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
105823977|NCT04493684|365012107|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823978|NCT00001703|365013083|FG000|Overall Study|progressed disease|2|||
105823979|NCT00001703|365013083|FG000|Overall Study|No evidence of disease|1|||
105823980|NCT00001703|365013083|FG000|Overall Study|recurrent disease|2|||
105823981|NCT05710718|365013088|FG000|Overall Study|Withdrawal by Subject|5|||
105823982|NCT05710718|365013089|FG001|Overall Study|Withdrawal by Subject|1|||
105823983|NCT05710718|365013088|FG000|Overall Study|Lost to Follow-up|0|||
105823984|NCT05710718|365013089|FG001|Overall Study|Lost to Follow-up|1|||
105823985|NCT05710718|365013088|FG000|Overall Study|Death|0|||
105823986|NCT05710718|365013089|FG001|Overall Study|Death|1|||
105823987|NCT04915755|365013090|FG000|Overall Study|Physician Decision|3|||
105823988|NCT04915755|365013091|FG001|Overall Study|Physician Decision|2|||
105823989|NCT04915755|365013090|FG000|Overall Study|Withdrawal by Subject|1|||
105823990|NCT04915755|365013091|FG001|Overall Study|Withdrawal by Subject|1|||
105823991|NCT04915755|365013090|FG000|Overall Study|Ongoing for PACT|3|||
105823992|NCT04915755|365013091|FG001|Overall Study|Ongoing for PACT|2|||
105823993|NCT04915755|365013090|FG000|Overall Study|Other|7|||
105823994|NCT04915755|365013091|FG001|Overall Study|Other|11|||
105823995|NCT02533258|365013092|FG000|Overall Study|Adverse Event|1|||
105823996|NCT02533258|365013092|FG000|Overall Study|Death|2|||
105823997|NCT02533258|365013092|FG000|Overall Study|Other|1|||
105823998|NCT02533258|365013092|FG000|Overall Study|Economic factor|1|||
105823999|NCT02533258|365013092|FG000|Overall Study|Progression of pleural effusion|1|||
105824000|NCT02533258|365013092|FG000|Overall Study|Lack of Efficacy|2|||
105824001|NCT03697109|365013097|FG000|Open-label (OL) Phase|Adverse Event|24|||
105824002|NCT03697109|365013098|FG001|Open-label (OL) Phase|Adverse Event|0|||
105824003|NCT03697109|365013099|FG002|Open-label (OL) Phase|Adverse Event|0|||
105824004|NCT03697109|365013097|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
105824005|NCT03697109|365013098|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
105824006|NCT03697109|365013099|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
105572381|NCT00569803|364094508|FG001|Overall Study|Withdrawal by Subject|0|||
105824007|NCT03697109|365013097|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
105824008|NCT03697109|365013098|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
105824009|NCT03697109|365013099|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
105824010|NCT03697109|365013097|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
105824011|NCT03697109|365013098|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
105824012|NCT03697109|365013099|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
105824013|NCT03697109|365013097|FG000|Open-label (OL) Phase|Physician Decision|2|||
105824014|NCT03697109|365013098|FG001|Open-label (OL) Phase|Physician Decision|0|||
105824015|NCT03697109|365013099|FG002|Open-label (OL) Phase|Physician Decision|0|||
105824016|NCT03697109|365013097|FG000|Open-label (OL) Phase|Death|2|||
105824017|NCT03697109|365013098|FG001|Open-label (OL) Phase|Death|0|||
105824018|NCT03697109|365013099|FG002|Open-label (OL) Phase|Death|0|||
105824019|NCT03697109|365013097|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
105824020|NCT03697109|365013098|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
105824021|NCT03697109|365013099|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
105824022|NCT03697109|365013097|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
105824023|NCT03697109|365013098|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
105824024|NCT03697109|365013099|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
105824025|NCT03697109|365013097|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
105824026|NCT03697109|365013098|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
105824027|NCT03697109|365013099|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
105824028|NCT02096211|365013104|FG000|Overall Study|Death|2|||
105824029|NCT02096211|365013104|FG000|Overall Study|Withdrawal by Subject|8|||
105824030|NCT02096211|365013104|FG000|Overall Study|Revision of implant|7|||
105824031|NCT02096211|365013104|FG000|Overall Study|Lost to Follow-up|43|||
105824032|NCT00519194|365013108|FG000|Overall Study|Withdrawal by Subject|9|||
105824033|NCT00519194|365013108|FG000|Overall Study|Death|9|||
105824034|NCT00519194|365013108|FG000|Overall Study|Lost to Follow-up|3|||
105824035|NCT03165994|365013109|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
105824036|NCT03165994|365013109|FG000|Overall Study|Death|2|||
105824037|NCT03165994|365013109|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
105824038|NCT03165994|365013109|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
105824039|NCT03165994|365013109|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
105824040|NCT03165994|365013109|FG000|Overall Study|Miscellaneous|1|||
105824041|NCT02301975|365013110|FG000|Overall Study|Adverse Event|8|||
105824042|NCT02301975|365013111|FG001|Overall Study|Adverse Event|3|||
105824043|NCT02301975|365013112|FG002|Overall Study|Adverse Event|2|||
105824044|NCT02301975|365013110|FG000|Overall Study|Lack of Efficacy|1|||
105824045|NCT02301975|365013111|FG001|Overall Study|Lack of Efficacy|1|||
105824046|NCT02301975|365013112|FG002|Overall Study|Lack of Efficacy|1|||
105824047|NCT02301975|365013110|FG000|Overall Study|Protocol Violation|3|||
105824048|NCT02301975|365013111|FG001|Overall Study|Protocol Violation|5|||
105824049|NCT02301975|365013112|FG002|Overall Study|Protocol Violation|3|||
105824050|NCT02301975|365013110|FG000|Overall Study|Lost to Follow-up|0|||
105824051|NCT02301975|365013111|FG001|Overall Study|Lost to Follow-up|2|||
105824052|NCT02301975|365013112|FG002|Overall Study|Lost to Follow-up|2|||
105824053|NCT02301975|365013110|FG000|Overall Study|Physician Decision|4|||
105824054|NCT02301975|365013111|FG001|Overall Study|Physician Decision|2|||
105824055|NCT02301975|365013112|FG002|Overall Study|Physician Decision|3|||
105824056|NCT02301975|365013110|FG000|Overall Study|Withdrawal by Subject|15|||
105824057|NCT02301975|365013111|FG001|Overall Study|Withdrawal by Subject|12|||
105824058|NCT02301975|365013112|FG002|Overall Study|Withdrawal by Subject|11|||
105824059|NCT00440518|365013114|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
105824060|NCT00440518|365013115|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
105824061|NCT00440518|365013116|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
105824062|NCT00440518|365013114|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
105824063|NCT00440518|365013115|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
105824064|NCT00440518|365013116|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
105824065|NCT00440518|365013114|FG000|Randomized /Titration Period|Protocol Deviation|1|||
105824066|NCT00440518|365013115|FG001|Randomized /Titration Period|Protocol Deviation|0|||
105824067|NCT00440518|365013116|FG002|Randomized /Titration Period|Protocol Deviation|0|||
105824068|NCT00440518|365013114|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
105824069|NCT00440518|365013115|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
105824070|NCT00440518|365013116|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
105824071|NCT00440518|365013114|FG000|Randomized /Titration Period|Other|1|||
105824072|NCT00440518|365013115|FG001|Randomized /Titration Period|Other|0|||
105824073|NCT00440518|365013116|FG002|Randomized /Titration Period|Other|0|||
105824074|NCT00440518|365013114|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
105824075|NCT00440518|365013115|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
105824076|NCT00440518|365013116|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
105824077|NCT00440518|365013114|FG000|Randomized /Titration Period|Adverse Event|2|||
105824078|NCT00440518|365013115|FG001|Randomized /Titration Period|Adverse Event|3|||
105824079|NCT00440518|365013116|FG002|Randomized /Titration Period|Adverse Event|0|||
105824080|NCT00440518|365013114|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
105824081|NCT00440518|365013115|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
105824082|NCT00440518|365013116|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
105824083|NCT00440518|365013114|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
105824084|NCT00440518|365013115|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
105824085|NCT00440518|365013116|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
105824086|NCT00440518|365013114|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
105824087|NCT00440518|365013115|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
105824088|NCT00440518|365013116|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
105824089|NCT00440518|365013114|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
105824090|NCT00440518|365013115|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
105824091|NCT00440518|365013116|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
105824092|NCT00440518|365013114|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
105824093|NCT00440518|365013115|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
105824094|NCT00440518|365013116|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
105824095|NCT00440518|365013114|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
105824096|NCT00440518|365013115|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
105824097|NCT00440518|365013116|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
105824098|NCT03733730|365013118|FG000|Overall Study|Lost to Follow-up|1|||
105824099|NCT03733730|365013119|FG001|Overall Study|Lost to Follow-up|32|||
105824100|NCT03733730|365013118|FG000|Overall Study|Other|1|||
105824101|NCT03733730|365013119|FG001|Overall Study|Other|0|||
105824102|NCT03733730|365013118|FG000|Overall Study|Adverse Event|0|||
105824103|NCT03733730|365013119|FG001|Overall Study|Adverse Event|4|||
105824104|NCT03733730|365013118|FG000|Overall Study|Death|0|||
105824105|NCT03733730|365013119|FG001|Overall Study|Death|5|||
105824106|NCT03733730|365013118|FG000|Overall Study|Withdrawal by Subject|0|||
105824107|NCT03733730|365013119|FG001|Overall Study|Withdrawal by Subject|8|||
105824108|NCT02563561|365013120|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
105824109|NCT02563561|365013121|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
105824110|NCT02563561|365013122|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
105824111|NCT02563561|365013120|FG000|Overall Study|Withdrew of Consent|1|||
105824112|NCT02563561|365013121|FG001|Overall Study|Withdrew of Consent|1|||
105824113|NCT02563561|365013122|FG002|Overall Study|Withdrew of Consent|2|||
105824114|NCT02563561|365013120|FG000|Overall Study|Lost to Follow-up|1|||
105824115|NCT02563561|365013121|FG001|Overall Study|Lost to Follow-up|1|||
105824116|NCT02563561|365013122|FG002|Overall Study|Lost to Follow-up|0|||
105824117|NCT02563561|365013120|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
105365474|NCT01746862|363343817|FG000|Overall Study|Entered puberty during the study|1|||
105365475|NCT01746862|363343818|FG001|Overall Study|Entered puberty during the study|0|||
105365476|NCT04742673|363343819|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
105365477|NCT04742673|363343820|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
105365478|NCT01900444|363343821|FG000|Overall Study|Protocol Violation|2|||
105365479|NCT01900444|363343821|FG000|Overall Study|Lost to Follow-up|1|||
105365480|NCT06058390|363343822|FG000|Overall Study|Lost to Follow-up|0|||
105365481|NCT06058390|363343823|FG001|Overall Study|Lost to Follow-up|0|||
105365482|NCT06058390|363343824|FG002|Overall Study|Lost to Follow-up|2|||
105824118|NCT02563561|365013121|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
105824119|NCT02563561|365013122|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
105365483|NCT06058390|363343825|FG003|Overall Study|Lost to Follow-up|1|||
105572382|NCT00569803|364094509|FG002|Overall Study|Withdrawal by Subject|0|||
105572383|NCT00569803|364094510|FG003|Overall Study|Withdrawal by Subject|0|||
105365484|NCT06058390|363343822|FG000|Overall Study|Physician Decision|0|||
105365485|NCT06058390|363343823|FG001|Overall Study|Physician Decision|0|||
105365486|NCT06058390|363343824|FG002|Overall Study|Physician Decision|0|||
105365487|NCT06058390|363343825|FG003|Overall Study|Physician Decision|1|||
105365488|NCT06058390|363343822|FG000|Overall Study|Participants did not receive any study intervention|0|||
105365489|NCT06058390|363343823|FG001|Overall Study|Participants did not receive any study intervention|0|||
105365490|NCT06058390|363343824|FG002|Overall Study|Participants did not receive any study intervention|0|||
105365491|NCT06058390|363343825|FG003|Overall Study|Participants did not receive any study intervention|1|||
105365492|NCT03361306|363343826|FG000|Overall Study|Death|6|||
105365493|NCT03473743|363343831|FG000|Overall Study|Withdrawal by Subject|0|||
105365494|NCT03473743|363343832|FG001|Overall Study|Withdrawal by Subject|0|||
105365495|NCT03473743|363343833|FG002|Overall Study|Withdrawal by Subject|0|||
105365496|NCT03473743|363343834|FG003|Overall Study|Withdrawal by Subject|0|||
105365497|NCT03473743|363343835|FG004|Overall Study|Withdrawal by Subject|0|||
105365498|NCT03473743|363343836|FG005|Overall Study|Withdrawal by Subject|0|||
105365499|NCT03473743|363343837|FG006|Overall Study|Withdrawal by Subject|0|||
105365500|NCT03473743|363343838|FG007|Overall Study|Withdrawal by Subject|3|||
105365501|NCT03473743|363343831|FG000|Overall Study|Other|0|||
105365502|NCT03473743|363343832|FG001|Overall Study|Other|0|||
105365503|NCT03473743|363343833|FG002|Overall Study|Other|0|||
105365504|NCT03473743|363343834|FG003|Overall Study|Other|1|||
105365505|NCT03473743|363343835|FG004|Overall Study|Other|0|||
105365506|NCT03473743|363343836|FG005|Overall Study|Other|0|||
105365507|NCT03473743|363343837|FG006|Overall Study|Other|0|||
105365508|NCT03473743|363343838|FG007|Overall Study|Other|0|||
105365509|NCT03473743|363343831|FG000|Overall Study|Ongoing|0|||
105365510|NCT03473743|363343832|FG001|Overall Study|Ongoing|0|||
105365511|NCT03473743|363343833|FG002|Overall Study|Ongoing|6|||
105824120|NCT02563561|365013120|FG000|Overall Study|Investigator Decision|3|||
105824121|NCT02563561|365013121|FG001|Overall Study|Investigator Decision|4|||
105824122|NCT02563561|365013122|FG002|Overall Study|Investigator Decision|2|||
105824123|NCT02563561|365013120|FG000|Overall Study|Sponsor Decision|5|||
105824124|NCT02563561|365013121|FG001|Overall Study|Sponsor Decision|2|||
105824125|NCT02563561|365013122|FG002|Overall Study|Sponsor Decision|4|||
105824126|NCT02563561|365013120|FG000|Overall Study|Other|1|||
105824127|NCT02563561|365013121|FG001|Overall Study|Other|5|||
105824128|NCT02563561|365013122|FG002|Overall Study|Other|2|||
105824129|NCT01056484|365013125|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
105824130|NCT01056484|365013126|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
105824131|NCT01056484|365013125|FG000|Randomized Controlled Trial|Physician Decision|1|||
105824132|NCT01056484|365013126|FG001|Randomized Controlled Trial|Physician Decision|0|||
105824133|NCT01056484|365013125|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
105824134|NCT01056484|365013126|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
105824135|NCT06195579|365013127|FG000|Overall Study|Withdrawal by Subject|1|||
105824136|NCT00446966|365013129|FG000|Overall Study|Lost to Follow-up|10|||
105824137|NCT00446966|365013130|FG001|Overall Study|Lost to Follow-up|7|||
105824138|NCT00835575|365013131|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
105824139|NCT00835575|365013132|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
105824140|NCT01440803|365013133|FG000|Overall Study|Met study stopping rule|2|||
105824141|NCT01440803|365013134|FG001|Overall Study|Met study stopping rule|1|||
105824142|NCT01440803|365013133|FG000|Overall Study|Lost to Follow-up|0|||
105824143|NCT01440803|365013134|FG001|Overall Study|Lost to Follow-up|2|||
105824144|NCT01440803|365013133|FG000|Overall Study|Withdrawal by Subject|0|||
105824145|NCT01440803|365013134|FG001|Overall Study|Withdrawal by Subject|1|||
105824146|NCT03868891|365013135|FG000|Overall Study|Adverse Event|1|||
105824147|NCT03868891|365013136|FG001|Overall Study|Adverse Event|0|||
105824148|NCT03868891|365013135|FG000|Overall Study|Lost to Follow-up|2|||
105824149|NCT03868891|365013136|FG001|Overall Study|Lost to Follow-up|1|||
105824150|NCT03868891|365013135|FG000|Overall Study|COVID-19 Restrictions|1|||
105824151|NCT03868891|365013136|FG001|Overall Study|COVID-19 Restrictions|2|||
105824152|NCT03123094|365013137|FG000|Overall Study|Withdrawal by Subject|0|||
105824153|NCT03123094|365013138|FG001|Overall Study|Withdrawal by Subject|2|||
105824154|NCT03123094|365013139|FG002|Overall Study|Withdrawal by Subject|1|||
105824155|NCT03123094|365013140|FG003|Overall Study|Withdrawal by Subject|0|||
105824156|NCT03123094|365013141|FG004|Overall Study|Withdrawal by Subject|1|||
105824157|NCT01158118|365013142|FG000|Overall Study|Screen failure|1|||
105824158|NCT01158118|365013143|FG001|Overall Study|Screen failure|0|||
105824159|NCT01158118|365013142|FG000|Overall Study|Donor match was a screen failure|0|||
105824160|NCT01158118|365013143|FG001|Overall Study|Donor match was a screen failure|1|||
105824161|NCT01158118|365013142|FG000|Overall Study|Suffered stroke prior to transplant|0|||
105365512|NCT03473743|363343834|FG003|Overall Study|Ongoing|8|||
105365513|NCT03473743|363343835|FG004|Overall Study|Ongoing|1|||
105365514|NCT03473743|363343836|FG005|Overall Study|Ongoing|1|||
105365515|NCT03473743|363343837|FG006|Overall Study|Ongoing|22|||
105365516|NCT03473743|363343838|FG007|Overall Study|Ongoing|24|||
105365517|NCT03473743|363343831|FG000|Overall Study|Randomized but not treated|0|||
105824162|NCT01158118|365013143|FG001|Overall Study|Suffered stroke prior to transplant|1|||
105824163|NCT01158118|365013142|FG000|Overall Study|Death|0|||
105824164|NCT01158118|365013143|FG001|Overall Study|Death|1|||
105824165|NCT02241551|365013144|FG000|Overall Study|Adverse Event|1|||
105824166|NCT02241551|365013145|FG001|Overall Study|Adverse Event|0|||
105824167|NCT03496623|365013146|FG000|Run-In Period (2 Weeks)|Death|1|||
105824168|NCT03496623|365013147|FG001|Run-In Period (2 Weeks)|Death|0|||
105824169|NCT03496623|365013148|FG002|Run-In Period (2 Weeks)|Death|0|||
105824170|NCT03496623|365013149|FG003|Run-In Period (2 Weeks)|Death|0|||
105824171|NCT03496623|365013150|FG004|Run-In Period (2 Weeks)|Death|0|||
105824172|NCT03496623|365013146|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
105824173|NCT03496623|365013147|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
105824174|NCT03496623|365013148|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
105824175|NCT03496623|365013149|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
105365518|NCT03473743|363343832|FG001|Overall Study|Randomized but not treated|0|||
105365519|NCT03473743|363343833|FG002|Overall Study|Randomized but not treated|0|||
105365520|NCT03473743|363343834|FG003|Overall Study|Randomized but not treated|0|||
105365521|NCT03473743|363343835|FG004|Overall Study|Randomized but not treated|0|||
105365522|NCT03473743|363343836|FG005|Overall Study|Randomized but not treated|0|||
105365523|NCT03473743|363343837|FG006|Overall Study|Randomized but not treated|1|||
105365524|NCT03473743|363343838|FG007|Overall Study|Randomized but not treated|1|||
105365525|NCT05214118|363343847|FG000|Overall Study|Lost to Follow-up|0|||
105365526|NCT05214118|363343848|FG001|Overall Study|Lost to Follow-up|2|||
105365527|NCT05214118|363343847|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
105365528|NCT05214118|363343848|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
105365529|NCT05214118|363343847|FG000|Overall Study|moved|1|||
105365530|NCT05214118|363343848|FG001|Overall Study|moved|0|||
105365531|NCT03462719|363343849|FG000|Overall Study|Withdrawal by Subject|4|||
105365532|NCT03462719|363343850|FG001|Overall Study|Withdrawal by Subject|3|||
105365533|NCT03462719|363343849|FG000|Overall Study|Ongoing|87|||
105365534|NCT03462719|363343850|FG001|Overall Study|Ongoing|72|||
105365535|NCT05547386|363343851|FG000|Overall Study|Withdrawal by Subject|7|||
105365536|NCT02287038|363343852|FG000|Overall Study|Stopped attending appointments|3|||
105365537|NCT02287038|363343853|FG001|Overall Study|Stopped attending appointments|2|||
105365538|NCT02287038|363343852|FG000|Overall Study|Anxiety after starting medication|0|||
105365539|NCT02287038|363343853|FG001|Overall Study|Anxiety after starting medication|1|||
105365540|NCT02287038|363343852|FG000|Overall Study|Nausea after starting medication|1|||
105824176|NCT03496623|365013150|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
105824177|NCT03496623|365013146|FG000|Period 1 (12 Weeks)|Death|0|||
105824178|NCT03496623|365013147|FG001|Period 1 (12 Weeks)|Death|3|||
105824179|NCT03496623|365013148|FG002|Period 1 (12 Weeks)|Death|0|||
105824180|NCT03496623|365013149|FG003|Period 1 (12 Weeks)|Death|0|||
105824181|NCT03496623|365013150|FG004|Period 1 (12 Weeks)|Death|0|||
105824182|NCT03496623|365013146|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
105824183|NCT03496623|365013147|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
105824184|NCT03496623|365013148|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
105365541|NCT02287038|363343853|FG001|Overall Study|Nausea after starting medication|0|||
105365542|NCT02287038|363343852|FG000|Overall Study|Abnormal ECG after starting medication|1|||
105365543|NCT02287038|363343853|FG001|Overall Study|Abnormal ECG after starting medication|0|||
105768431|NCT00441012|364802705|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
105768432|NCT00441012|364802706|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
105768433|NCT01976624|364802707|FG000|Overall Study|Participants contraindicated|2|||
105768434|NCT01976624|364802707|FG000|Overall Study|Participants age less than 19 years|12|||
105768435|NCT04350372|364802708|FG000|Overall Study|Death|1|||
105768436|NCT05116683|364802709|FG000|Overall Study|Physician Decision|4|||
105768437|NCT03782376|364802712|FG000|Overall Study|Lost to Follow-up|2|||
105768438|NCT03782376|364802713|FG001|Overall Study|Lost to Follow-up|2|||
105768439|NCT03782376|364802712|FG000|Overall Study|Withdrawal by Subject|7|||
105768440|NCT03782376|364802713|FG001|Overall Study|Withdrawal by Subject|11|||
105768441|NCT03782376|364802712|FG000|Overall Study|Death|1|||
105768442|NCT03782376|364802713|FG001|Overall Study|Death|0|||
105768443|NCT03782376|364802712|FG000|Overall Study|Other|16|||
105768444|NCT03782376|364802713|FG001|Overall Study|Other|17|||
105768445|NCT03559192|364802714|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
105768446|NCT03559192|364802715|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
105768447|NCT03559192|364802716|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
105768448|NCT03559192|364802714|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
105768449|NCT03559192|364802715|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
105768450|NCT03559192|364802716|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
105768451|NCT03559192|364802714|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
105768452|NCT03559192|364802715|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
105768453|NCT03559192|364802716|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
105768454|NCT03559192|364802714|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
105365544|NCT02283658|363343854|FG000|Overall Study|Withdrawal by Subject|1|||
105768455|NCT03559192|364802715|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
105824185|NCT03496623|365013149|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
105824186|NCT03496623|365013150|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
105824187|NCT03496623|365013146|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
105824188|NCT03496623|365013147|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
105824189|NCT03496623|365013148|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
105824190|NCT03496623|365013149|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
105824191|NCT03496623|365013150|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
105824192|NCT03496623|365013146|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
105824193|NCT03496623|365013147|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
105824194|NCT03496623|365013148|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
105824195|NCT03496623|365013149|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
105824196|NCT03496623|365013150|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
105824197|NCT03496623|365013146|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
105824198|NCT03496623|365013147|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
105824199|NCT03496623|365013148|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
105824200|NCT03496623|365013149|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
105824201|NCT03496623|365013150|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
105824202|NCT03496623|365013146|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
105824203|NCT03496623|365013147|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
105824204|NCT03496623|365013148|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
105824205|NCT03496623|365013149|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
105824206|NCT03496623|365013150|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
105824207|NCT03496623|365013146|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105824208|NCT03496623|365013147|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
105824209|NCT03496623|365013148|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
105824210|NCT03496623|365013149|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105824211|NCT03496623|365013150|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105824212|NCT01518972|365013151|FG000|Overall Study|Lost to Follow-up|2|||
105824213|NCT01518972|365013152|FG001|Overall Study|Lost to Follow-up|1|||
105824214|NCT01518972|365013151|FG000|Overall Study|Withdrawal by Subject|1|||
105824215|NCT01518972|365013152|FG001|Overall Study|Withdrawal by Subject|0|||
105824216|NCT01518972|365013151|FG000|Overall Study|Moved from area|1|||
105824217|NCT01518972|365013152|FG001|Overall Study|Moved from area|0|||
105824218|NCT01518972|365013151|FG000|Overall Study|Transportation problems|1|||
105824219|NCT01518972|365013152|FG001|Overall Study|Transportation problems|0|||
105824220|NCT01518972|365013151|FG000|Overall Study|Exclusionary medical condition|1|||
105824221|NCT01518972|365013152|FG001|Overall Study|Exclusionary medical condition|0|||
105824222|NCT01518972|365013151|FG000|Overall Study|Missed safety visits|0|||
105487211|NCT03533686|363794992|FG004|Overall Study|Withdrawal by Subject|5|||
105487212|NCT03533686|363794993|FG005|Overall Study|Withdrawal by Subject|1|||
105487213|NCT03533686|363794988|FG000|Overall Study|Lost to Follow-up|0|||
105487214|NCT03533686|363794989|FG001|Overall Study|Lost to Follow-up|1|||
105487215|NCT03533686|363794990|FG002|Overall Study|Lost to Follow-up|0|||
105487216|NCT03533686|363794991|FG003|Overall Study|Lost to Follow-up|0|||
105487217|NCT03533686|363794992|FG004|Overall Study|Lost to Follow-up|2|||
105487218|NCT03533686|363794993|FG005|Overall Study|Lost to Follow-up|0|||
105487219|NCT03533686|363794988|FG000|Overall Study|Screen Failure|0|||
105487220|NCT03533686|363794989|FG001|Overall Study|Screen Failure|0|||
105487221|NCT03533686|363794990|FG002|Overall Study|Screen Failure|0|||
105487222|NCT03533686|363794991|FG003|Overall Study|Screen Failure|2|||
105487223|NCT03533686|363794992|FG004|Overall Study|Screen Failure|0|||
105487224|NCT03533686|363794993|FG005|Overall Study|Screen Failure|0|||
105487225|NCT00327470|363794994|FG000|Overall Study|Randomized, but not treated|0|||
105487226|NCT00327470|363794995|FG001|Overall Study|Randomized, but not treated|2|||
105487227|NCT00327470|363794994|FG000|Overall Study|Adverse Event|9|||
105487228|NCT00327470|363794995|FG001|Overall Study|Adverse Event|14|||
105487229|NCT00327470|363794994|FG000|Overall Study|Lack of Efficacy|7|||
105487230|NCT00327470|363794995|FG001|Overall Study|Lack of Efficacy|19|||
105487231|NCT00327470|363794994|FG000|Overall Study|Other|5|||
105487232|NCT00327470|363794995|FG001|Overall Study|Other|9|||
105487233|NCT00327470|363794994|FG000|Overall Study|Lost to Follow-up|1|||
105824223|NCT01518972|365013152|FG001|Overall Study|Missed safety visits|1|||
105487234|NCT00327470|363794995|FG001|Overall Study|Lost to Follow-up|3|||
105487235|NCT00327470|363794994|FG000|Overall Study|Withdrawal by Subject|6|||
105487236|NCT00327470|363794995|FG001|Overall Study|Withdrawal by Subject|12|||
105487237|NCT00327470|363794994|FG000|Overall Study|Death|1|||
105487238|NCT00327470|363794995|FG001|Overall Study|Death|4|||
105487239|NCT01076075|363795000|FG000|Overall Study|Adverse Event|3|||
105824224|NCT01518972|365013151|FG000|Overall Study|Exclusionary medication|0|||
105824225|NCT01518972|365013152|FG001|Overall Study|Exclusionary medication|1|||
105824226|NCT01518972|365013151|FG000|Overall Study|Declined medication starting on day 12|0|||
105824227|NCT01518972|365013152|FG001|Overall Study|Declined medication starting on day 12|1|||
105824228|NCT02321098|365013154|FG000|12 Weeks Treament|Lost to Follow-up|1|||
105824229|NCT02321098|365013155|FG001|12 Weeks Treament|Lost to Follow-up|1|||
105487240|NCT01076075|363795001|FG001|Overall Study|Adverse Event|9|||
105487241|NCT01076075|363795000|FG000|Overall Study|Lack of Efficacy|5|||
105487242|NCT01076075|363795001|FG001|Overall Study|Lack of Efficacy|4|||
105487243|NCT01076075|363795000|FG000|Overall Study|Lost to Follow-up|6|||
105487244|NCT01076075|363795001|FG001|Overall Study|Lost to Follow-up|5|||
105487245|NCT01076075|363795000|FG000|Overall Study|other|19|||
105487246|NCT01076075|363795001|FG001|Overall Study|other|9|||
105487247|NCT01076075|363795000|FG000|Overall Study|Protocol Violation|0|||
105487248|NCT01076075|363795001|FG001|Overall Study|Protocol Violation|1|||
105487249|NCT01076075|363795000|FG000|Overall Study|Withdrawal by Subject|8|||
105487250|NCT01076075|363795001|FG001|Overall Study|Withdrawal by Subject|19|||
105487251|NCT01074047|363795006|FG000|Treatment Phase|Adverse Event|89|||
105487252|NCT01074047|363795007|FG001|Treatment Phase|Adverse Event|66|||
105487253|NCT01074047|363795006|FG000|Treatment Phase|Disease Progression|16|||
105487254|NCT01074047|363795007|FG001|Treatment Phase|Disease Progression|21|||
105487255|NCT01074047|363795006|FG000|Treatment Phase|Withdrawal by Subject|27|||
105487256|NCT01074047|363795007|FG001|Treatment Phase|Withdrawal by Subject|48|||
105487257|NCT01074047|363795006|FG000|Treatment Phase|Death|53|||
105487258|NCT01074047|363795007|FG001|Treatment Phase|Death|58|||
105487259|NCT01074047|363795006|FG000|Treatment Phase|Lost to Follow-up|0|||
105487260|NCT01074047|363795007|FG001|Treatment Phase|Lost to Follow-up|1|||
105487261|NCT01074047|363795006|FG000|Treatment Phase|Protocol Violation|0|||
105487262|NCT01074047|363795007|FG001|Treatment Phase|Protocol Violation|1|||
105487263|NCT01074047|363795006|FG000|Treatment Phase|Miscellaneous|32|||
105487264|NCT01074047|363795007|FG001|Treatment Phase|Miscellaneous|39|||
105487265|NCT01074047|363795006|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
105487266|NCT01074047|363795007|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
105487267|NCT01074047|363795006|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
105487268|NCT01074047|363795007|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
105487269|NCT01074047|363795006|FG000|Survival Follow-Up Phase|Death|116|||
105487270|NCT01074047|363795007|FG001|Survival Follow-Up Phase|Death|124|||
105487271|NCT01074047|363795006|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
105487272|NCT01074047|363795007|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
105487273|NCT01074047|363795006|FG000|Extension Phase|Physician Decision|1|||
105487274|NCT01074047|363795007|FG001|Extension Phase|Physician Decision|0|||
105487275|NCT01074047|363795006|FG000|Extension Phase|Adverse Event|5|||
105487276|NCT01074047|363795007|FG001|Extension Phase|Adverse Event|0|||
105487277|NCT01074047|363795006|FG000|Extension Phase|Disease Progression|9|||
105487278|NCT01074047|363795007|FG001|Extension Phase|Disease Progression|0|||
105487279|NCT01074047|363795006|FG000|Extension Phase|Withdrawal by Subject|2|||
105487280|NCT01074047|363795007|FG001|Extension Phase|Withdrawal by Subject|0|||
105487281|NCT01074047|363795006|FG000|Extension Phase|Death|5|||
105824230|NCT02321098|365013156|FG002|12 Weeks Treament|Lost to Follow-up|0|||
105824231|NCT02321098|365013154|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
105487282|NCT01074047|363795007|FG001|Extension Phase|Death|0|||
105487283|NCT04340063|363795008|FG000|Overall Study|Withdrawal by Subject|1|||
105487284|NCT04340063|363795009|FG001|Overall Study|Withdrawal by Subject|2|||
105487285|NCT04340063|363795008|FG000|Overall Study|Lost to Follow-up|3|||
105487286|NCT04340063|363795009|FG001|Overall Study|Lost to Follow-up|1|||
105487287|NCT04340063|363795008|FG000|Overall Study|Protocol Violation|0|||
105487288|NCT04340063|363795009|FG001|Overall Study|Protocol Violation|1|||
105824232|NCT02321098|365013155|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
105824233|NCT02321098|365013156|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
105824234|NCT02321098|365013154|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
105824235|NCT02321098|365013155|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
105824236|NCT02321098|365013156|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
105824237|NCT02321098|365013154|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
105824238|NCT02321098|365013155|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
105824239|NCT02321098|365013156|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
105824240|NCT01788423|365013157|FG000|Overall Study|See Comments in Completed (above)|0|||
105824241|NCT01788423|365013158|FG001|Overall Study|See Comments in Completed (above)|4|||
105824242|NCT01788423|365013159|FG002|Overall Study|See Comments in Completed (above)|5|||
105824243|NCT03190915|365013160|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
105824244|NCT03190915|365013160|FG000|Overall Study|Progressive Disease|3|||
105824245|NCT05211284|365013161|FG000|Overall Study|Study Terminated|3|||
105824246|NCT05211284|365013162|FG001|Overall Study|Study Terminated|1|||
105487289|NCT01857583|363795012|FG000|Overall Study|Adverse Event|0|||
105487290|NCT01857583|363795013|FG001|Overall Study|Adverse Event|0|||
105487291|NCT01857583|363795014|FG002|Overall Study|Adverse Event|1|||
105487292|NCT01857583|363795015|FG003|Overall Study|Adverse Event|1|||
105487293|NCT01857583|363795012|FG000|Overall Study|Death|0|||
105487294|NCT01857583|363795013|FG001|Overall Study|Death|1|||
105487295|NCT01857583|363795014|FG002|Overall Study|Death|1|||
105487296|NCT01857583|363795015|FG003|Overall Study|Death|0|||
105487297|NCT01857583|363795012|FG000|Overall Study|Physician Decision|0|||
105487298|NCT01857583|363795013|FG001|Overall Study|Physician Decision|0|||
105487299|NCT01857583|363795014|FG002|Overall Study|Physician Decision|0|||
105487300|NCT01857583|363795015|FG003|Overall Study|Physician Decision|1|||
105824247|NCT05630885|365013163|FG000|Study Completion|Took prohibited medications|2|||
105824248|NCT05630885|365013164|FG001|Study Completion|Took prohibited medications|0|||
105487301|NCT01857583|363795012|FG000|Overall Study|Withdrawal by Subject|1|||
105487302|NCT01857583|363795013|FG001|Overall Study|Withdrawal by Subject|0|||
105487303|NCT01857583|363795014|FG002|Overall Study|Withdrawal by Subject|1|||
105824249|NCT05630885|365013163|FG000|Study Completion|Non-compliance with study drug|1|||
105824250|NCT05630885|365013164|FG001|Study Completion|Non-compliance with study drug|0|||
105824251|NCT05630885|365013163|FG000|Study Completion|Adverse Event|1|||
105824252|NCT05630885|365013164|FG001|Study Completion|Adverse Event|0|||
105824253|NCT05630885|365013163|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
105824254|NCT05630885|365013164|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
105824255|NCT05630885|365013163|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
105824256|NCT05630885|365013164|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
105824257|NCT05921903|365013168|FG000|Overall Study|Unsolicited non-SAE|0|||
105824258|NCT05921903|365013169|FG001|Overall Study|Unsolicited non-SAE|1|||
105824259|NCT05921903|365013170|FG002|Overall Study|Unsolicited non-SAE|0|||
105824260|NCT05921903|365013168|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
105824261|NCT05921903|365013169|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
105824262|NCT05921903|365013170|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
105824263|NCT05921903|365013168|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
105824264|NCT05921903|365013169|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
105824265|NCT05921903|365013170|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
105824266|NCT06539676|365013171|FG000|Overall Study|Early study termination|1|||
105824267|NCT06539676|365013172|FG001|Overall Study|Early study termination|0|||
105824268|NCT06539676|365013173|FG002|Overall Study|Early study termination|6|||
105824269|NCT01825798|365013174|FG000|Overall Study|Adverse Event|1|||
105824270|NCT01825798|365013175|FG001|Overall Study|Adverse Event|5|||
105824271|NCT01825798|365013174|FG000|Overall Study|Lost to Follow-up|1|||
105824272|NCT01825798|365013175|FG001|Overall Study|Lost to Follow-up|0|||
105487304|NCT01857583|363795015|FG003|Overall Study|Withdrawal by Subject|2|||
105487305|NCT02211638|363795016|FG000|Overall Study|Case Report Forms Uncollected|291|||
105487306|NCT02211638|363795016|FG000|Overall Study|Protocol Violation|692|||
105487307|NCT02782923|363795017|FG000|Overall Study|Lost to Follow-up|15|||
105487308|NCT03287635|363795019|FG000|Overall Study|Lost to Follow-up|5|||
105824273|NCT01908205|365013176|FG000|Overall Study|Lost to Follow-up|2|||
105824274|NCT01908205|365013177|FG001|Overall Study|Lost to Follow-up|0|||
105824275|NCT01908205|365013176|FG000|Overall Study|Withdrawal by Subject|3|||
105824276|NCT01908205|365013177|FG001|Overall Study|Withdrawal by Subject|1|||
105824277|NCT05323396|365013182|FG000|Overall Study|Lost to Follow-up|1|||
105824278|NCT05323396|365013183|FG001|Overall Study|Lost to Follow-up|35|||
105824279|NCT05323396|365013182|FG000|Overall Study|Pregnancy|1|||
105824280|NCT05323396|365013183|FG001|Overall Study|Pregnancy|0|||
105824281|NCT02619682|365013184|FG000|Overall Study|Withdrawal by Subject|3|||
105824282|NCT02619682|365013184|FG000|Overall Study|Lack of Efficacy|8|||
105824283|NCT02619682|365013184|FG000|Overall Study|new secondary cancer|1|||
105824284|NCT02619682|365013184|FG000|Overall Study|post surgery complications|2|||
105824285|NCT01154231|365013188|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
105824286|NCT01154231|365013188|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
105824287|NCT02286739|365014428|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
105824288|NCT02286739|365014429|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
105824289|NCT02286739|365014428|FG000|Overall Study|No Verasense type documented|0|||
105824290|NCT02286739|365014429|FG001|Overall Study|No Verasense type documented|23|||
105824291|NCT02286739|365014428|FG000|Overall Study|Adverse Event|1|||
105824292|NCT02286739|365014429|FG001|Overall Study|Adverse Event|2|||
105824293|NCT02286739|365014428|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
105824294|NCT02286739|365014429|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
105824295|NCT03122535|365014434|FG000|Overall Study|Lost to Follow-up|68|||
105824296|NCT03122535|365014435|FG001|Overall Study|Lost to Follow-up|68|||
105824297|NCT03122535|365014434|FG000|Overall Study|Physician Decision|3|||
105824298|NCT03122535|365014435|FG001|Overall Study|Physician Decision|3|||
105824299|NCT03122535|365014434|FG000|Overall Study|Withdrawal by Subject|2|||
105824300|NCT03122535|365014435|FG001|Overall Study|Withdrawal by Subject|2|||
105824301|NCT01695239|365014443|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
105824302|NCT01695239|365014444|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
105824303|NCT01695239|365014445|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
105487309|NCT03287635|363795019|FG000|Overall Study|Withdrawal by Subject|1|||
105824304|NCT01695239|365014446|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
105824305|NCT01695239|365014447|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824306|NCT01695239|365014448|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824307|NCT01695239|365014449|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105487310|NCT03287635|363795019|FG000|Overall Study|Physician Decision|1|||
105487311|NCT00323869|363795022|FG000|Overall Study|Death|1|||
105487312|NCT02233946|363796967|FG000|Baseline|Withdrawal by Subject|2|||
105487313|NCT02233946|363796968|FG001|Baseline|Withdrawal by Subject|0|||
105487314|NCT02233946|363796967|FG000|3-months Follow-up|Lost to Follow-up|53|||
105487315|NCT02233946|363796968|FG001|3-months Follow-up|Lost to Follow-up|29|||
105824308|NCT01695239|365014450|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824309|NCT01695239|365014451|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824310|NCT01695239|365014452|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824311|NCT01695239|365014453|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824312|NCT01695239|365014454|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824313|NCT01695239|365014455|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824314|NCT01695239|365014456|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824315|NCT01695239|365014443|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
105824316|NCT01695239|365014444|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
105824317|NCT01695239|365014445|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
105824318|NCT01695239|365014446|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
105824319|NCT01695239|365014447|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824320|NCT01695239|365014448|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824321|NCT01695239|365014449|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824322|NCT01695239|365014450|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824323|NCT01695239|365014451|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824324|NCT01695239|365014452|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824325|NCT01695239|365014453|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824326|NCT01695239|365014454|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824327|NCT01695239|365014455|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824328|NCT01695239|365014456|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824329|NCT01695239|365014443|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
105824330|NCT01695239|365014444|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824331|NCT01695239|365014445|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
105824332|NCT01695239|365014446|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824333|NCT01695239|365014447|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824334|NCT01695239|365014448|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824335|NCT01695239|365014449|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824336|NCT01695239|365014450|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824337|NCT01695239|365014451|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824338|NCT01695239|365014452|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824339|NCT01695239|365014453|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824340|NCT01695239|365014454|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824341|NCT01695239|365014455|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824342|NCT01695239|365014456|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824343|NCT01695239|365014443|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
105824344|NCT01695239|365014444|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
105824345|NCT01695239|365014445|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
105824346|NCT01695239|365014446|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824347|NCT01695239|365014447|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824348|NCT01695239|365014448|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824349|NCT01695239|365014449|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824350|NCT01695239|365014450|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824351|NCT01695239|365014451|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824352|NCT01695239|365014452|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824353|NCT01695239|365014453|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824354|NCT01695239|365014454|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824355|NCT01695239|365014455|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824356|NCT01695239|365014456|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824357|NCT01695239|365014443|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
105824358|NCT01695239|365014444|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824359|NCT01695239|365014445|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
105824360|NCT01695239|365014446|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824361|NCT01695239|365014447|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824362|NCT01695239|365014448|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824363|NCT01695239|365014449|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824364|NCT01695239|365014450|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105487316|NCT02233946|363796967|FG000|6-months Follow-up|Lost to Follow-up|21|||
105487317|NCT02233946|363796968|FG001|6-months Follow-up|Lost to Follow-up|2|||
105824365|NCT01695239|365014451|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824366|NCT01695239|365014452|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824367|NCT01695239|365014453|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824368|NCT01695239|365014454|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824369|NCT01695239|365014455|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824370|NCT01695239|365014456|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824371|NCT01695239|365014443|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
105824372|NCT01695239|365014444|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824373|NCT01695239|365014445|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
105824374|NCT01695239|365014446|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824375|NCT01695239|365014447|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824376|NCT01695239|365014448|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824377|NCT01695239|365014449|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824378|NCT01695239|365014450|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824379|NCT01695239|365014451|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824380|NCT01695239|365014452|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824381|NCT01695239|365014453|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824382|NCT01695239|365014454|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824383|NCT01695239|365014455|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824384|NCT01695239|365014456|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824385|NCT01695239|365014443|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
105824386|NCT01695239|365014444|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824387|NCT01695239|365014445|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824388|NCT01695239|365014446|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824389|NCT01695239|365014447|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824390|NCT01695239|365014448|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824391|NCT01695239|365014449|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824392|NCT01695239|365014450|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824393|NCT01695239|365014451|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824394|NCT01695239|365014452|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824395|NCT01695239|365014453|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824396|NCT01695239|365014454|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824397|NCT01695239|365014455|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824398|NCT01695239|365014456|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824399|NCT01695239|365014443|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824400|NCT01695239|365014444|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824401|NCT01695239|365014445|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824402|NCT01695239|365014446|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824403|NCT01695239|365014447|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824404|NCT01695239|365014448|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824405|NCT01695239|365014449|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824406|NCT01695239|365014450|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
105824407|NCT01695239|365014451|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824408|NCT01695239|365014452|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824409|NCT01695239|365014453|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824410|NCT01695239|365014454|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824411|NCT01695239|365014455|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824412|NCT01695239|365014456|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824413|NCT01695239|365014443|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824414|NCT01695239|365014444|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824415|NCT01695239|365014445|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824416|NCT01695239|365014446|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824417|NCT01695239|365014447|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824418|NCT01695239|365014448|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105365545|NCT03311945|363343855|FG000|Overall Study|Adverse Event|2|||
105824419|NCT01695239|365014449|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824420|NCT01695239|365014450|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
105824421|NCT01695239|365014451|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824422|NCT01695239|365014452|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824423|NCT01695239|365014453|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824424|NCT01695239|365014454|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824425|NCT01695239|365014455|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824426|NCT01695239|365014456|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824427|NCT01695239|365014443|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824428|NCT01695239|365014444|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824429|NCT01695239|365014445|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824430|NCT01695239|365014446|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824431|NCT01695239|365014447|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824432|NCT01695239|365014448|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824433|NCT01695239|365014449|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824434|NCT01695239|365014450|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
105824435|NCT01695239|365014451|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824436|NCT01695239|365014452|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824437|NCT01695239|365014453|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824438|NCT01695239|365014454|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824439|NCT01695239|365014455|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824440|NCT01695239|365014456|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824441|NCT01695239|365014443|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824442|NCT01695239|365014444|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824443|NCT01695239|365014445|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824444|NCT01695239|365014446|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824445|NCT01695239|365014447|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824446|NCT01695239|365014448|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824447|NCT01695239|365014449|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824448|NCT01695239|365014450|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824449|NCT01695239|365014451|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
105824450|NCT01695239|365014452|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
105824451|NCT01695239|365014453|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824452|NCT01695239|365014454|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824453|NCT01695239|365014455|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824454|NCT01695239|365014456|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824455|NCT01695239|365014443|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
105824456|NCT01695239|365014444|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
105824457|NCT01695239|365014445|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
105824458|NCT01695239|365014446|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
105824459|NCT01695239|365014447|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
105824460|NCT01695239|365014448|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
105824461|NCT01695239|365014449|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
105824462|NCT01695239|365014450|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
105824463|NCT01695239|365014451|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
105824464|NCT01695239|365014452|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
105824465|NCT01695239|365014453|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
105824466|NCT01695239|365014454|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
105824467|NCT01695239|365014455|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
105824468|NCT01695239|365014456|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
105824469|NCT01695239|365014443|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824470|NCT01695239|365014444|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824471|NCT01695239|365014445|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824472|NCT01695239|365014446|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824473|NCT01695239|365014447|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824474|NCT01695239|365014448|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824475|NCT01695239|365014449|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824476|NCT01695239|365014450|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824477|NCT01695239|365014451|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
105824478|NCT01695239|365014452|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
105824479|NCT01695239|365014453|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824480|NCT01695239|365014454|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824481|NCT01695239|365014455|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824482|NCT01695239|365014456|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824483|NCT01695239|365014443|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
105824484|NCT01695239|365014444|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
105824485|NCT01695239|365014445|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
105824486|NCT01695239|365014446|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
105824487|NCT01695239|365014447|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
105824488|NCT01695239|365014448|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
105824489|NCT01695239|365014449|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
105824490|NCT01695239|365014450|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
105824491|NCT01695239|365014451|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
105824492|NCT01695239|365014452|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
105824493|NCT01695239|365014453|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
105824494|NCT01695239|365014454|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
105824495|NCT01695239|365014455|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
105824496|NCT01695239|365014456|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
105824497|NCT01695239|365014443|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824498|NCT01695239|365014444|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824499|NCT01695239|365014445|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824500|NCT01695239|365014446|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824501|NCT01695239|365014447|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824502|NCT01695239|365014448|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824503|NCT01695239|365014449|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824504|NCT01695239|365014450|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824505|NCT01695239|365014451|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
105824506|NCT01695239|365014452|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
105824507|NCT01695239|365014453|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824508|NCT01695239|365014454|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824509|NCT01695239|365014455|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105487318|NCT02233946|363796967|FG000|9-month Follow-up|Lost to Follow-up|20|||
105487319|NCT02233946|363796968|FG001|9-month Follow-up|Lost to Follow-up|11|||
105487320|NCT02233946|363796967|FG000|12-month Follow-up|Lost to Follow-up|28|||
105824510|NCT01695239|365014456|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824511|NCT01695239|365014443|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824512|NCT01695239|365014444|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824513|NCT01695239|365014445|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824514|NCT01695239|365014446|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824515|NCT01695239|365014447|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824516|NCT01695239|365014448|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824517|NCT01695239|365014449|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824518|NCT01695239|365014450|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824519|NCT01695239|365014451|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
105824520|NCT01695239|365014452|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
105824521|NCT01695239|365014453|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824522|NCT01695239|365014454|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824523|NCT01695239|365014455|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824524|NCT01695239|365014456|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824525|NCT01695239|365014443|FG000|Extension Long-Term Extension Periods|Death|0|||
105824526|NCT01695239|365014444|FG001|Extension Long-Term Extension Periods|Death|0|||
105824527|NCT01695239|365014445|FG002|Extension Long-Term Extension Periods|Death|0|||
105824528|NCT01695239|365014446|FG003|Extension Long-Term Extension Periods|Death|0|||
105824529|NCT01695239|365014447|FG004|Extension Long-Term Extension Periods|Death|0|||
105824530|NCT01695239|365014448|FG005|Extension Long-Term Extension Periods|Death|0|||
105824531|NCT01695239|365014449|FG006|Extension Long-Term Extension Periods|Death|0|||
105824532|NCT01695239|365014450|FG007|Extension Long-Term Extension Periods|Death|0|||
105824533|NCT01695239|365014451|FG008|Extension Long-Term Extension Periods|Death|1|||
105824534|NCT01695239|365014452|FG009|Extension Long-Term Extension Periods|Death|0|||
105824535|NCT01695239|365014453|FG010|Extension Long-Term Extension Periods|Death|0|||
105824536|NCT01695239|365014454|FG011|Extension Long-Term Extension Periods|Death|0|||
105824537|NCT01695239|365014455|FG012|Extension Long-Term Extension Periods|Death|0|||
105824538|NCT01695239|365014456|FG013|Extension Long-Term Extension Periods|Death|0|||
105824539|NCT01695239|365014443|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824540|NCT01695239|365014444|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824541|NCT01695239|365014445|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824542|NCT01695239|365014446|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824543|NCT01695239|365014447|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824544|NCT01695239|365014448|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824545|NCT01695239|365014449|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824546|NCT01695239|365014450|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824547|NCT01695239|365014451|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824548|NCT01695239|365014452|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824549|NCT01695239|365014453|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824550|NCT01695239|365014454|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
105824551|NCT01695239|365014455|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
105824552|NCT01695239|365014456|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
105824553|NCT01695239|365014443|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824554|NCT01695239|365014444|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824555|NCT01695239|365014445|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824556|NCT01695239|365014446|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824557|NCT01695239|365014447|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824558|NCT01695239|365014448|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824559|NCT01695239|365014449|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824560|NCT01695239|365014450|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824561|NCT01695239|365014451|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824562|NCT01695239|365014452|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824563|NCT01695239|365014453|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824564|NCT01695239|365014454|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824565|NCT01695239|365014455|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
105824566|NCT01695239|365014456|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
105824567|NCT01695239|365014443|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824568|NCT01695239|365014444|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824569|NCT01695239|365014445|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824570|NCT01695239|365014446|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824571|NCT01695239|365014447|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824572|NCT01695239|365014448|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824573|NCT01695239|365014449|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824574|NCT01695239|365014450|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824575|NCT01695239|365014451|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824576|NCT01695239|365014452|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824577|NCT01695239|365014453|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824578|NCT01695239|365014454|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824579|NCT01695239|365014455|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
105824580|NCT01695239|365014456|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824581|NCT01695239|365014443|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824582|NCT01695239|365014444|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824583|NCT01695239|365014445|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824584|NCT01695239|365014446|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824585|NCT01695239|365014447|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824586|NCT01695239|365014448|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824587|NCT01695239|365014449|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824588|NCT01695239|365014450|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824589|NCT01695239|365014451|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824590|NCT01695239|365014452|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824591|NCT01695239|365014453|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824592|NCT01695239|365014454|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824593|NCT01695239|365014455|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824594|NCT01695239|365014456|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
105824595|NCT04994535|365014458|FG000|Overall Study|Lost to Follow-up|7|||
105824596|NCT04994535|365014459|FG001|Overall Study|Lost to Follow-up|7|||
105824597|NCT04994535|365014458|FG000|Overall Study|Withdrawal by Subject|10|||
105824598|NCT04994535|365014459|FG001|Overall Study|Withdrawal by Subject|7|||
105824599|NCT04994535|365014458|FG000|Overall Study|Other|1|||
105824600|NCT04994535|365014459|FG001|Overall Study|Other|1|||
105824601|NCT00604162|365014462|FG000|Overall Study|Physician Decision|3|||
105824602|NCT00604162|365014462|FG000|Overall Study|Withdrawal by Subject|1|||
105824603|NCT02682238|365014464|FG000|Overall Study|Lost to Follow-up|0|||
105824604|NCT02682238|365014465|FG001|Overall Study|Lost to Follow-up|2|||
105824605|NCT02682238|365014464|FG000|Overall Study|Withdrawal by Subject|1|||
105824606|NCT02682238|365014465|FG001|Overall Study|Withdrawal by Subject|0|||
105824607|NCT02682238|365014464|FG000|Overall Study|Adverse Event|1|||
105824608|NCT02682238|365014465|FG001|Overall Study|Adverse Event|0|||
105824609|NCT02682238|365014464|FG000|Overall Study|Non-compliance with Study Drug|1|||
105824610|NCT02682238|365014465|FG001|Overall Study|Non-compliance with Study Drug|0|||
105824611|NCT02682238|365014464|FG000|Overall Study|Non-compliance with Protocol|0|||
105824612|NCT02682238|365014465|FG001|Overall Study|Non-compliance with Protocol|2|||
105824613|NCT00003659|365014470|FG000|Overall Study|Withdrawal by Subject|3|||
105824614|NCT00835263|365014471|FG000|Second Intervention|Adverse Event|1|||
105824615|NCT00835263|365014472|FG001|Second Intervention|Adverse Event|0|||
105824616|NCT01913405|365014473|FG000|Overall Study|Withdrawal by Subject|1|||
105824617|NCT01913405|365014473|FG000|Overall Study|Adverse Event|1|||
105824618|NCT00466167|365014474|FG000|Overall Study|Adverse Event|8|||
105824619|NCT00466167|365014475|FG001|Overall Study|Adverse Event|8|||
105824620|NCT00466167|365014476|FG002|Overall Study|Adverse Event|7|||
105824621|NCT00466167|365014474|FG000|Overall Study|Lack of Efficacy|2|||
105824622|NCT00466167|365014475|FG001|Overall Study|Lack of Efficacy|0|||
105824623|NCT00466167|365014476|FG002|Overall Study|Lack of Efficacy|3|||
105824624|NCT00466167|365014474|FG000|Overall Study|Protocol Violation|1|||
105824625|NCT00466167|365014475|FG001|Overall Study|Protocol Violation|1|||
105824626|NCT00466167|365014476|FG002|Overall Study|Protocol Violation|2|||
105824627|NCT00466167|365014474|FG000|Overall Study|Lost to Follow-up|3|||
105824628|NCT00466167|365014475|FG001|Overall Study|Lost to Follow-up|2|||
105824629|NCT00466167|365014476|FG002|Overall Study|Lost to Follow-up|2|||
105824630|NCT00466167|365014474|FG000|Overall Study|Withdrawal by Subject|4|||
105824631|NCT00466167|365014475|FG001|Overall Study|Withdrawal by Subject|1|||
105824632|NCT00466167|365014476|FG002|Overall Study|Withdrawal by Subject|6|||
105824633|NCT00466167|365014474|FG000|Overall Study|patient did not meet inclusion criteria|1|||
105824634|NCT00466167|365014475|FG001|Overall Study|patient did not meet inclusion criteria|0|||
105824635|NCT00466167|365014476|FG002|Overall Study|patient did not meet inclusion criteria|1|||
105824636|NCT00466167|365014474|FG000|Overall Study|Not treated|1|||
105824637|NCT00466167|365014475|FG001|Overall Study|Not treated|0|||
105824638|NCT00466167|365014476|FG002|Overall Study|Not treated|0|||
105824639|NCT01535222|365014477|FG000|Overall Study|Inclusion/exclusion|0|||
105824640|NCT01535222|365014478|FG001|Overall Study|Inclusion/exclusion|0|||
105824641|NCT01535222|365014479|FG002|Overall Study|Inclusion/exclusion|1|||
105824642|NCT01535222|365014480|FG003|Overall Study|Inclusion/exclusion|0|||
105824643|NCT01535222|365014481|FG004|Overall Study|Inclusion/exclusion|0|||
105824644|NCT01535222|365014482|FG005|Overall Study|Inclusion/exclusion|0|||
105824645|NCT00935012|365014483|FG000|Overall Study|Death|19|||
105824646|NCT00935012|365014483|FG000|Overall Study|Withdrawal by Subject|3|||
105824647|NCT00935012|365014483|FG000|Overall Study|Other|5|||
105824648|NCT00935012|365014483|FG000|Overall Study|Adverse Event|2|||
105824649|NCT01442155|365014484|FG000|Overall Study|Complete remission|35|||
105824650|NCT01442155|365014484|FG000|Overall Study|Recurrence|26|||
105824651|NCT01442155|365014484|FG000|Overall Study|Adverse Event|2|||
105824652|NCT01442155|365014484|FG000|Overall Study|Lost to Follow-up|2|||
105824653|NCT03366792|365014491|FG000|Overall Study|Withdrawal by Subject|7|||
105824654|NCT03366792|365014491|FG000|Overall Study|Lost to Follow-up|2|||
105824655|NCT03366792|365014491|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
105824656|NCT03366792|365014491|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
105824657|NCT05308290|365014493|FG000|Overall Study|Death|1|||
105824658|NCT05308290|365014494|FG001|Overall Study|Death|0|||
105824659|NCT05308290|365014493|FG000|Overall Study|Lost to Follow-up|2|||
105824660|NCT05308290|365014494|FG001|Overall Study|Lost to Follow-up|1|||
105824661|NCT05308290|365014493|FG000|Overall Study|still in study followup|0|||
105824662|NCT05308290|365014494|FG001|Overall Study|still in study followup|1|||
105824663|NCT01370733|365014495|FG000|Overall Study|Withdrawal by Subject|8|||
105824664|NCT01370733|365014496|FG001|Overall Study|Withdrawal by Subject|8|||
105824665|NCT01370733|365014495|FG000|Overall Study|Lost to Follow-up|3|||
105487321|NCT02233946|363796968|FG001|12-month Follow-up|Lost to Follow-up|11|||
105487322|NCT01314911|363796972|FG000|Overall Study|Lost to Follow-up|3|||
105824666|NCT01370733|365014496|FG001|Overall Study|Lost to Follow-up|0|||
105824667|NCT01370733|365014495|FG000|Overall Study|Adverse Event|2|||
105824668|NCT01370733|365014496|FG001|Overall Study|Adverse Event|4|||
105824669|NCT01370733|365014495|FG000|Overall Study|Lack of Efficacy|3|||
105824670|NCT01370733|365014496|FG001|Overall Study|Lack of Efficacy|5|||
105824671|NCT01370733|365014495|FG000|Overall Study|Physician Decision|0|||
105824672|NCT01370733|365014496|FG001|Overall Study|Physician Decision|2|||
105824673|NCT01370733|365014495|FG000|Overall Study|Protocol Violation|1|||
105824674|NCT01370733|365014496|FG001|Overall Study|Protocol Violation|3|||
105824675|NCT01237054|365014497|FG000|Overall Study|imaging 10C0096|1|||
105824676|NCT01983969|365014498|FG000|Overall Study|Disease Progression|0|||
105824677|NCT01983969|365014499|FG001|Overall Study|Disease Progression|1|||
105824678|NCT01983969|365014500|FG002|Overall Study|Disease Progression|0|||
105824679|NCT00436163|365014503|FG000|Overall Study|Lost to Follow-up|2|||
105824680|NCT00436163|365014503|FG000|Overall Study|Adverse Event|1|||
105824681|NCT06647173|365014509|FG000|Overall Study|Lost to Follow-up|24|||
105824682|NCT02286089|365014511|FG000|Overall Study|Ongoing in Study|1|||
105824683|NCT02286089|365014512|FG001|Overall Study|Ongoing in Study|1|||
105824684|NCT02286089|365014513|FG002|Overall Study|Ongoing in Study|4|||
105824685|NCT02286089|365014514|FG003|Overall Study|Ongoing in Study|10|||
105824686|NCT02286089|365014511|FG000|Overall Study|Withdrawal by Subject|0|||
105768456|NCT03559192|364802716|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
105768457|NCT03559192|364802714|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
105768458|NCT03559192|364802715|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
105824687|NCT02286089|365014512|FG001|Overall Study|Withdrawal by Subject|0|||
105824688|NCT02286089|365014513|FG002|Overall Study|Withdrawal by Subject|2|||
105824689|NCT02286089|365014514|FG003|Overall Study|Withdrawal by Subject|2|||
105824690|NCT01248728|365014515|FG000|Overall Study|Adverse Event|1|||
105824691|NCT01248728|365014516|FG001|Overall Study|Adverse Event|1|||
105824692|NCT01248728|365014515|FG000|Overall Study|Withdrawal by Subject|2|||
105824693|NCT01248728|365014516|FG001|Overall Study|Withdrawal by Subject|1|||
105824694|NCT01248728|365014515|FG000|Overall Study|Lack of Efficacy|1|||
105824695|NCT01248728|365014516|FG001|Overall Study|Lack of Efficacy|0|||
105824696|NCT03100344|365014517|FG000|Overall Study|Adverse Event|0|||
105824697|NCT03100344|365014518|FG001|Overall Study|Adverse Event|3|||
105824698|NCT03100344|365014519|FG002|Overall Study|Adverse Event|2|||
105824699|NCT03100344|365014520|FG003|Overall Study|Adverse Event|3|||
105824700|NCT03100344|365014517|FG000|Overall Study|Lack of Efficacy|2|||
105824701|NCT03100344|365014518|FG001|Overall Study|Lack of Efficacy|0|||
105824702|NCT03100344|365014519|FG002|Overall Study|Lack of Efficacy|0|||
105824703|NCT03100344|365014520|FG003|Overall Study|Lack of Efficacy|0|||
105824704|NCT03100344|365014517|FG000|Overall Study|Protocol Violation|1|||
105824705|NCT03100344|365014518|FG001|Overall Study|Protocol Violation|0|||
105824706|NCT03100344|365014519|FG002|Overall Study|Protocol Violation|0|||
105824707|NCT03100344|365014520|FG003|Overall Study|Protocol Violation|0|||
105824708|NCT03100344|365014517|FG000|Overall Study|Withdrawal by Subject|10|||
105824709|NCT03100344|365014518|FG001|Overall Study|Withdrawal by Subject|7|||
105824710|NCT03100344|365014519|FG002|Overall Study|Withdrawal by Subject|4|||
105824711|NCT03100344|365014520|FG003|Overall Study|Withdrawal by Subject|8|||
105824712|NCT03100344|365014517|FG000|Overall Study|Lost to Follow-up|1|||
105824713|NCT03100344|365014518|FG001|Overall Study|Lost to Follow-up|1|||
105824714|NCT03100344|365014519|FG002|Overall Study|Lost to Follow-up|1|||
105824715|NCT03100344|365014520|FG003|Overall Study|Lost to Follow-up|1|||
105824716|NCT03114891|365014521|FG000|First Treatment Round|Lost to Follow-up|0|||
105824717|NCT03114891|365014522|FG001|First Treatment Round|Lost to Follow-up|1|||
105824718|NCT03114891|365014523|FG002|First Treatment Round|Lost to Follow-up|1|||
105824719|NCT03114891|365014524|FG003|First Treatment Round|Lost to Follow-up|0|||
105824720|NCT03114891|365014521|FG000|First Treatment Round|Withdrawal by Subject|0|||
105768459|NCT03559192|364802716|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
105768460|NCT03559192|364802714|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
105768461|NCT03559192|364802715|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
105768462|NCT03559192|364802716|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
105768463|NCT03559192|364802714|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
105768464|NCT03559192|364802715|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
105768465|NCT03559192|364802716|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
105768466|NCT03559192|364802714|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
105768467|NCT03559192|364802715|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
105768468|NCT03559192|364802716|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
105768469|NCT03559192|364802714|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
105768470|NCT03559192|364802715|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
105768471|NCT03559192|364802716|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
105768472|NCT02422186|364802717|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
105768473|NCT02422186|364802718|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
105768474|NCT02422186|364802717|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
105768475|NCT02422186|364802718|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
105768476|NCT02422186|364802717|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
105768477|NCT02422186|364802718|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
105768478|NCT02422186|364802717|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
105768479|NCT02422186|364802718|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
105768480|NCT02422186|364802717|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
105768481|NCT02422186|364802718|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
105768482|NCT02422186|364802717|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
105768483|NCT02422186|364802718|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
105365546|NCT03311945|363343855|FG000|Overall Study|Lack of Efficacy|1|||
105365547|NCT00492726|363343856|FG000|Overall Study|Adverse Event|10|||
105365548|NCT00492726|363343857|FG001|Overall Study|Adverse Event|6|||
105365549|NCT00492726|363343856|FG000|Overall Study|Death|7|||
105768484|NCT02422186|364802717|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
105768485|NCT02422186|364802718|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
105768486|NCT02422186|364802717|FG000|Follow-up Phase (2 Weeks)|Other|3|||
105768487|NCT02422186|364802718|FG001|Follow-up Phase (2 Weeks)|Other|0|||
105768488|NCT01627782|364802723|FG000|Overall Study|Adverse Event|1|||
105768489|NCT01627782|364802724|FG001|Overall Study|Adverse Event|2|||
105768490|NCT01627782|364802725|FG002|Overall Study|Adverse Event|0|||
105768491|NCT01627782|364802726|FG003|Overall Study|Adverse Event|1|||
105768492|NCT01627782|364802723|FG000|Overall Study|Lack of Efficacy|11|||
105768493|NCT01627782|364802724|FG001|Overall Study|Lack of Efficacy|1|||
105768494|NCT01627782|364802725|FG002|Overall Study|Lack of Efficacy|15|||
105768495|NCT01627782|364802726|FG003|Overall Study|Lack of Efficacy|2|||
105768496|NCT01627782|364802723|FG000|Overall Study|Protocol Violation|1|||
105768497|NCT01627782|364802724|FG001|Overall Study|Protocol Violation|0|||
105768498|NCT01627782|364802725|FG002|Overall Study|Protocol Violation|0|||
105768499|NCT01627782|364802726|FG003|Overall Study|Protocol Violation|0|||
105768500|NCT01627782|364802723|FG000|Overall Study|Withdrawal by Subject|2|||
105768501|NCT01627782|364802724|FG001|Overall Study|Withdrawal by Subject|1|||
105768502|NCT01627782|364802725|FG002|Overall Study|Withdrawal by Subject|0|||
105768503|NCT01627782|364802726|FG003|Overall Study|Withdrawal by Subject|0|||
105768504|NCT01627782|364802723|FG000|Overall Study|Other|0|||
105768505|NCT01627782|364802724|FG001|Overall Study|Other|2|||
105768506|NCT01627782|364802725|FG002|Overall Study|Other|0|||
105768507|NCT01627782|364802726|FG003|Overall Study|Other|3|||
105768508|NCT01627782|364802723|FG000|Overall Study|Randomized But Not Treated|1|||
105768509|NCT01627782|364802724|FG001|Overall Study|Randomized But Not Treated|0|||
105768510|NCT01627782|364802725|FG002|Overall Study|Randomized But Not Treated|0|||
105768511|NCT01627782|364802726|FG003|Overall Study|Randomized But Not Treated|0|||
105768512|NCT03573401|364802727|FG000|Overall Study|Withdrawal by Subject|2|||
105768513|NCT03573401|364802728|FG001|Overall Study|Withdrawal by Subject|0|||
105768514|NCT03573401|364802727|FG000|Overall Study|Subject non-compliance with study schedule|1|||
105768515|NCT03573401|364802728|FG001|Overall Study|Subject non-compliance with study schedule|0|||
105768516|NCT03573401|364802727|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
105768517|NCT03573401|364802728|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
105768518|NCT03573401|364802727|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
105768519|NCT03573401|364802728|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
105768520|NCT05516134|364804424|FG000|Overall Study|Lost to Follow-up|1|||
105768521|NCT05516134|364804425|FG001|Overall Study|Lost to Follow-up|0|||
105768522|NCT05516134|364804426|FG002|Overall Study|Lost to Follow-up|0|||
105768523|NCT01408732|364804427|FG000|Overall Study|Withdrawal by Subject|2|||
105768524|NCT01408732|364804428|FG001|Overall Study|Withdrawal by Subject|2|||
105768525|NCT03377452|364804429|FG000|Overall Study|Refused assessment|0|||
105768526|NCT03377452|364804430|FG001|Overall Study|Refused assessment|2|||
105768527|NCT03377452|364804429|FG000|Overall Study|Lost to Follow-up|5|||
105768528|NCT03377452|364804430|FG001|Overall Study|Lost to Follow-up|4|||
105768529|NCT02040857|364804432|FG000|Overall Study|Adverse Event|14|||
105768530|NCT02040857|364804432|FG000|Overall Study|Physician Decision|5|||
105768531|NCT02040857|364804432|FG000|Overall Study|Withdrawal by Subject|31|||
105768532|NCT02040857|364804432|FG000|Overall Study|patient non-compliance|3|||
105768533|NCT02040857|364804432|FG000|Overall Study|Lost to Follow-up|2|||
105768534|NCT02040857|364804432|FG000|Overall Study|recurrence|4|||
105768535|NCT02040857|364804432|FG000|Overall Study|ineligible|1|||
105768536|NCT03146403|364804440|FG000|Overall Study|Withdrawal by Subject|0|||
105768537|NCT03146403|364804441|FG001|Overall Study|Withdrawal by Subject|3|||
105768538|NCT03146403|364804440|FG000|Overall Study|Lost to Follow-up|2|||
105768539|NCT03146403|364804441|FG001|Overall Study|Lost to Follow-up|0|||
105768540|NCT01024920|364804445|FG000|Overall Study|Progressive disease|47|||
105768541|NCT01024920|364804446|FG001|Overall Study|Progressive disease|25|||
105768542|NCT01024920|364804445|FG000|Overall Study|Adverse Event|8|||
105768543|NCT01024920|364804446|FG001|Overall Study|Adverse Event|4|||
105768544|NCT01024920|364804445|FG000|Overall Study|Lost to Follow-up|0|||
105768545|NCT01024920|364804446|FG001|Overall Study|Lost to Follow-up|1|||
105768546|NCT01024920|364804445|FG000|Overall Study|Patient refusal to continue|4|||
105768547|NCT01024920|364804446|FG001|Overall Study|Patient refusal to continue|0|||
105768548|NCT01024920|364804445|FG000|Overall Study|Other than listed|5|||
105768549|NCT01024920|364804446|FG001|Overall Study|Other than listed|1|||
105768550|NCT01024920|364804445|FG000|Overall Study|Not treated|3|||
105768551|NCT01024920|364804446|FG001|Overall Study|Not treated|0|||
105768552|NCT01024920|364804445|FG000|Overall Study|Protocol Violation|0|||
105768553|NCT01024920|364804446|FG001|Overall Study|Protocol Violation|1|||
105768554|NCT02977507|364804448|FG000|Overall Study|Protocol Deviation|1|||
105768555|NCT02977507|364804449|FG001|Overall Study|Protocol Deviation|0|||
105768556|NCT02977507|364804448|FG000|Overall Study|Lost to Follow-up|1|||
105365550|NCT00492726|363343857|FG001|Overall Study|Death|2|||
105487323|NCT01314911|363796973|FG001|Overall Study|Lost to Follow-up|2|||
105487324|NCT01314911|363796972|FG000|Overall Study|Withdrawal by Subject|1|||
105487325|NCT01314911|363796973|FG001|Overall Study|Withdrawal by Subject|3|||
105487326|NCT01314911|363796972|FG000|Overall Study|Received Non-randomized Study Drug|0|||
105487327|NCT01314911|363796973|FG001|Overall Study|Received Non-randomized Study Drug|1|||
105487328|NCT01314911|363796972|FG000|Overall Study|Never Started Treatment|1|||
105487329|NCT01314911|363796973|FG001|Overall Study|Never Started Treatment|0|||
105487330|NCT03384693|363796977|FG000|Overall Study|Adverse Event|3|||
105487331|NCT03387150|363796978|FG000|Overall Study|Withdrawal by Subject|3|||
105487332|NCT03387150|363796979|FG001|Overall Study|Withdrawal by Subject|0|||
105487333|NCT03387150|363796980|FG002|Overall Study|Withdrawal by Subject|3|||
105487334|NCT03387150|363796981|FG003|Overall Study|Withdrawal by Subject|4|||
105487335|NCT03387150|363796982|FG004|Overall Study|Withdrawal by Subject|1|||
105768557|NCT02977507|364804449|FG001|Overall Study|Lost to Follow-up|0|||
105768558|NCT01098032|364804450|FG000|Overall Study|Withdrawal by Subject|1|||
105768559|NCT01098032|364804451|FG001|Overall Study|Withdrawal by Subject|1|||
105768560|NCT00481988|364804452|FG000|Overall Study|Withdrawal by Subject|1|||
105768561|NCT00481988|364804453|FG001|Overall Study|Withdrawal by Subject|1|||
105768562|NCT00654420|364804455|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
105768563|NCT00654420|364804456|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
105768564|NCT00654420|364804457|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
105768565|NCT00654420|364804458|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
105768566|NCT00654420|364804455|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
105768567|NCT00654420|364804456|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
105768568|NCT00654420|364804457|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
105768569|NCT00654420|364804458|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
105768570|NCT00654420|364804455|FG000|Phase II|Adverse Event|0|||
105768571|NCT00654420|364804456|FG001|Phase II|Adverse Event|0|||
105768572|NCT00654420|364804457|FG002|Phase II|Adverse Event|3|||
105768573|NCT00654420|364804458|FG003|Phase II|Adverse Event|3|||
105768574|NCT00654420|364804455|FG000|Phase II|Lost to Follow-up|0|||
105768575|NCT00654420|364804456|FG001|Phase II|Lost to Follow-up|0|||
105768576|NCT00654420|364804457|FG002|Phase II|Lost to Follow-up|0|||
105768577|NCT00654420|364804458|FG003|Phase II|Lost to Follow-up|1|||
105768578|NCT00654420|364804455|FG000|Phase II|Physician Decision|0|||
105768579|NCT00654420|364804456|FG001|Phase II|Physician Decision|0|||
105768580|NCT00654420|364804457|FG002|Phase II|Physician Decision|0|||
105768581|NCT00654420|364804458|FG003|Phase II|Physician Decision|4|||
105768582|NCT00654420|364804455|FG000|Phase II|Progressive Disease|0|||
105768583|NCT00654420|364804456|FG001|Phase II|Progressive Disease|0|||
105768584|NCT00654420|364804457|FG002|Phase II|Progressive Disease|29|||
105768585|NCT00654420|364804458|FG003|Phase II|Progressive Disease|29|||
105768586|NCT00654420|364804455|FG000|Phase II|Withdrawal by Subject|0|||
105768587|NCT00654420|364804456|FG001|Phase II|Withdrawal by Subject|0|||
105768588|NCT00654420|364804457|FG002|Phase II|Withdrawal by Subject|4|||
105768589|NCT00654420|364804458|FG003|Phase II|Withdrawal by Subject|1|||
105768590|NCT00654420|364804455|FG000|Phase II|Missing Disposition Record|0|||
105768591|NCT00654420|364804456|FG001|Phase II|Missing Disposition Record|0|||
105768592|NCT00654420|364804457|FG002|Phase II|Missing Disposition Record|1|||
105768593|NCT00654420|364804458|FG003|Phase II|Missing Disposition Record|0|||
105768594|NCT02252588|364804462|FG000|Overall Study|Withdrawal by Subject|4|||
105768595|NCT02252588|364804463|FG001|Overall Study|Withdrawal by Subject|0|||
105768596|NCT03039790|364804468|FG000|Overall Study|Lost to Follow-up|2|||
105768597|NCT03039790|364804469|FG001|Overall Study|Lost to Follow-up|0|||
105768598|NCT03039790|364804470|FG002|Overall Study|Lost to Follow-up|1|||
105768599|NCT03039790|364804471|FG003|Overall Study|Lost to Follow-up|1|||
105768600|NCT03039790|364804472|FG004|Overall Study|Lost to Follow-up|0|||
105768601|NCT03039790|364804473|FG005|Overall Study|Lost to Follow-up|1|||
105768602|NCT03039790|364804474|FG006|Overall Study|Lost to Follow-up|1|||
105768603|NCT03039790|364804475|FG007|Overall Study|Lost to Follow-up|1|||
105768604|NCT03039790|364804476|FG008|Overall Study|Lost to Follow-up|0|||
105768605|NCT03039790|364804477|FG009|Overall Study|Lost to Follow-up|1|||
105768606|NCT03039790|364804478|FG010|Overall Study|Lost to Follow-up|1|||
105768607|NCT03039790|364804479|FG011|Overall Study|Lost to Follow-up|0|||
105768608|NCT03039790|364804480|FG012|Overall Study|Lost to Follow-up|1|||
105768609|NCT03039790|364804481|FG013|Overall Study|Lost to Follow-up|0|||
105768610|NCT03039790|364804482|FG014|Overall Study|Lost to Follow-up|3|||
105768611|NCT03039790|364804483|FG015|Overall Study|Lost to Follow-up|1|||
105768612|NCT03039790|364804484|FG016|Overall Study|Lost to Follow-up|2|||
105768613|NCT03039790|364804485|FG017|Overall Study|Lost to Follow-up|2|||
105768614|NCT03039790|364804486|FG018|Overall Study|Lost to Follow-up|1|||
105768615|NCT03039790|364804487|FG019|Overall Study|Lost to Follow-up|3|||
105768616|NCT03039790|364804468|FG000|Overall Study|Withdrawal of Consent|1|||
105768617|NCT03039790|364804469|FG001|Overall Study|Withdrawal of Consent|0|||
105487336|NCT03387150|363796983|FG005|Overall Study|Withdrawal by Subject|2|||
105487337|NCT03387150|363796984|FG006|Overall Study|Withdrawal by Subject|0|||
105487338|NCT03387150|363796978|FG000|Overall Study|Lost to Follow-up|3|||
105487339|NCT03387150|363796979|FG001|Overall Study|Lost to Follow-up|2|||
105487340|NCT03387150|363796980|FG002|Overall Study|Lost to Follow-up|2|||
105487341|NCT03387150|363796981|FG003|Overall Study|Lost to Follow-up|3|||
105487342|NCT03387150|363796982|FG004|Overall Study|Lost to Follow-up|3|||
105487343|NCT03387150|363796983|FG005|Overall Study|Lost to Follow-up|3|||
105487344|NCT03387150|363796984|FG006|Overall Study|Lost to Follow-up|0|||
105487345|NCT03387150|363796978|FG000|Overall Study|Participant unable to adhere to visit|0|||
105487346|NCT03387150|363796979|FG001|Overall Study|Participant unable to adhere to visit|1|||
105487347|NCT03387150|363796980|FG002|Overall Study|Participant unable to adhere to visit|0|||
105487348|NCT03387150|363796981|FG003|Overall Study|Participant unable to adhere to visit|0|||
105487349|NCT03387150|363796982|FG004|Overall Study|Participant unable to adhere to visit|2|||
105487350|NCT03387150|363796983|FG005|Overall Study|Participant unable to adhere to visit|2|||
105487351|NCT03387150|363796984|FG006|Overall Study|Participant unable to adhere to visit|0|||
105487352|NCT01461057|363796985|FG000|Overall Study|Death|10|||
105487353|NCT01461057|363796986|FG001|Overall Study|Death|9|||
105487354|NCT01461057|363796985|FG000|Overall Study|Withdrawal by Subject|2|||
105487355|NCT01461057|363796986|FG001|Overall Study|Withdrawal by Subject|3|||
105487356|NCT01461057|363796985|FG000|Overall Study|Physician Decision|0|||
105487357|NCT01461057|363796986|FG001|Overall Study|Physician Decision|2|||
105487358|NCT01461057|363796985|FG000|Overall Study|Adverse Event|0|||
105487359|NCT01461057|363796986|FG001|Overall Study|Adverse Event|1|||
105487360|NCT01461057|363796985|FG000|Overall Study|Progression of Disease|1|||
105487361|NCT01461057|363796986|FG001|Overall Study|Progression of Disease|0|||
105487362|NCT01461057|363796985|FG000|Overall Study|Study Terminated by Sponsor|2|||
105487363|NCT01461057|363796986|FG001|Overall Study|Study Terminated by Sponsor|0|||
105487364|NCT01606254|363796989|FG000|Overall Study|Withdrawal by Subject|1|||
105487365|NCT01606254|363796990|FG001|Overall Study|Withdrawal by Subject|3|||
105487366|NCT01606254|363796991|FG002|Overall Study|Withdrawal by Subject|0|||
105487367|NCT01606254|363796992|FG003|Overall Study|Withdrawal by Subject|2|||
105487368|NCT01606254|363796989|FG000|Overall Study|Adverse Event|1|||
105487369|NCT01606254|363796990|FG001|Overall Study|Adverse Event|1|||
105487370|NCT01606254|363796991|FG002|Overall Study|Adverse Event|0|||
105487371|NCT01606254|363796992|FG003|Overall Study|Adverse Event|1|||
105487372|NCT02011893|363796994|FG000|Enrollment to Randomization|Adverse Event|2|||
105487373|NCT02011893|363796995|FG001|Enrollment to Randomization|Adverse Event|0|||
105487374|NCT02011893|363796996|FG002|Enrollment to Randomization|Adverse Event|0|||
105487375|NCT02011893|363796994|FG000|Enrollment to Randomization|Physician Decision|10|||
105487376|NCT02011893|363796995|FG001|Enrollment to Randomization|Physician Decision|0|||
105487377|NCT02011893|363796996|FG002|Enrollment to Randomization|Physician Decision|0|||
105487378|NCT02011893|363796994|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
105487379|NCT02011893|363796995|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
105487380|NCT02011893|363796996|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
105487381|NCT02011893|363796994|FG000|Enrollment to Randomization|Screening Failure|29|||
105487382|NCT02011893|363796995|FG001|Enrollment to Randomization|Screening Failure|0|||
105487383|NCT02011893|363796996|FG002|Enrollment to Randomization|Screening Failure|0|||
105487384|NCT02011893|363796994|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
105487385|NCT02011893|363796995|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
105487386|NCT02011893|363796996|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
105487387|NCT02011893|363796994|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
105487388|NCT02011893|363796995|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
105487389|NCT02011893|363796996|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
105487390|NCT02011893|363796994|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
105487391|NCT02011893|363796995|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
105487392|NCT02011893|363796996|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
105487393|NCT02011893|363796994|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
105487394|NCT02011893|363796995|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
105487395|NCT02011893|363796996|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
105487396|NCT02011893|363796994|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
105487397|NCT02011893|363796995|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
105487398|NCT02011893|363796996|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
105487399|NCT02131532|363796997|FG000|Overall Study|Withdrawal by Subject|1|||
105487400|NCT02131532|363796997|FG000|Overall Study|Physician Decision|1|||
105487401|NCT02131532|363796997|FG000|Overall Study|Other health conditions|2|||
105487402|NCT01466595|363797001|FG000|Overall Study|Withdrawal by Subject|0|||
105487403|NCT01466595|363797002|FG001|Overall Study|Withdrawal by Subject|1|||
105487404|NCT03418571|363797003|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
105487405|NCT03418571|363797004|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
105487406|NCT02964507|363797005|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
105487407|NCT02964507|363797006|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
105365551|NCT00492726|363343856|FG000|Overall Study|Lack of Efficacy|0|||
105365552|NCT00492726|363343857|FG001|Overall Study|Lack of Efficacy|2|||
105365553|NCT00492726|363343856|FG000|Overall Study|Lost to Follow-up|27|||
105365554|NCT00492726|363343857|FG001|Overall Study|Lost to Follow-up|19|||
105365555|NCT00492726|363343856|FG000|Overall Study|Physician Decision|0|||
105365556|NCT00492726|363343857|FG001|Overall Study|Physician Decision|1|||
105365557|NCT00492726|363343856|FG000|Overall Study|Withdrawal by Subject|6|||
105365558|NCT00492726|363343857|FG001|Overall Study|Withdrawal by Subject|3|||
105365559|NCT00492726|363343856|FG000|Overall Study|Non compliant with study medication|0|||
105365560|NCT00492726|363343857|FG001|Overall Study|Non compliant with study medication|3|||
105365561|NCT03390504|363343858|FG000|Overall Study|Lost to Follow-up|2|||
105365562|NCT03390504|363343859|FG001|Overall Study|Lost to Follow-up|4|||
105365563|NCT03390504|363343860|FG002|Overall Study|Lost to Follow-up|0|||
105824721|NCT03114891|365014522|FG001|First Treatment Round|Withdrawal by Subject|2|||
105824722|NCT03114891|365014523|FG002|First Treatment Round|Withdrawal by Subject|0|||
105824723|NCT03114891|365014524|FG003|First Treatment Round|Withdrawal by Subject|1|||
105824724|NCT03114891|365014521|FG000|3 Week Break|Lost to Follow-up|1|||
105824725|NCT03114891|365014522|FG001|3 Week Break|Lost to Follow-up|0|||
105824726|NCT03114891|365014523|FG002|3 Week Break|Lost to Follow-up|0|||
105824727|NCT03114891|365014524|FG003|3 Week Break|Lost to Follow-up|1|||
105824728|NCT03114891|365014521|FG000|3 Week Break|Withdrawal by Subject|0|||
105824729|NCT03114891|365014522|FG001|3 Week Break|Withdrawal by Subject|1|||
105824730|NCT03114891|365014523|FG002|3 Week Break|Withdrawal by Subject|0|||
105824731|NCT03114891|365014524|FG003|3 Week Break|Withdrawal by Subject|0|||
105824732|NCT03114891|365014521|FG000|Second Treatment Round|Lost to Follow-up|1|||
105824733|NCT03114891|365014522|FG001|Second Treatment Round|Lost to Follow-up|0|||
105824734|NCT03114891|365014523|FG002|Second Treatment Round|Lost to Follow-up|0|||
105824735|NCT03114891|365014524|FG003|Second Treatment Round|Lost to Follow-up|0|||
105824736|NCT03114891|365014521|FG000|Second Treatment Round|Physician Decision|1|||
105824737|NCT03114891|365014522|FG001|Second Treatment Round|Physician Decision|0|||
105824738|NCT03114891|365014523|FG002|Second Treatment Round|Physician Decision|0|||
105824739|NCT03114891|365014524|FG003|Second Treatment Round|Physician Decision|0|||
105824740|NCT00849797|365014525|FG000|First Intervention|bad veins|1|||
105824741|NCT00849797|365014526|FG001|First Intervention|bad veins|0|||
105365564|NCT03390504|363343861|FG003|Overall Study|Lost to Follow-up|1|||
105365565|NCT03390504|363343858|FG000|Overall Study|Withdrawal by Subject|3|||
105365566|NCT03390504|363343859|FG001|Overall Study|Withdrawal by Subject|15|||
105365567|NCT03390504|363343860|FG002|Overall Study|Withdrawal by Subject|5|||
105365568|NCT03390504|363343861|FG003|Overall Study|Withdrawal by Subject|2|||
105365569|NCT03390504|363343858|FG000|Overall Study|Other|1|||
105365570|NCT03390504|363343859|FG001|Overall Study|Other|2|||
105365571|NCT03390504|363343860|FG002|Overall Study|Other|2|||
105365572|NCT03390504|363343861|FG003|Overall Study|Other|6|||
105365573|NCT04414787|363343862|FG000|Overall Study|Patient Death|18|||
105365574|NCT04414787|363343863|FG001|Overall Study|Patient Death|18|||
105365575|NCT04414787|363343864|FG002|Overall Study|Patient Death|15|||
105365576|NCT04414787|363343865|FG003|Overall Study|Patient Death|15|||
105365577|NCT04414787|363343862|FG000|Overall Study|Patient Hospitalization|1|||
105365578|NCT04414787|363343863|FG001|Overall Study|Patient Hospitalization|1|||
105365579|NCT04414787|363343864|FG002|Overall Study|Patient Hospitalization|2|||
105365580|NCT04414787|363343865|FG003|Overall Study|Patient Hospitalization|2|||
105365581|NCT04414787|363343862|FG000|Overall Study|Lost to Follow-up|7|||
105365582|NCT04414787|363343863|FG001|Overall Study|Lost to Follow-up|7|||
105365583|NCT04414787|363343864|FG002|Overall Study|Lost to Follow-up|5|||
105824742|NCT00849797|365014525|FG000|First Intervention|Adverse Event|0|||
105824743|NCT00849797|365014526|FG001|First Intervention|Adverse Event|1|||
105824744|NCT00849797|365014525|FG000|Washout: One Week|Withdrawal by Subject|0|||
105365584|NCT04414787|363343865|FG003|Overall Study|Lost to Follow-up|5|||
105365585|NCT04414787|363343862|FG000|Overall Study|Residence in post-acute care facility|3|||
105365586|NCT04414787|363343863|FG001|Overall Study|Residence in post-acute care facility|3|||
105365587|NCT04414787|363343864|FG002|Overall Study|Residence in post-acute care facility|5|||
105365588|NCT04414787|363343865|FG003|Overall Study|Residence in post-acute care facility|5|||
105365589|NCT04821830|363343866|FG000|Overall Study|Withdrawal by Subject|1|||
105824745|NCT00849797|365014526|FG001|Washout: One Week|Withdrawal by Subject|2|||
105365590|NCT04821830|363343867|FG001|Overall Study|Withdrawal by Subject|0|||
105365591|NCT03882918|363343868|FG000|Overall Study|Study terminated by sponsor|98|||
105365592|NCT03882918|363343868|FG000|Overall Study|Protocol Violation|1|||
105365593|NCT03882918|363343868|FG000|Overall Study|Other|9|||
105365594|NCT03882918|363343868|FG000|Overall Study|Lack of Efficacy|14|||
105365595|NCT03882918|363343868|FG000|Overall Study|Adverse Event|13|||
105365596|NCT03882918|363343868|FG000|Overall Study|Withdrawal by Subject|5|||
105365597|NCT03141359|363343869|FG000|Overall Study|Death|32|||
105365598|NCT03141359|363343869|FG000|Overall Study|Still On Study (in follow up)|29|||
105365599|NCT02059239|363345023|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
105365600|NCT02059239|363345024|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
105365601|NCT02059239|363345023|FG000|Overall Study|Physician Decision|1|||
105365602|NCT02059239|363345024|FG001|Overall Study|Physician Decision|0|||
105365603|NCT04176939|363345025|FG000|Overall Study|Withdrawal by Subject|5|||
105824746|NCT01249651|365014527|FG000|Overall Study|Withdrawal by Subject|4|||
105824747|NCT01249651|365014527|FG000|Overall Study|Adverse Event|1|||
105824748|NCT01249651|365014527|FG000|Overall Study|Protocol Violation|1|||
105824749|NCT01249651|365014527|FG000|Overall Study|Sponsor Decision|1|||
105824750|NCT04827394|365014532|FG000|Overall Study|Physician Decision|0|||
105824751|NCT04827394|365014533|FG001|Overall Study|Physician Decision|2|||
105824752|NCT03801707|365014534|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
105824753|NCT03500094|365014535|FG000|Overall Study|Withdrawal by Subject|1|||
105824754|NCT03500094|365014535|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
105824755|NCT03500094|365014535|FG000|Overall Study|Lost to Follow-up|1|||
105824756|NCT01030133|365014538|FG000|Overall Study|failed to experience pain at level 7/10|2|||
105824757|NCT01030133|365014539|FG001|Overall Study|failed to experience pain at level 7/10|2|||
105824758|NCT00829764|365014540|FG000|First Intervention|Adverse Event|1|||
105365604|NCT04176939|363345025|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
105824759|NCT00829764|365014541|FG001|First Intervention|Adverse Event|0|||
105824760|NCT00829764|365014540|FG000|First Intervention|Withdrawal by Subject|1|||
105365605|NCT04176939|363345025|FG000|Overall Study|Lost to Follow-up|2|||
105365606|NCT04176939|363345025|FG000|Overall Study|Unspecified reason|4|||
105365607|NCT04176939|363345025|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
105365608|NCT05817669|363345026|FG000|Overall Study|Prohibited medication used|1|||
105824761|NCT00829764|365014541|FG001|First Intervention|Withdrawal by Subject|1|||
105824762|NCT04594252|365014542|FG000|Overall Study|Adverse Event|0|||
105824763|NCT04594252|365014543|FG001|Overall Study|Adverse Event|2|||
105824764|NCT05152576|365014544|FG000|Overall Study|Lost to Follow-up|3|||
105824765|NCT05152576|365014545|FG001|Overall Study|Lost to Follow-up|0|||
105824766|NCT05152576|365014546|FG002|Overall Study|Lost to Follow-up|0|||
105824767|NCT05152576|365014547|FG003|Overall Study|Lost to Follow-up|1|||
105824768|NCT05152576|365014544|FG000|Overall Study|Withdrawal by Subject|0|||
105824769|NCT05152576|365014545|FG001|Overall Study|Withdrawal by Subject|1|||
105824770|NCT05152576|365014546|FG002|Overall Study|Withdrawal by Subject|0|||
105824771|NCT05152576|365014547|FG003|Overall Study|Withdrawal by Subject|1|||
105824772|NCT05152576|365014544|FG000|Overall Study|Other|2|||
105824773|NCT05152576|365014545|FG001|Overall Study|Other|0|||
105824774|NCT05152576|365014546|FG002|Overall Study|Other|0|||
105824775|NCT05152576|365014547|FG003|Overall Study|Other|0|||
105824776|NCT00835705|365016360|FG000|First Intervention|Difficulty with vein|1|||
105824777|NCT00835705|365016361|FG001|First Intervention|Difficulty with vein|0|||
105824778|NCT00835705|365016360|FG000|Second Intervention|Difficulty with vein|1|||
105824779|NCT00835705|365016361|FG001|Second Intervention|Difficulty with vein|0|||
105824780|NCT00594035|365016362|FG000|Overall Study|Lost to Follow-up|1|||
105824781|NCT00594035|365016363|FG001|Overall Study|Lost to Follow-up|1|||
105824782|NCT00594035|365016362|FG000|Overall Study|Withdrawal by Subject|1|||
105824783|NCT00594035|365016363|FG001|Overall Study|Withdrawal by Subject|0|||
105824784|NCT00594035|365016362|FG000|Overall Study|Subject transferred to nursing home|0|||
105824785|NCT00594035|365016363|FG001|Overall Study|Subject transferred to nursing home|1|||
105824786|NCT00594035|365016362|FG000|Overall Study|Subject couldn't return due to job|0|||
105824787|NCT00594035|365016363|FG001|Overall Study|Subject couldn't return due to job|1|||
105824788|NCT00795821|365016364|FG000|Acute Treatment Phase|Adverse Event|23|||
105824789|NCT00795821|365016365|FG001|Acute Treatment Phase|Adverse Event|4|||
105824790|NCT00795821|365016364|FG000|Acute Treatment Phase|Death|1|||
105824791|NCT00795821|365016365|FG001|Acute Treatment Phase|Death|0|||
105824792|NCT00795821|365016364|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
105824793|NCT00795821|365016365|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
105572384|NCT00569803|364094511|FG004|Overall Study|Withdrawal by Subject|0|||
105572385|NCT00569803|364094512|FG005|Overall Study|Withdrawal by Subject|0|||
105572386|NCT00569803|364094513|FG006|Overall Study|Withdrawal by Subject|0|||
105572387|NCT00569803|364094514|FG007|Overall Study|Withdrawal by Subject|1|||
105572388|NCT01077362|364094515|FG000|Overall Study|Lack of Efficacy|13|||
105572389|NCT01077362|364094516|FG001|Overall Study|Lack of Efficacy|8|||
105572390|NCT01077362|364094517|FG002|Overall Study|Lack of Efficacy|10|||
105572391|NCT01077362|364094515|FG000|Overall Study|Lost to Follow-up|1|||
105572392|NCT01077362|364094516|FG001|Overall Study|Lost to Follow-up|0|||
105572393|NCT01077362|364094517|FG002|Overall Study|Lost to Follow-up|3|||
105572394|NCT01077362|364094515|FG000|Overall Study|Adverse Event|12|||
105572395|NCT01077362|364094516|FG001|Overall Study|Adverse Event|7|||
105572396|NCT01077362|364094517|FG002|Overall Study|Adverse Event|4|||
105572397|NCT01077362|364094515|FG000|Overall Study|Withdrawal by Subject|5|||
105572398|NCT01077362|364094516|FG001|Overall Study|Withdrawal by Subject|3|||
105572399|NCT01077362|364094517|FG002|Overall Study|Withdrawal by Subject|5|||
105572400|NCT01077362|364094515|FG000|Overall Study|Other|0|||
105572401|NCT01077362|364094516|FG001|Overall Study|Other|1|||
105572402|NCT01077362|364094517|FG002|Overall Study|Other|2|||
105572403|NCT00641719|364094518|FG000|Overall Study|Lack of Efficacy|1|||
105572404|NCT00641719|364094519|FG001|Overall Study|Lack of Efficacy|2|||
105572405|NCT00641719|364094518|FG000|Overall Study|Adverse Event|24|||
105572406|NCT00641719|364094519|FG001|Overall Study|Adverse Event|29|||
105572407|NCT00641719|364094518|FG000|Overall Study|Withdrawal by Subject|4|||
105572408|NCT00641719|364094519|FG001|Overall Study|Withdrawal by Subject|4|||
105572409|NCT00641719|364094518|FG000|Overall Study|Reason Not Specified|1|||
105572410|NCT00641719|364094519|FG001|Overall Study|Reason Not Specified|2|||
105572411|NCT02306265|364094520|FG000|Overall Study|Withdrawal by Subject|1|||
105572412|NCT00452413|364094521|FG000|Overall Study|Progressive Disease|4|||
105572413|NCT00452413|364094522|FG001|Overall Study|Progressive Disease|11|||
105572414|NCT00452413|364094523|FG002|Overall Study|Progressive Disease|30|||
105572415|NCT00452413|364094521|FG000|Overall Study|Withdrawal by Subject|0|||
105572416|NCT00452413|364094522|FG001|Overall Study|Withdrawal by Subject|1|||
105572417|NCT00452413|364094523|FG002|Overall Study|Withdrawal by Subject|4|||
105572418|NCT00452413|364094521|FG000|Overall Study|Adverse Event|0|||
105572419|NCT00452413|364094522|FG001|Overall Study|Adverse Event|0|||
105824794|NCT00795821|365016364|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
105572420|NCT00452413|364094523|FG002|Overall Study|Adverse Event|5|||
105572421|NCT00452413|364094521|FG000|Overall Study|Physician Decision|0|||
105572422|NCT00452413|364094522|FG001|Overall Study|Physician Decision|0|||
105572423|NCT00452413|364094523|FG002|Overall Study|Physician Decision|4|||
105572424|NCT00452413|364094521|FG000|Overall Study|Death due to study disease|0|||
105572425|NCT00452413|364094522|FG001|Overall Study|Death due to study disease|0|||
105572426|NCT00452413|364094523|FG002|Overall Study|Death due to study disease|2|||
105824795|NCT00795821|365016365|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
105824796|NCT00795821|365016364|FG000|Acute Treatment Phase|Physician Decision|1|||
105824797|NCT00795821|365016365|FG001|Acute Treatment Phase|Physician Decision|1|||
105365609|NCT05817669|363345027|FG001|Overall Study|Prohibited medication used|2|||
105365610|NCT05817669|363345026|FG000|Overall Study|Adverse Event|1|||
105365611|NCT05817669|363345027|FG001|Overall Study|Adverse Event|0|||
105365612|NCT05817669|363345026|FG000|Overall Study|Withdrawal by Subject|1|||
105365613|NCT05817669|363345027|FG001|Overall Study|Withdrawal by Subject|2|||
105365614|NCT04083976|363345031|FG000|Overall Study|Lost to Follow-up|3|||
105365615|NCT04083976|363345032|FG001|Overall Study|Lost to Follow-up|0|||
105824798|NCT00795821|365016364|FG000|Acute Treatment Phase|Protocol Violation|1|||
105824799|NCT00795821|365016365|FG001|Acute Treatment Phase|Protocol Violation|2|||
105824800|NCT00795821|365016364|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
105824801|NCT00795821|365016365|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
105824802|NCT00795821|365016364|FG000|Long-term Extension Phase|Adverse Event|25|||
105824803|NCT00795821|365016365|FG001|Long-term Extension Phase|Adverse Event|32|||
105824804|NCT00795821|365016364|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
105824805|NCT00795821|365016365|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
105824806|NCT00795821|365016364|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
105824807|NCT00795821|365016365|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
105824808|NCT00795821|365016364|FG000|Long-term Extension Phase|Physician Decision|1|||
105824809|NCT00795821|365016365|FG001|Long-term Extension Phase|Physician Decision|2|||
105824810|NCT00795821|365016364|FG000|Long-term Extension Phase|Protocol Violation|3|||
105824811|NCT00795821|365016365|FG001|Long-term Extension Phase|Protocol Violation|5|||
105824812|NCT00795821|365016364|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
105824813|NCT00795821|365016365|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
105824814|NCT00795821|365016364|FG000|Taper Phase|Adverse Event|2|||
105824815|NCT00795821|365016365|FG001|Taper Phase|Adverse Event|0|||
105824816|NCT00795821|365016364|FG000|Taper Phase|Lost to Follow-up|1|||
105824817|NCT00795821|365016365|FG001|Taper Phase|Lost to Follow-up|0|||
105824818|NCT00795821|365016364|FG000|Taper Phase|Physician Decision|2|||
105824819|NCT00795821|365016365|FG001|Taper Phase|Physician Decision|0|||
105824820|NCT00795821|365016364|FG000|Taper Phase|Withdrawal by Subject|4|||
105824821|NCT00795821|365016365|FG001|Taper Phase|Withdrawal by Subject|0|||
105824822|NCT00712959|365016368|FG000|Overall Study|Protocol Violation|3|||
105824823|NCT00712959|365016369|FG001|Overall Study|Protocol Violation|1|||
105824824|NCT00712959|365016368|FG000|Overall Study|Lost to Follow-up|13|||
105824825|NCT00712959|365016369|FG001|Overall Study|Lost to Follow-up|2|||
105824826|NCT00712959|365016368|FG000|Overall Study|Withdrawal by Subject|3|||
105824827|NCT00712959|365016369|FG001|Overall Study|Withdrawal by Subject|0|||
105824828|NCT00508651|365016370|FG000|Overall Study|Lost to Follow-up|3|||
105824829|NCT00508651|365016371|FG001|Overall Study|Lost to Follow-up|1|||
105824830|NCT00508651|365016370|FG000|Overall Study|Withdrawal by Subject|1|||
105824831|NCT00508651|365016371|FG001|Overall Study|Withdrawal by Subject|1|||
105824832|NCT01531894|365016375|FG000|Overall Study|Physician Decision|8|||
105824833|NCT01531894|365016375|FG000|Overall Study|Death|1|||
105824834|NCT02125461|365016376|FG000|Overall Study|Withdrawal by Subject|30|||
105824835|NCT02125461|365016377|FG001|Overall Study|Withdrawal by Subject|16|||
105824836|NCT02125461|365016376|FG000|Overall Study|Lost to Follow-up|8|||
105824837|NCT02125461|365016377|FG001|Overall Study|Lost to Follow-up|3|||
105824838|NCT02125461|365016376|FG000|Overall Study|Death|260|||
105824839|NCT02125461|365016377|FG001|Overall Study|Death|149|||
105824840|NCT02125461|365016376|FG000|Overall Study|Missing Termination Reason|0|||
105824841|NCT02125461|365016377|FG001|Overall Study|Missing Termination Reason|1|||
105824842|NCT02888756|365016379|FG000|Analytical Treatment Interruption|Physician Decision|10|||
105824843|NCT02888756|365016380|FG001|Analytical Treatment Interruption|Physician Decision|6|||
105824844|NCT02888756|365016381|FG002|Analytical Treatment Interruption|Physician Decision|5|||
105824845|NCT01547286|365016387|FG000|Overall Study|Did not meet all eligibility criteria|1|||
105824846|NCT01547286|365016387|FG000|Overall Study|Physician Decision|1|||
105824847|NCT03502811|365016391|FG000|Overall Study|Death|157|||
105824848|NCT03502811|365016391|FG000|Overall Study|Withdrawal by Subject|105|||
105824849|NCT03502811|365016391|FG000|Overall Study|Lost to Follow-up|26|||
105824850|NCT03502811|365016391|FG000|Overall Study|No Visits (Missed)|31|||
105824851|NCT03913377|365016392|FG000|Period 1|Test Article no longer available|0|||
105824852|NCT03913377|365016393|FG001|Period 1|Test Article no longer available|1|||
105824853|NCT03913377|365016394|FG002|Period 1|Test Article no longer available|0|||
105824854|NCT03913377|365016392|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
105824855|NCT03913377|365016393|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
105824856|NCT03913377|365016394|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
105824857|NCT05239195|365016395|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
105824858|NCT05239195|365016396|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
105365616|NCT04083976|363345033|FG002|Overall Study|Lost to Follow-up|0|||
105824859|NCT03552484|365016397|FG000|Overall Study|Death|6|||
105824860|NCT03552484|365016398|FG001|Overall Study|Death|4|||
105824861|NCT03552484|365016397|FG000|Overall Study|Lost to Follow-up|0|||
105824862|NCT03552484|365016398|FG001|Overall Study|Lost to Follow-up|16|||
105824863|NCT01204294|365016401|FG000|Overall Study|Adverse Event|2|||
105824864|NCT01204294|365016402|FG001|Overall Study|Adverse Event|6|||
105365617|NCT04083976|363345034|FG003|Overall Study|Lost to Follow-up|1|||
105365618|NCT04083976|363345031|FG000|Overall Study|Withdrawal by Subject|16|||
105365619|NCT04083976|363345032|FG001|Overall Study|Withdrawal by Subject|1|||
105365620|NCT04083976|363345033|FG002|Overall Study|Withdrawal by Subject|9|||
105365621|NCT04083976|363345034|FG003|Overall Study|Withdrawal by Subject|0|||
105365622|NCT04083976|363345031|FG000|Overall Study|Sponsor Decision|14|||
105365623|NCT04083976|363345032|FG001|Overall Study|Sponsor Decision|0|||
105365624|NCT04083976|363345033|FG002|Overall Study|Sponsor Decision|0|||
105824865|NCT01204294|365016403|FG002|Overall Study|Adverse Event|0|||
105365625|NCT04083976|363345034|FG003|Overall Study|Sponsor Decision|7|||
105365626|NCT04083976|363345031|FG000|Overall Study|Other|1|||
105365627|NCT04083976|363345032|FG001|Overall Study|Other|0|||
105365628|NCT04083976|363345033|FG002|Overall Study|Other|1|||
105365629|NCT04083976|363345034|FG003|Overall Study|Other|0|||
105824866|NCT01204294|365016404|FG003|Overall Study|Adverse Event|7|||
105824867|NCT01204294|365016405|FG004|Overall Study|Adverse Event|1|||
105824868|NCT01204294|365016406|FG005|Overall Study|Adverse Event|4|||
105824869|NCT01204294|365016407|FG006|Overall Study|Adverse Event|0|||
105824870|NCT01204294|365016401|FG000|Overall Study|Protocol Violation|1|||
105824871|NCT01204294|365016402|FG001|Overall Study|Protocol Violation|0|||
105824872|NCT01204294|365016403|FG002|Overall Study|Protocol Violation|2|||
105824873|NCT01204294|365016404|FG003|Overall Study|Protocol Violation|1|||
105824874|NCT01204294|365016405|FG004|Overall Study|Protocol Violation|0|||
105824875|NCT01204294|365016406|FG005|Overall Study|Protocol Violation|0|||
105824876|NCT01204294|365016407|FG006|Overall Study|Protocol Violation|0|||
105824877|NCT01204294|365016401|FG000|Overall Study|Withdrawal by Subject|0|||
105824878|NCT01204294|365016402|FG001|Overall Study|Withdrawal by Subject|2|||
105824879|NCT01204294|365016403|FG002|Overall Study|Withdrawal by Subject|2|||
105824880|NCT01204294|365016404|FG003|Overall Study|Withdrawal by Subject|1|||
105365630|NCT01443858|363345035|FG000|Overall Study|Withdrawal by Subject|9|||
105365631|NCT01443858|363345036|FG001|Overall Study|Withdrawal by Subject|8|||
105365632|NCT01443858|363345037|FG002|Overall Study|Withdrawal by Subject|5|||
105365633|NCT01443858|363345035|FG000|Overall Study|Lack of Efficacy|1|||
105365634|NCT01443858|363345036|FG001|Overall Study|Lack of Efficacy|0|||
105365635|NCT01443858|363345037|FG002|Overall Study|Lack of Efficacy|0|||
105365636|NCT01443858|363345035|FG000|Overall Study|Lost to Follow-up|5|||
105365637|NCT01443858|363345036|FG001|Overall Study|Lost to Follow-up|5|||
105365638|NCT01443858|363345037|FG002|Overall Study|Lost to Follow-up|2|||
105365639|NCT03834493|363345038|FG000|Overall Study|Participants Ongoing|311|||
105365640|NCT03834493|363345039|FG001|Overall Study|Participants Ongoing|324|||
105365641|NCT03834493|363345038|FG000|Overall Study|Withdrawal by Subject|20|||
105365642|NCT03834493|363345039|FG001|Overall Study|Withdrawal by Subject|17|||
105365643|NCT03834493|363345038|FG000|Overall Study|Physician Decision|1|||
105365644|NCT03834493|363345039|FG001|Overall Study|Physician Decision|0|||
105365645|NCT03834493|363345038|FG000|Overall Study|Death|289|||
105365646|NCT03834493|363345039|FG001|Overall Study|Death|282|||
105365647|NCT05559905|363345040|FG000|Overall Study|Withdrawal by Subject|1|||
105365648|NCT05559905|363345041|FG001|Overall Study|Withdrawal by Subject|0|||
105365649|NCT05559905|363345042|FG002|Overall Study|Withdrawal by Subject|0|||
105365650|NCT05559905|363345040|FG000|Overall Study|Not Reported|1|||
105365651|NCT05559905|363345041|FG001|Overall Study|Not Reported|0|||
105365652|NCT05559905|363345042|FG002|Overall Study|Not Reported|0|||
105824881|NCT01204294|365016405|FG004|Overall Study|Withdrawal by Subject|1|||
105824882|NCT01204294|365016406|FG005|Overall Study|Withdrawal by Subject|1|||
105824883|NCT01204294|365016407|FG006|Overall Study|Withdrawal by Subject|2|||
105824884|NCT01204294|365016401|FG000|Overall Study|Lack of Efficacy|0|||
105824885|NCT01204294|365016402|FG001|Overall Study|Lack of Efficacy|0|||
105824886|NCT01204294|365016403|FG002|Overall Study|Lack of Efficacy|0|||
105824887|NCT01204294|365016404|FG003|Overall Study|Lack of Efficacy|2|||
105824888|NCT01204294|365016405|FG004|Overall Study|Lack of Efficacy|0|||
105824889|NCT01204294|365016406|FG005|Overall Study|Lack of Efficacy|0|||
105365653|NCT04003103|363345043|FG000|Overall Study|Death|1|||
105824890|NCT01204294|365016407|FG006|Overall Study|Lack of Efficacy|0|||
105824891|NCT01204294|365016401|FG000|Overall Study|Other (house moving)|0|||
105824892|NCT01204294|365016402|FG001|Overall Study|Other (house moving)|0|||
105824893|NCT01204294|365016403|FG002|Overall Study|Other (house moving)|1|||
105824894|NCT01204294|365016404|FG003|Overall Study|Other (house moving)|0|||
105824895|NCT01204294|365016405|FG004|Overall Study|Other (house moving)|0|||
105824896|NCT01204294|365016406|FG005|Overall Study|Other (house moving)|0|||
105824897|NCT01204294|365016407|FG006|Overall Study|Other (house moving)|0|||
105824898|NCT03128723|365016408|FG000|Overall Study|Withdrawal by Subject|2|||
105365654|NCT04003103|363345044|FG001|Overall Study|Death|0|||
105365655|NCT04003103|363345045|FG002|Overall Study|Death|0|||
105824899|NCT00075478|365016409|FG000|Overall Study|not eligible|1|||
105365656|NCT04003103|363345043|FG000|Overall Study|Lost to Follow-up|4|||
105365657|NCT04003103|363345044|FG001|Overall Study|Lost to Follow-up|3|||
105365658|NCT04003103|363345045|FG002|Overall Study|Lost to Follow-up|2|||
105365659|NCT04003103|363345043|FG000|Overall Study|Withdrawal by Subject|10|||
105824900|NCT00075478|365016410|FG001|Overall Study|not eligible|0|||
105365660|NCT04003103|363345044|FG001|Overall Study|Withdrawal by Subject|1|||
105824901|NCT00075478|365016409|FG000|Overall Study|Physician Decision|0|||
105824902|NCT00075478|365016410|FG001|Overall Study|Physician Decision|1|||
105824903|NCT02075463|365016411|FG000|Overall Study|Adverse Event|3|||
105824904|NCT02075463|365016411|FG000|Overall Study|Par. reached stopping criteria|4|||
105824905|NCT02075463|365016411|FG000|Overall Study|Withdrawal by Subject|1|||
105824906|NCT01642277|365016413|FG000|Overall Study|Adverse Event|10|||
105824907|NCT01642277|365016414|FG001|Overall Study|Adverse Event|0|||
105824908|NCT01642277|365016413|FG000|Overall Study|Physician Decision|2|||
105824909|NCT01642277|365016414|FG001|Overall Study|Physician Decision|0|||
105824910|NCT01642277|365016413|FG000|Overall Study|Protocol Violation|1|||
105824911|NCT01642277|365016414|FG001|Overall Study|Protocol Violation|0|||
105824912|NCT01642277|365016413|FG000|Overall Study|Withdrawal by Subject|11|||
105824913|NCT01642277|365016414|FG001|Overall Study|Withdrawal by Subject|0|||
105824914|NCT01444378|365016418|FG000|Overall Study|Lost to Follow-up|1|||
105824915|NCT01444378|365016418|FG000|Overall Study|Withdrawal by Subject|1|||
105824916|NCT01444378|365016418|FG000|Overall Study|Death|3|||
105824917|NCT01444378|365016418|FG000|Overall Study|Administrative Closure Of The Study|2|||
105824918|NCT01444378|365016418|FG000|Overall Study|Missed Visits|10|||
105824919|NCT04022954|365016419|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
105824920|NCT04022954|365016419|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
105824921|NCT04022954|365016419|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
105824922|NCT02558491|365016424|FG000|First Invention|Withdrawal by Subject|3|||
105824923|NCT02558491|365016425|FG001|First Invention|Withdrawal by Subject|1|||
105824924|NCT02558491|365016424|FG000|First Invention|Data collection issues|1|||
105824925|NCT02558491|365016425|FG001|First Invention|Data collection issues|0|||
105824926|NCT02558491|365016424|FG000|First Invention|Stopping criteria|0|||
105824927|NCT02558491|365016425|FG001|First Invention|Stopping criteria|1|||
105824928|NCT02558491|365016424|FG000|First Invention|Changed parameters during trial|1|||
105824929|NCT02558491|365016425|FG001|First Invention|Changed parameters during trial|0|||
105824930|NCT02558491|365016424|FG000|Second Intervention|Withdrawal by Subject|1|||
105824931|NCT02558491|365016425|FG001|Second Intervention|Withdrawal by Subject|0|||
105824932|NCT02558491|365016424|FG000|Second Intervention|Stopping Criteria|1|||
105824933|NCT02558491|365016425|FG001|Second Intervention|Stopping Criteria|0|||
105824934|NCT00834431|365016426|FG000|First Intervention|Adverse Event|0|||
105824935|NCT00834431|365016427|FG001|First Intervention|Adverse Event|1|||
105824936|NCT00834431|365016426|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
105824937|NCT00834431|365016427|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
105824938|NCT03249454|365016430|FG000|Overall Study|Withdrawal by Subject|0|||
105824939|NCT03249454|365016431|FG001|Overall Study|Withdrawal by Subject|0|||
105824940|NCT03249454|365016432|FG002|Overall Study|Withdrawal by Subject|0|||
105824941|NCT03249454|365016433|FG003|Overall Study|Withdrawal by Subject|0|||
105824942|NCT03249454|365016434|FG004|Overall Study|Withdrawal by Subject|0|||
105824943|NCT03249454|365016435|FG005|Overall Study|Withdrawal by Subject|0|||
105824944|NCT03249454|365016436|FG006|Overall Study|Withdrawal by Subject|0|||
105824945|NCT03249454|365016437|FG007|Overall Study|Withdrawal by Subject|0|||
105824946|NCT03249454|365016438|FG008|Overall Study|Withdrawal by Subject|0|||
105824947|NCT03249454|365016439|FG009|Overall Study|Withdrawal by Subject|1|||
105824948|NCT03249454|365016440|FG010|Overall Study|Withdrawal by Subject|1|||
105824949|NCT00796328|365016441|FG000|Overall Study|experienced hypotension requiring tx|6|||
105824950|NCT02842853|365016444|FG000|Overall Study|Non-compliance with the protocol|3|||
105824951|NCT02842853|365016445|FG001|Overall Study|Non-compliance with the protocol|7|||
105824952|NCT02842853|365016446|FG002|Overall Study|Non-compliance with the protocol|2|||
105824953|NCT02842853|365016447|FG003|Overall Study|Non-compliance with the protocol|5|||
105824954|NCT02842853|365016444|FG000|Overall Study|Subject met exclusion criteria|0|||
105824955|NCT02842853|365016445|FG001|Overall Study|Subject met exclusion criteria|1|||
105824956|NCT02842853|365016446|FG002|Overall Study|Subject met exclusion criteria|0|||
105824957|NCT02842853|365016447|FG003|Overall Study|Subject met exclusion criteria|0|||
105824958|NCT02842853|365016444|FG000|Overall Study|Withdrawal by Subject|11|||
105824959|NCT02842853|365016445|FG001|Overall Study|Withdrawal by Subject|13|||
105824960|NCT02842853|365016446|FG002|Overall Study|Withdrawal by Subject|9|||
105824961|NCT02842853|365016447|FG003|Overall Study|Withdrawal by Subject|8|||
105824962|NCT02842853|365016444|FG000|Overall Study|Lost to Follow-up|9|||
105824963|NCT02842853|365016445|FG001|Overall Study|Lost to Follow-up|13|||
105824964|NCT02842853|365016446|FG002|Overall Study|Lost to Follow-up|10|||
105824965|NCT02842853|365016447|FG003|Overall Study|Lost to Follow-up|11|||
105824966|NCT03261167|365016448|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
105824967|NCT03261167|365016449|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
105824968|NCT03261167|365016448|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
105824969|NCT03261167|365016449|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
105365661|NCT04003103|363345045|FG002|Overall Study|Withdrawal by Subject|1|||
105365662|NCT04003103|363345043|FG000|Overall Study|Status not recorded|0|||
105365663|NCT04003103|363345044|FG001|Overall Study|Status not recorded|2|||
105365664|NCT04003103|363345045|FG002|Overall Study|Status not recorded|0|||
105365665|NCT03829462|363345047|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
105365666|NCT03829462|363345048|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
105365667|NCT03829462|363345047|FG000|Overall Study|No treatment due to progression disease|0|||
105365668|NCT03829462|363345048|FG001|Overall Study|No treatment due to progression disease|1|||
105365669|NCT02718911|363345049|FG000|Overall Study|Adverse Event|0|||
105365670|NCT02718911|363345050|FG001|Overall Study|Adverse Event|0|||
105365671|NCT02718911|363345051|FG002|Overall Study|Adverse Event|0|||
105365672|NCT02718911|363345052|FG003|Overall Study|Adverse Event|0|||
105365673|NCT02718911|363345053|FG004|Overall Study|Adverse Event|0|||
105365674|NCT02718911|363345054|FG005|Overall Study|Adverse Event|0|||
105365675|NCT02718911|363345055|FG006|Overall Study|Adverse Event|0|||
105365676|NCT02718911|363345056|FG007|Overall Study|Adverse Event|0|||
105365677|NCT02718911|363345057|FG008|Overall Study|Adverse Event|0|||
105365678|NCT02718911|363345058|FG009|Overall Study|Adverse Event|2|||
105365679|NCT02718911|363345049|FG000|Overall Study|Death|2|||
105365680|NCT02718911|363345050|FG001|Overall Study|Death|3|||
105365681|NCT02718911|363345051|FG002|Overall Study|Death|1|||
105365682|NCT02718911|363345052|FG003|Overall Study|Death|0|||
105365683|NCT02718911|363345053|FG004|Overall Study|Death|1|||
105365684|NCT02718911|363345054|FG005|Overall Study|Death|3|||
105365685|NCT02718911|363345055|FG006|Overall Study|Death|1|||
105365686|NCT02718911|363345056|FG007|Overall Study|Death|1|||
105365687|NCT02718911|363345057|FG008|Overall Study|Death|4|||
105824970|NCT03261167|365016448|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
105824971|NCT03261167|365016449|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
105824972|NCT03261167|365016448|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
105824973|NCT03261167|365016449|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
105824974|NCT03261167|365016448|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
105824975|NCT03261167|365016449|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
105824976|NCT03889639|365016450|FG000|Overall Study|Withdrawal by Subject|0|||
105824977|NCT03889639|365016451|FG001|Overall Study|Withdrawal by Subject|0|||
105824978|NCT03889639|365016452|FG002|Overall Study|Withdrawal by Subject|0|||
105824979|NCT03889639|365016453|FG003|Overall Study|Withdrawal by Subject|0|||
105824980|NCT03889639|365016454|FG004|Overall Study|Withdrawal by Subject|0|||
105824981|NCT03889639|365016455|FG005|Overall Study|Withdrawal by Subject|0|||
105824982|NCT03889639|365016456|FG006|Overall Study|Withdrawal by Subject|0|||
105824983|NCT03889639|365016457|FG007|Overall Study|Withdrawal by Subject|1|||
105824984|NCT03256695|365016460|FG000|Overall Study|Adverse Event|8|||
105824985|NCT03256695|365016460|FG000|Overall Study|Death|2|||
105824986|NCT03256695|365016460|FG000|Overall Study|Withdrawal by Subject|14|||
105824987|NCT03256695|365016460|FG000|Overall Study|Non-compliance with study drug|1|||
105824988|NCT03256695|365016460|FG000|Overall Study|Lost to Follow-up|3|||
105824989|NCT03256695|365016460|FG000|Overall Study|Lack of Efficacy|3|||
105824990|NCT03256695|365016460|FG000|Overall Study|Protocol Violation|5|||
105824991|NCT03256695|365016460|FG000|Overall Study|Other than specified|3|||
105824992|NCT03930732|365016461|FG000|Overall Study|Adverse Event|9|||
105824993|NCT03930732|365016462|FG001|Overall Study|Adverse Event|7|||
105824994|NCT03930732|365016461|FG000|Overall Study|Poor compliance to protocol|0|||
105824995|NCT03930732|365016462|FG001|Overall Study|Poor compliance to protocol|1|||
105824996|NCT03930732|365016461|FG000|Overall Study|Withdrawal by Subject|23|||
105824997|NCT03930732|365016462|FG001|Overall Study|Withdrawal by Subject|11|||
105824998|NCT03930732|365016461|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
105824999|NCT03930732|365016462|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
105825000|NCT03930732|365016461|FG000|Overall Study|Other reason not related to COVID-19|5|||
105825001|NCT03930732|365016462|FG001|Overall Study|Other reason not related to COVID-19|8|||
105825002|NCT00606281|365016467|FG000|Overall Study|Adverse Event|11|||
105825003|NCT00606281|365016468|FG001|Overall Study|Adverse Event|12|||
105825004|NCT00606281|365016467|FG000|Overall Study|Death|1|||
105825005|NCT00606281|365016468|FG001|Overall Study|Death|0|||
105825006|NCT00606281|365016467|FG000|Overall Study|Lack of Efficacy|28|||
105825007|NCT00606281|365016468|FG001|Overall Study|Lack of Efficacy|35|||
105825008|NCT00606281|365016467|FG000|Overall Study|Physician Decision|0|||
105825009|NCT00606281|365016468|FG001|Overall Study|Physician Decision|1|||
105825010|NCT00606281|365016467|FG000|Overall Study|Protocol Violation|3|||
105825011|NCT00606281|365016468|FG001|Overall Study|Protocol Violation|3|||
105825012|NCT00606281|365016467|FG000|Overall Study|Withdrawal by Subject|11|||
105825013|NCT00606281|365016468|FG001|Overall Study|Withdrawal by Subject|13|||
105825014|NCT00606281|365016467|FG000|Overall Study|Progression to depressive phase|1|||
105825015|NCT00606281|365016468|FG001|Overall Study|Progression to depressive phase|1|||
105825016|NCT00606281|365016467|FG000|Overall Study|Change of residence or other commitments|1|||
105825017|NCT00606281|365016468|FG001|Overall Study|Change of residence or other commitments|1|||
105825018|NCT03236311|365016469|FG000|Overall Study|Study terminated by sponsor|0|||
105825019|NCT03236311|365016470|FG001|Overall Study|Study terminated by sponsor|2|||
105825020|NCT03236311|365016469|FG000|Overall Study|Adverse Event|0|||
105825021|NCT03236311|365016470|FG001|Overall Study|Adverse Event|1|||
105825022|NCT00796653|365016471|FG000|Overall Study|Adverse Event|19|||
105825023|NCT00796653|365016472|FG001|Overall Study|Adverse Event|16|||
105825024|NCT00796653|365016473|FG002|Overall Study|Adverse Event|16|||
105825025|NCT00796653|365016474|FG003|Overall Study|Adverse Event|16|||
105825026|NCT00796653|365016471|FG000|Overall Study|Lost to Follow-up|2|||
105825027|NCT00796653|365016472|FG001|Overall Study|Lost to Follow-up|1|||
105825028|NCT00796653|365016473|FG002|Overall Study|Lost to Follow-up|2|||
105825029|NCT00796653|365016474|FG003|Overall Study|Lost to Follow-up|3|||
105825030|NCT00796653|365016471|FG000|Overall Study|Withdrawal by Subject|16|||
105825031|NCT00796653|365016472|FG001|Overall Study|Withdrawal by Subject|8|||
105825032|NCT00796653|365016473|FG002|Overall Study|Withdrawal by Subject|8|||
105825033|NCT00796653|365016474|FG003|Overall Study|Withdrawal by Subject|13|||
105825034|NCT00796653|365016471|FG000|Overall Study|Lack of Efficacy|8|||
105825035|NCT00796653|365016472|FG001|Overall Study|Lack of Efficacy|1|||
105825036|NCT00796653|365016473|FG002|Overall Study|Lack of Efficacy|3|||
105825037|NCT00796653|365016474|FG003|Overall Study|Lack of Efficacy|2|||
105825038|NCT00796653|365016471|FG000|Overall Study|Non compliance with protocol|2|||
105825039|NCT00796653|365016472|FG001|Overall Study|Non compliance with protocol|2|||
105825040|NCT00796653|365016473|FG002|Overall Study|Non compliance with protocol|0|||
105825041|NCT00796653|365016474|FG003|Overall Study|Non compliance with protocol|2|||
105825042|NCT00796653|365016471|FG000|Overall Study|Other reason not described above|4|||
105825043|NCT00796653|365016472|FG001|Overall Study|Other reason not described above|9|||
105825044|NCT00796653|365016473|FG002|Overall Study|Other reason not described above|7|||
105825045|NCT00796653|365016474|FG003|Overall Study|Other reason not described above|4|||
105825046|NCT02409355|365016479|FG000|Overall Study|Withdrawal by Subject|1|||
105825047|NCT02409355|365016480|FG001|Overall Study|Withdrawal by Subject|0|||
105825048|NCT02409355|365016479|FG000|Overall Study|Death|1|||
105825049|NCT02409355|365016480|FG001|Overall Study|Death|1|||
105825050|NCT02409355|365016479|FG000|Overall Study|Study terminated by Sponsor|2|||
105825051|NCT02409355|365016480|FG001|Overall Study|Study terminated by Sponsor|3|||
105825052|NCT04633564|365016481|FG000|Period 1|Adverse Event|28|||
105825053|NCT04633564|365016482|FG001|Period 1|Adverse Event|19|||
105365688|NCT02718911|363345058|FG009|Overall Study|Death|3|||
105365689|NCT02718911|363345049|FG000|Overall Study|Lost to Follow-up|0|||
105365690|NCT02718911|363345050|FG001|Overall Study|Lost to Follow-up|0|||
105365691|NCT02718911|363345051|FG002|Overall Study|Lost to Follow-up|0|||
105365692|NCT02718911|363345052|FG003|Overall Study|Lost to Follow-up|0|||
105365693|NCT02718911|363345053|FG004|Overall Study|Lost to Follow-up|0|||
105365694|NCT02718911|363345054|FG005|Overall Study|Lost to Follow-up|0|||
105365695|NCT02718911|363345055|FG006|Overall Study|Lost to Follow-up|0|||
105365696|NCT02718911|363345056|FG007|Overall Study|Lost to Follow-up|0|||
105365697|NCT02718911|363345057|FG008|Overall Study|Lost to Follow-up|1|||
105365698|NCT02718911|363345058|FG009|Overall Study|Lost to Follow-up|0|||
105365699|NCT02718911|363345049|FG000|Overall Study|Physician Decision|2|||
105825054|NCT04633564|365016481|FG000|Period 1|Death|8|||
105825055|NCT04633564|365016482|FG001|Period 1|Death|7|||
105825056|NCT04633564|365016481|FG000|Period 1|Lost to Follow-up|3|||
105825057|NCT04633564|365016482|FG001|Period 1|Lost to Follow-up|5|||
105825058|NCT04633564|365016481|FG000|Period 1|Physician Decision|4|||
105825059|NCT04633564|365016482|FG001|Period 1|Physician Decision|12|||
105825060|NCT04633564|365016481|FG000|Period 1|Protocol Violation|0|||
105825061|NCT04633564|365016482|FG001|Period 1|Protocol Violation|1|||
105825062|NCT04633564|365016481|FG000|Period 1|Withdrawal by Subject|10|||
105365700|NCT02718911|363345050|FG001|Overall Study|Physician Decision|0|||
105365701|NCT02718911|363345051|FG002|Overall Study|Physician Decision|1|||
105825063|NCT04633564|365016482|FG001|Period 1|Withdrawal by Subject|8|||
105825064|NCT04633564|365016481|FG000|Period 1|Progressive disease|47|||
105825065|NCT04633564|365016482|FG001|Period 1|Progressive disease|51|||
105365702|NCT02718911|363345052|FG003|Overall Study|Physician Decision|1|||
105365703|NCT02718911|363345053|FG004|Overall Study|Physician Decision|0|||
105365704|NCT02718911|363345054|FG005|Overall Study|Physician Decision|0|||
105487408|NCT02964507|363797007|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
105365705|NCT02718911|363345055|FG006|Overall Study|Physician Decision|0|||
105825066|NCT04633564|365016481|FG000|Period 1|Terminated by Sponsor|8|||
105825067|NCT04633564|365016482|FG001|Period 1|Terminated by Sponsor|6|||
105825068|NCT04633564|365016481|FG000|Period 2|Adverse Event|3|||
105572427|NCT00452413|364094521|FG000|Overall Study|Death due to adverse event (AE)|0|||
105572428|NCT00452413|364094522|FG001|Overall Study|Death due to adverse event (AE)|0|||
105365706|NCT02718911|363345056|FG007|Overall Study|Physician Decision|1|||
105365707|NCT02718911|363345057|FG008|Overall Study|Physician Decision|2|||
105365708|NCT02718911|363345058|FG009|Overall Study|Physician Decision|1|||
105365709|NCT02718911|363345049|FG000|Overall Study|Withdrawal by Subject|0|||
105365710|NCT02718911|363345050|FG001|Overall Study|Withdrawal by Subject|0|||
105365711|NCT02718911|363345051|FG002|Overall Study|Withdrawal by Subject|0|||
105365712|NCT02718911|363345052|FG003|Overall Study|Withdrawal by Subject|0|||
105365713|NCT02718911|363345053|FG004|Overall Study|Withdrawal by Subject|1|||
105365714|NCT02718911|363345054|FG005|Overall Study|Withdrawal by Subject|0|||
105365715|NCT02718911|363345055|FG006|Overall Study|Withdrawal by Subject|0|||
105365716|NCT02718911|363345056|FG007|Overall Study|Withdrawal by Subject|0|||
105365717|NCT02718911|363345057|FG008|Overall Study|Withdrawal by Subject|1|||
105365718|NCT02718911|363345058|FG009|Overall Study|Withdrawal by Subject|4|||
105365719|NCT02718911|363345049|FG000|Overall Study|Reason Not Collected|0|||
105365720|NCT02718911|363345050|FG001|Overall Study|Reason Not Collected|0|||
105365721|NCT02718911|363345051|FG002|Overall Study|Reason Not Collected|1|||
105365722|NCT02718911|363345052|FG003|Overall Study|Reason Not Collected|0|||
105365723|NCT02718911|363345053|FG004|Overall Study|Reason Not Collected|0|||
105365724|NCT02718911|363345054|FG005|Overall Study|Reason Not Collected|0|||
105365725|NCT02718911|363345055|FG006|Overall Study|Reason Not Collected|2|||
105365726|NCT02718911|363345056|FG007|Overall Study|Reason Not Collected|1|||
105365727|NCT02718911|363345057|FG008|Overall Study|Reason Not Collected|4|||
105365728|NCT02718911|363345058|FG009|Overall Study|Reason Not Collected|9|||
105365729|NCT05002972|363345059|FG000|Overall Study|Withdrawal by Subject|2|||
105365730|NCT05518539|363345060|FG000|Overall Study|Lost to Follow-up|6|||
105365731|NCT03976375|363345063|FG000|Overall Study|Death|147|||
105365732|NCT03976375|363345064|FG001|Overall Study|Death|150|||
105365733|NCT03976375|363345065|FG002|Overall Study|Death|38|||
105365734|NCT03976375|363345063|FG000|Overall Study|Lost to Follow-up|1|||
105365735|NCT03976375|363345064|FG001|Overall Study|Lost to Follow-up|1|||
105365736|NCT03976375|363345065|FG002|Overall Study|Lost to Follow-up|1|||
105365737|NCT03976375|363345063|FG000|Overall Study|Withdrawal by Subject|4|||
105365738|NCT03976375|363345064|FG001|Overall Study|Withdrawal by Subject|9|||
105365739|NCT03976375|363345065|FG002|Overall Study|Withdrawal by Subject|4|||
105365740|NCT03976375|363345063|FG000|Overall Study|Ongoing|33|||
105365741|NCT03976375|363345064|FG001|Overall Study|Ongoing|29|||
105365742|NCT03976375|363345065|FG002|Overall Study|Ongoing|5|||
105365743|NCT05616013|363345066|FG000|Overall Study|Adverse Event|6|||
105365744|NCT05616013|363345067|FG001|Overall Study|Adverse Event|12|||
105365745|NCT05616013|363345068|FG002|Overall Study|Adverse Event|8|||
105365746|NCT05616013|363345069|FG003|Overall Study|Adverse Event|4|||
105365747|NCT05616013|363345070|FG004|Overall Study|Adverse Event|6|||
105365748|NCT05616013|363345071|FG005|Overall Study|Adverse Event|8|||
105365749|NCT05616013|363345072|FG006|Overall Study|Adverse Event|3|||
105365750|NCT05616013|363345073|FG007|Overall Study|Adverse Event|6|||
105365751|NCT05616013|363345074|FG008|Overall Study|Adverse Event|1|||
105365752|NCT05616013|363345066|FG000|Overall Study|Lost to Follow-up|5|||
105365753|NCT05616013|363345067|FG001|Overall Study|Lost to Follow-up|4|||
105825069|NCT04633564|365016482|FG001|Period 2|Adverse Event|4|||
105487409|NCT02964507|363797008|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
105487410|NCT02964507|363797009|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
105825070|NCT04633564|365016481|FG000|Period 2|Death|0|||
105825071|NCT04633564|365016482|FG001|Period 2|Death|2|||
105825072|NCT04633564|365016481|FG000|Period 2|Lost to Follow-up|0|||
105825073|NCT04633564|365016482|FG001|Period 2|Lost to Follow-up|1|||
105825074|NCT04633564|365016481|FG000|Period 2|Physician Decision|2|||
105825075|NCT04633564|365016482|FG001|Period 2|Physician Decision|4|||
105825076|NCT04633564|365016481|FG000|Period 2|Withdrawal by Subject|5|||
105825077|NCT04633564|365016482|FG001|Period 2|Withdrawal by Subject|1|||
105825078|NCT04633564|365016481|FG000|Period 2|Progressive Disease|74|||
105825079|NCT04633564|365016482|FG001|Period 2|Progressive Disease|82|||
105825080|NCT04633564|365016481|FG000|Period 2|Terminated by Sponsor|9|||
105825081|NCT04633564|365016482|FG001|Period 2|Terminated by Sponsor|3|||
105825082|NCT01010503|365016483|FG000|Overall Study|Adverse Event|1|||
105825083|NCT01010503|365016483|FG000|Overall Study|Death|1|||
105825084|NCT02358538|365016484|FG000|Through Week 26|Adverse Event|0|||
105825085|NCT02358538|365016485|FG001|Through Week 26|Adverse Event|1|||
105825086|NCT02358538|365016486|FG002|Through Week 26|Adverse Event|1|||
105825087|NCT02358538|365016487|FG003|Through Week 26|Adverse Event|2|||
105825088|NCT02358538|365016484|FG000|Through Week 26|Lack of Efficacy|1|||
105825089|NCT02358538|365016485|FG001|Through Week 26|Lack of Efficacy|1|||
105825090|NCT02358538|365016486|FG002|Through Week 26|Lack of Efficacy|3|||
105825091|NCT02358538|365016487|FG003|Through Week 26|Lack of Efficacy|3|||
105825092|NCT02358538|365016484|FG000|Through Week 26|Withdrawal by Subject|1|||
105825093|NCT02358538|365016485|FG001|Through Week 26|Withdrawal by Subject|0|||
105825094|NCT02358538|365016486|FG002|Through Week 26|Withdrawal by Subject|0|||
105825095|NCT02358538|365016487|FG003|Through Week 26|Withdrawal by Subject|0|||
105825096|NCT02358538|365016484|FG000|Through Week 26|Non-Compliance|0|||
105825097|NCT02358538|365016485|FG001|Through Week 26|Non-Compliance|0|||
105825098|NCT02358538|365016486|FG002|Through Week 26|Non-Compliance|1|||
105825099|NCT02358538|365016487|FG003|Through Week 26|Non-Compliance|0|||
105825100|NCT02358538|365016484|FG000|Through Week 26|Family did not see benefit from IP|1|||
105825101|NCT02358538|365016485|FG001|Through Week 26|Family did not see benefit from IP|0|||
105487411|NCT02964507|363797010|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
105825102|NCT02358538|365016486|FG002|Through Week 26|Family did not see benefit from IP|0|||
105825103|NCT02358538|365016487|FG003|Through Week 26|Family did not see benefit from IP|0|||
105825104|NCT02358538|365016484|FG000|52 Week Extension Period|Lack of Efficacy|0|||
105825105|NCT02358538|365016485|FG001|52 Week Extension Period|Lack of Efficacy|0|||
105365754|NCT05616013|363345068|FG002|Overall Study|Lost to Follow-up|3|||
105365755|NCT05616013|363345069|FG003|Overall Study|Lost to Follow-up|2|||
105365756|NCT05616013|363345070|FG004|Overall Study|Lost to Follow-up|0|||
105365757|NCT05616013|363345071|FG005|Overall Study|Lost to Follow-up|5|||
105365758|NCT05616013|363345072|FG006|Overall Study|Lost to Follow-up|2|||
105365759|NCT05616013|363345073|FG007|Overall Study|Lost to Follow-up|1|||
105365760|NCT05616013|363345074|FG008|Overall Study|Lost to Follow-up|2|||
105365761|NCT05616013|363345066|FG000|Overall Study|Non-compliance with study requirements|2|||
105365762|NCT05616013|363345067|FG001|Overall Study|Non-compliance with study requirements|2|||
105365763|NCT05616013|363345068|FG002|Overall Study|Non-compliance with study requirements|2|||
105825106|NCT02358538|365016486|FG002|52 Week Extension Period|Lack of Efficacy|2|||
105825107|NCT02358538|365016487|FG003|52 Week Extension Period|Lack of Efficacy|4|||
105825108|NCT01494532|365016490|FG000|Overall Study|Adverse Event|4|||
105825109|NCT01494532|365016491|FG001|Overall Study|Adverse Event|1|||
105825110|NCT01494532|365016492|FG002|Overall Study|Adverse Event|8|||
105825111|NCT01494532|365016493|FG003|Overall Study|Adverse Event|6|||
105825112|NCT01494532|365016494|FG004|Overall Study|Adverse Event|5|||
105825113|NCT01494532|365016495|FG005|Overall Study|Adverse Event|0|||
105825114|NCT01494532|365016490|FG000|Overall Study|Lack of Efficacy|0|||
105365764|NCT05616013|363345069|FG003|Overall Study|Non-compliance with study requirements|3|||
105365765|NCT05616013|363345070|FG004|Overall Study|Non-compliance with study requirements|0|||
105365766|NCT05616013|363345071|FG005|Overall Study|Non-compliance with study requirements|2|||
105365767|NCT05616013|363345072|FG006|Overall Study|Non-compliance with study requirements|1|||
105365768|NCT05616013|363345073|FG007|Overall Study|Non-compliance with study requirements|1|||
105365769|NCT05616013|363345074|FG008|Overall Study|Non-compliance with study requirements|4|||
105365770|NCT05616013|363345066|FG000|Overall Study|Withdrawal by Subject|11|||
105365771|NCT05616013|363345067|FG001|Overall Study|Withdrawal by Subject|9|||
105365772|NCT05616013|363345068|FG002|Overall Study|Withdrawal by Subject|8|||
105365773|NCT05616013|363345069|FG003|Overall Study|Withdrawal by Subject|6|||
105365774|NCT05616013|363345070|FG004|Overall Study|Withdrawal by Subject|3|||
105365775|NCT05616013|363345071|FG005|Overall Study|Withdrawal by Subject|4|||
105365776|NCT05616013|363345072|FG006|Overall Study|Withdrawal by Subject|6|||
105365777|NCT05616013|363345073|FG007|Overall Study|Withdrawal by Subject|5|||
105365778|NCT05616013|363345074|FG008|Overall Study|Withdrawal by Subject|4|||
105365779|NCT05616013|363345066|FG000|Overall Study|Physician Decision|0|||
105365780|NCT05616013|363345067|FG001|Overall Study|Physician Decision|0|||
105365781|NCT05616013|363345068|FG002|Overall Study|Physician Decision|1|||
105365782|NCT05616013|363345069|FG003|Overall Study|Physician Decision|0|||
105365783|NCT05616013|363345070|FG004|Overall Study|Physician Decision|0|||
105487412|NCT02964507|363797011|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
105487413|NCT02964507|363797012|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
105487414|NCT02964507|363797005|FG000|Overall Study|Study terminated by Sponsor|9|||
105487415|NCT02964507|363797006|FG001|Overall Study|Study terminated by Sponsor|1|||
105487416|NCT02964507|363797007|FG002|Overall Study|Study terminated by Sponsor|9|||
105825115|NCT01494532|365016491|FG001|Overall Study|Lack of Efficacy|0|||
105365784|NCT05616013|363345071|FG005|Overall Study|Physician Decision|1|||
105487417|NCT02964507|363797008|FG003|Overall Study|Study terminated by Sponsor|3|||
105825116|NCT01494532|365016492|FG002|Overall Study|Lack of Efficacy|0|||
105825117|NCT01494532|365016493|FG003|Overall Study|Lack of Efficacy|0|||
105825118|NCT01494532|365016494|FG004|Overall Study|Lack of Efficacy|2|||
105825119|NCT01494532|365016495|FG005|Overall Study|Lack of Efficacy|0|||
105825120|NCT01494532|365016490|FG000|Overall Study|Protocol deviation|2|||
105365785|NCT05616013|363345072|FG006|Overall Study|Physician Decision|3|||
105365786|NCT05616013|363345073|FG007|Overall Study|Physician Decision|0|||
105825121|NCT01494532|365016491|FG001|Overall Study|Protocol deviation|1|||
105825122|NCT01494532|365016492|FG002|Overall Study|Protocol deviation|3|||
105487418|NCT02964507|363797009|FG004|Overall Study|Study terminated by Sponsor|3|||
105487419|NCT02964507|363797010|FG005|Overall Study|Study terminated by Sponsor|2|||
105487420|NCT02964507|363797011|FG006|Overall Study|Study terminated by Sponsor|0|||
105487421|NCT02964507|363797012|FG007|Overall Study|Study terminated by Sponsor|0|||
105487422|NCT02964507|363797005|FG000|Overall Study|Other|3|||
105487423|NCT02964507|363797006|FG001|Overall Study|Other|0|||
105487424|NCT02964507|363797007|FG002|Overall Study|Other|0|||
105487425|NCT02964507|363797008|FG003|Overall Study|Other|0|||
105487426|NCT02964507|363797009|FG004|Overall Study|Other|1|||
105487427|NCT02964507|363797010|FG005|Overall Study|Other|0|||
105487428|NCT02964507|363797011|FG006|Overall Study|Other|0|||
105487429|NCT02964507|363797012|FG007|Overall Study|Other|0|||
105825123|NCT01494532|365016493|FG003|Overall Study|Protocol deviation|2|||
105825124|NCT01494532|365016494|FG004|Overall Study|Protocol deviation|3|||
105825125|NCT01494532|365016495|FG005|Overall Study|Protocol deviation|0|||
105487430|NCT02964507|363797005|FG000|Overall Study|Death|11|||
105487431|NCT02964507|363797006|FG001|Overall Study|Death|9|||
105487432|NCT02964507|363797007|FG002|Overall Study|Death|12|||
105487433|NCT02964507|363797008|FG003|Overall Study|Death|2|||
105487434|NCT02964507|363797009|FG004|Overall Study|Death|10|||
105487435|NCT02964507|363797010|FG005|Overall Study|Death|5|||
105487436|NCT02964507|363797011|FG006|Overall Study|Death|0|||
105487437|NCT02964507|363797012|FG007|Overall Study|Death|0|||
105487438|NCT02964507|363797005|FG000|Overall Study|Withdrawal by Subject|1|||
105487439|NCT02964507|363797006|FG001|Overall Study|Withdrawal by Subject|0|||
105825126|NCT01494532|365016490|FG000|Overall Study|Protocol-defined stopping criteria|0|||
105825127|NCT01494532|365016491|FG001|Overall Study|Protocol-defined stopping criteria|0|||
105825128|NCT01494532|365016492|FG002|Overall Study|Protocol-defined stopping criteria|1|||
105825129|NCT01494532|365016493|FG003|Overall Study|Protocol-defined stopping criteria|0|||
105825130|NCT01494532|365016494|FG004|Overall Study|Protocol-defined stopping criteria|0|||
105825131|NCT01494532|365016495|FG005|Overall Study|Protocol-defined stopping criteria|0|||
105825132|NCT01494532|365016490|FG000|Overall Study|Lost to Follow-up|1|||
105825133|NCT01494532|365016491|FG001|Overall Study|Lost to Follow-up|0|||
105825134|NCT01494532|365016492|FG002|Overall Study|Lost to Follow-up|0|||
105825135|NCT01494532|365016493|FG003|Overall Study|Lost to Follow-up|2|||
105825136|NCT01494532|365016494|FG004|Overall Study|Lost to Follow-up|0|||
105825137|NCT01494532|365016495|FG005|Overall Study|Lost to Follow-up|0|||
105825138|NCT01494532|365016490|FG000|Overall Study|Physician Decision|0|||
105825139|NCT01494532|365016491|FG001|Overall Study|Physician Decision|1|||
105825140|NCT01494532|365016492|FG002|Overall Study|Physician Decision|1|||
105825141|NCT01494532|365016493|FG003|Overall Study|Physician Decision|2|||
105825142|NCT01494532|365016494|FG004|Overall Study|Physician Decision|0|||
105825143|NCT01494532|365016495|FG005|Overall Study|Physician Decision|0|||
105825144|NCT01494532|365016490|FG000|Overall Study|Withdrawal by Subject|3|||
105825145|NCT01494532|365016491|FG001|Overall Study|Withdrawal by Subject|1|||
105825146|NCT01494532|365016492|FG002|Overall Study|Withdrawal by Subject|4|||
105825147|NCT01494532|365016493|FG003|Overall Study|Withdrawal by Subject|3|||
105825148|NCT01494532|365016494|FG004|Overall Study|Withdrawal by Subject|2|||
105825149|NCT01494532|365016495|FG005|Overall Study|Withdrawal by Subject|0|||
105825150|NCT00730691|365016497|FG000|Overall Study|Adverse Event|4|||
105825151|NCT00730691|365016498|FG001|Overall Study|Adverse Event|8|||
105825152|NCT00730691|365016499|FG002|Overall Study|Adverse Event|11|||
105825153|NCT00730691|365016500|FG003|Overall Study|Adverse Event|11|||
105825154|NCT00730691|365016501|FG004|Overall Study|Adverse Event|23|||
105825155|NCT00730691|365016497|FG000|Overall Study|Lack of Efficacy|4|||
105825156|NCT00730691|365016498|FG001|Overall Study|Lack of Efficacy|4|||
105487440|NCT02964507|363797007|FG002|Overall Study|Withdrawal by Subject|1|||
105825157|NCT00730691|365016499|FG002|Overall Study|Lack of Efficacy|2|||
105825158|NCT00730691|365016500|FG003|Overall Study|Lack of Efficacy|1|||
105825159|NCT00730691|365016501|FG004|Overall Study|Lack of Efficacy|1|||
105825160|NCT00730691|365016497|FG000|Overall Study|Non-compliance with Study Drug|6|||
105825161|NCT00730691|365016498|FG001|Overall Study|Non-compliance with Study Drug|1|||
105825162|NCT00730691|365016499|FG002|Overall Study|Non-compliance with Study Drug|6|||
105825163|NCT00730691|365016500|FG003|Overall Study|Non-compliance with Study Drug|3|||
105825164|NCT00730691|365016501|FG004|Overall Study|Non-compliance with Study Drug|3|||
105365787|NCT05616013|363345074|FG008|Overall Study|Physician Decision|0|||
105365788|NCT05616013|363345066|FG000|Overall Study|Protocol Violation|0|||
105365789|NCT05616013|363345067|FG001|Overall Study|Protocol Violation|0|||
105365790|NCT05616013|363345068|FG002|Overall Study|Protocol Violation|0|||
105365791|NCT05616013|363345069|FG003|Overall Study|Protocol Violation|0|||
105365792|NCT05616013|363345070|FG004|Overall Study|Protocol Violation|0|||
105365793|NCT05616013|363345071|FG005|Overall Study|Protocol Violation|0|||
105365794|NCT05616013|363345072|FG006|Overall Study|Protocol Violation|1|||
105365795|NCT05616013|363345073|FG007|Overall Study|Protocol Violation|0|||
105365796|NCT05616013|363345074|FG008|Overall Study|Protocol Violation|2|||
105365797|NCT05616013|363345066|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
105365798|NCT05616013|363345067|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
105365799|NCT05616013|363345068|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
105365800|NCT05616013|363345069|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
105365801|NCT05616013|363345070|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
105365802|NCT05616013|363345071|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
105365803|NCT05616013|363345072|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
105365804|NCT05616013|363345073|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
105365805|NCT05616013|363345074|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
105365806|NCT05616013|363345066|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
105365807|NCT05616013|363345067|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
105365808|NCT05616013|363345068|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
105365809|NCT05616013|363345069|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
105365810|NCT05616013|363345070|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
105365811|NCT05616013|363345071|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
105365812|NCT05616013|363345072|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
105365813|NCT05616013|363345073|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
105365814|NCT05616013|363345074|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
105365815|NCT05616013|363345066|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
105365816|NCT05616013|363345067|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105365817|NCT05616013|363345068|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105365818|NCT05616013|363345069|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105365819|NCT05616013|363345070|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105365820|NCT05616013|363345071|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105365821|NCT05616013|363345072|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105365822|NCT05616013|363345073|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105365823|NCT05616013|363345074|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105365824|NCT05616013|363345066|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105365825|NCT05616013|363345067|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
105365826|NCT05616013|363345068|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105365827|NCT05616013|363345069|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105365828|NCT05616013|363345070|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105365829|NCT05616013|363345071|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105365830|NCT05616013|363345072|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105365831|NCT05616013|363345073|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105365832|NCT05616013|363345074|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105365833|NCT05616013|363345066|FG000|Overall Study|Participant Decision, Time Constraints|0|||
105365834|NCT05616013|363345067|FG001|Overall Study|Participant Decision, Time Constraints|1|||
105365835|NCT05616013|363345068|FG002|Overall Study|Participant Decision, Time Constraints|0|||
105365836|NCT05616013|363345069|FG003|Overall Study|Participant Decision, Time Constraints|0|||
105365837|NCT05616013|363345070|FG004|Overall Study|Participant Decision, Time Constraints|0|||
105365838|NCT05616013|363345071|FG005|Overall Study|Participant Decision, Time Constraints|0|||
105365839|NCT05616013|363345072|FG006|Overall Study|Participant Decision, Time Constraints|0|||
105365840|NCT05616013|363345073|FG007|Overall Study|Participant Decision, Time Constraints|0|||
105365841|NCT05616013|363345074|FG008|Overall Study|Participant Decision, Time Constraints|0|||
105365842|NCT05616013|363345066|FG000|Overall Study|Prohibited Concomitant Medication|0|||
105365843|NCT05616013|363345067|FG001|Overall Study|Prohibited Concomitant Medication|0|||
105365844|NCT05616013|363345068|FG002|Overall Study|Prohibited Concomitant Medication|1|||
105365845|NCT05616013|363345069|FG003|Overall Study|Prohibited Concomitant Medication|0|||
105365846|NCT05616013|363345070|FG004|Overall Study|Prohibited Concomitant Medication|0|||
105825165|NCT00730691|365016497|FG000|Overall Study|Protocol Deviations|3|||
105365847|NCT05616013|363345071|FG005|Overall Study|Prohibited Concomitant Medication|0|||
105365848|NCT05616013|363345072|FG006|Overall Study|Prohibited Concomitant Medication|0|||
105365849|NCT05616013|363345073|FG007|Overall Study|Prohibited Concomitant Medication|0|||
105365850|NCT05616013|363345074|FG008|Overall Study|Prohibited Concomitant Medication|0|||
105487441|NCT02964507|363797008|FG003|Overall Study|Withdrawal by Subject|1|||
105487442|NCT02964507|363797009|FG004|Overall Study|Withdrawal by Subject|0|||
105487443|NCT02964507|363797010|FG005|Overall Study|Withdrawal by Subject|1|||
105768618|NCT03039790|364804470|FG002|Overall Study|Withdrawal of Consent|0|||
105768619|NCT03039790|364804471|FG003|Overall Study|Withdrawal of Consent|1|||
105768620|NCT03039790|364804472|FG004|Overall Study|Withdrawal of Consent|0|||
105768621|NCT03039790|364804473|FG005|Overall Study|Withdrawal of Consent|0|||
105768622|NCT03039790|364804474|FG006|Overall Study|Withdrawal of Consent|0|||
105768623|NCT03039790|364804475|FG007|Overall Study|Withdrawal of Consent|0|||
105768624|NCT03039790|364804476|FG008|Overall Study|Withdrawal of Consent|0|||
105768625|NCT03039790|364804477|FG009|Overall Study|Withdrawal of Consent|1|||
105768626|NCT03039790|364804478|FG010|Overall Study|Withdrawal of Consent|0|||
105768627|NCT03039790|364804479|FG011|Overall Study|Withdrawal of Consent|0|||
105768628|NCT03039790|364804480|FG012|Overall Study|Withdrawal of Consent|2|||
105768629|NCT03039790|364804481|FG013|Overall Study|Withdrawal of Consent|0|||
105768630|NCT03039790|364804482|FG014|Overall Study|Withdrawal of Consent|1|||
105768631|NCT03039790|364804483|FG015|Overall Study|Withdrawal of Consent|5|||
105768632|NCT03039790|364804484|FG016|Overall Study|Withdrawal of Consent|3|||
105768633|NCT03039790|364804485|FG017|Overall Study|Withdrawal of Consent|0|||
105768634|NCT03039790|364804486|FG018|Overall Study|Withdrawal of Consent|2|||
105768635|NCT03039790|364804487|FG019|Overall Study|Withdrawal of Consent|5|||
105768636|NCT03039790|364804468|FG000|Overall Study|Death|0|||
105768637|NCT03039790|364804469|FG001|Overall Study|Death|0|||
105768638|NCT03039790|364804470|FG002|Overall Study|Death|0|||
105768639|NCT03039790|364804471|FG003|Overall Study|Death|0|||
105768640|NCT03039790|364804472|FG004|Overall Study|Death|0|||
105768641|NCT03039790|364804473|FG005|Overall Study|Death|0|||
105768642|NCT03039790|364804474|FG006|Overall Study|Death|0|||
105825166|NCT00730691|365016498|FG001|Overall Study|Protocol Deviations|5|||
105825167|NCT00730691|365016499|FG002|Overall Study|Protocol Deviations|3|||
105825168|NCT00730691|365016500|FG003|Overall Study|Protocol Deviations|7|||
105825169|NCT00730691|365016501|FG004|Overall Study|Protocol Deviations|5|||
105825170|NCT00730691|365016497|FG000|Overall Study|Withdrawal of Consent|7|||
105825171|NCT00730691|365016498|FG001|Overall Study|Withdrawal of Consent|9|||
105825172|NCT00730691|365016499|FG002|Overall Study|Withdrawal of Consent|3|||
105825173|NCT00730691|365016500|FG003|Overall Study|Withdrawal of Consent|6|||
105825174|NCT00730691|365016501|FG004|Overall Study|Withdrawal of Consent|3|||
105825175|NCT00730691|365016497|FG000|Overall Study|Lost to Follow-up|11|||
105825176|NCT00730691|365016498|FG001|Overall Study|Lost to Follow-up|8|||
105825177|NCT00730691|365016499|FG002|Overall Study|Lost to Follow-up|13|||
105825178|NCT00730691|365016500|FG003|Overall Study|Lost to Follow-up|15|||
105825179|NCT00730691|365016501|FG004|Overall Study|Lost to Follow-up|13|||
105825180|NCT00730691|365016497|FG000|Overall Study|Other|1|||
105825181|NCT00730691|365016498|FG001|Overall Study|Other|1|||
105825182|NCT00730691|365016499|FG002|Overall Study|Other|1|||
105825183|NCT00730691|365016500|FG003|Overall Study|Other|2|||
105825184|NCT00730691|365016501|FG004|Overall Study|Other|2|||
105825185|NCT02554890|365016502|FG000|Double-blind|Adverse Event|45|||
105825186|NCT02554890|365016503|FG001|Double-blind|Adverse Event|51|||
105825187|NCT02554890|365016502|FG000|Double-blind|Death|6|||
105825188|NCT02554890|365016503|FG001|Double-blind|Death|4|||
105825189|NCT02554890|365016502|FG000|Double-blind|Protocol Violation|1|||
105825190|NCT02554890|365016503|FG001|Double-blind|Protocol Violation|1|||
105825191|NCT02554890|365016502|FG000|Double-blind|Physician Decision|4|||
105825192|NCT02554890|365016503|FG001|Double-blind|Physician Decision|3|||
105825193|NCT02554890|365016502|FG000|Double-blind|Subject/Guardian decision|21|||
105825194|NCT02554890|365016503|FG001|Double-blind|Subject/Guardian decision|16|||
105825195|NCT02554890|365016502|FG000|Double-blind|Lost to Follow-up|7|||
105825196|NCT02554890|365016503|FG001|Double-blind|Lost to Follow-up|5|||
105825197|NCT02554890|365016502|FG000|Double-blind|Technical problems|1|||
105825198|NCT02554890|365016503|FG001|Double-blind|Technical problems|0|||
105825199|NCT02554890|365016502|FG000|Double-blind|Withdrawal by Subject|5|||
105825200|NCT02554890|365016503|FG001|Double-blind|Withdrawal by Subject|6|||
105825201|NCT02554890|365016502|FG000|Double-blind|Noncompliance with study treatment|6|||
105825202|NCT02554890|365016503|FG001|Double-blind|Noncompliance with study treatment|5|||
105825203|NCT02554890|365016502|FG000|Open-label|Adverse Event|0|||
105825204|NCT02554890|365016503|FG001|Open-label|Adverse Event|30|||
105825205|NCT02554890|365016502|FG000|Open-label|Death|0|||
105825206|NCT02554890|365016503|FG001|Open-label|Death|1|||
105825207|NCT02554890|365016502|FG000|Open-label|Physician Decision|0|||
105825208|NCT02554890|365016503|FG001|Open-label|Physician Decision|1|||
105825209|NCT02554890|365016502|FG000|Open-label|Subject/Guardian decision|0|||
105825210|NCT02554890|365016503|FG001|Open-label|Subject/Guardian decision|11|||
105439860|NCT02476006|363615095|FG000|Overall Study|Enrolled but not treated|4|||
105825211|NCT02554890|365016502|FG000|Open-label|Lost to Follow-up|0|||
105825212|NCT02554890|365016503|FG001|Open-label|Lost to Follow-up|7|||
105825213|NCT02554890|365016502|FG000|Open-label|Technical problems|0|||
105825214|NCT02554890|365016503|FG001|Open-label|Technical problems|1|||
105825215|NCT02554890|365016502|FG000|Open-label|Withdrawal by Subject|0|||
105825216|NCT02554890|365016503|FG001|Open-label|Withdrawal by Subject|1|||
105825217|NCT03067987|365016504|FG000|Overall Study|Lost to Follow-up|7|||
105825218|NCT03067987|365016505|FG001|Overall Study|Lost to Follow-up|10|||
105825219|NCT03067987|365016504|FG000|Overall Study|Protocol Violation|1|||
105825220|NCT03067987|365016505|FG001|Overall Study|Protocol Violation|2|||
105825221|NCT03067987|365016504|FG000|Overall Study|Withdrawal by Subject|2|||
105825222|NCT03067987|365016505|FG001|Overall Study|Withdrawal by Subject|1|||
105825223|NCT00477594|365016508|FG000|Year 1 and Year 2|Adverse Event|4|||
105825224|NCT00477594|365016509|FG001|Year 1 and Year 2|Adverse Event|2|||
105825225|NCT00477594|365016508|FG000|Year 1 and Year 2|Physician Decision|2|||
105365851|NCT05616013|363345066|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
105365852|NCT05616013|363345067|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
105365853|NCT05616013|363345068|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
105365854|NCT05616013|363345069|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
105365855|NCT05616013|363345070|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
105365856|NCT05616013|363345071|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
105365857|NCT05616013|363345072|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
105365858|NCT05616013|363345073|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
105365859|NCT05616013|363345074|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
105365860|NCT05616013|363345066|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105365861|NCT05616013|363345067|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105365862|NCT05616013|363345068|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105440070|NCT05362058|363616698|FG000|Treatment Period|Protocol deviation|1|||
105440071|NCT05362058|363616699|FG001|Treatment Period|Protocol deviation|0|||
105825226|NCT00477594|365016509|FG001|Year 1 and Year 2|Physician Decision|1|||
105825227|NCT00477594|365016508|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
105825228|NCT00477594|365016509|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
105825229|NCT00477594|365016508|FG000|Year 1 and Year 2|Other|1|||
105825230|NCT00477594|365016509|FG001|Year 1 and Year 2|Other|0|||
105825231|NCT00477594|365016508|FG000|Year 3|Adverse Event|1|||
105825232|NCT00477594|365016509|FG001|Year 3|Adverse Event|0|||
105825233|NCT00477594|365016508|FG000|Year 3|Withdrawal by Subject|1|||
105825234|NCT00477594|365016509|FG001|Year 3|Withdrawal by Subject|0|||
105825235|NCT00477594|365016508|FG000|Follow-up Period|Withdrawal by Subject|2|||
105825236|NCT00477594|365016509|FG001|Follow-up Period|Withdrawal by Subject|1|||
105825237|NCT00477594|365016508|FG000|Follow-up Period|Other|1|||
105825238|NCT00477594|365016509|FG001|Follow-up Period|Other|0|||
105825239|NCT03447353|365018201|FG000|Overall Study|Failure at Screening Visit|2|||
105825240|NCT03447353|365018201|FG000|Overall Study|Lost to Follow-up|4|||
105825241|NCT03447353|365018201|FG000|Overall Study|Scheduling Conflicts|3|||
105825242|NCT03447353|365018201|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
105825243|NCT02222818|365018206|FG000|Period 1|Eligibility criteria not met|0|||
105825244|NCT02222818|365018207|FG001|Period 1|Eligibility criteria not met|3|||
105825245|NCT04183335|365018208|FG000|Overall Study|Adverse Event|1|||
105825246|NCT04183335|365018209|FG001|Overall Study|Adverse Event|0|||
105825247|NCT04183335|365018208|FG000|Overall Study|Withdrawal by Subject|12|||
105825248|NCT04183335|365018209|FG001|Overall Study|Withdrawal by Subject|3|||
105825249|NCT01660243|365018210|FG000|Overall Study|Adverse Event|1|||
105825250|NCT01660243|365018211|FG001|Overall Study|Adverse Event|0|||
105825251|NCT01660243|365018212|FG002|Overall Study|Adverse Event|1|||
105825252|NCT01660243|365018213|FG003|Overall Study|Adverse Event|0|||
105825253|NCT01660243|365018210|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
105825254|NCT01660243|365018211|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
105825255|NCT01660243|365018212|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
105825256|NCT01660243|365018213|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
105825257|NCT01660243|365018210|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
105825258|NCT01660243|365018211|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
105825259|NCT01660243|365018212|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
105825260|NCT01660243|365018213|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
105825261|NCT01660243|365018210|FG000|Overall Study|Randomization error|0|||
105825262|NCT01660243|365018211|FG001|Overall Study|Randomization error|0|||
105825263|NCT01660243|365018212|FG002|Overall Study|Randomization error|0|||
105825264|NCT01660243|365018213|FG003|Overall Study|Randomization error|1|||
105825265|NCT01319383|365018220|FG000|Overall Study|No ex vivo or in vivo response|4|||
105825266|NCT01319383|365018221|FG001|Overall Study|No ex vivo or in vivo response|0|||
105825267|NCT01319383|365018220|FG000|Overall Study|Physician Decision|3|||
105825268|NCT01319383|365018221|FG001|Overall Study|Physician Decision|0|||
105825269|NCT01319383|365018220|FG000|Overall Study|Lack of Efficacy|5|||
105825270|NCT01319383|365018221|FG001|Overall Study|Lack of Efficacy|9|||
105825271|NCT01319383|365018220|FG000|Overall Study|No in vivo response to interval doses|0|||
105825272|NCT01319383|365018221|FG001|Overall Study|No in vivo response to interval doses|1|||
105825273|NCT01987765|365018224|FG000|Overall Study|Protocol Violation|65|||
105825274|NCT01987765|365018224|FG000|Overall Study|Lost to Follow-up|37|||
105825275|NCT00772603|365018225|FG000|Overall Study|Withdrawal by Subject|11|||
105365863|NCT05616013|363345069|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
105365864|NCT05616013|363345070|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105365865|NCT05616013|363345071|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105487444|NCT02964507|363797011|FG006|Overall Study|Withdrawal by Subject|0|||
105487445|NCT02964507|363797012|FG007|Overall Study|Withdrawal by Subject|0|||
105825276|NCT00772603|365018226|FG001|Overall Study|Withdrawal by Subject|10|||
105825277|NCT00772603|365018227|FG002|Overall Study|Withdrawal by Subject|6|||
105825278|NCT00772603|365018225|FG000|Overall Study|Adverse Event|37|||
105825279|NCT00772603|365018226|FG001|Overall Study|Adverse Event|18|||
105825280|NCT00772603|365018227|FG002|Overall Study|Adverse Event|10|||
105825281|NCT00772603|365018225|FG000|Overall Study|Subject Non-compliance|1|||
105825282|NCT00772603|365018226|FG001|Overall Study|Subject Non-compliance|6|||
105825283|NCT00772603|365018227|FG002|Overall Study|Subject Non-compliance|4|||
105825284|NCT00772603|365018225|FG000|Overall Study|Protocol Violation|0|||
105825285|NCT00772603|365018226|FG001|Overall Study|Protocol Violation|1|||
105825286|NCT00772603|365018227|FG002|Overall Study|Protocol Violation|1|||
105572429|NCT00452413|364094523|FG002|Overall Study|Death due to adverse event (AE)|1|||
105572430|NCT00452413|364094521|FG000|Overall Study|On treatment|0|||
105572431|NCT00452413|364094522|FG001|Overall Study|On treatment|0|||
105572432|NCT00452413|364094523|FG002|Overall Study|On treatment|3|||
105572433|NCT01248962|364094524|FG000|Overall Study|Withdrawal by Subject|1|||
105572434|NCT01248962|364094525|FG001|Overall Study|Withdrawal by Subject|1|||
105572435|NCT01248962|364094524|FG000|Overall Study|Adverse Event|2|||
105572436|NCT01248962|364094525|FG001|Overall Study|Adverse Event|1|||
105572437|NCT01248962|364094524|FG000|Overall Study|Complete Response after 4 Cycles|1|||
105572438|NCT01248962|364094525|FG001|Overall Study|Complete Response after 4 Cycles|0|||
105572439|NCT01248962|364094524|FG000|Overall Study|Complete Response after 3 Cycles|0|||
105572440|NCT01248962|364094525|FG001|Overall Study|Complete Response after 3 Cycles|1|||
105572441|NCT01248962|364094524|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
105572442|NCT01248962|364094525|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
105572443|NCT00114634|364094527|FG000|Overall Study|failure to return forms|3|||
105572444|NCT01003184|364094536|FG000|Overall Study|Adverse Event|12|||
105572445|NCT01003184|364094537|FG001|Overall Study|Adverse Event|5|||
105572446|NCT01003184|364094536|FG000|Overall Study|Lost to Follow-up|1|||
105572447|NCT01003184|364094537|FG001|Overall Study|Lost to Follow-up|0|||
105572448|NCT01003184|364094536|FG000|Overall Study|Loss of glucose control|1|||
105572449|NCT01003184|364094537|FG001|Overall Study|Loss of glucose control|1|||
105572450|NCT01003184|364094536|FG000|Overall Study|Protocol Violation|3|||
105572451|NCT01003184|364094537|FG001|Overall Study|Protocol Violation|0|||
105572452|NCT01003184|364094536|FG000|Overall Study|Withdrawal by Subject|1|||
105572453|NCT01003184|364094537|FG001|Overall Study|Withdrawal by Subject|6|||
105572454|NCT01003184|364094536|FG000|Overall Study|Physician Decision|1|||
105572455|NCT01003184|364094537|FG001|Overall Study|Physician Decision|0|||
105572456|NCT02693834|364094538|FG000|Baseline Measurement|Withdrawal by Subject|1|||
105572457|NCT02693834|364094539|FG001|Baseline Measurement|Withdrawal by Subject|0|||
105572458|NCT02693834|364094538|FG000|Baseline Measurement|Adverse Event|1|||
105572459|NCT02693834|364094539|FG001|Baseline Measurement|Adverse Event|0|||
105572460|NCT02693834|364094538|FG000|Week 2 Practice|Adverse Event|0|||
105572461|NCT02693834|364094539|FG001|Week 2 Practice|Adverse Event|1|||
105572462|NCT01468922|364094542|FG000|Overall Study|Screening failure|0|||
105572463|NCT01468922|364094543|FG001|Overall Study|Screening failure|0|||
105572464|NCT01468922|364094544|FG002|Overall Study|Screening failure|0|||
105572465|NCT01468922|364094545|FG003|Overall Study|Screening failure|0|||
105572466|NCT01468922|364094546|FG004|Overall Study|Screening failure|0|||
105572467|NCT01468922|364094547|FG005|Overall Study|Screening failure|0|||
105572468|NCT01468922|364094548|FG006|Overall Study|Screening failure|0|||
105572469|NCT01468922|364094549|FG007|Overall Study|Screening failure|0|||
105572470|NCT01468922|364094550|FG008|Overall Study|Screening failure|1|||
105572471|NCT01468922|364094542|FG000|Overall Study|Per patient choice|1|||
105572472|NCT01468922|364094543|FG001|Overall Study|Per patient choice|0|||
105572473|NCT01468922|364094544|FG002|Overall Study|Per patient choice|0|||
105572474|NCT01468922|364094545|FG003|Overall Study|Per patient choice|0|||
105572475|NCT01468922|364094546|FG004|Overall Study|Per patient choice|0|||
105572476|NCT01468922|364094547|FG005|Overall Study|Per patient choice|0|||
105572477|NCT01468922|364094548|FG006|Overall Study|Per patient choice|0|||
105572478|NCT01468922|364094549|FG007|Overall Study|Per patient choice|0|||
105572479|NCT01468922|364094550|FG008|Overall Study|Per patient choice|0|||
105572480|NCT01468922|364094542|FG000|Overall Study|Switched to alternative treatment|1|||
105572481|NCT01468922|364094543|FG001|Overall Study|Switched to alternative treatment|0|||
105572482|NCT01468922|364094544|FG002|Overall Study|Switched to alternative treatment|0|||
105572483|NCT01468922|364094545|FG003|Overall Study|Switched to alternative treatment|0|||
105572484|NCT01468922|364094546|FG004|Overall Study|Switched to alternative treatment|1|||
105572485|NCT01468922|364094547|FG005|Overall Study|Switched to alternative treatment|0|||
105572486|NCT01468922|364094548|FG006|Overall Study|Switched to alternative treatment|0|||
105572487|NCT01468922|364094549|FG007|Overall Study|Switched to alternative treatment|0|||
105572488|NCT01468922|364094550|FG008|Overall Study|Switched to alternative treatment|0|||
105572489|NCT01468922|364094542|FG000|Overall Study|Enrolled on new protocol|0|||
105572490|NCT01468922|364094543|FG001|Overall Study|Enrolled on new protocol|0|||
105572491|NCT01468922|364094544|FG002|Overall Study|Enrolled on new protocol|0|||
105572492|NCT01468922|364094545|FG003|Overall Study|Enrolled on new protocol|0|||
105572493|NCT01468922|364094546|FG004|Overall Study|Enrolled on new protocol|1|||
105572494|NCT01468922|364094547|FG005|Overall Study|Enrolled on new protocol|0|||
105572495|NCT01468922|364094548|FG006|Overall Study|Enrolled on new protocol|0|||
105572496|NCT01468922|364094549|FG007|Overall Study|Enrolled on new protocol|0|||
105572497|NCT01468922|364094550|FG008|Overall Study|Enrolled on new protocol|0|||
105572498|NCT01468922|364094542|FG000|Overall Study|Adverse Event|0|||
105572499|NCT01468922|364094543|FG001|Overall Study|Adverse Event|0|||
105572500|NCT01468922|364094544|FG002|Overall Study|Adverse Event|0|||
105572501|NCT01468922|364094545|FG003|Overall Study|Adverse Event|0|||
105572502|NCT01468922|364094546|FG004|Overall Study|Adverse Event|0|||
105572503|NCT01468922|364094547|FG005|Overall Study|Adverse Event|0|||
105572504|NCT01468922|364094548|FG006|Overall Study|Adverse Event|0|||
105825287|NCT00772603|365018225|FG000|Overall Study|Lost to Follow-up|1|||
105825288|NCT00772603|365018226|FG001|Overall Study|Lost to Follow-up|5|||
105825289|NCT00772603|365018227|FG002|Overall Study|Lost to Follow-up|2|||
105825290|NCT00772603|365018225|FG000|Overall Study|Physician Decision|0|||
105825291|NCT00772603|365018226|FG001|Overall Study|Physician Decision|0|||
105825292|NCT00772603|365018227|FG002|Overall Study|Physician Decision|1|||
105825293|NCT00772603|365018225|FG000|Overall Study|Other|2|||
105825294|NCT00772603|365018226|FG001|Overall Study|Other|0|||
105825295|NCT00772603|365018227|FG002|Overall Study|Other|2|||
105825296|NCT01528696|365018228|FG000|Overall Study|See detailed description|18|||
105825297|NCT01528696|365018229|FG001|Overall Study|See detailed description|19|||
105825298|NCT03600805|365018230|FG000|Overall Study|Adverse Event|2|||
105825299|NCT03600805|365018231|FG001|Overall Study|Adverse Event|1|||
105825300|NCT03600805|365018232|FG002|Overall Study|Adverse Event|1|||
105825301|NCT03600805|365018233|FG003|Overall Study|Adverse Event|7|||
105825302|NCT03600805|365018230|FG000|Overall Study|Lack of Efficacy|2|||
105825303|NCT03600805|365018231|FG001|Overall Study|Lack of Efficacy|1|||
105825304|NCT03600805|365018232|FG002|Overall Study|Lack of Efficacy|0|||
105825305|NCT03600805|365018233|FG003|Overall Study|Lack of Efficacy|0|||
105825306|NCT03600805|365018230|FG000|Overall Study|Withdrawal by Subject|1|||
105825307|NCT03600805|365018231|FG001|Overall Study|Withdrawal by Subject|0|||
105825308|NCT03600805|365018232|FG002|Overall Study|Withdrawal by Subject|0|||
105825309|NCT03600805|365018233|FG003|Overall Study|Withdrawal by Subject|1|||
105825310|NCT03600805|365018230|FG000|Overall Study|Other unspecified|14|||
105825311|NCT03600805|365018231|FG001|Overall Study|Other unspecified|6|||
105825312|NCT03600805|365018232|FG002|Overall Study|Other unspecified|7|||
105825313|NCT03600805|365018233|FG003|Overall Study|Other unspecified|11|||
105825314|NCT02545283|365018234|FG000|Overall Study|Lost to Follow-up|2|||
105825315|NCT02545283|365018235|FG001|Overall Study|Lost to Follow-up|4|||
105825316|NCT02545283|365018234|FG000|Overall Study|Withdrawal by Subject|5|||
105825317|NCT02545283|365018235|FG001|Overall Study|Withdrawal by Subject|9|||
105825318|NCT02545283|365018234|FG000|Overall Study|Death|109|||
105825319|NCT02545283|365018235|FG001|Overall Study|Death|211|||
105825320|NCT02545283|365018234|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
105825321|NCT02545283|365018235|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
105825322|NCT02545283|365018234|FG000|Overall Study|Study Terminated By Sponsor|33|||
105825323|NCT02545283|365018235|FG001|Overall Study|Study Terminated By Sponsor|71|||
105825324|NCT01564394|365018240|FG000|Overall Study|Withdrawal by Subject|6|||
105825325|NCT01564394|365018241|FG001|Overall Study|Withdrawal by Subject|10|||
105825326|NCT00443651|365018244|FG000|Overall Study|Death|1|||
105825327|NCT00443651|365018245|FG001|Overall Study|Death|5|||
105825328|NCT00443651|365018244|FG000|Overall Study|Adverse Event|5|||
105825329|NCT00443651|365018245|FG001|Overall Study|Adverse Event|6|||
105825330|NCT00443651|365018244|FG000|Overall Study|Lost to Follow-up|18|||
105825331|NCT00443651|365018245|FG001|Overall Study|Lost to Follow-up|12|||
105825332|NCT00443651|365018244|FG000|Overall Study|Patient's/Guardian's Decision|58|||
105825333|NCT00443651|365018245|FG001|Overall Study|Patient's/Guardian's Decision|30|||
105825334|NCT00443651|365018244|FG000|Overall Study|Physician Decision|13|||
105825335|NCT00443651|365018245|FG001|Overall Study|Physician Decision|4|||
105825336|NCT00443651|365018244|FG000|Overall Study|Pregnancy|0|||
105365866|NCT05616013|363345072|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105440072|NCT05362058|363616698|FG000|Treatment Period|Withdrawal by Subject|10|||
105825337|NCT00443651|365018245|FG001|Overall Study|Pregnancy|1|||
105825338|NCT03606174|365018246|FG000|Overall Study|Death|37|||
105825339|NCT03606174|365018247|FG001|Overall Study|Death|15|||
105825340|NCT03606174|365018248|FG002|Overall Study|Death|15|||
105825341|NCT03606174|365018249|FG003|Overall Study|Death|7|||
105825342|NCT03606174|365018250|FG004|Overall Study|Death|35|||
105825343|NCT03606174|365018251|FG005|Overall Study|Death|12|||
105825344|NCT03606174|365018252|FG006|Overall Study|Death|35|||
105825345|NCT03606174|365018253|FG007|Overall Study|Death|8|||
105825346|NCT03606174|365018254|FG008|Overall Study|Death|5|||
105825347|NCT03606174|365018255|FG009|Overall Study|Death|3|||
105825348|NCT03606174|365018256|FG010|Overall Study|Death|0|||
105825349|NCT03606174|365018246|FG000|Overall Study|Lost to Follow-up|0|||
105825350|NCT03606174|365018247|FG001|Overall Study|Lost to Follow-up|0|||
105825351|NCT03606174|365018248|FG002|Overall Study|Lost to Follow-up|0|||
105825352|NCT03606174|365018249|FG003|Overall Study|Lost to Follow-up|0|||
105825353|NCT03606174|365018250|FG004|Overall Study|Lost to Follow-up|1|||
105825354|NCT03606174|365018251|FG005|Overall Study|Lost to Follow-up|1|||
105825355|NCT03606174|365018252|FG006|Overall Study|Lost to Follow-up|0|||
105825356|NCT03606174|365018253|FG007|Overall Study|Lost to Follow-up|0|||
105825357|NCT03606174|365018254|FG008|Overall Study|Lost to Follow-up|0|||
105825358|NCT03606174|365018255|FG009|Overall Study|Lost to Follow-up|0|||
105825359|NCT03606174|365018256|FG010|Overall Study|Lost to Follow-up|0|||
105825360|NCT03606174|365018246|FG000|Overall Study|Withdrawal by Subject|6|||
105825361|NCT03606174|365018247|FG001|Overall Study|Withdrawal by Subject|0|||
105440073|NCT05362058|363616699|FG001|Treatment Period|Withdrawal by Subject|11|||
105825362|NCT03606174|365018248|FG002|Overall Study|Withdrawal by Subject|0|||
105487446|NCT02964507|363797005|FG000|Overall Study|Physician Decision|2|||
105487447|NCT02964507|363797006|FG001|Overall Study|Physician Decision|0|||
105825363|NCT03606174|365018249|FG003|Overall Study|Withdrawal by Subject|1|||
105825364|NCT03606174|365018250|FG004|Overall Study|Withdrawal by Subject|2|||
105825365|NCT03606174|365018251|FG005|Overall Study|Withdrawal by Subject|1|||
105825366|NCT03606174|365018252|FG006|Overall Study|Withdrawal by Subject|4|||
105825367|NCT03606174|365018253|FG007|Overall Study|Withdrawal by Subject|0|||
105825368|NCT03606174|365018254|FG008|Overall Study|Withdrawal by Subject|0|||
105825369|NCT03606174|365018255|FG009|Overall Study|Withdrawal by Subject|0|||
105825370|NCT03606174|365018256|FG010|Overall Study|Withdrawal by Subject|1|||
105825371|NCT03606174|365018246|FG000|Overall Study|Study Terminated by Sponsor|5|||
105825372|NCT03606174|365018247|FG001|Overall Study|Study Terminated by Sponsor|7|||
105825373|NCT03606174|365018248|FG002|Overall Study|Study Terminated by Sponsor|3|||
105825374|NCT03606174|365018249|FG003|Overall Study|Study Terminated by Sponsor|0|||
105825375|NCT03606174|365018250|FG004|Overall Study|Study Terminated by Sponsor|11|||
105825376|NCT03606174|365018251|FG005|Overall Study|Study Terminated by Sponsor|6|||
105825377|NCT03606174|365018252|FG006|Overall Study|Study Terminated by Sponsor|12|||
105825378|NCT03606174|365018253|FG007|Overall Study|Study Terminated by Sponsor|1|||
105825379|NCT03606174|365018254|FG008|Overall Study|Study Terminated by Sponsor|3|||
105825380|NCT03606174|365018255|FG009|Overall Study|Study Terminated by Sponsor|1|||
105825381|NCT03606174|365018256|FG010|Overall Study|Study Terminated by Sponsor|2|||
105825382|NCT03606174|365018246|FG000|Overall Study|Miscellaneous|1|||
105825383|NCT03606174|365018247|FG001|Overall Study|Miscellaneous|1|||
105825384|NCT03606174|365018248|FG002|Overall Study|Miscellaneous|0|||
105825385|NCT03606174|365018249|FG003|Overall Study|Miscellaneous|1|||
105825386|NCT03606174|365018250|FG004|Overall Study|Miscellaneous|4|||
105825387|NCT03606174|365018251|FG005|Overall Study|Miscellaneous|7|||
105825388|NCT03606174|365018252|FG006|Overall Study|Miscellaneous|5|||
105825389|NCT03606174|365018253|FG007|Overall Study|Miscellaneous|0|||
105825390|NCT03606174|365018254|FG008|Overall Study|Miscellaneous|0|||
105825391|NCT03606174|365018255|FG009|Overall Study|Miscellaneous|0|||
105825392|NCT03606174|365018256|FG010|Overall Study|Miscellaneous|1|||
105825393|NCT00859521|365018257|FG000|Washout|Withdrawal by Subject|0|||
105825394|NCT00859521|365018258|FG001|Washout|Withdrawal by Subject|1|||
105825395|NCT01609257|365018259|FG000|Overall Study|Lost to Follow-up|2|||
105825396|NCT01609257|365018260|FG001|Overall Study|Lost to Follow-up|1|||
105825397|NCT01609257|365018259|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
105825398|NCT01609257|365018260|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
105825399|NCT01609257|365018259|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
105825400|NCT01609257|365018260|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
105825401|NCT03415308|365018263|FG000|Overall Study|Lost to Follow-up|0|||
105825402|NCT03415308|365018264|FG001|Overall Study|Lost to Follow-up|0|||
105825403|NCT03415308|365018265|FG002|Overall Study|Lost to Follow-up|1|||
105825404|NCT03415308|365018263|FG000|Overall Study|Scheduling Conflicts|0|||
105825405|NCT03415308|365018264|FG001|Overall Study|Scheduling Conflicts|0|||
105825406|NCT03415308|365018265|FG002|Overall Study|Scheduling Conflicts|7|||
105825407|NCT01471353|365018267|FG000|Overall Study|remain on study|3|||
105825408|NCT00736190|365018268|FG000|Overall Study|Pregnancy|1|||
105825409|NCT00736190|365018268|FG000|Overall Study|Withdrawal by Subject|1|||
105825410|NCT00736190|365018268|FG000|Overall Study|Adverse Event|1|||
105825411|NCT01896934|365018269|FG000|Overall Study|Adverse Event|1|||
105825412|NCT01896934|365018269|FG000|Overall Study|Withdrawal by Subject|1|||
105825413|NCT02197416|365018270|FG000|Overall Study|Other reasons|0|||
105365867|NCT05616013|363345073|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105365868|NCT05616013|363345074|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105365869|NCT05616013|363345066|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105365870|NCT05616013|363345067|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105365871|NCT05616013|363345068|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105365872|NCT05616013|363345069|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105365873|NCT05616013|363345070|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105365874|NCT05616013|363345071|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105365875|NCT05616013|363345072|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
105365876|NCT05616013|363345073|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105487448|NCT02964507|363797007|FG002|Overall Study|Physician Decision|3|||
105487449|NCT02964507|363797008|FG003|Overall Study|Physician Decision|0|||
105487450|NCT02964507|363797009|FG004|Overall Study|Physician Decision|1|||
105825414|NCT02197416|365018271|FG001|Overall Study|Other reasons|2|||
105825415|NCT02197416|365018272|FG002|Overall Study|Other reasons|5|||
105825416|NCT02197416|365018270|FG000|Overall Study|Withdrawal by Subject|0|||
105825417|NCT02197416|365018271|FG001|Overall Study|Withdrawal by Subject|2|||
105825418|NCT02197416|365018272|FG002|Overall Study|Withdrawal by Subject|1|||
105825419|NCT02197416|365018270|FG000|Overall Study|Protocol Violation|1|||
105825420|NCT02197416|365018271|FG001|Overall Study|Protocol Violation|0|||
105825421|NCT02197416|365018272|FG002|Overall Study|Protocol Violation|1|||
105825422|NCT02197416|365018270|FG000|Overall Study|Adverse Event|0|||
105825423|NCT02197416|365018271|FG001|Overall Study|Adverse Event|0|||
105825424|NCT02197416|365018272|FG002|Overall Study|Adverse Event|1|||
105487451|NCT02964507|363797010|FG005|Overall Study|Physician Decision|0|||
105487452|NCT02964507|363797011|FG006|Overall Study|Physician Decision|0|||
105487453|NCT02964507|363797012|FG007|Overall Study|Physician Decision|0|||
105487454|NCT04341662|363797013|FG000|Overall Study|Did not have source-verified blood loss data|423|||
105487455|NCT04341662|363797014|FG001|Overall Study|Did not have source-verified blood loss data|514|||
105487456|NCT02398227|363797015|FG000|Overall Study|Lost to Follow-up|21|||
105487457|NCT02398227|363797016|FG001|Overall Study|Lost to Follow-up|12|||
105487458|NCT02398227|363797015|FG000|Overall Study|Withdrawal by Subject|5|||
105487459|NCT02398227|363797016|FG001|Overall Study|Withdrawal by Subject|6|||
105487460|NCT02398227|363797015|FG000|Overall Study|Removed from treatment and dropped out|1|||
105487461|NCT02398227|363797016|FG001|Overall Study|Removed from treatment and dropped out|0|||
105487462|NCT03189381|363797017|FG000|Overall Study|Death|1|||
105487463|NCT03189381|363797018|FG001|Overall Study|Death|0|||
105487464|NCT01975831|363797019|FG000|Overall Study|Adverse Event|1|||
105487465|NCT01975831|363797020|FG001|Overall Study|Adverse Event|2|||
105487466|NCT01975831|363797021|FG002|Overall Study|Adverse Event|2|||
105487467|NCT01975831|363797022|FG003|Overall Study|Adverse Event|0|||
105487468|NCT01975831|363797023|FG004|Overall Study|Adverse Event|1|||
105487469|NCT01975831|363797024|FG005|Overall Study|Adverse Event|1|||
105487470|NCT01975831|363797025|FG006|Overall Study|Adverse Event|3|||
105487471|NCT01975831|363797026|FG007|Overall Study|Adverse Event|4|||
105487472|NCT01975831|363797027|FG008|Overall Study|Adverse Event|1|||
105487473|NCT01975831|363797019|FG000|Overall Study|Death|1|||
105487474|NCT01975831|363797020|FG001|Overall Study|Death|1|||
105487475|NCT01975831|363797021|FG002|Overall Study|Death|0|||
105487476|NCT01975831|363797022|FG003|Overall Study|Death|0|||
105487477|NCT01975831|363797023|FG004|Overall Study|Death|1|||
105487478|NCT01975831|363797024|FG005|Overall Study|Death|0|||
105487479|NCT01975831|363797025|FG006|Overall Study|Death|1|||
105487480|NCT01975831|363797026|FG007|Overall Study|Death|0|||
105487481|NCT01975831|363797027|FG008|Overall Study|Death|0|||
105487482|NCT01975831|363797019|FG000|Overall Study|Progressive Disease|1|||
105825425|NCT00488774|365018273|FG000|Overall Study|Withdrawal of consent|2|||
105825426|NCT00488774|365018274|FG001|Overall Study|Withdrawal of consent|2|||
105487483|NCT01975831|363797020|FG001|Overall Study|Progressive Disease|3|||
105487484|NCT01975831|363797021|FG002|Overall Study|Progressive Disease|2|||
105825427|NCT00488774|365018275|FG002|Overall Study|Withdrawal of consent|2|||
105825428|NCT00488774|365018276|FG003|Overall Study|Withdrawal of consent|0|||
105825429|NCT00488774|365018273|FG000|Overall Study|Other|6|||
105825430|NCT00488774|365018274|FG001|Overall Study|Other|3|||
105825431|NCT00488774|365018275|FG002|Overall Study|Other|2|||
105825432|NCT00488774|365018276|FG003|Overall Study|Other|2|||
105825433|NCT00488774|365018273|FG000|Overall Study|Lost to Follow-up|0|||
105825434|NCT00488774|365018274|FG001|Overall Study|Lost to Follow-up|0|||
105825435|NCT00488774|365018275|FG002|Overall Study|Lost to Follow-up|1|||
105487485|NCT01975831|363797022|FG003|Overall Study|Progressive Disease|4|||
105487486|NCT01975831|363797023|FG004|Overall Study|Progressive Disease|13|||
105487487|NCT01975831|363797024|FG005|Overall Study|Progressive Disease|9|||
105487488|NCT01975831|363797025|FG006|Overall Study|Progressive Disease|10|||
105487489|NCT01975831|363797026|FG007|Overall Study|Progressive Disease|8|||
105487490|NCT01975831|363797027|FG008|Overall Study|Progressive Disease|10|||
105825436|NCT00488774|365018276|FG003|Overall Study|Lost to Follow-up|1|||
105825437|NCT00673660|365018278|FG000|Overall Study|Lost to Follow-up|107|||
105825438|NCT00824291|365018279|FG000|Overall Study|Adverse Event|15|||
105825439|NCT00824291|365018280|FG001|Overall Study|Adverse Event|6|||
105825440|NCT00824291|365018279|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
105825441|NCT00824291|365018280|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
105825442|NCT00824291|365018279|FG000|Overall Study|Lost to Follow-up|11|||
105825443|NCT00824291|365018280|FG001|Overall Study|Lost to Follow-up|9|||
105825444|NCT00824291|365018279|FG000|Overall Study|Non-compliance|1|||
105825445|NCT00824291|365018280|FG001|Overall Study|Non-compliance|1|||
105825446|NCT00824291|365018279|FG000|Overall Study|Protocol Violation|4|||
105825447|NCT00824291|365018280|FG001|Overall Study|Protocol Violation|1|||
105825448|NCT00824291|365018279|FG000|Overall Study|Withdrawal by Subject|14|||
105825449|NCT00824291|365018280|FG001|Overall Study|Withdrawal by Subject|8|||
105825450|NCT00824291|365018279|FG000|Overall Study|Lack of Efficacy|7|||
105825451|NCT00824291|365018280|FG001|Overall Study|Lack of Efficacy|8|||
105825452|NCT00824291|365018279|FG000|Overall Study|Participant on prohibited medication|1|||
105825453|NCT00824291|365018280|FG001|Overall Study|Participant on prohibited medication|0|||
105825454|NCT01383486|365018281|FG000|Overall Study|Lost to Follow-up|10|||
105825455|NCT01383486|365018281|FG000|Overall Study|Incomplete information for analysis|2|||
105825456|NCT01383486|365018281|FG000|Overall Study|Did not take any product|6|||
105825457|NCT00245063|365018282|FG000|Overall Study|Adverse Event|6|||
105825458|NCT00245063|365018283|FG001|Overall Study|Adverse Event|5|||
105825459|NCT00245063|365018282|FG000|Overall Study|Death|1|||
105825460|NCT00245063|365018283|FG001|Overall Study|Death|0|||
105825461|NCT05099380|365018284|FG000|Overall Study|Subject enrolled in error|1|||
105825462|NCT05099380|365018285|FG001|Overall Study|Subject enrolled in error|0|||
105825463|NCT05099380|365018284|FG000|Overall Study|Study Procedure|1|||
105825464|NCT05099380|365018285|FG001|Overall Study|Study Procedure|0|||
105825465|NCT05099380|365018284|FG000|Overall Study|Protocol Violation|1|||
105825466|NCT05099380|365018285|FG001|Overall Study|Protocol Violation|0|||
105825467|NCT05099380|365018284|FG000|Overall Study|Adverse Event|1|||
105825468|NCT05099380|365018285|FG001|Overall Study|Adverse Event|1|||
105825469|NCT05099380|365018284|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
105825470|NCT05099380|365018285|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
105825471|NCT01839279|365018286|FG000|Overall Study|Adverse Event|4|||
105825472|NCT01839279|365018287|FG001|Overall Study|Adverse Event|1|||
105825473|NCT01839279|365018288|FG002|Overall Study|Adverse Event|1|||
105825474|NCT01839279|365018286|FG000|Overall Study|Withdrawal by Subject|4|||
105825475|NCT01839279|365018287|FG001|Overall Study|Withdrawal by Subject|1|||
105825476|NCT01839279|365018288|FG002|Overall Study|Withdrawal by Subject|1|||
105825477|NCT01839279|365018286|FG000|Overall Study|Classified as 'Other'|5|||
105825478|NCT01839279|365018287|FG001|Overall Study|Classified as 'Other'|0|||
105825479|NCT01839279|365018288|FG002|Overall Study|Classified as 'Other'|0|||
105825480|NCT01648582|365018289|FG000|Overall Study|Adverse Event|6|||
105825481|NCT01648582|365018290|FG001|Overall Study|Adverse Event|11|||
105825482|NCT01648582|365018291|FG002|Overall Study|Adverse Event|2|||
105825483|NCT01648582|365018289|FG000|Overall Study|Lost to Follow-up|9|||
105825484|NCT01648582|365018290|FG001|Overall Study|Lost to Follow-up|6|||
105825485|NCT01648582|365018291|FG002|Overall Study|Lost to Follow-up|8|||
105825486|NCT01648582|365018289|FG000|Overall Study|Protocol Violation|1|||
105825487|NCT01648582|365018290|FG001|Overall Study|Protocol Violation|2|||
105825488|NCT01648582|365018291|FG002|Overall Study|Protocol Violation|1|||
105825489|NCT01648582|365018289|FG000|Overall Study|Withdrawal by Subject|15|||
105825490|NCT01648582|365018290|FG001|Overall Study|Withdrawal by Subject|17|||
105825491|NCT01648582|365018291|FG002|Overall Study|Withdrawal by Subject|17|||
105825492|NCT01648582|365018289|FG000|Overall Study|Physician Decision|0|||
105825493|NCT01648582|365018290|FG001|Overall Study|Physician Decision|1|||
105825494|NCT01648582|365018291|FG002|Overall Study|Physician Decision|3|||
105825495|NCT01648582|365018289|FG000|Overall Study|Death|1|||
105825496|NCT01648582|365018290|FG001|Overall Study|Death|0|||
105825497|NCT01648582|365018291|FG002|Overall Study|Death|0|||
105825498|NCT01648582|365018289|FG000|Overall Study|Sponsor Decision|0|||
105825499|NCT01648582|365018290|FG001|Overall Study|Sponsor Decision|1|||
105825500|NCT01648582|365018291|FG002|Overall Study|Sponsor Decision|1|||
105825501|NCT02392195|365018292|FG000|Overall Study|Lost to Follow-up|4|||
105825502|NCT02392195|365018292|FG000|Overall Study|Withdrawal by Subject|4|||
105825503|NCT03276754|365018293|FG000|Overall Study|Withdrawal of informed consent|4|||
105825504|NCT03276754|365018293|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
105825505|NCT03276754|365018293|FG000|Overall Study|Lost to Follow-up|27|||
105825506|NCT03276754|365018293|FG000|Overall Study|No data reported at Month 24|31|||
105825507|NCT03276754|365018293|FG000|Overall Study|Death|39|||
105825508|NCT03437265|365018294|FG000|Overall Study|Protocol Violation|6|||
105825509|NCT02294786|365018297|FG000|Overall Study|Withdrawal by Subject|0|||
105365877|NCT05616013|363345074|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105365878|NCT05616013|363345066|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
105825510|NCT02294786|365018298|FG001|Overall Study|Withdrawal by Subject|1|||
105825511|NCT02294786|365018297|FG000|Overall Study|Physician Decision|6|||
105825512|NCT02294786|365018298|FG001|Overall Study|Physician Decision|7|||
105825513|NCT02294786|365018297|FG000|Overall Study|Lost to Follow-up|1|||
105365879|NCT05616013|363345067|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
105365880|NCT05616013|363345068|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
105365881|NCT05616013|363345069|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
105365882|NCT05616013|363345070|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
105825514|NCT02294786|365018298|FG001|Overall Study|Lost to Follow-up|2|||
105365883|NCT05616013|363345071|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
105365884|NCT05616013|363345072|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
105365885|NCT05616013|363345073|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
105365886|NCT05616013|363345074|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
105365887|NCT05616013|363345066|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
105365888|NCT05616013|363345067|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
105365889|NCT05616013|363345068|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
105365890|NCT05616013|363345069|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
105825515|NCT02294786|365018297|FG000|Overall Study|Protocol Violation|1|||
105825516|NCT02294786|365018298|FG001|Overall Study|Protocol Violation|0|||
105825517|NCT02294786|365018297|FG000|Overall Study|Adverse Event|1|||
105825518|NCT02294786|365018298|FG001|Overall Study|Adverse Event|1|||
105825519|NCT02294786|365018297|FG000|Overall Study|Death|2|||
105825520|NCT02294786|365018298|FG001|Overall Study|Death|3|||
105825521|NCT01778010|365018299|FG000|Overall Study|Withdrawal by Subject|2|||
105825522|NCT01778010|365018299|FG000|Overall Study|abnormal ECG before meds|1|||
105825523|NCT01778010|365018299|FG000|Overall Study|Arrested|1|||
105825524|NCT01778010|365018299|FG000|Overall Study|rash while on placebo|1|||
105825525|NCT05041361|365018300|FG000|Overall Study|Lost to Follow-up|1|||
105825526|NCT05041361|365018301|FG001|Overall Study|Lost to Follow-up|3|||
105825527|NCT00608322|365018304|FG000|Overall Study|Death|2|||
105825528|NCT00608322|365018305|FG001|Overall Study|Death|1|||
105825529|NCT00834444|365018306|FG000|First Intervention|Adverse Event|1|||
105825530|NCT00834444|365018307|FG001|First Intervention|Adverse Event|0|||
105825531|NCT00834444|365018306|FG000|First Intervention|Intolerance to Venopuncture|0|||
105825532|NCT00834444|365018307|FG001|First Intervention|Intolerance to Venopuncture|1|||
105825533|NCT00834444|365018306|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
105825534|NCT00834444|365018307|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
105825535|NCT00834444|365018306|FG000|Second Intervention|Adverse Event|1|||
105825536|NCT00834444|365018307|FG001|Second Intervention|Adverse Event|0|||
105825537|NCT05752721|365018308|FG000|Overall Study|Lost to Follow-up|22|||
105825538|NCT05752721|365018309|FG001|Overall Study|Lost to Follow-up|20|||
105825539|NCT05752721|365018308|FG000|Overall Study|Withdrawal by Subject|15|||
105365891|NCT05616013|363345070|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
105365892|NCT05616013|363345071|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
105365893|NCT05616013|363345072|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
105365894|NCT05616013|363345073|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
105365895|NCT05616013|363345074|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
105365896|NCT05116202|363345075|FG000|Overall Study|Study Terminated by Sponsor|21|||
105487491|NCT01975831|363797019|FG000|Overall Study|Withdrawal by Subject|0|||
105487492|NCT01975831|363797020|FG001|Overall Study|Withdrawal by Subject|3|||
105487493|NCT01975831|363797021|FG002|Overall Study|Withdrawal by Subject|0|||
105487494|NCT01975831|363797022|FG003|Overall Study|Withdrawal by Subject|0|||
105825540|NCT05752721|365018309|FG001|Overall Study|Withdrawal by Subject|12|||
105825541|NCT03419403|365018310|FG000|Overall Study|Withdrawal by Subject|5|||
105825542|NCT03419403|365018311|FG001|Overall Study|Withdrawal by Subject|2|||
105825543|NCT03419403|365018312|FG002|Overall Study|Withdrawal by Subject|5|||
105825544|NCT03419403|365018313|FG003|Overall Study|Withdrawal by Subject|1|||
105825545|NCT03419403|365018310|FG000|Overall Study|Progressive disease (per protocol)|0|||
105825546|NCT03419403|365018311|FG001|Overall Study|Progressive disease (per protocol)|2|||
105825547|NCT03419403|365018312|FG002|Overall Study|Progressive disease (per protocol)|2|||
105365897|NCT05116202|363345076|FG001|Overall Study|Study Terminated by Sponsor|38|||
105365898|NCT05116202|363345077|FG002|Overall Study|Study Terminated by Sponsor|17|||
105487495|NCT01975831|363797023|FG004|Overall Study|Withdrawal by Subject|3|||
105487496|NCT01975831|363797024|FG005|Overall Study|Withdrawal by Subject|1|||
105487497|NCT01975831|363797025|FG006|Overall Study|Withdrawal by Subject|1|||
105487498|NCT01975831|363797026|FG007|Overall Study|Withdrawal by Subject|0|||
105487499|NCT01975831|363797027|FG008|Overall Study|Withdrawal by Subject|0|||
105825548|NCT03419403|365018313|FG003|Overall Study|Progressive disease (per protocol)|0|||
105825549|NCT03419403|365018310|FG000|Overall Study|Other, not specified|6|||
105825550|NCT03419403|365018311|FG001|Overall Study|Other, not specified|4|||
105825551|NCT03419403|365018312|FG002|Overall Study|Other, not specified|5|||
105825552|NCT03419403|365018313|FG003|Overall Study|Other, not specified|1|||
105825553|NCT03419403|365018310|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
105825554|NCT03419403|365018311|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
105365899|NCT05116202|363345078|FG003|Overall Study|Study Terminated by Sponsor|18|||
105365900|NCT05116202|363345079|FG004|Overall Study|Study Terminated by Sponsor|0|||
105365901|NCT05116202|363345075|FG000|Overall Study|Withdrawal by Subject|0|||
105365902|NCT05116202|363345076|FG001|Overall Study|Withdrawal by Subject|1|||
105365903|NCT05116202|363345077|FG002|Overall Study|Withdrawal by Subject|1|||
105365904|NCT05116202|363345078|FG003|Overall Study|Withdrawal by Subject|1|||
105365905|NCT05116202|363345079|FG004|Overall Study|Withdrawal by Subject|1|||
105572505|NCT01468922|364094549|FG007|Overall Study|Adverse Event|1|||
105825555|NCT03419403|365018312|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
105825556|NCT03419403|365018313|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
105825557|NCT00418145|365018320|FG000|Overall Study|study terminated|6|||
105825558|NCT04345653|365018321|FG000|Overall Study|Withdrawal by Subject|2|||
105825559|NCT00418938|365018326|FG000|Overall Study|Reimbursement|1|||
105825560|NCT00418938|365018327|FG001|Overall Study|Reimbursement|0|||
105825561|NCT00418938|365018326|FG000|Overall Study|Administrative decision|3|||
105825562|NCT00418938|365018327|FG001|Overall Study|Administrative decision|3|||
105825563|NCT00418938|365018326|FG000|Overall Study|Withdrawal by Subject|16|||
105825564|NCT00418938|365018327|FG001|Overall Study|Withdrawal by Subject|15|||
105825565|NCT00418938|365018326|FG000|Overall Study|Lost to Follow-up|1|||
105825566|NCT00418938|365018327|FG001|Overall Study|Lost to Follow-up|3|||
105825567|NCT00418938|365018326|FG000|Overall Study|Adverse Event|1|||
105825568|NCT00418938|365018327|FG001|Overall Study|Adverse Event|1|||
105825569|NCT00418938|365018326|FG000|Overall Study|On-going|1|||
105825570|NCT00418938|365018327|FG001|Overall Study|On-going|1|||
105825571|NCT00418938|365018326|FG000|Overall Study|Ineligibility Determined|1|||
105825572|NCT00418938|365018327|FG001|Overall Study|Ineligibility Determined|0|||
105825573|NCT00115063|365018330|FG000|Overall Study|Lost to Follow-up|98|||
105825574|NCT00115063|365018331|FG001|Overall Study|Lost to Follow-up|104|||
105825575|NCT00115063|365018330|FG000|Overall Study|Death|1|||
105825576|NCT00115063|365018331|FG001|Overall Study|Death|0|||
105825577|NCT00191815|365018332|FG000|Overall Study|Adverse Event|2|||
105825578|NCT00191815|365018332|FG000|Overall Study|Disease progression or relapse|24|||
105825579|NCT00191815|365018332|FG000|Overall Study|Death|2|||
105825580|NCT00191815|365018332|FG000|Overall Study|Protocol Violation|3|||
105825581|NCT00191815|365018332|FG000|Overall Study|Physician Decision|2|||
105825582|NCT00191815|365018332|FG000|Overall Study|Withdrawal by Subject|7|||
105825583|NCT03808376|365018333|FG000|Overall Study|Withdrawal by Subject|10|||
105825584|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
105825585|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
105825586|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
105825587|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
105825588|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
105825589|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
105825590|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
105825591|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
105825592|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
105825593|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
105825594|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
105825595|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
105825596|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
105825597|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
105825598|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
105825599|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
105825600|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
105825601|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
105825602|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
105365906|NCT05116202|363345075|FG000|Overall Study|Lost to Follow-up|0|||
105365907|NCT05116202|363345076|FG001|Overall Study|Lost to Follow-up|0|||
105365908|NCT05116202|363345077|FG002|Overall Study|Lost to Follow-up|0|||
105365909|NCT05116202|363345078|FG003|Overall Study|Lost to Follow-up|0|||
105365910|NCT05116202|363345079|FG004|Overall Study|Lost to Follow-up|2|||
105572506|NCT01468922|364094550|FG008|Overall Study|Adverse Event|0|||
105572507|NCT01468922|364094542|FG000|Overall Study|Infection of blood|0|||
105572508|NCT01468922|364094543|FG001|Overall Study|Infection of blood|0|||
105572509|NCT01468922|364094544|FG002|Overall Study|Infection of blood|0|||
105572510|NCT01468922|364094545|FG003|Overall Study|Infection of blood|0|||
105365911|NCT05116202|363345075|FG000|Overall Study|Death|1|||
105365912|NCT05116202|363345076|FG001|Overall Study|Death|1|||
105825603|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
105825604|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
105825605|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
105825606|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
105825607|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
105365913|NCT05116202|363345077|FG002|Overall Study|Death|2|||
105365914|NCT05116202|363345078|FG003|Overall Study|Death|1|||
105365915|NCT05116202|363345079|FG004|Overall Study|Death|5|||
105365916|NCT03834506|363345080|FG000|Overall Study|Death|336|||
105825608|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
105825609|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
105825610|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
105825611|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
105825612|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
105825613|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
105825614|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
105825615|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
105825616|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
105825617|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
105825618|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
105825619|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
105825620|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
105825621|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
105825622|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
105825623|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
105825624|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
105825625|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
105825626|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
105825627|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
105825628|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
105825629|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
105825630|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
105825631|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
105825632|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
105825633|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
105825634|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
105825635|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
105825636|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
105825637|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
105825638|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
105825639|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
105825640|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
105825641|NCT01075516|365018347|FG000|Overall Study|Death|5|||
105825642|NCT01075516|365018348|FG001|Overall Study|Death|9|||
105825643|NCT01075516|365018347|FG000|Overall Study|Lost to Follow-up|10|||
105825644|NCT01075516|365018348|FG001|Overall Study|Lost to Follow-up|2|||
105572511|NCT01468922|364094546|FG004|Overall Study|Infection of blood|0|||
105572512|NCT01468922|364094547|FG005|Overall Study|Infection of blood|0|||
105572513|NCT01468922|364094548|FG006|Overall Study|Infection of blood|0|||
105572514|NCT01468922|364094549|FG007|Overall Study|Infection of blood|1|||
105572515|NCT01468922|364094550|FG008|Overall Study|Infection of blood|0|||
105572516|NCT01468922|364094542|FG000|Overall Study|Patient choice - surgery|0|||
105572517|NCT01468922|364094543|FG001|Overall Study|Patient choice - surgery|0|||
105572518|NCT01468922|364094544|FG002|Overall Study|Patient choice - surgery|0|||
105572519|NCT01468922|364094545|FG003|Overall Study|Patient choice - surgery|0|||
105572520|NCT01468922|364094546|FG004|Overall Study|Patient choice - surgery|0|||
105572521|NCT01468922|364094547|FG005|Overall Study|Patient choice - surgery|0|||
105572522|NCT01468922|364094548|FG006|Overall Study|Patient choice - surgery|0|||
105572523|NCT01468922|364094549|FG007|Overall Study|Patient choice - surgery|1|||
105572524|NCT01468922|364094550|FG008|Overall Study|Patient choice - surgery|0|||
105572525|NCT01468922|364094542|FG000|Overall Study|Refused further treatment|0|||
105572526|NCT01468922|364094543|FG001|Overall Study|Refused further treatment|0|||
105572527|NCT01468922|364094544|FG002|Overall Study|Refused further treatment|0|||
105572528|NCT01468922|364094545|FG003|Overall Study|Refused further treatment|0|||
105572529|NCT01468922|364094546|FG004|Overall Study|Refused further treatment|0|||
105572530|NCT01468922|364094547|FG005|Overall Study|Refused further treatment|0|||
105572531|NCT01468922|364094548|FG006|Overall Study|Refused further treatment|0|||
105572532|NCT01468922|364094549|FG007|Overall Study|Refused further treatment|1|||
105572533|NCT01468922|364094550|FG008|Overall Study|Refused further treatment|0|||
105572534|NCT03662997|364094559|FG000|Overall Study|Adverse Event|0|||
105572535|NCT03662997|364094560|FG001|Overall Study|Adverse Event|2|||
105572536|NCT03662997|364094561|FG002|Overall Study|Adverse Event|0|||
105572537|NCT03662997|364094562|FG003|Overall Study|Adverse Event|0|||
105572538|NCT01719224|364094563|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
105572539|NCT01719224|364094564|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
105572540|NCT02563522|364094565|FG000|Overall Study|Adverse Event|2|||
105572541|NCT02563522|364094566|FG001|Overall Study|Adverse Event|3|||
105572542|NCT02563522|364094565|FG000|Overall Study|Lost to Follow-up|1|||
105572543|NCT02563522|364094566|FG001|Overall Study|Lost to Follow-up|0|||
105572544|NCT02563522|364094565|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
105572545|NCT02563522|364094566|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
105572546|NCT00936221|364094567|FG000|Overall Study|Withdrawal by Subject|1|||
105572547|NCT00936221|364094568|FG001|Overall Study|Withdrawal by Subject|1|||
105572548|NCT03820323|364094569|FG000|Overall Study|Lost to Follow-up|2|||
105572549|NCT03820323|364094570|FG001|Overall Study|Lost to Follow-up|1|||
105572550|NCT03820323|364094569|FG000|Overall Study|Missed 12-month visit|22|||
105572551|NCT03820323|364094570|FG001|Overall Study|Missed 12-month visit|14|||
105572552|NCT03820323|364094569|FG000|Overall Study|Death|2|||
105572553|NCT03820323|364094570|FG001|Overall Study|Death|1|||
105572554|NCT03820323|364094569|FG000|Overall Study|Transferred out|13|||
105572555|NCT03820323|364094570|FG001|Overall Study|Transferred out|11|||
105572556|NCT03820323|364094569|FG000|Overall Study|Terminated|0|||
105572557|NCT03820323|364094570|FG001|Overall Study|Terminated|3|||
105572558|NCT03820323|364094569|FG000|Overall Study|Withdrawal by Subject|1|||
105572559|NCT03820323|364094570|FG001|Overall Study|Withdrawal by Subject|6|||
105572560|NCT02912468|364094571|FG000|Overall Study|Adverse Event|3|||
105572561|NCT02912468|364094572|FG001|Overall Study|Adverse Event|2|||
105572562|NCT02912468|364094571|FG000|Overall Study|Withdrawal by Subject|6|||
105572563|NCT02912468|364094572|FG001|Overall Study|Withdrawal by Subject|2|||
105572564|NCT02912468|364094571|FG000|Overall Study|Randomized and not treated|0|||
105572565|NCT02912468|364094572|FG001|Overall Study|Randomized and not treated|1|||
105572566|NCT01320735|364094579|FG000|Overall Study|Adverse Event|3|||
105572567|NCT01320735|364094579|FG000|Overall Study|Withdrawal by Subject|3|||
105572568|NCT01320735|364094579|FG000|Overall Study|Lost to Follow-up|13|||
105572569|NCT01320735|364094579|FG000|Overall Study|Administrative Reason|6|||
105572570|NCT01320735|364094579|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
105572571|NCT01320735|364094579|FG000|Overall Study|Protocol Violation|1|||
105572572|NCT01320735|364094579|FG000|Overall Study|Other|1|||
105572573|NCT01320735|364094579|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
105572574|NCT01320735|364094579|FG000|Overall Study|Investigator Unable to be Contacted|17|||
105365917|NCT03834506|363345081|FG001|Overall Study|Death|326|||
105825645|NCT01075516|365018347|FG000|Overall Study|Withdrawal by Subject|3|||
105825646|NCT01075516|365018348|FG001|Overall Study|Withdrawal by Subject|5|||
105825647|NCT00834873|365018351|FG000|First Intervention|Adverse Event|0|||
105825648|NCT00834873|365018352|FG001|First Intervention|Adverse Event|1|||
105825649|NCT00147498|365018355|FG000|Overall Study|Adverse Event|1|||
105825650|NCT00147498|365018356|FG001|Overall Study|Adverse Event|6|||
105825651|NCT00147498|365018357|FG002|Overall Study|Adverse Event|7|||
105825652|NCT00147498|365018358|FG003|Overall Study|Adverse Event|3|||
105825653|NCT00147498|365018355|FG000|Overall Study|Lack of Efficacy|1|||
105825654|NCT00147498|365018356|FG001|Overall Study|Lack of Efficacy|1|||
105825655|NCT00147498|365018357|FG002|Overall Study|Lack of Efficacy|1|||
105825656|NCT00147498|365018358|FG003|Overall Study|Lack of Efficacy|8|||
105825657|NCT00147498|365018355|FG000|Overall Study|Laboratory abnormality|0|||
105825658|NCT00147498|365018356|FG001|Overall Study|Laboratory abnormality|0|||
105825659|NCT00147498|365018357|FG002|Overall Study|Laboratory abnormality|2|||
105825660|NCT00147498|365018358|FG003|Overall Study|Laboratory abnormality|0|||
105825661|NCT00147498|365018355|FG000|Overall Study|Participant defaulted|0|||
105825662|NCT00147498|365018356|FG001|Overall Study|Participant defaulted|1|||
105825663|NCT00147498|365018357|FG002|Overall Study|Participant defaulted|4|||
105825664|NCT00147498|365018358|FG003|Overall Study|Participant defaulted|3|||
105825665|NCT00147498|365018355|FG000|Overall Study|Other|1|||
105365918|NCT03834506|363345080|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105365919|NCT03834506|363345081|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
105365920|NCT03834506|363345080|FG000|Overall Study|Withdrawal by Subject|10|||
105365921|NCT03834506|363345081|FG001|Overall Study|Withdrawal by Subject|8|||
105365922|NCT03834506|363345080|FG000|Overall Study|Sponsor decision|165|||
105365923|NCT03834506|363345081|FG001|Overall Study|Sponsor decision|178|||
105365924|NCT03834506|363345080|FG000|Overall Study|Physician Decision|3|||
105365925|NCT03834506|363345081|FG001|Overall Study|Physician Decision|1|||
105365926|NCT03834506|363345080|FG000|Overall Study|Lost to Follow-up|0|||
105365927|NCT03834506|363345081|FG001|Overall Study|Lost to Follow-up|1|||
105365928|NCT04386902|363345088|FG000|Overall Study|Withdrawal by Subject|5|||
105572575|NCT00406419|364094584|FG000|Overall Study|Death|3|||
105572576|NCT00406419|364094585|FG001|Overall Study|Death|1|||
105572577|NCT00406419|364094586|FG002|Overall Study|Death|4|||
105572578|NCT00406419|364094584|FG000|Overall Study|Protocol Violation|6|||
105572579|NCT00406419|364094585|FG001|Overall Study|Protocol Violation|2|||
105572580|NCT00406419|364094586|FG002|Overall Study|Protocol Violation|5|||
105572581|NCT00406419|364094584|FG000|Overall Study|Study Terminated by Sponsor|260|||
105572582|NCT00406419|364094585|FG001|Overall Study|Study Terminated by Sponsor|288|||
105572583|NCT00406419|364094586|FG002|Overall Study|Study Terminated by Sponsor|282|||
105572584|NCT00406419|364094584|FG000|Overall Study|Withdrawal by Subject|17|||
105572585|NCT00406419|364094585|FG001|Overall Study|Withdrawal by Subject|24|||
105572586|NCT00406419|364094586|FG002|Overall Study|Withdrawal by Subject|26|||
105572587|NCT00406419|364094584|FG000|Overall Study|Lack of Efficacy|12|||
105572588|NCT00406419|364094585|FG001|Overall Study|Lack of Efficacy|1|||
105572589|NCT00406419|364094586|FG002|Overall Study|Lack of Efficacy|6|||
105572590|NCT00406419|364094584|FG000|Overall Study|Non-Compliance with Study Drug|5|||
105572591|NCT00406419|364094585|FG001|Overall Study|Non-Compliance with Study Drug|6|||
105572592|NCT00406419|364094586|FG002|Overall Study|Non-Compliance with Study Drug|3|||
105572593|NCT00406419|364094584|FG000|Overall Study|Adverse Event|10|||
105572594|NCT00406419|364094585|FG001|Overall Study|Adverse Event|12|||
105572595|NCT00406419|364094586|FG002|Overall Study|Adverse Event|16|||
105572596|NCT00406419|364094584|FG000|Overall Study|Lost to Follow-up|11|||
105572597|NCT00406419|364094585|FG001|Overall Study|Lost to Follow-up|10|||
105572598|NCT00406419|364094586|FG002|Overall Study|Lost to Follow-up|5|||
105572599|NCT00308737|364094587|FG000|Overall Study|Adverse Event|104|||
105572600|NCT00308737|364094588|FG001|Overall Study|Adverse Event|9|||
105572601|NCT00308737|364094589|FG002|Overall Study|Adverse Event|0|||
105572602|NCT00308737|364094587|FG000|Overall Study|Death|4|||
105572603|NCT00308737|364094588|FG001|Overall Study|Death|3|||
105572604|NCT00308737|364094589|FG002|Overall Study|Death|0|||
105572605|NCT00308737|364094587|FG000|Overall Study|Lost to Follow-up|56|||
105572606|NCT00308737|364094588|FG001|Overall Study|Lost to Follow-up|80|||
105572607|NCT00308737|364094589|FG002|Overall Study|Lost to Follow-up|5|||
105572608|NCT00308737|364094587|FG000|Overall Study|Physician Decision|15|||
105572609|NCT00308737|364094588|FG001|Overall Study|Physician Decision|2|||
105572610|NCT00308737|364094589|FG002|Overall Study|Physician Decision|1|||
105572611|NCT00308737|364094587|FG000|Overall Study|Protocol Violation|34|||
105365929|NCT04386902|363345088|FG000|Overall Study|Technical problems in the recording|5|||
105572612|NCT00308737|364094588|FG001|Overall Study|Protocol Violation|9|||
105572613|NCT00308737|364094589|FG002|Overall Study|Protocol Violation|5|||
105825666|NCT00147498|365018356|FG001|Overall Study|Other|1|||
105825667|NCT00147498|365018357|FG002|Overall Study|Other|3|||
105825668|NCT00147498|365018358|FG003|Overall Study|Other|3|||
105825669|NCT01229150|365018361|FG000|Overall Study|Toxicity|2|||
105825670|NCT01229150|365018362|FG001|Overall Study|Toxicity|2|||
105825671|NCT01229150|365018363|FG002|Overall Study|Toxicity|0|||
105825672|NCT01229150|365018364|FG003|Overall Study|Toxicity|0|||
105365930|NCT02322749|363345089|FG000|Period 2|Adverse Event|0|||
105365931|NCT02322749|363345090|FG001|Period 2|Adverse Event|0|||
105365932|NCT02322749|363345091|FG002|Period 2|Adverse Event|0|||
105365933|NCT02322749|363345092|FG003|Period 2|Adverse Event|1|||
105365934|NCT02322749|363345093|FG004|Period 2|Adverse Event|0|||
105365935|NCT02322749|363345094|FG005|Period 2|Adverse Event|0|||
105365936|NCT02322749|363345089|FG000|Period 2|Withdrawal by Subject|0|||
105365937|NCT02322749|363345090|FG001|Period 2|Withdrawal by Subject|0|||
105365938|NCT02322749|363345091|FG002|Period 2|Withdrawal by Subject|0|||
105365939|NCT02322749|363345092|FG003|Period 2|Withdrawal by Subject|1|||
105365940|NCT02322749|363345093|FG004|Period 2|Withdrawal by Subject|0|||
105365941|NCT02322749|363345094|FG005|Period 2|Withdrawal by Subject|0|||
105365942|NCT02322749|363345089|FG000|Period 3|Withdrawal by Subject|0|||
105365943|NCT02322749|363345090|FG001|Period 3|Withdrawal by Subject|0|||
105365944|NCT02322749|363345091|FG002|Period 3|Withdrawal by Subject|1|||
105365945|NCT02322749|363345092|FG003|Period 3|Withdrawal by Subject|0|||
105365946|NCT02322749|363345093|FG004|Period 3|Withdrawal by Subject|0|||
105365947|NCT02322749|363345094|FG005|Period 3|Withdrawal by Subject|0|||
105365948|NCT03492177|363345099|FG000|Overall Study|Adverse Event|1|||
105365949|NCT03492177|363345100|FG001|Overall Study|Adverse Event|0|||
105365950|NCT03492177|363345101|FG002|Overall Study|Adverse Event|0|||
105365951|NCT03492177|363345099|FG000|Overall Study|Death|3|||
105487500|NCT01975831|363797019|FG000|Overall Study|Physician Decision|0|||
105487501|NCT01975831|363797020|FG001|Overall Study|Physician Decision|0|||
105487502|NCT01975831|363797021|FG002|Overall Study|Physician Decision|0|||
105487503|NCT01975831|363797022|FG003|Overall Study|Physician Decision|0|||
105487504|NCT01975831|363797023|FG004|Overall Study|Physician Decision|0|||
105487505|NCT01975831|363797024|FG005|Overall Study|Physician Decision|1|||
105487506|NCT01975831|363797025|FG006|Overall Study|Physician Decision|0|||
105487507|NCT01975831|363797026|FG007|Overall Study|Physician Decision|1|||
105572614|NCT00308737|364094587|FG000|Overall Study|Withdrawal by Subject|218|||
105572615|NCT00308737|364094588|FG001|Overall Study|Withdrawal by Subject|166|||
105572616|NCT00308737|364094589|FG002|Overall Study|Withdrawal by Subject|18|||
105572617|NCT00308737|364094587|FG000|Overall Study|Various|32|||
105572618|NCT00308737|364094588|FG001|Overall Study|Various|20|||
105572619|NCT00308737|364094589|FG002|Overall Study|Various|8|||
105572620|NCT05644353|364094590|FG000|Overall Study|Physician Decision|1|||
105572621|NCT05644353|364094591|FG001|Overall Study|Physician Decision|0|||
105572622|NCT05644353|364094592|FG002|Overall Study|Physician Decision|0|||
105572623|NCT05644353|364094593|FG003|Overall Study|Physician Decision|0|||
105572624|NCT05644353|364094594|FG004|Overall Study|Physician Decision|0|||
105572625|NCT05644353|364094595|FG005|Overall Study|Physician Decision|0|||
105572626|NCT05644353|364094590|FG000|Overall Study|Protocol Violation|1|||
105572627|NCT05644353|364094591|FG001|Overall Study|Protocol Violation|0|||
105572628|NCT05644353|364094592|FG002|Overall Study|Protocol Violation|0|||
105572629|NCT05644353|364094593|FG003|Overall Study|Protocol Violation|0|||
105572630|NCT05644353|364094594|FG004|Overall Study|Protocol Violation|0|||
105825673|NCT01015287|365020010|FG000|Overall Study|Death|21|||
105825674|NCT01015287|365020011|FG001|Overall Study|Death|16|||
105825675|NCT01015287|365020010|FG000|Overall Study|Adverse Event|1|||
105825676|NCT01015287|365020011|FG001|Overall Study|Adverse Event|0|||
105825677|NCT01015287|365020010|FG000|Overall Study|Sponsor Decision|3|||
105825678|NCT01015287|365020011|FG001|Overall Study|Sponsor Decision|7|||
105825679|NCT01015287|365020010|FG000|Overall Study|Physician Decision|19|||
105825680|NCT01015287|365020011|FG001|Overall Study|Physician Decision|21|||
105825681|NCT01015287|365020010|FG000|Overall Study|Withdrawal by Subject|14|||
105825682|NCT01015287|365020011|FG001|Overall Study|Withdrawal by Subject|19|||
105825683|NCT01015287|365020010|FG000|Overall Study|Entry Criteria not Met|11|||
105825684|NCT01015287|365020011|FG001|Overall Study|Entry Criteria not Met|14|||
105825685|NCT01015287|365020010|FG000|Overall Study|Lost to Follow-up|2|||
105825686|NCT01015287|365020011|FG001|Overall Study|Lost to Follow-up|1|||
105825687|NCT01015287|365020010|FG000|Overall Study|Protocol Violation|1|||
105825688|NCT01015287|365020011|FG001|Overall Study|Protocol Violation|1|||
105825689|NCT04590027|365020012|FG000|Overall Study|Lost to Follow-up|17|||
105825690|NCT04590027|365020013|FG001|Overall Study|Lost to Follow-up|14|||
105825691|NCT04590027|365020012|FG000|Overall Study|Protocol Violation|0|||
105825692|NCT04590027|365020013|FG001|Overall Study|Protocol Violation|3|||
105825693|NCT00392665|365020016|FG000|Overall Study|Death|16|||
105825694|NCT00392665|365020017|FG001|Overall Study|Death|14|||
105825695|NCT00392665|365020016|FG000|Overall Study|Lost to Follow-up|1|||
105825696|NCT00392665|365020017|FG001|Overall Study|Lost to Follow-up|1|||
105825697|NCT00840216|365020021|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
105825698|NCT00840216|365020022|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
105825699|NCT00545792|365020025|FG000|Overall Study|Withdrawal by Subject|1|||
105825700|NCT00316277|365020027|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
105825701|NCT00316277|365020028|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
105825702|NCT00316277|365020027|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
105365952|NCT03492177|363345100|FG001|Overall Study|Death|0|||
105365953|NCT03492177|363345101|FG002|Overall Study|Death|3|||
105365954|NCT03492177|363345099|FG000|Overall Study|Lack of Efficacy|1|||
105572631|NCT05644353|364094595|FG005|Overall Study|Protocol Violation|0|||
105572632|NCT05644353|364094590|FG000|Overall Study|Withdrawal by Subject|0|||
105572633|NCT05644353|364094591|FG001|Overall Study|Withdrawal by Subject|2|||
105572634|NCT05644353|364094592|FG002|Overall Study|Withdrawal by Subject|0|||
105572635|NCT05644353|364094593|FG003|Overall Study|Withdrawal by Subject|0|||
105572636|NCT05644353|364094594|FG004|Overall Study|Withdrawal by Subject|1|||
105572637|NCT05644353|364094595|FG005|Overall Study|Withdrawal by Subject|0|||
105572638|NCT05644353|364094590|FG000|Overall Study|Lost to Follow-up|0|||
105572639|NCT05644353|364094591|FG001|Overall Study|Lost to Follow-up|0|||
105572640|NCT05644353|364094592|FG002|Overall Study|Lost to Follow-up|1|||
105572641|NCT05644353|364094593|FG003|Overall Study|Lost to Follow-up|0|||
105572642|NCT05644353|364094594|FG004|Overall Study|Lost to Follow-up|0|||
105825703|NCT00316277|365020028|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
105572643|NCT05644353|364094595|FG005|Overall Study|Lost to Follow-up|0|||
105572644|NCT02120664|364094596|FG000|Overall Study|Withdrawal by Subject|0|||
105572645|NCT02120664|364094597|FG001|Overall Study|Withdrawal by Subject|0|||
105487508|NCT01975831|363797027|FG008|Overall Study|Physician Decision|0|||
105487509|NCT01975831|363797019|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
105487510|NCT01975831|363797020|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
105487511|NCT01975831|363797021|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
105487512|NCT01975831|363797022|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
105487513|NCT01975831|363797023|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
105487514|NCT01975831|363797024|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
105487515|NCT01975831|363797025|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
105487516|NCT01975831|363797026|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
105487517|NCT01975831|363797027|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
105487518|NCT01975831|363797019|FG000|Overall Study|Entered Hospice|0|||
105487519|NCT01975831|363797020|FG001|Overall Study|Entered Hospice|0|||
105487520|NCT01975831|363797021|FG002|Overall Study|Entered Hospice|0|||
105487521|NCT01975831|363797022|FG003|Overall Study|Entered Hospice|0|||
105487522|NCT01975831|363797023|FG004|Overall Study|Entered Hospice|0|||
105487523|NCT01975831|363797024|FG005|Overall Study|Entered Hospice|1|||
105487524|NCT01975831|363797025|FG006|Overall Study|Entered Hospice|0|||
105487525|NCT01975831|363797026|FG007|Overall Study|Entered Hospice|0|||
105487526|NCT01975831|363797027|FG008|Overall Study|Entered Hospice|0|||
105487527|NCT01975831|363797019|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
105487528|NCT01975831|363797020|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
105487529|NCT01975831|363797021|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
105487530|NCT01975831|363797022|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
105487531|NCT01975831|363797023|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
105487532|NCT01975831|363797024|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
105487533|NCT01975831|363797025|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
105487534|NCT01975831|363797026|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
105487535|NCT01975831|363797027|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
105487536|NCT01401959|363797028|FG000|Enrolled|Withdrawal by Subject|1|||
105487537|NCT01401959|363797029|FG001|Enrolled|Withdrawal by Subject|0|||
105487538|NCT01401959|363797030|FG002|Enrolled|Withdrawal by Subject|0|||
105487539|NCT01401959|363797028|FG000|Treated|Disease Progression|2|||
105487540|NCT01401959|363797029|FG001|Treated|Disease Progression|2|||
105487541|NCT01401959|363797030|FG002|Treated|Disease Progression|1|||
105487542|NCT01401959|363797028|FG000|Treated|Adverse Event|4|||
105487543|NCT01401959|363797029|FG001|Treated|Adverse Event|3|||
105487544|NCT01401959|363797030|FG002|Treated|Adverse Event|2|||
105487545|NCT01401959|363797028|FG000|Treated|Withdrawal by Subject|1|||
105487546|NCT01401959|363797029|FG001|Treated|Withdrawal by Subject|2|||
105487547|NCT01401959|363797030|FG002|Treated|Withdrawal by Subject|2|||
105487548|NCT01401959|363797028|FG000|Treated|Protocol Violation|0|||
105487549|NCT01401959|363797029|FG001|Treated|Protocol Violation|1|||
105487550|NCT01401959|363797030|FG002|Treated|Protocol Violation|0|||
105487551|NCT00251004|363797031|FG000|Overall Study|Withdrawal by Subject|23|||
105487552|NCT00251004|363797032|FG001|Overall Study|Withdrawal by Subject|16|||
105487553|NCT00251004|363797033|FG002|Overall Study|Withdrawal by Subject|14|||
105487554|NCT00251004|363797031|FG000|Overall Study|Death|9|||
105487555|NCT00251004|363797032|FG001|Overall Study|Death|10|||
105487556|NCT00251004|363797033|FG002|Overall Study|Death|8|||
105487557|NCT00251004|363797031|FG000|Overall Study|Lost to Follow-up|1|||
105487558|NCT00251004|363797032|FG001|Overall Study|Lost to Follow-up|2|||
105487559|NCT00251004|363797033|FG002|Overall Study|Lost to Follow-up|1|||
105487560|NCT00251004|363797031|FG000|Overall Study|Graft Loss|12|||
105487561|NCT00251004|363797032|FG001|Overall Study|Graft Loss|13|||
105487562|NCT00251004|363797033|FG002|Overall Study|Graft Loss|8|||
105487563|NCT00887744|363797034|FG000|Overall Study|Adverse Event|3|||
105572646|NCT02120664|364094598|FG002|Overall Study|Withdrawal by Subject|0|||
105572647|NCT02120664|364094599|FG003|Overall Study|Withdrawal by Subject|1|||
105487564|NCT00887744|363797034|FG000|Overall Study|Death|1|||
105487565|NCT00887744|363797034|FG000|Overall Study|Lost to Follow-up|3|||
105487566|NCT00887744|363797034|FG000|Overall Study|Withdrawal by Subject|18|||
105487567|NCT00887744|363797034|FG000|Overall Study|Various reasons|9|||
105487568|NCT00450385|363797035|FG000|Overall Study|Death|3|||
105487569|NCT00450385|363797035|FG000|Overall Study|Protocol Violation|1|||
105487570|NCT00450385|363797035|FG000|Overall Study|Withdrawal by Subject|2|||
105487571|NCT00450385|363797035|FG000|Overall Study|Lack of Efficacy|2|||
105487572|NCT00450385|363797035|FG000|Overall Study|Adverse Event|1|||
105487573|NCT00450385|363797035|FG000|Overall Study|Physician Decision|1|||
105487574|NCT00450385|363797035|FG000|Overall Study|Other|3|||
105487575|NCT01244490|363797037|FG000|Overall Study|Lack of Efficacy|14|||
105487576|NCT01244490|363797038|FG001|Overall Study|Lack of Efficacy|5|||
105487577|NCT01244490|363797039|FG002|Overall Study|Lack of Efficacy|5|||
105487578|NCT01244490|363797037|FG000|Overall Study|Withdrawal by Subject|4|||
105487579|NCT01244490|363797038|FG001|Overall Study|Withdrawal by Subject|4|||
105487580|NCT01244490|363797039|FG002|Overall Study|Withdrawal by Subject|9|||
105487581|NCT01244490|363797037|FG000|Overall Study|Adverse Event|1|||
105487582|NCT01244490|363797038|FG001|Overall Study|Adverse Event|9|||
105487583|NCT01244490|363797039|FG002|Overall Study|Adverse Event|5|||
105825704|NCT00316277|365020027|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
105825705|NCT00316277|365020028|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
105825706|NCT00316277|365020027|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
105825707|NCT00316277|365020028|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
105825708|NCT00316277|365020027|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
105825709|NCT00316277|365020028|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
105825710|NCT03679598|365020029|FG000|Overall Study|Adverse Event|2|||
105825711|NCT03679598|365020030|FG001|Overall Study|Adverse Event|0|||
105487584|NCT01244490|363797037|FG000|Overall Study|Lost to Follow-up|0|||
105487585|NCT01244490|363797038|FG001|Overall Study|Lost to Follow-up|6|||
105487586|NCT01244490|363797039|FG002|Overall Study|Lost to Follow-up|3|||
105487587|NCT01244490|363797037|FG000|Overall Study|Other|0|||
105487588|NCT01244490|363797038|FG001|Overall Study|Other|0|||
105487589|NCT01244490|363797039|FG002|Overall Study|Other|1|||
105487590|NCT00591578|363797044|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
105487591|NCT00591578|363797045|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
105487592|NCT00591578|363797046|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
105487593|NCT00591578|363797044|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
105487594|NCT00591578|363797045|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
105487595|NCT00591578|363797046|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
105487596|NCT00591578|363797044|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
105825712|NCT03605342|365020031|FG000|Overall Study|Withdrawal by Subject|9|||
105825713|NCT03605342|365020032|FG001|Overall Study|Withdrawal by Subject|7|||
105487597|NCT00591578|363797045|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
105487598|NCT00591578|363797046|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
105487599|NCT00591578|363797044|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
105487600|NCT00591578|363797045|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
105487601|NCT00591578|363797046|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
105487602|NCT00591578|363797044|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
105487603|NCT00591578|363797045|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
105487604|NCT00591578|363797046|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
105487605|NCT00591578|363797044|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
105487606|NCT00591578|363797045|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
105487607|NCT00591578|363797046|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
105487608|NCT00591578|363797044|FG000|Double-Blind Treatment Phase|Other|4|||
105487609|NCT00591578|363797045|FG001|Double-Blind Treatment Phase|Other|9|||
105487610|NCT00591578|363797046|FG002|Double-Blind Treatment Phase|Other|4|||
105487611|NCT00591578|363797044|FG000|Open-Label Extension Phase|Adverse Event|3|||
105487612|NCT00591578|363797045|FG001|Open-Label Extension Phase|Adverse Event|5|||
105487613|NCT00591578|363797046|FG002|Open-Label Extension Phase|Adverse Event|0|||
105487614|NCT00591578|363797044|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
105487615|NCT00591578|363797045|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
105487616|NCT00591578|363797046|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
105487617|NCT00591578|363797044|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
105487618|NCT00591578|363797045|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
105487619|NCT00591578|363797046|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
105487620|NCT00591578|363797044|FG000|Open-Label Extension Phase|Other|1|||
105487621|NCT00591578|363797045|FG001|Open-Label Extension Phase|Other|0|||
105487622|NCT00591578|363797046|FG002|Open-Label Extension Phase|Other|0|||
105487623|NCT03455764|363797048|FG000|Overall Study|Adverse Event|1|||
105487624|NCT03455764|363797049|FG001|Overall Study|Adverse Event|0|||
105487625|NCT03455764|363797050|FG002|Overall Study|Adverse Event|0|||
105487626|NCT03455764|363797051|FG003|Overall Study|Adverse Event|0|||
105487627|NCT03455764|363797052|FG004|Overall Study|Adverse Event|0|||
105487628|NCT03455764|363797048|FG000|Overall Study|Disease Progression|4|||
105487629|NCT03455764|363797049|FG001|Overall Study|Disease Progression|0|||
105487630|NCT03455764|363797050|FG002|Overall Study|Disease Progression|0|||
105487631|NCT03455764|363797051|FG003|Overall Study|Disease Progression|0|||
105487632|NCT03455764|363797052|FG004|Overall Study|Disease Progression|0|||
105487633|NCT03455764|363797048|FG000|Overall Study|On Treatment|1|||
105487634|NCT03455764|363797049|FG001|Overall Study|On Treatment|0|||
105487635|NCT03455764|363797050|FG002|Overall Study|On Treatment|0|||
105487636|NCT03455764|363797051|FG003|Overall Study|On Treatment|0|||
105487637|NCT03455764|363797052|FG004|Overall Study|On Treatment|0|||
105487638|NCT01017575|363797053|FG000|Overall Study|Lack of Efficacy|0|||
105487639|NCT01017575|363797054|FG001|Overall Study|Lack of Efficacy|1|||
105487640|NCT01017575|363797055|FG002|Overall Study|Lack of Efficacy|0|||
105825714|NCT03605342|365020031|FG000|Overall Study|Lost to Follow-up|1|||
105825715|NCT03605342|365020032|FG001|Overall Study|Lost to Follow-up|1|||
105487641|NCT01017575|363797056|FG003|Overall Study|Lack of Efficacy|1|||
105487642|NCT01017575|363797057|FG004|Overall Study|Lack of Efficacy|1|||
105487643|NCT01017575|363797053|FG000|Overall Study|Adverse Event|0|||
105487644|NCT01017575|363797054|FG001|Overall Study|Adverse Event|1|||
105487645|NCT01017575|363797055|FG002|Overall Study|Adverse Event|0|||
105487646|NCT01017575|363797056|FG003|Overall Study|Adverse Event|0|||
105487647|NCT01017575|363797057|FG004|Overall Study|Adverse Event|2|||
105487648|NCT01017575|363797053|FG000|Overall Study|Withdrawal by Subject|1|||
105487649|NCT01017575|363797054|FG001|Overall Study|Withdrawal by Subject|0|||
105487650|NCT01017575|363797055|FG002|Overall Study|Withdrawal by Subject|0|||
105487651|NCT01017575|363797056|FG003|Overall Study|Withdrawal by Subject|0|||
105572648|NCT02120664|364094600|FG004|Overall Study|Withdrawal by Subject|0|||
105572649|NCT02460263|364094601|FG000|Transition Period|Withdrawal by Subject|1|||
105572650|NCT02460263|364094601|FG000|Transition Period|Death|1|||
105365955|NCT03492177|363345100|FG001|Overall Study|Lack of Efficacy|2|||
105365956|NCT03492177|363345101|FG002|Overall Study|Lack of Efficacy|0|||
105572651|NCT04006925|364094602|FG000|Overall Study|Side effects|2|||
105825716|NCT01663233|365020033|FG000|Overall Study|Withdrawal by Subject|3|||
105572652|NCT04006925|364094603|FG001|Overall Study|Side effects|0|||
105365957|NCT03492177|363345099|FG000|Overall Study|Other|1|||
105572653|NCT02736968|364094609|FG000|Overall Study|Lost to Follow-up|0|||
105572654|NCT02736968|364094610|FG001|Overall Study|Lost to Follow-up|0|||
105572655|NCT02736968|364094611|FG002|Overall Study|Lost to Follow-up|0|||
105572656|NCT02736968|364094612|FG003|Overall Study|Lost to Follow-up|0|||
105572657|NCT02736968|364094613|FG004|Overall Study|Lost to Follow-up|0|||
105572658|NCT02736968|364094614|FG005|Overall Study|Lost to Follow-up|0|||
105572659|NCT02736968|364094615|FG006|Overall Study|Lost to Follow-up|5|||
105572660|NCT02736968|364094616|FG007|Overall Study|Lost to Follow-up|2|||
105572661|NCT02736968|364094609|FG000|Overall Study|COVID-19 Pandemic|0|||
105572662|NCT02736968|364094610|FG001|Overall Study|COVID-19 Pandemic|0|||
105572663|NCT02736968|364094611|FG002|Overall Study|COVID-19 Pandemic|0|||
105572664|NCT02736968|364094612|FG003|Overall Study|COVID-19 Pandemic|0|||
105572665|NCT02736968|364094613|FG004|Overall Study|COVID-19 Pandemic|0|||
105572666|NCT02736968|364094614|FG005|Overall Study|COVID-19 Pandemic|0|||
105572667|NCT02736968|364094615|FG006|Overall Study|COVID-19 Pandemic|2|||
105572668|NCT02736968|364094616|FG007|Overall Study|COVID-19 Pandemic|0|||
105572669|NCT02736968|364094609|FG000|Overall Study|Withdrawal by Subject|0|||
105572670|NCT02736968|364094610|FG001|Overall Study|Withdrawal by Subject|0|||
105572671|NCT02736968|364094611|FG002|Overall Study|Withdrawal by Subject|0|||
105572672|NCT02736968|364094612|FG003|Overall Study|Withdrawal by Subject|0|||
105572673|NCT02736968|364094613|FG004|Overall Study|Withdrawal by Subject|0|||
105572674|NCT02736968|364094614|FG005|Overall Study|Withdrawal by Subject|0|||
105572675|NCT02736968|364094615|FG006|Overall Study|Withdrawal by Subject|1|||
105825717|NCT01663233|365020034|FG001|Overall Study|Withdrawal by Subject|2|||
105825718|NCT01663233|365020033|FG000|Overall Study|Protocol Deviation|1|||
105572676|NCT02736968|364094616|FG007|Overall Study|Withdrawal by Subject|0|||
105572677|NCT03311230|364094621|FG000|Overall Study|Withdrawal by Subject|1|||
105572678|NCT03311230|364094622|FG001|Overall Study|Withdrawal by Subject|4|||
105572679|NCT03311230|364094623|FG002|Overall Study|Withdrawal by Subject|2|||
105572680|NCT03311230|364094624|FG003|Overall Study|Withdrawal by Subject|7|||
105572681|NCT03311230|364094621|FG000|Overall Study|Unrelated injury|0|||
105572682|NCT03311230|364094622|FG001|Overall Study|Unrelated injury|1|||
105572683|NCT03311230|364094623|FG002|Overall Study|Unrelated injury|0|||
105572684|NCT03311230|364094624|FG003|Overall Study|Unrelated injury|0|||
105572685|NCT00171873|364094625|FG000|Overall Study|Withdrawal by Subject|4|||
105572686|NCT00171873|364094626|FG001|Overall Study|Withdrawal by Subject|2|||
105572687|NCT00171873|364094625|FG000|Overall Study|Adverse Event|5|||
105572688|NCT00171873|364094626|FG001|Overall Study|Adverse Event|0|||
105572689|NCT00171873|364094625|FG000|Overall Study|Switched to Octreotide|0|||
105572690|NCT00171873|364094626|FG001|Overall Study|Switched to Octreotide|1|||
105572691|NCT02243631|364096347|FG000|Overall Study|no synovial fluid on second aspirate|0|||
105572692|NCT02243631|364096348|FG001|Overall Study|no synovial fluid on second aspirate|1|||
105572693|NCT01900054|364096349|FG000|Overall Study|Physician Decision|1|||
105572694|NCT01900054|364096349|FG000|Overall Study|Withdrawal by Subject|1|||
105572695|NCT01186328|364096350|FG000|Overall Study|Death|1|||
105825719|NCT01663233|365020034|FG001|Overall Study|Protocol Deviation|4|||
105825720|NCT01663233|365020033|FG000|Overall Study|Lost to Follow-up|0|||
105825721|NCT01663233|365020034|FG001|Overall Study|Lost to Follow-up|1|||
105825722|NCT01380782|365020035|FG000|Overall Study|Adverse Event|0|||
105825723|NCT01380782|365020036|FG001|Overall Study|Adverse Event|1|||
105825724|NCT01380782|365020037|FG002|Overall Study|Adverse Event|0|||
105825725|NCT01380782|365020038|FG003|Overall Study|Adverse Event|0|||
105825726|NCT01380782|365020035|FG000|Overall Study|Death|1|||
105825727|NCT01380782|365020036|FG001|Overall Study|Death|0|||
105825728|NCT01380782|365020037|FG002|Overall Study|Death|0|||
105825729|NCT01380782|365020038|FG003|Overall Study|Death|0|||
105825730|NCT01380782|365020035|FG000|Overall Study|Lack of Efficacy|10|||
105365958|NCT03492177|363345100|FG001|Overall Study|Other|0|||
105365959|NCT03492177|363345101|FG002|Overall Study|Other|0|||
105572696|NCT01186328|364096351|FG001|Overall Study|Death|0|||
105825731|NCT01380782|365020036|FG001|Overall Study|Lack of Efficacy|9|||
105572697|NCT01186328|364096352|FG002|Overall Study|Death|0|||
105572698|NCT03015116|364096353|FG000|Overall Study|Lost to Follow-up|3|||
105572699|NCT03015116|364096354|FG001|Overall Study|Lost to Follow-up|0|||
105825732|NCT01380782|365020037|FG002|Overall Study|Lack of Efficacy|10|||
105825733|NCT01380782|365020038|FG003|Overall Study|Lack of Efficacy|3|||
105365960|NCT03492177|363345099|FG000|Overall Study|Ongoing|16|||
105365961|NCT03492177|363345100|FG001|Overall Study|Ongoing|19|||
105365962|NCT03492177|363345101|FG002|Overall Study|Ongoing|17|||
105365963|NCT05158140|363345104|FG000|Overall Study|Death|0|||
105365964|NCT05158140|363345105|FG001|Overall Study|Death|0|||
105365965|NCT05158140|363345106|FG002|Overall Study|Death|0|||
105365966|NCT05158140|363345107|FG003|Overall Study|Death|1|||
105365967|NCT05158140|363345104|FG000|Overall Study|Lost to Follow-up|3|||
105365968|NCT05158140|363345105|FG001|Overall Study|Lost to Follow-up|6|||
105365969|NCT05158140|363345106|FG002|Overall Study|Lost to Follow-up|4|||
105365970|NCT05158140|363345107|FG003|Overall Study|Lost to Follow-up|3|||
105365971|NCT05158140|363345104|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105365972|NCT05158140|363345105|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105365973|NCT05158140|363345106|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
105365974|NCT05158140|363345107|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
105365975|NCT05158140|363345104|FG000|Overall Study|Withdrawal by Subject|3|||
105365976|NCT05158140|363345105|FG001|Overall Study|Withdrawal by Subject|7|||
105365977|NCT05158140|363345106|FG002|Overall Study|Withdrawal by Subject|3|||
105365978|NCT05158140|363345107|FG003|Overall Study|Withdrawal by Subject|7|||
105365979|NCT04647253|363345112|FG000|Overall Study|Death ≤ 365 Days|16|||
105365980|NCT04647253|363345113|FG001|Overall Study|Death ≤ 365 Days|7|||
105365981|NCT04647253|363345112|FG000|Overall Study|Physician Decision|0|||
105365982|NCT04647253|363345113|FG001|Overall Study|Physician Decision|1|||
105365983|NCT04647253|363345112|FG000|Overall Study|Withdrawal by Subject|7|||
105365984|NCT04647253|363345113|FG001|Overall Study|Withdrawal by Subject|2|||
105365985|NCT04647253|363345112|FG000|Overall Study|Missed 12-Month Visit|9|||
105365986|NCT04647253|363345113|FG001|Overall Study|Missed 12-Month Visit|7|||
105365987|NCT04647253|363345112|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
105365988|NCT04647253|363345113|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
105365989|NCT05079321|363345114|FG000|Overall Study|Withdrawal by Subject|2|||
105365990|NCT05079321|363345115|FG001|Overall Study|Withdrawal by Subject|2|||
105365991|NCT05079321|363345114|FG000|Overall Study|Lost to Follow-up|0|||
105365992|NCT05079321|363345115|FG001|Overall Study|Lost to Follow-up|1|||
105365993|NCT05965752|363345120|FG000|Overall Study|Adverse Event|0|||
105365994|NCT05965752|363345121|FG001|Overall Study|Adverse Event|1|||
105365995|NCT05965752|363345122|FG002|Overall Study|Adverse Event|0|||
105365996|NCT05965752|363345123|FG003|Overall Study|Adverse Event|1|||
105365997|NCT05965752|363345124|FG004|Overall Study|Adverse Event|3|||
105365998|NCT05965752|363345120|FG000|Overall Study|Lost to Follow-up|2|||
105365999|NCT05965752|363345121|FG001|Overall Study|Lost to Follow-up|0|||
105366000|NCT05965752|363345122|FG002|Overall Study|Lost to Follow-up|1|||
105366001|NCT05965752|363345123|FG003|Overall Study|Lost to Follow-up|1|||
105366002|NCT05965752|363345124|FG004|Overall Study|Lost to Follow-up|1|||
105366003|NCT05965752|363345120|FG000|Overall Study|Withdrawal by Subject|2|||
105366004|NCT05965752|363345121|FG001|Overall Study|Withdrawal by Subject|2|||
105366005|NCT05965752|363345122|FG002|Overall Study|Withdrawal by Subject|1|||
105366006|NCT05965752|363345123|FG003|Overall Study|Withdrawal by Subject|5|||
105366007|NCT05965752|363345124|FG004|Overall Study|Withdrawal by Subject|0|||
105366008|NCT05965752|363345120|FG000|Overall Study|Disease Relapse|1|||
105366009|NCT05965752|363345121|FG001|Overall Study|Disease Relapse|0|||
105366010|NCT05965752|363345122|FG002|Overall Study|Disease Relapse|1|||
105366011|NCT05965752|363345123|FG003|Overall Study|Disease Relapse|0|||
105366012|NCT05965752|363345124|FG004|Overall Study|Disease Relapse|0|||
105366013|NCT05965752|363345120|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
105366014|NCT05965752|363345121|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
105366015|NCT05965752|363345122|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
105366016|NCT05965752|363345123|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
105366017|NCT05965752|363345124|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
105366018|NCT05965752|363345120|FG000|Overall Study|Unable to Return for Study Visits|0|||
105366019|NCT05965752|363345121|FG001|Overall Study|Unable to Return for Study Visits|1|||
105366020|NCT05965752|363345122|FG002|Overall Study|Unable to Return for Study Visits|0|||
105366021|NCT05965752|363345123|FG003|Overall Study|Unable to Return for Study Visits|3|||
105366022|NCT05965752|363345124|FG004|Overall Study|Unable to Return for Study Visits|1|||
105366023|NCT05965752|363345120|FG000|Overall Study|Early Termination|0|||
105366024|NCT05965752|363345121|FG001|Overall Study|Early Termination|0|||
105366025|NCT05965752|363345122|FG002|Overall Study|Early Termination|1|||
105366026|NCT05965752|363345123|FG003|Overall Study|Early Termination|0|||
105366027|NCT05965752|363345124|FG004|Overall Study|Early Termination|0|||
105366028|NCT05965752|363345120|FG000|Overall Study|Reported Unwanted Symptoms|0|||
105366029|NCT05965752|363345121|FG001|Overall Study|Reported Unwanted Symptoms|0|||
105366030|NCT05965752|363345122|FG002|Overall Study|Reported Unwanted Symptoms|0|||
105366031|NCT05965752|363345123|FG003|Overall Study|Reported Unwanted Symptoms|0|||
105366032|NCT05965752|363345124|FG004|Overall Study|Reported Unwanted Symptoms|1|||
105366033|NCT05965752|363345120|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
105366034|NCT05965752|363345121|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
105366035|NCT05965752|363345122|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
105366036|NCT05965752|363345123|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
105366037|NCT05965752|363345124|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
105366038|NCT03638128|363346512|FG000|Overall Study|Withdrawal by Subject|1|||
105366039|NCT03638128|363346513|FG001|Overall Study|Withdrawal by Subject|7|||
105366040|NCT03638128|363346514|FG002|Overall Study|Withdrawal by Subject|6|||
105366041|NCT03638128|363346512|FG000|Overall Study|Sponsor Decision|15|||
105366042|NCT03638128|363346513|FG001|Overall Study|Sponsor Decision|12|||
105366043|NCT03638128|363346514|FG002|Overall Study|Sponsor Decision|19|||
105366044|NCT03638128|363346512|FG000|Overall Study|Lost to Follow-up|0|||
105366045|NCT03638128|363346513|FG001|Overall Study|Lost to Follow-up|0|||
105366046|NCT03638128|363346514|FG002|Overall Study|Lost to Follow-up|1|||
105366047|NCT01317641|363346515|FG000|Overall Study|Not treated|0|||
105366048|NCT01317641|363346516|FG001|Overall Study|Not treated|0|||
105366049|NCT01317641|363346517|FG002|Overall Study|Not treated|0|||
105366050|NCT01317641|363346518|FG003|Overall Study|Not treated|0|||
105366051|NCT01317641|363346519|FG004|Overall Study|Not treated|0|||
105366052|NCT01317641|363346520|FG005|Overall Study|Not treated|0|||
105366053|NCT01317641|363346521|FG006|Overall Study|Not treated|0|||
105366054|NCT01317641|363346522|FG007|Overall Study|Not treated|1|||
105366055|NCT01317641|363346523|FG008|Overall Study|Not treated|1|||
105366056|NCT01317641|363346515|FG000|Overall Study|Adverse Event|0|||
105366057|NCT01317641|363346516|FG001|Overall Study|Adverse Event|1|||
105366058|NCT01317641|363346517|FG002|Overall Study|Adverse Event|0|||
105825734|NCT01380782|365020035|FG000|Overall Study|Physician Decision|1|||
105825735|NCT01380782|365020036|FG001|Overall Study|Physician Decision|0|||
105825736|NCT01380782|365020037|FG002|Overall Study|Physician Decision|0|||
105825737|NCT01380782|365020038|FG003|Overall Study|Physician Decision|0|||
105825738|NCT01380782|365020035|FG000|Overall Study|Withdrawal by Subject|0|||
105825739|NCT01380782|365020036|FG001|Overall Study|Withdrawal by Subject|0|||
105825740|NCT01380782|365020037|FG002|Overall Study|Withdrawal by Subject|1|||
105825741|NCT01380782|365020038|FG003|Overall Study|Withdrawal by Subject|1|||
105825742|NCT01403194|365020039|FG000|Overall Study|Screen Failure|2|||
105825743|NCT01403194|365020039|FG000|Overall Study|Lost to Follow-up|8|||
105825744|NCT03987191|365020040|FG000|Overall Study|COVID-19 related research disruption|0|||
105825745|NCT03987191|365020041|FG001|Overall Study|COVID-19 related research disruption|2|||
105825746|NCT01020474|365020042|FG000|Overall Study|Adverse Event|4|||
105825747|NCT01020474|365020043|FG001|Overall Study|Adverse Event|4|||
105825748|NCT01020474|365020042|FG000|Overall Study|Protocol Violation|0|||
105825749|NCT01020474|365020043|FG001|Overall Study|Protocol Violation|2|||
105825750|NCT01020474|365020042|FG000|Overall Study|Withdrawal by Subject|5|||
105825751|NCT01020474|365020043|FG001|Overall Study|Withdrawal by Subject|7|||
105825752|NCT01020474|365020042|FG000|Overall Study|Other Reasons|1|||
105825753|NCT01020474|365020043|FG001|Overall Study|Other Reasons|1|||
105825754|NCT01020474|365020042|FG000|Overall Study|Insufficient Clinical Response|0|||
105825755|NCT01020474|365020043|FG001|Overall Study|Insufficient Clinical Response|3|||
105825756|NCT01701063|365020044|FG000|Overall Study|Lost to Follow-up|0|||
105825757|NCT01701063|365020045|FG001|Overall Study|Lost to Follow-up|1|||
105825758|NCT01701063|365020046|FG002|Overall Study|Lost to Follow-up|0|||
105825759|NCT01701063|365020044|FG000|Overall Study|Withdrawal by Subject|0|||
105825760|NCT01701063|365020045|FG001|Overall Study|Withdrawal by Subject|0|||
105825761|NCT01701063|365020046|FG002|Overall Study|Withdrawal by Subject|1|||
105825762|NCT01701063|365020044|FG000|Overall Study|Other|0|||
105366059|NCT01317641|363346518|FG003|Overall Study|Adverse Event|1|||
105825763|NCT01701063|365020045|FG001|Overall Study|Other|0|||
105825764|NCT01701063|365020046|FG002|Overall Study|Other|1|||
105825765|NCT05387408|365020049|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
105825766|NCT03199963|365020050|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
105825767|NCT03199963|365020051|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
105825768|NCT03199963|365020050|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
105825769|NCT03199963|365020051|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
105825770|NCT03199963|365020050|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
105825771|NCT03199963|365020051|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
105825772|NCT03199963|365020050|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
105825773|NCT03199963|365020051|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
105825774|NCT03199963|365020050|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
105825775|NCT03199963|365020051|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
105825776|NCT03199963|365020050|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
105825777|NCT03199963|365020051|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
105825778|NCT03364192|365020052|FG000|Overall Study|Ineligible|10|||
105825779|NCT03364192|365020052|FG000|Overall Study|Withdrawal by Subject|5|||
105825780|NCT03364192|365020052|FG000|Overall Study|Lost to Follow-up|1|||
105825781|NCT01919112|365020055|FG000|Secondary Analysis-day 30|Death|1|||
105825782|NCT01919112|365020056|FG001|Secondary Analysis-day 30|Death|1|||
105825783|NCT01919112|365020057|FG002|Secondary Analysis-day 30|Death|1|||
105825784|NCT01919112|365020055|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
105825785|NCT01919112|365020056|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
105825786|NCT01919112|365020057|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
105825787|NCT04692155|365020060|FG000|Overall Study|Death|1|||
105825788|NCT05133180|365020061|FG000|Overall Study|Withdrawal of consent|1|||
105825789|NCT05133180|365020062|FG001|Overall Study|Withdrawal of consent|1|||
105825790|NCT05133180|365020061|FG000|Overall Study|Lost to Follow-up|1|||
105825791|NCT05133180|365020062|FG001|Overall Study|Lost to Follow-up|1|||
105825792|NCT05133180|365020061|FG000|Overall Study|Documented disease progression|0|||
105825793|NCT05133180|365020062|FG001|Overall Study|Documented disease progression|1|||
105825794|NCT03446768|365020063|FG000|Overall Study|Withdrawal by Subject|0|||
105825795|NCT03446768|365020064|FG001|Overall Study|Withdrawal by Subject|1|||
105825796|NCT00705666|365020065|FG000|Overall Study|No post-treatment questionnaire|279|||
105825797|NCT00705666|365020065|FG000|Overall Study|Withdrawal by Subject|21|||
105825798|NCT00705666|365020065|FG000|Overall Study|Physician Decision|7|||
105825799|NCT00705666|365020065|FG000|Overall Study|Lost to Follow-up|5|||
105825800|NCT00705666|365020065|FG000|Overall Study|Death|1|||
105825801|NCT00705666|365020065|FG000|Overall Study|Adverse Event|4|||
105825802|NCT00705666|365020065|FG000|Overall Study|Other|12|||
105825803|NCT00705666|365020065|FG000|Overall Study|Other|2|||
105825804|NCT00705666|365020065|FG000|Overall Study|Lack of data|3|||
105825805|NCT00705666|365020065|FG000|Overall Study|Untreated|5|||
105825806|NCT00506831|365020066|FG000|Overall Study|Death|1|||
105825807|NCT00506831|365020066|FG000|Overall Study|Withdrawal by Subject|1|||
105825808|NCT03406156|365020073|FG000|Overall Study|Death|9|||
105572700|NCT03015116|364096355|FG002|Overall Study|Lost to Follow-up|2|||
105825809|NCT03406156|365020074|FG001|Overall Study|Death|3|||
105825810|NCT03406156|365020073|FG000|Overall Study|Withdrawal by Subject|1|||
105825811|NCT03406156|365020074|FG001|Overall Study|Withdrawal by Subject|2|||
105825812|NCT03406156|365020073|FG000|Overall Study|COVID-19 infection|1|||
105825813|NCT03406156|365020074|FG001|Overall Study|COVID-19 infection|0|||
105825814|NCT03406156|365020073|FG000|Overall Study|Non-compliance with study procedures|1|||
105825815|NCT03406156|365020074|FG001|Overall Study|Non-compliance with study procedures|1|||
105825816|NCT03406156|365020073|FG000|Overall Study|Lost to Follow-up|0|||
105572701|NCT03015116|364096353|FG000|Overall Study|Withdrawal by Subject|3|||
105572702|NCT03015116|364096354|FG001|Overall Study|Withdrawal by Subject|1|||
105572703|NCT03015116|364096355|FG002|Overall Study|Withdrawal by Subject|0|||
105572704|NCT03015116|364096353|FG000|Overall Study|Subject has New Medical Status|1|||
105572705|NCT03015116|364096354|FG001|Overall Study|Subject has New Medical Status|0|||
105572706|NCT03015116|364096355|FG002|Overall Study|Subject has New Medical Status|0|||
105572707|NCT03015116|364096353|FG000|Overall Study|Physician Decision|0|||
105572708|NCT03015116|364096354|FG001|Overall Study|Physician Decision|1|||
105572709|NCT03015116|364096355|FG002|Overall Study|Physician Decision|0|||
105572710|NCT02200939|364096357|FG000|Overall Study|Participant withdrew consent|0|||
105572711|NCT02200939|364096358|FG001|Overall Study|Participant withdrew consent|1|||
105572712|NCT02200939|364096357|FG000|Overall Study|Lost to Follow-up|2|||
105572713|NCT02200939|364096358|FG001|Overall Study|Lost to Follow-up|9|||
105572714|NCT02200939|364096357|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
105572715|NCT02200939|364096358|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
105572716|NCT04666922|364096359|FG000|Overall Study|Withdrawal by Subject|1|||
105572717|NCT04666922|364096360|FG001|Overall Study|Withdrawal by Subject|0|||
105572718|NCT04666922|364096361|FG002|Overall Study|Withdrawal by Subject|0|||
105572719|NCT04666922|364096362|FG003|Overall Study|Withdrawal by Subject|0|||
105572720|NCT04666922|364096363|FG004|Overall Study|Withdrawal by Subject|0|||
105572721|NCT04666922|364096364|FG005|Overall Study|Withdrawal by Subject|0|||
105572722|NCT04666922|364096365|FG006|Overall Study|Withdrawal by Subject|0|||
105572723|NCT00957931|364096366|FG000|Overall Study|Death|4|||
105572724|NCT04105972|364096373|FG000|Overall Study|Adverse Event|2|||
105572725|NCT04105972|364096374|FG001|Overall Study|Adverse Event|1|||
105572726|NCT00003511|364096377|FG000|Overall Study|Not evaluable|4|||
105572727|NCT02914184|364096378|FG000|Overall Study|Lost to Follow-up|7|||
105572728|NCT02914184|364096379|FG001|Overall Study|Lost to Follow-up|10|||
105572729|NCT02914184|364096380|FG002|Overall Study|Lost to Follow-up|8|||
105572730|NCT02914184|364096381|FG003|Overall Study|Lost to Follow-up|7|||
105572731|NCT02914184|364096378|FG000|Overall Study|Withdrawal by Subject|4|||
105572732|NCT02914184|364096379|FG001|Overall Study|Withdrawal by Subject|2|||
105572733|NCT02914184|364096380|FG002|Overall Study|Withdrawal by Subject|7|||
105572734|NCT02914184|364096381|FG003|Overall Study|Withdrawal by Subject|3|||
105572735|NCT02914184|364096378|FG000|Overall Study|Other|1|||
105572736|NCT02914184|364096379|FG001|Overall Study|Other|0|||
105572737|NCT02914184|364096380|FG002|Overall Study|Other|0|||
105572738|NCT02914184|364096381|FG003|Overall Study|Other|0|||
105572739|NCT02914184|364096378|FG000|Overall Study|Migrated/moved from the study area|2|||
105572740|NCT02914184|364096379|FG001|Overall Study|Migrated/moved from the study area|1|||
105572741|NCT02914184|364096380|FG002|Overall Study|Migrated/moved from the study area|2|||
105572742|NCT02914184|364096381|FG003|Overall Study|Migrated/moved from the study area|1|||
105572743|NCT01478113|364096384|FG000|Overall Study|Withdrawal by Subject|0|||
105572744|NCT01478113|364096385|FG001|Overall Study|Withdrawal by Subject|1|||
105572745|NCT01478113|364096384|FG000|Overall Study|Physician Decision|1|||
105572746|NCT01478113|364096385|FG001|Overall Study|Physician Decision|0|||
105572747|NCT00603265|364096391|FG000|Overall Study|Adverse Event|2|||
105572748|NCT00603265|364096392|FG001|Overall Study|Adverse Event|11|||
105572749|NCT00603265|364096393|FG002|Overall Study|Adverse Event|1|||
105572750|NCT00603265|364096391|FG000|Overall Study|Withdrawal by Subject|1|||
105572751|NCT00603265|364096392|FG001|Overall Study|Withdrawal by Subject|2|||
105572752|NCT00603265|364096393|FG002|Overall Study|Withdrawal by Subject|1|||
105572753|NCT00603265|364096391|FG000|Overall Study|Lack of Efficacy|3|||
105572754|NCT00603265|364096392|FG001|Overall Study|Lack of Efficacy|0|||
105572755|NCT00603265|364096393|FG002|Overall Study|Lack of Efficacy|3|||
105572756|NCT00603265|364096391|FG000|Overall Study|Lost to Follow-up|0|||
105572757|NCT00603265|364096392|FG001|Overall Study|Lost to Follow-up|1|||
105572758|NCT00603265|364096393|FG002|Overall Study|Lost to Follow-up|0|||
105572759|NCT00603265|364096391|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
105572760|NCT00603265|364096392|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
105572761|NCT00603265|364096393|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
105572762|NCT00603265|364096391|FG000|Overall Study|Participant Left Country, No Responses|0|||
105572763|NCT00603265|364096392|FG001|Overall Study|Participant Left Country, No Responses|1|||
105572764|NCT00603265|364096393|FG002|Overall Study|Participant Left Country, No Responses|0|||
105572765|NCT00603265|364096391|FG000|Overall Study|Protocol Violation|1|||
105572766|NCT00603265|364096392|FG001|Overall Study|Protocol Violation|0|||
105572767|NCT00603265|364096393|FG002|Overall Study|Protocol Violation|0|||
105572768|NCT02002884|364096394|FG000|Main Period (MP)|Other|0|||
105572769|NCT02002884|364096395|FG001|Main Period (MP)|Other|3|||
105572770|NCT02002884|364096396|FG002|Main Period (MP)|Other|3|||
105572771|NCT02002884|364096397|FG003|Main Period (MP)|Other|0|||
105572772|NCT02002884|364096394|FG000|Main Period (MP)|Adverse Event|0|||
105572773|NCT02002884|364096395|FG001|Main Period (MP)|Adverse Event|1|||
105572774|NCT02002884|364096396|FG002|Main Period (MP)|Adverse Event|1|||
105572775|NCT02002884|364096397|FG003|Main Period (MP)|Adverse Event|0|||
105572776|NCT02002884|364096394|FG000|Main Period (MP)|Withdrawal by Subject|6|||
105572777|NCT02002884|364096395|FG001|Main Period (MP)|Withdrawal by Subject|2|||
105487652|NCT01017575|363797057|FG004|Overall Study|Withdrawal by Subject|0|||
105487653|NCT01445886|363797058|FG000|Overall Study|Lost to Follow-up|2|||
105487654|NCT01445886|363797058|FG000|Overall Study|Protocol Violation|3|||
105487655|NCT04706416|363797061|FG000|Overall Study|Lost to Follow-up|2|||
105487656|NCT04706416|363797062|FG001|Overall Study|Lost to Follow-up|0|||
105487657|NCT00995865|363797066|FG000|Overall Study|Protocol Violation|2|||
105487658|NCT00995865|363797067|FG001|Overall Study|Protocol Violation|0|||
105487659|NCT00995865|363797068|FG002|Overall Study|Protocol Violation|0|||
105487660|NCT00995865|363797066|FG000|Overall Study|Lost to Follow-up|0|||
105487661|NCT00995865|363797067|FG001|Overall Study|Lost to Follow-up|0|||
105487662|NCT00995865|363797068|FG002|Overall Study|Lost to Follow-up|1|||
105487663|NCT00144027|363797069|FG000|Overall Study|Lost to Follow-up|1|||
105487664|NCT00144027|363797070|FG001|Overall Study|Lost to Follow-up|3|||
105487665|NCT00144027|363797069|FG000|Overall Study|Withdrawal by Subject|2|||
105487666|NCT00144027|363797070|FG001|Overall Study|Withdrawal by Subject|2|||
105487667|NCT00144027|363797069|FG000|Overall Study|did not complete baseline assessment|0|||
105487668|NCT00144027|363797070|FG001|Overall Study|did not complete baseline assessment|6|||
105487669|NCT02021656|363797092|FG000|Overall Study|Adverse Event|1|||
105487670|NCT02021656|363797092|FG000|Overall Study|Lack of Efficacy|2|||
105487671|NCT02021656|363797092|FG000|Overall Study|Lost to Follow-up|1|||
105487672|NCT02021656|363797092|FG000|Overall Study|Withdrew Consent|2|||
105487673|NCT03194490|363797095|FG000|Overall Study|Lost to Follow-up|1|||
105487674|NCT03194490|363797096|FG001|Overall Study|Lost to Follow-up|3|||
105487675|NCT03194490|363797095|FG000|Overall Study|participant developed specific neck pain|1|||
105487676|NCT03194490|363797096|FG001|Overall Study|participant developed specific neck pain|0|||
105487677|NCT03687970|363797097|FG000|Overall Study|visit scheduling conflicts|2|||
105487678|NCT03687970|363797098|FG001|Overall Study|visit scheduling conflicts|0|||
105487679|NCT02793128|363797112|FG000|Overall Study|Death|4|||
105487680|NCT02793128|363797112|FG000|Overall Study|Withdrawal by Subject|2|||
105487681|NCT02793128|363797112|FG000|Overall Study|Physician Decision|1|||
105487682|NCT02793128|363797112|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
105487683|NCT02793128|363797112|FG000|Overall Study|Patient elected nephroureterectomy|1|||
105487684|NCT01888003|363797116|FG000|Overall Study|Study Terminated|5|||
105487685|NCT01888003|363797117|FG001|Overall Study|Study Terminated|6|||
105487686|NCT01888003|363797118|FG002|Overall Study|Study Terminated|40|||
105487687|NCT02359851|363797119|FG000|Overall Study|Death|1|||
105487688|NCT02359851|363797119|FG000|Overall Study|Disease progression|1|||
105487689|NCT00055471|363797120|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
105487690|NCT00055471|363797121|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
105487691|NCT00055471|363797122|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
105487692|NCT00055471|363797120|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
105487693|NCT00055471|363797121|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
105487694|NCT00055471|363797122|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
105487695|NCT00055471|363797120|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
105487696|NCT00055471|363797121|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
105487697|NCT00055471|363797122|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
105487698|NCT01854944|363797123|FG000|Overall Study|Withdrawal by Subject|0|||
105487699|NCT01854944|363797124|FG001|Overall Study|Withdrawal by Subject|0|||
105487700|NCT01854944|363797125|FG002|Overall Study|Withdrawal by Subject|1|||
105572778|NCT02002884|364096396|FG002|Main Period (MP)|Withdrawal by Subject|2|||
105572779|NCT02002884|364096397|FG003|Main Period (MP)|Withdrawal by Subject|0|||
105572780|NCT02002884|364096394|FG000|Main Period (MP)|Lost to Follow-up|0|||
105572781|NCT02002884|364096395|FG001|Main Period (MP)|Lost to Follow-up|0|||
105572782|NCT02002884|364096396|FG002|Main Period (MP)|Lost to Follow-up|2|||
105572783|NCT02002884|364096397|FG003|Main Period (MP)|Lost to Follow-up|0|||
105572784|NCT02002884|364096394|FG000|Open-Label Extension Period (OLEX)|Other|0|||
105572785|NCT02002884|364096395|FG001|Open-Label Extension Period (OLEX)|Other|0|||
105572786|NCT02002884|364096396|FG002|Open-Label Extension Period (OLEX)|Other|0|||
105572787|NCT02002884|364096397|FG003|Open-Label Extension Period (OLEX)|Other|24|||
105572788|NCT02002884|364096394|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
105572789|NCT02002884|364096395|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
105572790|NCT02002884|364096396|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
105487701|NCT02101112|363797126|FG000|Overall Study|Adverse Event|0|||
105487702|NCT02101112|363797127|FG001|Overall Study|Adverse Event|0|||
105487703|NCT02101112|363797128|FG002|Overall Study|Adverse Event|1|||
105487704|NCT02101112|363797129|FG003|Overall Study|Adverse Event|0|||
105487705|NCT02101112|363797130|FG004|Overall Study|Adverse Event|0|||
105487706|NCT02101112|363797131|FG005|Overall Study|Adverse Event|0|||
105487707|NCT02101112|363797126|FG000|Overall Study|Withdrawal by Subject|0|||
105487708|NCT02101112|363797127|FG001|Overall Study|Withdrawal by Subject|0|||
105487709|NCT02101112|363797128|FG002|Overall Study|Withdrawal by Subject|0|||
105487710|NCT02101112|363797129|FG003|Overall Study|Withdrawal by Subject|0|||
105487711|NCT02101112|363797130|FG004|Overall Study|Withdrawal by Subject|1|||
105487712|NCT02101112|363797131|FG005|Overall Study|Withdrawal by Subject|0|||
105572791|NCT02002884|364096397|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
105825817|NCT03406156|365020074|FG001|Overall Study|Lost to Follow-up|2|||
105825818|NCT03406156|365020073|FG000|Overall Study|Other, not specified|72|||
105825819|NCT03406156|365020074|FG001|Overall Study|Other, not specified|28|||
105825820|NCT01410227|365020075|FG000|Overall Study|Adverse Event|1|||
105825821|NCT01410227|365020076|FG001|Overall Study|Adverse Event|0|||
105825822|NCT01410227|365020077|FG002|Overall Study|Adverse Event|0|||
105825823|NCT01410227|365020078|FG003|Overall Study|Adverse Event|0|||
105825824|NCT01410227|365020075|FG000|Overall Study|Withdrawal by Subject|3|||
105825825|NCT01410227|365020076|FG001|Overall Study|Withdrawal by Subject|0|||
105825826|NCT01410227|365020077|FG002|Overall Study|Withdrawal by Subject|1|||
105825827|NCT01410227|365020078|FG003|Overall Study|Withdrawal by Subject|0|||
105825828|NCT01410227|365020075|FG000|Overall Study|Pregnancy|0|||
105825829|NCT01410227|365020076|FG001|Overall Study|Pregnancy|0|||
105487713|NCT00395538|363797134|FG000|Overall Study|Did not re-consent to revised protocol|1|||
105487714|NCT00395538|363797135|FG001|Overall Study|Did not re-consent to revised protocol|10|||
105487715|NCT00395538|363797136|FG002|Overall Study|Did not re-consent to revised protocol|0|||
105487716|NCT00395538|363797134|FG000|Overall Study|FDA partial hold on PTH|0|||
105487717|NCT00395538|363797135|FG001|Overall Study|FDA partial hold on PTH|0|||
105825830|NCT01410227|365020077|FG002|Overall Study|Pregnancy|0|||
105825831|NCT01410227|365020078|FG003|Overall Study|Pregnancy|1|||
105825832|NCT01410227|365020075|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
105825833|NCT01410227|365020076|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
105825834|NCT01410227|365020077|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
105487718|NCT00395538|363797136|FG002|Overall Study|FDA partial hold on PTH|11|||
105487719|NCT00395538|363797134|FG000|Overall Study|Failed screening|0|||
105487720|NCT00395538|363797135|FG001|Overall Study|Failed screening|0|||
105487721|NCT00395538|363797136|FG002|Overall Study|Failed screening|4|||
105487722|NCT00395538|363797134|FG000|Overall Study|Switch to Natpara|0|||
105487723|NCT00395538|363797135|FG001|Overall Study|Switch to Natpara|0|||
105487724|NCT00395538|363797136|FG002|Overall Study|Switch to Natpara|3|||
105487725|NCT00395538|363797134|FG000|Overall Study|Adverse Event|1|||
105487726|NCT00395538|363797135|FG001|Overall Study|Adverse Event|0|||
105487727|NCT00395538|363797136|FG002|Overall Study|Adverse Event|2|||
105487728|NCT00395538|363797134|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
105487729|NCT00395538|363797135|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
105487730|NCT00395538|363797136|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
105487731|NCT00395538|363797134|FG000|Overall Study|Non-compliance with study protocol|0|||
105487732|NCT00395538|363797135|FG001|Overall Study|Non-compliance with study protocol|1|||
105487733|NCT00395538|363797136|FG002|Overall Study|Non-compliance with study protocol|0|||
105487734|NCT00395538|363797134|FG000|Overall Study|PTH resistance|0|||
105487735|NCT00395538|363797135|FG001|Overall Study|PTH resistance|0|||
105487736|NCT00395538|363797136|FG002|Overall Study|PTH resistance|1|||
105487737|NCT00395538|363797134|FG000|Overall Study|Pregnancy|1|||
105487738|NCT00395538|363797135|FG001|Overall Study|Pregnancy|0|||
105487739|NCT00395538|363797136|FG002|Overall Study|Pregnancy|0|||
105487740|NCT00395538|363797134|FG000|Overall Study|Partial recovery of parathyroid function|0|||
105487741|NCT00395538|363797135|FG001|Overall Study|Partial recovery of parathyroid function|0|||
105487742|NCT00395538|363797136|FG002|Overall Study|Partial recovery of parathyroid function|1|||
105487743|NCT00395538|363797134|FG000|Overall Study|Participant elected to discontinue|0|||
105487744|NCT00395538|363797135|FG001|Overall Study|Participant elected to discontinue|0|||
105487745|NCT00395538|363797136|FG002|Overall Study|Participant elected to discontinue|1|||
105487746|NCT01876810|363797139|FG000|Overall Study|Physician Decision|0|||
105487747|NCT01876810|363797140|FG001|Overall Study|Physician Decision|1|||
105487748|NCT04382755|363797143|FG000|Overall Study|Withdrawal by Subject|1|||
105487749|NCT04382755|363797144|FG001|Overall Study|Withdrawal by Subject|0|||
105487750|NCT04382755|363797143|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
105487751|NCT04382755|363797144|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
105487752|NCT04382755|363797143|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
105487753|NCT04382755|363797144|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
105487754|NCT00285207|363797146|FG000|Overall Study|Lost to Follow-up|3|||
105487755|NCT00285207|363797147|FG001|Overall Study|Lost to Follow-up|2|||
105487756|NCT00285207|363797146|FG000|Overall Study|Withdrawal by Subject|5|||
105487757|NCT00285207|363797147|FG001|Overall Study|Withdrawal by Subject|2|||
105487758|NCT00285207|363797146|FG000|Overall Study|Pregnancy|1|||
105487759|NCT00285207|363797147|FG001|Overall Study|Pregnancy|1|||
105487760|NCT00285207|363797146|FG000|Overall Study|non-compliance|0|||
105487761|NCT00285207|363797147|FG001|Overall Study|non-compliance|1|||
105487762|NCT04571515|363797148|FG000|Overall Study|Physician Decision|0|||
105487763|NCT04571515|363797149|FG001|Overall Study|Physician Decision|0|||
105487764|NCT04571515|363797150|FG002|Overall Study|Physician Decision|0|||
105825835|NCT01410227|365020078|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
105825836|NCT02699463|365020079|FG000|Overall Study|Lost to Follow-up|11|||
105825837|NCT02699463|365020080|FG001|Overall Study|Lost to Follow-up|8|||
105825838|NCT02699463|365020079|FG000|Overall Study|Withdrawal by Subject|4|||
105825839|NCT02699463|365020080|FG001|Overall Study|Withdrawal by Subject|1|||
105366060|NCT01317641|363346519|FG004|Overall Study|Adverse Event|0|||
105366061|NCT01317641|363346520|FG005|Overall Study|Adverse Event|0|||
105366062|NCT01317641|363346521|FG006|Overall Study|Adverse Event|2|||
105366063|NCT01317641|363346522|FG007|Overall Study|Adverse Event|1|||
105366064|NCT01317641|363346523|FG008|Overall Study|Adverse Event|0|||
105366065|NCT01317641|363346515|FG000|Overall Study|Protocol Violation|1|||
105366066|NCT01317641|363346516|FG001|Overall Study|Protocol Violation|0|||
105366067|NCT01317641|363346517|FG002|Overall Study|Protocol Violation|0|||
105366068|NCT01317641|363346518|FG003|Overall Study|Protocol Violation|0|||
105366069|NCT01317641|363346519|FG004|Overall Study|Protocol Violation|0|||
105487765|NCT04571515|363797151|FG003|Overall Study|Physician Decision|0|||
105487766|NCT04571515|363797152|FG004|Overall Study|Physician Decision|1|||
105487767|NCT04571515|363797148|FG000|Overall Study|Withdrawal by Subject|0|||
105487768|NCT04571515|363797149|FG001|Overall Study|Withdrawal by Subject|0|||
105487769|NCT04571515|363797150|FG002|Overall Study|Withdrawal by Subject|0|||
105487770|NCT04571515|363797151|FG003|Overall Study|Withdrawal by Subject|0|||
105487771|NCT04571515|363797152|FG004|Overall Study|Withdrawal by Subject|1|||
105487772|NCT04571515|363797148|FG000|Overall Study|insufficient pain|1|||
105487773|NCT04571515|363797149|FG001|Overall Study|insufficient pain|0|||
105487774|NCT04571515|363797150|FG002|Overall Study|insufficient pain|0|||
105825840|NCT01808651|365020081|FG000|Study Period 1|Lost to Follow-up|1|||
105825841|NCT01808651|365020082|FG001|Study Period 1|Lost to Follow-up|3|||
105825842|NCT01808651|365020083|FG002|Study Period 1|Lost to Follow-up|0|||
105366070|NCT01317641|363346520|FG005|Overall Study|Protocol Violation|0|||
105825843|NCT01808651|365020081|FG000|Study Period 1|Protocol Violation|1|||
105825844|NCT01808651|365020082|FG001|Study Period 1|Protocol Violation|0|||
105825845|NCT01808651|365020083|FG002|Study Period 1|Protocol Violation|1|||
105825846|NCT01808651|365020081|FG000|Study Period 1|Physician Decision|3|||
105825847|NCT01808651|365020082|FG001|Study Period 1|Physician Decision|2|||
105825848|NCT01808651|365020083|FG002|Study Period 1|Physician Decision|0|||
105825849|NCT01808651|365020081|FG000|Study Period 1|Lack of Efficacy|2|||
105825850|NCT01808651|365020082|FG001|Study Period 1|Lack of Efficacy|1|||
105825851|NCT01808651|365020083|FG002|Study Period 1|Lack of Efficacy|0|||
105825852|NCT01808651|365020081|FG000|Study Period 1|Adverse Event|10|||
105825853|NCT01808651|365020082|FG001|Study Period 1|Adverse Event|4|||
105825854|NCT01808651|365020083|FG002|Study Period 1|Adverse Event|1|||
105825855|NCT01808651|365020081|FG000|Study Period 1|Participant Decision|9|||
105825856|NCT01808651|365020082|FG001|Study Period 1|Participant Decision|7|||
105825857|NCT01808651|365020083|FG002|Study Period 1|Participant Decision|3|||
105825858|NCT00585286|365020085|FG000|Overall Study|Lost to Follow-up|1|||
105825859|NCT02488239|365020086|FG000|Overall Study|Death|3|||
105825860|NCT02488239|365020086|FG000|Overall Study|Withdrawal by Subject|3|||
105825861|NCT02488239|365020086|FG000|Overall Study|Physician Decision|2|||
105825862|NCT02488239|365020086|FG000|Overall Study|Consent ineligible|1|||
105825863|NCT02488239|365020086|FG000|Overall Study|Did not undergo implant procedure|1|||
105825864|NCT05479058|365020092|FG000|Overall Study|Withdrawal by Subject|1|||
105825865|NCT05479058|365020093|FG001|Overall Study|Withdrawal by Subject|1|||
105825866|NCT05479058|365020092|FG000|Overall Study|Study terminated by sponsor|10|||
105825867|NCT05479058|365020093|FG001|Overall Study|Study terminated by sponsor|10|||
105825868|NCT03325881|365020094|FG000|Overall Study|Protocol Violation|0|||
105825869|NCT03325881|365020095|FG001|Overall Study|Protocol Violation|1|||
105825870|NCT03325881|365020094|FG000|Overall Study|Withdrawal by Subject|0|||
105825871|NCT03325881|365020095|FG001|Overall Study|Withdrawal by Subject|2|||
105825872|NCT03325881|365020094|FG000|Overall Study|Lack of Efficacy|2|||
105825873|NCT03325881|365020095|FG001|Overall Study|Lack of Efficacy|0|||
105825874|NCT03325881|365020094|FG000|Overall Study|Not treated|1|||
105825875|NCT03325881|365020095|FG001|Overall Study|Not treated|0|||
105825876|NCT03676634|365020096|FG000|Overall Study|Red blood cell loss|1|||
105825877|NCT03676634|365020096|FG000|Overall Study|Out-of-limit pulse|2|||
105825878|NCT01484912|365020108|FG000|Overall Study|Withdrawal by Subject|1|||
105825879|NCT01484912|365020109|FG001|Overall Study|Withdrawal by Subject|0|||
105825880|NCT01484912|365020108|FG000|Overall Study|Physician Decision|0|||
105825881|NCT01484912|365020109|FG001|Overall Study|Physician Decision|1|||
105825882|NCT02294981|365020110|FG000|Overall Study|Lost to Follow-up|1|||
105825883|NCT02213263|365020113|FG000|Overall Study|Insufficient clinical response|4|||
105825884|NCT02213263|365020114|FG001|Overall Study|Insufficient clinical response|3|||
105825885|NCT02213263|365020113|FG000|Overall Study|Lost to Follow-up|0|||
105825886|NCT02213263|365020114|FG001|Overall Study|Lost to Follow-up|1|||
105825887|NCT02213263|365020113|FG000|Overall Study|No longer willing to participate|3|||
105487775|NCT04571515|363797151|FG003|Overall Study|insufficient pain|0|||
105825888|NCT02213263|365020114|FG001|Overall Study|No longer willing to participate|4|||
105825889|NCT02213263|365020113|FG000|Overall Study|Progressive disease|20|||
105825890|NCT02213263|365020114|FG001|Overall Study|Progressive disease|14|||
105825891|NCT02213263|365020113|FG000|Overall Study|Protocol Violation|0|||
105825892|NCT02213263|365020114|FG001|Overall Study|Protocol Violation|1|||
105825893|NCT02213263|365020113|FG000|Overall Study|Adverse Event|1|||
105825894|NCT02213263|365020114|FG001|Overall Study|Adverse Event|3|||
105825895|NCT01188681|365020115|FG000|Overall Study|bladder cancer|0|||
105825896|NCT01188681|365020116|FG001|Overall Study|bladder cancer|0|||
105825897|NCT01188681|365020117|FG002|Overall Study|bladder cancer|1|||
105825898|NCT01188681|365020118|FG003|Overall Study|bladder cancer|0|||
105825899|NCT01188681|365020115|FG000|Overall Study|Withdrawal by Subject|0|||
105825900|NCT01188681|365020116|FG001|Overall Study|Withdrawal by Subject|0|||
105825901|NCT01188681|365020117|FG002|Overall Study|Withdrawal by Subject|0|||
105825902|NCT01188681|365020118|FG003|Overall Study|Withdrawal by Subject|1|||
105825903|NCT00263588|365020119|FG000|Overall Study|Death|54|||
105825904|NCT00263588|365020120|FG001|Overall Study|Death|90|||
105825905|NCT00263588|365020119|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
105366071|NCT01317641|363346521|FG006|Overall Study|Protocol Violation|0|||
105487776|NCT04571515|363797152|FG004|Overall Study|insufficient pain|1|||
105487777|NCT03729362|363798655|FG000|Overall Study|Withdrawal by Subject|2|||
105487778|NCT03729362|363798656|FG001|Overall Study|Withdrawal by Subject|0|||
105487779|NCT03729362|363798655|FG000|Overall Study|Physician Decision|1|||
105487780|NCT03729362|363798656|FG001|Overall Study|Physician Decision|0|||
105487781|NCT03729362|363798655|FG000|Overall Study|COVID-19 Pandemic|1|||
105487782|NCT03729362|363798656|FG001|Overall Study|COVID-19 Pandemic|0|||
105825906|NCT00263588|365020120|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
105825907|NCT00263588|365020119|FG000|Overall Study|Lost to Follow-up|7|||
105825908|NCT00263588|365020120|FG001|Overall Study|Lost to Follow-up|10|||
105825909|NCT00263588|365020119|FG000|Overall Study|Withdrawal by Subject|3|||
105825910|NCT00263588|365020120|FG001|Overall Study|Withdrawal by Subject|4|||
105825911|NCT00263588|365020119|FG000|Overall Study|Protocol Violation|0|||
105825912|NCT00263588|365020120|FG001|Overall Study|Protocol Violation|1|||
105825913|NCT00263588|365020119|FG000|Overall Study|Investigator decision|7|||
105825914|NCT00263588|365020120|FG001|Overall Study|Investigator decision|15|||
105825915|NCT00263588|365020119|FG000|Overall Study|Sponsor terminated study|0|||
105825916|NCT00263588|365020120|FG001|Overall Study|Sponsor terminated study|1|||
105825917|NCT02890992|365020121|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
105825918|NCT02890992|365020122|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
105825919|NCT02890992|365020123|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
105825920|NCT02890992|365020124|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
105825921|NCT02890992|365020125|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
105825922|NCT02890992|365020126|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
105825923|NCT02890992|365020127|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
105825924|NCT02890992|365020128|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
105825925|NCT02890992|365020121|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
105825926|NCT02890992|365020122|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
105825927|NCT02890992|365020123|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
105825928|NCT02890992|365020124|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
105825929|NCT02890992|365020125|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
105825930|NCT02890992|365020126|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
105825931|NCT02890992|365020127|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
105825932|NCT02890992|365020128|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
105825933|NCT02890992|365020121|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
105825934|NCT02890992|365020122|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
105572792|NCT02002884|364096394|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
105825935|NCT02890992|365020123|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
105825936|NCT02890992|365020124|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
105825937|NCT02890992|365020125|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
105825938|NCT02890992|365020126|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
105572793|NCT02002884|364096395|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
105572794|NCT02002884|364096396|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
105572795|NCT02002884|364096397|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
105572796|NCT02002884|364096394|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
105572797|NCT02002884|364096395|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
105572798|NCT02002884|364096396|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
105572799|NCT02002884|364096397|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
105572800|NCT02002884|364096394|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
105572801|NCT02002884|364096395|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
105572802|NCT02002884|364096396|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
105572803|NCT02002884|364096397|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
105572804|NCT02966002|364096398|FG000|Overall Study|Withdrawal by Subject|2|||
105825939|NCT02890992|365020127|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
105825940|NCT02890992|365020128|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
105825941|NCT00918684|365020132|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
105825942|NCT00918684|365020132|FG000|Treatment Phase|Lack of Efficacy|6|||
105825943|NCT00918684|365020132|FG000|Treatment Phase|Lost to Follow-up|2|||
105825944|NCT00918684|365020132|FG000|Treatment Phase|Physician Decision|8|||
105825945|NCT00918684|365020132|FG000|Treatment Phase|Protocol Violation|1|||
105366072|NCT01317641|363346522|FG007|Overall Study|Protocol Violation|0|||
105572805|NCT02966002|364096398|FG000|Overall Study|Adverse Event|1|||
105572806|NCT02966002|364096398|FG000|Overall Study|Lost to Follow-up|1|||
105572807|NCT00067990|364096399|FG000|Overall Study|Death|5|||
105572808|NCT00067990|364096400|FG001|Overall Study|Death|7|||
105572809|NCT00067990|364096399|FG000|Overall Study|ESRD, Non IF/TA|1|||
105572810|NCT00067990|364096400|FG001|Overall Study|ESRD, Non IF/TA|3|||
105572811|NCT00067990|364096399|FG000|Overall Study|Withdrawal by Subject|4|||
105572812|NCT00067990|364096400|FG001|Overall Study|Withdrawal by Subject|12|||
105572813|NCT01118455|364096401|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
105572814|NCT01118455|364096402|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
105572815|NCT02396537|364096403|FG000|Overall Study|Protocol Violation|0|||
105572816|NCT02396537|364096404|FG001|Overall Study|Protocol Violation|1|||
105572817|NCT02291432|364096405|FG000|Overall Study|Withdrawal by Subject|2|||
105572818|NCT00152763|364096409|FG000|Overall Study|Death|4|||
105572819|NCT00152763|364096410|FG001|Overall Study|Death|1|||
105572820|NCT00152763|364096411|FG002|Overall Study|Death|2|||
105572821|NCT00152763|364096412|FG003|Overall Study|Death|1|||
105572822|NCT00152763|364096409|FG000|Overall Study|Lost to Follow-up|6|||
105572823|NCT00152763|364096410|FG001|Overall Study|Lost to Follow-up|4|||
105572824|NCT00152763|364096411|FG002|Overall Study|Lost to Follow-up|2|||
105825946|NCT00918684|365020132|FG000|Treatment Phase|Withdrawal by Subject|8|||
105825947|NCT00909038|365020133|FG000|Overall Study|Protocol Violation|187|||
105825948|NCT00909038|365020133|FG000|Overall Study|Non-evaluable Subjects|230|||
105825949|NCT00909753|365020134|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
105366073|NCT01317641|363346523|FG008|Overall Study|Protocol Violation|0|||
105366074|NCT01317641|363346515|FG000|Overall Study|Disease progression|0|||
105572825|NCT00152763|364096412|FG003|Overall Study|Lost to Follow-up|13|||
105572826|NCT00584805|364096413|FG000|Overall Study|No longer at risk of exposure|39|||
105572827|NCT00584805|364096413|FG000|Overall Study|Relocation|36|||
105572828|NCT00584805|364096413|FG000|Overall Study|Withdrawal by Subject|18|||
105572829|NCT00584805|364096413|FG000|Overall Study|Non-compliance|1|||
105572830|NCT00584805|364096413|FG000|Overall Study|Lost to follow up|3|||
105572831|NCT00584805|364096413|FG000|Overall Study|Screen failures|2|||
105572832|NCT01235975|364096416|FG000|Overall Study|Serious Adverse Event|0|||
105572833|NCT01235975|364096417|FG001|Overall Study|Serious Adverse Event|1|||
105572834|NCT01235975|364096416|FG000|Overall Study|Withdrawal by Subject|8|||
105572835|NCT01235975|364096417|FG001|Overall Study|Withdrawal by Subject|2|||
105572836|NCT01235975|364096416|FG000|Overall Study|Migrated/moved from study area|2|||
105572837|NCT01235975|364096417|FG001|Overall Study|Migrated/moved from study area|1|||
105572838|NCT01235975|364096416|FG000|Overall Study|Lost to Follow-up|7|||
105572839|NCT01235975|364096417|FG001|Overall Study|Lost to Follow-up|3|||
105572840|NCT02341456|364096418|FG000|Overall Study|Disease progression|2|||
105572841|NCT02341456|364096419|FG001|Overall Study|Disease progression|3|||
105572842|NCT02341456|364096420|FG002|Overall Study|Disease progression|1|||
105572843|NCT02341456|364096418|FG000|Overall Study|Death|1|||
105572844|NCT02341456|364096419|FG001|Overall Study|Death|1|||
105572845|NCT02341456|364096420|FG002|Overall Study|Death|1|||
105572846|NCT02341456|364096418|FG000|Overall Study|Withdrawal by Subject|0|||
105572847|NCT02341456|364096419|FG001|Overall Study|Withdrawal by Subject|1|||
105572848|NCT02341456|364096420|FG002|Overall Study|Withdrawal by Subject|1|||
105572849|NCT02341456|364096418|FG000|Overall Study|Moved to local access programme.|0|||
105572850|NCT02341456|364096419|FG001|Overall Study|Moved to local access programme.|1|||
105572851|NCT02341456|364096420|FG002|Overall Study|Moved to local access programme.|1|||
105572852|NCT02341456|364096418|FG000|Overall Study|Physician Decision|1|||
105572853|NCT02341456|364096419|FG001|Overall Study|Physician Decision|0|||
105572854|NCT02341456|364096420|FG002|Overall Study|Physician Decision|0|||
105572855|NCT00422799|364096421|FG000|Overall Study|Withdrawal by Subject|6|||
105572856|NCT00422799|364096421|FG000|Overall Study|Adverse Event|7|||
105572857|NCT03469349|364096423|FG000|Overall Study|Withdrawal by Subject|1|||
105366075|NCT01317641|363346516|FG001|Overall Study|Disease progression|0|||
105572858|NCT03469349|364096424|FG001|Overall Study|Withdrawal by Subject|3|||
105572859|NCT03469349|364096423|FG000|Overall Study|Progressive Disease|0|||
105572860|NCT03469349|364096424|FG001|Overall Study|Progressive Disease|1|||
105572861|NCT03469349|364096423|FG000|Overall Study|Lost to Follow-up|2|||
105572862|NCT03469349|364096424|FG001|Overall Study|Lost to Follow-up|2|||
105572863|NCT03469349|364096423|FG000|Overall Study|Adverse Event|2|||
105572864|NCT03469349|364096424|FG001|Overall Study|Adverse Event|4|||
105572865|NCT02917265|364096425|FG000|Overall Study|Physician Decision|1|||
105572866|NCT02917265|364096426|FG001|Overall Study|Physician Decision|0|||
105572867|NCT02917265|364096425|FG000|Overall Study|Withdrawal by Subject|1|||
105572868|NCT02917265|364096426|FG001|Overall Study|Withdrawal by Subject|0|||
105572869|NCT01737996|364096427|FG000|Overall Study|Adverse Event|0|||
105572870|NCT01737996|364096428|FG001|Overall Study|Adverse Event|1|||
105572871|NCT01737996|364096429|FG002|Overall Study|Adverse Event|1|||
105572872|NCT01737996|364096427|FG000|Overall Study|Withdrawal by Subject|0|||
105366076|NCT01317641|363346517|FG002|Overall Study|Disease progression|0|||
105572873|NCT01737996|364096428|FG001|Overall Study|Withdrawal by Subject|0|||
105572874|NCT01737996|364096429|FG002|Overall Study|Withdrawal by Subject|1|||
105572875|NCT01027364|364096430|FG000|Overall Study|Adverse Event|1|||
105572876|NCT01027364|364096431|FG001|Overall Study|Adverse Event|0|||
105572877|NCT01027364|364096432|FG002|Overall Study|Adverse Event|1|||
105572878|NCT01027364|364096433|FG003|Overall Study|Adverse Event|0|||
105572879|NCT01027364|364096430|FG000|Overall Study|Lost to Follow-up|1|||
105572880|NCT01027364|364096431|FG001|Overall Study|Lost to Follow-up|0|||
105572881|NCT01027364|364096432|FG002|Overall Study|Lost to Follow-up|0|||
105572882|NCT01027364|364096433|FG003|Overall Study|Lost to Follow-up|0|||
105572883|NCT01027364|364096430|FG000|Overall Study|Protocol Violation|1|||
105572884|NCT01027364|364096431|FG001|Overall Study|Protocol Violation|0|||
105572885|NCT01027364|364096432|FG002|Overall Study|Protocol Violation|0|||
105572886|NCT01027364|364096433|FG003|Overall Study|Protocol Violation|1|||
105572887|NCT01027364|364096430|FG000|Overall Study|Withdrawal by Subject|1|||
105572888|NCT01027364|364096431|FG001|Overall Study|Withdrawal by Subject|2|||
105572889|NCT01027364|364096432|FG002|Overall Study|Withdrawal by Subject|0|||
105572890|NCT01027364|364096433|FG003|Overall Study|Withdrawal by Subject|0|||
105572891|NCT03283696|364096434|FG000|Overall Study|Physician Decision|5|||
105572892|NCT03283696|364096435|FG001|Overall Study|Physician Decision|6|||
105572893|NCT03283696|364096434|FG000|Overall Study|Withdrawal by Subject|2|||
105572894|NCT03283696|364096435|FG001|Overall Study|Withdrawal by Subject|0|||
105572895|NCT02765490|364096436|FG000|Overall Study|Lost to Follow-up|1|||
105572896|NCT02765490|364096437|FG001|Overall Study|Lost to Follow-up|1|||
105572897|NCT02765490|364096436|FG000|Overall Study|Other|0|||
105572898|NCT02765490|364096437|FG001|Overall Study|Other|1|||
105572899|NCT02765490|364096436|FG000|Overall Study|Death|0|||
105572900|NCT02765490|364096437|FG001|Overall Study|Death|1|||
105572901|NCT00439179|364096438|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
105572902|NCT00439179|364096439|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
105572903|NCT00439179|364096440|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
105572904|NCT00439179|364096441|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
105572905|NCT00675506|364096443|FG000|Overall Study|Lost to Follow-up|1|||
105572906|NCT00675506|364096444|FG001|Overall Study|Lost to Follow-up|5|||
105572907|NCT00675506|364096443|FG000|Overall Study|Lost interest|3|||
105572908|NCT00675506|364096444|FG001|Overall Study|Lost interest|5|||
105572909|NCT00675506|364096443|FG000|Overall Study|Elevated fasting glucose|2|||
105572910|NCT00675506|364096444|FG001|Overall Study|Elevated fasting glucose|1|||
105572911|NCT00675506|364096443|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
105572912|NCT00675506|364096444|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
105572913|NCT00675506|364096443|FG000|Overall Study|Elevated IGF-1|2|||
105366077|NCT01317641|363346518|FG003|Overall Study|Disease progression|0|||
105366078|NCT01317641|363346519|FG004|Overall Study|Disease progression|0|||
105366079|NCT01317641|363346520|FG005|Overall Study|Disease progression|0|||
105366080|NCT01317641|363346521|FG006|Overall Study|Disease progression|0|||
105366081|NCT01317641|363346522|FG007|Overall Study|Disease progression|3|||
105366082|NCT01317641|363346523|FG008|Overall Study|Disease progression|4|||
105366083|NCT01317641|363346515|FG000|Overall Study|Withdrawal by Subject|0|||
105366084|NCT01317641|363346516|FG001|Overall Study|Withdrawal by Subject|0|||
105366085|NCT01317641|363346517|FG002|Overall Study|Withdrawal by Subject|0|||
105366086|NCT01317641|363346518|FG003|Overall Study|Withdrawal by Subject|0|||
105366087|NCT01317641|363346519|FG004|Overall Study|Withdrawal by Subject|0|||
105366088|NCT01317641|363346520|FG005|Overall Study|Withdrawal by Subject|0|||
105366089|NCT01317641|363346521|FG006|Overall Study|Withdrawal by Subject|1|||
105366090|NCT01317641|363346522|FG007|Overall Study|Withdrawal by Subject|0|||
105366091|NCT01317641|363346523|FG008|Overall Study|Withdrawal by Subject|0|||
105366092|NCT00611806|363346524|FG000|Overall Study|Withdrawal by Subject|8|||
105366093|NCT00611806|363346525|FG001|Overall Study|Withdrawal by Subject|2|||
105366094|NCT00611806|363346524|FG000|Overall Study|Adverse Event|2|||
105366095|NCT00611806|363346525|FG001|Overall Study|Adverse Event|1|||
105366096|NCT00611806|363346524|FG000|Overall Study|Lost to Follow-up|6|||
105366097|NCT00611806|363346525|FG001|Overall Study|Lost to Follow-up|0|||
105366098|NCT02611882|363346526|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
105366099|NCT02611882|363346527|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
105572914|NCT00675506|364096444|FG001|Overall Study|Elevated IGF-1|0|||
105572915|NCT00675506|364096443|FG000|Overall Study|Hypersensitivity Reaction|1|||
105366100|NCT02611882|363346528|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
105366101|NCT00715559|363346530|FG000|Overall Study|medication not tolerated - nausea|1|||
105366102|NCT01051921|363346531|FG000|Overall Study|Physician Decision|9|||
105366103|NCT01051921|363346531|FG000|Overall Study|Adverse Event|8|||
105366104|NCT01051921|363346531|FG000|Overall Study|Withdrawal by Subject|7|||
105366105|NCT01051921|363346531|FG000|Overall Study|Lost to Follow-up|4|||
105366106|NCT01051921|363346531|FG000|Overall Study|virological failure|1|||
105572916|NCT00675506|364096444|FG001|Overall Study|Hypersensitivity Reaction|0|||
105572917|NCT00675506|364096443|FG000|Overall Study|Disclosed history of cancer|1|||
105572918|NCT00675506|364096444|FG001|Overall Study|Disclosed history of cancer|0|||
105572919|NCT00675506|364096443|FG000|Overall Study|Declined participation|1|||
105572920|NCT00675506|364096444|FG001|Overall Study|Declined participation|0|||
105572921|NCT00675506|364096443|FG000|Overall Study|Schedule conflict|0|||
105572922|NCT00675506|364096444|FG001|Overall Study|Schedule conflict|1|||
105572923|NCT03151395|364096445|FG000|Overall Study|Adverse Event|2|||
105572924|NCT03151395|364096445|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
105572925|NCT03151395|364096445|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
105572926|NCT03151395|364096445|FG000|Overall Study|Unspecified reason|4|||
105572927|NCT01107743|364096447|FG000|Overall Study|Protocol Violation|46|||
105572928|NCT01290822|364096454|FG000|Overall Study|Withdrawal by Subject|1|||
105572929|NCT01290822|364096454|FG000|Overall Study|Physician Decision|10|||
105572930|NCT01155661|364096455|FG000|Overall Study|Adverse Event|101|||
105572931|NCT01155661|364096455|FG000|Overall Study|Death|1|||
105572932|NCT01155661|364096455|FG000|Overall Study|Lack of Efficacy|32|||
105572933|NCT01155661|364096455|FG000|Overall Study|Lost to Follow-up|22|||
105572934|NCT01155661|364096455|FG000|Overall Study|Physician Decision|3|||
105572935|NCT01155661|364096455|FG000|Overall Study|Protocol Violation|35|||
105572936|NCT01155661|364096455|FG000|Overall Study|Withdrawal by Subject|73|||
105572937|NCT01155661|364096455|FG000|Overall Study|Sponsor Decision|13|||
105572938|NCT03679767|364096456|FG000|Overall Study|Death|16|||
105572939|NCT03679767|364096457|FG001|Overall Study|Death|11|||
105572940|NCT03679767|364096458|FG002|Overall Study|Death|17|||
105572941|NCT03679767|364096459|FG003|Overall Study|Death|10|||
105572942|NCT03679767|364096456|FG000|Overall Study|Lost to Follow-up|1|||
105572943|NCT03679767|364096457|FG001|Overall Study|Lost to Follow-up|1|||
105572944|NCT03679767|364096458|FG002|Overall Study|Lost to Follow-up|1|||
105572945|NCT03679767|364096459|FG003|Overall Study|Lost to Follow-up|1|||
105572946|NCT03679767|364096456|FG000|Overall Study|Withdrawal by Subject|0|||
105572947|NCT03679767|364096457|FG001|Overall Study|Withdrawal by Subject|0|||
105572948|NCT03679767|364096458|FG002|Overall Study|Withdrawal by Subject|0|||
105572949|NCT03679767|364096459|FG003|Overall Study|Withdrawal by Subject|1|||
105572950|NCT03679767|364096456|FG000|Overall Study|Follow-up Completed|18|||
105572951|NCT03679767|364096457|FG001|Overall Study|Follow-up Completed|11|||
105572952|NCT03679767|364096458|FG002|Overall Study|Follow-up Completed|11|||
105572953|NCT03679767|364096459|FG003|Overall Study|Follow-up Completed|20|||
105572954|NCT03679767|364096456|FG000|Overall Study|Entered Hospice Care|0|||
105572955|NCT03679767|364096457|FG001|Overall Study|Entered Hospice Care|0|||
105572956|NCT03679767|364096458|FG002|Overall Study|Entered Hospice Care|0|||
105572957|NCT03679767|364096459|FG003|Overall Study|Entered Hospice Care|1|||
105572958|NCT03679767|364096456|FG000|Overall Study|Progressive Disease|0|||
105572959|NCT03679767|364096457|FG001|Overall Study|Progressive Disease|0|||
105572960|NCT03679767|364096458|FG002|Overall Study|Progressive Disease|0|||
105572961|NCT03679767|364096459|FG003|Overall Study|Progressive Disease|1|||
105572962|NCT02690077|364096460|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
105572963|NCT02690077|364096461|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
105572964|NCT02690077|364096460|FG000|Overall Study|Withdrawal by Subject|0|||
105572965|NCT02690077|364096461|FG001|Overall Study|Withdrawal by Subject|5|||
105572966|NCT02690077|364096460|FG000|Overall Study|Excluded by IRB|0|||
105572967|NCT02690077|364096461|FG001|Overall Study|Excluded by IRB|2|||
105572968|NCT00785707|364096462|FG000|Overall Study|Lost to Follow-up|7|||
105572969|NCT00105586|364096463|FG000|Overall Study|Adverse Event|4|||
105572970|NCT00105586|364096464|FG001|Overall Study|Adverse Event|3|||
105572971|NCT00105586|364096463|FG000|Overall Study|Physician Decision|13|||
105572972|NCT00105586|364096464|FG001|Overall Study|Physician Decision|13|||
105572973|NCT02917941|364096465|FG000|Treatment Period|Adverse Event|11|||
105572974|NCT02917941|364096465|FG000|Treatment Period|Progressive Disease|11|||
105825950|NCT00909753|365020135|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
105825951|NCT00909753|365020134|FG000|Period: Second Intervention|Protocol Violation|1|||
105825952|NCT00909753|365020135|FG001|Period: Second Intervention|Protocol Violation|0|||
105825953|NCT01895335|365020138|FG000|Overall Study|Adverse Event|106|||
105825954|NCT01895335|365020138|FG000|Overall Study|Lack of Efficacy|53|||
105572975|NCT02917941|364096465|FG000|Treatment Period|Reason not Specified|2|||
105572976|NCT02917941|364096465|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
105572977|NCT02917941|364096465|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
105572978|NCT02306122|364096466|FG000|Initial Physician Randomization|Physician Decision|0|||
105572979|NCT02306122|364096467|FG001|Initial Physician Randomization|Physician Decision|0|||
105572980|NCT02306122|364096468|FG002|Initial Physician Randomization|Physician Decision|0|||
105572981|NCT02306122|364096469|FG003|Initial Physician Randomization|Physician Decision|0|||
105572982|NCT02306122|364096470|FG004|Initial Physician Randomization|Physician Decision|0|||
105572983|NCT02306122|364096471|FG005|Initial Physician Randomization|Physician Decision|0|||
105572984|NCT02306122|364096472|FG006|Initial Physician Randomization|Physician Decision|0|||
105572985|NCT02306122|364096473|FG007|Initial Physician Randomization|Physician Decision|0|||
105572986|NCT02306122|364096474|FG008|Initial Physician Randomization|Physician Decision|1|||
105572987|NCT02306122|364096475|FG009|Initial Physician Randomization|Physician Decision|0|||
105572988|NCT02306122|364096476|FG010|Initial Physician Randomization|Physician Decision|0|||
105572989|NCT02638623|364096480|FG000|Overall Study|Surgery timing|5|||
105572990|NCT02638623|364096481|FG001|Overall Study|Surgery timing|6|||
105572991|NCT02638623|364096480|FG000|Overall Study|Not given intervention|2|||
105572992|NCT02638623|364096481|FG001|Overall Study|Not given intervention|0|||
105572993|NCT02322814|364096482|FG000|Overall Study|Death|7|||
105572994|NCT02322814|364096483|FG001|Overall Study|Death|29|||
105572995|NCT02322814|364096484|FG002|Overall Study|Death|32|||
105572996|NCT02322814|364096485|FG003|Overall Study|Death|23|||
105572997|NCT02322814|364096486|FG004|Overall Study|Death|14|||
105572998|NCT02322814|364096482|FG000|Overall Study|Lost to Follow-up|1|||
105572999|NCT02322814|364096483|FG001|Overall Study|Lost to Follow-up|3|||
105573000|NCT02322814|364096484|FG002|Overall Study|Lost to Follow-up|3|||
105573001|NCT02322814|364096485|FG003|Overall Study|Lost to Follow-up|1|||
105573002|NCT02322814|364096486|FG004|Overall Study|Lost to Follow-up|0|||
105573003|NCT02322814|364096482|FG000|Overall Study|Various Reasons|2|||
105573004|NCT02322814|364096483|FG001|Overall Study|Various Reasons|0|||
105573005|NCT02322814|364096484|FG002|Overall Study|Various Reasons|1|||
105573006|NCT02322814|364096485|FG003|Overall Study|Various Reasons|1|||
105573007|NCT02322814|364096486|FG004|Overall Study|Various Reasons|0|||
105825955|NCT01895335|365020138|FG000|Overall Study|Poor Compliance to Protocol|11|||
105825956|NCT01895335|365020138|FG000|Overall Study|Included But Not treated|1|||
105573008|NCT02322814|364096482|FG000|Overall Study|Progressive Disease|0|||
105573009|NCT02322814|364096483|FG001|Overall Study|Progressive Disease|0|||
105573010|NCT02322814|364096484|FG002|Overall Study|Progressive Disease|0|||
105573011|NCT02322814|364096485|FG003|Overall Study|Progressive Disease|1|||
105825957|NCT01895335|365020138|FG000|Overall Study|Other than Specified Above|44|||
105825958|NCT01906372|365020139|FG000|Overall Study|Withdrawal by Subject|2|||
105825959|NCT00847535|365020142|FG000|Overall Study|Withdrawal by Subject|2|||
105825960|NCT00847535|365020143|FG001|Overall Study|Withdrawal by Subject|1|||
105825961|NCT00847535|365020144|FG002|Overall Study|Withdrawal by Subject|1|||
105825962|NCT00847535|365020142|FG000|Overall Study|Lost to Follow-up|0|||
105825963|NCT00847535|365020143|FG001|Overall Study|Lost to Follow-up|1|||
105825964|NCT00847535|365020144|FG002|Overall Study|Lost to Follow-up|0|||
105825965|NCT01252953|365020145|FG000|Overall Study|Withdrawal by Subject|16|||
105825966|NCT01252953|365020146|FG001|Overall Study|Withdrawal by Subject|17|||
105825967|NCT01252953|365020145|FG000|Overall Study|Lost to Follow-up|22|||
105825968|NCT01252953|365020146|FG001|Overall Study|Lost to Follow-up|21|||
105825969|NCT03503318|365020157|FG000|Overall Study|Death|1|||
105825970|NCT03503318|365020158|FG001|Overall Study|Death|0|||
105825971|NCT03503318|365020159|FG002|Overall Study|Death|4|||
105825972|NCT03503318|365020157|FG000|Overall Study|Adverse Event|3|||
105825973|NCT03503318|365020158|FG001|Overall Study|Adverse Event|4|||
105825974|NCT03503318|365020159|FG002|Overall Study|Adverse Event|2|||
105825975|NCT03503318|365020157|FG000|Overall Study|Withdrawal by Subject|12|||
105825976|NCT03503318|365020158|FG001|Overall Study|Withdrawal by Subject|17|||
105487783|NCT03729362|363798655|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
105487784|NCT03729362|363798656|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
105487785|NCT03729362|363798655|FG000|Overall Study|Adverse Event|0|||
105487786|NCT03729362|363798656|FG001|Overall Study|Adverse Event|1|||
105487787|NCT03729362|363798655|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
105487788|NCT03729362|363798656|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
105487789|NCT04617795|363798657|FG000|Main Study|Lost to Follow-up|1|||
105487790|NCT04617795|363798658|FG001|Main Study|Lost to Follow-up|0|||
105487791|NCT00719264|363798659|FG000|Overall Study|Adverse Event|41|||
105487792|NCT00719264|363798660|FG001|Overall Study|Adverse Event|49|||
105487793|NCT00719264|363798659|FG000|Overall Study|Death|13|||
105487794|NCT00719264|363798660|FG001|Overall Study|Death|10|||
105825977|NCT03503318|365020159|FG002|Overall Study|Withdrawal by Subject|16|||
105825978|NCT03503318|365020157|FG000|Overall Study|Protocol Violation|5|||
105825979|NCT03503318|365020158|FG001|Overall Study|Protocol Violation|0|||
105573012|NCT02322814|364096486|FG004|Overall Study|Progressive Disease|1|||
105573013|NCT02322814|364096482|FG000|Overall Study|Protocol Violation|1|||
105573014|NCT02322814|364096483|FG001|Overall Study|Protocol Violation|0|||
105573015|NCT02322814|364096484|FG002|Overall Study|Protocol Violation|0|||
105573016|NCT02322814|364096485|FG003|Overall Study|Protocol Violation|0|||
105573017|NCT02322814|364096486|FG004|Overall Study|Protocol Violation|0|||
105573018|NCT02322814|364096482|FG000|Overall Study|Study Terminated by Sponsor|0|||
105573019|NCT02322814|364096483|FG001|Overall Study|Study Terminated by Sponsor|7|||
105573020|NCT02322814|364096484|FG002|Overall Study|Study Terminated by Sponsor|9|||
105573021|NCT02322814|364096485|FG003|Overall Study|Study Terminated by Sponsor|5|||
105573022|NCT02322814|364096486|FG004|Overall Study|Study Terminated by Sponsor|13|||
105573023|NCT02322814|364096482|FG000|Overall Study|Withdrawal by Subject|5|||
105573024|NCT02322814|364096483|FG001|Overall Study|Withdrawal by Subject|4|||
105573025|NCT02322814|364096484|FG002|Overall Study|Withdrawal by Subject|2|||
105573026|NCT02322814|364096485|FG003|Overall Study|Withdrawal by Subject|1|||
105573027|NCT02322814|364096486|FG004|Overall Study|Withdrawal by Subject|3|||
105573028|NCT00591864|364096487|FG000|Overall Study|Incomplete Imaging|5|||
105573029|NCT02459093|364096488|FG000|Overall Study|Protocol Violation|6|||
105573030|NCT02459093|364096489|FG001|Overall Study|Protocol Violation|11|||
105573031|NCT02459093|364096488|FG000|Overall Study|Lost to Follow-up|6|||
105573032|NCT02459093|364096489|FG001|Overall Study|Lost to Follow-up|7|||
105573033|NCT00118092|364096490|FG000|Overall Study|Withdrawal by Subject|1|||
105573034|NCT00118092|364096490|FG000|Overall Study|Protocol Violation|1|||
105573035|NCT01302938|364096495|FG000|Overall Study|Withdrawal by Subject|1|||
105573036|NCT01302938|364096496|FG001|Overall Study|Withdrawal by Subject|0|||
105573037|NCT01302938|364096495|FG000|Overall Study|Adverse Event|1|||
105573038|NCT01302938|364096496|FG001|Overall Study|Adverse Event|0|||
105573039|NCT03342053|364096497|FG000|Overall Study|Adverse Event|2|||
105573040|NCT03342053|364096498|FG001|Overall Study|Adverse Event|0|||
105573041|NCT03342053|364096497|FG000|Overall Study|Withdrawal by Subject|0|||
105573042|NCT03342053|364096498|FG001|Overall Study|Withdrawal by Subject|1|||
105573043|NCT02294474|364096499|FG000|Overall Study|Adverse Event|7|||
105573044|NCT02294474|364096500|FG001|Overall Study|Adverse Event|7|||
105573045|NCT02294474|364096499|FG000|Overall Study|Lack of Efficacy|2|||
105573046|NCT02294474|364096500|FG001|Overall Study|Lack of Efficacy|1|||
105573047|NCT02294474|364096499|FG000|Overall Study|Protocol Violation|4|||
105573048|NCT02294474|364096500|FG001|Overall Study|Protocol Violation|2|||
105573049|NCT02294474|364096499|FG000|Overall Study|Other than specified above|12|||
105573050|NCT02294474|364096500|FG001|Overall Study|Other than specified above|12|||
105573051|NCT00649389|364098425|FG000|Overall Study|Adverse Event|22|||
105573052|NCT00649389|364098426|FG001|Overall Study|Adverse Event|46|||
105573053|NCT00649389|364098427|FG002|Overall Study|Adverse Event|38|||
105573054|NCT00649389|364098428|FG003|Overall Study|Adverse Event|48|||
105573055|NCT00649389|364098425|FG000|Overall Study|Lost to Follow-up|15|||
105573056|NCT00649389|364098426|FG001|Overall Study|Lost to Follow-up|17|||
105573057|NCT00649389|364098427|FG002|Overall Study|Lost to Follow-up|21|||
105573058|NCT00649389|364098428|FG003|Overall Study|Lost to Follow-up|26|||
105573059|NCT00649389|364098425|FG000|Overall Study|Protocol Violation|11|||
105573060|NCT00649389|364098426|FG001|Overall Study|Protocol Violation|13|||
105573061|NCT00649389|364098427|FG002|Overall Study|Protocol Violation|9|||
105573062|NCT00649389|364098428|FG003|Overall Study|Protocol Violation|8|||
105573063|NCT00649389|364098425|FG000|Overall Study|Withdrawal by Subject|20|||
105573064|NCT00649389|364098426|FG001|Overall Study|Withdrawal by Subject|21|||
105573065|NCT00649389|364098427|FG002|Overall Study|Withdrawal by Subject|19|||
105573066|NCT00649389|364098428|FG003|Overall Study|Withdrawal by Subject|23|||
105573067|NCT00649389|364098425|FG000|Overall Study|Other|3|||
105573068|NCT00649389|364098426|FG001|Overall Study|Other|9|||
105573069|NCT00649389|364098427|FG002|Overall Study|Other|1|||
105573070|NCT00649389|364098428|FG003|Overall Study|Other|6|||
105573071|NCT02762981|364098429|FG000|Overall Study|Adverse Event|2|||
105573072|NCT02762981|364098430|FG001|Overall Study|Adverse Event|3|||
105573073|NCT02762981|364098431|FG002|Overall Study|Adverse Event|1|||
105573074|NCT02762981|364098432|FG003|Overall Study|Adverse Event|1|||
105573075|NCT02762981|364098433|FG004|Overall Study|Adverse Event|3|||
105573076|NCT02762981|364098429|FG000|Overall Study|Physician Decision|0|||
105573077|NCT02762981|364098430|FG001|Overall Study|Physician Decision|1|||
105573078|NCT02762981|364098431|FG002|Overall Study|Physician Decision|0|||
105573079|NCT02762981|364098432|FG003|Overall Study|Physician Decision|0|||
105573080|NCT02762981|364098433|FG004|Overall Study|Physician Decision|1|||
105573081|NCT02762981|364098429|FG000|Overall Study|Disease progression|11|||
105573082|NCT02762981|364098430|FG001|Overall Study|Disease progression|23|||
105573083|NCT02762981|364098431|FG002|Overall Study|Disease progression|4|||
105573084|NCT02762981|364098432|FG003|Overall Study|Disease progression|10|||
105573085|NCT02762981|364098433|FG004|Overall Study|Disease progression|1|||
105573086|NCT02762981|364098429|FG000|Overall Study|Enrolled not treated|1|||
105573087|NCT02762981|364098430|FG001|Overall Study|Enrolled not treated|5|||
105573088|NCT02762981|364098431|FG002|Overall Study|Enrolled not treated|0|||
105573089|NCT02762981|364098432|FG003|Overall Study|Enrolled not treated|2|||
105573090|NCT02762981|364098433|FG004|Overall Study|Enrolled not treated|0|||
105573091|NCT02762981|364098429|FG000|Overall Study|Other|2|||
105573092|NCT02762981|364098430|FG001|Overall Study|Other|3|||
105573093|NCT02762981|364098431|FG002|Overall Study|Other|1|||
105573094|NCT02762981|364098432|FG003|Overall Study|Other|0|||
105573095|NCT02762981|364098433|FG004|Overall Study|Other|0|||
105573096|NCT02762981|364098429|FG000|Overall Study|Missing|1|||
105573097|NCT02762981|364098430|FG001|Overall Study|Missing|0|||
105573098|NCT02762981|364098431|FG002|Overall Study|Missing|0|||
105573099|NCT02762981|364098432|FG003|Overall Study|Missing|0|||
105573100|NCT02762981|364098433|FG004|Overall Study|Missing|0|||
105573101|NCT02762981|364098429|FG000|Overall Study|Withdrawal by Subject|0|||
105573102|NCT02762981|364098430|FG001|Overall Study|Withdrawal by Subject|5|||
105573103|NCT02762981|364098431|FG002|Overall Study|Withdrawal by Subject|1|||
105573104|NCT02762981|364098432|FG003|Overall Study|Withdrawal by Subject|3|||
105573105|NCT02762981|364098433|FG004|Overall Study|Withdrawal by Subject|0|||
105573106|NCT01382940|364098434|FG000|Overall Study|Adverse Event|19|||
105573107|NCT01382940|364098434|FG000|Overall Study|Lost to Follow-up|4|||
105573108|NCT01382940|364098434|FG000|Overall Study|Physician Decision|7|||
105573109|NCT01382940|364098434|FG000|Overall Study|Withdrawal by Subject|23|||
105573110|NCT01382940|364098434|FG000|Overall Study|Protocol Violation|20|||
105573111|NCT00857805|364098439|FG000|Overall Study|Withdrawal by Subject|1|||
105573112|NCT00857805|364098440|FG001|Overall Study|Withdrawal by Subject|1|||
105825980|NCT03503318|365020159|FG002|Overall Study|Protocol Violation|3|||
105825981|NCT03503318|365020157|FG000|Overall Study|Lost to Follow-up|17|||
105825982|NCT03503318|365020158|FG001|Overall Study|Lost to Follow-up|15|||
105825983|NCT03503318|365020159|FG002|Overall Study|Lost to Follow-up|12|||
105825984|NCT03503318|365020157|FG000|Overall Study|Other than specified|1|||
105825985|NCT03503318|365020158|FG001|Overall Study|Other than specified|3|||
105487795|NCT00719264|363798659|FG000|Overall Study|Administrative Problems|6|||
105487796|NCT00719264|363798660|FG001|Overall Study|Administrative Problems|4|||
105487797|NCT00719264|363798659|FG000|Overall Study|Lost to Follow-up|1|||
105487798|NCT00719264|363798660|FG001|Overall Study|Lost to Follow-up|1|||
105487799|NCT00719264|363798659|FG000|Overall Study|Withdrawal by Subject|12|||
105487800|NCT00719264|363798660|FG001|Overall Study|Withdrawal by Subject|7|||
105487801|NCT00719264|363798659|FG000|Overall Study|Protocol Deviation|1|||
105487802|NCT00719264|363798660|FG001|Overall Study|Protocol Deviation|3|||
105487803|NCT00719264|363798659|FG000|Overall Study|New Cancer Therapy|4|||
105487804|NCT00719264|363798660|FG001|Overall Study|New Cancer Therapy|2|||
105487805|NCT00719264|363798659|FG000|Overall Study|Disease Progression|104|||
105487806|NCT00719264|363798660|FG001|Overall Study|Disease Progression|107|||
105487807|NCT00814879|363798661|FG000|By Week 24|Cancer Diagnosis|1|||
105487808|NCT00814879|363798662|FG001|By Week 24|Cancer Diagnosis|0|||
105487809|NCT00814879|363798661|FG000|By Week 24|Incarceration|0|||
105487810|NCT00814879|363798662|FG001|By Week 24|Incarceration|1|||
105487811|NCT00814879|363798661|FG000|By Week 48|Lost to Follow-up|2|||
105487812|NCT00814879|363798662|FG001|By Week 48|Lost to Follow-up|2|||
105487813|NCT00814879|363798661|FG000|By Week 48|Death|0|||
105487814|NCT00814879|363798662|FG001|By Week 48|Death|1|||
105487815|NCT01275339|363798663|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
105487816|NCT01275339|363798664|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
105487817|NCT01275339|363798665|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
105487818|NCT01275339|363798666|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
105487819|NCT01275339|363798663|FG000|Overall Study|Withdrawal by Subject|0|||
105487820|NCT01275339|363798664|FG001|Overall Study|Withdrawal by Subject|0|||
105487821|NCT01275339|363798665|FG002|Overall Study|Withdrawal by Subject|1|||
105487822|NCT01275339|363798666|FG003|Overall Study|Withdrawal by Subject|0|||
105487823|NCT05523323|363798667|FG000|Overall Study|Death|26|||
105487824|NCT05523323|363798668|FG001|Overall Study|Death|21|||
105487825|NCT05523323|363798667|FG000|Overall Study|Ongoing participants|35|||
105487826|NCT05523323|363798668|FG001|Overall Study|Ongoing participants|30|||
105487827|NCT02284178|363798671|FG000|Overall Study|Met exclusion criteria|49|||
105487828|NCT02284178|363798672|FG001|Overall Study|Met exclusion criteria|54|||
105487829|NCT00880685|363798675|FG000|Memantine 10mg|Lost to Follow-up|2|||
105487830|NCT00880685|363798675|FG000|Memantine 20mg|Withdrawal by Subject|1|||
105487831|NCT01083173|363798677|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
105487832|NCT01083173|363798678|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
105573113|NCT04867785|364098441|FG000|Overall Study|Adverse Event|1|||
105573114|NCT04867785|364098442|FG001|Overall Study|Adverse Event|0|||
105573115|NCT04867785|364098443|FG002|Overall Study|Adverse Event|1|||
105573116|NCT04867785|364098444|FG003|Overall Study|Adverse Event|0|||
105573117|NCT04867785|364098445|FG004|Overall Study|Adverse Event|0|||
105573118|NCT04867785|364098446|FG005|Overall Study|Adverse Event|0|||
105573119|NCT04867785|364098447|FG006|Overall Study|Adverse Event|0|||
105825986|NCT03503318|365020159|FG002|Overall Study|Other than specified|3|||
105825987|NCT02139826|365020160|FG000|Overall Study|Adverse Event|1|||
105825988|NCT02055547|365020161|FG000|Overall Study|Protocol Violation|0|||
105825989|NCT02055547|365020162|FG001|Overall Study|Protocol Violation|0|||
105825990|NCT02055547|365020163|FG002|Overall Study|Protocol Violation|1|||
105825991|NCT02055547|365020164|FG003|Overall Study|Protocol Violation|0|||
105825992|NCT02055547|365020165|FG004|Overall Study|Protocol Violation|0|||
105825993|NCT02055547|365020166|FG005|Overall Study|Protocol Violation|0|||
105825994|NCT02055547|365020167|FG006|Overall Study|Protocol Violation|1|||
105825995|NCT02055547|365020168|FG007|Overall Study|Protocol Violation|0|||
105825996|NCT02055547|365020169|FG008|Overall Study|Protocol Violation|0|||
105825997|NCT02055547|365020170|FG009|Overall Study|Protocol Violation|0|||
105825998|NCT02055547|365020171|FG010|Overall Study|Protocol Violation|0|||
105825999|NCT02055547|365020172|FG011|Overall Study|Protocol Violation|0|||
105826000|NCT02055547|365020173|FG012|Overall Study|Protocol Violation|0|||
105826001|NCT02055547|365020174|FG013|Overall Study|Protocol Violation|0|||
105826002|NCT02055547|365020175|FG014|Overall Study|Protocol Violation|0|||
105826003|NCT02055547|365020176|FG015|Overall Study|Protocol Violation|0|||
105826004|NCT02055547|365020177|FG016|Overall Study|Protocol Violation|0|||
105826005|NCT02055547|365020178|FG017|Overall Study|Protocol Violation|0|||
105826006|NCT02055547|365020179|FG018|Overall Study|Protocol Violation|0|||
105826007|NCT02055547|365020161|FG000|Overall Study|Physician Decision|0|||
105826008|NCT02055547|365020162|FG001|Overall Study|Physician Decision|1|||
105826009|NCT02055547|365020163|FG002|Overall Study|Physician Decision|1|||
105826010|NCT02055547|365020164|FG003|Overall Study|Physician Decision|0|||
105826011|NCT02055547|365020165|FG004|Overall Study|Physician Decision|1|||
105573120|NCT04867785|364098448|FG007|Overall Study|Adverse Event|2|||
105573121|NCT04867785|364098441|FG000|Overall Study|Lost to Follow-up|4|||
105573122|NCT04867785|364098442|FG001|Overall Study|Lost to Follow-up|4|||
105573123|NCT04867785|364098443|FG002|Overall Study|Lost to Follow-up|3|||
105573124|NCT04867785|364098444|FG003|Overall Study|Lost to Follow-up|2|||
105573125|NCT04867785|364098445|FG004|Overall Study|Lost to Follow-up|0|||
105573126|NCT04867785|364098446|FG005|Overall Study|Lost to Follow-up|1|||
105573127|NCT04867785|364098447|FG006|Overall Study|Lost to Follow-up|0|||
105573128|NCT04867785|364098448|FG007|Overall Study|Lost to Follow-up|1|||
105573129|NCT04867785|364098441|FG000|Overall Study|Withdrawal by Subject|6|||
105573130|NCT04867785|364098442|FG001|Overall Study|Withdrawal by Subject|2|||
105573131|NCT04867785|364098443|FG002|Overall Study|Withdrawal by Subject|2|||
105573132|NCT04867785|364098444|FG003|Overall Study|Withdrawal by Subject|1|||
105573133|NCT04867785|364098445|FG004|Overall Study|Withdrawal by Subject|2|||
105573134|NCT04867785|364098446|FG005|Overall Study|Withdrawal by Subject|0|||
105573135|NCT04867785|364098447|FG006|Overall Study|Withdrawal by Subject|2|||
105573136|NCT04867785|364098448|FG007|Overall Study|Withdrawal by Subject|5|||
105573137|NCT04867785|364098441|FG000|Overall Study|Physician Decision|0|||
105573138|NCT04867785|364098442|FG001|Overall Study|Physician Decision|0|||
105573139|NCT04867785|364098443|FG002|Overall Study|Physician Decision|0|||
105573140|NCT04867785|364098444|FG003|Overall Study|Physician Decision|0|||
105573141|NCT04867785|364098445|FG004|Overall Study|Physician Decision|0|||
105573142|NCT04867785|364098446|FG005|Overall Study|Physician Decision|0|||
105573143|NCT04867785|364098447|FG006|Overall Study|Physician Decision|0|||
105573144|NCT04867785|364098448|FG007|Overall Study|Physician Decision|1|||
105573145|NCT04867785|364098441|FG000|Overall Study|Inadvertent Enrollment|0|||
105573146|NCT04867785|364098442|FG001|Overall Study|Inadvertent Enrollment|0|||
105826012|NCT02055547|365020166|FG005|Overall Study|Physician Decision|0|||
105826013|NCT02055547|365020167|FG006|Overall Study|Physician Decision|0|||
105366107|NCT01051921|363346531|FG000|Overall Study|patient moved|1|||
105573147|NCT04867785|364098443|FG002|Overall Study|Inadvertent Enrollment|0|||
105573148|NCT04867785|364098444|FG003|Overall Study|Inadvertent Enrollment|1|||
105573149|NCT04867785|364098445|FG004|Overall Study|Inadvertent Enrollment|1|||
105573150|NCT04867785|364098446|FG005|Overall Study|Inadvertent Enrollment|0|||
105573151|NCT04867785|364098447|FG006|Overall Study|Inadvertent Enrollment|0|||
105573152|NCT04867785|364098448|FG007|Overall Study|Inadvertent Enrollment|1|||
105573153|NCT04867785|364098441|FG000|Overall Study|Eligibility Criteria Not Met|0|||
105826014|NCT02055547|365020168|FG007|Overall Study|Physician Decision|0|||
105826015|NCT02055547|365020169|FG008|Overall Study|Physician Decision|0|||
105826016|NCT02055547|365020170|FG009|Overall Study|Physician Decision|1|||
105826017|NCT02055547|365020171|FG010|Overall Study|Physician Decision|1|||
105826018|NCT02055547|365020172|FG011|Overall Study|Physician Decision|0|||
105826019|NCT02055547|365020173|FG012|Overall Study|Physician Decision|0|||
105487833|NCT01083173|363798677|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
105487834|NCT01083173|363798678|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
105487835|NCT01083173|363798677|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
105487836|NCT01083173|363798678|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
105487837|NCT01083173|363798677|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
105487838|NCT01083173|363798678|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
105487839|NCT01083173|363798677|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
105573154|NCT04867785|364098442|FG001|Overall Study|Eligibility Criteria Not Met|0|||
105487840|NCT01083173|363798678|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
105487841|NCT01083173|363798677|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
105487842|NCT01083173|363798678|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
105487843|NCT01083173|363798677|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
105487844|NCT01083173|363798678|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
105487845|NCT01083173|363798677|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
105487846|NCT01083173|363798678|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
105487847|NCT01083173|363798677|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
105487848|NCT01083173|363798678|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
105487849|NCT01083173|363798677|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
105487850|NCT01083173|363798678|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
105487851|NCT01083173|363798677|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
105487852|NCT01083173|363798678|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
105487853|NCT03981822|363798680|FG000|Overall Study|Lost to Follow-up|0|||
105487854|NCT03981822|363798681|FG001|Overall Study|Lost to Follow-up|1|||
105487855|NCT03981822|363798682|FG002|Overall Study|Lost to Follow-up|1|||
105487856|NCT03981822|363798683|FG003|Overall Study|Lost to Follow-up|0|||
105487857|NCT03981822|363798684|FG004|Overall Study|Lost to Follow-up|6|||
105487858|NCT03981822|363798685|FG005|Overall Study|Lost to Follow-up|4|||
105487859|NCT03981822|363798686|FG006|Overall Study|Lost to Follow-up|4|||
105487860|NCT03981822|363798687|FG007|Overall Study|Lost to Follow-up|2|||
105487861|NCT03981822|363798680|FG000|Overall Study|Withdrawal by Subject|0|||
105487862|NCT03981822|363798681|FG001|Overall Study|Withdrawal by Subject|1|||
105487863|NCT03981822|363798682|FG002|Overall Study|Withdrawal by Subject|0|||
105487864|NCT03981822|363798683|FG003|Overall Study|Withdrawal by Subject|0|||
105487865|NCT03981822|363798684|FG004|Overall Study|Withdrawal by Subject|0|||
105487866|NCT03981822|363798685|FG005|Overall Study|Withdrawal by Subject|1|||
105487867|NCT03981822|363798686|FG006|Overall Study|Withdrawal by Subject|0|||
105487868|NCT03981822|363798687|FG007|Overall Study|Withdrawal by Subject|2|||
105487869|NCT03981822|363798680|FG000|Overall Study|COVID-19 Related|0|||
105487870|NCT03981822|363798681|FG001|Overall Study|COVID-19 Related|0|||
105487871|NCT03981822|363798682|FG002|Overall Study|COVID-19 Related|0|||
105487872|NCT03981822|363798683|FG003|Overall Study|COVID-19 Related|0|||
105487873|NCT03981822|363798684|FG004|Overall Study|COVID-19 Related|2|||
105487874|NCT03981822|363798685|FG005|Overall Study|COVID-19 Related|1|||
105487875|NCT03981822|363798686|FG006|Overall Study|COVID-19 Related|2|||
105487876|NCT03981822|363798687|FG007|Overall Study|COVID-19 Related|1|||
105487877|NCT02987660|363798688|FG000|Overall Study|Study terminated by sponsor|10|||
105487878|NCT02987660|363798689|FG001|Overall Study|Study terminated by sponsor|10|||
105487879|NCT04704154|363798690|FG000|Overall Study|Adverse Event|3|||
105487880|NCT04704154|363798691|FG001|Overall Study|Adverse Event|2|||
105487881|NCT04704154|363798692|FG002|Overall Study|Adverse Event|4|||
105487882|NCT04704154|363798693|FG003|Overall Study|Adverse Event|2|||
105487883|NCT04704154|363798694|FG004|Overall Study|Adverse Event|3|||
105487884|NCT04704154|363798695|FG005|Overall Study|Adverse Event|0|||
105487885|NCT04704154|363798690|FG000|Overall Study|Death|3|||
105487886|NCT04704154|363798691|FG001|Overall Study|Death|0|||
105487887|NCT04704154|363798692|FG002|Overall Study|Death|0|||
105487888|NCT04704154|363798693|FG003|Overall Study|Death|0|||
105487889|NCT04704154|363798694|FG004|Overall Study|Death|3|||
105487890|NCT04704154|363798695|FG005|Overall Study|Death|0|||
105487891|NCT04704154|363798690|FG000|Overall Study|Physician Decision|1|||
105487892|NCT04704154|363798691|FG001|Overall Study|Physician Decision|0|||
105487893|NCT04704154|363798692|FG002|Overall Study|Physician Decision|1|||
105487894|NCT04704154|363798693|FG003|Overall Study|Physician Decision|0|||
105487895|NCT04704154|363798694|FG004|Overall Study|Physician Decision|2|||
105487896|NCT04704154|363798695|FG005|Overall Study|Physician Decision|0|||
105487897|NCT04704154|363798690|FG000|Overall Study|Participant Decision|1|||
105487898|NCT04704154|363798691|FG001|Overall Study|Participant Decision|1|||
105487899|NCT04704154|363798692|FG002|Overall Study|Participant Decision|0|||
105487900|NCT04704154|363798693|FG003|Overall Study|Participant Decision|0|||
105487901|NCT04704154|363798694|FG004|Overall Study|Participant Decision|0|||
105487902|NCT04704154|363798695|FG005|Overall Study|Participant Decision|0|||
105487903|NCT04704154|363798690|FG000|Overall Study|Progressive Disease|19|||
105573155|NCT04867785|364098443|FG002|Overall Study|Eligibility Criteria Not Met|0|||
105573156|NCT04867785|364098444|FG003|Overall Study|Eligibility Criteria Not Met|0|||
105573157|NCT04867785|364098445|FG004|Overall Study|Eligibility Criteria Not Met|0|||
105573158|NCT04867785|364098446|FG005|Overall Study|Eligibility Criteria Not Met|0|||
105573159|NCT04867785|364098447|FG006|Overall Study|Eligibility Criteria Not Met|0|||
105573160|NCT04867785|364098448|FG007|Overall Study|Eligibility Criteria Not Met|1|||
105573161|NCT01289041|364098449|FG000|Overall Study|Adverse Event|24|||
105573162|NCT01289041|364098449|FG000|Overall Study|Physician Decision|1|||
105366108|NCT00010257|363346536|FG000|Overall Study|Withdrawal by Subject|1|||
105366109|NCT00010257|363346537|FG001|Overall Study|Withdrawal by Subject|0|||
105366110|NCT01405560|363346544|FG000|Overall Study|Physician Decision|1|||
105366111|NCT01484951|363346545|FG000|Overall Study|Adverse Event|3|||
105366112|NCT01484951|363346545|FG000|Overall Study|Personal Reasons|1|||
105366113|NCT01484951|363346545|FG000|Overall Study|Non-Compliance|1|||
105366114|NCT00728494|363346560|FG000|Overall Study|Adverse Event|7|||
105366115|NCT00728494|363346561|FG001|Overall Study|Adverse Event|0|||
105366116|NCT00728494|363346560|FG000|Overall Study|Withdrawal by Subject|0|||
105366117|NCT00728494|363346561|FG001|Overall Study|Withdrawal by Subject|2|||
105366118|NCT00728494|363346560|FG000|Overall Study|Lack of Efficacy|2|||
105366119|NCT00728494|363346561|FG001|Overall Study|Lack of Efficacy|4|||
105366120|NCT00728494|363346560|FG000|Overall Study|No data available|0|||
105366121|NCT00728494|363346561|FG001|Overall Study|No data available|1|||
105366122|NCT03769649|363346562|FG000|Overall Study|Lost to Follow-up|4|||
105366123|NCT00473655|363346563|FG000|Overall Study|Lost to Follow-up|9|||
105366124|NCT00473655|363346564|FG001|Overall Study|Lost to Follow-up|5|||
105366125|NCT00473655|363346565|FG002|Overall Study|Lost to Follow-up|8|||
105366126|NCT03439137|363346566|FG000|Overall Study|Adverse Event|16|||
105366127|NCT03439137|363346567|FG001|Overall Study|Adverse Event|12|||
105366128|NCT03439137|363346566|FG000|Overall Study|Physician Decision|0|||
105366129|NCT03439137|363346567|FG001|Overall Study|Physician Decision|5|||
105366130|NCT03439137|363346566|FG000|Overall Study|Withdrawal by Subject|14|||
105366131|NCT03439137|363346567|FG001|Overall Study|Withdrawal by Subject|4|||
105366132|NCT03439137|363346566|FG000|Overall Study|Conducting rescue therapy|2|||
105366133|NCT03439137|363346567|FG001|Overall Study|Conducting rescue therapy|1|||
105366134|NCT03439137|363346566|FG000|Overall Study|Difficult to control Hb|10|||
105366135|NCT03439137|363346567|FG001|Overall Study|Difficult to control Hb|2|||
105573163|NCT01289041|364098449|FG000|Overall Study|Progressive Disease|41|||
105366136|NCT03439137|363346566|FG000|Overall Study|Initiation of a renal transplant|0|||
105366137|NCT03439137|363346567|FG001|Overall Study|Initiation of a renal transplant|2|||
105366138|NCT01240382|363346568|FG000|Overall Study|Adverse Event|2|||
105366139|NCT01240382|363346569|FG001|Overall Study|Adverse Event|1|||
105573164|NCT01289041|364098449|FG000|Overall Study|Withdrawal by Subject|3|||
105366140|NCT01240382|363346568|FG000|Overall Study|Lack of Efficacy|0|||
105366141|NCT01240382|363346569|FG001|Overall Study|Lack of Efficacy|2|||
105366142|NCT01240382|363346568|FG000|Overall Study|Fear of adverse events|0|||
105573165|NCT01289041|364098449|FG000|Overall Study|Death|1|||
105573166|NCT01486758|364098450|FG000|Overall Study|Lost to Follow-up|0|||
105573167|NCT01486758|364098451|FG001|Overall Study|Lost to Follow-up|1|||
105573168|NCT02254408|364098463|FG000|Overall Study|Randomized But Not Treated|1|||
105573169|NCT02254408|364098464|FG001|Overall Study|Randomized But Not Treated|3|||
105573170|NCT02254408|364098463|FG000|Overall Study|Adverse Event|1|||
105573171|NCT02254408|364098464|FG001|Overall Study|Adverse Event|0|||
105573172|NCT02254408|364098463|FG000|Overall Study|Death|2|||
105573173|NCT02254408|364098464|FG001|Overall Study|Death|3|||
105573174|NCT02254408|364098463|FG000|Overall Study|Investigator's Discretion|0|||
105573175|NCT02254408|364098464|FG001|Overall Study|Investigator's Discretion|1|||
105573176|NCT02254408|364098463|FG000|Overall Study|Withdrawal by Subject|3|||
105573177|NCT02254408|364098464|FG001|Overall Study|Withdrawal by Subject|3|||
105573178|NCT02254408|364098463|FG000|Overall Study|Lost to Follow-up|1|||
105573179|NCT02254408|364098464|FG001|Overall Study|Lost to Follow-up|0|||
105573180|NCT00553202|364098465|FG000|Overall Study|Death|16|||
105573181|NCT00553202|364098465|FG000|Overall Study|Lost to Follow-up|1|||
105573182|NCT00553202|364098465|FG000|Overall Study|Physician Decision|28|||
105573183|NCT00553202|364098465|FG000|Overall Study|Withdrawal by Subject|1|||
105573184|NCT00553202|364098465|FG000|Overall Study|No donor identified|16|||
105573185|NCT00553202|364098465|FG000|Overall Study|Fails to meet organ function|6|||
105573186|NCT04651114|364098466|FG000|Overall Study|Withdrawal by Subject|8|||
105573187|NCT01923896|364098467|FG000|Overall Study|Adverse Event|1|||
105573188|NCT01923896|364098468|FG001|Overall Study|Adverse Event|0|||
105573189|NCT00592319|364098469|FG000|Overall Study|Lost to Follow-up|0|||
105573190|NCT00592319|364098470|FG001|Overall Study|Lost to Follow-up|3|||
105573191|NCT00235443|364098473|FG000|Overall Study|Adverse Event|4|||
105573192|NCT00235443|364098474|FG001|Overall Study|Adverse Event|12|||
105573193|NCT00235443|364098475|FG002|Overall Study|Adverse Event|17|||
105573194|NCT00235443|364098476|FG003|Overall Study|Adverse Event|44|||
105573195|NCT00235443|364098477|FG004|Overall Study|Adverse Event|10|||
105573196|NCT00235443|364098478|FG005|Overall Study|Adverse Event|15|||
105573197|NCT00235443|364098473|FG000|Overall Study|Lack of Efficacy|0|||
105573198|NCT00235443|364098474|FG001|Overall Study|Lack of Efficacy|1|||
105573199|NCT00235443|364098475|FG002|Overall Study|Lack of Efficacy|5|||
105573200|NCT00235443|364098476|FG003|Overall Study|Lack of Efficacy|12|||
105573201|NCT00235443|364098477|FG004|Overall Study|Lack of Efficacy|2|||
105573202|NCT00235443|364098478|FG005|Overall Study|Lack of Efficacy|9|||
105573203|NCT00235443|364098473|FG000|Overall Study|Withdrawal by Subject|3|||
105573204|NCT00235443|364098474|FG001|Overall Study|Withdrawal by Subject|9|||
105573205|NCT00235443|364098475|FG002|Overall Study|Withdrawal by Subject|25|||
105573206|NCT00235443|364098476|FG003|Overall Study|Withdrawal by Subject|24|||
105573207|NCT00235443|364098477|FG004|Overall Study|Withdrawal by Subject|10|||
105573208|NCT00235443|364098478|FG005|Overall Study|Withdrawal by Subject|12|||
105573209|NCT00235443|364098473|FG000|Overall Study|Lost to Follow-up|0|||
105573210|NCT00235443|364098474|FG001|Overall Study|Lost to Follow-up|8|||
105573211|NCT00235443|364098475|FG002|Overall Study|Lost to Follow-up|6|||
105573212|NCT00235443|364098476|FG003|Overall Study|Lost to Follow-up|6|||
105573213|NCT00235443|364098477|FG004|Overall Study|Lost to Follow-up|4|||
105573214|NCT00235443|364098478|FG005|Overall Study|Lost to Follow-up|3|||
105573215|NCT00235443|364098473|FG000|Overall Study|Unsatisfactory compliance|0|||
105573216|NCT00235443|364098474|FG001|Overall Study|Unsatisfactory compliance|2|||
105573217|NCT00235443|364098475|FG002|Overall Study|Unsatisfactory compliance|3|||
105826020|NCT02055547|365020174|FG013|Overall Study|Physician Decision|0|||
105826021|NCT02055547|365020175|FG014|Overall Study|Physician Decision|0|||
105826022|NCT02055547|365020176|FG015|Overall Study|Physician Decision|0|||
105826023|NCT02055547|365020177|FG016|Overall Study|Physician Decision|0|||
105826024|NCT02055547|365020178|FG017|Overall Study|Physician Decision|0|||
105826025|NCT02055547|365020179|FG018|Overall Study|Physician Decision|0|||
105826026|NCT02055547|365020161|FG000|Overall Study|Adverse Event|0|||
105826027|NCT02055547|365020162|FG001|Overall Study|Adverse Event|0|||
105826028|NCT02055547|365020163|FG002|Overall Study|Adverse Event|0|||
105573218|NCT00235443|364098476|FG003|Overall Study|Unsatisfactory compliance|4|||
105573219|NCT00235443|364098477|FG004|Overall Study|Unsatisfactory compliance|1|||
105573220|NCT00235443|364098478|FG005|Overall Study|Unsatisfactory compliance|0|||
105573221|NCT00235443|364098473|FG000|Overall Study|Other reasons for premature termination|1|||
105573222|NCT00235443|364098474|FG001|Overall Study|Other reasons for premature termination|6|||
105573223|NCT00235443|364098475|FG002|Overall Study|Other reasons for premature termination|6|||
105826029|NCT02055547|365020164|FG003|Overall Study|Adverse Event|0|||
105826030|NCT02055547|365020165|FG004|Overall Study|Adverse Event|0|||
105826031|NCT02055547|365020166|FG005|Overall Study|Adverse Event|0|||
105826032|NCT02055547|365020167|FG006|Overall Study|Adverse Event|1|||
105826033|NCT02055547|365020168|FG007|Overall Study|Adverse Event|0|||
105826034|NCT02055547|365020169|FG008|Overall Study|Adverse Event|1|||
105573224|NCT00235443|364098476|FG003|Overall Study|Other reasons for premature termination|7|||
105826035|NCT02055547|365020170|FG009|Overall Study|Adverse Event|0|||
105573225|NCT00235443|364098477|FG004|Overall Study|Other reasons for premature termination|3|||
105573226|NCT00235443|364098478|FG005|Overall Study|Other reasons for premature termination|6|||
105573227|NCT03029247|364098479|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
105573228|NCT03029247|364098480|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
105573229|NCT03029247|364098479|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
105573230|NCT03029247|364098480|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
105487904|NCT04704154|363798691|FG001|Overall Study|Progressive Disease|17|||
105487905|NCT04704154|363798692|FG002|Overall Study|Progressive Disease|20|||
105487906|NCT04704154|363798693|FG003|Overall Study|Progressive Disease|18|||
105487907|NCT04704154|363798694|FG004|Overall Study|Progressive Disease|36|||
105487908|NCT04704154|363798695|FG005|Overall Study|Progressive Disease|30|||
105487909|NCT04704154|363798690|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
105487910|NCT04704154|363798691|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
105487911|NCT04704154|363798692|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
105487912|NCT04704154|363798693|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
105487913|NCT04704154|363798694|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
105487914|NCT04704154|363798695|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
105487915|NCT04704154|363798690|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
105487916|NCT04704154|363798691|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
105487917|NCT04704154|363798692|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
105487918|NCT04704154|363798693|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
105487919|NCT04704154|363798694|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
105487920|NCT04704154|363798695|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
105487921|NCT04251156|363798696|FG000|Overall Study|Lost to Follow-up|1|||
105487922|NCT04251156|363798697|FG001|Overall Study|Lost to Follow-up|1|||
105487923|NCT04251156|363798696|FG000|Overall Study|Withdrawal by Subject|4|||
105487924|NCT04251156|363798697|FG001|Overall Study|Withdrawal by Subject|4|||
105487925|NCT03553836|363798698|FG000|Overall Study|Ongoing in Study|460|||
105487926|NCT03553836|363798699|FG001|Overall Study|Ongoing in Study|459|||
105487927|NCT03553836|363798698|FG000|Overall Study|Withdrawal by Subject|9|||
105487928|NCT03553836|363798699|FG001|Overall Study|Withdrawal by Subject|10|||
105487929|NCT03553836|363798698|FG000|Overall Study|Lost to Follow-up|1|||
105487930|NCT03553836|363798699|FG001|Overall Study|Lost to Follow-up|3|||
105487931|NCT03553836|363798698|FG000|Overall Study|Death|17|||
105487932|NCT03553836|363798699|FG001|Overall Study|Death|17|||
105487933|NCT04423939|363798700|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
105487934|NCT04423939|363798701|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
105487935|NCT04423939|363798700|FG000|Overall Study|Death|3|||
105487936|NCT04423939|363798701|FG001|Overall Study|Death|0|||
105487937|NCT04423939|363798700|FG000|Overall Study|Withdrawal by Subject|3|||
105487938|NCT04423939|363798701|FG001|Overall Study|Withdrawal by Subject|0|||
105487939|NCT04423939|363798700|FG000|Overall Study|Caregiver to patient who died|0|||
105487940|NCT04423939|363798701|FG001|Overall Study|Caregiver to patient who died|3|||
105487941|NCT04423939|363798700|FG000|Overall Study|Caregiver to patient who withdrew|0|||
105487942|NCT04423939|363798701|FG001|Overall Study|Caregiver to patient who withdrew|3|||
105487943|NCT01041495|363798702|FG000|Overall Study|Withdrawal by Subject|2|||
105487944|NCT01041495|363798703|FG001|Overall Study|Withdrawal by Subject|5|||
105768643|NCT03039790|364804475|FG007|Overall Study|Death|0|||
105573231|NCT03029247|364098479|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
105573232|NCT03029247|364098480|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
105573233|NCT03029247|364098479|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
105573234|NCT03029247|364098480|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
105573235|NCT01993017|364098483|FG000|Overall Study|Death|23|||
105573236|NCT01993017|364098484|FG001|Overall Study|Death|26|||
105573237|NCT01993017|364098485|FG002|Overall Study|Death|18|||
105573238|NCT01993017|364098483|FG000|Overall Study|Could not be contacted|43|||
105573239|NCT01993017|364098484|FG001|Overall Study|Could not be contacted|42|||
105573240|NCT01993017|364098485|FG002|Overall Study|Could not be contacted|38|||
105573241|NCT01993017|364098483|FG000|Overall Study|Dropped out|19|||
105573242|NCT01993017|364098484|FG001|Overall Study|Dropped out|6|||
105573243|NCT01993017|364098485|FG002|Overall Study|Dropped out|11|||
105573244|NCT01993017|364098483|FG000|Overall Study|Other reasons|17|||
105573245|NCT01993017|364098484|FG001|Overall Study|Other reasons|11|||
105487945|NCT01041495|363798702|FG000|Overall Study|Adverse Event|2|||
105487946|NCT01041495|363798703|FG001|Overall Study|Adverse Event|1|||
105487947|NCT01041495|363798702|FG000|Overall Study|Lost to Follow-up|0|||
105487948|NCT01041495|363798703|FG001|Overall Study|Lost to Follow-up|1|||
105487949|NCT01479985|363798706|FG000|Overall Study|Tablet malfunction, no data saved|1|||
105487950|NCT01479985|363798707|FG001|Overall Study|Tablet malfunction, no data saved|1|||
105487951|NCT01479985|363798706|FG000|Overall Study|No decisional conflict scale responses|0|||
105487952|NCT01479985|363798707|FG001|Overall Study|No decisional conflict scale responses|2|||
105487953|NCT01479985|363798706|FG000|Overall Study|No post-visit survey|5|||
105487954|NCT01479985|363798707|FG001|Overall Study|No post-visit survey|3|||
105487955|NCT00367770|363798710|FG000|Overall Study|Adverse Event|1|||
105487956|NCT00367770|363798710|FG000|Overall Study|Withdrawal by Subject|1|||
105487957|NCT00998764|363798711|FG000|Overall Study|Lack of Efficacy|3|||
105487958|NCT00998764|363798712|FG001|Overall Study|Lack of Efficacy|6|||
105487959|NCT00998764|363798711|FG000|Overall Study|Adverse Event|17|||
105487960|NCT00998764|363798712|FG001|Overall Study|Adverse Event|12|||
105487961|NCT00998764|363798711|FG000|Overall Study|Withdrawal by Subject|19|||
105487962|NCT00998764|363798712|FG001|Overall Study|Withdrawal by Subject|25|||
105487963|NCT00998764|363798711|FG000|Overall Study|Physician Decision|3|||
105487964|NCT00998764|363798712|FG001|Overall Study|Physician Decision|3|||
105487965|NCT00998764|363798711|FG000|Overall Study|Death|3|||
105487966|NCT00998764|363798712|FG001|Overall Study|Death|1|||
105487967|NCT00998764|363798711|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
105487968|NCT00998764|363798712|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
105487969|NCT00998764|363798711|FG000|Overall Study|Protocol Violation|0|||
105487970|NCT00998764|363798712|FG001|Overall Study|Protocol Violation|1|||
105487971|NCT00998764|363798711|FG000|Overall Study|Failed to Return|1|||
105487972|NCT00998764|363798712|FG001|Overall Study|Failed to Return|1|||
105487973|NCT00998764|363798711|FG000|Overall Study|Lost to Follow-up|1|||
105487974|NCT00998764|363798712|FG001|Overall Study|Lost to Follow-up|1|||
105487975|NCT00998764|363798711|FG000|Overall Study|Loss of Caregiver|0|||
105487976|NCT00998764|363798712|FG001|Overall Study|Loss of Caregiver|3|||
105487977|NCT00998764|363798711|FG000|Overall Study|Other|4|||
105487978|NCT00998764|363798712|FG001|Overall Study|Other|4|||
105487979|NCT00998764|363798711|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
105487980|NCT00998764|363798712|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
105487981|NCT04543409|363798715|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105487982|NCT04543409|363798716|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105487983|NCT04543409|363798715|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
105487984|NCT04543409|363798716|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
105487985|NCT04543409|363798715|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
105487986|NCT04543409|363798716|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
105487987|NCT04543409|363798715|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
105487988|NCT04543409|363798716|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
105487989|NCT04543409|363798715|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
105487990|NCT04543409|363798716|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
105487991|NCT04543409|363798715|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
105487992|NCT04543409|363798716|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
105487993|NCT04543409|363798715|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
105487994|NCT04543409|363798716|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
105487995|NCT04543409|363798715|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
105487996|NCT04543409|363798716|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
105487997|NCT04543409|363798715|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
105487998|NCT04543409|363798716|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
105487999|NCT04543409|363798715|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
105488000|NCT04543409|363798716|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
105488001|NCT04543409|363798715|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
105488002|NCT04543409|363798716|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
105488003|NCT03977454|363798717|FG000|Overall Study|immediate postoperative revision|2|||
105488004|NCT03977454|363798718|FG001|Overall Study|immediate postoperative revision|2|||
105488005|NCT03416374|363798719|FG000|Between Treatment Period I and II|Other|0|||
105488006|NCT03416374|363798720|FG001|Between Treatment Period I and II|Other|9|||
105488007|NCT03416374|363798719|FG000|Treatment Period II|Lack of Efficacy|3|||
105488008|NCT03416374|363798720|FG001|Treatment Period II|Lack of Efficacy|11|||
105488009|NCT03416374|363798719|FG000|Treatment Period II|Adverse Event|1|||
105488010|NCT03416374|363798720|FG001|Treatment Period II|Adverse Event|4|||
105488011|NCT03416374|363798719|FG000|Treatment Period II|Death|0|||
105488012|NCT03416374|363798720|FG001|Treatment Period II|Death|1|||
105488013|NCT03416374|363798719|FG000|Treatment Period II|Other|0|||
105573246|NCT01993017|364098485|FG002|Overall Study|Other reasons|7|||
105573247|NCT01993017|364098483|FG000|Overall Study|Ineligible after randomization|4|||
105573248|NCT01993017|364098484|FG001|Overall Study|Ineligible after randomization|5|||
105573249|NCT01993017|364098485|FG002|Overall Study|Ineligible after randomization|5|||
105573250|NCT01976364|364098486|FG000|Main Study (36 Months)|Adverse Event|63|||
105573251|NCT01976364|364098487|FG001|Main Study (36 Months)|Adverse Event|0|||
105573252|NCT01976364|364098488|FG002|Main Study (36 Months)|Adverse Event|0|||
105573253|NCT01976364|364098486|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
105573254|NCT01976364|364098487|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
105573255|NCT01976364|364098488|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
105573256|NCT01976364|364098486|FG000|Main Study (36 Months)|Other|13|||
105573257|NCT01976364|364098487|FG001|Main Study (36 Months)|Other|0|||
105573258|NCT01976364|364098488|FG002|Main Study (36 Months)|Other|0|||
105573259|NCT01976364|364098486|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
105573260|NCT01976364|364098487|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
105573261|NCT01976364|364098488|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
105573262|NCT01976364|364098486|FG000|Main Study (36 Months)|Medication error|1|||
105573263|NCT01976364|364098487|FG001|Main Study (36 Months)|Medication error|0|||
105573264|NCT01976364|364098488|FG002|Main Study (36 Months)|Medication error|0|||
105573265|NCT01976364|364098486|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
105573266|NCT01976364|364098487|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
105573267|NCT01976364|364098488|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
105488014|NCT03416374|363798720|FG001|Treatment Period II|Other|2|||
105488015|NCT01565499|363798728|FG000|Overall Study|Physician Decision|1|||
105488016|NCT01565499|363798728|FG000|Overall Study|Adverse Event|5|||
105488017|NCT01565499|363798728|FG000|Overall Study|Withdrawal by Subject|2|||
105488018|NCT00174291|363798733|FG000|Overall Study|Lost to Follow-up|1|||
105488019|NCT00174291|363798734|FG001|Overall Study|Lost to Follow-up|1|||
105488020|NCT00174291|363798733|FG000|Overall Study|Protocol Violation|0|||
105488021|NCT00174291|363798734|FG001|Overall Study|Protocol Violation|2|||
105488022|NCT00174291|363798733|FG000|Overall Study|Study terminated by sponsor|1|||
105488023|NCT00174291|363798734|FG001|Overall Study|Study terminated by sponsor|0|||
105488024|NCT00174291|363798733|FG000|Overall Study|Withdrawal by Subject|3|||
105488025|NCT00174291|363798734|FG001|Overall Study|Withdrawal by Subject|3|||
105488026|NCT01923168|363798737|FG000|Overall Study|Protocol Violation|1|||
105488027|NCT01923168|363798738|FG001|Overall Study|Protocol Violation|1|||
105488028|NCT01923168|363798739|FG002|Overall Study|Protocol Violation|0|||
105488029|NCT01923168|363798737|FG000|Overall Study|Subject/guardian decision|14|||
105488030|NCT01923168|363798738|FG001|Overall Study|Subject/guardian decision|14|||
105488031|NCT01923168|363798739|FG002|Overall Study|Subject/guardian decision|4|||
105488032|NCT01923168|363798737|FG000|Overall Study|Adverse Event|12|||
105488033|NCT01923168|363798738|FG001|Overall Study|Adverse Event|12|||
105488034|NCT01923168|363798739|FG002|Overall Study|Adverse Event|0|||
105488035|NCT01923168|363798737|FG000|Overall Study|Physician Decision|6|||
105488036|NCT01923168|363798738|FG001|Overall Study|Physician Decision|9|||
105488037|NCT01923168|363798739|FG002|Overall Study|Physician Decision|5|||
105488038|NCT01923168|363798737|FG000|Overall Study|Progressive disease|4|||
105488039|NCT01923168|363798738|FG001|Overall Study|Progressive disease|3|||
105488040|NCT01923168|363798739|FG002|Overall Study|Progressive disease|7|||
105488041|NCT01923168|363798737|FG000|Overall Study|Death|0|||
105488042|NCT01923168|363798738|FG001|Overall Study|Death|0|||
105488043|NCT01923168|363798739|FG002|Overall Study|Death|1|||
105488044|NCT03116347|363798740|FG000|Overall Study|Withdrawal by Subject|1|||
105488045|NCT03116347|363798741|FG001|Overall Study|Withdrawal by Subject|2|||
105488046|NCT01255787|363798742|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
105488047|NCT01255787|363798743|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
105488048|NCT01255787|363798744|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
105573268|NCT01976364|364098486|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
105573269|NCT01976364|364098487|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
105573270|NCT01976364|364098488|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
105573271|NCT01976364|364098486|FG000|Main Study (36 Months)|Protocol Violation|13|||
105573272|NCT01976364|364098487|FG001|Main Study (36 Months)|Protocol Violation|0|||
105573273|NCT01976364|364098488|FG002|Main Study (36 Months)|Protocol Violation|0|||
105573274|NCT01976364|364098486|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
105573275|NCT01976364|364098487|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
105573276|NCT01976364|364098488|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
105573277|NCT01976364|364098486|FG000|Main Study (36 Months)|Death|5|||
105573278|NCT01976364|364098487|FG001|Main Study (36 Months)|Death|0|||
105573279|NCT01976364|364098488|FG002|Main Study (36 Months)|Death|0|||
105573280|NCT01976364|364098486|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
105573281|NCT01976364|364098487|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
105573282|NCT01976364|364098488|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
105573283|NCT01976364|364098486|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
105573284|NCT01976364|364098487|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
105573285|NCT01976364|364098488|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
105573286|NCT01976364|364098486|FG000|Sub-study (12 Months)|Protocol Violation|0|||
105573287|NCT01976364|364098487|FG001|Sub-study (12 Months)|Protocol Violation|1|||
105366143|NCT01240382|363346569|FG001|Overall Study|Fear of adverse events|1|||
105366144|NCT01408706|363346574|FG000|Overall Study|Physician Decision|1|||
105366145|NCT01408706|363346575|FG001|Overall Study|Physician Decision|0|||
105573288|NCT01976364|364098488|FG002|Sub-study (12 Months)|Protocol Violation|1|||
105573289|NCT01976364|364098486|FG000|Sub-study (12 Months)|Adverse Event|0|||
105573290|NCT01976364|364098487|FG001|Sub-study (12 Months)|Adverse Event|4|||
105573291|NCT01976364|364098488|FG002|Sub-study (12 Months)|Adverse Event|3|||
105573292|NCT01190215|364098489|FG000|Up to Month 6|Lost to Follow-up|2|||
105573293|NCT01190215|364098490|FG001|Up to Month 6|Lost to Follow-up|0|||
105366146|NCT01268267|363346576|FG000|Overall Study|Protocol Violation|1|||
105573294|NCT02670538|364098491|FG000|Overall Study|Withdrawal of Consent|8|||
105366147|NCT04919317|363346580|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
105366148|NCT04919317|363346581|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
105366149|NCT04919317|363346580|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
105366150|NCT04919317|363346581|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
105366151|NCT00698815|363346582|FG000|Overall Study|Death|1|||
105366152|NCT00698815|363346583|FG001|Overall Study|Death|2|||
105366153|NCT00698815|363346584|FG002|Overall Study|Death|4|||
105366154|NCT00698815|363346582|FG000|Overall Study|Withdrawal by Subject|6|||
105366155|NCT00698815|363346583|FG001|Overall Study|Withdrawal by Subject|3|||
105573295|NCT02670538|364098492|FG001|Overall Study|Withdrawal of Consent|6|||
105573296|NCT02670538|364098493|FG002|Overall Study|Withdrawal of Consent|5|||
105573297|NCT02670538|364098491|FG000|Overall Study|Lost to Follow-up|8|||
105573298|NCT02670538|364098492|FG001|Overall Study|Lost to Follow-up|12|||
105573299|NCT02670538|364098493|FG002|Overall Study|Lost to Follow-up|7|||
105573300|NCT02670538|364098491|FG000|Overall Study|Adverse Event|5|||
105573301|NCT02670538|364098492|FG001|Overall Study|Adverse Event|5|||
105573302|NCT02670538|364098493|FG002|Overall Study|Adverse Event|11|||
105573303|NCT02670538|364098491|FG000|Overall Study|Lack of Efficacy|7|||
105573304|NCT02670538|364098492|FG001|Overall Study|Lack of Efficacy|1|||
105573305|NCT02670538|364098493|FG002|Overall Study|Lack of Efficacy|2|||
105573306|NCT02670538|364098491|FG000|Overall Study|Protocol Violation|3|||
105573307|NCT02670538|364098492|FG001|Overall Study|Protocol Violation|4|||
105573308|NCT02670538|364098493|FG002|Overall Study|Protocol Violation|1|||
105573309|NCT02670538|364098491|FG000|Overall Study|Noncompliance with Study Drug|1|||
105573310|NCT02670538|364098492|FG001|Overall Study|Noncompliance with Study Drug|3|||
105573311|NCT02670538|364098493|FG002|Overall Study|Noncompliance with Study Drug|2|||
105573312|NCT02670538|364098491|FG000|Overall Study|Other Miscellaneous Reasons|0|||
105573313|NCT02670538|364098492|FG001|Overall Study|Other Miscellaneous Reasons|1|||
105573314|NCT02670538|364098493|FG002|Overall Study|Other Miscellaneous Reasons|2|||
105573315|NCT01336634|364098494|FG000|Overall Study|Study closed/terminated|5|||
105573316|NCT01336634|364098495|FG001|Overall Study|Study closed/terminated|6|||
105573317|NCT01336634|364098496|FG002|Overall Study|Study closed/terminated|6|||
105573318|NCT01336634|364098494|FG000|Overall Study|Lost to Follow-up|2|||
105573319|NCT01336634|364098495|FG001|Overall Study|Lost to Follow-up|1|||
105573320|NCT01336634|364098496|FG002|Overall Study|Lost to Follow-up|1|||
105573321|NCT01336634|364098494|FG000|Overall Study|Physician Decision|1|||
105573322|NCT01336634|364098495|FG001|Overall Study|Physician Decision|1|||
105573323|NCT01336634|364098496|FG002|Overall Study|Physician Decision|0|||
105573324|NCT01336634|364098494|FG000|Overall Study|Withdrawal by Subject|6|||
105573325|NCT01336634|364098495|FG001|Overall Study|Withdrawal by Subject|0|||
105826036|NCT02055547|365020171|FG010|Overall Study|Adverse Event|0|||
105826037|NCT02055547|365020172|FG011|Overall Study|Adverse Event|0|||
105826038|NCT02055547|365020173|FG012|Overall Study|Adverse Event|0|||
105826039|NCT02055547|365020174|FG013|Overall Study|Adverse Event|0|||
105826040|NCT02055547|365020175|FG014|Overall Study|Adverse Event|0|||
105826041|NCT02055547|365020176|FG015|Overall Study|Adverse Event|0|||
105826042|NCT02055547|365020177|FG016|Overall Study|Adverse Event|0|||
105826043|NCT02055547|365020178|FG017|Overall Study|Adverse Event|0|||
105826044|NCT02055547|365020179|FG018|Overall Study|Adverse Event|0|||
105826045|NCT02055547|365020161|FG000|Overall Study|Withdrawal by Subject|0|||
105826046|NCT02055547|365020162|FG001|Overall Study|Withdrawal by Subject|0|||
105826047|NCT02055547|365020163|FG002|Overall Study|Withdrawal by Subject|0|||
105366156|NCT00698815|363346584|FG002|Overall Study|Withdrawal by Subject|2|||
105573326|NCT01336634|364098496|FG002|Overall Study|Withdrawal by Subject|2|||
105573327|NCT02961881|364098497|FG000|Overall Study|Adverse Event|1|||
105573328|NCT02961881|364098498|FG001|Overall Study|Adverse Event|2|||
105573329|NCT02961881|364098499|FG002|Overall Study|Adverse Event|2|||
105573330|NCT02961881|364098500|FG003|Overall Study|Adverse Event|0|||
105573331|NCT02961881|364098501|FG004|Overall Study|Adverse Event|1|||
105573332|NCT02961881|364098497|FG000|Overall Study|Participant request|0|||
105826048|NCT02055547|365020164|FG003|Overall Study|Withdrawal by Subject|0|||
105826049|NCT02055547|365020165|FG004|Overall Study|Withdrawal by Subject|0|||
105826050|NCT02055547|365020166|FG005|Overall Study|Withdrawal by Subject|1|||
105826051|NCT02055547|365020167|FG006|Overall Study|Withdrawal by Subject|0|||
105826052|NCT02055547|365020168|FG007|Overall Study|Withdrawal by Subject|0|||
105826053|NCT02055547|365020169|FG008|Overall Study|Withdrawal by Subject|1|||
105573333|NCT02961881|364098498|FG001|Overall Study|Participant request|2|||
105573334|NCT02961881|364098499|FG002|Overall Study|Participant request|0|||
105573335|NCT02961881|364098500|FG003|Overall Study|Participant request|0|||
105573336|NCT02961881|364098501|FG004|Overall Study|Participant request|0|||
105573337|NCT02961881|364098497|FG000|Overall Study|Disease progression|1|||
105573338|NCT02961881|364098498|FG001|Overall Study|Disease progression|0|||
105573339|NCT02961881|364098499|FG002|Overall Study|Disease progression|1|||
105826054|NCT02055547|365020170|FG009|Overall Study|Withdrawal by Subject|0|||
105573340|NCT02961881|364098500|FG003|Overall Study|Disease progression|0|||
105573341|NCT02961881|364098501|FG004|Overall Study|Disease progression|0|||
105573342|NCT02632786|364098502|FG000|Overall Study|Adverse Event|2|||
105826055|NCT02055547|365020171|FG010|Overall Study|Withdrawal by Subject|0|||
105366157|NCT00698815|363346582|FG000|Overall Study|MD discretion|2|||
105366158|NCT00698815|363346583|FG001|Overall Study|MD discretion|7|||
105488049|NCT01255787|363798745|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
105366159|NCT00698815|363346584|FG002|Overall Study|MD discretion|2|||
105488050|NCT01255787|363798742|FG000|Overall Study|Major Protocol Deviation|1|||
105488051|NCT01255787|363798743|FG001|Overall Study|Major Protocol Deviation|1|||
105488052|NCT01255787|363798744|FG002|Overall Study|Major Protocol Deviation|0|||
105488053|NCT01255787|363798745|FG003|Overall Study|Major Protocol Deviation|4|||
105488054|NCT01255787|363798742|FG000|Overall Study|Lost to Follow-up|1|||
105488055|NCT01255787|363798743|FG001|Overall Study|Lost to Follow-up|2|||
105488056|NCT01255787|363798744|FG002|Overall Study|Lost to Follow-up|4|||
105488057|NCT01255787|363798745|FG003|Overall Study|Lost to Follow-up|2|||
105488058|NCT01255787|363798742|FG000|Overall Study|Withdrawal of Consent|3|||
105488059|NCT01255787|363798743|FG001|Overall Study|Withdrawal of Consent|9|||
105488060|NCT01255787|363798744|FG002|Overall Study|Withdrawal of Consent|3|||
105488061|NCT01255787|363798745|FG003|Overall Study|Withdrawal of Consent|4|||
105488062|NCT01255787|363798742|FG000|Overall Study|Pregnancy|0|||
105488063|NCT01255787|363798743|FG001|Overall Study|Pregnancy|0|||
105488064|NCT01255787|363798744|FG002|Overall Study|Pregnancy|0|||
105488065|NCT01255787|363798745|FG003|Overall Study|Pregnancy|1|||
105488066|NCT01255787|363798742|FG000|Overall Study|Lack of Efficacy|2|||
105488067|NCT01255787|363798743|FG001|Overall Study|Lack of Efficacy|2|||
105488068|NCT01255787|363798744|FG002|Overall Study|Lack of Efficacy|2|||
105488069|NCT01255787|363798745|FG003|Overall Study|Lack of Efficacy|2|||
105488070|NCT01255787|363798742|FG000|Overall Study|Noncompliance with Study Drug|3|||
105488071|NCT01255787|363798743|FG001|Overall Study|Noncompliance with Study Drug|1|||
105488072|NCT01255787|363798744|FG002|Overall Study|Noncompliance with Study Drug|0|||
105488073|NCT01255787|363798745|FG003|Overall Study|Noncompliance with Study Drug|0|||
105488074|NCT00476047|363798746|FG000|Overall Study|Lost to Follow-up|1|||
105488075|NCT03170232|363798747|FG000|Overall Study|Adverse Event|0|||
105488076|NCT03170232|363798748|FG001|Overall Study|Adverse Event|1|||
105488077|NCT03170232|363798747|FG000|Overall Study|Protocol Violation|0|||
105488078|NCT03170232|363798748|FG001|Overall Study|Protocol Violation|1|||
105488079|NCT03170232|363798747|FG000|Overall Study|Lack of Efficacy|0|||
105488080|NCT03170232|363798748|FG001|Overall Study|Lack of Efficacy|1|||
105488081|NCT03170232|363798747|FG000|Overall Study|Study closed/terminated|26|||
105488082|NCT03170232|363798748|FG001|Overall Study|Study closed/terminated|23|||
105488083|NCT03170232|363798747|FG000|Overall Study|Lost to Follow-up|1|||
105488084|NCT03170232|363798748|FG001|Overall Study|Lost to Follow-up|0|||
105488085|NCT03170232|363798747|FG000|Overall Study|Withdrawal by Subject|0|||
105488086|NCT03170232|363798748|FG001|Overall Study|Withdrawal by Subject|1|||
105366160|NCT00698815|363346582|FG000|Overall Study|Did not receive protocol treatment|1|||
105573343|NCT02632786|364098503|FG001|Overall Study|Adverse Event|1|||
105573344|NCT02632786|364098502|FG000|Overall Study|Death|3|||
105573345|NCT02632786|364098503|FG001|Overall Study|Death|2|||
105573346|NCT02632786|364098502|FG000|Overall Study|Physician Decision|5|||
105573347|NCT02632786|364098503|FG001|Overall Study|Physician Decision|4|||
105573348|NCT02632786|364098502|FG000|Overall Study|Withdrawal by Subject|1|||
105573349|NCT02632786|364098503|FG001|Overall Study|Withdrawal by Subject|0|||
105573350|NCT01928225|364098504|FG000|Overall Study|Pregnancy|1|||
105573351|NCT01928225|364098505|FG001|Overall Study|Pregnancy|0|||
105573352|NCT01928225|364098504|FG000|Overall Study|basaloid cervical cancer|1|||
105573353|NCT01928225|364098505|FG001|Overall Study|basaloid cervical cancer|0|||
105826056|NCT02055547|365020172|FG011|Overall Study|Withdrawal by Subject|0|||
105826057|NCT02055547|365020173|FG012|Overall Study|Withdrawal by Subject|0|||
105826058|NCT02055547|365020174|FG013|Overall Study|Withdrawal by Subject|1|||
105826059|NCT02055547|365020175|FG014|Overall Study|Withdrawal by Subject|0|||
105826060|NCT02055547|365020176|FG015|Overall Study|Withdrawal by Subject|1|||
105826061|NCT02055547|365020177|FG016|Overall Study|Withdrawal by Subject|0|||
105826062|NCT02055547|365020178|FG017|Overall Study|Withdrawal by Subject|0|||
105826063|NCT02055547|365020179|FG018|Overall Study|Withdrawal by Subject|0|||
105826064|NCT02055547|365020161|FG000|Overall Study|Lost to Follow-up|0|||
105826065|NCT02055547|365020162|FG001|Overall Study|Lost to Follow-up|0|||
105826066|NCT02055547|365020163|FG002|Overall Study|Lost to Follow-up|1|||
105826067|NCT02055547|365020164|FG003|Overall Study|Lost to Follow-up|0|||
105826068|NCT02055547|365020165|FG004|Overall Study|Lost to Follow-up|0|||
105826069|NCT02055547|365020166|FG005|Overall Study|Lost to Follow-up|0|||
105826070|NCT02055547|365020167|FG006|Overall Study|Lost to Follow-up|0|||
105826071|NCT02055547|365020168|FG007|Overall Study|Lost to Follow-up|0|||
105573354|NCT01928225|364098504|FG000|Overall Study|Lost to Follow-up|1|||
105573355|NCT01928225|364098505|FG001|Overall Study|Lost to Follow-up|3|||
105573356|NCT00365378|364098506|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
105573357|NCT00365378|364098507|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
105573358|NCT00365378|364098508|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
105573359|NCT00365378|364098506|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
105573360|NCT00365378|364098507|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
105573361|NCT00365378|364098508|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
105573362|NCT00365378|364098506|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
105573363|NCT00365378|364098507|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
105573364|NCT00365378|364098508|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
105573365|NCT00365378|364098506|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
105573366|NCT00365378|364098507|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
105573367|NCT00365378|364098508|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
105573368|NCT00365378|364098506|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
105573369|NCT00365378|364098507|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
105573370|NCT00365378|364098508|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
105573371|NCT00365378|364098506|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
105573372|NCT00365378|364098507|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
105573373|NCT00365378|364098508|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
105573374|NCT00365378|364098506|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
105573375|NCT00365378|364098507|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
105573376|NCT00365378|364098508|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
105573377|NCT00365378|364098506|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
105573378|NCT00365378|364098507|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
105573379|NCT00365378|364098508|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
105573380|NCT00365378|364098506|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
105573381|NCT00365378|364098507|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
105573382|NCT00365378|364098508|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
105573383|NCT00365378|364098506|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
105573384|NCT00365378|364098507|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
105573385|NCT00365378|364098508|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
105573386|NCT00365378|364098506|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
105573387|NCT00365378|364098507|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
105573388|NCT00365378|364098508|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
105573389|NCT00365378|364098506|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
105573390|NCT00365378|364098507|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
105573391|NCT00365378|364098508|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
105573392|NCT00365378|364098506|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
105573393|NCT00365378|364098507|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
105826072|NCT02055547|365020169|FG008|Overall Study|Lost to Follow-up|0|||
105573394|NCT00365378|364098508|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
105573395|NCT00365378|364098506|FG000|Extension|Adverse Event|0|||
105573396|NCT00365378|364098507|FG001|Extension|Adverse Event|0|||
105573397|NCT00365378|364098508|FG002|Extension|Adverse Event|1|||
105573398|NCT00365378|364098506|FG000|Extension|Moved|0|||
105440074|NCT05362058|363616698|FG000|Follow-Up Period|Death|1|||
105826073|NCT02055547|365020170|FG009|Overall Study|Lost to Follow-up|0|||
105826074|NCT02055547|365020171|FG010|Overall Study|Lost to Follow-up|0|||
105826075|NCT02055547|365020172|FG011|Overall Study|Lost to Follow-up|0|||
105826076|NCT02055547|365020173|FG012|Overall Study|Lost to Follow-up|0|||
105826077|NCT02055547|365020174|FG013|Overall Study|Lost to Follow-up|0|||
105826078|NCT02055547|365020175|FG014|Overall Study|Lost to Follow-up|0|||
105826079|NCT02055547|365020176|FG015|Overall Study|Lost to Follow-up|0|||
105826080|NCT02055547|365020177|FG016|Overall Study|Lost to Follow-up|0|||
105826081|NCT02055547|365020178|FG017|Overall Study|Lost to Follow-up|0|||
105826082|NCT02055547|365020179|FG018|Overall Study|Lost to Follow-up|0|||
105826083|NCT04198363|365020180|FG000|Overall Study|Adverse Event|1|||
105826084|NCT04198363|365020181|FG001|Overall Study|Adverse Event|1|||
105826085|NCT04198363|365020180|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
105826086|NCT04198363|365020181|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
105826087|NCT04198363|365020180|FG000|Overall Study|Reason not Specified|1|||
105826088|NCT04198363|365020181|FG001|Overall Study|Reason not Specified|0|||
105826089|NCT04236596|365020185|FG000|Overall Study|Withdrawal by Subject|1|||
105440075|NCT05362058|363616699|FG001|Follow-Up Period|Death|0|||
105440076|NCT05362058|363616698|FG000|Follow-Up Period|Lost to Follow-up|2|||
105366161|NCT00698815|363346583|FG001|Overall Study|Did not receive protocol treatment|2|||
105366162|NCT00698815|363346584|FG002|Overall Study|Did not receive protocol treatment|2|||
105366163|NCT00230048|363346585|FG000|Overall Study|Lost to Follow-up|13|||
105366164|NCT00230048|363346586|FG001|Overall Study|Lost to Follow-up|18|||
105366165|NCT01566604|363346591|FG000|Overall Study|Patient's inability to use the device|1|||
105366166|NCT01566604|363346592|FG001|Overall Study|Patient's inability to use the device|0|||
105488087|NCT00586326|363798749|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
105488088|NCT00586326|363798749|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
105573399|NCT00365378|364098507|FG001|Extension|Moved|0|||
105488089|NCT00586326|363798749|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
105488090|NCT00586326|363798749|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
105573400|NCT00365378|364098508|FG002|Extension|Moved|8|||
105573401|NCT00365378|364098506|FG000|Extension|Lost to Follow-up|0|||
105573402|NCT00365378|364098507|FG001|Extension|Lost to Follow-up|0|||
105573403|NCT00365378|364098508|FG002|Extension|Lost to Follow-up|57|||
105573404|NCT00365378|364098506|FG000|Extension|Protocol Violation|0|||
105573405|NCT00365378|364098507|FG001|Extension|Protocol Violation|0|||
105573406|NCT00365378|364098508|FG002|Extension|Protocol Violation|2|||
105488091|NCT00586326|363798749|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
105488092|NCT00586326|363798749|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
105488093|NCT00586326|363798749|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
105573407|NCT00365378|364098506|FG000|Extension|Withdrawal by Subject|0|||
105573408|NCT00365378|364098507|FG001|Extension|Withdrawal by Subject|0|||
105573409|NCT00365378|364098508|FG002|Extension|Withdrawal by Subject|98|||
105573410|NCT00365378|364098506|FG000|Extension|Other|0|||
105573411|NCT00365378|364098507|FG001|Extension|Other|0|||
105573412|NCT00365378|364098508|FG002|Extension|Other|31|||
105573413|NCT02006121|364098512|FG000|Double Blind Phase|Adverse Event|6|||
105573414|NCT02006121|364098513|FG001|Double Blind Phase|Adverse Event|0|||
105573415|NCT02006121|364098512|FG000|Double Blind Phase|Lack of Efficacy|1|||
105573416|NCT02006121|364098513|FG001|Double Blind Phase|Lack of Efficacy|16|||
105573417|NCT02006121|364098512|FG000|Double Blind Phase|Withdrawal by Subject|3|||
105826090|NCT04236596|365020185|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
105573418|NCT02006121|364098513|FG001|Double Blind Phase|Withdrawal by Subject|4|||
105573419|NCT02006121|364098512|FG000|Double Blind Phase|Non-compliance with study drug|1|||
105573420|NCT02006121|364098513|FG001|Double Blind Phase|Non-compliance with study drug|3|||
105573421|NCT02006121|364098512|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
105573422|NCT02006121|364098513|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
105573423|NCT02006121|364098512|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
105573424|NCT02006121|364098513|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
105573425|NCT02006121|364098512|FG000|Open Label Phase|Adverse Event|15|||
105573426|NCT02006121|364098513|FG001|Open Label Phase|Adverse Event|0|||
105573427|NCT02006121|364098512|FG000|Open Label Phase|Lack of Efficacy|2|||
105573428|NCT02006121|364098513|FG001|Open Label Phase|Lack of Efficacy|0|||
105573429|NCT02006121|364098512|FG000|Open Label Phase|Protocol Violation|2|||
105573430|NCT02006121|364098513|FG001|Open Label Phase|Protocol Violation|0|||
105573431|NCT02006121|364098512|FG000|Open Label Phase|Withdrawal by Subject|3|||
105573432|NCT02006121|364098513|FG001|Open Label Phase|Withdrawal by Subject|0|||
105573433|NCT02006121|364098512|FG000|Open Label Phase|Non-compliance with study drug|3|||
105573434|NCT02006121|364098513|FG001|Open Label Phase|Non-compliance with study drug|0|||
105573435|NCT02387216|364098517|FG000|Overall Study|Progressive disease|2|||
105573436|NCT02387216|364098518|FG001|Overall Study|Progressive disease|0|||
105573437|NCT02387216|364098517|FG000|Overall Study|Withdrawal by Subject|3|||
105573438|NCT02387216|364098518|FG001|Overall Study|Withdrawal by Subject|5|||
105573439|NCT02387216|364098517|FG000|Overall Study|Physician Decision|2|||
105573440|NCT02387216|364098518|FG001|Overall Study|Physician Decision|0|||
105573441|NCT02387216|364098517|FG000|Overall Study|Sponsor Decision|28|||
105573442|NCT02387216|364098518|FG001|Overall Study|Sponsor Decision|12|||
105573443|NCT02387216|364098517|FG000|Overall Study|Death|60|||
105573444|NCT02387216|364098518|FG001|Overall Study|Death|23|||
105573445|NCT02387216|364098517|FG000|Overall Study|Other|5|||
105573446|NCT02387216|364098518|FG001|Overall Study|Other|4|||
105826091|NCT04236596|365020185|FG000|Overall Study|Participants did not receive implant at all|4|||
105826092|NCT02588339|365020188|FG000|Overall Study|Withdrawal by Subject|1|||
105826093|NCT02588339|365020188|FG000|Overall Study|GVHD Progression prior to treatment|2|||
105826094|NCT01958294|365021999|FG000|Overall Study|Clinical Circumstances|2|||
105826095|NCT02566850|365022000|FG000|Overall Study|Protocol Violation|1|||
105826096|NCT02057835|365022006|FG000|Overall Study|Withdrawal by Subject|0|||
105826097|NCT02057835|365022007|FG001|Overall Study|Withdrawal by Subject|2|||
105826098|NCT02057835|365022008|FG002|Overall Study|Withdrawal by Subject|0|||
105826099|NCT02057835|365022009|FG003|Overall Study|Withdrawal by Subject|0|||
105826100|NCT02057835|365022010|FG004|Overall Study|Withdrawal by Subject|0|||
105826101|NCT02057835|365022011|FG005|Overall Study|Withdrawal by Subject|0|||
105826102|NCT02057835|365022012|FG006|Overall Study|Withdrawal by Subject|0|||
105826103|NCT02057835|365022013|FG007|Overall Study|Withdrawal by Subject|0|||
105826104|NCT02057835|365022014|FG008|Overall Study|Withdrawal by Subject|0|||
105826105|NCT02057835|365022015|FG009|Overall Study|Withdrawal by Subject|0|||
105826106|NCT02267187|365022016|FG000|Overall Study|Physician Decision|2|||
105826107|NCT02267187|365022016|FG000|Overall Study|Screen fail|3|||
105826108|NCT04035187|365022017|FG000|Overall Study|Withdrawal by Subject|2|||
105826109|NCT04035187|365022018|FG001|Overall Study|Withdrawal by Subject|1|||
105826110|NCT04035187|365022019|FG002|Overall Study|Withdrawal by Subject|0|||
105826111|NCT04035187|365022020|FG003|Overall Study|Withdrawal by Subject|0|||
105826112|NCT04035187|365022017|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
105826113|NCT04035187|365022018|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
105826114|NCT04035187|365022019|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
105826115|NCT04035187|365022020|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
105826116|NCT01592240|365022023|FG000|Overall Study|Adverse Event|1|||
105826117|NCT01592240|365022024|FG001|Overall Study|Adverse Event|0|||
105826118|NCT01592240|365022025|FG002|Overall Study|Adverse Event|0|||
105826119|NCT01592240|365022026|FG003|Overall Study|Adverse Event|1|||
105826120|NCT01592240|365022027|FG004|Overall Study|Adverse Event|1|||
105826121|NCT01592240|365022028|FG005|Overall Study|Adverse Event|0|||
105826122|NCT01592240|365022029|FG006|Overall Study|Adverse Event|0|||
105826123|NCT01592240|365022023|FG000|Overall Study|Death|0|||
105826124|NCT01592240|365022024|FG001|Overall Study|Death|1|||
105826125|NCT01592240|365022025|FG002|Overall Study|Death|0|||
105826126|NCT01592240|365022026|FG003|Overall Study|Death|0|||
105826127|NCT01592240|365022027|FG004|Overall Study|Death|0|||
105573447|NCT02387216|364098517|FG000|Overall Study|Lost to Follow-up|0|||
105826128|NCT01592240|365022028|FG005|Overall Study|Death|0|||
105826129|NCT01592240|365022029|FG006|Overall Study|Death|0|||
105826130|NCT01592240|365022023|FG000|Overall Study|Lost to Follow-up|1|||
105826131|NCT01592240|365022024|FG001|Overall Study|Lost to Follow-up|3|||
105826132|NCT01592240|365022025|FG002|Overall Study|Lost to Follow-up|1|||
105573448|NCT02387216|364098518|FG001|Overall Study|Lost to Follow-up|3|||
105826133|NCT01592240|365022026|FG003|Overall Study|Lost to Follow-up|0|||
105826134|NCT01592240|365022027|FG004|Overall Study|Lost to Follow-up|3|||
105826135|NCT01592240|365022028|FG005|Overall Study|Lost to Follow-up|2|||
105826136|NCT01592240|365022029|FG006|Overall Study|Lost to Follow-up|0|||
105826137|NCT01592240|365022023|FG000|Overall Study|Protocol Violation|0|||
105826138|NCT01592240|365022024|FG001|Overall Study|Protocol Violation|0|||
105826139|NCT01592240|365022025|FG002|Overall Study|Protocol Violation|0|||
105826140|NCT01592240|365022026|FG003|Overall Study|Protocol Violation|0|||
105826141|NCT01592240|365022027|FG004|Overall Study|Protocol Violation|0|||
105826142|NCT01592240|365022028|FG005|Overall Study|Protocol Violation|1|||
105826143|NCT01592240|365022029|FG006|Overall Study|Protocol Violation|0|||
105826144|NCT01592240|365022023|FG000|Overall Study|Withdrawal by Subject|0|||
105826145|NCT01592240|365022024|FG001|Overall Study|Withdrawal by Subject|4|||
105826146|NCT01592240|365022025|FG002|Overall Study|Withdrawal by Subject|4|||
105826147|NCT01592240|365022026|FG003|Overall Study|Withdrawal by Subject|1|||
105826148|NCT01592240|365022027|FG004|Overall Study|Withdrawal by Subject|3|||
105826149|NCT01592240|365022028|FG005|Overall Study|Withdrawal by Subject|0|||
105826150|NCT01592240|365022029|FG006|Overall Study|Withdrawal by Subject|2|||
105826151|NCT01592240|365022023|FG000|Overall Study|Other|0|||
105826152|NCT01592240|365022024|FG001|Overall Study|Other|3|||
105826153|NCT01592240|365022025|FG002|Overall Study|Other|1|||
105826154|NCT01592240|365022026|FG003|Overall Study|Other|1|||
105826155|NCT01592240|365022027|FG004|Overall Study|Other|0|||
105826156|NCT01592240|365022028|FG005|Overall Study|Other|0|||
105826157|NCT01592240|365022029|FG006|Overall Study|Other|1|||
105826158|NCT01592240|365022023|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
105826159|NCT01592240|365022024|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
105826160|NCT01592240|365022025|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
105826161|NCT01592240|365022026|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
105826162|NCT01592240|365022027|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
105826163|NCT01592240|365022028|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
105826164|NCT01592240|365022029|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
105366167|NCT01566604|363346591|FG000|Overall Study|Administrative problems|1|||
105366168|NCT01566604|363346592|FG001|Overall Study|Administrative problems|0|||
105366169|NCT01566604|363346591|FG000|Overall Study|Lack of Efficacy|1|||
105366170|NCT01566604|363346592|FG001|Overall Study|Lack of Efficacy|2|||
105366171|NCT01566604|363346591|FG000|Overall Study|Protocol deviation|2|||
105366172|NCT01566604|363346592|FG001|Overall Study|Protocol deviation|0|||
105366173|NCT01566604|363346591|FG000|Overall Study|Abnormal laboratory value|2|||
105366174|NCT01566604|363346592|FG001|Overall Study|Abnormal laboratory value|0|||
105366175|NCT01566604|363346591|FG000|Overall Study|Death|4|||
105366176|NCT01566604|363346592|FG001|Overall Study|Death|1|||
105366177|NCT01566604|363346591|FG000|Overall Study|Adverse Event|4|||
105366178|NCT01566604|363346592|FG001|Overall Study|Adverse Event|2|||
105366179|NCT01566604|363346591|FG000|Overall Study|Withdrawal by Subject|9|||
105366180|NCT01566604|363346592|FG001|Overall Study|Withdrawal by Subject|6|||
105366181|NCT01663402|363346594|FG000|Overall Study|Randomized but not treated|19|||
105366182|NCT01663402|363346595|FG001|Overall Study|Randomized but not treated|11|||
105488094|NCT00586326|363798749|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
105488095|NCT00586326|363798749|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
105488096|NCT00586326|363798749|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
105488097|NCT00586326|363798749|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
105488098|NCT00586326|363798749|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
105488099|NCT00586326|363798749|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
105488100|NCT00586326|363798749|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
105488101|NCT00586326|363798749|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
105488102|NCT00586326|363798749|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
105488103|NCT00586326|363798749|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
105488104|NCT03882008|363798750|FG000|Overall Study|Withdrawal by Subject|1|||
105488105|NCT03882008|363798750|FG000|Overall Study|Lost to Follow-up|1|||
105488106|NCT05153473|363798751|FG000|Overall Study|Death|46|||
105488107|NCT05153473|363798751|FG000|Overall Study|Lost to Follow-up|3|||
105488108|NCT03519386|363798752|FG000|Overall Study|Withdrawal by Subject|4|||
105488109|NCT03519386|363798753|FG001|Overall Study|Withdrawal by Subject|1|||
105488110|NCT03519386|363798754|FG002|Overall Study|Withdrawal by Subject|2|||
105488111|NCT03519386|363798752|FG000|Overall Study|Physician Decision|1|||
105488112|NCT03519386|363798753|FG001|Overall Study|Physician Decision|1|||
105488113|NCT03519386|363798754|FG002|Overall Study|Physician Decision|1|||
105488114|NCT03519386|363798752|FG000|Overall Study|Lost to Follow-up|0|||
105488115|NCT03519386|363798753|FG001|Overall Study|Lost to Follow-up|1|||
105488116|NCT03519386|363798754|FG002|Overall Study|Lost to Follow-up|1|||
105488117|NCT03519386|363798752|FG000|Overall Study|Death|1|||
105488118|NCT03519386|363798753|FG001|Overall Study|Death|0|||
105488119|NCT03519386|363798754|FG002|Overall Study|Death|4|||
105488120|NCT03519386|363798752|FG000|Overall Study|Adverse Event|2|||
105366183|NCT01663402|363346594|FG000|Overall Study|Adverse Event|347|||
105488121|NCT03519386|363798753|FG001|Overall Study|Adverse Event|1|||
105488122|NCT03519386|363798754|FG002|Overall Study|Adverse Event|2|||
105488123|NCT03519386|363798752|FG000|Overall Study|Explanted|2|||
105488124|NCT03519386|363798753|FG001|Overall Study|Explanted|1|||
105488125|NCT03519386|363798754|FG002|Overall Study|Explanted|0|||
105488126|NCT03519386|363798752|FG000|Overall Study|Ongoing in study|190|||
105488127|NCT03519386|363798753|FG001|Overall Study|Ongoing in study|192|||
105488128|NCT03519386|363798754|FG002|Overall Study|Ongoing in study|183|||
105488129|NCT00245583|363798755|FG000|Overall Study|Lost to Follow-up|1|||
105488130|NCT00245583|363798756|FG001|Overall Study|Lost to Follow-up|5|||
105488131|NCT00245583|363798755|FG000|Overall Study|Adverse Event|2|||
105488132|NCT00245583|363798756|FG001|Overall Study|Adverse Event|1|||
105488133|NCT00245583|363798755|FG000|Overall Study|Lack of Efficacy|1|||
105488134|NCT00245583|363798756|FG001|Overall Study|Lack of Efficacy|0|||
105488135|NCT00245583|363798755|FG000|Overall Study|Withdrawal by Subject|2|||
105488136|NCT00245583|363798756|FG001|Overall Study|Withdrawal by Subject|3|||
105488137|NCT02632838|363798757|FG000|Overall Study|Withdrawal by Subject|3|||
105488138|NCT02632838|363798758|FG001|Overall Study|Withdrawal by Subject|0|||
105488139|NCT02632838|363798757|FG000|Overall Study|Lost to Follow-up|0|||
105488140|NCT02632838|363798758|FG001|Overall Study|Lost to Follow-up|2|||
105488141|NCT03324581|363798763|FG000|Overall Study|Adverse Event|18|||
105488142|NCT03324581|363798764|FG001|Overall Study|Adverse Event|11|||
105488143|NCT03324581|363798765|FG002|Overall Study|Adverse Event|7|||
105488144|NCT03324581|363798763|FG000|Overall Study|Lack of Efficacy|0|||
105488145|NCT03324581|363798764|FG001|Overall Study|Lack of Efficacy|1|||
105488146|NCT03324581|363798765|FG002|Overall Study|Lack of Efficacy|0|||
105488147|NCT03324581|363798763|FG000|Overall Study|Lost to Follow-up|5|||
105488148|NCT03324581|363798764|FG001|Overall Study|Lost to Follow-up|3|||
105488149|NCT03324581|363798765|FG002|Overall Study|Lost to Follow-up|6|||
105488150|NCT03324581|363798763|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
105488151|NCT03324581|363798764|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
105488152|NCT03324581|363798765|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
105488153|NCT03324581|363798763|FG000|Overall Study|Physician Decision|0|||
105488154|NCT03324581|363798764|FG001|Overall Study|Physician Decision|1|||
105488155|NCT03324581|363798765|FG002|Overall Study|Physician Decision|2|||
105488156|NCT03324581|363798763|FG000|Overall Study|Protocol Deviation|8|||
105488157|NCT03324581|363798764|FG001|Overall Study|Protocol Deviation|9|||
105488158|NCT03324581|363798765|FG002|Overall Study|Protocol Deviation|4|||
105488159|NCT03324581|363798763|FG000|Overall Study|Withdrawal by Subject|6|||
105488160|NCT03324581|363798764|FG001|Overall Study|Withdrawal by Subject|8|||
105488161|NCT03324581|363798765|FG002|Overall Study|Withdrawal by Subject|6|||
105488162|NCT03324581|363798763|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
105488163|NCT03324581|363798764|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
105488164|NCT03324581|363798765|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
105488165|NCT00821327|363798766|FG000|Overall Study|Adverse Event|13|||
105488166|NCT00821327|363798766|FG000|Overall Study|Patient Request|1|||
105488167|NCT00821327|363798766|FG000|Overall Study|Investigator Request|2|||
105573449|NCT04498247|364098519|FG000|Overall Study|Lost to Follow-up|0|||
105573450|NCT04498247|364098520|FG001|Overall Study|Lost to Follow-up|0|||
105573451|NCT04498247|364098521|FG002|Overall Study|Lost to Follow-up|0|||
105573452|NCT04498247|364098522|FG003|Overall Study|Lost to Follow-up|1|||
105573453|NCT04498247|364098523|FG004|Overall Study|Lost to Follow-up|0|||
105573454|NCT04498247|364098524|FG005|Overall Study|Lost to Follow-up|0|||
105573455|NCT04498247|364098525|FG006|Overall Study|Lost to Follow-up|0|||
105573456|NCT04498247|364098526|FG007|Overall Study|Lost to Follow-up|0|||
105573457|NCT04498247|364098519|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
105573458|NCT04498247|364098520|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
105573459|NCT04498247|364098521|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
105573460|NCT04498247|364098522|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
105573461|NCT04498247|364098523|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
105573462|NCT04498247|364098524|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
105573463|NCT04498247|364098525|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
105573464|NCT04498247|364098526|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
105573465|NCT04498247|364098519|FG000|Overall Study|Withdrawal by Subject|0|||
105573466|NCT04498247|364098520|FG001|Overall Study|Withdrawal by Subject|8|||
105573467|NCT04498247|364098521|FG002|Overall Study|Withdrawal by Subject|0|||
105573468|NCT04498247|364098522|FG003|Overall Study|Withdrawal by Subject|7|||
105573469|NCT04498247|364098523|FG004|Overall Study|Withdrawal by Subject|0|||
105573470|NCT04498247|364098524|FG005|Overall Study|Withdrawal by Subject|0|||
105366184|NCT01663402|363346595|FG001|Overall Study|Adverse Event|362|||
105573471|NCT04498247|364098525|FG006|Overall Study|Withdrawal by Subject|1|||
105573472|NCT04498247|364098526|FG007|Overall Study|Withdrawal by Subject|0|||
105573473|NCT04498247|364098519|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
105573474|NCT04498247|364098520|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
105573475|NCT04498247|364098521|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
105488168|NCT00821327|363798766|FG000|Overall Study|Sponsor Request|1|||
105488169|NCT00821327|363798766|FG000|Overall Study|Disease Progression|13|||
105488170|NCT00821327|363798766|FG000|Overall Study|Other/Unknown|5|||
105573476|NCT04498247|364098522|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
105573477|NCT04498247|364098523|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
105573478|NCT04498247|364098524|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
105573479|NCT04498247|364098525|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
105573480|NCT04498247|364098526|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
105573481|NCT00192023|364098527|FG000|Period III - Double-Blind|Adverse Event|3|||
105573482|NCT00192023|364098528|FG001|Period III - Double-Blind|Adverse Event|0|||
105573483|NCT00192023|364098527|FG000|Period III - Double-Blind|Physician Decision|2|||
105573484|NCT00192023|364098528|FG001|Period III - Double-Blind|Physician Decision|0|||
105573485|NCT00192023|364098527|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
105573486|NCT00192023|364098528|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
105573487|NCT00192023|364098527|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
105573488|NCT00192023|364098528|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
105573489|NCT00192023|364098527|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
105573490|NCT00192023|364098528|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
105573491|NCT00192023|364098527|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
105573492|NCT00192023|364098528|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
105573493|NCT00192023|364098527|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
105573494|NCT00192023|364098528|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
105573495|NCT00192023|364098527|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
105573496|NCT00192023|364098528|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
105573497|NCT00192023|364098527|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
105573498|NCT00192023|364098528|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
105488171|NCT03783702|363798767|FG000|Overall Study|Lost to Follow-up|6|||
105488172|NCT03783702|363798768|FG001|Overall Study|Lost to Follow-up|8|||
105488173|NCT03783702|363798767|FG000|Overall Study|Protocol Violation|1|||
105488174|NCT03783702|363798768|FG001|Overall Study|Protocol Violation|3|||
105488175|NCT02274038|363798769|FG000|Overall Study|Death|1|||
105488176|NCT02942576|363798771|FG000|Overall Study|Adverse Event|28|||
105488177|NCT02942576|363798772|FG001|Overall Study|Adverse Event|6|||
105488178|NCT02942576|363798771|FG000|Overall Study|Withdrawal by Subject|7|||
105488179|NCT02942576|363798772|FG001|Overall Study|Withdrawal by Subject|5|||
105488180|NCT02942576|363798771|FG000|Overall Study|Physician Decision|1|||
105488181|NCT02942576|363798772|FG001|Overall Study|Physician Decision|4|||
105488182|NCT02942576|363798771|FG000|Overall Study|Other|10|||
105488183|NCT02942576|363798772|FG001|Overall Study|Other|8|||
105488184|NCT04473482|363798773|FG000|Overall Study|Death|0|||
105488185|NCT04473482|363798774|FG001|Overall Study|Death|3|||
105488186|NCT04473482|363798773|FG000|Overall Study|Lost to Follow-up|9|||
105488187|NCT04473482|363798774|FG001|Overall Study|Lost to Follow-up|7|||
105488188|NCT04473482|363798773|FG000|Overall Study|Withdrawal by Subject|2|||
105488189|NCT04473482|363798774|FG001|Overall Study|Withdrawal by Subject|1|||
105488190|NCT00459979|363798777|FG000|Overall Study|Withdrawal by Subject|1|||
105488191|NCT00459979|363798777|FG000|Overall Study|Protocol Violation|1|||
105488192|NCT00999921|363798778|FG000|Overall Study|Lost to Follow-up|10|||
105488193|NCT00999921|363798779|FG001|Overall Study|Lost to Follow-up|19|||
105488194|NCT00772070|363798780|FG000|Overall Study|Lost to Follow-up|0|||
105488195|NCT00772070|363798781|FG001|Overall Study|Lost to Follow-up|8|||
105488196|NCT00772070|363798780|FG000|Overall Study|Withdrawal by Subject|0|||
105488197|NCT00772070|363798781|FG001|Overall Study|Withdrawal by Subject|2|||
105488198|NCT00772070|363798780|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
105488199|NCT00772070|363798781|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
105488200|NCT02730208|363798785|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
105488201|NCT02730208|363798786|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
105488202|NCT00510952|363798790|FG000|Overall Study|Adverse Event|1|||
105488203|NCT00510952|363798791|FG001|Overall Study|Adverse Event|0|||
105488204|NCT00510952|363798790|FG000|Overall Study|Entry Criteria Not Met|3|||
105488205|NCT00510952|363798791|FG001|Overall Study|Entry Criteria Not Met|1|||
105573499|NCT00192023|364098527|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
105573500|NCT00192023|364098528|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
105573501|NCT00669903|364098529|FG000|Overall Study|Adverse Event|0|||
105488206|NCT00510952|363798790|FG000|Overall Study|Lost to Follow-up|5|||
105488207|NCT00510952|363798791|FG001|Overall Study|Lost to Follow-up|3|||
105488208|NCT00510952|363798790|FG000|Overall Study|Physician Decision|1|||
105488209|NCT00510952|363798791|FG001|Overall Study|Physician Decision|1|||
105488210|NCT00510952|363798790|FG000|Overall Study|Protocol Violation|7|||
105488211|NCT00510952|363798791|FG001|Overall Study|Protocol Violation|4|||
105488212|NCT00510952|363798790|FG000|Overall Study|Sponsor Decision|1|||
105488213|NCT00510952|363798791|FG001|Overall Study|Sponsor Decision|0|||
105488214|NCT00510952|363798790|FG000|Overall Study|Withdrawal by Subject|6|||
105488215|NCT00510952|363798791|FG001|Overall Study|Withdrawal by Subject|7|||
105488216|NCT00510952|363798790|FG000|Overall Study|Did Not Receive Study Drug|2|||
105488217|NCT00510952|363798791|FG001|Overall Study|Did Not Receive Study Drug|0|||
105488218|NCT01931202|363798793|FG000|Overall Study|Withdrawal by Subject|0|||
105488219|NCT01931202|363798794|FG001|Overall Study|Withdrawal by Subject|0|||
105488220|NCT01931202|363798795|FG002|Overall Study|Withdrawal by Subject|2|||
105488221|NCT01931202|363798793|FG000|Overall Study|Lost to Follow-up|0|||
105488222|NCT01931202|363798794|FG001|Overall Study|Lost to Follow-up|5|||
105488223|NCT01931202|363798795|FG002|Overall Study|Lost to Follow-up|2|||
105488224|NCT00458536|363798796|FG000|Overall Study|Disease progression prior to treatment|7|||
105573502|NCT00669903|364098530|FG001|Overall Study|Adverse Event|1|||
105573503|NCT00669903|364098531|FG002|Overall Study|Adverse Event|3|||
105573504|NCT00669903|364098532|FG003|Overall Study|Adverse Event|1|||
105573505|NCT00669903|364098529|FG000|Overall Study|Withdrawal by Subject|0|||
105573506|NCT00669903|364098530|FG001|Overall Study|Withdrawal by Subject|2|||
105573507|NCT00669903|364098531|FG002|Overall Study|Withdrawal by Subject|2|||
105573508|NCT00669903|364098532|FG003|Overall Study|Withdrawal by Subject|2|||
105573509|NCT00669903|364098529|FG000|Overall Study|Lost to Follow-up|1|||
105573510|NCT00669903|364098530|FG001|Overall Study|Lost to Follow-up|1|||
105573511|NCT00669903|364098531|FG002|Overall Study|Lost to Follow-up|0|||
105573512|NCT00669903|364098532|FG003|Overall Study|Lost to Follow-up|1|||
105573513|NCT00669903|364098529|FG000|Overall Study|Protocol Violation|0|||
105573514|NCT00669903|364098530|FG001|Overall Study|Protocol Violation|1|||
105573515|NCT00669903|364098531|FG002|Overall Study|Protocol Violation|0|||
105573516|NCT00669903|364098532|FG003|Overall Study|Protocol Violation|0|||
105573517|NCT00779584|364098533|FG000|Overall Study|Protocol Violation|0|||
105573518|NCT00779584|364098534|FG001|Overall Study|Protocol Violation|0|||
105573519|NCT00779584|364098535|FG002|Overall Study|Protocol Violation|0|||
105573520|NCT00779584|364098536|FG003|Overall Study|Protocol Violation|0|||
105573521|NCT00779584|364098537|FG004|Overall Study|Protocol Violation|0|||
105573522|NCT00779584|364098538|FG005|Overall Study|Protocol Violation|1|||
105573523|NCT00779584|364098539|FG006|Overall Study|Protocol Violation|0|||
105573524|NCT00779584|364098540|FG007|Overall Study|Protocol Violation|0|||
105573525|NCT00779584|364098541|FG008|Overall Study|Protocol Violation|0|||
105573526|NCT00779584|364098533|FG000|Overall Study|Withdrawal by Subject|1|||
105573527|NCT00779584|364098534|FG001|Overall Study|Withdrawal by Subject|1|||
105573528|NCT00779584|364098535|FG002|Overall Study|Withdrawal by Subject|2|||
105573529|NCT00779584|364098536|FG003|Overall Study|Withdrawal by Subject|0|||
105573530|NCT00779584|364098537|FG004|Overall Study|Withdrawal by Subject|0|||
105573531|NCT00779584|364098538|FG005|Overall Study|Withdrawal by Subject|2|||
105573532|NCT00779584|364098539|FG006|Overall Study|Withdrawal by Subject|1|||
105573533|NCT00779584|364098540|FG007|Overall Study|Withdrawal by Subject|0|||
105573534|NCT00779584|364098541|FG008|Overall Study|Withdrawal by Subject|0|||
105573535|NCT00779584|364098533|FG000|Overall Study|Lost to Follow-up|0|||
105573536|NCT00779584|364098534|FG001|Overall Study|Lost to Follow-up|0|||
105573537|NCT00779584|364098535|FG002|Overall Study|Lost to Follow-up|0|||
105573538|NCT00779584|364098536|FG003|Overall Study|Lost to Follow-up|0|||
105573539|NCT00779584|364098537|FG004|Overall Study|Lost to Follow-up|1|||
105573540|NCT00779584|364098538|FG005|Overall Study|Lost to Follow-up|0|||
105573541|NCT00779584|364098539|FG006|Overall Study|Lost to Follow-up|0|||
105573542|NCT00779584|364098540|FG007|Overall Study|Lost to Follow-up|0|||
105573543|NCT00779584|364098541|FG008|Overall Study|Lost to Follow-up|0|||
105573544|NCT00779584|364098533|FG000|Overall Study|Progression of Disease|0|||
105573545|NCT00779584|364098534|FG001|Overall Study|Progression of Disease|1|||
105573546|NCT00779584|364098535|FG002|Overall Study|Progression of Disease|2|||
105573547|NCT00779584|364098536|FG003|Overall Study|Progression of Disease|6|||
105573548|NCT00779584|364098537|FG004|Overall Study|Progression of Disease|5|||
105573549|NCT00779584|364098538|FG005|Overall Study|Progression of Disease|1|||
105573550|NCT00779584|364098539|FG006|Overall Study|Progression of Disease|4|||
105573551|NCT00779584|364098540|FG007|Overall Study|Progression of Disease|2|||
105573552|NCT00779584|364098541|FG008|Overall Study|Progression of Disease|1|||
105573553|NCT00779584|364098533|FG000|Overall Study|Adverse Event|1|||
105573554|NCT00779584|364098534|FG001|Overall Study|Adverse Event|0|||
105573555|NCT00779584|364098535|FG002|Overall Study|Adverse Event|2|||
105573556|NCT00779584|364098536|FG003|Overall Study|Adverse Event|0|||
105573557|NCT00779584|364098537|FG004|Overall Study|Adverse Event|0|||
105573558|NCT00779584|364098538|FG005|Overall Study|Adverse Event|0|||
105573559|NCT00779584|364098539|FG006|Overall Study|Adverse Event|2|||
105573560|NCT00779584|364098540|FG007|Overall Study|Adverse Event|1|||
105573561|NCT00779584|364098541|FG008|Overall Study|Adverse Event|1|||
105573562|NCT00779584|364098533|FG000|Overall Study|Symptomatic Deterioration|1|||
105573563|NCT00779584|364098534|FG001|Overall Study|Symptomatic Deterioration|1|||
105573564|NCT00779584|364098535|FG002|Overall Study|Symptomatic Deterioration|1|||
105573565|NCT00779584|364098536|FG003|Overall Study|Symptomatic Deterioration|0|||
105573566|NCT00779584|364098537|FG004|Overall Study|Symptomatic Deterioration|0|||
105573567|NCT00779584|364098538|FG005|Overall Study|Symptomatic Deterioration|1|||
105488225|NCT00458536|363798796|FG000|Overall Study|Unable to make vaccine|3|||
105573568|NCT00779584|364098539|FG006|Overall Study|Symptomatic Deterioration|1|||
105573569|NCT00779584|364098540|FG007|Overall Study|Symptomatic Deterioration|0|||
105488226|NCT00458536|363798796|FG000|Overall Study|No measurable disease after surgery|2|||
105573570|NCT00779584|364098541|FG008|Overall Study|Symptomatic Deterioration|0|||
105573571|NCT00779584|364098533|FG000|Overall Study|Ongoing in Study|0|||
105826165|NCT01205035|365022034|FG000|Overall Study|Withdrawal by Subject|1|||
105826166|NCT01205035|365022035|FG001|Overall Study|Withdrawal by Subject|0|||
105826167|NCT01205035|365022034|FG000|Overall Study|Physician Decision|1|||
105573572|NCT00779584|364098534|FG001|Overall Study|Ongoing in Study|0|||
105826168|NCT01205035|365022035|FG001|Overall Study|Physician Decision|0|||
105826169|NCT02663349|365022039|FG000|Overall Study|Withdrawal by Subject|6|||
105826170|NCT03246503|365022040|FG000|Overall Study|Lost to Follow-up|23|||
105826171|NCT03246503|365022040|FG000|Overall Study|Withdrawal by Subject|20|||
105826172|NCT03246503|365022040|FG000|Overall Study|Physician Decision|5|||
105488227|NCT00458536|363798796|FG000|Overall Study|Did not have renal cell carcinoma|2|||
105488228|NCT00458536|363798796|FG000|Overall Study|Patient did not have surgery|1|||
105488229|NCT00458536|363798796|FG000|Overall Study|Ineligible due to toxicity|1|||
105488230|NCT00458536|363798796|FG000|Overall Study|Withdrawal by Subject|1|||
105488231|NCT00458536|363798796|FG000|Overall Study|Progressive disease during treatment|2|||
105488232|NCT02003365|363800347|FG000|Overall Study|Lost to Follow-up|0|||
105488233|NCT02003365|363800348|FG001|Overall Study|Lost to Follow-up|0|||
105488234|NCT02003365|363800349|FG002|Overall Study|Lost to Follow-up|1|||
105488235|NCT00543855|363800356|FG000|Overall Study|Adverse Event|3|||
105488236|NCT00543855|363800357|FG001|Overall Study|Adverse Event|1|||
105488237|NCT00543855|363800358|FG002|Overall Study|Adverse Event|3|||
105488238|NCT00543855|363800359|FG003|Overall Study|Adverse Event|4|||
105488239|NCT00543855|363800356|FG000|Overall Study|Lost to Follow-up|0|||
105488240|NCT00543855|363800357|FG001|Overall Study|Lost to Follow-up|0|||
105488241|NCT00543855|363800358|FG002|Overall Study|Lost to Follow-up|1|||
105488242|NCT00543855|363800359|FG003|Overall Study|Lost to Follow-up|0|||
105488243|NCT00543855|363800356|FG000|Overall Study|Withdrawal by Subject|0|||
105488244|NCT00543855|363800357|FG001|Overall Study|Withdrawal by Subject|1|||
105488245|NCT00543855|363800358|FG002|Overall Study|Withdrawal by Subject|2|||
105488246|NCT00543855|363800359|FG003|Overall Study|Withdrawal by Subject|0|||
105488247|NCT00543855|363800356|FG000|Overall Study|Protocol Violation|1|||
105488248|NCT00543855|363800357|FG001|Overall Study|Protocol Violation|0|||
105488249|NCT00543855|363800358|FG002|Overall Study|Protocol Violation|0|||
105488250|NCT00543855|363800359|FG003|Overall Study|Protocol Violation|0|||
105488251|NCT04285580|363800360|FG000|Overall Study|Protocol Violation|0|||
105488252|NCT04285580|363800361|FG001|Overall Study|Protocol Violation|1|||
105488253|NCT00622739|363800362|FG000|Overall Study|Physician Decision|1|||
105488254|NCT00622739|363800363|FG001|Overall Study|Physician Decision|0|||
105488255|NCT00622739|363800362|FG000|Overall Study|Adverse Event|1|||
105488256|NCT00622739|363800363|FG001|Overall Study|Adverse Event|2|||
105488257|NCT00622739|363800362|FG000|Overall Study|Lack of Efficacy|0|||
105488258|NCT00622739|363800363|FG001|Overall Study|Lack of Efficacy|2|||
105488259|NCT00622739|363800362|FG000|Overall Study|Withdrawal by Subject|0|||
105488260|NCT00622739|363800363|FG001|Overall Study|Withdrawal by Subject|1|||
105488261|NCT00622739|363800362|FG000|Overall Study|Lost to Follow-up|0|||
105488262|NCT00622739|363800363|FG001|Overall Study|Lost to Follow-up|1|||
105488263|NCT00562627|363800364|FG000|Overall Study|Protocol Violation|1|||
105488264|NCT00562627|363800365|FG001|Overall Study|Protocol Violation|1|||
105488265|NCT00562627|363800366|FG002|Overall Study|Protocol Violation|1|||
105488266|NCT04099251|363800367|FG000|Pre-Treatment|Other reasons|1|||
105488267|NCT04099251|363800368|FG001|Pre-Treatment|Other reasons|0|||
105488268|NCT04099251|363800367|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
105488269|NCT04099251|363800368|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
105488270|NCT04099251|363800367|FG000|Blinded Treatment Phase|Other reasons|16|||
105488271|NCT04099251|363800368|FG001|Blinded Treatment Phase|Other reasons|7|||
105488272|NCT04099251|363800367|FG000|Blinded Treatment Phase|Disease recurrence|26|||
105488273|NCT04099251|363800368|FG001|Blinded Treatment Phase|Disease recurrence|41|||
105488274|NCT04099251|363800367|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
105488275|NCT04099251|363800368|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
105488276|NCT04099251|363800367|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
105488277|NCT04099251|363800368|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
105488278|NCT04099251|363800367|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
105488279|NCT04099251|363800368|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
105488280|NCT04099251|363800367|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
105488281|NCT04099251|363800368|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
105488282|NCT04099251|363800367|FG000|Blinded Treatment Phase|Death|6|||
105488283|NCT04099251|363800368|FG001|Blinded Treatment Phase|Death|2|||
105573573|NCT00779584|364098535|FG002|Overall Study|Ongoing in Study|0|||
105488284|NCT04099251|363800367|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
105488285|NCT04099251|363800368|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
105488286|NCT04099251|363800367|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
105488287|NCT04099251|363800368|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
105488288|NCT04099251|363800367|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
105366185|NCT01663402|363346594|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
105366186|NCT01663402|363346595|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
105366187|NCT01663402|363346594|FG000|Overall Study|Poor compliance to protocol|529|||
105366188|NCT01663402|363346595|FG001|Overall Study|Poor compliance to protocol|454|||
105366189|NCT01663402|363346594|FG000|Overall Study|Physician Decision|77|||
105366190|NCT01663402|363346595|FG001|Overall Study|Physician Decision|62|||
105366191|NCT01663402|363346594|FG000|Overall Study|Site terminated by sponsor|1|||
105573574|NCT00779584|364098536|FG003|Overall Study|Ongoing in Study|0|||
105826173|NCT03246503|365022040|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
105826174|NCT03206749|365022041|FG000|Overall Study|Withdrawal of consent|5|||
105826175|NCT03206749|365022042|FG001|Overall Study|Withdrawal of consent|3|||
105573575|NCT00779584|364098537|FG004|Overall Study|Ongoing in Study|1|||
105573576|NCT00779584|364098538|FG005|Overall Study|Ongoing in Study|1|||
105573577|NCT00779584|364098539|FG006|Overall Study|Ongoing in Study|0|||
105573578|NCT00779584|364098540|FG007|Overall Study|Ongoing in Study|0|||
105573579|NCT00779584|364098541|FG008|Overall Study|Ongoing in Study|0|||
105573580|NCT01003639|364098544|FG000|Overall Study|Lost to Follow-up|6|||
105573581|NCT01003639|364098545|FG001|Overall Study|Lost to Follow-up|9|||
105573582|NCT01003639|364098544|FG000|Overall Study|Withdrawal by Subject|9|||
105573583|NCT01003639|364098545|FG001|Overall Study|Withdrawal by Subject|5|||
105573584|NCT01003639|364098544|FG000|Overall Study|Lack of Efficacy|1|||
105573585|NCT01003639|364098545|FG001|Overall Study|Lack of Efficacy|6|||
105573586|NCT01003639|364098544|FG000|Overall Study|Adverse Event|0|||
105573587|NCT01003639|364098545|FG001|Overall Study|Adverse Event|1|||
105573588|NCT01003639|364098544|FG000|Overall Study|Protocol Violation|0|||
105573589|NCT01003639|364098545|FG001|Overall Study|Protocol Violation|1|||
105573590|NCT01003639|364098544|FG000|Overall Study|Physician Decision|1|||
105573591|NCT01003639|364098545|FG001|Overall Study|Physician Decision|0|||
105573592|NCT04986982|364098549|FG000|Overall Study|Withdrawal by Subject|3|||
105573593|NCT04986982|364098550|FG001|Overall Study|Withdrawal by Subject|1|||
105573594|NCT04986982|364098549|FG000|Overall Study|Lack of Efficacy|0|||
105573595|NCT04986982|364098550|FG001|Overall Study|Lack of Efficacy|2|||
105573596|NCT04986982|364098549|FG000|Overall Study|Ineligibility|3|||
105573597|NCT04986982|364098550|FG001|Overall Study|Ineligibility|0|||
105573598|NCT04986982|364098549|FG000|Overall Study|Adverse Event|4|||
105573599|NCT04986982|364098550|FG001|Overall Study|Adverse Event|4|||
105573600|NCT04986982|364098549|FG000|Overall Study|Lost to Follow-up|0|||
105573601|NCT04986982|364098550|FG001|Overall Study|Lost to Follow-up|1|||
105573602|NCT04986982|364098549|FG000|Overall Study|Sponsor's discretion|1|||
105573603|NCT04986982|364098550|FG001|Overall Study|Sponsor's discretion|0|||
105573604|NCT01535274|364098551|FG000|Overall Study|Determined to be ineligible|0|||
105573605|NCT01535274|364098552|FG001|Overall Study|Determined to be ineligible|1|||
105573606|NCT01535274|364098551|FG000|Overall Study|Misallocated to propofol intervention|0|||
105573607|NCT01535274|364098552|FG001|Overall Study|Misallocated to propofol intervention|1|||
105573608|NCT04186403|364098553|FG000|Overall Study|Adverse Event|1|||
105573609|NCT04186403|364098554|FG001|Overall Study|Adverse Event|8|||
105573610|NCT04186403|364098553|FG000|Overall Study|Lost to Follow-up|7|||
105573611|NCT04186403|364098554|FG001|Overall Study|Lost to Follow-up|3|||
105573612|NCT04186403|364098553|FG000|Overall Study|Physician Decision|1|||
105573613|NCT04186403|364098554|FG001|Overall Study|Physician Decision|0|||
105573614|NCT04186403|364098553|FG000|Overall Study|Withdrawal by Subject|7|||
105573615|NCT04186403|364098554|FG001|Overall Study|Withdrawal by Subject|8|||
105573616|NCT04186403|364098553|FG000|Overall Study|Other: Not Related to Covid-19|3|||
105573617|NCT04186403|364098554|FG001|Overall Study|Other: Not Related to Covid-19|0|||
105573618|NCT01407354|364098558|FG000|First Intervention|Withdrawal by Subject|0|||
105573619|NCT01407354|364098559|FG001|First Intervention|Withdrawal by Subject|2|||
105573620|NCT01407354|364098558|FG000|First Intervention|Adverse Event|1|||
105573621|NCT01407354|364098559|FG001|First Intervention|Adverse Event|0|||
105573622|NCT01407354|364098558|FG000|First Intervention|Physician Decision|1|||
105573623|NCT01407354|364098559|FG001|First Intervention|Physician Decision|0|||
105573624|NCT02778399|364098561|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
105573625|NCT02778399|364098562|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
105573626|NCT02778399|364098563|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
105573627|NCT02778399|364098564|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
105573628|NCT02778399|364098565|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
105366192|NCT01663402|363346595|FG001|Overall Study|Site terminated by sponsor|3|||
105573629|NCT02778399|364098566|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
105768644|NCT03039790|364804476|FG008|Overall Study|Death|0|||
105768645|NCT03039790|364804477|FG009|Overall Study|Death|0|||
105768646|NCT03039790|364804478|FG010|Overall Study|Death|0|||
105768647|NCT03039790|364804479|FG011|Overall Study|Death|0|||
105768648|NCT03039790|364804480|FG012|Overall Study|Death|0|||
105768649|NCT03039790|364804481|FG013|Overall Study|Death|0|||
105768650|NCT03039790|364804482|FG014|Overall Study|Death|0|||
105768651|NCT03039790|364804483|FG015|Overall Study|Death|1|||
105768652|NCT03039790|364804484|FG016|Overall Study|Death|3|||
105768653|NCT03039790|364804485|FG017|Overall Study|Death|0|||
105573630|NCT02778399|364098561|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
105573631|NCT02778399|364098562|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
105573632|NCT02778399|364098563|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
105573633|NCT02778399|364098564|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
105573634|NCT02778399|364098565|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
105573635|NCT02778399|364098566|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
105826176|NCT03206749|365022043|FG002|Overall Study|Withdrawal of consent|6|||
105826177|NCT03206749|365022041|FG000|Overall Study|Lost to Follow-up|0|||
105826178|NCT03206749|365022042|FG001|Overall Study|Lost to Follow-up|0|||
105826179|NCT03206749|365022043|FG002|Overall Study|Lost to Follow-up|1|||
105826180|NCT01492439|365022044|FG000|Overall Study|Withdrew from RTE|4|||
105826181|NCT01492439|365022045|FG001|Overall Study|Withdrew from RTE|9|||
105826182|NCT00716625|365022046|FG000|Overall Study|Safety was not Assessable|1|||
105826183|NCT00933686|365022048|FG000|Overall Study|Protocol Violation|0|||
105826184|NCT00933686|365022049|FG001|Overall Study|Protocol Violation|1|||
105826185|NCT00933686|365022048|FG000|Overall Study|Lost to Follow-up|2|||
105826186|NCT00933686|365022049|FG001|Overall Study|Lost to Follow-up|2|||
105826187|NCT00933686|365022048|FG000|Overall Study|Withdrawal by Subject|6|||
105826188|NCT00933686|365022049|FG001|Overall Study|Withdrawal by Subject|5|||
105826189|NCT00933686|365022048|FG000|Overall Study|Adverse Event|1|||
105573636|NCT02778399|364098561|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
105573637|NCT02778399|364098562|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
105573638|NCT02778399|364098563|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
105573639|NCT02778399|364098564|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
105573640|NCT02778399|364098565|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
105573641|NCT02778399|364098566|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
105573642|NCT02778399|364098561|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
105573643|NCT02778399|364098562|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
105573644|NCT02778399|364098563|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
105573645|NCT02778399|364098564|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
105573646|NCT02778399|364098565|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
105573647|NCT02778399|364098566|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
105573648|NCT02778399|364098561|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
105573649|NCT02778399|364098562|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
105573650|NCT02778399|364098563|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
105573651|NCT02778399|364098564|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
105573652|NCT02778399|364098565|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
105573653|NCT02778399|364098566|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
105573654|NCT02778399|364098561|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
105573655|NCT02778399|364098562|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
105573656|NCT02778399|364098563|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
105573657|NCT02778399|364098564|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
105573658|NCT02778399|364098565|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
105573659|NCT02778399|364098566|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
105573660|NCT02778399|364098561|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
105573661|NCT02778399|364098562|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
105573662|NCT02778399|364098563|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
105573663|NCT02778399|364098564|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
105573664|NCT02778399|364098565|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
105573665|NCT02778399|364098566|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
105573666|NCT02778399|364098561|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
105573667|NCT02778399|364098562|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
105573668|NCT02778399|364098563|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
105573669|NCT02778399|364098564|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
105573670|NCT02778399|364098565|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
105573671|NCT02778399|364098566|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
105573672|NCT02778399|364098561|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
105573673|NCT02778399|364098562|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
105573674|NCT02778399|364098563|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
105573675|NCT02778399|364098564|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
105573676|NCT02778399|364098565|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
105573677|NCT02778399|364098566|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
105573678|NCT02778399|364098561|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
105573679|NCT02778399|364098562|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
105826190|NCT00933686|365022049|FG001|Overall Study|Adverse Event|1|||
105573680|NCT02778399|364098563|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
105573681|NCT02778399|364098564|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
105573682|NCT02778399|364098565|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
105573683|NCT02778399|364098566|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
105573684|NCT02778399|364098561|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
105573685|NCT02778399|364098562|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
105573686|NCT02778399|364098563|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
105573687|NCT02778399|364098564|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
105573688|NCT02778399|364098565|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
105573689|NCT02778399|364098566|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
105573690|NCT02009696|364098568|FG000|Overall Study|Withdrawal by Subject|2|||
105573691|NCT02302066|364098570|FG000|Overall Study|Adverse Event|1|||
105573692|NCT02302066|364098571|FG001|Overall Study|Adverse Event|1|||
105573693|NCT02302066|364098572|FG002|Overall Study|Adverse Event|3|||
105573694|NCT02302066|364098573|FG003|Overall Study|Adverse Event|0|||
105573695|NCT02302066|364098570|FG000|Overall Study|Lost to Follow-up|4|||
105573696|NCT02302066|364098571|FG001|Overall Study|Lost to Follow-up|5|||
105573697|NCT02302066|364098572|FG002|Overall Study|Lost to Follow-up|24|||
105573698|NCT02302066|364098573|FG003|Overall Study|Lost to Follow-up|7|||
105573699|NCT02302066|364098570|FG000|Overall Study|Withdrawal by Subject|25|||
105573700|NCT02302066|364098571|FG001|Overall Study|Withdrawal by Subject|58|||
105573701|NCT02302066|364098572|FG002|Overall Study|Withdrawal by Subject|124|||
105573702|NCT02302066|364098573|FG003|Overall Study|Withdrawal by Subject|33|||
105573703|NCT02302066|364098570|FG000|Overall Study|Pregnancy|2|||
105573704|NCT02302066|364098571|FG001|Overall Study|Pregnancy|10|||
105573705|NCT02302066|364098572|FG002|Overall Study|Pregnancy|12|||
105366193|NCT01663402|363346594|FG000|Overall Study|Participant moved|139|||
105366194|NCT01663402|363346595|FG001|Overall Study|Participant moved|104|||
105366195|NCT01663402|363346594|FG000|Overall Study|Withdrawal by Subject|118|||
105366196|NCT01663402|363346595|FG001|Overall Study|Withdrawal by Subject|91|||
105366197|NCT01663402|363346594|FG000|Overall Study|Related to study drug administration|96|||
105366198|NCT01663402|363346595|FG001|Overall Study|Related to study drug administration|105|||
105366199|NCT01663402|363346594|FG000|Overall Study|Lost to Follow-up|17|||
105366200|NCT01663402|363346595|FG001|Overall Study|Lost to Follow-up|15|||
105366201|NCT01663402|363346594|FG000|Overall Study|Other than specified above|172|||
105366202|NCT01663402|363346595|FG001|Overall Study|Other than specified above|147|||
105366203|NCT03903172|363346600|FG000|Overall Study|screen fail|4|||
105366204|NCT03903172|363346601|FG001|Overall Study|screen fail|1|||
105366205|NCT00661089|363346602|FG000|Overall Study|1 subject withdrawal|0|||
105366206|NCT00661089|363346603|FG001|Overall Study|1 subject withdrawal|1|||
105366207|NCT00661089|363346602|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
105366208|NCT00661089|363346603|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
105366209|NCT01701245|363346605|FG000|Overall Study|Protocol Violation|1|||
105366210|NCT01701245|363346606|FG001|Overall Study|Protocol Violation|3|||
105366211|NCT01701245|363346605|FG000|Overall Study|Did not complete the open label period|11|||
105366212|NCT01701245|363346606|FG001|Overall Study|Did not complete the open label period|12|||
105366213|NCT00274742|363346607|FG000|Overall Study|Adverse Event|0|||
105366214|NCT00274742|363346608|FG001|Overall Study|Adverse Event|4|||
105573706|NCT02302066|364098573|FG003|Overall Study|Pregnancy|0|||
105573707|NCT02302066|364098570|FG000|Overall Study|Reason Not Specified|1|||
105573708|NCT02302066|364098571|FG001|Overall Study|Reason Not Specified|1|||
105573709|NCT02302066|364098572|FG002|Overall Study|Reason Not Specified|9|||
105573710|NCT02302066|364098573|FG003|Overall Study|Reason Not Specified|1|||
105573711|NCT00960752|364098574|FG000|Overall Study|Adverse Event|0|||
105573712|NCT00960752|364098575|FG001|Overall Study|Adverse Event|0|||
105573713|NCT00960752|364098576|FG002|Overall Study|Adverse Event|1|||
105573714|NCT00960752|364098574|FG000|Overall Study|Progression|0|||
105573715|NCT00960752|364098575|FG001|Overall Study|Progression|0|||
105573716|NCT00960752|364098576|FG002|Overall Study|Progression|1|||
105573717|NCT00447954|364098577|FG000|Overall Study|Adverse Event|0|||
105573718|NCT00447954|364098578|FG001|Overall Study|Adverse Event|2|||
105826191|NCT00933686|365022048|FG000|Overall Study|Physician Decision|1|||
105826192|NCT00933686|365022049|FG001|Overall Study|Physician Decision|0|||
105826193|NCT00933686|365022048|FG000|Overall Study|Failure to show up at endpoint visits|0|||
105826194|NCT00933686|365022049|FG001|Overall Study|Failure to show up at endpoint visits|2|||
105826195|NCT00927069|365022062|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
105826196|NCT00927069|365022063|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
105366215|NCT00274742|363346609|FG002|Overall Study|Adverse Event|1|||
105366216|NCT00274742|363346610|FG003|Overall Study|Adverse Event|4|||
105573719|NCT00447954|364098579|FG002|Overall Study|Adverse Event|0|||
105573720|NCT00447954|364098577|FG000|Overall Study|Withdrawal by Subject|0|||
105573721|NCT00447954|364098578|FG001|Overall Study|Withdrawal by Subject|1|||
105573722|NCT00447954|364098579|FG002|Overall Study|Withdrawal by Subject|1|||
105573723|NCT00447954|364098577|FG000|Overall Study|Lost to Follow-up|0|||
105366217|NCT00274742|363346611|FG004|Overall Study|Adverse Event|12|||
105366218|NCT00274742|363346612|FG005|Overall Study|Adverse Event|3|||
105573724|NCT00447954|364098578|FG001|Overall Study|Lost to Follow-up|1|||
105573725|NCT00447954|364098579|FG002|Overall Study|Lost to Follow-up|0|||
105488289|NCT04099251|363800368|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
105488290|NCT04099251|363800367|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
105488291|NCT04099251|363800368|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
105488292|NCT04099251|363800367|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
105488293|NCT04099251|363800368|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
105488294|NCT04099251|363800367|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
105488295|NCT04099251|363800368|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
105488296|NCT04099251|363800367|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
105488297|NCT04099251|363800368|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
105488298|NCT04099251|363800367|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
105488299|NCT04099251|363800368|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
105488300|NCT04099251|363800367|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
105488301|NCT04099251|363800368|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
105488302|NCT01107418|363800369|FG000|Overall Study|Disease Progression|45|||
105826197|NCT00927069|365022064|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
105826198|NCT00927069|365022065|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
105366219|NCT00274742|363346607|FG000|Overall Study|Lost to Follow-up|0|||
105488303|NCT01107418|363800369|FG000|Overall Study|Adverse Event|3|||
105488304|NCT01107418|363800369|FG000|Overall Study|Withdrawal by Subject|1|||
105488305|NCT01107418|363800369|FG000|Overall Study|Study Closing|1|||
105488306|NCT01107418|363800369|FG000|Overall Study|Started Other Therapy|1|||
105488307|NCT01107418|363800369|FG000|Overall Study|Entered Extension Study|1|||
105488308|NCT00597701|363800370|FG000|Overall Study|Withdrawal by Subject|5|||
105488309|NCT00597701|363800371|FG001|Overall Study|Withdrawal by Subject|5|||
105488310|NCT00597701|363800370|FG000|Overall Study|Death|0|||
105488311|NCT00597701|363800371|FG001|Overall Study|Death|1|||
105488312|NCT00597701|363800370|FG000|Overall Study|Physician Decision|2|||
105488313|NCT00597701|363800371|FG001|Overall Study|Physician Decision|0|||
105488314|NCT00597701|363800370|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
105488315|NCT00597701|363800371|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
105488316|NCT00076024|363800372|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
105488317|NCT00076024|363800373|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
105488318|NCT00076024|363800374|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
105488319|NCT00076024|363800375|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
105488320|NCT00076024|363800372|FG000|Phase 1, Lead-in|Adverse Event|1|||
105488321|NCT00076024|363800373|FG001|Phase 1, Lead-in|Adverse Event|0|||
105488322|NCT00076024|363800374|FG002|Phase 1, Lead-in|Adverse Event|0|||
105488323|NCT00076024|363800375|FG003|Phase 1, Lead-in|Adverse Event|0|||
105488324|NCT00076024|363800372|FG000|Phase 1, Lead-in|Clinical progression|1|||
105488325|NCT00076024|363800373|FG001|Phase 1, Lead-in|Clinical progression|0|||
105488326|NCT00076024|363800374|FG002|Phase 1, Lead-in|Clinical progression|0|||
105488327|NCT00076024|363800375|FG003|Phase 1, Lead-in|Clinical progression|0|||
105488328|NCT00076024|363800372|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
105488329|NCT00076024|363800373|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
105488330|NCT00076024|363800374|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
105488331|NCT00076024|363800375|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
105488332|NCT00076024|363800372|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
105488333|NCT00076024|363800373|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
105488334|NCT00076024|363800374|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
105488335|NCT00076024|363800375|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
105488336|NCT00076024|363800372|FG000|Phase 2, Double-blind|Adverse Event|0|||
105488337|NCT00076024|363800373|FG001|Phase 2, Double-blind|Adverse Event|25|||
105488338|NCT00076024|363800374|FG002|Phase 2, Double-blind|Adverse Event|6|||
105488339|NCT00076024|363800375|FG003|Phase 2, Double-blind|Adverse Event|0|||
105488340|NCT00076024|363800372|FG000|Phase 2, Double-blind|Un-specified|0|||
105488341|NCT00076024|363800373|FG001|Phase 2, Double-blind|Un-specified|14|||
105488342|NCT00076024|363800374|FG002|Phase 2, Double-blind|Un-specified|6|||
105488343|NCT00076024|363800375|FG003|Phase 2, Double-blind|Un-specified|0|||
105488344|NCT00076024|363800372|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
105488345|NCT00076024|363800373|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
105488346|NCT00076024|363800374|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
105488347|NCT00076024|363800375|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
105488348|NCT00076024|363800372|FG000|Phase 2, Open-label|Adverse Event|0|||
105488349|NCT00076024|363800373|FG001|Phase 2, Open-label|Adverse Event|0|||
105488350|NCT00076024|363800374|FG002|Phase 2, Open-label|Adverse Event|0|||
105488351|NCT00076024|363800375|FG003|Phase 2, Open-label|Adverse Event|2|||
105488352|NCT00076024|363800372|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
105573726|NCT00447954|364098577|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
105573727|NCT00447954|364098578|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
105573728|NCT00447954|364098579|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
105573729|NCT02301156|364098580|FG000|Overall Study|Adverse Event|13|||
105573730|NCT02301156|364098581|FG001|Overall Study|Adverse Event|14|||
105573731|NCT02301156|364098580|FG000|Overall Study|Death|1|||
105573732|NCT02301156|364098581|FG001|Overall Study|Death|5|||
105573733|NCT02301156|364098580|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
105573734|NCT02301156|364098581|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
105826199|NCT00927069|365022062|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
105488353|NCT00076024|363800373|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
105573735|NCT02301156|364098580|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
105573736|NCT02301156|364098581|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
105573737|NCT02301156|364098580|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
105573738|NCT02301156|364098581|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
105573739|NCT02301156|364098580|FG000|Overall Study|Reason not Specified|6|||
105573740|NCT02301156|364098581|FG001|Overall Study|Reason not Specified|3|||
105573741|NCT04921969|364098593|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
105573742|NCT04921969|364098594|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
105573743|NCT04921969|364098595|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
105573744|NCT04921969|364098596|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
105573745|NCT04921969|364098597|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
105573746|NCT04921969|364098598|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
105573747|NCT04921969|364098599|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
105573748|NCT04921969|364098593|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
105573749|NCT04921969|364098594|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105573750|NCT04921969|364098595|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105573751|NCT04921969|364098596|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105573752|NCT04921969|364098597|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105573753|NCT04921969|364098598|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105573754|NCT04921969|364098599|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105573755|NCT04921969|364098593|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
105573756|NCT04921969|364098594|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
105573757|NCT04921969|364098595|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
105573758|NCT04921969|364098596|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105573759|NCT04921969|364098597|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105573760|NCT04921969|364098598|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105573761|NCT04921969|364098599|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105573762|NCT04921969|364098593|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
105573763|NCT04921969|364098594|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
105573764|NCT04921969|364098595|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
105573765|NCT04921969|364098596|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
105573766|NCT04921969|364098597|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
105488354|NCT00076024|363800374|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
105573767|NCT04921969|364098598|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
105573768|NCT04921969|364098599|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
105573769|NCT04921969|364098593|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
105573770|NCT04921969|364098594|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
105573771|NCT04921969|364098595|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
105573772|NCT04921969|364098596|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
105573773|NCT04921969|364098597|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
105573774|NCT04921969|364098598|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
105573775|NCT04921969|364098599|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
105573776|NCT04921969|364098593|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
105488355|NCT00076024|363800375|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
105573777|NCT04921969|364098594|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
105573778|NCT04921969|364098595|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
105573779|NCT04921969|364098596|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105573780|NCT04921969|364098597|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105488356|NCT00076024|363800372|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
105573781|NCT04921969|364098598|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105573782|NCT04921969|364098599|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105573783|NCT04921969|364098593|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
105573784|NCT04921969|364098594|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
105573785|NCT04921969|364098595|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
105573786|NCT04921969|364098596|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
105573787|NCT04921969|364098597|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
105573788|NCT04921969|364098598|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
105573789|NCT04921969|364098599|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
105573790|NCT04921969|364098593|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
105573791|NCT04921969|364098594|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
105573792|NCT04921969|364098595|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
105573793|NCT04921969|364098596|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
105573794|NCT04921969|364098597|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
105573795|NCT04921969|364098598|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
105573796|NCT04921969|364098599|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
105573797|NCT04921969|364098593|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105573798|NCT04921969|364098594|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105826200|NCT00927069|365022063|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
105826201|NCT00927069|365022064|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
105826202|NCT00927069|365022065|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
105826203|NCT00927069|365022062|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
105826204|NCT00927069|365022063|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
105826205|NCT00927069|365022064|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
105826206|NCT00927069|365022065|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
105826207|NCT00927069|365022062|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
105826208|NCT00927069|365022063|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
105826209|NCT00927069|365022064|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
105826210|NCT00927069|365022065|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
105826211|NCT00927069|365022062|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
105826212|NCT00927069|365022063|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
105826213|NCT00927069|365022064|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
105826214|NCT00927069|365022065|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
105826215|NCT00848536|365022068|FG000|Overall Study|Adverse Event|2|||
105826216|NCT00848536|365022069|FG001|Overall Study|Adverse Event|2|||
105826217|NCT00848536|365022068|FG000|Overall Study|Withdrawal by Subject|0|||
105826218|NCT00848536|365022069|FG001|Overall Study|Withdrawal by Subject|1|||
105826219|NCT00848536|365022068|FG000|Overall Study|Protocol Violation|0|||
105826220|NCT00848536|365022069|FG001|Overall Study|Protocol Violation|1|||
105826221|NCT00848536|365022068|FG000|Overall Study|Noncompliance|1|||
105826222|NCT00848536|365022069|FG001|Overall Study|Noncompliance|0|||
105826223|NCT00848536|365022068|FG000|Overall Study|Inadequate Control of IOP|1|||
105826224|NCT00848536|365022069|FG001|Overall Study|Inadequate Control of IOP|1|||
105826225|NCT00848536|365022068|FG000|Overall Study|Patient Moved|0|||
105826226|NCT00848536|365022069|FG001|Overall Study|Patient Moved|2|||
105826227|NCT04089553|365022072|FG000|Overall Study|Death|1|||
105826228|NCT04089553|365022073|FG001|Overall Study|Death|1|||
105826229|NCT04089553|365022072|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
105826230|NCT04089553|365022073|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
105826231|NCT04089553|365022072|FG000|Overall Study|Withdrawal by Subject|3|||
105826232|NCT04089553|365022073|FG001|Overall Study|Withdrawal by Subject|3|||
105826233|NCT04089553|365022072|FG000|Overall Study|Physician Decision|1|||
105826234|NCT04089553|365022073|FG001|Overall Study|Physician Decision|0|||
105826235|NCT04089553|365022072|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
105826236|NCT04089553|365022073|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
105826237|NCT04089553|365022072|FG000|Overall Study|Other|1|||
105826238|NCT04089553|365022073|FG001|Overall Study|Other|0|||
105826239|NCT04089553|365022072|FG000|Overall Study|Adverse Event|1|||
105826240|NCT04089553|365022073|FG001|Overall Study|Adverse Event|1|||
105826241|NCT01572662|365022083|FG000|Overall Study|Withdrawal by Subject|1|||
105826242|NCT01572662|365022084|FG001|Overall Study|Withdrawal by Subject|0|||
105826243|NCT01572662|365022083|FG000|Overall Study|Physician Decision|0|||
105826244|NCT01572662|365022084|FG001|Overall Study|Physician Decision|1|||
105826245|NCT00835666|365022085|FG000|Washout|Protocol Violation|1|||
105826246|NCT00835666|365022086|FG001|Washout|Protocol Violation|0|||
105826247|NCT00835666|365022085|FG000|Washout|Withdrawal by Subject|1|||
105826248|NCT00835666|365022086|FG001|Washout|Withdrawal by Subject|0|||
105826249|NCT02450539|365022091|FG000|Overall Study|Withdrawal by Subject|12|||
105826250|NCT02450539|365022092|FG001|Overall Study|Withdrawal by Subject|6|||
105826251|NCT02450539|365022091|FG000|Overall Study|Lost to Follow-up|4|||
105826252|NCT02450539|365022092|FG001|Overall Study|Lost to Follow-up|1|||
105826253|NCT00829712|365022093|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
105826254|NCT00829712|365022094|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
105826255|NCT03131895|365022096|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
105826256|NCT03131895|365022097|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
105826257|NCT03131895|365022098|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
105826258|NCT03131895|365022099|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
105826259|NCT03131895|365022096|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
105826260|NCT03131895|365022097|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
105826261|NCT03131895|365022098|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
105826262|NCT03131895|365022099|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
105826263|NCT03131895|365022096|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105826264|NCT03131895|365022097|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
105826265|NCT03131895|365022098|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105826266|NCT03131895|365022099|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
105826267|NCT03131895|365022096|FG000|Washout Period (at Least 5 Days)|Other|0|||
105826268|NCT03131895|365022097|FG001|Washout Period (at Least 5 Days)|Other|0|||
105826269|NCT03131895|365022098|FG002|Washout Period (at Least 5 Days)|Other|2|||
105826270|NCT03131895|365022099|FG003|Washout Period (at Least 5 Days)|Other|0|||
105826271|NCT03131895|365022096|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
105826272|NCT03131895|365022097|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
105826273|NCT03131895|365022098|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
105826274|NCT03131895|365022099|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
105826275|NCT03131895|365022096|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
105826276|NCT03131895|365022097|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
105826277|NCT03131895|365022098|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
105826278|NCT03131895|365022099|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
105826279|NCT02622386|365022102|FG000|First Assignment|Withdrawal by Subject|3|||
105826280|NCT02622386|365022103|FG001|First Assignment|Withdrawal by Subject|2|||
105826281|NCT02622386|365022102|FG000|Washout|Withdrawal by Subject|4|||
105826282|NCT02622386|365022103|FG001|Washout|Withdrawal by Subject|4|||
105826283|NCT02622386|365022102|FG000|Second Assignment|Withdrawal by Subject|0|||
105826284|NCT02622386|365022103|FG001|Second Assignment|Withdrawal by Subject|2|||
105826285|NCT02412852|365022105|FG000|Overall Study|Withdrawal by Subject|0|||
105826286|NCT02412852|365022106|FG001|Overall Study|Withdrawal by Subject|1|||
105826287|NCT02412852|365022107|FG002|Overall Study|Withdrawal by Subject|0|||
105826288|NCT02412852|365022108|FG003|Overall Study|Withdrawal by Subject|0|||
105826289|NCT02412852|365022105|FG000|Overall Study|Physician Decision|0|||
105826290|NCT02412852|365022106|FG001|Overall Study|Physician Decision|0|||
105826291|NCT02412852|365022107|FG002|Overall Study|Physician Decision|0|||
105366220|NCT00274742|363346608|FG001|Overall Study|Lost to Follow-up|0|||
105366221|NCT00274742|363346609|FG002|Overall Study|Lost to Follow-up|0|||
105366222|NCT00274742|363346610|FG003|Overall Study|Lost to Follow-up|0|||
105366223|NCT00274742|363346611|FG004|Overall Study|Lost to Follow-up|1|||
105366224|NCT00274742|363346612|FG005|Overall Study|Lost to Follow-up|0|||
105366225|NCT00274742|363346607|FG000|Overall Study|End of Study|0|||
105366226|NCT00274742|363346608|FG001|Overall Study|End of Study|0|||
105366227|NCT00274742|363346609|FG002|Overall Study|End of Study|0|||
105366228|NCT00274742|363346610|FG003|Overall Study|End of Study|1|||
105826292|NCT02412852|365022108|FG003|Overall Study|Physician Decision|1|||
105826293|NCT01174186|365022109|FG000|Overall Study|Lost to Follow-up|0|||
105826294|NCT01174186|365022110|FG001|Overall Study|Lost to Follow-up|1|||
105826295|NCT01174186|365022109|FG000|Overall Study|Withdrawal by Subject|0|||
105826296|NCT01174186|365022110|FG001|Overall Study|Withdrawal by Subject|2|||
105826297|NCT00484679|365022111|FG000|Overall Study|Withdrawal by Subject|3|||
105826298|NCT00402103|365022112|FG000|Overall Study|Adverse Event|60|||
105826299|NCT00402103|365022113|FG001|Overall Study|Adverse Event|7|||
105826300|NCT00402103|365022112|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105826301|NCT00402103|365022113|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105826302|NCT00402103|365022112|FG000|Overall Study|Condition no longer requires study drug|2|||
105826303|NCT00402103|365022113|FG001|Overall Study|Condition no longer requires study drug|0|||
105826304|NCT00402103|365022112|FG000|Overall Study|Protocol Deviation|8|||
105826305|NCT00402103|365022113|FG001|Overall Study|Protocol Deviation|0|||
105366229|NCT00274742|363346611|FG004|Overall Study|End of Study|0|||
105366230|NCT00274742|363346612|FG005|Overall Study|End of Study|0|||
105366231|NCT00274742|363346607|FG000|Overall Study|Disease Progression|0|||
105366232|NCT00274742|363346608|FG001|Overall Study|Disease Progression|1|||
105826306|NCT00402103|365022112|FG000|Overall Study|Patient withdrew consent|12|||
105826307|NCT00402103|365022113|FG001|Overall Study|Patient withdrew consent|1|||
105826308|NCT00402103|365022112|FG000|Overall Study|Lost to Follow-up|6|||
105826309|NCT00402103|365022113|FG001|Overall Study|Lost to Follow-up|3|||
105826310|NCT00402103|365022112|FG000|Overall Study|Administrative problems|2|||
105826311|NCT00402103|365022113|FG001|Overall Study|Administrative problems|0|||
105826312|NCT00835692|365022114|FG000|First Intervention|Withdrawal by Subject|1|||
105826313|NCT00835692|365022115|FG001|First Intervention|Withdrawal by Subject|0|||
105826314|NCT00841542|365022116|FG000|Period 1|Adverse Event|1|||
105826315|NCT00841542|365022117|FG001|Period 1|Adverse Event|0|||
105826316|NCT03480763|365022118|FG000|Overall Study|Withdrawal by Subject|18|||
105826317|NCT03480763|365022119|FG001|Overall Study|Withdrawal by Subject|10|||
105826318|NCT03480763|365022118|FG000|Overall Study|Lost to Follow-up|4|||
105826319|NCT03480763|365022119|FG001|Overall Study|Lost to Follow-up|7|||
105826320|NCT03480763|365022118|FG000|Overall Study|non-study pneumococcal vaccine|1|||
105826321|NCT03480763|365022119|FG001|Overall Study|non-study pneumococcal vaccine|0|||
105826322|NCT03480763|365022118|FG000|Overall Study|oncological treatment|0|||
105826323|NCT03480763|365022119|FG001|Overall Study|oncological treatment|2|||
105826324|NCT03480763|365022118|FG000|Overall Study|pain with vaccination|1|||
105826325|NCT03480763|365022119|FG001|Overall Study|pain with vaccination|0|||
105826326|NCT03644550|365022122|FG000|Overall Study|Withdrawal by Subject|3|||
105826327|NCT03644550|365022122|FG000|Overall Study|Progressive disease|15|||
105826328|NCT01075282|365022123|FG000|Overall Study|Withdrawal by Subject|11|||
105826329|NCT01075282|365022124|FG001|Overall Study|Withdrawal by Subject|7|||
105826330|NCT01075282|365022125|FG002|Overall Study|Withdrawal by Subject|11|||
105826331|NCT01075282|365022123|FG000|Overall Study|Adverse Event|9|||
105826332|NCT01075282|365022124|FG001|Overall Study|Adverse Event|8|||
105826333|NCT01075282|365022125|FG002|Overall Study|Adverse Event|5|||
105826334|NCT01075282|365022123|FG000|Overall Study|Entry Criteria Not Met|3|||
105826335|NCT01075282|365022124|FG001|Overall Study|Entry Criteria Not Met|2|||
105826336|NCT01075282|365022125|FG002|Overall Study|Entry Criteria Not Met|0|||
105826337|NCT01075282|365022123|FG000|Overall Study|Lost to Follow-up|3|||
105826338|NCT01075282|365022124|FG001|Overall Study|Lost to Follow-up|3|||
105826339|NCT01075282|365022125|FG002|Overall Study|Lost to Follow-up|3|||
105826340|NCT01075282|365022123|FG000|Overall Study|Physician Decision|3|||
105826341|NCT01075282|365022124|FG001|Overall Study|Physician Decision|3|||
105826342|NCT01075282|365022125|FG002|Overall Study|Physician Decision|3|||
105826343|NCT01075282|365022123|FG000|Overall Study|Lack of Efficacy|1|||
105826344|NCT01075282|365022124|FG001|Overall Study|Lack of Efficacy|1|||
105826345|NCT01075282|365022125|FG002|Overall Study|Lack of Efficacy|0|||
105826346|NCT01075282|365022123|FG000|Overall Study|Treatment Non-compliance|1|||
105826347|NCT01075282|365022124|FG001|Overall Study|Treatment Non-compliance|2|||
105826348|NCT01075282|365022125|FG002|Overall Study|Treatment Non-compliance|2|||
105826349|NCT01075282|365022123|FG000|Overall Study|Protocol Violation|0|||
105826350|NCT01075282|365022124|FG001|Overall Study|Protocol Violation|2|||
105826351|NCT01075282|365022125|FG002|Overall Study|Protocol Violation|1|||
105826352|NCT01075282|365022123|FG000|Overall Study|Death|0|||
105826353|NCT01075282|365022124|FG001|Overall Study|Death|1|||
105826354|NCT01075282|365022125|FG002|Overall Study|Death|2|||
105826355|NCT00700739|365022126|FG000|Overall Study|Lost to Follow-up|4|||
105826356|NCT00700739|365022127|FG001|Overall Study|Lost to Follow-up|4|||
105826357|NCT00924638|365022128|FG000|Overall Study|Death|3|||
105826358|NCT00924638|365022129|FG001|Overall Study|Death|2|||
105826359|NCT00924638|365022128|FG000|Overall Study|Lost to Follow-up|1|||
105826360|NCT00924638|365022129|FG001|Overall Study|Lost to Follow-up|1|||
105826361|NCT00924638|365022128|FG000|Overall Study|Withdrawal by Subject|5|||
105826362|NCT00924638|365022129|FG001|Overall Study|Withdrawal by Subject|7|||
105826363|NCT00924638|365022128|FG000|Overall Study|Physician Decision|3|||
105826364|NCT00924638|365022129|FG001|Overall Study|Physician Decision|3|||
105488357|NCT00076024|363800373|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
105488358|NCT00076024|363800374|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
105488359|NCT00076024|363800375|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
105488360|NCT00076024|363800372|FG000|Phase 2, Open-label|Other|0|||
105488361|NCT00076024|363800373|FG001|Phase 2, Open-label|Other|0|||
105488362|NCT00076024|363800374|FG002|Phase 2, Open-label|Other|0|||
105488363|NCT00076024|363800375|FG003|Phase 2, Open-label|Other|2|||
105488364|NCT01155219|363800379|FG000|Overall Study|Adverse Event|3|||
105488365|NCT01155219|363800380|FG001|Overall Study|Adverse Event|1|||
105488366|NCT01155219|363800379|FG000|Overall Study|non-medical reason|1|||
105488367|NCT01155219|363800380|FG001|Overall Study|non-medical reason|2|||
105826365|NCT03488108|365022136|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
105826366|NCT03488108|365022137|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
105826367|NCT03488108|365022136|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
105826368|NCT03488108|365022137|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
105826369|NCT01438060|365022145|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
105826370|NCT01438060|365022146|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
105826371|NCT01438060|365022145|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
105488368|NCT03150485|363800381|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
105488369|NCT03150485|363800382|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
105488370|NCT03150485|363800383|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
105488371|NCT03150485|363800384|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
105488372|NCT03150485|363800385|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
105488373|NCT03150485|363800386|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
105826372|NCT01438060|365022146|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
105826373|NCT01438060|365022145|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
105826374|NCT01438060|365022146|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
105826375|NCT01438060|365022145|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
105826376|NCT01438060|365022146|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
105826377|NCT01438060|365022145|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
105826378|NCT01438060|365022146|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
105826379|NCT01438060|365022145|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
105826380|NCT01438060|365022146|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
105826381|NCT01438060|365022145|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
105826382|NCT01438060|365022146|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
105826383|NCT01438060|365022145|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
105826384|NCT01438060|365022146|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
105826385|NCT01438060|365022145|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
105826386|NCT01438060|365022146|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
105826387|NCT01438060|365022145|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
105826388|NCT01438060|365022146|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
105826389|NCT01438060|365022145|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
105826390|NCT01438060|365022146|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
105826391|NCT01438060|365022145|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
105826392|NCT01438060|365022146|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
105826393|NCT01438060|365022145|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
105826394|NCT01438060|365022146|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
105826395|NCT01438060|365022145|FG000|On Study Beyond Week 140|Adverse Event|0|||
105826396|NCT01438060|365022146|FG001|On Study Beyond Week 140|Adverse Event|2|||
105826397|NCT01438060|365022145|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
105826398|NCT01438060|365022146|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
105826399|NCT01438060|365022145|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
105826400|NCT01438060|365022146|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
105826401|NCT01438060|365022145|FG000|On Study Beyond Week 140|Death|0|||
105826402|NCT01438060|365022146|FG001|On Study Beyond Week 140|Death|1|||
105826403|NCT01438060|365022145|FG000|On Study Beyond Week 140|Other Reason|0|||
105826404|NCT01438060|365022146|FG001|On Study Beyond Week 140|Other Reason|3|||
105826405|NCT00858780|365022147|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
105826406|NCT00858780|365022148|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
105826407|NCT00858780|365022149|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
105826408|NCT00858780|365022150|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
105826409|NCT00858780|365022151|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
105826410|NCT00858780|365022147|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
105826411|NCT00858780|365022148|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
105826412|NCT00858780|365022149|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
105826413|NCT00858780|365022150|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
105826414|NCT00858780|365022151|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
105826415|NCT00858780|365022147|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
105826416|NCT00858780|365022148|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
105826417|NCT00858780|365022149|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
105826418|NCT00858780|365022150|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
105826419|NCT00858780|365022151|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
105826420|NCT00858780|365022147|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
105826421|NCT00858780|365022148|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
105826422|NCT00858780|365022149|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
105826423|NCT00858780|365022150|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
105826424|NCT00858780|365022151|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
105826425|NCT00858780|365022147|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
105826426|NCT00858780|365022148|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
105826427|NCT00858780|365022149|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
105826428|NCT00858780|365022150|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
105488374|NCT03206073|363800388|FG000|Overall Study|Participant Noncompliance|0|||
105488375|NCT03206073|363800389|FG001|Overall Study|Participant Noncompliance|1|||
105826429|NCT00858780|365022151|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
105488376|NCT03206073|363800390|FG002|Overall Study|Participant Noncompliance|0|||
105488377|NCT03206073|363800391|FG003|Overall Study|Participant Noncompliance|0|||
105768654|NCT03039790|364804486|FG018|Overall Study|Death|2|||
105768655|NCT03039790|364804487|FG019|Overall Study|Death|0|||
105768656|NCT03039790|364804468|FG000|Overall Study|Reason, not Specified|1|||
105768657|NCT03039790|364804469|FG001|Overall Study|Reason, not Specified|0|||
105768658|NCT03039790|364804470|FG002|Overall Study|Reason, not Specified|0|||
105768659|NCT03039790|364804471|FG003|Overall Study|Reason, not Specified|0|||
105768660|NCT03039790|364804472|FG004|Overall Study|Reason, not Specified|0|||
105768661|NCT03039790|364804473|FG005|Overall Study|Reason, not Specified|0|||
105768662|NCT03039790|364804474|FG006|Overall Study|Reason, not Specified|0|||
105768663|NCT03039790|364804475|FG007|Overall Study|Reason, not Specified|0|||
105768664|NCT03039790|364804476|FG008|Overall Study|Reason, not Specified|0|||
105768665|NCT03039790|364804477|FG009|Overall Study|Reason, not Specified|0|||
105768666|NCT03039790|364804478|FG010|Overall Study|Reason, not Specified|0|||
105768667|NCT03039790|364804479|FG011|Overall Study|Reason, not Specified|0|||
105768668|NCT03039790|364804480|FG012|Overall Study|Reason, not Specified|0|||
105768669|NCT03039790|364804481|FG013|Overall Study|Reason, not Specified|0|||
105768670|NCT03039790|364804482|FG014|Overall Study|Reason, not Specified|0|||
105768671|NCT03039790|364804483|FG015|Overall Study|Reason, not Specified|0|||
105768672|NCT03039790|364804484|FG016|Overall Study|Reason, not Specified|2|||
105768673|NCT03039790|364804485|FG017|Overall Study|Reason, not Specified|0|||
105768674|NCT03039790|364804486|FG018|Overall Study|Reason, not Specified|1|||
105768675|NCT03039790|364804487|FG019|Overall Study|Reason, not Specified|0|||
105768676|NCT02465489|364804491|FG000|Overall Study|Adverse Event|5|||
105768677|NCT04599972|364804494|FG000|Overall Study|Withdrawal by Subject|6|||
105768678|NCT04599972|364804495|FG001|Overall Study|Withdrawal by Subject|1|||
105768679|NCT04599972|364804494|FG000|Overall Study|Adverse Event|1|||
105768680|NCT04599972|364804495|FG001|Overall Study|Adverse Event|1|||
105768681|NCT04599972|364804494|FG000|Overall Study|Lost to Follow-up|1|||
105768682|NCT04599972|364804495|FG001|Overall Study|Lost to Follow-up|6|||
105768683|NCT04599972|364804494|FG000|Overall Study|Protocol Violation|1|||
105768684|NCT04599972|364804495|FG001|Overall Study|Protocol Violation|0|||
105768685|NCT04599972|364804494|FG000|Overall Study|Other reason|1|||
105768686|NCT04599972|364804495|FG001|Overall Study|Other reason|0|||
105768687|NCT03342404|364804496|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
105768688|NCT03342404|364804497|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
105768689|NCT03342404|364804496|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
105768690|NCT03342404|364804497|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
105768691|NCT03342404|364804496|FG000|Blinded Treatment Phase|Adverse Event|5|||
105768692|NCT03342404|364804497|FG001|Blinded Treatment Phase|Adverse Event|4|||
105768693|NCT03342404|364804496|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
105768694|NCT03342404|364804497|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
105768695|NCT03342404|364804496|FG000|Blinded Treatment Phase|Other reasons|1|||
105768696|NCT03342404|364804497|FG001|Blinded Treatment Phase|Other reasons|0|||
105768697|NCT03342404|364804496|FG000|Blinded Treatment Phase|Physician Decision|1|||
105768698|NCT03342404|364804497|FG001|Blinded Treatment Phase|Physician Decision|0|||
105768699|NCT03342404|364804496|FG000|Blinded Treatment Phase|Death|1|||
105768700|NCT03342404|364804497|FG001|Blinded Treatment Phase|Death|0|||
105768701|NCT03342404|364804496|FG000|Open-Label Phase|Lost to Follow-up|0|||
105768702|NCT03342404|364804497|FG001|Open-Label Phase|Lost to Follow-up|1|||
105768703|NCT03342404|364804496|FG000|Open-Label Phase|Other reasons|0|||
105768704|NCT03342404|364804497|FG001|Open-Label Phase|Other reasons|1|||
105768705|NCT03342404|364804496|FG000|Open-Label Phase|Adverse Event|0|||
105768706|NCT03342404|364804497|FG001|Open-Label Phase|Adverse Event|3|||
105768707|NCT03342404|364804496|FG000|Open-Label Phase|Withdrawal by Subject|0|||
105768708|NCT03342404|364804497|FG001|Open-Label Phase|Withdrawal by Subject|6|||
105768709|NCT01855425|364804502|FG000|Overall Study|Physician Decision|20|||
105768710|NCT00638690|364804503|FG000|Overall Study|Death|655|||
105768711|NCT00638690|364804504|FG001|Overall Study|Death|335|||
105768712|NCT00638690|364804503|FG000|Overall Study|Withdrawal by Subject|22|||
105768713|NCT00638690|364804504|FG001|Overall Study|Withdrawal by Subject|5|||
105768714|NCT00638690|364804503|FG000|Overall Study|Lost to Follow-up|4|||
105768715|NCT00638690|364804504|FG001|Overall Study|Lost to Follow-up|2|||
105768716|NCT02201251|364804512|FG000|Overall Study|Adverse Event|1|||
105826430|NCT00858780|365022147|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
105826431|NCT00858780|365022148|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
105826432|NCT00858780|365022149|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
105826433|NCT00858780|365022150|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
105826434|NCT00858780|365022151|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
105826435|NCT04631562|365022154|FG000|Overall Study|Withdrawal by Subject|0|||
105826436|NCT04631562|365022155|FG001|Overall Study|Withdrawal by Subject|0|||
105826437|NCT04631562|365022156|FG002|Overall Study|Withdrawal by Subject|0|||
105826438|NCT04631562|365022157|FG003|Overall Study|Withdrawal by Subject|0|||
105826439|NCT04631562|365022158|FG004|Overall Study|Withdrawal by Subject|0|||
105826440|NCT04631562|365022159|FG005|Overall Study|Withdrawal by Subject|0|||
105488378|NCT03206073|363800388|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
105488379|NCT03206073|363800389|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
105488380|NCT03206073|363800390|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
105488381|NCT03206073|363800391|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
105488382|NCT03206073|363800388|FG000|Overall Study|Death|0|||
105488383|NCT03206073|363800389|FG001|Overall Study|Death|0|||
105488384|NCT03206073|363800390|FG002|Overall Study|Death|1|||
105488385|NCT03206073|363800391|FG003|Overall Study|Death|0|||
105488386|NCT03206073|363800388|FG000|Overall Study|Taken off active treatment|0|||
105488387|NCT03206073|363800389|FG001|Overall Study|Taken off active treatment|0|||
105488388|NCT03206073|363800390|FG002|Overall Study|Taken off active treatment|3|||
105488389|NCT03206073|363800391|FG003|Overall Study|Taken off active treatment|0|||
105488390|NCT01394718|363800393|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
105488391|NCT01394718|363800394|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
105488392|NCT04006119|363800395|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
105488393|NCT04006119|363800395|FG000|End of Treatment Veledimex|Adverse Event|2|||
105488394|NCT04006119|363800395|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
105488395|NCT04006119|363800395|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
105488396|NCT04006119|363800395|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
105488397|NCT04006119|363800395|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
105488398|NCT01711879|363800396|FG000|Overall Study|Death|1|||
105488399|NCT01711879|363800397|FG001|Overall Study|Death|0|||
105488400|NCT00417482|363800400|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
105488401|NCT00417482|363800401|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
105488402|NCT00417482|363800402|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
105488403|NCT00417482|363800400|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
105488404|NCT00417482|363800401|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
105488405|NCT00417482|363800402|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
105488406|NCT00417482|363800400|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
105488407|NCT00417482|363800401|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
105488408|NCT00417482|363800402|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
105488409|NCT00417482|363800400|FG000|Phase B 1st 16 Weeks|Death|1|||
105488410|NCT00417482|363800401|FG001|Phase B 1st 16 Weeks|Death|0|||
105488411|NCT00417482|363800402|FG002|Phase B 1st 16 Weeks|Death|0|||
105488412|NCT00417482|363800400|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
105488413|NCT00417482|363800401|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
105488414|NCT00417482|363800402|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
105488415|NCT00417482|363800400|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
105488416|NCT00417482|363800401|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
105488417|NCT00417482|363800402|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
105488418|NCT00417482|363800400|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
105488419|NCT00417482|363800401|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
105488420|NCT00417482|363800402|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
105488421|NCT00417482|363800400|FG000|Phase B 2nd 16 Weeks|Death|1|||
105488422|NCT00417482|363800401|FG001|Phase B 2nd 16 Weeks|Death|1|||
105488423|NCT00417482|363800402|FG002|Phase B 2nd 16 Weeks|Death|0|||
105826441|NCT04631562|365022160|FG006|Overall Study|Withdrawal by Subject|0|||
105826442|NCT04631562|365022161|FG007|Overall Study|Withdrawal by Subject|1|||
105826443|NCT04631562|365022162|FG008|Overall Study|Withdrawal by Subject|0|||
105826444|NCT04631562|365022154|FG000|Overall Study|Other|0|||
105826445|NCT04631562|365022155|FG001|Overall Study|Other|0|||
105826446|NCT04631562|365022156|FG002|Overall Study|Other|0|||
105826447|NCT04631562|365022157|FG003|Overall Study|Other|0|||
105826448|NCT04631562|365022158|FG004|Overall Study|Other|0|||
105826449|NCT04631562|365022159|FG005|Overall Study|Other|0|||
105826450|NCT04631562|365022160|FG006|Overall Study|Other|0|||
105826451|NCT04631562|365022161|FG007|Overall Study|Other|0|||
105826452|NCT04631562|365022162|FG008|Overall Study|Other|1|||
105826453|NCT04631562|365022154|FG000|Overall Study|Lost to Follow-up|0|||
105826454|NCT04631562|365022155|FG001|Overall Study|Lost to Follow-up|0|||
105488424|NCT00829283|363800403|FG000|Overall Study|Lost to Follow-up|7|||
105488425|NCT00829283|363800404|FG001|Overall Study|Lost to Follow-up|25|||
105488426|NCT00667446|363800405|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
105488427|NCT00667446|363800406|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
105488428|NCT00667446|363800405|FG000|Treatment Period (36 Months)|Other|2|||
105488429|NCT00667446|363800406|FG001|Treatment Period (36 Months)|Other|2|||
105488430|NCT00667446|363800405|FG000|Treatment Period (36 Months)|Personal reasons|2|||
105488431|NCT00667446|363800406|FG001|Treatment Period (36 Months)|Personal reasons|2|||
105488432|NCT00667446|363800405|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
105826455|NCT04631562|365022156|FG002|Overall Study|Lost to Follow-up|0|||
105826456|NCT04631562|365022157|FG003|Overall Study|Lost to Follow-up|1|||
105826457|NCT04631562|365022158|FG004|Overall Study|Lost to Follow-up|0|||
105826458|NCT04631562|365022159|FG005|Overall Study|Lost to Follow-up|0|||
105488433|NCT00667446|363800406|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
105826459|NCT04631562|365022160|FG006|Overall Study|Lost to Follow-up|0|||
105826460|NCT04631562|365022161|FG007|Overall Study|Lost to Follow-up|0|||
105826461|NCT04631562|365022162|FG008|Overall Study|Lost to Follow-up|0|||
105826462|NCT04631562|365022154|FG000|Overall Study|Adverse Event|0|||
105826463|NCT04631562|365022155|FG001|Overall Study|Adverse Event|0|||
105826464|NCT04631562|365022156|FG002|Overall Study|Adverse Event|0|||
105826465|NCT04631562|365022157|FG003|Overall Study|Adverse Event|0|||
105826466|NCT04631562|365022158|FG004|Overall Study|Adverse Event|0|||
105826467|NCT04631562|365022159|FG005|Overall Study|Adverse Event|0|||
105826468|NCT04631562|365022160|FG006|Overall Study|Adverse Event|1|||
105826469|NCT04631562|365022161|FG007|Overall Study|Adverse Event|0|||
105826470|NCT04631562|365022162|FG008|Overall Study|Adverse Event|0|||
105826471|NCT01190865|365022167|FG000|Overall Study|Withdrawal by Subject|1|||
105826472|NCT01190865|365022167|FG000|Overall Study|Non-compliance|2|||
105826473|NCT00829452|365022168|FG000|First Intervention|Withdrawal by Subject|0|||
105826474|NCT00829452|365022169|FG001|First Intervention|Withdrawal by Subject|1|||
105826475|NCT00829452|365022168|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
105826476|NCT00829452|365022169|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
105826477|NCT00829452|365022168|FG000|Second Intervention|Physician Decision|0|||
105826478|NCT00829452|365022169|FG001|Second Intervention|Physician Decision|1|||
105826479|NCT02436200|365022171|FG000|Overall Study|Significant outlier|1|||
105826480|NCT05098743|365022176|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
105826481|NCT05098743|365022177|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
105826482|NCT05098743|365022176|FG000|Overall Study|Lost to Follow-up|1|||
105826483|NCT05098743|365022177|FG001|Overall Study|Lost to Follow-up|2|||
105826484|NCT00838539|365022178|FG000|Overall Study|Disease Progression|2|||
105826485|NCT00838539|365022179|FG001|Overall Study|Disease Progression|4|||
105826486|NCT00838539|365022180|FG002|Overall Study|Disease Progression|3|||
105826487|NCT00838539|365022181|FG003|Overall Study|Disease Progression|2|||
105826488|NCT00838539|365022182|FG004|Overall Study|Disease Progression|4|||
105826489|NCT00838539|365022183|FG005|Overall Study|Disease Progression|2|||
105826490|NCT00838539|365022184|FG006|Overall Study|Disease Progression|3|||
105826491|NCT00838539|365022185|FG007|Overall Study|Disease Progression|4|||
105826492|NCT00838539|365022186|FG008|Overall Study|Disease Progression|4|||
105826493|NCT00838539|365022187|FG009|Overall Study|Disease Progression|5|||
105826494|NCT00838539|365022188|FG010|Overall Study|Disease Progression|1|||
105826495|NCT00838539|365022189|FG011|Overall Study|Disease Progression|4|||
105826496|NCT00838539|365022178|FG000|Overall Study|Adverse Event|1|||
105826497|NCT00838539|365022179|FG001|Overall Study|Adverse Event|1|||
105826498|NCT00838539|365022180|FG002|Overall Study|Adverse Event|1|||
105826499|NCT00838539|365022181|FG003|Overall Study|Adverse Event|1|||
105826500|NCT00838539|365022182|FG004|Overall Study|Adverse Event|2|||
105826501|NCT00838539|365022183|FG005|Overall Study|Adverse Event|1|||
105826502|NCT00838539|365022184|FG006|Overall Study|Adverse Event|0|||
105826503|NCT00838539|365022185|FG007|Overall Study|Adverse Event|2|||
105826504|NCT00838539|365022186|FG008|Overall Study|Adverse Event|0|||
105826505|NCT00838539|365022187|FG009|Overall Study|Adverse Event|1|||
105826506|NCT00838539|365022188|FG010|Overall Study|Adverse Event|2|||
105826507|NCT00838539|365022189|FG011|Overall Study|Adverse Event|0|||
105826508|NCT00838539|365022178|FG000|Overall Study|Withdrawal by Subject|0|||
105826509|NCT00838539|365022179|FG001|Overall Study|Withdrawal by Subject|1|||
105826510|NCT00838539|365022180|FG002|Overall Study|Withdrawal by Subject|0|||
105826511|NCT00838539|365022181|FG003|Overall Study|Withdrawal by Subject|0|||
105826512|NCT00838539|365022182|FG004|Overall Study|Withdrawal by Subject|0|||
105826513|NCT00838539|365022183|FG005|Overall Study|Withdrawal by Subject|0|||
105826514|NCT00838539|365022184|FG006|Overall Study|Withdrawal by Subject|0|||
105826515|NCT00838539|365022185|FG007|Overall Study|Withdrawal by Subject|0|||
105826516|NCT00838539|365022186|FG008|Overall Study|Withdrawal by Subject|0|||
105826517|NCT00838539|365022187|FG009|Overall Study|Withdrawal by Subject|1|||
105826518|NCT00838539|365022188|FG010|Overall Study|Withdrawal by Subject|2|||
105826519|NCT00838539|365022189|FG011|Overall Study|Withdrawal by Subject|0|||
105826520|NCT00838539|365022178|FG000|Overall Study|Death|0|||
105826521|NCT00838539|365022179|FG001|Overall Study|Death|0|||
105366233|NCT00274742|363346609|FG002|Overall Study|Disease Progression|1|||
105366234|NCT00274742|363346610|FG003|Overall Study|Disease Progression|0|||
105826522|NCT00838539|365022180|FG002|Overall Study|Death|0|||
105826523|NCT00838539|365022181|FG003|Overall Study|Death|0|||
105826524|NCT00838539|365022182|FG004|Overall Study|Death|0|||
105826525|NCT00838539|365022183|FG005|Overall Study|Death|0|||
105826526|NCT00838539|365022184|FG006|Overall Study|Death|1|||
105826527|NCT00838539|365022185|FG007|Overall Study|Death|0|||
105826528|NCT00838539|365022186|FG008|Overall Study|Death|0|||
105826529|NCT00838539|365022187|FG009|Overall Study|Death|0|||
105826530|NCT00838539|365022188|FG010|Overall Study|Death|0|||
105826531|NCT00838539|365022189|FG011|Overall Study|Death|0|||
105826532|NCT00838539|365022178|FG000|Overall Study|Physician Decision|0|||
105826533|NCT00838539|365022179|FG001|Overall Study|Physician Decision|0|||
105826534|NCT00838539|365022180|FG002|Overall Study|Physician Decision|0|||
105826535|NCT00838539|365022181|FG003|Overall Study|Physician Decision|0|||
105826536|NCT00838539|365022182|FG004|Overall Study|Physician Decision|0|||
105826537|NCT00838539|365022183|FG005|Overall Study|Physician Decision|0|||
105826538|NCT00838539|365022184|FG006|Overall Study|Physician Decision|0|||
105826539|NCT00838539|365022185|FG007|Overall Study|Physician Decision|0|||
105826540|NCT00838539|365022186|FG008|Overall Study|Physician Decision|1|||
105826541|NCT00838539|365022187|FG009|Overall Study|Physician Decision|0|||
105826542|NCT00838539|365022188|FG010|Overall Study|Physician Decision|0|||
105826543|NCT00838539|365022189|FG011|Overall Study|Physician Decision|0|||
105826544|NCT00838539|365022178|FG000|Overall Study|Clinical Progression|0|||
105826545|NCT00838539|365022179|FG001|Overall Study|Clinical Progression|0|||
105826546|NCT00838539|365022180|FG002|Overall Study|Clinical Progression|0|||
105826547|NCT00838539|365022181|FG003|Overall Study|Clinical Progression|0|||
105826548|NCT00838539|365022182|FG004|Overall Study|Clinical Progression|0|||
105826549|NCT00838539|365022183|FG005|Overall Study|Clinical Progression|0|||
105826550|NCT00838539|365022184|FG006|Overall Study|Clinical Progression|1|||
105826551|NCT00838539|365022185|FG007|Overall Study|Clinical Progression|0|||
105826552|NCT00838539|365022186|FG008|Overall Study|Clinical Progression|0|||
105826553|NCT00838539|365022187|FG009|Overall Study|Clinical Progression|0|||
105826554|NCT00838539|365022188|FG010|Overall Study|Clinical Progression|0|||
105826555|NCT00838539|365022189|FG011|Overall Study|Clinical Progression|0|||
105826556|NCT00838539|365022178|FG000|Overall Study|Symptomatic Deterioration|0|||
105826557|NCT00838539|365022179|FG001|Overall Study|Symptomatic Deterioration|0|||
105826558|NCT00838539|365022180|FG002|Overall Study|Symptomatic Deterioration|1|||
105826559|NCT00838539|365022181|FG003|Overall Study|Symptomatic Deterioration|1|||
105826560|NCT00838539|365022182|FG004|Overall Study|Symptomatic Deterioration|0|||
105826561|NCT00838539|365022183|FG005|Overall Study|Symptomatic Deterioration|1|||
105826562|NCT00838539|365022184|FG006|Overall Study|Symptomatic Deterioration|0|||
105826563|NCT00838539|365022185|FG007|Overall Study|Symptomatic Deterioration|0|||
105826564|NCT00838539|365022186|FG008|Overall Study|Symptomatic Deterioration|0|||
105826565|NCT00838539|365022187|FG009|Overall Study|Symptomatic Deterioration|1|||
105826566|NCT00838539|365022188|FG010|Overall Study|Symptomatic Deterioration|0|||
105826567|NCT00838539|365022189|FG011|Overall Study|Symptomatic Deterioration|0|||
105826568|NCT02635750|365024218|FG000|Part 1, Period 2|Adverse Event|1|||
105826569|NCT02635750|365024219|FG001|Part 1, Period 2|Adverse Event|0|||
105826570|NCT02635750|365024220|FG002|Part 1, Period 2|Adverse Event|0|||
105826571|NCT02642653|365024222|FG000|Overall Study|Adverse Event|2|||
105826572|NCT02642653|365024223|FG001|Overall Study|Adverse Event|0|||
105826573|NCT00830258|365024224|FG000|First Intervention|Adverse Event|1|||
105826574|NCT00830258|365024225|FG001|First Intervention|Adverse Event|0|||
105826575|NCT00830258|365024224|FG000|Washout: 7 Days|Protocol Violation|1|||
105826576|NCT00830258|365024225|FG001|Washout: 7 Days|Protocol Violation|0|||
105826577|NCT00682461|365024230|FG000|Overall Study|Adverse Event|5|||
105826578|NCT00682461|365024231|FG001|Overall Study|Adverse Event|7|||
105826579|NCT00682461|365024230|FG000|Overall Study|Lost to Follow-up|8|||
105826580|NCT00682461|365024231|FG001|Overall Study|Lost to Follow-up|5|||
105826581|NCT00682461|365024230|FG000|Overall Study|Withdrawal by Subject|12|||
105826582|NCT00682461|365024231|FG001|Overall Study|Withdrawal by Subject|19|||
105826583|NCT02875392|365024232|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
105826584|NCT02875392|365024233|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
105826585|NCT03599193|365024236|FG000|Overall Study|Adverse Event|0|||
105826586|NCT03599193|365024237|FG001|Overall Study|Adverse Event|2|||
105826587|NCT03599193|365024236|FG000|Overall Study|Withdrawal by Subject|1|||
105826588|NCT03599193|365024237|FG001|Overall Study|Withdrawal by Subject|0|||
105826589|NCT03599193|365024236|FG000|Overall Study|Protocol Violation|1|||
105826590|NCT03599193|365024237|FG001|Overall Study|Protocol Violation|0|||
105826591|NCT03599193|365024236|FG000|Overall Study|Lost to Follow-up|0|||
105826592|NCT03599193|365024237|FG001|Overall Study|Lost to Follow-up|1|||
105826593|NCT00834717|365024238|FG000|First Intervention|Adverse Event|1|||
105826594|NCT00834717|365024239|FG001|First Intervention|Adverse Event|0|||
105826595|NCT00834717|365024238|FG000|First Intervention|Withdrawal by Subject|0|||
105826596|NCT00834717|365024239|FG001|First Intervention|Withdrawal by Subject|1|||
105826597|NCT04299087|365024240|FG000|Overall Study|Lost to Follow-up|2|||
105826598|NCT04299087|365024241|FG001|Overall Study|Lost to Follow-up|1|||
105826599|NCT03025087|365024242|FG000|Overall Study|Physician Decision|3|||
105826600|NCT03025087|365024243|FG001|Overall Study|Physician Decision|3|||
105826601|NCT03025087|365024244|FG002|Overall Study|Physician Decision|0|||
105826602|NCT03025087|365024245|FG003|Overall Study|Physician Decision|0|||
105826603|NCT03025087|365024246|FG004|Overall Study|Physician Decision|0|||
105826604|NCT03025087|365024242|FG000|Overall Study|Withdrawal by Subject|1|||
105826605|NCT03025087|365024243|FG001|Overall Study|Withdrawal by Subject|1|||
105826606|NCT03025087|365024244|FG002|Overall Study|Withdrawal by Subject|0|||
105826607|NCT03025087|365024245|FG003|Overall Study|Withdrawal by Subject|0|||
105826608|NCT03025087|365024246|FG004|Overall Study|Withdrawal by Subject|0|||
105826609|NCT03025087|365024242|FG000|Overall Study|Unable to complete MRI|2|||
105826610|NCT03025087|365024243|FG001|Overall Study|Unable to complete MRI|2|||
105826611|NCT03025087|365024244|FG002|Overall Study|Unable to complete MRI|0|||
105826612|NCT03025087|365024245|FG003|Overall Study|Unable to complete MRI|0|||
105826613|NCT03025087|365024246|FG004|Overall Study|Unable to complete MRI|0|||
105826614|NCT01116739|365024249|FG000|Overall Study|Child had 2 years of HS|110|||
105826615|NCT01116739|365024250|FG001|Overall Study|Child had 2 years of HS|128|||
105826616|NCT01116739|365024249|FG000|Overall Study|Withdrawal by Subject|6|||
105826617|NCT01116739|365024250|FG001|Overall Study|Withdrawal by Subject|0|||
105826618|NCT01116739|365024249|FG000|Overall Study|child too young|2|||
105826619|NCT01116739|365024250|FG001|Overall Study|child too young|6|||
105826620|NCT01116739|365024249|FG000|Overall Study|child not enrolled in head start|10|||
105826621|NCT01116739|365024250|FG001|Overall Study|child not enrolled in head start|2|||
105826622|NCT01116739|365024249|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
105826623|NCT01116739|365024250|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
105826624|NCT05511935|365024251|FG000|Overall Study|Lost to Follow-up|9|||
105826625|NCT05511935|365024252|FG001|Overall Study|Lost to Follow-up|27|||
105826626|NCT01376037|365024253|FG000|Overall Study|Lost to Follow-up|0|||
105826627|NCT01376037|365024254|FG001|Overall Study|Lost to Follow-up|2|||
105826628|NCT02328040|365024256|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
105826629|NCT02328040|365024257|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
105826630|NCT00660660|365024259|FG000|Overall Study|Adverse Event|1|||
105826631|NCT00660660|365024260|FG001|Overall Study|Adverse Event|0|||
105826632|NCT00660660|365024259|FG000|Overall Study|Lost to Follow-up|0|||
105826633|NCT00660660|365024260|FG001|Overall Study|Lost to Follow-up|6|||
105826634|NCT00660660|365024259|FG000|Overall Study|Lack of Efficacy|0|||
105826635|NCT00660660|365024260|FG001|Overall Study|Lack of Efficacy|2|||
105826636|NCT00660660|365024259|FG000|Overall Study|Withdrawal by Subject|3|||
105826637|NCT00660660|365024260|FG001|Overall Study|Withdrawal by Subject|0|||
105826638|NCT00660660|365024259|FG000|Overall Study|Incorrect enrollment and other|0|||
105826639|NCT00660660|365024260|FG001|Overall Study|Incorrect enrollment and other|1|||
105826640|NCT00660660|365024259|FG000|Overall Study|New medication after randomization|1|||
105826641|NCT00660660|365024260|FG001|Overall Study|New medication after randomization|0|||
105826642|NCT02832063|365024261|FG000|Overall Study|Adverse Event|2|||
105826643|NCT02832063|365024262|FG001|Overall Study|Adverse Event|1|||
105826644|NCT02832063|365024261|FG000|Overall Study|Physician Decision|5|||
105826645|NCT02832063|365024262|FG001|Overall Study|Physician Decision|7|||
105826646|NCT02832063|365024261|FG000|Overall Study|Lost to Follow-up|15|||
105826647|NCT02832063|365024262|FG001|Overall Study|Lost to Follow-up|8|||
105826648|NCT02832063|365024261|FG000|Overall Study|Withdrawal by Subject|10|||
105826649|NCT02832063|365024262|FG001|Overall Study|Withdrawal by Subject|21|||
105826650|NCT02832063|365024261|FG000|Overall Study|Other|2|||
105826651|NCT02832063|365024262|FG001|Overall Study|Other|1|||
105826652|NCT03086460|365024263|FG000|Study Participants|Lost to Follow-up|2|||
105826653|NCT03086460|365024263|FG000|Study Participants|Protocol Violation|1|||
105826654|NCT03086460|365024263|FG000|Study Participants|Withdrawal by Subject|6|||
105826655|NCT03086460|365024263|FG000|Treatment A|Lost to Follow-up|1|||
105826656|NCT03086460|365024263|FG000|Treatment A|Protocol Violation|1|||
105826657|NCT03086460|365024263|FG000|Treatment A|Withdrawal by Subject|2|||
105826658|NCT03086460|365024263|FG000|Treatment C|Withdrawal by Subject|2|||
105826659|NCT03086460|365024263|FG000|Treatment E|Lost to Follow-up|1|||
105826660|NCT03086460|365024263|FG000|Treatment E|Withdrawal by Subject|3|||
105826661|NCT00836472|365024276|FG000|Washout|Adverse Event|1|||
105826662|NCT00836472|365024277|FG001|Washout|Adverse Event|2|||
105826663|NCT00836472|365024276|FG000|Washout|Withdrawal by Subject|1|||
105826664|NCT00836472|365024277|FG001|Washout|Withdrawal by Subject|1|||
105826665|NCT01735994|365024278|FG000|Overall Study|Withdrawal by Subject|6|||
105826666|NCT01735994|365024279|FG001|Overall Study|Withdrawal by Subject|4|||
105826667|NCT01735994|365024278|FG000|Overall Study|Injury|2|||
105826668|NCT01735994|365024279|FG001|Overall Study|Injury|0|||
105826669|NCT01735994|365024278|FG000|Overall Study|Kicked off team|5|||
105826670|NCT01735994|365024279|FG001|Overall Study|Kicked off team|0|||
105826671|NCT01735994|365024278|FG000|Overall Study|Lost to Follow-up|50|||
105826672|NCT01735994|365024279|FG001|Overall Study|Lost to Follow-up|62|||
105826673|NCT03499353|365024280|FG000|Treatment|Adverse Event|3|||
105826674|NCT03499353|365024280|FG000|Treatment|Progressive Disease|10|||
105826675|NCT03499353|365024280|FG000|Treatment|Other|1|||
105826676|NCT03499353|365024280|FG000|Treatment|Withdrawal by Subject|2|||
105826677|NCT03499353|365024280|FG000|Long-Term Follow-up|Death|2|||
105826678|NCT03499353|365024280|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
105826679|NCT03499353|365024280|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
105826680|NCT00469898|365024284|FG000|Overall Study|Adverse Event|7|||
105826681|NCT00469898|365024284|FG000|Overall Study|Withdrawal by Subject|4|||
105826682|NCT00469898|365024284|FG000|Overall Study|Death|4|||
105826683|NCT00469898|365024284|FG000|Overall Study|Disease progression|9|||
105826684|NCT00469898|365024284|FG000|Overall Study|Decreased performance status|1|||
105826685|NCT02451696|365024286|FG000|Overall Study|Surgery postponed|1|||
105826686|NCT02451696|365024287|FG001|Overall Study|Surgery postponed|0|||
105826687|NCT00395694|365024288|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
105826688|NCT00395694|365024289|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
105826689|NCT00395694|365024288|FG000|Continuation Phase|Adverse Event|1|||
105826690|NCT00395694|365024289|FG001|Continuation Phase|Adverse Event|0|||
105826691|NCT00395694|365024288|FG000|Continuation Phase|Lack of Efficacy|12|||
105826692|NCT00395694|365024289|FG001|Continuation Phase|Lack of Efficacy|11|||
105826693|NCT00395694|365024288|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
105826694|NCT00395694|365024289|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
105826695|NCT00395694|365024288|FG000|Continuation Phase|Poor Compliance|1|||
105826696|NCT00395694|365024289|FG001|Continuation Phase|Poor Compliance|0|||
105826697|NCT00395694|365024288|FG000|Continuation Phase|Withdrawal by Subject|0|||
105826698|NCT00395694|365024289|FG001|Continuation Phase|Withdrawal by Subject|2|||
105826699|NCT02699866|365024290|FG000|Overall Study|Withdrawal by Subject|3|||
105826700|NCT02699866|365024290|FG000|Overall Study|Physician Decision|2|||
105826701|NCT02699866|365024290|FG000|Overall Study|Adverse Event|3|||
105826702|NCT01959672|365024291|FG000|Overall Study|Death|1|||
105826703|NCT01058668|365024292|FG000|Double-blind Treatment Phase|Adverse Event|8|||
105826704|NCT01058668|365024293|FG001|Double-blind Treatment Phase|Adverse Event|15|||
105826705|NCT01058668|365024294|FG002|Double-blind Treatment Phase|Adverse Event|25|||
105826706|NCT01058668|365024292|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
105826707|NCT01058668|365024293|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
105826708|NCT01058668|365024294|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
105826709|NCT01058668|365024292|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
105826710|NCT01058668|365024293|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
105826711|NCT01058668|365024294|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
105826712|NCT01058668|365024292|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
105826713|NCT01058668|365024293|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
105826714|NCT01058668|365024294|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
105826715|NCT01058668|365024292|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
105826716|NCT01058668|365024293|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
105826717|NCT01058668|365024294|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
105826718|NCT01058668|365024292|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
105826719|NCT01058668|365024293|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
105826720|NCT01058668|365024294|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
105826721|NCT01175135|365024298|FG000|Overall Study|Adverse Event|2|||
105826722|NCT01175135|365024299|FG001|Overall Study|Adverse Event|5|||
105826723|NCT01175135|365024300|FG002|Overall Study|Adverse Event|3|||
105826724|NCT01175135|365024301|FG003|Overall Study|Adverse Event|4|||
105826725|NCT01175135|365024298|FG000|Overall Study|Death|1|||
105826726|NCT01175135|365024299|FG001|Overall Study|Death|0|||
105826727|NCT01175135|365024300|FG002|Overall Study|Death|0|||
105826728|NCT01175135|365024301|FG003|Overall Study|Death|0|||
105826729|NCT01175135|365024298|FG000|Overall Study|Lack of Efficacy|4|||
105826730|NCT01175135|365024299|FG001|Overall Study|Lack of Efficacy|5|||
105826731|NCT01175135|365024300|FG002|Overall Study|Lack of Efficacy|0|||
105826732|NCT01175135|365024301|FG003|Overall Study|Lack of Efficacy|5|||
105826733|NCT01175135|365024298|FG000|Overall Study|Lost to Follow-up|1|||
105826734|NCT01175135|365024299|FG001|Overall Study|Lost to Follow-up|2|||
105826735|NCT01175135|365024300|FG002|Overall Study|Lost to Follow-up|0|||
105826736|NCT01175135|365024301|FG003|Overall Study|Lost to Follow-up|0|||
105826737|NCT01175135|365024298|FG000|Overall Study|Protocol Violation|1|||
105826738|NCT01175135|365024299|FG001|Overall Study|Protocol Violation|1|||
105826739|NCT01175135|365024300|FG002|Overall Study|Protocol Violation|0|||
105826740|NCT01175135|365024301|FG003|Overall Study|Protocol Violation|0|||
105826741|NCT01175135|365024298|FG000|Overall Study|Withdrawal by Subject|4|||
105826742|NCT01175135|365024299|FG001|Overall Study|Withdrawal by Subject|8|||
105826743|NCT01175135|365024300|FG002|Overall Study|Withdrawal by Subject|5|||
105826744|NCT01175135|365024301|FG003|Overall Study|Withdrawal by Subject|5|||
105826745|NCT01175135|365024298|FG000|Overall Study|Other|3|||
105826746|NCT01175135|365024299|FG001|Overall Study|Other|1|||
105826747|NCT01175135|365024300|FG002|Overall Study|Other|3|||
105826748|NCT01175135|365024301|FG003|Overall Study|Other|0|||
105826749|NCT01175135|365024298|FG000|Overall Study|Randomized But Not Treated|0|||
105826750|NCT01175135|365024299|FG001|Overall Study|Randomized But Not Treated|0|||
105826751|NCT01175135|365024300|FG002|Overall Study|Randomized But Not Treated|1|||
105826752|NCT01175135|365024301|FG003|Overall Study|Randomized But Not Treated|0|||
105826753|NCT03428750|365024305|FG000|Overall Study|Withdrawal by Subject|11|||
105826754|NCT03428750|365024306|FG001|Overall Study|Withdrawal by Subject|10|||
105826755|NCT03428750|365024305|FG000|Overall Study|Lost to Follow-up|3|||
105826756|NCT03428750|365024306|FG001|Overall Study|Lost to Follow-up|9|||
105826757|NCT03428750|365024305|FG000|Overall Study|Adverse Event|9|||
105826758|NCT03428750|365024306|FG001|Overall Study|Adverse Event|1|||
105826759|NCT03428750|365024305|FG000|Overall Study|Protocol Violation|1|||
105826760|NCT03428750|365024306|FG001|Overall Study|Protocol Violation|0|||
105826761|NCT03428750|365024305|FG000|Overall Study|Administrative|0|||
105826762|NCT03428750|365024306|FG001|Overall Study|Administrative|1|||
105826763|NCT02554877|365024309|FG000|Overall Study|Adverse Event|2|||
105826764|NCT02554877|365024310|FG001|Overall Study|Adverse Event|0|||
105826765|NCT02554877|365024311|FG002|Overall Study|Adverse Event|0|||
105826766|NCT02554877|365024312|FG003|Overall Study|Adverse Event|1|||
105826767|NCT02554877|365024309|FG000|Overall Study|Lost to Follow-up|1|||
105826768|NCT02554877|365024310|FG001|Overall Study|Lost to Follow-up|1|||
105826769|NCT02554877|365024311|FG002|Overall Study|Lost to Follow-up|1|||
105826770|NCT02554877|365024312|FG003|Overall Study|Lost to Follow-up|2|||
105826771|NCT02554877|365024309|FG000|Overall Study|Did not meet entrance criteria|0|||
105826772|NCT02554877|365024310|FG001|Overall Study|Did not meet entrance criteria|0|||
105826773|NCT02554877|365024311|FG002|Overall Study|Did not meet entrance criteria|1|||
105826774|NCT02554877|365024312|FG003|Overall Study|Did not meet entrance criteria|0|||
105826775|NCT02554877|365024309|FG000|Overall Study|No longer met eligibility criteria|1|||
105826776|NCT02554877|365024310|FG001|Overall Study|No longer met eligibility criteria|0|||
105826777|NCT02554877|365024311|FG002|Overall Study|No longer met eligibility criteria|1|||
105826778|NCT02554877|365024312|FG003|Overall Study|No longer met eligibility criteria|1|||
105826779|NCT02554877|365024309|FG000|Overall Study|Protocol Violation|3|||
105826780|NCT02554877|365024310|FG001|Overall Study|Protocol Violation|1|||
105826781|NCT02554877|365024311|FG002|Overall Study|Protocol Violation|1|||
105826782|NCT02554877|365024312|FG003|Overall Study|Protocol Violation|0|||
105826783|NCT02554877|365024309|FG000|Overall Study|Other|1|||
105826784|NCT02554877|365024310|FG001|Overall Study|Other|3|||
105826785|NCT02554877|365024311|FG002|Overall Study|Other|0|||
105826786|NCT02554877|365024312|FG003|Overall Study|Other|3|||
105826787|NCT02554877|365024309|FG000|Overall Study|Insufficient clinical response|4|||
105826788|NCT02554877|365024310|FG001|Overall Study|Insufficient clinical response|0|||
105826789|NCT02554877|365024311|FG002|Overall Study|Insufficient clinical response|0|||
105826790|NCT02554877|365024312|FG003|Overall Study|Insufficient clinical response|0|||
105826791|NCT02554877|365024309|FG000|Overall Study|No longer willing to participate|0|||
105826792|NCT02554877|365024310|FG001|Overall Study|No longer willing to participate|2|||
105826793|NCT02554877|365024311|FG002|Overall Study|No longer willing to participate|2|||
105826794|NCT02554877|365024312|FG003|Overall Study|No longer willing to participate|0|||
105826795|NCT00274651|365024313|FG000|Overall Study|Adverse Event|6|||
105826796|NCT00274651|365024314|FG001|Overall Study|Adverse Event|3|||
105826797|NCT00274651|365024313|FG000|Overall Study|Lack of Efficacy|13|||
105826798|NCT00274651|365024314|FG001|Overall Study|Lack of Efficacy|6|||
105826799|NCT00274651|365024313|FG000|Overall Study|Death|1|||
105826800|NCT00274651|365024314|FG001|Overall Study|Death|3|||
105826801|NCT00274651|365024313|FG000|Overall Study|Withdrawal by Subject|0|||
105826802|NCT00274651|365024314|FG001|Overall Study|Withdrawal by Subject|1|||
105826803|NCT00274651|365024313|FG000|Overall Study|Physician Decision|8|||
105826804|NCT00274651|365024314|FG001|Overall Study|Physician Decision|7|||
105826805|NCT00918645|365024315|FG000|Overall Study|Withdrawal by Subject|1|||
105826806|NCT00107991|365024316|FG000|Eligibility Assessment|Disease not severe enough|7|||
105826807|NCT00107991|365024316|FG000|Eligibility Assessment|Unwilling to participate|7|||
105826808|NCT00107991|365024316|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
105826809|NCT00107991|365024316|FG000|Eligibility Assessment|Abnormal labs|2|||
105826810|NCT00107991|365024316|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
105826811|NCT00107991|365024316|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
105826812|NCT00107991|365024316|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
105826813|NCT00107991|365024316|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
105826814|NCT00107991|365024316|FG000|12 Week Treatment Period|Adverse Event|1|||
105826815|NCT00107991|365024316|FG000|12 Week Treatment Period|Protocol Violation|1|||
105826816|NCT00107991|365024316|FG000|12 Week Treatment Period|Incarcerated|1|||
105826817|NCT00107991|365024316|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
105826818|NCT04547192|365024317|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
105826819|NCT04547192|365024318|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
105826820|NCT04547192|365024319|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
105366235|NCT00274742|363346611|FG004|Overall Study|Disease Progression|1|||
105826821|NCT04547192|365024320|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
105826822|NCT04547192|365024317|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
105826823|NCT04547192|365024318|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
105826824|NCT04547192|365024319|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
105826825|NCT04547192|365024320|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
105826826|NCT04547192|365024317|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
105826827|NCT04547192|365024318|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
105826828|NCT04547192|365024319|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
105826829|NCT04547192|365024320|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
105826830|NCT04547192|365024317|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
105826831|NCT04547192|365024318|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
105826832|NCT04547192|365024319|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
105826833|NCT04547192|365024320|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
105826834|NCT04547192|365024317|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
105826835|NCT04547192|365024318|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
105826836|NCT04547192|365024319|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
105826837|NCT04547192|365024320|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
105826838|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
105826839|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
105826840|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
105826841|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
105826842|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
105826843|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
105826844|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
105826845|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
105826846|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
105826847|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
105826848|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
105826849|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
105826850|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
105826851|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
105826852|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
105826853|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
105826854|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
105826855|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
105826856|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
105826857|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
105826858|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
105826859|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
105826860|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
105826861|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
105826862|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
105826863|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
105826864|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
105826865|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
105826866|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
105826867|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
105826868|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
105826869|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
105826870|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
105826871|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
105826872|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
105826873|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
105826874|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
105826875|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
105826876|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
105826877|NCT04194801|365024321|FG000|Part Ib/II End of Study|Death|2|||
105826878|NCT04194801|365024322|FG001|Part Ib/II End of Study|Death|3|||
105826879|NCT04194801|365024323|FG002|Part Ib/II End of Study|Death|3|||
105826880|NCT04194801|365024321|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
105488434|NCT00667446|363800405|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
105826881|NCT04194801|365024322|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
105366236|NCT00274742|363346612|FG005|Overall Study|Disease Progression|0|||
105768717|NCT02201251|364804513|FG001|Overall Study|Adverse Event|1|||
105768718|NCT02201251|364804512|FG000|Overall Study|Protocol Violation|1|||
105768719|NCT02201251|364804513|FG001|Overall Study|Protocol Violation|0|||
105768720|NCT02201251|364804512|FG000|Overall Study|Noncompliance with Study Drug|0|||
105768721|NCT02201251|364804513|FG001|Overall Study|Noncompliance with Study Drug|1|||
105768722|NCT02201251|364804512|FG000|Overall Study|Withdrawal by Subject|2|||
105768723|NCT02201251|364804513|FG001|Overall Study|Withdrawal by Subject|1|||
105768724|NCT01819194|364804514|FG000|Overall Study|Loss of study articles|2|||
105768725|NCT00023712|364804519|FG000|Overall Study|Not platinum sensitive|1|||
105768726|NCT00023712|364804520|FG001|Overall Study|Not platinum sensitive|0|||
105768727|NCT00023712|364804519|FG000|Overall Study|Never treated|1|||
105768728|NCT00023712|364804520|FG001|Overall Study|Never treated|1|||
105768729|NCT02392468|364804521|FG000|Overall Study|Adverse Event|0|||
105768730|NCT02392468|364804522|FG001|Overall Study|Adverse Event|1|||
105768731|NCT02392468|364804523|FG002|Overall Study|Adverse Event|0|||
105768732|NCT02392468|364804524|FG003|Overall Study|Adverse Event|0|||
105768733|NCT02392468|364804525|FG004|Overall Study|Adverse Event|0|||
105768734|NCT02392468|364804526|FG005|Overall Study|Adverse Event|1|||
105768735|NCT01039428|364804527|FG000|Overall Study|Protocol Violation|1|||
105768736|NCT01039428|364804528|FG001|Overall Study|Protocol Violation|0|||
105768737|NCT01039428|364804527|FG000|Overall Study|Withdrawal by Subject|1|||
105768738|NCT01039428|364804528|FG001|Overall Study|Withdrawal by Subject|0|||
105768739|NCT01922739|364804533|FG000|Titration/Adjustment Period|Adverse Event|3|||
105768740|NCT01922739|364804533|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
105768741|NCT01922739|364804533|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
105768742|NCT01922739|364804533|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
105768743|NCT01922739|364804533|FG000|Open-label Treatment Period|Adverse Event|6|||
105768744|NCT01922739|364804533|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
105768745|NCT01922739|364804533|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
105768746|NCT01922739|364804533|FG000|Open-label Treatment Period|Protocol Violation|5|||
105768747|NCT01922739|364804533|FG000|Open-label Treatment Period|Pregnancy|1|||
105768748|NCT01922739|364804533|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
105768749|NCT01922739|364804533|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
105768750|NCT01922739|364804533|FG000|Open-label Treatment Period|Physician Decision|1|||
105768751|NCT01922739|364804533|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
105768752|NCT01624467|364804535|FG000|Overall Study|Withdrawal by Subject|2|||
105768753|NCT01624467|364804535|FG000|Overall Study|Lost to Follow-up|1|||
105768754|NCT01624467|364804535|FG000|Overall Study|Adverse Event|7|||
105768755|NCT01624467|364804535|FG000|Overall Study|Progressive Disease|19|||
105768756|NCT01624467|364804535|FG000|Overall Study|Per Sponsor Requirement|1|||
105768757|NCT01624467|364804535|FG000|Overall Study|Subject Withdrew from Treatment|1|||
105768758|NCT04498468|364804536|FG000|Overall Study|Lost to Follow-up|3|||
105768759|NCT03399786|364804539|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
105768760|NCT03399786|364804540|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
105768761|NCT03399786|364804541|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
105768762|NCT03399786|364804542|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
105768763|NCT03399786|364804539|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
105768764|NCT03399786|364804540|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
105366237|NCT00274742|363346607|FG000|Overall Study|Other|0|||
105826882|NCT04194801|365024323|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
105366238|NCT00274742|363346608|FG001|Overall Study|Other|3|||
105366239|NCT00274742|363346609|FG002|Overall Study|Other|0|||
105366240|NCT00274742|363346610|FG003|Overall Study|Other|0|||
105366241|NCT00274742|363346611|FG004|Overall Study|Other|2|||
105366242|NCT00274742|363346612|FG005|Overall Study|Other|0|||
105366243|NCT02567188|363346613|FG000|Overall Study|Death|10|||
105366244|NCT02567188|363346613|FG000|Overall Study|Terminated Mircera Treatment|9|||
105366245|NCT02567188|363346613|FG000|Overall Study|Lost to Follow-up|5|||
105366246|NCT02567188|363346613|FG000|Overall Study|Adverse Event|1|||
105366247|NCT02567188|363346613|FG000|Overall Study|Withdrawal by Subject|1|||
105366248|NCT02567188|363346613|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
105366249|NCT02567188|363346613|FG000|Overall Study|Moved and Changed Clinic|1|||
105366250|NCT02567188|363346613|FG000|Overall Study|Started Hemodialysis|2|||
105366251|NCT02567188|363346613|FG000|Overall Study|Protocol Violation|5|||
105366252|NCT02666222|363346618|FG000|Overall Study|Death|2|||
105366253|NCT00072384|363346621|FG000|Overall Study|Physician Decision|1|||
105366254|NCT00072384|363346621|FG000|Overall Study|Ineligible|8|||
105366255|NCT04233879|363346623|FG000|Overall Study|Death|2|||
105366256|NCT04233879|363346624|FG001|Overall Study|Death|0|||
105366257|NCT04233879|363346623|FG000|Overall Study|Lost to Follow-up|3|||
105366258|NCT04233879|363346624|FG001|Overall Study|Lost to Follow-up|8|||
105366259|NCT04233879|363346623|FG000|Overall Study|Physician Decision|4|||
105366260|NCT04233879|363346624|FG001|Overall Study|Physician Decision|4|||
105366261|NCT04233879|363346623|FG000|Overall Study|Withdrawal by Subject|7|||
105366262|NCT04233879|363346624|FG001|Overall Study|Withdrawal by Subject|10|||
105366263|NCT04233879|363346623|FG000|Overall Study|Other|281|||
105366264|NCT04233879|363346624|FG001|Overall Study|Other|279|||
105366265|NCT02127658|363346627|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
105366266|NCT02127658|363346628|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
105366267|NCT02127658|363346627|FG000|Overall Study|Withdrawal by Subject|0|||
105366268|NCT02127658|363346628|FG001|Overall Study|Withdrawal by Subject|2|||
105488435|NCT00667446|363800406|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
105488436|NCT00667446|363800405|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
105366269|NCT02127658|363346627|FG000|Overall Study|Physician Decision|0|||
105366270|NCT02127658|363346628|FG001|Overall Study|Physician Decision|1|||
105366271|NCT01802385|363346629|FG000|Overall Study|Death|106|||
105366272|NCT01802385|363346630|FG001|Overall Study|Death|120|||
105366273|NCT02277028|363346635|FG000|Overall Study|Lost to Follow-up|1|||
105366274|NCT02277028|363346636|FG001|Overall Study|Lost to Follow-up|0|||
105826883|NCT04194801|365024321|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
105826884|NCT04194801|365024322|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
105826885|NCT04194801|365024323|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
105826886|NCT04194801|365024321|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
105826887|NCT04194801|365024322|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
105826888|NCT04194801|365024323|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
105826889|NCT04194801|365024321|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
105826890|NCT04194801|365024322|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
105826891|NCT04194801|365024323|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
105826892|NCT01923740|365024329|FG000|Overall Study|Lost to Follow-up|4|||
105826893|NCT01923740|365024330|FG001|Overall Study|Lost to Follow-up|9|||
105826894|NCT01923740|365024329|FG000|Overall Study|Withdrawal by Subject|2|||
105826895|NCT01923740|365024330|FG001|Overall Study|Withdrawal by Subject|0|||
105826896|NCT04723693|365024331|FG000|Overall Study|Withdrawal by Subject|2|||
105826897|NCT03669861|365024332|FG000|Overall Study|Disease Flare|5|||
105826898|NCT03669861|365024332|FG000|Overall Study|Lack of Efficacy|2|||
105826899|NCT00294047|365024333|FG000|Month 48|Adverse Event|28|||
105826900|NCT00294047|365024334|FG001|Month 48|Adverse Event|13|||
105826901|NCT00294047|365024333|FG000|Month 48|Protocol Violation|4|||
105826902|NCT00294047|365024334|FG001|Month 48|Protocol Violation|4|||
105366275|NCT02277028|363346635|FG000|Overall Study|Withdrawal by Subject|0|||
105366276|NCT02277028|363346636|FG001|Overall Study|Withdrawal by Subject|1|||
105366277|NCT01172873|363346638|FG000|Overall Study|Withdrawal by Subject|3|||
105366278|NCT01172873|363346639|FG001|Overall Study|Withdrawal by Subject|2|||
105366279|NCT01038687|363346644|FG000|Overall Study|Adverse Event|0|||
105366280|NCT01038687|363346645|FG001|Overall Study|Adverse Event|2|||
105366281|NCT01038687|363346646|FG002|Overall Study|Adverse Event|1|||
105366282|NCT04344301|363346647|FG000|Overall Study|Withdrawal by Subject|1|||
105366283|NCT04344301|363346648|FG001|Overall Study|Withdrawal by Subject|0|||
105366284|NCT04344301|363346647|FG000|Overall Study|Death|0|||
105366285|NCT04344301|363346648|FG001|Overall Study|Death|1|||
105366286|NCT00606307|363346653|FG000|Overall Study|Adverse Event|2|||
105366287|NCT00606307|363346653|FG000|Overall Study|Withdrawal by Subject|2|||
105366288|NCT00606307|363346653|FG000|Overall Study|Disease progression|6|||
105366289|NCT00606307|363346653|FG000|Overall Study|QTc prolongation|1|||
105366290|NCT03669588|363346661|FG000|Overall Study|Adverse Event|1|||
105366291|NCT03669588|363346662|FG001|Overall Study|Adverse Event|0|||
105366292|NCT03669588|363346661|FG000|Overall Study|Physician Decision|0|||
105366293|NCT03669588|363346662|FG001|Overall Study|Physician Decision|1|||
105366294|NCT03669588|363346661|FG000|Overall Study|Protocol Violation|1|||
105366295|NCT03669588|363346662|FG001|Overall Study|Protocol Violation|0|||
105366296|NCT03669588|363346661|FG000|Overall Study|Sponsor Decision|1|||
105366297|NCT03669588|363346662|FG001|Overall Study|Sponsor Decision|1|||
105366298|NCT03669588|363346661|FG000|Overall Study|Withdrawal by Subject|1|||
105488437|NCT00667446|363800406|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
105366299|NCT03669588|363346662|FG001|Overall Study|Withdrawal by Subject|4|||
105488438|NCT00667446|363800405|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
105488439|NCT00667446|363800406|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
105488440|NCT00667446|363800405|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
105488441|NCT00667446|363800406|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
105488442|NCT00667446|363800405|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
105488443|NCT00667446|363800406|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
105488444|NCT00136604|363800407|FG000|Overall Study|Lost to Follow-up|1|||
105488445|NCT00136604|363800408|FG001|Overall Study|Lost to Follow-up|0|||
105488446|NCT00136604|363800409|FG002|Overall Study|Lost to Follow-up|0|||
105488447|NCT00136604|363800410|FG003|Overall Study|Lost to Follow-up|0|||
105488448|NCT00136604|363800411|FG004|Overall Study|Lost to Follow-up|1|||
105366300|NCT03669588|363346661|FG000|Overall Study|Rescue Therapy Needed|0|||
105366301|NCT03669588|363346662|FG001|Overall Study|Rescue Therapy Needed|1|||
105366302|NCT02008526|363346663|FG000|Overall Study|Death|0|||
105366303|NCT02008526|363346664|FG001|Overall Study|Death|2|||
105366304|NCT02008526|363346665|FG002|Overall Study|Death|1|||
105366305|NCT02008526|363346663|FG000|Overall Study|Withdrawal by Subject|3|||
105366306|NCT02008526|363346664|FG001|Overall Study|Withdrawal by Subject|3|||
105366307|NCT02008526|363346665|FG002|Overall Study|Withdrawal by Subject|2|||
105366308|NCT02008526|363346663|FG000|Overall Study|Lost to Follow-up|5|||
105366309|NCT02008526|363346664|FG001|Overall Study|Lost to Follow-up|9|||
105366310|NCT02008526|363346665|FG002|Overall Study|Lost to Follow-up|6|||
105366311|NCT01883895|363346666|FG000|Overall Study|Lost to Follow-up|2|||
105366312|NCT01100502|363346667|FG000|Overall Study|Withdrawal by Subject|18|||
105366313|NCT01100502|363346668|FG001|Overall Study|Withdrawal by Subject|25|||
105366314|NCT01100502|363346667|FG000|Overall Study|Lost to Follow-up|13|||
105366315|NCT01100502|363346668|FG001|Overall Study|Lost to Follow-up|28|||
105366316|NCT01100502|363346667|FG000|Overall Study|Site request to end participation in study|0|||
105366317|NCT01100502|363346668|FG001|Overall Study|Site request to end participation in study|1|||
105366318|NCT01100502|363346667|FG000|Overall Study|Death|45|||
105366319|NCT01100502|363346668|FG001|Overall Study|Death|40|||
105366320|NCT04194814|363346669|FG000|Overall Study|Physician Decision|3|||
105366321|NCT04194814|363346670|FG001|Overall Study|Physician Decision|0|||
105366322|NCT04194814|363346669|FG000|Overall Study|Withdrawal by Subject|0|||
105366323|NCT04194814|363346670|FG001|Overall Study|Withdrawal by Subject|2|||
105366324|NCT01094288|363348352|FG000|Overall Study|Adverse Event|0|||
105366325|NCT01094288|363348353|FG001|Overall Study|Adverse Event|3|||
105366326|NCT01094288|363348354|FG002|Overall Study|Adverse Event|1|||
105366327|NCT01094288|363348355|FG003|Overall Study|Adverse Event|1|||
105573799|NCT04921969|364098595|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105573800|NCT04921969|364098596|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
105573801|NCT04921969|364098597|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105573802|NCT04921969|364098598|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
105573803|NCT04921969|364098599|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
105573804|NCT04921969|364098593|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
105573805|NCT04921969|364098594|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
105573806|NCT04921969|364098595|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
105573807|NCT04921969|364098596|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
105573808|NCT04921969|364098597|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
105573809|NCT04921969|364098598|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
105573810|NCT04921969|364098599|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
105573811|NCT04921969|364098593|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
105573812|NCT04921969|364098594|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
105573813|NCT04921969|364098595|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
105573814|NCT04921969|364098596|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
105573815|NCT04921969|364098597|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
105366328|NCT01094288|363348356|FG004|Overall Study|Adverse Event|0|||
105366329|NCT01094288|363348357|FG005|Overall Study|Adverse Event|0|||
105366330|NCT01094288|363348358|FG006|Overall Study|Adverse Event|0|||
105366331|NCT01094288|363348359|FG007|Overall Study|Adverse Event|0|||
105488449|NCT00136604|363800407|FG000|Overall Study|Migrated/moved from study area|0|||
105488450|NCT00136604|363800408|FG001|Overall Study|Migrated/moved from study area|1|||
105488451|NCT00136604|363800409|FG002|Overall Study|Migrated/moved from study area|0|||
105488452|NCT00136604|363800410|FG003|Overall Study|Migrated/moved from study area|0|||
105488453|NCT00136604|363800411|FG004|Overall Study|Migrated/moved from study area|0|||
105488454|NCT03945175|363800413|FG000|Overall Study|Did not meet inclusion criteria|31|||
105488455|NCT03945175|363800413|FG000|Overall Study|Withdrew consent|2|||
105488456|NCT03945175|363800413|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
105488457|NCT03945175|363800413|FG000|Overall Study|Early termination during Mydayis treatment|1|||
105488458|NCT00870233|363800417|FG000|Overall Study|Withdrawal by Subject|18|||
105488459|NCT00870233|363800417|FG000|Overall Study|Did not undergo laparotomy|3|||
105488460|NCT00870233|363800417|FG000|Overall Study|Incompatible internet browser|2|||
105488461|NCT00870233|363800417|FG000|Overall Study|Death|1|||
105488462|NCT01233687|363800419|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
105488463|NCT01233687|363800419|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
105488464|NCT01233687|363800419|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
105488465|NCT01858636|363800420|FG000|Overall Study|No Device Deployment Attempted|24|||
105488466|NCT01858636|363800420|FG000|Overall Study|Physician Decision|1|||
105488467|NCT01858636|363800420|FG000|Overall Study|Death|1|||
105488468|NCT01858636|363800420|FG000|Overall Study|Lost to Follow-up|1|||
105488469|NCT01858636|363800420|FG000|Overall Study|Withdrawal by Subject|1|||
105488470|NCT00006389|363800423|FG000|Overall Study|Adverse Event|1|||
105488471|NCT01227564|363800427|FG000|Overall Study|No Longer Willing to Participate|4|||
105488472|NCT01227564|363800428|FG001|Overall Study|No Longer Willing to Participate|2|||
105488473|NCT01227564|363800429|FG002|Overall Study|No Longer Willing to Participate|5|||
105488474|NCT01227564|363800427|FG000|Overall Study|Participant moved to another town|0|||
105488475|NCT01227564|363800428|FG001|Overall Study|Participant moved to another town|0|||
105488476|NCT01227564|363800429|FG002|Overall Study|Participant moved to another town|1|||
105488477|NCT00989573|363800438|FG000|Overall Study|Adverse Event|8|||
105488478|NCT00989573|363800439|FG001|Overall Study|Adverse Event|12|||
105488479|NCT00989573|363800440|FG002|Overall Study|Adverse Event|4|||
105488480|NCT00989573|363800438|FG000|Overall Study|Physician Decision|0|||
105488481|NCT00989573|363800439|FG001|Overall Study|Physician Decision|2|||
105488482|NCT00989573|363800440|FG002|Overall Study|Physician Decision|0|||
105488483|NCT00989573|363800438|FG000|Overall Study|Protocol Violation|1|||
105488484|NCT00989573|363800439|FG001|Overall Study|Protocol Violation|1|||
105488485|NCT00989573|363800440|FG002|Overall Study|Protocol Violation|1|||
105488486|NCT00989573|363800438|FG000|Overall Study|Withdrawal by Subject|4|||
105488487|NCT00989573|363800439|FG001|Overall Study|Withdrawal by Subject|7|||
105488488|NCT00989573|363800440|FG002|Overall Study|Withdrawal by Subject|3|||
105488489|NCT00194675|363800444|FG000|Overall Study|Lost to Follow-up|1|||
105488490|NCT00194675|363800445|FG001|Overall Study|Lost to Follow-up|1|||
105488491|NCT00194675|363800444|FG000|Overall Study|lack of interest|1|||
105488492|NCT00194675|363800445|FG001|Overall Study|lack of interest|1|||
105488493|NCT00194675|363800444|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
105488494|NCT00194675|363800445|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
105488495|NCT00194675|363800444|FG000|Overall Study|Protocol Violation|1|||
105488496|NCT00194675|363800445|FG001|Overall Study|Protocol Violation|0|||
105488497|NCT00194675|363800444|FG000|Overall Study|Death|1|||
105488498|NCT00194675|363800445|FG001|Overall Study|Death|0|||
105488499|NCT03500679|363800452|FG000|Overall Study|Lost to Follow-up|6|||
105488500|NCT03500679|363800453|FG001|Overall Study|Lost to Follow-up|3|||
105488501|NCT03500679|363800452|FG000|Overall Study|Withdrawal by Subject|3|||
105488502|NCT03500679|363800453|FG001|Overall Study|Withdrawal by Subject|0|||
105488503|NCT01962922|363800454|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
105488504|NCT01962922|363800455|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
105488505|NCT01962922|363800454|FG000|PK Portion Day 7|non-compliance|1|||
105488506|NCT01962922|363800455|FG001|PK Portion Day 7|non-compliance|0|||
105488507|NCT01962922|363800454|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
105488508|NCT01962922|363800455|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
105488509|NCT01962922|363800454|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
105488510|NCT01962922|363800455|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
105488511|NCT01476644|363800456|FG000|Overall Study|Death|5|||
105488512|NCT01476644|363800456|FG000|Overall Study|moved to another state|2|||
105488513|NCT01476644|363800456|FG000|Overall Study|Lost to Follow-up|19|||
105488514|NCT01476644|363800456|FG000|Overall Study|Withdrawal by Subject|13|||
105488515|NCT04271280|363800457|FG000|Overall Study|Lost to Follow-up|300|||
105488516|NCT04271280|363800457|FG000|Overall Study|Death|153|||
105488517|NCT04271280|363800457|FG000|Overall Study|Withdrawal of consent by patient|59|||
105488518|NCT04271280|363800457|FG000|Overall Study|Other|51|||
105488519|NCT04271280|363800457|FG000|Overall Study|No end of study information|42|||
105488520|NCT00744471|363800458|FG000|Overall Study|Randomized but not treated|1|||
105488521|NCT00744471|363800459|FG001|Overall Study|Randomized but not treated|1|||
105488522|NCT00744471|363800460|FG002|Overall Study|Randomized but not treated|4|||
105488523|NCT00744471|363800461|FG003|Overall Study|Randomized but not treated|0|||
105488524|NCT00744471|363800458|FG000|Overall Study|Death|0|||
105488525|NCT00744471|363800459|FG001|Overall Study|Death|0|||
105488526|NCT00744471|363800460|FG002|Overall Study|Death|0|||
105488527|NCT00744471|363800461|FG003|Overall Study|Death|1|||
105488528|NCT00744471|363800458|FG000|Overall Study|Adverse Event|6|||
105488529|NCT00744471|363800459|FG001|Overall Study|Adverse Event|7|||
105488530|NCT00744471|363800460|FG002|Overall Study|Adverse Event|5|||
105488531|NCT00744471|363800461|FG003|Overall Study|Adverse Event|9|||
105573816|NCT04921969|364098598|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
105573817|NCT04921969|364098599|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
105573818|NCT04921969|364098593|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
105573819|NCT04921969|364098594|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
105573820|NCT04921969|364098595|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
105573821|NCT04921969|364098596|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
105573822|NCT04921969|364098597|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
105573823|NCT04921969|364098598|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
105573824|NCT04921969|364098599|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
105488532|NCT00744471|363800458|FG000|Overall Study|Withdrawal by Subject|9|||
105488533|NCT00744471|363800459|FG001|Overall Study|Withdrawal by Subject|9|||
105488534|NCT00744471|363800460|FG002|Overall Study|Withdrawal by Subject|15|||
105488535|NCT00744471|363800461|FG003|Overall Study|Withdrawal by Subject|12|||
105488536|NCT00744471|363800458|FG000|Overall Study|Protocol Violation|1|||
105488537|NCT00744471|363800459|FG001|Overall Study|Protocol Violation|4|||
105488538|NCT00744471|363800460|FG002|Overall Study|Protocol Violation|1|||
105488539|NCT00744471|363800461|FG003|Overall Study|Protocol Violation|2|||
105488540|NCT00744471|363800458|FG000|Overall Study|Entered extension study|41|||
105488541|NCT00744471|363800459|FG001|Overall Study|Entered extension study|84|||
105488542|NCT00744471|363800460|FG002|Overall Study|Entered extension study|100|||
105488543|NCT00744471|363800461|FG003|Overall Study|Entered extension study|91|||
105488544|NCT00744471|363800458|FG000|Overall Study|Other|2|||
105488545|NCT00744471|363800459|FG001|Overall Study|Other|3|||
105573825|NCT04921969|364098593|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
105573826|NCT04921969|364098594|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
105826903|NCT00294047|365024333|FG000|Month 48|Withdrawal by Subject|111|||
105826904|NCT00294047|365024334|FG001|Month 48|Withdrawal by Subject|115|||
105826905|NCT00294047|365024333|FG000|Month 48|Lost to Follow-up|272|||
105826906|NCT00294047|365024334|FG001|Month 48|Lost to Follow-up|287|||
105826907|NCT00294047|365024333|FG000|Month 48|Other|10|||
105826908|NCT00294047|365024334|FG001|Month 48|Other|14|||
105826909|NCT00294047|365024333|FG000|Month 84|Adverse Event|4|||
105826910|NCT00294047|365024334|FG001|Month 84|Adverse Event|2|||
105826911|NCT00294047|365024333|FG000|Month 84|Protocol Violation|1|||
105826912|NCT00294047|365024334|FG001|Month 84|Protocol Violation|1|||
105826913|NCT00294047|365024333|FG000|Month 84|Withdrawal by Subject|33|||
105826914|NCT00294047|365024334|FG001|Month 84|Withdrawal by Subject|31|||
105826915|NCT00294047|365024333|FG000|Month 84|Lost to Follow-up|187|||
105826916|NCT00294047|365024334|FG001|Month 84|Lost to Follow-up|190|||
105826917|NCT00294047|365024333|FG000|Month 84|Absent Cervix|2|||
105826918|NCT00294047|365024334|FG001|Month 84|Absent Cervix|0|||
105826919|NCT00294047|365024333|FG000|Month 84|Work related reasons|4|||
105826920|NCT00294047|365024334|FG001|Month 84|Work related reasons|2|||
105826921|NCT00294047|365024333|FG000|Month 84|Center closed, subject did not transfer|1|||
105826922|NCT00294047|365024334|FG001|Month 84|Center closed, subject did not transfer|0|||
105826923|NCT00294047|365024333|FG000|Month 84|Family problems|2|||
105826924|NCT00294047|365024334|FG001|Month 84|Family problems|2|||
105573827|NCT04921969|364098595|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
105573828|NCT04921969|364098596|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
105573829|NCT04921969|364098597|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
105573830|NCT04921969|364098598|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
105573831|NCT04921969|364098599|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
105573832|NCT04921969|364098593|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
105826925|NCT00294047|365024333|FG000|Month 84|Lack of time|3|||
105826926|NCT00294047|365024334|FG001|Month 84|Lack of time|1|||
105826927|NCT00294047|365024333|FG000|Month 84|Personal reason|2|||
105366332|NCT01094288|363348352|FG000|Overall Study|Withdrawal by Subject|0|||
105366333|NCT01094288|363348353|FG001|Overall Study|Withdrawal by Subject|1|||
105573833|NCT04921969|364098594|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
105573834|NCT04921969|364098595|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
105573835|NCT04921969|364098596|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
105488546|NCT00744471|363800460|FG002|Overall Study|Other|6|||
105488547|NCT00744471|363800461|FG003|Overall Study|Other|2|||
105573836|NCT04921969|364098597|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
105488548|NCT00744471|363800458|FG000|Overall Study|Lack of Efficacy|83|||
105488549|NCT00744471|363800459|FG001|Overall Study|Lack of Efficacy|37|||
105826928|NCT00294047|365024334|FG001|Month 84|Personal reason|4|||
105826929|NCT00294047|365024333|FG000|Month 84|Subject does not want male physician|1|||
105573837|NCT04921969|364098598|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
105573838|NCT04921969|364098599|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
105573839|NCT04921969|364098593|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
105573840|NCT04921969|364098594|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
105573841|NCT04921969|364098595|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
105573842|NCT04921969|364098596|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
105573843|NCT04921969|364098597|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
105573844|NCT04921969|364098598|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
105573845|NCT04921969|364098599|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
105573846|NCT03391960|364098600|FG000|Overall Study|Protocol Violation|0|||
105573847|NCT03391960|364098601|FG001|Overall Study|Protocol Violation|0|||
105573848|NCT02924389|364098602|FG000|Overall Study|Lost to Follow-up|1|||
105826930|NCT00294047|365024334|FG001|Month 84|Subject does not want male physician|0|||
105573849|NCT02924389|364098603|FG001|Overall Study|Lost to Follow-up|0|||
105573850|NCT02924389|364098602|FG000|Overall Study|Physician Decision|2|||
105573851|NCT02924389|364098603|FG001|Overall Study|Physician Decision|0|||
105573852|NCT02924389|364098602|FG000|Overall Study|Withdrawal by Subject|3|||
105573853|NCT02924389|364098603|FG001|Overall Study|Withdrawal by Subject|0|||
105573854|NCT02924389|364098602|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
105573855|NCT02924389|364098603|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
105573856|NCT00663117|364100124|FG000|Overall Study|Lack of Efficacy|1|||
105573857|NCT00663117|364100125|FG001|Overall Study|Lack of Efficacy|0|||
105573858|NCT00767104|364100126|FG000|Overall Study|Lost to Follow-up|1|||
105573859|NCT00767104|364100127|FG001|Overall Study|Lost to Follow-up|2|||
105573860|NCT02791490|364100128|FG000|Overall Study|Lost to Follow-up|1|||
105573861|NCT02791490|364100129|FG001|Overall Study|Lost to Follow-up|2|||
105826931|NCT00294047|365024333|FG000|Month 84|Transport reimbursement delayed|0|||
105573862|NCT02791490|364100128|FG000|Overall Study|Withdrawal by Subject|2|||
105573863|NCT02791490|364100129|FG001|Overall Study|Withdrawal by Subject|6|||
105573864|NCT03462706|364100130|FG000|Overall Study|Polyp was pedunculated|1|||
105573865|NCT03462706|364100131|FG001|Overall Study|Polyp was pedunculated|0|||
105573866|NCT03462706|364100132|FG002|Overall Study|Polyp was pedunculated|1|||
105826932|NCT00294047|365024334|FG001|Month 84|Transport reimbursement delayed|1|||
105573867|NCT03462706|364100133|FG003|Overall Study|Polyp was pedunculated|0|||
105573868|NCT03462706|364100130|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
105573869|NCT03462706|364100131|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
105573870|NCT03462706|364100132|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
105573871|NCT03462706|364100133|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
105573872|NCT01984424|364100139|FG000|Overall Study|Withdrawal by Subject|3|||
105573873|NCT01984424|364100140|FG001|Overall Study|Withdrawal by Subject|5|||
105573874|NCT01984424|364100139|FG000|Overall Study|Sponsor Decision|0|||
105573875|NCT01984424|364100140|FG001|Overall Study|Sponsor Decision|1|||
105573876|NCT01984424|364100139|FG000|Overall Study|Lost to Follow-up|0|||
105573877|NCT01984424|364100140|FG001|Overall Study|Lost to Follow-up|1|||
105573878|NCT03661996|364100145|FG000|Overall Study|Adverse Event|0|||
105573879|NCT03661996|364100146|FG001|Overall Study|Adverse Event|0|||
105573880|NCT03661996|364100147|FG002|Overall Study|Adverse Event|1|||
105573881|NCT03661996|364100148|FG003|Overall Study|Adverse Event|1|||
105573882|NCT03661996|364100149|FG004|Overall Study|Adverse Event|0|||
105573883|NCT03661996|364100145|FG000|Overall Study|Lost to Follow-up|5|||
105573884|NCT03661996|364100146|FG001|Overall Study|Lost to Follow-up|1|||
105573885|NCT03661996|364100147|FG002|Overall Study|Lost to Follow-up|2|||
105573886|NCT03661996|364100148|FG003|Overall Study|Lost to Follow-up|2|||
105573887|NCT03661996|364100149|FG004|Overall Study|Lost to Follow-up|6|||
105573888|NCT03661996|364100145|FG000|Overall Study|Physician Decision|1|||
105573889|NCT03661996|364100146|FG001|Overall Study|Physician Decision|1|||
105573890|NCT03661996|364100147|FG002|Overall Study|Physician Decision|1|||
105573891|NCT03661996|364100148|FG003|Overall Study|Physician Decision|2|||
105573892|NCT03661996|364100149|FG004|Overall Study|Physician Decision|0|||
105573893|NCT03661996|364100145|FG000|Overall Study|Protocol Violation|0|||
105573894|NCT03661996|364100146|FG001|Overall Study|Protocol Violation|0|||
105573895|NCT03661996|364100147|FG002|Overall Study|Protocol Violation|0|||
105573896|NCT03661996|364100148|FG003|Overall Study|Protocol Violation|0|||
105573897|NCT03661996|364100149|FG004|Overall Study|Protocol Violation|1|||
105573898|NCT03661996|364100145|FG000|Overall Study|Withdrawal by Subject|3|||
105573899|NCT03661996|364100146|FG001|Overall Study|Withdrawal by Subject|5|||
105573900|NCT03661996|364100147|FG002|Overall Study|Withdrawal by Subject|1|||
105573901|NCT03661996|364100148|FG003|Overall Study|Withdrawal by Subject|7|||
105573902|NCT03661996|364100149|FG004|Overall Study|Withdrawal by Subject|7|||
105573903|NCT03661996|364100145|FG000|Overall Study|Sponsors Decision|2|||
105573904|NCT03661996|364100146|FG001|Overall Study|Sponsors Decision|0|||
105573905|NCT03661996|364100147|FG002|Overall Study|Sponsors Decision|0|||
105573906|NCT03661996|364100148|FG003|Overall Study|Sponsors Decision|0|||
105573907|NCT03661996|364100149|FG004|Overall Study|Sponsors Decision|0|||
105573908|NCT03661996|364100145|FG000|Overall Study|Other|1|||
105573909|NCT03661996|364100146|FG001|Overall Study|Other|1|||
105573910|NCT03661996|364100147|FG002|Overall Study|Other|1|||
105573911|NCT03661996|364100148|FG003|Overall Study|Other|1|||
105573912|NCT03661996|364100149|FG004|Overall Study|Other|0|||
105573913|NCT03321513|364100150|FG000|Overall Study|Death|11|||
105573914|NCT03321513|364100151|FG001|Overall Study|Death|5|||
105573915|NCT03321513|364100150|FG000|Overall Study|Withdrawal by Subject|5|||
105573916|NCT03321513|364100151|FG001|Overall Study|Withdrawal by Subject|10|||
105573917|NCT03321513|364100150|FG000|Overall Study|Lost to Follow-up|10|||
105573918|NCT03321513|364100151|FG001|Overall Study|Lost to Follow-up|11|||
105573919|NCT02593305|364100152|FG000|Post 1|Comparison only group. No intervention.|0|||
105573920|NCT02593305|364100153|FG001|Post 1|Comparison only group. No intervention.|0|||
105573921|NCT02593305|364100154|FG002|Post 1|Comparison only group. No intervention.|10|||
105573922|NCT01317875|364100155|FG000|Overall Study|Other|0|||
105573923|NCT01317875|364100156|FG001|Overall Study|Other|0|||
105573924|NCT01317875|364100157|FG002|Overall Study|Other|1|||
105573925|NCT01317875|364100158|FG003|Overall Study|Other|0|||
105573926|NCT01317875|364100159|FG004|Overall Study|Other|0|||
105573927|NCT01317875|364100160|FG005|Overall Study|Other|0|||
105573928|NCT01317875|364100161|FG006|Overall Study|Other|0|||
105573929|NCT01317875|364100162|FG007|Overall Study|Other|0|||
105573930|NCT01317875|364100163|FG008|Overall Study|Other|0|||
105573931|NCT01317875|364100164|FG009|Overall Study|Other|0|||
105573932|NCT01317875|364100155|FG000|Overall Study|Noncompliance with study drug|0|||
105573933|NCT01317875|364100156|FG001|Overall Study|Noncompliance with study drug|0|||
105573934|NCT01317875|364100157|FG002|Overall Study|Noncompliance with study drug|1|||
105573935|NCT01317875|364100158|FG003|Overall Study|Noncompliance with study drug|0|||
105573936|NCT01317875|364100159|FG004|Overall Study|Noncompliance with study drug|0|||
105573937|NCT01317875|364100160|FG005|Overall Study|Noncompliance with study drug|0|||
105573938|NCT01317875|364100161|FG006|Overall Study|Noncompliance with study drug|0|||
105573939|NCT01317875|364100162|FG007|Overall Study|Noncompliance with study drug|0|||
105573940|NCT01317875|364100163|FG008|Overall Study|Noncompliance with study drug|0|||
105573941|NCT01317875|364100164|FG009|Overall Study|Noncompliance with study drug|0|||
105573942|NCT01317875|364100155|FG000|Overall Study|Progressive Disease|1|||
105573943|NCT01317875|364100156|FG001|Overall Study|Progressive Disease|0|||
105573944|NCT01317875|364100157|FG002|Overall Study|Progressive Disease|2|||
105573945|NCT01317875|364100158|FG003|Overall Study|Progressive Disease|0|||
105573946|NCT01317875|364100159|FG004|Overall Study|Progressive Disease|1|||
105573947|NCT01317875|364100160|FG005|Overall Study|Progressive Disease|0|||
105573948|NCT01317875|364100161|FG006|Overall Study|Progressive Disease|0|||
105573949|NCT01317875|364100162|FG007|Overall Study|Progressive Disease|1|||
105573950|NCT01317875|364100163|FG008|Overall Study|Progressive Disease|0|||
105573951|NCT01317875|364100164|FG009|Overall Study|Progressive Disease|0|||
105573952|NCT01317875|364100155|FG000|Overall Study|Withdrawal by Subject|0|||
105573953|NCT01317875|364100156|FG001|Overall Study|Withdrawal by Subject|0|||
105573954|NCT01317875|364100157|FG002|Overall Study|Withdrawal by Subject|0|||
105573955|NCT01317875|364100158|FG003|Overall Study|Withdrawal by Subject|0|||
105573956|NCT01317875|364100159|FG004|Overall Study|Withdrawal by Subject|1|||
105573957|NCT01317875|364100160|FG005|Overall Study|Withdrawal by Subject|0|||
105573958|NCT01317875|364100161|FG006|Overall Study|Withdrawal by Subject|0|||
105573959|NCT01317875|364100162|FG007|Overall Study|Withdrawal by Subject|3|||
105573960|NCT01317875|364100163|FG008|Overall Study|Withdrawal by Subject|0|||
105573961|NCT01317875|364100164|FG009|Overall Study|Withdrawal by Subject|0|||
105573962|NCT01317875|364100155|FG000|Overall Study|Physician Decision|0|||
105826933|NCT00294047|365024333|FG000|Month 84|Unable to reach study site|1|||
105826934|NCT00294047|365024334|FG001|Month 84|Unable to reach study site|0|||
105826935|NCT00294047|365024333|FG000|Month 84|Under investigation locally|1|||
105826936|NCT00294047|365024334|FG001|Month 84|Under investigation locally|0|||
105826937|NCT00294047|365024333|FG000|Month 84|Visit missed|0|||
105826938|NCT00294047|365024334|FG001|Month 84|Visit missed|1|||
105826939|NCT00294047|365024333|FG000|Month 84|No consent for Month 84 Follow-up|731|||
105826940|NCT00294047|365024334|FG001|Month 84|No consent for Month 84 Follow-up|754|||
105826941|NCT02157974|365024335|FG000|Overall Study|Withdrawal by Subject|0|||
105826942|NCT02157974|365024336|FG001|Overall Study|Withdrawal by Subject|1|||
105826943|NCT02157974|365024337|FG002|Overall Study|Withdrawal by Subject|0|||
105826944|NCT02157974|365024338|FG003|Overall Study|Withdrawal by Subject|0|||
105826945|NCT02157974|365024339|FG004|Overall Study|Withdrawal by Subject|0|||
105826946|NCT02157974|365024335|FG000|Overall Study|Screen Failure|0|||
105826947|NCT02157974|365024336|FG001|Overall Study|Screen Failure|1|||
105826948|NCT02157974|365024337|FG002|Overall Study|Screen Failure|0|||
105826949|NCT02157974|365024338|FG003|Overall Study|Screen Failure|0|||
105826950|NCT02157974|365024339|FG004|Overall Study|Screen Failure|0|||
105826951|NCT02157974|365024335|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
105826952|NCT02157974|365024336|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
105826953|NCT02157974|365024337|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
105826954|NCT02157974|365024338|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
105573963|NCT01317875|364100156|FG001|Overall Study|Physician Decision|1|||
105573964|NCT01317875|364100157|FG002|Overall Study|Physician Decision|1|||
105573965|NCT01317875|364100158|FG003|Overall Study|Physician Decision|0|||
105573966|NCT01317875|364100159|FG004|Overall Study|Physician Decision|2|||
105573967|NCT01317875|364100160|FG005|Overall Study|Physician Decision|0|||
105573968|NCT01317875|364100161|FG006|Overall Study|Physician Decision|0|||
105573969|NCT01317875|364100162|FG007|Overall Study|Physician Decision|2|||
105573970|NCT01317875|364100163|FG008|Overall Study|Physician Decision|0|||
105573971|NCT01317875|364100164|FG009|Overall Study|Physician Decision|0|||
105573972|NCT01317875|364100155|FG000|Overall Study|Death|0|||
105573973|NCT01317875|364100156|FG001|Overall Study|Death|0|||
105573974|NCT01317875|364100157|FG002|Overall Study|Death|2|||
105573975|NCT01317875|364100158|FG003|Overall Study|Death|1|||
105573976|NCT01317875|364100159|FG004|Overall Study|Death|0|||
105573977|NCT01317875|364100160|FG005|Overall Study|Death|1|||
105573978|NCT01317875|364100161|FG006|Overall Study|Death|0|||
105573979|NCT01317875|364100162|FG007|Overall Study|Death|4|||
105573980|NCT01317875|364100163|FG008|Overall Study|Death|0|||
105573981|NCT01317875|364100164|FG009|Overall Study|Death|0|||
105573982|NCT01317875|364100155|FG000|Overall Study|Adverse Event|2|||
105573983|NCT01317875|364100156|FG001|Overall Study|Adverse Event|1|||
105573984|NCT01317875|364100157|FG002|Overall Study|Adverse Event|2|||
105573985|NCT01317875|364100158|FG003|Overall Study|Adverse Event|1|||
105573986|NCT01317875|364100159|FG004|Overall Study|Adverse Event|5|||
105573987|NCT01317875|364100160|FG005|Overall Study|Adverse Event|1|||
105573988|NCT01317875|364100161|FG006|Overall Study|Adverse Event|2|||
105573989|NCT01317875|364100162|FG007|Overall Study|Adverse Event|5|||
105573990|NCT01317875|364100163|FG008|Overall Study|Adverse Event|0|||
105573991|NCT01317875|364100164|FG009|Overall Study|Adverse Event|0|||
105573992|NCT00917267|364100165|FG000|Overall Study|Adverse Event|15|||
105573993|NCT00917267|364100166|FG001|Overall Study|Adverse Event|36|||
105573994|NCT00917267|364100165|FG000|Overall Study|Physician Decision|2|||
105573995|NCT00917267|364100166|FG001|Overall Study|Physician Decision|4|||
105573996|NCT00917267|364100165|FG000|Overall Study|Protocol Violation|9|||
105573997|NCT00917267|364100166|FG001|Overall Study|Protocol Violation|18|||
105573998|NCT00917267|364100165|FG000|Overall Study|Withdrawal by Subject|5|||
105573999|NCT00917267|364100166|FG001|Overall Study|Withdrawal by Subject|12|||
105574000|NCT00917267|364100165|FG000|Overall Study|Lost to follow up|0|||
105574001|NCT00917267|364100166|FG001|Overall Study|Lost to follow up|2|||
105574002|NCT00917267|364100165|FG000|Overall Study|Entry Criteria Not Met|1|||
105574003|NCT00917267|364100166|FG001|Overall Study|Entry Criteria Not Met|0|||
105574004|NCT00917267|364100165|FG000|Overall Study|Sponsor Decision|5|||
105574005|NCT00917267|364100166|FG001|Overall Study|Sponsor Decision|5|||
105574006|NCT00917267|364100165|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
105574007|NCT00917267|364100166|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
105574008|NCT00768430|364100167|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
105574009|NCT00768430|364100168|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
105574010|NCT01454830|364100185|FG000|Overall Study|Withdrawal by Subject|4|||
105574011|NCT01454830|364100186|FG001|Overall Study|Withdrawal by Subject|4|||
105574012|NCT01454830|364100185|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
105574013|NCT01454830|364100186|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
105574014|NCT01454830|364100185|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
105574015|NCT01454830|364100186|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
105574016|NCT01454830|364100185|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
105574017|NCT01454830|364100186|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
105574018|NCT01454830|364100185|FG000|Overall Study|Withdrawal - no polysomnography|3|||
105574019|NCT01454830|364100186|FG001|Overall Study|Withdrawal - no polysomnography|2|||
105574020|NCT03810313|364100187|FG000|Overall Study|Study terminated by sponsor|164|||
105574021|NCT03810313|364100188|FG001|Overall Study|Study terminated by sponsor|159|||
105574022|NCT03810313|364100187|FG000|Overall Study|Subject decision|10|||
105574023|NCT03810313|364100188|FG001|Overall Study|Subject decision|11|||
105574024|NCT03810313|364100187|FG000|Overall Study|Lost to Follow-up|3|||
105574025|NCT03810313|364100188|FG001|Overall Study|Lost to Follow-up|3|||
105574026|NCT03810313|364100187|FG000|Overall Study|Adverse Event|2|||
105574027|NCT03810313|364100188|FG001|Overall Study|Adverse Event|1|||
105574028|NCT03810313|364100187|FG000|Overall Study|Death|2|||
105574029|NCT03810313|364100188|FG001|Overall Study|Death|1|||
105574030|NCT03810313|364100187|FG000|Overall Study|Physician Decision|0|||
105574031|NCT03810313|364100188|FG001|Overall Study|Physician Decision|1|||
105574032|NCT03000673|364100218|FG000|Overall Study|Withdrawal by Subject|1|||
105574033|NCT03000673|364100219|FG001|Overall Study|Withdrawal by Subject|0|||
105574034|NCT03000673|364100220|FG002|Overall Study|Withdrawal by Subject|0|||
105366334|NCT01094288|363348354|FG002|Overall Study|Withdrawal by Subject|2|||
105366335|NCT01094288|363348355|FG003|Overall Study|Withdrawal by Subject|0|||
105574035|NCT03000673|364100221|FG003|Overall Study|Withdrawal by Subject|0|||
105574036|NCT00562978|364100223|FG000|Overall Study|Patient had imaging dose only|1|||
105574037|NCT00562978|364100224|FG001|Overall Study|Patient had imaging dose only|11|||
105574038|NCT00152971|364100228|FG000|Overall Study|Adverse Event|12|||
105574039|NCT00152971|364100229|FG001|Overall Study|Adverse Event|10|||
105574040|NCT00152971|364100230|FG002|Overall Study|Adverse Event|9|||
105574041|NCT00152971|364100228|FG000|Overall Study|Protocol Violation|10|||
105574042|NCT00152971|364100229|FG001|Overall Study|Protocol Violation|11|||
105574043|NCT00152971|364100230|FG002|Overall Study|Protocol Violation|8|||
105574044|NCT00152971|364100228|FG000|Overall Study|Lost to Follow-up|17|||
105574045|NCT00152971|364100229|FG001|Overall Study|Lost to Follow-up|14|||
105574046|NCT00152971|364100230|FG002|Overall Study|Lost to Follow-up|13|||
105574047|NCT00152971|364100228|FG000|Overall Study|Withdrawal by Subject|9|||
105574048|NCT00152971|364100229|FG001|Overall Study|Withdrawal by Subject|8|||
105574049|NCT00152971|364100230|FG002|Overall Study|Withdrawal by Subject|14|||
105574050|NCT00152971|364100228|FG000|Overall Study|Other|3|||
105574051|NCT00152971|364100229|FG001|Overall Study|Other|5|||
105574052|NCT00152971|364100230|FG002|Overall Study|Other|5|||
105574053|NCT00152971|364100228|FG000|Treatment|Adverse Event|49|||
105574054|NCT00152971|364100229|FG001|Treatment|Adverse Event|40|||
105574055|NCT00152971|364100230|FG002|Treatment|Adverse Event|54|||
105574056|NCT00152971|364100228|FG000|Treatment|Protocol Violation|8|||
105574057|NCT00152971|364100229|FG001|Treatment|Protocol Violation|6|||
105574058|NCT00152971|364100230|FG002|Treatment|Protocol Violation|10|||
105574059|NCT00152971|364100228|FG000|Treatment|Lost to Follow-up|1|||
105574060|NCT00152971|364100229|FG001|Treatment|Lost to Follow-up|2|||
105574061|NCT00152971|364100230|FG002|Treatment|Lost to Follow-up|1|||
105574062|NCT00152971|364100228|FG000|Treatment|Withdrawal by Subject|4|||
105574063|NCT00152971|364100229|FG001|Treatment|Withdrawal by Subject|4|||
105574064|NCT00152971|364100230|FG002|Treatment|Withdrawal by Subject|5|||
105574065|NCT00152971|364100228|FG000|Treatment|Other|9|||
105574066|NCT00152971|364100229|FG001|Treatment|Other|11|||
105574067|NCT00152971|364100230|FG002|Treatment|Other|10|||
105574068|NCT01613027|364100231|FG000|Overall Study|Lost to Follow-up|5|||
105574069|NCT01613027|364100231|FG000|Overall Study|Switched Physician|1|||
105574070|NCT01613027|364100231|FG000|Overall Study|Lack of Efficacy|1|||
105574071|NCT01613027|364100231|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
105574072|NCT02153359|364100232|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
105574073|NCT02153359|364100233|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
105574074|NCT04422639|364100234|FG000|Overall Study|Death|1|||
105574075|NCT04422639|364100235|FG001|Overall Study|Death|0|||
105574076|NCT04422639|364100234|FG000|Overall Study|study closed prior to completion of FU visits|0|||
105574077|NCT04422639|364100235|FG001|Overall Study|study closed prior to completion of FU visits|2|||
105574078|NCT01964521|364100236|FG000|Overall Study|Lost to Follow-up|4|||
105574079|NCT01108510|364100237|FG000|Overall Study|Randomized but Not Treated|5|||
105574080|NCT01108510|364100238|FG001|Overall Study|Randomized but Not Treated|1|||
105574081|NCT01108510|364100237|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
105574082|NCT01108510|364100238|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
105574083|NCT01108510|364100237|FG000|Overall Study|Adverse Event|26|||
105574084|NCT01108510|364100238|FG001|Overall Study|Adverse Event|19|||
105574085|NCT01108510|364100237|FG000|Overall Study|Lost to Follow-up|20|||
105574086|NCT01108510|364100238|FG001|Overall Study|Lost to Follow-up|17|||
105574087|NCT01108510|364100237|FG000|Overall Study|Withdrew Consent|21|||
105574088|NCT01108510|364100238|FG001|Overall Study|Withdrew Consent|15|||
105574089|NCT01108510|364100237|FG000|Overall Study|Investigator's Discretion|12|||
105574090|NCT01108510|364100238|FG001|Overall Study|Investigator's Discretion|10|||
105574091|NCT01108510|364100237|FG000|Overall Study|Participant Noncompliance|5|||
105574092|NCT01108510|364100238|FG001|Overall Study|Participant Noncompliance|7|||
105574093|NCT01108510|364100237|FG000|Overall Study|Lack of Efficacy|3|||
105574094|NCT01108510|364100238|FG001|Overall Study|Lack of Efficacy|0|||
105574095|NCT01108510|364100237|FG000|Overall Study|Pregnancy|0|||
105574096|NCT01108510|364100238|FG001|Overall Study|Pregnancy|3|||
105574097|NCT01108510|364100237|FG000|Overall Study|Death|1|||
105366336|NCT01094288|363348356|FG004|Overall Study|Withdrawal by Subject|0|||
105574098|NCT01108510|364100238|FG001|Overall Study|Death|1|||
105574099|NCT03853317|364100239|FG000|Overall Study|Progressive Disease|5|||
105574100|NCT03853317|364100239|FG000|Overall Study|Adverse Event|1|||
105574101|NCT03853317|364100239|FG000|Overall Study|Death|1|||
105574102|NCT03853317|364100239|FG000|Overall Study|other event|2|||
105574103|NCT03856996|364100243|FG000|Overall Study|Withdrawal by Subject|1|||
105574104|NCT03856996|364100244|FG001|Overall Study|Withdrawal by Subject|0|||
105574105|NCT03856996|364100243|FG000|Overall Study|Lost to Follow-up|0|||
105574106|NCT03856996|364100244|FG001|Overall Study|Lost to Follow-up|1|||
105574107|NCT03856996|364100243|FG000|Overall Study|Adverse Event|1|||
105574108|NCT03856996|364100244|FG001|Overall Study|Adverse Event|1|||
105574109|NCT03856996|364100243|FG000|Overall Study|Other|1|||
105574110|NCT03856996|364100244|FG001|Overall Study|Other|0|||
105574111|NCT00089895|364100245|FG000|Overall Study|Consent Withdrawn|11|||
105366337|NCT01094288|363348357|FG005|Overall Study|Withdrawal by Subject|0|||
105366338|NCT01094288|363348358|FG006|Overall Study|Withdrawal by Subject|0|||
105366339|NCT01094288|363348359|FG007|Overall Study|Withdrawal by Subject|2|||
105366340|NCT01094288|363348352|FG000|Overall Study|Initiation of Alternative Therapy|0|||
105574112|NCT00089895|364100246|FG001|Overall Study|Consent Withdrawn|14|||
105574113|NCT00089895|364100245|FG000|Overall Study|Technical reason|7|||
105574114|NCT00089895|364100246|FG001|Overall Study|Technical reason|2|||
105574115|NCT00089895|364100245|FG000|Overall Study|Surgery|0|||
105574116|NCT00089895|364100246|FG001|Overall Study|Surgery|1|||
105574117|NCT00089895|364100245|FG000|Overall Study|Bleeding|0|||
105574118|NCT00089895|364100246|FG001|Overall Study|Bleeding|2|||
105574119|NCT00089895|364100245|FG000|Overall Study|Physician Decision|3|||
105574120|NCT00089895|364100246|FG001|Overall Study|Physician Decision|7|||
105574121|NCT00089895|364100245|FG000|Overall Study|Exclusion criteria met|6|||
105574122|NCT00089895|364100246|FG001|Overall Study|Exclusion criteria met|6|||
105574123|NCT00089895|364100245|FG000|Overall Study|Not otherwise specified|4|||
105574124|NCT00089895|364100246|FG001|Overall Study|Not otherwise specified|8|||
105574125|NCT00089895|364100245|FG000|Overall Study|Missing|4|||
105574126|NCT00089895|364100246|FG001|Overall Study|Missing|2|||
105574127|NCT00785538|364100247|FG000|Treatment Period|Adverse Event|1|||
105574128|NCT00785538|364100248|FG001|Treatment Period|Adverse Event|2|||
105574129|NCT00785538|364100249|FG002|Treatment Period|Adverse Event|2|||
105574130|NCT00785538|364100250|FG003|Treatment Period|Adverse Event|0|||
105574131|NCT00785538|364100247|FG000|Treatment Period|Withdrawal by Subject|0|||
105574132|NCT00785538|364100248|FG001|Treatment Period|Withdrawal by Subject|0|||
105574133|NCT00785538|364100249|FG002|Treatment Period|Withdrawal by Subject|0|||
105574134|NCT00785538|364100250|FG003|Treatment Period|Withdrawal by Subject|1|||
105574135|NCT01234649|364100251|FG000|Overall Study|Withdrawal by Subject|32|||
105574136|NCT01234649|364100252|FG001|Overall Study|Withdrawal by Subject|26|||
105574137|NCT01234649|364100251|FG000|Overall Study|Pregnancy|6|||
105574138|NCT01234649|364100252|FG001|Overall Study|Pregnancy|6|||
105574139|NCT01234649|364100251|FG000|Overall Study|intolerant to side effects|4|||
105574140|NCT01234649|364100252|FG001|Overall Study|intolerant to side effects|3|||
105574141|NCT01234649|364100251|FG000|Overall Study|Allergic reaction|1|||
105574142|NCT01234649|364100252|FG001|Overall Study|Allergic reaction|0|||
105574143|NCT01234649|364100251|FG000|Overall Study|Lack of Efficacy|0|||
105574144|NCT01234649|364100252|FG001|Overall Study|Lack of Efficacy|3|||
105574145|NCT01396395|364100263|FG000|Overall Study|Withdrawal by Subject|10|||
105574146|NCT01396395|364100264|FG001|Overall Study|Withdrawal by Subject|12|||
105574147|NCT01396395|364100263|FG000|Overall Study|Protocol Violation|3|||
105574148|NCT01396395|364100264|FG001|Overall Study|Protocol Violation|1|||
105574149|NCT01396395|364100263|FG000|Overall Study|Adverse Event|10|||
105574150|NCT01396395|364100264|FG001|Overall Study|Adverse Event|2|||
105574151|NCT01396395|364100263|FG000|Overall Study|Lost to Follow-up|17|||
105574152|NCT01396395|364100264|FG001|Overall Study|Lost to Follow-up|11|||
105574153|NCT01396395|364100263|FG000|Overall Study|Other|0|||
105574154|NCT01396395|364100264|FG001|Overall Study|Other|1|||
105574155|NCT00882921|364100274|FG000|Overall Study|Death|2|||
105574156|NCT00882921|364100274|FG000|Overall Study|Other|3|||
105574157|NCT00882921|364100274|FG000|Overall Study|Lost to Follow-up|2|||
105574158|NCT00882921|364100274|FG000|Overall Study|Termination By Investigator|3|||
105574159|NCT00882921|364100274|FG000|Overall Study|Withdrawal Of Consent|1|||
105574160|NCT01370005|364100275|FG000|Overall Study|Not treated|1|||
105574161|NCT01370005|364100276|FG001|Overall Study|Not treated|0|||
105574162|NCT01370005|364100277|FG002|Overall Study|Not treated|0|||
105574163|NCT01370005|364100275|FG000|Overall Study|Adverse Event|5|||
105574164|NCT01370005|364100276|FG001|Overall Study|Adverse Event|5|||
105574165|NCT01370005|364100277|FG002|Overall Study|Adverse Event|6|||
105574166|NCT01370005|364100275|FG000|Overall Study|Lack of Efficacy|1|||
105574167|NCT01370005|364100276|FG001|Overall Study|Lack of Efficacy|0|||
105574168|NCT01370005|364100277|FG002|Overall Study|Lack of Efficacy|0|||
105574169|NCT01370005|364100275|FG000|Overall Study|Non compliant with protocol|0|||
105366341|NCT01094288|363348353|FG001|Overall Study|Initiation of Alternative Therapy|0|||
105366342|NCT01094288|363348354|FG002|Overall Study|Initiation of Alternative Therapy|1|||
105574170|NCT01370005|364100276|FG001|Overall Study|Non compliant with protocol|1|||
105574171|NCT01370005|364100277|FG002|Overall Study|Non compliant with protocol|2|||
105574172|NCT01370005|364100275|FG000|Overall Study|Lost to Follow-up|1|||
105574173|NCT01370005|364100276|FG001|Overall Study|Lost to Follow-up|1|||
105574174|NCT01370005|364100277|FG002|Overall Study|Lost to Follow-up|1|||
105574175|NCT01370005|364100275|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
105574176|NCT01370005|364100276|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
105574177|NCT01370005|364100277|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
105574178|NCT01370005|364100275|FG000|Overall Study|Other reason not defined above|3|||
105574179|NCT01370005|364100276|FG001|Overall Study|Other reason not defined above|0|||
105574180|NCT01370005|364100277|FG002|Overall Study|Other reason not defined above|2|||
105574181|NCT05490329|364100280|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
105574182|NCT05490329|364100281|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
105574183|NCT05490329|364100280|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
105488550|NCT00744471|363800460|FG002|Overall Study|Lack of Efficacy|19|||
105307095|NCT04713553|363122576|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
105307096|NCT04713553|363122577|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
105307097|NCT04713553|363122578|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
105307098|NCT04713553|363122579|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
105307099|NCT04713553|363122580|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
105307100|NCT04713553|363122581|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
105307101|NCT04713553|363122582|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
105488551|NCT00744471|363800461|FG003|Overall Study|Lack of Efficacy|31|||
105366343|NCT01094288|363348355|FG003|Overall Study|Initiation of Alternative Therapy|0|||
105488552|NCT00744471|363800458|FG000|Overall Study|Lost to Follow-up|0|||
105488553|NCT00744471|363800459|FG001|Overall Study|Lost to Follow-up|0|||
105488554|NCT00744471|363800460|FG002|Overall Study|Lost to Follow-up|2|||
105488555|NCT00744471|363800461|FG003|Overall Study|Lost to Follow-up|0|||
105488556|NCT00976573|363800468|FG000|Overall Study|Ineligible|0|||
105574184|NCT05490329|364100281|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
105574185|NCT05490329|364100280|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
105574186|NCT05490329|364100281|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
105574187|NCT00926003|364100282|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
105574188|NCT00926003|364100283|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
105574189|NCT00926003|364100284|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
105574190|NCT00926003|364100282|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
105574191|NCT00926003|364100283|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
105574192|NCT00926003|364100284|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
105574193|NCT01032044|364100285|FG000|Overall Study|Protocol Violation|14|||
105574194|NCT01032044|364100286|FG001|Overall Study|Protocol Violation|8|||
105574195|NCT01032044|364100285|FG000|Overall Study|Adverse Event|0|||
105574196|NCT01032044|364100286|FG001|Overall Study|Adverse Event|1|||
105574197|NCT01032044|364100285|FG000|Overall Study|Lost to Follow-up|11|||
105574198|NCT01032044|364100286|FG001|Overall Study|Lost to Follow-up|11|||
105574199|NCT01233609|364100287|FG000|Overall Study|Death|1|||
105574200|NCT01233609|364100288|FG001|Overall Study|Death|0|||
105574201|NCT01233609|364100287|FG000|Overall Study|Lost to Follow-up|3|||
105574202|NCT01233609|364100288|FG001|Overall Study|Lost to Follow-up|1|||
105574203|NCT01233609|364100287|FG000|Overall Study|Adverse Event|2|||
105826955|NCT02157974|365024339|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
105826956|NCT01590563|365024342|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
105826957|NCT01604941|365024343|FG000|Overall Study|Adverse Event|1|||
105826958|NCT01604941|365024344|FG001|Overall Study|Adverse Event|2|||
105826959|NCT01604941|365024345|FG002|Overall Study|Adverse Event|0|||
105826960|NCT01604941|365024346|FG003|Overall Study|Adverse Event|0|||
105826961|NCT01604941|365024347|FG004|Overall Study|Adverse Event|1|||
105574204|NCT01233609|364100288|FG001|Overall Study|Adverse Event|1|||
105574205|NCT01233609|364100287|FG000|Overall Study|Withdrawal by Subject|3|||
105574206|NCT01233609|364100288|FG001|Overall Study|Withdrawal by Subject|0|||
105574207|NCT00735644|364100289|FG000|Overall Study|Did not receive study vaccine|0|||
105574208|NCT00735644|364100290|FG001|Overall Study|Did not receive study vaccine|1|||
105574209|NCT00735644|364100291|FG002|Overall Study|Did not receive study vaccine|0|||
105574210|NCT00735644|364100292|FG003|Overall Study|Did not receive study vaccine|0|||
105574211|NCT00735644|364100293|FG004|Overall Study|Did not receive study vaccine|0|||
105574212|NCT00735644|364100289|FG000|Overall Study|Withdrawal by Subject|0|||
105574213|NCT00735644|364100290|FG001|Overall Study|Withdrawal by Subject|1|||
105366344|NCT01094288|363348356|FG004|Overall Study|Initiation of Alternative Therapy|0|||
105366345|NCT01094288|363348357|FG005|Overall Study|Initiation of Alternative Therapy|0|||
105366346|NCT01094288|363348358|FG006|Overall Study|Initiation of Alternative Therapy|0|||
105366347|NCT01094288|363348359|FG007|Overall Study|Initiation of Alternative Therapy|0|||
105366348|NCT01094288|363348352|FG000|Overall Study|Reason not Specified|2|||
105366349|NCT01094288|363348353|FG001|Overall Study|Reason not Specified|3|||
105366350|NCT01094288|363348354|FG002|Overall Study|Reason not Specified|0|||
105366351|NCT01094288|363348355|FG003|Overall Study|Reason not Specified|1|||
105366352|NCT01094288|363348356|FG004|Overall Study|Reason not Specified|0|||
105366353|NCT01094288|363348357|FG005|Overall Study|Reason not Specified|0|||
105366354|NCT01094288|363348358|FG006|Overall Study|Reason not Specified|0|||
105366355|NCT01094288|363348359|FG007|Overall Study|Reason not Specified|0|||
105366356|NCT01094288|363348352|FG000|Overall Study|Ongoing Participants|0|||
105366357|NCT01094288|363348353|FG001|Overall Study|Ongoing Participants|3|||
105366358|NCT01094288|363348354|FG002|Overall Study|Ongoing Participants|0|||
105366359|NCT01094288|363348355|FG003|Overall Study|Ongoing Participants|0|||
105366360|NCT01094288|363348356|FG004|Overall Study|Ongoing Participants|0|||
105366361|NCT01094288|363348357|FG005|Overall Study|Ongoing Participants|0|||
105366362|NCT01094288|363348358|FG006|Overall Study|Ongoing Participants|0|||
105366363|NCT01094288|363348359|FG007|Overall Study|Ongoing Participants|0|||
105366364|NCT01228591|363348360|FG000|Baseline|Lack of Efficacy|1|||
105366365|NCT01228591|363348361|FG001|Baseline|Lack of Efficacy|2|||
105366366|NCT02787304|363348362|FG000|Overall Study|Adverse Event|9|||
105366367|NCT02787304|363348363|FG001|Overall Study|Adverse Event|3|||
105366368|NCT02787304|363348364|FG002|Overall Study|Adverse Event|8|||
105366369|NCT02787304|363348365|FG003|Overall Study|Adverse Event|1|||
105366370|NCT02787304|363348362|FG000|Overall Study|Withdrawal by Subject|1|||
105366371|NCT02787304|363348363|FG001|Overall Study|Withdrawal by Subject|4|||
105574214|NCT00735644|364100291|FG002|Overall Study|Withdrawal by Subject|1|||
105366372|NCT02787304|363348364|FG002|Overall Study|Withdrawal by Subject|0|||
105366373|NCT02787304|363348365|FG003|Overall Study|Withdrawal by Subject|0|||
105574215|NCT00735644|364100292|FG003|Overall Study|Withdrawal by Subject|1|||
105574216|NCT00735644|364100293|FG004|Overall Study|Withdrawal by Subject|0|||
105574217|NCT02961374|364100294|FG000|Overall Study|Adverse Event|4|||
105574218|NCT01734434|364100295|FG000|Overall Study|Death Infant|3|||
105574219|NCT01734434|364100296|FG001|Overall Study|Death Infant|1|||
105826962|NCT01604941|365024348|FG005|Overall Study|Adverse Event|5|||
105826963|NCT01604941|365024343|FG000|Overall Study|Non-compliance|1|||
105826964|NCT01604941|365024344|FG001|Overall Study|Non-compliance|0|||
105307102|NCT04713553|363122576|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
105307103|NCT04713553|363122577|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
105307104|NCT04713553|363122578|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
105488557|NCT00976573|363800469|FG001|Overall Study|Ineligible|1|||
105488558|NCT00976573|363800468|FG000|Overall Study|Cancel prior to receiving treatment|4|||
105307105|NCT04713553|363122579|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
105307106|NCT04713553|363122580|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
105488559|NCT00976573|363800469|FG001|Overall Study|Cancel prior to receiving treatment|2|||
105488560|NCT04597918|363800474|FG000|Overall Study|Withdrawal by Subject|6|||
105488561|NCT04597918|363800474|FG000|Overall Study|Lost to Follow-up|3|||
105488562|NCT04597918|363800474|FG000|Overall Study|Death|1|||
105488563|NCT01015131|363800476|FG000|Overall Study|Physician Decision|1|||
105488564|NCT01015131|363800476|FG000|Overall Study|Protocol Violation|1|||
105488565|NCT01015131|363800476|FG000|Overall Study|Withdrawal by Subject|2|||
105488566|NCT01015131|363800476|FG000|Overall Study|Other Protocol Specified Criteria|4|||
105488567|NCT02775903|363800477|FG000|Overall Study|Death|7|||
105488568|NCT02775903|363800478|FG001|Overall Study|Death|11|||
105488569|NCT02775903|363800479|FG002|Overall Study|Death|12|||
105488570|NCT02775903|363800480|FG003|Overall Study|Death|11|||
105488571|NCT02775903|363800477|FG000|Overall Study|Adverse Event|0|||
105488572|NCT02775903|363800478|FG001|Overall Study|Adverse Event|1|||
105488573|NCT02775903|363800479|FG002|Overall Study|Adverse Event|12|||
105488574|NCT02775903|363800480|FG003|Overall Study|Adverse Event|3|||
105488575|NCT02775903|363800477|FG000|Overall Study|Progressive disease|15|||
105488576|NCT02775903|363800478|FG001|Overall Study|Progressive disease|14|||
105488577|NCT02775903|363800479|FG002|Overall Study|Progressive disease|30|||
105488578|NCT02775903|363800480|FG003|Overall Study|Progressive disease|20|||
105488579|NCT02775903|363800477|FG000|Overall Study|Lack of Efficacy|2|||
105488580|NCT02775903|363800478|FG001|Overall Study|Lack of Efficacy|2|||
105488581|NCT02775903|363800479|FG002|Overall Study|Lack of Efficacy|2|||
105488582|NCT02775903|363800480|FG003|Overall Study|Lack of Efficacy|6|||
105488583|NCT02775903|363800477|FG000|Overall Study|Withdrawal by Subject|7|||
105488584|NCT02775903|363800478|FG001|Overall Study|Withdrawal by Subject|5|||
105488585|NCT02775903|363800479|FG002|Overall Study|Withdrawal by Subject|5|||
105488586|NCT02775903|363800480|FG003|Overall Study|Withdrawal by Subject|8|||
105488587|NCT02775903|363800477|FG000|Overall Study|Other reasons|7|||
105488588|NCT02775903|363800478|FG001|Overall Study|Other reasons|8|||
105488589|NCT02775903|363800479|FG002|Overall Study|Other reasons|2|||
105488590|NCT02775903|363800480|FG003|Overall Study|Other reasons|12|||
105488591|NCT04041700|363800481|FG000|Overall Study|Pregnancy|1|||
105488592|NCT04041700|363800481|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
105488593|NCT05140382|363800482|FG000|Overall Study|Death|3|||
105488594|NCT05140382|363800483|FG001|Overall Study|Death|0|||
105488595|NCT05140382|363800484|FG002|Overall Study|Death|0|||
105488596|NCT05140382|363800482|FG000|Overall Study|Investigator decision|1|||
105488597|NCT05140382|363800483|FG001|Overall Study|Investigator decision|0|||
105488598|NCT05140382|363800484|FG002|Overall Study|Investigator decision|0|||
105488599|NCT05140382|363800482|FG000|Overall Study|Other|4|||
105488600|NCT05140382|363800483|FG001|Overall Study|Other|0|||
105488601|NCT05140382|363800484|FG002|Overall Study|Other|1|||
105488602|NCT05140382|363800482|FG000|Overall Study|Progressive disease|20|||
105488603|NCT05140382|363800483|FG001|Overall Study|Progressive disease|1|||
105488604|NCT05140382|363800484|FG002|Overall Study|Progressive disease|12|||
105488605|NCT05140382|363800482|FG000|Overall Study|Subjective disease progression|2|||
105488606|NCT05140382|363800483|FG001|Overall Study|Subjective disease progression|1|||
105488607|NCT05140382|363800484|FG002|Overall Study|Subjective disease progression|0|||
105488608|NCT05140382|363800482|FG000|Overall Study|Unknown at data cut-off|0|||
105488609|NCT05140382|363800483|FG001|Overall Study|Unknown at data cut-off|0|||
105488610|NCT05140382|363800484|FG002|Overall Study|Unknown at data cut-off|1|||
105488611|NCT05140382|363800482|FG000|Overall Study|Withdrawal by Subject|1|||
105488612|NCT05140382|363800483|FG001|Overall Study|Withdrawal by Subject|0|||
105488613|NCT05140382|363800484|FG002|Overall Study|Withdrawal by Subject|4|||
105488614|NCT05140382|363800482|FG000|Overall Study|Withdrawal of consent|0|||
105488615|NCT05140382|363800483|FG001|Overall Study|Withdrawal of consent|0|||
105488616|NCT05140382|363800484|FG002|Overall Study|Withdrawal of consent|1|||
105488617|NCT00884377|363801899|FG000|Overall Study|Withdrawal by Subject|1|||
105488618|NCT00884377|363801900|FG001|Overall Study|Withdrawal by Subject|0|||
105488619|NCT00884377|363801899|FG000|Overall Study|Could not confirm diagnosis|1|||
105488620|NCT00884377|363801900|FG001|Overall Study|Could not confirm diagnosis|0|||
105488621|NCT00884377|363801899|FG000|Overall Study|Physician Decision|0|||
105488622|NCT00884377|363801900|FG001|Overall Study|Physician Decision|1|||
105488623|NCT01683019|363801901|FG000|Overall Study|Withdrawal by Subject|2|||
105488624|NCT01683019|363801902|FG001|Overall Study|Withdrawal by Subject|1|||
105488625|NCT01683019|363801903|FG002|Overall Study|Withdrawal by Subject|4|||
105488626|NCT04854642|363801904|FG000|Overall Study|Adverse Event|1|||
105574220|NCT01734434|364100297|FG002|Overall Study|Death Infant|17|||
105574221|NCT01734434|364100298|FG003|Overall Study|Death Infant|5|||
105574222|NCT01734434|364100295|FG000|Overall Study|Lost to Follow-up|2|||
105574223|NCT01734434|364100296|FG001|Overall Study|Lost to Follow-up|9|||
105574224|NCT01734434|364100297|FG002|Overall Study|Lost to Follow-up|67|||
105574225|NCT01734434|364100298|FG003|Overall Study|Lost to Follow-up|11|||
105574226|NCT01734434|364100295|FG000|Overall Study|No Live Birth|1|||
105574227|NCT01734434|364100296|FG001|Overall Study|No Live Birth|2|||
105574228|NCT01734434|364100297|FG002|Overall Study|No Live Birth|32|||
105574229|NCT01734434|364100298|FG003|Overall Study|No Live Birth|6|||
105574230|NCT01734434|364100295|FG000|Overall Study|Withdrawal by Subject|4|||
105574231|NCT01734434|364100296|FG001|Overall Study|Withdrawal by Subject|0|||
105574232|NCT01734434|364100297|FG002|Overall Study|Withdrawal by Subject|8|||
105574233|NCT01734434|364100298|FG003|Overall Study|Withdrawal by Subject|1|||
105574234|NCT01734434|364100295|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
105574235|NCT01734434|364100296|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
105574236|NCT01734434|364100297|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
105574237|NCT01734434|364100298|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
105574238|NCT01734434|364100295|FG000|Overall Study|Subject Not Reachable|0|||
105574239|NCT01734434|364100296|FG001|Overall Study|Subject Not Reachable|0|||
105574240|NCT01734434|364100297|FG002|Overall Study|Subject Not Reachable|1|||
105574241|NCT01734434|364100298|FG003|Overall Study|Subject Not Reachable|0|||
105574242|NCT01734434|364100295|FG000|Overall Study|Treatment Defaulter|0|||
105574243|NCT01734434|364100296|FG001|Overall Study|Treatment Defaulter|0|||
105574244|NCT01734434|364100297|FG002|Overall Study|Treatment Defaulter|1|||
105574245|NCT01734434|364100298|FG003|Overall Study|Treatment Defaulter|0|||
105574246|NCT01734434|364100295|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
105574247|NCT01734434|364100296|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
105574248|NCT01734434|364100297|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
105574249|NCT01734434|364100298|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
105574250|NCT01734434|364100295|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
105574251|NCT01734434|364100296|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
105574252|NCT01734434|364100297|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
105574253|NCT01734434|364100298|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
105574254|NCT01567865|364100301|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
105574255|NCT01567865|364100302|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
105574256|NCT01567865|364100303|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
105574257|NCT01567865|364100304|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
105574258|NCT01567865|364100301|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
105574259|NCT01567865|364100302|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
105574260|NCT01567865|364100303|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
105574261|NCT01567865|364100304|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
105574262|NCT00311155|364102766|FG000|Overall Study|Adverse Event|21|||
105574263|NCT00311155|364102766|FG000|Overall Study|Withdrawal by Subject|17|||
105574264|NCT00311155|364102766|FG000|Overall Study|Did not meet entry criteria|55|||
105574265|NCT02769065|364102767|FG000|Overall Study|Voluntary Withdrawal|1|||
105574266|NCT02769065|364102768|FG001|Overall Study|Voluntary Withdrawal|0|||
105574267|NCT02769065|364102769|FG002|Overall Study|Voluntary Withdrawal|0|||
105574268|NCT02769065|364102770|FG003|Overall Study|Voluntary Withdrawal|0|||
105307107|NCT04713553|363122581|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
105307108|NCT04713553|363122582|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
105307109|NCT04713553|363122576|FG000|Primary Study (2 Months)|Other|1|||
105307110|NCT04713553|363122577|FG001|Primary Study (2 Months)|Other|2|||
105307111|NCT04713553|363122578|FG002|Primary Study (2 Months)|Other|0|||
105307112|NCT04713553|363122579|FG003|Primary Study (2 Months)|Other|0|||
105307113|NCT04713553|363122580|FG004|Primary Study (2 Months)|Other|1|||
105307114|NCT04713553|363122581|FG005|Primary Study (2 Months)|Other|0|||
105574269|NCT02769065|364102771|FG004|Overall Study|Voluntary Withdrawal|0|||
105574270|NCT02769065|364102772|FG005|Overall Study|Voluntary Withdrawal|0|||
105574271|NCT02769065|364102773|FG006|Overall Study|Voluntary Withdrawal|0|||
105574272|NCT02769065|364102774|FG007|Overall Study|Voluntary Withdrawal|0|||
105574273|NCT02769065|364102775|FG008|Overall Study|Voluntary Withdrawal|0|||
105574274|NCT02769065|364102776|FG009|Overall Study|Voluntary Withdrawal|0|||
105574275|NCT02769065|364102777|FG010|Overall Study|Voluntary Withdrawal|0|||
105574276|NCT02769065|364102778|FG011|Overall Study|Voluntary Withdrawal|0|||
105574277|NCT02769065|364102779|FG012|Overall Study|Voluntary Withdrawal|0|||
105307115|NCT04713553|363122582|FG006|Primary Study (2 Months)|Other|0|||
105574278|NCT02769065|364102780|FG013|Overall Study|Voluntary Withdrawal|0|||
105574279|NCT02769065|364102781|FG014|Overall Study|Voluntary Withdrawal|0|||
105574280|NCT02769065|364102782|FG015|Overall Study|Voluntary Withdrawal|0|||
105574281|NCT02769065|364102783|FG016|Overall Study|Voluntary Withdrawal|0|||
105574282|NCT02769065|364102784|FG017|Overall Study|Voluntary Withdrawal|0|||
105574283|NCT02769065|364102785|FG018|Overall Study|Voluntary Withdrawal|0|||
105574284|NCT02769065|364102786|FG019|Overall Study|Voluntary Withdrawal|0|||
105574285|NCT02769065|364102787|FG020|Overall Study|Voluntary Withdrawal|0|||
105574286|NCT02769065|364102788|FG021|Overall Study|Voluntary Withdrawal|0|||
105574287|NCT02769065|364102789|FG022|Overall Study|Voluntary Withdrawal|0|||
105574288|NCT02769065|364102790|FG023|Overall Study|Voluntary Withdrawal|0|||
105574289|NCT02769065|364102791|FG024|Overall Study|Voluntary Withdrawal|0|||
105574290|NCT02769065|364102792|FG025|Overall Study|Voluntary Withdrawal|0|||
105574291|NCT02769065|364102793|FG026|Overall Study|Voluntary Withdrawal|0|||
105574292|NCT02769065|364102794|FG027|Overall Study|Voluntary Withdrawal|0|||
105574293|NCT02769065|364102795|FG028|Overall Study|Voluntary Withdrawal|0|||
105574294|NCT02769065|364102796|FG029|Overall Study|Voluntary Withdrawal|0|||
105574295|NCT02769065|364102767|FG000|Overall Study|Reason Not Specified|0|||
105574296|NCT02769065|364102768|FG001|Overall Study|Reason Not Specified|0|||
105574297|NCT02769065|364102769|FG002|Overall Study|Reason Not Specified|0|||
105574298|NCT02769065|364102770|FG003|Overall Study|Reason Not Specified|0|||
105574299|NCT02769065|364102771|FG004|Overall Study|Reason Not Specified|0|||
105574300|NCT02769065|364102772|FG005|Overall Study|Reason Not Specified|0|||
105574301|NCT02769065|364102773|FG006|Overall Study|Reason Not Specified|1|||
105574302|NCT02769065|364102774|FG007|Overall Study|Reason Not Specified|0|||
105574303|NCT02769065|364102775|FG008|Overall Study|Reason Not Specified|0|||
105574304|NCT02769065|364102776|FG009|Overall Study|Reason Not Specified|0|||
105574305|NCT02769065|364102777|FG010|Overall Study|Reason Not Specified|0|||
105574306|NCT02769065|364102778|FG011|Overall Study|Reason Not Specified|0|||
105574307|NCT02769065|364102779|FG012|Overall Study|Reason Not Specified|0|||
105574308|NCT02769065|364102780|FG013|Overall Study|Reason Not Specified|0|||
105574309|NCT02769065|364102781|FG014|Overall Study|Reason Not Specified|0|||
105574310|NCT02769065|364102782|FG015|Overall Study|Reason Not Specified|0|||
105574311|NCT02769065|364102783|FG016|Overall Study|Reason Not Specified|0|||
105574312|NCT02769065|364102784|FG017|Overall Study|Reason Not Specified|0|||
105574313|NCT02769065|364102785|FG018|Overall Study|Reason Not Specified|0|||
105574314|NCT02769065|364102786|FG019|Overall Study|Reason Not Specified|0|||
105574315|NCT02769065|364102787|FG020|Overall Study|Reason Not Specified|0|||
105574316|NCT02769065|364102788|FG021|Overall Study|Reason Not Specified|0|||
105574317|NCT02769065|364102789|FG022|Overall Study|Reason Not Specified|0|||
105574318|NCT02769065|364102790|FG023|Overall Study|Reason Not Specified|0|||
105574319|NCT02769065|364102791|FG024|Overall Study|Reason Not Specified|0|||
105574320|NCT02769065|364102792|FG025|Overall Study|Reason Not Specified|0|||
105574321|NCT02769065|364102793|FG026|Overall Study|Reason Not Specified|0|||
105574322|NCT02769065|364102794|FG027|Overall Study|Reason Not Specified|0|||
105574323|NCT02769065|364102795|FG028|Overall Study|Reason Not Specified|0|||
105574324|NCT02769065|364102796|FG029|Overall Study|Reason Not Specified|0|||
105574325|NCT02769065|364102767|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574326|NCT02769065|364102768|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574327|NCT02769065|364102769|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574328|NCT02769065|364102770|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574329|NCT02769065|364102771|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574330|NCT02769065|364102772|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574331|NCT02769065|364102773|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574332|NCT02769065|364102774|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574333|NCT02769065|364102775|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574334|NCT02769065|364102776|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574335|NCT02769065|364102777|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
105574336|NCT02769065|364102778|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574337|NCT02769065|364102779|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574338|NCT02769065|364102780|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574339|NCT02769065|364102781|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574340|NCT02769065|364102782|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574341|NCT02769065|364102783|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574342|NCT02769065|364102784|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574343|NCT02769065|364102785|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574344|NCT02769065|364102786|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574345|NCT02769065|364102787|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574346|NCT02769065|364102788|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
105307116|NCT04713553|363122576|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
105574347|NCT02769065|364102789|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574348|NCT02769065|364102790|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574349|NCT02769065|364102791|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574350|NCT02769065|364102792|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574351|NCT02769065|364102793|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574352|NCT02769065|364102794|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574353|NCT02769065|364102795|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574354|NCT02769065|364102796|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
105574355|NCT03017235|364102797|FG000|Overall Study|Withdrawal by Subject|4|||
105574356|NCT03017235|364102798|FG001|Overall Study|Withdrawal by Subject|3|||
105574357|NCT03017235|364102797|FG000|Overall Study|Lost to Follow-up|2|||
105574358|NCT03017235|364102798|FG001|Overall Study|Lost to Follow-up|7|||
105574359|NCT03017235|364102797|FG000|Overall Study|Adverse Event|0|||
105574360|NCT03017235|364102798|FG001|Overall Study|Adverse Event|1|||
105574361|NCT03017235|364102797|FG000|Overall Study|Protocol Violation|2|||
105574362|NCT03017235|364102798|FG001|Overall Study|Protocol Violation|1|||
105574363|NCT03017235|364102797|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
105574364|NCT03017235|364102798|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
105574365|NCT02764775|364102799|FG000|Overall Study|Death|1|||
105574366|NCT02764775|364102799|FG000|Overall Study|Lost to Follow-up|2|||
105574367|NCT02764775|364102799|FG000|Overall Study|Withdrawal by Subject|3|||
105574368|NCT04022889|364102808|FG000|Stage 1: Period 1|Adverse Event|1|||
105574369|NCT04022889|364102809|FG001|Stage 1: Period 1|Adverse Event|0|||
105574370|NCT04022889|364102810|FG002|Stage 1: Period 1|Adverse Event|0|||
105574371|NCT04022889|364102808|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
105574372|NCT04022889|364102809|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
105574373|NCT04022889|364102810|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
105574374|NCT04022889|364102808|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
105574375|NCT04022889|364102809|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
105574376|NCT04022889|364102810|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
105574377|NCT04022889|364102808|FG000|Stage 2|Screen Failure|0|||
105574378|NCT04022889|364102809|FG001|Stage 2|Screen Failure|0|||
105574379|NCT04022889|364102810|FG002|Stage 2|Screen Failure|3|||
105574380|NCT04022889|364102808|FG000|Stage 2|Ineligible for apheresis donation|0|||
105574381|NCT04022889|364102809|FG001|Stage 2|Ineligible for apheresis donation|0|||
105574382|NCT04022889|364102810|FG002|Stage 2|Ineligible for apheresis donation|2|||
105574383|NCT04022889|364102808|FG000|Stage 2|Adverse Event|0|||
105574384|NCT04022889|364102809|FG001|Stage 2|Adverse Event|0|||
105574385|NCT04022889|364102810|FG002|Stage 2|Adverse Event|2|||
105574386|NCT04022889|364102808|FG000|Stage 2|Protocol Violation|0|||
105574387|NCT04022889|364102809|FG001|Stage 2|Protocol Violation|0|||
105574388|NCT04022889|364102810|FG002|Stage 2|Protocol Violation|1|||
105574389|NCT04022889|364102808|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
105574390|NCT04022889|364102809|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
105574391|NCT04022889|364102810|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
105574392|NCT02248961|364102811|FG000|Overall Study|Adverse Event|1|||
105574393|NCT02248961|364102812|FG001|Overall Study|Adverse Event|0|||
105574394|NCT02248961|364102811|FG000|Overall Study|Withdrawal by Subject|1|||
105574395|NCT02248961|364102812|FG001|Overall Study|Withdrawal by Subject|2|||
105574396|NCT02248961|364102811|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
105574397|NCT02248961|364102812|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
105574398|NCT02045433|364102817|FG000|Overall Study|Withdrawal by Subject|1|||
105574399|NCT01973491|364102818|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
105574400|NCT01973491|364102818|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
105574401|NCT01973491|364102818|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
105574402|NCT01863043|364102819|FG000|Overall Study|Death|6|||
105574403|NCT01863043|364102820|FG001|Overall Study|Death|1|||
105574404|NCT01863043|364102819|FG000|Overall Study|Withdrawal by Subject|0|||
105574405|NCT01863043|364102820|FG001|Overall Study|Withdrawal by Subject|2|||
105574406|NCT01863043|364102819|FG000|Overall Study|Adverse Event|7|||
105574407|NCT01863043|364102820|FG001|Overall Study|Adverse Event|8|||
105574408|NCT01863043|364102819|FG000|Overall Study|exclusion criteria found after enrollment|0|||
105574409|NCT01863043|364102820|FG001|Overall Study|exclusion criteria found after enrollment|1|||
105574410|NCT01533714|364102821|FG000|Overall Study|Adverse Event|0|||
105574411|NCT01533714|364102822|FG001|Overall Study|Adverse Event|1|||
105574412|NCT01533714|364102823|FG002|Overall Study|Adverse Event|2|||
105574413|NCT01533714|364102824|FG003|Overall Study|Adverse Event|2|||
105574414|NCT01533714|364102825|FG004|Overall Study|Adverse Event|2|||
105574415|NCT01533714|364102826|FG005|Overall Study|Adverse Event|1|||
105574416|NCT01533714|364102821|FG000|Overall Study|Lack of Efficacy|0|||
105574417|NCT01533714|364102822|FG001|Overall Study|Lack of Efficacy|0|||
105574418|NCT01533714|364102823|FG002|Overall Study|Lack of Efficacy|0|||
105574419|NCT01533714|364102824|FG003|Overall Study|Lack of Efficacy|0|||
105574420|NCT01533714|364102825|FG004|Overall Study|Lack of Efficacy|0|||
105574421|NCT01533714|364102826|FG005|Overall Study|Lack of Efficacy|1|||
105574422|NCT01533714|364102821|FG000|Overall Study|Withdrawal by Subject|0|||
105574423|NCT01533714|364102822|FG001|Overall Study|Withdrawal by Subject|1|||
105574424|NCT01533714|364102823|FG002|Overall Study|Withdrawal by Subject|0|||
105574425|NCT01533714|364102824|FG003|Overall Study|Withdrawal by Subject|1|||
105574426|NCT01533714|364102825|FG004|Overall Study|Withdrawal by Subject|1|||
105574427|NCT01533714|364102826|FG005|Overall Study|Withdrawal by Subject|0|||
105574428|NCT01533714|364102821|FG000|Overall Study|Exclusion criteria|0|||
105574429|NCT01533714|364102822|FG001|Overall Study|Exclusion criteria|1|||
105574430|NCT01533714|364102823|FG002|Overall Study|Exclusion criteria|0|||
105574431|NCT01533714|364102824|FG003|Overall Study|Exclusion criteria|0|||
105574432|NCT01533714|364102825|FG004|Overall Study|Exclusion criteria|0|||
105574433|NCT01533714|364102826|FG005|Overall Study|Exclusion criteria|0|||
105574434|NCT01533714|364102821|FG000|Overall Study|Positive for purified protein derivative|0|||
105574435|NCT01533714|364102822|FG001|Overall Study|Positive for purified protein derivative|0|||
105574436|NCT01533714|364102823|FG002|Overall Study|Positive for purified protein derivative|1|||
105574437|NCT01533714|364102824|FG003|Overall Study|Positive for purified protein derivative|0|||
105574438|NCT01533714|364102825|FG004|Overall Study|Positive for purified protein derivative|1|||
105574439|NCT01533714|364102826|FG005|Overall Study|Positive for purified protein derivative|0|||
105574440|NCT01533714|364102821|FG000|Overall Study|Withdrawal criteria|0|||
105574441|NCT01533714|364102822|FG001|Overall Study|Withdrawal criteria|0|||
105574442|NCT01533714|364102823|FG002|Overall Study|Withdrawal criteria|1|||
105574443|NCT01533714|364102824|FG003|Overall Study|Withdrawal criteria|0|||
105574444|NCT01533714|364102825|FG004|Overall Study|Withdrawal criteria|3|||
105574445|NCT01533714|364102826|FG005|Overall Study|Withdrawal criteria|1|||
105574446|NCT01533714|364102821|FG000|Overall Study|Ineligibility reason|0|||
105574447|NCT01533714|364102822|FG001|Overall Study|Ineligibility reason|0|||
105574448|NCT01533714|364102823|FG002|Overall Study|Ineligibility reason|0|||
105574449|NCT01533714|364102824|FG003|Overall Study|Ineligibility reason|1|||
105574450|NCT01533714|364102825|FG004|Overall Study|Ineligibility reason|0|||
105574451|NCT01533714|364102826|FG005|Overall Study|Ineligibility reason|0|||
105574452|NCT04250337|364102827|FG000|Overall Study|Adverse Event|0|||
105574453|NCT04250337|364102828|FG001|Overall Study|Adverse Event|3|||
105574454|NCT04250337|364102827|FG000|Overall Study|Lack of Efficacy|1|||
105574455|NCT04250337|364102828|FG001|Overall Study|Lack of Efficacy|3|||
105574456|NCT04250337|364102827|FG000|Overall Study|Physician Decision|1|||
105574457|NCT04250337|364102828|FG001|Overall Study|Physician Decision|0|||
105826965|NCT01604941|365024345|FG002|Overall Study|Non-compliance|0|||
105826966|NCT01604941|365024346|FG003|Overall Study|Non-compliance|0|||
105826967|NCT01604941|365024347|FG004|Overall Study|Non-compliance|0|||
105826968|NCT01604941|365024348|FG005|Overall Study|Non-compliance|0|||
105826969|NCT01604941|365024343|FG000|Overall Study|Participant Decision|0|||
105826970|NCT01604941|365024344|FG001|Overall Study|Participant Decision|0|||
105826971|NCT01604941|365024345|FG002|Overall Study|Participant Decision|0|||
105826972|NCT01604941|365024346|FG003|Overall Study|Participant Decision|0|||
105826973|NCT01604941|365024347|FG004|Overall Study|Participant Decision|0|||
105826974|NCT01604941|365024348|FG005|Overall Study|Participant Decision|2|||
105574458|NCT04250337|364102827|FG000|Overall Study|Protocol Deviation|2|||
105574459|NCT04250337|364102828|FG001|Overall Study|Protocol Deviation|2|||
105574460|NCT04250337|364102827|FG000|Overall Study|Withdrawal by Subject|4|||
105574461|NCT04250337|364102828|FG001|Overall Study|Withdrawal by Subject|3|||
105574462|NCT05033743|364102835|FG000|Overall Study|Lost to Follow-up|1|||
105574463|NCT05033743|364102835|FG000|Overall Study|Protocol Violation|2|||
105574464|NCT05033743|364102835|FG000|Overall Study|Withdrawal by Subject|1|||
105574465|NCT00791921|364102836|FG000|Overall Study|Protocol planed|24|||
105574466|NCT00791921|364102837|FG001|Overall Study|Protocol planed|88|||
105574467|NCT00791921|364102836|FG000|Overall Study|Withdrawal by Subject|1|||
105574468|NCT00791921|364102837|FG001|Overall Study|Withdrawal by Subject|2|||
105574469|NCT00791921|364102836|FG000|Overall Study|Adverse Event|8|||
105574470|NCT00791921|364102837|FG001|Overall Study|Adverse Event|2|||
105574471|NCT00791921|364102836|FG000|Overall Study|Lack of Efficacy|0|||
105574472|NCT00791921|364102837|FG001|Overall Study|Lack of Efficacy|2|||
105574473|NCT00791921|364102836|FG000|Overall Study|Lack of study drug administration|1|||
105574474|NCT00791921|364102837|FG001|Overall Study|Lack of study drug administration|1|||
105574475|NCT00791921|364102836|FG000|Overall Study|Reason other than those above|0|||
105574476|NCT00791921|364102837|FG001|Overall Study|Reason other than those above|1|||
105826975|NCT01604941|365024343|FG000|Overall Study|Early Study Termination|9|||
105826976|NCT01604941|365024344|FG001|Overall Study|Early Study Termination|2|||
105826977|NCT01604941|365024345|FG002|Overall Study|Early Study Termination|3|||
105826978|NCT01604941|365024346|FG003|Overall Study|Early Study Termination|3|||
105826979|NCT01604941|365024347|FG004|Overall Study|Early Study Termination|0|||
105826980|NCT01604941|365024348|FG005|Overall Study|Early Study Termination|0|||
105826981|NCT02280863|365024357|FG000|Integrated Platform|Met stopping criteria|0|||
105366374|NCT02787304|363348362|FG000|Overall Study|Lost to Follow-up|1|||
105574477|NCT01965158|364102839|FG000|Overall Study|Adverse Event|14|||
105574478|NCT01965158|364102840|FG001|Overall Study|Adverse Event|5|||
105574479|NCT01965158|364102839|FG000|Overall Study|Withdrawal by Subject|16|||
105574480|NCT01965158|364102840|FG001|Overall Study|Withdrawal by Subject|24|||
105574481|NCT01965158|364102839|FG000|Overall Study|Lost to Follow-up|7|||
105574482|NCT01965158|364102840|FG001|Overall Study|Lost to Follow-up|5|||
105574483|NCT01965158|364102839|FG000|Overall Study|Protocol Violation|1|||
105574484|NCT01965158|364102840|FG001|Overall Study|Protocol Violation|1|||
105574485|NCT01965158|364102839|FG000|Overall Study|Other - Miscellaneous|3|||
105574486|NCT01965158|364102840|FG001|Overall Study|Other - Miscellaneous|0|||
105574487|NCT00474175|364102841|FG000|Overall Study|Lack of Efficacy|0|||
105574488|NCT00474175|364102842|FG001|Overall Study|Lack of Efficacy|0|||
105574489|NCT00474175|364102843|FG002|Overall Study|Lack of Efficacy|1|||
105574490|NCT00474175|364102841|FG000|Overall Study|Withdrawal by Subject|0|||
105826982|NCT02280863|365024358|FG001|Integrated Platform|Met stopping criteria|1|||
105307117|NCT04713553|363122577|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
105574491|NCT00474175|364102842|FG001|Overall Study|Withdrawal by Subject|1|||
105307118|NCT04713553|363122578|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
105307119|NCT04713553|363122579|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
105307120|NCT04713553|363122580|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
105574492|NCT00474175|364102843|FG002|Overall Study|Withdrawal by Subject|1|||
105574493|NCT00474175|364102841|FG000|Overall Study|Ineligible|1|||
105574494|NCT00474175|364102842|FG001|Overall Study|Ineligible|3|||
105574495|NCT00474175|364102843|FG002|Overall Study|Ineligible|1|||
105574496|NCT00474175|364102841|FG000|Overall Study|Protocol Violation|0|||
105574497|NCT00474175|364102842|FG001|Overall Study|Protocol Violation|2|||
105574498|NCT00474175|364102843|FG002|Overall Study|Protocol Violation|1|||
105574499|NCT00474175|364102841|FG000|Overall Study|Administrative|0|||
105574500|NCT00474175|364102842|FG001|Overall Study|Administrative|1|||
105574501|NCT00474175|364102843|FG002|Overall Study|Administrative|0|||
105574502|NCT01619787|364102846|FG000|Overall Study|Lost to Follow-up|5|||
105574503|NCT04537897|364102847|FG000|Overall Study|Other than listed|0|||
105574504|NCT04537897|364102848|FG001|Overall Study|Other than listed|0|||
105574505|NCT04537897|364102849|FG002|Overall Study|Other than listed|0|||
105574506|NCT04537897|364102850|FG003|Overall Study|Other than listed|0|||
105574507|NCT04537897|364102851|FG004|Overall Study|Other than listed|0|||
105574508|NCT04537897|364102852|FG005|Overall Study|Other than listed|0|||
105574509|NCT04537897|364102853|FG006|Overall Study|Other than listed|1|||
105574510|NCT04537897|364102854|FG007|Overall Study|Other than listed|0|||
105574511|NCT04537897|364102855|FG008|Overall Study|Other than listed|0|||
105574512|NCT04537897|364102847|FG000|Overall Study|Adverse Event|0|||
105574513|NCT04537897|364102848|FG001|Overall Study|Adverse Event|0|||
105574514|NCT04537897|364102849|FG002|Overall Study|Adverse Event|0|||
105574515|NCT04537897|364102850|FG003|Overall Study|Adverse Event|1|||
105574516|NCT04537897|364102851|FG004|Overall Study|Adverse Event|0|||
105574517|NCT04537897|364102852|FG005|Overall Study|Adverse Event|0|||
105574518|NCT04537897|364102853|FG006|Overall Study|Adverse Event|0|||
105574519|NCT04537897|364102854|FG007|Overall Study|Adverse Event|0|||
105574520|NCT04537897|364102855|FG008|Overall Study|Adverse Event|0|||
105574521|NCT04537897|364102847|FG000|Overall Study|Withdrawal by Subject|0|||
105574522|NCT04537897|364102848|FG001|Overall Study|Withdrawal by Subject|1|||
105574523|NCT04537897|364102849|FG002|Overall Study|Withdrawal by Subject|0|||
105826983|NCT00216736|365024362|FG000|Overall Study|Lost to Follow-up|1|||
105826984|NCT00216736|365024363|FG001|Overall Study|Lost to Follow-up|1|||
105826985|NCT03158727|365024364|FG000|Overall Study|Withdrawal by Subject|2|||
105826986|NCT03158727|365024365|FG001|Overall Study|Withdrawal by Subject|6|||
105826987|NCT03158727|365024364|FG000|Overall Study|Death|11|||
105826988|NCT03158727|365024365|FG001|Overall Study|Death|12|||
105826989|NCT03158727|365024364|FG000|Overall Study|Lost to Follow-up|1|||
105826990|NCT03158727|365024365|FG001|Overall Study|Lost to Follow-up|0|||
105826991|NCT03158727|365024364|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
105826992|NCT03158727|365024365|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
105826993|NCT03158727|365024364|FG000|Overall Study|Visit 11 not done by mistake|0|||
105826994|NCT03158727|365024365|FG001|Overall Study|Visit 11 not done by mistake|1|||
105826995|NCT03158727|365024364|FG000|Overall Study|Enrolled, not treated|1|||
105826996|NCT03158727|365024365|FG001|Overall Study|Enrolled, not treated|0|||
105307121|NCT04713553|363122581|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
105307122|NCT04713553|363122582|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
105307123|NCT04713553|363122576|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
105307124|NCT04713553|363122577|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
105307125|NCT04713553|363122578|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
105307126|NCT04713553|363122579|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
105307127|NCT04713553|363122580|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
105307128|NCT04713553|363122581|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
105307129|NCT04713553|363122582|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
105574524|NCT04537897|364102850|FG003|Overall Study|Withdrawal by Subject|0|||
105574525|NCT04537897|364102851|FG004|Overall Study|Withdrawal by Subject|0|||
105826997|NCT00669162|365024366|FG000|Overall Study|Withdrawal by Subject|1|||
105826998|NCT00807495|365024367|FG000|Overall Study|Adverse Event|6|||
105826999|NCT00807495|365024368|FG001|Overall Study|Adverse Event|3|||
105827000|NCT00807495|365024369|FG002|Overall Study|Adverse Event|1|||
105827001|NCT00807495|365024370|FG003|Overall Study|Adverse Event|1|||
105827002|NCT00807495|365024371|FG004|Overall Study|Adverse Event|2|||
105827003|NCT00807495|365024367|FG000|Overall Study|Withdrawal by Patient|2|||
105827004|NCT00807495|365024368|FG001|Overall Study|Withdrawal by Patient|0|||
105574526|NCT04537897|364102852|FG005|Overall Study|Withdrawal by Subject|0|||
105827005|NCT00807495|365024369|FG002|Overall Study|Withdrawal by Patient|1|||
105488627|NCT04854642|363801905|FG001|Overall Study|Adverse Event|2|||
105488628|NCT04854642|363801904|FG000|Overall Study|Withdrawal by Subject|0|||
105488629|NCT04854642|363801905|FG001|Overall Study|Withdrawal by Subject|1|||
105827006|NCT00807495|365024370|FG003|Overall Study|Withdrawal by Patient|0|||
105827007|NCT00807495|365024371|FG004|Overall Study|Withdrawal by Patient|0|||
105827008|NCT00807495|365024367|FG000|Overall Study|Reason Not Specified|0|||
105827009|NCT00807495|365024368|FG001|Overall Study|Reason Not Specified|3|||
105827010|NCT00807495|365024369|FG002|Overall Study|Reason Not Specified|2|||
105827011|NCT00807495|365024370|FG003|Overall Study|Reason Not Specified|0|||
105574527|NCT04537897|364102853|FG006|Overall Study|Withdrawal by Subject|0|||
105574528|NCT04537897|364102854|FG007|Overall Study|Withdrawal by Subject|0|||
105574529|NCT04537897|364102855|FG008|Overall Study|Withdrawal by Subject|0|||
105574530|NCT01130883|364102858|FG000|Overall Study|Patient Noncompliance|6|||
105574531|NCT01130883|364102858|FG000|Overall Study|Reason Unknown|1|||
105574532|NCT01130883|364102858|FG000|Overall Study|Adverse Event|3|||
105574533|NCT03029780|364102862|FG000|Overall Study|Disease Progression|20|||
105574534|NCT03029780|364102863|FG001|Overall Study|Disease Progression|22|||
105574535|NCT03029780|364102862|FG000|Overall Study|Study Drug Toxicity|15|||
105574536|NCT03029780|364102863|FG001|Overall Study|Study Drug Toxicity|11|||
105574537|NCT03029780|364102862|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
105574538|NCT03029780|364102863|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
105574539|NCT03029780|364102862|FG000|Overall Study|Participant request to discontinue study treatment|4|||
105574540|NCT03029780|364102863|FG001|Overall Study|Participant request to discontinue study treatment|1|||
105574541|NCT03029780|364102862|FG000|Overall Study|Maximum clinical benefit|1|||
105574542|NCT03029780|364102863|FG001|Overall Study|Maximum clinical benefit|0|||
105488630|NCT02395016|363801906|FG000|Overall Study|Adverse Event|4|||
105488631|NCT02395016|363801907|FG001|Overall Study|Adverse Event|3|||
105488632|NCT02395016|363801906|FG000|Overall Study|Withdrawal by Subject|9|||
105574543|NCT03029780|364102862|FG000|Overall Study|Participant no longer meets study criteria|0|||
105574544|NCT03029780|364102863|FG001|Overall Study|Participant no longer meets study criteria|1|||
105574545|NCT03029780|364102862|FG000|Overall Study|Other reasons|6|||
105574546|NCT03029780|364102863|FG001|Overall Study|Other reasons|6|||
105574547|NCT03029780|364102862|FG000|Overall Study|Not reported|1|||
105574548|NCT03029780|364102863|FG001|Overall Study|Not reported|1|||
105574549|NCT03029780|364102862|FG000|Overall Study|Death|2|||
105574550|NCT03029780|364102863|FG001|Overall Study|Death|6|||
105574551|NCT03321006|364102866|FG000|Overall Study|Death|1|||
105574552|NCT03321006|364102867|FG001|Overall Study|Death|0|||
105574553|NCT03321006|364102866|FG000|Overall Study|Lack of Efficacy|1|||
105574554|NCT03321006|364102867|FG001|Overall Study|Lack of Efficacy|0|||
105574555|NCT00885352|364102870|FG000|Overall Study|Adverse Event|2|||
105574556|NCT00885352|364102871|FG001|Overall Study|Adverse Event|3|||
105574557|NCT00885352|364102870|FG000|Overall Study|Lost to Follow-up|2|||
105574558|NCT00885352|364102871|FG001|Overall Study|Lost to Follow-up|2|||
105574559|NCT00885352|364102870|FG000|Overall Study|Physician Decision|0|||
105574560|NCT00885352|364102871|FG001|Overall Study|Physician Decision|3|||
105574561|NCT00885352|364102870|FG000|Overall Study|Protocol Violation|0|||
105574562|NCT00885352|364102871|FG001|Overall Study|Protocol Violation|2|||
105574563|NCT00885352|364102870|FG000|Overall Study|Withdrawal by Subject|1|||
105574564|NCT00885352|364102871|FG001|Overall Study|Withdrawal by Subject|5|||
105574565|NCT00885352|364102870|FG000|Overall Study|Contradiction to study medication|0|||
105574566|NCT00885352|364102871|FG001|Overall Study|Contradiction to study medication|2|||
105574567|NCT00885352|364102870|FG000|Overall Study|Excluded medication|2|||
105574568|NCT00885352|364102871|FG001|Overall Study|Excluded medication|2|||
105574569|NCT00885352|364102870|FG000|Overall Study|Lab abnormalities|1|||
105574570|NCT00885352|364102871|FG001|Overall Study|Lab abnormalities|1|||
105574571|NCT04161807|364102872|FG000|Overall Study|Withdrawal by Subject|2|||
105574572|NCT04161807|364102872|FG000|Overall Study|Performed only 1 treatment|2|||
105574573|NCT04789577|364102883|FG000|Overall Study|Withdrawal by Subject|1|||
105574574|NCT04789577|364102884|FG001|Overall Study|Withdrawal by Subject|1|||
105574575|NCT04789577|364102885|FG002|Overall Study|Withdrawal by Subject|1|||
105574576|NCT04789577|364102886|FG003|Overall Study|Withdrawal by Subject|3|||
105488633|NCT02395016|363801907|FG001|Overall Study|Withdrawal by Subject|6|||
105488634|NCT02395016|363801906|FG000|Overall Study|Protocol Violation|2|||
105574577|NCT04789577|364102887|FG004|Overall Study|Withdrawal by Subject|1|||
105574578|NCT04789577|364102888|FG005|Overall Study|Withdrawal by Subject|7|||
105574579|NCT04789577|364102889|FG006|Overall Study|Withdrawal by Subject|1|||
105574580|NCT04789577|364102883|FG000|Overall Study|Lost to Follow-up|7|||
105574581|NCT04789577|364102884|FG001|Overall Study|Lost to Follow-up|12|||
105488635|NCT02395016|363801907|FG001|Overall Study|Protocol Violation|3|||
105574582|NCT04789577|364102885|FG002|Overall Study|Lost to Follow-up|7|||
105574583|NCT04789577|364102886|FG003|Overall Study|Lost to Follow-up|10|||
105574584|NCT04789577|364102887|FG004|Overall Study|Lost to Follow-up|8|||
105574585|NCT04789577|364102888|FG005|Overall Study|Lost to Follow-up|6|||
105574586|NCT04789577|364102889|FG006|Overall Study|Lost to Follow-up|10|||
105574587|NCT04789577|364102883|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
105574588|NCT04789577|364102884|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
105827012|NCT00807495|365024371|FG004|Overall Study|Reason Not Specified|3|||
105827013|NCT01051349|365024374|FG000|Overall Study|Adverse Event|88|||
105366375|NCT02787304|363348363|FG001|Overall Study|Lost to Follow-up|0|||
105366376|NCT02787304|363348364|FG002|Overall Study|Lost to Follow-up|0|||
105366377|NCT02787304|363348365|FG003|Overall Study|Lost to Follow-up|1|||
105827014|NCT01051349|365024374|FG000|Overall Study|Consent Withdrawn|54|||
105827015|NCT01051349|365024374|FG000|Overall Study|Investigator Decision|6|||
105827016|NCT01051349|365024374|FG000|Overall Study|Lost to Follow-up|6|||
105827017|NCT01051349|365024374|FG000|Overall Study|Subject non-compliance|7|||
105827018|NCT01051349|365024374|FG000|Overall Study|Reason not Specified|12|||
105827019|NCT02264977|365024385|FG000|Overall Study|Death|3|||
105827020|NCT02264977|365024385|FG000|Overall Study|Physician Decision|1|||
105827021|NCT02264977|365024385|FG000|Overall Study|Refuse to return|1|||
105827022|NCT03578809|365026355|FG000|Overall Study|Death|0|||
105827023|NCT03578809|365026356|FG001|Overall Study|Death|2|||
105827024|NCT03578809|365026357|FG002|Overall Study|Death|0|||
105827025|NCT03578809|365026358|FG003|Overall Study|Death|1|||
105827026|NCT03578809|365026355|FG000|Overall Study|Lost to Follow-up|0|||
105827027|NCT03578809|365026356|FG001|Overall Study|Lost to Follow-up|1|||
105827028|NCT03578809|365026357|FG002|Overall Study|Lost to Follow-up|0|||
105827029|NCT03578809|365026358|FG003|Overall Study|Lost to Follow-up|0|||
105827030|NCT03578809|365026355|FG000|Overall Study|Withdrawal by Subject|3|||
105827031|NCT03578809|365026356|FG001|Overall Study|Withdrawal by Subject|5|||
105827032|NCT03578809|365026357|FG002|Overall Study|Withdrawal by Subject|2|||
105827033|NCT03578809|365026358|FG003|Overall Study|Withdrawal by Subject|0|||
105366378|NCT02787304|363348362|FG000|Overall Study|Noncompliance with study drug|0|||
105488636|NCT01277042|363801908|FG000|Overall Study|Adverse Event|4|||
105488637|NCT01277042|363801909|FG001|Overall Study|Adverse Event|3|||
105488638|NCT01277042|363801908|FG000|Overall Study|Lost to Follow-up|2|||
105488639|NCT01277042|363801909|FG001|Overall Study|Lost to Follow-up|2|||
105488640|NCT01277042|363801908|FG000|Overall Study|Withdrawal by Subject|2|||
105488641|NCT01277042|363801909|FG001|Overall Study|Withdrawal by Subject|0|||
105488642|NCT00588952|363801910|FG000|Overall Study|Adverse Event|0|||
105488643|NCT00588952|363801911|FG001|Overall Study|Adverse Event|2|||
105488644|NCT00588952|363801910|FG000|Overall Study|Withdrawal by Subject|3|||
105488645|NCT00588952|363801911|FG001|Overall Study|Withdrawal by Subject|5|||
105488646|NCT03435640|363801912|FG000|Overall Study|Withdrawal by Subject|0|||
105488647|NCT03435640|363801913|FG001|Overall Study|Withdrawal by Subject|1|||
105488648|NCT03435640|363801914|FG002|Overall Study|Withdrawal by Subject|0|||
105488649|NCT03435640|363801915|FG003|Overall Study|Withdrawal by Subject|2|||
105488650|NCT03435640|363801916|FG004|Overall Study|Withdrawal by Subject|0|||
105488651|NCT03435640|363801917|FG005|Overall Study|Withdrawal by Subject|0|||
105488652|NCT03435640|363801918|FG006|Overall Study|Withdrawal by Subject|3|||
105488653|NCT03435640|363801919|FG007|Overall Study|Withdrawal by Subject|0|||
105488654|NCT03435640|363801920|FG008|Overall Study|Withdrawal by Subject|0|||
105488655|NCT03435640|363801921|FG009|Overall Study|Withdrawal by Subject|2|||
105488656|NCT03435640|363801922|FG010|Overall Study|Withdrawal by Subject|3|||
105488657|NCT03435640|363801912|FG000|Overall Study|Lost to Follow-up|0|||
105488658|NCT03435640|363801913|FG001|Overall Study|Lost to Follow-up|0|||
105488659|NCT03435640|363801914|FG002|Overall Study|Lost to Follow-up|1|||
105488660|NCT03435640|363801915|FG003|Overall Study|Lost to Follow-up|0|||
105488661|NCT03435640|363801916|FG004|Overall Study|Lost to Follow-up|0|||
105488662|NCT03435640|363801917|FG005|Overall Study|Lost to Follow-up|0|||
105488663|NCT03435640|363801918|FG006|Overall Study|Lost to Follow-up|0|||
105488664|NCT03435640|363801919|FG007|Overall Study|Lost to Follow-up|0|||
105488665|NCT03435640|363801920|FG008|Overall Study|Lost to Follow-up|0|||
105488666|NCT03435640|363801921|FG009|Overall Study|Lost to Follow-up|0|||
105488667|NCT03435640|363801922|FG010|Overall Study|Lost to Follow-up|0|||
105488668|NCT03868124|363801925|FG000|Overall Study|Withdrawal by Subject|4|||
105488669|NCT03868124|363801926|FG001|Overall Study|Withdrawal by Subject|0|||
105488670|NCT03868124|363801927|FG002|Overall Study|Withdrawal by Subject|1|||
105488671|NCT03868124|363801925|FG000|Overall Study|Physician Decision|1|||
105488672|NCT03868124|363801926|FG001|Overall Study|Physician Decision|0|||
105488673|NCT03868124|363801927|FG002|Overall Study|Physician Decision|1|||
105488674|NCT03868124|363801925|FG000|Overall Study|Lost to Follow-up|1|||
105488675|NCT03868124|363801926|FG001|Overall Study|Lost to Follow-up|1|||
105488676|NCT03868124|363801927|FG002|Overall Study|Lost to Follow-up|2|||
105488677|NCT03868124|363801925|FG000|Overall Study|Death|1|||
105488678|NCT03868124|363801926|FG001|Overall Study|Death|1|||
105488679|NCT03868124|363801927|FG002|Overall Study|Death|2|||
105488680|NCT03868124|363801925|FG000|Overall Study|Adverse Event|0|||
105488681|NCT03868124|363801926|FG001|Overall Study|Adverse Event|0|||
105488682|NCT03868124|363801927|FG002|Overall Study|Adverse Event|3|||
105488683|NCT03868124|363801925|FG000|Overall Study|Explanted|2|||
105488684|NCT03868124|363801926|FG001|Overall Study|Explanted|1|||
105488685|NCT03868124|363801927|FG002|Overall Study|Explanted|0|||
105488686|NCT03868124|363801925|FG000|Overall Study|Ongoing in study|176|||
105488687|NCT03868124|363801926|FG001|Overall Study|Ongoing in study|180|||
105827034|NCT03578809|365026355|FG000|Overall Study|Other|3|||
105827035|NCT03578809|365026356|FG001|Overall Study|Other|6|||
105827036|NCT03578809|365026357|FG002|Overall Study|Other|2|||
105827037|NCT03578809|365026358|FG003|Overall Study|Other|8|||
105827038|NCT01750294|365026359|FG000|Overall Study|Withdrawal by Subject|1|||
105827039|NCT01750294|365026359|FG000|Overall Study|Safety Endpoint|1|||
105827040|NCT00665925|365026360|FG000|Overall Study|Lack of Efficacy|10|||
105827041|NCT00665925|365026361|FG001|Overall Study|Lack of Efficacy|8|||
105827042|NCT00665925|365026362|FG002|Overall Study|Lack of Efficacy|9|||
105827043|NCT00665925|365026363|FG003|Overall Study|Lack of Efficacy|8|||
105827044|NCT00665925|365026360|FG000|Overall Study|Lost to Follow-up|1|||
105827045|NCT00665925|365026361|FG001|Overall Study|Lost to Follow-up|2|||
105827046|NCT00665925|365026362|FG002|Overall Study|Lost to Follow-up|2|||
105827047|NCT00665925|365026363|FG003|Overall Study|Lost to Follow-up|2|||
105827048|NCT00665925|365026360|FG000|Overall Study|Withdrawal by Subject|2|||
105827049|NCT00665925|365026361|FG001|Overall Study|Withdrawal by Subject|2|||
105827050|NCT00665925|365026362|FG002|Overall Study|Withdrawal by Subject|3|||
105827051|NCT00665925|365026363|FG003|Overall Study|Withdrawal by Subject|2|||
105827052|NCT00665925|365026360|FG000|Overall Study|Physician Decision|0|||
105827053|NCT00665925|365026361|FG001|Overall Study|Physician Decision|0|||
105827054|NCT00665925|365026362|FG002|Overall Study|Physician Decision|1|||
105827055|NCT00665925|365026363|FG003|Overall Study|Physician Decision|2|||
105827056|NCT00665925|365026360|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
105827057|NCT00665925|365026361|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
105827058|NCT00665925|365026362|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
105827059|NCT00665925|365026363|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
105827060|NCT00665925|365026360|FG000|Overall Study|Adverse Event|1|||
105827061|NCT00665925|365026361|FG001|Overall Study|Adverse Event|5|||
105827062|NCT00665925|365026362|FG002|Overall Study|Adverse Event|10|||
105827063|NCT00665925|365026363|FG003|Overall Study|Adverse Event|5|||
105827064|NCT00665925|365026360|FG000|Overall Study|Enrolled by mistake|0|||
105827065|NCT00665925|365026361|FG001|Overall Study|Enrolled by mistake|0|||
105827066|NCT00665925|365026362|FG002|Overall Study|Enrolled by mistake|0|||
105827067|NCT00665925|365026363|FG003|Overall Study|Enrolled by mistake|1|||
105827068|NCT00665925|365026360|FG000|Overall Study|Due to exclusion criteria|1|||
105827069|NCT00665925|365026361|FG001|Overall Study|Due to exclusion criteria|0|||
105827070|NCT00665925|365026362|FG002|Overall Study|Due to exclusion criteria|0|||
105827071|NCT00665925|365026363|FG003|Overall Study|Due to exclusion criteria|0|||
105827072|NCT02316223|365026370|FG000|Overall Study|Lack of Efficacy|0|||
105827073|NCT02316223|365026371|FG001|Overall Study|Lack of Efficacy|1|||
105827074|NCT02316223|365026372|FG002|Overall Study|Lack of Efficacy|1|||
105827075|NCT02316223|365026370|FG000|Overall Study|Lost to Follow-up|27|||
105827076|NCT02316223|365026371|FG001|Overall Study|Lost to Follow-up|34|||
105827077|NCT02316223|365026372|FG002|Overall Study|Lost to Follow-up|36|||
105827078|NCT02316223|365026370|FG000|Overall Study|COPD Diagnosis|3|||
105827079|NCT02316223|365026371|FG001|Overall Study|COPD Diagnosis|2|||
105827080|NCT02316223|365026372|FG002|Overall Study|COPD Diagnosis|3|||
105827081|NCT02316223|365026370|FG000|Overall Study|Reside outside study area|1|||
105827082|NCT02316223|365026371|FG001|Overall Study|Reside outside study area|1|||
105827083|NCT02316223|365026372|FG002|Overall Study|Reside outside study area|1|||
105827084|NCT02316223|365026370|FG000|Overall Study|No asthma|2|||
105827085|NCT02316223|365026371|FG001|Overall Study|No asthma|0|||
105827086|NCT02316223|365026372|FG002|Overall Study|No asthma|0|||
105827087|NCT02316223|365026370|FG000|Overall Study|Discontinued by PI|11|||
105366379|NCT02787304|363348363|FG001|Overall Study|Noncompliance with study drug|0|||
105827088|NCT02316223|365026371|FG001|Overall Study|Discontinued by PI|19|||
105827089|NCT02316223|365026372|FG002|Overall Study|Discontinued by PI|3|||
105827090|NCT02255149|365026373|FG000|Overall Study|Lost to Follow-up|2|||
105827091|NCT02255149|365026373|FG000|Overall Study|Withdrawal by Subject|1|||
105827092|NCT02255149|365026373|FG000|Overall Study|Withdrawal by PI|1|||
105827093|NCT02255149|365026373|FG000|Overall Study|Implant Failure|1|||
105827094|NCT03669250|365026374|FG000|Overall Study|Adverse Event|0|||
105827095|NCT03669250|365026375|FG001|Overall Study|Adverse Event|0|||
105827096|NCT03669250|365026376|FG002|Overall Study|Adverse Event|0|||
105827097|NCT03669250|365026377|FG003|Overall Study|Adverse Event|0|||
105827098|NCT03669250|365026378|FG004|Overall Study|Adverse Event|1|||
105488688|NCT03868124|363801927|FG002|Overall Study|Ongoing in study|183|||
105488689|NCT05128929|363801930|FG000|Overall Study|Adverse Event|0|||
105488690|NCT05128929|363801931|FG001|Overall Study|Adverse Event|1|||
105488691|NCT00397943|363801932|FG000|Overall Study|Unspecified reasons|12|||
105488692|NCT00397943|363801933|FG001|Overall Study|Unspecified reasons|9|||
105488693|NCT00397943|363801934|FG002|Overall Study|Unspecified reasons|0|||
105488694|NCT00397943|363801935|FG003|Overall Study|Unspecified reasons|0|||
105488695|NCT00397943|363801936|FG004|Overall Study|Unspecified reasons|0|||
105488696|NCT03220438|363801937|FG000|Overall Study|Lost to Follow-up|0|||
105488697|NCT03220438|363801938|FG001|Overall Study|Lost to Follow-up|0|||
105488698|NCT03220438|363801939|FG002|Overall Study|Lost to Follow-up|1|||
105488699|NCT03220438|363801940|FG003|Overall Study|Lost to Follow-up|0|||
105488700|NCT04062123|363801941|FG000|Overall Study|Withdrawal by Subject|0|||
105488701|NCT04062123|363801942|FG001|Overall Study|Withdrawal by Subject|1|||
105488702|NCT04062123|363801943|FG002|Overall Study|Withdrawal by Subject|0|||
105488703|NCT04626310|363801944|FG000|Overall Study|4-miss from treatment|6|||
105488704|NCT04626310|363801945|FG001|Overall Study|4-miss from treatment|5|||
105488705|NCT04626310|363801946|FG002|Overall Study|4-miss from treatment|5|||
105488706|NCT04626310|363801944|FG000|Overall Study|Withdrawal by Subject|1|||
105488707|NCT04626310|363801945|FG001|Overall Study|Withdrawal by Subject|0|||
105488708|NCT04626310|363801946|FG002|Overall Study|Withdrawal by Subject|3|||
105488709|NCT00589784|363801949|FG000|Overall Study|Withdrawal by Subject|0|||
105488710|NCT00589784|363801950|FG001|Overall Study|Withdrawal by Subject|6|||
105488711|NCT00589784|363801949|FG000|Overall Study|Patient inevaluable|1|||
105488712|NCT00589784|363801950|FG001|Overall Study|Patient inevaluable|0|||
105488713|NCT00589784|363801949|FG000|Overall Study|Adverse Event|0|||
105488714|NCT00589784|363801950|FG001|Overall Study|Adverse Event|4|||
105488715|NCT00521001|363801953|FG000|Overall Study|Ineligible|1|||
105488716|NCT05867342|363801955|FG000|Overall Study|Investigator Decision|3|||
105488717|NCT05867342|363801956|FG001|Overall Study|Investigator Decision|3|||
105488718|NCT01282203|363801959|FG000|Overall Study|Adverse Event|1|||
105488719|NCT03190369|363801963|FG000|Overall Study|Poor compliance to protocol|0|||
105488720|NCT03190369|363801964|FG001|Overall Study|Poor compliance to protocol|1|||
105488721|NCT03190369|363801963|FG000|Overall Study|Withdraw before treatment|1|||
105488722|NCT03190369|363801964|FG001|Overall Study|Withdraw before treatment|5|||
105488723|NCT03190369|363801963|FG000|Overall Study|Randomized but not treated|0|||
105488724|NCT03190369|363801964|FG001|Overall Study|Randomized but not treated|2|||
105488725|NCT02963831|363801969|FG000|Overall Study|Progressive Disease|3|||
105488726|NCT02963831|363801970|FG001|Overall Study|Progressive Disease|3|||
105488727|NCT02963831|363801971|FG002|Overall Study|Progressive Disease|16|||
105488728|NCT02963831|363801972|FG003|Overall Study|Progressive Disease|27|||
105488729|NCT02963831|363801969|FG000|Overall Study|Withdrawal by Subject|1|||
105488730|NCT02963831|363801970|FG001|Overall Study|Withdrawal by Subject|0|||
105488731|NCT02963831|363801971|FG002|Overall Study|Withdrawal by Subject|2|||
105488732|NCT02963831|363801972|FG003|Overall Study|Withdrawal by Subject|4|||
105488733|NCT02963831|363801969|FG000|Overall Study|Adverse Event|0|||
105488734|NCT02963831|363801970|FG001|Overall Study|Adverse Event|1|||
105488735|NCT02963831|363801971|FG002|Overall Study|Adverse Event|1|||
105488736|NCT02963831|363801972|FG003|Overall Study|Adverse Event|2|||
105488737|NCT02963831|363801969|FG000|Overall Study|Death|0|||
105488738|NCT02963831|363801970|FG001|Overall Study|Death|0|||
105488739|NCT02963831|363801971|FG002|Overall Study|Death|0|||
105488740|NCT02963831|363801972|FG003|Overall Study|Death|2|||
105488741|NCT03463031|363801975|FG000|Overall Study|Withdrawal by Subject|4|||
105488742|NCT03463031|363801976|FG001|Overall Study|Withdrawal by Subject|2|||
105488743|NCT03463031|363801975|FG000|Overall Study|Investigator/Sponsor Decision|0|||
105488744|NCT03463031|363801976|FG001|Overall Study|Investigator/Sponsor Decision|1|||
105488745|NCT03463031|363801975|FG000|Overall Study|Lost to Follow-up|1|||
105488746|NCT03463031|363801976|FG001|Overall Study|Lost to Follow-up|1|||
105488747|NCT03463031|363801975|FG000|Overall Study|Adverse Event|4|||
105488748|NCT03463031|363801976|FG001|Overall Study|Adverse Event|1|||
105488749|NCT03463031|363801975|FG000|Overall Study|Use of prohibited medication by subject|1|||
105488750|NCT03463031|363801976|FG001|Overall Study|Use of prohibited medication by subject|0|||
105488751|NCT01289782|363801977|FG000|Overall Study|Lost to Follow-up|14|||
105488752|NCT01289782|363801978|FG001|Overall Study|Lost to Follow-up|7|||
105488753|NCT01289782|363801977|FG000|Overall Study|Protocol Violation|1|||
105488754|NCT01289782|363801978|FG001|Overall Study|Protocol Violation|1|||
105488755|NCT01289782|363801977|FG000|Overall Study|Withdrawal by Subject|8|||
105488756|NCT01289782|363801978|FG001|Overall Study|Withdrawal by Subject|2|||
105488757|NCT01289782|363801977|FG000|Overall Study|Sponsor's Decision|1|||
105488758|NCT01289782|363801978|FG001|Overall Study|Sponsor's Decision|0|||
105488759|NCT01289782|363801977|FG000|Overall Study|Reason not specified|1|||
105488760|NCT01289782|363801978|FG001|Overall Study|Reason not specified|2|||
105488761|NCT00542451|363801979|FG000|Overall Study|Adverse Event|31|||
105488762|NCT00542451|363801979|FG000|Overall Study|Withdrawal by Subject|30|||
105827099|NCT03669250|365026379|FG005|Overall Study|Adverse Event|0|||
105827100|NCT03669250|365026374|FG000|Overall Study|Withdrawal by Subject|0|||
105827101|NCT03669250|365026375|FG001|Overall Study|Withdrawal by Subject|1|||
105827102|NCT03669250|365026376|FG002|Overall Study|Withdrawal by Subject|0|||
105827103|NCT03669250|365026377|FG003|Overall Study|Withdrawal by Subject|1|||
105827104|NCT03669250|365026378|FG004|Overall Study|Withdrawal by Subject|0|||
105827105|NCT03669250|365026379|FG005|Overall Study|Withdrawal by Subject|0|||
105827106|NCT00081653|365026394|FG000|Overall Study|Adverse Event|23|||
105827107|NCT00081653|365026395|FG001|Overall Study|Adverse Event|17|||
105827108|NCT00081653|365026394|FG000|Overall Study|Lost to Follow-up|2|||
105827109|NCT00081653|365026395|FG001|Overall Study|Lost to Follow-up|4|||
105488763|NCT00542451|363801979|FG000|Overall Study|Physician Decision|4|||
105488764|NCT00542451|363801979|FG000|Overall Study|Recurrent disease|1|||
105488765|NCT00542451|363801979|FG000|Overall Study|unknown reason|1|||
105488766|NCT00542451|363801979|FG000|Overall Study|Death|2|||
105488767|NCT00542451|363801979|FG000|Overall Study|Lost to Follow-up|10|||
105488768|NCT01058265|363801982|FG000|Overall Study|Lost to Follow-up|11|||
105488769|NCT01058265|363801983|FG001|Overall Study|Lost to Follow-up|12|||
105488770|NCT00984568|363801984|FG000|Overall Study|Withdrawal by Subject|1|||
105488771|NCT00984568|363801985|FG001|Overall Study|Withdrawal by Subject|2|||
105488772|NCT00984568|363801984|FG000|Overall Study|Lack of Efficacy|2|||
105488773|NCT00984568|363801985|FG001|Overall Study|Lack of Efficacy|0|||
105488774|NCT00984568|363801984|FG000|Overall Study|Adverse Event|2|||
105488775|NCT00984568|363801985|FG001|Overall Study|Adverse Event|0|||
105488776|NCT00984568|363801984|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
105488777|NCT00984568|363801985|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
105488778|NCT00984568|363801984|FG000|Overall Study|Lost to Follow-up|0|||
105488779|NCT00984568|363801985|FG001|Overall Study|Lost to Follow-up|1|||
105488780|NCT00984568|363801984|FG000|Overall Study|Opportunistic Infection|1|||
105488781|NCT00984568|363801985|FG001|Overall Study|Opportunistic Infection|0|||
105488782|NCT00984568|363801984|FG000|Overall Study|Unknown Reason|1|||
105488783|NCT00984568|363801985|FG001|Overall Study|Unknown Reason|3|||
105488784|NCT01367119|363801986|FG000|Overall Study|Adverse Event|1|||
105488785|NCT01367119|363801987|FG001|Overall Study|Adverse Event|0|||
105488786|NCT01367119|363801986|FG000|Overall Study|Withdrawal by Subject|1|||
105488787|NCT01367119|363801987|FG001|Overall Study|Withdrawal by Subject|1|||
105488788|NCT05342532|363801988|FG000|Overall Study|Adverse Event|5|||
105488789|NCT05342532|363801989|FG001|Overall Study|Adverse Event|20|||
105488790|NCT05342532|363801988|FG000|Overall Study|Lost to Follow-up|10|||
105488791|NCT05342532|363801989|FG001|Overall Study|Lost to Follow-up|15|||
105488792|NCT03180684|363801990|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
105488793|NCT03180684|363801991|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
105488794|NCT03180684|363801990|FG000|Overall Study|Physician Decision|1|||
105488795|NCT03180684|363801991|FG001|Overall Study|Physician Decision|0|||
105488796|NCT03180684|363801990|FG000|Overall Study|Lost to Follow-up|1|||
105488797|NCT03180684|363801991|FG001|Overall Study|Lost to Follow-up|0|||
105488798|NCT03180684|363801990|FG000|Overall Study|Progressive Disease|1|||
105488799|NCT03180684|363801991|FG001|Overall Study|Progressive Disease|0|||
105488800|NCT02414139|363801993|FG000|Treatment Period|Adverse Event|11|||
105488801|NCT02414139|363801994|FG001|Treatment Period|Adverse Event|6|||
105574589|NCT04789577|364102885|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
105574590|NCT04789577|364102886|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
105574591|NCT04789577|364102887|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
105574592|NCT04789577|364102888|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
105574593|NCT04789577|364102889|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
105574594|NCT04789577|364102883|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
105574595|NCT04789577|364102884|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
105574596|NCT04789577|364102885|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
105574597|NCT04789577|364102886|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
105574598|NCT04789577|364102887|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
105574599|NCT04789577|364102888|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
105574600|NCT04789577|364102889|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
105574601|NCT02441946|364102890|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
105574602|NCT02441946|364102891|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
105574603|NCT02441946|364102892|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
105574604|NCT02441946|364102890|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
105574605|NCT02441946|364102891|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
105574606|NCT02441946|364102892|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
105574607|NCT02441946|364102890|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
105574608|NCT02441946|364102891|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
105574609|NCT02441946|364102892|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
105574610|NCT02441946|364102890|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
105574611|NCT02441946|364102891|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
105574612|NCT02441946|364102892|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
105574613|NCT02441946|364102890|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
105574614|NCT02441946|364102891|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
105574615|NCT02441946|364102892|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
105574616|NCT02441946|364102890|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
105574617|NCT02441946|364102891|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
105574618|NCT02441946|364102892|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
105574619|NCT02441946|364102890|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
105574620|NCT02441946|364102891|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
105574621|NCT02441946|364102892|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
105574622|NCT02441946|364102890|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
105574623|NCT02441946|364102891|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
105574624|NCT02441946|364102892|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
105574625|NCT02441946|364102890|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
105574626|NCT02441946|364102891|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
105574627|NCT02441946|364102892|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
105574628|NCT02441946|364102890|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
105574629|NCT02441946|364102891|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
105574630|NCT02441946|364102892|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
105574631|NCT02441946|364102890|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
105574632|NCT02441946|364102891|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
105574633|NCT02441946|364102892|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
105574634|NCT04848662|364102893|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
105574635|NCT04848662|364102894|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
105574636|NCT01121484|364102895|FG000|Overall Study|Adverse Event|12|||
105574637|NCT01121484|364102896|FG001|Overall Study|Adverse Event|5|||
105574638|NCT01121484|364102895|FG000|Overall Study|Lack of Efficacy|3|||
105574639|NCT01121484|364102896|FG001|Overall Study|Lack of Efficacy|11|||
105574640|NCT01121484|364102895|FG000|Overall Study|Lost to Follow-up|5|||
105574641|NCT01121484|364102896|FG001|Overall Study|Lost to Follow-up|9|||
105574642|NCT01121484|364102895|FG000|Overall Study|Physician Decision|0|||
105574643|NCT01121484|364102896|FG001|Overall Study|Physician Decision|3|||
105574644|NCT01121484|364102895|FG000|Overall Study|Protocol Violation|1|||
105574645|NCT01121484|364102896|FG001|Overall Study|Protocol Violation|0|||
105574646|NCT01121484|364102895|FG000|Overall Study|Withdrawal by Subject|8|||
105574647|NCT01121484|364102896|FG001|Overall Study|Withdrawal by Subject|7|||
105574648|NCT01121484|364102895|FG000|Overall Study|Discontinuation of study by sponsor|0|||
105574649|NCT01121484|364102896|FG001|Overall Study|Discontinuation of study by sponsor|1|||
105574650|NCT01121484|364102895|FG000|Overall Study|Other|3|||
105574651|NCT01121484|364102896|FG001|Overall Study|Other|3|||
105574652|NCT01121484|364102895|FG000|Overall Study|Randomized, not treated|1|||
105574653|NCT01121484|364102896|FG001|Overall Study|Randomized, not treated|4|||
105574654|NCT01512745|364102897|FG000|Overall Study|Adverse Event|22|||
105574655|NCT01512745|364102898|FG001|Overall Study|Adverse Event|3|||
105574656|NCT01512745|364102897|FG000|Overall Study|Death|9|||
105574657|NCT01512745|364102898|FG001|Overall Study|Death|13|||
105574658|NCT01512745|364102897|FG000|Overall Study|Withdrawal by Subject|2|||
105574659|NCT01512745|364102898|FG001|Overall Study|Withdrawal by Subject|2|||
105574660|NCT01512745|364102897|FG000|Overall Study|Lost to Follow-up|4|||
105574661|NCT01512745|364102898|FG001|Overall Study|Lost to Follow-up|0|||
105574662|NCT01512745|364102897|FG000|Overall Study|Lack of Efficacy|2|||
105574663|NCT01512745|364102898|FG001|Overall Study|Lack of Efficacy|2|||
105574664|NCT01512745|364102897|FG000|Overall Study|Protocol Violation|1|||
105574665|NCT01512745|364102898|FG001|Overall Study|Protocol Violation|0|||
105574666|NCT03292146|364102905|FG000|Baseline to 12 Months|Relocation|1|||
105574667|NCT03292146|364102906|FG001|Baseline to 12 Months|Relocation|0|||
105574668|NCT03292146|364102905|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
105574669|NCT03292146|364102906|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
105574670|NCT03292146|364102905|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
105574671|NCT03292146|364102906|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
105574672|NCT03292146|364102905|FG000|12 Months to 24 Months|Planning pregnancy|2|||
105574673|NCT03292146|364102906|FG001|12 Months to 24 Months|Planning pregnancy|2|||
105574674|NCT03292146|364102905|FG000|12 Months to 24 Months|Personal reasons|1|||
105574675|NCT03292146|364102906|FG001|12 Months to 24 Months|Personal reasons|0|||
105574676|NCT03292146|364102905|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
105574677|NCT03292146|364102906|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
105574678|NCT00758160|364102907|FG000|Overall Study|No Longer Requires Study Medication|4|||
105574679|NCT00758160|364102907|FG000|Overall Study|Administration Problems|3|||
105574680|NCT00758160|364102907|FG000|Overall Study|Adverse Event|15|||
105827110|NCT00081653|365026394|FG000|Overall Study|Refused Treatment|18|||
105827111|NCT00081653|365026395|FG001|Overall Study|Refused Treatment|14|||
105574681|NCT00758160|364102907|FG000|Overall Study|Lack of Efficacy|10|||
105574682|NCT00758160|364102907|FG000|Overall Study|Lost to Follow-up|14|||
105574683|NCT00758160|364102907|FG000|Overall Study|Protocol Violation|12|||
105574684|NCT00758160|364102907|FG000|Overall Study|Withdrawal by Subject|8|||
105574685|NCT01586338|364102915|FG000|Overall Study|Adverse Event|3|||
105574686|NCT01586338|364102915|FG000|Overall Study|Lost to Follow-up|1|||
105574687|NCT01586338|364102915|FG000|Overall Study|Withdrawal by participant|3|||
105574688|NCT01586338|364102915|FG000|Overall Study|Other|1|||
105574689|NCT04078035|364102916|FG000|Session 2|Lost to Follow-up|3|||
105574690|NCT04078035|364102917|FG001|Session 2|Lost to Follow-up|1|||
105574691|NCT04078035|364102916|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
105574692|NCT04078035|364102917|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
105574693|NCT03560245|364102931|FG000|Overall Study|Withdrawal by Subject|3|||
105574694|NCT03560245|364102932|FG001|Overall Study|Withdrawal by Subject|2|||
105574695|NCT03560245|364102931|FG000|Overall Study|Adverse Event|1|||
105574696|NCT03560245|364102932|FG001|Overall Study|Adverse Event|1|||
105574697|NCT03560245|364102931|FG000|Overall Study|Protocol Violation|1|||
105574698|NCT03560245|364102932|FG001|Overall Study|Protocol Violation|0|||
105574699|NCT03560245|364102931|FG000|Overall Study|Death|0|||
105574700|NCT03560245|364102932|FG001|Overall Study|Death|1|||
105574701|NCT03560245|364102931|FG000|Overall Study|Lost to Follow-up|0|||
105574702|NCT03560245|364102932|FG001|Overall Study|Lost to Follow-up|1|||
105574703|NCT03560245|364102931|FG000|Overall Study|Physician Decision|0|||
105366380|NCT02787304|363348364|FG002|Overall Study|Noncompliance with study drug|1|||
105574704|NCT03560245|364102932|FG001|Overall Study|Physician Decision|1|||
105574705|NCT03560245|364102931|FG000|Overall Study|Other|0|||
105574706|NCT03560245|364102932|FG001|Overall Study|Other|1|||
105574707|NCT00337662|364102933|FG000|Study Period II|Lost to Follow-up|0|||
105574708|NCT00337662|364102934|FG001|Study Period II|Lost to Follow-up|0|||
105574709|NCT00337662|364102935|FG002|Study Period II|Lost to Follow-up|0|||
105574710|NCT00337662|364102936|FG003|Study Period II|Lost to Follow-up|35|||
105574711|NCT00337662|364102933|FG000|Study Period II|Withdrawal by Subject|0|||
105574712|NCT00337662|364102934|FG001|Study Period II|Withdrawal by Subject|0|||
105574713|NCT00337662|364102935|FG002|Study Period II|Withdrawal by Subject|0|||
105574714|NCT00337662|364102936|FG003|Study Period II|Withdrawal by Subject|20|||
105574715|NCT00337662|364102933|FG000|Study Period II|Adverse Event|0|||
105574716|NCT00337662|364102934|FG001|Study Period II|Adverse Event|0|||
105574717|NCT00337662|364102935|FG002|Study Period II|Adverse Event|0|||
105574718|NCT00337662|364102936|FG003|Study Period II|Adverse Event|16|||
105574719|NCT00337662|364102933|FG000|Study Period II|Physician Decision|0|||
105574720|NCT00337662|364102934|FG001|Study Period II|Physician Decision|0|||
105574721|NCT00337662|364102935|FG002|Study Period II|Physician Decision|0|||
105574722|NCT00337662|364102936|FG003|Study Period II|Physician Decision|13|||
105574723|NCT00337662|364102933|FG000|Study Period II|Entry Criteria Not Met|0|||
105574724|NCT00337662|364102934|FG001|Study Period II|Entry Criteria Not Met|0|||
105574725|NCT00337662|364102935|FG002|Study Period II|Entry Criteria Not Met|0|||
105574726|NCT00337662|364102936|FG003|Study Period II|Entry Criteria Not Met|6|||
105574727|NCT00337662|364102933|FG000|Study Period II|Protocol Violation|0|||
105574728|NCT00337662|364102934|FG001|Study Period II|Protocol Violation|0|||
105574729|NCT00337662|364102935|FG002|Study Period II|Protocol Violation|0|||
105574730|NCT00337662|364102936|FG003|Study Period II|Protocol Violation|6|||
105574731|NCT00337662|364102933|FG000|Study Period II|Lack of Efficacy|0|||
105574732|NCT00337662|364102934|FG001|Study Period II|Lack of Efficacy|0|||
105574733|NCT00337662|364102935|FG002|Study Period II|Lack of Efficacy|0|||
105827112|NCT00081653|365026394|FG000|Overall Study|Low bone mineral density|1|||
105366381|NCT02787304|363348365|FG003|Overall Study|Noncompliance with study drug|0|||
105366382|NCT02787304|363348362|FG000|Overall Study|Physician Decision|0|||
105366383|NCT02787304|363348363|FG001|Overall Study|Physician Decision|0|||
105366384|NCT02787304|363348364|FG002|Overall Study|Physician Decision|1|||
105366385|NCT02787304|363348365|FG003|Overall Study|Physician Decision|0|||
105366386|NCT02787304|363348362|FG000|Overall Study|Study terminated by sponsor|25|||
105366387|NCT02787304|363348363|FG001|Overall Study|Study terminated by sponsor|31|||
105366388|NCT02787304|363348364|FG002|Overall Study|Study terminated by sponsor|31|||
105366389|NCT02787304|363348365|FG003|Overall Study|Study terminated by sponsor|32|||
105366390|NCT02486692|363348366|FG000|Overall Study|did not login for randomization|4|||
105366391|NCT02486692|363348367|FG001|Overall Study|did not login for randomization|7|||
105366392|NCT03028142|363348368|FG000|Overall Study|Adverse Event|1|||
105366393|NCT03028142|363348369|FG001|Overall Study|Adverse Event|1|||
105366394|NCT03028142|363348370|FG002|Overall Study|Adverse Event|0|||
105366395|NCT03028142|363348371|FG003|Overall Study|Adverse Event|0|||
105366396|NCT03028142|363348372|FG004|Overall Study|Adverse Event|0|||
105366397|NCT03028142|363348373|FG005|Overall Study|Adverse Event|1|||
105366398|NCT03028142|363348368|FG000|Overall Study|Withdrawal by Subject|0|||
105366399|NCT03028142|363348369|FG001|Overall Study|Withdrawal by Subject|0|||
105366400|NCT03028142|363348370|FG002|Overall Study|Withdrawal by Subject|0|||
105366401|NCT03028142|363348371|FG003|Overall Study|Withdrawal by Subject|0|||
105366402|NCT03028142|363348372|FG004|Overall Study|Withdrawal by Subject|1|||
105366403|NCT03028142|363348373|FG005|Overall Study|Withdrawal by Subject|0|||
105366404|NCT00116688|363348376|FG000|Overall Study|Protocol deviation|1|||
105366405|NCT00116688|363348377|FG001|Overall Study|Protocol deviation|0|||
105366406|NCT00116688|363348376|FG000|Overall Study|Noncompliance|3|||
105366407|NCT00116688|363348377|FG001|Overall Study|Noncompliance|1|||
105366408|NCT00116688|363348376|FG000|Overall Study|Adverse Event|11|||
105366409|NCT00116688|363348377|FG001|Overall Study|Adverse Event|0|||
105366410|NCT00116688|363348376|FG000|Overall Study|Withdrawal by Subject|26|||
105366411|NCT00116688|363348377|FG001|Overall Study|Withdrawal by Subject|2|||
105366412|NCT00116688|363348376|FG000|Overall Study|Requirement for alternative therapy|11|||
105488802|NCT02414139|363801995|FG002|Treatment Period|Adverse Event|8|||
105366413|NCT00116688|363348377|FG001|Overall Study|Requirement for alternative therapy|1|||
105488803|NCT02414139|363801996|FG003|Treatment Period|Adverse Event|5|||
105488804|NCT02414139|363801997|FG004|Treatment Period|Adverse Event|14|||
105488805|NCT02414139|363801998|FG005|Treatment Period|Adverse Event|3|||
105366414|NCT00116688|363348376|FG000|Overall Study|Physician Decision|7|||
105366415|NCT00116688|363348377|FG001|Overall Study|Physician Decision|0|||
105366416|NCT00116688|363348376|FG000|Overall Study|Lost to Follow-up|3|||
105366417|NCT00116688|363348377|FG001|Overall Study|Lost to Follow-up|0|||
105488806|NCT02414139|363801999|FG006|Treatment Period|Adverse Event|6|||
105488807|NCT02414139|363802000|FG007|Treatment Period|Adverse Event|1|||
105488808|NCT02414139|363802001|FG008|Treatment Period|Adverse Event|6|||
105488809|NCT02414139|363802002|FG009|Treatment Period|Adverse Event|8|||
105488810|NCT02414139|363801993|FG000|Treatment Period|Death|0|||
105488811|NCT02414139|363801994|FG001|Treatment Period|Death|0|||
105488812|NCT02414139|363801995|FG002|Treatment Period|Death|1|||
105488813|NCT02414139|363801996|FG003|Treatment Period|Death|1|||
105488814|NCT02414139|363801997|FG004|Treatment Period|Death|0|||
105488815|NCT02414139|363801998|FG005|Treatment Period|Death|0|||
105488816|NCT02414139|363801999|FG006|Treatment Period|Death|0|||
105488817|NCT02414139|363802000|FG007|Treatment Period|Death|0|||
105488818|NCT02414139|363802001|FG008|Treatment Period|Death|0|||
105488819|NCT02414139|363802002|FG009|Treatment Period|Death|1|||
105488820|NCT02414139|363801993|FG000|Treatment Period|Physician Decision|5|||
105488821|NCT02414139|363801994|FG001|Treatment Period|Physician Decision|4|||
105488822|NCT02414139|363801995|FG002|Treatment Period|Physician Decision|6|||
105488823|NCT02414139|363801996|FG003|Treatment Period|Physician Decision|1|||
105488824|NCT02414139|363801997|FG004|Treatment Period|Physician Decision|4|||
105488825|NCT02414139|363801998|FG005|Treatment Period|Physician Decision|0|||
105488826|NCT02414139|363801999|FG006|Treatment Period|Physician Decision|2|||
105488827|NCT02414139|363802000|FG007|Treatment Period|Physician Decision|0|||
105488828|NCT02414139|363802001|FG008|Treatment Period|Physician Decision|1|||
105488829|NCT02414139|363802002|FG009|Treatment Period|Physician Decision|4|||
105488830|NCT02414139|363801993|FG000|Treatment Period|Progressive disease|48|||
105488831|NCT02414139|363801994|FG001|Treatment Period|Progressive disease|31|||
105488832|NCT02414139|363801995|FG002|Treatment Period|Progressive disease|37|||
105488833|NCT02414139|363801996|FG003|Treatment Period|Progressive disease|21|||
105488834|NCT02414139|363801997|FG004|Treatment Period|Progressive disease|43|||
105488835|NCT02414139|363801998|FG005|Treatment Period|Progressive disease|12|||
105488836|NCT02414139|363801999|FG006|Treatment Period|Progressive disease|16|||
105488837|NCT02414139|363802000|FG007|Treatment Period|Progressive disease|2|||
105488838|NCT02414139|363802001|FG008|Treatment Period|Progressive disease|20|||
105488839|NCT02414139|363802002|FG009|Treatment Period|Progressive disease|14|||
105488840|NCT02414139|363801993|FG000|Treatment Period|Protocol deviation|0|||
105488841|NCT02414139|363801994|FG001|Treatment Period|Protocol deviation|0|||
105827113|NCT00081653|365026395|FG001|Overall Study|Low bone mineral density|0|||
105827114|NCT00081653|365026394|FG000|Overall Study|Bone loss|2|||
105827115|NCT00081653|365026395|FG001|Overall Study|Bone loss|0|||
105827116|NCT00081653|365026394|FG000|Overall Study|Participant leaving country|1|||
105827117|NCT00081653|365026395|FG001|Overall Study|Participant leaving country|0|||
105827118|NCT00081653|365026394|FG000|Overall Study|Loss of bone mass|0|||
105827119|NCT00081653|365026395|FG001|Overall Study|Loss of bone mass|2|||
105827120|NCT01117623|365026396|FG000|Overall Study|Adverse Event|0|||
105827121|NCT01117623|365026397|FG001|Overall Study|Adverse Event|2|||
105827122|NCT01117623|365026398|FG002|Overall Study|Adverse Event|4|||
105827123|NCT01117623|365026399|FG003|Overall Study|Adverse Event|0|||
105827124|NCT01117623|365026400|FG004|Overall Study|Adverse Event|2|||
105827125|NCT01117623|365026401|FG005|Overall Study|Adverse Event|0|||
105827126|NCT01117623|365026402|FG006|Overall Study|Adverse Event|0|||
105827127|NCT01117623|365026403|FG007|Overall Study|Adverse Event|2|||
105827128|NCT01117623|365026396|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
105827129|NCT01117623|365026397|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
105827130|NCT01117623|365026398|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
105827131|NCT01117623|365026399|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
105488842|NCT02414139|363801995|FG002|Treatment Period|Protocol deviation|1|||
105488843|NCT02414139|363801996|FG003|Treatment Period|Protocol deviation|0|||
105488844|NCT02414139|363801997|FG004|Treatment Period|Protocol deviation|0|||
105488845|NCT02414139|363801998|FG005|Treatment Period|Protocol deviation|0|||
105488846|NCT02414139|363801999|FG006|Treatment Period|Protocol deviation|0|||
105488847|NCT02414139|363802000|FG007|Treatment Period|Protocol deviation|0|||
105488848|NCT02414139|363802001|FG008|Treatment Period|Protocol deviation|0|||
105488849|NCT02414139|363802002|FG009|Treatment Period|Protocol deviation|0|||
105488850|NCT02414139|363801993|FG000|Treatment Period|Subject/Guardian decision|5|||
105488851|NCT02414139|363801994|FG001|Treatment Period|Subject/Guardian decision|1|||
105488852|NCT02414139|363801995|FG002|Treatment Period|Subject/Guardian decision|1|||
105488853|NCT02414139|363801996|FG003|Treatment Period|Subject/Guardian decision|2|||
105488854|NCT02414139|363801997|FG004|Treatment Period|Subject/Guardian decision|5|||
105488855|NCT02414139|363801998|FG005|Treatment Period|Subject/Guardian decision|0|||
105488856|NCT02414139|363801999|FG006|Treatment Period|Subject/Guardian decision|2|||
105488857|NCT02414139|363802000|FG007|Treatment Period|Subject/Guardian decision|0|||
105488858|NCT02414139|363802001|FG008|Treatment Period|Subject/Guardian decision|1|||
105488859|NCT02414139|363802002|FG009|Treatment Period|Subject/Guardian decision|1|||
105488860|NCT02414139|363801993|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
105488861|NCT02414139|363801994|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
105488862|NCT02414139|363801995|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
105488863|NCT02414139|363801996|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
105488864|NCT02414139|363801997|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
105488865|NCT02414139|363801998|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
105488866|NCT02414139|363801999|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
105488867|NCT02414139|363802000|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
105488868|NCT02414139|363802001|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
105488869|NCT02414139|363802002|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
105488870|NCT02414139|363801993|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
105488871|NCT02414139|363801994|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
105488872|NCT02414139|363801995|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
105488873|NCT02414139|363801996|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
105488874|NCT02414139|363801997|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
105488875|NCT02414139|363801998|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
105488876|NCT02414139|363801999|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
105488877|NCT02414139|363802000|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
105488878|NCT02414139|363802001|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
105488879|NCT02414139|363802002|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
105488880|NCT02414139|363801993|FG000|Post-treatment Efficacy Follow-up|Death|0|||
105488881|NCT02414139|363801994|FG001|Post-treatment Efficacy Follow-up|Death|1|||
105488882|NCT02414139|363801995|FG002|Post-treatment Efficacy Follow-up|Death|0|||
105488883|NCT02414139|363801996|FG003|Post-treatment Efficacy Follow-up|Death|0|||
105488884|NCT02414139|363801997|FG004|Post-treatment Efficacy Follow-up|Death|1|||
105488885|NCT02414139|363801998|FG005|Post-treatment Efficacy Follow-up|Death|0|||
105488886|NCT02414139|363801999|FG006|Post-treatment Efficacy Follow-up|Death|0|||
105488887|NCT02414139|363802000|FG007|Post-treatment Efficacy Follow-up|Death|0|||
105488888|NCT02414139|363802001|FG008|Post-treatment Efficacy Follow-up|Death|0|||
105488889|NCT02414139|363802002|FG009|Post-treatment Efficacy Follow-up|Death|1|||
105488890|NCT02414139|363801993|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
105488891|NCT02414139|363801994|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
105488892|NCT02414139|363801995|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
105574734|NCT00337662|364102936|FG003|Study Period II|Lack of Efficacy|7|||
105574735|NCT00337662|364102933|FG000|Study Period II|Sponsor Decision|0|||
105574736|NCT00337662|364102934|FG001|Study Period II|Sponsor Decision|0|||
105827132|NCT01117623|365026400|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
105574737|NCT00337662|364102935|FG002|Study Period II|Sponsor Decision|0|||
105574738|NCT00337662|364102936|FG003|Study Period II|Sponsor Decision|2|||
105574739|NCT00337662|364102933|FG000|Study Period II|Parent/Caregiver Decision|0|||
105574740|NCT00337662|364102934|FG001|Study Period II|Parent/Caregiver Decision|0|||
105574741|NCT00337662|364102935|FG002|Study Period II|Parent/Caregiver Decision|0|||
105574742|NCT00337662|364102936|FG003|Study Period II|Parent/Caregiver Decision|1|||
105574743|NCT00337662|364102933|FG000|Study Period III|Lost to Follow-up|14|||
105574744|NCT00337662|364102934|FG001|Study Period III|Lost to Follow-up|16|||
105574745|NCT00337662|364102935|FG002|Study Period III|Lost to Follow-up|14|||
105574746|NCT00337662|364102936|FG003|Study Period III|Lost to Follow-up|0|||
105574747|NCT00337662|364102933|FG000|Study Period III|Withdrawal by Subject|18|||
105574748|NCT00337662|364102934|FG001|Study Period III|Withdrawal by Subject|14|||
105827133|NCT01117623|365026401|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
105827134|NCT01117623|365026402|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
105827135|NCT01117623|365026403|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
105574749|NCT00337662|364102935|FG002|Study Period III|Withdrawal by Subject|12|||
105574750|NCT00337662|364102936|FG003|Study Period III|Withdrawal by Subject|0|||
105574751|NCT00337662|364102933|FG000|Study Period III|Adverse Event|9|||
105574752|NCT00337662|364102934|FG001|Study Period III|Adverse Event|10|||
105574753|NCT00337662|364102935|FG002|Study Period III|Adverse Event|8|||
105574754|NCT00337662|364102936|FG003|Study Period III|Adverse Event|0|||
105574755|NCT00337662|364102933|FG000|Study Period III|Protocol Violation|3|||
105574756|NCT00337662|364102934|FG001|Study Period III|Protocol Violation|8|||
105574757|NCT00337662|364102935|FG002|Study Period III|Protocol Violation|2|||
105574758|NCT00337662|364102936|FG003|Study Period III|Protocol Violation|0|||
105574759|NCT00337662|364102933|FG000|Study Period III|Physician Decision|6|||
105574760|NCT00337662|364102934|FG001|Study Period III|Physician Decision|5|||
105574761|NCT00337662|364102935|FG002|Study Period III|Physician Decision|0|||
105574762|NCT00337662|364102936|FG003|Study Period III|Physician Decision|0|||
105574763|NCT00337662|364102933|FG000|Study Period III|Entry Criteria Not Met|4|||
105574764|NCT00337662|364102934|FG001|Study Period III|Entry Criteria Not Met|1|||
105574765|NCT00337662|364102935|FG002|Study Period III|Entry Criteria Not Met|3|||
105488893|NCT02414139|363801996|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
105488894|NCT02414139|363801997|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
105574766|NCT00337662|364102936|FG003|Study Period III|Entry Criteria Not Met|0|||
105574767|NCT00337662|364102933|FG000|Study Period III|Lack of Efficacy|4|||
105827136|NCT01117623|365026396|FG000|Overall Study|Withdrawal by Subject|0|||
105827137|NCT01117623|365026397|FG001|Overall Study|Withdrawal by Subject|0|||
105827138|NCT01117623|365026398|FG002|Overall Study|Withdrawal by Subject|2|||
105827139|NCT01117623|365026399|FG003|Overall Study|Withdrawal by Subject|0|||
105827140|NCT01117623|365026400|FG004|Overall Study|Withdrawal by Subject|0|||
105827141|NCT01117623|365026401|FG005|Overall Study|Withdrawal by Subject|1|||
105827142|NCT01117623|365026402|FG006|Overall Study|Withdrawal by Subject|1|||
105827143|NCT01117623|365026403|FG007|Overall Study|Withdrawal by Subject|1|||
105827144|NCT01117623|365026396|FG000|Overall Study|Non-compliance with study medication|0|||
105827145|NCT01117623|365026397|FG001|Overall Study|Non-compliance with study medication|0|||
105827146|NCT01117623|365026398|FG002|Overall Study|Non-compliance with study medication|0|||
105827147|NCT01117623|365026399|FG003|Overall Study|Non-compliance with study medication|0|||
105827148|NCT01117623|365026400|FG004|Overall Study|Non-compliance with study medication|0|||
105827149|NCT01117623|365026401|FG005|Overall Study|Non-compliance with study medication|0|||
105827150|NCT01117623|365026402|FG006|Overall Study|Non-compliance with study medication|0|||
105827151|NCT01117623|365026403|FG007|Overall Study|Non-compliance with study medication|1|||
105827152|NCT01117623|365026396|FG000|Overall Study|Invest. text: completed all planned txs|0|||
105827153|NCT01117623|365026397|FG001|Overall Study|Invest. text: completed all planned txs|0|||
105827154|NCT01117623|365026398|FG002|Overall Study|Invest. text: completed all planned txs|0|||
105827155|NCT01117623|365026399|FG003|Overall Study|Invest. text: completed all planned txs|0|||
105827156|NCT01117623|365026400|FG004|Overall Study|Invest. text: completed all planned txs|0|||
105827157|NCT01117623|365026401|FG005|Overall Study|Invest. text: completed all planned txs|1|||
105827158|NCT01117623|365026402|FG006|Overall Study|Invest. text: completed all planned txs|0|||
105827159|NCT01117623|365026403|FG007|Overall Study|Invest. text: completed all planned txs|0|||
105827160|NCT00540423|365026410|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105827161|NCT00540423|365026411|FG001|Double-Blind Treatment Period|Adverse Event|1|||
105827162|NCT00540423|365026412|FG002|Double-Blind Treatment Period|Adverse Event|0|||
105827163|NCT00540423|365026410|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
105827164|NCT00540423|365026411|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
105827165|NCT00540423|365026412|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
105827166|NCT01634139|365026413|FG000|Overall Study|Non compliant with protocol|1|||
105827167|NCT01634139|365026414|FG001|Overall Study|Non compliant with protocol|0|||
105827168|NCT01634139|365026415|FG002|Overall Study|Non compliant with protocol|0|||
105827169|NCT01634139|365026413|FG000|Overall Study|Consent withdrawn not due to AE|4|||
105827170|NCT01634139|365026414|FG001|Overall Study|Consent withdrawn not due to AE|3|||
105827171|NCT01634139|365026415|FG002|Overall Study|Consent withdrawn not due to AE|2|||
105827172|NCT01634139|365026413|FG000|Overall Study|Other|4|||
105488895|NCT02414139|363801998|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
105488896|NCT02414139|363801999|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
105488897|NCT02414139|363802000|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
105488898|NCT02414139|363802001|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
105488899|NCT02414139|363802002|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
105488900|NCT02414139|363801993|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
105488901|NCT02414139|363801994|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
105488902|NCT02414139|363801995|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
105488903|NCT02414139|363801996|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
105827173|NCT01634139|365026414|FG001|Overall Study|Other|0|||
105488904|NCT02414139|363801997|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
105574768|NCT00337662|364102934|FG001|Study Period III|Lack of Efficacy|4|||
105574769|NCT00337662|364102935|FG002|Study Period III|Lack of Efficacy|2|||
105574770|NCT00337662|364102936|FG003|Study Period III|Lack of Efficacy|0|||
105574771|NCT00337662|364102933|FG000|Study Period III|Parent/Caregiver Decision|0|||
105574772|NCT00337662|364102934|FG001|Study Period III|Parent/Caregiver Decision|0|||
105574773|NCT00337662|364102935|FG002|Study Period III|Parent/Caregiver Decision|2|||
105574774|NCT00337662|364102936|FG003|Study Period III|Parent/Caregiver Decision|0|||
105574775|NCT00337662|364102933|FG000|Study Period III|Sponsor Decision|1|||
105488905|NCT02414139|363801998|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
105574776|NCT00337662|364102934|FG001|Study Period III|Sponsor Decision|0|||
105574777|NCT00337662|364102935|FG002|Study Period III|Sponsor Decision|1|||
105574778|NCT00337662|364102936|FG003|Study Period III|Sponsor Decision|0|||
105574779|NCT00337662|364102933|FG000|Study Period III|Clinical Relapse|1|||
105574780|NCT00337662|364102934|FG001|Study Period III|Clinical Relapse|0|||
105574781|NCT00337662|364102935|FG002|Study Period III|Clinical Relapse|0|||
105574782|NCT00337662|364102936|FG003|Study Period III|Clinical Relapse|0|||
105574783|NCT01263106|364102937|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
105574784|NCT01263106|364102938|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
105574785|NCT02344537|364102942|FG000|Overall Study|Protocol Violation|1|||
105574786|NCT02344537|364102943|FG001|Overall Study|Protocol Violation|1|||
105574787|NCT02344537|364102942|FG000|Overall Study|Subject started another treatment after wk 6|1|||
105574788|NCT02344537|364102943|FG001|Overall Study|Subject started another treatment after wk 6|0|||
105574789|NCT02344537|364102942|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
105574790|NCT02344537|364102943|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
105574791|NCT00903786|364102947|FG000|Overall Study|Physician Decision|6|||
105574792|NCT00903786|364102947|FG000|Overall Study|Lack of Efficacy|5|||
105574793|NCT00903786|364102947|FG000|Overall Study|Reason other than lack of efficacy|4|||
105574794|NCT02058290|364102951|FG000|Overall Study|Protocol Violation|2|||
105574795|NCT02058290|364102952|FG001|Overall Study|Protocol Violation|1|||
105574796|NCT02058290|364102951|FG000|Overall Study|Physician Decision|1|||
105574797|NCT02058290|364102952|FG001|Overall Study|Physician Decision|0|||
105574798|NCT02058290|364102951|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
105574799|NCT02058290|364102952|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
105574800|NCT02058290|364102951|FG000|Overall Study|Withdrawal by Subject|0|||
105574801|NCT02058290|364102952|FG001|Overall Study|Withdrawal by Subject|1|||
105574802|NCT03012061|364102956|FG000|Overall Study|Withdrawal by Subject|1|||
105574803|NCT03012061|364102957|FG001|Overall Study|Withdrawal by Subject|5|||
105574804|NCT03012061|364102958|FG002|Overall Study|Withdrawal by Subject|4|||
105574805|NCT03012061|364102956|FG000|Overall Study|Investigator Site Closed|1|||
105574806|NCT03012061|364102957|FG001|Overall Study|Investigator Site Closed|2|||
105574807|NCT03012061|364102958|FG002|Overall Study|Investigator Site Closed|0|||
105574808|NCT03012061|364102956|FG000|Overall Study|Lost to Follow-up|2|||
105574809|NCT03012061|364102957|FG001|Overall Study|Lost to Follow-up|1|||
105574810|NCT03012061|364102958|FG002|Overall Study|Lost to Follow-up|0|||
105574811|NCT03012061|364102956|FG000|Overall Study|Study closed/ Terminated|0|||
105574812|NCT03012061|364102957|FG001|Overall Study|Study closed/ Terminated|0|||
105574813|NCT03012061|364102958|FG002|Overall Study|Study closed/ Terminated|1|||
105574814|NCT03012061|364102956|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
105574815|NCT03012061|364102957|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
105574816|NCT03012061|364102958|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
105574817|NCT03012061|364102956|FG000|Overall Study|Protocol Violation|0|||
105366418|NCT00116688|363348376|FG000|Overall Study|Death|15|||
105366419|NCT00116688|363348377|FG001|Overall Study|Death|0|||
105366420|NCT00116688|363348376|FG000|Overall Study|Protocol-specified criteria|3|||
105366421|NCT00116688|363348377|FG001|Overall Study|Protocol-specified criteria|0|||
105307293|NCT00289536|363122612|FG000|Period 3|Lost to Follow-up|0|||
105307294|NCT00289536|363122613|FG001|Period 3|Lost to Follow-up|0|||
105307295|NCT00289536|363122614|FG002|Period 3|Lost to Follow-up|1|||
105307296|NCT00988442|363122618|FG000|Overall Study|Death|1|||
105366422|NCT00116688|363348376|FG000|Overall Study|Pregnancy|1|||
105366423|NCT00116688|363348377|FG001|Overall Study|Pregnancy|0|||
105307297|NCT00988442|363122619|FG001|Overall Study|Death|2|||
105307298|NCT00988442|363122618|FG000|Overall Study|Lost to Follow-up|0|||
105307299|NCT00988442|363122619|FG001|Overall Study|Lost to Follow-up|1|||
105307300|NCT00988442|363122618|FG000|Overall Study|Early Study Closure|29|||
105307301|NCT00988442|363122619|FG001|Overall Study|Early Study Closure|25|||
105307302|NCT04053465|363122624|FG000|Overall Study|Withdrawal by Subject|4|||
105307303|NCT04053465|363122625|FG001|Overall Study|Withdrawal by Subject|4|||
105366424|NCT00116688|363348376|FG000|Overall Study|Other|11|||
105366425|NCT00116688|363348377|FG001|Overall Study|Other|0|||
105366426|NCT02224625|363348378|FG000|Irritation|Adverse Event|6|||
105366427|NCT02224625|363348378|FG000|Sensitization|Adverse Event|55|||
105366428|NCT01775670|363348379|FG000|Overall Study|Lost to Follow-up|1|||
105366429|NCT01775670|363348380|FG001|Overall Study|Lost to Follow-up|1|||
105574818|NCT03012061|364102957|FG001|Overall Study|Protocol Violation|0|||
105307304|NCT05297578|363122626|FG000|Overall Study|Lost to Follow-up|1|||
105307305|NCT05297578|363122627|FG001|Overall Study|Lost to Follow-up|1|||
105307306|NCT05297578|363122628|FG002|Overall Study|Lost to Follow-up|2|||
105307307|NCT05297578|363122629|FG003|Overall Study|Lost to Follow-up|1|||
105307308|NCT05297578|363122626|FG000|Overall Study|Death|0|||
105307309|NCT05297578|363122627|FG001|Overall Study|Death|1|||
105307310|NCT05297578|363122628|FG002|Overall Study|Death|0|||
105307311|NCT05297578|363122629|FG003|Overall Study|Death|0|||
105307312|NCT05297578|363122626|FG000|Overall Study|Withdrawal by Subject|0|||
105307313|NCT05297578|363122627|FG001|Overall Study|Withdrawal by Subject|0|||
105307314|NCT05297578|363122628|FG002|Overall Study|Withdrawal by Subject|1|||
105307315|NCT05297578|363122629|FG003|Overall Study|Withdrawal by Subject|0|||
105307316|NCT01468818|363122634|FG000|Overall Study|Death during treatment|2|||
105574819|NCT03012061|364102958|FG002|Overall Study|Protocol Violation|2|||
105307317|NCT01212588|363122635|FG000|Overall Study|Physician Decision|0|||
105307318|NCT01212588|363122636|FG001|Overall Study|Physician Decision|1|||
105307319|NCT01212588|363122635|FG000|Overall Study|Protocol Violation|1|||
105307320|NCT01212588|363122636|FG001|Overall Study|Protocol Violation|1|||
105307321|NCT02338193|363122637|FG000|Overall Study|Withdrawal by Subject|0|||
105307322|NCT02338193|363122638|FG001|Overall Study|Withdrawal by Subject|0|||
105307323|NCT02338193|363122639|FG002|Overall Study|Withdrawal by Subject|2|||
105307324|NCT02338193|363122637|FG000|Overall Study|Pregnancy|0|||
105307325|NCT02338193|363122638|FG001|Overall Study|Pregnancy|1|||
105307326|NCT02338193|363122639|FG002|Overall Study|Pregnancy|1|||
105307327|NCT02338193|363122637|FG000|Overall Study|Noncompliant with visits|2|||
105307328|NCT02338193|363122638|FG001|Overall Study|Noncompliant with visits|2|||
105307329|NCT02338193|363122639|FG002|Overall Study|Noncompliant with visits|7|||
105307330|NCT02338193|363122637|FG000|Overall Study|moved out of state|0|||
105307331|NCT02338193|363122638|FG001|Overall Study|moved out of state|1|||
105307332|NCT02338193|363122639|FG002|Overall Study|moved out of state|0|||
105307333|NCT02338193|363122637|FG000|Overall Study|intolerant of side effects|1|||
105307334|NCT02338193|363122638|FG001|Overall Study|intolerant of side effects|0|||
105307335|NCT02338193|363122639|FG002|Overall Study|intolerant of side effects|0|||
105307336|NCT00132028|363122640|FG000|Overall Study|Adverse Event|7|||
105307337|NCT00132028|363122640|FG000|Overall Study|Death|2|||
105307338|NCT00132028|363122640|FG000|Overall Study|Lack of Efficacy|11|||
105307339|NCT00132028|363122640|FG000|Overall Study|Withdrawal by Subject|2|||
105307340|NCT00132028|363122640|FG000|Overall Study|not eligible|2|||
105307341|NCT00132028|363122640|FG000|Overall Study|Physician Decision|3|||
105307342|NCT04228783|363122649|FG000|Overall Study|Adverse Event|1|||
105307343|NCT04228783|363122650|FG001|Overall Study|Adverse Event|0|||
105307344|NCT04228783|363122651|FG002|Overall Study|Adverse Event|2|||
105307345|NCT04228783|363122652|FG003|Overall Study|Adverse Event|0|||
105307346|NCT04228783|363122653|FG004|Overall Study|Adverse Event|0|||
105307347|NCT04228783|363122654|FG005|Overall Study|Adverse Event|1|||
105307348|NCT04228783|363122649|FG000|Overall Study|Death|0|||
105307349|NCT04228783|363122650|FG001|Overall Study|Death|0|||
105307350|NCT04228783|363122651|FG002|Overall Study|Death|0|||
105307351|NCT04228783|363122652|FG003|Overall Study|Death|0|||
105307352|NCT04228783|363122653|FG004|Overall Study|Death|1|||
105307353|NCT04228783|363122654|FG005|Overall Study|Death|0|||
105307354|NCT04228783|363122649|FG000|Overall Study|Lost to Follow-up|36|||
105307355|NCT04228783|363122650|FG001|Overall Study|Lost to Follow-up|36|||
105307356|NCT04228783|363122651|FG002|Overall Study|Lost to Follow-up|28|||
105307357|NCT04228783|363122652|FG003|Overall Study|Lost to Follow-up|6|||
105307358|NCT04228783|363122653|FG004|Overall Study|Lost to Follow-up|14|||
105307359|NCT04228783|363122654|FG005|Overall Study|Lost to Follow-up|3|||
105307360|NCT04228783|363122649|FG000|Overall Study|Physician Decision|1|||
105307361|NCT04228783|363122650|FG001|Overall Study|Physician Decision|2|||
105307362|NCT04228783|363122651|FG002|Overall Study|Physician Decision|0|||
105307363|NCT04228783|363122652|FG003|Overall Study|Physician Decision|0|||
105307364|NCT04228783|363122653|FG004|Overall Study|Physician Decision|0|||
105307365|NCT04228783|363122654|FG005|Overall Study|Physician Decision|0|||
105307366|NCT04228783|363122649|FG000|Overall Study|Protocol Violation|0|||
105307367|NCT04228783|363122650|FG001|Overall Study|Protocol Violation|0|||
105307368|NCT04228783|363122651|FG002|Overall Study|Protocol Violation|0|||
105307369|NCT04228783|363122652|FG003|Overall Study|Protocol Violation|1|||
105307370|NCT04228783|363122653|FG004|Overall Study|Protocol Violation|0|||
105307371|NCT04228783|363122654|FG005|Overall Study|Protocol Violation|0|||
105307372|NCT04228783|363122649|FG000|Overall Study|Withdrawal by Subject|6|||
105307373|NCT04228783|363122650|FG001|Overall Study|Withdrawal by Subject|10|||
105307374|NCT04228783|363122651|FG002|Overall Study|Withdrawal by Subject|19|||
105307375|NCT04228783|363122652|FG003|Overall Study|Withdrawal by Subject|1|||
105366430|NCT04006145|363348381|FG000|Overall Study|Lost to Follow-up|0|||
105366431|NCT04006145|363348382|FG001|Overall Study|Lost to Follow-up|1|||
105307376|NCT04228783|363122653|FG004|Overall Study|Withdrawal by Subject|2|||
105307377|NCT04228783|363122654|FG005|Overall Study|Withdrawal by Subject|0|||
105307378|NCT04228783|363122649|FG000|Overall Study|Other|4|||
105307379|NCT04228783|363122650|FG001|Overall Study|Other|3|||
105307380|NCT04228783|363122651|FG002|Overall Study|Other|2|||
105307381|NCT04228783|363122652|FG003|Overall Study|Other|1|||
105307382|NCT04228783|363122653|FG004|Overall Study|Other|0|||
105307383|NCT04228783|363122654|FG005|Overall Study|Other|0|||
105307384|NCT02266134|363122657|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
105307385|NCT02266134|363122658|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
105307386|NCT02266134|363122659|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
105307387|NCT02266134|363122660|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
105307388|NCT02266134|363122657|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
105307389|NCT02266134|363122658|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
105307390|NCT02266134|363122659|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
105307391|NCT02266134|363122660|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
105307392|NCT02266134|363122657|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
105307393|NCT02266134|363122658|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
105574820|NCT03012061|364102956|FG000|Overall Study|Lack of Efficacy|0|||
105307394|NCT02266134|363122659|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
105307395|NCT02266134|363122660|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
105307396|NCT02266134|363122657|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
105307397|NCT02266134|363122658|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
105307398|NCT02266134|363122659|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
105307399|NCT02266134|363122660|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
105307400|NCT02266134|363122657|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
105307401|NCT02266134|363122658|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
105307402|NCT02266134|363122659|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
105307403|NCT02266134|363122660|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
105307404|NCT02266134|363122657|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
105307405|NCT02266134|363122658|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
105307406|NCT02266134|363122659|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
105307407|NCT02266134|363122660|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
105307408|NCT00742924|363122661|FG000|Overall Study|Adverse Event|0|||
105307409|NCT00742924|363122662|FG001|Overall Study|Adverse Event|0|||
105307410|NCT00742924|363122663|FG002|Overall Study|Adverse Event|1|||
105307411|NCT00742924|363122664|FG003|Overall Study|Adverse Event|1|||
105307412|NCT00742924|363122661|FG000|Overall Study|Lack of Efficacy|5|||
105307413|NCT00742924|363122662|FG001|Overall Study|Lack of Efficacy|1|||
105307414|NCT00742924|363122663|FG002|Overall Study|Lack of Efficacy|2|||
105307415|NCT00742924|363122664|FG003|Overall Study|Lack of Efficacy|4|||
105307416|NCT00742924|363122661|FG000|Overall Study|Physician Decision|0|||
105307417|NCT00742924|363122662|FG001|Overall Study|Physician Decision|0|||
105307418|NCT00742924|363122663|FG002|Overall Study|Physician Decision|0|||
105307419|NCT00742924|363122664|FG003|Overall Study|Physician Decision|1|||
105307420|NCT00742924|363122661|FG000|Overall Study|Withdrawal by Subject|0|||
105307421|NCT00742924|363122662|FG001|Overall Study|Withdrawal by Subject|1|||
105307422|NCT00742924|363122663|FG002|Overall Study|Withdrawal by Subject|1|||
105307423|NCT00742924|363122664|FG003|Overall Study|Withdrawal by Subject|0|||
105307424|NCT00660400|363122665|FG000|Overall Study|Lack of insurance approval|1|||
105307425|NCT00660400|363122665|FG000|Overall Study|Suboptimal organ function|1|||
105307426|NCT00660400|363122665|FG000|Overall Study|Intracranial hemorrhage|1|||
105307427|NCT00660400|363122665|FG000|Overall Study|Withdrawal by Subject|1|||
105307428|NCT04647721|363122666|FG000|Overall Study|Withdrawal by Subject|0|||
105307429|NCT04647721|363122667|FG001|Overall Study|Withdrawal by Subject|2|||
105307430|NCT04647721|363122666|FG000|Overall Study|Lost to Follow-up|2|||
105307431|NCT04647721|363122667|FG001|Overall Study|Lost to Follow-up|0|||
105307432|NCT03196635|363122670|FG000|Overall Study|Withdrawal by Subject|1|||
105307433|NCT01974440|363122674|FG000|Overall Study|Lost to Follow-up|7|||
105307434|NCT01974440|363122675|FG001|Overall Study|Lost to Follow-up|7|||
105307435|NCT01974440|363122674|FG000|Overall Study|Withdrawal by Subject|24|||
105307436|NCT01974440|363122675|FG001|Overall Study|Withdrawal by Subject|20|||
105307437|NCT01974440|363122674|FG000|Overall Study|Sponsor decision|109|||
105307438|NCT01974440|363122675|FG001|Overall Study|Sponsor decision|110|||
105307439|NCT00085423|363122676|FG000|Overall Study|Withdrawal by Subject|1|||
105307440|NCT00085423|363122676|FG000|Overall Study|screen failure|1|||
105307441|NCT01341782|363122677|FG000|Overall Study|Adverse Event|1|||
105307442|NCT01341782|363122678|FG001|Overall Study|Adverse Event|1|||
105307443|NCT01341782|363122677|FG000|Overall Study|Withdrawal by Subject|6|||
105307444|NCT01341782|363122678|FG001|Overall Study|Withdrawal by Subject|5|||
105307445|NCT01341782|363122677|FG000|Overall Study|Missed 3 consecutive doses|0|||
105307446|NCT01341782|363122678|FG001|Overall Study|Missed 3 consecutive doses|4|||
105307447|NCT01341782|363122677|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
105307448|NCT01341782|363122678|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
105307449|NCT01341782|363122677|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
105307450|NCT01341782|363122678|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
105307451|NCT01341782|363122677|FG000|Overall Study|Other|5|||
105307452|NCT01341782|363122678|FG001|Overall Study|Other|0|||
105574821|NCT03012061|364102957|FG001|Overall Study|Lack of Efficacy|1|||
105574822|NCT03012061|364102958|FG002|Overall Study|Lack of Efficacy|0|||
105574823|NCT03012061|364102956|FG000|Overall Study|Adverse Event|2|||
105307453|NCT02036775|363122679|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
105307454|NCT02036775|363122680|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
105307455|NCT02036775|363122681|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
105307456|NCT02036775|363122682|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
105307457|NCT02036775|363122683|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
105307458|NCT02036775|363122684|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
105307459|NCT02365558|363122687|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
105307460|NCT02365558|363122688|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
105307461|NCT02365558|363122687|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
105307462|NCT02365558|363122688|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
105574824|NCT03012061|364102957|FG001|Overall Study|Adverse Event|0|||
105574825|NCT03012061|364102958|FG002|Overall Study|Adverse Event|0|||
105574826|NCT02696902|364102959|FG000|Overall Study|Lost to Follow-up|0|||
105574827|NCT02696902|364102960|FG001|Overall Study|Lost to Follow-up|1|||
105574828|NCT02696902|364102961|FG002|Overall Study|Lost to Follow-up|1|||
105574829|NCT02696902|364102959|FG000|Overall Study|Withdrawal by Subject|0|||
105574830|NCT02696902|364102960|FG001|Overall Study|Withdrawal by Subject|0|||
105574831|NCT02696902|364102961|FG002|Overall Study|Withdrawal by Subject|1|||
105574832|NCT02696902|364102959|FG000|Overall Study|Death|19|||
105574833|NCT02696902|364102960|FG001|Overall Study|Death|3|||
105574834|NCT02696902|364102961|FG002|Overall Study|Death|24|||
105574835|NCT02696902|364102959|FG000|Overall Study|Participant not fit post-randomization|0|||
105574836|NCT02696902|364102960|FG001|Overall Study|Participant not fit post-randomization|0|||
105574837|NCT02696902|364102961|FG002|Overall Study|Participant not fit post-randomization|1|||
105574838|NCT02696902|364102959|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
105574839|NCT02696902|364102960|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
105574840|NCT02696902|364102961|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
105574841|NCT02696902|364102959|FG000|Overall Study|Principal investigator's decision|1|||
105574842|NCT02696902|364102960|FG001|Overall Study|Principal investigator's decision|0|||
105574843|NCT02696902|364102961|FG002|Overall Study|Principal investigator's decision|0|||
105574844|NCT02696902|364102959|FG000|Overall Study|Sponsor's decision|1|||
105574845|NCT02696902|364102960|FG001|Overall Study|Sponsor's decision|0|||
105574846|NCT02696902|364102961|FG002|Overall Study|Sponsor's decision|0|||
105574847|NCT02696902|364102959|FG000|Overall Study|Transferred to other hospital|1|||
105574848|NCT02696902|364102960|FG001|Overall Study|Transferred to other hospital|0|||
105827174|NCT01634139|365026415|FG002|Overall Study|Other|3|||
105827175|NCT01634139|365026413|FG000|Overall Study|Lost to Follow-up|0|||
105827176|NCT01634139|365026414|FG001|Overall Study|Lost to Follow-up|2|||
105827177|NCT01634139|365026415|FG002|Overall Study|Lost to Follow-up|0|||
105827178|NCT01634139|365026413|FG000|Overall Study|Not treated|1|||
105827179|NCT01634139|365026414|FG001|Overall Study|Not treated|1|||
105827180|NCT01634139|365026415|FG002|Overall Study|Not treated|0|||
105827181|NCT02441686|365026416|FG000|Induction|Adverse Event|4|||
105827182|NCT02441686|365026416|FG000|Induction|Complicating disease|1|||
105827183|NCT02441686|365026416|FG000|Induction|Physician Decision|1|||
105827184|NCT02441686|365026416|FG000|Induction|Withdrawal by Subject|1|||
105827185|NCT02441686|365026416|FG000|Induction|Did not receive treatment|1|||
105827186|NCT02441686|365026416|FG000|Maintenance|Remaining on Treatment|23|||
105827187|NCT02441686|365026416|FG000|Maintenance|Physician Decision|1|||
105827188|NCT02441686|365026416|FG000|Maintenance|Adverse Event|3|||
105827189|NCT02441686|365026416|FG000|Maintenance|Progressive Disease|10|||
105827190|NCT02441686|365026416|FG000|Maintenance|Withdrawal by Subject|1|||
105827191|NCT01647828|365026418|FG000|Overall Study|Death|3|||
105827192|NCT01647828|365026419|FG001|Overall Study|Death|4|||
105827193|NCT01647828|365026420|FG002|Overall Study|Death|4|||
105827194|NCT01647828|365026421|FG003|Overall Study|Death|5|||
105827195|NCT01647828|365026422|FG004|Overall Study|Death|6|||
105827196|NCT01647828|365026423|FG005|Overall Study|Death|3|||
105827197|NCT01647828|365026424|FG006|Overall Study|Death|10|||
105827198|NCT01647828|365026425|FG007|Overall Study|Death|60|||
105827199|NCT01647828|365026426|FG008|Overall Study|Death|71|||
105827200|NCT01647828|365026418|FG000|Overall Study|Withdrawal by Subject|2|||
105827201|NCT01647828|365026419|FG001|Overall Study|Withdrawal by Subject|0|||
105827202|NCT01647828|365026420|FG002|Overall Study|Withdrawal by Subject|0|||
105827203|NCT01647828|365026421|FG003|Overall Study|Withdrawal by Subject|1|||
105827204|NCT01647828|365026422|FG004|Overall Study|Withdrawal by Subject|0|||
105827205|NCT01647828|365026423|FG005|Overall Study|Withdrawal by Subject|0|||
105827206|NCT01647828|365026424|FG006|Overall Study|Withdrawal by Subject|1|||
105827207|NCT01647828|365026425|FG007|Overall Study|Withdrawal by Subject|0|||
105827208|NCT01647828|365026426|FG008|Overall Study|Withdrawal by Subject|2|||
105827209|NCT01647828|365026418|FG000|Overall Study|Study terminated by Sponsor|0|||
105827210|NCT01647828|365026419|FG001|Overall Study|Study terminated by Sponsor|0|||
105827211|NCT01647828|365026420|FG002|Overall Study|Study terminated by Sponsor|0|||
105827212|NCT01647828|365026421|FG003|Overall Study|Study terminated by Sponsor|0|||
105827213|NCT01647828|365026422|FG004|Overall Study|Study terminated by Sponsor|0|||
105827214|NCT01647828|365026423|FG005|Overall Study|Study terminated by Sponsor|0|||
105827215|NCT01647828|365026424|FG006|Overall Study|Study terminated by Sponsor|1|||
105827216|NCT01647828|365026425|FG007|Overall Study|Study terminated by Sponsor|26|||
105574849|NCT02696902|364102961|FG002|Overall Study|Transferred to other hospital|0|||
105574850|NCT01871558|364102966|FG000|Overall Study|Other reason|0|||
105574851|NCT01871558|364102967|FG001|Overall Study|Other reason|1|||
105827217|NCT01647828|365026426|FG008|Overall Study|Study terminated by Sponsor|16|||
105827218|NCT01647828|365026418|FG000|Overall Study|Lost to Follow-up|0|||
105827219|NCT01647828|365026419|FG001|Overall Study|Lost to Follow-up|0|||
105827220|NCT01647828|365026420|FG002|Overall Study|Lost to Follow-up|0|||
105827221|NCT01647828|365026421|FG003|Overall Study|Lost to Follow-up|0|||
105827222|NCT01647828|365026422|FG004|Overall Study|Lost to Follow-up|0|||
105827223|NCT01647828|365026423|FG005|Overall Study|Lost to Follow-up|0|||
105827224|NCT01647828|365026424|FG006|Overall Study|Lost to Follow-up|0|||
105488906|NCT02414139|363801999|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
105488907|NCT02414139|363802000|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
105488908|NCT02414139|363802001|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
105488909|NCT02414139|363802002|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
105488910|NCT02414139|363801993|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
105488911|NCT02414139|363801994|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
105488912|NCT02414139|363801995|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
105488913|NCT02414139|363801996|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
105488914|NCT02414139|363801997|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
105488915|NCT02414139|363801998|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
105488916|NCT02414139|363801999|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
105488917|NCT02414139|363802000|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
105488918|NCT02414139|363802001|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
105488919|NCT02414139|363802002|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
105488920|NCT02414139|363801993|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
105307463|NCT00855803|363122690|FG000|Overall Study|Death|2|||
105307464|NCT00855803|363122690|FG000|Overall Study|Lost to Follow-up|2|||
105307465|NCT00855803|363122690|FG000|Overall Study|Technical inability to undergo procedure|2|||
105307466|NCT00855803|363122690|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
105307467|NCT00855803|363122690|FG000|Overall Study|Withdrawal by Subject|3|||
105307468|NCT00855803|363122690|FG000|Overall Study|Physician Decision|3|||
105307469|NCT02991430|363122691|FG000|Treatment Period 1|Adverse Event|1|||
105307470|NCT02991430|363122692|FG001|Treatment Period 1|Adverse Event|0|||
105307471|NCT02991430|363122693|FG002|Treatment Period 1|Adverse Event|2|||
105307472|NCT02991430|363122691|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105307473|NCT02991430|363122692|FG001|Treatment Period 1|Withdrawal by Subject|4|||
105307474|NCT02991430|363122693|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105307475|NCT02991430|363122691|FG000|Treatment Period 2|Study Termination|6|||
105307476|NCT02991430|363122692|FG001|Treatment Period 2|Study Termination|3|||
105307477|NCT02991430|363122693|FG002|Treatment Period 2|Study Termination|3|||
105307478|NCT02991430|363122691|FG000|Treatment Period 2|Lost to Follow-up|0|||
105307479|NCT02991430|363122692|FG001|Treatment Period 2|Lost to Follow-up|0|||
105307480|NCT02991430|363122693|FG002|Treatment Period 2|Lost to Follow-up|1|||
105307481|NCT02991430|363122691|FG000|Post-treatment Observation Period|Study Termination|3|||
105307482|NCT02991430|363122692|FG001|Post-treatment Observation Period|Study Termination|6|||
105307483|NCT02991430|363122693|FG002|Post-treatment Observation Period|Study Termination|5|||
105307484|NCT01672970|363122694|FG000|Overall Study|Lack of Efficacy|12|||
105307485|NCT01672970|363122694|FG000|Overall Study|Adverse Event|18|||
105307486|NCT01672970|363122694|FG000|Overall Study|Withdrawal by Subject|2|||
105307487|NCT01672970|363122694|FG000|Overall Study|Lost to Follow-up|5|||
105307488|NCT01672970|363122694|FG000|Overall Study|Other|9|||
105307489|NCT01672970|363122694|FG000|Overall Study|Enrolled but not treated|1|||
105307490|NCT03918109|363122695|FG000|Overall Study|Withdrawal by Subject|0|||
105307491|NCT03918109|363122696|FG001|Overall Study|Withdrawal by Subject|0|||
105307492|NCT03918109|363122697|FG002|Overall Study|Withdrawal by Subject|2|||
105307493|NCT03918109|363122698|FG003|Overall Study|Withdrawal by Subject|1|||
105307494|NCT03918109|363122695|FG000|Overall Study|Lost to Follow-up|0|||
105307495|NCT03918109|363122696|FG001|Overall Study|Lost to Follow-up|0|||
105307496|NCT03918109|363122697|FG002|Overall Study|Lost to Follow-up|0|||
105307497|NCT03918109|363122698|FG003|Overall Study|Lost to Follow-up|1|||
105307498|NCT03185013|363122701|FG000|Overall Study|Withdrawal by Subject|5|||
105307499|NCT03185013|363122702|FG001|Overall Study|Withdrawal by Subject|3|||
105307500|NCT03185013|363122701|FG000|Overall Study|Adverse Event|1|||
105307501|NCT03185013|363122702|FG001|Overall Study|Adverse Event|0|||
105307502|NCT03185013|363122701|FG000|Overall Study|Progressive Disease|1|||
105307503|NCT03185013|363122702|FG001|Overall Study|Progressive Disease|0|||
105307504|NCT03185013|363122701|FG000|Overall Study|Lost to Follow-up|8|||
105307505|NCT03185013|363122702|FG001|Overall Study|Lost to Follow-up|2|||
105307506|NCT03185013|363122701|FG000|Overall Study|Physician Decision|1|||
105307507|NCT03185013|363122702|FG001|Overall Study|Physician Decision|0|||
105307508|NCT03185013|363122701|FG000|Overall Study|Protocol Deviation|2|||
105307509|NCT03185013|363122702|FG001|Overall Study|Protocol Deviation|0|||
105488921|NCT02414139|363801994|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
105307510|NCT03185013|363122701|FG000|Overall Study|Reason not Specified|3|||
105307511|NCT03185013|363122702|FG001|Overall Study|Reason not Specified|2|||
105307512|NCT03185013|363122701|FG000|Overall Study|Death|1|||
105488922|NCT02414139|363801995|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
105307513|NCT03185013|363122702|FG001|Overall Study|Death|0|||
105307514|NCT04430855|363122705|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
105307515|NCT04430855|363122706|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
105307516|NCT04430855|363122705|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
105307517|NCT04430855|363122706|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
105307518|NCT04430855|363122705|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
105307519|NCT04430855|363122706|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
105574852|NCT01871558|364102966|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
105574853|NCT01871558|364102967|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
105574854|NCT01871558|364102966|FG000|Overall Study|Withdrawal by Subject|2|||
105574855|NCT01871558|364102967|FG001|Overall Study|Withdrawal by Subject|0|||
105574856|NCT02401308|364102970|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
105574857|NCT02401308|364102971|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
105574858|NCT00147225|364102972|FG000|Overall Study|Withdrawal by Subject|1|||
105574859|NCT00147225|364102973|FG001|Overall Study|Withdrawal by Subject|0|||
105574860|NCT00147225|364102974|FG002|Overall Study|Withdrawal by Subject|1|||
105574861|NCT00147225|364102975|FG003|Overall Study|Withdrawal by Subject|0|||
105574862|NCT00147225|364102976|FG004|Overall Study|Withdrawal by Subject|0|||
105574863|NCT00147225|364102977|FG005|Overall Study|Withdrawal by Subject|1|||
105574864|NCT00147225|364102972|FG000|Overall Study|Adverse Event|0|||
105574865|NCT00147225|364102973|FG001|Overall Study|Adverse Event|0|||
105574866|NCT00147225|364102974|FG002|Overall Study|Adverse Event|1|||
105574867|NCT00147225|364102975|FG003|Overall Study|Adverse Event|1|||
105574868|NCT00147225|364102976|FG004|Overall Study|Adverse Event|0|||
105574869|NCT00147225|364102977|FG005|Overall Study|Adverse Event|0|||
105574870|NCT00147225|364102972|FG000|Overall Study|Screen Failure|0|||
105574871|NCT00147225|364102973|FG001|Overall Study|Screen Failure|0|||
105574872|NCT00147225|364102974|FG002|Overall Study|Screen Failure|0|||
105574873|NCT00147225|364102975|FG003|Overall Study|Screen Failure|0|||
105574874|NCT00147225|364102976|FG004|Overall Study|Screen Failure|1|||
105574875|NCT00147225|364102977|FG005|Overall Study|Screen Failure|0|||
105574876|NCT00147225|364102972|FG000|Overall Study|Chemotherapy Changed|0|||
105574877|NCT00147225|364102973|FG001|Overall Study|Chemotherapy Changed|0|||
105574878|NCT00147225|364102974|FG002|Overall Study|Chemotherapy Changed|0|||
105574879|NCT00147225|364102975|FG003|Overall Study|Chemotherapy Changed|0|||
105574880|NCT00147225|364102976|FG004|Overall Study|Chemotherapy Changed|0|||
105574881|NCT00147225|364102977|FG005|Overall Study|Chemotherapy Changed|1|||
105574882|NCT02875834|364102980|FG000|Open-label Phase|Withdrawal by Subject|3|||
105574883|NCT02875834|364102981|FG001|Open-label Phase|Withdrawal by Subject|0|||
105574884|NCT02875834|364102982|FG002|Open-label Phase|Withdrawal by Subject|0|||
105574885|NCT02875834|364102983|FG003|Open-label Phase|Withdrawal by Subject|0|||
105574886|NCT02875834|364102980|FG000|Open-label Phase|(Not collected)|4|||
105574887|NCT02875834|364102981|FG001|Open-label Phase|(Not collected)|0|||
105574888|NCT02875834|364102982|FG002|Open-label Phase|(Not collected)|0|||
105574889|NCT02875834|364102983|FG003|Open-label Phase|(Not collected)|0|||
105574890|NCT02875834|364102980|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
105574891|NCT02875834|364102981|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
105574892|NCT02875834|364102982|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
105574893|NCT02875834|364102983|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
105574894|NCT02875834|364102980|FG000|Randomized Treatment Phase|Protocol Violation|0|||
105574895|NCT02875834|364102981|FG001|Randomized Treatment Phase|Protocol Violation|2|||
105574896|NCT02875834|364102982|FG002|Randomized Treatment Phase|Protocol Violation|0|||
105574897|NCT02875834|364102983|FG003|Randomized Treatment Phase|Protocol Violation|0|||
105574898|NCT02875834|364102980|FG000|Randomized Treatment Phase|(Not collected)|0|||
105574899|NCT02875834|364102981|FG001|Randomized Treatment Phase|(Not collected)|9|||
105574900|NCT02875834|364102982|FG002|Randomized Treatment Phase|(Not collected)|10|||
105574901|NCT02875834|364102983|FG003|Randomized Treatment Phase|(Not collected)|9|||
105574902|NCT00720902|364104330|FG000|Overall Study|Withdrawal by Subject|1|||
105574903|NCT00720902|364104331|FG001|Overall Study|Withdrawal by Subject|0|||
105827225|NCT01647828|365026425|FG007|Overall Study|Lost to Follow-up|2|||
105827226|NCT01647828|365026426|FG008|Overall Study|Lost to Follow-up|0|||
105827227|NCT03629054|365026428|FG000|Period 2 (4 Days)|Not treated|0|||
105827228|NCT03629054|365026429|FG001|Period 2 (4 Days)|Not treated|1|||
105827229|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
105827230|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
105827231|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
105827232|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
105827233|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
105827234|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
105827235|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Death|9|||
105827236|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Death|7|||
105827237|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Death|14|||
105827238|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Death|7|||
105827239|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Death|0|||
105827240|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Death|0|||
105827241|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
105827242|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
105827243|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
105827244|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
105827245|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
105827246|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
105827247|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Other Event|49|||
105827248|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Other Event|52|||
105827249|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Other Event|41|||
105827250|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Other Event|58|||
105827251|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Other Event|0|||
105827252|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Other Event|0|||
105827253|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
105827254|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
105827255|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
105827256|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
105827257|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
105827258|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
105827259|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
105827260|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
105307520|NCT04430855|363122705|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
105307521|NCT04430855|363122706|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
105307522|NCT04430855|363122705|FG000|Period 1 (Weeks 1-12)|Other|0|||
105307523|NCT04430855|363122706|FG001|Period 1 (Weeks 1-12)|Other|1|||
105307524|NCT04430855|363122705|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
105307525|NCT04430855|363122706|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
105307526|NCT04430855|363122705|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
105307527|NCT04430855|363122706|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
105307528|NCT04430855|363122705|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
105307529|NCT04430855|363122706|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
105307530|NCT03835221|363122707|FG000|Methafilcon A|Withdrawal by Subject|1|||
105307531|NCT04874636|363122708|FG000|Overall Study|Adverse Event|17|||
105307532|NCT04874636|363122709|FG001|Overall Study|Adverse Event|7|||
105307533|NCT04874636|363122708|FG000|Overall Study|Lost to Follow-up|1|||
105307534|NCT04874636|363122709|FG001|Overall Study|Lost to Follow-up|0|||
105307535|NCT04874636|363122708|FG000|Overall Study|Non-Compliance with Study Drug|2|||
105307536|NCT04874636|363122709|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105307537|NCT04874636|363122708|FG000|Overall Study|Physician Decision|1|||
105307538|NCT04874636|363122709|FG001|Overall Study|Physician Decision|0|||
105307539|NCT04874636|363122708|FG000|Overall Study|Withdrawal by Subject|6|||
105307540|NCT04874636|363122709|FG001|Overall Study|Withdrawal by Subject|5|||
105307541|NCT00446199|363122710|FG000|Overall Study|Adverse Event|7|||
105307542|NCT00446199|363122711|FG001|Overall Study|Adverse Event|4|||
105307543|NCT00446199|363122712|FG002|Overall Study|Adverse Event|6|||
105307544|NCT00446199|363122713|FG003|Overall Study|Adverse Event|4|||
105307545|NCT00446199|363122710|FG000|Overall Study|Lost to Follow-up|4|||
105307546|NCT00446199|363122711|FG001|Overall Study|Lost to Follow-up|5|||
105307547|NCT00446199|363122712|FG002|Overall Study|Lost to Follow-up|2|||
105307548|NCT00446199|363122713|FG003|Overall Study|Lost to Follow-up|6|||
105307549|NCT00446199|363122710|FG000|Overall Study|Protocol Violation|1|||
105366432|NCT04006145|363348381|FG000|Overall Study|Other|1|||
105366433|NCT04006145|363348382|FG001|Overall Study|Other|2|||
105366434|NCT01001429|363348383|FG000|Overall Study|surgery cancelled|0|||
105366435|NCT01001429|363348384|FG001|Overall Study|surgery cancelled|1|||
105366436|NCT01053741|363348387|FG000|2nd Study Intervention|Physician Decision|0|||
105366437|NCT01053741|363348388|FG001|2nd Study Intervention|Physician Decision|1|||
105366438|NCT02498678|363348390|FG000|Overall Study|interference from the surgical team|0|||
105366439|NCT02498678|363348391|FG001|Overall Study|interference from the surgical team|2|||
105366440|NCT01811732|363348401|FG000|Overall Study|Lost to Follow-up|24|||
105366441|NCT01811732|363348402|FG001|Overall Study|Lost to Follow-up|30|||
105366442|NCT01811732|363348401|FG000|Overall Study|Withdrawal by Subject|16|||
105366443|NCT01811732|363348402|FG001|Overall Study|Withdrawal by Subject|10|||
105366444|NCT01811732|363348401|FG000|Overall Study|Adverse Event|3|||
105366445|NCT01811732|363348402|FG001|Overall Study|Adverse Event|9|||
105366446|NCT01811732|363348401|FG000|Overall Study|Lack of Efficacy|3|||
105366447|NCT01811732|363348402|FG001|Overall Study|Lack of Efficacy|1|||
105366448|NCT01811732|363348401|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
105366449|NCT01811732|363348402|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
105366450|NCT01811732|363348401|FG000|Overall Study|Physician Decision|2|||
105366451|NCT01811732|363348402|FG001|Overall Study|Physician Decision|0|||
105307550|NCT00446199|363122711|FG001|Overall Study|Protocol Violation|2|||
105307551|NCT00446199|363122712|FG002|Overall Study|Protocol Violation|1|||
105366452|NCT01811732|363348401|FG000|Overall Study|Death|1|||
105366453|NCT01811732|363348402|FG001|Overall Study|Death|1|||
105366454|NCT01811732|363348401|FG000|Overall Study|Insufficient venous access|0|||
105366455|NCT01811732|363348402|FG001|Overall Study|Insufficient venous access|1|||
105366456|NCT01811732|363348401|FG000|Overall Study|Protocol Violation|0|||
105366457|NCT01811732|363348402|FG001|Overall Study|Protocol Violation|1|||
105827261|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
105307552|NCT00446199|363122713|FG003|Overall Study|Protocol Violation|3|||
105307553|NCT00446199|363122710|FG000|Overall Study|Withdrawal by Subject|2|||
105307554|NCT00446199|363122711|FG001|Overall Study|Withdrawal by Subject|5|||
105307555|NCT00446199|363122712|FG002|Overall Study|Withdrawal by Subject|9|||
105307556|NCT00446199|363122713|FG003|Overall Study|Withdrawal by Subject|10|||
105307557|NCT00446199|363122710|FG000|Overall Study|Site termination|2|||
105307558|NCT00446199|363122711|FG001|Overall Study|Site termination|0|||
105307559|NCT00446199|363122712|FG002|Overall Study|Site termination|0|||
105307560|NCT00446199|363122713|FG003|Overall Study|Site termination|1|||
105307561|NCT00446199|363122710|FG000|Overall Study|Randomization in Error|2|||
105827262|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
105827263|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
105307562|NCT00446199|363122711|FG001|Overall Study|Randomization in Error|0|||
105307563|NCT00446199|363122712|FG002|Overall Study|Randomization in Error|1|||
105307564|NCT00446199|363122713|FG003|Overall Study|Randomization in Error|1|||
105307565|NCT00446199|363122710|FG000|Overall Study|Lack of Efficacy|1|||
105307566|NCT00446199|363122711|FG001|Overall Study|Lack of Efficacy|0|||
105307567|NCT00446199|363122712|FG002|Overall Study|Lack of Efficacy|0|||
105626667|NCT04167553|364298145|FG005|Overall Study|Withdrawal by Subject|0|||
105307568|NCT00446199|363122713|FG003|Overall Study|Lack of Efficacy|1|||
105307569|NCT00446199|363122710|FG000|Overall Study|Non-compliant with study drug|1|||
105307570|NCT00446199|363122711|FG001|Overall Study|Non-compliant with study drug|0|||
105307571|NCT00446199|363122712|FG002|Overall Study|Non-compliant with study drug|5|||
105827264|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
105827265|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
105827266|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
105827267|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
105827268|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
105827269|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
105827270|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
105827271|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
105827272|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
105827273|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
105827274|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
105827275|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
105827276|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
105827277|NCT00205777|365026430|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
105827278|NCT00205777|365026431|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
105827279|NCT00205777|365026432|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
105827280|NCT00205777|365026433|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
105827281|NCT00205777|365026434|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
105827282|NCT00205777|365026435|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
105827283|NCT00205777|365026430|FG000|Completed Core Study, Entered SE I|Other Event|52|||
105827284|NCT00205777|365026431|FG001|Completed Core Study, Entered SE I|Other Event|46|||
105827285|NCT00205777|365026432|FG002|Completed Core Study, Entered SE I|Other Event|47|||
105827286|NCT00205777|365026433|FG003|Completed Core Study, Entered SE I|Other Event|50|||
105827287|NCT00205777|365026434|FG004|Completed Core Study, Entered SE I|Other Event|0|||
105827288|NCT00205777|365026435|FG005|Completed Core Study, Entered SE I|Other Event|0|||
105827289|NCT00205777|365026430|FG000|Study Extension I|Adverse Event|57|||
105827290|NCT00205777|365026431|FG001|Study Extension I|Adverse Event|0|||
105827291|NCT00205777|365026432|FG002|Study Extension I|Adverse Event|0|||
105827292|NCT00205777|365026433|FG003|Study Extension I|Adverse Event|61|||
105827293|NCT00205777|365026434|FG004|Study Extension I|Adverse Event|58|||
105827294|NCT00205777|365026435|FG005|Study Extension I|Adverse Event|0|||
105827295|NCT00205777|365026430|FG000|Study Extension I|Death|5|||
105827296|NCT00205777|365026431|FG001|Study Extension I|Death|0|||
105827297|NCT00205777|365026432|FG002|Study Extension I|Death|0|||
105827298|NCT00205777|365026433|FG003|Study Extension I|Death|1|||
105827299|NCT00205777|365026434|FG004|Study Extension I|Death|2|||
105827300|NCT00205777|365026435|FG005|Study Extension I|Death|0|||
105827301|NCT00205777|365026430|FG000|Study Extension I|Withdrawal by Subject|99|||
105827302|NCT00205777|365026431|FG001|Study Extension I|Withdrawal by Subject|0|||
105827303|NCT00205777|365026432|FG002|Study Extension I|Withdrawal by Subject|0|||
105827304|NCT00205777|365026433|FG003|Study Extension I|Withdrawal by Subject|106|||
105827305|NCT00205777|365026434|FG004|Study Extension I|Withdrawal by Subject|89|||
105827306|NCT00205777|365026435|FG005|Study Extension I|Withdrawal by Subject|0|||
105827307|NCT00205777|365026430|FG000|Study Extension I|Protocol Violation|4|||
105827308|NCT00205777|365026431|FG001|Study Extension I|Protocol Violation|0|||
105827309|NCT00205777|365026432|FG002|Study Extension I|Protocol Violation|0|||
105827310|NCT00205777|365026433|FG003|Study Extension I|Protocol Violation|8|||
105827311|NCT00205777|365026434|FG004|Study Extension I|Protocol Violation|8|||
105827312|NCT00205777|365026435|FG005|Study Extension I|Protocol Violation|0|||
105827313|NCT00205777|365026430|FG000|Study Extension I|Lack of Efficacy|0|||
105827314|NCT00205777|365026431|FG001|Study Extension I|Lack of Efficacy|0|||
105827315|NCT00205777|365026432|FG002|Study Extension I|Lack of Efficacy|0|||
105827316|NCT00205777|365026433|FG003|Study Extension I|Lack of Efficacy|1|||
105827317|NCT00205777|365026434|FG004|Study Extension I|Lack of Efficacy|2|||
105307572|NCT00446199|363122713|FG003|Overall Study|Non-compliant with study drug|0|||
105307573|NCT00446199|363122710|FG000|Overall Study|Non-compliant with visit schedule|1|||
105307574|NCT00446199|363122711|FG001|Overall Study|Non-compliant with visit schedule|1|||
105307575|NCT00446199|363122712|FG002|Overall Study|Non-compliant with visit schedule|1|||
105307576|NCT00446199|363122713|FG003|Overall Study|Non-compliant with visit schedule|2|||
105307577|NCT00446199|363122710|FG000|Overall Study|Hormone fear|0|||
105307578|NCT00446199|363122711|FG001|Overall Study|Hormone fear|0|||
105307579|NCT00446199|363122712|FG002|Overall Study|Hormone fear|0|||
105307580|NCT00446199|363122713|FG003|Overall Study|Hormone fear|1|||
105307581|NCT00446199|363122710|FG000|Overall Study|Lost interest in study participation|0|||
105307582|NCT00446199|363122711|FG001|Overall Study|Lost interest in study participation|1|||
105307583|NCT00446199|363122712|FG002|Overall Study|Lost interest in study participation|0|||
105307584|NCT00446199|363122713|FG003|Overall Study|Lost interest in study participation|0|||
105307585|NCT00446199|363122710|FG000|Overall Study|In-/Exclusion criterion violated|2|||
105307586|NCT00446199|363122711|FG001|Overall Study|In-/Exclusion criterion violated|1|||
105307587|NCT00446199|363122712|FG002|Overall Study|In-/Exclusion criterion violated|2|||
105307588|NCT00446199|363122713|FG003|Overall Study|In-/Exclusion criterion violated|1|||
105307589|NCT00446199|363122710|FG000|Overall Study|Move|0|||
105307590|NCT00446199|363122711|FG001|Overall Study|Move|1|||
105307591|NCT00446199|363122712|FG002|Overall Study|Move|0|||
105307592|NCT00446199|363122713|FG003|Overall Study|Move|0|||
105307593|NCT04188301|363122720|FG000|Month 3|Lost to Follow-up|0|||
105827318|NCT00205777|365026435|FG005|Study Extension I|Lack of Efficacy|0|||
105307594|NCT04188301|363122721|FG001|Month 3|Lost to Follow-up|0|||
105307595|NCT04188301|363122722|FG002|Month 3|Lost to Follow-up|1|||
105307596|NCT04188301|363122720|FG000|Month 12|Lost to Follow-up|0|||
105307597|NCT04188301|363122721|FG001|Month 12|Lost to Follow-up|0|||
105307598|NCT04188301|363122722|FG002|Month 12|Lost to Follow-up|2|||
105307599|NCT04188301|363122720|FG000|Month 12|Death|1|||
105307600|NCT04188301|363122721|FG001|Month 12|Death|1|||
105307601|NCT04188301|363122722|FG002|Month 12|Death|0|||
105307602|NCT04188301|363122720|FG000|Month 18|Lost to Follow-up|6|||
105307603|NCT04188301|363122721|FG001|Month 18|Lost to Follow-up|0|||
105307604|NCT04188301|363122722|FG002|Month 18|Lost to Follow-up|0|||
105307605|NCT04639713|363122723|FG000|Overall Study|Protocol Noncompliance|2|||
105307606|NCT04639713|363122723|FG000|Overall Study|Withdrawal by Subject|1|||
105307607|NCT00857584|363122724|FG000|Overall Study|Lack of Efficacy|1|||
105307608|NCT00857584|363122725|FG001|Overall Study|Lack of Efficacy|2|||
105307609|NCT00857584|363122724|FG000|Overall Study|Adverse Event|2|||
105307610|NCT00857584|363122725|FG001|Overall Study|Adverse Event|2|||
105307611|NCT00857584|363122724|FG000|Overall Study|Physician Decision|1|||
105307612|NCT00857584|363122725|FG001|Overall Study|Physician Decision|1|||
105307613|NCT00390221|363122726|FG000|Overall Study|Lost to Follow-up|0|||
105307614|NCT00390221|363122727|FG001|Overall Study|Lost to Follow-up|3|||
105307615|NCT00390221|363122728|FG002|Overall Study|Lost to Follow-up|0|||
105307616|NCT00390221|363122726|FG000|Overall Study|Adverse Event|1|||
105307617|NCT00390221|363122727|FG001|Overall Study|Adverse Event|4|||
105307618|NCT00390221|363122728|FG002|Overall Study|Adverse Event|3|||
105307619|NCT00390221|363122726|FG000|Overall Study|Investigator Decision|0|||
105307620|NCT00390221|363122727|FG001|Overall Study|Investigator Decision|0|||
105307621|NCT00390221|363122728|FG002|Overall Study|Investigator Decision|1|||
105307622|NCT00390221|363122726|FG000|Overall Study|Withdrawal by Subject|13|||
105488923|NCT02414139|363801996|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
105488924|NCT02414139|363801997|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
105488925|NCT02414139|363801998|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
105488926|NCT02414139|363801999|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
105488927|NCT02414139|363802000|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
105488928|NCT02414139|363802001|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
105488929|NCT02414139|363802002|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
105307623|NCT00390221|363122727|FG001|Overall Study|Withdrawal by Subject|9|||
105307624|NCT00390221|363122728|FG002|Overall Study|Withdrawal by Subject|7|||
105307625|NCT00390221|363122726|FG000|Overall Study|Subject Non-compliance|1|||
105307626|NCT00390221|363122727|FG001|Overall Study|Subject Non-compliance|0|||
105307627|NCT00390221|363122728|FG002|Overall Study|Subject Non-compliance|2|||
105307628|NCT00390221|363122726|FG000|Overall Study|Other|3|||
105307629|NCT00390221|363122727|FG001|Overall Study|Other|4|||
105307630|NCT00390221|363122728|FG002|Overall Study|Other|2|||
105307631|NCT00960115|363122731|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
105307632|NCT00960115|363122732|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
105307633|NCT01177059|363122738|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
105307634|NCT01177059|363122738|FG000|Overall Study|Withdrew consent|2|||
105307635|NCT01177059|363122738|FG000|Overall Study|Lost to Follow-up|18|||
105307636|NCT03190330|363125140|FG000|Overall Study|Adverse Event|2|||
105488930|NCT02414139|363801993|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
105488931|NCT02414139|363801994|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
105488932|NCT02414139|363801995|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
105488933|NCT02414139|363801996|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
105307637|NCT03190330|363125140|FG000|Overall Study|Death|10|||
105307638|NCT03190330|363125140|FG000|Overall Study|Lost to Follow-up|1|||
105307639|NCT03190330|363125140|FG000|Overall Study|Withdrawal by Subject|6|||
105307640|NCT03190330|363125140|FG000|Overall Study|Progressive Disease|1|||
105307641|NCT00006721|363125149|FG000|Overall Study|Adverse Event|0|||
105307642|NCT00006721|363125150|FG001|Overall Study|Adverse Event|4|||
105307643|NCT00006721|363125151|FG002|Overall Study|Adverse Event|4|||
105307644|NCT00006721|363125149|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
105307645|NCT00006721|363125150|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
105307646|NCT00006721|363125151|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
105307647|NCT00006721|363125149|FG000|Overall Study|Progression/Relapse|0|||
105307648|NCT00006721|363125150|FG001|Overall Study|Progression/Relapse|1|||
105307649|NCT00006721|363125151|FG002|Overall Study|Progression/Relapse|2|||
105307650|NCT00006721|363125149|FG000|Overall Study|Death|0|||
105307651|NCT00006721|363125150|FG001|Overall Study|Death|1|||
105307652|NCT00006721|363125151|FG002|Overall Study|Death|2|||
105307653|NCT00006721|363125149|FG000|Overall Study|Other - Not Protocol Specified|0|||
105307654|NCT00006721|363125150|FG001|Overall Study|Other - Not Protocol Specified|7|||
105307655|NCT00006721|363125151|FG002|Overall Study|Other - Not Protocol Specified|7|||
105307656|NCT00006721|363125149|FG000|Overall Study|Ineligible|2|||
105307657|NCT00006721|363125150|FG001|Overall Study|Ineligible|12|||
105307658|NCT00006721|363125151|FG002|Overall Study|Ineligible|10|||
105307659|NCT00006721|363125149|FG000|Overall Study|Eligible but no Treatment Received|1|||
105307660|NCT00006721|363125150|FG001|Overall Study|Eligible but no Treatment Received|0|||
105307661|NCT00006721|363125151|FG002|Overall Study|Eligible but no Treatment Received|0|||
105307662|NCT03845296|363125152|FG000|Overall Study|On Treatment|2|||
105307663|NCT03845296|363125153|FG001|Overall Study|On Treatment|1|||
105307664|NCT03845296|363125152|FG000|Overall Study|Adverse Event|4|||
105307665|NCT03845296|363125153|FG001|Overall Study|Adverse Event|11|||
105307666|NCT03845296|363125152|FG000|Overall Study|Refusal unrelated to adverse event|0|||
105307667|NCT03845296|363125153|FG001|Overall Study|Refusal unrelated to adverse event|1|||
105307668|NCT03845296|363125152|FG000|Overall Study|Progression/relapse|14|||
105307669|NCT03845296|363125153|FG001|Overall Study|Progression/relapse|18|||
105307670|NCT03845296|363125152|FG000|Overall Study|Death|4|||
105574904|NCT00720902|364104330|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
105574905|NCT00720902|364104331|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
105574906|NCT02959671|364104332|FG000|Overall Study|Adverse Event|2|||
105574907|NCT02959671|364104332|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
105574908|NCT00077636|364104333|FG000|Overall Study|Refused Treatment|9|||
105574909|NCT00077636|364104334|FG001|Overall Study|Refused Treatment|31|||
105574910|NCT00077636|364104333|FG000|Overall Study|Admin|3|||
105574911|NCT00077636|364104334|FG001|Overall Study|Admin|3|||
105574912|NCT00077636|364104333|FG000|Overall Study|Withdrawal by Subject|2|||
105574913|NCT00077636|364104334|FG001|Overall Study|Withdrawal by Subject|2|||
105574914|NCT00077636|364104333|FG000|Overall Study|Adverse Event|17|||
105574915|NCT00077636|364104334|FG001|Overall Study|Adverse Event|34|||
105574916|NCT00077636|364104333|FG000|Overall Study|Protocol Violation|0|||
105574917|NCT00077636|364104334|FG001|Overall Study|Protocol Violation|2|||
105574918|NCT00077636|364104333|FG000|Overall Study|Lost to Follow-up|10|||
105574919|NCT00077636|364104334|FG001|Overall Study|Lost to Follow-up|18|||
105827319|NCT00205777|365026430|FG000|Study Extension I|Failed to return|15|||
105827320|NCT00205777|365026431|FG001|Study Extension I|Failed to return|0|||
105827321|NCT00205777|365026432|FG002|Study Extension I|Failed to return|0|||
105827322|NCT00205777|365026433|FG003|Study Extension I|Failed to return|17|||
105827323|NCT00205777|365026434|FG004|Study Extension I|Failed to return|13|||
105827324|NCT00205777|365026435|FG005|Study Extension I|Failed to return|0|||
105827325|NCT00205777|365026430|FG000|Study Extension I|Other Event|34|||
105827326|NCT00205777|365026431|FG001|Study Extension I|Other Event|0|||
105827327|NCT00205777|365026432|FG002|Study Extension I|Other Event|0|||
105827328|NCT00205777|365026433|FG003|Study Extension I|Other Event|34|||
105574920|NCT00077636|364104333|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
105574921|NCT00077636|364104334|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
105574922|NCT00474929|364104342|FG000|Overall Study|Withdrawal by Subject|0|||
105574923|NCT00474929|364104343|FG001|Overall Study|Withdrawal by Subject|1|||
105574924|NCT00474929|364104344|FG002|Overall Study|Withdrawal by Subject|0|||
105307671|NCT03845296|363125153|FG001|Overall Study|Death|0|||
105307672|NCT03845296|363125152|FG000|Overall Study|Other - not protocol specified|1|||
105307673|NCT03845296|363125153|FG001|Overall Study|Other - not protocol specified|3|||
105574925|NCT00474929|364104345|FG003|Overall Study|Withdrawal by Subject|0|||
105574926|NCT00474929|364104346|FG004|Overall Study|Withdrawal by Subject|0|||
105574927|NCT00474929|364104342|FG000|Overall Study|Unrelated medical condition|0|||
105307674|NCT05091307|363125154|FG000|Overall Study|Death|0|||
105307675|NCT05091307|363125155|FG001|Overall Study|Death|0|||
105307676|NCT05091307|363125156|FG002|Overall Study|Death|1|||
105307677|NCT05091307|363125157|FG003|Overall Study|Death|0|||
105307678|NCT05091307|363125154|FG000|Overall Study|Lost to Follow-up|33|||
105307679|NCT05091307|363125155|FG001|Overall Study|Lost to Follow-up|33|||
105574928|NCT00474929|364104343|FG001|Overall Study|Unrelated medical condition|0|||
105574929|NCT00474929|364104344|FG002|Overall Study|Unrelated medical condition|1|||
105574930|NCT00474929|364104345|FG003|Overall Study|Unrelated medical condition|0|||
105574931|NCT00474929|364104346|FG004|Overall Study|Unrelated medical condition|0|||
105574932|NCT00474929|364104342|FG000|Overall Study|Physician Decision|0|||
105574933|NCT00474929|364104343|FG001|Overall Study|Physician Decision|0|||
105574934|NCT00474929|364104344|FG002|Overall Study|Physician Decision|1|||
105574935|NCT00474929|364104345|FG003|Overall Study|Physician Decision|2|||
105574936|NCT00474929|364104346|FG004|Overall Study|Physician Decision|0|||
105574937|NCT00068380|364104350|FG000|Overall Study|Withdrawal by Subject|3|||
105574938|NCT00068380|364104350|FG000|Overall Study|Adverse Event|2|||
105574939|NCT02757521|364104351|FG000|Overall Study|Adverse Event|1|||
105574940|NCT02757521|364104352|FG001|Overall Study|Adverse Event|0|||
105574941|NCT03239873|364104353|FG000|Overall Study|Lost to Follow-up|15|||
105574942|NCT03239873|364104354|FG001|Overall Study|Lost to Follow-up|16|||
105574943|NCT03239873|364104353|FG000|Overall Study|Physician Decision|1|||
105574944|NCT03239873|364104354|FG001|Overall Study|Physician Decision|0|||
105574945|NCT03239873|364104353|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
105574946|NCT03239873|364104354|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
105574947|NCT03239873|364104353|FG000|Overall Study|Withdrawal by Subject|2|||
105574948|NCT03239873|364104354|FG001|Overall Study|Withdrawal by Subject|0|||
105574949|NCT03239873|364104353|FG000|Overall Study|Contraindication to study medication|1|||
105574950|NCT03239873|364104354|FG001|Overall Study|Contraindication to study medication|0|||
105574951|NCT03239873|364104353|FG000|Overall Study|Protocol Violation|1|||
105574952|NCT03239873|364104354|FG001|Overall Study|Protocol Violation|0|||
105574953|NCT00605319|364104355|FG000|Overall Study|Adverse Event|6|||
105574954|NCT02960763|364104356|FG000|Step 1|Withdrawal by Subject|10|||
105574955|NCT02960763|364104357|FG001|Step 1|Withdrawal by Subject|8|||
105574956|NCT02960763|364104358|FG002|Step 1|Withdrawal by Subject|13|||
105574957|NCT02960763|364104359|FG003|Step 1|Withdrawal by Subject|0|||
105574958|NCT02960763|364104360|FG004|Step 1|Withdrawal by Subject|0|||
105574959|NCT02960763|364104356|FG000|Step 1|Lost to Follow-up|7|||
105574960|NCT02960763|364104357|FG001|Step 1|Lost to Follow-up|9|||
105574961|NCT02960763|364104358|FG002|Step 1|Lost to Follow-up|12|||
105574962|NCT02960763|364104359|FG003|Step 1|Lost to Follow-up|0|||
105574963|NCT02960763|364104360|FG004|Step 1|Lost to Follow-up|0|||
105574964|NCT02960763|364104356|FG000|Step 1|Death|1|||
105574965|NCT02960763|364104357|FG001|Step 1|Death|1|||
105574966|NCT02960763|364104358|FG002|Step 1|Death|1|||
105574967|NCT02960763|364104359|FG003|Step 1|Death|0|||
105574968|NCT02960763|364104360|FG004|Step 1|Death|0|||
105574969|NCT02960763|364104356|FG000|Step 1|Investigator discretion|1|||
105574970|NCT02960763|364104357|FG001|Step 1|Investigator discretion|0|||
105574971|NCT02960763|364104358|FG002|Step 1|Investigator discretion|1|||
105574972|NCT02960763|364104359|FG003|Step 1|Investigator discretion|0|||
105574973|NCT02960763|364104360|FG004|Step 1|Investigator discretion|0|||
105574974|NCT02960763|364104356|FG000|Step 1|Other|0|||
105574975|NCT02960763|364104357|FG001|Step 1|Other|0|||
105574976|NCT02960763|364104358|FG002|Step 1|Other|1|||
105574977|NCT02960763|364104359|FG003|Step 1|Other|0|||
105574978|NCT02960763|364104360|FG004|Step 1|Other|0|||
105574979|NCT02960763|364104356|FG000|Step 2|Withdrawal by Subject|0|||
105574980|NCT02960763|364104357|FG001|Step 2|Withdrawal by Subject|0|||
105574981|NCT02960763|364104358|FG002|Step 2|Withdrawal by Subject|0|||
105574982|NCT02960763|364104359|FG003|Step 2|Withdrawal by Subject|7|||
105574983|NCT02960763|364104360|FG004|Step 2|Withdrawal by Subject|3|||
105574984|NCT02960763|364104356|FG000|Step 2|Lost to Follow-up|0|||
105574985|NCT02960763|364104357|FG001|Step 2|Lost to Follow-up|0|||
105574986|NCT02960763|364104358|FG002|Step 2|Lost to Follow-up|0|||
105574987|NCT02960763|364104359|FG003|Step 2|Lost to Follow-up|4|||
105574988|NCT02960763|364104360|FG004|Step 2|Lost to Follow-up|1|||
105574989|NCT02960763|364104356|FG000|Step 2|Investigator discretion|0|||
105574990|NCT02960763|364104357|FG001|Step 2|Investigator discretion|0|||
105574991|NCT02960763|364104358|FG002|Step 2|Investigator discretion|0|||
105574992|NCT02960763|364104359|FG003|Step 2|Investigator discretion|0|||
105574993|NCT02960763|364104360|FG004|Step 2|Investigator discretion|1|||
105574994|NCT01868035|364104363|FG000|Overall Study|Lost to Follow-up|3|||
105574995|NCT01868035|364104363|FG000|Overall Study|Withdrawal by Subject|1|||
105574996|NCT01868035|364104363|FG000|Overall Study|Progressive Disease|2|||
105574997|NCT01868035|364104363|FG000|Overall Study|Non-compliance|1|||
105574998|NCT02318719|364104364|FG000|Double-blind Phase|Adverse Event|7|||
105574999|NCT02318719|364104365|FG001|Double-blind Phase|Adverse Event|6|||
105575000|NCT02318719|364104366|FG002|Double-blind Phase|Adverse Event|12|||
105575001|NCT02318719|364104367|FG003|Double-blind Phase|Adverse Event|4|||
105575002|NCT02318719|364104368|FG004|Double-blind Phase|Adverse Event|0|||
105575003|NCT02318719|364104364|FG000|Double-blind Phase|Lack of Efficacy|5|||
105575004|NCT02318719|364104365|FG001|Double-blind Phase|Lack of Efficacy|0|||
105575005|NCT02318719|364104366|FG002|Double-blind Phase|Lack of Efficacy|1|||
105575006|NCT02318719|364104367|FG003|Double-blind Phase|Lack of Efficacy|1|||
105575007|NCT02318719|364104368|FG004|Double-blind Phase|Lack of Efficacy|0|||
105575008|NCT02318719|364104364|FG000|Double-blind Phase|Protocol Violation|0|||
105575009|NCT02318719|364104365|FG001|Double-blind Phase|Protocol Violation|1|||
105575010|NCT02318719|364104366|FG002|Double-blind Phase|Protocol Violation|3|||
105575011|NCT02318719|364104367|FG003|Double-blind Phase|Protocol Violation|0|||
105575012|NCT02318719|364104368|FG004|Double-blind Phase|Protocol Violation|0|||
105575013|NCT02318719|364104364|FG000|Double-blind Phase|Withdrawal by Subject|25|||
105575014|NCT02318719|364104365|FG001|Double-blind Phase|Withdrawal by Subject|7|||
105575015|NCT02318719|364104366|FG002|Double-blind Phase|Withdrawal by Subject|9|||
105575016|NCT02318719|364104367|FG003|Double-blind Phase|Withdrawal by Subject|10|||
105575017|NCT02318719|364104368|FG004|Double-blind Phase|Withdrawal by Subject|0|||
105575018|NCT02318719|364104364|FG000|Double-blind Phase|Other|1|||
105575019|NCT02318719|364104365|FG001|Double-blind Phase|Other|2|||
105575020|NCT02318719|364104366|FG002|Double-blind Phase|Other|0|||
105575021|NCT02318719|364104367|FG003|Double-blind Phase|Other|0|||
105575022|NCT02318719|364104368|FG004|Double-blind Phase|Other|0|||
105575023|NCT02318719|364104364|FG000|Open-label Extension Phase|Adverse Event|0|||
105575024|NCT02318719|364104365|FG001|Open-label Extension Phase|Adverse Event|0|||
105575025|NCT02318719|364104366|FG002|Open-label Extension Phase|Adverse Event|0|||
105575026|NCT02318719|364104367|FG003|Open-label Extension Phase|Adverse Event|0|||
105575027|NCT02318719|364104368|FG004|Open-label Extension Phase|Adverse Event|15|||
105575028|NCT02318719|364104364|FG000|Open-label Extension Phase|Death|0|||
105575029|NCT02318719|364104365|FG001|Open-label Extension Phase|Death|0|||
105575030|NCT02318719|364104366|FG002|Open-label Extension Phase|Death|0|||
105575031|NCT02318719|364104367|FG003|Open-label Extension Phase|Death|0|||
105575032|NCT02318719|364104368|FG004|Open-label Extension Phase|Death|1|||
105575033|NCT02318719|364104364|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
105575034|NCT02318719|364104365|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
105575035|NCT02318719|364104366|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
105575036|NCT02318719|364104367|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
105575037|NCT02318719|364104368|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
105575038|NCT02318719|364104364|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
105575039|NCT02318719|364104365|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
105575040|NCT02318719|364104366|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
105575041|NCT02318719|364104367|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
105575042|NCT02318719|364104368|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
105575043|NCT02318719|364104364|FG000|Open-label Extension Phase|Other|0|||
105575044|NCT02318719|364104365|FG001|Open-label Extension Phase|Other|0|||
105575045|NCT02318719|364104366|FG002|Open-label Extension Phase|Other|0|||
105575046|NCT02318719|364104367|FG003|Open-label Extension Phase|Other|0|||
105575047|NCT02318719|364104368|FG004|Open-label Extension Phase|Other|7|||
105575048|NCT00423293|364104369|FG000|Overall Study|Ineligible / No protocol treatment|11|||
105575049|NCT00251927|364104372|FG000|Overall Study|Adverse Event|3|||
105575050|NCT00251927|364104373|FG001|Overall Study|Adverse Event|15|||
105575051|NCT00251927|364104372|FG000|Overall Study|Lack of Efficacy|22|||
105575052|NCT00251927|364104373|FG001|Overall Study|Lack of Efficacy|16|||
105575053|NCT00251927|364104372|FG000|Overall Study|Lost to Follow-up|22|||
105575054|NCT00251927|364104373|FG001|Overall Study|Lost to Follow-up|8|||
105575055|NCT00251927|364104372|FG000|Overall Study|Protocol Violation|1|||
105575056|NCT00251927|364104373|FG001|Overall Study|Protocol Violation|2|||
105575057|NCT00251927|364104372|FG000|Overall Study|Pregnancy|2|||
105575058|NCT00251927|364104373|FG001|Overall Study|Pregnancy|0|||
105575059|NCT00251927|364104372|FG000|Overall Study|Withdrawal by Subject|40|||
105575060|NCT00251927|364104373|FG001|Overall Study|Withdrawal by Subject|25|||
105575061|NCT00251927|364104372|FG000|Overall Study|Study-specific discont. achieved|13|||
105575062|NCT00251927|364104373|FG001|Overall Study|Study-specific discont. achieved|2|||
105575063|NCT00251927|364104372|FG000|Overall Study|Study procedure non-compliance|5|||
105575064|NCT00251927|364104373|FG001|Overall Study|Study procedure non-compliance|6|||
105575065|NCT02111213|364104379|FG000|Overall Study|Withdrawal by Subject|3|||
105575066|NCT02111213|364104380|FG001|Overall Study|Withdrawal by Subject|2|||
105575067|NCT02111213|364104379|FG000|Overall Study|Lost to Follow-up|3|||
105575068|NCT02111213|364104380|FG001|Overall Study|Lost to Follow-up|4|||
105575069|NCT00545363|364104383|FG000|Overall Study|Adverse Event|6|||
105575070|NCT00545363|364104384|FG001|Overall Study|Adverse Event|7|||
105575071|NCT00545363|364104383|FG000|Overall Study|Withdrawal by Subject|6|||
105575072|NCT00545363|364104384|FG001|Overall Study|Withdrawal by Subject|5|||
105575073|NCT00545363|364104383|FG000|Overall Study|Non-compliance|3|||
105575074|NCT00545363|364104384|FG001|Overall Study|Non-compliance|1|||
105575075|NCT00545363|364104383|FG000|Overall Study|Did not meet entry criteria|1|||
105575076|NCT00545363|364104384|FG001|Overall Study|Did not meet entry criteria|1|||
105575077|NCT00545363|364104383|FG000|Overall Study|Lost to Follow-up|2|||
105575078|NCT00545363|364104384|FG001|Overall Study|Lost to Follow-up|0|||
105575079|NCT00545363|364104383|FG000|Overall Study|Other|1|||
105575080|NCT00545363|364104384|FG001|Overall Study|Other|1|||
105575081|NCT00993317|364104385|FG000|Overall Study|Adverse Event|2|||
105575082|NCT00993317|364104386|FG001|Overall Study|Adverse Event|4|||
105575083|NCT00993317|364104385|FG000|Overall Study|Lack of Efficacy|18|||
105575084|NCT00993317|364104386|FG001|Overall Study|Lack of Efficacy|18|||
105575085|NCT00993317|364104385|FG000|Overall Study|Withdrawal by Subject|0|||
105575086|NCT00993317|364104386|FG001|Overall Study|Withdrawal by Subject|2|||
105575087|NCT00993317|364104385|FG000|Overall Study|Investigator's opinion|0|||
105307680|NCT05091307|363125156|FG002|Overall Study|Lost to Follow-up|2|||
105307681|NCT05091307|363125157|FG003|Overall Study|Lost to Follow-up|0|||
105307682|NCT05091307|363125154|FG000|Overall Study|Physician Decision|1|||
105307683|NCT05091307|363125155|FG001|Overall Study|Physician Decision|0|||
105307684|NCT05091307|363125156|FG002|Overall Study|Physician Decision|0|||
105307685|NCT05091307|363125157|FG003|Overall Study|Physician Decision|0|||
105307686|NCT05091307|363125154|FG000|Overall Study|Protocol Violation|1|||
105307687|NCT05091307|363125155|FG001|Overall Study|Protocol Violation|0|||
105307688|NCT05091307|363125156|FG002|Overall Study|Protocol Violation|0|||
105307689|NCT05091307|363125157|FG003|Overall Study|Protocol Violation|0|||
105307690|NCT05091307|363125154|FG000|Overall Study|Withdrawal by Subject|16|||
105307691|NCT05091307|363125155|FG001|Overall Study|Withdrawal by Subject|16|||
105307692|NCT05091307|363125156|FG002|Overall Study|Withdrawal by Subject|0|||
105307693|NCT05091307|363125157|FG003|Overall Study|Withdrawal by Subject|1|||
105307694|NCT05091307|363125154|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
105307695|NCT05091307|363125155|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
105307696|NCT05091307|363125156|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
105307697|NCT05091307|363125157|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
105307698|NCT05091307|363125154|FG000|Overall Study|Initiated Prohibited Medication|1|||
105307699|NCT05091307|363125155|FG001|Overall Study|Initiated Prohibited Medication|0|||
105307700|NCT05091307|363125156|FG002|Overall Study|Initiated Prohibited Medication|0|||
105307701|NCT05091307|363125157|FG003|Overall Study|Initiated Prohibited Medication|0|||
105307702|NCT05091307|363125154|FG000|Overall Study|Other|4|||
105307703|NCT05091307|363125155|FG001|Overall Study|Other|4|||
105307704|NCT05091307|363125156|FG002|Overall Study|Other|0|||
105307705|NCT05091307|363125157|FG003|Overall Study|Other|0|||
105307706|NCT05091307|363125154|FG000|Overall Study|Randomized but not vaccinated|0|||
105307707|NCT05091307|363125155|FG001|Overall Study|Randomized but not vaccinated|2|||
105307708|NCT05091307|363125156|FG002|Overall Study|Randomized but not vaccinated|0|||
105366458|NCT01811732|363348401|FG000|Overall Study|Subject incarcerated|1|||
105366459|NCT01811732|363348402|FG001|Overall Study|Subject incarcerated|2|||
105366460|NCT01811732|363348401|FG000|Overall Study|Admitted to another facility|1|||
105366461|NCT01811732|363348402|FG001|Overall Study|Admitted to another facility|0|||
105366462|NCT01811732|363348401|FG000|Overall Study|Correct study drug not available on site|1|||
105366463|NCT01811732|363348402|FG001|Overall Study|Correct study drug not available on site|0|||
105366464|NCT00744939|363348403|FG000|Overall Study|Withdrawal by Subject|9|||
105307709|NCT05091307|363125157|FG003|Overall Study|Randomized but not vaccinated|0|||
105366465|NCT00744939|363348403|FG000|Overall Study|Protocol Violation|13|||
105366466|NCT00744939|363348403|FG000|Overall Study|Death|24|||
105307710|NCT06077487|363125160|FG000|Overall Study|Withdrawal by Subject|0|||
105307711|NCT06077487|363125161|FG001|Overall Study|Withdrawal by Subject|1|||
105488934|NCT02414139|363801997|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
105307712|NCT04994483|363125163|FG000|Overall Study|Adverse Event|26|||
105307713|NCT04994483|363125164|FG001|Overall Study|Adverse Event|17|||
105366467|NCT00744939|363348403|FG000|Overall Study|distance|4|||
105366468|NCT00744939|363348403|FG000|Overall Study|Lost to Follow-up|12|||
105307714|NCT04994483|363125163|FG000|Overall Study|Lost to Follow-up|6|||
105307715|NCT04994483|363125164|FG001|Overall Study|Lost to Follow-up|10|||
105488935|NCT02414139|363801998|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
105488936|NCT02414139|363801999|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
105488937|NCT02414139|363802000|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
105488938|NCT02414139|363802001|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
105488939|NCT02414139|363802002|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
105488940|NCT01343901|363802003|FG000|Overall Study|Death|85|||
105488941|NCT01343901|363802003|FG000|Overall Study|Physician Decision|4|||
105488942|NCT01343901|363802003|FG000|Overall Study|Lost to Follow-up|12|||
105488943|NCT01343901|363802003|FG000|Overall Study|Management by another medical team|11|||
105488944|NCT01343901|363802003|FG000|Overall Study|Participant decision|1|||
105488945|NCT03631355|363802004|FG000|Overall Study|Lost to Follow-up|1|||
105488946|NCT03631355|363802005|FG001|Overall Study|Lost to Follow-up|2|||
105488947|NCT00938964|363802008|FG000|Overall Study|Death|3|||
105488948|NCT00938964|363802009|FG001|Overall Study|Death|3|||
105488949|NCT00938964|363802008|FG000|Overall Study|Lost to Follow-up|2|||
105488950|NCT00938964|363802009|FG001|Overall Study|Lost to Follow-up|3|||
105488951|NCT00938964|363802008|FG000|Overall Study|Withdrawal by Subject|22|||
105488952|NCT00938964|363802009|FG001|Overall Study|Withdrawal by Subject|18|||
105488953|NCT00938964|363802008|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
105488954|NCT00938964|363802009|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
105488955|NCT00321893|363802010|FG000|Overall Study|Non-Compliance/Refusal|16|||
105488956|NCT00321893|363802011|FG001|Overall Study|Non-Compliance/Refusal|10|||
105488957|NCT00321893|363802010|FG000|Overall Study|Lost to Follow-up|2|||
105488958|NCT00321893|363802011|FG001|Overall Study|Lost to Follow-up|1|||
105488959|NCT00321893|363802010|FG000|Overall Study|Adverse Event|6|||
105488960|NCT00321893|363802011|FG001|Overall Study|Adverse Event|3|||
105488961|NCT00769483|363802012|FG000|Overall Study|Withdrawal by Subject|0|||
105575088|NCT00993317|364104386|FG001|Overall Study|Investigator's opinion|1|||
105575089|NCT00993317|364104385|FG000|Overall Study|Early study termination at the site|1|||
105575090|NCT00993317|364104386|FG001|Overall Study|Early study termination at the site|0|||
105575091|NCT01348776|364104389|FG000|Overall Study|Lost to Follow-up|3|||
105575092|NCT01463293|364104393|FG000|Overall Study|Lost to Follow-up|1|||
105575093|NCT01463293|364104394|FG001|Overall Study|Lost to Follow-up|4|||
105575094|NCT01463293|364104395|FG002|Overall Study|Lost to Follow-up|5|||
105575095|NCT01463293|364104393|FG000|Overall Study|Adverse Event|1|||
105575096|NCT01463293|364104394|FG001|Overall Study|Adverse Event|2|||
105575097|NCT01463293|364104395|FG002|Overall Study|Adverse Event|0|||
105575098|NCT01463293|364104393|FG000|Overall Study|Withdrawal by Subject|4|||
105575099|NCT01463293|364104394|FG001|Overall Study|Withdrawal by Subject|10|||
105575100|NCT01463293|364104395|FG002|Overall Study|Withdrawal by Subject|5|||
105575101|NCT01463293|364104393|FG000|Overall Study|Other|0|||
105575102|NCT01463293|364104394|FG001|Overall Study|Other|0|||
105575103|NCT01463293|364104395|FG002|Overall Study|Other|2|||
105575104|NCT02878213|364104406|FG000|Overall Study|Withdrawal by Subject|2|||
105575105|NCT02878213|364104406|FG000|Overall Study|Adverse Event|1|||
105575106|NCT00924469|364104407|FG000|Overall Study|Adverse Event|2|||
105575107|NCT00924469|364104408|FG001|Overall Study|Adverse Event|0|||
105575108|NCT00924469|364104407|FG000|Overall Study|Withdrawal by Subject|0|||
105575109|NCT00924469|364104408|FG001|Overall Study|Withdrawal by Subject|1|||
105575110|NCT00924469|364104407|FG000|Overall Study|Lost to Follow-up|0|||
105575111|NCT00924469|364104408|FG001|Overall Study|Lost to Follow-up|1|||
105575112|NCT01088529|364104412|FG000|Overall Study|Did not receive study treatment|0|||
105575113|NCT01088529|364104413|FG001|Overall Study|Did not receive study treatment|1|||
105575114|NCT01821898|364104414|FG000|Overall Study|Withdrawal by Subject|2|||
105575115|NCT01821898|364104415|FG001|Overall Study|Withdrawal by Subject|1|||
105575116|NCT03691948|364104416|FG000|Overall Study|Lost to Follow-up|1|||
105575117|NCT03691948|364104417|FG001|Overall Study|Lost to Follow-up|3|||
105575118|NCT02611830|364104421|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
105575119|NCT02611830|364104422|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
105575120|NCT02611830|364104423|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
105575121|NCT02611830|364104424|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
105575122|NCT02611830|364104421|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
105575123|NCT02611830|364104422|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
105575124|NCT02611830|364104423|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
105575125|NCT02611830|364104424|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
105575126|NCT02611830|364104421|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
105575127|NCT02611830|364104422|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
105575128|NCT02611830|364104423|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
105575129|NCT02611830|364104424|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
105575130|NCT02611830|364104421|FG000|OL Induction Phase|Lack of Efficacy|9|||
105575131|NCT02611830|364104422|FG001|OL Induction Phase|Lack of Efficacy|0|||
105575132|NCT02611830|364104423|FG002|OL Induction Phase|Lack of Efficacy|0|||
105575133|NCT02611830|364104424|FG003|OL Induction Phase|Lack of Efficacy|0|||
105575134|NCT02611830|364104421|FG000|OL Induction Phase|Reason not specified|3|||
105575135|NCT02611830|364104422|FG001|OL Induction Phase|Reason not specified|0|||
105575136|NCT02611830|364104423|FG002|OL Induction Phase|Reason not specified|0|||
105575137|NCT02611830|364104424|FG003|OL Induction Phase|Reason not specified|0|||
105575138|NCT02611830|364104421|FG000|Maintenance Phase|Lack of Efficacy|0|||
105575139|NCT02611830|364104422|FG001|Maintenance Phase|Lack of Efficacy|29|||
105575140|NCT02611830|364104423|FG002|Maintenance Phase|Lack of Efficacy|18|||
105575141|NCT02611830|364104424|FG003|Maintenance Phase|Lack of Efficacy|6|||
105575142|NCT02611830|364104421|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
105575143|NCT02611830|364104422|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
105575144|NCT02611830|364104423|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
105575145|NCT02611830|364104424|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
105575146|NCT02611830|364104421|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
105575147|NCT02611830|364104422|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
105575148|NCT02611830|364104423|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
105575149|NCT02611830|364104424|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
105575150|NCT02611830|364104421|FG000|Maintenance Phase|Lost to Follow-up|0|||
105575151|NCT02611830|364104422|FG001|Maintenance Phase|Lost to Follow-up|0|||
105575152|NCT02611830|364104423|FG002|Maintenance Phase|Lost to Follow-up|0|||
105575153|NCT02611830|364104424|FG003|Maintenance Phase|Lost to Follow-up|1|||
105575154|NCT02611830|364104421|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
105575155|NCT02611830|364104422|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
105575156|NCT02611830|364104423|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
105575157|NCT02611830|364104424|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
105575158|NCT02611830|364104421|FG000|Maintenance Phase|Pregnancy|0|||
105575159|NCT02611830|364104422|FG001|Maintenance Phase|Pregnancy|0|||
105575160|NCT02611830|364104423|FG002|Maintenance Phase|Pregnancy|1|||
105575161|NCT02611830|364104424|FG003|Maintenance Phase|Pregnancy|0|||
105575162|NCT02611830|364104421|FG000|Maintenance Phase|Reason not specified|0|||
105575163|NCT02611830|364104422|FG001|Maintenance Phase|Reason not specified|1|||
105488962|NCT00769483|363802013|FG001|Overall Study|Withdrawal by Subject|1|||
105488963|NCT00769483|363802014|FG002|Overall Study|Withdrawal by Subject|0|||
105488964|NCT00769483|363802015|FG003|Overall Study|Withdrawal by Subject|0|||
105488965|NCT00769483|363802016|FG004|Overall Study|Withdrawal by Subject|1|||
105488966|NCT00769483|363802017|FG005|Overall Study|Withdrawal by Subject|0|||
105488967|NCT01306877|363802018|FG000|Overall Study|Lost to Follow-up|3|||
105575164|NCT02611830|364104423|FG002|Maintenance Phase|Reason not specified|4|||
105575165|NCT02611830|364104424|FG003|Maintenance Phase|Reason not specified|0|||
105575166|NCT02180438|364104427|FG000|Overall Study|Lost to Follow-up|1|||
105575167|NCT00195715|364104428|FG000|Overall Study|Adverse Event|122|||
105575168|NCT00195715|364104428|FG000|Overall Study|Withdrawal by Subject|58|||
105575169|NCT00195715|364104428|FG000|Overall Study|Lost to Follow-up|27|||
105575170|NCT00195715|364104428|FG000|Overall Study|Protocol Violation|13|||
105575171|NCT00195715|364104428|FG000|Overall Study|Lack of Efficacy|93|||
105575172|NCT00195715|364104428|FG000|Overall Study|Pregnancy|14|||
105575173|NCT00195715|364104428|FG000|Overall Study|Investigative site closure|8|||
105575174|NCT00195715|364104428|FG000|Overall Study|Subject moved/relocated|7|||
105575175|NCT00195715|364104428|FG000|Overall Study|Subject non-compliance|6|||
105575176|NCT00195715|364104428|FG000|Overall Study|Subject started commercial Humira|5|||
105575177|NCT00195715|364104428|FG000|Overall Study|Subject choice|3|||
105575178|NCT00195715|364104428|FG000|Overall Study|Loss of response/no improvement|3|||
105575179|NCT00195715|364104428|FG000|Overall Study|Sponsor stopped study|1|||
105575180|NCT00195715|364104428|FG000|Overall Study|Administrative reasons|2|||
105575181|NCT00195715|364104428|FG000|Overall Study|Investigator's decision|2|||
105575182|NCT00195715|364104428|FG000|Overall Study|Subject wants to get pregnant|4|||
105575183|NCT00195715|364104428|FG000|Overall Study|Use of prohibited medication|2|||
105575184|NCT00195715|364104428|FG000|Overall Study|Planned surgery|2|||
105575185|NCT00195715|364104428|FG000|Overall Study|Increased infection rate|1|||
105575186|NCT00195715|364104428|FG000|Overall Study|Ineligible|1|||
105575187|NCT00195715|364104428|FG000|Overall Study|Colonic stricture|1|||
105575188|NCT00195715|364104428|FG000|Overall Study|Sponsor discontinued trial|1|||
105575189|NCT00195715|364104428|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
105575190|NCT05822921|364104431|FG000|Overall Study|Lost to Follow-up|1|||
105575191|NCT05822921|364104432|FG001|Overall Study|Lost to Follow-up|1|||
105575192|NCT03406702|364104433|FG000|Overall Study|Missed Day 27 Dosing|1|||
105575193|NCT00845871|364104438|FG000|Assessment Period|Adverse Event|2|||
105575194|NCT00845871|364104438|FG000|Assessment Period|Abnormal laboratory values|1|||
105575195|NCT00845871|364104438|FG000|Assessment Period|Abnormal test procedure results|1|||
105575196|NCT00845871|364104438|FG000|Assessment Period|Patient withdrew consent|3|||
105575197|NCT01857622|364104439|FG000|Overall Study|Adverse Event|5|||
105575198|NCT01857622|364104440|FG001|Overall Study|Adverse Event|0|||
105575199|NCT01857622|364104441|FG002|Overall Study|Adverse Event|2|||
105575200|NCT01857622|364104439|FG000|Overall Study|Physician Decision|1|||
105575201|NCT01857622|364104440|FG001|Overall Study|Physician Decision|0|||
105575202|NCT01857622|364104441|FG002|Overall Study|Physician Decision|0|||
105575203|NCT01857622|364104439|FG000|Overall Study|Protocol Violation|4|||
105575204|NCT01857622|364104440|FG001|Overall Study|Protocol Violation|1|||
105575205|NCT01857622|364104441|FG002|Overall Study|Protocol Violation|0|||
105575206|NCT01857622|364104439|FG000|Overall Study|Withdrawal by Subject|1|||
105575207|NCT01857622|364104440|FG001|Overall Study|Withdrawal by Subject|0|||
105575208|NCT01857622|364104441|FG002|Overall Study|Withdrawal by Subject|0|||
105575209|NCT01267253|364104444|FG000|Overall Study|Ineligible - required test not done|1|||
105575210|NCT01267253|364104444|FG000|Overall Study|Inevaluable-never received study treatme|2|||
105575211|NCT04318093|364104445|FG000|Overall Study|Adverse Event|2|||
105575212|NCT04318093|364104446|FG001|Overall Study|Adverse Event|2|||
105575213|NCT04318093|364104445|FG000|Overall Study|Participant withdrew consent|1|||
105575214|NCT04318093|364104446|FG001|Overall Study|Participant withdrew consent|0|||
105575215|NCT04318093|364104445|FG000|Overall Study|Other reasons|0|||
105575216|NCT04318093|364104446|FG001|Overall Study|Other reasons|1|||
105575217|NCT02998021|364104447|FG000|Overall Study|Withdrawal by Subject|3|||
105575218|NCT02998021|364104448|FG001|Overall Study|Withdrawal by Subject|1|||
105575219|NCT02998021|364104447|FG000|Overall Study|unsafe home|0|||
105307716|NCT04994483|363125163|FG000|Overall Study|Noncompliance with study drug|8|||
105488968|NCT01306877|363802019|FG001|Overall Study|Lost to Follow-up|3|||
105488969|NCT01306877|363802018|FG000|Overall Study|Physician Decision|0|||
105575220|NCT02998021|364104448|FG001|Overall Study|unsafe home|1|||
105575221|NCT00514046|364104449|FG000|Overall Study|transferred to another protocol|2|||
105575222|NCT00514046|364104450|FG001|Overall Study|transferred to another protocol|1|||
105575223|NCT00514046|364104451|FG002|Overall Study|transferred to another protocol|3|||
105575224|NCT00514046|364104452|FG003|Overall Study|transferred to another protocol|0|||
105575225|NCT00514046|364104453|FG004|Overall Study|transferred to another protocol|1|||
105575226|NCT00514046|364104454|FG005|Overall Study|transferred to another protocol|0|||
105575227|NCT00514046|364104455|FG006|Overall Study|transferred to another protocol|0|||
105575228|NCT00514046|364104456|FG007|Overall Study|transferred to another protocol|0|||
105575229|NCT00514046|364104457|FG008|Overall Study|transferred to another protocol|0|||
105575230|NCT00514046|364104449|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
105575231|NCT00514046|364104450|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
105575232|NCT00514046|364104451|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
105575233|NCT00514046|364104452|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
105575234|NCT00514046|364104453|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
105575235|NCT00514046|364104454|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
105575236|NCT00514046|364104455|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
105575237|NCT00514046|364104456|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
105575238|NCT00514046|364104457|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
105575239|NCT00514046|364104449|FG000|Overall Study|Disease progression on study|0|||
105575240|NCT00514046|364104450|FG001|Overall Study|Disease progression on study|0|||
105575241|NCT00514046|364104451|FG002|Overall Study|Disease progression on study|2|||
105575242|NCT00514046|364104452|FG003|Overall Study|Disease progression on study|0|||
105575243|NCT00514046|364104453|FG004|Overall Study|Disease progression on study|0|||
105575244|NCT00514046|364104454|FG005|Overall Study|Disease progression on study|1|||
105575245|NCT00514046|364104455|FG006|Overall Study|Disease progression on study|0|||
105575246|NCT00514046|364104456|FG007|Overall Study|Disease progression on study|0|||
105575247|NCT00514046|364104457|FG008|Overall Study|Disease progression on study|0|||
105575248|NCT00655551|364104458|FG000|All Periods Combined|Adverse Event|0|||
105575249|NCT00655551|364104459|FG001|All Periods Combined|Adverse Event|3|||
105575250|NCT00655551|364104460|FG002|All Periods Combined|Adverse Event|4|||
105575251|NCT00655551|364104458|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
105575252|NCT00655551|364104459|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
105575253|NCT00655551|364104460|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
105575254|NCT00655551|364104458|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
105575255|NCT00655551|364104459|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
105575256|NCT00655551|364104460|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
105575257|NCT00655551|364104458|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
105575258|NCT00655551|364104459|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
105575259|NCT00655551|364104460|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
105575260|NCT00309608|364104470|FG000|Overall Study|Adverse Event|1|||
105575261|NCT00309608|364104471|FG001|Overall Study|Adverse Event|5|||
105575262|NCT00309608|364104472|FG002|Overall Study|Adverse Event|3|||
105575263|NCT00309608|364104473|FG003|Overall Study|Adverse Event|2|||
105575264|NCT00309608|364104474|FG004|Overall Study|Adverse Event|3|||
105575265|NCT00309608|364104470|FG000|Overall Study|Protocol Violation|2|||
105575266|NCT00309608|364104471|FG001|Overall Study|Protocol Violation|0|||
105575267|NCT00309608|364104472|FG002|Overall Study|Protocol Violation|0|||
105575268|NCT00309608|364104473|FG003|Overall Study|Protocol Violation|0|||
105575269|NCT00309608|364104474|FG004|Overall Study|Protocol Violation|0|||
105575270|NCT00309608|364104470|FG000|Overall Study|Lost to Follow-up|0|||
105575271|NCT00309608|364104471|FG001|Overall Study|Lost to Follow-up|0|||
105575272|NCT00309608|364104472|FG002|Overall Study|Lost to Follow-up|2|||
105575273|NCT00309608|364104473|FG003|Overall Study|Lost to Follow-up|0|||
105575274|NCT00309608|364104474|FG004|Overall Study|Lost to Follow-up|1|||
105575275|NCT00309608|364104470|FG000|Overall Study|Withdrawal by Subject|1|||
105575276|NCT00309608|364104471|FG001|Overall Study|Withdrawal by Subject|4|||
105575277|NCT00309608|364104472|FG002|Overall Study|Withdrawal by Subject|2|||
105575278|NCT00309608|364104473|FG003|Overall Study|Withdrawal by Subject|0|||
105575279|NCT00309608|364104474|FG004|Overall Study|Withdrawal by Subject|0|||
105575280|NCT00309608|364104470|FG000|Overall Study|Other incl. Lack of efficacy|10|||
105575281|NCT00309608|364104471|FG001|Overall Study|Other incl. Lack of efficacy|4|||
105575282|NCT00309608|364104472|FG002|Overall Study|Other incl. Lack of efficacy|3|||
105575283|NCT00309608|364104473|FG003|Overall Study|Other incl. Lack of efficacy|4|||
105575284|NCT00309608|364104474|FG004|Overall Study|Other incl. Lack of efficacy|0|||
105575285|NCT01051063|364104475|FG000|Overall Study|Death|2|||
105575286|NCT01051063|364104476|FG001|Overall Study|Death|2|||
105575287|NCT01051063|364104475|FG000|Overall Study|Withdrawal by Subject|1|||
105575288|NCT01051063|364104476|FG001|Overall Study|Withdrawal by Subject|1|||
105575289|NCT01051063|364104475|FG000|Overall Study|Termination of the study|5|||
105575290|NCT01051063|364104476|FG001|Overall Study|Termination of the study|0|||
105575291|NCT01051063|364104475|FG000|Overall Study|Moved from the study site area|1|||
105575292|NCT01051063|364104476|FG001|Overall Study|Moved from the study site area|0|||
105575293|NCT01051063|364104475|FG000|Overall Study|Other|1|||
105575294|NCT01051063|364104476|FG001|Overall Study|Other|0|||
105575295|NCT01051063|364104475|FG000|Overall Study|Lost to Follow-up|0|||
105575296|NCT01051063|364104476|FG001|Overall Study|Lost to Follow-up|1|||
105575297|NCT00547911|364104480|FG000|Overall Study|Adverse Event|0|||
105575298|NCT00547911|364104481|FG001|Overall Study|Adverse Event|0|||
105575299|NCT00547911|364104482|FG002|Overall Study|Adverse Event|0|||
105575300|NCT00547911|364104483|FG003|Overall Study|Adverse Event|1|||
105575301|NCT00547911|364104484|FG004|Overall Study|Adverse Event|0|||
105575302|NCT00547911|364104485|FG005|Overall Study|Adverse Event|0|||
105575303|NCT03872388|364104487|FG000|Overall Study|Disease Progression|0|||
105575304|NCT03872388|364104488|FG001|Overall Study|Disease Progression|0|||
105575305|NCT03872388|364104489|FG002|Overall Study|Disease Progression|0|||
105575306|NCT03872388|364104490|FG003|Overall Study|Disease Progression|0|||
105575307|NCT03872388|364104491|FG004|Overall Study|Disease Progression|0|||
105575308|NCT03872388|364104492|FG005|Overall Study|Disease Progression|0|||
105575309|NCT03872388|364104493|FG006|Overall Study|Disease Progression|1|||
105575310|NCT03872388|364104494|FG007|Overall Study|Disease Progression|1|||
105575311|NCT01282476|364106113|FG000|Overall Study|Death|11|||
105575312|NCT00437125|364106116|FG000|Overall Study|Adverse Event|12|||
105575313|NCT00437125|364106116|FG000|Overall Study|Death|1|||
105575314|NCT00437125|364106116|FG000|Overall Study|Clinical Relapse|1|||
105575315|NCT00437125|364106116|FG000|Overall Study|Lack of Efficacy|1|||
105575316|NCT00437125|364106116|FG000|Overall Study|Lost to Follow-up|1|||
105575317|NCT00437125|364106116|FG000|Overall Study|Withdrawal by Subject|13|||
105575318|NCT00437125|364106116|FG000|Overall Study|Withdrawal by Caregiver|2|||
105575319|NCT00437125|364106116|FG000|Overall Study|Physician Decision|1|||
105575320|NCT00871351|364106123|FG000|Overall Study|Withdrawal by Subject|1|||
105575321|NCT00871351|364106124|FG001|Overall Study|Withdrawal by Subject|0|||
105575322|NCT00871351|364106125|FG002|Overall Study|Withdrawal by Subject|0|||
105575323|NCT00871351|364106123|FG000|Overall Study|Adverse Event|3|||
105575324|NCT00871351|364106124|FG001|Overall Study|Adverse Event|1|||
105575325|NCT00871351|364106125|FG002|Overall Study|Adverse Event|0|||
105575326|NCT02032173|364106128|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
105575327|NCT01912222|364106151|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
105575328|NCT01912222|364106152|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
105575329|NCT01912222|364106153|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
105575330|NCT01912222|364106151|FG000|Part B: Treatment Period|Progressive disease|10|||
105575331|NCT01912222|364106152|FG001|Part B: Treatment Period|Progressive disease|12|||
105827329|NCT00205777|365026434|FG004|Study Extension I|Other Event|29|||
105827330|NCT00205777|365026435|FG005|Study Extension I|Other Event|0|||
105366469|NCT00744939|363348403|FG000|Overall Study|Medical history exclusionary|1|||
105366470|NCT00744939|363348403|FG000|Overall Study|Did not receive Magnevist|7|||
105488970|NCT01306877|363802019|FG001|Overall Study|Physician Decision|1|||
105366471|NCT00744939|363348403|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
105488971|NCT03523000|363802020|FG000|Overall Study|Withdrawal by Subject|3|||
105488972|NCT03523000|363802021|FG001|Overall Study|Withdrawal by Subject|0|||
105488973|NCT03523000|363802020|FG000|Overall Study|Unsuccessful trial|2|||
105488974|NCT03523000|363802021|FG001|Overall Study|Unsuccessful trial|0|||
105488975|NCT02862600|363802027|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
105488976|NCT02862600|363802027|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
105488977|NCT02862600|363802027|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
105488978|NCT02862600|363802027|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
105488979|NCT04650854|363802028|FG000|Overall Study|Adverse Event|1|||
105488980|NCT04650854|363802029|FG001|Overall Study|Adverse Event|12|||
105488981|NCT04650854|363802030|FG002|Overall Study|Adverse Event|14|||
105488982|NCT04650854|363802028|FG000|Overall Study|Lack of Efficacy|1|||
105488983|NCT04650854|363802029|FG001|Overall Study|Lack of Efficacy|3|||
105488984|NCT04650854|363802030|FG002|Overall Study|Lack of Efficacy|6|||
105488985|NCT04650854|363802028|FG000|Overall Study|Lost to Follow-up|1|||
105488986|NCT04650854|363802029|FG001|Overall Study|Lost to Follow-up|1|||
105488987|NCT04650854|363802030|FG002|Overall Study|Lost to Follow-up|0|||
105488988|NCT04650854|363802028|FG000|Overall Study|Withdrawal by Subject|2|||
105488989|NCT04650854|363802029|FG001|Overall Study|Withdrawal by Subject|17|||
105488990|NCT04650854|363802030|FG002|Overall Study|Withdrawal by Subject|9|||
105488991|NCT04650854|363802028|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
105488992|NCT04650854|363802029|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
105488993|NCT04650854|363802030|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
105488994|NCT04650854|363802028|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
105488995|NCT04650854|363802029|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
105488996|NCT04650854|363802030|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
105488997|NCT04650854|363802028|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
105488998|NCT04650854|363802029|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
105488999|NCT04650854|363802030|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
105489000|NCT04650854|363802028|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
105489001|NCT04650854|363802029|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
105489002|NCT04650854|363802030|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
105489003|NCT04650854|363802028|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
105489004|NCT04650854|363802029|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
105489005|NCT04650854|363802030|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
105489006|NCT04650854|363802028|FG000|Overall Study|Use of Rescue Medication|0|||
105489007|NCT04650854|363802029|FG001|Overall Study|Use of Rescue Medication|0|||
105489008|NCT04650854|363802030|FG002|Overall Study|Use of Rescue Medication|1|||
105489009|NCT04650854|363802028|FG000|Overall Study|Last Treatment Per Sponsor|0|||
105366472|NCT00744939|363348403|FG000|Overall Study|coma|1|||
105366473|NCT00744939|363348403|FG000|Overall Study|incorrect race|1|||
105366474|NCT03102762|363348405|FG000|Overall Study|Lost to Follow-up|1|||
105366475|NCT03102762|363348406|FG001|Overall Study|Lost to Follow-up|0|||
105575332|NCT01912222|364106153|FG002|Part B: Treatment Period|Progressive disease|15|||
105575333|NCT01912222|364106151|FG000|Part B: Treatment Period|Adverse Event|1|||
105575334|NCT01912222|364106152|FG001|Part B: Treatment Period|Adverse Event|2|||
105575335|NCT01912222|364106153|FG002|Part B: Treatment Period|Adverse Event|3|||
105575336|NCT01912222|364106151|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
105575337|NCT01912222|364106152|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
105575338|NCT01912222|364106153|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
105575339|NCT01912781|364106155|FG000|Overall Study|Withdrawal by Subject|2|||
105575340|NCT01912781|364106156|FG001|Overall Study|Withdrawal by Subject|0|||
105575341|NCT03377790|364106157|FG000|Overall Study|Withdrawal by Subject|1|||
105575342|NCT03377790|364106158|FG001|Overall Study|Withdrawal by Subject|0|||
105575343|NCT03377790|364106157|FG000|Overall Study|Adverse Event|1|||
105575344|NCT03377790|364106158|FG001|Overall Study|Adverse Event|0|||
105575345|NCT03377790|364106157|FG000|Overall Study|Lost to Follow-up|0|||
105575346|NCT03377790|364106158|FG001|Overall Study|Lost to Follow-up|2|||
105575347|NCT03377790|364106157|FG000|Overall Study|Randomized but not treated|1|||
105575348|NCT03377790|364106158|FG001|Overall Study|Randomized but not treated|0|||
105575349|NCT03377790|364106157|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
105575350|NCT03377790|364106158|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
105575351|NCT00854295|364106159|FG000|Overall Study|Death|7|||
105575352|NCT00854295|364106160|FG001|Overall Study|Death|0|||
105575353|NCT00854295|364106161|FG002|Overall Study|Death|1|||
105575354|NCT00854295|364106162|FG003|Overall Study|Death|1|||
105575355|NCT00854295|364106159|FG000|Overall Study|Adverse Event|6|||
105575356|NCT00854295|364106160|FG001|Overall Study|Adverse Event|1|||
105575357|NCT00854295|364106161|FG002|Overall Study|Adverse Event|1|||
105575358|NCT00854295|364106162|FG003|Overall Study|Adverse Event|3|||
105575359|NCT00854295|364106159|FG000|Overall Study|Lost to Follow-up|18|||
105575360|NCT00854295|364106160|FG001|Overall Study|Lost to Follow-up|5|||
105575361|NCT00854295|364106161|FG002|Overall Study|Lost to Follow-up|21|||
105575362|NCT00854295|364106162|FG003|Overall Study|Lost to Follow-up|21|||
105575363|NCT00854295|364106159|FG000|Overall Study|Physician Decision|10|||
105575364|NCT00854295|364106160|FG001|Overall Study|Physician Decision|0|||
105575365|NCT00854295|364106161|FG002|Overall Study|Physician Decision|0|||
105575366|NCT00854295|364106162|FG003|Overall Study|Physician Decision|0|||
105575367|NCT03154359|364106164|FG000|Overall Study|Adverse Event|1|||
105575368|NCT03154359|364106164|FG000|Overall Study|Lack of Efficacy|2|||
105575369|NCT03154359|364106164|FG000|Overall Study|Lost to Follow-up|3|||
105575370|NCT03154359|364106164|FG000|Overall Study|Physician Decision|3|||
105575371|NCT03154359|364106164|FG000|Overall Study|Protocol Violation|4|||
105575372|NCT03154359|364106164|FG000|Overall Study|Withdrawal by Subject|5|||
105575373|NCT03154359|364106164|FG000|Overall Study|Disruption of study due to COVID-19|4|||
105575374|NCT00467142|364106166|FG000|Overall Study|Withdrawal by Subject|1|||
105575375|NCT00467142|364106166|FG000|Overall Study|Adverse Event|1|||
105575376|NCT00467142|364106166|FG000|Overall Study|Protocol Violation|1|||
105575377|NCT02091739|364106168|FG000|MP: 16 Weeks|Adverse Event|1|||
105575378|NCT02091739|364106169|FG001|MP: 16 Weeks|Adverse Event|1|||
105575379|NCT02091739|364106170|FG002|MP: 16 Weeks|Adverse Event|1|||
105575380|NCT02091739|364106171|FG003|MP: 16 Weeks|Adverse Event|0|||
105575381|NCT02091739|364106172|FG004|MP: 16 Weeks|Adverse Event|0|||
105575382|NCT02091739|364106168|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
105575383|NCT02091739|364106169|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
105575384|NCT02091739|364106170|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
105575385|NCT02091739|364106171|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
105575386|NCT02091739|364106172|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
105575387|NCT02091739|364106168|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
105575388|NCT02091739|364106169|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
105366476|NCT02495389|363348410|FG000|Overall Study|Withdrawal by Subject|40|||
105366477|NCT01867008|363348413|FG000|Overall Study|Withdrawal by Subject|1|||
105575389|NCT02091739|364106170|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
105575390|NCT02091739|364106171|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
105575391|NCT02091739|364106172|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
105366478|NCT00338741|363348418|FG000|Overall Study|Lost to Follow-up|2|||
105366479|NCT00338741|363348419|FG001|Overall Study|Lost to Follow-up|0|||
105575392|NCT02091739|364106168|FG000|EP: 48 Weeks|Other|0|||
105575393|NCT02091739|364106169|FG001|EP: 48 Weeks|Other|0|||
105575394|NCT02091739|364106170|FG002|EP: 48 Weeks|Other|0|||
105575395|NCT02091739|364106171|FG003|EP: 48 Weeks|Other|1|||
105575396|NCT02091739|364106172|FG004|EP: 48 Weeks|Other|0|||
105575397|NCT02091739|364106168|FG000|EP: 48 Weeks|Death|0|||
105575398|NCT02091739|364106169|FG001|EP: 48 Weeks|Death|0|||
105575399|NCT02091739|364106170|FG002|EP: 48 Weeks|Death|0|||
105575400|NCT02091739|364106171|FG003|EP: 48 Weeks|Death|3|||
105575401|NCT02091739|364106172|FG004|EP: 48 Weeks|Death|2|||
105575402|NCT02091739|364106168|FG000|EP: 48 Weeks|Adverse Event|0|||
105575403|NCT02091739|364106169|FG001|EP: 48 Weeks|Adverse Event|0|||
105827331|NCT00205777|365026430|FG000|Study Extension I|Withdrawn as per protocol|0|||
105827332|NCT00205777|365026431|FG001|Study Extension I|Withdrawn as per protocol|0|||
105827333|NCT00205777|365026432|FG002|Study Extension I|Withdrawn as per protocol|1070|||
105827334|NCT00205777|365026433|FG003|Study Extension I|Withdrawn as per protocol|0|||
105827335|NCT00205777|365026434|FG004|Study Extension I|Withdrawn as per protocol|0|||
105827336|NCT00205777|365026435|FG005|Study Extension I|Withdrawn as per protocol|0|||
105827337|NCT00205777|365026430|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
105827338|NCT00205777|365026431|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
105827339|NCT00205777|365026432|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
105827340|NCT00205777|365026433|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
105575404|NCT02091739|364106170|FG002|EP: 48 Weeks|Adverse Event|0|||
105575405|NCT02091739|364106171|FG003|EP: 48 Weeks|Adverse Event|2|||
105575406|NCT02091739|364106172|FG004|EP: 48 Weeks|Adverse Event|6|||
105575407|NCT02091739|364106168|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
105575408|NCT02091739|364106169|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
105575409|NCT02091739|364106170|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
105575410|NCT02091739|364106171|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
105575411|NCT02091739|364106172|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
105575412|NCT02823964|364106177|FG000|Overall Study|Adverse Event|2|||
105575413|NCT02823964|364106177|FG000|Overall Study|Physician Decision|1|||
105575414|NCT02823964|364106177|FG000|Overall Study|Lack of Efficacy|1|||
105575415|NCT02823964|364106177|FG000|Overall Study|Withdrawal by Subject|1|||
105575416|NCT01275196|364106183|FG000|Overall Study|Adverse Event|3|||
105575417|NCT01275196|364106184|FG001|Overall Study|Adverse Event|5|||
105575418|NCT01275196|364106183|FG000|Overall Study|Withdrawal by Subject|4|||
105575419|NCT01275196|364106184|FG001|Overall Study|Withdrawal by Subject|5|||
105575420|NCT01275196|364106183|FG000|Overall Study|Lost to Follow-up|1|||
105575421|NCT01275196|364106184|FG001|Overall Study|Lost to Follow-up|0|||
105575422|NCT01275196|364106183|FG000|Overall Study|Disease Progression|6|||
105575423|NCT01275196|364106184|FG001|Overall Study|Disease Progression|5|||
105575424|NCT01275196|364106183|FG000|Overall Study|Protocol Violation|1|||
105575425|NCT01275196|364106184|FG001|Overall Study|Protocol Violation|0|||
105575426|NCT01275196|364106183|FG000|Overall Study|Suboptimal response/treatment failure|5|||
105575427|NCT01275196|364106184|FG001|Overall Study|Suboptimal response/treatment failure|6|||
105575428|NCT01827254|364106185|FG000|Overall Study|Death|10|||
105575429|NCT01827254|364106185|FG000|Overall Study|Case report form not completed|4|||
105575430|NCT01827254|364106185|FG000|Overall Study|Invalidated centre|3|||
105575431|NCT01827254|364106185|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
105827341|NCT00205777|365026434|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
105575432|NCT01827254|364106185|FG000|Overall Study|Did not complete re-challenge|1|||
105575433|NCT01827254|364106185|FG000|Overall Study|Disease progression|36|||
105827342|NCT00205777|365026435|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
105827343|NCT00205777|365026430|FG000|Study Extension II|Adverse Event|0|||
105827344|NCT00205777|365026431|FG001|Study Extension II|Adverse Event|0|||
105827345|NCT00205777|365026432|FG002|Study Extension II|Adverse Event|0|||
105827346|NCT00205777|365026433|FG003|Study Extension II|Adverse Event|14|||
105827347|NCT00205777|365026434|FG004|Study Extension II|Adverse Event|0|||
105827348|NCT00205777|365026435|FG005|Study Extension II|Adverse Event|30|||
105827349|NCT00205777|365026430|FG000|Study Extension II|Death|0|||
105827350|NCT00205777|365026431|FG001|Study Extension II|Death|0|||
105827351|NCT00205777|365026432|FG002|Study Extension II|Death|0|||
105827352|NCT00205777|365026433|FG003|Study Extension II|Death|2|||
105827353|NCT00205777|365026434|FG004|Study Extension II|Death|0|||
105827354|NCT00205777|365026435|FG005|Study Extension II|Death|5|||
105827355|NCT00205777|365026430|FG000|Study Extension II|Withdrawal by Subject|0|||
105827356|NCT00205777|365026431|FG001|Study Extension II|Withdrawal by Subject|0|||
105827357|NCT00205777|365026432|FG002|Study Extension II|Withdrawal by Subject|0|||
105827358|NCT00205777|365026433|FG003|Study Extension II|Withdrawal by Subject|35|||
105827359|NCT00205777|365026434|FG004|Study Extension II|Withdrawal by Subject|0|||
105575434|NCT01827254|364106185|FG000|Overall Study|Intolerance to treatment|4|||
105827360|NCT00205777|365026435|FG005|Study Extension II|Withdrawal by Subject|59|||
105827361|NCT00205777|365026430|FG000|Study Extension II|Protocol Violation|0|||
105827362|NCT00205777|365026431|FG001|Study Extension II|Protocol Violation|0|||
105827363|NCT00205777|365026432|FG002|Study Extension II|Protocol Violation|0|||
105827364|NCT00205777|365026433|FG003|Study Extension II|Protocol Violation|1|||
105827365|NCT00205777|365026434|FG004|Study Extension II|Protocol Violation|0|||
105827366|NCT00205777|365026435|FG005|Study Extension II|Protocol Violation|10|||
105307717|NCT04994483|363125164|FG001|Overall Study|Noncompliance with study drug|5|||
105307718|NCT04994483|363125163|FG000|Overall Study|Physician Decision|5|||
105575435|NCT02222896|364106193|FG000|Abdomen|Did not qualify|34|||
105575436|NCT02222896|364106194|FG001|Abdomen|Did not qualify|10|||
105575437|NCT02222896|364106195|FG002|Abdomen|Did not qualify|32|||
105575438|NCT02222896|364106193|FG000|Groin|Did not qualify|43|||
105575439|NCT02222896|364106194|FG001|Groin|Did not qualify|9|||
105575440|NCT02222896|364106195|FG002|Groin|Did not qualify|40|||
105307719|NCT04994483|363125164|FG001|Overall Study|Physician Decision|0|||
105307720|NCT04994483|363125163|FG000|Overall Study|Withdrawal by Subject|41|||
105307721|NCT04994483|363125164|FG001|Overall Study|Withdrawal by Subject|38|||
105307722|NCT04994483|363125163|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
105307723|NCT04994483|363125164|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
105307724|NCT04994483|363125163|FG000|Overall Study|Met stopping criteria|1|||
105307725|NCT04994483|363125164|FG001|Overall Study|Met stopping criteria|0|||
105307726|NCT04994483|363125163|FG000|Overall Study|Randomized in error, not treated|4|||
105307727|NCT04994483|363125164|FG001|Overall Study|Randomized in error, not treated|3|||
105307728|NCT04994483|363125163|FG000|Overall Study|Lack of a reliable study partner|0|||
105307729|NCT04994483|363125164|FG001|Overall Study|Lack of a reliable study partner|1|||
105307730|NCT04994483|363125163|FG000|Overall Study|Met MRI exclusion criteria|0|||
105307731|NCT04994483|363125164|FG001|Overall Study|Met MRI exclusion criteria|1|||
105827367|NCT00205777|365026430|FG000|Study Extension II|Lack of Efficacy|0|||
105827368|NCT00205777|365026431|FG001|Study Extension II|Lack of Efficacy|0|||
105827369|NCT00205777|365026432|FG002|Study Extension II|Lack of Efficacy|0|||
105827370|NCT00205777|365026433|FG003|Study Extension II|Lack of Efficacy|0|||
105827371|NCT00205777|365026434|FG004|Study Extension II|Lack of Efficacy|0|||
105827372|NCT00205777|365026435|FG005|Study Extension II|Lack of Efficacy|1|||
105827373|NCT00205777|365026430|FG000|Study Extension II|Failed to return|0|||
105827374|NCT00205777|365026431|FG001|Study Extension II|Failed to return|0|||
105827375|NCT00205777|365026432|FG002|Study Extension II|Failed to return|0|||
105827376|NCT00205777|365026433|FG003|Study Extension II|Failed to return|14|||
105827377|NCT00205777|365026434|FG004|Study Extension II|Failed to return|0|||
105827378|NCT00205777|365026435|FG005|Study Extension II|Failed to return|26|||
105827379|NCT00205777|365026430|FG000|Study Extension II|Other Event|0|||
105827380|NCT00205777|365026431|FG001|Study Extension II|Other Event|0|||
105827381|NCT00205777|365026432|FG002|Study Extension II|Other Event|0|||
105575441|NCT01844115|364106197|FG000|Overall Study|Adverse Event|4|||
105575442|NCT01844115|364106198|FG001|Overall Study|Adverse Event|22|||
105575443|NCT01844115|364106197|FG000|Overall Study|Lack of Efficacy|1|||
105575444|NCT01844115|364106198|FG001|Overall Study|Lack of Efficacy|4|||
105575445|NCT01844115|364106197|FG000|Overall Study|Protocol Violation|12|||
105575446|NCT01844115|364106198|FG001|Overall Study|Protocol Violation|10|||
105575447|NCT01844115|364106197|FG000|Overall Study|Withdrawal by Subject|11|||
105575448|NCT01844115|364106198|FG001|Overall Study|Withdrawal by Subject|11|||
105575449|NCT01844115|364106197|FG000|Overall Study|Lost to Follow-up|11|||
105575450|NCT01844115|364106198|FG001|Overall Study|Lost to Follow-up|10|||
105575451|NCT01844115|364106197|FG000|Overall Study|Pregnancy|0|||
105575452|NCT01844115|364106198|FG001|Overall Study|Pregnancy|1|||
105575453|NCT00366301|364106199|FG000|Overall Study|Lost to Follow-up|4|||
105575454|NCT00366301|364106200|FG001|Overall Study|Lost to Follow-up|4|||
105575455|NCT00366301|364106201|FG002|Overall Study|Lost to Follow-up|3|||
105575456|NCT00366301|364106202|FG003|Overall Study|Lost to Follow-up|7|||
105575457|NCT00366301|364106199|FG000|Overall Study|Withdrawal by Subject|4|||
105575458|NCT00366301|364106200|FG001|Overall Study|Withdrawal by Subject|2|||
105575459|NCT00366301|364106201|FG002|Overall Study|Withdrawal by Subject|1|||
105575460|NCT00366301|364106202|FG003|Overall Study|Withdrawal by Subject|1|||
105575461|NCT01372605|364106203|FG000|Overall Study|Death|1|||
105575462|NCT01372605|364106204|FG001|Overall Study|Death|2|||
105575463|NCT01372605|364106203|FG000|Overall Study|Lost to Follow-up|2|||
105575464|NCT01372605|364106204|FG001|Overall Study|Lost to Follow-up|1|||
105575465|NCT01372605|364106203|FG000|Overall Study|Withdrawal by Subject|4|||
105575466|NCT01372605|364106204|FG001|Overall Study|Withdrawal by Subject|7|||
105575467|NCT01372605|364106203|FG000|Overall Study|Moved|3|||
105575468|NCT01372605|364106204|FG001|Overall Study|Moved|0|||
105575469|NCT01372605|364106203|FG000|Overall Study|Changed medical home|2|||
105827382|NCT00205777|365026433|FG003|Study Extension II|Other Event|12|||
105827383|NCT00205777|365026434|FG004|Study Extension II|Other Event|0|||
105827384|NCT00205777|365026435|FG005|Study Extension II|Other Event|20|||
105827385|NCT00205777|365026430|FG000|Study Extension II|Enrolled but not treated|0|||
105827386|NCT00205777|365026431|FG001|Study Extension II|Enrolled but not treated|0|||
105827387|NCT00205777|365026432|FG002|Study Extension II|Enrolled but not treated|0|||
105827388|NCT00205777|365026433|FG003|Study Extension II|Enrolled but not treated|71|||
105307732|NCT03283319|363125170|FG000|Overall Study|Lost to Follow-up|5|||
105307733|NCT03283319|363125171|FG001|Overall Study|Lost to Follow-up|4|||
105307734|NCT03283319|363125172|FG002|Overall Study|Lost to Follow-up|5|||
105827389|NCT00205777|365026434|FG004|Study Extension II|Enrolled but not treated|0|||
105307735|NCT03283319|363125173|FG003|Overall Study|Lost to Follow-up|5|||
105307736|NCT03283319|363125174|FG004|Overall Study|Lost to Follow-up|4|||
105575470|NCT01372605|364106204|FG001|Overall Study|Changed medical home|0|||
105575471|NCT02796963|364106208|FG000|Overall Study|Lost to Follow-up|89|||
105575472|NCT02796963|364106209|FG001|Overall Study|Lost to Follow-up|76|||
105575473|NCT02796963|364106210|FG002|Overall Study|Lost to Follow-up|69|||
105575474|NCT02796963|364106211|FG003|Overall Study|Lost to Follow-up|72|||
105575475|NCT00951509|364106212|FG000|Overall Study|Withdrawal by Subject|2|||
105575476|NCT01751113|364106213|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
105307737|NCT03283319|363125175|FG005|Overall Study|Lost to Follow-up|3|||
105307738|NCT03283319|363125170|FG000|Overall Study|Withdrawal by Subject|2|||
105307739|NCT03283319|363125171|FG001|Overall Study|Withdrawal by Subject|2|||
105307740|NCT03283319|363125172|FG002|Overall Study|Withdrawal by Subject|2|||
105307741|NCT03283319|363125173|FG003|Overall Study|Withdrawal by Subject|1|||
105307742|NCT03283319|363125174|FG004|Overall Study|Withdrawal by Subject|0|||
105307743|NCT03283319|363125175|FG005|Overall Study|Withdrawal by Subject|1|||
105307744|NCT03283319|363125170|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
105575477|NCT01751113|364106214|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
105575478|NCT01751113|364106215|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
105575479|NCT01751113|364106216|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
105575480|NCT01751113|364106217|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
105575481|NCT01751113|364106218|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
105575482|NCT01751113|364106213|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
105575483|NCT01751113|364106214|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
105575484|NCT01751113|364106215|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
105575485|NCT01751113|364106216|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
105575486|NCT01751113|364106217|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
105575487|NCT01751113|364106218|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
105575488|NCT05284019|364106220|FG000|Overall Study|Study terminated|2|||
105575489|NCT05284019|364106221|FG001|Overall Study|Study terminated|2|||
105575490|NCT05284019|364106222|FG002|Overall Study|Study terminated|2|||
105575491|NCT05284019|364106223|FG003|Overall Study|Study terminated|5|||
105575492|NCT05284019|364106224|FG004|Overall Study|Study terminated|15|||
105575493|NCT05284019|364106220|FG000|Overall Study|Withdrawal by Subject|0|||
105575494|NCT05284019|364106221|FG001|Overall Study|Withdrawal by Subject|0|||
105575495|NCT05284019|364106222|FG002|Overall Study|Withdrawal by Subject|0|||
105575496|NCT05284019|364106223|FG003|Overall Study|Withdrawal by Subject|1|||
105575497|NCT05284019|364106224|FG004|Overall Study|Withdrawal by Subject|1|||
105575498|NCT05284019|364106220|FG000|Overall Study|Lost to Follow-up|1|||
105575499|NCT05284019|364106221|FG001|Overall Study|Lost to Follow-up|0|||
105575500|NCT05284019|364106222|FG002|Overall Study|Lost to Follow-up|0|||
105575501|NCT05284019|364106223|FG003|Overall Study|Lost to Follow-up|2|||
105575502|NCT05284019|364106224|FG004|Overall Study|Lost to Follow-up|1|||
105575503|NCT02743793|364106225|FG000|Overall Study|Death|1|||
105575504|NCT02743793|364106226|FG001|Overall Study|Death|1|||
105575505|NCT02743793|364106225|FG000|Overall Study|Withdrawal by Subject|0|||
105575506|NCT02743793|364106226|FG001|Overall Study|Withdrawal by Subject|1|||
105575507|NCT02743793|364106225|FG000|Overall Study|Screen Failure|4|||
105575508|NCT02743793|364106226|FG001|Overall Study|Screen Failure|0|||
105575509|NCT02743793|364106225|FG000|Overall Study|No Primary Care Physician|0|||
105575510|NCT02743793|364106226|FG001|Overall Study|No Primary Care Physician|1|||
105575511|NCT02743793|364106225|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
105575512|NCT02743793|364106226|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
105575513|NCT02743793|364106225|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
105575514|NCT02743793|364106226|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
105575515|NCT01231503|364106227|FG000|Overall Study|Adverse Event|0|||
105575516|NCT01231503|364106228|FG001|Overall Study|Adverse Event|0|||
105575517|NCT01231503|364106229|FG002|Overall Study|Adverse Event|0|||
105575518|NCT01231503|364106230|FG003|Overall Study|Adverse Event|0|||
105575519|NCT01231503|364106231|FG004|Overall Study|Adverse Event|0|||
105575520|NCT01231503|364106232|FG005|Overall Study|Adverse Event|1|||
105575521|NCT01231503|364106233|FG006|Overall Study|Adverse Event|0|||
105575522|NCT01231503|364106234|FG007|Overall Study|Adverse Event|0|||
105575523|NCT01231503|364106227|FG000|Overall Study|Adverse event, serious fatal|0|||
105575524|NCT01231503|364106228|FG001|Overall Study|Adverse event, serious fatal|0|||
105575525|NCT01231503|364106229|FG002|Overall Study|Adverse event, serious fatal|1|||
105575526|NCT01231503|364106230|FG003|Overall Study|Adverse event, serious fatal|1|||
105575527|NCT01231503|364106231|FG004|Overall Study|Adverse event, serious fatal|0|||
105575528|NCT01231503|364106232|FG005|Overall Study|Adverse event, serious fatal|1|||
105575529|NCT01231503|364106233|FG006|Overall Study|Adverse event, serious fatal|0|||
105575530|NCT01231503|364106234|FG007|Overall Study|Adverse event, serious fatal|0|||
105575531|NCT01231503|364106227|FG000|Overall Study|Withdrawal by Subject|6|||
105307745|NCT03283319|363125171|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
105307746|NCT03283319|363125172|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
105307747|NCT03283319|363125173|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
105575532|NCT01231503|364106228|FG001|Overall Study|Withdrawal by Subject|3|||
105575533|NCT01231503|364106229|FG002|Overall Study|Withdrawal by Subject|3|||
105575534|NCT01231503|364106230|FG003|Overall Study|Withdrawal by Subject|1|||
105575535|NCT01231503|364106231|FG004|Overall Study|Withdrawal by Subject|3|||
105575536|NCT01231503|364106232|FG005|Overall Study|Withdrawal by Subject|5|||
105575537|NCT01231503|364106233|FG006|Overall Study|Withdrawal by Subject|1|||
105575538|NCT01231503|364106234|FG007|Overall Study|Withdrawal by Subject|2|||
105575539|NCT01231503|364106227|FG000|Overall Study|Lost to Follow-up|8|||
105489010|NCT04650854|363802029|FG001|Overall Study|Last Treatment Per Sponsor|0|||
105489011|NCT04650854|363802030|FG002|Overall Study|Last Treatment Per Sponsor|2|||
105489012|NCT04650854|363802028|FG000|Overall Study|Rescue Medication|0|||
105489013|NCT04650854|363802029|FG001|Overall Study|Rescue Medication|0|||
105489014|NCT04650854|363802030|FG002|Overall Study|Rescue Medication|1|||
105489015|NCT04650854|363802028|FG000|Overall Study|Participant Want to Start a Family|0|||
105489016|NCT04650854|363802029|FG001|Overall Study|Participant Want to Start a Family|0|||
105489017|NCT04650854|363802030|FG002|Overall Study|Participant Want to Start a Family|1|||
105489018|NCT04650854|363802028|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
105489019|NCT04650854|363802029|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
105489020|NCT04650854|363802030|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
105489021|NCT04650854|363802028|FG000|Overall Study|Participant Screened For MG0020|0|||
105489022|NCT04650854|363802029|FG001|Overall Study|Participant Screened For MG0020|2|||
105489023|NCT04650854|363802030|FG002|Overall Study|Participant Screened For MG0020|3|||
105489024|NCT04650854|363802028|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
105489025|NCT04650854|363802029|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
105489026|NCT04650854|363802030|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
105489027|NCT04650854|363802028|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
105489028|NCT04650854|363802029|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
105489029|NCT04650854|363802030|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
105489030|NCT04650854|363802028|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
105489031|NCT04650854|363802029|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
105489032|NCT04650854|363802030|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
105489033|NCT04650854|363802028|FG000|Overall Study|End Of Study|0|||
105489034|NCT04650854|363802029|FG001|Overall Study|End Of Study|2|||
105489035|NCT04650854|363802030|FG002|Overall Study|End Of Study|1|||
105489036|NCT04650854|363802028|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
105489037|NCT04650854|363802029|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
105489038|NCT04650854|363802030|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
105489039|NCT04650854|363802028|FG000|Overall Study|Participant Received Rescue Medication|0|||
105489040|NCT04650854|363802029|FG001|Overall Study|Participant Received Rescue Medication|1|||
105489041|NCT04650854|363802030|FG002|Overall Study|Participant Received Rescue Medication|0|||
105489042|NCT04650854|363802028|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
105489043|NCT04650854|363802029|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
105489044|NCT04650854|363802030|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
105489045|NCT04650854|363802028|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
105489046|NCT04650854|363802029|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
105489047|NCT04650854|363802030|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
105489048|NCT04650854|363802028|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
105489049|NCT04650854|363802029|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
105489050|NCT04650854|363802030|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
105489051|NCT04650854|363802028|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
105489052|NCT04650854|363802029|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
105489053|NCT04650854|363802030|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
105489054|NCT04650854|363802028|FG000|Overall Study|Enrollment Cup|0|||
105489055|NCT04650854|363802029|FG001|Overall Study|Enrollment Cup|0|||
105489056|NCT04650854|363802030|FG002|Overall Study|Enrollment Cup|1|||
105489057|NCT01574079|363802036|FG000|Overall Study|Physician Decision|0|||
105489058|NCT01574079|363802037|FG001|Overall Study|Physician Decision|2|||
105489059|NCT01574079|363802036|FG000|Overall Study|Lost to Follow-up|1|||
105489060|NCT01574079|363802037|FG001|Overall Study|Lost to Follow-up|0|||
105489061|NCT00625742|363803955|FG000|Overall Study|Disease Progression|2|||
105489062|NCT00625742|363803955|FG000|Overall Study|Withdrawal by Subject|1|||
105489063|NCT00625742|363803955|FG000|Overall Study|Adverse Event|4|||
105489064|NCT00625742|363803955|FG000|Overall Study|Lost to Follow-up|4|||
105489065|NCT00625742|363803955|FG000|Overall Study|Ineligible|1|||
105489066|NCT04050371|363803956|FG000|Overall Study|Withdrawal by Subject|1|||
105489067|NCT04050371|363803957|FG001|Overall Study|Withdrawal by Subject|0|||
105489068|NCT00301821|363803959|FG000|Overall Study|Ineligible|25|||
105489069|NCT00301821|363803959|FG000|Overall Study|Cancel|1|||
105489070|NCT00472459|363803962|FG000|Overall Study|Adverse Event|13|||
105489071|NCT00472459|363803963|FG001|Overall Study|Adverse Event|13|||
105489072|NCT00472459|363803962|FG000|Overall Study|Withdrawal by Subject|5|||
105489073|NCT00472459|363803963|FG001|Overall Study|Withdrawal by Subject|5|||
105489074|NCT00472459|363803962|FG000|Overall Study|Protocol Violation|3|||
105489075|NCT00472459|363803963|FG001|Overall Study|Protocol Violation|3|||
105489076|NCT00472459|363803962|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
105489077|NCT00472459|363803963|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
105489078|NCT00472459|363803962|FG000|Overall Study|Lost to Follow-up|1|||
105366480|NCT00570401|363348424|FG000|Overall Study|Adverse Event|2|||
105366481|NCT02849587|363348425|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
105575540|NCT01231503|364106228|FG001|Overall Study|Lost to Follow-up|10|||
105575541|NCT01231503|364106229|FG002|Overall Study|Lost to Follow-up|8|||
105575542|NCT01231503|364106230|FG003|Overall Study|Lost to Follow-up|5|||
105575543|NCT01231503|364106231|FG004|Overall Study|Lost to Follow-up|7|||
105575544|NCT01231503|364106232|FG005|Overall Study|Lost to Follow-up|9|||
105575545|NCT01231503|364106233|FG006|Overall Study|Lost to Follow-up|6|||
105575546|NCT01231503|364106234|FG007|Overall Study|Lost to Follow-up|6|||
105575547|NCT01231503|364106227|FG000|Overall Study|Protocol Violation|0|||
105575548|NCT01231503|364106228|FG001|Overall Study|Protocol Violation|0|||
105575549|NCT01231503|364106229|FG002|Overall Study|Protocol Violation|0|||
105575550|NCT01231503|364106230|FG003|Overall Study|Protocol Violation|1|||
105575551|NCT01231503|364106231|FG004|Overall Study|Protocol Violation|0|||
105827390|NCT00205777|365026435|FG005|Study Extension II|Enrolled but not treated|131|||
105827391|NCT02462837|365026436|FG000|Overall Study|pt developed hives|1|||
105827392|NCT02462837|365026437|FG001|Overall Study|pt developed hives|0|||
105827393|NCT02462837|365026436|FG000|Overall Study|Withdrawal by Subject|1|||
105827394|NCT02462837|365026437|FG001|Overall Study|Withdrawal by Subject|0|||
105827395|NCT04411680|365026442|FG000|Treatment Period|Adverse Event|3|||
105827396|NCT04411680|365026443|FG001|Treatment Period|Adverse Event|0|||
105827397|NCT04411680|365026442|FG000|Treatment Period|Discharged from hospital|18|||
105827398|NCT04411680|365026443|FG001|Treatment Period|Discharged from hospital|7|||
105827399|NCT04411680|365026442|FG000|Treatment Period|Missed 1 or more doses|8|||
105827400|NCT04411680|365026443|FG001|Treatment Period|Missed 1 or more doses|0|||
105827401|NCT04411680|365026442|FG000|Treatment Period|Transferred to another hospital|0|||
105827402|NCT04411680|365026443|FG001|Treatment Period|Transferred to another hospital|1|||
105827403|NCT04411680|365026442|FG000|Follow up Period|Withdrawal by Subject|2|||
105827404|NCT04411680|365026443|FG001|Follow up Period|Withdrawal by Subject|0|||
105827405|NCT04411680|365026442|FG000|Follow up Period|Lost to Follow-up|5|||
105827406|NCT04411680|365026443|FG001|Follow up Period|Lost to Follow-up|6|||
105827407|NCT04411680|365026442|FG000|Follow up Period|Death|11|||
105827408|NCT04411680|365026443|FG001|Follow up Period|Death|8|||
105827409|NCT00748566|365026444|FG000|Overall Study|Adverse Event|49|||
105827410|NCT00748566|365026444|FG000|Overall Study|Death|1|||
105827411|NCT00748566|365026444|FG000|Overall Study|Lack of Efficacy|12|||
105827412|NCT00748566|365026444|FG000|Overall Study|Lost to Follow-up|1|||
105827413|NCT00748566|365026444|FG000|Overall Study|Protocol Violation|13|||
105827414|NCT00748566|365026444|FG000|Overall Study|Withdrawal by Subject|22|||
105827415|NCT00748566|365026444|FG000|Overall Study|Study terminated by sponsor|5|||
105827416|NCT00748566|365026444|FG000|Overall Study|Other|9|||
105827417|NCT02426918|365026448|FG000|Overall Study|Adverse Event|2|||
105827418|NCT02426918|365026449|FG001|Overall Study|Adverse Event|2|||
105827419|NCT02426918|365026450|FG002|Overall Study|Adverse Event|0|||
105827420|NCT02426918|365026448|FG000|Overall Study|Physician Decision|1|||
105827421|NCT02426918|365026449|FG001|Overall Study|Physician Decision|1|||
105827422|NCT02426918|365026450|FG002|Overall Study|Physician Decision|1|||
105827423|NCT02426918|365026448|FG000|Overall Study|Withdrawal by Subject|5|||
105827424|NCT02426918|365026449|FG001|Overall Study|Withdrawal by Subject|5|||
105827425|NCT02426918|365026450|FG002|Overall Study|Withdrawal by Subject|4|||
105827426|NCT02426918|365026448|FG000|Overall Study|Other|9|||
105827427|NCT02426918|365026449|FG001|Overall Study|Other|11|||
105827428|NCT02426918|365026450|FG002|Overall Study|Other|9|||
105827429|NCT01442376|365026451|FG000|Overall Study|Adverse Event|0|||
105827430|NCT01442376|365026452|FG001|Overall Study|Adverse Event|3|||
105827431|NCT01442376|365026453|FG002|Overall Study|Adverse Event|2|||
105827432|NCT01442376|365026451|FG000|Overall Study|Death|0|||
105827433|NCT01442376|365026452|FG001|Overall Study|Death|1|||
105827434|NCT01442376|365026453|FG002|Overall Study|Death|1|||
105827435|NCT01442376|365026451|FG000|Overall Study|Withdrawal of consent|0|||
105827436|NCT01442376|365026452|FG001|Overall Study|Withdrawal of consent|0|||
105827437|NCT01442376|365026453|FG002|Overall Study|Withdrawal of consent|1|||
105827438|NCT01442376|365026451|FG000|Overall Study|Patients not treated|2|||
105827439|NCT01442376|365026452|FG001|Overall Study|Patients not treated|3|||
105827440|NCT01442376|365026453|FG002|Overall Study|Patients not treated|1|||
105827441|NCT01442376|365026451|FG000|Overall Study|Not eligible for subsequent cycles|1|||
105827442|NCT01442376|365026452|FG001|Overall Study|Not eligible for subsequent cycles|2|||
105827443|NCT01442376|365026453|FG002|Overall Study|Not eligible for subsequent cycles|0|||
105827444|NCT00863330|365026454|FG000|Overall Study|study terminated early due to administra|6|||
105827445|NCT01297504|365026455|FG000|Overall Study|Invalid Consent|1|||
105366482|NCT02849587|363348426|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
105575552|NCT01231503|364106232|FG005|Overall Study|Protocol Violation|0|||
105827446|NCT01297504|365026455|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
105575553|NCT01231503|364106233|FG006|Overall Study|Protocol Violation|0|||
105575554|NCT01231503|364106234|FG007|Overall Study|Protocol Violation|0|||
105575555|NCT00284089|364106236|FG000|Multiple Dose Phase|Adverse Event|1|||
105575556|NCT00284089|364106237|FG001|Multiple Dose Phase|Adverse Event|0|||
105575557|NCT00284089|364106238|FG002|Multiple Dose Phase|Adverse Event|1|||
105575558|NCT00284089|364106239|FG003|Multiple Dose Phase|Adverse Event|1|||
105575559|NCT00284089|364106236|FG000|Multiple Dose Phase|Protocol Violation|0|||
105575560|NCT00284089|364106237|FG001|Multiple Dose Phase|Protocol Violation|0|||
105575561|NCT00284089|364106238|FG002|Multiple Dose Phase|Protocol Violation|1|||
105575562|NCT00284089|364106239|FG003|Multiple Dose Phase|Protocol Violation|0|||
105575563|NCT00284089|364106236|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
105575564|NCT00284089|364106237|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
105489079|NCT00472459|363803963|FG001|Overall Study|Lost to Follow-up|1|||
105489080|NCT04850313|363803964|FG000|Overall Study|Withdrawal by Subject|0|||
105489081|NCT04850313|363803965|FG001|Overall Study|Withdrawal by Subject|1|||
105489082|NCT04761822|363803966|FG000|Overall Study|Adverse Event|3|||
105489083|NCT04761822|363803967|FG001|Overall Study|Adverse Event|1|||
105489084|NCT04761822|363803968|FG002|Overall Study|Adverse Event|1|||
105489085|NCT04761822|363803969|FG003|Overall Study|Adverse Event|3|||
105489086|NCT04761822|363803966|FG000|Overall Study|Lost to Follow-up|1|||
105489087|NCT04761822|363803967|FG001|Overall Study|Lost to Follow-up|0|||
105489088|NCT04761822|363803968|FG002|Overall Study|Lost to Follow-up|2|||
105489089|NCT04761822|363803969|FG003|Overall Study|Lost to Follow-up|3|||
105489090|NCT04761822|363803966|FG000|Overall Study|Physician Decision|0|||
105575565|NCT00284089|364106238|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
105575566|NCT00284089|364106239|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
105575567|NCT00284089|364106236|FG000|Multiple Dose Phase|Death|0|||
105575568|NCT00284089|364106237|FG001|Multiple Dose Phase|Death|0|||
105575569|NCT00284089|364106238|FG002|Multiple Dose Phase|Death|1|||
105575570|NCT00284089|364106239|FG003|Multiple Dose Phase|Death|1|||
105575571|NCT00284089|364106236|FG000|Extension Phase|Adverse Event|0|||
105575572|NCT00284089|364106237|FG001|Extension Phase|Adverse Event|0|||
105575573|NCT00284089|364106238|FG002|Extension Phase|Adverse Event|2|||
105575574|NCT00284089|364106239|FG003|Extension Phase|Adverse Event|2|||
105575575|NCT00284089|364106236|FG000|Extension Phase|condition no longer requires study drug|2|||
105575576|NCT00284089|364106237|FG001|Extension Phase|condition no longer requires study drug|0|||
105575577|NCT00284089|364106238|FG002|Extension Phase|condition no longer requires study drug|2|||
105575578|NCT00284089|364106239|FG003|Extension Phase|condition no longer requires study drug|7|||
105575579|NCT00284089|364106236|FG000|Extension Phase|Protocol Violation|0|||
105575580|NCT00284089|364106237|FG001|Extension Phase|Protocol Violation|0|||
105575581|NCT00284089|364106238|FG002|Extension Phase|Protocol Violation|1|||
105575582|NCT00284089|364106239|FG003|Extension Phase|Protocol Violation|0|||
105575583|NCT00284089|364106236|FG000|Extension Phase|Withdrawal by Subject|0|||
105575584|NCT00284089|364106237|FG001|Extension Phase|Withdrawal by Subject|0|||
105575585|NCT00284089|364106238|FG002|Extension Phase|Withdrawal by Subject|1|||
105575586|NCT00284089|364106239|FG003|Extension Phase|Withdrawal by Subject|3|||
105575587|NCT03051659|364106240|FG000|Treatment Period|Withdrawal by Subject|0|||
105575588|NCT03051659|364106241|FG001|Treatment Period|Withdrawal by Subject|2|||
105575589|NCT03051659|364106240|FG000|Survival Follow-up|Lost to Follow-up|23|||
105575590|NCT03051659|364106241|FG001|Survival Follow-up|Lost to Follow-up|22|||
105575591|NCT04362137|364106242|FG000|Overall Study|Death|9|||
105575592|NCT04362137|364106243|FG001|Overall Study|Death|3|||
105575593|NCT04362137|364106242|FG000|Overall Study|Patient decision|6|||
105575594|NCT04362137|364106243|FG001|Overall Study|Patient decision|3|||
105575595|NCT04362137|364106242|FG000|Overall Study|Adverse Event|1|||
105575596|NCT04362137|364106243|FG001|Overall Study|Adverse Event|0|||
105575597|NCT04362137|364106242|FG000|Overall Study|Lost to Follow-up|1|||
105575598|NCT04362137|364106243|FG001|Overall Study|Lost to Follow-up|0|||
105575599|NCT04362137|364106242|FG000|Overall Study|Protocol deviation|1|||
105575600|NCT04362137|364106243|FG001|Overall Study|Protocol deviation|0|||
105575601|NCT00967018|364106248|FG000|Overall Study|Adverse Event|2|||
105575602|NCT00967018|364106248|FG000|Overall Study|Physician Decision|7|||
105575603|NCT00967018|364106248|FG000|Overall Study|Lost to Follow-up|2|||
105575604|NCT00967018|364106248|FG000|Overall Study|Withdrawal by Subject|1|||
105575605|NCT00967018|364106248|FG000|Overall Study|Miscellaneous Reasons|9|||
105489091|NCT04761822|363803967|FG001|Overall Study|Physician Decision|1|||
105489092|NCT04761822|363803968|FG002|Overall Study|Physician Decision|0|||
105489093|NCT04761822|363803969|FG003|Overall Study|Physician Decision|0|||
105489094|NCT04761822|363803966|FG000|Overall Study|Withdrawal by Subject|3|||
105489095|NCT04761822|363803967|FG001|Overall Study|Withdrawal by Subject|8|||
105489096|NCT04761822|363803968|FG002|Overall Study|Withdrawal by Subject|1|||
105575606|NCT02494206|364106249|FG000|Overall Study|Adverse Event|1|||
105575607|NCT02494206|364106249|FG000|Overall Study|Disease Progression|1|||
105575608|NCT04276090|364106251|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
105575609|NCT04276090|364106252|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
105575610|NCT00318149|364106253|FG000|Overall Study|Adverse Event|0|||
105575611|NCT00318149|364106254|FG001|Overall Study|Adverse Event|0|||
105575612|NCT00318149|364106255|FG002|Overall Study|Adverse Event|0|||
105575613|NCT00318149|364106256|FG003|Overall Study|Adverse Event|0|||
105575614|NCT00318149|364106257|FG004|Overall Study|Adverse Event|0|||
105575615|NCT00318149|364106258|FG005|Overall Study|Adverse Event|2|||
105575616|NCT00383240|364106263|FG000|Overall Study|Adverse Event|4|||
105575617|NCT00383240|364106264|FG001|Overall Study|Adverse Event|6|||
105575618|NCT00383240|364106265|FG002|Overall Study|Adverse Event|9|||
105575619|NCT00383240|364106266|FG003|Overall Study|Adverse Event|7|||
105575620|NCT00383240|364106263|FG000|Overall Study|Treatment Failure|8|||
105575621|NCT00383240|364106264|FG001|Overall Study|Treatment Failure|13|||
105575622|NCT00383240|364106265|FG002|Overall Study|Treatment Failure|47|||
105575623|NCT00383240|364106266|FG003|Overall Study|Treatment Failure|46|||
105575624|NCT00383240|364106263|FG000|Overall Study|Lost to Follow-up|3|||
105827447|NCT01297504|365026455|FG000|Overall Study|No Study Visits|4|||
105827448|NCT01297504|365026455|FG000|Overall Study|Death|3|||
105575625|NCT00383240|364106264|FG001|Overall Study|Lost to Follow-up|0|||
105575626|NCT00383240|364106265|FG002|Overall Study|Lost to Follow-up|0|||
105575627|NCT00383240|364106266|FG003|Overall Study|Lost to Follow-up|2|||
105575628|NCT00383240|364106263|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
105575629|NCT00383240|364106264|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
105575630|NCT00383240|364106265|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
105575631|NCT00383240|364106266|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
105575632|NCT00383240|364106263|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
105575633|NCT00383240|364106264|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
105575634|NCT00383240|364106265|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
105575635|NCT00383240|364106266|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
105575636|NCT00383240|364106263|FG000|Overall Study|Protocol Violation|4|||
105575637|NCT00383240|364106264|FG001|Overall Study|Protocol Violation|5|||
105575638|NCT00383240|364106265|FG002|Overall Study|Protocol Violation|9|||
105575639|NCT00383240|364106266|FG003|Overall Study|Protocol Violation|6|||
105575640|NCT00383240|364106263|FG000|Overall Study|Did not meet protocol eligibility|9|||
105575641|NCT00383240|364106264|FG001|Overall Study|Did not meet protocol eligibility|4|||
105575642|NCT00383240|364106265|FG002|Overall Study|Did not meet protocol eligibility|9|||
105575643|NCT00383240|364106266|FG003|Overall Study|Did not meet protocol eligibility|3|||
105575644|NCT00383240|364106263|FG000|Overall Study|Administrative|1|||
105575645|NCT00383240|364106264|FG001|Overall Study|Administrative|1|||
105575646|NCT00383240|364106265|FG002|Overall Study|Administrative|0|||
105575647|NCT00383240|364106266|FG003|Overall Study|Administrative|0|||
105575648|NCT00641186|364106267|FG000|Overall Study|Adverse Event|3|||
105575649|NCT02388074|364106268|FG000|Overall Study|Lost in Transit|2|||
105575650|NCT02388074|364106268|FG000|Overall Study|Sample Not Returned|1|||
105575651|NCT00003458|364106269|FG000|Overall Study|Not evaluable|4|||
105575652|NCT02601937|364106270|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
105575653|NCT02601937|364106271|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
105575654|NCT02601937|364106272|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
105575655|NCT02601937|364106273|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
105575656|NCT02601937|364106274|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
105575657|NCT02601937|364106275|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
105575658|NCT02601937|364106276|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
105575659|NCT02601937|364106277|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
105575660|NCT02601937|364106278|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
105575661|NCT02601937|364106279|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
105575662|NCT02601937|364106280|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
105575663|NCT02601937|364106270|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
105575664|NCT02601937|364106271|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
105575665|NCT02601937|364106272|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
105575666|NCT02601937|364106273|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
105575667|NCT02601937|364106274|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
105575668|NCT02601937|364106275|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
105575669|NCT02601937|364106276|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
105575670|NCT02601937|364106277|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
105575671|NCT02601937|364106278|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
105575672|NCT02601937|364106279|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
105575673|NCT02601937|364106280|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
105575674|NCT02601937|364106270|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
105575675|NCT02601937|364106271|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
105575676|NCT02601937|364106272|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
105575677|NCT02601937|364106273|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
105575678|NCT02601937|364106274|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
105575679|NCT02601937|364106275|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
105575680|NCT02601937|364106276|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
105575681|NCT02601937|364106277|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
105575682|NCT02601937|364106278|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
105827449|NCT01297504|365026455|FG000|Overall Study|Lost to Follow-up|43|||
105575683|NCT02601937|364106279|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
105575684|NCT02601937|364106280|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
105575685|NCT02601937|364106270|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
105575686|NCT02601937|364106271|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
105575687|NCT02601937|364106272|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
105575688|NCT02601937|364106273|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
105575689|NCT02601937|364106274|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
105575690|NCT02601937|364106275|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
105575691|NCT02601937|364106276|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
105575692|NCT02601937|364106277|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
105575693|NCT02601937|364106278|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
105575694|NCT02601937|364106279|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
105575695|NCT02601937|364106280|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
105575696|NCT02601937|364106270|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
105575697|NCT02601937|364106271|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
105575698|NCT02601937|364106272|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
105575699|NCT02601937|364106273|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
105575700|NCT02601937|364106274|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
105575701|NCT02601937|364106275|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
105575702|NCT02601937|364106276|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
105575703|NCT02601937|364106277|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
105575704|NCT02601937|364106278|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
105575705|NCT02601937|364106279|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
105575706|NCT02601937|364106280|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
105575707|NCT02601937|364106270|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
105575708|NCT02601937|364106271|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
105575709|NCT02601937|364106272|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
105575710|NCT02601937|364106273|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
105575711|NCT02601937|364106274|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
105575712|NCT02601937|364106275|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
105575713|NCT02601937|364106276|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
105575714|NCT02601937|364106277|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
105575715|NCT02601937|364106278|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
105575716|NCT02601937|364106279|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
105575717|NCT02601937|364106280|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
105575718|NCT02601937|364106270|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
105575719|NCT02601937|364106271|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
105575720|NCT02601937|364106272|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
105575721|NCT02601937|364106273|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
105575722|NCT02601937|364106274|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
105575723|NCT02601937|364106275|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
105575724|NCT02601937|364106276|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
105575725|NCT02601937|364106277|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
105575726|NCT02601937|364106278|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
105575727|NCT02601937|364106279|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
105575728|NCT02601937|364106280|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
105575729|NCT02601937|364106270|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
105575730|NCT02601937|364106271|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
105575731|NCT02601937|364106272|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
105575732|NCT02601937|364106273|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
105575733|NCT02601937|364106274|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
105575734|NCT02601937|364106275|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
105575735|NCT02601937|364106276|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
105575736|NCT02601937|364106277|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
105575737|NCT02601937|364106278|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
105827450|NCT01297504|365026455|FG000|Overall Study|Withdrawal by Subject|9|||
105827451|NCT01297504|365026455|FG000|Overall Study|Site Closure|3|||
105575738|NCT02601937|364106279|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
105575739|NCT02601937|364106280|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
105827452|NCT01297504|365026455|FG000|Overall Study|Protocol Violation|3|||
105827453|NCT04404725|365026456|FG000|First Intervention|Withdrawal by Subject|0|||
105827454|NCT04404725|365026457|FG001|First Intervention|Withdrawal by Subject|2|||
105827455|NCT04404725|365026456|FG000|Second Intervention|Adverse Event|1|||
105307748|NCT03283319|363125174|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
105827456|NCT04404725|365026457|FG001|Second Intervention|Adverse Event|1|||
105307749|NCT03283319|363125175|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
105307750|NCT00721630|363125176|FG000|Overall Study|Participant found to be ineligible|1|||
105307751|NCT03186781|363125177|FG000|Overall Study|Lost to Follow-up|0|||
105307752|NCT03186781|363125178|FG001|Overall Study|Lost to Follow-up|0|||
105307753|NCT03186781|363125179|FG002|Overall Study|Lost to Follow-up|1|||
105307754|NCT03186781|363125180|FG003|Overall Study|Lost to Follow-up|0|||
105307755|NCT03186781|363125181|FG004|Overall Study|Lost to Follow-up|1|||
105307756|NCT03186781|363125182|FG005|Overall Study|Lost to Follow-up|0|||
105307757|NCT03186781|363125177|FG000|Overall Study|Moved from Area|0|||
105307758|NCT03186781|363125178|FG001|Overall Study|Moved from Area|0|||
105307759|NCT03186781|363125179|FG002|Overall Study|Moved from Area|0|||
105307760|NCT03186781|363125180|FG003|Overall Study|Moved from Area|0|||
105307761|NCT03186781|363125181|FG004|Overall Study|Moved from Area|1|||
105307762|NCT03186781|363125182|FG005|Overall Study|Moved from Area|0|||
105307763|NCT03186781|363125177|FG000|Overall Study|Withdrawal by Subject|0|||
105307764|NCT03186781|363125178|FG001|Overall Study|Withdrawal by Subject|0|||
105307765|NCT03186781|363125179|FG002|Overall Study|Withdrawal by Subject|0|||
105307766|NCT03186781|363125180|FG003|Overall Study|Withdrawal by Subject|0|||
105307767|NCT03186781|363125181|FG004|Overall Study|Withdrawal by Subject|1|||
105307768|NCT03186781|363125182|FG005|Overall Study|Withdrawal by Subject|0|||
105307769|NCT00191113|363125191|FG000|Core Study|Withdrawal by Subject|25|||
105307770|NCT00191113|363125192|FG001|Core Study|Withdrawal by Subject|9|||
105307771|NCT00191113|363125191|FG000|Core Study|Protocol Violation|6|||
105307772|NCT00191113|363125192|FG001|Core Study|Protocol Violation|2|||
105307773|NCT00191113|363125191|FG000|Core Study|Lost to Follow-up|3|||
105307774|NCT00191113|363125192|FG001|Core Study|Lost to Follow-up|0|||
105307775|NCT00191113|363125191|FG000|Core Study|Adverse Event|0|||
105307776|NCT00191113|363125192|FG001|Core Study|Adverse Event|2|||
105307777|NCT00191113|363125191|FG000|Core Study|Lack of Efficacy|0|||
105366483|NCT02849587|363348427|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
105366484|NCT02849587|363348425|FG000|Overall Study|Withdrawal by Subject|0|||
105366485|NCT02849587|363348426|FG001|Overall Study|Withdrawal by Subject|1|||
105366486|NCT02849587|363348427|FG002|Overall Study|Withdrawal by Subject|0|||
105366487|NCT00617357|363348428|FG000|Overall Study|Lost to Follow-up|7|||
105366488|NCT00617357|363348428|FG000|Overall Study|Death|5|||
105366489|NCT00617357|363348428|FG000|Overall Study|insurance concerns|2|||
105366490|NCT00617357|363348428|FG000|Overall Study|Withdrawal by Subject|1|||
105366491|NCT00617357|363348428|FG000|Overall Study|Physician Decision|1|||
105366492|NCT00427908|363348429|FG000|Primary Phase|Lost to Follow-up|4|||
105366493|NCT00427908|363348430|FG001|Primary Phase|Lost to Follow-up|0|||
105366494|NCT00427908|363348431|FG002|Primary Phase|Lost to Follow-up|2|||
105366495|NCT00427908|363348432|FG003|Primary Phase|Lost to Follow-up|0|||
105366496|NCT00427908|363348429|FG000|Primary Phase|Withdrawal by Subject|1|||
105366497|NCT00427908|363348430|FG001|Primary Phase|Withdrawal by Subject|2|||
105366498|NCT00427908|363348431|FG002|Primary Phase|Withdrawal by Subject|1|||
105366499|NCT00427908|363348432|FG003|Primary Phase|Withdrawal by Subject|0|||
105366500|NCT00427908|363348429|FG000|Primary Phase|Adverse Event|0|||
105366501|NCT00427908|363348430|FG001|Primary Phase|Adverse Event|1|||
105366502|NCT00427908|363348431|FG002|Primary Phase|Adverse Event|0|||
105366503|NCT00427908|363348432|FG003|Primary Phase|Adverse Event|0|||
105366504|NCT01710020|363348433|FG000|Period 1|Protocol Violation|1|||
105366505|NCT02984982|363348434|FG000|Overall Study|Adverse Event|2|||
105366506|NCT02984982|363348435|FG001|Overall Study|Adverse Event|5|||
105366507|NCT02984982|363348434|FG000|Overall Study|Poor Compliance to Protocol|4|||
105366508|NCT02984982|363348435|FG001|Overall Study|Poor Compliance to Protocol|4|||
105366509|NCT02984982|363348434|FG000|Overall Study|Withdrawal by Subject|2|||
105366510|NCT02984982|363348435|FG001|Overall Study|Withdrawal by Subject|0|||
105366511|NCT02984982|363348434|FG000|Overall Study|Randomized but not treated|0|||
105366512|NCT02984982|363348435|FG001|Overall Study|Randomized but not treated|1|||
105366513|NCT01747499|363348437|FG000|Overall Study|Steroid refractory aGvHD|1|||
105489097|NCT04761822|363803969|FG003|Overall Study|Withdrawal by Subject|11|||
105489098|NCT04761822|363803966|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
105489099|NCT04761822|363803967|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
105307778|NCT00191113|363125192|FG001|Core Study|Lack of Efficacy|2|||
105307779|NCT00191113|363125191|FG000|Core Study|Death|1|||
105366514|NCT01747499|363348438|FG001|Overall Study|Steroid refractory aGvHD|0|||
105366515|NCT01747499|363348439|FG002|Overall Study|Steroid refractory aGvHD|0|||
105366516|NCT01747499|363348440|FG003|Overall Study|Steroid refractory aGvHD|1|||
105366517|NCT01747499|363348441|FG004|Overall Study|Steroid refractory aGvHD|4|||
105366518|NCT01747499|363348437|FG000|Overall Study|Physician Decision|0|||
105366519|NCT01747499|363348438|FG001|Overall Study|Physician Decision|1|||
105366520|NCT01747499|363348439|FG002|Overall Study|Physician Decision|0|||
105366521|NCT01747499|363348440|FG003|Overall Study|Physician Decision|0|||
105489100|NCT04761822|363803968|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
105489101|NCT04761822|363803969|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
105307780|NCT00191113|363125192|FG001|Core Study|Death|0|||
105307781|NCT04709835|363125196|FG000|Overall Study|Withdrawal by Subject|0|||
105366522|NCT01747499|363348441|FG004|Overall Study|Physician Decision|2|||
105489102|NCT04761822|363803966|FG000|Overall Study|Participant requested unblinding|0|||
105489103|NCT04761822|363803967|FG001|Overall Study|Participant requested unblinding|0|||
105489104|NCT04761822|363803968|FG002|Overall Study|Participant requested unblinding|0|||
105489105|NCT04761822|363803969|FG003|Overall Study|Participant requested unblinding|1|||
105489106|NCT03034200|363803971|FG000|Overall Study|Disease progression|8|||
105489107|NCT03034200|363803972|FG001|Overall Study|Disease progression|10|||
105489108|NCT03034200|363803973|FG002|Overall Study|Disease progression|4|||
105489109|NCT03034200|363803971|FG000|Overall Study|Physician Decision|2|||
105489110|NCT03034200|363803972|FG001|Overall Study|Physician Decision|0|||
105827457|NCT04404725|365026456|FG000|Second Intervention|Withdrawal by Subject|0|||
105827458|NCT04404725|365026457|FG001|Second Intervention|Withdrawal by Subject|1|||
105827459|NCT03602339|365026458|FG000|Overall Study|Withdrawal by Subject|9|||
105827460|NCT03602339|365026458|FG000|Overall Study|Physician Decision|2|||
105827461|NCT03602339|365026458|FG000|Overall Study|Other reason|4|||
105827462|NCT02252016|365026459|FG000|Overall Study|Lost to Follow-up|2|||
105827463|NCT02252016|365026460|FG001|Overall Study|Lost to Follow-up|1|||
105827464|NCT02252016|365026459|FG000|Overall Study|Physician Decision|1|||
105827465|NCT02252016|365026460|FG001|Overall Study|Physician Decision|0|||
105827466|NCT02252016|365026459|FG000|Overall Study|Withdrawal by Subject|0|||
105827467|NCT02252016|365026460|FG001|Overall Study|Withdrawal by Subject|2|||
105827468|NCT02615249|365026462|FG000|Overall Study|Withdrawal by Subject|1|||
105827469|NCT00574847|365026463|FG000|Overall Study|Adverse Event|2|||
105827470|NCT00574847|365026464|FG001|Overall Study|Adverse Event|0|||
105827471|NCT00574847|365026463|FG000|Overall Study|Death|1|||
105827472|NCT00574847|365026464|FG001|Overall Study|Death|0|||
105827473|NCT00574847|365026463|FG000|Overall Study|Withdrawal by Subject|2|||
105827474|NCT00574847|365026464|FG001|Overall Study|Withdrawal by Subject|2|||
105827475|NCT00574847|365026463|FG000|Overall Study|Physician Decision|1|||
105827476|NCT00574847|365026464|FG001|Overall Study|Physician Decision|0|||
105827477|NCT00574847|365026463|FG000|Overall Study|Did not receive medication (declined)|2|||
105827478|NCT00574847|365026464|FG001|Overall Study|Did not receive medication (declined)|5|||
105827479|NCT00957021|365026467|FG000|Overall Study|Death|5|||
105827480|NCT00957021|365026467|FG000|Overall Study|Lost to Follow-up|8|||
105827481|NCT00957021|365026467|FG000|Overall Study|Withdrawal by Subject|34|||
105827482|NCT00957021|365026467|FG000|Overall Study|No 2 yr ROM data|35|||
105827483|NCT00957021|365026467|FG000|Overall Study|Revised study component by 2 yr visit|8|||
105827484|NCT00957021|365026467|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
105489111|NCT03034200|363803973|FG002|Overall Study|Physician Decision|3|||
105575740|NCT02601937|364106270|FG000|Period 2: Dose Expansion Cohort|Other|0|||
105575741|NCT02601937|364106271|FG001|Period 2: Dose Expansion Cohort|Other|0|||
105575742|NCT02601937|364106272|FG002|Period 2: Dose Expansion Cohort|Other|0|||
105575743|NCT02601937|364106273|FG003|Period 2: Dose Expansion Cohort|Other|0|||
105575744|NCT02601937|364106274|FG004|Period 2: Dose Expansion Cohort|Other|0|||
105575745|NCT02601937|364106275|FG005|Period 2: Dose Expansion Cohort|Other|0|||
105575746|NCT02601937|364106276|FG006|Period 2: Dose Expansion Cohort|Other|0|||
105575747|NCT02601937|364106277|FG007|Period 2: Dose Expansion Cohort|Other|0|||
105575748|NCT02601937|364106278|FG008|Period 2: Dose Expansion Cohort|Other|2|||
105575749|NCT02601937|364106279|FG009|Period 2: Dose Expansion Cohort|Other|2|||
105575750|NCT02601937|364106280|FG010|Period 2: Dose Expansion Cohort|Other|0|||
105575751|NCT02601937|364106270|FG000|Period 2: Dose Expansion Cohort|Death|0|||
105575752|NCT02601937|364106271|FG001|Period 2: Dose Expansion Cohort|Death|0|||
105575753|NCT02601937|364106272|FG002|Period 2: Dose Expansion Cohort|Death|0|||
105575754|NCT02601937|364106273|FG003|Period 2: Dose Expansion Cohort|Death|0|||
105575755|NCT02601937|364106274|FG004|Period 2: Dose Expansion Cohort|Death|0|||
105575756|NCT02601937|364106275|FG005|Period 2: Dose Expansion Cohort|Death|0|||
105575757|NCT02601937|364106276|FG006|Period 2: Dose Expansion Cohort|Death|0|||
105575758|NCT02601937|364106277|FG007|Period 2: Dose Expansion Cohort|Death|0|||
105575759|NCT02601937|364106278|FG008|Period 2: Dose Expansion Cohort|Death|1|||
105489112|NCT03034200|363803971|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
105489113|NCT03034200|363803972|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
105575760|NCT02601937|364106279|FG009|Period 2: Dose Expansion Cohort|Death|0|||
105575761|NCT02601937|364106280|FG010|Period 2: Dose Expansion Cohort|Death|0|||
105575762|NCT04399551|364108318|FG000|Overall Study|Adverse Event|15|||
105575763|NCT04399551|364108318|FG000|Overall Study|Withdrawal by Subject|6|||
105575764|NCT04399551|364108318|FG000|Overall Study|Physician Decision|3|||
105575765|NCT04399551|364108318|FG000|Overall Study|Lost to Follow-up|2|||
105575766|NCT04399551|364108318|FG000|Overall Study|Protocol Deviation|2|||
105575767|NCT02254421|364108321|FG000|Overall Study|Randomized but Not Treated|1|||
105489114|NCT03034200|363803973|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
105575768|NCT02254421|364108322|FG001|Overall Study|Randomized but Not Treated|0|||
105575769|NCT02254421|364108321|FG000|Overall Study|Death|0|||
105575770|NCT02254421|364108322|FG001|Overall Study|Death|2|||
105575771|NCT02254421|364108321|FG000|Overall Study|Withdrew Consent|1|||
105827485|NCT00957021|365026467|FG000|Overall Study|Surgery Cancelled|9|||
105827486|NCT00957021|365026467|FG000|Overall Study|Termination due to language issue|2|||
105827487|NCT00487435|365026470|FG000|Overall Study|Adverse Event|146|||
105307782|NCT04709835|363125197|FG001|Overall Study|Withdrawal by Subject|1|||
105307783|NCT04709835|363125198|FG002|Overall Study|Withdrawal by Subject|0|||
105307784|NCT03954834|363125199|FG000|Overall Study|Adverse Event|1|||
105307785|NCT03954834|363125200|FG001|Overall Study|Adverse Event|3|||
105307786|NCT03954834|363125201|FG002|Overall Study|Adverse Event|1|||
105307787|NCT03954834|363125202|FG003|Overall Study|Adverse Event|1|||
105307788|NCT03954834|363125199|FG000|Overall Study|Death|0|||
105307789|NCT03954834|363125200|FG001|Overall Study|Death|0|||
105307790|NCT03954834|363125201|FG002|Overall Study|Death|0|||
105307791|NCT03954834|363125202|FG003|Overall Study|Death|1|||
105307792|NCT03954834|363125199|FG000|Overall Study|Physician Decision|0|||
105307793|NCT03954834|363125200|FG001|Overall Study|Physician Decision|1|||
105307794|NCT03954834|363125201|FG002|Overall Study|Physician Decision|0|||
105307795|NCT03954834|363125202|FG003|Overall Study|Physician Decision|2|||
105307796|NCT03954834|363125199|FG000|Overall Study|Protocol Violation|1|||
105307797|NCT03954834|363125200|FG001|Overall Study|Protocol Violation|0|||
105307798|NCT03954834|363125201|FG002|Overall Study|Protocol Violation|0|||
105307799|NCT03954834|363125202|FG003|Overall Study|Protocol Violation|1|||
105307800|NCT03954834|363125199|FG000|Overall Study|Withdrawal by Subject|2|||
105307801|NCT03954834|363125200|FG001|Overall Study|Withdrawal by Subject|3|||
105307802|NCT03954834|363125201|FG002|Overall Study|Withdrawal by Subject|13|||
105307803|NCT03954834|363125202|FG003|Overall Study|Withdrawal by Subject|6|||
105307804|NCT03954834|363125199|FG000|Overall Study|Participant left the country|0|||
105307805|NCT03954834|363125200|FG001|Overall Study|Participant left the country|0|||
105307806|NCT03954834|363125201|FG002|Overall Study|Participant left the country|1|||
105307807|NCT03954834|363125202|FG003|Overall Study|Participant left the country|0|||
105307808|NCT03954834|363125199|FG000|Overall Study|Lost to Follow-up|3|||
105307809|NCT03954834|363125200|FG001|Overall Study|Lost to Follow-up|2|||
105307810|NCT03954834|363125201|FG002|Overall Study|Lost to Follow-up|3|||
105307811|NCT03954834|363125202|FG003|Overall Study|Lost to Follow-up|5|||
105307812|NCT00324649|363125208|FG000|Overall Study|Adverse Event|1|||
105307813|NCT00324649|363125209|FG001|Overall Study|Adverse Event|4|||
105307814|NCT00324649|363125208|FG000|Overall Study|Withdrawal by Subject|0|||
105307815|NCT00324649|363125209|FG001|Overall Study|Withdrawal by Subject|1|||
105307816|NCT00324649|363125208|FG000|Overall Study|Noncompliance|1|||
105307817|NCT00324649|363125209|FG001|Overall Study|Noncompliance|0|||
105307818|NCT00540293|363125210|FG000|Overall Study|Adverse event related to study drug|10|||
105307819|NCT00540293|363125210|FG000|Overall Study|Adverse event not related to study drug|7|||
105307820|NCT00540293|363125210|FG000|Overall Study|Withdrawal by Subject|6|||
105575772|NCT02254421|364108322|FG001|Overall Study|Withdrew Consent|1|||
105575773|NCT00313911|364108323|FG000|Overall Study|Serious adverse event|6|||
105575774|NCT00313911|364108324|FG001|Overall Study|Serious adverse event|1|||
105575775|NCT00313911|364108323|FG000|Overall Study|Adverse Event|2|||
105575776|NCT00313911|364108324|FG001|Overall Study|Adverse Event|3|||
105575777|NCT00313911|364108323|FG000|Overall Study|Protocol Violation|19|||
105575778|NCT00313911|364108324|FG001|Overall Study|Protocol Violation|10|||
105575779|NCT00313911|364108323|FG000|Overall Study|Lost to Follow-up|27|||
105575780|NCT00313911|364108324|FG001|Overall Study|Lost to Follow-up|14|||
105307821|NCT00540293|363125210|FG000|Overall Study|Protocol violation, & subject schedule|12|||
105307822|NCT01007942|363125213|FG000|Overall Study|Adverse Event|29|||
105307823|NCT01007942|363125214|FG001|Overall Study|Adverse Event|14|||
105307824|NCT01007942|363125213|FG000|Overall Study|Abnormal test procedure|0|||
105307825|NCT01007942|363125214|FG001|Overall Study|Abnormal test procedure|1|||
105307826|NCT01007942|363125213|FG000|Overall Study|Disease progression|217|||
105307827|NCT01007942|363125214|FG001|Overall Study|Disease progression|242|||
105307828|NCT01007942|363125213|FG000|Overall Study|New cancer therapy|5|||
105575781|NCT00313911|364108323|FG000|Overall Study|Withdrawal by Subject|39|||
105575782|NCT00313911|364108324|FG001|Overall Study|Withdrawal by Subject|12|||
105575783|NCT00313911|364108323|FG000|Overall Study|Did not meet age criteria|1|||
105575784|NCT00313911|364108324|FG001|Overall Study|Did not meet age criteria|1|||
105575785|NCT02086552|364108327|FG000|Overall Study|Withdrawal by Subject|1|||
105575786|NCT00708305|364108328|FG000|Period 1|Protocol Violation|1|||
105575787|NCT00708305|364108329|FG001|Period 1|Protocol Violation|0|||
105575788|NCT00708305|364108330|FG002|Period 1|Protocol Violation|1|||
105575789|NCT00708305|364108331|FG003|Period 1|Protocol Violation|0|||
105575790|NCT00708305|364108328|FG000|Period 1|Other Reason|0|||
105575791|NCT00708305|364108329|FG001|Period 1|Other Reason|0|||
105307829|NCT01007942|363125214|FG001|Overall Study|New cancer therapy|1|||
105307830|NCT01007942|363125213|FG000|Overall Study|Protocol Violation|1|||
105575792|NCT00708305|364108330|FG002|Period 1|Other Reason|0|||
105307831|NCT01007942|363125214|FG001|Overall Study|Protocol Violation|1|||
105307832|NCT01007942|363125213|FG000|Overall Study|Withdrawal by Subject|19|||
105575793|NCT00708305|364108331|FG003|Period 1|Other Reason|2|||
105575794|NCT00708305|364108328|FG000|Period 2|Lost to Follow-up|0|||
105575795|NCT00708305|364108329|FG001|Period 2|Lost to Follow-up|1|||
105307833|NCT01007942|363125214|FG001|Overall Study|Withdrawal by Subject|14|||
105307834|NCT01007942|363125213|FG000|Overall Study|Lost to Follow-up|1|||
105575796|NCT00708305|364108330|FG002|Period 2|Lost to Follow-up|0|||
105575797|NCT00708305|364108331|FG003|Period 2|Lost to Follow-up|0|||
105489115|NCT03034200|363803971|FG000|Overall Study|Adjuvant Therapy|0|||
105489116|NCT03034200|363803972|FG001|Overall Study|Adjuvant Therapy|0|||
105489117|NCT03034200|363803973|FG002|Overall Study|Adjuvant Therapy|1|||
105489118|NCT01251146|363803978|FG000|Overall Study|Lost to Follow-up|3|||
105489119|NCT01251146|363803979|FG001|Overall Study|Lost to Follow-up|10|||
105489120|NCT03350984|363803980|FG000|Overall Study|Death|1|||
105489121|NCT03350984|363803981|FG001|Overall Study|Death|0|||
105489122|NCT03350984|363803980|FG000|Overall Study|Lost to Follow-up|5|||
105489123|NCT03350984|363803981|FG001|Overall Study|Lost to Follow-up|6|||
105489124|NCT03350984|363803980|FG000|Overall Study|Protocol Violation|1|||
105489125|NCT03350984|363803981|FG001|Overall Study|Protocol Violation|2|||
105489126|NCT03350984|363803980|FG000|Overall Study|Physician Decision|1|||
105489127|NCT03350984|363803981|FG001|Overall Study|Physician Decision|0|||
105489128|NCT00642473|363803982|FG000|Overall Study|Withdrawal by Subject|0|||
105489129|NCT00642473|363803983|FG001|Overall Study|Withdrawal by Subject|5|||
105489130|NCT00642473|363803982|FG000|Overall Study|Progression or death|2|||
105489131|NCT00642473|363803983|FG001|Overall Study|Progression or death|4|||
105489132|NCT00642473|363803982|FG000|Overall Study|Other|2|||
105489133|NCT00642473|363803983|FG001|Overall Study|Other|2|||
105489134|NCT01466179|363803987|FG000|Overall Study|Ongoing in core study|2|||
105489135|NCT01466179|363803987|FG000|Overall Study|Physician Decision|46|||
105489136|NCT01466179|363803987|FG000|Overall Study|Progressive disease|43|||
105489137|NCT01466179|363803987|FG000|Overall Study|Adverse Event|32|||
105489138|NCT01466179|363803987|FG000|Overall Study|Disease relapse|23|||
105489139|NCT01466179|363803987|FG000|Overall Study|Lack of Efficacy|14|||
105489140|NCT01466179|363803987|FG000|Overall Study|Death|7|||
105489141|NCT01466179|363803987|FG000|Overall Study|Withdrawal by Subject|7|||
105489142|NCT01466179|363803987|FG000|Overall Study|Protocol Violation|2|||
105489143|NCT01466179|363803987|FG000|Overall Study|Other|3|||
105489144|NCT03569293|363803988|FG000|Overall Study|Adverse Event|4|||
105489145|NCT03569293|363803989|FG001|Overall Study|Adverse Event|1|||
105489146|NCT03569293|363803990|FG002|Overall Study|Adverse Event|5|||
105489147|NCT03569293|363803991|FG003|Overall Study|Adverse Event|1|||
105489148|NCT03569293|363803992|FG004|Overall Study|Adverse Event|0|||
105489149|NCT03569293|363803993|FG005|Overall Study|Adverse Event|0|||
105489150|NCT03569293|363803988|FG000|Overall Study|Withdrawal by Subject|16|||
105489151|NCT03569293|363803989|FG001|Overall Study|Withdrawal by Subject|2|||
105489152|NCT03569293|363803990|FG002|Overall Study|Withdrawal by Subject|4|||
105489153|NCT03569293|363803991|FG003|Overall Study|Withdrawal by Subject|1|||
105489154|NCT03569293|363803992|FG004|Overall Study|Withdrawal by Subject|0|||
105489155|NCT03569293|363803993|FG005|Overall Study|Withdrawal by Subject|0|||
105489156|NCT03569293|363803988|FG000|Overall Study|Lost to Follow-up|1|||
105489157|NCT03569293|363803989|FG001|Overall Study|Lost to Follow-up|3|||
105575798|NCT00708305|364108328|FG000|Period 2|Protocol Violation|0|||
105575799|NCT00708305|364108329|FG001|Period 2|Protocol Violation|1|||
105575800|NCT00708305|364108330|FG002|Period 2|Protocol Violation|0|||
105575801|NCT00708305|364108331|FG003|Period 2|Protocol Violation|0|||
105575802|NCT00708305|364108328|FG000|Period 2|Other Reason|1|||
105575803|NCT00708305|364108329|FG001|Period 2|Other Reason|0|||
105575804|NCT00708305|364108330|FG002|Period 2|Other Reason|0|||
105575805|NCT00708305|364108331|FG003|Period 2|Other Reason|1|||
105575806|NCT00708305|364108328|FG000|Period 3|Protocol Violation|0|||
105575807|NCT00708305|364108329|FG001|Period 3|Protocol Violation|2|||
105575808|NCT00708305|364108330|FG002|Period 3|Protocol Violation|0|||
105575809|NCT00708305|364108331|FG003|Period 3|Protocol Violation|0|||
105575810|NCT00708305|364108328|FG000|Period 3|Other Reason|1|||
105827488|NCT00487435|365026470|FG000|Overall Study|Death|2|||
105827489|NCT00487435|365026470|FG000|Overall Study|Lack of Efficacy|33|||
105827490|NCT00487435|365026470|FG000|Overall Study|Lost to Follow-up|54|||
105827491|NCT00487435|365026470|FG000|Overall Study|Pregnancy|2|||
105827492|NCT00487435|365026470|FG000|Overall Study|Withdrawal by Subject|132|||
105489158|NCT03569293|363803990|FG002|Overall Study|Lost to Follow-up|1|||
105489159|NCT03569293|363803991|FG003|Overall Study|Lost to Follow-up|1|||
105827493|NCT00487435|365026470|FG000|Overall Study|Resolution Of Pain|1|||
105827494|NCT00487435|365026470|FG000|Overall Study|Study Medication Non-Compliant|32|||
105489160|NCT03569293|363803992|FG004|Overall Study|Lost to Follow-up|0|||
105489161|NCT03569293|363803993|FG005|Overall Study|Lost to Follow-up|0|||
105827495|NCT00487435|365026470|FG000|Overall Study|Other|83|||
105827496|NCT00868998|365026471|FG000|Overall Study|Screen Failure|1|||
105489162|NCT03569293|363803988|FG000|Overall Study|Other|8|||
105489163|NCT03569293|363803989|FG001|Overall Study|Other|2|||
105489164|NCT03569293|363803990|FG002|Overall Study|Other|1|||
105489165|NCT03569293|363803991|FG003|Overall Study|Other|1|||
105489166|NCT03569293|363803992|FG004|Overall Study|Other|0|||
105489167|NCT03569293|363803993|FG005|Overall Study|Other|0|||
105489168|NCT03569293|363803988|FG000|Overall Study|Ongoing at Time of Analysis|8|||
105489169|NCT03569293|363803989|FG001|Overall Study|Ongoing at Time of Analysis|1|||
105489170|NCT03569293|363803990|FG002|Overall Study|Ongoing at Time of Analysis|3|||
105575811|NCT00708305|364108329|FG001|Period 3|Other Reason|0|||
105827497|NCT00868998|365026471|FG000|Overall Study|Withdrawal by Subject|1|||
105827498|NCT00868998|365026471|FG000|Overall Study|Progression of disease|2|||
105827499|NCT00868998|365026471|FG000|Overall Study|Death|1|||
105827500|NCT01986647|365026472|FG000|Overall Study|Lost to Follow-up|4|||
105827501|NCT01986647|365026473|FG001|Overall Study|Lost to Follow-up|1|||
105827502|NCT01986647|365026474|FG002|Overall Study|Lost to Follow-up|4|||
105827503|NCT01986647|365026475|FG003|Overall Study|Lost to Follow-up|4|||
105827504|NCT01986647|365026472|FG000|Overall Study|Withdrawal by Subject|1|||
105827505|NCT01986647|365026473|FG001|Overall Study|Withdrawal by Subject|3|||
105827506|NCT01986647|365026474|FG002|Overall Study|Withdrawal by Subject|2|||
105827507|NCT01986647|365026475|FG003|Overall Study|Withdrawal by Subject|3|||
105827508|NCT01986647|365026472|FG000|Overall Study|Health|5|||
105827509|NCT01986647|365026473|FG001|Overall Study|Health|3|||
105827510|NCT01986647|365026474|FG002|Overall Study|Health|6|||
105827511|NCT01986647|365026475|FG003|Overall Study|Health|4|||
105827512|NCT01507662|365026476|FG000|Overall Study|Death|26|||
105827513|NCT01507662|365026477|FG001|Overall Study|Death|18|||
105827514|NCT01507662|365026476|FG000|Overall Study|Withdrawal by Subject|290|||
105827515|NCT01507662|365026477|FG001|Overall Study|Withdrawal by Subject|287|||
105827516|NCT01507662|365026476|FG000|Overall Study|Lost to Follow-up|498|||
105827517|NCT01507662|365026477|FG001|Overall Study|Lost to Follow-up|523|||
105827518|NCT01507662|365026476|FG000|Overall Study|Proxy interview done|2|||
105827519|NCT01507662|365026477|FG001|Overall Study|Proxy interview done|3|||
105827520|NCT02911025|365026478|FG000|Overall Study|Lost to Follow-up|3|||
105827521|NCT02272803|365026479|FG000|Overall Study|Disease progression|16|||
105827522|NCT02272803|365026480|FG001|Overall Study|Disease progression|8|||
105827523|NCT02272803|365026479|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
105827524|NCT02272803|365026480|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
105827525|NCT02272803|365026479|FG000|Overall Study|Study drug toxicity|4|||
105827526|NCT02272803|365026480|FG001|Overall Study|Study drug toxicity|9|||
105827527|NCT02272803|365026479|FG000|Overall Study|Participant request to discontinue study treatment|3|||
105307835|NCT01007942|363125214|FG001|Overall Study|Lost to Follow-up|0|||
105307836|NCT01007942|363125213|FG000|Overall Study|Administrative problems|2|||
105307837|NCT01007942|363125214|FG001|Overall Study|Administrative problems|0|||
105307838|NCT01007942|363125213|FG000|Overall Study|Death|3|||
105307839|NCT01007942|363125214|FG001|Overall Study|Death|2|||
105307840|NCT01007942|363125213|FG000|Overall Study|Patients untreated|4|||
105307841|NCT01007942|363125214|FG001|Overall Study|Patients untreated|3|||
105307842|NCT00325195|363125215|FG000|Randomized|Not dosed|5|||
105307843|NCT00325195|363125216|FG001|Randomized|Not dosed|5|||
105307844|NCT00325195|363125217|FG002|Randomized|Not dosed|3|||
105307845|NCT00325195|363125215|FG000|Received Intervention: ITT Population|Adverse Event|15|||
105307846|NCT00325195|363125216|FG001|Received Intervention: ITT Population|Adverse Event|17|||
105307847|NCT00325195|363125217|FG002|Received Intervention: ITT Population|Adverse Event|1|||
105307848|NCT00325195|363125215|FG000|Received Intervention: ITT Population|Death|3|||
105307849|NCT00325195|363125216|FG001|Received Intervention: ITT Population|Death|1|||
105307850|NCT00325195|363125217|FG002|Received Intervention: ITT Population|Death|0|||
105307851|NCT00325195|363125215|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
105307852|NCT00325195|363125216|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
105307853|NCT00325195|363125217|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
105307854|NCT00325195|363125215|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
105307855|NCT00325195|363125216|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
105307856|NCT00325195|363125217|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
105307857|NCT00325195|363125215|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
105307858|NCT00325195|363125216|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
105307859|NCT00325195|363125217|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
105307860|NCT04585789|363125218|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
105307861|NCT04585789|363125219|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
105307862|NCT04585789|363125220|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
105307863|NCT04585789|363125218|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
105307864|NCT04585789|363125219|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
105307865|NCT04585789|363125220|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
105307866|NCT05083585|363125221|FG000|Overall Study|Death|1|||
105366523|NCT01747499|363348437|FG000|Overall Study|Death|0|||
105366524|NCT01747499|363348438|FG001|Overall Study|Death|0|||
105366525|NCT01747499|363348439|FG002|Overall Study|Death|0|||
105366526|NCT01747499|363348440|FG003|Overall Study|Death|1|||
105366527|NCT01747499|363348441|FG004|Overall Study|Death|1|||
105366528|NCT01747499|363348437|FG000|Overall Study|Withdrawal by Subject|0|||
105366529|NCT01747499|363348438|FG001|Overall Study|Withdrawal by Subject|0|||
105366530|NCT01747499|363348439|FG002|Overall Study|Withdrawal by Subject|0|||
105366531|NCT01747499|363348440|FG003|Overall Study|Withdrawal by Subject|0|||
105366532|NCT01747499|363348441|FG004|Overall Study|Withdrawal by Subject|6|||
105366533|NCT01747499|363348437|FG000|Overall Study|Developed AML and death|0|||
105307867|NCT05083585|363125222|FG001|Overall Study|Death|1|||
105366534|NCT01747499|363348438|FG001|Overall Study|Developed AML and death|0|||
105827528|NCT02272803|365026480|FG001|Overall Study|Participant request to discontinue study treatment|7|||
105827529|NCT02272803|365026479|FG000|Overall Study|Maximum clinical benefit|4|||
105827530|NCT02272803|365026480|FG001|Overall Study|Maximum clinical benefit|2|||
105827531|NCT02272803|365026479|FG000|Overall Study|Poor/non-compliance|2|||
105827532|NCT02272803|365026480|FG001|Overall Study|Poor/non-compliance|2|||
105827533|NCT02272803|365026479|FG000|Overall Study|Withdrawal by Subject|2|||
105827534|NCT02272803|365026480|FG001|Overall Study|Withdrawal by Subject|1|||
105827535|NCT02272803|365026479|FG000|Overall Study|Death|0|||
105827536|NCT02272803|365026480|FG001|Overall Study|Death|1|||
105827537|NCT02272803|365026479|FG000|Overall Study|Other reasons|1|||
105827538|NCT02272803|365026480|FG001|Overall Study|Other reasons|3|||
105827539|NCT02272803|365026479|FG000|Overall Study|Administrative reason by sponsor|5|||
105827540|NCT02272803|365026480|FG001|Overall Study|Administrative reason by sponsor|4|||
105827541|NCT00725322|365026481|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
105827542|NCT00725322|365026482|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
105827543|NCT00725322|365026481|FG000|Washout (28 Days)|Protocol Violation|0|||
105827544|NCT00725322|365026482|FG001|Washout (28 Days)|Protocol Violation|1|||
105827545|NCT04474405|365028012|FG000|Overall Study|Withdrawal by Subject|0|||
105827546|NCT04474405|365028013|FG001|Overall Study|Withdrawal by Subject|0|||
105827547|NCT04474405|365028014|FG002|Overall Study|Withdrawal by Subject|1|||
105827548|NCT04474405|365028015|FG003|Overall Study|Withdrawal by Subject|0|||
105827549|NCT04474405|365028016|FG004|Overall Study|Withdrawal by Subject|1|||
105827550|NCT04474405|365028017|FG005|Overall Study|Withdrawal by Subject|0|||
105827551|NCT04474405|365028012|FG000|Overall Study|Other|0|||
105827552|NCT04474405|365028013|FG001|Overall Study|Other|0|||
105827553|NCT04474405|365028014|FG002|Overall Study|Other|0|||
105827554|NCT04474405|365028015|FG003|Overall Study|Other|0|||
105827555|NCT04474405|365028016|FG004|Overall Study|Other|3|||
105827556|NCT04474405|365028017|FG005|Overall Study|Other|0|||
105827557|NCT03599362|365028018|FG000|Overall Study|Screen Failure|3|||
105827558|NCT00635648|365028019|FG000|Overall Study|Adverse Event|12|||
105827559|NCT00635648|365028019|FG000|Overall Study|Withdrawal by Subject|9|||
105827560|NCT00635648|365028019|FG000|Overall Study|Physician Decision|4|||
105827561|NCT00635648|365028019|FG000|Overall Study|Rapid progression of baseline disease|4|||
105827562|NCT00635648|365028019|FG000|Overall Study|Use of other antifungal agent needed|1|||
105827563|NCT00635648|365028019|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
105827564|NCT00635648|365028019|FG000|Overall Study|Noncompliance with protocol|1|||
105827565|NCT00635648|365028019|FG000|Overall Study|Other reason|2|||
105827566|NCT01537887|365028020|FG000|Period 1|Physician Decision|0|||
105827567|NCT01537887|365028021|FG001|Period 1|Physician Decision|0|||
105827568|NCT01537887|365028022|FG002|Period 1|Physician Decision|0|||
105827569|NCT01537887|365028023|FG003|Period 1|Physician Decision|0|||
105827570|NCT01537887|365028024|FG004|Period 1|Physician Decision|1|||
105827571|NCT01537887|365028025|FG005|Period 1|Physician Decision|1|||
105827572|NCT01537887|365028020|FG000|Period 1|Did not receive treatment|0|||
105827573|NCT01537887|365028021|FG001|Period 1|Did not receive treatment|0|||
105827574|NCT01537887|365028022|FG002|Period 1|Did not receive treatment|1|||
105827575|NCT01537887|365028023|FG003|Period 1|Did not receive treatment|0|||
105827576|NCT01537887|365028024|FG004|Period 1|Did not receive treatment|0|||
105827577|NCT01537887|365028025|FG005|Period 1|Did not receive treatment|0|||
105827578|NCT01537887|365028020|FG000|Period 2|Withdrawal by Subject|0|||
105827579|NCT01537887|365028021|FG001|Period 2|Withdrawal by Subject|1|||
105827580|NCT01537887|365028022|FG002|Period 2|Withdrawal by Subject|0|||
105827581|NCT01537887|365028023|FG003|Period 2|Withdrawal by Subject|0|||
105827582|NCT01537887|365028024|FG004|Period 2|Withdrawal by Subject|0|||
105827583|NCT01537887|365028025|FG005|Period 2|Withdrawal by Subject|0|||
105827584|NCT01537887|365028020|FG000|Period 3|Adverse Event|0|||
105827585|NCT01537887|365028021|FG001|Period 3|Adverse Event|0|||
105827586|NCT01537887|365028022|FG002|Period 3|Adverse Event|1|||
105827587|NCT01537887|365028023|FG003|Period 3|Adverse Event|0|||
105575812|NCT00708305|364108330|FG002|Period 3|Other Reason|0|||
105827588|NCT01537887|365028024|FG004|Period 3|Adverse Event|0|||
105827589|NCT01537887|365028025|FG005|Period 3|Adverse Event|0|||
105827590|NCT01537887|365028020|FG000|Period 3|Withdrawal by Subject|0|||
105307868|NCT05083585|363125221|FG000|Overall Study|Lost to Follow-up|1|||
105827591|NCT01537887|365028021|FG001|Period 3|Withdrawal by Subject|1|||
105827592|NCT01537887|365028022|FG002|Period 3|Withdrawal by Subject|0|||
105827593|NCT01537887|365028023|FG003|Period 3|Withdrawal by Subject|0|||
105827594|NCT01537887|365028024|FG004|Period 3|Withdrawal by Subject|0|||
105827595|NCT01537887|365028025|FG005|Period 3|Withdrawal by Subject|0|||
105827596|NCT01370083|365028027|FG000|Overall Study|Lost to Follow-up|2|||
105827597|NCT01370083|365028028|FG001|Overall Study|Lost to Follow-up|0|||
105827598|NCT01370083|365028027|FG000|Overall Study|Adverse Event|0|||
105827599|NCT01370083|365028028|FG001|Overall Study|Adverse Event|1|||
105827600|NCT03497130|365028032|FG000|Overall Study|Lost to Follow-up|1|||
105827601|NCT03497130|365028033|FG001|Overall Study|Lost to Follow-up|1|||
105827602|NCT04002648|365028034|FG000|Overall Study|Lost to Follow-up|2|||
105307869|NCT05083585|363125222|FG001|Overall Study|Lost to Follow-up|1|||
105827603|NCT04002648|365028035|FG001|Overall Study|Lost to Follow-up|0|||
105827604|NCT03358147|365028037|FG000|Overall Study|Withdrawal by Subject|13|||
105827605|NCT03358147|365028038|FG001|Overall Study|Withdrawal by Subject|19|||
105827606|NCT03358147|365028039|FG002|Overall Study|Withdrawal by Subject|16|||
105827607|NCT03358147|365028040|FG003|Overall Study|Withdrawal by Subject|10|||
105827608|NCT03358147|365028041|FG004|Overall Study|Withdrawal by Subject|5|||
105827609|NCT03358147|365028037|FG000|Overall Study|Adverse Event|3|||
105827610|NCT03358147|365028038|FG001|Overall Study|Adverse Event|9|||
105827611|NCT03358147|365028039|FG002|Overall Study|Adverse Event|7|||
105827612|NCT03358147|365028040|FG003|Overall Study|Adverse Event|5|||
105827613|NCT03358147|365028041|FG004|Overall Study|Adverse Event|2|||
105827614|NCT03358147|365028037|FG000|Overall Study|Lost to Follow-up|4|||
105827615|NCT03358147|365028038|FG001|Overall Study|Lost to Follow-up|3|||
105827616|NCT03358147|365028039|FG002|Overall Study|Lost to Follow-up|7|||
105827617|NCT03358147|365028040|FG003|Overall Study|Lost to Follow-up|6|||
105827618|NCT03358147|365028041|FG004|Overall Study|Lost to Follow-up|4|||
105827619|NCT03358147|365028037|FG000|Overall Study|Major Protocol Deviation|11|||
105827620|NCT03358147|365028038|FG001|Overall Study|Major Protocol Deviation|3|||
105827621|NCT03358147|365028039|FG002|Overall Study|Major Protocol Deviation|2|||
105827622|NCT03358147|365028040|FG003|Overall Study|Major Protocol Deviation|3|||
105827623|NCT03358147|365028041|FG004|Overall Study|Major Protocol Deviation|1|||
105827624|NCT03358147|365028037|FG000|Overall Study|Protocol specified criteria|2|||
105827625|NCT03358147|365028038|FG001|Overall Study|Protocol specified criteria|3|||
105827626|NCT03358147|365028039|FG002|Overall Study|Protocol specified criteria|0|||
105827627|NCT03358147|365028040|FG003|Overall Study|Protocol specified criteria|3|||
105827628|NCT03358147|365028041|FG004|Overall Study|Protocol specified criteria|1|||
105827629|NCT03358147|365028037|FG000|Overall Study|Physician Decision|1|||
105827630|NCT03358147|365028038|FG001|Overall Study|Physician Decision|0|||
105827631|NCT03358147|365028039|FG002|Overall Study|Physician Decision|1|||
105827632|NCT03358147|365028040|FG003|Overall Study|Physician Decision|6|||
105827633|NCT03358147|365028041|FG004|Overall Study|Physician Decision|1|||
105827634|NCT03358147|365028037|FG000|Overall Study|Administrative reasons|0|||
105827635|NCT03358147|365028038|FG001|Overall Study|Administrative reasons|1|||
105827636|NCT03358147|365028039|FG002|Overall Study|Administrative reasons|0|||
105827637|NCT03358147|365028040|FG003|Overall Study|Administrative reasons|3|||
105827638|NCT03358147|365028041|FG004|Overall Study|Administrative reasons|0|||
105827639|NCT03358147|365028037|FG000|Overall Study|Lack of Efficacy|0|||
105827640|NCT03358147|365028038|FG001|Overall Study|Lack of Efficacy|1|||
105827641|NCT03358147|365028039|FG002|Overall Study|Lack of Efficacy|1|||
105827642|NCT03358147|365028040|FG003|Overall Study|Lack of Efficacy|0|||
105827643|NCT03358147|365028041|FG004|Overall Study|Lack of Efficacy|0|||
105827644|NCT00731939|365028044|FG000|Overall Study|Adverse Event|6|||
105827645|NCT00731939|365028044|FG000|Overall Study|Lost to Follow-up|15|||
105827646|NCT00731939|365028044|FG000|Overall Study|Not implanted with study device|9|||
105827647|NCT00731939|365028044|FG000|Overall Study|Withdrawal by Subject|2|||
105827648|NCT00731939|365028044|FG000|Overall Study|Did not meet enrollment criteria|2|||
105827649|NCT02072096|365028045|FG000|Overall Study|Lack of Efficacy|18|||
105827650|NCT02072096|365028046|FG001|Overall Study|Lack of Efficacy|29|||
105827651|NCT02072096|365028045|FG000|Overall Study|Protocol Violation|7|||
105827652|NCT02072096|365028046|FG001|Overall Study|Protocol Violation|7|||
105827653|NCT02072096|365028045|FG000|Overall Study|Withdrawal by Subject|5|||
105827654|NCT02072096|365028046|FG001|Overall Study|Withdrawal by Subject|7|||
105827655|NCT02072096|365028045|FG000|Overall Study|Adverse Event|5|||
105827656|NCT02072096|365028046|FG001|Overall Study|Adverse Event|2|||
105827657|NCT02072096|365028045|FG000|Overall Study|No Reason Provided|4|||
105827658|NCT02072096|365028046|FG001|Overall Study|No Reason Provided|2|||
105827659|NCT02072096|365028045|FG000|Overall Study|Death|2|||
105827660|NCT02072096|365028046|FG001|Overall Study|Death|0|||
105827661|NCT02072096|365028045|FG000|Overall Study|Physician Decision|0|||
105827662|NCT02072096|365028046|FG001|Overall Study|Physician Decision|1|||
105827663|NCT02072096|365028045|FG000|Overall Study|Study Terminated by Sponsor|43|||
105827664|NCT02072096|365028046|FG001|Overall Study|Study Terminated by Sponsor|30|||
105827665|NCT02072096|365028045|FG000|Overall Study|Lost to Follow-up|1|||
105827666|NCT02072096|365028046|FG001|Overall Study|Lost to Follow-up|0|||
105827667|NCT02704091|365028047|FG000|Overall Study|Adverse Event|4|||
105827668|NCT02704091|365028048|FG001|Overall Study|Adverse Event|3|||
105827669|NCT02704091|365028047|FG000|Overall Study|Protocol Violation|5|||
105827670|NCT02704091|365028048|FG001|Overall Study|Protocol Violation|3|||
105827671|NCT02704091|365028047|FG000|Overall Study|Consent withdrawn|4|||
105827672|NCT02704091|365028048|FG001|Overall Study|Consent withdrawn|4|||
105827673|NCT02704091|365028047|FG000|Overall Study|Lost to Follow-up|13|||
105827674|NCT02704091|365028048|FG001|Overall Study|Lost to Follow-up|5|||
105827675|NCT02704091|365028047|FG000|Overall Study|Other|2|||
105827676|NCT02704091|365028048|FG001|Overall Study|Other|8|||
105827677|NCT03214588|365028049|FG000|Overall Study|Adverse Event|1|||
105307870|NCT05083585|363125221|FG000|Overall Study|Withdrawal by Subject|2|||
105827678|NCT03214588|365028050|FG001|Overall Study|Adverse Event|0|||
105827679|NCT03214588|365028051|FG002|Overall Study|Adverse Event|2|||
105827680|NCT03214588|365028049|FG000|Overall Study|Reason Not Specified|0|||
105827681|NCT03214588|365028050|FG001|Overall Study|Reason Not Specified|1|||
105827682|NCT03214588|365028051|FG002|Overall Study|Reason Not Specified|0|||
105827683|NCT02679729|365028054|FG000|Overall Study|Lost to Follow-up|0|||
105827684|NCT02679729|365028055|FG001|Overall Study|Lost to Follow-up|1|||
105827685|NCT02679729|365028056|FG002|Overall Study|Lost to Follow-up|0|||
105827686|NCT02679729|365028057|FG003|Overall Study|Lost to Follow-up|0|||
105827687|NCT02679729|365028058|FG004|Overall Study|Lost to Follow-up|1|||
105827688|NCT02679729|365028059|FG005|Overall Study|Lost to Follow-up|0|||
105827689|NCT02679729|365028060|FG006|Overall Study|Lost to Follow-up|0|||
105827690|NCT02679729|365028061|FG007|Overall Study|Lost to Follow-up|0|||
105827691|NCT02679729|365028062|FG008|Overall Study|Lost to Follow-up|0|||
105827692|NCT02679729|365028054|FG000|Overall Study|Participant decision|0|||
105827693|NCT02679729|365028055|FG001|Overall Study|Participant decision|1|||
105827694|NCT02679729|365028056|FG002|Overall Study|Participant decision|0|||
105827695|NCT02679729|365028057|FG003|Overall Study|Participant decision|0|||
105827696|NCT02679729|365028058|FG004|Overall Study|Participant decision|0|||
105827697|NCT02679729|365028059|FG005|Overall Study|Participant decision|0|||
105827698|NCT02679729|365028060|FG006|Overall Study|Participant decision|1|||
105827699|NCT02679729|365028061|FG007|Overall Study|Participant decision|0|||
105827700|NCT02679729|365028062|FG008|Overall Study|Participant decision|0|||
105827701|NCT01186458|365028063|FG000|Overall Study|Adverse Event|1|||
105827702|NCT04567329|365028064|FG000|Overall Study|Withdrawal by Subject|5|||
105827703|NCT04567329|365028065|FG001|Overall Study|Withdrawal by Subject|6|||
105827704|NCT04567329|365028064|FG000|Overall Study|Protocol Violation|2|||
105827705|NCT04567329|365028065|FG001|Overall Study|Protocol Violation|3|||
105827706|NCT04567329|365028064|FG000|Overall Study|Discontinued|2|||
105827707|NCT04567329|365028065|FG001|Overall Study|Discontinued|2|||
105827708|NCT04567329|365028064|FG000|Overall Study|Lost to Follow-up|0|||
105827709|NCT04567329|365028065|FG001|Overall Study|Lost to Follow-up|1|||
105827710|NCT04567329|365028064|FG000|Overall Study|Lack of Efficacy|0|||
105827711|NCT04567329|365028065|FG001|Overall Study|Lack of Efficacy|1|||
105827712|NCT02933060|365028068|FG000|Overall Study|Withdrawal by Subject|0|||
105827713|NCT02933060|365028069|FG001|Overall Study|Withdrawal by Subject|1|||
105827714|NCT05034874|365028070|FG000|Overall Study|Withdrawal by Subject|6|||
105827715|NCT05034874|365028071|FG001|Overall Study|Withdrawal by Subject|6|||
105827716|NCT05034874|365028070|FG000|Overall Study|Lost to Follow-up|18|||
105827717|NCT05034874|365028071|FG001|Overall Study|Lost to Follow-up|8|||
105827718|NCT05034874|365028070|FG000|Overall Study|Physician Decision|0|||
105827719|NCT05034874|365028071|FG001|Overall Study|Physician Decision|1|||
105827720|NCT05034874|365028070|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
105827721|NCT05034874|365028071|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
105827722|NCT00989950|365028072|FG000|Randomized Phase|Protocol Violation|1|||
105827723|NCT00989950|365028073|FG001|Randomized Phase|Protocol Violation|0|||
105827724|NCT00989950|365028074|FG002|Randomized Phase|Protocol Violation|0|||
105575813|NCT00708305|364108331|FG003|Period 3|Other Reason|0|||
105575814|NCT02771210|364108332|FG000|Period 1|Adverse Event|5|||
105827725|NCT00989950|365028075|FG003|Randomized Phase|Protocol Violation|0|||
105827726|NCT00989950|365028072|FG000|Randomized Phase|Adverse Event|0|||
105827727|NCT00989950|365028073|FG001|Randomized Phase|Adverse Event|1|||
105827728|NCT00989950|365028074|FG002|Randomized Phase|Adverse Event|0|||
105827729|NCT00989950|365028075|FG003|Randomized Phase|Adverse Event|0|||
105827730|NCT00474058|365028076|FG000|Overall Study|Adverse Event|11|||
105827731|NCT00474058|365028077|FG001|Overall Study|Adverse Event|6|||
105827732|NCT00474058|365028076|FG000|Overall Study|Lack of Efficacy|0|||
105827733|NCT00474058|365028077|FG001|Overall Study|Lack of Efficacy|4|||
105827734|NCT00474058|365028076|FG000|Overall Study|Withdrawal by Subject|11|||
105827735|NCT00474058|365028077|FG001|Overall Study|Withdrawal by Subject|7|||
105827736|NCT00474058|365028076|FG000|Overall Study|Other|2|||
105827737|NCT00474058|365028077|FG001|Overall Study|Other|0|||
105827738|NCT00624286|365028078|FG000|Overall Study|Protocol Deviation|7|||
105827739|NCT00624286|365028079|FG001|Overall Study|Protocol Deviation|9|||
105827740|NCT00624286|365028078|FG000|Overall Study|Adverse Event|6|||
105827741|NCT00624286|365028079|FG001|Overall Study|Adverse Event|3|||
105827742|NCT00624286|365028078|FG000|Overall Study|Withdrawal by Subject|5|||
105827743|NCT00624286|365028079|FG001|Overall Study|Withdrawal by Subject|4|||
105827744|NCT00624286|365028078|FG000|Overall Study|Lost to Follow-up|3|||
105827745|NCT00624286|365028079|FG001|Overall Study|Lost to Follow-up|2|||
105827746|NCT00624286|365028078|FG000|Overall Study|Administrative problems|3|||
105827747|NCT00624286|365028079|FG001|Overall Study|Administrative problems|0|||
105827748|NCT00624286|365028078|FG000|Overall Study|Lack of Efficacy|1|||
105827749|NCT00624286|365028079|FG001|Overall Study|Lack of Efficacy|6|||
105827750|NCT00624286|365028078|FG000|Overall Study|Not stated|0|||
105827751|NCT00624286|365028079|FG001|Overall Study|Not stated|1|||
105827752|NCT00624286|365028078|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105827753|NCT00624286|365028079|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105827754|NCT00624286|365028078|FG000|Overall Study|Death|0|||
105827755|NCT00624286|365028079|FG001|Overall Study|Death|1|||
105827756|NCT00841659|365028083|FG000|Washout: 2 Weeks|Protocol Violation|1|||
105827757|NCT00841659|365028084|FG001|Washout: 2 Weeks|Protocol Violation|0|||
105827758|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Refused|1|||
105827759|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Refused|3|||
105307871|NCT05083585|363125222|FG001|Overall Study|Withdrawal by Subject|0|||
105307872|NCT05083585|363125221|FG000|Overall Study|Randomized but not vaccinated|2|||
105307873|NCT05083585|363125222|FG001|Overall Study|Randomized but not vaccinated|0|||
105307874|NCT03929757|363125223|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
105307875|NCT03929757|363125224|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
105307876|NCT03929757|363125225|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
105307877|NCT03929757|363125223|FG000|Main Study: Up to Day 365|Other|1|||
105307878|NCT03929757|363125224|FG001|Main Study: Up to Day 365|Other|0|||
105307879|NCT03929757|363125225|FG002|Main Study: Up to Day 365|Other|0|||
105307880|NCT03929757|363125223|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
105307881|NCT03929757|363125224|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
105307882|NCT03929757|363125225|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
105307883|NCT03469336|363125229|FG000|Overall Study|Adverse Event|1|||
105307884|NCT02006693|363125231|FG000|Overall Study|No Reason Specified|6|||
105489171|NCT03569293|363803991|FG003|Overall Study|Ongoing at Time of Analysis|0|||
105489172|NCT03569293|363803992|FG004|Overall Study|Ongoing at Time of Analysis|0|||
105489173|NCT03569293|363803993|FG005|Overall Study|Ongoing at Time of Analysis|0|||
105489174|NCT06460493|363803997|FG000|Overall Study|Withdrawal by Subject|2|||
105489175|NCT03489551|363804000|FG000|Overall Study|Withdrawal by Subject|2|||
105489176|NCT00054717|363804003|FG000|Overall Study|Randomized but not treated|2|||
105489177|NCT00054717|363804004|FG001|Overall Study|Randomized but not treated|8|||
105489178|NCT00054717|363804003|FG000|Overall Study|Adverse Event|70|||
105489179|NCT00054717|363804004|FG001|Overall Study|Adverse Event|22|||
105489180|NCT00054717|363804003|FG000|Overall Study|Protocol Violation|18|||
105489181|NCT00054717|363804004|FG001|Overall Study|Protocol Violation|19|||
105489182|NCT00054717|363804003|FG000|Overall Study|Lost to Follow-up|23|||
105489183|NCT00054717|363804004|FG001|Overall Study|Lost to Follow-up|13|||
105489184|NCT00054717|363804003|FG000|Overall Study|Withdrawal by Subject|32|||
105489185|NCT00054717|363804004|FG001|Overall Study|Withdrawal by Subject|20|||
105489186|NCT00054717|363804003|FG000|Overall Study|Other reason not defined above|117|||
105489187|NCT00054717|363804004|FG001|Overall Study|Other reason not defined above|217|||
105827760|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Medical|0|||
105827761|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Medical|1|||
105827762|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
105827763|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
105827764|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
105827765|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
105827766|NCT02054715|365028085|FG000|Baseline/Follow-up 1|No Reason|0|||
105827767|NCT02054715|365028086|FG001|Baseline/Follow-up 1|No Reason|1|||
105827768|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
105827769|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
105827770|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Ineligible|3|||
105827771|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Ineligible|0|||
105827772|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Hospitalization|1|||
105827773|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Hospitalization|0|||
105827774|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Changed Mind|1|||
105827775|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Changed Mind|0|||
105827776|NCT02054715|365028085|FG000|Follow-up 2|Lost to Followup|3|||
105827777|NCT02054715|365028086|FG001|Follow-up 2|Lost to Followup|1|||
105827778|NCT02054715|365028085|FG000|Follow-up 2|Refused|3|||
105827779|NCT02054715|365028086|FG001|Follow-up 2|Refused|2|||
105827780|NCT02054715|365028085|FG000|Follow-up 2|Followup Not Completed|3|||
105827781|NCT02054715|365028086|FG001|Follow-up 2|Followup Not Completed|4|||
105827782|NCT02054715|365028085|FG000|Follow-up 2|Ineligible|4|||
105827783|NCT02054715|365028086|FG001|Follow-up 2|Ineligible|5|||
105827784|NCT02054715|365028085|FG000|Follow-up 2|Death|3|||
105827785|NCT02054715|365028086|FG001|Follow-up 2|Death|3|||
105827786|NCT02054715|365028085|FG000|Follow-up 2|Hospitalization|0|||
105827787|NCT02054715|365028086|FG001|Follow-up 2|Hospitalization|2|||
105827788|NCT02054715|365028085|FG000|Follow-up 2|Changed MD/Facility|0|||
105827789|NCT02054715|365028086|FG001|Follow-up 2|Changed MD/Facility|1|||
105827790|NCT02054715|365028085|FG000|Follow-up 2|Changed Mind|0|||
105827791|NCT02054715|365028086|FG001|Follow-up 2|Changed Mind|1|||
105827792|NCT02054715|365028085|FG000|Follow-up 2|No Reason|2|||
105827793|NCT02054715|365028086|FG001|Follow-up 2|No Reason|0|||
105827794|NCT02054715|365028085|FG000|Follow-up 2|Treatment Change or Delay|1|||
105827795|NCT02054715|365028086|FG001|Follow-up 2|Treatment Change or Delay|0|||
105827796|NCT03499873|365028090|FG000|Overall Study|Withdrawal by Subject|4|||
105827797|NCT03499873|365028091|FG001|Overall Study|Withdrawal by Subject|6|||
105827798|NCT03499873|365028092|FG002|Overall Study|Withdrawal by Subject|1|||
105827799|NCT03499873|365028090|FG000|Overall Study|Subjects condition worsened|0|||
105827800|NCT03499873|365028091|FG001|Overall Study|Subjects condition worsened|3|||
105827801|NCT03499873|365028092|FG002|Overall Study|Subjects condition worsened|11|||
105307885|NCT02006693|363125232|FG001|Overall Study|No Reason Specified|8|||
105489188|NCT03707184|363804005|FG000|Overall Study|Withdrawal by Subject|2|||
105489189|NCT02604017|363804008|FG000|Overall Study|Withdrew Consent|0|||
105827802|NCT03499873|365028090|FG000|Overall Study|Adverse Event|8|||
105827803|NCT03499873|365028091|FG001|Overall Study|Adverse Event|3|||
105827804|NCT03499873|365028092|FG002|Overall Study|Adverse Event|6|||
105827805|NCT03499873|365028090|FG000|Overall Study|Physician Decision|1|||
105827806|NCT03499873|365028091|FG001|Overall Study|Physician Decision|0|||
105827807|NCT03499873|365028092|FG002|Overall Study|Physician Decision|0|||
105827808|NCT03499873|365028090|FG000|Overall Study|Administrative reasons|0|||
105827809|NCT03499873|365028091|FG001|Overall Study|Administrative reasons|1|||
105827810|NCT03499873|365028092|FG002|Overall Study|Administrative reasons|0|||
105827811|NCT03499873|365028090|FG000|Overall Study|Concomitant therapy|5|||
105827812|NCT03499873|365028091|FG001|Overall Study|Concomitant therapy|4|||
105827813|NCT03499873|365028092|FG002|Overall Study|Concomitant therapy|7|||
105827814|NCT03499873|365028090|FG000|Overall Study|Miscellaneous|1|||
105827815|NCT03499873|365028091|FG001|Overall Study|Miscellaneous|2|||
105827816|NCT03499873|365028092|FG002|Overall Study|Miscellaneous|2|||
105827817|NCT03499873|365028090|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
105827818|NCT03499873|365028091|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
105827819|NCT03499873|365028092|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
105827820|NCT01964950|365028093|FG000|Overall Study|Protocol Violation|25|||
105827821|NCT03255980|365028094|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
105827822|NCT03255980|365028095|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
105827823|NCT03255980|365028096|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
105827824|NCT03255980|365028097|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
105827825|NCT03255980|365028094|FG000|Overall Study|Adverse Event|1|||
105827826|NCT03255980|365028095|FG001|Overall Study|Adverse Event|1|||
105827827|NCT03255980|365028096|FG002|Overall Study|Adverse Event|0|||
105827828|NCT03255980|365028097|FG003|Overall Study|Adverse Event|1|||
105827829|NCT03255980|365028094|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
105827830|NCT03255980|365028095|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
105827831|NCT03255980|365028096|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
105827832|NCT03255980|365028097|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
105827833|NCT03255980|365028094|FG000|Overall Study|Lost to Follow-up|1|||
105827834|NCT03255980|365028095|FG001|Overall Study|Lost to Follow-up|1|||
105827835|NCT03255980|365028096|FG002|Overall Study|Lost to Follow-up|0|||
105827836|NCT03255980|365028097|FG003|Overall Study|Lost to Follow-up|3|||
105827837|NCT03255980|365028094|FG000|Overall Study|Withdrawal by Subject|0|||
105827838|NCT03255980|365028095|FG001|Overall Study|Withdrawal by Subject|1|||
105827839|NCT03255980|365028096|FG002|Overall Study|Withdrawal by Subject|0|||
105827840|NCT03255980|365028097|FG003|Overall Study|Withdrawal by Subject|3|||
105366535|NCT01747499|363348439|FG002|Overall Study|Developed AML and death|0|||
105366536|NCT01747499|363348440|FG003|Overall Study|Developed AML and death|0|||
105366537|NCT01747499|363348441|FG004|Overall Study|Developed AML and death|1|||
105366538|NCT01747499|363348437|FG000|Overall Study|Determined not to be eligible|0|||
105366539|NCT01747499|363348438|FG001|Overall Study|Determined not to be eligible|0|||
105366540|NCT01747499|363348439|FG002|Overall Study|Determined not to be eligible|0|||
105366541|NCT01747499|363348440|FG003|Overall Study|Determined not to be eligible|0|||
105366542|NCT01747499|363348441|FG004|Overall Study|Determined not to be eligible|1|||
105366543|NCT00072410|363348442|FG000|Overall Study|Progressive disease|0|||
105366544|NCT00072410|363348443|FG001|Overall Study|Progressive disease|3|||
105366545|NCT00372424|363348444|FG000|Overall Study|Adverse Event|2|||
105366546|NCT00372424|363348444|FG000|Overall Study|Withdrawal by Subject|1|||
105366547|NCT00372424|363348444|FG000|Overall Study|Death|1|||
105366548|NCT00372424|363348444|FG000|Overall Study|Objective Progression or Relapse|14|||
105489190|NCT02604017|363804009|FG001|Overall Study|Withdrew Consent|2|||
105489191|NCT02604017|363804008|FG000|Overall Study|Lost to Follow-up|5|||
105489192|NCT02604017|363804009|FG001|Overall Study|Lost to Follow-up|6|||
105489193|NCT02604017|363804008|FG000|Overall Study|Other|1|||
105827841|NCT01395017|365028098|FG000|Overall Study|Lost to Follow-up|1|||
105827842|NCT01395017|365028099|FG001|Overall Study|Lost to Follow-up|0|||
105827843|NCT01395017|365028098|FG000|Overall Study|Adverse Event|26|||
105827844|NCT01395017|365028099|FG001|Overall Study|Adverse Event|12|||
105827845|NCT01395017|365028098|FG000|Overall Study|Physician Decision|11|||
105489194|NCT02604017|363804009|FG001|Overall Study|Other|0|||
105489195|NCT00740246|363804010|FG000|Overall Study|Received Blood Transfusion|0|||
105489196|NCT00740246|363804011|FG001|Overall Study|Received Blood Transfusion|1|||
105489197|NCT00740246|363804010|FG000|Overall Study|Adverse Event|1|||
105489198|NCT00740246|363804011|FG001|Overall Study|Adverse Event|2|||
105827846|NCT01395017|365028099|FG001|Overall Study|Physician Decision|15|||
105827847|NCT01395017|365028098|FG000|Overall Study|Withdrawal by Subject|14|||
105366549|NCT00372424|363348444|FG000|Overall Study|Other|7|||
105366550|NCT00372424|363348444|FG000|Overall Study|Enrolled, Not Treated|1|||
105366551|NCT04010461|363348447|FG000|Overall Study|COVID based withdrawal|5|||
105366552|NCT04010461|363348447|FG000|Overall Study|Withdrawal by Subject|5|||
105575815|NCT02771210|364108333|FG001|Period 1|Adverse Event|3|||
105827848|NCT01395017|365028099|FG001|Overall Study|Withdrawal by Subject|8|||
105827849|NCT01395017|365028098|FG000|Overall Study|Protocol deviation|1|||
105827850|NCT01395017|365028099|FG001|Overall Study|Protocol deviation|2|||
105827851|NCT01395017|365028098|FG000|Overall Study|Death|4|||
105827852|NCT01395017|365028099|FG001|Overall Study|Death|3|||
105307886|NCT02006693|363125231|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
105307887|NCT02006693|363125232|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
105307888|NCT02006693|363125231|FG000|Overall Study|XEN Implant Explantation|0|||
105307889|NCT02006693|363125232|FG001|Overall Study|XEN Implant Explantation|1|||
105307890|NCT02006693|363125231|FG000|Overall Study|Death|2|||
105307891|NCT02006693|363125232|FG001|Overall Study|Death|2|||
105307892|NCT02006693|363125231|FG000|Overall Study|Lost to Follow-up|4|||
105307893|NCT02006693|363125232|FG001|Overall Study|Lost to Follow-up|1|||
105307894|NCT02006693|363125231|FG000|Overall Study|Patient Decision|4|||
105307895|NCT02006693|363125232|FG001|Overall Study|Patient Decision|0|||
105307896|NCT04729309|363125233|FG000|Period 1|Subject unable to return for Period 2|3|||
105307897|NCT04729309|363125234|FG001|Period 1|Subject unable to return for Period 2|0|||
105307898|NCT04729309|363125233|FG000|Period 1|Lost to Follow-up|1|||
105307899|NCT04729309|363125234|FG001|Period 1|Lost to Follow-up|0|||
105307900|NCT00117325|363125235|FG000|Overall Study|Adverse Event|3|||
105307901|NCT00117325|363125236|FG001|Overall Study|Adverse Event|3|||
105489199|NCT00740246|363804010|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
105489200|NCT00740246|363804011|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
105489201|NCT00740246|363804010|FG000|Overall Study|Lost to Follow-up|2|||
105489202|NCT00740246|363804011|FG001|Overall Study|Lost to Follow-up|2|||
105489203|NCT00740246|363804010|FG000|Overall Study|Withdrawal by Subject|4|||
105489204|NCT00740246|363804011|FG001|Overall Study|Withdrawal by Subject|3|||
105489205|NCT00740246|363804010|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
105489206|NCT00740246|363804011|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
105489207|NCT00740246|363804010|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
105489208|NCT00740246|363804011|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
105489209|NCT00740246|363804010|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
105489210|NCT00740246|363804011|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
105489211|NCT00740246|363804010|FG000|Overall Study|Unable To Comply With Study Visits|2|||
105489212|NCT00740246|363804011|FG001|Overall Study|Unable To Comply With Study Visits|0|||
105489213|NCT00740246|363804010|FG000|Overall Study|Unable to Access Vein|0|||
105489214|NCT00740246|363804011|FG001|Overall Study|Unable to Access Vein|2|||
105489215|NCT00740246|363804010|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
105489216|NCT00740246|363804011|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
105489217|NCT00206076|363804012|FG000|Overall Study|Physician Decision|2|||
105489218|NCT00206076|363804013|FG001|Overall Study|Physician Decision|0|||
105489219|NCT00206076|363804012|FG000|Overall Study|Withdrawal by Subject|1|||
105489220|NCT00206076|363804013|FG001|Overall Study|Withdrawal by Subject|1|||
105489221|NCT01751802|363804017|FG000|Overall Study|Adverse Event|4|||
105489222|NCT01751802|363804018|FG001|Overall Study|Adverse Event|2|||
105489223|NCT00608543|363804019|FG000|Overall Study|Adverse Event|4|||
105489224|NCT04163718|363804022|FG000|Overall Study|Study terminated|12|||
105489225|NCT01241240|363804023|FG000|Overall Study|Adverse Event|5|||
105489226|NCT01241240|363804024|FG001|Overall Study|Adverse Event|4|||
105489227|NCT01241240|363804023|FG000|Overall Study|Lost to Follow-up|2|||
105489228|NCT01241240|363804024|FG001|Overall Study|Lost to Follow-up|4|||
105489229|NCT01241240|363804023|FG000|Overall Study|Personal Reasons|1|||
105489230|NCT01241240|363804024|FG001|Overall Study|Personal Reasons|1|||
105489231|NCT00450112|363804027|FG000|Overall Study|Other Treatment Required|5|||
105827853|NCT01395017|365028098|FG000|Overall Study|Disease progression|42|||
105827854|NCT01395017|365028099|FG001|Overall Study|Disease progression|58|||
105827855|NCT01395017|365028098|FG000|Overall Study|Sponsor discontinued study|1|||
105827856|NCT01395017|365028099|FG001|Overall Study|Sponsor discontinued study|4|||
105827857|NCT01451541|365028100|FG000|Overall Study|Adverse Event|4|||
105827858|NCT01451541|365028101|FG001|Overall Study|Adverse Event|3|||
105827859|NCT01451541|365028102|FG002|Overall Study|Adverse Event|6|||
105827860|NCT01451541|365028100|FG000|Overall Study|Lack of Efficacy|2|||
105827861|NCT01451541|365028101|FG001|Overall Study|Lack of Efficacy|0|||
105827862|NCT01451541|365028102|FG002|Overall Study|Lack of Efficacy|0|||
105827863|NCT01451541|365028100|FG000|Overall Study|Lost to Follow-up|4|||
105827864|NCT01451541|365028101|FG001|Overall Study|Lost to Follow-up|4|||
105827865|NCT01451541|365028102|FG002|Overall Study|Lost to Follow-up|7|||
105827866|NCT01451541|365028100|FG000|Overall Study|Withdrawal by Subject|15|||
105307902|NCT00117325|363125235|FG000|Overall Study|Lost to Follow-up|1|||
105307903|NCT00117325|363125236|FG001|Overall Study|Lost to Follow-up|1|||
105489232|NCT00450112|363804028|FG001|Overall Study|Other Treatment Required|1|||
105489233|NCT00450112|363804027|FG000|Overall Study|Withdrawal by Subject|4|||
105489234|NCT00450112|363804028|FG001|Overall Study|Withdrawal by Subject|1|||
105489235|NCT00450112|363804027|FG000|Overall Study|Lost to Follow-up|2|||
105489236|NCT00450112|363804028|FG001|Overall Study|Lost to Follow-up|1|||
105307904|NCT00117325|363125235|FG000|Overall Study|Protocol Violation|2|||
105489237|NCT00450112|363804027|FG000|Overall Study|Others|2|||
105489238|NCT00450112|363804028|FG001|Overall Study|Others|3|||
105827867|NCT01451541|365028101|FG001|Overall Study|Withdrawal by Subject|8|||
105827868|NCT01451541|365028102|FG002|Overall Study|Withdrawal by Subject|6|||
105827869|NCT01451541|365028100|FG000|Overall Study|randomization error, noncompliance|11|||
105827870|NCT01451541|365028101|FG001|Overall Study|randomization error, noncompliance|10|||
105827871|NCT01451541|365028102|FG002|Overall Study|randomization error, noncompliance|8|||
105827872|NCT03366428|365028104|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
105827873|NCT03366428|365028104|FG000|Overall Study|Adverse Event|12|||
105827874|NCT03366428|365028104|FG000|Overall Study|Clinical progression|2|||
105827875|NCT03366428|365028104|FG000|Overall Study|Withdrawal by Subject|4|||
105827876|NCT01004510|365028105|FG000|Overall Study|Adverse Event|1|||
105489239|NCT00433654|363804029|FG000|Overall Study|Death|4|||
105489240|NCT00433654|363804030|FG001|Overall Study|Death|0|||
105489241|NCT00433654|363804029|FG000|Overall Study|Missed visit|6|||
105489242|NCT00433654|363804030|FG001|Overall Study|Missed visit|3|||
105489243|NCT00433654|363804029|FG000|Overall Study|Subject not yet due for visit|4|||
105489244|NCT00433654|363804030|FG001|Overall Study|Subject not yet due for visit|0|||
105489245|NCT00433654|363804029|FG000|Overall Study|Withdrawal by Subject|1|||
105489246|NCT00433654|363804030|FG001|Overall Study|Withdrawal by Subject|2|||
105489247|NCT01151098|363804031|FG000|Overall Study|Adverse Event|82|||
105489248|NCT01151098|363804031|FG000|Overall Study|Lost to Follow-up|6|||
105489249|NCT01151098|363804031|FG000|Overall Study|Lack of Efficacy|15|||
105489250|NCT01151098|363804031|FG000|Overall Study|Protocol Violation|1|||
105489251|NCT01151098|363804031|FG000|Overall Study|Miscellaneous|13|||
105827877|NCT03541252|365028109|FG000|Overall Study|Withdrawal by Subject|1|||
105827878|NCT03218787|365028119|FG000|Overall Study|Lost to Follow-up|12|||
105827879|NCT03218787|365028119|FG000|Overall Study|Withdrawal by Subject|72|||
105307905|NCT00117325|363125236|FG001|Overall Study|Protocol Violation|3|||
105307906|NCT00117325|363125235|FG000|Overall Study|Withdrawal by Subject|3|||
105307907|NCT00117325|363125236|FG001|Overall Study|Withdrawal by Subject|2|||
105307908|NCT00117325|363125235|FG000|Overall Study|Lack of Efficacy|1|||
105307909|NCT00117325|363125236|FG001|Overall Study|Lack of Efficacy|0|||
105307910|NCT00117325|363125235|FG000|Overall Study|Use of prohibited medicine|1|||
105827880|NCT03218787|365028119|FG000|Overall Study|Physician Decision|11|||
105827881|NCT03218787|365028119|FG000|Overall Study|Death|111|||
105827882|NCT01960296|365028120|FG000|Overall Study|Postponed surgery|1|||
105827883|NCT01960296|365028121|FG001|Overall Study|Postponed surgery|0|||
105827884|NCT01960296|365028120|FG000|Overall Study|Received different procedure|1|||
105827885|NCT01960296|365028121|FG001|Overall Study|Received different procedure|3|||
105827886|NCT02003391|365028122|FG000|Overall Study|Withdrawal by Subject|2|||
105827887|NCT02003391|365028123|FG001|Overall Study|Withdrawal by Subject|1|||
105827888|NCT02003391|365028122|FG000|Overall Study|Protocol Violation|0|||
105827889|NCT02003391|365028123|FG001|Overall Study|Protocol Violation|1|||
105827890|NCT02003391|365028122|FG000|Overall Study|Adverse Event|1|||
105827891|NCT02003391|365028123|FG001|Overall Study|Adverse Event|0|||
105827892|NCT03719040|365028124|FG000|Overall Study|Withdrawal by Subject|177|||
105827893|NCT03719040|365028124|FG000|Overall Study|Lost to Follow-up|26|||
105827894|NCT00227370|365028125|FG000|Overall Study|Withdrawal by Subject|1|||
105827895|NCT00227370|365028126|FG001|Overall Study|Withdrawal by Subject|2|||
105827896|NCT00227370|365028125|FG000|Overall Study|Death|3|||
105827897|NCT00227370|365028126|FG001|Overall Study|Death|4|||
105827898|NCT00227370|365028125|FG000|Overall Study|Adverse Event|6|||
105827899|NCT00227370|365028126|FG001|Overall Study|Adverse Event|11|||
105827900|NCT00227370|365028125|FG000|Overall Study|Physician Decision|9|||
105827901|NCT00227370|365028126|FG001|Overall Study|Physician Decision|6|||
105827902|NCT00227370|365028125|FG000|Overall Study|Other reasons|2|||
105827903|NCT00227370|365028126|FG001|Overall Study|Other reasons|1|||
105827904|NCT05315713|365028129|FG000|Overall Study|Death|5|||
105827905|NCT05315713|365028129|FG000|Overall Study|Progressive disease|1|||
105827906|NCT05315713|365028129|FG000|Overall Study|Withdrawal by Subject|1|||
105827907|NCT05315713|365028129|FG000|Overall Study|Study terminated by sponsor|1|||
105827908|NCT03961204|365028130|FG000|Overall Study|Withdrawal by Subject|2|||
105827909|NCT03961204|365028130|FG000|Overall Study|Lost to Follow-up|3|||
105827910|NCT03961204|365028130|FG000|Overall Study|Other|1|||
105827911|NCT03961204|365028130|FG000|Overall Study|Missing|1|||
105827912|NCT01120028|365028131|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
105827913|NCT01120028|365028132|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
105489252|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
105489253|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
105827914|NCT01120028|365028133|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
105307911|NCT00117325|363125236|FG001|Overall Study|Use of prohibited medicine|2|||
105307912|NCT00117325|363125235|FG000|Overall Study|Early termination|1|||
105307913|NCT00117325|363125236|FG001|Overall Study|Early termination|1|||
105827915|NCT01120028|365028134|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
105827916|NCT01120028|365028131|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
105827917|NCT01120028|365028132|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
105827918|NCT01120028|365028133|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
105489254|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
105827919|NCT01120028|365028134|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
105827920|NCT01838681|365028137|FG000|Period A|Adverse Event|39|||
105366553|NCT04010461|363348447|FG000|Overall Study|Adverse Event|1|||
105366554|NCT04010461|363348447|FG000|Overall Study|No Motor Threshold obtainable|1|||
105827921|NCT01838681|365028138|FG001|Period A|Adverse Event|0|||
105827922|NCT01838681|365028139|FG002|Period A|Adverse Event|0|||
105827923|NCT01838681|365028140|FG003|Period A|Adverse Event|0|||
105827924|NCT01838681|365028137|FG000|Period A|Lack of Efficacy|21|||
105827925|NCT01838681|365028138|FG001|Period A|Lack of Efficacy|0|||
105827926|NCT01838681|365028139|FG002|Period A|Lack of Efficacy|0|||
105827927|NCT01838681|365028140|FG003|Period A|Lack of Efficacy|0|||
105827928|NCT01838681|365028137|FG000|Period A|Early response|148|||
105827929|NCT01838681|365028138|FG001|Period A|Early response|0|||
105827930|NCT01838681|365028139|FG002|Period A|Early response|0|||
105827931|NCT01838681|365028140|FG003|Period A|Early response|0|||
105827932|NCT01838681|365028137|FG000|Period A|Withdrawal by Subject|70|||
105827933|NCT01838681|365028138|FG001|Period A|Withdrawal by Subject|0|||
105827934|NCT01838681|365028139|FG002|Period A|Withdrawal by Subject|0|||
105827935|NCT01838681|365028140|FG003|Period A|Withdrawal by Subject|0|||
105827936|NCT01838681|365028137|FG000|Period A|Protocol Violation|16|||
105827937|NCT01838681|365028138|FG001|Period A|Protocol Violation|0|||
105827938|NCT01838681|365028139|FG002|Period A|Protocol Violation|0|||
105827939|NCT01838681|365028140|FG003|Period A|Protocol Violation|0|||
105827940|NCT01838681|365028137|FG000|Period A|Non-compliance with IMP|6|||
105827941|NCT01838681|365028138|FG001|Period A|Non-compliance with IMP|0|||
105827942|NCT01838681|365028139|FG002|Period A|Non-compliance with IMP|0|||
105827943|NCT01838681|365028140|FG003|Period A|Non-compliance with IMP|0|||
105827944|NCT01838681|365028137|FG000|Period A|Lost to Follow-up|4|||
105827945|NCT01838681|365028138|FG001|Period A|Lost to Follow-up|0|||
105827946|NCT01838681|365028139|FG002|Period A|Lost to Follow-up|0|||
105827947|NCT01838681|365028140|FG003|Period A|Lost to Follow-up|0|||
105827948|NCT01838681|365028137|FG000|Period A|Withdrawal before treatment|4|||
105827949|NCT01838681|365028138|FG001|Period A|Withdrawal before treatment|0|||
105827950|NCT01838681|365028139|FG002|Period A|Withdrawal before treatment|0|||
105827951|NCT01838681|365028140|FG003|Period A|Withdrawal before treatment|0|||
105827952|NCT01838681|365028137|FG000|Period A|Administrative or other reasons|17|||
105827953|NCT01838681|365028138|FG001|Period A|Administrative or other reasons|0|||
105827954|NCT01838681|365028139|FG002|Period A|Administrative or other reasons|0|||
105827955|NCT01838681|365028140|FG003|Period A|Administrative or other reasons|0|||
105827956|NCT01838681|365028137|FG000|Period B/A+|Adverse Event|0|||
105827957|NCT01838681|365028138|FG001|Period B/A+|Adverse Event|13|||
105827958|NCT01838681|365028139|FG002|Period B/A+|Adverse Event|27|||
105827959|NCT01838681|365028140|FG003|Period B/A+|Adverse Event|16|||
105827960|NCT01838681|365028137|FG000|Period B/A+|Lack of Efficacy|0|||
105827961|NCT01838681|365028138|FG001|Period B/A+|Lack of Efficacy|9|||
105827962|NCT01838681|365028139|FG002|Period B/A+|Lack of Efficacy|11|||
105827963|NCT01838681|365028140|FG003|Period B/A+|Lack of Efficacy|6|||
105827964|NCT01838681|365028137|FG000|Period B/A+|Withdrawal by Subject|0|||
105827965|NCT01838681|365028138|FG001|Period B/A+|Withdrawal by Subject|28|||
105827966|NCT01838681|365028139|FG002|Period B/A+|Withdrawal by Subject|35|||
105827967|NCT01838681|365028140|FG003|Period B/A+|Withdrawal by Subject|47|||
105827968|NCT01838681|365028137|FG000|Period B/A+|Protocol Violation|0|||
105827969|NCT01838681|365028138|FG001|Period B/A+|Protocol Violation|1|||
105827970|NCT01838681|365028139|FG002|Period B/A+|Protocol Violation|4|||
105827971|NCT01838681|365028140|FG003|Period B/A+|Protocol Violation|6|||
105827972|NCT01838681|365028137|FG000|Period B/A+|Non-compliance with IMP|0|||
105827973|NCT01838681|365028138|FG001|Period B/A+|Non-compliance with IMP|2|||
105827974|NCT01838681|365028139|FG002|Period B/A+|Non-compliance with IMP|3|||
105827975|NCT01838681|365028140|FG003|Period B/A+|Non-compliance with IMP|3|||
105827976|NCT01838681|365028137|FG000|Period B/A+|Lost to Follow-up|0|||
105827977|NCT01838681|365028138|FG001|Period B/A+|Lost to Follow-up|2|||
105827978|NCT01838681|365028139|FG002|Period B/A+|Lost to Follow-up|5|||
105827979|NCT01838681|365028140|FG003|Period B/A+|Lost to Follow-up|11|||
105827980|NCT01838681|365028137|FG000|Period B/A+|Withdrawal before treatment|0|||
105827981|NCT01838681|365028138|FG001|Period B/A+|Withdrawal before treatment|1|||
105366555|NCT04010461|363348447|FG000|Overall Study|Physician Decision|1|||
105366556|NCT02314728|363348448|FG000|Overall Study|Protocol Violation|1|||
105366557|NCT02314728|363348449|FG001|Overall Study|Protocol Violation|0|||
105827982|NCT01838681|365028139|FG002|Period B/A+|Withdrawal before treatment|0|||
105827983|NCT01838681|365028140|FG003|Period B/A+|Withdrawal before treatment|0|||
105827984|NCT01838681|365028137|FG000|Period B/A+|Administrative or other reasons|0|||
105827985|NCT01838681|365028138|FG001|Period B/A+|Administrative or other reasons|6|||
105827986|NCT01838681|365028139|FG002|Period B/A+|Administrative or other reasons|10|||
105827987|NCT01838681|365028140|FG003|Period B/A+|Administrative or other reasons|28|||
105827988|NCT02452463|365028143|FG000|Overall Study|Death|1|||
105827989|NCT02452463|365028144|FG001|Overall Study|Death|0|||
105827990|NCT02452463|365028145|FG002|Overall Study|Death|0|||
105827991|NCT02452463|365028143|FG000|Overall Study|Study Suspended|1|||
105827992|NCT02452463|365028144|FG001|Overall Study|Study Suspended|0|||
105827993|NCT02452463|365028145|FG002|Overall Study|Study Suspended|0|||
105827994|NCT02452463|365028143|FG000|Overall Study|Recommended by DSMB|0|||
105827995|NCT02452463|365028144|FG001|Overall Study|Recommended by DSMB|1|||
105827996|NCT02452463|365028145|FG002|Overall Study|Recommended by DSMB|0|||
105827997|NCT02452463|365028143|FG000|Overall Study|Withdrawal by Subject|0|||
105827998|NCT02452463|365028144|FG001|Overall Study|Withdrawal by Subject|1|||
105827999|NCT02452463|365028145|FG002|Overall Study|Withdrawal by Subject|0|||
105828000|NCT03867760|365028146|FG000|Overall Study|Lost to Follow-up|2|||
105828001|NCT03867760|365028147|FG001|Overall Study|Lost to Follow-up|3|||
105828002|NCT03867760|365028146|FG000|Overall Study|Withdrawal by Subject|1|||
105828003|NCT03867760|365028147|FG001|Overall Study|Withdrawal by Subject|2|||
105828004|NCT03867760|365028146|FG000|Overall Study|subject could not meet study logistics|3|||
105828005|NCT03867760|365028147|FG001|Overall Study|subject could not meet study logistics|3|||
105828006|NCT01528735|365028149|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
105828007|NCT01528735|365028150|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
105828008|NCT01528735|365028149|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
105828009|NCT01528735|365028150|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
105828010|NCT00556673|365028151|FG000|Overall Study|Protocol deviation|3|||
105828011|NCT00556673|365028152|FG001|Overall Study|Protocol deviation|2|||
105828012|NCT01401062|365028153|FG000|Overall Study|Death|9|||
105828013|NCT01401062|365028154|FG001|Overall Study|Death|7|||
105828014|NCT01401062|365028153|FG000|Overall Study|Physician Decision|1|||
105828015|NCT01401062|365028154|FG001|Overall Study|Physician Decision|0|||
105828016|NCT01401062|365028153|FG000|Overall Study|Withdrawal by Subject|1|||
105828017|NCT01401062|365028154|FG001|Overall Study|Withdrawal by Subject|1|||
105828018|NCT01131260|365028155|FG000|Overall Study|Randomization error|5|||
105828019|NCT01131260|365028156|FG001|Overall Study|Randomization error|1|||
105828020|NCT01131260|365028155|FG000|Overall Study|Declined to continue participation|8|||
105828021|NCT01131260|365028156|FG001|Overall Study|Declined to continue participation|13|||
105828022|NCT01131260|365028155|FG000|Overall Study|Physician Decision|22|||
105828023|NCT01131260|365028156|FG001|Overall Study|Physician Decision|24|||
105828024|NCT01131260|365028155|FG000|Overall Study|Technical problems|7|||
105828025|NCT01131260|365028156|FG001|Overall Study|Technical problems|6|||
105828026|NCT01131260|365028155|FG000|Overall Study|Staff error|2|||
105828027|NCT01131260|365028156|FG001|Overall Study|Staff error|1|||
105828028|NCT01131260|365028155|FG000|Overall Study|Ineligible|0|||
105828029|NCT01131260|365028156|FG001|Overall Study|Ineligible|2|||
105828030|NCT02011945|365028160|FG000|Overall Study|Participant requested to Discontinue|0|||
105828031|NCT02011945|365028161|FG001|Overall Study|Participant requested to Discontinue|1|||
105828032|NCT02011945|365028162|FG002|Overall Study|Participant requested to Discontinue|1|||
105828033|NCT02011945|365028160|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
105828034|NCT02011945|365028161|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
105828035|NCT02011945|365028162|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
105828036|NCT02011945|365028160|FG000|Overall Study|Study Drug Toxicity|0|||
105828037|NCT02011945|365028161|FG001|Overall Study|Study Drug Toxicity|0|||
105828038|NCT02011945|365028162|FG002|Overall Study|Study Drug Toxicity|1|||
105828039|NCT02011945|365028160|FG000|Overall Study|Treatment Failure|0|||
105828040|NCT02011945|365028161|FG001|Overall Study|Treatment Failure|7|||
105828041|NCT02011945|365028162|FG002|Overall Study|Treatment Failure|6|||
105828042|NCT02011945|365028160|FG000|Overall Study|No Longer Meets Study Criteria|1|||
105828043|NCT02011945|365028161|FG001|Overall Study|No Longer Meets Study Criteria|0|||
105828044|NCT02011945|365028162|FG002|Overall Study|No Longer Meets Study Criteria|0|||
105828045|NCT02011945|365028160|FG000|Overall Study|Proceeded to stem cell transplant|0|||
105828046|NCT02011945|365028161|FG001|Overall Study|Proceeded to stem cell transplant|0|||
105828047|NCT02011945|365028162|FG002|Overall Study|Proceeded to stem cell transplant|1|||
105828048|NCT02011945|365028160|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
105828049|NCT02011945|365028161|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
105828050|NCT02011945|365028162|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
105828051|NCT00679081|365028163|FG000|Overall Study|Lost to Follow-up|1|||
105828052|NCT01566435|365028164|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
105828053|NCT02286466|365028165|FG000|Overall Study|Death|1|||
105828054|NCT02286466|365028166|FG001|Overall Study|Death|3|||
105828055|NCT02286466|365028165|FG000|Overall Study|Withdrawal by Subject|5|||
105828056|NCT02286466|365028166|FG001|Overall Study|Withdrawal by Subject|2|||
105828057|NCT02286466|365028165|FG000|Overall Study|Lost to Follow-up|1|||
105828058|NCT02286466|365028166|FG001|Overall Study|Lost to Follow-up|4|||
105828059|NCT02286466|365028165|FG000|Overall Study|Declined Clinician Assessment|0|||
105828060|NCT02286466|365028166|FG001|Overall Study|Declined Clinician Assessment|1|||
105828061|NCT01912807|365028169|FG000|Overall Study|Did not meet elegibility criteria|6|||
105828062|NCT01912807|365028170|FG001|Overall Study|Did not meet elegibility criteria|4|||
105828063|NCT01912807|365028169|FG000|Overall Study|Lost to Follow-up|36|||
105828064|NCT01912807|365028170|FG001|Overall Study|Lost to Follow-up|37|||
105828065|NCT04750239|365028171|FG000|Overall Study|Withdrawal by Subject|2|||
105828066|NCT04750239|365028171|FG000|Overall Study|Trial terminated by sponsor|1|||
105828067|NCT00919711|365028172|FG000|Overall Study|Withdrawal by Subject|15|||
105828068|NCT00919711|365028173|FG001|Overall Study|Withdrawal by Subject|7|||
105828069|NCT00919711|365028172|FG000|Overall Study|Adverse Event|13|||
105828070|NCT00919711|365028173|FG001|Overall Study|Adverse Event|3|||
105828071|NCT00919711|365028172|FG000|Overall Study|Other|1|||
105828072|NCT00919711|365028173|FG001|Overall Study|Other|2|||
105828073|NCT00919711|365028172|FG000|Overall Study|Administrative Decision|0|||
105828074|NCT00919711|365028173|FG001|Overall Study|Administrative Decision|1|||
105828075|NCT00919711|365028172|FG000|Overall Study|Lost to Follow-up|2|||
105828076|NCT00919711|365028173|FG001|Overall Study|Lost to Follow-up|0|||
105828077|NCT00919711|365028172|FG000|Overall Study|Death|1|||
105828078|NCT00919711|365028173|FG001|Overall Study|Death|0|||
105828079|NCT00919711|365028172|FG000|Overall Study|Noncompliance|1|||
105828080|NCT00919711|365028173|FG001|Overall Study|Noncompliance|0|||
105828081|NCT02535923|365028179|FG000|Overall Study|Lost to Follow-up|5|||
105828082|NCT02535923|365028180|FG001|Overall Study|Lost to Follow-up|5|||
105828083|NCT02535923|365028179|FG000|Overall Study|Withdrawal by Subject|4|||
105828084|NCT02535923|365028180|FG001|Overall Study|Withdrawal by Subject|3|||
105828085|NCT01253564|365028181|FG000|Overall Study|Disease Progression|22|||
105828086|NCT01253564|365028181|FG000|Overall Study|Withdrawal by Subject|1|||
105828087|NCT01253564|365028181|FG000|Overall Study|Serious Adverse Event|1|||
105828088|NCT03694197|365028182|FG000|Overall Study|Adverse Event|9|||
105828089|NCT03694197|365028182|FG000|Overall Study|Protocol became inconvenient to participate|1|||
105828090|NCT03694197|365028182|FG000|Overall Study|Physician Decision|4|||
105828091|NCT03694197|365028182|FG000|Overall Study|Study terminated by sponsor|1350|||
105828092|NCT03694197|365028182|FG000|Overall Study|Participant moved|5|||
105828093|NCT03694197|365028182|FG000|Overall Study|Participant withdrew consent|10|||
105828094|NCT03694197|365028182|FG000|Overall Study|Related to IMP administration|1|||
105828095|NCT03694197|365028182|FG000|Overall Study|Not disclosed|5|||
105828096|NCT01952691|365030525|FG000|Overall Study|Lost to Follow-up|2|||
105828097|NCT00529763|365030526|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
105828098|NCT00529763|365030527|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
105828099|NCT00529763|365030528|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
105828100|NCT00529763|365030526|FG000|Overall Study|Death|1|||
105828101|NCT00529763|365030527|FG001|Overall Study|Death|1|||
105828102|NCT00529763|365030528|FG002|Overall Study|Death|1|||
105828103|NCT00529763|365030526|FG000|Overall Study|Disease Progression|10|||
105828104|NCT00529763|365030527|FG001|Overall Study|Disease Progression|16|||
105828105|NCT00529763|365030528|FG002|Overall Study|Disease Progression|11|||
105828106|NCT00529763|365030526|FG000|Overall Study|Lost to Follow-up|1|||
105828107|NCT00529763|365030527|FG001|Overall Study|Lost to Follow-up|2|||
105828108|NCT00529763|365030528|FG002|Overall Study|Lost to Follow-up|3|||
105828109|NCT00529763|365030526|FG000|Overall Study|Stem Cell Transplant|0|||
105828110|NCT00529763|365030527|FG001|Overall Study|Stem Cell Transplant|3|||
105828111|NCT00529763|365030528|FG002|Overall Study|Stem Cell Transplant|1|||
105828112|NCT00529763|365030526|FG000|Overall Study|Study Drug Toxicity|3|||
105828113|NCT00529763|365030527|FG001|Overall Study|Study Drug Toxicity|6|||
105828114|NCT00529763|365030528|FG002|Overall Study|Study Drug Toxicity|4|||
105828115|NCT00529763|365030526|FG000|Overall Study|Participant Withdrew Consent|2|||
105828116|NCT00529763|365030527|FG001|Overall Study|Participant Withdrew Consent|3|||
105828117|NCT00529763|365030528|FG002|Overall Study|Participant Withdrew Consent|4|||
105828118|NCT00529763|365030526|FG000|Overall Study|Other reasons|2|||
105828119|NCT00529763|365030527|FG001|Overall Study|Other reasons|0|||
105828120|NCT00529763|365030528|FG002|Overall Study|Other reasons|2|||
105828121|NCT00529763|365030526|FG000|Overall Study|Participant request to discontinue treatment|1|||
105828122|NCT00529763|365030527|FG001|Overall Study|Participant request to discontinue treatment|1|||
105828123|NCT00529763|365030528|FG002|Overall Study|Participant request to discontinue treatment|3|||
105828124|NCT02997176|365030529|FG000|Overall Study|Adverse Event|0|||
105828125|NCT02997176|365030530|FG001|Overall Study|Adverse Event|0|||
105828126|NCT02997176|365030531|FG002|Overall Study|Adverse Event|0|||
105828127|NCT02997176|365030532|FG003|Overall Study|Adverse Event|8|||
105828128|NCT02997176|365030529|FG000|Overall Study|Progressive Disease|1|||
105828129|NCT02997176|365030530|FG001|Overall Study|Progressive Disease|0|||
105828130|NCT02997176|365030531|FG002|Overall Study|Progressive Disease|1|||
105307914|NCT00117325|363125235|FG000|Overall Study|Admisnitrative|1|||
105307915|NCT00117325|363125236|FG001|Overall Study|Admisnitrative|0|||
105307916|NCT02885181|363125239|FG000|Overall Study|Investigator's Discretion|0|||
105307917|NCT02885181|363125240|FG001|Overall Study|Investigator's Discretion|1|||
105307918|NCT02885181|363125241|FG002|Overall Study|Investigator's Discretion|0|||
105307919|NCT02885181|363125242|FG003|Overall Study|Investigator's Discretion|1|||
105307920|NCT02885181|363125239|FG000|Overall Study|Adverse Event|0|||
105307921|NCT02885181|363125240|FG001|Overall Study|Adverse Event|0|||
105307922|NCT02885181|363125241|FG002|Overall Study|Adverse Event|0|||
105828131|NCT02997176|365030532|FG003|Overall Study|Progressive Disease|1|||
105828132|NCT02997176|365030529|FG000|Overall Study|Death|0|||
105828133|NCT02997176|365030530|FG001|Overall Study|Death|0|||
105828134|NCT02997176|365030531|FG002|Overall Study|Death|1|||
105828135|NCT02997176|365030532|FG003|Overall Study|Death|1|||
105828136|NCT02997176|365030529|FG000|Overall Study|Withdrawal by Subject|0|||
105828137|NCT02997176|365030530|FG001|Overall Study|Withdrawal by Subject|2|||
105828138|NCT02997176|365030531|FG002|Overall Study|Withdrawal by Subject|0|||
105828139|NCT02997176|365030532|FG003|Overall Study|Withdrawal by Subject|1|||
105828140|NCT02751424|365030533|FG000|Part 2|Adverse Event|0|||
105828141|NCT02751424|365030534|FG001|Part 2|Adverse Event|0|||
105828142|NCT02751424|365030535|FG002|Part 2|Adverse Event|0|||
105828143|NCT02751424|365030536|FG003|Part 2|Adverse Event|0|||
105828144|NCT02751424|365030537|FG004|Part 2|Adverse Event|0|||
105828145|NCT02751424|365030538|FG005|Part 2|Adverse Event|0|||
105828146|NCT02751424|365030539|FG006|Part 2|Adverse Event|0|||
105828147|NCT02751424|365030540|FG007|Part 2|Adverse Event|5|||
105828148|NCT02751424|365030541|FG008|Part 2|Adverse Event|0|||
105828149|NCT00985439|365030542|FG000|Overall Study|Adverse Event|0|||
105828150|NCT00985439|365030543|FG001|Overall Study|Adverse Event|0|||
105828151|NCT00985439|365030544|FG002|Overall Study|Adverse Event|1|||
105828152|NCT00985439|365030545|FG003|Overall Study|Adverse Event|0|||
105828153|NCT00367133|365030553|FG000|2 Years|Death|20|||
105828154|NCT00367133|365030554|FG001|2 Years|Death|12|||
105828155|NCT00367133|365030555|FG002|2 Years|Death|12|||
105828156|NCT00367133|365030553|FG000|2 Years|Dropped|34|||
105828157|NCT00367133|365030554|FG001|2 Years|Dropped|19|||
105828158|NCT00367133|365030555|FG002|2 Years|Dropped|33|||
105828159|NCT00367133|365030553|FG000|2 Years|Missed visit|4|||
105828160|NCT00367133|365030554|FG001|2 Years|Missed visit|5|||
105828161|NCT00367133|365030555|FG002|2 Years|Missed visit|4|||
105828162|NCT02336074|365030557|FG000|Overall Study|Adverse Event|0|||
105828163|NCT02336074|365030558|FG001|Overall Study|Adverse Event|2|||
105828164|NCT00958724|365030564|FG000|Overall Study|Disease Progression|6|||
105828165|NCT05604014|365030582|FG000|Overall Study|Lost to Follow-up|13|||
105828166|NCT01168856|365030583|FG000|Overall Study|Lost to Follow-up|4|||
105828167|NCT01168856|365030584|FG001|Overall Study|Lost to Follow-up|34|||
105828168|NCT01168856|365030583|FG000|Overall Study|Withdrawal by Subject|6|||
105828169|NCT01168856|365030584|FG001|Overall Study|Withdrawal by Subject|8|||
105828170|NCT01168856|365030583|FG000|Overall Study|Physician Decision|2|||
105828171|NCT01168856|365030584|FG001|Overall Study|Physician Decision|1|||
105828172|NCT01168856|365030583|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
105828173|NCT01168856|365030584|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
105828174|NCT01168856|365030583|FG000|Overall Study|Participant received anti-HCV treatment|1|||
105828175|NCT01168856|365030584|FG001|Overall Study|Participant received anti-HCV treatment|0|||
105828176|NCT01168856|365030583|FG000|Overall Study|Death|0|||
105828177|NCT01168856|365030584|FG001|Overall Study|Death|2|||
105828178|NCT01168856|365030583|FG000|Overall Study|Other|1|||
105828179|NCT01168856|365030584|FG001|Overall Study|Other|291|||
105828180|NCT01168856|365030583|FG000|Overall Study|Protocol Violation|4|||
105828181|NCT01168856|365030584|FG001|Overall Study|Protocol Violation|6|||
105828182|NCT01266902|365030585|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
105828183|NCT01266902|365030586|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
105828184|NCT01266902|365030587|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
105828185|NCT01266902|365030585|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
105828186|NCT01266902|365030586|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
105828187|NCT01266902|365030587|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
105828188|NCT01266902|365030585|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
105828189|NCT01266902|365030586|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
105828190|NCT01266902|365030587|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
105828191|NCT01266902|365030585|FG000|Period 1 (Main Study)|Adverse Event|3|||
105828192|NCT01266902|365030586|FG001|Period 1 (Main Study)|Adverse Event|11|||
105828193|NCT01266902|365030587|FG002|Period 1 (Main Study)|Adverse Event|0|||
105828194|NCT01266902|365030585|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
105828195|NCT01266902|365030586|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
105828196|NCT01266902|365030587|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
105828197|NCT01266902|365030585|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
105828198|NCT01266902|365030586|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
105828199|NCT01266902|365030587|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
105828200|NCT01266902|365030585|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
105828201|NCT01266902|365030586|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
105828202|NCT01266902|365030587|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
105828203|NCT01266902|365030585|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
105828204|NCT01266902|365030586|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
105828205|NCT01266902|365030587|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
105828206|NCT01266902|365030585|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
105828207|NCT01266902|365030586|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
105828208|NCT01266902|365030587|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
105828209|NCT01266902|365030585|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
105828210|NCT01266902|365030586|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
105828211|NCT01266902|365030587|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
105828212|NCT02121184|365030588|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
105828213|NCT02121184|365030589|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
105828214|NCT02121184|365030588|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
105828215|NCT02121184|365030589|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
105828216|NCT02121184|365030588|FG000|Overall Study|Emergency cesarean section required|0|||
105828217|NCT02121184|365030589|FG001|Overall Study|Emergency cesarean section required|2|||
105828218|NCT02121184|365030588|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
105307923|NCT02885181|363125242|FG003|Overall Study|Adverse Event|1|||
105307924|NCT02885181|363125239|FG000|Overall Study|Withdrawal by Subject|0|||
105307925|NCT02885181|363125240|FG001|Overall Study|Withdrawal by Subject|0|||
105307926|NCT02885181|363125241|FG002|Overall Study|Withdrawal by Subject|0|||
105307927|NCT02885181|363125242|FG003|Overall Study|Withdrawal by Subject|1|||
105307928|NCT04091659|363125243|FG000|Overall Study|Protocol Violation|3|||
105307929|NCT04091659|363125244|FG001|Overall Study|Protocol Violation|0|||
105307930|NCT04091659|363125243|FG000|Overall Study|Lost to Follow-up|0|||
105307931|NCT04091659|363125244|FG001|Overall Study|Lost to Follow-up|1|||
105307932|NCT00626392|363125245|FG000|Run-in Period|Adverse Event|0|||
105307933|NCT00626392|363125246|FG001|Run-in Period|Adverse Event|0|||
105307934|NCT00626392|363125247|FG002|Run-in Period|Adverse Event|1|||
105307935|NCT00626392|363125248|FG003|Run-in Period|Adverse Event|0|||
105307936|NCT00626392|363125249|FG004|Run-in Period|Adverse Event|1|||
105307937|NCT00626392|363125250|FG005|Run-in Period|Adverse Event|0|||
105307938|NCT00626392|363125245|FG000|Run-in Period|Withdrawal by Subject|0|||
105307939|NCT00626392|363125246|FG001|Run-in Period|Withdrawal by Subject|1|||
105307940|NCT00626392|363125247|FG002|Run-in Period|Withdrawal by Subject|1|||
105307941|NCT00626392|363125248|FG003|Run-in Period|Withdrawal by Subject|1|||
105307942|NCT00626392|363125249|FG004|Run-in Period|Withdrawal by Subject|3|||
105307943|NCT00626392|363125250|FG005|Run-in Period|Withdrawal by Subject|1|||
105307944|NCT00626392|363125245|FG000|Run-in Period|Noncompliance|1|||
105307945|NCT00626392|363125246|FG001|Run-in Period|Noncompliance|0|||
105307946|NCT00626392|363125247|FG002|Run-in Period|Noncompliance|1|||
105307947|NCT00626392|363125248|FG003|Run-in Period|Noncompliance|0|||
105307948|NCT00626392|363125249|FG004|Run-in Period|Noncompliance|0|||
105307949|NCT00626392|363125250|FG005|Run-in Period|Noncompliance|0|||
105307950|NCT00626392|363125245|FG000|Coadministration Period|Adverse Event|3|||
105307951|NCT00626392|363125246|FG001|Coadministration Period|Adverse Event|1|||
105307952|NCT00626392|363125247|FG002|Coadministration Period|Adverse Event|7|||
105307953|NCT00626392|363125248|FG003|Coadministration Period|Adverse Event|4|||
105307954|NCT00626392|363125249|FG004|Coadministration Period|Adverse Event|3|||
105307955|NCT00626392|363125250|FG005|Coadministration Period|Adverse Event|4|||
105307956|NCT00626392|363125245|FG000|Coadministration Period|Withdrawal by Subject|1|||
105307957|NCT00626392|363125246|FG001|Coadministration Period|Withdrawal by Subject|1|||
105307958|NCT00626392|363125247|FG002|Coadministration Period|Withdrawal by Subject|0|||
105307959|NCT00626392|363125248|FG003|Coadministration Period|Withdrawal by Subject|1|||
105307960|NCT00626392|363125249|FG004|Coadministration Period|Withdrawal by Subject|0|||
105307961|NCT00626392|363125250|FG005|Coadministration Period|Withdrawal by Subject|1|||
105307962|NCT00626392|363125245|FG000|Coadministration Period|Protocol Violation|0|||
105307963|NCT00626392|363125246|FG001|Coadministration Period|Protocol Violation|1|||
105307964|NCT00626392|363125247|FG002|Coadministration Period|Protocol Violation|0|||
105307965|NCT00626392|363125248|FG003|Coadministration Period|Protocol Violation|1|||
105307966|NCT00626392|363125249|FG004|Coadministration Period|Protocol Violation|1|||
105307967|NCT00626392|363125250|FG005|Coadministration Period|Protocol Violation|0|||
105307968|NCT00626392|363125245|FG000|Coadministration Period|Other|0|||
105307969|NCT00626392|363125246|FG001|Coadministration Period|Other|2|||
105307970|NCT00626392|363125247|FG002|Coadministration Period|Other|3|||
105307971|NCT00626392|363125248|FG003|Coadministration Period|Other|1|||
105307972|NCT00626392|363125249|FG004|Coadministration Period|Other|1|||
105307973|NCT00626392|363125250|FG005|Coadministration Period|Other|1|||
105307974|NCT05084963|363125251|FG000|Overall Study|Withdrawal by Subject|0|||
105307975|NCT05084963|363125252|FG001|Overall Study|Withdrawal by Subject|0|||
105307976|NCT05084963|363125253|FG002|Overall Study|Withdrawal by Subject|1|||
105307977|NCT03569228|363125254|FG000|Overall Study|Withdrawal by PI|0|||
105307978|NCT03569228|363125255|FG001|Overall Study|Withdrawal by PI|0|||
105307979|NCT03569228|363125256|FG002|Overall Study|Withdrawal by PI|2|||
105307980|NCT03569228|363125257|FG003|Overall Study|Withdrawal by PI|2|||
105307981|NCT03569228|363125258|FG004|Overall Study|Withdrawal by PI|1|||
105307982|NCT03569228|363125259|FG005|Overall Study|Withdrawal by PI|0|||
105307983|NCT03569228|363125260|FG006|Overall Study|Withdrawal by PI|0|||
105307984|NCT03569228|363125261|FG007|Overall Study|Withdrawal by PI|0|||
105307985|NCT03569228|363125262|FG008|Overall Study|Withdrawal by PI|0|||
105307986|NCT03569228|363125254|FG000|Overall Study|Lost to Follow-up|0|||
105307987|NCT03569228|363125255|FG001|Overall Study|Lost to Follow-up|0|||
105307988|NCT03569228|363125256|FG002|Overall Study|Lost to Follow-up|0|||
105307989|NCT03569228|363125257|FG003|Overall Study|Lost to Follow-up|0|||
105307990|NCT03569228|363125258|FG004|Overall Study|Lost to Follow-up|0|||
105307991|NCT03569228|363125259|FG005|Overall Study|Lost to Follow-up|0|||
105307992|NCT03569228|363125260|FG006|Overall Study|Lost to Follow-up|0|||
105307993|NCT03569228|363125261|FG007|Overall Study|Lost to Follow-up|0|||
105307994|NCT03569228|363125262|FG008|Overall Study|Lost to Follow-up|1|||
105307995|NCT03569228|363125254|FG000|Overall Study|Screen Fail|2|||
105307996|NCT03569228|363125255|FG001|Overall Study|Screen Fail|2|||
105307997|NCT03569228|363125256|FG002|Overall Study|Screen Fail|1|||
105307998|NCT03569228|363125257|FG003|Overall Study|Screen Fail|1|||
105307999|NCT03569228|363125258|FG004|Overall Study|Screen Fail|1|||
105308000|NCT03569228|363125259|FG005|Overall Study|Screen Fail|3|||
105308001|NCT03569228|363125260|FG006|Overall Study|Screen Fail|1|||
105308002|NCT03569228|363125261|FG007|Overall Study|Screen Fail|5|||
105308003|NCT03569228|363125262|FG008|Overall Study|Screen Fail|2|||
105308004|NCT05442866|363125263|FG000|Overall Study|Death|1|||
105308005|NCT05442866|363125263|FG000|Overall Study|Lost to Follow-up|9|||
105308006|NCT05442866|363125263|FG000|Overall Study|Protocol Violation|1|||
105308007|NCT03384654|363125264|FG000|Overall Study|Withdrawal by Subject|0|||
105308008|NCT03384654|363125265|FG001|Overall Study|Withdrawal by Subject|0|||
105308009|NCT03384654|363125266|FG002|Overall Study|Withdrawal by Subject|1|||
105308010|NCT03384654|363125267|FG003|Overall Study|Withdrawal by Subject|0|||
105308011|NCT02329847|363125274|FG000|Overall Study|Death|4|||
105308012|NCT02329847|363125275|FG001|Overall Study|Death|4|||
105308013|NCT02329847|363125276|FG002|Overall Study|Death|22|||
105308014|NCT02329847|363125277|FG003|Overall Study|Death|12|||
105308015|NCT02329847|363125278|FG004|Overall Study|Death|20|||
105308016|NCT02329847|363125279|FG005|Overall Study|Death|13|||
105308017|NCT02329847|363125274|FG000|Overall Study|Lost to Follow-up|0|||
105308018|NCT02329847|363125275|FG001|Overall Study|Lost to Follow-up|0|||
105308019|NCT02329847|363125276|FG002|Overall Study|Lost to Follow-up|2|||
105308020|NCT02329847|363125277|FG003|Overall Study|Lost to Follow-up|3|||
105308021|NCT02329847|363125278|FG004|Overall Study|Lost to Follow-up|0|||
105308022|NCT02329847|363125279|FG005|Overall Study|Lost to Follow-up|1|||
105308023|NCT02329847|363125274|FG000|Overall Study|Physician Decision|0|||
105308024|NCT02329847|363125275|FG001|Overall Study|Physician Decision|0|||
105308025|NCT02329847|363125276|FG002|Overall Study|Physician Decision|0|||
105308026|NCT02329847|363125277|FG003|Overall Study|Physician Decision|0|||
105308027|NCT02329847|363125278|FG004|Overall Study|Physician Decision|1|||
105308028|NCT02329847|363125279|FG005|Overall Study|Physician Decision|0|||
105308029|NCT02329847|363125274|FG000|Overall Study|Withdrawal by Subject|2|||
105308030|NCT02329847|363125275|FG001|Overall Study|Withdrawal by Subject|1|||
105308031|NCT02329847|363125276|FG002|Overall Study|Withdrawal by Subject|5|||
105308032|NCT02329847|363125277|FG003|Overall Study|Withdrawal by Subject|7|||
105308033|NCT02329847|363125278|FG004|Overall Study|Withdrawal by Subject|8|||
105308034|NCT02329847|363125279|FG005|Overall Study|Withdrawal by Subject|3|||
105308035|NCT02329847|363125274|FG000|Overall Study|Other|1|||
105308036|NCT02329847|363125275|FG001|Overall Study|Other|2|||
105308037|NCT02329847|363125276|FG002|Overall Study|Other|6|||
105308038|NCT02329847|363125277|FG003|Overall Study|Other|13|||
105308039|NCT02329847|363125278|FG004|Overall Study|Other|10|||
105308040|NCT02329847|363125279|FG005|Overall Study|Other|3|||
105308041|NCT03290079|363125280|FG000|Overall Study|Death|2|||
105308042|NCT01910389|363125283|FG000|Overall Study|Withdrawal by Subject|2|||
105308043|NCT01910389|363125284|FG001|Overall Study|Withdrawal by Subject|0|||
105308044|NCT01910389|363125283|FG000|Overall Study|Study Closed|13|||
105308045|NCT01910389|363125284|FG001|Overall Study|Study Closed|8|||
105308046|NCT04669691|363125288|FG000|Overall Study|Death|0|||
105308047|NCT04669691|363125289|FG001|Overall Study|Death|1|||
105308048|NCT04669691|363125290|FG002|Overall Study|Death|0|||
105308049|NCT04669691|363125291|FG003|Overall Study|Death|0|||
105308050|NCT04669691|363125292|FG004|Overall Study|Death|0|||
105308051|NCT04669691|363125293|FG005|Overall Study|Death|0|||
105308052|NCT03276780|363125295|FG000|Overall Study|Withdrawal by Subject|5|||
105308053|NCT03276780|363125296|FG001|Overall Study|Withdrawal by Subject|3|||
105308054|NCT03276780|363125295|FG000|Overall Study|Lost to Follow-up|3|||
105308055|NCT03276780|363125296|FG001|Overall Study|Lost to Follow-up|5|||
105308056|NCT03276780|363125295|FG000|Overall Study|Moved out of state|1|||
105308057|NCT03276780|363125296|FG001|Overall Study|Moved out of state|1|||
105308058|NCT03276780|363125295|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
105308059|NCT03276780|363125296|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
105308060|NCT03276780|363125295|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
105308061|NCT03276780|363125296|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
105308062|NCT02533375|363125297|FG000|Overall Study|Lack of Efficacy|3|||
105308063|NCT02533375|363125297|FG000|Overall Study|Adverse Event|2|||
105308064|NCT00673387|363125298|FG000|Overall Study|Withdrawal by Subject|15|||
105308065|NCT00673387|363125299|FG001|Overall Study|Withdrawal by Subject|16|||
105308066|NCT00673387|363125300|FG002|Overall Study|Withdrawal by Subject|20|||
105308067|NCT00673387|363125301|FG003|Overall Study|Withdrawal by Subject|16|||
105308068|NCT00673387|363125302|FG004|Overall Study|Withdrawal by Subject|18|||
105308069|NCT00673387|363125303|FG005|Overall Study|Withdrawal by Subject|21|||
105308070|NCT00673387|363125304|FG006|Overall Study|Withdrawal by Subject|15|||
105308071|NCT00673387|363125305|FG007|Overall Study|Withdrawal by Subject|21|||
105308072|NCT00673387|363125298|FG000|Overall Study|Adverse Event|3|||
105308073|NCT00673387|363125299|FG001|Overall Study|Adverse Event|1|||
105308074|NCT00673387|363125300|FG002|Overall Study|Adverse Event|5|||
105308075|NCT00673387|363125301|FG003|Overall Study|Adverse Event|2|||
105308076|NCT00673387|363125302|FG004|Overall Study|Adverse Event|6|||
105308077|NCT00673387|363125303|FG005|Overall Study|Adverse Event|2|||
105308078|NCT00673387|363125304|FG006|Overall Study|Adverse Event|5|||
105308079|NCT00673387|363125305|FG007|Overall Study|Adverse Event|5|||
105308080|NCT00673387|363125298|FG000|Overall Study|Physician Decision|0|||
105308081|NCT00673387|363125299|FG001|Overall Study|Physician Decision|0|||
105308082|NCT00673387|363125300|FG002|Overall Study|Physician Decision|0|||
105308083|NCT00673387|363125301|FG003|Overall Study|Physician Decision|0|||
105308084|NCT00673387|363125302|FG004|Overall Study|Physician Decision|0|||
105308085|NCT00673387|363125303|FG005|Overall Study|Physician Decision|5|||
105308086|NCT00673387|363125304|FG006|Overall Study|Physician Decision|1|||
105828219|NCT02121184|365030589|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
105828220|NCT00840203|365030590|FG000|First Intervention|Protocol Violation|1|||
105828221|NCT00840203|365030591|FG001|First Intervention|Protocol Violation|1|||
105828222|NCT00840203|365030590|FG000|Washout|Protocol Violation|1|||
105828223|NCT00840203|365030591|FG001|Washout|Protocol Violation|0|||
105828224|NCT05562011|365030600|FG000|Overall Study|Withdrawal by Subject|3|||
105828225|NCT05562011|365030600|FG000|Overall Study|Lost to Follow-up|1|||
105828226|NCT05562011|365030600|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
105828227|NCT05562011|365030600|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
105828228|NCT05562011|365030600|FG000|Overall Study|Device malfunction|13|||
105828229|NCT00387153|365030605|FG000|Overall Study|Adverse Event|1|||
105828230|NCT00387153|365030605|FG000|Overall Study|Disease Progression|3|||
105828231|NCT00387153|365030605|FG000|Overall Study|Lack of Response|4|||
105828232|NCT03073798|365030606|FG000|Overall Study|Adverse Event|1|||
105828233|NCT03073798|365030606|FG000|Overall Study|Withdrawal by Subject|1|||
105828234|NCT01945580|365030609|FG000|Overall Study|Withdrawal by Subject|13|||
105828235|NCT01945580|365030610|FG001|Overall Study|Withdrawal by Subject|35|||
105828236|NCT01945580|365030609|FG000|Overall Study|Physician Decision|3|||
105828237|NCT01945580|365030610|FG001|Overall Study|Physician Decision|2|||
105828238|NCT01945580|365030609|FG000|Overall Study|Lost to Follow-up|26|||
105828239|NCT01945580|365030610|FG001|Overall Study|Lost to Follow-up|39|||
105828240|NCT01945580|365030609|FG000|Overall Study|Death|7|||
105828241|NCT01945580|365030610|FG001|Overall Study|Death|2|||
105828242|NCT01945580|365030609|FG000|Overall Study|Patient moved out of state|0|||
105828243|NCT01945580|365030610|FG001|Overall Study|Patient moved out of state|1|||
105828244|NCT01945580|365030609|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
105828245|NCT01945580|365030610|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
105828246|NCT01945580|365030609|FG000|Overall Study|Family illness - unable to return|0|||
105828247|NCT01945580|365030610|FG001|Overall Study|Family illness - unable to return|1|||
105828248|NCT01945580|365030609|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
105828249|NCT01945580|365030610|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
105828250|NCT01945580|365030609|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
105828251|NCT01945580|365030610|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
105828252|NCT01945580|365030609|FG000|Overall Study|Noncompliance with 36 month visit|1|||
105828253|NCT01945580|365030610|FG001|Overall Study|Noncompliance with 36 month visit|0|||
105828254|NCT01945580|365030609|FG000|Overall Study|The patient moved.|1|||
105828255|NCT01945580|365030610|FG001|Overall Study|The patient moved.|0|||
105828256|NCT01945580|365030609|FG000|Overall Study|No data available|0|||
105828257|NCT01945580|365030610|FG001|Overall Study|No data available|2|||
105828258|NCT02957331|365030613|FG000|Overall Study|Protocol Violation|1|||
105828259|NCT02957331|365030614|FG001|Overall Study|Protocol Violation|0|||
105828260|NCT00101439|365030615|FG000|Period 2|Withdrawal by Subject|0|||
105828261|NCT00101439|365030616|FG001|Period 2|Withdrawal by Subject|2|||
105828262|NCT00840658|365030617|FG000|Overall Study|Death|2|||
105828263|NCT00840658|365030618|FG001|Overall Study|Death|2|||
105828264|NCT00840658|365030619|FG002|Overall Study|Death|3|||
105828265|NCT00840658|365030620|FG003|Overall Study|Death|3|||
105828266|NCT00840658|365030617|FG000|Overall Study|Lost to Follow-up|3|||
105828267|NCT00840658|365030618|FG001|Overall Study|Lost to Follow-up|1|||
105828268|NCT00840658|365030619|FG002|Overall Study|Lost to Follow-up|2|||
105828269|NCT00840658|365030620|FG003|Overall Study|Lost to Follow-up|1|||
105828270|NCT01867658|365030621|FG000|Overall Study|Withdrawal by Subject|6|||
105828271|NCT01867658|365030621|FG000|Overall Study|Death|2|||
105828272|NCT01867658|365030621|FG000|Overall Study|Subject could not be contacted|1|||
105828273|NCT03101358|365030622|FG000|Overall Study|Non-compliance with study schedule|1|||
105828274|NCT03101358|365030623|FG001|Overall Study|Non-compliance with study schedule|0|||
105828275|NCT03101358|365030624|FG002|Overall Study|Non-compliance with study schedule|0|||
105828276|NCT03101358|365030625|FG003|Overall Study|Non-compliance with study schedule|1|||
105308087|NCT00673387|363125305|FG007|Overall Study|Physician Decision|1|||
105308088|NCT00673387|363125298|FG000|Overall Study|Protocol Violation|3|||
105308089|NCT00673387|363125299|FG001|Overall Study|Protocol Violation|0|||
105308090|NCT00673387|363125300|FG002|Overall Study|Protocol Violation|1|||
105308091|NCT00673387|363125301|FG003|Overall Study|Protocol Violation|2|||
105308092|NCT00673387|363125302|FG004|Overall Study|Protocol Violation|0|||
105308093|NCT00673387|363125303|FG005|Overall Study|Protocol Violation|1|||
105308094|NCT00673387|363125304|FG006|Overall Study|Protocol Violation|1|||
105308095|NCT00673387|363125305|FG007|Overall Study|Protocol Violation|3|||
105308096|NCT00673387|363125298|FG000|Overall Study|Lost to Follow-up|8|||
105308097|NCT00673387|363125299|FG001|Overall Study|Lost to Follow-up|6|||
105308098|NCT00673387|363125300|FG002|Overall Study|Lost to Follow-up|5|||
105308099|NCT00673387|363125301|FG003|Overall Study|Lost to Follow-up|6|||
105308100|NCT00673387|363125302|FG004|Overall Study|Lost to Follow-up|6|||
105308101|NCT00673387|363125303|FG005|Overall Study|Lost to Follow-up|5|||
105828277|NCT03101358|365030622|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
105828278|NCT03101358|365030623|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
105828279|NCT03101358|365030624|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
105308102|NCT00673387|363125304|FG006|Overall Study|Lost to Follow-up|8|||
105308103|NCT00673387|363125305|FG007|Overall Study|Lost to Follow-up|5|||
105308104|NCT02582866|363125309|FG000|Overall Study|Death|1|||
105308105|NCT02582866|363125309|FG000|Overall Study|Lack of Efficacy|2|||
105308106|NCT02582866|363125309|FG000|Overall Study|Lost to Follow-up|2|||
105308107|NCT02582866|363125309|FG000|Overall Study|Withdrawal by Subject|7|||
105308108|NCT02582866|363125309|FG000|Overall Study|Investigator decision|5|||
105308109|NCT02582866|363125309|FG000|Overall Study|Participant wants to get pregnant|1|||
105308110|NCT02582866|363125309|FG000|Overall Study|Pregnancy|2|||
105308111|NCT02582866|363125309|FG000|Overall Study|Sponsor decision|1|||
105308112|NCT02582866|363125309|FG000|Overall Study|Withdrawal due to personal reasons|1|||
105308113|NCT01709838|363125312|FG000|Overall Study|Withdrawal by Subject|21|||
105308114|NCT01709838|363125312|FG000|Overall Study|Lost to Follow-up|16|||
105308115|NCT01709838|363125312|FG000|Overall Study|Pregnancy|10|||
105308116|NCT01709838|363125312|FG000|Overall Study|Subject/guardian decision|8|||
105308117|NCT01709838|363125312|FG000|Overall Study|Adverse Event|4|||
105308118|NCT01709838|363125312|FG000|Overall Study|Physician Decision|4|||
105308119|NCT01709838|363125312|FG000|Overall Study|Death|3|||
105308120|NCT01709838|363125312|FG000|Overall Study|Protocol Violation|1|||
105308121|NCT03365011|363125313|FG000|Overall Study|Withdrawal by Subject|1|||
105308122|NCT03365011|363125314|FG001|Overall Study|Withdrawal by Subject|2|||
105308123|NCT01193127|363125315|FG000|Randomized|Surgery Cancelled|0|||
105308124|NCT01193127|363125316|FG001|Randomized|Surgery Cancelled|0|||
105308125|NCT01193127|363125317|FG002|Randomized|Surgery Cancelled|0|||
105308126|NCT01193127|363125318|FG003|Randomized|Surgery Cancelled|1|||
105308127|NCT01193127|363125315|FG000|Treated|Withdrawal by Subject|0|||
105308128|NCT01193127|363125316|FG001|Treated|Withdrawal by Subject|0|||
105308129|NCT01193127|363125317|FG002|Treated|Withdrawal by Subject|0|||
105308130|NCT01193127|363125318|FG003|Treated|Withdrawal by Subject|1|||
105308131|NCT04853992|363125319|FG000|Treatment Period A|Adverse Event|0|||
105308132|NCT04853992|363125320|FG001|Treatment Period A|Adverse Event|1|||
105308133|NCT04853992|363125319|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
105308134|NCT04853992|363125320|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
105308135|NCT03246646|363125321|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
105308136|NCT03246646|363125322|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
105308137|NCT03246646|363125321|FG000|Overall Study|Withdrawal by Subject|3|||
105308138|NCT03246646|363125322|FG001|Overall Study|Withdrawal by Subject|0|||
105828280|NCT03101358|365030625|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
105828281|NCT03101358|365030622|FG000|Overall Study|Physician Decision|1|||
105828282|NCT03101358|365030623|FG001|Overall Study|Physician Decision|0|||
105828283|NCT03101358|365030624|FG002|Overall Study|Physician Decision|0|||
105828284|NCT03101358|365030625|FG003|Overall Study|Physician Decision|3|||
105828285|NCT03101358|365030622|FG000|Overall Study|Adverse Event|0|||
105828286|NCT03101358|365030623|FG001|Overall Study|Adverse Event|0|||
105308139|NCT03246646|363125321|FG000|Overall Study|Lost to Follow-up|7|||
105308140|NCT03246646|363125322|FG001|Overall Study|Lost to Follow-up|0|||
105308141|NCT03582826|363125323|FG000|Overall Study|Lost to Follow-up|39|||
105308142|NCT03582826|363125324|FG001|Overall Study|Lost to Follow-up|0|||
105308143|NCT03582826|363125323|FG000|Overall Study|Withdrawal by Subject|2|||
105828287|NCT03101358|365030624|FG002|Overall Study|Adverse Event|1|||
105828288|NCT03101358|365030625|FG003|Overall Study|Adverse Event|0|||
105308144|NCT03582826|363125324|FG001|Overall Study|Withdrawal by Subject|0|||
105308145|NCT00499174|363125325|FG000|Overall Study|Physician Decision|78|||
105308146|NCT00499174|363125326|FG001|Overall Study|Physician Decision|9|||
105308147|NCT01496976|363127107|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
105308148|NCT03548064|363127108|FG000|Overall Study|Withdrawal by Subject|0|||
105308149|NCT03548064|363127109|FG001|Overall Study|Withdrawal by Subject|0|||
105308150|NCT03548064|363127110|FG002|Overall Study|Withdrawal by Subject|0|||
105308151|NCT03548064|363127111|FG003|Overall Study|Withdrawal by Subject|1|||
105308152|NCT03548064|363127112|FG004|Overall Study|Withdrawal by Subject|0|||
105308153|NCT03548064|363127113|FG005|Overall Study|Withdrawal by Subject|0|||
105308154|NCT03548064|363127114|FG006|Overall Study|Withdrawal by Subject|0|||
105828289|NCT03101358|365030622|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
105828290|NCT03101358|365030623|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
105828291|NCT03101358|365030624|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
105828292|NCT03101358|365030625|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
105828293|NCT03101358|365030622|FG000|Overall Study|Lost to Follow-up|1|||
105828294|NCT03101358|365030623|FG001|Overall Study|Lost to Follow-up|0|||
105828295|NCT03101358|365030624|FG002|Overall Study|Lost to Follow-up|0|||
105828296|NCT03101358|365030625|FG003|Overall Study|Lost to Follow-up|1|||
105828297|NCT02845336|365030630|FG000|Overall Study|Lost to Follow-up|3|||
105828298|NCT02845336|365030631|FG001|Overall Study|Lost to Follow-up|1|||
105828299|NCT02845336|365030630|FG000|Overall Study|Inability to get medication|2|||
105828300|NCT02845336|365030631|FG001|Overall Study|Inability to get medication|0|||
105828301|NCT01496118|365030632|FG000|Overall Study|Disease progression|3|||
105828302|NCT01496118|365030633|FG001|Overall Study|Disease progression|2|||
105828303|NCT01496118|365030634|FG002|Overall Study|Disease progression|3|||
105828304|NCT01496118|365030635|FG003|Overall Study|Disease progression|1|||
105828305|NCT01496118|365030636|FG004|Overall Study|Disease progression|2|||
105828306|NCT01496118|365030637|FG005|Overall Study|Disease progression|2|||
105828307|NCT01496118|365030638|FG006|Overall Study|Disease progression|14|||
105828308|NCT01496118|365030639|FG007|Overall Study|Disease progression|10|||
105828309|NCT01496118|365030632|FG000|Overall Study|Physician Decision|0|||
105828310|NCT01496118|365030633|FG001|Overall Study|Physician Decision|0|||
105828311|NCT01496118|365030634|FG002|Overall Study|Physician Decision|0|||
105828312|NCT01496118|365030635|FG003|Overall Study|Physician Decision|0|||
105828313|NCT01496118|365030636|FG004|Overall Study|Physician Decision|1|||
105828314|NCT01496118|365030637|FG005|Overall Study|Physician Decision|0|||
105828315|NCT01496118|365030638|FG006|Overall Study|Physician Decision|3|||
105828316|NCT01496118|365030639|FG007|Overall Study|Physician Decision|6|||
105828317|NCT01496118|365030632|FG000|Overall Study|Adverse Event|1|||
105828318|NCT01496118|365030633|FG001|Overall Study|Adverse Event|1|||
105828319|NCT01496118|365030634|FG002|Overall Study|Adverse Event|0|||
105828320|NCT01496118|365030635|FG003|Overall Study|Adverse Event|0|||
105828321|NCT01496118|365030636|FG004|Overall Study|Adverse Event|0|||
105828322|NCT01496118|365030637|FG005|Overall Study|Adverse Event|0|||
105828323|NCT01496118|365030638|FG006|Overall Study|Adverse Event|6|||
105828324|NCT01496118|365030639|FG007|Overall Study|Adverse Event|10|||
105828325|NCT01496118|365030632|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
105828326|NCT01496118|365030633|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
105828327|NCT01496118|365030634|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
105828328|NCT01496118|365030635|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
105828329|NCT01496118|365030636|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
105828330|NCT01496118|365030637|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
105828331|NCT01496118|365030638|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
105828332|NCT01496118|365030639|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
105828333|NCT01496118|365030632|FG000|Overall Study|Death|0|||
105828334|NCT01496118|365030633|FG001|Overall Study|Death|0|||
105828335|NCT01496118|365030634|FG002|Overall Study|Death|0|||
105828336|NCT01496118|365030635|FG003|Overall Study|Death|0|||
105828337|NCT01496118|365030636|FG004|Overall Study|Death|0|||
105828338|NCT01496118|365030637|FG005|Overall Study|Death|0|||
105828339|NCT01496118|365030638|FG006|Overall Study|Death|1|||
105828340|NCT01496118|365030639|FG007|Overall Study|Death|1|||
105828341|NCT01496118|365030632|FG000|Overall Study|Withdrawal by Subject|0|||
105828342|NCT01496118|365030633|FG001|Overall Study|Withdrawal by Subject|0|||
105828343|NCT01496118|365030634|FG002|Overall Study|Withdrawal by Subject|0|||
105828344|NCT01496118|365030635|FG003|Overall Study|Withdrawal by Subject|2|||
105828345|NCT01496118|365030636|FG004|Overall Study|Withdrawal by Subject|0|||
105828346|NCT01496118|365030637|FG005|Overall Study|Withdrawal by Subject|1|||
105828347|NCT01496118|365030638|FG006|Overall Study|Withdrawal by Subject|6|||
105828348|NCT01496118|365030639|FG007|Overall Study|Withdrawal by Subject|3|||
105828349|NCT00654186|365030652|FG000|Overall Study|Withdrawal by Subject|5|||
105828350|NCT03306277|365030654|FG000|Overall Study|Death|1|||
105828351|NCT03306277|365030654|FG000|Overall Study|Adverse Event|1|||
105828352|NCT03306277|365030654|FG000|Overall Study|Withdrawal by Subject|1|||
105828353|NCT00881751|365030655|FG000|Overall Study|Physician Decision|0|||
105828354|NCT00881751|365030656|FG001|Overall Study|Physician Decision|1|||
105828355|NCT00881751|365030655|FG000|Overall Study|Adverse Event|0|||
105828356|NCT00881751|365030656|FG001|Overall Study|Adverse Event|2|||
105828357|NCT00881751|365030655|FG000|Overall Study|Withdrawal by Subject|0|||
105828358|NCT00881751|365030656|FG001|Overall Study|Withdrawal by Subject|2|||
105828359|NCT00301964|365030657|FG000|Overall Study|Second primary|2|||
105828360|NCT00301964|365030657|FG000|Overall Study|Wrong primary|1|||
105828361|NCT00301964|365030657|FG000|Overall Study|Inadequate pathology|1|||
105828362|NCT02385708|365030658|FG000|Overall Study|Withdrawal by Subject|0|||
105308155|NCT03548064|363127115|FG007|Overall Study|Withdrawal by Subject|0|||
105308156|NCT03548064|363127108|FG000|Overall Study|Lost to Follow-up|0|||
105308157|NCT03548064|363127109|FG001|Overall Study|Lost to Follow-up|0|||
105308158|NCT03548064|363127110|FG002|Overall Study|Lost to Follow-up|0|||
105308159|NCT03548064|363127111|FG003|Overall Study|Lost to Follow-up|0|||
105308160|NCT03548064|363127112|FG004|Overall Study|Lost to Follow-up|2|||
105308161|NCT03548064|363127113|FG005|Overall Study|Lost to Follow-up|0|||
105308162|NCT03548064|363127114|FG006|Overall Study|Lost to Follow-up|0|||
105308163|NCT03548064|363127115|FG007|Overall Study|Lost to Follow-up|0|||
105308164|NCT03548064|363127108|FG000|Overall Study|Covid-19 Pandemic|0|||
105308165|NCT03548064|363127109|FG001|Overall Study|Covid-19 Pandemic|0|||
105308166|NCT03548064|363127110|FG002|Overall Study|Covid-19 Pandemic|0|||
105308167|NCT03548064|363127111|FG003|Overall Study|Covid-19 Pandemic|0|||
105308168|NCT03548064|363127112|FG004|Overall Study|Covid-19 Pandemic|10|||
105308169|NCT03548064|363127113|FG005|Overall Study|Covid-19 Pandemic|3|||
105308170|NCT03548064|363127114|FG006|Overall Study|Covid-19 Pandemic|0|||
105308171|NCT03548064|363127115|FG007|Overall Study|Covid-19 Pandemic|0|||
105308172|NCT05011123|363127116|FG000|Overall Study|Withdrawal by Subject|4|||
105308173|NCT05011123|363127117|FG001|Overall Study|Withdrawal by Subject|2|||
105828363|NCT02385708|365030659|FG001|Overall Study|Withdrawal by Subject|2|||
105308174|NCT05011123|363127116|FG000|Overall Study|Lost to Follow-up|7|||
105308175|NCT05011123|363127117|FG001|Overall Study|Lost to Follow-up|6|||
105308176|NCT05011123|363127116|FG000|Overall Study|Ongoing at the time of DBL date|36|||
105308177|NCT05011123|363127117|FG001|Overall Study|Ongoing at the time of DBL date|10|||
105308178|NCT05011123|363127116|FG000|Overall Study|Randomized but did not receive vaccination|1|||
105308179|NCT05011123|363127117|FG001|Overall Study|Randomized but did not receive vaccination|0|||
105308180|NCT04941729|363127118|FG000|Overall Study|Death|0|||
105308181|NCT04941729|363127119|FG001|Overall Study|Death|1|||
105308182|NCT04941729|363127118|FG000|Overall Study|Study terminated by sponsor|11|||
105308183|NCT04941729|363127119|FG001|Overall Study|Study terminated by sponsor|10|||
105308184|NCT04221789|363127120|FG000|Overall Study|deviation from protoco|22|||
105308185|NCT04221789|363127121|FG001|Overall Study|deviation from protoco|8|||
105308186|NCT03611543|363127122|FG000|Overall Study|Withdrawal by Subject|4|||
105308187|NCT03611543|363127123|FG001|Overall Study|Withdrawal by Subject|4|||
105308188|NCT03611543|363127122|FG000|Overall Study|Physician Decision|1|||
105308189|NCT03611543|363127123|FG001|Overall Study|Physician Decision|1|||
105308190|NCT03611543|363127122|FG000|Overall Study|Protocol Violation|2|||
105308191|NCT03611543|363127123|FG001|Overall Study|Protocol Violation|2|||
105308192|NCT03611543|363127122|FG000|Overall Study|Device failure|2|||
105308193|NCT03611543|363127123|FG001|Overall Study|Device failure|2|||
105308194|NCT03611543|363127122|FG000|Overall Study|Missing information|5|||
105308195|NCT03611543|363127123|FG001|Overall Study|Missing information|5|||
105308196|NCT02081209|363127124|FG000|Overall Study|Withdrawal by Subject|1|||
105308197|NCT05061134|363127132|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
105308198|NCT05061134|363127133|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
105308199|NCT05061134|363127134|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
105308200|NCT05061134|363127132|FG000|Overall Study|Subject not treated|0|||
105308201|NCT05061134|363127133|FG001|Overall Study|Subject not treated|0|||
105308202|NCT05061134|363127134|FG002|Overall Study|Subject not treated|2|||
105308203|NCT05061134|363127132|FG000|Overall Study|Other|0|||
105308204|NCT05061134|363127133|FG001|Overall Study|Other|0|||
105308205|NCT05061134|363127134|FG002|Overall Study|Other|9|||
105308206|NCT05061134|363127132|FG000|Overall Study|Withdrawal by Subject|9|||
105308207|NCT05061134|363127133|FG001|Overall Study|Withdrawal by Subject|8|||
105308208|NCT05061134|363127134|FG002|Overall Study|Withdrawal by Subject|5|||
105308209|NCT05061134|363127132|FG000|Overall Study|Study Terminated by Sponsor|22|||
105308210|NCT05061134|363127133|FG001|Overall Study|Study Terminated by Sponsor|14|||
105308211|NCT05061134|363127134|FG002|Overall Study|Study Terminated by Sponsor|7|||
105308212|NCT05061134|363127132|FG000|Overall Study|Progressive Disease|1|||
105308213|NCT05061134|363127133|FG001|Overall Study|Progressive Disease|2|||
105308214|NCT05061134|363127134|FG002|Overall Study|Progressive Disease|0|||
105308215|NCT05061134|363127132|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
105308216|NCT05061134|363127133|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
105308217|NCT05061134|363127134|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
105308218|NCT05061134|363127132|FG000|Overall Study|Lost to Follow-up|1|||
105308219|NCT05061134|363127133|FG001|Overall Study|Lost to Follow-up|0|||
105308220|NCT05061134|363127134|FG002|Overall Study|Lost to Follow-up|0|||
105308221|NCT05061134|363127132|FG000|Overall Study|Physician Decision|1|||
105308222|NCT05061134|363127133|FG001|Overall Study|Physician Decision|1|||
105308223|NCT05061134|363127134|FG002|Overall Study|Physician Decision|0|||
105308224|NCT05061134|363127132|FG000|Overall Study|Disease progression|1|||
105308225|NCT05061134|363127133|FG001|Overall Study|Disease progression|0|||
105308226|NCT05061134|363127134|FG002|Overall Study|Disease progression|0|||
105308227|NCT05061134|363127132|FG000|Overall Study|Death|43|||
105308228|NCT05061134|363127133|FG001|Overall Study|Death|23|||
105308229|NCT05061134|363127134|FG002|Overall Study|Death|14|||
105308230|NCT05061134|363127132|FG000|Overall Study|Database lock|2|||
105828364|NCT02385708|365030658|FG000|Overall Study|Withdrawn - surgery canceled|2|||
105828365|NCT02385708|365030659|FG001|Overall Study|Withdrawn - surgery canceled|5|||
105828366|NCT02385708|365030658|FG000|Overall Study|Investigator decision|5|||
105828367|NCT02385708|365030659|FG001|Overall Study|Investigator decision|7|||
105828368|NCT02385708|365030658|FG000|Overall Study|Protocol Violation|1|||
105828369|NCT02385708|365030659|FG001|Overall Study|Protocol Violation|1|||
105828370|NCT02471807|365030665|FG000|Overall Study|Death|14|||
105828371|NCT02471807|365030665|FG000|Overall Study|Withdrawal by Subject|2|||
105828372|NCT02471807|365030665|FG000|Overall Study|Explant|5|||
105828373|NCT02471807|365030665|FG000|Overall Study|Lost to Follow-up|1|||
105828374|NCT00672984|365030668|FG000|First Intervention|Adverse Event|5|||
105828375|NCT00672984|365030669|FG001|First Intervention|Adverse Event|0|||
105828376|NCT00672984|365030670|FG002|First Intervention|Adverse Event|0|||
105828377|NCT00672984|365030668|FG000|First Intervention|Withdrawal by Subject|1|||
105828378|NCT00672984|365030669|FG001|First Intervention|Withdrawal by Subject|2|||
105828379|NCT00672984|365030670|FG002|First Intervention|Withdrawal by Subject|2|||
105828380|NCT00672984|365030668|FG000|First Intervention|Sponsor decision|3|||
105828381|NCT00672984|365030669|FG001|First Intervention|Sponsor decision|0|||
105828382|NCT00672984|365030670|FG002|First Intervention|Sponsor decision|0|||
105828383|NCT00672984|365030668|FG000|Second Intervention|Non-compliance with facility policies|0|||
105828384|NCT00672984|365030669|FG001|Second Intervention|Non-compliance with facility policies|2|||
105828385|NCT00672984|365030670|FG002|Second Intervention|Non-compliance with facility policies|0|||
105828386|NCT00672984|365030668|FG000|Second Intervention|Withdrawal by Subject|0|||
105828387|NCT00672984|365030669|FG001|Second Intervention|Withdrawal by Subject|3|||
105828388|NCT00672984|365030670|FG002|Second Intervention|Withdrawal by Subject|0|||
105828389|NCT00672984|365030668|FG000|Second Intervention|Protocol Violation|0|||
105828390|NCT00672984|365030669|FG001|Second Intervention|Protocol Violation|1|||
105828391|NCT00672984|365030670|FG002|Second Intervention|Protocol Violation|1|||
105828392|NCT00672984|365030668|FG000|Third Intervention|Adverse Event|1|||
105828393|NCT00672984|365030669|FG001|Third Intervention|Adverse Event|0|||
105828394|NCT00672984|365030670|FG002|Third Intervention|Adverse Event|1|||
105828395|NCT00354835|365030671|FG000|Overall Study|Death|1|||
105828396|NCT00354835|365030672|FG001|Overall Study|Death|1|||
105828397|NCT00354835|365030671|FG000|Overall Study|Physician Decision|8|||
105828398|NCT00354835|365030672|FG001|Overall Study|Physician Decision|13|||
105828399|NCT00354835|365030671|FG000|Overall Study|Withdrawal by Subject|2|||
105828400|NCT00354835|365030672|FG001|Overall Study|Withdrawal by Subject|1|||
105828401|NCT00354835|365030671|FG000|Overall Study|Ineligible|17|||
105828402|NCT00354835|365030672|FG001|Overall Study|Ineligible|16|||
105828403|NCT00354835|365030671|FG000|Overall Study|Disease progression or relapse|15|||
105828404|NCT00354835|365030672|FG001|Overall Study|Disease progression or relapse|22|||
105828405|NCT00354835|365030671|FG000|Overall Study|Adverse Event|6|||
105828406|NCT00354835|365030672|FG001|Overall Study|Adverse Event|0|||
105828407|NCT00354835|365030671|FG000|Overall Study|Refusal of further therapy|3|||
105828408|NCT00354835|365030672|FG001|Overall Study|Refusal of further therapy|8|||
105828409|NCT03277248|365030680|FG000|Overall Study|Adverse Event|3|||
105828410|NCT03277248|365030681|FG001|Overall Study|Adverse Event|1|||
105828411|NCT03277248|365030680|FG000|Overall Study|Subject Withdrawal of Consent|6|||
105828412|NCT03277248|365030681|FG001|Overall Study|Subject Withdrawal of Consent|23|||
105828413|NCT03277248|365030680|FG000|Overall Study|Investigator/Sponsor Decision|2|||
105828414|NCT03277248|365030681|FG001|Overall Study|Investigator/Sponsor Decision|2|||
105828415|NCT03277248|365030680|FG000|Overall Study|Pregnancy|4|||
105828416|NCT03277248|365030681|FG001|Overall Study|Pregnancy|1|||
105828417|NCT03277248|365030680|FG000|Overall Study|Lost to Follow-up|0|||
105828418|NCT03277248|365030681|FG001|Overall Study|Lost to Follow-up|2|||
105828419|NCT03277248|365030680|FG000|Overall Study|Lack of Efficacy|0|||
105828420|NCT03277248|365030681|FG001|Overall Study|Lack of Efficacy|2|||
105828421|NCT03277248|365030680|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
105828422|NCT03277248|365030681|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
105828423|NCT01663896|365030684|FG000|Overall Study|Various reasons|43|||
105828424|NCT01046084|365030691|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
105828425|NCT01046084|365030692|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
105828426|NCT00999687|365030693|FG000|First Intervention|Withdrawal by Subject|1|||
105828427|NCT00999687|365030693|FG000|Second Intervention|Withdrawal by Subject|2|||
105828428|NCT00999687|365030693|FG000|Second Intervention|Lack of Efficacy|1|||
105828429|NCT00474188|365030696|FG000|Overall Study|Withdrawal by Subject|1|||
105828430|NCT00474188|365030696|FG000|Overall Study|Study discontinued by sponsor|5|||
105828431|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
105828432|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
105828433|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
105828434|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
105828435|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
105828436|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828437|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828438|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828439|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
105308231|NCT05061134|363127133|FG001|Overall Study|Database lock|0|||
105308232|NCT05061134|363127134|FG002|Overall Study|Database lock|0|||
105308233|NCT04654468|363127135|FG000|Overall Study|Death|1|||
105308234|NCT04654468|363127135|FG000|Overall Study|Ongoing in the Study|50|||
105308235|NCT03786718|363127138|FG000|Overall Study|Lost to Follow-up|3|||
105308236|NCT03786718|363127138|FG000|Overall Study|Withdrawal by Subject|1|||
105308237|NCT03786718|363127138|FG000|Overall Study|Did not use the intervention|2|||
105308238|NCT03786718|363127138|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
105308239|NCT04710979|363127139|FG000|Overall Study|Lost to Follow-up|2|||
105308240|NCT04710979|363127140|FG001|Overall Study|Lost to Follow-up|4|||
105308241|NCT04710979|363127139|FG000|Overall Study|Withdrawal by Subject|1|||
105308242|NCT04710979|363127140|FG001|Overall Study|Withdrawal by Subject|0|||
105308243|NCT04241315|363127149|FG000|Overall Study|Withdrawal by Subject|0|||
105308244|NCT04241315|363127150|FG001|Overall Study|Withdrawal by Subject|1|||
105308245|NCT00372411|363127153|FG000|Overall Study|Withdrawal by Subject|3|||
105308246|NCT00372411|363127154|FG001|Overall Study|Withdrawal by Subject|4|||
105308247|NCT00372411|363127155|FG002|Overall Study|Withdrawal by Subject|1|||
105308248|NCT00372411|363127153|FG000|Overall Study|Death|0|||
105308249|NCT00372411|363127154|FG001|Overall Study|Death|2|||
105308250|NCT00372411|363127155|FG002|Overall Study|Death|1|||
105308251|NCT00372411|363127153|FG000|Overall Study|Lost to Follow-up|1|||
105308252|NCT00372411|363127154|FG001|Overall Study|Lost to Follow-up|1|||
105308253|NCT00372411|363127155|FG002|Overall Study|Lost to Follow-up|1|||
105308254|NCT00372411|363127153|FG000|Overall Study|Adverse Event|1|||
105308255|NCT00372411|363127154|FG001|Overall Study|Adverse Event|1|||
105308256|NCT00372411|363127155|FG002|Overall Study|Adverse Event|0|||
105308257|NCT01398514|363127160|FG000|Overall Study|Adverse Event|1|||
105308258|NCT01398514|363127161|FG001|Overall Study|Adverse Event|0|||
105308259|NCT01398514|363127160|FG000|Overall Study|Non-compliance with study procedures|2|||
105308260|NCT01398514|363127161|FG001|Overall Study|Non-compliance with study procedures|0|||
105308261|NCT01398514|363127160|FG000|Overall Study|Physiologic non-responsiveness|1|||
105308262|NCT01398514|363127161|FG001|Overall Study|Physiologic non-responsiveness|3|||
105308263|NCT01398514|363127160|FG000|Overall Study|Failure to show a conditioned response|4|||
105308264|NCT01398514|363127161|FG001|Overall Study|Failure to show a conditioned response|3|||
105366558|NCT02314728|363348448|FG000|Overall Study|Lost to Follow-up|0|||
105828440|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828441|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828442|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828443|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828444|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828445|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828446|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828447|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828448|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828449|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828450|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828451|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828452|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828453|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828454|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828455|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828456|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828457|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828458|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
105828459|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828460|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828461|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828462|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828463|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828464|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828465|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828466|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828467|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828468|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105366559|NCT02314728|363348449|FG001|Overall Study|Lost to Follow-up|1|||
105366560|NCT03177148|363348456|FG000|Overall Study|Lost to Follow-up|50|||
105828469|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105308265|NCT01284361|363127162|FG000|Overall Study|Withdrawal by Subject|1|||
105308266|NCT01284361|363127162|FG000|Overall Study|Protocol Violation|5|||
105308267|NCT01284361|363127162|FG000|Overall Study|Adverse Event|1|||
105308268|NCT01284361|363127162|FG000|Overall Study|Lost to Follow-up|2|||
105308269|NCT04283500|363127168|FG000|Overall Study|Lost to Follow-up|8|||
105366561|NCT03177148|363348457|FG001|Overall Study|Lost to Follow-up|1|||
105828470|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828471|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828472|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828473|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828474|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828475|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828476|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828477|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828478|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828479|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828480|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828481|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828482|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828483|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828484|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
105828485|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828486|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828487|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828488|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828489|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828490|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828491|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828492|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828493|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828494|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828495|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828496|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828497|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828498|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828499|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828500|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828501|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828502|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828503|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828504|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828505|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828506|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828507|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828508|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828509|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
105828510|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828511|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
105828512|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
105828513|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
105828514|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828515|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828516|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828517|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828518|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828519|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828520|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828521|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828522|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828523|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828524|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828525|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828526|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828527|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828528|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828529|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828530|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828531|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828532|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828533|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828534|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828535|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
105828536|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
105828537|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
105828538|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
105828539|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
105828540|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105489255|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
105828541|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828542|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828543|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828544|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828545|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828546|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828547|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828548|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828549|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828550|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828551|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828552|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828553|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828554|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828555|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828556|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828557|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828558|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828559|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828560|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828561|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|moved|0|||
105828562|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|moved|1|||
105828563|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|moved|1|||
105828564|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|moved|0|||
105828565|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|moved|0|||
105828566|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|moved|0|||
105828567|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|moved|0|||
105828568|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|moved|0|||
105828569|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|moved|0|||
105828570|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|moved|0|||
105828571|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|moved|0|||
105828572|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|moved|0|||
105828573|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|moved|0|||
105828574|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|moved|0|||
105828575|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|moved|0|||
105828576|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|moved|0|||
105828577|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|moved|0|||
105828578|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|moved|0|||
105828579|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|moved|0|||
105489256|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
105489257|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
105489258|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
105489259|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
105489260|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
105489261|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
105489262|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
105489263|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
105828580|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|moved|0|||
105828581|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|moved|0|||
105828582|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|moved|0|||
105828583|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|moved|0|||
105828584|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|moved|0|||
105828585|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|moved|0|||
105828586|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|moved|0|||
105828587|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828588|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828589|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828590|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
105828591|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828592|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828593|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828594|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828595|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828596|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105489264|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
105489265|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
105489266|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
105828597|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828598|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828599|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828600|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828601|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828602|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828603|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828604|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828605|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828606|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828607|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828608|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828609|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828610|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828611|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828612|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828613|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828614|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828615|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828616|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828617|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
105828618|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828619|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828620|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828621|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828622|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828623|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828624|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828625|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828626|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828627|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828628|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828629|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828630|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828631|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828632|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828633|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828634|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828635|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828636|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828637|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828638|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828639|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
105828640|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
105828641|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
105828642|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
105828643|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
105828644|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
105828645|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
105828646|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
105828647|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
105828648|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
105828649|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
105828650|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
105828651|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
105828652|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
105828653|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
105828654|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
105828655|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
105828656|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
105828657|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
105828658|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
105828659|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
105828660|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
105828661|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
105828662|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
105828663|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
105828664|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
105828665|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828666|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828667|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828668|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828669|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828670|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
105828671|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
105828672|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828673|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828674|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
105828675|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828676|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828677|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828678|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828679|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828680|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828681|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828682|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828683|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828684|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828685|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828686|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828687|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828688|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828689|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828690|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828691|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828692|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828693|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828694|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828695|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828696|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828697|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828698|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828699|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
105828700|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828701|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828702|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828703|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828704|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828705|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828706|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828707|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828708|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828709|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828710|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828711|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828712|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828713|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828714|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828715|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828716|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828717|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828718|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828719|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828720|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828721|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828722|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828723|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828724|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828725|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
105828726|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828727|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828728|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828729|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828730|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828731|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
105489267|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
105828732|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828733|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828734|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828735|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828736|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828737|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828738|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828739|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828740|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828741|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828742|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828743|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828744|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828745|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828746|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828747|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828748|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
105828749|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
105828750|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
105828751|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
105828752|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
105828753|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828754|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828755|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828756|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828757|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828758|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828759|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828760|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828761|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828762|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828763|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828764|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828765|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828766|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828767|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828768|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828769|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828770|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828771|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828772|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828773|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828774|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828775|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828776|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828777|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828778|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
105828779|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828780|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828781|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828782|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828783|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828784|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105308270|NCT04283500|363127168|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
105308271|NCT01119508|363127173|FG000|Overall Study|Adverse Event|56|||
105489268|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Program Termination|3|||
105489269|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Program Termination|0|||
105489270|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Program Termination|1|||
105489271|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Program Termination|1|||
105828785|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828786|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828787|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828788|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828789|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105308272|NCT01119508|363127173|FG000|Overall Study|Withdrawal by Subject|2|||
105828790|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828791|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828792|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828793|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828794|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828795|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828796|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828797|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828798|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828799|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828800|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828801|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828802|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828803|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828804|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
105828805|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828806|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828807|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828808|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828809|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828810|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828811|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828812|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828813|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828814|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828815|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828816|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828817|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828818|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828819|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828820|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828821|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|Moved|0|||
105828822|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|Moved|0|||
105828823|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|Moved|0|||
105828824|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|Moved|0|||
105828825|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|Moved|0|||
105828826|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|Moved|0|||
105828827|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|Moved|0|||
105828828|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|Moved|0|||
105828829|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|Moved|0|||
105828830|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|Moved|1|||
105828831|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|Moved|0|||
105828832|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|Moved|0|||
105828833|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|Moved|0|||
105828834|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|Moved|0|||
105828835|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|Moved|0|||
105828836|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|Moved|0|||
105828837|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|Moved|0|||
105828838|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|Moved|0|||
105828839|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|Moved|0|||
105828840|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|Moved|0|||
105828841|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|Moved|0|||
105828842|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|Moved|0|||
105828843|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|Moved|0|||
105828844|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|Moved|0|||
105828845|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|Moved|0|||
105828846|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|Moved|0|||
105828847|NCT00112437|365030697|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
105828848|NCT00112437|365030698|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
105828849|NCT00112437|365030699|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
105308273|NCT01119508|363127173|FG000|Overall Study|Died before tumor response evaluation|1|||
105308274|NCT02315196|363127174|FG000|Overall Study|Withdrew consent|9|||
105308275|NCT01087489|363127175|FG000|Overall Study|enrolled in another VA study|0|||
105828850|NCT00112437|365030700|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
105828851|NCT00112437|365030701|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
105828852|NCT00112437|365030702|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
105828853|NCT00112437|365030703|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
105828854|NCT00112437|365030704|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
105828855|NCT00112437|365030705|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
105828856|NCT00112437|365030706|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
105828857|NCT00112437|365030707|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
105828858|NCT00112437|365030708|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
105308276|NCT01087489|363127176|FG001|Overall Study|enrolled in another VA study|1|||
105828859|NCT00112437|365030709|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
105828860|NCT00112437|365030710|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
105828861|NCT00112437|365030711|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
105828862|NCT00112437|365030712|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
105828863|NCT00112437|365030713|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
105828864|NCT00112437|365030714|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
105828865|NCT00112437|365030715|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
105828866|NCT00112437|365030716|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
105828867|NCT00112437|365030717|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
105828868|NCT00112437|365030718|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
105828869|NCT00112437|365030719|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
105828870|NCT00112437|365030720|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
105828871|NCT00112437|365030721|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
105828872|NCT00112437|365030722|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
105828873|NCT00112437|365030697|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828874|NCT00112437|365030698|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828875|NCT00112437|365030699|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828876|NCT00112437|365030700|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828877|NCT00112437|365030701|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828878|NCT00112437|365030702|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828879|NCT00112437|365030703|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828880|NCT00112437|365030704|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828881|NCT00112437|365030705|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828882|NCT00112437|365030706|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828883|NCT00112437|365030707|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828884|NCT00112437|365030708|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
105828885|NCT00112437|365030709|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828886|NCT00112437|365030710|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
105828887|NCT00112437|365030711|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828888|NCT00112437|365030712|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
105828889|NCT00112437|365030713|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828890|NCT00112437|365030714|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828891|NCT00112437|365030715|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
105828892|NCT00112437|365030716|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828893|NCT00112437|365030717|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828894|NCT00112437|365030718|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828895|NCT00112437|365030719|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828896|NCT00112437|365030720|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828897|NCT00112437|365030721|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828898|NCT00112437|365030722|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828899|NCT00112437|365030697|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828900|NCT00112437|365030698|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828901|NCT00112437|365030699|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828902|NCT00112437|365030700|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828903|NCT00112437|365030701|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828904|NCT00112437|365030702|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828905|NCT00112437|365030703|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828906|NCT00112437|365030704|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828907|NCT00112437|365030705|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828908|NCT00112437|365030706|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828909|NCT00112437|365030707|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828910|NCT00112437|365030708|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828911|NCT00112437|365030709|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828912|NCT00112437|365030710|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828913|NCT00112437|365030711|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828914|NCT00112437|365030712|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
105828915|NCT00112437|365030713|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828916|NCT00112437|365030714|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828917|NCT00112437|365030715|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105489272|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
105575816|NCT02771210|364108332|FG000|Period 1|Lack of Efficacy|3|||
105828918|NCT00112437|365030716|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828919|NCT00112437|365030717|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828920|NCT00112437|365030718|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828921|NCT00112437|365030719|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828922|NCT00112437|365030720|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828923|NCT00112437|365030721|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828924|NCT00112437|365030722|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828925|NCT00112437|365030697|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828926|NCT00112437|365030698|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828927|NCT00112437|365030699|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828928|NCT00112437|365030700|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828929|NCT00112437|365030701|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828930|NCT00112437|365030702|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828931|NCT00112437|365030703|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828932|NCT00112437|365030704|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828933|NCT00112437|365030705|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828934|NCT00112437|365030706|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828935|NCT00112437|365030707|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828936|NCT00112437|365030708|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828937|NCT00112437|365030709|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828938|NCT00112437|365030710|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828939|NCT00112437|365030711|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828940|NCT00112437|365030712|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
105828941|NCT00112437|365030713|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828942|NCT00112437|365030714|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828943|NCT00112437|365030715|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828944|NCT00112437|365030716|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828945|NCT00112437|365030717|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828946|NCT00112437|365030718|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828947|NCT00112437|365030719|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828948|NCT00112437|365030720|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828949|NCT00112437|365030721|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828950|NCT00112437|365030722|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828951|NCT00112437|365030697|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828952|NCT00112437|365030698|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828953|NCT00112437|365030699|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828954|NCT00112437|365030700|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828955|NCT00112437|365030701|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828956|NCT00112437|365030702|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828957|NCT00112437|365030703|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828958|NCT00112437|365030704|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828959|NCT00112437|365030705|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828960|NCT00112437|365030706|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828961|NCT00112437|365030707|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828962|NCT00112437|365030708|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
105828963|NCT00112437|365030709|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828964|NCT00112437|365030710|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828965|NCT00112437|365030711|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
105828966|NCT00112437|365030712|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828967|NCT00112437|365030713|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828968|NCT00112437|365030714|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828969|NCT00112437|365030715|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828970|NCT00112437|365030716|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828971|NCT00112437|365030717|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828972|NCT00112437|365030718|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828973|NCT00112437|365030719|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828974|NCT00112437|365030720|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828975|NCT00112437|365030721|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828976|NCT00112437|365030722|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828977|NCT00112437|365030697|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828978|NCT00112437|365030698|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828979|NCT00112437|365030699|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828980|NCT00112437|365030700|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828981|NCT00112437|365030701|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828982|NCT00112437|365030702|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828983|NCT00112437|365030703|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828984|NCT00112437|365030704|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828985|NCT00112437|365030705|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828986|NCT00112437|365030706|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828987|NCT00112437|365030707|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
105828988|NCT00112437|365030708|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
105828989|NCT00112437|365030709|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828990|NCT00112437|365030710|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828991|NCT00112437|365030711|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828992|NCT00112437|365030712|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828993|NCT00112437|365030713|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105308277|NCT01087489|363127175|FG000|Overall Study|Death|0|||
105308278|NCT01087489|363127176|FG001|Overall Study|Death|1|||
105828994|NCT00112437|365030714|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828995|NCT00112437|365030715|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828996|NCT00112437|365030716|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828997|NCT00112437|365030717|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828998|NCT00112437|365030718|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828999|NCT00112437|365030719|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105829000|NCT00112437|365030720|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105829001|NCT00112437|365030721|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105829002|NCT00112437|365030722|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105829003|NCT00112437|365030697|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829004|NCT00112437|365030698|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829005|NCT00112437|365030699|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829006|NCT00112437|365030700|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829007|NCT00112437|365030701|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829008|NCT00112437|365030702|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829009|NCT00112437|365030703|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829010|NCT00112437|365030704|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829011|NCT00112437|365030705|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829012|NCT00112437|365030706|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829013|NCT00112437|365030707|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829014|NCT00112437|365030708|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829015|NCT00112437|365030709|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829016|NCT00112437|365030710|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829017|NCT00112437|365030711|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829018|NCT00112437|365030712|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829019|NCT00112437|365030713|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829020|NCT00112437|365030714|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829021|NCT00112437|365030715|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829022|NCT00112437|365030716|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829023|NCT00112437|365030717|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
105829024|NCT00112437|365030718|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
105829025|NCT00112437|365030719|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829026|NCT00112437|365030720|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829027|NCT00112437|365030721|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829028|NCT00112437|365030722|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829029|NCT00112437|365030697|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829030|NCT00112437|365030698|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829031|NCT00112437|365030699|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829032|NCT00112437|365030700|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829033|NCT00112437|365030701|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829034|NCT00112437|365030702|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829035|NCT00112437|365030703|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829036|NCT00112437|365030704|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829037|NCT00112437|365030705|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829038|NCT00112437|365030706|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829039|NCT00112437|365030707|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829040|NCT00112437|365030708|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829041|NCT00112437|365030709|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829042|NCT00112437|365030710|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829043|NCT00112437|365030711|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829044|NCT00112437|365030712|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829045|NCT00112437|365030713|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829046|NCT00112437|365030714|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829047|NCT00112437|365030715|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829048|NCT00112437|365030716|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829049|NCT00112437|365030717|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
105829050|NCT00112437|365030718|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829051|NCT00112437|365030719|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829052|NCT00112437|365030720|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829053|NCT00112437|365030721|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829054|NCT00112437|365030722|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829055|NCT00112437|365030697|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829056|NCT00112437|365030698|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829057|NCT00112437|365030699|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829058|NCT00112437|365030700|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829059|NCT00112437|365030701|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829060|NCT00112437|365030702|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829061|NCT00112437|365030703|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829062|NCT00112437|365030704|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829063|NCT00112437|365030705|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829064|NCT00112437|365030706|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829065|NCT00112437|365030707|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829066|NCT00112437|365030708|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829067|NCT00112437|365030709|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829068|NCT00112437|365030710|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829069|NCT00112437|365030711|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829070|NCT00112437|365030712|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829071|NCT00112437|365030713|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829072|NCT00112437|365030714|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829073|NCT00112437|365030715|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829074|NCT00112437|365030716|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829075|NCT00112437|365030717|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829076|NCT00112437|365030718|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
105829077|NCT00112437|365030719|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829078|NCT00112437|365030720|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829079|NCT00112437|365030721|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829080|NCT00112437|365030722|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829081|NCT00112437|365030697|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829082|NCT00112437|365030698|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829083|NCT00112437|365030699|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829084|NCT00112437|365030700|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829085|NCT00112437|365030701|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829086|NCT00112437|365030702|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829087|NCT00112437|365030703|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829088|NCT00112437|365030704|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829089|NCT00112437|365030705|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829090|NCT00112437|365030706|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829091|NCT00112437|365030707|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829092|NCT00112437|365030708|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829093|NCT00112437|365030709|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829094|NCT00112437|365030710|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829095|NCT00112437|365030711|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829096|NCT00112437|365030712|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829097|NCT00112437|365030713|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829098|NCT00112437|365030714|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829099|NCT00112437|365030715|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829100|NCT00112437|365030716|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829101|NCT00112437|365030717|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829102|NCT00112437|365030718|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
105829103|NCT00112437|365030719|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829104|NCT00112437|365030720|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829105|NCT00112437|365030721|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829106|NCT00112437|365030722|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
105489273|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
105829107|NCT00112437|365030697|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829108|NCT00112437|365030698|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829109|NCT00112437|365030699|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829110|NCT00112437|365030700|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829111|NCT00112437|365030701|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829112|NCT00112437|365030702|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829113|NCT00112437|365030703|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829114|NCT00112437|365030704|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829115|NCT00112437|365030705|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829116|NCT00112437|365030706|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829117|NCT00112437|365030707|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829118|NCT00112437|365030708|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829119|NCT00112437|365030709|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829120|NCT00112437|365030710|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829121|NCT00112437|365030711|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829122|NCT00112437|365030712|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105489274|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
105829123|NCT00112437|365030713|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829124|NCT00112437|365030714|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105366562|NCT03177148|363348456|FG000|Overall Study|Death|1|||
105366563|NCT03177148|363348457|FG001|Overall Study|Death|0|||
105829125|NCT00112437|365030715|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829126|NCT00112437|365030716|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829127|NCT00112437|365030717|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
105829128|NCT00112437|365030718|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
105829129|NCT00112437|365030719|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829130|NCT00112437|365030720|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829131|NCT00112437|365030721|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829132|NCT00112437|365030722|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829133|NCT00112437|365030697|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829134|NCT00112437|365030698|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829135|NCT00112437|365030699|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829136|NCT00112437|365030700|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829137|NCT00112437|365030701|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829138|NCT00112437|365030702|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829139|NCT00112437|365030703|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829140|NCT00112437|365030704|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829141|NCT00112437|365030705|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829142|NCT00112437|365030706|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829143|NCT00112437|365030707|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829144|NCT00112437|365030708|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829145|NCT00112437|365030709|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829146|NCT00112437|365030710|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829147|NCT00112437|365030711|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829148|NCT00112437|365030712|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829149|NCT00112437|365030713|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829150|NCT00112437|365030714|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829151|NCT00112437|365030715|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829152|NCT00112437|365030716|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829153|NCT00112437|365030717|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829154|NCT00112437|365030718|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829155|NCT00112437|365030719|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
105829156|NCT00112437|365030720|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
105829157|NCT00112437|365030721|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829158|NCT00112437|365030722|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
105829159|NCT00112437|365030697|FG000|Years 6-10 (60-Month Extension)|Death|0|||
105829160|NCT00112437|365030698|FG001|Years 6-10 (60-Month Extension)|Death|0|||
105829161|NCT00112437|365030699|FG002|Years 6-10 (60-Month Extension)|Death|0|||
105829162|NCT00112437|365030700|FG003|Years 6-10 (60-Month Extension)|Death|0|||
105829163|NCT00112437|365030701|FG004|Years 6-10 (60-Month Extension)|Death|0|||
105829164|NCT00112437|365030702|FG005|Years 6-10 (60-Month Extension)|Death|0|||
105829165|NCT00112437|365030703|FG006|Years 6-10 (60-Month Extension)|Death|0|||
105829166|NCT00112437|365030704|FG007|Years 6-10 (60-Month Extension)|Death|0|||
105829167|NCT00112437|365030705|FG008|Years 6-10 (60-Month Extension)|Death|0|||
105829168|NCT00112437|365030706|FG009|Years 6-10 (60-Month Extension)|Death|0|||
105829169|NCT00112437|365030707|FG010|Years 6-10 (60-Month Extension)|Death|0|||
105829170|NCT00112437|365030708|FG011|Years 6-10 (60-Month Extension)|Death|0|||
105829171|NCT00112437|365030709|FG012|Years 6-10 (60-Month Extension)|Death|0|||
105829172|NCT00112437|365030710|FG013|Years 6-10 (60-Month Extension)|Death|0|||
105829173|NCT00112437|365030711|FG014|Years 6-10 (60-Month Extension)|Death|0|||
105829174|NCT00112437|365030712|FG015|Years 6-10 (60-Month Extension)|Death|0|||
105829175|NCT00112437|365030713|FG016|Years 6-10 (60-Month Extension)|Death|0|||
105829176|NCT00112437|365030714|FG017|Years 6-10 (60-Month Extension)|Death|0|||
105829177|NCT00112437|365030715|FG018|Years 6-10 (60-Month Extension)|Death|0|||
105829178|NCT00112437|365030716|FG019|Years 6-10 (60-Month Extension)|Death|0|||
105829179|NCT00112437|365030717|FG020|Years 6-10 (60-Month Extension)|Death|0|||
105829180|NCT00112437|365030718|FG021|Years 6-10 (60-Month Extension)|Death|0|||
105829181|NCT00112437|365030719|FG022|Years 6-10 (60-Month Extension)|Death|0|||
105829182|NCT00112437|365030720|FG023|Years 6-10 (60-Month Extension)|Death|2|||
105829183|NCT00112437|365030721|FG024|Years 6-10 (60-Month Extension)|Death|0|||
105829184|NCT00112437|365030722|FG025|Years 6-10 (60-Month Extension)|Death|0|||
105829185|NCT00112437|365030697|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829186|NCT00112437|365030698|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829187|NCT00112437|365030699|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829188|NCT00112437|365030700|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829189|NCT00112437|365030701|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829190|NCT00112437|365030702|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829191|NCT00112437|365030703|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829192|NCT00112437|365030704|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829193|NCT00112437|365030705|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829194|NCT00112437|365030706|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829195|NCT00112437|365030707|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829196|NCT00112437|365030708|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829197|NCT00112437|365030709|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829198|NCT00112437|365030710|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829199|NCT00112437|365030711|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829200|NCT00112437|365030712|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829201|NCT00112437|365030713|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829202|NCT00112437|365030714|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829203|NCT00112437|365030715|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829204|NCT00112437|365030716|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829205|NCT00112437|365030717|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829206|NCT00112437|365030718|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829207|NCT00112437|365030719|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829208|NCT00112437|365030720|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829209|NCT00112437|365030721|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829210|NCT00112437|365030722|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
105829211|NCT00112437|365030697|FG000|Years 6-10 (60-Month Extension)|Other|0|||
105829212|NCT00112437|365030698|FG001|Years 6-10 (60-Month Extension)|Other|0|||
105829213|NCT00112437|365030699|FG002|Years 6-10 (60-Month Extension)|Other|0|||
105829214|NCT00112437|365030700|FG003|Years 6-10 (60-Month Extension)|Other|0|||
105829215|NCT00112437|365030701|FG004|Years 6-10 (60-Month Extension)|Other|0|||
105829216|NCT00112437|365030702|FG005|Years 6-10 (60-Month Extension)|Other|0|||
105829217|NCT00112437|365030703|FG006|Years 6-10 (60-Month Extension)|Other|0|||
105829218|NCT00112437|365030704|FG007|Years 6-10 (60-Month Extension)|Other|0|||
105829219|NCT00112437|365030705|FG008|Years 6-10 (60-Month Extension)|Other|0|||
105829220|NCT00112437|365030706|FG009|Years 6-10 (60-Month Extension)|Other|0|||
105829221|NCT00112437|365030707|FG010|Years 6-10 (60-Month Extension)|Other|0|||
105829222|NCT00112437|365030708|FG011|Years 6-10 (60-Month Extension)|Other|0|||
105829223|NCT00112437|365030709|FG012|Years 6-10 (60-Month Extension)|Other|0|||
105829224|NCT00112437|365030710|FG013|Years 6-10 (60-Month Extension)|Other|0|||
105829225|NCT00112437|365030711|FG014|Years 6-10 (60-Month Extension)|Other|0|||
105829226|NCT00112437|365030712|FG015|Years 6-10 (60-Month Extension)|Other|0|||
105829227|NCT00112437|365030713|FG016|Years 6-10 (60-Month Extension)|Other|0|||
105829228|NCT00112437|365030714|FG017|Years 6-10 (60-Month Extension)|Other|0|||
105829229|NCT00112437|365030715|FG018|Years 6-10 (60-Month Extension)|Other|0|||
105829230|NCT00112437|365030716|FG019|Years 6-10 (60-Month Extension)|Other|0|||
105829231|NCT00112437|365030717|FG020|Years 6-10 (60-Month Extension)|Other|0|||
105829232|NCT00112437|365030718|FG021|Years 6-10 (60-Month Extension)|Other|0|||
105829233|NCT00112437|365030719|FG022|Years 6-10 (60-Month Extension)|Other|0|||
105829234|NCT00112437|365030720|FG023|Years 6-10 (60-Month Extension)|Other|0|||
105829235|NCT00112437|365030721|FG024|Years 6-10 (60-Month Extension)|Other|1|||
105829236|NCT00112437|365030722|FG025|Years 6-10 (60-Month Extension)|Other|0|||
105829237|NCT00112437|365030697|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829238|NCT00112437|365030698|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829239|NCT00112437|365030699|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829240|NCT00112437|365030700|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829241|NCT00112437|365030701|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829242|NCT00112437|365030702|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829243|NCT00112437|365030703|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829244|NCT00112437|365030704|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829245|NCT00112437|365030705|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829246|NCT00112437|365030706|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829247|NCT00112437|365030707|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829248|NCT00112437|365030708|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829249|NCT00112437|365030709|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105489275|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
105489276|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
105489277|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
105829250|NCT00112437|365030710|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829251|NCT00112437|365030711|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829252|NCT00112437|365030712|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829253|NCT00112437|365030713|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829254|NCT00112437|365030714|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829255|NCT00112437|365030715|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829256|NCT00112437|365030716|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829257|NCT00112437|365030717|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829258|NCT00112437|365030718|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829259|NCT00112437|365030719|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829260|NCT00112437|365030720|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
105829261|NCT00112437|365030721|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105366564|NCT01419314|363348458|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
105829262|NCT00112437|365030722|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829263|NCT00112437|365030697|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829264|NCT00112437|365030698|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829265|NCT00112437|365030699|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829266|NCT00112437|365030700|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829267|NCT00112437|365030701|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829268|NCT00112437|365030702|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829269|NCT00112437|365030703|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829270|NCT00112437|365030704|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829271|NCT00112437|365030705|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829272|NCT00112437|365030706|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829273|NCT00112437|365030707|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829274|NCT00112437|365030708|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829275|NCT00112437|365030709|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829276|NCT00112437|365030710|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829277|NCT00112437|365030711|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829278|NCT00112437|365030712|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105575817|NCT02771210|364108333|FG001|Period 1|Lack of Efficacy|6|||
105575818|NCT02771210|364108332|FG000|Period 1|Lost to Follow-up|2|||
105829279|NCT00112437|365030713|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829280|NCT00112437|365030714|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829281|NCT00112437|365030715|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829282|NCT00112437|365030716|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829283|NCT00112437|365030717|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829284|NCT00112437|365030718|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829285|NCT00112437|365030719|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
105829286|NCT00112437|365030720|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
105829287|NCT00112437|365030721|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829288|NCT00112437|365030722|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
105829289|NCT03614728|365030724|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
105829290|NCT03614728|365030725|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
105829291|NCT03614728|365030726|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
105829292|NCT03614728|365030727|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
105829293|NCT03614728|365030724|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
105829294|NCT03614728|365030725|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
105829295|NCT03614728|365030726|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
105829296|NCT03614728|365030727|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
105829297|NCT01691612|365030728|FG000|Overall Study|deemed ineligible after 1st visit|6|||
105829298|NCT01691612|365030728|FG000|Overall Study|Adverse Event|1|||
105829299|NCT05740098|365030729|FG000|Overall Study|Lost to Follow-up|26|||
105366565|NCT01419314|363348459|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
105366566|NCT01419314|363348458|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
105366567|NCT01419314|363348459|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
105829300|NCT05740098|365030730|FG001|Overall Study|Lost to Follow-up|17|||
105829301|NCT05740098|365030731|FG002|Overall Study|Lost to Follow-up|21|||
105829302|NCT01018862|365030732|FG000|Overall Study|Adverse Event|2|||
105829303|NCT01018862|365030733|FG001|Overall Study|Adverse Event|0|||
105829304|NCT01018862|365030734|FG002|Overall Study|Adverse Event|6|||
105829305|NCT01018862|365030732|FG000|Overall Study|Lack of Efficacy|1|||
105829306|NCT01018862|365030733|FG001|Overall Study|Lack of Efficacy|0|||
105829307|NCT01018862|365030734|FG002|Overall Study|Lack of Efficacy|2|||
105829308|NCT01018862|365030732|FG000|Overall Study|Lost to Follow-up|3|||
105829309|NCT01018862|365030733|FG001|Overall Study|Lost to Follow-up|1|||
105829310|NCT01018862|365030734|FG002|Overall Study|Lost to Follow-up|0|||
105829311|NCT01018862|365030732|FG000|Overall Study|Protocol Violation|1|||
105829312|NCT01018862|365030733|FG001|Overall Study|Protocol Violation|3|||
105829313|NCT01018862|365030734|FG002|Overall Study|Protocol Violation|3|||
105829314|NCT01018862|365030732|FG000|Overall Study|Withdrawal by Subject|1|||
105829315|NCT01018862|365030733|FG001|Overall Study|Withdrawal by Subject|2|||
105829316|NCT01018862|365030734|FG002|Overall Study|Withdrawal by Subject|1|||
105366568|NCT01419314|363348458|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
105366569|NCT01419314|363348459|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
105829317|NCT01018862|365030732|FG000|Overall Study|administrative problems|5|||
105829318|NCT01018862|365030733|FG001|Overall Study|administrative problems|4|||
105829319|NCT01018862|365030734|FG002|Overall Study|administrative problems|4|||
105829320|NCT00798603|365032180|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
105829321|NCT00798603|365032180|FG000|Overall Study|Withdrawal by Subject|10|||
105829322|NCT00798603|365032180|FG000|Overall Study|Adverse Event|22|||
105366570|NCT01405898|363348465|FG000|Overall Study|Withdrawal by Subject|2|||
105575819|NCT02771210|364108333|FG001|Period 1|Lost to Follow-up|0|||
105829323|NCT00798603|365032180|FG000|Overall Study|Physician Decision|1|||
105829324|NCT00798603|365032180|FG000|Overall Study|Lack of insurance coverage|1|||
105829325|NCT01490190|365032183|FG000|Overall Study|Withdrawal by Subject|9|||
105829326|NCT01490190|365032183|FG000|Overall Study|Adverse Event|17|||
105829327|NCT01490190|365032183|FG000|Overall Study|Protocol Violation|5|||
105829328|NCT01490190|365032183|FG000|Overall Study|Lost to Follow-up|13|||
105829329|NCT01490190|365032183|FG000|Overall Study|Relocation|1|||
105829330|NCT01490190|365032183|FG000|Overall Study|Inconvenience|1|||
105829331|NCT01490190|365032183|FG000|Overall Study|Ring expulsion|2|||
105829332|NCT02664415|365032184|FG000|Overall Study|Adverse Event|1|||
105829333|NCT02664415|365032185|FG001|Overall Study|Adverse Event|0|||
105829334|NCT04408924|365032186|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
105829335|NCT04408924|365032186|FG000|Overall Study|Lost to Follow-up|3|||
105829336|NCT04408924|365032186|FG000|Overall Study|Withdrawal by Subject|5|||
105829337|NCT04408924|365032186|FG000|Overall Study|Sponsor Decision|2|||
105829338|NCT01993186|365032187|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
105829339|NCT01993186|365032188|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
105829340|NCT01993186|365032187|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
105829341|NCT01993186|365032188|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
105575820|NCT02771210|364108332|FG000|Period 1|Physician Decision|0|||
105829342|NCT01993186|365032187|FG000|Open-Label Extension Period|Other, Not Specified|0|||
105829343|NCT01993186|365032188|FG001|Open-Label Extension Period|Other, Not Specified|1|||
105829344|NCT01993186|365032187|FG000|Open-Label Extension Period|Adverse Event|1|||
105829345|NCT01993186|365032188|FG001|Open-Label Extension Period|Adverse Event|0|||
105829346|NCT01993186|365032187|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
105829347|NCT01993186|365032188|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
105829348|NCT01993186|365032187|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
105829349|NCT01993186|365032188|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
105829350|NCT01993186|365032187|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
105829351|NCT01993186|365032188|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
105829352|NCT00084864|365032193|FG000|Overall Study|Adverse Event|1|||
105829353|NCT00084864|365032194|FG001|Overall Study|Adverse Event|0|||
105829354|NCT00084864|365032195|FG002|Overall Study|Adverse Event|0|||
105829355|NCT00084864|365032196|FG003|Overall Study|Adverse Event|0|||
105829356|NCT00385736|365032197|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
105829357|NCT00385736|365032198|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
105829358|NCT00385736|365032199|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
105829359|NCT00385736|365032197|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
105829360|NCT00385736|365032198|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
105829361|NCT00385736|365032199|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
105829362|NCT00385736|365032197|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
105829363|NCT00385736|365032198|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
105829364|NCT00385736|365032199|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
105829365|NCT00385736|365032197|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
105829366|NCT00385736|365032198|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
105829367|NCT00385736|365032199|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
105829368|NCT00385736|365032197|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
105308279|NCT01087489|363127175|FG000|Overall Study|unable to survey by telephone|0|||
105308280|NCT01087489|363127176|FG001|Overall Study|unable to survey by telephone|1|||
105308281|NCT03327792|363127177|FG000|Overall Study|Adverse Event|4|||
105308282|NCT03327792|363127178|FG001|Overall Study|Adverse Event|0|||
105308283|NCT03327792|363127177|FG000|Overall Study|Family/Personal issues|3|||
105575821|NCT02771210|364108333|FG001|Period 1|Physician Decision|1|||
105829369|NCT00385736|365032198|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
105829370|NCT00385736|365032199|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
105829371|NCT00385736|365032197|FG000|Efficacy Analysis Set - Induction|Other|0|||
105829372|NCT00385736|365032198|FG001|Efficacy Analysis Set - Induction|Other|0|||
105829373|NCT00385736|365032199|FG002|Efficacy Analysis Set - Induction|Other|1|||
105829374|NCT00385736|365032197|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
105308284|NCT03327792|363127178|FG001|Overall Study|Family/Personal issues|2|||
105308285|NCT03327792|363127177|FG000|Overall Study|Lost to Follow-up|0|||
105308286|NCT03327792|363127178|FG001|Overall Study|Lost to Follow-up|1|||
105829375|NCT00385736|365032198|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
105829376|NCT00385736|365032199|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
105308287|NCT00338455|363127179|FG000|Overall Study|Death|2|||
105308288|NCT00338455|363127180|FG001|Overall Study|Death|1|||
105829377|NCT00385736|365032197|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
105829378|NCT00385736|365032198|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
105829379|NCT00385736|365032199|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
105829380|NCT00385736|365032197|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
105829381|NCT00385736|365032198|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
105308289|NCT00338455|363127179|FG000|Overall Study|Physician Decision|1|||
105829382|NCT00385736|365032199|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
105829383|NCT00385736|365032197|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
105829384|NCT00385736|365032198|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
105829385|NCT00385736|365032199|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
105829386|NCT00385736|365032197|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
105829387|NCT00385736|365032198|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
105829388|NCT00385736|365032199|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
105829389|NCT00385736|365032197|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
105829390|NCT00385736|365032198|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
105829391|NCT00385736|365032199|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
105829392|NCT00385736|365032197|FG000|Safety Analysis Set|Adverse Event|23|||
105829393|NCT00385736|365032198|FG001|Safety Analysis Set|Adverse Event|15|||
105829394|NCT00385736|365032199|FG002|Safety Analysis Set|Adverse Event|23|||
105829395|NCT00385736|365032197|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
105829396|NCT00385736|365032198|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
105829397|NCT00385736|365032199|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
105829398|NCT00385736|365032197|FG000|Safety Analysis Set|Lost to Follow-up|0|||
105829399|NCT00385736|365032198|FG001|Safety Analysis Set|Lost to Follow-up|2|||
105829400|NCT00385736|365032199|FG002|Safety Analysis Set|Lost to Follow-up|2|||
105829401|NCT00385736|365032197|FG000|Safety Analysis Set|Lack of Efficacy|38|||
105829402|NCT00385736|365032198|FG001|Safety Analysis Set|Lack of Efficacy|16|||
105829403|NCT00385736|365032199|FG002|Safety Analysis Set|Lack of Efficacy|31|||
105829404|NCT00385736|365032197|FG000|Safety Analysis Set|Protocol Violation|2|||
105829405|NCT00385736|365032198|FG001|Safety Analysis Set|Protocol Violation|1|||
105829406|NCT00385736|365032199|FG002|Safety Analysis Set|Protocol Violation|6|||
105829407|NCT00385736|365032197|FG000|Safety Analysis Set|Other|1|||
105829408|NCT00385736|365032198|FG001|Safety Analysis Set|Other|4|||
105829409|NCT00385736|365032199|FG002|Safety Analysis Set|Other|4|||
105829410|NCT02727192|365032209|FG000|Overall Study|Lost to Follow-up|1|||
105829411|NCT02727192|365032210|FG001|Overall Study|Lost to Follow-up|0|||
105829412|NCT02727192|365032211|FG002|Overall Study|Lost to Follow-up|0|||
105829413|NCT00928057|365032212|FG000|Overall Study|Adverse Event|1|||
105829414|NCT00928057|365032213|FG001|Overall Study|Adverse Event|2|||
105829415|NCT00928057|365032212|FG000|Overall Study|Withdrawal by Subject|1|||
105829416|NCT00928057|365032213|FG001|Overall Study|Withdrawal by Subject|0|||
105829417|NCT00928057|365032212|FG000|Overall Study|Lost to Follow-up|0|||
105829418|NCT00928057|365032213|FG001|Overall Study|Lost to Follow-up|1|||
105829419|NCT00928057|365032212|FG000|Overall Study|Protocol Violation|0|||
105829420|NCT00928057|365032213|FG001|Overall Study|Protocol Violation|1|||
105829421|NCT05497557|365032220|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
105829422|NCT05497557|365032221|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
105829423|NCT05497557|365032222|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
105829424|NCT03387462|365032223|FG000|Overall Study|Lost to Follow-up|1|||
105829425|NCT03540160|365032226|FG000|Overall Study|Protocol Violation|1|||
105829426|NCT03540160|365032226|FG000|Overall Study|Physician Decision|8|||
105829427|NCT03540160|365032226|FG000|Overall Study|Lack of Efficacy|60|||
105829428|NCT03540160|365032226|FG000|Overall Study|Pregnancy|1|||
105829429|NCT03540160|365032226|FG000|Overall Study|Adverse Event|20|||
105829430|NCT03540160|365032226|FG000|Overall Study|Withdrawal by Subject|68|||
105829431|NCT03540160|365032226|FG000|Overall Study|COVID-19|2|||
105829432|NCT03540160|365032226|FG000|Overall Study|Study Closure|10|||
105829433|NCT03540160|365032226|FG000|Overall Study|Lost to Follow-up|18|||
105829434|NCT03540160|365032226|FG000|Overall Study|Sponsor decision|191|||
105829435|NCT01853176|365032230|FG000|Overall Study|Study terminated|4|||
105829436|NCT01853176|365032231|FG001|Overall Study|Study terminated|0|||
105829437|NCT00198133|365032232|FG000|Overall Study|Disease progression|2|||
105829438|NCT00198133|365032233|FG001|Overall Study|Disease progression|5|||
105829439|NCT00198133|365032232|FG000|Overall Study|Adverse Event|1|||
105829440|NCT00198133|365032233|FG001|Overall Study|Adverse Event|3|||
105829441|NCT00198133|365032232|FG000|Overall Study|Withdrawal by Subject|1|||
105829442|NCT00198133|365032233|FG001|Overall Study|Withdrawal by Subject|0|||
105829443|NCT00198133|365032232|FG000|Overall Study|Physician Decision|1|||
105308290|NCT00338455|363127180|FG001|Overall Study|Physician Decision|0|||
105829444|NCT00198133|365032233|FG001|Overall Study|Physician Decision|0|||
105829445|NCT01557751|365032237|FG000|Overall Study|Physician Decision|3|||
105829446|NCT02043132|365032241|FG000|Overall Study|Lost to Follow-up|1|||
105829447|NCT02043132|365032242|FG001|Overall Study|Lost to Follow-up|1|||
105829448|NCT02043132|365032241|FG000|Overall Study|screen failures|4|||
105829449|NCT02043132|365032242|FG001|Overall Study|screen failures|8|||
105829450|NCT05274763|365032249|FG000|Overall Study|Lost to Follow-up|1|||
105829451|NCT00425308|365032250|FG000|Overall Study|Adverse Event|2|||
105829452|NCT00425308|365032251|FG001|Overall Study|Adverse Event|1|||
105829453|NCT00425308|365032250|FG000|Overall Study|Withdrawal by Subject|1|||
105829454|NCT00425308|365032251|FG001|Overall Study|Withdrawal by Subject|0|||
105829455|NCT00425308|365032250|FG000|Overall Study|Death|1|||
105829456|NCT00425308|365032251|FG001|Overall Study|Death|0|||
105308291|NCT01475097|363127183|FG000|Overall Study|Protocol Violation|1|||
105308292|NCT01475097|363127184|FG001|Overall Study|Protocol Violation|1|||
105829457|NCT00472212|365032252|FG000|Overall Study|Lost to Follow-up|6|||
105829458|NCT00472212|365032253|FG001|Overall Study|Lost to Follow-up|4|||
105829459|NCT01143337|365032268|FG000|Overall Study|Adverse Event|3|||
105829460|NCT01143337|365032269|FG001|Overall Study|Adverse Event|9|||
105829461|NCT01143337|365032270|FG002|Overall Study|Adverse Event|5|||
105829462|NCT01143337|365032268|FG000|Overall Study|Lack of Efficacy|6|||
105829463|NCT01143337|365032269|FG001|Overall Study|Lack of Efficacy|2|||
105829464|NCT01143337|365032270|FG002|Overall Study|Lack of Efficacy|1|||
105829465|NCT01143337|365032268|FG000|Overall Study|Protocol Violation|1|||
105829466|NCT01143337|365032269|FG001|Overall Study|Protocol Violation|0|||
105308293|NCT00528411|363127185|FG000|Overall Study|Adverse Event|4|||
105308294|NCT00528411|363127186|FG001|Overall Study|Adverse Event|0|||
105308295|NCT00528411|363127187|FG002|Overall Study|Adverse Event|1|||
105308296|NCT00528411|363127185|FG000|Overall Study|Incorrect Enrolment|1|||
105308297|NCT00528411|363127186|FG001|Overall Study|Incorrect Enrolment|1|||
105308298|NCT00528411|363127187|FG002|Overall Study|Incorrect Enrolment|0|||
105308299|NCT00528411|363127185|FG000|Overall Study|Severe non-compliance to protocol|0|||
105308300|NCT00528411|363127186|FG001|Overall Study|Severe non-compliance to protocol|1|||
105308301|NCT00528411|363127187|FG002|Overall Study|Severe non-compliance to protocol|0|||
105308302|NCT00528411|363127185|FG000|Overall Study|Prior commitment medication|0|||
105829467|NCT01143337|365032270|FG002|Overall Study|Protocol Violation|0|||
105829468|NCT01143337|365032268|FG000|Overall Study|Withdrawal by Subject|0|||
105829469|NCT01143337|365032269|FG001|Overall Study|Withdrawal by Subject|0|||
105829470|NCT01143337|365032270|FG002|Overall Study|Withdrawal by Subject|1|||
105829471|NCT01143337|365032268|FG000|Overall Study|Other reason|0|||
105829472|NCT01143337|365032269|FG001|Overall Study|Other reason|0|||
105829473|NCT01143337|365032270|FG002|Overall Study|Other reason|5|||
105829474|NCT01559363|365032277|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
105829475|NCT01559363|365032278|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
105829476|NCT01559363|365032279|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
105829477|NCT01559363|365032280|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
105829478|NCT01559363|365032281|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
105829479|NCT01559363|365032282|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
105829480|NCT01559363|365032277|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
105829481|NCT01559363|365032278|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
105829482|NCT01559363|365032279|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
105829483|NCT01559363|365032280|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
105829484|NCT01559363|365032281|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
105829485|NCT01559363|365032282|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
105829486|NCT01559363|365032277|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
105829487|NCT01559363|365032278|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
105829488|NCT01559363|365032279|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
105829489|NCT01559363|365032280|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
105829490|NCT01559363|365032281|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
105829491|NCT01559363|365032282|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
105829492|NCT01559363|365032277|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
105829493|NCT01559363|365032278|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
105829494|NCT01559363|365032279|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
105829495|NCT01559363|365032280|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
105829496|NCT01559363|365032281|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
105829497|NCT01559363|365032282|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
105829498|NCT01559363|365032277|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
105829499|NCT01559363|365032278|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
105829500|NCT01559363|365032279|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
105829501|NCT01559363|365032280|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
105829502|NCT01559363|365032281|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
105829503|NCT01559363|365032282|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
105829504|NCT01559363|365032277|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
105829505|NCT01559363|365032278|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
105829506|NCT01559363|365032279|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
105829507|NCT01559363|365032280|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
105829508|NCT01559363|365032281|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
105829509|NCT01559363|365032282|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
105829510|NCT01559363|365032277|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
105308303|NCT00528411|363127186|FG001|Overall Study|Prior commitment medication|1|||
105308304|NCT00528411|363127187|FG002|Overall Study|Prior commitment medication|0|||
105308305|NCT04524364|363127191|FG000|Overall Study|Physician Decision|3|||
105829511|NCT01559363|365032278|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
105829512|NCT01559363|365032279|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
105829513|NCT01559363|365032280|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
105308306|NCT04524364|363127192|FG001|Overall Study|Physician Decision|6|||
105308307|NCT04524364|363127191|FG000|Overall Study|Adverse Event|0|||
105829514|NCT01559363|365032281|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
105829515|NCT01559363|365032282|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
105829516|NCT01868243|365032283|FG000|Overall Study|Death|0|||
105829517|NCT01868243|365032284|FG001|Overall Study|Death|1|||
105829518|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
105829519|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
105829520|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
105829521|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
105829522|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
105829523|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
105829524|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
105829525|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
105829526|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
105829527|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
105829528|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
105829529|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
105829530|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
105829531|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
105829532|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
105829533|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
105829534|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
105829535|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
105829536|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
105829537|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
105829538|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
105829539|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
105829540|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
105829541|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
105829542|NCT02227238|365032285|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
105829543|NCT02227238|365032286|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
105829544|NCT02227238|365032287|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
105489278|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
105489279|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
105489280|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
105829545|NCT02227238|365032285|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
105829546|NCT02227238|365032286|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
105829547|NCT02227238|365032287|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
105829548|NCT02227238|365032285|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
105829549|NCT02227238|365032286|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
105829550|NCT02227238|365032287|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
105829551|NCT02227238|365032285|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
105829552|NCT02227238|365032286|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
105829553|NCT02227238|365032287|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
105829554|NCT02227238|365032285|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
105829555|NCT02227238|365032286|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
105829556|NCT02227238|365032287|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
105829557|NCT02227238|365032285|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
105829558|NCT02227238|365032286|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
105829559|NCT02227238|365032287|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
105829560|NCT01632306|365032288|FG000|Overall Study|Protocol Violation|1|||
105829561|NCT01632306|365032289|FG001|Overall Study|Protocol Violation|0|||
105829562|NCT01632306|365032290|FG002|Overall Study|Protocol Violation|0|||
105829563|NCT00985751|365032291|FG000|Overall Study|Adverse Event|0|||
105829564|NCT00985751|365032292|FG001|Overall Study|Adverse Event|0|||
105829565|NCT00985751|365032293|FG002|Overall Study|Adverse Event|0|||
105829566|NCT00985751|365032294|FG003|Overall Study|Adverse Event|0|||
105829567|NCT00985751|365032295|FG004|Overall Study|Adverse Event|1|||
105829568|NCT00380588|365032296|FG000|Overall Study|Unequivocal Disease Progression|25|||
105829569|NCT00380588|365032297|FG001|Overall Study|Unequivocal Disease Progression|34|||
105829570|NCT00380588|365032296|FG000|Overall Study|Next Cycle Not Started|4|||
105829571|NCT00380588|365032297|FG001|Overall Study|Next Cycle Not Started|0|||
105829572|NCT00380588|365032296|FG000|Overall Study|Adverse Event|7|||
105829573|NCT00380588|365032297|FG001|Overall Study|Adverse Event|3|||
105829574|NCT00380588|365032296|FG000|Overall Study|Withdrawal by Subject|1|||
105489281|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
105829575|NCT00380588|365032297|FG001|Overall Study|Withdrawal by Subject|3|||
105829576|NCT00380588|365032296|FG000|Overall Study|Physician Decision|2|||
105829577|NCT00380588|365032297|FG001|Overall Study|Physician Decision|0|||
105489282|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
105829578|NCT01483820|365032298|FG000|Overall Study|Lack of Efficacy|6|||
105829579|NCT01483820|365032298|FG000|Overall Study|Adverse Event|1|||
105829580|NCT01483820|365032298|FG000|Overall Study|Death|1|||
105829581|NCT03498560|365032299|FG000|Overall Study|Found Ineligible|2|||
105829582|NCT03498560|365032299|FG000|Overall Study|Withdrawal by Subject|14|||
105829583|NCT03498560|365032299|FG000|Overall Study|Lost to Follow-up|4|||
105829584|NCT03498560|365032299|FG000|Overall Study|Death|1|||
105829585|NCT00867360|365032300|FG000|Overall Study|Withdrawal by Subject|1|||
105829586|NCT00867360|365032301|FG001|Overall Study|Withdrawal by Subject|0|||
105829587|NCT00867360|365032300|FG000|Overall Study|Physician Decision|0|||
105829588|NCT00867360|365032301|FG001|Overall Study|Physician Decision|1|||
105829589|NCT00842309|365032304|FG000|Overall Study|Withdrawal by Subject|3|||
105829590|NCT00842309|365032305|FG001|Overall Study|Withdrawal by Subject|1|||
105829591|NCT00533507|365032306|FG000|Overall Study|Withdrawal by Subject|1|||
105829592|NCT01576705|365032307|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
105829593|NCT01576705|365032308|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
105829594|NCT01576705|365032309|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
105829595|NCT01576705|365032310|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
105829596|NCT01576705|365032307|FG000|Overall Study|invalid ICF|0|||
105829597|NCT01576705|365032308|FG001|Overall Study|invalid ICF|1|||
105829598|NCT01576705|365032309|FG002|Overall Study|invalid ICF|0|||
105829599|NCT01576705|365032310|FG003|Overall Study|invalid ICF|0|||
105829600|NCT03573544|365032311|FG000|Overall Study|Adverse Event|0|||
105829601|NCT03573544|365032312|FG001|Overall Study|Adverse Event|0|||
105829602|NCT03573544|365032313|FG002|Overall Study|Adverse Event|0|||
105829603|NCT03573544|365032314|FG003|Overall Study|Adverse Event|3|||
105829604|NCT03573544|365032315|FG004|Overall Study|Adverse Event|1|||
105829605|NCT03573544|365032316|FG005|Overall Study|Adverse Event|0|||
105829606|NCT03573544|365032317|FG006|Overall Study|Adverse Event|2|||
105829607|NCT03573544|365032318|FG007|Overall Study|Adverse Event|0|||
105829608|NCT03573544|365032311|FG000|Overall Study|Physician Decision|0|||
105829609|NCT03573544|365032312|FG001|Overall Study|Physician Decision|0|||
105829610|NCT03573544|365032313|FG002|Overall Study|Physician Decision|0|||
105829611|NCT03573544|365032314|FG003|Overall Study|Physician Decision|0|||
105829612|NCT03573544|365032315|FG004|Overall Study|Physician Decision|0|||
105829613|NCT03573544|365032316|FG005|Overall Study|Physician Decision|0|||
105829614|NCT03573544|365032317|FG006|Overall Study|Physician Decision|1|||
105829615|NCT03573544|365032318|FG007|Overall Study|Physician Decision|0|||
105829616|NCT03573544|365032311|FG000|Overall Study|Withdrawal by Subject|2|||
105829617|NCT03573544|365032312|FG001|Overall Study|Withdrawal by Subject|0|||
105829618|NCT03573544|365032313|FG002|Overall Study|Withdrawal by Subject|0|||
105829619|NCT03573544|365032314|FG003|Overall Study|Withdrawal by Subject|1|||
105829620|NCT03573544|365032315|FG004|Overall Study|Withdrawal by Subject|1|||
105829621|NCT03573544|365032316|FG005|Overall Study|Withdrawal by Subject|1|||
105829622|NCT03573544|365032317|FG006|Overall Study|Withdrawal by Subject|0|||
105829623|NCT03573544|365032318|FG007|Overall Study|Withdrawal by Subject|1|||
105829624|NCT03573544|365032311|FG000|Overall Study|Disease progression|3|||
105829625|NCT03573544|365032312|FG001|Overall Study|Disease progression|3|||
105829626|NCT03573544|365032313|FG002|Overall Study|Disease progression|6|||
105829627|NCT03573544|365032314|FG003|Overall Study|Disease progression|4|||
105829628|NCT03573544|365032315|FG004|Overall Study|Disease progression|5|||
105829629|NCT03573544|365032316|FG005|Overall Study|Disease progression|7|||
105829630|NCT03573544|365032317|FG006|Overall Study|Disease progression|6|||
105829631|NCT03573544|365032318|FG007|Overall Study|Disease progression|7|||
105829632|NCT00757172|365032322|FG000|Overall Study|Withdrawal by Subject|4|||
105829633|NCT00757172|365032322|FG000|Overall Study|Physician Decision|3|||
105829634|NCT00757172|365032322|FG000|Overall Study|Progression|4|||
105829635|NCT03555695|365032323|FG000|Overall Study|Withdrawal by Subject|1|||
105829636|NCT03555695|365032323|FG000|Overall Study|Lost to Follow-up|1|||
105829637|NCT03555695|365032323|FG000|Overall Study|appendicitis (unrelated)|1|||
105829638|NCT03555695|365032323|FG000|Overall Study|pre-existing sciatica|1|||
105829639|NCT01426854|365032324|FG000|Overall Study|Adverse Event|1|||
105829640|NCT01426854|365032325|FG001|Overall Study|Adverse Event|5|||
105489283|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
105489284|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
105829641|NCT01426854|365032324|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
105829642|NCT01426854|365032325|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
105829643|NCT01426854|365032324|FG000|Overall Study|Lost to Follow-up|3|||
105829644|NCT01426854|365032325|FG001|Overall Study|Lost to Follow-up|0|||
105829645|NCT01426854|365032324|FG000|Overall Study|Noncompliance|0|||
105829646|NCT01426854|365032325|FG001|Overall Study|Noncompliance|1|||
105829647|NCT01426854|365032324|FG000|Overall Study|Treatment Failure|0|||
105829648|NCT01426854|365032325|FG001|Overall Study|Treatment Failure|16|||
105829649|NCT01426854|365032324|FG000|Overall Study|Protocol Deviation|0|||
105829650|NCT01426854|365032325|FG001|Overall Study|Protocol Deviation|1|||
105829651|NCT01426854|365032324|FG000|Overall Study|Other|3|||
105829652|NCT01426854|365032325|FG001|Overall Study|Other|2|||
105829653|NCT01942135|365032330|FG000|Overall Study|Adverse Event|21|||
105829654|NCT01942135|365032331|FG001|Overall Study|Adverse Event|7|||
105829655|NCT01942135|365032330|FG000|Overall Study|Global Deterioration of Health Status|9|||
105829656|NCT01942135|365032331|FG001|Overall Study|Global Deterioration of Health Status|6|||
105829657|NCT01942135|365032330|FG000|Overall Study|Randomized Not Treated|2|||
105829658|NCT01942135|365032331|FG001|Overall Study|Randomized Not Treated|2|||
105829659|NCT01942135|365032330|FG000|Overall Study|Death|2|||
105829660|NCT01942135|365032331|FG001|Overall Study|Death|1|||
105829661|NCT01942135|365032330|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
105829662|NCT01942135|365032331|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
105829663|NCT01942135|365032330|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
105829664|NCT01942135|365032331|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
105829665|NCT01942135|365032330|FG000|Overall Study|Withdrawal by Subject|4|||
105829666|NCT01942135|365032331|FG001|Overall Study|Withdrawal by Subject|3|||
105829667|NCT01942135|365032330|FG000|Overall Study|Protocol Violation|1|||
105829668|NCT01942135|365032331|FG001|Overall Study|Protocol Violation|0|||
105829669|NCT01942135|365032330|FG000|Overall Study|Other|19|||
105829670|NCT01942135|365032331|FG001|Overall Study|Other|4|||
105829671|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
105829672|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
105829673|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
105829674|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
105829675|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
105829676|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
105829677|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
105829678|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
105829679|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
105829680|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
105829681|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
105829682|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
105829683|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
105829684|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
105829685|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
105829686|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
105829687|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
105829688|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
105829689|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
105829690|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
105829691|NCT00950300|365032332|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
105829692|NCT00950300|365032333|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
105829693|NCT00950300|365032332|FG000|TFFU Period|Death|4|||
105829694|NCT00950300|365032333|FG001|TFFU Period|Death|1|||
105829695|NCT00950300|365032332|FG000|TFFU Period|Refused Treatment|10|||
105829696|NCT00950300|365032333|FG001|TFFU Period|Refused Treatment|11|||
105829697|NCT00950300|365032332|FG000|TFFU Period|Failure to Return|16|||
105829698|NCT00950300|365032333|FG001|TFFU Period|Failure to Return|16|||
105829699|NCT00950300|365032332|FG000|TFFU Period|Recurrence of Disease|63|||
105829700|NCT00950300|365032333|FG001|TFFU Period|Recurrence of Disease|72|||
105829701|NCT00950300|365032332|FG000|TFFU Period|Other|4|||
105829702|NCT00950300|365032333|FG001|TFFU Period|Other|3|||
105829703|NCT00950300|365032332|FG000|SFU Period|Death|44|||
105829704|NCT00950300|365032333|FG001|SFU Period|Death|42|||
105829705|NCT00950300|365032332|FG000|SFU Period|Lost to Follow-up|30|||
105829706|NCT00950300|365032333|FG001|SFU Period|Lost to Follow-up|28|||
105829707|NCT00950300|365032332|FG000|SFU Period|Withdrawal by Subject|4|||
105829708|NCT00950300|365032333|FG001|SFU Period|Withdrawal by Subject|8|||
105829709|NCT00902538|365032334|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
105829710|NCT00902538|365032335|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
105829711|NCT00902538|365032336|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
105829712|NCT00902538|365032337|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
105829713|NCT00902538|365032338|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
105829714|NCT00902538|365032339|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
105308308|NCT04524364|363127192|FG001|Overall Study|Adverse Event|1|||
105308309|NCT04524364|363127191|FG000|Overall Study|Investigational device deficiency|0|||
105308310|NCT04524364|363127192|FG001|Overall Study|Investigational device deficiency|1|||
105829715|NCT00902538|365032334|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
105829716|NCT00902538|365032335|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
105308311|NCT04524364|363127191|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
105308312|NCT04524364|363127192|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
105829717|NCT00902538|365032336|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
105489285|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
105489286|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
105489287|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
105489288|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
105489289|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
105489290|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
105489291|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
105489292|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
105489293|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
105489294|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
105489295|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
105489296|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
105489297|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
105489298|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
105829718|NCT00902538|365032337|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
105829719|NCT00902538|365032338|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
105829720|NCT00902538|365032339|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
105829721|NCT00902538|365032334|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
105829722|NCT00902538|365032335|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
105829723|NCT00902538|365032336|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
105829724|NCT00902538|365032337|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
105829725|NCT00902538|365032338|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
105829726|NCT00902538|365032339|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
105829727|NCT00902538|365032334|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
105829728|NCT00902538|365032335|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
105829729|NCT00902538|365032336|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
105829730|NCT00902538|365032337|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
105829731|NCT00902538|365032338|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
105829732|NCT00902538|365032339|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
105829733|NCT00902538|365032334|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
105829734|NCT00902538|365032335|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
105829735|NCT00902538|365032336|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
105829736|NCT00902538|365032337|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
105829737|NCT00902538|365032338|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
105829738|NCT00902538|365032339|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
105829739|NCT00902538|365032334|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
105829740|NCT00902538|365032335|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
105829741|NCT00902538|365032336|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
105829742|NCT00902538|365032337|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
105829743|NCT00902538|365032338|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
105829744|NCT00902538|365032339|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
105829745|NCT00902538|365032334|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
105829746|NCT00902538|365032335|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
105829747|NCT00902538|365032336|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
105829748|NCT00902538|365032337|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
105829749|NCT00902538|365032338|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
105829750|NCT00902538|365032339|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
105829751|NCT00902538|365032334|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
105829752|NCT00902538|365032335|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
105829753|NCT00902538|365032336|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
105829754|NCT00902538|365032337|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
105829755|NCT00902538|365032338|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
105829756|NCT00902538|365032339|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
105829757|NCT00902538|365032334|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
105829758|NCT00902538|365032335|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
105829759|NCT00902538|365032336|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
105829760|NCT00902538|365032337|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
105829761|NCT00902538|365032338|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
105829762|NCT00902538|365032339|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
105829763|NCT00902538|365032334|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
105829764|NCT00902538|365032335|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
105829765|NCT00902538|365032336|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
105829766|NCT00902538|365032337|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
105829767|NCT00902538|365032338|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
105575822|NCT02771210|364108332|FG000|Period 1|Withdrawal by Subject|0|||
105829768|NCT00902538|365032339|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
105829769|NCT00902538|365032334|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
105829770|NCT00902538|365032335|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
105829771|NCT00902538|365032336|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
105829772|NCT00902538|365032337|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
105829773|NCT00902538|365032338|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
105829774|NCT00902538|365032339|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
105829775|NCT00902538|365032334|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
105829776|NCT00902538|365032335|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
105829777|NCT00902538|365032336|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
105829778|NCT00902538|365032337|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
105829779|NCT00902538|365032338|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
105829780|NCT00902538|365032339|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
105829781|NCT00902538|365032334|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
105308313|NCT04524364|363127191|FG000|Overall Study|Device unavailability|0|||
105308314|NCT04524364|363127192|FG001|Overall Study|Device unavailability|2|||
105308315|NCT04524364|363127191|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
105308316|NCT04524364|363127192|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
105308317|NCT04524364|363127191|FG000|Overall Study|Low International normalized ratio (INR)|1|||
105308318|NCT04524364|363127192|FG001|Overall Study|Low International normalized ratio (INR)|0|||
105308319|NCT00380744|363127193|FG000|Overall Study|Death|0|||
105308320|NCT00380744|363127194|FG001|Overall Study|Death|0|||
105308321|NCT00380744|363127195|FG002|Overall Study|Death|0|||
105308322|NCT00380744|363127196|FG003|Overall Study|Death|0|||
105308323|NCT00380744|363127197|FG004|Overall Study|Death|0|||
105308324|NCT00380744|363127198|FG005|Overall Study|Death|0|||
105308325|NCT00380744|363127199|FG006|Overall Study|Death|1|||
105308326|NCT00380744|363127193|FG000|Overall Study|Withdrawal by Subject|1|||
105308327|NCT00380744|363127194|FG001|Overall Study|Withdrawal by Subject|0|||
105308328|NCT00380744|363127195|FG002|Overall Study|Withdrawal by Subject|0|||
105308329|NCT00380744|363127196|FG003|Overall Study|Withdrawal by Subject|0|||
105308330|NCT00380744|363127197|FG004|Overall Study|Withdrawal by Subject|0|||
105308331|NCT00380744|363127198|FG005|Overall Study|Withdrawal by Subject|0|||
105308332|NCT00380744|363127199|FG006|Overall Study|Withdrawal by Subject|0|||
105308333|NCT01441947|363127200|FG000|Overall Study|Withdrawal by Subject|3|||
105308334|NCT01441947|363127201|FG001|Overall Study|Withdrawal by Subject|0|||
105308335|NCT04480021|363127202|FG000|Overall Study|Lost to Follow-up|3|||
105308336|NCT04480021|363127203|FG001|Overall Study|Lost to Follow-up|4|||
105308337|NCT01584843|363127207|FG000|First Treatment Period|Adverse Event|0|||
105308338|NCT01584843|363127208|FG001|First Treatment Period|Adverse Event|0|||
105308339|NCT01584843|363127209|FG002|First Treatment Period|Adverse Event|1|||
105308340|NCT01584843|363127210|FG003|First Treatment Period|Adverse Event|0|||
105489299|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
105366571|NCT01405898|363348466|FG001|Overall Study|Withdrawal by Subject|2|||
105366572|NCT00846586|363348478|FG000|Overall Study|Adverse Event|20|||
105366573|NCT00846586|363348479|FG001|Overall Study|Adverse Event|10|||
105366574|NCT00846586|363348478|FG000|Overall Study|Subject withdrew consent|8|||
105366575|NCT00846586|363348479|FG001|Overall Study|Subject withdrew consent|10|||
105366576|NCT00846586|363348478|FG000|Overall Study|Administrative problems|5|||
105366577|NCT00846586|363348479|FG001|Overall Study|Administrative problems|4|||
105366578|NCT00846586|363348478|FG000|Overall Study|Death|2|||
105366579|NCT00846586|363348479|FG001|Overall Study|Death|0|||
105366580|NCT00846586|363348478|FG000|Overall Study|Protocol deviation|2|||
105366581|NCT00846586|363348479|FG001|Overall Study|Protocol deviation|6|||
105366582|NCT00846586|363348478|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105366583|NCT00846586|363348479|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105366584|NCT00846586|363348478|FG000|Overall Study|Lost to Follow-up|1|||
105366585|NCT00846586|363348479|FG001|Overall Study|Lost to Follow-up|4|||
105366586|NCT00846586|363348478|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105489300|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
105489301|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
105489302|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
105489303|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
105489304|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
105489305|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
105366587|NCT00846586|363348479|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105489306|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
105489307|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
105575823|NCT02771210|364108333|FG001|Period 1|Withdrawal by Subject|3|||
105308341|NCT01584843|363127211|FG004|First Treatment Period|Adverse Event|0|||
105308342|NCT01584843|363127212|FG005|First Treatment Period|Adverse Event|0|||
105366588|NCT00780975|363348485|FG000|Overall Study|Progressive disease|3|||
105366589|NCT00780975|363348485|FG000|Overall Study|Toxicity|5|||
105489308|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
105489309|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
105489310|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
105489311|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
105489312|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
105489313|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
105489314|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
105489315|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
105489316|NCT03739840|363804034|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
105489317|NCT03739840|363804035|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
105489318|NCT03739840|363804036|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
105489319|NCT03739840|363804037|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
105489320|NCT03739840|363804034|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
105489321|NCT03739840|363804035|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
105489322|NCT03739840|363804036|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
105489323|NCT03739840|363804037|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
105489324|NCT03739840|363804034|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
105489325|NCT03739840|363804035|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
105489326|NCT03739840|363804036|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
105489327|NCT03739840|363804037|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
105489328|NCT03739840|363804034|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
105489329|NCT03739840|363804035|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
105489330|NCT03739840|363804036|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
105829782|NCT00902538|365032335|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
105829783|NCT00902538|365032336|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
105829784|NCT00902538|365032337|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
105829785|NCT00902538|365032338|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
105829786|NCT00902538|365032339|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
105829787|NCT00902538|365032334|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
105829788|NCT00902538|365032335|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
105829789|NCT00902538|365032336|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
105829790|NCT00902538|365032337|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
105829791|NCT00902538|365032338|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
105829792|NCT00902538|365032339|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
105829793|NCT00902538|365032334|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
105829794|NCT00902538|365032335|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
105829795|NCT00902538|365032336|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
105829796|NCT00902538|365032337|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
105829797|NCT00902538|365032338|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
105829798|NCT00902538|365032339|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
105829799|NCT00902538|365032334|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
105829800|NCT00902538|365032335|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
105829801|NCT00902538|365032336|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
105829802|NCT00902538|365032337|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
105829803|NCT00902538|365032338|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
105829804|NCT00902538|365032339|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
105829805|NCT00902538|365032334|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
105829806|NCT00902538|365032335|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
105829807|NCT00902538|365032336|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
105829808|NCT00902538|365032337|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
105829809|NCT00902538|365032338|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
105829810|NCT00902538|365032339|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
105829811|NCT03531827|365032340|FG000|Overall Study|Adverse Event|2|||
105829812|NCT03531827|365032341|FG001|Overall Study|Adverse Event|0|||
105829813|NCT03531827|365032340|FG000|Overall Study|Progressive disease|1|||
105829814|NCT03531827|365032341|FG001|Overall Study|Progressive disease|0|||
105829815|NCT01717040|365032342|FG000|Overall Study|Lost to Follow-up|2|||
105829816|NCT01717040|365032343|FG001|Overall Study|Lost to Follow-up|3|||
105829817|NCT01717040|365032342|FG000|Overall Study|Lack of Efficacy|1|||
105829818|NCT01717040|365032343|FG001|Overall Study|Lack of Efficacy|1|||
105829819|NCT01717040|365032342|FG000|Overall Study|Adverse Event|1|||
105829820|NCT01717040|365032343|FG001|Overall Study|Adverse Event|0|||
105829821|NCT01717040|365032342|FG000|Overall Study|Required Medication Change|0|||
105829822|NCT01717040|365032343|FG001|Overall Study|Required Medication Change|1|||
105489331|NCT03739840|363804037|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
105829823|NCT01717040|365032342|FG000|Overall Study|New Substance Use Disorder|1|||
105829824|NCT01717040|365032343|FG001|Overall Study|New Substance Use Disorder|0|||
105489332|NCT03739840|363804034|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
105489333|NCT03739840|363804035|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
105489334|NCT03739840|363804036|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
105489335|NCT03739840|363804037|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
105489336|NCT03739840|363804034|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
105489337|NCT03739840|363804035|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
105489338|NCT03739840|363804036|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
105489339|NCT03739840|363804037|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
105489340|NCT03739840|363804034|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
105308343|NCT01584843|363127207|FG000|First Treatment Period|Protocol Violation|0|||
105308344|NCT01584843|363127208|FG001|First Treatment Period|Protocol Violation|0|||
105308345|NCT01584843|363127209|FG002|First Treatment Period|Protocol Violation|0|||
105308346|NCT01584843|363127210|FG003|First Treatment Period|Protocol Violation|0|||
105308347|NCT01584843|363127211|FG004|First Treatment Period|Protocol Violation|0|||
105829825|NCT03684928|365032344|FG000|First Intervention|Lost to Follow-up|0|||
105829826|NCT03684928|365032345|FG001|First Intervention|Lost to Follow-up|1|||
105829827|NCT03684928|365032344|FG000|First Intervention|Withdrawal by Subject|0|||
105829828|NCT03684928|365032345|FG001|First Intervention|Withdrawal by Subject|2|||
105829829|NCT03684928|365032344|FG000|Second Intervention|Soft Tissue Injury|1|||
105829830|NCT03684928|365032345|FG001|Second Intervention|Soft Tissue Injury|0|||
105308348|NCT01584843|363127212|FG005|First Treatment Period|Protocol Violation|1|||
105308349|NCT01584843|363127207|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
105308350|NCT01584843|363127208|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
105308351|NCT01584843|363127209|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
105308352|NCT01584843|363127210|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
105308353|NCT01584843|363127211|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
105308354|NCT01584843|363127212|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
105829831|NCT00452348|365033948|FG000|Overall Study|Adverse Event|6|||
105829832|NCT00452348|365033949|FG001|Overall Study|Adverse Event|9|||
105829833|NCT00452348|365033948|FG000|Overall Study|Lack of Efficacy|10|||
105829834|NCT00452348|365033949|FG001|Overall Study|Lack of Efficacy|9|||
105829835|NCT00452348|365033948|FG000|Overall Study|Lost to Follow-up|14|||
105829836|NCT00452348|365033949|FG001|Overall Study|Lost to Follow-up|8|||
105829837|NCT00452348|365033948|FG000|Overall Study|Protocol Violation|22|||
105829838|NCT00452348|365033949|FG001|Overall Study|Protocol Violation|28|||
105829839|NCT00452348|365033948|FG000|Overall Study|Withdrawal by Subject|18|||
105829840|NCT00452348|365033949|FG001|Overall Study|Withdrawal by Subject|21|||
105829841|NCT00452348|365033948|FG000|Overall Study|Other|9|||
105829842|NCT00452348|365033949|FG001|Overall Study|Other|9|||
105829843|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Subject request|8|||
105829844|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Subject request|11|||
105829845|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
105829846|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
105829847|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
105829848|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
105829849|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
105829850|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
105829851|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
105575824|NCT02771210|364108332|FG000|Period 1|Withdrawal of informed consent|1|||
105575825|NCT02771210|364108333|FG001|Period 1|Withdrawal of informed consent|5|||
105575826|NCT02771210|364108332|FG000|Period 2|Adverse Event|1|||
105575827|NCT02771210|364108333|FG001|Period 2|Adverse Event|0|||
105575828|NCT02771210|364108332|FG000|Period 2|Lack of Efficacy|0|||
105829852|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
105829853|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
105366590|NCT01939314|363348486|FG000|Overall Study|Withdrawal by Subject|3|||
105366591|NCT01939314|363348487|FG001|Overall Study|Withdrawal by Subject|1|||
105366592|NCT01939314|363348486|FG000|Overall Study|Protocol Violation|1|||
105366593|NCT01939314|363348487|FG001|Overall Study|Protocol Violation|0|||
105366594|NCT01939314|363348486|FG000|Overall Study|Pregnancy|0|||
105366595|NCT01939314|363348487|FG001|Overall Study|Pregnancy|1|||
105366596|NCT01939314|363348486|FG000|Overall Study|Lost to Follow-up|5|||
105366597|NCT01939314|363348487|FG001|Overall Study|Lost to Follow-up|6|||
105366598|NCT01061606|363348488|FG000|Overall Study|Adverse Event|1|||
105366599|NCT01061606|363348488|FG000|Overall Study|Death|1|||
105366600|NCT01061606|363348488|FG000|Overall Study|Disease Progression|4|||
105366601|NCT01061606|363348488|FG000|Overall Study|alternative therapy|2|||
105366602|NCT00735007|363348489|FG000|Overall Study|Adverse Event|4|||
105366603|NCT00735007|363348489|FG000|Overall Study|Protocol Violation|1|||
105366604|NCT03044314|363348491|FG000|Overall Study|Physician Decision|2|||
105366605|NCT03044314|363348491|FG000|Overall Study|Withdrawal by Subject|1|||
105366606|NCT03044314|363348491|FG000|Overall Study|Connector tubing not available|1|||
105366607|NCT00715403|363348492|FG000|Overall Study|Progressive disease|0|||
105366608|NCT00715403|363348493|FG001|Overall Study|Progressive disease|1|||
105366609|NCT00715403|363348494|FG002|Overall Study|Progressive disease|3|||
105366610|NCT00715403|363348495|FG003|Overall Study|Progressive disease|9|||
105366611|NCT00715403|363348496|FG004|Overall Study|Progressive disease|5|||
105366612|NCT00715403|363348497|FG005|Overall Study|Progressive disease|14|||
105366613|NCT00715403|363348498|FG006|Overall Study|Progressive disease|1|||
105366614|NCT00715403|363348492|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
105366615|NCT00715403|363348493|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
105366616|NCT00715403|363348494|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
105366617|NCT00715403|363348495|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
105366618|NCT00715403|363348496|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
105366619|NCT00715403|363348497|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
105366620|NCT00715403|363348498|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
105366621|NCT00715403|363348492|FG000|Overall Study|Other Adverse Event than DLT|1|||
105366622|NCT00715403|363348493|FG001|Overall Study|Other Adverse Event than DLT|0|||
105366623|NCT00715403|363348494|FG002|Overall Study|Other Adverse Event than DLT|0|||
105366624|NCT00715403|363348495|FG003|Overall Study|Other Adverse Event than DLT|0|||
105366625|NCT00715403|363348496|FG004|Overall Study|Other Adverse Event than DLT|0|||
105366626|NCT00715403|363348497|FG005|Overall Study|Other Adverse Event than DLT|2|||
105366627|NCT00715403|363348498|FG006|Overall Study|Other Adverse Event than DLT|0|||
105366628|NCT00715403|363348492|FG000|Overall Study|Protocol Violation|0|||
105366629|NCT00715403|363348493|FG001|Overall Study|Protocol Violation|0|||
105366630|NCT00715403|363348494|FG002|Overall Study|Protocol Violation|0|||
105366631|NCT00715403|363348495|FG003|Overall Study|Protocol Violation|0|||
105575829|NCT02771210|364108333|FG001|Period 2|Lack of Efficacy|1|||
105575830|NCT02771210|364108332|FG000|Period 2|Withdrawal by Subject|1|||
105575831|NCT02771210|364108333|FG001|Period 2|Withdrawal by Subject|0|||
105829854|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
105829855|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Death|1|||
105829856|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Death|0|||
105575832|NCT02771210|364108332|FG000|Period 2|Withdrawal of informed consent|0|||
105366632|NCT00715403|363348496|FG004|Overall Study|Protocol Violation|0|||
105366633|NCT00715403|363348497|FG005|Overall Study|Protocol Violation|1|||
105366634|NCT00715403|363348498|FG006|Overall Study|Protocol Violation|0|||
105366635|NCT00715403|363348492|FG000|Overall Study|Other reason not defined above|0|||
105366636|NCT00715403|363348493|FG001|Overall Study|Other reason not defined above|0|||
105366637|NCT00715403|363348494|FG002|Overall Study|Other reason not defined above|1|||
105366638|NCT00715403|363348495|FG003|Overall Study|Other reason not defined above|0|||
105366639|NCT00715403|363348496|FG004|Overall Study|Other reason not defined above|1|||
105366640|NCT00715403|363348497|FG005|Overall Study|Other reason not defined above|1|||
105366641|NCT00715403|363348498|FG006|Overall Study|Other reason not defined above|0|||
105366642|NCT01789047|363348499|FG000|Overall Study|Adverse Event|3|||
105366643|NCT01789047|363348500|FG001|Overall Study|Adverse Event|2|||
105366644|NCT01789047|363348499|FG000|Overall Study|Withdrawal by Subject|1|||
105366645|NCT01789047|363348500|FG001|Overall Study|Withdrawal by Subject|2|||
105366646|NCT03644017|363348501|FG000|Overall Study|Access Abandonment|5|||
105366647|NCT03644017|363348501|FG000|Overall Study|Kidney Transplant|2|||
105366648|NCT00449163|363348502|FG000|Overall Study|Physician Decision|3|||
105366649|NCT00969228|363348503|FG000|Overall Study|Adverse Event|1|||
105366650|NCT00969228|363348504|FG001|Overall Study|Adverse Event|0|||
105366651|NCT00969228|363348503|FG000|Overall Study|Withdrawal by Subject|4|||
105366652|NCT00969228|363348504|FG001|Overall Study|Withdrawal by Subject|0|||
105366653|NCT00969228|363348503|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
105366654|NCT00969228|363348504|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
105489341|NCT03739840|363804035|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
105366655|NCT01274533|363348507|FG000|Overall Study|Withdrawal by Subject|1|||
105366656|NCT01274533|363348507|FG000|Overall Study|Non-compliance|1|||
105829857|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
105829858|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
105829859|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
105829860|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
105829861|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
105829862|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
105829863|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
105829864|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
105829865|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
105829866|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
105829867|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
105829868|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
105829869|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
105366657|NCT01274533|363348507|FG000|Overall Study|Disease progression|2|||
105366658|NCT02668640|363348508|FG000|Overall Study|Lost to Follow-up|13|||
105366659|NCT02668640|363348508|FG000|Overall Study|Other, not specified|1|||
105366660|NCT02563899|363348509|FG000|Overall Study|Protocol Violation|1|||
105366661|NCT02563899|363348510|FG001|Overall Study|Protocol Violation|0|||
105366662|NCT02563899|363348511|FG002|Overall Study|Protocol Violation|0|||
105489342|NCT03739840|363804036|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
105829870|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
105829871|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
105829872|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
105829873|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
105829874|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
105829875|NCT00521586|365033950|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
105829876|NCT00521586|365033951|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
105829877|NCT00521586|365033950|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
105829878|NCT00521586|365033951|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
105829879|NCT00521586|365033950|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
105829880|NCT00521586|365033951|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
105829881|NCT03234907|365033952|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
105829882|NCT03234907|365033953|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
105829883|NCT03234907|365033954|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
105829884|NCT03234907|365033955|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
105829885|NCT03234907|365033956|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
105829886|NCT03234907|365033957|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
105829887|NCT03234907|365033952|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
105366663|NCT02563899|363348512|FG003|Overall Study|Protocol Violation|0|||
105366664|NCT02563899|363348509|FG000|Overall Study|Withdrawal by Subject|0|||
105366665|NCT02563899|363348510|FG001|Overall Study|Withdrawal by Subject|0|||
105366666|NCT02563899|363348511|FG002|Overall Study|Withdrawal by Subject|1|||
105366667|NCT02563899|363348512|FG003|Overall Study|Withdrawal by Subject|0|||
105366668|NCT00073918|363348515|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
105829888|NCT03234907|365033953|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
105829889|NCT03234907|365033954|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
105829890|NCT03234907|365033955|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
105829891|NCT03234907|365033956|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
105829892|NCT03234907|365033957|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
105829893|NCT03234907|365033952|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
105829894|NCT03234907|365033953|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
105829895|NCT03234907|365033954|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
105829896|NCT03234907|365033955|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
105829897|NCT03234907|365033956|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
105829898|NCT03234907|365033957|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
105829899|NCT03234907|365033952|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
105829900|NCT03234907|365033953|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
105829901|NCT03234907|365033954|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
105829902|NCT03234907|365033955|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
105829903|NCT03234907|365033956|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
105829904|NCT03234907|365033957|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
105829905|NCT03234907|365033952|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
105829906|NCT03234907|365033953|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
105829907|NCT03234907|365033954|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
105829908|NCT03234907|365033955|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
105829909|NCT03234907|365033956|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
105829910|NCT03234907|365033957|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
105829911|NCT03234907|365033952|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
105829912|NCT03234907|365033953|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
105829913|NCT03234907|365033954|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
105829914|NCT03234907|365033955|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
105829915|NCT03234907|365033956|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
105829916|NCT03234907|365033957|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
105829917|NCT03234907|365033952|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
105829918|NCT03234907|365033953|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
105829919|NCT03234907|365033954|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
105829920|NCT03234907|365033955|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
105829921|NCT03234907|365033956|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
105829922|NCT03234907|365033957|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
105829923|NCT02583048|365033965|FG000|Overall Study|Withdrawal by Subject|0|||
105829924|NCT02583048|365033966|FG001|Overall Study|Withdrawal by Subject|1|||
105829925|NCT02583048|365033967|FG002|Overall Study|Withdrawal by Subject|0|||
105829926|NCT02583048|365033965|FG000|Overall Study|Failed to meet eligibility criterion|0|||
105829927|NCT02583048|365033966|FG001|Overall Study|Failed to meet eligibility criterion|0|||
105829928|NCT02583048|365033967|FG002|Overall Study|Failed to meet eligibility criterion|1|||
105829929|NCT00414726|365033972|FG000|Overall Study|Withdrawal by Subject|0|||
105829930|NCT00414726|365033973|FG001|Overall Study|Withdrawal by Subject|1|||
105829931|NCT02107196|365033974|FG000|12-week Treatment Period|Adverse Event|6|||
105829932|NCT02107196|365033975|FG001|12-week Treatment Period|Adverse Event|3|||
105829933|NCT02107196|365033974|FG000|12-week Treatment Period|Lack of Efficacy|2|||
105829934|NCT02107196|365033975|FG001|12-week Treatment Period|Lack of Efficacy|1|||
105829935|NCT02107196|365033974|FG000|12-week Treatment Period|Lost to Follow-up|3|||
105829936|NCT02107196|365033975|FG001|12-week Treatment Period|Lost to Follow-up|6|||
105829937|NCT02107196|365033974|FG000|12-week Treatment Period|Physician Decision|0|||
105829938|NCT02107196|365033975|FG001|12-week Treatment Period|Physician Decision|1|||
105829939|NCT02107196|365033974|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
105829940|NCT02107196|365033975|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
105829941|NCT02107196|365033974|FG000|12-week Treatment Period|Protocol Violation|7|||
105829942|NCT02107196|365033975|FG001|12-week Treatment Period|Protocol Violation|8|||
105829943|NCT02107196|365033974|FG000|12-week Treatment Period|Reason Missing|11|||
105308355|NCT01584843|363127207|FG000|Second Treatment Period|Withdrawal by Subject|0|||
105308356|NCT01584843|363127208|FG001|Second Treatment Period|Withdrawal by Subject|0|||
105308357|NCT01584843|363127209|FG002|Second Treatment Period|Withdrawal by Subject|0|||
105829944|NCT02107196|365033975|FG001|12-week Treatment Period|Reason Missing|8|||
105829945|NCT02107196|365033974|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
105829946|NCT02107196|365033975|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
105829947|NCT02107196|365033974|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
105829948|NCT02107196|365033975|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
105308358|NCT01584843|363127210|FG003|Second Treatment Period|Withdrawal by Subject|0|||
105308359|NCT01584843|363127211|FG004|Second Treatment Period|Withdrawal by Subject|0|||
105829949|NCT02107196|365033974|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
105829950|NCT02107196|365033975|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
105829951|NCT02107196|365033974|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
105829952|NCT02107196|365033975|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
105829953|NCT00516295|365033976|FG000|Overall Study|Lack of Efficacy|2|||
105829954|NCT00516295|365033977|FG001|Overall Study|Lack of Efficacy|0|||
105829955|NCT00516295|365033978|FG002|Overall Study|Lack of Efficacy|0|||
105829956|NCT00516295|365033976|FG000|Overall Study|Ineligible|1|||
105829957|NCT00516295|365033977|FG001|Overall Study|Ineligible|0|||
105829958|NCT00516295|365033978|FG002|Overall Study|Ineligible|0|||
105829959|NCT02034513|365033979|FG000|Overall Study|Adverse Event|11|||
105829960|NCT02034513|365033980|FG001|Overall Study|Adverse Event|10|||
105829961|NCT02034513|365033979|FG000|Overall Study|Lack of Efficacy|0|||
105829962|NCT02034513|365033980|FG001|Overall Study|Lack of Efficacy|1|||
105829963|NCT02034513|365033979|FG000|Overall Study|Lost to Follow-up|6|||
105829964|NCT02034513|365033980|FG001|Overall Study|Lost to Follow-up|7|||
105829965|NCT02034513|365033979|FG000|Overall Study|Pregnancy|0|||
105829966|NCT02034513|365033980|FG001|Overall Study|Pregnancy|3|||
105829967|NCT02034513|365033979|FG000|Overall Study|Protocol Violation|7|||
105829968|NCT02034513|365033980|FG001|Overall Study|Protocol Violation|10|||
105829969|NCT02034513|365033979|FG000|Overall Study|Withdrawal by Subject|25|||
105829970|NCT02034513|365033980|FG001|Overall Study|Withdrawal by Subject|25|||
105829971|NCT02034513|365033979|FG000|Overall Study|Unclassified|0|||
105829972|NCT02034513|365033980|FG001|Overall Study|Unclassified|1|||
105829973|NCT01151280|365033981|FG000|Overall Study|Adverse Event|1|||
105829974|NCT01151280|365033981|FG000|Overall Study|Lack of Efficacy|3|||
105829975|NCT01243151|365033984|FG000|Overall Study|Adverse Event|0|||
105829976|NCT01243151|365033985|FG001|Overall Study|Adverse Event|1|||
105829977|NCT01243151|365033986|FG002|Overall Study|Adverse Event|0|||
105829978|NCT01243151|365033987|FG003|Overall Study|Adverse Event|0|||
105829979|NCT01243151|365033988|FG004|Overall Study|Adverse Event|0|||
105829980|NCT01243151|365033984|FG000|Overall Study|Protocol Violation|0|||
105829981|NCT01243151|365033985|FG001|Overall Study|Protocol Violation|0|||
105829982|NCT01243151|365033986|FG002|Overall Study|Protocol Violation|1|||
105829983|NCT01243151|365033987|FG003|Overall Study|Protocol Violation|0|||
105829984|NCT01243151|365033988|FG004|Overall Study|Protocol Violation|0|||
105829985|NCT01243151|365033984|FG000|Overall Study|Other|0|||
105829986|NCT01243151|365033985|FG001|Overall Study|Other|0|||
105829987|NCT01243151|365033986|FG002|Overall Study|Other|0|||
105829988|NCT01243151|365033987|FG003|Overall Study|Other|1|||
105829989|NCT01243151|365033988|FG004|Overall Study|Other|0|||
105829990|NCT01243151|365033984|FG000|Overall Study|Randomized but not treated|0|||
105829991|NCT01243151|365033985|FG001|Overall Study|Randomized but not treated|0|||
105829992|NCT01243151|365033986|FG002|Overall Study|Randomized but not treated|0|||
105829993|NCT01243151|365033987|FG003|Overall Study|Randomized but not treated|1|||
105829994|NCT01243151|365033988|FG004|Overall Study|Randomized but not treated|0|||
105829995|NCT00757705|365033989|FG000|Overall Study|Adverse Event|19|||
105829996|NCT00757705|365033989|FG000|Overall Study|Lost to Follow-up|16|||
105829997|NCT00757705|365033989|FG000|Overall Study|Withdrawal by Subject|25|||
105829998|NCT00757705|365033989|FG000|Overall Study|Insufficient Response|26|||
105829999|NCT00757705|365033989|FG000|Overall Study|Ineligible to continue|8|||
105830000|NCT00757705|365033989|FG000|Overall Study|Non-compliant|9|||
105830001|NCT00757705|365033989|FG000|Overall Study|Other|18|||
105830002|NCT02308241|365033991|FG000|Overall Study|Withdrawal by Subject|3|||
105830003|NCT00659815|365033992|FG000|Overall Study|Study related symptoms and complaints|2|||
105830004|NCT00659815|365033993|FG001|Overall Study|Study related symptoms and complaints|1|||
105830005|NCT00659815|365033992|FG000|Overall Study|Inability to maintain wearing schedule|1|||
105830006|NCT00659815|365033993|FG001|Overall Study|Inability to maintain wearing schedule|2|||
105830007|NCT00659815|365033992|FG000|Overall Study|Withdrawal by Subject|1|||
105830008|NCT00659815|365033993|FG001|Overall Study|Withdrawal by Subject|1|||
105830009|NCT02651987|365033994|FG000|Overall Study|Adverse Event|2|||
105830010|NCT02651987|365033995|FG001|Overall Study|Adverse Event|2|||
105830011|NCT02651987|365033994|FG000|Overall Study|Consent Withdrawn|2|||
105830012|NCT02651987|365033995|FG001|Overall Study|Consent Withdrawn|0|||
105830013|NCT02651987|365033994|FG000|Overall Study|Local PD|0|||
105830014|NCT02651987|365033995|FG001|Overall Study|Local PD|2|||
105830015|NCT02651987|365033994|FG000|Overall Study|Investigator Decision|1|||
105830016|NCT02651987|365033995|FG001|Overall Study|Investigator Decision|1|||
105830017|NCT00691704|365033996|FG000|Induction Therapy|Disease Progression|1|||
105830018|NCT00691704|365033996|FG000|Induction Therapy|Active Hepatitis|1|||
105830019|NCT00691704|365033996|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
105830020|NCT00691704|365033996|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
105830021|NCT00691704|365033996|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
105830022|NCT05061992|365033999|FG000|Overall Study|Excess bowel movements|1|||
105830023|NCT05061992|365034000|FG001|Overall Study|Excess bowel movements|0|||
105830024|NCT05061992|365033999|FG000|Overall Study|Complications of Medical Care|1|||
105830025|NCT05061992|365034000|FG001|Overall Study|Complications of Medical Care|0|||
105489343|NCT03739840|363804037|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
105489344|NCT03739840|363804034|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
105489345|NCT03739840|363804035|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
105489346|NCT03739840|363804036|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
105489347|NCT03739840|363804037|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
105489348|NCT03739840|363804034|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
105489349|NCT03739840|363804035|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
105308360|NCT01584843|363127212|FG005|Second Treatment Period|Withdrawal by Subject|1|||
105308361|NCT02640053|363127214|FG000|Overall Study|Withdrawal by Subject|2|||
105308362|NCT02640053|363127215|FG001|Overall Study|Withdrawal by Subject|1|||
105308363|NCT02640053|363127214|FG000|Overall Study|Adverse Event|1|||
105489350|NCT03739840|363804036|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
105489351|NCT03739840|363804037|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
105489352|NCT02788474|363804038|FG000|Double Blind Treatment Period|Not treated|1|||
105489353|NCT02788474|363804039|FG001|Double Blind Treatment Period|Not treated|0|||
105489354|NCT02788474|363804038|FG000|Double Blind Treatment Period|Patient's refusal|3|||
105489355|NCT02788474|363804039|FG001|Double Blind Treatment Period|Patient's refusal|0|||
105489356|NCT02788474|363804038|FG000|Double Blind Treatment Period|Adverse Event|6|||
105489357|NCT02788474|363804039|FG001|Double Blind Treatment Period|Adverse Event|4|||
105489358|NCT02788474|363804038|FG000|Open Label Treatment Period|Adverse Event|29|||
105489359|NCT02788474|363804039|FG001|Open Label Treatment Period|Adverse Event|9|||
105489360|NCT02788474|363804038|FG000|Open Label Treatment Period|Other than reason specified|1|||
105575833|NCT02771210|364108333|FG001|Period 2|Withdrawal of informed consent|2|||
105575834|NCT01923389|364108335|FG000|Overall Study|Protocol Violation|1|||
105830026|NCT05061992|365033999|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
105830027|NCT05061992|365034000|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
105830028|NCT05061992|365033999|FG000|Overall Study|Withdrawal by Subject|0|||
105830029|NCT05061992|365034000|FG001|Overall Study|Withdrawal by Subject|1|||
105830030|NCT04523480|365034001|FG000|Overall Study|Lost to Follow-up|30|||
105830031|NCT04523480|365034002|FG001|Overall Study|Lost to Follow-up|35|||
105830032|NCT04523480|365034003|FG002|Overall Study|Lost to Follow-up|0|||
105830033|NCT00397254|365034015|FG000|Overall Study|Lost to Follow-up|2|||
105830034|NCT00397254|365034016|FG001|Overall Study|Lost to Follow-up|2|||
105830035|NCT03827395|365034018|FG000|Overall Study|Lost to Follow-up|1|||
105830036|NCT03827395|365034019|FG001|Overall Study|Lost to Follow-up|0|||
105830037|NCT03827395|365034018|FG000|Overall Study|Protocol Violation|1|||
105830038|NCT03827395|365034019|FG001|Overall Study|Protocol Violation|0|||
105830039|NCT03827395|365034018|FG000|Overall Study|Became ineligible after enrollment|1|||
105830040|NCT03827395|365034019|FG001|Overall Study|Became ineligible after enrollment|2|||
105830041|NCT02420353|365034020|FG000|Overall Study|Withdrawal by Subject|0|||
105830042|NCT02420353|365034021|FG001|Overall Study|Withdrawal by Subject|1|||
105830043|NCT00875524|365034024|FG000|Overall Study|Serious adverse event|0|||
105830044|NCT00875524|365034025|FG001|Overall Study|Serious adverse event|1|||
105830045|NCT00875524|365034024|FG000|Overall Study|Protocol Violation|4|||
105830046|NCT00875524|365034025|FG001|Overall Study|Protocol Violation|0|||
105830047|NCT00875524|365034024|FG000|Overall Study|Lost to Follow-up|1|||
105830048|NCT00875524|365034025|FG001|Overall Study|Lost to Follow-up|0|||
105830049|NCT00875524|365034024|FG000|Overall Study|Withdrawal by Subject|3|||
105830050|NCT00875524|365034025|FG001|Overall Study|Withdrawal by Subject|5|||
105308364|NCT02640053|363127215|FG001|Overall Study|Adverse Event|1|||
105308365|NCT02640053|363127214|FG000|Overall Study|Alternative Therapy|1|||
105308366|NCT02640053|363127215|FG001|Overall Study|Alternative Therapy|1|||
105308367|NCT02640053|363127214|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
105308368|NCT02640053|363127215|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
105308369|NCT03283761|363127216|FG000|Study Treatment|Patient Non-Compliance|1|||
105308370|NCT03283761|363127216|FG000|Study Treatment|Alternative Cancer Therapy|7|||
105308371|NCT03283761|363127216|FG000|Study Treatment|Disease progression|21|||
105308372|NCT03283761|363127216|FG000|Study Treatment|Adverse Event|3|||
105308373|NCT03283761|363127216|FG000|Study Treatment|Withdrawal by Subject|4|||
105308374|NCT03283761|363127216|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
105308375|NCT03283761|363127216|FG000|Study Treatment|Symptomatic Deterioration|1|||
105308376|NCT03283761|363127216|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
105575835|NCT01923389|364108336|FG001|Overall Study|Protocol Violation|0|||
105830051|NCT01859598|365034033|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
105308377|NCT03283761|363127216|FG000|Follow up|Lost to Follow-up|1|||
105308378|NCT03283761|363127216|FG000|Follow up|Symptomatic Deterioration|1|||
105308379|NCT03283761|363127216|FG000|Follow up|Death|29|||
105308380|NCT03283761|363127216|FG000|Follow up|study terminated|4|||
105308381|NCT03283761|363127216|FG000|Follow up|Primary Investigator Withdrawal|1|||
105575836|NCT04467840|364108339|FG000|Overall Study|Death|35|||
105830052|NCT01968551|365034034|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
105830053|NCT01968551|365034035|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
105830054|NCT01968551|365034036|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
105830055|NCT01968551|365034034|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
105830056|NCT01968551|365034035|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
105830057|NCT01968551|365034036|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
105830058|NCT01968551|365034034|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
105830059|NCT01968551|365034035|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
105308382|NCT03283761|363127216|FG000|Follow up|Switched to alternative therapy|1|||
105308383|NCT03283761|363127216|FG000|Follow up|Subject is now in Hospice|1|||
105830060|NCT01968551|365034036|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
105830061|NCT01968551|365034034|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
105830062|NCT01968551|365034035|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
105830063|NCT01968551|365034036|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
105830064|NCT01968551|365034034|FG000|Extension Phase|Adverse Event|0|||
105830065|NCT01968551|365034035|FG001|Extension Phase|Adverse Event|0|||
105830066|NCT01968551|365034036|FG002|Extension Phase|Adverse Event|2|||
105830067|NCT01968551|365034034|FG000|Extension Phase|Death|0|||
105830068|NCT01968551|365034035|FG001|Extension Phase|Death|1|||
105830069|NCT01968551|365034036|FG002|Extension Phase|Death|0|||
105830070|NCT01968551|365034034|FG000|Extension Phase|Withdrew Consent|0|||
105830071|NCT01968551|365034035|FG001|Extension Phase|Withdrew Consent|0|||
105830072|NCT01968551|365034036|FG002|Extension Phase|Withdrew Consent|1|||
105830073|NCT01968551|365034034|FG000|Extension Phase|Lost to Follow-up|1|||
105830074|NCT01968551|365034035|FG001|Extension Phase|Lost to Follow-up|0|||
105830075|NCT01968551|365034036|FG002|Extension Phase|Lost to Follow-up|1|||
105830076|NCT00645853|365034037|FG000|Overall Study|Adverse Event|18|||
105830077|NCT00645853|365034038|FG001|Overall Study|Adverse Event|7|||
105830078|NCT00645853|365034037|FG000|Overall Study|AZ study closure in Hungary|60|||
105830079|NCT00645853|365034038|FG001|Overall Study|AZ study closure in Hungary|40|||
105830080|NCT00645853|365034037|FG000|Overall Study|Withdrawal by Subject|5|||
105830081|NCT00645853|365034038|FG001|Overall Study|Withdrawal by Subject|2|||
105830082|NCT00645853|365034037|FG000|Overall Study|Protocol Violation|0|||
105830083|NCT00645853|365034038|FG001|Overall Study|Protocol Violation|2|||
105830084|NCT00645853|365034037|FG000|Overall Study|Discontinuation criteria|2|||
105830085|NCT00645853|365034038|FG001|Overall Study|Discontinuation criteria|2|||
105830086|NCT00645853|365034037|FG000|Overall Study|recall of ICF, planned operation, death|7|||
105830087|NCT00645853|365034038|FG001|Overall Study|recall of ICF, planned operation, death|4|||
105830088|NCT00819169|365034039|FG000|Overall Study|Withdrawal by Subject|2|||
105830089|NCT00819169|365034040|FG001|Overall Study|Withdrawal by Subject|0|||
105830090|NCT00819169|365034041|FG002|Overall Study|Withdrawal by Subject|0|||
105830091|NCT00819169|365034042|FG003|Overall Study|Withdrawal by Subject|1|||
105830092|NCT00819169|365034043|FG004|Overall Study|Withdrawal by Subject|1|||
105830093|NCT00819169|365034044|FG005|Overall Study|Withdrawal by Subject|1|||
105830094|NCT00819169|365034045|FG006|Overall Study|Withdrawal by Subject|5|||
105830095|NCT00819169|365034046|FG007|Overall Study|Withdrawal by Subject|1|||
105830096|NCT00819169|365034047|FG008|Overall Study|Withdrawal by Subject|4|||
105830097|NCT00819169|365034039|FG000|Overall Study|Lost to Follow-up|0|||
105830098|NCT00819169|365034040|FG001|Overall Study|Lost to Follow-up|2|||
105830099|NCT00819169|365034041|FG002|Overall Study|Lost to Follow-up|0|||
105830100|NCT00819169|365034042|FG003|Overall Study|Lost to Follow-up|1|||
105830101|NCT00819169|365034043|FG004|Overall Study|Lost to Follow-up|0|||
105830102|NCT00819169|365034044|FG005|Overall Study|Lost to Follow-up|6|||
105830103|NCT00819169|365034045|FG006|Overall Study|Lost to Follow-up|2|||
105830104|NCT00819169|365034046|FG007|Overall Study|Lost to Follow-up|2|||
105830105|NCT00819169|365034047|FG008|Overall Study|Lost to Follow-up|1|||
105830106|NCT00819169|365034039|FG000|Overall Study|Death|1|||
105830107|NCT00819169|365034040|FG001|Overall Study|Death|1|||
105830108|NCT00819169|365034041|FG002|Overall Study|Death|3|||
105830109|NCT00819169|365034042|FG003|Overall Study|Death|8|||
105830110|NCT00819169|365034043|FG004|Overall Study|Death|5|||
105830111|NCT00819169|365034044|FG005|Overall Study|Death|7|||
105830112|NCT00819169|365034045|FG006|Overall Study|Death|9|||
105830113|NCT00819169|365034046|FG007|Overall Study|Death|4|||
105830114|NCT00819169|365034047|FG008|Overall Study|Death|7|||
105830115|NCT00819169|365034039|FG000|Overall Study|Ineligibility determined|0|||
105830116|NCT00819169|365034040|FG001|Overall Study|Ineligibility determined|0|||
105830117|NCT00819169|365034041|FG002|Overall Study|Ineligibility determined|0|||
105830118|NCT00819169|365034042|FG003|Overall Study|Ineligibility determined|2|||
105830119|NCT00819169|365034043|FG004|Overall Study|Ineligibility determined|0|||
105830120|NCT00819169|365034044|FG005|Overall Study|Ineligibility determined|0|||
105830121|NCT00819169|365034045|FG006|Overall Study|Ineligibility determined|0|||
105830122|NCT00819169|365034046|FG007|Overall Study|Ineligibility determined|0|||
105830123|NCT00819169|365034047|FG008|Overall Study|Ineligibility determined|1|||
105830124|NCT00819169|365034039|FG000|Overall Study|Adverse Event|0|||
105830125|NCT00819169|365034040|FG001|Overall Study|Adverse Event|0|||
105830126|NCT00819169|365034041|FG002|Overall Study|Adverse Event|0|||
105830127|NCT00819169|365034042|FG003|Overall Study|Adverse Event|0|||
105830128|NCT00819169|365034043|FG004|Overall Study|Adverse Event|1|||
105830129|NCT00819169|365034044|FG005|Overall Study|Adverse Event|0|||
105830130|NCT00819169|365034045|FG006|Overall Study|Adverse Event|0|||
105830131|NCT00819169|365034046|FG007|Overall Study|Adverse Event|0|||
105830132|NCT00819169|365034047|FG008|Overall Study|Adverse Event|0|||
105830133|NCT00819169|365034039|FG000|Overall Study|Administrative Decision|0|||
105830134|NCT00819169|365034040|FG001|Overall Study|Administrative Decision|0|||
105830135|NCT00819169|365034041|FG002|Overall Study|Administrative Decision|0|||
105830136|NCT00819169|365034042|FG003|Overall Study|Administrative Decision|0|||
105830137|NCT00819169|365034043|FG004|Overall Study|Administrative Decision|1|||
105830138|NCT00819169|365034044|FG005|Overall Study|Administrative Decision|2|||
105830139|NCT00819169|365034045|FG006|Overall Study|Administrative Decision|0|||
105830140|NCT00819169|365034046|FG007|Overall Study|Administrative Decision|2|||
105830141|NCT00819169|365034047|FG008|Overall Study|Administrative Decision|0|||
105830142|NCT04060251|365034058|FG000|Overall Study|Study terminated due to low enrollment.|7|||
105830143|NCT04060251|365034059|FG001|Overall Study|Study terminated due to low enrollment.|5|||
105830144|NCT04060251|365034060|FG002|Overall Study|Study terminated due to low enrollment.|7|||
105830145|NCT04060251|365034058|FG000|Overall Study|Adverse Event|1|||
105830146|NCT04060251|365034059|FG001|Overall Study|Adverse Event|1|||
105830147|NCT04060251|365034060|FG002|Overall Study|Adverse Event|0|||
105830148|NCT01087502|365034062|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
105830149|NCT01087502|365034063|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
105830150|NCT01087502|365034062|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
105830151|NCT01087502|365034063|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
105830152|NCT01087502|365034062|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
105830153|NCT01087502|365034063|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
105830154|NCT01087502|365034062|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
105830155|NCT01087502|365034063|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
105830156|NCT01087502|365034062|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
105830157|NCT01087502|365034063|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
105830158|NCT01087502|365034062|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
105830159|NCT01087502|365034063|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
105830160|NCT01087502|365034062|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
105830161|NCT01087502|365034063|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
105830162|NCT01087502|365034062|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
105830163|NCT01087502|365034063|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
105830164|NCT01087502|365034062|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
105830165|NCT01087502|365034063|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
105830166|NCT01087502|365034062|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
105830167|NCT01087502|365034063|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
105830168|NCT01087502|365034062|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
105830169|NCT01087502|365034063|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
105830170|NCT01087502|365034062|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
105830171|NCT01087502|365034063|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
105830172|NCT01728116|365034064|FG000|Overall Study|Sponsor Terminated Study|106|||
105830173|NCT01728116|365034065|FG001|Overall Study|Sponsor Terminated Study|35|||
105830174|NCT01728116|365034064|FG000|Overall Study|Withdrawal by Subject|16|||
105830175|NCT01728116|365034065|FG001|Overall Study|Withdrawal by Subject|9|||
105830176|NCT01728116|365034064|FG000|Overall Study|Adverse Event|13|||
105830177|NCT01728116|365034065|FG001|Overall Study|Adverse Event|0|||
105830178|NCT01728116|365034064|FG000|Overall Study|Procedure/device failure|7|||
105830179|NCT01728116|365034065|FG001|Overall Study|Procedure/device failure|0|||
105830180|NCT01728116|365034064|FG000|Overall Study|Lost to Follow-up|9|||
105830181|NCT01728116|365034065|FG001|Overall Study|Lost to Follow-up|2|||
105830182|NCT01728116|365034064|FG000|Overall Study|Physician Decision|2|||
105830183|NCT01728116|365034065|FG001|Overall Study|Physician Decision|0|||
105830184|NCT01728116|365034064|FG000|Overall Study|Subject Non-Compliance|2|||
105830185|NCT01728116|365034065|FG001|Overall Study|Subject Non-Compliance|0|||
105830186|NCT01728116|365034064|FG000|Overall Study|Inter-current finding at procedure|1|||
105830187|NCT01728116|365034065|FG001|Overall Study|Inter-current finding at procedure|0|||
105830188|NCT01728116|365034064|FG000|Overall Study|Incorrectly enrolled in Study|0|||
105308384|NCT00620555|363127218|FG000|Overall Study|Adverse Event|4|||
105308385|NCT00620555|363127218|FG000|Overall Study|Protocol Violation|2|||
105308386|NCT00620555|363127218|FG000|Overall Study|Lack of Efficacy|12|||
105308387|NCT00620555|363127218|FG000|Overall Study|Withdrawal by Subject|1|||
105308388|NCT00620555|363127218|FG000|Overall Study|Choice of other treatment|1|||
105308389|NCT00620555|363127218|FG000|Overall Study|Visit failure against planned|1|||
105308390|NCT01268501|363127219|FG000|Overall Study|Lost to Follow-up|1|||
105308391|NCT01268501|363127219|FG000|Overall Study|Withdrawal by Subject|3|||
105830189|NCT01728116|365034065|FG001|Overall Study|Incorrectly enrolled in Study|1|||
105830190|NCT01728116|365034064|FG000|Overall Study|various not noted previously|5|||
105830191|NCT01728116|365034065|FG001|Overall Study|various not noted previously|0|||
105830192|NCT01559116|365034067|FG000|Overall Study|Adverse Event|10|||
105308392|NCT01268501|363127219|FG000|Overall Study|Unacceptable Subjective Vision|3|||
105308393|NCT01268501|363127219|FG000|Overall Study|Handling Difficulties|2|||
105830193|NCT01559116|365034067|FG000|Overall Study|Lack of Efficacy|1|||
105830194|NCT01559116|365034067|FG000|Overall Study|Lost to Follow-up|1|||
105830195|NCT01559116|365034067|FG000|Overall Study|Protocol Violation|1|||
105830196|NCT01559116|365034067|FG000|Overall Study|Withdrawal by Subject|4|||
105830197|NCT01559116|365034067|FG000|Overall Study|other than stated above|9|||
105830198|NCT01151618|365034068|FG000|Overall Study|Adverse Event|2|||
105830199|NCT01151618|365034068|FG000|Overall Study|Withdrawal by Subject|7|||
105830200|NCT00562718|365034069|FG000|Overall Study|Death|1|||
105830201|NCT00562718|365034069|FG000|Overall Study|Withdrawal by Subject|3|||
105830202|NCT00562718|365034069|FG000|Overall Study|Adverse Event|4|||
105830203|NCT00562718|365034069|FG000|Overall Study|Lack of Efficacy|2|||
105830204|NCT00562718|365034069|FG000|Overall Study|not stated|1|||
105830205|NCT04025021|365034070|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
105830206|NCT04025021|365034071|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
105830207|NCT03966911|365034072|FG000|Overall Study|Adverse Event|1|||
105830208|NCT03966911|365034073|FG001|Overall Study|Adverse Event|1|||
105830209|NCT03966911|365034072|FG000|Overall Study|Withdrawal by Subject|8|||
105830210|NCT03966911|365034073|FG001|Overall Study|Withdrawal by Subject|2|||
105830211|NCT03966911|365034072|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
105830212|NCT03966911|365034073|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
105830213|NCT02905435|365034078|FG000|Overall Study|Death|2|||
105830214|NCT02905435|365034078|FG000|Overall Study|Physician Decision|1|||
105830215|NCT02905435|365034078|FG000|Overall Study|Lost to Follow-up|4|||
105830216|NCT03259165|365034083|FG000|Overall Study|COVID 19 pandemic|1|||
105830217|NCT03259165|365034084|FG001|Overall Study|COVID 19 pandemic|1|||
105830218|NCT00903877|365034085|FG000|Overall Study|Did not meet study criteria|33|||
105830219|NCT00903877|365034085|FG000|Overall Study|Withdrawal by Subject|3|||
105830220|NCT00903877|365034085|FG000|Overall Study|Adverse Event|2|||
105830221|NCT00903877|365034085|FG000|Overall Study|Lost to Follow-up|1|||
105830222|NCT00903877|365034085|FG000|Overall Study|Participation put on hold|4|||
105830223|NCT00840879|365034090|FG000|Second Intervention|Withdrawal by Subject|1|||
105830224|NCT00840879|365034091|FG001|Second Intervention|Withdrawal by Subject|0|||
105830225|NCT00828321|365035430|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
105830226|NCT00828321|365035431|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
105830227|NCT00828321|365035430|FG000|Second Intervention|Protocol Violation|0|||
105830228|NCT00828321|365035431|FG001|Second Intervention|Protocol Violation|1|||
105830229|NCT00642993|365035432|FG000|Overall Study|Adverse Event|85|||
105830230|NCT00642993|365035433|FG001|Overall Study|Adverse Event|4|||
105830231|NCT00642993|365035432|FG000|Overall Study|Lost to Follow-up|8|||
105830232|NCT00642993|365035433|FG001|Overall Study|Lost to Follow-up|4|||
105830233|NCT00642993|365035432|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
105830234|NCT00642993|365035433|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
105830235|NCT00642993|365035432|FG000|Overall Study|Protocol Violation|1|||
105830236|NCT00642993|365035433|FG001|Overall Study|Protocol Violation|4|||
105830237|NCT00642993|365035432|FG000|Overall Study|Did not meet protocol eligibility|0|||
105830238|NCT00642993|365035433|FG001|Overall Study|Did not meet protocol eligibility|1|||
105830239|NCT00642993|365035432|FG000|Overall Study|Administrative|1|||
105830240|NCT00642993|365035433|FG001|Overall Study|Administrative|0|||
105830241|NCT01624233|365035434|FG000|Period 2 - Induction|Adverse Event|1|||
105830242|NCT01624233|365035434|FG000|Period 3 - Maintenance|Adverse Event|2|||
105830243|NCT01624233|365035434|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
105830244|NCT01624233|365035434|FG000|Period 3 - Maintenance|Physician Decision|2|||
105830245|NCT01624233|365035434|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
105830246|NCT01624233|365035434|FG000|Period 4 - Drug Free Period|Relapsed|61|||
105830247|NCT01624233|365035434|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
105830248|NCT01624233|365035434|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
105830249|NCT01624233|365035434|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
105489361|NCT02788474|363804039|FG001|Open Label Treatment Period|Other than reason specified|0|||
105830250|NCT01624233|365035434|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
105830251|NCT01624233|365035434|FG000|Period 6: Follow-up|Adverse Event|3|||
105830252|NCT01624233|365035434|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
105830253|NCT01624233|365035434|FG000|Period 6: Follow-up|Physician Decision|1|||
105489362|NCT02788474|363804038|FG000|Open Label Treatment Period|Patient's refusal|1|||
105489363|NCT02788474|363804039|FG001|Open Label Treatment Period|Patient's refusal|3|||
105489364|NCT02788474|363804038|FG000|Open Label Treatment Period|Non-compliance|1|||
105489365|NCT02788474|363804039|FG001|Open Label Treatment Period|Non-compliance|0|||
105830254|NCT01624233|365035434|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
105830255|NCT00373256|365035438|FG000|Overall Study|Adverse Event (AE)|1|||
105830256|NCT00373256|365035439|FG001|Overall Study|Adverse Event (AE)|5|||
105830257|NCT00373256|365035438|FG000|Overall Study|Lost to Follow-up|2|||
105830258|NCT00373256|365035439|FG001|Overall Study|Lost to Follow-up|1|||
105830259|NCT00373256|365035438|FG000|Overall Study|Death|9|||
105830260|NCT00373256|365035439|FG001|Overall Study|Death|8|||
105830261|NCT00373256|365035438|FG000|Overall Study|Objective Progression or Relapse|111|||
105830262|NCT00373256|365035439|FG001|Overall Study|Objective Progression or Relapse|104|||
105308394|NCT01140503|363127220|FG000|Overall Study|Withdrawal by Subject|1|||
105308395|NCT04453202|363127221|FG000|Overall Study|Adverse Event|0|||
105308396|NCT04453202|363127222|FG001|Overall Study|Adverse Event|0|||
105308397|NCT04453202|363127223|FG002|Overall Study|Adverse Event|0|||
105308398|NCT04453202|363127224|FG003|Overall Study|Adverse Event|0|||
105308399|NCT04453202|363127225|FG004|Overall Study|Adverse Event|0|||
105308400|NCT04453202|363127226|FG005|Overall Study|Adverse Event|0|||
105308401|NCT04453202|363127227|FG006|Overall Study|Adverse Event|1|||
105308402|NCT04453202|363127228|FG007|Overall Study|Adverse Event|0|||
105308403|NCT04453202|363127229|FG008|Overall Study|Adverse Event|0|||
105308404|NCT04453202|363127230|FG009|Overall Study|Adverse Event|0|||
105308405|NCT04453202|363127231|FG010|Overall Study|Adverse Event|0|||
105308406|NCT04453202|363127221|FG000|Overall Study|Death|0|||
105308407|NCT04453202|363127222|FG001|Overall Study|Death|0|||
105308408|NCT04453202|363127223|FG002|Overall Study|Death|0|||
105308409|NCT04453202|363127224|FG003|Overall Study|Death|0|||
105308410|NCT04453202|363127225|FG004|Overall Study|Death|0|||
105308411|NCT04453202|363127226|FG005|Overall Study|Death|0|||
105308412|NCT04453202|363127227|FG006|Overall Study|Death|0|||
105308413|NCT04453202|363127228|FG007|Overall Study|Death|0|||
105308414|NCT04453202|363127229|FG008|Overall Study|Death|0|||
105308415|NCT04453202|363127230|FG009|Overall Study|Death|1|||
105308416|NCT04453202|363127231|FG010|Overall Study|Death|0|||
105308417|NCT04453202|363127221|FG000|Overall Study|Lost to Follow-up|0|||
105308418|NCT04453202|363127222|FG001|Overall Study|Lost to Follow-up|1|||
105308419|NCT04453202|363127223|FG002|Overall Study|Lost to Follow-up|0|||
105308420|NCT04453202|363127224|FG003|Overall Study|Lost to Follow-up|1|||
105308421|NCT04453202|363127225|FG004|Overall Study|Lost to Follow-up|0|||
105308422|NCT04453202|363127226|FG005|Overall Study|Lost to Follow-up|0|||
105308423|NCT04453202|363127227|FG006|Overall Study|Lost to Follow-up|0|||
105308424|NCT04453202|363127228|FG007|Overall Study|Lost to Follow-up|0|||
105308425|NCT04453202|363127229|FG008|Overall Study|Lost to Follow-up|0|||
105308426|NCT04453202|363127230|FG009|Overall Study|Lost to Follow-up|1|||
105308427|NCT04453202|363127231|FG010|Overall Study|Lost to Follow-up|1|||
105308428|NCT04453202|363127221|FG000|Overall Study|Withdrawal by Subject|1|||
105308429|NCT04453202|363127222|FG001|Overall Study|Withdrawal by Subject|2|||
105308430|NCT04453202|363127223|FG002|Overall Study|Withdrawal by Subject|1|||
105308431|NCT04453202|363127224|FG003|Overall Study|Withdrawal by Subject|2|||
105308432|NCT04453202|363127225|FG004|Overall Study|Withdrawal by Subject|1|||
105308433|NCT04453202|363127226|FG005|Overall Study|Withdrawal by Subject|1|||
105308434|NCT04453202|363127227|FG006|Overall Study|Withdrawal by Subject|0|||
105308435|NCT04453202|363127228|FG007|Overall Study|Withdrawal by Subject|0|||
105308436|NCT04453202|363127229|FG008|Overall Study|Withdrawal by Subject|0|||
105308437|NCT04453202|363127230|FG009|Overall Study|Withdrawal by Subject|1|||
105308438|NCT04453202|363127231|FG010|Overall Study|Withdrawal by Subject|0|||
105308439|NCT04453202|363127221|FG000|Overall Study|Adverse Event|0|||
105308440|NCT04453202|363127222|FG001|Overall Study|Adverse Event|0|||
105308441|NCT04453202|363127223|FG002|Overall Study|Adverse Event|0|||
105308442|NCT04453202|363127224|FG003|Overall Study|Adverse Event|0|||
105308443|NCT04453202|363127225|FG004|Overall Study|Adverse Event|0|||
105308444|NCT04453202|363127226|FG005|Overall Study|Adverse Event|1|||
105308445|NCT04453202|363127227|FG006|Overall Study|Adverse Event|0|||
105308446|NCT04453202|363127228|FG007|Overall Study|Adverse Event|0|||
105308447|NCT04453202|363127229|FG008|Overall Study|Adverse Event|0|||
105308448|NCT04453202|363127230|FG009|Overall Study|Adverse Event|0|||
105308449|NCT04453202|363127231|FG010|Overall Study|Adverse Event|0|||
105366669|NCT00073918|363348515|FG000|Overall Study|Rapid disease progression|2|||
105366670|NCT00073918|363348515|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
105366671|NCT02100124|363348516|FG000|Overall Study|Lost to Follow-up|5|||
105366672|NCT02100124|363348517|FG001|Overall Study|Lost to Follow-up|11|||
105366673|NCT02100124|363348518|FG002|Overall Study|Lost to Follow-up|3|||
105366674|NCT02100124|363348516|FG000|Overall Study|Withdrawal by Subject|1|||
105308450|NCT02056392|363127235|FG000|Overall Study|Lost to Follow-up|0|||
105308451|NCT02056392|363127236|FG001|Overall Study|Lost to Follow-up|1|||
105308452|NCT02056392|363127237|FG002|Overall Study|Lost to Follow-up|2|||
105308453|NCT02056392|363127238|FG003|Overall Study|Lost to Follow-up|0|||
105308454|NCT02056392|363127239|FG004|Overall Study|Lost to Follow-up|0|||
105308455|NCT02056392|363127240|FG005|Overall Study|Lost to Follow-up|0|||
105308456|NCT02056392|363127235|FG000|Overall Study|Protocol Violation|1|||
105308457|NCT02056392|363127236|FG001|Overall Study|Protocol Violation|0|||
105308458|NCT02056392|363127237|FG002|Overall Study|Protocol Violation|1|||
105308459|NCT02056392|363127238|FG003|Overall Study|Protocol Violation|0|||
105308460|NCT02056392|363127239|FG004|Overall Study|Protocol Violation|0|||
105308461|NCT02056392|363127240|FG005|Overall Study|Protocol Violation|0|||
105308462|NCT02056392|363127235|FG000|Overall Study|Withdrawal by Subject|1|||
105308463|NCT02056392|363127236|FG001|Overall Study|Withdrawal by Subject|0|||
105308464|NCT02056392|363127237|FG002|Overall Study|Withdrawal by Subject|0|||
105308465|NCT02056392|363127238|FG003|Overall Study|Withdrawal by Subject|0|||
105308466|NCT02056392|363127239|FG004|Overall Study|Withdrawal by Subject|1|||
105366675|NCT02100124|363348517|FG001|Overall Study|Withdrawal by Subject|0|||
105830263|NCT00373256|365035438|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
105830264|NCT00373256|365035439|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
105830265|NCT00373256|365035438|FG000|Overall Study|Other|73|||
105830266|NCT00373256|365035439|FG001|Overall Study|Other|107|||
105830267|NCT00373256|365035438|FG000|Overall Study|Protocol Violation|0|||
105830268|NCT00373256|365035439|FG001|Overall Study|Protocol Violation|2|||
105830269|NCT00373256|365035438|FG000|Overall Study|Study Terminated by Sponsor|41|||
105830270|NCT00373256|365035439|FG001|Overall Study|Study Terminated by Sponsor|13|||
105830271|NCT02986139|365035440|FG000|Overall Study|Sponsor Decision|1|||
105830272|NCT02986139|365035441|FG001|Overall Study|Sponsor Decision|2|||
105830273|NCT02986139|365035440|FG000|Overall Study|Withdrawal by Subject|0|||
105830274|NCT02986139|365035441|FG001|Overall Study|Withdrawal by Subject|1|||
105830275|NCT02986139|365035440|FG000|Overall Study|Lost to Follow-up|0|||
105830276|NCT02986139|365035441|FG001|Overall Study|Lost to Follow-up|1|||
105830277|NCT00735696|365035444|FG000|Overall Study|Withdrawal by Subject|1|||
105830278|NCT00735696|365035444|FG000|Overall Study|Enrolled but never Treated|1|||
105830279|NCT00874822|365035445|FG000|Overall Study|excluded by criteria|8|||
105830280|NCT02627963|365035446|FG000|Overall Study|Randomized but not treated|2|||
105830281|NCT02627963|365035447|FG001|Overall Study|Randomized but not treated|6|||
105830282|NCT03807440|365035451|FG000|Overall Study|No documentation of index date 2|320|||
105830283|NCT03807440|365035451|FG000|Overall Study|No informed consent for index date 2|117|||
105830284|NCT01024855|365035454|FG000|Overall Study|Inclusion/exclusion criteria|1|||
105830285|NCT02372006|365035455|FG000|Overall Study|Progressive disease|8|||
105830286|NCT02372006|365035456|FG001|Overall Study|Progressive disease|7|||
105830287|NCT02372006|365035457|FG002|Overall Study|Progressive disease|34|||
105830288|NCT02372006|365035455|FG000|Overall Study|Dose limiting toxicity|0|||
105830289|NCT02372006|365035456|FG001|Overall Study|Dose limiting toxicity|1|||
105830290|NCT02372006|365035457|FG002|Overall Study|Dose limiting toxicity|0|||
105830291|NCT02372006|365035455|FG000|Overall Study|Adverse Event|0|||
105830292|NCT02372006|365035456|FG001|Overall Study|Adverse Event|0|||
105830293|NCT02372006|365035457|FG002|Overall Study|Adverse Event|3|||
105830294|NCT02372006|365035455|FG000|Overall Study|Withdrawal by Subject|0|||
105830295|NCT02372006|365035456|FG001|Overall Study|Withdrawal by Subject|1|||
105830296|NCT02372006|365035457|FG002|Overall Study|Withdrawal by Subject|1|||
105830297|NCT02372006|365035455|FG000|Overall Study|Other reason for not completing|0|||
105830298|NCT02372006|365035456|FG001|Overall Study|Other reason for not completing|0|||
105830299|NCT02372006|365035457|FG002|Overall Study|Other reason for not completing|1|||
105830300|NCT01717313|365035461|FG000|Phase A (Weeks 0 to 24)|Death|0|||
105830301|NCT01717313|365035462|FG001|Phase A (Weeks 0 to 24)|Death|1|||
105830302|NCT01717313|365035461|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
105830303|NCT01717313|365035462|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
105830304|NCT01717313|365035461|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
105830305|NCT01717313|365035462|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
105830306|NCT01717313|365035461|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
105830307|NCT01717313|365035462|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
105830308|NCT01717313|365035461|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
105830309|NCT01717313|365035462|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
105830310|NCT01717313|365035461|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
105830311|NCT01717313|365035462|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
105830312|NCT01717313|365035461|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
105830313|NCT01717313|365035462|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
105830314|NCT01717313|365035461|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
105830315|NCT01717313|365035462|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
105830316|NCT01717313|365035461|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
105830317|NCT01717313|365035462|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
105830318|NCT01567527|365035463|FG000|Conversion Phase.|Protocol deviation|3|||
105830319|NCT01567527|365035464|FG001|Conversion Phase.|Protocol deviation|0|||
105830320|NCT01567527|365035465|FG002|Conversion Phase.|Protocol deviation|0|||
105830321|NCT01567527|365035466|FG003|Conversion Phase.|Protocol deviation|0|||
105830322|NCT01567527|365035467|FG004|Conversion Phase.|Protocol deviation|0|||
105830323|NCT01567527|365035463|FG000|Conversion Phase.|Met withdrawal criteria|10|||
105830324|NCT01567527|365035464|FG001|Conversion Phase.|Met withdrawal criteria|0|||
105830325|NCT01567527|365035465|FG002|Conversion Phase.|Met withdrawal criteria|0|||
105830326|NCT01567527|365035466|FG003|Conversion Phase.|Met withdrawal criteria|0|||
105830327|NCT01567527|365035467|FG004|Conversion Phase.|Met withdrawal criteria|0|||
105830328|NCT01567527|365035463|FG000|Conversion Phase.|Withdrawal by Subject|32|||
105830329|NCT01567527|365035464|FG001|Conversion Phase.|Withdrawal by Subject|0|||
105830330|NCT01567527|365035465|FG002|Conversion Phase.|Withdrawal by Subject|0|||
105830331|NCT01567527|365035466|FG003|Conversion Phase.|Withdrawal by Subject|0|||
105830332|NCT01567527|365035467|FG004|Conversion Phase.|Withdrawal by Subject|0|||
105830333|NCT01567527|365035463|FG000|Conversion Phase.|Lost to Follow-up|16|||
105830334|NCT01567527|365035464|FG001|Conversion Phase.|Lost to Follow-up|0|||
105830335|NCT01567527|365035465|FG002|Conversion Phase.|Lost to Follow-up|0|||
105308467|NCT02056392|363127240|FG005|Overall Study|Withdrawal by Subject|0|||
105308468|NCT00761865|363127243|FG000|Overall Study|Lost to Follow-up|8|||
105308469|NCT00761865|363127244|FG001|Overall Study|Lost to Follow-up|7|||
105308470|NCT00574912|363127245|FG000|Overall Study|Could not place IV lines.|3|||
105308471|NCT00574912|363127245|FG000|Overall Study|scheduling conflicts|3|||
105830336|NCT01567527|365035466|FG003|Conversion Phase.|Lost to Follow-up|0|||
105830337|NCT01567527|365035467|FG004|Conversion Phase.|Lost to Follow-up|0|||
105830338|NCT01567527|365035463|FG000|Conversion Phase.|Lack of Efficacy|2|||
105830339|NCT01567527|365035464|FG001|Conversion Phase.|Lack of Efficacy|0|||
105830340|NCT01567527|365035465|FG002|Conversion Phase.|Lack of Efficacy|0|||
105830341|NCT01567527|365035466|FG003|Conversion Phase.|Lack of Efficacy|0|||
105830342|NCT01567527|365035467|FG004|Conversion Phase.|Lack of Efficacy|0|||
105830343|NCT01567527|365035463|FG000|Conversion Phase.|Adverse Event|33|||
105830344|NCT01567527|365035464|FG001|Conversion Phase.|Adverse Event|0|||
105830345|NCT01567527|365035465|FG002|Conversion Phase.|Adverse Event|0|||
105830346|NCT01567527|365035466|FG003|Conversion Phase.|Adverse Event|0|||
105830347|NCT01567527|365035467|FG004|Conversion Phase.|Adverse Event|0|||
105830348|NCT01567527|365035463|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
105830349|NCT01567527|365035464|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
105830350|NCT01567527|365035465|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
105830351|NCT01567527|365035466|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
105830352|NCT01567527|365035467|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
105830353|NCT01567527|365035463|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
105830354|NCT01567527|365035464|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
105830355|NCT01567527|365035465|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
105830356|NCT01567527|365035466|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
105830357|NCT01567527|365035467|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
105830358|NCT01567527|365035463|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
105830359|NCT01567527|365035464|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
105830360|NCT01567527|365035465|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
105830361|NCT01567527|365035466|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
105830362|NCT01567527|365035467|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
105830363|NCT01567527|365035463|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
105830364|NCT01567527|365035464|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
105830365|NCT01567527|365035465|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
105830366|NCT01567527|365035466|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
105830367|NCT01567527|365035467|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
105830368|NCT01567527|365035463|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
105830369|NCT01567527|365035464|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
105830370|NCT01567527|365035465|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
105830371|NCT01567527|365035466|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
105830372|NCT01567527|365035467|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
105830373|NCT01567527|365035463|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
105830374|NCT01567527|365035464|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
105830375|NCT01567527|365035465|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
105830376|NCT01567527|365035466|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
105830377|NCT01567527|365035467|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
105830378|NCT01567527|365035463|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
105830379|NCT01567527|365035464|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
105830380|NCT01567527|365035465|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
105308472|NCT00574912|363127245|FG000|Overall Study|Physician Decision|2|||
105308473|NCT00968799|363127253|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
105830381|NCT01567527|365035466|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
105830382|NCT01567527|365035467|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
105830383|NCT01567527|365035463|FG000|IM Depot Stabilization.|Protocol deviation|0|||
105830384|NCT01567527|365035464|FG001|IM Depot Stabilization.|Protocol deviation|0|||
105830385|NCT01567527|365035465|FG002|IM Depot Stabilization.|Protocol deviation|5|||
105830386|NCT01567527|365035466|FG003|IM Depot Stabilization.|Protocol deviation|0|||
105830387|NCT01567527|365035467|FG004|IM Depot Stabilization.|Protocol deviation|0|||
105830388|NCT01567527|365035463|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
105830389|NCT01567527|365035464|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
105830390|NCT01567527|365035465|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
105830391|NCT01567527|365035466|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
105830392|NCT01567527|365035467|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
105830393|NCT01567527|365035463|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
105830394|NCT01567527|365035464|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
105489366|NCT02962765|363804040|FG000|Overall Study|Protocol Violation|9|||
105489367|NCT02962765|363804040|FG000|Overall Study|Withdrawal by Subject|3|||
105830395|NCT01567527|365035465|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
105489368|NCT02962765|363804040|FG000|Overall Study|Lost to Follow-up|1|||
105489369|NCT02962765|363804040|FG000|Overall Study|Death|1|||
105489370|NCT02962765|363804040|FG000|Overall Study|Limited access to study medication|3|||
105830396|NCT01567527|365035466|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
105830397|NCT01567527|365035467|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
105830398|NCT01567527|365035463|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
105830399|NCT01567527|365035464|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
105830400|NCT01567527|365035465|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
105830401|NCT01567527|365035466|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
105830402|NCT01567527|365035467|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
105830403|NCT01567527|365035463|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
105830404|NCT01567527|365035464|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
105830405|NCT01567527|365035465|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
105830406|NCT01567527|365035466|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
105830407|NCT01567527|365035467|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
105830408|NCT01567527|365035463|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
105830409|NCT01567527|365035464|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
105830410|NCT01567527|365035465|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
105830411|NCT01567527|365035466|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
105830412|NCT01567527|365035467|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
105830413|NCT01567527|365035463|FG000|IM Depot Stabilization.|Adverse Event|0|||
105830414|NCT01567527|365035464|FG001|IM Depot Stabilization.|Adverse Event|0|||
105830415|NCT01567527|365035465|FG002|IM Depot Stabilization.|Adverse Event|37|||
105830416|NCT01567527|365035466|FG003|IM Depot Stabilization.|Adverse Event|0|||
105830417|NCT01567527|365035467|FG004|IM Depot Stabilization.|Adverse Event|0|||
105830418|NCT01567527|365035463|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
105830419|NCT01567527|365035464|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
105830420|NCT01567527|365035465|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
105830421|NCT01567527|365035466|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
105830422|NCT01567527|365035467|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
105830423|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
105830424|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
105830425|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
105830426|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
105830427|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
105830428|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
105830429|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
105830430|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
105830431|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
105830432|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
105830433|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
105830434|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
105830435|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
105830436|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
105830437|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
105830438|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
105830439|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
105830440|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
105830441|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
105830442|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
105830443|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
105830444|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
105830445|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
105830446|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
105830447|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
105830448|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
105830449|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
105830450|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
105489371|NCT00750880|363804046|FG000|Overall Study|Adverse Event|76|||
105489372|NCT00750880|363804046|FG000|Overall Study|Death|4|||
105489373|NCT00750880|363804046|FG000|Overall Study|Lack of Efficacy|46|||
105830451|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
105830452|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
105830453|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
105489374|NCT00750880|363804046|FG000|Overall Study|Lost to Follow-up|10|||
105830454|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
105830455|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
105830456|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
105830457|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
105830458|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105830459|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105830460|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105830461|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
105830462|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
105830463|NCT01958476|365035470|FG000|Overall Study|Parent requested exclusion from analysis|1|||
105830464|NCT01958476|365035471|FG001|Overall Study|Parent requested exclusion from analysis|0|||
105830465|NCT02004691|365035472|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
105830466|NCT02004691|365035473|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
105830467|NCT02004691|365035472|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
105830468|NCT02004691|365035473|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
105830469|NCT02004691|365035472|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
105830470|NCT02004691|365035473|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
105830471|NCT02004691|365035472|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
105830472|NCT02004691|365035473|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
105830473|NCT02004691|365035472|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
105830474|NCT02004691|365035473|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
105830475|NCT02004691|365035472|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
105830476|NCT02004691|365035473|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
105830477|NCT00884390|365035475|FG000|Overall Study|Adverse Event|0|||
105830478|NCT00884390|365035476|FG001|Overall Study|Adverse Event|1|||
105830479|NCT00884390|365035475|FG000|Overall Study|Lost to Follow-up|0|||
105830480|NCT00884390|365035476|FG001|Overall Study|Lost to Follow-up|1|||
105830481|NCT00884390|365035475|FG000|Overall Study|Physician Decision|2|||
105830482|NCT00884390|365035476|FG001|Overall Study|Physician Decision|1|||
105830483|NCT00884390|365035475|FG000|Overall Study|Protocol Violation|4|||
105830484|NCT00884390|365035476|FG001|Overall Study|Protocol Violation|1|||
105830485|NCT00884390|365035475|FG000|Overall Study|Withdrawal by Subject|4|||
105830486|NCT00884390|365035476|FG001|Overall Study|Withdrawal by Subject|1|||
105830487|NCT00884390|365035475|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
105830488|NCT00884390|365035476|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
105830489|NCT00884390|365035475|FG000|Overall Study|Other|11|||
105830490|NCT00884390|365035476|FG001|Overall Study|Other|1|||
105830491|NCT00751023|365035479|FG000|Overall Study|Lost to Follow-up|11|||
105830492|NCT00751023|365035480|FG001|Overall Study|Lost to Follow-up|7|||
105830493|NCT02623218|365035481|FG000|Overall Study|Lost to Follow-up|0|||
105830494|NCT02623218|365035482|FG001|Overall Study|Lost to Follow-up|1|||
105830495|NCT02623218|365035483|FG002|Overall Study|Lost to Follow-up|0|||
105830496|NCT02623218|365035484|FG003|Overall Study|Lost to Follow-up|0|||
105830497|NCT02623218|365035485|FG004|Overall Study|Lost to Follow-up|0|||
105830498|NCT00702507|365035486|FG000|Initial Treatment Phase|Adverse Event|2|||
105830499|NCT00702507|365035486|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
105830500|NCT00702507|365035486|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
105308474|NCT04730349|363127258|FG000|Overall Study|Participant withdrew consent|1|||
105308475|NCT04730349|363127259|FG001|Overall Study|Participant withdrew consent|0|||
105308476|NCT04730349|363127258|FG000|Overall Study|Disease progression|6|||
105830501|NCT00702507|365035486|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
105830502|NCT00702507|365035486|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
105830503|NCT00702507|365035486|FG000|Follow-up Phase|Protocol Violation|2|||
105830504|NCT00702507|365035486|FG000|Follow-up Phase|Lost to Follow-up|23|||
105830505|NCT00702507|365035486|FG000|Follow-up Phase|Late Enrollment|1|||
105830506|NCT05412121|365035493|FG000|Overall Study|Withdrawal by Subject|4|||
105830507|NCT05412121|365035493|FG000|Overall Study|Physician Decision|1|||
105830508|NCT05412121|365035493|FG000|Overall Study|Lost to Follow-up|5|||
105830509|NCT02670551|365035497|FG000|Overall Study|Adverse Event|4|||
105830510|NCT02670551|365035498|FG001|Overall Study|Adverse Event|7|||
105830511|NCT02670551|365035499|FG002|Overall Study|Adverse Event|9|||
105830512|NCT02670551|365035497|FG000|Overall Study|Lack of Efficacy|2|||
105830513|NCT02670551|365035498|FG001|Overall Study|Lack of Efficacy|0|||
105830514|NCT02670551|365035499|FG002|Overall Study|Lack of Efficacy|3|||
105830515|NCT02670551|365035497|FG000|Overall Study|Withdrawal of Consent|6|||
105830516|NCT02670551|365035498|FG001|Overall Study|Withdrawal of Consent|3|||
105830517|NCT02670551|365035499|FG002|Overall Study|Withdrawal of Consent|8|||
105830518|NCT02670551|365035497|FG000|Overall Study|Lost to Follow-up|5|||
105830519|NCT02670551|365035498|FG001|Overall Study|Lost to Follow-up|7|||
105830520|NCT02670551|365035499|FG002|Overall Study|Lost to Follow-up|6|||
105830521|NCT02670551|365035497|FG000|Overall Study|Protocol Violation|1|||
105830522|NCT02670551|365035498|FG001|Overall Study|Protocol Violation|0|||
105830523|NCT02670551|365035499|FG002|Overall Study|Protocol Violation|0|||
105830524|NCT02670551|365035497|FG000|Overall Study|Noncompliance with study drug|3|||
105830525|NCT02670551|365035498|FG001|Overall Study|Noncompliance with study drug|3|||
105830526|NCT02670551|365035499|FG002|Overall Study|Noncompliance with study drug|2|||
105830527|NCT02670551|365035497|FG000|Overall Study|Other Miscellaneous Reasons|2|||
105830528|NCT02670551|365035498|FG001|Overall Study|Other Miscellaneous Reasons|3|||
105830529|NCT02670551|365035499|FG002|Overall Study|Other Miscellaneous Reasons|3|||
105830530|NCT02670551|365035497|FG000|Overall Study|Did Not Receive Treatment|5|||
105830531|NCT02670551|365035498|FG001|Overall Study|Did Not Receive Treatment|3|||
105830532|NCT02670551|365035499|FG002|Overall Study|Did Not Receive Treatment|0|||
105830533|NCT01971645|365035502|FG000|Overall Study|Adverse Event|1|||
105830534|NCT01971645|365035503|FG001|Overall Study|Adverse Event|0|||
105830535|NCT01971645|365035504|FG002|Overall Study|Adverse Event|0|||
105830536|NCT01971645|365035502|FG000|Overall Study|Lost to Follow-up|1|||
105830537|NCT01971645|365035503|FG001|Overall Study|Lost to Follow-up|0|||
105830538|NCT01971645|365035504|FG002|Overall Study|Lost to Follow-up|1|||
105830539|NCT01971645|365035502|FG000|Overall Study|Protocol Violation|0|||
105830540|NCT01971645|365035503|FG001|Overall Study|Protocol Violation|0|||
105830541|NCT01971645|365035504|FG002|Overall Study|Protocol Violation|1|||
105830542|NCT01962298|365035505|FG000|Overall Study|Protocol Violation|1|||
105830543|NCT01962298|365035506|FG001|Overall Study|Protocol Violation|0|||
105830544|NCT01962298|365035507|FG002|Overall Study|Protocol Violation|1|||
105830545|NCT01962298|365035508|FG003|Overall Study|Protocol Violation|1|||
105830546|NCT01962298|365035509|FG004|Overall Study|Protocol Violation|0|||
105830547|NCT01962298|365035505|FG000|Overall Study|Data quality insufficient|2|||
105830548|NCT01962298|365035506|FG001|Overall Study|Data quality insufficient|0|||
105830549|NCT01962298|365035507|FG002|Overall Study|Data quality insufficient|3|||
105830550|NCT01962298|365035508|FG003|Overall Study|Data quality insufficient|1|||
105830551|NCT01962298|365035509|FG004|Overall Study|Data quality insufficient|4|||
105830552|NCT01962298|365035505|FG000|Overall Study|Insufficient data|0|||
105830553|NCT01962298|365035506|FG001|Overall Study|Insufficient data|2|||
105830554|NCT01962298|365035507|FG002|Overall Study|Insufficient data|1|||
105830555|NCT01962298|365035508|FG003|Overall Study|Insufficient data|0|||
105830556|NCT01962298|365035509|FG004|Overall Study|Insufficient data|1|||
105830557|NCT01962298|365035505|FG000|Overall Study|Incorrect data recorded|0|||
105830558|NCT01962298|365035506|FG001|Overall Study|Incorrect data recorded|1|||
105830559|NCT01962298|365035507|FG002|Overall Study|Incorrect data recorded|0|||
105830560|NCT01962298|365035508|FG003|Overall Study|Incorrect data recorded|0|||
105830561|NCT01962298|365035509|FG004|Overall Study|Incorrect data recorded|0|||
105830562|NCT01962298|365035505|FG000|Overall Study|Physician Decision|0|||
105830563|NCT01962298|365035506|FG001|Overall Study|Physician Decision|1|||
105830564|NCT01962298|365035507|FG002|Overall Study|Physician Decision|0|||
105830565|NCT01962298|365035508|FG003|Overall Study|Physician Decision|0|||
105830566|NCT01962298|365035509|FG004|Overall Study|Physician Decision|1|||
105830567|NCT00537095|365035510|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
105830568|NCT00537095|365035511|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
105830569|NCT00537095|365035510|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
105830570|NCT00537095|365035511|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
105830571|NCT00537095|365035510|FG000|Randomized Treatment Period (433 Days)|Death|3|||
105830572|NCT00537095|365035511|FG001|Randomized Treatment Period (433 Days)|Death|1|||
105830573|NCT00537095|365035510|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
105830574|NCT00537095|365035511|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
105830575|NCT00537095|365035510|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
105830576|NCT00537095|365035511|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
105830577|NCT00537095|365035510|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
105308477|NCT04730349|363127259|FG001|Overall Study|Disease progression|4|||
105308478|NCT04730349|363127258|FG000|Overall Study|Study drug toxicity|0|||
105308479|NCT04730349|363127259|FG001|Overall Study|Study drug toxicity|1|||
105308480|NCT00638027|363127262|FG000|Overall Study|Adverse Event|0|||
105308481|NCT00638027|363127263|FG001|Overall Study|Adverse Event|2|||
105308482|NCT00371397|363127264|FG000|Session 1|Withdrawal by Subject|1|||
105308483|NCT00371397|363127265|FG001|Session 1|Withdrawal by Subject|0|||
105308484|NCT00371397|363127266|FG002|Session 1|Withdrawal by Subject|0|||
105489375|NCT00750880|363804046|FG000|Overall Study|Protocol Violation|15|||
105489376|NCT00750880|363804046|FG000|Overall Study|Withdrawal by Subject|33|||
105830578|NCT00537095|365035511|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
105830579|NCT00537095|365035510|FG000|Open-label Period (590 Days)|Adverse Event|2|||
105830580|NCT00537095|365035511|FG001|Open-label Period (590 Days)|Adverse Event|11|||
105830581|NCT00537095|365035510|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
105830582|NCT00537095|365035511|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
105830583|NCT00537095|365035510|FG000|Open-label Period (590 Days)|Death|2|||
105830584|NCT00537095|365035511|FG001|Open-label Period (590 Days)|Death|2|||
105830585|NCT00537095|365035510|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
105308485|NCT00371397|363127267|FG003|Session 1|Withdrawal by Subject|0|||
105830586|NCT00537095|365035511|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
105830587|NCT00537095|365035510|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
105830588|NCT00537095|365035511|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
105830589|NCT03727139|365035512|FG000|Overall Study|Protocol Violation|60|||
105830590|NCT00566722|365035513|FG000|Overall Study|Adverse Event|0|||
105830591|NCT00566722|365035514|FG001|Overall Study|Adverse Event|1|||
105830592|NCT00566722|365035515|FG002|Overall Study|Adverse Event|0|||
105830593|NCT00566722|365035513|FG000|Overall Study|Withdrawal by Subject|0|||
105830594|NCT00566722|365035514|FG001|Overall Study|Withdrawal by Subject|0|||
105830595|NCT00566722|365035515|FG002|Overall Study|Withdrawal by Subject|1|||
105830596|NCT00566722|365035513|FG000|Overall Study|Lost to Follow-up|1|||
105830597|NCT00566722|365035514|FG001|Overall Study|Lost to Follow-up|1|||
105830598|NCT00566722|365035515|FG002|Overall Study|Lost to Follow-up|1|||
105830599|NCT00566722|365035513|FG000|Overall Study|Lack of Efficacy|1|||
105830600|NCT00566722|365035514|FG001|Overall Study|Lack of Efficacy|2|||
105830601|NCT00566722|365035515|FG002|Overall Study|Lack of Efficacy|4|||
105830602|NCT00566722|365035513|FG000|Overall Study|Did not meet exclusion criteria|0|||
105830603|NCT00566722|365035514|FG001|Overall Study|Did not meet exclusion criteria|0|||
105830604|NCT00566722|365035515|FG002|Overall Study|Did not meet exclusion criteria|2|||
105830605|NCT00566722|365035513|FG000|Overall Study|Serious adverse event|0|||
105830606|NCT00566722|365035514|FG001|Overall Study|Serious adverse event|1|||
105830607|NCT00566722|365035515|FG002|Overall Study|Serious adverse event|0|||
105830608|NCT00566722|365035513|FG000|Overall Study|Noncompliant with drug administration|0|||
105830609|NCT00566722|365035514|FG001|Overall Study|Noncompliant with drug administration|0|||
105830610|NCT00566722|365035515|FG002|Overall Study|Noncompliant with drug administration|1|||
105830611|NCT03105297|365035516|FG000|Baseline Phase (Day 1)|Other|21|||
105830612|NCT03105297|365035516|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
105830613|NCT03105297|365035516|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
105830614|NCT05065619|365035517|FG000|Up to Day 42|Lost to Follow-up|1|||
105830615|NCT05065619|365035518|FG001|Up to Day 42|Lost to Follow-up|0|||
105830616|NCT05065619|365035517|FG000|Up to Day 42|Withdrawal by Subject|1|||
105830617|NCT05065619|365035518|FG001|Up to Day 42|Withdrawal by Subject|0|||
105830618|NCT05065619|365035517|FG000|After Day 43|Lost to Follow-up|1|||
105830619|NCT05065619|365035518|FG001|After Day 43|Lost to Follow-up|0|||
105830620|NCT05065619|365035517|FG000|After Day 43|Physician Decision|3|||
105830621|NCT05065619|365035518|FG001|After Day 43|Physician Decision|0|||
105830622|NCT05065619|365035517|FG000|After Day 43|Withdrawal by Subject|1|||
105830623|NCT05065619|365035518|FG001|After Day 43|Withdrawal by Subject|2|||
105830624|NCT05065619|365035517|FG000|After Day 43|Public vaccination|6|||
105830625|NCT05065619|365035518|FG001|After Day 43|Public vaccination|8|||
105830626|NCT05065619|365035517|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
105830627|NCT05065619|365035518|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
105830628|NCT05065619|365035517|FG000|After Day 43|Study Terminated by Sponsor|88|||
105830629|NCT05065619|365035518|FG001|After Day 43|Study Terminated by Sponsor|16|||
105830630|NCT00835081|365035522|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
105830631|NCT00835081|365035523|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
105830632|NCT00421304|365035524|FG000|Overall Study|Lost to Follow-up|5|||
105830633|NCT00421304|365035525|FG001|Overall Study|Lost to Follow-up|2|||
105830634|NCT00421304|365035526|FG002|Overall Study|Lost to Follow-up|5|||
105830635|NCT00421304|365035524|FG000|Overall Study|Withdrawal by Subject|2|||
105830636|NCT00421304|365035525|FG001|Overall Study|Withdrawal by Subject|2|||
105830637|NCT00421304|365035526|FG002|Overall Study|Withdrawal by Subject|2|||
105830638|NCT00421304|365035524|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
105830639|NCT00421304|365035525|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
105830640|NCT00421304|365035526|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
105830641|NCT00421304|365035524|FG000|Overall Study|Did not attend Day 360 visit|0|||
105830642|NCT00421304|365035525|FG001|Overall Study|Did not attend Day 360 visit|0|||
105830643|NCT00421304|365035526|FG002|Overall Study|Did not attend Day 360 visit|1|||
105830644|NCT01968031|365035529|FG000|Overall Study|Adverse Event|13|||
105830645|NCT01968031|365035530|FG001|Overall Study|Adverse Event|10|||
105830646|NCT01968031|365035531|FG002|Overall Study|Adverse Event|22|||
105830647|NCT01968031|365035529|FG000|Overall Study|Withdrawal by Subject|3|||
105830648|NCT01968031|365035530|FG001|Overall Study|Withdrawal by Subject|7|||
105830649|NCT01968031|365035531|FG002|Overall Study|Withdrawal by Subject|3|||
105830650|NCT01968031|365035529|FG000|Overall Study|Did not meet entry criteria|1|||
105830651|NCT01968031|365035530|FG001|Overall Study|Did not meet entry criteria|1|||
105830652|NCT01968031|365035531|FG002|Overall Study|Did not meet entry criteria|1|||
105830653|NCT01968031|365035529|FG000|Overall Study|Noncompliance|0|||
105830654|NCT01968031|365035530|FG001|Overall Study|Noncompliance|0|||
105308486|NCT00371397|363127268|FG004|Session 1|Withdrawal by Subject|0|||
105308487|NCT00371397|363127269|FG005|Session 1|Withdrawal by Subject|0|||
105830655|NCT01968031|365035531|FG002|Overall Study|Noncompliance|2|||
105830656|NCT01968031|365035529|FG000|Overall Study|Failed inclusion criteria|0|||
105830657|NCT01968031|365035530|FG001|Overall Study|Failed inclusion criteria|2|||
105830658|NCT01968031|365035531|FG002|Overall Study|Failed inclusion criteria|0|||
105830659|NCT01968031|365035529|FG000|Overall Study|Death|0|||
105830660|NCT01968031|365035530|FG001|Overall Study|Death|0|||
105830661|NCT01968031|365035531|FG002|Overall Study|Death|1|||
105830662|NCT01968031|365035529|FG000|Overall Study|Prohibited concomitant medication|1|||
105830663|NCT01968031|365035530|FG001|Overall Study|Prohibited concomitant medication|0|||
105830664|NCT01968031|365035531|FG002|Overall Study|Prohibited concomitant medication|0|||
105830665|NCT00685334|365035537|FG000|Overall Study|Withdrawal by Subject|5|||
105830666|NCT00685334|365035538|FG001|Overall Study|Withdrawal by Subject|6|||
105830667|NCT00685334|365035537|FG000|Overall Study|Lost to Follow-up|4|||
105830668|NCT00685334|365035538|FG001|Overall Study|Lost to Follow-up|0|||
105830669|NCT00685334|365035537|FG000|Overall Study|Chose to enter hospital|1|||
105830670|NCT00685334|365035538|FG001|Overall Study|Chose to enter hospital|1|||
105830671|NCT01891357|365035539|FG000|Overall Study|Protocol Violation|3|||
105830672|NCT00874276|365035540|FG000|Overall Study|Withdrawal by Subject|1|||
105830673|NCT00874276|365035541|FG001|Overall Study|Withdrawal by Subject|1|||
105830674|NCT01520987|365037091|FG000|Overall Study|Withdrawal by Subject|1|||
105830675|NCT01520987|365037092|FG001|Overall Study|Withdrawal by Subject|0|||
105830676|NCT01520987|365037093|FG002|Overall Study|Withdrawal by Subject|0|||
105830677|NCT01520987|365037094|FG003|Overall Study|Withdrawal by Subject|0|||
105830678|NCT01520987|365037095|FG004|Overall Study|Withdrawal by Subject|0|||
105830679|NCT01520987|365037096|FG005|Overall Study|Withdrawal by Subject|1|||
105830680|NCT01520987|365037097|FG006|Overall Study|Withdrawal by Subject|0|||
105830681|NCT01520987|365037098|FG007|Overall Study|Withdrawal by Subject|0|||
105830682|NCT01691430|365037099|FG000|Overall Study|Death|17|||
105366676|NCT02100124|363348518|FG002|Overall Study|Withdrawal by Subject|0|||
105830683|NCT01691430|365037100|FG001|Overall Study|Death|16|||
105830684|NCT01691430|365037099|FG000|Overall Study|Withdrawal by Subject|5|||
105830685|NCT01691430|365037100|FG001|Overall Study|Withdrawal by Subject|1|||
105830686|NCT01691430|365037099|FG000|Overall Study|Lost to Follow-up|0|||
105830687|NCT01691430|365037100|FG001|Overall Study|Lost to Follow-up|3|||
105830688|NCT01109849|365037103|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
105830689|NCT01109849|365037104|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
105830690|NCT01109849|365037105|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
105830691|NCT01109849|365037106|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
105830692|NCT01109849|365037107|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
105830693|NCT01109849|365037103|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
105830694|NCT01109849|365037104|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
105830695|NCT01109849|365037105|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
105830696|NCT01109849|365037106|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
105830697|NCT01109849|365037107|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
105830698|NCT01109849|365037103|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
105830699|NCT01109849|365037104|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
105830700|NCT01109849|365037105|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
105830701|NCT01109849|365037106|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
105830702|NCT01109849|365037107|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
105830703|NCT01109849|365037103|FG000|Initial Randomization: ADHD Treatment|move away|2|||
105830704|NCT01109849|365037104|FG001|Initial Randomization: ADHD Treatment|move away|7|||
105830705|NCT01109849|365037105|FG002|Initial Randomization: ADHD Treatment|move away|0|||
105830706|NCT01109849|365037106|FG003|Initial Randomization: ADHD Treatment|move away|0|||
105830707|NCT01109849|365037107|FG004|Initial Randomization: ADHD Treatment|move away|0|||
105830708|NCT01109849|365037103|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
105830709|NCT01109849|365037104|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
105830710|NCT01109849|365037105|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
105830711|NCT01109849|365037106|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
105830712|NCT01109849|365037107|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
105830713|NCT01109849|365037103|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
105830714|NCT01109849|365037104|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
105830715|NCT01109849|365037105|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
105830716|NCT01109849|365037106|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
105830717|NCT01109849|365037107|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
105830718|NCT05776901|365037108|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
105830719|NCT03119662|365037116|FG000|Overall Study|Withdrawal by Subject|0|||
105830720|NCT03119662|365037117|FG001|Overall Study|Withdrawal by Subject|1|||
105830721|NCT01630616|365037124|FG000|Overall Study|Adverse Event|0|||
105830722|NCT01630616|365037125|FG001|Overall Study|Adverse Event|0|||
105366677|NCT04980014|363350004|FG000|Overall Study|Participants who are Duplicated|1|||
105366678|NCT04980014|363350004|FG000|Overall Study|Follow-up Failure|13|||
105830723|NCT01630616|365037126|FG002|Overall Study|Adverse Event|0|||
105830724|NCT01630616|365037127|FG003|Overall Study|Adverse Event|1|||
105830725|NCT01630616|365037128|FG004|Overall Study|Adverse Event|0|||
105830726|NCT01630616|365037129|FG005|Overall Study|Adverse Event|0|||
105308488|NCT00371397|363127270|FG006|Session 1|Withdrawal by Subject|0|||
105308489|NCT00371397|363127271|FG007|Session 1|Withdrawal by Subject|1|||
105308490|NCT00371397|363127272|FG008|Session 1|Withdrawal by Subject|0|||
105308491|NCT00371397|363127273|FG009|Session 1|Withdrawal by Subject|0|||
105308492|NCT00371397|363127274|FG010|Session 1|Withdrawal by Subject|0|||
105308493|NCT00371397|363127275|FG011|Session 1|Withdrawal by Subject|0|||
105308494|NCT03014180|363127276|FG000|Overall Study|Protocol Violation|2|||
105308495|NCT01284621|363127277|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
105308496|NCT01284621|363127278|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
105308497|NCT01284621|363127279|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
105308498|NCT01284621|363127280|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
105308499|NCT01284621|363127281|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
105308500|NCT01284621|363127282|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
105308501|NCT02802631|363127285|FG000|Overall Study|Withdrawal by Subject|1|||
105308502|NCT02802631|363127286|FG001|Overall Study|Withdrawal by Subject|0|||
105308503|NCT02802631|363127287|FG002|Overall Study|Withdrawal by Subject|0|||
105308504|NCT02802631|363127288|FG003|Overall Study|Withdrawal by Subject|0|||
105308505|NCT02802631|363127289|FG004|Overall Study|Withdrawal by Subject|0|||
105308506|NCT02802631|363127290|FG005|Overall Study|Withdrawal by Subject|0|||
105308507|NCT02802631|363127291|FG006|Overall Study|Withdrawal by Subject|0|||
105308508|NCT02802631|363127292|FG007|Overall Study|Withdrawal by Subject|0|||
105308509|NCT02802631|363127285|FG000|Overall Study|Physician Decision|1|||
105308510|NCT02802631|363127286|FG001|Overall Study|Physician Decision|0|||
105308511|NCT02802631|363127287|FG002|Overall Study|Physician Decision|0|||
105308512|NCT02802631|363127288|FG003|Overall Study|Physician Decision|0|||
105308513|NCT02802631|363127289|FG004|Overall Study|Physician Decision|0|||
105308514|NCT02802631|363127290|FG005|Overall Study|Physician Decision|0|||
105308515|NCT02802631|363127291|FG006|Overall Study|Physician Decision|1|||
105308516|NCT02802631|363127292|FG007|Overall Study|Physician Decision|0|||
105308517|NCT02802631|363127285|FG000|Overall Study|Adverse Event|0|||
105308518|NCT02802631|363127286|FG001|Overall Study|Adverse Event|2|||
105308519|NCT02802631|363127287|FG002|Overall Study|Adverse Event|0|||
105308520|NCT02802631|363127288|FG003|Overall Study|Adverse Event|1|||
105308521|NCT02802631|363127289|FG004|Overall Study|Adverse Event|6|||
105308522|NCT02802631|363127290|FG005|Overall Study|Adverse Event|1|||
105308523|NCT02802631|363127291|FG006|Overall Study|Adverse Event|4|||
105308524|NCT02802631|363127292|FG007|Overall Study|Adverse Event|0|||
105308525|NCT02802631|363127285|FG000|Overall Study|Sponsor Decision|0|||
105308526|NCT02802631|363127286|FG001|Overall Study|Sponsor Decision|0|||
105308527|NCT02802631|363127287|FG002|Overall Study|Sponsor Decision|6|||
105308528|NCT02802631|363127288|FG003|Overall Study|Sponsor Decision|0|||
105308529|NCT02802631|363127289|FG004|Overall Study|Sponsor Decision|2|||
105308530|NCT02802631|363127290|FG005|Overall Study|Sponsor Decision|0|||
105308531|NCT02802631|363127291|FG006|Overall Study|Sponsor Decision|0|||
105308532|NCT02802631|363127292|FG007|Overall Study|Sponsor Decision|4|||
105308533|NCT02377427|363127293|FG000|Part A (Up to Week 20)|Physician Decision|1|||
105308534|NCT02377427|363127294|FG001|Part A (Up to Week 20)|Physician Decision|0|||
105308535|NCT02377427|363127295|FG002|Part A (Up to Week 20)|Physician Decision|0|||
105308536|NCT02377427|363127296|FG003|Part A (Up to Week 20)|Physician Decision|0|||
105830727|NCT01630616|365037124|FG000|Overall Study|Withdrawal by Subject|0|||
105830728|NCT01630616|365037125|FG001|Overall Study|Withdrawal by Subject|0|||
105830729|NCT01630616|365037126|FG002|Overall Study|Withdrawal by Subject|0|||
105830730|NCT01630616|365037127|FG003|Overall Study|Withdrawal by Subject|2|||
105830731|NCT01630616|365037128|FG004|Overall Study|Withdrawal by Subject|0|||
105830732|NCT01630616|365037129|FG005|Overall Study|Withdrawal by Subject|0|||
105830733|NCT00856349|365037131|FG000|Overall Study|Death|418|||
105830734|NCT00856349|365037131|FG000|Overall Study|Withdrawal by Subject|116|||
105830735|NCT00856349|365037131|FG000|Overall Study|Lost to Follow-up|91|||
105830736|NCT00856349|365037131|FG000|Overall Study|Protocol Violation|38|||
105830737|NCT00856349|365037131|FG000|Overall Study|Physician Decision|13|||
105830738|NCT00856349|365037131|FG000|Overall Study|Subject relocation|104|||
105830739|NCT00856349|365037131|FG000|Overall Study|Device explant|33|||
105830740|NCT00856349|365037131|FG000|Overall Study|Site closure|78|||
105308537|NCT02377427|363127297|FG004|Part A (Up to Week 20)|Physician Decision|0|||
105308538|NCT02377427|363127293|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
105308539|NCT02377427|363127294|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
105489377|NCT00750880|363804046|FG000|Overall Study|Physician Decision|20|||
105308540|NCT02377427|363127295|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
105308541|NCT02377427|363127296|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
105308542|NCT02377427|363127297|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
105308543|NCT02377427|363127293|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
105489378|NCT00750880|363804046|FG000|Overall Study|Administrative|11|||
105489379|NCT04505540|363804047|FG000|Baseline|Protocol Violation|10|||
105575837|NCT04467840|364108340|FG001|Overall Study|Death|39|||
105830741|NCT00856349|365037131|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
105830742|NCT02725515|365037132|FG000|Overall Study|Refused infusion (no study treatment)|1|||
105830743|NCT02725515|365037133|FG001|Overall Study|Refused infusion (no study treatment)|0|||
105830744|NCT02725515|365037132|FG000|Overall Study|Loss of Improvement per Protocol|14|||
105830745|NCT02725515|365037133|FG001|Overall Study|Loss of Improvement per Protocol|25|||
105830746|NCT02725515|365037132|FG000|Overall Study|Withdrawal by Subject|2|||
105830747|NCT02725515|365037133|FG001|Overall Study|Withdrawal by Subject|1|||
105830748|NCT02725515|365037132|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105830749|NCT02725515|365037133|FG001|Overall Study|Non-Compliance With Study Drug|3|||
105830750|NCT02725515|365037132|FG000|Overall Study|Lost to Follow-up|1|||
105830751|NCT02725515|365037133|FG001|Overall Study|Lost to Follow-up|1|||
105830752|NCT02725515|365037132|FG000|Overall Study|Adverse Event|7|||
105830753|NCT02725515|365037133|FG001|Overall Study|Adverse Event|2|||
105830754|NCT02725515|365037132|FG000|Overall Study|No Documented Disease Improvement|0|||
105830755|NCT02725515|365037133|FG001|Overall Study|No Documented Disease Improvement|1|||
105830756|NCT02725515|365037132|FG000|Overall Study|Completed Study Under Original Protocol|0|||
105830757|NCT02725515|365037133|FG001|Overall Study|Completed Study Under Original Protocol|1|||
105830758|NCT02725515|365037132|FG000|Overall Study|Lack of Response|0|||
105830759|NCT02725515|365037133|FG001|Overall Study|Lack of Response|1|||
105830760|NCT02313558|365037135|FG000|Overall Study|Withdrawal by Subject|2|||
105830761|NCT02313558|365037136|FG001|Overall Study|Withdrawal by Subject|0|||
105830762|NCT02313558|365037135|FG000|Overall Study|Lost to Follow-up|4|||
105830763|NCT02313558|365037136|FG001|Overall Study|Lost to Follow-up|4|||
105830764|NCT00874549|365037137|FG000|Overall Study|Adverse Event|0|||
105830765|NCT00874549|365037138|FG001|Overall Study|Adverse Event|0|||
105830766|NCT00874549|365037139|FG002|Overall Study|Adverse Event|1|||
105830767|NCT00874549|365037140|FG003|Overall Study|Adverse Event|0|||
105830768|NCT00874549|365037137|FG000|Overall Study|Protocol Violation|1|||
105830769|NCT00874549|365037138|FG001|Overall Study|Protocol Violation|0|||
105830770|NCT00874549|365037139|FG002|Overall Study|Protocol Violation|2|||
105830771|NCT00874549|365037140|FG003|Overall Study|Protocol Violation|1|||
105830772|NCT00874549|365037137|FG000|Overall Study|Lost to Follow-up|0|||
105830773|NCT00874549|365037138|FG001|Overall Study|Lost to Follow-up|0|||
105830774|NCT00874549|365037139|FG002|Overall Study|Lost to Follow-up|1|||
105830775|NCT00874549|365037140|FG003|Overall Study|Lost to Follow-up|0|||
105830776|NCT00874549|365037137|FG000|Overall Study|Withdrawal by Subject|0|||
105830777|NCT00874549|365037138|FG001|Overall Study|Withdrawal by Subject|1|||
105830778|NCT00874549|365037139|FG002|Overall Study|Withdrawal by Subject|0|||
105830779|NCT00874549|365037140|FG003|Overall Study|Withdrawal by Subject|1|||
105830780|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
105830781|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
105830782|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
105830783|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
105830784|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
105830785|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
105830786|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
105830787|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
105830788|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
105830789|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
105830790|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
105830791|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
105830792|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
105308544|NCT02377427|363127294|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
105308545|NCT02377427|363127295|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
105308546|NCT02377427|363127296|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
105308547|NCT02377427|363127297|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
105308548|NCT02377427|363127293|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
105308549|NCT02377427|363127294|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
105308550|NCT02377427|363127295|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
105308551|NCT02377427|363127296|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
105308552|NCT02377427|363127297|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
105308553|NCT02013674|363127298|FG000|Overall Study|Death|0|||
105308554|NCT02013674|363127299|FG001|Overall Study|Death|1|||
105308555|NCT02013674|363127298|FG000|Overall Study|Lost to Follow-up|1|||
105308556|NCT02013674|363127299|FG001|Overall Study|Lost to Follow-up|0|||
105308557|NCT00416884|363127300|FG000|Overall Study|Study terminated due to low accrual|1|||
105308558|NCT00719849|363127301|FG000|Overall Study|Death|0|||
105308559|NCT00719849|363127302|FG001|Overall Study|Death|1|||
105308560|NCT00278889|363127305|FG000|Overall Study|Withdrawal by Subject|0|||
105308561|NCT00278889|363127306|FG001|Overall Study|Withdrawal by Subject|5|||
105308562|NCT00278889|363127307|FG002|Overall Study|Withdrawal by Subject|3|||
105830793|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
105830794|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
105830795|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
105830796|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
105830797|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
105830798|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
105830799|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
105830800|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
105830801|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
105830802|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
105830803|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
105830804|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
105830805|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
105830806|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
105830807|NCT01710358|365037143|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
105830808|NCT01710358|365037144|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
105830809|NCT01710358|365037145|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
105830810|NCT01710358|365037143|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
105830811|NCT01710358|365037144|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
105308563|NCT00278889|363127305|FG000|Overall Study|Lost to Follow-up|1|||
105308564|NCT00278889|363127306|FG001|Overall Study|Lost to Follow-up|1|||
105308565|NCT00278889|363127307|FG002|Overall Study|Lost to Follow-up|0|||
105308566|NCT00278889|363127305|FG000|Overall Study|Death|24|||
105308567|NCT00278889|363127306|FG001|Overall Study|Death|21|||
105308568|NCT00278889|363127307|FG002|Overall Study|Death|17|||
105308569|NCT01372774|363127308|FG000|Overall Study|Withdrawal prior to treatment|4|||
105308570|NCT01372774|363127309|FG001|Overall Study|Withdrawal prior to treatment|5|||
105308571|NCT02799095|363128827|FG000|Part A|Adverse Event|1|||
105308572|NCT02799095|363128828|FG001|Part A|Adverse Event|0|||
105308573|NCT02799095|363128829|FG002|Part A|Adverse Event|1|||
105308574|NCT02799095|363128830|FG003|Part A|Adverse Event|4|||
105308575|NCT02799095|363128831|FG004|Part A|Adverse Event|1|||
105308576|NCT02799095|363128832|FG005|Part A|Adverse Event|0|||
105308577|NCT02799095|363128833|FG006|Part A|Adverse Event|0|||
105308578|NCT02799095|363128834|FG007|Part A|Adverse Event|0|||
105308579|NCT02799095|363128835|FG008|Part A|Adverse Event|0|||
105308580|NCT02799095|363128836|FG009|Part A|Adverse Event|0|||
105308581|NCT02799095|363128837|FG010|Part A|Adverse Event|0|||
105308582|NCT02799095|363128838|FG011|Part A|Adverse Event|0|||
105308583|NCT02799095|363128839|FG012|Part A|Adverse Event|0|||
105308584|NCT02799095|363128840|FG013|Part A|Adverse Event|0|||
105308585|NCT02799095|363128841|FG014|Part A|Adverse Event|0|||
105308586|NCT02799095|363128842|FG015|Part A|Adverse Event|0|||
105308587|NCT02799095|363128843|FG016|Part A|Adverse Event|0|||
105308588|NCT02799095|363128827|FG000|Part A|Death|0|||
105308589|NCT02799095|363128828|FG001|Part A|Death|0|||
105308590|NCT02799095|363128829|FG002|Part A|Death|0|||
105308591|NCT02799095|363128830|FG003|Part A|Death|0|||
105308592|NCT02799095|363128831|FG004|Part A|Death|0|||
105308593|NCT02799095|363128832|FG005|Part A|Death|0|||
105308594|NCT02799095|363128833|FG006|Part A|Death|3|||
105308595|NCT02799095|363128834|FG007|Part A|Death|0|||
105308596|NCT02799095|363128835|FG008|Part A|Death|0|||
105308597|NCT02799095|363128836|FG009|Part A|Death|0|||
105308598|NCT02799095|363128837|FG010|Part A|Death|0|||
105308599|NCT02799095|363128838|FG011|Part A|Death|0|||
105308600|NCT02799095|363128839|FG012|Part A|Death|0|||
105308601|NCT02799095|363128840|FG013|Part A|Death|0|||
105308602|NCT02799095|363128841|FG014|Part A|Death|0|||
105308603|NCT02799095|363128842|FG015|Part A|Death|0|||
105308604|NCT02799095|363128843|FG016|Part A|Death|0|||
105308605|NCT02799095|363128827|FG000|Part A|Lost to Follow-up|0|||
105308606|NCT02799095|363128828|FG001|Part A|Lost to Follow-up|1|||
105308607|NCT02799095|363128829|FG002|Part A|Lost to Follow-up|0|||
105489380|NCT04505540|363804047|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
105489381|NCT04505540|363804047|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
105830812|NCT01710358|365037145|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
105830813|NCT01710358|365037143|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
105308608|NCT02799095|363128830|FG003|Part A|Lost to Follow-up|0|||
105308609|NCT02799095|363128831|FG004|Part A|Lost to Follow-up|0|||
105308610|NCT02799095|363128832|FG005|Part A|Lost to Follow-up|0|||
105308611|NCT02799095|363128833|FG006|Part A|Lost to Follow-up|1|||
105308612|NCT02799095|363128834|FG007|Part A|Lost to Follow-up|0|||
105308613|NCT02799095|363128835|FG008|Part A|Lost to Follow-up|0|||
105308614|NCT02799095|363128836|FG009|Part A|Lost to Follow-up|0|||
105308615|NCT02799095|363128837|FG010|Part A|Lost to Follow-up|0|||
105308616|NCT02799095|363128838|FG011|Part A|Lost to Follow-up|0|||
105308617|NCT02799095|363128839|FG012|Part A|Lost to Follow-up|0|||
105308618|NCT02799095|363128840|FG013|Part A|Lost to Follow-up|0|||
105308619|NCT02799095|363128841|FG014|Part A|Lost to Follow-up|0|||
105308620|NCT02799095|363128842|FG015|Part A|Lost to Follow-up|0|||
105308621|NCT02799095|363128843|FG016|Part A|Lost to Follow-up|0|||
105308622|NCT02799095|363128827|FG000|Part A|Progressive Disease|3|||
105308623|NCT02799095|363128828|FG001|Part A|Progressive Disease|3|||
105830814|NCT01710358|365037144|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
105830815|NCT01710358|365037145|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
105830816|NCT01710358|365037143|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
105830817|NCT01710358|365037144|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
105830818|NCT01710358|365037145|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
105830819|NCT01710358|365037143|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
105830820|NCT01710358|365037144|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
105830821|NCT01710358|365037145|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
105830822|NCT01710358|365037143|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
105830823|NCT01710358|365037144|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
105830824|NCT01710358|365037145|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
105830825|NCT01710358|365037143|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
105830826|NCT01710358|365037144|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
105830827|NCT01710358|365037145|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
105830828|NCT01710358|365037143|FG000|Rescue Period|Adverse Event|0|||
105830829|NCT01710358|365037144|FG001|Rescue Period|Adverse Event|15|||
105830830|NCT01710358|365037145|FG002|Rescue Period|Adverse Event|0|||
105830831|NCT01710358|365037143|FG000|Rescue Period|Death|0|||
105830832|NCT01710358|365037144|FG001|Rescue Period|Death|1|||
105830833|NCT01710358|365037145|FG002|Rescue Period|Death|0|||
105830834|NCT01710358|365037143|FG000|Rescue Period|Lack of Efficacy|0|||
105830835|NCT01710358|365037144|FG001|Rescue Period|Lack of Efficacy|7|||
105830836|NCT01710358|365037145|FG002|Rescue Period|Lack of Efficacy|0|||
105830837|NCT01710358|365037143|FG000|Rescue Period|Withdrawal by Subject|0|||
105830838|NCT01710358|365037144|FG001|Rescue Period|Withdrawal by Subject|8|||
105830839|NCT01710358|365037145|FG002|Rescue Period|Withdrawal by Subject|0|||
105830840|NCT02906917|365037151|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
105830841|NCT02906917|365037152|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
105830842|NCT02906917|365037151|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
105830843|NCT02906917|365037152|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
105830844|NCT02906917|365037151|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
105830845|NCT02906917|365037152|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
105830846|NCT02906917|365037151|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
105830847|NCT02906917|365037152|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
105830848|NCT02906917|365037151|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
105830849|NCT02906917|365037152|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
105830850|NCT02906917|365037151|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
105830851|NCT02906917|365037152|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
105830852|NCT02906917|365037151|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
105830853|NCT02906917|365037152|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
105830854|NCT02906917|365037151|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
105830855|NCT02906917|365037152|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
105830856|NCT00210639|365037153|FG000|Overall Study|Lost to Follow-up|37|||
105830857|NCT00210639|365037154|FG001|Overall Study|Lost to Follow-up|29|||
105830858|NCT00210639|365037153|FG000|Overall Study|Withdrawal by Subject|8|||
105830859|NCT00210639|365037154|FG001|Overall Study|Withdrawal by Subject|1|||
105830860|NCT00210639|365037153|FG000|Overall Study|Other|18|||
105830861|NCT00210639|365037154|FG001|Overall Study|Other|12|||
105830862|NCT03707587|365037157|FG000|Overall Study|Death|0|||
105830863|NCT03707587|365037158|FG001|Overall Study|Death|1|||
105830864|NCT02854800|365037159|FG000|Overall Study|Protocol Violation|16|||
105830865|NCT02854800|365037160|FG001|Overall Study|Protocol Violation|11|||
105830866|NCT02854800|365037161|FG002|Overall Study|Protocol Violation|3|||
105830867|NCT02854800|365037159|FG000|Overall Study|Withdrawal by Subject|4|||
105830868|NCT02854800|365037160|FG001|Overall Study|Withdrawal by Subject|2|||
105830869|NCT02854800|365037161|FG002|Overall Study|Withdrawal by Subject|3|||
105366679|NCT04980014|363350004|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
105366680|NCT04980014|363350004|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
105366681|NCT04980014|363350004|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
105366682|NCT00619827|363350018|FG000|Overall Study|Adverse Event|1|||
105366683|NCT00619827|363350019|FG001|Overall Study|Adverse Event|2|||
105366684|NCT00619827|363350018|FG000|Overall Study|Withdrawal by Subject|2|||
105366685|NCT00619827|363350019|FG001|Overall Study|Withdrawal by Subject|2|||
105366686|NCT01587885|363350031|FG000|Treatment Period 1|Failure to Return|0|||
105366687|NCT01587885|363350032|FG001|Treatment Period 1|Failure to Return|1|||
105366688|NCT01587885|363350031|FG000|Treatment Period 1|Protocol Violation|0|||
105366689|NCT01587885|363350032|FG001|Treatment Period 1|Protocol Violation|2|||
105575838|NCT04467840|364108339|FG000|Overall Study|Withdrawal by Subject|8|||
105830870|NCT04442503|365037162|FG000|Overall Study|Adverse Event|1|||
105830871|NCT04442503|365037163|FG001|Overall Study|Adverse Event|1|||
105366690|NCT02643693|363350035|FG000|Overall Study|Physician Decision|0|||
105366691|NCT02643693|363350036|FG001|Overall Study|Physician Decision|1|||
105830872|NCT04442503|365037162|FG000|Overall Study|Lost to Follow-up|8|||
105830873|NCT04442503|365037163|FG001|Overall Study|Lost to Follow-up|6|||
105830874|NCT04442503|365037162|FG000|Overall Study|Physician Decision|0|||
105830875|NCT04442503|365037163|FG001|Overall Study|Physician Decision|2|||
105830876|NCT04442503|365037162|FG000|Overall Study|Withdrawal by Subject|3|||
105830877|NCT04442503|365037163|FG001|Overall Study|Withdrawal by Subject|4|||
105830878|NCT04442503|365037162|FG000|Overall Study|Reason not Specified|0|||
105830879|NCT04442503|365037163|FG001|Overall Study|Reason not Specified|1|||
105830880|NCT04442503|365037162|FG000|Overall Study|Randomized but not Treated|3|||
105830881|NCT04442503|365037163|FG001|Overall Study|Randomized but not Treated|1|||
105830882|NCT00503867|365037166|FG000|Overall Study|Lost to Follow-up|1|||
105830883|NCT00503867|365037166|FG000|Overall Study|Adverse Event|1|||
105830884|NCT00323258|365037168|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
105830885|NCT00323258|365037169|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
105830886|NCT00323258|365037168|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
105830887|NCT00323258|365037169|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
105308624|NCT02799095|363128829|FG002|Part A|Progressive Disease|3|||
105308625|NCT02799095|363128830|FG003|Part A|Progressive Disease|2|||
105366692|NCT02643693|363350037|FG002|Overall Study|Physician Decision|0|||
105366693|NCT02643693|363350038|FG003|Overall Study|Physician Decision|0|||
105366694|NCT02643693|363350039|FG004|Overall Study|Physician Decision|0|||
105366695|NCT02643693|363350040|FG005|Overall Study|Physician Decision|0|||
105366696|NCT02643693|363350035|FG000|Overall Study|Withdrawal by Subject|0|||
105366697|NCT02643693|363350036|FG001|Overall Study|Withdrawal by Subject|1|||
105366698|NCT02643693|363350037|FG002|Overall Study|Withdrawal by Subject|0|||
105366699|NCT02643693|363350038|FG003|Overall Study|Withdrawal by Subject|0|||
105366700|NCT02643693|363350039|FG004|Overall Study|Withdrawal by Subject|0|||
105366701|NCT02643693|363350040|FG005|Overall Study|Withdrawal by Subject|0|||
105366702|NCT02643693|363350035|FG000|Overall Study|Protocol Adherence Issues|2|||
105366703|NCT02643693|363350036|FG001|Overall Study|Protocol Adherence Issues|0|||
105366704|NCT02643693|363350037|FG002|Overall Study|Protocol Adherence Issues|1|||
105366705|NCT02643693|363350038|FG003|Overall Study|Protocol Adherence Issues|0|||
105366706|NCT02643693|363350039|FG004|Overall Study|Protocol Adherence Issues|0|||
105366707|NCT02643693|363350040|FG005|Overall Study|Protocol Adherence Issues|1|||
105366708|NCT00909844|363350042|FG000|Overall Study|Adverse Event|1|||
105366709|NCT00909844|363350042|FG000|Overall Study|Withdrawal by Subject|1|||
105366710|NCT00909844|363350042|FG000|Overall Study|Lost to Follow-up|2|||
105366711|NCT00297648|363350043|FG000|Overall Study|Adverse Event|13|||
105366712|NCT00297648|363350043|FG000|Overall Study|Lack of Efficacy|18|||
105366713|NCT00297648|363350043|FG000|Overall Study|Lost to Follow-up|1|||
105366714|NCT00297648|363350043|FG000|Overall Study|Withdrawal by Subject|3|||
105366715|NCT00297648|363350043|FG000|Overall Study|Other: Incompliance|1|||
105366716|NCT03555149|363350044|FG000|Overall Study|Death|18|||
105366717|NCT03555149|363350045|FG001|Overall Study|Death|15|||
105366718|NCT03555149|363350046|FG002|Overall Study|Death|15|||
105366719|NCT03555149|363350047|FG003|Overall Study|Death|4|||
105366720|NCT03555149|363350048|FG004|Overall Study|Death|4|||
105366721|NCT03555149|363350049|FG005|Overall Study|Death|11|||
105366722|NCT03555149|363350050|FG006|Overall Study|Death|12|||
105366723|NCT03555149|363350051|FG007|Overall Study|Death|1|||
105366724|NCT03555149|363350044|FG000|Overall Study|Lost to Follow-up|1|||
105366725|NCT03555149|363350045|FG001|Overall Study|Lost to Follow-up|0|||
105366726|NCT03555149|363350046|FG002|Overall Study|Lost to Follow-up|0|||
105366727|NCT03555149|363350047|FG003|Overall Study|Lost to Follow-up|0|||
105366728|NCT03555149|363350048|FG004|Overall Study|Lost to Follow-up|0|||
105366729|NCT03555149|363350049|FG005|Overall Study|Lost to Follow-up|1|||
105308626|NCT02799095|363128831|FG004|Part A|Progressive Disease|2|||
105308627|NCT02799095|363128832|FG005|Part A|Progressive Disease|0|||
105308628|NCT02799095|363128833|FG006|Part A|Progressive Disease|0|||
105308629|NCT02799095|363128834|FG007|Part A|Progressive Disease|0|||
105308630|NCT02799095|363128835|FG008|Part A|Progressive Disease|0|||
105308631|NCT02799095|363128836|FG009|Part A|Progressive Disease|0|||
105830888|NCT00323258|365037168|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
105308632|NCT02799095|363128837|FG010|Part A|Progressive Disease|0|||
105308633|NCT02799095|363128838|FG011|Part A|Progressive Disease|0|||
105308634|NCT02799095|363128839|FG012|Part A|Progressive Disease|0|||
105308635|NCT02799095|363128840|FG013|Part A|Progressive Disease|0|||
105366730|NCT03555149|363350050|FG006|Overall Study|Lost to Follow-up|0|||
105366731|NCT03555149|363350051|FG007|Overall Study|Lost to Follow-up|0|||
105366732|NCT03555149|363350044|FG000|Overall Study|Physician Decision|1|||
105366733|NCT03555149|363350045|FG001|Overall Study|Physician Decision|0|||
105366734|NCT03555149|363350046|FG002|Overall Study|Physician Decision|0|||
105366735|NCT03555149|363350047|FG003|Overall Study|Physician Decision|0|||
105366736|NCT03555149|363350048|FG004|Overall Study|Physician Decision|0|||
105366737|NCT03555149|363350049|FG005|Overall Study|Physician Decision|0|||
105366738|NCT03555149|363350050|FG006|Overall Study|Physician Decision|0|||
105366739|NCT03555149|363350051|FG007|Overall Study|Physician Decision|0|||
105366740|NCT03555149|363350044|FG000|Overall Study|Study Terminated By Sponsor|1|||
105830889|NCT00323258|365037169|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
105830890|NCT00323258|365037168|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
105830891|NCT00323258|365037169|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
105830892|NCT00323258|365037168|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
105830893|NCT00323258|365037169|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
105830894|NCT00323258|365037168|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
105830895|NCT00323258|365037169|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
105830896|NCT00323258|365037168|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
105830897|NCT00323258|365037169|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
105830898|NCT05616728|365037173|FG000|Overall Study|Lost to Follow-up|0|||
105830899|NCT05616728|365037174|FG001|Overall Study|Lost to Follow-up|0|||
105830900|NCT05616728|365037175|FG002|Overall Study|Lost to Follow-up|1|||
105830901|NCT05616728|365037173|FG000|Overall Study|Withdrawal by Subject|1|||
105830902|NCT05616728|365037174|FG001|Overall Study|Withdrawal by Subject|1|||
105830903|NCT05616728|365037175|FG002|Overall Study|Withdrawal by Subject|0|||
105830904|NCT05616728|365037173|FG000|Overall Study|Physician Decision|1|||
105830905|NCT05616728|365037174|FG001|Overall Study|Physician Decision|1|||
105830906|NCT05616728|365037175|FG002|Overall Study|Physician Decision|1|||
105830907|NCT05616728|365037173|FG000|Overall Study|Other|0|||
105830908|NCT05616728|365037174|FG001|Overall Study|Other|2|||
105830909|NCT05616728|365037175|FG002|Overall Study|Other|0|||
105830910|NCT00577655|365037176|FG000|Overall Study|Patient Request|0|||
105830911|NCT00577655|365037177|FG001|Overall Study|Patient Request|2|||
105830912|NCT00577655|365037176|FG000|Overall Study|Protocol Violation|0|||
105830913|NCT00577655|365037177|FG001|Overall Study|Protocol Violation|1|||
105830914|NCT00577655|365037176|FG000|Overall Study|Lost to Follow-up|1|||
105830915|NCT00577655|365037177|FG001|Overall Study|Lost to Follow-up|1|||
105830916|NCT01055834|365037178|FG000|Treatment Period I|Adverse Event|1|||
105830917|NCT01055834|365037179|FG001|Treatment Period I|Adverse Event|0|||
105830918|NCT01370863|365037180|FG000|Overall Study|Adverse Event|1|||
105830919|NCT01370863|365037181|FG001|Overall Study|Adverse Event|1|||
105830920|NCT01370863|365037180|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
105830921|NCT01370863|365037181|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
105830922|NCT01370863|365037180|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
105830923|NCT01370863|365037181|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
105830924|NCT04133311|365037185|FG000|Period 1 Double Masked Treatment Period|Death|1|||
105830925|NCT04133311|365037186|FG001|Period 1 Double Masked Treatment Period|Death|0|||
105830926|NCT04133311|365037187|FG002|Period 1 Double Masked Treatment Period|Death|0|||
105830927|NCT04133311|365037188|FG003|Period 1 Double Masked Treatment Period|Death|0|||
105830928|NCT04133311|365037185|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
105830929|NCT04133311|365037186|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
105830930|NCT04133311|365037187|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
105830931|NCT04133311|365037188|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
105830932|NCT04133311|365037185|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
105830933|NCT04133311|365037186|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
105830934|NCT04133311|365037187|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
105830935|NCT04133311|365037188|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
105830936|NCT04133311|365037185|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
105830937|NCT04133311|365037186|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
105830938|NCT04133311|365037187|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
105308636|NCT02799095|363128841|FG014|Part A|Progressive Disease|0|||
105308637|NCT02799095|363128842|FG015|Part A|Progressive Disease|0|||
105308638|NCT02799095|363128843|FG016|Part A|Progressive Disease|0|||
105308639|NCT02799095|363128827|FG000|Part A|Clinical Progression|1|||
105308640|NCT02799095|363128828|FG001|Part A|Clinical Progression|0|||
105308641|NCT02799095|363128829|FG002|Part A|Clinical Progression|2|||
105308642|NCT02799095|363128830|FG003|Part A|Clinical Progression|1|||
105308643|NCT02799095|363128831|FG004|Part A|Clinical Progression|5|||
105308644|NCT02799095|363128832|FG005|Part A|Clinical Progression|0|||
105308645|NCT02799095|363128833|FG006|Part A|Clinical Progression|0|||
105308646|NCT02799095|363128834|FG007|Part A|Clinical Progression|0|||
105308647|NCT02799095|363128835|FG008|Part A|Clinical Progression|0|||
105308648|NCT02799095|363128836|FG009|Part A|Clinical Progression|0|||
105308649|NCT02799095|363128837|FG010|Part A|Clinical Progression|0|||
105308650|NCT02799095|363128838|FG011|Part A|Clinical Progression|0|||
105308651|NCT02799095|363128839|FG012|Part A|Clinical Progression|0|||
105308652|NCT02799095|363128840|FG013|Part A|Clinical Progression|0|||
105308653|NCT02799095|363128841|FG014|Part A|Clinical Progression|0|||
105830939|NCT04133311|365037188|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
105308654|NCT02799095|363128842|FG015|Part A|Clinical Progression|0|||
105308655|NCT02799095|363128843|FG016|Part A|Clinical Progression|0|||
105308656|NCT02799095|363128827|FG000|Part A|Protocol Deviation|0|||
105308657|NCT02799095|363128828|FG001|Part A|Protocol Deviation|0|||
105308658|NCT02799095|363128829|FG002|Part A|Protocol Deviation|1|||
105308659|NCT02799095|363128830|FG003|Part A|Protocol Deviation|0|||
105308660|NCT02799095|363128831|FG004|Part A|Protocol Deviation|0|||
105308661|NCT02799095|363128832|FG005|Part A|Protocol Deviation|0|||
105308662|NCT02799095|363128833|FG006|Part A|Protocol Deviation|0|||
105308663|NCT02799095|363128834|FG007|Part A|Protocol Deviation|0|||
105308664|NCT02799095|363128835|FG008|Part A|Protocol Deviation|0|||
105308665|NCT02799095|363128836|FG009|Part A|Protocol Deviation|0|||
105308666|NCT02799095|363128837|FG010|Part A|Protocol Deviation|0|||
105308667|NCT02799095|363128838|FG011|Part A|Protocol Deviation|0|||
105308668|NCT02799095|363128839|FG012|Part A|Protocol Deviation|0|||
105308669|NCT02799095|363128840|FG013|Part A|Protocol Deviation|0|||
105308670|NCT02799095|363128841|FG014|Part A|Protocol Deviation|0|||
105308671|NCT02799095|363128842|FG015|Part A|Protocol Deviation|0|||
105308672|NCT02799095|363128843|FG016|Part A|Protocol Deviation|0|||
105308673|NCT02799095|363128827|FG000|Part A|Withdrawal by Subject|0|||
105308674|NCT02799095|363128828|FG001|Part A|Withdrawal by Subject|0|||
105308675|NCT02799095|363128829|FG002|Part A|Withdrawal by Subject|0|||
105308676|NCT02799095|363128830|FG003|Part A|Withdrawal by Subject|1|||
105308677|NCT02799095|363128831|FG004|Part A|Withdrawal by Subject|3|||
105308678|NCT02799095|363128832|FG005|Part A|Withdrawal by Subject|1|||
105308679|NCT02799095|363128833|FG006|Part A|Withdrawal by Subject|1|||
105830940|NCT04133311|365037185|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
105830941|NCT04133311|365037186|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
105830942|NCT04133311|365037187|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
105830943|NCT04133311|365037188|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
105830944|NCT04133311|365037185|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
105830945|NCT04133311|365037186|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
105830946|NCT04133311|365037187|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
105830947|NCT04133311|365037188|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
105830948|NCT04133311|365037185|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
105830949|NCT04133311|365037186|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
105830950|NCT04133311|365037187|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
105830951|NCT04133311|365037188|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
105830952|NCT04133311|365037185|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
105830953|NCT04133311|365037186|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
105830954|NCT04133311|365037187|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
105830955|NCT04133311|365037188|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
105830956|NCT00728754|365037193|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
105830957|NCT00728754|365037194|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
105830958|NCT00728754|365037193|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
105830959|NCT00728754|365037194|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
105830960|NCT00728754|365037193|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
105830961|NCT00728754|365037194|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
105830962|NCT01926119|365037195|FG000|Overall Study|Withdrawal by Subject|1|||
105830963|NCT00573313|365037196|FG000|Overall Study|Protocol Violation|5|||
105830964|NCT00573313|365037197|FG001|Overall Study|Protocol Violation|0|||
105830965|NCT00573313|365037198|FG002|Overall Study|Protocol Violation|6|||
105830966|NCT00573313|365037199|FG003|Overall Study|Protocol Violation|0|||
105830967|NCT00406393|365037200|FG000|Overall Study|Did not undergo transplantation|2|||
105830968|NCT00406393|365037201|FG001|Overall Study|Did not undergo transplantation|1|||
105830969|NCT02611362|365037210|FG000|Overall Study|Withdrawal by Subject|7|||
105830970|NCT02611362|365037211|FG001|Overall Study|Withdrawal by Subject|2|||
105830971|NCT02611362|365037210|FG000|Overall Study|Lost to Follow-up|2|||
105830972|NCT02611362|365037211|FG001|Overall Study|Lost to Follow-up|4|||
105830973|NCT02046122|365037212|FG000|Overall Study|Physician Decision|8|||
105830974|NCT02046122|365037212|FG000|Overall Study|Withdrawal by Subject|1|||
105308680|NCT02799095|363128834|FG007|Part A|Withdrawal by Subject|0|||
105308681|NCT02799095|363128835|FG008|Part A|Withdrawal by Subject|0|||
105308682|NCT02799095|363128836|FG009|Part A|Withdrawal by Subject|0|||
105308683|NCT02799095|363128837|FG010|Part A|Withdrawal by Subject|0|||
105830975|NCT01653704|365037213|FG000|Overall Study|Technical failure during recording|1|||
105830976|NCT01653704|365037214|FG001|Overall Study|Technical failure during recording|1|||
105830977|NCT01653704|365037213|FG000|Overall Study|Performance not reflective of training|1|||
105830978|NCT01653704|365037214|FG001|Overall Study|Performance not reflective of training|0|||
105830979|NCT02705716|365037217|FG000|Overall Study|Adverse Event|0|||
105830980|NCT02705716|365037218|FG001|Overall Study|Adverse Event|1|||
105830981|NCT02705716|365037217|FG000|Overall Study|Protocol Violation|3|||
105308684|NCT02799095|363128838|FG011|Part A|Withdrawal by Subject|0|||
105308685|NCT02799095|363128839|FG012|Part A|Withdrawal by Subject|0|||
105308686|NCT02799095|363128840|FG013|Part A|Withdrawal by Subject|0|||
105308687|NCT02799095|363128841|FG014|Part A|Withdrawal by Subject|0|||
105308688|NCT02799095|363128842|FG015|Part A|Withdrawal by Subject|0|||
105308689|NCT02799095|363128843|FG016|Part A|Withdrawal by Subject|0|||
105308690|NCT02799095|363128827|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
105830982|NCT02705716|365037218|FG001|Overall Study|Protocol Violation|0|||
105830983|NCT02705716|365037217|FG000|Overall Study|Withdrawal of Consent|1|||
105830984|NCT02705716|365037218|FG001|Overall Study|Withdrawal of Consent|1|||
105830985|NCT01196390|365037219|FG000|Overall Study|Protocol Violation|4|||
105830986|NCT01196390|365037220|FG001|Overall Study|Protocol Violation|5|||
105830987|NCT01532908|365037221|FG000|Overall Study|Not Transplanted|1|||
105830988|NCT01532908|365037222|FG001|Overall Study|Not Transplanted|0|||
105830989|NCT00467597|365037225|FG000|Overall Study|Withdrawal by Subject|2|||
105830990|NCT00467597|365037226|FG001|Overall Study|Withdrawal by Subject|0|||
105830991|NCT01949532|365037235|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
105830992|NCT01949532|365037236|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
105830993|NCT05665387|365037237|FG000|Overall Study|Withdrawal by Subject|1|||
105830994|NCT05665387|365037238|FG001|Overall Study|Withdrawal by Subject|0|||
105830995|NCT05665387|365037239|FG002|Overall Study|Withdrawal by Subject|1|||
105830996|NCT00379353|365037240|FG000|Overall Study|Hospitalization|3|||
105830997|NCT00379353|365037241|FG001|Overall Study|Hospitalization|3|||
105308691|NCT02799095|363128828|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
105308692|NCT02799095|363128829|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
105308693|NCT02799095|363128830|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
105308694|NCT02799095|363128831|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
105489382|NCT04505540|363804047|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
105489383|NCT04505540|363804047|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
105489384|NCT04505540|363804047|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
105489385|NCT04505540|363804047|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
105489386|NCT04505540|363804047|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
105489387|NCT04505540|363804047|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
105489388|NCT04505540|363804047|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
105489389|NCT04505540|363804047|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
105489390|NCT04505540|363804047|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
105489391|NCT04505540|363804047|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
105489392|NCT02057393|363804048|FG000|Overall Study|Withdrawal by Subject|1|||
105489393|NCT02057393|363804048|FG000|Overall Study|Patient did not meet criteria|1|||
105489394|NCT02310321|363804049|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
105489395|NCT02310321|363804050|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
105489396|NCT02310321|363804051|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
105489397|NCT02310321|363804049|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
105489398|NCT02310321|363804050|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
105489399|NCT02310321|363804051|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
105489400|NCT02310321|363804049|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
105830998|NCT00379353|365037240|FG000|Overall Study|Withdrawal by Subject|5|||
105308695|NCT02799095|363128832|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
105308696|NCT02799095|363128833|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
105308697|NCT02799095|363128834|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
105308698|NCT02799095|363128835|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
105308699|NCT02799095|363128836|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
105308700|NCT02799095|363128837|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
105308701|NCT02799095|363128838|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
105308702|NCT02799095|363128839|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
105308703|NCT02799095|363128840|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
105308704|NCT02799095|363128841|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
105308705|NCT02799095|363128842|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
105308706|NCT02799095|363128843|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
105308707|NCT02799095|363128827|FG000|Part B|Death|0|||
105308708|NCT02799095|363128828|FG001|Part B|Death|0|||
105308709|NCT02799095|363128829|FG002|Part B|Death|0|||
105308710|NCT02799095|363128830|FG003|Part B|Death|0|||
105308711|NCT02799095|363128831|FG004|Part B|Death|0|||
105308712|NCT02799095|363128832|FG005|Part B|Death|0|||
105308713|NCT02799095|363128833|FG006|Part B|Death|0|||
105308714|NCT02799095|363128834|FG007|Part B|Death|7|||
105308715|NCT02799095|363128835|FG008|Part B|Death|7|||
105308716|NCT02799095|363128836|FG009|Part B|Death|0|||
105308717|NCT02799095|363128837|FG010|Part B|Death|0|||
105308718|NCT02799095|363128838|FG011|Part B|Death|0|||
105308719|NCT02799095|363128839|FG012|Part B|Death|0|||
105308720|NCT02799095|363128840|FG013|Part B|Death|0|||
105308721|NCT02799095|363128841|FG014|Part B|Death|0|||
105830999|NCT00379353|365037241|FG001|Overall Study|Withdrawal by Subject|2|||
105831000|NCT00379353|365037240|FG000|Overall Study|Death|1|||
105831001|NCT00379353|365037241|FG001|Overall Study|Death|0|||
105831002|NCT00379353|365037240|FG000|Overall Study|Cardiac Tamponade|1|||
105831003|NCT00379353|365037241|FG001|Overall Study|Cardiac Tamponade|0|||
105831004|NCT00379353|365037240|FG000|Overall Study|Non-compliance|1|||
105831005|NCT00379353|365037241|FG001|Overall Study|Non-compliance|0|||
105831006|NCT00379353|365037240|FG000|Overall Study|Conflicting drug treatment|0|||
105308722|NCT02799095|363128842|FG015|Part B|Death|0|||
105308723|NCT02799095|363128843|FG016|Part B|Death|0|||
105831007|NCT00379353|365037241|FG001|Overall Study|Conflicting drug treatment|1|||
105831008|NCT03732833|365037242|FG000|Overall Study|Adverse Event|0|||
105831009|NCT03732833|365037243|FG001|Overall Study|Adverse Event|3|||
105831010|NCT03732833|365037244|FG002|Overall Study|Adverse Event|1|||
105831011|NCT03732833|365037242|FG000|Overall Study|Withdrawal by Subject|11|||
105831012|NCT03732833|365037243|FG001|Overall Study|Withdrawal by Subject|13|||
105831013|NCT03732833|365037244|FG002|Overall Study|Withdrawal by Subject|8|||
105831014|NCT03732833|365037242|FG000|Overall Study|Lost to Follow-up|3|||
105831015|NCT03732833|365037243|FG001|Overall Study|Lost to Follow-up|5|||
105831016|NCT03732833|365037244|FG002|Overall Study|Lost to Follow-up|4|||
105831017|NCT03732833|365037242|FG000|Overall Study|Pregnancy|0|||
105831018|NCT03732833|365037243|FG001|Overall Study|Pregnancy|2|||
105831019|NCT03732833|365037244|FG002|Overall Study|Pregnancy|0|||
105831020|NCT03732833|365037242|FG000|Overall Study|Physician Decision|2|||
105831021|NCT03732833|365037243|FG001|Overall Study|Physician Decision|3|||
105831022|NCT03732833|365037244|FG002|Overall Study|Physician Decision|1|||
105831023|NCT03732833|365037242|FG000|Overall Study|Covid-19 related and other reasons|2|||
105831024|NCT03732833|365037243|FG001|Overall Study|Covid-19 related and other reasons|7|||
105831025|NCT03732833|365037244|FG002|Overall Study|Covid-19 related and other reasons|3|||
105831026|NCT04320745|365037245|FG000|Overall Study|Adverse Event|26|||
105831027|NCT04320745|365037245|FG000|Overall Study|Withdrawal by Subject|4|||
105831028|NCT04320745|365037245|FG000|Overall Study|Lost to Follow-up|12|||
105831029|NCT04320745|365037245|FG000|Overall Study|Protocol Deviation|2|||
105831030|NCT04320745|365037245|FG000|Overall Study|Non-compliance With Study Drug|2|||
105831031|NCT04320745|365037245|FG000|Overall Study|Reason Not Specified|1|||
105831032|NCT00021541|365037246|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
105831033|NCT00021541|365037247|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
105831034|NCT00021541|365037246|FG000|Period 1-First Treatment|Adverse Event|2|||
105831035|NCT00021541|365037247|FG001|Period 1-First Treatment|Adverse Event|1|||
105831036|NCT00021541|365037246|FG000|Period 1-First Treatment|non-adherence|3|||
105831037|NCT00021541|365037247|FG001|Period 1-First Treatment|non-adherence|0|||
105831038|NCT00021541|365037246|FG000|Period 1-First Treatment|Death|1|||
105831039|NCT00021541|365037247|FG001|Period 1-First Treatment|Death|0|||
105831040|NCT00021541|365037246|FG000|Period 1-First Treatment|Pts that did not progress|2|||
105831041|NCT00021541|365037247|FG001|Period 1-First Treatment|Pts that did not progress|2|||
105831042|NCT00021541|365037246|FG000|Period 1-First Treatment|Ineligible|0|||
105831043|NCT00021541|365037247|FG001|Period 1-First Treatment|Ineligible|2|||
105831044|NCT00021541|365037246|FG000|Period 2-crossover|refused phase B|2|||
105831045|NCT00021541|365037247|FG001|Period 2-crossover|refused phase B|2|||
105831046|NCT00021541|365037246|FG000|Period 2-crossover|Withdrawal by Subject|3|||
105831047|NCT00021541|365037247|FG001|Period 2-crossover|Withdrawal by Subject|4|||
105831048|NCT00021541|365037246|FG000|Period 2-crossover|Adverse Event|2|||
105831049|NCT00021541|365037247|FG001|Period 2-crossover|Adverse Event|2|||
105831050|NCT00021541|365037246|FG000|Period 2-crossover|non-adherence|1|||
105831051|NCT00021541|365037247|FG001|Period 2-crossover|non-adherence|0|||
105831052|NCT00021541|365037246|FG000|Period 2-crossover|Pts that did not progress|2|||
105831053|NCT00021541|365037247|FG001|Period 2-crossover|Pts that did not progress|3|||
105831054|NCT01874535|365037248|FG000|Overall Study|Lost to Follow-up|10|||
105831055|NCT01874535|365037249|FG001|Overall Study|Lost to Follow-up|9|||
105831056|NCT01874535|365037248|FG000|Overall Study|incomplete symptom resolution|45|||
105831057|NCT01874535|365037249|FG001|Overall Study|incomplete symptom resolution|35|||
105831058|NCT02611323|365037250|FG000|Overall Study|Death|3|||
105831059|NCT02611323|365037251|FG001|Overall Study|Death|1|||
105831060|NCT02611323|365037252|FG002|Overall Study|Death|0|||
105831061|NCT02611323|365037253|FG003|Overall Study|Death|0|||
105831062|NCT02611323|365037254|FG004|Overall Study|Death|1|||
105831063|NCT02611323|365037255|FG005|Overall Study|Death|1|||
105831064|NCT02611323|365037256|FG006|Overall Study|Death|8|||
105831065|NCT02611323|365037257|FG007|Overall Study|Death|0|||
105831066|NCT02611323|365037258|FG008|Overall Study|Death|4|||
105831067|NCT02611323|365037259|FG009|Overall Study|Death|6|||
105831068|NCT02611323|365037260|FG010|Overall Study|Death|26|||
105831069|NCT02611323|365037250|FG000|Overall Study|Lost to Follow-up|1|||
105831070|NCT02611323|365037251|FG001|Overall Study|Lost to Follow-up|0|||
105831071|NCT02611323|365037252|FG002|Overall Study|Lost to Follow-up|0|||
105308724|NCT02799095|363128827|FG000|Part B|Progressive Disease|0|||
105308725|NCT02799095|363128828|FG001|Part B|Progressive Disease|0|||
105831072|NCT02611323|365037253|FG003|Overall Study|Lost to Follow-up|0|||
105308726|NCT02799095|363128829|FG002|Part B|Progressive Disease|0|||
105308727|NCT02799095|363128830|FG003|Part B|Progressive Disease|0|||
105831073|NCT02611323|365037254|FG004|Overall Study|Lost to Follow-up|0|||
105831074|NCT02611323|365037255|FG005|Overall Study|Lost to Follow-up|0|||
105831075|NCT02611323|365037256|FG006|Overall Study|Lost to Follow-up|3|||
105831076|NCT02611323|365037257|FG007|Overall Study|Lost to Follow-up|0|||
105831077|NCT02611323|365037258|FG008|Overall Study|Lost to Follow-up|0|||
105831078|NCT02611323|365037259|FG009|Overall Study|Lost to Follow-up|0|||
105831079|NCT02611323|365037260|FG010|Overall Study|Lost to Follow-up|2|||
105831080|NCT02611323|365037250|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831081|NCT02611323|365037251|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831082|NCT02611323|365037252|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831083|NCT02611323|365037253|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831084|NCT02611323|365037254|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831085|NCT02611323|365037255|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831086|NCT02611323|365037256|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831087|NCT02611323|365037257|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831088|NCT02611323|365037258|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831089|NCT02611323|365037259|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
105831090|NCT02611323|365037260|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831091|NCT02611323|365037250|FG000|Overall Study|Progressive Disease|0|||
105831092|NCT02611323|365037251|FG001|Overall Study|Progressive Disease|0|||
105831093|NCT02611323|365037252|FG002|Overall Study|Progressive Disease|0|||
105831094|NCT02611323|365037253|FG003|Overall Study|Progressive Disease|0|||
105831095|NCT02611323|365037254|FG004|Overall Study|Progressive Disease|0|||
105831096|NCT02611323|365037255|FG005|Overall Study|Progressive Disease|0|||
105831097|NCT02611323|365037256|FG006|Overall Study|Progressive Disease|0|||
105831098|NCT02611323|365037257|FG007|Overall Study|Progressive Disease|0|||
105831099|NCT02611323|365037258|FG008|Overall Study|Progressive Disease|0|||
105831100|NCT02611323|365037259|FG009|Overall Study|Progressive Disease|0|||
105831101|NCT02611323|365037260|FG010|Overall Study|Progressive Disease|1|||
105831102|NCT02611323|365037250|FG000|Overall Study|Withdrawal by Subject|1|||
105831103|NCT02611323|365037251|FG001|Overall Study|Withdrawal by Subject|0|||
105831104|NCT02611323|365037252|FG002|Overall Study|Withdrawal by Subject|0|||
105831105|NCT02611323|365037253|FG003|Overall Study|Withdrawal by Subject|0|||
105831106|NCT02611323|365037254|FG004|Overall Study|Withdrawal by Subject|0|||
105831107|NCT02611323|365037255|FG005|Overall Study|Withdrawal by Subject|0|||
105831108|NCT02611323|365037256|FG006|Overall Study|Withdrawal by Subject|0|||
105831109|NCT02611323|365037257|FG007|Overall Study|Withdrawal by Subject|1|||
105831110|NCT02611323|365037258|FG008|Overall Study|Withdrawal by Subject|0|||
105831111|NCT02611323|365037259|FG009|Overall Study|Withdrawal by Subject|1|||
105831112|NCT02611323|365037260|FG010|Overall Study|Withdrawal by Subject|0|||
105831113|NCT00858403|365037261|FG000|Overall Study|Withdrawal by Subject|1|||
105831114|NCT00858403|365037261|FG000|Overall Study|Death|3|||
105831115|NCT00858403|365037261|FG000|Overall Study|Disease Progression|1|||
105831116|NCT02597049|365037262|FG000|Overall Study|Lost to Follow-up|0|||
105831117|NCT02597049|365037263|FG001|Overall Study|Lost to Follow-up|3|||
105831118|NCT02597049|365037264|FG002|Overall Study|Lost to Follow-up|2|||
105831119|NCT02597049|365037262|FG000|Overall Study|Withdrawal by Subject|2|||
105831120|NCT02597049|365037263|FG001|Overall Study|Withdrawal by Subject|2|||
105831121|NCT02597049|365037264|FG002|Overall Study|Withdrawal by Subject|1|||
105831122|NCT02597049|365037262|FG000|Overall Study|Adverse Event|2|||
105831123|NCT02597049|365037263|FG001|Overall Study|Adverse Event|0|||
105831124|NCT02597049|365037264|FG002|Overall Study|Adverse Event|0|||
105831125|NCT02597049|365037262|FG000|Overall Study|Death|2|||
105831126|NCT02597049|365037263|FG001|Overall Study|Death|0|||
105831127|NCT02597049|365037264|FG002|Overall Study|Death|0|||
105831128|NCT02597049|365037262|FG000|Overall Study|Noncompliant with Study Visits|1|||
105831129|NCT02597049|365037263|FG001|Overall Study|Noncompliant with Study Visits|0|||
105831130|NCT02597049|365037264|FG002|Overall Study|Noncompliant with Study Visits|0|||
105831131|NCT01215721|365037267|FG000|Overall Study|Adverse Event|2|||
105831132|NCT00243347|365037269|FG000|Overall Study|Lack of Efficacy|4|||
105831133|NCT00243347|365037269|FG000|Overall Study|Adverse Event|2|||
105831134|NCT00243347|365037269|FG000|Overall Study|Death|1|||
105831135|NCT00243347|365037269|FG000|Overall Study|Withdrawal by Subject|5|||
105831136|NCT00243347|365037269|FG000|Overall Study|Condition worsened|7|||
105831137|NCT00199901|365038907|FG000|Overall Study|Protocol Violation|2|||
105831138|NCT00199901|365038908|FG001|Overall Study|Protocol Violation|0|||
105831139|NCT00199901|365038907|FG000|Overall Study|Withdrawal by Subject|1|||
105308728|NCT02799095|363128831|FG004|Part B|Progressive Disease|0|||
105308729|NCT02799095|363128832|FG005|Part B|Progressive Disease|0|||
105308730|NCT02799095|363128833|FG006|Part B|Progressive Disease|0|||
105308731|NCT02799095|363128834|FG007|Part B|Progressive Disease|1|||
105308732|NCT02799095|363128835|FG008|Part B|Progressive Disease|0|||
105308733|NCT02799095|363128836|FG009|Part B|Progressive Disease|0|||
105308734|NCT02799095|363128837|FG010|Part B|Progressive Disease|0|||
105308735|NCT02799095|363128838|FG011|Part B|Progressive Disease|0|||
105308736|NCT02799095|363128839|FG012|Part B|Progressive Disease|0|||
105308737|NCT02799095|363128840|FG013|Part B|Progressive Disease|0|||
105308738|NCT02799095|363128841|FG014|Part B|Progressive Disease|0|||
105308739|NCT02799095|363128842|FG015|Part B|Progressive Disease|0|||
105831140|NCT00199901|365038908|FG001|Overall Study|Withdrawal by Subject|0|||
105831141|NCT00199901|365038907|FG000|Overall Study|Progressive Disease|24|||
105831142|NCT00199901|365038908|FG001|Overall Study|Progressive Disease|24|||
105308740|NCT02799095|363128843|FG016|Part B|Progressive Disease|0|||
105308741|NCT02799095|363128827|FG000|Part B|Withdrawal by Subject|0|||
105831143|NCT04729101|365038911|FG000|Overall Study|Adverse Event|1|||
105831144|NCT04729101|365038912|FG001|Overall Study|Adverse Event|0|||
105831145|NCT04729101|365038911|FG000|Overall Study|Physician Decision|1|||
105831146|NCT04729101|365038912|FG001|Overall Study|Physician Decision|0|||
105831147|NCT04729101|365038911|FG000|Overall Study|Withdrawal by Subject|1|||
105831148|NCT04729101|365038912|FG001|Overall Study|Withdrawal by Subject|0|||
105831149|NCT03969641|365038915|FG000|Overall Study|Lost to Follow-up|5|||
105831150|NCT03969641|365038916|FG001|Overall Study|Lost to Follow-up|3|||
105831151|NCT03969641|365038915|FG000|Overall Study|Withdrawal by Subject|1|||
105831152|NCT03969641|365038916|FG001|Overall Study|Withdrawal by Subject|2|||
105831153|NCT03969641|365038915|FG000|Overall Study|Found to be ineligible|1|||
105831154|NCT03969641|365038916|FG001|Overall Study|Found to be ineligible|1|||
105831155|NCT03969641|365038915|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
105831156|NCT03969641|365038916|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
105831157|NCT03969641|365038915|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
105831158|NCT03969641|365038916|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
105831159|NCT03969641|365038915|FG000|Overall Study|Elective termination|0|||
105831160|NCT03969641|365038916|FG001|Overall Study|Elective termination|1|||
105831161|NCT00762411|365038917|FG000|Initial Treatment|Death|7|||
105831162|NCT00762411|365038918|FG001|Initial Treatment|Death|6|||
105831163|NCT00762411|365038917|FG000|Initial Treatment|Adverse Event|132|||
105831164|NCT00762411|365038918|FG001|Initial Treatment|Adverse Event|40|||
105831165|NCT00762411|365038917|FG000|Initial Treatment|Protocol Violation|4|||
105831166|NCT00762411|365038918|FG001|Initial Treatment|Protocol Violation|1|||
105831167|NCT00762411|365038917|FG000|Initial Treatment|Withdrawal by Subject|65|||
105831168|NCT00762411|365038918|FG001|Initial Treatment|Withdrawal by Subject|52|||
105831169|NCT00762411|365038917|FG000|Initial Treatment|Physician Decision|1|||
105831170|NCT00762411|365038918|FG001|Initial Treatment|Physician Decision|0|||
105831171|NCT00762411|365038917|FG000|Initial Treatment|Sponsor Decision|293|||
105831172|NCT00762411|365038918|FG001|Initial Treatment|Sponsor Decision|401|||
105831173|NCT00762411|365038917|FG000|Initial Treatment|Lost to Follow-up|5|||
105831174|NCT00762411|365038918|FG001|Initial Treatment|Lost to Follow-up|0|||
105831175|NCT00762411|365038917|FG000|Initial Treatment|Caregiver Decision|21|||
105831176|NCT00762411|365038918|FG001|Initial Treatment|Caregiver Decision|16|||
105831177|NCT00762411|365038917|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
105831178|NCT00762411|365038918|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
105831179|NCT00762411|365038917|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
105831180|NCT00762411|365038918|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
105831181|NCT00762411|365038917|FG000|Delayed Start|Adverse Event|0|||
105831182|NCT00762411|365038918|FG001|Delayed Start|Adverse Event|4|||
105831183|NCT00762411|365038917|FG000|Delayed Start|Protocol Violation|0|||
105831184|NCT00762411|365038918|FG001|Delayed Start|Protocol Violation|1|||
105831185|NCT00762411|365038917|FG000|Delayed Start|Sponsor Decision|16|||
105831186|NCT00762411|365038918|FG001|Delayed Start|Sponsor Decision|20|||
105831187|NCT00762411|365038917|FG000|Delayed Start|Caregiver Decision|1|||
105831188|NCT00762411|365038918|FG001|Delayed Start|Caregiver Decision|1|||
105831189|NCT00762411|365038917|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
105831190|NCT00762411|365038918|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
105831191|NCT00762411|365038917|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
105831192|NCT00762411|365038918|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
105831193|NCT00762411|365038917|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
105831194|NCT00762411|365038918|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
105831195|NCT00762411|365038917|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
105831196|NCT00762411|365038918|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
105831197|NCT00762411|365038917|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
105308742|NCT02799095|363128828|FG001|Part B|Withdrawal by Subject|0|||
105489401|NCT02310321|363804050|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
105489402|NCT02310321|363804051|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
105831198|NCT00762411|365038918|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
105831199|NCT00762411|365038917|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
105831200|NCT00762411|365038918|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
105831201|NCT01541215|365038919|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
105831202|NCT01541215|365038920|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
105831203|NCT01541215|365038919|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
105831204|NCT01541215|365038920|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
105831205|NCT01541215|365038919|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
105831206|NCT01541215|365038920|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
105831207|NCT01541215|365038919|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
105831208|NCT01541215|365038920|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
105831209|NCT01541215|365038919|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
105831210|NCT01541215|365038920|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
105831211|NCT01541215|365038919|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
105831212|NCT01541215|365038920|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
105831213|NCT02302716|365038923|FG000|Overall Study|Adverse Event|1|||
105831214|NCT02302716|365038924|FG001|Overall Study|Adverse Event|1|||
105831215|NCT02302716|365038923|FG000|Overall Study|Death|0|||
105831216|NCT02302716|365038924|FG001|Overall Study|Death|1|||
105831217|NCT02302716|365038923|FG000|Overall Study|Lack of Efficacy|0|||
105831218|NCT02302716|365038924|FG001|Overall Study|Lack of Efficacy|1|||
105831219|NCT02302716|365038923|FG000|Overall Study|Lost to Follow-up|2|||
105831220|NCT02302716|365038924|FG001|Overall Study|Lost to Follow-up|4|||
105831221|NCT02302716|365038923|FG000|Overall Study|Physician Decision|3|||
105831222|NCT02302716|365038924|FG001|Overall Study|Physician Decision|4|||
105831223|NCT02302716|365038923|FG000|Overall Study|Withdrawal by Subject|13|||
105831224|NCT02302716|365038924|FG001|Overall Study|Withdrawal by Subject|7|||
105831225|NCT02302716|365038923|FG000|Overall Study|Protocol Violation|0|||
105831226|NCT02302716|365038924|FG001|Overall Study|Protocol Violation|1|||
105831227|NCT02817828|365038930|FG000|Overall Study|Lost to Follow-up|41|||
105831228|NCT02817828|365038930|FG000|Overall Study|Adverse event not related to bleeding|104|||
105831229|NCT02817828|365038930|FG000|Overall Study|Adverse event related to bleeding|53|||
105831230|NCT02817828|365038930|FG000|Overall Study|Protocol Violation|11|||
105831231|NCT02817828|365038930|FG000|Overall Study|Pregnancy|7|||
105831232|NCT02817828|365038930|FG000|Overall Study|Pregnancy wish|15|||
105831233|NCT02817828|365038930|FG000|Overall Study|Withdrawal by Subject|78|||
105831234|NCT02817828|365038930|FG000|Overall Study|Other|26|||
105831235|NCT00486434|365038931|FG000|Overall Study|Withdrawal by Subject|34|||
105831236|NCT00486434|365038932|FG001|Overall Study|Withdrawal by Subject|39|||
105831237|NCT00486434|365038931|FG000|Overall Study|Adverse Event|118|||
105831238|NCT00486434|365038932|FG001|Overall Study|Adverse Event|44|||
105831239|NCT00486434|365038931|FG000|Overall Study|Protocol Violation|22|||
105831240|NCT00486434|365038932|FG001|Overall Study|Protocol Violation|21|||
105831241|NCT00486434|365038931|FG000|Overall Study|Lack of Efficacy|12|||
105831242|NCT00486434|365038932|FG001|Overall Study|Lack of Efficacy|19|||
105831243|NCT00486434|365038931|FG000|Overall Study|Lost to Follow-up|2|||
105831244|NCT00486434|365038932|FG001|Overall Study|Lost to Follow-up|3|||
105831245|NCT00486434|365038931|FG000|Overall Study|Death|1|||
105831246|NCT00486434|365038932|FG001|Overall Study|Death|2|||
105831247|NCT00486434|365038931|FG000|Overall Study|Personal reasons|5|||
105831248|NCT00486434|365038932|FG001|Overall Study|Personal reasons|6|||
105831249|NCT04661202|365038933|FG000|Overall Study|Withdrawal by Subject|1|||
105831250|NCT04661202|365038934|FG001|Overall Study|Withdrawal by Subject|1|||
105831251|NCT04661202|365038933|FG000|Overall Study|Lack of Efficacy|2|||
105831252|NCT04661202|365038934|FG001|Overall Study|Lack of Efficacy|0|||
105831253|NCT02578641|365038935|FG000|Overall Study|Adverse Event|5|||
105831254|NCT02578641|365038936|FG001|Overall Study|Adverse Event|15|||
105831255|NCT02578641|365038935|FG000|Overall Study|Death|16|||
105831256|NCT02578641|365038936|FG001|Overall Study|Death|8|||
105831257|NCT02578641|365038935|FG000|Overall Study|Lost to Follow-up|0|||
105831258|NCT02578641|365038936|FG001|Overall Study|Lost to Follow-up|1|||
105831259|NCT02578641|365038935|FG000|Overall Study|Withdrawal by Subject|14|||
105831260|NCT02578641|365038936|FG001|Overall Study|Withdrawal by Subject|7|||
105366741|NCT03555149|363350045|FG001|Overall Study|Study Terminated By Sponsor|0|||
105366742|NCT03555149|363350046|FG002|Overall Study|Study Terminated By Sponsor|0|||
105366743|NCT03555149|363350047|FG003|Overall Study|Study Terminated By Sponsor|0|||
105366744|NCT03555149|363350048|FG004|Overall Study|Study Terminated By Sponsor|0|||
105366745|NCT03555149|363350049|FG005|Overall Study|Study Terminated By Sponsor|2|||
105366746|NCT03555149|363350050|FG006|Overall Study|Study Terminated By Sponsor|3|||
105366747|NCT03555149|363350051|FG007|Overall Study|Study Terminated By Sponsor|1|||
105366748|NCT03555149|363350044|FG000|Overall Study|Withdrawal by Subject|3|||
105366749|NCT03555149|363350045|FG001|Overall Study|Withdrawal by Subject|0|||
105366750|NCT03555149|363350046|FG002|Overall Study|Withdrawal by Subject|0|||
105366751|NCT03555149|363350047|FG003|Overall Study|Withdrawal by Subject|2|||
105366752|NCT03555149|363350048|FG004|Overall Study|Withdrawal by Subject|0|||
105366753|NCT03555149|363350049|FG005|Overall Study|Withdrawal by Subject|1|||
105366754|NCT03555149|363350050|FG006|Overall Study|Withdrawal by Subject|0|||
105366755|NCT03555149|363350051|FG007|Overall Study|Withdrawal by Subject|0|||
105366756|NCT01255163|363350052|FG000|Overall Study|Withdrawal by Subject|1|||
105366757|NCT01255163|363350053|FG001|Overall Study|Withdrawal by Subject|0|||
105831261|NCT02578641|365038935|FG000|Overall Study|Progressive Disease|69|||
105831262|NCT02578641|365038936|FG001|Overall Study|Progressive Disease|21|||
105831263|NCT02578641|365038935|FG000|Overall Study|No Study Drug|2|||
105831264|NCT02578641|365038936|FG001|Overall Study|No Study Drug|0|||
105831265|NCT02578641|365038935|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
105831266|NCT02578641|365038936|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
105831267|NCT02578641|365038935|FG000|Overall Study|Non-compliance with Study Schedule|1|||
105831268|NCT02578641|365038936|FG001|Overall Study|Non-compliance with Study Schedule|0|||
105831269|NCT02578641|365038935|FG000|Overall Study|Other|1|||
105366758|NCT01255163|363350052|FG000|Overall Study|Lost to Follow-up|2|||
105366759|NCT01255163|363350053|FG001|Overall Study|Lost to Follow-up|0|||
105831270|NCT02578641|365038936|FG001|Overall Study|Other|10|||
105831271|NCT02578641|365038935|FG000|Overall Study|Not treated|1|||
105831272|NCT02578641|365038936|FG001|Overall Study|Not treated|4|||
105831273|NCT04158687|365038938|FG000|Overall Study|Adverse Event|2|||
105831274|NCT04158687|365038939|FG001|Overall Study|Adverse Event|3|||
105831275|NCT04158687|365038940|FG002|Overall Study|Adverse Event|0|||
105831276|NCT04158687|365038941|FG003|Overall Study|Adverse Event|3|||
105831277|NCT04158687|365038938|FG000|Overall Study|Lost to Follow-up|5|||
105831278|NCT04158687|365038939|FG001|Overall Study|Lost to Follow-up|12|||
105831279|NCT04158687|365038940|FG002|Overall Study|Lost to Follow-up|4|||
105831280|NCT04158687|365038941|FG003|Overall Study|Lost to Follow-up|5|||
105489403|NCT02310321|363804049|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
105489404|NCT02310321|363804050|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
105489405|NCT02310321|363804051|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
105489406|NCT02310321|363804049|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
105489407|NCT02310321|363804050|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
105489408|NCT02310321|363804051|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
105489409|NCT02310321|363804049|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
105489410|NCT02310321|363804050|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
105489411|NCT02310321|363804051|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
105489412|NCT02310321|363804049|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
105489413|NCT02310321|363804050|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
105489414|NCT02310321|363804051|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
105489415|NCT02310321|363804049|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
105489416|NCT02310321|363804050|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
105489417|NCT02310321|363804051|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
105489418|NCT02310321|363804049|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
105489419|NCT02310321|363804050|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
105489420|NCT02310321|363804051|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
105489421|NCT02310321|363804049|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
105489422|NCT02310321|363804050|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
105489423|NCT02310321|363804051|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
105831281|NCT04158687|365038938|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
105831282|NCT04158687|365038939|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
105831283|NCT04158687|365038940|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
105831284|NCT04158687|365038941|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
105831285|NCT04158687|365038938|FG000|Overall Study|Non-Compliance with Study Medication|2|||
105831286|NCT04158687|365038939|FG001|Overall Study|Non-Compliance with Study Medication|2|||
105831287|NCT04158687|365038940|FG002|Overall Study|Non-Compliance with Study Medication|3|||
105831288|NCT04158687|365038941|FG003|Overall Study|Non-Compliance with Study Medication|0|||
105831289|NCT04158687|365038938|FG000|Overall Study|Investigator Decision|0|||
105831290|NCT04158687|365038939|FG001|Overall Study|Investigator Decision|0|||
105831291|NCT04158687|365038940|FG002|Overall Study|Investigator Decision|2|||
105831292|NCT04158687|365038941|FG003|Overall Study|Investigator Decision|0|||
105831293|NCT04158687|365038938|FG000|Overall Study|Protocol Violation|0|||
105831294|NCT04158687|365038939|FG001|Overall Study|Protocol Violation|2|||
105831295|NCT04158687|365038940|FG002|Overall Study|Protocol Violation|1|||
105831296|NCT04158687|365038941|FG003|Overall Study|Protocol Violation|0|||
105831297|NCT04158687|365038938|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
105831298|NCT04158687|365038939|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
105831299|NCT04158687|365038940|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
105831300|NCT04158687|365038941|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
105831301|NCT04158687|365038938|FG000|Overall Study|Reason not Specified|3|||
105831302|NCT04158687|365038939|FG001|Overall Study|Reason not Specified|2|||
105831303|NCT04158687|365038940|FG002|Overall Study|Reason not Specified|4|||
105831304|NCT04158687|365038941|FG003|Overall Study|Reason not Specified|4|||
105831305|NCT02694536|365038944|FG000|Overall Study|Progressive Disease|40|||
105831306|NCT02694536|365038944|FG000|Overall Study|Lost to Follow-up|1|||
105831307|NCT02694536|365038944|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
105831308|NCT02694536|365038944|FG000|Overall Study|Withdrawal by Subject|8|||
105831309|NCT02694536|365038944|FG000|Overall Study|Death|8|||
105831310|NCT02694536|365038944|FG000|Overall Study|Other|22|||
105831311|NCT01824576|365038949|FG000|Overall Study|Device deficiency|2|||
105831312|NCT00045162|365038950|FG000|Overall Study|Ineligible|12|||
105831313|NCT00045162|365038951|FG001|Overall Study|Ineligible|8|||
105831314|NCT00045162|365038950|FG000|Overall Study|Not treated|7|||
105831315|NCT00045162|365038951|FG001|Overall Study|Not treated|2|||
105831316|NCT00045162|365038950|FG000|Overall Study|Adverse Event|55|||
105831317|NCT00045162|365038951|FG001|Overall Study|Adverse Event|50|||
105831318|NCT00045162|365038950|FG000|Overall Study|Lack of Efficacy|32|||
105831319|NCT00045162|365038951|FG001|Overall Study|Lack of Efficacy|29|||
105831320|NCT00045162|365038950|FG000|Overall Study|Death|10|||
105831321|NCT00045162|365038951|FG001|Overall Study|Death|10|||
105831322|NCT00045162|365038950|FG000|Overall Study|Withdrawal by Subject|5|||
105831323|NCT00045162|365038951|FG001|Overall Study|Withdrawal by Subject|3|||
105366760|NCT01255163|363350052|FG000|Overall Study|Adverse Event|0|||
105308743|NCT02799095|363128829|FG002|Part B|Withdrawal by Subject|0|||
105308744|NCT02799095|363128830|FG003|Part B|Withdrawal by Subject|0|||
105308745|NCT02799095|363128831|FG004|Part B|Withdrawal by Subject|0|||
105308746|NCT02799095|363128832|FG005|Part B|Withdrawal by Subject|0|||
105308747|NCT02799095|363128833|FG006|Part B|Withdrawal by Subject|0|||
105308748|NCT02799095|363128834|FG007|Part B|Withdrawal by Subject|10|||
105308749|NCT02799095|363128835|FG008|Part B|Withdrawal by Subject|7|||
105308750|NCT02799095|363128836|FG009|Part B|Withdrawal by Subject|0|||
105308751|NCT02799095|363128837|FG010|Part B|Withdrawal by Subject|0|||
105308752|NCT02799095|363128838|FG011|Part B|Withdrawal by Subject|0|||
105308753|NCT02799095|363128839|FG012|Part B|Withdrawal by Subject|0|||
105308754|NCT02799095|363128840|FG013|Part B|Withdrawal by Subject|0|||
105308755|NCT02799095|363128841|FG014|Part B|Withdrawal by Subject|0|||
105308756|NCT02799095|363128842|FG015|Part B|Withdrawal by Subject|0|||
105308757|NCT02799095|363128843|FG016|Part B|Withdrawal by Subject|0|||
105308758|NCT02799095|363128827|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
105308759|NCT02799095|363128828|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
105308760|NCT02799095|363128829|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
105308761|NCT02799095|363128830|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
105308762|NCT02799095|363128831|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
105308763|NCT02799095|363128832|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
105308764|NCT02799095|363128833|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
105308765|NCT02799095|363128834|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
105308766|NCT02799095|363128835|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
105308767|NCT02799095|363128836|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
105308768|NCT02799095|363128837|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
105308769|NCT02799095|363128838|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
105308770|NCT02799095|363128839|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
105308771|NCT02799095|363128840|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
105308772|NCT02799095|363128841|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
105308773|NCT02799095|363128842|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
105308774|NCT02799095|363128843|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
105308775|NCT02799095|363128827|FG000|Part C|Adverse Event|0|||
105308776|NCT02799095|363128828|FG001|Part C|Adverse Event|0|||
105308777|NCT02799095|363128829|FG002|Part C|Adverse Event|0|||
105308778|NCT02799095|363128830|FG003|Part C|Adverse Event|0|||
105308779|NCT02799095|363128831|FG004|Part C|Adverse Event|0|||
105308780|NCT02799095|363128832|FG005|Part C|Adverse Event|0|||
105308781|NCT02799095|363128833|FG006|Part C|Adverse Event|0|||
105308782|NCT02799095|363128834|FG007|Part C|Adverse Event|0|||
105308783|NCT02799095|363128835|FG008|Part C|Adverse Event|0|||
105308784|NCT02799095|363128836|FG009|Part C|Adverse Event|0|||
105308785|NCT02799095|363128837|FG010|Part C|Adverse Event|3|||
105308786|NCT02799095|363128838|FG011|Part C|Adverse Event|1|||
105308787|NCT02799095|363128839|FG012|Part C|Adverse Event|0|||
105308788|NCT02799095|363128840|FG013|Part C|Adverse Event|1|||
105831324|NCT00045162|365038950|FG000|Overall Study|Other|21|||
105831325|NCT00045162|365038951|FG001|Overall Study|Other|16|||
105831326|NCT01044433|365038952|FG000|Overall Study|Lost to Follow-up|3|||
105831327|NCT01044433|365038952|FG000|Overall Study|Withdrawal by Subject|3|||
105831328|NCT00714051|365038961|FG000|Overall Study|Withdrawal by Subject|1|||
105831329|NCT00714051|365038962|FG001|Overall Study|Withdrawal by Subject|0|||
105831330|NCT00714051|365038961|FG000|Overall Study|Death|0|||
105831331|NCT00714051|365038962|FG001|Overall Study|Death|1|||
105831332|NCT01390948|365038964|FG000|Overall Study|End of Study|1|||
105831333|NCT01390948|365038965|FG001|Overall Study|End of Study|0|||
105831334|NCT01390948|365038966|FG002|Overall Study|End of Study|0|||
105831335|NCT01390948|365038964|FG000|Overall Study|Withdrew consent|2|||
105831336|NCT01390948|365038965|FG001|Overall Study|Withdrew consent|2|||
105831337|NCT01390948|365038966|FG002|Overall Study|Withdrew consent|0|||
105831338|NCT01390948|365038964|FG000|Overall Study|Progressive Disease|2|||
105831339|NCT01390948|365038965|FG001|Overall Study|Progressive Disease|5|||
105831340|NCT01390948|365038966|FG002|Overall Study|Progressive Disease|0|||
105831341|NCT01390948|365038964|FG000|Overall Study|Death during follow-up|10|||
105831342|NCT01390948|365038965|FG001|Overall Study|Death during follow-up|11|||
105831343|NCT01390948|365038966|FG002|Overall Study|Death during follow-up|1|||
105831344|NCT05692154|365038967|FG000|Overall Study|Adverse Event|0|||
105308789|NCT02799095|363128841|FG014|Part C|Adverse Event|0|||
105308790|NCT02799095|363128842|FG015|Part C|Adverse Event|0|||
105308791|NCT02799095|363128843|FG016|Part C|Adverse Event|0|||
105308792|NCT02799095|363128827|FG000|Part C|Death|0|||
105308793|NCT02799095|363128828|FG001|Part C|Death|0|||
105308794|NCT02799095|363128829|FG002|Part C|Death|0|||
105308795|NCT02799095|363128830|FG003|Part C|Death|0|||
105308796|NCT02799095|363128831|FG004|Part C|Death|0|||
105308797|NCT02799095|363128832|FG005|Part C|Death|0|||
105308798|NCT02799095|363128833|FG006|Part C|Death|0|||
105308799|NCT02799095|363128834|FG007|Part C|Death|0|||
105308800|NCT02799095|363128835|FG008|Part C|Death|0|||
105831345|NCT05692154|365038968|FG001|Overall Study|Adverse Event|1|||
105831346|NCT03250117|365038969|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
105308801|NCT02799095|363128836|FG009|Part C|Death|0|||
105308802|NCT02799095|363128837|FG010|Part C|Death|7|||
105308803|NCT02799095|363128838|FG011|Part C|Death|5|||
105308804|NCT02799095|363128839|FG012|Part C|Death|6|||
105308805|NCT02799095|363128840|FG013|Part C|Death|8|||
105308806|NCT02799095|363128841|FG014|Part C|Death|1|||
105308807|NCT02799095|363128842|FG015|Part C|Death|8|||
105308808|NCT02799095|363128843|FG016|Part C|Death|1|||
105308809|NCT02799095|363128827|FG000|Part C|Lost to Follow-up|0|||
105308810|NCT02799095|363128828|FG001|Part C|Lost to Follow-up|0|||
105308811|NCT02799095|363128829|FG002|Part C|Lost to Follow-up|0|||
105308812|NCT02799095|363128830|FG003|Part C|Lost to Follow-up|0|||
105308813|NCT02799095|363128831|FG004|Part C|Lost to Follow-up|0|||
105308814|NCT02799095|363128832|FG005|Part C|Lost to Follow-up|0|||
105308815|NCT02799095|363128833|FG006|Part C|Lost to Follow-up|0|||
105308816|NCT02799095|363128834|FG007|Part C|Lost to Follow-up|0|||
105308817|NCT02799095|363128835|FG008|Part C|Lost to Follow-up|0|||
105308818|NCT02799095|363128836|FG009|Part C|Lost to Follow-up|0|||
105308819|NCT02799095|363128837|FG010|Part C|Lost to Follow-up|1|||
105308820|NCT02799095|363128838|FG011|Part C|Lost to Follow-up|1|||
105308821|NCT02799095|363128839|FG012|Part C|Lost to Follow-up|1|||
105308822|NCT02799095|363128840|FG013|Part C|Lost to Follow-up|3|||
105308823|NCT02799095|363128841|FG014|Part C|Lost to Follow-up|0|||
105308824|NCT02799095|363128842|FG015|Part C|Lost to Follow-up|0|||
105308825|NCT02799095|363128843|FG016|Part C|Lost to Follow-up|0|||
105308826|NCT02799095|363128827|FG000|Part C|Progressive Disease|0|||
105308827|NCT02799095|363128828|FG001|Part C|Progressive Disease|0|||
105308828|NCT02799095|363128829|FG002|Part C|Progressive Disease|0|||
105308829|NCT02799095|363128830|FG003|Part C|Progressive Disease|0|||
105308830|NCT02799095|363128831|FG004|Part C|Progressive Disease|0|||
105308831|NCT02799095|363128832|FG005|Part C|Progressive Disease|0|||
105308832|NCT02799095|363128833|FG006|Part C|Progressive Disease|0|||
105308833|NCT02799095|363128834|FG007|Part C|Progressive Disease|0|||
105308834|NCT02799095|363128835|FG008|Part C|Progressive Disease|0|||
105308835|NCT02799095|363128836|FG009|Part C|Progressive Disease|2|||
105308836|NCT02799095|363128837|FG010|Part C|Progressive Disease|13|||
105308837|NCT02799095|363128838|FG011|Part C|Progressive Disease|2|||
105308838|NCT02799095|363128839|FG012|Part C|Progressive Disease|0|||
105308839|NCT02799095|363128840|FG013|Part C|Progressive Disease|1|||
105308840|NCT02799095|363128841|FG014|Part C|Progressive Disease|0|||
105308841|NCT02799095|363128842|FG015|Part C|Progressive Disease|0|||
105308842|NCT02799095|363128843|FG016|Part C|Progressive Disease|0|||
105308843|NCT02799095|363128827|FG000|Part C|Clinical Progression|0|||
105308844|NCT02799095|363128828|FG001|Part C|Clinical Progression|0|||
105308845|NCT02799095|363128829|FG002|Part C|Clinical Progression|0|||
105308846|NCT02799095|363128830|FG003|Part C|Clinical Progression|0|||
105308847|NCT02799095|363128831|FG004|Part C|Clinical Progression|0|||
105308848|NCT02799095|363128832|FG005|Part C|Clinical Progression|0|||
105308849|NCT02799095|363128833|FG006|Part C|Clinical Progression|0|||
105308850|NCT02799095|363128834|FG007|Part C|Clinical Progression|0|||
105308851|NCT02799095|363128835|FG008|Part C|Clinical Progression|0|||
105308852|NCT02799095|363128836|FG009|Part C|Clinical Progression|1|||
105308853|NCT02799095|363128837|FG010|Part C|Clinical Progression|3|||
105308854|NCT02799095|363128838|FG011|Part C|Clinical Progression|0|||
105308855|NCT02799095|363128839|FG012|Part C|Clinical Progression|0|||
105308856|NCT02799095|363128840|FG013|Part C|Clinical Progression|1|||
105308857|NCT02799095|363128841|FG014|Part C|Clinical Progression|0|||
105308858|NCT02799095|363128842|FG015|Part C|Clinical Progression|0|||
105308859|NCT02799095|363128843|FG016|Part C|Clinical Progression|0|||
105308860|NCT02799095|363128827|FG000|Part C|Withdrawal by Subject|0|||
105308861|NCT02799095|363128828|FG001|Part C|Withdrawal by Subject|0|||
105308862|NCT02799095|363128829|FG002|Part C|Withdrawal by Subject|0|||
105308863|NCT02799095|363128830|FG003|Part C|Withdrawal by Subject|0|||
105308864|NCT02799095|363128831|FG004|Part C|Withdrawal by Subject|0|||
105489424|NCT02310321|363804049|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
105489425|NCT02310321|363804050|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
105308865|NCT02799095|363128832|FG005|Part C|Withdrawal by Subject|0|||
105308866|NCT02799095|363128833|FG006|Part C|Withdrawal by Subject|0|||
105308867|NCT02799095|363128834|FG007|Part C|Withdrawal by Subject|0|||
105308868|NCT02799095|363128835|FG008|Part C|Withdrawal by Subject|0|||
105308869|NCT02799095|363128836|FG009|Part C|Withdrawal by Subject|0|||
105308870|NCT02799095|363128837|FG010|Part C|Withdrawal by Subject|13|||
105308871|NCT02799095|363128838|FG011|Part C|Withdrawal by Subject|15|||
105308872|NCT02799095|363128839|FG012|Part C|Withdrawal by Subject|13|||
105308873|NCT02799095|363128840|FG013|Part C|Withdrawal by Subject|21|||
105308874|NCT02799095|363128841|FG014|Part C|Withdrawal by Subject|0|||
105308875|NCT02799095|363128842|FG015|Part C|Withdrawal by Subject|12|||
105308876|NCT02799095|363128843|FG016|Part C|Withdrawal by Subject|1|||
105308877|NCT02799095|363128827|FG000|Part C|Physician Decision|0|||
105308878|NCT02799095|363128828|FG001|Part C|Physician Decision|0|||
105308879|NCT02799095|363128829|FG002|Part C|Physician Decision|0|||
105308880|NCT02799095|363128830|FG003|Part C|Physician Decision|0|||
105308881|NCT02799095|363128831|FG004|Part C|Physician Decision|0|||
105308882|NCT02799095|363128832|FG005|Part C|Physician Decision|0|||
105308883|NCT02799095|363128833|FG006|Part C|Physician Decision|0|||
105308884|NCT02799095|363128834|FG007|Part C|Physician Decision|0|||
105831347|NCT03250117|365038970|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
105831348|NCT03250117|365038971|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
105831349|NCT03250117|365038972|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
105308885|NCT02799095|363128835|FG008|Part C|Physician Decision|0|||
105308886|NCT02799095|363128836|FG009|Part C|Physician Decision|0|||
105308887|NCT02799095|363128837|FG010|Part C|Physician Decision|1|||
105308888|NCT02799095|363128838|FG011|Part C|Physician Decision|0|||
105308889|NCT02799095|363128839|FG012|Part C|Physician Decision|0|||
105308890|NCT02799095|363128840|FG013|Part C|Physician Decision|0|||
105831350|NCT01073631|365038973|FG000|Overall Study|Death|82|||
105831351|NCT01073631|365038973|FG000|Overall Study|Adverse Event|24|||
105831352|NCT01073631|365038973|FG000|Overall Study|Other|63|||
105831353|NCT00860262|365038976|FG000|Overall Study|Adverse Event|9|||
105831354|NCT00860262|365038977|FG001|Overall Study|Adverse Event|6|||
105831355|NCT00860262|365038978|FG002|Overall Study|Adverse Event|7|||
105831356|NCT00860262|365038976|FG000|Overall Study|Protocol Violation|0|||
105831357|NCT00860262|365038977|FG001|Overall Study|Protocol Violation|1|||
105831358|NCT00860262|365038978|FG002|Overall Study|Protocol Violation|0|||
105831359|NCT00860262|365038976|FG000|Overall Study|Lost to Follow-up|2|||
105831360|NCT00860262|365038977|FG001|Overall Study|Lost to Follow-up|0|||
105831361|NCT00860262|365038978|FG002|Overall Study|Lost to Follow-up|1|||
105831362|NCT00860262|365038976|FG000|Overall Study|Withdrawal by Subject|4|||
105831363|NCT00860262|365038977|FG001|Overall Study|Withdrawal by Subject|8|||
105831364|NCT00860262|365038978|FG002|Overall Study|Withdrawal by Subject|6|||
105831365|NCT00860262|365038976|FG000|Overall Study|Lack of Efficacy|0|||
105831366|NCT00860262|365038977|FG001|Overall Study|Lack of Efficacy|4|||
105831367|NCT00860262|365038978|FG002|Overall Study|Lack of Efficacy|3|||
105831368|NCT00860262|365038976|FG000|Overall Study|Other|5|||
105831369|NCT00860262|365038977|FG001|Overall Study|Other|3|||
105831370|NCT00860262|365038978|FG002|Overall Study|Other|1|||
105831371|NCT01971554|365038983|FG000|Overall Study|Lost to Follow-up|1|||
105831372|NCT01971554|365038984|FG001|Overall Study|Lost to Follow-up|0|||
105831373|NCT01971554|365038985|FG002|Overall Study|Lost to Follow-up|0|||
105831374|NCT01971554|365038986|FG003|Overall Study|Lost to Follow-up|0|||
105831375|NCT00494013|365038987|FG000|Overall Study|Adverse Event|0|||
105831376|NCT00494013|365038988|FG001|Overall Study|Adverse Event|1|||
105831377|NCT00494013|365038987|FG000|Overall Study|Entry Criteria Not Met|1|||
105831378|NCT00494013|365038988|FG001|Overall Study|Entry Criteria Not Met|4|||
105831379|NCT00494013|365038987|FG000|Overall Study|Lost to Follow-up|5|||
105831380|NCT00494013|365038988|FG001|Overall Study|Lost to Follow-up|6|||
105831381|NCT00494013|365038987|FG000|Overall Study|Physician Decision|3|||
105831382|NCT00494013|365038988|FG001|Overall Study|Physician Decision|5|||
105831383|NCT00494013|365038987|FG000|Overall Study|Protocol Violation|8|||
105831384|NCT00494013|365038988|FG001|Overall Study|Protocol Violation|5|||
105831385|NCT00494013|365038987|FG000|Overall Study|Withdrawal by Subject|13|||
105831386|NCT00494013|365038988|FG001|Overall Study|Withdrawal by Subject|14|||
105831387|NCT00494013|365038987|FG000|Overall Study|Sponsor Decision|0|||
105831388|NCT00494013|365038988|FG001|Overall Study|Sponsor Decision|1|||
105831389|NCT04194151|365038989|FG000|Overall Study|Physician Decision|1|||
105831390|NCT04194151|365038990|FG001|Overall Study|Physician Decision|1|||
105831391|NCT04194151|365038991|FG002|Overall Study|Physician Decision|1|||
105831392|NCT04194151|365038992|FG003|Overall Study|Physician Decision|1|||
105831393|NCT04194151|365038993|FG004|Overall Study|Physician Decision|0|||
105831394|NCT04194151|365038994|FG005|Overall Study|Physician Decision|1|||
105831395|NCT04194151|365038989|FG000|Overall Study|Monitorization problem|0|||
105831396|NCT04194151|365038990|FG001|Overall Study|Monitorization problem|1|||
105308891|NCT02799095|363128841|FG014|Part C|Physician Decision|0|||
105831397|NCT04194151|365038991|FG002|Overall Study|Monitorization problem|0|||
105831398|NCT04194151|365038992|FG003|Overall Study|Monitorization problem|0|||
105831399|NCT04194151|365038993|FG004|Overall Study|Monitorization problem|0|||
105831400|NCT04194151|365038994|FG005|Overall Study|Monitorization problem|0|||
105831401|NCT00593827|365038995|FG000|Overall Study|On Active Treatment/Pending|0|||
105831402|NCT00593827|365038996|FG001|Overall Study|On Active Treatment/Pending|2|||
105831403|NCT01499043|365038997|FG000|Overall Study|Progressive disease (radiographic)|2|||
105831404|NCT01499043|365038997|FG000|Overall Study|Progressive disease (clinical)|1|||
105308892|NCT02799095|363128842|FG015|Part C|Physician Decision|0|||
105831405|NCT01499043|365038997|FG000|Overall Study|Withdrawal by Subject|2|||
105831406|NCT01499043|365038997|FG000|Overall Study|Adverse Event|1|||
105308893|NCT02799095|363128843|FG016|Part C|Physician Decision|0|||
105308894|NCT02799095|363128827|FG000|Part C|Other|0|||
105831407|NCT04203823|365038998|FG000|Overall Study|Withdrawal by Subject|2|||
105831408|NCT04203823|365038999|FG001|Overall Study|Withdrawal by Subject|2|||
105831409|NCT04203823|365038998|FG000|Overall Study|Adverse Event|1|||
105831410|NCT04203823|365038999|FG001|Overall Study|Adverse Event|1|||
105831411|NCT04203823|365038998|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105831412|NCT04203823|365038999|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
105308895|NCT02799095|363128828|FG001|Part C|Other|0|||
105308896|NCT02799095|363128829|FG002|Part C|Other|0|||
105308897|NCT02799095|363128830|FG003|Part C|Other|0|||
105308898|NCT02799095|363128831|FG004|Part C|Other|0|||
105308899|NCT02799095|363128832|FG005|Part C|Other|0|||
105308900|NCT02799095|363128833|FG006|Part C|Other|0|||
105308901|NCT02799095|363128834|FG007|Part C|Other|0|||
105308902|NCT02799095|363128835|FG008|Part C|Other|0|||
105308903|NCT02799095|363128836|FG009|Part C|Other|0|||
105308904|NCT02799095|363128837|FG010|Part C|Other|0|||
105308905|NCT02799095|363128838|FG011|Part C|Other|2|||
105308906|NCT02799095|363128839|FG012|Part C|Other|2|||
105308907|NCT02799095|363128840|FG013|Part C|Other|0|||
105308908|NCT02799095|363128841|FG014|Part C|Other|0|||
105308909|NCT02799095|363128842|FG015|Part C|Other|0|||
105308910|NCT02799095|363128843|FG016|Part C|Other|0|||
105308911|NCT04347122|363128844|FG000|Overall Study|Physician Decision|0|||
105308912|NCT04347122|363128845|FG001|Overall Study|Physician Decision|3|||
105308913|NCT04347122|363128846|FG002|Overall Study|Physician Decision|3|||
105308914|NCT04347122|363128847|FG003|Overall Study|Physician Decision|6|||
105308915|NCT04663295|363128850|FG000|Run-in Period|Withdrawal by Subject|3|||
105308916|NCT04663295|363128850|FG000|Overall Study Period|Pregnancy|1|||
105308917|NCT04663295|363128850|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
105308918|NCT00699283|363128853|FG000|Overall Study|Lack of Efficacy|15|||
105308919|NCT00699283|363128854|FG001|Overall Study|Lack of Efficacy|5|||
105308920|NCT00699283|363128853|FG000|Overall Study|Lost to Follow-up|2|||
105308921|NCT00699283|363128854|FG001|Overall Study|Lost to Follow-up|0|||
105308922|NCT00699283|363128853|FG000|Overall Study|Withdrawal by Subject|1|||
105308923|NCT00699283|363128854|FG001|Overall Study|Withdrawal by Subject|0|||
105831413|NCT01598896|365039001|FG000|Overall Study|Withdrawal by Subject|0|||
105831414|NCT01598896|365039002|FG001|Overall Study|Withdrawal by Subject|1|||
105308924|NCT00699283|363128853|FG000|Overall Study|Other Reason|5|||
105366761|NCT01255163|363350053|FG001|Overall Study|Adverse Event|2|||
105366762|NCT01255163|363350052|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
105366763|NCT01255163|363350053|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
105366764|NCT00731822|363350054|FG000|Overall Study|Adverse Event|2|||
105366765|NCT00731822|363350055|FG001|Overall Study|Adverse Event|1|||
105831415|NCT01598896|365039001|FG000|Overall Study|Lack of Efficacy|0|||
105831416|NCT01598896|365039002|FG001|Overall Study|Lack of Efficacy|1|||
105831417|NCT00438633|365039003|FG000|Overall Study|Withdrawal by Subject|1|||
105831418|NCT00438633|365039004|FG001|Overall Study|Withdrawal by Subject|0|||
105831419|NCT00438633|365039003|FG000|Overall Study|Lost to Follow-up|15|||
105831420|NCT00438633|365039004|FG001|Overall Study|Lost to Follow-up|17|||
105831421|NCT03193021|365039005|FG000|Overall Study|Lost to Follow-up|1|||
105831422|NCT03193021|365039006|FG001|Overall Study|Lost to Follow-up|1|||
105831423|NCT03196284|365039009|FG000|Main Part|Withdrawal by Subject|0|||
105831424|NCT03196284|365039010|FG001|Main Part|Withdrawal by Subject|1|||
105831425|NCT03196284|365039011|FG002|Main Part|Withdrawal by Subject|0|||
105831426|NCT03196284|365039009|FG000|Extension Part|Lack of Efficacy|0|||
105831427|NCT03196284|365039010|FG001|Extension Part|Lack of Efficacy|0|||
105831428|NCT03196284|365039011|FG002|Extension Part|Lack of Efficacy|1|||
105831429|NCT03196284|365039009|FG000|Extension Part|Withdrawal by Subject|0|||
105831430|NCT03196284|365039010|FG001|Extension Part|Withdrawal by Subject|0|||
105831431|NCT03196284|365039011|FG002|Extension Part|Withdrawal by Subject|1|||
105831432|NCT03196284|365039009|FG000|Extension Part|Physician Decision|0|||
105831433|NCT03196284|365039010|FG001|Extension Part|Physician Decision|0|||
105831434|NCT03196284|365039011|FG002|Extension Part|Physician Decision|1|||
105831435|NCT01139762|365039012|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
105308925|NCT00699283|363128854|FG001|Overall Study|Other Reason|1|||
105308926|NCT00699283|363128853|FG000|Overall Study|SAE, non-fatal|1|||
105831436|NCT01139762|365039013|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
105831437|NCT01139762|365039014|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
105366766|NCT00731822|363350054|FG000|Overall Study|Protocol Violation|1|||
105831438|NCT01139762|365039012|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
105831439|NCT01139762|365039013|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
105831440|NCT01139762|365039014|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
105831441|NCT01139762|365039012|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
105831442|NCT01139762|365039013|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
105831443|NCT01139762|365039014|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
105308927|NCT00699283|363128854|FG001|Overall Study|SAE, non-fatal|1|||
105308928|NCT00699283|363128853|FG000|Overall Study|AE, non-serious non-fatal|8|||
105831444|NCT01139762|365039012|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
105366767|NCT00731822|363350055|FG001|Overall Study|Protocol Violation|0|||
105366768|NCT00731822|363350054|FG000|Overall Study|Lost to Follow-up|1|||
105308929|NCT00699283|363128854|FG001|Overall Study|AE, non-serious non-fatal|1|||
105308930|NCT00699283|363128853|FG000|Overall Study|AE of unknown type|1|||
105308931|NCT00699283|363128854|FG001|Overall Study|AE of unknown type|0|||
105308932|NCT00394524|363128855|FG000|Overall Study|Protocol Violation|2|||
105308933|NCT00394524|363128856|FG001|Overall Study|Protocol Violation|3|||
105308934|NCT00394524|363128855|FG000|Overall Study|Death|1|||
105831445|NCT01139762|365039013|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
105831446|NCT01139762|365039014|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
105831447|NCT01139762|365039012|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
105831448|NCT01139762|365039013|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
105831449|NCT01139762|365039014|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
105831450|NCT01139762|365039012|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
105831451|NCT01139762|365039013|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
105831452|NCT01139762|365039014|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
105831453|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
105831454|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
105831455|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
105831456|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Death|0|||
105831457|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Death|1|||
105831458|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Death|1|||
105831459|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
105831460|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
105831461|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
105831462|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
105831463|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
105831464|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
105831465|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
105831466|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
105831467|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
105831468|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
105831469|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
105831470|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
105831471|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
105831472|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
105831473|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
105831474|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
105831475|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
105831476|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
105831477|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
105831478|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
105831479|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
105831480|NCT01675596|365039015|FG000|Overall Study|Death|6|||
105831481|NCT01675596|365039015|FG000|Overall Study|Exit with other reason|1|||
105831482|NCT01675596|365039015|FG000|Overall Study|Missed Visit|1|||
105831483|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Adverse Event|8|||
105831484|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Adverse Event|5|||
105831485|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Adverse Event|9|||
105831486|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Adverse Event|0|||
105831487|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Adverse Event|0|||
105831488|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Adverse Event|0|||
105831489|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
105831490|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
105831491|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
105831492|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
105831493|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
105831494|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
105831495|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
105831496|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
105831497|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
105831498|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
105831499|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
105831500|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
105831501|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Physician Decision|4|||
105831502|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Physician Decision|0|||
105831503|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Physician Decision|2|||
105831504|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Physician Decision|0|||
105831505|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Physician Decision|0|||
105366769|NCT00731822|363350055|FG001|Overall Study|Lost to Follow-up|0|||
105366770|NCT03585270|363350060|FG000|Overall Study|Withdrawal by Subject|2|||
105366771|NCT03585270|363350061|FG001|Overall Study|Withdrawal by Subject|6|||
105366772|NCT03585270|363350060|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
105831506|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Physician Decision|0|||
105366773|NCT03585270|363350061|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
105308935|NCT00394524|363128856|FG001|Overall Study|Death|0|||
105831507|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Pregnancy|1|||
105831508|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Pregnancy|2|||
105831509|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Pregnancy|0|||
105831510|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Pregnancy|0|||
105831511|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Pregnancy|0|||
105831512|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Pregnancy|0|||
105831513|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
105831514|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
105831515|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
105831516|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
105831517|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
105831518|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
105831519|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
105831520|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
105831521|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
105831522|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
105831523|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
105831524|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
105831525|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
105831526|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
105831527|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
105831528|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
105831529|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
105831530|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
105831531|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
105831532|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
105831533|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
105831534|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
105831535|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
105831536|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
105831537|NCT02614196|365039016|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
105831538|NCT02614196|365039017|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
105831539|NCT02614196|365039018|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
105831540|NCT02614196|365039019|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
105831541|NCT02614196|365039020|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
105308936|NCT00394524|363128855|FG000|Overall Study|Withdrawal by Subject|0|||
105308937|NCT00394524|363128856|FG001|Overall Study|Withdrawal by Subject|1|||
105308938|NCT02932306|363128862|FG000|Overall Study|Withdrawal by Subject|16|||
105308939|NCT02932306|363128863|FG001|Overall Study|Withdrawal by Subject|25|||
105308940|NCT02932306|363128862|FG000|Overall Study|Adverse Event|3|||
105308941|NCT02932306|363128863|FG001|Overall Study|Adverse Event|0|||
105308942|NCT02932306|363128862|FG000|Overall Study|Pregnancy|2|||
105308943|NCT02932306|363128863|FG001|Overall Study|Pregnancy|0|||
105308944|NCT02932306|363128862|FG000|Overall Study|Protocol Violation|1|||
105308945|NCT02932306|363128863|FG001|Overall Study|Protocol Violation|1|||
105308946|NCT02932306|363128862|FG000|Overall Study|Noncompliance with Study Drug|1|||
105308947|NCT02932306|363128863|FG001|Overall Study|Noncompliance with Study Drug|1|||
105308948|NCT02932306|363128862|FG000|Overall Study|Lost to Follow-up|36|||
105308949|NCT02932306|363128863|FG001|Overall Study|Lost to Follow-up|40|||
105308950|NCT02932306|363128862|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
105308951|NCT02932306|363128863|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
105308952|NCT02932306|363128862|FG000|Overall Study|Lack of Efficacy|0|||
105308953|NCT02932306|363128863|FG001|Overall Study|Lack of Efficacy|2|||
105308954|NCT02932306|363128862|FG000|Overall Study|Worsening condition|2|||
105308955|NCT02932306|363128863|FG001|Overall Study|Worsening condition|0|||
105308956|NCT02932306|363128862|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
105831542|NCT02614196|365039021|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
105831543|NCT02614196|365039016|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
105831544|NCT02614196|365039017|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
105831545|NCT02614196|365039018|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
105831546|NCT02614196|365039019|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
105308957|NCT02932306|363128863|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
105308958|NCT02116608|363128865|FG000|Overall Study|Lost to Follow-up|0|||
105308959|NCT02116608|363128866|FG001|Overall Study|Lost to Follow-up|0|||
105308960|NCT02116608|363128867|FG002|Overall Study|Lost to Follow-up|1|||
105308961|NCT02116608|363128865|FG000|Overall Study|Physician Decision|0|||
105831547|NCT02614196|365039020|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
105308962|NCT02116608|363128866|FG001|Overall Study|Physician Decision|1|||
105308963|NCT02116608|363128867|FG002|Overall Study|Physician Decision|0|||
105308964|NCT02116608|363128865|FG000|Overall Study|Death|0|||
105308965|NCT02116608|363128866|FG001|Overall Study|Death|1|||
105366774|NCT03585270|363350060|FG000|Overall Study|Adverse Event|5|||
105831548|NCT02614196|365039021|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
105831549|NCT02614196|365039016|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
105831550|NCT02614196|365039017|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
105831551|NCT02614196|365039018|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
105308966|NCT02116608|363128867|FG002|Overall Study|Death|0|||
105831552|NCT02614196|365039019|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
105831553|NCT02614196|365039020|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
105831554|NCT02614196|365039021|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
105831555|NCT02614196|365039016|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
105308967|NCT00265395|363128868|FG000|Overall Study|Adverse Event|3|||
105308968|NCT00265395|363128869|FG001|Overall Study|Adverse Event|6|||
105308969|NCT00265395|363128868|FG000|Overall Study|Lost to Follow-up|2|||
105308970|NCT00265395|363128869|FG001|Overall Study|Lost to Follow-up|1|||
105308971|NCT00265395|363128868|FG000|Overall Study|Withdrawal by Subject|1|||
105308972|NCT00265395|363128869|FG001|Overall Study|Withdrawal by Subject|6|||
105308973|NCT00265395|363128868|FG000|Overall Study|Protocol Violation|2|||
105308974|NCT00265395|363128869|FG001|Overall Study|Protocol Violation|2|||
105308975|NCT00265395|363128868|FG000|Overall Study|Lack of Efficacy|0|||
105308976|NCT00265395|363128869|FG001|Overall Study|Lack of Efficacy|1|||
105308977|NCT00265395|363128868|FG000|Overall Study|Administrative|0|||
105308978|NCT00265395|363128869|FG001|Overall Study|Administrative|1|||
105308979|NCT00552578|363128872|FG000|Overall Study|Lost to Follow-up|1|||
105308980|NCT00552578|363128873|FG001|Overall Study|Lost to Follow-up|1|||
105308981|NCT03400943|363128874|FG000|Treatment Period 1|Adverse Event|0|||
105308982|NCT03400943|363128875|FG001|Treatment Period 1|Adverse Event|0|||
105308983|NCT03400943|363128876|FG002|Treatment Period 1|Adverse Event|0|||
105308984|NCT03400943|363128877|FG003|Treatment Period 1|Adverse Event|1|||
105308985|NCT03400943|363128874|FG000|Treatment Period 1|Lost to Follow-up|1|||
105308986|NCT03400943|363128875|FG001|Treatment Period 1|Lost to Follow-up|0|||
105308987|NCT03400943|363128876|FG002|Treatment Period 1|Lost to Follow-up|0|||
105308988|NCT03400943|363128877|FG003|Treatment Period 1|Lost to Follow-up|0|||
105308989|NCT03400943|363128874|FG000|Treatment Period 1|Protocol Violation|0|||
105308990|NCT03400943|363128875|FG001|Treatment Period 1|Protocol Violation|1|||
105308991|NCT03400943|363128876|FG002|Treatment Period 1|Protocol Violation|1|||
105308992|NCT03400943|363128877|FG003|Treatment Period 1|Protocol Violation|0|||
105308993|NCT03400943|363128874|FG000|Treatment Period 1|Study terminated by sponsor|2|||
105308994|NCT03400943|363128875|FG001|Treatment Period 1|Study terminated by sponsor|0|||
105308995|NCT03400943|363128876|FG002|Treatment Period 1|Study terminated by sponsor|0|||
105308996|NCT03400943|363128877|FG003|Treatment Period 1|Study terminated by sponsor|1|||
105308997|NCT03400943|363128874|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105308998|NCT03400943|363128875|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105308999|NCT03400943|363128876|FG002|Treatment Period 1|Withdrawal by Subject|3|||
105309000|NCT03400943|363128877|FG003|Treatment Period 1|Withdrawal by Subject|1|||
105309001|NCT03400943|363128874|FG000|Treatment Period 1|Other|2|||
105309002|NCT03400943|363128875|FG001|Treatment Period 1|Other|1|||
105309003|NCT03400943|363128876|FG002|Treatment Period 1|Other|2|||
105309004|NCT03400943|363128877|FG003|Treatment Period 1|Other|2|||
105309005|NCT03400943|363128874|FG000|Post-treatment Period 1|Adverse Event|2|||
105309006|NCT03400943|363128875|FG001|Post-treatment Period 1|Adverse Event|0|||
105309007|NCT03400943|363128876|FG002|Post-treatment Period 1|Adverse Event|0|||
105309008|NCT03400943|363128877|FG003|Post-treatment Period 1|Adverse Event|0|||
105309009|NCT03400943|363128874|FG000|Post-treatment Period 1|Protocol Violation|1|||
105309010|NCT03400943|363128875|FG001|Post-treatment Period 1|Protocol Violation|0|||
105309011|NCT03400943|363128876|FG002|Post-treatment Period 1|Protocol Violation|0|||
105366775|NCT03585270|363350061|FG001|Overall Study|Adverse Event|2|||
105831556|NCT02614196|365039017|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
105831557|NCT02614196|365039018|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
105831558|NCT02614196|365039019|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
105831559|NCT02614196|365039020|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
105309012|NCT03400943|363128877|FG003|Post-treatment Period 1|Protocol Violation|0|||
105309013|NCT03400943|363128874|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
105309014|NCT03400943|363128875|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
105309015|NCT03400943|363128876|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
105309016|NCT03400943|363128877|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
105309017|NCT03400943|363128874|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
105309018|NCT03400943|363128875|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
105309019|NCT03400943|363128876|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
105309020|NCT03400943|363128877|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
105309021|NCT03400943|363128874|FG000|Post-treatment Period 1|Other|2|||
105309022|NCT03400943|363128875|FG001|Post-treatment Period 1|Other|0|||
105309023|NCT03400943|363128876|FG002|Post-treatment Period 1|Other|4|||
105309024|NCT03400943|363128877|FG003|Post-treatment Period 1|Other|5|||
105309025|NCT03400943|363128874|FG000|Treatment Period 2|Study terminated by sponsor|0|||
105309026|NCT03400943|363128875|FG001|Treatment Period 2|Study terminated by sponsor|1|||
105366776|NCT03585270|363350060|FG000|Overall Study|Lost to Follow-up|1|||
105831560|NCT02614196|365039021|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
105831561|NCT00642811|365039022|FG000|Overall Study|Adverse Event|2|||
105831562|NCT00642811|365039023|FG001|Overall Study|Adverse Event|3|||
105831563|NCT00642811|365039024|FG002|Overall Study|Adverse Event|0|||
105831564|NCT00642811|365039025|FG003|Overall Study|Adverse Event|0|||
105831565|NCT00642811|365039026|FG004|Overall Study|Adverse Event|0|||
105831566|NCT00642811|365039027|FG005|Overall Study|Adverse Event|1|||
105831567|NCT00642811|365039022|FG000|Overall Study|Developement of discontinuation criteria|0|||
105831568|NCT00642811|365039023|FG001|Overall Study|Developement of discontinuation criteria|0|||
105831569|NCT00642811|365039024|FG002|Overall Study|Developement of discontinuation criteria|0|||
105831570|NCT00642811|365039025|FG003|Overall Study|Developement of discontinuation criteria|0|||
105831571|NCT00642811|365039026|FG004|Overall Study|Developement of discontinuation criteria|1|||
105831572|NCT00642811|365039027|FG005|Overall Study|Developement of discontinuation criteria|0|||
105831573|NCT00642811|365039022|FG000|Overall Study|Severe Non-compliance to protocol|1|||
105831574|NCT00642811|365039023|FG001|Overall Study|Severe Non-compliance to protocol|0|||
105831575|NCT00642811|365039024|FG002|Overall Study|Severe Non-compliance to protocol|0|||
105831576|NCT00642811|365039025|FG003|Overall Study|Severe Non-compliance to protocol|0|||
105831577|NCT00642811|365039026|FG004|Overall Study|Severe Non-compliance to protocol|0|||
105831578|NCT00642811|365039027|FG005|Overall Study|Severe Non-compliance to protocol|0|||
105831579|NCT00642811|365039022|FG000|Overall Study|Other|0|||
105831580|NCT00642811|365039023|FG001|Overall Study|Other|1|||
105831581|NCT00642811|365039024|FG002|Overall Study|Other|0|||
105831582|NCT00642811|365039025|FG003|Overall Study|Other|1|||
105831583|NCT00642811|365039026|FG004|Overall Study|Other|0|||
105831584|NCT00642811|365039027|FG005|Overall Study|Other|0|||
105831585|NCT00087529|365039028|FG000|Overall Study|Death|1|||
105831586|NCT00087529|365039029|FG001|Overall Study|Death|0|||
105831587|NCT00087529|365039028|FG000|Overall Study|Adverse Event|0|||
105831588|NCT00087529|365039029|FG001|Overall Study|Adverse Event|8|||
105831589|NCT00087529|365039028|FG000|Overall Study|Pregnancy|0|||
105831590|NCT00087529|365039029|FG001|Overall Study|Pregnancy|1|||
105831591|NCT00087529|365039028|FG000|Overall Study|Lost to Follow-up|2|||
105831592|NCT00087529|365039029|FG001|Overall Study|Lost to Follow-up|3|||
105831593|NCT00087529|365039028|FG000|Overall Study|Participant Decision|14|||
105831594|NCT00087529|365039029|FG001|Overall Study|Participant Decision|37|||
105831595|NCT00087529|365039028|FG000|Overall Study|Physician Decision|4|||
105831596|NCT00087529|365039029|FG001|Overall Study|Physician Decision|8|||
105831597|NCT00087529|365039028|FG000|Overall Study|Initiation of Excluded Therapy|0|||
105831598|NCT00087529|365039029|FG001|Overall Study|Initiation of Excluded Therapy|1|||
105831599|NCT00087529|365039028|FG000|Overall Study|Participant Noncompliance|0|||
105831600|NCT00087529|365039029|FG001|Overall Study|Participant Noncompliance|1|||
105831601|NCT00087529|365039028|FG000|Overall Study|Disease Progression|5|||
105831602|NCT00087529|365039029|FG001|Overall Study|Disease Progression|4|||
105831603|NCT00087529|365039028|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
105831604|NCT00087529|365039029|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
105831605|NCT04553406|365039030|FG000|Overall Study|Study Discontinuation|0|||
105831606|NCT04553406|365039031|FG001|Overall Study|Study Discontinuation|1|||
105831607|NCT01539239|365039032|FG000|Overall Study|Death|5|||
105831608|NCT01539239|365039033|FG001|Overall Study|Death|5|||
105831609|NCT01539239|365039032|FG000|Overall Study|Lost to Follow-up|7|||
105831610|NCT01539239|365039033|FG001|Overall Study|Lost to Follow-up|12|||
105831611|NCT01223027|365039037|FG000|Overall Study|Adverse Event|20|||
105831612|NCT01223027|365039038|FG001|Overall Study|Adverse Event|10|||
105831613|NCT01223027|365039037|FG000|Overall Study|Death|42|||
105831614|NCT01223027|365039038|FG001|Overall Study|Death|42|||
105831615|NCT01223027|365039037|FG000|Overall Study|Lost to Follow-up|2|||
105831616|NCT01223027|365039038|FG001|Overall Study|Lost to Follow-up|1|||
105309027|NCT03400943|363128876|FG002|Treatment Period 2|Study terminated by sponsor|0|||
105309028|NCT03400943|363128877|FG003|Treatment Period 2|Study terminated by sponsor|0|||
105309029|NCT03400943|363128874|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105831617|NCT01223027|365039037|FG000|Overall Study|Physician Decision|4|||
105831618|NCT01223027|365039038|FG001|Overall Study|Physician Decision|8|||
105831619|NCT01223027|365039037|FG000|Overall Study|Progressive Disease|167|||
105831620|NCT01223027|365039038|FG001|Overall Study|Progressive Disease|183|||
105831621|NCT01223027|365039037|FG000|Overall Study|Protocol Violation|2|||
105831622|NCT01223027|365039038|FG001|Overall Study|Protocol Violation|1|||
105831623|NCT01223027|365039037|FG000|Overall Study|Subject/guardian decicion|18|||
105831624|NCT01223027|365039038|FG001|Overall Study|Subject/guardian decicion|16|||
105831625|NCT01223027|365039037|FG000|Overall Study|New therapy for study indication|17|||
105831626|NCT01223027|365039038|FG001|Overall Study|New therapy for study indication|8|||
105831627|NCT01223027|365039037|FG000|Overall Study|Study terminated by sponsor|2|||
105309030|NCT03400943|363128875|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105831628|NCT01223027|365039038|FG001|Overall Study|Study terminated by sponsor|8|||
105831629|NCT01992094|365039040|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
105831630|NCT01992094|365039041|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
105831631|NCT01992094|365039042|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
105309031|NCT03400943|363128876|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105831632|NCT01992094|365039040|FG000|Overall Study|Adverse Event|1|||
105831633|NCT01992094|365039041|FG001|Overall Study|Adverse Event|0|||
105831634|NCT01992094|365039042|FG002|Overall Study|Adverse Event|0|||
105831635|NCT01992094|365039040|FG000|Overall Study|Death|5|||
105309032|NCT03400943|363128877|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105309033|NCT03400943|363128874|FG000|Treatment Period 2|Other|1|||
105309034|NCT03400943|363128875|FG001|Treatment Period 2|Other|6|||
105309035|NCT03400943|363128876|FG002|Treatment Period 2|Other|0|||
105309036|NCT03400943|363128877|FG003|Treatment Period 2|Other|0|||
105309037|NCT03400943|363128874|FG000|Follow-up Period|Withdrawal by Subject|1|||
105831636|NCT01992094|365039041|FG001|Overall Study|Death|5|||
105831637|NCT01992094|365039042|FG002|Overall Study|Death|2|||
105831638|NCT01992094|365039040|FG000|Overall Study|Lost to Follow-up|26|||
105831639|NCT01992094|365039041|FG001|Overall Study|Lost to Follow-up|9|||
105831640|NCT01992094|365039042|FG002|Overall Study|Lost to Follow-up|13|||
105831641|NCT01992094|365039040|FG000|Overall Study|OTHER|4|||
105831642|NCT01992094|365039041|FG001|Overall Study|OTHER|0|||
105831643|NCT01992094|365039042|FG002|Overall Study|OTHER|0|||
105831644|NCT01992094|365039040|FG000|Overall Study|Protocol Violation|1|||
105831645|NCT01992094|365039041|FG001|Overall Study|Protocol Violation|0|||
105831646|NCT01992094|365039042|FG002|Overall Study|Protocol Violation|1|||
105831647|NCT01992094|365039040|FG000|Overall Study|Withdrawal by Subject|7|||
105831648|NCT01992094|365039041|FG001|Overall Study|Withdrawal by Subject|3|||
105831649|NCT01992094|365039042|FG002|Overall Study|Withdrawal by Subject|4|||
105831650|NCT04428645|365039043|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
105831651|NCT03201003|365039044|FG000|Overall Study|Adverse Event|14|||
105831652|NCT03201003|365039045|FG001|Overall Study|Adverse Event|1|||
105831653|NCT03201003|365039044|FG000|Overall Study|Other reasons|5|||
105831654|NCT03201003|365039045|FG001|Overall Study|Other reasons|1|||
105831655|NCT03201003|365039044|FG000|Overall Study|Withdrawal by Subject|4|||
105831656|NCT03201003|365039045|FG001|Overall Study|Withdrawal by Subject|1|||
105831657|NCT03201003|365039044|FG000|Overall Study|Lost to Follow-up|2|||
105831658|NCT03201003|365039045|FG001|Overall Study|Lost to Follow-up|0|||
105831659|NCT03201003|365039044|FG000|Overall Study|Protocol Violation|1|||
105831660|NCT03201003|365039045|FG001|Overall Study|Protocol Violation|0|||
105831661|NCT00834613|365039046|FG000|First Intervention|Protocol Violation|1|||
105831662|NCT00834613|365039047|FG001|First Intervention|Protocol Violation|0|||
105831663|NCT00663234|365039048|FG000|Overall Study|Not willing to adhere to requirements|1|||
105831664|NCT01709903|365039049|FG000|Overall Study|administrative problems|2|||
105831665|NCT01709903|365039050|FG001|Overall Study|administrative problems|6|||
105831666|NCT01709903|365039049|FG000|Overall Study|Abnormal test procedure results|1|||
105831667|NCT01709903|365039050|FG001|Overall Study|Abnormal test procedure results|0|||
105831668|NCT01709903|365039049|FG000|Overall Study|In ability to use device|1|||
105831669|NCT01709903|365039050|FG001|Overall Study|In ability to use device|1|||
105831670|NCT01709903|365039049|FG000|Overall Study|no longer needed study drug|0|||
105831671|NCT01709903|365039050|FG001|Overall Study|no longer needed study drug|1|||
105831672|NCT01709903|365039049|FG000|Overall Study|Lost to Follow-up|0|||
105831673|NCT01709903|365039050|FG001|Overall Study|Lost to Follow-up|2|||
105831674|NCT01709903|365039049|FG000|Overall Study|Death|2|||
105831675|NCT01709903|365039050|FG001|Overall Study|Death|0|||
105831676|NCT01709903|365039049|FG000|Overall Study|Protocol Violation|3|||
105831677|NCT01709903|365039050|FG001|Overall Study|Protocol Violation|2|||
105831678|NCT01709903|365039049|FG000|Overall Study|Lack of Efficacy|3|||
105831679|NCT01709903|365039050|FG001|Overall Study|Lack of Efficacy|3|||
105309038|NCT03400943|363128875|FG001|Follow-up Period|Withdrawal by Subject|0|||
105309039|NCT03400943|363128876|FG002|Follow-up Period|Withdrawal by Subject|0|||
105309040|NCT03400943|363128877|FG003|Follow-up Period|Withdrawal by Subject|0|||
105309041|NCT02563106|363128878|FG000|Overall Study|Withdrawal by Subject|7|||
105309042|NCT02563106|363128879|FG001|Overall Study|Withdrawal by Subject|8|||
105309043|NCT02563106|363128878|FG000|Overall Study|Adverse Event|17|||
105575839|NCT04467840|364108340|FG001|Overall Study|Withdrawal by Subject|4|||
105831680|NCT01709903|365039049|FG000|Overall Study|Withdrawal by Subject|6|||
105831681|NCT01709903|365039050|FG001|Overall Study|Withdrawal by Subject|6|||
105831682|NCT01709903|365039049|FG000|Overall Study|Adverse Event|11|||
105831683|NCT01709903|365039050|FG001|Overall Study|Adverse Event|18|||
105831684|NCT02061280|365039051|FG000|Overall Study|Protocol Violation|12|||
105831685|NCT02061280|365039052|FG001|Overall Study|Protocol Violation|8|||
105831686|NCT02061280|365039051|FG000|Overall Study|moved out of state|0|||
105831687|NCT02061280|365039052|FG001|Overall Study|moved out of state|1|||
105831688|NCT02061280|365039051|FG000|Overall Study|Withdrawal by Subject|1|||
105831689|NCT02061280|365039052|FG001|Overall Study|Withdrawal by Subject|2|||
105831690|NCT02061280|365039051|FG000|Overall Study|Lost to Follow-up|5|||
105831691|NCT02061280|365039052|FG001|Overall Study|Lost to Follow-up|1|||
105309044|NCT02563106|363128879|FG001|Overall Study|Adverse Event|15|||
105309045|NCT02563106|363128878|FG000|Overall Study|Protocol Violation|1|||
105831692|NCT02473393|365040870|FG000|Overall Study|Adverse Event|0|||
105831693|NCT02473393|365040871|FG001|Overall Study|Adverse Event|0|||
105831694|NCT02473393|365040872|FG002|Overall Study|Adverse Event|1|||
105831695|NCT02473393|365040873|FG003|Overall Study|Adverse Event|0|||
105831696|NCT02473393|365040870|FG000|Overall Study|Withdrawal by Subject|0|||
105831697|NCT02473393|365040871|FG001|Overall Study|Withdrawal by Subject|0|||
105831698|NCT02473393|365040872|FG002|Overall Study|Withdrawal by Subject|1|||
105831699|NCT02473393|365040873|FG003|Overall Study|Withdrawal by Subject|1|||
105831700|NCT00640393|365040874|FG000|Part 1|Lost to Follow-up|2|||
105831701|NCT00640393|365040875|FG001|Part 1|Lost to Follow-up|0|||
105831702|NCT00640393|365040876|FG002|Part 1|Lost to Follow-up|0|||
105831703|NCT00640393|365040874|FG000|Part 1|Withdrawal by Subject|3|||
105831704|NCT00640393|365040875|FG001|Part 1|Withdrawal by Subject|0|||
105831705|NCT00640393|365040876|FG002|Part 1|Withdrawal by Subject|0|||
105831706|NCT00640393|365040874|FG000|Randomization|Withdrawn per protocol|17|||
105831707|NCT00640393|365040875|FG001|Randomization|Withdrawn per protocol|0|||
105831708|NCT00640393|365040876|FG002|Randomization|Withdrawn per protocol|0|||
105831709|NCT00640393|365040874|FG000|Randomization|Never randomized by site|2|||
105831710|NCT00640393|365040875|FG001|Randomization|Never randomized by site|0|||
105831711|NCT00640393|365040876|FG002|Randomization|Never randomized by site|0|||
105831712|NCT00640393|365040874|FG000|Part 2|Lost to Follow-up|0|||
105831713|NCT00640393|365040875|FG001|Part 2|Lost to Follow-up|2|||
105831714|NCT00640393|365040876|FG002|Part 2|Lost to Follow-up|2|||
105831715|NCT00640393|365040874|FG000|Part 2|Withdrawal by Subject|0|||
105831716|NCT00640393|365040875|FG001|Part 2|Withdrawal by Subject|6|||
105831717|NCT00640393|365040876|FG002|Part 2|Withdrawal by Subject|1|||
105831718|NCT00640393|365040874|FG000|Part 2|Non-adherence|0|||
105831719|NCT00640393|365040875|FG001|Part 2|Non-adherence|1|||
105831720|NCT00640393|365040876|FG002|Part 2|Non-adherence|0|||
105831721|NCT00640393|365040874|FG000|Part 2|Adverse Event|0|||
105831722|NCT00640393|365040875|FG001|Part 2|Adverse Event|1|||
105831723|NCT00640393|365040876|FG002|Part 2|Adverse Event|0|||
105831724|NCT04406194|365040878|FG000|Period 1|Withdrawal by Subject|0|||
105831725|NCT04406194|365040879|FG001|Period 1|Withdrawal by Subject|1|||
105831726|NCT04102345|365040886|FG000|Overall Study|Withdrawal by Subject|1|||
105831727|NCT04102345|365040887|FG001|Overall Study|Withdrawal by Subject|0|||
105831728|NCT02419573|365040888|FG000|Overall Study|Lost to Follow-up|3|||
105831729|NCT02419573|365040889|FG001|Overall Study|Lost to Follow-up|0|||
105831730|NCT02419573|365040888|FG000|Overall Study|Withdrawal by Subject|1|||
105831731|NCT02419573|365040889|FG001|Overall Study|Withdrawal by Subject|0|||
105831732|NCT01513239|365040903|FG000|Period 1: Main Phase|Adverse Event|1|||
105831733|NCT01513239|365040904|FG001|Period 1: Main Phase|Adverse Event|1|||
105831734|NCT01513239|365040905|FG002|Period 1: Main Phase|Adverse Event|2|||
105831735|NCT01513239|365040906|FG003|Period 1: Main Phase|Adverse Event|0|||
105831736|NCT01513239|365040907|FG004|Period 1: Main Phase|Adverse Event|0|||
105831737|NCT01513239|365040908|FG005|Period 1: Main Phase|Adverse Event|0|||
105831738|NCT01513239|365040903|FG000|Period 1: Main Phase|Death|29|||
105831739|NCT01513239|365040904|FG001|Period 1: Main Phase|Death|22|||
105831740|NCT01513239|365040905|FG002|Period 1: Main Phase|Death|32|||
105831741|NCT01513239|365040906|FG003|Period 1: Main Phase|Death|0|||
105831742|NCT01513239|365040907|FG004|Period 1: Main Phase|Death|0|||
105831743|NCT01513239|365040908|FG005|Period 1: Main Phase|Death|0|||
105831744|NCT01513239|365040903|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
105831745|NCT01513239|365040904|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
105831746|NCT01513239|365040905|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
105831747|NCT01513239|365040906|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
105831748|NCT01513239|365040907|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
105831749|NCT01513239|365040908|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
105831750|NCT01513239|365040903|FG000|Period 1: Main Phase|Physician Decision|4|||
105831751|NCT01513239|365040904|FG001|Period 1: Main Phase|Physician Decision|4|||
105831752|NCT01513239|365040905|FG002|Period 1: Main Phase|Physician Decision|4|||
105831753|NCT01513239|365040906|FG003|Period 1: Main Phase|Physician Decision|0|||
105831754|NCT01513239|365040907|FG004|Period 1: Main Phase|Physician Decision|0|||
105831755|NCT01513239|365040908|FG005|Period 1: Main Phase|Physician Decision|0|||
105831756|NCT01513239|365040903|FG000|Period 1: Main Phase|Protocol Violation|2|||
105831757|NCT01513239|365040904|FG001|Period 1: Main Phase|Protocol Violation|2|||
105831758|NCT01513239|365040905|FG002|Period 1: Main Phase|Protocol Violation|2|||
105831759|NCT01513239|365040906|FG003|Period 1: Main Phase|Protocol Violation|0|||
105309046|NCT02563106|363128879|FG001|Overall Study|Protocol Violation|0|||
105309047|NCT02563106|363128878|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
105309048|NCT02563106|363128879|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
105309049|NCT02563106|363128878|FG000|Overall Study|Lost to Follow-up|3|||
105309050|NCT02563106|363128879|FG001|Overall Study|Lost to Follow-up|2|||
105309051|NCT02563106|363128878|FG000|Overall Study|Physician Decision|3|||
105831760|NCT01513239|365040907|FG004|Period 1: Main Phase|Protocol Violation|0|||
105831761|NCT01513239|365040908|FG005|Period 1: Main Phase|Protocol Violation|0|||
105831762|NCT01513239|365040903|FG000|Period 1: Main Phase|Technical Problems|1|||
105831763|NCT01513239|365040904|FG001|Period 1: Main Phase|Technical Problems|2|||
105831764|NCT01513239|365040905|FG002|Period 1: Main Phase|Technical Problems|0|||
105831765|NCT01513239|365040906|FG003|Period 1: Main Phase|Technical Problems|0|||
105831766|NCT01513239|365040907|FG004|Period 1: Main Phase|Technical Problems|0|||
105831767|NCT01513239|365040908|FG005|Period 1: Main Phase|Technical Problems|0|||
105831768|NCT01513239|365040903|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
105831769|NCT01513239|365040904|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
105831770|NCT01513239|365040905|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
105831771|NCT01513239|365040906|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
105831772|NCT01513239|365040907|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
105831773|NCT01513239|365040908|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
105831774|NCT01513239|365040903|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
105831775|NCT01513239|365040904|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
105831776|NCT01513239|365040905|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
105831777|NCT01513239|365040906|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
105831778|NCT01513239|365040907|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
105831779|NCT01513239|365040908|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
105831780|NCT01513239|365040903|FG000|Period 2: 9 Month Extension Phase|Death|0|||
105831781|NCT01513239|365040904|FG001|Period 2: 9 Month Extension Phase|Death|0|||
105831782|NCT01513239|365040905|FG002|Period 2: 9 Month Extension Phase|Death|0|||
105831783|NCT01513239|365040906|FG003|Period 2: 9 Month Extension Phase|Death|2|||
105831784|NCT01513239|365040907|FG004|Period 2: 9 Month Extension Phase|Death|5|||
105831785|NCT01513239|365040908|FG005|Period 2: 9 Month Extension Phase|Death|2|||
105831786|NCT01513239|365040903|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
105831787|NCT01513239|365040904|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
105831788|NCT01513239|365040905|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
105831789|NCT01513239|365040906|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
105831790|NCT01513239|365040907|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
105831791|NCT01513239|365040908|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
105831792|NCT01513239|365040903|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
105831793|NCT01513239|365040904|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
105831794|NCT01513239|365040905|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
105831795|NCT01513239|365040906|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
105831796|NCT01513239|365040907|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
105831797|NCT01513239|365040908|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
105831798|NCT01513239|365040903|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
105831799|NCT01513239|365040904|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
105831800|NCT01513239|365040905|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
105831801|NCT01513239|365040906|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
105831802|NCT01513239|365040907|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
105831803|NCT01513239|365040908|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
105831804|NCT00396162|365040909|FG000|Overall Study|Withdrawal by Subject|2|||
105831805|NCT00396162|365040910|FG001|Overall Study|Withdrawal by Subject|3|||
105831806|NCT03167606|365040913|FG000|Overall Study|Lost to Follow-up|73|||
105831807|NCT03167606|365040914|FG001|Overall Study|Lost to Follow-up|64|||
105831808|NCT03167606|365040913|FG000|Overall Study|Withdrawal by Subject|6|||
105831809|NCT03167606|365040914|FG001|Overall Study|Withdrawal by Subject|5|||
105831810|NCT03167606|365040913|FG000|Overall Study|Withdrawal by Investigator|0|||
105831811|NCT03167606|365040914|FG001|Overall Study|Withdrawal by Investigator|2|||
105831812|NCT00059332|365040915|FG000|Overall Study|Withdrawal by Subject|2|||
105831813|NCT00059332|365040916|FG001|Overall Study|Withdrawal by Subject|1|||
105831814|NCT00059332|365040915|FG000|Overall Study|Lost to Follow-up|1|||
105831815|NCT00059332|365040916|FG001|Overall Study|Lost to Follow-up|1|||
105831816|NCT01741545|365040917|FG000|Treatment Period|Lack of Efficacy|0|||
105309052|NCT02563106|363128879|FG001|Overall Study|Physician Decision|1|||
105309053|NCT02563106|363128878|FG000|Overall Study|Other reason - not specified|2|||
105309054|NCT02563106|363128879|FG001|Overall Study|Other reason - not specified|1|||
105831817|NCT01741545|365040918|FG001|Treatment Period|Lack of Efficacy|1|||
105831818|NCT01741545|365040917|FG000|Treatment Period|Adverse event, non-fatal|1|||
105831819|NCT01741545|365040918|FG001|Treatment Period|Adverse event, non-fatal|3|||
105831820|NCT01741545|365040917|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
105831821|NCT01741545|365040918|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
105831822|NCT01741545|365040917|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
105831823|NCT01741545|365040918|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
105831824|NCT01456962|365040919|FG000|Overall Study|Lost to Follow-up|2|||
105831825|NCT01456962|365040920|FG001|Overall Study|Lost to Follow-up|1|||
105831826|NCT01911429|365040921|FG000|Overall Study|Adverse Event|5|||
105831827|NCT01911429|365040922|FG001|Overall Study|Adverse Event|3|||
105831828|NCT01911429|365040923|FG002|Overall Study|Adverse Event|9|||
105309055|NCT01059539|363128880|FG000|Overall Study|Adverse Event|66|||
105309056|NCT01059539|363128880|FG000|Overall Study|Insufficient Therapeutic Response|26|||
105831829|NCT01911429|365040921|FG000|Overall Study|Lack of Efficacy|1|||
105831830|NCT01911429|365040922|FG001|Overall Study|Lack of Efficacy|2|||
105309057|NCT01059539|363128880|FG000|Overall Study|Protocol Violation|55|||
105831831|NCT01911429|365040923|FG002|Overall Study|Lack of Efficacy|4|||
105831832|NCT01911429|365040921|FG000|Overall Study|Lost to Follow-up|0|||
105831833|NCT01911429|365040922|FG001|Overall Study|Lost to Follow-up|0|||
105831834|NCT01911429|365040923|FG002|Overall Study|Lost to Follow-up|1|||
105831835|NCT01911429|365040921|FG000|Overall Study|Protocol Violation|0|||
105831836|NCT01911429|365040922|FG001|Overall Study|Protocol Violation|0|||
105831837|NCT01911429|365040923|FG002|Overall Study|Protocol Violation|1|||
105831838|NCT01911429|365040921|FG000|Overall Study|Withdrawal by Subject|5|||
105831839|NCT01911429|365040922|FG001|Overall Study|Withdrawal by Subject|5|||
105831840|NCT01911429|365040923|FG002|Overall Study|Withdrawal by Subject|4|||
105831841|NCT01911429|365040921|FG000|Overall Study|Accidental randomization|0|||
105831842|NCT01911429|365040922|FG001|Overall Study|Accidental randomization|0|||
105831843|NCT01911429|365040923|FG002|Overall Study|Accidental randomization|1|||
105831844|NCT01911429|365040921|FG000|Overall Study|subject left study|1|||
105831845|NCT01911429|365040922|FG001|Overall Study|subject left study|0|||
105831846|NCT01911429|365040923|FG002|Overall Study|subject left study|0|||
105831847|NCT00413049|365040927|FG000|Overall Study|Adverse Event|10|||
105831848|NCT00413049|365040928|FG001|Overall Study|Adverse Event|8|||
105831849|NCT00413049|365040927|FG000|Overall Study|Withdrawal by Subject|7|||
105831850|NCT00413049|365040928|FG001|Overall Study|Withdrawal by Subject|5|||
105831851|NCT00413049|365040927|FG000|Overall Study|Lost to Follow-up|2|||
105831852|NCT00413049|365040928|FG001|Overall Study|Lost to Follow-up|3|||
105831853|NCT00413049|365040927|FG000|Overall Study|Protocol Violation|3|||
105831854|NCT00413049|365040928|FG001|Overall Study|Protocol Violation|1|||
105831855|NCT00413049|365040927|FG000|Overall Study|Subject no longer requires study drug|0|||
105831856|NCT00413049|365040928|FG001|Overall Study|Subject no longer requires study drug|1|||
105831857|NCT00413049|365040927|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105831858|NCT00413049|365040928|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105831859|NCT00413049|365040927|FG000|Overall Study|Lack of Efficacy|1|||
105831860|NCT00413049|365040928|FG001|Overall Study|Lack of Efficacy|0|||
105831861|NCT01460628|365040929|FG000|Overall Study|Adverse Event|3|||
105831862|NCT01460628|365040929|FG000|Overall Study|Withdrawal by Subject|2|||
105831863|NCT02587143|365040930|FG000|Overall Study|Adverse Event|1|||
105831864|NCT02587143|365040931|FG001|Overall Study|Adverse Event|0|||
105831865|NCT01664039|365040933|FG000|Overall Study|Adverse Event|3|||
105831866|NCT01664039|365040934|FG001|Overall Study|Adverse Event|4|||
105831867|NCT01664039|365040933|FG000|Overall Study|Lost to Follow-up|1|||
105831868|NCT01664039|365040934|FG001|Overall Study|Lost to Follow-up|1|||
105831869|NCT01664039|365040933|FG000|Overall Study|Withdrawal by Subject|1|||
105831870|NCT01664039|365040934|FG001|Overall Study|Withdrawal by Subject|3|||
105831871|NCT01664039|365040933|FG000|Overall Study|Noncompliance|1|||
105831872|NCT01664039|365040934|FG001|Overall Study|Noncompliance|1|||
105831873|NCT03314857|365040935|FG000|Overall Study|Death|4|||
105831874|NCT03314857|365040935|FG000|Overall Study|Physician Decision|1|||
105831875|NCT02167594|365040937|FG000|Overall Study|Withdrawal by Subject|2|||
105831876|NCT02167594|365040938|FG001|Overall Study|Withdrawal by Subject|0|||
105831877|NCT02167594|365040939|FG002|Overall Study|Withdrawal by Subject|0|||
105831878|NCT02167594|365040937|FG000|Overall Study|Death|0|||
105831879|NCT02167594|365040938|FG001|Overall Study|Death|1|||
105831880|NCT02167594|365040939|FG002|Overall Study|Death|0|||
105831881|NCT04281472|365040947|FG000|Stage A|Lack of Efficacy|8|||
105831882|NCT04281472|365040948|FG001|Stage A|Lack of Efficacy|0|||
105831883|NCT04281472|365040949|FG002|Stage A|Lack of Efficacy|0|||
105831884|NCT04281472|365040947|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
105831885|NCT04281472|365040948|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
105831886|NCT04281472|365040949|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
105831887|NCT04281472|365040947|FG000|Stage A|Adverse Event|20|||
105831888|NCT04281472|365040948|FG001|Stage A|Adverse Event|0|||
105831889|NCT04281472|365040949|FG002|Stage A|Adverse Event|0|||
105831890|NCT04281472|365040947|FG000|Stage A|Death|1|||
105831891|NCT04281472|365040948|FG001|Stage A|Death|0|||
105831892|NCT04281472|365040949|FG002|Stage A|Death|0|||
105831893|NCT04281472|365040947|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
105831894|NCT04281472|365040948|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
105831895|NCT04281472|365040949|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
105309058|NCT01059539|363128880|FG000|Overall Study|Withdrawal of Consent|80|||
105309059|NCT01059539|363128880|FG000|Overall Study|Lost to Follow-up|42|||
105309060|NCT01059539|363128880|FG000|Overall Study|Reason Not Specified|2|||
105309061|NCT00537303|363128881|FG000|Overall Study|Adverse Event|1|||
105831896|NCT04281472|365040947|FG000|Stage A|Lost to Follow-up|2|||
105831897|NCT04281472|365040948|FG001|Stage A|Lost to Follow-up|0|||
105831898|NCT04281472|365040949|FG002|Stage A|Lost to Follow-up|0|||
105831899|NCT04281472|365040947|FG000|Stage A|Non-compliance with study drug|1|||
105831900|NCT04281472|365040948|FG001|Stage A|Non-compliance with study drug|0|||
105831901|NCT04281472|365040949|FG002|Stage A|Non-compliance with study drug|0|||
105831902|NCT04281472|365040947|FG000|Stage A|Physician Decision|1|||
105831903|NCT04281472|365040948|FG001|Stage A|Physician Decision|0|||
105831904|NCT04281472|365040949|FG002|Stage A|Physician Decision|0|||
105309062|NCT00537303|363128882|FG001|Overall Study|Adverse Event|4|||
105309063|NCT00537303|363128881|FG000|Overall Study|Lack of Efficacy|6|||
105309064|NCT00537303|363128882|FG001|Overall Study|Lack of Efficacy|7|||
105831905|NCT04281472|365040947|FG000|Stage A|Prohibited medications|2|||
105831906|NCT04281472|365040948|FG001|Stage A|Prohibited medications|0|||
105831907|NCT04281472|365040949|FG002|Stage A|Prohibited medications|0|||
105831908|NCT04281472|365040947|FG000|Stage A|Withdrawal by Subject|11|||
105831909|NCT04281472|365040948|FG001|Stage A|Withdrawal by Subject|0|||
105831910|NCT04281472|365040949|FG002|Stage A|Withdrawal by Subject|0|||
105831911|NCT04281472|365040947|FG000|Stage A|Other|5|||
105831912|NCT04281472|365040948|FG001|Stage A|Other|0|||
105831913|NCT04281472|365040949|FG002|Stage A|Other|0|||
105831914|NCT04281472|365040947|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
105831915|NCT04281472|365040948|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
105831916|NCT04281472|365040949|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
105831917|NCT04281472|365040947|FG000|Stage B|Adverse Event|0|||
105831918|NCT04281472|365040948|FG001|Stage B|Adverse Event|3|||
105831919|NCT04281472|365040949|FG002|Stage B|Adverse Event|0|||
105831920|NCT04281472|365040947|FG000|Stage B|Death|0|||
105831921|NCT04281472|365040948|FG001|Stage B|Death|0|||
105831922|NCT04281472|365040949|FG002|Stage B|Death|1|||
105831923|NCT04281472|365040947|FG000|Stage B|Lack of Efficacy|0|||
105831924|NCT04281472|365040948|FG001|Stage B|Lack of Efficacy|0|||
105831925|NCT04281472|365040949|FG002|Stage B|Lack of Efficacy|1|||
105831926|NCT04281472|365040947|FG000|Stage B|Lost to Follow-up|0|||
105831927|NCT04281472|365040948|FG001|Stage B|Lost to Follow-up|0|||
105831928|NCT04281472|365040949|FG002|Stage B|Lost to Follow-up|2|||
105831929|NCT04281472|365040947|FG000|Stage B|Prohibited medications|0|||
105831930|NCT04281472|365040948|FG001|Stage B|Prohibited medications|2|||
105831931|NCT04281472|365040949|FG002|Stage B|Prohibited medications|1|||
105831932|NCT04281472|365040947|FG000|Stage B|Protocol Violation|0|||
105831933|NCT04281472|365040948|FG001|Stage B|Protocol Violation|1|||
105831934|NCT04281472|365040949|FG002|Stage B|Protocol Violation|1|||
105831935|NCT04281472|365040947|FG000|Stage B|Sponsor decision|0|||
105831936|NCT04281472|365040948|FG001|Stage B|Sponsor decision|0|||
105831937|NCT04281472|365040949|FG002|Stage B|Sponsor decision|1|||
105831938|NCT04281472|365040947|FG000|Stage B|Withdrawal by Subject|0|||
105831939|NCT04281472|365040948|FG001|Stage B|Withdrawal by Subject|3|||
105831940|NCT04281472|365040949|FG002|Stage B|Withdrawal by Subject|3|||
105831941|NCT04281472|365040947|FG000|Stage B|Other|0|||
105831942|NCT04281472|365040948|FG001|Stage B|Other|3|||
105831943|NCT04281472|365040949|FG002|Stage B|Other|0|||
105831944|NCT05278858|365040950|FG000|Overall Study|Withdrawal by Subject|1|||
105831945|NCT02640235|365040951|FG000|Overall Study|Withdrawal by Subject|7|||
105309065|NCT00537303|363128881|FG000|Overall Study|Protocol Violation|8|||
105309066|NCT00537303|363128882|FG001|Overall Study|Protocol Violation|4|||
105309067|NCT00537303|363128881|FG000|Overall Study|Withdrawal criteria|3|||
105309068|NCT00537303|363128882|FG001|Overall Study|Withdrawal criteria|3|||
105309069|NCT00537303|363128881|FG000|Overall Study|Unclassified|8|||
105309070|NCT00537303|363128882|FG001|Overall Study|Unclassified|7|||
105309071|NCT02085135|363128883|FG000|Overall Study|Adverse Event|4|||
105309072|NCT02085135|363128884|FG001|Overall Study|Adverse Event|7|||
105309073|NCT02085135|363128883|FG000|Overall Study|Lost to Follow-up|2|||
105309074|NCT02085135|363128884|FG001|Overall Study|Lost to Follow-up|2|||
105309075|NCT02085135|363128883|FG000|Overall Study|Withdrawal by Subject|3|||
105309076|NCT02085135|363128884|FG001|Overall Study|Withdrawal by Subject|0|||
105309077|NCT02085135|363128883|FG000|Overall Study|Lack of Efficacy|2|||
105309078|NCT02085135|363128884|FG001|Overall Study|Lack of Efficacy|0|||
105309079|NCT03317834|363128885|FG000|Overall Study|Death|2|||
105309080|NCT03317834|363128885|FG000|Overall Study|Device Revision|5|||
105309081|NCT03317834|363128885|FG000|Overall Study|Withdrawal by Subject|13|||
105309082|NCT03317834|363128885|FG000|Overall Study|Lost to Follow-up|13|||
105309083|NCT03839823|363128886|FG000|Overall Study|Adverse Event|8|||
105309084|NCT03839823|363128887|FG001|Overall Study|Adverse Event|4|||
105309085|NCT03839823|363128886|FG000|Overall Study|Death|1|||
105309086|NCT03839823|363128887|FG001|Overall Study|Death|0|||
105309087|NCT03839823|363128886|FG000|Overall Study|Physician Decision|1|||
105309088|NCT03839823|363128887|FG001|Overall Study|Physician Decision|5|||
105309089|NCT03839823|363128886|FG000|Overall Study|Progressive Disease (PD)|65|||
105309090|NCT03839823|363128887|FG001|Overall Study|Progressive Disease (PD)|65|||
105309091|NCT03839823|363128886|FG000|Overall Study|Subject Decision|2|||
105309092|NCT03839823|363128887|FG001|Overall Study|Subject Decision|9|||
105309093|NCT03839823|363128886|FG000|Overall Study|Not Treated|0|||
105309094|NCT03839823|363128887|FG001|Overall Study|Not Treated|10|||
105309095|NCT01739348|363128890|FG000|Part I (Base Study)|Adverse Event|41|||
105309096|NCT01739348|363128891|FG001|Part I (Base Study)|Adverse Event|52|||
105309097|NCT01739348|363128892|FG002|Part I (Base Study)|Adverse Event|8|||
105309098|NCT01739348|363128893|FG003|Part I (Base Study)|Adverse Event|33|||
105309099|NCT01739348|363128890|FG000|Part I (Base Study)|Death|10|||
105309100|NCT01739348|363128891|FG001|Part I (Base Study)|Death|7|||
105309101|NCT01739348|363128892|FG002|Part I (Base Study)|Death|2|||
105309102|NCT01739348|363128893|FG003|Part I (Base Study)|Death|8|||
105831946|NCT02640235|365040952|FG001|Overall Study|Withdrawal by Subject|6|||
105831947|NCT02640235|365040951|FG000|Overall Study|Lost to Follow-up|4|||
105831948|NCT02640235|365040952|FG001|Overall Study|Lost to Follow-up|3|||
105831949|NCT02640235|365040951|FG000|Overall Study|Death|2|||
105831950|NCT02640235|365040952|FG001|Overall Study|Death|3|||
105831951|NCT02640235|365040951|FG000|Overall Study|Other|1|||
105831952|NCT02640235|365040952|FG001|Overall Study|Other|2|||
105831953|NCT00152451|365040953|FG000|Overall Study|Adverse Event|4|||
105831954|NCT04697173|365040956|FG000|Overall Study|Withdrawal by Subject|34|||
105831955|NCT04697173|365040957|FG001|Overall Study|Withdrawal by Subject|38|||
105831956|NCT04608448|365040958|FG000|Overall Study|Withdrawal by Subject|1|||
105831957|NCT04608448|365040958|FG000|Overall Study|Adverse Event|1|||
105831958|NCT00674128|365040961|FG000|Overall Study|Withdrawal by Subject|25|||
105831959|NCT00674128|365040962|FG001|Overall Study|Withdrawal by Subject|23|||
105831960|NCT05004649|365040971|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
105831961|NCT05004649|365040971|FG000|Overall Study|Lost to Follow-up|1|||
105831962|NCT05004649|365040971|FG000|Overall Study|Withdrawal by Subject|2|||
105309103|NCT01739348|363128890|FG000|Part I (Base Study)|Lack of Efficacy|3|||
105831963|NCT05004649|365040971|FG000|Overall Study|COVID-19|1|||
105831964|NCT03504085|365040973|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
105831965|NCT03504085|365040974|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
105831966|NCT03504085|365040973|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
105831967|NCT03504085|365040974|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
105831968|NCT02761915|365040975|FG000|Overall Study|Death|3|||
105831969|NCT02761915|365040976|FG001|Overall Study|Death|1|||
105831970|NCT02761915|365040977|FG002|Overall Study|Death|1|||
105831971|NCT02761915|365040978|FG003|Overall Study|Death|1|||
105831972|NCT02761915|365040979|FG004|Overall Study|Death|0|||
105831973|NCT02761915|365040980|FG005|Overall Study|Death|1|||
105831974|NCT02761915|365040975|FG000|Overall Study|Withdrawal by Subject|1|||
105831975|NCT02761915|365040976|FG001|Overall Study|Withdrawal by Subject|0|||
105831976|NCT02761915|365040977|FG002|Overall Study|Withdrawal by Subject|0|||
105831977|NCT02761915|365040978|FG003|Overall Study|Withdrawal by Subject|0|||
105831978|NCT02761915|365040979|FG004|Overall Study|Withdrawal by Subject|1|||
105831979|NCT02761915|365040980|FG005|Overall Study|Withdrawal by Subject|2|||
105831980|NCT02761915|365040975|FG000|Overall Study|Disease Progression|0|||
105831981|NCT02761915|365040976|FG001|Overall Study|Disease Progression|0|||
105831982|NCT02761915|365040977|FG002|Overall Study|Disease Progression|0|||
105831983|NCT02761915|365040978|FG003|Overall Study|Disease Progression|2|||
105831984|NCT02761915|365040979|FG004|Overall Study|Disease Progression|2|||
105831985|NCT02761915|365040980|FG005|Overall Study|Disease Progression|2|||
105831986|NCT01617096|365040992|FG000|Overall Study|Withdrawal by Subject|96|||
105831987|NCT01617096|365040993|FG001|Overall Study|Withdrawal by Subject|81|||
105831988|NCT01617096|365040992|FG000|Overall Study|Lost to Follow-up|37|||
105831989|NCT01617096|365040993|FG001|Overall Study|Lost to Follow-up|32|||
105831990|NCT01617096|365040992|FG000|Overall Study|Physician Decision|10|||
105831991|NCT01617096|365040993|FG001|Overall Study|Physician Decision|18|||
105831992|NCT01617096|365040992|FG000|Overall Study|Death|4|||
105831993|NCT01617096|365040993|FG001|Overall Study|Death|3|||
105831994|NCT01617096|365040992|FG000|Overall Study|Other|1|||
105831995|NCT01617096|365040993|FG001|Overall Study|Other|3|||
105831996|NCT04473326|365040994|FG000|Overall Study|Death|0|||
105831997|NCT04473326|365040995|FG001|Overall Study|Death|1|||
105831998|NCT04473326|365040994|FG000|Overall Study|Withdrawal by Subject|1|||
105831999|NCT04473326|365040995|FG001|Overall Study|Withdrawal by Subject|2|||
105832000|NCT02229084|365040996|FG000|Overall Study|Adverse Event|1|||
105832001|NCT02229084|365040997|FG001|Overall Study|Adverse Event|0|||
105832002|NCT02229084|365040998|FG002|Overall Study|Adverse Event|0|||
105832003|NCT02229084|365040999|FG003|Overall Study|Adverse Event|0|||
105832004|NCT02229084|365041000|FG004|Overall Study|Adverse Event|0|||
105832005|NCT02229084|365041001|FG005|Overall Study|Adverse Event|0|||
105832006|NCT02229084|365041002|FG006|Overall Study|Adverse Event|0|||
105832007|NCT02229084|365040996|FG000|Overall Study|Lost to Follow-up|0|||
105832008|NCT02229084|365040997|FG001|Overall Study|Lost to Follow-up|0|||
105832009|NCT02229084|365040998|FG002|Overall Study|Lost to Follow-up|1|||
105309104|NCT01739348|363128891|FG001|Part I (Base Study)|Lack of Efficacy|8|||
105832010|NCT02229084|365040999|FG003|Overall Study|Lost to Follow-up|1|||
105832011|NCT02229084|365041000|FG004|Overall Study|Lost to Follow-up|0|||
105832012|NCT02229084|365041001|FG005|Overall Study|Lost to Follow-up|0|||
105309105|NCT01739348|363128892|FG002|Part I (Base Study)|Lack of Efficacy|0|||
105309106|NCT01739348|363128893|FG003|Part I (Base Study)|Lack of Efficacy|7|||
105832013|NCT02229084|365041002|FG006|Overall Study|Lost to Follow-up|1|||
105832014|NCT02229084|365040996|FG000|Overall Study|Physician Decision|0|||
105832015|NCT02229084|365040997|FG001|Overall Study|Physician Decision|0|||
105832016|NCT02229084|365040998|FG002|Overall Study|Physician Decision|0|||
105832017|NCT02229084|365040999|FG003|Overall Study|Physician Decision|1|||
105309107|NCT01739348|363128890|FG000|Part I (Base Study)|Lost to Follow-up|4|||
105309108|NCT01739348|363128891|FG001|Part I (Base Study)|Lost to Follow-up|2|||
105309109|NCT01739348|363128892|FG002|Part I (Base Study)|Lost to Follow-up|4|||
105832018|NCT02229084|365041000|FG004|Overall Study|Physician Decision|3|||
105832019|NCT02229084|365041001|FG005|Overall Study|Physician Decision|0|||
105832020|NCT02229084|365041002|FG006|Overall Study|Physician Decision|1|||
105832021|NCT02229084|365040996|FG000|Overall Study|Withdrawal by Subject|0|||
105309110|NCT01739348|363128893|FG003|Part I (Base Study)|Lost to Follow-up|4|||
105309111|NCT01739348|363128890|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
105309112|NCT01739348|363128891|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
105309113|NCT01739348|363128892|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
105309114|NCT01739348|363128893|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
105309115|NCT01739348|363128890|FG000|Part I (Base Study)|Physician Decision|10|||
105309116|NCT01739348|363128891|FG001|Part I (Base Study)|Physician Decision|7|||
105832022|NCT02229084|365040997|FG001|Overall Study|Withdrawal by Subject|0|||
105832023|NCT02229084|365040998|FG002|Overall Study|Withdrawal by Subject|1|||
105832024|NCT02229084|365040999|FG003|Overall Study|Withdrawal by Subject|0|||
105832025|NCT02229084|365041000|FG004|Overall Study|Withdrawal by Subject|1|||
105832026|NCT02229084|365041001|FG005|Overall Study|Withdrawal by Subject|1|||
105832027|NCT02229084|365041002|FG006|Overall Study|Withdrawal by Subject|1|||
105832028|NCT02229084|365040996|FG000|Overall Study|Death|0|||
105832029|NCT02229084|365040997|FG001|Overall Study|Death|0|||
105832030|NCT02229084|365040998|FG002|Overall Study|Death|0|||
105832031|NCT02229084|365040999|FG003|Overall Study|Death|0|||
105832032|NCT02229084|365041000|FG004|Overall Study|Death|0|||
105309117|NCT01739348|363128892|FG002|Part I (Base Study)|Physician Decision|1|||
105309118|NCT01739348|363128893|FG003|Part I (Base Study)|Physician Decision|4|||
105309119|NCT01739348|363128890|FG000|Part I (Base Study)|Protocol Violation|2|||
105309120|NCT01739348|363128891|FG001|Part I (Base Study)|Protocol Violation|0|||
105309121|NCT01739348|363128892|FG002|Part I (Base Study)|Protocol Violation|1|||
105309122|NCT01739348|363128893|FG003|Part I (Base Study)|Protocol Violation|2|||
105832033|NCT02229084|365041001|FG005|Overall Study|Death|0|||
105832034|NCT02229084|365041002|FG006|Overall Study|Death|1|||
105309123|NCT01739348|363128890|FG000|Part I (Base Study)|Screen Failure|2|||
105309124|NCT01739348|363128891|FG001|Part I (Base Study)|Screen Failure|0|||
105309125|NCT01739348|363128892|FG002|Part I (Base Study)|Screen Failure|0|||
105309126|NCT01739348|363128893|FG003|Part I (Base Study)|Screen Failure|0|||
105309127|NCT01739348|363128890|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
105309128|NCT01739348|363128891|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
105309129|NCT01739348|363128892|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
105309130|NCT01739348|363128893|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
105309131|NCT01739348|363128890|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
105309132|NCT01739348|363128891|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
105309133|NCT01739348|363128892|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
105309134|NCT01739348|363128893|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
105309135|NCT01739348|363128890|FG000|Part I (Base Study)|Participant Moved|4|||
105309136|NCT01739348|363128891|FG001|Part I (Base Study)|Participant Moved|3|||
105832035|NCT01344018|365041003|FG000|Overall Study|Death|22|||
105832036|NCT01344018|365041004|FG001|Overall Study|Death|25|||
105309137|NCT01739348|363128892|FG002|Part I (Base Study)|Participant Moved|1|||
105366777|NCT03585270|363350061|FG001|Overall Study|Lost to Follow-up|4|||
105366778|NCT03585270|363350060|FG000|Overall Study|Death|5|||
105366779|NCT03585270|363350061|FG001|Overall Study|Death|3|||
105366780|NCT03585270|363350060|FG000|Overall Study|Other reasons|2|||
105366781|NCT03585270|363350061|FG001|Overall Study|Other reasons|2|||
105366782|NCT03292016|363350062|FG000|Second Washout|Adverse Event|0|||
105366783|NCT03292016|363350063|FG001|Second Washout|Adverse Event|1|||
105366784|NCT03292016|363350064|FG002|Second Washout|Adverse Event|0|||
105366785|NCT03292016|363350065|FG003|Second Washout|Adverse Event|0|||
105366786|NCT03292016|363350066|FG004|Second Washout|Adverse Event|0|||
105366787|NCT03292016|363350067|FG005|Second Washout|Adverse Event|0|||
105366788|NCT00983372|363350068|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
105366789|NCT00983372|363350068|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
105366790|NCT00983372|363350068|FG000|Diltiazem ER Alone|Adverse Event|1|||
105366791|NCT03797898|363350072|FG000|Overall Study|Lost to Follow-up|60|||
105366792|NCT03797898|363350073|FG001|Overall Study|Lost to Follow-up|69|||
105366793|NCT03797898|363350072|FG000|Overall Study|Withdrawal by Subject|9|||
105366794|NCT03797898|363350073|FG001|Overall Study|Withdrawal by Subject|7|||
105575840|NCT04467840|364108339|FG000|Overall Study|Adverse Event|2|||
105309138|NCT01739348|363128893|FG003|Part I (Base Study)|Participant Moved|7|||
105309139|NCT01739348|363128890|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
105309140|NCT01739348|363128891|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
105309141|NCT01739348|363128892|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
105832037|NCT01344018|365041003|FG000|Overall Study|Lost to Follow-up|4|||
105832038|NCT01344018|365041004|FG001|Overall Study|Lost to Follow-up|7|||
105309142|NCT01739348|363128893|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
105309143|NCT01739348|363128890|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
105309144|NCT01739348|363128891|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
105366795|NCT03797898|363350072|FG000|Overall Study|Became ineligible|5|||
105366796|NCT03797898|363350073|FG001|Overall Study|Became ineligible|2|||
105575841|NCT04467840|364108340|FG001|Overall Study|Adverse Event|0|||
105832039|NCT02096705|365041011|FG000|Treatment|Adverse Event|6|||
105832040|NCT02096705|365041012|FG001|Treatment|Adverse Event|3|||
105832041|NCT02096705|365041011|FG000|Treatment|Subject request to discontinue treatment|1|||
105832042|NCT02096705|365041012|FG001|Treatment|Subject request to discontinue treatment|1|||
105832043|NCT02096705|365041011|FG000|Treatment|Withdrawal by Subject|1|||
105832044|NCT02096705|365041012|FG001|Treatment|Withdrawal by Subject|0|||
105832045|NCT02096705|365041011|FG000|Treatment|Other|1|||
105832046|NCT02096705|365041012|FG001|Treatment|Other|1|||
105832047|NCT02096705|365041011|FG000|Follow-up|Withdrawal by Subject|1|||
105832048|NCT02096705|365041012|FG001|Follow-up|Withdrawal by Subject|0|||
105832049|NCT02096705|365041011|FG000|Follow-up|Adverse Event|2|||
105832050|NCT02096705|365041012|FG001|Follow-up|Adverse Event|2|||
105832051|NCT02096705|365041011|FG000|Follow-up|Subjects not reporting status|1|||
105832052|NCT02096705|365041012|FG001|Follow-up|Subjects not reporting status|2|||
105832053|NCT01097694|365041013|FG000|Overall Study|Adverse Event|5|||
105832054|NCT01097694|365041014|FG001|Overall Study|Adverse Event|0|||
105832055|NCT01097694|365041013|FG000|Overall Study|Lost to Follow-up|0|||
105832056|NCT01097694|365041014|FG001|Overall Study|Lost to Follow-up|3|||
105832057|NCT01097694|365041013|FG000|Overall Study|Withdrawal by Subject|3|||
105832058|NCT01097694|365041014|FG001|Overall Study|Withdrawal by Subject|1|||
105832059|NCT02858037|365041017|FG000|Overall Study|Death|1|||
105832060|NCT02858037|365041017|FG000|Overall Study|Withdrawal by Subject|18|||
105832061|NCT02858037|365041017|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
105832062|NCT02858037|365041017|FG000|Overall Study|Lost to Follow-up|3|||
105832063|NCT02858037|365041017|FG000|Overall Study|Other|4|||
105832064|NCT01670097|365041018|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
105832065|NCT01670097|365041019|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
105832066|NCT01670097|365041018|FG000|Overall Study|Study burden|1|||
105832067|NCT01670097|365041019|FG001|Overall Study|Study burden|0|||
105832068|NCT01670097|365041018|FG000|Overall Study|COPD exacerbation|0|||
105832069|NCT01670097|365041019|FG001|Overall Study|COPD exacerbation|1|||
105832070|NCT01670097|365041018|FG000|Overall Study|Neutropenia|0|||
105832071|NCT01670097|365041019|FG001|Overall Study|Neutropenia|1|||
105832072|NCT01670097|365041018|FG000|Overall Study|Clinical deterioration|0|||
105832073|NCT01670097|365041019|FG001|Overall Study|Clinical deterioration|1|||
105832074|NCT01670097|365041018|FG000|Overall Study|Disease progression|0|||
105832075|NCT01670097|365041019|FG001|Overall Study|Disease progression|1|||
105832076|NCT00697827|365041020|FG000|Overall Study|enrolled but not treated|2|||
105832077|NCT00697827|365041021|FG001|Overall Study|enrolled but not treated|1|||
105832078|NCT02166606|365041026|FG000|Overall Study|Adverse Event|3|||
105832079|NCT02166606|365041026|FG000|Overall Study|Death|31|||
105832080|NCT02166606|365041026|FG000|Overall Study|Protocol Violation|7|||
105832081|NCT02166606|365041026|FG000|Overall Study|Lost to Follow-up|30|||
105832082|NCT02166606|365041026|FG000|Overall Study|Withdrawal by Subject|1|||
105832083|NCT02166606|365041026|FG000|Overall Study|Physician Decision|1|||
105832084|NCT02166606|365041026|FG000|Overall Study|Device upgrade|1|||
105832085|NCT02166606|365041026|FG000|Overall Study|Enrolled after End of Enrollment|4|||
105309145|NCT01739348|363128892|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
105309146|NCT01739348|363128893|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
105309147|NCT01739348|363128890|FG000|Part II (Extension Study)|Adverse Event|10|||
105309148|NCT01739348|363128891|FG001|Part II (Extension Study)|Adverse Event|11|||
105309149|NCT01739348|363128892|FG002|Part II (Extension Study)|Adverse Event|7|||
105309150|NCT01739348|363128893|FG003|Part II (Extension Study)|Adverse Event|26|||
105309151|NCT01739348|363128890|FG000|Part II (Extension Study)|Death|3|||
105309152|NCT01739348|363128891|FG001|Part II (Extension Study)|Death|3|||
105309153|NCT01739348|363128892|FG002|Part II (Extension Study)|Death|2|||
105309154|NCT01739348|363128893|FG003|Part II (Extension Study)|Death|6|||
105309155|NCT01739348|363128890|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
105489426|NCT02310321|363804051|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
105489427|NCT02310321|363804049|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
105489428|NCT02310321|363804050|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
105489429|NCT02310321|363804051|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
105489430|NCT02310321|363804049|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
105489431|NCT02310321|363804050|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
105489432|NCT02310321|363804051|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
105489433|NCT02310321|363804049|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
105832086|NCT02311894|365041029|FG000|Overall Study|Discontinued in error|1|||
105309156|NCT01739348|363128891|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
105309157|NCT01739348|363128892|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
105309158|NCT01739348|363128893|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
105309159|NCT01739348|363128890|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
105309160|NCT01739348|363128891|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
105832087|NCT02311894|365041029|FG000|Overall Study|Lost to Follow-up|1|||
105832088|NCT02311894|365041029|FG000|Overall Study|Adverse Event|1|||
105832089|NCT02311894|365041029|FG000|Overall Study|Withdrawal by Subject|1|||
105832090|NCT02472639|365041030|FG000|Overall Study|Physician Decision|4|||
105832091|NCT02472639|365041031|FG001|Overall Study|Physician Decision|3|||
105832092|NCT01726803|365041032|FG000|Overall Study|Lost to Follow-up|6|||
105489434|NCT02310321|363804050|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
105489435|NCT02310321|363804051|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
105489436|NCT02310321|363804049|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
105489437|NCT02310321|363804050|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
105489438|NCT02310321|363804051|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
105489439|NCT02310321|363804049|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
105489440|NCT02310321|363804050|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
105489441|NCT02310321|363804051|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|16|||
105489442|NCT02310321|363804049|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
105832093|NCT01726803|365041033|FG001|Overall Study|Lost to Follow-up|1|||
105832094|NCT01726803|365041032|FG000|Overall Study|Withdrawal by Subject|1|||
105832095|NCT01726803|365041033|FG001|Overall Study|Withdrawal by Subject|0|||
105832096|NCT01751087|365041035|FG000|Overall Study|Withdrawal by Subject|1|||
105832097|NCT01751087|365041036|FG001|Overall Study|Withdrawal by Subject|0|||
105832098|NCT01751087|365041037|FG002|Overall Study|Withdrawal by Subject|0|||
105832099|NCT01751087|365041035|FG000|Overall Study|Physician Decision|0|||
105832100|NCT01751087|365041036|FG001|Overall Study|Physician Decision|0|||
105832101|NCT01751087|365041037|FG002|Overall Study|Physician Decision|1|||
105832102|NCT00724958|365041046|FG000|Overall Study|Adverse Event|28|||
105832103|NCT00724958|365041046|FG000|Overall Study|Loss of Response|40|||
105832104|NCT00724958|365041046|FG000|Overall Study|No Response|18|||
105832105|NCT00724958|365041046|FG000|Overall Study|Remission|7|||
105832106|NCT00724958|365041046|FG000|Overall Study|Other Reason|76|||
105832107|NCT00724958|365041046|FG000|Overall Study|No documentation for end of therapy|13|||
105832108|NCT03247686|365042658|FG000|Overall Study|Withdrawal by Subject|1|||
105832109|NCT03247686|365042659|FG001|Overall Study|Withdrawal by Subject|2|||
105832110|NCT01894230|365042660|FG000|Overall Study|Lost to Follow-up|2|||
105832111|NCT01894230|365042661|FG001|Overall Study|Lost to Follow-up|2|||
105832112|NCT01894230|365042660|FG000|Overall Study|Withdrawal by Subject|4|||
105832113|NCT01894230|365042661|FG001|Overall Study|Withdrawal by Subject|4|||
105832114|NCT01894230|365042660|FG000|Overall Study|Non-adherent|0|||
105832115|NCT01894230|365042661|FG001|Overall Study|Non-adherent|1|||
105832116|NCT01894230|365042660|FG000|Overall Study|Death|1|||
105832117|NCT01894230|365042661|FG001|Overall Study|Death|0|||
105832118|NCT01098851|365042669|FG000|Overall Study|Equipment failure|1|||
105832119|NCT01098851|365042670|FG001|Overall Study|Equipment failure|0|||
105832120|NCT02435433|365042671|FG000|Overall Study|Withdrawal by Subject|2|||
105832121|NCT02435433|365042672|FG001|Overall Study|Withdrawal by Subject|3|||
105832122|NCT02435433|365042673|FG002|Overall Study|Withdrawal by Subject|1|||
105832123|NCT02435433|365042674|FG003|Overall Study|Withdrawal by Subject|0|||
105832124|NCT02435433|365042675|FG004|Overall Study|Withdrawal by Subject|0|||
105832125|NCT02435433|365042671|FG000|Overall Study|Lost to Follow-up|2|||
105832126|NCT02435433|365042672|FG001|Overall Study|Lost to Follow-up|2|||
105832127|NCT02435433|365042673|FG002|Overall Study|Lost to Follow-up|4|||
105832128|NCT02435433|365042674|FG003|Overall Study|Lost to Follow-up|1|||
105832129|NCT02435433|365042675|FG004|Overall Study|Lost to Follow-up|0|||
105832130|NCT02218541|365042676|FG000|Overall Study|Lost to Follow-up|2|||
105832131|NCT02218541|365042677|FG001|Overall Study|Lost to Follow-up|1|||
105832132|NCT02218541|365042676|FG000|Overall Study|Implant Failure|4|||
105832133|NCT02218541|365042677|FG001|Overall Study|Implant Failure|1|||
105832134|NCT00544167|365042678|FG000|Overall Study|Adverse Event|21|||
105832135|NCT00544167|365042678|FG000|Overall Study|Physician Decision|8|||
105832136|NCT01944722|365042682|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
105832137|NCT01944722|365042682|FG000|Overall Study|Specimen Shipping Issues|34|||
105366797|NCT01791595|363350074|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
105366798|NCT01791595|363350075|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
105366799|NCT01791595|363350076|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
105366800|NCT01791595|363350077|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
105366801|NCT01791595|363350078|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
105366802|NCT01791595|363350079|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
105832138|NCT01944722|365042682|FG000|Overall Study|Improper Storage/Transport|5|||
105832139|NCT01944722|365042682|FG000|Overall Study|Insufficient Volume for Test|1|||
105832140|NCT01944722|365042682|FG000|Overall Study|Missing Specimens|3|||
105832141|NCT01944722|365042682|FG000|Overall Study|Specimens Mislabeled|2|||
105832142|NCT01944722|365042682|FG000|Overall Study|Withdrawal by Subject|8|||
105832143|NCT01944722|365042682|FG000|Overall Study|NILM Subjects <30 years old|8106|||
105832144|NCT01944722|365042682|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
105832145|NCT01944722|365042682|FG000|Overall Study|>ASCUS Cytology|1122|||
105832146|NCT02340780|365042689|FG000|Overall Study|Ineligible|1|||
105832147|NCT01149057|365042690|FG000|Overall Study|Lack of Efficacy|16|||
105366803|NCT01791595|363350080|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
105366804|NCT01791595|363350074|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
105832148|NCT01149057|365042690|FG000|Overall Study|Adverse Event|13|||
105832149|NCT01149057|365042690|FG000|Overall Study|Withdrawal by Subject|9|||
105832150|NCT01149057|365042690|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
105832151|NCT01149057|365042690|FG000|Overall Study|B Cell Depletion|4|||
105832152|NCT01149057|365042690|FG000|Overall Study|Participant Non-Compliance|2|||
105309161|NCT01739348|363128892|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
105309162|NCT01739348|363128893|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
105309163|NCT01739348|363128890|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
105309164|NCT01739348|363128891|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
105309165|NCT01739348|363128892|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
105309166|NCT01739348|363128893|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
105309167|NCT01739348|363128890|FG000|Part II (Extension Study)|Physician Decision|7|||
105309168|NCT01739348|363128891|FG001|Part II (Extension Study)|Physician Decision|11|||
105309169|NCT01739348|363128892|FG002|Part II (Extension Study)|Physician Decision|6|||
105309170|NCT01739348|363128893|FG003|Part II (Extension Study)|Physician Decision|12|||
105309171|NCT01739348|363128890|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
105309172|NCT01739348|363128891|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
105309173|NCT01739348|363128892|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
105309174|NCT01739348|363128893|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
105309175|NCT01739348|363128890|FG000|Part II (Extension Study)|Participant Moved|3|||
105309176|NCT01739348|363128891|FG001|Part II (Extension Study)|Participant Moved|3|||
105366805|NCT01791595|363350075|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
105366806|NCT01791595|363350076|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
105366807|NCT01791595|363350077|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
105832153|NCT01149057|365042690|FG000|Overall Study|Lost to Follow-up|1|||
105832154|NCT01149057|365042690|FG000|Overall Study|High Parathyroid Hormone Value|1|||
105832155|NCT01149057|365042690|FG000|Overall Study|Other|6|||
105832156|NCT02654145|365042691|FG000|Overall Study|Lack of Efficacy|1|||
105832157|NCT02654145|365042691|FG000|Overall Study|Protocol Violation|1|||
105832158|NCT02654145|365042691|FG000|Overall Study|Withdrawal by Subject|5|||
105832159|NCT00009945|365042692|FG000|Overall Study|no follow up data|7|||
105832160|NCT00009945|365042693|FG001|Overall Study|no follow up data|5|||
105832161|NCT01943435|365042694|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
105366808|NCT01791595|363350078|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
105366809|NCT01791595|363350079|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
105366810|NCT01791595|363350080|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
105366811|NCT01791595|363350074|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
105366812|NCT01791595|363350075|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
105366813|NCT01791595|363350076|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
105366814|NCT01791595|363350077|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
105366815|NCT01791595|363350078|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
105366816|NCT01791595|363350079|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
105366817|NCT01791595|363350080|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
105366818|NCT01791595|363350074|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
105366819|NCT01791595|363350075|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
105366820|NCT01791595|363350076|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
105366821|NCT01791595|363350077|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
105366822|NCT01791595|363350078|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
105366823|NCT01791595|363350079|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
105366824|NCT01791595|363350080|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
105366825|NCT01791595|363350074|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
105366826|NCT01791595|363350075|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
105366827|NCT01791595|363350076|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
105366828|NCT01791595|363350077|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
105366829|NCT01791595|363350078|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
105366830|NCT01791595|363350079|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
105366831|NCT01791595|363350080|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
105366832|NCT01791595|363350074|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
105366833|NCT01791595|363350075|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
105366834|NCT01791595|363350076|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
105366835|NCT01791595|363350077|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
105366836|NCT01791595|363350078|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
105366837|NCT01791595|363350079|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
105366838|NCT01791595|363350080|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
105366839|NCT01791595|363350074|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
105366840|NCT01791595|363350075|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
105832162|NCT01943435|365042695|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
105832163|NCT01943435|365042696|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
105832164|NCT01943435|365042694|FG000|Intervention Period|Withdrawal by Subject|3|||
105832165|NCT01943435|365042695|FG001|Intervention Period|Withdrawal by Subject|3|||
105575842|NCT04467840|364108339|FG000|Overall Study|Lost to Follow-up|1|||
105832166|NCT01943435|365042696|FG002|Intervention Period|Withdrawal by Subject|4|||
105832167|NCT01943435|365042694|FG000|2 Month Follow up|Lost to Follow-up|2|||
105832168|NCT01943435|365042695|FG001|2 Month Follow up|Lost to Follow-up|3|||
105832169|NCT01943435|365042696|FG002|2 Month Follow up|Lost to Follow-up|0|||
105832170|NCT01943435|365042694|FG000|6 Month Follow up|Lost to Follow-up|12|||
105832171|NCT01943435|365042695|FG001|6 Month Follow up|Lost to Follow-up|7|||
105832172|NCT01943435|365042696|FG002|6 Month Follow up|Lost to Follow-up|15|||
105832173|NCT00295490|365042697|FG000|Overall Study|Protocol Violation|0|||
105832174|NCT00295490|365042698|FG001|Overall Study|Protocol Violation|0|||
105832175|NCT00295490|365042699|FG002|Overall Study|Protocol Violation|3|||
105832176|NCT00295490|365042700|FG003|Overall Study|Protocol Violation|3|||
105832177|NCT00295490|365042697|FG000|Overall Study|Withdrawal by Subject|0|||
105832178|NCT00295490|365042698|FG001|Overall Study|Withdrawal by Subject|2|||
105832179|NCT00295490|365042699|FG002|Overall Study|Withdrawal by Subject|0|||
105832180|NCT00295490|365042700|FG003|Overall Study|Withdrawal by Subject|1|||
105832181|NCT00295490|365042697|FG000|Overall Study|Lost to Follow-up|0|||
105832182|NCT00295490|365042698|FG001|Overall Study|Lost to Follow-up|0|||
105832183|NCT00295490|365042699|FG002|Overall Study|Lost to Follow-up|1|||
105832184|NCT00295490|365042700|FG003|Overall Study|Lost to Follow-up|0|||
105832185|NCT00295490|365042697|FG000|Overall Study|Adverse Event|1|||
105832186|NCT00295490|365042698|FG001|Overall Study|Adverse Event|0|||
105832187|NCT00295490|365042699|FG002|Overall Study|Adverse Event|0|||
105832188|NCT00295490|365042700|FG003|Overall Study|Adverse Event|0|||
105832189|NCT00295490|365042697|FG000|Overall Study|Other|0|||
105832190|NCT00295490|365042698|FG001|Overall Study|Other|2|||
105832191|NCT00295490|365042699|FG002|Overall Study|Other|0|||
105309177|NCT01739348|363128892|FG002|Part II (Extension Study)|Participant Moved|0|||
105309178|NCT01739348|363128893|FG003|Part II (Extension Study)|Participant Moved|3|||
105309179|NCT01739348|363128890|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
105309180|NCT01739348|363128891|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
105309181|NCT01739348|363128892|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
105309182|NCT01739348|363128893|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
105309183|NCT01739348|363128890|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
105309184|NCT01739348|363128891|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
105309185|NCT01739348|363128892|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
105309186|NCT01739348|363128893|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
105309187|NCT01447420|363128897|FG000|Overall Study|Adverse Event|2|||
105309188|NCT01447420|363128898|FG001|Overall Study|Adverse Event|4|||
105309189|NCT01447420|363128899|FG002|Overall Study|Adverse Event|2|||
105309190|NCT01447420|363128897|FG000|Overall Study|Protocol Violation|3|||
105309191|NCT01447420|363128898|FG001|Overall Study|Protocol Violation|3|||
105309192|NCT01447420|363128899|FG002|Overall Study|Protocol Violation|0|||
105309193|NCT01447420|363128897|FG000|Overall Study|Withdrawal by Subject|4|||
105309194|NCT01447420|363128898|FG001|Overall Study|Withdrawal by Subject|1|||
105309195|NCT01447420|363128899|FG002|Overall Study|Withdrawal by Subject|0|||
105309196|NCT01447420|363128897|FG000|Overall Study|Lack of Efficacy|1|||
105309197|NCT01447420|363128898|FG001|Overall Study|Lack of Efficacy|19|||
105309198|NCT01447420|363128899|FG002|Overall Study|Lack of Efficacy|8|||
105309199|NCT01777620|363128900|FG000|Overall Study|Subject Withdrawal|1|||
105309200|NCT01777620|363128901|FG001|Overall Study|Subject Withdrawal|0|||
105309201|NCT04516759|363128911|FG000|Overall Study|Withdrawal by Subject|1|||
105309202|NCT04516759|363128912|FG001|Overall Study|Withdrawal by Subject|1|||
105309203|NCT04516759|363128911|FG000|Overall Study|Other|0|||
105309204|NCT04516759|363128912|FG001|Overall Study|Other|1|||
105309205|NCT00936897|363128915|FG000|Overall Study|Withdrawal by Subject|9|||
105309206|NCT00936897|363128916|FG001|Overall Study|Withdrawal by Subject|19|||
105309207|NCT00936897|363128915|FG000|Overall Study|Adverse Event|4|||
105309208|NCT00936897|363128916|FG001|Overall Study|Adverse Event|13|||
105309209|NCT00936897|363128915|FG000|Overall Study|Other|3|||
105309210|NCT00936897|363128916|FG001|Overall Study|Other|9|||
105309211|NCT00936897|363128915|FG000|Overall Study|Lost to Follow-up|1|||
105309212|NCT00936897|363128916|FG001|Overall Study|Lost to Follow-up|10|||
105309213|NCT00936897|363128915|FG000|Overall Study|Administrative Decision|1|||
105309214|NCT00936897|363128916|FG001|Overall Study|Administrative Decision|2|||
105309215|NCT00936897|363128915|FG000|Overall Study|Protocol Violation|1|||
105309216|NCT00936897|363128916|FG001|Overall Study|Protocol Violation|1|||
105309217|NCT00936897|363128915|FG000|Overall Study|Ineligibility Determined|0|||
105309218|NCT00936897|363128916|FG001|Overall Study|Ineligibility Determined|3|||
105832192|NCT00295490|365042700|FG003|Overall Study|Other|1|||
105832193|NCT01597791|365042701|FG000|Overall Study|Physician Decision|2|||
105832194|NCT01597791|365042702|FG001|Overall Study|Physician Decision|1|||
105832195|NCT01597791|365042701|FG000|Overall Study|Cesarean Section|6|||
105832196|NCT01597791|365042702|FG001|Overall Study|Cesarean Section|7|||
105832197|NCT01597791|365042701|FG000|Overall Study|Subject withdrawal|0|||
105309219|NCT00936897|363128915|FG000|Overall Study|Noncompliance|0|||
105309220|NCT00936897|363128916|FG001|Overall Study|Noncompliance|2|||
105309221|NCT00936897|363128915|FG000|Overall Study|Death|0|||
105309222|NCT00936897|363128916|FG001|Overall Study|Death|1|||
105309223|NCT01283035|363128917|FG000|Overall Study|Subject later found ineligible|1|||
105309224|NCT03257865|363128920|FG000|Overall Study|Adverse Event|4|||
105309225|NCT03257865|363128921|FG001|Overall Study|Adverse Event|8|||
105309226|NCT03257865|363128920|FG000|Overall Study|Lack of Efficacy|1|||
105309227|NCT03257865|363128921|FG001|Overall Study|Lack of Efficacy|2|||
105309228|NCT03257865|363128920|FG000|Overall Study|Non-compliance with Study Drug|0|||
105309229|NCT03257865|363128921|FG001|Overall Study|Non-compliance with Study Drug|2|||
105309230|NCT03257865|363128920|FG000|Overall Study|Withdrawal by Subject|23|||
105309231|NCT03257865|363128921|FG001|Overall Study|Withdrawal by Subject|17|||
105309232|NCT03257865|363128920|FG000|Overall Study|Physician Decision|3|||
105309233|NCT03257865|363128921|FG001|Overall Study|Physician Decision|1|||
105309234|NCT03257865|363128920|FG000|Overall Study|Other|0|||
105309235|NCT03257865|363128921|FG001|Overall Study|Other|1|||
105309236|NCT03257865|363128920|FG000|Overall Study|Lost to Follow-up|4|||
105309237|NCT03257865|363128921|FG001|Overall Study|Lost to Follow-up|4|||
105309238|NCT02865460|363128925|FG000|Overall Study|Adverse Event|1|||
105309239|NCT02865460|363128926|FG001|Overall Study|Adverse Event|0|||
105309240|NCT02865460|363128925|FG000|Overall Study|Withdrawal by Subject|1|||
105309241|NCT02865460|363128926|FG001|Overall Study|Withdrawal by Subject|1|||
105309242|NCT02865460|363128925|FG000|Overall Study|Lost to Follow-up|7|||
105309243|NCT02865460|363128926|FG001|Overall Study|Lost to Follow-up|4|||
105309244|NCT02865460|363128925|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
105832198|NCT01597791|365042702|FG001|Overall Study|Subject withdrawal|1|||
105309245|NCT02865460|363128926|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
105309246|NCT04546724|363128931|FG000|Overall Study|Withdrawal by Subject|145|||
105309247|NCT04546724|363128932|FG001|Overall Study|Withdrawal by Subject|41|||
105309248|NCT04546724|363128931|FG000|Overall Study|Adverse Event|1|||
105309249|NCT04546724|363128932|FG001|Overall Study|Adverse Event|1|||
105309250|NCT04546724|363128931|FG000|Overall Study|Lost to Follow-up|186|||
105489443|NCT02310321|363804050|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
105489444|NCT02310321|363804051|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|3|||
105489445|NCT02310321|363804049|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
105309251|NCT04546724|363128932|FG001|Overall Study|Lost to Follow-up|63|||
105309252|NCT04546724|363128931|FG000|Overall Study|Physician Decision|8|||
105309253|NCT04546724|363128932|FG001|Overall Study|Physician Decision|2|||
105309254|NCT04546724|363128931|FG000|Overall Study|Death|2|||
105309255|NCT04546724|363128932|FG001|Overall Study|Death|1|||
105309256|NCT04546724|363128931|FG000|Overall Study|subject has been out of town|1|||
105309257|NCT04546724|363128932|FG001|Overall Study|subject has been out of town|0|||
105309258|NCT04546724|363128931|FG000|Overall Study|subject is incarcerated|2|||
105309259|NCT04546724|363128932|FG001|Overall Study|subject is incarcerated|0|||
105309260|NCT04546724|363128931|FG000|Overall Study|subject is relocating|12|||
105309261|NCT04546724|363128932|FG001|Overall Study|subject is relocating|4|||
105309262|NCT04546724|363128931|FG000|Overall Study|Subject in another study|1|||
105309263|NCT04546724|363128932|FG001|Overall Study|Subject in another study|1|||
105832199|NCT01597791|365042701|FG000|Overall Study|Protocol Violation|0|||
105832200|NCT01597791|365042702|FG001|Overall Study|Protocol Violation|1|||
105832201|NCT01155531|365042703|FG000|Overall Study|Adverse Event|0|||
105832202|NCT01155531|365042704|FG001|Overall Study|Adverse Event|0|||
105832203|NCT01155531|365042705|FG002|Overall Study|Adverse Event|1|||
105832204|NCT01155531|365042706|FG003|Overall Study|Adverse Event|0|||
105832205|NCT01155531|365042703|FG000|Overall Study|Lost to Follow-up|0|||
105832206|NCT01155531|365042704|FG001|Overall Study|Lost to Follow-up|0|||
105832207|NCT01155531|365042705|FG002|Overall Study|Lost to Follow-up|0|||
105832208|NCT01155531|365042706|FG003|Overall Study|Lost to Follow-up|1|||
105832209|NCT01155531|365042703|FG000|Overall Study|Withdrawal by Subject|1|||
105832210|NCT01155531|365042704|FG001|Overall Study|Withdrawal by Subject|0|||
105832211|NCT01155531|365042705|FG002|Overall Study|Withdrawal by Subject|1|||
105309264|NCT02238795|363128933|FG000|Overall Study|Patient without purpura fulminans|1|||
105309265|NCT00077857|363128934|FG000|Overall Study|Adverse Event|30|||
105309266|NCT00077857|363128935|FG001|Overall Study|Adverse Event|32|||
105489446|NCT02310321|363804050|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
105832212|NCT01155531|365042706|FG003|Overall Study|Withdrawal by Subject|0|||
105832213|NCT00354159|365042707|FG000|Randomized Study Period|Withdrawal by Subject|5|||
105309267|NCT00077857|363128934|FG000|Overall Study|Death|7|||
105309268|NCT00077857|363128935|FG001|Overall Study|Death|3|||
105309269|NCT00077857|363128934|FG000|Overall Study|Insufficient therapeutic response|112|||
105309270|NCT00077857|363128935|FG001|Overall Study|Insufficient therapeutic response|128|||
105309271|NCT00077857|363128934|FG000|Overall Study|Violation of selection criteria at entry|3|||
105309272|NCT00077857|363128935|FG001|Overall Study|Violation of selection criteria at entry|1|||
105309273|NCT00077857|363128934|FG000|Overall Study|Other protocol violation|0|||
105309274|NCT00077857|363128935|FG001|Overall Study|Other protocol violation|1|||
105832214|NCT00354159|365042708|FG001|Randomized Study Period|Withdrawal by Subject|3|||
105832215|NCT00354159|365042707|FG000|Randomized Study Period|Physician Decision|6|||
105832216|NCT00354159|365042708|FG001|Randomized Study Period|Physician Decision|10|||
105832217|NCT00354159|365042707|FG000|Randomized Study Period|Lost to Follow-up|4|||
105832218|NCT00354159|365042708|FG001|Randomized Study Period|Lost to Follow-up|0|||
105832219|NCT00354159|365042707|FG000|Randomized Study Period|Death|7|||
105832220|NCT00354159|365042708|FG001|Randomized Study Period|Death|9|||
105832221|NCT00354159|365042707|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
105832222|NCT00354159|365042708|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
105832223|NCT00354159|365042707|FG000|Long-term Follow-up|Physician Decision|127|||
105832224|NCT00354159|365042708|FG001|Long-term Follow-up|Physician Decision|122|||
105832225|NCT00354159|365042707|FG000|Long-term Follow-up|Lost to Follow-up|1|||
105832226|NCT00354159|365042708|FG001|Long-term Follow-up|Lost to Follow-up|0|||
105832227|NCT00354159|365042707|FG000|Long-term Follow-up|Death|14|||
105832228|NCT00354159|365042708|FG001|Long-term Follow-up|Death|11|||
105832229|NCT00354159|365042707|FG000|Long-term Follow-up|Study Closed|29|||
105832230|NCT00354159|365042708|FG001|Long-term Follow-up|Study Closed|34|||
105832231|NCT05070754|365042717|FG000|Overall Study|Withdrawal by Subject|0|||
105832232|NCT05070754|365042718|FG001|Overall Study|Withdrawal by Subject|0|||
105832233|NCT05070754|365042719|FG002|Overall Study|Withdrawal by Subject|0|||
105832234|NCT05070754|365042720|FG003|Overall Study|Withdrawal by Subject|1|||
105832235|NCT05070754|365042717|FG000|Overall Study|Protocol Violation|0|||
105832236|NCT05070754|365042718|FG001|Overall Study|Protocol Violation|0|||
105832237|NCT05070754|365042719|FG002|Overall Study|Protocol Violation|0|||
105832238|NCT05070754|365042720|FG003|Overall Study|Protocol Violation|1|||
105832239|NCT04535986|365042721|FG000|Overall Study|Death|4|||
105832240|NCT04535986|365042722|FG001|Overall Study|Death|5|||
105832241|NCT04535986|365042721|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
105832242|NCT04535986|365042722|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
105832243|NCT04535986|365042721|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
105832244|NCT04535986|365042722|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
105832245|NCT04535986|365042721|FG000|Overall Study|Adverse Event|10|||
105832246|NCT04535986|365042722|FG001|Overall Study|Adverse Event|1|||
105832247|NCT04535986|365042721|FG000|Overall Study|Lack of Efficacy|3|||
105832248|NCT04535986|365042722|FG001|Overall Study|Lack of Efficacy|2|||
105832249|NCT04535986|365042721|FG000|Overall Study|Investigator discretion|3|||
105832250|NCT04535986|365042722|FG001|Overall Study|Investigator discretion|0|||
105832251|NCT04535986|365042721|FG000|Overall Study|Withdrawal by Subject|32|||
105832252|NCT04535986|365042722|FG001|Overall Study|Withdrawal by Subject|14|||
105832253|NCT04535986|365042721|FG000|Overall Study|Lost to Follow-up|5|||
105832254|NCT04535986|365042722|FG001|Overall Study|Lost to Follow-up|3|||
105832255|NCT04535986|365042721|FG000|Overall Study|Other|7|||
105832256|NCT04535986|365042722|FG001|Overall Study|Other|3|||
105832257|NCT00252564|365042725|FG000|Overall Study|Adverse Event|17|||
105832258|NCT00252564|365042726|FG001|Overall Study|Adverse Event|13|||
105832259|NCT00252564|365042725|FG000|Overall Study|Unrelated Complication|2|||
105832260|NCT00252564|365042726|FG001|Overall Study|Unrelated Complication|1|||
105832261|NCT00252564|365042725|FG000|Overall Study|Disease Progression|14|||
105832262|NCT00252564|365042726|FG001|Overall Study|Disease Progression|20|||
105832263|NCT00252564|365042725|FG000|Overall Study|Death|0|||
105832264|NCT00252564|365042726|FG001|Overall Study|Death|3|||
105832265|NCT00252564|365042725|FG000|Overall Study|Physician Decision|1|||
105832266|NCT00252564|365042726|FG001|Overall Study|Physician Decision|0|||
105832267|NCT00252564|365042725|FG000|Overall Study|Lost to Follow-up|1|||
105832268|NCT00252564|365042726|FG001|Overall Study|Lost to Follow-up|0|||
105832269|NCT00252564|365042725|FG000|Overall Study|Patient Request|4|||
105832270|NCT00252564|365042726|FG001|Overall Study|Patient Request|5|||
105832271|NCT00252564|365042725|FG000|Overall Study|Withdrawal by Subject|0|||
105832272|NCT00252564|365042726|FG001|Overall Study|Withdrawal by Subject|2|||
105832273|NCT01745094|365042727|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
105832274|NCT01745094|365042728|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
105832275|NCT01745094|365042729|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
105832276|NCT01745094|365042730|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
105832277|NCT01745094|365042727|FG000|Overall Study|Adverse Event|0|||
105832278|NCT01745094|365042728|FG001|Overall Study|Adverse Event|0|||
105832279|NCT01745094|365042729|FG002|Overall Study|Adverse Event|3|||
105832280|NCT01745094|365042730|FG003|Overall Study|Adverse Event|0|||
105832281|NCT01745094|365042727|FG000|Overall Study|Withdrawal by Subject|2|||
105832282|NCT01745094|365042728|FG001|Overall Study|Withdrawal by Subject|0|||
105832283|NCT01745094|365042729|FG002|Overall Study|Withdrawal by Subject|1|||
105832284|NCT01745094|365042730|FG003|Overall Study|Withdrawal by Subject|2|||
105832285|NCT01745094|365042727|FG000|Overall Study|Protocol Violation|1|||
105832286|NCT01745094|365042728|FG001|Overall Study|Protocol Violation|0|||
105832287|NCT01745094|365042729|FG002|Overall Study|Protocol Violation|3|||
105832288|NCT01745094|365042730|FG003|Overall Study|Protocol Violation|1|||
105832289|NCT01745094|365042727|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
105832290|NCT01745094|365042728|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
105832291|NCT01745094|365042729|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
105832292|NCT01745094|365042730|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
105832293|NCT01745094|365042727|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
105309275|NCT00077857|363128934|FG000|Overall Study|Refused treatment|29|||
105309276|NCT00077857|363128935|FG001|Overall Study|Refused treatment|21|||
105309277|NCT00077857|363128934|FG000|Overall Study|Failure to return|5|||
105309278|NCT00077857|363128935|FG001|Overall Study|Failure to return|5|||
105309279|NCT00077857|363128934|FG000|Overall Study|Other|15|||
105309280|NCT00077857|363128935|FG001|Overall Study|Other|13|||
105309281|NCT04874155|363128936|FG000|Overall Study|Lost to Follow-up|1|||
105309282|NCT04874155|363128937|FG001|Overall Study|Lost to Follow-up|1|||
105309283|NCT04874155|363128936|FG000|Overall Study|Withdrawal by Subject|2|||
105832294|NCT01745094|365042728|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
105832295|NCT01745094|365042729|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
105832296|NCT01745094|365042730|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
105832297|NCT01745094|365042727|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
105832298|NCT01745094|365042728|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
105832299|NCT01745094|365042729|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
105832300|NCT01745094|365042730|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
105832301|NCT01993940|365042731|FG000|Overall Study|Adverse Event|16|||
105832302|NCT01993940|365042732|FG001|Overall Study|Adverse Event|11|||
105832303|NCT01993940|365042731|FG000|Overall Study|Withdrawal by Subject|15|||
105832304|NCT01993940|365042732|FG001|Overall Study|Withdrawal by Subject|19|||
105832305|NCT01993940|365042731|FG000|Overall Study|Lost to Follow-up|2|||
105832306|NCT01993940|365042732|FG001|Overall Study|Lost to Follow-up|5|||
105832307|NCT01993940|365042731|FG000|Overall Study|Protocol Violation|5|||
105832308|NCT01993940|365042732|FG001|Overall Study|Protocol Violation|8|||
105832309|NCT01993940|365042731|FG000|Overall Study|Death|1|||
105832310|NCT01993940|365042732|FG001|Overall Study|Death|0|||
105832311|NCT01993940|365042731|FG000|Overall Study|Other - Miscellaneous|1|||
105832312|NCT01993940|365042732|FG001|Overall Study|Other - Miscellaneous|1|||
105832313|NCT02308696|365042738|FG000|Overall Study|Lost to Follow-up|28|||
105832314|NCT02308696|365042739|FG001|Overall Study|Lost to Follow-up|21|||
105832315|NCT02308696|365042738|FG000|Overall Study|Death|8|||
105832316|NCT02308696|365042739|FG001|Overall Study|Death|4|||
105832317|NCT02308696|365042738|FG000|Overall Study|Moved to a Higher Level of Care|17|||
105832318|NCT02308696|365042739|FG001|Overall Study|Moved to a Higher Level of Care|6|||
105832319|NCT01211262|365042740|FG000|Overall Study|Progressive Disease|18|||
105832320|NCT01211262|365042741|FG001|Overall Study|Progressive Disease|9|||
105832321|NCT01211262|365042740|FG000|Overall Study|Adverse Event|4|||
105832322|NCT01211262|365042741|FG001|Overall Study|Adverse Event|0|||
105832323|NCT01211262|365042740|FG000|Overall Study|Withdrawal of Consent|1|||
105832324|NCT01211262|365042741|FG001|Overall Study|Withdrawal of Consent|0|||
105832325|NCT01211262|365042740|FG000|Overall Study|Other|0|||
105832326|NCT01211262|365042741|FG001|Overall Study|Other|1|||
105832327|NCT01277510|365042742|FG000|Double-blind Phase|Non-compliance|0|||
105832328|NCT01277510|365042743|FG001|Double-blind Phase|Non-compliance|1|||
105832329|NCT01277510|365042742|FG000|Double-blind Phase|Adverse Event|1|||
105832330|NCT01277510|365042743|FG001|Double-blind Phase|Adverse Event|0|||
105832331|NCT01277510|365042742|FG000|Double-blind Phase|Withdrawal by Subject|2|||
105832332|NCT01277510|365042743|FG001|Double-blind Phase|Withdrawal by Subject|0|||
105832333|NCT01277510|365042742|FG000|Double-blind Phase|Administrative decision|7|||
105832334|NCT01277510|365042743|FG001|Double-blind Phase|Administrative decision|9|||
105832335|NCT01277510|365042742|FG000|Double-blind Phase|Death|0|||
105832336|NCT01277510|365042743|FG001|Double-blind Phase|Death|1|||
105832337|NCT01277510|365042742|FG000|Double-blind Phase|Protocol-specified criteria|2|||
105832338|NCT01277510|365042743|FG001|Double-blind Phase|Protocol-specified criteria|6|||
105832339|NCT01277510|365042742|FG000|Double-blind Phase|Other|1|||
105832340|NCT01277510|365042743|FG001|Double-blind Phase|Other|1|||
105832341|NCT01277510|365042742|FG000|Open-label Phase|Administrative decision|4|||
105832342|NCT01277510|365042743|FG001|Open-label Phase|Administrative decision|3|||
105832343|NCT01277510|365042742|FG000|Open-label Phase|Protocol-specified criteria|1|||
105832344|NCT01277510|365042743|FG001|Open-label Phase|Protocol-specified criteria|0|||
105832345|NCT01277510|365042742|FG000|Open-label Phase|Never received investigational product|2|||
105309284|NCT04874155|363128937|FG001|Overall Study|Withdrawal by Subject|2|||
105309285|NCT03477903|363128938|FG000|Overall Study|Study Terminated by Sponsor|1|||
105309286|NCT03201965|363128939|FG000|Overall Study|Death|5|||
105309287|NCT03201965|363128940|FG001|Overall Study|Death|27|||
105309288|NCT03201965|363128941|FG002|Overall Study|Death|27|||
105309289|NCT03201965|363128939|FG000|Overall Study|Lost to Follow-up|0|||
105309290|NCT03201965|363128940|FG001|Overall Study|Lost to Follow-up|1|||
105832346|NCT01277510|365042743|FG001|Open-label Phase|Never received investigational product|0|||
105832347|NCT01685008|365042744|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
105832348|NCT01685008|365042745|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
105832349|NCT01685008|365042746|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
105832350|NCT01685008|365042747|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
105832351|NCT01685008|365042744|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
105309291|NCT03201965|363128941|FG002|Overall Study|Lost to Follow-up|0|||
105309292|NCT03201965|363128939|FG000|Overall Study|Withdrawal by Subject|3|||
105309293|NCT03201965|363128940|FG001|Overall Study|Withdrawal by Subject|13|||
105832352|NCT01685008|365042745|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
105832353|NCT01685008|365042746|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
105832354|NCT01685008|365042747|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
105832355|NCT01685008|365042744|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
105832356|NCT01685008|365042745|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
105832357|NCT01685008|365042746|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
105832358|NCT01685008|365042747|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
105832359|NCT01685008|365042744|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
105832360|NCT01685008|365042745|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
105832361|NCT01685008|365042746|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
105832362|NCT01685008|365042747|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
105832363|NCT01685008|365042744|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
105832364|NCT01685008|365042745|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
105832365|NCT01685008|365042746|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
105832366|NCT01685008|365042747|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
105832367|NCT04476277|365042748|FG000|Overall Study|Withdrawal by Subject|0|||
105832368|NCT04476277|365042749|FG001|Overall Study|Withdrawal by Subject|0|||
105832369|NCT04476277|365042750|FG002|Overall Study|Withdrawal by Subject|1|||
105832370|NCT04476277|365042751|FG003|Overall Study|Withdrawal by Subject|0|||
105832371|NCT03980522|365042760|FG000|Treatment Period|Adverse Event|1|||
105832372|NCT03980522|365042761|FG001|Treatment Period|Adverse Event|0|||
105832373|NCT03980522|365042762|FG002|Treatment Period|Adverse Event|0|||
105832374|NCT03980522|365042763|FG003|Treatment Period|Adverse Event|0|||
105832375|NCT03980522|365042764|FG004|Treatment Period|Adverse Event|0|||
105832376|NCT02896296|365042765|FG000|Overall Study|Adverse Event|1|||
105832377|NCT02896296|365042765|FG000|Overall Study|Lost to Follow-up|19|||
105832378|NCT02896296|365042765|FG000|Overall Study|Pregnancy|1|||
105832379|NCT02896296|365042765|FG000|Overall Study|Physician Decision|2|||
105832380|NCT02896296|365042765|FG000|Overall Study|Withdrawal by Subject|10|||
105832381|NCT02896296|365042765|FG000|Overall Study|Site closing|7|||
105832382|NCT02896296|365042765|FG000|Overall Study|Incarceration|1|||
105832383|NCT02896296|365042765|FG000|Overall Study|Relocation|1|||
105832384|NCT00939523|365042771|FG000|Overall Study|Lack of Efficacy|1|||
105832385|NCT00939523|365042771|FG000|Overall Study|Physician Decision|2|||
105832386|NCT00024258|365042772|FG000|Overall Study|Withdrawal by Subject|1|||
105832387|NCT00024258|365042772|FG000|Overall Study|Disease Progression|8|||
105832388|NCT01050764|365042773|FG000|Overall Study|Death, before HSCT|1|||
105832389|NCT01050764|365042773|FG000|Overall Study|Donor mobilization failure, death|1|||
105832390|NCT01050764|365042773|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
105832391|NCT02416934|365042785|FG000|Overall Study|given steroids|1|||
105832392|NCT02416934|365042786|FG001|Overall Study|given steroids|2|||
105832393|NCT02416934|365042785|FG000|Overall Study|Lost to Follow-up|0|||
105832394|NCT02416934|365042786|FG001|Overall Study|Lost to Follow-up|2|||
105832395|NCT02416934|365042785|FG000|Overall Study|Withdrawal by Subject|1|||
105832396|NCT02416934|365042786|FG001|Overall Study|Withdrawal by Subject|0|||
105309294|NCT03201965|363128941|FG002|Overall Study|Withdrawal by Subject|4|||
105309295|NCT03201965|363128939|FG000|Overall Study|Ongoing|20|||
105309296|NCT03201965|363128940|FG001|Overall Study|Ongoing|152|||
105309297|NCT03201965|363128941|FG002|Overall Study|Ongoing|164|||
105309298|NCT05293639|363128942|FG000|Overall Study|Withdrawal by Subject|1|||
105309299|NCT05293639|363128943|FG001|Overall Study|Withdrawal by Subject|1|||
105309300|NCT05293639|363128944|FG002|Overall Study|Withdrawal by Subject|2|||
105309301|NCT05293639|363128942|FG000|Overall Study|Death|0|||
105309302|NCT05293639|363128943|FG001|Overall Study|Death|1|||
105309303|NCT05293639|363128944|FG002|Overall Study|Death|0|||
105309304|NCT05293639|363128942|FG000|Overall Study|Lost to Follow-up|0|||
105309305|NCT05293639|363128943|FG001|Overall Study|Lost to Follow-up|0|||
105309306|NCT05293639|363128944|FG002|Overall Study|Lost to Follow-up|5|||
105309307|NCT05293639|363128942|FG000|Overall Study|Other|0|||
105309308|NCT05293639|363128943|FG001|Overall Study|Other|0|||
105309309|NCT05293639|363128944|FG002|Overall Study|Other|1|||
105832397|NCT02416934|365042785|FG000|Overall Study|recruited during continuing renewal proc|0|||
105832398|NCT02416934|365042786|FG001|Overall Study|recruited during continuing renewal proc|1|||
105832399|NCT02416934|365042785|FG000|Overall Study|Protocol Violation|0|||
105832400|NCT02416934|365042786|FG001|Overall Study|Protocol Violation|1|||
105832401|NCT02416934|365042785|FG000|Overall Study|surgery started late|0|||
105832402|NCT02416934|365042786|FG001|Overall Study|surgery started late|1|||
105832403|NCT02416934|365042785|FG000|Overall Study|re-operation|1|||
105309310|NCT00827632|363128945|FG000|Overall Study|Lost to Follow-up|8|||
105309311|NCT00827632|363128946|FG001|Overall Study|Lost to Follow-up|12|||
105309312|NCT00827632|363128945|FG000|Overall Study|Early withdrawal|14|||
105309313|NCT00827632|363128946|FG001|Overall Study|Early withdrawal|11|||
105832404|NCT02416934|365042786|FG001|Overall Study|re-operation|0|||
105832405|NCT00124618|365042788|FG000|Overall Study|Ineligible|1|||
105309314|NCT03456453|363128947|FG000|Overall Study|Withdrawal by Subject|2|||
105832406|NCT02387762|365042789|FG000|Overall Study|Withdrawal by Subject|1|||
105832407|NCT02387762|365042790|FG001|Overall Study|Withdrawal by Subject|0|||
105832408|NCT03370510|365042794|FG000|Overall Study|COVID-19|2|||
105832409|NCT03370510|365042795|FG001|Overall Study|COVID-19|0|||
105832410|NCT04388787|365042796|FG000|Blinded Period|Patient could not follow instructions|1|||
105832411|NCT04388787|365042796|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
105832412|NCT03108820|365042797|FG000|Overall Study|Lost to Follow-up|30|||
105832413|NCT03108820|365042798|FG001|Overall Study|Lost to Follow-up|28|||
105832414|NCT03108820|365042797|FG000|Overall Study|Withdrawal by Subject|32|||
105832415|NCT03108820|365042798|FG001|Overall Study|Withdrawal by Subject|24|||
105832416|NCT03108820|365042797|FG000|Overall Study|Death|6|||
105832417|NCT03108820|365042798|FG001|Overall Study|Death|11|||
105832418|NCT00688844|365042801|FG000|Overall Study|Lost to Follow-up|10|||
105832419|NCT01374451|365042802|FG000|Overall Study|Administrative problems|1|||
105832420|NCT01374451|365042803|FG001|Overall Study|Administrative problems|0|||
105832421|NCT03493919|365042806|FG000|Overall Study|Other|2|||
105832422|NCT03493919|365042807|FG001|Overall Study|Other|0|||
105832423|NCT03493919|365042808|FG002|Overall Study|Other|1|||
105832424|NCT03493919|365042809|FG003|Overall Study|Other|0|||
105832425|NCT03493919|365042806|FG000|Overall Study|Withdrawal by Subject|9|||
105832426|NCT03493919|365042807|FG001|Overall Study|Withdrawal by Subject|3|||
105832427|NCT03493919|365042808|FG002|Overall Study|Withdrawal by Subject|1|||
105832428|NCT03493919|365042809|FG003|Overall Study|Withdrawal by Subject|1|||
105832429|NCT03493919|365042806|FG000|Overall Study|Lost to Follow-up|5|||
105832430|NCT03493919|365042807|FG001|Overall Study|Lost to Follow-up|0|||
105832431|NCT03493919|365042808|FG002|Overall Study|Lost to Follow-up|0|||
105832432|NCT03493919|365042809|FG003|Overall Study|Lost to Follow-up|3|||
105832433|NCT03493919|365042806|FG000|Overall Study|Adverse Event|0|||
105832434|NCT03493919|365042807|FG001|Overall Study|Adverse Event|1|||
105832435|NCT03493919|365042808|FG002|Overall Study|Adverse Event|0|||
105832436|NCT03493919|365042809|FG003|Overall Study|Adverse Event|0|||
105832437|NCT00697619|365042810|FG000|Overall Study|Lack of Efficacy|2|||
105832438|NCT00697619|365042811|FG001|Overall Study|Lack of Efficacy|2|||
105832439|NCT00697619|365042810|FG000|Overall Study|Adverse Event|4|||
105832440|NCT00697619|365042811|FG001|Overall Study|Adverse Event|6|||
105832441|NCT00640341|365044668|FG000|Overall Study|Adverse Event|0|||
105832442|NCT00640341|365044669|FG001|Overall Study|Adverse Event|0|||
105832443|NCT00640341|365044670|FG002|Overall Study|Adverse Event|1|||
105832444|NCT00640341|365044668|FG000|Overall Study|Positive Slit Lamp Findings|0|||
105832445|NCT00640341|365044669|FG001|Overall Study|Positive Slit Lamp Findings|0|||
105832446|NCT00640341|365044670|FG002|Overall Study|Positive Slit Lamp Findings|1|||
105832447|NCT00640341|365044668|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
105832448|NCT00640341|365044669|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
105832449|NCT00640341|365044670|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
105832450|NCT00640341|365044668|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
105832451|NCT00640341|365044669|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
105832452|NCT00640341|365044670|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
105832453|NCT00640341|365044668|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
105832454|NCT00640341|365044669|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
105832455|NCT00640341|365044670|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
105832456|NCT00640341|365044668|FG000|Overall Study|Lost to Follow-up|2|||
105832457|NCT00640341|365044669|FG001|Overall Study|Lost to Follow-up|0|||
105832458|NCT00640341|365044670|FG002|Overall Study|Lost to Follow-up|0|||
105832459|NCT00640341|365044668|FG000|Overall Study|Withdrawal by Subject|4|||
105832460|NCT00640341|365044669|FG001|Overall Study|Withdrawal by Subject|0|||
105832461|NCT00640341|365044670|FG002|Overall Study|Withdrawal by Subject|1|||
105832462|NCT00640341|365044668|FG000|Overall Study|Unacceptable Lens Movement|1|||
105832463|NCT00640341|365044669|FG001|Overall Study|Unacceptable Lens Movement|0|||
105832464|NCT00640341|365044670|FG002|Overall Study|Unacceptable Lens Movement|0|||
105832465|NCT00640341|365044668|FG000|Overall Study|Poor fit/Uncomfortable|4|||
105832466|NCT00640341|365044669|FG001|Overall Study|Poor fit/Uncomfortable|0|||
105832467|NCT00640341|365044670|FG002|Overall Study|Poor fit/Uncomfortable|0|||
105832468|NCT00640341|365044668|FG000|Overall Study|Ineligable at Baseline|5|||
105832469|NCT00640341|365044669|FG001|Overall Study|Ineligable at Baseline|3|||
105832470|NCT00640341|365044670|FG002|Overall Study|Ineligable at Baseline|2|||
105832471|NCT00640341|365044668|FG000|Overall Study|Adverse event and positive slit lamp|1|||
105832472|NCT00640341|365044669|FG001|Overall Study|Adverse event and positive slit lamp|0|||
105832473|NCT00640341|365044670|FG002|Overall Study|Adverse event and positive slit lamp|0|||
105832474|NCT04573309|365044674|FG000|Overall Study|Protocol Violation|1|||
105832475|NCT04573309|365044675|FG001|Overall Study|Protocol Violation|0|||
105832476|NCT00660387|365044676|FG000|Overall Study|Adverse Event|1|||
105832477|NCT00660387|365044677|FG001|Overall Study|Adverse Event|2|||
105832478|NCT00660387|365044676|FG000|Overall Study|Lack of Efficacy|0|||
105832479|NCT00660387|365044677|FG001|Overall Study|Lack of Efficacy|1|||
105832480|NCT00660387|365044676|FG000|Overall Study|Protocol Violation|1|||
105832481|NCT00660387|365044677|FG001|Overall Study|Protocol Violation|0|||
105832482|NCT00557245|365044681|FG000|Overall Study|Lost to Follow-up|7|||
105832483|NCT00557245|365044682|FG001|Overall Study|Lost to Follow-up|8|||
105309315|NCT03456453|363128948|FG001|Overall Study|Withdrawal by Subject|0|||
105832484|NCT00557245|365044683|FG002|Overall Study|Lost to Follow-up|10|||
105832485|NCT00557245|365044681|FG000|Overall Study|Ineligible|5|||
105832486|NCT00557245|365044682|FG001|Overall Study|Ineligible|4|||
105832487|NCT00557245|365044683|FG002|Overall Study|Ineligible|2|||
105832488|NCT04364854|365044684|FG000|Overall Study|Withdrawal by Subject|1|||
105832489|NCT04364854|365044685|FG001|Overall Study|Withdrawal by Subject|0|||
105832490|NCT04364854|365044686|FG002|Overall Study|Withdrawal by Subject|1|||
105832491|NCT04364854|365044687|FG003|Overall Study|Withdrawal by Subject|3|||
105832492|NCT04364854|365044684|FG000|Overall Study|Death|1|||
105832493|NCT04364854|365044685|FG001|Overall Study|Death|0|||
105832494|NCT04364854|365044686|FG002|Overall Study|Death|0|||
105832495|NCT04364854|365044687|FG003|Overall Study|Death|0|||
105832496|NCT04364854|365044684|FG000|Overall Study|Lost to Follow-up|0|||
105832497|NCT04364854|365044685|FG001|Overall Study|Lost to Follow-up|0|||
105832498|NCT04364854|365044686|FG002|Overall Study|Lost to Follow-up|0|||
105832499|NCT04364854|365044687|FG003|Overall Study|Lost to Follow-up|1|||
105832500|NCT01453153|365044690|FG000|Overall Study|Physician Decision|0|||
105832501|NCT01453153|365044691|FG001|Overall Study|Physician Decision|0|||
105832502|NCT01453153|365044692|FG002|Overall Study|Physician Decision|1|||
105832503|NCT01453153|365044690|FG000|Overall Study|Progressive Disease|3|||
105832504|NCT01453153|365044691|FG001|Overall Study|Progressive Disease|2|||
105832505|NCT01453153|365044692|FG002|Overall Study|Progressive Disease|16|||
105832506|NCT01453153|365044690|FG000|Overall Study|Withdrawal by Subject|0|||
105832507|NCT01453153|365044691|FG001|Overall Study|Withdrawal by Subject|1|||
105832508|NCT01453153|365044692|FG002|Overall Study|Withdrawal by Subject|2|||
105832509|NCT01453153|365044690|FG000|Overall Study|Adverse Event|1|||
105832510|NCT01453153|365044691|FG001|Overall Study|Adverse Event|1|||
105832511|NCT01453153|365044692|FG002|Overall Study|Adverse Event|1|||
105832512|NCT00960154|365044694|FG000|Overall Study|Study termination|25|||
105832513|NCT00960154|365044695|FG001|Overall Study|Study termination|25|||
105832514|NCT00522041|365044698|FG000|Overall Study|Adverse Event|9|||
105832515|NCT00522041|365044699|FG001|Overall Study|Adverse Event|3|||
105832516|NCT00522041|365044698|FG000|Overall Study|Protocol Violation|2|||
105832517|NCT00522041|365044699|FG001|Overall Study|Protocol Violation|0|||
105832518|NCT00522041|365044698|FG000|Overall Study|Lost to Follow-up|1|||
105309316|NCT03456453|363128947|FG000|Overall Study|Not released to community|1|||
105309317|NCT03456453|363128948|FG001|Overall Study|Not released to community|5|||
105309318|NCT03456453|363128947|FG000|Overall Study|Lost to Follow-up|0|||
105309319|NCT03456453|363128948|FG001|Overall Study|Lost to Follow-up|2|||
105309320|NCT04762277|363128949|FG000|Overall Study|Withdrawal by Subject|0|||
105832519|NCT00522041|365044699|FG001|Overall Study|Lost to Follow-up|4|||
105832520|NCT00522041|365044698|FG000|Overall Study|Voluntary withdrawal|5|||
105309321|NCT04762277|363128950|FG001|Overall Study|Withdrawal by Subject|2|||
105309322|NCT04762277|363128949|FG000|Overall Study|Protocol Violation|0|||
105309323|NCT04762277|363128950|FG001|Overall Study|Protocol Violation|1|||
105309324|NCT04762277|363128949|FG000|Overall Study|Adverse Event|1|||
105309325|NCT04762277|363128950|FG001|Overall Study|Adverse Event|0|||
105309326|NCT02828241|363128957|FG000|Overall Study|Adverse Event|7|||
105309327|NCT02828241|363128958|FG001|Overall Study|Adverse Event|2|||
105309328|NCT02828241|363128957|FG000|Overall Study|Protocol Violation|1|||
105309329|NCT02828241|363128958|FG001|Overall Study|Protocol Violation|0|||
105309330|NCT02288182|363128961|FG000|Overall Study|Adverse Event|0|||
105309331|NCT02288182|363128962|FG001|Overall Study|Adverse Event|1|||
105309332|NCT02288182|363128961|FG000|Overall Study|Lost to Follow-up|0|||
105309333|NCT02288182|363128962|FG001|Overall Study|Lost to Follow-up|1|||
105309334|NCT02823652|363128963|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
105309335|NCT02823652|363128964|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
105309336|NCT02823652|363128965|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
105309337|NCT02823652|363128963|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
105309338|NCT02823652|363128964|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
105309339|NCT02823652|363128965|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
105309340|NCT02823652|363128963|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
105309341|NCT02823652|363128964|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
105309342|NCT02823652|363128965|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
105309343|NCT02823652|363128963|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
105309344|NCT02823652|363128964|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
105309345|NCT02823652|363128965|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
105832521|NCT00522041|365044699|FG001|Overall Study|Voluntary withdrawal|4|||
105832522|NCT00522041|365044698|FG000|Overall Study|Did not receive treatment|0|||
105832523|NCT00522041|365044699|FG001|Overall Study|Did not receive treatment|1|||
105832524|NCT00288704|365044700|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
105832525|NCT00288704|365044701|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
105832526|NCT00288704|365044702|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
105832527|NCT00288704|365044700|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
105832528|NCT00288704|365044701|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
105832529|NCT00288704|365044702|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
105309346|NCT03567382|363128974|FG000|Overall Study|Lost to Follow-up|1|||
105832530|NCT00288704|365044700|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
105832531|NCT00288704|365044701|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
105309347|NCT03567382|363128975|FG001|Overall Study|Lost to Follow-up|21|||
105309348|NCT03567382|363128976|FG002|Overall Study|Lost to Follow-up|1|||
105309349|NCT03567382|363128977|FG003|Overall Study|Lost to Follow-up|21|||
105309350|NCT03567382|363128974|FG000|Overall Study|Withdrawal by Subject|2|||
105309351|NCT03567382|363128975|FG001|Overall Study|Withdrawal by Subject|14|||
105309352|NCT03567382|363128976|FG002|Overall Study|Withdrawal by Subject|1|||
105309353|NCT03567382|363128977|FG003|Overall Study|Withdrawal by Subject|12|||
105309354|NCT01197755|363128980|FG000|Overall Study|Adverse Event|8|||
105309355|NCT01197755|363128981|FG001|Overall Study|Adverse Event|10|||
105309356|NCT01197755|363128982|FG002|Overall Study|Adverse Event|10|||
105309357|NCT01197755|363128980|FG000|Overall Study|Study-specific discontinuation criteria|2|||
105309358|NCT01197755|363128981|FG001|Overall Study|Study-specific discontinuation criteria|1|||
105309359|NCT01197755|363128982|FG002|Overall Study|Study-specific discontinuation criteria|0|||
105309360|NCT01197755|363128980|FG000|Overall Study|Entered the long-term extension study|18|||
105309361|NCT01197755|363128981|FG001|Overall Study|Entered the long-term extension study|21|||
105309362|NCT01197755|363128982|FG002|Overall Study|Entered the long-term extension study|35|||
105309363|NCT01197755|363128980|FG000|Overall Study|Lack of therapeutic response|0|||
105309364|NCT01197755|363128981|FG001|Overall Study|Lack of therapeutic response|7|||
105309365|NCT01197755|363128982|FG002|Overall Study|Lack of therapeutic response|4|||
105309366|NCT01197755|363128980|FG000|Overall Study|Severe non-compliance to the protocol|2|||
105309367|NCT01197755|363128981|FG001|Overall Study|Severe non-compliance to the protocol|1|||
105832532|NCT00288704|365044702|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
105832533|NCT00288704|365044700|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
105832534|NCT00288704|365044701|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
105832535|NCT00288704|365044702|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
105832536|NCT00288704|365044700|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
105832537|NCT00288704|365044701|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
105832538|NCT00288704|365044702|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
105832539|NCT00288704|365044700|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
105832540|NCT00288704|365044701|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
105832541|NCT00288704|365044702|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
105832542|NCT00288704|365044700|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
105832543|NCT00288704|365044701|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
105832544|NCT00288704|365044702|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
105832545|NCT01802216|365044703|FG000|4 Month Visit|Participant did not show to visit|3|||
105832546|NCT01802216|365044704|FG001|4 Month Visit|Participant did not show to visit|4|||
105832547|NCT01802216|365044703|FG000|8 Month Visit|Participant did not show to visit|3|||
105832548|NCT01802216|365044704|FG001|8 Month Visit|Participant did not show to visit|5|||
105832549|NCT01802216|365044703|FG000|12 Month Visit|Participant did not show to visit|3|||
105832550|NCT01802216|365044704|FG001|12 Month Visit|Participant did not show to visit|4|||
105832551|NCT04982445|365044707|FG000|Overall Study|Protocol Violation|1|||
105832552|NCT04982445|365044707|FG000|Overall Study|Withdrawal by Subject|4|||
105832553|NCT04982445|365044707|FG000|Overall Study|Lost to Follow-up|1|||
105832554|NCT02483416|365044708|FG000|Overall Study|Other reason|0|||
105832555|NCT02483416|365044709|FG001|Overall Study|Other reason|1|||
105832556|NCT02483416|365044708|FG000|Overall Study|Treatment stop|3|||
105832557|NCT02483416|365044709|FG001|Overall Study|Treatment stop|0|||
105832558|NCT03885934|365044714|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
105832559|NCT03885934|365044715|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
105832560|NCT03885934|365044716|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
105832561|NCT03885934|365044717|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
105832562|NCT03885934|365044718|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
105832563|NCT03885934|365044719|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
105832564|NCT00881569|365044722|FG000|Overall Study|Disease progression|1|||
105309368|NCT01197755|363128982|FG002|Overall Study|Severe non-compliance to the protocol|2|||
105309369|NCT01197755|363128980|FG000|Overall Study|Withdrawal by Subject|1|||
105309370|NCT01197755|363128981|FG001|Overall Study|Withdrawal by Subject|0|||
105309371|NCT01197755|363128982|FG002|Overall Study|Withdrawal by Subject|0|||
105309372|NCT01197755|363128980|FG000|Overall Study|Lost to Follow-up|0|||
105309373|NCT01197755|363128981|FG001|Overall Study|Lost to Follow-up|0|||
105309374|NCT01197755|363128982|FG002|Overall Study|Lost to Follow-up|1|||
105309375|NCT01197755|363128980|FG000|Overall Study|eg, change in circumstances|7|||
105309376|NCT01197755|363128981|FG001|Overall Study|eg, change in circumstances|3|||
105832565|NCT00881569|365044723|FG001|Overall Study|Disease progression|1|||
105832566|NCT00640926|365044724|FG000|Overall Study|Adverse Event|2|||
105832567|NCT00640926|365044725|FG001|Overall Study|Adverse Event|3|||
105832568|NCT00640926|365044726|FG002|Overall Study|Adverse Event|2|||
105832569|NCT00640926|365044724|FG000|Overall Study|Lack of Efficacy|0|||
105309377|NCT01197755|363128982|FG002|Overall Study|eg, change in circumstances|2|||
105832570|NCT00640926|365044725|FG001|Overall Study|Lack of Efficacy|2|||
105832571|NCT00640926|365044726|FG002|Overall Study|Lack of Efficacy|1|||
105832572|NCT00640926|365044724|FG000|Overall Study|Protocol Violation|2|||
105832573|NCT00640926|365044725|FG001|Overall Study|Protocol Violation|0|||
105832574|NCT00640926|365044726|FG002|Overall Study|Protocol Violation|2|||
105832575|NCT00640926|365044724|FG000|Overall Study|Lost to Follow-up|3|||
105832576|NCT00640926|365044725|FG001|Overall Study|Lost to Follow-up|1|||
105832577|NCT00640926|365044726|FG002|Overall Study|Lost to Follow-up|2|||
105832578|NCT00640926|365044724|FG000|Overall Study|Withdrawal by Subject|1|||
105832579|NCT00640926|365044725|FG001|Overall Study|Withdrawal by Subject|0|||
105832580|NCT00640926|365044726|FG002|Overall Study|Withdrawal by Subject|1|||
105832581|NCT04892147|365044730|FG000|Overall Study|Withdrawal by Subject|2|||
105832582|NCT04892147|365044731|FG001|Overall Study|Withdrawal by Subject|0|||
105832583|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
105832584|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
105832585|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
105832586|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
105832587|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
105832588|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
105832589|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
105832590|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
105832591|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
105832592|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
105832593|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
105832594|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
105832595|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
105832596|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
105832597|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
105832598|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
105832599|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
105832600|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
105832601|NCT01067521|365044733|FG000|Open-Label Period|Death|3|||
105832602|NCT01067521|365044734|FG001|Open-Label Period|Death|1|||
105832603|NCT01067521|365044733|FG000|Open-Label Period|Adverse Event|30|||
105832604|NCT01067521|365044734|FG001|Open-Label Period|Adverse Event|28|||
105832605|NCT01067521|365044733|FG000|Open-Label Period|Withdrawal by Subject|160|||
105832606|NCT01067521|365044734|FG001|Open-Label Period|Withdrawal by Subject|88|||
105832607|NCT01067521|365044733|FG000|Open-Label Period|Physician Decision|13|||
105832608|NCT01067521|365044734|FG001|Open-Label Period|Physician Decision|11|||
105832609|NCT01067521|365044733|FG000|Open-Label Period|Non-compliance with study drug|5|||
105832610|NCT01067521|365044734|FG001|Open-Label Period|Non-compliance with study drug|0|||
105832611|NCT01067521|365044733|FG000|Open-Label Period|Protocol Violation|3|||
105832612|NCT01067521|365044734|FG001|Open-Label Period|Protocol Violation|0|||
105832613|NCT01067521|365044733|FG000|Open-Label Period|Pregnancy|14|||
105832614|NCT01067521|365044734|FG001|Open-Label Period|Pregnancy|8|||
105832615|NCT01067521|365044733|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
105832616|NCT01067521|365044734|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
105832617|NCT01067521|365044733|FG000|Open-Label Period|Lost to Follow-up|21|||
105832618|NCT01067521|365044734|FG001|Open-Label Period|Lost to Follow-up|20|||
105832619|NCT01547728|365044738|FG000|Overall Study|Change in procedure and equipment|1|||
105832620|NCT01547728|365044738|FG000|Overall Study|Drug not ready for subject|1|||
105832621|NCT01547728|365044738|FG000|Overall Study|Screen failure|39|||
105309378|NCT03047330|363130900|FG000|Sleep Block 1|Withdrawal by Subject|3|||
105309379|NCT03493386|363130906|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105309380|NCT03493386|363130907|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
105309381|NCT03493386|363130908|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105309382|NCT03493386|363130909|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105309383|NCT03262038|363130915|FG000|Overall Study|Withdrawal by Subject|0|||
105309384|NCT03262038|363130916|FG001|Overall Study|Withdrawal by Subject|1|||
105309385|NCT01716715|363130918|FG000|Overall Study|Never Treated|2|||
105309386|NCT01716715|363130919|FG001|Overall Study|Never Treated|4|||
105309387|NCT01085734|363130920|FG000|Overall Study|Adverse Event|0|||
105832622|NCT03828539|365044739|FG000|Overall Study|Adverse Event|3|||
105309388|NCT01085734|363130921|FG001|Overall Study|Adverse Event|2|||
105309389|NCT01085734|363130920|FG000|Overall Study|Death|1|||
105832623|NCT03828539|365044740|FG001|Overall Study|Adverse Event|12|||
105832624|NCT03828539|365044739|FG000|Overall Study|Patient's/guardian's decision|3|||
105832625|NCT03828539|365044740|FG001|Overall Study|Patient's/guardian's decision|5|||
105832626|NCT03828539|365044739|FG000|Overall Study|Lost to Follow-up|4|||
105832627|NCT03828539|365044740|FG001|Overall Study|Lost to Follow-up|2|||
105309390|NCT01085734|363130921|FG001|Overall Study|Death|0|||
105309391|NCT01085734|363130920|FG000|Overall Study|Lost to Follow-up|0|||
105832628|NCT03828539|365044739|FG000|Overall Study|Protocol Violation|3|||
105832629|NCT03828539|365044740|FG001|Overall Study|Protocol Violation|2|||
105832630|NCT03828539|365044739|FG000|Overall Study|Withdrawal of informed consent|2|||
105832631|NCT03828539|365044740|FG001|Overall Study|Withdrawal of informed consent|1|||
105832632|NCT03828539|365044739|FG000|Overall Study|New therapy for study indication|1|||
105832633|NCT03828539|365044740|FG001|Overall Study|New therapy for study indication|0|||
105832634|NCT00057941|365044741|FG000|Overall Study|Death|1|||
105832635|NCT00057941|365044742|FG001|Overall Study|Death|2|||
105832636|NCT00057941|365044741|FG000|Overall Study|Adverse Event|7|||
105832637|NCT00057941|365044742|FG001|Overall Study|Adverse Event|9|||
105832638|NCT00057941|365044741|FG000|Overall Study|Lack of Efficacy|54|||
105832639|NCT00057941|365044742|FG001|Overall Study|Lack of Efficacy|53|||
105832640|NCT00057941|365044741|FG000|Overall Study|Withdrawal by Subject|6|||
105832641|NCT00057941|365044742|FG001|Overall Study|Withdrawal by Subject|1|||
105832642|NCT00057941|365044741|FG000|Overall Study|still on treatment|3|||
105832643|NCT00057941|365044742|FG001|Overall Study|still on treatment|1|||
105832644|NCT00057941|365044741|FG000|Overall Study|insurance, symptomatic deterioration|1|||
105832645|NCT00057941|365044742|FG001|Overall Study|insurance, symptomatic deterioration|3|||
105832646|NCT00057941|365044741|FG000|Overall Study|Ineligible|2|||
105832647|NCT00057941|365044742|FG001|Overall Study|Ineligible|5|||
105832648|NCT02616380|365044743|FG000|Overall Study|Lost to Follow-up|1|||
105832649|NCT02616380|365044743|FG000|Overall Study|Other|2|||
105832650|NCT02760433|365044744|FG000|Overall Study|Lost to Follow-up|1|||
105832651|NCT02760433|365044745|FG001|Overall Study|Lost to Follow-up|0|||
105832652|NCT02760433|365044746|FG002|Overall Study|Lost to Follow-up|1|||
105832653|NCT02760433|365044747|FG003|Overall Study|Lost to Follow-up|0|||
105832654|NCT02760433|365044748|FG004|Overall Study|Lost to Follow-up|0|||
105832655|NCT02760433|365044744|FG000|Overall Study|Withdrawal by Subject|23|||
105832656|NCT02760433|365044745|FG001|Overall Study|Withdrawal by Subject|9|||
105832657|NCT02760433|365044746|FG002|Overall Study|Withdrawal by Subject|0|||
105832658|NCT02760433|365044747|FG003|Overall Study|Withdrawal by Subject|2|||
105832659|NCT02760433|365044748|FG004|Overall Study|Withdrawal by Subject|9|||
105832660|NCT02760433|365044744|FG000|Overall Study|Lack of Response At Week 14|0|||
105832661|NCT02760433|365044745|FG001|Overall Study|Lack of Response At Week 14|0|||
105832662|NCT02760433|365044746|FG002|Overall Study|Lack of Response At Week 14|0|||
105832663|NCT02760433|365044747|FG003|Overall Study|Lack of Response At Week 14|0|||
105832664|NCT02760433|365044748|FG004|Overall Study|Lack of Response At Week 14|1|||
105832665|NCT02760433|365044744|FG000|Overall Study|Subject refused to continue the study|1|||
105832666|NCT02760433|365044745|FG001|Overall Study|Subject refused to continue the study|0|||
105832667|NCT02760433|365044746|FG002|Overall Study|Subject refused to continue the study|0|||
105832668|NCT02760433|365044747|FG003|Overall Study|Subject refused to continue the study|0|||
105832669|NCT02760433|365044748|FG004|Overall Study|Subject refused to continue the study|0|||
105832670|NCT02760433|365044744|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
105832671|NCT02760433|365044745|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
105832672|NCT02760433|365044746|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
105832673|NCT02760433|365044747|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
105832674|NCT02760433|365044748|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
105832675|NCT02760433|365044744|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
105832676|NCT02760433|365044745|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
105832677|NCT02760433|365044746|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
105832678|NCT02760433|365044747|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
105309392|NCT01085734|363130921|FG001|Overall Study|Lost to Follow-up|1|||
105309393|NCT01085734|363130920|FG000|Overall Study|Withdrawal by Subject|0|||
105309394|NCT01085734|363130921|FG001|Overall Study|Withdrawal by Subject|1|||
105309395|NCT03678285|363130922|FG000|Overall Study|Adverse Event|2|||
105832679|NCT02760433|365044748|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
105832680|NCT00766493|365044749|FG000|30 Days Post-Procedure|Discontinued|7|||
105832681|NCT00766493|365044749|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
105832682|NCT00766493|365044749|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
105832683|NCT03407729|365044750|FG000|Overall Study|Lost to Follow-up|2|||
105832684|NCT03407729|365044751|FG001|Overall Study|Lost to Follow-up|0|||
105832685|NCT03407729|365044750|FG000|Overall Study|Unable to schedule|0|||
105832686|NCT03407729|365044751|FG001|Overall Study|Unable to schedule|3|||
105832687|NCT02914457|365044754|FG000|Overall Study|Withdrawal by Subject|1|||
105832688|NCT02914457|365044754|FG000|Overall Study|Physician Decision|1|||
105832689|NCT02914457|365044754|FG000|Overall Study|No veins available for lead placement|1|||
105832690|NCT02914457|365044754|FG000|Overall Study|Electrical instability of patient|1|||
105832691|NCT02914457|365044754|FG000|Overall Study|ECG acquisition error due to sweating|1|||
105309396|NCT03678285|363130922|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
105832692|NCT02914457|365044754|FG000|Overall Study|Protocol Violation|1|||
105309397|NCT03678285|363130922|FG000|Overall Study|Dehydrated prior to start of workout|1|||
105832693|NCT02943096|365044755|FG000|Overall Study|Lack of Efficacy|0|||
105832694|NCT02943096|365044756|FG001|Overall Study|Lack of Efficacy|1|||
105832695|NCT04142658|365044757|FG000|Overall Study|Death|2|||
105832696|NCT04142658|365044758|FG001|Overall Study|Death|1|||
105832697|NCT04142658|365044757|FG000|Overall Study|Lost to Follow-up|4|||
105832698|NCT04142658|365044758|FG001|Overall Study|Lost to Follow-up|13|||
105832699|NCT04142658|365044757|FG000|Overall Study|Withdrawal by Subject|9|||
105832700|NCT04142658|365044758|FG001|Overall Study|Withdrawal by Subject|16|||
105832701|NCT03950674|365044759|FG000|Overall Study|Death|16|||
105832702|NCT03950674|365044760|FG001|Overall Study|Death|15|||
105832703|NCT03950674|365044759|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
105832704|NCT03950674|365044760|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
105832705|NCT02174276|365044761|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
105832706|NCT02174276|365044762|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
105832707|NCT02174276|365044763|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
105832708|NCT02174276|365044764|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
105832709|NCT02174276|365044761|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
105832710|NCT02174276|365044762|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
105832711|NCT02174276|365044763|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
105832712|NCT02174276|365044764|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
105832713|NCT02174276|365044761|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
105832714|NCT02174276|365044762|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
105832715|NCT02174276|365044763|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
105832716|NCT02174276|365044764|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
105832717|NCT02174276|365044761|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
105832718|NCT02174276|365044762|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
105832719|NCT02174276|365044763|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
105832720|NCT02174276|365044764|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
105832721|NCT02174276|365044761|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
105832722|NCT02174276|365044762|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
105832723|NCT02174276|365044763|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
105832724|NCT02174276|365044764|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
105832725|NCT02174276|365044761|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
105832726|NCT02174276|365044762|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
105832727|NCT02174276|365044763|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
105832728|NCT02174276|365044764|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
105832729|NCT02119936|365044767|FG000|Overall Study|Lost to Follow-up|10|||
105832730|NCT00570128|365044768|FG000|Overall Study|Adverse Event|1|||
105832731|NCT00570128|365044769|FG001|Overall Study|Adverse Event|0|||
105832732|NCT00570128|365044768|FG000|Overall Study|Lost to Follow-up|1|||
105832733|NCT00570128|365044769|FG001|Overall Study|Lost to Follow-up|0|||
105832734|NCT00570128|365044768|FG000|Overall Study|Withdrawal by Subject|2|||
105832735|NCT00570128|365044769|FG001|Overall Study|Withdrawal by Subject|0|||
105832736|NCT00609154|365044770|FG000|Overall Study|Protocol Violation|1|||
105832737|NCT00609154|365044771|FG001|Overall Study|Protocol Violation|2|||
105832738|NCT00609154|365044770|FG000|Overall Study|Unable to establish IV access|0|||
105832739|NCT00609154|365044771|FG001|Overall Study|Unable to establish IV access|4|||
105832740|NCT00609154|365044770|FG000|Overall Study|Adverse Event|0|||
105832741|NCT00609154|365044771|FG001|Overall Study|Adverse Event|2|||
105832742|NCT01898598|365044772|FG000|Overall Study|Adverse Event|1|||
105832743|NCT01898598|365044773|FG001|Overall Study|Adverse Event|0|||
105832744|NCT01898598|365044772|FG000|Overall Study|Withdrawal by Subject|3|||
105832745|NCT01898598|365044773|FG001|Overall Study|Withdrawal by Subject|0|||
105832746|NCT01898598|365044772|FG000|Overall Study|Lost to Follow-up|0|||
105832747|NCT01898598|365044773|FG001|Overall Study|Lost to Follow-up|1|||
105832748|NCT01898598|365044772|FG000|Overall Study|Other|0|||
105832749|NCT01898598|365044773|FG001|Overall Study|Other|1|||
105309398|NCT03247816|363130925|FG000|Overall Study|Adverse Event|12|||
105832750|NCT01499160|365044776|FG000|Overall Study|Adverse Event|1|||
105832751|NCT01499160|365044776|FG000|Overall Study|Withdrawal by Subject|1|||
105832752|NCT03868631|365044781|FG000|Baseline to Week 6|Adverse Event|0|||
105832753|NCT03868631|365044782|FG001|Baseline to Week 6|Adverse Event|3|||
105832754|NCT03868631|365044781|FG000|Baseline to Week 6|Protocol Violation|1|||
105832755|NCT03868631|365044782|FG001|Baseline to Week 6|Protocol Violation|1|||
105832756|NCT03868631|365044781|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
105832757|NCT03868631|365044782|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
105832758|NCT03868631|365044781|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
105832759|NCT03868631|365044782|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
105832760|NCT03868631|365044781|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
105832761|NCT03868631|365044782|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
105832762|NCT03868631|365044781|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
105832763|NCT03868631|365044782|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
105832764|NCT03448692|365044783|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
105832765|NCT03448692|365044784|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
105832766|NCT03448692|365044783|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
105832767|NCT03448692|365044784|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
105832768|NCT03448692|365044783|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
105832769|NCT03448692|365044784|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
105832770|NCT03448692|365044783|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
105832771|NCT03448692|365044784|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
105832772|NCT03448692|365044783|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
105832773|NCT03448692|365044784|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
105832774|NCT01077258|365044786|FG000|Overall Study|Lost to Follow-up|1390|||
105832775|NCT01077258|365044786|FG000|Overall Study|Adverse drug reaction|218|||
105832776|NCT01077258|365044786|FG000|Overall Study|Lack of Efficacy|663|||
105832777|NCT01077258|365044786|FG000|Overall Study|Clinical remission|37|||
105832778|NCT01077258|365044786|FG000|Overall Study|Other reasons|260|||
105832779|NCT00726895|365044790|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
105832780|NCT00726895|365044791|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105832781|NCT04194008|365044796|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
105832782|NCT04194008|365044796|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
105832783|NCT04194008|365044796|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
105832784|NCT04194008|365044796|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
105832785|NCT04194008|365044796|FG000|Treatment Phase With Nerivio|Missing data|4|||
105832786|NCT04194008|365044796|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
105832787|NCT01785615|365044797|FG000|Dietary Phase|Lost to Follow-up|0|||
105832788|NCT01785615|365044798|FG001|Dietary Phase|Lost to Follow-up|0|||
105832789|NCT01785615|365044799|FG002|Dietary Phase|Lost to Follow-up|0|||
105832790|NCT01785615|365044800|FG003|Dietary Phase|Lost to Follow-up|24|||
105832791|NCT00982228|365044803|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
105832792|NCT00982228|365044804|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
105832793|NCT00982228|365044803|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
105832794|NCT00982228|365044804|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
105832795|NCT00982228|365044803|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
105832796|NCT00982228|365044804|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
105832797|NCT00982228|365044803|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
105832798|NCT00982228|365044804|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
105832799|NCT00982228|365044803|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
105832800|NCT00982228|365044804|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
105832801|NCT00982228|365044803|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
105832802|NCT00982228|365044804|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
105832803|NCT00982228|365044803|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
105832804|NCT00982228|365044804|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
105832805|NCT00982228|365044803|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
105832806|NCT00982228|365044804|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
105832807|NCT00982228|365044803|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
105832808|NCT00982228|365044804|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
105832809|NCT00982228|365044803|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
105832810|NCT00982228|365044804|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
105832811|NCT01929681|365044805|FG000|Overall Study|Withdrawal by Subject|1|||
105832812|NCT01929681|365044806|FG001|Overall Study|Withdrawal by Subject|0|||
105832813|NCT01929681|365044805|FG000|Overall Study|Physician Decision|1|||
105832814|NCT01929681|365044806|FG001|Overall Study|Physician Decision|1|||
105832815|NCT02218216|365044807|FG000|Overall Study|Study terminated before completed|6|||
105832816|NCT02218216|365044808|FG001|Overall Study|Study terminated before completed|0|||
105832817|NCT02218216|365044809|FG002|Overall Study|Study terminated before completed|0|||
105832818|NCT01596127|365044810|FG000|Overall Study|Patient Ineligible|1|||
105832819|NCT00772148|365044812|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
105832820|NCT00772148|365044813|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
105832821|NCT00772148|365044812|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
105832822|NCT00772148|365044813|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
105832823|NCT00772148|365044812|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
105309399|NCT03247816|363130925|FG000|Overall Study|Physician Decision|3|||
105309400|NCT03247816|363130925|FG000|Overall Study|Lack of Efficacy|1|||
105309401|NCT03247816|363130925|FG000|Overall Study|Lost to Follow-up|10|||
105309402|NCT03247816|363130925|FG000|Overall Study|Missing Feraccru stop date|3|||
105309403|NCT00867503|363130928|FG000|Overall Study|Withdrawal by Subject|1|||
105309404|NCT01442688|363130929|FG000|First Intervention|Withdrawal by Subject|1|||
105309405|NCT01442688|363130930|FG001|First Intervention|Withdrawal by Subject|0|||
105309406|NCT01442688|363130929|FG000|First Intervention|subject incarcerated|1|||
105309407|NCT01442688|363130930|FG001|First Intervention|subject incarcerated|0|||
105832824|NCT00772148|365044813|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
105832825|NCT00772148|365044812|FG000|Maintenance Phase (Week 52)|Death|2|||
105832826|NCT00772148|365044813|FG001|Maintenance Phase (Week 52)|Death|2|||
105832827|NCT00772148|365044812|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
105832828|NCT00772148|365044813|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
105832829|NCT00772148|365044812|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
105832830|NCT00772148|365044813|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
105832831|NCT00772148|365044812|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
105832832|NCT00772148|365044813|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
105832833|NCT01562613|365044814|FG000|Overall Study|Lost to Follow-up|2|||
105832834|NCT01562613|365044814|FG000|Overall Study|Withdrawal by Subject|2|||
105832835|NCT00633022|365044815|FG000|Overall Study|Adverse Event|1|||
105832836|NCT00633022|365044816|FG001|Overall Study|Adverse Event|0|||
105832837|NCT00633022|365044817|FG002|Overall Study|Adverse Event|5|||
105832838|NCT00633022|365044815|FG000|Overall Study|Physician Decision|0|||
105832839|NCT00633022|365044816|FG001|Overall Study|Physician Decision|1|||
105832840|NCT00633022|365044817|FG002|Overall Study|Physician Decision|0|||
105832841|NCT03573336|365044819|FG000|Overall Study|Study terminated|2|||
105832842|NCT03573336|365044820|FG001|Overall Study|Study terminated|4|||
105832843|NCT03573336|365044821|FG002|Overall Study|Study terminated|2|||
105832844|NCT01525628|365044822|FG000|Overall Study|Adverse Event|1|||
105832845|NCT01525628|365044823|FG001|Overall Study|Adverse Event|1|||
105832846|NCT01525628|365044824|FG002|Overall Study|Adverse Event|2|||
105832847|NCT01525628|365044825|FG003|Overall Study|Adverse Event|0|||
105832848|NCT01525628|365044826|FG004|Overall Study|Adverse Event|1|||
105832849|NCT01525628|365044822|FG000|Overall Study|Lack of Efficacy|0|||
105832850|NCT01525628|365044823|FG001|Overall Study|Lack of Efficacy|2|||
105832851|NCT01525628|365044824|FG002|Overall Study|Lack of Efficacy|2|||
105832852|NCT01525628|365044825|FG003|Overall Study|Lack of Efficacy|1|||
105832853|NCT01525628|365044826|FG004|Overall Study|Lack of Efficacy|2|||
105832854|NCT01525628|365044822|FG000|Overall Study|Protocol Violation|0|||
105832855|NCT01525628|365044823|FG001|Overall Study|Protocol Violation|0|||
105832856|NCT01525628|365044824|FG002|Overall Study|Protocol Violation|1|||
105832857|NCT01525628|365044825|FG003|Overall Study|Protocol Violation|0|||
105832858|NCT01525628|365044826|FG004|Overall Study|Protocol Violation|0|||
105832859|NCT01525628|365044822|FG000|Overall Study|Lost to Follow-up|1|||
105832860|NCT01525628|365044823|FG001|Overall Study|Lost to Follow-up|1|||
105832861|NCT01525628|365044824|FG002|Overall Study|Lost to Follow-up|0|||
105832862|NCT01525628|365044825|FG003|Overall Study|Lost to Follow-up|0|||
105832863|NCT01525628|365044826|FG004|Overall Study|Lost to Follow-up|0|||
105832864|NCT01525628|365044822|FG000|Overall Study|Withdrawal by Subject|0|||
105832865|NCT01525628|365044823|FG001|Overall Study|Withdrawal by Subject|1|||
105832866|NCT01525628|365044824|FG002|Overall Study|Withdrawal by Subject|0|||
105832867|NCT01525628|365044825|FG003|Overall Study|Withdrawal by Subject|0|||
105832868|NCT01525628|365044826|FG004|Overall Study|Withdrawal by Subject|0|||
105832869|NCT01525628|365044822|FG000|Overall Study|Other reason not defined above|0|||
105832870|NCT01525628|365044823|FG001|Overall Study|Other reason not defined above|0|||
105832871|NCT01525628|365044824|FG002|Overall Study|Other reason not defined above|0|||
105832872|NCT01525628|365044825|FG003|Overall Study|Other reason not defined above|3|||
105832873|NCT01525628|365044826|FG004|Overall Study|Other reason not defined above|0|||
105832874|NCT02614898|365044827|FG000|Overall Study|Participated until study termination|10|||
105832875|NCT02614898|365044828|FG001|Overall Study|Participated until study termination|26|||
105832876|NCT02614898|365044827|FG000|Overall Study|Lost to Follow-up|0|||
105832877|NCT02614898|365044828|FG001|Overall Study|Lost to Follow-up|2|||
105832878|NCT02614898|365044827|FG000|Overall Study|Physician Decision|1|||
105832879|NCT02614898|365044828|FG001|Overall Study|Physician Decision|8|||
105832880|NCT02614898|365044827|FG000|Overall Study|Study Terminated by Sponsor|3|||
105832881|NCT02614898|365044828|FG001|Overall Study|Study Terminated by Sponsor|0|||
105832882|NCT02614898|365044827|FG000|Overall Study|Withdrawal by Subject|0|||
105832883|NCT02614898|365044828|FG001|Overall Study|Withdrawal by Subject|2|||
105832884|NCT02614898|365044827|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105832885|NCT02614898|365044828|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
105832886|NCT02614898|365044827|FG000|Overall Study|Other-Additional Information Unavailable|0|||
105832887|NCT02614898|365044828|FG001|Overall Study|Other-Additional Information Unavailable|11|||
105832888|NCT02614898|365044827|FG000|Overall Study|Missing|0|||
105832889|NCT02614898|365044828|FG001|Overall Study|Missing|1|||
105832890|NCT00239005|365044829|FG000|Overall Study|Adverse Event|6|||
105832891|NCT00239005|365044830|FG001|Overall Study|Adverse Event|6|||
105832892|NCT00239005|365044829|FG000|Overall Study|Withdrawal by Subject|3|||
105832893|NCT00239005|365044830|FG001|Overall Study|Withdrawal by Subject|4|||
105309408|NCT01442688|363130929|FG000|Second Intervention|Adverse Event|1|||
105309409|NCT01442688|363130930|FG001|Second Intervention|Adverse Event|0|||
105309410|NCT02677714|363130931|FG000|Overall Study|Withdrawal by Subject|2|||
105832894|NCT00239005|365044829|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
105309411|NCT02677714|363130932|FG001|Overall Study|Withdrawal by Subject|0|||
105309412|NCT02643355|363130933|FG000|Overall Study|Withdrawal by Subject|1|||
105309413|NCT02643355|363130934|FG001|Overall Study|Withdrawal by Subject|3|||
105309414|NCT02643355|363130933|FG000|Overall Study|Protocol Violation|0|||
105309415|NCT02643355|363130934|FG001|Overall Study|Protocol Violation|2|||
105309416|NCT03464630|363130935|FG000|Overall Study|Lost to Follow-up|62|||
105309417|NCT03464630|363130936|FG001|Overall Study|Lost to Follow-up|52|||
105309418|NCT03464630|363130935|FG000|Overall Study|Withdrawal by Subject|16|||
105309419|NCT03464630|363130936|FG001|Overall Study|Withdrawal by Subject|10|||
105309420|NCT03464630|363130935|FG000|Overall Study|Passive Disengagement|8|||
105309421|NCT03464630|363130936|FG001|Overall Study|Passive Disengagement|4|||
105309422|NCT00191165|363130937|FG000|Overall Study|Adverse Event|2|||
105309423|NCT00191165|363130938|FG001|Overall Study|Adverse Event|0|||
105309424|NCT00191165|363130937|FG000|Overall Study|Protocol Violation|0|||
105309425|NCT00191165|363130938|FG001|Overall Study|Protocol Violation|1|||
105309426|NCT00191165|363130937|FG000|Overall Study|Participant Moved Away|0|||
105309427|NCT00191165|363130938|FG001|Overall Study|Participant Moved Away|1|||
105309428|NCT04480710|363130947|FG000|Overall Study|Adverse Event|0|||
105309429|NCT04480710|363130948|FG001|Overall Study|Adverse Event|2|||
105309430|NCT04480710|363130949|FG002|Overall Study|Adverse Event|0|||
105309431|NCT04480710|363130950|FG003|Overall Study|Adverse Event|0|||
105309432|NCT04480710|363130947|FG000|Overall Study|Withdrawal by Subject|0|||
105309433|NCT04480710|363130948|FG001|Overall Study|Withdrawal by Subject|1|||
105309434|NCT04480710|363130949|FG002|Overall Study|Withdrawal by Subject|0|||
105309435|NCT04480710|363130950|FG003|Overall Study|Withdrawal by Subject|0|||
105309436|NCT04480710|363130947|FG000|Overall Study|Physician Decision|0|||
105309437|NCT04480710|363130948|FG001|Overall Study|Physician Decision|0|||
105309438|NCT04480710|363130949|FG002|Overall Study|Physician Decision|1|||
105309439|NCT04480710|363130950|FG003|Overall Study|Physician Decision|0|||
105309440|NCT00468650|363130952|FG000|Overall Study|Lost to Follow-up|4|||
105309441|NCT00468650|363130952|FG000|Overall Study|Withdrawal by Subject|2|||
105309442|NCT00468650|363130952|FG000|Overall Study|Protocol Violation|1|||
105309443|NCT05119569|363130953|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
105309444|NCT05119569|363130954|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
105366841|NCT01791595|363350076|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
105366842|NCT01791595|363350077|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
105366843|NCT01791595|363350078|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
105366844|NCT01791595|363350079|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
105366845|NCT01791595|363350080|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
105366846|NCT01791595|363350074|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
105366847|NCT01791595|363350075|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
105366848|NCT01791595|363350076|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
105366849|NCT01791595|363350077|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
105366850|NCT01791595|363350078|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
105366851|NCT01791595|363350079|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
105366852|NCT01791595|363350080|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
105366853|NCT01791595|363350074|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
105366854|NCT01791595|363350075|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
105366855|NCT01791595|363350076|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
105366856|NCT01791595|363350077|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
105366857|NCT01791595|363350078|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
105366858|NCT01791595|363350079|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
105366859|NCT01791595|363350080|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
105366860|NCT01791595|363350074|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
105366861|NCT01791595|363350075|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
105366862|NCT01791595|363350076|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
105366863|NCT01791595|363350077|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
105366864|NCT01791595|363350078|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
105366865|NCT01791595|363350079|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
105366866|NCT01791595|363350080|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
105366867|NCT01791595|363350074|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
105366868|NCT01791595|363350075|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
105366869|NCT01791595|363350076|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
105366870|NCT01791595|363350077|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
105366871|NCT01791595|363350078|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
105366872|NCT01791595|363350079|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
105366873|NCT01791595|363350080|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
105366874|NCT01791595|363350074|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
105366875|NCT01791595|363350075|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
105366876|NCT01791595|363350076|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
105489447|NCT02310321|363804051|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|3|||
105309445|NCT05119569|363130955|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
105309446|NCT05119569|363130956|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
105309447|NCT05119569|363130953|FG000|Double Blind Treatment Phase|Adverse Event|6|||
105309448|NCT05119569|363130954|FG001|Double Blind Treatment Phase|Adverse Event|0|||
105832895|NCT00239005|365044830|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
105832896|NCT00239005|365044829|FG000|Overall Study|Protocol Violation|1|||
105832897|NCT00239005|365044830|FG001|Overall Study|Protocol Violation|0|||
105832898|NCT00239005|365044829|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
105832899|NCT00239005|365044830|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
105832900|NCT00239005|365044829|FG000|Overall Study|Lost to Follow-up|0|||
105832901|NCT00239005|365044830|FG001|Overall Study|Lost to Follow-up|1|||
105832902|NCT03382041|365044831|FG000|Overall Study|Consent Form Lost|2|||
105832903|NCT03382041|365044832|FG001|Overall Study|Consent Form Lost|1|||
105832904|NCT03382041|365044831|FG000|Overall Study|Withdrawal by Subject|1|||
105832905|NCT03382041|365044832|FG001|Overall Study|Withdrawal by Subject|4|||
105832906|NCT03382041|365044831|FG000|Overall Study|Lost to Follow-up|1|||
105832907|NCT03382041|365044832|FG001|Overall Study|Lost to Follow-up|4|||
105832908|NCT00787605|365044833|FG000|Overall Study|Administrative Problems|3|||
105832909|NCT00787605|365044834|FG001|Overall Study|Administrative Problems|0|||
105832910|NCT00787605|365044833|FG000|Overall Study|Adverse Event|14|||
105832911|NCT00787605|365044834|FG001|Overall Study|Adverse Event|25|||
105832912|NCT00787605|365044833|FG000|Overall Study|Lost to Follow-up|3|||
105832913|NCT00787605|365044834|FG001|Overall Study|Lost to Follow-up|6|||
105832914|NCT00787605|365044833|FG000|Overall Study|Protocol Violation|7|||
105832915|NCT00787605|365044834|FG001|Overall Study|Protocol Violation|3|||
105832916|NCT00787605|365044833|FG000|Overall Study|Withdrawal by Subject|6|||
105832917|NCT00787605|365044834|FG001|Overall Study|Withdrawal by Subject|13|||
105832918|NCT00787605|365044833|FG000|Overall Study|Lack of Efficacy|13|||
105832919|NCT00787605|365044834|FG001|Overall Study|Lack of Efficacy|9|||
105832920|NCT04640194|365044840|FG000|Overall Study|Adverse Event|3|||
105832921|NCT04640194|365044841|FG001|Overall Study|Adverse Event|7|||
105832922|NCT04640194|365044842|FG002|Overall Study|Adverse Event|0|||
105832923|NCT04640194|365044843|FG003|Overall Study|Adverse Event|5|||
105309449|NCT05119569|363130955|FG002|Double Blind Treatment Phase|Adverse Event|0|||
105309450|NCT05119569|363130956|FG003|Double Blind Treatment Phase|Adverse Event|0|||
105309451|NCT05119569|363130953|FG000|Open Label Extension Phase|Ongoing in the study|0|||
105309452|NCT05119569|363130954|FG001|Open Label Extension Phase|Ongoing in the study|0|||
105309453|NCT05119569|363130955|FG002|Open Label Extension Phase|Ongoing in the study|65|||
105309454|NCT05119569|363130956|FG003|Open Label Extension Phase|Ongoing in the study|34|||
105309455|NCT00426361|363130957|FG000|Overall Study|Lost to Follow-up|3|||
105366877|NCT01791595|363350077|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
105366878|NCT01791595|363350078|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
105366879|NCT01791595|363350079|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
105366880|NCT01791595|363350080|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
105366881|NCT01791595|363350074|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
105366882|NCT01791595|363350075|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
105366883|NCT01791595|363350076|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
105366884|NCT01791595|363350077|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
105366885|NCT01791595|363350078|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
105366886|NCT01791595|363350079|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
105366887|NCT01791595|363350080|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
105366888|NCT01791595|363350074|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
105366889|NCT01791595|363350075|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
105366890|NCT01791595|363350076|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
105366891|NCT01791595|363350077|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
105366892|NCT01791595|363350078|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
105366893|NCT01791595|363350079|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
105366894|NCT01791595|363350080|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
105366895|NCT01791595|363350074|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
105366896|NCT01791595|363350075|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
105366897|NCT01791595|363350076|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
105366898|NCT01791595|363350077|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
105366899|NCT01791595|363350078|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
105366900|NCT01791595|363350079|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
105489448|NCT02310321|363804049|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
105489449|NCT02310321|363804050|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
105489450|NCT02310321|363804051|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|3|||
105832924|NCT04640194|365044844|FG004|Overall Study|Adverse Event|0|||
105832925|NCT04640194|365044845|FG005|Overall Study|Adverse Event|4|||
105309456|NCT00426361|363130958|FG001|Overall Study|Lost to Follow-up|2|||
105489451|NCT02310321|363804049|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
105489452|NCT02310321|363804050|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
105832926|NCT04640194|365044846|FG006|Overall Study|Adverse Event|0|||
105832927|NCT04640194|365044840|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
105832928|NCT04640194|365044841|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
105832929|NCT04640194|365044842|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
105832930|NCT04640194|365044843|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
105832931|NCT04640194|365044844|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
105832932|NCT04640194|365044845|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
105832933|NCT04640194|365044846|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
105832934|NCT04640194|365044840|FG000|Overall Study|fibrinogen level too low|0|||
105489453|NCT02310321|363804051|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|26|||
105489454|NCT02310321|363804049|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
105489455|NCT02310321|363804050|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
105489456|NCT02310321|363804051|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|1|||
105489457|NCT02310321|363804049|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
105489458|NCT02310321|363804050|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
105489459|NCT02310321|363804051|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|1|||
105489460|NCT01222403|363804052|FG000|Overall Study|Inappropriate enrollment|0|||
105489461|NCT01222403|363804053|FG001|Overall Study|Inappropriate enrollment|2|||
105489462|NCT01262352|363804054|FG000|Period 1|Illness after randomization|1|||
105489463|NCT01262352|363804055|FG001|Period 1|Illness after randomization|0|||
105489464|NCT01262352|363804054|FG000|Washout|Adverse Event|1|||
105489465|NCT01262352|363804055|FG001|Washout|Adverse Event|1|||
105489466|NCT01262352|363804054|FG000|Washout|Extended Washout|0|||
105489467|NCT01262352|363804055|FG001|Washout|Extended Washout|1|||
105309457|NCT00426361|363130959|FG002|Overall Study|Lost to Follow-up|5|||
105309458|NCT00426361|363130957|FG000|Overall Study|Withdrawal by Subject|1|||
105309459|NCT00426361|363130958|FG001|Overall Study|Withdrawal by Subject|3|||
105309460|NCT00426361|363130959|FG002|Overall Study|Withdrawal by Subject|0|||
105309461|NCT01458106|363130960|FG000|Overall Study|Withdrawal by Subject|2|||
105309462|NCT01458106|363130961|FG001|Overall Study|Withdrawal by Subject|0|||
105309463|NCT01458106|363130960|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
105309464|NCT01458106|363130961|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
105309465|NCT01458106|363130960|FG000|Overall Study|Withdrawn Per Protocol|0|||
105309466|NCT01458106|363130961|FG001|Overall Study|Withdrawn Per Protocol|1|||
105309467|NCT02132754|363130962|FG000|Overall Study|Adverse Event|0|||
105309468|NCT02132754|363130963|FG001|Overall Study|Adverse Event|0|||
105309469|NCT02132754|363130964|FG002|Overall Study|Adverse Event|0|||
105309470|NCT02132754|363130965|FG003|Overall Study|Adverse Event|0|||
105309471|NCT02132754|363130966|FG004|Overall Study|Adverse Event|0|||
105309472|NCT02132754|363130967|FG005|Overall Study|Adverse Event|0|||
105309473|NCT02132754|363130968|FG006|Overall Study|Adverse Event|0|||
105309474|NCT02132754|363130969|FG007|Overall Study|Adverse Event|0|||
105309475|NCT02132754|363130970|FG008|Overall Study|Adverse Event|0|||
105309476|NCT02132754|363130971|FG009|Overall Study|Adverse Event|0|||
105309477|NCT02132754|363130972|FG010|Overall Study|Adverse Event|0|||
105309478|NCT02132754|363130973|FG011|Overall Study|Adverse Event|0|||
105309479|NCT02132754|363130974|FG012|Overall Study|Adverse Event|0|||
105309480|NCT02132754|363130975|FG013|Overall Study|Adverse Event|0|||
105309481|NCT02132754|363130976|FG014|Overall Study|Adverse Event|0|||
105309482|NCT02132754|363130977|FG015|Overall Study|Adverse Event|0|||
105309483|NCT02132754|363130978|FG016|Overall Study|Adverse Event|0|||
105309484|NCT02132754|363130979|FG017|Overall Study|Adverse Event|1|||
105309485|NCT02132754|363130980|FG018|Overall Study|Adverse Event|0|||
105309486|NCT02132754|363130981|FG019|Overall Study|Adverse Event|0|||
105309487|NCT02132754|363130982|FG020|Overall Study|Adverse Event|0|||
105309488|NCT02132754|363130983|FG021|Overall Study|Adverse Event|0|||
105309489|NCT02132754|363130984|FG022|Overall Study|Adverse Event|0|||
105309490|NCT02132754|363130985|FG023|Overall Study|Adverse Event|0|||
105309491|NCT02132754|363130986|FG024|Overall Study|Adverse Event|0|||
105309492|NCT02132754|363130987|FG025|Overall Study|Adverse Event|1|||
105309493|NCT02132754|363130988|FG026|Overall Study|Adverse Event|1|||
105309494|NCT02132754|363130989|FG027|Overall Study|Adverse Event|0|||
105309495|NCT02132754|363130990|FG028|Overall Study|Adverse Event|0|||
105309496|NCT02132754|363130991|FG029|Overall Study|Adverse Event|0|||
105309497|NCT02132754|363130992|FG030|Overall Study|Adverse Event|1|||
105309498|NCT02132754|363130993|FG031|Overall Study|Adverse Event|0|||
105309499|NCT02132754|363130994|FG032|Overall Study|Adverse Event|1|||
105309500|NCT02132754|363130995|FG033|Overall Study|Adverse Event|1|||
105309501|NCT02132754|363130962|FG000|Overall Study|Clinical Progression|0|||
105309502|NCT02132754|363130963|FG001|Overall Study|Clinical Progression|0|||
105309503|NCT02132754|363130964|FG002|Overall Study|Clinical Progression|0|||
105309504|NCT02132754|363130965|FG003|Overall Study|Clinical Progression|0|||
105309505|NCT02132754|363130966|FG004|Overall Study|Clinical Progression|0|||
105309506|NCT02132754|363130967|FG005|Overall Study|Clinical Progression|0|||
105309507|NCT02132754|363130968|FG006|Overall Study|Clinical Progression|0|||
105309508|NCT02132754|363130969|FG007|Overall Study|Clinical Progression|0|||
105309509|NCT02132754|363130970|FG008|Overall Study|Clinical Progression|0|||
105309510|NCT02132754|363130971|FG009|Overall Study|Clinical Progression|1|||
105309511|NCT02132754|363130972|FG010|Overall Study|Clinical Progression|0|||
105309512|NCT02132754|363130973|FG011|Overall Study|Clinical Progression|0|||
105309513|NCT02132754|363130974|FG012|Overall Study|Clinical Progression|0|||
105489468|NCT00064298|363804056|FG000|Overall Study|Withdrawal by Subject|2|||
105489469|NCT00064298|363804057|FG001|Overall Study|Withdrawal by Subject|1|||
105489470|NCT00064298|363804056|FG000|Overall Study|Lost to Follow-up|2|||
105489471|NCT00064298|363804057|FG001|Overall Study|Lost to Follow-up|2|||
105489472|NCT00064298|363804056|FG000|Overall Study|Death|0|||
105489473|NCT00064298|363804057|FG001|Overall Study|Death|1|||
105489474|NCT00064298|363804056|FG000|Overall Study|Disease Progression|2|||
105489475|NCT00064298|363804057|FG001|Overall Study|Disease Progression|1|||
105489476|NCT03614975|363804058|FG000|Overall Study|Physician Decision|7|||
105489477|NCT03614975|363804059|FG001|Overall Study|Physician Decision|5|||
105489478|NCT03614975|363804058|FG000|Overall Study|Withdrawal by Subject|2|||
105489479|NCT03614975|363804059|FG001|Overall Study|Withdrawal by Subject|2|||
105489480|NCT03614975|363804058|FG000|Overall Study|Specimens not in lab batch shipment|1|||
105575843|NCT04467840|364108340|FG001|Overall Study|Lost to Follow-up|3|||
105575844|NCT04467840|364108339|FG000|Overall Study|Physician Decision|1|||
105575845|NCT04467840|364108340|FG001|Overall Study|Physician Decision|0|||
105575846|NCT04467840|364108339|FG000|Overall Study|Other|1|||
105575847|NCT04467840|364108340|FG001|Overall Study|Other|5|||
105575848|NCT04467840|364108339|FG000|Overall Study|Missing study completion status|3|||
105575849|NCT04467840|364108340|FG001|Overall Study|Missing study completion status|1|||
105575850|NCT02226172|364108341|FG000|Overall Study|Participant refused further follow-up|4|||
105575851|NCT02226172|364108341|FG000|Overall Study|Other|5|||
105575852|NCT02226172|364108341|FG000|Overall Study|Death|1|||
105575853|NCT02226172|364108341|FG000|Overall Study|Study terminated by sponsor|1|||
105575854|NCT02226172|364108341|FG000|Overall Study|Adverse Event|6|||
105575855|NCT01865617|364108342|FG000|Overall Study|Death|27|||
105575856|NCT01865617|364108343|FG001|Overall Study|Death|3|||
105832935|NCT04640194|365044841|FG001|Overall Study|fibrinogen level too low|0|||
105309514|NCT02132754|363130975|FG013|Overall Study|Clinical Progression|0|||
105309515|NCT02132754|363130976|FG014|Overall Study|Clinical Progression|0|||
105489481|NCT03614975|363804059|FG001|Overall Study|Specimens not in lab batch shipment|1|||
105832936|NCT04640194|365044842|FG002|Overall Study|fibrinogen level too low|0|||
105832937|NCT04640194|365044843|FG003|Overall Study|fibrinogen level too low|1|||
105832938|NCT04640194|365044844|FG004|Overall Study|fibrinogen level too low|0|||
105832939|NCT04640194|365044845|FG005|Overall Study|fibrinogen level too low|0|||
105832940|NCT04640194|365044846|FG006|Overall Study|fibrinogen level too low|0|||
105832941|NCT04640194|365044840|FG000|Overall Study|mild bleeding|0|||
105832942|NCT04640194|365044841|FG001|Overall Study|mild bleeding|0|||
105832943|NCT04640194|365044842|FG002|Overall Study|mild bleeding|0|||
105832944|NCT04640194|365044843|FG003|Overall Study|mild bleeding|1|||
105832945|NCT04640194|365044844|FG004|Overall Study|mild bleeding|0|||
105832946|NCT04640194|365044845|FG005|Overall Study|mild bleeding|0|||
105832947|NCT04640194|365044846|FG006|Overall Study|mild bleeding|0|||
105832948|NCT04640194|365044840|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
105832949|NCT04640194|365044841|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
105832950|NCT04640194|365044842|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
105832951|NCT04640194|365044843|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
105832952|NCT04640194|365044844|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
105832953|NCT04640194|365044845|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
105832954|NCT04640194|365044846|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
105832955|NCT04773600|365044851|FG000|Overall Study|Withdrawal by Subject|15|||
105832956|NCT04773600|365044852|FG001|Overall Study|Withdrawal by Subject|9|||
105832957|NCT04773600|365044851|FG000|Overall Study|Lost to Follow-up|10|||
105832958|NCT04773600|365044852|FG001|Overall Study|Lost to Follow-up|6|||
105832959|NCT04773600|365044851|FG000|Overall Study|Adverse Event|8|||
105832960|NCT04773600|365044852|FG001|Overall Study|Adverse Event|2|||
105832961|NCT04773600|365044851|FG000|Overall Study|Lack of Efficacy|2|||
105832962|NCT04773600|365044852|FG001|Overall Study|Lack of Efficacy|3|||
105832963|NCT04773600|365044851|FG000|Overall Study|Noncompliance|2|||
105832964|NCT04773600|365044852|FG001|Overall Study|Noncompliance|0|||
105832965|NCT04773600|365044851|FG000|Overall Study|Protocol Violation|2|||
105832966|NCT04773600|365044852|FG001|Overall Study|Protocol Violation|0|||
105832967|NCT04773600|365044851|FG000|Overall Study|Physician Decision|0|||
105832968|NCT04773600|365044852|FG001|Overall Study|Physician Decision|1|||
105832969|NCT04773600|365044851|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
105832970|NCT04773600|365044852|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
105489482|NCT01569464|363804060|FG000|Overall Study|Adverse Event|4|||
105489483|NCT01569464|363804061|FG001|Overall Study|Adverse Event|0|||
105575857|NCT01865617|364108344|FG002|Overall Study|Death|1|||
105832971|NCT04773600|365044851|FG000|Overall Study|Emergency Travel Out of Country|1|||
105832972|NCT04773600|365044852|FG001|Overall Study|Emergency Travel Out of Country|0|||
105832973|NCT03506633|365046411|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
105832974|NCT03506633|365046412|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
105832975|NCT00258856|365046413|FG000|Overall Study|Lost to Follow-up|1|||
105832976|NCT00258856|365046414|FG001|Overall Study|Lost to Follow-up|0|||
105489484|NCT01569464|363804060|FG000|Overall Study|Lack of Efficacy|1|||
105832977|NCT00258856|365046415|FG002|Overall Study|Lost to Follow-up|2|||
105832978|NCT00258856|365046416|FG003|Overall Study|Lost to Follow-up|0|||
105832979|NCT00258856|365046413|FG000|Overall Study|Non-compliance|2|||
105832980|NCT00258856|365046414|FG001|Overall Study|Non-compliance|0|||
105832981|NCT00258856|365046415|FG002|Overall Study|Non-compliance|0|||
105832982|NCT00258856|365046416|FG003|Overall Study|Non-compliance|1|||
105832983|NCT02005562|365046417|FG000|Overall Study|Death|2|||
105832984|NCT02005562|365046418|FG001|Overall Study|Death|2|||
105832985|NCT02005562|365046417|FG000|Overall Study|Graft loss|7|||
105832986|NCT02005562|365046418|FG001|Overall Study|Graft loss|6|||
105309516|NCT02132754|363130977|FG015|Overall Study|Clinical Progression|0|||
105309517|NCT02132754|363130978|FG016|Overall Study|Clinical Progression|1|||
105832987|NCT02005562|365046417|FG000|Overall Study|Withdrawal by Subject|2|||
105832988|NCT02005562|365046418|FG001|Overall Study|Withdrawal by Subject|2|||
105832989|NCT02005562|365046417|FG000|Overall Study|No transplant|1|||
105832990|NCT02005562|365046418|FG001|Overall Study|No transplant|4|||
105832991|NCT02005562|365046417|FG000|Overall Study|Physician Decision|0|||
105309518|NCT02132754|363130979|FG017|Overall Study|Clinical Progression|1|||
105309519|NCT02132754|363130980|FG018|Overall Study|Clinical Progression|0|||
105309520|NCT02132754|363130981|FG019|Overall Study|Clinical Progression|1|||
105309521|NCT02132754|363130982|FG020|Overall Study|Clinical Progression|0|||
105309522|NCT02132754|363130983|FG021|Overall Study|Clinical Progression|0|||
105309523|NCT02132754|363130984|FG022|Overall Study|Clinical Progression|1|||
105309524|NCT02132754|363130985|FG023|Overall Study|Clinical Progression|0|||
105309525|NCT02132754|363130986|FG024|Overall Study|Clinical Progression|1|||
105309526|NCT02132754|363130987|FG025|Overall Study|Clinical Progression|1|||
105309527|NCT02132754|363130988|FG026|Overall Study|Clinical Progression|0|||
105309528|NCT02132754|363130989|FG027|Overall Study|Clinical Progression|1|||
105309529|NCT02132754|363130990|FG028|Overall Study|Clinical Progression|1|||
105309530|NCT02132754|363130991|FG029|Overall Study|Clinical Progression|0|||
105309531|NCT02132754|363130992|FG030|Overall Study|Clinical Progression|1|||
105309532|NCT02132754|363130993|FG031|Overall Study|Clinical Progression|0|||
105309533|NCT02132754|363130994|FG032|Overall Study|Clinical Progression|0|||
105309534|NCT02132754|363130995|FG033|Overall Study|Clinical Progression|2|||
105309535|NCT02132754|363130962|FG000|Overall Study|Death|0|||
105309536|NCT02132754|363130963|FG001|Overall Study|Death|0|||
105489485|NCT01569464|363804061|FG001|Overall Study|Lack of Efficacy|0|||
105832992|NCT02005562|365046418|FG001|Overall Study|Physician Decision|1|||
105832993|NCT02219009|365046421|FG000|Overall Study|Withdrawal by Subject|5|||
105832994|NCT02219009|365046422|FG001|Overall Study|Withdrawal by Subject|1|||
105832995|NCT02219009|365046421|FG000|Overall Study|Adverse Event|2|||
105832996|NCT02219009|365046422|FG001|Overall Study|Adverse Event|4|||
105309537|NCT02132754|363130964|FG002|Overall Study|Death|0|||
105489486|NCT01569464|363804060|FG000|Overall Study|Protocol Violation|1|||
105489487|NCT01569464|363804061|FG001|Overall Study|Protocol Violation|0|||
105489488|NCT01569464|363804060|FG000|Overall Study|Lost to Follow-up|2|||
105489489|NCT01569464|363804061|FG001|Overall Study|Lost to Follow-up|3|||
105489490|NCT01569464|363804060|FG000|Overall Study|Withdrawal by Subject|1|||
105489491|NCT01569464|363804061|FG001|Overall Study|Withdrawal by Subject|1|||
105489492|NCT01569464|363804060|FG000|Overall Study|Other|1|||
105489493|NCT01569464|363804061|FG001|Overall Study|Other|1|||
105309538|NCT02132754|363130965|FG003|Overall Study|Death|0|||
105309539|NCT02132754|363130966|FG004|Overall Study|Death|0|||
105309540|NCT02132754|363130967|FG005|Overall Study|Death|0|||
105309541|NCT02132754|363130968|FG006|Overall Study|Death|0|||
105309542|NCT02132754|363130969|FG007|Overall Study|Death|0|||
105309543|NCT02132754|363130970|FG008|Overall Study|Death|0|||
105309544|NCT02132754|363130971|FG009|Overall Study|Death|0|||
105309545|NCT02132754|363130972|FG010|Overall Study|Death|0|||
105309546|NCT02132754|363130973|FG011|Overall Study|Death|0|||
105309547|NCT02132754|363130974|FG012|Overall Study|Death|0|||
105309548|NCT02132754|363130975|FG013|Overall Study|Death|0|||
105309549|NCT02132754|363130976|FG014|Overall Study|Death|0|||
105309550|NCT02132754|363130977|FG015|Overall Study|Death|1|||
105309551|NCT02132754|363130978|FG016|Overall Study|Death|0|||
105309552|NCT02132754|363130979|FG017|Overall Study|Death|0|||
105309553|NCT02132754|363130980|FG018|Overall Study|Death|0|||
105309554|NCT02132754|363130981|FG019|Overall Study|Death|1|||
105309555|NCT02132754|363130982|FG020|Overall Study|Death|0|||
105309556|NCT02132754|363130983|FG021|Overall Study|Death|1|||
105489494|NCT03063203|363804062|FG000|Overall Study|Chose alternative therapy|3|||
105832997|NCT02219009|365046421|FG000|Overall Study|Lost to Follow-up|2|||
105832998|NCT02219009|365046422|FG001|Overall Study|Lost to Follow-up|2|||
105832999|NCT02219009|365046421|FG000|Overall Study|Protocol deviation|1|||
105833000|NCT02219009|365046422|FG001|Overall Study|Protocol deviation|0|||
105833001|NCT02219009|365046421|FG000|Overall Study|Physician Decision|0|||
105833002|NCT02219009|365046422|FG001|Overall Study|Physician Decision|1|||
105833003|NCT02488109|365046423|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
105833004|NCT02488109|365046424|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
105309557|NCT02132754|363130984|FG022|Overall Study|Death|0|||
105489495|NCT03063203|363804062|FG000|Overall Study|Death|2|||
105833005|NCT02488109|365046423|FG000|12-month Follow-Up|Lost to Follow-up|4|||
105833006|NCT02488109|365046424|FG001|12-month Follow-Up|Lost to Follow-up|7|||
105833007|NCT03086135|365046427|FG000|Overall Study|Adverse Event|1|||
105833008|NCT03086135|365046427|FG000|Overall Study|Lost to Follow-up|2|||
105833009|NCT02966340|365046430|FG000|Overall Study|Adverse Event|0|||
105833010|NCT02966340|365046431|FG001|Overall Study|Adverse Event|1|||
105833011|NCT02966340|365046430|FG000|Overall Study|Lost to Follow-up|0|||
105833012|NCT02966340|365046431|FG001|Overall Study|Lost to Follow-up|1|||
105833013|NCT02966340|365046430|FG000|Overall Study|Withdrawal by Subject|1|||
105833014|NCT02966340|365046431|FG001|Overall Study|Withdrawal by Subject|0|||
105833015|NCT02966340|365046430|FG000|Overall Study|data acquisition error|1|||
105833016|NCT02966340|365046431|FG001|Overall Study|data acquisition error|0|||
105833017|NCT02966340|365046430|FG000|Overall Study|startle non-responder|1|||
105833018|NCT02966340|365046431|FG001|Overall Study|startle non-responder|1|||
105833019|NCT02259348|365046432|FG000|Overall Study|Donors|6|||
105833020|NCT02259348|365046432|FG000|Overall Study|Death|4|||
105833021|NCT04211766|365046433|FG000|Overall Study|Withdrawal by Subject|5|||
105833022|NCT04211766|365046434|FG001|Overall Study|Withdrawal by Subject|1|||
105833023|NCT02710214|365046435|FG000|Overall Study|Lost to Follow-up|1|||
105833024|NCT02710214|365046436|FG001|Overall Study|Lost to Follow-up|0|||
105833025|NCT02710214|365046435|FG000|Overall Study|Lack of Efficacy|0|||
105833026|NCT02710214|365046436|FG001|Overall Study|Lack of Efficacy|1|||
105833027|NCT02710214|365046435|FG000|Overall Study|Death|0|||
105833028|NCT02710214|365046436|FG001|Overall Study|Death|1|||
105833029|NCT01120899|365046445|FG000|Overall Study|Withdrawal by Subject|3|||
105833030|NCT03686215|365046446|FG000|Overall Study|Adverse Event|0|||
105833031|NCT03686215|365046447|FG001|Overall Study|Adverse Event|0|||
105833032|NCT03686215|365046448|FG002|Overall Study|Adverse Event|7|||
105833033|NCT03686215|365046446|FG000|Overall Study|Physician Decision|0|||
105833034|NCT03686215|365046447|FG001|Overall Study|Physician Decision|0|||
105833035|NCT03686215|365046448|FG002|Overall Study|Physician Decision|1|||
105833036|NCT03686215|365046446|FG000|Overall Study|Protocol Violation|0|||
105833037|NCT03686215|365046447|FG001|Overall Study|Protocol Violation|0|||
105833038|NCT03686215|365046448|FG002|Overall Study|Protocol Violation|4|||
105833039|NCT03686215|365046446|FG000|Overall Study|Device issue|1|||
105833040|NCT03686215|365046447|FG001|Overall Study|Device issue|0|||
105833041|NCT03686215|365046448|FG002|Overall Study|Device issue|2|||
105833042|NCT01188226|365046454|FG000|Overall Study|Withdrawal by Subject|4|||
105833043|NCT00202839|365046455|FG000|Overall Study|Adverse Event|1|||
105833044|NCT00202839|365046456|FG001|Overall Study|Adverse Event|5|||
105833045|NCT00202839|365046455|FG000|Overall Study|Physician Decision|12|||
105833046|NCT00202839|365046456|FG001|Overall Study|Physician Decision|0|||
105833047|NCT00202839|365046455|FG000|Overall Study|Withdrawal by Subject|6|||
105833048|NCT00202839|365046456|FG001|Overall Study|Withdrawal by Subject|2|||
105833049|NCT00202839|365046455|FG000|Overall Study|Protocol Violation|2|||
105833050|NCT00202839|365046456|FG001|Overall Study|Protocol Violation|1|||
105833051|NCT00202839|365046455|FG000|Overall Study|Lost to Follow-up|3|||
105833052|NCT00202839|365046456|FG001|Overall Study|Lost to Follow-up|2|||
105833053|NCT01662024|365046457|FG000|Overall Study|Pregnancy|2|||
105833054|NCT01662024|365046457|FG000|Overall Study|Withdrawal by Subject|3|||
105833055|NCT04980456|365046458|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
105833056|NCT04980456|365046459|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
105833057|NCT04980456|365046458|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
105833058|NCT04980456|365046459|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
105833059|NCT04980456|365046458|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
105833060|NCT04980456|365046459|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
105833061|NCT04980456|365046458|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
105833062|NCT04980456|365046459|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
105833063|NCT04832971|365046460|FG000|Overall Study|Death|1|||
105833064|NCT04832971|365046461|FG001|Overall Study|Death|0|||
105833065|NCT04832971|365046462|FG002|Overall Study|Death|0|||
105833066|NCT04832971|365046463|FG003|Overall Study|Death|0|||
105833067|NCT04832971|365046460|FG000|Overall Study|Lost to Follow-up|1|||
105833068|NCT04832971|365046461|FG001|Overall Study|Lost to Follow-up|1|||
105833069|NCT04832971|365046462|FG002|Overall Study|Lost to Follow-up|1|||
105833070|NCT04832971|365046463|FG003|Overall Study|Lost to Follow-up|0|||
105833071|NCT04832971|365046460|FG000|Overall Study|Withdrawal by Subject|1|||
105366901|NCT01791595|363350080|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
105833072|NCT04832971|365046461|FG001|Overall Study|Withdrawal by Subject|3|||
105833073|NCT04832971|365046462|FG002|Overall Study|Withdrawal by Subject|2|||
105833074|NCT04832971|365046463|FG003|Overall Study|Withdrawal by Subject|2|||
105833075|NCT04832971|365046460|FG000|Overall Study|Other, Not Specified|0|||
105833076|NCT04832971|365046461|FG001|Overall Study|Other, Not Specified|0|||
105833077|NCT04832971|365046462|FG002|Overall Study|Other, Not Specified|1|||
105833078|NCT04832971|365046463|FG003|Overall Study|Other, Not Specified|0|||
105833079|NCT04768296|365046464|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
105833080|NCT04768296|365046465|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
105833081|NCT03035890|365046470|FG000|Overall Study|Death|1|||
105833082|NCT01579006|365046471|FG000|Overall Study|Lack of Efficacy|10|||
105833083|NCT01579006|365046471|FG000|Overall Study|Adverse Event|13|||
105833084|NCT01579006|365046471|FG000|Overall Study|Withdrawal by Subject|5|||
105833085|NCT01579006|365046471|FG000|Overall Study|Non-compliance|3|||
105833086|NCT01579006|365046471|FG000|Overall Study|Due to participant's health fund|1|||
105833087|NCT01579006|365046471|FG000|Overall Study|Scheduled surgery|1|||
105833088|NCT02998541|365046472|FG000|Overall Study|Adverse Event|4|||
105833089|NCT02998541|365046473|FG001|Overall Study|Adverse Event|5|||
105833090|NCT02998541|365046474|FG002|Overall Study|Adverse Event|1|||
105833091|NCT02998541|365046472|FG000|Overall Study|Protocol Violation|1|||
105833092|NCT02998541|365046473|FG001|Overall Study|Protocol Violation|0|||
105833093|NCT02998541|365046474|FG002|Overall Study|Protocol Violation|0|||
105833094|NCT02998541|365046472|FG000|Overall Study|Withdrawal by Subject|3|||
105833095|NCT02998541|365046473|FG001|Overall Study|Withdrawal by Subject|1|||
105833096|NCT02998541|365046474|FG002|Overall Study|Withdrawal by Subject|0|||
105833097|NCT02998541|365046472|FG000|Overall Study|Lost to Follow-up|0|||
105833098|NCT02998541|365046473|FG001|Overall Study|Lost to Follow-up|3|||
105833099|NCT02998541|365046474|FG002|Overall Study|Lost to Follow-up|1|||
105833100|NCT02998541|365046472|FG000|Overall Study|Physician Decision|0|||
105833101|NCT02998541|365046473|FG001|Overall Study|Physician Decision|0|||
105833102|NCT02998541|365046474|FG002|Overall Study|Physician Decision|3|||
105833103|NCT02998541|365046472|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105833104|NCT02998541|365046473|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105833105|NCT02998541|365046474|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
105833106|NCT00487695|365046477|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
105833107|NCT00487695|365046478|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
105833108|NCT00487695|365046477|FG000|First Procedure|active wheezing (did not have procedure)|1|||
105833109|NCT00487695|365046478|FG001|First Procedure|active wheezing (did not have procedure)|0|||
105833110|NCT00487695|365046477|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
105833111|NCT00487695|365046478|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
105833112|NCT00487695|365046477|FG000|Second Procedure|active wheezing|0|||
105833113|NCT00487695|365046478|FG001|Second Procedure|active wheezing|1|||
105833114|NCT00487695|365046477|FG000|Second Procedure|Withdrawal by Subject|1|||
105833115|NCT00487695|365046478|FG001|Second Procedure|Withdrawal by Subject|2|||
105833116|NCT02786953|365046481|FG000|Overall Study|Withdrawal by Subject|3|||
105833117|NCT02786953|365046482|FG001|Overall Study|Withdrawal by Subject|0|||
105833118|NCT02786953|365046481|FG000|Overall Study|Physician Decision|0|||
105833119|NCT02786953|365046482|FG001|Overall Study|Physician Decision|1|||
105833120|NCT00177164|365046483|FG000|Overall Study|Protocol Violation|0|||
105833121|NCT00177164|365046484|FG001|Overall Study|Protocol Violation|7|||
105833122|NCT00177164|365046483|FG000|Overall Study|Lost to Follow-up|4|||
105833123|NCT00177164|365046484|FG001|Overall Study|Lost to Follow-up|5|||
105833124|NCT00177164|365046483|FG000|Overall Study|increase in alcohol and drug use|1|||
105833125|NCT00177164|365046484|FG001|Overall Study|increase in alcohol and drug use|2|||
105833126|NCT00177164|365046483|FG000|Overall Study|Adverse Event|1|||
105833127|NCT00177164|365046484|FG001|Overall Study|Adverse Event|0|||
105833128|NCT00177164|365046483|FG000|Overall Study|discharge from hospital|1|||
105833129|NCT00177164|365046484|FG001|Overall Study|discharge from hospital|0|||
105833130|NCT00177164|365046483|FG000|Overall Study|Lack of Efficacy|2|||
105833131|NCT00177164|365046484|FG001|Overall Study|Lack of Efficacy|1|||
105833132|NCT00177164|365046483|FG000|Overall Study|Pregnancy|0|||
105833133|NCT00177164|365046484|FG001|Overall Study|Pregnancy|1|||
105833134|NCT00965757|365046485|FG000|Double-blind Phase|Progression of concomitant disease|1|||
105833135|NCT00965757|365046486|FG001|Double-blind Phase|Progression of concomitant disease|2|||
105833136|NCT00965757|365046487|FG002|Double-blind Phase|Progression of concomitant disease|0|||
105833137|NCT00965757|365046488|FG003|Double-blind Phase|Progression of concomitant disease|0|||
105833138|NCT00965757|365046485|FG000|Double-blind Phase|Adverse drug reaction|2|||
105833139|NCT00965757|365046486|FG001|Double-blind Phase|Adverse drug reaction|1|||
105833140|NCT00965757|365046487|FG002|Double-blind Phase|Adverse drug reaction|0|||
105833141|NCT00965757|365046488|FG003|Double-blind Phase|Adverse drug reaction|0|||
105833142|NCT00965757|365046485|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
105833143|NCT00965757|365046486|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
105833144|NCT00965757|365046487|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
105833145|NCT00965757|365046488|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
105833146|NCT00965757|365046485|FG000|Double-blind Phase|Lack of Efficacy|7|||
105833147|NCT00965757|365046486|FG001|Double-blind Phase|Lack of Efficacy|11|||
105833148|NCT00965757|365046487|FG002|Double-blind Phase|Lack of Efficacy|0|||
105833149|NCT00965757|365046488|FG003|Double-blind Phase|Lack of Efficacy|0|||
105833150|NCT00965757|365046485|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
105833151|NCT00965757|365046486|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
105833152|NCT00965757|365046487|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
105833153|NCT00965757|365046488|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
105833154|NCT00965757|365046485|FG000|Double-blind Phase|Lost to Follow-up|0|||
105833155|NCT00965757|365046486|FG001|Double-blind Phase|Lost to Follow-up|1|||
105833156|NCT00965757|365046487|FG002|Double-blind Phase|Lost to Follow-up|0|||
105833157|NCT00965757|365046488|FG003|Double-blind Phase|Lost to Follow-up|0|||
105833158|NCT00965757|365046485|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
105833159|NCT00965757|365046486|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
105833160|NCT00965757|365046487|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
105833161|NCT00965757|365046488|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
105833162|NCT00965757|365046485|FG000|Double-blind Phase|Other|1|||
105833163|NCT00965757|365046486|FG001|Double-blind Phase|Other|0|||
105833164|NCT00965757|365046487|FG002|Double-blind Phase|Other|0|||
105833165|NCT00965757|365046488|FG003|Double-blind Phase|Other|0|||
105833166|NCT00965757|365046485|FG000|Extension Phase|Progression of concomitant disease|0|||
105833167|NCT00965757|365046486|FG001|Extension Phase|Progression of concomitant disease|0|||
105833168|NCT00965757|365046487|FG002|Extension Phase|Progression of concomitant disease|4|||
105833169|NCT00965757|365046488|FG003|Extension Phase|Progression of concomitant disease|2|||
105833170|NCT00965757|365046485|FG000|Extension Phase|Adverse drug reaction|0|||
105833171|NCT00965757|365046486|FG001|Extension Phase|Adverse drug reaction|0|||
105833172|NCT00965757|365046487|FG002|Extension Phase|Adverse drug reaction|6|||
105833173|NCT00965757|365046488|FG003|Extension Phase|Adverse drug reaction|3|||
105833174|NCT00965757|365046485|FG000|Extension Phase|Abnormal Laboratory Value|0|||
105833175|NCT00965757|365046486|FG001|Extension Phase|Abnormal Laboratory Value|0|||
105833176|NCT00965757|365046487|FG002|Extension Phase|Abnormal Laboratory Value|6|||
105833177|NCT00965757|365046488|FG003|Extension Phase|Abnormal Laboratory Value|1|||
105833178|NCT00965757|365046485|FG000|Extension Phase|Lack of Efficacy|0|||
105833179|NCT00965757|365046486|FG001|Extension Phase|Lack of Efficacy|0|||
105833180|NCT00965757|365046487|FG002|Extension Phase|Lack of Efficacy|8|||
105833181|NCT00965757|365046488|FG003|Extension Phase|Lack of Efficacy|12|||
105833182|NCT00965757|365046485|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
105833183|NCT00965757|365046486|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
105833184|NCT00965757|365046487|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
105833185|NCT00965757|365046488|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
105833186|NCT00965757|365046485|FG000|Extension Phase|Lost to Follow-up|0|||
105833187|NCT00965757|365046486|FG001|Extension Phase|Lost to Follow-up|0|||
105833188|NCT00965757|365046487|FG002|Extension Phase|Lost to Follow-up|0|||
105833189|NCT00965757|365046488|FG003|Extension Phase|Lost to Follow-up|1|||
105833190|NCT00965757|365046485|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
105833191|NCT00965757|365046486|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
105833192|NCT00965757|365046487|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
105833193|NCT00965757|365046488|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
105833194|NCT00965757|365046485|FG000|Extension Phase|Protocol Violation|0|||
105833195|NCT00965757|365046486|FG001|Extension Phase|Protocol Violation|0|||
105833196|NCT00965757|365046487|FG002|Extension Phase|Protocol Violation|0|||
105833197|NCT00965757|365046488|FG003|Extension Phase|Protocol Violation|1|||
105833198|NCT00965757|365046485|FG000|Extension Phase|Other|0|||
105833199|NCT00965757|365046486|FG001|Extension Phase|Other|0|||
105833200|NCT00965757|365046487|FG002|Extension Phase|Other|2|||
105833201|NCT00965757|365046488|FG003|Extension Phase|Other|1|||
105833202|NCT02451358|365046489|FG000|Overall Study|Withdrawal by Subject|1|||
105833203|NCT02451358|365046490|FG001|Overall Study|Withdrawal by Subject|1|||
105833204|NCT02451358|365046491|FG002|Overall Study|Withdrawal by Subject|0|||
105833205|NCT02451358|365046492|FG003|Overall Study|Withdrawal by Subject|0|||
105833206|NCT02451358|365046489|FG000|Overall Study|Protocol Violation|0|||
105833207|NCT02451358|365046490|FG001|Overall Study|Protocol Violation|1|||
105833208|NCT02451358|365046491|FG002|Overall Study|Protocol Violation|1|||
105833209|NCT02451358|365046492|FG003|Overall Study|Protocol Violation|0|||
105833210|NCT01698554|365046494|FG000|Overall Study|Adverse Event|2|||
105833211|NCT01698554|365046495|FG001|Overall Study|Adverse Event|5|||
105833212|NCT01698554|365046496|FG002|Overall Study|Adverse Event|0|||
105833213|NCT01698554|365046497|FG003|Overall Study|Adverse Event|1|||
105833214|NCT01698554|365046494|FG000|Overall Study|Lost to Follow-up|1|||
105833215|NCT01698554|365046495|FG001|Overall Study|Lost to Follow-up|0|||
105833216|NCT01698554|365046496|FG002|Overall Study|Lost to Follow-up|0|||
105833217|NCT01698554|365046497|FG003|Overall Study|Lost to Follow-up|0|||
105833218|NCT01698554|365046494|FG000|Overall Study|Personal Reasons|0|||
105833219|NCT01698554|365046495|FG001|Overall Study|Personal Reasons|5|||
105833220|NCT01698554|365046496|FG002|Overall Study|Personal Reasons|1|||
105833221|NCT01698554|365046497|FG003|Overall Study|Personal Reasons|1|||
105833222|NCT01698554|365046494|FG000|Overall Study|Protocol Violation|2|||
105833223|NCT01698554|365046495|FG001|Overall Study|Protocol Violation|0|||
105833224|NCT01698554|365046496|FG002|Overall Study|Protocol Violation|1|||
105833225|NCT01698554|365046497|FG003|Overall Study|Protocol Violation|0|||
105833226|NCT01698554|365046494|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105833227|NCT01698554|365046495|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105833228|NCT01698554|365046496|FG002|Overall Study|Other Miscellaneous Reasons|0|||
105833229|NCT01698554|365046497|FG003|Overall Study|Other Miscellaneous Reasons|0|||
105833230|NCT01398787|365046500|FG000|Overall Study|Adverse Event|1|||
105833231|NCT03141151|365046501|FG000|Overall Study|Lost to Follow-up|3|||
105833232|NCT03141151|365046502|FG001|Overall Study|Lost to Follow-up|2|||
105833233|NCT03141151|365046501|FG000|Overall Study|Withdrawal by Subject|3|||
105309558|NCT02132754|363130985|FG023|Overall Study|Death|0|||
105309559|NCT02132754|363130986|FG024|Overall Study|Death|0|||
105309560|NCT02132754|363130987|FG025|Overall Study|Death|0|||
105309561|NCT02132754|363130988|FG026|Overall Study|Death|1|||
105309562|NCT02132754|363130989|FG027|Overall Study|Death|0|||
105309563|NCT02132754|363130990|FG028|Overall Study|Death|0|||
105309564|NCT02132754|363130991|FG029|Overall Study|Death|0|||
105309565|NCT02132754|363130992|FG030|Overall Study|Death|0|||
105309566|NCT02132754|363130993|FG031|Overall Study|Death|0|||
105309567|NCT02132754|363130994|FG032|Overall Study|Death|0|||
105309568|NCT02132754|363130995|FG033|Overall Study|Death|2|||
105309569|NCT02132754|363130962|FG000|Overall Study|Excluded Medication|0|||
105309570|NCT02132754|363130963|FG001|Overall Study|Excluded Medication|0|||
105309571|NCT02132754|363130964|FG002|Overall Study|Excluded Medication|0|||
105309572|NCT02132754|363130965|FG003|Overall Study|Excluded Medication|0|||
105309573|NCT02132754|363130966|FG004|Overall Study|Excluded Medication|0|||
105309574|NCT02132754|363130967|FG005|Overall Study|Excluded Medication|0|||
105309575|NCT02132754|363130968|FG006|Overall Study|Excluded Medication|0|||
105309576|NCT02132754|363130969|FG007|Overall Study|Excluded Medication|0|||
105309577|NCT02132754|363130970|FG008|Overall Study|Excluded Medication|0|||
105309578|NCT02132754|363130971|FG009|Overall Study|Excluded Medication|0|||
105309579|NCT02132754|363130972|FG010|Overall Study|Excluded Medication|0|||
105309580|NCT02132754|363130973|FG011|Overall Study|Excluded Medication|0|||
105309581|NCT02132754|363130974|FG012|Overall Study|Excluded Medication|0|||
105309582|NCT02132754|363130975|FG013|Overall Study|Excluded Medication|0|||
105309583|NCT02132754|363130976|FG014|Overall Study|Excluded Medication|0|||
105309584|NCT02132754|363130977|FG015|Overall Study|Excluded Medication|0|||
105309585|NCT02132754|363130978|FG016|Overall Study|Excluded Medication|0|||
105309586|NCT02132754|363130979|FG017|Overall Study|Excluded Medication|0|||
105309587|NCT02132754|363130980|FG018|Overall Study|Excluded Medication|0|||
105309588|NCT02132754|363130981|FG019|Overall Study|Excluded Medication|0|||
105309589|NCT02132754|363130982|FG020|Overall Study|Excluded Medication|1|||
105309590|NCT02132754|363130983|FG021|Overall Study|Excluded Medication|0|||
105309591|NCT02132754|363130984|FG022|Overall Study|Excluded Medication|0|||
105309592|NCT02132754|363130985|FG023|Overall Study|Excluded Medication|0|||
105309593|NCT02132754|363130986|FG024|Overall Study|Excluded Medication|0|||
105309594|NCT02132754|363130987|FG025|Overall Study|Excluded Medication|0|||
105309595|NCT02132754|363130988|FG026|Overall Study|Excluded Medication|0|||
105309596|NCT02132754|363130989|FG027|Overall Study|Excluded Medication|0|||
105309597|NCT02132754|363130990|FG028|Overall Study|Excluded Medication|0|||
105309598|NCT02132754|363130991|FG029|Overall Study|Excluded Medication|0|||
105309599|NCT02132754|363130992|FG030|Overall Study|Excluded Medication|0|||
105309600|NCT02132754|363130993|FG031|Overall Study|Excluded Medication|0|||
105309601|NCT02132754|363130994|FG032|Overall Study|Excluded Medication|0|||
105309602|NCT02132754|363130995|FG033|Overall Study|Excluded Medication|1|||
105489496|NCT03063203|363804062|FG000|Overall Study|Disease progression|4|||
105833234|NCT03141151|365046502|FG001|Overall Study|Withdrawal by Subject|2|||
105833235|NCT04561115|365046503|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
105833236|NCT04561115|365046504|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
105833237|NCT04561115|365046503|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
105833238|NCT04561115|365046504|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
105833239|NCT04561115|365046503|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
105833240|NCT04561115|365046504|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
105833241|NCT04610580|365046505|FG000|Two-way Crossover Period|Adverse Event|1|||
105833242|NCT04610580|365046506|FG001|Two-way Crossover Period|Adverse Event|0|||
105833243|NCT04610580|365046507|FG002|Two-way Crossover Period|Adverse Event|0|||
105489497|NCT03063203|363804062|FG000|Overall Study|Physician Decision|5|||
105489498|NCT00256282|363804065|FG000|Overall Study|Disease progression, relapse during acti|12|||
105489499|NCT00256282|363804065|FG000|Overall Study|Adverse Event|3|||
105833244|NCT04610580|365046508|FG003|Two-way Crossover Period|Adverse Event|0|||
105833245|NCT04610580|365046509|FG004|Two-way Crossover Period|Adverse Event|0|||
105489500|NCT00256282|363804065|FG000|Overall Study|Physician Decision|1|||
105489501|NCT02431247|363804066|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
105489502|NCT02431247|363804067|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
105309603|NCT02132754|363130962|FG000|Overall Study|Physician Decision|0|||
105309604|NCT02132754|363130963|FG001|Overall Study|Physician Decision|0|||
105309605|NCT02132754|363130964|FG002|Overall Study|Physician Decision|0|||
105489503|NCT02431247|363804068|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
105309606|NCT02132754|363130965|FG003|Overall Study|Physician Decision|0|||
105309607|NCT02132754|363130966|FG004|Overall Study|Physician Decision|0|||
105309608|NCT02132754|363130967|FG005|Overall Study|Physician Decision|0|||
105309609|NCT02132754|363130968|FG006|Overall Study|Physician Decision|0|||
105309610|NCT02132754|363130969|FG007|Overall Study|Physician Decision|0|||
105309611|NCT02132754|363130970|FG008|Overall Study|Physician Decision|0|||
105309612|NCT02132754|363130971|FG009|Overall Study|Physician Decision|1|||
105309613|NCT02132754|363130972|FG010|Overall Study|Physician Decision|0|||
105833246|NCT04610580|365046510|FG005|Two-way Crossover Period|Adverse Event|0|||
105833247|NCT04610580|365046505|FG000|Two-way Crossover Period|Physician Decision|1|||
105833248|NCT04610580|365046506|FG001|Two-way Crossover Period|Physician Decision|0|||
105833249|NCT04610580|365046507|FG002|Two-way Crossover Period|Physician Decision|0|||
105833250|NCT04610580|365046508|FG003|Two-way Crossover Period|Physician Decision|0|||
105833251|NCT04610580|365046509|FG004|Two-way Crossover Period|Physician Decision|0|||
105833252|NCT04610580|365046510|FG005|Two-way Crossover Period|Physician Decision|0|||
105833253|NCT04610580|365046505|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
105833254|NCT04610580|365046506|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
105833255|NCT04610580|365046507|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
105833256|NCT04610580|365046508|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
105833257|NCT04610580|365046509|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
105833258|NCT04610580|365046510|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
105833259|NCT04610580|365046505|FG000|Two-way Crossover Period|Other than specified|0|||
105833260|NCT04610580|365046506|FG001|Two-way Crossover Period|Other than specified|1|||
105833261|NCT04610580|365046507|FG002|Two-way Crossover Period|Other than specified|0|||
105833262|NCT04610580|365046508|FG003|Two-way Crossover Period|Other than specified|0|||
105833263|NCT04610580|365046509|FG004|Two-way Crossover Period|Other than specified|0|||
105833264|NCT04610580|365046510|FG005|Two-way Crossover Period|Other than specified|0|||
105833265|NCT04610580|365046505|FG000|Washout Before Extension Period|Other than specified|0|||
105833266|NCT04610580|365046506|FG001|Washout Before Extension Period|Other than specified|1|||
105833267|NCT04610580|365046507|FG002|Washout Before Extension Period|Other than specified|0|||
105833268|NCT04610580|365046508|FG003|Washout Before Extension Period|Other than specified|0|||
105833269|NCT04610580|365046509|FG004|Washout Before Extension Period|Other than specified|0|||
105833270|NCT04610580|365046510|FG005|Washout Before Extension Period|Other than specified|0|||
105833271|NCT04610580|365046505|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
105833272|NCT04610580|365046506|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
105833273|NCT04610580|365046507|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
105833274|NCT04610580|365046508|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
105833275|NCT04610580|365046509|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
105833276|NCT04610580|365046510|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
105833277|NCT04610580|365046505|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
105833278|NCT04610580|365046506|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
105833279|NCT04610580|365046507|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
105833280|NCT04610580|365046508|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
105833281|NCT04610580|365046509|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
105833282|NCT04610580|365046510|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
105833283|NCT03922750|365046519|FG000|Overall Study|Unclassified|0|||
105833284|NCT03922750|365046520|FG001|Overall Study|Unclassified|0|||
105833285|NCT03922750|365046521|FG002|Overall Study|Unclassified|1|||
105833286|NCT03922750|365046519|FG000|Overall Study|Adverse Event|0|||
105833287|NCT03922750|365046520|FG001|Overall Study|Adverse Event|1|||
105833288|NCT03922750|365046521|FG002|Overall Study|Adverse Event|0|||
105833289|NCT02985398|365046522|FG000|Overall Study|Adverse Event|1|||
105833290|NCT02985398|365046522|FG000|Overall Study|Lost to Follow-up|4|||
105833291|NCT02985398|365046522|FG000|Overall Study|Withdrawal by Subject|8|||
105833292|NCT02985398|365046522|FG000|Overall Study|Study Burden|9|||
105833293|NCT00668395|365046525|FG000|Overall Study|Withdrawal by Subject|4|||
105833294|NCT00668395|365046526|FG001|Overall Study|Withdrawal by Subject|4|||
105833295|NCT00668395|365046527|FG002|Overall Study|Withdrawal by Subject|1|||
105833296|NCT00668395|365046525|FG000|Overall Study|Adverse Event|1|||
105833297|NCT00668395|365046526|FG001|Overall Study|Adverse Event|1|||
105833298|NCT00668395|365046527|FG002|Overall Study|Adverse Event|0|||
105833299|NCT00668395|365046525|FG000|Overall Study|Physician Decision|1|||
105833300|NCT00668395|365046526|FG001|Overall Study|Physician Decision|1|||
105833301|NCT00668395|365046527|FG002|Overall Study|Physician Decision|0|||
105833302|NCT04164758|365046528|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
105833303|NCT04164758|365046529|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
105833304|NCT04164758|365046530|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
105833305|NCT04164758|365046528|FG000|Overall Study|Adverse Event|0|||
105833306|NCT04164758|365046529|FG001|Overall Study|Adverse Event|1|||
105833307|NCT04164758|365046530|FG002|Overall Study|Adverse Event|0|||
105833308|NCT00283842|365046531|FG000|Overall Study|Adverse Event|8|||
105833309|NCT00283842|365046532|FG001|Overall Study|Adverse Event|7|||
105833310|NCT00283842|365046533|FG002|Overall Study|Adverse Event|21|||
105833311|NCT00283842|365046534|FG003|Overall Study|Adverse Event|21|||
105833312|NCT00283842|365046535|FG004|Overall Study|Adverse Event|5|||
105833313|NCT00283842|365046531|FG000|Overall Study|Protocol Violation|1|||
105833314|NCT00283842|365046532|FG001|Overall Study|Protocol Violation|5|||
105833315|NCT00283842|365046533|FG002|Overall Study|Protocol Violation|4|||
105833316|NCT00283842|365046534|FG003|Overall Study|Protocol Violation|0|||
105833317|NCT00283842|365046535|FG004|Overall Study|Protocol Violation|0|||
105833318|NCT00283842|365046531|FG000|Overall Study|Protocol deviation|0|||
105833319|NCT00283842|365046532|FG001|Overall Study|Protocol deviation|0|||
105833320|NCT00283842|365046533|FG002|Overall Study|Protocol deviation|0|||
105833321|NCT00283842|365046534|FG003|Overall Study|Protocol deviation|0|||
105833322|NCT00283842|365046535|FG004|Overall Study|Protocol deviation|2|||
105833323|NCT00283842|365046531|FG000|Overall Study|Withdrawal by Subject|2|||
105833324|NCT00283842|365046532|FG001|Overall Study|Withdrawal by Subject|1|||
105833325|NCT00283842|365046533|FG002|Overall Study|Withdrawal by Subject|1|||
105833326|NCT00283842|365046534|FG003|Overall Study|Withdrawal by Subject|5|||
105833327|NCT00283842|365046535|FG004|Overall Study|Withdrawal by Subject|4|||
105833328|NCT00283842|365046531|FG000|Overall Study|Lack of Efficacy|1|||
105833329|NCT00283842|365046532|FG001|Overall Study|Lack of Efficacy|3|||
105833330|NCT00283842|365046533|FG002|Overall Study|Lack of Efficacy|1|||
105833331|NCT00283842|365046534|FG003|Overall Study|Lack of Efficacy|0|||
105833332|NCT00283842|365046535|FG004|Overall Study|Lack of Efficacy|3|||
105833333|NCT00283842|365046531|FG000|Overall Study|Lost to Follow-up|0|||
105833334|NCT00283842|365046532|FG001|Overall Study|Lost to Follow-up|2|||
105833335|NCT00283842|365046533|FG002|Overall Study|Lost to Follow-up|4|||
105833336|NCT00283842|365046534|FG003|Overall Study|Lost to Follow-up|1|||
105833337|NCT00283842|365046535|FG004|Overall Study|Lost to Follow-up|1|||
105833338|NCT00550147|365046538|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
105833339|NCT00550147|365046538|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
105833340|NCT00550147|365046538|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
105833341|NCT00550147|365046538|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
105833342|NCT00550147|365046538|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
105833343|NCT01824498|365046539|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
105833344|NCT01824498|365046540|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
105833345|NCT01824498|365046541|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
105833346|NCT01824498|365046542|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
105833347|NCT01824498|365046543|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
105833348|NCT01824498|365046544|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
105833349|NCT02448563|365046546|FG000|Overall Study|Lost to Follow-up|16|||
105833350|NCT02448563|365046547|FG001|Overall Study|Lost to Follow-up|10|||
105833351|NCT02448563|365046546|FG000|Overall Study|Withdrawal by Subject|0|||
105833352|NCT02448563|365046547|FG001|Overall Study|Withdrawal by Subject|1|||
105833353|NCT04049097|365046552|FG000|Overall Study|Adverse Event|18|||
105833354|NCT04049097|365046552|FG000|Overall Study|Death|2|||
105833355|NCT04049097|365046552|FG000|Overall Study|Lost to Follow-up|1|||
105833356|NCT04049097|365046552|FG000|Overall Study|Physician Decision|2|||
105833357|NCT04049097|365046552|FG000|Overall Study|Withdrawal by Subject|9|||
105833358|NCT04049097|365046552|FG000|Overall Study|Protocol Violation|2|||
105833359|NCT04049097|365046552|FG000|Overall Study|Other|1|||
105833360|NCT04049097|365046552|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
105833361|NCT00715676|365046553|FG000|Overall Study|Adverse Event|3|||
105833362|NCT00715676|365046554|FG001|Overall Study|Adverse Event|5|||
105833363|NCT00715676|365046555|FG002|Overall Study|Adverse Event|21|||
105833364|NCT00715676|365046553|FG000|Overall Study|Withdrawal by Subject|1|||
105833365|NCT00715676|365046554|FG001|Overall Study|Withdrawal by Subject|3|||
105833366|NCT00715676|365046555|FG002|Overall Study|Withdrawal by Subject|8|||
105833367|NCT00715676|365046553|FG000|Overall Study|Lost to Follow-up|1|||
105833368|NCT00715676|365046554|FG001|Overall Study|Lost to Follow-up|2|||
105833369|NCT00715676|365046555|FG002|Overall Study|Lost to Follow-up|1|||
105833370|NCT00715676|365046553|FG000|Overall Study|Terminated by Sponsor|1|||
105833371|NCT00715676|365046554|FG001|Overall Study|Terminated by Sponsor|0|||
105833372|NCT00715676|365046555|FG002|Overall Study|Terminated by Sponsor|0|||
105833373|NCT00715676|365046553|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
105833374|NCT00715676|365046554|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
105833375|NCT00715676|365046555|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
105833376|NCT00715676|365046553|FG000|Overall Study|Use of Exclusionary Medication|0|||
105833377|NCT00715676|365046554|FG001|Overall Study|Use of Exclusionary Medication|0|||
105833378|NCT00715676|365046555|FG002|Overall Study|Use of Exclusionary Medication|1|||
105833379|NCT00715676|365046553|FG000|Overall Study|Elevated Blood Glucose|0|||
105833380|NCT00715676|365046554|FG001|Overall Study|Elevated Blood Glucose|1|||
105833381|NCT00715676|365046555|FG002|Overall Study|Elevated Blood Glucose|0|||
105833382|NCT01320722|365046556|FG000|Overall Study|Did not Receive Intervention|3|||
105833383|NCT01320722|365046557|FG001|Overall Study|Did not Receive Intervention|2|||
105833384|NCT01320722|365046558|FG002|Overall Study|Did not Receive Intervention|1|||
105833385|NCT01320722|365046559|FG003|Overall Study|Did not Receive Intervention|1|||
105833386|NCT01320722|365046560|FG004|Overall Study|Did not Receive Intervention|2|||
105833387|NCT01320722|365046556|FG000|Overall Study|Lost to Follow-up|0|||
105833388|NCT01320722|365046557|FG001|Overall Study|Lost to Follow-up|1|||
105833389|NCT01320722|365046558|FG002|Overall Study|Lost to Follow-up|0|||
105833390|NCT01320722|365046559|FG003|Overall Study|Lost to Follow-up|1|||
105833391|NCT01320722|365046560|FG004|Overall Study|Lost to Follow-up|3|||
105833392|NCT01320722|365046556|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
105833393|NCT01320722|365046557|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
105833394|NCT01320722|365046558|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
105309614|NCT02132754|363130973|FG011|Overall Study|Physician Decision|1|||
105309615|NCT02132754|363130974|FG012|Overall Study|Physician Decision|1|||
105309616|NCT02132754|363130975|FG013|Overall Study|Physician Decision|0|||
105309617|NCT02132754|363130976|FG014|Overall Study|Physician Decision|0|||
105309618|NCT02132754|363130977|FG015|Overall Study|Physician Decision|1|||
105309619|NCT02132754|363130978|FG016|Overall Study|Physician Decision|0|||
105309620|NCT02132754|363130979|FG017|Overall Study|Physician Decision|0|||
105309621|NCT02132754|363130980|FG018|Overall Study|Physician Decision|0|||
105309622|NCT02132754|363130981|FG019|Overall Study|Physician Decision|0|||
105309623|NCT02132754|363130982|FG020|Overall Study|Physician Decision|0|||
105309624|NCT02132754|363130983|FG021|Overall Study|Physician Decision|0|||
105309625|NCT02132754|363130984|FG022|Overall Study|Physician Decision|0|||
105309626|NCT02132754|363130985|FG023|Overall Study|Physician Decision|0|||
105309627|NCT02132754|363130986|FG024|Overall Study|Physician Decision|1|||
105309628|NCT02132754|363130987|FG025|Overall Study|Physician Decision|0|||
105309629|NCT02132754|363130988|FG026|Overall Study|Physician Decision|0|||
105309630|NCT02132754|363130989|FG027|Overall Study|Physician Decision|0|||
105309631|NCT02132754|363130990|FG028|Overall Study|Physician Decision|0|||
105309632|NCT02132754|363130991|FG029|Overall Study|Physician Decision|0|||
105309633|NCT02132754|363130992|FG030|Overall Study|Physician Decision|0|||
105309634|NCT02132754|363130993|FG031|Overall Study|Physician Decision|1|||
105309635|NCT02132754|363130994|FG032|Overall Study|Physician Decision|0|||
105309636|NCT02132754|363130995|FG033|Overall Study|Physician Decision|3|||
105309637|NCT02132754|363130962|FG000|Overall Study|Progressive Disease|1|||
105309638|NCT02132754|363130963|FG001|Overall Study|Progressive Disease|1|||
105575858|NCT01865617|364108345|FG003|Overall Study|Death|1|||
105575859|NCT01865617|364108346|FG004|Overall Study|Death|5|||
105833395|NCT01320722|365046559|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
105833396|NCT01320722|365046560|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
105833397|NCT01320722|365046556|FG000|Overall Study|Participant Developed a Rash|0|||
105833398|NCT01320722|365046557|FG001|Overall Study|Participant Developed a Rash|0|||
105575860|NCT01865617|364108347|FG005|Overall Study|Death|1|||
105833399|NCT01320722|365046558|FG002|Overall Study|Participant Developed a Rash|2|||
105833400|NCT01320722|365046559|FG003|Overall Study|Participant Developed a Rash|1|||
105833401|NCT01320722|365046560|FG004|Overall Study|Participant Developed a Rash|1|||
105833402|NCT01320722|365046556|FG000|Overall Study|Non-compliant with Medication|0|||
105833403|NCT01320722|365046557|FG001|Overall Study|Non-compliant with Medication|0|||
105833404|NCT01320722|365046558|FG002|Overall Study|Non-compliant with Medication|1|||
105833405|NCT01320722|365046559|FG003|Overall Study|Non-compliant with Medication|0|||
105833406|NCT01320722|365046560|FG004|Overall Study|Non-compliant with Medication|0|||
105833407|NCT01320722|365046556|FG000|Overall Study|Adverse Event|0|||
105833408|NCT01320722|365046557|FG001|Overall Study|Adverse Event|0|||
105833409|NCT01320722|365046558|FG002|Overall Study|Adverse Event|3|||
105833410|NCT01320722|365046559|FG003|Overall Study|Adverse Event|6|||
105833411|NCT01320722|365046560|FG004|Overall Study|Adverse Event|0|||
105833412|NCT01320722|365046556|FG000|Overall Study|Not Compliant with Study Procedures|0|||
105833413|NCT01320722|365046557|FG001|Overall Study|Not Compliant with Study Procedures|0|||
105833414|NCT01320722|365046558|FG002|Overall Study|Not Compliant with Study Procedures|0|||
105833415|NCT01320722|365046559|FG003|Overall Study|Not Compliant with Study Procedures|4|||
105833416|NCT01320722|365046560|FG004|Overall Study|Not Compliant with Study Procedures|0|||
105833417|NCT01320722|365046556|FG000|Overall Study|Pregnancy|0|||
105833418|NCT01320722|365046557|FG001|Overall Study|Pregnancy|0|||
105833419|NCT01320722|365046558|FG002|Overall Study|Pregnancy|0|||
105833420|NCT01320722|365046559|FG003|Overall Study|Pregnancy|1|||
105833421|NCT01320722|365046560|FG004|Overall Study|Pregnancy|0|||
105833422|NCT01320722|365046556|FG000|Overall Study|Started an Exclusionary Medication|0|||
105833423|NCT01320722|365046557|FG001|Overall Study|Started an Exclusionary Medication|0|||
105833424|NCT01320722|365046558|FG002|Overall Study|Started an Exclusionary Medication|0|||
105833425|NCT01320722|365046559|FG003|Overall Study|Started an Exclusionary Medication|0|||
105833426|NCT01320722|365046560|FG004|Overall Study|Started an Exclusionary Medication|1|||
105309639|NCT02132754|363130964|FG002|Overall Study|Progressive Disease|1|||
105309640|NCT02132754|363130965|FG003|Overall Study|Progressive Disease|1|||
105309641|NCT02132754|363130966|FG004|Overall Study|Progressive Disease|1|||
105309642|NCT02132754|363130967|FG005|Overall Study|Progressive Disease|1|||
105309643|NCT02132754|363130968|FG006|Overall Study|Progressive Disease|1|||
105309644|NCT02132754|363130969|FG007|Overall Study|Progressive Disease|1|||
105309645|NCT02132754|363130970|FG008|Overall Study|Progressive Disease|1|||
105309646|NCT02132754|363130971|FG009|Overall Study|Progressive Disease|3|||
105575861|NCT01865617|364108348|FG006|Overall Study|Death|11|||
105575862|NCT01865617|364108349|FG007|Overall Study|Death|1|||
105575863|NCT01865617|364108350|FG008|Overall Study|Death|11|||
105833427|NCT01320722|365046556|FG000|Overall Study|Withdrew due to Health Condition|0|||
105833428|NCT01320722|365046557|FG001|Overall Study|Withdrew due to Health Condition|0|||
105833429|NCT01320722|365046558|FG002|Overall Study|Withdrew due to Health Condition|0|||
105833430|NCT01320722|365046559|FG003|Overall Study|Withdrew due to Health Condition|0|||
105833431|NCT01320722|365046560|FG004|Overall Study|Withdrew due to Health Condition|1|||
105833432|NCT01899053|365046562|FG000|Overall Study|Progressive Disease|4|||
105833433|NCT01899053|365046563|FG001|Overall Study|Progressive Disease|0|||
105309647|NCT02132754|363130972|FG010|Overall Study|Progressive Disease|3|||
105309648|NCT02132754|363130973|FG011|Overall Study|Progressive Disease|2|||
105309649|NCT02132754|363130974|FG012|Overall Study|Progressive Disease|2|||
105309650|NCT02132754|363130975|FG013|Overall Study|Progressive Disease|3|||
105309651|NCT02132754|363130976|FG014|Overall Study|Progressive Disease|2|||
105309652|NCT02132754|363130977|FG015|Overall Study|Progressive Disease|1|||
105309653|NCT02132754|363130978|FG016|Overall Study|Progressive Disease|2|||
105309654|NCT02132754|363130979|FG017|Overall Study|Progressive Disease|1|||
105309655|NCT02132754|363130980|FG018|Overall Study|Progressive Disease|3|||
105309656|NCT02132754|363130981|FG019|Overall Study|Progressive Disease|1|||
105309657|NCT02132754|363130982|FG020|Overall Study|Progressive Disease|1|||
105309658|NCT02132754|363130983|FG021|Overall Study|Progressive Disease|3|||
105309659|NCT02132754|363130984|FG022|Overall Study|Progressive Disease|2|||
105309660|NCT02132754|363130985|FG023|Overall Study|Progressive Disease|3|||
105309661|NCT02132754|363130986|FG024|Overall Study|Progressive Disease|0|||
105309662|NCT02132754|363130987|FG025|Overall Study|Progressive Disease|1|||
105309663|NCT02132754|363130988|FG026|Overall Study|Progressive Disease|2|||
105309664|NCT02132754|363130989|FG027|Overall Study|Progressive Disease|1|||
105309665|NCT02132754|363130990|FG028|Overall Study|Progressive Disease|2|||
105309666|NCT02132754|363130991|FG029|Overall Study|Progressive Disease|3|||
105309667|NCT02132754|363130992|FG030|Overall Study|Progressive Disease|1|||
105309668|NCT02132754|363130993|FG031|Overall Study|Progressive Disease|1|||
105309669|NCT02132754|363130994|FG032|Overall Study|Progressive Disease|3|||
105309670|NCT02132754|363130995|FG033|Overall Study|Progressive Disease|6|||
105309671|NCT02132754|363130962|FG000|Overall Study|Screen Failure|0|||
105309672|NCT02132754|363130963|FG001|Overall Study|Screen Failure|0|||
105309673|NCT02132754|363130964|FG002|Overall Study|Screen Failure|0|||
105309674|NCT02132754|363130965|FG003|Overall Study|Screen Failure|0|||
105309675|NCT02132754|363130966|FG004|Overall Study|Screen Failure|0|||
105309676|NCT02132754|363130967|FG005|Overall Study|Screen Failure|0|||
105309677|NCT02132754|363130968|FG006|Overall Study|Screen Failure|0|||
105309678|NCT02132754|363130969|FG007|Overall Study|Screen Failure|0|||
105309679|NCT02132754|363130970|FG008|Overall Study|Screen Failure|0|||
105309680|NCT02132754|363130971|FG009|Overall Study|Screen Failure|0|||
105309681|NCT02132754|363130972|FG010|Overall Study|Screen Failure|0|||
105309682|NCT02132754|363130973|FG011|Overall Study|Screen Failure|0|||
105309683|NCT02132754|363130974|FG012|Overall Study|Screen Failure|0|||
105309684|NCT02132754|363130975|FG013|Overall Study|Screen Failure|0|||
105309685|NCT02132754|363130976|FG014|Overall Study|Screen Failure|0|||
105309686|NCT02132754|363130977|FG015|Overall Study|Screen Failure|0|||
105309687|NCT02132754|363130978|FG016|Overall Study|Screen Failure|0|||
105309688|NCT02132754|363130979|FG017|Overall Study|Screen Failure|0|||
105309689|NCT02132754|363130980|FG018|Overall Study|Screen Failure|0|||
105309690|NCT02132754|363130981|FG019|Overall Study|Screen Failure|1|||
105309691|NCT02132754|363130982|FG020|Overall Study|Screen Failure|0|||
105309692|NCT02132754|363130983|FG021|Overall Study|Screen Failure|1|||
105309693|NCT02132754|363130984|FG022|Overall Study|Screen Failure|0|||
105309694|NCT02132754|363130985|FG023|Overall Study|Screen Failure|0|||
105309695|NCT02132754|363130986|FG024|Overall Study|Screen Failure|0|||
105309696|NCT02132754|363130987|FG025|Overall Study|Screen Failure|0|||
105309697|NCT02132754|363130988|FG026|Overall Study|Screen Failure|0|||
105309698|NCT02132754|363130989|FG027|Overall Study|Screen Failure|0|||
105309699|NCT02132754|363130990|FG028|Overall Study|Screen Failure|0|||
105309700|NCT02132754|363130991|FG029|Overall Study|Screen Failure|0|||
105309701|NCT02132754|363130992|FG030|Overall Study|Screen Failure|0|||
105309702|NCT02132754|363130993|FG031|Overall Study|Screen Failure|0|||
105309703|NCT02132754|363130994|FG032|Overall Study|Screen Failure|0|||
105309704|NCT02132754|363130995|FG033|Overall Study|Screen Failure|0|||
105309705|NCT02132754|363130962|FG000|Overall Study|Transferred to Extension Study|0|||
105309706|NCT02132754|363130963|FG001|Overall Study|Transferred to Extension Study|0|||
105309707|NCT02132754|363130964|FG002|Overall Study|Transferred to Extension Study|0|||
105309708|NCT02132754|363130965|FG003|Overall Study|Transferred to Extension Study|0|||
105309709|NCT02132754|363130966|FG004|Overall Study|Transferred to Extension Study|0|||
105309710|NCT02132754|363130967|FG005|Overall Study|Transferred to Extension Study|0|||
105309711|NCT02132754|363130968|FG006|Overall Study|Transferred to Extension Study|0|||
105309712|NCT02132754|363130969|FG007|Overall Study|Transferred to Extension Study|0|||
105309713|NCT02132754|363130970|FG008|Overall Study|Transferred to Extension Study|0|||
105309714|NCT02132754|363130971|FG009|Overall Study|Transferred to Extension Study|0|||
105309715|NCT02132754|363130972|FG010|Overall Study|Transferred to Extension Study|0|||
105309716|NCT02132754|363130973|FG011|Overall Study|Transferred to Extension Study|0|||
105309717|NCT02132754|363130974|FG012|Overall Study|Transferred to Extension Study|0|||
105309718|NCT02132754|363130975|FG013|Overall Study|Transferred to Extension Study|0|||
105309719|NCT02132754|363130976|FG014|Overall Study|Transferred to Extension Study|0|||
105309720|NCT02132754|363130977|FG015|Overall Study|Transferred to Extension Study|0|||
105309721|NCT02132754|363130978|FG016|Overall Study|Transferred to Extension Study|0|||
105309722|NCT02132754|363130979|FG017|Overall Study|Transferred to Extension Study|0|||
105309723|NCT02132754|363130980|FG018|Overall Study|Transferred to Extension Study|0|||
105489504|NCT02431247|363804066|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
105489505|NCT02431247|363804067|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
105489506|NCT02431247|363804068|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
105833434|NCT01899053|365046564|FG002|Overall Study|Progressive Disease|3|||
105833435|NCT01899053|365046565|FG003|Overall Study|Progressive Disease|0|||
105833436|NCT01899053|365046566|FG004|Overall Study|Progressive Disease|3|||
105833437|NCT01899053|365046567|FG005|Overall Study|Progressive Disease|1|||
105833438|NCT01899053|365046568|FG006|Overall Study|Progressive Disease|1|||
105833439|NCT01899053|365046569|FG007|Overall Study|Progressive Disease|1|||
105833440|NCT01899053|365046570|FG008|Overall Study|Progressive Disease|4|||
105833441|NCT01899053|365046571|FG009|Overall Study|Progressive Disease|3|||
105833442|NCT01899053|365046572|FG010|Overall Study|Progressive Disease|12|||
105833443|NCT01899053|365046573|FG011|Overall Study|Progressive Disease|5|||
105833444|NCT01899053|365046574|FG012|Overall Study|Progressive Disease|8|||
105833445|NCT01899053|365046575|FG013|Overall Study|Progressive Disease|17|||
105833446|NCT01899053|365046562|FG000|Overall Study|Adverse Event|1|||
105833447|NCT01899053|365046563|FG001|Overall Study|Adverse Event|1|||
105833448|NCT01899053|365046564|FG002|Overall Study|Adverse Event|1|||
105833449|NCT01899053|365046565|FG003|Overall Study|Adverse Event|3|||
105833450|NCT01899053|365046566|FG004|Overall Study|Adverse Event|1|||
105833451|NCT01899053|365046567|FG005|Overall Study|Adverse Event|1|||
105833452|NCT01899053|365046568|FG006|Overall Study|Adverse Event|1|||
105833453|NCT01899053|365046569|FG007|Overall Study|Adverse Event|0|||
105833454|NCT01899053|365046570|FG008|Overall Study|Adverse Event|2|||
105833455|NCT01899053|365046571|FG009|Overall Study|Adverse Event|0|||
105833456|NCT01899053|365046572|FG010|Overall Study|Adverse Event|3|||
105833457|NCT01899053|365046573|FG011|Overall Study|Adverse Event|1|||
105833458|NCT01899053|365046574|FG012|Overall Study|Adverse Event|2|||
105833459|NCT01899053|365046575|FG013|Overall Study|Adverse Event|2|||
105833460|NCT01899053|365046562|FG000|Overall Study|Reason Not Specified|0|||
105833461|NCT01899053|365046563|FG001|Overall Study|Reason Not Specified|0|||
105833462|NCT01899053|365046564|FG002|Overall Study|Reason Not Specified|0|||
105833463|NCT01899053|365046565|FG003|Overall Study|Reason Not Specified|0|||
105833464|NCT01899053|365046566|FG004|Overall Study|Reason Not Specified|0|||
105833465|NCT01899053|365046567|FG005|Overall Study|Reason Not Specified|0|||
105833466|NCT01899053|365046568|FG006|Overall Study|Reason Not Specified|1|||
105833467|NCT01899053|365046569|FG007|Overall Study|Reason Not Specified|0|||
105833468|NCT01899053|365046570|FG008|Overall Study|Reason Not Specified|0|||
105833469|NCT01899053|365046571|FG009|Overall Study|Reason Not Specified|0|||
105833470|NCT01899053|365046572|FG010|Overall Study|Reason Not Specified|0|||
105833471|NCT01899053|365046573|FG011|Overall Study|Reason Not Specified|0|||
105833472|NCT01899053|365046574|FG012|Overall Study|Reason Not Specified|1|||
105833473|NCT01899053|365046575|FG013|Overall Study|Reason Not Specified|0|||
105833474|NCT01899053|365046562|FG000|Overall Study|Withdrawal by Subject|1|||
105833475|NCT01899053|365046563|FG001|Overall Study|Withdrawal by Subject|1|||
105833476|NCT01899053|365046564|FG002|Overall Study|Withdrawal by Subject|2|||
105833477|NCT01899053|365046565|FG003|Overall Study|Withdrawal by Subject|0|||
105833478|NCT01899053|365046566|FG004|Overall Study|Withdrawal by Subject|2|||
105833479|NCT01899053|365046567|FG005|Overall Study|Withdrawal by Subject|0|||
105833480|NCT01899053|365046568|FG006|Overall Study|Withdrawal by Subject|0|||
105833481|NCT01899053|365046569|FG007|Overall Study|Withdrawal by Subject|1|||
105833482|NCT01899053|365046570|FG008|Overall Study|Withdrawal by Subject|0|||
105833483|NCT01899053|365046571|FG009|Overall Study|Withdrawal by Subject|0|||
105833484|NCT01899053|365046572|FG010|Overall Study|Withdrawal by Subject|0|||
105833485|NCT01899053|365046573|FG011|Overall Study|Withdrawal by Subject|0|||
105309724|NCT02132754|363130981|FG019|Overall Study|Transferred to Extension Study|0|||
105309725|NCT02132754|363130982|FG020|Overall Study|Transferred to Extension Study|0|||
105309726|NCT02132754|363130983|FG021|Overall Study|Transferred to Extension Study|0|||
105309727|NCT02132754|363130984|FG022|Overall Study|Transferred to Extension Study|0|||
105309728|NCT02132754|363130985|FG023|Overall Study|Transferred to Extension Study|0|||
105309729|NCT02132754|363130986|FG024|Overall Study|Transferred to Extension Study|0|||
105309730|NCT02132754|363130987|FG025|Overall Study|Transferred to Extension Study|0|||
105309731|NCT02132754|363130988|FG026|Overall Study|Transferred to Extension Study|0|||
105309732|NCT02132754|363130989|FG027|Overall Study|Transferred to Extension Study|0|||
105309733|NCT02132754|363130990|FG028|Overall Study|Transferred to Extension Study|0|||
105489507|NCT02431247|363804066|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
105489508|NCT02431247|363804067|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
105833486|NCT01899053|365046574|FG012|Overall Study|Withdrawal by Subject|1|||
105833487|NCT01899053|365046575|FG013|Overall Study|Withdrawal by Subject|1|||
105833488|NCT01899053|365046562|FG000|Overall Study|Protocol Violation|0|||
105833489|NCT01899053|365046563|FG001|Overall Study|Protocol Violation|0|||
105833490|NCT01899053|365046564|FG002|Overall Study|Protocol Violation|1|||
105833491|NCT01899053|365046565|FG003|Overall Study|Protocol Violation|0|||
105833492|NCT01899053|365046566|FG004|Overall Study|Protocol Violation|0|||
105833493|NCT01899053|365046567|FG005|Overall Study|Protocol Violation|0|||
105833494|NCT01899053|365046568|FG006|Overall Study|Protocol Violation|0|||
105833495|NCT01899053|365046569|FG007|Overall Study|Protocol Violation|0|||
105833496|NCT01899053|365046570|FG008|Overall Study|Protocol Violation|0|||
105833497|NCT01899053|365046571|FG009|Overall Study|Protocol Violation|0|||
105833498|NCT01899053|365046572|FG010|Overall Study|Protocol Violation|0|||
105833499|NCT01899053|365046573|FG011|Overall Study|Protocol Violation|0|||
105833500|NCT01899053|365046574|FG012|Overall Study|Protocol Violation|0|||
105833501|NCT01899053|365046575|FG013|Overall Study|Protocol Violation|0|||
105833502|NCT01899053|365046562|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
105833503|NCT01899053|365046563|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
105833504|NCT01899053|365046564|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833505|NCT01899053|365046565|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833506|NCT01899053|365046566|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833507|NCT01899053|365046567|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833508|NCT01899053|365046568|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833509|NCT01899053|365046569|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833510|NCT01899053|365046570|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833511|NCT01899053|365046571|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833512|NCT01899053|365046572|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
105833513|NCT01899053|365046573|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833514|NCT01899053|365046574|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833515|NCT01899053|365046575|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833516|NCT01899053|365046562|FG000|Overall Study|Symptomatic Deterioration|0|||
105833517|NCT01899053|365046563|FG001|Overall Study|Symptomatic Deterioration|0|||
105833518|NCT01899053|365046564|FG002|Overall Study|Symptomatic Deterioration|0|||
105833519|NCT01899053|365046565|FG003|Overall Study|Symptomatic Deterioration|0|||
105833520|NCT01899053|365046566|FG004|Overall Study|Symptomatic Deterioration|0|||
105833521|NCT01899053|365046567|FG005|Overall Study|Symptomatic Deterioration|1|||
105833522|NCT01899053|365046568|FG006|Overall Study|Symptomatic Deterioration|0|||
105833523|NCT01899053|365046569|FG007|Overall Study|Symptomatic Deterioration|1|||
105833524|NCT01899053|365046570|FG008|Overall Study|Symptomatic Deterioration|0|||
105833525|NCT01899053|365046571|FG009|Overall Study|Symptomatic Deterioration|0|||
105833526|NCT01899053|365046572|FG010|Overall Study|Symptomatic Deterioration|0|||
105833527|NCT01899053|365046573|FG011|Overall Study|Symptomatic Deterioration|1|||
105833528|NCT01899053|365046574|FG012|Overall Study|Symptomatic Deterioration|2|||
105833529|NCT01899053|365046575|FG013|Overall Study|Symptomatic Deterioration|0|||
105833530|NCT01341405|365046576|FG000|Overall Study|Adverse Event|0|||
105833531|NCT01341405|365046577|FG001|Overall Study|Adverse Event|1|||
105833532|NCT01341405|365046578|FG002|Overall Study|Adverse Event|1|||
105833533|NCT01341405|365046576|FG000|Overall Study|Withdrawal by Subject|3|||
105833534|NCT01341405|365046577|FG001|Overall Study|Withdrawal by Subject|2|||
105833535|NCT01341405|365046578|FG002|Overall Study|Withdrawal by Subject|1|||
105833536|NCT00826241|365046579|FG000|Overall Study|Withdrawal from Follow-up|1|||
105833537|NCT00826241|365046579|FG000|Overall Study|Withdrew consent|2|||
105833538|NCT00826241|365046579|FG000|Overall Study|Death|4|||
105833539|NCT00826241|365046579|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
105833540|NCT00826241|365046579|FG000|Overall Study|Non-compliance|1|||
105833541|NCT00826241|365046579|FG000|Overall Study|Progression of disease|1|||
105833542|NCT00826241|365046579|FG000|Overall Study|Patient refused follow-up|3|||
105833543|NCT00826241|365046579|FG000|Overall Study|Lost to Follow-up|9|||
105833544|NCT00826241|365046579|FG000|Overall Study|Could not obtain records|1|||
105833545|NCT00826241|365046579|FG000|Overall Study|Screen failure|2|||
105833546|NCT00826241|365046579|FG000|Overall Study|Pt unable to proceed to registration|1|||
105833547|NCT00826241|365046579|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
105833548|NCT02300987|365048598|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
105833549|NCT02300987|365048599|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
105833550|NCT02300987|365048598|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
105833551|NCT02300987|365048599|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
105833552|NCT02300987|365048598|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
105833553|NCT02300987|365048599|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
105833554|NCT02300987|365048598|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
105833555|NCT02300987|365048599|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
105309734|NCT02132754|363130991|FG029|Overall Study|Transferred to Extension Study|0|||
105309735|NCT02132754|363130992|FG030|Overall Study|Transferred to Extension Study|0|||
105309736|NCT02132754|363130993|FG031|Overall Study|Transferred to Extension Study|0|||
105309737|NCT02132754|363130994|FG032|Overall Study|Transferred to Extension Study|0|||
105833556|NCT02300987|365048598|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
105833557|NCT02300987|365048599|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
105833558|NCT04264819|365048600|FG000|Overall Study|Physician Decision|19|||
105833559|NCT04264819|365048600|FG000|Overall Study|Adverse Event|12|||
105833560|NCT04264819|365048600|FG000|Overall Study|Withdrawal by Subject|11|||
105833561|NCT04264819|365048600|FG000|Overall Study|Lost to Follow-up|2|||
105833562|NCT04264819|365048600|FG000|Overall Study|Death|2|||
105833563|NCT00754052|365048601|FG000|Overall Study|Study terminated by Sponsor|5|||
105833564|NCT00754052|365048602|FG001|Overall Study|Study terminated by Sponsor|3|||
105833565|NCT01680016|365048603|FG000|Overall Study|Adverse Event|0|||
105833566|NCT01680016|365048604|FG001|Overall Study|Adverse Event|0|||
105833567|NCT01680016|365048605|FG002|Overall Study|Adverse Event|1|||
105833568|NCT01680016|365048606|FG003|Overall Study|Adverse Event|4|||
105833569|NCT01680016|365048603|FG000|Overall Study|The Subject went out of The Trial|1|||
105833570|NCT01680016|365048604|FG001|Overall Study|The Subject went out of The Trial|0|||
105833571|NCT01680016|365048605|FG002|Overall Study|The Subject went out of The Trial|3|||
105833572|NCT01680016|365048606|FG003|Overall Study|The Subject went out of The Trial|0|||
105833573|NCT01680016|365048603|FG000|Overall Study|Protocol Violation|0|||
105833574|NCT01680016|365048604|FG001|Overall Study|Protocol Violation|1|||
105833575|NCT01680016|365048605|FG002|Overall Study|Protocol Violation|0|||
105833576|NCT01680016|365048606|FG003|Overall Study|Protocol Violation|0|||
105833577|NCT01680016|365048603|FG000|Overall Study|Withdrawal by Subject|5|||
105833578|NCT01680016|365048604|FG001|Overall Study|Withdrawal by Subject|7|||
105833579|NCT01680016|365048605|FG002|Overall Study|Withdrawal by Subject|1|||
105833580|NCT01680016|365048606|FG003|Overall Study|Withdrawal by Subject|1|||
105833581|NCT02846883|365048609|FG000|Overall Study|Death|0|||
105833582|NCT02846883|365048610|FG001|Overall Study|Death|1|||
105833583|NCT02846883|365048611|FG002|Overall Study|Death|1|||
105833584|NCT02846883|365048609|FG000|Overall Study|Lost to Follow-up|0|||
105833585|NCT02846883|365048610|FG001|Overall Study|Lost to Follow-up|0|||
105833586|NCT02846883|365048611|FG002|Overall Study|Lost to Follow-up|1|||
105833587|NCT02846883|365048609|FG000|Overall Study|Withdrawal by Subject|1|||
105833588|NCT02846883|365048610|FG001|Overall Study|Withdrawal by Subject|0|||
105833589|NCT02846883|365048611|FG002|Overall Study|Withdrawal by Subject|0|||
105833590|NCT02846883|365048609|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
105833591|NCT02846883|365048610|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
105833592|NCT02846883|365048611|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
105833593|NCT02846883|365048609|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
105309738|NCT02132754|363130995|FG033|Overall Study|Transferred to Extension Study|6|||
105309739|NCT02132754|363130962|FG000|Overall Study|Withdrawal by Subject|0|||
105309740|NCT02132754|363130963|FG001|Overall Study|Withdrawal by Subject|0|||
105309741|NCT02132754|363130964|FG002|Overall Study|Withdrawal by Subject|0|||
105309742|NCT02132754|363130965|FG003|Overall Study|Withdrawal by Subject|0|||
105309743|NCT02132754|363130966|FG004|Overall Study|Withdrawal by Subject|0|||
105309744|NCT02132754|363130967|FG005|Overall Study|Withdrawal by Subject|0|||
105309745|NCT02132754|363130968|FG006|Overall Study|Withdrawal by Subject|0|||
105309746|NCT02132754|363130969|FG007|Overall Study|Withdrawal by Subject|0|||
105309747|NCT02132754|363130970|FG008|Overall Study|Withdrawal by Subject|0|||
105309748|NCT02132754|363130971|FG009|Overall Study|Withdrawal by Subject|1|||
105309749|NCT02132754|363130972|FG010|Overall Study|Withdrawal by Subject|0|||
105309750|NCT02132754|363130973|FG011|Overall Study|Withdrawal by Subject|0|||
105309751|NCT02132754|363130974|FG012|Overall Study|Withdrawal by Subject|1|||
105309752|NCT02132754|363130975|FG013|Overall Study|Withdrawal by Subject|0|||
105309753|NCT02132754|363130976|FG014|Overall Study|Withdrawal by Subject|1|||
105309754|NCT02132754|363130977|FG015|Overall Study|Withdrawal by Subject|2|||
105309755|NCT02132754|363130978|FG016|Overall Study|Withdrawal by Subject|1|||
105309756|NCT02132754|363130979|FG017|Overall Study|Withdrawal by Subject|0|||
105309757|NCT02132754|363130980|FG018|Overall Study|Withdrawal by Subject|0|||
105309758|NCT02132754|363130981|FG019|Overall Study|Withdrawal by Subject|0|||
105309759|NCT02132754|363130982|FG020|Overall Study|Withdrawal by Subject|1|||
105309760|NCT02132754|363130983|FG021|Overall Study|Withdrawal by Subject|0|||
105309761|NCT02132754|363130984|FG022|Overall Study|Withdrawal by Subject|0|||
105309762|NCT02132754|363130985|FG023|Overall Study|Withdrawal by Subject|0|||
105309763|NCT02132754|363130986|FG024|Overall Study|Withdrawal by Subject|1|||
105309764|NCT02132754|363130987|FG025|Overall Study|Withdrawal by Subject|0|||
105309765|NCT02132754|363130988|FG026|Overall Study|Withdrawal by Subject|0|||
105309766|NCT02132754|363130989|FG027|Overall Study|Withdrawal by Subject|1|||
105309767|NCT02132754|363130990|FG028|Overall Study|Withdrawal by Subject|0|||
105309768|NCT02132754|363130991|FG029|Overall Study|Withdrawal by Subject|0|||
105309769|NCT02132754|363130992|FG030|Overall Study|Withdrawal by Subject|0|||
105309770|NCT02132754|363130993|FG031|Overall Study|Withdrawal by Subject|1|||
105309771|NCT02132754|363130994|FG032|Overall Study|Withdrawal by Subject|0|||
105309772|NCT02132754|363130995|FG033|Overall Study|Withdrawal by Subject|2|||
105309773|NCT03050060|363130999|FG000|Overall Study|Adverse Event|7|||
105489509|NCT02431247|363804068|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
105489510|NCT02431247|363804066|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
105489511|NCT02431247|363804067|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
105489512|NCT02431247|363804068|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
105489513|NCT02431247|363804066|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
105489514|NCT02431247|363804067|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
105489515|NCT02431247|363804068|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
105489516|NCT02431247|363804066|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
105833594|NCT02846883|365048610|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
105833595|NCT02846883|365048611|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
105309774|NCT03050060|363130999|FG000|Overall Study|Withdrawal by Subject|1|||
105309775|NCT03050060|363130999|FG000|Overall Study|Progression|7|||
105309776|NCT00510289|363131000|FG000|Overall Study|Withdrawal by Subject|7|||
105309777|NCT00510289|363131000|FG000|Overall Study|Refused bone marrow biopsy|2|||
105309778|NCT00510289|363131000|FG000|Overall Study|Lost to Follow-up|1|||
105309779|NCT00510289|363131000|FG000|Overall Study|Progressed prior to starting drug|2|||
105309780|NCT00197496|363131002|FG000|Baseline to Discharge|not interested|1|||
105309781|NCT00197496|363131003|FG001|Baseline to Discharge|not interested|0|||
105309782|NCT00197496|363131002|FG000|Baseline to Discharge|MRSA|1|||
105309783|NCT00197496|363131003|FG001|Baseline to Discharge|MRSA|0|||
105309784|NCT00197496|363131002|FG000|Baseline to Discharge|Physician Decision|0|||
105309785|NCT00197496|363131003|FG001|Baseline to Discharge|Physician Decision|1|||
105309786|NCT00197496|363131002|FG000|Baseline to Discharge|Protocol Violation|0|||
105309787|NCT00197496|363131003|FG001|Baseline to Discharge|Protocol Violation|1|||
105309788|NCT00197496|363131002|FG000|Follow-up|Lost to Follow-up|2|||
105309789|NCT00197496|363131003|FG001|Follow-up|Lost to Follow-up|1|||
105309790|NCT01770392|363131004|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
105309791|NCT03401450|363131008|FG000|Overall Study|Lost to Follow-up|4|||
105309792|NCT03401450|363131009|FG001|Overall Study|Lost to Follow-up|6|||
105309793|NCT03401450|363131008|FG000|Overall Study|Anesthesia plan changed|2|||
105309794|NCT03401450|363131009|FG001|Overall Study|Anesthesia plan changed|2|||
105309795|NCT03401450|363131008|FG000|Overall Study|Did not complete medication diary|4|||
105309796|NCT03401450|363131009|FG001|Overall Study|Did not complete medication diary|2|||
105309797|NCT03401450|363131008|FG000|Overall Study|post surgery medication change|2|||
105366902|NCT01791595|363350074|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
105366903|NCT01791595|363350075|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
105366904|NCT01791595|363350076|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
105366905|NCT01791595|363350077|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
105366906|NCT01791595|363350078|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
105366907|NCT01791595|363350079|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
105366908|NCT01791595|363350080|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
105366909|NCT01791595|363350074|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
105366910|NCT01791595|363350075|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
105366911|NCT01791595|363350076|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
105366912|NCT01791595|363350077|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
105366913|NCT01791595|363350078|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
105366914|NCT01791595|363350079|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
105366915|NCT01791595|363350080|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
105366916|NCT01791595|363350074|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
105366917|NCT01791595|363350075|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
105366918|NCT01791595|363350076|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
105366919|NCT01791595|363350077|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
105366920|NCT01791595|363350078|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
105366921|NCT01791595|363350079|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
105366922|NCT01791595|363350080|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
105366923|NCT03080935|363350081|FG000|Overall Study|Death|34|||
105366924|NCT03080935|363350082|FG001|Overall Study|Death|50|||
105366925|NCT03080935|363350081|FG000|Overall Study|Lost to Follow-up|5|||
105366926|NCT03080935|363350082|FG001|Overall Study|Lost to Follow-up|4|||
105366927|NCT03080935|363350081|FG000|Overall Study|Withdrawal by Subject|11|||
105366928|NCT03080935|363350082|FG001|Overall Study|Withdrawal by Subject|15|||
105366929|NCT03118934|363350083|FG000|Overall Study|Adverse Event|0|||
105366930|NCT03118934|363350084|FG001|Overall Study|Adverse Event|0|||
105366931|NCT03118934|363350085|FG002|Overall Study|Adverse Event|0|||
105366932|NCT03118934|363350086|FG003|Overall Study|Adverse Event|0|||
105366933|NCT03118934|363350087|FG004|Overall Study|Adverse Event|0|||
105366934|NCT03118934|363350088|FG005|Overall Study|Adverse Event|1|||
105366935|NCT03118934|363350083|FG000|Overall Study|Physician Decision|0|||
105366936|NCT03118934|363350084|FG001|Overall Study|Physician Decision|0|||
105366937|NCT03118934|363350085|FG002|Overall Study|Physician Decision|0|||
105366938|NCT03118934|363350086|FG003|Overall Study|Physician Decision|0|||
105366939|NCT03118934|363350087|FG004|Overall Study|Physician Decision|0|||
105366940|NCT03118934|363350088|FG005|Overall Study|Physician Decision|1|||
105366941|NCT03118934|363350083|FG000|Overall Study|Discontinued prior to exposure|0|||
105366942|NCT03118934|363350084|FG001|Overall Study|Discontinued prior to exposure|1|||
105366943|NCT03118934|363350085|FG002|Overall Study|Discontinued prior to exposure|1|||
105575864|NCT01865617|364108351|FG009|Overall Study|Death|3|||
105575865|NCT01865617|364108352|FG010|Overall Study|Death|32|||
105309798|NCT03401450|363131009|FG001|Overall Study|post surgery medication change|1|||
105309799|NCT03401450|363131008|FG000|Overall Study|Cancelled surgery|0|||
105309800|NCT03401450|363131009|FG001|Overall Study|Cancelled surgery|2|||
105309801|NCT00861198|363131014|FG000|Overall Study|SpyGlass Failed|5|||
105309802|NCT00259272|363131017|FG000|Overall Study|Adverse Event|2|||
105489517|NCT02431247|363804067|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
105489518|NCT02431247|363804068|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
105489519|NCT02431247|363804066|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
105489520|NCT02431247|363804067|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
105489521|NCT02431247|363804068|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
105489522|NCT02431247|363804066|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
105489523|NCT02431247|363804067|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
105489524|NCT02431247|363804068|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
105489525|NCT02431247|363804066|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
105489526|NCT02431247|363804067|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
105489527|NCT02431247|363804068|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
105489528|NCT02431247|363804066|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
105489529|NCT02431247|363804067|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
105489530|NCT02431247|363804068|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
105489531|NCT02431247|363804066|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
105489532|NCT02431247|363804067|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
105489533|NCT02431247|363804068|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
105489534|NCT02431247|363804066|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
105489535|NCT02431247|363804067|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
105489536|NCT02431247|363804068|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
105489537|NCT02431247|363804066|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
105489538|NCT02431247|363804067|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
105489539|NCT02431247|363804068|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
105489540|NCT02431247|363804066|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
105489541|NCT02431247|363804067|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
105489542|NCT02431247|363804068|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
105489543|NCT02273739|363804069|FG000|Overall Study|Progression of Disease|3|||
105489544|NCT02273739|363804070|FG001|Overall Study|Progression of Disease|4|||
105489545|NCT02273739|363804071|FG002|Overall Study|Progression of Disease|5|||
105489546|NCT02273739|363804072|FG003|Overall Study|Progression of Disease|2|||
105489547|NCT02273739|363804069|FG000|Overall Study|Death|0|||
105489548|NCT02273739|363804070|FG001|Overall Study|Death|0|||
105489549|NCT02273739|363804071|FG002|Overall Study|Death|0|||
105489550|NCT02273739|363804072|FG003|Overall Study|Death|2|||
105489551|NCT02273739|363804069|FG000|Overall Study|Adverse Event|0|||
105489552|NCT02273739|363804070|FG001|Overall Study|Adverse Event|0|||
105489553|NCT02273739|363804071|FG002|Overall Study|Adverse Event|0|||
105489554|NCT02273739|363804072|FG003|Overall Study|Adverse Event|1|||
105489555|NCT02273739|363804069|FG000|Overall Study|Withdrawal by Subject|0|||
105489556|NCT02273739|363804070|FG001|Overall Study|Withdrawal by Subject|0|||
105489557|NCT02273739|363804071|FG002|Overall Study|Withdrawal by Subject|2|||
105489558|NCT02273739|363804072|FG003|Overall Study|Withdrawal by Subject|1|||
105489559|NCT02273739|363804069|FG000|Overall Study|Physician Decision|0|||
105489560|NCT02273739|363804070|FG001|Overall Study|Physician Decision|0|||
105489561|NCT02273739|363804071|FG002|Overall Study|Physician Decision|0|||
105489562|NCT02273739|363804072|FG003|Overall Study|Physician Decision|1|||
105489563|NCT00322153|363804073|FG000|Overall Study|Adverse Event|21|||
105489564|NCT00322153|363804074|FG001|Overall Study|Adverse Event|34|||
105489565|NCT00322153|363804073|FG000|Overall Study|Protocol Violation|6|||
105489566|NCT00322153|363804074|FG001|Overall Study|Protocol Violation|14|||
105575866|NCT01865617|364108353|FG011|Overall Study|Death|6|||
105575867|NCT01865617|364108354|FG012|Overall Study|Death|13|||
105833596|NCT05393271|365048618|FG000|Overall Study|Physician Decision|0|||
105833597|NCT05393271|365048619|FG001|Overall Study|Physician Decision|0|||
105833598|NCT05393271|365048620|FG002|Overall Study|Physician Decision|0|||
105833599|NCT05393271|365048621|FG003|Overall Study|Physician Decision|0|||
105833600|NCT05393271|365048622|FG004|Overall Study|Physician Decision|0|||
105833601|NCT05393271|365048623|FG005|Overall Study|Physician Decision|0|||
105833602|NCT05393271|365048624|FG006|Overall Study|Physician Decision|1|||
105833603|NCT05393271|365048625|FG007|Overall Study|Physician Decision|0|||
105833604|NCT05393271|365048626|FG008|Overall Study|Physician Decision|0|||
105833605|NCT05393271|365048627|FG009|Overall Study|Physician Decision|0|||
105833606|NCT05393271|365048628|FG010|Overall Study|Physician Decision|0|||
105833607|NCT02943993|365048629|FG000|Overall Study|Withdrawal by Subject|52|||
105489567|NCT00322153|363804073|FG000|Overall Study|Withdrawal by Subject|18|||
105489568|NCT00322153|363804074|FG001|Overall Study|Withdrawal by Subject|10|||
105575868|NCT01865617|364108342|FG000|Overall Study|Lost to Follow-up|2|||
105833608|NCT02943993|365048629|FG000|Overall Study|Transfer to another institution|6|||
105489569|NCT00322153|363804073|FG000|Overall Study|Lack of Efficacy|8|||
105489570|NCT00322153|363804074|FG001|Overall Study|Lack of Efficacy|3|||
105575869|NCT01865617|364108343|FG001|Overall Study|Lost to Follow-up|0|||
105575870|NCT01865617|364108344|FG002|Overall Study|Lost to Follow-up|0|||
105575871|NCT01865617|364108345|FG003|Overall Study|Lost to Follow-up|0|||
105833609|NCT02943993|365048629|FG000|Overall Study|Lost to Follow-up|135|||
105833610|NCT02943993|365048629|FG000|Overall Study|Death|98|||
105833611|NCT02943993|365048629|FG000|Overall Study|Other reason for premature termination|32|||
105309803|NCT00259272|363131018|FG001|Overall Study|Adverse Event|1|||
105309804|NCT00259272|363131019|FG002|Overall Study|Adverse Event|0|||
105309805|NCT00259272|363131020|FG003|Overall Study|Adverse Event|3|||
105309806|NCT00259272|363131017|FG000|Overall Study|Lack of Efficacy|5|||
105309807|NCT00259272|363131018|FG001|Overall Study|Lack of Efficacy|1|||
105309808|NCT00259272|363131019|FG002|Overall Study|Lack of Efficacy|2|||
105309809|NCT00259272|363131020|FG003|Overall Study|Lack of Efficacy|6|||
105309810|NCT00259272|363131017|FG000|Overall Study|Physician Decision|1|||
105309811|NCT00259272|363131018|FG001|Overall Study|Physician Decision|2|||
105309812|NCT00259272|363131019|FG002|Overall Study|Physician Decision|1|||
105309813|NCT00259272|363131020|FG003|Overall Study|Physician Decision|3|||
105309814|NCT00259272|363131017|FG000|Overall Study|Protocol Violation|2|||
105309815|NCT00259272|363131018|FG001|Overall Study|Protocol Violation|0|||
105309816|NCT00259272|363131019|FG002|Overall Study|Protocol Violation|0|||
105833612|NCT02943993|365048629|FG000|Overall Study|Missing reason for termination|7|||
105309817|NCT00259272|363131020|FG003|Overall Study|Protocol Violation|1|||
105309818|NCT00259272|363131017|FG000|Overall Study|Sponsor Decision|0|||
105309819|NCT00259272|363131018|FG001|Overall Study|Sponsor Decision|1|||
105309820|NCT00259272|363131019|FG002|Overall Study|Sponsor Decision|0|||
105309821|NCT00259272|363131020|FG003|Overall Study|Sponsor Decision|0|||
105309822|NCT00259272|363131017|FG000|Overall Study|Withdrawal by Subject|4|||
105309823|NCT00259272|363131018|FG001|Overall Study|Withdrawal by Subject|2|||
105309824|NCT00259272|363131019|FG002|Overall Study|Withdrawal by Subject|2|||
105309825|NCT00259272|363131020|FG003|Overall Study|Withdrawal by Subject|7|||
105309826|NCT00259272|363131017|FG000|Overall Study|Lost to Follow-up|1|||
105309827|NCT00259272|363131018|FG001|Overall Study|Lost to Follow-up|0|||
105309828|NCT00259272|363131019|FG002|Overall Study|Lost to Follow-up|0|||
105309829|NCT00259272|363131020|FG003|Overall Study|Lost to Follow-up|1|||
105309830|NCT00319982|363131021|FG000|Overall Study|Withdrawal by Subject|1|||
105309831|NCT00319982|363131022|FG001|Overall Study|Withdrawal by Subject|0|||
105309832|NCT03480386|363131023|FG000|Overall Study|Did not complete measures at 3-months|17|||
105309833|NCT03480386|363131024|FG001|Overall Study|Did not complete measures at 3-months|14|||
105309834|NCT03480386|363131023|FG000|Overall Study|No baseline measures|11|||
105309835|NCT03480386|363131024|FG001|Overall Study|No baseline measures|14|||
105309836|NCT03480386|363131023|FG000|Overall Study|Death|0|||
105309837|NCT03480386|363131024|FG001|Overall Study|Death|5|||
105309838|NCT03480386|363131023|FG000|Overall Study|Withdrawal by Subject|12|||
105309839|NCT03480386|363131024|FG001|Overall Study|Withdrawal by Subject|8|||
105309840|NCT03480386|363131023|FG000|Overall Study|Lost to Follow-up|2|||
105309841|NCT03480386|363131024|FG001|Overall Study|Lost to Follow-up|1|||
105309842|NCT03480386|363131023|FG000|Overall Study|Complicating disease|0|||
105309843|NCT03480386|363131024|FG001|Overall Study|Complicating disease|1|||
105309844|NCT03480386|363131023|FG000|Overall Study|Disease progression|3|||
105309845|NCT03480386|363131024|FG001|Overall Study|Disease progression|0|||
105309846|NCT03480386|363131023|FG000|Overall Study|Became ineligible|0|||
105309847|NCT03480386|363131024|FG001|Overall Study|Became ineligible|2|||
105309848|NCT01094886|363131025|FG000|Overall Study|Adverse Event|2|||
105833613|NCT04968925|365048633|FG000|Phase I- Period 1|COVID-19 related|0|||
105833614|NCT04968925|365048634|FG001|Phase I- Period 1|COVID-19 related|1|||
105833615|NCT04968925|365048635|FG002|Phase I- Period 1|COVID-19 related|0|||
105833616|NCT04968925|365048636|FG003|Phase I- Period 1|COVID-19 related|0|||
105833617|NCT04968925|365048633|FG000|Phase I- Period 1|Subject enrolled in error|1|||
105833618|NCT04968925|365048634|FG001|Phase I- Period 1|Subject enrolled in error|1|||
105833619|NCT04968925|365048635|FG002|Phase I- Period 1|Subject enrolled in error|0|||
105833620|NCT04968925|365048636|FG003|Phase I- Period 1|Subject enrolled in error|0|||
105833621|NCT04968925|365048633|FG000|Phase II- Period 1|COVID-19 Related|0|||
105833622|NCT04968925|365048634|FG001|Phase II- Period 1|COVID-19 Related|0|||
105833623|NCT04968925|365048635|FG002|Phase II- Period 1|COVID-19 Related|6|||
105833624|NCT04968925|365048636|FG003|Phase II- Period 1|COVID-19 Related|6|||
105833625|NCT04968925|365048633|FG000|Phase II- Period 1|Subject enrolled in error|0|||
105575872|NCT01865617|364108346|FG004|Overall Study|Lost to Follow-up|0|||
105833626|NCT04968925|365048634|FG001|Phase II- Period 1|Subject enrolled in error|0|||
105833627|NCT04968925|365048635|FG002|Phase II- Period 1|Subject enrolled in error|1|||
105833628|NCT04968925|365048636|FG003|Phase II- Period 1|Subject enrolled in error|0|||
105833629|NCT04968925|365048633|FG000|Phase II -Period 2|COVID-19 related|0|||
105309849|NCT01094886|363131025|FG000|Overall Study|Withdrawal by Subject|5|||
105309850|NCT03866902|363131027|FG000|Overall Study|Lost to Follow-up|98|||
105309851|NCT03866902|363131028|FG001|Overall Study|Lost to Follow-up|82|||
105309852|NCT03866902|363131027|FG000|Overall Study|Pregnancy|18|||
105309853|NCT03866902|363131028|FG001|Overall Study|Pregnancy|24|||
105309854|NCT02342639|363131029|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
105309855|NCT02342639|363131030|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
105309856|NCT02342639|363131029|FG000|Overall Study|Protocol Violation|0|||
105833630|NCT04968925|365048634|FG001|Phase II -Period 2|COVID-19 related|0|||
105833631|NCT04968925|365048635|FG002|Phase II -Period 2|COVID-19 related|4|||
105833632|NCT04968925|365048636|FG003|Phase II -Period 2|COVID-19 related|3|||
105833633|NCT04968925|365048633|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
105833634|NCT04968925|365048634|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
105833635|NCT04968925|365048635|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
105833636|NCT04968925|365048636|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
105833637|NCT01119625|365048637|FG000|Overall Study|Lost to Follow-up|1|||
105833638|NCT01119625|365048638|FG001|Overall Study|Lost to Follow-up|2|||
105833639|NCT01119625|365048637|FG000|Overall Study|Withdrawal by Subject|2|||
105833640|NCT01119625|365048638|FG001|Overall Study|Withdrawal by Subject|1|||
105833641|NCT01119625|365048637|FG000|Overall Study|Other|0|||
105833642|NCT01119625|365048638|FG001|Overall Study|Other|1|||
105833643|NCT00876265|365048639|FG000|Overall Study|Miscellaneous reasons|4|||
105833644|NCT00876265|365048639|FG000|Overall Study|Lost to Follow-up|6|||
105833645|NCT00876265|365048639|FG000|Overall Study|Withdrawal by Subject|2|||
105833646|NCT01721772|365048640|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
105833647|NCT01721772|365048641|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
105833648|NCT01721772|365048640|FG000|Pre-Treatment|Poor/non-compliance|0|||
105833649|NCT01721772|365048641|FG001|Pre-Treatment|Poor/non-compliance|1|||
105833650|NCT01721772|365048640|FG000|Pre-Treatment|Participant withdrew consent|0|||
105833651|NCT01721772|365048641|FG001|Pre-Treatment|Participant withdrew consent|1|||
105833652|NCT01721772|365048640|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
105833653|NCT01721772|365048641|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
105833654|NCT01721772|365048640|FG000|Treatment|Disease progression|119|||
105833655|NCT01721772|365048641|FG001|Treatment|Disease progression|168|||
105833656|NCT01721772|365048640|FG000|Treatment|Study drug toxicity|19|||
105833657|NCT01721772|365048641|FG001|Treatment|Study drug toxicity|10|||
105833658|NCT01721772|365048640|FG000|Treatment|Adverse event unrelated to study drug|7|||
105833659|NCT01721772|365048641|FG001|Treatment|Adverse event unrelated to study drug|7|||
105833660|NCT01721772|365048640|FG000|Treatment|Maximum clinical benefit|16|||
105833661|NCT01721772|365048641|FG001|Treatment|Maximum clinical benefit|4|||
105833662|NCT01721772|365048640|FG000|Treatment|Other|19|||
105833663|NCT01721772|365048641|FG001|Treatment|Other|2|||
105833664|NCT01721772|365048640|FG000|Treatment|Participant withdrew consent|2|||
105833665|NCT01721772|365048641|FG001|Treatment|Participant withdrew consent|5|||
105833666|NCT01721772|365048640|FG000|Treatment|Participant request to discontinue study treatment|21|||
105833667|NCT01721772|365048641|FG001|Treatment|Participant request to discontinue study treatment|8|||
105833668|NCT01721772|365048640|FG000|Treatment|Death|1|||
105833669|NCT01721772|365048641|FG001|Treatment|Death|0|||
105833670|NCT01721772|365048640|FG000|Treatment|Not reported|1|||
105833671|NCT01721772|365048641|FG001|Treatment|Not reported|0|||
105833672|NCT01721772|365048640|FG000|Treatment|Poor/non-compliance|1|||
105833673|NCT01721772|365048641|FG001|Treatment|Poor/non-compliance|0|||
105833674|NCT01721772|365048640|FG000|Treatment|Lost to Follow-up|0|||
105833675|NCT01721772|365048641|FG001|Treatment|Lost to Follow-up|1|||
105833676|NCT02754492|365048642|FG000|Overall Study|Protocol Violation|2|||
105833677|NCT02754492|365048643|FG001|Overall Study|Protocol Violation|2|||
105833678|NCT02754492|365048644|FG002|Overall Study|Protocol Violation|0|||
105833679|NCT02754492|365048645|FG003|Overall Study|Protocol Violation|1|||
105833680|NCT02754492|365048642|FG000|Overall Study|Withdrawal by Subject|2|||
105833681|NCT02754492|365048643|FG001|Overall Study|Withdrawal by Subject|0|||
105833682|NCT02754492|365048644|FG002|Overall Study|Withdrawal by Subject|0|||
105833683|NCT02754492|365048645|FG003|Overall Study|Withdrawal by Subject|0|||
105366944|NCT03118934|363350086|FG003|Overall Study|Discontinued prior to exposure|1|||
105489571|NCT00322153|363804073|FG000|Overall Study|Lost to Follow-up|5|||
105489572|NCT00322153|363804074|FG001|Overall Study|Lost to Follow-up|4|||
105489573|NCT00322153|363804073|FG000|Overall Study|Withdrawn for other reasons|5|||
105489574|NCT00322153|363804074|FG001|Overall Study|Withdrawn for other reasons|4|||
105833684|NCT02754492|365048642|FG000|Overall Study|Equipment malfuntion|0|||
105833685|NCT02754492|365048643|FG001|Overall Study|Equipment malfuntion|0|||
105833686|NCT02754492|365048644|FG002|Overall Study|Equipment malfuntion|2|||
105833687|NCT02754492|365048645|FG003|Overall Study|Equipment malfuntion|5|||
105833688|NCT02754492|365048642|FG000|Overall Study|Adverse Event|0|||
105833689|NCT02754492|365048643|FG001|Overall Study|Adverse Event|0|||
105833690|NCT02754492|365048644|FG002|Overall Study|Adverse Event|0|||
105833691|NCT02754492|365048645|FG003|Overall Study|Adverse Event|13|||
105833692|NCT02754492|365048642|FG000|Overall Study|Venous access issues not resulting in AE|0|||
105489575|NCT01309893|363804075|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
105575873|NCT01865617|364108347|FG005|Overall Study|Lost to Follow-up|0|||
105833693|NCT02754492|365048643|FG001|Overall Study|Venous access issues not resulting in AE|0|||
105833694|NCT02754492|365048644|FG002|Overall Study|Venous access issues not resulting in AE|0|||
105833695|NCT02754492|365048645|FG003|Overall Study|Venous access issues not resulting in AE|4|||
105833696|NCT02327325|365048646|FG000|Overall Study|Withdrawal by Subject|1|||
105833697|NCT02327325|365048647|FG001|Overall Study|Withdrawal by Subject|4|||
105833698|NCT02327325|365048648|FG002|Overall Study|Withdrawal by Subject|4|||
105833699|NCT02327325|365048646|FG000|Overall Study|Excluded by Study Team|0|||
105833700|NCT02327325|365048647|FG001|Overall Study|Excluded by Study Team|0|||
105833701|NCT02327325|365048648|FG002|Overall Study|Excluded by Study Team|1|||
105366945|NCT03118934|363350087|FG004|Overall Study|Discontinued prior to exposure|2|||
105366946|NCT03118934|363350088|FG005|Overall Study|Discontinued prior to exposure|0|||
105366947|NCT01614470|363350089|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
105366948|NCT01614470|363350090|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
105366949|NCT01614470|363350091|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
105366950|NCT01614470|363350089|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
105366951|NCT01614470|363350090|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
105366952|NCT01614470|363350091|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
105366953|NCT03902613|363350092|FG000|Overall Study|Physician Decision|1|||
105366954|NCT04249427|363350097|FG000|Overall Study|Adverse Event|3|||
105366955|NCT04249427|363350098|FG001|Overall Study|Adverse Event|1|||
105366956|NCT04249427|363350097|FG000|Overall Study|Lack of Efficacy|0|||
105366957|NCT04249427|363350098|FG001|Overall Study|Lack of Efficacy|1|||
105366958|NCT04249427|363350097|FG000|Overall Study|Withdrawal by Subject|1|||
105366959|NCT04249427|363350098|FG001|Overall Study|Withdrawal by Subject|2|||
105366960|NCT02557399|363350102|FG000|Overall Study|Adverse Event|6|||
105366961|NCT02557399|363350103|FG001|Overall Study|Adverse Event|5|||
105366962|NCT02557399|363350102|FG000|Overall Study|Protocol Violation|0|||
105366963|NCT02557399|363350103|FG001|Overall Study|Protocol Violation|1|||
105366964|NCT02557399|363350102|FG000|Overall Study|Protocol-defined stopping criteria|0|||
105366965|NCT02557399|363350103|FG001|Overall Study|Protocol-defined stopping criteria|1|||
105366966|NCT02557399|363350102|FG000|Overall Study|Withdrawal by Subject|1|||
105366967|NCT02557399|363350103|FG001|Overall Study|Withdrawal by Subject|1|||
105366968|NCT02848664|363350106|FG000|Overall Study|Withdrawal by Subject|2|||
105366969|NCT02848664|363350106|FG000|Overall Study|Adverse Event|1|||
105366970|NCT02848664|363350106|FG000|Overall Study|no assistance for device training|1|||
105366971|NCT00931632|363350107|FG000|Overall Study|Withdrawal by Subject|2|||
105366972|NCT00931632|363350108|FG001|Overall Study|Withdrawal by Subject|3|||
105366973|NCT00931632|363350107|FG000|Overall Study|Adverse Event|19|||
105366974|NCT00931632|363350108|FG001|Overall Study|Adverse Event|15|||
105366975|NCT00732069|363350109|FG000|Washout After First Study Drug|Adverse Event|1|||
105366976|NCT00732069|363350110|FG001|Washout After First Study Drug|Adverse Event|0|||
105366977|NCT00732069|363350111|FG002|Washout After First Study Drug|Adverse Event|0|||
105366978|NCT00732069|363350112|FG003|Washout After First Study Drug|Adverse Event|0|||
105366979|NCT00732069|363350113|FG004|Washout After First Study Drug|Adverse Event|0|||
105366980|NCT00732069|363350114|FG005|Washout After First Study Drug|Adverse Event|0|||
105366981|NCT04460326|363350115|FG000|Completed at Least 4 Meals|Early discharge|5|||
105366982|NCT04460326|363350116|FG001|Completed at Least 4 Meals|Early discharge|5|||
105366983|NCT04460326|363350115|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
105366984|NCT04460326|363350116|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
105366985|NCT04460326|363350115|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
105366986|NCT04460326|363350116|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
105366987|NCT04460326|363350115|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
105366988|NCT04460326|363350116|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
105366989|NCT04460326|363350115|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
105366990|NCT04460326|363350116|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
105366991|NCT04460326|363350115|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
105366992|NCT04460326|363350116|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
105366993|NCT00577317|363350117|FG000|Overall Study|Study Terminated|0|||
105366994|NCT00577317|363350118|FG001|Overall Study|Study Terminated|2|||
105366995|NCT03160716|363350119|FG000|Overall Study|Lost to Follow-up|1|||
105366996|NCT03139552|363350124|FG000|Overall Study|unable to attend tasting due to schedule|3|||
105366997|NCT03106077|363350127|FG000|Overall Study|Screen Failure|94|||
105366998|NCT03106077|363350128|FG001|Overall Study|Screen Failure|0|||
105366999|NCT01118052|363350130|FG000|Overall Study|Never treated|2|||
105367000|NCT02949947|363350131|FG000|Overall Study|Non Compliance|0|||
105367001|NCT02949947|363350132|FG001|Overall Study|Non Compliance|1|||
105367002|NCT02949947|363350131|FG000|Overall Study|Insurance change|1|||
105367003|NCT02949947|363350132|FG001|Overall Study|Insurance change|0|||
105367004|NCT00794664|363350133|FG000|Treatment Period|Withdrawal by Subject|0|||
105367005|NCT00794664|363350134|FG001|Treatment Period|Withdrawal by Subject|2|||
105367006|NCT00794664|363350133|FG000|Treatment Period|Protocol non-compliance|0|||
105367007|NCT00794664|363350134|FG001|Treatment Period|Protocol non-compliance|1|||
105367008|NCT00794664|363350133|FG000|Treatment Period|Other|0|||
105367009|NCT00794664|363350134|FG001|Treatment Period|Other|1|||
105367010|NCT00794664|363350133|FG000|Treatment Period|Adverse Event|1|||
105367011|NCT00794664|363350134|FG001|Treatment Period|Adverse Event|8|||
105489576|NCT01309893|363804076|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
105367012|NCT00794664|363350133|FG000|Follow-up Period|Other|1|||
105367013|NCT00794664|363350134|FG001|Follow-up Period|Other|2|||
105367014|NCT00794664|363350133|FG000|Follow-up Period|Withdrawal by Subject|0|||
105367015|NCT00794664|363350134|FG001|Follow-up Period|Withdrawal by Subject|2|||
105367016|NCT00794664|363350133|FG000|Follow-up Period|Protocol non-compliance|0|||
105309857|NCT02342639|363131030|FG001|Overall Study|Protocol Violation|2|||
105309858|NCT03155945|363131031|FG000|Overall Study|Lost to Follow-up|0|||
105309859|NCT03155945|363131032|FG001|Overall Study|Lost to Follow-up|1|||
105309860|NCT03155945|363131031|FG000|Overall Study|Withdrawal by Subject|0|||
105309861|NCT03155945|363131032|FG001|Overall Study|Withdrawal by Subject|1|||
105309862|NCT03155945|363131031|FG000|Overall Study|Other Reason|0|||
105309863|NCT03155945|363131032|FG001|Overall Study|Other Reason|1|||
105309864|NCT03462459|363131037|FG000|Overall Study|Death|1|||
105309865|NCT03462459|363131038|FG001|Overall Study|Death|0|||
105309866|NCT03462459|363131037|FG000|Overall Study|Lack of Efficacy|2|||
105309867|NCT03462459|363131038|FG001|Overall Study|Lack of Efficacy|4|||
105309868|NCT03462459|363131037|FG000|Overall Study|Lost to Follow-up|1|||
105309869|NCT03462459|363131038|FG001|Overall Study|Lost to Follow-up|3|||
105309870|NCT03462459|363131037|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
105309871|NCT03462459|363131038|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
105309872|NCT03462459|363131037|FG000|Overall Study|Withdrawal by Subject|3|||
105309873|NCT03462459|363131038|FG001|Overall Study|Withdrawal by Subject|2|||
105309874|NCT03462459|363131037|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
105309875|NCT03462459|363131038|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
105309876|NCT04191096|363131039|FG000|Overall Study|Death|102|||
105833702|NCT01408888|365048649|FG000|First Intervention|Adverse Event|0|||
105833703|NCT01408888|365048650|FG001|First Intervention|Adverse Event|1|||
105833704|NCT01408888|365048649|FG000|First Intervention|Withdrawal by Subject|0|||
105833705|NCT01408888|365048650|FG001|First Intervention|Withdrawal by Subject|2|||
105833706|NCT01408888|365048649|FG000|Second Intervention|Withdrawal by Subject|1|||
105833707|NCT01408888|365048650|FG001|Second Intervention|Withdrawal by Subject|0|||
105833708|NCT01408888|365048649|FG000|Second Intervention|Adverse Event|1|||
105833709|NCT01408888|365048650|FG001|Second Intervention|Adverse Event|0|||
105833710|NCT01957150|365048651|FG000|Overall Study|Adverse Event|23|||
105833711|NCT01957150|365048652|FG001|Overall Study|Adverse Event|20|||
105833712|NCT01957150|365048651|FG000|Overall Study|Withdrawal by Subject|13|||
105833713|NCT01957150|365048652|FG001|Overall Study|Withdrawal by Subject|17|||
105833714|NCT01957150|365048651|FG000|Overall Study|Physician Decision|3|||
105833715|NCT01957150|365048652|FG001|Overall Study|Physician Decision|6|||
105833716|NCT01957150|365048651|FG000|Overall Study|Lost to Follow-up|4|||
105833717|NCT01957150|365048652|FG001|Overall Study|Lost to Follow-up|4|||
105833718|NCT01957150|365048651|FG000|Overall Study|Protocol Violation|1|||
105833719|NCT01957150|365048652|FG001|Overall Study|Protocol Violation|0|||
105833720|NCT01957150|365048651|FG000|Overall Study|Lack of Efficacy|11|||
105833721|NCT01957150|365048652|FG001|Overall Study|Lack of Efficacy|11|||
105833722|NCT02416180|365048659|FG000|Overall Study|Withdrawal by Subject|1|||
105833723|NCT02179190|365048660|FG000|Enrollment|Exit Prior to Device Attempt|11|||
105833724|NCT02179190|365048660|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
105833725|NCT02179190|365048660|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
105833726|NCT02179190|365048660|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
105833727|NCT02179190|365048660|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
105833728|NCT02179190|365048660|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
105833729|NCT02377349|365048662|FG000|Overall Study|Serious Adverse Event|1|||
105833730|NCT02377349|365048663|FG001|Overall Study|Serious Adverse Event|0|||
105833731|NCT02377349|365048662|FG000|Overall Study|Protocol Violation|3|||
105833732|NCT02377349|365048663|FG001|Overall Study|Protocol Violation|2|||
105309877|NCT04191096|363131040|FG001|Overall Study|Death|89|||
105309878|NCT04191096|363131039|FG000|Overall Study|Lost to Follow-up|1|||
105309879|NCT04191096|363131040|FG001|Overall Study|Lost to Follow-up|1|||
105309880|NCT04191096|363131039|FG000|Overall Study|Withdrawal by Subject|5|||
105309881|NCT04191096|363131040|FG001|Overall Study|Withdrawal by Subject|5|||
105309882|NCT04191096|363131039|FG000|Overall Study|Participants Ongoing|518|||
105309883|NCT04191096|363131040|FG001|Overall Study|Participants Ongoing|530|||
105833733|NCT02377349|365048662|FG000|Overall Study|Withdrawal by Subject|5|||
105833734|NCT02377349|365048663|FG001|Overall Study|Withdrawal by Subject|3|||
105833735|NCT02377349|365048662|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
105833736|NCT02377349|365048663|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
105833737|NCT02377349|365048662|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
105833738|NCT02377349|365048663|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
105833739|NCT02377349|365048662|FG000|Overall Study|Other|0|||
105309884|NCT04051619|363131041|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
105309885|NCT04051619|363131042|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
105309886|NCT04051619|363131041|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
105309887|NCT04051619|363131042|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
105309888|NCT04395001|363132400|FG000|Overall Study|Lost to Follow-up|8|||
105833740|NCT02377349|365048663|FG001|Overall Study|Other|1|||
105833741|NCT04010227|365048664|FG000|Overall Study|Death|1|||
105833742|NCT04010227|365048665|FG001|Overall Study|Death|2|||
105833743|NCT04010227|365048664|FG000|Overall Study|Medical Reasons|4|||
105833744|NCT04010227|365048665|FG001|Overall Study|Medical Reasons|3|||
105489577|NCT01309893|363804075|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
105489578|NCT01309893|363804076|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
105833745|NCT04010227|365048664|FG000|Overall Study|Withdrawal by Subject|2|||
105833746|NCT04010227|365048665|FG001|Overall Study|Withdrawal by Subject|0|||
105833747|NCT04010227|365048664|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
105833748|NCT04010227|365048665|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
105833749|NCT01841073|365048670|FG000|Overall Study|Adverse Event|1|||
105833750|NCT01841073|365048671|FG001|Overall Study|Adverse Event|1|||
105833751|NCT01841073|365048670|FG000|Overall Study|Physician Decision|1|||
105833752|NCT01841073|365048671|FG001|Overall Study|Physician Decision|0|||
105833753|NCT01841073|365048670|FG000|Overall Study|Lost to Follow-up|0|||
105833754|NCT01841073|365048671|FG001|Overall Study|Lost to Follow-up|2|||
105833755|NCT00046839|365048672|FG000|Overall Study|Ineligible / No protocol treatment|0|||
105833756|NCT00046839|365048673|FG001|Overall Study|Ineligible / No protocol treatment|2|||
105833757|NCT00046839|365048672|FG000|Overall Study|Withdrawal of consent|1|||
105833758|NCT00046839|365048673|FG001|Overall Study|Withdrawal of consent|0|||
105833759|NCT01970592|365048675|FG000|Overall Study|Withdrawal by Subject|4|||
105833760|NCT01970592|365048675|FG000|Overall Study|Physician Decision|1|||
105833761|NCT01970592|365048675|FG000|Overall Study|Adverse Event|1|||
105833762|NCT05263505|365048678|FG000|Overall Study|Adverse Event|0|||
105833763|NCT05263505|365048679|FG001|Overall Study|Adverse Event|1|||
105833764|NCT00965731|365048681|FG000|Overall Study|Death|0|||
105833765|NCT00965731|365048682|FG001|Overall Study|Death|4|||
105833766|NCT00965731|365048681|FG000|Overall Study|Withdrawal by Subject|0|||
105833767|NCT00965731|365048682|FG001|Overall Study|Withdrawal by Subject|1|||
105833768|NCT00965731|365048681|FG000|Overall Study|Other|7|||
105833769|NCT00965731|365048682|FG001|Overall Study|Other|15|||
105833770|NCT01098539|365048685|FG000|Overall Study|Adverse Event|26|||
105833771|NCT01098539|365048686|FG001|Overall Study|Adverse Event|26|||
105833772|NCT01098539|365048685|FG000|Overall Study|Protocol Violation|1|||
105833773|NCT01098539|365048686|FG001|Overall Study|Protocol Violation|4|||
105833774|NCT01098539|365048685|FG000|Overall Study|Noncompliance|3|||
105833775|NCT01098539|365048686|FG001|Overall Study|Noncompliance|5|||
105833776|NCT01098539|365048685|FG000|Overall Study|Lost to Follow-up|4|||
105833777|NCT01098539|365048686|FG001|Overall Study|Lost to Follow-up|4|||
105833778|NCT01098539|365048685|FG000|Overall Study|Withdrawal by Subject|12|||
105833779|NCT01098539|365048686|FG001|Overall Study|Withdrawal by Subject|26|||
105833780|NCT01098539|365048685|FG000|Overall Study|Physician Decision|5|||
105833781|NCT01098539|365048686|FG001|Overall Study|Physician Decision|3|||
105833782|NCT03843125|365048687|FG000|Overall Study|Adverse Event|17|||
105833783|NCT03843125|365048688|FG001|Overall Study|Adverse Event|13|||
105833784|NCT03843125|365048689|FG002|Overall Study|Adverse Event|5|||
105833785|NCT03843125|365048690|FG003|Overall Study|Adverse Event|9|||
105833786|NCT03843125|365048687|FG000|Overall Study|Death|0|||
105833787|NCT03843125|365048688|FG001|Overall Study|Death|6|||
105833788|NCT03843125|365048689|FG002|Overall Study|Death|2|||
105833789|NCT03843125|365048690|FG003|Overall Study|Death|0|||
105833790|NCT03843125|365048687|FG000|Overall Study|Lack of Efficacy|14|||
105833791|NCT03843125|365048688|FG001|Overall Study|Lack of Efficacy|11|||
105833792|NCT03843125|365048689|FG002|Overall Study|Lack of Efficacy|9|||
105833793|NCT03843125|365048690|FG003|Overall Study|Lack of Efficacy|4|||
105833794|NCT03843125|365048687|FG000|Overall Study|Lost to Follow-up|3|||
105833795|NCT03843125|365048688|FG001|Overall Study|Lost to Follow-up|4|||
105833796|NCT03843125|365048689|FG002|Overall Study|Lost to Follow-up|0|||
105833797|NCT03843125|365048690|FG003|Overall Study|Lost to Follow-up|2|||
105833798|NCT03843125|365048687|FG000|Overall Study|Other|12|||
105833799|NCT03843125|365048688|FG001|Overall Study|Other|14|||
105833800|NCT03843125|365048689|FG002|Overall Study|Other|3|||
105833801|NCT03843125|365048690|FG003|Overall Study|Other|4|||
105833802|NCT03843125|365048687|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
105833803|NCT03843125|365048688|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
105833804|NCT03843125|365048689|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
105833805|NCT03843125|365048690|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
105833806|NCT03843125|365048687|FG000|Overall Study|Study Terminated by Sponsor|318|||
105833807|NCT03843125|365048688|FG001|Overall Study|Study Terminated by Sponsor|318|||
105833808|NCT03843125|365048689|FG002|Overall Study|Study Terminated by Sponsor|163|||
105833809|NCT03843125|365048690|FG003|Overall Study|Study Terminated by Sponsor|163|||
105833810|NCT03843125|365048687|FG000|Overall Study|Withdrawal by Subject|23|||
105833811|NCT03843125|365048688|FG001|Overall Study|Withdrawal by Subject|12|||
105833812|NCT03843125|365048689|FG002|Overall Study|Withdrawal by Subject|6|||
105833813|NCT03843125|365048690|FG003|Overall Study|Withdrawal by Subject|9|||
105833814|NCT03843125|365048687|FG000|Overall Study|Missing data|0|||
105833815|NCT03843125|365048688|FG001|Overall Study|Missing data|1|||
105833816|NCT03843125|365048689|FG002|Overall Study|Missing data|1|||
105833817|NCT03843125|365048690|FG003|Overall Study|Missing data|0|||
105833818|NCT01292837|365048694|FG000|Overall Study|Adverse Event|1|||
105833819|NCT01292837|365048694|FG000|Overall Study|Further treatment determined|1|||
105833820|NCT02661022|365048703|FG000|Overall Study|Withdrawal by Subject|3|||
105833821|NCT02661022|365048704|FG001|Overall Study|Withdrawal by Subject|0|||
105833822|NCT02661022|365048703|FG000|Overall Study|Adverse Event|1|||
105833823|NCT02661022|365048704|FG001|Overall Study|Adverse Event|1|||
105833824|NCT02661022|365048703|FG000|Overall Study|Physician Decision|1|||
105833825|NCT02661022|365048704|FG001|Overall Study|Physician Decision|0|||
105833826|NCT02661022|365048703|FG000|Overall Study|Progressive Disease|2|||
105833827|NCT02661022|365048704|FG001|Overall Study|Progressive Disease|1|||
105833828|NCT00830167|365048705|FG000|Overall Study|Lack of Efficacy|26|||
105833829|NCT00830167|365048706|FG001|Overall Study|Lack of Efficacy|10|||
105833830|NCT00830167|365048705|FG000|Overall Study|Adverse Event|8|||
105833831|NCT00830167|365048706|FG001|Overall Study|Adverse Event|24|||
105833832|NCT00830167|365048705|FG000|Overall Study|Not meeting entrance criteria|2|||
105833833|NCT00830167|365048706|FG001|Overall Study|Not meeting entrance criteria|5|||
105833834|NCT00830167|365048705|FG000|Overall Study|Withdrawal by Subject|2|||
105833835|NCT00830167|365048706|FG001|Overall Study|Withdrawal by Subject|0|||
105833836|NCT00830167|365048705|FG000|Overall Study|Lost to Follow-up|0|||
105833837|NCT00830167|365048706|FG001|Overall Study|Lost to Follow-up|1|||
105833838|NCT00830167|365048705|FG000|Overall Study|Protocol Violation|0|||
105833839|NCT00830167|365048706|FG001|Overall Study|Protocol Violation|1|||
105833840|NCT00830167|365048705|FG000|Overall Study|Other|2|||
105833841|NCT00830167|365048706|FG001|Overall Study|Other|2|||
105833842|NCT02224053|365048707|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
105833843|NCT02224053|365048707|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
105833844|NCT02224053|365048707|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
105833845|NCT02224053|365048707|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
105833846|NCT02224053|365048707|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
105833847|NCT03833427|365048710|FG000|Overall Study|Death|4|||
105833848|NCT03833427|365048711|FG001|Overall Study|Death|2|||
105833849|NCT03833427|365048712|FG002|Overall Study|Death|9|||
105833850|NCT03833427|365048713|FG003|Overall Study|Death|11|||
105833851|NCT03833427|365048714|FG004|Overall Study|Death|0|||
105833852|NCT03833427|365048715|FG005|Overall Study|Death|0|||
105833853|NCT03833427|365048716|FG006|Overall Study|Death|0|||
105833854|NCT03833427|365048710|FG000|Overall Study|Withdrawal by Subject|0|||
105833855|NCT03833427|365048711|FG001|Overall Study|Withdrawal by Subject|1|||
105833856|NCT03833427|365048712|FG002|Overall Study|Withdrawal by Subject|1|||
105833857|NCT03833427|365048713|FG003|Overall Study|Withdrawal by Subject|0|||
105833858|NCT03833427|365048714|FG004|Overall Study|Withdrawal by Subject|0|||
105833859|NCT03833427|365048715|FG005|Overall Study|Withdrawal by Subject|0|||
105833860|NCT03833427|365048716|FG006|Overall Study|Withdrawal by Subject|0|||
105833861|NCT03833427|365048710|FG000|Overall Study|Sponsor Decision|0|||
105833862|NCT03833427|365048711|FG001|Overall Study|Sponsor Decision|0|||
105833863|NCT03833427|365048712|FG002|Overall Study|Sponsor Decision|1|||
105833864|NCT03833427|365048713|FG003|Overall Study|Sponsor Decision|3|||
105833865|NCT03833427|365048714|FG004|Overall Study|Sponsor Decision|0|||
105833866|NCT03833427|365048715|FG005|Overall Study|Sponsor Decision|0|||
105833867|NCT03833427|365048716|FG006|Overall Study|Sponsor Decision|0|||
105833868|NCT02250651|365048721|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
105833869|NCT02250651|365048722|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
105833870|NCT02250651|365048723|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
105833871|NCT02250651|365048721|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
105833872|NCT02250651|365048722|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
105833873|NCT02250651|365048723|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
105833874|NCT02250651|365048721|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
105833875|NCT02250651|365048722|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
105833876|NCT02250651|365048723|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
105833877|NCT02250651|365048721|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
105833878|NCT02250651|365048722|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
105833879|NCT02250651|365048723|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
105833880|NCT02250651|365048721|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
105489579|NCT01562873|363804077|FG000|Overall Study|Disease Progression per RECIST|10|||
105833881|NCT02250651|365048722|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
105833882|NCT02250651|365048723|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
105833883|NCT02250651|365048721|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
105833884|NCT02250651|365048722|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
105833885|NCT02250651|365048723|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
105489580|NCT01562873|363804078|FG001|Overall Study|Disease Progression per RECIST|0|||
105489581|NCT01562873|363804077|FG000|Overall Study|Adverse Event|1|||
105489582|NCT01562873|363804078|FG001|Overall Study|Adverse Event|0|||
105833886|NCT02250651|365048721|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
105833887|NCT02250651|365048722|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
105833888|NCT02250651|365048723|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
105833889|NCT02250651|365048721|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
105489583|NCT01562873|363804077|FG000|Overall Study|Clinical Disease Progression|9|||
105489584|NCT01562873|363804078|FG001|Overall Study|Clinical Disease Progression|0|||
105489585|NCT01562873|363804077|FG000|Overall Study|Clinical PD and adverse event|1|||
105489586|NCT01562873|363804078|FG001|Overall Study|Clinical PD and adverse event|0|||
105489587|NCT00873860|363804082|FG000|Overall Study|Lost to Follow-up|1|||
105489588|NCT00873860|363804083|FG001|Overall Study|Lost to Follow-up|0|||
105489589|NCT00873860|363804084|FG002|Overall Study|Lost to Follow-up|0|||
105489590|NCT00873860|363804085|FG003|Overall Study|Lost to Follow-up|1|||
105489591|NCT00873860|363804082|FG000|Overall Study|Withdrawal by Subject|1|||
105489592|NCT00873860|363804083|FG001|Overall Study|Withdrawal by Subject|0|||
105489593|NCT00873860|363804084|FG002|Overall Study|Withdrawal by Subject|2|||
105489594|NCT00873860|363804085|FG003|Overall Study|Withdrawal by Subject|0|||
105489595|NCT00873860|363804082|FG000|Overall Study|Death|1|||
105489596|NCT00873860|363804083|FG001|Overall Study|Death|0|||
105489597|NCT00873860|363804084|FG002|Overall Study|Death|0|||
105489598|NCT00873860|363804085|FG003|Overall Study|Death|0|||
105489599|NCT00873860|363804082|FG000|Overall Study|Other|1|||
105489600|NCT00873860|363804083|FG001|Overall Study|Other|0|||
105489601|NCT00873860|363804084|FG002|Overall Study|Other|1|||
105489602|NCT00873860|363804085|FG003|Overall Study|Other|0|||
105489603|NCT02764190|363804087|FG000|Overall Study|Lost to Follow-up|17|||
105489604|NCT02764190|363804088|FG001|Overall Study|Lost to Follow-up|13|||
105489605|NCT00089674|363804089|FG000|Overall Study|Physician Decision|4|||
105489606|NCT00089674|363804090|FG001|Overall Study|Physician Decision|2|||
105489607|NCT00089674|363804089|FG000|Overall Study|Adverse Event|23|||
105367017|NCT00794664|363350134|FG001|Follow-up Period|Protocol non-compliance|1|||
105367018|NCT01305564|363350137|FG000|Overall Study|Death|21|||
105367019|NCT01305564|363350137|FG000|Overall Study|Lost to Follow-up|12|||
105367020|NCT01305564|363350137|FG000|Overall Study|Withdrawal by Subject|1|||
105367021|NCT01305564|363350137|FG000|Overall Study|Physician Decision|3|||
105367022|NCT00828711|363350139|FG000|Overall Study|Lost to Follow-up|1|||
105489608|NCT00089674|363804090|FG001|Overall Study|Adverse Event|29|||
105489609|NCT00089674|363804089|FG000|Overall Study|Withdrawal by Subject|143|||
105489610|NCT00089674|363804090|FG001|Overall Study|Withdrawal by Subject|127|||
105575874|NCT01865617|364108348|FG006|Overall Study|Lost to Follow-up|0|||
105575875|NCT01865617|364108349|FG007|Overall Study|Lost to Follow-up|0|||
105575876|NCT01865617|364108350|FG008|Overall Study|Lost to Follow-up|0|||
105575877|NCT01865617|364108351|FG009|Overall Study|Lost to Follow-up|0|||
105575878|NCT01865617|364108352|FG010|Overall Study|Lost to Follow-up|0|||
105367023|NCT00828711|363350140|FG001|Overall Study|Lost to Follow-up|0|||
105367024|NCT00828711|363350141|FG002|Overall Study|Lost to Follow-up|0|||
105367025|NCT01618968|363350142|FG000|Overall Study|Adverse Event|1|||
105367026|NCT01618968|363350143|FG001|Overall Study|Adverse Event|0|||
105367027|NCT01618968|363350144|FG002|Overall Study|Adverse Event|0|||
105367028|NCT01618968|363350145|FG003|Overall Study|Adverse Event|0|||
105367029|NCT01618968|363350142|FG000|Overall Study|Death|0|||
105367030|NCT01618968|363350143|FG001|Overall Study|Death|0|||
105367031|NCT01618968|363350144|FG002|Overall Study|Death|0|||
105367032|NCT01618968|363350145|FG003|Overall Study|Death|1|||
105367033|NCT02230891|363350146|FG000|Baseline|Did not meet inclusion|0|||
105367034|NCT02230891|363350147|FG001|Baseline|Did not meet inclusion|1|||
105367035|NCT02230891|363350148|FG002|Baseline|Did not meet inclusion|1|||
105367036|NCT02230891|363350146|FG000|2 Week|Withdrawal by Subject|2|||
105367037|NCT02230891|363350147|FG001|2 Week|Withdrawal by Subject|2|||
105367038|NCT02230891|363350148|FG002|2 Week|Withdrawal by Subject|0|||
105489611|NCT00089674|363804089|FG000|Overall Study|Death|43|||
105489612|NCT00089674|363804090|FG001|Overall Study|Death|43|||
105489613|NCT00089674|363804089|FG000|Overall Study|Disease progression|21|||
105575879|NCT01865617|364108353|FG011|Overall Study|Lost to Follow-up|0|||
105575880|NCT01865617|364108354|FG012|Overall Study|Lost to Follow-up|0|||
105575881|NCT01865617|364108342|FG000|Overall Study|Withdrawal by Subject|1|||
105575882|NCT01865617|364108343|FG001|Overall Study|Withdrawal by Subject|0|||
105575883|NCT01865617|364108344|FG002|Overall Study|Withdrawal by Subject|0|||
105575884|NCT01865617|364108345|FG003|Overall Study|Withdrawal by Subject|0|||
105489614|NCT00089674|363804090|FG001|Overall Study|Disease progression|23|||
105489615|NCT00089674|363804089|FG000|Overall Study|Ineligibility determined|8|||
105489616|NCT00089674|363804090|FG001|Overall Study|Ineligibility determined|10|||
105489617|NCT00089674|363804089|FG000|Overall Study|Lost to Follow-up|21|||
105367039|NCT02230891|363350146|FG000|2 Week|Consent withdrawn|1|||
105367040|NCT02230891|363350147|FG001|2 Week|Consent withdrawn|0|||
105367041|NCT02230891|363350148|FG002|2 Week|Consent withdrawn|0|||
105367042|NCT02230891|363350146|FG000|6 Month|Withdrawal by Subject|1|||
105489618|NCT00089674|363804090|FG001|Overall Study|Lost to Follow-up|17|||
105575885|NCT01865617|364108346|FG004|Overall Study|Withdrawal by Subject|0|||
105575886|NCT01865617|364108347|FG005|Overall Study|Withdrawal by Subject|0|||
105367043|NCT02230891|363350147|FG001|6 Month|Withdrawal by Subject|1|||
105367044|NCT02230891|363350148|FG002|6 Month|Withdrawal by Subject|1|||
105489619|NCT00089674|363804089|FG000|Overall Study|Noncompliance|7|||
105489620|NCT00089674|363804090|FG001|Overall Study|Noncompliance|3|||
105489621|NCT00089674|363804089|FG000|Overall Study|Other|5|||
105489622|NCT00089674|363804090|FG001|Overall Study|Other|9|||
105575887|NCT01865617|364108348|FG006|Overall Study|Withdrawal by Subject|0|||
105575888|NCT01865617|364108349|FG007|Overall Study|Withdrawal by Subject|0|||
105575889|NCT01865617|364108350|FG008|Overall Study|Withdrawal by Subject|0|||
105575890|NCT01865617|364108351|FG009|Overall Study|Withdrawal by Subject|0|||
105575891|NCT01865617|364108352|FG010|Overall Study|Withdrawal by Subject|0|||
105575892|NCT01865617|364108353|FG011|Overall Study|Withdrawal by Subject|0|||
105575893|NCT01865617|364108354|FG012|Overall Study|Withdrawal by Subject|0|||
105575894|NCT01865617|364108342|FG000|Overall Study|Patient proceeded to new therapy|0|||
105575895|NCT01865617|364108343|FG001|Overall Study|Patient proceeded to new therapy|0|||
105575896|NCT01865617|364108344|FG002|Overall Study|Patient proceeded to new therapy|0|||
105833890|NCT02250651|365048722|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
105833891|NCT02250651|365048723|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
105833892|NCT02250651|365048721|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
105833893|NCT02250651|365048722|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
105833894|NCT02250651|365048723|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
105833895|NCT02250651|365048721|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
105833896|NCT02250651|365048722|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
105833897|NCT02250651|365048723|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
105833898|NCT02250651|365048721|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
105833899|NCT02250651|365048722|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
105833900|NCT02250651|365048723|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
105833901|NCT02250651|365048721|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
105833902|NCT02250651|365048722|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
105833903|NCT02250651|365048723|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
105833904|NCT02250651|365048721|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
105833905|NCT02250651|365048722|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
105833906|NCT02250651|365048723|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
105833907|NCT02250651|365048721|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
105833908|NCT02250651|365048722|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
105833909|NCT02250651|365048723|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
105833910|NCT02250651|365048721|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
105833911|NCT02250651|365048722|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
105833912|NCT02250651|365048723|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
105833913|NCT01438476|365048724|FG000|Overall Study|Protocol Violation|1|||
105833914|NCT01438476|365048725|FG001|Overall Study|Protocol Violation|0|||
105833915|NCT01438476|365048724|FG000|Overall Study|Withdrawal by Subject|1|||
105833916|NCT01438476|365048725|FG001|Overall Study|Withdrawal by Subject|0|||
105833917|NCT01438476|365048724|FG000|Overall Study|No Surgery- Disease|8|||
105833918|NCT01438476|365048725|FG001|Overall Study|No Surgery- Disease|10|||
105833919|NCT01438476|365048724|FG000|Overall Study|Communication barrier|0|||
105833920|NCT01438476|365048725|FG001|Overall Study|Communication barrier|1|||
105833921|NCT03310619|365048726|FG000|Pre-Treatment Period|Death|1|||
105833922|NCT03310619|365048727|FG001|Pre-Treatment Period|Death|0|||
105833923|NCT03310619|365048728|FG002|Pre-Treatment Period|Death|0|||
105833924|NCT03310619|365048729|FG003|Pre-Treatment Period|Death|0|||
105833925|NCT03310619|365048730|FG004|Pre-Treatment Period|Death|1|||
105833926|NCT03310619|365048731|FG005|Pre-Treatment Period|Death|0|||
105833927|NCT03310619|365048732|FG006|Pre-Treatment Period|Death|0|||
105833928|NCT03310619|365048733|FG007|Pre-Treatment Period|Death|0|||
105833929|NCT03310619|365048726|FG000|Pre-Treatment Period|Other reasons|2|||
105833930|NCT03310619|365048727|FG001|Pre-Treatment Period|Other reasons|1|||
105833931|NCT03310619|365048728|FG002|Pre-Treatment Period|Other reasons|2|||
105833932|NCT03310619|365048729|FG003|Pre-Treatment Period|Other reasons|0|||
105833933|NCT03310619|365048730|FG004|Pre-Treatment Period|Other reasons|0|||
105833934|NCT03310619|365048731|FG005|Pre-Treatment Period|Other reasons|0|||
105833935|NCT03310619|365048732|FG006|Pre-Treatment Period|Other reasons|2|||
105833936|NCT03310619|365048733|FG007|Pre-Treatment Period|Other reasons|0|||
105833937|NCT03310619|365048726|FG000|Treatment Period|Death|1|||
105833938|NCT03310619|365048727|FG001|Treatment Period|Death|2|||
105833939|NCT03310619|365048728|FG002|Treatment Period|Death|0|||
105833940|NCT03310619|365048729|FG003|Treatment Period|Death|0|||
105833941|NCT03310619|365048730|FG004|Treatment Period|Death|1|||
105833942|NCT03310619|365048731|FG005|Treatment Period|Death|0|||
105833943|NCT03310619|365048732|FG006|Treatment Period|Death|2|||
105833944|NCT03310619|365048733|FG007|Treatment Period|Death|0|||
105833945|NCT03310619|365048726|FG000|Treatment Period|Adverse Event|0|||
105833946|NCT03310619|365048727|FG001|Treatment Period|Adverse Event|1|||
105833947|NCT03310619|365048728|FG002|Treatment Period|Adverse Event|4|||
105833948|NCT03310619|365048729|FG003|Treatment Period|Adverse Event|1|||
105309889|NCT04395001|363132401|FG001|Overall Study|Lost to Follow-up|9|||
105575897|NCT01865617|364108345|FG003|Overall Study|Patient proceeded to new therapy|0|||
105833949|NCT03310619|365048730|FG004|Treatment Period|Adverse Event|0|||
105833950|NCT03310619|365048731|FG005|Treatment Period|Adverse Event|0|||
105833951|NCT03310619|365048732|FG006|Treatment Period|Adverse Event|0|||
105833952|NCT03310619|365048733|FG007|Treatment Period|Adverse Event|0|||
105833953|NCT03310619|365048726|FG000|Treatment Period|Withdrawal by participant|0|||
105833954|NCT03310619|365048727|FG001|Treatment Period|Withdrawal by participant|0|||
105833955|NCT03310619|365048728|FG002|Treatment Period|Withdrawal by participant|1|||
105833956|NCT03310619|365048729|FG003|Treatment Period|Withdrawal by participant|0|||
105833957|NCT03310619|365048730|FG004|Treatment Period|Withdrawal by participant|0|||
105833958|NCT03310619|365048731|FG005|Treatment Period|Withdrawal by participant|0|||
105833959|NCT03310619|365048732|FG006|Treatment Period|Withdrawal by participant|0|||
105833960|NCT03310619|365048733|FG007|Treatment Period|Withdrawal by participant|0|||
105833961|NCT03310619|365048726|FG000|Treatment Period|Lost to Follow-up|0|||
105833962|NCT03310619|365048727|FG001|Treatment Period|Lost to Follow-up|0|||
105833963|NCT03310619|365048728|FG002|Treatment Period|Lost to Follow-up|0|||
105833964|NCT03310619|365048729|FG003|Treatment Period|Lost to Follow-up|0|||
105833965|NCT03310619|365048730|FG004|Treatment Period|Lost to Follow-up|0|||
105833966|NCT03310619|365048731|FG005|Treatment Period|Lost to Follow-up|0|||
105833967|NCT03310619|365048732|FG006|Treatment Period|Lost to Follow-up|0|||
105833968|NCT03310619|365048733|FG007|Treatment Period|Lost to Follow-up|1|||
105833969|NCT03310619|365048726|FG000|Treatment Period|Study terminated by sponsor|0|||
105833970|NCT03310619|365048727|FG001|Treatment Period|Study terminated by sponsor|0|||
105833971|NCT03310619|365048728|FG002|Treatment Period|Study terminated by sponsor|0|||
105833972|NCT03310619|365048729|FG003|Treatment Period|Study terminated by sponsor|0|||
105833973|NCT03310619|365048730|FG004|Treatment Period|Study terminated by sponsor|0|||
105833974|NCT03310619|365048731|FG005|Treatment Period|Study terminated by sponsor|0|||
105833975|NCT03310619|365048732|FG006|Treatment Period|Study terminated by sponsor|0|||
105833976|NCT03310619|365048733|FG007|Treatment Period|Study terminated by sponsor|1|||
105833977|NCT03310619|365048726|FG000|Treatment Period|Physician Decision|0|||
105833978|NCT03310619|365048727|FG001|Treatment Period|Physician Decision|0|||
105833979|NCT03310619|365048728|FG002|Treatment Period|Physician Decision|0|||
105833980|NCT03310619|365048729|FG003|Treatment Period|Physician Decision|0|||
105833981|NCT03310619|365048730|FG004|Treatment Period|Physician Decision|3|||
105833982|NCT03310619|365048731|FG005|Treatment Period|Physician Decision|0|||
105833983|NCT03310619|365048732|FG006|Treatment Period|Physician Decision|0|||
105833984|NCT03310619|365048733|FG007|Treatment Period|Physician Decision|0|||
105833985|NCT03310619|365048726|FG000|Treatment Period|Other reasons|1|||
105833986|NCT03310619|365048727|FG001|Treatment Period|Other reasons|0|||
105833987|NCT03310619|365048728|FG002|Treatment Period|Other reasons|2|||
105833988|NCT03310619|365048729|FG003|Treatment Period|Other reasons|0|||
105833989|NCT03310619|365048730|FG004|Treatment Period|Other reasons|0|||
105833990|NCT03310619|365048731|FG005|Treatment Period|Other reasons|0|||
105833991|NCT03310619|365048732|FG006|Treatment Period|Other reasons|0|||
105833992|NCT03310619|365048733|FG007|Treatment Period|Other reasons|0|||
105489623|NCT00089674|363804089|FG000|Overall Study|Requirement for alternative therapy|14|||
105489624|NCT00089674|363804090|FG001|Overall Study|Requirement for alternative therapy|4|||
105489625|NCT01484938|363804091|FG000|Overall Study|Adverse Event|2|||
105833993|NCT04979858|365048734|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
105833994|NCT04979858|365048735|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
105833995|NCT04974580|365048736|FG000|Overall Study|Lost to Follow-up|33|||
105833996|NCT04974580|365048737|FG001|Overall Study|Lost to Follow-up|39|||
105833997|NCT04974580|365048738|FG002|Overall Study|Lost to Follow-up|30|||
105833998|NCT04974580|365048739|FG003|Overall Study|Lost to Follow-up|29|||
105833999|NCT00398073|365048742|FG000|Overall Study|Withdrawal by Subject|1|||
105834000|NCT00398073|365048743|FG001|Overall Study|Withdrawal by Subject|0|||
105309890|NCT04395001|363132402|FG002|Overall Study|Lost to Follow-up|5|||
105309891|NCT04395001|363132400|FG000|Overall Study|Withdrawal by Subject|3|||
105309892|NCT04395001|363132401|FG001|Overall Study|Withdrawal by Subject|1|||
105309893|NCT04395001|363132402|FG002|Overall Study|Withdrawal by Subject|3|||
105309894|NCT04395001|363132400|FG000|Overall Study|missed appointment|7|||
105309895|NCT04395001|363132401|FG001|Overall Study|missed appointment|4|||
105309896|NCT04395001|363132402|FG002|Overall Study|missed appointment|1|||
105309897|NCT00633243|363132406|FG000|Overall Study|Withdrawal by Subject|0|||
105309898|NCT00633243|363132407|FG001|Overall Study|Withdrawal by Subject|1|||
105309899|NCT00633243|363132406|FG000|Overall Study|incarceration|0|||
105309900|NCT00633243|363132407|FG001|Overall Study|incarceration|2|||
105309901|NCT00633243|363132406|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
105834001|NCT00879684|365048747|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
105834002|NCT00879684|365048748|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
105834003|NCT00879684|365048749|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
105834004|NCT00879684|365048750|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
105834005|NCT00879684|365048751|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
105834006|NCT00879684|365048752|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
105309902|NCT00633243|363132407|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
105834007|NCT00879684|365048753|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
105309903|NCT00633243|363132406|FG000|Overall Study|Not comfortable with self-injecting|0|||
105834008|NCT00879684|365048747|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
105834009|NCT00879684|365048748|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
105834010|NCT00879684|365048749|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
105834011|NCT00879684|365048750|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
105834012|NCT00879684|365048751|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
105834013|NCT00879684|365048752|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
105834014|NCT00879684|365048753|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
105834015|NCT00879684|365048747|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
105834016|NCT00879684|365048748|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
105834017|NCT00879684|365048749|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
105834018|NCT00879684|365048750|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
105834019|NCT00879684|365048751|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
105834020|NCT00879684|365048752|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
105834021|NCT00879684|365048753|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
105834022|NCT00879684|365048747|FG000|Stage 1: Dose Escalation|Death|0|||
105834023|NCT00879684|365048748|FG001|Stage 1: Dose Escalation|Death|0|||
105834024|NCT00879684|365048749|FG002|Stage 1: Dose Escalation|Death|1|||
105834025|NCT00879684|365048750|FG003|Stage 1: Dose Escalation|Death|0|||
105834026|NCT00879684|365048751|FG004|Stage 1: Dose Escalation|Death|0|||
105834027|NCT00879684|365048752|FG005|Stage 1: Dose Escalation|Death|0|||
105834028|NCT00879684|365048753|FG006|Stage 1: Dose Escalation|Death|0|||
105834029|NCT00879684|365048747|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
105834030|NCT00879684|365048748|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
105834031|NCT00879684|365048749|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
105834032|NCT00879684|365048750|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
105834033|NCT00879684|365048751|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
105834034|NCT00879684|365048752|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
105834035|NCT00879684|365048753|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
105834036|NCT00879684|365048747|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
105834037|NCT00879684|365048748|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
105834038|NCT00879684|365048749|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
105834039|NCT00879684|365048750|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
105834040|NCT00879684|365048751|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
105834041|NCT00879684|365048752|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
105834042|NCT00879684|365048753|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
105834043|NCT00879684|365048747|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
105834044|NCT00879684|365048748|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
105834045|NCT00879684|365048749|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
105834046|NCT00879684|365048750|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
105834047|NCT00879684|365048751|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
105834048|NCT00879684|365048752|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
105834049|NCT00879684|365048753|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
105834050|NCT01160640|365048754|FG000|Overall Study|Physician Decision|3|||
105834051|NCT01160640|365048755|FG001|Overall Study|Physician Decision|3|||
105834052|NCT01160640|365048754|FG000|Overall Study|Incarceration|1|||
105834053|NCT01160640|365048755|FG001|Overall Study|Incarceration|0|||
105834054|NCT01160640|365048754|FG000|Overall Study|Withdrawal by Subject|0|||
105834055|NCT01160640|365048755|FG001|Overall Study|Withdrawal by Subject|3|||
105834056|NCT01148225|365048764|FG000|Overall Study|Other|185|||
105834057|NCT04148287|365048765|FG000|Overall Study|Death|2|||
105834058|NCT02490800|365048766|FG000|Overall Study|Adverse Event|0|||
105834059|NCT02490800|365048767|FG001|Overall Study|Adverse Event|0|||
105834060|NCT02490800|365048768|FG002|Overall Study|Adverse Event|0|||
105834061|NCT02490800|365048769|FG003|Overall Study|Adverse Event|2|||
105834062|NCT02490800|365048770|FG004|Overall Study|Adverse Event|3|||
105834063|NCT02490800|365048771|FG005|Overall Study|Adverse Event|2|||
105834064|NCT02490800|365048772|FG006|Overall Study|Adverse Event|0|||
105834065|NCT02490800|365048773|FG007|Overall Study|Adverse Event|0|||
105834066|NCT02490800|365048774|FG008|Overall Study|Adverse Event|0|||
105834067|NCT02490800|365048775|FG009|Overall Study|Adverse Event|0|||
105834068|NCT02490800|365048776|FG010|Overall Study|Adverse Event|0|||
105834069|NCT02490800|365048777|FG011|Overall Study|Adverse Event|2|||
105834070|NCT02490800|365048778|FG012|Overall Study|Adverse Event|2|||
105834071|NCT02490800|365048766|FG000|Overall Study|Withdrawal by Subject|0|||
105834072|NCT02490800|365048767|FG001|Overall Study|Withdrawal by Subject|0|||
105834073|NCT02490800|365048768|FG002|Overall Study|Withdrawal by Subject|0|||
105834074|NCT02490800|365048769|FG003|Overall Study|Withdrawal by Subject|1|||
105834075|NCT02490800|365048770|FG004|Overall Study|Withdrawal by Subject|0|||
105834076|NCT02490800|365048771|FG005|Overall Study|Withdrawal by Subject|0|||
105834077|NCT02490800|365048772|FG006|Overall Study|Withdrawal by Subject|0|||
105834078|NCT02490800|365048773|FG007|Overall Study|Withdrawal by Subject|0|||
105834079|NCT02490800|365048774|FG008|Overall Study|Withdrawal by Subject|1|||
105834080|NCT02490800|365048775|FG009|Overall Study|Withdrawal by Subject|0|||
105834081|NCT02490800|365048776|FG010|Overall Study|Withdrawal by Subject|0|||
105834082|NCT02490800|365048777|FG011|Overall Study|Withdrawal by Subject|0|||
105834083|NCT02490800|365048778|FG012|Overall Study|Withdrawal by Subject|0|||
105834084|NCT02490800|365048766|FG000|Overall Study|Progressive disease|3|||
105834085|NCT02490800|365048767|FG001|Overall Study|Progressive disease|3|||
105834086|NCT02490800|365048768|FG002|Overall Study|Progressive disease|3|||
105834087|NCT02490800|365048769|FG003|Overall Study|Progressive disease|4|||
105834088|NCT02490800|365048770|FG004|Overall Study|Progressive disease|4|||
105834089|NCT02490800|365048771|FG005|Overall Study|Progressive disease|1|||
105834090|NCT02490800|365048772|FG006|Overall Study|Progressive disease|4|||
105834091|NCT02490800|365048773|FG007|Overall Study|Progressive disease|3|||
105834092|NCT02490800|365048774|FG008|Overall Study|Progressive disease|6|||
105834093|NCT02490800|365048775|FG009|Overall Study|Progressive disease|2|||
105834094|NCT02490800|365048776|FG010|Overall Study|Progressive disease|7|||
105834095|NCT02490800|365048777|FG011|Overall Study|Progressive disease|1|||
105834096|NCT02490800|365048778|FG012|Overall Study|Progressive disease|10|||
105834097|NCT02490800|365048766|FG000|Overall Study|Patient enrolled in post-trial access|0|||
105834098|NCT02490800|365048767|FG001|Overall Study|Patient enrolled in post-trial access|0|||
105834099|NCT02490800|365048768|FG002|Overall Study|Patient enrolled in post-trial access|0|||
105834100|NCT02490800|365048769|FG003|Overall Study|Patient enrolled in post-trial access|0|||
105834101|NCT02490800|365048770|FG004|Overall Study|Patient enrolled in post-trial access|0|||
105834102|NCT02490800|365048771|FG005|Overall Study|Patient enrolled in post-trial access|0|||
105834103|NCT02490800|365048772|FG006|Overall Study|Patient enrolled in post-trial access|0|||
105834104|NCT02490800|365048773|FG007|Overall Study|Patient enrolled in post-trial access|0|||
105834105|NCT02490800|365048774|FG008|Overall Study|Patient enrolled in post-trial access|0|||
105834106|NCT02490800|365048775|FG009|Overall Study|Patient enrolled in post-trial access|1|||
105834107|NCT02490800|365048776|FG010|Overall Study|Patient enrolled in post-trial access|1|||
105834108|NCT02490800|365048777|FG011|Overall Study|Patient enrolled in post-trial access|0|||
105834109|NCT02490800|365048778|FG012|Overall Study|Patient enrolled in post-trial access|6|||
105834110|NCT01214239|365048779|FG000|Overall Study|Adverse Event|3|||
105834111|NCT01214239|365048780|FG001|Overall Study|Adverse Event|4|||
105834112|NCT01214239|365048779|FG000|Overall Study|Protocol Violation|2|||
105834113|NCT01214239|365048780|FG001|Overall Study|Protocol Violation|1|||
105834114|NCT01214239|365048779|FG000|Overall Study|Lost to Follow-up|1|||
105834115|NCT01214239|365048780|FG001|Overall Study|Lost to Follow-up|1|||
105834116|NCT01214239|365048779|FG000|Overall Study|Withdrawal by Subject|4|||
105834117|NCT01214239|365048780|FG001|Overall Study|Withdrawal by Subject|9|||
105834118|NCT01214239|365048779|FG000|Overall Study|Lack of Efficacy|1|||
105834119|NCT01214239|365048780|FG001|Overall Study|Lack of Efficacy|2|||
105834120|NCT01214239|365048779|FG000|Overall Study|patient's private reason|1|||
105834121|NCT01214239|365048780|FG001|Overall Study|patient's private reason|1|||
105834122|NCT01049581|365048781|FG000|Overall Study|Lost to Follow-up|2|||
105834123|NCT01049581|365048782|FG001|Overall Study|Lost to Follow-up|1|||
105834124|NCT02625974|365048786|FG000|Part 1|Lost to Follow-up|9|||
105834125|NCT02625974|365048787|FG001|Part 1|Lost to Follow-up|3|||
105834126|NCT02625974|365048786|FG000|Part 2|Lost to Follow-up|4|||
105834127|NCT02625974|365048787|FG001|Part 2|Lost to Follow-up|6|||
105834128|NCT02625974|365048786|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
105834129|NCT02625974|365048787|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
105834130|NCT05068284|365048792|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
105834131|NCT05068284|365048793|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
105834132|NCT05068284|365048794|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
105834133|NCT05068284|365048795|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
105834134|NCT05068284|365048796|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
105834135|NCT05068284|365048797|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
105834136|NCT05068284|365048798|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
105834137|NCT05068284|365048799|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
105834138|NCT05068284|365048792|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
105834139|NCT05068284|365048793|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
105834140|NCT05068284|365048794|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
105834141|NCT05068284|365048795|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
105834142|NCT05068284|365048796|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
105834143|NCT05068284|365048797|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
105834144|NCT05068284|365048798|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
105834145|NCT05068284|365048799|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
105834146|NCT05068284|365048792|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
105834147|NCT05068284|365048793|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
105575898|NCT01865617|364108346|FG004|Overall Study|Patient proceeded to new therapy|2|||
105834148|NCT05068284|365048794|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
105834149|NCT05068284|365048795|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
105834150|NCT05068284|365048796|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
105575899|NCT01865617|364108347|FG005|Overall Study|Patient proceeded to new therapy|0|||
105489626|NCT01484938|363804091|FG000|Overall Study|Lost to Follow-up|1|||
105489627|NCT01484938|363804091|FG000|Overall Study|Noncompliance|1|||
105489628|NCT02140775|363804093|FG000|Overall Study|Withdrawal by Subject|30|||
105489629|NCT02140775|363804094|FG001|Overall Study|Withdrawal by Subject|7|||
105489630|NCT01285960|363804103|FG000|Overall Study|Withdrawal by Subject|2|||
105489631|NCT01285960|363804103|FG000|Overall Study|Lost to Follow-up|2|||
105489632|NCT01285960|363804103|FG000|Overall Study|2 subjects received less 10 sonications|2|||
105489633|NCT00495131|363804106|FG000|Overall Study|Adverse Event|6|||
105489634|NCT00495131|363804107|FG001|Overall Study|Adverse Event|2|||
105489635|NCT00495131|363804106|FG000|Overall Study|Lack of Efficacy|0|||
105489636|NCT00495131|363804107|FG001|Overall Study|Lack of Efficacy|2|||
105489637|NCT00495131|363804106|FG000|Overall Study|Lost to Follow-up|0|||
105489638|NCT00495131|363804107|FG001|Overall Study|Lost to Follow-up|2|||
105489639|NCT00495131|363804106|FG000|Overall Study|Withdrawal by Subject|1|||
105489640|NCT00495131|363804107|FG001|Overall Study|Withdrawal by Subject|0|||
105489641|NCT02204007|363804108|FG000|Overall Study|Surgery Canceled|1|||
105489642|NCT02204007|363804109|FG001|Overall Study|Surgery Canceled|1|||
105489643|NCT03911843|363804115|FG000|Overall Study|Adverse Event|2|||
105489644|NCT03911843|363804116|FG001|Overall Study|Adverse Event|0|||
105489645|NCT03911843|363804115|FG000|Overall Study|Protocol Violation|2|||
105489646|NCT03911843|363804116|FG001|Overall Study|Protocol Violation|0|||
105489647|NCT03911843|363804115|FG000|Overall Study|Lost to Follow-up|0|||
105489648|NCT03911843|363804116|FG001|Overall Study|Lost to Follow-up|1|||
105489649|NCT04533880|363805585|FG000|Overall Study|Lost to Follow-up|0|||
105489650|NCT04533880|363805586|FG001|Overall Study|Lost to Follow-up|1|||
105575900|NCT01865617|364108348|FG006|Overall Study|Patient proceeded to new therapy|0|||
105575901|NCT01865617|364108349|FG007|Overall Study|Patient proceeded to new therapy|0|||
105575902|NCT01865617|364108350|FG008|Overall Study|Patient proceeded to new therapy|0|||
105834151|NCT05068284|365048797|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
105834152|NCT05068284|365048798|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
105834153|NCT05068284|365048799|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
105834154|NCT05068284|365048792|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
105834155|NCT05068284|365048793|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
105834156|NCT05068284|365048794|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
105834157|NCT05068284|365048795|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
105834158|NCT05068284|365048796|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
105834159|NCT05068284|365048797|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
105834160|NCT05068284|365048798|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
105834161|NCT05068284|365048799|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
105834162|NCT05068284|365048792|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
105834163|NCT05068284|365048793|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
105834164|NCT05068284|365048794|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
105834165|NCT05068284|365048795|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
105834166|NCT05068284|365048796|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
105834167|NCT05068284|365048797|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
105489651|NCT04533880|363805587|FG002|Overall Study|Lost to Follow-up|1|||
105489652|NCT01483690|363805591|FG000|Overall Study|Adverse Event|1|||
105489653|NCT01483690|363805592|FG001|Overall Study|Adverse Event|2|||
105489654|NCT01483690|363805591|FG000|Overall Study|clinical deterioration|1|||
105489655|NCT01483690|363805592|FG001|Overall Study|clinical deterioration|0|||
105489656|NCT01483690|363805591|FG000|Overall Study|Physician Decision|0|||
105489657|NCT01483690|363805592|FG001|Overall Study|Physician Decision|2|||
105309904|NCT00633243|363132407|FG001|Overall Study|Not comfortable with self-injecting|1|||
105309905|NCT00633243|363132406|FG000|Overall Study|Mental Health--Depression|0|||
105309906|NCT00633243|363132407|FG001|Overall Study|Mental Health--Depression|1|||
105309907|NCT00633243|363132406|FG000|Overall Study|Couldn't tolerate side-effects|1|||
105309908|NCT00633243|363132407|FG001|Overall Study|Couldn't tolerate side-effects|1|||
105309909|NCT02022748|363132408|FG000|Overall Study|Adverse Event|1|||
105309910|NCT02022748|363132409|FG001|Overall Study|Adverse Event|1|||
105309911|NCT02022748|363132410|FG002|Overall Study|Adverse Event|0|||
105309912|NCT02022748|363132408|FG000|Overall Study|Withdrawal by Subject|0|||
105309913|NCT02022748|363132409|FG001|Overall Study|Withdrawal by Subject|1|||
105309914|NCT02022748|363132410|FG002|Overall Study|Withdrawal by Subject|0|||
105309915|NCT04240392|363132415|FG000|Overall Study|Withdrawal by Subject|13|||
105309916|NCT04240392|363132416|FG001|Overall Study|Withdrawal by Subject|4|||
105309917|NCT04240392|363132415|FG000|Overall Study|Lost to Follow-up|11|||
105309918|NCT04240392|363132416|FG001|Overall Study|Lost to Follow-up|12|||
105309919|NCT03589768|363132421|FG000|Overall Study|Death|1|||
105309920|NCT03589768|363132422|FG001|Overall Study|Death|0|||
105309921|NCT03589768|363132423|FG002|Overall Study|Death|8|||
105309922|NCT03589768|363132424|FG003|Overall Study|Death|3|||
105309923|NCT03589768|363132421|FG000|Overall Study|Withdrawal by Subject|2|||
105309924|NCT03589768|363132422|FG001|Overall Study|Withdrawal by Subject|0|||
105489658|NCT01483690|363805591|FG000|Overall Study|exclusionary procedure|0|||
105834168|NCT05068284|365048798|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
105834169|NCT05068284|365048799|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
105367045|NCT02230891|363350146|FG000|6 Month|Physician Decision|0|||
105367046|NCT02230891|363350147|FG001|6 Month|Physician Decision|2|||
105367047|NCT02230891|363350148|FG002|6 Month|Physician Decision|0|||
105367048|NCT02230891|363350146|FG000|12 Month|Death|1|||
105367049|NCT02230891|363350147|FG001|12 Month|Death|0|||
105367050|NCT02230891|363350148|FG002|12 Month|Death|0|||
105367051|NCT02230891|363350146|FG000|12 Month|Lost to Follow-up|0|||
105367052|NCT02230891|363350147|FG001|12 Month|Lost to Follow-up|1|||
105367053|NCT02230891|363350148|FG002|12 Month|Lost to Follow-up|0|||
105367054|NCT02230891|363350146|FG000|12 Month|Withdrawal by Subject|0|||
105367055|NCT02230891|363350147|FG001|12 Month|Withdrawal by Subject|2|||
105367056|NCT02230891|363350148|FG002|12 Month|Withdrawal by Subject|0|||
105367057|NCT02230891|363350146|FG000|18 Month End of Study|Death|0|||
105367058|NCT02230891|363350147|FG001|18 Month End of Study|Death|0|||
105367059|NCT02230891|363350148|FG002|18 Month End of Study|Death|1|||
105367060|NCT02230891|363350146|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
105367061|NCT02230891|363350147|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
105367062|NCT02230891|363350148|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
105367063|NCT03641508|363350149|FG000|First Injection|Lost to Follow-up|2|||
105367064|NCT03641508|363350150|FG001|First Injection|Lost to Follow-up|0|||
105367065|NCT02404545|363350151|FG000|Overall Study|Sponsor Termination|6|||
105367066|NCT02404545|363350152|FG001|Overall Study|Sponsor Termination|6|||
105367067|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
105367068|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
105367069|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
105367070|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
105367071|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
105367072|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
105367073|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
105367074|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
105367075|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
105367076|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
105367077|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
105367078|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
105367079|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
105367080|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
105367081|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
105367082|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
105367083|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
105367084|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
105367085|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
105367086|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
105367087|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
105367088|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
105367089|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
105367090|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
105367091|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
105367092|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
105367093|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
105367094|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
105367095|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
105367096|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
105367097|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
105367098|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
105367099|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
105367100|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
105367101|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
105367102|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
105367103|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
105489659|NCT01483690|363805592|FG001|Overall Study|exclusionary procedure|1|||
105834170|NCT05068284|365048792|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
105367104|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
105367105|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
105367106|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
105489660|NCT02239224|363805596|FG000|Overall Study|Administrative|0|||
105489661|NCT02239224|363805597|FG001|Overall Study|Administrative|0|||
105489662|NCT02239224|363805598|FG002|Overall Study|Administrative|3|||
105489663|NCT02239224|363805599|FG003|Overall Study|Administrative|1|||
105489664|NCT03183778|363805600|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
105489665|NCT00749580|363805601|FG000|Overall Study|Lost to Follow-up|4|||
105489666|NCT00749580|363805602|FG001|Overall Study|Lost to Follow-up|8|||
105489667|NCT00749580|363805601|FG000|Overall Study|Adverse Event|0|||
105489668|NCT00749580|363805602|FG001|Overall Study|Adverse Event|1|||
105489669|NCT02428608|363805606|FG000|Overall Study|Pregnancy|2|||
105489670|NCT02428608|363805606|FG000|Overall Study|Lost to Follow-up|37|||
105489671|NCT02428608|363805606|FG000|Overall Study|Withdrawal by Subject|2|||
105489672|NCT02428608|363805606|FG000|Overall Study|scheduling conflicts|15|||
105489673|NCT02428608|363805606|FG000|Overall Study|moved away|10|||
105834171|NCT05068284|365048793|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
105834172|NCT05068284|365048794|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
105834173|NCT05068284|365048795|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
105834174|NCT05068284|365048796|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
105834175|NCT05068284|365048797|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
105834176|NCT05068284|365048798|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
105489674|NCT02428608|363805606|FG000|Overall Study|Death|1|||
105489675|NCT02428608|363805606|FG000|Overall Study|various|16|||
105489676|NCT04209426|363805609|FG000|Overall Study|Lost to Follow-up|3|||
105834177|NCT05068284|365048799|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
105834178|NCT05068284|365048792|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
105834179|NCT05068284|365048793|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
105834180|NCT05068284|365048794|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
105834181|NCT05068284|365048795|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
105834182|NCT05068284|365048796|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
105834183|NCT05068284|365048797|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
105834184|NCT05068284|365048798|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
105834185|NCT05068284|365048799|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
105834186|NCT05068284|365048792|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
105834187|NCT05068284|365048793|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
105834188|NCT05068284|365048794|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
105834189|NCT05068284|365048795|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
105834190|NCT05068284|365048796|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
105834191|NCT05068284|365048797|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
105834192|NCT05068284|365048798|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
105834193|NCT05068284|365048799|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
105834194|NCT05068284|365048792|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
105834195|NCT05068284|365048793|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
105834196|NCT05068284|365048794|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
105834197|NCT05068284|365048795|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
105834198|NCT05068284|365048796|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
105834199|NCT05068284|365048797|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
105834200|NCT05068284|365048798|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
105834201|NCT05068284|365048799|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
105834202|NCT05068284|365048792|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
105834203|NCT05068284|365048793|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
105834204|NCT05068284|365048794|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
105834205|NCT05068284|365048795|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
105834206|NCT05068284|365048796|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
105834207|NCT05068284|365048797|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
105834208|NCT05068284|365048798|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
105834209|NCT05068284|365048799|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
105834210|NCT05068284|365048792|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
105834211|NCT05068284|365048793|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
105834212|NCT05068284|365048794|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
105834213|NCT05068284|365048795|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
105834214|NCT05068284|365048796|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
105489677|NCT04209426|363805610|FG001|Overall Study|Lost to Follow-up|2|||
105489678|NCT02278341|363805611|FG000|Overall Study|Randomized but never received study drug|1|||
105489679|NCT02278341|363805612|FG001|Overall Study|Randomized but never received study drug|1|||
105834215|NCT05068284|365048797|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
105834216|NCT05068284|365048798|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
105834217|NCT05068284|365048799|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
105834218|NCT05068284|365048792|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
105834219|NCT05068284|365048793|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
105834220|NCT05068284|365048794|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
105834221|NCT05068284|365048795|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
105309925|NCT03589768|363132423|FG002|Overall Study|Withdrawal by Subject|0|||
105309926|NCT03589768|363132424|FG003|Overall Study|Withdrawal by Subject|0|||
105309927|NCT03589768|363132421|FG000|Overall Study|Protocol Violation|1|||
105309928|NCT03589768|363132422|FG001|Overall Study|Protocol Violation|0|||
105309929|NCT03589768|363132423|FG002|Overall Study|Protocol Violation|0|||
105309930|NCT03589768|363132424|FG003|Overall Study|Protocol Violation|0|||
105309931|NCT02903030|363132425|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
105309932|NCT02903030|363132426|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
105309933|NCT01502410|363132427|FG000|Overall Study|Adverse Event|1|||
105309934|NCT01502410|363132428|FG001|Overall Study|Adverse Event|2|||
105309935|NCT01502410|363132429|FG002|Overall Study|Adverse Event|0|||
105309936|NCT01502410|363132430|FG003|Overall Study|Adverse Event|0|||
105309937|NCT01502410|363132427|FG000|Overall Study|Lack of Efficacy|7|||
105309938|NCT01502410|363132428|FG001|Overall Study|Lack of Efficacy|7|||
105309939|NCT01502410|363132429|FG002|Overall Study|Lack of Efficacy|0|||
105309940|NCT01502410|363132430|FG003|Overall Study|Lack of Efficacy|0|||
105309941|NCT01502410|363132427|FG000|Overall Study|Physician Decision|0|||
105309942|NCT01502410|363132428|FG001|Overall Study|Physician Decision|1|||
105309943|NCT01502410|363132429|FG002|Overall Study|Physician Decision|0|||
105309944|NCT01502410|363132430|FG003|Overall Study|Physician Decision|0|||
105309945|NCT01502410|363132427|FG000|Overall Study|Withdrawal by Subject|2|||
105309946|NCT01502410|363132428|FG001|Overall Study|Withdrawal by Subject|0|||
105367107|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
105367108|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
105367109|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
105367110|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
105367111|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
105367112|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
105367113|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
105367114|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
105367115|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
105367116|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
105367117|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
105367118|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
105367119|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
105367120|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
105367121|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
105367122|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
105367123|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
105367124|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
105367125|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
105367126|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
105367127|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
105367128|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
105367129|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
105367130|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
105367131|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
105489680|NCT02278341|363805611|FG000|Overall Study|Adverse Event|3|||
105309947|NCT01502410|363132429|FG002|Overall Study|Withdrawal by Subject|0|||
105309948|NCT01502410|363132430|FG003|Overall Study|Withdrawal by Subject|0|||
105309949|NCT03700385|363132436|FG000|Overall Study|Lost to Follow-up|1|||
105309950|NCT04590040|363132437|FG000|Treatment Period|Lost to Follow-up|2|||
105309951|NCT04590040|363132438|FG001|Treatment Period|Lost to Follow-up|5|||
105309952|NCT04590040|363132439|FG002|Treatment Period|Lost to Follow-up|0|||
105309953|NCT04590040|363132437|FG000|Treatment Period|Physician Decision|0|||
105309954|NCT04590040|363132438|FG001|Treatment Period|Physician Decision|0|||
105309955|NCT04590040|363132439|FG002|Treatment Period|Physician Decision|2|||
105309956|NCT00663026|363132446|FG000|Overall Study|Lost to Follow-up|1|||
105309957|NCT00663026|363132447|FG001|Overall Study|Lost to Follow-up|0|||
105309958|NCT00663026|363132448|FG002|Overall Study|Lost to Follow-up|0|||
105309959|NCT00663026|363132446|FG000|Overall Study|Other|1|||
105309960|NCT00663026|363132447|FG001|Overall Study|Other|2|||
105309961|NCT00663026|363132448|FG002|Overall Study|Other|0|||
105309962|NCT00663026|363132446|FG000|Overall Study|Adverse Event|0|||
105309963|NCT00663026|363132447|FG001|Overall Study|Adverse Event|2|||
105309964|NCT00663026|363132448|FG002|Overall Study|Adverse Event|3|||
105309965|NCT00663026|363132446|FG000|Overall Study|Caregiver Request|0|||
105309966|NCT00663026|363132447|FG001|Overall Study|Caregiver Request|2|||
105309967|NCT00663026|363132448|FG002|Overall Study|Caregiver Request|0|||
105309968|NCT00663026|363132446|FG000|Overall Study|Withdrawal by Subject|0|||
105309969|NCT00663026|363132447|FG001|Overall Study|Withdrawal by Subject|0|||
105309970|NCT00663026|363132448|FG002|Overall Study|Withdrawal by Subject|1|||
105309971|NCT01570686|363132449|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105309972|NCT01570686|363132450|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105309973|NCT01570686|363132449|FG000|Overall Study|Administrative problems|0|||
105309974|NCT01570686|363132450|FG001|Overall Study|Administrative problems|1|||
105309975|NCT01570686|363132449|FG000|Overall Study|Adverse Event|8|||
105309976|NCT01570686|363132450|FG001|Overall Study|Adverse Event|6|||
105309977|NCT01570686|363132449|FG000|Overall Study|Lost to Follow-up|4|||
105309978|NCT01570686|363132450|FG001|Overall Study|Lost to Follow-up|3|||
105309979|NCT01570686|363132449|FG000|Overall Study|Protocol Deviation|3|||
105309980|NCT01570686|363132450|FG001|Overall Study|Protocol Deviation|0|||
105309981|NCT01570686|363132449|FG000|Overall Study|Withdrawal by Subject|4|||
105309982|NCT01570686|363132450|FG001|Overall Study|Withdrawal by Subject|4|||
105309983|NCT01570686|363132449|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105309984|NCT01570686|363132450|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105309985|NCT04003896|363132451|FG000|Overall Study|Withdrawal by Subject|3|||
105309986|NCT04003896|363132451|FG000|Overall Study|Physician Decision|1|||
105309987|NCT03537599|363132455|FG000|Overall Study|Disease Progression|2|||
105309988|NCT03537599|363132456|FG001|Overall Study|Disease Progression|1|||
105309989|NCT03537599|363132455|FG000|Overall Study|Death|0|||
105309990|NCT03537599|363132456|FG001|Overall Study|Death|1|||
105309991|NCT00686075|363132461|FG000|Overall Study|Withdrawal by Subject|4|||
105309992|NCT00686075|363132462|FG001|Overall Study|Withdrawal by Subject|3|||
105309993|NCT00686075|363132463|FG002|Overall Study|Withdrawal by Subject|3|||
105309994|NCT00686075|363132464|FG003|Overall Study|Withdrawal by Subject|7|||
105309995|NCT00686075|363132465|FG004|Overall Study|Withdrawal by Subject|1|||
105309996|NCT00686075|363132466|FG005|Overall Study|Withdrawal by Subject|0|||
105309997|NCT00686075|363132467|FG006|Overall Study|Withdrawal by Subject|0|||
105309998|NCT00686075|363132468|FG007|Overall Study|Withdrawal by Subject|2|||
105309999|NCT00686075|363132469|FG008|Overall Study|Withdrawal by Subject|4|||
105310000|NCT00686075|363132470|FG009|Overall Study|Withdrawal by Subject|6|||
105310001|NCT00686075|363132461|FG000|Overall Study|Lost to Follow-up|3|||
105310002|NCT00686075|363132462|FG001|Overall Study|Lost to Follow-up|6|||
105310003|NCT00686075|363132463|FG002|Overall Study|Lost to Follow-up|3|||
105310004|NCT00686075|363132464|FG003|Overall Study|Lost to Follow-up|2|||
105310005|NCT00686075|363132465|FG004|Overall Study|Lost to Follow-up|3|||
105310006|NCT00686075|363132466|FG005|Overall Study|Lost to Follow-up|3|||
105310007|NCT00686075|363132467|FG006|Overall Study|Lost to Follow-up|0|||
105310008|NCT00686075|363132468|FG007|Overall Study|Lost to Follow-up|0|||
105310009|NCT00686075|363132469|FG008|Overall Study|Lost to Follow-up|2|||
105310010|NCT00686075|363132470|FG009|Overall Study|Lost to Follow-up|3|||
105310011|NCT00686075|363132461|FG000|Overall Study|Other|1|||
105310012|NCT00686075|363132462|FG001|Overall Study|Other|1|||
105310013|NCT00686075|363132463|FG002|Overall Study|Other|0|||
105310014|NCT00686075|363132464|FG003|Overall Study|Other|0|||
105310015|NCT00686075|363132465|FG004|Overall Study|Other|0|||
105310016|NCT00686075|363132466|FG005|Overall Study|Other|0|||
105310017|NCT00686075|363132467|FG006|Overall Study|Other|0|||
105310018|NCT00686075|363132468|FG007|Overall Study|Other|0|||
105310019|NCT00686075|363132469|FG008|Overall Study|Other|0|||
105310020|NCT00686075|363132470|FG009|Overall Study|Other|1|||
105310021|NCT05776862|363132472|FG000|Overall Study|Adverse Event|0|||
105310022|NCT05776862|363132473|FG001|Overall Study|Adverse Event|1|||
105310023|NCT05776862|363132472|FG000|Overall Study|non-compliance|1|||
105310024|NCT05776862|363132473|FG001|Overall Study|non-compliance|0|||
105310025|NCT01682863|363132474|FG000|Overall Study|Subject/guardian decision|19|||
105310026|NCT01682863|363132475|FG001|Overall Study|Subject/guardian decision|12|||
105310027|NCT01682863|363132476|FG002|Overall Study|Subject/guardian decision|10|||
105310028|NCT01682863|363132474|FG000|Overall Study|Lost to Follow-up|5|||
105310029|NCT01682863|363132475|FG001|Overall Study|Lost to Follow-up|1|||
105310030|NCT01682863|363132476|FG002|Overall Study|Lost to Follow-up|6|||
105310031|NCT01682863|363132474|FG000|Overall Study|Death|1|||
105310032|NCT01682863|363132475|FG001|Overall Study|Death|3|||
105310033|NCT01682863|363132476|FG002|Overall Study|Death|4|||
105310034|NCT01682863|363132474|FG000|Overall Study|Protocol deviation|1|||
105310035|NCT01682863|363132475|FG001|Overall Study|Protocol deviation|0|||
105310036|NCT01682863|363132476|FG002|Overall Study|Protocol deviation|1|||
105310037|NCT01682863|363132474|FG000|Overall Study|Technical problems|1|||
105310038|NCT01682863|363132475|FG001|Overall Study|Technical problems|0|||
105310039|NCT01682863|363132476|FG002|Overall Study|Technical problems|0|||
105310040|NCT01682863|363132474|FG000|Overall Study|Adverse Event|0|||
105310041|NCT01682863|363132475|FG001|Overall Study|Adverse Event|1|||
105310042|NCT01682863|363132476|FG002|Overall Study|Adverse Event|2|||
105310043|NCT01682863|363132474|FG000|Overall Study|Physician Decision|0|||
105310044|NCT01682863|363132475|FG001|Overall Study|Physician Decision|0|||
105310045|NCT01682863|363132476|FG002|Overall Study|Physician Decision|1|||
105310046|NCT00918138|363132477|FG000|Overall Study|Subject withdrew consent|1|||
105310047|NCT00918138|363132478|FG001|Overall Study|Subject withdrew consent|1|||
105310048|NCT00918138|363132477|FG000|Overall Study|Death|1|||
105834222|NCT05068284|365048796|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
105834223|NCT05068284|365048797|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
105834224|NCT05068284|365048798|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
105834225|NCT05068284|365048799|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
105310049|NCT00918138|363132478|FG001|Overall Study|Death|0|||
105310050|NCT02448706|363132481|FG000|Overall Study|Withdrawal by Subject|4|||
105310051|NCT02448706|363132482|FG001|Overall Study|Withdrawal by Subject|3|||
105310052|NCT02448706|363132481|FG000|Overall Study|Protocol Violation|1|||
105310053|NCT02448706|363132482|FG001|Overall Study|Protocol Violation|1|||
105310054|NCT00699374|363132483|FG000|Overall Study|Death|93|||
105310055|NCT00699374|363132484|FG001|Overall Study|Death|83|||
105310056|NCT00699374|363132483|FG000|Overall Study|Adverse Event|70|||
105310057|NCT00699374|363132484|FG001|Overall Study|Adverse Event|67|||
105310058|NCT00699374|363132483|FG000|Overall Study|Global deterioration of health status|7|||
105310059|NCT00699374|363132484|FG001|Overall Study|Global deterioration of health status|8|||
105310060|NCT00699374|363132483|FG000|Overall Study|Lost to Follow-up|3|||
105310061|NCT00699374|363132484|FG001|Overall Study|Lost to Follow-up|5|||
105310062|NCT00699374|363132483|FG000|Overall Study|Withdrawal by Subject|34|||
105310063|NCT00699374|363132484|FG001|Overall Study|Withdrawal by Subject|44|||
105310064|NCT00699374|363132483|FG000|Overall Study|Objective progression or relapse|281|||
105310065|NCT00699374|363132484|FG001|Overall Study|Objective progression or relapse|277|||
105310066|NCT00699374|363132483|FG000|Overall Study|Other|18|||
105310067|NCT00699374|363132484|FG001|Overall Study|Other|15|||
105310068|NCT00699374|363132483|FG000|Overall Study|Protocol Violation|2|||
105310069|NCT00699374|363132484|FG001|Overall Study|Protocol Violation|6|||
105310070|NCT00699374|363132483|FG000|Overall Study|Study terminated by sponsor|13|||
105310071|NCT00699374|363132484|FG001|Overall Study|Study terminated by sponsor|28|||
105310072|NCT00699374|363132483|FG000|Overall Study|Randomized but not treated|4|||
105310073|NCT00699374|363132484|FG001|Overall Study|Randomized but not treated|2|||
105310074|NCT00699374|363132483|FG000|Overall Study|Died 28 days after last dose|5|||
105310075|NCT00699374|363132484|FG001|Overall Study|Died 28 days after last dose|9|||
105310076|NCT03972163|363132488|FG000|Overall Study|Death|0|||
105310077|NCT03972163|363132489|FG001|Overall Study|Death|1|||
105310078|NCT01199471|363132490|FG000|Overall Study|Protocol Violation|4|||
105310079|NCT01199471|363132490|FG000|Overall Study|Withdrawal by Subject|1|||
105310080|NCT01199471|363132490|FG000|Overall Study|Physician Decision|1|||
105310081|NCT01136967|363132494|FG000|Overall Study|Adverse Event|9|||
105310082|NCT01136967|363132495|FG001|Overall Study|Adverse Event|12|||
105310083|NCT01136967|363132494|FG000|Overall Study|Participant Choice|8|||
105310084|NCT01136967|363132495|FG001|Overall Study|Participant Choice|3|||
105310085|NCT01136967|363132494|FG000|Overall Study|Lost to Follow-up|0|||
105310086|NCT01136967|363132495|FG001|Overall Study|Lost to Follow-up|1|||
105310087|NCT01136967|363132494|FG000|Overall Study|Withdrawal by Subject|1|||
105310088|NCT01136967|363132495|FG001|Overall Study|Withdrawal by Subject|2|||
105310089|NCT01136967|363132494|FG000|Overall Study|Clinical Progression|3|||
105310090|NCT01136967|363132495|FG001|Overall Study|Clinical Progression|5|||
105310091|NCT01136967|363132494|FG000|Overall Study|Radiation|1|||
105310092|NCT01136967|363132495|FG001|Overall Study|Radiation|0|||
105310093|NCT01136967|363132494|FG000|Overall Study|Non-compliance|1|||
105310094|NCT01136967|363132495|FG001|Overall Study|Non-compliance|0|||
105310095|NCT01136967|363132494|FG000|Overall Study|Investigator's Choice|1|||
105310096|NCT01136967|363132495|FG001|Overall Study|Investigator's Choice|1|||
105310097|NCT01136967|363132494|FG000|Overall Study|Increase in Lesion Size|0|||
105310098|NCT01136967|363132495|FG001|Overall Study|Increase in Lesion Size|2|||
105310099|NCT01136967|363132494|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
105310100|NCT01136967|363132495|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
105310101|NCT03151811|363132498|FG000|Overall Study|Randomized But Not Treated|18|||
105310102|NCT03151811|363132499|FG001|Overall Study|Randomized But Not Treated|3|||
105310103|NCT03151811|363132498|FG000|Overall Study|Progressive Disease|130|||
105310104|NCT03151811|363132499|FG001|Overall Study|Progressive Disease|170|||
105310105|NCT03151811|363132498|FG000|Overall Study|Adverse Event|49|||
105310106|NCT03151811|363132499|FG001|Overall Study|Adverse Event|40|||
105310107|NCT03151811|363132498|FG000|Overall Study|Lack of Efficacy|6|||
105310108|NCT03151811|363132499|FG001|Overall Study|Lack of Efficacy|8|||
105310109|NCT03151811|363132498|FG000|Overall Study|Physician Decision|21|||
105367132|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
105834226|NCT05068284|365048792|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
105834227|NCT05068284|365048793|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
105834228|NCT05068284|365048794|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
105834229|NCT05068284|365048795|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
105834230|NCT05068284|365048796|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
105834231|NCT05068284|365048797|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
105834232|NCT05068284|365048798|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
105834233|NCT05068284|365048799|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
105834234|NCT05068284|365048792|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
105834235|NCT05068284|365048793|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
105834236|NCT05068284|365048794|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
105834237|NCT05068284|365048795|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
105834238|NCT05068284|365048796|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
105834239|NCT05068284|365048797|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
105834240|NCT05068284|365048798|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
105834241|NCT05068284|365048799|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
105834246|NCT00274625|365050176|FG000|Overall Study|Lost to Follow-up|46|||
105834247|NCT00274625|365050177|FG001|Overall Study|Lost to Follow-up|54|||
105834248|NCT00274625|365050176|FG000|Overall Study|Excluded from analysis|14|||
105834249|NCT00274625|365050177|FG001|Overall Study|Excluded from analysis|8|||
105834250|NCT01023061|365050178|FG000|Overall Study|Withdrawal prior to treatment|2|||
105834251|NCT01622660|365050179|FG000|Overall Study|Adverse Event|1|||
105834252|NCT04812548|365050180|FG000|Overall Study|Adverse Event|2|||
105834253|NCT04812548|365050181|FG001|Overall Study|Adverse Event|7|||
105834254|NCT04812548|365050180|FG000|Overall Study|HSCT Planned|2|||
105834255|NCT04812548|365050181|FG001|Overall Study|HSCT Planned|3|||
105834256|NCT04812548|365050180|FG000|Overall Study|Progressive Disease|0|||
105834257|NCT04812548|365050181|FG001|Overall Study|Progressive Disease|2|||
105834258|NCT04812548|365050180|FG000|Overall Study|Death|0|||
105834259|NCT04812548|365050181|FG001|Overall Study|Death|1|||
105834260|NCT04812548|365050180|FG000|Overall Study|Post Study Access to Treatment|0|||
105834261|NCT04812548|365050181|FG001|Overall Study|Post Study Access to Treatment|1|||
105834262|NCT04812548|365050180|FG000|Overall Study|Withdrawal by Subject|0|||
105834263|NCT04812548|365050181|FG001|Overall Study|Withdrawal by Subject|1|||
105834264|NCT04812548|365050180|FG000|Overall Study|Physician Decision|1|||
105834265|NCT04812548|365050181|FG001|Overall Study|Physician Decision|0|||
105834266|NCT01754376|365050183|FG000|Overall Study|Adverse Event|1|||
105834267|NCT01754376|365050183|FG000|Overall Study|Lack of Efficacy|2|||
105834268|NCT04590781|365050184|FG000|Overall Study|Death|0|||
105834269|NCT04590781|365050185|FG001|Overall Study|Death|2|||
105834270|NCT04590781|365050184|FG000|Overall Study|Withdrawal by Subject|2|||
105834271|NCT04590781|365050185|FG001|Overall Study|Withdrawal by Subject|0|||
105834272|NCT04556734|365050186|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
105834273|NCT04556734|365050187|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
105310110|NCT03151811|363132499|FG001|Overall Study|Physician Decision|9|||
105310111|NCT03151811|363132498|FG000|Overall Study|Withdrawal by Subject|17|||
105310112|NCT03151811|363132499|FG001|Overall Study|Withdrawal by Subject|7|||
105310113|NCT03151811|363132498|FG000|Overall Study|Lost to Follow-up|0|||
105310114|NCT03151811|363132499|FG001|Overall Study|Lost to Follow-up|1|||
105310115|NCT03151811|363132498|FG000|Overall Study|Study Terminated by Sponsor|5|||
105310116|NCT03151811|363132499|FG001|Overall Study|Study Terminated by Sponsor|11|||
105310117|NCT01664130|363132502|FG000|Overall Study|competing secondary disease|2|||
105310118|NCT01081834|363132507|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
105310119|NCT01081834|363132508|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
105310120|NCT01081834|363132509|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
105310121|NCT01081834|363132510|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
105489681|NCT02278341|363805612|FG001|Overall Study|Adverse Event|0|||
105489682|NCT02278341|363805611|FG000|Overall Study|Death|68|||
105834274|NCT04556734|365050188|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
105834275|NCT04556734|365050189|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105310122|NCT01081834|363132511|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
105310123|NCT01081834|363132507|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
105310124|NCT01081834|363132508|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
105310125|NCT01081834|363132509|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
105310126|NCT01081834|363132510|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
105310127|NCT01081834|363132511|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
105310128|NCT01081834|363132507|FG000|Core Period: Baseline to Week 26|Death|1|||
105489683|NCT02278341|363805612|FG001|Overall Study|Death|56|||
105834276|NCT04556734|365050190|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105834277|NCT04556734|365050191|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105834278|NCT04556734|365050192|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105834279|NCT04556734|365050193|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105834280|NCT04556734|365050186|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
105834281|NCT04556734|365050187|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105834282|NCT04556734|365050188|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105834283|NCT04556734|365050189|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105834284|NCT04556734|365050190|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105834285|NCT04556734|365050191|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105834286|NCT04556734|365050192|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105834287|NCT04556734|365050193|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105834288|NCT04556734|365050186|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105834289|NCT04556734|365050187|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105834290|NCT04556734|365050188|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105834291|NCT04556734|365050189|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105834292|NCT04556734|365050190|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105834293|NCT04556734|365050191|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105834294|NCT04556734|365050192|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105834295|NCT04556734|365050193|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105834296|NCT04556734|365050186|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
105834297|NCT04556734|365050187|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105834298|NCT04556734|365050188|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105834299|NCT04556734|365050189|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105834300|NCT04556734|365050190|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105834301|NCT04556734|365050191|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105834302|NCT04556734|365050192|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105834303|NCT04556734|365050193|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105834304|NCT04556734|365050186|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
105834305|NCT04556734|365050187|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
105834306|NCT04556734|365050188|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
105834307|NCT04556734|365050189|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
105834308|NCT04556734|365050190|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
105834309|NCT04556734|365050191|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
105834310|NCT04556734|365050192|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
105834311|NCT04556734|365050193|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
105834312|NCT04556734|365050186|FG000|OLE Period (28 Weeks)|Not reported|0|||
105834313|NCT04556734|365050187|FG001|OLE Period (28 Weeks)|Not reported|0|||
105834314|NCT04556734|365050188|FG002|OLE Period (28 Weeks)|Not reported|0|||
105834315|NCT04556734|365050189|FG003|OLE Period (28 Weeks)|Not reported|0|||
105834316|NCT04556734|365050190|FG004|OLE Period (28 Weeks)|Not reported|0|||
105834317|NCT04556734|365050191|FG005|OLE Period (28 Weeks)|Not reported|1|||
105834318|NCT04556734|365050192|FG006|OLE Period (28 Weeks)|Not reported|0|||
105834319|NCT04556734|365050193|FG007|OLE Period (28 Weeks)|Not reported|0|||
105834320|NCT04556734|365050186|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105834321|NCT04556734|365050187|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105834322|NCT04556734|365050188|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105834323|NCT04556734|365050189|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105834324|NCT04556734|365050190|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105834325|NCT04556734|365050191|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105834326|NCT04556734|365050192|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105310129|NCT01081834|363132508|FG001|Core Period: Baseline to Week 26|Death|0|||
105310130|NCT01081834|363132509|FG002|Core Period: Baseline to Week 26|Death|0|||
105310131|NCT01081834|363132510|FG003|Core Period: Baseline to Week 26|Death|0|||
105310132|NCT01081834|363132511|FG004|Core Period: Baseline to Week 26|Death|0|||
105310133|NCT01081834|363132507|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
105310134|NCT01081834|363132508|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
105489684|NCT02278341|363805611|FG000|Overall Study|Withdrawal by Subject|30|||
105489685|NCT02278341|363805612|FG001|Overall Study|Withdrawal by Subject|19|||
105489686|NCT02278341|363805611|FG000|Overall Study|Lost to Follow-up|0|||
105489687|NCT02278341|363805612|FG001|Overall Study|Lost to Follow-up|1|||
105489688|NCT02278341|363805611|FG000|Overall Study|Physician Decision|1|||
105834327|NCT04556734|365050193|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
105834328|NCT04556734|365050186|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
105834329|NCT04556734|365050187|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
105834330|NCT04556734|365050188|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
105834331|NCT04556734|365050189|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
105834332|NCT04556734|365050190|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
105834333|NCT04556734|365050191|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
105834334|NCT04556734|365050192|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
105834335|NCT04556734|365050193|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
105489689|NCT02278341|363805612|FG001|Overall Study|Physician Decision|1|||
105310135|NCT01081834|363132509|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
105310136|NCT01081834|363132510|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
105310137|NCT01081834|363132511|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
105310138|NCT01081834|363132507|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
105310139|NCT01081834|363132508|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
105310140|NCT01081834|363132509|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
105310141|NCT01081834|363132510|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
105310142|NCT01081834|363132511|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
105310143|NCT01081834|363132507|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
105310144|NCT01081834|363132508|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
105310145|NCT01081834|363132509|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
105310146|NCT01081834|363132510|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
105310147|NCT01081834|363132511|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
105310148|NCT01081834|363132507|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
105310149|NCT01081834|363132508|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
105310150|NCT01081834|363132509|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
105310151|NCT01081834|363132510|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
105310152|NCT01081834|363132511|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
105310153|NCT01081834|363132507|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
105310154|NCT01081834|363132508|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
105310155|NCT01081834|363132509|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
105310156|NCT01081834|363132510|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
105310157|NCT01081834|363132511|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
105310158|NCT01081834|363132507|FG000|Core Period: Baseline to Week 26|Other|4|||
105310159|NCT01081834|363132508|FG001|Core Period: Baseline to Week 26|Other|4|||
105310160|NCT01081834|363132509|FG002|Core Period: Baseline to Week 26|Other|3|||
105310161|NCT01081834|363132510|FG003|Core Period: Baseline to Week 26|Other|1|||
105310162|NCT01081834|363132511|FG004|Core Period: Baseline to Week 26|Other|0|||
105310163|NCT01081834|363132507|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
105310164|NCT01081834|363132508|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
105310165|NCT01081834|363132509|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
105310166|NCT01081834|363132510|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
105310167|NCT01081834|363132511|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
105310168|NCT01081834|363132507|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
105310169|NCT01081834|363132508|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
105310170|NCT01081834|363132509|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
105310171|NCT01081834|363132510|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
105310172|NCT01081834|363132511|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
105310173|NCT01081834|363132507|FG000|Extension Period: Week 26 to Week 52|Death|1|||
105310174|NCT01081834|363132508|FG001|Extension Period: Week 26 to Week 52|Death|0|||
105310175|NCT01081834|363132509|FG002|Extension Period: Week 26 to Week 52|Death|0|||
105310176|NCT01081834|363132510|FG003|Extension Period: Week 26 to Week 52|Death|0|||
105310177|NCT01081834|363132511|FG004|Extension Period: Week 26 to Week 52|Death|0|||
105310178|NCT01081834|363132507|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
105310179|NCT01081834|363132508|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
105310180|NCT01081834|363132509|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
105310181|NCT01081834|363132510|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
105310182|NCT01081834|363132511|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
105310183|NCT01081834|363132507|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105310184|NCT01081834|363132508|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
105310185|NCT01081834|363132509|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105310186|NCT01081834|363132510|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105310187|NCT01081834|363132511|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105367133|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
105367134|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
105367135|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
105367136|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
105367137|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
105367138|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
105310188|NCT01081834|363132507|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
105310189|NCT01081834|363132508|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
105310190|NCT01081834|363132509|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
105310191|NCT01081834|363132510|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
105310192|NCT01081834|363132511|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
105489690|NCT02278341|363805611|FG000|Overall Study|Miscellaneous|15|||
105489691|NCT02278341|363805612|FG001|Overall Study|Miscellaneous|14|||
105489692|NCT04902326|363805613|FG000|Overall Study|Withdrawal by Subject|1|||
105489693|NCT04902326|363805614|FG001|Overall Study|Withdrawal by Subject|3|||
105489694|NCT04902326|363805615|FG002|Overall Study|Withdrawal by Subject|0|||
105489695|NCT04902326|363805616|FG003|Overall Study|Withdrawal by Subject|1|||
105489696|NCT04902326|363805613|FG000|Overall Study|Lost to Follow-up|14|||
105834336|NCT04556734|365050186|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
105834337|NCT04556734|365050187|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
105834338|NCT04556734|365050188|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
105834339|NCT04556734|365050189|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
105834340|NCT04556734|365050190|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
105834341|NCT04556734|365050191|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
105834342|NCT04556734|365050192|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
105834343|NCT04556734|365050193|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
105834344|NCT02658019|365050200|FG000|Overall Study|Adverse Event|1|||
105834345|NCT02722616|365050201|FG000|Overall Study|Sponsor closed study after one month|2|||
105834346|NCT02722616|365050202|FG001|Overall Study|Sponsor closed study after one month|0|||
105834347|NCT02722616|365050203|FG002|Overall Study|Sponsor closed study after one month|0|||
105834348|NCT00820599|365050206|FG000|Overall Study|Death|129|||
105834349|NCT00820599|365050206|FG000|Overall Study|Withdrawal by Subject|2|||
105834350|NCT02485158|365050207|FG000|Overall Study|Withdrawal by Subject|3|||
105834351|NCT02485158|365050207|FG000|Overall Study|expected drug side effect|1|||
105834352|NCT00442351|365050208|FG000|Overall Study|Administrative|6|||
105834353|NCT00442351|365050209|FG001|Overall Study|Administrative|5|||
105834354|NCT00442351|365050208|FG000|Overall Study|Did not meet protocol eligibility|1|||
105834355|NCT00442351|365050209|FG001|Overall Study|Did not meet protocol eligibility|0|||
105834356|NCT00442351|365050208|FG000|Overall Study|Other|0|||
105367139|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
105367140|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
105367141|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
105367142|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
105367143|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
105367144|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
105367145|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
105367146|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
105367147|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
105367148|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
105367149|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
105367150|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
105367151|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
105367152|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
105489697|NCT04902326|363805614|FG001|Overall Study|Lost to Follow-up|14|||
105489698|NCT04902326|363805615|FG002|Overall Study|Lost to Follow-up|14|||
105489699|NCT04902326|363805616|FG003|Overall Study|Lost to Follow-up|6|||
105489700|NCT01117051|363805624|FG000|Overall Study|Withdrawal by Subject|5|||
105489701|NCT01117051|363805625|FG001|Overall Study|Withdrawal by Subject|3|||
105489702|NCT01117051|363805624|FG000|Overall Study|Adverse Event|4|||
105489703|NCT01117051|363805625|FG001|Overall Study|Adverse Event|3|||
105489704|NCT01117051|363805624|FG000|Overall Study|Lost to Follow-up|0|||
105489705|NCT01117051|363805625|FG001|Overall Study|Lost to Follow-up|1|||
105489706|NCT01117051|363805624|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
105489707|NCT01117051|363805625|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
105489708|NCT01117051|363805624|FG000|Overall Study|Sponsor's decision|3|||
105489709|NCT01117051|363805625|FG001|Overall Study|Sponsor's decision|1|||
105489710|NCT01117051|363805624|FG000|Overall Study|Surgical procedure|0|||
105489711|NCT01117051|363805625|FG001|Overall Study|Surgical procedure|1|||
105489712|NCT01117051|363805624|FG000|Overall Study|Randomized by mistake|0|||
105489713|NCT01117051|363805625|FG001|Overall Study|Randomized by mistake|1|||
105489714|NCT01117051|363805624|FG000|Overall Study|Convenience issue|1|||
105489715|NCT01117051|363805625|FG001|Overall Study|Convenience issue|0|||
105489716|NCT00427960|363805627|FG000|Overall Study|Adverse Event|2|||
105834357|NCT00442351|365050209|FG001|Overall Study|Other|1|||
105834358|NCT03087786|365050210|FG000|Overall Study|Withdrawal by Subject|2|||
105834359|NCT03087786|365050211|FG001|Overall Study|Withdrawal by Subject|0|||
105489717|NCT00427960|363805628|FG001|Overall Study|Adverse Event|0|||
105834360|NCT01813435|365050212|FG000|Overall Study|did not finish experimental regimen|1902|||
105834361|NCT01813435|365050213|FG001|Overall Study|did not finish experimental regimen|770|||
105834362|NCT01813435|365050212|FG000|Overall Study|Lost to Follow-up|268|||
105834363|NCT01813435|365050213|FG001|Overall Study|Lost to Follow-up|237|||
105834364|NCT03243396|365050214|FG000|Overall Study|Lost to Follow-up|2|||
105834365|NCT03243396|365050215|FG001|Overall Study|Lost to Follow-up|3|||
105575903|NCT01865617|364108351|FG009|Overall Study|Patient proceeded to new therapy|0|||
105575904|NCT01865617|364108352|FG010|Overall Study|Patient proceeded to new therapy|0|||
105575905|NCT01865617|364108353|FG011|Overall Study|Patient proceeded to new therapy|0|||
105575906|NCT01865617|364108354|FG012|Overall Study|Patient proceeded to new therapy|0|||
105575907|NCT01865617|364108342|FG000|Overall Study|Other|0|||
105575908|NCT01865617|364108343|FG001|Overall Study|Other|0|||
105575909|NCT01865617|364108344|FG002|Overall Study|Other|0|||
105575910|NCT01865617|364108345|FG003|Overall Study|Other|0|||
105575911|NCT01865617|364108346|FG004|Overall Study|Other|0|||
105575912|NCT01865617|364108347|FG005|Overall Study|Other|0|||
105575913|NCT01865617|364108348|FG006|Overall Study|Other|1|||
105575914|NCT01865617|364108349|FG007|Overall Study|Other|0|||
105575915|NCT01865617|364108350|FG008|Overall Study|Other|0|||
105575916|NCT01865617|364108351|FG009|Overall Study|Other|0|||
105575917|NCT01865617|364108352|FG010|Overall Study|Other|0|||
105575918|NCT01865617|364108353|FG011|Overall Study|Other|0|||
105575919|NCT01865617|364108354|FG012|Overall Study|Other|0|||
105575920|NCT00258440|364108359|FG000|Overall Study|Withdrawal by Subject|0|||
105575921|NCT00258440|364108360|FG001|Overall Study|Withdrawal by Subject|0|||
105575922|NCT00258440|364108361|FG002|Overall Study|Withdrawal by Subject|1|||
105575923|NCT00737061|364108362|FG000|Waiting Period|Lost to Follow-up|6|||
105575924|NCT00737061|364108362|FG000|Waiting Period|Withdrawal by Subject|1|||
105575925|NCT00737061|364108362|FG000|Waiting Period|Bilateral placement failure|34|||
105575926|NCT00737061|364108362|FG000|Waiting Period|Deemed patent following HSG|26|||
105575927|NCT00737061|364108362|FG000|Waiting Period|Alternative contraception failure|3|||
105575928|NCT00737061|364108362|FG000|Waiting Period|Elected surgical tubal ligation|5|||
105575929|NCT00737061|364108362|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
105575930|NCT00737061|364108362|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
105575931|NCT00737061|364108362|FG000|1 Year Wearing Period|Discontinued reilance|3|||
105575932|NCT00737061|364108362|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
105575933|NCT01830881|364108369|FG000|Overall Study|Changed decision to have an abortion|0|||
105575934|NCT01830881|364108370|FG001|Overall Study|Changed decision to have an abortion|1|||
105575935|NCT01258660|364108371|FG000|Overall Study|Adverse Event|2|||
105575936|NCT01258660|364108372|FG001|Overall Study|Adverse Event|4|||
105575937|NCT01258660|364108371|FG000|Overall Study|Withdrawal by Subject|3|||
105575938|NCT01258660|364108372|FG001|Overall Study|Withdrawal by Subject|0|||
105575939|NCT01258660|364108371|FG000|Overall Study|due to relocation|2|||
105575940|NCT01258660|364108372|FG001|Overall Study|due to relocation|0|||
105575941|NCT01258660|364108371|FG000|Overall Study|Protocol Violation|0|||
105575942|NCT01258660|364108372|FG001|Overall Study|Protocol Violation|1|||
105575943|NCT01258660|364108371|FG000|Overall Study|Invalid for primary analysis data set|4|||
105575944|NCT01258660|364108372|FG001|Overall Study|Invalid for primary analysis data set|6|||
105575945|NCT00119262|364108373|FG000|Overall Study|Lack of Efficacy|0|||
105575946|NCT00119262|364108374|FG001|Overall Study|Lack of Efficacy|3|||
105575947|NCT00119262|364108373|FG000|Overall Study|Withdrawal by Subject|12|||
105575948|NCT00119262|364108374|FG001|Overall Study|Withdrawal by Subject|11|||
105575949|NCT00119262|364108373|FG000|Overall Study|Adverse Event|33|||
105575950|NCT00119262|364108374|FG001|Overall Study|Adverse Event|35|||
105575951|NCT00119262|364108373|FG000|Overall Study|other disease|0|||
105575952|NCT00119262|364108374|FG001|Overall Study|other disease|2|||
105575953|NCT00119262|364108373|FG000|Overall Study|ineligble|1|||
105575954|NCT00119262|364108374|FG001|Overall Study|ineligble|2|||
105575955|NCT00119262|364108373|FG000|Overall Study|others|0|||
105575956|NCT00119262|364108374|FG001|Overall Study|others|5|||
105575957|NCT03125941|364108375|FG000|Overall Study|did not receive intervention|1|||
105575958|NCT03125941|364108376|FG001|Overall Study|did not receive intervention|2|||
105310193|NCT01081834|363132507|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
105310194|NCT01081834|363132508|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
105310195|NCT01081834|363132509|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
105310196|NCT01081834|363132510|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
105310197|NCT01081834|363132511|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
105310198|NCT01081834|363132507|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
105310199|NCT01081834|363132508|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
105310200|NCT01081834|363132509|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
105310201|NCT01081834|363132510|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
105575959|NCT00582491|364108377|FG000|Overall Study|Withdrawal by Subject|1|||
105575960|NCT00582491|364108378|FG001|Overall Study|Withdrawal by Subject|0|||
105575961|NCT04192630|364108380|FG000|Overall Study|Discontinued before surgery|2|||
105575962|NCT04192630|364108381|FG001|Overall Study|Discontinued before surgery|0|||
105575963|NCT04192630|364108380|FG000|Overall Study|Discontinued after surgery|5|||
105575964|NCT04192630|364108381|FG001|Overall Study|Discontinued after surgery|3|||
105575965|NCT01193582|364108382|FG000|Vaccination Series|Withdrawal by Subject|11|||
105575966|NCT01193582|364108383|FG001|Vaccination Series|Withdrawal by Subject|13|||
105575967|NCT01193582|364108384|FG002|Vaccination Series|Withdrawal by Subject|8|||
105310202|NCT01081834|363132511|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
105310203|NCT01081834|363132507|FG000|Extension Period: Week 26 to Week 52|Other|4|||
105310204|NCT01081834|363132508|FG001|Extension Period: Week 26 to Week 52|Other|5|||
105310205|NCT01081834|363132509|FG002|Extension Period: Week 26 to Week 52|Other|4|||
105310206|NCT01081834|363132510|FG003|Extension Period: Week 26 to Week 52|Other|0|||
105310207|NCT01081834|363132511|FG004|Extension Period: Week 26 to Week 52|Other|0|||
105310208|NCT01081834|363132507|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
105310209|NCT01081834|363132508|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
105310210|NCT01081834|363132509|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
105310211|NCT01081834|363132510|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
105310212|NCT01081834|363132511|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
105310213|NCT01081834|363132507|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
105310214|NCT01081834|363132508|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
105310215|NCT01081834|363132509|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
105575968|NCT01193582|364108385|FG003|Vaccination Series|Withdrawal by Subject|3|||
105575969|NCT01193582|364108382|FG000|12 Month Follow-up|Death|0|||
105575970|NCT01193582|364108383|FG001|12 Month Follow-up|Death|0|||
105575971|NCT01193582|364108384|FG002|12 Month Follow-up|Death|1|||
105575972|NCT01193582|364108385|FG003|12 Month Follow-up|Death|0|||
105575973|NCT01193582|364108382|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
105575974|NCT01193582|364108383|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
105575975|NCT01193582|364108384|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
105575976|NCT01193582|364108385|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
105575977|NCT01425632|364108390|FG000|Overall Study|Adverse Event|0|||
105575978|NCT01425632|364108391|FG001|Overall Study|Adverse Event|1|||
105575979|NCT01425632|364108392|FG002|Overall Study|Adverse Event|1|||
105575980|NCT01425632|364108390|FG000|Overall Study|Physician Decision|1|||
105575981|NCT01425632|364108391|FG001|Overall Study|Physician Decision|0|||
105575982|NCT01425632|364108392|FG002|Overall Study|Physician Decision|0|||
105575983|NCT01425632|364108390|FG000|Overall Study|Protocol Violation|0|||
105575984|NCT01425632|364108391|FG001|Overall Study|Protocol Violation|0|||
105575985|NCT01425632|364108392|FG002|Overall Study|Protocol Violation|2|||
105575986|NCT01425632|364108390|FG000|Overall Study|Withdrawal by Subject|0|||
105575987|NCT01425632|364108391|FG001|Overall Study|Withdrawal by Subject|0|||
105575988|NCT01425632|364108392|FG002|Overall Study|Withdrawal by Subject|1|||
105575989|NCT03632434|364108394|FG000|Overall Study|Withdrawal by Subject|2|||
105575990|NCT01775930|364108397|FG000|Overall Study|Futility stopping boundary met|1|||
105575991|NCT01551303|364108398|FG000|Overall Study|failed awareness check on vision test|4|||
105575992|NCT01551303|364108399|FG001|Overall Study|failed awareness check on vision test|7|||
105575993|NCT01208415|364108400|FG000|Overall Study|Death|1|||
105575994|NCT01208415|364108400|FG000|Overall Study|Lost to Follow-up|2|||
105575995|NCT01208415|364108400|FG000|Overall Study|Withdrawal by Subject|3|||
105575996|NCT01208415|364108400|FG000|Overall Study|Device not placed|1|||
105575997|NCT01208415|364108400|FG000|Overall Study|Still be eligible for follow-up|33|||
105575998|NCT00363896|364108401|FG000|Overall Study|Withdrawal by Subject|29|||
105575999|NCT00363896|364108402|FG001|Overall Study|Withdrawal by Subject|16|||
105576000|NCT00363896|364108401|FG000|Overall Study|Adverse Event|24|||
105576001|NCT00363896|364108402|FG001|Overall Study|Adverse Event|13|||
105576002|NCT00363896|364108401|FG000|Overall Study|COPD exacerbation|13|||
105576003|NCT00363896|364108402|FG001|Overall Study|COPD exacerbation|7|||
105576004|NCT00363896|364108401|FG000|Overall Study|Lack of Efficacy|12|||
105576005|NCT00363896|364108402|FG001|Overall Study|Lack of Efficacy|8|||
105576006|NCT00363896|364108401|FG000|Overall Study|Protocol Violation|6|||
105576007|NCT00363896|364108402|FG001|Overall Study|Protocol Violation|1|||
105576008|NCT00363896|364108401|FG000|Overall Study|Lost to Follow-up|3|||
105576009|NCT00363896|364108402|FG001|Overall Study|Lost to Follow-up|0|||
105576010|NCT00363896|364108401|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
105576011|NCT00363896|364108402|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
105576012|NCT00363896|364108401|FG000|Overall Study|Other|1|||
105310216|NCT01081834|363132510|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
105576013|NCT00363896|364108402|FG001|Overall Study|Other|2|||
105576014|NCT01651936|364108405|FG000|Base Study|Adverse Event|3|||
105576015|NCT01651936|364108406|FG001|Base Study|Adverse Event|0|||
105310217|NCT01081834|363132511|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
105310218|NCT00554606|363132512|FG000|Overall Study|Adverse Event|3|||
105367153|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
105367154|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
105576016|NCT01651936|364108407|FG002|Base Study|Adverse Event|0|||
105576017|NCT01651936|364108405|FG000|Base Study|Withdrawal by Subject|1|||
105576018|NCT01651936|364108406|FG001|Base Study|Withdrawal by Subject|1|||
105576019|NCT01651936|364108407|FG002|Base Study|Withdrawal by Subject|0|||
105576020|NCT01651936|364108405|FG000|Base Study|Early Escape|2|||
105576021|NCT01651936|364108406|FG001|Base Study|Early Escape|8|||
105576022|NCT01651936|364108407|FG002|Base Study|Early Escape|0|||
105576023|NCT01651936|364108405|FG000|Base Study|Study terminated by sponsor|21|||
105576024|NCT01651936|364108406|FG001|Base Study|Study terminated by sponsor|16|||
105576025|NCT01651936|364108407|FG002|Base Study|Study terminated by sponsor|0|||
105576026|NCT01651936|364108405|FG000|Extension Study|Lack of Efficacy|0|||
105576027|NCT01651936|364108406|FG001|Extension Study|Lack of Efficacy|0|||
105576028|NCT01651936|364108407|FG002|Extension Study|Lack of Efficacy|1|||
105576029|NCT01651936|364108405|FG000|Extension Study|Study terminated by sponsor|0|||
105576030|NCT01651936|364108406|FG001|Extension Study|Study terminated by sponsor|0|||
105576031|NCT01651936|364108407|FG002|Extension Study|Study terminated by sponsor|13|||
105576032|NCT03044353|364108411|FG000|Overall Study|Adverse Event|0|||
105576033|NCT03044353|364108412|FG001|Overall Study|Adverse Event|1|||
105576034|NCT03044353|364108413|FG002|Overall Study|Adverse Event|0|||
105576035|NCT02340520|364108424|FG000|Overall Study|Lost to Follow-up|1|||
105576036|NCT02340520|364108424|FG000|Overall Study|Patient did not take drug as specified|1|||
105576037|NCT02340520|364108424|FG000|Overall Study|Withdrawal by Subject|1|||
105576038|NCT01146574|364108427|FG000|Overall Study|Death|0|||
105576039|NCT01146574|364108428|FG001|Overall Study|Death|1|||
105576040|NCT01146574|364108429|FG002|Overall Study|Death|1|||
105576041|NCT01146574|364108430|FG003|Overall Study|Death|0|||
105576042|NCT01146574|364108431|FG004|Overall Study|Death|0|||
105576043|NCT01146574|364108432|FG005|Overall Study|Death|0|||
105576044|NCT01146574|364108433|FG006|Overall Study|Death|0|||
105576045|NCT01146574|364108427|FG000|Overall Study|Other reasons|0|||
105576046|NCT01146574|364108428|FG001|Overall Study|Other reasons|0|||
105576047|NCT01146574|364108429|FG002|Overall Study|Other reasons|3|||
105576048|NCT01146574|364108430|FG003|Overall Study|Other reasons|0|||
105576049|NCT01146574|364108431|FG004|Overall Study|Other reasons|0|||
105576050|NCT01146574|364108432|FG005|Overall Study|Other reasons|0|||
105576051|NCT01146574|364108433|FG006|Overall Study|Other reasons|0|||
105576052|NCT01146574|364108427|FG000|Overall Study|Kidney transplant|0|||
105576053|NCT01146574|364108428|FG001|Overall Study|Kidney transplant|0|||
105576054|NCT01146574|364108429|FG002|Overall Study|Kidney transplant|1|||
105576055|NCT01146574|364108430|FG003|Overall Study|Kidney transplant|1|||
105576056|NCT01146574|364108431|FG004|Overall Study|Kidney transplant|0|||
105576057|NCT01146574|364108432|FG005|Overall Study|Kidney transplant|0|||
105576058|NCT01146574|364108433|FG006|Overall Study|Kidney transplant|0|||
105576059|NCT01146574|364108427|FG000|Overall Study|Withdrew consent|0|||
105576060|NCT01146574|364108428|FG001|Overall Study|Withdrew consent|0|||
105576061|NCT01146574|364108429|FG002|Overall Study|Withdrew consent|1|||
105576062|NCT01146574|364108430|FG003|Overall Study|Withdrew consent|1|||
105576063|NCT01146574|364108431|FG004|Overall Study|Withdrew consent|2|||
105576064|NCT01146574|364108432|FG005|Overall Study|Withdrew consent|1|||
105576065|NCT01146574|364108433|FG006|Overall Study|Withdrew consent|1|||
105576066|NCT01076088|364108436|FG000|Overall Study|Adverse Event|1|||
105576067|NCT01076088|364108437|FG001|Overall Study|Adverse Event|6|||
105576068|NCT01076088|364108438|FG002|Overall Study|Adverse Event|3|||
105576069|NCT01076088|364108439|FG003|Overall Study|Adverse Event|2|||
105576070|NCT01076088|364108440|FG004|Overall Study|Adverse Event|3|||
105576071|NCT01076088|364108441|FG005|Overall Study|Adverse Event|3|||
105576072|NCT01076088|364108436|FG000|Overall Study|Lost to Follow-up|1|||
105576073|NCT01076088|364108437|FG001|Overall Study|Lost to Follow-up|1|||
105576074|NCT01076088|364108438|FG002|Overall Study|Lost to Follow-up|0|||
105576075|NCT01076088|364108439|FG003|Overall Study|Lost to Follow-up|1|||
105576076|NCT01076088|364108440|FG004|Overall Study|Lost to Follow-up|1|||
105576077|NCT01076088|364108441|FG005|Overall Study|Lost to Follow-up|2|||
105576078|NCT01076088|364108436|FG000|Overall Study|Non-compliance with study drug|0|||
105576079|NCT01076088|364108437|FG001|Overall Study|Non-compliance with study drug|0|||
105576080|NCT01076088|364108438|FG002|Overall Study|Non-compliance with study drug|0|||
105576081|NCT01076088|364108439|FG003|Overall Study|Non-compliance with study drug|1|||
105576082|NCT01076088|364108440|FG004|Overall Study|Non-compliance with study drug|0|||
105576083|NCT01076088|364108441|FG005|Overall Study|Non-compliance with study drug|0|||
105576084|NCT01076088|364108436|FG000|Overall Study|Physician Decision|1|||
105310219|NCT00554606|363132512|FG000|Overall Study|Abnormal laboratory values|1|||
105576085|NCT01076088|364108437|FG001|Overall Study|Physician Decision|3|||
105310220|NCT00554606|363132512|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
105310221|NCT00554606|363132512|FG000|Overall Study|Subject withdrew consent|2|||
105576086|NCT01076088|364108438|FG002|Overall Study|Physician Decision|0|||
105576087|NCT01076088|364108439|FG003|Overall Study|Physician Decision|1|||
105576088|NCT01076088|364108440|FG004|Overall Study|Physician Decision|1|||
105310222|NCT00554606|363132512|FG000|Overall Study|Lost to Follow-up|2|||
105310223|NCT00554606|363132512|FG000|Overall Study|Administrative problems|60|||
105576089|NCT01076088|364108441|FG005|Overall Study|Physician Decision|0|||
105576090|NCT01076088|364108436|FG000|Overall Study|Withdrawal by Subject|8|||
105576091|NCT01076088|364108437|FG001|Overall Study|Withdrawal by Subject|8|||
105576092|NCT01076088|364108438|FG002|Overall Study|Withdrawal by Subject|14|||
105576093|NCT01076088|364108439|FG003|Overall Study|Withdrawal by Subject|10|||
105576094|NCT01076088|364108440|FG004|Overall Study|Withdrawal by Subject|11|||
105576095|NCT01076088|364108441|FG005|Overall Study|Withdrawal by Subject|17|||
105576096|NCT01076088|364108436|FG000|Overall Study|Other protocol specified criteria|0|||
105576097|NCT01076088|364108437|FG001|Overall Study|Other protocol specified criteria|0|||
105576098|NCT01076088|364108438|FG002|Overall Study|Other protocol specified criteria|0|||
105576099|NCT01076088|364108439|FG003|Overall Study|Other protocol specified criteria|0|||
105576100|NCT01076088|364108440|FG004|Overall Study|Other protocol specified criteria|0|||
105576101|NCT01076088|364108441|FG005|Overall Study|Other protocol specified criteria|1|||
105576102|NCT00786474|364108442|FG000|Overall Study|Death|5|||
105576103|NCT00786474|364108443|FG001|Overall Study|Death|4|||
105576104|NCT00786474|364108442|FG000|Overall Study|Withdrawal by Subject|23|||
105576105|NCT00786474|364108443|FG001|Overall Study|Withdrawal by Subject|31|||
105576106|NCT00786474|364108442|FG000|Overall Study|Lost to Follow-up|3|||
105576107|NCT00786474|364108443|FG001|Overall Study|Lost to Follow-up|3|||
105576108|NCT00786474|364108442|FG000|Overall Study|Physician Decision|2|||
105576109|NCT00786474|364108443|FG001|Overall Study|Physician Decision|1|||
105576110|NCT00786474|364108442|FG000|Overall Study|Other|4|||
105576111|NCT00786474|364108443|FG001|Overall Study|Other|4|||
105576112|NCT03053492|364108444|FG000|Overall Study|Adverse Event|1|||
105576113|NCT03053492|364108445|FG001|Overall Study|Adverse Event|1|||
105576114|NCT03053492|364108444|FG000|Overall Study|Withdrawal by Subject|7|||
105576115|NCT03053492|364108445|FG001|Overall Study|Withdrawal by Subject|5|||
105576116|NCT01868074|364108446|FG000|Overall Study|Lost to Follow-up|3|||
105576117|NCT01868074|364108447|FG001|Overall Study|Lost to Follow-up|2|||
105576118|NCT01868074|364108446|FG000|Overall Study|Withdrawal by Subject|4|||
105576119|NCT01868074|364108447|FG001|Overall Study|Withdrawal by Subject|2|||
105576120|NCT03306043|364108448|FG000|Overall Study|Adverse Event|1|||
105576121|NCT03306043|364108448|FG000|Overall Study|Lost to Follow-up|1|||
105576122|NCT03306043|364108448|FG000|Overall Study|Withdrawal by Subject|2|||
105576123|NCT01799720|364108449|FG000|Overall Study|Withdrawal by Subject|3|||
105576124|NCT01799720|364108450|FG001|Overall Study|Withdrawal by Subject|0|||
105576125|NCT01799720|364108451|FG002|Overall Study|Withdrawal by Subject|0|||
105576126|NCT01799720|364108449|FG000|Overall Study|Protocol Violation|0|||
105576127|NCT01799720|364108450|FG001|Overall Study|Protocol Violation|1|||
105576128|NCT01799720|364108451|FG002|Overall Study|Protocol Violation|0|||
105576129|NCT01799720|364108449|FG000|Overall Study|Pregnancy|0|||
105576130|NCT01799720|364108450|FG001|Overall Study|Pregnancy|0|||
105576131|NCT01799720|364108451|FG002|Overall Study|Pregnancy|1|||
105576132|NCT04642469|364108456|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
105576133|NCT04642469|364108457|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
105576134|NCT04642469|364108456|FG000|Overall Study|Death|1|||
105576135|NCT04642469|364108457|FG001|Overall Study|Death|2|||
105576136|NCT04642469|364108456|FG000|Overall Study|Study/site closed following amendment 1|11|||
105576137|NCT04642469|364108457|FG001|Overall Study|Study/site closed following amendment 1|11|||
105576138|NCT04642469|364108456|FG000|Overall Study|Other|1|||
105576139|NCT04642469|364108457|FG001|Overall Study|Other|1|||
105576140|NCT04642469|364108456|FG000|Overall Study|Withdrawal by Subject|1|||
105576141|NCT04642469|364108457|FG001|Overall Study|Withdrawal by Subject|0|||
105576142|NCT00680056|364108459|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
105576143|NCT00680056|364108460|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
105576144|NCT00680056|364108459|FG000|Second Intervention|Protocol Violation|3|||
105576145|NCT00680056|364108460|FG001|Second Intervention|Protocol Violation|1|||
105576146|NCT02733042|364108466|FG000|Overall Study|Adverse Event|1|||
105576147|NCT02733042|364108467|FG001|Overall Study|Adverse Event|0|||
105576148|NCT02733042|364108468|FG002|Overall Study|Adverse Event|1|||
105576149|NCT02733042|364108469|FG003|Overall Study|Adverse Event|1|||
105576150|NCT02733042|364108470|FG004|Overall Study|Adverse Event|0|||
105576151|NCT02733042|364108471|FG005|Overall Study|Adverse Event|0|||
105576152|NCT02733042|364108472|FG006|Overall Study|Adverse Event|0|||
105576153|NCT02733042|364108473|FG007|Overall Study|Adverse Event|0|||
105576154|NCT02733042|364108474|FG008|Overall Study|Adverse Event|0|||
105576155|NCT02733042|364108475|FG009|Overall Study|Adverse Event|0|||
105576156|NCT02733042|364108476|FG010|Overall Study|Adverse Event|2|||
105576157|NCT02733042|364108477|FG011|Overall Study|Adverse Event|2|||
105576158|NCT02733042|364108478|FG012|Overall Study|Adverse Event|0|||
105576159|NCT02733042|364108479|FG013|Overall Study|Adverse Event|2|||
105576160|NCT02733042|364108480|FG014|Overall Study|Adverse Event|0|||
105576161|NCT02733042|364108481|FG015|Overall Study|Adverse Event|0|||
105576162|NCT02733042|364108482|FG016|Overall Study|Adverse Event|0|||
105367155|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
105576163|NCT02733042|364108483|FG017|Overall Study|Adverse Event|1|||
105576164|NCT02733042|364108484|FG018|Overall Study|Adverse Event|0|||
105576165|NCT02733042|364108466|FG000|Overall Study|Progressive Disease|2|||
105576166|NCT02733042|364108467|FG001|Overall Study|Progressive Disease|1|||
105576167|NCT02733042|364108468|FG002|Overall Study|Progressive Disease|3|||
105576168|NCT02733042|364108469|FG003|Overall Study|Progressive Disease|1|||
105576169|NCT02733042|364108470|FG004|Overall Study|Progressive Disease|2|||
105576170|NCT02733042|364108471|FG005|Overall Study|Progressive Disease|3|||
105576171|NCT02733042|364108472|FG006|Overall Study|Progressive Disease|0|||
105576172|NCT02733042|364108473|FG007|Overall Study|Progressive Disease|3|||
105576173|NCT02733042|364108474|FG008|Overall Study|Progressive Disease|3|||
105576174|NCT02733042|364108475|FG009|Overall Study|Progressive Disease|2|||
105576175|NCT02733042|364108476|FG010|Overall Study|Progressive Disease|2|||
105576176|NCT02733042|364108477|FG011|Overall Study|Progressive Disease|2|||
105576177|NCT02733042|364108478|FG012|Overall Study|Progressive Disease|8|||
105576178|NCT02733042|364108479|FG013|Overall Study|Progressive Disease|1|||
105576179|NCT02733042|364108480|FG014|Overall Study|Progressive Disease|4|||
105576180|NCT02733042|364108481|FG015|Overall Study|Progressive Disease|7|||
105576181|NCT02733042|364108482|FG016|Overall Study|Progressive Disease|2|||
105576182|NCT02733042|364108483|FG017|Overall Study|Progressive Disease|3|||
105576183|NCT02733042|364108484|FG018|Overall Study|Progressive Disease|4|||
105576184|NCT02733042|364108466|FG000|Overall Study|Withdrawal by Subject|0|||
105576185|NCT02733042|364108467|FG001|Overall Study|Withdrawal by Subject|1|||
105576186|NCT02733042|364108468|FG002|Overall Study|Withdrawal by Subject|2|||
105576187|NCT02733042|364108469|FG003|Overall Study|Withdrawal by Subject|1|||
105576188|NCT02733042|364108470|FG004|Overall Study|Withdrawal by Subject|1|||
105576189|NCT02733042|364108471|FG005|Overall Study|Withdrawal by Subject|0|||
105576190|NCT02733042|364108472|FG006|Overall Study|Withdrawal by Subject|0|||
105576191|NCT02733042|364108473|FG007|Overall Study|Withdrawal by Subject|0|||
105576192|NCT02733042|364108474|FG008|Overall Study|Withdrawal by Subject|1|||
105834366|NCT03243396|365050216|FG002|Overall Study|Lost to Follow-up|15|||
105834367|NCT03243396|365050217|FG003|Overall Study|Lost to Follow-up|8|||
105367156|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
105367157|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
105367158|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
105367159|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
105367160|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
105367161|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
105367162|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
105367163|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
105367164|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
105367165|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
105367166|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
105367167|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
105367168|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
105367169|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
105367170|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
105367171|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
105367172|NCT02717195|363350153|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
105367173|NCT02717195|363350154|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
105367174|NCT02717195|363350155|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
105367175|NCT02717195|363350156|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
105367176|NCT02717195|363350157|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
105367177|NCT02717195|363350153|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
105367178|NCT02717195|363350154|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
105367179|NCT02717195|363350155|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
105367180|NCT02717195|363350156|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
105367181|NCT02717195|363350157|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
105367182|NCT02717195|363350153|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
105367183|NCT02717195|363350154|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
105367184|NCT02717195|363350155|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
105367185|NCT02717195|363350156|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
105367186|NCT02717195|363350157|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
105367187|NCT02717195|363350153|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
105367188|NCT02717195|363350154|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
105367189|NCT02717195|363350155|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
105367190|NCT02717195|363350156|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
105576193|NCT02733042|364108475|FG009|Overall Study|Withdrawal by Subject|1|||
105576194|NCT02733042|364108476|FG010|Overall Study|Withdrawal by Subject|0|||
105576195|NCT02733042|364108477|FG011|Overall Study|Withdrawal by Subject|2|||
105576196|NCT02733042|364108478|FG012|Overall Study|Withdrawal by Subject|1|||
105834368|NCT03243396|365050218|FG004|Overall Study|Lost to Follow-up|1|||
105834369|NCT03243396|365050219|FG005|Overall Study|Lost to Follow-up|4|||
105834370|NCT03243396|365050220|FG006|Overall Study|Lost to Follow-up|9|||
105834371|NCT03687242|365050221|FG000|Overall Study|Adverse Event|1|||
105834372|NCT00377156|365050224|FG000|Overall Study|Death|23|||
105834373|NCT00377156|365050225|FG001|Overall Study|Death|19|||
105834374|NCT00377156|365050224|FG000|Overall Study|Withdrawal by Subject|16|||
105834375|NCT00377156|365050225|FG001|Overall Study|Withdrawal by Subject|24|||
105834376|NCT00377156|365050224|FG000|Overall Study|Had follow-up <90 d|3|||
105576197|NCT02733042|364108479|FG013|Overall Study|Withdrawal by Subject|1|||
105834377|NCT00377156|365050225|FG001|Overall Study|Had follow-up <90 d|6|||
105834378|NCT00377156|365050224|FG000|Overall Study|Cancellation|1|||
105834379|NCT00377156|365050225|FG001|Overall Study|Cancellation|0|||
105576198|NCT02733042|364108480|FG014|Overall Study|Withdrawal by Subject|0|||
105576199|NCT02733042|364108481|FG015|Overall Study|Withdrawal by Subject|0|||
105576200|NCT02733042|364108482|FG016|Overall Study|Withdrawal by Subject|0|||
105576201|NCT02733042|364108483|FG017|Overall Study|Withdrawal by Subject|0|||
105576202|NCT02733042|364108484|FG018|Overall Study|Withdrawal by Subject|0|||
105576203|NCT02733042|364108466|FG000|Overall Study|Other Reasons|0|||
105576204|NCT02733042|364108467|FG001|Overall Study|Other Reasons|0|||
105576205|NCT02733042|364108468|FG002|Overall Study|Other Reasons|1|||
105576206|NCT02733042|364108469|FG003|Overall Study|Other Reasons|0|||
105576207|NCT02733042|364108470|FG004|Overall Study|Other Reasons|0|||
105576208|NCT02733042|364108471|FG005|Overall Study|Other Reasons|0|||
105576209|NCT02733042|364108472|FG006|Overall Study|Other Reasons|0|||
105576210|NCT02733042|364108473|FG007|Overall Study|Other Reasons|0|||
105576211|NCT02733042|364108474|FG008|Overall Study|Other Reasons|0|||
105576212|NCT02733042|364108475|FG009|Overall Study|Other Reasons|1|||
105576213|NCT02733042|364108476|FG010|Overall Study|Other Reasons|1|||
105576214|NCT02733042|364108477|FG011|Overall Study|Other Reasons|0|||
105576215|NCT02733042|364108478|FG012|Overall Study|Other Reasons|0|||
105576216|NCT02733042|364108479|FG013|Overall Study|Other Reasons|0|||
105576217|NCT02733042|364108480|FG014|Overall Study|Other Reasons|0|||
105576218|NCT02733042|364108481|FG015|Overall Study|Other Reasons|1|||
105576219|NCT02733042|364108482|FG016|Overall Study|Other Reasons|0|||
105576220|NCT02733042|364108483|FG017|Overall Study|Other Reasons|1|||
105576221|NCT02733042|364108484|FG018|Overall Study|Other Reasons|0|||
105576222|NCT02733042|364108466|FG000|Overall Study|Death|0|||
105576223|NCT02733042|364108467|FG001|Overall Study|Death|0|||
105576224|NCT02733042|364108468|FG002|Overall Study|Death|0|||
105576225|NCT02733042|364108469|FG003|Overall Study|Death|0|||
105576226|NCT02733042|364108470|FG004|Overall Study|Death|0|||
105576227|NCT02733042|364108471|FG005|Overall Study|Death|0|||
105576228|NCT02733042|364108472|FG006|Overall Study|Death|1|||
105576229|NCT02733042|364108473|FG007|Overall Study|Death|0|||
105576230|NCT02733042|364108474|FG008|Overall Study|Death|1|||
105576231|NCT02733042|364108475|FG009|Overall Study|Death|0|||
105576232|NCT02733042|364108476|FG010|Overall Study|Death|1|||
105576233|NCT02733042|364108477|FG011|Overall Study|Death|0|||
105576234|NCT02733042|364108478|FG012|Overall Study|Death|0|||
105576235|NCT02733042|364108479|FG013|Overall Study|Death|0|||
105576236|NCT02733042|364108480|FG014|Overall Study|Death|1|||
105576237|NCT02733042|364108481|FG015|Overall Study|Death|2|||
105576238|NCT02733042|364108482|FG016|Overall Study|Death|0|||
105576239|NCT02733042|364108483|FG017|Overall Study|Death|0|||
105576240|NCT02733042|364108484|FG018|Overall Study|Death|0|||
105576241|NCT02838628|364108486|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
105576242|NCT02838628|364108487|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
105576243|NCT02838628|364108486|FG000|Recurrence Follow-up Period|Adverse Event|1|||
105576244|NCT02838628|364108487|FG001|Recurrence Follow-up Period|Adverse Event|0|||
105576245|NCT02838628|364108486|FG000|Recurrence Follow-up Period|Non-compliance|0|||
105576246|NCT02838628|364108487|FG001|Recurrence Follow-up Period|Non-compliance|1|||
105576247|NCT02838628|364108486|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
105576248|NCT02838628|364108487|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
105576249|NCT02838628|364108486|FG000|Recurrence Follow-up Period|Other un-specified|1|||
105576250|NCT02838628|364108487|FG001|Recurrence Follow-up Period|Other un-specified|1|||
105576251|NCT02397460|364108488|FG000|Treatment Period 2|Adverse Event|0|||
105576252|NCT02397460|364108489|FG001|Treatment Period 2|Adverse Event|0|||
105576253|NCT02397460|364108490|FG002|Treatment Period 2|Adverse Event|0|||
105576254|NCT02397460|364108491|FG003|Treatment Period 2|Adverse Event|0|||
105576255|NCT02397460|364108492|FG004|Treatment Period 2|Adverse Event|0|||
105576256|NCT02397460|364108493|FG005|Treatment Period 2|Adverse Event|0|||
105576257|NCT02397460|364108494|FG006|Treatment Period 2|Adverse Event|0|||
105576258|NCT02397460|364108495|FG007|Treatment Period 2|Adverse Event|1|||
105576259|NCT02397460|364108488|FG000|Treatment Period 4|Adverse Event|0|||
105576260|NCT02397460|364108489|FG001|Treatment Period 4|Adverse Event|1|||
105576261|NCT02397460|364108490|FG002|Treatment Period 4|Adverse Event|0|||
105834380|NCT00377156|365050224|FG000|Overall Study|Refused testing|0|||
105310224|NCT00554606|363132512|FG000|Overall Study|Death|1|||
105310225|NCT00554606|363132512|FG000|Overall Study|Protocol deviation|2|||
105310226|NCT00123474|363132513|FG000|Randomized to Treatment|Randomized, never treated|1|||
105310227|NCT00123474|363132514|FG001|Randomized to Treatment|Randomized, never treated|4|||
105310228|NCT00123474|363132515|FG002|Randomized to Treatment|Randomized, never treated|2|||
105576262|NCT02397460|364108491|FG003|Treatment Period 4|Adverse Event|0|||
105576263|NCT02397460|364108492|FG004|Treatment Period 4|Adverse Event|0|||
105576264|NCT02397460|364108493|FG005|Treatment Period 4|Adverse Event|0|||
105576265|NCT02397460|364108494|FG006|Treatment Period 4|Adverse Event|0|||
105576266|NCT02397460|364108495|FG007|Treatment Period 4|Adverse Event|0|||
105310229|NCT00123474|363132516|FG003|Randomized to Treatment|Randomized, never treated|1|||
105576267|NCT02397460|364108488|FG000|Treatment Period 4|Physician Decision|0|||
105576268|NCT02397460|364108489|FG001|Treatment Period 4|Physician Decision|0|||
105576269|NCT02397460|364108490|FG002|Treatment Period 4|Physician Decision|0|||
105576270|NCT02397460|364108491|FG003|Treatment Period 4|Physician Decision|0|||
105576271|NCT02397460|364108492|FG004|Treatment Period 4|Physician Decision|1|||
105576272|NCT02397460|364108493|FG005|Treatment Period 4|Physician Decision|0|||
105576273|NCT02397460|364108494|FG006|Treatment Period 4|Physician Decision|0|||
105576274|NCT02397460|364108495|FG007|Treatment Period 4|Physician Decision|0|||
105576275|NCT02066532|364108498|FG000|Phase II|Withdrawal by Subject|1|||
105576276|NCT02066532|364108499|FG001|Phase II|Withdrawal by Subject|0|||
105576277|NCT02066532|364108500|FG002|Phase II|Withdrawal by Subject|0|||
105576278|NCT02066532|364108501|FG003|Phase II|Withdrawal by Subject|0|||
105576279|NCT05033080|364108502|FG000|Overall Study|Adverse Event|4|||
105576280|NCT05033080|364108503|FG001|Overall Study|Adverse Event|4|||
105576281|NCT05033080|364108502|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
105576282|NCT05033080|364108503|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
105576283|NCT05033080|364108502|FG000|Overall Study|Lost to Follow-up|1|||
105576284|NCT05033080|364108503|FG001|Overall Study|Lost to Follow-up|0|||
105576285|NCT05033080|364108502|FG000|Overall Study|Other non-compliance|0|||
105576286|NCT05033080|364108503|FG001|Overall Study|Other non-compliance|1|||
105576287|NCT05033080|364108502|FG000|Overall Study|Physician Decision|0|||
105576288|NCT05033080|364108503|FG001|Overall Study|Physician Decision|1|||
105576289|NCT05033080|364108502|FG000|Overall Study|Other|1|||
105576290|NCT05033080|364108503|FG001|Overall Study|Other|1|||
105576291|NCT02584855|364108512|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
105576292|NCT02584855|364108513|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
105576293|NCT02584855|364108514|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
105576294|NCT02584855|364108515|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
105576295|NCT02584855|364108516|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
105576296|NCT02584855|364108517|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
105576297|NCT02584855|364108512|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
105576298|NCT02584855|364108513|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
105576299|NCT02584855|364108514|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
105576300|NCT02584855|364108515|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
105576301|NCT02584855|364108516|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
105576302|NCT02584855|364108517|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
105576303|NCT02584855|364108512|FG000|Open-Label Treatment Period|Adverse Event|14|||
105576304|NCT02584855|364108513|FG001|Open-Label Treatment Period|Adverse Event|0|||
105576305|NCT02584855|364108514|FG002|Open-Label Treatment Period|Adverse Event|0|||
105576306|NCT02584855|364108515|FG003|Open-Label Treatment Period|Adverse Event|0|||
105576307|NCT02584855|364108516|FG004|Open-Label Treatment Period|Adverse Event|0|||
105576308|NCT02584855|364108517|FG005|Open-Label Treatment Period|Adverse Event|0|||
105576309|NCT02584855|364108512|FG000|Open-Label Treatment Period|Death|2|||
105576310|NCT02584855|364108513|FG001|Open-Label Treatment Period|Death|0|||
105576311|NCT02584855|364108514|FG002|Open-Label Treatment Period|Death|0|||
105576312|NCT02584855|364108515|FG003|Open-Label Treatment Period|Death|0|||
105576313|NCT02584855|364108516|FG004|Open-Label Treatment Period|Death|0|||
105576314|NCT02584855|364108517|FG005|Open-Label Treatment Period|Death|0|||
105576315|NCT02584855|364108512|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
105576316|NCT02584855|364108513|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
105576317|NCT02584855|364108514|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
105576318|NCT02584855|364108515|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
105576319|NCT02584855|364108516|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
105576320|NCT02584855|364108517|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
105576321|NCT02584855|364108512|FG000|Open-Label Treatment Period|Protocol Violation|1|||
105576322|NCT02584855|364108513|FG001|Open-Label Treatment Period|Protocol Violation|0|||
105576323|NCT02584855|364108514|FG002|Open-Label Treatment Period|Protocol Violation|0|||
105576324|NCT02584855|364108515|FG003|Open-Label Treatment Period|Protocol Violation|0|||
105576325|NCT02584855|364108516|FG004|Open-Label Treatment Period|Protocol Violation|0|||
105576326|NCT02584855|364108517|FG005|Open-Label Treatment Period|Protocol Violation|0|||
105576327|NCT02584855|364108512|FG000|Open-Label Treatment Period|No PI Available|2|||
105576328|NCT02584855|364108513|FG001|Open-Label Treatment Period|No PI Available|0|||
105576329|NCT02584855|364108514|FG002|Open-Label Treatment Period|No PI Available|0|||
105576330|NCT02584855|364108515|FG003|Open-Label Treatment Period|No PI Available|0|||
105576331|NCT02584855|364108516|FG004|Open-Label Treatment Period|No PI Available|0|||
105576332|NCT02584855|364108517|FG005|Open-Label Treatment Period|No PI Available|0|||
105576333|NCT02584855|364108512|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
105576334|NCT02584855|364108513|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
105576335|NCT02584855|364108514|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
105576336|NCT02584855|364108515|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
105576337|NCT02584855|364108516|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
105576338|NCT02584855|364108517|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
105576339|NCT02584855|364108512|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
105576340|NCT02584855|364108513|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
105576341|NCT02584855|364108514|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
105576342|NCT02584855|364108515|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
105834381|NCT00377156|365050225|FG001|Overall Study|Refused testing|1|||
105576343|NCT02584855|364108516|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
105576344|NCT02584855|364108517|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
105576345|NCT02584855|364108512|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
105576346|NCT02584855|364108513|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
105576347|NCT02584855|364108514|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
105576348|NCT02584855|364108515|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
105576349|NCT02584855|364108516|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
105576350|NCT02584855|364108517|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
105576351|NCT02584855|364108512|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
105576352|NCT02584855|364108513|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
105576353|NCT02584855|364108514|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
105576354|NCT02584855|364108515|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
105576355|NCT02584855|364108516|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
105576356|NCT02584855|364108517|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
105576357|NCT02584855|364108512|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
105576358|NCT02584855|364108513|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
105576359|NCT02584855|364108514|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
105576360|NCT02584855|364108515|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
105576361|NCT02584855|364108516|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
105576362|NCT02584855|364108517|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
105576363|NCT02584855|364108512|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
105576364|NCT02584855|364108513|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
105576365|NCT02584855|364108514|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
105576366|NCT02584855|364108515|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
105576367|NCT02584855|364108516|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
105576368|NCT02584855|364108517|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
105576369|NCT02584855|364108512|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
105576370|NCT02584855|364108513|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
105576371|NCT02584855|364108514|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
105576372|NCT02584855|364108515|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
105576373|NCT02584855|364108516|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
105576374|NCT02584855|364108517|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
105576375|NCT02262260|364108522|FG000|Overall Study|Adverse Event|4|||
105576376|NCT02262260|364108523|FG001|Overall Study|Adverse Event|1|||
105576377|NCT02262260|364108522|FG000|Overall Study|Withdrawal of consent|4|||
105576378|NCT02262260|364108523|FG001|Overall Study|Withdrawal of consent|2|||
105576379|NCT02262260|364108522|FG000|Overall Study|Lost to Follow-up|1|||
105576380|NCT02262260|364108523|FG001|Overall Study|Lost to Follow-up|2|||
105576381|NCT02262260|364108522|FG000|Overall Study|Protocol deviation|2|||
105576382|NCT02262260|364108523|FG001|Overall Study|Protocol deviation|5|||
105576383|NCT01794117|364108524|FG000|Overall Study|Adverse Event|1|||
105576384|NCT01794117|364108525|FG001|Overall Study|Adverse Event|0|||
105576385|NCT01794117|364108526|FG002|Overall Study|Adverse Event|0|||
105576386|NCT01794117|364108527|FG003|Overall Study|Adverse Event|0|||
105576387|NCT01794117|364108524|FG000|Overall Study|Participant noncompliance|0|||
105576388|NCT01794117|364108525|FG001|Overall Study|Participant noncompliance|1|||
105576389|NCT01794117|364108526|FG002|Overall Study|Participant noncompliance|0|||
105576390|NCT01794117|364108527|FG003|Overall Study|Participant noncompliance|0|||
105576391|NCT01794117|364108524|FG000|Overall Study|Refused further treatment|0|||
105576392|NCT01794117|364108525|FG001|Overall Study|Refused further treatment|2|||
105576393|NCT01794117|364108526|FG002|Overall Study|Refused further treatment|0|||
105576394|NCT01794117|364108527|FG003|Overall Study|Refused further treatment|0|||
105576395|NCT01078662|364108532|FG000|Overall Study|Death|41|||
105576396|NCT01078662|364108533|FG001|Overall Study|Death|103|||
105576397|NCT01078662|364108534|FG002|Overall Study|Death|18|||
105576398|NCT01078662|364108535|FG003|Overall Study|Death|5|||
105576399|NCT01078662|364108536|FG004|Overall Study|Death|8|||
105576400|NCT01078662|364108532|FG000|Overall Study|Patients reached data cut-off|12|||
105576401|NCT01078662|364108533|FG001|Overall Study|Patients reached data cut-off|53|||
105576402|NCT01078662|364108534|FG002|Overall Study|Patients reached data cut-off|2|||
105576403|NCT01078662|364108535|FG003|Overall Study|Patients reached data cut-off|2|||
105576404|NCT01078662|364108536|FG004|Overall Study|Patients reached data cut-off|3|||
105576405|NCT01078662|364108532|FG000|Overall Study|Withdrawal by Subject|4|||
105576406|NCT01078662|364108533|FG001|Overall Study|Withdrawal by Subject|11|||
105576407|NCT01078662|364108534|FG002|Overall Study|Withdrawal by Subject|1|||
105310230|NCT00123474|363132513|FG000|As Treated at Study Closure|not reported when site closed|1|||
105310231|NCT00123474|363132514|FG001|As Treated at Study Closure|not reported when site closed|0|||
105310232|NCT00123474|363132515|FG002|As Treated at Study Closure|not reported when site closed|1|||
105310233|NCT00123474|363132516|FG003|As Treated at Study Closure|not reported when site closed|0|||
105310234|NCT00123474|363132513|FG000|As Treated at Study Closure|Adverse Event|10|||
105310235|NCT00123474|363132514|FG001|As Treated at Study Closure|Adverse Event|4|||
105310236|NCT00123474|363132515|FG002|As Treated at Study Closure|Adverse Event|10|||
105310237|NCT00123474|363132516|FG003|As Treated at Study Closure|Adverse Event|8|||
105310238|NCT00123474|363132513|FG000|As Treated at Study Closure|Disease Progression|35|||
105310239|NCT00123474|363132514|FG001|As Treated at Study Closure|Disease Progression|42|||
105310240|NCT00123474|363132515|FG002|As Treated at Study Closure|Disease Progression|29|||
105310241|NCT00123474|363132516|FG003|As Treated at Study Closure|Disease Progression|27|||
105310242|NCT00123474|363132513|FG000|As Treated at Study Closure|Investigator Request|12|||
105310243|NCT00123474|363132514|FG001|As Treated at Study Closure|Investigator Request|6|||
105310244|NCT00123474|363132515|FG002|As Treated at Study Closure|Investigator Request|7|||
105310245|NCT00123474|363132516|FG003|As Treated at Study Closure|Investigator Request|5|||
105310246|NCT00123474|363132513|FG000|As Treated at Study Closure|non-specified|54|||
105310247|NCT00123474|363132514|FG001|As Treated at Study Closure|non-specified|47|||
105310248|NCT00123474|363132515|FG002|As Treated at Study Closure|non-specified|57|||
105310249|NCT00123474|363132516|FG003|As Treated at Study Closure|non-specified|60|||
105310250|NCT00123474|363132513|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
105310251|NCT00123474|363132514|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
105310252|NCT00123474|363132515|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
105310253|NCT00123474|363132516|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
105310254|NCT00123474|363132513|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
105310255|NCT00123474|363132514|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
105310256|NCT00123474|363132515|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
105310257|NCT00123474|363132516|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
105310258|NCT00616629|363132517|FG000|Overall Study|Protocol Violation|1|||
105310259|NCT00616629|363132518|FG001|Overall Study|Protocol Violation|2|||
105310260|NCT00616629|363132519|FG002|Overall Study|Protocol Violation|1|||
105310261|NCT00616629|363132520|FG003|Overall Study|Protocol Violation|0|||
105310262|NCT00616629|363132521|FG004|Overall Study|Protocol Violation|0|||
105310263|NCT00616629|363132517|FG000|Overall Study|AV-block|1|||
105310264|NCT00616629|363132518|FG001|Overall Study|AV-block|0|||
105310265|NCT00616629|363132519|FG002|Overall Study|AV-block|0|||
105310266|NCT00616629|363132520|FG003|Overall Study|AV-block|0|||
105310267|NCT00616629|363132521|FG004|Overall Study|AV-block|0|||
105310268|NCT01059344|363132522|FG000|Overall Study|Adverse Event|12|||
105310269|NCT01059344|363132523|FG001|Overall Study|Adverse Event|30|||
105310270|NCT01059344|363132522|FG000|Overall Study|Withdrawal by Subject|6|||
105310271|NCT01059344|363132523|FG001|Overall Study|Withdrawal by Subject|9|||
105310272|NCT01059344|363132522|FG000|Overall Study|Lost to Follow-up|1|||
105310273|NCT01059344|363132523|FG001|Overall Study|Lost to Follow-up|1|||
105310274|NCT01059344|363132522|FG000|Overall Study|Other|3|||
105310275|NCT01059344|363132523|FG001|Overall Study|Other|6|||
105310276|NCT00492024|363132530|FG000|Treatment|Adverse Event|3|||
105310277|NCT00492024|363132531|FG001|Treatment|Adverse Event|1|||
105310278|NCT00492024|363132530|FG000|Treatment|Lack of Efficacy|21|||
105310279|NCT00492024|363132531|FG001|Treatment|Lack of Efficacy|20|||
105310280|NCT00492024|363132530|FG000|Treatment|Lost to Follow-up|3|||
105310281|NCT00492024|363132531|FG001|Treatment|Lost to Follow-up|1|||
105310282|NCT00492024|363132530|FG000|Treatment|Withdrawal by Subject|2|||
105310283|NCT00492024|363132531|FG001|Treatment|Withdrawal by Subject|0|||
105310284|NCT00492024|363132530|FG000|Follow up|Lack of Efficacy|0|||
105310285|NCT00492024|363132531|FG001|Follow up|Lack of Efficacy|1|||
105310286|NCT00492024|363132530|FG000|Follow up|Lost to Follow-up|1|||
105310287|NCT00492024|363132531|FG001|Follow up|Lost to Follow-up|1|||
105310288|NCT00678886|363132534|FG000|Overall Study|Withdrawal by Subject|0|||
105310289|NCT00678886|363132535|FG001|Overall Study|Withdrawal by Subject|0|||
105310290|NCT00678886|363132536|FG002|Overall Study|Withdrawal by Subject|4|||
105310291|NCT00678886|363132537|FG003|Overall Study|Withdrawal by Subject|6|||
105310292|NCT00678886|363132534|FG000|Overall Study|Physician Decision|0|||
105310293|NCT00678886|363132535|FG001|Overall Study|Physician Decision|0|||
105310294|NCT00678886|363132536|FG002|Overall Study|Physician Decision|1|||
105310295|NCT00678886|363132537|FG003|Overall Study|Physician Decision|1|||
105310296|NCT00678886|363132534|FG000|Overall Study|Lost to Follow-up|0|||
105367191|NCT02717195|363350157|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
105367192|NCT02717195|363350153|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
105367193|NCT02717195|363350154|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
105367194|NCT02717195|363350155|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
105310297|NCT00678886|363132535|FG001|Overall Study|Lost to Follow-up|0|||
105310298|NCT00678886|363132536|FG002|Overall Study|Lost to Follow-up|3|||
105310299|NCT00678886|363132537|FG003|Overall Study|Lost to Follow-up|2|||
105310300|NCT00678886|363132534|FG000|Overall Study|Other|0|||
105310301|NCT00678886|363132535|FG001|Overall Study|Other|0|||
105310302|NCT00678886|363132536|FG002|Overall Study|Other|1|||
105310303|NCT00678886|363132537|FG003|Overall Study|Other|0|||
105310304|NCT00206323|363132538|FG000|Overall Study|Lack of Efficacy|4|||
105310305|NCT00206323|363132539|FG001|Overall Study|Lack of Efficacy|1|||
105834382|NCT00377156|365050224|FG000|Overall Study|Ineligible|0|||
105310306|NCT00206323|363132538|FG000|Overall Study|Adverse Event|1|||
105310307|NCT00206323|363132539|FG001|Overall Study|Adverse Event|1|||
105310308|NCT00206323|363132538|FG000|Overall Study|Lost to Follow-up|1|||
105576408|NCT01078662|364108535|FG003|Overall Study|Withdrawal by Subject|0|||
105576409|NCT01078662|364108536|FG004|Overall Study|Withdrawal by Subject|0|||
105576410|NCT01078662|364108532|FG000|Overall Study|Protocol Violation|0|||
105576411|NCT01078662|364108533|FG001|Overall Study|Protocol Violation|1|||
105576412|NCT01078662|364108534|FG002|Overall Study|Protocol Violation|0|||
105576413|NCT01078662|364108535|FG003|Overall Study|Protocol Violation|0|||
105576414|NCT01078662|364108536|FG004|Overall Study|Protocol Violation|0|||
105576415|NCT01078662|364108532|FG000|Overall Study|Lost to Follow-up|1|||
105576416|NCT01078662|364108533|FG001|Overall Study|Lost to Follow-up|0|||
105576417|NCT01078662|364108534|FG002|Overall Study|Lost to Follow-up|0|||
105576418|NCT01078662|364108535|FG003|Overall Study|Lost to Follow-up|0|||
105576419|NCT01078662|364108536|FG004|Overall Study|Lost to Follow-up|0|||
105576420|NCT04157686|364108537|FG000|Overall Study|Adverse Event|1|||
105576421|NCT04157686|364108538|FG001|Overall Study|Adverse Event|0|||
105576422|NCT04157686|364108539|FG002|Overall Study|Adverse Event|1|||
105576423|NCT04157686|364108540|FG003|Overall Study|Adverse Event|0|||
105834383|NCT00377156|365050225|FG001|Overall Study|Ineligible|1|||
105834384|NCT00377156|365050224|FG000|Overall Study|Disability or language problem|0|||
105834385|NCT00377156|365050225|FG001|Overall Study|Disability or language problem|1|||
105834386|NCT00377156|365050224|FG000|Overall Study|Other|5|||
105834387|NCT00377156|365050225|FG001|Overall Study|Other|2|||
105834388|NCT00799708|365050226|FG000|Overall Study|non-compliance|1|||
105834389|NCT00799708|365050227|FG001|Overall Study|non-compliance|0|||
105834390|NCT00799708|365050228|FG002|Overall Study|non-compliance|0|||
105834391|NCT00880334|365050229|FG000|Randomized Phase|Physician Decision|1|||
105834392|NCT00880334|365050230|FG001|Randomized Phase|Physician Decision|0|||
105834393|NCT00880334|365050229|FG000|Randomized Phase|Withdrawal by Subject|2|||
105834394|NCT00880334|365050230|FG001|Randomized Phase|Withdrawal by Subject|1|||
105834395|NCT00880334|365050229|FG000|Randomized Phase|Inadequate Labs|1|||
105834396|NCT00880334|365050230|FG001|Randomized Phase|Inadequate Labs|1|||
105834397|NCT00880334|365050229|FG000|Randomized Phase|Brain Metastasis|0|||
105834398|NCT00880334|365050230|FG001|Randomized Phase|Brain Metastasis|1|||
105834399|NCT00880334|365050229|FG000|Randomized Phase|Crossover Participants|0|||
105834400|NCT00880334|365050230|FG001|Randomized Phase|Crossover Participants|37|||
105834401|NCT03343639|365050231|FG000|Overall Study|Withdrawal by Subject|10|||
105834402|NCT03343639|365050232|FG001|Overall Study|Withdrawal by Subject|6|||
105834403|NCT03343639|365050231|FG000|Overall Study|Lost to Follow-up|4|||
105834404|NCT03343639|365050232|FG001|Overall Study|Lost to Follow-up|5|||
105834405|NCT03343639|365050231|FG000|Overall Study|Protocol Violation|0|||
105834406|NCT03343639|365050232|FG001|Overall Study|Protocol Violation|1|||
105834407|NCT02697617|365050238|FG000|Overall Study|Withdrawal by Subject|0|||
105834408|NCT02697617|365050239|FG001|Overall Study|Withdrawal by Subject|2|||
105834409|NCT02697617|365050238|FG000|Overall Study|Pregnancy|1|||
105834410|NCT02697617|365050239|FG001|Overall Study|Pregnancy|0|||
105834411|NCT02274558|365050242|FG000|Overall Study|Adverse Event|2|||
105834412|NCT02274558|365050243|FG001|Overall Study|Adverse Event|4|||
105834413|NCT02274558|365050244|FG002|Overall Study|Adverse Event|2|||
105310309|NCT00206323|363132539|FG001|Overall Study|Lost to Follow-up|1|||
105310310|NCT02269163|363132543|FG000|Overall Study|Lost to Follow-up|1|||
105310311|NCT02269163|363132544|FG001|Overall Study|Lost to Follow-up|0|||
105310312|NCT02269163|363132543|FG000|Overall Study|Major protocol violation|0|||
105310313|NCT02269163|363132544|FG001|Overall Study|Major protocol violation|1|||
105367195|NCT02717195|363350156|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
105576424|NCT04157686|364108541|FG004|Overall Study|Adverse Event|1|||
105576425|NCT04157686|364108542|FG005|Overall Study|Adverse Event|0|||
105310314|NCT02269163|363132543|FG000|Overall Study|Other|2|||
105310315|NCT02269163|363132544|FG001|Overall Study|Other|2|||
105310316|NCT02269163|363132543|FG000|Overall Study|Withdrawal by Subject|0|||
105310317|NCT02269163|363132544|FG001|Overall Study|Withdrawal by Subject|3|||
105576426|NCT04157686|364108543|FG006|Overall Study|Adverse Event|0|||
105576427|NCT04157686|364108544|FG007|Overall Study|Adverse Event|0|||
105576428|NCT04157686|364108537|FG000|Overall Study|Pregnancy|0|||
105834414|NCT02274558|365050242|FG000|Overall Study|Non-compliance|2|||
105310318|NCT02269163|363132543|FG000|Overall Study|Physician Decision|0|||
105367196|NCT02717195|363350157|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
105576429|NCT04157686|364108538|FG001|Overall Study|Pregnancy|1|||
105576430|NCT04157686|364108539|FG002|Overall Study|Pregnancy|3|||
105576431|NCT04157686|364108540|FG003|Overall Study|Pregnancy|0|||
105834415|NCT02274558|365050243|FG001|Overall Study|Non-compliance|1|||
105834416|NCT02274558|365050244|FG002|Overall Study|Non-compliance|0|||
105834417|NCT02274558|365050242|FG000|Overall Study|Withdrawal by Subject|1|||
105834418|NCT02274558|365050243|FG001|Overall Study|Withdrawal by Subject|5|||
105834419|NCT02274558|365050244|FG002|Overall Study|Withdrawal by Subject|4|||
105310319|NCT02269163|363132544|FG001|Overall Study|Physician Decision|1|||
105310320|NCT04042376|363132549|FG000|Overall Study|Withdrawal by Subject|1|||
105310321|NCT04042376|363132549|FG000|Overall Study|Death|3|||
105576432|NCT04157686|364108541|FG004|Overall Study|Pregnancy|0|||
105576433|NCT04157686|364108542|FG005|Overall Study|Pregnancy|0|||
105576434|NCT04157686|364108543|FG006|Overall Study|Pregnancy|3|||
105576435|NCT04157686|364108544|FG007|Overall Study|Pregnancy|0|||
105834420|NCT02274558|365050242|FG000|Overall Study|Death|0|||
105834421|NCT02274558|365050243|FG001|Overall Study|Death|0|||
105834422|NCT02274558|365050244|FG002|Overall Study|Death|1|||
105834423|NCT02274558|365050242|FG000|Overall Study|Lost to Follow-up|2|||
105834424|NCT02274558|365050243|FG001|Overall Study|Lost to Follow-up|1|||
105834425|NCT02274558|365050244|FG002|Overall Study|Lost to Follow-up|1|||
105834426|NCT02274558|365050242|FG000|Overall Study|Physician Decision|0|||
105834427|NCT02274558|365050243|FG001|Overall Study|Physician Decision|2|||
105834428|NCT02274558|365050244|FG002|Overall Study|Physician Decision|1|||
105834429|NCT02655224|365050245|FG000|Overall Study|Adverse Event|1|||
105834430|NCT02655224|365050246|FG001|Overall Study|Adverse Event|1|||
105834431|NCT01257581|365050247|FG000|Overall Study|Early Termination|3|||
105834432|NCT01257581|365050248|FG001|Overall Study|Early Termination|1|||
105834433|NCT01257581|365050249|FG002|Overall Study|Early Termination|2|||
105834434|NCT01257581|365050247|FG000|Overall Study|Death|2|||
105834435|NCT01257581|365050248|FG001|Overall Study|Death|2|||
105834436|NCT01257581|365050249|FG002|Overall Study|Death|4|||
105834437|NCT01157234|365050250|FG000|Overall Study|Withdrawal by Subject|1|||
105834438|NCT01157234|365050251|FG001|Overall Study|Withdrawal by Subject|0|||
105834439|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
105834440|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
105834441|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
105834442|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
105834443|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
105834444|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
105834445|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
105834446|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
105834447|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
105834448|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
105834449|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
105834450|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
105834451|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
105834452|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
105834453|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
105834454|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
105834455|NCT04592419|365050252|FG000|Open-Label Extension Period|Adverse Event|1|||
105834456|NCT04592419|365050253|FG001|Open-Label Extension Period|Adverse Event|2|||
105834457|NCT04592419|365050252|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
105834458|NCT04592419|365050253|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
105834459|NCT04592419|365050252|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
105834460|NCT04592419|365050253|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
105834461|NCT04592419|365050252|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
105834462|NCT04592419|365050253|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
105834463|NCT04592419|365050252|FG000|Open-Label Extension Period|Sponsor Request|73|||
105834464|NCT04592419|365050253|FG001|Open-Label Extension Period|Sponsor Request|84|||
105834465|NCT01765270|365050260|FG000|Overall Study|Physician Decision|1|||
105834466|NCT01765270|365050261|FG001|Overall Study|Physician Decision|0|||
105834467|NCT01765270|365050260|FG000|Overall Study|Withdrawal by Subject|0|||
105834468|NCT01765270|365050261|FG001|Overall Study|Withdrawal by Subject|1|||
105834469|NCT00517192|365050262|FG000|Overall Study|Adverse Event|1|||
105834470|NCT00517192|365050263|FG001|Overall Study|Adverse Event|1|||
105834471|NCT00517192|365050262|FG000|Overall Study|Lost to Follow-up|1|||
105834472|NCT00517192|365050263|FG001|Overall Study|Lost to Follow-up|1|||
105834473|NCT00517192|365050262|FG000|Overall Study|Withdrawal by Subject|1|||
105834474|NCT00517192|365050263|FG001|Overall Study|Withdrawal by Subject|0|||
105834475|NCT00517192|365050262|FG000|Overall Study|Early termination of the trial|16|||
105834476|NCT00517192|365050263|FG001|Overall Study|Early termination of the trial|18|||
105834477|NCT02733627|365050271|FG000|Overall Study|Adverse Event|0|||
105834478|NCT02733627|365050272|FG001|Overall Study|Adverse Event|1|||
105834479|NCT02733627|365050273|FG002|Overall Study|Adverse Event|1|||
105834480|NCT02733627|365050274|FG003|Overall Study|Adverse Event|0|||
105834481|NCT02733627|365050271|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
105834482|NCT02733627|365050272|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
105834483|NCT02733627|365050273|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
105834484|NCT02733627|365050274|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
105834485|NCT02246764|365050275|FG000|Overall Study|Adverse Event|15|||
105834486|NCT02246764|365050276|FG001|Overall Study|Adverse Event|29|||
105834487|NCT02246764|365050277|FG002|Overall Study|Adverse Event|1|||
105834488|NCT02246764|365050275|FG000|Overall Study|Withdrawal by Subject|0|||
105834489|NCT02246764|365050276|FG001|Overall Study|Withdrawal by Subject|0|||
105834490|NCT02246764|365050277|FG002|Overall Study|Withdrawal by Subject|1|||
105834491|NCT02246764|365050275|FG000|Overall Study|Disallowed Concomitant Medication|1|||
105834492|NCT02246764|365050276|FG001|Overall Study|Disallowed Concomitant Medication|0|||
105834493|NCT02246764|365050277|FG002|Overall Study|Disallowed Concomitant Medication|0|||
105834494|NCT02246764|365050275|FG000|Overall Study|Physician Decision|0|||
105834495|NCT02246764|365050276|FG001|Overall Study|Physician Decision|2|||
105834496|NCT02246764|365050277|FG002|Overall Study|Physician Decision|1|||
105834497|NCT02246764|365050275|FG000|Overall Study|Protocol Violation|2|||
105834498|NCT02246764|365050276|FG001|Overall Study|Protocol Violation|1|||
105834499|NCT02246764|365050277|FG002|Overall Study|Protocol Violation|1|||
105834500|NCT00183196|365050278|FG000|Overall Study|Withdrawal by Subject|18|||
105310322|NCT03395405|363134270|FG000|Overall Study|Death|0|||
105310323|NCT03395405|363134271|FG001|Overall Study|Death|2|||
105310324|NCT03395405|363134270|FG000|Overall Study|Lost to Follow-up|0|||
105310325|NCT03395405|363134271|FG001|Overall Study|Lost to Follow-up|1|||
105310326|NCT03395405|363134270|FG000|Overall Study|Protocol Violation|0|||
105310327|NCT03395405|363134271|FG001|Overall Study|Protocol Violation|1|||
105310328|NCT03395405|363134270|FG000|Overall Study|Withdrawal by Subject|3|||
105310329|NCT03395405|363134271|FG001|Overall Study|Withdrawal by Subject|1|||
105310330|NCT03395405|363134270|FG000|Overall Study|COVID-19 Pandemic|1|||
105310331|NCT03395405|363134271|FG001|Overall Study|COVID-19 Pandemic|0|||
105834501|NCT00183196|365050279|FG001|Overall Study|Withdrawal by Subject|11|||
105834502|NCT00183196|365050280|FG002|Overall Study|Withdrawal by Subject|13|||
105834503|NCT00183196|365050278|FG000|Overall Study|Adverse Event|1|||
105834504|NCT00183196|365050279|FG001|Overall Study|Adverse Event|2|||
105834505|NCT00183196|365050280|FG002|Overall Study|Adverse Event|2|||
105834506|NCT00183196|365050278|FG000|Overall Study|Legal event|1|||
105834507|NCT00183196|365050279|FG001|Overall Study|Legal event|1|||
105834508|NCT00183196|365050280|FG002|Overall Study|Legal event|1|||
105834509|NCT00183196|365050278|FG000|Overall Study|Required more intensive care|0|||
105834510|NCT00183196|365050279|FG001|Overall Study|Required more intensive care|1|||
105834511|NCT00183196|365050280|FG002|Overall Study|Required more intensive care|2|||
105834512|NCT00695110|365050286|FG000|Treatment Period 1|Adverse Event|1|||
105834513|NCT00695110|365050286|FG000|Treatment Period 1|Withdrawal by Subject|2|||
105834514|NCT00695110|365050286|FG000|Treatment Period 3|Withdrawal by Subject|1|||
105834515|NCT00695110|365050286|FG000|Treatment Period 4|Adverse Event|1|||
105834516|NCT00348816|365050289|FG000|Overall Study|Noncompliance with radiation treatment|1|||
105834517|NCT02161549|365050290|FG000|Overall Study|Physician Decision|6|||
105834518|NCT02161549|365050291|FG001|Overall Study|Physician Decision|2|||
105834519|NCT03433703|365050292|FG000|Overall Study|Study terminated by Sponsor|2|||
105834520|NCT02637141|365050297|FG000|Overall Study|Adverse Event|1|||
105834521|NCT02637141|365050298|FG001|Overall Study|Adverse Event|1|||
105834522|NCT02637141|365050299|FG002|Overall Study|Adverse Event|0|||
105834523|NCT02637141|365050297|FG000|Overall Study|Withdrawal by Subject|1|||
105834524|NCT02637141|365050298|FG001|Overall Study|Withdrawal by Subject|1|||
105834525|NCT02637141|365050299|FG002|Overall Study|Withdrawal by Subject|1|||
105834526|NCT00743145|365050305|FG000|Overall Study|Withdrawal by Subject|1|||
105834527|NCT00743145|365050305|FG000|Overall Study|Adverse Event|2|||
105834528|NCT00743145|365050305|FG000|Overall Study|Pregnancy|1|||
105834529|NCT01583530|365050306|FG000|Overall Study|Adverse Event|0|||
105834530|NCT01583530|365050307|FG001|Overall Study|Adverse Event|0|||
105834531|NCT01583530|365050308|FG002|Overall Study|Adverse Event|0|||
105834532|NCT01583530|365050309|FG003|Overall Study|Adverse Event|0|||
105834533|NCT01583530|365050310|FG004|Overall Study|Adverse Event|0|||
105834534|NCT01583530|365050311|FG005|Overall Study|Adverse Event|1|||
105834535|NCT01583530|365050306|FG000|Overall Study|Withdrawal by Subject|0|||
105834536|NCT01583530|365050307|FG001|Overall Study|Withdrawal by Subject|3|||
105834537|NCT01583530|365050308|FG002|Overall Study|Withdrawal by Subject|0|||
105310332|NCT01523457|363134272|FG000|Overall Study|Withdrawal by Subject|7|||
105310333|NCT01523457|363134273|FG001|Overall Study|Withdrawal by Subject|2|||
105576436|NCT04157686|364108537|FG000|Overall Study|Lost to Follow-up|1|||
105576437|NCT04157686|364108538|FG001|Overall Study|Lost to Follow-up|2|||
105834538|NCT01583530|365050309|FG003|Overall Study|Withdrawal by Subject|1|||
105834539|NCT01583530|365050310|FG004|Overall Study|Withdrawal by Subject|1|||
105576438|NCT04157686|364108539|FG002|Overall Study|Lost to Follow-up|8|||
105834540|NCT01583530|365050311|FG005|Overall Study|Withdrawal by Subject|2|||
105834541|NCT01583530|365050306|FG000|Overall Study|Lost to Follow-up|0|||
105834542|NCT01583530|365050307|FG001|Overall Study|Lost to Follow-up|0|||
105834543|NCT01583530|365050308|FG002|Overall Study|Lost to Follow-up|0|||
105834544|NCT01583530|365050309|FG003|Overall Study|Lost to Follow-up|0|||
105834545|NCT01583530|365050310|FG004|Overall Study|Lost to Follow-up|3|||
105834546|NCT01583530|365050311|FG005|Overall Study|Lost to Follow-up|0|||
105834547|NCT01583530|365050306|FG000|Overall Study|Lack of compliance|0|||
105576439|NCT04157686|364108540|FG003|Overall Study|Lost to Follow-up|6|||
105834548|NCT01583530|365050307|FG001|Overall Study|Lack of compliance|0|||
105834549|NCT01583530|365050308|FG002|Overall Study|Lack of compliance|0|||
105834550|NCT01583530|365050309|FG003|Overall Study|Lack of compliance|0|||
105310334|NCT04345601|363134274|FG000|Overall Study|Death|0|||
105310335|NCT04345601|363134275|FG001|Overall Study|Death|3|||
105310336|NCT04345601|363134276|FG002|Overall Study|Death|2|||
105310337|NCT04345601|363134274|FG000|Overall Study|Lost to Follow-up|0|||
105834551|NCT01583530|365050310|FG004|Overall Study|Lack of compliance|1|||
105834552|NCT01583530|365050311|FG005|Overall Study|Lack of compliance|0|||
105834553|NCT03414034|365050312|FG000|Overall Study|Adverse Event|6|||
105834554|NCT03414034|365050313|FG001|Overall Study|Adverse Event|1|||
105834555|NCT03414034|365050314|FG002|Overall Study|Adverse Event|1|||
105834556|NCT03414034|365050312|FG000|Overall Study|Death|0|||
105834557|NCT03414034|365050313|FG001|Overall Study|Death|0|||
105834558|NCT03414034|365050314|FG002|Overall Study|Death|1|||
105834559|NCT03414034|365050312|FG000|Overall Study|Non-compliance With Study Drug|0|||
105834560|NCT03414034|365050313|FG001|Overall Study|Non-compliance With Study Drug|0|||
105834561|NCT03414034|365050314|FG002|Overall Study|Non-compliance With Study Drug|1|||
105834562|NCT03414034|365050312|FG000|Overall Study|Physician Decision|1|||
105834563|NCT03414034|365050313|FG001|Overall Study|Physician Decision|3|||
105834564|NCT03414034|365050314|FG002|Overall Study|Physician Decision|2|||
105834565|NCT03414034|365050312|FG000|Overall Study|Withdrawal of Informed Consent|2|||
105834566|NCT03414034|365050313|FG001|Overall Study|Withdrawal of Informed Consent|1|||
105834567|NCT03414034|365050314|FG002|Overall Study|Withdrawal of Informed Consent|4|||
105834568|NCT03414034|365050312|FG000|Overall Study|Progressive Disease|15|||
105834569|NCT03414034|365050313|FG001|Overall Study|Progressive Disease|15|||
105834570|NCT03414034|365050314|FG002|Overall Study|Progressive Disease|17|||
105834571|NCT03414034|365050312|FG000|Overall Study|Miscellaneous|0|||
105834572|NCT03414034|365050313|FG001|Overall Study|Miscellaneous|0|||
105834573|NCT03414034|365050314|FG002|Overall Study|Miscellaneous|2|||
105834574|NCT02351167|365050316|FG000|Overall Study|Withdrawal by Subject|19|||
105834575|NCT02351167|365050317|FG001|Overall Study|Withdrawal by Subject|18|||
105834576|NCT02351167|365050318|FG002|Overall Study|Withdrawal by Subject|21|||
105834577|NCT01332968|365050319|FG000|Induction Period|Adverse Event|23|||
105834578|NCT01332968|365050320|FG001|Induction Period|Adverse Event|26|||
105834579|NCT01332968|365050321|FG002|Induction Period|Adverse Event|0|||
105834580|NCT01332968|365050322|FG003|Induction Period|Adverse Event|0|||
105834581|NCT01332968|365050323|FG004|Induction Period|Adverse Event|0|||
105834582|NCT01332968|365050324|FG005|Induction Period|Adverse Event|0|||
105834583|NCT01332968|365050325|FG006|Induction Period|Adverse Event|0|||
105834584|NCT01332968|365050326|FG007|Induction Period|Adverse Event|0|||
105834585|NCT01332968|365050319|FG000|Induction Period|Death|1|||
105834586|NCT01332968|365050320|FG001|Induction Period|Death|4|||
105834587|NCT01332968|365050321|FG002|Induction Period|Death|0|||
105834588|NCT01332968|365050322|FG003|Induction Period|Death|0|||
105834589|NCT01332968|365050323|FG004|Induction Period|Death|0|||
105834590|NCT01332968|365050324|FG005|Induction Period|Death|0|||
105834591|NCT01332968|365050325|FG006|Induction Period|Death|0|||
105834592|NCT01332968|365050326|FG007|Induction Period|Death|0|||
105834593|NCT01332968|365050319|FG000|Induction Period|Non-compliance|1|||
105834594|NCT01332968|365050320|FG001|Induction Period|Non-compliance|0|||
105310338|NCT04345601|363134275|FG001|Overall Study|Lost to Follow-up|0|||
105310339|NCT04345601|363134276|FG002|Overall Study|Lost to Follow-up|2|||
105310340|NCT03610516|363134277|FG000|Treatment Epoch|Adverse Event|3|||
105310341|NCT03610516|363134278|FG001|Treatment Epoch|Adverse Event|1|||
105310342|NCT03610516|363134277|FG000|Treatment Epoch|Death|1|||
105310343|NCT03610516|363134278|FG001|Treatment Epoch|Death|0|||
105310344|NCT03610516|363134277|FG000|Treatment Epoch|Lack of Efficacy|0|||
105310345|NCT03610516|363134278|FG001|Treatment Epoch|Lack of Efficacy|1|||
105310346|NCT03610516|363134277|FG000|Treatment Epoch|No longer requires treatment|1|||
105310347|NCT03610516|363134278|FG001|Treatment Epoch|No longer requires treatment|0|||
105310348|NCT03610516|363134277|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
105310349|NCT03610516|363134278|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
105310350|NCT03610516|363134277|FG000|Treatment Epoch|Physician Decision|8|||
105310351|NCT03610516|363134278|FG001|Treatment Epoch|Physician Decision|5|||
105310352|NCT03610516|363134277|FG000|Treatment Epoch|Protocol Deviation|1|||
105310353|NCT03610516|363134278|FG001|Treatment Epoch|Protocol Deviation|0|||
105310354|NCT03610516|363134277|FG000|Treatment Epoch|Withdrawal by Subject|3|||
105834595|NCT01332968|365050321|FG002|Induction Period|Non-compliance|0|||
105834596|NCT01332968|365050322|FG003|Induction Period|Non-compliance|0|||
105310355|NCT03610516|363134278|FG001|Treatment Epoch|Withdrawal by Subject|1|||
105834597|NCT01332968|365050323|FG004|Induction Period|Non-compliance|0|||
105834598|NCT01332968|365050324|FG005|Induction Period|Non-compliance|0|||
105367197|NCT02717195|363350153|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
105367198|NCT02717195|363350154|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
105834599|NCT01332968|365050325|FG006|Induction Period|Non-compliance|0|||
105834600|NCT01332968|365050326|FG007|Induction Period|Non-compliance|0|||
105310356|NCT03610516|363134277|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
105310357|NCT03610516|363134278|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
105310358|NCT03610516|363134277|FG000|Post-Treatment Follow-up|Death|1|||
105834601|NCT01332968|365050319|FG000|Induction Period|Other|2|||
105834602|NCT01332968|365050320|FG001|Induction Period|Other|2|||
105834603|NCT01332968|365050321|FG002|Induction Period|Other|0|||
105834604|NCT01332968|365050322|FG003|Induction Period|Other|0|||
105834605|NCT01332968|365050323|FG004|Induction Period|Other|0|||
105834606|NCT01332968|365050324|FG005|Induction Period|Other|0|||
105834607|NCT01332968|365050325|FG006|Induction Period|Other|0|||
105834608|NCT01332968|365050326|FG007|Induction Period|Other|0|||
105834609|NCT01332968|365050319|FG000|Induction Period|Physician Decision|6|||
105834610|NCT01332968|365050320|FG001|Induction Period|Physician Decision|1|||
105834611|NCT01332968|365050321|FG002|Induction Period|Physician Decision|0|||
105834612|NCT01332968|365050322|FG003|Induction Period|Physician Decision|0|||
105834613|NCT01332968|365050323|FG004|Induction Period|Physician Decision|0|||
105834614|NCT01332968|365050324|FG005|Induction Period|Physician Decision|0|||
105834615|NCT01332968|365050325|FG006|Induction Period|Physician Decision|0|||
105834616|NCT01332968|365050326|FG007|Induction Period|Physician Decision|0|||
105834617|NCT01332968|365050319|FG000|Induction Period|Progressive Disease|15|||
105834618|NCT01332968|365050320|FG001|Induction Period|Progressive Disease|7|||
105834619|NCT01332968|365050321|FG002|Induction Period|Progressive Disease|0|||
105834620|NCT01332968|365050322|FG003|Induction Period|Progressive Disease|0|||
105834621|NCT01332968|365050323|FG004|Induction Period|Progressive Disease|0|||
105834622|NCT01332968|365050324|FG005|Induction Period|Progressive Disease|0|||
105834623|NCT01332968|365050325|FG006|Induction Period|Progressive Disease|0|||
105834624|NCT01332968|365050326|FG007|Induction Period|Progressive Disease|0|||
105834625|NCT01332968|365050319|FG000|Induction Period|Protocol Violation|3|||
105834626|NCT01332968|365050320|FG001|Induction Period|Protocol Violation|4|||
105834627|NCT01332968|365050321|FG002|Induction Period|Protocol Violation|0|||
105834628|NCT01332968|365050322|FG003|Induction Period|Protocol Violation|0|||
105834629|NCT01332968|365050323|FG004|Induction Period|Protocol Violation|0|||
105834630|NCT01332968|365050324|FG005|Induction Period|Protocol Violation|0|||
105834631|NCT01332968|365050325|FG006|Induction Period|Protocol Violation|0|||
105834632|NCT01332968|365050326|FG007|Induction Period|Protocol Violation|0|||
105834633|NCT01332968|365050319|FG000|Induction Period|Withdrawal by Subject|3|||
105834634|NCT01332968|365050320|FG001|Induction Period|Withdrawal by Subject|5|||
105834635|NCT01332968|365050321|FG002|Induction Period|Withdrawal by Subject|0|||
105834636|NCT01332968|365050322|FG003|Induction Period|Withdrawal by Subject|0|||
105834637|NCT01332968|365050323|FG004|Induction Period|Withdrawal by Subject|0|||
105834638|NCT01332968|365050324|FG005|Induction Period|Withdrawal by Subject|0|||
105834639|NCT01332968|365050325|FG006|Induction Period|Withdrawal by Subject|0|||
105834640|NCT01332968|365050326|FG007|Induction Period|Withdrawal by Subject|0|||
105834641|NCT01332968|365050319|FG000|Induction Period|Randomised but not treated|4|||
105834642|NCT01332968|365050320|FG001|Induction Period|Randomised but not treated|7|||
105834643|NCT01332968|365050321|FG002|Induction Period|Randomised but not treated|0|||
105834644|NCT01332968|365050322|FG003|Induction Period|Randomised but not treated|0|||
105834645|NCT01332968|365050323|FG004|Induction Period|Randomised but not treated|0|||
105834646|NCT01332968|365050324|FG005|Induction Period|Randomised but not treated|0|||
105834647|NCT01332968|365050325|FG006|Induction Period|Randomised but not treated|0|||
105834648|NCT01332968|365050326|FG007|Induction Period|Randomised but not treated|0|||
105834649|NCT01332968|365050319|FG000|Maintenance/Observation Period|Adverse Event|0|||
105834650|NCT01332968|365050320|FG001|Maintenance/Observation Period|Adverse Event|0|||
105834651|NCT01332968|365050321|FG002|Maintenance/Observation Period|Adverse Event|53|||
105834652|NCT01332968|365050322|FG003|Maintenance/Observation Period|Adverse Event|66|||
105834653|NCT01332968|365050323|FG004|Maintenance/Observation Period|Adverse Event|0|||
105834654|NCT01332968|365050324|FG005|Maintenance/Observation Period|Adverse Event|0|||
105834655|NCT01332968|365050325|FG006|Maintenance/Observation Period|Adverse Event|0|||
105834656|NCT01332968|365050326|FG007|Maintenance/Observation Period|Adverse Event|0|||
105834657|NCT01332968|365050319|FG000|Maintenance/Observation Period|Death|0|||
105834658|NCT01332968|365050320|FG001|Maintenance/Observation Period|Death|0|||
105834659|NCT01332968|365050321|FG002|Maintenance/Observation Period|Death|5|||
105834660|NCT01332968|365050322|FG003|Maintenance/Observation Period|Death|6|||
105834661|NCT01332968|365050323|FG004|Maintenance/Observation Period|Death|0|||
105834662|NCT01332968|365050324|FG005|Maintenance/Observation Period|Death|0|||
105834663|NCT01332968|365050325|FG006|Maintenance/Observation Period|Death|0|||
105834664|NCT01332968|365050326|FG007|Maintenance/Observation Period|Death|0|||
105834665|NCT01332968|365050319|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
105834666|NCT01332968|365050320|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
105834667|NCT01332968|365050321|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
105834668|NCT01332968|365050322|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
105834669|NCT01332968|365050323|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
105834670|NCT01332968|365050324|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
105834671|NCT01332968|365050325|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
105834672|NCT01332968|365050326|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
105834673|NCT01332968|365050319|FG000|Maintenance/Observation Period|Non-compliance|0|||
105834674|NCT01332968|365050320|FG001|Maintenance/Observation Period|Non-compliance|0|||
105576440|NCT04157686|364108541|FG004|Overall Study|Lost to Follow-up|6|||
105834675|NCT01332968|365050321|FG002|Maintenance/Observation Period|Non-compliance|4|||
105834676|NCT01332968|365050322|FG003|Maintenance/Observation Period|Non-compliance|3|||
105834677|NCT01332968|365050323|FG004|Maintenance/Observation Period|Non-compliance|0|||
105834678|NCT01332968|365050324|FG005|Maintenance/Observation Period|Non-compliance|0|||
105834679|NCT01332968|365050325|FG006|Maintenance/Observation Period|Non-compliance|0|||
105834680|NCT01332968|365050326|FG007|Maintenance/Observation Period|Non-compliance|0|||
105834681|NCT01332968|365050319|FG000|Maintenance/Observation Period|Other|0|||
105576441|NCT04157686|364108542|FG005|Overall Study|Lost to Follow-up|3|||
105576442|NCT04157686|364108543|FG006|Overall Study|Lost to Follow-up|7|||
105576443|NCT04157686|364108544|FG007|Overall Study|Lost to Follow-up|9|||
105834682|NCT01332968|365050320|FG001|Maintenance/Observation Period|Other|0|||
105834683|NCT01332968|365050321|FG002|Maintenance/Observation Period|Other|4|||
105834684|NCT01332968|365050322|FG003|Maintenance/Observation Period|Other|7|||
105834685|NCT01332968|365050323|FG004|Maintenance/Observation Period|Other|0|||
105834686|NCT01332968|365050324|FG005|Maintenance/Observation Period|Other|0|||
105576444|NCT04157686|364108537|FG000|Overall Study|Lack of Efficacy|0|||
105576445|NCT04157686|364108538|FG001|Overall Study|Lack of Efficacy|0|||
105576446|NCT04157686|364108539|FG002|Overall Study|Lack of Efficacy|0|||
105576447|NCT04157686|364108540|FG003|Overall Study|Lack of Efficacy|0|||
105576448|NCT04157686|364108541|FG004|Overall Study|Lack of Efficacy|0|||
105576449|NCT04157686|364108542|FG005|Overall Study|Lack of Efficacy|2|||
105576450|NCT04157686|364108543|FG006|Overall Study|Lack of Efficacy|0|||
105576451|NCT04157686|364108544|FG007|Overall Study|Lack of Efficacy|1|||
105576452|NCT04157686|364108537|FG000|Overall Study|Withdrawal by Subject|10|||
105576453|NCT04157686|364108538|FG001|Overall Study|Withdrawal by Subject|10|||
105576454|NCT04157686|364108539|FG002|Overall Study|Withdrawal by Subject|12|||
105576455|NCT04157686|364108540|FG003|Overall Study|Withdrawal by Subject|20|||
105834687|NCT01332968|365050325|FG006|Maintenance/Observation Period|Other|0|||
105834688|NCT01332968|365050326|FG007|Maintenance/Observation Period|Other|0|||
105834689|NCT01332968|365050319|FG000|Maintenance/Observation Period|Physician Decision|0|||
105834690|NCT01332968|365050320|FG001|Maintenance/Observation Period|Physician Decision|0|||
105834691|NCT01332968|365050321|FG002|Maintenance/Observation Period|Physician Decision|14|||
105834692|NCT01332968|365050322|FG003|Maintenance/Observation Period|Physician Decision|19|||
105834693|NCT01332968|365050323|FG004|Maintenance/Observation Period|Physician Decision|0|||
105834694|NCT01332968|365050324|FG005|Maintenance/Observation Period|Physician Decision|1|||
105834695|NCT01332968|365050325|FG006|Maintenance/Observation Period|Physician Decision|0|||
105834696|NCT01332968|365050326|FG007|Maintenance/Observation Period|Physician Decision|0|||
105834697|NCT01332968|365050319|FG000|Maintenance/Observation Period|Progressive Disease|0|||
105834698|NCT01332968|365050320|FG001|Maintenance/Observation Period|Progressive Disease|0|||
105834699|NCT01332968|365050321|FG002|Maintenance/Observation Period|Progressive Disease|72|||
105834700|NCT01332968|365050322|FG003|Maintenance/Observation Period|Progressive Disease|40|||
105834701|NCT01332968|365050323|FG004|Maintenance/Observation Period|Progressive Disease|0|||
105834702|NCT01332968|365050324|FG005|Maintenance/Observation Period|Progressive Disease|0|||
105834703|NCT01332968|365050325|FG006|Maintenance/Observation Period|Progressive Disease|0|||
105834704|NCT01332968|365050326|FG007|Maintenance/Observation Period|Progressive Disease|0|||
105834705|NCT01332968|365050319|FG000|Maintenance/Observation Period|Protocol Violation|0|||
105834706|NCT01332968|365050320|FG001|Maintenance/Observation Period|Protocol Violation|0|||
105834707|NCT01332968|365050321|FG002|Maintenance/Observation Period|Protocol Violation|1|||
105834708|NCT01332968|365050322|FG003|Maintenance/Observation Period|Protocol Violation|1|||
105834709|NCT01332968|365050323|FG004|Maintenance/Observation Period|Protocol Violation|0|||
105834710|NCT01332968|365050324|FG005|Maintenance/Observation Period|Protocol Violation|0|||
105834711|NCT01332968|365050325|FG006|Maintenance/Observation Period|Protocol Violation|0|||
105834712|NCT01332968|365050326|FG007|Maintenance/Observation Period|Protocol Violation|0|||
105834713|NCT01332968|365050319|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
105834714|NCT01332968|365050320|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
105834715|NCT01332968|365050321|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
105834716|NCT01332968|365050322|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
105834717|NCT01332968|365050323|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
105834718|NCT01332968|365050324|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
105834719|NCT01332968|365050325|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
105834720|NCT01332968|365050326|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
105834721|NCT01332968|365050319|FG000|Follow-Up Period|Adverse Event|0|||
105834722|NCT01332968|365050320|FG001|Follow-Up Period|Adverse Event|0|||
105834723|NCT01332968|365050321|FG002|Follow-Up Period|Adverse Event|0|||
105834724|NCT01332968|365050322|FG003|Follow-Up Period|Adverse Event|0|||
105834725|NCT01332968|365050323|FG004|Follow-Up Period|Adverse Event|0|||
105834726|NCT01332968|365050324|FG005|Follow-Up Period|Adverse Event|0|||
105834727|NCT01332968|365050325|FG006|Follow-Up Period|Adverse Event|0|||
105834728|NCT01332968|365050326|FG007|Follow-Up Period|Adverse Event|4|||
105576456|NCT04157686|364108541|FG004|Overall Study|Withdrawal by Subject|12|||
105834729|NCT01332968|365050319|FG000|Follow-Up Period|Death|0|||
105834730|NCT01332968|365050320|FG001|Follow-Up Period|Death|0|||
105834731|NCT01332968|365050321|FG002|Follow-Up Period|Death|0|||
105834732|NCT01332968|365050322|FG003|Follow-Up Period|Death|0|||
105834733|NCT01332968|365050323|FG004|Follow-Up Period|Death|0|||
105834734|NCT01332968|365050324|FG005|Follow-Up Period|Death|0|||
105834735|NCT01332968|365050325|FG006|Follow-Up Period|Death|27|||
105576457|NCT04157686|364108542|FG005|Overall Study|Withdrawal by Subject|11|||
105489718|NCT00427960|363805627|FG000|Overall Study|Withdrawal by Subject|0|||
105489719|NCT00427960|363805628|FG001|Overall Study|Withdrawal by Subject|3|||
105489720|NCT00427960|363805627|FG000|Overall Study|Other|0|||
105489721|NCT00427960|363805628|FG001|Overall Study|Other|1|||
105489722|NCT01052844|363805634|FG000|Overall Study|Adverse Event|0|||
105489723|NCT01052844|363805635|FG001|Overall Study|Adverse Event|1|||
105489724|NCT00518973|363805636|FG000|Overall Study|Withdrawal by Subject|3|||
105489725|NCT00518973|363805637|FG001|Overall Study|Withdrawal by Subject|2|||
105576458|NCT04157686|364108543|FG006|Overall Study|Withdrawal by Subject|18|||
105834736|NCT01332968|365050326|FG007|Follow-Up Period|Death|30|||
105576459|NCT04157686|364108544|FG007|Overall Study|Withdrawal by Subject|24|||
105576460|NCT04157686|364108537|FG000|Overall Study|Physician Decision|0|||
105576461|NCT04157686|364108538|FG001|Overall Study|Physician Decision|0|||
105576462|NCT04157686|364108539|FG002|Overall Study|Physician Decision|1|||
105576463|NCT04157686|364108540|FG003|Overall Study|Physician Decision|0|||
105576464|NCT04157686|364108541|FG004|Overall Study|Physician Decision|1|||
105576465|NCT04157686|364108542|FG005|Overall Study|Physician Decision|0|||
105576466|NCT04157686|364108543|FG006|Overall Study|Physician Decision|3|||
105576467|NCT04157686|364108544|FG007|Overall Study|Physician Decision|0|||
105576468|NCT04157686|364108537|FG000|Overall Study|Death|0|||
105576469|NCT04157686|364108538|FG001|Overall Study|Death|0|||
105576470|NCT04157686|364108539|FG002|Overall Study|Death|0|||
105576471|NCT04157686|364108540|FG003|Overall Study|Death|2|||
105576472|NCT04157686|364108541|FG004|Overall Study|Death|0|||
105576473|NCT04157686|364108542|FG005|Overall Study|Death|0|||
105576474|NCT04157686|364108543|FG006|Overall Study|Death|0|||
105367199|NCT02717195|363350155|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
105489726|NCT01264016|363805642|FG000|Overall Study|Withdrawal by Subject|1|||
105834737|NCT01332968|365050319|FG000|Follow-Up Period|Lost to Follow-up|0|||
105834738|NCT01332968|365050320|FG001|Follow-Up Period|Lost to Follow-up|0|||
105834739|NCT01332968|365050321|FG002|Follow-Up Period|Lost to Follow-up|0|||
105834740|NCT01332968|365050322|FG003|Follow-Up Period|Lost to Follow-up|0|||
105834741|NCT01332968|365050323|FG004|Follow-Up Period|Lost to Follow-up|0|||
105834742|NCT01332968|365050324|FG005|Follow-Up Period|Lost to Follow-up|0|||
105834743|NCT01332968|365050325|FG006|Follow-Up Period|Lost to Follow-up|11|||
105834744|NCT01332968|365050326|FG007|Follow-Up Period|Lost to Follow-up|15|||
105834745|NCT01332968|365050319|FG000|Follow-Up Period|Non-compliance|0|||
105834746|NCT01332968|365050320|FG001|Follow-Up Period|Non-compliance|0|||
105834747|NCT01332968|365050321|FG002|Follow-Up Period|Non-compliance|0|||
105834748|NCT01332968|365050322|FG003|Follow-Up Period|Non-compliance|0|||
105834749|NCT01332968|365050323|FG004|Follow-Up Period|Non-compliance|0|||
105834750|NCT01332968|365050324|FG005|Follow-Up Period|Non-compliance|0|||
105834751|NCT01332968|365050325|FG006|Follow-Up Period|Non-compliance|4|||
105834752|NCT01332968|365050326|FG007|Follow-Up Period|Non-compliance|9|||
105834753|NCT01332968|365050319|FG000|Follow-Up Period|Other|0|||
105834754|NCT01332968|365050320|FG001|Follow-Up Period|Other|0|||
105834755|NCT01332968|365050321|FG002|Follow-Up Period|Other|0|||
105834756|NCT01332968|365050322|FG003|Follow-Up Period|Other|0|||
105834757|NCT01332968|365050323|FG004|Follow-Up Period|Other|0|||
105834758|NCT01332968|365050324|FG005|Follow-Up Period|Other|0|||
105834759|NCT01332968|365050325|FG006|Follow-Up Period|Other|18|||
105834760|NCT01332968|365050326|FG007|Follow-Up Period|Other|21|||
105834761|NCT01332968|365050319|FG000|Follow-Up Period|Physician Decision|0|||
105834762|NCT01332968|365050320|FG001|Follow-Up Period|Physician Decision|0|||
105834763|NCT01332968|365050321|FG002|Follow-Up Period|Physician Decision|0|||
105834764|NCT01332968|365050322|FG003|Follow-Up Period|Physician Decision|0|||
105834765|NCT01332968|365050323|FG004|Follow-Up Period|Physician Decision|0|||
105367200|NCT02717195|363350156|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
105367201|NCT02717195|363350157|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
105367202|NCT02717195|363350153|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
105367203|NCT02717195|363350154|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
105367204|NCT02717195|363350155|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
105367205|NCT02717195|363350156|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
105367206|NCT02717195|363350157|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
105576475|NCT04157686|364108544|FG007|Overall Study|Death|0|||
105576476|NCT04157686|364108537|FG000|Overall Study|Protocol Violation|0|||
105576477|NCT04157686|364108538|FG001|Overall Study|Protocol Violation|0|||
105576478|NCT04157686|364108539|FG002|Overall Study|Protocol Violation|0|||
105834766|NCT01332968|365050324|FG005|Follow-Up Period|Physician Decision|0|||
105834767|NCT01332968|365050325|FG006|Follow-Up Period|Physician Decision|12|||
105834768|NCT01332968|365050326|FG007|Follow-Up Period|Physician Decision|15|||
105834769|NCT01332968|365050319|FG000|Follow-Up Period|Progressive Disease|0|||
105834770|NCT01332968|365050320|FG001|Follow-Up Period|Progressive Disease|0|||
105834771|NCT01332968|365050321|FG002|Follow-Up Period|Progressive Disease|0|||
105834772|NCT01332968|365050322|FG003|Follow-Up Period|Progressive Disease|0|||
105834773|NCT01332968|365050323|FG004|Follow-Up Period|Progressive Disease|0|||
105834774|NCT01332968|365050324|FG005|Follow-Up Period|Progressive Disease|0|||
105834775|NCT01332968|365050325|FG006|Follow-Up Period|Progressive Disease|126|||
105834776|NCT01332968|365050326|FG007|Follow-Up Period|Progressive Disease|106|||
105834777|NCT01332968|365050319|FG000|Follow-Up Period|Protocol Violation|0|||
105834778|NCT01332968|365050320|FG001|Follow-Up Period|Protocol Violation|0|||
105834779|NCT01332968|365050321|FG002|Follow-Up Period|Protocol Violation|0|||
105834780|NCT01332968|365050322|FG003|Follow-Up Period|Protocol Violation|0|||
105834781|NCT01332968|365050323|FG004|Follow-Up Period|Protocol Violation|0|||
105834782|NCT01332968|365050324|FG005|Follow-Up Period|Protocol Violation|0|||
105834783|NCT01332968|365050325|FG006|Follow-Up Period|Protocol Violation|1|||
105834784|NCT01332968|365050326|FG007|Follow-Up Period|Protocol Violation|0|||
105834785|NCT01332968|365050319|FG000|Follow-Up Period|Withdrawal by Subject|0|||
105834786|NCT01332968|365050320|FG001|Follow-Up Period|Withdrawal by Subject|0|||
105834787|NCT01332968|365050321|FG002|Follow-Up Period|Withdrawal by Subject|0|||
105834788|NCT01332968|365050322|FG003|Follow-Up Period|Withdrawal by Subject|0|||
105834789|NCT01332968|365050323|FG004|Follow-Up Period|Withdrawal by Subject|0|||
105834790|NCT01332968|365050324|FG005|Follow-Up Period|Withdrawal by Subject|0|||
105834791|NCT01332968|365050325|FG006|Follow-Up Period|Withdrawal by Subject|29|||
105834792|NCT01332968|365050326|FG007|Follow-Up Period|Withdrawal by Subject|32|||
105834793|NCT01332968|365050319|FG000|Follow-Up Period|No reason provided|0|||
105834794|NCT01332968|365050320|FG001|Follow-Up Period|No reason provided|0|||
105834795|NCT01332968|365050321|FG002|Follow-Up Period|No reason provided|0|||
105834796|NCT01332968|365050322|FG003|Follow-Up Period|No reason provided|0|||
105834797|NCT01332968|365050323|FG004|Follow-Up Period|No reason provided|0|||
105834798|NCT01332968|365050324|FG005|Follow-Up Period|No reason provided|0|||
105834799|NCT01332968|365050325|FG006|Follow-Up Period|No reason provided|2|||
105834800|NCT01332968|365050326|FG007|Follow-Up Period|No reason provided|3|||
105834801|NCT00515216|365050327|FG000|Overall Study|Withdrawal by Subject|1|||
105834802|NCT01450800|365050328|FG000|Overall Study|Protocol Violation|1|||
105834803|NCT01450800|365050329|FG001|Overall Study|Protocol Violation|3|||
105834804|NCT04106817|365050330|FG000|Overall Study|Lost to Follow-up|1|||
105834805|NCT04106817|365050331|FG001|Overall Study|Lost to Follow-up|0|||
105834806|NCT04106817|365050332|FG002|Overall Study|Lost to Follow-up|0|||
105834807|NCT02460835|365051861|FG000|Overall Study|Disease progression prior to treatment|3|||
105834808|NCT02460835|365051861|FG000|Overall Study|Unable to complete planning scans|2|||
105834809|NCT02460835|365051861|FG000|Overall Study|Decrease in performance status|1|||
105834810|NCT02460835|365051861|FG000|Overall Study|Withdrawal by Subject|3|||
105834811|NCT02460835|365051861|FG000|Overall Study|Underwent fractionated RT|10|||
105834812|NCT02460835|365051861|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
105834813|NCT04129944|365051864|FG000|Overall Study|Death|0|||
105834814|NCT04129944|365051865|FG001|Overall Study|Death|0|||
105834815|NCT04129944|365051866|FG002|Overall Study|Death|0|||
105834816|NCT04129944|365051867|FG003|Overall Study|Death|1|||
105834817|NCT04129944|365051864|FG000|Overall Study|Lost to Follow-up|1|||
105834818|NCT04129944|365051865|FG001|Overall Study|Lost to Follow-up|0|||
105834819|NCT04129944|365051866|FG002|Overall Study|Lost to Follow-up|0|||
105834820|NCT04129944|365051867|FG003|Overall Study|Lost to Follow-up|0|||
105834821|NCT04129944|365051864|FG000|Overall Study|Withdrawal by Subject|1|||
105834822|NCT04129944|365051865|FG001|Overall Study|Withdrawal by Subject|0|||
105834823|NCT04129944|365051866|FG002|Overall Study|Withdrawal by Subject|1|||
105834824|NCT04129944|365051867|FG003|Overall Study|Withdrawal by Subject|2|||
105834825|NCT00493792|365051870|FG000|Overall Study|Death|55|||
105834826|NCT00493792|365051871|FG001|Overall Study|Death|50|||
105834827|NCT00493792|365051870|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
105834828|NCT00493792|365051871|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
105834829|NCT03008005|365051874|FG000|Overall Study|Physician Decision|1|||
105834830|NCT03008005|365051875|FG001|Overall Study|Physician Decision|0|||
105834831|NCT03008005|365051876|FG002|Overall Study|Physician Decision|0|||
105834832|NCT03008005|365051874|FG000|Overall Study|Withdrawal by Subject|1|||
105834833|NCT03008005|365051875|FG001|Overall Study|Withdrawal by Subject|0|||
105834834|NCT03008005|365051876|FG002|Overall Study|Withdrawal by Subject|0|||
105834835|NCT03008005|365051874|FG000|Overall Study|Ineligible|0|||
105834836|NCT03008005|365051875|FG001|Overall Study|Ineligible|1|||
105834837|NCT03008005|365051876|FG002|Overall Study|Ineligible|0|||
105834838|NCT01628549|365051877|FG000|Overall Study|Adverse Event|1|||
105834839|NCT01628549|365051878|FG001|Overall Study|Adverse Event|1|||
105834840|NCT01628549|365051879|FG002|Overall Study|Adverse Event|0|||
105834841|NCT01628549|365051880|FG003|Overall Study|Adverse Event|4|||
105834842|NCT01628549|365051877|FG000|Overall Study|Lost to Follow-up|3|||
105834843|NCT01628549|365051878|FG001|Overall Study|Lost to Follow-up|4|||
105834844|NCT01628549|365051879|FG002|Overall Study|Lost to Follow-up|3|||
105834845|NCT01628549|365051880|FG003|Overall Study|Lost to Follow-up|3|||
105834846|NCT01628549|365051877|FG000|Overall Study|Withdrawal by Subject|3|||
105834847|NCT01628549|365051878|FG001|Overall Study|Withdrawal by Subject|4|||
105834848|NCT01628549|365051879|FG002|Overall Study|Withdrawal by Subject|4|||
105834849|NCT01628549|365051880|FG003|Overall Study|Withdrawal by Subject|1|||
105834850|NCT01628549|365051877|FG000|Overall Study|Protocol Violation|2|||
105834851|NCT01628549|365051878|FG001|Overall Study|Protocol Violation|1|||
105834852|NCT01628549|365051879|FG002|Overall Study|Protocol Violation|1|||
105834853|NCT01628549|365051880|FG003|Overall Study|Protocol Violation|0|||
105834854|NCT01628549|365051877|FG000|Overall Study|withdrawn for noncompliance|0|||
105834855|NCT01628549|365051878|FG001|Overall Study|withdrawn for noncompliance|2|||
105834856|NCT01628549|365051879|FG002|Overall Study|withdrawn for noncompliance|1|||
105489727|NCT01264016|363805642|FG000|Overall Study|Felt faint at sight of blood|1|||
105489728|NCT06400979|363805643|FG000|Overall Study|Lost to Follow-up|29|||
105489729|NCT06400979|363805643|FG000|Overall Study|Withdrawal by Subject|1|||
105489730|NCT02675231|363805646|FG000|Overall Study|Withdrawal by Subject|2|||
105834857|NCT01628549|365051880|FG003|Overall Study|withdrawn for noncompliance|0|||
105834858|NCT01628549|365051877|FG000|Overall Study|abnormal laboratory test results|0|||
105834859|NCT01628549|365051878|FG001|Overall Study|abnormal laboratory test results|0|||
105834860|NCT01628549|365051879|FG002|Overall Study|abnormal laboratory test results|1|||
105834861|NCT01628549|365051880|FG003|Overall Study|abnormal laboratory test results|0|||
105834862|NCT01628549|365051877|FG000|Overall Study|positive pregnancy test|0|||
105834863|NCT01628549|365051878|FG001|Overall Study|positive pregnancy test|0|||
105834864|NCT01628549|365051879|FG002|Overall Study|positive pregnancy test|0|||
105834865|NCT01628549|365051880|FG003|Overall Study|positive pregnancy test|1|||
105834866|NCT03480022|365051885|FG000|Overall Study|Pregnancy|2|||
105834867|NCT03480022|365051886|FG001|Overall Study|Pregnancy|0|||
105834868|NCT03480022|365051885|FG000|Overall Study|Adverse Event|6|||
105834869|NCT03480022|365051886|FG001|Overall Study|Adverse Event|0|||
105834870|NCT03480022|365051885|FG000|Overall Study|Lack of Efficacy|0|||
105834871|NCT03480022|365051886|FG001|Overall Study|Lack of Efficacy|2|||
105834872|NCT03480022|365051885|FG000|Overall Study|Physician Decision|0|||
105834873|NCT03480022|365051886|FG001|Overall Study|Physician Decision|1|||
105834874|NCT03480022|365051885|FG000|Overall Study|Withdrawal by Subject|2|||
105834875|NCT03480022|365051886|FG001|Overall Study|Withdrawal by Subject|0|||
105834876|NCT03480022|365051885|FG000|Overall Study|Medication concerns|1|||
105834877|NCT03480022|365051886|FG001|Overall Study|Medication concerns|0|||
105834878|NCT03480022|365051885|FG000|Overall Study|Family member COVID exposure|0|||
105834879|NCT03480022|365051886|FG001|Overall Study|Family member COVID exposure|1|||
105834880|NCT02050321|365051891|FG000|Overall Study|Withdrawal by Subject|1|||
105834881|NCT02050321|365051891|FG000|Overall Study|Adverse Event|1|||
105834882|NCT04768114|365051892|FG000|Overall Study|Lost to Follow-up|5|||
105834883|NCT04768114|365051893|FG001|Overall Study|Lost to Follow-up|10|||
105834884|NCT04768114|365051892|FG000|Overall Study|Withdrawal by Subject|0|||
105834885|NCT04768114|365051893|FG001|Overall Study|Withdrawal by Subject|1|||
105834886|NCT00113919|365051894|FG000|Overall Study|Physician Decision|8|||
105834887|NCT00113919|365051894|FG000|Overall Study|Death|6|||
105834888|NCT02005276|365051895|FG000|Overall Study|No longer interested|5|||
105834889|NCT02005276|365051896|FG001|Overall Study|No longer interested|2|||
105834890|NCT02005276|365051897|FG002|Overall Study|No longer interested|3|||
105834891|NCT02005276|365051898|FG003|Overall Study|No longer interested|3|||
105834892|NCT01963260|365051899|FG000|Overall Study|Withdrawal by Subject|2|||
105834893|NCT01963260|365051900|FG001|Overall Study|Withdrawal by Subject|0|||
105834894|NCT01963260|365051901|FG002|Overall Study|Withdrawal by Subject|0|||
105834895|NCT01963260|365051902|FG003|Overall Study|Withdrawal by Subject|1|||
105834896|NCT01963260|365051903|FG004|Overall Study|Withdrawal by Subject|2|||
105834897|NCT01963260|365051904|FG005|Overall Study|Withdrawal by Subject|0|||
105834898|NCT01963260|365051905|FG006|Overall Study|Withdrawal by Subject|0|||
105834899|NCT01963260|365051906|FG007|Overall Study|Withdrawal by Subject|0|||
105834900|NCT01963260|365051907|FG008|Overall Study|Withdrawal by Subject|0|||
105834901|NCT01963260|365051908|FG009|Overall Study|Withdrawal by Subject|0|||
105834902|NCT00530348|365051909|FG000|Overall Study|Adverse Event|5|||
105489731|NCT02675231|363805647|FG001|Overall Study|Withdrawal by Subject|4|||
105489732|NCT02675231|363805648|FG002|Overall Study|Withdrawal by Subject|2|||
105489733|NCT02675231|363805646|FG000|Overall Study|Lost to Follow-up|3|||
105489734|NCT02675231|363805647|FG001|Overall Study|Lost to Follow-up|4|||
105489735|NCT02675231|363805648|FG002|Overall Study|Lost to Follow-up|3|||
105489736|NCT02652767|363805654|FG000|Overall Study|Death|2|||
105489737|NCT02652767|363805654|FG000|Overall Study|Lost to Follow-up|1|||
105489738|NCT02652767|363805654|FG000|Overall Study|Withdrawal by Subject|1|||
105489739|NCT01856023|363805656|FG000|Overall Study|Death|1|||
105834903|NCT00530348|365051910|FG001|Overall Study|Adverse Event|1|||
105834904|NCT00530348|365051909|FG000|Overall Study|Death|0|||
105834905|NCT00530348|365051910|FG001|Overall Study|Death|1|||
105834906|NCT00530348|365051909|FG000|Overall Study|Lack of Efficacy|2|||
105834907|NCT00530348|365051910|FG001|Overall Study|Lack of Efficacy|0|||
105834908|NCT00530348|365051909|FG000|Overall Study|Lost to Follow-up|0|||
105834909|NCT00530348|365051910|FG001|Overall Study|Lost to Follow-up|2|||
105834910|NCT00530348|365051909|FG000|Overall Study|Physician Decision|1|||
105834911|NCT00530348|365051910|FG001|Overall Study|Physician Decision|2|||
105834912|NCT00530348|365051909|FG000|Overall Study|Pregnancy|1|||
105834913|NCT00530348|365051910|FG001|Overall Study|Pregnancy|0|||
105834914|NCT00530348|365051909|FG000|Overall Study|Withdrawal by Subject|12|||
105834915|NCT00530348|365051910|FG001|Overall Study|Withdrawal by Subject|12|||
105834916|NCT00530348|365051909|FG000|Overall Study|Randomised in error|1|||
105834917|NCT00530348|365051910|FG001|Overall Study|Randomised in error|0|||
105834918|NCT00530348|365051909|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
105834919|NCT00530348|365051910|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
105834920|NCT00372996|365051911|FG000|Overall Study|Death|11|||
105834921|NCT00372996|365051912|FG001|Overall Study|Death|4|||
105834922|NCT00372996|365051913|FG002|Overall Study|Death|8|||
105834923|NCT00372996|365051914|FG003|Overall Study|Death|7|||
105834924|NCT00372996|365051911|FG000|Overall Study|Lost to Follow-up|0|||
105834925|NCT00372996|365051912|FG001|Overall Study|Lost to Follow-up|2|||
105834926|NCT00372996|365051913|FG002|Overall Study|Lost to Follow-up|0|||
105834927|NCT00372996|365051914|FG003|Overall Study|Lost to Follow-up|1|||
105834928|NCT00372996|365051911|FG000|Overall Study|Withdrawal by Subject|12|||
105834929|NCT00372996|365051912|FG001|Overall Study|Withdrawal by Subject|6|||
105834930|NCT00372996|365051913|FG002|Overall Study|Withdrawal by Subject|9|||
105834931|NCT00372996|365051914|FG003|Overall Study|Withdrawal by Subject|5|||
105834932|NCT00372996|365051911|FG000|Overall Study|Study Terminated by Sponsor|4|||
105834933|NCT00372996|365051912|FG001|Overall Study|Study Terminated by Sponsor|0|||
105834934|NCT00372996|365051913|FG002|Overall Study|Study Terminated by Sponsor|4|||
105834935|NCT00372996|365051914|FG003|Overall Study|Study Terminated by Sponsor|0|||
105834936|NCT00372996|365051911|FG000|Overall Study|Other|10|||
105834937|NCT00372996|365051912|FG001|Overall Study|Other|2|||
105834938|NCT00372996|365051913|FG002|Overall Study|Other|7|||
105834939|NCT00372996|365051914|FG003|Overall Study|Other|7|||
105834940|NCT01091363|365051915|FG000|Overall Study|Withdrawal by Subject|11|||
105834941|NCT01091363|365051916|FG001|Overall Study|Withdrawal by Subject|15|||
105310359|NCT03610516|363134278|FG001|Post-Treatment Follow-up|Death|0|||
105310360|NCT01555671|363134281|FG000|Overall Study|Physician Decision|20|||
105310361|NCT01555671|363134282|FG001|Overall Study|Physician Decision|25|||
105310362|NCT00000378|363134289|FG000|Overall Study|Lack of Efficacy|16|||
105310363|NCT00000378|363134290|FG001|Overall Study|Lack of Efficacy|14|||
105310364|NCT00660907|363134291|FG000|Overall Study|Incorrect Enrollment|1|||
105310365|NCT00660907|363134292|FG001|Overall Study|Incorrect Enrollment|1|||
105310366|NCT00660907|363134291|FG000|Overall Study|Adverse Event|33|||
105310367|NCT00660907|363134292|FG001|Overall Study|Adverse Event|19|||
105310368|NCT00660907|363134291|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
105310369|NCT00660907|363134292|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
105310370|NCT00660907|363134291|FG000|Overall Study|Withdrawal by Subject|23|||
105310371|NCT00660907|363134292|FG001|Overall Study|Withdrawal by Subject|32|||
105310372|NCT00660907|363134291|FG000|Overall Study|Lost to Follow-up|3|||
105310373|NCT00660907|363134292|FG001|Overall Study|Lost to Follow-up|3|||
105310374|NCT00660907|363134291|FG000|Overall Study|Poor/Non-Compliance|5|||
105310375|NCT00660907|363134292|FG001|Overall Study|Poor/Non-Compliance|1|||
105310376|NCT00660907|363134291|FG000|Overall Study|Safety|1|||
105310377|NCT00660907|363134292|FG001|Overall Study|Safety|0|||
105310378|NCT00660907|363134291|FG000|Overall Study|Death|1|||
105310379|NCT00660907|363134292|FG001|Overall Study|Death|3|||
105310380|NCT00660907|363134291|FG000|Overall Study|Various|11|||
105310381|NCT00660907|363134292|FG001|Overall Study|Various|8|||
105310382|NCT00631657|363134297|FG000|6-Month Treatment Period|Adverse Event|47|||
105310383|NCT00631657|363134298|FG001|6-Month Treatment Period|Adverse Event|0|||
105310384|NCT00631657|363134299|FG002|6-Month Treatment Period|Adverse Event|7|||
105310385|NCT00631657|363134297|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
105310386|NCT00631657|363134298|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
105310387|NCT00631657|363134299|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
105310388|NCT00631657|363134297|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
105310389|NCT00631657|363134298|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
105310390|NCT00631657|363134299|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
105310391|NCT00631657|363134297|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
105310392|NCT00631657|363134298|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
105310393|NCT00631657|363134299|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
105310394|NCT00631657|363134297|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
105310395|NCT00631657|363134298|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
105367207|NCT02717195|363350153|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
105834942|NCT01091363|365051915|FG000|Overall Study|Lost to Follow-up|2|||
105834943|NCT01091363|365051916|FG001|Overall Study|Lost to Follow-up|2|||
105310396|NCT00631657|363134299|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
105310397|NCT00631657|363134297|FG000|6-Month Treatment Period|Other|16|||
105310398|NCT00631657|363134298|FG001|6-Month Treatment Period|Other|0|||
105310399|NCT00631657|363134299|FG002|6-Month Treatment Period|Other|4|||
105834944|NCT03419962|365051919|FG000|Overall Study|Change to other medication|1|||
105310400|NCT00631657|363134297|FG000|6-Month Treatment Period|Not Treated|2|||
105310401|NCT00631657|363134298|FG001|6-Month Treatment Period|Not Treated|0|||
105310402|NCT00631657|363134299|FG002|6-Month Treatment Period|Not Treated|1|||
105310403|NCT00631657|363134297|FG000|7-Day Discontinuation Period|Not Treated|1|||
105310404|NCT00631657|363134298|FG001|7-Day Discontinuation Period|Not Treated|1|||
105834945|NCT03419962|365051919|FG000|Overall Study|Refusal of continuing with trial drug|1|||
105834946|NCT03419962|365051919|FG000|Overall Study|Lost to Follow-up|3|||
105834947|NCT03419962|365051919|FG000|Overall Study|Difficulty in inhaling the doses|1|||
105834948|NCT03419962|365051919|FG000|Overall Study|Missing completion data|31|||
105834949|NCT01781234|365051922|FG000|Overall Study|Adverse Event|2|||
105834950|NCT01781234|365051923|FG001|Overall Study|Adverse Event|0|||
105834951|NCT01781234|365051922|FG000|Overall Study|Protocol Violation|3|||
105834952|NCT01781234|365051923|FG001|Overall Study|Protocol Violation|0|||
105834953|NCT01781234|365051922|FG000|Overall Study|Withdrawal by Subject|4|||
105834954|NCT01781234|365051923|FG001|Overall Study|Withdrawal by Subject|3|||
105834955|NCT00721955|365051924|FG000|Overall Study|Adverse Event|0|||
105834956|NCT00721955|365051925|FG001|Overall Study|Adverse Event|0|||
105834957|NCT00721955|365051926|FG002|Overall Study|Adverse Event|2|||
105834958|NCT03439085|365051927|FG000|Overall Study|Death|2|||
105834959|NCT03439085|365051927|FG000|Overall Study|Screen Failure|20|||
105834960|NCT01863433|365051928|FG000|Overall Study|Protocol Violation|1|||
105834961|NCT01206439|365051930|FG000|Overall Study|subject did not meet inclusion criteria|1|||
105834962|NCT05889039|365051931|FG000|Overall Study|error in completing survey|0|||
105834963|NCT05889039|365051932|FG001|Overall Study|error in completing survey|2|||
105834964|NCT05889039|365051933|FG002|Overall Study|error in completing survey|0|||
105834965|NCT05889039|365051934|FG003|Overall Study|error in completing survey|0|||
105834966|NCT05889039|365051931|FG000|Overall Study|Lost to Follow-up|4|||
105834967|NCT05889039|365051932|FG001|Overall Study|Lost to Follow-up|0|||
105834968|NCT05889039|365051933|FG002|Overall Study|Lost to Follow-up|0|||
105834969|NCT05889039|365051934|FG003|Overall Study|Lost to Follow-up|0|||
105834970|NCT00725764|365051937|FG000|Overall Study|Withdrawal by Subject|2|||
105834971|NCT00725764|365051937|FG000|Overall Study|Physician Decision|1|||
105834972|NCT00725764|365051937|FG000|Overall Study|Progressive Disease|7|||
105834973|NCT00725764|365051937|FG000|Overall Study|Lost to Follow-up|1|||
105834974|NCT00725764|365051937|FG000|Overall Study|Death|1|||
105834975|NCT00725764|365051937|FG000|Overall Study|Participant non compliant with protocol|1|||
105367208|NCT02717195|363350154|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
105367209|NCT02717195|363350155|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
105367210|NCT02717195|363350156|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
105367211|NCT02717195|363350157|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
105367212|NCT02717195|363350153|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
105367213|NCT02717195|363350154|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
105367214|NCT02717195|363350155|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
105367215|NCT02717195|363350156|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
105367216|NCT02717195|363350157|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
105367217|NCT02717195|363350153|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
105367218|NCT02717195|363350154|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
105367219|NCT02717195|363350155|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
105367220|NCT02717195|363350156|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
105367221|NCT02717195|363350157|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
105367222|NCT02717195|363350153|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
105367223|NCT02717195|363350154|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
105367224|NCT02717195|363350155|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
105367225|NCT02717195|363350156|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
105367226|NCT02717195|363350157|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
105367227|NCT02717195|363350153|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
105367228|NCT02717195|363350154|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
105367229|NCT02717195|363350155|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
105367230|NCT02717195|363350156|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
105367231|NCT02717195|363350157|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
105367232|NCT02717195|363350153|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
105367233|NCT02717195|363350154|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
105367234|NCT02717195|363350155|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
105367235|NCT02717195|363350156|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
105367236|NCT02717195|363350157|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
105367237|NCT02717195|363350153|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
105367238|NCT02717195|363350154|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
105367239|NCT02717195|363350155|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
105367240|NCT02717195|363350156|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
105367241|NCT02717195|363350157|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
105834976|NCT00725764|365051937|FG000|Overall Study|Decline in performance status|1|||
105834977|NCT02972515|365051938|FG000|Overall Study|Lost to Follow-up|78|||
105834978|NCT04531527|365051939|FG000|Overall Study|Found to be Ineligible|3|||
105834979|NCT03428945|365051955|FG000|Overall Study|Lost to Follow-up|5|||
105834980|NCT03428945|365051956|FG001|Overall Study|Lost to Follow-up|3|||
105834981|NCT03428945|365051955|FG000|Overall Study|Withdrawal by Subject|10|||
105834982|NCT03428945|365051956|FG001|Overall Study|Withdrawal by Subject|10|||
105834983|NCT02522780|365051961|FG000|Overall Study|Consent withdrawn by subject|5|||
105834984|NCT02522780|365051962|FG001|Overall Study|Consent withdrawn by subject|7|||
105834985|NCT02522780|365051961|FG000|Overall Study|Protocol deviation|1|||
105834986|NCT02522780|365051962|FG001|Overall Study|Protocol deviation|3|||
105834987|NCT02522780|365051961|FG000|Overall Study|Subject refused endoscopic procedure|0|||
105834988|NCT02522780|365051962|FG001|Overall Study|Subject refused endoscopic procedure|1|||
105834989|NCT02522780|365051961|FG000|Overall Study|Adverse event, non-fatal|11|||
105834990|NCT02522780|365051962|FG001|Overall Study|Adverse event, non-fatal|16|||
105834991|NCT02058160|365051963|FG000|Overall Study|Randomized but not treated|2|||
105834992|NCT02058160|365051964|FG001|Overall Study|Randomized but not treated|4|||
105834993|NCT02058160|365051963|FG000|Overall Study|Poor compliance to protocol|4|||
105834994|NCT02058160|365051964|FG001|Overall Study|Poor compliance to protocol|1|||
105834995|NCT02058160|365051963|FG000|Overall Study|Adverse Event|12|||
105834996|NCT02058160|365051964|FG001|Overall Study|Adverse Event|3|||
105834997|NCT02058160|365051963|FG000|Overall Study|Lost to Follow-up|1|||
105834998|NCT02058160|365051964|FG001|Overall Study|Lost to Follow-up|0|||
105834999|NCT02058160|365051963|FG000|Overall Study|Other than specified above|12|||
105835000|NCT02058160|365051964|FG001|Overall Study|Other than specified above|6|||
105835001|NCT01203917|365051967|FG000|Overall Study|Death|29|||
105835002|NCT01203917|365051967|FG000|Overall Study|Lost to Follow-up|2|||
105835003|NCT01203917|365051967|FG000|Overall Study|Withdrawal by Subject|3|||
105835004|NCT01203917|365051967|FG000|Overall Study|Due to objective disease progression|1|||
105835005|NCT01203917|365051967|FG000|Overall Study|Due to EGFR M+I patient|1|||
105835006|NCT02427399|365051968|FG000|Overall Study|Protocol Violation|14|||
105835007|NCT02427399|365051969|FG001|Overall Study|Protocol Violation|16|||
105835008|NCT02427399|365051970|FG002|Overall Study|Protocol Violation|12|||
105835009|NCT02427399|365051971|FG003|Overall Study|Protocol Violation|18|||
105835010|NCT02427399|365051972|FG004|Overall Study|Protocol Violation|15|||
105835011|NCT01115933|365051973|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
105835012|NCT00926367|365051974|FG000|Overall Study|Withdrawal by Subject|0|||
105835013|NCT00926367|365051975|FG001|Overall Study|Withdrawal by Subject|1|||
105835014|NCT00926367|365051974|FG000|Overall Study|Lost to Follow-up|1|||
105835015|NCT00926367|365051975|FG001|Overall Study|Lost to Follow-up|0|||
105835016|NCT00926367|365051974|FG000|Overall Study|Skin Irritation|1|||
105835017|NCT00926367|365051975|FG001|Overall Study|Skin Irritation|2|||
105835018|NCT03294317|365051976|FG000|Overall Study|Physician Decision|1|||
105835019|NCT03294317|365051976|FG000|Overall Study|Withdrawal by Subject|6|||
105835020|NCT03294317|365051976|FG000|Overall Study|Lost to Follow-up|1|||
105835021|NCT03294317|365051976|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
105835022|NCT03294317|365051976|FG000|Overall Study|Failed HB lead implant|8|||
105835023|NCT03294317|365051976|FG000|Overall Study|Received CRT instead|1|||
105835024|NCT03294317|365051976|FG000|Overall Study|Exited after lead revision|2|||
105835025|NCT01266603|365051977|FG000|Overall Study|Adverse Event|1|||
105835026|NCT01266603|365051977|FG000|Overall Study|Lack of Efficacy|14|||
105835027|NCT01266603|365051977|FG000|Overall Study|Withdrawal by Subject|1|||
105835028|NCT01266603|365051977|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
105835029|NCT02725411|365051978|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
105835030|NCT02725411|365051979|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
105835031|NCT02725411|365051980|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
105835032|NCT02725411|365051978|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
105835033|NCT02725411|365051979|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
105835034|NCT02725411|365051980|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
105835035|NCT02725411|365051978|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
105835036|NCT02725411|365051979|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
105835037|NCT02725411|365051980|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
105835038|NCT02725411|365051978|FG000|Treatment Period (56 Weeks)|Other|1|||
105835039|NCT02725411|365051979|FG001|Treatment Period (56 Weeks)|Other|4|||
105835040|NCT02725411|365051980|FG002|Treatment Period (56 Weeks)|Other|5|||
105835041|NCT02725411|365051978|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
105835042|NCT02725411|365051979|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
105835043|NCT02725411|365051980|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
105835044|NCT02725411|365051978|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
105835045|NCT02725411|365051979|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
105835046|NCT02725411|365051980|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
105835047|NCT02725411|365051978|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
105835048|NCT02725411|365051979|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
105835049|NCT02725411|365051980|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
105835050|NCT02725411|365051978|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
105835051|NCT02725411|365051979|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
105835052|NCT02725411|365051980|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
105835053|NCT02725411|365051978|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
105835054|NCT02725411|365051979|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
105835055|NCT02725411|365051980|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
105576479|NCT04157686|364108540|FG003|Overall Study|Protocol Violation|0|||
105576480|NCT04157686|364108541|FG004|Overall Study|Protocol Violation|1|||
105835056|NCT02725411|365051978|FG000|Follow-up Period (24 Weeks)|Other|1|||
105835057|NCT02725411|365051979|FG001|Follow-up Period (24 Weeks)|Other|4|||
105835058|NCT02725411|365051980|FG002|Follow-up Period (24 Weeks)|Other|2|||
105835059|NCT02725411|365051978|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
105835060|NCT02725411|365051979|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
105835061|NCT02725411|365051980|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
105835062|NCT02786927|365051981|FG000|Overall Study|Adverse Event|1|||
105835063|NCT02786927|365051981|FG000|Overall Study|Protocol Violation|4|||
105835064|NCT01685216|365051982|FG000|Overall Study|Did not receive study drug|1|||
105835065|NCT02911935|365051985|FG000|Overall Study|Lost to Follow-up|5|||
105835066|NCT02911935|365051986|FG001|Overall Study|Lost to Follow-up|7|||
105835067|NCT00756717|365051987|FG000|Overall Study|Withdrawal by Subject|2|||
105835068|NCT00685750|365051988|FG000|Overall Study|Tumor sampling failure|0|||
105835069|NCT00685750|365051989|FG001|Overall Study|Tumor sampling failure|0|||
105835070|NCT00685750|365051990|FG002|Overall Study|Tumor sampling failure|1|||
105835071|NCT00685750|365051991|FG003|Overall Study|Tumor sampling failure|0|||
105835072|NCT00685750|365051992|FG004|Overall Study|Tumor sampling failure|0|||
105835073|NCT00685750|365051993|FG005|Overall Study|Tumor sampling failure|0|||
105835074|NCT00685750|365051994|FG006|Overall Study|Tumor sampling failure|0|||
105835075|NCT00685750|365051988|FG000|Overall Study|Patient didn't receive the treatment|0|||
105835076|NCT00685750|365051989|FG001|Overall Study|Patient didn't receive the treatment|0|||
105835077|NCT00685750|365051990|FG002|Overall Study|Patient didn't receive the treatment|0|||
105835078|NCT00685750|365051991|FG003|Overall Study|Patient didn't receive the treatment|0|||
105835079|NCT00685750|365051992|FG004|Overall Study|Patient didn't receive the treatment|0|||
105835080|NCT00685750|365051993|FG005|Overall Study|Patient didn't receive the treatment|0|||
105835081|NCT00685750|365051994|FG006|Overall Study|Patient didn't receive the treatment|1|||
105835082|NCT00685750|365051988|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105835083|NCT00685750|365051989|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105835084|NCT00685750|365051990|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
105835085|NCT00685750|365051991|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
105835086|NCT00685750|365051992|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
105835087|NCT00685750|365051993|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
105835088|NCT00685750|365051994|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
105835089|NCT02654015|365051995|FG000|Overall Study|Death|12|||
105835090|NCT02654015|365051995|FG000|Overall Study|Lost to Follow-up|3|||
105835091|NCT01896505|365051996|FG000|Overall Study|Adverse Event|1|||
105835092|NCT01896505|365051997|FG001|Overall Study|Adverse Event|0|||
105835093|NCT01896505|365051998|FG002|Overall Study|Adverse Event|2|||
105835094|NCT01896505|365051999|FG003|Overall Study|Adverse Event|1|||
105835095|NCT01896505|365052000|FG004|Overall Study|Adverse Event|1|||
105835096|NCT01896505|365052001|FG005|Overall Study|Adverse Event|0|||
105835097|NCT01896505|365051996|FG000|Overall Study|Physician Decision|1|||
105835098|NCT01896505|365051997|FG001|Overall Study|Physician Decision|3|||
105835099|NCT01896505|365051998|FG002|Overall Study|Physician Decision|2|||
105835100|NCT01896505|365051999|FG003|Overall Study|Physician Decision|0|||
105835101|NCT01896505|365052000|FG004|Overall Study|Physician Decision|0|||
105835102|NCT01896505|365052001|FG005|Overall Study|Physician Decision|1|||
105835103|NCT01896505|365051996|FG000|Overall Study|Withdrawal by Subject|1|||
105835104|NCT01896505|365051997|FG001|Overall Study|Withdrawal by Subject|0|||
105835105|NCT01896505|365051998|FG002|Overall Study|Withdrawal by Subject|3|||
105835106|NCT01896505|365051999|FG003|Overall Study|Withdrawal by Subject|1|||
105835107|NCT01896505|365052000|FG004|Overall Study|Withdrawal by Subject|0|||
105835108|NCT01896505|365052001|FG005|Overall Study|Withdrawal by Subject|0|||
105835109|NCT01896505|365051996|FG000|Overall Study|Disease Progression|7|||
105835110|NCT01896505|365051997|FG001|Overall Study|Disease Progression|5|||
105835111|NCT01896505|365051998|FG002|Overall Study|Disease Progression|8|||
105835112|NCT01896505|365051999|FG003|Overall Study|Disease Progression|4|||
105310405|NCT00631657|363134299|FG002|7-Day Discontinuation Period|Not Treated|1|||
105310406|NCT00631657|363134297|FG000|7-Day Discontinuation Period|Other|1|||
105835113|NCT01896505|365052000|FG004|Overall Study|Disease Progression|4|||
105835114|NCT01896505|365052001|FG005|Overall Study|Disease Progression|4|||
105835115|NCT01896505|365051996|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
105835116|NCT01896505|365051997|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
105310407|NCT00631657|363134298|FG001|7-Day Discontinuation Period|Other|0|||
105310408|NCT00631657|363134299|FG002|7-Day Discontinuation Period|Other|0|||
105310409|NCT02886624|363134303|FG000|12-week Post Treatment Follow-up|Death|1|||
105310410|NCT02886624|363134303|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
105835117|NCT01896505|365051998|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
105835118|NCT01896505|365051999|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
105835119|NCT01896505|365052000|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
105835120|NCT01896505|365052001|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
105835121|NCT01896505|365051996|FG000|Overall Study|Intercurrent illness|0|||
105835122|NCT01896505|365051997|FG001|Overall Study|Intercurrent illness|1|||
105310411|NCT00805675|363134310|FG000|Overall Study|Adverse Event|0|||
105310412|NCT00805675|363134311|FG001|Overall Study|Adverse Event|0|||
105310413|NCT00805675|363134312|FG002|Overall Study|Adverse Event|1|||
105835123|NCT01896505|365051998|FG002|Overall Study|Intercurrent illness|0|||
105835124|NCT01896505|365051999|FG003|Overall Study|Intercurrent illness|0|||
105835125|NCT01896505|365052000|FG004|Overall Study|Intercurrent illness|0|||
105835126|NCT01896505|365052001|FG005|Overall Study|Intercurrent illness|0|||
105835127|NCT01896505|365051996|FG000|Overall Study|Death|0|||
105835128|NCT01896505|365051997|FG001|Overall Study|Death|0|||
105835129|NCT01896505|365051998|FG002|Overall Study|Death|1|||
105835130|NCT01896505|365051999|FG003|Overall Study|Death|1|||
105835131|NCT01896505|365052000|FG004|Overall Study|Death|0|||
105835132|NCT01896505|365052001|FG005|Overall Study|Death|1|||
105835133|NCT00250705|365052004|FG000|Overall Study|Lack of Efficacy|2|||
105835134|NCT00889252|365052008|FG000|Overall Study|Adverse Event|2|||
105835135|NCT00889252|365052009|FG001|Overall Study|Adverse Event|4|||
105835136|NCT00889252|365052008|FG000|Overall Study|Withdrawal by Subject|3|||
105835137|NCT00889252|365052009|FG001|Overall Study|Withdrawal by Subject|0|||
105835138|NCT00889252|365052008|FG000|Overall Study|Protocol Violation|2|||
105835139|NCT00889252|365052009|FG001|Overall Study|Protocol Violation|0|||
105835140|NCT01020526|365052010|FG000|Overall Study|Withdrawal by Subject|5|||
105835141|NCT01020526|365052010|FG000|Overall Study|Other reasons|3|||
105835142|NCT01020526|365052010|FG000|Overall Study|Insufficient clinical response|3|||
105835143|NCT01020526|365052010|FG000|Overall Study|Lost to Follow-up|1|||
105835144|NCT01020526|365052010|FG000|Overall Study|Adverse Event|2|||
105835145|NCT00420095|365052016|FG000|Overall Study|Adverse Event|1|||
105835146|NCT00420095|365052017|FG001|Overall Study|Adverse Event|0|||
105835147|NCT00420095|365052016|FG000|Overall Study|Protocol Violation|1|||
105835148|NCT00420095|365052017|FG001|Overall Study|Protocol Violation|1|||
105835149|NCT00420095|365052016|FG000|Overall Study|Lost to Follow-up|1|||
105835150|NCT00420095|365052017|FG001|Overall Study|Lost to Follow-up|0|||
105835151|NCT01378962|365052018|FG000|Overall Study|Death|14|||
105835152|NCT01378962|365052018|FG000|Overall Study|Lost to Follow-up|1|||
105835153|NCT01378962|365052018|FG000|Overall Study|Other|2|||
105835154|NCT02129062|365053681|FG000|Overall Study|Death|1|||
105835155|NCT02129062|365053681|FG000|Overall Study|Disease Progression|2|||
105835156|NCT02940522|365053682|FG000|Overall Study|Lost to Follow-up|1|||
105835157|NCT02940522|365053683|FG001|Overall Study|Lost to Follow-up|2|||
105835158|NCT02940522|365053682|FG000|Overall Study|Withdrawal by Subject|1|||
105835159|NCT02940522|365053683|FG001|Overall Study|Withdrawal by Subject|0|||
105835160|NCT00559637|365053684|FG000|Overall Study|Adverse Event|22|||
105835161|NCT00559637|365053684|FG000|Overall Study|Withdrawal by Subject|4|||
105835162|NCT00559637|365053684|FG000|Overall Study|Protocol Violation|6|||
105835163|NCT00559637|365053684|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
105835164|NCT00559637|365053684|FG000|Overall Study|Failure to return|6|||
105835165|NCT00559637|365053684|FG000|Overall Study|Insufficient response|3|||
105835166|NCT00559637|365053684|FG000|Overall Study|Started requiring dialysis after month 7|2|||
105835167|NCT00559637|365053684|FG000|Overall Study|Suspected lung cancer|1|||
105835168|NCT00559637|365053684|FG000|Overall Study|Participation in another study|1|||
105835169|NCT00559637|365053684|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
105835170|NCT00559637|365053684|FG000|Overall Study|Change of center|1|||
105835171|NCT00559637|365053684|FG000|Overall Study|Change of home|1|||
105835172|NCT00559637|365053684|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
105835173|NCT02832167|365053685|FG000|Treatment Period 1|Disease progression|90|||
105835174|NCT02832167|365053685|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
105835175|NCT02832167|365053685|FG000|Treatment Period 1|Death|2|||
105835176|NCT02832167|365053685|FG000|Treatment Period 1|Study Drug Toxicity|6|||
105835177|NCT02832167|365053685|FG000|Treatment Period 1|Participant request to discontinue|9|||
105835178|NCT02832167|365053685|FG000|Treatment Period 1|No longer meet study criteria|1|||
105835179|NCT02832167|365053685|FG000|Treatment Period 1|Participant withdrew consent|3|||
105835180|NCT02832167|365053685|FG000|Treatment Period 1|Other reasons|6|||
105835181|NCT02832167|365053685|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
105835182|NCT02832167|365053685|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
105835183|NCT02832167|365053685|FG000|Transition From Period 1 to Period 2|Death|2|||
105310414|NCT02585934|363134315|FG000|Overall Study|Lost to Follow-up|2|||
105310415|NCT02585934|363134316|FG001|Overall Study|Lost to Follow-up|2|||
105576481|NCT04157686|364108542|FG005|Overall Study|Protocol Violation|0|||
105835184|NCT02832167|365053685|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
105310416|NCT02585934|363134315|FG000|Overall Study|Protocol Violation|14|||
105310417|NCT02585934|363134316|FG001|Overall Study|Protocol Violation|11|||
105835185|NCT02832167|365053685|FG000|Treatment Period 2|Disease progression|69|||
105835186|NCT02832167|365053685|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
105835187|NCT02832167|365053685|FG000|Treatment Period 2|Maximum clinical benefit|1|||
105835188|NCT02832167|365053685|FG000|Treatment Period 2|Study Drug Toxicity|5|||
105835189|NCT02832167|365053685|FG000|Treatment Period 2|Participant request to discontinue|2|||
105835190|NCT02832167|365053685|FG000|Treatment Period 2|Participant withdrew consent|3|||
105835191|NCT02832167|365053685|FG000|Treatment Period 2|Other reasons|3|||
105835192|NCT00685035|365053686|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
105310418|NCT02585934|363134315|FG000|Overall Study|Adverse Event|21|||
105489740|NCT01856023|363805657|FG001|Overall Study|Death|2|||
105489741|NCT01856023|363805656|FG000|Overall Study|Adverse Event|2|||
105835193|NCT00685035|365053687|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
105835194|NCT01235715|365053688|FG000|Overall Study|Physician Decision|0|||
105835195|NCT01235715|365053689|FG001|Overall Study|Physician Decision|2|||
105835196|NCT00687739|365053697|FG000|Overall Study|Lost to Follow-up|2|||
105835197|NCT00687739|365053698|FG001|Overall Study|Lost to Follow-up|2|||
105835198|NCT00687739|365053699|FG002|Overall Study|Lost to Follow-up|1|||
105835199|NCT00687739|365053700|FG003|Overall Study|Lost to Follow-up|2|||
105835200|NCT00687739|365053697|FG000|Overall Study|Adverse Event|0|||
105835201|NCT00687739|365053698|FG001|Overall Study|Adverse Event|1|||
105835202|NCT00687739|365053699|FG002|Overall Study|Adverse Event|1|||
105835203|NCT00687739|365053700|FG003|Overall Study|Adverse Event|0|||
105835204|NCT01190930|365053702|FG000|Induction|Adverse Event|17|||
105835205|NCT01190930|365053703|FG001|Induction|Adverse Event|0|||
105835206|NCT01190930|365053704|FG002|Induction|Adverse Event|0|||
105835207|NCT01190930|365053705|FG003|Induction|Adverse Event|0|||
105835208|NCT01190930|365053706|FG004|Induction|Adverse Event|0|||
105835209|NCT01190930|365053707|FG005|Induction|Adverse Event|0|||
105835210|NCT01190930|365053708|FG006|Induction|Adverse Event|0|||
105835211|NCT01190930|365053709|FG007|Induction|Adverse Event|0|||
105367242|NCT02717195|363350153|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
105367243|NCT02717195|363350154|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
105367244|NCT02717195|363350155|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
105367245|NCT02717195|363350156|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
105367246|NCT02717195|363350157|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
105367247|NCT02033759|363350158|FG000|Overall Study|Withdrawal by Subject|2|||
105835212|NCT01190930|365053710|FG008|Induction|Adverse Event|0|||
105835213|NCT01190930|365053711|FG009|Induction|Adverse Event|0|||
105835214|NCT01190930|365053702|FG000|Induction|Death|34|||
105835215|NCT01190930|365053703|FG001|Induction|Death|0|||
105835216|NCT01190930|365053704|FG002|Induction|Death|0|||
105835217|NCT01190930|365053705|FG003|Induction|Death|0|||
105835218|NCT01190930|365053706|FG004|Induction|Death|0|||
105835219|NCT01190930|365053707|FG005|Induction|Death|0|||
105835220|NCT01190930|365053708|FG006|Induction|Death|0|||
105835221|NCT01190930|365053709|FG007|Induction|Death|0|||
105835222|NCT01190930|365053710|FG008|Induction|Death|0|||
105835223|NCT01190930|365053711|FG009|Induction|Death|0|||
105835224|NCT01190930|365053702|FG000|Induction|Lost to Follow-up|1|||
105835225|NCT01190930|365053703|FG001|Induction|Lost to Follow-up|0|||
105835226|NCT01190930|365053704|FG002|Induction|Lost to Follow-up|0|||
105835227|NCT01190930|365053705|FG003|Induction|Lost to Follow-up|0|||
105835228|NCT01190930|365053706|FG004|Induction|Lost to Follow-up|0|||
105835229|NCT01190930|365053707|FG005|Induction|Lost to Follow-up|0|||
105835230|NCT01190930|365053708|FG006|Induction|Lost to Follow-up|0|||
105835231|NCT01190930|365053709|FG007|Induction|Lost to Follow-up|0|||
105835232|NCT01190930|365053710|FG008|Induction|Lost to Follow-up|0|||
105835233|NCT01190930|365053711|FG009|Induction|Lost to Follow-up|0|||
105835234|NCT01190930|365053702|FG000|Induction|Physician Decision|125|||
105835235|NCT01190930|365053703|FG001|Induction|Physician Decision|3|||
105835236|NCT01190930|365053704|FG002|Induction|Physician Decision|0|||
105835237|NCT01190930|365053705|FG003|Induction|Physician Decision|0|||
105835238|NCT01190930|365053706|FG004|Induction|Physician Decision|0|||
105835239|NCT01190930|365053707|FG005|Induction|Physician Decision|0|||
105835240|NCT01190930|365053708|FG006|Induction|Physician Decision|0|||
105367248|NCT02033759|363350159|FG001|Overall Study|Withdrawal by Subject|1|||
105367249|NCT02033759|363350158|FG000|Overall Study|Protocol Violation|1|||
105367250|NCT02033759|363350159|FG001|Overall Study|Protocol Violation|1|||
105367251|NCT01081626|363350163|FG000|Overall Study|Dosing error|1|||
105835241|NCT01190930|365053709|FG007|Induction|Physician Decision|0|||
105835242|NCT01190930|365053710|FG008|Induction|Physician Decision|0|||
105835243|NCT01190930|365053711|FG009|Induction|Physician Decision|0|||
105835244|NCT01190930|365053702|FG000|Induction|Withdrawal by Subject|9|||
105367252|NCT01081626|363350164|FG001|Overall Study|Dosing error|1|||
105835245|NCT01190930|365053703|FG001|Induction|Withdrawal by Subject|0|||
105835246|NCT01190930|365053704|FG002|Induction|Withdrawal by Subject|0|||
105367253|NCT01081626|363350163|FG000|Overall Study|Missing Estradiol|25|||
105835247|NCT01190930|365053705|FG003|Induction|Withdrawal by Subject|0|||
105835248|NCT01190930|365053706|FG004|Induction|Withdrawal by Subject|0|||
105835249|NCT01190930|365053707|FG005|Induction|Withdrawal by Subject|0|||
105489742|NCT01856023|363805657|FG001|Overall Study|Adverse Event|1|||
105835250|NCT01190930|365053708|FG006|Induction|Withdrawal by Subject|0|||
105835251|NCT01190930|365053709|FG007|Induction|Withdrawal by Subject|0|||
105489743|NCT01856023|363805656|FG000|Overall Study|Lack of Efficacy|5|||
105835252|NCT01190930|365053710|FG008|Induction|Withdrawal by Subject|0|||
105835253|NCT01190930|365053711|FG009|Induction|Withdrawal by Subject|0|||
105835254|NCT01190930|365053702|FG000|Induction|Refusal|235|||
105835255|NCT01190930|365053703|FG001|Induction|Refusal|0|||
105835256|NCT01190930|365053704|FG002|Induction|Refusal|0|||
105835257|NCT01190930|365053705|FG003|Induction|Refusal|0|||
105835258|NCT01190930|365053706|FG004|Induction|Refusal|0|||
105835259|NCT01190930|365053707|FG005|Induction|Refusal|0|||
105835260|NCT01190930|365053708|FG006|Induction|Refusal|0|||
105835261|NCT01190930|365053709|FG007|Induction|Refusal|0|||
105835262|NCT01190930|365053710|FG008|Induction|Refusal|0|||
105835263|NCT01190930|365053711|FG009|Induction|Refusal|0|||
105835264|NCT01190930|365053702|FG000|Induction|Inevaluable|23|||
105835265|NCT01190930|365053703|FG001|Induction|Inevaluable|1|||
105835266|NCT01190930|365053704|FG002|Induction|Inevaluable|0|||
105835267|NCT01190930|365053705|FG003|Induction|Inevaluable|0|||
105835268|NCT01190930|365053706|FG004|Induction|Inevaluable|0|||
105835269|NCT01190930|365053707|FG005|Induction|Inevaluable|0|||
105835270|NCT01190930|365053708|FG006|Induction|Inevaluable|0|||
105835271|NCT01190930|365053709|FG007|Induction|Inevaluable|0|||
105835272|NCT01190930|365053710|FG008|Induction|Inevaluable|0|||
105835273|NCT01190930|365053711|FG009|Induction|Inevaluable|0|||
105835274|NCT01190930|365053702|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
105835275|NCT01190930|365053703|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835276|NCT01190930|365053704|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835277|NCT01190930|365053705|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835278|NCT01190930|365053706|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835279|NCT01190930|365053707|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835280|NCT01190930|365053708|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835281|NCT01190930|365053709|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835282|NCT01190930|365053710|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835283|NCT01190930|365053711|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835284|NCT01190930|365053702|FG000|Induction|High Risk Downs|80|||
105835285|NCT01190930|365053703|FG001|Induction|High Risk Downs|0|||
105835286|NCT01190930|365053704|FG002|Induction|High Risk Downs|0|||
105835287|NCT01190930|365053705|FG003|Induction|High Risk Downs|0|||
105835288|NCT01190930|365053706|FG004|Induction|High Risk Downs|0|||
105835289|NCT01190930|365053707|FG005|Induction|High Risk Downs|0|||
105835290|NCT01190930|365053708|FG006|Induction|High Risk Downs|0|||
105835291|NCT01190930|365053709|FG007|Induction|High Risk Downs|0|||
105835292|NCT01190930|365053710|FG008|Induction|High Risk Downs|0|||
105835293|NCT01190930|365053711|FG009|Induction|High Risk Downs|0|||
105835294|NCT01190930|365053702|FG000|Induction|Enrollment onto another COG Protocol|1|||
105835295|NCT01190930|365053703|FG001|Induction|Enrollment onto another COG Protocol|0|||
105835296|NCT01190930|365053704|FG002|Induction|Enrollment onto another COG Protocol|0|||
105835297|NCT01190930|365053705|FG003|Induction|Enrollment onto another COG Protocol|0|||
105835298|NCT01190930|365053706|FG004|Induction|Enrollment onto another COG Protocol|0|||
105835299|NCT01190930|365053707|FG005|Induction|Enrollment onto another COG Protocol|0|||
105835300|NCT01190930|365053708|FG006|Induction|Enrollment onto another COG Protocol|0|||
105835301|NCT01190930|365053709|FG007|Induction|Enrollment onto another COG Protocol|0|||
105835302|NCT01190930|365053710|FG008|Induction|Enrollment onto another COG Protocol|0|||
105835303|NCT01190930|365053711|FG009|Induction|Enrollment onto another COG Protocol|0|||
105835304|NCT01190930|365053702|FG000|Induction|Average Risk|1847|||
105310419|NCT02585934|363134316|FG001|Overall Study|Adverse Event|22|||
105310420|NCT02585934|363134315|FG000|Overall Study|Physician Decision|3|||
105835305|NCT01190930|365053703|FG001|Induction|Average Risk|0|||
105835306|NCT01190930|365053704|FG002|Induction|Average Risk|0|||
105835307|NCT01190930|365053705|FG003|Induction|Average Risk|0|||
105835308|NCT01190930|365053706|FG004|Induction|Average Risk|0|||
105835309|NCT01190930|365053707|FG005|Induction|Average Risk|0|||
105835310|NCT01190930|365053708|FG006|Induction|Average Risk|0|||
105835311|NCT01190930|365053709|FG007|Induction|Average Risk|0|||
105835312|NCT01190930|365053710|FG008|Induction|Average Risk|0|||
105835313|NCT01190930|365053711|FG009|Induction|Average Risk|0|||
105835314|NCT01190930|365053702|FG000|Induction|High Risk|1227|||
105835315|NCT01190930|365053703|FG001|Induction|High Risk|0|||
105310421|NCT02585934|363134316|FG001|Overall Study|Physician Decision|2|||
105489744|NCT01856023|363805657|FG001|Overall Study|Lack of Efficacy|5|||
105489745|NCT01856023|363805656|FG000|Overall Study|non compliance, study closure|1|||
105489746|NCT01856023|363805657|FG001|Overall Study|non compliance, study closure|3|||
105489747|NCT01856023|363805656|FG000|Overall Study|Withdrawal by Subject|1|||
105835316|NCT01190930|365053704|FG002|Induction|High Risk|0|||
105835317|NCT01190930|365053705|FG003|Induction|High Risk|0|||
105310422|NCT02585934|363134315|FG000|Overall Study|Withdrawal by Subject|7|||
105835318|NCT01190930|365053706|FG004|Induction|High Risk|0|||
105835319|NCT01190930|365053707|FG005|Induction|High Risk|0|||
105835320|NCT01190930|365053708|FG006|Induction|High Risk|0|||
105835321|NCT01190930|365053709|FG007|Induction|High Risk|0|||
105835322|NCT01190930|365053710|FG008|Induction|High Risk|0|||
105835323|NCT01190930|365053711|FG009|Induction|High Risk|0|||
105835324|NCT01190930|365053702|FG000|Induction|Low Risk|443|||
105835325|NCT01190930|365053703|FG001|Induction|Low Risk|0|||
105310423|NCT02585934|363134316|FG001|Overall Study|Withdrawal by Subject|21|||
105489748|NCT01856023|363805657|FG001|Overall Study|Withdrawal by Subject|1|||
105489749|NCT03091777|363805660|FG000|Overall Study|Pregnancy|2|||
105835326|NCT01190930|365053704|FG002|Induction|Low Risk|0|||
105835327|NCT01190930|365053705|FG003|Induction|Low Risk|0|||
105835328|NCT01190930|365053706|FG004|Induction|Low Risk|0|||
105835329|NCT01190930|365053707|FG005|Induction|Low Risk|0|||
105835330|NCT01190930|365053708|FG006|Induction|Low Risk|0|||
105835331|NCT01190930|365053709|FG007|Induction|Low Risk|0|||
105835332|NCT01190930|365053710|FG008|Induction|Low Risk|0|||
105835333|NCT01190930|365053711|FG009|Induction|Low Risk|0|||
105835334|NCT01190930|365053702|FG000|Induction|Very High Risk|1012|||
105835335|NCT01190930|365053703|FG001|Induction|Very High Risk|0|||
105835336|NCT01190930|365053704|FG002|Induction|Very High Risk|0|||
105835337|NCT01190930|365053705|FG003|Induction|Very High Risk|0|||
105835338|NCT01190930|365053706|FG004|Induction|Very High Risk|0|||
105835339|NCT01190930|365053707|FG005|Induction|Very High Risk|0|||
105835340|NCT01190930|365053708|FG006|Induction|Very High Risk|0|||
105835341|NCT01190930|365053709|FG007|Induction|Very High Risk|0|||
105835342|NCT01190930|365053710|FG008|Induction|Very High Risk|0|||
105835343|NCT01190930|365053711|FG009|Induction|Very High Risk|0|||
105835344|NCT01190930|365053702|FG000|Induction|Philadelphia chromosome-positive|99|||
105835345|NCT01190930|365053703|FG001|Induction|Philadelphia chromosome-positive|0|||
105835346|NCT01190930|365053704|FG002|Induction|Philadelphia chromosome-positive|0|||
105835347|NCT01190930|365053705|FG003|Induction|Philadelphia chromosome-positive|0|||
105835348|NCT01190930|365053706|FG004|Induction|Philadelphia chromosome-positive|0|||
105835349|NCT01190930|365053707|FG005|Induction|Philadelphia chromosome-positive|0|||
105835350|NCT01190930|365053708|FG006|Induction|Philadelphia chromosome-positive|0|||
105835351|NCT01190930|365053709|FG007|Induction|Philadelphia chromosome-positive|0|||
105835352|NCT01190930|365053710|FG008|Induction|Philadelphia chromosome-positive|0|||
105835353|NCT01190930|365053711|FG009|Induction|Philadelphia chromosome-positive|0|||
105835354|NCT01190930|365053702|FG000|Induction|Incomplete Induction data|63|||
105835355|NCT01190930|365053703|FG001|Induction|Incomplete Induction data|0|||
105835356|NCT01190930|365053704|FG002|Induction|Incomplete Induction data|0|||
105835357|NCT01190930|365053705|FG003|Induction|Incomplete Induction data|0|||
105835358|NCT01190930|365053706|FG004|Induction|Incomplete Induction data|0|||
105835359|NCT01190930|365053707|FG005|Induction|Incomplete Induction data|0|||
105835360|NCT01190930|365053708|FG006|Induction|Incomplete Induction data|0|||
105835361|NCT01190930|365053709|FG007|Induction|Incomplete Induction data|0|||
105835362|NCT01190930|365053710|FG008|Induction|Incomplete Induction data|0|||
105835363|NCT01190930|365053711|FG009|Induction|Incomplete Induction data|0|||
105835364|NCT01190930|365053702|FG000|Induction|Progressive disease|0|||
105835365|NCT01190930|365053703|FG001|Induction|Progressive disease|1|||
105835366|NCT01190930|365053704|FG002|Induction|Progressive disease|0|||
105835367|NCT01190930|365053705|FG003|Induction|Progressive disease|0|||
105835368|NCT01190930|365053706|FG004|Induction|Progressive disease|0|||
105835369|NCT01190930|365053707|FG005|Induction|Progressive disease|0|||
105835370|NCT01190930|365053708|FG006|Induction|Progressive disease|0|||
105835371|NCT01190930|365053709|FG007|Induction|Progressive disease|0|||
105835372|NCT01190930|365053710|FG008|Induction|Progressive disease|0|||
105835373|NCT01190930|365053711|FG009|Induction|Progressive disease|0|||
105835374|NCT01190930|365053702|FG000|Induction|No treatment|3|||
105835375|NCT01190930|365053703|FG001|Induction|No treatment|0|||
105835376|NCT01190930|365053704|FG002|Induction|No treatment|0|||
105835377|NCT01190930|365053705|FG003|Induction|No treatment|0|||
105835378|NCT01190930|365053706|FG004|Induction|No treatment|0|||
105835379|NCT01190930|365053707|FG005|Induction|No treatment|0|||
105835380|NCT01190930|365053708|FG006|Induction|No treatment|0|||
105835381|NCT01190930|365053709|FG007|Induction|No treatment|0|||
105835382|NCT01190930|365053710|FG008|Induction|No treatment|0|||
105835383|NCT01190930|365053711|FG009|Induction|No treatment|0|||
105835384|NCT01190930|365053702|FG000|Induction|Ineligible|69|||
105835385|NCT01190930|365053703|FG001|Induction|Ineligible|4|||
105835386|NCT01190930|365053704|FG002|Induction|Ineligible|0|||
105835387|NCT01190930|365053705|FG003|Induction|Ineligible|0|||
105835388|NCT01190930|365053706|FG004|Induction|Ineligible|0|||
105835389|NCT01190930|365053707|FG005|Induction|Ineligible|0|||
105835390|NCT01190930|365053708|FG006|Induction|Ineligible|0|||
105835391|NCT01190930|365053709|FG007|Induction|Ineligible|0|||
105489750|NCT03091777|363805661|FG001|Overall Study|Pregnancy|1|||
105489751|NCT03091777|363805662|FG002|Overall Study|Pregnancy|0|||
105835392|NCT01190930|365053710|FG008|Induction|Ineligible|0|||
105835393|NCT01190930|365053711|FG009|Induction|Ineligible|0|||
105835394|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
105835395|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
105835396|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
105835397|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
105835398|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
105835399|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
105835400|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
105835401|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
105835402|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
105489752|NCT03091777|363805660|FG000|Overall Study|Adverse Event|2|||
105489753|NCT03091777|363805661|FG001|Overall Study|Adverse Event|1|||
105835403|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
105835404|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Death|0|||
105835405|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Death|0|||
105835406|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Death|8|||
105835407|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Death|4|||
105835408|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Death|0|||
105835409|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Death|0|||
105835410|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Death|0|||
105835411|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Death|0|||
105835412|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Death|0|||
105835413|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Death|0|||
105835414|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
105835415|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
105835416|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
105835417|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
105835418|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
105835419|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
105835420|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
105835421|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
105835422|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
105835423|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
105835424|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
105835425|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
105835426|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
105835427|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
105835428|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
105835429|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
105835430|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
105835431|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
105835432|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
105835433|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
105835434|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Refusal|0|||
105835435|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Refusal|2|||
105835436|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Refusal|694|||
105835437|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Refusal|4|||
105835438|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Refusal|0|||
105835439|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Refusal|3|||
105835440|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Refusal|0|||
105835441|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Refusal|0|||
105835442|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Refusal|0|||
105835443|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Refusal|0|||
105835444|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
105835445|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
105835446|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
105835447|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
105835448|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
105835449|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
105835450|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
105835451|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
105835452|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
105835453|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
105835454|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835455|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
105835456|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835457|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835458|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835459|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835460|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835461|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835462|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835463|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835464|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
105835465|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
105835466|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
105835467|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
105835468|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
105835469|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
105367254|NCT01081626|363350164|FG001|Overall Study|Missing Estradiol|28|||
105835470|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
105835471|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
105835472|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
105835473|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
105310424|NCT02585934|363134315|FG000|Overall Study|Lack of Efficacy|2|||
105310425|NCT02585934|363134316|FG001|Overall Study|Lack of Efficacy|1|||
105310426|NCT02585934|363134315|FG000|Overall Study|Death|2|||
105835474|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Relapse|0|||
105835475|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Relapse|0|||
105835476|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Relapse|1|||
105835477|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Relapse|0|||
105835478|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Relapse|0|||
105835479|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Relapse|0|||
105835480|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Relapse|0|||
105835481|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Relapse|0|||
105835482|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Relapse|0|||
105835483|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Relapse|0|||
105835484|NCT01190930|365053702|FG000|Maintenance|Adverse Event|0|||
105835485|NCT01190930|365053703|FG001|Maintenance|Adverse Event|0|||
105835486|NCT01190930|365053704|FG002|Maintenance|Adverse Event|0|||
105835487|NCT01190930|365053705|FG003|Maintenance|Adverse Event|0|||
105835488|NCT01190930|365053706|FG004|Maintenance|Adverse Event|0|||
105835489|NCT01190930|365053707|FG005|Maintenance|Adverse Event|1|||
105835490|NCT01190930|365053708|FG006|Maintenance|Adverse Event|1|||
105835491|NCT01190930|365053709|FG007|Maintenance|Adverse Event|3|||
105835492|NCT01190930|365053710|FG008|Maintenance|Adverse Event|3|||
105835493|NCT01190930|365053711|FG009|Maintenance|Adverse Event|0|||
105835494|NCT01190930|365053702|FG000|Maintenance|Death|0|||
105835495|NCT01190930|365053703|FG001|Maintenance|Death|0|||
105835496|NCT01190930|365053704|FG002|Maintenance|Death|0|||
105835497|NCT01190930|365053705|FG003|Maintenance|Death|1|||
105835498|NCT01190930|365053706|FG004|Maintenance|Death|0|||
105835499|NCT01190930|365053707|FG005|Maintenance|Death|0|||
105835500|NCT01190930|365053708|FG006|Maintenance|Death|2|||
105835501|NCT01190930|365053709|FG007|Maintenance|Death|2|||
105835502|NCT01190930|365053710|FG008|Maintenance|Death|2|||
105835503|NCT01190930|365053711|FG009|Maintenance|Death|2|||
105835504|NCT01190930|365053702|FG000|Maintenance|Lost to Follow-up|0|||
105835505|NCT01190930|365053703|FG001|Maintenance|Lost to Follow-up|0|||
105835506|NCT01190930|365053704|FG002|Maintenance|Lost to Follow-up|0|||
105835507|NCT01190930|365053705|FG003|Maintenance|Lost to Follow-up|0|||
105835508|NCT01190930|365053706|FG004|Maintenance|Lost to Follow-up|0|||
105835509|NCT01190930|365053707|FG005|Maintenance|Lost to Follow-up|0|||
105835510|NCT01190930|365053708|FG006|Maintenance|Lost to Follow-up|1|||
105835511|NCT01190930|365053709|FG007|Maintenance|Lost to Follow-up|1|||
105835512|NCT01190930|365053710|FG008|Maintenance|Lost to Follow-up|1|||
105835513|NCT01190930|365053711|FG009|Maintenance|Lost to Follow-up|0|||
105835514|NCT01190930|365053702|FG000|Maintenance|Physician Decision|0|||
105835515|NCT01190930|365053703|FG001|Maintenance|Physician Decision|1|||
105835516|NCT01190930|365053704|FG002|Maintenance|Physician Decision|0|||
105835517|NCT01190930|365053705|FG003|Maintenance|Physician Decision|5|||
105835518|NCT01190930|365053706|FG004|Maintenance|Physician Decision|9|||
105835519|NCT01190930|365053707|FG005|Maintenance|Physician Decision|4|||
105835520|NCT01190930|365053708|FG006|Maintenance|Physician Decision|8|||
105835521|NCT01190930|365053709|FG007|Maintenance|Physician Decision|8|||
105835522|NCT01190930|365053710|FG008|Maintenance|Physician Decision|10|||
105835523|NCT01190930|365053711|FG009|Maintenance|Physician Decision|17|||
105835524|NCT01190930|365053702|FG000|Maintenance|Withdrawal by Subject|0|||
105835525|NCT01190930|365053703|FG001|Maintenance|Withdrawal by Subject|0|||
105310427|NCT02585934|363134316|FG001|Overall Study|Death|0|||
105310428|NCT02585934|363134315|FG000|Overall Study|Caregiver Withdrew Consent|7|||
105310429|NCT02585934|363134316|FG001|Overall Study|Caregiver Withdrew Consent|7|||
105310430|NCT02585934|363134315|FG000|Overall Study|Sponsor Termination|1|||
105310431|NCT02585934|363134316|FG001|Overall Study|Sponsor Termination|2|||
105367255|NCT01081626|363350163|FG000|Overall Study|Low antral follicle count|1|||
105367256|NCT01081626|363350164|FG001|Overall Study|Low antral follicle count|0|||
105367257|NCT01081626|363350163|FG000|Overall Study|Overstimulation|0|||
105489754|NCT03091777|363805662|FG002|Overall Study|Adverse Event|4|||
105835526|NCT01190930|365053704|FG002|Maintenance|Withdrawal by Subject|0|||
105310432|NCT02585934|363134315|FG000|Overall Study|Another Reason|10|||
105310433|NCT02585934|363134316|FG001|Overall Study|Another Reason|5|||
105367258|NCT01081626|363350164|FG001|Overall Study|Overstimulation|1|||
105489755|NCT03091777|363805660|FG000|Overall Study|Withdrawal by Subject|4|||
105835527|NCT01190930|365053705|FG003|Maintenance|Withdrawal by Subject|0|||
105835528|NCT01190930|365053706|FG004|Maintenance|Withdrawal by Subject|0|||
105835529|NCT01190930|365053707|FG005|Maintenance|Withdrawal by Subject|0|||
105835530|NCT01190930|365053708|FG006|Maintenance|Withdrawal by Subject|2|||
105835531|NCT01190930|365053709|FG007|Maintenance|Withdrawal by Subject|1|||
105835532|NCT01190930|365053710|FG008|Maintenance|Withdrawal by Subject|4|||
105310434|NCT02065700|363134318|FG000|Overall Study|Adverse Event|165|||
105310435|NCT02065700|363134319|FG001|Overall Study|Adverse Event|101|||
105835533|NCT01190930|365053711|FG009|Maintenance|Withdrawal by Subject|1|||
105835534|NCT01190930|365053702|FG000|Maintenance|Refusal|0|||
105835535|NCT01190930|365053703|FG001|Maintenance|Refusal|1|||
105835536|NCT01190930|365053704|FG002|Maintenance|Refusal|0|||
105835537|NCT01190930|365053705|FG003|Maintenance|Refusal|2|||
105835538|NCT01190930|365053706|FG004|Maintenance|Refusal|0|||
105835539|NCT01190930|365053707|FG005|Maintenance|Refusal|4|||
105835540|NCT01190930|365053708|FG006|Maintenance|Refusal|5|||
105835541|NCT01190930|365053709|FG007|Maintenance|Refusal|17|||
105835542|NCT01190930|365053710|FG008|Maintenance|Refusal|13|||
105835543|NCT01190930|365053711|FG009|Maintenance|Refusal|6|||
105835544|NCT01190930|365053702|FG000|Maintenance|second malignant neoplasm|0|||
105835545|NCT01190930|365053703|FG001|Maintenance|second malignant neoplasm|0|||
105835546|NCT01190930|365053704|FG002|Maintenance|second malignant neoplasm|0|||
105835547|NCT01190930|365053705|FG003|Maintenance|second malignant neoplasm|1|||
105835548|NCT01190930|365053706|FG004|Maintenance|second malignant neoplasm|0|||
105835549|NCT01190930|365053707|FG005|Maintenance|second malignant neoplasm|1|||
105835550|NCT01190930|365053708|FG006|Maintenance|second malignant neoplasm|0|||
105835551|NCT01190930|365053709|FG007|Maintenance|second malignant neoplasm|0|||
105835552|NCT01190930|365053710|FG008|Maintenance|second malignant neoplasm|1|||
105835553|NCT01190930|365053711|FG009|Maintenance|second malignant neoplasm|0|||
105835554|NCT01190930|365053702|FG000|Maintenance|Inevaluable|0|||
105835555|NCT01190930|365053703|FG001|Maintenance|Inevaluable|0|||
105835556|NCT01190930|365053704|FG002|Maintenance|Inevaluable|0|||
105835557|NCT01190930|365053705|FG003|Maintenance|Inevaluable|0|||
105835558|NCT01190930|365053706|FG004|Maintenance|Inevaluable|0|||
105835559|NCT01190930|365053707|FG005|Maintenance|Inevaluable|1|||
105835560|NCT01190930|365053708|FG006|Maintenance|Inevaluable|1|||
105835561|NCT01190930|365053709|FG007|Maintenance|Inevaluable|1|||
105835562|NCT01190930|365053710|FG008|Maintenance|Inevaluable|0|||
105576482|NCT04157686|364108543|FG006|Overall Study|Protocol Violation|0|||
105835563|NCT01190930|365053711|FG009|Maintenance|Inevaluable|0|||
105835564|NCT01190930|365053702|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
105835565|NCT01190930|365053703|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
105835566|NCT01190930|365053704|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
105835567|NCT01190930|365053705|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
105835568|NCT01190930|365053706|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
105835569|NCT01190930|365053707|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
105835570|NCT01190930|365053708|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
105835571|NCT01190930|365053709|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
105835572|NCT01190930|365053710|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
105835573|NCT01190930|365053711|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
105835574|NCT01190930|365053702|FG000|Maintenance|Relapse|0|||
105835575|NCT01190930|365053703|FG001|Maintenance|Relapse|0|||
105835576|NCT01190930|365053704|FG002|Maintenance|Relapse|0|||
105835577|NCT01190930|365053705|FG003|Maintenance|Relapse|2|||
105835578|NCT01190930|365053706|FG004|Maintenance|Relapse|0|||
105835579|NCT01190930|365053707|FG005|Maintenance|Relapse|1|||
105835580|NCT01190930|365053708|FG006|Maintenance|Relapse|6|||
105835581|NCT01190930|365053709|FG007|Maintenance|Relapse|13|||
105835582|NCT01190930|365053710|FG008|Maintenance|Relapse|11|||
105835583|NCT01190930|365053711|FG009|Maintenance|Relapse|11|||
105835584|NCT01190930|365053702|FG000|Maintenance|Still on therapy|0|||
105367259|NCT01081626|363350163|FG000|Overall Study|Lost to Follow-up|0|||
105367260|NCT01081626|363350164|FG001|Overall Study|Lost to Follow-up|1|||
105367261|NCT01081626|363350163|FG000|Overall Study|Other|33|||
105367262|NCT01081626|363350164|FG001|Overall Study|Other|30|||
105367263|NCT02003144|363350165|FG000|Open Label Maintenance Phase|Other than specified|2|||
105367264|NCT02003144|363350166|FG001|Open Label Maintenance Phase|Other than specified|4|||
105367265|NCT02003144|363350165|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
105367266|NCT02003144|363350166|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
105367267|NCT02003144|363350165|FG000|Open Label Maintenance Phase|Pregnancy|0|||
105367268|NCT02003144|363350166|FG001|Open Label Maintenance Phase|Pregnancy|2|||
105367269|NCT02003144|363350165|FG000|Open Label Maintenance Phase|Physician Decision|1|||
105367270|NCT02003144|363350166|FG001|Open Label Maintenance Phase|Physician Decision|1|||
105367271|NCT02003144|363350165|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
105367272|NCT02003144|363350166|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
105835585|NCT01190930|365053703|FG001|Maintenance|Still on therapy|8|||
105367273|NCT02003144|363350165|FG000|Open Label Maintenance Phase|Adverse Event|2|||
105835586|NCT01190930|365053704|FG002|Maintenance|Still on therapy|0|||
105835587|NCT01190930|365053705|FG003|Maintenance|Still on therapy|29|||
105835588|NCT01190930|365053706|FG004|Maintenance|Still on therapy|0|||
105835589|NCT01190930|365053707|FG005|Maintenance|Still on therapy|0|||
105835590|NCT01190930|365053708|FG006|Maintenance|Still on therapy|0|||
105835591|NCT01190930|365053709|FG007|Maintenance|Still on therapy|0|||
105835592|NCT01190930|365053710|FG008|Maintenance|Still on therapy|0|||
105835593|NCT01190930|365053711|FG009|Maintenance|Still on therapy|0|||
105835594|NCT02340962|365053714|FG000|Overall Study|Lost to Follow-up|1|||
105835595|NCT02340962|365053715|FG001|Overall Study|Lost to Follow-up|0|||
105835596|NCT01186016|365053716|FG000|Overall Study|Withdrawal by Subject|46|||
105835597|NCT01186016|365053717|FG001|Overall Study|Withdrawal by Subject|29|||
105835598|NCT00160524|365053718|FG000|Overall Study|Adverse Event|119|||
105835599|NCT00160524|365053718|FG000|Overall Study|Adverse Event and Other|94|||
105835600|NCT00160524|365053718|FG000|Overall Study|Protocol Violation|16|||
105835601|NCT00160524|365053718|FG000|Overall Study|Protocol Violation and Other|2|||
105835602|NCT00160524|365053718|FG000|Overall Study|Withdrawal by Subject|141|||
105835603|NCT00160524|365053718|FG000|Overall Study|Withdrawal by Subject and Other|17|||
105835604|NCT00160524|365053718|FG000|Overall Study|Physician Decision|27|||
105835605|NCT00160524|365053718|FG000|Overall Study|Physician Decision and Other|6|||
105835606|NCT00160524|365053718|FG000|Overall Study|Lost to Follow-up|13|||
105835607|NCT00160524|365053718|FG000|Overall Study|Lost to Follow-up and Other|1|||
105835608|NCT00160524|365053718|FG000|Overall Study|Lack of Efficacy|21|||
105835609|NCT00160524|365053718|FG000|Overall Study|Lack of Efficacy and Other|1|||
105835610|NCT00160524|365053718|FG000|Overall Study|Other|20|||
105835611|NCT03750695|365053720|FG000|Overall Study|Lost to Follow-up|0|||
105835612|NCT03750695|365053721|FG001|Overall Study|Lost to Follow-up|1|||
105835613|NCT02151149|365053722|FG000|Treatment Period|Death|2|||
105835614|NCT02151149|365053723|FG001|Treatment Period|Death|3|||
105835615|NCT02151149|365053722|FG000|Treatment Period|Adverse Event|17|||
105835616|NCT02151149|365053723|FG001|Treatment Period|Adverse Event|14|||
105835617|NCT02151149|365053722|FG000|Treatment Period|Progressive Disease|25|||
105835618|NCT02151149|365053723|FG001|Treatment Period|Progressive Disease|24|||
105835619|NCT02151149|365053722|FG000|Treatment Period|Symptomatic Deterioration|2|||
105835620|NCT02151149|365053723|FG001|Treatment Period|Symptomatic Deterioration|10|||
105835621|NCT02151149|365053722|FG000|Treatment Period|Withdrawal by Subject|13|||
105835622|NCT02151149|365053723|FG001|Treatment Period|Withdrawal by Subject|11|||
105835623|NCT02151149|365053722|FG000|Treatment Period|Miscellaneous|8|||
105835624|NCT02151149|365053723|FG001|Treatment Period|Miscellaneous|7|||
105835625|NCT02151149|365053722|FG000|Treatment Period|Participants randomized but not treated|3|||
105835626|NCT02151149|365053723|FG001|Treatment Period|Participants randomized but not treated|2|||
105835627|NCT02151149|365053722|FG000|Follow-Up Period|Lost to Follow-up|2|||
105835628|NCT02151149|365053723|FG001|Follow-Up Period|Lost to Follow-up|3|||
105835629|NCT02151149|365053722|FG000|Follow-Up Period|Death|37|||
105835630|NCT02151149|365053723|FG001|Follow-Up Period|Death|34|||
105835631|NCT03173560|365053724|FG000|Overall Study|Death|70|||
105835632|NCT03173560|365053725|FG001|Overall Study|Death|60|||
105835633|NCT03173560|365053724|FG000|Overall Study|Lost to Follow-up|1|||
105835634|NCT03173560|365053725|FG001|Overall Study|Lost to Follow-up|4|||
105835635|NCT03173560|365053724|FG000|Overall Study|Withdrawal by Subject|10|||
105835636|NCT03173560|365053725|FG001|Overall Study|Withdrawal by Subject|5|||
105835637|NCT03173560|365053724|FG000|Overall Study|Other|0|||
105835638|NCT03173560|365053725|FG001|Overall Study|Other|1|||
105835639|NCT02289820|365053730|FG000|Overall Study|Withdrawal by Subject|2|||
105835640|NCT02289820|365053731|FG001|Overall Study|Withdrawal by Subject|1|||
105835641|NCT02289820|365053732|FG002|Overall Study|Withdrawal by Subject|2|||
105835642|NCT02289820|365053733|FG003|Overall Study|Withdrawal by Subject|1|||
105835643|NCT02289820|365053734|FG004|Overall Study|Withdrawal by Subject|0|||
105835644|NCT02289820|365053735|FG005|Overall Study|Withdrawal by Subject|0|||
105835645|NCT02289820|365053736|FG006|Overall Study|Withdrawal by Subject|1|||
105835646|NCT02289820|365053730|FG000|Overall Study|Death|0|||
105835647|NCT02289820|365053731|FG001|Overall Study|Death|0|||
105835648|NCT02289820|365053732|FG002|Overall Study|Death|1|||
105835649|NCT02289820|365053733|FG003|Overall Study|Death|0|||
105835650|NCT02289820|365053734|FG004|Overall Study|Death|0|||
105835651|NCT02289820|365053735|FG005|Overall Study|Death|0|||
105835652|NCT02289820|365053736|FG006|Overall Study|Death|0|||
105835653|NCT02289820|365053730|FG000|Overall Study|Lost to Follow-up|0|||
105835654|NCT02289820|365053731|FG001|Overall Study|Lost to Follow-up|0|||
105835655|NCT02289820|365053732|FG002|Overall Study|Lost to Follow-up|3|||
105835656|NCT02289820|365053733|FG003|Overall Study|Lost to Follow-up|1|||
105835657|NCT02289820|365053734|FG004|Overall Study|Lost to Follow-up|0|||
105835658|NCT02289820|365053735|FG005|Overall Study|Lost to Follow-up|1|||
105835659|NCT02289820|365053736|FG006|Overall Study|Lost to Follow-up|1|||
105835660|NCT02289820|365053730|FG000|Overall Study|withdrawal of consent|0|||
105835661|NCT02289820|365053731|FG001|Overall Study|withdrawal of consent|1|||
105835662|NCT02289820|365053732|FG002|Overall Study|withdrawal of consent|0|||
105835663|NCT02289820|365053733|FG003|Overall Study|withdrawal of consent|0|||
105835664|NCT02289820|365053734|FG004|Overall Study|withdrawal of consent|0|||
105835665|NCT02289820|365053735|FG005|Overall Study|withdrawal of consent|0|||
105835666|NCT02289820|365053736|FG006|Overall Study|withdrawal of consent|0|||
105835667|NCT01517867|365053740|FG000|Overall Study|never started treatment|29|||
105835668|NCT01517867|365053741|FG001|Overall Study|never started treatment|32|||
105835669|NCT01517867|365053740|FG000|Overall Study|Withdrawal by Subject|34|||
105835670|NCT01517867|365053741|FG001|Overall Study|Withdrawal by Subject|30|||
105835671|NCT01517867|365053740|FG000|Overall Study|Still in treatment at study end|0|||
105835672|NCT01517867|365053741|FG001|Overall Study|Still in treatment at study end|3|||
105835673|NCT01294449|365053749|FG000|Overall Study|Death|11|||
105835674|NCT01294449|365053750|FG001|Overall Study|Death|12|||
105835675|NCT01294449|365053749|FG000|Overall Study|Withdrawal by Subject|1|||
105835676|NCT01294449|365053750|FG001|Overall Study|Withdrawal by Subject|3|||
105835677|NCT02418754|365053753|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
105835678|NCT02418754|365053754|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
105489756|NCT03091777|363805661|FG001|Overall Study|Withdrawal by Subject|2|||
105489757|NCT03091777|363805662|FG002|Overall Study|Withdrawal by Subject|6|||
105489758|NCT03091777|363805660|FG000|Overall Study|Protocol Violation|2|||
105489759|NCT03091777|363805661|FG001|Overall Study|Protocol Violation|1|||
105489760|NCT03091777|363805662|FG002|Overall Study|Protocol Violation|1|||
105489761|NCT03091777|363805660|FG000|Overall Study|Lost to Follow-up|12|||
105489762|NCT03091777|363805661|FG001|Overall Study|Lost to Follow-up|14|||
105489763|NCT03091777|363805662|FG002|Overall Study|Lost to Follow-up|7|||
105489764|NCT03091777|363805660|FG000|Overall Study|Lack of Efficacy|0|||
105489765|NCT03091777|363805661|FG001|Overall Study|Lack of Efficacy|0|||
105489766|NCT03091777|363805662|FG002|Overall Study|Lack of Efficacy|5|||
105489767|NCT03091777|363805660|FG000|Overall Study|Noncompliance with study drug|2|||
105489768|NCT03091777|363805661|FG001|Overall Study|Noncompliance with study drug|3|||
105489769|NCT03091777|363805662|FG002|Overall Study|Noncompliance with study drug|1|||
105489770|NCT03091777|363805660|FG000|Overall Study|Physician Decision|1|||
105489771|NCT03091777|363805661|FG001|Overall Study|Physician Decision|0|||
105489772|NCT03091777|363805662|FG002|Overall Study|Physician Decision|1|||
105489773|NCT03091777|363805660|FG000|Overall Study|Abnormal Laboratory Value|7|||
105489774|NCT03091777|363805661|FG001|Overall Study|Abnormal Laboratory Value|11|||
105489775|NCT03091777|363805662|FG002|Overall Study|Abnormal Laboratory Value|12|||
105489776|NCT02536833|363805663|FG000|Overall Study|Discontinued Before Treatment|0|||
105489777|NCT02536833|363805664|FG001|Overall Study|Discontinued Before Treatment|0|||
105489778|NCT02536833|363805665|FG002|Overall Study|Discontinued Before Treatment|1|||
105489779|NCT02536833|363805666|FG003|Overall Study|Discontinued Before Treatment|2|||
105489780|NCT02536833|363805663|FG000|Overall Study|Adverse Event|1|||
105489781|NCT02536833|363805664|FG001|Overall Study|Adverse Event|3|||
105835679|NCT02418754|365053755|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
105835680|NCT02418754|365053756|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
105835681|NCT02418754|365053757|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
105835682|NCT02418754|365053753|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
105835683|NCT02418754|365053754|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
105489782|NCT02536833|363805665|FG002|Overall Study|Adverse Event|4|||
105835684|NCT02418754|365053755|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
105835685|NCT02418754|365053756|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
105835686|NCT02418754|365053757|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
105835687|NCT02418754|365053753|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
105835688|NCT02418754|365053754|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
105835689|NCT02418754|365053755|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
105835690|NCT02418754|365053756|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
105835691|NCT02418754|365053757|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
105835692|NCT02418754|365053753|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
105835693|NCT02418754|365053754|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
105835694|NCT02418754|365053755|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
105835695|NCT02418754|365053756|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
105835696|NCT02418754|365053757|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
105835697|NCT02418754|365053753|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
105835698|NCT02418754|365053754|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
105835699|NCT02418754|365053755|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
105835700|NCT02418754|365053756|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
105835701|NCT02418754|365053757|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
105835702|NCT02418754|365053753|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
105835703|NCT02418754|365053754|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
105835704|NCT02418754|365053755|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
105835705|NCT02418754|365053756|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
105835706|NCT02418754|365053757|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
105835707|NCT02418754|365053753|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
105835708|NCT02418754|365053754|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
105835709|NCT02418754|365053755|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
105835710|NCT02418754|365053756|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
105835711|NCT02418754|365053757|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
105835712|NCT02418754|365053753|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
105835713|NCT02418754|365053754|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
105835714|NCT02418754|365053755|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
105835715|NCT02418754|365053756|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
105835716|NCT02418754|365053757|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
105489783|NCT02536833|363805666|FG003|Overall Study|Adverse Event|1|||
105489784|NCT02536833|363805663|FG000|Overall Study|Lost to Follow-up|2|||
105489785|NCT02536833|363805664|FG001|Overall Study|Lost to Follow-up|1|||
105489786|NCT02536833|363805665|FG002|Overall Study|Lost to Follow-up|2|||
105489787|NCT02536833|363805666|FG003|Overall Study|Lost to Follow-up|2|||
105489788|NCT02536833|363805663|FG000|Overall Study|Physician Decision|0|||
105489789|NCT02536833|363805664|FG001|Overall Study|Physician Decision|0|||
105489790|NCT02536833|363805665|FG002|Overall Study|Physician Decision|0|||
105835717|NCT02418754|365053753|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
105835718|NCT02418754|365053754|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
105835719|NCT02418754|365053755|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
105835720|NCT02418754|365053756|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
105835721|NCT02418754|365053757|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
105835722|NCT02418754|365053753|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
105835723|NCT02418754|365053754|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
105835724|NCT02418754|365053755|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
105835725|NCT02418754|365053756|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
105835726|NCT02418754|365053757|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
105835727|NCT02418754|365053753|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
105835728|NCT02418754|365053754|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
105835729|NCT02418754|365053755|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
105835730|NCT02418754|365053756|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
105835731|NCT02418754|365053757|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
105835732|NCT02063217|365053759|FG000|Overall Study|Withdrawal by Subject|1|||
105835733|NCT02063217|365053760|FG001|Overall Study|Withdrawal by Subject|0|||
105835734|NCT02063217|365053761|FG002|Overall Study|Withdrawal by Subject|0|||
105835735|NCT01833169|365053762|FG000|Overall Study|Disease Progression|99|||
105835736|NCT01833169|365053762|FG000|Overall Study|Adverse Event|33|||
105835737|NCT01833169|365053762|FG000|Overall Study|Withdrawal by Subject|9|||
105835738|NCT01833169|365053762|FG000|Overall Study|Death|3|||
105835739|NCT01833169|365053762|FG000|Overall Study|Physician Decision|2|||
105835740|NCT00127166|365053763|FG000|Period I|Protocol Violation|0|||
105835741|NCT00127166|365053764|FG001|Period I|Protocol Violation|2|||
105835742|NCT00127166|365053763|FG000|Period I|Withdrawal by Subject|2|||
105835743|NCT00127166|365053764|FG001|Period I|Withdrawal by Subject|0|||
105835744|NCT00127166|365053763|FG000|Period I|Patient did not meet inclusion criteria|1|||
105835745|NCT00127166|365053764|FG001|Period I|Patient did not meet inclusion criteria|0|||
105835746|NCT00127166|365053763|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
105835747|NCT00127166|365053764|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
105835748|NCT00127166|365053763|FG000|Period II|Withdrawal by Subject|2|||
105835749|NCT00127166|365053764|FG001|Period II|Withdrawal by Subject|0|||
105835750|NCT00127166|365053763|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
105835751|NCT00127166|365053764|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
105835752|NCT00105157|365053765|FG000|Double-Blind (DB)|Never Treated|1|||
105835753|NCT00105157|365053766|FG001|Double-Blind (DB)|Never Treated|0|||
105835754|NCT00105157|365053767|FG002|Double-Blind (DB)|Never Treated|0|||
105835755|NCT00105157|365053768|FG003|Double-Blind (DB)|Never Treated|0|||
105835756|NCT00105157|365053765|FG000|Double-Blind (DB)|Adverse Event|2|||
105835757|NCT00105157|365053766|FG001|Double-Blind (DB)|Adverse Event|0|||
105835758|NCT00105157|365053767|FG002|Double-Blind (DB)|Adverse Event|1|||
105835759|NCT00105157|365053768|FG003|Double-Blind (DB)|Adverse Event|1|||
105835760|NCT00105157|365053765|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
105835761|NCT00105157|365053766|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
105835762|NCT00105157|365053767|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
105835763|NCT00105157|365053768|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
105835764|NCT00105157|365053765|FG000|Open-Label Continuation of DB|Adverse Event|3|||
105835765|NCT00105157|365053766|FG001|Open-Label Continuation of DB|Adverse Event|1|||
105310436|NCT02065700|363134318|FG000|Overall Study|Withdrawal by Subject|90|||
105310437|NCT02065700|363134319|FG001|Overall Study|Withdrawal by Subject|29|||
105310438|NCT02065700|363134318|FG000|Overall Study|Lost to Follow-up|12|||
105310439|NCT02065700|363134319|FG001|Overall Study|Lost to Follow-up|9|||
105310440|NCT02065700|363134318|FG000|Overall Study|Physician Decision|2|||
105310441|NCT02065700|363134319|FG001|Overall Study|Physician Decision|0|||
105310442|NCT02065700|363134318|FG000|Overall Study|Sponsor Request|38|||
105310443|NCT02065700|363134319|FG001|Overall Study|Sponsor Request|15|||
105310444|NCT02065700|363134318|FG000|Overall Study|Treatment Failure|3|||
105310445|NCT02065700|363134319|FG001|Overall Study|Treatment Failure|2|||
105310446|NCT02065700|363134318|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
105310447|NCT02065700|363134319|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
105310448|NCT02065700|363134318|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
105310449|NCT02065700|363134319|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
105310450|NCT02065700|363134318|FG000|Overall Study|Non-compliance with Study Procedures|2|||
105310451|NCT02065700|363134319|FG001|Overall Study|Non-compliance with Study Procedures|0|||
105576483|NCT04157686|364108544|FG007|Overall Study|Protocol Violation|0|||
105576484|NCT04157686|364108537|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
105310452|NCT02065700|363134318|FG000|Overall Study|Not Defined|21|||
105835766|NCT00105157|365053767|FG002|Open-Label Continuation of DB|Adverse Event|0|||
105310453|NCT02065700|363134319|FG001|Overall Study|Not Defined|3|||
105310454|NCT03151408|363134320|FG000|Overall Study|Adverse Event|24|||
105310455|NCT03151408|363134321|FG001|Overall Study|Adverse Event|23|||
105835767|NCT00105157|365053768|FG003|Open-Label Continuation of DB|Adverse Event|0|||
105835768|NCT00105157|365053765|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
105835769|NCT00105157|365053766|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
105835770|NCT00105157|365053767|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
105835771|NCT00105157|365053768|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
105835772|NCT00105157|365053765|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
105835773|NCT00105157|365053766|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
105835774|NCT00105157|365053767|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
105835775|NCT00105157|365053768|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
105835776|NCT00105157|365053765|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
105835777|NCT00105157|365053766|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
105835778|NCT00105157|365053767|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
105835779|NCT00105157|365053768|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
105835780|NCT00105157|365053765|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
105835781|NCT00105157|365053766|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
105835782|NCT00105157|365053767|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
105835783|NCT00105157|365053768|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
105835784|NCT00105157|365053765|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
105835785|NCT00105157|365053766|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
105835786|NCT00105157|365053767|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
105835787|NCT00105157|365053768|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
105835788|NCT00105157|365053765|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
105835789|NCT00105157|365053766|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
105835790|NCT00105157|365053767|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
105835791|NCT00105157|365053768|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
105835792|NCT00105157|365053765|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
105835793|NCT00105157|365053766|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
105835794|NCT00105157|365053767|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
105310456|NCT03151408|363134320|FG000|Overall Study|Death|46|||
105310457|NCT03151408|363134321|FG001|Overall Study|Death|26|||
105310458|NCT03151408|363134320|FG000|Overall Study|Physician Decision|13|||
105310459|NCT03151408|363134321|FG001|Overall Study|Physician Decision|19|||
105310460|NCT03151408|363134320|FG000|Overall Study|Withdrawal by Subject|16|||
105310461|NCT03151408|363134321|FG001|Overall Study|Withdrawal by Subject|20|||
105310462|NCT03151408|363134320|FG000|Overall Study|Progressive disease|45|||
105310463|NCT03151408|363134321|FG001|Overall Study|Progressive disease|61|||
105310464|NCT03151408|363134320|FG000|Overall Study|non-compliance by patient|1|||
105310465|NCT03151408|363134321|FG001|Overall Study|non-compliance by patient|0|||
105310466|NCT03151408|363134320|FG000|Overall Study|other reasons|56|||
105310467|NCT03151408|363134321|FG001|Overall Study|other reasons|52|||
105310468|NCT03151408|363134320|FG000|Overall Study|randomized and not treated|2|||
105310469|NCT03151408|363134321|FG001|Overall Study|randomized and not treated|2|||
105310470|NCT00837473|363134324|FG000|Overall Study|Lost to Follow-up|1|||
105310471|NCT00837473|363134324|FG000|Overall Study|Withdrawal by Subject|2|||
105310472|NCT00470067|363134325|FG000|Overall Study|Death|1|||
105310473|NCT00470067|363134325|FG000|Overall Study|Disease Progression|6|||
105310474|NCT01635218|363134326|FG000|Overall Study|Lost to Follow-up|3|||
105310475|NCT01635218|363134327|FG001|Overall Study|Lost to Follow-up|7|||
105310476|NCT01635218|363134328|FG002|Overall Study|Lost to Follow-up|6|||
105310477|NCT03559400|363134329|FG000|Overall Study|Lost to Follow-up|9|||
105310478|NCT03559400|363134330|FG001|Overall Study|Lost to Follow-up|7|||
105310479|NCT03559400|363134329|FG000|Overall Study|Death|0|||
105310480|NCT03559400|363134330|FG001|Overall Study|Death|2|||
105310481|NCT01517373|363134339|FG000|Run-in Period|Death|1|||
105310482|NCT01517373|363134340|FG001|Run-in Period|Death|0|||
105310483|NCT01517373|363134341|FG002|Run-in Period|Death|0|||
105310484|NCT01517373|363134342|FG003|Run-in Period|Death|0|||
105310485|NCT01517373|363134343|FG004|Run-in Period|Death|0|||
105310486|NCT01517373|363134344|FG005|Run-in Period|Death|0|||
105310487|NCT01517373|363134339|FG000|Run-in Period|Adverse Event|5|||
105310488|NCT01517373|363134340|FG001|Run-in Period|Adverse Event|0|||
105310489|NCT01517373|363134341|FG002|Run-in Period|Adverse Event|0|||
105310490|NCT01517373|363134342|FG003|Run-in Period|Adverse Event|0|||
105310491|NCT01517373|363134343|FG004|Run-in Period|Adverse Event|0|||
105310492|NCT01517373|363134344|FG005|Run-in Period|Adverse Event|0|||
105310493|NCT01517373|363134339|FG000|Run-in Period|Did not meet eligibility criteria|34|||
105310494|NCT01517373|363134340|FG001|Run-in Period|Did not meet eligibility criteria|0|||
105310495|NCT01517373|363134341|FG002|Run-in Period|Did not meet eligibility criteria|0|||
105310496|NCT01517373|363134342|FG003|Run-in Period|Did not meet eligibility criteria|0|||
105310497|NCT01517373|363134343|FG004|Run-in Period|Did not meet eligibility criteria|0|||
105310498|NCT01517373|363134344|FG005|Run-in Period|Did not meet eligibility criteria|0|||
105310499|NCT01517373|363134339|FG000|Run-in Period|Lost to Follow-up|1|||
105310500|NCT01517373|363134340|FG001|Run-in Period|Lost to Follow-up|0|||
105835795|NCT00105157|365053768|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
105835796|NCT00105157|365053765|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
105835797|NCT00105157|365053766|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
105835798|NCT00105157|365053767|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
105835799|NCT00105157|365053768|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
105835800|NCT00105157|365053765|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
105835801|NCT00105157|365053766|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
105835802|NCT00105157|365053767|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
105835803|NCT00105157|365053768|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
105835804|NCT00105157|365053765|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
105835805|NCT00105157|365053766|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
105310501|NCT01517373|363134341|FG002|Run-in Period|Lost to Follow-up|0|||
105310502|NCT01517373|363134342|FG003|Run-in Period|Lost to Follow-up|0|||
105310503|NCT01517373|363134343|FG004|Run-in Period|Lost to Follow-up|0|||
105310504|NCT01517373|363134344|FG005|Run-in Period|Lost to Follow-up|0|||
105310505|NCT01517373|363134339|FG000|Run-in Period|Withdrawal by Subject|12|||
105310506|NCT01517373|363134340|FG001|Run-in Period|Withdrawal by Subject|0|||
105310507|NCT01517373|363134341|FG002|Run-in Period|Withdrawal by Subject|0|||
105310508|NCT01517373|363134342|FG003|Run-in Period|Withdrawal by Subject|0|||
105310509|NCT01517373|363134343|FG004|Run-in Period|Withdrawal by Subject|0|||
105310510|NCT01517373|363134344|FG005|Run-in Period|Withdrawal by Subject|0|||
105310511|NCT01517373|363134339|FG000|Run-in Period|Sponsor Decision|3|||
105310512|NCT01517373|363134340|FG001|Run-in Period|Sponsor Decision|0|||
105310513|NCT01517373|363134341|FG002|Run-in Period|Sponsor Decision|0|||
105310514|NCT01517373|363134342|FG003|Run-in Period|Sponsor Decision|0|||
105310515|NCT01517373|363134343|FG004|Run-in Period|Sponsor Decision|0|||
105310516|NCT01517373|363134344|FG005|Run-in Period|Sponsor Decision|0|||
105310517|NCT01517373|363134339|FG000|Run-in Period|Other|1|||
105310518|NCT01517373|363134340|FG001|Run-in Period|Other|0|||
105310519|NCT01517373|363134341|FG002|Run-in Period|Other|0|||
105310520|NCT01517373|363134342|FG003|Run-in Period|Other|0|||
105310521|NCT01517373|363134343|FG004|Run-in Period|Other|0|||
105310522|NCT01517373|363134344|FG005|Run-in Period|Other|0|||
105310523|NCT01517373|363134339|FG000|Treatment Period|Adverse Event|0|||
105310524|NCT01517373|363134340|FG001|Treatment Period|Adverse Event|0|||
105310525|NCT01517373|363134341|FG002|Treatment Period|Adverse Event|0|||
105310526|NCT01517373|363134342|FG003|Treatment Period|Adverse Event|0|||
105310527|NCT01517373|363134343|FG004|Treatment Period|Adverse Event|0|||
105310528|NCT01517373|363134344|FG005|Treatment Period|Adverse Event|2|||
105310529|NCT01517373|363134339|FG000|Treatment Period|Lost to Follow-up|0|||
105310530|NCT01517373|363134340|FG001|Treatment Period|Lost to Follow-up|0|||
105310531|NCT01517373|363134341|FG002|Treatment Period|Lost to Follow-up|1|||
105310532|NCT01517373|363134342|FG003|Treatment Period|Lost to Follow-up|1|||
105310533|NCT01517373|363134343|FG004|Treatment Period|Lost to Follow-up|0|||
105310534|NCT01517373|363134344|FG005|Treatment Period|Lost to Follow-up|0|||
105310535|NCT01517373|363134339|FG000|Treatment Period|Withdrawal by Subject|0|||
105310536|NCT01517373|363134340|FG001|Treatment Period|Withdrawal by Subject|3|||
105310537|NCT01517373|363134341|FG002|Treatment Period|Withdrawal by Subject|2|||
105310538|NCT01517373|363134342|FG003|Treatment Period|Withdrawal by Subject|2|||
105310539|NCT01517373|363134343|FG004|Treatment Period|Withdrawal by Subject|2|||
105310540|NCT01517373|363134344|FG005|Treatment Period|Withdrawal by Subject|3|||
105310541|NCT01517373|363134339|FG000|Treatment Period|Other|0|||
105310542|NCT01517373|363134340|FG001|Treatment Period|Other|0|||
105310543|NCT01517373|363134341|FG002|Treatment Period|Other|0|||
105310544|NCT01517373|363134342|FG003|Treatment Period|Other|0|||
105310545|NCT01517373|363134343|FG004|Treatment Period|Other|1|||
105310546|NCT01517373|363134344|FG005|Treatment Period|Other|0|||
105310547|NCT01517373|363134339|FG000|Treatment Period|Protocol Violation|0|||
105310548|NCT01517373|363134340|FG001|Treatment Period|Protocol Violation|0|||
105310549|NCT01517373|363134341|FG002|Treatment Period|Protocol Violation|0|||
105310550|NCT01517373|363134342|FG003|Treatment Period|Protocol Violation|0|||
105310551|NCT01517373|363134343|FG004|Treatment Period|Protocol Violation|1|||
105310552|NCT01517373|363134344|FG005|Treatment Period|Protocol Violation|0|||
105310553|NCT01517373|363134339|FG000|Treatment Period|Lack of Efficacy|0|||
105310554|NCT01517373|363134340|FG001|Treatment Period|Lack of Efficacy|1|||
105310555|NCT01517373|363134341|FG002|Treatment Period|Lack of Efficacy|1|||
105310556|NCT01517373|363134342|FG003|Treatment Period|Lack of Efficacy|3|||
105310557|NCT01517373|363134343|FG004|Treatment Period|Lack of Efficacy|2|||
105310558|NCT01517373|363134344|FG005|Treatment Period|Lack of Efficacy|0|||
105310559|NCT01517373|363134339|FG000|Treatment Period|Medication error without AEs|0|||
105310560|NCT01517373|363134340|FG001|Treatment Period|Medication error without AEs|0|||
105310561|NCT01517373|363134341|FG002|Treatment Period|Medication error without AEs|2|||
105310562|NCT01517373|363134342|FG003|Treatment Period|Medication error without AEs|1|||
105310563|NCT01517373|363134343|FG004|Treatment Period|Medication error without AEs|0|||
105310564|NCT01517373|363134344|FG005|Treatment Period|Medication error without AEs|2|||
105489791|NCT02536833|363805666|FG003|Overall Study|Physician Decision|1|||
105489792|NCT02536833|363805663|FG000|Overall Study|Site Terminated by Sponsor|2|||
105489793|NCT02536833|363805664|FG001|Overall Study|Site Terminated by Sponsor|2|||
105489794|NCT02536833|363805665|FG002|Overall Study|Site Terminated by Sponsor|2|||
105489795|NCT02536833|363805666|FG003|Overall Study|Site Terminated by Sponsor|2|||
105489796|NCT02536833|363805663|FG000|Overall Study|Subject Non-Compliance|0|||
105489797|NCT02536833|363805664|FG001|Overall Study|Subject Non-Compliance|1|||
105489798|NCT02536833|363805665|FG002|Overall Study|Subject Non-Compliance|1|||
105489799|NCT02536833|363805666|FG003|Overall Study|Subject Non-Compliance|0|||
105489800|NCT02536833|363805663|FG000|Overall Study|Withdrawal by Subject|4|||
105489801|NCT02536833|363805664|FG001|Overall Study|Withdrawal by Subject|3|||
105489802|NCT02536833|363805665|FG002|Overall Study|Withdrawal by Subject|5|||
105489803|NCT02536833|363805666|FG003|Overall Study|Withdrawal by Subject|11|||
105489804|NCT02220998|363805667|FG000|Overall Study|Randomized but Never Treated|1|||
105489805|NCT02220998|363805668|FG001|Overall Study|Randomized but Never Treated|2|||
105489806|NCT02220998|363805667|FG000|Overall Study|Death|2|||
105489807|NCT02220998|363805668|FG001|Overall Study|Death|0|||
105489808|NCT02220998|363805667|FG000|Overall Study|Lack of Efficacy|0|||
105489809|NCT02220998|363805668|FG001|Overall Study|Lack of Efficacy|5|||
105489810|NCT02220998|363805667|FG000|Overall Study|Lost to Follow-up|4|||
105489811|NCT02220998|363805668|FG001|Overall Study|Lost to Follow-up|4|||
105489812|NCT03309046|363805669|FG000|Overall Study|Withdrawal by Subject|4|||
105489813|NCT03309046|363805670|FG001|Overall Study|Withdrawal by Subject|17|||
105489814|NCT02314143|363805671|FG000|Overall Study|Adverse Event|0|||
105489815|NCT02314143|363805672|FG001|Overall Study|Adverse Event|6|||
105489816|NCT02314143|363805673|FG002|Overall Study|Adverse Event|4|||
105489817|NCT02314143|363805671|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
105489818|NCT02314143|363805672|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
105489819|NCT02314143|363805673|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
105489820|NCT02314143|363805671|FG000|Overall Study|Physician Decision|2|||
105489821|NCT02314143|363805672|FG001|Overall Study|Physician Decision|1|||
105489822|NCT02314143|363805673|FG002|Overall Study|Physician Decision|0|||
105489823|NCT02314143|363805671|FG000|Overall Study|Withdrawal by Subject|1|||
105489824|NCT02314143|363805672|FG001|Overall Study|Withdrawal by Subject|0|||
105489825|NCT02314143|363805673|FG002|Overall Study|Withdrawal by Subject|1|||
105489826|NCT03963401|363805674|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
105489827|NCT03963401|363805675|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
105489828|NCT03963401|363805676|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
105489829|NCT03963401|363805677|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
105835806|NCT00105157|365053767|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
105835807|NCT00105157|365053768|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
105835808|NCT00708682|365053769|FG000|Infant Series|Adverse Event|1|||
105835809|NCT00708682|365053769|FG000|Infant Series|Lost to Follow-up|4|||
105835810|NCT00708682|365053769|FG000|Infant Series|Protocol Violation|1|||
105835811|NCT00708682|365053769|FG000|Infant Series|Parent/legal guardian request|6|||
105835812|NCT00708682|365053769|FG000|Infant Series|Failed to return|2|||
105835813|NCT00708682|365053769|FG000|Infant Series|Other|19|||
105367274|NCT02003144|363350166|FG001|Open Label Maintenance Phase|Adverse Event|1|||
105367275|NCT01814007|363350170|FG000|Overall Study|Withdrawal by Subject|1|||
105367276|NCT04350827|363350171|FG000|Overall Study|Lost to Follow-up|1|||
105367277|NCT04350827|363350172|FG001|Overall Study|Lost to Follow-up|2|||
105367278|NCT02481050|363352245|FG000|Overall Study|Adverse Event|1|||
105367279|NCT02481050|363352245|FG000|Overall Study|Disease Progression|47|||
105367280|NCT02481050|363352245|FG000|Overall Study|Withdrawal by Subject|7|||
105835814|NCT00708682|365053769|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
105367281|NCT02481050|363352245|FG000|Overall Study|Other|3|||
105367282|NCT01386606|363352246|FG000|Overall Study|Adverse Event|0|||
105367283|NCT01386606|363352247|FG001|Overall Study|Adverse Event|1|||
105367284|NCT01386606|363352248|FG002|Overall Study|Adverse Event|0|||
105367285|NCT01386606|363352249|FG003|Overall Study|Adverse Event|0|||
105367286|NCT01386606|363352246|FG000|Overall Study|Withdrawal by Subject|0|||
105367287|NCT01386606|363352247|FG001|Overall Study|Withdrawal by Subject|1|||
105367288|NCT01386606|363352248|FG002|Overall Study|Withdrawal by Subject|1|||
105367289|NCT01386606|363352249|FG003|Overall Study|Withdrawal by Subject|0|||
105367290|NCT01386606|363352246|FG000|Overall Study|Protocol Violation|1|||
105367291|NCT01386606|363352247|FG001|Overall Study|Protocol Violation|0|||
105489830|NCT03963401|363805678|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
105489831|NCT03963401|363805679|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
105576485|NCT04157686|364108538|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
105367292|NCT01386606|363352248|FG002|Overall Study|Protocol Violation|1|||
105489832|NCT03963401|363805674|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
105835815|NCT00708682|365053769|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
105835816|NCT00708682|365053769|FG000|Toddler Dose|Lost to Follow-up|3|||
105489833|NCT03963401|363805675|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
105489834|NCT03963401|363805676|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
105489835|NCT03963401|363805677|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
105576486|NCT04157686|364108539|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
105310565|NCT01085201|363134362|FG000|Overall Study|Scheduling conflict|1|||
105310566|NCT01085201|363134363|FG001|Overall Study|Scheduling conflict|0|||
105310567|NCT01085201|363134364|FG002|Overall Study|Scheduling conflict|1|||
105310568|NCT01085201|363134365|FG003|Overall Study|Scheduling conflict|0|||
105310569|NCT01085201|363134366|FG004|Overall Study|Scheduling conflict|0|||
105310570|NCT01085201|363134362|FG000|Overall Study|Unknown- no study drug|2|||
105310571|NCT01085201|363134363|FG001|Overall Study|Unknown- no study drug|0|||
105310572|NCT01085201|363134364|FG002|Overall Study|Unknown- no study drug|0|||
105310573|NCT01085201|363134365|FG003|Overall Study|Unknown- no study drug|0|||
105310574|NCT01085201|363134366|FG004|Overall Study|Unknown- no study drug|0|||
105310575|NCT01085201|363134362|FG000|Overall Study|Fond ineligible after consent|0|||
105310576|NCT01085201|363134363|FG001|Overall Study|Fond ineligible after consent|1|||
105310577|NCT01085201|363134364|FG002|Overall Study|Fond ineligible after consent|1|||
105310578|NCT01085201|363134365|FG003|Overall Study|Fond ineligible after consent|0|||
105310579|NCT01085201|363134366|FG004|Overall Study|Fond ineligible after consent|0|||
105310580|NCT00049530|363134371|FG000|Overall Study|Lack of Efficacy|25|||
105310581|NCT00049530|363134371|FG000|Overall Study|Adverse Event|2|||
105310582|NCT00049530|363134371|FG000|Overall Study|Death|1|||
105310583|NCT00049530|363134371|FG000|Overall Study|symptomatic deterioration|1|||
105310584|NCT00049530|363134371|FG000|Overall Study|ineligible|3|||
105310585|NCT01438996|363134372|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
105310586|NCT01438996|363134373|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
105310587|NCT01438996|363134374|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
105310588|NCT02540850|363134375|FG000|Overall Study|Lost to Follow-up|69|||
105310589|NCT02540850|363134376|FG001|Overall Study|Lost to Follow-up|66|||
105310590|NCT02540850|363134377|FG002|Overall Study|Lost to Follow-up|34|||
105310591|NCT03511326|363134378|FG000|Overall Study|Withdrawal by Subject|1|||
105310592|NCT04005352|363134379|FG000|Overall Study|Adverse Event|4|||
105310593|NCT04005352|363134380|FG001|Overall Study|Adverse Event|5|||
105310594|NCT04005352|363134379|FG000|Overall Study|Death|4|||
105310595|NCT04005352|363134380|FG001|Overall Study|Death|2|||
105310596|NCT04005352|363134379|FG000|Overall Study|Lost to Follow-up|6|||
105310597|NCT04005352|363134380|FG001|Overall Study|Lost to Follow-up|2|||
105310598|NCT04005352|363134379|FG000|Overall Study|Physician Decision|7|||
105310599|NCT04005352|363134380|FG001|Overall Study|Physician Decision|13|||
105310600|NCT04005352|363134379|FG000|Overall Study|Protocol Violation|0|||
105310601|NCT04005352|363134380|FG001|Overall Study|Protocol Violation|1|||
105310602|NCT04005352|363134379|FG000|Overall Study|Withdrawal by Subject|28|||
105310603|NCT04005352|363134380|FG001|Overall Study|Withdrawal by Subject|38|||
105310604|NCT02704403|363134381|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
105310605|NCT02704403|363134382|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
105310606|NCT02704403|363134381|FG000|Overall Study|Administrative reasons by sponsor|1251|||
105310607|NCT02704403|363134382|FG001|Overall Study|Administrative reasons by sponsor|616|||
105310608|NCT02704403|363134381|FG000|Overall Study|Death|4|||
105310609|NCT02704403|363134382|FG001|Overall Study|Death|3|||
105310610|NCT02704403|363134381|FG000|Overall Study|Endpoint event|52|||
105310611|NCT02704403|363134382|FG001|Overall Study|Endpoint event|24|||
105310612|NCT02704403|363134381|FG000|Overall Study|Lost to Follow-up|22|||
105310613|NCT02704403|363134382|FG001|Overall Study|Lost to Follow-up|11|||
105310614|NCT02704403|363134381|FG000|Overall Study|Protocol Violation|15|||
105310615|NCT02704403|363134382|FG001|Overall Study|Protocol Violation|15|||
105310616|NCT02704403|363134381|FG000|Overall Study|Adverse Event|2|||
105310617|NCT02704403|363134382|FG001|Overall Study|Adverse Event|0|||
105310618|NCT02704403|363134381|FG000|Overall Study|Withdrawal by Subject|85|||
105310619|NCT02704403|363134382|FG001|Overall Study|Withdrawal by Subject|45|||
105310620|NCT02704403|363134381|FG000|Overall Study|Investigator decision|1|||
105310621|NCT02704403|363134382|FG001|Overall Study|Investigator decision|1|||
105310622|NCT02704403|363134381|FG000|Overall Study|Follow-up not possible|1|||
105310623|NCT02704403|363134382|FG001|Overall Study|Follow-up not possible|2|||
105310624|NCT01844856|363134383|FG000|Overall Study|Lost to Follow-up|15|||
105310625|NCT01844856|363134384|FG001|Overall Study|Lost to Follow-up|3|||
105310626|NCT01844856|363134383|FG000|Overall Study|Adverse Event|3|||
105310627|NCT01844856|363134384|FG001|Overall Study|Adverse Event|6|||
105310628|NCT01844856|363134383|FG000|Overall Study|Withdrawal by Subject|3|||
105310629|NCT01844856|363134384|FG001|Overall Study|Withdrawal by Subject|2|||
105310630|NCT01844856|363134383|FG000|Overall Study|Noncompliance|2|||
105310631|NCT01844856|363134384|FG001|Overall Study|Noncompliance|3|||
105310632|NCT01844856|363134383|FG000|Overall Study|Enterococcus Resistant|0|||
105310633|NCT01844856|363134384|FG001|Overall Study|Enterococcus Resistant|1|||
105310634|NCT01844856|363134383|FG000|Overall Study|Inadvertently Not Scheduled|1|||
105310635|NCT01844856|363134384|FG001|Overall Study|Inadvertently Not Scheduled|0|||
105310636|NCT01844856|363134383|FG000|Overall Study|Randomized but was a Screen Failure|0|||
105310637|NCT01844856|363134384|FG001|Overall Study|Randomized but was a Screen Failure|1|||
105310638|NCT01221363|363134385|FG000|Overall Study|Pregnancy|1|||
105310639|NCT01221363|363134386|FG001|Overall Study|Pregnancy|0|||
105310640|NCT01221363|363134385|FG000|Overall Study|Withdrawal by Subject|11|||
105367293|NCT01386606|363352249|FG003|Overall Study|Protocol Violation|1|||
105367294|NCT01386606|363352246|FG000|Overall Study|Lost to Follow-up|2|||
105367295|NCT01386606|363352247|FG001|Overall Study|Lost to Follow-up|0|||
105367296|NCT01386606|363352248|FG002|Overall Study|Lost to Follow-up|0|||
105367297|NCT01386606|363352249|FG003|Overall Study|Lost to Follow-up|0|||
105367298|NCT01386606|363352246|FG000|Overall Study|Subject incarcerated|0|||
105367299|NCT01386606|363352247|FG001|Overall Study|Subject incarcerated|1|||
105367300|NCT01386606|363352248|FG002|Overall Study|Subject incarcerated|0|||
105367301|NCT01386606|363352249|FG003|Overall Study|Subject incarcerated|0|||
105367302|NCT01386606|363352246|FG000|Overall Study|Unable to draw PK|1|||
105835817|NCT00708682|365053769|FG000|Toddler Dose|Failed to Return|4|||
105835818|NCT02212457|365053774|FG000|Overall Study|Adverse Event|1|||
105835819|NCT02212457|365053775|FG001|Overall Study|Adverse Event|2|||
105835820|NCT02212457|365053776|FG002|Overall Study|Adverse Event|2|||
105835821|NCT02212457|365053777|FG003|Overall Study|Adverse Event|2|||
105835822|NCT02212457|365053778|FG004|Overall Study|Adverse Event|0|||
105835823|NCT02212457|365053779|FG005|Overall Study|Adverse Event|1|||
105835824|NCT02212457|365053774|FG000|Overall Study|Withdrawal by Subject|8|||
105835825|NCT02212457|365053775|FG001|Overall Study|Withdrawal by Subject|10|||
105835826|NCT02212457|365053776|FG002|Overall Study|Withdrawal by Subject|8|||
105835827|NCT02212457|365053777|FG003|Overall Study|Withdrawal by Subject|6|||
105835828|NCT02212457|365053778|FG004|Overall Study|Withdrawal by Subject|5|||
105367303|NCT01386606|363352247|FG001|Overall Study|Unable to draw PK|0|||
105367304|NCT01386606|363352248|FG002|Overall Study|Unable to draw PK|0|||
105367305|NCT01386606|363352249|FG003|Overall Study|Unable to draw PK|0|||
105367306|NCT01386606|363352246|FG000|Overall Study|T levels too high|0|||
105367307|NCT01386606|363352247|FG001|Overall Study|T levels too high|1|||
105835829|NCT02212457|365053779|FG005|Overall Study|Withdrawal by Subject|4|||
105835830|NCT02212457|365053774|FG000|Overall Study|Lost to Follow-up|6|||
105835831|NCT02212457|365053775|FG001|Overall Study|Lost to Follow-up|7|||
105835832|NCT02212457|365053776|FG002|Overall Study|Lost to Follow-up|4|||
105835833|NCT02212457|365053777|FG003|Overall Study|Lost to Follow-up|1|||
105835834|NCT02212457|365053778|FG004|Overall Study|Lost to Follow-up|8|||
105835835|NCT02212457|365053779|FG005|Overall Study|Lost to Follow-up|4|||
105835836|NCT02212457|365053774|FG000|Overall Study|Protocol Violation|2|||
105835837|NCT02212457|365053775|FG001|Overall Study|Protocol Violation|1|||
105310641|NCT01221363|363134386|FG001|Overall Study|Withdrawal by Subject|5|||
105310642|NCT04628793|363134387|FG000|Overall Study|Study terminated by sponsor|0|||
105310643|NCT04628793|363134388|FG001|Overall Study|Study terminated by sponsor|0|||
105310644|NCT04628793|363134389|FG002|Overall Study|Study terminated by sponsor|8|||
105310645|NCT04628793|363134387|FG000|Overall Study|Withdrawal by Subject|2|||
105310646|NCT04628793|363134388|FG001|Overall Study|Withdrawal by Subject|3|||
105310647|NCT04628793|363134389|FG002|Overall Study|Withdrawal by Subject|0|||
105310648|NCT04628793|363134387|FG000|Overall Study|Lost to Follow-up|0|||
105310649|NCT04628793|363134388|FG001|Overall Study|Lost to Follow-up|1|||
105310650|NCT04628793|363134389|FG002|Overall Study|Lost to Follow-up|0|||
105310651|NCT02278055|363134392|FG000|Overall Study|Adverse Event|1|||
105310652|NCT02278055|363134392|FG000|Overall Study|Lost to Follow-up|1|||
105310653|NCT02278055|363134392|FG000|Overall Study|Withdrawal by Subject|2|||
105310654|NCT02278055|363134392|FG000|Overall Study|Progressive Disease|4|||
105310655|NCT01934335|363134394|FG000|Overall Study|Withdrawal by Subject|1|||
105310656|NCT01934335|363134395|FG001|Overall Study|Withdrawal by Subject|1|||
105310657|NCT04040192|363134396|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
105310658|NCT04040192|363134397|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
105310659|NCT04040192|363134398|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
105310660|NCT04040192|363134396|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
105310661|NCT04040192|363134397|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
105310662|NCT04040192|363134398|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
105310663|NCT04040192|363134396|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
105310664|NCT04040192|363134397|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
105310665|NCT04040192|363134398|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
105310666|NCT04040192|363134396|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
105310667|NCT04040192|363134397|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
105310668|NCT04040192|363134398|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
105367308|NCT01386606|363352248|FG002|Overall Study|T levels too high|1|||
105367309|NCT01386606|363352249|FG003|Overall Study|T levels too high|0|||
105367310|NCT01548599|363352250|FG000|Overall Study|Lost to Follow-up|0|||
105367311|NCT01548599|363352251|FG001|Overall Study|Lost to Follow-up|1|||
105489836|NCT03963401|363805678|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
105489837|NCT03963401|363805679|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
105835838|NCT02212457|365053776|FG002|Overall Study|Protocol Violation|0|||
105835839|NCT02212457|365053777|FG003|Overall Study|Protocol Violation|1|||
105835840|NCT02212457|365053778|FG004|Overall Study|Protocol Violation|2|||
105835841|NCT02212457|365053779|FG005|Overall Study|Protocol Violation|3|||
105835842|NCT02212457|365053774|FG000|Overall Study|Other|2|||
105835843|NCT02212457|365053775|FG001|Overall Study|Other|1|||
105835844|NCT02212457|365053776|FG002|Overall Study|Other|2|||
105835845|NCT02212457|365053777|FG003|Overall Study|Other|1|||
105835846|NCT02212457|365053778|FG004|Overall Study|Other|0|||
105835847|NCT02212457|365053779|FG005|Overall Study|Other|1|||
105835848|NCT00393705|365053780|FG000|Overall Study|Adverse Event|0|||
105835849|NCT00393705|365053781|FG001|Overall Study|Adverse Event|2|||
105835850|NCT00393705|365053780|FG000|Overall Study|Death|0|||
105835851|NCT00393705|365053781|FG001|Overall Study|Death|1|||
105835852|NCT00393705|365053780|FG000|Overall Study|Lost to Follow-up|2|||
105835853|NCT00393705|365053781|FG001|Overall Study|Lost to Follow-up|2|||
105835854|NCT00393705|365053780|FG000|Overall Study|Entry Criteria Not Met|10|||
105835855|NCT00393705|365053781|FG001|Overall Study|Entry Criteria Not Met|10|||
105835856|NCT00393705|365053780|FG000|Overall Study|Protocol Violation|4|||
105835857|NCT00393705|365053781|FG001|Overall Study|Protocol Violation|3|||
105835858|NCT00393705|365053780|FG000|Overall Study|Withdrawal by Subject|5|||
105835859|NCT00393705|365053781|FG001|Overall Study|Withdrawal by Subject|3|||
105310669|NCT04040192|363134396|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
105310670|NCT04040192|363134397|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
105310671|NCT04040192|363134398|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
105310672|NCT04040192|363134396|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
105310673|NCT04040192|363134397|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
105310674|NCT04040192|363134398|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
105310675|NCT04040192|363134396|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
105310676|NCT04040192|363134397|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
105310677|NCT04040192|363134398|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
105310678|NCT04040192|363134396|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
105310679|NCT04040192|363134397|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
105367312|NCT01548599|363352250|FG000|Overall Study|Withdrawal by Subject|4|||
105367313|NCT01548599|363352251|FG001|Overall Study|Withdrawal by Subject|0|||
105835860|NCT00393705|365053780|FG000|Overall Study|Physician Decision|2|||
105835861|NCT00393705|365053781|FG001|Overall Study|Physician Decision|2|||
105835862|NCT01120691|365053782|FG000|Overall Study|Adverse Event|59|||
105835863|NCT01120691|365053783|FG001|Overall Study|Adverse Event|67|||
105835864|NCT01120691|365053784|FG002|Overall Study|Adverse Event|47|||
105835865|NCT01120691|365053782|FG000|Overall Study|Subject withdrew consent|33|||
105835866|NCT01120691|365053783|FG001|Overall Study|Subject withdrew consent|50|||
105835867|NCT01120691|365053784|FG002|Overall Study|Subject withdrew consent|44|||
105835868|NCT01120691|365053782|FG000|Overall Study|Death|21|||
105835869|NCT01120691|365053783|FG001|Overall Study|Death|22|||
105835870|NCT01120691|365053784|FG002|Overall Study|Death|24|||
105835871|NCT01120691|365053782|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
105835872|NCT01120691|365053783|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
105835873|NCT01120691|365053784|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
105835874|NCT01120691|365053782|FG000|Overall Study|Administrative problems|15|||
105835875|NCT01120691|365053783|FG001|Overall Study|Administrative problems|8|||
105835876|NCT01120691|365053784|FG002|Overall Study|Administrative problems|9|||
105835877|NCT01120691|365053782|FG000|Overall Study|Protocol deviation|13|||
105835878|NCT01120691|365053783|FG001|Overall Study|Protocol deviation|12|||
105835879|NCT01120691|365053784|FG002|Overall Study|Protocol deviation|12|||
105835880|NCT01120691|365053782|FG000|Overall Study|Lost to Follow-up|5|||
105835881|NCT01120691|365053783|FG001|Overall Study|Lost to Follow-up|6|||
105835882|NCT01120691|365053784|FG002|Overall Study|Lost to Follow-up|4|||
105835883|NCT01120691|365053782|FG000|Overall Study|Abnormal test procedure result(s)|3|||
105835884|NCT01120691|365053783|FG001|Overall Study|Abnormal test procedure result(s)|2|||
105835885|NCT01120691|365053784|FG002|Overall Study|Abnormal test procedure result(s)|1|||
105835886|NCT01120691|365053782|FG000|Overall Study|Patient's inability to use the device|3|||
105835887|NCT01120691|365053783|FG001|Overall Study|Patient's inability to use the device|1|||
105835888|NCT01120691|365053784|FG002|Overall Study|Patient's inability to use the device|0|||
105835889|NCT01120691|365053782|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105835890|NCT01120691|365053783|FG001|Overall Study|Abnormal laboratory value(s)|3|||
105835891|NCT01120691|365053784|FG002|Overall Study|Abnormal laboratory value(s)|4|||
105310680|NCT04040192|363134398|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
105310681|NCT04040192|363134396|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
105367314|NCT01548599|363352250|FG000|Overall Study|Death|2|||
105367315|NCT01548599|363352251|FG001|Overall Study|Death|1|||
105489838|NCT03963401|363805674|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
105489839|NCT03963401|363805675|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
105835892|NCT02030535|365053785|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
105835893|NCT03185741|365053792|FG000|Baseline|Withdrawal by Subject|1|||
105835894|NCT03185741|365053793|FG001|Baseline|Withdrawal by Subject|3|||
105835895|NCT03185741|365053794|FG002|Baseline|Withdrawal by Subject|2|||
105835896|NCT03185741|365053792|FG000|Baseline|Lost to Follow-up|1|||
105835897|NCT03185741|365053793|FG001|Baseline|Lost to Follow-up|2|||
105835898|NCT03185741|365053794|FG002|Baseline|Lost to Follow-up|3|||
105489840|NCT03963401|363805676|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
105489841|NCT03963401|363805677|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
105489842|NCT03963401|363805678|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
105835899|NCT03185741|365053792|FG000|3Month|Death|1|||
105835900|NCT03185741|365053793|FG001|3Month|Death|1|||
105489843|NCT03963401|363805679|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
105835901|NCT03185741|365053794|FG002|3Month|Death|2|||
105835902|NCT03185741|365053792|FG000|3Month|Withdrawal by Subject|1|||
105835903|NCT03185741|365053793|FG001|3Month|Withdrawal by Subject|5|||
105835904|NCT03185741|365053794|FG002|3Month|Withdrawal by Subject|1|||
105835905|NCT03185741|365053792|FG000|3Month|Lost to Follow-up|7|||
105835906|NCT03185741|365053793|FG001|3Month|Lost to Follow-up|9|||
105835907|NCT03185741|365053794|FG002|3Month|Lost to Follow-up|8|||
105835908|NCT03185741|365053792|FG000|3Month|Unavailable for 3Month|11|||
105835909|NCT03185741|365053793|FG001|3Month|Unavailable for 3Month|10|||
105835910|NCT03185741|365053794|FG002|3Month|Unavailable for 3Month|11|||
105489844|NCT03963401|363805674|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
105489845|NCT03963401|363805675|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
105835911|NCT03185741|365053792|FG000|3Month|Protocol Violation|0|||
105835912|NCT03185741|365053793|FG001|3Month|Protocol Violation|0|||
105835913|NCT03185741|365053794|FG002|3Month|Protocol Violation|3|||
105835914|NCT03185741|365053792|FG000|6Month|Death|1|||
105835915|NCT03185741|365053793|FG001|6Month|Death|1|||
105835916|NCT03185741|365053794|FG002|6Month|Death|2|||
105835917|NCT03185741|365053792|FG000|6Month|Withdrawal by Subject|2|||
105835918|NCT03185741|365053793|FG001|6Month|Withdrawal by Subject|3|||
105835919|NCT03185741|365053794|FG002|6Month|Withdrawal by Subject|1|||
105835920|NCT03185741|365053792|FG000|6Month|Lost to Follow-up|16|||
105835921|NCT03185741|365053793|FG001|6Month|Lost to Follow-up|15|||
105835922|NCT03185741|365053794|FG002|6Month|Lost to Follow-up|16|||
105835923|NCT01588548|365053795|FG000|Overall Study|Withdrawal by Subject|0|||
105835924|NCT01588548|365053796|FG001|Overall Study|Withdrawal by Subject|1|||
105835925|NCT01588548|365053797|FG002|Overall Study|Withdrawal by Subject|1|||
105835926|NCT01588548|365053798|FG003|Overall Study|Withdrawal by Subject|1|||
105835927|NCT01588548|365053799|FG004|Overall Study|Withdrawal by Subject|2|||
105835928|NCT01588548|365053800|FG005|Overall Study|Withdrawal by Subject|3|||
105835929|NCT01588548|365053795|FG000|Overall Study|Adverse Event|0|||
105835930|NCT01588548|365053796|FG001|Overall Study|Adverse Event|0|||
105835931|NCT01588548|365053797|FG002|Overall Study|Adverse Event|1|||
105835932|NCT01588548|365053798|FG003|Overall Study|Adverse Event|2|||
105835933|NCT01588548|365053799|FG004|Overall Study|Adverse Event|1|||
105835934|NCT01588548|365053800|FG005|Overall Study|Adverse Event|0|||
105835935|NCT01588548|365053795|FG000|Overall Study|Condition Under Investigation Worsened|3|||
105835936|NCT01588548|365053796|FG001|Overall Study|Condition Under Investigation Worsened|6|||
105835937|NCT01588548|365053797|FG002|Overall Study|Condition Under Investigation Worsened|4|||
105835938|NCT01588548|365053798|FG003|Overall Study|Condition Under Investigation Worsened|4|||
105835939|NCT01588548|365053799|FG004|Overall Study|Condition Under Investigation Worsened|3|||
105835940|NCT01588548|365053800|FG005|Overall Study|Condition Under Investigation Worsened|3|||
105835941|NCT00089973|365053805|FG000|Overall Study|Adverse Event|3|||
105835942|NCT00089973|365053805|FG000|Overall Study|Withdrawal by Subject|1|||
105835943|NCT00089973|365053805|FG000|Overall Study|Disease progression|45|||
105835944|NCT00089973|365053805|FG000|Overall Study|Death|1|||
105835945|NCT01634854|365053806|FG000|Overall Study|Cesarean delivery|2|||
105310682|NCT04040192|363134397|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
105310683|NCT04040192|363134398|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
105310684|NCT04040192|363134396|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
105310685|NCT04040192|363134397|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
105310686|NCT04040192|363134398|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
105310687|NCT04040192|363134396|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
105310688|NCT04040192|363134397|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
105310689|NCT04040192|363134398|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
105310690|NCT04040192|363134396|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
105310691|NCT04040192|363134397|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
105310692|NCT04040192|363134398|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
105310693|NCT04040192|363134396|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
105310694|NCT04040192|363134397|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
105310695|NCT04040192|363134398|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
105367316|NCT02873689|363352252|FG000|Overall Study|Lack of Efficacy|1|||
105835946|NCT01634854|365053807|FG001|Overall Study|Cesarean delivery|7|||
105835947|NCT00654641|365053808|FG000|Overall Study|Lost to Follow-up|2|||
105835948|NCT00654641|365053809|FG001|Overall Study|Lost to Follow-up|3|||
105835949|NCT01337596|365053810|FG000|Overall Study|Withdrawal by Subject|0|||
105835950|NCT01337596|365053811|FG001|Overall Study|Withdrawal by Subject|0|||
105835951|NCT01337596|365053812|FG002|Overall Study|Withdrawal by Subject|0|||
105835952|NCT01337596|365053813|FG003|Overall Study|Withdrawal by Subject|0|||
105835953|NCT01337596|365053814|FG004|Overall Study|Withdrawal by Subject|2|||
105835954|NCT01337596|365053815|FG005|Overall Study|Withdrawal by Subject|0|||
105835955|NCT01337596|365053816|FG006|Overall Study|Withdrawal by Subject|0|||
105835956|NCT01337596|365053817|FG007|Overall Study|Withdrawal by Subject|0|||
105835957|NCT01337596|365053818|FG008|Overall Study|Withdrawal by Subject|0|||
105835958|NCT03365791|365053819|FG000|Overall Study|Adverse Event|5|||
105835959|NCT03365791|365053819|FG000|Overall Study|Death|1|||
105835960|NCT03365791|365053819|FG000|Overall Study|Lost to Follow-up|1|||
105835961|NCT03365791|365053819|FG000|Overall Study|Physician Decision|9|||
105835962|NCT03365791|365053819|FG000|Overall Study|Progressive disease|51|||
105835963|NCT03365791|365053819|FG000|Overall Study|Subject/guardian decision|5|||
105835964|NCT01362296|365053820|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
105835965|NCT01362296|365053821|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
105835966|NCT01362296|365053822|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
105835967|NCT01362296|365053823|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
105835968|NCT01362296|365053820|FG000|Randomized Phase (RP)|Physician Decision|1|||
105835969|NCT01362296|365053821|FG001|Randomized Phase (RP)|Physician Decision|9|||
105835970|NCT01362296|365053822|FG002|Randomized Phase (RP)|Physician Decision|0|||
105835971|NCT01362296|365053823|FG003|Randomized Phase (RP)|Physician Decision|0|||
105835972|NCT01362296|365053820|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
105835973|NCT01362296|365053821|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
105835974|NCT01362296|365053822|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
105835975|NCT01362296|365053823|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
105835976|NCT01362296|365053820|FG000|Randomized Phase (RP)|Adverse Event|20|||
105835977|NCT01362296|365053821|FG001|Randomized Phase (RP)|Adverse Event|4|||
105835978|NCT01362296|365053822|FG002|Randomized Phase (RP)|Adverse Event|0|||
105835979|NCT01362296|365053823|FG003|Randomized Phase (RP)|Adverse Event|0|||
105835980|NCT01362296|365053820|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
105835981|NCT01362296|365053821|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
105835982|NCT01362296|365053822|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
105835983|NCT01362296|365053823|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
105835984|NCT01362296|365053820|FG000|Crossover Phase|PD including Death due to PD|0|||
105835985|NCT01362296|365053821|FG001|Crossover Phase|PD including Death due to PD|0|||
105835986|NCT01362296|365053822|FG002|Crossover Phase|PD including Death due to PD|16|||
105835987|NCT01362296|365053823|FG003|Crossover Phase|PD including Death due to PD|1|||
105835988|NCT01362296|365053820|FG000|Crossover Phase|Withdrawal by Subject|0|||
105835989|NCT01362296|365053821|FG001|Crossover Phase|Withdrawal by Subject|0|||
105835990|NCT01362296|365053822|FG002|Crossover Phase|Withdrawal by Subject|2|||
105835991|NCT01362296|365053823|FG003|Crossover Phase|Withdrawal by Subject|1|||
105835992|NCT01362296|365053820|FG000|Crossover Phase|Adverse Event|0|||
105835993|NCT01362296|365053821|FG001|Crossover Phase|Adverse Event|0|||
105835994|NCT01362296|365053822|FG002|Crossover Phase|Adverse Event|4|||
105835995|NCT01362296|365053823|FG003|Crossover Phase|Adverse Event|0|||
105835996|NCT01362296|365053820|FG000|Crossover Phase|Study Closed/Terminated|0|||
105835997|NCT01362296|365053821|FG001|Crossover Phase|Study Closed/Terminated|0|||
105835998|NCT01362296|365053822|FG002|Crossover Phase|Study Closed/Terminated|1|||
105835999|NCT01362296|365053823|FG003|Crossover Phase|Study Closed/Terminated|0|||
105836000|NCT03693950|365053824|FG000|Overall Study|Withdrawal by Subject|1|||
105836001|NCT03693950|365053825|FG001|Overall Study|Withdrawal by Subject|0|||
105836002|NCT01475487|365053826|FG000|Overall Study|had to leave early for personal reasons|2|||
105836003|NCT01475487|365053827|FG001|Overall Study|had to leave early for personal reasons|1|||
105836004|NCT01321697|365053832|FG000|Overall Study|Study Terminated|7|||
105836005|NCT00857818|365053833|FG000|Overall Study|Lack of Efficacy|1|||
105836006|NCT00857818|365053834|FG001|Overall Study|Lack of Efficacy|0|||
105836007|NCT00857818|365053833|FG000|Overall Study|Adverse Event|3|||
105836008|NCT00857818|365053834|FG001|Overall Study|Adverse Event|0|||
105836009|NCT00857818|365053833|FG000|Overall Study|Withdrawal by Subject|0|||
105836010|NCT00857818|365053834|FG001|Overall Study|Withdrawal by Subject|4|||
105836011|NCT00857818|365053833|FG000|Overall Study|Sponsor terminated study|6|||
105836012|NCT00857818|365053834|FG001|Overall Study|Sponsor terminated study|4|||
105836013|NCT00857818|365053833|FG000|Overall Study|Investigator decision|1|||
105836014|NCT00857818|365053834|FG001|Overall Study|Investigator decision|0|||
105310696|NCT04040192|363134396|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
105310697|NCT04040192|363134397|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
105310698|NCT04040192|363134398|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
105310699|NCT04040192|363134396|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
105310700|NCT04040192|363134397|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
105310701|NCT04040192|363134398|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
105836015|NCT00434590|365053835|FG000|Overall Study|Administrative problems|5|||
105836016|NCT00434590|365053836|FG001|Overall Study|Administrative problems|5|||
105836017|NCT02028455|365053837|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
105836018|NCT02028455|365053838|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
105367317|NCT02873689|363352253|FG001|Overall Study|Lack of Efficacy|0|||
105367318|NCT02873689|363352252|FG000|Overall Study|Withdrawal by Subject|2|||
105367319|NCT02873689|363352253|FG001|Overall Study|Withdrawal by Subject|2|||
105367320|NCT02873689|363352252|FG000|Overall Study|Protocol Violation|1|||
105367321|NCT02873689|363352253|FG001|Overall Study|Protocol Violation|0|||
105367322|NCT02873689|363352252|FG000|Overall Study|Adverse Event|2|||
105310702|NCT04040192|363134396|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
105310703|NCT04040192|363134397|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
105310704|NCT04040192|363134398|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
105310705|NCT04040192|363134396|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
105310706|NCT04040192|363134397|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
105310707|NCT04040192|363134398|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
105310708|NCT03597529|363134401|FG000|Overall Study|Lost to Follow-up|10|||
105310709|NCT03597529|363134402|FG001|Overall Study|Lost to Follow-up|12|||
105310710|NCT03597529|363134401|FG000|Overall Study|Physician Decision|3|||
105367323|NCT02873689|363352253|FG001|Overall Study|Adverse Event|2|||
105836019|NCT02028455|365053839|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
105836020|NCT02028455|365053840|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
105836021|NCT02028455|365053841|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
105836022|NCT02028455|365053842|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
105836023|NCT02028455|365053843|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
105836024|NCT02028455|365053844|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
105836025|NCT02028455|365053837|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
105836026|NCT02028455|365053838|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
105836027|NCT02028455|365053839|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
105836028|NCT02028455|365053840|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
105836029|NCT02028455|365053841|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
105836030|NCT02028455|365053842|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
105836031|NCT02028455|365053843|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
105836032|NCT02028455|365053844|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
105836033|NCT02028455|365053837|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
105836034|NCT02028455|365053838|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
105836035|NCT02028455|365053839|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
105836036|NCT02028455|365053840|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
105836037|NCT02028455|365053841|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
105836038|NCT02028455|365053842|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
105836039|NCT02028455|365053843|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
105836040|NCT02028455|365053844|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
105836041|NCT02028455|365053837|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
105836042|NCT02028455|365053838|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
105836043|NCT02028455|365053839|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
105836044|NCT02028455|365053840|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
105836045|NCT02028455|365053841|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
105836046|NCT02028455|365053842|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
105836047|NCT02028455|365053843|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
105836048|NCT02028455|365053844|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
105836049|NCT05135273|365054977|FG000|Overall Study|Recruited into the army|0|||
105836050|NCT05135273|365054978|FG001|Overall Study|Recruited into the army|0|||
105836051|NCT05135273|365054979|FG002|Overall Study|Recruited into the army|0|||
105836052|NCT05135273|365054980|FG003|Overall Study|Recruited into the army|0|||
105836053|NCT05135273|365054981|FG004|Overall Study|Recruited into the army|1|||
105836054|NCT05135273|365054982|FG005|Overall Study|Recruited into the army|0|||
105836055|NCT05135273|365054983|FG006|Overall Study|Recruited into the army|0|||
105836056|NCT05135273|365054984|FG007|Overall Study|Recruited into the army|0|||
105836057|NCT05135273|365054977|FG000|Overall Study|Moved away from study site|0|||
105836058|NCT05135273|365054978|FG001|Overall Study|Moved away from study site|0|||
105836059|NCT05135273|365054979|FG002|Overall Study|Moved away from study site|0|||
105836060|NCT05135273|365054980|FG003|Overall Study|Moved away from study site|0|||
105836061|NCT05135273|365054981|FG004|Overall Study|Moved away from study site|0|||
105836062|NCT05135273|365054982|FG005|Overall Study|Moved away from study site|1|||
105367324|NCT02873689|363352252|FG000|Overall Study|Randomized but not Treated|1|||
105367325|NCT02873689|363352253|FG001|Overall Study|Randomized but not Treated|1|||
105367326|NCT04113694|363352254|FG000|Overall Study|Adverse Event|2|||
105489846|NCT03963401|363805676|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
105489847|NCT03963401|363805677|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
105310711|NCT03597529|363134402|FG001|Overall Study|Physician Decision|1|||
105489848|NCT03963401|363805678|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
105836063|NCT05135273|365054983|FG006|Overall Study|Moved away from study site|1|||
105836064|NCT05135273|365054984|FG007|Overall Study|Moved away from study site|0|||
105836065|NCT05135273|365054977|FG000|Overall Study|Travel|0|||
105836066|NCT05135273|365054978|FG001|Overall Study|Travel|0|||
105836067|NCT05135273|365054979|FG002|Overall Study|Travel|0|||
105836068|NCT05135273|365054980|FG003|Overall Study|Travel|0|||
105836069|NCT05135273|365054981|FG004|Overall Study|Travel|0|||
105836070|NCT05135273|365054982|FG005|Overall Study|Travel|0|||
105836071|NCT05135273|365054983|FG006|Overall Study|Travel|0|||
105836072|NCT05135273|365054984|FG007|Overall Study|Travel|1|||
105836073|NCT01958060|365054989|FG000|Overall Study|Not treated|2|||
105836074|NCT01958060|365054990|FG001|Overall Study|Not treated|0|||
105836075|NCT01958060|365054991|FG002|Overall Study|Not treated|0|||
105836076|NCT01958060|365054992|FG003|Overall Study|Not treated|0|||
105836077|NCT01958060|365054993|FG004|Overall Study|Not treated|1|||
105836078|NCT01958060|365054994|FG005|Overall Study|Not treated|0|||
105836079|NCT01705717|365054997|FG000|Overall Study|Adverse Event|2|||
105836080|NCT01705717|365054998|FG001|Overall Study|Adverse Event|2|||
105836081|NCT01705717|365054997|FG000|Overall Study|Lack of Efficacy|0|||
105836082|NCT01705717|365054998|FG001|Overall Study|Lack of Efficacy|1|||
105836083|NCT01705717|365054997|FG000|Overall Study|Other|0|||
105836084|NCT01705717|365054998|FG001|Overall Study|Other|2|||
105836085|NCT02031237|365055002|FG000|Overall Study|Death|1|||
105836086|NCT02031237|365055003|FG001|Overall Study|Death|5|||
105836087|NCT02031237|365055004|FG002|Overall Study|Death|0|||
105836088|NCT02031237|365055002|FG000|Overall Study|Physician Decision|0|||
105836089|NCT02031237|365055003|FG001|Overall Study|Physician Decision|1|||
105836090|NCT02031237|365055004|FG002|Overall Study|Physician Decision|0|||
105836091|NCT02031237|365055002|FG000|Overall Study|Withdrawal by Subject|2|||
105836092|NCT02031237|365055003|FG001|Overall Study|Withdrawal by Subject|2|||
105836093|NCT02031237|365055004|FG002|Overall Study|Withdrawal by Subject|0|||
105836094|NCT02031237|365055002|FG000|Overall Study|Protocol Violation|2|||
105836095|NCT02031237|365055003|FG001|Overall Study|Protocol Violation|6|||
105836096|NCT02031237|365055004|FG002|Overall Study|Protocol Violation|0|||
105836097|NCT02031237|365055002|FG000|Overall Study|Alternate Treatment Given|0|||
105836098|NCT02031237|365055003|FG001|Overall Study|Alternate Treatment Given|0|||
105836099|NCT02031237|365055004|FG002|Overall Study|Alternate Treatment Given|3|||
105836100|NCT00927251|365055005|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
105836101|NCT05996198|365055008|FG000|Overall Study|Withdrawal by Subject|1|||
105836102|NCT05996198|365055009|FG001|Overall Study|Withdrawal by Subject|0|||
105836103|NCT00835796|365055010|FG000|First Intervention|Withdrawal by Subject|0|||
105836104|NCT00835796|365055011|FG001|First Intervention|Withdrawal by Subject|1|||
105836105|NCT00396630|365055012|FG000|Overall Study|Lost to Follow-up|1|||
105836106|NCT00396630|365055013|FG001|Overall Study|Lost to Follow-up|1|||
105836107|NCT00396630|365055012|FG000|Overall Study|Withdrawal by Subject|1|||
105836108|NCT00396630|365055013|FG001|Overall Study|Withdrawal by Subject|1|||
105836109|NCT00396630|365055012|FG000|Overall Study|Not vaccinated at Visit 3|3|||
105836110|NCT00396630|365055013|FG001|Overall Study|Not vaccinated at Visit 3|3|||
105836111|NCT04542694|365055014|FG000|Overall Study|The need for prohibited therapy|2|||
105836112|NCT04542694|365055015|FG001|Overall Study|The need for prohibited therapy|0|||
105836113|NCT04542694|365055014|FG000|Overall Study|Adverse Event|1|||
105836114|NCT04542694|365055015|FG001|Overall Study|Adverse Event|0|||
105836115|NCT04542694|365055014|FG000|Overall Study|Protocol Violation|1|||
105836116|NCT04542694|365055015|FG001|Overall Study|Protocol Violation|0|||
105836117|NCT00996437|365055016|FG000|Overall Study|Death|1|||
105836118|NCT00996437|365055017|FG001|Overall Study|Death|0|||
105836119|NCT00996437|365055016|FG000|Overall Study|Dropped|2|||
105836120|NCT00996437|365055017|FG001|Overall Study|Dropped|2|||
105836121|NCT00996437|365055016|FG000|Overall Study|Missed|2|||
105836122|NCT00996437|365055017|FG001|Overall Study|Missed|5|||
105836123|NCT01755975|365055018|FG000|Overall Study|Adverse Event|0|||
105836124|NCT01755975|365055019|FG001|Overall Study|Adverse Event|0|||
105836125|NCT01755975|365055020|FG002|Overall Study|Adverse Event|1|||
105836126|NCT01755975|365055021|FG003|Overall Study|Adverse Event|0|||
105836127|NCT01755975|365055022|FG004|Overall Study|Adverse Event|2|||
105836128|NCT04412057|365055023|FG000|Overall Study|Death|3|||
105836129|NCT04412057|365055024|FG001|Overall Study|Death|7|||
105836130|NCT04412057|365055023|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
105836131|NCT04412057|365055024|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
105836132|NCT02104817|365055025|FG000|Overall Study|Death|363|||
105836133|NCT02104817|365055026|FG001|Overall Study|Death|330|||
105836134|NCT02104817|365055025|FG000|Overall Study|Lost to Follow-up|3|||
105836135|NCT02104817|365055026|FG001|Overall Study|Lost to Follow-up|2|||
105836136|NCT02104817|365055025|FG000|Overall Study|Protocol Violation|0|||
105836137|NCT02104817|365055026|FG001|Overall Study|Protocol Violation|1|||
105836138|NCT02104817|365055025|FG000|Overall Study|Study terminated by sponsor|5854|||
105836139|NCT02104817|365055026|FG001|Overall Study|Study terminated by sponsor|5901|||
105836140|NCT02104817|365055025|FG000|Overall Study|Withdrawal by Subject|111|||
105836141|NCT02104817|365055026|FG001|Overall Study|Withdrawal by Subject|78|||
105836142|NCT02104817|365055025|FG000|Overall Study|Other reasons|128|||
105836143|NCT02104817|365055026|FG001|Overall Study|Other reasons|135|||
105836144|NCT03223909|365055035|FG000|Overall Study|Protocol Violation|48|||
105836145|NCT03223909|365055036|FG001|Overall Study|Protocol Violation|45|||
105836146|NCT03223909|365055037|FG002|Overall Study|Protocol Violation|16|||
105836147|NCT04886063|365055040|FG000|Overall Study|Adverse Event|50|||
105836148|NCT04886063|365055040|FG000|Overall Study|Lack of Efficacy|31|||
105836149|NCT04886063|365055040|FG000|Overall Study|Withdrawal by Subject|45|||
105836150|NCT04886063|365055040|FG000|Overall Study|Physician Decision|3|||
105836151|NCT04886063|365055040|FG000|Overall Study|Protocol Violation|3|||
105836152|NCT04886063|365055040|FG000|Overall Study|Site closure|4|||
105836153|NCT04886063|365055040|FG000|Overall Study|Nursing home replacement|3|||
105836154|NCT04886063|365055040|FG000|Overall Study|Lost to Follow-up|5|||
105836155|NCT04886063|365055040|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
105836156|NCT04886063|365055040|FG000|Overall Study|>1 reason|20|||
105836157|NCT01055886|365055045|FG000|Overall Study|Withdrawal by Subject|4|||
105836158|NCT01055886|365055046|FG001|Overall Study|Withdrawal by Subject|9|||
105836159|NCT01055886|365055045|FG000|Overall Study|Lost to Follow-up|1|||
105836160|NCT01055886|365055046|FG001|Overall Study|Lost to Follow-up|1|||
105836161|NCT01055886|365055045|FG000|Overall Study|Withdrawal by PI|0|||
105836162|NCT01055886|365055046|FG001|Overall Study|Withdrawal by PI|1|||
105836163|NCT02359864|365055048|FG000|Overall Study|Withdrawal by Subject|1|||
105836164|NCT02359864|365055049|FG001|Overall Study|Withdrawal by Subject|0|||
105836165|NCT04254809|365055053|FG000|Overall Study|Lost to Follow-up|5|||
105836166|NCT04254809|365055054|FG001|Overall Study|Lost to Follow-up|10|||
105836167|NCT04480307|365055055|FG000|Overall Study|Withdrawal by Subject|0|||
105836168|NCT04480307|365055056|FG001|Overall Study|Withdrawal by Subject|1|||
105836169|NCT04480307|365055057|FG002|Overall Study|Withdrawal by Subject|0|||
105836170|NCT04480307|365055058|FG003|Overall Study|Withdrawal by Subject|0|||
105836171|NCT04480307|365055055|FG000|Overall Study|Adverse Event|0|||
105836172|NCT04480307|365055056|FG001|Overall Study|Adverse Event|0|||
105836173|NCT04480307|365055057|FG002|Overall Study|Adverse Event|0|||
105836174|NCT04480307|365055058|FG003|Overall Study|Adverse Event|1|||
105836175|NCT01928615|365055059|FG000|Overall Study|Study Terminated by Sponsor|2|||
105836176|NCT01881737|365055062|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
105836177|NCT01881737|365055062|FG000|Overall Study|Withdrawal by Subject|1|||
105836178|NCT01881737|365055062|FG000|Overall Study|Worsening of baseline behavior|1|||
105836179|NCT03496298|365055063|FG000|Overall Study|Adverse Event|49|||
105836180|NCT03496298|365055064|FG001|Overall Study|Adverse Event|68|||
105836181|NCT03496298|365055065|FG002|Overall Study|Adverse Event|79|||
105836182|NCT03496298|365055063|FG000|Overall Study|Study terminated by Sponsor|1050|||
105836183|NCT03496298|365055064|FG001|Overall Study|Study terminated by Sponsor|1063|||
105836184|NCT03496298|365055065|FG002|Overall Study|Study terminated by Sponsor|1071|||
105836185|NCT03496298|365055063|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
105836186|NCT03496298|365055064|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
105836187|NCT03496298|365055065|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
105836188|NCT03496298|365055063|FG000|Overall Study|Withdrawal by Subject|176|||
105836189|NCT03496298|365055064|FG001|Overall Study|Withdrawal by Subject|154|||
105836190|NCT03496298|365055065|FG002|Overall Study|Withdrawal by Subject|151|||
105836191|NCT03496298|365055063|FG000|Overall Study|Other|29|||
105836192|NCT03496298|365055064|FG001|Overall Study|Other|20|||
105836193|NCT03496298|365055065|FG002|Overall Study|Other|23|||
105836194|NCT03496298|365055063|FG000|Overall Study|Randomized and not treated|1|||
105836195|NCT03496298|365055064|FG001|Overall Study|Randomized and not treated|1|||
105836196|NCT03496298|365055065|FG002|Overall Study|Randomized and not treated|1|||
105836197|NCT02608476|365055068|FG000|Overall Study|Withdrawal by Subject|30|||
105836198|NCT02608476|365055069|FG001|Overall Study|Withdrawal by Subject|37|||
105836199|NCT02608476|365055068|FG000|Overall Study|Lost to Follow-up|24|||
105836200|NCT02608476|365055069|FG001|Overall Study|Lost to Follow-up|24|||
105836201|NCT02608476|365055068|FG000|Overall Study|Adverse Event|2|||
105836202|NCT02608476|365055069|FG001|Overall Study|Adverse Event|8|||
105836203|NCT02608476|365055068|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
105836204|NCT02608476|365055069|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
105489849|NCT03963401|363805679|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
105836205|NCT02608476|365055068|FG000|Overall Study|Noncompliance with treatment|1|||
105836206|NCT02608476|365055069|FG001|Overall Study|Noncompliance with treatment|5|||
105836207|NCT02608476|365055068|FG000|Overall Study|Lack of Efficacy|3|||
105836208|NCT02608476|365055069|FG001|Overall Study|Lack of Efficacy|1|||
105836209|NCT02608476|365055068|FG000|Overall Study|Other|0|||
105836210|NCT02608476|365055069|FG001|Overall Study|Other|1|||
105367327|NCT04113694|363352254|FG000|Overall Study|Lost to Follow-up|2|||
105836211|NCT02608476|365055068|FG000|Overall Study|Physician Decision|1|||
105836212|NCT02608476|365055069|FG001|Overall Study|Physician Decision|0|||
105836213|NCT02608476|365055068|FG000|Overall Study|Pregnancy|0|||
105836214|NCT02608476|365055069|FG001|Overall Study|Pregnancy|1|||
105836215|NCT02608476|365055068|FG000|Overall Study|Progressive disease|1|||
105836216|NCT02608476|365055069|FG001|Overall Study|Progressive disease|0|||
105836217|NCT02795676|365055070|FG000|Overall Study|Adverse Event|2|||
105836218|NCT02795676|365055071|FG001|Overall Study|Adverse Event|0|||
105836219|NCT02795676|365055070|FG000|Overall Study|Withdrawal by Subject|3|||
105836220|NCT02795676|365055071|FG001|Overall Study|Withdrawal by Subject|1|||
105836221|NCT01264835|365055072|FG000|Overall Study|Lost to Follow-up|1|||
105836222|NCT02260635|365055073|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
105836223|NCT02260635|365055074|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
105836224|NCT02260635|365055073|FG000|Open-Label Extension|Study Termination|25|||
105836225|NCT02260635|365055074|FG001|Open-Label Extension|Study Termination|25|||
105836226|NCT02260635|365055073|FG000|Open-Label Extension|Withdrawal by Subject|1|||
105836227|NCT02260635|365055074|FG001|Open-Label Extension|Withdrawal by Subject|0|||
105836228|NCT00152516|365055075|FG000|Overall Study|Adverse Event|18|||
105836229|NCT00152516|365055075|FG000|Overall Study|Lack and Loss of Efficacy|30|||
105836230|NCT00152516|365055075|FG000|Overall Study|Lost to Follow-up|5|||
105836231|NCT00152516|365055075|FG000|Overall Study|Withdrawal by Subject|8|||
105836232|NCT00152516|365055075|FG000|Overall Study|Protocol Violation|3|||
105836233|NCT00152516|365055075|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
105836234|NCT00152516|365055075|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
105836235|NCT00152516|365055075|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
105836236|NCT00152516|365055075|FG000|Overall Study|Other: Non-Compliance|2|||
105836237|NCT00152516|365055075|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
105836238|NCT00152516|365055075|FG000|Overall Study|Other: Moved Out Of State|1|||
105836239|NCT00152516|365055075|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
105836240|NCT00152516|365055075|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
105836241|NCT00360490|365055076|FG000|Overall Study|Adverse Event|4|||
105836242|NCT00360490|365055077|FG001|Overall Study|Adverse Event|2|||
105836243|NCT00360490|365055076|FG000|Overall Study|Lost to Follow-up|2|||
105836244|NCT00360490|365055077|FG001|Overall Study|Lost to Follow-up|1|||
105836245|NCT00360490|365055076|FG000|Overall Study|Physician Decision|2|||
105836246|NCT00360490|365055077|FG001|Overall Study|Physician Decision|1|||
105836247|NCT00360490|365055076|FG000|Overall Study|Protocol Violation|0|||
105836248|NCT00360490|365055077|FG001|Overall Study|Protocol Violation|4|||
105836249|NCT00360490|365055076|FG000|Overall Study|Withdrawal by Subject|1|||
105836250|NCT00360490|365055077|FG001|Overall Study|Withdrawal by Subject|3|||
105836251|NCT00605176|365055080|FG000|Overall Study|Adverse Event|2|||
105836252|NCT00605176|365055081|FG001|Overall Study|Adverse Event|1|||
105836253|NCT00605176|365055082|FG002|Overall Study|Adverse Event|3|||
105836254|NCT00605176|365055080|FG000|Overall Study|Withdrawal by Subject|4|||
105836255|NCT00605176|365055081|FG001|Overall Study|Withdrawal by Subject|2|||
105836256|NCT00605176|365055082|FG002|Overall Study|Withdrawal by Subject|4|||
105836257|NCT00605176|365055080|FG000|Overall Study|Lost to Follow-up|2|||
105836258|NCT00605176|365055081|FG001|Overall Study|Lost to Follow-up|2|||
105836259|NCT00605176|365055082|FG002|Overall Study|Lost to Follow-up|1|||
105836260|NCT00605176|365055080|FG000|Overall Study|Non-complicance with study procedures|1|||
105836261|NCT00605176|365055081|FG001|Overall Study|Non-complicance with study procedures|0|||
105836262|NCT00605176|365055082|FG002|Overall Study|Non-complicance with study procedures|0|||
105836263|NCT00605176|365055080|FG000|Overall Study|Use of concomitant therapy|1|||
105836264|NCT00605176|365055081|FG001|Overall Study|Use of concomitant therapy|0|||
105836265|NCT00605176|365055082|FG002|Overall Study|Use of concomitant therapy|1|||
105836266|NCT00605176|365055080|FG000|Overall Study|Other (not due to AE)|1|||
105836267|NCT00605176|365055081|FG001|Overall Study|Other (not due to AE)|1|||
105836268|NCT00605176|365055082|FG002|Overall Study|Other (not due to AE)|0|||
105836269|NCT01256060|365055087|FG000|Overall Study|Lost to Follow-up|0|||
105836270|NCT01256060|365055088|FG001|Overall Study|Lost to Follow-up|1|||
105836271|NCT01256060|365055089|FG002|Overall Study|Lost to Follow-up|0|||
105836272|NCT01256060|365055090|FG003|Overall Study|Lost to Follow-up|0|||
105836273|NCT00603512|365055095|FG000|Overall Study|Adverse Event|0|||
105836274|NCT00603512|365055096|FG001|Overall Study|Adverse Event|2|||
105836275|NCT00603512|365055097|FG002|Overall Study|Adverse Event|4|||
105836276|NCT00603512|365055098|FG003|Overall Study|Adverse Event|4|||
105836277|NCT00603512|365055099|FG004|Overall Study|Adverse Event|2|||
105836278|NCT00603512|365055095|FG000|Overall Study|Lack of Efficacy|0|||
105836279|NCT00603512|365055096|FG001|Overall Study|Lack of Efficacy|1|||
105836280|NCT00603512|365055097|FG002|Overall Study|Lack of Efficacy|0|||
105836281|NCT00603512|365055098|FG003|Overall Study|Lack of Efficacy|0|||
105836282|NCT00603512|365055099|FG004|Overall Study|Lack of Efficacy|1|||
105836283|NCT00603512|365055095|FG000|Overall Study|Other|2|||
105836284|NCT00603512|365055096|FG001|Overall Study|Other|1|||
105836285|NCT00603512|365055097|FG002|Overall Study|Other|0|||
105836286|NCT00603512|365055098|FG003|Overall Study|Other|1|||
105836287|NCT00603512|365055099|FG004|Overall Study|Other|1|||
105836288|NCT00603512|365055095|FG000|Overall Study|Withdrawal by Subject|0|||
105836289|NCT00603512|365055096|FG001|Overall Study|Withdrawal by Subject|0|||
105836290|NCT00603512|365055097|FG002|Overall Study|Withdrawal by Subject|0|||
105836291|NCT00603512|365055098|FG003|Overall Study|Withdrawal by Subject|0|||
105836292|NCT00603512|365055099|FG004|Overall Study|Withdrawal by Subject|1|||
105836293|NCT00603512|365055095|FG000|Overall Study|Randomized but not treated|0|||
105836294|NCT00603512|365055096|FG001|Overall Study|Randomized but not treated|1|||
105836295|NCT00603512|365055097|FG002|Overall Study|Randomized but not treated|1|||
105836296|NCT00603512|365055098|FG003|Overall Study|Randomized but not treated|2|||
105836297|NCT00603512|365055099|FG004|Overall Study|Randomized but not treated|0|||
105836298|NCT02297841|365056875|FG000|Overall Study|Withdrawal by Subject|1|||
105836299|NCT02297841|365056875|FG000|Overall Study|Protocol Violation|7|||
105836300|NCT03429049|365056876|FG000|Overall Study|Adverse Event|2|||
105836301|NCT03429049|365056877|FG001|Overall Study|Adverse Event|3|||
105836302|NCT03429049|365056876|FG000|Overall Study|Death|0|||
105836303|NCT03429049|365056877|FG001|Overall Study|Death|1|||
105836304|NCT03429049|365056876|FG000|Overall Study|Lack of Efficacy|4|||
105836305|NCT03429049|365056877|FG001|Overall Study|Lack of Efficacy|2|||
105836306|NCT03429049|365056876|FG000|Overall Study|Lost to Follow-up|9|||
105836307|NCT03429049|365056877|FG001|Overall Study|Lost to Follow-up|8|||
105836308|NCT03429049|365056876|FG000|Overall Study|Physician Decision|1|||
105836309|NCT03429049|365056877|FG001|Overall Study|Physician Decision|0|||
105836310|NCT03429049|365056876|FG000|Overall Study|Protocol Violation|3|||
105836311|NCT03429049|365056877|FG001|Overall Study|Protocol Violation|0|||
105836312|NCT03429049|365056876|FG000|Overall Study|Sponsor Decision|2|||
105836313|NCT03429049|365056877|FG001|Overall Study|Sponsor Decision|0|||
105836314|NCT03429049|365056876|FG000|Overall Study|Withdrawal by Subject|4|||
105836315|NCT03429049|365056877|FG001|Overall Study|Withdrawal by Subject|20|||
105836316|NCT03429049|365056876|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
105836317|NCT03429049|365056877|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
105836318|NCT01841060|365056878|FG000|Overall Study|Protocol Violation|10|||
105836319|NCT01872715|365056882|FG000|Overall Study|Adverse Event|1|||
105836320|NCT01872715|365056882|FG000|Overall Study|Protocol Violation|1|||
105836321|NCT01872715|365056882|FG000|Overall Study|Withdrawal by Subject|2|||
105836322|NCT00683592|365056883|FG000|Overall Study|Adverse Event|12|||
105836323|NCT00683592|365056884|FG001|Overall Study|Adverse Event|4|||
105836324|NCT00683592|365056883|FG000|Overall Study|Withdrawal by Subject|11|||
105836325|NCT00683592|365056884|FG001|Overall Study|Withdrawal by Subject|11|||
105836326|NCT00683592|365056883|FG000|Overall Study|Lost to Follow-up|17|||
105836327|NCT00683592|365056884|FG001|Overall Study|Lost to Follow-up|17|||
105836328|NCT00683592|365056883|FG000|Overall Study|Lack of Efficacy|3|||
105836329|NCT00683592|365056884|FG001|Overall Study|Lack of Efficacy|7|||
105836330|NCT00683592|365056883|FG000|Overall Study|Physician Decision|0|||
105836331|NCT00683592|365056884|FG001|Overall Study|Physician Decision|1|||
105836332|NCT00683592|365056883|FG000|Overall Study|Non-compliance|3|||
105836333|NCT00683592|365056884|FG001|Overall Study|Non-compliance|5|||
105836334|NCT00683592|365056883|FG000|Overall Study|Other|1|||
105836335|NCT00683592|365056884|FG001|Overall Study|Other|1|||
105836336|NCT05258630|365056885|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
105836337|NCT05258630|365056886|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
105836338|NCT05258630|365056885|FG000|Overall Study|Lost to Follow-up|0|||
105836339|NCT05258630|365056886|FG001|Overall Study|Lost to Follow-up|2|||
105836340|NCT01848210|365056896|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
105836341|NCT01848210|365056897|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
105836342|NCT01848210|365056896|FG000|Overall Study|Lost to Follow-up|24|||
105836343|NCT01848210|365056897|FG001|Overall Study|Lost to Follow-up|12|||
105836344|NCT01848210|365056896|FG000|Overall Study|Protocol Violation|3|||
105836345|NCT01848210|365056897|FG001|Overall Study|Protocol Violation|5|||
105836346|NCT01848210|365056896|FG000|Overall Study|Use of Forbidden Drugs|9|||
105836347|NCT01848210|365056897|FG001|Overall Study|Use of Forbidden Drugs|10|||
105836348|NCT01848210|365056896|FG000|Overall Study|Impedition Condition|5|||
105836349|NCT01848210|365056897|FG001|Overall Study|Impedition Condition|9|||
105836350|NCT01848210|365056896|FG000|Overall Study|Adverse Event|7|||
105836351|NCT01848210|365056897|FG001|Overall Study|Adverse Event|9|||
105836352|NCT01848210|365056896|FG000|Overall Study|Discontinuation Criterion|5|||
105836353|NCT01848210|365056897|FG001|Overall Study|Discontinuation Criterion|7|||
105836354|NCT01848210|365056896|FG000|Overall Study|Hypesensitivity|1|||
105836355|NCT01848210|365056897|FG001|Overall Study|Hypesensitivity|0|||
105836356|NCT01848210|365056896|FG000|Overall Study|Hepatic Function Alteration|4|||
105836357|NCT01848210|365056897|FG001|Overall Study|Hepatic Function Alteration|0|||
105836358|NCT01848210|365056896|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
105836359|NCT01848210|365056897|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
105836360|NCT01848210|365056896|FG000|Overall Study|Administrative|1|||
105836361|NCT01848210|365056897|FG001|Overall Study|Administrative|0|||
105836362|NCT00381849|365056898|FG000|Wash Out|Withdrawal by Subject|0|||
105836363|NCT00381849|365056899|FG001|Wash Out|Withdrawal by Subject|1|||
105836364|NCT00651183|365056902|FG000|Overall Study|Lack of Efficacy|1|||
105836365|NCT00651183|365056903|FG001|Overall Study|Lack of Efficacy|0|||
105836366|NCT00651183|365056902|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
105836367|NCT00651183|365056903|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
105836368|NCT00651183|365056902|FG000|Overall Study|Tolerability insufficient|5|||
105836369|NCT00651183|365056903|FG001|Overall Study|Tolerability insufficient|2|||
105836370|NCT00651183|365056902|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
105836371|NCT00651183|365056903|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
105836372|NCT00651183|365056902|FG000|Overall Study|Withdrawal by Subject|6|||
105836373|NCT00651183|365056903|FG001|Overall Study|Withdrawal by Subject|3|||
105836374|NCT00651183|365056902|FG000|Overall Study|Lost to Follow-up|3|||
105836375|NCT00651183|365056903|FG001|Overall Study|Lost to Follow-up|1|||
105836376|NCT00651183|365056902|FG000|Overall Study|Other reasons|4|||
105836377|NCT00651183|365056903|FG001|Overall Study|Other reasons|2|||
105836378|NCT00651183|365056902|FG000|Overall Study|missing|1|||
105836379|NCT00651183|365056903|FG001|Overall Study|missing|0|||
105836380|NCT02576717|365056905|FG000|Overall Study|Other Reasons|16|||
105836381|NCT02576717|365056906|FG001|Overall Study|Other Reasons|18|||
105836382|NCT02576717|365056907|FG002|Overall Study|Other Reasons|15|||
105836383|NCT02576717|365056905|FG000|Overall Study|Covid-19 Pandemic|0|||
105836384|NCT02576717|365056906|FG001|Overall Study|Covid-19 Pandemic|1|||
105836385|NCT02576717|365056907|FG002|Overall Study|Covid-19 Pandemic|1|||
105836386|NCT02576717|365056905|FG000|Overall Study|Sponsor Decision|0|||
105836387|NCT02576717|365056906|FG001|Overall Study|Sponsor Decision|0|||
105836388|NCT02576717|365056907|FG002|Overall Study|Sponsor Decision|1|||
105836389|NCT02576717|365056905|FG000|Overall Study|Physician Decision|3|||
105836390|NCT02576717|365056906|FG001|Overall Study|Physician Decision|8|||
105836391|NCT02576717|365056907|FG002|Overall Study|Physician Decision|9|||
105836392|NCT02576717|365056905|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
105836393|NCT02576717|365056906|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
105836394|NCT02576717|365056907|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
105836395|NCT02576717|365056905|FG000|Overall Study|Death|3|||
105836396|NCT02576717|365056906|FG001|Overall Study|Death|5|||
105836397|NCT02576717|365056907|FG002|Overall Study|Death|3|||
105836398|NCT02576717|365056905|FG000|Overall Study|Lost to Follow-up|9|||
105836399|NCT02576717|365056906|FG001|Overall Study|Lost to Follow-up|10|||
105836400|NCT02576717|365056907|FG002|Overall Study|Lost to Follow-up|19|||
105836401|NCT02576717|365056905|FG000|Overall Study|Protocol Violation|4|||
105836402|NCT02576717|365056906|FG001|Overall Study|Protocol Violation|0|||
105836403|NCT02576717|365056907|FG002|Overall Study|Protocol Violation|5|||
105836404|NCT02576717|365056905|FG000|Overall Study|Lack of Efficacy|24|||
105836405|NCT02576717|365056906|FG001|Overall Study|Lack of Efficacy|28|||
105836406|NCT02576717|365056907|FG002|Overall Study|Lack of Efficacy|20|||
105836407|NCT02576717|365056905|FG000|Overall Study|Adverse Event|26|||
105836408|NCT02576717|365056906|FG001|Overall Study|Adverse Event|32|||
105836409|NCT02576717|365056907|FG002|Overall Study|Adverse Event|26|||
105836410|NCT00969124|365056908|FG000|Overall Study|Protocol Violation|2|||
105836411|NCT00969124|365056908|FG000|Overall Study|Inadequate bowel preparation|15|||
105836412|NCT00969124|365056908|FG000|Overall Study|Inability to reach cecum|9|||
105836413|NCT00969124|365056908|FG000|Overall Study|Previously unrecognized disease|3|||
105836414|NCT00969124|365056908|FG000|Overall Study|Technical error|1|||
105836415|NCT00763555|365056913|FG000|Overall Study|Adverse Event|2|||
105836416|NCT00763555|365056914|FG001|Overall Study|Adverse Event|1|||
105836417|NCT00763555|365056913|FG000|Overall Study|Withdrawal by Subject|2|||
105836418|NCT00763555|365056914|FG001|Overall Study|Withdrawal by Subject|6|||
105836419|NCT00763555|365056913|FG000|Overall Study|Lost to Follow-up|0|||
105836420|NCT00763555|365056914|FG001|Overall Study|Lost to Follow-up|3|||
105836421|NCT01729026|365056915|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
105836422|NCT01729026|365056916|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
105836423|NCT01729026|365056915|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
105836424|NCT01729026|365056916|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
105836425|NCT02575339|365056917|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
105836426|NCT02575339|365056918|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
105836427|NCT02575339|365056919|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
105836428|NCT02575339|365056917|FG000|Study Treatment|Disease Progression|5|||
105836429|NCT02575339|365056918|FG001|Study Treatment|Disease Progression|2|||
105836430|NCT02575339|365056919|FG002|Study Treatment|Disease Progression|0|||
105836431|NCT02575339|365056917|FG000|Study Treatment|Adverse Event|1|||
105836432|NCT02575339|365056918|FG001|Study Treatment|Adverse Event|2|||
105836433|NCT02575339|365056919|FG002|Study Treatment|Adverse Event|0|||
105836434|NCT02575339|365056917|FG000|Follow up|Death|6|||
105836435|NCT02575339|365056918|FG001|Follow up|Death|2|||
105836436|NCT02575339|365056919|FG002|Follow up|Death|0|||
105836437|NCT02575339|365056917|FG000|Follow up|Study Terminated|0|||
105836438|NCT02575339|365056918|FG001|Follow up|Study Terminated|2|||
105836439|NCT02575339|365056919|FG002|Follow up|Study Terminated|0|||
105836440|NCT02575339|365056917|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
105836441|NCT02575339|365056918|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
105836442|NCT02575339|365056919|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
105836443|NCT04633642|365056920|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
105836444|NCT04633642|365056921|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
105836445|NCT04675775|365056922|FG000|Overall Study|Withdrawal by Subject|7|||
105836446|NCT00434837|365056929|FG000|Overall Study|Lost to Follow-up|20|||
105836447|NCT00434837|365056930|FG001|Overall Study|Lost to Follow-up|23|||
105836448|NCT00434837|365056931|FG002|Overall Study|Lost to Follow-up|30|||
105836449|NCT03023137|365056932|FG000|Overall Study|Multiple pregnancy|2|||
105836450|NCT03023137|365056933|FG001|Overall Study|Multiple pregnancy|4|||
105836451|NCT03023137|365056932|FG000|Overall Study|Lost to Follow-up|1|||
105836452|NCT03023137|365056933|FG001|Overall Study|Lost to Follow-up|1|||
105836453|NCT03023137|365056932|FG000|Overall Study|Protocol Violation|0|||
105836454|NCT03023137|365056933|FG001|Overall Study|Protocol Violation|4|||
105836455|NCT03023137|365056932|FG000|Overall Study|Lost the baby in a car accident|1|||
105836456|NCT03023137|365056933|FG001|Overall Study|Lost the baby in a car accident|0|||
105836457|NCT01086969|365056938|FG000|Overall Study|Withdrawal by Subject|1|||
105836458|NCT01086969|365056939|FG001|Overall Study|Withdrawal by Subject|2|||
105836459|NCT01086969|365056940|FG002|Overall Study|Withdrawal by Subject|0|||
105836460|NCT03847974|365056945|FG000|Overall Study|relocated out of region|3|||
105836461|NCT03847974|365056945|FG000|Overall Study|Withdrawal by Subject|2|||
105836462|NCT03847974|365056945|FG000|Overall Study|Adverse Event|1|||
105836463|NCT02466386|365056956|FG000|Overall Study|Adverse Event|5|||
105836464|NCT02466386|365056956|FG000|Overall Study|Protocol Violation|2|||
105836465|NCT02466386|365056956|FG000|Overall Study|Withdrawal by Subject|14|||
105836466|NCT02466386|365056956|FG000|Overall Study|Lost to Follow-up|5|||
105836467|NCT02466386|365056956|FG000|Overall Study|Lack of Efficacy|8|||
105836468|NCT02466386|365056956|FG000|Overall Study|Other|10|||
105310712|NCT03597529|363134401|FG000|Overall Study|Withdrawal by Subject|6|||
105310713|NCT03597529|363134402|FG001|Overall Study|Withdrawal by Subject|3|||
105836469|NCT05317195|365056957|FG000|Randomization|Withdrawal by Subject|1|||
105836470|NCT05317195|365056957|FG000|Randomization|Discontinued|6|||
105836471|NCT05317195|365056957|FG000|Admission|Withdrawal by Subject|2|||
105836472|NCT00220727|365056970|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
105836473|NCT00220727|365056971|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
105836474|NCT05103657|365056972|FG000|Overall Study|Other reasons than listed|9|||
105836475|NCT05103657|365056973|FG001|Overall Study|Other reasons than listed|8|||
105836476|NCT05103657|365056972|FG000|Overall Study|Protocol deviation|2|||
105836477|NCT05103657|365056973|FG001|Overall Study|Protocol deviation|2|||
105836478|NCT05103657|365056972|FG000|Overall Study|No reason available|5|||
105310714|NCT03597529|363134401|FG000|Overall Study|Non-compliant with study activities|1|||
105310715|NCT03597529|363134402|FG001|Overall Study|Non-compliant with study activities|2|||
105836479|NCT05103657|365056973|FG001|Overall Study|No reason available|4|||
105836480|NCT05103657|365056972|FG000|Overall Study|Burden of study procedures|3|||
105310716|NCT01292226|363134403|FG000|Overall Study|Adverse Event|5|||
105310717|NCT01292226|363134403|FG000|Overall Study|Death|1|||
105310718|NCT01292226|363134403|FG000|Overall Study|Graft loss|1|||
105310719|NCT01292226|363134403|FG000|Overall Study|Protocol Violation|3|||
105310720|NCT01292226|363134403|FG000|Overall Study|Withdrawal by Subject|1|||
105310721|NCT01292226|363134403|FG000|Overall Study|Other|2|||
105310722|NCT01844505|363134404|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
105310723|NCT01844505|363134405|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
105310724|NCT01844505|363134406|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
105310725|NCT01844505|363134404|FG000|Treatment Period|Other Reasons|120|||
105310726|NCT01844505|363134405|FG001|Treatment Period|Other Reasons|136|||
105310727|NCT01844505|363134406|FG002|Treatment Period|Other Reasons|58|||
105310728|NCT01844505|363134404|FG000|Treatment Period|Lost to Follow-up|9|||
105310729|NCT01844505|363134405|FG001|Treatment Period|Lost to Follow-up|11|||
105310730|NCT01844505|363134406|FG002|Treatment Period|Lost to Follow-up|6|||
105367328|NCT04113694|363352254|FG000|Overall Study|Withdrawal by Subject|6|||
105367329|NCT04113694|363352254|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
105367330|NCT05630196|363352255|FG000|Overall Study|Adverse Event|2|||
105367331|NCT05630196|363352256|FG001|Overall Study|Adverse Event|1|||
105367332|NCT05630196|363352255|FG000|Overall Study|Lost to Follow-up|1|||
105367333|NCT05630196|363352256|FG001|Overall Study|Lost to Follow-up|1|||
105367334|NCT05630196|363352255|FG000|Overall Study|Protocol Violation|2|||
105367335|NCT05630196|363352256|FG001|Overall Study|Protocol Violation|3|||
105836481|NCT05103657|365056973|FG001|Overall Study|Burden of study procedures|1|||
105836482|NCT05103657|365056972|FG000|Overall Study|Perceived lack of efficacy|1|||
105310731|NCT01844505|363134404|FG000|Treatment Period|Death|175|||
105367336|NCT05630196|363352255|FG000|Overall Study|Physician Decision|1|||
105367337|NCT05630196|363352256|FG001|Overall Study|Physician Decision|0|||
105367338|NCT05630196|363352255|FG000|Overall Study|Withdrawal by Subject|3|||
105367339|NCT05630196|363352256|FG001|Overall Study|Withdrawal by Subject|4|||
105367340|NCT00352118|363352257|FG000|Overall Study|Physician Decision|4|||
105367341|NCT00903201|363352258|FG000|Overall Study|Adverse Event|1|||
105367342|NCT00903201|363352259|FG001|Overall Study|Adverse Event|4|||
105367343|NCT00903201|363352260|FG002|Overall Study|Adverse Event|0|||
105367344|NCT00903201|363352258|FG000|Overall Study|Protocol Violation|2|||
105367345|NCT00903201|363352259|FG001|Overall Study|Protocol Violation|1|||
105836483|NCT05103657|365056973|FG001|Overall Study|Perceived lack of efficacy|1|||
105836484|NCT05103657|365056972|FG000|Overall Study|Adverse Event|6|||
105836485|NCT05103657|365056973|FG001|Overall Study|Adverse Event|14|||
105836486|NCT05103657|365056972|FG000|Overall Study|Not Treated|1|||
105836487|NCT05103657|365056973|FG001|Overall Study|Not Treated|1|||
105836488|NCT00585312|365056984|FG000|Overall Study|Adverse Event|3|||
105836489|NCT00585312|365056985|FG001|Overall Study|Adverse Event|0|||
105836490|NCT00585312|365056984|FG000|Overall Study|Lack of Efficacy|6|||
105836491|NCT00585312|365056985|FG001|Overall Study|Lack of Efficacy|11|||
105836492|NCT00585312|365056984|FG000|Overall Study|Lost to Follow-up|1|||
105836493|NCT00585312|365056985|FG001|Overall Study|Lost to Follow-up|1|||
105836494|NCT00585312|365056984|FG000|Overall Study|Reason not specified|2|||
105836495|NCT00585312|365056985|FG001|Overall Study|Reason not specified|0|||
105836496|NCT00585312|365056984|FG000|Overall Study|Withdrawal by Subject|5|||
105836497|NCT00585312|365056985|FG001|Overall Study|Withdrawal by Subject|1|||
105836498|NCT00585312|365056984|FG000|Overall Study|Study terminated by the sponsor|34|||
105836499|NCT00585312|365056985|FG001|Overall Study|Study terminated by the sponsor|31|||
105836500|NCT03919695|365056991|FG000|3-month Follow-up|Death|1|||
105836501|NCT03919695|365056992|FG001|3-month Follow-up|Death|1|||
105836502|NCT03919695|365056991|FG000|3-month Follow-up|unable to contact|0|||
105836503|NCT03919695|365056992|FG001|3-month Follow-up|unable to contact|3|||
105836504|NCT03919695|365056991|FG000|3-month Follow-up|in prison|0|||
105836505|NCT03919695|365056992|FG001|3-month Follow-up|in prison|1|||
105310732|NCT01844505|363134405|FG001|Treatment Period|Death|154|||
105310733|NCT01844505|363134406|FG002|Treatment Period|Death|228|||
105310734|NCT04555720|363134409|FG000|Overall Study|Lost to Follow-up|2|||
105310735|NCT04555720|363134410|FG001|Overall Study|Lost to Follow-up|0|||
105310736|NCT04555720|363134411|FG002|Overall Study|Lost to Follow-up|0|||
105310737|NCT04555720|363134412|FG003|Overall Study|Lost to Follow-up|0|||
105310738|NCT04555720|363134409|FG000|Overall Study|Withdrawal by Subject|4|||
105310739|NCT04555720|363134410|FG001|Overall Study|Withdrawal by Subject|6|||
105310740|NCT04555720|363134411|FG002|Overall Study|Withdrawal by Subject|0|||
105310741|NCT04555720|363134412|FG003|Overall Study|Withdrawal by Subject|0|||
105310742|NCT02952898|363134418|FG000|Overall Study|Withdrawal by Subject|10|||
105310743|NCT02952898|363134419|FG001|Overall Study|Withdrawal by Subject|8|||
105310744|NCT02952898|363134420|FG002|Overall Study|Withdrawal by Subject|8|||
105310745|NCT02952898|363134418|FG000|Overall Study|Adverse Event|8|||
105310746|NCT02952898|363134419|FG001|Overall Study|Adverse Event|8|||
105310747|NCT02952898|363134420|FG002|Overall Study|Adverse Event|3|||
105310748|NCT02952898|363134418|FG000|Overall Study|Lost to Follow-up|3|||
105310749|NCT02952898|363134419|FG001|Overall Study|Lost to Follow-up|2|||
105310750|NCT02952898|363134420|FG002|Overall Study|Lost to Follow-up|2|||
105310751|NCT02952898|363134418|FG000|Overall Study|Non-compliance with study drug|1|||
105310752|NCT02952898|363134419|FG001|Overall Study|Non-compliance with study drug|1|||
105310753|NCT02952898|363134420|FG002|Overall Study|Non-compliance with study drug|2|||
105310754|NCT02099682|363134421|FG000|Overall Study|Data Not Available|51|||
105310755|NCT02099682|363134421|FG000|Overall Study|Lost to Follow-up|31|||
105310756|NCT02099682|363134421|FG000|Overall Study|Other|29|||
105310757|NCT02212379|363134422|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
105310758|NCT02212379|363134422|FG000|From Baseline to Week 48|Adverse Event|7|||
105310759|NCT02212379|363134422|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
105310760|NCT02212379|363134422|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
105310761|NCT02212379|363134422|FG000|From Week 48 to Week 96|Adverse Event|1|||
105310762|NCT02212379|363134422|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
105310763|NCT04576923|363136180|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
105310764|NCT02679235|363136181|FG000|Overall Study|Withdrawal by Subject|3|||
105310765|NCT02679235|363136181|FG000|Overall Study|Adverse Event|1|||
105310766|NCT01161407|363136182|FG000|Overall Study|Protocol Violation|3|||
105310767|NCT01161407|363136183|FG001|Overall Study|Protocol Violation|1|||
105310768|NCT01635283|363136186|FG000|Overall Study|Tumor Progression|3|||
105310769|NCT01635283|363136186|FG000|Overall Study|Lost to Follow-up|1|||
105310770|NCT00927394|363136189|FG000|Overall Study|Adverse Event|14|||
105310771|NCT00927394|363136190|FG001|Overall Study|Adverse Event|9|||
105310772|NCT00927394|363136189|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
105310773|NCT00927394|363136190|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
105310774|NCT00927394|363136189|FG000|Overall Study|Withdrawal by Subject|20|||
105310775|NCT00927394|363136190|FG001|Overall Study|Withdrawal by Subject|24|||
105310776|NCT00927394|363136189|FG000|Overall Study|Lost to Follow-up|8|||
105310777|NCT00927394|363136190|FG001|Overall Study|Lost to Follow-up|14|||
105836506|NCT03919695|365056991|FG000|6-month Follow-up|Death|0|||
105836507|NCT03919695|365056992|FG001|6-month Follow-up|Death|1|||
105836508|NCT03919695|365056991|FG000|6-month Follow-up|Lost to Follow-up|1|||
105836509|NCT03919695|365056992|FG001|6-month Follow-up|Lost to Follow-up|2|||
105836510|NCT03919695|365056991|FG000|6-month Follow-up|in prison|0|||
105836511|NCT03919695|365056992|FG001|6-month Follow-up|in prison|2|||
105310778|NCT00927394|363136189|FG000|Overall Study|Administrative Problem|1|||
105310779|NCT00927394|363136190|FG001|Overall Study|Administrative Problem|0|||
105310780|NCT00927394|363136189|FG000|Overall Study|Death|1|||
105310781|NCT00927394|363136190|FG001|Overall Study|Death|1|||
105310782|NCT00927394|363136189|FG000|Overall Study|Protocol deviation|16|||
105310783|NCT00927394|363136190|FG001|Overall Study|Protocol deviation|13|||
105310784|NCT00927394|363136189|FG000|Overall Study|Randomized in error|0|||
105836512|NCT03919695|365056991|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
105836513|NCT03919695|365056992|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
105489850|NCT03963401|363805674|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
105489851|NCT03963401|363805675|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
105489852|NCT03963401|363805676|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
105489853|NCT03963401|363805677|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
105489854|NCT03963401|363805678|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
105489855|NCT03963401|363805679|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
105836514|NCT03919695|365056991|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
105836515|NCT03919695|365056992|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
105836516|NCT03635983|365056993|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
105836517|NCT03635983|365056994|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
105836518|NCT03635983|365056993|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
105836519|NCT03635983|365056994|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105836520|NCT03635983|365056993|FG000|Pre-Treatment Period|Other reasons|0|||
105836521|NCT03635983|365056994|FG001|Pre-Treatment Period|Other reasons|1|||
105836522|NCT03635983|365056993|FG000|Pre-Treatment Period|Disease Progression|0|||
105836523|NCT03635983|365056994|FG001|Pre-Treatment Period|Disease Progression|1|||
105836524|NCT03635983|365056993|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
105836525|NCT03635983|365056994|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
105836526|NCT03635983|365056993|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
105836527|NCT03635983|365056994|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
105836528|NCT03635983|365056993|FG000|Treatment Period|Withdrawal by Subject|3|||
105836529|NCT03635983|365056994|FG001|Treatment Period|Withdrawal by Subject|5|||
105836530|NCT03635983|365056993|FG000|Treatment Period|Death|3|||
105836531|NCT03635983|365056994|FG001|Treatment Period|Death|5|||
105836532|NCT03635983|365056993|FG000|Treatment Period|Poor/Non-compliance|2|||
105836533|NCT03635983|365056994|FG001|Treatment Period|Poor/Non-compliance|1|||
105836534|NCT03635983|365056993|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
105836535|NCT03635983|365056994|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
105836536|NCT03635983|365056993|FG000|Treatment Period|Other reasons|7|||
105836537|NCT03635983|365056994|FG001|Treatment Period|Other reasons|4|||
105836538|NCT03635983|365056993|FG000|Treatment Period|Disease progression|230|||
105836539|NCT03635983|365056994|FG001|Treatment Period|Disease progression|201|||
105836540|NCT03635983|365056993|FG000|Treatment Period|Study drug toxicity|35|||
105836541|NCT03635983|365056994|FG001|Treatment Period|Study drug toxicity|36|||
105836542|NCT03635983|365056993|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
105836543|NCT03635983|365056994|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
105836544|NCT03635983|365056993|FG000|Treatment Period|Maximum clinical benefit|3|||
105836545|NCT03635983|365056994|FG001|Treatment Period|Maximum clinical benefit|5|||
105836546|NCT03635983|365056993|FG000|Treatment Period|Administrative reason by the sponsor|1|||
105836547|NCT03635983|365056994|FG001|Treatment Period|Administrative reason by the sponsor|2|||
105836548|NCT03635983|365056993|FG000|Treatment Period|Lost to Follow-up|0|||
105836549|NCT03635983|365056994|FG001|Treatment Period|Lost to Follow-up|1|||
105836550|NCT04531982|365056996|FG000|Overall Study|Withdrawal by Subject|10|||
105836551|NCT04531982|365056997|FG001|Overall Study|Withdrawal by Subject|11|||
105836552|NCT04531982|365056996|FG000|Overall Study|Adverse Event|6|||
105836553|NCT04531982|365056997|FG001|Overall Study|Adverse Event|14|||
105836554|NCT04531982|365056996|FG000|Overall Study|Protocol Violation|6|||
105836555|NCT04531982|365056997|FG001|Overall Study|Protocol Violation|9|||
105836556|NCT04531982|365056996|FG000|Overall Study|Non-compliance with study drug|3|||
105836557|NCT04531982|365056997|FG001|Overall Study|Non-compliance with study drug|2|||
105836558|NCT04531982|365056996|FG000|Overall Study|Use of prohibited medication|2|||
105836559|NCT04531982|365056997|FG001|Overall Study|Use of prohibited medication|0|||
105836560|NCT04531982|365056996|FG000|Overall Study|Lost to Follow-up|0|||
105836561|NCT04531982|365056997|FG001|Overall Study|Lost to Follow-up|1|||
105836562|NCT04531982|365056996|FG000|Overall Study|Geopolitical conflict|2|||
105310785|NCT00927394|363136190|FG001|Overall Study|Randomized in error|1|||
105310786|NCT01329549|363136195|FG000|Overall Study|Withdrawal by Subject|1|||
105310787|NCT01329549|363136195|FG000|Overall Study|Adverse Event|1|||
105310788|NCT05384171|363136196|FG000|Overall Study|Lost to Follow-up|9|||
105489856|NCT03963401|363805674|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
105836563|NCT04531982|365056997|FG001|Overall Study|Geopolitical conflict|0|||
105836564|NCT04531982|365056996|FG000|Overall Study|Lack of Efficacy|3|||
105836565|NCT04531982|365056997|FG001|Overall Study|Lack of Efficacy|1|||
105836566|NCT01688882|365056998|FG000|Overall Study|Adverse Event|1|||
105836567|NCT01688882|365056999|FG001|Overall Study|Adverse Event|0|||
105836568|NCT01688882|365056998|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105836569|NCT01688882|365056999|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105836570|NCT01688882|365056998|FG000|Overall Study|Administrative problems|1|||
105836571|NCT01688882|365056999|FG001|Overall Study|Administrative problems|0|||
105836572|NCT03259789|365057000|FG000|Overall Study|Adverse Event|3|||
105836573|NCT03259789|365057001|FG001|Overall Study|Adverse Event|2|||
105836574|NCT03259789|365057002|FG002|Overall Study|Adverse Event|1|||
105836575|NCT03259789|365057000|FG000|Overall Study|Withdrawal by Subject|9|||
105836576|NCT03259789|365057001|FG001|Overall Study|Withdrawal by Subject|5|||
105836577|NCT03259789|365057002|FG002|Overall Study|Withdrawal by Subject|1|||
105836578|NCT03259789|365057000|FG000|Overall Study|Lost to Follow-up|5|||
105836579|NCT03259789|365057001|FG001|Overall Study|Lost to Follow-up|9|||
105836580|NCT03259789|365057002|FG002|Overall Study|Lost to Follow-up|4|||
105836581|NCT03259789|365057000|FG000|Overall Study|Physician Decision|0|||
105836582|NCT03259789|365057001|FG001|Overall Study|Physician Decision|1|||
105836583|NCT03259789|365057002|FG002|Overall Study|Physician Decision|0|||
105836584|NCT01235442|365057004|FG000|Overall Study|Lost to Follow-up|12|||
105836585|NCT01235442|365057005|FG001|Overall Study|Lost to Follow-up|10|||
105836586|NCT01235442|365057004|FG000|Overall Study|Death|0|||
105836587|NCT01235442|365057005|FG001|Overall Study|Death|2|||
105836588|NCT01235442|365057004|FG000|Overall Study|Pregnancy|1|||
105836589|NCT01235442|365057005|FG001|Overall Study|Pregnancy|1|||
105836590|NCT01235442|365057004|FG000|Overall Study|Ineligibility determined|5|||
105836591|NCT01235442|365057005|FG001|Overall Study|Ineligibility determined|4|||
105836592|NCT01235442|365057004|FG000|Overall Study|Protocol Violation|3|||
105836593|NCT01235442|365057005|FG001|Overall Study|Protocol Violation|3|||
105836594|NCT01235442|365057004|FG000|Overall Study|Adverse Event|4|||
105836595|NCT01235442|365057005|FG001|Overall Study|Adverse Event|6|||
105836596|NCT01235442|365057004|FG000|Overall Study|Withdrawal by Subject|15|||
105836597|NCT01235442|365057005|FG001|Overall Study|Withdrawal by Subject|9|||
105836598|NCT01235442|365057004|FG000|Overall Study|Lack of Efficacy|1|||
105836599|NCT01235442|365057005|FG001|Overall Study|Lack of Efficacy|3|||
105836600|NCT01235442|365057004|FG000|Overall Study|Noncompliance|1|||
105836601|NCT01235442|365057005|FG001|Overall Study|Noncompliance|2|||
105836602|NCT01235442|365057004|FG000|Overall Study|Administrative decision|1|||
105836603|NCT01235442|365057005|FG001|Overall Study|Administrative decision|2|||
105836604|NCT01235442|365057004|FG000|Overall Study|Other unspecified|1|||
105836605|NCT01235442|365057005|FG001|Overall Study|Other unspecified|2|||
105836606|NCT04291508|365057006|FG000|Overall Study|Withdrawal by Subject|1|||
105836607|NCT04291508|365057007|FG001|Overall Study|Withdrawal by Subject|0|||
105836608|NCT04291508|365057008|FG002|Overall Study|Withdrawal by Subject|1|||
105836609|NCT04291508|365057009|FG003|Overall Study|Withdrawal by Subject|0|||
105836610|NCT04291508|365057006|FG000|Overall Study|lost to follow up|4|||
105836611|NCT04291508|365057007|FG001|Overall Study|lost to follow up|0|||
105836612|NCT04291508|365057008|FG002|Overall Study|lost to follow up|1|||
105836613|NCT04291508|365057009|FG003|Overall Study|lost to follow up|0|||
105836614|NCT01701973|365057010|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
105836615|NCT01701973|365057011|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
105836616|NCT01701973|365057012|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
105836617|NCT01701973|365057013|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
105836618|NCT01701973|365057014|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
105836619|NCT01701973|365057015|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
105836620|NCT01701973|365057016|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
105836621|NCT01701973|365057017|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
105836622|NCT03566238|365057018|FG000|Overall Study|Adverse Event|0|||
105836623|NCT03566238|365057019|FG001|Overall Study|Adverse Event|1|||
105836624|NCT03566238|365057020|FG002|Overall Study|Adverse Event|0|||
105836625|NCT03566238|365057018|FG000|Overall Study|Lack of Efficacy|4|||
105836626|NCT03566238|365057019|FG001|Overall Study|Lack of Efficacy|2|||
105836627|NCT03566238|365057020|FG002|Overall Study|Lack of Efficacy|5|||
105836628|NCT03566238|365057018|FG000|Overall Study|Other|1|||
105836629|NCT03566238|365057019|FG001|Overall Study|Other|0|||
105836630|NCT03566238|365057020|FG002|Overall Study|Other|0|||
105836631|NCT04449341|365057023|FG000|Overall Study|Protocol Violation|1|||
105836632|NCT04449341|365057024|FG001|Overall Study|Protocol Violation|0|||
105836633|NCT04499482|365057025|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
105836634|NCT04314843|365057026|FG000|Overall Study|Death|2|||
105836635|NCT04314843|365057027|FG001|Overall Study|Death|2|||
105836636|NCT04314843|365057026|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
105836637|NCT04314843|365057027|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
105836638|NCT00551616|365057029|FG000|Overall Study|Lost to Follow-up|48|||
105836639|NCT00551616|365057030|FG001|Overall Study|Lost to Follow-up|40|||
105836640|NCT01263561|365057031|FG000|Overall Study|Death|1|||
105836641|NCT01263561|365057032|FG001|Overall Study|Death|2|||
105836642|NCT04203667|365057033|FG000|Overall Study|Withdrawal by Subject|1|||
105836643|NCT04203667|365057033|FG000|Overall Study|Lost to Follow-up|1|||
105836644|NCT04203667|365057033|FG000|Overall Study|Death|1|||
105836645|NCT04203667|365057033|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
105836646|NCT03942211|365057034|FG000|Overall Study|Death|1|||
105836647|NCT03942211|365057035|FG001|Overall Study|Death|0|||
105836648|NCT03942211|365057034|FG000|Overall Study|Study terminated by sponsor|5|||
105836649|NCT03942211|365057035|FG001|Overall Study|Study terminated by sponsor|3|||
105836650|NCT03942211|365057034|FG000|Overall Study|Adverse Event|0|||
105836651|NCT03942211|365057035|FG001|Overall Study|Adverse Event|1|||
105836652|NCT02169336|365057038|FG000|Overall Study|Lack of Efficacy|1|||
105836653|NCT02169336|365057039|FG001|Overall Study|Lack of Efficacy|1|||
105836654|NCT02169336|365057040|FG002|Overall Study|Lack of Efficacy|0|||
105836655|NCT02169336|365057038|FG000|Overall Study|Adverse Event|2|||
105836656|NCT02169336|365057039|FG001|Overall Study|Adverse Event|3|||
105836657|NCT02169336|365057040|FG002|Overall Study|Adverse Event|1|||
105836658|NCT02169336|365057038|FG000|Overall Study|Withdrawal by Subject|1|||
105836659|NCT02169336|365057039|FG001|Overall Study|Withdrawal by Subject|0|||
105836660|NCT02169336|365057040|FG002|Overall Study|Withdrawal by Subject|0|||
105836661|NCT02169336|365057038|FG000|Overall Study|Physician Decision|0|||
105836662|NCT02169336|365057039|FG001|Overall Study|Physician Decision|0|||
105836663|NCT02169336|365057040|FG002|Overall Study|Physician Decision|1|||
105836664|NCT02169336|365057038|FG000|Overall Study|Subject declined to continue dosing|0|||
105836665|NCT02169336|365057039|FG001|Overall Study|Subject declined to continue dosing|0|||
105836666|NCT02169336|365057040|FG002|Overall Study|Subject declined to continue dosing|1|||
105836667|NCT01396421|365057041|FG000|Overall Study|Lost to Follow-up|0|||
105836668|NCT01396421|365057042|FG001|Overall Study|Lost to Follow-up|0|||
105836669|NCT01396421|365057043|FG002|Overall Study|Lost to Follow-up|0|||
105836670|NCT01396421|365057044|FG003|Overall Study|Lost to Follow-up|1|||
105836671|NCT01396421|365057041|FG000|Overall Study|Adverse Event|17|||
105836672|NCT01396421|365057042|FG001|Overall Study|Adverse Event|15|||
105836673|NCT01396421|365057043|FG002|Overall Study|Adverse Event|12|||
105836674|NCT01396421|365057044|FG003|Overall Study|Adverse Event|32|||
105836675|NCT01396421|365057041|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
105836676|NCT01396421|365057042|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
105836677|NCT01396421|365057043|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
105836678|NCT01396421|365057044|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
105836679|NCT01396421|365057041|FG000|Overall Study|Physician Decision|1|||
105836680|NCT01396421|365057042|FG001|Overall Study|Physician Decision|1|||
105836681|NCT01396421|365057043|FG002|Overall Study|Physician Decision|0|||
105836682|NCT01396421|365057044|FG003|Overall Study|Physician Decision|3|||
105836683|NCT01396421|365057041|FG000|Overall Study|Withdrawal by Subject|31|||
105836684|NCT01396421|365057042|FG001|Overall Study|Withdrawal by Subject|24|||
105836685|NCT01396421|365057043|FG002|Overall Study|Withdrawal by Subject|13|||
105836686|NCT01396421|365057044|FG003|Overall Study|Withdrawal by Subject|21|||
105836687|NCT01396421|365057041|FG000|Overall Study|Protocol Deviation|2|||
105836688|NCT01396421|365057042|FG001|Overall Study|Protocol Deviation|1|||
105836689|NCT01396421|365057043|FG002|Overall Study|Protocol Deviation|1|||
105836690|NCT01396421|365057044|FG003|Overall Study|Protocol Deviation|0|||
105836691|NCT01396421|365057041|FG000|Overall Study|Lack of Efficacy|7|||
105836692|NCT01396421|365057042|FG001|Overall Study|Lack of Efficacy|17|||
105836693|NCT01396421|365057043|FG002|Overall Study|Lack of Efficacy|7|||
105836694|NCT01396421|365057044|FG003|Overall Study|Lack of Efficacy|18|||
105836695|NCT01977456|365057051|FG000|Overall Study|Death|5|||
105836696|NCT01142661|365057052|FG000|Overall Study|Adverse Event|2|||
105836697|NCT01142661|365057052|FG000|Overall Study|Withdrawal by Subject|1|||
105836698|NCT01142661|365057052|FG000|Overall Study|Physician Decision|1|||
105836699|NCT02293460|365058771|FG000|Overall Study|Protocol Violation|1|||
105836700|NCT02293460|365058771|FG000|Overall Study|Lack of Efficacy|2|||
105836701|NCT02293460|365058771|FG000|Overall Study|Adverse Event|2|||
105836702|NCT02293460|365058771|FG000|Overall Study|Withdrawal by Subject|1|||
105836703|NCT00500318|365058772|FG000|Overall Study|Adverse Event|3|||
105836704|NCT00500318|365058773|FG001|Overall Study|Adverse Event|8|||
105836705|NCT00500318|365058772|FG000|Overall Study|Protocol Violation|1|||
105836706|NCT00500318|365058773|FG001|Overall Study|Protocol Violation|3|||
105836707|NCT00500318|365058772|FG000|Overall Study|Withdrawal by Subject|1|||
105836708|NCT00500318|365058773|FG001|Overall Study|Withdrawal by Subject|2|||
105836709|NCT00500318|365058772|FG000|Overall Study|Lack of Efficacy|0|||
105489857|NCT03963401|363805675|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
105489858|NCT03963401|363805676|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
105489859|NCT03963401|363805677|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
105836710|NCT00500318|365058773|FG001|Overall Study|Lack of Efficacy|3|||
105836711|NCT00500318|365058772|FG000|Overall Study|Other Reason|0|||
105836712|NCT00500318|365058773|FG001|Overall Study|Other Reason|1|||
105836713|NCT01074008|365058774|FG000|Overall Study|Adverse Event|0|||
105836714|NCT01074008|365058775|FG001|Overall Study|Adverse Event|1|||
105836715|NCT01074008|365058776|FG002|Overall Study|Adverse Event|0|||
105836716|NCT01074008|365058777|FG003|Overall Study|Adverse Event|0|||
105836717|NCT01074008|365058778|FG004|Overall Study|Adverse Event|0|||
105836718|NCT01074008|365058779|FG005|Overall Study|Adverse Event|0|||
105836719|NCT01074008|365058780|FG006|Overall Study|Adverse Event|0|||
105836720|NCT01074008|365058781|FG007|Overall Study|Adverse Event|0|||
105836721|NCT01074008|365058782|FG008|Overall Study|Adverse Event|0|||
105836722|NCT01074008|365058774|FG000|Overall Study|Withdrawal by Subject|1|||
105836723|NCT01074008|365058775|FG001|Overall Study|Withdrawal by Subject|1|||
105836724|NCT01074008|365058776|FG002|Overall Study|Withdrawal by Subject|1|||
105836725|NCT01074008|365058777|FG003|Overall Study|Withdrawal by Subject|0|||
105836726|NCT01074008|365058778|FG004|Overall Study|Withdrawal by Subject|1|||
105836727|NCT01074008|365058779|FG005|Overall Study|Withdrawal by Subject|0|||
105836728|NCT01074008|365058780|FG006|Overall Study|Withdrawal by Subject|0|||
105836729|NCT01074008|365058781|FG007|Overall Study|Withdrawal by Subject|0|||
105836730|NCT01074008|365058782|FG008|Overall Study|Withdrawal by Subject|0|||
105836731|NCT01074008|365058774|FG000|Overall Study|Lost to Follow-up|0|||
105836732|NCT01074008|365058775|FG001|Overall Study|Lost to Follow-up|1|||
105836733|NCT01074008|365058776|FG002|Overall Study|Lost to Follow-up|1|||
105836734|NCT01074008|365058777|FG003|Overall Study|Lost to Follow-up|1|||
105836735|NCT01074008|365058778|FG004|Overall Study|Lost to Follow-up|1|||
105836736|NCT01074008|365058779|FG005|Overall Study|Lost to Follow-up|0|||
105836737|NCT01074008|365058780|FG006|Overall Study|Lost to Follow-up|1|||
105836738|NCT01074008|365058781|FG007|Overall Study|Lost to Follow-up|0|||
105836739|NCT01074008|365058782|FG008|Overall Study|Lost to Follow-up|4|||
105836740|NCT00224484|365058785|FG000|Overall Study|Serious Adverse Event|1|||
105836741|NCT00224484|365058786|FG001|Overall Study|Serious Adverse Event|1|||
105836742|NCT00224484|365058787|FG002|Overall Study|Serious Adverse Event|0|||
105836743|NCT00224484|365058785|FG000|Overall Study|Non-Serious Adverse Event|5|||
105836744|NCT00224484|365058786|FG001|Overall Study|Non-Serious Adverse Event|7|||
105836745|NCT00224484|365058787|FG002|Overall Study|Non-Serious Adverse Event|3|||
105836746|NCT00224484|365058785|FG000|Overall Study|Protocol Violation|2|||
105836747|NCT00224484|365058786|FG001|Overall Study|Protocol Violation|2|||
105836748|NCT00224484|365058787|FG002|Overall Study|Protocol Violation|0|||
105836749|NCT00224484|365058785|FG000|Overall Study|Withdrawal by Subject|49|||
105836750|NCT00224484|365058786|FG001|Overall Study|Withdrawal by Subject|18|||
105836751|NCT00224484|365058787|FG002|Overall Study|Withdrawal by Subject|16|||
105836752|NCT00224484|365058785|FG000|Overall Study|Migrated/moved from study area|18|||
105836753|NCT00224484|365058786|FG001|Overall Study|Migrated/moved from study area|5|||
105836754|NCT00224484|365058787|FG002|Overall Study|Migrated/moved from study area|5|||
105836755|NCT00224484|365058785|FG000|Overall Study|Lost to Follow-up|66|||
105836756|NCT00224484|365058786|FG001|Overall Study|Lost to Follow-up|28|||
105836757|NCT00224484|365058787|FG002|Overall Study|Lost to Follow-up|36|||
105836758|NCT00224484|365058785|FG000|Overall Study|Reason not specified|5|||
105836759|NCT00224484|365058786|FG001|Overall Study|Reason not specified|4|||
105836760|NCT00224484|365058787|FG002|Overall Study|Reason not specified|2|||
105836761|NCT02805309|365058788|FG000|Overall Study|Lost to Follow-up|2|||
105836762|NCT02805309|365058789|FG001|Overall Study|Lost to Follow-up|2|||
105836763|NCT02805309|365058790|FG002|Overall Study|Lost to Follow-up|2|||
105836764|NCT02805309|365058788|FG000|Overall Study|Post-Randomization Exclusion|0|||
105836765|NCT02805309|365058789|FG001|Overall Study|Post-Randomization Exclusion|2|||
105836766|NCT02805309|365058790|FG002|Overall Study|Post-Randomization Exclusion|1|||
105836767|NCT00108628|365058798|FG000|Overall Study|Withdrawal by Subject|17|||
105836768|NCT00108628|365058799|FG001|Overall Study|Withdrawal by Subject|9|||
105836769|NCT00108628|365058798|FG000|Overall Study|Lack of Efficacy|2|||
105836770|NCT00108628|365058799|FG001|Overall Study|Lack of Efficacy|1|||
105836771|NCT00108628|365058798|FG000|Overall Study|Death|1|||
105836772|NCT00108628|365058799|FG001|Overall Study|Death|0|||
105836773|NCT01350934|365058800|FG000|Base Study|Adverse Event|6|||
105836774|NCT01350934|365058801|FG001|Base Study|Adverse Event|0|||
105836775|NCT01350934|365058800|FG000|Base Study|Lost to Follow-up|1|||
105836776|NCT01350934|365058801|FG001|Base Study|Lost to Follow-up|0|||
105836777|NCT01350934|365058800|FG000|Base Study|Protocol Violation|1|||
105836778|NCT01350934|365058801|FG001|Base Study|Protocol Violation|1|||
105836779|NCT01350934|365058800|FG000|Base Study|Withdrawal by Subject|1|||
105836780|NCT01350934|365058801|FG001|Base Study|Withdrawal by Subject|2|||
105836781|NCT01350934|365058800|FG000|Base Study|Non-Compliance With Study Drug|2|||
105836782|NCT01350934|365058801|FG001|Base Study|Non-Compliance With Study Drug|0|||
105836783|NCT01350934|365058800|FG000|Extension Study|Adverse Event|2|||
105836784|NCT01350934|365058801|FG001|Extension Study|Adverse Event|1|||
105836785|NCT01350934|365058800|FG000|Extension Study|Lost to Follow-up|2|||
105836786|NCT01350934|365058801|FG001|Extension Study|Lost to Follow-up|0|||
105489860|NCT03963401|363805678|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
105836787|NCT01350934|365058800|FG000|Extension Study|Protocol Violation|1|||
105836788|NCT01350934|365058801|FG001|Extension Study|Protocol Violation|1|||
105836789|NCT01350934|365058800|FG000|Extension Study|Lack of Efficacy|0|||
105836790|NCT01350934|365058801|FG001|Extension Study|Lack of Efficacy|1|||
105836791|NCT01350934|365058800|FG000|Extension Study|Withdrawal by Subject|0|||
105836792|NCT01350934|365058801|FG001|Extension Study|Withdrawal by Subject|1|||
105836793|NCT03547635|365058804|FG000|Overall Study|Adverse Event|5|||
105836794|NCT03547635|365058805|FG001|Overall Study|Adverse Event|2|||
105836795|NCT03547635|365058806|FG002|Overall Study|Adverse Event|3|||
105836796|NCT03547635|365058804|FG000|Overall Study|Lost to Follow-up|1|||
105836797|NCT03547635|365058805|FG001|Overall Study|Lost to Follow-up|3|||
105836798|NCT03547635|365058806|FG002|Overall Study|Lost to Follow-up|4|||
105836799|NCT03547635|365058804|FG000|Overall Study|Withdrawal by Subject|1|||
105836800|NCT03547635|365058805|FG001|Overall Study|Withdrawal by Subject|0|||
105836801|NCT03547635|365058806|FG002|Overall Study|Withdrawal by Subject|0|||
105836802|NCT03547635|365058804|FG000|Overall Study|Withdrawal By PI|0|||
105836803|NCT03547635|365058805|FG001|Overall Study|Withdrawal By PI|1|||
105836804|NCT03547635|365058806|FG002|Overall Study|Withdrawal By PI|0|||
105836805|NCT03547635|365058804|FG000|Overall Study|Withdrawal by Sponsor|0|||
105836806|NCT03547635|365058805|FG001|Overall Study|Withdrawal by Sponsor|0|||
105836807|NCT03547635|365058806|FG002|Overall Study|Withdrawal by Sponsor|1|||
105836808|NCT03547635|365058804|FG000|Overall Study|Errant Randomization before Treatment|0|||
105836809|NCT03547635|365058805|FG001|Overall Study|Errant Randomization before Treatment|1|||
105836810|NCT03547635|365058806|FG002|Overall Study|Errant Randomization before Treatment|0|||
105836811|NCT03547635|365058804|FG000|Overall Study|Withdrawal by Subject|1|||
105836812|NCT03547635|365058805|FG001|Overall Study|Withdrawal by Subject|0|||
105836813|NCT03547635|365058806|FG002|Overall Study|Withdrawal by Subject|0|||
105836814|NCT01011335|365058807|FG000|Overall Study|Lost to Follow-up|0|||
105836815|NCT01011335|365058808|FG001|Overall Study|Lost to Follow-up|0|||
105836816|NCT01011335|365058809|FG002|Overall Study|Lost to Follow-up|1|||
105836817|NCT01011335|365058810|FG003|Overall Study|Lost to Follow-up|1|||
105836818|NCT01011335|365058811|FG004|Overall Study|Lost to Follow-up|1|||
105836819|NCT01011335|365058812|FG005|Overall Study|Lost to Follow-up|1|||
105836820|NCT01011335|365058813|FG006|Overall Study|Lost to Follow-up|2|||
105836821|NCT01011335|365058814|FG007|Overall Study|Lost to Follow-up|2|||
105836822|NCT01011335|365058815|FG008|Overall Study|Lost to Follow-up|1|||
105836823|NCT01011335|365058816|FG009|Overall Study|Lost to Follow-up|0|||
105836824|NCT01011335|365058817|FG010|Overall Study|Lost to Follow-up|0|||
105836825|NCT01011335|365058818|FG011|Overall Study|Lost to Follow-up|1|||
105836826|NCT01011335|365058819|FG012|Overall Study|Lost to Follow-up|2|||
105836827|NCT01011335|365058807|FG000|Overall Study|Protocol Violation|0|||
105836828|NCT01011335|365058808|FG001|Overall Study|Protocol Violation|1|||
105836829|NCT01011335|365058809|FG002|Overall Study|Protocol Violation|0|||
105836830|NCT01011335|365058810|FG003|Overall Study|Protocol Violation|0|||
105836831|NCT01011335|365058811|FG004|Overall Study|Protocol Violation|0|||
105836832|NCT01011335|365058812|FG005|Overall Study|Protocol Violation|0|||
105836833|NCT01011335|365058813|FG006|Overall Study|Protocol Violation|0|||
105836834|NCT01011335|365058814|FG007|Overall Study|Protocol Violation|0|||
105836835|NCT01011335|365058815|FG008|Overall Study|Protocol Violation|0|||
105836836|NCT01011335|365058816|FG009|Overall Study|Protocol Violation|0|||
105836837|NCT01011335|365058817|FG010|Overall Study|Protocol Violation|0|||
105836838|NCT01011335|365058818|FG011|Overall Study|Protocol Violation|0|||
105836839|NCT01011335|365058819|FG012|Overall Study|Protocol Violation|0|||
105836840|NCT01011335|365058807|FG000|Overall Study|Moved/deployed or no booster|1|||
105836841|NCT01011335|365058808|FG001|Overall Study|Moved/deployed or no booster|0|||
105836842|NCT01011335|365058809|FG002|Overall Study|Moved/deployed or no booster|0|||
105836843|NCT01011335|365058810|FG003|Overall Study|Moved/deployed or no booster|1|||
105836844|NCT01011335|365058811|FG004|Overall Study|Moved/deployed or no booster|0|||
105836845|NCT01011335|365058812|FG005|Overall Study|Moved/deployed or no booster|0|||
105836846|NCT01011335|365058813|FG006|Overall Study|Moved/deployed or no booster|1|||
105836847|NCT01011335|365058814|FG007|Overall Study|Moved/deployed or no booster|0|||
105836848|NCT01011335|365058815|FG008|Overall Study|Moved/deployed or no booster|1|||
105836849|NCT01011335|365058816|FG009|Overall Study|Moved/deployed or no booster|0|||
105836850|NCT01011335|365058817|FG010|Overall Study|Moved/deployed or no booster|2|||
105836851|NCT01011335|365058818|FG011|Overall Study|Moved/deployed or no booster|0|||
105836852|NCT01011335|365058819|FG012|Overall Study|Moved/deployed or no booster|0|||
105836853|NCT01011335|365058807|FG000|Overall Study|Adverse Event|0|||
105310789|NCT05384171|363136197|FG001|Overall Study|Lost to Follow-up|9|||
105310790|NCT05384171|363136196|FG000|Overall Study|Withdrawal by Subject|3|||
105310791|NCT05384171|363136197|FG001|Overall Study|Withdrawal by Subject|0|||
105310792|NCT00780910|363136198|FG000|Overall Study|Adverse Event|2|||
105310793|NCT00106964|363136199|FG000|Overall Study|Lost to Follow-up|8|||
105310794|NCT00106964|363136200|FG001|Overall Study|Lost to Follow-up|6|||
105310795|NCT00106964|363136201|FG002|Overall Study|Lost to Follow-up|2|||
105310796|NCT00106964|363136199|FG000|Overall Study|Pregnancy|2|||
105367346|NCT00903201|363352260|FG002|Overall Study|Protocol Violation|0|||
105367347|NCT00903201|363352258|FG000|Overall Study|Lost to Follow-up|0|||
105367348|NCT00903201|363352259|FG001|Overall Study|Lost to Follow-up|1|||
105367349|NCT00903201|363352260|FG002|Overall Study|Lost to Follow-up|0|||
105836854|NCT01011335|365058808|FG001|Overall Study|Adverse Event|0|||
105836855|NCT01011335|365058809|FG002|Overall Study|Adverse Event|0|||
105836856|NCT01011335|365058810|FG003|Overall Study|Adverse Event|0|||
105836857|NCT01011335|365058811|FG004|Overall Study|Adverse Event|0|||
105836858|NCT01011335|365058812|FG005|Overall Study|Adverse Event|0|||
105836859|NCT01011335|365058813|FG006|Overall Study|Adverse Event|0|||
105836860|NCT01011335|365058814|FG007|Overall Study|Adverse Event|0|||
105836861|NCT01011335|365058815|FG008|Overall Study|Adverse Event|0|||
105836862|NCT01011335|365058816|FG009|Overall Study|Adverse Event|0|||
105836863|NCT01011335|365058817|FG010|Overall Study|Adverse Event|4|||
105310797|NCT00106964|363136200|FG001|Overall Study|Pregnancy|3|||
105367350|NCT00903201|363352258|FG000|Overall Study|Physician Decision|1|||
105310798|NCT00106964|363136201|FG002|Overall Study|Pregnancy|2|||
105836864|NCT01011335|365058818|FG011|Overall Study|Adverse Event|0|||
105836865|NCT01011335|365058819|FG012|Overall Study|Adverse Event|1|||
105367351|NCT00903201|363352259|FG001|Overall Study|Physician Decision|0|||
105367352|NCT00903201|363352260|FG002|Overall Study|Physician Decision|1|||
105836866|NCT01636934|365058822|FG000|Overall Study|Withdrawal by Subject|3|||
105836867|NCT01636934|365058823|FG001|Overall Study|Withdrawal by Subject|2|||
105836868|NCT01636934|365058822|FG000|Overall Study|Chemo cancel|1|||
105836869|NCT01636934|365058823|FG001|Overall Study|Chemo cancel|0|||
105836870|NCT01636934|365058822|FG000|Overall Study|Too ill to continue|1|||
105836871|NCT01636934|365058823|FG001|Overall Study|Too ill to continue|0|||
105836872|NCT01636934|365058822|FG000|Overall Study|Never started study medication|1|||
105836873|NCT01636934|365058823|FG001|Overall Study|Never started study medication|1|||
105836874|NCT02415387|365058833|FG000|Overall Study|Withdrawal by Subject|6|||
105836875|NCT02415387|365058834|FG001|Overall Study|Withdrawal by Subject|1|||
105836876|NCT02415387|365058833|FG000|Overall Study|blood draw problem|0|||
105836877|NCT02415387|365058834|FG001|Overall Study|blood draw problem|1|||
105836878|NCT02415387|365058833|FG000|Overall Study|Protocol Violation|1|||
105836879|NCT02415387|365058834|FG001|Overall Study|Protocol Violation|0|||
105836880|NCT02447887|365058837|FG000|Overall Study|Study was terminated|3|||
105836881|NCT01765751|365058838|FG000|Overall Study|Lost to Follow-up|0|||
105836882|NCT01765751|365058839|FG001|Overall Study|Lost to Follow-up|2|||
105836883|NCT01765751|365058840|FG002|Overall Study|Lost to Follow-up|1|||
105836884|NCT00653159|365058841|FG000|Overall Study|Adverse Event|4|||
105836885|NCT00653159|365058842|FG001|Overall Study|Adverse Event|1|||
105836886|NCT00653159|365058841|FG000|Overall Study|Lost to Follow-up|1|||
105836887|NCT00653159|365058842|FG001|Overall Study|Lost to Follow-up|2|||
105836888|NCT00412737|365058843|FG000|Overall Study|Death|1|||
105836889|NCT00412737|365058844|FG001|Overall Study|Death|0|||
105836890|NCT00412737|365058843|FG000|Overall Study|Adverse Event|3|||
105836891|NCT00412737|365058844|FG001|Overall Study|Adverse Event|2|||
105836892|NCT00412737|365058843|FG000|Overall Study|Refused Treatment|6|||
105836893|NCT00412737|365058844|FG001|Overall Study|Refused Treatment|2|||
105836894|NCT00412737|365058843|FG000|Overall Study|Failure to Return|6|||
105836895|NCT00412737|365058844|FG001|Overall Study|Failure to Return|2|||
105836896|NCT00979212|365058845|FG000|Overall Study|Protocol Violation|1|||
105836897|NCT00979212|365058846|FG001|Overall Study|Protocol Violation|8|||
105836898|NCT00979212|365058845|FG000|Overall Study|No protocol therapy received|1|||
105836899|NCT00979212|365058846|FG001|Overall Study|No protocol therapy received|0|||
105836900|NCT01801917|365058848|FG000|Period 1 - Randomized|Adverse Event|1|||
105836901|NCT01801917|365058849|FG001|Period 1 - Randomized|Adverse Event|0|||
105836902|NCT01801917|365058850|FG002|Period 1 - Randomized|Adverse Event|1|||
105836903|NCT01801917|365058851|FG003|Period 1 - Randomized|Adverse Event|0|||
105836904|NCT01924364|365058852|FG000|Overall Study|Physician Decision|3|||
105836905|NCT04307849|365058853|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
105836906|NCT04307849|365058854|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
105836907|NCT04307849|365058855|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
105836908|NCT04307849|365058856|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
105836909|NCT04307849|365058857|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
105836910|NCT04307849|365058858|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
105836911|NCT04307849|365058853|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
105836912|NCT04307849|365058854|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
105836913|NCT04307849|365058855|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
105836914|NCT04307849|365058856|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
105836915|NCT04307849|365058857|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
105836916|NCT04307849|365058858|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
105836917|NCT04307849|365058853|FG000|Overall Study|Family member did not want them to continue|0|||
105836918|NCT04307849|365058854|FG001|Overall Study|Family member did not want them to continue|0|||
105836919|NCT04307849|365058855|FG002|Overall Study|Family member did not want them to continue|1|||
105367353|NCT00903201|363352258|FG000|Overall Study|Withdrawal by Subject|1|||
105367354|NCT00903201|363352259|FG001|Overall Study|Withdrawal by Subject|0|||
105367355|NCT00903201|363352260|FG002|Overall Study|Withdrawal by Subject|1|||
105367356|NCT01389232|363352261|FG000|Overall Study|Had scaffold removed|15|||
105367357|NCT01389232|363352261|FG000|Overall Study|Personal reasons|2|||
105367358|NCT01389232|363352261|FG000|Overall Study|Adverse Event|1|||
105367359|NCT01389232|363352261|FG000|Overall Study|Death|1|||
105836920|NCT04307849|365058856|FG003|Overall Study|Family member did not want them to continue|0|||
105836921|NCT04307849|365058857|FG004|Overall Study|Family member did not want them to continue|0|||
105836922|NCT04307849|365058858|FG005|Overall Study|Family member did not want them to continue|0|||
105836923|NCT04307849|365058853|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
105836924|NCT04307849|365058854|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
105836925|NCT04307849|365058855|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
105367360|NCT02990000|363352262|FG000|Overall Study|Failed to provide data beyond baseline|36|||
105367361|NCT02990000|363352263|FG001|Overall Study|Failed to provide data beyond baseline|34|||
105836926|NCT04307849|365058856|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
105836927|NCT04307849|365058857|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
105836928|NCT04307849|365058858|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
105836929|NCT00265785|365058861|FG000|Overall Study|Adverse Event|4|||
105836930|NCT00265785|365058861|FG000|Overall Study|Withdrawal by Subject|3|||
105836931|NCT00265785|365058861|FG000|Overall Study|Progression/Relapse|15|||
105836932|NCT00265785|365058861|FG000|Overall Study|Not protocol specified|2|||
105836933|NCT00265785|365058861|FG000|Overall Study|Ineligible|1|||
105836934|NCT00265785|365058861|FG000|Overall Study|Did not receive protocol treatment|2|||
105836935|NCT04253236|365058864|FG000|Overall Study|Adverse Event|1|||
105836936|NCT04253236|365058865|FG001|Overall Study|Adverse Event|0|||
105836937|NCT04253236|365058864|FG000|Overall Study|Safety Concerns|1|||
105836938|NCT04253236|365058865|FG001|Overall Study|Safety Concerns|0|||
105836939|NCT04253236|365058864|FG000|Overall Study|Study Terminated by Sponsor|1|||
105836940|NCT04253236|365058865|FG001|Overall Study|Study Terminated by Sponsor|0|||
105836941|NCT00587431|365058868|FG000|Overall Study|Adverse Event|1|||
105836942|NCT00587431|365058869|FG001|Overall Study|Adverse Event|0|||
105836943|NCT00587431|365058868|FG000|Overall Study|Withdrawal by Subject|0|||
105836944|NCT00587431|365058869|FG001|Overall Study|Withdrawal by Subject|1|||
105836945|NCT05467982|365058870|FG000|Overall Study|Death|0|||
105836946|NCT05467982|365058871|FG001|Overall Study|Death|1|||
105836947|NCT05467982|365058870|FG000|Overall Study|Lost to Follow-up|3|||
105836948|NCT05467982|365058871|FG001|Overall Study|Lost to Follow-up|1|||
105836949|NCT00613730|365058872|FG000|Overall Study|Disease progression|2|||
105836950|NCT00613730|365058872|FG000|Overall Study|Administrative decision|1|||
105836951|NCT00569777|365058873|FG000|Overall Study|Withdrawal by Subject|4|||
105836952|NCT00569777|365058874|FG001|Overall Study|Withdrawal by Subject|0|||
105836953|NCT00569777|365058873|FG000|Overall Study|Adverse Event|3|||
105836954|NCT00569777|365058874|FG001|Overall Study|Adverse Event|0|||
105836955|NCT00569777|365058873|FG000|Overall Study|Lost to Follow-up|1|||
105836956|NCT00569777|365058874|FG001|Overall Study|Lost to Follow-up|0|||
105836957|NCT00569777|365058873|FG000|Overall Study|scheduled eye surgery|0|||
105836958|NCT00569777|365058874|FG001|Overall Study|scheduled eye surgery|1|||
105836959|NCT00569777|365058873|FG000|Overall Study|did not meet exclusion criteria|1|||
105836960|NCT00569777|365058874|FG001|Overall Study|did not meet exclusion criteria|2|||
105836961|NCT00569777|365058873|FG000|Overall Study|pregnant|1|||
105836962|NCT00569777|365058874|FG001|Overall Study|pregnant|0|||
105836963|NCT05766787|365058875|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
105836964|NCT05766787|365058876|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
105836965|NCT05766787|365058875|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
105836966|NCT05766787|365058876|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
105836967|NCT05766787|365058875|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
105836968|NCT05766787|365058876|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
105836969|NCT01117987|365058877|FG000|Overall Study|Protocol deviation|0|||
105836970|NCT01117987|365058878|FG001|Overall Study|Protocol deviation|1|||
105836971|NCT01117987|365058877|FG000|Overall Study|Subject no longer requires study drug|1|||
105836972|NCT01117987|365058878|FG001|Overall Study|Subject no longer requires study drug|0|||
105836973|NCT01117987|365058877|FG000|Overall Study|Lost to Follow-up|1|||
105836974|NCT01117987|365058878|FG001|Overall Study|Lost to Follow-up|1|||
105836975|NCT01117987|365058877|FG000|Overall Study|Abnormal test procedure result|2|||
105836976|NCT01117987|365058878|FG001|Overall Study|Abnormal test procedure result|0|||
105836977|NCT01117987|365058877|FG000|Overall Study|Lack of Efficacy|3|||
105836978|NCT01117987|365058878|FG001|Overall Study|Lack of Efficacy|4|||
105836979|NCT01117987|365058877|FG000|Overall Study|Death|5|||
105836980|NCT01117987|365058878|FG001|Overall Study|Death|10|||
105836981|NCT01117987|365058877|FG000|Overall Study|Withdrawal by Subject|5|||
105836982|NCT01117987|365058878|FG001|Overall Study|Withdrawal by Subject|10|||
105310799|NCT00106964|363136199|FG000|Overall Study|Death|1|||
105310800|NCT00106964|363136200|FG001|Overall Study|Death|1|||
105310801|NCT00106964|363136201|FG002|Overall Study|Death|0|||
105310802|NCT00106964|363136199|FG000|Overall Study|Incarceration|0|||
105310803|NCT00106964|363136200|FG001|Overall Study|Incarceration|1|||
105310804|NCT00106964|363136201|FG002|Overall Study|Incarceration|0|||
105836983|NCT01117987|365058877|FG000|Overall Study|Adverse Event|19|||
105836984|NCT01117987|365058878|FG001|Overall Study|Adverse Event|26|||
105836985|NCT01117987|365058877|FG000|Overall Study|Administrative problems|25|||
105836986|NCT01117987|365058878|FG001|Overall Study|Administrative problems|22|||
105836987|NCT00292227|365058880|FG000|Patch Period|Adverse Event|1|||
105836988|NCT00292227|365058881|FG001|Patch Period|Adverse Event|0|||
105836989|NCT00292227|365058882|FG002|Patch Period|Adverse Event|2|||
105836990|NCT00292227|365058880|FG000|Patch Period|Withdrawal by Subject|0|||
105836991|NCT00292227|365058881|FG001|Patch Period|Withdrawal by Subject|0|||
105836992|NCT00292227|365058882|FG002|Patch Period|Withdrawal by Subject|1|||
105836993|NCT01835548|365058884|FG000|Dose Optimization Period|Adverse Event|0|||
105836994|NCT01835548|365058885|FG001|Dose Optimization Period|Adverse Event|0|||
105836995|NCT01835548|365058886|FG002|Dose Optimization Period|Adverse Event|1|||
105310805|NCT00106964|363136199|FG000|Overall Study|Site Funding Terminated|0|||
105836996|NCT01835548|365058884|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
105836997|NCT01835548|365058885|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
105836998|NCT01835548|365058886|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
105836999|NCT01835548|365058884|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105837000|NCT01835548|365058885|FG001|Double-Blind Treatment Period|Adverse Event|1|||
105837001|NCT01835548|365058886|FG002|Double-Blind Treatment Period|Adverse Event|0|||
105837002|NCT01835548|365058884|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105837003|NCT01835548|365058885|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105837004|NCT01835548|365058886|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105837005|NCT01169038|365058887|FG000|Overall Study|Death|1|||
105837006|NCT01169038|365058887|FG000|Overall Study|Adverse Event|5|||
105837007|NCT01169038|365058887|FG000|Overall Study|Required antibiotic administration|1|||
105837008|NCT01488448|365058888|FG000|Overall Study|Withdrawal by Subject|3|||
105837009|NCT01488448|365058889|FG001|Overall Study|Withdrawal by Subject|1|||
105837010|NCT01488448|365058888|FG000|Overall Study|Adverse Event|9|||
105837011|NCT01488448|365058889|FG001|Overall Study|Adverse Event|4|||
105837012|NCT01488448|365058888|FG000|Overall Study|Physician Decision|4|||
105837013|NCT01488448|365058889|FG001|Overall Study|Physician Decision|9|||
105837014|NCT01488448|365058888|FG000|Overall Study|Protocol Violation|4|||
105837015|NCT01488448|365058889|FG001|Overall Study|Protocol Violation|3|||
105837016|NCT00537017|365058890|FG000|Treatment Phase|Adverse Event|19|||
105837017|NCT00537017|365058890|FG000|Treatment Phase|Withdrawal by Subject|13|||
105837018|NCT00537017|365058890|FG000|Treatment Phase|Protocol Violation|2|||
105837019|NCT00537017|365058890|FG000|Follow-up Phase|Withdrawal by Subject|9|||
105837020|NCT03257254|365058891|FG000|Overall Study|Withdrawal by Subject|7|||
105837021|NCT03257254|365058891|FG000|Overall Study|Lost to Follow-up|9|||
105837022|NCT03257254|365058891|FG000|Overall Study|Study discontinued by sponsor|5|||
105837023|NCT03234608|365058892|FG000|Overall Study|Lost to Follow-up|23|||
105837024|NCT03234608|365058893|FG001|Overall Study|Lost to Follow-up|21|||
105837025|NCT02329431|365058894|FG000|Overall Study|Lost to Follow-up|20|||
105837026|NCT02329431|365058895|FG001|Overall Study|Lost to Follow-up|13|||
105837027|NCT03168906|365058896|FG000|Overall Study|Lack of Efficacy|6|||
105837028|NCT03168906|365058897|FG001|Overall Study|Lack of Efficacy|6|||
105837029|NCT02219308|365058900|FG000|Overall Study|Withdrawal by Subject|1|||
105837030|NCT02219308|365058901|FG001|Overall Study|Withdrawal by Subject|2|||
105837031|NCT01557582|365058902|FG000|Overall Study|Protocol Violation|4|||
105837032|NCT01557582|365058902|FG000|Overall Study|Operator error|2|||
105837033|NCT03840382|365058903|FG000|Overall Study|Lost to Follow-up|11|||
105837034|NCT03203642|365058905|FG000|Overall Study|Adverse Event|3|||
105837035|NCT03203642|365058906|FG001|Overall Study|Adverse Event|1|||
105837036|NCT03203642|365058905|FG000|Overall Study|Withdrawal by Subject|6|||
105837037|NCT03203642|365058906|FG001|Overall Study|Withdrawal by Subject|6|||
105837038|NCT03203642|365058905|FG000|Overall Study|Lost to Follow-up|2|||
105837039|NCT03203642|365058906|FG001|Overall Study|Lost to Follow-up|1|||
105837040|NCT03203642|365058905|FG000|Overall Study|Termination of the study by sponsor|1|||
105837041|NCT03203642|365058906|FG001|Overall Study|Termination of the study by sponsor|1|||
105837042|NCT03203642|365058905|FG000|Overall Study|Participant moved|0|||
105837043|NCT03203642|365058906|FG001|Overall Study|Participant moved|1|||
105837044|NCT03203642|365058905|FG000|Overall Study|Investigator's decision|3|||
105837045|NCT03203642|365058906|FG001|Overall Study|Investigator's decision|0|||
105837046|NCT03203642|365058905|FG000|Overall Study|Other than above specified|0|||
105837047|NCT03203642|365058906|FG001|Overall Study|Other than above specified|1|||
105837048|NCT02413294|365058907|FG000|Overall Study|Withdrawal by Subject|1|||
105837049|NCT03303417|365060322|FG000|Overall Study|Withdrawal by Subject|1|||
105837050|NCT03303417|365060323|FG001|Overall Study|Withdrawal by Subject|1|||
105837051|NCT00784979|365060334|FG000|Overall Study|incomplete data|6|||
105837052|NCT00631007|365060336|FG000|Overall Study|Adverse Event|0|||
105837053|NCT00631007|365060337|FG001|Overall Study|Adverse Event|2|||
105837054|NCT00631007|365060338|FG002|Overall Study|Adverse Event|0|||
105837055|NCT00631007|365060339|FG003|Overall Study|Adverse Event|2|||
105837056|NCT00631007|365060340|FG004|Overall Study|Adverse Event|3|||
105837057|NCT00631007|365060341|FG005|Overall Study|Adverse Event|2|||
105837058|NCT00631007|365060336|FG000|Overall Study|Lost to Follow-up|2|||
105837059|NCT00631007|365060337|FG001|Overall Study|Lost to Follow-up|1|||
105837060|NCT00631007|365060338|FG002|Overall Study|Lost to Follow-up|2|||
105837061|NCT00631007|365060339|FG003|Overall Study|Lost to Follow-up|4|||
105837062|NCT00631007|365060340|FG004|Overall Study|Lost to Follow-up|5|||
105837063|NCT00631007|365060341|FG005|Overall Study|Lost to Follow-up|3|||
105837064|NCT00631007|365060336|FG000|Overall Study|Physician Decision|1|||
105837065|NCT00631007|365060337|FG001|Overall Study|Physician Decision|0|||
105837066|NCT00631007|365060338|FG002|Overall Study|Physician Decision|1|||
105837067|NCT00631007|365060339|FG003|Overall Study|Physician Decision|0|||
105837068|NCT00631007|365060340|FG004|Overall Study|Physician Decision|0|||
105837069|NCT00631007|365060341|FG005|Overall Study|Physician Decision|2|||
105837070|NCT00631007|365060336|FG000|Overall Study|Persistent Hyperglycemia|2|||
105837071|NCT00631007|365060337|FG001|Overall Study|Persistent Hyperglycemia|2|||
105837072|NCT00631007|365060338|FG002|Overall Study|Persistent Hyperglycemia|5|||
105837073|NCT00631007|365060339|FG003|Overall Study|Persistent Hyperglycemia|1|||
105837074|NCT00631007|365060340|FG004|Overall Study|Persistent Hyperglycemia|2|||
105837075|NCT00631007|365060341|FG005|Overall Study|Persistent Hyperglycemia|5|||
105837076|NCT00631007|365060336|FG000|Overall Study|Withdrawal by Subject|4|||
105837077|NCT00631007|365060337|FG001|Overall Study|Withdrawal by Subject|5|||
105837078|NCT00631007|365060338|FG002|Overall Study|Withdrawal by Subject|2|||
105837079|NCT00631007|365060339|FG003|Overall Study|Withdrawal by Subject|2|||
105837080|NCT00631007|365060340|FG004|Overall Study|Withdrawal by Subject|1|||
105837081|NCT00631007|365060341|FG005|Overall Study|Withdrawal by Subject|3|||
105837082|NCT00631007|365060336|FG000|Overall Study|Other|2|||
105837083|NCT00631007|365060337|FG001|Overall Study|Other|1|||
105837084|NCT00631007|365060338|FG002|Overall Study|Other|0|||
105837085|NCT00631007|365060339|FG003|Overall Study|Other|0|||
105837086|NCT00631007|365060340|FG004|Overall Study|Other|1|||
105837087|NCT00631007|365060341|FG005|Overall Study|Other|0|||
105837088|NCT02674633|365060342|FG000|Overall Study|Lost to Follow-up|3|||
105837089|NCT02674633|365060343|FG001|Overall Study|Lost to Follow-up|2|||
105837090|NCT02674633|365060342|FG000|Overall Study|Physician Decision|1|||
105837091|NCT02674633|365060343|FG001|Overall Study|Physician Decision|0|||
105837092|NCT02674633|365060342|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105837093|NCT02674633|365060343|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
105837094|NCT00683787|365060344|FG000|Overall Study|Progression|3|||
105837095|NCT00683787|365060345|FG001|Overall Study|Progression|3|||
105837096|NCT00683787|365060346|FG002|Overall Study|Progression|0|||
105837097|NCT00683787|365060344|FG000|Overall Study|Adverse Event|0|||
105837098|NCT00683787|365060345|FG001|Overall Study|Adverse Event|0|||
105837099|NCT00683787|365060346|FG002|Overall Study|Adverse Event|2|||
105837100|NCT04167618|365060347|FG000|Overall Study|Trial terminated by sponsor|1|||
105837101|NCT04167618|365060348|FG001|Overall Study|Trial terminated by sponsor|1|||
105837102|NCT00460109|365060349|FG000|Overall Study|Death|1|||
105837103|NCT01363011|365060355|FG000|Main Study|Adverse Event|2|||
105837104|NCT01363011|365060356|FG001|Main Study|Adverse Event|3|||
105837105|NCT01363011|365060355|FG000|Main Study|Investigator's Discretion|1|||
105837106|NCT01363011|365060356|FG001|Main Study|Investigator's Discretion|1|||
105837107|NCT01363011|365060355|FG000|Main Study|Withdrew Consent|1|||
105837108|NCT01363011|365060356|FG001|Main Study|Withdrew Consent|4|||
105837109|NCT01363011|365060355|FG000|Main Study|Protocol Violation|0|||
105837110|NCT01363011|365060356|FG001|Main Study|Protocol Violation|1|||
105837111|NCT01363011|365060355|FG000|Extension Phase|Adverse Event|1|||
105837112|NCT01363011|365060356|FG001|Extension Phase|Adverse Event|1|||
105837113|NCT01363011|365060355|FG000|Extension Phase|Lack of Efficacy|0|||
105837114|NCT01363011|365060356|FG001|Extension Phase|Lack of Efficacy|1|||
105837115|NCT01363011|365060355|FG000|Extension Phase|Investigator's Discretion|2|||
105837116|NCT01363011|365060356|FG001|Extension Phase|Investigator's Discretion|2|||
105837117|NCT01363011|365060355|FG000|Extension Phase|Withdrew Consent|0|||
105837118|NCT01363011|365060356|FG001|Extension Phase|Withdrew Consent|1|||
105837119|NCT01363011|365060355|FG000|Extension Phase|Lost to Follow-up|0|||
105837120|NCT01363011|365060356|FG001|Extension Phase|Lost to Follow-up|2|||
105837121|NCT01363011|365060355|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
105837122|NCT01363011|365060356|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
105837123|NCT00399893|365060357|FG000|Overall Study|Withdrawal by Subject|1|||
105837124|NCT00399893|365060358|FG001|Overall Study|Withdrawal by Subject|0|||
105837125|NCT03653026|365060359|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
105837126|NCT03653026|365060360|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
105837127|NCT03653026|365060361|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
105837128|NCT03653026|365060362|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
105837129|NCT03653026|365060359|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
105837130|NCT03653026|365060360|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
105367362|NCT04969289|363352264|FG000|Overall Study|Lost to Follow-up|13|||
105367363|NCT04969289|363352265|FG001|Overall Study|Lost to Follow-up|9|||
105367364|NCT00593814|363352266|FG000|Overall Study|Death|7|||
105576487|NCT04157686|364108540|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
105576488|NCT04157686|364108541|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
105837131|NCT03653026|365060361|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105837132|NCT03653026|365060362|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105837133|NCT03653026|365060359|FG000|Part 1: Placebo-controlled Period|Other|0|||
105837134|NCT03653026|365060360|FG001|Part 1: Placebo-controlled Period|Other|3|||
105837135|NCT03653026|365060361|FG002|Part 1: Placebo-controlled Period|Other|0|||
105837136|NCT03653026|365060362|FG003|Part 1: Placebo-controlled Period|Other|0|||
105837137|NCT03653026|365060359|FG000|Part 2: Open-label Extension|Adverse Event|0|||
105837138|NCT03653026|365060360|FG001|Part 2: Open-label Extension|Adverse Event|0|||
105837139|NCT03653026|365060361|FG002|Part 2: Open-label Extension|Adverse Event|1|||
105837140|NCT03653026|365060362|FG003|Part 2: Open-label Extension|Adverse Event|1|||
105837141|NCT03653026|365060359|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
105837142|NCT03653026|365060360|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
105367365|NCT00593814|363352267|FG001|Overall Study|Death|0|||
105837143|NCT03653026|365060361|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
105837144|NCT03653026|365060362|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
105837145|NCT03653026|365060359|FG000|Part 2: Open-label Extension|Other|0|||
105837146|NCT03653026|365060360|FG001|Part 2: Open-label Extension|Other|0|||
105837147|NCT03653026|365060361|FG002|Part 2: Open-label Extension|Other|1|||
105837148|NCT03653026|365060362|FG003|Part 2: Open-label Extension|Other|2|||
105837149|NCT02457819|365060365|FG000|Overall Study|reason not given|8|||
105837150|NCT02457819|365060365|FG000|Overall Study|Withdrawal by Subject|24|||
105837151|NCT02457819|365060365|FG000|Overall Study|Protocol Violation|1|||
105837152|NCT02457819|365060365|FG000|Overall Study|non compliance with study drug|4|||
105837153|NCT02457819|365060365|FG000|Overall Study|Lost to Follow-up|10|||
105837154|NCT02457819|365060365|FG000|Overall Study|Lack of Efficacy|19|||
105837155|NCT02457819|365060365|FG000|Overall Study|Adverse Event|33|||
105837156|NCT03330236|365060366|FG000|Overall Study|Death|2|||
105837157|NCT03330236|365060367|FG001|Overall Study|Death|1|||
105837158|NCT03330236|365060366|FG000|Overall Study|Withdrawal by Subject|2|||
105837159|NCT03330236|365060367|FG001|Overall Study|Withdrawal by Subject|4|||
105837160|NCT03330236|365060366|FG000|Overall Study|Lost to Follow-up|0|||
105837161|NCT03330236|365060367|FG001|Overall Study|Lost to Follow-up|2|||
105837162|NCT03330236|365060366|FG000|Overall Study|Physician Decision|2|||
105837163|NCT03330236|365060367|FG001|Overall Study|Physician Decision|0|||
105837164|NCT03330236|365060366|FG000|Overall Study|Protocol Violation|4|||
105837165|NCT03330236|365060367|FG001|Overall Study|Protocol Violation|3|||
105837166|NCT03330236|365060366|FG000|Overall Study|SedLine malfunction/blinding|19|||
105837167|NCT03330236|365060367|FG001|Overall Study|SedLine malfunction/blinding|14|||
105837168|NCT03330236|365060366|FG000|Overall Study|Volatile anesthetics used|11|||
105837169|NCT03330236|365060367|FG001|Overall Study|Volatile anesthetics used|8|||
105837170|NCT03330236|365060366|FG000|Overall Study|Surgery aborted/converted to open|60|||
105837171|NCT03330236|365060367|FG001|Overall Study|Surgery aborted/converted to open|52|||
105837172|NCT01901848|365060369|FG000|Randomized and Treated|Lost to Follow-up|3|||
105837173|NCT01901848|365060370|FG001|Randomized and Treated|Lost to Follow-up|6|||
105837174|NCT01901848|365060369|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
105837175|NCT01901848|365060370|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
105837176|NCT04823130|365060371|FG000|Overall Study|Withdrawal by Subject|2|||
105837177|NCT04823130|365060372|FG001|Overall Study|Withdrawal by Subject|3|||
105837178|NCT04823130|365060371|FG000|Overall Study|Failure to meet inclusion criteria|6|||
105837179|NCT04823130|365060372|FG001|Overall Study|Failure to meet inclusion criteria|4|||
105837180|NCT04823130|365060371|FG000|Overall Study|Other-unspecified|1|||
105837181|NCT04823130|365060372|FG001|Overall Study|Other-unspecified|0|||
105837182|NCT02488824|365060373|FG000|Overall Study|Adverse Event|1|||
105837183|NCT02488824|365060374|FG001|Overall Study|Adverse Event|1|||
105837184|NCT02356211|365060375|FG000|Overall Study|Withdrawal by Subject|2|||
105837185|NCT02356211|365060376|FG001|Overall Study|Withdrawal by Subject|2|||
105837186|NCT02356211|365060375|FG000|Overall Study|ineligible|1|||
105837187|NCT02356211|365060376|FG001|Overall Study|ineligible|8|||
105837188|NCT02510261|365060379|FG000|Overall Study|Adverse Event|5|||
105837189|NCT02510261|365060380|FG001|Overall Study|Adverse Event|8|||
105837190|NCT02510261|365060381|FG002|Overall Study|Adverse Event|0|||
105837191|NCT02510261|365060379|FG000|Overall Study|Physician Decision|1|||
105837192|NCT02510261|365060380|FG001|Overall Study|Physician Decision|5|||
105837193|NCT02510261|365060381|FG002|Overall Study|Physician Decision|0|||
105837194|NCT02510261|365060379|FG000|Overall Study|Death|19|||
105837195|NCT02510261|365060380|FG001|Overall Study|Death|19|||
105837196|NCT02510261|365060381|FG002|Overall Study|Death|0|||
105837197|NCT02510261|365060379|FG000|Overall Study|Withdrawal by Subject|3|||
105837198|NCT02510261|365060380|FG001|Overall Study|Withdrawal by Subject|10|||
105837199|NCT02510261|365060381|FG002|Overall Study|Withdrawal by Subject|3|||
105367366|NCT00593814|363352266|FG000|Overall Study|Withdrawal by Subject|7|||
105367367|NCT00593814|363352267|FG001|Overall Study|Withdrawal by Subject|0|||
105367368|NCT00593814|363352266|FG000|Overall Study|Lost to Follow-up|7|||
105367369|NCT00593814|363352267|FG001|Overall Study|Lost to Follow-up|0|||
105367370|NCT00593814|363352266|FG000|Overall Study|Physician Decision|3|||
105367371|NCT00593814|363352267|FG001|Overall Study|Physician Decision|0|||
105367372|NCT00557466|363352268|FG000|Overall Study|Adverse Event|3|||
105837200|NCT00108082|365060382|FG000|Overall Study|Adverse Event|14|||
105837201|NCT00108082|365060383|FG001|Overall Study|Adverse Event|12|||
105837202|NCT00108082|365060384|FG002|Overall Study|Adverse Event|17|||
105837203|NCT00108082|365060382|FG000|Overall Study|Lost to Follow-up|6|||
105837204|NCT00108082|365060383|FG001|Overall Study|Lost to Follow-up|3|||
105837205|NCT00108082|365060384|FG002|Overall Study|Lost to Follow-up|7|||
105837206|NCT00108082|365060382|FG000|Overall Study|Consent Withdrawn|3|||
105837207|NCT00108082|365060383|FG001|Overall Study|Consent Withdrawn|3|||
105367373|NCT00557466|363352269|FG001|Overall Study|Adverse Event|1|||
105367374|NCT00557466|363352270|FG002|Overall Study|Adverse Event|4|||
105367375|NCT00557466|363352271|FG003|Overall Study|Adverse Event|1|||
105367376|NCT00557466|363352272|FG004|Overall Study|Adverse Event|2|||
105837208|NCT00108082|365060384|FG002|Overall Study|Consent Withdrawn|5|||
105837209|NCT00108082|365060382|FG000|Overall Study|Protocol Violation|1|||
105367377|NCT00557466|363352273|FG005|Overall Study|Adverse Event|4|||
105367378|NCT00557466|363352268|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105367379|NCT00557466|363352269|FG001|Overall Study|Abnormal laboratory value(s)|2|||
105367380|NCT00557466|363352270|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105367381|NCT00557466|363352271|FG003|Overall Study|Abnormal laboratory value(s)|0|||
105367382|NCT00557466|363352272|FG004|Overall Study|Abnormal laboratory value(s)|0|||
105367383|NCT00557466|363352273|FG005|Overall Study|Abnormal laboratory value(s)|0|||
105367384|NCT00557466|363352268|FG000|Overall Study|Protocol deviation|0|||
105367385|NCT00557466|363352269|FG001|Overall Study|Protocol deviation|1|||
105367386|NCT00557466|363352270|FG002|Overall Study|Protocol deviation|0|||
105367387|NCT00557466|363352271|FG003|Overall Study|Protocol deviation|2|||
105367388|NCT00557466|363352272|FG004|Overall Study|Protocol deviation|0|||
105367389|NCT00557466|363352273|FG005|Overall Study|Protocol deviation|0|||
105367390|NCT00557466|363352268|FG000|Overall Study|Subject withdrew consent|0|||
105367391|NCT00557466|363352269|FG001|Overall Study|Subject withdrew consent|0|||
105367392|NCT00557466|363352270|FG002|Overall Study|Subject withdrew consent|0|||
105367393|NCT00557466|363352271|FG003|Overall Study|Subject withdrew consent|0|||
105367394|NCT00557466|363352272|FG004|Overall Study|Subject withdrew consent|1|||
105367395|NCT00557466|363352273|FG005|Overall Study|Subject withdrew consent|2|||
105367396|NCT00557466|363352268|FG000|Overall Study|Administrative problems|0|||
105367397|NCT00557466|363352269|FG001|Overall Study|Administrative problems|1|||
105367398|NCT00557466|363352270|FG002|Overall Study|Administrative problems|1|||
105367399|NCT00557466|363352271|FG003|Overall Study|Administrative problems|0|||
105367400|NCT00557466|363352272|FG004|Overall Study|Administrative problems|0|||
105367401|NCT00557466|363352273|FG005|Overall Study|Administrative problems|0|||
105367402|NCT00557466|363352268|FG000|Overall Study|Abnormal test procedure results|0|||
105367403|NCT00557466|363352269|FG001|Overall Study|Abnormal test procedure results|0|||
105367404|NCT00557466|363352270|FG002|Overall Study|Abnormal test procedure results|1|||
105367405|NCT00557466|363352271|FG003|Overall Study|Abnormal test procedure results|0|||
105367406|NCT00557466|363352272|FG004|Overall Study|Abnormal test procedure results|0|||
105367407|NCT00557466|363352273|FG005|Overall Study|Abnormal test procedure results|0|||
105367408|NCT00557466|363352268|FG000|Overall Study|Lost to Follow-up|0|||
105367409|NCT00557466|363352269|FG001|Overall Study|Lost to Follow-up|0|||
105367410|NCT00557466|363352270|FG002|Overall Study|Lost to Follow-up|0|||
105367411|NCT00557466|363352271|FG003|Overall Study|Lost to Follow-up|1|||
105367412|NCT00557466|363352272|FG004|Overall Study|Lost to Follow-up|0|||
105367413|NCT00557466|363352273|FG005|Overall Study|Lost to Follow-up|0|||
105367414|NCT03205150|363352274|FG000|Overall Study|Protocol deviation|1|||
105367415|NCT03205150|363352275|FG001|Overall Study|Protocol deviation|3|||
105367416|NCT03205150|363352276|FG002|Overall Study|Protocol deviation|0|||
105367417|NCT03205150|363352274|FG000|Overall Study|Patient/guardian decision|0|||
105367418|NCT03205150|363352275|FG001|Overall Study|Patient/guardian decision|3|||
105837210|NCT00108082|365060383|FG001|Overall Study|Protocol Violation|2|||
105837211|NCT00108082|365060384|FG002|Overall Study|Protocol Violation|0|||
105837212|NCT00108082|365060382|FG000|Overall Study|Lack of Efficacy|3|||
105837213|NCT00108082|365060383|FG001|Overall Study|Lack of Efficacy|1|||
105837214|NCT00108082|365060384|FG002|Overall Study|Lack of Efficacy|2|||
105837215|NCT00108082|365060382|FG000|Overall Study|Amendment 4: > Month 12|5|||
105837216|NCT00108082|365060383|FG001|Overall Study|Amendment 4: > Month 12|7|||
105837217|NCT00108082|365060384|FG002|Overall Study|Amendment 4: > Month 12|5|||
105837218|NCT00108082|365060382|FG000|Overall Study|Woman of Child-bearing Potential|2|||
105837219|NCT00108082|365060383|FG001|Overall Study|Woman of Child-bearing Potential|0|||
105837220|NCT00108082|365060384|FG002|Overall Study|Woman of Child-bearing Potential|2|||
105837221|NCT00108082|365060382|FG000|Overall Study|Incorrectly Randomized|0|||
105367419|NCT03205150|363352276|FG002|Overall Study|Patient/guardian decision|0|||
105367420|NCT03205150|363352274|FG000|Overall Study|Adverse Event|1|||
105367421|NCT03205150|363352275|FG001|Overall Study|Adverse Event|1|||
105367422|NCT03205150|363352276|FG002|Overall Study|Adverse Event|1|||
105367423|NCT03205150|363352274|FG000|Overall Study|Lost to Follow-up|0|||
105367424|NCT03205150|363352275|FG001|Overall Study|Lost to Follow-up|0|||
105367425|NCT03205150|363352276|FG002|Overall Study|Lost to Follow-up|1|||
105837222|NCT00108082|365060383|FG001|Overall Study|Incorrectly Randomized|0|||
105837223|NCT00108082|365060384|FG002|Overall Study|Incorrectly Randomized|2|||
105837224|NCT00108082|365060382|FG000|Overall Study|Non-compliance|1|||
105837225|NCT00108082|365060383|FG001|Overall Study|Non-compliance|0|||
105837226|NCT00108082|365060384|FG002|Overall Study|Non-compliance|2|||
105837227|NCT00108082|365060382|FG000|Overall Study|Stopped Study Medication|0|||
105837228|NCT00108082|365060383|FG001|Overall Study|Stopped Study Medication|0|||
105837229|NCT00108082|365060384|FG002|Overall Study|Stopped Study Medication|1|||
105837230|NCT00108082|365060382|FG000|Overall Study|Site Closed Study|0|||
105837231|NCT00108082|365060383|FG001|Overall Study|Site Closed Study|2|||
105837232|NCT00108082|365060384|FG002|Overall Study|Site Closed Study|0|||
105837233|NCT00108082|365060382|FG000|Overall Study|Protocol Amendment|0|||
105837234|NCT00108082|365060383|FG001|Overall Study|Protocol Amendment|1|||
105837235|NCT00108082|365060384|FG002|Overall Study|Protocol Amendment|0|||
105837236|NCT00108082|365060382|FG000|Overall Study|Study Medication Not Tapered|0|||
105837237|NCT00108082|365060383|FG001|Overall Study|Study Medication Not Tapered|1|||
105837238|NCT00108082|365060384|FG002|Overall Study|Study Medication Not Tapered|0|||
105837239|NCT00108082|365060382|FG000|Overall Study|Subject Left Site Location|1|||
105837240|NCT00108082|365060383|FG001|Overall Study|Subject Left Site Location|0|||
105837241|NCT00108082|365060384|FG002|Overall Study|Subject Left Site Location|0|||
105837242|NCT00108082|365060382|FG000|Overall Study|Investigator Not at Site|1|||
105837243|NCT00108082|365060383|FG001|Overall Study|Investigator Not at Site|0|||
105837244|NCT00108082|365060384|FG002|Overall Study|Investigator Not at Site|0|||
105837245|NCT00108082|365060382|FG000|Overall Study|Blood Pressure Not Controlled|1|||
105837246|NCT00108082|365060383|FG001|Overall Study|Blood Pressure Not Controlled|0|||
105837247|NCT00108082|365060384|FG002|Overall Study|Blood Pressure Not Controlled|0|||
105837248|NCT01270620|365060386|FG000|Overall Study|Withdrawal by Subject|1|||
105837249|NCT01270620|365060387|FG001|Overall Study|Withdrawal by Subject|3|||
105310806|NCT00106964|363136200|FG001|Overall Study|Site Funding Terminated|1|||
105310807|NCT00106964|363136201|FG002|Overall Study|Site Funding Terminated|1|||
105310808|NCT00106964|363136199|FG000|Overall Study|Failure to adhere|2|||
105310809|NCT00106964|363136200|FG001|Overall Study|Failure to adhere|0|||
105310810|NCT00106964|363136201|FG002|Overall Study|Failure to adhere|0|||
105310811|NCT00106964|363136199|FG000|Overall Study|Did not meet eligibility criteria|0|||
105310812|NCT00106964|363136200|FG001|Overall Study|Did not meet eligibility criteria|2|||
105310813|NCT00106964|363136201|FG002|Overall Study|Did not meet eligibility criteria|2|||
105310814|NCT00106964|363136199|FG000|Overall Study|Required disallowed medication|0|||
105310815|NCT00106964|363136200|FG001|Overall Study|Required disallowed medication|1|||
105310816|NCT00106964|363136201|FG002|Overall Study|Required disallowed medication|0|||
105310817|NCT04746794|363136202|FG000|Overall Study|Did not complete any study assessment|50303|||
105310818|NCT04746794|363136203|FG001|Overall Study|Did not complete any study assessment|44997|||
105310819|NCT01422187|363136213|FG000|Overall Study|Personal reason|1|||
105310820|NCT01422187|363136214|FG001|Overall Study|Personal reason|0|||
105310821|NCT01422187|363136215|FG002|Overall Study|Personal reason|0|||
105310822|NCT01422187|363136213|FG000|Overall Study|Lost to Follow-up|0|||
105310823|NCT01422187|363136214|FG001|Overall Study|Lost to Follow-up|1|||
105310824|NCT01422187|363136215|FG002|Overall Study|Lost to Follow-up|0|||
105310825|NCT00168818|363136216|FG000|Overall Study|Adverse Event|23|||
105310826|NCT00168818|363136217|FG001|Overall Study|Adverse Event|29|||
105310827|NCT00168818|363136218|FG002|Overall Study|Adverse Event|31|||
105310828|NCT00168818|363136216|FG000|Overall Study|Protocol Violation|16|||
105310829|NCT00168818|363136217|FG001|Overall Study|Protocol Violation|11|||
105310830|NCT00168818|363136218|FG002|Overall Study|Protocol Violation|11|||
105310831|NCT00168818|363136216|FG000|Overall Study|Lost to Follow-up|13|||
105310832|NCT00168818|363136217|FG001|Overall Study|Lost to Follow-up|4|||
105310833|NCT00168818|363136218|FG002|Overall Study|Lost to Follow-up|15|||
105310834|NCT00168818|363136216|FG000|Overall Study|Withdrawal by Subject|43|||
105310835|NCT00168818|363136217|FG001|Overall Study|Withdrawal by Subject|41|||
105310836|NCT00168818|363136218|FG002|Overall Study|Withdrawal by Subject|37|||
105310837|NCT00168818|363136216|FG000|Overall Study|Other|22|||
105310838|NCT00168818|363136217|FG001|Overall Study|Other|24|||
105310839|NCT00168818|363136218|FG002|Overall Study|Other|30|||
105310840|NCT00168818|363136216|FG000|Treatment|Adverse Event|77|||
105310841|NCT00168818|363136217|FG001|Treatment|Adverse Event|89|||
105310842|NCT00168818|363136218|FG002|Treatment|Adverse Event|68|||
105310843|NCT00168818|363136216|FG000|Treatment|Protocol Violation|8|||
105310844|NCT00168818|363136217|FG001|Treatment|Protocol Violation|11|||
105310845|NCT00168818|363136218|FG002|Treatment|Protocol Violation|11|||
105310846|NCT00168818|363136216|FG000|Treatment|Lost to Follow-up|0|||
105310847|NCT00168818|363136217|FG001|Treatment|Lost to Follow-up|2|||
105310848|NCT00168818|363136218|FG002|Treatment|Lost to Follow-up|1|||
105310849|NCT00168818|363136216|FG000|Treatment|Withdrawal by Subject|25|||
105310850|NCT00168818|363136217|FG001|Treatment|Withdrawal by Subject|20|||
105310851|NCT00168818|363136218|FG002|Treatment|Withdrawal by Subject|22|||
105310852|NCT00168818|363136216|FG000|Treatment|Other|23|||
105310853|NCT00168818|363136217|FG001|Treatment|Other|29|||
105367426|NCT02723188|363352277|FG000|Overall Study|Withdrawal by Subject|1|||
105367427|NCT02723188|363352278|FG001|Overall Study|Withdrawal by Subject|0|||
105367428|NCT02723188|363352279|FG002|Overall Study|Withdrawal by Subject|0|||
105367429|NCT01251952|363352280|FG000|Overall Study|Adverse Event|1|||
105367430|NCT00496769|363352281|FG000|Double Blind|>=1 reason assigned per patient|558|||
105367431|NCT00496769|363352282|FG001|Double Blind|>=1 reason assigned per patient|649|||
105367432|NCT00496769|363352283|FG002|Double Blind|>=1 reason assigned per patient|0|||
105310854|NCT00168818|363136218|FG002|Treatment|Other|31|||
105310855|NCT02695537|363136219|FG000|Overall Study|Adverse Event|3|||
105310856|NCT02695537|363136219|FG000|Overall Study|Lack of Efficacy|28|||
105310857|NCT02695537|363136219|FG000|Overall Study|Withdrawal by Subject|4|||
105310858|NCT02695537|363136219|FG000|Overall Study|Protocol Violation|3|||
105837250|NCT00848042|365060400|FG000|Overall Study|Death|1|||
105310859|NCT02794246|363136220|FG000|Overall Study|Withdrawal by Subject|2|||
105310860|NCT02794246|363136220|FG000|Overall Study|Physician Decision|4|||
105310861|NCT02792699|363136223|FG000|Overall Study|Adverse Event|1|||
105837251|NCT00848042|365060401|FG001|Overall Study|Death|2|||
105837252|NCT00848042|365060402|FG002|Overall Study|Death|0|||
105837253|NCT00848042|365060400|FG000|Overall Study|Other Therapy|3|||
105837254|NCT00848042|365060401|FG001|Overall Study|Other Therapy|0|||
105837255|NCT00848042|365060402|FG002|Overall Study|Other Therapy|0|||
105837256|NCT01049412|365060404|FG000|Period I|Withdrawal by Subject|4|||
105837257|NCT01049412|365060405|FG001|Period I|Withdrawal by Subject|6|||
105837258|NCT01049412|365060404|FG000|Period I|Lost to Follow-up|2|||
105837259|NCT01049412|365060405|FG001|Period I|Lost to Follow-up|2|||
105837260|NCT01049412|365060404|FG000|Period I|Physician Decision|0|||
105837261|NCT01049412|365060405|FG001|Period I|Physician Decision|3|||
105837262|NCT01049412|365060404|FG000|Period I|Protocol Violation|1|||
105837263|NCT01049412|365060405|FG001|Period I|Protocol Violation|2|||
105837264|NCT01049412|365060404|FG000|Period I|Adverse Event|1|||
105837265|NCT01049412|365060405|FG001|Period I|Adverse Event|0|||
105837266|NCT01049412|365060404|FG000|Period II|Withdrawal by Subject|2|||
105837267|NCT01049412|365060405|FG001|Period II|Withdrawal by Subject|3|||
105837268|NCT01049412|365060404|FG000|Period II|Adverse Event|1|||
105837269|NCT01049412|365060405|FG001|Period II|Adverse Event|0|||
105837270|NCT01049412|365060404|FG000|Period II|Lost to Follow-up|1|||
105837271|NCT01049412|365060405|FG001|Period II|Lost to Follow-up|0|||
105837272|NCT00112294|365060406|FG000|Overall Study|Still on study|5|||
105837273|NCT00112294|365060407|FG001|Overall Study|Still on study|0|||
105837274|NCT05966090|365060408|FG000|Overall Study|Lost to Follow-up|6|||
105837275|NCT05966090|365060409|FG001|Overall Study|Lost to Follow-up|6|||
105837276|NCT05966090|365060408|FG000|Overall Study|Adverse Event|1|||
105837277|NCT05966090|365060409|FG001|Overall Study|Adverse Event|1|||
105837278|NCT05966090|365060408|FG000|Overall Study|Withdrawal by Subject|1|||
105837279|NCT05966090|365060409|FG001|Overall Study|Withdrawal by Subject|1|||
105310862|NCT02792699|363136224|FG001|Overall Study|Adverse Event|2|||
105310863|NCT02792699|363136225|FG002|Overall Study|Adverse Event|4|||
105310864|NCT02792699|363136223|FG000|Overall Study|Withdrawal by Subject|4|||
105310865|NCT02792699|363136224|FG001|Overall Study|Withdrawal by Subject|4|||
105310866|NCT02792699|363136225|FG002|Overall Study|Withdrawal by Subject|3|||
105310867|NCT02792699|363136223|FG000|Overall Study|Lost to Follow-up|0|||
105310868|NCT02792699|363136224|FG001|Overall Study|Lost to Follow-up|1|||
105310869|NCT02792699|363136225|FG002|Overall Study|Lost to Follow-up|2|||
105310870|NCT02792699|363136223|FG000|Overall Study|Physician Decision|2|||
105310871|NCT02792699|363136224|FG001|Overall Study|Physician Decision|0|||
105310872|NCT02792699|363136225|FG002|Overall Study|Physician Decision|0|||
105310873|NCT02792699|363136223|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
105310874|NCT02792699|363136224|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
105310875|NCT02792699|363136225|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
105310876|NCT02792699|363136223|FG000|Overall Study|Other|1|||
105310877|NCT02792699|363136224|FG001|Overall Study|Other|0|||
105310878|NCT02792699|363136225|FG002|Overall Study|Other|0|||
105310879|NCT00715624|363136226|FG000|Overall Study|Adverse Event|12|||
105310880|NCT00715624|363136227|FG001|Overall Study|Adverse Event|37|||
105310881|NCT00715624|363136226|FG000|Overall Study|Lack of Efficacy|11|||
105310882|NCT00715624|363136227|FG001|Overall Study|Lack of Efficacy|11|||
105310883|NCT00715624|363136226|FG000|Overall Study|Lost to Follow-up|1|||
105310884|NCT00715624|363136227|FG001|Overall Study|Lost to Follow-up|2|||
105310885|NCT00715624|363136226|FG000|Overall Study|Protocol Violation|1|||
105310886|NCT00715624|363136227|FG001|Overall Study|Protocol Violation|0|||
105310887|NCT00715624|363136226|FG000|Overall Study|Withdrawal by Subject|11|||
105310888|NCT00715624|363136227|FG001|Overall Study|Withdrawal by Subject|25|||
105310889|NCT00715624|363136226|FG000|Overall Study|Familial and personal reasons|10|||
105310890|NCT00715624|363136227|FG001|Overall Study|Familial and personal reasons|22|||
105310891|NCT00715624|363136226|FG000|Overall Study|Poor compliance|6|||
105310892|NCT00715624|363136227|FG001|Overall Study|Poor compliance|13|||
105310893|NCT00715624|363136226|FG000|Overall Study|Sponsor decision|0|||
105310894|NCT00715624|363136227|FG001|Overall Study|Sponsor decision|4|||
105310895|NCT00715624|363136226|FG000|Overall Study|Incorrect randomization (not treated)|0|||
105310896|NCT00715624|363136227|FG001|Overall Study|Incorrect randomization (not treated)|1|||
105310897|NCT00715624|363136226|FG000|Overall Study|Other|0|||
105310898|NCT00715624|363136227|FG001|Overall Study|Other|1|||
105310899|NCT03200912|363136228|FG000|Overall Study|Adverse Event|3|||
105310900|NCT03200912|363136229|FG001|Overall Study|Adverse Event|0|||
105837280|NCT05966090|365060408|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105837281|NCT05966090|365060409|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
105837282|NCT05966090|365060408|FG000|Overall Study|Other|1|||
105837283|NCT05966090|365060409|FG001|Overall Study|Other|1|||
105837284|NCT01142908|365060410|FG000|Overall Study|Lost to Follow-up|19|||
105310901|NCT03200912|363136230|FG002|Overall Study|Adverse Event|0|||
105310902|NCT03200912|363136228|FG000|Overall Study|Withdrawal by Subject|1|||
105310903|NCT03200912|363136229|FG001|Overall Study|Withdrawal by Subject|2|||
105310904|NCT03200912|363136230|FG002|Overall Study|Withdrawal by Subject|4|||
105310905|NCT03200912|363136228|FG000|Overall Study|Non-compliance with study drug|0|||
105310906|NCT03200912|363136229|FG001|Overall Study|Non-compliance with study drug|1|||
105310907|NCT03200912|363136230|FG002|Overall Study|Non-compliance with study drug|0|||
105837285|NCT01142908|365060411|FG001|Overall Study|Lost to Follow-up|13|||
105367433|NCT00496769|363352281|FG000|Open Label|>=1 reason assigned per patient|0|||
105367434|NCT00496769|363352282|FG001|Open Label|>=1 reason assigned per patient|0|||
105367435|NCT00496769|363352283|FG002|Open Label|>=1 reason assigned per patient|1011|||
105367436|NCT03110354|363352284|FG000|Overall Study|Death|1|||
105489861|NCT03963401|363805679|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
105489862|NCT03963401|363805674|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
105489863|NCT03963401|363805675|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
105489864|NCT03963401|363805676|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
105489865|NCT03963401|363805677|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
105489866|NCT03963401|363805678|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
105489867|NCT03963401|363805679|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
105489868|NCT03963401|363805674|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
105489869|NCT03963401|363805675|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
105489870|NCT03963401|363805676|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
105489871|NCT03963401|363805677|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
105489872|NCT03963401|363805678|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
105489873|NCT03963401|363805679|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
105489874|NCT03963401|363805674|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
105489875|NCT03963401|363805675|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
105489876|NCT03963401|363805676|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
105837286|NCT01142908|365060410|FG000|Overall Study|Death|1|||
105837287|NCT01142908|365060411|FG001|Overall Study|Death|4|||
105837288|NCT01142908|365060410|FG000|Overall Study|Excluded - did not meet criteria|9|||
105837289|NCT01142908|365060411|FG001|Overall Study|Excluded - did not meet criteria|5|||
105837290|NCT01142908|365060410|FG000|Overall Study|Withdrawal by Subject|3|||
105837291|NCT01142908|365060411|FG001|Overall Study|Withdrawal by Subject|0|||
105367437|NCT03110354|363352285|FG001|Overall Study|Death|0|||
105367438|NCT03110354|363352286|FG002|Overall Study|Death|0|||
105367439|NCT03110354|363352287|FG003|Overall Study|Death|1|||
105367440|NCT03110354|363352288|FG004|Overall Study|Death|0|||
105367441|NCT03110354|363352284|FG000|Overall Study|Start of new therapy|0|||
105367442|NCT03110354|363352285|FG001|Overall Study|Start of new therapy|0|||
105367443|NCT03110354|363352286|FG002|Overall Study|Start of new therapy|0|||
105367444|NCT03110354|363352287|FG003|Overall Study|Start of new therapy|0|||
105367445|NCT03110354|363352288|FG004|Overall Study|Start of new therapy|1|||
105367446|NCT03110354|363352284|FG000|Overall Study|Failure to achieve response|2|||
105367447|NCT03110354|363352285|FG001|Overall Study|Failure to achieve response|3|||
105367448|NCT03110354|363352286|FG002|Overall Study|Failure to achieve response|0|||
105367449|NCT03110354|363352287|FG003|Overall Study|Failure to achieve response|2|||
105367450|NCT03110354|363352288|FG004|Overall Study|Failure to achieve response|1|||
105367451|NCT03110354|363352284|FG000|Overall Study|Progressive disease|1|||
105367452|NCT03110354|363352285|FG001|Overall Study|Progressive disease|1|||
105367453|NCT03110354|363352286|FG002|Overall Study|Progressive disease|3|||
105367454|NCT03110354|363352287|FG003|Overall Study|Progressive disease|4|||
105367455|NCT03110354|363352288|FG004|Overall Study|Progressive disease|2|||
105367456|NCT03110354|363352284|FG000|Overall Study|Adverse Event|0|||
105367457|NCT03110354|363352285|FG001|Overall Study|Adverse Event|0|||
105367458|NCT03110354|363352286|FG002|Overall Study|Adverse Event|0|||
105367459|NCT03110354|363352287|FG003|Overall Study|Adverse Event|2|||
105576489|NCT04157686|364108542|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
105576490|NCT04157686|364108543|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
105837292|NCT00035555|365060416|FG000|Overall Study|Adverse Event|5|||
105837293|NCT00035555|365060417|FG001|Overall Study|Adverse Event|8|||
105837294|NCT00035555|365060418|FG002|Overall Study|Adverse Event|9|||
105837295|NCT00035555|365060416|FG000|Overall Study|Allograft loss|1|||
105837296|NCT00035555|365060417|FG001|Overall Study|Allograft loss|1|||
105837297|NCT00035555|365060418|FG002|Overall Study|Allograft loss|2|||
105837298|NCT00035555|365060416|FG000|Overall Study|Death|0|||
105837299|NCT00035555|365060417|FG001|Overall Study|Death|0|||
105837300|NCT00035555|365060418|FG002|Overall Study|Death|2|||
105837301|NCT00035555|365060416|FG000|Overall Study|Lost to Follow-up|0|||
105837302|NCT00035555|365060417|FG001|Overall Study|Lost to Follow-up|0|||
105837303|NCT00035555|365060418|FG002|Overall Study|Lost to Follow-up|1|||
105837304|NCT00035555|365060416|FG000|Overall Study|Noncompliance|0|||
105367460|NCT03110354|363352288|FG004|Overall Study|Adverse Event|2|||
105367461|NCT03110354|363352284|FG000|Overall Study|Other|0|||
105367462|NCT03110354|363352285|FG001|Overall Study|Other|0|||
105367463|NCT03110354|363352286|FG002|Overall Study|Other|0|||
105367464|NCT03110354|363352287|FG003|Overall Study|Other|1|||
105837305|NCT00035555|365060417|FG001|Overall Study|Noncompliance|1|||
105837306|NCT00035555|365060418|FG002|Overall Study|Noncompliance|1|||
105837307|NCT00035555|365060416|FG000|Overall Study|Prohibited medication|1|||
105367465|NCT03110354|363352288|FG004|Overall Study|Other|1|||
105367466|NCT01198002|363352289|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
105367467|NCT01198002|363352290|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
105837308|NCT00035555|365060417|FG001|Overall Study|Prohibited medication|1|||
105837309|NCT00035555|365060418|FG002|Overall Study|Prohibited medication|0|||
105837310|NCT00035555|365060416|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
105837311|NCT00035555|365060417|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
105837312|NCT00035555|365060418|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
105837313|NCT00035555|365060416|FG000|Overall Study|Withdrawal by Subject|2|||
105837314|NCT00035555|365060417|FG001|Overall Study|Withdrawal by Subject|0|||
105837315|NCT00035555|365060418|FG002|Overall Study|Withdrawal by Subject|2|||
105837316|NCT00035555|365060416|FG000|Overall Study|Investigator deemed not a good candidate|0|||
105837317|NCT00035555|365060417|FG001|Overall Study|Investigator deemed not a good candidate|0|||
105837318|NCT00035555|365060418|FG002|Overall Study|Investigator deemed not a good candidate|1|||
105837319|NCT00035555|365060416|FG000|Overall Study|Received cyclosporin in error|0|||
105837320|NCT00035555|365060417|FG001|Overall Study|Received cyclosporin in error|0|||
105837321|NCT00035555|365060418|FG002|Overall Study|Received cyclosporin in error|1|||
105837322|NCT00309985|365060427|FG000|Overall Study|Disease progression|12|||
105837323|NCT00309985|365060428|FG001|Overall Study|Disease progression|0|||
105837324|NCT00309985|365060427|FG000|Overall Study|Adverse Event|30|||
105837325|NCT00309985|365060428|FG001|Overall Study|Adverse Event|0|||
105837326|NCT00309985|365060427|FG000|Overall Study|Death|2|||
105837327|NCT00309985|365060428|FG001|Overall Study|Death|0|||
105837328|NCT00309985|365060427|FG000|Overall Study|Withdrawal by Subject|5|||
105837329|NCT00309985|365060428|FG001|Overall Study|Withdrawal by Subject|1|||
105837330|NCT00309985|365060427|FG000|Overall Study|Physician Decision|3|||
105837331|NCT00309985|365060428|FG001|Overall Study|Physician Decision|0|||
105837332|NCT00309985|365060427|FG000|Overall Study|Never started treatment|7|||
105837333|NCT00309985|365060428|FG001|Overall Study|Never started treatment|0|||
105837334|NCT00309985|365060427|FG000|Overall Study|Complicating disease|1|||
105837335|NCT00309985|365060428|FG001|Overall Study|Complicating disease|0|||
105837336|NCT00309985|365060427|FG000|Overall Study|Non-compliance|1|||
105837337|NCT00309985|365060428|FG001|Overall Study|Non-compliance|0|||
105837338|NCT00309985|365060427|FG000|Overall Study|Chemotherapy discontinued only|1|||
105837339|NCT00309985|365060428|FG001|Overall Study|Chemotherapy discontinued only|0|||
105837340|NCT04205162|365060439|FG000|Overall Study|Lost to Follow-up|1|||
105837341|NCT04205162|365060440|FG001|Overall Study|Lost to Follow-up|0|||
105837342|NCT04205162|365060439|FG000|Overall Study|Withdrawal by Subject|2|||
105837343|NCT04205162|365060440|FG001|Overall Study|Withdrawal by Subject|0|||
105837344|NCT04205162|365060439|FG000|Overall Study|University closure due to COVID-19|1|||
105837345|NCT04205162|365060440|FG001|Overall Study|University closure due to COVID-19|0|||
105837346|NCT01011556|365060444|FG000|Overall Study|Adverse Event|1|||
105837347|NCT01011556|365060445|FG001|Overall Study|Adverse Event|3|||
105837348|NCT01011556|365060446|FG002|Overall Study|Adverse Event|2|||
105837349|NCT01011556|365060447|FG003|Overall Study|Adverse Event|1|||
105837350|NCT01011556|365060444|FG000|Overall Study|Lost to Follow-up|1|||
105837351|NCT01011556|365060445|FG001|Overall Study|Lost to Follow-up|0|||
105837352|NCT01011556|365060446|FG002|Overall Study|Lost to Follow-up|0|||
105837353|NCT01011556|365060447|FG003|Overall Study|Lost to Follow-up|0|||
105837354|NCT01011556|365060444|FG000|Overall Study|Physician Decision|1|||
105837355|NCT01011556|365060445|FG001|Overall Study|Physician Decision|0|||
105837356|NCT01011556|365060446|FG002|Overall Study|Physician Decision|0|||
105837357|NCT01011556|365060447|FG003|Overall Study|Physician Decision|1|||
105837358|NCT01011556|365060444|FG000|Overall Study|Protocol Violation|0|||
105837359|NCT01011556|365060445|FG001|Overall Study|Protocol Violation|1|||
105837360|NCT01011556|365060446|FG002|Overall Study|Protocol Violation|0|||
105837361|NCT01011556|365060447|FG003|Overall Study|Protocol Violation|0|||
105837362|NCT01011556|365060444|FG000|Overall Study|Withdrawal by Subject|1|||
105837363|NCT01011556|365060445|FG001|Overall Study|Withdrawal by Subject|2|||
105837364|NCT01011556|365060446|FG002|Overall Study|Withdrawal by Subject|4|||
105837365|NCT01011556|365060447|FG003|Overall Study|Withdrawal by Subject|4|||
105837366|NCT01011556|365060444|FG000|Overall Study|Sponsor decision|0|||
105837367|NCT01011556|365060445|FG001|Overall Study|Sponsor decision|1|||
105837368|NCT01011556|365060446|FG002|Overall Study|Sponsor decision|1|||
105837369|NCT01011556|365060447|FG003|Overall Study|Sponsor decision|2|||
105837370|NCT01011556|365060444|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
105837371|NCT01011556|365060445|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
105837372|NCT01011556|365060446|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
105837373|NCT01011556|365060447|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
105837374|NCT01098110|365060451|FG000|Overall Study|Withdrawal by Subject|14|||
105837375|NCT01098110|365060452|FG001|Overall Study|Withdrawal by Subject|24|||
105837376|NCT01098110|365060453|FG002|Overall Study|Withdrawal by Subject|19|||
105837377|NCT01098110|365060451|FG000|Overall Study|Adverse Event|30|||
105837378|NCT01098110|365060452|FG001|Overall Study|Adverse Event|32|||
105837379|NCT01098110|365060453|FG002|Overall Study|Adverse Event|43|||
105837380|NCT01098110|365060451|FG000|Overall Study|Lack of Efficacy|13|||
105837381|NCT01098110|365060452|FG001|Overall Study|Lack of Efficacy|9|||
105837382|NCT01098110|365060453|FG002|Overall Study|Lack of Efficacy|27|||
105837383|NCT01098110|365060451|FG000|Overall Study|Other|4|||
105837384|NCT01098110|365060452|FG001|Overall Study|Other|7|||
105837385|NCT01098110|365060453|FG002|Overall Study|Other|5|||
105837386|NCT01098110|365060451|FG000|Overall Study|Untreated|1|||
105837387|NCT01098110|365060452|FG001|Overall Study|Untreated|1|||
105837388|NCT01098110|365060453|FG002|Overall Study|Untreated|0|||
105837389|NCT02147587|365060454|FG000|Overall Study|Adverse Event|9|||
105837390|NCT02147587|365060455|FG001|Overall Study|Adverse Event|4|||
105837391|NCT02147587|365060454|FG000|Overall Study|Lack of Efficacy|2|||
105837392|NCT02147587|365060455|FG001|Overall Study|Lack of Efficacy|1|||
105837393|NCT01355302|365060456|FG000|Phase 1b|Death|4|||
105837394|NCT01355302|365060457|FG001|Phase 1b|Death|0|||
105837395|NCT01355302|365060458|FG002|Phase 1b|Death|0|||
105837396|NCT01355302|365060456|FG000|Phase 1b|Study terminated by sponsor|2|||
105837397|NCT01355302|365060457|FG001|Phase 1b|Study terminated by sponsor|0|||
105837398|NCT01355302|365060458|FG002|Phase 1b|Study terminated by sponsor|0|||
105837399|NCT00779402|365060459|FG000|Treatment Phase 1|Disease Progression|1|||
105837400|NCT00779402|365060460|FG001|Treatment Phase 1|Disease Progression|0|||
105837401|NCT00779402|365060459|FG000|Treatment Phase 1|Adverse Event|2|||
105837402|NCT00779402|365060460|FG001|Treatment Phase 1|Adverse Event|0|||
105837403|NCT00779402|365060459|FG000|Treatment Phase 1|Protocol Violation|1|||
105837404|NCT00779402|365060460|FG001|Treatment Phase 1|Protocol Violation|0|||
105837405|NCT00779402|365060459|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
105837406|NCT00779402|365060460|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
105837407|NCT00779402|365060459|FG000|Treatment Phase 1|Lost to Follow-up|0|||
105837408|NCT00779402|365060460|FG001|Treatment Phase 1|Lost to Follow-up|1|||
105837409|NCT00779402|365060459|FG000|Treatment Phase 1|Death|0|||
105837410|NCT00779402|365060460|FG001|Treatment Phase 1|Death|1|||
105310908|NCT00998309|363136233|FG000|Overall Study|Protocol Violation|4|||
105310909|NCT01338870|363136241|FG000|Overall Study|Lost to Follow-up|0|||
105310910|NCT01338870|363136242|FG001|Overall Study|Lost to Follow-up|0|||
105310911|NCT01338870|363136243|FG002|Overall Study|Lost to Follow-up|1|||
105310912|NCT01338870|363136244|FG003|Overall Study|Lost to Follow-up|0|||
105310913|NCT01338870|363136245|FG004|Overall Study|Lost to Follow-up|1|||
105310914|NCT01338870|363136246|FG005|Overall Study|Lost to Follow-up|0|||
105310915|NCT01338870|363136241|FG000|Overall Study|Withdrawal by Subject|2|||
105310916|NCT01338870|363136242|FG001|Overall Study|Withdrawal by Subject|3|||
105310917|NCT01338870|363136243|FG002|Overall Study|Withdrawal by Subject|4|||
105310918|NCT01338870|363136244|FG003|Overall Study|Withdrawal by Subject|0|||
105310919|NCT01338870|363136245|FG004|Overall Study|Withdrawal by Subject|0|||
105310920|NCT01338870|363136246|FG005|Overall Study|Withdrawal by Subject|2|||
105837411|NCT00779402|365060459|FG000|Treatment Phase 1|Intercurrent Illness|1|||
105837412|NCT00779402|365060460|FG001|Treatment Phase 1|Intercurrent Illness|1|||
105837413|NCT00779402|365060459|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
105837414|NCT00779402|365060460|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
105837415|NCT00779402|365060459|FG000|Treatment Phase 1|Other|4|||
105837416|NCT00779402|365060460|FG001|Treatment Phase 1|Other|2|||
105837417|NCT00779402|365060459|FG000|Treatment Phase 1|Closure of Study|3|||
105837418|NCT00779402|365060460|FG001|Treatment Phase 1|Closure of Study|2|||
105837419|NCT00779402|365060459|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
105837420|NCT00779402|365060460|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
105837421|NCT00779402|365060459|FG000|Surveillance Phase|Protocol Violation|0|||
105837422|NCT00779402|365060460|FG001|Surveillance Phase|Protocol Violation|1|||
105837423|NCT00779402|365060459|FG000|Surveillance Phase|Patient refused to continue|22|||
105837424|NCT00779402|365060460|FG001|Surveillance Phase|Patient refused to continue|14|||
105310921|NCT01338870|363136241|FG000|Overall Study|Other|3|||
105837425|NCT00779402|365060459|FG000|Surveillance Phase|Lost to Follow-up|2|||
105310922|NCT01338870|363136242|FG001|Overall Study|Other|3|||
105310923|NCT01338870|363136243|FG002|Overall Study|Other|3|||
105310924|NCT01338870|363136244|FG003|Overall Study|Other|2|||
105310925|NCT01338870|363136245|FG004|Overall Study|Other|0|||
105310926|NCT01338870|363136246|FG005|Overall Study|Other|2|||
105310927|NCT01338870|363136241|FG000|Overall Study|Protocol Violation|0|||
105837426|NCT00779402|365060460|FG001|Surveillance Phase|Lost to Follow-up|1|||
105837427|NCT00779402|365060459|FG000|Surveillance Phase|Death|0|||
105837428|NCT00779402|365060460|FG001|Surveillance Phase|Death|1|||
105310928|NCT01338870|363136242|FG001|Overall Study|Protocol Violation|2|||
105310929|NCT01338870|363136243|FG002|Overall Study|Protocol Violation|2|||
105310930|NCT01338870|363136244|FG003|Overall Study|Protocol Violation|2|||
105837429|NCT00779402|365060459|FG000|Surveillance Phase|Intercurrent Illness|2|||
105310931|NCT01338870|363136245|FG004|Overall Study|Protocol Violation|1|||
105310932|NCT01338870|363136246|FG005|Overall Study|Protocol Violation|1|||
105310933|NCT01338870|363136241|FG000|Overall Study|Adverse Event|4|||
105310934|NCT01338870|363136242|FG001|Overall Study|Adverse Event|4|||
105310935|NCT01338870|363136243|FG002|Overall Study|Adverse Event|1|||
105837430|NCT00779402|365060460|FG001|Surveillance Phase|Intercurrent Illness|0|||
105837431|NCT00779402|365060459|FG000|Surveillance Phase|Other|5|||
105310936|NCT01338870|363136244|FG003|Overall Study|Adverse Event|5|||
105837432|NCT00779402|365060460|FG001|Surveillance Phase|Other|5|||
105837433|NCT00779402|365060459|FG000|Surveillance Phase|Withdrawal by Subject|4|||
105837434|NCT00779402|365060460|FG001|Surveillance Phase|Withdrawal by Subject|1|||
105837435|NCT00779402|365060459|FG000|Surveillance Phase|Closure of study|5|||
105837436|NCT00779402|365060460|FG001|Surveillance Phase|Closure of study|6|||
105837437|NCT00779402|365060459|FG000|Surveillance Phase|Completed Protocol Visits|3|||
105837438|NCT00779402|365060460|FG001|Surveillance Phase|Completed Protocol Visits|2|||
105837439|NCT00779402|365060459|FG000|Long-term Follow-up|Patient refused to continue|2|||
105837440|NCT00779402|365060460|FG001|Long-term Follow-up|Patient refused to continue|0|||
105837441|NCT00779402|365060459|FG000|Long-term Follow-up|Other|5|||
105837442|NCT00779402|365060460|FG001|Long-term Follow-up|Other|0|||
105837443|NCT00779402|365060459|FG000|Long-term Follow-up|Closure of Study|8|||
105837444|NCT00779402|365060460|FG001|Long-term Follow-up|Closure of Study|4|||
105837445|NCT00779402|365060459|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
105837446|NCT00779402|365060460|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
105837447|NCT04994431|365060462|FG000|Overall Study|Adverse Event|1|||
105837448|NCT04994431|365060463|FG001|Overall Study|Adverse Event|0|||
105837449|NCT04364763|365060464|FG000|Overall Study|Death|1|||
105837450|NCT04364763|365060465|FG001|Overall Study|Death|2|||
105837451|NCT04364763|365060464|FG000|Overall Study|Lost to Follow-up|1|||
105837452|NCT04364763|365060465|FG001|Overall Study|Lost to Follow-up|0|||
105837453|NCT01386125|365060466|FG000|Overall Study|Lost to Follow-up|3|||
105837454|NCT01386125|365060467|FG001|Overall Study|Lost to Follow-up|9|||
105837455|NCT01386125|365060466|FG000|Overall Study|Physician Decision|0|||
105837456|NCT01386125|365060467|FG001|Overall Study|Physician Decision|1|||
105837457|NCT01386125|365060466|FG000|Overall Study|Protocol Violation|5|||
105837458|NCT01386125|365060467|FG001|Overall Study|Protocol Violation|7|||
105837459|NCT01386125|365060466|FG000|Overall Study|Disease Progress|1|||
105837460|NCT01386125|365060467|FG001|Overall Study|Disease Progress|2|||
105837461|NCT01386125|365060466|FG000|Overall Study|Withdrawal by Subject|13|||
105837462|NCT01386125|365060467|FG001|Overall Study|Withdrawal by Subject|12|||
105837463|NCT01386125|365060466|FG000|Overall Study|Adverse Event|2|||
105837464|NCT01386125|365060467|FG001|Overall Study|Adverse Event|5|||
105837465|NCT01386125|365060466|FG000|Overall Study|Lack of Efficacy|0|||
105837466|NCT01386125|365060467|FG001|Overall Study|Lack of Efficacy|1|||
105837467|NCT01386125|365060466|FG000|Overall Study|Participant Leaving Country|1|||
105837468|NCT01386125|365060467|FG001|Overall Study|Participant Leaving Country|0|||
105837469|NCT01849458|365060468|FG000|Overall Study|Lost to Follow-up|4|||
105837470|NCT00090753|365060470|FG000|First Treatment Period|Adverse Event|20|||
105837471|NCT00090753|365060471|FG001|First Treatment Period|Adverse Event|8|||
105837472|NCT00090753|365060470|FG000|First Treatment Period|Death|88|||
105837473|NCT00090753|365060471|FG001|First Treatment Period|Death|62|||
105837474|NCT00090753|365060470|FG000|First Treatment Period|Lack of Efficacy|2|||
105837475|NCT00090753|365060471|FG001|First Treatment Period|Lack of Efficacy|1|||
105837476|NCT00090753|365060470|FG000|First Treatment Period|Refused Treatment|32|||
105837477|NCT00090753|365060471|FG001|First Treatment Period|Refused Treatment|25|||
105837478|NCT00090753|365060470|FG000|First Treatment Period|Lost to Follow-up|4|||
105837479|NCT00090753|365060471|FG001|First Treatment Period|Lost to Follow-up|4|||
105837480|NCT00090753|365060470|FG000|First Treatment Period|Renal Transplant|70|||
105837481|NCT00090753|365060471|FG001|First Treatment Period|Renal Transplant|50|||
105837482|NCT00090753|365060470|FG000|First Treatment Period|Mircera Commercialization|1|||
105837483|NCT00090753|365060471|FG001|First Treatment Period|Mircera Commercialization|0|||
105837484|NCT00090753|365060470|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
105837485|NCT00090753|365060471|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
105837486|NCT00090753|365060470|FG000|Extended Treatment Period|Adverse Event|11|||
105837487|NCT00090753|365060471|FG001|Extended Treatment Period|Adverse Event|0|||
105837488|NCT00090753|365060470|FG000|Extended Treatment Period|Death|58|||
105837489|NCT00090753|365060471|FG001|Extended Treatment Period|Death|30|||
105837490|NCT00090753|365060470|FG000|Extended Treatment Period|Lack of Efficacy|1|||
105837491|NCT00090753|365060471|FG001|Extended Treatment Period|Lack of Efficacy|0|||
105837492|NCT00090753|365060470|FG000|Extended Treatment Period|Refused Treatment|18|||
105837493|NCT00090753|365060471|FG001|Extended Treatment Period|Refused Treatment|12|||
105837494|NCT00090753|365060470|FG000|Extended Treatment Period|Lost to Follow-up|3|||
105310937|NCT01338870|363136245|FG004|Overall Study|Adverse Event|4|||
105837495|NCT00090753|365060471|FG001|Extended Treatment Period|Lost to Follow-up|1|||
105310938|NCT01338870|363136246|FG005|Overall Study|Adverse Event|1|||
105837496|NCT00090753|365060470|FG000|Extended Treatment Period|Renal Transplant|15|||
105837497|NCT00090753|365060471|FG001|Extended Treatment Period|Renal Transplant|12|||
105837498|NCT00090753|365060470|FG000|Extended Treatment Period|Mircera Commercialization|188|||
105837499|NCT00090753|365060471|FG001|Extended Treatment Period|Mircera Commercialization|93|||
105837500|NCT00090753|365060470|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
105837501|NCT00090753|365060471|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
105837502|NCT02175368|365060474|FG000|Overall Study|Lost to Follow-up|1|||
105837503|NCT02839798|365062201|FG000|Overall Study|Withdrawal by Subject|2|||
105837504|NCT00676650|365062202|FG000|Overall Study|Death|45|||
105310939|NCT01955083|363136249|FG000|Overall Study|Lost to Follow-up|1|||
105837505|NCT00676650|365062203|FG001|Overall Study|Death|14|||
105837506|NCT00676650|365062202|FG000|Overall Study|Adverse Event|159|||
105837507|NCT00676650|365062203|FG001|Overall Study|Adverse Event|21|||
105310940|NCT01955083|363136250|FG001|Overall Study|Lost to Follow-up|1|||
105837508|NCT00676650|365062202|FG000|Overall Study|Global deterioration of health status|66|||
105837509|NCT00676650|365062203|FG001|Overall Study|Global deterioration of health status|31|||
105310941|NCT02871492|363136253|FG000|Overall Study|Lost to Follow-up|6|||
105310942|NCT02871492|363136254|FG001|Overall Study|Lost to Follow-up|3|||
105310943|NCT02871492|363136255|FG002|Overall Study|Lost to Follow-up|5|||
105310944|NCT02871492|363136253|FG000|Overall Study|Withdrawal by Subject|0|||
105837510|NCT00676650|365062202|FG000|Overall Study|Lost to Follow-up|0|||
105837511|NCT00676650|365062203|FG001|Overall Study|Lost to Follow-up|1|||
105837512|NCT00676650|365062202|FG000|Overall Study|Objective progression or relapse|189|||
105837513|NCT00676650|365062203|FG001|Overall Study|Objective progression or relapse|140|||
105837514|NCT00676650|365062202|FG000|Overall Study|Other|14|||
105837515|NCT00676650|365062203|FG001|Overall Study|Other|10|||
105837516|NCT00676650|365062202|FG000|Overall Study|Protocol Violation|3|||
105837517|NCT00676650|365062203|FG001|Overall Study|Protocol Violation|1|||
105837518|NCT00676650|365062202|FG000|Overall Study|Study terminated by sponsor|57|||
105837519|NCT00676650|365062203|FG001|Overall Study|Study terminated by sponsor|43|||
105837520|NCT00676650|365062202|FG000|Overall Study|Withdrawal by Subject|48|||
105837521|NCT00676650|365062203|FG001|Overall Study|Withdrawal by Subject|24|||
105837522|NCT00676650|365062202|FG000|Overall Study|Randomized but not treated|3|||
105837523|NCT00676650|365062203|FG001|Overall Study|Randomized but not treated|4|||
105837524|NCT00109837|365062204|FG000|Overall Study|Adverse Event|2|||
105837525|NCT00109837|365062204|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
105837526|NCT00109837|365062204|FG000|Overall Study|Death|1|||
105837527|NCT00109837|365062204|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
105837528|NCT00109837|365062204|FG000|Overall Study|Not treated|1|||
105837529|NCT00109837|365062204|FG000|Overall Study|Ineligible|1|||
105837530|NCT03431337|365062205|FG000|Overall Study|Lost to Follow-up|21|||
105837531|NCT03431337|365062206|FG001|Overall Study|Lost to Follow-up|19|||
105837532|NCT03431337|365062205|FG000|Overall Study|Withdrawal by Subject|8|||
105837533|NCT03431337|365062206|FG001|Overall Study|Withdrawal by Subject|3|||
105837534|NCT00329160|365062207|FG000|Overall Study|Adverse Event|27|||
105837535|NCT00329160|365062207|FG000|Overall Study|Withdrawal by Subject|13|||
105837536|NCT00329160|365062207|FG000|Overall Study|Protocol Violation|2|||
105837537|NCT00329160|365062207|FG000|Overall Study|Did not Receive Study Drug|1|||
105837538|NCT00329160|365062207|FG000|Overall Study|Incomplete IVUS|45|||
105837539|NCT04501094|365062208|FG000|Overall Study|Death (unrelated to research)|1|||
105837540|NCT04501094|365062209|FG001|Overall Study|Death (unrelated to research)|0|||
105837541|NCT00063258|365062210|FG000|Overall Study|Physician Decision|2|||
105837542|NCT00063258|365062211|FG001|Overall Study|Physician Decision|0|||
105837543|NCT00063258|365062210|FG000|Overall Study|Lack of Efficacy|2|||
105837544|NCT00063258|365062211|FG001|Overall Study|Lack of Efficacy|0|||
105837545|NCT02426541|365062214|FG000|Overall Study|Protocol Violation|1|||
105837546|NCT02426541|365062215|FG001|Overall Study|Protocol Violation|0|||
105837547|NCT00894933|365062216|FG000|Overall Study|Lost to Follow-up|2|||
105837548|NCT00894933|365062216|FG000|Overall Study|Cancelled Procedure|1|||
105837549|NCT00894933|365062216|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
105837550|NCT04241133|365062217|FG000|Overall Study|COVID19 Precautions|14|||
105837551|NCT04241133|365062218|FG001|Overall Study|COVID19 Precautions|34|||
105837552|NCT02994394|365062219|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
105837553|NCT02994394|365062220|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
105837554|NCT02994394|365062221|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
105837555|NCT02994394|365062222|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
105837556|NCT02994394|365062223|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
105837557|NCT02994394|365062224|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
105837558|NCT02994394|365062219|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
105837559|NCT02994394|365062220|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
105837560|NCT02994394|365062221|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
105837561|NCT02994394|365062222|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
105837562|NCT02994394|365062223|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
105310945|NCT02871492|363136254|FG001|Overall Study|Withdrawal by Subject|0|||
105310946|NCT02871492|363136255|FG002|Overall Study|Withdrawal by Subject|1|||
105310947|NCT02256436|363136256|FG000|Overall Study|Adverse Event|9|||
105837563|NCT02994394|365062224|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
105837564|NCT03619876|365062225|FG000|Overall Study|Withdrawal by Subject|1|||
105837565|NCT03619876|365062226|FG001|Overall Study|Withdrawal by Subject|2|||
105837566|NCT03619876|365062225|FG000|Overall Study|Withdrawal due to incidental finding|0|||
105310948|NCT02256436|363136257|FG001|Overall Study|Adverse Event|14|||
105837567|NCT03619876|365062226|FG001|Overall Study|Withdrawal due to incidental finding|2|||
105837568|NCT01546519|365062229|FG000|Overall Study|Adverse Event|0|||
105837569|NCT01546519|365062230|FG001|Overall Study|Adverse Event|0|||
105837570|NCT01546519|365062231|FG002|Overall Study|Adverse Event|1|||
105310949|NCT02256436|363136256|FG000|Overall Study|Death|216|||
105837571|NCT01546519|365062232|FG003|Overall Study|Adverse Event|1|||
105837572|NCT01546519|365062229|FG000|Overall Study|Death|0|||
105837573|NCT01546519|365062230|FG001|Overall Study|Death|1|||
105837574|NCT01546519|365062231|FG002|Overall Study|Death|3|||
105837575|NCT01546519|365062232|FG003|Overall Study|Death|1|||
105310950|NCT02256436|363136257|FG001|Overall Study|Death|208|||
105310951|NCT02256436|363136256|FG000|Overall Study|Lost to Follow-up|1|||
105837576|NCT01546519|365062229|FG000|Overall Study|related to disease progression|2|||
105837577|NCT01546519|365062230|FG001|Overall Study|related to disease progression|2|||
105837578|NCT01546519|365062231|FG002|Overall Study|related to disease progression|2|||
105837579|NCT01546519|365062232|FG003|Overall Study|related to disease progression|1|||
105837580|NCT01546519|365062229|FG000|Overall Study|Physician Decision|6|||
105837581|NCT01546519|365062230|FG001|Overall Study|Physician Decision|5|||
105837582|NCT01546519|365062231|FG002|Overall Study|Physician Decision|2|||
105837583|NCT01546519|365062232|FG003|Overall Study|Physician Decision|3|||
105837584|NCT01546519|365062229|FG000|Overall Study|Withdrawal by Subject|1|||
105837585|NCT01546519|365062230|FG001|Overall Study|Withdrawal by Subject|0|||
105837586|NCT01546519|365062231|FG002|Overall Study|Withdrawal by Subject|0|||
105837587|NCT01546519|365062232|FG003|Overall Study|Withdrawal by Subject|0|||
105837588|NCT02531594|365062233|FG000|Overall Study|Withdrawal by Subject|7|||
105837589|NCT02531594|365062234|FG001|Overall Study|Withdrawal by Subject|8|||
105837590|NCT00732160|365062238|FG000|Overall Study|Adverse Event|1|||
105837591|NCT00732160|365062239|FG001|Overall Study|Adverse Event|0|||
105837592|NCT00732160|365062240|FG002|Overall Study|Adverse Event|1|||
105837593|NCT00732160|365062241|FG003|Overall Study|Adverse Event|1|||
105837594|NCT00732160|365062238|FG000|Overall Study|scheduling|4|||
105837595|NCT00732160|365062239|FG001|Overall Study|scheduling|4|||
105837596|NCT00732160|365062240|FG002|Overall Study|scheduling|2|||
105837597|NCT00732160|365062241|FG003|Overall Study|scheduling|1|||
105837598|NCT04660032|365062246|FG000|Overall Study|Protocol Violation|1|||
105837599|NCT04660032|365062247|FG001|Overall Study|Protocol Violation|1|||
105837600|NCT01609582|365062256|FG000|Overall Study|Adverse Event|20|||
105837601|NCT01609582|365062257|FG001|Overall Study|Adverse Event|18|||
105837602|NCT01609582|365062256|FG000|Overall Study|Lost to Follow-up|10|||
105837603|NCT01609582|365062257|FG001|Overall Study|Lost to Follow-up|10|||
105837604|NCT01609582|365062256|FG000|Overall Study|Withdrawal by Subject|21|||
105837605|NCT01609582|365062257|FG001|Overall Study|Withdrawal by Subject|15|||
105837606|NCT01609582|365062256|FG000|Overall Study|Study Terminated by Sponsor|1543|||
105837607|NCT01609582|365062257|FG001|Overall Study|Study Terminated by Sponsor|1548|||
105837608|NCT01609582|365062256|FG000|Overall Study|Other|9|||
105837609|NCT01609582|365062257|FG001|Overall Study|Other|10|||
105837610|NCT01609582|365062256|FG000|Overall Study|Randomized, but not treated|0|||
105837611|NCT01609582|365062257|FG001|Overall Study|Randomized, but not treated|3|||
105837612|NCT01808248|365062258|FG000|Overall Study|Lack of Efficacy|3|||
105837613|NCT01808248|365062258|FG000|Overall Study|Withdrawal by Subject|1|||
105837614|NCT01808248|365062258|FG000|Overall Study|Lost to Follow-up|1|||
105837615|NCT04220775|365062259|FG000|Overall Study|Adverse Event|1|||
105837616|NCT04220775|365062260|FG001|Overall Study|Adverse Event|0|||
105837617|NCT04220775|365062259|FG000|Overall Study|Disease Progression|1|||
105837618|NCT04220775|365062260|FG001|Overall Study|Disease Progression|0|||
105837619|NCT00436917|365062261|FG000|Overall Study|Withdrawal by Subject|13|||
105837620|NCT00436917|365062261|FG000|Overall Study|Adverse Event|2|||
105837621|NCT00436917|365062261|FG000|Overall Study|Physician Decision|1|||
105837622|NCT00436917|365062261|FG000|Overall Study|Death|1|||
105837623|NCT00436917|365062261|FG000|Overall Study|Lost to Follow-up|1|||
105837624|NCT00436917|365062261|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
105837625|NCT00436917|365062261|FG000|Overall Study|Increased creatinine|1|||
105837626|NCT00436917|365062261|FG000|Overall Study|Personal conflicts of patient|1|||
105837627|NCT00808509|365062262|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
105837628|NCT00808509|365062263|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
105837629|NCT00808509|365062262|FG000|Randomized Phase|Reduced methotrexate dose|1|||
105837630|NCT00808509|365062263|FG001|Randomized Phase|Reduced methotrexate dose|2|||
105837631|NCT00808509|365062262|FG000|Randomized Phase|Patient refused rescue therapy|0|||
105837632|NCT00808509|365062263|FG001|Randomized Phase|Patient refused rescue therapy|3|||
105837633|NCT00559364|365062268|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
105837634|NCT00559364|365062269|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
105837635|NCT04126343|365062270|FG000|Overall Study|Adverse Event|0|||
105837636|NCT04126343|365062271|FG001|Overall Study|Adverse Event|0|||
105837637|NCT04126343|365062272|FG002|Overall Study|Adverse Event|0|||
105837638|NCT04126343|365062273|FG003|Overall Study|Adverse Event|0|||
105837639|NCT04126343|365062274|FG004|Overall Study|Adverse Event|0|||
105837640|NCT04126343|365062275|FG005|Overall Study|Adverse Event|1|||
105837641|NCT04126343|365062270|FG000|Overall Study|Withdrawal by Subject|0|||
105310952|NCT02256436|363136257|FG001|Overall Study|Lost to Follow-up|2|||
105837642|NCT04126343|365062271|FG001|Overall Study|Withdrawal by Subject|0|||
105837643|NCT04126343|365062272|FG002|Overall Study|Withdrawal by Subject|0|||
105310953|NCT02256436|363136256|FG000|Overall Study|Physician Decision|1|||
105837644|NCT04126343|365062273|FG003|Overall Study|Withdrawal by Subject|1|||
105837645|NCT04126343|365062274|FG004|Overall Study|Withdrawal by Subject|0|||
105837646|NCT04126343|365062275|FG005|Overall Study|Withdrawal by Subject|0|||
105837647|NCT04126343|365062270|FG000|Overall Study|Related to COVID-19 pandemic|3|||
105310954|NCT02256436|363136257|FG001|Overall Study|Physician Decision|0|||
105837648|NCT04126343|365062271|FG001|Overall Study|Related to COVID-19 pandemic|4|||
105837649|NCT04126343|365062272|FG002|Overall Study|Related to COVID-19 pandemic|3|||
105837650|NCT04126343|365062273|FG003|Overall Study|Related to COVID-19 pandemic|3|||
105837651|NCT04126343|365062274|FG004|Overall Study|Related to COVID-19 pandemic|3|||
105837652|NCT04126343|365062275|FG005|Overall Study|Related to COVID-19 pandemic|3|||
105837653|NCT00129116|365062278|FG000|Primary Phase|Lost to Follow-up|1|||
105837654|NCT00129116|365062279|FG001|Primary Phase|Lost to Follow-up|1|||
105837655|NCT00129116|365062280|FG002|Primary Phase|Lost to Follow-up|0|||
105837656|NCT00129116|365062281|FG003|Primary Phase|Lost to Follow-up|1|||
105837657|NCT00129116|365062282|FG004|Primary Phase|Lost to Follow-up|1|||
105837658|NCT00129116|365062278|FG000|Primary Phase|Protocol Violation|0|||
105837659|NCT00129116|365062279|FG001|Primary Phase|Protocol Violation|1|||
105837660|NCT00129116|365062280|FG002|Primary Phase|Protocol Violation|0|||
105837661|NCT00129116|365062281|FG003|Primary Phase|Protocol Violation|0|||
105837662|NCT00129116|365062282|FG004|Primary Phase|Protocol Violation|0|||
105837663|NCT00129116|365062278|FG000|Primary Phase|Adverse Event|1|||
105837664|NCT00129116|365062279|FG001|Primary Phase|Adverse Event|1|||
105837665|NCT00129116|365062280|FG002|Primary Phase|Adverse Event|0|||
105837666|NCT00129116|365062281|FG003|Primary Phase|Adverse Event|0|||
105837667|NCT00129116|365062282|FG004|Primary Phase|Adverse Event|0|||
105837668|NCT00129116|365062278|FG000|Primary Phase|Withdrawal by Subject|0|||
105837669|NCT00129116|365062279|FG001|Primary Phase|Withdrawal by Subject|1|||
105837670|NCT00129116|365062280|FG002|Primary Phase|Withdrawal by Subject|0|||
105837671|NCT00129116|365062281|FG003|Primary Phase|Withdrawal by Subject|0|||
105837672|NCT00129116|365062282|FG004|Primary Phase|Withdrawal by Subject|0|||
105837673|NCT00129116|365062278|FG000|Primary Phase|Other|0|||
105837674|NCT00129116|365062279|FG001|Primary Phase|Other|0|||
105837675|NCT00129116|365062280|FG002|Primary Phase|Other|1|||
105837676|NCT00129116|365062281|FG003|Primary Phase|Other|0|||
105837677|NCT00129116|365062282|FG004|Primary Phase|Other|0|||
105837678|NCT00129116|365062278|FG000|Booster Phase|Lost to Follow-up|2|||
105837679|NCT00129116|365062279|FG001|Booster Phase|Lost to Follow-up|0|||
105837680|NCT00129116|365062280|FG002|Booster Phase|Lost to Follow-up|0|||
105837681|NCT00129116|365062281|FG003|Booster Phase|Lost to Follow-up|0|||
105837682|NCT00129116|365062282|FG004|Booster Phase|Lost to Follow-up|1|||
105837683|NCT00388037|365062284|FG000|Overall Study|Protocol Violation|1|||
105837684|NCT02941523|365062287|FG000|Monotherapy|Withdrawal by Subject|0|||
105837685|NCT02941523|365062288|FG001|Monotherapy|Withdrawal by Subject|1|||
105837686|NCT02941523|365062287|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
105837687|NCT02941523|365062288|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
105837688|NCT02941523|365062287|FG000|Carboplatin Combination Therapy|Death|1|||
105837689|NCT02941523|365062288|FG001|Carboplatin Combination Therapy|Death|2|||
105837690|NCT02941523|365062287|FG000|Carboplatin Combination Therapy|Disease progression|2|||
105837691|NCT02941523|365062288|FG001|Carboplatin Combination Therapy|Disease progression|0|||
105837692|NCT02941523|365062287|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
105837693|NCT02941523|365062288|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
105837694|NCT04330157|365062289|FG000|Overall Study|Protocol Violation|4|||
105837695|NCT04330157|365062289|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
105837696|NCT00869440|365062290|FG000|Overall Study|Withdrawal by Subject|1|||
105837697|NCT00869440|365062291|FG001|Overall Study|Withdrawal by Subject|0|||
105837698|NCT00869440|365062292|FG002|Overall Study|Withdrawal by Subject|0|||
105837699|NCT00869440|365062293|FG003|Overall Study|Withdrawal by Subject|0|||
105837700|NCT00869440|365062290|FG000|Overall Study|Physician Decision|1|||
105837701|NCT00869440|365062291|FG001|Overall Study|Physician Decision|1|||
105837702|NCT00869440|365062292|FG002|Overall Study|Physician Decision|0|||
105837703|NCT00869440|365062293|FG003|Overall Study|Physician Decision|0|||
105837704|NCT00373425|365062295|FG000|Overall Study|Relapse of NSCLC|116|||
105310955|NCT02256436|363136256|FG000|Overall Study|Protocol Violation|0|||
105310956|NCT02256436|363136257|FG001|Overall Study|Protocol Violation|1|||
105837705|NCT00373425|365062296|FG001|Overall Study|Relapse of NSCLC|104|||
105837706|NCT00373425|365062297|FG002|Overall Study|Relapse of NSCLC|19|||
105837707|NCT00373425|365062298|FG003|Overall Study|Relapse of NSCLC|2|||
105837708|NCT00373425|365062299|FG004|Overall Study|Relapse of NSCLC|26|||
105837709|NCT00373425|365062295|FG000|Overall Study|Adverse Event|191|||
105310957|NCT02256436|363136256|FG000|Overall Study|Withdrawal by Subject|26|||
105310958|NCT02256436|363136257|FG001|Overall Study|Withdrawal by Subject|10|||
105837710|NCT00373425|365062296|FG001|Overall Study|Adverse Event|22|||
105837711|NCT00373425|365062297|FG002|Overall Study|Adverse Event|59|||
105837712|NCT00373425|365062298|FG003|Overall Study|Adverse Event|0|||
105837713|NCT00373425|365062299|FG004|Overall Study|Adverse Event|34|||
105837714|NCT00373425|365062295|FG000|Overall Study|Patient request|35|||
105837715|NCT00373425|365062296|FG001|Overall Study|Patient request|18|||
105837716|NCT00373425|365062297|FG002|Overall Study|Patient request|43|||
105837717|NCT00373425|365062298|FG003|Overall Study|Patient request|6|||
105837718|NCT00373425|365062299|FG004|Overall Study|Patient request|7|||
105837719|NCT00373425|365062295|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
105837720|NCT00373425|365062296|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
105837721|NCT00373425|365062297|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
105837722|NCT00373425|365062298|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
105837723|NCT00373425|365062299|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
105837724|NCT00373425|365062295|FG000|Overall Study|Death|7|||
105837725|NCT00373425|365062296|FG001|Overall Study|Death|0|||
105837726|NCT00373425|365062297|FG002|Overall Study|Death|3|||
105837727|NCT00373425|365062298|FG003|Overall Study|Death|1|||
105837728|NCT00373425|365062299|FG004|Overall Study|Death|0|||
105837729|NCT02808819|365062300|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
105837730|NCT02808819|365062301|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
105837731|NCT02808819|365062300|FG000|Overall Study|Withdrawal by Subject|10|||
105837732|NCT02808819|365062301|FG001|Overall Study|Withdrawal by Subject|13|||
105837733|NCT02808819|365062300|FG000|Overall Study|Site terminated by sponsor|2|||
105837734|NCT02808819|365062301|FG001|Overall Study|Site terminated by sponsor|0|||
105837735|NCT02808819|365062300|FG000|Overall Study|Pregnancy|1|||
105837736|NCT02808819|365062301|FG001|Overall Study|Pregnancy|0|||
105837737|NCT02808819|365062300|FG000|Overall Study|Lost to Follow-up|1|||
105837738|NCT02808819|365062301|FG001|Overall Study|Lost to Follow-up|6|||
105837739|NCT02808819|365062300|FG000|Overall Study|Protocol Violation|0|||
105837740|NCT02808819|365062301|FG001|Overall Study|Protocol Violation|1|||
105837741|NCT02808819|365062300|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
105837742|NCT02808819|365062301|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
105837743|NCT02808819|365062300|FG000|Overall Study|Death|1|||
105837744|NCT02808819|365062301|FG001|Overall Study|Death|0|||
105837745|NCT02808819|365062300|FG000|Overall Study|Adverse Event|3|||
105837746|NCT02808819|365062301|FG001|Overall Study|Adverse Event|4|||
105837747|NCT01083680|365062302|FG000|Overall Study|Lost to Follow-up|2758|||
105837748|NCT01083680|365062302|FG000|Overall Study|Withdrawal by Subject|1086|||
105837749|NCT03546647|365062303|FG000|Overall Study|Adverse Event|1|||
105837750|NCT03546647|365062304|FG001|Overall Study|Adverse Event|0|||
105837751|NCT01183884|365062305|FG000|Overall Study|Progressive Disease|26|||
105837752|NCT01183884|365062305|FG000|Overall Study|Adverse Event|3|||
105837753|NCT01183884|365062305|FG000|Overall Study|Withdrawal by Subject|1|||
105837754|NCT01183884|365062305|FG000|Overall Study|Other Complicating Disease|3|||
105837755|NCT01183884|365062305|FG000|Overall Study|Not Treated|1|||
105837756|NCT01183884|365062305|FG000|Overall Study|Other|4|||
105837757|NCT02260258|365062306|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
105837758|NCT02260258|365062307|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
105837759|NCT03689894|365062312|FG000|Overall Study|Adverse Event|1|||
105837760|NCT01644149|365062321|FG000|Overall Study|Withdrawal by Subject|1|||
105837761|NCT01644149|365062322|FG001|Overall Study|Withdrawal by Subject|0|||
105837762|NCT01644149|365062321|FG000|Overall Study|Lost to Follow-up|3|||
105837763|NCT01644149|365062322|FG001|Overall Study|Lost to Follow-up|1|||
105837764|NCT04718129|365062323|FG000|Overall Study|Lost to Follow-up|6|||
105837765|NCT04718129|365062324|FG001|Overall Study|Lost to Follow-up|7|||
105837766|NCT04405739|365062327|FG000|Overall Study|Adverse Event|0|||
105837767|NCT04405739|365062328|FG001|Overall Study|Adverse Event|1|||
105837768|NCT04405739|365062329|FG002|Overall Study|Adverse Event|0|||
105837769|NCT04405739|365062330|FG003|Overall Study|Adverse Event|0|||
105837770|NCT04405739|365062327|FG000|Overall Study|Lost to Follow-up|0|||
105837771|NCT04405739|365062328|FG001|Overall Study|Lost to Follow-up|2|||
105837772|NCT04405739|365062329|FG002|Overall Study|Lost to Follow-up|1|||
105837773|NCT04405739|365062330|FG003|Overall Study|Lost to Follow-up|3|||
105837774|NCT04405739|365062327|FG000|Overall Study|Withdrawal by Subject|0|||
105837775|NCT04405739|365062328|FG001|Overall Study|Withdrawal by Subject|2|||
105837776|NCT04405739|365062329|FG002|Overall Study|Withdrawal by Subject|1|||
105837777|NCT04405739|365062330|FG003|Overall Study|Withdrawal by Subject|1|||
105837778|NCT04405739|365062327|FG000|Overall Study|Death|0|||
105837779|NCT04405739|365062328|FG001|Overall Study|Death|0|||
105837780|NCT04405739|365062329|FG002|Overall Study|Death|1|||
105837781|NCT04405739|365062330|FG003|Overall Study|Death|0|||
105837782|NCT04405739|365062327|FG000|Overall Study|Transferred to rehab|0|||
105837783|NCT04405739|365062328|FG001|Overall Study|Transferred to rehab|0|||
105837784|NCT04405739|365062329|FG002|Overall Study|Transferred to rehab|0|||
105837785|NCT04405739|365062330|FG003|Overall Study|Transferred to rehab|1|||
105837786|NCT04405739|365062327|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
105837787|NCT04405739|365062328|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
105837788|NCT04405739|365062329|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
105837789|NCT04405739|365062330|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
105837790|NCT01436643|365062331|FG000|2-week Pre-treatment|Abnormal test result|0|||
105837791|NCT01436643|365062332|FG001|2-week Pre-treatment|Abnormal test result|0|||
105837792|NCT01436643|365062333|FG002|2-week Pre-treatment|Abnormal test result|0|||
105837793|NCT01436643|365062334|FG003|2-week Pre-treatment|Abnormal test result|1|||
105837794|NCT01436643|365062331|FG000|2-week Pre-treatment|Adverse Event|0|||
105837795|NCT01436643|365062332|FG001|2-week Pre-treatment|Adverse Event|0|||
105837796|NCT01436643|365062333|FG002|2-week Pre-treatment|Adverse Event|0|||
105837797|NCT01436643|365062334|FG003|2-week Pre-treatment|Adverse Event|5|||
105837798|NCT01436643|365062331|FG000|2-week Pre-treatment|Protocol Violation|0|||
105367468|NCT01198002|363352291|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
105837799|NCT01436643|365062332|FG001|2-week Pre-treatment|Protocol Violation|0|||
105837800|NCT01436643|365062333|FG002|2-week Pre-treatment|Protocol Violation|0|||
105367469|NCT01198002|363352289|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
105367470|NCT01198002|363352290|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
105367471|NCT01198002|363352291|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
105367472|NCT01198002|363352289|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
105367473|NCT01198002|363352290|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
105367474|NCT01198002|363352291|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
105367475|NCT01198002|363352289|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
105367476|NCT01198002|363352290|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
105837801|NCT01436643|365062334|FG003|2-week Pre-treatment|Protocol Violation|4|||
105837802|NCT01436643|365062331|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
105837803|NCT01436643|365062332|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
105837804|NCT01436643|365062333|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
105837805|NCT01436643|365062334|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
105837806|NCT01436643|365062331|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
105837807|NCT01436643|365062332|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
105837808|NCT01436643|365062333|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
105837809|NCT01436643|365062334|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
105837810|NCT01436643|365062331|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
105837811|NCT01436643|365062332|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
105837812|NCT01436643|365062333|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
105837813|NCT01436643|365062334|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
105837814|NCT03718117|365062335|FG000|Overall Study|Death|12|||
105837815|NCT03718117|365062336|FG001|Overall Study|Death|11|||
105837816|NCT03718117|365062337|FG002|Overall Study|Death|0|||
105837817|NCT03718117|365062335|FG000|Overall Study|Other|0|||
105837818|NCT03718117|365062336|FG001|Overall Study|Other|1|||
105837819|NCT03718117|365062337|FG002|Overall Study|Other|0|||
105837820|NCT03718117|365062335|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
105837821|NCT03718117|365062336|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
105837822|NCT03718117|365062337|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
105837823|NCT03718117|365062335|FG000|Overall Study|Participant not met eligibility criteria|0|||
105837824|NCT03718117|365062336|FG001|Overall Study|Participant not met eligibility criteria|0|||
105837825|NCT03718117|365062337|FG002|Overall Study|Participant not met eligibility criteria|2|||
105837826|NCT03069417|365062338|FG000|Overall Study|Lost to Follow-up|2|||
105837827|NCT03069417|365062339|FG001|Overall Study|Lost to Follow-up|0|||
105837828|NCT03069417|365062338|FG000|Overall Study|Reason Unknown|4|||
105837829|NCT03069417|365062339|FG001|Overall Study|Reason Unknown|7|||
105837830|NCT00206102|365062342|FG000|Overall Study|Adverse Event|119|||
105837831|NCT00206102|365062343|FG001|Overall Study|Adverse Event|82|||
105837832|NCT00206102|365062342|FG000|Overall Study|Protocol Violation|0|||
105837833|NCT00206102|365062343|FG001|Overall Study|Protocol Violation|2|||
105837834|NCT00206102|365062342|FG000|Overall Study|Lack of therapeutic response|16|||
105837835|NCT00206102|365062343|FG001|Overall Study|Lack of therapeutic response|11|||
105837836|NCT00206102|365062342|FG000|Overall Study|Lost to Follow-up|95|||
105837837|NCT00206102|365062343|FG001|Overall Study|Lost to Follow-up|66|||
105837838|NCT00206102|365062342|FG000|Overall Study|Withdrawal by Subject|118|||
105837839|NCT00206102|365062343|FG001|Overall Study|Withdrawal by Subject|101|||
105837840|NCT00206102|365062342|FG000|Overall Study|Study-specific discontinuation criteria|18|||
105837841|NCT00206102|365062343|FG001|Overall Study|Study-specific discontinuation criteria|17|||
105837842|NCT00206102|365062342|FG000|Overall Study|None of those categories|42|||
105837843|NCT00206102|365062343|FG001|Overall Study|None of those categories|36|||
105837844|NCT04230876|365062347|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
105837845|NCT04230876|365062348|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
105837846|NCT00810602|365062349|FG000|Overall Study|Withdrawal by Subject|8|||
105837847|NCT00810602|365062350|FG001|Overall Study|Withdrawal by Subject|3|||
105837848|NCT04149535|365062353|FG000|Overall Study|Death|11|||
105837849|NCT04149535|365062354|FG001|Overall Study|Death|7|||
105837850|NCT04149535|365062353|FG000|Overall Study|Physician Decision|10|||
105837851|NCT04149535|365062354|FG001|Overall Study|Physician Decision|4|||
105837852|NCT04149535|365062353|FG000|Overall Study|Withdrawal by Subject|6|||
105367477|NCT01198002|363352291|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
105489877|NCT03963401|363805677|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
105837853|NCT04149535|365062354|FG001|Overall Study|Withdrawal by Subject|7|||
105837854|NCT04149535|365062353|FG000|Overall Study|Not described|2|||
105837855|NCT04149535|365062354|FG001|Overall Study|Not described|0|||
105837856|NCT02875028|365062355|FG000|Washout Period|Withdrawal by Subject|0|||
105837857|NCT02875028|365062356|FG001|Washout Period|Withdrawal by Subject|1|||
105837858|NCT03036839|365064405|FG000|Overall Study|Adverse Event|0|||
105837859|NCT03036839|365064406|FG001|Overall Study|Adverse Event|0|||
105837860|NCT03036839|365064407|FG002|Overall Study|Adverse Event|1|||
105837861|NCT03036839|365064405|FG000|Overall Study|Death|3|||
105837862|NCT03036839|365064406|FG001|Overall Study|Death|0|||
105310959|NCT02256436|363136256|FG000|Overall Study|Transferred to Extension Study|11|||
105310960|NCT02256436|363136257|FG001|Overall Study|Transferred to Extension Study|23|||
105310961|NCT02256436|363136256|FG000|Overall Study|Did Not Continue on Extension Study|8|||
105310962|NCT02256436|363136257|FG001|Overall Study|Did Not Continue on Extension Study|12|||
105310963|NCT03583086|363136258|FG000|Overall Study|Death|2|||
105310964|NCT03583086|363136259|FG001|Overall Study|Death|6|||
105310965|NCT03583086|363136260|FG002|Overall Study|Death|12|||
105310966|NCT03583086|363136261|FG003|Overall Study|Death|10|||
105310967|NCT03583086|363136262|FG004|Overall Study|Death|14|||
105310968|NCT03583086|363136263|FG005|Overall Study|Death|14|||
105310969|NCT03583086|363136264|FG006|Overall Study|Death|4|||
105310970|NCT03583086|363136258|FG000|Overall Study|Withdrawal by Subject|0|||
105310971|NCT03583086|363136259|FG001|Overall Study|Withdrawal by Subject|0|||
105310972|NCT03583086|363136260|FG002|Overall Study|Withdrawal by Subject|1|||
105310973|NCT03583086|363136261|FG003|Overall Study|Withdrawal by Subject|0|||
105310974|NCT03583086|363136262|FG004|Overall Study|Withdrawal by Subject|0|||
105310975|NCT03583086|363136263|FG005|Overall Study|Withdrawal by Subject|0|||
105310976|NCT03583086|363136264|FG006|Overall Study|Withdrawal by Subject|1|||
105310977|NCT03583086|363136258|FG000|Overall Study|Refused follow-up|0|||
105310978|NCT03583086|363136259|FG001|Overall Study|Refused follow-up|0|||
105310979|NCT03583086|363136260|FG002|Overall Study|Refused follow-up|1|||
105310980|NCT03583086|363136261|FG003|Overall Study|Refused follow-up|0|||
105310981|NCT03583086|363136262|FG004|Overall Study|Refused follow-up|1|||
105310982|NCT03583086|363136263|FG005|Overall Study|Refused follow-up|0|||
105310983|NCT03583086|363136264|FG006|Overall Study|Refused follow-up|0|||
105310984|NCT03583086|363136258|FG000|Overall Study|Declining Performance Status|0|||
105310985|NCT03583086|363136259|FG001|Overall Study|Declining Performance Status|0|||
105310986|NCT03583086|363136260|FG002|Overall Study|Declining Performance Status|1|||
105310987|NCT03583086|363136261|FG003|Overall Study|Declining Performance Status|0|||
105310988|NCT03583086|363136262|FG004|Overall Study|Declining Performance Status|0|||
105310989|NCT03583086|363136263|FG005|Overall Study|Declining Performance Status|0|||
105310990|NCT03583086|363136264|FG006|Overall Study|Declining Performance Status|0|||
105310991|NCT03583086|363136258|FG000|Overall Study|Still on study|0|||
105310992|NCT03583086|363136259|FG001|Overall Study|Still on study|0|||
105310993|NCT03583086|363136260|FG002|Overall Study|Still on study|0|||
105310994|NCT03583086|363136261|FG003|Overall Study|Still on study|1|||
105310995|NCT03583086|363136262|FG004|Overall Study|Still on study|0|||
105310996|NCT03583086|363136263|FG005|Overall Study|Still on study|0|||
105310997|NCT03583086|363136264|FG006|Overall Study|Still on study|1|||
105310998|NCT03583086|363136258|FG000|Overall Study|Disease progression|0|||
105310999|NCT03583086|363136259|FG001|Overall Study|Disease progression|0|||
105311000|NCT03583086|363136260|FG002|Overall Study|Disease progression|0|||
105311001|NCT03583086|363136261|FG003|Overall Study|Disease progression|0|||
105311002|NCT03583086|363136262|FG004|Overall Study|Disease progression|0|||
105311003|NCT03583086|363136263|FG005|Overall Study|Disease progression|0|||
105311004|NCT03583086|363136264|FG006|Overall Study|Disease progression|1|||
105311005|NCT03583086|363136258|FG000|Overall Study|Undergoing radiation therapy|0|||
105311006|NCT03583086|363136259|FG001|Overall Study|Undergoing radiation therapy|0|||
105311007|NCT03583086|363136260|FG002|Overall Study|Undergoing radiation therapy|0|||
105311008|NCT03583086|363136261|FG003|Overall Study|Undergoing radiation therapy|0|||
105311009|NCT03583086|363136262|FG004|Overall Study|Undergoing radiation therapy|0|||
105311010|NCT03583086|363136263|FG005|Overall Study|Undergoing radiation therapy|0|||
105311011|NCT03583086|363136264|FG006|Overall Study|Undergoing radiation therapy|1|||
105311012|NCT03583086|363136258|FG000|Overall Study|Lost to Follow-up|0|||
105367478|NCT01198002|363352289|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
105367479|NCT01198002|363352290|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
105367480|NCT01198002|363352291|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
105367481|NCT01198002|363352289|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
105367482|NCT01198002|363352290|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
105367483|NCT01198002|363352291|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
105367484|NCT01198002|363352289|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
105367485|NCT01198002|363352290|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
105367486|NCT01198002|363352291|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
105367487|NCT01198002|363352289|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
105311013|NCT03583086|363136259|FG001|Overall Study|Lost to Follow-up|0|||
105311014|NCT03583086|363136260|FG002|Overall Study|Lost to Follow-up|0|||
105311015|NCT03583086|363136261|FG003|Overall Study|Lost to Follow-up|0|||
105311016|NCT03583086|363136262|FG004|Overall Study|Lost to Follow-up|0|||
105367488|NCT01198002|363352290|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
105311017|NCT03583086|363136263|FG005|Overall Study|Lost to Follow-up|1|||
105311018|NCT03583086|363136264|FG006|Overall Study|Lost to Follow-up|0|||
105311019|NCT03583086|363136258|FG000|Overall Study|Adverse Event|0|||
105311020|NCT03583086|363136259|FG001|Overall Study|Adverse Event|0|||
105311021|NCT03583086|363136260|FG002|Overall Study|Adverse Event|0|||
105311022|NCT03583086|363136261|FG003|Overall Study|Adverse Event|0|||
105311023|NCT03583086|363136262|FG004|Overall Study|Adverse Event|0|||
105837863|NCT03036839|365064407|FG002|Overall Study|Death|3|||
105837864|NCT03036839|365064405|FG000|Overall Study|Withdrew Consent|0|||
105837865|NCT03036839|365064406|FG001|Overall Study|Withdrew Consent|0|||
105837866|NCT03036839|365064407|FG002|Overall Study|Withdrew Consent|1|||
105837867|NCT03042468|365064409|FG000|Overall Study|Death|0|||
105837868|NCT03042468|365064410|FG001|Overall Study|Death|1|||
105837869|NCT03042468|365064411|FG002|Overall Study|Death|1|||
105837870|NCT03042468|365064412|FG003|Overall Study|Death|0|||
105837871|NCT03042468|365064413|FG004|Overall Study|Death|0|||
105837872|NCT03042468|365064414|FG005|Overall Study|Death|0|||
105837873|NCT03042468|365064409|FG000|Overall Study|Withdrawal by Subject|0|||
105837874|NCT03042468|365064410|FG001|Overall Study|Withdrawal by Subject|0|||
105837875|NCT03042468|365064411|FG002|Overall Study|Withdrawal by Subject|0|||
105837876|NCT03042468|365064412|FG003|Overall Study|Withdrawal by Subject|0|||
105837877|NCT03042468|365064413|FG004|Overall Study|Withdrawal by Subject|0|||
105837878|NCT03042468|365064414|FG005|Overall Study|Withdrawal by Subject|1|||
105837879|NCT03042468|365064409|FG000|Overall Study|Lost to Follow-up|0|||
105837880|NCT03042468|365064410|FG001|Overall Study|Lost to Follow-up|0|||
105837881|NCT03042468|365064411|FG002|Overall Study|Lost to Follow-up|0|||
105837882|NCT03042468|365064412|FG003|Overall Study|Lost to Follow-up|0|||
105837883|NCT03042468|365064413|FG004|Overall Study|Lost to Follow-up|1|||
105837884|NCT03042468|365064414|FG005|Overall Study|Lost to Follow-up|1|||
105837885|NCT01064531|365064416|FG000|Overall Study|Lost to Follow-up|0|||
105837886|NCT01064531|365064417|FG001|Overall Study|Lost to Follow-up|2|||
105837887|NCT01064531|365064416|FG000|Overall Study|Physician Decision|0|||
105837888|NCT01064531|365064417|FG001|Overall Study|Physician Decision|1|||
105837889|NCT01064531|365064416|FG000|Overall Study|Withdrawal by Subject|2|||
105837890|NCT01064531|365064417|FG001|Overall Study|Withdrawal by Subject|2|||
105837891|NCT01064531|365064416|FG000|Overall Study|Revision due to femoral stem loosening|1|||
105837892|NCT01064531|365064417|FG001|Overall Study|Revision due to femoral stem loosening|0|||
105837893|NCT01064531|365064416|FG000|Overall Study|Revision due to dislocation|0|||
105837894|NCT01064531|365064417|FG001|Overall Study|Revision due to dislocation|1|||
105837895|NCT01064531|365064416|FG000|Overall Study|Death|0|||
105837896|NCT01064531|365064417|FG001|Overall Study|Death|1|||
105837897|NCT00298740|365064418|FG000|Overall Study|Lack of Efficacy|6|||
105837898|NCT00298740|365064418|FG000|Overall Study|Withdrawal by Subject|3|||
105837899|NCT03449199|365064422|FG000|Overall Study|Lost to Follow-up|1|||
105837900|NCT03449199|365064423|FG001|Overall Study|Lost to Follow-up|1|||
105837901|NCT03449199|365064424|FG002|Overall Study|Lost to Follow-up|0|||
105837902|NCT03449199|365064422|FG000|Overall Study|Protocol Deviation|0|||
105837903|NCT03449199|365064423|FG001|Overall Study|Protocol Deviation|0|||
105837904|NCT03449199|365064424|FG002|Overall Study|Protocol Deviation|1|||
105837905|NCT03449199|365064422|FG000|Overall Study|Withdrawal by Subject|0|||
105837906|NCT03449199|365064423|FG001|Overall Study|Withdrawal by Subject|0|||
105837907|NCT03449199|365064424|FG002|Overall Study|Withdrawal by Subject|1|||
105837908|NCT01091103|365064425|FG000|Overall Study|Adverse Event|1|||
105837909|NCT01091103|365064425|FG000|Overall Study|Progressive Disease|3|||
105837910|NCT00684567|365064427|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
105837911|NCT00684567|365064427|FG000|Monotherapy Period|Adverse Event|2|||
105311024|NCT03583086|363136263|FG005|Overall Study|Adverse Event|1|||
105311025|NCT03583086|363136264|FG006|Overall Study|Adverse Event|0|||
105311026|NCT03503864|363136268|FG000|Overall Study|Protocol Violation|6|||
105311027|NCT03503864|363136268|FG000|Overall Study|Withdrawal by Subject|7|||
105311028|NCT04083781|363136269|FG000|Main Part|Physician Decision|0|||
105311029|NCT04083781|363136270|FG001|Main Part|Physician Decision|1|||
105311030|NCT04083781|363136271|FG002|Main Part|Physician Decision|2|||
105311031|NCT04083781|363136272|FG003|Main Part|Physician Decision|0|||
105311032|NCT04083781|363136269|FG000|Main Part|Death|1|||
105837912|NCT00684567|365064427|FG000|Monotherapy Period|Death|1|||
105837913|NCT00684567|365064427|FG000|Monotherapy Period|Progression of primary disease|11|||
105837914|NCT03136406|365064430|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
105837915|NCT00988208|365064436|FG000|Overall Study|Adverse Event|71|||
105837916|NCT00988208|365064437|FG001|Overall Study|Adverse Event|122|||
105311033|NCT04083781|363136270|FG001|Main Part|Death|3|||
105311034|NCT04083781|363136271|FG002|Main Part|Death|1|||
105837917|NCT00988208|365064436|FG000|Overall Study|Disease Progression|103|||
105837918|NCT00988208|365064437|FG001|Overall Study|Disease Progression|89|||
105837919|NCT00988208|365064436|FG000|Overall Study|Withdrawal by Subject|50|||
105837920|NCT00988208|365064437|FG001|Overall Study|Withdrawal by Subject|57|||
105837921|NCT00988208|365064436|FG000|Overall Study|Death|9|||
105837922|NCT00988208|365064437|FG001|Overall Study|Death|15|||
105837923|NCT00988208|365064436|FG000|Overall Study|Lost to Follow-up|2|||
105837924|NCT00988208|365064437|FG001|Overall Study|Lost to Follow-up|3|||
105837925|NCT00988208|365064436|FG000|Overall Study|Protocol Violation|9|||
105837926|NCT00988208|365064437|FG001|Overall Study|Protocol Violation|2|||
105837927|NCT00988208|365064436|FG000|Overall Study|Sponsor Decision|102|||
105837928|NCT00988208|365064437|FG001|Overall Study|Sponsor Decision|78|||
105837929|NCT00988208|365064436|FG000|Overall Study|Clinical Progression|17|||
105837930|NCT00988208|365064437|FG001|Overall Study|Clinical Progression|16|||
105837931|NCT00988208|365064436|FG000|Overall Study|Biochemical Progression|21|||
105837932|NCT00988208|365064437|FG001|Overall Study|Biochemical Progression|7|||
105837933|NCT00988208|365064436|FG000|Overall Study|Clinical Deterioration|7|||
105837934|NCT00988208|365064437|FG001|Overall Study|Clinical Deterioration|14|||
105837935|NCT00988208|365064436|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
105837936|NCT00988208|365064437|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
105837937|NCT00988208|365064436|FG000|Overall Study|Other|8|||
105837938|NCT00988208|365064437|FG001|Overall Study|Other|3|||
105311035|NCT04083781|363136272|FG003|Main Part|Death|0|||
105311036|NCT04083781|363136269|FG000|Main Part|Withdrawal by Subject|5|||
105311037|NCT04083781|363136270|FG001|Main Part|Withdrawal by Subject|2|||
105311038|NCT04083781|363136271|FG002|Main Part|Withdrawal by Subject|3|||
105311039|NCT04083781|363136272|FG003|Main Part|Withdrawal by Subject|7|||
105311040|NCT04083781|363136269|FG000|Extension Part|Physician Decision|0|||
105311041|NCT04083781|363136270|FG001|Extension Part|Physician Decision|0|||
105311042|NCT04083781|363136271|FG002|Extension Part|Physician Decision|0|||
105311043|NCT04083781|363136272|FG003|Extension Part|Physician Decision|1|||
105311044|NCT04083781|363136269|FG000|Extension Part|Death|0|||
105311045|NCT04083781|363136270|FG001|Extension Part|Death|1|||
105576491|NCT04157686|364108544|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
105576492|NCT01167179|364110170|FG000|Overall Study|disease recurrence|4|||
105576493|NCT01167179|364110171|FG001|Overall Study|disease recurrence|4|||
105311046|NCT04083781|363136271|FG002|Extension Part|Death|0|||
105311047|NCT04083781|363136272|FG003|Extension Part|Death|1|||
105311048|NCT04083781|363136269|FG000|Extension Part|Withdrawal by Subject|0|||
105311049|NCT04083781|363136270|FG001|Extension Part|Withdrawal by Subject|1|||
105311050|NCT04083781|363136271|FG002|Extension Part|Withdrawal by Subject|0|||
105311051|NCT04083781|363136272|FG003|Extension Part|Withdrawal by Subject|0|||
105311052|NCT04083781|363136269|FG000|Extension Part|Ongoing|13|||
105311053|NCT04083781|363136270|FG001|Extension Part|Ongoing|25|||
105311054|NCT04083781|363136271|FG002|Extension Part|Ongoing|15|||
105311055|NCT04083781|363136272|FG003|Extension Part|Ongoing|51|||
105311056|NCT02639052|363136274|FG000|Overall Study|Lost to Follow-up|1|||
105311057|NCT00128830|363136275|FG000|Overall Study|Adverse Event|10|||
105311058|NCT00128830|363136275|FG000|Overall Study|Withdrawal by Subject|14|||
105311059|NCT00128830|363136275|FG000|Overall Study|Lost to Follow-up|4|||
105311060|NCT00128830|363136275|FG000|Overall Study|Reached a virologic endpoint|29|||
105311061|NCT00128830|363136275|FG000|Overall Study|Non-compliant|4|||
105311062|NCT00128830|363136275|FG000|Overall Study|Discontinued or ineligible for study|2|||
105311063|NCT00128830|363136275|FG000|Overall Study|Other|9|||
105311064|NCT02927366|363136278|FG000|Overall Study|Adverse Event|1|||
105311065|NCT02927366|363136279|FG001|Overall Study|Adverse Event|0|||
105311066|NCT02927366|363136278|FG000|Overall Study|Patient schedule|1|||
105311067|NCT02927366|363136279|FG001|Overall Study|Patient schedule|0|||
105311068|NCT00478426|363136280|FG000|Overall Study|Withdrawal by Subject|1|||
105311069|NCT00530218|363136283|FG000|Overall Study|CMV Not Detected|13|||
105311070|NCT00530218|363136283|FG000|Overall Study|Death|12|||
105311071|NCT03136965|363136284|FG000|Overall Study|Lost to Follow-up|0|||
105311072|NCT03136965|363136285|FG001|Overall Study|Lost to Follow-up|1|||
105311073|NCT03136965|363136286|FG002|Overall Study|Lost to Follow-up|0|||
105311074|NCT03489109|363136288|FG000|Overall Study|Lost to Follow-up|1|||
105311075|NCT03489109|363136289|FG001|Overall Study|Lost to Follow-up|2|||
105311076|NCT03485365|363136290|FG000|Overall Study|Protocol Violation|0|||
105311077|NCT03485365|363136291|FG001|Overall Study|Protocol Violation|0|||
105311078|NCT03485365|363136292|FG002|Overall Study|Protocol Violation|0|||
105311079|NCT03485365|363136293|FG003|Overall Study|Protocol Violation|1|||
105311080|NCT03485365|363136294|FG004|Overall Study|Protocol Violation|0|||
105576494|NCT01167179|364110170|FG000|Overall Study|Death|4|||
105576495|NCT01167179|364110171|FG001|Overall Study|Death|10|||
105837939|NCT01796964|365064438|FG000|Overall Study|Adverse Event|1|||
105837940|NCT01796964|365064439|FG001|Overall Study|Adverse Event|1|||
105837941|NCT01796964|365064438|FG000|Overall Study|Death|1|||
105311081|NCT03485365|363136295|FG005|Overall Study|Protocol Violation|0|||
105311082|NCT03485365|363136296|FG006|Overall Study|Protocol Violation|1|||
105311083|NCT03485365|363136297|FG007|Overall Study|Protocol Violation|0|||
105311084|NCT03485365|363136298|FG008|Overall Study|Protocol Violation|0|||
105576496|NCT01167179|364110170|FG000|Overall Study|Withdrawal by Subject|1|||
105311085|NCT02181790|363136301|FG000|Overall Study|study terminated|2|||
105311086|NCT02181790|363136302|FG001|Overall Study|study terminated|0|||
105576497|NCT01167179|364110171|FG001|Overall Study|Withdrawal by Subject|2|||
105837942|NCT01796964|365064439|FG001|Overall Study|Death|0|||
105837943|NCT01796964|365064438|FG000|Overall Study|Protocol Violation|0|||
105311087|NCT00813800|363136309|FG000|Overall Study|Screen Failure after Consent|2|||
105311088|NCT00813800|363136309|FG000|Overall Study|Adverse Event|1|||
105311089|NCT00813800|363136309|FG000|Overall Study|Worsening of depression|2|||
105311090|NCT00813800|363136309|FG000|Overall Study|Physician Decision|1|||
105311091|NCT01860677|363136310|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
105311092|NCT01860677|363136311|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
105311093|NCT00642278|363136314|FG000|Overall Study|Adverse Event|2|||
105576498|NCT01167179|364110170|FG000|Overall Study|diverse|6|||
105837944|NCT01796964|365064439|FG001|Overall Study|Protocol Violation|1|||
105576499|NCT01167179|364110171|FG001|Overall Study|diverse|5|||
105837945|NCT01796964|365064438|FG000|Overall Study|Withdrawal by Subject|1|||
105837946|NCT01796964|365064439|FG001|Overall Study|Withdrawal by Subject|1|||
105837947|NCT00611884|365064440|FG000|Overall Study|Adverse Event|1|||
105837948|NCT00611884|365064441|FG001|Overall Study|Adverse Event|0|||
105837949|NCT00611884|365064442|FG002|Overall Study|Adverse Event|0|||
105837950|NCT00611884|365064443|FG003|Overall Study|Adverse Event|1|||
105837951|NCT00611884|365064440|FG000|Overall Study|Non-Compliance|1|||
105837952|NCT00611884|365064441|FG001|Overall Study|Non-Compliance|4|||
105837953|NCT00611884|365064442|FG002|Overall Study|Non-Compliance|2|||
105837954|NCT00611884|365064443|FG003|Overall Study|Non-Compliance|2|||
105837955|NCT00611884|365064440|FG000|Overall Study|Lack of Efficacy|0|||
105837956|NCT00611884|365064441|FG001|Overall Study|Lack of Efficacy|1|||
105837957|NCT00611884|365064442|FG002|Overall Study|Lack of Efficacy|0|||
105837958|NCT00611884|365064443|FG003|Overall Study|Lack of Efficacy|0|||
105837959|NCT00611884|365064440|FG000|Overall Study|Unclassified|7|||
105837960|NCT00611884|365064441|FG001|Overall Study|Unclassified|4|||
105837961|NCT00611884|365064442|FG002|Overall Study|Unclassified|2|||
105837962|NCT00611884|365064443|FG003|Overall Study|Unclassified|3|||
105837963|NCT01201759|365064444|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
105837964|NCT01201759|365064445|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
105837965|NCT01201759|365064444|FG000|Visit 3 - Washout|Adverse Event|0|||
105837966|NCT01201759|365064445|FG001|Visit 3 - Washout|Adverse Event|3|||
105837967|NCT01201759|365064444|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
105837968|NCT01201759|365064445|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
105837969|NCT01201759|365064444|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
105837970|NCT01201759|365064445|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
105837971|NCT00981799|365064446|FG000|Overall Study|Adverse Event|1|||
105837972|NCT00981799|365064447|FG001|Overall Study|Adverse Event|1|||
105837973|NCT00981799|365064448|FG002|Overall Study|Adverse Event|0|||
105837974|NCT00981799|365064449|FG003|Overall Study|Adverse Event|0|||
105837975|NCT01844531|365064452|FG000|Overall Study|Withdrawal by Subject|0|||
105837976|NCT01844531|365064453|FG001|Overall Study|Withdrawal by Subject|1|||
105837977|NCT01844531|365064454|FG002|Overall Study|Withdrawal by Subject|0|||
105837978|NCT01844531|365064455|FG003|Overall Study|Withdrawal by Subject|0|||
105837979|NCT00906373|365064456|FG000|Overall Study|Withdrawal by Subject|0|||
105837980|NCT00906373|365064457|FG001|Overall Study|Withdrawal by Subject|5|||
105837981|NCT00906373|365064456|FG000|Overall Study|Other|0|||
105837982|NCT00906373|365064457|FG001|Overall Study|Other|1|||
105837983|NCT00906373|365064456|FG000|Overall Study|Still on treatment at cutoff date|0|||
105837984|NCT00906373|365064457|FG001|Overall Study|Still on treatment at cutoff date|2|||
105837985|NCT01597479|365064458|FG000|Overall Study|Protocol Violation|1|||
105837986|NCT01597479|365064459|FG001|Overall Study|Protocol Violation|0|||
105837987|NCT01597479|365064458|FG000|Overall Study|Lost to Follow-up|1|||
105837988|NCT01597479|365064459|FG001|Overall Study|Lost to Follow-up|0|||
105837989|NCT01045707|365064462|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
105837990|NCT01045707|365064463|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
105837991|NCT01045707|365064462|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
105837992|NCT01045707|365064463|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
105837993|NCT01045707|365064462|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
105837994|NCT01045707|365064463|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
105837995|NCT01045707|365064462|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
105837996|NCT01045707|365064463|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
105837997|NCT01045707|365064462|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
105837998|NCT01045707|365064463|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
105837999|NCT01045707|365064462|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
105838000|NCT01045707|365064463|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
105838001|NCT01045707|365064462|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
105838002|NCT01045707|365064463|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
105838003|NCT01045707|365064462|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
105838004|NCT01045707|365064463|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
105838005|NCT01045707|365064462|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
105576500|NCT01158378|364110172|FG000|Overall Study|Death|4|||
105576501|NCT01158378|364110173|FG001|Overall Study|Death|5|||
105838006|NCT01045707|365064463|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
105838007|NCT00317642|365064476|FG000|Overall Study|Not Received Either Study Drug|1|||
105838008|NCT00317642|365064477|FG001|Overall Study|Not Received Either Study Drug|3|||
105838009|NCT00317642|365064476|FG000|Overall Study|Physician Decision|15|||
105838010|NCT00317642|365064477|FG001|Overall Study|Physician Decision|7|||
105838011|NCT00317642|365064476|FG000|Overall Study|Participant declined treatment|14|||
105576502|NCT01158378|364110172|FG000|Overall Study|Lost to Follow-up|2|||
105838012|NCT00317642|365064477|FG001|Overall Study|Participant declined treatment|3|||
105838013|NCT00317642|365064476|FG000|Overall Study|Adverse Event|17|||
105838014|NCT00317642|365064477|FG001|Overall Study|Adverse Event|5|||
105838015|NCT00317642|365064476|FG000|Overall Study|Treatment Failure|56|||
105367489|NCT01198002|363352291|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
105367490|NCT01198002|363352289|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
105367491|NCT01198002|363352290|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
105838016|NCT00317642|365064477|FG001|Overall Study|Treatment Failure|102|||
105838017|NCT00317642|365064476|FG000|Overall Study|Disease Recurrence|1|||
105838018|NCT00317642|365064477|FG001|Overall Study|Disease Recurrence|2|||
105838019|NCT00317642|365064476|FG000|Overall Study|Death|14|||
105838020|NCT00317642|365064477|FG001|Overall Study|Death|7|||
105838021|NCT00317642|365064476|FG000|Overall Study|Not Continue to Consolidation|2|||
105838022|NCT00317642|365064477|FG001|Overall Study|Not Continue to Consolidation|0|||
105838023|NCT00317642|365064476|FG000|Overall Study|Withdrawal by Subject|0|||
105838024|NCT00317642|365064477|FG001|Overall Study|Withdrawal by Subject|1|||
105838025|NCT00317642|365064476|FG000|Overall Study|Referred For Transplantation|1|||
105838026|NCT00317642|365064477|FG001|Overall Study|Referred For Transplantation|0|||
105838027|NCT00317642|365064476|FG000|Overall Study|AML Not Centrally Confirmed|1|||
105838028|NCT00317642|365064477|FG001|Overall Study|AML Not Centrally Confirmed|5|||
105838029|NCT04317599|365064478|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
105838030|NCT04317599|365064478|FG000|Overall Study|treatment outside standard of care|4|||
105838031|NCT00809965|365064479|FG000|Overall Study|Death|194|||
105838032|NCT00809965|365064480|FG001|Overall Study|Death|147|||
105838033|NCT00809965|365064481|FG002|Overall Study|Death|196|||
105838034|NCT00809965|365064479|FG000|Overall Study|Lost to Follow-up|17|||
105838035|NCT00809965|365064480|FG001|Overall Study|Lost to Follow-up|10|||
105838036|NCT00809965|365064481|FG002|Overall Study|Lost to Follow-up|18|||
105838037|NCT00809965|365064479|FG000|Overall Study|Withdrawal by Subject|405|||
105838038|NCT00809965|365064480|FG001|Overall Study|Withdrawal by Subject|448|||
105838039|NCT00809965|365064481|FG002|Overall Study|Withdrawal by Subject|441|||
105838040|NCT00809965|365064479|FG000|Overall Study|Other Reason|167|||
105838041|NCT00809965|365064480|FG001|Overall Study|Other Reason|170|||
105838042|NCT00809965|365064481|FG002|Overall Study|Other Reason|189|||
105838043|NCT02315066|365064482|FG000|Overall Study|Lost to Follow-up|0|||
105838044|NCT02315066|365064483|FG001|Overall Study|Lost to Follow-up|1|||
105838045|NCT02315066|365064484|FG002|Overall Study|Lost to Follow-up|1|||
105838046|NCT02315066|365064485|FG003|Overall Study|Lost to Follow-up|0|||
105838047|NCT02315066|365064486|FG004|Overall Study|Lost to Follow-up|1|||
105838048|NCT02315066|365064487|FG005|Overall Study|Lost to Follow-up|0|||
105838049|NCT02315066|365064488|FG006|Overall Study|Lost to Follow-up|2|||
105838050|NCT02315066|365064489|FG007|Overall Study|Lost to Follow-up|1|||
105838051|NCT02315066|365064490|FG008|Overall Study|Lost to Follow-up|0|||
105838052|NCT02315066|365064491|FG009|Overall Study|Lost to Follow-up|0|||
105838053|NCT02315066|365064492|FG010|Overall Study|Lost to Follow-up|1|||
105838054|NCT02315066|365064493|FG011|Overall Study|Lost to Follow-up|2|||
105838055|NCT02315066|365064494|FG012|Overall Study|Lost to Follow-up|0|||
105838056|NCT02315066|365064495|FG013|Overall Study|Lost to Follow-up|4|||
105838057|NCT02315066|365064482|FG000|Overall Study|Death|2|||
105838058|NCT02315066|365064483|FG001|Overall Study|Death|7|||
105838059|NCT02315066|365064484|FG002|Overall Study|Death|6|||
105838060|NCT02315066|365064485|FG003|Overall Study|Death|11|||
105838061|NCT02315066|365064486|FG004|Overall Study|Death|10|||
105838062|NCT02315066|365064487|FG005|Overall Study|Death|3|||
105838063|NCT02315066|365064488|FG006|Overall Study|Death|9|||
105838064|NCT02315066|365064489|FG007|Overall Study|Death|9|||
105838065|NCT02315066|365064490|FG008|Overall Study|Death|10|||
105838066|NCT02315066|365064491|FG009|Overall Study|Death|8|||
105838067|NCT02315066|365064492|FG010|Overall Study|Death|10|||
105838068|NCT02315066|365064493|FG011|Overall Study|Death|7|||
105838069|NCT02315066|365064494|FG012|Overall Study|Death|8|||
105838070|NCT02315066|365064495|FG013|Overall Study|Death|21|||
105838071|NCT02315066|365064482|FG000|Overall Study|Other|0|||
105838072|NCT02315066|365064483|FG001|Overall Study|Other|0|||
105838073|NCT02315066|365064484|FG002|Overall Study|Other|0|||
105838074|NCT02315066|365064485|FG003|Overall Study|Other|0|||
105838075|NCT02315066|365064486|FG004|Overall Study|Other|0|||
105838076|NCT02315066|365064487|FG005|Overall Study|Other|0|||
105838077|NCT02315066|365064488|FG006|Overall Study|Other|0|||
105838078|NCT02315066|365064489|FG007|Overall Study|Other|1|||
105838079|NCT02315066|365064490|FG008|Overall Study|Other|1|||
105838080|NCT02315066|365064491|FG009|Overall Study|Other|2|||
105838081|NCT02315066|365064492|FG010|Overall Study|Other|0|||
105838082|NCT02315066|365064493|FG011|Overall Study|Other|0|||
105838083|NCT02315066|365064494|FG012|Overall Study|Other|0|||
105489878|NCT03963401|363805678|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
105838084|NCT02315066|365064495|FG013|Overall Study|Other|0|||
105838085|NCT02315066|365064482|FG000|Overall Study|Subject refused further follow-up|0|||
105367492|NCT01198002|363352291|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
105838086|NCT02315066|365064483|FG001|Overall Study|Subject refused further follow-up|2|||
105838087|NCT02315066|365064484|FG002|Overall Study|Subject refused further follow-up|2|||
105838088|NCT02315066|365064485|FG003|Overall Study|Subject refused further follow-up|0|||
105838089|NCT02315066|365064486|FG004|Overall Study|Subject refused further follow-up|0|||
105838090|NCT02315066|365064487|FG005|Overall Study|Subject refused further follow-up|0|||
105311094|NCT00642278|363136315|FG001|Overall Study|Adverse Event|1|||
105311095|NCT00642278|363136316|FG002|Overall Study|Adverse Event|3|||
105311096|NCT00642278|363136317|FG003|Overall Study|Adverse Event|1|||
105311097|NCT00642278|363136318|FG004|Overall Study|Adverse Event|2|||
105311098|NCT00642278|363136319|FG005|Overall Study|Adverse Event|2|||
105311099|NCT00642278|363136320|FG006|Overall Study|Adverse Event|0|||
105311100|NCT00642278|363136314|FG000|Overall Study|Lack of Efficacy|0|||
105311101|NCT00642278|363136315|FG001|Overall Study|Lack of Efficacy|1|||
105311102|NCT00642278|363136316|FG002|Overall Study|Lack of Efficacy|0|||
105311103|NCT00642278|363136317|FG003|Overall Study|Lack of Efficacy|0|||
105311104|NCT00642278|363136318|FG004|Overall Study|Lack of Efficacy|0|||
105311105|NCT00642278|363136319|FG005|Overall Study|Lack of Efficacy|0|||
105311106|NCT00642278|363136320|FG006|Overall Study|Lack of Efficacy|0|||
105311107|NCT00642278|363136314|FG000|Overall Study|Lost to Follow-up|5|||
105311108|NCT00642278|363136315|FG001|Overall Study|Lost to Follow-up|1|||
105311109|NCT00642278|363136316|FG002|Overall Study|Lost to Follow-up|0|||
105311110|NCT00642278|363136317|FG003|Overall Study|Lost to Follow-up|1|||
105311111|NCT00642278|363136318|FG004|Overall Study|Lost to Follow-up|0|||
105311112|NCT00642278|363136319|FG005|Overall Study|Lost to Follow-up|1|||
105311113|NCT00642278|363136320|FG006|Overall Study|Lost to Follow-up|1|||
105311114|NCT00642278|363136314|FG000|Overall Study|Physician Decision|0|||
105311115|NCT00642278|363136315|FG001|Overall Study|Physician Decision|0|||
105311116|NCT00642278|363136316|FG002|Overall Study|Physician Decision|0|||
105311117|NCT00642278|363136317|FG003|Overall Study|Physician Decision|1|||
105311118|NCT00642278|363136318|FG004|Overall Study|Physician Decision|0|||
105311119|NCT00642278|363136319|FG005|Overall Study|Physician Decision|0|||
105311120|NCT00642278|363136320|FG006|Overall Study|Physician Decision|0|||
105311121|NCT00642278|363136314|FG000|Overall Study|Protocol Violation|0|||
105311122|NCT00642278|363136315|FG001|Overall Study|Protocol Violation|0|||
105311123|NCT00642278|363136316|FG002|Overall Study|Protocol Violation|1|||
105311124|NCT00642278|363136317|FG003|Overall Study|Protocol Violation|1|||
105311125|NCT00642278|363136318|FG004|Overall Study|Protocol Violation|0|||
105311126|NCT00642278|363136319|FG005|Overall Study|Protocol Violation|1|||
105311127|NCT00642278|363136320|FG006|Overall Study|Protocol Violation|2|||
105311128|NCT00642278|363136314|FG000|Overall Study|Withdrawal by Subject|1|||
105311129|NCT00642278|363136315|FG001|Overall Study|Withdrawal by Subject|1|||
105311130|NCT00642278|363136316|FG002|Overall Study|Withdrawal by Subject|1|||
105311131|NCT00642278|363136317|FG003|Overall Study|Withdrawal by Subject|3|||
105311132|NCT00642278|363136318|FG004|Overall Study|Withdrawal by Subject|6|||
105311133|NCT00642278|363136319|FG005|Overall Study|Withdrawal by Subject|2|||
105311134|NCT00642278|363136320|FG006|Overall Study|Withdrawal by Subject|2|||
105311135|NCT00642278|363136314|FG000|Overall Study|Noncompliance with study drug regimen|0|||
105311136|NCT00642278|363136315|FG001|Overall Study|Noncompliance with study drug regimen|0|||
105311137|NCT00642278|363136316|FG002|Overall Study|Noncompliance with study drug regimen|0|||
105311138|NCT00642278|363136317|FG003|Overall Study|Noncompliance with study drug regimen|1|||
105311139|NCT00642278|363136318|FG004|Overall Study|Noncompliance with study drug regimen|0|||
105311140|NCT00642278|363136319|FG005|Overall Study|Noncompliance with study drug regimen|0|||
105311141|NCT00642278|363136320|FG006|Overall Study|Noncompliance with study drug regimen|0|||
105311142|NCT00642278|363136314|FG000|Overall Study|Other|2|||
105311143|NCT00642278|363136315|FG001|Overall Study|Other|1|||
105311144|NCT00642278|363136316|FG002|Overall Study|Other|0|||
105311145|NCT00642278|363136317|FG003|Overall Study|Other|1|||
105311146|NCT00642278|363136318|FG004|Overall Study|Other|0|||
105311147|NCT00642278|363136319|FG005|Overall Study|Other|1|||
105311148|NCT00642278|363136320|FG006|Overall Study|Other|0|||
105311149|NCT03713619|363136323|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
105311150|NCT03713619|363136324|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
105311151|NCT03713619|363136325|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
105311152|NCT03713619|363136326|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
105311153|NCT03713619|363136327|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
105311154|NCT03713619|363136323|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
105311155|NCT03713619|363136324|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
105311156|NCT03713619|363136325|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
105311157|NCT03713619|363136326|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
105311158|NCT03713619|363136327|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
105311159|NCT03713619|363136323|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
105311160|NCT03713619|363136324|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
105311161|NCT03713619|363136325|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
105311162|NCT03713619|363136326|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
105311163|NCT03713619|363136327|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
105311164|NCT03713619|363136323|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
105311165|NCT03713619|363136324|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
105311166|NCT03713619|363136325|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
105576503|NCT01158378|364110173|FG001|Overall Study|Lost to Follow-up|4|||
105576504|NCT01158378|364110172|FG000|Overall Study|Withdrawal by Subject|4|||
105311167|NCT03713619|363136326|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
105311168|NCT03713619|363136327|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
105311169|NCT03713619|363136323|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
105311170|NCT03713619|363136324|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
105311171|NCT03713619|363136325|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
105311172|NCT03713619|363136326|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
105311173|NCT03713619|363136327|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
105311174|NCT03713619|363136323|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
105311175|NCT03713619|363136324|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
105311176|NCT03713619|363136325|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
105311177|NCT03713619|363136326|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
105311178|NCT03713619|363136327|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
105311179|NCT03713619|363136323|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
105311180|NCT03713619|363136324|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
105311181|NCT03713619|363136325|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
105311182|NCT03713619|363136326|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
105311183|NCT03713619|363136327|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
105311184|NCT03713619|363136323|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
105311185|NCT03713619|363136324|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
105311186|NCT03713619|363136325|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
105311187|NCT03713619|363136326|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
105311188|NCT03713619|363136327|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
105311189|NCT03713619|363136323|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
105311190|NCT03713619|363136324|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
105311191|NCT03713619|363136325|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
105311192|NCT03713619|363136326|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
105311193|NCT03713619|363136327|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
105311194|NCT03713619|363136323|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
105367493|NCT01198002|363352289|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
105367494|NCT01198002|363352290|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
105367495|NCT01198002|363352291|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
105367496|NCT01198002|363352289|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
105367497|NCT01198002|363352290|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
105367498|NCT01198002|363352291|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
105367499|NCT01198002|363352289|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
105367500|NCT01198002|363352290|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
105367501|NCT01198002|363352291|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
105367502|NCT01198002|363352289|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
105367503|NCT01198002|363352290|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
105367504|NCT01198002|363352291|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
105311195|NCT03713619|363136324|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
105311196|NCT03713619|363136325|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
105311197|NCT03713619|363136326|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
105311198|NCT03713619|363136327|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
105311199|NCT03713619|363136323|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
105311200|NCT03713619|363136324|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
105311201|NCT03713619|363136325|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
105311202|NCT03713619|363136326|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
105311203|NCT03713619|363136327|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
105311204|NCT03713619|363136323|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
105311205|NCT03713619|363136324|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
105311206|NCT03713619|363136325|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
105311207|NCT03713619|363136326|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
105311208|NCT03713619|363136327|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
105311209|NCT03713619|363136323|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
105311210|NCT03713619|363136324|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
105311211|NCT03713619|363136325|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
105367505|NCT01198002|363352289|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
105367506|NCT01198002|363352290|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
105367507|NCT01198002|363352291|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
105311212|NCT03713619|363136326|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
105311213|NCT03713619|363136327|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
105311214|NCT04642365|363136331|FG000|Overall Study|Death|3|||
105367508|NCT01198002|363352289|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
105367509|NCT01198002|363352290|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
105367510|NCT01198002|363352291|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
105367511|NCT02810418|363352292|FG000|Arm A Dose Escalation|Adverse Event|2|||
105838091|NCT02315066|365064488|FG006|Overall Study|Subject refused further follow-up|2|||
105838092|NCT02315066|365064489|FG007|Overall Study|Subject refused further follow-up|3|||
105838093|NCT02315066|365064490|FG008|Overall Study|Subject refused further follow-up|0|||
105367512|NCT02810418|363352293|FG001|Arm A Dose Escalation|Adverse Event|1|||
105367513|NCT02810418|363352294|FG002|Arm A Dose Escalation|Adverse Event|0|||
105367514|NCT02810418|363352295|FG003|Arm A Dose Escalation|Adverse Event|0|||
105367515|NCT02810418|363352296|FG004|Arm A Dose Escalation|Adverse Event|0|||
105367516|NCT02810418|363352297|FG005|Arm A Dose Escalation|Adverse Event|0|||
105367517|NCT02810418|363352298|FG006|Arm A Dose Escalation|Adverse Event|0|||
105367518|NCT02810418|363352292|FG000|Dose Expansion|Adverse Event|0|||
105367519|NCT02810418|363352293|FG001|Dose Expansion|Adverse Event|1|||
105367520|NCT02810418|363352294|FG002|Dose Expansion|Adverse Event|1|||
105367521|NCT02810418|363352295|FG003|Dose Expansion|Adverse Event|0|||
105367522|NCT02810418|363352296|FG004|Dose Expansion|Adverse Event|0|||
105367523|NCT02810418|363352297|FG005|Dose Expansion|Adverse Event|0|||
105367524|NCT02810418|363352298|FG006|Dose Expansion|Adverse Event|0|||
105367525|NCT02810418|363352292|FG000|Dose Expansion|Physician Decision|0|||
105367526|NCT02810418|363352293|FG001|Dose Expansion|Physician Decision|0|||
105367527|NCT02810418|363352294|FG002|Dose Expansion|Physician Decision|2|||
105838094|NCT02315066|365064491|FG009|Overall Study|Subject refused further follow-up|1|||
105838095|NCT02315066|365064492|FG010|Overall Study|Subject refused further follow-up|1|||
105838096|NCT02315066|365064493|FG011|Overall Study|Subject refused further follow-up|2|||
105838097|NCT02315066|365064494|FG012|Overall Study|Subject refused further follow-up|2|||
105838098|NCT02315066|365064495|FG013|Overall Study|Subject refused further follow-up|4|||
105838099|NCT02315066|365064482|FG000|Overall Study|Study ongoing at date of cut-off|0|||
105838100|NCT02315066|365064483|FG001|Overall Study|Study ongoing at date of cut-off|0|||
105838101|NCT02315066|365064484|FG002|Overall Study|Study ongoing at date of cut-off|0|||
105838102|NCT02315066|365064485|FG003|Overall Study|Study ongoing at date of cut-off|0|||
105838103|NCT02315066|365064486|FG004|Overall Study|Study ongoing at date of cut-off|0|||
105838104|NCT02315066|365064487|FG005|Overall Study|Study ongoing at date of cut-off|0|||
105838105|NCT02315066|365064488|FG006|Overall Study|Study ongoing at date of cut-off|0|||
105838106|NCT02315066|365064489|FG007|Overall Study|Study ongoing at date of cut-off|0|||
105838107|NCT02315066|365064490|FG008|Overall Study|Study ongoing at date of cut-off|0|||
105838108|NCT02315066|365064491|FG009|Overall Study|Study ongoing at date of cut-off|0|||
105838109|NCT02315066|365064492|FG010|Overall Study|Study ongoing at date of cut-off|0|||
105838110|NCT02315066|365064493|FG011|Overall Study|Study ongoing at date of cut-off|0|||
105838111|NCT02315066|365064494|FG012|Overall Study|Study ongoing at date of cut-off|0|||
105838112|NCT02315066|365064495|FG013|Overall Study|Study ongoing at date of cut-off|1|||
105838113|NCT03180801|365064496|FG000|Overall Study|Physician Decision|3|||
105838114|NCT03180801|365064497|FG001|Overall Study|Physician Decision|3|||
105838115|NCT03180801|365064498|FG002|Overall Study|Physician Decision|1|||
105838116|NCT03180801|365064496|FG000|Overall Study|Non-compliance|1|||
105838117|NCT03180801|365064497|FG001|Overall Study|Non-compliance|4|||
105838118|NCT03180801|365064498|FG002|Overall Study|Non-compliance|0|||
105838119|NCT03180801|365064496|FG000|Overall Study|Inoculation Target Reached|1|||
105838120|NCT03180801|365064497|FG001|Overall Study|Inoculation Target Reached|1|||
105838121|NCT03180801|365064498|FG002|Overall Study|Inoculation Target Reached|3|||
105838122|NCT03180801|365064496|FG000|Overall Study|Adverse Event|1|||
105838123|NCT03180801|365064497|FG001|Overall Study|Adverse Event|0|||
105838124|NCT03180801|365064498|FG002|Overall Study|Adverse Event|2|||
105838125|NCT03180801|365064496|FG000|Overall Study|Withdrawal by Subject|2|||
105838126|NCT03180801|365064497|FG001|Overall Study|Withdrawal by Subject|2|||
105838127|NCT03180801|365064498|FG002|Overall Study|Withdrawal by Subject|1|||
105838128|NCT03180801|365064496|FG000|Overall Study|Lost to Follow-up|0|||
105838129|NCT03180801|365064497|FG001|Overall Study|Lost to Follow-up|2|||
105838130|NCT03180801|365064498|FG002|Overall Study|Lost to Follow-up|3|||
105838131|NCT02618382|365064499|FG000|Overall Study|Physician Decision|1|||
105838132|NCT02618382|365064499|FG000|Overall Study|Withdrawal by Subject|1|||
105367528|NCT02810418|363352295|FG003|Dose Expansion|Physician Decision|0|||
105367529|NCT02810418|363352296|FG004|Dose Expansion|Physician Decision|0|||
105367530|NCT02810418|363352297|FG005|Dose Expansion|Physician Decision|0|||
105367531|NCT02810418|363352298|FG006|Dose Expansion|Physician Decision|0|||
105367532|NCT02810418|363352292|FG000|Arm B Dose Escalation|Adverse Event|0|||
105367533|NCT02810418|363352293|FG001|Arm B Dose Escalation|Adverse Event|0|||
105576505|NCT01158378|364110173|FG001|Overall Study|Withdrawal by Subject|0|||
105838133|NCT02618382|365064499|FG000|Overall Study|Protocol Violation|1|||
105838134|NCT01999894|365064500|FG000|Overall Study|Adverse Event|9|||
105838135|NCT01999894|365064500|FG000|Overall Study|Lack of Efficacy|5|||
105838136|NCT01999894|365064500|FG000|Overall Study|Protocol Violation|1|||
105367534|NCT02810418|363352294|FG002|Arm B Dose Escalation|Adverse Event|0|||
105367535|NCT02810418|363352295|FG003|Arm B Dose Escalation|Adverse Event|0|||
105576506|NCT01340482|364110175|FG000|Overall Study|Adverse Event|2|||
105576507|NCT01340482|364110176|FG001|Overall Study|Adverse Event|0|||
105838137|NCT01999894|365064500|FG000|Overall Study|Withdrawal by Subject|7|||
105367536|NCT02810418|363352296|FG004|Arm B Dose Escalation|Adverse Event|1|||
105367537|NCT02810418|363352297|FG005|Arm B Dose Escalation|Adverse Event|2|||
105311215|NCT04642365|363136332|FG001|Overall Study|Death|2|||
105311216|NCT04642365|363136333|FG002|Overall Study|Death|4|||
105311217|NCT04642365|363136334|FG003|Overall Study|Death|5|||
105311218|NCT04642365|363136335|FG004|Overall Study|Death|5|||
105311219|NCT04642365|363136336|FG005|Overall Study|Death|3|||
105311220|NCT04642365|363136337|FG006|Overall Study|Death|2|||
105311221|NCT04642365|363136338|FG007|Overall Study|Death|1|||
105311222|NCT04642365|363136331|FG000|Overall Study|Physician Decision|1|||
105311223|NCT04642365|363136332|FG001|Overall Study|Physician Decision|0|||
105311224|NCT04642365|363136333|FG002|Overall Study|Physician Decision|0|||
105311225|NCT04642365|363136334|FG003|Overall Study|Physician Decision|0|||
105311226|NCT04642365|363136335|FG004|Overall Study|Physician Decision|0|||
105367538|NCT02810418|363352298|FG006|Arm B Dose Escalation|Adverse Event|0|||
105367539|NCT02812186|363352302|FG000|Period 1|Post randomization screen failure|5|||
105367540|NCT02812186|363352303|FG001|Period 1|Post randomization screen failure|9|||
105367541|NCT02812186|363352302|FG000|Period 1|nonevaluable data sets|6|||
105367542|NCT02812186|363352303|FG001|Period 1|nonevaluable data sets|6|||
105367543|NCT00789321|363352309|FG000|Overall Study|Adverse Event|0|||
105367544|NCT00789321|363352310|FG001|Overall Study|Adverse Event|1|||
105367545|NCT01965327|363352313|FG000|Overall Study|Physician Decision|2|||
105367546|NCT03342001|363352314|FG000|Overall Study|Adverse Event|1|||
105367547|NCT03342001|363352314|FG000|Overall Study|Lost to Follow-up|1|||
105367548|NCT01100853|363352319|FG000|Overall Study|Lost to Follow-up|11|||
105367549|NCT01100853|363352320|FG001|Overall Study|Lost to Follow-up|6|||
105367550|NCT01100853|363352319|FG000|Overall Study|Received <4 study injections|10|||
105367551|NCT01100853|363352320|FG001|Overall Study|Received <4 study injections|13|||
105367552|NCT01100853|363352319|FG000|Overall Study|Withdrawal by Subject|6|||
105367553|NCT01100853|363352320|FG001|Overall Study|Withdrawal by Subject|4|||
105367554|NCT04161391|363352321|FG000|Overall Study|Adverse Event|0|||
105367555|NCT04161391|363352322|FG001|Overall Study|Adverse Event|1|||
105367556|NCT04161391|363352323|FG002|Overall Study|Adverse Event|0|||
105367557|NCT04161391|363352324|FG003|Overall Study|Adverse Event|1|||
105367558|NCT04161391|363352325|FG004|Overall Study|Adverse Event|0|||
105367559|NCT04161391|363352326|FG005|Overall Study|Adverse Event|0|||
105367560|NCT04161391|363352327|FG006|Overall Study|Adverse Event|0|||
105367561|NCT04161391|363352328|FG007|Overall Study|Adverse Event|3|||
105367562|NCT04161391|363352329|FG008|Overall Study|Adverse Event|0|||
105367563|NCT04161391|363352321|FG000|Overall Study|Death|0|||
105367564|NCT04161391|363352322|FG001|Overall Study|Death|0|||
105367565|NCT04161391|363352323|FG002|Overall Study|Death|0|||
105367566|NCT04161391|363352324|FG003|Overall Study|Death|0|||
105838138|NCT01999894|365064500|FG000|Overall Study|Lost to Follow-up|10|||
105838139|NCT01999894|365064500|FG000|Overall Study|Other Reason|3|||
105838140|NCT01999894|365064500|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
105838141|NCT00263887|365064502|FG000|Overall Study|Withdrawal by Subject|1|||
105838142|NCT00263887|365064503|FG001|Overall Study|Withdrawal by Subject|1|||
105838143|NCT00263887|365064502|FG000|Overall Study|Lung transplantation|1|||
105838144|NCT00263887|365064503|FG001|Overall Study|Lung transplantation|2|||
105838145|NCT00263887|365064502|FG000|Overall Study|Too ill to attend visit|1|||
105838146|NCT00263887|365064503|FG001|Overall Study|Too ill to attend visit|0|||
105838147|NCT00263887|365064502|FG000|Overall Study|Adverse Event|0|||
105838148|NCT00263887|365064503|FG001|Overall Study|Adverse Event|2|||
105838149|NCT00263887|365064502|FG000|Overall Study|Disease progression|0|||
105838150|NCT00263887|365064503|FG001|Overall Study|Disease progression|1|||
105838151|NCT00263887|365064502|FG000|Overall Study|Lack of Efficacy|0|||
105838152|NCT00263887|365064503|FG001|Overall Study|Lack of Efficacy|1|||
105838153|NCT00676494|365064513|FG000|Overall Study|Missed Visit|8|||
105838154|NCT00676494|365064513|FG000|Overall Study|Withdrawal by Subject|6|||
105838155|NCT01466036|365064516|FG000|Overall Study|Death|1|||
105367567|NCT04161391|363352325|FG004|Overall Study|Death|0|||
105367568|NCT04161391|363352326|FG005|Overall Study|Death|0|||
105367569|NCT04161391|363352327|FG006|Overall Study|Death|0|||
105489879|NCT03963401|363805679|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
105489880|NCT03963401|363805674|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
105838156|NCT01466036|365064517|FG001|Overall Study|Death|1|||
105838157|NCT01466036|365064516|FG000|Overall Study|Physician Decision|0|||
105838158|NCT01466036|365064517|FG001|Overall Study|Physician Decision|4|||
105367570|NCT04161391|363352328|FG007|Overall Study|Death|1|||
105367571|NCT04161391|363352329|FG008|Overall Study|Death|0|||
105367572|NCT04161391|363352321|FG000|Overall Study|Physician Decision|0|||
105489881|NCT03963401|363805675|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
105838159|NCT01466036|365064516|FG000|Overall Study|Adverse Event|2|||
105838160|NCT01466036|365064517|FG001|Overall Study|Adverse Event|6|||
105311227|NCT04642365|363136336|FG005|Overall Study|Physician Decision|0|||
105367573|NCT04161391|363352322|FG001|Overall Study|Physician Decision|0|||
105367574|NCT04161391|363352323|FG002|Overall Study|Physician Decision|1|||
105367575|NCT04161391|363352324|FG003|Overall Study|Physician Decision|2|||
105367576|NCT04161391|363352325|FG004|Overall Study|Physician Decision|0|||
105367577|NCT04161391|363352326|FG005|Overall Study|Physician Decision|0|||
105838161|NCT01466036|365064516|FG000|Overall Study|Withdrawal by Subject|2|||
105838162|NCT01466036|365064517|FG001|Overall Study|Withdrawal by Subject|8|||
105838163|NCT01466036|365064516|FG000|Overall Study|progression/relapse|14|||
105838164|NCT01466036|365064517|FG001|Overall Study|progression/relapse|21|||
105838165|NCT01466036|365064516|FG000|Overall Study|prolonged treatment delay|1|||
105838166|NCT01466036|365064517|FG001|Overall Study|prolonged treatment delay|1|||
105838167|NCT00819767|365064518|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105838168|NCT00819767|365064519|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105838169|NCT00983476|365064520|FG000|Overall Study|Did not receive intervention|17|||
105838170|NCT00983476|365064521|FG001|Overall Study|Did not receive intervention|22|||
105838171|NCT00983476|365064522|FG002|Overall Study|Did not receive intervention|0|||
105838172|NCT00761176|365064523|FG000|Overall Study|Death|1|||
105838173|NCT00761176|365064524|FG001|Overall Study|Death|0|||
105838174|NCT00761176|365064523|FG000|Overall Study|Withdrawal by Subject|1|||
105838175|NCT00761176|365064524|FG001|Overall Study|Withdrawal by Subject|1|||
105838176|NCT02020967|365064526|FG000|Overall Study|Withdrawal by Subject|51|||
105838177|NCT01857206|365064528|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
105838178|NCT01857206|365064529|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
105838179|NCT01857206|365064528|FG000|Overall Study|Lost to Follow-up|9|||
105838180|NCT01857206|365064529|FG001|Overall Study|Lost to Follow-up|6|||
105838181|NCT01857206|365064528|FG000|Overall Study|Unclassified|3|||
105838182|NCT01857206|365064529|FG001|Overall Study|Unclassified|3|||
105838183|NCT01857206|365064528|FG000|Overall Study|Withdrawal by Subject|1|||
105838184|NCT01857206|365064529|FG001|Overall Study|Withdrawal by Subject|0|||
105838185|NCT00476593|365064530|FG000|Overall Study|Lost to Follow-up|10|||
105838186|NCT00476593|365064531|FG001|Overall Study|Lost to Follow-up|2|||
105838187|NCT00476593|365064532|FG002|Overall Study|Lost to Follow-up|8|||
105838188|NCT00476593|365064533|FG003|Overall Study|Lost to Follow-up|22|||
105838189|NCT03430011|365064534|FG000|Pre-Treatment|Death|1|||
105838190|NCT03430011|365064535|FG001|Pre-Treatment|Death|0|||
105838191|NCT03430011|365064536|FG002|Pre-Treatment|Death|0|||
105838192|NCT03430011|365064537|FG003|Pre-Treatment|Death|0|||
105838193|NCT03430011|365064538|FG004|Pre-Treatment|Death|1|||
105838194|NCT03430011|365064539|FG005|Pre-Treatment|Death|0|||
105838195|NCT03430011|365064540|FG006|Pre-Treatment|Death|1|||
105838196|NCT03430011|365064541|FG007|Pre-Treatment|Death|0|||
105838197|NCT03430011|365064534|FG000|Pre-Treatment|Screen Fail|0|||
105838198|NCT03430011|365064535|FG001|Pre-Treatment|Screen Fail|0|||
105838199|NCT03430011|365064536|FG002|Pre-Treatment|Screen Fail|0|||
105838200|NCT03430011|365064537|FG003|Pre-Treatment|Screen Fail|0|||
105838201|NCT03430011|365064538|FG004|Pre-Treatment|Screen Fail|1|||
105838202|NCT03430011|365064539|FG005|Pre-Treatment|Screen Fail|0|||
105838203|NCT03430011|365064540|FG006|Pre-Treatment|Screen Fail|0|||
105838204|NCT03430011|365064541|FG007|Pre-Treatment|Screen Fail|0|||
105838205|NCT03430011|365064534|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
105838206|NCT03430011|365064535|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
105838207|NCT03430011|365064536|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
105838208|NCT03430011|365064537|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
105838209|NCT03430011|365064538|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
105838210|NCT03430011|365064539|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
105838211|NCT03430011|365064540|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
105838212|NCT03430011|365064541|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
105838213|NCT03430011|365064534|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
105838214|NCT03430011|365064535|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
105838215|NCT03430011|365064536|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
105838216|NCT03430011|365064537|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
105838217|NCT03430011|365064538|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
105838218|NCT03430011|365064539|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
105838219|NCT03430011|365064540|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
105838220|NCT03430011|365064541|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
105838221|NCT03430011|365064534|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
105838222|NCT03430011|365064535|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
105838223|NCT03430011|365064536|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
105838224|NCT03430011|365064537|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
105838225|NCT03430011|365064538|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
105838226|NCT03430011|365064539|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
105838227|NCT03430011|365064540|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
105838228|NCT03430011|365064541|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
105838229|NCT03430011|365064534|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
105838230|NCT03430011|365064535|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
105838231|NCT03430011|365064536|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
105838232|NCT03430011|365064537|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
105838233|NCT03430011|365064538|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
105838234|NCT03430011|365064539|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
105311228|NCT04642365|363136337|FG006|Overall Study|Physician Decision|0|||
105311229|NCT04642365|363136338|FG007|Overall Study|Physician Decision|0|||
105838235|NCT03430011|365064540|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
105838236|NCT03430011|365064541|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
105838237|NCT03430011|365064534|FG000|JCARH125 Treatment|Death|4|||
105838238|NCT03430011|365064535|FG001|JCARH125 Treatment|Death|19|||
105838239|NCT03430011|365064536|FG002|JCARH125 Treatment|Death|10|||
105838240|NCT03430011|365064537|FG003|JCARH125 Treatment|Death|8|||
105838241|NCT03430011|365064538|FG004|JCARH125 Treatment|Death|5|||
105838242|NCT03430011|365064539|FG005|JCARH125 Treatment|Death|3|||
105838243|NCT03430011|365064540|FG006|JCARH125 Treatment|Death|4|||
105838244|NCT03430011|365064541|FG007|JCARH125 Treatment|Death|2|||
105838245|NCT03430011|365064534|FG000|JCARH125 Treatment|Other reasons|1|||
105838246|NCT03430011|365064535|FG001|JCARH125 Treatment|Other reasons|0|||
105838247|NCT03430011|365064536|FG002|JCARH125 Treatment|Other reasons|4|||
105838248|NCT03430011|365064537|FG003|JCARH125 Treatment|Other reasons|2|||
105838249|NCT03430011|365064538|FG004|JCARH125 Treatment|Other reasons|2|||
105838250|NCT03430011|365064539|FG005|JCARH125 Treatment|Other reasons|1|||
105838251|NCT03430011|365064540|FG006|JCARH125 Treatment|Other reasons|3|||
105838252|NCT03430011|365064541|FG007|JCARH125 Treatment|Other reasons|2|||
105838253|NCT00575380|365064542|FG000|Overall Study|Withdrawal by Subject|1|||
105838254|NCT00575380|365064543|FG001|Overall Study|Withdrawal by Subject|0|||
105838255|NCT00575380|365064542|FG000|Overall Study|Adverse Event|0|||
105838256|NCT00575380|365064543|FG001|Overall Study|Adverse Event|1|||
105838257|NCT00575380|365064542|FG000|Overall Study|Various|0|||
105838258|NCT00575380|365064543|FG001|Overall Study|Various|2|||
105838259|NCT03712124|365064553|FG000|Overall Study|Protocol Violation|1|||
105838260|NCT03712124|365064554|FG001|Overall Study|Protocol Violation|0|||
105838261|NCT01731886|365064555|FG000|Overall Study|Death|1|||
105838262|NCT01731886|365064556|FG001|Overall Study|Death|0|||
105838263|NCT01731886|365064555|FG000|Overall Study|Never started treatment|0|||
105838264|NCT01731886|365064556|FG001|Overall Study|Never started treatment|1|||
105838265|NCT01731886|365064555|FG000|Overall Study|Non-compliant|1|||
105838266|NCT01731886|365064556|FG001|Overall Study|Non-compliant|0|||
105838267|NCT00271024|365064557|FG000|Overall Study|Lost Interest|3|||
105838268|NCT00271024|365064558|FG001|Overall Study|Lost Interest|4|||
105838269|NCT00271024|365064559|FG002|Overall Study|Lost Interest|2|||
105838270|NCT00271024|365064560|FG003|Overall Study|Lost Interest|3|||
105838271|NCT00271024|365064557|FG000|Overall Study|Unknown/Unspecified|11|||
105838272|NCT00271024|365064558|FG001|Overall Study|Unknown/Unspecified|11|||
105838273|NCT00271024|365064559|FG002|Overall Study|Unknown/Unspecified|8|||
105838274|NCT00271024|365064560|FG003|Overall Study|Unknown/Unspecified|4|||
105838275|NCT00271024|365064557|FG000|Overall Study|Protocol Violation|1|||
105838276|NCT00271024|365064558|FG001|Overall Study|Protocol Violation|6|||
105838277|NCT00271024|365064559|FG002|Overall Study|Protocol Violation|5|||
105838278|NCT00271024|365064560|FG003|Overall Study|Protocol Violation|11|||
105838279|NCT00271024|365064557|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
105838280|NCT00271024|365064558|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
105838281|NCT00271024|365064559|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
105838282|NCT00271024|365064560|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
105838283|NCT00271024|365064557|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
105838284|NCT00271024|365064558|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
105838285|NCT00271024|365064559|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
105838286|NCT00271024|365064560|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
105838287|NCT02105701|365064564|FG000|Overall Study|Lost to Follow-up|1|||
105838288|NCT02105701|365064565|FG001|Overall Study|Lost to Follow-up|0|||
105838289|NCT02105701|365064566|FG002|Overall Study|Lost to Follow-up|2|||
105838290|NCT02105701|365064567|FG003|Overall Study|Lost to Follow-up|1|||
105838291|NCT02105701|365064564|FG000|Overall Study|Protocol Violation|0|||
105838292|NCT02105701|365064565|FG001|Overall Study|Protocol Violation|0|||
105838293|NCT02105701|365064566|FG002|Overall Study|Protocol Violation|1|||
105838294|NCT02105701|365064567|FG003|Overall Study|Protocol Violation|0|||
105838295|NCT02105701|365064564|FG000|Overall Study|Withdrawal by Subject|2|||
105838296|NCT02105701|365064565|FG001|Overall Study|Withdrawal by Subject|1|||
105838297|NCT02105701|365064566|FG002|Overall Study|Withdrawal by Subject|0|||
105838298|NCT02105701|365064567|FG003|Overall Study|Withdrawal by Subject|1|||
105838299|NCT02105701|365064564|FG000|Overall Study|Death|1|||
105838300|NCT02105701|365064565|FG001|Overall Study|Death|0|||
105838301|NCT02105701|365064566|FG002|Overall Study|Death|0|||
105838302|NCT02105701|365064567|FG003|Overall Study|Death|0|||
105838303|NCT03078478|365064568|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
105838304|NCT03078478|365064569|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
105838305|NCT03078478|365064568|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
105838306|NCT03078478|365064569|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
105838307|NCT03078478|365064568|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
105838308|NCT03078478|365064569|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
105838309|NCT03078478|365064568|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
105838310|NCT03078478|365064569|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
105838311|NCT03078478|365064568|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
105838312|NCT03078478|365064569|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
105838313|NCT03078478|365064568|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
105838314|NCT03078478|365064569|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
105838315|NCT03078478|365064568|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
105838316|NCT03078478|365064569|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
105838317|NCT03078478|365064568|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
105838318|NCT03078478|365064569|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
105838319|NCT02459418|365066222|FG000|Overall Study|Exclusion Criteria|4|||
105838320|NCT02459418|365066223|FG001|Overall Study|Exclusion Criteria|0|||
105838321|NCT02459418|365066222|FG000|Overall Study|Protocol Violation|0|||
105838322|NCT02459418|365066223|FG001|Overall Study|Protocol Violation|2|||
105838323|NCT02459418|365066222|FG000|Overall Study|Physician Decision|0|||
105838324|NCT02459418|365066223|FG001|Overall Study|Physician Decision|2|||
105838325|NCT02459418|365066222|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
105838326|NCT02459418|365066223|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
105838327|NCT02459418|365066222|FG000|Overall Study|Adverse Event|0|||
105838328|NCT02459418|365066223|FG001|Overall Study|Adverse Event|1|||
105838329|NCT02459418|365066222|FG000|Overall Study|Withdrawal by Subject|1|||
105838330|NCT02459418|365066223|FG001|Overall Study|Withdrawal by Subject|1|||
105838331|NCT02459418|365066222|FG000|Overall Study|Elevated Creatine Kinase|1|||
105838332|NCT02459418|365066223|FG001|Overall Study|Elevated Creatine Kinase|0|||
105838333|NCT02459418|365066222|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
105838334|NCT02459418|365066223|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
105838335|NCT01989676|365066224|FG000|Overall Study|Death|52|||
105838336|NCT01989676|365066225|FG001|Overall Study|Death|60|||
105838337|NCT01989676|365066224|FG000|Overall Study|Protocol Violation|2|||
105838338|NCT01989676|365066225|FG001|Overall Study|Protocol Violation|1|||
105838339|NCT01989676|365066224|FG000|Overall Study|Lost to Follow-up|8|||
105838340|NCT01989676|365066225|FG001|Overall Study|Lost to Follow-up|18|||
105838341|NCT01989676|365066224|FG000|Overall Study|No longer willing to participate in study|26|||
105838342|NCT01989676|365066225|FG001|Overall Study|No longer willing to participate in study|26|||
105838343|NCT01989676|365066224|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
105838344|NCT01989676|365066225|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
105838345|NCT01989676|365066224|FG000|Overall Study|Other|4|||
105838346|NCT01989676|365066225|FG001|Overall Study|Other|3|||
105838347|NCT03941834|365066226|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
105838348|NCT03941834|365066227|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
105838349|NCT03941834|365066228|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
105838350|NCT03941834|365066226|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
105838351|NCT03941834|365066227|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
105838352|NCT03941834|365066228|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
105838353|NCT03941834|365066226|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
105838354|NCT03941834|365066227|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
105838355|NCT03941834|365066228|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
105838356|NCT03941834|365066226|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
105838357|NCT03941834|365066227|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
105838358|NCT03941834|365066228|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
105838359|NCT03941834|365066226|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
105838360|NCT03941834|365066227|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
105838361|NCT03941834|365066228|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
105838362|NCT03941834|365066226|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
105838363|NCT03941834|365066227|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
105838364|NCT03941834|365066228|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
105838365|NCT02788513|365066233|FG000|Overall Study|Withdrawal by Subject|3|||
105838366|NCT02788513|365066234|FG001|Overall Study|Withdrawal by Subject|0|||
105838367|NCT02788513|365066235|FG002|Overall Study|Withdrawal by Subject|2|||
105838368|NCT02788513|365066236|FG003|Overall Study|Withdrawal by Subject|3|||
105838369|NCT02788513|365066237|FG004|Overall Study|Withdrawal by Subject|1|||
105838370|NCT02788513|365066233|FG000|Overall Study|Lost to Follow-up|1|||
105838371|NCT02788513|365066234|FG001|Overall Study|Lost to Follow-up|0|||
105838372|NCT02788513|365066235|FG002|Overall Study|Lost to Follow-up|0|||
105838373|NCT02788513|365066236|FG003|Overall Study|Lost to Follow-up|0|||
105838374|NCT02788513|365066237|FG004|Overall Study|Lost to Follow-up|1|||
105838375|NCT02788513|365066233|FG000|Overall Study|Adverse Event|5|||
105838376|NCT02788513|365066234|FG001|Overall Study|Adverse Event|8|||
105838377|NCT02788513|365066235|FG002|Overall Study|Adverse Event|4|||
105838378|NCT02788513|365066236|FG003|Overall Study|Adverse Event|2|||
105838379|NCT02788513|365066237|FG004|Overall Study|Adverse Event|2|||
105838380|NCT02788513|365066233|FG000|Overall Study|Protocol Violation|0|||
105838381|NCT02788513|365066234|FG001|Overall Study|Protocol Violation|0|||
105838382|NCT02788513|365066235|FG002|Overall Study|Protocol Violation|1|||
105489882|NCT03963401|363805676|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
105489883|NCT03963401|363805677|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
105838383|NCT02788513|365066236|FG003|Overall Study|Protocol Violation|1|||
105838384|NCT02788513|365066237|FG004|Overall Study|Protocol Violation|0|||
105838385|NCT02788513|365066233|FG000|Overall Study|Subject decided to stop taking treatment|0|||
105311230|NCT04642365|363136331|FG000|Overall Study|Progressive Disease|1|||
105311231|NCT04642365|363136332|FG001|Overall Study|Progressive Disease|1|||
105311232|NCT04642365|363136333|FG002|Overall Study|Progressive Disease|1|||
105311233|NCT04642365|363136334|FG003|Overall Study|Progressive Disease|0|||
105311234|NCT04642365|363136335|FG004|Overall Study|Progressive Disease|0|||
105311235|NCT04642365|363136336|FG005|Overall Study|Progressive Disease|0|||
105311236|NCT04642365|363136337|FG006|Overall Study|Progressive Disease|1|||
105311237|NCT04642365|363136338|FG007|Overall Study|Progressive Disease|0|||
105311238|NCT04642365|363136331|FG000|Overall Study|Study Terminated By Sponsor|0|||
105311239|NCT04642365|363136332|FG001|Overall Study|Study Terminated By Sponsor|2|||
105311240|NCT04642365|363136333|FG002|Overall Study|Study Terminated By Sponsor|1|||
105311241|NCT04642365|363136334|FG003|Overall Study|Study Terminated By Sponsor|1|||
105311242|NCT04642365|363136335|FG004|Overall Study|Study Terminated By Sponsor|1|||
105311243|NCT04642365|363136336|FG005|Overall Study|Study Terminated By Sponsor|2|||
105311244|NCT04642365|363136337|FG006|Overall Study|Study Terminated By Sponsor|2|||
105311245|NCT04642365|363136338|FG007|Overall Study|Study Terminated By Sponsor|1|||
105311246|NCT04642365|363136331|FG000|Overall Study|Symptomatic Deterioration|1|||
105311247|NCT04642365|363136332|FG001|Overall Study|Symptomatic Deterioration|1|||
105311248|NCT04642365|363136333|FG002|Overall Study|Symptomatic Deterioration|0|||
105311249|NCT04642365|363136334|FG003|Overall Study|Symptomatic Deterioration|0|||
105311250|NCT04642365|363136335|FG004|Overall Study|Symptomatic Deterioration|0|||
105311251|NCT04642365|363136336|FG005|Overall Study|Symptomatic Deterioration|1|||
105311252|NCT04642365|363136337|FG006|Overall Study|Symptomatic Deterioration|0|||
105311253|NCT04642365|363136338|FG007|Overall Study|Symptomatic Deterioration|0|||
105311254|NCT04642365|363136331|FG000|Overall Study|Withdrawal by Subject|0|||
105311255|NCT04642365|363136332|FG001|Overall Study|Withdrawal by Subject|0|||
105311256|NCT04642365|363136333|FG002|Overall Study|Withdrawal by Subject|1|||
105311257|NCT04642365|363136334|FG003|Overall Study|Withdrawal by Subject|1|||
105311258|NCT04642365|363136335|FG004|Overall Study|Withdrawal by Subject|0|||
105311259|NCT04642365|363136336|FG005|Overall Study|Withdrawal by Subject|0|||
105311260|NCT04642365|363136337|FG006|Overall Study|Withdrawal by Subject|2|||
105311261|NCT04642365|363136338|FG007|Overall Study|Withdrawal by Subject|0|||
105311262|NCT04642365|363136331|FG000|Overall Study|Adverse Event|0|||
105311263|NCT04642365|363136332|FG001|Overall Study|Adverse Event|0|||
105311264|NCT04642365|363136333|FG002|Overall Study|Adverse Event|0|||
105311265|NCT04642365|363136334|FG003|Overall Study|Adverse Event|0|||
105311266|NCT04642365|363136335|FG004|Overall Study|Adverse Event|0|||
105311267|NCT04642365|363136336|FG005|Overall Study|Adverse Event|0|||
105311268|NCT04642365|363136337|FG006|Overall Study|Adverse Event|0|||
105311269|NCT04642365|363136338|FG007|Overall Study|Adverse Event|1|||
105311270|NCT01144715|363136339|FG000|Overall Study|Lost to Follow-up|2|||
105311271|NCT01144715|363136340|FG001|Overall Study|Lost to Follow-up|1|||
105311272|NCT01144715|363136339|FG000|Overall Study|Withdrawal by Subject|2|||
105311273|NCT01144715|363136340|FG001|Overall Study|Withdrawal by Subject|1|||
105311274|NCT01144715|363136339|FG000|Overall Study|Adverse Event|0|||
105311275|NCT01144715|363136340|FG001|Overall Study|Adverse Event|1|||
105311276|NCT06281171|363136341|FG000|Timepoint 2|Lost to Follow-up|6|||
105311277|NCT06281171|363136342|FG001|Timepoint 2|Lost to Follow-up|4|||
105311278|NCT06281171|363136341|FG000|Timepoint 3|Lost to Follow-up|0|||
105311279|NCT06281171|363136342|FG001|Timepoint 3|Lost to Follow-up|5|||
105311280|NCT00418821|363136350|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
105311281|NCT00461253|363137843|FG000|Overall Study|Death|985|||
105311282|NCT00461253|363137844|FG001|Overall Study|Death|0|||
105311283|NCT00461253|363137843|FG000|Overall Study|Protocol Violation|613|||
105311284|NCT00461253|363137844|FG001|Overall Study|Protocol Violation|236|||
105311285|NCT00461253|363137843|FG000|Overall Study|no response|2609|||
105311286|NCT00461253|363137844|FG001|Overall Study|no response|11789|||
105311287|NCT00461253|363137843|FG000|Overall Study|administrative|773|||
105311288|NCT00461253|363137844|FG001|Overall Study|administrative|7773|||
105311289|NCT05307510|363137845|FG000|Overall Study|Lost to Follow-up|3|||
105311290|NCT05307510|363137846|FG001|Overall Study|Lost to Follow-up|6|||
105311291|NCT05307510|363137845|FG000|Overall Study|Withdrawal by Subject|0|||
105311292|NCT05307510|363137846|FG001|Overall Study|Withdrawal by Subject|1|||
105311293|NCT01957397|363137847|FG000|Test Period 1|sudden leakage/small bag|1|||
105311294|NCT01957397|363137848|FG001|Test Period 1|sudden leakage/small bag|1|||
105311295|NCT01957397|363137847|FG000|Test Period 1|Withdrawal by Subject|1|||
105311296|NCT01957397|363137848|FG001|Test Period 1|Withdrawal by Subject|0|||
105311297|NCT01957397|363137847|FG000|Test Period 2|Adverse Event|0|||
105311298|NCT01957397|363137848|FG001|Test Period 2|Adverse Event|1|||
105311299|NCT01957397|363137847|FG000|Test Period 3|Adverse Event|1|||
105311300|NCT01957397|363137848|FG001|Test Period 3|Adverse Event|2|||
105311301|NCT01957397|363137847|FG000|Test Period 3|the adhesive did not work|1|||
105311302|NCT01957397|363137848|FG001|Test Period 3|the adhesive did not work|0|||
105311303|NCT02618759|363137849|FG000|Overall Study|Lost to Follow-up|0|||
105311304|NCT02618759|363137850|FG001|Overall Study|Lost to Follow-up|1|||
105311305|NCT02618759|363137849|FG000|Overall Study|Withdrawal by Subject|1|||
105311306|NCT02618759|363137850|FG001|Overall Study|Withdrawal by Subject|0|||
105311307|NCT02618759|363137849|FG000|Overall Study|Other Reasons|1|||
105838386|NCT02788513|365066234|FG001|Overall Study|Subject decided to stop taking treatment|0|||
105838387|NCT02788513|365066235|FG002|Overall Study|Subject decided to stop taking treatment|1|||
105838388|NCT02788513|365066236|FG003|Overall Study|Subject decided to stop taking treatment|0|||
105838389|NCT02788513|365066237|FG004|Overall Study|Subject decided to stop taking treatment|0|||
105838390|NCT02788513|365066233|FG000|Overall Study|Decision by the study team|0|||
105838391|NCT02788513|365066234|FG001|Overall Study|Decision by the study team|0|||
105838392|NCT02788513|365066235|FG002|Overall Study|Decision by the study team|0|||
105838393|NCT02788513|365066236|FG003|Overall Study|Decision by the study team|0|||
105838394|NCT02788513|365066237|FG004|Overall Study|Decision by the study team|1|||
105838395|NCT02012452|365066238|FG000|Overall Study|Lost to Follow-up|2|||
105838396|NCT02012452|365066239|FG001|Overall Study|Lost to Follow-up|1|||
105838397|NCT02012452|365066238|FG000|Overall Study|Withdrawal by Subject|4|||
105838398|NCT02012452|365066239|FG001|Overall Study|Withdrawal by Subject|0|||
105838399|NCT02938442|365066240|FG000|Overall Study|Death|0|||
105838400|NCT02938442|365066241|FG001|Overall Study|Death|1|||
105838401|NCT02938442|365066240|FG000|Overall Study|Lost to Follow-up|0|||
105838402|NCT02938442|365066241|FG001|Overall Study|Lost to Follow-up|1|||
105838403|NCT02938442|365066240|FG000|Overall Study|Physician Decision|0|||
105838404|NCT02938442|365066241|FG001|Overall Study|Physician Decision|1|||
105838405|NCT02938442|365066240|FG000|Overall Study|Withdrawal by Subject|2|||
105838406|NCT02938442|365066241|FG001|Overall Study|Withdrawal by Subject|0|||
105838407|NCT04403399|365066242|FG000|Period 2|Physician Decision|0|||
105838408|NCT04403399|365066243|FG001|Period 2|Physician Decision|1|||
105838409|NCT02014441|365066244|FG000|Overall Study|Withdrawal by Subject|12|||
105838410|NCT00802178|365066245|FG000|Overall Study|Lack of Efficacy|36|||
105838411|NCT00802178|365066245|FG000|Overall Study|Insufficient tolerability (IT)|17|||
105838412|NCT00802178|365066245|FG000|Overall Study|Withdrawal by Subject|18|||
105838413|NCT00802178|365066245|FG000|Overall Study|Other|32|||
105838414|NCT00802178|365066245|FG000|Overall Study|Lack of efficacy and patient wish|1|||
105838415|NCT00802178|365066245|FG000|Overall Study|IT and patient wish|8|||
105838416|NCT00802178|365066245|FG000|Overall Study|Patients wish and other reason|1|||
105838417|NCT01606228|365066246|FG000|Overall Study|Lost to Follow-up|20|||
105838418|NCT01606228|365066246|FG000|Overall Study|Withdrawal by Subject|3|||
105838419|NCT01606228|365066246|FG000|Overall Study|Non-compliant|3|||
105838420|NCT01606228|365066246|FG000|Overall Study|Lack of Efficacy|2|||
105838421|NCT01606228|365066246|FG000|Overall Study|Adverse Event|1|||
105838422|NCT00546910|365066247|FG000|Overall Study|Adverse Event|2|||
105838423|NCT00546910|365066248|FG001|Overall Study|Adverse Event|3|||
105838424|NCT00546910|365066247|FG000|Overall Study|Lack of Efficacy|5|||
105838425|NCT00546910|365066248|FG001|Overall Study|Lack of Efficacy|7|||
105838426|NCT00546910|365066247|FG000|Overall Study|Physician Decision|0|||
105838427|NCT00546910|365066248|FG001|Overall Study|Physician Decision|1|||
105838428|NCT00546910|365066247|FG000|Overall Study|Withdrawal by Subject|2|||
105838429|NCT00546910|365066248|FG001|Overall Study|Withdrawal by Subject|0|||
105838430|NCT01933919|365066250|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
105838431|NCT01933919|365066251|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
105838432|NCT01933919|365066250|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
105367578|NCT04161391|363352327|FG006|Overall Study|Physician Decision|2|||
105367579|NCT04161391|363352328|FG007|Overall Study|Physician Decision|0|||
105489884|NCT03963401|363805678|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
105838433|NCT01933919|365066251|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
105838434|NCT01933919|365066250|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
105838435|NCT01933919|365066251|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
105838436|NCT01933919|365066250|FG000|Open-label Long-term Phase|Adverse Event|2|||
105838437|NCT01933919|365066251|FG001|Open-label Long-term Phase|Adverse Event|0|||
105838438|NCT01933919|365066250|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
105838439|NCT01933919|365066251|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
105838440|NCT01933919|365066250|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
105838441|NCT01933919|365066251|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
105838442|NCT01933919|365066250|FG000|Open-label Long-term Phase|Other|1|||
105838443|NCT01933919|365066251|FG001|Open-label Long-term Phase|Other|2|||
105838444|NCT01961882|365066252|FG000|Overall Study|Adverse Event|3|||
105838445|NCT01961882|365066253|FG001|Overall Study|Adverse Event|2|||
105838446|NCT01961882|365066252|FG000|Overall Study|Physician Decision|1|||
105838447|NCT01961882|365066253|FG001|Overall Study|Physician Decision|0|||
105838448|NCT01961882|365066252|FG000|Overall Study|Withdrawal by Subject|4|||
105838449|NCT01961882|365066253|FG001|Overall Study|Withdrawal by Subject|1|||
105838450|NCT01961882|365066252|FG000|Overall Study|Relapse of AML|39|||
105838451|NCT01961882|365066253|FG001|Overall Study|Relapse of AML|37|||
105838452|NCT01961882|365066252|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
105838453|NCT01961882|365066253|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
105576508|NCT01340482|364110177|FG002|Overall Study|Adverse Event|0|||
105838454|NCT01961882|365066252|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
105838455|NCT01961882|365066253|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
105838456|NCT00991510|365066254|FG000|Period I (Days 1-14)|Adverse Event|1|||
105838457|NCT00991510|365066255|FG001|Period I (Days 1-14)|Adverse Event|0|||
105838458|NCT00991510|365066254|FG000|Period III (Days 29-112)|Adverse Event|1|||
105838459|NCT00991510|365066255|FG001|Period III (Days 29-112)|Adverse Event|1|||
105838460|NCT00852917|365066262|FG000|Overall Study|Adverse Event|13|||
105838461|NCT00852917|365066263|FG001|Overall Study|Adverse Event|20|||
105838462|NCT00852917|365066264|FG002|Overall Study|Adverse Event|35|||
105838463|NCT00852917|365066265|FG003|Overall Study|Adverse Event|17|||
105838464|NCT00852917|365066262|FG000|Overall Study|Lack of Efficacy|21|||
105838465|NCT00852917|365066263|FG001|Overall Study|Lack of Efficacy|11|||
105838466|NCT00852917|365066264|FG002|Overall Study|Lack of Efficacy|11|||
105838467|NCT00852917|365066265|FG003|Overall Study|Lack of Efficacy|47|||
105838468|NCT00852917|365066262|FG000|Overall Study|Withdrawal by Subject|4|||
105838469|NCT00852917|365066263|FG001|Overall Study|Withdrawal by Subject|8|||
105838470|NCT00852917|365066264|FG002|Overall Study|Withdrawal by Subject|10|||
105838471|NCT00852917|365066265|FG003|Overall Study|Withdrawal by Subject|9|||
105838472|NCT00852917|365066262|FG000|Overall Study|Physician Decision|6|||
105838473|NCT00852917|365066263|FG001|Overall Study|Physician Decision|7|||
105838474|NCT00852917|365066264|FG002|Overall Study|Physician Decision|2|||
105838475|NCT00852917|365066265|FG003|Overall Study|Physician Decision|19|||
105838476|NCT00852917|365066262|FG000|Overall Study|Death|0|||
105838477|NCT00852917|365066263|FG001|Overall Study|Death|0|||
105838478|NCT00852917|365066264|FG002|Overall Study|Death|0|||
105838479|NCT00852917|365066265|FG003|Overall Study|Death|1|||
105838480|NCT03710590|365066266|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
105838481|NCT03710590|365066267|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
105838482|NCT01976728|365066269|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
105838483|NCT01976728|365066270|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
105838484|NCT01976728|365066271|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
105838485|NCT01976728|365066272|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
105838486|NCT02443324|365066274|FG000|Overall Study|Death|4|||
105838487|NCT02443324|365066275|FG001|Overall Study|Death|1|||
105838488|NCT02443324|365066276|FG002|Overall Study|Death|0|||
105838489|NCT02443324|365066277|FG003|Overall Study|Death|3|||
105838490|NCT02443324|365066278|FG004|Overall Study|Death|1|||
105838491|NCT02443324|365066279|FG005|Overall Study|Death|3|||
105838492|NCT02443324|365066280|FG006|Overall Study|Death|2|||
105838493|NCT02443324|365066274|FG000|Overall Study|Lost to Follow-up|0|||
105838494|NCT02443324|365066275|FG001|Overall Study|Lost to Follow-up|0|||
105838495|NCT02443324|365066276|FG002|Overall Study|Lost to Follow-up|0|||
105838496|NCT02443324|365066277|FG003|Overall Study|Lost to Follow-up|1|||
105838497|NCT02443324|365066278|FG004|Overall Study|Lost to Follow-up|0|||
105838498|NCT02443324|365066279|FG005|Overall Study|Lost to Follow-up|1|||
105838499|NCT02443324|365066280|FG006|Overall Study|Lost to Follow-up|0|||
105838500|NCT02443324|365066274|FG000|Overall Study|Physician Decision|0|||
105838501|NCT02443324|365066275|FG001|Overall Study|Physician Decision|3|||
105838502|NCT02443324|365066276|FG002|Overall Study|Physician Decision|5|||
105838503|NCT02443324|365066277|FG003|Overall Study|Physician Decision|1|||
105838504|NCT02443324|365066278|FG004|Overall Study|Physician Decision|1|||
105838505|NCT02443324|365066279|FG005|Overall Study|Physician Decision|0|||
105838506|NCT02443324|365066280|FG006|Overall Study|Physician Decision|2|||
105838507|NCT02443324|365066274|FG000|Overall Study|Progressive Disease|20|||
105838508|NCT02443324|365066275|FG001|Overall Study|Progressive Disease|20|||
105838509|NCT02443324|365066276|FG002|Overall Study|Progressive Disease|13|||
105838510|NCT02443324|365066277|FG003|Overall Study|Progressive Disease|10|||
105838511|NCT02443324|365066278|FG004|Overall Study|Progressive Disease|13|||
105838512|NCT02443324|365066279|FG005|Overall Study|Progressive Disease|17|||
105838513|NCT02443324|365066280|FG006|Overall Study|Progressive Disease|10|||
105838514|NCT02443324|365066274|FG000|Overall Study|Withdrawal by Subject|0|||
105838515|NCT02443324|365066275|FG001|Overall Study|Withdrawal by Subject|0|||
105838516|NCT02443324|365066276|FG002|Overall Study|Withdrawal by Subject|3|||
105838517|NCT02443324|365066277|FG003|Overall Study|Withdrawal by Subject|1|||
105838518|NCT02443324|365066278|FG004|Overall Study|Withdrawal by Subject|1|||
105838519|NCT02443324|365066279|FG005|Overall Study|Withdrawal by Subject|0|||
105838520|NCT02443324|365066280|FG006|Overall Study|Withdrawal by Subject|1|||
105838521|NCT02443324|365066274|FG000|Overall Study|Adverse Event|0|||
105838522|NCT02443324|365066275|FG001|Overall Study|Adverse Event|1|||
105838523|NCT02443324|365066276|FG002|Overall Study|Adverse Event|3|||
105838524|NCT02443324|365066277|FG003|Overall Study|Adverse Event|0|||
105838525|NCT02443324|365066278|FG004|Overall Study|Adverse Event|4|||
105838526|NCT02443324|365066279|FG005|Overall Study|Adverse Event|3|||
105838527|NCT02443324|365066280|FG006|Overall Study|Adverse Event|3|||
105838528|NCT02443324|365066274|FG000|Overall Study|Enrolled but Never Treated|0|||
105838529|NCT02443324|365066275|FG001|Overall Study|Enrolled but Never Treated|0|||
105838530|NCT02443324|365066276|FG002|Overall Study|Enrolled but Never Treated|1|||
105838531|NCT02443324|365066277|FG003|Overall Study|Enrolled but Never Treated|0|||
105838532|NCT02443324|365066278|FG004|Overall Study|Enrolled but Never Treated|1|||
105838533|NCT02443324|365066279|FG005|Overall Study|Enrolled but Never Treated|0|||
105838534|NCT02443324|365066280|FG006|Overall Study|Enrolled but Never Treated|1|||
105838535|NCT04025684|365066281|FG000|Overall Study|Withdrawal by Subject|1|||
105838536|NCT04025684|365066282|FG001|Overall Study|Withdrawal by Subject|1|||
105838537|NCT04025684|365066283|FG002|Overall Study|Withdrawal by Subject|0|||
105838538|NCT04025684|365066284|FG003|Overall Study|Withdrawal by Subject|0|||
105838539|NCT04025684|365066281|FG000|Overall Study|Multiple reasons|1|||
105838540|NCT04025684|365066282|FG001|Overall Study|Multiple reasons|3|||
105838541|NCT04025684|365066283|FG002|Overall Study|Multiple reasons|0|||
105838542|NCT04025684|365066284|FG003|Overall Study|Multiple reasons|1|||
105838543|NCT02744755|365066287|FG000|Study Period 1|Protocol Violation|2|||
105838544|NCT02744755|365066288|FG001|Study Period 1|Protocol Violation|1|||
105838545|NCT02744755|365066287|FG000|Study Period 1|not defined|0|||
105838546|NCT02744755|365066288|FG001|Study Period 1|not defined|1|||
105838547|NCT02744755|365066287|FG000|Study Period 1|Pregnancy|1|||
105838548|NCT02744755|365066288|FG001|Study Period 1|Pregnancy|0|||
105838549|NCT02744755|365066287|FG000|Study Period 1|Adverse Event|1|||
105838550|NCT02744755|365066288|FG001|Study Period 1|Adverse Event|1|||
105838551|NCT02744755|365066287|FG000|Study Period 1|Lost to Follow-up|1|||
105838552|NCT02744755|365066288|FG001|Study Period 1|Lost to Follow-up|1|||
105838553|NCT02744755|365066287|FG000|Study Period 1|Lack of Efficacy|1|||
105838554|NCT02744755|365066288|FG001|Study Period 1|Lack of Efficacy|0|||
105838555|NCT02744755|365066287|FG000|Study Period 1|Withdrawal by Subject|8|||
105838556|NCT02744755|365066288|FG001|Study Period 1|Withdrawal by Subject|4|||
105838557|NCT02744755|365066287|FG000|Study Period 2|Adverse Event|5|||
105838558|NCT02744755|365066288|FG001|Study Period 2|Adverse Event|0|||
105838559|NCT02744755|365066287|FG000|Study Period 2|Protocol Violation|1|||
105838560|NCT02744755|365066288|FG001|Study Period 2|Protocol Violation|0|||
105838561|NCT02744755|365066287|FG000|Study Period 2|not defined|3|||
105838562|NCT02744755|365066288|FG001|Study Period 2|not defined|2|||
105838563|NCT02744755|365066287|FG000|Study Period 2|Lost to Follow-up|0|||
105838564|NCT02744755|365066288|FG001|Study Period 2|Lost to Follow-up|2|||
105838565|NCT02744755|365066287|FG000|Study Period 2|Withdrawal by Subject|2|||
105838566|NCT02744755|365066288|FG001|Study Period 2|Withdrawal by Subject|2|||
105838567|NCT02744755|365066287|FG000|Study Period 2|Lack of Efficacy|3|||
105838568|NCT02744755|365066288|FG001|Study Period 2|Lack of Efficacy|2|||
105838569|NCT01239472|365066290|FG000|Overall Study|Withdrawal by Subject|5|||
105838570|NCT01239472|365066291|FG001|Overall Study|Withdrawal by Subject|1|||
105838571|NCT01239472|365066290|FG000|Overall Study|Adverse Event|0|||
105838572|NCT01239472|365066291|FG001|Overall Study|Adverse Event|1|||
105838573|NCT01239472|365066290|FG000|Overall Study|Lack of Efficacy|0|||
105838574|NCT01239472|365066291|FG001|Overall Study|Lack of Efficacy|1|||
105838575|NCT02780167|365066292|FG000|Overall Study|Adverse Event|9|||
105838576|NCT02780167|365066293|FG001|Overall Study|Adverse Event|8|||
105838577|NCT02780167|365066294|FG002|Overall Study|Adverse Event|8|||
105838578|NCT02780167|365066295|FG003|Overall Study|Adverse Event|12|||
105838579|NCT02780167|365066296|FG004|Overall Study|Adverse Event|8|||
105838580|NCT02780167|365066292|FG000|Overall Study|Lack of Efficacy|6|||
105838581|NCT02780167|365066293|FG001|Overall Study|Lack of Efficacy|5|||
105838582|NCT02780167|365066294|FG002|Overall Study|Lack of Efficacy|6|||
105838583|NCT02780167|365066295|FG003|Overall Study|Lack of Efficacy|1|||
105838584|NCT02780167|365066296|FG004|Overall Study|Lack of Efficacy|0|||
105838585|NCT02780167|365066292|FG000|Overall Study|Lost to Follow-up|2|||
105838586|NCT02780167|365066293|FG001|Overall Study|Lost to Follow-up|0|||
105838587|NCT02780167|365066294|FG002|Overall Study|Lost to Follow-up|1|||
105838588|NCT02780167|365066295|FG003|Overall Study|Lost to Follow-up|0|||
105838589|NCT02780167|365066296|FG004|Overall Study|Lost to Follow-up|0|||
105838590|NCT02780167|365066292|FG000|Overall Study|Does not meet entrance criteria|0|||
105838591|NCT02780167|365066293|FG001|Overall Study|Does not meet entrance criteria|0|||
105838592|NCT02780167|365066294|FG002|Overall Study|Does not meet entrance criteria|1|||
105838593|NCT02780167|365066295|FG003|Overall Study|Does not meet entrance criteria|0|||
105838594|NCT02780167|365066296|FG004|Overall Study|Does not meet entrance criteria|0|||
105838595|NCT02780167|365066292|FG000|Overall Study|No longer meets eligibility criteria|0|||
105838596|NCT02780167|365066293|FG001|Overall Study|No longer meets eligibility criteria|0|||
105838597|NCT02780167|365066294|FG002|Overall Study|No longer meets eligibility criteria|0|||
105311308|NCT02618759|363137850|FG001|Overall Study|Other Reasons|4|||
105838598|NCT02780167|365066295|FG003|Overall Study|No longer meets eligibility criteria|1|||
105838599|NCT02780167|365066296|FG004|Overall Study|No longer meets eligibility criteria|1|||
105838600|NCT02780167|365066292|FG000|Overall Study|Protocol Violation|5|||
105838601|NCT02780167|365066293|FG001|Overall Study|Protocol Violation|5|||
105838602|NCT02780167|365066294|FG002|Overall Study|Protocol Violation|1|||
105838603|NCT02780167|365066295|FG003|Overall Study|Protocol Violation|1|||
105838604|NCT02780167|365066296|FG004|Overall Study|Protocol Violation|2|||
105838605|NCT02780167|365066292|FG000|Overall Study|Withdrawal by Subject|6|||
105838606|NCT02780167|365066293|FG001|Overall Study|Withdrawal by Subject|4|||
105838607|NCT02780167|365066294|FG002|Overall Study|Withdrawal by Subject|4|||
105838608|NCT02780167|365066295|FG003|Overall Study|Withdrawal by Subject|3|||
105838609|NCT02780167|365066296|FG004|Overall Study|Withdrawal by Subject|4|||
105838610|NCT02780167|365066292|FG000|Overall Study|Other|0|||
105838611|NCT02780167|365066293|FG001|Overall Study|Other|0|||
105838612|NCT02780167|365066294|FG002|Overall Study|Other|3|||
105838613|NCT02780167|365066295|FG003|Overall Study|Other|1|||
105838614|NCT02780167|365066296|FG004|Overall Study|Other|2|||
105838615|NCT02916693|365066297|FG000|Overall Study|Lost to Follow-up|7|||
105838616|NCT01223235|365066298|FG000|Overall Study|Withdrawal by Subject|1|||
105838617|NCT03235479|365066301|FG000|Overall Study|Lost to Follow-up|8|||
105838618|NCT03235479|365066302|FG001|Overall Study|Lost to Follow-up|11|||
105838619|NCT03235479|365066301|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
105838620|NCT03235479|365066302|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
105838621|NCT03235479|365066301|FG000|Overall Study|Pregnancy|1|||
105838622|NCT03235479|365066302|FG001|Overall Study|Pregnancy|0|||
105838623|NCT03235479|365066301|FG000|Overall Study|Protocol Deviation|1|||
105838624|NCT03235479|365066302|FG001|Overall Study|Protocol Deviation|3|||
105838625|NCT03235479|365066301|FG000|Overall Study|Technical Problems|3|||
105838626|NCT03235479|365066302|FG001|Overall Study|Technical Problems|2|||
105838627|NCT03235479|365066301|FG000|Overall Study|Withdrawal by Subject|2|||
105838628|NCT03235479|365066302|FG001|Overall Study|Withdrawal by Subject|2|||
105838629|NCT03235479|365066301|FG000|Overall Study|Other Reasons|3|||
105838630|NCT03235479|365066302|FG001|Overall Study|Other Reasons|5|||
105838631|NCT02001051|365066303|FG000|Overall Study|Deemed not eligible following enrollment|0|||
105838632|NCT02001051|365066304|FG001|Overall Study|Deemed not eligible following enrollment|1|||
105838633|NCT00529217|365066306|FG000|Overall Study|Lack of Efficacy|2|||
105311309|NCT04933968|363137851|FG000|Overall Study|Adverse Event|0|||
105311310|NCT04933968|363137852|FG001|Overall Study|Adverse Event|0|||
105311311|NCT04933968|363137853|FG002|Overall Study|Adverse Event|1|||
105311312|NCT04933968|363137854|FG003|Overall Study|Adverse Event|1|||
105311313|NCT04933968|363137855|FG004|Overall Study|Adverse Event|0|||
105311314|NCT04933968|363137856|FG005|Overall Study|Adverse Event|0|||
105311315|NCT04933968|363137851|FG000|Overall Study|Lost to Follow-up|1|||
105311316|NCT04933968|363137852|FG001|Overall Study|Lost to Follow-up|0|||
105311317|NCT04933968|363137853|FG002|Overall Study|Lost to Follow-up|1|||
105311318|NCT04933968|363137854|FG003|Overall Study|Lost to Follow-up|0|||
105311319|NCT04933968|363137855|FG004|Overall Study|Lost to Follow-up|0|||
105311320|NCT04933968|363137856|FG005|Overall Study|Lost to Follow-up|0|||
105311321|NCT04933968|363137851|FG000|Overall Study|Randomized not treated|1|||
105311322|NCT04933968|363137852|FG001|Overall Study|Randomized not treated|0|||
105311323|NCT04933968|363137853|FG002|Overall Study|Randomized not treated|0|||
105311324|NCT04933968|363137854|FG003|Overall Study|Randomized not treated|0|||
105311325|NCT04933968|363137855|FG004|Overall Study|Randomized not treated|0|||
105311326|NCT04933968|363137856|FG005|Overall Study|Randomized not treated|0|||
105311327|NCT04933968|363137851|FG000|Overall Study|Sponsor terminated study|0|||
105311328|NCT04933968|363137852|FG001|Overall Study|Sponsor terminated study|0|||
105311329|NCT04933968|363137853|FG002|Overall Study|Sponsor terminated study|0|||
105311330|NCT04933968|363137854|FG003|Overall Study|Sponsor terminated study|1|||
105311331|NCT04933968|363137855|FG004|Overall Study|Sponsor terminated study|2|||
105311332|NCT04933968|363137856|FG005|Overall Study|Sponsor terminated study|0|||
105311333|NCT04933968|363137851|FG000|Overall Study|Other|0|||
105311334|NCT04933968|363137852|FG001|Overall Study|Other|0|||
105311335|NCT04933968|363137853|FG002|Overall Study|Other|0|||
105311336|NCT04933968|363137854|FG003|Overall Study|Other|1|||
105311337|NCT04933968|363137855|FG004|Overall Study|Other|0|||
105311338|NCT04933968|363137856|FG005|Overall Study|Other|0|||
105311339|NCT04933968|363137851|FG000|Overall Study|Missing|1|||
105311340|NCT04933968|363137852|FG001|Overall Study|Missing|3|||
105311341|NCT04933968|363137853|FG002|Overall Study|Missing|2|||
105311342|NCT04933968|363137854|FG003|Overall Study|Missing|1|||
105311343|NCT04933968|363137855|FG004|Overall Study|Missing|1|||
105311344|NCT04933968|363137856|FG005|Overall Study|Missing|0|||
105311345|NCT01724489|363137857|FG000|Overall Study|Adverse Event|8|||
105311346|NCT01724489|363137858|FG001|Overall Study|Adverse Event|3|||
105311347|NCT01724489|363137857|FG000|Overall Study|Surgery, medication|1|||
105311348|NCT01724489|363137858|FG001|Overall Study|Surgery, medication|1|||
105311349|NCT01724489|363137857|FG000|Overall Study|Lost to Follow-up|1|||
105311350|NCT01724489|363137858|FG001|Overall Study|Lost to Follow-up|2|||
105311351|NCT01724489|363137857|FG000|Overall Study|Withdrawal by Subject|6|||
105311352|NCT01724489|363137858|FG001|Overall Study|Withdrawal by Subject|6|||
105311353|NCT00923273|363137859|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
105311354|NCT00923273|363137860|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
105311355|NCT00923273|363137861|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
105311356|NCT00923273|363137862|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
105311357|NCT00923273|363137863|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
105311358|NCT00923273|363137859|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
105311359|NCT00923273|363137860|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
105311360|NCT00923273|363137861|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
105838634|NCT00529217|365066306|FG000|Overall Study|Unable to adhere to study schedule|2|||
105838635|NCT01790113|365066307|FG000|Overall Study|Adverse Event|2|||
105838636|NCT01790113|365066308|FG001|Overall Study|Adverse Event|7|||
105838637|NCT01790113|365066307|FG000|Overall Study|Study ended due to FDA clearance|1|||
105838638|NCT01790113|365066308|FG001|Overall Study|Study ended due to FDA clearance|68|||
105838639|NCT01519947|365066309|FG000|Overall Study|Death|0|||
105838640|NCT01519947|365066310|FG001|Overall Study|Death|0|||
105838641|NCT01519947|365066311|FG002|Overall Study|Death|0|||
105838642|NCT01519947|365066312|FG003|Overall Study|Death|1|||
105838643|NCT01519947|365066309|FG000|Overall Study|Protocol Violation|0|||
105838644|NCT01519947|365066310|FG001|Overall Study|Protocol Violation|0|||
105838645|NCT01519947|365066311|FG002|Overall Study|Protocol Violation|2|||
105838646|NCT01519947|365066312|FG003|Overall Study|Protocol Violation|1|||
105838647|NCT01519947|365066309|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
105838648|NCT01519947|365066310|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
105838649|NCT01519947|365066311|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
105838650|NCT01519947|365066312|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
105838651|NCT01519947|365066309|FG000|Overall Study|Development of Anemia|0|||
105838652|NCT01519947|365066310|FG001|Overall Study|Development of Anemia|1|||
105838653|NCT01519947|365066311|FG002|Overall Study|Development of Anemia|0|||
105838654|NCT01519947|365066312|FG003|Overall Study|Development of Anemia|1|||
105838655|NCT01519947|365066309|FG000|Overall Study|Blood Transfusion|0|||
105838656|NCT01519947|365066310|FG001|Overall Study|Blood Transfusion|1|||
105838657|NCT01519947|365066311|FG002|Overall Study|Blood Transfusion|1|||
105838658|NCT01519947|365066312|FG003|Overall Study|Blood Transfusion|0|||
105838659|NCT01519947|365066309|FG000|Overall Study|Withdrawal by Subject|0|||
105838660|NCT01519947|365066310|FG001|Overall Study|Withdrawal by Subject|1|||
105838661|NCT01519947|365066311|FG002|Overall Study|Withdrawal by Subject|0|||
105838662|NCT01519947|365066312|FG003|Overall Study|Withdrawal by Subject|1|||
105838663|NCT01519947|365066309|FG000|Overall Study|Lost to Follow-up|0|||
105838664|NCT01519947|365066310|FG001|Overall Study|Lost to Follow-up|0|||
105838665|NCT01519947|365066311|FG002|Overall Study|Lost to Follow-up|3|||
105838666|NCT01519947|365066312|FG003|Overall Study|Lost to Follow-up|2|||
105838667|NCT01519947|365066309|FG000|Overall Study|Poor Response|1|||
105838668|NCT01519947|365066310|FG001|Overall Study|Poor Response|0|||
105838669|NCT01519947|365066311|FG002|Overall Study|Poor Response|0|||
105838670|NCT01519947|365066312|FG003|Overall Study|Poor Response|1|||
105838671|NCT01519947|365066309|FG000|Overall Study|Adverse Event|1|||
105838672|NCT01519947|365066310|FG001|Overall Study|Adverse Event|0|||
105838673|NCT01519947|365066311|FG002|Overall Study|Adverse Event|1|||
105838674|NCT01519947|365066312|FG003|Overall Study|Adverse Event|1|||
105838675|NCT02274948|365066313|FG000|Overall Study|Lost to Follow-up|28|||
105838676|NCT02274948|365066314|FG001|Overall Study|Lost to Follow-up|25|||
105838677|NCT02274948|365066313|FG000|Overall Study|Withdrawal by Subject|64|||
105838678|NCT02274948|365066314|FG001|Overall Study|Withdrawal by Subject|58|||
105838679|NCT02274948|365066313|FG000|Overall Study|Stopped on family Practitioner advice|2|||
105838680|NCT02274948|365066314|FG001|Overall Study|Stopped on family Practitioner advice|5|||
105838681|NCT02274948|365066313|FG000|Overall Study|Left the area|4|||
105838682|NCT02274948|365066314|FG001|Overall Study|Left the area|3|||
105838683|NCT00707434|365066315|FG000|Overall Study|Adverse Event|1|||
105838684|NCT00931463|365066324|FG000|Overall Study|Death|8|||
105838685|NCT00931463|365066325|FG001|Overall Study|Death|4|||
105838686|NCT00931463|365066324|FG000|Overall Study|Withdrawal by Subject|5|||
105838687|NCT00931463|365066325|FG001|Overall Study|Withdrawal by Subject|0|||
105838688|NCT00931463|365066324|FG000|Overall Study|Lost to Follow-up|4|||
105838689|NCT00931463|365066325|FG001|Overall Study|Lost to Follow-up|1|||
105838690|NCT02169791|365066326|FG000|Overall Study|Death|6|||
105838691|NCT02169791|365066326|FG000|Overall Study|patient withdrew consent|1|||
105838692|NCT01009515|365066329|FG000|Overall Study|Withdrawal by Subject|3|||
105838693|NCT02539368|365066336|FG000|Overall Study|Death|4|||
105838694|NCT02539368|365066337|FG001|Overall Study|Death|2|||
105838695|NCT02539368|365066338|FG002|Overall Study|Death|1|||
105838696|NCT02539368|365066339|FG003|Overall Study|Death|0|||
105838697|NCT02539368|365066340|FG004|Overall Study|Death|0|||
105838698|NCT02539368|365066336|FG000|Overall Study|Withdrawal by Subject|44|||
105838699|NCT02539368|365066337|FG001|Overall Study|Withdrawal by Subject|35|||
105367580|NCT04161391|363352329|FG008|Overall Study|Physician Decision|0|||
105838700|NCT02539368|365066338|FG002|Overall Study|Withdrawal by Subject|9|||
105838701|NCT02539368|365066339|FG003|Overall Study|Withdrawal by Subject|1|||
105838702|NCT02539368|365066340|FG004|Overall Study|Withdrawal by Subject|3|||
105838703|NCT02539368|365066336|FG000|Overall Study|Physician Decision|49|||
105838704|NCT02539368|365066337|FG001|Overall Study|Physician Decision|15|||
105838705|NCT02539368|365066338|FG002|Overall Study|Physician Decision|7|||
105838706|NCT02539368|365066339|FG003|Overall Study|Physician Decision|0|||
105838707|NCT02539368|365066340|FG004|Overall Study|Physician Decision|2|||
105838708|NCT02539368|365066336|FG000|Overall Study|Lost to Follow-up|96|||
105838709|NCT02539368|365066337|FG001|Overall Study|Lost to Follow-up|21|||
105838710|NCT02539368|365066338|FG002|Overall Study|Lost to Follow-up|16|||
105838711|NCT02539368|365066339|FG003|Overall Study|Lost to Follow-up|4|||
105838712|NCT02539368|365066340|FG004|Overall Study|Lost to Follow-up|3|||
105838713|NCT02539368|365066336|FG000|Overall Study|Adverse Event|44|||
105838714|NCT02539368|365066337|FG001|Overall Study|Adverse Event|5|||
105838715|NCT02539368|365066338|FG002|Overall Study|Adverse Event|9|||
105838716|NCT02539368|365066339|FG003|Overall Study|Adverse Event|0|||
105838717|NCT02539368|365066340|FG004|Overall Study|Adverse Event|3|||
105838718|NCT02539368|365066336|FG000|Overall Study|Participant Non-compliant|13|||
105838719|NCT02539368|365066337|FG001|Overall Study|Participant Non-compliant|2|||
105838720|NCT02539368|365066338|FG002|Overall Study|Participant Non-compliant|1|||
105838721|NCT02539368|365066339|FG003|Overall Study|Participant Non-compliant|1|||
105838722|NCT02539368|365066340|FG004|Overall Study|Participant Non-compliant|0|||
105838723|NCT02539368|365066336|FG000|Overall Study|Other|145|||
105838724|NCT02539368|365066337|FG001|Overall Study|Other|18|||
105838725|NCT02539368|365066338|FG002|Overall Study|Other|24|||
105838726|NCT02539368|365066339|FG003|Overall Study|Other|1|||
105838727|NCT02539368|365066340|FG004|Overall Study|Other|3|||
105838728|NCT02539368|365066336|FG000|Overall Study|Missing|10|||
105838729|NCT02539368|365066337|FG001|Overall Study|Missing|3|||
105838730|NCT02539368|365066338|FG002|Overall Study|Missing|0|||
105838731|NCT02539368|365066339|FG003|Overall Study|Missing|0|||
105838732|NCT02539368|365066340|FG004|Overall Study|Missing|0|||
105838733|NCT01899326|365066342|FG000|Overall Study|Withdrawal by Subject|1|||
105838734|NCT01899326|365066342|FG000|Overall Study|Adverse Event|2|||
105838735|NCT01899326|365066342|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
105838736|NCT02752802|365066345|FG000|Overall Study|Contrast Volume Not Collected|1|||
105838737|NCT02752802|365066346|FG001|Overall Study|Contrast Volume Not Collected|0|||
105838738|NCT00588731|365066347|FG000|Overall Study|Withdrawal by Subject|3|||
105838739|NCT00588731|365066348|FG001|Overall Study|Withdrawal by Subject|2|||
105838740|NCT00171340|365066349|FG000|Overall Study|Adverse Event|46|||
105838741|NCT00171340|365066350|FG001|Overall Study|Adverse Event|42|||
105838742|NCT00171340|365066349|FG000|Overall Study|Lack of Efficacy|29|||
105838743|NCT00171340|365066350|FG001|Overall Study|Lack of Efficacy|41|||
105838744|NCT00171340|365066349|FG000|Overall Study|Protocol Violation|7|||
105838745|NCT00171340|365066350|FG001|Overall Study|Protocol Violation|8|||
105838746|NCT00171340|365066349|FG000|Overall Study|Withdrawal by Subject|22|||
105838747|NCT00171340|365066350|FG001|Overall Study|Withdrawal by Subject|19|||
105838748|NCT00171340|365066349|FG000|Overall Study|Lost to Follow-up|0|||
105311361|NCT00923273|363137862|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
105311362|NCT00923273|363137863|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
105311363|NCT01544179|363137864|FG000|Overall Study|Death|50|||
105311364|NCT01544179|363137865|FG001|Overall Study|Death|37|||
105311365|NCT01544179|363137864|FG000|Overall Study|Lost to Follow-up|0|||
105311366|NCT01544179|363137865|FG001|Overall Study|Lost to Follow-up|1|||
105311367|NCT01544179|363137864|FG000|Overall Study|Adverse Event|0|||
105311368|NCT01544179|363137865|FG001|Overall Study|Adverse Event|1|||
105311369|NCT01544179|363137864|FG000|Overall Study|Withdrawal by Subject|12|||
105311370|NCT01544179|363137865|FG001|Overall Study|Withdrawal by Subject|7|||
105311371|NCT01544179|363137864|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
105311372|NCT01544179|363137865|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105311373|NCT01305044|363137866|FG000|Overall Study|Withdrawal by Subject|3|||
105311374|NCT01305044|363137867|FG001|Overall Study|Withdrawal by Subject|6|||
105311375|NCT04497948|363137868|FG000|Overall Study|Death|2|||
105311376|NCT00849186|363137871|FG000|Overall Study|Adverse Event|2|||
105311377|NCT00849186|363137871|FG000|Overall Study|Withdrawal by Subject|1|||
105311378|NCT00849186|363137871|FG000|Overall Study|not treated|6|||
105311379|NCT00849186|363137871|FG000|Overall Study|Other|1|||
105311380|NCT02861014|363137874|FG000|Primary Analysis|Adverse Event|7|||
105311381|NCT02861014|363137874|FG000|Primary Analysis|Death|1|||
105311382|NCT02861014|363137874|FG000|Primary Analysis|Lack of Efficacy|3|||
105576509|NCT02593539|364110178|FG000|Overall Study|Adverse Event|1|||
105838749|NCT00171340|365066350|FG001|Overall Study|Lost to Follow-up|5|||
105838750|NCT00171340|365066349|FG000|Overall Study|Abnormal Laboratory Results|2|||
105838751|NCT00171340|365066350|FG001|Overall Study|Abnormal Laboratory Results|0|||
105838752|NCT00171340|365066349|FG000|Overall Study|Abnormal Test Procedure Results|6|||
105838753|NCT00171340|365066350|FG001|Overall Study|Abnormal Test Procedure Results|11|||
105838754|NCT00171340|365066349|FG000|Overall Study|No Longer Required Study Drug|1|||
105311383|NCT02861014|363137874|FG000|Primary Analysis|Physician Decision|2|||
105311384|NCT02861014|363137874|FG000|Primary Analysis|Pregnancy|4|||
105311385|NCT02861014|363137874|FG000|Primary Analysis|Protocol Violation|2|||
105311386|NCT02861014|363137874|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
105311387|NCT02861014|363137874|FG000|Primary Analysis|Withdrawal by Subject|14|||
105838755|NCT00171340|365066350|FG001|Overall Study|No Longer Required Study Drug|1|||
105838756|NCT00171340|365066349|FG000|Overall Study|Administrative Problems|5|||
105838757|NCT00171340|365066350|FG001|Overall Study|Administrative Problems|2|||
105838758|NCT00171340|365066349|FG000|Overall Study|Death|6|||
105838759|NCT00171340|365066350|FG001|Overall Study|Death|6|||
105838760|NCT00063882|365066355|FG000|Overall Study|Protocol Violation|3|||
105838761|NCT00063882|365066356|FG001|Overall Study|Protocol Violation|3|||
105311388|NCT02861014|363137874|FG000|Primary Analysis|Commercial ocrelizumab|3|||
105311389|NCT02861014|363137874|FG000|Safety Follow-up|Adverse Event|1|||
105838762|NCT00063882|365066355|FG000|Overall Study|Withdrawal by Subject|2|||
105838763|NCT00063882|365066356|FG001|Overall Study|Withdrawal by Subject|1|||
105838764|NCT03314662|365066359|FG000|Overall Study|Withdrawal by Subject|1|||
105838765|NCT03314662|365066360|FG001|Overall Study|Withdrawal by Subject|1|||
105838766|NCT03314662|365066361|FG002|Overall Study|Withdrawal by Subject|1|||
105838767|NCT03314662|365066359|FG000|Overall Study|Lost to Follow-up|5|||
105838768|NCT03314662|365066360|FG001|Overall Study|Lost to Follow-up|4|||
105838769|NCT03314662|365066361|FG002|Overall Study|Lost to Follow-up|4|||
105838770|NCT03314662|365066359|FG000|Overall Study|Death|2|||
105838771|NCT03314662|365066360|FG001|Overall Study|Death|0|||
105838772|NCT03314662|365066361|FG002|Overall Study|Death|0|||
105838773|NCT01117766|365066362|FG000|First Intervention|Adverse Event|0|||
105838774|NCT01117766|365066363|FG001|First Intervention|Adverse Event|1|||
105838775|NCT01117766|365066362|FG000|First Intervention|Protocol Violation|1|||
105838776|NCT01117766|365066363|FG001|First Intervention|Protocol Violation|0|||
105838777|NCT01117766|365066362|FG000|Washout Period|Protocol Violation|0|||
105838778|NCT01117766|365066363|FG001|Washout Period|Protocol Violation|2|||
105838779|NCT01117766|365066362|FG000|Second Intervention|Lost to Follow-up|1|||
105838780|NCT01117766|365066363|FG001|Second Intervention|Lost to Follow-up|0|||
105838781|NCT01117766|365066362|FG000|Second Intervention|Other|1|||
105838782|NCT01117766|365066363|FG001|Second Intervention|Other|2|||
105838783|NCT01117766|365066362|FG000|Second Intervention|Adverse Event|0|||
105838784|NCT01117766|365066363|FG001|Second Intervention|Adverse Event|2|||
105838785|NCT01117766|365066362|FG000|Second Intervention|Withdrawal by Subject|0|||
105838786|NCT01117766|365066363|FG001|Second Intervention|Withdrawal by Subject|1|||
105838787|NCT00438659|365066364|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
105838788|NCT00438659|365066365|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
105838789|NCT00438659|365066364|FG000|Overall Study|Cancel|5|||
105838790|NCT00438659|365066365|FG001|Overall Study|Cancel|2|||
105838791|NCT01115855|365067670|FG000|Overall Study|Adverse Event|16|||
105838792|NCT01115855|365067671|FG001|Overall Study|Adverse Event|18|||
105838793|NCT01115855|365067670|FG000|Overall Study|Death|6|||
105838794|NCT01115855|365067671|FG001|Overall Study|Death|5|||
105838795|NCT01115855|365067670|FG000|Overall Study|Lab Abnormality|1|||
105838796|NCT01115855|365067671|FG001|Overall Study|Lab Abnormality|1|||
105838797|NCT01115855|365067670|FG000|Overall Study|Protocol Violation|0|||
105838798|NCT01115855|365067671|FG001|Overall Study|Protocol Violation|1|||
105838799|NCT01115855|365067670|FG000|Overall Study|Withdrawal by Subject|5|||
105838800|NCT01115855|365067671|FG001|Overall Study|Withdrawal by Subject|5|||
105838801|NCT01115855|365067670|FG000|Overall Study|Other|8|||
105838802|NCT01115855|365067671|FG001|Overall Study|Other|6|||
105838803|NCT00114231|365067674|FG000|Overall Study|No consent|2|||
105838804|NCT00114231|365067675|FG001|Overall Study|No consent|0|||
105838805|NCT00114231|365067674|FG000|Overall Study|QARC requirement not met|1|||
105838806|NCT00114231|365067675|FG001|Overall Study|QARC requirement not met|0|||
105838807|NCT00114231|365067674|FG000|Overall Study|Suspected metastatic disease|1|||
105838808|NCT00114231|365067675|FG001|Overall Study|Suspected metastatic disease|0|||
105838809|NCT00114231|365067674|FG000|Overall Study|No adenocarcinoma|1|||
105838810|NCT00114231|365067675|FG001|Overall Study|No adenocarcinoma|0|||
105838811|NCT00114231|365067674|FG000|Overall Study|Low creatinine clearance|0|||
105838812|NCT00114231|365067675|FG001|Overall Study|Low creatinine clearance|1|||
105838813|NCT00114231|365067674|FG000|Overall Study|Tumor size > 4cm|1|||
105838814|NCT00114231|365067675|FG001|Overall Study|Tumor size > 4cm|0|||
105311390|NCT02861014|363137874|FG000|Safety Follow-up|Pregnancy|1|||
105311391|NCT02861014|363137874|FG000|Safety Follow-up|Withdrawal by Subject|9|||
105311392|NCT02861014|363137874|FG000|Safety Follow-up|Study terminated by sponsor|1|||
105311393|NCT02861014|363137874|FG000|Safety Follow-up|Physician Decision|1|||
105311394|NCT02861014|363137874|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
105838815|NCT00114231|365067674|FG000|Overall Study|Tumor fixed on digital exam|0|||
105838816|NCT00114231|365067675|FG001|Overall Study|Tumor fixed on digital exam|1|||
105838817|NCT00114231|365067674|FG000|Overall Study|No Absolute Neutrophil Count|2|||
105838818|NCT00114231|365067675|FG001|Overall Study|No Absolute Neutrophil Count|0|||
105311395|NCT02861014|363137874|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
105311396|NCT00417170|363137875|FG000|Overall Study|Adverse Event|1|||
105311397|NCT00417170|363137876|FG001|Overall Study|Adverse Event|1|||
105311398|NCT00417170|363137875|FG000|Overall Study|Withdrawal by Subject|1|||
105311399|NCT00417170|363137876|FG001|Overall Study|Withdrawal by Subject|1|||
105838819|NCT00114231|365067674|FG000|Overall Study|Biopsy done after registration|1|||
105838820|NCT00114231|365067675|FG001|Overall Study|Biopsy done after registration|0|||
105838821|NCT01563237|365067678|FG000|Overall Study|Lost to Follow-up|6|||
105838822|NCT01563237|365067679|FG001|Overall Study|Lost to Follow-up|0|||
105838823|NCT01563237|365067678|FG000|Overall Study|Withdrawal by Subject|1|||
105838824|NCT01563237|365067679|FG001|Overall Study|Withdrawal by Subject|0|||
105838825|NCT01563237|365067678|FG000|Overall Study|Adverse Event|1|||
105838826|NCT01563237|365067679|FG001|Overall Study|Adverse Event|0|||
105838827|NCT01563237|365067678|FG000|Overall Study|Medical Reasons|1|||
105838828|NCT01563237|365067679|FG001|Overall Study|Medical Reasons|0|||
105838829|NCT01563237|365067678|FG000|Overall Study|Death|1|||
105838830|NCT01563237|365067679|FG001|Overall Study|Death|0|||
105838831|NCT02668822|365067680|FG000|Overall Study|Protocol Violation|2|||
105838832|NCT02668822|365067681|FG001|Overall Study|Protocol Violation|0|||
105838833|NCT02668822|365067680|FG000|Overall Study|Study Terminated by Sponsor|7|||
105838834|NCT02668822|365067681|FG001|Overall Study|Study Terminated by Sponsor|9|||
105838835|NCT02000531|365067682|FG000|Overall Study|Lost to Follow-up|1|||
105838836|NCT02000531|365067683|FG001|Overall Study|Lost to Follow-up|0|||
105838837|NCT02000531|365067682|FG000|Overall Study|Discontinued due to data cut-off|3|||
105838838|NCT02000531|365067683|FG001|Overall Study|Discontinued due to data cut-off|8|||
105838839|NCT00337428|365067687|FG000|Overall Study|Withdrawal by Subject|1|||
105838840|NCT00337428|365067688|FG001|Overall Study|Withdrawal by Subject|2|||
105838841|NCT00337428|365067687|FG000|Overall Study|Lack of Time|1|||
105838842|NCT00337428|365067688|FG001|Overall Study|Lack of Time|1|||
105838843|NCT00337428|365067687|FG000|Overall Study|Unwilling to Continue|1|||
105838844|NCT00337428|365067688|FG001|Overall Study|Unwilling to Continue|0|||
105838845|NCT00337428|365067687|FG000|Overall Study|Anorexia|1|||
105838846|NCT00337428|365067688|FG001|Overall Study|Anorexia|0|||
105838847|NCT03756883|365067689|FG000|Overall Study|Adverse Event|2|||
105838848|NCT03756883|365067690|FG001|Overall Study|Adverse Event|2|||
105838849|NCT03756883|365067691|FG002|Overall Study|Adverse Event|2|||
105838850|NCT03756883|365067689|FG000|Overall Study|Lack of Efficacy|0|||
105838851|NCT03756883|365067690|FG001|Overall Study|Lack of Efficacy|1|||
105838852|NCT03756883|365067691|FG002|Overall Study|Lack of Efficacy|2|||
105838853|NCT03756883|365067689|FG000|Overall Study|Lost to Follow-up|3|||
105838854|NCT03756883|365067690|FG001|Overall Study|Lost to Follow-up|3|||
105838855|NCT03756883|365067691|FG002|Overall Study|Lost to Follow-up|0|||
105838856|NCT03756883|365067689|FG000|Overall Study|Protocol Violation|2|||
105838857|NCT03756883|365067690|FG001|Overall Study|Protocol Violation|0|||
105838858|NCT03756883|365067691|FG002|Overall Study|Protocol Violation|1|||
105838859|NCT03756883|365067689|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
105838860|NCT03756883|365067690|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
105838861|NCT03756883|365067691|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
105838862|NCT03756883|365067689|FG000|Overall Study|Withdrawal by Subject|4|||
105838863|NCT03756883|365067690|FG001|Overall Study|Withdrawal by Subject|1|||
105838864|NCT03756883|365067691|FG002|Overall Study|Withdrawal by Subject|0|||
105838865|NCT03756883|365067689|FG000|Overall Study|Other Reasons|2|||
105838866|NCT03756883|365067690|FG001|Overall Study|Other Reasons|4|||
105838867|NCT03756883|365067691|FG002|Overall Study|Other Reasons|0|||
105838868|NCT01470417|365067692|FG000|Overall Study|Disease progression|0|||
105838869|NCT01470417|365067693|FG001|Overall Study|Disease progression|2|||
105838870|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
105838871|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
105838872|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
105838873|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
105838874|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
105838875|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
105838876|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105838877|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105838878|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
105838879|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
105838880|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
105838881|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
105838882|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
105838883|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
105838884|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
105838885|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
105838886|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Death|2|||
105838887|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Death|1|||
105367581|NCT04161391|363352321|FG000|Overall Study|Progressive Disease|4|||
105576510|NCT04424290|364110181|FG000|Overall Study|Not treated|0|||
105576511|NCT04424290|364110182|FG001|Overall Study|Not treated|0|||
105838888|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Death|0|||
105838889|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Death|0|||
105838890|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
105576512|NCT04424290|364110183|FG002|Overall Study|Not treated|1|||
105576513|NCT04424290|364110184|FG003|Overall Study|Not treated|0|||
105576514|NCT04424290|364110185|FG004|Overall Study|Not treated|1|||
105576515|NCT04424290|364110181|FG000|Overall Study|Adverse Event|0|||
105838891|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
105838892|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
105838893|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
105838894|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
105838895|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
105838896|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
105838897|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
105838898|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
105838899|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
105838900|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
105838901|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
105838902|NCT03110380|365067696|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
105838903|NCT03110380|365067697|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
105838904|NCT03110380|365067698|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
105838905|NCT03110380|365067699|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
105838906|NCT03110380|365067696|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
105838907|NCT03110380|365067697|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
105838908|NCT03110380|365067698|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
105838909|NCT03110380|365067699|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
105838910|NCT03110380|365067696|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
105838911|NCT03110380|365067697|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
105838912|NCT03110380|365067698|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
105838913|NCT03110380|365067699|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
105838914|NCT00693225|365067700|FG000|Overall Study|Lost to Follow-up|1|||
105838915|NCT00693225|365067701|FG001|Overall Study|Lost to Follow-up|2|||
105838916|NCT00693225|365067700|FG000|Overall Study|Adverse Event|1|||
105838917|NCT00693225|365067701|FG001|Overall Study|Adverse Event|3|||
105838918|NCT01315028|365067702|FG000|Overall Study|Lost to Follow-up|1|||
105838919|NCT01315028|365067703|FG001|Overall Study|Lost to Follow-up|0|||
105838920|NCT01315028|365067702|FG000|Overall Study|Death|0|||
105838921|NCT01315028|365067703|FG001|Overall Study|Death|1|||
105838922|NCT00985231|365067708|FG000|Overall Study|ineligible|1|||
105838923|NCT00985231|365067709|FG001|Overall Study|ineligible|0|||
105838924|NCT00985231|365067708|FG000|Overall Study|Protocol Violation|1|||
105838925|NCT00985231|365067709|FG001|Overall Study|Protocol Violation|0|||
105838926|NCT00985231|365067708|FG000|Overall Study|Withdrawal by Subject|1|||
105838927|NCT00985231|365067709|FG001|Overall Study|Withdrawal by Subject|0|||
105838928|NCT00985231|365067708|FG000|Overall Study|Lost to Follow-up|0|||
105838929|NCT00985231|365067709|FG001|Overall Study|Lost to Follow-up|1|||
105838930|NCT00985231|365067708|FG000|Overall Study|Study related symptoms & complaints|0|||
105838931|NCT00985231|365067709|FG001|Overall Study|Study related symptoms & complaints|2|||
105838932|NCT01740791|365067710|FG000|Overall Study|Randomized but never treated|5|||
105838933|NCT01740791|365067711|FG001|Overall Study|Randomized but never treated|3|||
105838934|NCT01740791|365067712|FG002|Overall Study|Randomized but never treated|2|||
105838935|NCT01740791|365067713|FG003|Overall Study|Randomized but never treated|2|||
105838936|NCT01740791|365067714|FG004|Overall Study|Randomized but never treated|1|||
105838937|NCT01740791|365067715|FG005|Overall Study|Randomized but never treated|3|||
105838938|NCT01740791|365067710|FG000|Overall Study|Lost to Follow-up|2|||
105838939|NCT01740791|365067711|FG001|Overall Study|Lost to Follow-up|0|||
105838940|NCT01740791|365067712|FG002|Overall Study|Lost to Follow-up|2|||
105838941|NCT01740791|365067713|FG003|Overall Study|Lost to Follow-up|3|||
105838942|NCT01740791|365067714|FG004|Overall Study|Lost to Follow-up|2|||
105838943|NCT01740791|365067715|FG005|Overall Study|Lost to Follow-up|3|||
105838944|NCT01740791|365067710|FG000|Overall Study|Withdrew Consent|4|||
105838945|NCT01740791|365067711|FG001|Overall Study|Withdrew Consent|0|||
105838946|NCT01740791|365067712|FG002|Overall Study|Withdrew Consent|1|||
105838947|NCT01740791|365067713|FG003|Overall Study|Withdrew Consent|2|||
105838948|NCT01740791|365067714|FG004|Overall Study|Withdrew Consent|0|||
105838949|NCT01740791|365067715|FG005|Overall Study|Withdrew Consent|3|||
105838950|NCT01740791|365067710|FG000|Overall Study|Investigator's discretion|1|||
105838951|NCT01740791|365067711|FG001|Overall Study|Investigator's discretion|0|||
105838952|NCT01740791|365067712|FG002|Overall Study|Investigator's discretion|1|||
105838953|NCT01740791|365067713|FG003|Overall Study|Investigator's discretion|0|||
105838954|NCT01740791|365067714|FG004|Overall Study|Investigator's discretion|0|||
105838955|NCT01740791|365067715|FG005|Overall Study|Investigator's discretion|1|||
105838956|NCT01740791|365067710|FG000|Overall Study|Adverse Event|0|||
105838957|NCT01740791|365067711|FG001|Overall Study|Adverse Event|0|||
105838958|NCT01740791|365067712|FG002|Overall Study|Adverse Event|0|||
105838959|NCT01740791|365067713|FG003|Overall Study|Adverse Event|0|||
105838960|NCT01740791|365067714|FG004|Overall Study|Adverse Event|0|||
105838961|NCT01740791|365067715|FG005|Overall Study|Adverse Event|1|||
105838962|NCT01463982|365067716|FG000|Overall Study|Withdrawal by Subject|0|||
105838963|NCT01463982|365067717|FG001|Overall Study|Withdrawal by Subject|1|||
105838964|NCT01463982|365067718|FG002|Overall Study|Withdrawal by Subject|1|||
105838965|NCT01463982|365067719|FG003|Overall Study|Withdrawal by Subject|0|||
105838966|NCT01463982|365067716|FG000|Overall Study|Treatment delay over 5 week|0|||
105838967|NCT01463982|365067717|FG001|Overall Study|Treatment delay over 5 week|0|||
105489885|NCT03963401|363805679|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
105838968|NCT01463982|365067718|FG002|Overall Study|Treatment delay over 5 week|1|||
105838969|NCT01463982|365067719|FG003|Overall Study|Treatment delay over 5 week|0|||
105489886|NCT03963401|363805674|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
105489887|NCT03963401|363805675|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
105489888|NCT03963401|363805676|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
105489889|NCT03963401|363805677|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
105489890|NCT03963401|363805678|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
105838970|NCT03170869|365067724|FG000|Overall Study|Protocol Violation|5|||
105838971|NCT03170869|365067724|FG000|Overall Study|Early study termination|3|||
105838972|NCT02762994|365067726|FG000|Overall Study|Withdrawal by Subject|0|||
105838973|NCT02762994|365067727|FG001|Overall Study|Withdrawal by Subject|1|||
105838974|NCT02762994|365067728|FG002|Overall Study|Withdrawal by Subject|2|||
105838975|NCT02762994|365067729|FG003|Overall Study|Withdrawal by Subject|0|||
105838976|NCT02762994|365067726|FG000|Overall Study|Protocol Violation|1|||
105838977|NCT02762994|365067727|FG001|Overall Study|Protocol Violation|0|||
105838978|NCT02762994|365067728|FG002|Overall Study|Protocol Violation|0|||
105838979|NCT02762994|365067729|FG003|Overall Study|Protocol Violation|2|||
105838980|NCT03507686|365067730|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
105838981|NCT03507686|365067731|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
105838982|NCT03507686|365067730|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
105838983|NCT03507686|365067731|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
105838984|NCT03507686|365067730|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
105838985|NCT03507686|365067731|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
105838986|NCT03507686|365067730|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
105838987|NCT03507686|365067731|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
105838988|NCT03507686|365067730|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
105838989|NCT03507686|365067731|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
105838990|NCT03507686|365067730|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
105838991|NCT03507686|365067731|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
105838992|NCT02508116|365067734|FG000|Overall Study|Lost to Follow-up|2|||
105838993|NCT02508116|365067735|FG001|Overall Study|Lost to Follow-up|3|||
105838994|NCT02508116|365067734|FG000|Overall Study|Withdrawal by Subject|3|||
105838995|NCT02508116|365067735|FG001|Overall Study|Withdrawal by Subject|2|||
105838996|NCT02508116|365067734|FG000|Overall Study|Protocol Violation|1|||
105838997|NCT02508116|365067735|FG001|Overall Study|Protocol Violation|2|||
105838998|NCT02508116|365067734|FG000|Overall Study|Physician Decision|2|||
105838999|NCT02508116|365067735|FG001|Overall Study|Physician Decision|0|||
105839000|NCT00109850|365067736|FG000|Overall Study|Adverse Event|1|||
105839001|NCT00109850|365067736|FG000|Overall Study|Death|2|||
105839002|NCT00109850|365067736|FG000|Overall Study|Ineligible|1|||
105839003|NCT04234464|365067737|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
105839004|NCT04234464|365067738|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
105839005|NCT00983528|365067739|FG000|Overall Study|Death|4|||
105839006|NCT00983528|365067739|FG000|Overall Study|Lost to Follow-up|1|||
105839007|NCT00983528|365067739|FG000|Overall Study|Study Terminated|1|||
105839008|NCT00084799|365067740|FG000|Overall Study|Disease Progression|1|||
105839009|NCT00084799|365067741|FG001|Overall Study|Disease Progression|0|||
105839010|NCT00330460|365067746|FG000|Overall Study|Physician Decision|1|||
105839011|NCT00330460|365067747|FG001|Overall Study|Physician Decision|0|||
105839012|NCT00330460|365067746|FG000|Overall Study|Adverse Event|10|||
105839013|NCT00330460|365067747|FG001|Overall Study|Adverse Event|8|||
105839014|NCT00330460|365067746|FG000|Overall Study|Withdrawal by Subject|18|||
105839015|NCT00330460|365067747|FG001|Overall Study|Withdrawal by Subject|17|||
105839016|NCT00330460|365067746|FG000|Overall Study|Death|1|||
105839017|NCT00330460|365067747|FG001|Overall Study|Death|1|||
105839018|NCT00330460|365067746|FG000|Overall Study|Ineligibility determined|1|||
105839019|NCT00330460|365067747|FG001|Overall Study|Ineligibility determined|3|||
105839020|NCT00330460|365067746|FG000|Overall Study|Lost to Follow-up|8|||
105839021|NCT00330460|365067747|FG001|Overall Study|Lost to Follow-up|3|||
105839022|NCT00330460|365067746|FG000|Overall Study|Noncompliance|2|||
105489891|NCT03963401|363805679|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
105489892|NCT01172275|363805682|FG000|Overall Study|Lost to Follow-up|1|||
105489893|NCT01172275|363805683|FG001|Overall Study|Lost to Follow-up|0|||
105839023|NCT00330460|365067747|FG001|Overall Study|Noncompliance|1|||
105839024|NCT00330460|365067746|FG000|Overall Study|Other|1|||
105839025|NCT00330460|365067747|FG001|Overall Study|Other|0|||
105839026|NCT01857973|365067748|FG000|Overall Study|Subject did not meet required BG range|3|||
105839027|NCT01857973|365067748|FG000|Overall Study|drop out after 3 failed attempts|1|||
105839028|NCT01857973|365067748|FG000|Overall Study|Physician Decision|1|||
105839029|NCT02663882|365067749|FG000|Overall Study|Lost to Follow-up|4|||
105839030|NCT02663882|365067750|FG001|Overall Study|Lost to Follow-up|2|||
105839031|NCT00602537|365067753|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
105839032|NCT00602537|365067754|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
105839033|NCT00602537|365067753|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
105839034|NCT00602537|365067754|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
105311400|NCT00417170|363137875|FG000|Overall Study|Lost to Follow-up|0|||
105311401|NCT00417170|363137876|FG001|Overall Study|Lost to Follow-up|1|||
105311402|NCT04058067|363137877|FG000|Overall Study|Adverse Event|2|||
105311403|NCT04058067|363137878|FG001|Overall Study|Adverse Event|0|||
105311404|NCT04058067|363137877|FG000|Overall Study|Death|0|||
105311405|NCT04058067|363137878|FG001|Overall Study|Death|1|||
105311406|NCT04058067|363137877|FG000|Overall Study|Physician Decision|3|||
105311407|NCT04058067|363137878|FG001|Overall Study|Physician Decision|1|||
105311408|NCT04058067|363137877|FG000|Overall Study|Protocol Violation|0|||
105311409|NCT04058067|363137878|FG001|Overall Study|Protocol Violation|1|||
105311410|NCT04058067|363137877|FG000|Overall Study|Withdrawal by Subject|7|||
105311411|NCT04058067|363137878|FG001|Overall Study|Withdrawal by Subject|8|||
105311412|NCT05005312|363137879|FG000|Overall Study|Enrolled, but not treated|0|||
105311413|NCT05005312|363137880|FG001|Overall Study|Enrolled, but not treated|1|||
105311414|NCT00851318|363137881|FG000|Overall Study|Withdrawal by Subject|7|||
105311415|NCT00851318|363137882|FG001|Overall Study|Withdrawal by Subject|1|||
105311416|NCT00851318|363137883|FG002|Overall Study|Withdrawal by Subject|5|||
105311417|NCT00851318|363137884|FG003|Overall Study|Withdrawal by Subject|3|||
105311418|NCT00851318|363137881|FG000|Overall Study|Adverse Event|13|||
105311419|NCT00851318|363137882|FG001|Overall Study|Adverse Event|2|||
105489894|NCT01172275|363805682|FG000|Overall Study|Protocol Violation|1|||
105489895|NCT01172275|363805683|FG001|Overall Study|Protocol Violation|0|||
105489896|NCT00095628|363805684|FG000|Overall Study|Disease progression prior to treatment|1|||
105489897|NCT01484054|363805690|FG000|Period 1|Withdrawal by Subject|0|||
105311420|NCT00851318|363137883|FG002|Overall Study|Adverse Event|9|||
105311421|NCT00851318|363137884|FG003|Overall Study|Adverse Event|12|||
105311422|NCT00851318|363137881|FG000|Overall Study|Pregnancy|0|||
105311423|NCT00851318|363137882|FG001|Overall Study|Pregnancy|0|||
105311424|NCT00851318|363137883|FG002|Overall Study|Pregnancy|1|||
105311425|NCT00851318|363137884|FG003|Overall Study|Pregnancy|1|||
105311426|NCT00851318|363137881|FG000|Overall Study|Lack of Efficacy|8|||
105367582|NCT04161391|363352322|FG001|Overall Study|Progressive Disease|3|||
105367583|NCT04161391|363352323|FG002|Overall Study|Progressive Disease|3|||
105367584|NCT04161391|363352324|FG003|Overall Study|Progressive Disease|5|||
105367585|NCT04161391|363352325|FG004|Overall Study|Progressive Disease|3|||
105367586|NCT04161391|363352326|FG005|Overall Study|Progressive Disease|3|||
105367587|NCT04161391|363352327|FG006|Overall Study|Progressive Disease|5|||
105367588|NCT04161391|363352328|FG007|Overall Study|Progressive Disease|2|||
105367589|NCT04161391|363352329|FG008|Overall Study|Progressive Disease|2|||
105367590|NCT01162343|363352332|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
105367591|NCT01162343|363352332|FG000|Overall Study|Refused psychiatrist assessment|12|||
105367592|NCT03964207|363352334|FG000|First Treatment|Withdrawal by Subject|1|||
105367593|NCT03964207|363352335|FG001|First Treatment|Withdrawal by Subject|2|||
105367594|NCT03964207|363352334|FG000|First Treatment|Protocol Violation|1|||
105367595|NCT03964207|363352335|FG001|First Treatment|Protocol Violation|0|||
105367596|NCT03964207|363352334|FG000|First Treatment|Lost to Follow-up|1|||
105367597|NCT03964207|363352335|FG001|First Treatment|Lost to Follow-up|0|||
105367598|NCT03964207|363352334|FG000|Second Treatment|Lost to Follow-up|0|||
105367599|NCT03964207|363352335|FG001|Second Treatment|Lost to Follow-up|1|||
105367600|NCT03964207|363352334|FG000|Second Treatment|Adverse Event|1|||
105367601|NCT03964207|363352335|FG001|Second Treatment|Adverse Event|2|||
105367602|NCT02579629|363352337|FG000|Overall Study|Withdrawal by Subject|0|||
105367603|NCT02579629|363352338|FG001|Overall Study|Withdrawal by Subject|1|||
105367604|NCT02579629|363352339|FG002|Overall Study|Withdrawal by Subject|0|||
105367605|NCT02579629|363352337|FG000|Overall Study|Screen Failure|2|||
105367606|NCT02579629|363352338|FG001|Overall Study|Screen Failure|0|||
105311427|NCT00851318|363137882|FG001|Overall Study|Lack of Efficacy|2|||
105311428|NCT00851318|363137883|FG002|Overall Study|Lack of Efficacy|4|||
105311429|NCT00851318|363137884|FG003|Overall Study|Lack of Efficacy|2|||
105367607|NCT02579629|363352339|FG002|Overall Study|Screen Failure|2|||
105489898|NCT01484054|363805691|FG001|Period 1|Withdrawal by Subject|1|||
105489899|NCT01539317|363805692|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
105489900|NCT01539317|363805693|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
105489901|NCT02117427|363805694|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
105311430|NCT00851318|363137881|FG000|Overall Study|Non-compliance with Study Procedures|2|||
105311431|NCT00851318|363137882|FG001|Overall Study|Non-compliance with Study Procedures|0|||
105311432|NCT00851318|363137883|FG002|Overall Study|Non-compliance with Study Procedures|1|||
105311433|NCT00851318|363137884|FG003|Overall Study|Non-compliance with Study Procedures|0|||
105311434|NCT00851318|363137881|FG000|Overall Study|Physician Decision|0|||
105311435|NCT00851318|363137882|FG001|Overall Study|Physician Decision|0|||
105311436|NCT00851318|363137883|FG002|Overall Study|Physician Decision|1|||
105311437|NCT00851318|363137884|FG003|Overall Study|Physician Decision|1|||
105311438|NCT01001988|363137891|FG000|Overall Study|Protocol Violation|84|||
105367608|NCT01930539|363352340|FG000|Overall Study|Withdrawal by Subject|2|||
105367609|NCT01930539|363352341|FG001|Overall Study|Withdrawal by Subject|2|||
105367610|NCT00830219|363352342|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
105367611|NCT00830219|363352343|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
105311439|NCT01001988|363137891|FG000|Overall Study|Withdrawal by Subject|18|||
105311440|NCT01001988|363137891|FG000|Overall Study|Lost to Follow-up|15|||
105311441|NCT03016975|363137902|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
105311442|NCT03016975|363137903|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
105311443|NCT03016975|363137904|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
105311444|NCT03016975|363137902|FG000|At 6 Months Follow-up|Death|2|||
105311445|NCT03016975|363137903|FG001|At 6 Months Follow-up|Death|0|||
105311446|NCT03016975|363137904|FG002|At 6 Months Follow-up|Death|0|||
105311447|NCT03016975|363137902|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
105311448|NCT03016975|363137903|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
105311449|NCT03016975|363137904|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
105311450|NCT03016975|363137902|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
105311451|NCT03016975|363137903|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
105311452|NCT03016975|363137904|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
105311453|NCT03016975|363137902|FG000|At 6 Months Follow-up|Aborted implant|1|||
105311454|NCT03016975|363137903|FG001|At 6 Months Follow-up|Aborted implant|0|||
105311455|NCT03016975|363137904|FG002|At 6 Months Follow-up|Aborted implant|0|||
105367612|NCT01241279|363352344|FG000|Overall Study|Lost to Follow-up|0|||
105367613|NCT01241279|363352345|FG001|Overall Study|Lost to Follow-up|1|||
105367614|NCT02683109|363352348|FG000|Overall Study|Adverse Event|1|||
105367615|NCT02683109|363352349|FG001|Overall Study|Adverse Event|0|||
105839035|NCT00602537|365067753|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
105839036|NCT00602537|365067754|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
105839037|NCT00602537|365067753|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
105839038|NCT00602537|365067754|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
105839039|NCT00602537|365067753|FG000|Follow Up Study Comparison|Adverse Event|1|||
105839040|NCT00602537|365067754|FG001|Follow Up Study Comparison|Adverse Event|0|||
105839041|NCT00602537|365067753|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
105839042|NCT00602537|365067754|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
105839043|NCT00602537|365067753|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
105839044|NCT00602537|365067754|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
105839045|NCT02412722|365067761|FG000|Overall Study|Adverse Event|0|||
105839046|NCT02412722|365067762|FG001|Overall Study|Adverse Event|2|||
105839047|NCT02412722|365067763|FG002|Overall Study|Adverse Event|0|||
105839048|NCT02412722|365067764|FG003|Overall Study|Adverse Event|3|||
105839049|NCT02412722|365067765|FG004|Overall Study|Adverse Event|0|||
105839050|NCT02412722|365067766|FG005|Overall Study|Adverse Event|3|||
105839051|NCT02412722|365067761|FG000|Overall Study|Progressive Disease|6|||
105839052|NCT02412722|365067762|FG001|Overall Study|Progressive Disease|4|||
105839053|NCT02412722|365067763|FG002|Overall Study|Progressive Disease|4|||
105839054|NCT02412722|365067764|FG003|Overall Study|Progressive Disease|9|||
105839055|NCT02412722|365067765|FG004|Overall Study|Progressive Disease|3|||
105839056|NCT02412722|365067766|FG005|Overall Study|Progressive Disease|3|||
105839057|NCT02412722|365067761|FG000|Overall Study|Withdrawal by Subject|2|||
105839058|NCT02412722|365067762|FG001|Overall Study|Withdrawal by Subject|0|||
105839059|NCT02412722|365067763|FG002|Overall Study|Withdrawal by Subject|1|||
105839060|NCT02412722|365067764|FG003|Overall Study|Withdrawal by Subject|2|||
105839061|NCT02412722|365067765|FG004|Overall Study|Withdrawal by Subject|1|||
105839062|NCT02412722|365067766|FG005|Overall Study|Withdrawal by Subject|1|||
105839063|NCT02412722|365067761|FG000|Overall Study|Lost to Follow-up|0|||
105839064|NCT02412722|365067762|FG001|Overall Study|Lost to Follow-up|0|||
105839065|NCT02412722|365067763|FG002|Overall Study|Lost to Follow-up|0|||
105839066|NCT02412722|365067764|FG003|Overall Study|Lost to Follow-up|0|||
105839067|NCT02412722|365067765|FG004|Overall Study|Lost to Follow-up|1|||
105839068|NCT02412722|365067766|FG005|Overall Study|Lost to Follow-up|0|||
105839069|NCT02412722|365067761|FG000|Overall Study|Received drug in run-in and discontinued|0|||
105839070|NCT02412722|365067762|FG001|Overall Study|Received drug in run-in and discontinued|2|||
105839071|NCT02412722|365067763|FG002|Overall Study|Received drug in run-in and discontinued|0|||
105839072|NCT02412722|365067764|FG003|Overall Study|Received drug in run-in and discontinued|0|||
105839073|NCT02412722|365067765|FG004|Overall Study|Received drug in run-in and discontinued|0|||
105839074|NCT02412722|365067766|FG005|Overall Study|Received drug in run-in and discontinued|0|||
105839075|NCT02412722|365067761|FG000|Overall Study|Reason not Specified|3|||
105839076|NCT02412722|365067762|FG001|Overall Study|Reason not Specified|0|||
105367616|NCT01699750|363352350|FG000|Overall Study|Withdrew Consent|0|||
105839077|NCT02412722|365067763|FG002|Overall Study|Reason not Specified|2|||
105839078|NCT02412722|365067764|FG003|Overall Study|Reason not Specified|1|||
105839079|NCT02412722|365067765|FG004|Overall Study|Reason not Specified|2|||
105311456|NCT03016975|363137902|FG000|At 2 Year Follow-up|Death|1|||
105311457|NCT03016975|363137903|FG001|At 2 Year Follow-up|Death|0|||
105311458|NCT03016975|363137904|FG002|At 2 Year Follow-up|Death|0|||
105367617|NCT01699750|363352351|FG001|Overall Study|Withdrew Consent|1|||
105367618|NCT01699750|363352350|FG000|Overall Study|Other|0|||
105367619|NCT01699750|363352351|FG001|Overall Study|Other|2|||
105839080|NCT02412722|365067766|FG005|Overall Study|Reason not Specified|6|||
105839081|NCT03558139|365067772|FG000|Overall Study|Consent Withdrawn|1|||
105839082|NCT03558139|365067773|FG001|Overall Study|Consent Withdrawn|1|||
105839083|NCT03558139|365067774|FG002|Overall Study|Consent Withdrawn|4|||
105839084|NCT03558139|365067772|FG000|Overall Study|Death|5|||
105839085|NCT03558139|365067773|FG001|Overall Study|Death|3|||
105839086|NCT03558139|365067774|FG002|Overall Study|Death|8|||
105839087|NCT03558139|365067772|FG000|Overall Study|Lost to Follow-up|0|||
105839088|NCT03558139|365067773|FG001|Overall Study|Lost to Follow-up|0|||
105839089|NCT03558139|365067774|FG002|Overall Study|Lost to Follow-up|3|||
105839090|NCT03558139|365067772|FG000|Overall Study|Study Ended Per Protocol|0|||
105839091|NCT03558139|365067773|FG001|Overall Study|Study Ended Per Protocol|3|||
105839092|NCT03558139|365067774|FG002|Overall Study|Study Ended Per Protocol|6|||
105839093|NCT03573817|365067775|FG000|Overall Study|Adverse Event|0|||
105839094|NCT03573817|365067776|FG001|Overall Study|Adverse Event|2|||
105839095|NCT03573817|365067775|FG000|Overall Study|Protocol Violation|0|||
105839096|NCT03573817|365067776|FG001|Overall Study|Protocol Violation|1|||
105839097|NCT03573817|365067775|FG000|Overall Study|Withdrawal by Subject|1|||
105839098|NCT03573817|365067776|FG001|Overall Study|Withdrawal by Subject|1|||
105839099|NCT02339740|365067777|FG000|Overall Study|Death|1|||
105839100|NCT02339740|365067778|FG001|Overall Study|Death|0|||
105839101|NCT02339740|365067777|FG000|Overall Study|Physician Decision|0|||
105839102|NCT02339740|365067778|FG001|Overall Study|Physician Decision|2|||
105839103|NCT02339740|365067777|FG000|Overall Study|Withdrawal by Subject|5|||
105839104|NCT02339740|365067778|FG001|Overall Study|Withdrawal by Subject|1|||
105839105|NCT02339740|365067777|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
105839106|NCT02339740|365067778|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
105839107|NCT00104247|365067779|FG000|Overall Study|Withdrawal by Subject|1|||
105839108|NCT00104247|365067780|FG001|Overall Study|Withdrawal by Subject|0|||
105839109|NCT00104247|365067779|FG000|Overall Study|Noncompliant with dosing|0|||
105839110|NCT00104247|365067780|FG001|Overall Study|Noncompliant with dosing|1|||
105839111|NCT02056652|365067784|FG000|Overall Study|Withdrawal by Subject|1|||
105839112|NCT02056652|365067785|FG001|Overall Study|Withdrawal by Subject|0|||
105839113|NCT02056652|365067784|FG000|Overall Study|Lost to Follow-up|0|||
105839114|NCT02056652|365067785|FG001|Overall Study|Lost to Follow-up|3|||
105839115|NCT00402025|365067786|FG000|Overall Study|Adverse Event|0|||
105839116|NCT00402025|365067787|FG001|Overall Study|Adverse Event|0|||
105839117|NCT00402025|365067788|FG002|Overall Study|Adverse Event|2|||
105839118|NCT00402025|365067786|FG000|Overall Study|Death|0|||
105839119|NCT00402025|365067787|FG001|Overall Study|Death|1|||
105839120|NCT00402025|365067788|FG002|Overall Study|Death|5|||
105839121|NCT00402025|365067786|FG000|Overall Study|Disease Progression|1|||
105839122|NCT00402025|365067787|FG001|Overall Study|Disease Progression|1|||
105839123|NCT00402025|365067788|FG002|Overall Study|Disease Progression|2|||
105839124|NCT00402025|365067786|FG000|Overall Study|Physician Decision|1|||
105839125|NCT00402025|365067787|FG001|Overall Study|Physician Decision|1|||
105839126|NCT00402025|365067788|FG002|Overall Study|Physician Decision|0|||
105839127|NCT00402025|365067786|FG000|Overall Study|Participant Decision|0|||
105839128|NCT00402025|365067787|FG001|Overall Study|Participant Decision|0|||
105839129|NCT00402025|365067788|FG002|Overall Study|Participant Decision|1|||
105839130|NCT01917968|365067790|FG000|Overall Study|Death|3|||
105839131|NCT01917968|365067791|FG001|Overall Study|Death|2|||
105839132|NCT01917968|365067790|FG000|Overall Study|Lost to Follow-up|21|||
105839133|NCT01917968|365067791|FG001|Overall Study|Lost to Follow-up|39|||
105839134|NCT01917968|365067790|FG000|Overall Study|Physician Decision|1|||
105839135|NCT01917968|365067791|FG001|Overall Study|Physician Decision|2|||
105839136|NCT01917968|365067790|FG000|Overall Study|Withdrawal by Subject|20|||
105839137|NCT01917968|365067791|FG001|Overall Study|Withdrawal by Subject|35|||
105839138|NCT01917968|365067790|FG000|Overall Study|Subject Relocation|5|||
105839139|NCT01917968|365067791|FG001|Overall Study|Subject Relocation|1|||
105839140|NCT01917968|365067790|FG000|Overall Study|36M Missed Visit|3|||
105839141|NCT01917968|365067791|FG001|Overall Study|36M Missed Visit|2|||
105839142|NCT01917968|365067790|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
105367620|NCT04635839|363352352|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
105839143|NCT01917968|365067791|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
105839144|NCT01917968|365067790|FG000|Overall Study|Change in Family Circumstances|0|||
105839145|NCT01917968|365067791|FG001|Overall Study|Change in Family Circumstances|1|||
105839146|NCT01917968|365067790|FG000|Overall Study|No Data Available|0|||
105839147|NCT01917968|365067791|FG001|Overall Study|No Data Available|2|||
105839148|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
105839149|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
105839150|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
105839151|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
105839152|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
105839153|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
105839154|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
105839155|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
105839156|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
105839157|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
105839158|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
105839159|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
105839160|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
105839161|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
105839162|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
105839163|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
105839164|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
105839165|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
105839166|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
105839167|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
105839168|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
105839169|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
105839170|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
105839171|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
105839172|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
105839173|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
105839174|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
105839175|NCT01435928|365067792|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
105839176|NCT01435928|365067793|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
105839177|NCT01435928|365067794|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
105839178|NCT01435928|365067792|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
105839179|NCT01435928|365067793|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
105839180|NCT01435928|365067794|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
105839181|NCT01435928|365067792|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
105839182|NCT01435928|365067793|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
105839183|NCT01435928|365067794|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
105839184|NCT01435928|365067792|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
105839185|NCT01435928|365067793|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
105839186|NCT01435928|365067794|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
105839187|NCT01435928|365067792|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
105839188|NCT01435928|365067793|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
105839189|NCT01435928|365067794|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
105839190|NCT01435928|365067792|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
105839191|NCT01435928|365067793|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
105839192|NCT01435928|365067794|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
105839193|NCT01435928|365067792|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
105839194|NCT01435928|365067793|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
105839195|NCT01435928|365067794|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
105839196|NCT04034355|365067806|FG000|Overall Study|Study terminated by Sponsor|10|||
105839197|NCT04034355|365067807|FG001|Overall Study|Study terminated by Sponsor|17|||
105839198|NCT04034355|365067806|FG000|Overall Study|Withdrawal by Subject|12|||
105839199|NCT04034355|365067807|FG001|Overall Study|Withdrawal by Subject|11|||
105839200|NCT04034355|365067806|FG000|Overall Study|Site terminated by Sponsor|4|||
105839201|NCT04034355|365067807|FG001|Overall Study|Site terminated by Sponsor|5|||
105839202|NCT04034355|365067806|FG000|Overall Study|Adverse Event|2|||
105839203|NCT04034355|365067807|FG001|Overall Study|Adverse Event|0|||
105839204|NCT04034355|365067806|FG000|Overall Study|Death|1|||
105839205|NCT04034355|365067807|FG001|Overall Study|Death|1|||
105839206|NCT04034355|365067806|FG000|Overall Study|Not reported|2|||
105839207|NCT04034355|365067807|FG001|Overall Study|Not reported|0|||
105839208|NCT04034355|365067806|FG000|Overall Study|Lost to Follow-up|1|||
105839209|NCT04034355|365067807|FG001|Overall Study|Lost to Follow-up|0|||
105839210|NCT04034355|365067806|FG000|Overall Study|Physician Decision|1|||
105839211|NCT04034355|365067807|FG001|Overall Study|Physician Decision|0|||
105839212|NCT04034355|365067806|FG000|Overall Study|Protocol Violation|0|||
105839213|NCT04034355|365067807|FG001|Overall Study|Protocol Violation|1|||
105839214|NCT04034355|365067806|FG000|Overall Study|Progressive disease|1|||
105839215|NCT04034355|365067807|FG001|Overall Study|Progressive disease|0|||
105839216|NCT01923311|365069956|FG000|Overall Study|Pregnancy|1|||
105839217|NCT01923311|365069957|FG001|Overall Study|Pregnancy|0|||
105839218|NCT01923311|365069956|FG000|Overall Study|Investigator's Discretion|1|||
105839219|NCT01923311|365069957|FG001|Overall Study|Investigator's Discretion|0|||
105839220|NCT01923311|365069956|FG000|Overall Study|Non-Compliance with Study Drug|2|||
105839221|NCT01923311|365069957|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105839222|NCT01923311|365069956|FG000|Overall Study|Withdrew Consent|1|||
105839223|NCT01923311|365069957|FG001|Overall Study|Withdrew Consent|0|||
105839224|NCT01923311|365069956|FG000|Overall Study|Study Terminated by Sponsor|12|||
105839225|NCT01923311|365069957|FG001|Overall Study|Study Terminated by Sponsor|0|||
105839226|NCT03180528|365069962|FG000|Overall Study|Adverse Event|1|||
105839227|NCT03180528|365069962|FG000|Overall Study|Withdrawal by Subject|1|||
105839228|NCT03180528|365069962|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
105839229|NCT04703855|365069963|FG000|Overall Study|Heart Transplant|1|||
105367621|NCT04635839|363352353|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
105367622|NCT02737358|363352354|FG000|Overall Study|Withdrawal by Subject|7|||
105367623|NCT02737358|363352355|FG001|Overall Study|Withdrawal by Subject|12|||
105839230|NCT00401245|365069967|FG000|Double Blind Titration Phase|Adverse Event|3|||
105839231|NCT00401245|365069968|FG001|Double Blind Titration Phase|Adverse Event|2|||
105839232|NCT00401245|365069969|FG002|Double Blind Titration Phase|Adverse Event|5|||
105839233|NCT00401245|365069970|FG003|Double Blind Titration Phase|Adverse Event|12|||
105839234|NCT00401245|365069971|FG004|Double Blind Titration Phase|Adverse Event|0|||
105839235|NCT00401245|365069972|FG005|Double Blind Titration Phase|Adverse Event|0|||
105839236|NCT00401245|365069973|FG006|Double Blind Titration Phase|Adverse Event|0|||
105839237|NCT00401245|365069974|FG007|Double Blind Titration Phase|Adverse Event|0|||
105839238|NCT00401245|365069967|FG000|Double Blind Titration Phase|Other|0|||
105839239|NCT00401245|365069968|FG001|Double Blind Titration Phase|Other|0|||
105839240|NCT00401245|365069969|FG002|Double Blind Titration Phase|Other|1|||
105839241|NCT00401245|365069970|FG003|Double Blind Titration Phase|Other|0|||
105839242|NCT00401245|365069971|FG004|Double Blind Titration Phase|Other|0|||
105839243|NCT00401245|365069972|FG005|Double Blind Titration Phase|Other|0|||
105839244|NCT00401245|365069973|FG006|Double Blind Titration Phase|Other|0|||
105839245|NCT00401245|365069974|FG007|Double Blind Titration Phase|Other|0|||
105839246|NCT00401245|365069967|FG000|Double Blind Titration Phase|Protocol Violation|0|||
105839247|NCT00401245|365069968|FG001|Double Blind Titration Phase|Protocol Violation|0|||
105839248|NCT00401245|365069969|FG002|Double Blind Titration Phase|Protocol Violation|0|||
105839249|NCT00401245|365069970|FG003|Double Blind Titration Phase|Protocol Violation|1|||
105839250|NCT00401245|365069971|FG004|Double Blind Titration Phase|Protocol Violation|0|||
105839251|NCT00401245|365069972|FG005|Double Blind Titration Phase|Protocol Violation|0|||
105839252|NCT00401245|365069973|FG006|Double Blind Titration Phase|Protocol Violation|0|||
105839253|NCT00401245|365069974|FG007|Double Blind Titration Phase|Protocol Violation|0|||
105839254|NCT00401245|365069967|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
105839255|NCT00401245|365069968|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
105839256|NCT00401245|365069969|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
105839257|NCT00401245|365069970|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
105839258|NCT00401245|365069971|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
105839259|NCT00401245|365069972|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
105839260|NCT00401245|365069973|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
105839261|NCT00401245|365069974|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
105839262|NCT00401245|365069967|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
105839263|NCT00401245|365069968|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
105839264|NCT00401245|365069969|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
105839265|NCT00401245|365069970|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
105839266|NCT00401245|365069971|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
105839267|NCT00401245|365069972|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
105839268|NCT00401245|365069973|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
105839269|NCT00401245|365069974|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
105839270|NCT00401245|365069967|FG000|Open Label Phase|Adverse Event|5|||
105839271|NCT00401245|365069968|FG001|Open Label Phase|Adverse Event|14|||
105839272|NCT00401245|365069969|FG002|Open Label Phase|Adverse Event|6|||
105839273|NCT00401245|365069970|FG003|Open Label Phase|Adverse Event|7|||
105839274|NCT00401245|365069971|FG004|Open Label Phase|Adverse Event|0|||
105839275|NCT00401245|365069972|FG005|Open Label Phase|Adverse Event|0|||
105839276|NCT00401245|365069973|FG006|Open Label Phase|Adverse Event|0|||
105839277|NCT00401245|365069974|FG007|Open Label Phase|Adverse Event|0|||
105839278|NCT00401245|365069967|FG000|Open Label Phase|Lost to Follow-up|5|||
105839279|NCT00401245|365069968|FG001|Open Label Phase|Lost to Follow-up|7|||
105839280|NCT00401245|365069969|FG002|Open Label Phase|Lost to Follow-up|5|||
105839281|NCT00401245|365069970|FG003|Open Label Phase|Lost to Follow-up|4|||
105839282|NCT00401245|365069971|FG004|Open Label Phase|Lost to Follow-up|0|||
105839283|NCT00401245|365069972|FG005|Open Label Phase|Lost to Follow-up|0|||
105839284|NCT00401245|365069973|FG006|Open Label Phase|Lost to Follow-up|0|||
105839285|NCT00401245|365069974|FG007|Open Label Phase|Lost to Follow-up|0|||
105367624|NCT02737358|363352354|FG000|Overall Study|Lost to Follow-up|2|||
105367625|NCT02737358|363352355|FG001|Overall Study|Lost to Follow-up|3|||
105367626|NCT00896493|363352356|FG000|Overall Study|Early disease relapse|3|||
105367627|NCT02452047|363352357|FG000|Overall Study|Adverse Event|0|||
105367628|NCT02452047|363352358|FG001|Overall Study|Adverse Event|1|||
105367629|NCT02452047|363352359|FG002|Overall Study|Adverse Event|1|||
105367630|NCT02452047|363352357|FG000|Overall Study|Death|1|||
105839286|NCT00401245|365069967|FG000|Open Label Phase|Other|4|||
105839287|NCT00401245|365069968|FG001|Open Label Phase|Other|8|||
105839288|NCT00401245|365069969|FG002|Open Label Phase|Other|7|||
105839289|NCT00401245|365069970|FG003|Open Label Phase|Other|8|||
105839290|NCT00401245|365069971|FG004|Open Label Phase|Other|0|||
105839291|NCT00401245|365069972|FG005|Open Label Phase|Other|0|||
105311459|NCT03016975|363137902|FG000|At 3 Year Follow-up|Death|1|||
105311460|NCT03016975|363137903|FG001|At 3 Year Follow-up|Death|0|||
105311461|NCT03016975|363137904|FG002|At 3 Year Follow-up|Death|0|||
105311462|NCT03016975|363137902|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
105311463|NCT03016975|363137903|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
105839292|NCT00401245|365069973|FG006|Open Label Phase|Other|0|||
105839293|NCT00401245|365069974|FG007|Open Label Phase|Other|0|||
105839294|NCT00401245|365069967|FG000|Open Label Phase|Protocol Violation|0|||
105839295|NCT00401245|365069968|FG001|Open Label Phase|Protocol Violation|1|||
105839296|NCT00401245|365069969|FG002|Open Label Phase|Protocol Violation|0|||
105839297|NCT00401245|365069970|FG003|Open Label Phase|Protocol Violation|1|||
105839298|NCT00401245|365069971|FG004|Open Label Phase|Protocol Violation|0|||
105839299|NCT00401245|365069972|FG005|Open Label Phase|Protocol Violation|0|||
105839300|NCT00401245|365069973|FG006|Open Label Phase|Protocol Violation|0|||
105839301|NCT00401245|365069974|FG007|Open Label Phase|Protocol Violation|0|||
105839302|NCT00401245|365069967|FG000|Open Label Phase|Withdrawal by Subject|3|||
105839303|NCT00401245|365069968|FG001|Open Label Phase|Withdrawal by Subject|3|||
105839304|NCT00401245|365069969|FG002|Open Label Phase|Withdrawal by Subject|2|||
105839305|NCT00401245|365069970|FG003|Open Label Phase|Withdrawal by Subject|1|||
105839306|NCT00401245|365069971|FG004|Open Label Phase|Withdrawal by Subject|0|||
105839307|NCT00401245|365069972|FG005|Open Label Phase|Withdrawal by Subject|0|||
105839308|NCT00401245|365069973|FG006|Open Label Phase|Withdrawal by Subject|0|||
105839309|NCT00401245|365069974|FG007|Open Label Phase|Withdrawal by Subject|0|||
105839310|NCT00401245|365069967|FG000|Open Label Phase|Lack of Efficacy|4|||
105839311|NCT00401245|365069968|FG001|Open Label Phase|Lack of Efficacy|2|||
105839312|NCT00401245|365069969|FG002|Open Label Phase|Lack of Efficacy|3|||
105839313|NCT00401245|365069970|FG003|Open Label Phase|Lack of Efficacy|0|||
105839314|NCT00401245|365069971|FG004|Open Label Phase|Lack of Efficacy|0|||
105839315|NCT00401245|365069972|FG005|Open Label Phase|Lack of Efficacy|0|||
105839316|NCT00401245|365069973|FG006|Open Label Phase|Lack of Efficacy|0|||
105839317|NCT00401245|365069974|FG007|Open Label Phase|Lack of Efficacy|0|||
105839318|NCT00401245|365069967|FG000|Double Blind Tapering Phase|Adverse Event|0|||
105839319|NCT00401245|365069968|FG001|Double Blind Tapering Phase|Adverse Event|0|||
105839320|NCT00401245|365069969|FG002|Double Blind Tapering Phase|Adverse Event|0|||
105839321|NCT00401245|365069970|FG003|Double Blind Tapering Phase|Adverse Event|0|||
105839322|NCT00401245|365069971|FG004|Double Blind Tapering Phase|Adverse Event|1|||
105839323|NCT00401245|365069972|FG005|Double Blind Tapering Phase|Adverse Event|1|||
105839324|NCT00401245|365069973|FG006|Double Blind Tapering Phase|Adverse Event|2|||
105839325|NCT00401245|365069974|FG007|Double Blind Tapering Phase|Adverse Event|4|||
105839326|NCT00401245|365069967|FG000|Double Blind Tapering Phase|Investigator request|0|||
105839327|NCT00401245|365069968|FG001|Double Blind Tapering Phase|Investigator request|0|||
105839328|NCT00401245|365069969|FG002|Double Blind Tapering Phase|Investigator request|0|||
105839329|NCT00401245|365069970|FG003|Double Blind Tapering Phase|Investigator request|0|||
105311464|NCT03016975|363137904|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
105311465|NCT03016975|363137902|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
105311466|NCT03016975|363137903|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
105311467|NCT03016975|363137904|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
105311468|NCT01590797|363137905|FG000|Overall Study|Adverse Event|4|||
105311469|NCT01590797|363137906|FG001|Overall Study|Adverse Event|3|||
105311470|NCT01590797|363137905|FG000|Overall Study|Lack of Efficacy|0|||
105311471|NCT01590797|363137906|FG001|Overall Study|Lack of Efficacy|2|||
105311472|NCT01590797|363137905|FG000|Overall Study|Lost to Follow-up|0|||
105311473|NCT01590797|363137906|FG001|Overall Study|Lost to Follow-up|1|||
105311474|NCT01590797|363137905|FG000|Overall Study|Protocol Violation|4|||
105311475|NCT01590797|363137906|FG001|Overall Study|Protocol Violation|1|||
105311476|NCT01590797|363137905|FG000|Overall Study|Withdrawal by Subject|7|||
105311477|NCT01590797|363137906|FG001|Overall Study|Withdrawal by Subject|5|||
105311478|NCT01590797|363137905|FG000|Overall Study|Other Protocol Specified Criteria|2|||
105311479|NCT01590797|363137906|FG001|Overall Study|Other Protocol Specified Criteria|4|||
105311480|NCT00901576|363137907|FG000|Second Intervention|Withdrawal by Subject|0|||
105311481|NCT00901576|363137908|FG001|Second Intervention|Withdrawal by Subject|0|||
105311482|NCT00901576|363137909|FG002|Second Intervention|Withdrawal by Subject|0|||
105311483|NCT00901576|363137910|FG003|Second Intervention|Withdrawal by Subject|1|||
105311484|NCT00901576|363137911|FG004|Second Intervention|Withdrawal by Subject|0|||
105311485|NCT00901576|363137912|FG005|Second Intervention|Withdrawal by Subject|1|||
105311486|NCT00901576|363137907|FG000|Second Intervention|Physician Decision|1|||
105311487|NCT00901576|363137908|FG001|Second Intervention|Physician Decision|0|||
105311488|NCT00901576|363137909|FG002|Second Intervention|Physician Decision|0|||
105839330|NCT00401245|365069971|FG004|Double Blind Tapering Phase|Investigator request|0|||
105311489|NCT00901576|363137910|FG003|Second Intervention|Physician Decision|0|||
105311490|NCT00901576|363137911|FG004|Second Intervention|Physician Decision|0|||
105311491|NCT00901576|363137912|FG005|Second Intervention|Physician Decision|0|||
105839331|NCT00401245|365069972|FG005|Double Blind Tapering Phase|Investigator request|0|||
105839332|NCT00401245|365069973|FG006|Double Blind Tapering Phase|Investigator request|0|||
105839333|NCT00401245|365069974|FG007|Double Blind Tapering Phase|Investigator request|1|||
105311492|NCT01559389|363137913|FG000|Overall Study|Withdrawal by Subject|20|||
105311493|NCT01559389|363137914|FG001|Overall Study|Withdrawal by Subject|20|||
105311494|NCT02252406|363137915|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
105311495|NCT02252406|363137916|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
105311496|NCT02252406|363137915|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
105311497|NCT02252406|363137916|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
105311498|NCT02252406|363137915|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
105311499|NCT02252406|363137916|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
105311500|NCT02252406|363137915|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
105311501|NCT02252406|363137916|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
105311502|NCT02252406|363137915|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
105311503|NCT02252406|363137916|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
105311504|NCT03796039|363137919|FG000|Overall Study|Death|2|||
105311505|NCT03796039|363137920|FG001|Overall Study|Death|1|||
105311506|NCT03796039|363137919|FG000|Overall Study|Withdrawal by Subject|7|||
105311507|NCT03796039|363137920|FG001|Overall Study|Withdrawal by Subject|4|||
105311508|NCT02910063|363137923|FG000|Phase 2|Withdrawal by Subject|3|||
105311509|NCT02910063|363137924|FG001|Phase 2|Withdrawal by Subject|0|||
105311510|NCT02910063|363137925|FG002|Phase 2|Withdrawal by Subject|0|||
105311511|NCT02910063|363137923|FG000|Phase 2|Lost to Follow-up|1|||
105311512|NCT02910063|363137924|FG001|Phase 2|Lost to Follow-up|0|||
105311513|NCT02910063|363137925|FG002|Phase 2|Lost to Follow-up|0|||
105311514|NCT02910063|363137923|FG000|Phase 2|Death|24|||
105311515|NCT02910063|363137924|FG001|Phase 2|Death|0|||
105311516|NCT02910063|363137925|FG002|Phase 2|Death|0|||
105311517|NCT04693416|363137926|FG000|Overall Study|Lost to Follow-up|13|||
105311518|NCT04693416|363137927|FG001|Overall Study|Lost to Follow-up|0|||
105311519|NCT00369317|363137928|FG000|Overall Study|Adverse Event|3|||
105311520|NCT00369317|363137928|FG000|Overall Study|Death|1|||
105311521|NCT00369317|363137928|FG000|Overall Study|Lack of Efficacy|5|||
105311522|NCT00369317|363137928|FG000|Overall Study|Physician Decision|2|||
105311523|NCT00369317|363137928|FG000|Overall Study|Withdrawal by Subject|8|||
105311524|NCT00369317|363137928|FG000|Overall Study|Ineligible|1|||
105311525|NCT02552212|363137940|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
105311526|NCT02552212|363137941|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
105311527|NCT02552212|363137942|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
105311528|NCT02552212|363137940|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
105311529|NCT02552212|363137941|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
105311530|NCT02552212|363137942|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
105311531|NCT02552212|363137940|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
105311532|NCT02552212|363137941|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
105311533|NCT02552212|363137942|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
105311534|NCT02552212|363137940|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
105311535|NCT02552212|363137941|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
105311536|NCT02552212|363137942|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
105311537|NCT02552212|363137940|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
105311538|NCT02552212|363137941|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
105311539|NCT02552212|363137942|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
105311540|NCT02552212|363137940|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
105311541|NCT02552212|363137941|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
105311542|NCT02552212|363137942|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
105311543|NCT02552212|363137940|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
105311544|NCT02552212|363137941|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
105311545|NCT02552212|363137942|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
105311546|NCT02552212|363137940|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
105367631|NCT02452047|363352358|FG001|Overall Study|Death|3|||
105367632|NCT02452047|363352359|FG002|Overall Study|Death|1|||
105367633|NCT02452047|363352357|FG000|Overall Study|Physician Decision|1|||
105311547|NCT02552212|363137941|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
105311548|NCT02552212|363137942|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
105311549|NCT02552212|363137940|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
105311550|NCT02552212|363137941|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
105311551|NCT02552212|363137942|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
105311552|NCT02552212|363137940|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
105367634|NCT02452047|363352358|FG001|Overall Study|Physician Decision|0|||
105367635|NCT02452047|363352359|FG002|Overall Study|Physician Decision|0|||
105367636|NCT02452047|363352357|FG000|Overall Study|Lost to Follow-up|1|||
105311553|NCT02552212|363137941|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
105311554|NCT02552212|363137942|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
105311555|NCT02552212|363137940|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
105367637|NCT02452047|363352358|FG001|Overall Study|Lost to Follow-up|1|||
105839334|NCT00401245|365069967|FG000|Double Blind Tapering Phase|Other|0|||
105489902|NCT02117427|363805695|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
105489903|NCT02117427|363805696|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
105839335|NCT00401245|365069968|FG001|Double Blind Tapering Phase|Other|0|||
105839336|NCT00401245|365069969|FG002|Double Blind Tapering Phase|Other|0|||
105839337|NCT00401245|365069970|FG003|Double Blind Tapering Phase|Other|0|||
105839338|NCT00401245|365069971|FG004|Double Blind Tapering Phase|Other|1|||
105311556|NCT02552212|363137941|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
105311557|NCT02552212|363137942|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
105311558|NCT02552212|363137940|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
105311559|NCT02552212|363137941|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
105311560|NCT02552212|363137942|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
105311561|NCT02552212|363137940|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
105311562|NCT02552212|363137941|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
105311563|NCT02552212|363137942|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
105311564|NCT02552212|363137940|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
105367638|NCT02452047|363352359|FG002|Overall Study|Lost to Follow-up|0|||
105367639|NCT02452047|363352357|FG000|Overall Study|Withdrawal by Subject|1|||
105367640|NCT02452047|363352358|FG001|Overall Study|Withdrawal by Subject|0|||
105367641|NCT02452047|363352359|FG002|Overall Study|Withdrawal by Subject|0|||
105367642|NCT01868646|363352368|FG000|Overall Study|Do not meet inclusion criteria|3|||
105367643|NCT01868646|363352369|FG001|Overall Study|Do not meet inclusion criteria|5|||
105367644|NCT02026141|363352372|FG000|Overall Study|Protocol Violation|0|||
105367645|NCT02026141|363352373|FG001|Overall Study|Protocol Violation|1|||
105367646|NCT01218308|363352374|FG000|Overall Study|Adverse Event|1|||
105367647|NCT01218308|363352375|FG001|Overall Study|Adverse Event|2|||
105367648|NCT01218308|363352374|FG000|Overall Study|Protocol Violation|0|||
105367649|NCT01218308|363352375|FG001|Overall Study|Protocol Violation|2|||
105367650|NCT01218308|363352374|FG000|Overall Study|Withdrawal by Subject|61|||
105367651|NCT01218308|363352375|FG001|Overall Study|Withdrawal by Subject|64|||
105367652|NCT01218308|363352374|FG000|Overall Study|Lost to Follow-up|27|||
105367653|NCT01218308|363352375|FG001|Overall Study|Lost to Follow-up|31|||
105367654|NCT01218308|363352374|FG000|Overall Study|Other|14|||
105367655|NCT01218308|363352375|FG001|Overall Study|Other|21|||
105367656|NCT01450813|363352376|FG000|Overall Study|Physician Decision|1|||
105367657|NCT01450813|363352377|FG001|Overall Study|Physician Decision|1|||
105367658|NCT01450813|363352378|FG002|Overall Study|Physician Decision|0|||
105367659|NCT01450813|363352379|FG003|Overall Study|Physician Decision|3|||
105367660|NCT00960193|363352380|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
105367661|NCT02051296|363352390|FG000|Overall Study|Lost to Follow-up|1|||
105367662|NCT02051296|363352391|FG001|Overall Study|Lost to Follow-up|2|||
105367663|NCT02051296|363352390|FG000|Overall Study|withdraw prior to treatment|7|||
105367664|NCT02051296|363352391|FG001|Overall Study|withdraw prior to treatment|7|||
105367665|NCT00473083|363352392|FG000|Overall Study|Adverse Event|1|||
105367666|NCT00473083|363352393|FG001|Overall Study|Adverse Event|0|||
105367667|NCT00473083|363352394|FG002|Overall Study|Adverse Event|0|||
105367668|NCT00748241|363352395|FG000|Overall Study|Implant failure|1|||
105367669|NCT00748241|363352395|FG000|Overall Study|Lost to Follow-up|5|||
105367670|NCT00748241|363352395|FG000|Overall Study|Death|2|||
105367671|NCT00492297|363352399|FG000|Treatment|Death|2|||
105367672|NCT00492297|363352399|FG000|Treatment|Study terminated by sponsor|3|||
105367673|NCT00492297|363352399|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
105367674|NCT00492297|363352399|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
105367675|NCT00492297|363352399|FG000|Survival Only Follow-up|Death|46|||
105839339|NCT00401245|365069972|FG005|Double Blind Tapering Phase|Other|0|||
105839340|NCT00401245|365069973|FG006|Double Blind Tapering Phase|Other|2|||
105839341|NCT00401245|365069974|FG007|Double Blind Tapering Phase|Other|2|||
105839342|NCT00401245|365069967|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
105839343|NCT00401245|365069968|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
105839344|NCT00401245|365069969|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
105839345|NCT00401245|365069970|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
105839346|NCT00401245|365069971|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
105839347|NCT00401245|365069972|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
105839348|NCT00401245|365069973|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
105839349|NCT00401245|365069974|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
105839350|NCT00401245|365069967|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
105839351|NCT00401245|365069968|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
105839352|NCT00401245|365069969|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
105839353|NCT00401245|365069970|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
105839354|NCT00401245|365069971|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
105839355|NCT00401245|365069972|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
105839356|NCT00401245|365069973|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
105839357|NCT00401245|365069974|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
105839358|NCT01560819|365069977|FG000|Overall Study|Physician Decision|1|||
105839359|NCT01560819|365069978|FG001|Overall Study|Physician Decision|0|||
105367676|NCT00492297|363352399|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
105367677|NCT00492297|363352399|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
105367678|NCT00113607|363352400|FG000|Overall Study|Adverse Event|40|||
105367679|NCT00113607|363352401|FG001|Overall Study|Adverse Event|71|||
105311565|NCT02552212|363137941|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
105311566|NCT02552212|363137942|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
105311567|NCT02552212|363137940|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
105311568|NCT02552212|363137941|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
105311569|NCT02552212|363137942|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
105311570|NCT02552212|363137940|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
105311571|NCT02552212|363137941|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
105311572|NCT02552212|363137942|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
105311573|NCT02552212|363137940|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
105311574|NCT02552212|363137941|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
105311575|NCT02552212|363137942|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
105367680|NCT00113607|363352400|FG000|Overall Study|Death|8|||
105839360|NCT01619579|365069979|FG000|Overall Study|Withdrawal by Subject|0|||
105839361|NCT01619579|365069980|FG001|Overall Study|Withdrawal by Subject|3|||
105839362|NCT02344745|365069981|FG000|Overall Study|Data collection sheets were lost|2|||
105839363|NCT02344745|365069982|FG001|Overall Study|Data collection sheets were lost|0|||
105839364|NCT02124902|365069983|FG000|Overall Study|Adverse Event|7|||
105839365|NCT02124902|365069984|FG001|Overall Study|Adverse Event|2|||
105839366|NCT02124902|365069983|FG000|Overall Study|Went to alternative treatment|4|||
105839367|NCT02124902|365069984|FG001|Overall Study|Went to alternative treatment|0|||
105839368|NCT02124902|365069983|FG000|Overall Study|Withdrawal by Subject|2|||
105839369|NCT02124902|365069984|FG001|Overall Study|Withdrawal by Subject|1|||
105839370|NCT02124902|365069983|FG000|Overall Study|Physician Decision|2|||
105839371|NCT02124902|365069984|FG001|Overall Study|Physician Decision|0|||
105839372|NCT02124902|365069983|FG000|Overall Study|Not eligible|1|||
105839373|NCT02124902|365069984|FG001|Overall Study|Not eligible|0|||
105839374|NCT02124902|365069983|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
105839375|NCT02124902|365069984|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
105839376|NCT01937351|365069985|FG000|Overall Study|Withdrawal by Subject|4|||
105839377|NCT01937351|365069986|FG001|Overall Study|Withdrawal by Subject|2|||
105839378|NCT01937351|365069985|FG000|Overall Study|Death|1|||
105839379|NCT01937351|365069986|FG001|Overall Study|Death|0|||
105839380|NCT01937351|365069985|FG000|Overall Study|Not treated w device, per protocol fail|4|||
105839381|NCT01937351|365069986|FG001|Overall Study|Not treated w device, per protocol fail|0|||
105839382|NCT01961687|365069987|FG000|Overall Study|Lost to Follow-up|19|||
105839383|NCT01961687|365069987|FG000|Overall Study|Re-operation|17|||
105367681|NCT00113607|363352401|FG001|Overall Study|Death|8|||
105367682|NCT00113607|363352400|FG000|Overall Study|Withdrawal by Subject|50|||
105489904|NCT02117427|363805694|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
105489905|NCT02117427|363805695|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
105839384|NCT01961687|365069987|FG000|Overall Study|Death|7|||
105839385|NCT01961687|365069987|FG000|Overall Study|Withdrawal by Subject|6|||
105839386|NCT01961687|365069987|FG000|Overall Study|Adverse Event|6|||
105839387|NCT01961687|365069987|FG000|Overall Study|Moved to area without study site|2|||
105839388|NCT01961687|365069987|FG000|Overall Study|Sponsor decision|2|||
105839389|NCT01961687|365069987|FG000|Overall Study|Physician Decision|1|||
105839390|NCT01961687|365069987|FG000|Overall Study|Unable to meet follow-up requirements|1|||
105839391|NCT02688387|365069990|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839392|NCT02688387|365069991|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839393|NCT02688387|365069992|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
105839394|NCT02688387|365069993|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839395|NCT02688387|365069994|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839396|NCT02688387|365069995|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839397|NCT02688387|365069996|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839398|NCT02688387|365069997|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839399|NCT02688387|365069998|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839400|NCT02688387|365069999|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839401|NCT02688387|365070000|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839402|NCT02688387|365070001|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839403|NCT02688387|365070002|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839404|NCT02688387|365070003|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839405|NCT02688387|365070004|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839406|NCT02688387|365070005|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839407|NCT02688387|365070006|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839408|NCT02688387|365070007|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839409|NCT02688387|365070008|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839410|NCT02688387|365070009|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839411|NCT02688387|365070010|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839412|NCT02688387|365070011|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839413|NCT02688387|365069990|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839414|NCT02688387|365069991|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105367683|NCT00113607|363352401|FG001|Overall Study|Withdrawal by Subject|58|||
105839415|NCT02688387|365069992|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839416|NCT02688387|365069993|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
105839417|NCT02688387|365069994|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839418|NCT02688387|365069995|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839419|NCT02688387|365069996|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839420|NCT02688387|365069997|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839421|NCT02688387|365069998|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839422|NCT02688387|365069999|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839423|NCT02688387|365070000|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839424|NCT02688387|365070001|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839425|NCT02688387|365070002|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839426|NCT02688387|365070003|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839427|NCT02688387|365070004|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839428|NCT02688387|365070005|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839429|NCT02688387|365070006|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839430|NCT02688387|365070007|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839431|NCT02688387|365070008|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839432|NCT02688387|365070009|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839433|NCT02688387|365070010|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839434|NCT02688387|365070011|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839435|NCT02688387|365069990|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839436|NCT02688387|365069991|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
105839437|NCT02688387|365069992|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839438|NCT02688387|365069993|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839439|NCT02688387|365069994|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839440|NCT02688387|365069995|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839441|NCT02688387|365069996|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839442|NCT02688387|365069997|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839443|NCT02688387|365069998|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839444|NCT02688387|365069999|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839445|NCT02688387|365070000|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839446|NCT02688387|365070001|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839447|NCT02688387|365070002|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839448|NCT02688387|365070003|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839449|NCT02688387|365070004|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839450|NCT02688387|365070005|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839451|NCT02688387|365070006|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839452|NCT02688387|365070007|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839453|NCT02688387|365070008|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839454|NCT02688387|365070009|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839455|NCT02688387|365070010|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839456|NCT02688387|365070011|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839457|NCT02688387|365069990|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839458|NCT02688387|365069991|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839459|NCT02688387|365069992|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
105839460|NCT02688387|365069993|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839461|NCT02688387|365069994|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
105839462|NCT02688387|365069995|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839463|NCT02688387|365069996|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839464|NCT02688387|365069997|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839465|NCT02688387|365069998|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105311576|NCT02552212|363137940|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
105311577|NCT02552212|363137941|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
105311578|NCT02552212|363137942|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
105311579|NCT02552212|363137940|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
105311580|NCT02552212|363137941|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
105311581|NCT02552212|363137942|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
105311582|NCT02552212|363137940|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
105311583|NCT02552212|363137941|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
105367684|NCT00113607|363352400|FG000|Overall Study|Lost to Follow-up|0|||
105311584|NCT02552212|363137942|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
105311585|NCT02552212|363137940|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
105311586|NCT02552212|363137941|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
105311587|NCT02552212|363137942|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
105311588|NCT05038800|363137943|FG000|Overall Study|Death|1|||
105311589|NCT05038800|363137944|FG001|Overall Study|Death|1|||
105311590|NCT05038800|363137945|FG002|Overall Study|Death|5|||
105311591|NCT05038800|363137946|FG003|Overall Study|Death|3|||
105839466|NCT02688387|365069999|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105311592|NCT05038800|363137947|FG004|Overall Study|Death|1|||
105839467|NCT02688387|365070000|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839468|NCT02688387|365070001|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839469|NCT02688387|365070002|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839470|NCT02688387|365070003|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839471|NCT02688387|365070004|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839472|NCT02688387|365070005|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839473|NCT02688387|365070006|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839474|NCT02688387|365070007|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839475|NCT02688387|365070008|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839476|NCT02688387|365070009|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839477|NCT02688387|365070010|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839478|NCT02688387|365070011|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839479|NCT02688387|365069990|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
105839480|NCT02688387|365069991|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839481|NCT02688387|365069992|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839482|NCT02688387|365069993|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839483|NCT02688387|365069994|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839484|NCT02688387|365069995|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839485|NCT02688387|365069996|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839486|NCT02688387|365069997|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839487|NCT02688387|365069998|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839488|NCT02688387|365069999|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839489|NCT02688387|365070000|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839490|NCT02688387|365070001|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839491|NCT02688387|365070002|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839492|NCT02688387|365070003|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839493|NCT02688387|365070004|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839494|NCT02688387|365070005|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839495|NCT02688387|365070006|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839496|NCT02688387|365070007|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839497|NCT02688387|365070008|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839498|NCT02688387|365070009|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839499|NCT02688387|365070010|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839500|NCT02688387|365070011|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839501|NCT02688387|365069990|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839502|NCT02688387|365069991|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839503|NCT02688387|365069992|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839504|NCT02688387|365069993|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839505|NCT02688387|365069994|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839506|NCT02688387|365069995|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839507|NCT02688387|365069996|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839508|NCT02688387|365069997|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839509|NCT02688387|365069998|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105311593|NCT05038800|363137943|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105311594|NCT05038800|363137944|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105311595|NCT05038800|363137945|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105311596|NCT05038800|363137946|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105311597|NCT05038800|363137947|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
105311598|NCT05038800|363137943|FG000|Overall Study|Lack of Efficacy|0|||
105311599|NCT05038800|363137944|FG001|Overall Study|Lack of Efficacy|0|||
105311600|NCT05038800|363137945|FG002|Overall Study|Lack of Efficacy|0|||
105311601|NCT05038800|363137946|FG003|Overall Study|Lack of Efficacy|0|||
105367685|NCT00113607|363352401|FG001|Overall Study|Lost to Follow-up|2|||
105367686|NCT00113607|363352400|FG000|Overall Study|Disease Progression|180|||
105576516|NCT04424290|364110182|FG001|Overall Study|Adverse Event|0|||
105576517|NCT04424290|364110183|FG002|Overall Study|Adverse Event|0|||
105367687|NCT00113607|363352401|FG001|Overall Study|Disease Progression|142|||
105839510|NCT02688387|365069999|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839511|NCT02688387|365070000|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
105839512|NCT02688387|365070001|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839513|NCT02688387|365070002|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839514|NCT02688387|365070003|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839515|NCT02688387|365070004|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839516|NCT02688387|365070005|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839517|NCT02688387|365070006|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839518|NCT02688387|365070007|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839519|NCT02688387|365070008|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839520|NCT02688387|365070009|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839521|NCT02688387|365070010|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839522|NCT02688387|365070011|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839523|NCT02688387|365069990|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839524|NCT02688387|365069991|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839525|NCT02688387|365069992|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105489906|NCT02117427|363805696|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
105489907|NCT02117427|363805694|FG000|Overall Study|Physician Decision|0|||
105489908|NCT02117427|363805695|FG001|Overall Study|Physician Decision|2|||
105489909|NCT02117427|363805696|FG002|Overall Study|Physician Decision|0|||
105489910|NCT02117427|363805694|FG000|Overall Study|No longer meets inclusion criteria|0|||
105489911|NCT02117427|363805695|FG001|Overall Study|No longer meets inclusion criteria|1|||
105489912|NCT02117427|363805696|FG002|Overall Study|No longer meets inclusion criteria|0|||
105489913|NCT02117427|363805694|FG000|Overall Study|Death|0|||
105489914|NCT02117427|363805695|FG001|Overall Study|Death|1|||
105489915|NCT02117427|363805696|FG002|Overall Study|Death|0|||
105839526|NCT02688387|365069993|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839527|NCT02688387|365069994|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839528|NCT02688387|365069995|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839529|NCT02688387|365069996|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839530|NCT02688387|365069997|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839531|NCT02688387|365069998|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839532|NCT02688387|365069999|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839533|NCT02688387|365070000|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839534|NCT02688387|365070001|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105489916|NCT00364130|363805697|FG000|Intervention Period|Lost to Follow-up|4|||
105839535|NCT02688387|365070002|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839536|NCT02688387|365070003|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839537|NCT02688387|365070004|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
105839538|NCT02688387|365070005|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839539|NCT02688387|365070006|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839540|NCT02688387|365070007|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839541|NCT02688387|365070008|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839542|NCT02688387|365070009|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839543|NCT02688387|365070010|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839544|NCT02688387|365070011|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839545|NCT02688387|365069990|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839546|NCT02688387|365069991|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839547|NCT02688387|365069992|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839548|NCT02688387|365069993|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839549|NCT02688387|365069994|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839550|NCT02688387|365069995|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839551|NCT02688387|365069996|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839552|NCT02688387|365069997|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839553|NCT02688387|365069998|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839554|NCT02688387|365069999|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839555|NCT02688387|365070000|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839556|NCT02688387|365070001|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839557|NCT02688387|365070002|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839558|NCT02688387|365070003|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105311602|NCT05038800|363137947|FG004|Overall Study|Lack of Efficacy|1|||
105489917|NCT00364130|363805698|FG001|Intervention Period|Lost to Follow-up|3|||
105489918|NCT00364130|363805697|FG000|Intervention Period|Pregnancy|1|||
105576518|NCT04424290|364110184|FG003|Overall Study|Adverse Event|2|||
105576519|NCT04424290|364110185|FG004|Overall Study|Adverse Event|0|||
105576520|NCT04424290|364110181|FG000|Overall Study|Withdrawal by Subject|0|||
105839559|NCT02688387|365070004|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839560|NCT02688387|365070005|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839561|NCT02688387|365070006|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839562|NCT02688387|365070007|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839563|NCT02688387|365070008|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839564|NCT02688387|365070009|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839565|NCT02688387|365070010|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
105839566|NCT02688387|365070011|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839567|NCT02688387|365069990|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839568|NCT02688387|365069991|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839569|NCT02688387|365069992|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839570|NCT02688387|365069993|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839571|NCT02688387|365069994|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839572|NCT02688387|365069995|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839573|NCT02688387|365069996|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839574|NCT02688387|365069997|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839575|NCT02688387|365069998|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839576|NCT02688387|365069999|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839577|NCT02688387|365070000|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839578|NCT02688387|365070001|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839579|NCT02688387|365070002|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839580|NCT02688387|365070003|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839581|NCT02688387|365070004|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839582|NCT02688387|365070005|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839583|NCT02688387|365070006|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839584|NCT02688387|365070007|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839585|NCT02688387|365070008|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
105839586|NCT02688387|365070009|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839587|NCT02688387|365070010|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
105839588|NCT02688387|365070011|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839589|NCT02688387|365069990|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839590|NCT02688387|365069991|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839591|NCT02688387|365069992|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839592|NCT02688387|365069993|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839593|NCT02688387|365069994|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839594|NCT02688387|365069995|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839595|NCT02688387|365069996|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839596|NCT02688387|365069997|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839597|NCT02688387|365069998|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839598|NCT02688387|365069999|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839599|NCT02688387|365070000|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839600|NCT02688387|365070001|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839601|NCT02688387|365070002|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839602|NCT02688387|365070003|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839603|NCT02688387|365070004|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839604|NCT02688387|365070005|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839605|NCT02688387|365070006|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839606|NCT02688387|365070007|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839607|NCT02688387|365070008|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839608|NCT02688387|365070009|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
105839609|NCT02688387|365070010|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839610|NCT02688387|365070011|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839611|NCT01467479|365070014|FG000|Overall Study|No Study Medication|1|||
105839612|NCT01467479|365070015|FG001|Overall Study|No Study Medication|0|||
105839613|NCT01467479|365070016|FG002|Overall Study|No Study Medication|2|||
105367688|NCT00113607|363352400|FG000|Overall Study|Complete Response (Confirmed)|14|||
105367689|NCT00113607|363352401|FG001|Overall Study|Complete Response (Confirmed)|24|||
105367690|NCT00113607|363352400|FG000|Overall Study|Other|43|||
105367691|NCT00113607|363352401|FG001|Overall Study|Other|32|||
105367692|NCT01222104|363352402|FG000|Overall Study|Lost to Follow-up|37|||
105367693|NCT01222104|363352402|FG000|Overall Study|Death|10|||
105367694|NCT03885908|363352403|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
105367695|NCT03885908|363352404|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
105367696|NCT03885908|363352403|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
105367697|NCT03885908|363352404|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
105367698|NCT03885908|363352403|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
105839614|NCT01467479|365070014|FG000|Overall Study|Adverse Event|1|||
105839615|NCT01467479|365070015|FG001|Overall Study|Adverse Event|2|||
105839616|NCT01467479|365070016|FG002|Overall Study|Adverse Event|0|||
105839617|NCT01467479|365070014|FG000|Overall Study|Death|0|||
105367699|NCT03885908|363352404|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
105367700|NCT03885908|363352403|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
105367701|NCT03885908|363352404|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
105367702|NCT00706004|363352405|FG000|Overall Study|Did not meet eligibility criteria|2|||
105367703|NCT03575702|363352406|FG000|Overall Study|Withdrawal by Subject|1|||
105489919|NCT00364130|363805698|FG001|Intervention Period|Pregnancy|0|||
105839618|NCT01467479|365070015|FG001|Overall Study|Death|0|||
105839619|NCT01467479|365070016|FG002|Overall Study|Death|1|||
105839620|NCT01467479|365070014|FG000|Overall Study|Lost to Follow-up|2|||
105839621|NCT01467479|365070015|FG001|Overall Study|Lost to Follow-up|5|||
105839622|NCT01467479|365070016|FG002|Overall Study|Lost to Follow-up|3|||
105839623|NCT01467479|365070014|FG000|Overall Study|Withdrawal of Consent|3|||
105839624|NCT01467479|365070015|FG001|Overall Study|Withdrawal of Consent|7|||
105839625|NCT01467479|365070016|FG002|Overall Study|Withdrawal of Consent|7|||
105839626|NCT01467479|365070014|FG000|Overall Study|Study Terminated by Sponsor|1|||
105839627|NCT01467479|365070015|FG001|Overall Study|Study Terminated by Sponsor|3|||
105839628|NCT01467479|365070016|FG002|Overall Study|Study Terminated by Sponsor|3|||
105839629|NCT01467479|365070014|FG000|Overall Study|Other|1|||
105839630|NCT01467479|365070015|FG001|Overall Study|Other|0|||
105839631|NCT01467479|365070016|FG002|Overall Study|Other|0|||
105839632|NCT04100096|365070027|FG000|Overall Study|Adverse Event|19|||
105839633|NCT04100096|365070028|FG001|Overall Study|Adverse Event|7|||
105839634|NCT04100096|365070027|FG000|Overall Study|Lack of Efficacy|0|||
105839635|NCT04100096|365070028|FG001|Overall Study|Lack of Efficacy|1|||
105839636|NCT04100096|365070027|FG000|Overall Study|Lost to Follow-up|13|||
105839637|NCT04100096|365070028|FG001|Overall Study|Lost to Follow-up|11|||
105839638|NCT04100096|365070027|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105839639|NCT04100096|365070028|FG001|Overall Study|Non-Compliance With Study Drug|3|||
105839640|NCT04100096|365070027|FG000|Overall Study|Protocol Deviation|1|||
105839641|NCT04100096|365070028|FG001|Overall Study|Protocol Deviation|1|||
105839642|NCT04100096|365070027|FG000|Overall Study|Withdrawal by Participant|13|||
105839643|NCT04100096|365070028|FG001|Overall Study|Withdrawal by Participant|15|||
105839644|NCT00831233|365070030|FG000|Overall Study|Adverse Event|0|||
105839645|NCT00831233|365070031|FG001|Overall Study|Adverse Event|1|||
105839646|NCT00831233|365070030|FG000|Overall Study|Protocol Violation|1|||
105839647|NCT00831233|365070031|FG001|Overall Study|Protocol Violation|0|||
105839648|NCT00831233|365070030|FG000|Overall Study|Selection Criteria Not Met|2|||
105839649|NCT00831233|365070031|FG001|Overall Study|Selection Criteria Not Met|0|||
105839650|NCT02284347|365070032|FG000|Overall Study|Lost to Follow-up|2|||
105839651|NCT02284347|365070032|FG000|Overall Study|Withdrawn prior to treatment|1|||
105839652|NCT01684215|365070034|FG000|Phase 1, Part 1|Adverse Event|1|||
105839653|NCT01684215|365070035|FG001|Phase 1, Part 1|Adverse Event|0|||
105839654|NCT01684215|365070036|FG002|Phase 1, Part 1|Adverse Event|0|||
105839655|NCT01684215|365070037|FG003|Phase 1, Part 1|Adverse Event|0|||
105839656|NCT01684215|365070034|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
105839657|NCT01684215|365070035|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
105839658|NCT01684215|365070036|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
105839659|NCT01684215|365070037|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
105839660|NCT01684215|365070034|FG000|Phase 1, Part 2|Adverse Event|0|||
105839661|NCT01684215|365070035|FG001|Phase 1, Part 2|Adverse Event|0|||
105839662|NCT01684215|365070036|FG002|Phase 1, Part 2|Adverse Event|1|||
105839663|NCT01684215|365070037|FG003|Phase 1, Part 2|Adverse Event|0|||
105839664|NCT01684215|365070034|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
105839665|NCT01684215|365070035|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
105839666|NCT01684215|365070036|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
105839667|NCT01684215|365070037|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
105839668|NCT01684215|365070034|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
105839669|NCT01684215|365070035|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
105839670|NCT01684215|365070036|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
105839671|NCT01684215|365070037|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
105839672|NCT01684215|365070034|FG000|Phase 2|Death|0|||
105839673|NCT01684215|365070035|FG001|Phase 2|Death|0|||
105839674|NCT01684215|365070036|FG002|Phase 2|Death|0|||
105839675|NCT01684215|365070037|FG003|Phase 2|Death|8|||
105839676|NCT01684215|365070034|FG000|Phase 2|Study terminated by sponsor|0|||
105839677|NCT01684215|365070035|FG001|Phase 2|Study terminated by sponsor|0|||
105839678|NCT01684215|365070036|FG002|Phase 2|Study terminated by sponsor|0|||
105839679|NCT01684215|365070037|FG003|Phase 2|Study terminated by sponsor|30|||
105839680|NCT01684215|365070034|FG000|Phase 2|Enrolled but not treated|0|||
105839681|NCT01684215|365070035|FG001|Phase 2|Enrolled but not treated|0|||
105839682|NCT01684215|365070036|FG002|Phase 2|Enrolled but not treated|0|||
105839683|NCT01684215|365070037|FG003|Phase 2|Enrolled but not treated|1|||
105839684|NCT01684215|365070034|FG000|Phase 2|Lost to Follow-up|0|||
105839685|NCT01684215|365070035|FG001|Phase 2|Lost to Follow-up|0|||
105839686|NCT01684215|365070036|FG002|Phase 2|Lost to Follow-up|0|||
105839687|NCT01684215|365070037|FG003|Phase 2|Lost to Follow-up|4|||
105839688|NCT00407745|365070038|FG000|Overall Study|Lack of Efficacy|1|||
105839689|NCT00407745|365070039|FG001|Overall Study|Lack of Efficacy|2|||
105839690|NCT00407745|365070038|FG000|Overall Study|Withdrawal by Subject|3|||
105839691|NCT00407745|365070039|FG001|Overall Study|Withdrawal by Subject|3|||
105839692|NCT00407745|365070038|FG000|Overall Study|Protocol Violation|5|||
105839693|NCT00407745|365070039|FG001|Overall Study|Protocol Violation|3|||
105839694|NCT00407745|365070038|FG000|Overall Study|Adverse Event|8|||
105839695|NCT00407745|365070039|FG001|Overall Study|Adverse Event|8|||
105839696|NCT00407745|365070038|FG000|Overall Study|Other|2|||
105839697|NCT00407745|365070039|FG001|Overall Study|Other|0|||
105839698|NCT00407745|365070038|FG000|Overall Study|Randomized, unknown if treated|0|||
105839699|NCT00407745|365070039|FG001|Overall Study|Randomized, unknown if treated|1|||
105839700|NCT01552369|365070040|FG000|Overall Study|Did not consent to extended follow up|8|||
105839701|NCT01552369|365070041|FG001|Overall Study|Did not consent to extended follow up|9|||
105839702|NCT02211014|365070042|FG000|Overall Study|Adverse Event|0|||
105839703|NCT02211014|365070043|FG001|Overall Study|Adverse Event|2|||
105839704|NCT02211014|365070042|FG000|Overall Study|Physician Decision|1|||
105839705|NCT02211014|365070043|FG001|Overall Study|Physician Decision|2|||
105839706|NCT02211014|365070042|FG000|Overall Study|Started another cancer therapy|1|||
105839707|NCT02211014|365070043|FG001|Overall Study|Started another cancer therapy|0|||
105839708|NCT02211014|365070042|FG000|Overall Study|Withdrawal by Subject|0|||
105839709|NCT02211014|365070043|FG001|Overall Study|Withdrawal by Subject|1|||
105839710|NCT02211014|365070042|FG000|Overall Study|In agreement with patient, no benefit|0|||
105839711|NCT02211014|365070043|FG001|Overall Study|In agreement with patient, no benefit|1|||
105839712|NCT00966381|365070044|FG000|Overall Study|Withdrawal by Subject|2|||
105839713|NCT00966381|365070045|FG001|Overall Study|Withdrawal by Subject|2|||
105839714|NCT01915940|365070046|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
105839715|NCT01915940|365070047|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
105839716|NCT01915940|365070048|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
105839717|NCT01915940|365070046|FG000|Treatment Period|Decision of Participant|0|||
105839718|NCT01915940|365070047|FG001|Treatment Period|Decision of Participant|1|||
105839719|NCT01915940|365070048|FG002|Treatment Period|Decision of Participant|3|||
105839720|NCT01915940|365070046|FG000|Treatment Period|Adverse Event|0|||
105839721|NCT01915940|365070047|FG001|Treatment Period|Adverse Event|9|||
105839722|NCT01915940|365070048|FG002|Treatment Period|Adverse Event|1|||
105839723|NCT01915940|365070046|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
105839724|NCT01915940|365070047|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
105839725|NCT01915940|365070048|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
105839726|NCT01124695|365070051|FG000|Overall Study|Disease progression|77|||
105839727|NCT01124695|365070051|FG000|Overall Study|Adverse Event|11|||
105839728|NCT01124695|365070051|FG000|Overall Study|Death|1|||
105839729|NCT01124695|365070051|FG000|Overall Study|Withdrawal by Subject|7|||
105839730|NCT01124695|365070051|FG000|Overall Study|Physician Decision|3|||
105839731|NCT01124695|365070051|FG000|Overall Study|Alternative therapy|9|||
105839732|NCT01124695|365070051|FG000|Overall Study|No documentation that patient went off treatment|4|||
105839733|NCT01124695|365070051|FG000|Overall Study|Ineligible|9|||
105839734|NCT01124695|365070051|FG000|Overall Study|Ineligible and never start treatment|2|||
105839735|NCT00097786|365070057|FG000|Overall Study|lost to follow-up for all-cause death|296|||
105839736|NCT00097786|365070058|FG001|Overall Study|lost to follow-up for all-cause death|292|||
105839737|NCT00097786|365070059|FG002|Overall Study|lost to follow-up for all-cause death|313|||
105839738|NCT00097786|365070060|FG003|Overall Study|lost to follow-up for all-cause death|310|||
105839739|NCT02940730|365070061|FG000|Intervention 2|Physician Decision|7|||
105839740|NCT02940730|365070062|FG001|Intervention 2|Physician Decision|0|||
105839741|NCT02960438|365070063|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
105839742|NCT02960438|365070064|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
105839743|NCT02960438|365070065|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
105839744|NCT02960438|365070066|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
105839745|NCT02960438|365070063|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
105839746|NCT02960438|365070064|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
105839747|NCT02960438|365070065|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
105311603|NCT01104792|363137955|FG000|Overall Study|Adverse Event|77|||
105311604|NCT01104792|363137955|FG000|Overall Study|Insufficient Therapeutic Response|22|||
105311605|NCT01104792|363137955|FG000|Overall Study|Protocol Violation|45|||
105311606|NCT01104792|363137955|FG000|Overall Study|Withdrawal of Consent|179|||
105311607|NCT01104792|363137955|FG000|Overall Study|Lost to Follow-up|43|||
105311608|NCT01104792|363137955|FG000|Overall Study|Reasons Not Specified|27|||
105839748|NCT02960438|365070066|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
105839749|NCT02960438|365070063|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
105839750|NCT02960438|365070064|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
105839751|NCT02960438|365070065|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
105839752|NCT02960438|365070066|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
105839753|NCT02960438|365070063|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
105839754|NCT02960438|365070064|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
105311609|NCT01104792|363137955|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
105489920|NCT00364130|363805697|FG000|Intervention Period|Withdrawal by Subject|4|||
105489921|NCT00364130|363805698|FG001|Intervention Period|Withdrawal by Subject|5|||
105489922|NCT00364130|363805697|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
105489923|NCT00364130|363805698|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
105489924|NCT05281601|363805699|FG000|Overall Study|Physician Decision|2|||
105489925|NCT05281601|363805700|FG001|Overall Study|Physician Decision|0|||
105489926|NCT05281601|363805699|FG000|Overall Study|Lost to Follow-up|2|||
105489927|NCT05281601|363805700|FG001|Overall Study|Lost to Follow-up|0|||
105489928|NCT05281601|363805699|FG000|Overall Study|Death|1|||
105839755|NCT02960438|365070065|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
105839756|NCT02960438|365070066|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
105839757|NCT02960438|365070063|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
105839758|NCT02960438|365070064|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
105839759|NCT02960438|365070065|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
105839760|NCT02960438|365070066|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
105839761|NCT02960438|365070063|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
105839762|NCT02960438|365070064|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
105839763|NCT02960438|365070065|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
105839764|NCT02960438|365070066|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
105839765|NCT02960438|365070063|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
105839766|NCT02960438|365070064|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
105839767|NCT02960438|365070065|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
105839768|NCT02960438|365070066|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
105839769|NCT02960438|365070063|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
105839770|NCT02960438|365070064|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
105839771|NCT02960438|365070065|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
105839772|NCT02960438|365070066|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
105839773|NCT02960438|365070063|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
105839774|NCT02960438|365070064|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
105839775|NCT02960438|365070065|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
105839776|NCT02960438|365070066|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
105839777|NCT02960438|365070063|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
105839778|NCT02960438|365070064|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
105839779|NCT02960438|365070065|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
105839780|NCT02960438|365070066|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
105839781|NCT02960438|365070063|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
105839782|NCT02960438|365070064|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
105839783|NCT02960438|365070065|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
105839784|NCT02960438|365070066|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
105839785|NCT02960438|365070063|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
105839786|NCT02960438|365070064|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
105839787|NCT02960438|365070065|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
105839788|NCT02960438|365070066|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
105839789|NCT01522950|365070070|FG000|Overall Study|Withdrawal by Subject|3|||
105839790|NCT01522950|365070071|FG001|Overall Study|Withdrawal by Subject|2|||
105839791|NCT01522950|365070072|FG002|Overall Study|Withdrawal by Subject|1|||
105839792|NCT01522950|365070070|FG000|Overall Study|Adverse Event|3|||
105839793|NCT01522950|365070071|FG001|Overall Study|Adverse Event|1|||
105839794|NCT01522950|365070072|FG002|Overall Study|Adverse Event|1|||
105839795|NCT01522950|365070070|FG000|Overall Study|Protocol Violation|0|||
105839796|NCT01522950|365070071|FG001|Overall Study|Protocol Violation|0|||
105839797|NCT01522950|365070072|FG002|Overall Study|Protocol Violation|2|||
105839798|NCT01522950|365070070|FG000|Overall Study|Death|0|||
105839799|NCT01522950|365070071|FG001|Overall Study|Death|1|||
105839800|NCT01522950|365070072|FG002|Overall Study|Death|1|||
105839801|NCT01522950|365070070|FG000|Overall Study|Study Medication Sensitivity|0|||
105839802|NCT01522950|365070071|FG001|Overall Study|Study Medication Sensitivity|1|||
105839803|NCT01522950|365070072|FG002|Overall Study|Study Medication Sensitivity|0|||
105839804|NCT01647711|365070077|FG000|Overall Study|Progressive disease|6|||
105839805|NCT01647711|365070078|FG001|Overall Study|Progressive disease|2|||
105839806|NCT01647711|365070079|FG002|Overall Study|Progressive disease|6|||
105839807|NCT01647711|365070080|FG003|Overall Study|Progressive disease|8|||
105839808|NCT01647711|365070081|FG004|Overall Study|Progressive disease|2|||
105839809|NCT01647711|365070077|FG000|Overall Study|Other adverse event|0|||
105839810|NCT01647711|365070078|FG001|Overall Study|Other adverse event|0|||
105839811|NCT01647711|365070079|FG002|Overall Study|Other adverse event|2|||
105839812|NCT01647711|365070080|FG003|Overall Study|Other adverse event|0|||
105839813|NCT01647711|365070081|FG004|Overall Study|Other adverse event|2|||
105839814|NCT01647711|365070077|FG000|Overall Study|Protocol Violation|0|||
105839815|NCT01647711|365070078|FG001|Overall Study|Protocol Violation|0|||
105839816|NCT01647711|365070079|FG002|Overall Study|Protocol Violation|0|||
105311610|NCT01102374|363137956|FG000|Overall Study|Death|9|||
105311611|NCT01102374|363137957|FG001|Overall Study|Death|13|||
105311612|NCT01102374|363137956|FG000|Overall Study|Lost to Follow-up|7|||
105311613|NCT01102374|363137957|FG001|Overall Study|Lost to Follow-up|6|||
105311614|NCT02071849|363137958|FG000|6-month Primary Endpoint|Did not receive device|4|||
105311615|NCT02071849|363137958|FG000|6-month Primary Endpoint|Adverse Event|1|||
105311616|NCT02071849|363137958|FG000|2-year Extended Follow-up|Adverse Event|1|||
105311617|NCT04619992|363137959|FG000|Overall Study|Withdrawal by Subject|1|||
105311618|NCT04619992|363137960|FG001|Overall Study|Withdrawal by Subject|0|||
105311619|NCT02011386|363137961|FG000|Overall Study|Non-compliance|2|||
105311620|NCT02011386|363137961|FG000|Overall Study|Lack of Efficacy|3|||
105311621|NCT03255655|363137962|FG000|Overall Study|Lost to Follow-up|7|||
105311622|NCT03255655|363137963|FG001|Overall Study|Lost to Follow-up|4|||
105311623|NCT04428333|363137964|FG000|Overall Study|Physician Decision|5|||
105311624|NCT04428333|363137965|FG001|Overall Study|Physician Decision|6|||
105311625|NCT04428333|363137964|FG000|Overall Study|Withdrawal by Subject|1|||
105311626|NCT04428333|363137965|FG001|Overall Study|Withdrawal by Subject|3|||
105311627|NCT04428333|363137964|FG000|Overall Study|Study Terminated By Sponsor|14|||
105311628|NCT04428333|363137965|FG001|Overall Study|Study Terminated By Sponsor|16|||
105311629|NCT02351960|363137967|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
105311630|NCT02351960|363137968|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
105311631|NCT02351960|363137967|FG000|Overall Study|Voluntary Withdrawal|5|||
105311632|NCT02351960|363137968|FG001|Overall Study|Voluntary Withdrawal|4|||
105311633|NCT02351960|363137967|FG000|Overall Study|Significant Protocol Deviation|0|||
105839817|NCT01647711|365070080|FG003|Overall Study|Protocol Violation|0|||
105839818|NCT01647711|365070081|FG004|Overall Study|Protocol Violation|1|||
105839819|NCT01647711|365070077|FG000|Overall Study|Refused to continue taking medication|0|||
105839820|NCT01647711|365070078|FG001|Overall Study|Refused to continue taking medication|0|||
105839821|NCT01647711|365070079|FG002|Overall Study|Refused to continue taking medication|0|||
105839822|NCT01647711|365070080|FG003|Overall Study|Refused to continue taking medication|2|||
105839823|NCT01647711|365070081|FG004|Overall Study|Refused to continue taking medication|1|||
105839824|NCT01647711|365070077|FG000|Overall Study|Other reason not defined|0|||
105839825|NCT01647711|365070078|FG001|Overall Study|Other reason not defined|1|||
105839826|NCT01647711|365070079|FG002|Overall Study|Other reason not defined|1|||
105839827|NCT01647711|365070080|FG003|Overall Study|Other reason not defined|1|||
105839828|NCT01647711|365070081|FG004|Overall Study|Other reason not defined|0|||
105839829|NCT02999984|365070086|FG000|Overall Study|Treatment Failure|1|||
105839830|NCT04019054|365070090|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
105839831|NCT04019054|365070091|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
105839832|NCT04019054|365070090|FG000|Overall Study|Withdrawal by Subject|3|||
105839833|NCT04019054|365070091|FG001|Overall Study|Withdrawal by Subject|1|||
105839834|NCT02013531|365070098|FG000|Overall Study|Lost to Follow-up|3|||
105839835|NCT02013531|365070098|FG000|Overall Study|Met Withdrawal Criteria|1|||
105839836|NCT02013531|365070098|FG000|Overall Study|Withdrawal by Subject|1|||
105839837|NCT03554317|365070099|FG000|Overall Study|Withdrawal by Subject|1|||
105839838|NCT03554317|365070099|FG000|Overall Study|PSA Progression|3|||
105839839|NCT03554317|365070099|FG000|Overall Study|Radiographic Progression|4|||
105839840|NCT02400476|365070100|FG000|Overall Study|Adverse Event|57|||
105839841|NCT02400476|365070101|FG001|Overall Study|Adverse Event|10|||
105839842|NCT02400476|365070102|FG002|Overall Study|Adverse Event|22|||
105839843|NCT02400476|365070103|FG003|Overall Study|Adverse Event|19|||
105839844|NCT02400476|365070104|FG004|Overall Study|Adverse Event|5|||
105839845|NCT02400476|365070105|FG005|Overall Study|Adverse Event|8|||
105839846|NCT02400476|365070100|FG000|Overall Study|Withdrawal by Subject|4|||
105839847|NCT02400476|365070101|FG001|Overall Study|Withdrawal by Subject|1|||
105839848|NCT02400476|365070102|FG002|Overall Study|Withdrawal by Subject|12|||
105839849|NCT02400476|365070103|FG003|Overall Study|Withdrawal by Subject|7|||
105839850|NCT02400476|365070104|FG004|Overall Study|Withdrawal by Subject|5|||
105839851|NCT02400476|365070105|FG005|Overall Study|Withdrawal by Subject|5|||
105839852|NCT02400476|365070100|FG000|Overall Study|Lost to Follow-up|0|||
105839853|NCT02400476|365070101|FG001|Overall Study|Lost to Follow-up|0|||
105839854|NCT02400476|365070102|FG002|Overall Study|Lost to Follow-up|0|||
105839855|NCT02400476|365070103|FG003|Overall Study|Lost to Follow-up|1|||
105311634|NCT02351960|363137968|FG001|Overall Study|Significant Protocol Deviation|5|||
105311635|NCT00758680|363137969|FG000|Overall Study|Adverse Event|0|||
105311636|NCT00758680|363137970|FG001|Overall Study|Adverse Event|0|||
105311637|NCT00758680|363137971|FG002|Overall Study|Adverse Event|0|||
105311638|NCT00758680|363137972|FG003|Overall Study|Adverse Event|0|||
105839856|NCT02400476|365070104|FG004|Overall Study|Lost to Follow-up|3|||
105311639|NCT00758680|363137973|FG004|Overall Study|Adverse Event|0|||
105311640|NCT00758680|363137974|FG005|Overall Study|Adverse Event|0|||
105311641|NCT00758680|363137975|FG006|Overall Study|Adverse Event|0|||
105311642|NCT00758680|363137976|FG007|Overall Study|Adverse Event|1|||
105311643|NCT00758680|363137977|FG008|Overall Study|Adverse Event|0|||
105311644|NCT00758680|363137978|FG009|Overall Study|Adverse Event|1|||
105839857|NCT02400476|365070105|FG005|Overall Study|Lost to Follow-up|1|||
105311645|NCT00758680|363137969|FG000|Overall Study|Laboratory Adverse Event|0|||
105311646|NCT00758680|363137970|FG001|Overall Study|Laboratory Adverse Event|0|||
105311647|NCT00758680|363137971|FG002|Overall Study|Laboratory Adverse Event|0|||
105311648|NCT00758680|363137972|FG003|Overall Study|Laboratory Adverse Event|0|||
105311649|NCT00758680|363137973|FG004|Overall Study|Laboratory Adverse Event|0|||
105311650|NCT00758680|363137974|FG005|Overall Study|Laboratory Adverse Event|0|||
105311651|NCT00758680|363137975|FG006|Overall Study|Laboratory Adverse Event|0|||
105311652|NCT00758680|363137976|FG007|Overall Study|Laboratory Adverse Event|0|||
105311653|NCT00758680|363137977|FG008|Overall Study|Laboratory Adverse Event|1|||
105311654|NCT00758680|363137978|FG009|Overall Study|Laboratory Adverse Event|0|||
105311655|NCT00758680|363137969|FG000|Overall Study|Withdrawal by Subject|0|||
105311656|NCT00758680|363137970|FG001|Overall Study|Withdrawal by Subject|0|||
105311657|NCT00758680|363137971|FG002|Overall Study|Withdrawal by Subject|0|||
105311658|NCT00758680|363137972|FG003|Overall Study|Withdrawal by Subject|0|||
105311659|NCT00758680|363137973|FG004|Overall Study|Withdrawal by Subject|0|||
105311660|NCT00758680|363137974|FG005|Overall Study|Withdrawal by Subject|0|||
105311661|NCT00758680|363137975|FG006|Overall Study|Withdrawal by Subject|1|||
105311662|NCT00758680|363137976|FG007|Overall Study|Withdrawal by Subject|0|||
105367704|NCT03575702|363352407|FG001|Overall Study|Withdrawal by Subject|1|||
105367705|NCT03575702|363352406|FG000|Overall Study|Lost to Follow-up|1|||
105367706|NCT03575702|363352407|FG001|Overall Study|Lost to Follow-up|2|||
105839858|NCT02400476|365070100|FG000|Overall Study|Physician Decision|0|||
105839859|NCT02400476|365070101|FG001|Overall Study|Physician Decision|0|||
105839860|NCT02400476|365070102|FG002|Overall Study|Physician Decision|1|||
105839861|NCT02400476|365070103|FG003|Overall Study|Physician Decision|1|||
105839862|NCT02400476|365070104|FG004|Overall Study|Physician Decision|0|||
105839863|NCT02400476|365070105|FG005|Overall Study|Physician Decision|1|||
105839864|NCT02400476|365070100|FG000|Overall Study|Other, Disease Progression|0|||
105839865|NCT02400476|365070101|FG001|Overall Study|Other, Disease Progression|1|||
105839866|NCT02400476|365070102|FG002|Overall Study|Other, Disease Progression|2|||
105839867|NCT02400476|365070103|FG003|Overall Study|Other, Disease Progression|1|||
105839868|NCT02400476|365070104|FG004|Overall Study|Other, Disease Progression|2|||
105839869|NCT02400476|365070105|FG005|Overall Study|Other, Disease Progression|1|||
105839870|NCT02400476|365070100|FG000|Overall Study|Other, Decreased Quality of Life|0|||
105839871|NCT02400476|365070101|FG001|Overall Study|Other, Decreased Quality of Life|0|||
105839872|NCT02400476|365070102|FG002|Overall Study|Other, Decreased Quality of Life|2|||
105839873|NCT02400476|365070103|FG003|Overall Study|Other, Decreased Quality of Life|0|||
105839874|NCT02400476|365070104|FG004|Overall Study|Other, Decreased Quality of Life|0|||
105839875|NCT02400476|365070105|FG005|Overall Study|Other, Decreased Quality of Life|0|||
105839876|NCT02400476|365070100|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
105839877|NCT02400476|365070101|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
105839878|NCT02400476|365070102|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
105839879|NCT02400476|365070103|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
105839880|NCT02400476|365070104|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
105839881|NCT02400476|365070105|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
105839882|NCT02487082|365070106|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
105839883|NCT02487082|365070107|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
105839884|NCT02487082|365070106|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
105839885|NCT02487082|365070107|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
105839886|NCT00003531|365070110|FG000|Overall Study|Not evaluable|10|||
105839887|NCT00346164|365070113|FG000|Overall Study|Adverse Event|0|||
105839888|NCT00346164|365070114|FG001|Overall Study|Adverse Event|0|||
105839889|NCT00346164|365070115|FG002|Overall Study|Adverse Event|0|||
105839890|NCT00346164|365070116|FG003|Overall Study|Adverse Event|1|||
105839891|NCT00346164|365070113|FG000|Overall Study|Lack of Efficacy|0|||
105839892|NCT00346164|365070114|FG001|Overall Study|Lack of Efficacy|1|||
105839893|NCT00346164|365070115|FG002|Overall Study|Lack of Efficacy|7|||
105839894|NCT00346164|365070116|FG003|Overall Study|Lack of Efficacy|25|||
105839895|NCT00346164|365070113|FG000|Overall Study|Physician Decision|0|||
105839896|NCT00346164|365070114|FG001|Overall Study|Physician Decision|1|||
105839897|NCT00346164|365070115|FG002|Overall Study|Physician Decision|2|||
105839898|NCT00346164|365070116|FG003|Overall Study|Physician Decision|27|||
105839899|NCT00346164|365070113|FG000|Overall Study|Protocol Violation|6|||
105311663|NCT00758680|363137977|FG008|Overall Study|Withdrawal by Subject|1|||
105311664|NCT00758680|363137978|FG009|Overall Study|Withdrawal by Subject|0|||
105311665|NCT00103610|363137979|FG000|Overall Study|Entered Rescue Procedure|10|||
105311666|NCT00103610|363137980|FG001|Overall Study|Entered Rescue Procedure|52|||
105311667|NCT00103610|363137979|FG000|Overall Study|Death|16|||
105311668|NCT00103610|363137980|FG001|Overall Study|Death|12|||
105367707|NCT03575702|363352406|FG000|Overall Study|Protocol Violation|0|||
105839900|NCT00346164|365070114|FG001|Overall Study|Protocol Violation|2|||
105367708|NCT03575702|363352407|FG001|Overall Study|Protocol Violation|1|||
105489929|NCT05281601|363805700|FG001|Overall Study|Death|0|||
105839901|NCT00346164|365070115|FG002|Overall Study|Protocol Violation|10|||
105311669|NCT00103610|363137979|FG000|Overall Study|Elective Withdrawal|4|||
105311670|NCT00103610|363137980|FG001|Overall Study|Elective Withdrawal|0|||
105839902|NCT00346164|365070116|FG003|Overall Study|Protocol Violation|4|||
105839903|NCT00346164|365070113|FG000|Overall Study|Withdrawal by Subject|0|||
105839904|NCT00346164|365070114|FG001|Overall Study|Withdrawal by Subject|0|||
105839905|NCT00346164|365070115|FG002|Overall Study|Withdrawal by Subject|2|||
105839906|NCT00346164|365070116|FG003|Overall Study|Withdrawal by Subject|0|||
105839907|NCT00346164|365070113|FG000|Overall Study|Ineligible|11|||
105839908|NCT00346164|365070114|FG001|Overall Study|Ineligible|2|||
105839909|NCT00346164|365070115|FG002|Overall Study|Ineligible|2|||
105839910|NCT00346164|365070116|FG003|Overall Study|Ineligible|23|||
105839911|NCT00346164|365070113|FG000|Overall Study|Refusal of further protocol therapy|0|||
105839912|NCT00346164|365070114|FG001|Overall Study|Refusal of further protocol therapy|1|||
105839913|NCT00346164|365070115|FG002|Overall Study|Refusal of further protocol therapy|3|||
105839914|NCT00346164|365070116|FG003|Overall Study|Refusal of further protocol therapy|15|||
105839915|NCT00346164|365070113|FG000|Overall Study|Inability to start week 16 tx on time|0|||
105839916|NCT00346164|365070114|FG001|Overall Study|Inability to start week 16 tx on time|0|||
105839917|NCT00346164|365070115|FG002|Overall Study|Inability to start week 16 tx on time|0|||
105839918|NCT00346164|365070116|FG003|Overall Study|Inability to start week 16 tx on time|11|||
105839919|NCT03297294|365070117|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
105839920|NCT03297294|365070118|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
105839921|NCT03297294|365070119|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105839922|NCT03297294|365070120|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105839923|NCT03297294|365070121|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105839924|NCT03297294|365070117|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
105839925|NCT03297294|365070118|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
105839926|NCT03297294|365070119|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105839927|NCT03297294|365070120|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105839928|NCT03297294|365070121|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105839929|NCT03297294|365070117|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
105839930|NCT03297294|365070118|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
105839931|NCT03297294|365070119|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105839932|NCT03297294|365070120|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105839933|NCT03297294|365070121|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105839934|NCT03297294|365070117|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
105839935|NCT03297294|365070118|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
105839936|NCT03297294|365070119|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105839937|NCT03297294|365070120|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105839938|NCT03297294|365070121|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105839939|NCT03297294|365070117|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
105839940|NCT03297294|365070118|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
105839941|NCT03297294|365070119|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
105839942|NCT03297294|365070120|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
105839943|NCT03297294|365070121|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
105839944|NCT01198873|365070122|FG000|Overall Study|Adverse Event|4|||
105839945|NCT01198873|365070123|FG001|Overall Study|Adverse Event|7|||
105839946|NCT01198873|365070122|FG000|Overall Study|Study closure|29|||
105311671|NCT00103610|363137979|FG000|Overall Study|Lost to Follow-up|3|||
105311672|NCT00103610|363137980|FG001|Overall Study|Lost to Follow-up|1|||
105311673|NCT00103610|363137979|FG000|Overall Study|Adverse Event|2|||
105311674|NCT00103610|363137980|FG001|Overall Study|Adverse Event|2|||
105311675|NCT00103610|363137979|FG000|Overall Study|Other|2|||
105311676|NCT00103610|363137980|FG001|Overall Study|Other|7|||
105311677|NCT00103610|363137979|FG000|Overall Study|Failed mobilization|1|||
105311678|NCT00103610|363137980|FG001|Overall Study|Failed mobilization|5|||
105311679|NCT00103610|363137979|FG000|Overall Study|Noncompliance|0|||
105311680|NCT00103610|363137980|FG001|Overall Study|Noncompliance|1|||
105311681|NCT00725205|363137981|FG000|Overall Study|Adverse Event|22|||
105311682|NCT00725205|363137981|FG000|Overall Study|Investigator Discontinued|1|||
105311683|NCT00725205|363137981|FG000|Overall Study|Non-compliance With Protocol|14|||
105311684|NCT00725205|363137981|FG000|Overall Study|Other|8|||
105489930|NCT05281601|363805699|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105489931|NCT05281601|363805700|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105489932|NCT01674634|363805702|FG000|Overall Study|Withdrawal by Subject|3|||
105489933|NCT01674634|363805702|FG000|Overall Study|Lost to Follow-up|3|||
105489934|NCT01505647|363805703|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
105489935|NCT01505647|363805704|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
105489936|NCT01505647|363805703|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
105489937|NCT01505647|363805704|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
105311685|NCT00725205|363137981|FG000|Overall Study|Protocol Defined Clinical Event|1|||
105311686|NCT00725205|363137981|FG000|Overall Study|Treatment Failure|41|||
105367709|NCT03575702|363352406|FG000|Overall Study|Patient non compliance|4|||
105489938|NCT01505647|363805703|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
105839947|NCT01198873|365070123|FG001|Overall Study|Study closure|23|||
105839948|NCT01198873|365070122|FG000|Overall Study|Other than above|4|||
105839949|NCT01198873|365070123|FG001|Overall Study|Other than above|2|||
105839950|NCT02820740|365070124|FG000|Overall Study|Did not have procedure|2|||
105839951|NCT00562120|365070128|FG000|First Intervention Period|Adverse Event|1|||
105839952|NCT00562120|365070129|FG001|First Intervention Period|Adverse Event|0|||
105839953|NCT00562120|365070130|FG002|First Intervention Period|Adverse Event|0|||
105839954|NCT00562120|365070131|FG003|First Intervention Period|Adverse Event|0|||
105839955|NCT00562120|365070128|FG000|First Intervention Period|Randomized but not Treated|1|||
105839956|NCT00562120|365070129|FG001|First Intervention Period|Randomized but not Treated|0|||
105839957|NCT00562120|365070130|FG002|First Intervention Period|Randomized but not Treated|0|||
105839958|NCT00562120|365070131|FG003|First Intervention Period|Randomized but not Treated|0|||
105839959|NCT04232540|365070132|FG000|Overall Study|Lost to Follow-up|1|||
105839960|NCT04232540|365070133|FG001|Overall Study|Lost to Follow-up|0|||
105839961|NCT03450629|365070134|FG000|Overall Study|Adverse Event|15|||
105839962|NCT03450629|365070135|FG001|Overall Study|Adverse Event|14|||
105839963|NCT03450629|365070134|FG000|Overall Study|Physician Decision|2|||
105839964|NCT03450629|365070135|FG001|Overall Study|Physician Decision|2|||
105839965|NCT03450629|365070134|FG000|Overall Study|Lack of Efficacy|2|||
105839966|NCT03450629|365070135|FG001|Overall Study|Lack of Efficacy|0|||
105839967|NCT03450629|365070134|FG000|Overall Study|Lost to Follow-up|4|||
105839968|NCT03450629|365070135|FG001|Overall Study|Lost to Follow-up|2|||
105839969|NCT03450629|365070134|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
105839970|NCT03450629|365070135|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
105839971|NCT03450629|365070134|FG000|Overall Study|Non-Compliance With Study Drug|2|||
105839972|NCT03450629|365070135|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105839973|NCT03450629|365070134|FG000|Overall Study|Protocol Violation|11|||
105839974|NCT03450629|365070135|FG001|Overall Study|Protocol Violation|8|||
105839975|NCT03450629|365070134|FG000|Overall Study|Withdrawal by Subject|12|||
105839976|NCT03450629|365070135|FG001|Overall Study|Withdrawal by Subject|6|||
105839977|NCT03366194|365070139|FG000|Overall Study|Lost to Follow-up|2|||
105839978|NCT00987831|365070146|FG000|Overall Study|Never flared in 12 months|1|||
105839979|NCT00987831|365070147|FG001|Overall Study|Never flared in 12 months|0|||
105839980|NCT00987831|365070148|FG002|Overall Study|Never flared in 12 months|0|||
105839981|NCT00987831|365070146|FG000|Overall Study|Lost to Follow-up|0|||
105839982|NCT00987831|365070147|FG001|Overall Study|Lost to Follow-up|3|||
105839983|NCT00987831|365070148|FG002|Overall Study|Lost to Follow-up|0|||
105839984|NCT03253094|365070149|FG000|Overall Study|Adverse Event|2|||
105839985|NCT03253094|365070150|FG001|Overall Study|Adverse Event|0|||
105839986|NCT03253094|365070151|FG002|Overall Study|Adverse Event|0|||
105839987|NCT03253094|365070152|FG003|Overall Study|Adverse Event|0|||
105839988|NCT03253094|365070153|FG004|Overall Study|Adverse Event|0|||
105839989|NCT03253094|365070154|FG005|Overall Study|Adverse Event|0|||
105839990|NCT03253094|365070149|FG000|Overall Study|Lack of Efficacy|0|||
105839991|NCT03253094|365070150|FG001|Overall Study|Lack of Efficacy|0|||
105839992|NCT03253094|365070151|FG002|Overall Study|Lack of Efficacy|2|||
105839993|NCT03253094|365070152|FG003|Overall Study|Lack of Efficacy|1|||
105839994|NCT03253094|365070153|FG004|Overall Study|Lack of Efficacy|2|||
105839995|NCT03253094|365070154|FG005|Overall Study|Lack of Efficacy|1|||
105839996|NCT03253094|365070149|FG000|Overall Study|Lost to Follow-up|0|||
105839997|NCT03253094|365070150|FG001|Overall Study|Lost to Follow-up|0|||
105839998|NCT03253094|365070151|FG002|Overall Study|Lost to Follow-up|1|||
105839999|NCT03253094|365070152|FG003|Overall Study|Lost to Follow-up|1|||
105840000|NCT03253094|365070153|FG004|Overall Study|Lost to Follow-up|0|||
105840001|NCT03253094|365070154|FG005|Overall Study|Lost to Follow-up|1|||
105840002|NCT03253094|365070149|FG000|Overall Study|Physician Decision|1|||
105840003|NCT03253094|365070150|FG001|Overall Study|Physician Decision|0|||
105840004|NCT03253094|365070151|FG002|Overall Study|Physician Decision|0|||
105840005|NCT03253094|365070152|FG003|Overall Study|Physician Decision|1|||
105311687|NCT02105974|363137982|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
105840006|NCT03253094|365070153|FG004|Overall Study|Physician Decision|0|||
105311688|NCT02105974|363137983|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
105311689|NCT02105974|363137984|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
105840007|NCT03253094|365070154|FG005|Overall Study|Physician Decision|2|||
105840008|NCT03253094|365070149|FG000|Overall Study|Withdrawal by Subject|1|||
105840009|NCT03253094|365070150|FG001|Overall Study|Withdrawal by Subject|2|||
105311690|NCT02105974|363137982|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
105840010|NCT03253094|365070151|FG002|Overall Study|Withdrawal by Subject|1|||
105840011|NCT03253094|365070152|FG003|Overall Study|Withdrawal by Subject|0|||
105840012|NCT03253094|365070153|FG004|Overall Study|Withdrawal by Subject|3|||
105840013|NCT03253094|365070154|FG005|Overall Study|Withdrawal by Subject|0|||
105311691|NCT02105974|363137983|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
105311692|NCT02105974|363137984|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
105840014|NCT03253094|365070149|FG000|Overall Study|Other|0|||
105840015|NCT03253094|365070150|FG001|Overall Study|Other|1|||
105840016|NCT03253094|365070151|FG002|Overall Study|Other|2|||
105840017|NCT03253094|365070152|FG003|Overall Study|Other|1|||
105840018|NCT03253094|365070153|FG004|Overall Study|Other|0|||
105840019|NCT03253094|365070154|FG005|Overall Study|Other|0|||
105840020|NCT02339090|365070155|FG000|Overall Study|Adverse Event|1|||
105840021|NCT02339090|365070156|FG001|Overall Study|Adverse Event|0|||
105840022|NCT02339090|365070155|FG000|Overall Study|Lost to Follow-up|0|||
105840023|NCT02339090|365070156|FG001|Overall Study|Lost to Follow-up|1|||
105840024|NCT02339090|365070155|FG000|Overall Study|Non-compliance With Study Drug|0|||
105840025|NCT02339090|365070156|FG001|Overall Study|Non-compliance With Study Drug|1|||
105840026|NCT02339090|365070155|FG000|Overall Study|Withdrawal by Subject|2|||
105840027|NCT02339090|365070156|FG001|Overall Study|Withdrawal by Subject|1|||
105840028|NCT02339090|365070155|FG000|Overall Study|Poor Growth|3|||
105840029|NCT02339090|365070156|FG001|Overall Study|Poor Growth|0|||
105840030|NCT02339090|365070155|FG000|Overall Study|Randomized but not treated|0|||
105840031|NCT02339090|365070156|FG001|Overall Study|Randomized but not treated|2|||
105840032|NCT02792218|365070157|FG000|Overall Study|Patient/guardian decision|15|||
105840033|NCT02792218|365070158|FG001|Overall Study|Patient/guardian decision|42|||
105840034|NCT02792218|365070157|FG000|Overall Study|Adverse Event|15|||
105840035|NCT02792218|365070158|FG001|Overall Study|Adverse Event|14|||
105840036|NCT02792218|365070157|FG000|Overall Study|Lost to Follow-up|10|||
105840037|NCT02792218|365070158|FG001|Overall Study|Lost to Follow-up|5|||
105840038|NCT02792218|365070157|FG000|Overall Study|Lack of Efficacy|1|||
105840039|NCT02792218|365070158|FG001|Overall Study|Lack of Efficacy|12|||
105840040|NCT02792218|365070157|FG000|Overall Study|Physician Decision|4|||
105840041|NCT02792218|365070158|FG001|Overall Study|Physician Decision|4|||
105840042|NCT02792218|365070157|FG000|Overall Study|Protocol deviation|3|||
105840043|NCT02792218|365070158|FG001|Overall Study|Protocol deviation|2|||
105840044|NCT02792218|365070157|FG000|Overall Study|New therapy for study indication|0|||
105840045|NCT02792218|365070158|FG001|Overall Study|New therapy for study indication|1|||
105840046|NCT02792218|365070157|FG000|Overall Study|Non-compliance with study treatment|0|||
105840047|NCT02792218|365070158|FG001|Overall Study|Non-compliance with study treatment|1|||
105840048|NCT02792218|365070157|FG000|Overall Study|Pregnancy|1|||
105840049|NCT02792218|365070158|FG001|Overall Study|Pregnancy|0|||
105840050|NCT00442546|365070159|FG000|Overall Study|Adverse Event|11|||
105840051|NCT00442546|365070160|FG001|Overall Study|Adverse Event|17|||
105840052|NCT00442546|365070161|FG002|Overall Study|Adverse Event|13|||
105840053|NCT00442546|365070159|FG000|Overall Study|Lost to Follow-up|1|||
105840054|NCT00442546|365070160|FG001|Overall Study|Lost to Follow-up|2|||
105840055|NCT00442546|365070161|FG002|Overall Study|Lost to Follow-up|1|||
105840056|NCT00442546|365070159|FG000|Overall Study|Other|4|||
105840057|NCT00442546|365070160|FG001|Overall Study|Other|9|||
105840058|NCT00442546|365070161|FG002|Overall Study|Other|6|||
105840059|NCT00442546|365070159|FG000|Overall Study|Withdrawal by Subject|5|||
105840060|NCT00442546|365070160|FG001|Overall Study|Withdrawal by Subject|5|||
105840061|NCT00442546|365070161|FG002|Overall Study|Withdrawal by Subject|7|||
105840062|NCT00442546|365070159|FG000|Overall Study|Randomized But Not Treated|5|||
105840063|NCT00442546|365070160|FG001|Overall Study|Randomized But Not Treated|4|||
105840064|NCT00442546|365070161|FG002|Overall Study|Randomized But Not Treated|6|||
105840065|NCT02843659|365070162|FG000|Overall Study|Subject Withdrew Consent|0|||
105840066|NCT02843659|365070163|FG001|Overall Study|Subject Withdrew Consent|0|||
105840067|NCT02843659|365070164|FG002|Overall Study|Subject Withdrew Consent|1|||
105840068|NCT02843659|365070162|FG000|Overall Study|Administrative Reason by Sponsor|4|||
105840069|NCT02843659|365070163|FG001|Overall Study|Administrative Reason by Sponsor|5|||
105840070|NCT02843659|365070164|FG002|Overall Study|Administrative Reason by Sponsor|4|||
105840071|NCT02843659|365070162|FG000|Overall Study|Adverse Event|0|||
105840072|NCT02843659|365070163|FG001|Overall Study|Adverse Event|1|||
105840073|NCT02843659|365070164|FG002|Overall Study|Adverse Event|0|||
105840074|NCT00955721|365070165|FG000|Overall Study|Physician Decision|1|||
105840075|NCT00955721|365070166|FG001|Overall Study|Physician Decision|0|||
105840076|NCT00955721|365070165|FG000|Overall Study|Death|1|||
105311693|NCT02105974|363137982|FG000|2 Week Run-in Period|Adverse Event|6|||
105311694|NCT02105974|363137983|FG001|2 Week Run-in Period|Adverse Event|0|||
105840077|NCT00955721|365070166|FG001|Overall Study|Death|0|||
105840078|NCT00955721|365070165|FG000|Overall Study|Withdrawal by Subject|1|||
105840079|NCT00955721|365070166|FG001|Overall Study|Withdrawal by Subject|0|||
105840080|NCT01253317|365070178|FG000|Overall Study|Adverse Event|2|||
105840081|NCT00749411|365070181|FG000|Overall Study|Adverse Event|0|||
105840082|NCT00749411|365070182|FG001|Overall Study|Adverse Event|2|||
105840083|NCT00749411|365070181|FG000|Overall Study|Lack of Efficacy|0|||
105840084|NCT00749411|365070182|FG001|Overall Study|Lack of Efficacy|1|||
105840085|NCT00749411|365070181|FG000|Overall Study|Protocol Violation|1|||
105840086|NCT00749411|365070182|FG001|Overall Study|Protocol Violation|1|||
105840087|NCT00749411|365070181|FG000|Overall Study|Protocol-defined stopping criteria|0|||
105840088|NCT00749411|365070182|FG001|Overall Study|Protocol-defined stopping criteria|1|||
105840089|NCT03183141|365070183|FG000|Overall Study|Withdrawal by Subject|2|||
105311695|NCT02105974|363137984|FG002|2 Week Run-in Period|Adverse Event|0|||
105840090|NCT03183141|365070184|FG001|Overall Study|Withdrawal by Subject|4|||
105840091|NCT03183141|365070183|FG000|Overall Study|Death|0|||
105840092|NCT03183141|365070184|FG001|Overall Study|Death|8|||
105840093|NCT02190279|365071485|FG000|Overall Study|Withdrawal consent|1|||
105311696|NCT02105974|363137982|FG000|2 Week Run-in Period|Study closed/terminated|1|||
105311697|NCT02105974|363137983|FG001|2 Week Run-in Period|Study closed/terminated|0|||
105311698|NCT02105974|363137984|FG002|2 Week Run-in Period|Study closed/terminated|0|||
105311699|NCT02105974|363137982|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
105311700|NCT02105974|363137983|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
105311701|NCT02105974|363137984|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
105311702|NCT02105974|363137982|FG000|2 Week Run-in Period|Withdrew consent|23|||
105311703|NCT02105974|363137983|FG001|2 Week Run-in Period|Withdrew consent|0|||
105311704|NCT02105974|363137984|FG002|2 Week Run-in Period|Withdrew consent|0|||
105311705|NCT02105974|363137982|FG000|2 Week Run-in Period|Investigator discretion|8|||
105311706|NCT02105974|363137983|FG001|2 Week Run-in Period|Investigator discretion|0|||
105311707|NCT02105974|363137984|FG002|2 Week Run-in Period|Investigator discretion|0|||
105311708|NCT02105974|363137982|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
105311709|NCT02105974|363137983|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
105311710|NCT02105974|363137984|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
105311711|NCT02105974|363137982|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
105311712|NCT02105974|363137983|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
105311713|NCT02105974|363137984|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
105311714|NCT02105974|363137982|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
105311715|NCT02105974|363137983|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
105311716|NCT02105974|363137984|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
105311717|NCT02105974|363137982|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
105311718|NCT02105974|363137983|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
105311719|NCT02105974|363137984|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
105311720|NCT02105974|363137982|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
105311721|NCT02105974|363137983|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
105311722|NCT02105974|363137984|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
105311723|NCT02105974|363137982|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
105311724|NCT02105974|363137983|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
105311725|NCT02105974|363137984|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
105311726|NCT02105974|363137982|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
105840094|NCT02190279|365071486|FG001|Overall Study|Withdrawal consent|0|||
105840095|NCT02190279|365071487|FG002|Overall Study|Withdrawal consent|1|||
105840096|NCT02190279|365071485|FG000|Overall Study|Lost to Follow-up|2|||
105840097|NCT02190279|365071486|FG001|Overall Study|Lost to Follow-up|0|||
105840098|NCT02190279|365071487|FG002|Overall Study|Lost to Follow-up|0|||
105840099|NCT02190279|365071485|FG000|Overall Study|Refused further treatment|0|||
105840100|NCT02190279|365071486|FG001|Overall Study|Refused further treatment|0|||
105840101|NCT02190279|365071487|FG002|Overall Study|Refused further treatment|1|||
105840102|NCT02190279|365071485|FG000|Overall Study|Screening failure|0|||
105840103|NCT02190279|365071486|FG001|Overall Study|Screening failure|0|||
105840104|NCT02190279|365071487|FG002|Overall Study|Screening failure|1|||
105840105|NCT04039919|365071492|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105840106|NCT04039919|365071493|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105840107|NCT04039919|365071494|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105840108|NCT04039919|365071495|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105840109|NCT04039919|365071496|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105840110|NCT04039919|365071492|FG000|Treatment Period 1|Sponsor's decision|0|||
105840111|NCT04039919|365071493|FG001|Treatment Period 1|Sponsor's decision|0|||
105840112|NCT04039919|365071494|FG002|Treatment Period 1|Sponsor's decision|0|||
105840113|NCT04039919|365071495|FG003|Treatment Period 1|Sponsor's decision|0|||
105840114|NCT04039919|365071496|FG004|Treatment Period 1|Sponsor's decision|16|||
105840115|NCT04039919|365071492|FG000|Treatment Period 5|Withdrawal by Subject|1|||
105840116|NCT04039919|365071493|FG001|Treatment Period 5|Withdrawal by Subject|0|||
105840117|NCT04039919|365071494|FG002|Treatment Period 5|Withdrawal by Subject|0|||
105840118|NCT04039919|365071495|FG003|Treatment Period 5|Withdrawal by Subject|0|||
105840119|NCT04039919|365071496|FG004|Treatment Period 5|Withdrawal by Subject|0|||
105311727|NCT02105974|363137983|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
105311728|NCT02105974|363137984|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
105367710|NCT03575702|363352407|FG001|Overall Study|Patient non compliance|0|||
105576521|NCT04424290|364110182|FG001|Overall Study|Withdrawal by Subject|0|||
105840120|NCT00983918|365071501|FG000|Overall Study|conversion to open cholecystectomy|0|||
105840121|NCT00983918|365071502|FG001|Overall Study|conversion to open cholecystectomy|2|||
105840122|NCT00983918|365071503|FG002|Overall Study|conversion to open cholecystectomy|2|||
105840123|NCT00983918|365071504|FG003|Overall Study|conversion to open cholecystectomy|2|||
105840124|NCT05132569|365071505|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
105840125|NCT05132569|365071506|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
105840126|NCT05132569|365071505|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
105840127|NCT05132569|365071506|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
105311729|NCT05065567|363137986|FG000|Overall Study|Lost to Follow-up|10|||
105367711|NCT01545388|363352408|FG000|Overall Study|Adverse Event|2|||
105311730|NCT05065567|363137987|FG001|Overall Study|Lost to Follow-up|9|||
105311731|NCT05065567|363137988|FG002|Overall Study|Lost to Follow-up|6|||
105311732|NCT03510598|363139010|FG000|Overall Study|Withdrawal by Subject|1|||
105311733|NCT00359801|363139016|FG000|Overall Study|Lost to Follow-up|72|||
105311734|NCT00359801|363139017|FG001|Overall Study|Lost to Follow-up|58|||
105311735|NCT00359801|363139016|FG000|Overall Study|Withdrawal by Subject|143|||
105311736|NCT00359801|363139017|FG001|Overall Study|Withdrawal by Subject|96|||
105311737|NCT00359801|363139016|FG000|Overall Study|Other|66|||
105311738|NCT00359801|363139017|FG001|Overall Study|Other|46|||
105311739|NCT00359801|363139016|FG000|Overall Study|Final Status Unknown: missing data|7|||
105311740|NCT00359801|363139017|FG001|Overall Study|Final Status Unknown: missing data|4|||
105311741|NCT00359801|363139016|FG000|Overall Study|Sponsor Decision|17|||
105311742|NCT00359801|363139017|FG001|Overall Study|Sponsor Decision|16|||
105311743|NCT00754650|363139027|FG000|Overall Study|Disease Progression|2|||
105311744|NCT03323437|363139031|FG000|Overall Study|Withdrawal by Subject|0|||
105311745|NCT03323437|363139032|FG001|Overall Study|Withdrawal by Subject|4|||
105311746|NCT00605540|363139033|FG000|Overall Study|Death|15|||
105311747|NCT00605540|363139033|FG000|Overall Study|Lost to Follow-up|23|||
105311748|NCT00094861|363139036|FG000|Overall Study|Adverse Event|5|||
105311749|NCT00094861|363139037|FG001|Overall Study|Adverse Event|2|||
105311750|NCT00094861|363139036|FG000|Overall Study|Withdrawal by Subject|5|||
105311751|NCT00094861|363139037|FG001|Overall Study|Withdrawal by Subject|3|||
105311752|NCT00094861|363139036|FG000|Overall Study|Physician Decision|1|||
105311753|NCT00094861|363139037|FG001|Overall Study|Physician Decision|1|||
105311754|NCT00094861|363139036|FG000|Overall Study|Lost to Follow-up|0|||
105311755|NCT00094861|363139037|FG001|Overall Study|Lost to Follow-up|1|||
105311756|NCT00094861|363139036|FG000|Overall Study|Death|4|||
105311757|NCT00094861|363139037|FG001|Overall Study|Death|2|||
105311758|NCT00094861|363139036|FG000|Overall Study|Other|3|||
105311759|NCT00094861|363139037|FG001|Overall Study|Other|0|||
105311760|NCT02383810|363139039|FG000|Overall Study|Physician Decision|1|||
105311761|NCT02383810|363139040|FG001|Overall Study|Physician Decision|1|||
105311762|NCT02383810|363139041|FG002|Overall Study|Physician Decision|0|||
105311763|NCT02383810|363139042|FG003|Overall Study|Physician Decision|0|||
105311764|NCT02383810|363139043|FG004|Overall Study|Physician Decision|0|||
105311765|NCT02383810|363139044|FG005|Overall Study|Physician Decision|0|||
105311766|NCT02383810|363139045|FG006|Overall Study|Physician Decision|0|||
105311767|NCT02383810|363139046|FG007|Overall Study|Physician Decision|0|||
105311768|NCT02383810|363139039|FG000|Overall Study|Withdrawal by Subject|2|||
105311769|NCT02383810|363139040|FG001|Overall Study|Withdrawal by Subject|3|||
105311770|NCT02383810|363139041|FG002|Overall Study|Withdrawal by Subject|3|||
105311771|NCT02383810|363139042|FG003|Overall Study|Withdrawal by Subject|3|||
105311772|NCT02383810|363139043|FG004|Overall Study|Withdrawal by Subject|0|||
105311773|NCT02383810|363139044|FG005|Overall Study|Withdrawal by Subject|0|||
105311774|NCT02383810|363139045|FG006|Overall Study|Withdrawal by Subject|0|||
105311775|NCT02383810|363139046|FG007|Overall Study|Withdrawal by Subject|0|||
105311776|NCT02383810|363139039|FG000|Overall Study|Adverse Event|0|||
105311777|NCT02383810|363139040|FG001|Overall Study|Adverse Event|2|||
105311778|NCT02383810|363139041|FG002|Overall Study|Adverse Event|4|||
105311779|NCT02383810|363139042|FG003|Overall Study|Adverse Event|5|||
105311780|NCT02383810|363139043|FG004|Overall Study|Adverse Event|0|||
105311781|NCT02383810|363139044|FG005|Overall Study|Adverse Event|1|||
105311782|NCT02383810|363139045|FG006|Overall Study|Adverse Event|1|||
105311783|NCT02383810|363139046|FG007|Overall Study|Adverse Event|0|||
105311784|NCT02383810|363139039|FG000|Overall Study|Lost to Follow-up|0|||
105311785|NCT02383810|363139040|FG001|Overall Study|Lost to Follow-up|1|||
105311786|NCT02383810|363139041|FG002|Overall Study|Lost to Follow-up|0|||
105311787|NCT02383810|363139042|FG003|Overall Study|Lost to Follow-up|1|||
105367712|NCT01545388|363352409|FG001|Overall Study|Adverse Event|4|||
105367713|NCT01545388|363352410|FG002|Overall Study|Adverse Event|1|||
105367714|NCT01545388|363352408|FG000|Overall Study|Lack of Efficacy|3|||
105311788|NCT02383810|363139043|FG004|Overall Study|Lost to Follow-up|0|||
105311789|NCT02383810|363139044|FG005|Overall Study|Lost to Follow-up|0|||
105311790|NCT02383810|363139045|FG006|Overall Study|Lost to Follow-up|0|||
105311791|NCT02383810|363139046|FG007|Overall Study|Lost to Follow-up|0|||
105367715|NCT01545388|363352409|FG001|Overall Study|Lack of Efficacy|2|||
105367716|NCT01545388|363352410|FG002|Overall Study|Lack of Efficacy|5|||
105311792|NCT02383810|363139039|FG000|Overall Study|other|0|||
105311793|NCT02383810|363139040|FG001|Overall Study|other|0|||
105311794|NCT02383810|363139041|FG002|Overall Study|other|0|||
105311795|NCT02383810|363139042|FG003|Overall Study|other|2|||
105311796|NCT02383810|363139043|FG004|Overall Study|other|0|||
105311797|NCT02383810|363139044|FG005|Overall Study|other|0|||
105367717|NCT01545388|363352408|FG000|Overall Study|Participant moved or relocated|1|||
105311798|NCT02383810|363139045|FG006|Overall Study|other|0|||
105311799|NCT02383810|363139046|FG007|Overall Study|other|0|||
105311800|NCT02383810|363139039|FG000|Overall Study|subject did not receive study treatment|0|||
105311801|NCT02383810|363139040|FG001|Overall Study|subject did not receive study treatment|1|||
105311802|NCT02383810|363139041|FG002|Overall Study|subject did not receive study treatment|0|||
105311803|NCT02383810|363139042|FG003|Overall Study|subject did not receive study treatment|0|||
105311804|NCT02383810|363139043|FG004|Overall Study|subject did not receive study treatment|0|||
105311805|NCT02383810|363139044|FG005|Overall Study|subject did not receive study treatment|0|||
105311806|NCT02383810|363139045|FG006|Overall Study|subject did not receive study treatment|0|||
105311807|NCT02383810|363139046|FG007|Overall Study|subject did not receive study treatment|0|||
105311808|NCT00282919|363139051|FG000|Overall Study|Lack of Efficacy|4|||
105311809|NCT00282919|363139051|FG000|Overall Study|Withdrawal by Subject|1|||
105311810|NCT00282919|363139051|FG000|Overall Study|Asymptomatic Parasitemia|2|||
105311811|NCT01433549|363139052|FG000|Phase 2: Second Study Product|Adverse Event|0|||
105311812|NCT01433549|363139053|FG001|Phase 2: Second Study Product|Adverse Event|1|||
105311813|NCT01696058|363139057|FG000|Overall Study|Adverse Event|21|||
105311814|NCT01696058|363139058|FG001|Overall Study|Adverse Event|11|||
105311815|NCT01696058|363139057|FG000|Overall Study|Lack of Efficacy|2|||
105311816|NCT01696058|363139058|FG001|Overall Study|Lack of Efficacy|3|||
105311817|NCT01696058|363139057|FG000|Overall Study|Protocol Violation|9|||
105311818|NCT01696058|363139058|FG001|Overall Study|Protocol Violation|3|||
105311819|NCT01696058|363139057|FG000|Overall Study|Lost to Follow-up|2|||
105311820|NCT01696058|363139058|FG001|Overall Study|Lost to Follow-up|5|||
105311821|NCT01696058|363139057|FG000|Overall Study|Withdrawal by Subject|4|||
105311822|NCT01696058|363139058|FG001|Overall Study|Withdrawal by Subject|6|||
105311823|NCT01696058|363139057|FG000|Overall Study|Other reason prematurely discontinued|5|||
105311824|NCT01696058|363139058|FG001|Overall Study|Other reason prematurely discontinued|3|||
105311825|NCT02549027|363139063|FG000|Washout After Period 4|Withdrawal by Subject|0|||
105311826|NCT02549027|363139064|FG001|Washout After Period 4|Withdrawal by Subject|1|||
105311827|NCT02549027|363139065|FG002|Washout After Period 4|Withdrawal by Subject|1|||
105311828|NCT02549027|363139066|FG003|Washout After Period 4|Withdrawal by Subject|1|||
105311829|NCT02549027|363139067|FG004|Washout After Period 4|Withdrawal by Subject|0|||
105311830|NCT02549027|363139068|FG005|Washout After Period 4|Withdrawal by Subject|0|||
105311831|NCT02549027|363139063|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
105311832|NCT02549027|363139064|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
105311833|NCT02549027|363139065|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
105311834|NCT02549027|363139066|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
105311835|NCT02549027|363139067|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
105311836|NCT02549027|363139068|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
105311837|NCT02186834|363139069|FG000|Dose Escalation|Death|0|||
105311838|NCT02186834|363139070|FG001|Dose Escalation|Death|0|||
105311839|NCT02186834|363139071|FG002|Dose Escalation|Death|0|||
105311840|NCT02186834|363139072|FG003|Dose Escalation|Death|1|||
105311841|NCT02186834|363139073|FG004|Dose Escalation|Death|0|||
105311842|NCT02186834|363139074|FG005|Dose Escalation|Death|0|||
105311843|NCT02186834|363139069|FG000|Treatment at RP2D|Died prior to treatment|0|||
105311844|NCT02186834|363139070|FG001|Treatment at RP2D|Died prior to treatment|0|||
105311845|NCT02186834|363139071|FG002|Treatment at RP2D|Died prior to treatment|0|||
105311846|NCT02186834|363139072|FG003|Treatment at RP2D|Died prior to treatment|0|||
105367718|NCT01545388|363352409|FG001|Overall Study|Participant moved or relocated|0|||
105367719|NCT01545388|363352410|FG002|Overall Study|Participant moved or relocated|0|||
105367720|NCT01545388|363352408|FG000|Overall Study|Withdrawal by Subject|1|||
105367721|NCT01545388|363352409|FG001|Overall Study|Withdrawal by Subject|4|||
105367722|NCT01545388|363352410|FG002|Overall Study|Withdrawal by Subject|2|||
105367723|NCT01545388|363352408|FG000|Overall Study|Other|1|||
105367724|NCT01545388|363352409|FG001|Overall Study|Other|1|||
105311847|NCT02186834|363139073|FG004|Treatment at RP2D|Died prior to treatment|0|||
105311848|NCT02186834|363139074|FG005|Treatment at RP2D|Died prior to treatment|1|||
105311849|NCT01756079|363139085|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
105311850|NCT01756079|363139085|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
105311851|NCT01756079|363139085|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
105311852|NCT01756079|363139085|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
105311853|NCT01756079|363139085|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
105311854|NCT03207243|363139088|FG000|Overall Study|Adverse Event|2|||
105311855|NCT03207243|363139089|FG001|Overall Study|Adverse Event|2|||
105311856|NCT03207243|363139088|FG000|Overall Study|Loss of Asthma Control|47|||
105311857|NCT03207243|363139089|FG001|Overall Study|Loss of Asthma Control|31|||
105311858|NCT03207243|363139088|FG000|Overall Study|Withdrawal by Subject|2|||
105311859|NCT03207243|363139089|FG001|Overall Study|Withdrawal by Subject|4|||
105311860|NCT03207243|363139088|FG000|Overall Study|Physician Decision|1|||
105311861|NCT03207243|363139089|FG001|Overall Study|Physician Decision|1|||
105311862|NCT03207243|363139088|FG000|Overall Study|Lost to Follow-up|0|||
105311863|NCT03207243|363139089|FG001|Overall Study|Lost to Follow-up|1|||
105311864|NCT03207243|363139088|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
105367725|NCT01545388|363352410|FG002|Overall Study|Other|0|||
105367726|NCT00086190|363352411|FG000|Overall Study|Adverse Event|6|||
105311865|NCT03207243|363139089|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
105311866|NCT03207243|363139088|FG000|Overall Study|Protocol Violation|0|||
105367727|NCT00086190|363352412|FG001|Overall Study|Adverse Event|2|||
105367728|NCT00086190|363352413|FG002|Overall Study|Adverse Event|2|||
105840128|NCT05132569|365071505|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
105840129|NCT05132569|365071506|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
105840130|NCT01197417|365071507|FG000|Overall Study|Physician Decision|3|||
105840131|NCT01197417|365071508|FG001|Overall Study|Physician Decision|2|||
105840132|NCT01197417|365071507|FG000|Overall Study|Withdrawal by Subject|2|||
105840133|NCT01197417|365071508|FG001|Overall Study|Withdrawal by Subject|4|||
105840134|NCT01197417|365071507|FG000|Overall Study|Site miscommunication|0|||
105840135|NCT01197417|365071508|FG001|Overall Study|Site miscommunication|1|||
105840136|NCT01197417|365071507|FG000|Overall Study|Subject transferred to intensive care|0|||
105840137|NCT01197417|365071508|FG001|Overall Study|Subject transferred to intensive care|1|||
105840138|NCT01197417|365071507|FG000|Overall Study|Not consented in time to receive drug|0|||
105840139|NCT01197417|365071508|FG001|Overall Study|Not consented in time to receive drug|1|||
105840140|NCT01197417|365071507|FG000|Overall Study|Hypotension|1|||
105840141|NCT01197417|365071508|FG001|Overall Study|Hypotension|2|||
105840142|NCT01197417|365071507|FG000|Overall Study|Found to be ineligible|2|||
105840143|NCT01197417|365071508|FG001|Overall Study|Found to be ineligible|5|||
105840144|NCT01197417|365071507|FG000|Overall Study|No 25-hour magnesium level|0|||
105840145|NCT01197417|365071508|FG001|Overall Study|No 25-hour magnesium level|2|||
105840146|NCT00977548|365071509|FG000|Overall Study|Ineligible|4|||
105840147|NCT00977548|365071509|FG000|Overall Study|Adverse Event|8|||
105840148|NCT00977548|365071509|FG000|Overall Study|Withdrawal by Subject|1|||
105840149|NCT04142242|365071511|FG000|Stage I|Non-compliance with the protocol|1|||
105840150|NCT04142242|365071512|FG001|Stage I|Non-compliance with the protocol|0|||
105840151|NCT04142242|365071513|FG002|Stage I|Non-compliance with the protocol|0|||
105840152|NCT04142242|365071514|FG003|Stage I|Non-compliance with the protocol|0|||
105840153|NCT04142242|365071515|FG004|Stage I|Non-compliance with the protocol|0|||
105840154|NCT04142242|365071516|FG005|Stage I|Non-compliance with the protocol|1|||
105840155|NCT04142242|365071511|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
105840156|NCT04142242|365071512|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
105840157|NCT04142242|365071513|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
105840158|NCT04142242|365071514|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
105840159|NCT04142242|365071515|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
105840160|NCT04142242|365071516|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
105840161|NCT04142242|365071511|FG000|Stage II|Non-compliance with the protocol|0|||
105840162|NCT04142242|365071512|FG001|Stage II|Non-compliance with the protocol|0|||
105840163|NCT04142242|365071513|FG002|Stage II|Non-compliance with the protocol|0|||
105840164|NCT04142242|365071514|FG003|Stage II|Non-compliance with the protocol|2|||
105840165|NCT04142242|365071515|FG004|Stage II|Non-compliance with the protocol|0|||
105840166|NCT04142242|365071516|FG005|Stage II|Non-compliance with the protocol|0|||
105840167|NCT04142242|365071511|FG000|Stage II|Lost to Follow-up|0|||
105840168|NCT04142242|365071512|FG001|Stage II|Lost to Follow-up|0|||
105840169|NCT04142242|365071513|FG002|Stage II|Lost to Follow-up|1|||
105840170|NCT04142242|365071514|FG003|Stage II|Lost to Follow-up|2|||
105840171|NCT04142242|365071515|FG004|Stage II|Lost to Follow-up|0|||
105840172|NCT04142242|365071516|FG005|Stage II|Lost to Follow-up|0|||
105840173|NCT04142242|365071511|FG000|Stage II|Withdrawal by Subject|0|||
105840174|NCT04142242|365071512|FG001|Stage II|Withdrawal by Subject|0|||
105840175|NCT04142242|365071513|FG002|Stage II|Withdrawal by Subject|5|||
105840176|NCT04142242|365071514|FG003|Stage II|Withdrawal by Subject|9|||
105840177|NCT04142242|365071515|FG004|Stage II|Withdrawal by Subject|0|||
105840178|NCT04142242|365071516|FG005|Stage II|Withdrawal by Subject|0|||
105840179|NCT02070757|365071517|FG000|Overall Study|Adverse Event|107|||
105840180|NCT02070757|365071518|FG001|Overall Study|Adverse Event|99|||
105840181|NCT02070757|365071517|FG000|Overall Study|Lost to Follow-up|7|||
105840182|NCT02070757|365071518|FG001|Overall Study|Lost to Follow-up|4|||
105840183|NCT02070757|365071517|FG000|Overall Study|Protocol Violation|0|||
105840184|NCT02070757|365071518|FG001|Overall Study|Protocol Violation|4|||
105840185|NCT02070757|365071517|FG000|Overall Study|Withdrawal by Subject|1|||
105840186|NCT02070757|365071518|FG001|Overall Study|Withdrawal by Subject|3|||
105840187|NCT02070757|365071517|FG000|Overall Study|Investigator Decision|0|||
105840188|NCT02070757|365071518|FG001|Overall Study|Investigator Decision|2|||
105840189|NCT02070757|365071517|FG000|Overall Study|Discharged from Study Hospital|2|||
105840190|NCT02070757|365071518|FG001|Overall Study|Discharged from Study Hospital|2|||
105840191|NCT01546922|365071519|FG000|First Period of 10 Weeks|Protocol Violation|3|||
105840192|NCT01546922|365071520|FG001|First Period of 10 Weeks|Protocol Violation|1|||
105311867|NCT03207243|363139089|FG001|Overall Study|Protocol Violation|3|||
105311868|NCT02552303|363139096|FG000|Allocation|Withdrawal by Subject|2|||
105311869|NCT02552303|363139097|FG001|Allocation|Withdrawal by Subject|1|||
105311870|NCT02552303|363139098|FG002|Allocation|Withdrawal by Subject|1|||
105840193|NCT01546922|365071519|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
105840194|NCT01546922|365071520|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
105840195|NCT01546922|365071519|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
105840196|NCT01546922|365071520|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
105311871|NCT02552303|363139099|FG003|Allocation|Withdrawal by Subject|1|||
105311872|NCT02552303|363139096|FG000|Allocation|ineligible|1|||
105311873|NCT02552303|363139097|FG001|Allocation|ineligible|1|||
105311874|NCT02552303|363139098|FG002|Allocation|ineligible|0|||
105311875|NCT02552303|363139099|FG003|Allocation|ineligible|0|||
105311876|NCT02552303|363139096|FG000|Follow-Up|Lost to Follow-up|0|||
105311877|NCT02552303|363139097|FG001|Follow-Up|Lost to Follow-up|0|||
105311878|NCT02552303|363139098|FG002|Follow-Up|Lost to Follow-up|1|||
105311879|NCT02552303|363139099|FG003|Follow-Up|Lost to Follow-up|0|||
105311880|NCT02552303|363139096|FG000|Follow-Up|ineligible|0|||
105311881|NCT02552303|363139097|FG001|Follow-Up|ineligible|2|||
105311882|NCT02552303|363139098|FG002|Follow-Up|ineligible|0|||
105311883|NCT02552303|363139099|FG003|Follow-Up|ineligible|0|||
105311884|NCT01377987|363139100|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
105311885|NCT01377987|363139101|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
105311886|NCT04015908|363139102|FG000|Overall Study|Lost to Follow-up|0|||
105311887|NCT04015908|363139103|FG001|Overall Study|Lost to Follow-up|1|||
105311888|NCT00856375|363139107|FG000|Overall Study|Other|0|||
105311889|NCT00856375|363139108|FG001|Overall Study|Other|1|||
105311890|NCT00856375|363139107|FG000|Overall Study|Death|32|||
105311891|NCT00856375|363139108|FG001|Overall Study|Death|30|||
105311892|NCT00856375|363139107|FG000|Overall Study|Sponsor Terminated Study|7|||
105311893|NCT00856375|363139108|FG001|Overall Study|Sponsor Terminated Study|7|||
105311894|NCT00856375|363139107|FG000|Overall Study|Withdrawal by Subject|2|||
105311895|NCT00856375|363139108|FG001|Overall Study|Withdrawal by Subject|1|||
105311896|NCT00856375|363139107|FG000|Overall Study|Lost to Follow-up|1|||
105311897|NCT00856375|363139108|FG001|Overall Study|Lost to Follow-up|2|||
105311898|NCT02227446|363139111|FG000|Overall Study|not eligible post randomization|18|||
105311899|NCT02227446|363139112|FG001|Overall Study|not eligible post randomization|29|||
105311900|NCT02227446|363139111|FG000|Overall Study|Withdrawal by Subject|4|||
105311901|NCT02227446|363139112|FG001|Overall Study|Withdrawal by Subject|5|||
105311902|NCT01755767|363139113|FG000|Overall Study|Progressive Disease|8|||
105311903|NCT01755767|363139114|FG001|Overall Study|Progressive Disease|7|||
105311904|NCT01755767|363139115|FG002|Overall Study|Progressive Disease|91|||
105311905|NCT01755767|363139116|FG003|Overall Study|Progressive Disease|43|||
105311906|NCT01755767|363139113|FG000|Overall Study|Clinical Disease Progression|4|||
105311907|NCT01755767|363139114|FG001|Overall Study|Clinical Disease Progression|2|||
105311908|NCT01755767|363139115|FG002|Overall Study|Clinical Disease Progression|29|||
105311909|NCT01755767|363139116|FG003|Overall Study|Clinical Disease Progression|20|||
105311910|NCT01755767|363139113|FG000|Overall Study|Radiographic Disease Progression|9|||
105311911|NCT01755767|363139114|FG001|Overall Study|Radiographic Disease Progression|4|||
105311912|NCT01755767|363139115|FG002|Overall Study|Radiographic Disease Progression|44|||
105311913|NCT01755767|363139116|FG003|Overall Study|Radiographic Disease Progression|27|||
105311914|NCT01755767|363139113|FG000|Overall Study|Adverse Event|6|||
105311915|NCT01755767|363139114|FG001|Overall Study|Adverse Event|0|||
105311916|NCT01755767|363139115|FG002|Overall Study|Adverse Event|28|||
105311917|NCT01755767|363139116|FG003|Overall Study|Adverse Event|11|||
105311918|NCT01755767|363139113|FG000|Overall Study|Death|1|||
105311919|NCT01755767|363139114|FG001|Overall Study|Death|2|||
105311920|NCT01755767|363139115|FG002|Overall Study|Death|15|||
105311921|NCT01755767|363139116|FG003|Overall Study|Death|4|||
105311922|NCT01755767|363139113|FG000|Overall Study|Subject Decision|0|||
105311923|NCT01755767|363139114|FG001|Overall Study|Subject Decision|0|||
105311924|NCT01755767|363139115|FG002|Overall Study|Subject Decision|10|||
105311925|NCT01755767|363139116|FG003|Overall Study|Subject Decision|3|||
105311926|NCT01755767|363139113|FG000|Overall Study|Withdrawal by Subject|0|||
105311927|NCT01755767|363139114|FG001|Overall Study|Withdrawal by Subject|0|||
105311928|NCT01755767|363139115|FG002|Overall Study|Withdrawal by Subject|2|||
105311929|NCT01755767|363139116|FG003|Overall Study|Withdrawal by Subject|1|||
105311930|NCT01755767|363139113|FG000|Overall Study|Other|0|||
105311931|NCT01755767|363139114|FG001|Overall Study|Other|0|||
105311932|NCT01755767|363139115|FG002|Overall Study|Other|2|||
105311933|NCT01755767|363139116|FG003|Overall Study|Other|3|||
105311934|NCT01755767|363139113|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
105311935|NCT01755767|363139114|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
105311936|NCT01755767|363139115|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
105311937|NCT01755767|363139116|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
105311938|NCT04623086|363139117|FG000|Overall Study|Withdrawal by Subject|0|||
105311939|NCT04623086|363139118|FG001|Overall Study|Withdrawal by Subject|0|||
105311940|NCT04623086|363139119|FG002|Overall Study|Withdrawal by Subject|10|||
105311941|NCT02538965|363139120|FG000|Treatment Period|Other = Death due to disease progression|1|||
105311942|NCT02538965|363139120|FG000|Treatment Period|Adverse Event|2|||
105311943|NCT02538965|363139120|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
105576522|NCT04424290|364110183|FG002|Overall Study|Withdrawal by Subject|0|||
105311944|NCT02538965|363139120|FG000|Treatment Period|Treatment Failure|9|||
105311945|NCT02538965|363139120|FG000|Treatment Period|Disease Progression|1|||
105311946|NCT02538965|363139120|FG000|Treatment Period|Physician Decision|2|||
105311947|NCT02538965|363139120|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
105311948|NCT02538965|363139120|FG000|Follow-Up Period|Withdrawal by Parent|4|||
105367729|NCT00086190|363352411|FG000|Overall Study|Withdrawal by Subject|0|||
105367730|NCT00086190|363352412|FG001|Overall Study|Withdrawal by Subject|2|||
105311949|NCT00875797|363139121|FG000|Overall Study|Protocol Violation|6|||
105311950|NCT00875797|363139122|FG001|Overall Study|Protocol Violation|3|||
105311951|NCT02121392|363139126|FG000|Prior to Intervention|Protocol Violation|40|||
105311952|NCT02121392|363139127|FG001|Prior to Intervention|Protocol Violation|35|||
105311953|NCT02121392|363139126|FG000|Prior to Intervention|Withdrawal by Subject|8|||
105311954|NCT02121392|363139127|FG001|Prior to Intervention|Withdrawal by Subject|6|||
105311955|NCT02121392|363139126|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
105311956|NCT02121392|363139127|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
105311957|NCT02121392|363139126|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
105311958|NCT02121392|363139127|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
105311959|NCT01352416|363139128|FG000|Overall Study|Physician Decision|1|||
105311960|NCT01352416|363139129|FG001|Overall Study|Physician Decision|2|||
105311961|NCT01352416|363139130|FG002|Overall Study|Physician Decision|2|||
105311962|NCT01352416|363139131|FG003|Overall Study|Physician Decision|1|||
105311963|NCT01696279|363139142|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
105311964|NCT01696279|363139143|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
105311965|NCT01696279|363139144|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
105311966|NCT01696279|363139145|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
105311967|NCT01696279|363139142|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
105311968|NCT01696279|363139143|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
105311969|NCT01696279|363139144|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
105311970|NCT01696279|363139145|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
105311971|NCT01696279|363139142|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
105311972|NCT01696279|363139143|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
105311973|NCT01696279|363139144|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
105311974|NCT01696279|363139145|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
105311975|NCT01696279|363139142|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
105311976|NCT01696279|363139143|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
105311977|NCT01696279|363139144|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
105311978|NCT01696279|363139145|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
105311979|NCT01696279|363139142|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
105311980|NCT01696279|363139143|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
105311981|NCT01696279|363139144|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
105311982|NCT01696279|363139145|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
105367731|NCT00086190|363352413|FG002|Overall Study|Withdrawal by Subject|2|||
105367732|NCT00086190|363352411|FG000|Overall Study|Protocol Violation|1|||
105367733|NCT00086190|363352412|FG001|Overall Study|Protocol Violation|0|||
105367734|NCT00086190|363352413|FG002|Overall Study|Protocol Violation|0|||
105367735|NCT00086190|363352411|FG000|Overall Study|Moved|1|||
105367736|NCT00086190|363352412|FG001|Overall Study|Moved|0|||
105367737|NCT00086190|363352413|FG002|Overall Study|Moved|0|||
105367738|NCT00086190|363352411|FG000|Overall Study|Worsening depression|0|||
105367739|NCT00086190|363352412|FG001|Overall Study|Worsening depression|0|||
105367740|NCT00086190|363352413|FG002|Overall Study|Worsening depression|2|||
105367741|NCT02175121|363352414|FG000|Overall Study|Lack of Efficacy|1|||
105367742|NCT02175121|363352415|FG001|Overall Study|Lack of Efficacy|0|||
105367743|NCT02175121|363352416|FG002|Overall Study|Lack of Efficacy|0|||
105367744|NCT02175121|363352417|FG003|Overall Study|Lack of Efficacy|0|||
105367745|NCT02175121|363352418|FG004|Overall Study|Lack of Efficacy|0|||
105367746|NCT02175121|363352414|FG000|Overall Study|Lost to Follow-up|0|||
105367747|NCT02175121|363352415|FG001|Overall Study|Lost to Follow-up|1|||
105367748|NCT02175121|363352416|FG002|Overall Study|Lost to Follow-up|0|||
105367749|NCT02175121|363352417|FG003|Overall Study|Lost to Follow-up|1|||
105367750|NCT02175121|363352418|FG004|Overall Study|Lost to Follow-up|0|||
105367751|NCT02175121|363352414|FG000|Overall Study|Personal emergency|0|||
105367752|NCT02175121|363352415|FG001|Overall Study|Personal emergency|0|||
105367753|NCT02175121|363352416|FG002|Overall Study|Personal emergency|0|||
105367754|NCT02175121|363352417|FG003|Overall Study|Personal emergency|0|||
105367755|NCT02175121|363352418|FG004|Overall Study|Personal emergency|1|||
105367756|NCT02175121|363352414|FG000|Overall Study|Schedule conflict|0|||
105367757|NCT02175121|363352415|FG001|Overall Study|Schedule conflict|0|||
105576523|NCT04424290|364110184|FG003|Overall Study|Withdrawal by Subject|0|||
105311983|NCT01696279|363139142|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
105311984|NCT01696279|363139143|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
105367758|NCT02175121|363352416|FG002|Overall Study|Schedule conflict|1|||
105367759|NCT02175121|363352417|FG003|Overall Study|Schedule conflict|0|||
105367760|NCT02175121|363352418|FG004|Overall Study|Schedule conflict|0|||
105367761|NCT02175121|363352414|FG000|Overall Study|Time issues|0|||
105367762|NCT02175121|363352415|FG001|Overall Study|Time issues|0|||
105576524|NCT04424290|364110185|FG004|Overall Study|Withdrawal by Subject|1|||
105367763|NCT02175121|363352416|FG002|Overall Study|Time issues|1|||
105367764|NCT02175121|363352417|FG003|Overall Study|Time issues|0|||
105840197|NCT01546922|365071519|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
105840198|NCT01546922|365071520|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
105840199|NCT01546922|365071519|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
105840200|NCT01546922|365071520|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
105840201|NCT01613378|365071523|FG000|Overall Study|Lack of Efficacy|13|||
105840202|NCT01613378|365071523|FG000|Overall Study|Adverse Event|11|||
105840203|NCT01613378|365071523|FG000|Overall Study|Withdrawal by Subject|8|||
105840204|NCT01613378|365071523|FG000|Overall Study|Death|2|||
105840205|NCT01613378|365071523|FG000|Overall Study|Lost to Follow-up|1|||
105840206|NCT01613378|365071523|FG000|Overall Study|Other Reason|4|||
105840207|NCT00794417|365071524|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
105840208|NCT00794417|365071525|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
105840209|NCT00794417|365071526|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
105840210|NCT00794417|365071527|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
105840211|NCT00794417|365071524|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
105840212|NCT00794417|365071525|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
105840213|NCT00794417|365071526|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
105840214|NCT00794417|365071527|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
105840215|NCT00794417|365071524|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
105840216|NCT00794417|365071525|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
105840217|NCT00794417|365071526|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
105840218|NCT00794417|365071527|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
105840219|NCT00794417|365071524|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
105840220|NCT00794417|365071525|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
105840221|NCT00794417|365071526|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
105840222|NCT00794417|365071527|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
105840223|NCT00794417|365071524|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
105840224|NCT00794417|365071525|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
105840225|NCT00794417|365071526|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
105840226|NCT00794417|365071527|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
105840227|NCT00794417|365071524|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
105840228|NCT00794417|365071525|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
105840229|NCT00794417|365071526|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
105840230|NCT00794417|365071527|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
105840231|NCT01042535|365071528|FG000|Overall Study|disease progression prior to treatment|3|||
105840232|NCT01042535|365071528|FG000|Overall Study|disease progression during treatment|3|||
105840233|NCT01042535|365071528|FG000|Overall Study|complications from other disease|2|||
105840234|NCT01345318|365071529|FG000|Overall Study|Adverse Event|16|||
105840235|NCT01345318|365071529|FG000|Overall Study|Lack of Efficacy|17|||
105840236|NCT01345318|365071529|FG000|Overall Study|Lost to Follow-up|2|||
105840237|NCT01345318|365071529|FG000|Overall Study|Protocol Violation|1|||
105840238|NCT01345318|365071529|FG000|Overall Study|Withdrawal by Subject|41|||
105840239|NCT01345318|365071529|FG000|Overall Study|Other|3|||
105840240|NCT01546142|365071532|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
105840241|NCT01546142|365071533|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
105840242|NCT01546142|365071532|FG000|Overall Study|Subject Noncompliance|1|||
105840243|NCT01546142|365071533|FG001|Overall Study|Subject Noncompliance|1|||
105840244|NCT01546142|365071532|FG000|Overall Study|Adverse Event|6|||
105840245|NCT01546142|365071533|FG001|Overall Study|Adverse Event|3|||
105840246|NCT01546142|365071532|FG000|Overall Study|Lost to Follow-up|20|||
105840247|NCT01546142|365071533|FG001|Overall Study|Lost to Follow-up|15|||
105840248|NCT01546142|365071532|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
105840249|NCT01546142|365071533|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
105840250|NCT01546142|365071532|FG000|Overall Study|Subject Randomized but Not Treated|1|||
105840251|NCT01546142|365071533|FG001|Overall Study|Subject Randomized but Not Treated|0|||
105840252|NCT01213836|365071534|FG000|Period 1, First Intervention|Adverse Event|2|||
105840253|NCT01213836|365071535|FG001|Period 1, First Intervention|Adverse Event|1|||
105840254|NCT01213836|365071534|FG000|Period 1, First Intervention|Protocol Violation|0|||
105840255|NCT01213836|365071535|FG001|Period 1, First Intervention|Protocol Violation|1|||
105311985|NCT01696279|363139144|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
105311986|NCT01696279|363139145|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
105840256|NCT01213836|365071534|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
105840257|NCT01213836|365071535|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
105840258|NCT00255151|365071536|FG000|Overall Study|Adverse Event|10|||
105840259|NCT00255151|365071537|FG001|Overall Study|Adverse Event|6|||
105840260|NCT00255151|365071538|FG002|Overall Study|Adverse Event|9|||
105840261|NCT00255151|365071536|FG000|Overall Study|Lost to Follow-up|4|||
105840262|NCT00255151|365071537|FG001|Overall Study|Lost to Follow-up|3|||
105840263|NCT00255151|365071538|FG002|Overall Study|Lost to Follow-up|4|||
105840264|NCT00255151|365071536|FG000|Overall Study|Withdrawal by Subject|18|||
105367765|NCT02175121|363352418|FG004|Overall Study|Time issues|0|||
105367766|NCT02027025|363352419|FG000|Overall Study|Adverse Event|0|||
105367767|NCT02027025|363352420|FG001|Overall Study|Adverse Event|1|||
105367768|NCT02027025|363352421|FG002|Overall Study|Adverse Event|1|||
105367769|NCT02027025|363352419|FG000|Overall Study|Protocol Violation|1|||
105367770|NCT02027025|363352420|FG001|Overall Study|Protocol Violation|0|||
105367771|NCT02027025|363352421|FG002|Overall Study|Protocol Violation|0|||
105367772|NCT02027025|363352419|FG000|Overall Study|Lost to Follow-up|0|||
105576525|NCT04424290|364110181|FG000|Overall Study|Other than listed|0|||
105367773|NCT02027025|363352420|FG001|Overall Study|Lost to Follow-up|2|||
105367774|NCT02027025|363352421|FG002|Overall Study|Lost to Follow-up|0|||
105367775|NCT02027025|363352419|FG000|Overall Study|Withdrawal by Subject|0|||
105367776|NCT02027025|363352420|FG001|Overall Study|Withdrawal by Subject|1|||
105367777|NCT02027025|363352421|FG002|Overall Study|Withdrawal by Subject|0|||
105367778|NCT02027025|363352419|FG000|Overall Study|Sponsor's decision|0|||
105367779|NCT02027025|363352420|FG001|Overall Study|Sponsor's decision|1|||
105367780|NCT02027025|363352421|FG002|Overall Study|Sponsor's decision|0|||
105367781|NCT00069264|363352422|FG000|Overall Study|Adverse Event|3|||
105367782|NCT00069264|363352422|FG000|Overall Study|Progressive Disease|23|||
105367783|NCT00069264|363352422|FG000|Overall Study|Withdrawal by Subject|3|||
105367784|NCT00069264|363352422|FG000|Overall Study|Discon Therapy|3|||
105367785|NCT02895347|363352423|FG000|Overall Study|Withdrawal by Subject|3|||
105367786|NCT02895347|363352424|FG001|Overall Study|Withdrawal by Subject|1|||
105367787|NCT01673178|363352425|FG000|Overall Study|Lost to Follow-up|0|||
105367788|NCT01673178|363352426|FG001|Overall Study|Lost to Follow-up|1|||
105367789|NCT01673178|363352427|FG002|Overall Study|Lost to Follow-up|0|||
105367790|NCT01673178|363352428|FG003|Overall Study|Lost to Follow-up|0|||
105367791|NCT01673178|363352429|FG004|Overall Study|Lost to Follow-up|0|||
105367792|NCT01673178|363352425|FG000|Overall Study|Withdrawal by Subject|0|||
105576526|NCT04424290|364110182|FG001|Overall Study|Other than listed|0|||
105840265|NCT00255151|365071537|FG001|Overall Study|Withdrawal by Subject|17|||
105840266|NCT00255151|365071538|FG002|Overall Study|Withdrawal by Subject|8|||
105840267|NCT00255151|365071536|FG000|Overall Study|Noncompliance|0|||
105840268|NCT00255151|365071537|FG001|Overall Study|Noncompliance|1|||
105840269|NCT00255151|365071538|FG002|Overall Study|Noncompliance|2|||
105840270|NCT00255151|365071536|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
105840271|NCT00255151|365071537|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
105840272|NCT00255151|365071538|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
105840273|NCT00255151|365071536|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
105840274|NCT00255151|365071537|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
105840275|NCT00255151|365071538|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
105840276|NCT00255151|365071536|FG000|Overall Study|Possible Barrett's Esophagus|1|||
105840277|NCT00255151|365071537|FG001|Overall Study|Possible Barrett's Esophagus|3|||
105840278|NCT00255151|365071538|FG002|Overall Study|Possible Barrett's Esophagus|8|||
105840279|NCT00255151|365071536|FG000|Overall Study|Esophageal Stricture|0|||
105840280|NCT00255151|365071537|FG001|Overall Study|Esophageal Stricture|0|||
105840281|NCT00255151|365071538|FG002|Overall Study|Esophageal Stricture|1|||
105840282|NCT00255151|365071536|FG000|Overall Study|Therapeutic Failure|11|||
105840283|NCT00255151|365071537|FG001|Overall Study|Therapeutic Failure|2|||
105840284|NCT00255151|365071538|FG002|Overall Study|Therapeutic Failure|3|||
105840285|NCT03438539|365071544|FG000|Overall Study|Lost to Follow-up|8|||
105840286|NCT03438539|365071545|FG001|Overall Study|Lost to Follow-up|4|||
105840287|NCT03438539|365071546|FG002|Overall Study|Lost to Follow-up|10|||
105840288|NCT03438539|365071547|FG003|Overall Study|Lost to Follow-up|9|||
105840289|NCT03438539|365071548|FG004|Overall Study|Lost to Follow-up|3|||
105840290|NCT03438539|365071549|FG005|Overall Study|Lost to Follow-up|8|||
105840291|NCT02065713|365071550|FG000|Overall Study|Adverse Event|0|||
105840292|NCT02065713|365071551|FG001|Overall Study|Adverse Event|1|||
105840293|NCT02065713|365071550|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105840294|NCT02065713|365071551|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105840295|NCT01005329|365071554|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
105840296|NCT00483548|365071555|FG000|Overall Study|Randomized; not treated with study drug|1|||
105840297|NCT00483548|365071556|FG001|Overall Study|Randomized; not treated with study drug|3|||
105840298|NCT00483548|365071555|FG000|Overall Study|Adverse Event|25|||
105840299|NCT00483548|365071556|FG001|Overall Study|Adverse Event|14|||
105840300|NCT00483548|365071555|FG000|Overall Study|Laboratory abnormality|1|||
105367793|NCT01673178|363352426|FG001|Overall Study|Withdrawal by Subject|0|||
105576527|NCT04424290|364110183|FG002|Overall Study|Other than listed|0|||
105576528|NCT04424290|364110184|FG003|Overall Study|Other than listed|1|||
105367794|NCT01673178|363352427|FG002|Overall Study|Withdrawal by Subject|1|||
105367795|NCT01673178|363352428|FG003|Overall Study|Withdrawal by Subject|4|||
105367796|NCT01673178|363352429|FG004|Overall Study|Withdrawal by Subject|2|||
105367797|NCT01673178|363352425|FG000|Overall Study|Protocol Violation|1|||
105576529|NCT04424290|364110185|FG004|Overall Study|Other than listed|0|||
105367798|NCT01673178|363352426|FG001|Overall Study|Protocol Violation|1|||
105840301|NCT00483548|365071556|FG001|Overall Study|Laboratory abnormality|2|||
105840302|NCT00483548|365071555|FG000|Overall Study|Lack of Efficacy|4|||
105367799|NCT01673178|363352427|FG002|Overall Study|Protocol Violation|0|||
105311987|NCT01696279|363139142|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
105311988|NCT01696279|363139143|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
105311989|NCT01696279|363139144|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
105311990|NCT01696279|363139145|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
105311991|NCT01696279|363139142|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
105311992|NCT01696279|363139143|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
105311993|NCT01696279|363139144|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
105311994|NCT01696279|363139145|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
105311995|NCT01696279|363139142|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
105311996|NCT01696279|363139143|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
105311997|NCT01696279|363139144|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
105311998|NCT01696279|363139145|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
105311999|NCT01696279|363139142|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
105312000|NCT01696279|363139143|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
105312001|NCT01696279|363139144|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
105312002|NCT01696279|363139145|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
105312003|NCT01696279|363139142|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
105312004|NCT01696279|363139143|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
105312005|NCT01696279|363139144|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
105312006|NCT01696279|363139145|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
105312007|NCT00396812|363139146|FG000|Overall Study|Physician Decision|1|||
105312008|NCT02730351|363139148|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
105312009|NCT02730351|363139149|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
105312010|NCT02730351|363139148|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
105312011|NCT02730351|363139149|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
105312012|NCT02730351|363139148|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
105312013|NCT02730351|363139149|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
105312014|NCT02730351|363139148|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
105312015|NCT02730351|363139149|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
105312016|NCT02730351|363139148|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
105312017|NCT02730351|363139149|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
105312018|NCT00213135|363140910|FG000|Overall Study|Adverse Event|9|||
105312019|NCT00213135|363140911|FG001|Overall Study|Adverse Event|5|||
105312020|NCT00213135|363140912|FG002|Overall Study|Adverse Event|5|||
105312021|NCT00213135|363140910|FG000|Overall Study|Lost to Follow-up|11|||
105312022|NCT00213135|363140911|FG001|Overall Study|Lost to Follow-up|8|||
105312023|NCT00213135|363140912|FG002|Overall Study|Lost to Follow-up|4|||
105312024|NCT00213135|363140910|FG000|Overall Study|Protocol Violation|4|||
105312025|NCT00213135|363140911|FG001|Overall Study|Protocol Violation|4|||
105312026|NCT00213135|363140912|FG002|Overall Study|Protocol Violation|10|||
105312027|NCT00213135|363140910|FG000|Overall Study|Death|1|||
105312028|NCT00213135|363140911|FG001|Overall Study|Death|1|||
105312029|NCT00213135|363140912|FG002|Overall Study|Death|2|||
105312030|NCT00213135|363140910|FG000|Overall Study|Disease progression|4|||
105312031|NCT00213135|363140911|FG001|Overall Study|Disease progression|5|||
105312032|NCT00213135|363140912|FG002|Overall Study|Disease progression|21|||
105312033|NCT00213135|363140910|FG000|Overall Study|Other|21|||
105312034|NCT00213135|363140911|FG001|Overall Study|Other|12|||
105312035|NCT00213135|363140912|FG002|Overall Study|Other|15|||
105312036|NCT01908907|363140913|FG000|Overall Study|Physician Decision|1|||
105312037|NCT01908907|363140914|FG001|Overall Study|Physician Decision|0|||
105312038|NCT01908907|363140913|FG000|Overall Study|Protocol Violation|1|||
105367800|NCT01673178|363352428|FG003|Overall Study|Protocol Violation|1|||
105367801|NCT01673178|363352429|FG004|Overall Study|Protocol Violation|0|||
105367802|NCT01673178|363352425|FG000|Overall Study|Adverse Event|1|||
105367803|NCT01673178|363352426|FG001|Overall Study|Adverse Event|0|||
105367804|NCT01673178|363352427|FG002|Overall Study|Adverse Event|0|||
105367805|NCT01673178|363352428|FG003|Overall Study|Adverse Event|2|||
105367806|NCT01673178|363352429|FG004|Overall Study|Adverse Event|0|||
105367807|NCT01673178|363352425|FG000|Overall Study|Other|1|||
105367808|NCT01673178|363352426|FG001|Overall Study|Other|0|||
105367809|NCT01673178|363352427|FG002|Overall Study|Other|2|||
105367810|NCT01673178|363352428|FG003|Overall Study|Other|1|||
105367811|NCT01673178|363352429|FG004|Overall Study|Other|0|||
105312039|NCT01908907|363140914|FG001|Overall Study|Protocol Violation|0|||
105312040|NCT00749892|363140915|FG000|Overall Study|Withdrawal by Subject|3|||
105312041|NCT04581369|363140916|FG000|Overall Study|Death|7|||
105312042|NCT04581369|363140917|FG001|Overall Study|Death|6|||
105312043|NCT04581369|363140918|FG002|Overall Study|Death|0|||
105312044|NCT04581369|363140916|FG000|Overall Study|Lost to Follow-up|7|||
105312045|NCT04581369|363140917|FG001|Overall Study|Lost to Follow-up|3|||
105367812|NCT00402727|363352433|FG000|Overall Study|Adverse Event|10|||
105367813|NCT00402727|363352434|FG001|Overall Study|Adverse Event|6|||
105367814|NCT00402727|363352433|FG000|Overall Study|Death|1|||
105367815|NCT00402727|363352434|FG001|Overall Study|Death|0|||
105312046|NCT04581369|363140918|FG002|Overall Study|Lost to Follow-up|0|||
105312047|NCT04581369|363140916|FG000|Overall Study|liver transplant|2|||
105312048|NCT04581369|363140917|FG001|Overall Study|liver transplant|2|||
105312049|NCT04581369|363140918|FG002|Overall Study|liver transplant|0|||
105312050|NCT04581369|363140916|FG000|Overall Study|transitioned to hospice care|0|||
105312051|NCT04581369|363140917|FG001|Overall Study|transitioned to hospice care|5|||
105312052|NCT04581369|363140918|FG002|Overall Study|transitioned to hospice care|0|||
105312053|NCT02473523|363140919|FG000|Overall Study|Death|1|||
105312054|NCT02473523|363140919|FG000|Overall Study|Lost to Follow-up|1|||
105312055|NCT01111825|363140920|FG000|Overall Study|Withdrawal by Subject|0|||
105312056|NCT01111825|363140921|FG001|Overall Study|Withdrawal by Subject|0|||
105312057|NCT01111825|363140922|FG002|Overall Study|Withdrawal by Subject|1|||
105312058|NCT01111825|363140923|FG003|Overall Study|Withdrawal by Subject|0|||
105312059|NCT01111825|363140920|FG000|Overall Study|Lost to Follow-up|0|||
105312060|NCT01111825|363140921|FG001|Overall Study|Lost to Follow-up|0|||
105312061|NCT01111825|363140922|FG002|Overall Study|Lost to Follow-up|3|||
105312062|NCT01111825|363140923|FG003|Overall Study|Lost to Follow-up|1|||
105312063|NCT01111825|363140920|FG000|Overall Study|Adverse Event|2|||
105312064|NCT01111825|363140921|FG001|Overall Study|Adverse Event|1|||
105312065|NCT01111825|363140922|FG002|Overall Study|Adverse Event|4|||
105312066|NCT01111825|363140923|FG003|Overall Study|Adverse Event|0|||
105312067|NCT01111825|363140920|FG000|Overall Study|Disease Progression|1|||
105312068|NCT01111825|363140921|FG001|Overall Study|Disease Progression|0|||
105312069|NCT01111825|363140922|FG002|Overall Study|Disease Progression|0|||
105312070|NCT01111825|363140923|FG003|Overall Study|Disease Progression|0|||
105312071|NCT01111825|363140920|FG000|Overall Study|Discontinuation by Sponsor|0|||
105312072|NCT01111825|363140921|FG001|Overall Study|Discontinuation by Sponsor|0|||
105312073|NCT01111825|363140922|FG002|Overall Study|Discontinuation by Sponsor|0|||
105312074|NCT01111825|363140923|FG003|Overall Study|Discontinuation by Sponsor|20|||
105312075|NCT01191944|363140924|FG000|Overall Study|Adverse Event|11|||
105312076|NCT01191944|363140925|FG001|Overall Study|Adverse Event|12|||
105312077|NCT01191944|363140924|FG000|Overall Study|Protocol Violation|1|||
105312078|NCT01191944|363140925|FG001|Overall Study|Protocol Violation|2|||
105312079|NCT01191944|363140924|FG000|Overall Study|Withdrawal by Subject|4|||
105312080|NCT01191944|363140925|FG001|Overall Study|Withdrawal by Subject|2|||
105312081|NCT01191944|363140924|FG000|Overall Study|Other|1|||
105312082|NCT01191944|363140925|FG001|Overall Study|Other|3|||
105312083|NCT01346293|363140933|FG000|Overall Study|Protocol Violation|30|||
105312084|NCT01346293|363140934|FG001|Overall Study|Protocol Violation|9|||
105312085|NCT01346293|363140933|FG000|Overall Study|Lost to Follow-up|21|||
105312086|NCT01346293|363140934|FG001|Overall Study|Lost to Follow-up|8|||
105312087|NCT01346293|363140933|FG000|Overall Study|Withdrawal by Subject|15|||
105312088|NCT01346293|363140934|FG001|Overall Study|Withdrawal by Subject|4|||
105312089|NCT01346293|363140933|FG000|Overall Study|Other|1|||
105312090|NCT01346293|363140934|FG001|Overall Study|Other|0|||
105312091|NCT02015065|363140937|FG000|Overall Study|Death on study|1|||
105312092|NCT02015065|363140938|FG001|Overall Study|Death on study|2|||
105312093|NCT02015065|363140939|FG002|Overall Study|Death on study|1|||
105312094|NCT04106661|363140974|FG000|Overall Study|Protocol Violation|3|||
105312095|NCT04106661|363140975|FG001|Overall Study|Protocol Violation|0|||
105312096|NCT04106661|363140974|FG000|Overall Study|Scheduling difficulties|1|||
105312097|NCT04106661|363140975|FG001|Overall Study|Scheduling difficulties|1|||
105312098|NCT00233402|363140976|FG000|Overall Study|No pathology data|12|||
105312099|NCT00233402|363140977|FG001|Overall Study|No pathology data|9|||
105312100|NCT00233402|363140976|FG000|Overall Study|No Ta/T1|89|||
105312101|NCT00233402|363140977|FG001|Overall Study|No Ta/T1|94|||
105312102|NCT00233402|363140976|FG000|Overall Study|Lost to follow up etc|3|||
105312103|NCT00233402|363140977|FG001|Overall Study|Lost to follow up etc|21|||
105312104|NCT00895414|363140980|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
105312105|NCT00895414|363140981|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
105312106|NCT00895414|363140980|FG000|First Intervention (14 Days)|Physician Decision|0|||
105312107|NCT00895414|363140981|FG001|First Intervention (14 Days)|Physician Decision|1|||
105367816|NCT00402727|363352433|FG000|Overall Study|Lack of Efficacy|1|||
105367817|NCT00402727|363352434|FG001|Overall Study|Lack of Efficacy|3|||
105367818|NCT00402727|363352433|FG000|Overall Study|Lost to Follow-up|24|||
105312108|NCT00252239|363140982|FG000|Overall Study|Withdrawal by Subject|1|||
105312109|NCT00252239|363140983|FG001|Overall Study|Withdrawal by Subject|0|||
105312110|NCT00252239|363140984|FG002|Overall Study|Withdrawal by Subject|0|||
105367819|NCT00402727|363352434|FG001|Overall Study|Lost to Follow-up|11|||
105312111|NCT00252239|363140985|FG003|Overall Study|Withdrawal by Subject|1|||
105312112|NCT00252239|363140982|FG000|Overall Study|Lost to Follow-up|0|||
105367820|NCT00402727|363352433|FG000|Overall Study|Physician Decision|1|||
105367821|NCT00402727|363352434|FG001|Overall Study|Physician Decision|1|||
105312113|NCT00252239|363140983|FG001|Overall Study|Lost to Follow-up|0|||
105312114|NCT00252239|363140984|FG002|Overall Study|Lost to Follow-up|2|||
105312115|NCT00252239|363140985|FG003|Overall Study|Lost to Follow-up|0|||
105312116|NCT02257385|363140990|FG000|Overall Study|Adverse Event|12|||
105312117|NCT02257385|363140991|FG001|Overall Study|Adverse Event|8|||
105367822|NCT00402727|363352433|FG000|Overall Study|Protocol Violation|0|||
105312118|NCT02257385|363140990|FG000|Overall Study|Lack of Efficacy|1|||
105312119|NCT02257385|363140991|FG001|Overall Study|Lack of Efficacy|2|||
105840303|NCT00483548|365071556|FG001|Overall Study|Lack of Efficacy|8|||
105312120|NCT02257385|363140990|FG000|Overall Study|Protocol Violation|5|||
105312121|NCT02257385|363140991|FG001|Overall Study|Protocol Violation|7|||
105312122|NCT02257385|363140990|FG000|Overall Study|Lost to Follow-up|0|||
105312123|NCT02257385|363140991|FG001|Overall Study|Lost to Follow-up|1|||
105312124|NCT02257385|363140990|FG000|Overall Study|Withdrawal by Subject|4|||
105312125|NCT02257385|363140991|FG001|Overall Study|Withdrawal by Subject|4|||
105312126|NCT02087189|363140992|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
105312127|NCT00789737|363140997|FG000|Overall Study|Withdrawal by Subject|13|||
105312128|NCT00789737|363140998|FG001|Overall Study|Withdrawal by Subject|22|||
105312129|NCT00789737|363140997|FG000|Overall Study|Lost to Follow-up|10|||
105312130|NCT00789737|363140998|FG001|Overall Study|Lost to Follow-up|14|||
105312131|NCT00789737|363140997|FG000|Overall Study|Adverse Event|8|||
105312132|NCT00789737|363140998|FG001|Overall Study|Adverse Event|8|||
105367823|NCT00402727|363352434|FG001|Overall Study|Protocol Violation|4|||
105367824|NCT00402727|363352433|FG000|Overall Study|Withdrawal by Subject|3|||
105367825|NCT00402727|363352434|FG001|Overall Study|Withdrawal by Subject|7|||
105367826|NCT00402727|363352433|FG000|Overall Study|supply problems|2|||
105367827|NCT00402727|363352434|FG001|Overall Study|supply problems|1|||
105367828|NCT00402727|363352433|FG000|Overall Study|non-compliance|0|||
105367829|NCT00402727|363352434|FG001|Overall Study|non-compliance|1|||
105367830|NCT04794751|363352437|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
105367831|NCT04794751|363352438|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
105367832|NCT04794751|363352437|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
105367833|NCT04794751|363352438|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
105367834|NCT04794751|363352437|FG000|Period 1|Protocol Violation|0|||
105367835|NCT04794751|363352438|FG001|Period 1|Protocol Violation|2|||
105367836|NCT04794751|363352437|FG000|Period 1|Withdrawal by Subject|0|||
105367837|NCT04794751|363352438|FG001|Period 1|Withdrawal by Subject|1|||
105367838|NCT04794751|363352437|FG000|Period 2|Withdrawal by Subject|0|||
105367839|NCT04794751|363352438|FG001|Period 2|Withdrawal by Subject|1|||
105367840|NCT04794751|363352437|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
105367841|NCT04794751|363352438|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
105367842|NCT04794751|363352437|FG000|Period 2|Protocol Violation|1|||
105367843|NCT04794751|363352438|FG001|Period 2|Protocol Violation|0|||
105367844|NCT00887484|363352442|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
105367845|NCT00887484|363352442|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
105367846|NCT00887484|363352442|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
105367847|NCT02357459|363354072|FG000|Overall Study|Adverse Event|0|||
105367848|NCT02357459|363354073|FG001|Overall Study|Adverse Event|1|||
105367849|NCT02357459|363354074|FG002|Overall Study|Adverse Event|1|||
105367850|NCT02357459|363354072|FG000|Overall Study|Withdrawal by Subject|5|||
105367851|NCT02357459|363354073|FG001|Overall Study|Withdrawal by Subject|3|||
105367852|NCT02357459|363354074|FG002|Overall Study|Withdrawal by Subject|3|||
105367853|NCT02357459|363354072|FG000|Overall Study|Physician Decision|0|||
105367854|NCT02357459|363354073|FG001|Overall Study|Physician Decision|2|||
105367855|NCT02357459|363354074|FG002|Overall Study|Physician Decision|0|||
105367856|NCT02357459|363354072|FG000|Overall Study|Protocol Violation|1|||
105367857|NCT02357459|363354073|FG001|Overall Study|Protocol Violation|1|||
105367858|NCT02357459|363354074|FG002|Overall Study|Protocol Violation|0|||
105367859|NCT02357459|363354072|FG000|Overall Study|Lost to Follow-up|1|||
105367860|NCT02357459|363354073|FG001|Overall Study|Lost to Follow-up|3|||
105367861|NCT02357459|363354074|FG002|Overall Study|Lost to Follow-up|0|||
105367862|NCT02357459|363354072|FG000|Overall Study|Lack of Efficacy|7|||
105367863|NCT02357459|363354073|FG001|Overall Study|Lack of Efficacy|4|||
105367864|NCT02357459|363354074|FG002|Overall Study|Lack of Efficacy|4|||
105367865|NCT02357459|363354072|FG000|Overall Study|Patient Relocated|2|||
105367866|NCT02357459|363354073|FG001|Overall Study|Patient Relocated|0|||
105489939|NCT01505647|363805704|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
105489940|NCT01505647|363805703|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
105489941|NCT01505647|363805704|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
105489942|NCT01505647|363805703|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
105367867|NCT02357459|363354074|FG002|Overall Study|Patient Relocated|0|||
105489943|NCT01505647|363805704|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
105489944|NCT01907100|363805705|FG000|Overall Study|PD based on modified RECIST criteria|31|||
105840304|NCT00483548|365071555|FG000|Overall Study|Protocol Violation|11|||
105367868|NCT02357459|363354072|FG000|Overall Study|Instruction from PCP|1|||
105367869|NCT02357459|363354073|FG001|Overall Study|Instruction from PCP|0|||
105367870|NCT02357459|363354074|FG002|Overall Study|Instruction from PCP|0|||
105367871|NCT02357459|363354072|FG000|Overall Study|Incarceration|0|||
105367872|NCT02357459|363354073|FG001|Overall Study|Incarceration|0|||
105367873|NCT02357459|363354074|FG002|Overall Study|Incarceration|1|||
105367874|NCT02357459|363354072|FG000|Overall Study|Pre-planned Knee surgery|0|||
105312133|NCT00789737|363140997|FG000|Overall Study|Protocol Violation|3|||
105367875|NCT02357459|363354073|FG001|Overall Study|Pre-planned Knee surgery|0|||
105840305|NCT00483548|365071556|FG001|Overall Study|Protocol Violation|7|||
105840306|NCT00483548|365071555|FG000|Overall Study|Pregnancy|1|||
105840307|NCT00483548|365071556|FG001|Overall Study|Pregnancy|0|||
105840308|NCT00483548|365071555|FG000|Overall Study|Protocol required discontinuation|6|||
105840309|NCT00483548|365071556|FG001|Overall Study|Protocol required discontinuation|6|||
105840310|NCT00483548|365071555|FG000|Overall Study|Unable to comply with protocol schedule|1|||
105840311|NCT00483548|365071556|FG001|Overall Study|Unable to comply with protocol schedule|0|||
105840312|NCT00483548|365071555|FG000|Overall Study|Non-compliance with medication|2|||
105840313|NCT00483548|365071556|FG001|Overall Study|Non-compliance with medication|0|||
105840314|NCT00483548|365071555|FG000|Overall Study|Lost to Follow-up|3|||
105840315|NCT00483548|365071556|FG001|Overall Study|Lost to Follow-up|4|||
105840316|NCT00483548|365071555|FG000|Overall Study|Withdrawal by Subject|5|||
105840317|NCT00483548|365071556|FG001|Overall Study|Withdrawal by Subject|2|||
105840318|NCT00892281|365071561|FG000|Overall Study|Adverse Event|65|||
105840319|NCT00892281|365071562|FG001|Overall Study|Adverse Event|8|||
105840320|NCT00892281|365071561|FG000|Overall Study|Lost to Follow-up|81|||
105840321|NCT00892281|365071562|FG001|Overall Study|Lost to Follow-up|8|||
105840322|NCT00892281|365071561|FG000|Overall Study|Pregnancy|1|||
105840323|NCT00892281|365071562|FG001|Overall Study|Pregnancy|0|||
105840324|NCT00892281|365071561|FG000|Overall Study|Protocol Violation|7|||
105840325|NCT00892281|365071562|FG001|Overall Study|Protocol Violation|2|||
105840326|NCT00892281|365071561|FG000|Overall Study|Withdrawal by Subject|86|||
105840327|NCT00892281|365071562|FG001|Overall Study|Withdrawal by Subject|14|||
105840328|NCT00892281|365071561|FG000|Overall Study|Subject failed to return for final visit|2|||
105840329|NCT00892281|365071562|FG001|Overall Study|Subject failed to return for final visit|0|||
105840330|NCT00892281|365071561|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
105840331|NCT00892281|365071562|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
105840332|NCT00892281|365071561|FG000|Overall Study|Final visit completed 4 weeks late|0|||
105840333|NCT00892281|365071562|FG001|Overall Study|Final visit completed 4 weeks late|1|||
105840334|NCT00892281|365071561|FG000|Overall Study|Subject completed day after study closed|1|||
105840335|NCT00892281|365071562|FG001|Overall Study|Subject completed day after study closed|0|||
105840336|NCT00892281|365071561|FG000|Overall Study|Family emergency|1|||
105840337|NCT00892281|365071562|FG001|Overall Study|Family emergency|0|||
105840338|NCT00892281|365071561|FG000|Overall Study|Last visit not done - death in family|1|||
105840339|NCT00892281|365071562|FG001|Overall Study|Last visit not done - death in family|0|||
105840340|NCT00892281|365071561|FG000|Overall Study|Did not meet incl/excl criteria|1|||
105840341|NCT00892281|365071562|FG001|Overall Study|Did not meet incl/excl criteria|0|||
105840342|NCT00892281|365071561|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
105840343|NCT00892281|365071562|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
105840344|NCT00892281|365071561|FG000|Overall Study|Unable to redeem the drug voucher|1|||
105840345|NCT00892281|365071562|FG001|Overall Study|Unable to redeem the drug voucher|0|||
105840346|NCT00892281|365071561|FG000|Overall Study|Subject not good candidate for study|1|||
105840347|NCT00892281|365071562|FG001|Overall Study|Subject not good candidate for study|0|||
105840348|NCT00892281|365071561|FG000|Overall Study|Subject did not return for any visits|1|||
105840349|NCT00892281|365071562|FG001|Overall Study|Subject did not return for any visits|0|||
105840350|NCT00892281|365071561|FG000|Overall Study|Subject missed several visits/lost meds|1|||
105840351|NCT00892281|365071562|FG001|Overall Study|Subject missed several visits/lost meds|0|||
105840352|NCT00892281|365071561|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
105840353|NCT00892281|365071562|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
105840354|NCT00892281|365071561|FG000|Overall Study|Scheduled for knee replacement|0|||
105840355|NCT00892281|365071562|FG001|Overall Study|Scheduled for knee replacement|1|||
105840356|NCT00892281|365071561|FG000|Overall Study|PI complained of inadequate compensation|3|||
105840357|NCT00892281|365071562|FG001|Overall Study|PI complained of inadequate compensation|0|||
105840358|NCT00892281|365071561|FG000|Overall Study|Subject lost interest in program|0|||
105840359|NCT00892281|365071562|FG001|Overall Study|Subject lost interest in program|1|||
105840360|NCT00892281|365071561|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
105840361|NCT00892281|365071562|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
105840362|NCT00892281|365071561|FG000|Overall Study|Death in family|1|||
105840363|NCT00892281|365071562|FG001|Overall Study|Death in family|0|||
105840364|NCT00892281|365071561|FG000|Overall Study|Lack of efficacy of study product|2|||
105840365|NCT00892281|365071562|FG001|Overall Study|Lack of efficacy of study product|0|||
105840366|NCT00892281|365071561|FG000|Overall Study|Subject not seen by PI at final visit|1|||
105840367|NCT00892281|365071562|FG001|Overall Study|Subject not seen by PI at final visit|0|||
105312134|NCT00789737|363140998|FG001|Overall Study|Protocol Violation|0|||
105312135|NCT00789737|363140997|FG000|Overall Study|Lack of Efficacy|3|||
105840368|NCT00892281|365071561|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
105840369|NCT00892281|365071562|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
105840370|NCT00892281|365071561|FG000|Overall Study|Missed multiple visits|1|||
105840371|NCT00892281|365071562|FG001|Overall Study|Missed multiple visits|0|||
105840372|NCT00892281|365071561|FG000|Overall Study|Missed visits rescheduled out of window|1|||
105312136|NCT00789737|363140998|FG001|Overall Study|Lack of Efficacy|0|||
105840373|NCT00892281|365071562|FG001|Overall Study|Missed visits rescheduled out of window|0|||
105840374|NCT00892281|365071561|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
105840375|NCT00892281|365071562|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
105840376|NCT00892281|365071561|FG000|Overall Study|Subject had history of drug abuse|1|||
105840377|NCT00892281|365071562|FG001|Overall Study|Subject had history of drug abuse|0|||
105840378|NCT00892281|365071561|FG000|Overall Study|Rash on hand|1|||
105840379|NCT00892281|365071562|FG001|Overall Study|Rash on hand|0|||
105840380|NCT00892281|365071561|FG000|Overall Study|Visit 4 date out of window|1|||
105840381|NCT00892281|365071562|FG001|Overall Study|Visit 4 date out of window|0|||
105840382|NCT02694549|365071563|FG000|Overall Study|screen failures|2|||
105840383|NCT01534078|365071566|FG000|Overall Study|Death|1|||
105840384|NCT01534078|365071566|FG000|Overall Study|Withdrawal by Subject|1|||
105840385|NCT00089076|365071577|FG000|Overall Study|Alternate Therapy|1|||
105840386|NCT00089076|365071577|FG000|Overall Study|Withdrawal by Subject|2|||
105840387|NCT00089076|365071577|FG000|Overall Study|Progression|7|||
105840388|NCT01501110|365071580|FG000|Overall Study|Death|0|||
105840389|NCT01501110|365071581|FG001|Overall Study|Death|1|||
105840390|NCT02462486|365071582|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
105840391|NCT02462486|365071583|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
105840392|NCT02462486|365071584|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
105840393|NCT02462486|365071582|FG000|Overall Study|Adverse Event|53|||
105840394|NCT02462486|365071583|FG001|Overall Study|Adverse Event|48|||
105840395|NCT02462486|365071584|FG002|Overall Study|Adverse Event|21|||
105840396|NCT02462486|365071582|FG000|Overall Study|Lack of Efficacy|6|||
105840397|NCT02462486|365071583|FG001|Overall Study|Lack of Efficacy|12|||
105840398|NCT02462486|365071584|FG002|Overall Study|Lack of Efficacy|3|||
105840399|NCT02462486|365071582|FG000|Overall Study|Lost to Follow-up|3|||
105840400|NCT02462486|365071583|FG001|Overall Study|Lost to Follow-up|4|||
105840401|NCT02462486|365071584|FG002|Overall Study|Lost to Follow-up|2|||
105840402|NCT02462486|365071582|FG000|Overall Study|Withdrawal by Subject|25|||
105840403|NCT02462486|365071583|FG001|Overall Study|Withdrawal by Subject|22|||
105840404|NCT02462486|365071584|FG002|Overall Study|Withdrawal by Subject|19|||
105840405|NCT02462486|365071582|FG000|Overall Study|Protocol Violation|3|||
105840406|NCT02462486|365071583|FG001|Overall Study|Protocol Violation|1|||
105840407|NCT02462486|365071584|FG002|Overall Study|Protocol Violation|1|||
105840408|NCT02462486|365071582|FG000|Overall Study|Reason not Specified|3|||
105840409|NCT02462486|365071583|FG001|Overall Study|Reason not Specified|4|||
105840410|NCT02462486|365071584|FG002|Overall Study|Reason not Specified|3|||
105840411|NCT01483625|365071585|FG000|Overall Study|Adverse Event|1|||
105840412|NCT01483625|365071586|FG001|Overall Study|Adverse Event|1|||
105840413|NCT01483625|365071585|FG000|Overall Study|Refused to continue medication|2|||
105840414|NCT01483625|365071586|FG001|Overall Study|Refused to continue medication|1|||
105840415|NCT01483625|365071585|FG000|Overall Study|Due to other reason|1|||
105840416|NCT01483625|365071586|FG001|Overall Study|Due to other reason|0|||
105840417|NCT02280187|365071587|FG000|Overall Study|Lost to Follow-up|218|||
105840418|NCT02094261|365071588|FG000|Overall Study|Death|24|||
105840419|NCT02094261|365071588|FG000|Overall Study|Lost to Follow-up|1|||
105840420|NCT02094261|365071588|FG000|Overall Study|Withdrawal by Subject|4|||
105840421|NCT02094261|365071588|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
105840422|NCT00251316|365071591|FG000|Overall Study|Physician Decision|2|||
105840423|NCT00251316|365071592|FG001|Overall Study|Physician Decision|3|||
105840424|NCT02039063|365071594|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
105840425|NCT02039063|365071595|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
105840426|NCT02039063|365071596|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
105840427|NCT02039063|365071597|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
105840428|NCT02039063|365071594|FG000|Treatment Phase|Progression of disease|0|||
105840429|NCT02039063|365071595|FG001|Treatment Phase|Progression of disease|0|||
105840430|NCT02039063|365071596|FG002|Treatment Phase|Progression of disease|1|||
105840431|NCT02039063|365071597|FG003|Treatment Phase|Progression of disease|1|||
105367876|NCT02357459|363354074|FG002|Overall Study|Pre-planned Knee surgery|2|||
105367877|NCT02357459|363354072|FG000|Overall Study|Job Commitments|0|||
105367878|NCT02357459|363354073|FG001|Overall Study|Job Commitments|0|||
105367879|NCT02357459|363354074|FG002|Overall Study|Job Commitments|1|||
105367880|NCT02188160|363354075|FG000|Overall Study|Adverse Event|1|||
105840432|NCT02039063|365071594|FG000|Extension Phase|Inadequate therapeutic effect|0|||
105840433|NCT02039063|365071595|FG001|Extension Phase|Inadequate therapeutic effect|1|||
105840434|NCT02039063|365071596|FG002|Extension Phase|Inadequate therapeutic effect|2|||
105840435|NCT02039063|365071597|FG003|Extension Phase|Inadequate therapeutic effect|0|||
105840436|NCT02039063|365071594|FG000|Extension Phase|Progression of disease|0|||
105840437|NCT02039063|365071595|FG001|Extension Phase|Progression of disease|0|||
105840438|NCT02039063|365071596|FG002|Extension Phase|Progression of disease|0|||
105840439|NCT02039063|365071597|FG003|Extension Phase|Progression of disease|1|||
105840440|NCT02039063|365071594|FG000|Extension Phase|Adverse Event|0|||
105367881|NCT02188160|363354076|FG001|Overall Study|Adverse Event|0|||
105840441|NCT02039063|365071595|FG001|Extension Phase|Adverse Event|0|||
105840442|NCT02039063|365071596|FG002|Extension Phase|Adverse Event|1|||
105312137|NCT00789737|363140997|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
105312138|NCT00789737|363140998|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
105312139|NCT00789737|363140997|FG000|Overall Study|Other|11|||
105312140|NCT00789737|363140998|FG001|Overall Study|Other|7|||
105312141|NCT01189487|363141005|FG000|Overall Study|Lack of Efficacy|2|||
105312142|NCT01189487|363141005|FG000|Overall Study|Adverse Event|1|||
105312143|NCT00587990|363141006|FG000|Overall Study|Death|0|||
105312144|NCT00587990|363141007|FG001|Overall Study|Death|0|||
105840443|NCT02039063|365071597|FG003|Extension Phase|Adverse Event|0|||
105840444|NCT00467831|365071598|FG000|Overall Study|Death|2|||
105840445|NCT00467831|365071598|FG000|Overall Study|Withdrawal by Subject|1|||
105840446|NCT00612677|365071599|FG000|Overall Study|study closed before treatment started|1|||
105840447|NCT03139240|365071600|FG000|Overall Study|Lost to Follow-up|0|||
105840448|NCT03139240|365071601|FG001|Overall Study|Lost to Follow-up|1|||
105840449|NCT03139240|365071602|FG002|Overall Study|Lost to Follow-up|1|||
105840450|NCT03139240|365071603|FG003|Overall Study|Lost to Follow-up|0|||
105840451|NCT03417830|365071605|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
105840452|NCT03417830|365071606|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
105840453|NCT00823199|365071607|FG000|Overall Study|Withdrawal by Subject|2|||
105840454|NCT01825837|365071608|FG000|PART I|Withdrawal by Subject|0|||
105840455|NCT01825837|365071609|FG001|PART I|Withdrawal by Subject|0|||
105840456|NCT01825837|365071610|FG002|PART I|Withdrawal by Subject|0|||
105840457|NCT01825837|365071611|FG003|PART I|Withdrawal by Subject|6|||
105840458|NCT01825837|365071608|FG000|PART I|Patient non-compliance|0|||
105840459|NCT01825837|365071609|FG001|PART I|Patient non-compliance|0|||
105840460|NCT01825837|365071610|FG002|PART I|Patient non-compliance|0|||
105840461|NCT01825837|365071611|FG003|PART I|Patient non-compliance|1|||
105840462|NCT01825837|365071608|FG000|PART I|Treatment failure|0|||
105840463|NCT01825837|365071609|FG001|PART I|Treatment failure|0|||
105840464|NCT01825837|365071610|FG002|PART I|Treatment failure|0|||
105840465|NCT01825837|365071611|FG003|PART I|Treatment failure|7|||
105840466|NCT01825837|365071608|FG000|PART I|reason unspecified|0|||
105840467|NCT01825837|365071609|FG001|PART I|reason unspecified|0|||
105840468|NCT01825837|365071610|FG002|PART I|reason unspecified|0|||
105840469|NCT01825837|365071611|FG003|PART I|reason unspecified|3|||
105840470|NCT01825837|365071608|FG000|PART II|Withdrawal by Subject|3|||
105840471|NCT01825837|365071609|FG001|PART II|Withdrawal by Subject|3|||
105840472|NCT01825837|365071610|FG002|PART II|Withdrawal by Subject|7|||
105840473|NCT01825837|365071611|FG003|PART II|Withdrawal by Subject|0|||
105840474|NCT01825837|365071608|FG000|PART II|Patient non-compliance|5|||
105840475|NCT01825837|365071609|FG001|PART II|Patient non-compliance|2|||
105840476|NCT01825837|365071610|FG002|PART II|Patient non-compliance|4|||
105840477|NCT01825837|365071611|FG003|PART II|Patient non-compliance|0|||
105840478|NCT01825837|365071608|FG000|PART II|Adverse Event|3|||
105840479|NCT01825837|365071609|FG001|PART II|Adverse Event|3|||
105840480|NCT01825837|365071610|FG002|PART II|Adverse Event|1|||
105840481|NCT01825837|365071611|FG003|PART II|Adverse Event|0|||
105840482|NCT01825837|365071608|FG000|PART II|Treatment failure|6|||
105840483|NCT01825837|365071609|FG001|PART II|Treatment failure|4|||
105840484|NCT01825837|365071610|FG002|PART II|Treatment failure|5|||
105840485|NCT01825837|365071611|FG003|PART II|Treatment failure|0|||
105840486|NCT01825837|365071608|FG000|PART II|reason unspecified|2|||
105840487|NCT01825837|365071609|FG001|PART II|reason unspecified|2|||
105840488|NCT01825837|365071610|FG002|PART II|reason unspecified|2|||
105840489|NCT01825837|365071611|FG003|PART II|reason unspecified|0|||
105840490|NCT00645944|365071614|FG000|Randomized|Withdrawal by Subject|1|||
105840491|NCT00645944|365071615|FG001|Randomized|Withdrawal by Subject|2|||
105840492|NCT00645944|365071614|FG000|Received Medication|Adverse Event|2|||
105840493|NCT00645944|365071615|FG001|Received Medication|Adverse Event|1|||
105840494|NCT00645944|365071614|FG000|Received Medication|Withdrawal by Subject|1|||
105840495|NCT00645944|365071615|FG001|Received Medication|Withdrawal by Subject|1|||
105312145|NCT00587990|363141008|FG002|Overall Study|Death|1|||
105840496|NCT00645944|365071614|FG000|Received Medication|Lost to Follow-up|1|||
105840497|NCT00645944|365071615|FG001|Received Medication|Lost to Follow-up|0|||
105840498|NCT00645944|365071614|FG000|Received Medication|Protocol Violation|2|||
105840499|NCT00645944|365071615|FG001|Received Medication|Protocol Violation|1|||
105840500|NCT04117945|365071618|FG000|Overall Study|Death|1|||
105840501|NCT04117945|365071619|FG001|Overall Study|Death|0|||
105840502|NCT04117945|365071618|FG000|Overall Study|Withdrawal by Subject|3|||
105840503|NCT04117945|365071619|FG001|Overall Study|Withdrawal by Subject|1|||
105840504|NCT04117945|365071618|FG000|Overall Study|Disease Progression|0|||
105312146|NCT04630158|363141009|FG000|Overall Study|Adverse Event|1|||
105312147|NCT04630158|363141010|FG001|Overall Study|Adverse Event|1|||
105840505|NCT04117945|365071619|FG001|Overall Study|Disease Progression|2|||
105840506|NCT04117945|365071618|FG000|Overall Study|Ineligible|8|||
105840507|NCT04117945|365071619|FG001|Overall Study|Ineligible|7|||
105840508|NCT02093923|365071620|FG000|Overall Study|Lost to Follow-up|0|||
105840509|NCT02093923|365071621|FG001|Overall Study|Lost to Follow-up|0|||
105840510|NCT02093923|365071622|FG002|Overall Study|Lost to Follow-up|0|||
105840511|NCT02093923|365071623|FG003|Overall Study|Lost to Follow-up|1|||
105840512|NCT02093923|365071624|FG004|Overall Study|Lost to Follow-up|0|||
105840513|NCT02093923|365071620|FG000|Overall Study|Screen failure after randomization|0|||
105840514|NCT02093923|365071621|FG001|Overall Study|Screen failure after randomization|0|||
105840515|NCT02093923|365071622|FG002|Overall Study|Screen failure after randomization|0|||
105840516|NCT02093923|365071623|FG003|Overall Study|Screen failure after randomization|1|||
105840517|NCT02093923|365071624|FG004|Overall Study|Screen failure after randomization|0|||
105840518|NCT01662362|365071625|FG000|Overall Study|Lost to Follow-up|38|||
105840519|NCT01181531|365071626|FG000|Overall Study|Other|17|||
105840520|NCT01181531|365071627|FG001|Overall Study|Other|12|||
105840521|NCT01181531|365071626|FG000|Overall Study|Partial consent by subject withdrawn|0|||
105840522|NCT01181531|365071627|FG001|Overall Study|Partial consent by subject withdrawn|1|||
105840523|NCT01181531|365071626|FG000|Overall Study|Physician Decision|3|||
105840524|NCT01181531|365071627|FG001|Overall Study|Physician Decision|1|||
105840525|NCT01181531|365071626|FG000|Overall Study|Noncompliance|2|||
105840526|NCT01181531|365071627|FG001|Overall Study|Noncompliance|2|||
105840527|NCT01181531|365071626|FG000|Overall Study|Ineligibility determined|1|||
105840528|NCT01181531|365071627|FG001|Overall Study|Ineligibility determined|2|||
105840529|NCT01181531|365071626|FG000|Overall Study|Protocol Specified Criteria|15|||
105840530|NCT01181531|365071627|FG001|Overall Study|Protocol Specified Criteria|8|||
105840531|NCT01181531|365071626|FG000|Overall Study|Pregnancy|0|||
105840532|NCT01181531|365071627|FG001|Overall Study|Pregnancy|1|||
105840533|NCT01181531|365071626|FG000|Overall Study|Withdrawal by Subject|8|||
105840534|NCT01181531|365071627|FG001|Overall Study|Withdrawal by Subject|7|||
105840535|NCT01181531|365071626|FG000|Overall Study|Protocol Violation|6|||
105840536|NCT01181531|365071627|FG001|Overall Study|Protocol Violation|6|||
105840537|NCT01181531|365071626|FG000|Overall Study|Death|9|||
105840538|NCT01181531|365071627|FG001|Overall Study|Death|12|||
105840539|NCT01181531|365071626|FG000|Overall Study|Adverse Event|0|||
105840540|NCT01181531|365071627|FG001|Overall Study|Adverse Event|1|||
105840541|NCT02756637|365071630|FG000|Overall Study|Not eligible for initial SWOG study|10|||
105840542|NCT02756637|365071631|FG001|Overall Study|Not eligible for initial SWOG study|10|||
105840543|NCT02756637|365071630|FG000|Overall Study|No available NLR value|44|||
105840544|NCT02756637|365071631|FG001|Overall Study|No available NLR value|44|||
105840545|NCT02756637|365071630|FG000|Overall Study|Did not complete curative therapy|33|||
105840546|NCT02756637|365071631|FG001|Overall Study|Did not complete curative therapy|0|||
105840547|NCT01220609|365073683|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
105840548|NCT01220609|365073683|FG000|Overall Study|Ineligible- Wrong cell type|1|||
105840549|NCT01220609|365073683|FG000|Overall Study|Ineligible-Never treated|1|||
105840550|NCT02225665|365073686|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
105840551|NCT02225665|365073687|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
105840552|NCT02225665|365073686|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
105840553|NCT02225665|365073687|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
105840554|NCT02973321|365073688|FG000|Overall Study|Other than specified|0|||
105840555|NCT02973321|365073689|FG001|Overall Study|Other than specified|5|||
105840556|NCT02973321|365073690|FG002|Overall Study|Other than specified|3|||
105840557|NCT02973321|365073691|FG003|Overall Study|Other than specified|3|||
105840558|NCT02973321|365073692|FG004|Overall Study|Other than specified|1|||
105840559|NCT02973321|365073688|FG000|Overall Study|Lack of Efficacy|0|||
105840560|NCT02973321|365073689|FG001|Overall Study|Lack of Efficacy|0|||
105840561|NCT02973321|365073690|FG002|Overall Study|Lack of Efficacy|0|||
105840562|NCT02973321|365073691|FG003|Overall Study|Lack of Efficacy|0|||
105840563|NCT02973321|365073692|FG004|Overall Study|Lack of Efficacy|1|||
105840564|NCT02973321|365073688|FG000|Overall Study|Adverse Event|1|||
105840565|NCT02973321|365073689|FG001|Overall Study|Adverse Event|10|||
105840566|NCT02973321|365073690|FG002|Overall Study|Adverse Event|11|||
105840567|NCT02973321|365073691|FG003|Overall Study|Adverse Event|13|||
105840568|NCT02973321|365073692|FG004|Overall Study|Adverse Event|3|||
105840569|NCT01714739|365073694|FG000|Overall Study|Disease progression|3|||
105840570|NCT01714739|365073695|FG001|Overall Study|Disease progression|5|||
105840571|NCT01714739|365073696|FG002|Overall Study|Disease progression|5|||
105840572|NCT01714739|365073697|FG003|Overall Study|Disease progression|204|||
105840573|NCT01714739|365073698|FG004|Overall Study|Disease progression|1|||
105840574|NCT01714739|365073699|FG005|Overall Study|Disease progression|3|||
105840575|NCT01714739|365073700|FG006|Overall Study|Disease progression|5|||
105840576|NCT01714739|365073694|FG000|Overall Study|Study drug toxicity|1|||
105312148|NCT04630158|363141011|FG002|Overall Study|Adverse Event|1|||
105312149|NCT04630158|363141009|FG000|Overall Study|Physician Decision|0|||
105312150|NCT04630158|363141010|FG001|Overall Study|Physician Decision|2|||
105312151|NCT04630158|363141011|FG002|Overall Study|Physician Decision|0|||
105840577|NCT01714739|365073695|FG001|Overall Study|Study drug toxicity|1|||
105840578|NCT01714739|365073696|FG002|Overall Study|Study drug toxicity|1|||
105840579|NCT01714739|365073697|FG003|Overall Study|Study drug toxicity|15|||
105312152|NCT04630158|363141009|FG000|Overall Study|Protocol Violation|1|||
105312153|NCT04630158|363141010|FG001|Overall Study|Protocol Violation|0|||
105840580|NCT01714739|365073698|FG004|Overall Study|Study drug toxicity|0|||
105840581|NCT01714739|365073699|FG005|Overall Study|Study drug toxicity|0|||
105840582|NCT01714739|365073700|FG006|Overall Study|Study drug toxicity|5|||
105840583|NCT01714739|365073694|FG000|Overall Study|Death|0|||
105840584|NCT01714739|365073695|FG001|Overall Study|Death|0|||
105840585|NCT01714739|365073696|FG002|Overall Study|Death|0|||
105312154|NCT04630158|363141011|FG002|Overall Study|Protocol Violation|1|||
105312155|NCT04630158|363141009|FG000|Overall Study|Withdrawal by Subject|2|||
105312156|NCT04630158|363141010|FG001|Overall Study|Withdrawal by Subject|1|||
105312157|NCT04630158|363141011|FG002|Overall Study|Withdrawal by Subject|2|||
105312158|NCT02754856|363141012|FG000|Overall Study|Withdrawal by Subject|1|||
105312159|NCT04868968|363141017|FG000|Overall Study|Lost to Follow-up|1|||
105840586|NCT01714739|365073697|FG003|Overall Study|Death|1|||
105840587|NCT01714739|365073698|FG004|Overall Study|Death|0|||
105840588|NCT01714739|365073699|FG005|Overall Study|Death|0|||
105840589|NCT01714739|365073700|FG006|Overall Study|Death|0|||
105840590|NCT01714739|365073694|FG000|Overall Study|Adverse Event unrelated to drug|0|||
105840591|NCT01714739|365073695|FG001|Overall Study|Adverse Event unrelated to drug|0|||
105840592|NCT01714739|365073696|FG002|Overall Study|Adverse Event unrelated to drug|3|||
105840593|NCT01714739|365073697|FG003|Overall Study|Adverse Event unrelated to drug|21|||
105840594|NCT01714739|365073698|FG004|Overall Study|Adverse Event unrelated to drug|0|||
105840595|NCT01714739|365073699|FG005|Overall Study|Adverse Event unrelated to drug|0|||
105840596|NCT01714739|365073700|FG006|Overall Study|Adverse Event unrelated to drug|0|||
105840597|NCT01714739|365073694|FG000|Overall Study|Participant request to stop therapy|0|||
105840598|NCT01714739|365073695|FG001|Overall Study|Participant request to stop therapy|1|||
105840599|NCT01714739|365073696|FG002|Overall Study|Participant request to stop therapy|0|||
105840600|NCT01714739|365073697|FG003|Overall Study|Participant request to stop therapy|6|||
105840601|NCT01714739|365073698|FG004|Overall Study|Participant request to stop therapy|0|||
105840602|NCT01714739|365073699|FG005|Overall Study|Participant request to stop therapy|0|||
105840603|NCT01714739|365073700|FG006|Overall Study|Participant request to stop therapy|0|||
105840604|NCT01714739|365073694|FG000|Overall Study|Participant withdrew consent|0|||
105840605|NCT01714739|365073695|FG001|Overall Study|Participant withdrew consent|1|||
105840606|NCT01714739|365073696|FG002|Overall Study|Participant withdrew consent|0|||
105840607|NCT01714739|365073697|FG003|Overall Study|Participant withdrew consent|8|||
105840608|NCT01714739|365073698|FG004|Overall Study|Participant withdrew consent|0|||
105840609|NCT01714739|365073699|FG005|Overall Study|Participant withdrew consent|0|||
105840610|NCT01714739|365073700|FG006|Overall Study|Participant withdrew consent|0|||
105840611|NCT01714739|365073694|FG000|Overall Study|Lost to Follow-up|0|||
105840612|NCT01714739|365073695|FG001|Overall Study|Lost to Follow-up|0|||
105840613|NCT01714739|365073696|FG002|Overall Study|Lost to Follow-up|0|||
105840614|NCT01714739|365073697|FG003|Overall Study|Lost to Follow-up|1|||
105840615|NCT01714739|365073698|FG004|Overall Study|Lost to Follow-up|0|||
105840616|NCT01714739|365073699|FG005|Overall Study|Lost to Follow-up|0|||
105840617|NCT01714739|365073700|FG006|Overall Study|Lost to Follow-up|0|||
105840618|NCT01714739|365073694|FG000|Overall Study|Maximum clinical benefit|0|||
105840619|NCT01714739|365073695|FG001|Overall Study|Maximum clinical benefit|1|||
105840620|NCT01714739|365073696|FG002|Overall Study|Maximum clinical benefit|1|||
105840621|NCT01714739|365073697|FG003|Overall Study|Maximum clinical benefit|3|||
105840622|NCT01714739|365073698|FG004|Overall Study|Maximum clinical benefit|0|||
105840623|NCT01714739|365073699|FG005|Overall Study|Maximum clinical benefit|0|||
105840624|NCT01714739|365073700|FG006|Overall Study|Maximum clinical benefit|0|||
105840625|NCT01714739|365073694|FG000|Overall Study|Poor/non-comliance|0|||
105840626|NCT01714739|365073695|FG001|Overall Study|Poor/non-comliance|1|||
105840627|NCT01714739|365073696|FG002|Overall Study|Poor/non-comliance|0|||
105840628|NCT01714739|365073697|FG003|Overall Study|Poor/non-comliance|1|||
105840629|NCT01714739|365073698|FG004|Overall Study|Poor/non-comliance|0|||
105840630|NCT01714739|365073699|FG005|Overall Study|Poor/non-comliance|0|||
105840631|NCT01714739|365073700|FG006|Overall Study|Poor/non-comliance|0|||
105840632|NCT01714739|365073694|FG000|Overall Study|No longer meets study criteria|0|||
105840633|NCT01714739|365073695|FG001|Overall Study|No longer meets study criteria|0|||
105840634|NCT01714739|365073696|FG002|Overall Study|No longer meets study criteria|0|||
105840635|NCT01714739|365073697|FG003|Overall Study|No longer meets study criteria|1|||
105840636|NCT01714739|365073698|FG004|Overall Study|No longer meets study criteria|0|||
105840637|NCT01714739|365073699|FG005|Overall Study|No longer meets study criteria|0|||
105489945|NCT01907100|363805706|FG001|Overall Study|PD based on modified RECIST criteria|32|||
105489946|NCT01907100|363805707|FG002|Overall Study|PD based on modified RECIST criteria|95|||
105840638|NCT01714739|365073700|FG006|Overall Study|No longer meets study criteria|0|||
105840639|NCT01714739|365073694|FG000|Overall Study|Other reason|0|||
105840640|NCT01714739|365073695|FG001|Overall Study|Other reason|0|||
105840641|NCT01714739|365073696|FG002|Overall Study|Other reason|0|||
105840642|NCT01714739|365073697|FG003|Overall Study|Other reason|3|||
105840643|NCT01714739|365073698|FG004|Overall Study|Other reason|1|||
105840644|NCT01714739|365073699|FG005|Overall Study|Other reason|0|||
105840645|NCT01714739|365073700|FG006|Overall Study|Other reason|0|||
105840646|NCT01175473|365073702|FG000|Overall Study|Adverse Event|2|||
105840647|NCT01175473|365073703|FG001|Overall Study|Adverse Event|2|||
105840648|NCT02674386|365073704|FG000|Overall Study|Lost to Follow-up|0|||
105840649|NCT02674386|365073705|FG001|Overall Study|Lost to Follow-up|1|||
105840650|NCT02674386|365073706|FG002|Overall Study|Lost to Follow-up|1|||
105840651|NCT02674386|365073704|FG000|Overall Study|Withdrawal by Subject|0|||
105489947|NCT01907100|363805708|FG003|Overall Study|PD based on modified RECIST criteria|92|||
105840652|NCT02674386|365073705|FG001|Overall Study|Withdrawal by Subject|4|||
105840653|NCT02674386|365073706|FG002|Overall Study|Withdrawal by Subject|0|||
105367882|NCT02188160|363354075|FG000|Overall Study|Use of an excluded medication|0|||
105367883|NCT02188160|363354076|FG001|Overall Study|Use of an excluded medication|1|||
105367884|NCT00916578|363354077|FG000|Overall Study|Physician Decision|2|||
105367885|NCT00916578|363354077|FG000|Overall Study|Withdrawal by Subject|3|||
105367886|NCT00916578|363354077|FG000|Overall Study|Insurance Denial|2|||
105367887|NCT01307787|363354080|FG000|Overall Study|Withdrawal by Subject|2|||
105367888|NCT01307787|363354081|FG001|Overall Study|Withdrawal by Subject|0|||
105367889|NCT01573000|363354082|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
105367890|NCT01573000|363354083|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
105367891|NCT01573000|363354082|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
105367892|NCT01573000|363354083|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
105367893|NCT01573000|363354082|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
105489948|NCT01907100|363805705|FG000|Overall Study|Withdrawal by Subject|2|||
105489949|NCT01907100|363805706|FG001|Overall Study|Withdrawal by Subject|5|||
105840654|NCT02674386|365073704|FG000|Overall Study|Other|0|||
105840655|NCT02674386|365073705|FG001|Overall Study|Other|1|||
105840656|NCT02674386|365073706|FG002|Overall Study|Other|0|||
105840657|NCT02674386|365073704|FG000|Overall Study|Enrolled but not evaluated|0|||
105840658|NCT02674386|365073705|FG001|Overall Study|Enrolled but not evaluated|4|||
105840659|NCT02674386|365073706|FG002|Overall Study|Enrolled but not evaluated|0|||
105840660|NCT01439724|365073707|FG000|Overall Study|missing consultation|9|||
105840661|NCT01439724|365073708|FG001|Overall Study|missing consultation|8|||
105840662|NCT02310763|365073716|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
105840663|NCT02310763|365073717|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
105840664|NCT02310763|365073718|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
105840665|NCT02310763|365073716|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
105840666|NCT02310763|365073717|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
105840667|NCT02310763|365073718|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
105840668|NCT02310763|365073716|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
105840669|NCT02310763|365073717|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
105840670|NCT02310763|365073718|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
105840671|NCT02310763|365073716|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
105840672|NCT02310763|365073717|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
105840673|NCT02310763|365073718|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
105840674|NCT02310763|365073716|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
105840675|NCT02310763|365073717|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
105840676|NCT02310763|365073718|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
105840677|NCT01040793|365073721|FG000|Overall Study|Adverse Event|5|||
105840678|NCT01040793|365073722|FG001|Overall Study|Adverse Event|3|||
105840679|NCT01040793|365073723|FG002|Overall Study|Adverse Event|0|||
105840680|NCT01040793|365073724|FG003|Overall Study|Adverse Event|2|||
105840681|NCT01040793|365073725|FG004|Overall Study|Adverse Event|2|||
105840682|NCT01040793|365073726|FG005|Overall Study|Adverse Event|1|||
105840683|NCT01040793|365073721|FG000|Overall Study|Protocol Violation|1|||
105840684|NCT01040793|365073722|FG001|Overall Study|Protocol Violation|1|||
105840685|NCT01040793|365073723|FG002|Overall Study|Protocol Violation|1|||
105840686|NCT01040793|365073724|FG003|Overall Study|Protocol Violation|0|||
105840687|NCT01040793|365073725|FG004|Overall Study|Protocol Violation|1|||
105840688|NCT01040793|365073726|FG005|Overall Study|Protocol Violation|0|||
105840689|NCT01040793|365073721|FG000|Overall Study|Lost to Follow-up|0|||
105840690|NCT01040793|365073722|FG001|Overall Study|Lost to Follow-up|1|||
105840691|NCT01040793|365073723|FG002|Overall Study|Lost to Follow-up|1|||
105367894|NCT01573000|363354083|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
105367895|NCT01573000|363354082|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
105489950|NCT01907100|363805707|FG002|Overall Study|Withdrawal by Subject|10|||
105489951|NCT01907100|363805708|FG003|Overall Study|Withdrawal by Subject|13|||
105489952|NCT01907100|363805705|FG000|Overall Study|Protocol Violation|0|||
105840692|NCT01040793|365073724|FG003|Overall Study|Lost to Follow-up|0|||
105840693|NCT01040793|365073725|FG004|Overall Study|Lost to Follow-up|0|||
105840694|NCT01040793|365073726|FG005|Overall Study|Lost to Follow-up|0|||
105840695|NCT01040793|365073721|FG000|Overall Study|Withdrawal by Subject|0|||
105840696|NCT01040793|365073722|FG001|Overall Study|Withdrawal by Subject|0|||
105840697|NCT01040793|365073723|FG002|Overall Study|Withdrawal by Subject|0|||
105840698|NCT01040793|365073724|FG003|Overall Study|Withdrawal by Subject|2|||
105840699|NCT01040793|365073725|FG004|Overall Study|Withdrawal by Subject|0|||
105840700|NCT01040793|365073726|FG005|Overall Study|Withdrawal by Subject|0|||
105840701|NCT01040793|365073721|FG000|Overall Study|Other reasons not listed above|0|||
105840702|NCT01040793|365073722|FG001|Overall Study|Other reasons not listed above|0|||
105840703|NCT01040793|365073723|FG002|Overall Study|Other reasons not listed above|1|||
105840704|NCT01040793|365073724|FG003|Overall Study|Other reasons not listed above|0|||
105840705|NCT01040793|365073725|FG004|Overall Study|Other reasons not listed above|1|||
105840706|NCT01040793|365073726|FG005|Overall Study|Other reasons not listed above|0|||
105840707|NCT01998243|365073731|FG000|Overall Study|Pregnancy|0|||
105840708|NCT01998243|365073732|FG001|Overall Study|Pregnancy|1|||
105840709|NCT01998243|365073731|FG000|Overall Study|Protocol Violation|5|||
105840710|NCT01998243|365073732|FG001|Overall Study|Protocol Violation|2|||
105840711|NCT01998243|365073731|FG000|Overall Study|Withdrawal by Subject|3|||
105840712|NCT01998243|365073732|FG001|Overall Study|Withdrawal by Subject|4|||
105840713|NCT01056640|365073734|FG000|Overall Study|Withdrawal by Subject|11|||
105840714|NCT01056640|365073735|FG001|Overall Study|Withdrawal by Subject|8|||
105840715|NCT01056640|365073734|FG000|Overall Study|Death|15|||
105840716|NCT01056640|365073735|FG001|Overall Study|Death|4|||
105840717|NCT00268892|365073736|FG000|Overall Study|Adverse Event|14|||
105840718|NCT00268892|365073737|FG001|Overall Study|Adverse Event|17|||
105840719|NCT00268892|365073738|FG002|Overall Study|Adverse Event|20|||
105840720|NCT00268892|365073736|FG000|Overall Study|Lack of Efficacy|1|||
105840721|NCT00268892|365073737|FG001|Overall Study|Lack of Efficacy|3|||
105840722|NCT00268892|365073738|FG002|Overall Study|Lack of Efficacy|0|||
105840723|NCT00268892|365073736|FG000|Overall Study|Withdrawal by Subject|14|||
105840724|NCT00268892|365073737|FG001|Overall Study|Withdrawal by Subject|15|||
105840725|NCT00268892|365073738|FG002|Overall Study|Withdrawal by Subject|13|||
105840726|NCT00268892|365073736|FG000|Overall Study|Physician Decision|0|||
105840727|NCT00268892|365073737|FG001|Overall Study|Physician Decision|1|||
105840728|NCT00268892|365073738|FG002|Overall Study|Physician Decision|0|||
105840729|NCT00268892|365073736|FG000|Overall Study|Lost to Follow-up|5|||
105840730|NCT00268892|365073737|FG001|Overall Study|Lost to Follow-up|2|||
105840731|NCT00268892|365073738|FG002|Overall Study|Lost to Follow-up|4|||
105840732|NCT00268892|365073736|FG000|Overall Study|Protocol Violation|0|||
105840733|NCT00268892|365073737|FG001|Overall Study|Protocol Violation|1|||
105840734|NCT00268892|365073738|FG002|Overall Study|Protocol Violation|0|||
105840735|NCT00268892|365073736|FG000|Overall Study|Disease Progression|1|||
105840736|NCT00268892|365073737|FG001|Overall Study|Disease Progression|1|||
105840737|NCT00268892|365073738|FG002|Overall Study|Disease Progression|0|||
105840738|NCT00268892|365073736|FG000|Overall Study|Trial Site Closed|4|||
105840739|NCT00268892|365073737|FG001|Overall Study|Trial Site Closed|2|||
105840740|NCT00268892|365073738|FG002|Overall Study|Trial Site Closed|2|||
105840741|NCT04569786|365073745|FG000|Overall Study|Lost to Follow-up|1|||
105840742|NCT04569786|365073746|FG001|Overall Study|Lost to Follow-up|0|||
105840743|NCT04569786|365073747|FG002|Overall Study|Lost to Follow-up|4|||
105840744|NCT04569786|365073748|FG003|Overall Study|Lost to Follow-up|1|||
105840745|NCT04569786|365073749|FG004|Overall Study|Lost to Follow-up|0|||
105840746|NCT04569786|365073745|FG000|Overall Study|Withdrawal by Subject|0|||
105840747|NCT04569786|365073746|FG001|Overall Study|Withdrawal by Subject|0|||
105840748|NCT04569786|365073747|FG002|Overall Study|Withdrawal by Subject|0|||
105840749|NCT04569786|365073748|FG003|Overall Study|Withdrawal by Subject|5|||
105840750|NCT04569786|365073749|FG004|Overall Study|Withdrawal by Subject|1|||
105840751|NCT04569786|365073745|FG000|Overall Study|Physician Decision|0|||
105840752|NCT04569786|365073746|FG001|Overall Study|Physician Decision|0|||
105840753|NCT04569786|365073747|FG002|Overall Study|Physician Decision|0|||
105840754|NCT04569786|365073748|FG003|Overall Study|Physician Decision|1|||
105840755|NCT04569786|365073749|FG004|Overall Study|Physician Decision|0|||
105840756|NCT01640184|365073750|FG000|Overall Study|Death|1|||
105840757|NCT01640184|365073751|FG001|Overall Study|Death|0|||
105840758|NCT01640184|365073752|FG002|Overall Study|Death|0|||
105840759|NCT01640184|365073750|FG000|Overall Study|Lost to Follow-up|4|||
105840760|NCT01640184|365073751|FG001|Overall Study|Lost to Follow-up|1|||
105840761|NCT01640184|365073752|FG002|Overall Study|Lost to Follow-up|0|||
105840762|NCT01640184|365073750|FG000|Overall Study|Physician Decision|3|||
105840763|NCT01640184|365073751|FG001|Overall Study|Physician Decision|0|||
105367896|NCT01573000|363354083|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
105576530|NCT01267825|364110186|FG000|Overall Study|study terminated. no data collected.|1|||
105576531|NCT01267825|364110187|FG001|Overall Study|study terminated. no data collected.|0|||
105840764|NCT01640184|365073752|FG002|Overall Study|Physician Decision|0|||
105840765|NCT01640184|365073750|FG000|Overall Study|Withdrawal by Subject|0|||
105840766|NCT01640184|365073751|FG001|Overall Study|Withdrawal by Subject|1|||
105840767|NCT01640184|365073752|FG002|Overall Study|Withdrawal by Subject|1|||
105840768|NCT01640184|365073750|FG000|Overall Study|Protocol Violation|0|||
105840769|NCT01640184|365073751|FG001|Overall Study|Protocol Violation|0|||
105840770|NCT01640184|365073752|FG002|Overall Study|Protocol Violation|1|||
105840771|NCT01202877|365073753|FG000|Overall Study|Disease Progression|0|||
105840772|NCT01202877|365073754|FG001|Overall Study|Disease Progression|1|||
105840773|NCT01202877|365073755|FG002|Overall Study|Disease Progression|2|||
105840774|NCT01202877|365073753|FG000|Overall Study|Adverse Event|0|||
105840775|NCT01202877|365073754|FG001|Overall Study|Adverse Event|0|||
105576532|NCT03722264|364110188|FG000|Overall Study|Physician Decision|3|||
105840776|NCT01202877|365073755|FG002|Overall Study|Adverse Event|2|||
105840777|NCT01202877|365073753|FG000|Overall Study|Withdrawal by Subject|0|||
105840778|NCT01202877|365073754|FG001|Overall Study|Withdrawal by Subject|0|||
105840779|NCT01202877|365073755|FG002|Overall Study|Withdrawal by Subject|1|||
105840780|NCT01202877|365073753|FG000|Overall Study|Death|0|||
105840781|NCT01202877|365073754|FG001|Overall Study|Death|0|||
105840782|NCT01202877|365073755|FG002|Overall Study|Death|1|||
105840783|NCT01351350|365073756|FG000|Overall Study|Disease Progression|5|||
105840784|NCT01351350|365073757|FG001|Overall Study|Disease Progression|13|||
105840785|NCT01351350|365073758|FG002|Overall Study|Disease Progression|6|||
105840786|NCT01351350|365073759|FG003|Overall Study|Disease Progression|8|||
105840787|NCT01351350|365073760|FG004|Overall Study|Disease Progression|5|||
105840788|NCT01351350|365073756|FG000|Overall Study|Adverse Event|1|||
105840789|NCT01351350|365073757|FG001|Overall Study|Adverse Event|10|||
105840790|NCT01351350|365073758|FG002|Overall Study|Adverse Event|1|||
105840791|NCT01351350|365073759|FG003|Overall Study|Adverse Event|2|||
105840792|NCT01351350|365073760|FG004|Overall Study|Adverse Event|0|||
105840793|NCT01351350|365073756|FG000|Overall Study|Participant Decision|2|||
105840794|NCT01351350|365073757|FG001|Overall Study|Participant Decision|6|||
105840795|NCT01351350|365073758|FG002|Overall Study|Participant Decision|3|||
105840796|NCT01351350|365073759|FG003|Overall Study|Participant Decision|3|||
105840797|NCT01351350|365073760|FG004|Overall Study|Participant Decision|2|||
105840798|NCT01351350|365073756|FG000|Overall Study|Enrolled but not Treated|0|||
105840799|NCT01351350|365073757|FG001|Overall Study|Enrolled but not Treated|0|||
105840800|NCT01351350|365073758|FG002|Overall Study|Enrolled but not Treated|1|||
105840801|NCT01351350|365073759|FG003|Overall Study|Enrolled but not Treated|0|||
105840802|NCT01351350|365073760|FG004|Overall Study|Enrolled but not Treated|0|||
105840803|NCT01684878|365073768|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
105840804|NCT01684878|365073769|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
105840805|NCT01684878|365073770|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
105840806|NCT01684878|365073771|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
105840807|NCT01684878|365073768|FG000|Part 1: Safety Run in Phase|Death|15|||
105840808|NCT01684878|365073769|FG001|Part 1: Safety Run in Phase|Death|20|||
105840809|NCT01684878|365073770|FG002|Part 1: Safety Run in Phase|Death|0|||
105840810|NCT01684878|365073771|FG003|Part 1: Safety Run in Phase|Death|0|||
105840811|NCT01684878|365073768|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
105840812|NCT01684878|365073769|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
105840813|NCT01684878|365073770|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
105840814|NCT01684878|365073771|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
105840815|NCT01684878|365073768|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
105840816|NCT01684878|365073769|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
105840817|NCT01684878|365073770|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
105840818|NCT01684878|365073771|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
105840819|NCT01684878|365073768|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
105840820|NCT01684878|365073769|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
105840821|NCT01684878|365073770|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
105840822|NCT01684878|365073771|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
105840823|NCT01684878|365073768|FG000|Part 2: Randomized Phase|Death|0|||
105840824|NCT01684878|365073769|FG001|Part 2: Randomized Phase|Death|0|||
105312160|NCT00384930|363141020|FG000|Overall Study|Adverse Event|5|||
105312161|NCT00384930|363141021|FG001|Overall Study|Adverse Event|4|||
105312162|NCT00384930|363141022|FG002|Overall Study|Adverse Event|12|||
105312163|NCT00384930|363141023|FG003|Overall Study|Adverse Event|11|||
105312164|NCT00384930|363141024|FG004|Overall Study|Adverse Event|14|||
105312165|NCT00384930|363141020|FG000|Overall Study|Entry Criteria Not Met|2|||
105312166|NCT00384930|363141021|FG001|Overall Study|Entry Criteria Not Met|6|||
105312167|NCT00384930|363141022|FG002|Overall Study|Entry Criteria Not Met|7|||
105312168|NCT00384930|363141023|FG003|Overall Study|Entry Criteria Not Met|8|||
105312169|NCT00384930|363141024|FG004|Overall Study|Entry Criteria Not Met|4|||
105312170|NCT00384930|363141020|FG000|Overall Study|Lack of Efficacy|1|||
105312171|NCT00384930|363141021|FG001|Overall Study|Lack of Efficacy|1|||
105312172|NCT00384930|363141022|FG002|Overall Study|Lack of Efficacy|2|||
105312173|NCT00384930|363141023|FG003|Overall Study|Lack of Efficacy|1|||
105312174|NCT00384930|363141024|FG004|Overall Study|Lack of Efficacy|2|||
105312175|NCT00384930|363141020|FG000|Overall Study|Lost to Follow-up|5|||
105312176|NCT00384930|363141021|FG001|Overall Study|Lost to Follow-up|3|||
105312177|NCT00384930|363141022|FG002|Overall Study|Lost to Follow-up|0|||
105312178|NCT00384930|363141023|FG003|Overall Study|Lost to Follow-up|4|||
105840825|NCT01684878|365073770|FG002|Part 2: Randomized Phase|Death|62|||
105840826|NCT01684878|365073771|FG003|Part 2: Randomized Phase|Death|68|||
105840827|NCT01684878|365073768|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
105312179|NCT00384930|363141024|FG004|Overall Study|Lost to Follow-up|6|||
105312180|NCT00384930|363141020|FG000|Overall Study|Physician Decision|0|||
105840828|NCT01684878|365073769|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
105840829|NCT01684878|365073770|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
105312181|NCT00384930|363141021|FG001|Overall Study|Physician Decision|1|||
105312182|NCT00384930|363141022|FG002|Overall Study|Physician Decision|1|||
105840830|NCT01684878|365073771|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
105840831|NCT01684878|365073768|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
105840832|NCT01684878|365073769|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
105840833|NCT01684878|365073770|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
105840834|NCT01684878|365073771|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
105840835|NCT04647383|365073772|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
105840836|NCT04647383|365073773|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
105840837|NCT04647383|365073774|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
105840838|NCT04647383|365073775|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
105840839|NCT00775528|365073776|FG000|Overall Study|Protocol Violation|1|||
105840840|NCT02692482|365073777|FG000|Overall Study|Death|2|||
105840841|NCT02692482|365073778|FG001|Overall Study|Death|2|||
105840842|NCT02692482|365073777|FG000|Overall Study|Withdrawal by Subject|1|||
105840843|NCT02692482|365073778|FG001|Overall Study|Withdrawal by Subject|2|||
105840844|NCT02492841|365073779|FG000|Overall Study|Lost to Follow-up|34|||
105840845|NCT02492841|365073780|FG001|Overall Study|Lost to Follow-up|31|||
105840846|NCT02492841|365073781|FG002|Overall Study|Lost to Follow-up|35|||
105840847|NCT00479388|365073789|FG000|Overall Study|Adverse Event|90|||
105840848|NCT00479388|365073790|FG001|Overall Study|Adverse Event|45|||
105840849|NCT00479388|365073789|FG000|Overall Study|Lost to Follow-up|0|||
105840850|NCT00479388|365073790|FG001|Overall Study|Lost to Follow-up|2|||
105840851|NCT00479388|365073789|FG000|Overall Study|Protocol Violation|10|||
105840852|NCT00479388|365073790|FG001|Overall Study|Protocol Violation|9|||
105840853|NCT00479388|365073789|FG000|Overall Study|Withdrawal by Subject|32|||
105840854|NCT00479388|365073790|FG001|Overall Study|Withdrawal by Subject|17|||
105840855|NCT01876368|365073791|FG000|Overall Study|Adverse Event|2|||
105840856|NCT01876368|365073792|FG001|Overall Study|Adverse Event|5|||
105840857|NCT01876368|365073791|FG000|Overall Study|Lack of Efficacy|1|||
105840858|NCT01876368|365073792|FG001|Overall Study|Lack of Efficacy|0|||
105840859|NCT01876368|365073791|FG000|Overall Study|Lost to Follow-up|0|||
105840860|NCT01876368|365073792|FG001|Overall Study|Lost to Follow-up|1|||
105840861|NCT01876368|365073791|FG000|Overall Study|Non-compliance with study treatment|0|||
105840862|NCT01876368|365073792|FG001|Overall Study|Non-compliance with study treatment|1|||
105840863|NCT01876368|365073791|FG000|Overall Study|Physician Decision|0|||
105840864|NCT01876368|365073792|FG001|Overall Study|Physician Decision|2|||
105840865|NCT01876368|365073791|FG000|Overall Study|Protocol deviation|3|||
105840866|NCT01876368|365073792|FG001|Overall Study|Protocol deviation|3|||
105840867|NCT01876368|365073791|FG000|Overall Study|Subject/guardian decision|3|||
105840868|NCT01876368|365073792|FG001|Overall Study|Subject/guardian decision|1|||
105840869|NCT04099641|365073793|FG000|Overall Study|Death|46|||
105840870|NCT04099641|365073794|FG001|Overall Study|Death|12|||
105840871|NCT04099641|365073793|FG000|Overall Study|Lost to Follow-up|1|||
105840872|NCT04099641|365073794|FG001|Overall Study|Lost to Follow-up|0|||
105840873|NCT04099641|365073793|FG000|Overall Study|Withdrawal by Subject|2|||
105840874|NCT04099641|365073794|FG001|Overall Study|Withdrawal by Subject|0|||
105840875|NCT00895037|365073795|FG000|Overall Study|Death|0|||
105840876|NCT00895037|365073796|FG001|Overall Study|Death|2|||
105840877|NCT00895037|365073797|FG002|Overall Study|Death|1|||
105840878|NCT02096588|365073800|FG000|Overall Study|Lack of Efficacy|2|||
105840879|NCT02096588|365073801|FG001|Overall Study|Lack of Efficacy|0|||
105840880|NCT02096588|365073800|FG000|Overall Study|Withdrawal by Subject|0|||
105840881|NCT02096588|365073801|FG001|Overall Study|Withdrawal by Subject|1|||
105840882|NCT01192399|365073804|FG000|Overall Study|Lack of Efficacy|2|||
105840883|NCT01930175|365073805|FG000|Core Study|Lost to Follow-up|0|||
105840884|NCT01930175|365073806|FG001|Core Study|Lost to Follow-up|1|||
105840885|NCT01930175|365073807|FG002|Core Study|Lost to Follow-up|0|||
105840886|NCT01930175|365073805|FG000|Core Study|Adverse Event|0|||
105840887|NCT01930175|365073806|FG001|Core Study|Adverse Event|0|||
105840888|NCT01930175|365073807|FG002|Core Study|Adverse Event|1|||
105840889|NCT01867606|365073811|FG000|Overall Study|Withdrawal by Subject|10|||
105840890|NCT01867606|365073812|FG001|Overall Study|Withdrawal by Subject|14|||
105840891|NCT01867606|365073811|FG000|Overall Study|Protocol Violation|0|||
105840892|NCT01867606|365073812|FG001|Overall Study|Protocol Violation|1|||
105840893|NCT00440115|365073814|FG000|Overall Study|Death|7|||
105840894|NCT00440115|365073815|FG001|Overall Study|Death|9|||
105840895|NCT00440115|365073816|FG002|Overall Study|Death|5|||
105840896|NCT00440115|365073814|FG000|Overall Study|Incarceration|0|||
105840897|NCT00440115|365073815|FG001|Overall Study|Incarceration|2|||
105312183|NCT00384930|363141023|FG003|Overall Study|Physician Decision|0|||
105312184|NCT00384930|363141024|FG004|Overall Study|Physician Decision|1|||
105312185|NCT00384930|363141020|FG000|Overall Study|Protocol Violation|1|||
105840898|NCT00440115|365073816|FG002|Overall Study|Incarceration|1|||
105840899|NCT02244424|365073819|FG000|Overall Study|Lost to Follow-up|20|||
105840900|NCT02244424|365073820|FG001|Overall Study|Lost to Follow-up|10|||
105840901|NCT02148445|365073823|FG000|Overall Study|Death|1|||
105840902|NCT02148445|365073824|FG001|Overall Study|Death|3|||
105840903|NCT03438006|365073826|FG000|Overall Study|Adverse Event|1|||
105840904|NCT03438006|365073826|FG000|Overall Study|Lost to Follow-up|67|||
105840905|NCT03438006|365073826|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
105840906|NCT03438006|365073826|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
105840907|NCT00739973|365073837|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
105840908|NCT00739973|365073838|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
105840909|NCT00739973|365073839|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
105367897|NCT01573000|363354082|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
105367898|NCT01573000|363354083|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
105367899|NCT01573000|363354082|FG000|Crossover Phase|Lack of Efficacy|0|||
105367900|NCT01573000|363354083|FG001|Crossover Phase|Lack of Efficacy|13|||
105367901|NCT01573000|363354082|FG000|Crossover Phase|Lost to Follow-up|0|||
105367902|NCT01573000|363354083|FG001|Crossover Phase|Lost to Follow-up|2|||
105367903|NCT01573000|363354082|FG000|Crossover Phase|Death|0|||
105367904|NCT01573000|363354083|FG001|Crossover Phase|Death|3|||
105367905|NCT01573000|363354082|FG000|Long-Term Follow-Up|Death|3|||
105367906|NCT01573000|363354083|FG001|Long-Term Follow-Up|Death|0|||
105367907|NCT01573000|363354082|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
105367908|NCT01573000|363354083|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
105367909|NCT03353792|363354084|FG000|Overall Study|Lost to Follow-up|1|||
105367910|NCT03353792|363354085|FG001|Overall Study|Lost to Follow-up|0|||
105367911|NCT03353792|363354084|FG000|Overall Study|Participant Unable to Manage Device|1|||
105367912|NCT03353792|363354085|FG001|Overall Study|Participant Unable to Manage Device|0|||
105312186|NCT00384930|363141021|FG001|Overall Study|Protocol Violation|0|||
105312187|NCT00384930|363141022|FG002|Overall Study|Protocol Violation|1|||
105312188|NCT00384930|363141023|FG003|Overall Study|Protocol Violation|6|||
105312189|NCT00384930|363141024|FG004|Overall Study|Protocol Violation|4|||
105312190|NCT00384930|363141020|FG000|Overall Study|Sponsor Decision|3|||
105312191|NCT00384930|363141021|FG001|Overall Study|Sponsor Decision|4|||
105312192|NCT00384930|363141022|FG002|Overall Study|Sponsor Decision|0|||
105312193|NCT00384930|363141023|FG003|Overall Study|Sponsor Decision|5|||
105312194|NCT00384930|363141024|FG004|Overall Study|Sponsor Decision|0|||
105312195|NCT00384930|363141020|FG000|Overall Study|Withdrawal by Subject|9|||
105312196|NCT00384930|363141021|FG001|Overall Study|Withdrawal by Subject|7|||
105312197|NCT00384930|363141022|FG002|Overall Study|Withdrawal by Subject|7|||
105312198|NCT00384930|363141023|FG003|Overall Study|Withdrawal by Subject|6|||
105312199|NCT00384930|363141024|FG004|Overall Study|Withdrawal by Subject|16|||
105312200|NCT00384930|363141020|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
105367913|NCT03652818|363354087|FG000|Overall Study|Adverse Event|1|||
105367914|NCT03652818|363354088|FG001|Overall Study|Adverse Event|0|||
105367915|NCT03652818|363354089|FG002|Overall Study|Adverse Event|0|||
105367916|NCT03652818|363354090|FG003|Overall Study|Adverse Event|0|||
105367917|NCT03652818|363354091|FG004|Overall Study|Adverse Event|0|||
105367918|NCT03652818|363354087|FG000|Overall Study|Physician Decision|1|||
105367919|NCT03652818|363354088|FG001|Overall Study|Physician Decision|0|||
105367920|NCT03652818|363354089|FG002|Overall Study|Physician Decision|0|||
105367921|NCT03652818|363354090|FG003|Overall Study|Physician Decision|0|||
105367922|NCT03652818|363354091|FG004|Overall Study|Physician Decision|0|||
105367923|NCT03652818|363354087|FG000|Overall Study|Lost to Follow-up|0|||
105367924|NCT03652818|363354088|FG001|Overall Study|Lost to Follow-up|1|||
105367925|NCT03652818|363354089|FG002|Overall Study|Lost to Follow-up|2|||
105312201|NCT00384930|363141021|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
105312202|NCT00384930|363141022|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
105312203|NCT00384930|363141023|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
105312204|NCT00384930|363141024|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
105312205|NCT01147107|363141025|FG000|Overall Study|Lack of Efficacy|5|||
105312206|NCT01147107|363141026|FG001|Overall Study|Lack of Efficacy|0|||
105367926|NCT03652818|363354090|FG003|Overall Study|Lost to Follow-up|1|||
105312207|NCT01147107|363141025|FG000|Overall Study|Withdrawal by Subject|1|||
105312208|NCT01147107|363141026|FG001|Overall Study|Withdrawal by Subject|1|||
105312209|NCT02752087|363141034|FG000|Washout|Physician Decision|1|||
105312210|NCT02752087|363141035|FG001|Washout|Physician Decision|0|||
105312211|NCT00843635|363141036|FG000|Overall Study|Adverse Event|2|||
105367927|NCT03652818|363354091|FG004|Overall Study|Lost to Follow-up|1|||
105312212|NCT00843635|363141037|FG001|Overall Study|Adverse Event|2|||
105367928|NCT01130272|363354094|FG000|Overall Study|Adverse Event|2|||
105312213|NCT00843635|363141038|FG002|Overall Study|Adverse Event|0|||
105312214|NCT03496610|363141039|FG000|Overall Study|Lost to Follow-up|3|||
105312215|NCT03496610|363141040|FG001|Overall Study|Lost to Follow-up|2|||
105312216|NCT03496610|363141039|FG000|Overall Study|Physician Decision|1|||
105312217|NCT03496610|363141040|FG001|Overall Study|Physician Decision|0|||
105312218|NCT03496610|363141039|FG000|Overall Study|Withdrawal by Subject|1|||
105312219|NCT03496610|363141040|FG001|Overall Study|Withdrawal by Subject|0|||
105312220|NCT02714426|363141044|FG000|Overall Study|Withdrawal by Subject|2|||
105312221|NCT02714426|363141045|FG001|Overall Study|Withdrawal by Subject|2|||
105312222|NCT02774642|363141049|FG000|Overall Study|Lost to Follow-up|9|||
105312223|NCT02774642|363141050|FG001|Overall Study|Lost to Follow-up|7|||
105312224|NCT00896480|363141051|FG000|Overall Study|Disease progression/recurrence|21|||
105367929|NCT01130272|363354095|FG001|Overall Study|Adverse Event|5|||
105367930|NCT01130272|363354096|FG002|Overall Study|Adverse Event|6|||
105367931|NCT01130272|363354097|FG003|Overall Study|Adverse Event|22|||
105367932|NCT01130272|363354098|FG004|Overall Study|Adverse Event|7|||
105367933|NCT01130272|363354094|FG000|Overall Study|IVRS-confirmed constipation|0|||
105367934|NCT01130272|363354095|FG001|Overall Study|IVRS-confirmed constipation|1|||
105367935|NCT01130272|363354096|FG002|Overall Study|IVRS-confirmed constipation|1|||
105367936|NCT01130272|363354097|FG003|Overall Study|IVRS-confirmed constipation|2|||
105367937|NCT01130272|363354098|FG004|Overall Study|IVRS-confirmed constipation|0|||
105367938|NCT01130272|363354094|FG000|Overall Study|Rescue medications due to diarrhea|3|||
105367939|NCT01130272|363354095|FG001|Overall Study|Rescue medications due to diarrhea|5|||
105367940|NCT01130272|363354096|FG002|Overall Study|Rescue medications due to diarrhea|8|||
105367941|NCT01130272|363354097|FG003|Overall Study|Rescue medications due to diarrhea|8|||
105367942|NCT01130272|363354098|FG004|Overall Study|Rescue medications due to diarrhea|6|||
105367943|NCT01130272|363354094|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
105367944|NCT01130272|363354095|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
105367945|NCT01130272|363354096|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
105367946|NCT01130272|363354097|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
105367947|NCT01130272|363354098|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
105367948|NCT01130272|363354094|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
105367949|NCT01130272|363354095|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
105367950|NCT01130272|363354096|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
105489953|NCT01907100|363805706|FG001|Overall Study|Protocol Violation|0|||
105489954|NCT01907100|363805707|FG002|Overall Study|Protocol Violation|1|||
105489955|NCT01907100|363805708|FG003|Overall Study|Protocol Violation|1|||
105489956|NCT01907100|363805705|FG000|Overall Study|Lost to Follow-up|0|||
105489957|NCT01907100|363805706|FG001|Overall Study|Lost to Follow-up|0|||
105489958|NCT01907100|363805707|FG002|Overall Study|Lost to Follow-up|0|||
105489959|NCT01907100|363805708|FG003|Overall Study|Lost to Follow-up|1|||
105840910|NCT00739973|365073840|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
105840911|NCT00739973|365073841|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
105367951|NCT01130272|363354097|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
105367952|NCT01130272|363354098|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
105367953|NCT01130272|363354094|FG000|Overall Study|Protocol Violation|0|||
105367954|NCT01130272|363354095|FG001|Overall Study|Protocol Violation|0|||
105367955|NCT01130272|363354096|FG002|Overall Study|Protocol Violation|3|||
105367956|NCT01130272|363354097|FG003|Overall Study|Protocol Violation|5|||
105367957|NCT01130272|363354098|FG004|Overall Study|Protocol Violation|5|||
105367958|NCT01130272|363354094|FG000|Overall Study|Lost to Follow-up|4|||
105367959|NCT01130272|363354095|FG001|Overall Study|Lost to Follow-up|3|||
105367960|NCT01130272|363354096|FG002|Overall Study|Lost to Follow-up|4|||
105367961|NCT01130272|363354097|FG003|Overall Study|Lost to Follow-up|7|||
105367962|NCT01130272|363354098|FG004|Overall Study|Lost to Follow-up|6|||
105367963|NCT01130272|363354094|FG000|Overall Study|Withdrawal by Subject|4|||
105367964|NCT01130272|363354095|FG001|Overall Study|Withdrawal by Subject|11|||
105367965|NCT01130272|363354096|FG002|Overall Study|Withdrawal by Subject|10|||
105367966|NCT01130272|363354097|FG003|Overall Study|Withdrawal by Subject|9|||
105367967|NCT01130272|363354098|FG004|Overall Study|Withdrawal by Subject|8|||
105367968|NCT01130272|363354094|FG000|Overall Study|Physician Decision|1|||
105367969|NCT01130272|363354095|FG001|Overall Study|Physician Decision|1|||
105367970|NCT01130272|363354096|FG002|Overall Study|Physician Decision|0|||
105367971|NCT01130272|363354097|FG003|Overall Study|Physician Decision|1|||
105367972|NCT01130272|363354098|FG004|Overall Study|Physician Decision|2|||
105367973|NCT01130272|363354094|FG000|Overall Study|Sponsor decision|6|||
105367974|NCT01130272|363354095|FG001|Overall Study|Sponsor decision|15|||
105367975|NCT01130272|363354096|FG002|Overall Study|Sponsor decision|16|||
105367976|NCT01130272|363354097|FG003|Overall Study|Sponsor decision|13|||
105367977|NCT01130272|363354098|FG004|Overall Study|Sponsor decision|16|||
105367978|NCT01130272|363354094|FG000|Overall Study|Study arm discontinued|38|||
105367979|NCT01130272|363354095|FG001|Overall Study|Study arm discontinued|0|||
105367980|NCT01130272|363354096|FG002|Overall Study|Study arm discontinued|0|||
105367981|NCT01130272|363354097|FG003|Overall Study|Study arm discontinued|0|||
105489960|NCT01907100|363805705|FG000|Overall Study|Not treated|2|||
105489961|NCT01907100|363805706|FG001|Overall Study|Not treated|0|||
105840912|NCT00739973|365073842|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
105840913|NCT00739973|365073843|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
105840914|NCT00739973|365073844|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
105840915|NCT00739973|365073845|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
105840916|NCT00739973|365073837|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
105840917|NCT00739973|365073838|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
105367982|NCT01130272|363354098|FG004|Overall Study|Study arm discontinued|0|||
105367983|NCT01548404|363354099|FG000|Overall Study|Adverse Event|3|||
105489962|NCT01907100|363805707|FG002|Overall Study|Not treated|1|||
105489963|NCT01907100|363805708|FG003|Overall Study|Not treated|2|||
105489964|NCT01907100|363805705|FG000|Overall Study|Other than reasons specified|1|||
105367984|NCT01548404|363354100|FG001|Overall Study|Adverse Event|1|||
105489965|NCT01907100|363805706|FG001|Overall Study|Other than reasons specified|0|||
105367985|NCT01548404|363354099|FG000|Overall Study|Physician Decision|2|||
105367986|NCT01548404|363354100|FG001|Overall Study|Physician Decision|1|||
105367987|NCT01548404|363354099|FG000|Overall Study|Inadequate response to study treatment|23|||
105367988|NCT01548404|363354100|FG001|Overall Study|Inadequate response to study treatment|7|||
105489966|NCT01907100|363805707|FG002|Overall Study|Other than reasons specified|10|||
105312225|NCT00090363|363141052|FG000|Overall Study|Lost to Follow-up|1|||
105312226|NCT00090363|363141053|FG001|Overall Study|Lost to Follow-up|2|||
105312227|NCT00090363|363141054|FG002|Overall Study|Lost to Follow-up|1|||
105312228|NCT00090363|363141052|FG000|Overall Study|Withdrawal by Subject|7|||
105312229|NCT00090363|363141053|FG001|Overall Study|Withdrawal by Subject|7|||
105312230|NCT00090363|363141054|FG002|Overall Study|Withdrawal by Subject|6|||
105312231|NCT00090363|363141052|FG000|Overall Study|Study-specific discontinuation criteria|75|||
105312232|NCT00090363|363141053|FG001|Overall Study|Study-specific discontinuation criteria|74|||
105312233|NCT00090363|363141054|FG002|Overall Study|Study-specific discontinuation criteria|62|||
105312234|NCT00090363|363141052|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105312235|NCT00090363|363141053|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105312236|NCT00090363|363141054|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
105312237|NCT00090363|363141052|FG000|Overall Study|Consent expired|7|||
105312238|NCT00090363|363141053|FG001|Overall Study|Consent expired|10|||
105312239|NCT00090363|363141054|FG002|Overall Study|Consent expired|9|||
105312240|NCT00090363|363141052|FG000|Overall Study|Reasons not specified|2|||
105312241|NCT00090363|363141053|FG001|Overall Study|Reasons not specified|1|||
105312242|NCT00090363|363141054|FG002|Overall Study|Reasons not specified|1|||
105312243|NCT00090363|363141052|FG000|Overall Study|Continuing on study off treatment|14|||
105312244|NCT00090363|363141053|FG001|Overall Study|Continuing on study off treatment|13|||
105312245|NCT00090363|363141054|FG002|Overall Study|Continuing on study off treatment|16|||
105312246|NCT03553576|363141055|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
105312247|NCT03553576|363141056|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
105312248|NCT03553576|363141055|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
105312249|NCT03553576|363141056|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
105312250|NCT03553576|363141055|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
105312251|NCT03553576|363141056|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
105312252|NCT03553576|363141055|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
105312253|NCT03553576|363141056|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
105312254|NCT03553576|363141055|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
105312255|NCT03553576|363141056|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
105312256|NCT03553576|363141055|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
105312257|NCT03553576|363141056|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
105312258|NCT03553576|363141055|FG000|Overall Study|Physician Decision|2|||
105367989|NCT01548404|363354099|FG000|Overall Study|Lost to Follow-up|2|||
105367990|NCT01548404|363354100|FG001|Overall Study|Lost to Follow-up|0|||
105840918|NCT00739973|365073839|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
105840919|NCT00739973|365073840|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
105840920|NCT00739973|365073841|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
105840921|NCT00739973|365073842|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
105840922|NCT00739973|365073843|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
105840923|NCT00739973|365073844|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
105840924|NCT00739973|365073845|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
105840925|NCT00739973|365073837|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
105840926|NCT00739973|365073838|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840927|NCT00739973|365073839|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840928|NCT00739973|365073840|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840929|NCT00739973|365073841|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840930|NCT00739973|365073842|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840931|NCT00739973|365073843|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840932|NCT00739973|365073844|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840933|NCT00739973|365073845|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840934|NCT00739973|365073837|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
105840935|NCT00739973|365073838|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105840936|NCT00739973|365073839|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105840937|NCT00739973|365073840|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105840938|NCT00739973|365073841|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105840939|NCT00739973|365073842|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105312259|NCT03553576|363141056|FG001|Overall Study|Physician Decision|5|||
105367991|NCT01548404|363354099|FG000|Overall Study|Withdrawal by Subject|0|||
105367992|NCT01548404|363354100|FG001|Overall Study|Withdrawal by Subject|3|||
105840940|NCT00739973|365073843|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105840941|NCT00739973|365073844|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105367993|NCT01548404|363354099|FG000|Overall Study|Other than specified above|0|||
105367994|NCT01548404|363354100|FG001|Overall Study|Other than specified above|2|||
105367995|NCT00239720|363354101|FG000|Overall Study|Adverse Event|1|||
105367996|NCT00239720|363354102|FG001|Overall Study|Adverse Event|0|||
105840942|NCT00739973|365073845|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105840943|NCT00739973|365073837|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
105840944|NCT00739973|365073838|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840945|NCT00739973|365073839|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840946|NCT00739973|365073840|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840947|NCT00739973|365073841|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840948|NCT00739973|365073842|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840949|NCT00739973|365073843|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840950|NCT00739973|365073844|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840951|NCT00739973|365073845|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840952|NCT00739973|365073837|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
105840953|NCT00739973|365073838|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840954|NCT00739973|365073839|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840955|NCT00739973|365073840|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840956|NCT00739973|365073841|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840957|NCT00739973|365073842|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840958|NCT00739973|365073843|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840959|NCT00739973|365073844|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840960|NCT00739973|365073845|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840961|NCT00739973|365073837|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
105840962|NCT00739973|365073838|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840963|NCT00739973|365073839|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840964|NCT00739973|365073840|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840965|NCT00739973|365073841|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840966|NCT00739973|365073842|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840967|NCT00739973|365073843|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840968|NCT00739973|365073844|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840969|NCT00739973|365073845|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840970|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
105840971|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
105840972|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
105840973|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
105840974|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
105840975|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
105840976|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
105840977|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
105840978|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
105840979|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
105840980|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
105840981|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
105840982|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
105840983|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
105840984|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
105840985|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
105840986|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
105840987|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
105840988|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
105840989|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
105840990|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
105367997|NCT00239720|363354101|FG000|Overall Study|Lost to Follow-up|0|||
105367998|NCT00239720|363354102|FG001|Overall Study|Lost to Follow-up|1|||
105367999|NCT00606008|363354106|FG000|Overall Study|Adverse Event|1|||
105840991|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
105840992|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
105840993|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
105840994|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
105840995|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
105368000|NCT00606008|363354106|FG000|Overall Study|Withdrawal by Subject|4|||
105368001|NCT04400318|363354107|FG000|Overall Study|Adverse Event|1|||
105368002|NCT04400318|363354108|FG001|Overall Study|Adverse Event|0|||
105840996|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
105840997|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
105840998|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
105840999|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
105841000|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
105841001|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
105841002|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
105841003|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
105841004|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
105841005|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
105841006|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841007|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841008|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
105841009|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841010|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841011|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841012|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841013|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841014|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841015|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
105841016|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
105841017|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
105841018|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
105841019|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
105841020|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
105841021|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
105841022|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
105841023|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
105841024|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
105841025|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
105841026|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
105841027|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
105841028|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
105841029|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
105841030|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
105312260|NCT01671332|363141057|FG000|Overall Study|Withdrawal by Subject|1|||
105312261|NCT01671332|363141058|FG001|Overall Study|Withdrawal by Subject|1|||
105312262|NCT00205803|363141059|FG000|Infant Series|Lost to Follow-up|10|||
105312263|NCT00205803|363141060|FG001|Infant Series|Lost to Follow-up|4|||
105312264|NCT00205803|363141059|FG000|Infant Series|Withdrawal by Subject|2|||
105312265|NCT00205803|363141060|FG001|Infant Series|Withdrawal by Subject|5|||
105312266|NCT00205803|363141059|FG000|Infant Series|Physician Decision|3|||
105312267|NCT00205803|363141060|FG001|Infant Series|Physician Decision|1|||
105312268|NCT00205803|363141059|FG000|Infant Series|Protocol Violation|1|||
105312269|NCT00205803|363141060|FG001|Infant Series|Protocol Violation|0|||
105312270|NCT00205803|363141059|FG000|Infant Series|Lost Kaiser coverage|0|||
105312271|NCT00205803|363141060|FG001|Infant Series|Lost Kaiser coverage|1|||
105312272|NCT00205803|363141059|FG000|Infant Series|Non-compliant|1|||
105312273|NCT00205803|363141060|FG001|Infant Series|Non-compliant|0|||
105312274|NCT00205803|363141059|FG000|Infant Series|Sponsor request|1|||
105312275|NCT00205803|363141060|FG001|Infant Series|Sponsor request|0|||
105312276|NCT00205803|363141059|FG000|After Infant Series|Adverse Event|1|||
105312277|NCT00205803|363141060|FG001|After Infant Series|Adverse Event|1|||
105312278|NCT00205803|363141059|FG000|After Infant Series|Protocol Violation|1|||
105312279|NCT00205803|363141060|FG001|After Infant Series|Protocol Violation|1|||
105312280|NCT00205803|363141059|FG000|After Infant Series|Lost to Follow-up|2|||
105312281|NCT00205803|363141060|FG001|After Infant Series|Lost to Follow-up|1|||
105312282|NCT00205803|363141059|FG000|After Infant Series|Physician Decision|3|||
105312283|NCT00205803|363141060|FG001|After Infant Series|Physician Decision|2|||
105312284|NCT00205803|363141059|FG000|After Infant Series|Withdrawal by Subject|1|||
105312285|NCT00205803|363141060|FG001|After Infant Series|Withdrawal by Subject|4|||
105312286|NCT00205803|363141059|FG000|After Infant Series|Other|10|||
105312287|NCT00205803|363141060|FG001|After Infant Series|Other|4|||
105368003|NCT04400318|363354107|FG000|Overall Study|Withdrawal by Subject|1|||
105312288|NCT00205803|363141059|FG000|Toddler Dose|Lost to Follow-up|2|||
105312289|NCT00205803|363141060|FG001|Toddler Dose|Lost to Follow-up|3|||
105312290|NCT02369458|363141063|FG000|Overall Study|Determined to be not eligible|1|||
105312291|NCT02369458|363141064|FG001|Overall Study|Determined to be not eligible|0|||
105312292|NCT04572893|363141065|FG000|Part A|Adverse Event|1|||
105312293|NCT04572893|363141066|FG001|Part A|Adverse Event|0|||
105312294|NCT04572893|363141067|FG002|Part A|Adverse Event|0|||
105312295|NCT04572893|363141068|FG003|Part A|Adverse Event|0|||
105312296|NCT04572893|363141069|FG004|Part A|Adverse Event|0|||
105312297|NCT04572893|363141070|FG005|Part A|Adverse Event|0|||
105312298|NCT04572893|363141071|FG006|Part A|Adverse Event|0|||
105312299|NCT04572893|363141065|FG000|Part B|Withdrawal by Subject|0|||
105312300|NCT04572893|363141066|FG001|Part B|Withdrawal by Subject|0|||
105312301|NCT04572893|363141067|FG002|Part B|Withdrawal by Subject|0|||
105312302|NCT04572893|363141068|FG003|Part B|Withdrawal by Subject|0|||
105312303|NCT04572893|363141069|FG004|Part B|Withdrawal by Subject|0|||
105312304|NCT04572893|363141070|FG005|Part B|Withdrawal by Subject|1|||
105312305|NCT04572893|363141071|FG006|Part B|Withdrawal by Subject|0|||
105312306|NCT04572893|363141065|FG000|Part B|Study terminated by sponsor|0|||
105312307|NCT04572893|363141066|FG001|Part B|Study terminated by sponsor|0|||
105312308|NCT04572893|363141067|FG002|Part B|Study terminated by sponsor|0|||
105312309|NCT04572893|363141068|FG003|Part B|Study terminated by sponsor|0|||
105312310|NCT04572893|363141069|FG004|Part B|Study terminated by sponsor|7|||
105312311|NCT04572893|363141070|FG005|Part B|Study terminated by sponsor|5|||
105312312|NCT04572893|363141071|FG006|Part B|Study terminated by sponsor|3|||
105312313|NCT04572893|363141065|FG000|Part B|Lost to Follow-up|0|||
105312314|NCT04572893|363141066|FG001|Part B|Lost to Follow-up|0|||
105312315|NCT04572893|363141067|FG002|Part B|Lost to Follow-up|0|||
105312316|NCT04572893|363141068|FG003|Part B|Lost to Follow-up|0|||
105312317|NCT04572893|363141069|FG004|Part B|Lost to Follow-up|0|||
105312318|NCT04572893|363141070|FG005|Part B|Lost to Follow-up|0|||
105312319|NCT04572893|363141071|FG006|Part B|Lost to Follow-up|1|||
105312320|NCT04572893|363141065|FG000|Part B|Adverse Event|0|||
105312321|NCT04572893|363141066|FG001|Part B|Adverse Event|0|||
105312322|NCT04572893|363141067|FG002|Part B|Adverse Event|0|||
105312323|NCT04572893|363141068|FG003|Part B|Adverse Event|0|||
105312324|NCT04572893|363141069|FG004|Part B|Adverse Event|1|||
105312325|NCT04572893|363141070|FG005|Part B|Adverse Event|1|||
105312326|NCT04572893|363141071|FG006|Part B|Adverse Event|0|||
105312327|NCT00121134|363141072|FG000|Overall Study|Progression of Disease|5|||
105312328|NCT00121134|363141073|FG001|Overall Study|Progression of Disease|3|||
105312329|NCT00121134|363141074|FG002|Overall Study|Progression of Disease|4|||
105312330|NCT00121134|363141075|FG003|Overall Study|Progression of Disease|2|||
105312331|NCT00121134|363141072|FG000|Overall Study|Toxicity|4|||
105312332|NCT00121134|363141073|FG001|Overall Study|Toxicity|7|||
105312333|NCT00121134|363141074|FG002|Overall Study|Toxicity|13|||
105312334|NCT00121134|363141075|FG003|Overall Study|Toxicity|5|||
105312335|NCT00121134|363141072|FG000|Overall Study|Physician Decision|6|||
105312336|NCT00121134|363141073|FG001|Overall Study|Physician Decision|4|||
105312337|NCT00121134|363141074|FG002|Overall Study|Physician Decision|4|||
105312338|NCT00121134|363141075|FG003|Overall Study|Physician Decision|1|||
105312339|NCT00121134|363141072|FG000|Overall Study|Treatment Delay|1|||
105312340|NCT00121134|363141073|FG001|Overall Study|Treatment Delay|0|||
105312341|NCT00121134|363141074|FG002|Overall Study|Treatment Delay|0|||
105312342|NCT00121134|363141075|FG003|Overall Study|Treatment Delay|0|||
105312343|NCT00121134|363141072|FG000|Overall Study|Intercurrent Illness|0|||
105312344|NCT00121134|363141073|FG001|Overall Study|Intercurrent Illness|0|||
105312345|NCT00121134|363141074|FG002|Overall Study|Intercurrent Illness|0|||
105312346|NCT00121134|363141075|FG003|Overall Study|Intercurrent Illness|1|||
105312347|NCT00121134|363141072|FG000|Overall Study|Patient Personal Reasons|0|||
105312348|NCT00121134|363141073|FG001|Overall Study|Patient Personal Reasons|1|||
105312349|NCT00121134|363141074|FG002|Overall Study|Patient Personal Reasons|0|||
105368004|NCT04400318|363354108|FG001|Overall Study|Withdrawal by Subject|1|||
105368005|NCT04400318|363354107|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
105368006|NCT04400318|363354108|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
105368007|NCT00752089|363354109|FG000|Overall Study|Adverse Event|1|||
105368008|NCT00752089|363354109|FG000|Overall Study|Protocol Deviation|2|||
105312350|NCT00121134|363141075|FG003|Overall Study|Patient Personal Reasons|0|||
105312351|NCT00658021|363141077|FG000|28-Week Treatment Period|Adverse Event|3|||
105312352|NCT00658021|363141078|FG001|28-Week Treatment Period|Adverse Event|1|||
105312353|NCT00658021|363141079|FG002|28-Week Treatment Period|Adverse Event|0|||
105312354|NCT00658021|363141077|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
105312355|NCT00658021|363141078|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
105312356|NCT00658021|363141079|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
105312357|NCT00658021|363141077|FG000|28-Week Treatment Period|Protocol Violation|0|||
105312358|NCT00658021|363141078|FG001|28-Week Treatment Period|Protocol Violation|2|||
105312359|NCT00658021|363141079|FG002|28-Week Treatment Period|Protocol Violation|1|||
105312360|NCT00658021|363141077|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
105312361|NCT00658021|363141078|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
105312362|NCT00658021|363141079|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
105841031|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
105841032|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
105841033|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105841034|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105841035|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105841036|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105312363|NCT00658021|363141077|FG000|28-Week Treatment Period|Physician Decision|1|||
105312364|NCT00658021|363141078|FG001|28-Week Treatment Period|Physician Decision|2|||
105312365|NCT00658021|363141079|FG002|28-Week Treatment Period|Physician Decision|1|||
105312366|NCT00658021|363141077|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
105312367|NCT00658021|363141078|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
105312368|NCT00658021|363141079|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
105312369|NCT00658021|363141077|FG000|28-Week Treatment Period|Loss of glucose control|1|||
105312370|NCT00658021|363141078|FG001|28-Week Treatment Period|Loss of glucose control|1|||
105312371|NCT00658021|363141079|FG002|28-Week Treatment Period|Loss of glucose control|10|||
105312372|NCT00658021|363141077|FG000|28-Week Treatment Period|Other|2|||
105312373|NCT00658021|363141078|FG001|28-Week Treatment Period|Other|3|||
105312374|NCT00658021|363141079|FG002|28-Week Treatment Period|Other|1|||
105312375|NCT00658021|363141077|FG000|28-Week Treatment Period|Did not receive treatment|2|||
105312376|NCT00658021|363141078|FG001|28-Week Treatment Period|Did not receive treatment|0|||
105312377|NCT00658021|363141079|FG002|28-Week Treatment Period|Did not receive treatment|0|||
105312378|NCT00658021|363141077|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
105312379|NCT00658021|363141078|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
105312380|NCT00658021|363141079|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
105312381|NCT00658021|363141077|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
105312382|NCT00658021|363141078|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
105312383|NCT00658021|363141079|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
105312384|NCT01806506|363141080|FG000|Overall Study|Lost to Follow-up|2|||
105312385|NCT01806506|363141081|FG001|Overall Study|Lost to Follow-up|1|||
105312386|NCT04614246|363141082|FG000|Overall Study|Adverse Event|0|||
105312387|NCT04614246|363141083|FG001|Overall Study|Adverse Event|1|||
105312388|NCT04614246|363141084|FG002|Overall Study|Adverse Event|1|||
105312389|NCT04614246|363141085|FG003|Overall Study|Adverse Event|2|||
105312390|NCT04614246|363141086|FG004|Overall Study|Adverse Event|1|||
105312391|NCT04614246|363141082|FG000|Overall Study|Lost to Follow-up|0|||
105312392|NCT04614246|363141083|FG001|Overall Study|Lost to Follow-up|1|||
105312393|NCT04614246|363141084|FG002|Overall Study|Lost to Follow-up|0|||
105312394|NCT04614246|363141085|FG003|Overall Study|Lost to Follow-up|1|||
105312395|NCT04614246|363141086|FG004|Overall Study|Lost to Follow-up|3|||
105312396|NCT04614246|363141082|FG000|Overall Study|Other reason|0|||
105312397|NCT04614246|363141083|FG001|Overall Study|Other reason|1|||
105312398|NCT04614246|363141084|FG002|Overall Study|Other reason|2|||
105312399|NCT04614246|363141085|FG003|Overall Study|Other reason|0|||
105312400|NCT04614246|363141086|FG004|Overall Study|Other reason|0|||
105312401|NCT04614246|363141082|FG000|Overall Study|Withdrawal by Subject|4|||
105312402|NCT04614246|363141083|FG001|Overall Study|Withdrawal by Subject|2|||
105312403|NCT04614246|363141084|FG002|Overall Study|Withdrawal by Subject|4|||
105312404|NCT04614246|363141085|FG003|Overall Study|Withdrawal by Subject|3|||
105312405|NCT04614246|363141086|FG004|Overall Study|Withdrawal by Subject|4|||
105312406|NCT04614246|363141082|FG000|Overall Study|Physician Decision|0|||
105312407|NCT04614246|363141083|FG001|Overall Study|Physician Decision|2|||
105312408|NCT04614246|363141084|FG002|Overall Study|Physician Decision|1|||
105312409|NCT04614246|363141085|FG003|Overall Study|Physician Decision|0|||
105312410|NCT04614246|363141086|FG004|Overall Study|Physician Decision|0|||
105312411|NCT04614246|363141082|FG000|Overall Study|Study terminated by sponsor|10|||
105312412|NCT04614246|363141083|FG001|Overall Study|Study terminated by sponsor|15|||
105312413|NCT04614246|363141084|FG002|Overall Study|Study terminated by sponsor|12|||
105312414|NCT04614246|363141085|FG003|Overall Study|Study terminated by sponsor|13|||
105312415|NCT04614246|363141086|FG004|Overall Study|Study terminated by sponsor|9|||
105312416|NCT04614246|363141082|FG000|Overall Study|Pregnancy|2|||
105312417|NCT04614246|363141083|FG001|Overall Study|Pregnancy|0|||
105312418|NCT04614246|363141084|FG002|Overall Study|Pregnancy|1|||
105312419|NCT04614246|363141085|FG003|Overall Study|Pregnancy|0|||
105312420|NCT04614246|363141086|FG004|Overall Study|Pregnancy|0|||
105312421|NCT05819203|363141091|FG000|Overall Study|Protocol Violation|1|||
105841037|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105312422|NCT05819203|363141092|FG001|Overall Study|Protocol Violation|2|||
105312423|NCT05819203|363141091|FG000|Overall Study|Withdrawal by Subject|1|||
105312424|NCT05819203|363141092|FG001|Overall Study|Withdrawal by Subject|0|||
105312425|NCT00477633|363141093|FG000|Overall Study|Did not receive treatment|23|||
105312426|NCT00477633|363141093|FG000|Overall Study|Adverse Event|143|||
105312427|NCT00477633|363141093|FG000|Overall Study|Pregnancy|23|||
105312428|NCT00477633|363141093|FG000|Overall Study|Lost to Follow-up|271|||
105841038|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105841039|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
105841040|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105841041|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105841042|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
105841043|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
105841044|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
105841045|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
105841046|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
105841047|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
105841048|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
105841049|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
105841050|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
105841051|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
105841052|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
105841053|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
105841054|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
105841055|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
105841056|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
105841057|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
105841058|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
105841059|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
105841060|NCT02737592|365073847|FG000|Overall Study|Withdrawal by Subject|1|||
105841061|NCT00576303|365073849|FG000|Dose Titration Period|Early withdrawal|17|||
105841062|NCT00576303|365073849|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
105841063|NCT00576303|365073849|FG000|Long Term Safety Period|Early withdrawal|16|||
105841064|NCT00824369|365073853|FG000|Overall Study|Nolonger willing to participate in study|1|||
105841065|NCT00824369|365073854|FG001|Overall Study|Nolonger willing to participate in study|0|||
105841066|NCT00824369|365073855|FG002|Overall Study|Nolonger willing to participate in study|1|||
105841067|NCT00824369|365073856|FG003|Overall Study|Nolonger willing to participate in study|2|||
105841068|NCT00824369|365073857|FG004|Overall Study|Nolonger willing to participate in study|0|||
105841069|NCT00824369|365073858|FG005|Overall Study|Nolonger willing to participate in study|1|||
105841070|NCT00824369|365073853|FG000|Overall Study|Lost to Follow-up|0|||
105841071|NCT00824369|365073854|FG001|Overall Study|Lost to Follow-up|0|||
105841072|NCT00824369|365073855|FG002|Overall Study|Lost to Follow-up|0|||
105841073|NCT00824369|365073856|FG003|Overall Study|Lost to Follow-up|0|||
105841074|NCT00824369|365073857|FG004|Overall Study|Lost to Follow-up|1|||
105841075|NCT00824369|365073858|FG005|Overall Study|Lost to Follow-up|0|||
105841076|NCT00248170|365073859|FG000|Overall Study|Withdrawal by Subject|71|||
105841077|NCT00248170|365073860|FG001|Overall Study|Withdrawal by Subject|79|||
105841078|NCT00248170|365073859|FG000|Overall Study|Protocol Violation|35|||
105841079|NCT00248170|365073860|FG001|Overall Study|Protocol Violation|30|||
105841080|NCT00248170|365073859|FG000|Overall Study|Lost to Follow-up|28|||
105841081|NCT00248170|365073860|FG001|Overall Study|Lost to Follow-up|35|||
105841082|NCT00248170|365073859|FG000|Overall Study|Disease progression|196|||
105841083|NCT00248170|365073860|FG001|Overall Study|Disease progression|216|||
105841084|NCT00248170|365073859|FG000|Overall Study|Death|28|||
105841085|NCT00248170|365073860|FG001|Overall Study|Death|47|||
105841086|NCT00248170|365073859|FG000|Overall Study|Adverse Event|311|||
105841087|NCT00248170|365073860|FG001|Overall Study|Adverse Event|296|||
105841088|NCT00248170|365073859|FG000|Overall Study|Administrative problems|22|||
105841089|NCT00248170|365073860|FG001|Overall Study|Administrative problems|25|||
105841090|NCT00248170|365073859|FG000|Overall Study|Abnormal test procedure(s) result|49|||
105841091|NCT00248170|365073860|FG001|Overall Study|Abnormal test procedure(s) result|61|||
105841092|NCT00248170|365073859|FG000|Overall Study|Abnormal laboratory values|4|||
105841093|NCT00248170|365073860|FG001|Overall Study|Abnormal laboratory values|0|||
105841094|NCT00248170|365073859|FG000|Overall Study|Protocol deviation|17|||
105841095|NCT00248170|365073860|FG001|Overall Study|Protocol deviation|19|||
105841096|NCT03123783|365073865|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
105841097|NCT03123783|365073866|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
105841098|NCT03123783|365073867|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
105312429|NCT00477633|363141093|FG000|Overall Study|Withdrawal by Subject|149|||
105312430|NCT00477633|363141093|FG000|Overall Study|Protocol Violation|25|||
105312431|NCT00477633|363141093|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
105841099|NCT03123783|365073868|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
105841100|NCT03123783|365073869|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
105841101|NCT03123783|365073870|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
105841102|NCT03123783|365073871|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
105841103|NCT03123783|365073865|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
105489967|NCT01907100|363805708|FG003|Overall Study|Other than reasons specified|6|||
105841104|NCT03123783|365073866|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
105841105|NCT03123783|365073867|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
105841106|NCT03123783|365073868|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
105841107|NCT03123783|365073869|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
105841108|NCT03123783|365073870|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
105841109|NCT03123783|365073871|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
105841110|NCT03123783|365073865|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
105841111|NCT03123783|365073866|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
105841112|NCT03123783|365073867|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
105841113|NCT03123783|365073868|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
105841114|NCT03123783|365073869|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
105841115|NCT03123783|365073870|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
105841116|NCT03123783|365073871|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
105841117|NCT03123783|365073865|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
105841118|NCT03123783|365073866|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
105841119|NCT03123783|365073867|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
105841120|NCT03123783|365073868|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
105841121|NCT03123783|365073869|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
105841122|NCT03123783|365073870|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
105841123|NCT03123783|365073871|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
105841124|NCT01507090|365073877|FG000|Overall Study|incomplete dataset|18|||
105841125|NCT00952276|365073880|FG000|Overall Study|Withdrawal by Subject|1|||
105841126|NCT00952276|365073881|FG001|Overall Study|Withdrawal by Subject|0|||
105841127|NCT00952276|365073882|FG002|Overall Study|Withdrawal by Subject|0|||
105841128|NCT00952276|365073883|FG003|Overall Study|Withdrawal by Subject|1|||
105841129|NCT00952276|365073884|FG004|Overall Study|Withdrawal by Subject|0|||
105841130|NCT02985879|365073885|FG000|Overall Study|Adverse Event|7|||
105841131|NCT02985879|365073886|FG001|Overall Study|Adverse Event|9|||
105841132|NCT02985879|365073887|FG002|Overall Study|Adverse Event|7|||
105841133|NCT02985879|365073885|FG000|Overall Study|Withdrew consent|6|||
105841134|NCT02985879|365073886|FG001|Overall Study|Withdrew consent|8|||
105841135|NCT02985879|365073887|FG002|Overall Study|Withdrew consent|10|||
105841136|NCT02985879|365073885|FG000|Overall Study|Lost to Follow-up|1|||
105841137|NCT02985879|365073886|FG001|Overall Study|Lost to Follow-up|0|||
105841138|NCT02985879|365073887|FG002|Overall Study|Lost to Follow-up|2|||
105841139|NCT02985879|365073885|FG000|Overall Study|Other, not specified|62|||
105841140|NCT02985879|365073886|FG001|Overall Study|Other, not specified|58|||
105841141|NCT02985879|365073887|FG002|Overall Study|Other, not specified|58|||
105841142|NCT04086641|365075196|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
105841143|NCT04086641|365075197|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
105841144|NCT04776746|365075200|FG000|Overall Study|Study terminated by sponsor|61|||
105841145|NCT04776746|365075200|FG000|Overall Study|Adverse Event|5|||
105841146|NCT04776746|365075200|FG000|Overall Study|Death|4|||
105841147|NCT04776746|365075200|FG000|Overall Study|Lack of Efficacy|3|||
105312432|NCT02203331|363141097|FG000|Overall Study|Pregnancy|1|||
105312433|NCT02203331|363141098|FG001|Overall Study|Pregnancy|0|||
105312434|NCT02203331|363141099|FG002|Overall Study|Pregnancy|0|||
105312435|NCT02203331|363141100|FG003|Overall Study|Pregnancy|0|||
105312436|NCT02203331|363141101|FG004|Overall Study|Pregnancy|2|||
105312437|NCT02203331|363141102|FG005|Overall Study|Pregnancy|0|||
105489968|NCT01907100|363805705|FG000|Overall Study|Adverse event (AE)|6|||
105841148|NCT04776746|365075200|FG000|Overall Study|Noncompliance with study drug|2|||
105841149|NCT04776746|365075200|FG000|Overall Study|Not related to COVID-19|2|||
105841150|NCT01652729|365075201|FG000|Overall Study|Withdrawal by Subject|14|||
105841151|NCT01652729|365075202|FG001|Overall Study|Withdrawal by Subject|7|||
105841152|NCT01652729|365075203|FG002|Overall Study|Withdrawal by Subject|7|||
105841153|NCT01652729|365075201|FG000|Overall Study|Adverse Event|4|||
105841154|NCT01652729|365075202|FG001|Overall Study|Adverse Event|0|||
105841155|NCT01652729|365075203|FG002|Overall Study|Adverse Event|3|||
105841156|NCT01652729|365075201|FG000|Overall Study|Physician Decision|1|||
105841157|NCT01652729|365075202|FG001|Overall Study|Physician Decision|0|||
105841158|NCT01652729|365075203|FG002|Overall Study|Physician Decision|1|||
105841159|NCT01652729|365075201|FG000|Overall Study|Protocol Violation|1|||
105841160|NCT01652729|365075202|FG001|Overall Study|Protocol Violation|0|||
105841161|NCT01652729|365075203|FG002|Overall Study|Protocol Violation|0|||
105841162|NCT01652729|365075201|FG000|Overall Study|Lost to Follow-up|6|||
105841163|NCT01652729|365075202|FG001|Overall Study|Lost to Follow-up|6|||
105312438|NCT02203331|363141097|FG000|Overall Study|Withdrawal by Subject|1|||
105312439|NCT02203331|363141098|FG001|Overall Study|Withdrawal by Subject|0|||
105312440|NCT02203331|363141099|FG002|Overall Study|Withdrawal by Subject|1|||
105312441|NCT02203331|363141100|FG003|Overall Study|Withdrawal by Subject|0|||
105312442|NCT02203331|363141101|FG004|Overall Study|Withdrawal by Subject|0|||
105312443|NCT02203331|363141102|FG005|Overall Study|Withdrawal by Subject|3|||
105312444|NCT02203331|363141097|FG000|Overall Study|Adverse Event|4|||
105312445|NCT02203331|363141098|FG001|Overall Study|Adverse Event|8|||
105312446|NCT02203331|363141099|FG002|Overall Study|Adverse Event|3|||
105312447|NCT02203331|363141100|FG003|Overall Study|Adverse Event|4|||
105312448|NCT02203331|363141101|FG004|Overall Study|Adverse Event|3|||
105312449|NCT02203331|363141102|FG005|Overall Study|Adverse Event|3|||
105312450|NCT02203331|363141097|FG000|Overall Study|Other Reasons|1|||
105312451|NCT02203331|363141098|FG001|Overall Study|Other Reasons|2|||
105312452|NCT02203331|363141099|FG002|Overall Study|Other Reasons|0|||
105312453|NCT02203331|363141100|FG003|Overall Study|Other Reasons|2|||
105312454|NCT02203331|363141101|FG004|Overall Study|Other Reasons|0|||
105312455|NCT02203331|363141102|FG005|Overall Study|Other Reasons|0|||
105312456|NCT02203331|363141097|FG000|Overall Study|Lack of Efficacy|0|||
105312457|NCT02203331|363141098|FG001|Overall Study|Lack of Efficacy|2|||
105312458|NCT02203331|363141099|FG002|Overall Study|Lack of Efficacy|1|||
105312459|NCT02203331|363141100|FG003|Overall Study|Lack of Efficacy|0|||
105312460|NCT02203331|363141101|FG004|Overall Study|Lack of Efficacy|0|||
105312461|NCT02203331|363141102|FG005|Overall Study|Lack of Efficacy|1|||
105312462|NCT02203331|363141097|FG000|Overall Study|Protocol Violation|0|||
105312463|NCT02203331|363141098|FG001|Overall Study|Protocol Violation|2|||
105312464|NCT02203331|363141099|FG002|Overall Study|Protocol Violation|0|||
105312465|NCT02203331|363141100|FG003|Overall Study|Protocol Violation|1|||
105312466|NCT02203331|363141101|FG004|Overall Study|Protocol Violation|1|||
105312467|NCT02203331|363141102|FG005|Overall Study|Protocol Violation|0|||
105312468|NCT02203331|363141097|FG000|Overall Study|Lost to Follow-up|0|||
105312469|NCT02203331|363141098|FG001|Overall Study|Lost to Follow-up|0|||
105312470|NCT02203331|363141099|FG002|Overall Study|Lost to Follow-up|0|||
105312471|NCT02203331|363141100|FG003|Overall Study|Lost to Follow-up|0|||
105312472|NCT02203331|363141101|FG004|Overall Study|Lost to Follow-up|1|||
105312473|NCT02203331|363141102|FG005|Overall Study|Lost to Follow-up|0|||
105312474|NCT01374269|363141110|FG000|Overall Study|Withdrawal by Subject|4|||
105312475|NCT01374269|363141111|FG001|Overall Study|Withdrawal by Subject|0|||
105312476|NCT01374269|363141110|FG000|Overall Study|Lost to Follow-up|1|||
105312477|NCT01374269|363141111|FG001|Overall Study|Lost to Follow-up|3|||
105312478|NCT01374269|363141110|FG000|Overall Study|closed research|1|||
105312479|NCT01374269|363141111|FG001|Overall Study|closed research|2|||
105312480|NCT04007991|363141112|FG000|Overall Study|Withdrawal by Subject|1|||
105312481|NCT04007991|363141113|FG001|Overall Study|Withdrawal by Subject|1|||
105312482|NCT04007991|363141112|FG000|Overall Study|Physician Decision|1|||
105312483|NCT04007991|363141113|FG001|Overall Study|Physician Decision|1|||
105312484|NCT04007991|363141112|FG000|Overall Study|Non-compliance with Study Drug|0|||
105312485|NCT04007991|363141113|FG001|Overall Study|Non-compliance with Study Drug|1|||
105312486|NCT04007991|363141112|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
105312487|NCT04007991|363141113|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
105312488|NCT04007991|363141112|FG000|Overall Study|Adverse event, non-fatal|5|||
105312489|NCT04007991|363141113|FG001|Overall Study|Adverse event, non-fatal|0|||
105312490|NCT04007991|363141112|FG000|Overall Study|Lost to Follow-up|2|||
105312491|NCT04007991|363141113|FG001|Overall Study|Lost to Follow-up|1|||
105312492|NCT01987479|363141114|FG000|Overall Study|Protocol Violation|1|||
105312493|NCT01987479|363141114|FG000|Overall Study|Physician Decision|2|||
105312494|NCT01987479|363141114|FG000|Overall Study|Participant/legal guardian decision|1|||
105312495|NCT01987479|363141114|FG000|Overall Study|Other|5|||
105312496|NCT01987479|363141114|FG000|Overall Study|Lost to Follow-up|1|||
105312497|NCT01987479|363141114|FG000|Overall Study|Adverse Event|7|||
105312498|NCT00805467|363143868|FG000|Overall Study|Lack of Efficacy|0|||
105312499|NCT00805467|363143869|FG001|Overall Study|Lack of Efficacy|8|||
105312500|NCT00805467|363143870|FG002|Overall Study|Lack of Efficacy|13|||
105312501|NCT00805467|363143871|FG003|Overall Study|Lack of Efficacy|86|||
105312502|NCT00805467|363143868|FG000|Overall Study|Lost to Follow-up|0|||
105312503|NCT00805467|363143869|FG001|Overall Study|Lost to Follow-up|1|||
105368009|NCT00752089|363354109|FG000|Overall Study|Could not attend visit 9|1|||
105368010|NCT00752089|363354109|FG000|Overall Study|Not capable of wearing partial denture|1|||
105368011|NCT00752089|363354109|FG000|Overall Study|Cannot continue the study|1|||
105368012|NCT00785356|363354112|FG000|Overall Study|Study prematurely terminated|8|||
105368013|NCT03238417|363354114|FG000|Overall|non-response|955|||
105368014|NCT03238417|363354115|FG001|Overall|non-response|1920|||
105368015|NCT03238417|363354114|FG000|Overall|partial completion|48|||
105368016|NCT03238417|363354115|FG001|Overall|partial completion|68|||
105489969|NCT01907100|363805706|FG001|Overall Study|Adverse event (AE)|3|||
105312504|NCT00805467|363143870|FG002|Overall Study|Lost to Follow-up|7|||
105312505|NCT00805467|363143871|FG003|Overall Study|Lost to Follow-up|21|||
105312506|NCT00805467|363143868|FG000|Overall Study|Withdrawal by Subject|0|||
105312507|NCT00805467|363143869|FG001|Overall Study|Withdrawal by Subject|6|||
105368017|NCT03238417|363354114|FG000|Baseline|Partial completion|17|||
105489970|NCT01907100|363805707|FG002|Overall Study|Adverse event (AE)|22|||
105312508|NCT00805467|363143870|FG002|Overall Study|Withdrawal by Subject|45|||
105841164|NCT01652729|365075203|FG002|Overall Study|Lost to Follow-up|3|||
105841165|NCT01652729|365075201|FG000|Overall Study|Administrative|1|||
105841166|NCT01652729|365075202|FG001|Overall Study|Administrative|0|||
105841167|NCT01652729|365075203|FG002|Overall Study|Administrative|0|||
105841168|NCT00126126|365075204|FG000|Overall Study|Lost to Follow-up|0|||
105841169|NCT00126126|365075205|FG001|Overall Study|Lost to Follow-up|2|||
105841170|NCT02459665|365075206|FG000|Overall Study|Withdrawal by Subject|0|||
105841171|NCT02459665|365075207|FG001|Overall Study|Withdrawal by Subject|1|||
105841172|NCT02459665|365075208|FG002|Overall Study|Withdrawal by Subject|1|||
105841173|NCT02459665|365075209|FG003|Overall Study|Withdrawal by Subject|2|||
105841174|NCT01567826|365075210|FG000|Overall Study|Lost to Follow-up|3|||
105841175|NCT01567826|365075211|FG001|Overall Study|Lost to Follow-up|2|||
105841176|NCT04364737|365075212|FG000|Overall Study|Withdrawal by Subject|4|||
105841177|NCT04364737|365075213|FG001|Overall Study|Withdrawal by Subject|9|||
105841178|NCT04364737|365075212|FG000|Overall Study|Lost to Follow-up|1|||
105841179|NCT04364737|365075213|FG001|Overall Study|Lost to Follow-up|1|||
105841180|NCT00868296|365075214|FG000|Overall Study|Adverse Event|0|||
105841181|NCT00868296|365075215|FG001|Overall Study|Adverse Event|2|||
105841182|NCT00868296|365075214|FG000|Overall Study|Withdrawal by Subject|0|||
105841183|NCT00868296|365075215|FG001|Overall Study|Withdrawal by Subject|1|||
105841184|NCT01280617|365075220|FG000|Overall Study|Adverse Event|0|||
105841185|NCT01280617|365075221|FG001|Overall Study|Adverse Event|1|||
105841186|NCT01311557|365075222|FG000|Overall Study|Serious adverse event|0|||
105841187|NCT01311557|365075223|FG001|Overall Study|Serious adverse event|1|||
105841188|NCT01311557|365075222|FG000|Overall Study|Protocol Violation|4|||
105841189|NCT01311557|365075223|FG001|Overall Study|Protocol Violation|2|||
105841190|NCT01311557|365075222|FG000|Overall Study|Lost to Follow-up|0|||
105841191|NCT01311557|365075223|FG001|Overall Study|Lost to Follow-up|1|||
105841192|NCT01311557|365075222|FG000|Overall Study|Withdrawal by Subject|1|||
105841193|NCT01311557|365075223|FG001|Overall Study|Withdrawal by Subject|2|||
105841194|NCT02418455|365075224|FG000|48-Week Treatment Period|Other- Not Specified|1|||
105841195|NCT02418455|365075224|FG000|Continuation Period|Sponsor Decision|7|||
105841196|NCT02457611|365075225|FG000|Overall Study|Lost to Follow-up|3|||
105841197|NCT00384293|365075226|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
105841198|NCT00384293|365075227|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
105841199|NCT00384293|365075228|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
105841200|NCT00384293|365075226|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
105841201|NCT00384293|365075227|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
105841202|NCT00384293|365075228|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
105841203|NCT00384293|365075226|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
105841204|NCT00384293|365075227|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
105841205|NCT00384293|365075228|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
105841206|NCT00384293|365075226|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
105841207|NCT00384293|365075227|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
105841208|NCT00384293|365075228|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
105841209|NCT00384293|365075226|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
105841210|NCT00384293|365075227|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
105841211|NCT00384293|365075228|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
105841212|NCT00384293|365075226|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
105841213|NCT00384293|365075227|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
105312509|NCT00805467|363143871|FG003|Overall Study|Withdrawal by Subject|50|||
105312510|NCT00805467|363143868|FG000|Overall Study|Protocol Violation|0|||
105312511|NCT00805467|363143869|FG001|Overall Study|Protocol Violation|3|||
105312512|NCT00805467|363143870|FG002|Overall Study|Protocol Violation|0|||
105312513|NCT00805467|363143871|FG003|Overall Study|Protocol Violation|5|||
105312514|NCT00805467|363143868|FG000|Overall Study|Adverse Event|0|||
105312515|NCT00805467|363143869|FG001|Overall Study|Adverse Event|13|||
105312516|NCT00805467|363143870|FG002|Overall Study|Adverse Event|26|||
105312517|NCT00805467|363143871|FG003|Overall Study|Adverse Event|57|||
105312518|NCT00805467|363143868|FG000|Overall Study|Death|0|||
105312519|NCT00805467|363143869|FG001|Overall Study|Death|2|||
105312520|NCT00805467|363143870|FG002|Overall Study|Death|7|||
105312521|NCT00805467|363143871|FG003|Overall Study|Death|5|||
105841214|NCT00384293|365075228|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
105841215|NCT00384293|365075226|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
105841216|NCT00384293|365075227|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
105841217|NCT00384293|365075228|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
105841218|NCT00384293|365075226|FG000|Post-randomization Period|Adverse Event|0|||
105841219|NCT00384293|365075227|FG001|Post-randomization Period|Adverse Event|23|||
105312522|NCT00805467|363143868|FG000|Overall Study|Physician Decision|0|||
105312523|NCT00805467|363143869|FG001|Overall Study|Physician Decision|1|||
105312524|NCT00805467|363143870|FG002|Overall Study|Physician Decision|2|||
105489971|NCT01907100|363805708|FG003|Overall Study|Adverse event (AE)|23|||
105489972|NCT01907100|363805705|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
105489973|NCT01907100|363805706|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
105489974|NCT01907100|363805707|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
105489975|NCT01907100|363805708|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
105489976|NCT03112590|363805709|FG000|Overall Study|Adverse Event|0|||
105489977|NCT03112590|363805710|FG001|Overall Study|Adverse Event|1|||
105489978|NCT03112590|363805711|FG002|Overall Study|Adverse Event|0|||
105489979|NCT01758289|363805712|FG000|Overall Study|Premature Study Termination|44|||
105489980|NCT01758289|363805712|FG000|Overall Study|Adverse Event|9|||
105489981|NCT02059005|363805715|FG000|Overall Study|Death|1|||
105489982|NCT02059005|363805716|FG001|Overall Study|Death|3|||
105489983|NCT02059005|363805715|FG000|Overall Study|Lost to Follow-up|19|||
105489984|NCT02059005|363805716|FG001|Overall Study|Lost to Follow-up|19|||
105489985|NCT02059005|363805715|FG000|Overall Study|Incarceration|0|||
105489986|NCT02059005|363805716|FG001|Overall Study|Incarceration|1|||
105489987|NCT02059005|363805715|FG000|Overall Study|Inpatient|0|||
105489988|NCT02059005|363805716|FG001|Overall Study|Inpatient|1|||
105489989|NCT01436162|363805718|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
105489990|NCT01436162|363805719|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
105489991|NCT01436162|363805720|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
105489992|NCT01436162|363805718|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
105489993|NCT01436162|363805719|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
105489994|NCT01436162|363805720|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
105489995|NCT01436162|363805718|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
105489996|NCT01436162|363805719|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
105489997|NCT01436162|363805720|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
105489998|NCT01436162|363805718|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
105489999|NCT01436162|363805719|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
105490000|NCT01436162|363805720|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
105490001|NCT01436162|363805718|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
105490002|NCT01436162|363805719|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
105490003|NCT01436162|363805720|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
105490004|NCT01436162|363805718|FG000|Single-blind Lead-in Phase|Other|107|||
105841220|NCT00384293|365075228|FG002|Post-randomization Period|Adverse Event|7|||
105490005|NCT01436162|363805719|FG001|Single-blind Lead-in Phase|Other|0|||
105490006|NCT01436162|363805720|FG002|Single-blind Lead-in Phase|Other|0|||
105490007|NCT01436162|363805718|FG000|Randomized Phase|Adverse Event|1|||
105490008|NCT01436162|363805719|FG001|Randomized Phase|Adverse Event|5|||
105490009|NCT01436162|363805720|FG002|Randomized Phase|Adverse Event|6|||
105841221|NCT00384293|365075226|FG000|Post-randomization Period|Lost to Follow-up|0|||
105841222|NCT00384293|365075227|FG001|Post-randomization Period|Lost to Follow-up|2|||
105841223|NCT00384293|365075228|FG002|Post-randomization Period|Lost to Follow-up|1|||
105841224|NCT00384293|365075226|FG000|Post-randomization Period|Protocol Violation|0|||
105841225|NCT00384293|365075227|FG001|Post-randomization Period|Protocol Violation|1|||
105841226|NCT00384293|365075228|FG002|Post-randomization Period|Protocol Violation|0|||
105841227|NCT00384293|365075226|FG000|Post-randomization Period|Withdrawal by Subject|0|||
105841228|NCT00384293|365075227|FG001|Post-randomization Period|Withdrawal by Subject|8|||
105841229|NCT00384293|365075228|FG002|Post-randomization Period|Withdrawal by Subject|6|||
105841230|NCT00384293|365075226|FG000|Post-randomization Period|Trial Termination|0|||
105841231|NCT00384293|365075227|FG001|Post-randomization Period|Trial Termination|180|||
105841232|NCT00384293|365075228|FG002|Post-randomization Period|Trial Termination|204|||
105841233|NCT00384293|365075226|FG000|Post-randomization Period|Patient Randomized in Error|0|||
105841234|NCT00384293|365075227|FG001|Post-randomization Period|Patient Randomized in Error|0|||
105841235|NCT00384293|365075228|FG002|Post-randomization Period|Patient Randomized in Error|1|||
105841236|NCT00194792|365075235|FG000|Overall Study|Withdrawal by Subject|1|||
105841237|NCT00493454|365075236|FG000|Overall Study|Withdrawal by Subject|1|||
105841238|NCT03585959|365075237|FG000|Overall Study|Physician Decision|1|||
105841239|NCT03585959|365075237|FG000|Overall Study|Unsuccessful Procedure|2|||
105841240|NCT03920280|365075238|FG000|Overall Study|Adverse Event|2|||
105841241|NCT03920280|365075239|FG001|Overall Study|Adverse Event|3|||
105841242|NCT03920280|365075238|FG000|Overall Study|Lost to Follow-up|0|||
105841243|NCT03920280|365075239|FG001|Overall Study|Lost to Follow-up|1|||
105841244|NCT03920280|365075238|FG000|Overall Study|Withdrawal by Subject|1|||
105841245|NCT03920280|365075239|FG001|Overall Study|Withdrawal by Subject|1|||
105841246|NCT03920280|365075238|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
105841247|NCT03920280|365075239|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
105841248|NCT01557920|365075240|FG000|Overall Study|Withdrawal by Subject|2|||
105841249|NCT01557920|365075241|FG001|Overall Study|Withdrawal by Subject|3|||
105841250|NCT01557920|365075240|FG000|Overall Study|Lack of Efficacy|1|||
105490010|NCT01436162|363805718|FG000|Randomized Phase|Protocol Violation|4|||
105490011|NCT01436162|363805719|FG001|Randomized Phase|Protocol Violation|4|||
105490012|NCT01436162|363805720|FG002|Randomized Phase|Protocol Violation|2|||
105841251|NCT01557920|365075241|FG001|Overall Study|Lack of Efficacy|0|||
105841252|NCT05444543|365075251|FG000|Overall Study|Withdrawal by Subject|1|||
105841253|NCT05444543|365075252|FG001|Overall Study|Withdrawal by Subject|0|||
105841254|NCT05444543|365075251|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
105841255|NCT05444543|365075252|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
105841256|NCT05444543|365075251|FG000|Overall Study|Adverse Event|0|||
105841257|NCT05444543|365075252|FG001|Overall Study|Adverse Event|1|||
105841258|NCT05444543|365075251|FG000|Overall Study|Family relocating at a distance from study site|0|||
105841259|NCT05444543|365075252|FG001|Overall Study|Family relocating at a distance from study site|1|||
105841260|NCT01261624|365075253|FG000|Week 0 to Week 12|Disease Progression|1|||
105841261|NCT01261624|365075254|FG001|Week 0 to Week 12|Disease Progression|1|||
105841262|NCT01261624|365075253|FG000|Week 0 to Week 12|Insufficient Response|0|||
105841263|NCT01261624|365075254|FG001|Week 0 to Week 12|Insufficient Response|2|||
105841264|NCT01261624|365075253|FG000|Week 13 to Week 24|Insufficient Response|0|||
105841265|NCT01261624|365075254|FG001|Week 13 to Week 24|Insufficient Response|1|||
105841266|NCT01134627|365075261|FG000|Overall Study|Adverse Event|47|||
105841267|NCT01134627|365075262|FG001|Overall Study|Adverse Event|31|||
105841268|NCT01134627|365075261|FG000|Overall Study|Lost to Follow-up|1|||
105841269|NCT01134627|365075262|FG001|Overall Study|Lost to Follow-up|2|||
105841270|NCT01134627|365075261|FG000|Overall Study|Protocol Violation|3|||
105841271|NCT01134627|365075262|FG001|Overall Study|Protocol Violation|5|||
105841272|NCT01134627|365075261|FG000|Overall Study|Lack of Efficacy|2|||
105841273|NCT01134627|365075262|FG001|Overall Study|Lack of Efficacy|12|||
105841274|NCT01134627|365075261|FG000|Overall Study|Withdrawal by Subject|4|||
105841275|NCT01134627|365075262|FG001|Overall Study|Withdrawal by Subject|3|||
105841276|NCT01134627|365075261|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
105841277|NCT01134627|365075262|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
105841278|NCT01134627|365075261|FG000|Overall Study|Other|11|||
105841279|NCT01134627|365075262|FG001|Overall Study|Other|14|||
105841280|NCT01719562|365075263|FG000|Overall Study|Lost to Follow-up|1|||
105841281|NCT01719562|365075264|FG001|Overall Study|Lost to Follow-up|0|||
105841282|NCT01719562|365075263|FG000|Overall Study|Death|1|||
105841283|NCT01719562|365075264|FG001|Overall Study|Death|0|||
105841284|NCT01719562|365075263|FG000|Overall Study|New cancer diagnosis|1|||
105841285|NCT01719562|365075264|FG001|Overall Study|New cancer diagnosis|0|||
105841286|NCT00396331|365075267|FG000|Overall Study|Failed to mobilize - no transplant|8|||
105841287|NCT00396331|365075267|FG000|Overall Study|Did not go on to transplant|5|||
105841288|NCT00396331|365075267|FG000|Overall Study|Lost to Follow-up|3|||
105841289|NCT00396331|365075267|FG000|Overall Study|Death|16|||
105841290|NCT01884688|365075268|FG000|Overall Study|Screen Failure|2|||
105841291|NCT01955044|365075272|FG000|Overall Study|Death|1|||
105841292|NCT01955044|365075273|FG001|Overall Study|Death|1|||
105841293|NCT01955044|365075274|FG002|Overall Study|Death|0|||
105841294|NCT02563769|365075275|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
105841295|NCT02563769|365075276|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
105841296|NCT02563769|365075277|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
105841297|NCT02953678|365075278|FG000|Overall Study|Adverse Event|20|||
105841298|NCT02953678|365075278|FG000|Overall Study|Death|7|||
105841299|NCT02953678|365075278|FG000|Overall Study|Physician Decision|23|||
105841300|NCT02953678|365075278|FG000|Overall Study|Progressive Disease of GVHD|7|||
105841301|NCT02953678|365075278|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
105841302|NCT02953678|365075278|FG000|Overall Study|Withdrawal by participant|3|||
105841303|NCT02953678|365075278|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
105841304|NCT02953678|365075278|FG000|Overall Study|Participants were transferred to commercial product.|3|||
105841305|NCT00605917|365075290|FG000|Overall Study|Protocol Violation|79|||
105841306|NCT00890552|365075291|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
105841307|NCT00890552|365075291|FG000|On-treatment|Early prog disease/ death|10|||
105841308|NCT00767520|365075293|FG000|Overall Study|Participants still on treatment|11|||
105841309|NCT00767520|365075294|FG001|Overall Study|Participants still on treatment|15|||
105841310|NCT00767520|365075293|FG000|Overall Study|Randomized in error and Never treated|0|||
105841311|NCT00767520|365075294|FG001|Overall Study|Randomized in error and Never treated|2|||
105841312|NCT04965389|365075295|FG000|Overall Study|Other reasons|1|||
105841313|NCT04965389|365075296|FG001|Overall Study|Other reasons|0|||
105841314|NCT04965389|365075297|FG002|Overall Study|Other reasons|0|||
105841315|NCT04965389|365075298|FG003|Overall Study|Other reasons|0|||
105841316|NCT04965389|365075295|FG000|Overall Study|Participant withdrew consent|0|||
105841317|NCT04965389|365075296|FG001|Overall Study|Participant withdrew consent|1|||
105841318|NCT04965389|365075297|FG002|Overall Study|Participant withdrew consent|0|||
105841319|NCT04965389|365075298|FG003|Overall Study|Participant withdrew consent|0|||
105841320|NCT04965389|365075295|FG000|Overall Study|Poor/Non-compliance|0|||
105312525|NCT00805467|363143871|FG003|Overall Study|Physician Decision|6|||
105841321|NCT04965389|365075296|FG001|Overall Study|Poor/Non-compliance|1|||
105841322|NCT04965389|365075297|FG002|Overall Study|Poor/Non-compliance|0|||
105841323|NCT04965389|365075298|FG003|Overall Study|Poor/Non-compliance|0|||
105841324|NCT02377921|365075301|FG000|Overall Study|Subject non-compliance|1|||
105841325|NCT02377921|365075302|FG001|Overall Study|Subject non-compliance|1|||
105368018|NCT03238417|363354115|FG001|Baseline|Partial completion|48|||
105368019|NCT03238417|363354114|FG000|Baseline|non-response|372|||
105368020|NCT03238417|363354115|FG001|Baseline|non-response|669|||
105368021|NCT03238417|363354114|FG000|12-month|non-response|296|||
105368022|NCT03238417|363354115|FG001|12-month|non-response|669|||
105368023|NCT03238417|363354114|FG000|12-month|partial completion|23|||
105368024|NCT03238417|363354115|FG001|12-month|partial completion|37|||
105368025|NCT03238417|363354114|FG000|24-month|non-response|287|||
105368026|NCT03238417|363354115|FG001|24-month|non-response|594|||
105368027|NCT03238417|363354114|FG000|24-month|partial completion|8|||
105368028|NCT03238417|363354115|FG001|24-month|partial completion|31|||
105368029|NCT01239797|363354116|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
105368030|NCT01239797|363354117|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
105368031|NCT01239797|363354116|FG000|Randomized Participants|Participant withdrew consent|1|||
105368032|NCT01239797|363354117|FG001|Randomized Participants|Participant withdrew consent|7|||
105368033|NCT01239797|363354116|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
105368034|NCT01239797|363354117|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
105368035|NCT01239797|363354116|FG000|Treated Participants|Disease progression|185|||
105368036|NCT01239797|363354117|FG001|Treated Participants|Disease progression|185|||
105368037|NCT01239797|363354116|FG000|Treated Participants|Study drug toxicity|39|||
105368038|NCT01239797|363354117|FG001|Treated Participants|Study drug toxicity|45|||
105368039|NCT01239797|363354116|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
105368040|NCT01239797|363354117|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
105368041|NCT01239797|363354116|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
105368042|NCT01239797|363354117|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
105368043|NCT01239797|363354116|FG000|Treated Participants|Administrative reason by sponsor|13|||
105368044|NCT01239797|363354117|FG001|Treated Participants|Administrative reason by sponsor|4|||
105368045|NCT01239797|363354116|FG000|Treated Participants|Other reasons|14|||
105368046|NCT01239797|363354117|FG001|Treated Participants|Other reasons|14|||
105368047|NCT01239797|363354116|FG000|Treated Participants|Participant withdrew consent|6|||
105368048|NCT01239797|363354117|FG001|Treated Participants|Participant withdrew consent|11|||
105368049|NCT01239797|363354116|FG000|Treated Participants|Death|1|||
105368050|NCT01239797|363354117|FG001|Treated Participants|Death|1|||
105368051|NCT01239797|363354116|FG000|Treated Participants|Participant no longer meets study criteria|1|||
105368052|NCT01239797|363354117|FG001|Treated Participants|Participant no longer meets study criteria|1|||
105368053|NCT01239797|363354116|FG000|Treated Participants|Poor/non-compliance|0|||
105368054|NCT01239797|363354117|FG001|Treated Participants|Poor/non-compliance|1|||
105368055|NCT00001566|363354118|FG000|Overall Study|patients' choice to discontinue protocol|3|||
105368056|NCT00001566|363354118|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
105368057|NCT00001566|363354118|FG000|Overall Study|Death|13|||
105368058|NCT00001566|363354118|FG000|Overall Study|Lost to Follow-up|1|||
105368059|NCT00001566|363354118|FG000|Overall Study|unable to complete initial apheresis|1|||
105368060|NCT00853762|363354119|FG000|Overall Study|Premature Termination|16|||
105368061|NCT00853762|363354120|FG001|Overall Study|Premature Termination|15|||
105368062|NCT00853762|363354121|FG002|Overall Study|Premature Termination|14|||
105368063|NCT00853762|363354122|FG003|Overall Study|Premature Termination|21|||
105368064|NCT00853762|363354119|FG000|Overall Study|Protocol Violation|0|||
105368065|NCT00853762|363354120|FG001|Overall Study|Protocol Violation|0|||
105368066|NCT00853762|363354121|FG002|Overall Study|Protocol Violation|0|||
105841326|NCT02443545|365075303|FG000|Overall Study|Adverse Event|1|||
105841327|NCT02443545|365075304|FG001|Overall Study|Adverse Event|1|||
105841328|NCT02443545|365075303|FG000|Overall Study|Lost to Follow-up|0|||
105841329|NCT02443545|365075304|FG001|Overall Study|Lost to Follow-up|2|||
105841330|NCT02443545|365075303|FG000|Overall Study|Physician Decision|3|||
105841331|NCT02443545|365075304|FG001|Overall Study|Physician Decision|0|||
105841332|NCT02443545|365075303|FG000|Overall Study|Protocol Violation|8|||
105841333|NCT02443545|365075304|FG001|Overall Study|Protocol Violation|1|||
105841334|NCT02443545|365075303|FG000|Overall Study|Pregnancy|1|||
105841335|NCT02443545|365075304|FG001|Overall Study|Pregnancy|1|||
105841336|NCT02443545|365075303|FG000|Overall Study|Withdrawal by Subject|6|||
105841337|NCT02443545|365075304|FG001|Overall Study|Withdrawal by Subject|3|||
105841338|NCT02443545|365075303|FG000|Overall Study|Termination of study|20|||
105841339|NCT02443545|365075304|FG001|Overall Study|Termination of study|11|||
105368067|NCT00853762|363354122|FG003|Overall Study|Protocol Violation|1|||
105841340|NCT00724373|365075305|FG000|Overall Study|Adverse Event|41|||
105841341|NCT00724373|365075305|FG000|Overall Study|Lack of Efficacy|82|||
105368068|NCT00853762|363354119|FG000|Overall Study|Withdrawal by Subject|0|||
105368069|NCT00853762|363354120|FG001|Overall Study|Withdrawal by Subject|0|||
105368070|NCT00853762|363354121|FG002|Overall Study|Withdrawal by Subject|1|||
105368071|NCT00853762|363354122|FG003|Overall Study|Withdrawal by Subject|0|||
105841342|NCT00724373|365075305|FG000|Overall Study|Lost to Follow-up|7|||
105841343|NCT00724373|365075305|FG000|Overall Study|Non-compliance|2|||
105841344|NCT00724373|365075305|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
105841345|NCT00724373|365075305|FG000|Overall Study|Participant moved away|1|||
105576533|NCT01683994|364110194|FG000|Overall Study|Withdrawal by Subject|1|||
105576534|NCT01683994|364110195|FG001|Overall Study|Withdrawal by Subject|0|||
105576535|NCT01683994|364110196|FG002|Overall Study|Withdrawal by Subject|0|||
105576536|NCT01683994|364110197|FG003|Overall Study|Withdrawal by Subject|1|||
105576537|NCT01683994|364110198|FG004|Overall Study|Withdrawal by Subject|0|||
105576538|NCT01683994|364110194|FG000|Overall Study|Intercurrent illness|0|||
105576539|NCT01683994|364110195|FG001|Overall Study|Intercurrent illness|0|||
105576540|NCT01683994|364110196|FG002|Overall Study|Intercurrent illness|0|||
105576541|NCT01683994|364110197|FG003|Overall Study|Intercurrent illness|2|||
105576542|NCT01683994|364110198|FG004|Overall Study|Intercurrent illness|1|||
105576543|NCT00636792|364110199|FG000|Overall Study|Adverse Event|16|||
105576544|NCT00636792|364110199|FG000|Overall Study|Physician Decision|7|||
105576545|NCT00636792|364110199|FG000|Overall Study|Progressive Disease|4|||
105576546|NCT00636792|364110199|FG000|Overall Study|Withdrawal by Subject|3|||
105576547|NCT00636792|364110199|FG000|Overall Study|Other|3|||
105841346|NCT00724373|365075305|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
105312526|NCT00805467|363143868|FG000|Overall Study|Not reported|0|||
105312527|NCT00805467|363143869|FG001|Overall Study|Not reported|0|||
105312528|NCT00805467|363143870|FG002|Overall Study|Not reported|3|||
105312529|NCT00805467|363143871|FG003|Overall Study|Not reported|7|||
105312530|NCT04975191|363143872|FG000|Overall Study|Protocol Violation|1|||
105312531|NCT04975191|363143873|FG001|Overall Study|Protocol Violation|2|||
105312532|NCT04975191|363143874|FG002|Overall Study|Protocol Violation|2|||
105312533|NCT04975191|363143875|FG003|Overall Study|Protocol Violation|2|||
105312534|NCT04975191|363143872|FG000|Overall Study|Lost to Follow-up|13|||
105312535|NCT04975191|363143873|FG001|Overall Study|Lost to Follow-up|3|||
105312536|NCT04975191|363143874|FG002|Overall Study|Lost to Follow-up|8|||
105312537|NCT04975191|363143875|FG003|Overall Study|Lost to Follow-up|8|||
105312538|NCT00402116|363143879|FG000|Overall Study|Jaw infection after surgery-other|1|||
105312539|NCT00402116|363143880|FG001|Overall Study|Jaw infection after surgery-other|0|||
105312540|NCT00402116|363143881|FG002|Overall Study|Jaw infection after surgery-other|0|||
105312541|NCT00402116|363143879|FG000|Overall Study|Withdrawal by Subject|1|||
105312542|NCT00402116|363143880|FG001|Overall Study|Withdrawal by Subject|0|||
105312543|NCT00402116|363143881|FG002|Overall Study|Withdrawal by Subject|5|||
105312544|NCT00402116|363143879|FG000|Overall Study|Treatment completed per protocol|1|||
105312545|NCT00402116|363143880|FG001|Overall Study|Treatment completed per protocol|1|||
105312546|NCT00402116|363143881|FG002|Overall Study|Treatment completed per protocol|2|||
105312547|NCT00402116|363143879|FG000|Overall Study|other complicating disease|0|||
105312548|NCT00402116|363143880|FG001|Overall Study|other complicating disease|0|||
105312549|NCT00402116|363143881|FG002|Overall Study|other complicating disease|2|||
105312550|NCT00402116|363143879|FG000|Overall Study|Disease Progression|0|||
105312551|NCT00402116|363143880|FG001|Overall Study|Disease Progression|4|||
105312552|NCT00402116|363143881|FG002|Overall Study|Disease Progression|38|||
105312553|NCT00402116|363143879|FG000|Overall Study|mistaken thrombocytopenia|0|||
105312554|NCT00402116|363143880|FG001|Overall Study|mistaken thrombocytopenia|0|||
105312555|NCT00402116|363143881|FG002|Overall Study|mistaken thrombocytopenia|1|||
105312556|NCT00402116|363143879|FG000|Overall Study|decline related hyponatremia/tumor|0|||
105312557|NCT00402116|363143880|FG001|Overall Study|decline related hyponatremia/tumor|0|||
105312558|NCT00402116|363143881|FG002|Overall Study|decline related hyponatremia/tumor|1|||
105576548|NCT01987596|364110200|FG000|Overall Study|Physician Decision|1|||
105841347|NCT00724373|365075305|FG000|Overall Study|Only to have 24 week regimen|1|||
105841348|NCT00724373|365075305|FG000|Overall Study|Viral Relapse|1|||
105841349|NCT00724373|365075305|FG000|Overall Study|Acute HCV infection|1|||
105841350|NCT00724373|365075305|FG000|Overall Study|Drug Relapse|1|||
105841351|NCT00724373|365075305|FG000|Overall Study|Tolerability|23|||
105312559|NCT00402116|363143879|FG000|Overall Study|Adverse Event|0|||
105312560|NCT00402116|363143880|FG001|Overall Study|Adverse Event|1|||
105312561|NCT00402116|363143881|FG002|Overall Study|Adverse Event|6|||
105312562|NCT01396512|363143882|FG000|Overall Study|Withdrawal by Subject|0|||
105312563|NCT01396512|363143883|FG001|Overall Study|Withdrawal by Subject|1|||
105312564|NCT01443728|363143891|FG000|Overall Study|Lost to Follow-up|2|||
105312565|NCT01443728|363143892|FG001|Overall Study|Lost to Follow-up|0|||
105312566|NCT01443728|363143891|FG000|Overall Study|Withdrawal by Subject|1|||
105841352|NCT01610063|365075308|FG000|Overall Study|Lost to Follow-up|42|||
105312567|NCT01443728|363143892|FG001|Overall Study|Withdrawal by Subject|1|||
105841353|NCT01610063|365075309|FG001|Overall Study|Lost to Follow-up|20|||
105312568|NCT01443728|363143891|FG000|Overall Study|Adverse Event|0|||
105312569|NCT01443728|363143892|FG001|Overall Study|Adverse Event|2|||
105312570|NCT00509366|363143893|FG000|Overall Study|Not Treated (Screen Failure)|1|||
105312571|NCT00509366|363143894|FG001|Overall Study|Not Treated (Screen Failure)|1|||
105841354|NCT03043560|365075310|FG000|Overall Study|Discontinued Intervention|1|||
105576549|NCT01987596|364110201|FG001|Overall Study|Physician Decision|0|||
105576550|NCT01987596|364110200|FG000|Overall Study|Progressive Disease; missing all period|0|||
105841355|NCT03043560|365075311|FG001|Overall Study|Discontinued Intervention|2|||
105312572|NCT00509366|363143895|FG002|Overall Study|Not Treated (Screen Failure)|1|||
105576551|NCT01987596|364110201|FG001|Overall Study|Progressive Disease; missing all period|1|||
105841356|NCT03043560|365075310|FG000|Overall Study|Lost to Follow-up|0|||
105841357|NCT03043560|365075311|FG001|Overall Study|Lost to Follow-up|1|||
105841358|NCT01425528|365075312|FG000|Overall Study|Withdrawal by Subject|1|||
105841359|NCT01425528|365075313|FG001|Overall Study|Withdrawal by Subject|1|||
105841360|NCT01118117|365075314|FG000|Overall Study|Death|8|||
105368072|NCT00853762|363354119|FG000|Overall Study|Other|0|||
105368073|NCT00853762|363354120|FG001|Overall Study|Other|2|||
105368074|NCT00853762|363354121|FG002|Overall Study|Other|0|||
105368075|NCT00853762|363354122|FG003|Overall Study|Other|0|||
105368076|NCT00853762|363354119|FG000|Overall Study|Randomised but not Treated|0|||
105368077|NCT00853762|363354120|FG001|Overall Study|Randomised but not Treated|2|||
105368078|NCT00853762|363354121|FG002|Overall Study|Randomised but not Treated|2|||
105368079|NCT00853762|363354122|FG003|Overall Study|Randomised but not Treated|0|||
105368080|NCT02000921|363354123|FG000|Overall Study|Withdrawal by Subject|3|||
105368081|NCT02000921|363354124|FG001|Overall Study|Withdrawal by Subject|10|||
105368082|NCT02000921|363354125|FG002|Overall Study|Withdrawal by Subject|5|||
105368083|NCT02000921|363354123|FG000|Overall Study|Lost to Follow-up|2|||
105368084|NCT02000921|363354124|FG001|Overall Study|Lost to Follow-up|4|||
105368085|NCT02000921|363354125|FG002|Overall Study|Lost to Follow-up|5|||
105368086|NCT02000921|363354123|FG000|Overall Study|Physician Decision|0|||
105368087|NCT02000921|363354124|FG001|Overall Study|Physician Decision|2|||
105368088|NCT02000921|363354125|FG002|Overall Study|Physician Decision|0|||
105368089|NCT01418339|363354132|FG000|Overall Study|Adverse Event|5|||
105368090|NCT01418339|363354133|FG001|Overall Study|Adverse Event|2|||
105368091|NCT01418339|363354132|FG000|Overall Study|Subject Withdrew Consent|1|||
105368092|NCT01418339|363354133|FG001|Overall Study|Subject Withdrew Consent|2|||
105368093|NCT01418339|363354132|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
105368094|NCT01418339|363354133|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
105368095|NCT02204917|363354134|FG000|Overall Study|Protocol Violation|1|||
105368096|NCT00749398|363354135|FG000|Overall Study|Lack of Efficacy|7|||
105368097|NCT00749398|363354135|FG000|Overall Study|Adverse Event|4|||
105368098|NCT00749398|363354135|FG000|Overall Study|Serious adverse event|11|||
105368099|NCT00749398|363354135|FG000|Overall Study|Withdrawal by Subject|17|||
105368100|NCT00749398|363354135|FG000|Overall Study|Lost to Follow-up|11|||
105368101|NCT00749398|363354135|FG000|Overall Study|Reason not specified|2|||
105368102|NCT00749398|363354135|FG000|Overall Study|Unknown reason|1|||
105368103|NCT04210986|363354136|FG000|Overall Study|Lost to Follow-up|5|||
105368104|NCT04210986|363354137|FG001|Overall Study|Lost to Follow-up|2|||
105368105|NCT04210986|363354136|FG000|Overall Study|Withdrawal by Subject|3|||
105368106|NCT04210986|363354137|FG001|Overall Study|Withdrawal by Subject|1|||
105368107|NCT04210986|363354136|FG000|Overall Study|Protocol Violation|1|||
105368108|NCT04210986|363354137|FG001|Overall Study|Protocol Violation|1|||
105368109|NCT04210986|363354136|FG000|Overall Study|Physician Decision|0|||
105368110|NCT04210986|363354137|FG001|Overall Study|Physician Decision|1|||
105841361|NCT01118117|365075315|FG001|Overall Study|Death|0|||
105841362|NCT01118117|365075314|FG000|Overall Study|Lost to Follow-up|6|||
105841363|NCT01118117|365075315|FG001|Overall Study|Lost to Follow-up|0|||
105841364|NCT01118117|365075314|FG000|Overall Study|Missed 12 Month Visit|7|||
105841365|NCT01118117|365075315|FG001|Overall Study|Missed 12 Month Visit|0|||
105841366|NCT00545688|365075319|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
105841367|NCT00545688|365075320|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
105841368|NCT00545688|365075321|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
105841369|NCT00545688|365075322|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
105841370|NCT00545688|365075319|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
105841371|NCT00545688|365075320|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
105841372|NCT00545688|365075321|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
105841373|NCT00545688|365075322|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
105841374|NCT00545688|365075319|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
105841375|NCT00545688|365075320|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
105368111|NCT03863353|363354138|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
105368112|NCT03863353|363354139|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
105490013|NCT01436162|363805718|FG000|Randomized Phase|Withdrawal by Subject|16|||
105490014|NCT01436162|363805719|FG001|Randomized Phase|Withdrawal by Subject|9|||
105368113|NCT03810183|363354140|FG000|Overall Study|Study terminated by Sponsor|2|||
105368114|NCT03810183|363354141|FG001|Overall Study|Study terminated by Sponsor|1|||
105368115|NCT03786380|363354142|FG000|Overall Study|Adverse Event|1|||
105490015|NCT01436162|363805720|FG002|Randomized Phase|Withdrawal by Subject|8|||
105490016|NCT01436162|363805718|FG000|Randomized Phase|Lost to Follow-up|17|||
105841376|NCT00545688|365075321|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
105841377|NCT00545688|365075322|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
105841378|NCT00545688|365075319|FG000|Neo-Adjuvant Treatment Period|Death|0|||
105368116|NCT03786380|363354143|FG001|Overall Study|Adverse Event|0|||
105368117|NCT03786380|363354144|FG002|Overall Study|Adverse Event|0|||
105368118|NCT03786380|363354145|FG003|Overall Study|Adverse Event|3|||
105368119|NCT03786380|363354146|FG004|Overall Study|Adverse Event|1|||
105368120|NCT03786380|363354142|FG000|Overall Study|Lack of Efficacy|0|||
105312573|NCT00509366|363143896|FG003|Overall Study|Not Treated (Screen Failure)|0|||
105312574|NCT00509366|363143897|FG004|Overall Study|Not Treated (Screen Failure)|0|||
105312575|NCT02906358|363143898|FG000|Overall Study|Withdrawal by Subject|10|||
105312576|NCT02906358|363143899|FG001|Overall Study|Withdrawal by Subject|7|||
105312577|NCT02906358|363143898|FG000|Overall Study|Lost to Follow-up|12|||
105312578|NCT02906358|363143899|FG001|Overall Study|Lost to Follow-up|15|||
105841379|NCT00545688|365075320|FG001|Neo-Adjuvant Treatment Period|Death|1|||
105841380|NCT00545688|365075321|FG002|Neo-Adjuvant Treatment Period|Death|0|||
105841381|NCT00545688|365075322|FG003|Neo-Adjuvant Treatment Period|Death|0|||
105841382|NCT00545688|365075319|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
105841383|NCT00545688|365075320|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
105841384|NCT00545688|365075321|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
105841385|NCT00545688|365075322|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
105841386|NCT00545688|365075319|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
105841387|NCT00545688|365075320|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
105841388|NCT00545688|365075321|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
105841389|NCT00545688|365075322|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
105841390|NCT00545688|365075319|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
105841391|NCT00545688|365075320|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
105841392|NCT00545688|365075321|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
105841393|NCT00545688|365075322|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
105841394|NCT00545688|365075319|FG000|Adjuvant Treatment Period|Disease Progression|3|||
105841395|NCT00545688|365075320|FG001|Adjuvant Treatment Period|Disease Progression|3|||
105841396|NCT00545688|365075321|FG002|Adjuvant Treatment Period|Disease Progression|0|||
105841397|NCT00545688|365075322|FG003|Adjuvant Treatment Period|Disease Progression|7|||
105841398|NCT00545688|365075319|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
105841399|NCT00545688|365075320|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
105841400|NCT00545688|365075321|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
105841401|NCT00545688|365075322|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
105841402|NCT00545688|365075319|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
105841403|NCT00545688|365075320|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
105841404|NCT00545688|365075321|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
105841405|NCT00545688|365075322|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
105841406|NCT00545688|365075319|FG000|Adjuvant Treatment Period|Adverse Event|0|||
105841407|NCT00545688|365075320|FG001|Adjuvant Treatment Period|Adverse Event|3|||
105312579|NCT01473524|363143900|FG000|DB Phase|Adverse Event|4|||
105312580|NCT01473524|363143901|FG001|DB Phase|Adverse Event|8|||
105312581|NCT01473524|363143902|FG002|DB Phase|Adverse Event|2|||
105312582|NCT01473524|363143903|FG003|DB Phase|Adverse Event|0|||
105312583|NCT01473524|363143904|FG004|DB Phase|Adverse Event|0|||
105312584|NCT01473524|363143905|FG005|DB Phase|Adverse Event|0|||
105312585|NCT01473524|363143900|FG000|DB Phase|Death|1|||
105312586|NCT01473524|363143901|FG001|DB Phase|Death|0|||
105312587|NCT01473524|363143902|FG002|DB Phase|Death|0|||
105312588|NCT01473524|363143903|FG003|DB Phase|Death|0|||
105312589|NCT01473524|363143904|FG004|DB Phase|Death|0|||
105312590|NCT01473524|363143905|FG005|DB Phase|Death|0|||
105312591|NCT01473524|363143900|FG000|DB Phase|Withdrawal by Subject|2|||
105312592|NCT01473524|363143901|FG001|DB Phase|Withdrawal by Subject|1|||
105312593|NCT01473524|363143902|FG002|DB Phase|Withdrawal by Subject|1|||
105312594|NCT01473524|363143903|FG003|DB Phase|Withdrawal by Subject|0|||
105312595|NCT01473524|363143904|FG004|DB Phase|Withdrawal by Subject|0|||
105312596|NCT01473524|363143905|FG005|DB Phase|Withdrawal by Subject|0|||
105312597|NCT01473524|363143900|FG000|LTSE Phase|Withdrawal by Subject|0|||
105312598|NCT01473524|363143901|FG001|LTSE Phase|Withdrawal by Subject|0|||
105312599|NCT01473524|363143902|FG002|LTSE Phase|Withdrawal by Subject|0|||
105312600|NCT01473524|363143903|FG003|LTSE Phase|Withdrawal by Subject|3|||
105312601|NCT01473524|363143904|FG004|LTSE Phase|Withdrawal by Subject|3|||
105312602|NCT01473524|363143905|FG005|LTSE Phase|Withdrawal by Subject|6|||
105312603|NCT01473524|363143900|FG000|LTSE Phase|Death|0|||
105312604|NCT01473524|363143901|FG001|LTSE Phase|Death|0|||
105312605|NCT01473524|363143902|FG002|LTSE Phase|Death|0|||
105312606|NCT01473524|363143903|FG003|LTSE Phase|Death|0|||
105312607|NCT01473524|363143904|FG004|LTSE Phase|Death|1|||
105312608|NCT01473524|363143905|FG005|LTSE Phase|Death|0|||
105312609|NCT01473524|363143900|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
105312610|NCT01473524|363143901|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
105312611|NCT01473524|363143902|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
105312612|NCT01473524|363143903|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
105312613|NCT01473524|363143904|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
105841408|NCT00545688|365075321|FG002|Adjuvant Treatment Period|Adverse Event|2|||
105841409|NCT00545688|365075322|FG003|Adjuvant Treatment Period|Adverse Event|2|||
105312614|NCT01473524|363143905|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
105312615|NCT01473524|363143900|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
105312616|NCT01473524|363143901|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
105312617|NCT01473524|363143902|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
105368121|NCT03786380|363354143|FG001|Overall Study|Lack of Efficacy|0|||
105368122|NCT03786380|363354144|FG002|Overall Study|Lack of Efficacy|0|||
105368123|NCT03786380|363354145|FG003|Overall Study|Lack of Efficacy|0|||
105368124|NCT03786380|363354146|FG004|Overall Study|Lack of Efficacy|1|||
105368125|NCT03786380|363354142|FG000|Overall Study|Withdrawal by Subject|1|||
105368126|NCT03786380|363354143|FG001|Overall Study|Withdrawal by Subject|2|||
105368127|NCT03786380|363354144|FG002|Overall Study|Withdrawal by Subject|2|||
105368128|NCT03786380|363354145|FG003|Overall Study|Withdrawal by Subject|1|||
105368129|NCT03786380|363354146|FG004|Overall Study|Withdrawal by Subject|2|||
105368130|NCT03786380|363354142|FG000|Overall Study|Lost to Follow-up|3|||
105368131|NCT03786380|363354143|FG001|Overall Study|Lost to Follow-up|0|||
105368132|NCT03786380|363354144|FG002|Overall Study|Lost to Follow-up|1|||
105841410|NCT00545688|365075319|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
105841411|NCT00545688|365075320|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
105841412|NCT00545688|365075321|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
105841413|NCT00545688|365075322|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
105841414|NCT00545688|365075319|FG000|Follow-Up Period|Death|4|||
105841415|NCT00545688|365075320|FG001|Follow-Up Period|Death|2|||
105841416|NCT00545688|365075321|FG002|Follow-Up Period|Death|2|||
105841417|NCT00545688|365075322|FG003|Follow-Up Period|Death|6|||
105841418|NCT00545688|365075319|FG000|Follow-Up Period|Disease Progression|6|||
105841419|NCT00545688|365075320|FG001|Follow-Up Period|Disease Progression|5|||
105841420|NCT00545688|365075321|FG002|Follow-Up Period|Disease Progression|9|||
105841421|NCT00545688|365075322|FG003|Follow-Up Period|Disease Progression|9|||
105841422|NCT00545688|365075319|FG000|Follow-Up Period|Refused Treatment|6|||
105841423|NCT00545688|365075320|FG001|Follow-Up Period|Refused Treatment|2|||
105841424|NCT00545688|365075321|FG002|Follow-Up Period|Refused Treatment|0|||
105841425|NCT00545688|365075322|FG003|Follow-Up Period|Refused Treatment|2|||
105841426|NCT00545688|365075319|FG000|Follow-Up Period|Lost to Follow-up|3|||
105841427|NCT00545688|365075320|FG001|Follow-Up Period|Lost to Follow-up|3|||
105841428|NCT00545688|365075321|FG002|Follow-Up Period|Lost to Follow-up|3|||
105841429|NCT00545688|365075322|FG003|Follow-Up Period|Lost to Follow-up|1|||
105841430|NCT00545688|365075319|FG000|Follow-Up Period|Unspecified Reason|2|||
105841431|NCT00545688|365075320|FG001|Follow-Up Period|Unspecified Reason|5|||
105841432|NCT00545688|365075321|FG002|Follow-Up Period|Unspecified Reason|6|||
105841433|NCT00545688|365075322|FG003|Follow-Up Period|Unspecified Reason|8|||
105841434|NCT00545688|365075319|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
105841435|NCT00545688|365075320|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
105841436|NCT00545688|365075321|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
105841437|NCT00545688|365075322|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
105841438|NCT02858726|365075325|FG000|Overall Study|Adverse Event|4|||
105841439|NCT02858726|365075326|FG001|Overall Study|Adverse Event|4|||
105841440|NCT02858726|365075327|FG002|Overall Study|Adverse Event|9|||
105841441|NCT02858726|365075328|FG003|Overall Study|Adverse Event|1|||
105841442|NCT02858726|365075325|FG000|Overall Study|Physician Decision|0|||
105841443|NCT02858726|365075326|FG001|Overall Study|Physician Decision|0|||
105841444|NCT02858726|365075327|FG002|Overall Study|Physician Decision|1|||
105841445|NCT02858726|365075328|FG003|Overall Study|Physician Decision|0|||
105841446|NCT02858726|365075325|FG000|Overall Study|Protocol Violation|0|||
105841447|NCT02858726|365075326|FG001|Overall Study|Protocol Violation|0|||
105841448|NCT02858726|365075327|FG002|Overall Study|Protocol Violation|0|||
105841449|NCT02858726|365075328|FG003|Overall Study|Protocol Violation|1|||
105841450|NCT02858726|365075325|FG000|Overall Study|Study Terminated by Sponsor|0|||
105841451|NCT02858726|365075326|FG001|Overall Study|Study Terminated by Sponsor|0|||
105841452|NCT02858726|365075327|FG002|Overall Study|Study Terminated by Sponsor|0|||
105841453|NCT02858726|365075328|FG003|Overall Study|Study Terminated by Sponsor|1|||
105841454|NCT02858726|365075325|FG000|Overall Study|Withdrawal by Subject|1|||
105841455|NCT02858726|365075326|FG001|Overall Study|Withdrawal by Subject|2|||
105841456|NCT02858726|365075327|FG002|Overall Study|Withdrawal by Subject|1|||
105841457|NCT02858726|365075328|FG003|Overall Study|Withdrawal by Subject|0|||
105841458|NCT02858726|365075325|FG000|Overall Study|Noncompliance|0|||
105841459|NCT02858726|365075326|FG001|Overall Study|Noncompliance|1|||
105841460|NCT02858726|365075327|FG002|Overall Study|Noncompliance|0|||
105841461|NCT02858726|365075328|FG003|Overall Study|Noncompliance|0|||
105368133|NCT03786380|363354145|FG003|Overall Study|Lost to Follow-up|2|||
105368134|NCT03786380|363354146|FG004|Overall Study|Lost to Follow-up|0|||
105841462|NCT00233987|365075329|FG000|Overall Study|Withdrawal by Subject|1|||
105841463|NCT00233987|365075329|FG000|Overall Study|Lack of Efficacy|2|||
105841464|NCT00233987|365075329|FG000|Overall Study|Reason Under Review|1|||
105368135|NCT03786380|363354142|FG000|Overall Study|Physician Decision|0|||
105368136|NCT03786380|363354143|FG001|Overall Study|Physician Decision|0|||
105368137|NCT03786380|363354144|FG002|Overall Study|Physician Decision|1|||
105841465|NCT00233987|365075329|FG000|Overall Study|Other - Not Protocol Specified|5|||
105841466|NCT00233987|365075329|FG000|Overall Study|Eligible but No Treatment Received|2|||
105841467|NCT00233987|365075329|FG000|Overall Study|Ineligible|4|||
105841468|NCT03581188|365077565|FG000|Overall Study|Inclusion criteria not met|3|||
105841469|NCT03581188|365077566|FG001|Overall Study|Inclusion criteria not met|2|||
105841470|NCT03581188|365077565|FG000|Overall Study|Lost to Follow-up|5|||
105841471|NCT03581188|365077566|FG001|Overall Study|Lost to Follow-up|5|||
105841472|NCT03581188|365077565|FG000|Overall Study|Discontinued intervention|11|||
105841473|NCT03581188|365077566|FG001|Overall Study|Discontinued intervention|8|||
105841474|NCT04974619|365077569|FG000|Overall Study|Lost to Follow-up|0|||
105841475|NCT04974619|365077570|FG001|Overall Study|Lost to Follow-up|0|||
105841476|NCT04974619|365077571|FG002|Overall Study|Lost to Follow-up|1|||
105841477|NCT04974619|365077569|FG000|Overall Study|Withdrawal by Subject|0|||
105841478|NCT04974619|365077570|FG001|Overall Study|Withdrawal by Subject|0|||
105841479|NCT04974619|365077571|FG002|Overall Study|Withdrawal by Subject|1|||
105841480|NCT04974619|365077569|FG000|Overall Study|Protocol Violation|0|||
105841481|NCT04974619|365077570|FG001|Overall Study|Protocol Violation|1|||
105841482|NCT04974619|365077571|FG002|Overall Study|Protocol Violation|0|||
105841483|NCT01010126|365077580|FG000|Overall Study|Withdrawal by Subject|1|||
105841484|NCT01010126|365077581|FG001|Overall Study|Withdrawal by Subject|0|||
105841485|NCT01010126|365077582|FG002|Overall Study|Withdrawal by Subject|1|||
105841486|NCT01010126|365077583|FG003|Overall Study|Withdrawal by Subject|0|||
105841487|NCT01010126|365077584|FG004|Overall Study|Withdrawal by Subject|3|||
105841488|NCT01010126|365077585|FG005|Overall Study|Withdrawal by Subject|0|||
105841489|NCT01730040|365077595|FG000|Overall Study|Randomized but not treated|0|||
105841490|NCT01730040|365077596|FG001|Overall Study|Randomized but not treated|0|||
105841491|NCT01730040|365077597|FG002|Overall Study|Randomized but not treated|0|||
105841492|NCT01730040|365077598|FG003|Overall Study|Randomized but not treated|0|||
105841493|NCT01730040|365077599|FG004|Overall Study|Randomized but not treated|0|||
105841494|NCT01730040|365077600|FG005|Overall Study|Randomized but not treated|1|||
105841495|NCT01730040|365077601|FG006|Overall Study|Randomized but not treated|0|||
105841496|NCT01730040|365077595|FG000|Overall Study|Subject moved|0|||
105841497|NCT01730040|365077596|FG001|Overall Study|Subject moved|0|||
105841498|NCT01730040|365077597|FG002|Overall Study|Subject moved|1|||
105841499|NCT01730040|365077598|FG003|Overall Study|Subject moved|0|||
105841500|NCT01730040|365077599|FG004|Overall Study|Subject moved|0|||
105841501|NCT01730040|365077600|FG005|Overall Study|Subject moved|0|||
105841502|NCT01730040|365077601|FG006|Overall Study|Subject moved|1|||
105841503|NCT01730040|365077595|FG000|Overall Study|Physician Decision|0|||
105841504|NCT01730040|365077596|FG001|Overall Study|Physician Decision|0|||
105841505|NCT01730040|365077597|FG002|Overall Study|Physician Decision|0|||
105841506|NCT01730040|365077598|FG003|Overall Study|Physician Decision|0|||
105841507|NCT01730040|365077599|FG004|Overall Study|Physician Decision|0|||
105841508|NCT01730040|365077600|FG005|Overall Study|Physician Decision|1|||
105841509|NCT01730040|365077601|FG006|Overall Study|Physician Decision|1|||
105841510|NCT01730040|365077595|FG000|Overall Study|Other than specified|7|||
105841511|NCT01730040|365077596|FG001|Overall Study|Other than specified|8|||
105841512|NCT01730040|365077597|FG002|Overall Study|Other than specified|5|||
105841513|NCT01730040|365077598|FG003|Overall Study|Other than specified|5|||
105841514|NCT01730040|365077599|FG004|Overall Study|Other than specified|5|||
105841515|NCT01730040|365077600|FG005|Overall Study|Other than specified|4|||
105841516|NCT01730040|365077601|FG006|Overall Study|Other than specified|4|||
105841517|NCT01730040|365077595|FG000|Overall Study|Adverse Event|4|||
105841518|NCT01730040|365077596|FG001|Overall Study|Adverse Event|3|||
105841519|NCT01730040|365077597|FG002|Overall Study|Adverse Event|5|||
105841520|NCT01730040|365077598|FG003|Overall Study|Adverse Event|3|||
105841521|NCT01730040|365077599|FG004|Overall Study|Adverse Event|1|||
105841522|NCT01730040|365077600|FG005|Overall Study|Adverse Event|1|||
105841523|NCT01730040|365077601|FG006|Overall Study|Adverse Event|2|||
105841524|NCT01730040|365077595|FG000|Overall Study|Poor compliance to protocol|2|||
105841525|NCT01730040|365077596|FG001|Overall Study|Poor compliance to protocol|4|||
105841526|NCT01730040|365077597|FG002|Overall Study|Poor compliance to protocol|0|||
105841527|NCT01730040|365077598|FG003|Overall Study|Poor compliance to protocol|0|||
105841528|NCT01730040|365077599|FG004|Overall Study|Poor compliance to protocol|0|||
105841529|NCT01730040|365077600|FG005|Overall Study|Poor compliance to protocol|0|||
105841530|NCT01730040|365077601|FG006|Overall Study|Poor compliance to protocol|1|||
105841531|NCT01301482|365077604|FG000|Overall Study|Withdrawal by Subject|1|||
105841532|NCT01647958|365077605|FG000|Initial Study|Lost to Follow-up|2|||
105841533|NCT01647958|365077606|FG001|Initial Study|Lost to Follow-up|3|||
105841534|NCT01647958|365077605|FG000|Continuation Phase|treatment received during Overall Study|39|||
105841535|NCT01647958|365077606|FG001|Continuation Phase|treatment received during Overall Study|0|||
105841536|NCT01647958|365077605|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
105312618|NCT01473524|363143903|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
105312619|NCT01473524|363143904|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
105841537|NCT01647958|365077606|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
105841538|NCT00480324|365077609|FG000|Overall Study|Adverse Event|1|||
105841539|NCT00480324|365077610|FG001|Overall Study|Adverse Event|1|||
105841540|NCT00480324|365077609|FG000|Overall Study|Protocol Violation|0|||
105841541|NCT00480324|365077610|FG001|Overall Study|Protocol Violation|1|||
105841542|NCT00480324|365077609|FG000|Overall Study|Withdrawal by Subject|14|||
105841543|NCT00480324|365077610|FG001|Overall Study|Withdrawal by Subject|5|||
105841544|NCT00480324|365077609|FG000|Overall Study|Lost to Follow-up|17|||
105841545|NCT00480324|365077610|FG001|Overall Study|Lost to Follow-up|8|||
105312620|NCT01473524|363143905|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
105312621|NCT01473524|363143900|FG000|LTSE Phase|Lost to Follow-up|0|||
105312622|NCT01473524|363143901|FG001|LTSE Phase|Lost to Follow-up|0|||
105312623|NCT01473524|363143902|FG002|LTSE Phase|Lost to Follow-up|0|||
105312624|NCT01473524|363143903|FG003|LTSE Phase|Lost to Follow-up|1|||
105312625|NCT01473524|363143904|FG004|LTSE Phase|Lost to Follow-up|3|||
105312626|NCT01473524|363143905|FG005|LTSE Phase|Lost to Follow-up|2|||
105312627|NCT01473524|363143900|FG000|LTSE Phase|Principal Investigator Decision|0|||
105312628|NCT01473524|363143901|FG001|LTSE Phase|Principal Investigator Decision|0|||
105312629|NCT01473524|363143902|FG002|LTSE Phase|Principal Investigator Decision|0|||
105312630|NCT01473524|363143903|FG003|LTSE Phase|Principal Investigator Decision|1|||
105312631|NCT01473524|363143904|FG004|LTSE Phase|Principal Investigator Decision|1|||
105312632|NCT01473524|363143905|FG005|LTSE Phase|Principal Investigator Decision|3|||
105312633|NCT01473524|363143900|FG000|LTSE Phase|Liver Transplantation|0|||
105312634|NCT01473524|363143901|FG001|LTSE Phase|Liver Transplantation|0|||
105312635|NCT01473524|363143902|FG002|LTSE Phase|Liver Transplantation|0|||
105312636|NCT01473524|363143903|FG003|LTSE Phase|Liver Transplantation|0|||
105312637|NCT01473524|363143904|FG004|LTSE Phase|Liver Transplantation|0|||
105312638|NCT01473524|363143905|FG005|LTSE Phase|Liver Transplantation|1|||
105312639|NCT01473524|363143900|FG000|LTSE Phase|Pregnancy|0|||
105312640|NCT01473524|363143901|FG001|LTSE Phase|Pregnancy|0|||
105312641|NCT01473524|363143902|FG002|LTSE Phase|Pregnancy|0|||
105312642|NCT01473524|363143903|FG003|LTSE Phase|Pregnancy|1|||
105312643|NCT01473524|363143904|FG004|LTSE Phase|Pregnancy|0|||
105312644|NCT01473524|363143905|FG005|LTSE Phase|Pregnancy|0|||
105312645|NCT01473524|363143900|FG000|LTSE Phase|Protocol Violation|0|||
105312646|NCT01473524|363143901|FG001|LTSE Phase|Protocol Violation|0|||
105312647|NCT01473524|363143902|FG002|LTSE Phase|Protocol Violation|0|||
105312648|NCT01473524|363143903|FG003|LTSE Phase|Protocol Violation|0|||
105312649|NCT01473524|363143904|FG004|LTSE Phase|Protocol Violation|0|||
105312650|NCT01473524|363143905|FG005|LTSE Phase|Protocol Violation|1|||
105312651|NCT02119819|363143906|FG000|Overall Study|Adverse Event|3|||
105312652|NCT02119819|363143907|FG001|Overall Study|Adverse Event|1|||
105312653|NCT02119819|363143908|FG002|Overall Study|Adverse Event|2|||
105312654|NCT02119819|363143909|FG003|Overall Study|Adverse Event|3|||
105312655|NCT02119819|363143910|FG004|Overall Study|Adverse Event|0|||
105312656|NCT02119819|363143911|FG005|Overall Study|Adverse Event|1|||
105312657|NCT02119819|363143906|FG000|Overall Study|Lack of Efficacy|0|||
105312658|NCT02119819|363143907|FG001|Overall Study|Lack of Efficacy|0|||
105312659|NCT02119819|363143908|FG002|Overall Study|Lack of Efficacy|0|||
105312660|NCT02119819|363143909|FG003|Overall Study|Lack of Efficacy|0|||
105312661|NCT02119819|363143910|FG004|Overall Study|Lack of Efficacy|0|||
105312662|NCT02119819|363143911|FG005|Overall Study|Lack of Efficacy|1|||
105312663|NCT02119819|363143906|FG000|Overall Study|Lost to Follow-up|0|||
105312664|NCT02119819|363143907|FG001|Overall Study|Lost to Follow-up|0|||
105312665|NCT02119819|363143908|FG002|Overall Study|Lost to Follow-up|1|||
105312666|NCT02119819|363143909|FG003|Overall Study|Lost to Follow-up|2|||
105312667|NCT02119819|363143910|FG004|Overall Study|Lost to Follow-up|1|||
105312668|NCT02119819|363143911|FG005|Overall Study|Lost to Follow-up|2|||
105312669|NCT02119819|363143906|FG000|Overall Study|Physician Decision|1|||
105312670|NCT02119819|363143907|FG001|Overall Study|Physician Decision|1|||
105312671|NCT02119819|363143908|FG002|Overall Study|Physician Decision|0|||
105312672|NCT02119819|363143909|FG003|Overall Study|Physician Decision|0|||
105312673|NCT02119819|363143910|FG004|Overall Study|Physician Decision|0|||
105312674|NCT02119819|363143911|FG005|Overall Study|Physician Decision|1|||
105312675|NCT02119819|363143906|FG000|Overall Study|Withdrawal by Subject|5|||
105312676|NCT02119819|363143907|FG001|Overall Study|Withdrawal by Subject|3|||
105312677|NCT02119819|363143908|FG002|Overall Study|Withdrawal by Subject|0|||
105312678|NCT02119819|363143909|FG003|Overall Study|Withdrawal by Subject|0|||
105312679|NCT02119819|363143910|FG004|Overall Study|Withdrawal by Subject|6|||
105312680|NCT02119819|363143911|FG005|Overall Study|Withdrawal by Subject|10|||
105312681|NCT02119819|363143906|FG000|Overall Study|Jury Duty|0|||
105312682|NCT02119819|363143907|FG001|Overall Study|Jury Duty|0|||
105312683|NCT02119819|363143908|FG002|Overall Study|Jury Duty|1|||
105312684|NCT02119819|363143909|FG003|Overall Study|Jury Duty|0|||
105312685|NCT02119819|363143910|FG004|Overall Study|Jury Duty|0|||
105368138|NCT03786380|363354145|FG003|Overall Study|Physician Decision|0|||
105368139|NCT03786380|363354146|FG004|Overall Study|Physician Decision|0|||
105312686|NCT02119819|363143911|FG005|Overall Study|Jury Duty|0|||
105312687|NCT02119819|363143906|FG000|Overall Study|Protocol Violation|0|||
105312688|NCT02119819|363143907|FG001|Overall Study|Protocol Violation|0|||
105312689|NCT02119819|363143908|FG002|Overall Study|Protocol Violation|0|||
105312690|NCT02119819|363143909|FG003|Overall Study|Protocol Violation|1|||
105312691|NCT02119819|363143910|FG004|Overall Study|Protocol Violation|0|||
105312692|NCT02119819|363143911|FG005|Overall Study|Protocol Violation|0|||
105312693|NCT02119819|363143906|FG000|Overall Study|Left the city to get a job|0|||
105312694|NCT02119819|363143907|FG001|Overall Study|Left the city to get a job|0|||
105312695|NCT02119819|363143908|FG002|Overall Study|Left the city to get a job|0|||
105312696|NCT02119819|363143909|FG003|Overall Study|Left the city to get a job|1|||
105312697|NCT02119819|363143910|FG004|Overall Study|Left the city to get a job|0|||
105368140|NCT03786380|363354142|FG000|Overall Study|Study Terminated by the Sponsor|30|||
105368141|NCT03786380|363354143|FG001|Overall Study|Study Terminated by the Sponsor|20|||
105368142|NCT03786380|363354144|FG002|Overall Study|Study Terminated by the Sponsor|50|||
105368143|NCT03786380|363354145|FG003|Overall Study|Study Terminated by the Sponsor|57|||
105368144|NCT03786380|363354146|FG004|Overall Study|Study Terminated by the Sponsor|23|||
105368145|NCT03786380|363354142|FG000|Overall Study|Reason Not Specified|0|||
105368146|NCT03786380|363354143|FG001|Overall Study|Reason Not Specified|0|||
105368147|NCT03786380|363354144|FG002|Overall Study|Reason Not Specified|0|||
105368148|NCT03786380|363354145|FG003|Overall Study|Reason Not Specified|0|||
105368149|NCT03786380|363354146|FG004|Overall Study|Reason Not Specified|1|||
105368150|NCT01664091|363354147|FG000|Overall Study|Death|1|||
105368151|NCT01664091|363354147|FG000|Overall Study|Disease Progression|2|||
105368152|NCT01664091|363354147|FG000|Overall Study|Lost to Follow-up|2|||
105368153|NCT01664091|363354147|FG000|Overall Study|Withdrawal by Subject|1|||
105841546|NCT00480324|365077609|FG000|Overall Study|Subject's mother pregnant|0|||
105841547|NCT00480324|365077610|FG001|Overall Study|Subject's mother pregnant|1|||
105841548|NCT03785145|365077611|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
105841549|NCT03785145|365077612|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
105841550|NCT03785145|365077611|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
105841551|NCT03785145|365077612|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
105841552|NCT03785145|365077611|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
105841553|NCT03785145|365077612|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
105841554|NCT03785145|365077611|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
105841555|NCT03785145|365077612|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
105841556|NCT03785145|365077611|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
105841557|NCT03785145|365077612|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
105841558|NCT03785145|365077611|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
105841559|NCT03785145|365077612|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
105841560|NCT03785145|365077611|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
105841561|NCT03785145|365077612|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
105841562|NCT03785145|365077611|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
105841563|NCT03785145|365077612|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
105841564|NCT03785145|365077611|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
105841565|NCT03785145|365077612|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
105841566|NCT03785145|365077611|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
105841567|NCT03785145|365077612|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
105841568|NCT03785145|365077611|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
105841569|NCT03785145|365077612|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
105841570|NCT03686150|365077620|FG000|Overall Study|Withdrawal by Subject|1|||
105841571|NCT03686150|365077621|FG001|Overall Study|Withdrawal by Subject|1|||
105841572|NCT03686150|365077622|FG002|Overall Study|Withdrawal by Subject|1|||
105841573|NCT03686150|365077623|FG003|Overall Study|Withdrawal by Subject|0|||
105841574|NCT03686150|365077624|FG004|Overall Study|Withdrawal by Subject|1|||
105841575|NCT03686150|365077625|FG005|Overall Study|Withdrawal by Subject|2|||
105841576|NCT03686150|365077620|FG000|Overall Study|Physician Decision|1|||
105841577|NCT03686150|365077621|FG001|Overall Study|Physician Decision|0|||
105841578|NCT03686150|365077622|FG002|Overall Study|Physician Decision|0|||
105841579|NCT03686150|365077623|FG003|Overall Study|Physician Decision|0|||
105841580|NCT03686150|365077624|FG004|Overall Study|Physician Decision|0|||
105841581|NCT03686150|365077625|FG005|Overall Study|Physician Decision|1|||
105841582|NCT03686150|365077620|FG000|Overall Study|Lost to Follow-up|0|||
105841583|NCT03686150|365077621|FG001|Overall Study|Lost to Follow-up|1|||
105841584|NCT03686150|365077622|FG002|Overall Study|Lost to Follow-up|0|||
105841585|NCT03686150|365077623|FG003|Overall Study|Lost to Follow-up|0|||
105841586|NCT03686150|365077624|FG004|Overall Study|Lost to Follow-up|0|||
105841587|NCT03686150|365077625|FG005|Overall Study|Lost to Follow-up|0|||
105841588|NCT00614926|365077626|FG000|Overall Study|Burden of travel|1|||
105841589|NCT00614926|365077627|FG001|Overall Study|Burden of travel|0|||
105841590|NCT00614926|365077626|FG000|Overall Study|Adverse Event|3|||
105841591|NCT00614926|365077627|FG001|Overall Study|Adverse Event|0|||
105841592|NCT01207440|365077628|FG000|Overall Study|Adverse Event|46|||
105841593|NCT01207440|365077629|FG001|Overall Study|Adverse Event|11|||
105368154|NCT01909804|363354148|FG000|Overall Study|Randomized but Never Treated|0|||
105368155|NCT01909804|363354149|FG001|Overall Study|Randomized but Never Treated|0|||
105490017|NCT01436162|363805719|FG001|Randomized Phase|Lost to Follow-up|5|||
105490018|NCT01436162|363805720|FG002|Randomized Phase|Lost to Follow-up|4|||
105490019|NCT01436162|363805718|FG000|Randomized Phase|Lack of Efficacy|0|||
105490020|NCT01436162|363805719|FG001|Randomized Phase|Lack of Efficacy|1|||
105841594|NCT01207440|365077630|FG002|Overall Study|Adverse Event|7|||
105841595|NCT01207440|365077631|FG003|Overall Study|Adverse Event|2|||
105841596|NCT01207440|365077632|FG004|Overall Study|Adverse Event|6|||
105490021|NCT01436162|363805720|FG002|Randomized Phase|Lack of Efficacy|1|||
105841597|NCT01207440|365077633|FG005|Overall Study|Adverse Event|6|||
105312698|NCT02119819|363143911|FG005|Overall Study|Left the city to get a job|0|||
105841598|NCT01207440|365077634|FG006|Overall Study|Adverse Event|2|||
105841599|NCT01207440|365077628|FG000|Overall Study|Death|6|||
105841600|NCT01207440|365077629|FG001|Overall Study|Death|3|||
105841601|NCT01207440|365077630|FG002|Overall Study|Death|2|||
105841602|NCT01207440|365077631|FG003|Overall Study|Death|2|||
105841603|NCT01207440|365077632|FG004|Overall Study|Death|7|||
105841604|NCT01207440|365077633|FG005|Overall Study|Death|5|||
105841605|NCT01207440|365077634|FG006|Overall Study|Death|1|||
105841606|NCT01207440|365077628|FG000|Overall Study|Lack of Efficacy|13|||
105841607|NCT01207440|365077629|FG001|Overall Study|Lack of Efficacy|2|||
105841608|NCT01207440|365077630|FG002|Overall Study|Lack of Efficacy|5|||
105841609|NCT01207440|365077631|FG003|Overall Study|Lack of Efficacy|1|||
105841610|NCT01207440|365077632|FG004|Overall Study|Lack of Efficacy|2|||
105841611|NCT01207440|365077633|FG005|Overall Study|Lack of Efficacy|3|||
105841612|NCT01207440|365077634|FG006|Overall Study|Lack of Efficacy|0|||
105841613|NCT01207440|365077628|FG000|Overall Study|Lost to Follow-up|0|||
105841614|NCT01207440|365077629|FG001|Overall Study|Lost to Follow-up|0|||
105841615|NCT01207440|365077630|FG002|Overall Study|Lost to Follow-up|2|||
105841616|NCT01207440|365077631|FG003|Overall Study|Lost to Follow-up|1|||
105841617|NCT01207440|365077632|FG004|Overall Study|Lost to Follow-up|0|||
105841618|NCT01207440|365077633|FG005|Overall Study|Lost to Follow-up|0|||
105841619|NCT01207440|365077634|FG006|Overall Study|Lost to Follow-up|0|||
105841620|NCT01207440|365077628|FG000|Overall Study|Non-compliance with Study Drug|3|||
105841621|NCT01207440|365077629|FG001|Overall Study|Non-compliance with Study Drug|0|||
105841622|NCT01207440|365077630|FG002|Overall Study|Non-compliance with Study Drug|1|||
105841623|NCT01207440|365077631|FG003|Overall Study|Non-compliance with Study Drug|0|||
105841624|NCT01207440|365077632|FG004|Overall Study|Non-compliance with Study Drug|0|||
105841625|NCT01207440|365077633|FG005|Overall Study|Non-compliance with Study Drug|0|||
105841626|NCT01207440|365077634|FG006|Overall Study|Non-compliance with Study Drug|0|||
105841627|NCT01207440|365077628|FG000|Overall Study|Physician Decision|6|||
105841628|NCT01207440|365077629|FG001|Overall Study|Physician Decision|5|||
105841629|NCT01207440|365077630|FG002|Overall Study|Physician Decision|5|||
105841630|NCT01207440|365077631|FG003|Overall Study|Physician Decision|0|||
105841631|NCT01207440|365077632|FG004|Overall Study|Physician Decision|1|||
105841632|NCT01207440|365077633|FG005|Overall Study|Physician Decision|0|||
105841633|NCT01207440|365077634|FG006|Overall Study|Physician Decision|0|||
105841634|NCT01207440|365077628|FG000|Overall Study|Progressive Disease|19|||
105841635|NCT01207440|365077629|FG001|Overall Study|Progressive Disease|10|||
105841636|NCT01207440|365077630|FG002|Overall Study|Progressive Disease|19|||
105841637|NCT01207440|365077631|FG003|Overall Study|Progressive Disease|7|||
105841638|NCT01207440|365077632|FG004|Overall Study|Progressive Disease|23|||
105841639|NCT01207440|365077633|FG005|Overall Study|Progressive Disease|27|||
105841640|NCT01207440|365077634|FG006|Overall Study|Progressive Disease|0|||
105841641|NCT01207440|365077628|FG000|Overall Study|Protocol Violation|2|||
105841642|NCT01207440|365077629|FG001|Overall Study|Protocol Violation|0|||
105841643|NCT01207440|365077630|FG002|Overall Study|Protocol Violation|0|||
105841644|NCT01207440|365077631|FG003|Overall Study|Protocol Violation|0|||
105841645|NCT01207440|365077632|FG004|Overall Study|Protocol Violation|0|||
105841646|NCT01207440|365077633|FG005|Overall Study|Protocol Violation|0|||
105841647|NCT01207440|365077634|FG006|Overall Study|Protocol Violation|0|||
105841648|NCT01207440|365077628|FG000|Overall Study|Site Terminated by Sponsor|69|||
105841649|NCT01207440|365077629|FG001|Overall Study|Site Terminated by Sponsor|19|||
105841650|NCT01207440|365077630|FG002|Overall Study|Site Terminated by Sponsor|12|||
105841651|NCT01207440|365077631|FG003|Overall Study|Site Terminated by Sponsor|2|||
105841652|NCT01207440|365077632|FG004|Overall Study|Site Terminated by Sponsor|3|||
105841653|NCT01207440|365077633|FG005|Overall Study|Site Terminated by Sponsor|0|||
105841654|NCT01207440|365077634|FG006|Overall Study|Site Terminated by Sponsor|2|||
105841655|NCT01207440|365077628|FG000|Overall Study|Withdrawal by Subject|29|||
105841656|NCT01207440|365077629|FG001|Overall Study|Withdrawal by Subject|4|||
105841657|NCT01207440|365077630|FG002|Overall Study|Withdrawal by Subject|5|||
105841658|NCT01207440|365077631|FG003|Overall Study|Withdrawal by Subject|3|||
105841659|NCT01207440|365077632|FG004|Overall Study|Withdrawal by Subject|2|||
105841660|NCT01207440|365077633|FG005|Overall Study|Withdrawal by Subject|2|||
105312699|NCT02699684|363143913|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
105312700|NCT02699684|363143914|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
105312701|NCT01145508|363143915|FG000|Overall Study|Adverse Event|1|||
105841661|NCT01207440|365077634|FG006|Overall Study|Withdrawal by Subject|0|||
105841662|NCT01207440|365077628|FG000|Overall Study|Reason Not Specified|10|||
105312702|NCT01145508|363143916|FG001|Overall Study|Adverse Event|0|||
105841663|NCT01207440|365077629|FG001|Overall Study|Reason Not Specified|10|||
105841664|NCT01207440|365077630|FG002|Overall Study|Reason Not Specified|7|||
105841665|NCT01207440|365077631|FG003|Overall Study|Reason Not Specified|0|||
105841666|NCT01207440|365077632|FG004|Overall Study|Reason Not Specified|4|||
105841667|NCT01207440|365077633|FG005|Overall Study|Reason Not Specified|3|||
105841668|NCT01207440|365077634|FG006|Overall Study|Reason Not Specified|0|||
105841669|NCT01316419|365077638|FG000|Overall Study|Not treated|103|||
105312703|NCT01145508|363143915|FG000|Overall Study|Death|1|||
105312704|NCT01145508|363143916|FG001|Overall Study|Death|0|||
105312705|NCT01145508|363143915|FG000|Overall Study|Physician Decision|2|||
105312706|NCT01145508|363143916|FG001|Overall Study|Physician Decision|1|||
105312707|NCT01145508|363143915|FG000|Overall Study|Never started treatment|1|||
105312708|NCT01145508|363143916|FG001|Overall Study|Never started treatment|1|||
105312709|NCT02045147|363143917|FG000|Overall Study|Withdrawal by Subject|2|||
105312710|NCT02045147|363143918|FG001|Overall Study|Withdrawal by Subject|0|||
105312711|NCT02045147|363143919|FG002|Overall Study|Withdrawal by Subject|0|||
105312712|NCT02045147|363143920|FG003|Overall Study|Withdrawal by Subject|0|||
105312713|NCT02045147|363143921|FG004|Overall Study|Withdrawal by Subject|0|||
105312714|NCT02045147|363143922|FG005|Overall Study|Withdrawal by Subject|0|||
105312715|NCT02045147|363143923|FG006|Overall Study|Withdrawal by Subject|0|||
105312716|NCT02045147|363143924|FG007|Overall Study|Withdrawal by Subject|1|||
105312717|NCT02045147|363143917|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
105312718|NCT02045147|363143918|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
105312719|NCT02045147|363143919|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
105312720|NCT02045147|363143920|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
105312721|NCT02045147|363143921|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
105312722|NCT02045147|363143922|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
105312723|NCT02045147|363143923|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
105312724|NCT02045147|363143924|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
105312725|NCT04839692|363143925|FG000|Overall Study|Withdrawal by Subject|0|||
105312726|NCT04839692|363143926|FG001|Overall Study|Withdrawal by Subject|3|||
105312727|NCT04839692|363143925|FG000|Overall Study|Physician Decision|1|||
105312728|NCT04839692|363143926|FG001|Overall Study|Physician Decision|0|||
105312729|NCT03146962|363143927|FG000|Overall Study|Lost to Follow-up|1|||
105312730|NCT03146962|363143928|FG001|Overall Study|Lost to Follow-up|1|||
105312731|NCT03146962|363143929|FG002|Overall Study|Lost to Follow-up|0|||
105312732|NCT03146962|363143930|FG003|Overall Study|Lost to Follow-up|0|||
105312733|NCT03146962|363143931|FG004|Overall Study|Lost to Follow-up|0|||
105312734|NCT03146962|363143932|FG005|Overall Study|Lost to Follow-up|0|||
105312735|NCT03146962|363143933|FG006|Overall Study|Lost to Follow-up|0|||
105312736|NCT03146962|363143934|FG007|Overall Study|Lost to Follow-up|0|||
105312737|NCT03146962|363143935|FG008|Overall Study|Lost to Follow-up|0|||
105312738|NCT03146962|363143936|FG009|Overall Study|Lost to Follow-up|0|||
105312739|NCT03146962|363143927|FG000|Overall Study|Adverse Event|0|||
105312740|NCT03146962|363143928|FG001|Overall Study|Adverse Event|3|||
105312741|NCT03146962|363143929|FG002|Overall Study|Adverse Event|0|||
105312742|NCT03146962|363143930|FG003|Overall Study|Adverse Event|0|||
105312743|NCT03146962|363143931|FG004|Overall Study|Adverse Event|0|||
105312744|NCT03146962|363143932|FG005|Overall Study|Adverse Event|0|||
105312745|NCT03146962|363143933|FG006|Overall Study|Adverse Event|0|||
105312746|NCT03146962|363143934|FG007|Overall Study|Adverse Event|1|||
105312747|NCT03146962|363143935|FG008|Overall Study|Adverse Event|0|||
105312748|NCT03146962|363143936|FG009|Overall Study|Adverse Event|0|||
105312749|NCT03146962|363143927|FG000|Overall Study|Withdrawal by Subject|0|||
105312750|NCT03146962|363143928|FG001|Overall Study|Withdrawal by Subject|0|||
105312751|NCT03146962|363143929|FG002|Overall Study|Withdrawal by Subject|0|||
105312752|NCT03146962|363143930|FG003|Overall Study|Withdrawal by Subject|0|||
105312753|NCT03146962|363143931|FG004|Overall Study|Withdrawal by Subject|1|||
105312754|NCT03146962|363143932|FG005|Overall Study|Withdrawal by Subject|0|||
105312755|NCT03146962|363143933|FG006|Overall Study|Withdrawal by Subject|0|||
105312756|NCT03146962|363143934|FG007|Overall Study|Withdrawal by Subject|0|||
105312757|NCT03146962|363143935|FG008|Overall Study|Withdrawal by Subject|0|||
105312758|NCT03146962|363143936|FG009|Overall Study|Withdrawal by Subject|0|||
105312759|NCT03146962|363143927|FG000|Overall Study|Death|0|||
105312760|NCT03146962|363143928|FG001|Overall Study|Death|1|||
105312761|NCT03146962|363143929|FG002|Overall Study|Death|0|||
105312762|NCT03146962|363143930|FG003|Overall Study|Death|0|||
105312763|NCT03146962|363143931|FG004|Overall Study|Death|0|||
105312764|NCT03146962|363143932|FG005|Overall Study|Death|0|||
105312765|NCT03146962|363143933|FG006|Overall Study|Death|0|||
105312766|NCT03146962|363143934|FG007|Overall Study|Death|0|||
105368156|NCT01909804|363354150|FG002|Overall Study|Randomized but Never Treated|0|||
105368157|NCT01909804|363354151|FG003|Overall Study|Randomized but Never Treated|0|||
105368158|NCT01909804|363354152|FG004|Overall Study|Randomized but Never Treated|0|||
105368159|NCT01909804|363354153|FG005|Overall Study|Randomized but Never Treated|0|||
105312767|NCT03146962|363143935|FG008|Overall Study|Death|0|||
105312768|NCT03146962|363143936|FG009|Overall Study|Death|0|||
105312769|NCT03146962|363143927|FG000|Overall Study|COVID Precautions|1|||
105312770|NCT03146962|363143928|FG001|Overall Study|COVID Precautions|0|||
105312771|NCT03146962|363143929|FG002|Overall Study|COVID Precautions|0|||
105312772|NCT03146962|363143930|FG003|Overall Study|COVID Precautions|0|||
105312773|NCT03146962|363143931|FG004|Overall Study|COVID Precautions|0|||
105312774|NCT03146962|363143932|FG005|Overall Study|COVID Precautions|0|||
105576552|NCT00451217|364110204|FG000|Overall Study|Lost to Follow-up|0|||
105312775|NCT03146962|363143933|FG006|Overall Study|COVID Precautions|0|||
105312776|NCT03146962|363143934|FG007|Overall Study|COVID Precautions|0|||
105312777|NCT03146962|363143935|FG008|Overall Study|COVID Precautions|0|||
105312778|NCT03146962|363143936|FG009|Overall Study|COVID Precautions|0|||
105312779|NCT03146962|363143927|FG000|Overall Study|Physician Decision|0|||
105312780|NCT03146962|363143928|FG001|Overall Study|Physician Decision|0|||
105312781|NCT03146962|363143929|FG002|Overall Study|Physician Decision|0|||
105312782|NCT03146962|363143930|FG003|Overall Study|Physician Decision|0|||
105312783|NCT03146962|363143931|FG004|Overall Study|Physician Decision|0|||
105312784|NCT03146962|363143932|FG005|Overall Study|Physician Decision|0|||
105312785|NCT03146962|363143933|FG006|Overall Study|Physician Decision|0|||
105312786|NCT03146962|363143934|FG007|Overall Study|Physician Decision|0|||
105312787|NCT03146962|363143935|FG008|Overall Study|Physician Decision|0|||
105312788|NCT03146962|363143936|FG009|Overall Study|Physician Decision|1|||
105312789|NCT03146962|363143927|FG000|Overall Study|Started New Treatment|0|||
105312790|NCT03146962|363143928|FG001|Overall Study|Started New Treatment|1|||
105312791|NCT03146962|363143929|FG002|Overall Study|Started New Treatment|0|||
105312792|NCT03146962|363143930|FG003|Overall Study|Started New Treatment|0|||
105312793|NCT03146962|363143931|FG004|Overall Study|Started New Treatment|0|||
105312794|NCT03146962|363143932|FG005|Overall Study|Started New Treatment|0|||
105312795|NCT03146962|363143933|FG006|Overall Study|Started New Treatment|0|||
105312796|NCT03146962|363143934|FG007|Overall Study|Started New Treatment|0|||
105312797|NCT03146962|363143935|FG008|Overall Study|Started New Treatment|0|||
105312798|NCT03146962|363143936|FG009|Overall Study|Started New Treatment|0|||
105312799|NCT00264550|363143939|FG000|Overall Study|Death|0|||
105312800|NCT00264550|363143940|FG001|Overall Study|Death|3|||
105312801|NCT00264550|363143941|FG002|Overall Study|Death|0|||
105312802|NCT00264550|363143942|FG003|Overall Study|Death|0|||
105312803|NCT00264550|363143939|FG000|Overall Study|Lost to Follow-up|3|||
105312804|NCT00264550|363143940|FG001|Overall Study|Lost to Follow-up|1|||
105312805|NCT00264550|363143941|FG002|Overall Study|Lost to Follow-up|1|||
105312806|NCT00264550|363143942|FG003|Overall Study|Lost to Follow-up|1|||
105312807|NCT00264550|363143939|FG000|Overall Study|Adverse Event|23|||
105312808|NCT00264550|363143940|FG001|Overall Study|Adverse Event|18|||
105312809|NCT00264550|363143941|FG002|Overall Study|Adverse Event|9|||
105312810|NCT00264550|363143942|FG003|Overall Study|Adverse Event|14|||
105312811|NCT00264550|363143939|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105312812|NCT00264550|363143940|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
105312813|NCT00264550|363143941|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
105312814|NCT00264550|363143942|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
105312815|NCT00264550|363143939|FG000|Overall Study|Discontinued oral study agent|0|||
105312816|NCT00264550|363143940|FG001|Overall Study|Discontinued oral study agent|1|||
105312817|NCT00264550|363143941|FG002|Overall Study|Discontinued oral study agent|0|||
105312818|NCT00264550|363143942|FG003|Overall Study|Discontinued oral study agent|0|||
105312819|NCT00264550|363143939|FG000|Overall Study|Other|13|||
105312820|NCT00264550|363143940|FG001|Overall Study|Other|7|||
105312821|NCT00264550|363143941|FG002|Overall Study|Other|3|||
105312822|NCT00264550|363143942|FG003|Overall Study|Other|9|||
105312823|NCT00469144|363143947|FG000|Overall Study|Death|0|||
105312824|NCT00469144|363143948|FG001|Overall Study|Death|1|||
105312825|NCT00469144|363143947|FG000|Overall Study|No Response|5|||
105312826|NCT00469144|363143948|FG001|Overall Study|No Response|5|||
105312827|NCT00469144|363143947|FG000|Overall Study|Progressive Disease|1|||
105312828|NCT00469144|363143948|FG001|Overall Study|Progressive Disease|0|||
105312829|NCT00603837|363143949|FG000|Overall Study|Physician Decision|3|||
105312830|NCT00603837|363143950|FG001|Overall Study|Physician Decision|0|||
105312831|NCT01994291|363143951|FG000|Overall Study|Adverse Event|4|||
105312832|NCT01994291|363143952|FG001|Overall Study|Adverse Event|1|||
105312833|NCT01994291|363143953|FG002|Overall Study|Adverse Event|3|||
105312834|NCT01994291|363143951|FG000|Overall Study|Lost to Follow-up|1|||
105312835|NCT01994291|363143952|FG001|Overall Study|Lost to Follow-up|1|||
105312836|NCT01994291|363143953|FG002|Overall Study|Lost to Follow-up|0|||
105312837|NCT01994291|363143951|FG000|Overall Study|Does not meet entrance criteria|1|||
105312838|NCT01994291|363143952|FG001|Overall Study|Does not meet entrance criteria|0|||
105312839|NCT01994291|363143953|FG002|Overall Study|Does not meet entrance criteria|0|||
105312840|NCT01994291|363143951|FG000|Overall Study|Medication error without associated AE|1|||
105312841|NCT01994291|363143952|FG001|Overall Study|Medication error without associated AE|0|||
105312842|NCT01994291|363143953|FG002|Overall Study|Medication error without associated AE|1|||
105312843|NCT01994291|363143951|FG000|Overall Study|Protocol Violation|1|||
105312844|NCT01994291|363143952|FG001|Overall Study|Protocol Violation|0|||
105312845|NCT01994291|363143953|FG002|Overall Study|Protocol Violation|0|||
105312846|NCT01994291|363143951|FG000|Overall Study|Withdrawal by Subject|6|||
105312847|NCT01994291|363143952|FG001|Overall Study|Withdrawal by Subject|3|||
105312848|NCT01994291|363143953|FG002|Overall Study|Withdrawal by Subject|5|||
105312849|NCT01994291|363143951|FG000|Overall Study|Other|1|||
105312850|NCT01994291|363143952|FG001|Overall Study|Other|2|||
105312851|NCT01994291|363143953|FG002|Overall Study|Other|0|||
105312852|NCT00229723|363143954|FG000|Concomitant Phase|Adverse Event|4|||
105312853|NCT00229723|363143955|FG001|Concomitant Phase|Adverse Event|2|||
105841670|NCT01316419|365077638|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
105841671|NCT01316419|365077638|FG000|Overall Study|Lost to Follow-up|19|||
105841672|NCT03341000|365077641|FG000|Overall Study|Adverse Event|1|||
105841673|NCT00754013|365077642|FG000|Overall Study|Lost to Follow-up|1|||
105841674|NCT00754013|365077643|FG001|Overall Study|Lost to Follow-up|1|||
105841675|NCT00754013|365077642|FG000|Overall Study|didn't return after study termed|3|||
105841676|NCT00754013|365077643|FG001|Overall Study|didn't return after study termed|4|||
105841677|NCT02310789|365077644|FG000|Overall Study|Adverse Event|1|||
105841678|NCT00792623|365077646|FG000|Overall Study|Adverse Event|2|||
105841679|NCT00792623|365077646|FG000|Overall Study|Withdrawal by Subject|5|||
105841680|NCT00107042|365077647|FG000|Overall Study|Lost to Follow-up|9|||
105841681|NCT00107042|365077648|FG001|Overall Study|Lost to Follow-up|7|||
105841682|NCT00107042|365077647|FG000|Overall Study|Withdrawal by Subject|6|||
105841683|NCT00107042|365077648|FG001|Overall Study|Withdrawal by Subject|1|||
105841684|NCT00107042|365077647|FG000|Overall Study|Moved out of area|5|||
105841685|NCT00107042|365077648|FG001|Overall Study|Moved out of area|3|||
105841686|NCT00107042|365077647|FG000|Overall Study|Pregnancy|1|||
105841687|NCT00107042|365077648|FG001|Overall Study|Pregnancy|1|||
105841688|NCT00107042|365077647|FG000|Overall Study|Inadvertent enrollment|0|||
105841689|NCT00107042|365077648|FG001|Overall Study|Inadvertent enrollment|1|||
105841690|NCT00107042|365077647|FG000|Overall Study|vaccinated outside window|1|||
105841691|NCT00107042|365077648|FG001|Overall Study|vaccinated outside window|1|||
105841692|NCT00107042|365077647|FG000|Overall Study|Disallowed medications|0|||
105841693|NCT00107042|365077648|FG001|Overall Study|Disallowed medications|2|||
105841694|NCT03919448|365077649|FG000|Overall Study|Withdrawal by Subject|1|||
105841695|NCT03919448|365077650|FG001|Overall Study|Withdrawal by Subject|0|||
105841696|NCT03919448|365077651|FG002|Overall Study|Withdrawal by Subject|0|||
105841697|NCT04213209|365077652|FG000|Overall Study|Protocol Violation|1|||
105841698|NCT04213209|365077653|FG001|Overall Study|Protocol Violation|0|||
105841699|NCT04213209|365077654|FG002|Overall Study|Protocol Violation|0|||
105841700|NCT04213209|365077655|FG003|Overall Study|Protocol Violation|0|||
105841701|NCT04213209|365077656|FG004|Overall Study|Protocol Violation|0|||
105841702|NCT04213209|365077657|FG005|Overall Study|Protocol Violation|0|||
105841703|NCT02776553|365077664|FG000|Overall Study|Lost to Follow-up|1|||
105841704|NCT02776553|365077665|FG001|Overall Study|Lost to Follow-up|0|||
105841705|NCT02776553|365077664|FG000|Overall Study|got liver transplant|1|||
105841706|NCT02776553|365077665|FG001|Overall Study|got liver transplant|2|||
105841707|NCT02776553|365077664|FG000|Overall Study|had other surgery|1|||
105841708|NCT02776553|365077665|FG001|Overall Study|had other surgery|0|||
105841709|NCT02776553|365077664|FG000|Overall Study|Protocol Violation|0|||
105841710|NCT02776553|365077665|FG001|Overall Study|Protocol Violation|1|||
105841711|NCT03827018|365077668|FG000|Overall Study|Adverse Event|1|||
105841712|NCT03827018|365077669|FG001|Overall Study|Adverse Event|0|||
105841713|NCT03827018|365077668|FG000|Overall Study|Withdrawal by Subject|2|||
105841714|NCT03827018|365077669|FG001|Overall Study|Withdrawal by Subject|2|||
105841715|NCT03827018|365077668|FG000|Overall Study|Lack of Efficacy|0|||
105841716|NCT03827018|365077669|FG001|Overall Study|Lack of Efficacy|1|||
105841717|NCT01803269|365077674|FG000|Overall Study|Withdrawal by Subject|3|||
105841718|NCT01803269|365077675|FG001|Overall Study|Withdrawal by Subject|0|||
105841719|NCT01803269|365077676|FG002|Overall Study|Withdrawal by Subject|0|||
105841720|NCT01435031|365077680|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
105841721|NCT01435031|365077680|FG000|ITT at 1 Month|Death|1|||
105841722|NCT01435031|365077680|FG000|ITT at 1 Month|Lost to Follow-up|4|||
105841723|NCT01435031|365077680|FG000|ITT at 6 Months|Death|2|||
105841724|NCT01435031|365077680|FG000|ITT at 6 Months|Lost to Follow-up|3|||
105841725|NCT01435031|365077680|FG000|ITT at 1 Year|Death|1|||
105841726|NCT01435031|365077680|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
105841727|NCT01435031|365077680|FG000|ITT at 1 Year|Lost to Follow-up|6|||
105841728|NCT01435031|365077680|FG000|ITT at 2 Years|Death|7|||
105841729|NCT01435031|365077680|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
105841730|NCT01435031|365077680|FG000|ITT at 2 Years|Lost to Follow-up|4|||
105841731|NCT01435031|365077680|FG000|ITT at 3 Years|Death|5|||
105841732|NCT01435031|365077680|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
105490022|NCT01436162|363805718|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
105490023|NCT01436162|363805719|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
105841733|NCT01435031|365077680|FG000|ITT at 3 Years|Lost to Follow-up|4|||
105841734|NCT01435031|365077680|FG000|ITT at 4 Years|Death|4|||
105490024|NCT01436162|363805720|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
105841735|NCT01435031|365077680|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
105841736|NCT01435031|365077680|FG000|ITT at 4 Years|Lost to Follow-up|1|||
105841737|NCT02927834|365077681|FG000|Overall Study|Lost to Follow-up|1|||
105841738|NCT02927834|365077682|FG001|Overall Study|Lost to Follow-up|2|||
105841739|NCT02927834|365077683|FG002|Overall Study|Lost to Follow-up|2|||
105841740|NCT03812991|365077684|FG000|Overall Study|Lost to Follow-up|3|||
105841741|NCT03812991|365077685|FG001|Overall Study|Lost to Follow-up|1|||
105841742|NCT04798482|365077697|FG000|Overall Study|Physician Decision|1|||
105841743|NCT04798482|365077697|FG000|Overall Study|Lost eligibility|1|||
105841744|NCT04349631|365077698|FG000|Overall Study|Lost to Follow-up|3|||
105841745|NCT04349631|365077698|FG000|Overall Study|Withdrawal by Subject|7|||
105312854|NCT00229723|363143956|FG002|Concomitant Phase|Adverse Event|5|||
105312855|NCT00229723|363143957|FG003|Concomitant Phase|Adverse Event|2|||
105312856|NCT00229723|363143958|FG004|Concomitant Phase|Adverse Event|0|||
105312857|NCT00229723|363143959|FG005|Concomitant Phase|Adverse Event|1|||
105312858|NCT00229723|363143960|FG006|Concomitant Phase|Adverse Event|2|||
105312859|NCT00229723|363143954|FG000|Concomitant Phase|Objective disease progression|0|||
105312860|NCT00229723|363143955|FG001|Concomitant Phase|Objective disease progression|0|||
105312861|NCT00229723|363143956|FG002|Concomitant Phase|Objective disease progression|0|||
105312862|NCT00229723|363143957|FG003|Concomitant Phase|Objective disease progression|0|||
105312863|NCT00229723|363143958|FG004|Concomitant Phase|Objective disease progression|0|||
105312864|NCT00229723|363143959|FG005|Concomitant Phase|Objective disease progression|0|||
105312865|NCT00229723|363143960|FG006|Concomitant Phase|Objective disease progression|0|||
105312866|NCT00229723|363143954|FG000|Concomitant Phase|Clinical progression|0|||
105312867|NCT00229723|363143955|FG001|Concomitant Phase|Clinical progression|0|||
105312868|NCT00229723|363143956|FG002|Concomitant Phase|Clinical progression|0|||
105312869|NCT00229723|363143957|FG003|Concomitant Phase|Clinical progression|0|||
105312870|NCT00229723|363143958|FG004|Concomitant Phase|Clinical progression|0|||
105312871|NCT00229723|363143959|FG005|Concomitant Phase|Clinical progression|0|||
105312872|NCT00229723|363143960|FG006|Concomitant Phase|Clinical progression|1|||
105312873|NCT00229723|363143954|FG000|Concomitant Phase|Lost to Follow-up|0|||
105312874|NCT00229723|363143955|FG001|Concomitant Phase|Lost to Follow-up|0|||
105312875|NCT00229723|363143956|FG002|Concomitant Phase|Lost to Follow-up|0|||
105312876|NCT00229723|363143957|FG003|Concomitant Phase|Lost to Follow-up|0|||
105312877|NCT00229723|363143958|FG004|Concomitant Phase|Lost to Follow-up|1|||
105312878|NCT00229723|363143959|FG005|Concomitant Phase|Lost to Follow-up|0|||
105312879|NCT00229723|363143960|FG006|Concomitant Phase|Lost to Follow-up|0|||
105312880|NCT00229723|363143954|FG000|Concomitant Phase|Informed consent withdrawn|3|||
105312881|NCT00229723|363143955|FG001|Concomitant Phase|Informed consent withdrawn|2|||
105312882|NCT00229723|363143956|FG002|Concomitant Phase|Informed consent withdrawn|0|||
105312883|NCT00229723|363143957|FG003|Concomitant Phase|Informed consent withdrawn|2|||
105312884|NCT00229723|363143958|FG004|Concomitant Phase|Informed consent withdrawn|0|||
105312885|NCT00229723|363143959|FG005|Concomitant Phase|Informed consent withdrawn|0|||
105312886|NCT00229723|363143960|FG006|Concomitant Phase|Informed consent withdrawn|0|||
105312887|NCT00229723|363143954|FG000|Concomitant Phase|Severe non-compliance|0|||
105312888|NCT00229723|363143955|FG001|Concomitant Phase|Severe non-compliance|1|||
105312889|NCT00229723|363143956|FG002|Concomitant Phase|Severe non-compliance|0|||
105312890|NCT00229723|363143957|FG003|Concomitant Phase|Severe non-compliance|0|||
105312891|NCT00229723|363143958|FG004|Concomitant Phase|Severe non-compliance|1|||
105312892|NCT00229723|363143959|FG005|Concomitant Phase|Severe non-compliance|0|||
105312893|NCT00229723|363143960|FG006|Concomitant Phase|Severe non-compliance|0|||
105312894|NCT00229723|363143954|FG000|Concomitant Phase|Other|3|||
105312895|NCT00229723|363143955|FG001|Concomitant Phase|Other|0|||
105312896|NCT00229723|363143956|FG002|Concomitant Phase|Other|1|||
105312897|NCT00229723|363143957|FG003|Concomitant Phase|Other|1|||
105312898|NCT00229723|363143958|FG004|Concomitant Phase|Other|0|||
105312899|NCT00229723|363143959|FG005|Concomitant Phase|Other|2|||
105312900|NCT00229723|363143960|FG006|Concomitant Phase|Other|0|||
105312901|NCT00229723|363143954|FG000|Maintenance Phase|Adverse Event|7|||
105312902|NCT00229723|363143955|FG001|Maintenance Phase|Adverse Event|2|||
105312903|NCT00229723|363143956|FG002|Maintenance Phase|Adverse Event|1|||
105312904|NCT00229723|363143957|FG003|Maintenance Phase|Adverse Event|4|||
105312905|NCT00229723|363143958|FG004|Maintenance Phase|Adverse Event|7|||
105312906|NCT00229723|363143959|FG005|Maintenance Phase|Adverse Event|5|||
105312907|NCT00229723|363143960|FG006|Maintenance Phase|Adverse Event|2|||
105312908|NCT00229723|363143954|FG000|Maintenance Phase|Objective disease progression|5|||
105312909|NCT00229723|363143955|FG001|Maintenance Phase|Objective disease progression|5|||
105312910|NCT00229723|363143956|FG002|Maintenance Phase|Objective disease progression|3|||
105312911|NCT00229723|363143957|FG003|Maintenance Phase|Objective disease progression|6|||
105312912|NCT00229723|363143958|FG004|Maintenance Phase|Objective disease progression|2|||
105312913|NCT00229723|363143959|FG005|Maintenance Phase|Objective disease progression|9|||
105312914|NCT00229723|363143960|FG006|Maintenance Phase|Objective disease progression|5|||
105312915|NCT00229723|363143954|FG000|Maintenance Phase|Clinical progression|4|||
105312916|NCT00229723|363143955|FG001|Maintenance Phase|Clinical progression|1|||
105312917|NCT00229723|363143956|FG002|Maintenance Phase|Clinical progression|2|||
105312918|NCT00229723|363143957|FG003|Maintenance Phase|Clinical progression|2|||
105312919|NCT00229723|363143958|FG004|Maintenance Phase|Clinical progression|1|||
105312920|NCT00229723|363143959|FG005|Maintenance Phase|Clinical progression|1|||
105312921|NCT00229723|363143960|FG006|Maintenance Phase|Clinical progression|1|||
105312922|NCT00229723|363143954|FG000|Maintenance Phase|Lost to Follow-up|0|||
105312923|NCT00229723|363143955|FG001|Maintenance Phase|Lost to Follow-up|1|||
105312924|NCT00229723|363143956|FG002|Maintenance Phase|Lost to Follow-up|2|||
105312925|NCT00229723|363143957|FG003|Maintenance Phase|Lost to Follow-up|2|||
105312926|NCT00229723|363143958|FG004|Maintenance Phase|Lost to Follow-up|0|||
105312927|NCT00229723|363143959|FG005|Maintenance Phase|Lost to Follow-up|0|||
105312928|NCT00229723|363143960|FG006|Maintenance Phase|Lost to Follow-up|1|||
105490025|NCT01436162|363805718|FG000|Randomized Phase|Other|2|||
105841746|NCT01258101|365077701|FG000|Overall Study|Adverse Event|5|||
105841747|NCT01258101|365077702|FG001|Overall Study|Adverse Event|6|||
105841748|NCT01258101|365077703|FG002|Overall Study|Adverse Event|0|||
105841749|NCT01258101|365077704|FG003|Overall Study|Adverse Event|0|||
105841750|NCT01258101|365077701|FG000|Overall Study|Extra exclusion criterion amended|2|||
105841751|NCT01258101|365077702|FG001|Overall Study|Extra exclusion criterion amended|1|||
105841752|NCT01258101|365077703|FG002|Overall Study|Extra exclusion criterion amended|1|||
105841753|NCT01258101|365077704|FG003|Overall Study|Extra exclusion criterion amended|1|||
105841754|NCT01258101|365077701|FG000|Overall Study|Informed consent has been withdrawn|2|||
105841755|NCT01258101|365077702|FG001|Overall Study|Informed consent has been withdrawn|2|||
105841756|NCT01258101|365077703|FG002|Overall Study|Informed consent has been withdrawn|1|||
105841757|NCT01258101|365077704|FG003|Overall Study|Informed consent has been withdrawn|1|||
105841758|NCT01258101|365077701|FG000|Overall Study|Patient is not able to attend visits|8|||
105841759|NCT01258101|365077702|FG001|Overall Study|Patient is not able to attend visits|9|||
105841760|NCT01258101|365077703|FG002|Overall Study|Patient is not able to attend visits|7|||
105841761|NCT01258101|365077704|FG003|Overall Study|Patient is not able to attend visits|6|||
105841762|NCT01258101|365077701|FG000|Overall Study|Patient´s compliance|4|||
105841763|NCT01258101|365077702|FG001|Overall Study|Patient´s compliance|3|||
105841764|NCT01258101|365077703|FG002|Overall Study|Patient´s compliance|1|||
105841765|NCT01258101|365077704|FG003|Overall Study|Patient´s compliance|2|||
105312929|NCT00229723|363143954|FG000|Maintenance Phase|Informed consent withdrawn|1|||
105312930|NCT00229723|363143955|FG001|Maintenance Phase|Informed consent withdrawn|0|||
105312931|NCT00229723|363143956|FG002|Maintenance Phase|Informed consent withdrawn|0|||
105312932|NCT00229723|363143957|FG003|Maintenance Phase|Informed consent withdrawn|1|||
105312933|NCT00229723|363143958|FG004|Maintenance Phase|Informed consent withdrawn|1|||
105312934|NCT00229723|363143959|FG005|Maintenance Phase|Informed consent withdrawn|1|||
105312935|NCT00229723|363143960|FG006|Maintenance Phase|Informed consent withdrawn|0|||
105312936|NCT00229723|363143954|FG000|Maintenance Phase|Severe non-compliance|3|||
105312937|NCT00229723|363143955|FG001|Maintenance Phase|Severe non-compliance|1|||
105312938|NCT00229723|363143956|FG002|Maintenance Phase|Severe non-compliance|0|||
105312939|NCT00229723|363143957|FG003|Maintenance Phase|Severe non-compliance|0|||
105312940|NCT00229723|363143958|FG004|Maintenance Phase|Severe non-compliance|1|||
105312941|NCT00229723|363143959|FG005|Maintenance Phase|Severe non-compliance|0|||
105312942|NCT00229723|363143960|FG006|Maintenance Phase|Severe non-compliance|0|||
105312943|NCT00229723|363143954|FG000|Maintenance Phase|Other|5|||
105312944|NCT00229723|363143955|FG001|Maintenance Phase|Other|4|||
105312945|NCT00229723|363143956|FG002|Maintenance Phase|Other|1|||
105312946|NCT00229723|363143957|FG003|Maintenance Phase|Other|2|||
105312947|NCT00229723|363143958|FG004|Maintenance Phase|Other|3|||
105312948|NCT00229723|363143959|FG005|Maintenance Phase|Other|3|||
105312949|NCT00229723|363143960|FG006|Maintenance Phase|Other|1|||
105312950|NCT00838435|363143963|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
105312951|NCT00838435|363143963|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
105312952|NCT00838435|363143963|FG000|Part 2 (7 Years)|Adverse Event|2|||
105312953|NCT00838435|363143963|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
105312954|NCT00838435|363143963|FG000|Part 2 (7 Years)|Physician Decision|1|||
105312955|NCT00838435|363143963|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
105312956|NCT00838435|363143963|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
105312957|NCT04988087|363143964|FG000|Overall Study|Adverse Event|4|||
105312958|NCT04988087|363143965|FG001|Overall Study|Adverse Event|0|||
105312959|NCT04988087|363143966|FG002|Overall Study|Adverse Event|0|||
105312960|NCT04988087|363143967|FG003|Overall Study|Adverse Event|0|||
105312961|NCT04988087|363143964|FG000|Overall Study|Withdrawal by Subject|1|||
105312962|NCT04988087|363143965|FG001|Overall Study|Withdrawal by Subject|1|||
105312963|NCT04988087|363143966|FG002|Overall Study|Withdrawal by Subject|0|||
105312964|NCT04988087|363143967|FG003|Overall Study|Withdrawal by Subject|0|||
105312965|NCT04988087|363143964|FG000|Overall Study|Technical problems|7|||
105312966|NCT04988087|363143965|FG001|Overall Study|Technical problems|9|||
105312967|NCT04988087|363143966|FG002|Overall Study|Technical problems|1|||
105312968|NCT04988087|363143967|FG003|Overall Study|Technical problems|2|||
105312969|NCT02458287|363143968|FG000|Overall Study|Adverse Event|0|||
105368160|NCT01909804|363354154|FG006|Overall Study|Randomized but Never Treated|1|||
105368161|NCT01909804|363354155|FG007|Overall Study|Randomized but Never Treated|0|||
105841766|NCT01258101|365077701|FG000|Overall Study|Lost to Follow-up|5|||
105841767|NCT01258101|365077702|FG001|Overall Study|Lost to Follow-up|5|||
105841768|NCT01258101|365077703|FG002|Overall Study|Lost to Follow-up|0|||
105312970|NCT02458287|363143969|FG001|Overall Study|Adverse Event|0|||
105490026|NCT01436162|363805719|FG001|Randomized Phase|Other|5|||
105312971|NCT02458287|363143970|FG002|Overall Study|Adverse Event|0|||
105312972|NCT02458287|363143971|FG003|Overall Study|Adverse Event|1|||
105841769|NCT01258101|365077704|FG003|Overall Study|Lost to Follow-up|6|||
105841770|NCT01258101|365077701|FG000|Overall Study|PCR positive at week 24|0|||
105312973|NCT02458287|363143968|FG000|Overall Study|Lost to Follow-up|0|||
105312974|NCT02458287|363143969|FG001|Overall Study|Lost to Follow-up|1|||
105312975|NCT02458287|363143970|FG002|Overall Study|Lost to Follow-up|1|||
105312976|NCT02458287|363143971|FG003|Overall Study|Lost to Follow-up|0|||
105312977|NCT02458287|363143968|FG000|Overall Study|Protocol Violation|0|||
105312978|NCT02458287|363143969|FG001|Overall Study|Protocol Violation|1|||
105312979|NCT02458287|363143970|FG002|Overall Study|Protocol Violation|0|||
105312980|NCT02458287|363143971|FG003|Overall Study|Protocol Violation|0|||
105312981|NCT02458287|363143968|FG000|Overall Study|Withdrawal by Subject|0|||
105312982|NCT02458287|363143969|FG001|Overall Study|Withdrawal by Subject|2|||
105312983|NCT02458287|363143970|FG002|Overall Study|Withdrawal by Subject|2|||
105312984|NCT02458287|363143971|FG003|Overall Study|Withdrawal by Subject|1|||
105312985|NCT02458287|363143968|FG000|Overall Study|Relocated Out of State|0|||
105312986|NCT02458287|363143969|FG001|Overall Study|Relocated Out of State|0|||
105312987|NCT02458287|363143970|FG002|Overall Study|Relocated Out of State|0|||
105312988|NCT02458287|363143971|FG003|Overall Study|Relocated Out of State|1|||
105312989|NCT02613182|363143972|FG000|Overall Study|Death|6|||
105312990|NCT02613182|363143972|FG000|Overall Study|Physician Decision|1|||
105312991|NCT02613182|363143972|FG000|Overall Study|Study Terminated by Sponsor|21|||
105312992|NCT02613182|363143972|FG000|Overall Study|Withdrawal by Subject|6|||
105312993|NCT01547130|363143973|FG000|Overall Study|Lost to Follow-up|9|||
105312994|NCT01547130|363143974|FG001|Overall Study|Lost to Follow-up|5|||
105312995|NCT04435184|363143975|FG000|Overall Study|follow-up blood draws missing|3|||
105312996|NCT04435184|363143976|FG001|Overall Study|follow-up blood draws missing|5|||
105312997|NCT00025259|363143977|FG000|Overall Study|Death|1|||
105312998|NCT00025259|363143978|FG001|Overall Study|Death|3|||
105312999|NCT00025259|363143979|FG002|Overall Study|Death|0|||
105313000|NCT00025259|363143980|FG003|Overall Study|Death|3|||
105313001|NCT00025259|363143981|FG004|Overall Study|Death|0|||
105313002|NCT00025259|363143982|FG005|Overall Study|Death|1|||
105313003|NCT00025259|363143983|FG006|Overall Study|Death|2|||
105313004|NCT00025259|363143977|FG000|Overall Study|Lack of Efficacy|2|||
105313005|NCT00025259|363143978|FG001|Overall Study|Lack of Efficacy|46|||
105313006|NCT00025259|363143979|FG002|Overall Study|Lack of Efficacy|60|||
105313007|NCT00025259|363143980|FG003|Overall Study|Lack of Efficacy|78|||
105313008|NCT00025259|363143981|FG004|Overall Study|Lack of Efficacy|11|||
105313009|NCT00025259|363143982|FG005|Overall Study|Lack of Efficacy|30|||
105313010|NCT00025259|363143983|FG006|Overall Study|Lack of Efficacy|38|||
105313011|NCT00025259|363143977|FG000|Overall Study|Lost to Follow-up|2|||
105313012|NCT00025259|363143978|FG001|Overall Study|Lost to Follow-up|9|||
105313013|NCT00025259|363143979|FG002|Overall Study|Lost to Follow-up|13|||
105313014|NCT00025259|363143980|FG003|Overall Study|Lost to Follow-up|13|||
105313015|NCT00025259|363143981|FG004|Overall Study|Lost to Follow-up|1|||
105313016|NCT00025259|363143982|FG005|Overall Study|Lost to Follow-up|3|||
105313017|NCT00025259|363143983|FG006|Overall Study|Lost to Follow-up|1|||
105313018|NCT00025259|363143977|FG000|Overall Study|Physician Decision|12|||
105313019|NCT00025259|363143978|FG001|Overall Study|Physician Decision|1|||
105313020|NCT00025259|363143979|FG002|Overall Study|Physician Decision|0|||
105313021|NCT00025259|363143980|FG003|Overall Study|Physician Decision|5|||
105313022|NCT00025259|363143981|FG004|Overall Study|Physician Decision|4|||
105313023|NCT00025259|363143982|FG005|Overall Study|Physician Decision|2|||
105313024|NCT00025259|363143983|FG006|Overall Study|Physician Decision|1|||
105313025|NCT00025259|363143977|FG000|Overall Study|Protocol Violation|3|||
105313026|NCT00025259|363143978|FG001|Overall Study|Protocol Violation|2|||
105313027|NCT00025259|363143979|FG002|Overall Study|Protocol Violation|2|||
105313028|NCT00025259|363143980|FG003|Overall Study|Protocol Violation|1|||
105313029|NCT00025259|363143981|FG004|Overall Study|Protocol Violation|2|||
105313030|NCT00025259|363143982|FG005|Overall Study|Protocol Violation|1|||
105313031|NCT00025259|363143983|FG006|Overall Study|Protocol Violation|3|||
105313032|NCT00025259|363143977|FG000|Overall Study|Withdrawal by Subject|9|||
105313033|NCT00025259|363143978|FG001|Overall Study|Withdrawal by Subject|27|||
105313034|NCT00025259|363143979|FG002|Overall Study|Withdrawal by Subject|6|||
105313035|NCT00025259|363143980|FG003|Overall Study|Withdrawal by Subject|14|||
105313036|NCT00025259|363143981|FG004|Overall Study|Withdrawal by Subject|11|||
105313037|NCT00025259|363143982|FG005|Overall Study|Withdrawal by Subject|8|||
105313038|NCT00025259|363143983|FG006|Overall Study|Withdrawal by Subject|3|||
105313039|NCT00025259|363143977|FG000|Overall Study|Ineligible|14|||
105313040|NCT00025259|363143978|FG001|Overall Study|Ineligible|1|||
105313041|NCT00025259|363143979|FG002|Overall Study|Ineligible|0|||
105313042|NCT00025259|363143980|FG003|Overall Study|Ineligible|0|||
105313043|NCT00025259|363143981|FG004|Overall Study|Ineligible|6|||
105313044|NCT00025259|363143982|FG005|Overall Study|Ineligible|0|||
105313045|NCT00025259|363143983|FG006|Overall Study|Ineligible|1|||
105313046|NCT00025259|363143977|FG000|Overall Study|Randomization error|1|||
105313047|NCT00025259|363143978|FG001|Overall Study|Randomization error|0|||
105313048|NCT00025259|363143979|FG002|Overall Study|Randomization error|0|||
105313049|NCT00025259|363143980|FG003|Overall Study|Randomization error|0|||
105313050|NCT00025259|363143981|FG004|Overall Study|Randomization error|1|||
105313051|NCT00025259|363143982|FG005|Overall Study|Randomization error|7|||
105313052|NCT00025259|363143983|FG006|Overall Study|Randomization error|2|||
105313053|NCT00025259|363143977|FG000|Overall Study|Adverse Event|1|||
105313054|NCT00025259|363143978|FG001|Overall Study|Adverse Event|0|||
105313055|NCT00025259|363143979|FG002|Overall Study|Adverse Event|0|||
105313056|NCT00025259|363143980|FG003|Overall Study|Adverse Event|0|||
105313057|NCT00025259|363143981|FG004|Overall Study|Adverse Event|0|||
105490027|NCT01436162|363805720|FG002|Randomized Phase|Other|4|||
105841771|NCT01258101|365077702|FG001|Overall Study|PCR positive at week 24|0|||
105841772|NCT01258101|365077703|FG002|Overall Study|PCR positive at week 24|0|||
105841773|NCT01258101|365077704|FG003|Overall Study|PCR positive at week 24|1|||
105841774|NCT01258101|365077701|FG000|Overall Study|Other reason|7|||
105841775|NCT01258101|365077702|FG001|Overall Study|Other reason|8|||
105841776|NCT01258101|365077703|FG002|Overall Study|Other reason|1|||
105841777|NCT01258101|365077704|FG003|Overall Study|Other reason|8|||
105841778|NCT00303667|365077705|FG000|Overall Study|Death|0|||
105841779|NCT00303667|365077706|FG001|Overall Study|Death|4|||
105841780|NCT01807117|365077707|FG000|Overall Study|Physician Decision|2|||
105841781|NCT01807117|365077707|FG000|Overall Study|Disease diagnosis not a study disease|1|||
105841782|NCT01029392|365077708|FG000|Overall Study|Withdrawal by Subject|18|||
105841783|NCT01029392|365077709|FG001|Overall Study|Withdrawal by Subject|11|||
105841784|NCT01029392|365077708|FG000|Overall Study|Physician Decision|2|||
105841785|NCT01029392|365077709|FG001|Overall Study|Physician Decision|0|||
105841786|NCT01103479|365077710|FG000|Overall Study|Up to date with CRC screening|1|||
105841787|NCT01103479|365077711|FG001|Overall Study|Up to date with CRC screening|9|||
105841788|NCT01103479|365077712|FG002|Overall Study|Up to date with CRC screening|12|||
105841789|NCT01103479|365077710|FG000|Overall Study|Family history of CRC|1|||
105841790|NCT01103479|365077711|FG001|Overall Study|Family history of CRC|0|||
105841791|NCT01103479|365077712|FG002|Overall Study|Family history of CRC|2|||
105841792|NCT01103479|365077710|FG000|Overall Study|Active cancer|1|||
105841793|NCT01103479|365077711|FG001|Overall Study|Active cancer|0|||
105841794|NCT01103479|365077712|FG002|Overall Study|Active cancer|0|||
105841795|NCT01103479|365077710|FG000|Overall Study|Saw non-study physician|2|||
105841796|NCT01103479|365077711|FG001|Overall Study|Saw non-study physician|0|||
105841797|NCT01103479|365077712|FG002|Overall Study|Saw non-study physician|0|||
105841798|NCT01534637|365077713|FG000|Overall Study|Physician Decision|3|||
105841799|NCT01534637|365077713|FG000|Overall Study|Lack of Efficacy|3|||
105841800|NCT01534637|365077713|FG000|Overall Study|Withdrawal by Subject|1|||
105841801|NCT01534637|365077713|FG000|Overall Study|Adverse Event|1|||
105841802|NCT01534637|365077713|FG000|Overall Study|Liver Mets before treatment|1|||
105841803|NCT00834899|365077714|FG000|Overall Study|Withdrawal by Subject|1|||
105841804|NCT00834899|365077715|FG001|Overall Study|Withdrawal by Subject|1|||
105841805|NCT02709486|365077719|FG000|Overall Study|Adverse Event|2|||
105841806|NCT02709486|365077720|FG001|Overall Study|Adverse Event|5|||
105841807|NCT02709486|365077721|FG002|Overall Study|Adverse Event|3|||
105841808|NCT02709486|365077719|FG000|Overall Study|Death|0|||
105841809|NCT02709486|365077720|FG001|Overall Study|Death|0|||
105841810|NCT02709486|365077721|FG002|Overall Study|Death|2|||
105841811|NCT02709486|365077719|FG000|Overall Study|Insufficient clinical response|7|||
105841812|NCT02709486|365077720|FG001|Overall Study|Insufficient clinical response|3|||
105841813|NCT02709486|365077721|FG002|Overall Study|Insufficient clinical response|3|||
105841814|NCT02709486|365077719|FG000|Overall Study|Lost to Follow-up|3|||
105841815|NCT02709486|365077720|FG001|Overall Study|Lost to Follow-up|2|||
105841816|NCT02709486|365077721|FG002|Overall Study|Lost to Follow-up|2|||
105841817|NCT02709486|365077719|FG000|Overall Study|Other|0|||
105841818|NCT02709486|365077720|FG001|Overall Study|Other|2|||
105841819|NCT02709486|365077721|FG002|Overall Study|Other|3|||
105841820|NCT02709486|365077719|FG000|Overall Study|Withdrawal by Subject|32|||
105841821|NCT02709486|365077720|FG001|Overall Study|Withdrawal by Subject|22|||
105841822|NCT02709486|365077721|FG002|Overall Study|Withdrawal by Subject|32|||
105841823|NCT03903159|365077725|FG000|Overall Study|Discharged with Staff Approval|2|||
105841824|NCT03903159|365077725|FG000|Overall Study|Discharged at Staff Request|2|||
105841825|NCT03903159|365077725|FG000|Overall Study|Discharged Against Staff Advice|1|||
105841826|NCT00720226|365077730|FG000|Overall Study|Withdrawal by Subject|7|||
105841827|NCT00720226|365077731|FG001|Overall Study|Withdrawal by Subject|4|||
105841828|NCT00536484|365077733|FG000|Overall Study|Adverse Event|21|||
105841829|NCT00536484|365077734|FG001|Overall Study|Adverse Event|34|||
105841830|NCT00536484|365077733|FG000|Overall Study|Withdrawal by Subject|11|||
105841831|NCT00536484|365077734|FG001|Overall Study|Withdrawal by Subject|11|||
105841832|NCT00536484|365077733|FG000|Overall Study|Lost to Follow-up|8|||
105841833|NCT00536484|365077734|FG001|Overall Study|Lost to Follow-up|6|||
105313058|NCT00025259|363143982|FG005|Overall Study|Adverse Event|0|||
105313059|NCT00025259|363143983|FG006|Overall Study|Adverse Event|0|||
105313060|NCT00474266|363143984|FG000|Overall Study|Withdrawal by Subject|7|||
105313061|NCT00474266|363143985|FG001|Overall Study|Withdrawal by Subject|20|||
105313062|NCT00474266|363143986|FG002|Overall Study|Withdrawal by Subject|4|||
105313063|NCT00474266|363143987|FG003|Overall Study|Withdrawal by Subject|7|||
105313064|NCT00863772|363143988|FG000|Overall Study|Adverse Event|1|||
105313065|NCT00863772|363143989|FG001|Overall Study|Adverse Event|4|||
105313066|NCT00863772|363143990|FG002|Overall Study|Adverse Event|0|||
105313067|NCT00863772|363143988|FG000|Overall Study|Lack of Efficacy|4|||
105313068|NCT00863772|363143989|FG001|Overall Study|Lack of Efficacy|2|||
105313069|NCT00863772|363143990|FG002|Overall Study|Lack of Efficacy|4|||
105313070|NCT00863772|363143988|FG000|Overall Study|Lost to Follow-up|5|||
105313071|NCT00863772|363143989|FG001|Overall Study|Lost to Follow-up|1|||
105313072|NCT00863772|363143990|FG002|Overall Study|Lost to Follow-up|1|||
105313073|NCT00863772|363143988|FG000|Overall Study|Protocol Violation|2|||
105313074|NCT00863772|363143989|FG001|Overall Study|Protocol Violation|0|||
105313075|NCT00863772|363143990|FG002|Overall Study|Protocol Violation|2|||
105313076|NCT00863772|363143988|FG000|Overall Study|Withdrawal by Subject|4|||
105313077|NCT00863772|363143989|FG001|Overall Study|Withdrawal by Subject|7|||
105313078|NCT00863772|363143990|FG002|Overall Study|Withdrawal by Subject|5|||
105313079|NCT00863772|363143988|FG000|Overall Study|Study terminated by sponsor|44|||
105313080|NCT00863772|363143989|FG001|Overall Study|Study terminated by sponsor|45|||
105313081|NCT00863772|363143990|FG002|Overall Study|Study terminated by sponsor|36|||
105313082|NCT00863772|363143988|FG000|Overall Study|Entered extension study|6|||
105313083|NCT00863772|363143989|FG001|Overall Study|Entered extension study|4|||
105313084|NCT00863772|363143990|FG002|Overall Study|Entered extension study|9|||
105313085|NCT00863772|363143988|FG000|Overall Study|Other|1|||
105313086|NCT00863772|363143989|FG001|Overall Study|Other|2|||
105313087|NCT00863772|363143990|FG002|Overall Study|Other|4|||
105313088|NCT00863772|363143988|FG000|Overall Study|Randomized but not Treated|1|||
105313089|NCT00863772|363143989|FG001|Overall Study|Randomized but not Treated|0|||
105313090|NCT00863772|363143990|FG002|Overall Study|Randomized but not Treated|0|||
105313091|NCT01449370|363143991|FG000|Overall Study|Disease Progression|5|||
105313092|NCT01449370|363143992|FG001|Overall Study|Disease Progression|4|||
105313093|NCT01449370|363143993|FG002|Overall Study|Disease Progression|8|||
105313094|NCT01449370|363143994|FG003|Overall Study|Disease Progression|3|||
105313095|NCT01449370|363143995|FG004|Overall Study|Disease Progression|3|||
105313096|NCT01449370|363143996|FG005|Overall Study|Disease Progression|3|||
105313097|NCT01449370|363143997|FG006|Overall Study|Disease Progression|3|||
105313098|NCT01449370|363143998|FG007|Overall Study|Disease Progression|2|||
105313099|NCT01449370|363143999|FG008|Overall Study|Disease Progression|9|||
105313100|NCT01449370|363144000|FG009|Overall Study|Disease Progression|1|||
105313101|NCT01449370|363144001|FG010|Overall Study|Disease Progression|3|||
105313102|NCT01449370|363144002|FG011|Overall Study|Disease Progression|3|||
105313103|NCT01449370|363144003|FG012|Overall Study|Disease Progression|2|||
105313104|NCT01449370|363144004|FG013|Overall Study|Disease Progression|8|||
105313105|NCT01449370|363144005|FG014|Overall Study|Disease Progression|3|||
105313106|NCT01449370|363144006|FG015|Overall Study|Disease Progression|1|||
105313107|NCT01449370|363144007|FG016|Overall Study|Disease Progression|4|||
105313108|NCT01449370|363144008|FG017|Overall Study|Disease Progression|3|||
105313109|NCT01449370|363144009|FG018|Overall Study|Disease Progression|1|||
105313110|NCT01449370|363144010|FG019|Overall Study|Disease Progression|2|||
105313111|NCT01449370|363144011|FG020|Overall Study|Disease Progression|5|||
105313112|NCT01449370|363144012|FG021|Overall Study|Disease Progression|2|||
105313113|NCT01449370|363144013|FG022|Overall Study|Disease Progression|3|||
105313114|NCT01449370|363144014|FG023|Overall Study|Disease Progression|7|||
105313115|NCT01449370|363144015|FG024|Overall Study|Disease Progression|3|||
105313116|NCT01449370|363143991|FG000|Overall Study|Adverse Event|1|||
105313117|NCT01449370|363143992|FG001|Overall Study|Adverse Event|2|||
105313118|NCT01449370|363143993|FG002|Overall Study|Adverse Event|0|||
105313119|NCT01449370|363143994|FG003|Overall Study|Adverse Event|1|||
105313120|NCT01449370|363143995|FG004|Overall Study|Adverse Event|0|||
105841834|NCT00536484|365077733|FG000|Overall Study|Lack of Efficacy|16|||
105841835|NCT00536484|365077734|FG001|Overall Study|Lack of Efficacy|5|||
105841836|NCT00536484|365077733|FG000|Overall Study|Other|4|||
105841837|NCT00536484|365077734|FG001|Overall Study|Other|0|||
105841838|NCT00706355|365077735|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
105841839|NCT00706355|365077736|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
105841840|NCT00706355|365077737|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
105841841|NCT00706355|365077738|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
105841842|NCT00706355|365077735|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
105841843|NCT00706355|365077736|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
105841844|NCT00706355|365077737|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
105841845|NCT00706355|365077738|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
105841846|NCT00706355|365077735|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
105841847|NCT00706355|365077736|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
105841848|NCT00706355|365077737|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
105841849|NCT00706355|365077738|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
105841850|NCT00706355|365077735|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
105841851|NCT00706355|365077736|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
105841852|NCT00706355|365077737|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
105841853|NCT00706355|365077738|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
105841854|NCT00706355|365077735|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
105313121|NCT01449370|363143996|FG005|Overall Study|Adverse Event|0|||
105313122|NCT01449370|363143997|FG006|Overall Study|Adverse Event|0|||
105313123|NCT01449370|363143998|FG007|Overall Study|Adverse Event|0|||
105313124|NCT01449370|363143999|FG008|Overall Study|Adverse Event|1|||
105313125|NCT01449370|363144000|FG009|Overall Study|Adverse Event|1|||
105313126|NCT01449370|363144001|FG010|Overall Study|Adverse Event|0|||
105313127|NCT01449370|363144002|FG011|Overall Study|Adverse Event|0|||
105313128|NCT01449370|363144003|FG012|Overall Study|Adverse Event|0|||
105313129|NCT01449370|363144004|FG013|Overall Study|Adverse Event|2|||
105313130|NCT01449370|363144005|FG014|Overall Study|Adverse Event|0|||
105313131|NCT01449370|363144006|FG015|Overall Study|Adverse Event|1|||
105313132|NCT01449370|363144007|FG016|Overall Study|Adverse Event|0|||
105313133|NCT01449370|363144008|FG017|Overall Study|Adverse Event|0|||
105313134|NCT01449370|363144009|FG018|Overall Study|Adverse Event|1|||
105313135|NCT01449370|363144010|FG019|Overall Study|Adverse Event|1|||
105313136|NCT01449370|363144011|FG020|Overall Study|Adverse Event|0|||
105313137|NCT01449370|363144012|FG021|Overall Study|Adverse Event|1|||
105313138|NCT01449370|363144013|FG022|Overall Study|Adverse Event|0|||
105313139|NCT01449370|363144014|FG023|Overall Study|Adverse Event|1|||
105313140|NCT01449370|363144015|FG024|Overall Study|Adverse Event|3|||
105313141|NCT01449370|363143991|FG000|Overall Study|Participant Decision|0|||
105313142|NCT01449370|363143992|FG001|Overall Study|Participant Decision|0|||
105313143|NCT01449370|363143993|FG002|Overall Study|Participant Decision|0|||
105313144|NCT01449370|363143994|FG003|Overall Study|Participant Decision|0|||
105313145|NCT01449370|363143995|FG004|Overall Study|Participant Decision|0|||
105313146|NCT01449370|363143996|FG005|Overall Study|Participant Decision|0|||
105313147|NCT01449370|363143997|FG006|Overall Study|Participant Decision|0|||
105313148|NCT01449370|363143998|FG007|Overall Study|Participant Decision|1|||
105313149|NCT01449370|363143999|FG008|Overall Study|Participant Decision|1|||
105313150|NCT01449370|363144000|FG009|Overall Study|Participant Decision|0|||
105313151|NCT01449370|363144001|FG010|Overall Study|Participant Decision|0|||
105313152|NCT01449370|363144002|FG011|Overall Study|Participant Decision|0|||
105313153|NCT01449370|363144003|FG012|Overall Study|Participant Decision|1|||
105313154|NCT01449370|363144004|FG013|Overall Study|Participant Decision|1|||
105313155|NCT01449370|363144005|FG014|Overall Study|Participant Decision|0|||
105313156|NCT01449370|363144006|FG015|Overall Study|Participant Decision|1|||
105313157|NCT01449370|363144007|FG016|Overall Study|Participant Decision|3|||
105313158|NCT01449370|363144008|FG017|Overall Study|Participant Decision|0|||
105313159|NCT01449370|363144009|FG018|Overall Study|Participant Decision|1|||
105313160|NCT01449370|363144010|FG019|Overall Study|Participant Decision|0|||
105313161|NCT01449370|363144011|FG020|Overall Study|Participant Decision|0|||
105313162|NCT01449370|363144012|FG021|Overall Study|Participant Decision|1|||
105313163|NCT01449370|363144013|FG022|Overall Study|Participant Decision|0|||
105313164|NCT01449370|363144014|FG023|Overall Study|Participant Decision|0|||
105313165|NCT01449370|363144015|FG024|Overall Study|Participant Decision|1|||
105313166|NCT01449370|363143991|FG000|Overall Study|Lost to Follow-up|0|||
105313167|NCT01449370|363143992|FG001|Overall Study|Lost to Follow-up|0|||
105313168|NCT01449370|363143993|FG002|Overall Study|Lost to Follow-up|0|||
105313169|NCT01449370|363143994|FG003|Overall Study|Lost to Follow-up|0|||
105313170|NCT01449370|363143995|FG004|Overall Study|Lost to Follow-up|0|||
105313171|NCT01449370|363143996|FG005|Overall Study|Lost to Follow-up|0|||
105313172|NCT01449370|363143997|FG006|Overall Study|Lost to Follow-up|0|||
105313173|NCT01449370|363143998|FG007|Overall Study|Lost to Follow-up|0|||
105313174|NCT01449370|363143999|FG008|Overall Study|Lost to Follow-up|0|||
105313175|NCT01449370|363144000|FG009|Overall Study|Lost to Follow-up|0|||
105313176|NCT01449370|363144001|FG010|Overall Study|Lost to Follow-up|0|||
105313177|NCT01449370|363144002|FG011|Overall Study|Lost to Follow-up|0|||
105313178|NCT01449370|363144003|FG012|Overall Study|Lost to Follow-up|0|||
105313179|NCT01449370|363144004|FG013|Overall Study|Lost to Follow-up|0|||
105313180|NCT01449370|363144005|FG014|Overall Study|Lost to Follow-up|0|||
105313181|NCT01449370|363144006|FG015|Overall Study|Lost to Follow-up|0|||
105313182|NCT01449370|363144007|FG016|Overall Study|Lost to Follow-up|0|||
105313183|NCT01449370|363144008|FG017|Overall Study|Lost to Follow-up|0|||
105368162|NCT01909804|363354156|FG008|Overall Study|Randomized but Never Treated|0|||
105490028|NCT00760084|363805721|FG000|Overall Study|Physician Decision|5|||
105313184|NCT01449370|363144009|FG018|Overall Study|Lost to Follow-up|0|||
105313185|NCT01449370|363144010|FG019|Overall Study|Lost to Follow-up|0|||
105313186|NCT01449370|363144011|FG020|Overall Study|Lost to Follow-up|1|||
105313187|NCT01449370|363144012|FG021|Overall Study|Lost to Follow-up|0|||
105313188|NCT01449370|363144013|FG022|Overall Study|Lost to Follow-up|0|||
105313189|NCT01449370|363144014|FG023|Overall Study|Lost to Follow-up|0|||
105313190|NCT01449370|363144015|FG024|Overall Study|Lost to Follow-up|0|||
105313191|NCT01449370|363143991|FG000|Overall Study|Other|0|||
105313192|NCT01449370|363143992|FG001|Overall Study|Other|0|||
105313193|NCT01449370|363143993|FG002|Overall Study|Other|0|||
105313194|NCT01449370|363143994|FG003|Overall Study|Other|0|||
105313195|NCT01449370|363143995|FG004|Overall Study|Other|0|||
105313196|NCT01449370|363143996|FG005|Overall Study|Other|0|||
105313197|NCT01449370|363143997|FG006|Overall Study|Other|0|||
105313198|NCT01449370|363143998|FG007|Overall Study|Other|0|||
105313199|NCT01449370|363143999|FG008|Overall Study|Other|1|||
105313200|NCT01449370|363144000|FG009|Overall Study|Other|1|||
105313201|NCT01449370|363144001|FG010|Overall Study|Other|0|||
105313202|NCT01449370|363144002|FG011|Overall Study|Other|0|||
105313203|NCT01449370|363144003|FG012|Overall Study|Other|0|||
105313204|NCT01449370|363144004|FG013|Overall Study|Other|0|||
105313205|NCT01449370|363144005|FG014|Overall Study|Other|0|||
105313206|NCT01449370|363144006|FG015|Overall Study|Other|0|||
105313207|NCT01449370|363144007|FG016|Overall Study|Other|0|||
105313208|NCT01449370|363144008|FG017|Overall Study|Other|0|||
105313209|NCT01449370|363144009|FG018|Overall Study|Other|0|||
105313210|NCT01449370|363144010|FG019|Overall Study|Other|0|||
105313211|NCT01449370|363144011|FG020|Overall Study|Other|0|||
105313212|NCT01449370|363144012|FG021|Overall Study|Other|0|||
105313213|NCT01449370|363144013|FG022|Overall Study|Other|1|||
105313214|NCT01449370|363144014|FG023|Overall Study|Other|1|||
105313215|NCT01449370|363144015|FG024|Overall Study|Other|0|||
105313216|NCT01449370|363143991|FG000|Overall Study|Medication Prohibited by Protocol|0|||
105313217|NCT01449370|363143992|FG001|Overall Study|Medication Prohibited by Protocol|0|||
105313218|NCT01449370|363143993|FG002|Overall Study|Medication Prohibited by Protocol|0|||
105313219|NCT01449370|363143994|FG003|Overall Study|Medication Prohibited by Protocol|0|||
105313220|NCT01449370|363143995|FG004|Overall Study|Medication Prohibited by Protocol|0|||
105313221|NCT01449370|363143996|FG005|Overall Study|Medication Prohibited by Protocol|0|||
105313222|NCT01449370|363143997|FG006|Overall Study|Medication Prohibited by Protocol|0|||
105313223|NCT01449370|363143998|FG007|Overall Study|Medication Prohibited by Protocol|0|||
105313224|NCT01449370|363143999|FG008|Overall Study|Medication Prohibited by Protocol|0|||
105313225|NCT01449370|363144000|FG009|Overall Study|Medication Prohibited by Protocol|0|||
105313226|NCT01449370|363144001|FG010|Overall Study|Medication Prohibited by Protocol|0|||
105313227|NCT01449370|363144002|FG011|Overall Study|Medication Prohibited by Protocol|0|||
105313228|NCT01449370|363144003|FG012|Overall Study|Medication Prohibited by Protocol|0|||
105313229|NCT01449370|363144004|FG013|Overall Study|Medication Prohibited by Protocol|0|||
105313230|NCT01449370|363144005|FG014|Overall Study|Medication Prohibited by Protocol|0|||
105313231|NCT01449370|363144006|FG015|Overall Study|Medication Prohibited by Protocol|0|||
105313232|NCT01449370|363144007|FG016|Overall Study|Medication Prohibited by Protocol|0|||
105313233|NCT01449370|363144008|FG017|Overall Study|Medication Prohibited by Protocol|0|||
105313234|NCT01449370|363144009|FG018|Overall Study|Medication Prohibited by Protocol|0|||
105313235|NCT01449370|363144010|FG019|Overall Study|Medication Prohibited by Protocol|0|||
105313236|NCT01449370|363144011|FG020|Overall Study|Medication Prohibited by Protocol|0|||
105313237|NCT01449370|363144012|FG021|Overall Study|Medication Prohibited by Protocol|0|||
105313238|NCT01449370|363144013|FG022|Overall Study|Medication Prohibited by Protocol|0|||
105313239|NCT01449370|363144014|FG023|Overall Study|Medication Prohibited by Protocol|1|||
105313240|NCT01449370|363144015|FG024|Overall Study|Medication Prohibited by Protocol|0|||
105313241|NCT01449370|363143991|FG000|Overall Study|Death|0|||
105313242|NCT01449370|363143992|FG001|Overall Study|Death|0|||
105313243|NCT01449370|363143993|FG002|Overall Study|Death|0|||
105313244|NCT01449370|363143994|FG003|Overall Study|Death|0|||
105313245|NCT01449370|363143995|FG004|Overall Study|Death|0|||
105313246|NCT01449370|363143996|FG005|Overall Study|Death|0|||
105313247|NCT01449370|363143997|FG006|Overall Study|Death|0|||
105313248|NCT01449370|363143998|FG007|Overall Study|Death|0|||
105313249|NCT01449370|363143999|FG008|Overall Study|Death|0|||
105313250|NCT01449370|363144000|FG009|Overall Study|Death|0|||
105313251|NCT01449370|363144001|FG010|Overall Study|Death|0|||
105313252|NCT01449370|363144002|FG011|Overall Study|Death|0|||
105313253|NCT01449370|363144003|FG012|Overall Study|Death|0|||
105313254|NCT01449370|363144004|FG013|Overall Study|Death|0|||
105313255|NCT01449370|363144005|FG014|Overall Study|Death|0|||
105313256|NCT01449370|363144006|FG015|Overall Study|Death|0|||
105313257|NCT01449370|363144007|FG016|Overall Study|Death|0|||
105313258|NCT01449370|363144008|FG017|Overall Study|Death|0|||
105313259|NCT01449370|363144009|FG018|Overall Study|Death|0|||
105313260|NCT01449370|363144010|FG019|Overall Study|Death|0|||
105313261|NCT01449370|363144011|FG020|Overall Study|Death|0|||
105313262|NCT01449370|363144012|FG021|Overall Study|Death|0|||
105313263|NCT01449370|363144013|FG022|Overall Study|Death|0|||
105313264|NCT01449370|363144014|FG023|Overall Study|Death|0|||
105313265|NCT01449370|363144015|FG024|Overall Study|Death|1|||
105313266|NCT00534404|363144016|FG000|Overall Study|Death|0|||
105313267|NCT00534404|363144017|FG001|Overall Study|Death|0|||
105313268|NCT00534404|363144018|FG002|Overall Study|Death|2|||
105313269|NCT00534404|363144016|FG000|Overall Study|Withdrawal by Subject|8|||
105313270|NCT00534404|363144017|FG001|Overall Study|Withdrawal by Subject|2|||
105313271|NCT00534404|363144018|FG002|Overall Study|Withdrawal by Subject|38|||
105313272|NCT00534404|363144016|FG000|Overall Study|Removed by study staff|2|||
105313273|NCT00534404|363144017|FG001|Overall Study|Removed by study staff|3|||
105313274|NCT00534404|363144018|FG002|Overall Study|Removed by study staff|1|||
105313275|NCT00534404|363144016|FG000|Overall Study|Lost to Follow-up|170|||
105313276|NCT00534404|363144017|FG001|Overall Study|Lost to Follow-up|138|||
105313277|NCT00534404|363144018|FG002|Overall Study|Lost to Follow-up|201|||
105313278|NCT03301623|363144023|FG000|Overall Study|Death|3|||
105313279|NCT03301623|363144024|FG001|Overall Study|Death|1|||
105313280|NCT03301623|363144023|FG000|Overall Study|Withdrawal by Subject|11|||
105313281|NCT03301623|363144024|FG001|Overall Study|Withdrawal by Subject|13|||
105313282|NCT03301623|363144023|FG000|Overall Study|Lost to Follow-up|3|||
105313283|NCT03301623|363144024|FG001|Overall Study|Lost to Follow-up|1|||
105313284|NCT00315731|363144025|FG000|Overall Study|Lost to Follow-up|1|||
105313285|NCT00315731|363144025|FG000|Overall Study|Death|5|||
105313286|NCT04400682|363144026|FG000|Period 1|Withdrawal by Subject|1|||
105313287|NCT04400682|363144027|FG001|Period 1|Withdrawal by Subject|4|||
105313288|NCT04784533|363144034|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
105313289|NCT04784533|363144035|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
105313290|NCT04784533|363144036|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105313291|NCT04784533|363144037|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105313292|NCT04784533|363144038|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105313293|NCT04784533|363144039|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105313294|NCT04784533|363144040|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105368163|NCT01909804|363354157|FG009|Overall Study|Randomized but Never Treated|0|||
105368164|NCT01909804|363354158|FG010|Overall Study|Randomized but Never Treated|0|||
105368165|NCT01909804|363354159|FG011|Overall Study|Randomized but Never Treated|1|||
105368166|NCT01909804|363354148|FG000|Overall Study|Death|0|||
105368167|NCT01909804|363354149|FG001|Overall Study|Death|0|||
105368168|NCT01909804|363354150|FG002|Overall Study|Death|0|||
105368169|NCT01909804|363354151|FG003|Overall Study|Death|0|||
105368170|NCT01909804|363354152|FG004|Overall Study|Death|0|||
105368171|NCT01909804|363354153|FG005|Overall Study|Death|0|||
105368172|NCT01909804|363354154|FG006|Overall Study|Death|0|||
105368173|NCT01909804|363354155|FG007|Overall Study|Death|0|||
105368174|NCT01909804|363354156|FG008|Overall Study|Death|0|||
105368175|NCT01909804|363354157|FG009|Overall Study|Death|0|||
105368176|NCT01909804|363354158|FG010|Overall Study|Death|1|||
105368177|NCT01909804|363354159|FG011|Overall Study|Death|0|||
105368178|NCT01909804|363354148|FG000|Overall Study|Lack of Efficacy|4|||
105368179|NCT01909804|363354149|FG001|Overall Study|Lack of Efficacy|1|||
105368180|NCT01909804|363354150|FG002|Overall Study|Lack of Efficacy|0|||
105368181|NCT01909804|363354151|FG003|Overall Study|Lack of Efficacy|0|||
105368182|NCT01909804|363354152|FG004|Overall Study|Lack of Efficacy|7|||
105368183|NCT01909804|363354153|FG005|Overall Study|Lack of Efficacy|3|||
105368184|NCT01909804|363354154|FG006|Overall Study|Lack of Efficacy|1|||
105368185|NCT01909804|363354155|FG007|Overall Study|Lack of Efficacy|1|||
105368186|NCT01909804|363354156|FG008|Overall Study|Lack of Efficacy|0|||
105368187|NCT01909804|363354157|FG009|Overall Study|Lack of Efficacy|1|||
105368188|NCT01909804|363354158|FG010|Overall Study|Lack of Efficacy|0|||
105368189|NCT01909804|363354159|FG011|Overall Study|Lack of Efficacy|1|||
105368190|NCT01909804|363354148|FG000|Overall Study|Withdrew Consent|0|||
105368191|NCT01909804|363354149|FG001|Overall Study|Withdrew Consent|0|||
105368192|NCT01909804|363354150|FG002|Overall Study|Withdrew Consent|0|||
105368193|NCT01909804|363354151|FG003|Overall Study|Withdrew Consent|0|||
105368194|NCT01909804|363354152|FG004|Overall Study|Withdrew Consent|1|||
105368195|NCT01909804|363354153|FG005|Overall Study|Withdrew Consent|1|||
105368196|NCT01909804|363354154|FG006|Overall Study|Withdrew Consent|0|||
105368197|NCT01909804|363354155|FG007|Overall Study|Withdrew Consent|0|||
105368198|NCT01909804|363354156|FG008|Overall Study|Withdrew Consent|0|||
105368199|NCT01909804|363354157|FG009|Overall Study|Withdrew Consent|0|||
105368200|NCT01909804|363354158|FG010|Overall Study|Withdrew Consent|0|||
105368201|NCT01909804|363354159|FG011|Overall Study|Withdrew Consent|0|||
105368202|NCT01909804|363354148|FG000|Overall Study|Protocol Violation|0|||
105368203|NCT01909804|363354149|FG001|Overall Study|Protocol Violation|0|||
105368204|NCT01909804|363354150|FG002|Overall Study|Protocol Violation|0|||
105368205|NCT01909804|363354151|FG003|Overall Study|Protocol Violation|0|||
105368206|NCT01909804|363354152|FG004|Overall Study|Protocol Violation|0|||
105368207|NCT01909804|363354153|FG005|Overall Study|Protocol Violation|0|||
105368208|NCT01909804|363354154|FG006|Overall Study|Protocol Violation|0|||
105368209|NCT01909804|363354155|FG007|Overall Study|Protocol Violation|0|||
105368210|NCT01909804|363354156|FG008|Overall Study|Protocol Violation|0|||
105368211|NCT01909804|363354157|FG009|Overall Study|Protocol Violation|0|||
105368212|NCT01909804|363354158|FG010|Overall Study|Protocol Violation|0|||
105368213|NCT01909804|363354159|FG011|Overall Study|Protocol Violation|1|||
105313295|NCT04784533|363144041|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105313296|NCT04784533|363144042|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105368214|NCT05222880|363354162|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
105368215|NCT05222880|363354162|FG000|Overall Study|Withdrew Consent during Study|1|||
105368216|NCT05222880|363354162|FG000|Overall Study|COVID-19 Related|1|||
105368217|NCT00791999|363354163|FG000|Overall Study|Protocol planed withdrawal|14|||
105368218|NCT00791999|363354164|FG001|Overall Study|Protocol planed withdrawal|11|||
105368219|NCT00791999|363354165|FG002|Overall Study|Protocol planed withdrawal|11|||
105490029|NCT00760084|363805721|FG000|Overall Study|Withdrawal by Subject|2|||
105368220|NCT00791999|363354166|FG003|Overall Study|Protocol planed withdrawal|45|||
105490030|NCT00760084|363805721|FG000|Overall Study|Progressive Disease|3|||
105490031|NCT02628769|363805722|FG000|First Intervention|Adverse Event|1|||
105368221|NCT00791999|363354163|FG000|Overall Study|Withdrawal by Subject|0|||
105368222|NCT00791999|363354164|FG001|Overall Study|Withdrawal by Subject|1|||
105368223|NCT00791999|363354165|FG002|Overall Study|Withdrawal by Subject|0|||
105313297|NCT04784533|363144043|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105313298|NCT04784533|363144034|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
105313299|NCT04784533|363144035|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
105313300|NCT04784533|363144036|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
105313301|NCT04784533|363144037|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
105313302|NCT04784533|363144038|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
105313303|NCT04784533|363144039|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
105313304|NCT04784533|363144040|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
105313305|NCT04784533|363144041|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
105313306|NCT04784533|363144042|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
105313307|NCT04784533|363144043|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
105313308|NCT04784533|363144034|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105313309|NCT04784533|363144035|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
105313310|NCT04784533|363144036|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105313311|NCT04784533|363144037|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105313312|NCT04784533|363144038|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105313313|NCT04784533|363144039|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105313314|NCT04784533|363144040|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105313315|NCT04784533|363144041|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105313316|NCT04784533|363144042|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105313317|NCT04784533|363144043|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105313318|NCT04784533|363144034|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
105313319|NCT04784533|363144035|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105313320|NCT04784533|363144036|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105490032|NCT02628769|363805723|FG001|First Intervention|Adverse Event|0|||
105490033|NCT02628769|363805722|FG000|First Intervention|Withdrawal by Subject|0|||
105490034|NCT02628769|363805723|FG001|First Intervention|Withdrawal by Subject|1|||
105313321|NCT04784533|363144037|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105313322|NCT04784533|363144038|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105313323|NCT04784533|363144039|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105313324|NCT04784533|363144040|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105313325|NCT04784533|363144041|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105313326|NCT04784533|363144042|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105313327|NCT04784533|363144043|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105313328|NCT04784533|363144034|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
105313329|NCT04784533|363144035|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
105313330|NCT04784533|363144036|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105313331|NCT04784533|363144037|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105313332|NCT04784533|363144038|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105313333|NCT04784533|363144039|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105313334|NCT04784533|363144040|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105313335|NCT04784533|363144041|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105313336|NCT04784533|363144042|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105313337|NCT04784533|363144043|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105313338|NCT04784533|363144034|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
105313339|NCT04784533|363144035|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
105313340|NCT04784533|363144036|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105313341|NCT04784533|363144037|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105313342|NCT04784533|363144038|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105313343|NCT04784533|363144039|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105313344|NCT04784533|363144040|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105313345|NCT04784533|363144041|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105313346|NCT04784533|363144042|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105313347|NCT04784533|363144043|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105313348|NCT04784533|363144034|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105313349|NCT04784533|363144035|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105313350|NCT04784533|363144036|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
105313351|NCT04784533|363144037|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105313352|NCT04784533|363144038|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105313353|NCT04784533|363144039|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105313354|NCT04784533|363144040|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105313355|NCT04784533|363144041|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105313356|NCT04784533|363144042|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105313357|NCT04784533|363144043|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105490035|NCT02628769|363805722|FG000|Second Intervention|Adverse Event|2|||
105313358|NCT04784533|363144034|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105313359|NCT04784533|363144035|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105313360|NCT04784533|363144036|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105313361|NCT04784533|363144037|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105313362|NCT04784533|363144038|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105313363|NCT04784533|363144039|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105313364|NCT04784533|363144040|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105313365|NCT04784533|363144041|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105313366|NCT04784533|363144042|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
105313367|NCT04784533|363144043|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105313368|NCT04784533|363144034|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105313369|NCT04784533|363144035|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105313370|NCT04784533|363144036|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105313371|NCT04784533|363144037|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105313372|NCT04784533|363144038|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105313373|NCT04784533|363144039|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105313374|NCT04784533|363144040|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105313375|NCT04784533|363144041|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105313376|NCT04784533|363144042|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
105313377|NCT04784533|363144043|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
105313378|NCT03597464|363144044|FG000|Overall Study|Withdrawal by Subject|4|||
105313379|NCT03597464|363144045|FG001|Overall Study|Withdrawal by Subject|5|||
105313380|NCT03597464|363144044|FG000|Overall Study|Lost to Follow-up|3|||
105313381|NCT03597464|363144045|FG001|Overall Study|Lost to Follow-up|1|||
105313382|NCT03597464|363144044|FG000|Overall Study|Pregnancy|3|||
105313383|NCT03597464|363144045|FG001|Overall Study|Pregnancy|1|||
105313384|NCT03597464|363144044|FG000|Overall Study|Lack of Efficacy|2|||
105313385|NCT03597464|363144045|FG001|Overall Study|Lack of Efficacy|0|||
105313386|NCT03597464|363144044|FG000|Overall Study|Physician Decision|2|||
105313387|NCT03597464|363144045|FG001|Overall Study|Physician Decision|2|||
105313388|NCT03597464|363144044|FG000|Overall Study|Protocol Violation|1|||
105313389|NCT03597464|363144045|FG001|Overall Study|Protocol Violation|1|||
105313390|NCT03597464|363144044|FG000|Overall Study|Adverse Event|0|||
105313391|NCT03597464|363144045|FG001|Overall Study|Adverse Event|2|||
105313392|NCT03597464|363144044|FG000|Overall Study|Death|0|||
105313393|NCT03597464|363144045|FG001|Overall Study|Death|3|||
105313394|NCT02542605|363144046|FG000|Part B: Challenge Phase|Sponsor decision|1|||
105313395|NCT02542605|363144047|FG001|Part B: Challenge Phase|Sponsor decision|0|||
105313396|NCT02542605|363144048|FG002|Part B: Challenge Phase|Sponsor decision|0|||
105313397|NCT02542605|363144046|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
105313398|NCT02542605|363144047|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
105313399|NCT02542605|363144048|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
105313400|NCT04102189|363144049|FG000|Overall Study|Withdrawal by Subject|1|||
105313401|NCT04102189|363144050|FG001|Overall Study|Withdrawal by Subject|2|||
105313402|NCT04102189|363144049|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105313403|NCT04102189|363144050|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105490036|NCT02628769|363805723|FG001|Second Intervention|Adverse Event|0|||
105490037|NCT02628769|363805722|FG000|Second Intervention|Physician Decision|0|||
105313404|NCT04102189|363144049|FG000|Overall Study|Lost to Follow-up|1|||
105313405|NCT04102189|363144050|FG001|Overall Study|Lost to Follow-up|0|||
105313406|NCT00143247|363144051|FG000|Overall Study|Death|8|||
105313407|NCT00143247|363144051|FG000|Overall Study|Adverse Event|19|||
105313408|NCT00143247|363144051|FG000|Overall Study|Lack of Efficacy|3|||
105313409|NCT00143247|363144051|FG000|Overall Study|Withdrawal by Subject|55|||
105313410|NCT00143247|363144051|FG000|Overall Study|Study terminated by sponsor|31|||
105313411|NCT00143247|363144051|FG000|Overall Study|Protocol Violation|15|||
105313412|NCT00143247|363144051|FG000|Overall Study|Lost to Follow-up|12|||
105313413|NCT00143247|363144051|FG000|Overall Study|following inaccurate lab adverse event|1|||
105313414|NCT00143247|363144051|FG000|Overall Study|Other|12|||
105313415|NCT00340678|363144057|FG000|Overall Study|Lost to Follow-up|1|||
105313416|NCT00340678|363144058|FG001|Overall Study|Lost to Follow-up|0|||
105313417|NCT00340678|363144059|FG002|Overall Study|Lost to Follow-up|0|||
105313418|NCT00340678|363144060|FG003|Overall Study|Lost to Follow-up|0|||
105313419|NCT02766283|363144061|FG000|Overall Study|Lost to Follow-up|27|||
105313420|NCT00721227|363144062|FG000|Overall Study|Lost to Follow-up|3|||
105313421|NCT00721227|363144063|FG001|Overall Study|Lost to Follow-up|0|||
105313422|NCT00721227|363144062|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
105313423|NCT00721227|363144063|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
105313424|NCT00996892|363144064|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
105313425|NCT00996892|363144065|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
105313426|NCT00996892|363144066|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
105313427|NCT00996892|363144067|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
105313428|NCT00996892|363144068|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
105313429|NCT00996892|363144069|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
105313430|NCT00996892|363144070|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
105490038|NCT02628769|363805723|FG001|Second Intervention|Physician Decision|1|||
105313431|NCT00996892|363144071|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
105313432|NCT00996892|363144072|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
105313433|NCT00996892|363144073|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
105313434|NCT00996892|363144074|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
105313435|NCT00996892|363144075|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
105313436|NCT00996892|363144076|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
105313437|NCT00996892|363144077|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
105313438|NCT00996892|363144078|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
105313439|NCT00996892|363144079|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
105313440|NCT00996892|363144080|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
105313441|NCT00996892|363144081|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
105313442|NCT00996892|363144082|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
105313443|NCT00996892|363144083|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
105313444|NCT00996892|363144064|FG000|Dose-Escalation Stage 1|Death|1|||
105313445|NCT00996892|363144065|FG001|Dose-Escalation Stage 1|Death|0|||
105313446|NCT00996892|363144066|FG002|Dose-Escalation Stage 1|Death|0|||
105313447|NCT00996892|363144067|FG003|Dose-Escalation Stage 1|Death|0|||
105313448|NCT00996892|363144068|FG004|Dose-Escalation Stage 1|Death|0|||
105313449|NCT00996892|363144069|FG005|Dose-Escalation Stage 1|Death|1|||
105313450|NCT00996892|363144070|FG006|Dose-Escalation Stage 1|Death|0|||
105313451|NCT00996892|363144071|FG007|Dose-Escalation Stage 1|Death|0|||
105313452|NCT00996892|363144072|FG008|Dose-Escalation Stage 1|Death|0|||
105313453|NCT00996892|363144073|FG009|Dose-Escalation Stage 1|Death|0|||
105313454|NCT00996892|363144074|FG010|Dose-Escalation Stage 1|Death|0|||
105313455|NCT00996892|363144075|FG011|Dose-Escalation Stage 1|Death|0|||
105313456|NCT00996892|363144076|FG012|Dose-Escalation Stage 1|Death|0|||
105313457|NCT00996892|363144077|FG013|Dose-Escalation Stage 1|Death|0|||
105313458|NCT00996892|363144078|FG014|Dose-Escalation Stage 1|Death|0|||
105313459|NCT00996892|363144079|FG015|Dose-Escalation Stage 1|Death|0|||
105313460|NCT00996892|363144080|FG016|Dose-Escalation Stage 1|Death|0|||
105313461|NCT00996892|363144081|FG017|Dose-Escalation Stage 1|Death|0|||
105313462|NCT00996892|363144082|FG018|Dose-Escalation Stage 1|Death|0|||
105313463|NCT00996892|363144083|FG019|Dose-Escalation Stage 1|Death|0|||
105313464|NCT00996892|363144064|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
105313465|NCT00996892|363144065|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
105313466|NCT00996892|363144066|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
105313467|NCT00996892|363144067|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
105313468|NCT00996892|363144068|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
105313469|NCT00996892|363144069|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
105313470|NCT00996892|363144070|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
105313471|NCT00996892|363144071|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
105313472|NCT00996892|363144072|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
105313473|NCT00996892|363144073|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
105313474|NCT00996892|363144074|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
105313475|NCT00996892|363144075|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
105313476|NCT00996892|363144076|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
105313477|NCT00996892|363144077|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
105313478|NCT00996892|363144078|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
105313479|NCT00996892|363144079|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
105313480|NCT00996892|363144080|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
105313481|NCT00996892|363144081|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
105313482|NCT00996892|363144082|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
105313483|NCT00996892|363144083|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
105313484|NCT00996892|363144064|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105313485|NCT00996892|363144065|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
105313486|NCT00996892|363144066|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105313487|NCT00996892|363144067|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
105313488|NCT00996892|363144068|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
105313489|NCT00996892|363144069|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
105313490|NCT00996892|363144070|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
105313491|NCT00996892|363144071|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105313492|NCT00996892|363144072|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105313493|NCT00996892|363144073|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105313494|NCT00996892|363144074|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105313495|NCT00996892|363144075|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105313496|NCT00996892|363144076|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105313497|NCT00996892|363144077|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105313498|NCT00996892|363144078|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105313499|NCT00996892|363144079|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105313500|NCT00996892|363144080|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105313501|NCT00996892|363144081|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105313502|NCT00996892|363144082|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105313503|NCT00996892|363144083|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105313504|NCT00996892|363144064|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
105490039|NCT02452697|363805725|FG000|Overall Study|Physician Decision|4|||
105841855|NCT00706355|365077736|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
105841856|NCT00706355|365077737|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
105841857|NCT00706355|365077738|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
105841858|NCT00706355|365077735|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
105841859|NCT00706355|365077736|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
105841860|NCT00706355|365077737|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
105841861|NCT00706355|365077738|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
105841862|NCT00706355|365077735|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
105841863|NCT00706355|365077736|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
105841864|NCT00706355|365077737|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
105841865|NCT00706355|365077738|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
105841866|NCT00706355|365077735|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
105841867|NCT00706355|365077736|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
105841868|NCT00706355|365077737|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
105841869|NCT00706355|365077738|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
105841870|NCT00706355|365077735|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
105841871|NCT00706355|365077736|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
105841872|NCT00706355|365077737|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
105841873|NCT00706355|365077738|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
105841874|NCT02549573|365077739|FG000|Overall Study|Withdrawal by Subject|0|||
105841875|NCT02549573|365077740|FG001|Overall Study|Withdrawal by Subject|2|||
105841876|NCT02549573|365077739|FG000|Overall Study|Protocol Violation|0|||
105841877|NCT02549573|365077740|FG001|Overall Study|Protocol Violation|1|||
105841878|NCT01660022|365077741|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
105841879|NCT01660022|365077742|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
105841880|NCT01660022|365077743|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
105841881|NCT01660022|365077744|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
105841882|NCT01660022|365077745|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
105841883|NCT01660022|365077746|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
105841884|NCT01660022|365077741|FG000|First Sequence (7 Days)|Adverse Event|0|||
105841885|NCT01660022|365077742|FG001|First Sequence (7 Days)|Adverse Event|0|||
105841886|NCT01660022|365077743|FG002|First Sequence (7 Days)|Adverse Event|0|||
105841887|NCT01660022|365077744|FG003|First Sequence (7 Days)|Adverse Event|0|||
105841888|NCT01660022|365077745|FG004|First Sequence (7 Days)|Adverse Event|1|||
105841889|NCT01660022|365077746|FG005|First Sequence (7 Days)|Adverse Event|3|||
105841890|NCT01660022|365077741|FG000|First Sequence (7 Days)|Protocol Violation|0|||
105841891|NCT01660022|365077742|FG001|First Sequence (7 Days)|Protocol Violation|0|||
105841892|NCT01660022|365077743|FG002|First Sequence (7 Days)|Protocol Violation|0|||
105841893|NCT01660022|365077744|FG003|First Sequence (7 Days)|Protocol Violation|0|||
105841894|NCT01660022|365077745|FG004|First Sequence (7 Days)|Protocol Violation|0|||
105841895|NCT01660022|365077746|FG005|First Sequence (7 Days)|Protocol Violation|1|||
105841896|NCT03064438|365078940|FG000|Overall Study|Lost to Follow-up|1|||
105841897|NCT03064438|365078941|FG001|Overall Study|Lost to Follow-up|0|||
105313505|NCT00996892|363144065|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
105313506|NCT00996892|363144066|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
105313507|NCT00996892|363144067|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
105313508|NCT00996892|363144068|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
105313509|NCT00996892|363144069|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
105313510|NCT00996892|363144070|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
105313511|NCT00996892|363144071|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
105313512|NCT00996892|363144072|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
105313513|NCT00996892|363144073|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
105313514|NCT00996892|363144074|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
105313515|NCT00996892|363144075|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
105313516|NCT00996892|363144076|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
105313517|NCT00996892|363144077|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
105313518|NCT00996892|363144078|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
105313519|NCT00996892|363144079|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
105313520|NCT00996892|363144080|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
105313521|NCT00996892|363144081|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
105313522|NCT00996892|363144082|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
105313523|NCT00996892|363144083|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
105313524|NCT00996892|363144064|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
105313525|NCT00996892|363144065|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
105490040|NCT02452697|363805726|FG001|Overall Study|Physician Decision|4|||
105841898|NCT03064438|365078940|FG000|Overall Study|Withdrawal by Subject|0|||
105841899|NCT03064438|365078941|FG001|Overall Study|Withdrawal by Subject|1|||
105313526|NCT00996892|363144066|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
105313527|NCT00996892|363144067|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
105313528|NCT00996892|363144068|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
105841900|NCT00595335|365078942|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
105841901|NCT00595335|365078943|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
105841902|NCT00595335|365078942|FG000|Baseline to Six Months|Disease Progression|1|||
105841903|NCT00595335|365078943|FG001|Baseline to Six Months|Disease Progression|1|||
105841904|NCT00595335|365078942|FG000|Baseline to Six Months|Adverse Event|1|||
105841905|NCT00595335|365078943|FG001|Baseline to Six Months|Adverse Event|0|||
105841906|NCT00595335|365078942|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
105841907|NCT00595335|365078943|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
105841908|NCT00595335|365078942|FG000|Six Months to Twelve Months|Disease Progression|1|||
105841909|NCT00595335|365078943|FG001|Six Months to Twelve Months|Disease Progression|0|||
105841910|NCT00493779|365078948|FG000|Overall Study|Logistical issue at site|1|||
105841911|NCT00544817|365078949|FG000|Combined Modality|Lack of Efficacy|2|||
105841912|NCT00544817|365078949|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
105841913|NCT00544817|365078949|FG000|Combined Modality|Adverse Event|2|||
105841914|NCT00544817|365078949|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
105841915|NCT00544817|365078949|FG000|No Treatment Interval|Lack of Efficacy|8|||
105841916|NCT00544817|365078949|FG000|No Treatment Interval|Physician Decision|3|||
105841917|NCT00544817|365078949|FG000|No Treatment Interval|Adverse Event|1|||
105841918|NCT00544817|365078949|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
105841919|NCT00544817|365078949|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
105841920|NCT00544817|365078949|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
105841921|NCT01131299|365078950|FG000|Overall Study|Withdrawal by Subject|4|||
105841922|NCT01131299|365078951|FG001|Overall Study|Withdrawal by Subject|7|||
105841923|NCT01885182|365078952|FG000|Overall Study|Adverse Event|11|||
105841924|NCT01885182|365078953|FG001|Overall Study|Adverse Event|13|||
105841925|NCT01885182|365078952|FG000|Overall Study|Withdrawal by Subject|13|||
105841926|NCT01885182|365078953|FG001|Overall Study|Withdrawal by Subject|6|||
105841927|NCT01885182|365078952|FG000|Overall Study|Lost to Follow-up|2|||
105841928|NCT01885182|365078953|FG001|Overall Study|Lost to Follow-up|2|||
105841929|NCT01885182|365078952|FG000|Overall Study|Lack of Efficacy|8|||
105841930|NCT01885182|365078953|FG001|Overall Study|Lack of Efficacy|1|||
105841931|NCT01592721|365078954|FG000|Long-term Follow-up|Death|1|||
105841932|NCT01432574|365078957|FG000|Overall Study|Moved|2|||
105841933|NCT01432574|365078957|FG000|Overall Study|Not interested|1|||
105841934|NCT01475253|365078966|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
105841935|NCT01475253|365078967|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
105841936|NCT01475253|365078968|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
105841937|NCT01475253|365078969|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
105841938|NCT01475253|365078966|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
105841939|NCT01475253|365078967|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
105841940|NCT01475253|365078968|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
105841941|NCT01475253|365078969|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
105841942|NCT03135899|365078970|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
105841943|NCT03135899|365078971|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
105841944|NCT03135899|365078972|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
105841945|NCT03135899|365078973|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
105841946|NCT03135899|365078974|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
105841947|NCT03135899|365078975|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
105841948|NCT03135899|365078976|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
105841949|NCT03135899|365078977|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
105841950|NCT03135899|365078970|FG000|Overall Study|Withdrawal by Subject|0|||
105841951|NCT03135899|365078971|FG001|Overall Study|Withdrawal by Subject|0|||
105841952|NCT03135899|365078972|FG002|Overall Study|Withdrawal by Subject|0|||
105841953|NCT03135899|365078973|FG003|Overall Study|Withdrawal by Subject|0|||
105841954|NCT03135899|365078974|FG004|Overall Study|Withdrawal by Subject|0|||
105841955|NCT03135899|365078975|FG005|Overall Study|Withdrawal by Subject|2|||
105313529|NCT00996892|363144069|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
105313530|NCT00996892|363144070|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
105313531|NCT00996892|363144071|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
105313532|NCT00996892|363144072|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
105313533|NCT00996892|363144073|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
105313534|NCT00996892|363144074|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
105313535|NCT00996892|363144075|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
105313536|NCT00996892|363144076|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
105313537|NCT00996892|363144077|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
105841956|NCT03135899|365078976|FG006|Overall Study|Withdrawal by Subject|0|||
105841957|NCT03135899|365078977|FG007|Overall Study|Withdrawal by Subject|0|||
105313538|NCT00996892|363144078|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
105313539|NCT00996892|363144079|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
105313540|NCT00996892|363144080|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
105841958|NCT01559935|365078978|FG000|Car Phase|Toxicity|4|||
105841959|NCT01559935|365078978|FG000|Car Phase|Death|1|||
105841960|NCT01559935|365078978|FG000|Car Phase|Lack of Efficacy|2|||
105841961|NCT01559935|365078978|FG000|Car Phase|Lost to Follow-up|1|||
105841962|NCT01559935|365078978|FG000|Car Phase|Physician Decision|1|||
105841963|NCT01559935|365078978|FG000|Car Phase|Withdrawal by Subject|2|||
105841964|NCT01559935|365078978|FG000|Car Phase|Per protocol|1|||
105841965|NCT01559935|365078978|FG000|Car Phase|Insurance|1|||
105841966|NCT01559935|365078978|FG000|Car Phase|non-compliance|1|||
105841967|NCT01559935|365078978|FG000|BiRD Phase|Toxicity|1|||
105841968|NCT01559935|365078978|FG000|BiRD Phase|Lack of Efficacy|1|||
105841969|NCT01559935|365078978|FG000|BiRD Phase|Withdrawal by Subject|2|||
105841970|NCT01559935|365078978|FG000|Maintenance Phase|Remains on study|28|||
105841971|NCT01559935|365078978|FG000|Maintenance Phase|Toxicity|1|||
105841972|NCT01559935|365078978|FG000|Maintenance Phase|Lack of Efficacy|18|||
105841973|NCT01559935|365078978|FG000|Maintenance Phase|Withdrawal by Subject|5|||
105841974|NCT01559935|365078978|FG000|Maintenance Phase|Non-compliance|2|||
105841975|NCT01685073|365078979|FG000|Overall Study|Lost to Follow-up|6|||
105841976|NCT01685073|365078980|FG001|Overall Study|Lost to Follow-up|8|||
105841977|NCT01685073|365078979|FG000|Overall Study|Withdrawal by Subject|24|||
105841978|NCT01685073|365078980|FG001|Overall Study|Withdrawal by Subject|24|||
105841979|NCT02075606|365078993|FG000|Overall Study|Adverse Event|5|||
105841980|NCT02075606|365078993|FG000|Overall Study|Withdrawal by Subject|1|||
105841981|NCT02075606|365078993|FG000|Overall Study|Death|1|||
105841982|NCT02075606|365078993|FG000|Overall Study|Investigator's decision|1|||
105841983|NCT02075606|365078993|FG000|Overall Study|Symptom management|1|||
105841984|NCT02075606|365078993|FG000|Overall Study|Increasing Symptoms|1|||
105841985|NCT02751827|365078994|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
105841986|NCT02751827|365078995|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
105841987|NCT02751827|365078996|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
105841988|NCT03847194|365078997|FG000|Overall Study|Lost to Follow-up|2|||
105841989|NCT03847194|365078998|FG001|Overall Study|Lost to Follow-up|5|||
105841990|NCT03847194|365078997|FG000|Overall Study|Withdrawal by Subject|1|||
105841991|NCT03847194|365078998|FG001|Overall Study|Withdrawal by Subject|2|||
105841992|NCT03847194|365078997|FG000|Overall Study|Death|0|||
105841993|NCT03847194|365078998|FG001|Overall Study|Death|1|||
105841994|NCT00508027|365078999|FG000|Dose Level 1|Lost to Follow-up|4|||
105841995|NCT00508027|365078999|FG000|Dose Level 1|Withdrawal by Subject|2|||
105841996|NCT00508027|365078999|FG000|Dose Level 1|Physician Decision|2|||
105841997|NCT00508027|365078999|FG000|Dose Level 2|Lost to Follow-up|2|||
105841998|NCT00508027|365078999|FG000|Dose Level 2|Withdrawal by Subject|2|||
105841999|NCT03877926|365079000|FG000|Overall Study|Adverse Event|1|||
105842000|NCT03877926|365079001|FG001|Overall Study|Adverse Event|0|||
105842001|NCT03877926|365079002|FG002|Overall Study|Adverse Event|0|||
105842002|NCT03877926|365079003|FG003|Overall Study|Adverse Event|0|||
105842003|NCT03877926|365079000|FG000|Overall Study|Death|2|||
105842004|NCT03877926|365079001|FG001|Overall Study|Death|2|||
105842005|NCT03877926|365079002|FG002|Overall Study|Death|2|||
105842006|NCT03877926|365079003|FG003|Overall Study|Death|0|||
105842007|NCT03877926|365079000|FG000|Overall Study|Lost to Follow-up|41|||
105842008|NCT03877926|365079001|FG001|Overall Study|Lost to Follow-up|52|||
105842009|NCT03877926|365079002|FG002|Overall Study|Lost to Follow-up|45|||
105842010|NCT03877926|365079003|FG003|Overall Study|Lost to Follow-up|17|||
105842011|NCT03877926|365079000|FG000|Overall Study|Physician Decision|2|||
105842012|NCT03877926|365079001|FG001|Overall Study|Physician Decision|0|||
105842013|NCT03877926|365079002|FG002|Overall Study|Physician Decision|2|||
105313541|NCT00996892|363144081|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
105313542|NCT00996892|363144082|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
105313543|NCT00996892|363144083|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
105313544|NCT00996892|363144064|FG000|Dose-Escalation Stage 1A|Death|0|||
105313545|NCT00996892|363144065|FG001|Dose-Escalation Stage 1A|Death|0|||
105313546|NCT00996892|363144066|FG002|Dose-Escalation Stage 1A|Death|0|||
105313547|NCT00996892|363144067|FG003|Dose-Escalation Stage 1A|Death|0|||
105842014|NCT03877926|365079003|FG003|Overall Study|Physician Decision|0|||
105842015|NCT03877926|365079000|FG000|Overall Study|Withdrawal by Subject|18|||
105842016|NCT03877926|365079001|FG001|Overall Study|Withdrawal by Subject|21|||
105842017|NCT03877926|365079002|FG002|Overall Study|Withdrawal by Subject|12|||
105842018|NCT03877926|365079003|FG003|Overall Study|Withdrawal by Subject|4|||
105842019|NCT03877926|365079000|FG000|Overall Study|Other - Various|4|||
105842020|NCT03877926|365079001|FG001|Overall Study|Other - Various|1|||
105842021|NCT03877926|365079002|FG002|Overall Study|Other - Various|1|||
105313548|NCT00996892|363144068|FG004|Dose-Escalation Stage 1A|Death|0|||
105313549|NCT00996892|363144069|FG005|Dose-Escalation Stage 1A|Death|0|||
105842022|NCT03877926|365079003|FG003|Overall Study|Other - Various|0|||
105842023|NCT03877926|365079000|FG000|Overall Study|Not Treated|3|||
105842024|NCT03877926|365079001|FG001|Overall Study|Not Treated|1|||
105842025|NCT03877926|365079002|FG002|Overall Study|Not Treated|1|||
105842026|NCT03877926|365079003|FG003|Overall Study|Not Treated|0|||
105842027|NCT00537199|365079008|FG000|Overall Study|Study Terminated|1|||
105842028|NCT03891329|365079009|FG000|Overall Study|Death|5|||
105842029|NCT03891329|365079009|FG000|Overall Study|Lost to Follow-up|4|||
105842030|NCT03891329|365079009|FG000|Overall Study|Physician Decision|4|||
105842031|NCT03891329|365079009|FG000|Overall Study|Device explanted|3|||
105313550|NCT00996892|363144070|FG006|Dose-Escalation Stage 1A|Death|0|||
105313551|NCT00996892|363144071|FG007|Dose-Escalation Stage 1A|Death|0|||
105313552|NCT00996892|363144072|FG008|Dose-Escalation Stage 1A|Death|0|||
105313553|NCT00996892|363144073|FG009|Dose-Escalation Stage 1A|Death|2|||
105313554|NCT00996892|363144074|FG010|Dose-Escalation Stage 1A|Death|0|||
105313555|NCT00996892|363144075|FG011|Dose-Escalation Stage 1A|Death|1|||
105313556|NCT00996892|363144076|FG012|Dose-Escalation Stage 1A|Death|1|||
105313557|NCT00996892|363144077|FG013|Dose-Escalation Stage 1A|Death|0|||
105313558|NCT00996892|363144078|FG014|Dose-Escalation Stage 1A|Death|0|||
105313559|NCT00996892|363144079|FG015|Dose-Escalation Stage 1A|Death|0|||
105313560|NCT00996892|363144080|FG016|Dose-Escalation Stage 1A|Death|0|||
105313561|NCT00996892|363144081|FG017|Dose-Escalation Stage 1A|Death|0|||
105313562|NCT00996892|363144082|FG018|Dose-Escalation Stage 1A|Death|0|||
105313563|NCT00996892|363144083|FG019|Dose-Escalation Stage 1A|Death|0|||
105313564|NCT00996892|363144064|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
105313565|NCT00996892|363144065|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
105313566|NCT00996892|363144066|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
105313567|NCT00996892|363144067|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
105313568|NCT00996892|363144068|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
105313569|NCT00996892|363144069|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
105313570|NCT00996892|363144070|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
105313571|NCT00996892|363144071|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
105313572|NCT00996892|363144072|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
105313573|NCT00996892|363144073|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
105313574|NCT00996892|363144074|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
105313575|NCT00996892|363144075|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
105313576|NCT00996892|363144076|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
105313577|NCT00996892|363144077|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
105313578|NCT00996892|363144078|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
105313579|NCT00996892|363144079|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
105313580|NCT00996892|363144080|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
105313581|NCT00996892|363144081|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
105313582|NCT00996892|363144082|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
105313583|NCT00996892|363144083|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
105313584|NCT00996892|363144064|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105313585|NCT00996892|363144065|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105313586|NCT00996892|363144066|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105313587|NCT00996892|363144067|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105313588|NCT00996892|363144068|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105313589|NCT00996892|363144069|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105313590|NCT00996892|363144070|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105313591|NCT00996892|363144071|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105313592|NCT00996892|363144072|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105313593|NCT00996892|363144073|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
105313594|NCT00996892|363144074|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
105313595|NCT00996892|363144075|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
105313596|NCT00996892|363144076|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
105313597|NCT00996892|363144077|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105313598|NCT00996892|363144078|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105313599|NCT00996892|363144079|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105313600|NCT00996892|363144080|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105313601|NCT00996892|363144081|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105313602|NCT00996892|363144082|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105313603|NCT00996892|363144083|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105842032|NCT03891329|365079009|FG000|Overall Study|No study device implanted|3|||
105842033|NCT00941720|365079013|FG000|Overall Study|Withdrawal by Subject|1|||
105842034|NCT00941720|365079013|FG000|Overall Study|Insurance denied participation|11|||
105842035|NCT00941720|365079013|FG000|Overall Study|ineligible|2|||
105313604|NCT00996892|363144064|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
105313605|NCT00996892|363144065|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
105313606|NCT00996892|363144066|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
105313607|NCT00996892|363144067|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
105313608|NCT00996892|363144068|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
105313609|NCT00996892|363144069|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
105313610|NCT00996892|363144070|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
105313611|NCT00996892|363144071|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
105313612|NCT00996892|363144072|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
105313613|NCT00996892|363144073|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
105313614|NCT00996892|363144074|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
105313615|NCT00996892|363144075|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
105313616|NCT00996892|363144076|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
105313617|NCT00996892|363144077|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
105313618|NCT00996892|363144078|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
105313619|NCT00996892|363144079|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
105313620|NCT00996892|363144080|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
105313621|NCT00996892|363144081|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
105313622|NCT00996892|363144082|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
105313623|NCT00996892|363144083|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
105313624|NCT00996892|363144064|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
105313625|NCT00996892|363144065|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
105313626|NCT00996892|363144066|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
105313627|NCT00996892|363144067|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
105313628|NCT00996892|363144068|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
105313629|NCT00996892|363144069|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
105313630|NCT00996892|363144070|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
105313631|NCT00996892|363144071|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
105313632|NCT00996892|363144072|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
105313633|NCT00996892|363144073|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
105313634|NCT00996892|363144074|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
105313635|NCT00996892|363144075|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
105313636|NCT00996892|363144076|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
105313637|NCT00996892|363144077|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
105313638|NCT00996892|363144078|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
105313639|NCT00996892|363144079|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
105313640|NCT00996892|363144080|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
105313641|NCT00996892|363144081|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
105313642|NCT00996892|363144082|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
105313643|NCT00996892|363144083|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
105313644|NCT00996892|363144064|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
105313645|NCT00996892|363144065|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
105313646|NCT00996892|363144066|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
105313647|NCT00996892|363144067|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
105313648|NCT00996892|363144068|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
105313649|NCT00996892|363144069|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
105313650|NCT00996892|363144070|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
105313651|NCT00996892|363144071|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
105313652|NCT00996892|363144072|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
105313653|NCT00996892|363144073|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
105313654|NCT00996892|363144074|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
105313655|NCT00996892|363144075|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
105313656|NCT00996892|363144076|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
105313657|NCT00996892|363144077|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
105313658|NCT00996892|363144078|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
105313659|NCT00996892|363144079|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
105313660|NCT00996892|363144080|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
105313661|NCT00996892|363144081|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
105313662|NCT00996892|363144082|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
105313663|NCT00996892|363144083|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
105313664|NCT00996892|363144064|FG000|Expansion Stage 2|Adverse Event|0|||
105313665|NCT00996892|363144065|FG001|Expansion Stage 2|Adverse Event|0|||
105313666|NCT00996892|363144066|FG002|Expansion Stage 2|Adverse Event|0|||
105313667|NCT00996892|363144067|FG003|Expansion Stage 2|Adverse Event|0|||
105313668|NCT00996892|363144068|FG004|Expansion Stage 2|Adverse Event|0|||
105313669|NCT00996892|363144069|FG005|Expansion Stage 2|Adverse Event|0|||
105313670|NCT00996892|363144070|FG006|Expansion Stage 2|Adverse Event|0|||
105313671|NCT00996892|363144071|FG007|Expansion Stage 2|Adverse Event|0|||
105313672|NCT00996892|363144072|FG008|Expansion Stage 2|Adverse Event|0|||
105313673|NCT00996892|363144073|FG009|Expansion Stage 2|Adverse Event|0|||
105313674|NCT00996892|363144074|FG010|Expansion Stage 2|Adverse Event|0|||
105313675|NCT00996892|363144075|FG011|Expansion Stage 2|Adverse Event|0|||
105313676|NCT00996892|363144076|FG012|Expansion Stage 2|Adverse Event|0|||
105313677|NCT00996892|363144077|FG013|Expansion Stage 2|Adverse Event|0|||
105313678|NCT00996892|363144078|FG014|Expansion Stage 2|Adverse Event|0|||
105313679|NCT00996892|363144079|FG015|Expansion Stage 2|Adverse Event|0|||
105313680|NCT00996892|363144080|FG016|Expansion Stage 2|Adverse Event|0|||
105313681|NCT00996892|363144081|FG017|Expansion Stage 2|Adverse Event|0|||
105313682|NCT00996892|363144082|FG018|Expansion Stage 2|Adverse Event|3|||
105313683|NCT00996892|363144083|FG019|Expansion Stage 2|Adverse Event|0|||
105313684|NCT00996892|363144064|FG000|Expansion Stage 2|Death|0|||
105313685|NCT00996892|363144065|FG001|Expansion Stage 2|Death|0|||
105313686|NCT00996892|363144066|FG002|Expansion Stage 2|Death|0|||
105313687|NCT00996892|363144067|FG003|Expansion Stage 2|Death|0|||
105313688|NCT00996892|363144068|FG004|Expansion Stage 2|Death|0|||
105313689|NCT00996892|363144069|FG005|Expansion Stage 2|Death|0|||
105313690|NCT00996892|363144070|FG006|Expansion Stage 2|Death|0|||
105313691|NCT00996892|363144071|FG007|Expansion Stage 2|Death|0|||
105842036|NCT00904748|365079014|FG000|Overall Study|Withdrawal by Subject|1|||
105842037|NCT00904748|365079015|FG001|Overall Study|Withdrawal by Subject|1|||
105842038|NCT00904748|365079016|FG002|Overall Study|Withdrawal by Subject|1|||
105842039|NCT00904748|365079017|FG003|Overall Study|Withdrawal by Subject|2|||
105842040|NCT00904748|365079018|FG004|Overall Study|Withdrawal by Subject|0|||
105842041|NCT00904748|365079019|FG005|Overall Study|Withdrawal by Subject|0|||
105842042|NCT00904748|365079014|FG000|Overall Study|Adverse Event|0|||
105842043|NCT00904748|365079015|FG001|Overall Study|Adverse Event|0|||
105842044|NCT00904748|365079016|FG002|Overall Study|Adverse Event|0|||
105842045|NCT00904748|365079017|FG003|Overall Study|Adverse Event|0|||
105842046|NCT00904748|365079018|FG004|Overall Study|Adverse Event|1|||
105842047|NCT00904748|365079019|FG005|Overall Study|Adverse Event|0|||
105842048|NCT00350402|365079020|FG000|Overall Study|Lost to Follow-up|1|||
105842049|NCT00350402|365079021|FG001|Overall Study|Lost to Follow-up|1|||
105842050|NCT00690482|365079024|FG000|Overall Study|Adverse Event|2|||
105842051|NCT00690482|365079025|FG001|Overall Study|Adverse Event|1|||
105842052|NCT00690482|365079024|FG000|Overall Study|Incorrect enrolment|0|||
105842053|NCT00690482|365079025|FG001|Overall Study|Incorrect enrolment|1|||
105842054|NCT00690482|365079024|FG000|Overall Study|Study-specific discontinuation criteria|1|||
105842055|NCT00690482|365079025|FG001|Overall Study|Study-specific discontinuation criteria|0|||
105842056|NCT00690482|365079024|FG000|Overall Study|Intake of prohibited medicine|1|||
105842057|NCT00690482|365079025|FG001|Overall Study|Intake of prohibited medicine|0|||
105842058|NCT00690482|365079024|FG000|Overall Study|withdrew consent at rand.day|0|||
105842059|NCT00690482|365079025|FG001|Overall Study|withdrew consent at rand.day|1|||
105842060|NCT01020799|365079029|FG000|Overall Study|Adverse Event|4|||
105842061|NCT01020799|365079030|FG001|Overall Study|Adverse Event|3|||
105842062|NCT01020799|365079031|FG002|Overall Study|Adverse Event|2|||
105842063|NCT01020799|365079029|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
105842064|NCT01020799|365079030|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
105842065|NCT01020799|365079031|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
105842066|NCT01020799|365079029|FG000|Overall Study|Protocol Violation|3|||
105842067|NCT01020799|365079030|FG001|Overall Study|Protocol Violation|2|||
105842068|NCT01020799|365079031|FG002|Overall Study|Protocol Violation|0|||
105842069|NCT01020799|365079029|FG000|Overall Study|Withdrawal by Subject|2|||
105842070|NCT01020799|365079030|FG001|Overall Study|Withdrawal by Subject|2|||
105842071|NCT01020799|365079031|FG002|Overall Study|Withdrawal by Subject|3|||
105842072|NCT01020799|365079029|FG000|Overall Study|Lost to Follow-up|6|||
105842073|NCT01020799|365079030|FG001|Overall Study|Lost to Follow-up|4|||
105842074|NCT01020799|365079031|FG002|Overall Study|Lost to Follow-up|2|||
105842075|NCT02697773|365079032|FG000|Overall Study|Adverse Event|2|||
105842076|NCT02697773|365079033|FG001|Overall Study|Adverse Event|1|||
105842077|NCT02697773|365079034|FG002|Overall Study|Adverse Event|2|||
105842078|NCT02697773|365079032|FG000|Overall Study|Death|0|||
105842079|NCT02697773|365079033|FG001|Overall Study|Death|0|||
105842080|NCT02697773|365079034|FG002|Overall Study|Death|2|||
105842081|NCT02697773|365079032|FG000|Overall Study|Lack of Efficacy|4|||
105842082|NCT02697773|365079033|FG001|Overall Study|Lack of Efficacy|6|||
105842083|NCT02697773|365079034|FG002|Overall Study|Lack of Efficacy|6|||
105842084|NCT02697773|365079032|FG000|Overall Study|Lost to Follow-up|5|||
105842085|NCT02697773|365079033|FG001|Overall Study|Lost to Follow-up|5|||
105842086|NCT02697773|365079034|FG002|Overall Study|Lost to Follow-up|7|||
105842087|NCT02697773|365079032|FG000|Overall Study|Other|15|||
105842088|NCT02697773|365079033|FG001|Overall Study|Other|11|||
105842089|NCT02697773|365079034|FG002|Overall Study|Other|10|||
105842090|NCT02697773|365079032|FG000|Overall Study|Protocol Violation|1|||
105842091|NCT02697773|365079033|FG001|Overall Study|Protocol Violation|1|||
105842092|NCT02697773|365079034|FG002|Overall Study|Protocol Violation|0|||
105842093|NCT02697773|365079032|FG000|Overall Study|Withdrawal by Subject|10|||
105842094|NCT02697773|365079033|FG001|Overall Study|Withdrawal by Subject|13|||
105842095|NCT02697773|365079034|FG002|Overall Study|Withdrawal by Subject|13|||
105842096|NCT02697773|365079032|FG000|Overall Study|Randomized but not treated|1|||
105842097|NCT02697773|365079033|FG001|Overall Study|Randomized but not treated|1|||
105842098|NCT02697773|365079034|FG002|Overall Study|Randomized but not treated|0|||
105842099|NCT02939950|365079035|FG000|Overall Study|Lost to Follow-up|13|||
105842100|NCT02939950|365079036|FG001|Overall Study|Lost to Follow-up|16|||
105842101|NCT02939950|365079035|FG000|Overall Study|Positive slit lamp findings|0|||
105842102|NCT02939950|365079036|FG001|Overall Study|Positive slit lamp findings|1|||
105842103|NCT02939950|365079035|FG000|Overall Study|Chalazion upper lid|0|||
105842104|NCT02939950|365079036|FG001|Overall Study|Chalazion upper lid|1|||
105842105|NCT02939950|365079035|FG000|Overall Study|Lack of motivation|0|||
105842106|NCT02939950|365079036|FG001|Overall Study|Lack of motivation|2|||
105842107|NCT02939950|365079035|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
105576553|NCT00451217|364110205|FG001|Overall Study|Lost to Follow-up|1|||
105842108|NCT02939950|365079036|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
105842109|NCT02939950|365079035|FG000|Overall Study|Military orders|1|||
105842110|NCT02939950|365079036|FG001|Overall Study|Military orders|0|||
105842111|NCT02939950|365079035|FG000|Overall Study|Participant Relocated|5|||
105842112|NCT02939950|365079036|FG001|Overall Study|Participant Relocated|3|||
105368224|NCT00791999|363354166|FG003|Overall Study|Withdrawal by Subject|2|||
105368225|NCT00791999|363354163|FG000|Overall Study|Protocol Violation|3|||
105368226|NCT00791999|363354164|FG001|Overall Study|Protocol Violation|0|||
105368227|NCT00791999|363354165|FG002|Overall Study|Protocol Violation|1|||
105368228|NCT00791999|363354166|FG003|Overall Study|Protocol Violation|0|||
105368229|NCT00791999|363354163|FG000|Overall Study|Adverse Event|3|||
105368230|NCT00791999|363354164|FG001|Overall Study|Adverse Event|3|||
105368231|NCT00791999|363354165|FG002|Overall Study|Adverse Event|7|||
105368232|NCT00791999|363354166|FG003|Overall Study|Adverse Event|3|||
105368233|NCT00791999|363354163|FG000|Overall Study|Lack of Efficacy|0|||
105368234|NCT00791999|363354164|FG001|Overall Study|Lack of Efficacy|1|||
105368235|NCT00791999|363354165|FG002|Overall Study|Lack of Efficacy|0|||
105368236|NCT00791999|363354166|FG003|Overall Study|Lack of Efficacy|2|||
105368237|NCT00791999|363354163|FG000|Overall Study|Reason other than those above|1|||
105368238|NCT00791999|363354164|FG001|Overall Study|Reason other than those above|0|||
105368239|NCT00791999|363354165|FG002|Overall Study|Reason other than those above|1|||
105368240|NCT00791999|363354166|FG003|Overall Study|Reason other than those above|0|||
105368241|NCT01077323|363354167|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
105368242|NCT01077323|363354168|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
105368243|NCT01077323|363354169|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
105368244|NCT01077323|363354167|FG000|Overall Study|Dispensing of drug in baseline period|0|||
105368245|NCT01077323|363354168|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
105368246|NCT01077323|363354169|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
105368247|NCT01077323|363354167|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
105368248|NCT01077323|363354168|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
105368249|NCT01077323|363354169|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
105368250|NCT02153918|363354170|FG000|Overall Study|Refused further treatment|1|||
105368251|NCT01764841|363354171|FG000|Overall Study|Logistical Difficulties|0|||
105842113|NCT02939950|365079035|FG000|Overall Study|Study related symptoms|8|||
105368252|NCT01764841|363354172|FG001|Overall Study|Logistical Difficulties|1|||
105368253|NCT01764841|363354173|FG002|Overall Study|Logistical Difficulties|0|||
105368254|NCT01764841|363354174|FG003|Overall Study|Logistical Difficulties|0|||
105368255|NCT01764841|363354171|FG000|Overall Study|Death|3|||
105368256|NCT01764841|363354172|FG001|Overall Study|Death|0|||
105368257|NCT01764841|363354173|FG002|Overall Study|Death|1|||
105368258|NCT01764841|363354174|FG003|Overall Study|Death|4|||
105368259|NCT01764841|363354171|FG000|Overall Study|No Follow Up|1|||
105368260|NCT01764841|363354172|FG001|Overall Study|No Follow Up|0|||
105368261|NCT01764841|363354173|FG002|Overall Study|No Follow Up|1|||
105368262|NCT01764841|363354174|FG003|Overall Study|No Follow Up|0|||
105368263|NCT01764841|363354171|FG000|Overall Study|Protocol Violation|0|||
105368264|NCT01764841|363354172|FG001|Overall Study|Protocol Violation|1|||
105368265|NCT01764841|363354173|FG002|Overall Study|Protocol Violation|0|||
105368266|NCT01764841|363354174|FG003|Overall Study|Protocol Violation|0|||
105368267|NCT01764841|363354171|FG000|Overall Study|Withdrawal by Subject|16|||
105842114|NCT02939950|365079036|FG001|Overall Study|Study related symptoms|8|||
105842115|NCT02939950|365079035|FG000|Overall Study|Unacceptable lens movement|2|||
105842116|NCT02939950|365079036|FG001|Overall Study|Unacceptable lens movement|0|||
105842117|NCT02939950|365079035|FG000|Overall Study|Protocol Violation|6|||
105842118|NCT02939950|365079036|FG001|Overall Study|Protocol Violation|3|||
105842119|NCT02939950|365079035|FG000|Overall Study|Physician Decision|2|||
105842120|NCT02939950|365079036|FG001|Overall Study|Physician Decision|0|||
105842121|NCT02939950|365079035|FG000|Overall Study|Pregnancy|6|||
105842122|NCT02939950|365079036|FG001|Overall Study|Pregnancy|7|||
105842123|NCT02939950|365079035|FG000|Overall Study|Withdrawal by Subject|12|||
105842124|NCT02939950|365079036|FG001|Overall Study|Withdrawal by Subject|28|||
105842125|NCT02939950|365079035|FG000|Overall Study|Adverse Event|7|||
105842126|NCT02939950|365079036|FG001|Overall Study|Adverse Event|3|||
105842127|NCT02939950|365079035|FG000|Overall Study|Randomized, not dispensed|1|||
105842128|NCT02939950|365079036|FG001|Overall Study|Randomized, not dispensed|0|||
105842129|NCT02939950|365079035|FG000|Overall Study|Ineligible at Baseline|2|||
105842130|NCT02939950|365079036|FG001|Overall Study|Ineligible at Baseline|8|||
105842131|NCT01382251|365079040|FG000|Overall Study|Surgeries cancelled or delayed|16|||
105842132|NCT01382251|365079041|FG001|Overall Study|Surgeries cancelled or delayed|16|||
105368268|NCT01764841|363354172|FG001|Overall Study|Withdrawal by Subject|24|||
105368269|NCT01764841|363354173|FG002|Overall Study|Withdrawal by Subject|11|||
105368270|NCT01764841|363354174|FG003|Overall Study|Withdrawal by Subject|15|||
105368271|NCT01764841|363354171|FG000|Overall Study|Lost to Follow-up|3|||
105368272|NCT01764841|363354172|FG001|Overall Study|Lost to Follow-up|0|||
105368273|NCT01764841|363354173|FG002|Overall Study|Lost to Follow-up|1|||
105368274|NCT01764841|363354174|FG003|Overall Study|Lost to Follow-up|0|||
105368275|NCT02144701|363354175|FG000|Overall Study|development of relapse, GVHD or death|9|||
105368276|NCT02144701|363354176|FG001|Overall Study|development of relapse, GVHD or death|3|||
105576554|NCT00451217|364110206|FG002|Overall Study|Lost to Follow-up|1|||
105842133|NCT01382251|365079040|FG000|Overall Study|Lost to Follow-up|4|||
105842134|NCT01382251|365079041|FG001|Overall Study|Lost to Follow-up|4|||
105313692|NCT00996892|363144072|FG008|Expansion Stage 2|Death|0|||
105313693|NCT00996892|363144073|FG009|Expansion Stage 2|Death|0|||
105313694|NCT00996892|363144074|FG010|Expansion Stage 2|Death|0|||
105313695|NCT00996892|363144075|FG011|Expansion Stage 2|Death|0|||
105313696|NCT00996892|363144076|FG012|Expansion Stage 2|Death|0|||
105313697|NCT00996892|363144077|FG013|Expansion Stage 2|Death|0|||
105313698|NCT00996892|363144078|FG014|Expansion Stage 2|Death|0|||
105313699|NCT00996892|363144079|FG015|Expansion Stage 2|Death|0|||
105313700|NCT00996892|363144080|FG016|Expansion Stage 2|Death|0|||
105313701|NCT00996892|363144081|FG017|Expansion Stage 2|Death|0|||
105313702|NCT00996892|363144082|FG018|Expansion Stage 2|Death|2|||
105313703|NCT00996892|363144083|FG019|Expansion Stage 2|Death|0|||
105313704|NCT00996892|363144064|FG000|Expansion Stage 2|Physician Decision|0|||
105313705|NCT00996892|363144065|FG001|Expansion Stage 2|Physician Decision|0|||
105313706|NCT00996892|363144066|FG002|Expansion Stage 2|Physician Decision|0|||
105313707|NCT00996892|363144067|FG003|Expansion Stage 2|Physician Decision|0|||
105313708|NCT00996892|363144068|FG004|Expansion Stage 2|Physician Decision|0|||
105313709|NCT00996892|363144069|FG005|Expansion Stage 2|Physician Decision|0|||
105313710|NCT00996892|363144070|FG006|Expansion Stage 2|Physician Decision|0|||
105313711|NCT00996892|363144071|FG007|Expansion Stage 2|Physician Decision|0|||
105313712|NCT00996892|363144072|FG008|Expansion Stage 2|Physician Decision|0|||
105313713|NCT00996892|363144073|FG009|Expansion Stage 2|Physician Decision|0|||
105313714|NCT00996892|363144074|FG010|Expansion Stage 2|Physician Decision|0|||
105313715|NCT00996892|363144075|FG011|Expansion Stage 2|Physician Decision|0|||
105313716|NCT00996892|363144076|FG012|Expansion Stage 2|Physician Decision|0|||
105313717|NCT00996892|363144077|FG013|Expansion Stage 2|Physician Decision|0|||
105313718|NCT00996892|363144078|FG014|Expansion Stage 2|Physician Decision|0|||
105313719|NCT00996892|363144079|FG015|Expansion Stage 2|Physician Decision|0|||
105313720|NCT00996892|363144080|FG016|Expansion Stage 2|Physician Decision|0|||
105313721|NCT00996892|363144081|FG017|Expansion Stage 2|Physician Decision|0|||
105313722|NCT00996892|363144082|FG018|Expansion Stage 2|Physician Decision|1|||
105313723|NCT00996892|363144083|FG019|Expansion Stage 2|Physician Decision|0|||
105313724|NCT00996892|363144064|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
105313725|NCT00996892|363144065|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
105313726|NCT00996892|363144066|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
105313727|NCT00996892|363144067|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
105313728|NCT00996892|363144068|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
105313729|NCT00996892|363144069|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
105313730|NCT00996892|363144070|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
105313731|NCT00996892|363144071|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
105313732|NCT00996892|363144072|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
105313733|NCT00996892|363144073|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
105313734|NCT00996892|363144074|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
105313735|NCT00996892|363144075|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
105313736|NCT00996892|363144076|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
105313737|NCT00996892|363144077|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
105313738|NCT00996892|363144078|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
105313739|NCT00996892|363144079|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
105313740|NCT00996892|363144080|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
105313741|NCT00996892|363144081|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
105313742|NCT00996892|363144082|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
105313743|NCT00996892|363144083|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
105313744|NCT00996892|363144064|FG000|Expansion Stage 2|Disease Progression|0|||
105313745|NCT00996892|363144065|FG001|Expansion Stage 2|Disease Progression|0|||
105313746|NCT00996892|363144066|FG002|Expansion Stage 2|Disease Progression|0|||
105313747|NCT00996892|363144067|FG003|Expansion Stage 2|Disease Progression|0|||
105313748|NCT00996892|363144068|FG004|Expansion Stage 2|Disease Progression|0|||
105313749|NCT00996892|363144069|FG005|Expansion Stage 2|Disease Progression|0|||
105313750|NCT00996892|363144070|FG006|Expansion Stage 2|Disease Progression|0|||
105313751|NCT00996892|363144071|FG007|Expansion Stage 2|Disease Progression|0|||
105313752|NCT00996892|363144072|FG008|Expansion Stage 2|Disease Progression|0|||
105313753|NCT00996892|363144073|FG009|Expansion Stage 2|Disease Progression|0|||
105313754|NCT00996892|363144074|FG010|Expansion Stage 2|Disease Progression|0|||
105313755|NCT00996892|363144075|FG011|Expansion Stage 2|Disease Progression|0|||
105313756|NCT00996892|363144076|FG012|Expansion Stage 2|Disease Progression|0|||
105313757|NCT00996892|363144077|FG013|Expansion Stage 2|Disease Progression|0|||
105313758|NCT00996892|363144078|FG014|Expansion Stage 2|Disease Progression|0|||
105313759|NCT00996892|363144079|FG015|Expansion Stage 2|Disease Progression|0|||
105313760|NCT00996892|363144080|FG016|Expansion Stage 2|Disease Progression|0|||
105313761|NCT00996892|363144081|FG017|Expansion Stage 2|Disease Progression|0|||
105313762|NCT00996892|363144082|FG018|Expansion Stage 2|Disease Progression|28|||
105313763|NCT00996892|363144083|FG019|Expansion Stage 2|Disease Progression|0|||
105313764|NCT00996892|363144064|FG000|Expansion Stage 2A|Adverse Event|0|||
105313765|NCT00996892|363144065|FG001|Expansion Stage 2A|Adverse Event|0|||
105313766|NCT00996892|363144066|FG002|Expansion Stage 2A|Adverse Event|0|||
105313767|NCT00996892|363144067|FG003|Expansion Stage 2A|Adverse Event|0|||
105313768|NCT00996892|363144068|FG004|Expansion Stage 2A|Adverse Event|0|||
105842135|NCT01382251|365079040|FG000|Overall Study|Contacted after study closed|1|||
105842136|NCT01382251|365079041|FG001|Overall Study|Contacted after study closed|1|||
105842137|NCT02746627|365079043|FG000|Overall Study|Withdrawal by Subject|1|||
105842138|NCT02746627|365079044|FG001|Overall Study|Withdrawal by Subject|1|||
105842139|NCT02746627|365079045|FG002|Overall Study|Withdrawal by Subject|1|||
105842140|NCT02181296|365079046|FG000|Overall Study|Lost to Follow-up|7|||
105842141|NCT02181296|365079047|FG001|Overall Study|Lost to Follow-up|6|||
105842142|NCT03166124|365079048|FG000|Treatment Period 1|Adverse Event|0|||
105842143|NCT03166124|365079049|FG001|Treatment Period 1|Adverse Event|0|||
105842144|NCT03166124|365079050|FG002|Treatment Period 1|Adverse Event|1|||
105842145|NCT03166124|365079051|FG003|Treatment Period 1|Adverse Event|0|||
105842146|NCT03166124|365079048|FG000|Wash-out Period|Withdrawal by Subject|0|||
105842147|NCT03166124|365079049|FG001|Wash-out Period|Withdrawal by Subject|1|||
105842148|NCT03166124|365079050|FG002|Wash-out Period|Withdrawal by Subject|0|||
105842149|NCT03166124|365079051|FG003|Wash-out Period|Withdrawal by Subject|1|||
105842150|NCT03166124|365079048|FG000|Wash-out Period|Adverse Event|0|||
105842151|NCT03166124|365079049|FG001|Wash-out Period|Adverse Event|1|||
105842152|NCT03166124|365079050|FG002|Wash-out Period|Adverse Event|1|||
105842153|NCT03166124|365079051|FG003|Wash-out Period|Adverse Event|0|||
105842154|NCT03351231|365079054|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
105842155|NCT03351231|365079054|FG000|Combination Therapy Period|Disease progression|2|||
105842156|NCT03351231|365079054|FG000|Combination Therapy Period|Study drug toxicity|1|||
105842157|NCT03351231|365079054|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
105842158|NCT03351231|365079054|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
105842159|NCT03351231|365079054|FG000|Safety Follow-Up Period|Other reason|2|||
105842160|NCT02148913|365080660|FG000|Overall Study|Death|0|||
105842161|NCT02148913|365080661|FG001|Overall Study|Death|1|||
105842162|NCT02148913|365080662|FG002|Overall Study|Death|0|||
105842163|NCT02148913|365080663|FG003|Overall Study|Death|0|||
105842164|NCT01272921|365080666|FG000|Overall Study|Protocol Violation|2|||
105842165|NCT01272921|365080667|FG001|Overall Study|Protocol Violation|1|||
105842166|NCT01132664|365080668|FG000|Phase lb|Adverse Event|0|||
105842167|NCT01132664|365080669|FG001|Phase lb|Adverse Event|1|||
105490041|NCT02452697|363805727|FG002|Overall Study|Physician Decision|3|||
105490042|NCT02452697|363805728|FG003|Overall Study|Physician Decision|2|||
105490043|NCT02452697|363805725|FG000|Overall Study|Withdrawal by Subject|1|||
105490044|NCT02452697|363805726|FG001|Overall Study|Withdrawal by Subject|0|||
105842168|NCT01132664|365080670|FG002|Phase lb|Adverse Event|0|||
105842169|NCT01132664|365080671|FG003|Phase lb|Adverse Event|0|||
105842170|NCT01132664|365080672|FG004|Phase lb|Adverse Event|0|||
105842171|NCT01132664|365080668|FG000|Phase lb|Withdrawal by Subject|1|||
105842172|NCT01132664|365080669|FG001|Phase lb|Withdrawal by Subject|2|||
105842173|NCT01132664|365080670|FG002|Phase lb|Withdrawal by Subject|0|||
105842174|NCT01132664|365080671|FG003|Phase lb|Withdrawal by Subject|0|||
105842175|NCT01132664|365080672|FG004|Phase lb|Withdrawal by Subject|0|||
105842176|NCT01132664|365080668|FG000|Phase lb|Disease Progression|4|||
105842177|NCT01132664|365080669|FG001|Phase lb|Disease Progression|9|||
105842178|NCT01132664|365080670|FG002|Phase lb|Disease Progression|0|||
105313769|NCT00996892|363144069|FG005|Expansion Stage 2A|Adverse Event|0|||
105313770|NCT00996892|363144070|FG006|Expansion Stage 2A|Adverse Event|0|||
105313771|NCT00996892|363144071|FG007|Expansion Stage 2A|Adverse Event|0|||
105313772|NCT00996892|363144072|FG008|Expansion Stage 2A|Adverse Event|0|||
105313773|NCT00996892|363144073|FG009|Expansion Stage 2A|Adverse Event|0|||
105313774|NCT00996892|363144074|FG010|Expansion Stage 2A|Adverse Event|0|||
105313775|NCT00996892|363144075|FG011|Expansion Stage 2A|Adverse Event|0|||
105313776|NCT00996892|363144076|FG012|Expansion Stage 2A|Adverse Event|0|||
105313777|NCT00996892|363144077|FG013|Expansion Stage 2A|Adverse Event|0|||
105313778|NCT00996892|363144078|FG014|Expansion Stage 2A|Adverse Event|0|||
105313779|NCT00996892|363144079|FG015|Expansion Stage 2A|Adverse Event|0|||
105313780|NCT00996892|363144080|FG016|Expansion Stage 2A|Adverse Event|0|||
105313781|NCT00996892|363144081|FG017|Expansion Stage 2A|Adverse Event|0|||
105313782|NCT00996892|363144082|FG018|Expansion Stage 2A|Adverse Event|0|||
105313783|NCT00996892|363144083|FG019|Expansion Stage 2A|Adverse Event|8|||
105313784|NCT00996892|363144064|FG000|Expansion Stage 2A|Physician Decision|0|||
105313785|NCT00996892|363144065|FG001|Expansion Stage 2A|Physician Decision|0|||
105842179|NCT01132664|365080671|FG003|Phase lb|Disease Progression|0|||
105842180|NCT01132664|365080672|FG004|Phase lb|Disease Progression|0|||
105842181|NCT01132664|365080668|FG000|Phase ll|Death|0|||
105842182|NCT01132664|365080669|FG001|Phase ll|Death|0|||
105842183|NCT01132664|365080670|FG002|Phase ll|Death|2|||
105842184|NCT01132664|365080671|FG003|Phase ll|Death|0|||
105842185|NCT01132664|365080672|FG004|Phase ll|Death|0|||
105842186|NCT01132664|365080668|FG000|Phase ll|Adverse Event|0|||
105842187|NCT01132664|365080669|FG001|Phase ll|Adverse Event|0|||
105842188|NCT01132664|365080670|FG002|Phase ll|Adverse Event|10|||
105842189|NCT01132664|365080671|FG003|Phase ll|Adverse Event|0|||
105842190|NCT01132664|365080672|FG004|Phase ll|Adverse Event|0|||
105842191|NCT01132664|365080668|FG000|Phase ll|Withdrawal by Subject|0|||
105842192|NCT01132664|365080669|FG001|Phase ll|Withdrawal by Subject|0|||
105313786|NCT00996892|363144066|FG002|Expansion Stage 2A|Physician Decision|0|||
105576555|NCT00451217|364110207|FG003|Overall Study|Lost to Follow-up|1|||
105842193|NCT01132664|365080670|FG002|Phase ll|Withdrawal by Subject|3|||
105842194|NCT01132664|365080671|FG003|Phase ll|Withdrawal by Subject|0|||
105842195|NCT01132664|365080672|FG004|Phase ll|Withdrawal by Subject|0|||
105842196|NCT01132664|365080668|FG000|Phase ll|Disease progression|0|||
105842197|NCT01132664|365080669|FG001|Phase ll|Disease progression|0|||
105842198|NCT01132664|365080670|FG002|Phase ll|Disease progression|35|||
105842199|NCT01132664|365080671|FG003|Phase ll|Disease progression|0|||
105842200|NCT01132664|365080672|FG004|Phase ll|Disease progression|0|||
105842201|NCT01132664|365080668|FG000|BM Cohort|Disease progression|0|||
105842202|NCT01132664|365080669|FG001|BM Cohort|Disease progression|0|||
105842203|NCT01132664|365080670|FG002|BM Cohort|Disease progression|0|||
105842204|NCT01132664|365080671|FG003|BM Cohort|Disease progression|3|||
105842205|NCT01132664|365080672|FG004|BM Cohort|Disease progression|4|||
105842206|NCT01132664|365080668|FG000|BM Cohort|Adverse Event|0|||
105842207|NCT01132664|365080669|FG001|BM Cohort|Adverse Event|0|||
105842208|NCT01132664|365080670|FG002|BM Cohort|Adverse Event|0|||
105842209|NCT01132664|365080671|FG003|BM Cohort|Adverse Event|0|||
105842210|NCT01132664|365080672|FG004|BM Cohort|Adverse Event|1|||
105842211|NCT01132664|365080668|FG000|BM Cohort|Withdrawal by Subject|0|||
105842212|NCT01132664|365080669|FG001|BM Cohort|Withdrawal by Subject|0|||
105842213|NCT01132664|365080670|FG002|BM Cohort|Withdrawal by Subject|0|||
105842214|NCT01132664|365080671|FG003|BM Cohort|Withdrawal by Subject|0|||
105842215|NCT01132664|365080672|FG004|BM Cohort|Withdrawal by Subject|1|||
105842216|NCT00865098|365080674|FG000|Overall Study|Progressive disease|1|||
105842217|NCT00573170|365080683|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
105842218|NCT00573170|365080684|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
105842219|NCT00573170|365080685|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
105842220|NCT00573170|365080686|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
105842221|NCT00573170|365080687|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
105842222|NCT00573170|365080688|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
105842223|NCT00573170|365080683|FG000|First Washout Period|Adverse Event|1|||
105842224|NCT00573170|365080684|FG001|First Washout Period|Adverse Event|1|||
105842225|NCT00573170|365080685|FG002|First Washout Period|Adverse Event|0|||
105842226|NCT00573170|365080686|FG003|First Washout Period|Adverse Event|0|||
105842227|NCT00573170|365080687|FG004|First Washout Period|Adverse Event|0|||
105842228|NCT00573170|365080688|FG005|First Washout Period|Adverse Event|1|||
105842229|NCT00573170|365080683|FG000|First Washout Period|Lack of Efficacy|0|||
105842230|NCT00573170|365080684|FG001|First Washout Period|Lack of Efficacy|0|||
105842231|NCT00573170|365080685|FG002|First Washout Period|Lack of Efficacy|0|||
105842232|NCT00573170|365080686|FG003|First Washout Period|Lack of Efficacy|0|||
105842233|NCT00573170|365080687|FG004|First Washout Period|Lack of Efficacy|0|||
105842234|NCT00573170|365080688|FG005|First Washout Period|Lack of Efficacy|1|||
105842235|NCT00573170|365080683|FG000|First Washout Period|Lost to Follow-up|1|||
105842236|NCT00573170|365080684|FG001|First Washout Period|Lost to Follow-up|1|||
105842237|NCT00573170|365080685|FG002|First Washout Period|Lost to Follow-up|0|||
105842238|NCT00573170|365080686|FG003|First Washout Period|Lost to Follow-up|2|||
105842239|NCT00573170|365080687|FG004|First Washout Period|Lost to Follow-up|0|||
105842240|NCT00573170|365080688|FG005|First Washout Period|Lost to Follow-up|2|||
105842241|NCT00573170|365080683|FG000|First Washout Period|Withdrawal by Subject|2|||
105842242|NCT00573170|365080684|FG001|First Washout Period|Withdrawal by Subject|0|||
105842243|NCT00573170|365080685|FG002|First Washout Period|Withdrawal by Subject|0|||
105842244|NCT00573170|365080686|FG003|First Washout Period|Withdrawal by Subject|2|||
105842245|NCT00573170|365080687|FG004|First Washout Period|Withdrawal by Subject|3|||
105842246|NCT00573170|365080688|FG005|First Washout Period|Withdrawal by Subject|3|||
105842247|NCT00573170|365080683|FG000|First Washout Period|Other|4|||
105842248|NCT00573170|365080684|FG001|First Washout Period|Other|0|||
105842249|NCT00573170|365080685|FG002|First Washout Period|Other|1|||
105842250|NCT00573170|365080686|FG003|First Washout Period|Other|1|||
105842251|NCT00573170|365080687|FG004|First Washout Period|Other|0|||
105842252|NCT00573170|365080688|FG005|First Washout Period|Other|0|||
105842253|NCT00573170|365080683|FG000|Second Washout Period|Adverse Event|1|||
105842254|NCT00573170|365080684|FG001|Second Washout Period|Adverse Event|0|||
105842255|NCT00573170|365080685|FG002|Second Washout Period|Adverse Event|0|||
105842256|NCT00573170|365080686|FG003|Second Washout Period|Adverse Event|0|||
105842257|NCT00573170|365080687|FG004|Second Washout Period|Adverse Event|1|||
105842258|NCT00573170|365080688|FG005|Second Washout Period|Adverse Event|0|||
105842259|NCT00573170|365080683|FG000|Second Washout Period|Protocol Violation|2|||
105842260|NCT00573170|365080684|FG001|Second Washout Period|Protocol Violation|1|||
105842261|NCT00573170|365080685|FG002|Second Washout Period|Protocol Violation|1|||
105842262|NCT00573170|365080686|FG003|Second Washout Period|Protocol Violation|0|||
105842263|NCT00573170|365080687|FG004|Second Washout Period|Protocol Violation|0|||
105842264|NCT00573170|365080688|FG005|Second Washout Period|Protocol Violation|0|||
105842265|NCT00573170|365080683|FG000|Second Washout Period|Withdrawal by Subject|1|||
105842266|NCT00573170|365080684|FG001|Second Washout Period|Withdrawal by Subject|1|||
105842267|NCT00573170|365080685|FG002|Second Washout Period|Withdrawal by Subject|2|||
105842268|NCT00573170|365080686|FG003|Second Washout Period|Withdrawal by Subject|0|||
105313787|NCT00996892|363144067|FG003|Expansion Stage 2A|Physician Decision|0|||
105313788|NCT00996892|363144068|FG004|Expansion Stage 2A|Physician Decision|0|||
105313789|NCT00996892|363144069|FG005|Expansion Stage 2A|Physician Decision|0|||
105313790|NCT00996892|363144070|FG006|Expansion Stage 2A|Physician Decision|0|||
105313791|NCT00996892|363144071|FG007|Expansion Stage 2A|Physician Decision|0|||
105313792|NCT00996892|363144072|FG008|Expansion Stage 2A|Physician Decision|0|||
105313793|NCT00996892|363144073|FG009|Expansion Stage 2A|Physician Decision|0|||
105313794|NCT00996892|363144074|FG010|Expansion Stage 2A|Physician Decision|0|||
105313795|NCT00996892|363144075|FG011|Expansion Stage 2A|Physician Decision|0|||
105313796|NCT00996892|363144076|FG012|Expansion Stage 2A|Physician Decision|0|||
105313797|NCT00996892|363144077|FG013|Expansion Stage 2A|Physician Decision|0|||
105313798|NCT00996892|363144078|FG014|Expansion Stage 2A|Physician Decision|0|||
105313799|NCT00996892|363144079|FG015|Expansion Stage 2A|Physician Decision|0|||
105313800|NCT00996892|363144080|FG016|Expansion Stage 2A|Physician Decision|0|||
105313801|NCT00996892|363144081|FG017|Expansion Stage 2A|Physician Decision|0|||
105313802|NCT00996892|363144082|FG018|Expansion Stage 2A|Physician Decision|0|||
105313803|NCT00996892|363144083|FG019|Expansion Stage 2A|Physician Decision|2|||
105313804|NCT00996892|363144064|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
105313805|NCT00996892|363144065|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
105313806|NCT00996892|363144066|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
105313807|NCT00996892|363144067|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
105313808|NCT00996892|363144068|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
105313809|NCT00996892|363144069|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
105313810|NCT00996892|363144070|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
105313811|NCT00996892|363144071|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
105313812|NCT00996892|363144072|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
105313813|NCT00996892|363144073|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
105313814|NCT00996892|363144074|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
105313815|NCT00996892|363144075|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
105313816|NCT00996892|363144076|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
105313817|NCT00996892|363144077|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
105313818|NCT00996892|363144078|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
105313819|NCT00996892|363144079|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
105313820|NCT00996892|363144080|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
105313821|NCT00996892|363144081|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
105313822|NCT00996892|363144082|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
105313823|NCT00996892|363144083|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
105313824|NCT00996892|363144064|FG000|Expansion Stage 2A|Disease Progression|0|||
105313825|NCT00996892|363144065|FG001|Expansion Stage 2A|Disease Progression|0|||
105313826|NCT00996892|363144066|FG002|Expansion Stage 2A|Disease Progression|0|||
105313827|NCT00996892|363144067|FG003|Expansion Stage 2A|Disease Progression|0|||
105313828|NCT00996892|363144068|FG004|Expansion Stage 2A|Disease Progression|0|||
105313829|NCT00996892|363144069|FG005|Expansion Stage 2A|Disease Progression|0|||
105313830|NCT00996892|363144070|FG006|Expansion Stage 2A|Disease Progression|0|||
105313831|NCT00996892|363144071|FG007|Expansion Stage 2A|Disease Progression|0|||
105313832|NCT00996892|363144072|FG008|Expansion Stage 2A|Disease Progression|0|||
105313833|NCT00996892|363144073|FG009|Expansion Stage 2A|Disease Progression|0|||
105313834|NCT00996892|363144074|FG010|Expansion Stage 2A|Disease Progression|0|||
105313835|NCT00996892|363144075|FG011|Expansion Stage 2A|Disease Progression|0|||
105313836|NCT00996892|363144076|FG012|Expansion Stage 2A|Disease Progression|0|||
105313837|NCT00996892|363144077|FG013|Expansion Stage 2A|Disease Progression|0|||
105313838|NCT00996892|363144078|FG014|Expansion Stage 2A|Disease Progression|0|||
105313839|NCT00996892|363144079|FG015|Expansion Stage 2A|Disease Progression|0|||
105313840|NCT00996892|363144080|FG016|Expansion Stage 2A|Disease Progression|0|||
105313841|NCT00996892|363144081|FG017|Expansion Stage 2A|Disease Progression|0|||
105313842|NCT00996892|363144082|FG018|Expansion Stage 2A|Disease Progression|0|||
105313843|NCT00996892|363144083|FG019|Expansion Stage 2A|Disease Progression|31|||
105313844|NCT01653912|363144084|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
105313845|NCT01653912|363144085|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
105313846|NCT01653912|363144086|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
105313847|NCT01653912|363144087|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
105313848|NCT01653912|363144088|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
105313849|NCT01653912|363144089|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
105313850|NCT01653912|363144084|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
105576556|NCT00451217|364110204|FG000|Overall Study|Withdrawal by Subject|1|||
105576557|NCT00451217|364110205|FG001|Overall Study|Withdrawal by Subject|0|||
105313851|NCT01653912|363144085|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
105313852|NCT01653912|363144086|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
105576558|NCT00451217|364110206|FG002|Overall Study|Withdrawal by Subject|0|||
105576559|NCT00451217|364110207|FG003|Overall Study|Withdrawal by Subject|0|||
105313853|NCT01653912|363144087|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
105313854|NCT01653912|363144088|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
105313855|NCT01653912|363144089|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
105313856|NCT01653912|363144084|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
105313857|NCT01653912|363144085|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
105313858|NCT01653912|363144086|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
105313859|NCT01653912|363144087|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
105313860|NCT01653912|363144088|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
105313861|NCT01653912|363144089|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
105313862|NCT01653912|363144084|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
105313863|NCT01653912|363144085|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
105313864|NCT01653912|363144086|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
105313865|NCT01653912|363144087|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
105313866|NCT01653912|363144088|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
105313867|NCT01653912|363144089|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
105313868|NCT01653912|363144084|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
105313869|NCT01653912|363144085|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
105313870|NCT01653912|363144086|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
105313871|NCT01653912|363144087|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
105313872|NCT01653912|363144088|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
105313873|NCT01653912|363144089|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
105313874|NCT01653912|363144084|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
105313875|NCT01653912|363144085|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
105313876|NCT01653912|363144086|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
105313877|NCT01653912|363144087|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
105313878|NCT01653912|363144088|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
105313879|NCT01653912|363144089|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
105313880|NCT01653912|363144084|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
105313881|NCT01653912|363144085|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
105313882|NCT01653912|363144086|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
105313883|NCT01653912|363144087|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
105313884|NCT01653912|363144088|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
105313885|NCT01653912|363144089|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
105313886|NCT03654599|363144090|FG000|Overall Study|Lost to Follow-up|14|||
105313887|NCT03654599|363144091|FG001|Overall Study|Lost to Follow-up|12|||
105313888|NCT03654599|363144090|FG000|Overall Study|Death|8|||
105313889|NCT03654599|363144091|FG001|Overall Study|Death|6|||
105313890|NCT03654599|363144090|FG000|Overall Study|Withdrawal by Subject|6|||
105313891|NCT03654599|363144091|FG001|Overall Study|Withdrawal by Subject|4|||
105313892|NCT05314816|363144093|FG000|Overall Study|Lost to Follow-up|5|||
105313893|NCT05314816|363144094|FG001|Overall Study|Lost to Follow-up|0|||
105313894|NCT05314816|363144095|FG002|Overall Study|Lost to Follow-up|1|||
105313895|NCT05314816|363144093|FG000|Overall Study|Protocol Violation|13|||
105313896|NCT05314816|363144094|FG001|Overall Study|Protocol Violation|8|||
105313897|NCT05314816|363144095|FG002|Overall Study|Protocol Violation|0|||
105490045|NCT02452697|363805727|FG002|Overall Study|Withdrawal by Subject|0|||
105313898|NCT02899195|363145858|FG000|Concurrent Durvalumab|Adverse Event|4|||
105313899|NCT02899195|363145858|FG000|Concurrent Durvalumab|Physician Decision|1|||
105313900|NCT02899195|363145858|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
105313901|NCT02899195|363145858|FG000|Concurrent Durvalumab|Progressive Disease|5|||
105313902|NCT02899195|363145858|FG000|Maintenance Durvalumab|Adverse Event|1|||
105313903|NCT02899195|363145858|FG000|Maintenance Durvalumab|Physician Decision|1|||
105313904|NCT02899195|363145858|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
105313905|NCT02899195|363145858|FG000|Maintenance Durvalumab|Progressive Disease|31|||
105313906|NCT02242045|363145865|FG000|Overall Study|Investigator's Discretion|1|||
105313907|NCT02242045|363145865|FG000|Overall Study|Progressive Disease|2|||
105313908|NCT02242045|363145865|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
105313909|NCT02242045|363145865|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
105313910|NCT02954991|363145866|FG000|Overall Study|Death|92|||
105313911|NCT02954991|363145867|FG001|Overall Study|Death|11|||
105313912|NCT02954991|363145868|FG002|Overall Study|Death|2|||
105313913|NCT02954991|363145866|FG000|Overall Study|Lost to Follow-up|3|||
105313914|NCT02954991|363145867|FG001|Overall Study|Lost to Follow-up|2|||
105313915|NCT02954991|363145868|FG002|Overall Study|Lost to Follow-up|0|||
105313916|NCT02954991|363145866|FG000|Overall Study|Withdrawal by Subject|9|||
105313917|NCT02954991|363145867|FG001|Overall Study|Withdrawal by Subject|8|||
105313918|NCT02954991|363145868|FG002|Overall Study|Withdrawal by Subject|1|||
105313919|NCT02954991|363145866|FG000|Overall Study|Study Terminated by Sponsor|18|||
105313920|NCT02954991|363145867|FG001|Overall Study|Study Terminated by Sponsor|10|||
105313921|NCT02954991|363145868|FG002|Overall Study|Study Terminated by Sponsor|1|||
105313922|NCT02954991|363145866|FG000|Overall Study|Miscellaneous|2|||
105313923|NCT02954991|363145867|FG001|Overall Study|Miscellaneous|1|||
105313924|NCT02954991|363145868|FG002|Overall Study|Miscellaneous|1|||
105313925|NCT00741286|363145871|FG000|Overall Study|Lost to Follow-up|15|||
105313926|NCT00741286|363145872|FG001|Overall Study|Lost to Follow-up|10|||
105313927|NCT00741286|363145871|FG000|Overall Study|Adverse Event|1|||
105313928|NCT00741286|363145872|FG001|Overall Study|Adverse Event|6|||
105842269|NCT00573170|365080687|FG004|Second Washout Period|Withdrawal by Subject|1|||
105313929|NCT00741286|363145871|FG000|Overall Study|Protocol Violation|3|||
105313930|NCT00741286|363145872|FG001|Overall Study|Protocol Violation|2|||
105313931|NCT00741286|363145871|FG000|Overall Study|Primary Outcome|1|||
105313932|NCT00741286|363145872|FG001|Overall Study|Primary Outcome|1|||
105313933|NCT01831258|363145873|FG000|Overall Study|Withdrawal by Subject|2|||
105313934|NCT01831258|363145874|FG001|Overall Study|Withdrawal by Subject|1|||
105313935|NCT01831258|363145873|FG000|Overall Study|Lost to Follow-up|3|||
105313936|NCT01831258|363145874|FG001|Overall Study|Lost to Follow-up|2|||
105313937|NCT00253448|363145884|FG000|Overall Study|Withdrawal by Subject|1|||
105313938|NCT00000620|363145885|FG000|Overall Study|Death|86|||
105313939|NCT00000620|363145886|FG001|Overall Study|Death|67|||
105313940|NCT00000620|363145887|FG002|Overall Study|Death|112|||
105313941|NCT00000620|363145888|FG003|Overall Study|Death|126|||
105313942|NCT00000620|363145889|FG004|Overall Study|Death|64|||
105313943|NCT00000620|363145890|FG005|Overall Study|Death|77|||
105313944|NCT00000620|363145891|FG006|Overall Study|Death|91|||
105313945|NCT00000620|363145892|FG007|Overall Study|Death|95|||
105313946|NCT00000620|363145885|FG000|Overall Study|Lost to Follow-up|14|||
105313947|NCT00000620|363145886|FG001|Overall Study|Lost to Follow-up|14|||
105313948|NCT00000620|363145887|FG002|Overall Study|Lost to Follow-up|14|||
105313949|NCT00000620|363145888|FG003|Overall Study|Lost to Follow-up|14|||
105313950|NCT00000620|363145889|FG004|Overall Study|Lost to Follow-up|15|||
105313951|NCT00000620|363145890|FG005|Overall Study|Lost to Follow-up|15|||
105313952|NCT00000620|363145891|FG006|Overall Study|Lost to Follow-up|13|||
105313953|NCT00000620|363145892|FG007|Overall Study|Lost to Follow-up|14|||
105842270|NCT00573170|365080688|FG005|Second Washout Period|Withdrawal by Subject|0|||
105842271|NCT00573170|365080683|FG000|Second Washout Period|Lost to Follow-up|0|||
105842272|NCT00573170|365080684|FG001|Second Washout Period|Lost to Follow-up|0|||
105842273|NCT00573170|365080685|FG002|Second Washout Period|Lost to Follow-up|0|||
105842274|NCT00573170|365080686|FG003|Second Washout Period|Lost to Follow-up|1|||
105842275|NCT00573170|365080687|FG004|Second Washout Period|Lost to Follow-up|0|||
105842276|NCT00573170|365080688|FG005|Second Washout Period|Lost to Follow-up|0|||
105842277|NCT00573170|365080683|FG000|Second Washout Period|Other|1|||
105842278|NCT00573170|365080684|FG001|Second Washout Period|Other|2|||
105842279|NCT00573170|365080685|FG002|Second Washout Period|Other|1|||
105842280|NCT00573170|365080686|FG003|Second Washout Period|Other|4|||
105842281|NCT00573170|365080687|FG004|Second Washout Period|Other|6|||
105842282|NCT00573170|365080688|FG005|Second Washout Period|Other|2|||
105842283|NCT00573170|365080683|FG000|Third Treatment Period|Withdrawal by Subject|1|||
105842284|NCT00573170|365080684|FG001|Third Treatment Period|Withdrawal by Subject|0|||
105842285|NCT00573170|365080685|FG002|Third Treatment Period|Withdrawal by Subject|0|||
105842286|NCT00573170|365080686|FG003|Third Treatment Period|Withdrawal by Subject|0|||
105842287|NCT00573170|365080687|FG004|Third Treatment Period|Withdrawal by Subject|0|||
105842288|NCT00573170|365080688|FG005|Third Treatment Period|Withdrawal by Subject|0|||
105842289|NCT00573170|365080683|FG000|Third Treatment Period|Lost to Follow-up|0|||
105842290|NCT00573170|365080684|FG001|Third Treatment Period|Lost to Follow-up|0|||
105842291|NCT00573170|365080685|FG002|Third Treatment Period|Lost to Follow-up|0|||
105842292|NCT00573170|365080686|FG003|Third Treatment Period|Lost to Follow-up|0|||
105842293|NCT00573170|365080687|FG004|Third Treatment Period|Lost to Follow-up|0|||
105842294|NCT00573170|365080688|FG005|Third Treatment Period|Lost to Follow-up|2|||
105842295|NCT00918463|365080690|FG000|Overall Study|Death|1|||
105842296|NCT00918463|365080690|FG000|Overall Study|Lack of Efficacy|1|||
105842297|NCT01715896|365080695|FG000|Overall Study|Lost to Follow-up|0|||
105842298|NCT01715896|365080696|FG001|Overall Study|Lost to Follow-up|2|||
105842299|NCT01715896|365080695|FG000|Overall Study|Withdrawal by Subject|1|||
105842300|NCT01715896|365080696|FG001|Overall Study|Withdrawal by Subject|4|||
105842301|NCT01715896|365080695|FG000|Overall Study|Other|2|||
105842302|NCT01715896|365080696|FG001|Overall Study|Other|5|||
105842303|NCT01045993|365080699|FG000|Overall Study|Treated-later found eligibility not met|0|||
105842304|NCT01045993|365080700|FG001|Overall Study|Treated-later found eligibility not met|1|||
105842305|NCT01045993|365080701|FG002|Overall Study|Treated-later found eligibility not met|0|||
105842306|NCT01045993|365080702|FG003|Overall Study|Treated-later found eligibility not met|0|||
105842307|NCT00685802|365080709|FG000|Washout Period of 7 Days|Protocol Violation|2|||
105842308|NCT00685802|365080710|FG001|Washout Period of 7 Days|Protocol Violation|0|||
105313954|NCT00000620|363145885|FG000|Overall Study|Withdrawal by Subject|40|||
105313955|NCT00000620|363145886|FG001|Overall Study|Withdrawal by Subject|27|||
105313956|NCT00000620|363145887|FG002|Overall Study|Withdrawal by Subject|28|||
105313957|NCT00000620|363145888|FG003|Overall Study|Withdrawal by Subject|27|||
105313958|NCT00000620|363145889|FG004|Overall Study|Withdrawal by Subject|30|||
105313959|NCT00000620|363145890|FG005|Overall Study|Withdrawal by Subject|32|||
105842309|NCT00685802|365080709|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
105842310|NCT00685802|365080710|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105842311|NCT01048502|365080711|FG000|Overall Study|Lost to Follow-up|2|||
105842312|NCT01048502|365080712|FG001|Overall Study|Lost to Follow-up|0|||
105313960|NCT00000620|363145891|FG006|Overall Study|Withdrawal by Subject|32|||
105313961|NCT00000620|363145892|FG007|Overall Study|Withdrawal by Subject|21|||
105842313|NCT01048502|365080713|FG002|Overall Study|Lost to Follow-up|0|||
105842314|NCT01048502|365080714|FG003|Overall Study|Lost to Follow-up|0|||
105842315|NCT01048502|365080711|FG000|Overall Study|Adverse Event|1|||
105842316|NCT01048502|365080712|FG001|Overall Study|Adverse Event|0|||
105842317|NCT01048502|365080713|FG002|Overall Study|Adverse Event|0|||
105842318|NCT01048502|365080714|FG003|Overall Study|Adverse Event|0|||
105842319|NCT01048502|365080711|FG000|Overall Study|Withdrawal by Subject|1|||
105842320|NCT01048502|365080712|FG001|Overall Study|Withdrawal by Subject|4|||
105842321|NCT01048502|365080713|FG002|Overall Study|Withdrawal by Subject|5|||
105842322|NCT01048502|365080714|FG003|Overall Study|Withdrawal by Subject|3|||
105842323|NCT01048502|365080711|FG000|Overall Study|Physician Decision|0|||
105842324|NCT01048502|365080712|FG001|Overall Study|Physician Decision|3|||
105842325|NCT01048502|365080713|FG002|Overall Study|Physician Decision|0|||
105842326|NCT01048502|365080714|FG003|Overall Study|Physician Decision|1|||
105842327|NCT03336242|365080718|FG000|Overall Study|Adverse Event|0|||
105313962|NCT00000620|363145885|FG000|Overall Study|missed closeout visit|22|||
105842328|NCT03336242|365080719|FG001|Overall Study|Adverse Event|1|||
105842329|NCT02100319|365080720|FG000|Overall Study|Case Report Forms Uncollected|11|||
105842330|NCT02100319|365080720|FG000|Overall Study|Protocol Deviation|5|||
105842331|NCT02224573|365080722|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
105313963|NCT00000620|363145886|FG001|Overall Study|missed closeout visit|28|||
105313964|NCT00000620|363145887|FG002|Overall Study|missed closeout visit|16|||
105313965|NCT00000620|363145888|FG003|Overall Study|missed closeout visit|11|||
105313966|NCT00000620|363145889|FG004|Overall Study|missed closeout visit|26|||
105313967|NCT00000620|363145890|FG005|Overall Study|missed closeout visit|28|||
105313968|NCT00000620|363145891|FG006|Overall Study|missed closeout visit|13|||
105313969|NCT00000620|363145892|FG007|Overall Study|missed closeout visit|16|||
105313970|NCT01609023|363145904|FG000|Overall Study|Lack of Efficacy|3|||
105313971|NCT01609023|363145904|FG000|Overall Study|Withdrawal by Subject|4|||
105313972|NCT01609023|363145904|FG000|Overall Study|Lost to Follow-up|8|||
105313973|NCT01609023|363145904|FG000|Overall Study|Toxicity|3|||
105313974|NCT01609023|363145904|FG000|Overall Study|Disease progression|10|||
105313975|NCT01609023|363145904|FG000|Overall Study|Physician Decision|2|||
105313976|NCT01609023|363145904|FG000|Overall Study|Death|2|||
105313977|NCT01609023|363145904|FG000|Overall Study|Personal reasons|1|||
105313978|NCT00171951|363145905|FG000|Overall Study|Adverse Event|1|||
105313979|NCT00171951|363145905|FG000|Overall Study|Abnormal Laboratory Values|2|||
105313980|NCT00171951|363145905|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
105313981|NCT00171951|363145905|FG000|Overall Study|Participants Withdrew Consent|3|||
105313982|NCT00171951|363145905|FG000|Overall Study|New Cancer Therapy|5|||
105313983|NCT00171951|363145905|FG000|Overall Study|Reason not Specified|2|||
105313984|NCT00314951|363145906|FG000|Treatment|Didn't meet criteria for mITT population|16|||
105313985|NCT00314951|363145907|FG001|Treatment|Didn't meet criteria for mITT population|11|||
105313986|NCT00314951|363145906|FG000|Follow-up|mITT failure|44|||
105313987|NCT00314951|363145907|FG001|Follow-up|mITT failure|34|||
105313988|NCT01228019|363145908|FG000|Overall Study|Dose Violation|70|||
105313989|NCT01228019|363145908|FG000|Overall Study|Duplicate enrollment|1|||
105313990|NCT01228019|363145908|FG000|Overall Study|Missing pre-treatment data|72|||
105313991|NCT01228019|363145908|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
105313992|NCT01228019|363145908|FG000|Overall Study|Violation of Entry Criterion|9|||
105313993|NCT00492778|363145909|FG000|Overall Study|Ineligible by Pathology Review|8|||
105313994|NCT00492778|363145910|FG001|Overall Study|Ineligible by Pathology Review|1|||
105313995|NCT03717012|363145911|FG000|Overall Study|Due to trial termination|1|||
105313996|NCT03717012|363145912|FG001|Overall Study|Due to trial termination|2|||
105313997|NCT03717012|363145911|FG000|Overall Study|Protocol Violation|0|||
105313998|NCT03717012|363145912|FG001|Overall Study|Protocol Violation|2|||
105313999|NCT03717012|363145911|FG000|Overall Study|Adverse Event|0|||
105314000|NCT03717012|363145912|FG001|Overall Study|Adverse Event|1|||
105314001|NCT03717012|363145911|FG000|Overall Study|Lung transplant|0|||
105314002|NCT03717012|363145912|FG001|Overall Study|Lung transplant|1|||
105314003|NCT00789035|363145913|FG000|Overall Study|Adverse Event|0|||
105314004|NCT00789035|363145914|FG001|Overall Study|Adverse Event|2|||
105368277|NCT03327324|363354177|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105368278|NCT03327324|363354178|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
105842332|NCT02224573|365080723|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
105314005|NCT00789035|363145915|FG002|Overall Study|Adverse Event|0|||
105314006|NCT00789035|363145916|FG003|Overall Study|Adverse Event|1|||
105314007|NCT00789035|363145917|FG004|Overall Study|Adverse Event|3|||
105314008|NCT00789035|363145913|FG000|Overall Study|Lack of Efficacy|3|||
105314009|NCT00789035|363145914|FG001|Overall Study|Lack of Efficacy|0|||
105314010|NCT00789035|363145915|FG002|Overall Study|Lack of Efficacy|0|||
105314011|NCT00789035|363145916|FG003|Overall Study|Lack of Efficacy|0|||
105314012|NCT00789035|363145917|FG004|Overall Study|Lack of Efficacy|2|||
105842333|NCT02224573|365080722|FG000|Treatment Phase|Started on Other IMP|1|||
105842334|NCT02224573|365080723|FG001|Treatment Phase|Started on Other IMP|0|||
105842335|NCT02224573|365080722|FG000|Treatment Phase|Participant Discontinued IMP|0|||
105314013|NCT00789035|363145913|FG000|Overall Study|Protocol Violation|1|||
105314014|NCT00789035|363145914|FG001|Overall Study|Protocol Violation|0|||
105314015|NCT00789035|363145915|FG002|Overall Study|Protocol Violation|0|||
105314016|NCT00789035|363145916|FG003|Overall Study|Protocol Violation|0|||
105314017|NCT00789035|363145917|FG004|Overall Study|Protocol Violation|0|||
105314018|NCT00789035|363145913|FG000|Overall Study|Withdrawal by Subject|0|||
105314019|NCT00789035|363145914|FG001|Overall Study|Withdrawal by Subject|2|||
105314020|NCT00789035|363145915|FG002|Overall Study|Withdrawal by Subject|0|||
105314021|NCT00789035|363145916|FG003|Overall Study|Withdrawal by Subject|0|||
105314022|NCT00789035|363145917|FG004|Overall Study|Withdrawal by Subject|0|||
105314023|NCT00789035|363145913|FG000|Overall Study|Other reason not defined above|2|||
105314024|NCT00789035|363145914|FG001|Overall Study|Other reason not defined above|3|||
105314025|NCT00789035|363145915|FG002|Overall Study|Other reason not defined above|1|||
105314026|NCT00789035|363145916|FG003|Overall Study|Other reason not defined above|0|||
105314027|NCT00789035|363145917|FG004|Overall Study|Other reason not defined above|1|||
105314028|NCT00796107|363145925|FG000|Overall Study|Lack of Efficacy|1|||
105314029|NCT00796107|363145925|FG000|Overall Study|Progressive Disease|5|||
105314030|NCT01420965|363145930|FG000|Overall Study|Withdrawal by Subject|1|||
105314031|NCT01420965|363145931|FG001|Overall Study|Withdrawal by Subject|0|||
105314032|NCT01420965|363145932|FG002|Overall Study|Withdrawal by Subject|0|||
105314033|NCT01420965|363145930|FG000|Overall Study|Adverse Event|0|||
105314034|NCT01420965|363145931|FG001|Overall Study|Adverse Event|1|||
105314035|NCT01420965|363145932|FG002|Overall Study|Adverse Event|0|||
105314036|NCT00339144|363145933|FG000|Overall Study|Disease progression|5|||
105314037|NCT00339144|363145934|FG001|Overall Study|Disease progression|2|||
105314038|NCT00339144|363145935|FG002|Overall Study|Disease progression|2|||
105314039|NCT00339144|363145933|FG000|Overall Study|Study drug toxicity|3|||
105314040|NCT00339144|363145934|FG001|Overall Study|Study drug toxicity|1|||
105314041|NCT00339144|363145935|FG002|Overall Study|Study drug toxicity|1|||
105314042|NCT00339144|363145933|FG000|Overall Study|Participant's request to discontinuation|1|||
105314043|NCT00339144|363145934|FG001|Overall Study|Participant's request to discontinuation|0|||
105314044|NCT00339144|363145935|FG002|Overall Study|Participant's request to discontinuation|1|||
105314045|NCT01822366|363145939|FG000|Overall Study|Lost to Follow-up|5|||
105314046|NCT01822366|363145940|FG001|Overall Study|Lost to Follow-up|1|||
105314047|NCT01822366|363145941|FG002|Overall Study|Lost to Follow-up|5|||
105314048|NCT01822366|363145942|FG003|Overall Study|Lost to Follow-up|1|||
105314049|NCT01822366|363145939|FG000|Overall Study|Withdrawal by Subject|0|||
105314050|NCT01822366|363145940|FG001|Overall Study|Withdrawal by Subject|6|||
105314051|NCT01822366|363145941|FG002|Overall Study|Withdrawal by Subject|0|||
105314052|NCT01822366|363145942|FG003|Overall Study|Withdrawal by Subject|6|||
105314053|NCT01822366|363145939|FG000|Overall Study|Partial Intervention Completion|0|||
105314054|NCT01822366|363145940|FG001|Overall Study|Partial Intervention Completion|15|||
105314055|NCT01822366|363145941|FG002|Overall Study|Partial Intervention Completion|0|||
105314056|NCT01822366|363145942|FG003|Overall Study|Partial Intervention Completion|15|||
105314057|NCT01275430|363145943|FG000|Overall Study|Adverse Event|1|||
105314058|NCT01275430|363145943|FG000|Overall Study|No Contrast Injection|6|||
105314059|NCT01275430|363145943|FG000|Overall Study|Device Malfunction|1|||
105314060|NCT01275430|363145943|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
105314061|NCT04759768|363145945|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
105314062|NCT04759768|363145946|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
105314063|NCT04759768|363145945|FG000|Washout (7 Days)|Physician Decision|0|||
105314064|NCT04759768|363145946|FG001|Washout (7 Days)|Physician Decision|1|||
105314065|NCT02785952|363145950|FG000|Overall Study|Adverse Event|31|||
105314066|NCT02785952|363145951|FG001|Overall Study|Adverse Event|19|||
105314067|NCT02785952|363145950|FG000|Overall Study|Refusal unrelated to adverse events|10|||
105314068|NCT02785952|363145951|FG001|Overall Study|Refusal unrelated to adverse events|5|||
105314069|NCT02785952|363145950|FG000|Overall Study|Disease progression/relapse|61|||
105314070|NCT02785952|363145951|FG001|Overall Study|Disease progression/relapse|89|||
105314071|NCT02785952|363145950|FG000|Overall Study|Death|11|||
105314072|NCT02785952|363145951|FG001|Overall Study|Death|7|||
105314073|NCT02785952|363145950|FG000|Overall Study|Other- not protocol specified|6|||
105314074|NCT02785952|363145951|FG001|Overall Study|Other- not protocol specified|4|||
105314075|NCT02785952|363145950|FG000|Overall Study|On protocol treatment|6|||
105314076|NCT02785952|363145951|FG001|Overall Study|On protocol treatment|3|||
105314077|NCT01004003|363145953|FG000|Overall Study|Progressive disease|2|||
105314078|NCT01004003|363145954|FG001|Overall Study|Progressive disease|1|||
105314079|NCT01004003|363145955|FG002|Overall Study|Progressive disease|1|||
105314080|NCT01004003|363145956|FG003|Overall Study|Progressive disease|0|||
105314081|NCT01004003|363145957|FG004|Overall Study|Progressive disease|2|||
105314082|NCT01004003|363145958|FG005|Overall Study|Progressive disease|1|||
105314083|NCT01004003|363145959|FG006|Overall Study|Progressive disease|1|||
105314084|NCT01004003|363145960|FG007|Overall Study|Progressive disease|39|||
105314085|NCT01004003|363145961|FG008|Overall Study|Progressive disease|22|||
105314086|NCT01004003|363145953|FG000|Overall Study|Adverse Event|4|||
105314087|NCT01004003|363145954|FG001|Overall Study|Adverse Event|2|||
105314088|NCT01004003|363145955|FG002|Overall Study|Adverse Event|3|||
105842336|NCT02224573|365080723|FG001|Treatment Phase|Participant Discontinued IMP|1|||
105842337|NCT02224573|365080722|FG000|Treatment Phase|Lack of Efficacy|15|||
105842338|NCT02224573|365080723|FG001|Treatment Phase|Lack of Efficacy|8|||
105842339|NCT02224573|365080722|FG000|Treatment Phase|Began Commercial Product|1|||
105842340|NCT02224573|365080723|FG001|Treatment Phase|Began Commercial Product|0|||
105842341|NCT02224573|365080722|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
105842342|NCT02224573|365080723|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
105842343|NCT02224573|365080722|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
105842344|NCT02224573|365080723|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
105842345|NCT02224573|365080722|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
105842346|NCT02224573|365080723|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
105842347|NCT02224573|365080722|FG000|Treatment Phase|Continued Compassionate Use|1|||
105842348|NCT02224573|365080723|FG001|Treatment Phase|Continued Compassionate Use|0|||
105842349|NCT02224573|365080722|FG000|Treatment Phase|Lack of Efficiency|2|||
105842350|NCT02224573|365080723|FG001|Treatment Phase|Lack of Efficiency|1|||
105842351|NCT02224573|365080722|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
105842352|NCT02224573|365080723|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
105842353|NCT02224573|365080722|FG000|Treatment Phase|Participant Moved|2|||
105314089|NCT01004003|363145956|FG003|Overall Study|Adverse Event|3|||
105314090|NCT01004003|363145957|FG004|Overall Study|Adverse Event|2|||
105314091|NCT01004003|363145958|FG005|Overall Study|Adverse Event|2|||
105314092|NCT01004003|363145959|FG006|Overall Study|Adverse Event|7|||
105314093|NCT01004003|363145960|FG007|Overall Study|Adverse Event|21|||
105314094|NCT01004003|363145961|FG008|Overall Study|Adverse Event|6|||
105314095|NCT01004003|363145953|FG000|Overall Study|Refused to continue taking trial med.|0|||
105314096|NCT01004003|363145954|FG001|Overall Study|Refused to continue taking trial med.|0|||
105314097|NCT01004003|363145955|FG002|Overall Study|Refused to continue taking trial med.|0|||
105314098|NCT01004003|363145956|FG003|Overall Study|Refused to continue taking trial med.|0|||
105314099|NCT01004003|363145957|FG004|Overall Study|Refused to continue taking trial med.|0|||
105314100|NCT01004003|363145958|FG005|Overall Study|Refused to continue taking trial med.|0|||
105314101|NCT01004003|363145959|FG006|Overall Study|Refused to continue taking trial med.|0|||
105314102|NCT01004003|363145960|FG007|Overall Study|Refused to continue taking trial med.|0|||
105314103|NCT01004003|363145961|FG008|Overall Study|Refused to continue taking trial med.|2|||
105314104|NCT01004003|363145953|FG000|Overall Study|Other|0|||
105314105|NCT01004003|363145954|FG001|Overall Study|Other|0|||
105314106|NCT01004003|363145955|FG002|Overall Study|Other|0|||
105314107|NCT01004003|363145956|FG003|Overall Study|Other|0|||
105314108|NCT01004003|363145957|FG004|Overall Study|Other|0|||
105314109|NCT01004003|363145958|FG005|Overall Study|Other|1|||
105314110|NCT01004003|363145959|FG006|Overall Study|Other|0|||
105314111|NCT01004003|363145960|FG007|Overall Study|Other|0|||
105314112|NCT01004003|363145961|FG008|Overall Study|Other|0|||
105314113|NCT02728843|363145967|FG000|Overall Study|Adverse Event|0|||
105314114|NCT02728843|363145968|FG001|Overall Study|Adverse Event|2|||
105314115|NCT02728843|363145969|FG002|Overall Study|Adverse Event|3|||
105314116|NCT02728843|363145970|FG003|Overall Study|Adverse Event|1|||
105314117|NCT02728843|363145971|FG004|Overall Study|Adverse Event|2|||
105314118|NCT02728843|363145967|FG000|Overall Study|Lack of Efficacy|0|||
105314119|NCT02728843|363145968|FG001|Overall Study|Lack of Efficacy|1|||
105314120|NCT02728843|363145969|FG002|Overall Study|Lack of Efficacy|1|||
105314121|NCT02728843|363145970|FG003|Overall Study|Lack of Efficacy|0|||
105314122|NCT02728843|363145971|FG004|Overall Study|Lack of Efficacy|0|||
105314123|NCT02728843|363145967|FG000|Overall Study|Protocol Violation|2|||
105314124|NCT02728843|363145968|FG001|Overall Study|Protocol Violation|0|||
105314125|NCT02728843|363145969|FG002|Overall Study|Protocol Violation|4|||
105314126|NCT02728843|363145970|FG003|Overall Study|Protocol Violation|2|||
105314127|NCT02728843|363145971|FG004|Overall Study|Protocol Violation|2|||
105314128|NCT02728843|363145967|FG000|Overall Study|Withdrawal by Subject|1|||
105314129|NCT02728843|363145968|FG001|Overall Study|Withdrawal by Subject|0|||
105314130|NCT02728843|363145969|FG002|Overall Study|Withdrawal by Subject|0|||
105314131|NCT02728843|363145970|FG003|Overall Study|Withdrawal by Subject|1|||
105314132|NCT02728843|363145971|FG004|Overall Study|Withdrawal by Subject|0|||
105314133|NCT02728843|363145967|FG000|Overall Study|Use of rescue medication|0|||
105314134|NCT02728843|363145968|FG001|Overall Study|Use of rescue medication|2|||
105314135|NCT02728843|363145969|FG002|Overall Study|Use of rescue medication|0|||
105314136|NCT02728843|363145970|FG003|Overall Study|Use of rescue medication|2|||
105314137|NCT02728843|363145971|FG004|Overall Study|Use of rescue medication|1|||
105314138|NCT03371459|363145973|FG000|Washout|Lost to Follow-up|0|||
105314139|NCT03371459|363145974|FG001|Washout|Lost to Follow-up|1|||
105314140|NCT00351533|363145975|FG000|Overall Study|Extubated before first BAL|1|||
105314141|NCT00351533|363145976|FG001|Overall Study|Extubated before first BAL|0|||
105314142|NCT00351533|363145975|FG000|Overall Study|Lost to Follow-up|1|||
105314143|NCT00351533|363145976|FG001|Overall Study|Lost to Follow-up|3|||
105314144|NCT00351533|363145975|FG000|Overall Study|Physician Decision|0|||
105368279|NCT03327324|363354179|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105368280|NCT03327324|363354180|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
105368281|NCT03327324|363354181|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105368282|NCT03327324|363354182|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
105368283|NCT03327324|363354177|FG000|Baseline (Month 0-Month 3)|Refused|0|||
105368284|NCT03327324|363354178|FG001|Baseline (Month 0-Month 3)|Refused|0|||
105368285|NCT03327324|363354179|FG002|Baseline (Month 0-Month 3)|Refused|0|||
105368286|NCT03327324|363354180|FG003|Baseline (Month 0-Month 3)|Refused|0|||
105368287|NCT03327324|363354181|FG004|Baseline (Month 0-Month 3)|Refused|1|||
105368288|NCT03327324|363354182|FG005|Baseline (Month 0-Month 3)|Refused|0|||
105368289|NCT03327324|363354177|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
105368290|NCT03327324|363354178|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
105368291|NCT03327324|363354179|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
105368292|NCT03327324|363354180|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
105368293|NCT03327324|363354181|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
105368294|NCT03327324|363354182|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
105368295|NCT03327324|363354177|FG000|Baseline (Month 0-Month 3)|Death|0|||
105368296|NCT03327324|363354178|FG001|Baseline (Month 0-Month 3)|Death|0|||
105368297|NCT03327324|363354179|FG002|Baseline (Month 0-Month 3)|Death|0|||
105368298|NCT03327324|363354180|FG003|Baseline (Month 0-Month 3)|Death|0|||
105368299|NCT03327324|363354181|FG004|Baseline (Month 0-Month 3)|Death|1|||
105368300|NCT03327324|363354182|FG005|Baseline (Month 0-Month 3)|Death|0|||
105368301|NCT03327324|363354177|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105368302|NCT03327324|363354178|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105368303|NCT03327324|363354179|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105368304|NCT03327324|363354180|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105368305|NCT03327324|363354181|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105368306|NCT03327324|363354182|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
105368307|NCT03327324|363354177|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105368308|NCT03327324|363354178|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105368309|NCT03327324|363354179|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
105368310|NCT03327324|363354180|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105368311|NCT03327324|363354181|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105368312|NCT03327324|363354182|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105368313|NCT03327324|363354177|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
105368314|NCT03327324|363354178|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
105368315|NCT03327324|363354179|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
105368316|NCT03327324|363354180|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
105368317|NCT03327324|363354181|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
105368318|NCT03327324|363354182|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
105368319|NCT03327324|363354177|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
105368320|NCT03327324|363354178|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
105368321|NCT03327324|363354179|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
105368322|NCT03327324|363354180|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
105368323|NCT03327324|363354181|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
105368324|NCT03327324|363354182|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
105368325|NCT03327324|363354177|FG000|Intervention (Month 3-Month 6)|Death|1|||
105368326|NCT03327324|363354178|FG001|Intervention (Month 3-Month 6)|Death|0|||
105368327|NCT03327324|363354179|FG002|Intervention (Month 3-Month 6)|Death|1|||
105368328|NCT03327324|363354180|FG003|Intervention (Month 3-Month 6)|Death|1|||
105368329|NCT03327324|363354181|FG004|Intervention (Month 3-Month 6)|Death|1|||
105368330|NCT03327324|363354182|FG005|Intervention (Month 3-Month 6)|Death|0|||
105368331|NCT03327324|363354177|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105368332|NCT03327324|363354178|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105440077|NCT05362058|363616699|FG001|Follow-Up Period|Lost to Follow-up|1|||
105576560|NCT00451217|364110204|FG000|Overall Study|Not Treated|1|||
105576561|NCT00451217|364110205|FG001|Overall Study|Not Treated|1|||
105576562|NCT00451217|364110206|FG002|Overall Study|Not Treated|3|||
105576563|NCT00451217|364110207|FG003|Overall Study|Not Treated|4|||
105576564|NCT00358150|364110210|FG000|Overall Study|Adverse Event|3|||
105576565|NCT00358150|364110210|FG000|Overall Study|Withdrawal by Subject|1|||
105842354|NCT02224573|365080723|FG001|Treatment Phase|Participant Moved|0|||
105842355|NCT02224573|365080722|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
105842356|NCT02224573|365080723|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
105842357|NCT02224573|365080722|FG000|Treatment Phase|Refused Medication|1|||
105842358|NCT02224573|365080723|FG001|Treatment Phase|Refused Medication|1|||
105842359|NCT02224573|365080722|FG000|Treatment Phase|Adverse Event|26|||
105842360|NCT02224573|365080723|FG001|Treatment Phase|Adverse Event|38|||
105842361|NCT02224573|365080722|FG000|Treatment Phase|Placed in Group Home|0|||
105842362|NCT02224573|365080723|FG001|Treatment Phase|Placed in Group Home|1|||
105842363|NCT02224573|365080722|FG000|Treatment Phase|Pursued Other Trials|1|||
105842364|NCT02224573|365080723|FG001|Treatment Phase|Pursued Other Trials|0|||
105842365|NCT02224573|365080722|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
105842366|NCT02224573|365080723|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
105842367|NCT02224573|365080722|FG000|Treatment Phase|Lost to Follow-up|2|||
105842368|NCT02224573|365080723|FG001|Treatment Phase|Lost to Follow-up|1|||
105842369|NCT02224573|365080722|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
105842370|NCT02224573|365080723|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
105842371|NCT02224573|365080722|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
105842372|NCT02224573|365080723|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
105842373|NCT02224573|365080722|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
105842374|NCT02224573|365080723|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
105842375|NCT02224573|365080722|FG000|Taper Phase|Adverse Event|1|||
105314145|NCT00351533|363145976|FG001|Overall Study|Physician Decision|1|||
105314146|NCT00351533|363145975|FG000|Overall Study|Withdrawal by Subject|0|||
105314147|NCT00351533|363145976|FG001|Overall Study|Withdrawal by Subject|1|||
105314148|NCT01589497|363145978|FG000|Overall Study|Withdrawal by Subject|0|||
105314149|NCT01589497|363145979|FG001|Overall Study|Withdrawal by Subject|1|||
105842376|NCT02224573|365080723|FG001|Taper Phase|Adverse Event|1|||
105842377|NCT01138826|365080724|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
105842378|NCT01138826|365080725|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
105842379|NCT01138826|365080726|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
105842380|NCT01138826|365080727|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
105842381|NCT01138826|365080728|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
105842382|NCT01138826|365080729|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
105842383|NCT01333072|365080730|FG000|Overall Study|Lost to Follow-up|3|||
105842384|NCT01333072|365080731|FG001|Overall Study|Lost to Follow-up|0|||
105842385|NCT01333072|365080730|FG000|Overall Study|Adverse Event|2|||
105842386|NCT01333072|365080731|FG001|Overall Study|Adverse Event|4|||
105842387|NCT01333072|365080730|FG000|Overall Study|Physician Decision|1|||
105842388|NCT01333072|365080731|FG001|Overall Study|Physician Decision|0|||
105314150|NCT01589497|363145980|FG002|Overall Study|Withdrawal by Subject|0|||
105314151|NCT01589497|363145981|FG003|Overall Study|Withdrawal by Subject|1|||
105314152|NCT01589497|363145978|FG000|Overall Study|Death|1|||
105314153|NCT01589497|363145979|FG001|Overall Study|Death|0|||
105314154|NCT01589497|363145980|FG002|Overall Study|Death|0|||
105314155|NCT01589497|363145981|FG003|Overall Study|Death|0|||
105314156|NCT01589497|363145978|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
105314157|NCT01589497|363145979|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
105314158|NCT01589497|363145980|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
105314159|NCT01589497|363145981|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
105314160|NCT02092467|363145990|FG000|Overall Study|Death|49|||
105314161|NCT02092467|363145991|FG001|Overall Study|Death|66|||
105314162|NCT02092467|363145992|FG002|Overall Study|Death|38|||
105314163|NCT02092467|363145990|FG000|Overall Study|Lost to Follow-up|38|||
105314164|NCT02092467|363145991|FG001|Overall Study|Lost to Follow-up|35|||
105314165|NCT02092467|363145992|FG002|Overall Study|Lost to Follow-up|40|||
105314166|NCT02092467|363145990|FG000|Overall Study|Global Deterioration of Health Status|1|||
105314167|NCT02092467|363145991|FG001|Overall Study|Global Deterioration of Health Status|0|||
105314168|NCT02092467|363145992|FG002|Overall Study|Global Deterioration of Health Status|0|||
105314169|NCT02092467|363145990|FG000|Overall Study|Other|32|||
105314170|NCT02092467|363145991|FG001|Overall Study|Other|30|||
105314171|NCT02092467|363145992|FG002|Overall Study|Other|24|||
105314172|NCT02092467|363145990|FG000|Overall Study|Withdrawal by Subject|282|||
105314173|NCT02092467|363145991|FG001|Overall Study|Withdrawal by Subject|327|||
105314174|NCT02092467|363145992|FG002|Overall Study|Withdrawal by Subject|289|||
105842389|NCT03451006|365080735|FG000|Overall Study|Withdrawal by Subject|2|||
105842390|NCT03451006|365080736|FG001|Overall Study|Withdrawal by Subject|2|||
105842391|NCT00949988|365080737|FG000|Overall Study|Withdrawal by Subject|3|||
105842392|NCT03649412|365080738|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
105842393|NCT03649412|365080739|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
105842394|NCT03649412|365080738|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
105842395|NCT03649412|365080739|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
105842396|NCT03649412|365080738|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
105314175|NCT02092467|363145990|FG000|Overall Study|Randomized but not treated|2|||
105314176|NCT02092467|363145991|FG001|Overall Study|Randomized but not treated|1|||
105314177|NCT02092467|363145992|FG002|Overall Study|Randomized but not treated|7|||
105314178|NCT01680497|363145993|FG000|Overall Study|Lost to Follow-up|2|||
105314179|NCT04844762|363145998|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105314180|NCT04844762|363145999|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105314181|NCT04844762|363146000|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
105314182|NCT04844762|363146001|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105842397|NCT03649412|365080739|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105842398|NCT03649412|365080738|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
105842399|NCT03649412|365080739|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
105842400|NCT03649412|365080738|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
105842401|NCT03649412|365080739|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
105842402|NCT03649412|365080738|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
105842403|NCT03649412|365080739|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
105842404|NCT00865514|365080740|FG000|Overall Study|Infusion cost exceeded funding|2|||
105842405|NCT04668274|365080741|FG000|Part 1 Study Period 1|Adverse Event|3|||
105842406|NCT04668274|365080742|FG001|Part 1 Study Period 1|Adverse Event|0|||
105842407|NCT04668274|365080743|FG002|Part 1 Study Period 1|Adverse Event|0|||
105842408|NCT04668274|365080744|FG003|Part 1 Study Period 1|Adverse Event|0|||
105842409|NCT04668274|365080741|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
105842410|NCT04668274|365080742|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
105842411|NCT04668274|365080743|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
105842412|NCT04668274|365080744|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
105842413|NCT04668274|365080741|FG000|Part 1 Study Period 2|Other|0|||
105842414|NCT04668274|365080742|FG001|Part 1 Study Period 2|Other|1|||
105842415|NCT04668274|365080743|FG002|Part 1 Study Period 2|Other|0|||
105842416|NCT04668274|365080744|FG003|Part 1 Study Period 2|Other|0|||
105842417|NCT04668274|365080741|FG000|Part 1 Study Period 3|Adverse Event|0|||
105842418|NCT04668274|365080742|FG001|Part 1 Study Period 3|Adverse Event|0|||
105842419|NCT04668274|365080743|FG002|Part 1 Study Period 3|Adverse Event|1|||
105842420|NCT04668274|365080744|FG003|Part 1 Study Period 3|Adverse Event|0|||
105842421|NCT04668274|365080741|FG000|Part 1 Study Period 3|Other|0|||
105842422|NCT04668274|365080742|FG001|Part 1 Study Period 3|Other|0|||
105842423|NCT04668274|365080743|FG002|Part 1 Study Period 3|Other|2|||
105842424|NCT04668274|365080744|FG003|Part 1 Study Period 3|Other|0|||
105842425|NCT04668274|365080741|FG000|Part 2 Study Period 4|Other|0|||
105842426|NCT04668274|365080742|FG001|Part 2 Study Period 4|Other|0|||
105842427|NCT04668274|365080743|FG002|Part 2 Study Period 4|Other|0|||
105842428|NCT04668274|365080744|FG003|Part 2 Study Period 4|Other|1|||
105842429|NCT02408120|365080747|FG000|Overall Study|Withdrawal by Subject|0|||
105842430|NCT02408120|365080748|FG001|Overall Study|Withdrawal by Subject|1|||
105842431|NCT02408120|365080747|FG000|Overall Study|Treatment Refusal|1|||
105842432|NCT02408120|365080748|FG001|Overall Study|Treatment Refusal|0|||
105842433|NCT02408120|365080747|FG000|Overall Study|Received Steroids|1|||
105842434|NCT02408120|365080748|FG001|Overall Study|Received Steroids|1|||
105842435|NCT02408120|365080747|FG000|Overall Study|Discharged same day|1|||
105842436|NCT02408120|365080748|FG001|Overall Study|Discharged same day|1|||
105842437|NCT02408120|365080747|FG000|Overall Study|Did not receive insulin|1|||
105842438|NCT02408120|365080748|FG001|Overall Study|Did not receive insulin|2|||
105842439|NCT00351351|365080749|FG000|Overall Study|surgical access pbs; device issues|9|||
105842440|NCT00351351|365080750|FG001|Overall Study|surgical access pbs; device issues|4|||
105842441|NCT01341587|365080751|FG000|Overall Study|Lost to Follow-up|2|||
105842442|NCT01341587|365080752|FG001|Overall Study|Lost to Follow-up|0|||
105842443|NCT01341587|365080751|FG000|Overall Study|stopped using the meters|2|||
105842444|NCT01341587|365080752|FG001|Overall Study|stopped using the meters|10|||
105842445|NCT00939627|365080757|FG000|Overall Study|Disease Progression|16|||
105842446|NCT00939627|365080758|FG001|Overall Study|Disease Progression|12|||
105842447|NCT00939627|365080759|FG002|Overall Study|Disease Progression|0|||
105842448|NCT00939627|365080757|FG000|Overall Study|Adverse Event|6|||
105842449|NCT00939627|365080758|FG001|Overall Study|Adverse Event|7|||
105842450|NCT00939627|365080759|FG002|Overall Study|Adverse Event|0|||
105842451|NCT00939627|365080757|FG000|Overall Study|Death|0|||
105842452|NCT00939627|365080758|FG001|Overall Study|Death|2|||
105842453|NCT00939627|365080759|FG002|Overall Study|Death|0|||
105842454|NCT00939627|365080757|FG000|Overall Study|Withdrawal by Subject|2|||
105842455|NCT00939627|365080758|FG001|Overall Study|Withdrawal by Subject|4|||
105842456|NCT00939627|365080759|FG002|Overall Study|Withdrawal by Subject|0|||
105576566|NCT00358150|364110210|FG000|Overall Study|Undefined|3|||
105842457|NCT00939627|365080757|FG000|Overall Study|Other complicating disease|1|||
105842458|NCT00939627|365080758|FG001|Overall Study|Other complicating disease|1|||
105842459|NCT00939627|365080759|FG002|Overall Study|Other complicating disease|0|||
105842460|NCT00939627|365080757|FG000|Overall Study|Not compliant|2|||
105842461|NCT00939627|365080758|FG001|Overall Study|Not compliant|0|||
105842462|NCT00939627|365080759|FG002|Overall Study|Not compliant|0|||
105842463|NCT00939627|365080757|FG000|Overall Study|No off-tx reason given|0|||
105842464|NCT00939627|365080758|FG001|Overall Study|No off-tx reason given|2|||
105842465|NCT00939627|365080759|FG002|Overall Study|No off-tx reason given|0|||
105576567|NCT01622348|364110215|FG000|Overall Study|Withdrawal by Subject|1|||
105314183|NCT04844762|363146002|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105314184|NCT04844762|363146003|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105314185|NCT04844762|363145998|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
105314186|NCT04844762|363145999|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
105314187|NCT04844762|363146000|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
105314188|NCT04844762|363146001|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
105314189|NCT04844762|363146002|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
105314190|NCT04844762|363146003|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
105314191|NCT04844762|363145998|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105314192|NCT04844762|363145999|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105314193|NCT04844762|363146000|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
105314194|NCT04844762|363146001|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
105314195|NCT04844762|363146002|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105314196|NCT04844762|363146003|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
105314197|NCT04844762|363145998|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105314198|NCT04844762|363145999|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105314199|NCT04844762|363146000|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
105314200|NCT04844762|363146001|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
105314201|NCT04844762|363146002|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
105314202|NCT04844762|363146003|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105314203|NCT04844762|363145998|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
105314204|NCT04844762|363145999|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
105314205|NCT04844762|363146000|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105314206|NCT04844762|363146001|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105314207|NCT04844762|363146002|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105314208|NCT04844762|363146003|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105314209|NCT04844762|363145998|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
105314210|NCT04844762|363145999|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105314211|NCT04844762|363146000|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105314212|NCT04844762|363146001|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105314213|NCT04844762|363146002|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105314214|NCT04844762|363146003|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105314215|NCT04844762|363145998|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105314216|NCT04844762|363145999|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105314217|NCT04844762|363146000|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105314218|NCT04844762|363146001|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105314219|NCT04844762|363146002|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
105314220|NCT04844762|363146003|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105314221|NCT04844762|363145998|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
105314222|NCT04844762|363145999|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105314223|NCT04844762|363146000|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105314224|NCT04844762|363146001|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105314225|NCT04844762|363146002|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105576568|NCT01622348|364110216|FG001|Overall Study|Withdrawal by Subject|0|||
105842466|NCT00124462|365080760|FG000|Overall Study|Lost to Follow-up|3|||
105842467|NCT00124462|365080761|FG001|Overall Study|Lost to Follow-up|3|||
105842468|NCT00124462|365080760|FG000|Overall Study|Physician Decision|3|||
105842469|NCT00124462|365080761|FG001|Overall Study|Physician Decision|4|||
105842470|NCT00124462|365080760|FG000|Overall Study|Withdrawal by Subject|4|||
105842471|NCT00124462|365080761|FG001|Overall Study|Withdrawal by Subject|5|||
105842472|NCT00124462|365080760|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
105842473|NCT00124462|365080761|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
105842474|NCT01832402|365080766|FG000|Overall Study|Lost to Follow-up|2|||
105842475|NCT01832402|365080767|FG001|Overall Study|Lost to Follow-up|0|||
105842476|NCT01832402|365080766|FG000|Overall Study|Withdrawal by Subject|3|||
105842477|NCT01832402|365080767|FG001|Overall Study|Withdrawal by Subject|3|||
105842478|NCT01832402|365080766|FG000|Overall Study|Declining Performance status|2|||
105842479|NCT01832402|365080767|FG001|Overall Study|Declining Performance status|1|||
105842480|NCT00860743|365080768|FG000|Overall Study|Withdrawal by Subject|3|||
105842481|NCT00860743|365080769|FG001|Overall Study|Withdrawal by Subject|0|||
105842482|NCT01682148|365080770|FG000|Overall Study|Withdrawal by Subject|2|||
105842483|NCT01682148|365080771|FG001|Overall Study|Withdrawal by Subject|0|||
105314226|NCT04844762|363146003|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105842484|NCT01682148|365080770|FG000|Overall Study|Lost to Follow-up|1|||
105842485|NCT01682148|365080771|FG001|Overall Study|Lost to Follow-up|2|||
105842486|NCT01682148|365080770|FG000|Overall Study|Protocol Violation|1|||
105842487|NCT01682148|365080771|FG001|Overall Study|Protocol Violation|1|||
105842488|NCT02087176|365080772|FG000|Overall Study|Withdrawal by Subject|1|||
105842489|NCT02087176|365080772|FG000|Overall Study|Death|10|||
105842490|NCT02087176|365080772|FG000|Overall Study|Censored|19|||
105842491|NCT02087176|365080772|FG000|Overall Study|Study Terminated by Sponsor|2|||
105842492|NCT00873119|365080773|FG000|Overall Study|Patient request|4|||
105842493|NCT00873119|365080774|FG001|Overall Study|Patient request|2|||
105842494|NCT00873119|365080773|FG000|Overall Study|Adverse Event|8|||
105842495|NCT00873119|365080774|FG001|Overall Study|Adverse Event|0|||
105842496|NCT00873119|365080773|FG000|Overall Study|Progressive disease|26|||
105842497|NCT00873119|365080774|FG001|Overall Study|Progressive disease|18|||
105842498|NCT00873119|365080773|FG000|Overall Study|Death|2|||
105842499|NCT00873119|365080774|FG001|Overall Study|Death|1|||
105842500|NCT00873119|365080773|FG000|Overall Study|Other|2|||
105842501|NCT00873119|365080774|FG001|Overall Study|Other|5|||
105842502|NCT00873119|365080773|FG000|Overall Study|Not treated|2|||
105842503|NCT00873119|365080774|FG001|Overall Study|Not treated|0|||
105842504|NCT03648879|365080775|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
105842505|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
105842506|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
105842507|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
105842508|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
105842509|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
105842510|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
105842511|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
105842512|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
105842513|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
105842514|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
105842515|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
105842516|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
105842517|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
105842518|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
105842519|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
105842520|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
105842521|NCT04740931|365080776|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
105842522|NCT04740931|365080777|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
105842523|NCT04740931|365080776|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
105842524|NCT04740931|365080777|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
105842525|NCT04740931|365080776|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
105842526|NCT04740931|365080777|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
105842527|NCT04740931|365080776|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
105842528|NCT04740931|365080777|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
105842529|NCT04740931|365080776|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
105842530|NCT04740931|365080777|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
105842531|NCT04740931|365080776|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
105842532|NCT04740931|365080777|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
105842533|NCT04740931|365080776|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
105842534|NCT04740931|365080777|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
105842535|NCT00958126|365080783|FG000|Overall Study|Serious Adverse Event|0|||
105842536|NCT00958126|365080784|FG001|Overall Study|Serious Adverse Event|2|||
105842537|NCT00958126|365080785|FG002|Overall Study|Serious Adverse Event|0|||
105842538|NCT00958126|365080786|FG003|Overall Study|Serious Adverse Event|0|||
105842539|NCT00958126|365080787|FG004|Overall Study|Serious Adverse Event|0|||
105842540|NCT00958126|365080788|FG005|Overall Study|Serious Adverse Event|0|||
105842541|NCT00958126|365080789|FG006|Overall Study|Serious Adverse Event|1|||
105842542|NCT00958126|365080790|FG007|Overall Study|Serious Adverse Event|0|||
105842543|NCT00958126|365080783|FG000|Overall Study|Withdrawal by Subject|0|||
105842544|NCT00958126|365080784|FG001|Overall Study|Withdrawal by Subject|2|||
105842545|NCT00958126|365080785|FG002|Overall Study|Withdrawal by Subject|0|||
105314227|NCT04844762|363145998|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
105314228|NCT04844762|363145999|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105314229|NCT04844762|363146000|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105314230|NCT04844762|363146001|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105314231|NCT04844762|363146002|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105314232|NCT04844762|363146003|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
105314233|NCT04844762|363145998|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
105314234|NCT04844762|363145999|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
105314235|NCT04844762|363146000|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
105314236|NCT04844762|363146001|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
105314237|NCT04844762|363146002|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
105439861|NCT05066165|363616623|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
105842546|NCT00958126|365080786|FG003|Overall Study|Withdrawal by Subject|0|||
105842547|NCT00958126|365080787|FG004|Overall Study|Withdrawal by Subject|0|||
105490046|NCT02452697|363805728|FG003|Overall Study|Withdrawal by Subject|0|||
105490047|NCT02452697|363805725|FG000|Overall Study|still in follow-up|2|||
105490048|NCT02452697|363805726|FG001|Overall Study|still in follow-up|2|||
105490049|NCT02452697|363805727|FG002|Overall Study|still in follow-up|1|||
105490050|NCT02452697|363805728|FG003|Overall Study|still in follow-up|3|||
105842548|NCT00958126|365080788|FG005|Overall Study|Withdrawal by Subject|0|||
105842549|NCT00958126|365080789|FG006|Overall Study|Withdrawal by Subject|0|||
105842550|NCT00958126|365080790|FG007|Overall Study|Withdrawal by Subject|0|||
105842551|NCT00958126|365080783|FG000|Overall Study|Moved away from study area|0|||
105842552|NCT00958126|365080784|FG001|Overall Study|Moved away from study area|0|||
105842553|NCT00958126|365080785|FG002|Overall Study|Moved away from study area|1|||
105842554|NCT00958126|365080786|FG003|Overall Study|Moved away from study area|1|||
105842555|NCT00958126|365080787|FG004|Overall Study|Moved away from study area|0|||
105842556|NCT00958126|365080788|FG005|Overall Study|Moved away from study area|0|||
105842557|NCT00958126|365080789|FG006|Overall Study|Moved away from study area|0|||
105842558|NCT00958126|365080790|FG007|Overall Study|Moved away from study area|0|||
105842559|NCT00958126|365080783|FG000|Overall Study|Lost to Follow-up|1|||
105842560|NCT00958126|365080784|FG001|Overall Study|Lost to Follow-up|5|||
105842561|NCT00958126|365080785|FG002|Overall Study|Lost to Follow-up|9|||
105842562|NCT00958126|365080786|FG003|Overall Study|Lost to Follow-up|8|||
105842563|NCT00958126|365080787|FG004|Overall Study|Lost to Follow-up|0|||
105842564|NCT00958126|365080788|FG005|Overall Study|Lost to Follow-up|0|||
105842565|NCT00958126|365080789|FG006|Overall Study|Lost to Follow-up|0|||
105842566|NCT00958126|365080790|FG007|Overall Study|Lost to Follow-up|0|||
105842567|NCT00958126|365080783|FG000|Overall Study|Sponsor/Investigator decision|0|||
105842568|NCT00958126|365080784|FG001|Overall Study|Sponsor/Investigator decision|0|||
105842569|NCT00958126|365080785|FG002|Overall Study|Sponsor/Investigator decision|0|||
105842570|NCT00958126|365080786|FG003|Overall Study|Sponsor/Investigator decision|1|||
105842571|NCT00958126|365080787|FG004|Overall Study|Sponsor/Investigator decision|0|||
105842572|NCT00958126|365080788|FG005|Overall Study|Sponsor/Investigator decision|0|||
105842573|NCT00958126|365080789|FG006|Overall Study|Sponsor/Investigator decision|0|||
105842574|NCT00958126|365080790|FG007|Overall Study|Sponsor/Investigator decision|0|||
105842575|NCT00958126|365080783|FG000|Overall Study|Other Reason|0|||
105842576|NCT00958126|365080784|FG001|Overall Study|Other Reason|0|||
105842577|NCT00958126|365080785|FG002|Overall Study|Other Reason|0|||
105842578|NCT00958126|365080786|FG003|Overall Study|Other Reason|1|||
105842579|NCT00958126|365080787|FG004|Overall Study|Other Reason|0|||
105842580|NCT00958126|365080788|FG005|Overall Study|Other Reason|1|||
105842581|NCT00958126|365080789|FG006|Overall Study|Other Reason|0|||
105842582|NCT00958126|365080790|FG007|Overall Study|Other Reason|0|||
105842583|NCT01506908|365080791|FG000|Overall Study|Adverse Event|1|||
105842584|NCT01506908|365080792|FG001|Overall Study|Adverse Event|0|||
105842585|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
105842586|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
105842587|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
105842588|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
105842589|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
105842590|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
105842591|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
105842592|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
105842593|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
105842594|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
105842595|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
105842596|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
105842597|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
105842598|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
105842599|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
105842600|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
105842601|NCT02510014|365080793|FG000|Treatment Period|Adverse Event|11|||
105842602|NCT02510014|365080794|FG001|Treatment Period|Adverse Event|4|||
105490051|NCT01709578|363807445|FG000|Overall Study|Rescued and entered in long term safety|63|||
105842603|NCT02510014|365080793|FG000|Treatment Period|Withdrawal symptoms|3|||
105842604|NCT02510014|365080794|FG001|Treatment Period|Withdrawal symptoms|0|||
105490052|NCT01709578|363807446|FG001|Overall Study|Rescued and entered in long term safety|25|||
105842605|NCT02510014|365080793|FG000|Treatment Period|Lost to Follow-up|80|||
105842606|NCT02510014|365080794|FG001|Treatment Period|Lost to Follow-up|19|||
105842607|NCT02510014|365080793|FG000|Treatment Period|Physician Decision|5|||
105842608|NCT02510014|365080794|FG001|Treatment Period|Physician Decision|0|||
105842609|NCT02510014|365080793|FG000|Treatment Period|Withdrawal by Subject|67|||
105842610|NCT02510014|365080794|FG001|Treatment Period|Withdrawal by Subject|24|||
105842611|NCT02510014|365080793|FG000|Treatment Period|Withdrawn by the investigator|7|||
105842612|NCT02510014|365080794|FG001|Treatment Period|Withdrawn by the investigator|1|||
105842613|NCT02510014|365080793|FG000|Treatment Period|Protocol Violation|4|||
105490053|NCT01709578|363807447|FG002|Overall Study|Rescued and entered in long term safety|26|||
105314238|NCT04844762|363146003|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
105314239|NCT04844762|363145998|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
105314240|NCT04844762|363145999|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
105314241|NCT04844762|363146000|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
105314242|NCT04844762|363146001|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
105314243|NCT04844762|363146002|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
105314244|NCT04844762|363146003|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
105314245|NCT02293863|363146005|FG000|Overall Study|Death|4|||
105314246|NCT02293863|363146006|FG001|Overall Study|Death|6|||
105314247|NCT02293863|363146007|FG002|Overall Study|Death|4|||
105314248|NCT02293863|363146005|FG000|Overall Study|Lost to Follow-up|2|||
105314249|NCT02293863|363146006|FG001|Overall Study|Lost to Follow-up|2|||
105314250|NCT02293863|363146007|FG002|Overall Study|Lost to Follow-up|2|||
105314251|NCT02293863|363146005|FG000|Overall Study|Withdrawal by Subject|3|||
105314252|NCT02293863|363146006|FG001|Overall Study|Withdrawal by Subject|3|||
105314253|NCT02293863|363146007|FG002|Overall Study|Withdrawal by Subject|1|||
105314254|NCT02293863|363146005|FG000|Overall Study|Reason Not Specified|0|||
105314255|NCT02293863|363146006|FG001|Overall Study|Reason Not Specified|2|||
105314256|NCT02293863|363146007|FG002|Overall Study|Reason Not Specified|2|||
105314257|NCT00174954|363146008|FG000|Overall Study|Adverse Event|2|||
105314258|NCT00174954|363146008|FG000|Overall Study|No tophi found in MRI|1|||
105314259|NCT00174954|363146008|FG000|Overall Study|Physician Decision|1|||
105314260|NCT02185053|363146009|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
105314261|NCT02185053|363146010|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
105314262|NCT02185053|363146011|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
105314263|NCT02185053|363146009|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
105314264|NCT02185053|363146010|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
105314265|NCT02185053|363146011|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
105314266|NCT02185053|363146009|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
105314267|NCT02185053|363146010|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
105314268|NCT02185053|363146011|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
105314269|NCT02185053|363146009|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
105314270|NCT02185053|363146010|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
105314271|NCT02185053|363146011|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
105314272|NCT02185053|363146009|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
105314273|NCT02185053|363146010|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
105314274|NCT02185053|363146011|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
105314275|NCT02185053|363146009|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
105314276|NCT02185053|363146010|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
105314277|NCT02185053|363146011|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
105314278|NCT02185053|363146009|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
105314279|NCT02185053|363146010|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
105314280|NCT02185053|363146011|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
105314281|NCT02185053|363146009|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
105314282|NCT02185053|363146010|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
105314283|NCT02185053|363146011|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
105314284|NCT04123561|363146013|FG000|Overall Study|Lost to Follow-up|20|||
105314285|NCT04123561|363146014|FG001|Overall Study|Lost to Follow-up|12|||
105490054|NCT01709578|363807445|FG000|Overall Study|Adverse Event|9|||
105490055|NCT01709578|363807446|FG001|Overall Study|Adverse Event|18|||
105314286|NCT04123561|363146015|FG002|Overall Study|Lost to Follow-up|5|||
105314287|NCT04123561|363146013|FG000|Overall Study|Withdrawal by Subject|9|||
105314288|NCT04123561|363146014|FG001|Overall Study|Withdrawal by Subject|7|||
105314289|NCT04123561|363146015|FG002|Overall Study|Withdrawal by Subject|9|||
105314290|NCT04123561|363146013|FG000|Overall Study|Lack of Efficacy|7|||
105314291|NCT04123561|363146014|FG001|Overall Study|Lack of Efficacy|8|||
105314292|NCT04123561|363146015|FG002|Overall Study|Lack of Efficacy|6|||
105314293|NCT04123561|363146013|FG000|Overall Study|Adverse Event|5|||
105314294|NCT04123561|363146014|FG001|Overall Study|Adverse Event|2|||
105314295|NCT04123561|363146015|FG002|Overall Study|Adverse Event|3|||
105368333|NCT03327324|363354179|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105490056|NCT01709578|363807447|FG002|Overall Study|Adverse Event|17|||
105490057|NCT01709578|363807445|FG000|Overall Study|Lack of Efficacy|5|||
105490058|NCT01709578|363807446|FG001|Overall Study|Lack of Efficacy|4|||
105490059|NCT01709578|363807447|FG002|Overall Study|Lack of Efficacy|2|||
105314296|NCT04123561|363146013|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
105314297|NCT04123561|363146014|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
105314298|NCT04123561|363146015|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
105490060|NCT01709578|363807445|FG000|Overall Study|Poor compliance to protocol|1|||
105490061|NCT01709578|363807446|FG001|Overall Study|Poor compliance to protocol|2|||
105490062|NCT01709578|363807447|FG002|Overall Study|Poor compliance to protocol|1|||
105314299|NCT04123561|363146013|FG000|Overall Study|Death|0|||
105314300|NCT04123561|363146014|FG001|Overall Study|Death|0|||
105314301|NCT04123561|363146015|FG002|Overall Study|Death|1|||
105314302|NCT04123561|363146013|FG000|Overall Study|Protocol Violation|0|||
105314303|NCT04123561|363146014|FG001|Overall Study|Protocol Violation|1|||
105314304|NCT04123561|363146015|FG002|Overall Study|Protocol Violation|0|||
105314305|NCT02521376|363146020|FG000|Overall Study|Enrolled, But Not Treated|1|||
105314306|NCT02521376|363146021|FG001|Overall Study|Enrolled, But Not Treated|0|||
105314307|NCT02521376|363146022|FG002|Overall Study|Enrolled, But Not Treated|0|||
105314308|NCT02521376|363146023|FG003|Overall Study|Enrolled, But Not Treated|0|||
105314309|NCT02933255|363146026|FG000|Overall Study|Discontinued due to study closure.|1|||
105314310|NCT02933255|363146027|FG001|Overall Study|Discontinued due to study closure.|0|||
105314311|NCT00451178|363146028|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
105314312|NCT00451178|363146029|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
105314313|NCT00451178|363146028|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
105314314|NCT00451178|363146029|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
105314315|NCT00451178|363146028|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
105314316|NCT00451178|363146029|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
105314317|NCT00451178|363146028|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
105314318|NCT00451178|363146029|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
105842614|NCT02510014|365080794|FG001|Treatment Period|Protocol Violation|4|||
105842615|NCT02510014|365080793|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
105842616|NCT02510014|365080794|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
105842617|NCT01949116|365080806|FG000|Overall Study|Death|2|||
105842618|NCT01949116|365080807|FG001|Overall Study|Death|0|||
105842619|NCT01949116|365080806|FG000|Overall Study|Lost to Follow-up|1|||
105842620|NCT01949116|365080807|FG001|Overall Study|Lost to Follow-up|3|||
105842621|NCT01949116|365080806|FG000|Overall Study|Withdrawal by Subject|5|||
105842622|NCT01949116|365080807|FG001|Overall Study|Withdrawal by Subject|3|||
105842623|NCT03407118|365080808|FG000|Period 2|Withdrawal by Subject|1|||
105842624|NCT03407118|365080809|FG001|Period 2|Withdrawal by Subject|0|||
105842625|NCT01855048|365080812|FG000|Overall Study|Withdrawal by Subject|0|||
105842626|NCT01855048|365080813|FG001|Overall Study|Withdrawal by Subject|1|||
105842627|NCT01855048|365080814|FG002|Overall Study|Withdrawal by Subject|0|||
105842628|NCT01855048|365080815|FG003|Overall Study|Withdrawal by Subject|0|||
105842629|NCT01855048|365080816|FG004|Overall Study|Withdrawal by Subject|1|||
105842630|NCT01855048|365080817|FG005|Overall Study|Withdrawal by Subject|0|||
105842631|NCT00925301|365080818|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
105842632|NCT00925301|365080819|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
105842633|NCT00925301|365080820|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
105842634|NCT00925301|365080821|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
105842635|NCT00925301|365080818|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
105842636|NCT00925301|365080819|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
105842637|NCT00925301|365080820|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
105842638|NCT00925301|365080821|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
105842639|NCT00925301|365080818|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
105842640|NCT00925301|365080819|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
105842641|NCT00925301|365080820|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
105842642|NCT00925301|365080821|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
105842643|NCT00925301|365080818|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
105842644|NCT00925301|365080819|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
105842645|NCT00925301|365080820|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
105842646|NCT00925301|365080821|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
105842647|NCT00925301|365080818|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
105842648|NCT00925301|365080819|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
105842649|NCT00925301|365080820|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
105842650|NCT00925301|365080821|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
105842651|NCT00925301|365080818|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
105842652|NCT00925301|365080819|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
105842653|NCT00925301|365080820|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
105842654|NCT00925301|365080821|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
105842655|NCT00925301|365080818|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
105314319|NCT00451178|363146028|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
105314320|NCT00451178|363146029|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
105314321|NCT00451178|363146028|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
105314322|NCT00451178|363146029|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
105314323|NCT00451178|363146028|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
105314324|NCT00451178|363146029|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
105314325|NCT00451178|363146028|FG000|Prior to Maintenance Therapy|PD|2|||
105314326|NCT00451178|363146029|FG001|Prior to Maintenance Therapy|PD|0|||
105314327|NCT00451178|363146028|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
105368334|NCT03327324|363354180|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105368335|NCT03327324|363354181|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105368336|NCT03327324|363354182|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
105368337|NCT03327324|363354177|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
105368338|NCT03327324|363354178|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105368339|NCT03327324|363354179|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105368340|NCT03327324|363354180|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105314328|NCT00451178|363146029|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
105314329|NCT00451178|363146028|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
105314330|NCT00451178|363146029|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
105314331|NCT00451178|363146028|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
105314332|NCT00451178|363146029|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
105314333|NCT00451178|363146028|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
105314334|NCT00451178|363146029|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
105314335|NCT00451178|363146028|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
105314336|NCT00451178|363146029|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
105314337|NCT00451178|363146028|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
105314338|NCT00451178|363146029|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
105314339|NCT00451178|363146028|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
105314340|NCT00451178|363146029|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
105314341|NCT00912912|363146030|FG000|Overall Study|Withdrawal by Subject|1|||
105314342|NCT00912912|363146030|FG000|Overall Study|Disease Progression|3|||
105314343|NCT00761657|363148476|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
105314344|NCT00761657|363148477|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
105314345|NCT00761657|363148478|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
105314346|NCT00761657|363148479|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
105314347|NCT00761657|363148480|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
105314348|NCT00761657|363148481|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
105314349|NCT00761657|363148482|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
105314350|NCT00761657|363148483|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
105314351|NCT00761657|363148484|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
105314352|NCT00761657|363148476|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
105314353|NCT00761657|363148477|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
105314354|NCT00761657|363148478|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
105314355|NCT00761657|363148479|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
105314356|NCT00761657|363148480|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
105314357|NCT00761657|363148481|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
105314358|NCT00761657|363148482|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
105314359|NCT00761657|363148483|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
105314360|NCT00761657|363148484|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
105314361|NCT00761657|363148476|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
105314362|NCT00761657|363148477|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
105314363|NCT00761657|363148478|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
105314364|NCT00761657|363148479|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
105368341|NCT03327324|363354181|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105368342|NCT03327324|363354182|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105368343|NCT03327324|363354177|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
105368344|NCT03327324|363354178|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
105368345|NCT03327324|363354179|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
105368346|NCT03327324|363354180|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
105314365|NCT00761657|363148480|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
105314366|NCT00761657|363148481|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
105314367|NCT00761657|363148482|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
105314368|NCT00761657|363148483|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
105314369|NCT00761657|363148484|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
105314370|NCT00761657|363148476|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
105314371|NCT00761657|363148477|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
105314372|NCT00761657|363148478|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
105314373|NCT00761657|363148479|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
105314374|NCT00761657|363148480|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
105314375|NCT00761657|363148481|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
105314376|NCT00761657|363148482|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
105314377|NCT00761657|363148483|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
105314378|NCT00761657|363148484|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
105314379|NCT00478244|363148487|FG000|Overall Study|Did not receive transplant|1|||
105842656|NCT00925301|365080819|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
105842657|NCT00925301|365080820|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
105842658|NCT00925301|365080821|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
105842659|NCT00613834|365080822|FG000|Overall Study|Withdrawal by Subject|0|||
105842660|NCT00613834|365080823|FG001|Overall Study|Withdrawal by Subject|3|||
105842661|NCT05626803|365082391|FG000|Overall Study|Lost to Follow-up|0|||
105842662|NCT05626803|365082392|FG001|Overall Study|Lost to Follow-up|1|||
105842663|NCT05626803|365082393|FG002|Overall Study|Lost to Follow-up|0|||
105842664|NCT05626803|365082394|FG003|Overall Study|Lost to Follow-up|0|||
105842665|NCT01000610|365082397|FG000|Overall Study|Adverse Event|1|||
105842666|NCT01000610|365082397|FG000|Overall Study|Lost to Follow-up|4|||
105842667|NCT01000610|365082397|FG000|Overall Study|Treatment failure|1|||
105842668|NCT02631876|365082404|FG000|Overall Study|Death|96|||
105842669|NCT02631876|365082405|FG001|Overall Study|Death|50|||
105842670|NCT02631876|365082404|FG000|Overall Study|Investigator's discretion|1|||
105842671|NCT02631876|365082405|FG001|Overall Study|Investigator's discretion|0|||
105842672|NCT02631876|365082404|FG000|Overall Study|Lost to Follow-up|2|||
105842673|NCT02631876|365082405|FG001|Overall Study|Lost to Follow-up|0|||
105842674|NCT02631876|365082404|FG000|Overall Study|Withdrawal by Subject|16|||
105842675|NCT02631876|365082405|FG001|Overall Study|Withdrawal by Subject|9|||
105842676|NCT02631876|365082404|FG000|Overall Study|Other than specified|4|||
105842677|NCT02631876|365082405|FG001|Overall Study|Other than specified|4|||
105842678|NCT02658487|365082406|FG000|Overall Study|Death|2|||
105842679|NCT02658487|365082406|FG000|Overall Study|Disease progression|10|||
105842680|NCT02658487|365082406|FG000|Overall Study|Alternative therapy|1|||
105842681|NCT02658487|365082406|FG000|Overall Study|Adverse Event|1|||
105842682|NCT02658487|365082406|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
105842683|NCT02658487|365082406|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
105842684|NCT00784134|365082407|FG000|Overall Study|Lost to Follow-up|3|||
105842685|NCT00784134|365082408|FG001|Overall Study|Lost to Follow-up|6|||
105842686|NCT01408563|365082414|FG000|Overall Study|Ineligible after consent/ registration|2|||
105842687|NCT02516410|365082415|FG000|Overall Study|Adverse Event|0|||
105842688|NCT02516410|365082416|FG001|Overall Study|Adverse Event|1|||
105842689|NCT02516410|365082415|FG000|Overall Study|Withdrawal by Subject|0|||
105842690|NCT02516410|365082416|FG001|Overall Study|Withdrawal by Subject|1|||
105842691|NCT03250299|365082418|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
105842692|NCT03250299|365082419|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
105842693|NCT03250299|365082420|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
105842694|NCT03250299|365082421|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
105842695|NCT03250299|365082422|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
105842696|NCT03250299|365082418|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
105842697|NCT03250299|365082419|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
105842698|NCT03250299|365082420|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
105842699|NCT03250299|365082421|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
105842700|NCT03250299|365082422|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
105842701|NCT03250299|365082418|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
105842702|NCT03250299|365082419|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
105842703|NCT03250299|365082420|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
105842704|NCT03250299|365082421|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
105842705|NCT03250299|365082422|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
105842706|NCT03250299|365082418|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
105842707|NCT03250299|365082419|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
105842708|NCT03250299|365082420|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
105842709|NCT03250299|365082421|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
105842710|NCT03250299|365082422|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
105842711|NCT03346070|365082423|FG000|Overall Study|Death|0|||
105842712|NCT03346070|365082424|FG001|Overall Study|Death|0|||
105842713|NCT03346070|365082425|FG002|Overall Study|Death|0|||
105842714|NCT03346070|365082426|FG003|Overall Study|Death|0|||
105842715|NCT03346070|365082427|FG004|Overall Study|Death|1|||
105842716|NCT03346070|365082423|FG000|Overall Study|Lost to Follow-up|0|||
105842717|NCT03346070|365082424|FG001|Overall Study|Lost to Follow-up|1|||
105842718|NCT03346070|365082425|FG002|Overall Study|Lost to Follow-up|2|||
105842719|NCT03346070|365082426|FG003|Overall Study|Lost to Follow-up|0|||
105842720|NCT03346070|365082427|FG004|Overall Study|Lost to Follow-up|0|||
105842721|NCT03346070|365082423|FG000|Overall Study|Physician Decision|0|||
105842722|NCT03346070|365082424|FG001|Overall Study|Physician Decision|0|||
105314380|NCT02929056|363148492|FG000|Overall Study|Lost to Follow-up|0|||
105314381|NCT02929056|363148493|FG001|Overall Study|Lost to Follow-up|1|||
105842723|NCT03346070|365082425|FG002|Overall Study|Physician Decision|0|||
105842724|NCT03346070|365082426|FG003|Overall Study|Physician Decision|1|||
105842725|NCT03346070|365082427|FG004|Overall Study|Physician Decision|1|||
105314382|NCT02245412|363148494|FG000|Treatment Period|Death|1|||
105842726|NCT03346070|365082423|FG000|Overall Study|Withdrawal by Subject|1|||
105842727|NCT03346070|365082424|FG001|Overall Study|Withdrawal by Subject|0|||
105842728|NCT03346070|365082425|FG002|Overall Study|Withdrawal by Subject|0|||
105842729|NCT03346070|365082426|FG003|Overall Study|Withdrawal by Subject|1|||
105368347|NCT03327324|363354181|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
105368348|NCT03327324|363354182|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
105368349|NCT03327324|363354177|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
105368350|NCT03327324|363354178|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
105368351|NCT03327324|363354179|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
105368352|NCT03327324|363354180|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
105368353|NCT03327324|363354181|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
105368354|NCT03327324|363354182|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
105368355|NCT03327324|363354177|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105368356|NCT03327324|363354178|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105368357|NCT03327324|363354179|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105368358|NCT03327324|363354180|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
105368359|NCT03327324|363354181|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
105368360|NCT03327324|363354182|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105368361|NCT03327324|363354177|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
105368362|NCT03327324|363354178|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
105368363|NCT03327324|363354179|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
105368364|NCT03327324|363354180|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
105368365|NCT03327324|363354181|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
105368366|NCT03327324|363354182|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
105368367|NCT03327324|363354177|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
105368368|NCT03327324|363354178|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
105368369|NCT03327324|363354179|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
105368370|NCT03327324|363354180|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
105368371|NCT03327324|363354181|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
105368372|NCT03327324|363354182|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
105368373|NCT01103323|363354183|FG000|Without/Before Drug Switch|Adverse Event|50|||
105368374|NCT01103323|363354184|FG001|Without/Before Drug Switch|Adverse Event|7|||
105368375|NCT01103323|363354183|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
105368376|NCT01103323|363354184|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
105368377|NCT01103323|363354183|FG000|Without/Before Drug Switch|Protocol Violation|2|||
105368378|NCT01103323|363354184|FG001|Without/Before Drug Switch|Protocol Violation|0|||
105368379|NCT01103323|363354183|FG000|Without/Before Drug Switch|Physician Decision|2|||
105368380|NCT01103323|363354184|FG001|Without/Before Drug Switch|Physician Decision|0|||
105314383|NCT02245412|363148495|FG001|Treatment Period|Death|1|||
105314384|NCT02245412|363148496|FG002|Treatment Period|Death|0|||
105314385|NCT02245412|363148494|FG000|Treatment Period|Physician Decision|1|||
105314386|NCT02245412|363148495|FG001|Treatment Period|Physician Decision|1|||
105314387|NCT02245412|363148496|FG002|Treatment Period|Physician Decision|0|||
105314388|NCT02245412|363148494|FG000|Treatment Period|Withdrawal by Subject|2|||
105314389|NCT02245412|363148495|FG001|Treatment Period|Withdrawal by Subject|1|||
105314390|NCT02245412|363148496|FG002|Treatment Period|Withdrawal by Subject|0|||
105314391|NCT02245412|363148494|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
105314392|NCT02245412|363148495|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
105314393|NCT02245412|363148496|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
105314394|NCT02245412|363148494|FG000|Follow-Up Period|Death|4|||
105314395|NCT02245412|363148495|FG001|Follow-Up Period|Death|2|||
105314396|NCT02245412|363148496|FG002|Follow-Up Period|Death|1|||
105314397|NCT02245412|363148494|FG000|Follow-Up Period|Physician Decision|1|||
105314398|NCT02245412|363148495|FG001|Follow-Up Period|Physician Decision|0|||
105314399|NCT02245412|363148496|FG002|Follow-Up Period|Physician Decision|0|||
105314400|NCT02245412|363148494|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
105368381|NCT01103323|363354183|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
105368382|NCT01103323|363354184|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
105368383|NCT01103323|363354183|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
105368384|NCT01103323|363354184|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
105368385|NCT01103323|363354183|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
105368386|NCT01103323|363354184|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
105490063|NCT01709578|363807445|FG000|Overall Study|Other, not related to safety or efficacy|2|||
105490064|NCT01709578|363807446|FG001|Overall Study|Other, not related to safety or efficacy|7|||
105314401|NCT02245412|363148495|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
105314402|NCT02245412|363148496|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
105314403|NCT03132155|363148497|FG000|Overall Study|Lack of Efficacy|6|||
105314404|NCT03132155|363148497|FG000|Overall Study|Lost to Follow-up|1|||
105314405|NCT03132155|363148497|FG000|Overall Study|Withdrawal by Subject|1|||
105314406|NCT01056289|363148498|FG000|Open-label Phase|Adverse Event|29|||
105314407|NCT01056289|363148499|FG001|Open-label Phase|Adverse Event|0|||
105314408|NCT01056289|363148500|FG002|Open-label Phase|Adverse Event|0|||
105314409|NCT01056289|363148501|FG003|Open-label Phase|Adverse Event|0|||
105314410|NCT01056289|363148498|FG000|Open-label Phase|Lost to Follow-up|30|||
105314411|NCT01056289|363148499|FG001|Open-label Phase|Lost to Follow-up|0|||
105314412|NCT01056289|363148500|FG002|Open-label Phase|Lost to Follow-up|0|||
105314413|NCT01056289|363148501|FG003|Open-label Phase|Lost to Follow-up|0|||
105314414|NCT01056289|363148498|FG000|Open-label Phase|Other|9|||
105314415|NCT01056289|363148499|FG001|Open-label Phase|Other|0|||
105314416|NCT01056289|363148500|FG002|Open-label Phase|Other|0|||
105314417|NCT01056289|363148501|FG003|Open-label Phase|Other|0|||
105314418|NCT01056289|363148498|FG000|Open-label Phase|Protocol Violation|6|||
105314419|NCT01056289|363148499|FG001|Open-label Phase|Protocol Violation|0|||
105368387|NCT03217591|363354185|FG000|Overall Study|Adverse Event|1|||
105368388|NCT03217591|363354186|FG001|Overall Study|Adverse Event|2|||
105368389|NCT03217591|363354187|FG002|Overall Study|Adverse Event|6|||
105368390|NCT03217591|363354185|FG000|Overall Study|Withdrawal by Subject|0|||
105368391|NCT03217591|363354186|FG001|Overall Study|Withdrawal by Subject|1|||
105368392|NCT03217591|363354187|FG002|Overall Study|Withdrawal by Subject|3|||
105368393|NCT03217591|363354185|FG000|Overall Study|Lost to Follow-up|1|||
105368394|NCT03217591|363354186|FG001|Overall Study|Lost to Follow-up|0|||
105368395|NCT03217591|363354187|FG002|Overall Study|Lost to Follow-up|0|||
105368396|NCT03217591|363354185|FG000|Overall Study|Protocol Violation|1|||
105368397|NCT03217591|363354186|FG001|Overall Study|Protocol Violation|0|||
105368398|NCT03217591|363354187|FG002|Overall Study|Protocol Violation|1|||
105368399|NCT02475369|363354198|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
105368400|NCT02475369|363354199|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
105368401|NCT03372798|363354202|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
105368402|NCT03372798|363354203|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
105368403|NCT03372798|363354202|FG000|Overall Study|Failure of imaging probe|0|||
105368404|NCT03372798|363354203|FG001|Overall Study|Failure of imaging probe|1|||
105368405|NCT03188055|363354204|FG000|Overall Study|Unavailable for training|0|||
105368406|NCT03188055|363354205|FG001|Overall Study|Unavailable for training|0|||
105368407|NCT03188055|363354206|FG002|Overall Study|Unavailable for training|19|||
105368408|NCT03188055|363354207|FG003|Overall Study|Unavailable for training|0|||
105368409|NCT03188055|363354208|FG004|Overall Study|Unavailable for training|0|||
105368410|NCT03188055|363354209|FG005|Overall Study|Unavailable for training|0|||
105368411|NCT03188055|363354204|FG000|Overall Study|Lost to Follow-up|0|||
105368412|NCT03188055|363354205|FG001|Overall Study|Lost to Follow-up|18|||
105368413|NCT03188055|363354206|FG002|Overall Study|Lost to Follow-up|0|||
105368414|NCT03188055|363354207|FG003|Overall Study|Lost to Follow-up|11|||
105368415|NCT03188055|363354208|FG004|Overall Study|Lost to Follow-up|0|||
105368416|NCT03188055|363354209|FG005|Overall Study|Lost to Follow-up|0|||
105368417|NCT03188055|363354204|FG000|Overall Study|Withdrawal by Subject|0|||
105368418|NCT03188055|363354205|FG001|Overall Study|Withdrawal by Subject|1|||
105368419|NCT03188055|363354206|FG002|Overall Study|Withdrawal by Subject|0|||
105368420|NCT03188055|363354207|FG003|Overall Study|Withdrawal by Subject|1|||
105368421|NCT03188055|363354208|FG004|Overall Study|Withdrawal by Subject|0|||
105368422|NCT03188055|363354209|FG005|Overall Study|Withdrawal by Subject|0|||
105368423|NCT00875810|363354210|FG000|Overall Study|Withdrawal by Subject|1|||
105368424|NCT00875810|363354210|FG000|Overall Study|Physician Decision|3|||
105368425|NCT00875810|363354210|FG000|Overall Study|Lost to Follow-up|39|||
105368426|NCT00875810|363354210|FG000|Overall Study|Patient enroled but not implanted|2|||
105368427|NCT00875810|363354210|FG000|Overall Study|Device explanted|1|||
105368428|NCT01204671|363354215|FG000|Overall Study|Adverse Event|4|||
105368429|NCT01204671|363354216|FG001|Overall Study|Adverse Event|3|||
105368430|NCT01204671|363354217|FG002|Overall Study|Adverse Event|3|||
105368431|NCT01204671|363354218|FG003|Overall Study|Adverse Event|3|||
105368432|NCT01204671|363354219|FG004|Overall Study|Adverse Event|1|||
105368433|NCT01204671|363354215|FG000|Overall Study|Withdrawal by Subject|2|||
105490065|NCT01709578|363807447|FG002|Overall Study|Other, not related to safety or efficacy|5|||
105490066|NCT00920829|363807450|FG000|Allocation|No post randomization data|3|||
105490067|NCT00920829|363807451|FG001|Allocation|No post randomization data|1|||
105490068|NCT00920829|363807452|FG002|Allocation|No post randomization data|0|||
105490069|NCT00920829|363807453|FG003|Allocation|No post randomization data|2|||
105314420|NCT01056289|363148500|FG002|Open-label Phase|Protocol Violation|0|||
105368434|NCT01204671|363354216|FG001|Overall Study|Withdrawal by Subject|3|||
105368435|NCT01204671|363354217|FG002|Overall Study|Withdrawal by Subject|4|||
105314421|NCT01056289|363148501|FG003|Open-label Phase|Protocol Violation|0|||
105314422|NCT01056289|363148498|FG000|Open-label Phase|Withdrawal by Subject|26|||
105314423|NCT01056289|363148499|FG001|Open-label Phase|Withdrawal by Subject|0|||
105314424|NCT01056289|363148500|FG002|Open-label Phase|Withdrawal by Subject|0|||
105314425|NCT01056289|363148501|FG003|Open-label Phase|Withdrawal by Subject|0|||
105314426|NCT01056289|363148498|FG000|Open-label Phase|Lack of Efficacy|18|||
105368436|NCT01204671|363354218|FG003|Overall Study|Withdrawal by Subject|5|||
105368437|NCT01204671|363354219|FG004|Overall Study|Withdrawal by Subject|3|||
105368438|NCT01204671|363354215|FG000|Overall Study|Lost to Follow-up|7|||
105842730|NCT03346070|365082427|FG004|Overall Study|Withdrawal by Subject|0|||
105842731|NCT03346070|365082423|FG000|Overall Study|Study medication not received as planned|2|||
105842732|NCT03346070|365082424|FG001|Overall Study|Study medication not received as planned|3|||
105842733|NCT03346070|365082425|FG002|Overall Study|Study medication not received as planned|2|||
105842734|NCT03346070|365082426|FG003|Overall Study|Study medication not received as planned|3|||
105842735|NCT03346070|365082427|FG004|Overall Study|Study medication not received as planned|2|||
105842736|NCT03346070|365082423|FG000|Overall Study|Screen Failure|0|||
105842737|NCT03346070|365082424|FG001|Overall Study|Screen Failure|0|||
105842738|NCT03346070|365082425|FG002|Overall Study|Screen Failure|0|||
105842739|NCT03346070|365082426|FG003|Overall Study|Screen Failure|1|||
105842740|NCT03346070|365082427|FG004|Overall Study|Screen Failure|1|||
105842741|NCT02813421|365082428|FG000|Overall Study|Withdrawal by Subject|1|||
105842742|NCT02813421|365082429|FG001|Overall Study|Withdrawal by Subject|2|||
105842743|NCT02813421|365082428|FG000|Overall Study|Lost to Follow-up|1|||
105842744|NCT02813421|365082429|FG001|Overall Study|Lost to Follow-up|1|||
105842745|NCT05142566|365082430|FG000|Overall Study|Protocol Violation|1|||
105842746|NCT04146363|365082439|FG000|Induction Period|Adverse Event|1|||
105842747|NCT04146363|365082440|FG001|Induction Period|Adverse Event|2|||
105842748|NCT04146363|365082441|FG002|Induction Period|Adverse Event|0|||
105842749|NCT04146363|365082442|FG003|Induction Period|Adverse Event|0|||
105842750|NCT04146363|365082443|FG004|Induction Period|Adverse Event|0|||
105842751|NCT04146363|365082444|FG005|Induction Period|Adverse Event|0|||
105842752|NCT04146363|365082445|FG006|Induction Period|Adverse Event|0|||
105842753|NCT04146363|365082446|FG007|Induction Period|Adverse Event|0|||
105842754|NCT04146363|365082447|FG008|Induction Period|Adverse Event|0|||
105842755|NCT04146363|365082448|FG009|Induction Period|Adverse Event|0|||
105842756|NCT04146363|365082449|FG010|Induction Period|Adverse Event|0|||
105842757|NCT04146363|365082439|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
105842758|NCT04146363|365082440|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
105842759|NCT04146363|365082441|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
105842760|NCT04146363|365082442|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
105842761|NCT04146363|365082443|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
105842762|NCT04146363|365082444|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
105842763|NCT04146363|365082445|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
105842764|NCT04146363|365082446|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
105842765|NCT04146363|365082447|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
105842766|NCT04146363|365082448|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
105842767|NCT04146363|365082449|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
105842768|NCT04146363|365082439|FG000|Induction Period|Lack of Efficacy|7|||
105842769|NCT04146363|365082440|FG001|Induction Period|Lack of Efficacy|2|||
105842770|NCT04146363|365082441|FG002|Induction Period|Lack of Efficacy|0|||
105842771|NCT04146363|365082442|FG003|Induction Period|Lack of Efficacy|0|||
105842772|NCT04146363|365082443|FG004|Induction Period|Lack of Efficacy|0|||
105842773|NCT04146363|365082444|FG005|Induction Period|Lack of Efficacy|0|||
105842774|NCT04146363|365082445|FG006|Induction Period|Lack of Efficacy|0|||
105842775|NCT04146363|365082446|FG007|Induction Period|Lack of Efficacy|0|||
105842776|NCT04146363|365082447|FG008|Induction Period|Lack of Efficacy|0|||
105842777|NCT04146363|365082448|FG009|Induction Period|Lack of Efficacy|0|||
105842778|NCT04146363|365082449|FG010|Induction Period|Lack of Efficacy|0|||
105842779|NCT04146363|365082439|FG000|Induction Period|Lost to Follow-up|1|||
105842780|NCT04146363|365082440|FG001|Induction Period|Lost to Follow-up|4|||
105842781|NCT04146363|365082441|FG002|Induction Period|Lost to Follow-up|0|||
105842782|NCT04146363|365082442|FG003|Induction Period|Lost to Follow-up|0|||
105842783|NCT04146363|365082443|FG004|Induction Period|Lost to Follow-up|0|||
105842784|NCT04146363|365082444|FG005|Induction Period|Lost to Follow-up|0|||
105842785|NCT04146363|365082445|FG006|Induction Period|Lost to Follow-up|0|||
105842786|NCT04146363|365082446|FG007|Induction Period|Lost to Follow-up|0|||
105842787|NCT04146363|365082447|FG008|Induction Period|Lost to Follow-up|0|||
105842788|NCT04146363|365082448|FG009|Induction Period|Lost to Follow-up|0|||
105842789|NCT04146363|365082449|FG010|Induction Period|Lost to Follow-up|0|||
105842790|NCT04146363|365082439|FG000|Induction Period|Positive quantiferon test|0|||
105842791|NCT04146363|365082440|FG001|Induction Period|Positive quantiferon test|1|||
105842792|NCT04146363|365082441|FG002|Induction Period|Positive quantiferon test|0|||
105842793|NCT04146363|365082442|FG003|Induction Period|Positive quantiferon test|0|||
105842794|NCT04146363|365082443|FG004|Induction Period|Positive quantiferon test|0|||
105842795|NCT04146363|365082444|FG005|Induction Period|Positive quantiferon test|0|||
105368439|NCT01204671|363354216|FG001|Overall Study|Lost to Follow-up|8|||
105842796|NCT04146363|365082445|FG006|Induction Period|Positive quantiferon test|0|||
105842797|NCT04146363|365082446|FG007|Induction Period|Positive quantiferon test|0|||
105842798|NCT04146363|365082447|FG008|Induction Period|Positive quantiferon test|0|||
105842799|NCT04146363|365082448|FG009|Induction Period|Positive quantiferon test|0|||
105842800|NCT04146363|365082449|FG010|Induction Period|Positive quantiferon test|0|||
105842801|NCT04146363|365082439|FG000|Induction Period|Protocol Deviation|5|||
105842802|NCT04146363|365082440|FG001|Induction Period|Protocol Deviation|6|||
105368440|NCT01204671|363354217|FG002|Overall Study|Lost to Follow-up|6|||
105368441|NCT01204671|363354218|FG003|Overall Study|Lost to Follow-up|4|||
105490070|NCT00920829|363807450|FG000|Available for Analysis|Withdrawal by Subject|6|||
105842803|NCT04146363|365082441|FG002|Induction Period|Protocol Deviation|0|||
105842804|NCT04146363|365082442|FG003|Induction Period|Protocol Deviation|0|||
105842805|NCT04146363|365082443|FG004|Induction Period|Protocol Deviation|0|||
105842806|NCT04146363|365082444|FG005|Induction Period|Protocol Deviation|0|||
105842807|NCT04146363|365082445|FG006|Induction Period|Protocol Deviation|0|||
105842808|NCT04146363|365082446|FG007|Induction Period|Protocol Deviation|0|||
105842809|NCT04146363|365082447|FG008|Induction Period|Protocol Deviation|0|||
105842810|NCT04146363|365082448|FG009|Induction Period|Protocol Deviation|0|||
105842811|NCT04146363|365082449|FG010|Induction Period|Protocol Deviation|0|||
105842812|NCT04146363|365082439|FG000|Induction Period|Withdrawal by Subject|6|||
105842813|NCT04146363|365082440|FG001|Induction Period|Withdrawal by Subject|3|||
105842814|NCT04146363|365082441|FG002|Induction Period|Withdrawal by Subject|0|||
105842815|NCT04146363|365082442|FG003|Induction Period|Withdrawal by Subject|0|||
105842816|NCT04146363|365082443|FG004|Induction Period|Withdrawal by Subject|0|||
105842817|NCT04146363|365082444|FG005|Induction Period|Withdrawal by Subject|0|||
105842818|NCT04146363|365082445|FG006|Induction Period|Withdrawal by Subject|0|||
105842819|NCT04146363|365082446|FG007|Induction Period|Withdrawal by Subject|0|||
105842820|NCT04146363|365082447|FG008|Induction Period|Withdrawal by Subject|0|||
105842821|NCT04146363|365082448|FG009|Induction Period|Withdrawal by Subject|0|||
105842822|NCT04146363|365082449|FG010|Induction Period|Withdrawal by Subject|0|||
105842823|NCT04146363|365082439|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842824|NCT04146363|365082440|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842825|NCT04146363|365082441|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842826|NCT04146363|365082442|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842827|NCT04146363|365082443|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842828|NCT04146363|365082444|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842829|NCT04146363|365082445|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
105842830|NCT04146363|365082446|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
105842831|NCT04146363|365082447|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842832|NCT04146363|365082448|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842833|NCT04146363|365082449|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842834|NCT04146363|365082439|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842835|NCT04146363|365082440|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842836|NCT04146363|365082441|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842837|NCT04146363|365082442|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842838|NCT04146363|365082443|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842839|NCT04146363|365082444|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842840|NCT04146363|365082445|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842841|NCT04146363|365082446|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
105842842|NCT04146363|365082447|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842843|NCT04146363|365082448|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842844|NCT04146363|365082449|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842845|NCT04146363|365082439|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842846|NCT04146363|365082440|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842847|NCT04146363|365082441|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842848|NCT04146363|365082442|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842849|NCT04146363|365082443|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842850|NCT04146363|365082444|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842851|NCT04146363|365082445|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
105842852|NCT04146363|365082446|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
105842853|NCT04146363|365082447|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842854|NCT04146363|365082448|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842855|NCT04146363|365082449|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842856|NCT04146363|365082439|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842857|NCT04146363|365082440|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842858|NCT04146363|365082441|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
105842859|NCT04146363|365082442|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842860|NCT04146363|365082443|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842861|NCT04146363|365082444|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
105842862|NCT04146363|365082445|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842863|NCT04146363|365082446|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842864|NCT04146363|365082447|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842865|NCT04146363|365082448|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842866|NCT04146363|365082449|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842867|NCT04146363|365082439|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105842868|NCT04146363|365082440|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105490071|NCT00920829|363807451|FG001|Available for Analysis|Withdrawal by Subject|6|||
105842869|NCT04146363|365082441|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105842870|NCT04146363|365082442|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105842871|NCT04146363|365082443|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
105842872|NCT04146363|365082444|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
105842873|NCT04146363|365082445|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
105842874|NCT04146363|365082446|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
105842875|NCT04146363|365082447|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105842876|NCT04146363|365082448|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105842877|NCT04146363|365082449|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105842878|NCT04146363|365082439|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105842879|NCT04146363|365082440|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105314427|NCT01056289|363148499|FG001|Open-label Phase|Lack of Efficacy|0|||
105314428|NCT01056289|363148500|FG002|Open-label Phase|Lack of Efficacy|0|||
105314429|NCT01056289|363148501|FG003|Open-label Phase|Lack of Efficacy|0|||
105314430|NCT01056289|363148498|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
105314431|NCT01056289|363148499|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
105314432|NCT01056289|363148500|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
105314433|NCT01056289|363148501|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
105314434|NCT01056289|363148498|FG000|Double-blind Phase|Adverse Event|0|||
105314435|NCT01056289|363148499|FG001|Double-blind Phase|Adverse Event|1|||
105314436|NCT01056289|363148500|FG002|Double-blind Phase|Adverse Event|2|||
105314437|NCT01056289|363148501|FG003|Double-blind Phase|Adverse Event|1|||
105314438|NCT01056289|363148498|FG000|Double-blind Phase|Lost to Follow-up|0|||
105314439|NCT01056289|363148499|FG001|Double-blind Phase|Lost to Follow-up|2|||
105314440|NCT01056289|363148500|FG002|Double-blind Phase|Lost to Follow-up|2|||
105314441|NCT01056289|363148501|FG003|Double-blind Phase|Lost to Follow-up|2|||
105314442|NCT01056289|363148498|FG000|Double-blind Phase|Other|0|||
105314443|NCT01056289|363148499|FG001|Double-blind Phase|Other|0|||
105314444|NCT01056289|363148500|FG002|Double-blind Phase|Other|1|||
105314445|NCT01056289|363148501|FG003|Double-blind Phase|Other|2|||
105314446|NCT01056289|363148498|FG000|Double-blind Phase|Protocol Violation|0|||
105314447|NCT01056289|363148499|FG001|Double-blind Phase|Protocol Violation|0|||
105314448|NCT01056289|363148500|FG002|Double-blind Phase|Protocol Violation|1|||
105314449|NCT01056289|363148501|FG003|Double-blind Phase|Protocol Violation|1|||
105314450|NCT01056289|363148498|FG000|Double-blind Phase|Withdrawal by Subject|0|||
105314451|NCT01056289|363148499|FG001|Double-blind Phase|Withdrawal by Subject|0|||
105314452|NCT01056289|363148500|FG002|Double-blind Phase|Withdrawal by Subject|4|||
105314453|NCT01056289|363148501|FG003|Double-blind Phase|Withdrawal by Subject|2|||
105314454|NCT01056289|363148498|FG000|Double-blind Phase|Discontinuation symptom|0|||
105314455|NCT01056289|363148499|FG001|Double-blind Phase|Discontinuation symptom|1|||
105314456|NCT01056289|363148500|FG002|Double-blind Phase|Discontinuation symptom|2|||
105314457|NCT01056289|363148501|FG003|Double-blind Phase|Discontinuation symptom|2|||
105314458|NCT01056289|363148498|FG000|Double-blind Phase|Physician Decision|0|||
105314459|NCT01056289|363148499|FG001|Double-blind Phase|Physician Decision|0|||
105314460|NCT01056289|363148500|FG002|Double-blind Phase|Physician Decision|1|||
105314461|NCT01056289|363148501|FG003|Double-blind Phase|Physician Decision|0|||
105314462|NCT02925403|363148516|FG000|Overall Study|Lost to Follow-up|0|||
105314463|NCT02925403|363148517|FG001|Overall Study|Lost to Follow-up|1|||
105314464|NCT00459043|363148518|FG000|Overall Study|Withdrawal by Subject|1|||
105314465|NCT00459043|363148519|FG001|Overall Study|Withdrawal by Subject|0|||
105314466|NCT01392963|363148520|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
105314467|NCT01392963|363148521|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
105314468|NCT01392963|363148520|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
105314469|NCT01392963|363148521|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
105314470|NCT01392963|363148520|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
105314471|NCT01392963|363148521|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
105842880|NCT04146363|365082441|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
105842881|NCT04146363|365082442|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105842882|NCT04146363|365082443|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105314472|NCT00369486|363148522|FG000|4-Week Visit|Missed visit|2|||
105314473|NCT00369486|363148523|FG001|4-Week Visit|Missed visit|2|||
105314474|NCT00369486|363148524|FG002|4-Week Visit|Missed visit|0|||
105314475|NCT00369486|363148525|FG003|4-Week Visit|Missed visit|2|||
105314476|NCT00369486|363148526|FG004|4-Week Visit|Missed visit|1|||
105314477|NCT00369486|363148522|FG000|4-Week Visit|Dropped|0|||
105314478|NCT00369486|363148523|FG001|4-Week Visit|Dropped|0|||
105314479|NCT00369486|363148524|FG002|4-Week Visit|Dropped|1|||
105314480|NCT00369486|363148525|FG003|4-Week Visit|Dropped|0|||
105314481|NCT00369486|363148526|FG004|4-Week Visit|Dropped|0|||
105314482|NCT00369486|363148522|FG000|8-Week Visit|Missed visit|0|||
105314483|NCT00369486|363148523|FG001|8-Week Visit|Missed visit|1|||
105314484|NCT00369486|363148524|FG002|8-Week Visit|Missed visit|0|||
105314485|NCT00369486|363148525|FG003|8-Week Visit|Missed visit|0|||
105314486|NCT00369486|363148526|FG004|8-Week Visit|Missed visit|1|||
105314487|NCT00369486|363148522|FG000|8-Week Visit|Dropped|0|||
105314488|NCT00369486|363148523|FG001|8-Week Visit|Dropped|0|||
105314489|NCT00369486|363148524|FG002|8-Week Visit|Dropped|0|||
105314490|NCT00369486|363148525|FG003|8-Week Visit|Dropped|1|||
105314491|NCT00369486|363148526|FG004|8-Week Visit|Dropped|0|||
105314492|NCT00369486|363148522|FG000|17-Week Visit|Missed visit|0|||
105314493|NCT00369486|363148523|FG001|17-Week Visit|Missed visit|0|||
105314494|NCT00369486|363148524|FG002|17-Week Visit|Missed visit|1|||
105314495|NCT00369486|363148525|FG003|17-Week Visit|Missed visit|1|||
105314496|NCT00369486|363148526|FG004|17-Week Visit|Missed visit|1|||
105314497|NCT00369486|363148522|FG000|34-Week Visit|Dropped|0|||
105314498|NCT00369486|363148523|FG001|34-Week Visit|Dropped|1|||
105842883|NCT04146363|365082444|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
105842884|NCT04146363|365082445|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
105842885|NCT04146363|365082446|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
105842886|NCT04146363|365082447|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105842887|NCT04146363|365082448|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105842888|NCT04146363|365082449|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105842889|NCT04146363|365082439|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842890|NCT04146363|365082440|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842891|NCT04146363|365082441|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842892|NCT04146363|365082442|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842893|NCT04146363|365082443|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842894|NCT04146363|365082444|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842895|NCT04146363|365082445|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842896|NCT04146363|365082446|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842897|NCT04146363|365082447|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
105842898|NCT04146363|365082448|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
105842899|NCT04146363|365082449|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842900|NCT04146363|365082439|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842901|NCT04146363|365082440|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842902|NCT04146363|365082441|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842903|NCT04146363|365082442|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842904|NCT04146363|365082443|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842905|NCT04146363|365082444|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842906|NCT04146363|365082445|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842907|NCT04146363|365082446|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842908|NCT04146363|365082447|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
105842909|NCT04146363|365082448|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
105842910|NCT04146363|365082449|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
105842911|NCT04146363|365082439|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842912|NCT04146363|365082440|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842913|NCT04146363|365082441|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842914|NCT04146363|365082442|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842915|NCT04146363|365082443|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842916|NCT04146363|365082444|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842917|NCT04146363|365082445|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842918|NCT04146363|365082446|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842919|NCT04146363|365082447|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
105842920|NCT04146363|365082448|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
105842921|NCT04146363|365082449|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842922|NCT04146363|365082439|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842923|NCT04146363|365082440|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842924|NCT04146363|365082441|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842925|NCT04146363|365082442|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842926|NCT04146363|365082443|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842927|NCT04146363|365082444|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
105314499|NCT00369486|363148524|FG002|34-Week Visit|Dropped|1|||
105314500|NCT00369486|363148525|FG003|34-Week Visit|Dropped|3|||
105314501|NCT00369486|363148526|FG004|34-Week Visit|Dropped|3|||
105314502|NCT00270855|363148527|FG000|Overall Study|Withdrawal by Subject|8|||
105314503|NCT00270855|363148528|FG001|Overall Study|Withdrawal by Subject|8|||
105314504|NCT03156504|363148532|FG000|Overall Study|Withdrawal by Subject|1|||
105314505|NCT00450801|363148533|FG000|Overall Study|Death|1|||
105314506|NCT03452137|363148534|FG000|Overall Study|Death|67|||
105314507|NCT03452137|363148535|FG001|Overall Study|Death|70|||
105314508|NCT03452137|363148534|FG000|Overall Study|Lost to Follow-up|4|||
105314509|NCT03452137|363148535|FG001|Overall Study|Lost to Follow-up|2|||
105314510|NCT03452137|363148534|FG000|Overall Study|Physician Decision|0|||
105314511|NCT03452137|363148535|FG001|Overall Study|Physician Decision|1|||
105314512|NCT03452137|363148534|FG000|Overall Study|Study Terminated by Sponsor|120|||
105314513|NCT03452137|363148535|FG001|Overall Study|Study Terminated by Sponsor|121|||
105368442|NCT01204671|363354219|FG004|Overall Study|Lost to Follow-up|0|||
105368443|NCT01204671|363354215|FG000|Overall Study|Unknown Completion Status|1|||
105368444|NCT01204671|363354216|FG001|Overall Study|Unknown Completion Status|1|||
105368445|NCT01204671|363354217|FG002|Overall Study|Unknown Completion Status|0|||
105368446|NCT01204671|363354218|FG003|Overall Study|Unknown Completion Status|0|||
105368447|NCT01204671|363354219|FG004|Overall Study|Unknown Completion Status|0|||
105368448|NCT01204671|363354215|FG000|Overall Study|Physician Decision|0|||
105368449|NCT01204671|363354216|FG001|Overall Study|Physician Decision|0|||
105368450|NCT01204671|363354217|FG002|Overall Study|Physician Decision|0|||
105368451|NCT01204671|363354218|FG003|Overall Study|Physician Decision|1|||
105314514|NCT03452137|363148534|FG000|Overall Study|Withdrawal by Subject|12|||
105314515|NCT03452137|363148535|FG001|Overall Study|Withdrawal by Subject|9|||
105314516|NCT02864992|363148536|FG000|Overall Study|still on treatment|15|||
105314517|NCT02864992|363148537|FG001|Overall Study|still on treatment|1|||
105314518|NCT02864992|363148538|FG002|Overall Study|still on treatment|33|||
105314519|NCT03772717|363148539|FG000|Overall Study|Withdrawal by Subject|2|||
105314520|NCT01810302|363148540|FG000|Overall Study|Death|1|||
105314521|NCT01810302|363148541|FG001|Overall Study|Death|0|||
105314522|NCT01810302|363148540|FG000|Overall Study|Physician Decision|0|||
105314523|NCT01810302|363148541|FG001|Overall Study|Physician Decision|1|||
105314524|NCT00587860|363148542|FG000|Overall Study|Lost to Follow-up|2|||
105314525|NCT00587860|363148543|FG001|Overall Study|Lost to Follow-up|2|||
105314526|NCT00587860|363148542|FG000|Overall Study|Withdrawal by Subject|3|||
105314527|NCT00587860|363148543|FG001|Overall Study|Withdrawal by Subject|3|||
105314528|NCT00261443|363148544|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
105314529|NCT00261443|363148545|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
105314530|NCT00261443|363148546|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
105314531|NCT00261443|363148544|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
105314532|NCT00261443|363148545|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
105314533|NCT00261443|363148546|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
105314534|NCT00261443|363148544|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
105314535|NCT00261443|363148545|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
105314536|NCT00261443|363148546|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
105314537|NCT00261443|363148544|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
105314538|NCT00261443|363148545|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
105314539|NCT00261443|363148546|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
105314540|NCT00261443|363148544|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
105314541|NCT00261443|363148545|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
105314542|NCT00261443|363148546|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
105314543|NCT00261443|363148544|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
105314544|NCT00261443|363148545|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
105314545|NCT00261443|363148546|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
105314546|NCT00261443|363148544|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
105314547|NCT00261443|363148545|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
105314548|NCT00261443|363148546|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
105314549|NCT00261443|363148544|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
105314550|NCT00261443|363148545|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
105314551|NCT00261443|363148546|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
105314552|NCT00261443|363148544|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
105368452|NCT01204671|363354219|FG004|Overall Study|Physician Decision|0|||
105490072|NCT00920829|363807452|FG002|Available for Analysis|Withdrawal by Subject|6|||
105490073|NCT00920829|363807453|FG003|Available for Analysis|Withdrawal by Subject|10|||
105490074|NCT00920829|363807450|FG000|Available for Analysis|Required Medical Treatment|0|||
105490075|NCT00920829|363807451|FG001|Available for Analysis|Required Medical Treatment|1|||
105490076|NCT00920829|363807452|FG002|Available for Analysis|Required Medical Treatment|2|||
105314553|NCT00261443|363148545|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
105314554|NCT00261443|363148546|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
105314555|NCT00261443|363148544|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
105314556|NCT00261443|363148545|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
105314557|NCT00261443|363148546|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
105314558|NCT00261443|363148544|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
105314559|NCT00261443|363148545|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
105314560|NCT00261443|363148546|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
105314561|NCT00261443|363148544|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
105368453|NCT01316224|363354220|FG000|Overall Study|Protocol Violation|3|||
105368454|NCT01316224|363354220|FG000|Overall Study|Adverse Event|3|||
105368455|NCT01316224|363354220|FG000|Overall Study|Lack of Efficacy|1|||
105368456|NCT01316224|363354220|FG000|Overall Study|Withdrawal by Subject|1|||
105490077|NCT00920829|363807453|FG003|Available for Analysis|Required Medical Treatment|0|||
105490078|NCT00920829|363807450|FG000|Available for Analysis|Adverse Event|1|||
105314562|NCT00261443|363148545|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
105314563|NCT00261443|363148546|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
105314564|NCT00261443|363148544|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
105314565|NCT00261443|363148545|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
105314566|NCT00261443|363148546|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
105314567|NCT00261443|363148544|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
105314568|NCT00261443|363148545|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
105314569|NCT00261443|363148546|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
105314570|NCT00261443|363148544|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
105314571|NCT00261443|363148545|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
105314572|NCT00261443|363148546|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
105314573|NCT00261443|363148544|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
105314574|NCT00261443|363148545|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
105314575|NCT00261443|363148546|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
105314576|NCT00261443|363148544|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
105314577|NCT00261443|363148545|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
105314578|NCT00261443|363148546|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
105314579|NCT00261443|363148544|FG000|3: Assessment of Relapse|Adverse Event|0|||
105314580|NCT00261443|363148545|FG001|3: Assessment of Relapse|Adverse Event|15|||
105314581|NCT00261443|363148546|FG002|3: Assessment of Relapse|Adverse Event|19|||
105314582|NCT00261443|363148544|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
105314583|NCT00261443|363148545|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
105314584|NCT00261443|363148546|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
105314585|NCT00261443|363148544|FG000|3: Assessment of Relapse|Death|0|||
105314586|NCT00261443|363148545|FG001|3: Assessment of Relapse|Death|0|||
105314587|NCT00261443|363148546|FG002|3: Assessment of Relapse|Death|1|||
105314588|NCT00261443|363148544|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
105314589|NCT00261443|363148545|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
105314590|NCT00261443|363148546|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
105314591|NCT00261443|363148544|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
105314592|NCT00261443|363148545|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
105314593|NCT00261443|363148546|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
105314594|NCT00261443|363148544|FG000|3: Assessment of Relapse|Pregnancy|0|||
105314595|NCT00261443|363148545|FG001|3: Assessment of Relapse|Pregnancy|2|||
105314596|NCT00261443|363148546|FG002|3: Assessment of Relapse|Pregnancy|1|||
105314597|NCT00261443|363148544|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
105314598|NCT00261443|363148545|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
105314599|NCT00261443|363148546|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
105314600|NCT00261443|363148544|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
105314601|NCT00261443|363148545|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
105314602|NCT00261443|363148546|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
105314603|NCT00261443|363148544|FG000|3: Assessment of Relapse|Other Reasons|0|||
105314604|NCT00261443|363148545|FG001|3: Assessment of Relapse|Other Reasons|4|||
105314605|NCT00261443|363148546|FG002|3: Assessment of Relapse|Other Reasons|3|||
105314606|NCT00261443|363148544|FG000|4: Extension Phase|Adverse Event|0|||
105314607|NCT00261443|363148545|FG001|4: Extension Phase|Adverse Event|1|||
105314608|NCT00261443|363148546|FG002|4: Extension Phase|Adverse Event|0|||
105368457|NCT01316224|363354220|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
105368458|NCT01316224|363354220|FG000|Overall Study|Other|1|||
105368459|NCT00264147|363354221|FG000|Treatment I Period|Adverse Event|3|||
105368460|NCT00264147|363354222|FG001|Treatment I Period|Adverse Event|6|||
105368461|NCT00264147|363354223|FG002|Treatment I Period|Adverse Event|3|||
105368462|NCT00264147|363354224|FG003|Treatment I Period|Adverse Event|5|||
105368463|NCT00264147|363354225|FG004|Treatment I Period|Adverse Event|7|||
105368464|NCT00264147|363354226|FG005|Treatment I Period|Adverse Event|0|||
105368465|NCT00264147|363354221|FG000|Treatment I Period|Laboratory Adverse Event|0|||
105314609|NCT00261443|363148544|FG000|4: Extension Phase|Withdrawal by Subject|0|||
105314610|NCT00261443|363148545|FG001|4: Extension Phase|Withdrawal by Subject|1|||
105314611|NCT00261443|363148546|FG002|4: Extension Phase|Withdrawal by Subject|2|||
105314612|NCT00261443|363148544|FG000|4: Extension Phase|Lost to Follow-up|0|||
105314613|NCT00261443|363148545|FG001|4: Extension Phase|Lost to Follow-up|1|||
105314614|NCT00261443|363148546|FG002|4: Extension Phase|Lost to Follow-up|0|||
105314615|NCT02152605|363148549|FG000|Overall Study|Adverse Event|6|||
105314616|NCT02152605|363148550|FG001|Overall Study|Adverse Event|8|||
105314617|NCT02152605|363148549|FG000|Overall Study|Lack of Efficacy|7|||
105314618|NCT02152605|363148550|FG001|Overall Study|Lack of Efficacy|4|||
105314619|NCT02152605|363148549|FG000|Overall Study|Protocol deviation|1|||
105314620|NCT02152605|363148550|FG001|Overall Study|Protocol deviation|4|||
105314621|NCT02152605|363148549|FG000|Overall Study|Lost to Follow-up|1|||
105314622|NCT02152605|363148550|FG001|Overall Study|Lost to Follow-up|0|||
105368466|NCT00264147|363354222|FG001|Treatment I Period|Laboratory Adverse Event|0|||
105368467|NCT00264147|363354223|FG002|Treatment I Period|Laboratory Adverse Event|0|||
105314623|NCT02152605|363148549|FG000|Overall Study|Withdrew consent|4|||
105314624|NCT02152605|363148550|FG001|Overall Study|Withdrew consent|2|||
105314625|NCT02500043|363148553|FG000|Overall Study|Randomized, but not Treated|2|||
105368468|NCT00264147|363354224|FG003|Treatment I Period|Laboratory Adverse Event|1|||
105314626|NCT02500043|363148554|FG001|Overall Study|Randomized, but not Treated|2|||
105314627|NCT02500043|363148553|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
105314628|NCT02500043|363148554|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
105314629|NCT02500043|363148553|FG000|Overall Study|Adverse Event|33|||
105314630|NCT02500043|363148554|FG001|Overall Study|Adverse Event|11|||
105314631|NCT02500043|363148553|FG000|Overall Study|Clinical Progression|54|||
105314632|NCT02500043|363148554|FG001|Overall Study|Clinical Progression|35|||
105314633|NCT02500043|363148553|FG000|Overall Study|Radiological Progression|192|||
105314634|NCT02500043|363148554|FG001|Overall Study|Radiological Progression|110|||
105314635|NCT02500043|363148553|FG000|Overall Study|Physician's Decision|11|||
105314636|NCT02500043|363148554|FG001|Overall Study|Physician's Decision|3|||
105368469|NCT00264147|363354225|FG004|Treatment I Period|Laboratory Adverse Event|0|||
105368470|NCT00264147|363354226|FG005|Treatment I Period|Laboratory Adverse Event|0|||
105368471|NCT00264147|363354221|FG000|Treatment I Period|Lack of Efficacy|6|||
105368472|NCT00264147|363354222|FG001|Treatment I Period|Lack of Efficacy|2|||
105368473|NCT00264147|363354223|FG002|Treatment I Period|Lack of Efficacy|8|||
105368474|NCT00264147|363354224|FG003|Treatment I Period|Lack of Efficacy|0|||
105314637|NCT02500043|363148553|FG000|Overall Study|Withdrawal by Subject|14|||
105314638|NCT02500043|363148554|FG001|Overall Study|Withdrawal by Subject|4|||
105314639|NCT02500043|363148553|FG000|Overall Study|Death|11|||
105314640|NCT02500043|363148554|FG001|Overall Study|Death|2|||
105314641|NCT02500043|363148553|FG000|Overall Study|Protocol Deviation|1|||
105314642|NCT02500043|363148554|FG001|Overall Study|Protocol Deviation|0|||
105314643|NCT04971187|363148557|FG000|Overall Study|Screen failures|2|||
105314644|NCT02246114|363148562|FG000|Overall Study|miscarriage|1|||
105368475|NCT00264147|363354225|FG004|Treatment I Period|Lack of Efficacy|1|||
105368476|NCT00264147|363354226|FG005|Treatment I Period|Lack of Efficacy|0|||
105368477|NCT00264147|363354221|FG000|Treatment I Period|Lost to Follow-up|1|||
105842928|NCT04146363|365082445|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842929|NCT04146363|365082446|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842930|NCT04146363|365082447|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
105842931|NCT04146363|365082448|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
105842932|NCT04146363|365082449|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842933|NCT04146363|365082439|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842934|NCT04146363|365082440|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842935|NCT04146363|365082441|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842936|NCT04146363|365082442|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842937|NCT04146363|365082443|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842938|NCT04146363|365082444|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842939|NCT04146363|365082445|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842940|NCT04146363|365082446|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842941|NCT04146363|365082447|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
105842942|NCT04146363|365082448|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
105842943|NCT04146363|365082449|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
105842944|NCT04146363|365082439|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842945|NCT04146363|365082440|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842946|NCT04146363|365082441|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842947|NCT04146363|365082442|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842948|NCT04146363|365082443|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842949|NCT04146363|365082444|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842950|NCT04146363|365082445|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842951|NCT04146363|365082446|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842952|NCT04146363|365082447|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842953|NCT04146363|365082448|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
105842954|NCT04146363|365082449|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842955|NCT04146363|365082439|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842956|NCT04146363|365082440|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842957|NCT04146363|365082441|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842958|NCT04146363|365082442|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842959|NCT04146363|365082443|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105314645|NCT02246114|363148563|FG001|Overall Study|miscarriage|0|||
105368478|NCT00264147|363354222|FG001|Treatment I Period|Lost to Follow-up|0|||
105368479|NCT00264147|363354223|FG002|Treatment I Period|Lost to Follow-up|0|||
105314646|NCT01439009|363148569|FG000|Overall Study|Physician Decision|5|||
105314647|NCT01439009|363148570|FG001|Overall Study|Physician Decision|3|||
105314648|NCT01439009|363148569|FG000|Overall Study|Protocol Violation|2|||
105314649|NCT01439009|363148570|FG001|Overall Study|Protocol Violation|0|||
105314650|NCT01439009|363148569|FG000|Overall Study|Deviation of exclusion criteria|1|||
105314651|NCT01439009|363148570|FG001|Overall Study|Deviation of exclusion criteria|0|||
105314652|NCT00926783|363148571|FG000|Overall Study|Incomplete CFAE Procedures|3|||
105314653|NCT00926783|363148572|FG001|Overall Study|Incomplete CFAE Procedures|3|||
105314654|NCT00696787|363148573|FG000|Overall Study|Adverse Event|1|||
105314655|NCT00696787|363148574|FG001|Overall Study|Adverse Event|0|||
105314656|NCT00696787|363148575|FG002|Overall Study|Adverse Event|6|||
105314657|NCT00696787|363148573|FG000|Overall Study|Discontinuation by Sponsor|9|||
105314658|NCT00696787|363148574|FG001|Overall Study|Discontinuation by Sponsor|13|||
105314659|NCT00696787|363148575|FG002|Overall Study|Discontinuation by Sponsor|14|||
105314660|NCT00696787|363148573|FG000|Overall Study|Lack of Efficacy|0|||
105314661|NCT00696787|363148574|FG001|Overall Study|Lack of Efficacy|1|||
105314662|NCT00696787|363148575|FG002|Overall Study|Lack of Efficacy|0|||
105314663|NCT00696787|363148573|FG000|Overall Study|Lost to Follow-up|4|||
105314664|NCT00696787|363148574|FG001|Overall Study|Lost to Follow-up|0|||
105314665|NCT00696787|363148575|FG002|Overall Study|Lost to Follow-up|3|||
105314666|NCT00696787|363148573|FG000|Overall Study|Withdrawal by Subject|0|||
105314667|NCT00696787|363148574|FG001|Overall Study|Withdrawal by Subject|3|||
105314668|NCT00696787|363148575|FG002|Overall Study|Withdrawal by Subject|2|||
105314669|NCT00696787|363148573|FG000|Overall Study|Failed to return|1|||
105314670|NCT00696787|363148574|FG001|Overall Study|Failed to return|3|||
105314671|NCT00696787|363148575|FG002|Overall Study|Failed to return|1|||
105314672|NCT00976911|363148578|FG000|Overall Study|Withdrawal by Subject|4|||
105314673|NCT00976911|363148579|FG001|Overall Study|Withdrawal by Subject|6|||
105314674|NCT00976911|363148578|FG000|Overall Study|Death|138|||
105314675|NCT00976911|363148579|FG001|Overall Study|Death|126|||
105314676|NCT00976911|363148578|FG000|Overall Study|Adverse Event|0|||
105314677|NCT00976911|363148579|FG001|Overall Study|Adverse Event|1|||
105314678|NCT00976911|363148578|FG000|Overall Study|Protocol Violation|2|||
105314679|NCT00976911|363148579|FG001|Overall Study|Protocol Violation|0|||
105314680|NCT00976911|363148578|FG000|Overall Study|Other|8|||
105314681|NCT00976911|363148579|FG001|Overall Study|Other|9|||
105314682|NCT00976911|363148578|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
105314683|NCT00976911|363148579|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
105314684|NCT00576316|363148580|FG000|Overall Study|Adverse Event|9|||
105314685|NCT00576316|363148580|FG000|Overall Study|Withdrawal by Subject|2|||
105314686|NCT00576316|363148580|FG000|Overall Study|Protocol Violation|9|||
105314687|NCT00425373|363148644|FG000|Overall Study|Adverse Event|2|||
105314688|NCT00425373|363148645|FG001|Overall Study|Adverse Event|2|||
105314689|NCT00425373|363148646|FG002|Overall Study|Adverse Event|0|||
105314690|NCT00425373|363148647|FG003|Overall Study|Adverse Event|1|||
105314691|NCT00425373|363148648|FG004|Overall Study|Adverse Event|4|||
105314692|NCT00425373|363148649|FG005|Overall Study|Adverse Event|6|||
105314693|NCT00425373|363148650|FG006|Overall Study|Adverse Event|2|||
105314694|NCT00425373|363148651|FG007|Overall Study|Adverse Event|3|||
105314695|NCT00425373|363148652|FG008|Overall Study|Adverse Event|8|||
105314696|NCT00425373|363148644|FG000|Overall Study|Lost to Follow-up|0|||
105314697|NCT00425373|363148645|FG001|Overall Study|Lost to Follow-up|1|||
105314698|NCT00425373|363148646|FG002|Overall Study|Lost to Follow-up|0|||
105314699|NCT00425373|363148647|FG003|Overall Study|Lost to Follow-up|0|||
105314700|NCT00425373|363148648|FG004|Overall Study|Lost to Follow-up|1|||
105314701|NCT00425373|363148649|FG005|Overall Study|Lost to Follow-up|0|||
105314702|NCT00425373|363148650|FG006|Overall Study|Lost to Follow-up|0|||
105314703|NCT00425373|363148651|FG007|Overall Study|Lost to Follow-up|0|||
105314704|NCT00425373|363148652|FG008|Overall Study|Lost to Follow-up|0|||
105314705|NCT00425373|363148644|FG000|Overall Study|Protocol Violation|1|||
105314706|NCT00425373|363148645|FG001|Overall Study|Protocol Violation|0|||
105314707|NCT00425373|363148646|FG002|Overall Study|Protocol Violation|1|||
105314708|NCT00425373|363148647|FG003|Overall Study|Protocol Violation|0|||
105314709|NCT00425373|363148648|FG004|Overall Study|Protocol Violation|0|||
105314710|NCT00425373|363148649|FG005|Overall Study|Protocol Violation|0|||
105314711|NCT00425373|363148650|FG006|Overall Study|Protocol Violation|0|||
105314712|NCT00425373|363148651|FG007|Overall Study|Protocol Violation|5|||
105314713|NCT00425373|363148652|FG008|Overall Study|Protocol Violation|3|||
105314714|NCT00425373|363148644|FG000|Overall Study|Withdrawal by Subject|2|||
105314715|NCT00425373|363148645|FG001|Overall Study|Withdrawal by Subject|0|||
105314716|NCT00425373|363148646|FG002|Overall Study|Withdrawal by Subject|2|||
105314717|NCT00425373|363148647|FG003|Overall Study|Withdrawal by Subject|1|||
105314718|NCT00425373|363148648|FG004|Overall Study|Withdrawal by Subject|4|||
105314719|NCT00425373|363148649|FG005|Overall Study|Withdrawal by Subject|0|||
105314720|NCT00425373|363148650|FG006|Overall Study|Withdrawal by Subject|2|||
105314721|NCT00425373|363148651|FG007|Overall Study|Withdrawal by Subject|2|||
105314722|NCT00425373|363148652|FG008|Overall Study|Withdrawal by Subject|2|||
105314723|NCT00425373|363148644|FG000|Overall Study|Lack of Efficacy|0|||
105314724|NCT00425373|363148645|FG001|Overall Study|Lack of Efficacy|0|||
105314725|NCT00425373|363148646|FG002|Overall Study|Lack of Efficacy|0|||
105314726|NCT00425373|363148647|FG003|Overall Study|Lack of Efficacy|0|||
105314727|NCT00425373|363148648|FG004|Overall Study|Lack of Efficacy|1|||
105314728|NCT00425373|363148649|FG005|Overall Study|Lack of Efficacy|3|||
105314729|NCT00425373|363148650|FG006|Overall Study|Lack of Efficacy|3|||
105314730|NCT00425373|363148651|FG007|Overall Study|Lack of Efficacy|0|||
105314731|NCT00425373|363148652|FG008|Overall Study|Lack of Efficacy|5|||
105314732|NCT02309138|363148654|FG000|Overall Study|Withdrawal by Subject|44|||
105314733|NCT02309138|363148655|FG001|Overall Study|Withdrawal by Subject|15|||
105314734|NCT02309138|363148654|FG000|Overall Study|Protocol Violation|4|||
105314735|NCT02309138|363148655|FG001|Overall Study|Protocol Violation|2|||
105314736|NCT02309138|363148654|FG000|Overall Study|delivered before visit 2|0|||
105314737|NCT02309138|363148655|FG001|Overall Study|delivered before visit 2|1|||
105314738|NCT02564887|363148656|FG000|Overall Study|Lost to Follow-up|6|||
105314739|NCT02564887|363148657|FG001|Overall Study|Lost to Follow-up|0|||
105314740|NCT02052011|363148661|FG000|Overall Study|Lost to Follow-up|3|||
105314741|NCT02052011|363148662|FG001|Overall Study|Lost to Follow-up|0|||
105314742|NCT02052011|363148661|FG000|Overall Study|Withdrawal by Subject|1|||
105314743|NCT02052011|363148662|FG001|Overall Study|Withdrawal by Subject|2|||
105314744|NCT00735397|363148665|FG000|Overall Study|Adverse Event|194|||
105314745|NCT00735397|363148665|FG000|Overall Study|Lost to Follow-up|33|||
105314746|NCT00735397|363148665|FG000|Overall Study|Participant choice|252|||
105314747|NCT00735397|363148665|FG000|Overall Study|Inadequate therapeutic effect|202|||
105314748|NCT00735397|363148665|FG000|Overall Study|Administrative/Other|502|||
105314749|NCT01851330|363148666|FG000|Overall Study|Lack of Efficacy|10|||
105314750|NCT01851330|363148667|FG001|Overall Study|Lack of Efficacy|9|||
105314751|NCT01851330|363148668|FG002|Overall Study|Lack of Efficacy|2|||
105314752|NCT01851330|363148666|FG000|Overall Study|Lost to Follow-up|1|||
105314753|NCT01851330|363148667|FG001|Overall Study|Lost to Follow-up|6|||
105314754|NCT01851330|363148668|FG002|Overall Study|Lost to Follow-up|9|||
105314755|NCT01851330|363148666|FG000|Overall Study|Withdrew Consent|2|||
105314756|NCT01851330|363148667|FG001|Overall Study|Withdrew Consent|1|||
105314757|NCT01851330|363148668|FG002|Overall Study|Withdrew Consent|0|||
105314758|NCT01851330|363148666|FG000|Overall Study|Investigator's Discretion|0|||
105314759|NCT01851330|363148667|FG001|Overall Study|Investigator's Discretion|0|||
105314760|NCT01851330|363148668|FG002|Overall Study|Investigator's Discretion|1|||
105314761|NCT03421730|363148669|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105314762|NCT03421730|363148670|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
105314763|NCT03421730|363148671|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105314764|NCT03421730|363148672|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105314765|NCT03421730|363148673|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105314766|NCT03421730|363148674|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105314767|NCT03421730|363148675|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105314768|NCT03421730|363148676|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105314769|NCT03421730|363148677|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105314770|NCT03421730|363148678|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105314771|NCT03421730|363148679|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105314772|NCT03421730|363148680|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105314773|NCT03421730|363148669|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105314774|NCT03421730|363148670|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105314775|NCT03421730|363148671|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105314776|NCT03421730|363148672|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105314777|NCT03421730|363148673|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
105314778|NCT03421730|363148674|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105314779|NCT03421730|363148675|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105314780|NCT03421730|363148676|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105314781|NCT03421730|363148677|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105314782|NCT03421730|363148678|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105314783|NCT03421730|363148679|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105314784|NCT03421730|363148680|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105314785|NCT02648932|363148681|FG000|Overall Study|No transplant|3|||
105314786|NCT02648932|363148682|FG001|Overall Study|No transplant|1|||
105314787|NCT01199016|363148683|FG000|Overall Study|No longer meets eligibility criteria|4|||
105314788|NCT01199016|363148683|FG000|Overall Study|Entrance criteria|5|||
105314789|NCT01199016|363148683|FG000|Overall Study|Protocol Violation|9|||
105368480|NCT00264147|363354224|FG003|Treatment I Period|Lost to Follow-up|1|||
105314790|NCT01199016|363148683|FG000|Overall Study|Other|13|||
105314791|NCT01199016|363148683|FG000|Overall Study|Withdrawal by Subject|21|||
105314792|NCT01199016|363148683|FG000|Overall Study|Lost to Follow-up|25|||
105314793|NCT02960490|363148692|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
105314794|NCT02960490|363148693|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
105314795|NCT02960490|363148694|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
105314796|NCT02960490|363148695|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
105314797|NCT02960490|363148696|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
105842960|NCT04146363|365082444|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842961|NCT04146363|365082445|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842962|NCT04146363|365082446|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842963|NCT04146363|365082447|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842964|NCT04146363|365082448|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
105842965|NCT04146363|365082449|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842966|NCT02914236|365082456|FG000|Overall Study|Lost to Follow-up|1|||
105842967|NCT02676284|365082463|FG000|Overall Study|Withdrawal by Subject|1|||
105842968|NCT01221090|365082464|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
105842969|NCT01221090|365082465|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
105842970|NCT01221090|365082466|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
105842971|NCT01221090|365082467|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
105842972|NCT01221090|365082464|FG000|Overall Study|Withdrawal by Subject|0|||
105842973|NCT01221090|365082465|FG001|Overall Study|Withdrawal by Subject|22|||
105842974|NCT01221090|365082466|FG002|Overall Study|Withdrawal by Subject|27|||
105842975|NCT01221090|365082467|FG003|Overall Study|Withdrawal by Subject|2|||
105842976|NCT00708708|365082468|FG000|Overall Study|Another therapy instead of Enbrel|141|||
105842977|NCT00708708|365082468|FG000|Overall Study|Lost to Follow-up|52|||
105842978|NCT00708708|365082468|FG000|Overall Study|Withdrawal by Subject|51|||
105842979|NCT00708708|365082468|FG000|Overall Study|Intolerance|42|||
105842980|NCT00708708|365082468|FG000|Overall Study|Another therapy along with Enbrel|15|||
105842981|NCT00708708|365082468|FG000|Overall Study|Other unspecified|11|||
105842982|NCT00708708|365082468|FG000|Overall Study|Good effectiveness|9|||
105842983|NCT00708708|365082468|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
105842984|NCT00708708|365082468|FG000|Overall Study|Administrative reasons|7|||
105842985|NCT00708708|365082468|FG000|Overall Study|Lack of effectiveness|4|||
105842986|NCT00708708|365082468|FG000|Overall Study|Lack of compliance|3|||
105842987|NCT00708708|365082468|FG000|Overall Study|Pregnancy|3|||
105842988|NCT00708708|365082468|FG000|Overall Study|Adverse Event|3|||
105842989|NCT00708708|365082468|FG000|Overall Study|Missing values|392|||
105842990|NCT00440466|365082472|FG000|Overall Study|Death|3|||
105842991|NCT00440466|365082473|FG001|Overall Study|Death|2|||
105842992|NCT00440466|365082474|FG002|Overall Study|Death|9|||
105842993|NCT00440466|365082472|FG000|Overall Study|Adverse Event|3|||
105842994|NCT00440466|365082473|FG001|Overall Study|Adverse Event|4|||
105842995|NCT00440466|365082474|FG002|Overall Study|Adverse Event|11|||
105842996|NCT00440466|365082472|FG000|Overall Study|Lost to Follow-up|1|||
105842997|NCT00440466|365082473|FG001|Overall Study|Lost to Follow-up|0|||
105842998|NCT00440466|365082474|FG002|Overall Study|Lost to Follow-up|2|||
105842999|NCT00440466|365082472|FG000|Overall Study|Physician Decision|2|||
105843000|NCT00440466|365082473|FG001|Overall Study|Physician Decision|0|||
105843001|NCT00440466|365082474|FG002|Overall Study|Physician Decision|1|||
105843002|NCT00440466|365082472|FG000|Overall Study|Protocol Violation|2|||
105843003|NCT00440466|365082473|FG001|Overall Study|Protocol Violation|0|||
105843004|NCT00440466|365082474|FG002|Overall Study|Protocol Violation|4|||
105843005|NCT00440466|365082472|FG000|Overall Study|Withdrawal by Subject|2|||
105843006|NCT00440466|365082473|FG001|Overall Study|Withdrawal by Subject|5|||
105843007|NCT00440466|365082474|FG002|Overall Study|Withdrawal by Subject|9|||
105843008|NCT00440466|365082472|FG000|Overall Study|Began Dialysis|0|||
105843009|NCT00440466|365082473|FG001|Overall Study|Began Dialysis|0|||
105843010|NCT00440466|365082474|FG002|Overall Study|Began Dialysis|1|||
105314798|NCT02960490|363148697|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
105314799|NCT02960490|363148698|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
105314800|NCT02960490|363148699|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
105314801|NCT02960490|363148700|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
105314802|NCT02960490|363148701|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
105314803|NCT02960490|363148692|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105314804|NCT02960490|363148693|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
105314805|NCT02960490|363148694|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105314806|NCT02960490|363148695|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105314807|NCT02960490|363148696|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105843011|NCT00440466|365082472|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
105843012|NCT00440466|365082473|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
105843013|NCT00440466|365082474|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
105843014|NCT00880087|365082475|FG000|Overall Study|Lost to Follow-up|0|||
105843015|NCT00880087|365082476|FG001|Overall Study|Lost to Follow-up|2|||
105843016|NCT01286558|365082479|FG000|Overall Study|Adverse Event|1|||
105843017|NCT01286558|365082480|FG001|Overall Study|Adverse Event|1|||
105843018|NCT01286558|365082479|FG000|Overall Study|Withdrawal by Subject|0|||
105843019|NCT01286558|365082480|FG001|Overall Study|Withdrawal by Subject|1|||
105314808|NCT02960490|363148697|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105314809|NCT02960490|363148698|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105843020|NCT00418522|365082487|FG000|Overall Study|Adverse Event|7|||
105843021|NCT00418522|365082488|FG001|Overall Study|Adverse Event|1|||
105843022|NCT00418522|365082487|FG000|Overall Study|Lack of Efficacy|1|||
105843023|NCT00418522|365082488|FG001|Overall Study|Lack of Efficacy|3|||
105843024|NCT00418522|365082487|FG000|Overall Study|Lost to Follow-up|10|||
105843025|NCT00418522|365082488|FG001|Overall Study|Lost to Follow-up|4|||
105843026|NCT00418522|365082487|FG000|Overall Study|Withdrawal by Subject|31|||
105843027|NCT00418522|365082488|FG001|Overall Study|Withdrawal by Subject|7|||
105843028|NCT00418522|365082487|FG000|Overall Study|Other|27|||
105843029|NCT00418522|365082488|FG001|Overall Study|Other|23|||
105843030|NCT00418522|365082487|FG000|Overall Study|Randomized but did not receive treatment|7|||
105843031|NCT00418522|365082488|FG001|Overall Study|Randomized but did not receive treatment|4|||
105843032|NCT02695719|365082490|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
105843033|NCT02695719|365082491|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
105843034|NCT02695719|365082490|FG000|Overall Study|Significant Protocol Deviation|0|||
105843035|NCT02695719|365082491|FG001|Overall Study|Significant Protocol Deviation|1|||
105843036|NCT02695719|365082490|FG000|Overall Study|Voluntary Withdrawal|1|||
105843037|NCT02695719|365082491|FG001|Overall Study|Voluntary Withdrawal|0|||
105843038|NCT02129647|365082498|FG000|Overall Study|Adverse Event|2|||
105843039|NCT02129647|365082498|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
105843040|NCT01117337|365082499|FG000|Overall Study|Lost to Follow-up|4|||
105843041|NCT01117337|365082500|FG001|Overall Study|Lost to Follow-up|0|||
105843042|NCT01231373|365082504|FG000|Overall Study|Withdrew consent prior to randomization|2|||
105843043|NCT01231373|365082505|FG001|Overall Study|Withdrew consent prior to randomization|1|||
105843044|NCT01231373|365082506|FG002|Overall Study|Withdrew consent prior to randomization|0|||
105843045|NCT01231373|365082507|FG003|Overall Study|Withdrew consent prior to randomization|0|||
105843046|NCT01231373|365082504|FG000|Overall Study|Lost to Follow-up|0|||
105843047|NCT01231373|365082505|FG001|Overall Study|Lost to Follow-up|0|||
105843048|NCT01231373|365082506|FG002|Overall Study|Lost to Follow-up|0|||
105843049|NCT01231373|365082507|FG003|Overall Study|Lost to Follow-up|1|||
105843050|NCT01231373|365082504|FG000|Overall Study|Withdrew Consent|1|||
105843051|NCT01231373|365082505|FG001|Overall Study|Withdrew Consent|0|||
105843052|NCT01231373|365082506|FG002|Overall Study|Withdrew Consent|0|||
105843053|NCT01231373|365082507|FG003|Overall Study|Withdrew Consent|0|||
105843054|NCT00614822|365082512|FG000|Overall Study|Adverse Event|3|||
105843055|NCT00102687|365082515|FG000|Initial Period|Withdrawal by Subject|6|||
105843056|NCT00102687|365082516|FG001|Initial Period|Withdrawal by Subject|3|||
105843057|NCT00102687|365082517|FG002|Initial Period|Withdrawal by Subject|5|||
105843058|NCT00102687|365082518|FG003|Initial Period|Withdrawal by Subject|0|||
105843059|NCT00102687|365082519|FG004|Initial Period|Withdrawal by Subject|0|||
105843060|NCT00102687|365082515|FG000|Initial Period|Adverse Event|4|||
105843061|NCT00102687|365082516|FG001|Initial Period|Adverse Event|7|||
105843062|NCT00102687|365082517|FG002|Initial Period|Adverse Event|9|||
105843063|NCT00102687|365082518|FG003|Initial Period|Adverse Event|0|||
105843064|NCT00102687|365082519|FG004|Initial Period|Adverse Event|0|||
105843065|NCT00102687|365082515|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
105843066|NCT00102687|365082516|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
105843067|NCT00102687|365082517|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
105843068|NCT00102687|365082518|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
105843069|NCT00102687|365082519|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
105843070|NCT00102687|365082515|FG000|Initial Period|Protocol Violation|0|||
105843071|NCT00102687|365082516|FG001|Initial Period|Protocol Violation|0|||
105843072|NCT00102687|365082517|FG002|Initial Period|Protocol Violation|2|||
105843073|NCT00102687|365082518|FG003|Initial Period|Protocol Violation|0|||
105843074|NCT00102687|365082519|FG004|Initial Period|Protocol Violation|0|||
105843075|NCT00102687|365082515|FG000|Initial Period|Physician Decision|2|||
105843076|NCT00102687|365082516|FG001|Initial Period|Physician Decision|9|||
105843077|NCT00102687|365082517|FG002|Initial Period|Physician Decision|6|||
105843078|NCT00102687|365082518|FG003|Initial Period|Physician Decision|0|||
105314810|NCT02960490|363148699|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105843079|NCT00102687|365082519|FG004|Initial Period|Physician Decision|0|||
105843080|NCT00102687|365082515|FG000|Initial Period|Sponsor's decision|0|||
105843081|NCT00102687|365082516|FG001|Initial Period|Sponsor's decision|1|||
105843082|NCT00102687|365082517|FG002|Initial Period|Sponsor's decision|1|||
105843083|NCT00102687|365082518|FG003|Initial Period|Sponsor's decision|0|||
105843084|NCT00102687|365082519|FG004|Initial Period|Sponsor's decision|0|||
105843085|NCT00102687|365082515|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
105843086|NCT00102687|365082516|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
105843087|NCT00102687|365082517|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
105843088|NCT00102687|365082518|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
105843089|NCT00102687|365082519|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
105843090|NCT00102687|365082515|FG000|Initial Period|Death|1|||
105843091|NCT00102687|365082516|FG001|Initial Period|Death|1|||
105843092|NCT00102687|365082517|FG002|Initial Period|Death|1|||
105843093|NCT00102687|365082518|FG003|Initial Period|Death|0|||
105843094|NCT00102687|365082519|FG004|Initial Period|Death|0|||
105843095|NCT00102687|365082515|FG000|Maintenance Period|Withdrawal by Subject|4|||
105843096|NCT00102687|365082516|FG001|Maintenance Period|Withdrawal by Subject|0|||
105843097|NCT00102687|365082517|FG002|Maintenance Period|Withdrawal by Subject|2|||
105843098|NCT00102687|365082518|FG003|Maintenance Period|Withdrawal by Subject|3|||
105843099|NCT00102687|365082519|FG004|Maintenance Period|Withdrawal by Subject|1|||
105843100|NCT00102687|365082515|FG000|Maintenance Period|Adverse Event|1|||
105843101|NCT00102687|365082516|FG001|Maintenance Period|Adverse Event|0|||
105843102|NCT00102687|365082517|FG002|Maintenance Period|Adverse Event|0|||
105843103|NCT00102687|365082518|FG003|Maintenance Period|Adverse Event|1|||
105843104|NCT00102687|365082519|FG004|Maintenance Period|Adverse Event|3|||
105843105|NCT00102687|365082515|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
105843106|NCT00102687|365082516|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
105843107|NCT00102687|365082517|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
105843108|NCT00102687|365082518|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
105843109|NCT00102687|365082519|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
105843110|NCT00102687|365082515|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
105843111|NCT00102687|365082516|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
105843112|NCT00102687|365082517|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
105843113|NCT00102687|365082518|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
105843114|NCT00102687|365082519|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
105843115|NCT00102687|365082515|FG000|Maintenance Period|Death|0|||
105843116|NCT00102687|365082516|FG001|Maintenance Period|Death|0|||
105843117|NCT00102687|365082517|FG002|Maintenance Period|Death|0|||
105843118|NCT00102687|365082518|FG003|Maintenance Period|Death|1|||
105843119|NCT00102687|365082519|FG004|Maintenance Period|Death|1|||
105843120|NCT00102687|365082515|FG000|Maintenance Period|Physician Decision|1|||
105843121|NCT00102687|365082516|FG001|Maintenance Period|Physician Decision|2|||
105843122|NCT00102687|365082517|FG002|Maintenance Period|Physician Decision|3|||
105843123|NCT00102687|365082518|FG003|Maintenance Period|Physician Decision|0|||
105843124|NCT00102687|365082519|FG004|Maintenance Period|Physician Decision|4|||
105843125|NCT02865395|365082524|FG000|Overall Study|Physician Decision|6|||
105314811|NCT02960490|363148700|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105314812|NCT02960490|363148701|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105314813|NCT02960490|363148692|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
105314814|NCT02960490|363148693|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
105314815|NCT02960490|363148694|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105314816|NCT02960490|363148695|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105314817|NCT02960490|363148696|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105314818|NCT02960490|363148697|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105314819|NCT02960490|363148698|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105314820|NCT02960490|363148699|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105314821|NCT02960490|363148700|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105314822|NCT02960490|363148701|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105314823|NCT02960490|363148692|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
105314824|NCT02960490|363148693|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
105314825|NCT02960490|363148694|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
105314826|NCT02960490|363148695|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
105314827|NCT02960490|363148696|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
105314828|NCT02960490|363148697|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
105314829|NCT02960490|363148698|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
105314830|NCT02960490|363148699|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
105314831|NCT02960490|363148700|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
105314832|NCT02960490|363148701|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
105314833|NCT02960490|363148692|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
105314834|NCT02960490|363148693|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
105314835|NCT02960490|363148694|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
105314836|NCT02960490|363148695|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
105314837|NCT02960490|363148696|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
105314838|NCT02960490|363148697|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
105314839|NCT02960490|363148698|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
105314840|NCT02960490|363148699|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
105314841|NCT02960490|363148700|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
105314842|NCT02960490|363148701|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
105314843|NCT02960490|363148692|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105314844|NCT02960490|363148693|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105314845|NCT02960490|363148694|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
105314846|NCT02960490|363148695|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105314847|NCT02960490|363148696|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
105314848|NCT02960490|363148697|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105314849|NCT02960490|363148698|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105843126|NCT02865395|365082525|FG001|Overall Study|Physician Decision|10|||
105843127|NCT02865395|365082526|FG002|Overall Study|Physician Decision|7|||
105843128|NCT02363439|365082528|FG000|Overall Study|Lack of Efficacy|4|||
105843129|NCT01875471|365082530|FG000|Overall Study|Adverse Event|0|||
105843130|NCT01875471|365082531|FG001|Overall Study|Adverse Event|1|||
105843131|NCT01875471|365082530|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
105843132|NCT01875471|365082531|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
105843133|NCT02610816|365082534|FG000|Phase 1|Withdrawal by Subject|2|||
105843134|NCT02610816|365082535|FG001|Phase 1|Withdrawal by Subject|6|||
105843135|NCT02610816|365082536|FG002|Phase 1|Withdrawal by Subject|0|||
105843136|NCT02610816|365082537|FG003|Phase 1|Withdrawal by Subject|0|||
105843137|NCT02610816|365082534|FG000|Phase 1|Lost to Follow-up|2|||
105843138|NCT02610816|365082535|FG001|Phase 1|Lost to Follow-up|1|||
105843139|NCT02610816|365082536|FG002|Phase 1|Lost to Follow-up|0|||
105843140|NCT02610816|365082537|FG003|Phase 1|Lost to Follow-up|0|||
105843141|NCT02610816|365082534|FG000|Phase 1|Physician Decision|0|||
105843142|NCT02610816|365082535|FG001|Phase 1|Physician Decision|1|||
105843143|NCT02610816|365082536|FG002|Phase 1|Physician Decision|0|||
105843144|NCT02610816|365082537|FG003|Phase 1|Physician Decision|0|||
105843145|NCT02610816|365082534|FG000|Phase 2|Withdrawal by Subject|0|||
105843146|NCT02610816|365082535|FG001|Phase 2|Withdrawal by Subject|0|||
105843147|NCT02610816|365082536|FG002|Phase 2|Withdrawal by Subject|9|||
105843148|NCT02610816|365082537|FG003|Phase 2|Withdrawal by Subject|3|||
105843149|NCT02610816|365082534|FG000|Phase 2|Lost to Follow-up|0|||
105843150|NCT02610816|365082535|FG001|Phase 2|Lost to Follow-up|0|||
105843151|NCT02610816|365082536|FG002|Phase 2|Lost to Follow-up|2|||
105843152|NCT02610816|365082537|FG003|Phase 2|Lost to Follow-up|0|||
105843153|NCT02610816|365082534|FG000|Phase 2|Physician Decision|0|||
105843154|NCT02610816|365082535|FG001|Phase 2|Physician Decision|0|||
105843155|NCT02610816|365082536|FG002|Phase 2|Physician Decision|0|||
105843156|NCT02610816|365082537|FG003|Phase 2|Physician Decision|2|||
105843157|NCT02610816|365082534|FG000|Phase 2|Pregnancy|0|||
105843158|NCT02610816|365082535|FG001|Phase 2|Pregnancy|0|||
105843159|NCT02610816|365082536|FG002|Phase 2|Pregnancy|0|||
105843160|NCT02610816|365082537|FG003|Phase 2|Pregnancy|1|||
105843161|NCT02691741|365082538|FG000|Overall Study|Adverse Event|0|||
105843162|NCT02691741|365082539|FG001|Overall Study|Adverse Event|2|||
105843163|NCT02691741|365082538|FG000|Overall Study|Lost to Follow-up|1|||
105314850|NCT02960490|363148699|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105314851|NCT02960490|363148700|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105314852|NCT02960490|363148701|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105314853|NCT02960490|363148692|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
105314854|NCT02960490|363148693|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
105314855|NCT02960490|363148694|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
105314856|NCT02960490|363148695|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
105314857|NCT02960490|363148696|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
105314858|NCT02960490|363148697|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
105314859|NCT02960490|363148698|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
105314860|NCT02960490|363148699|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
105314861|NCT02960490|363148700|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
105314862|NCT02960490|363148701|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
105314863|NCT02960490|363148692|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
105314864|NCT02960490|363148693|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
105314865|NCT02960490|363148694|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
105314866|NCT02960490|363148695|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
105314867|NCT02960490|363148696|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
105314868|NCT02960490|363148697|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
105314869|NCT02960490|363148698|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
105314870|NCT02960490|363148699|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
105314871|NCT02960490|363148700|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
105314872|NCT02960490|363148701|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
105314873|NCT02960490|363148692|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105314874|NCT02960490|363148693|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105314875|NCT02960490|363148694|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105314876|NCT02960490|363148695|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105314877|NCT02960490|363148696|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105314878|NCT02960490|363148697|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105843164|NCT02691741|365082539|FG001|Overall Study|Lost to Follow-up|0|||
105843165|NCT02691741|365082538|FG000|Overall Study|Physician Decision|0|||
105843166|NCT02691741|365082539|FG001|Overall Study|Physician Decision|1|||
105843167|NCT02691741|365082538|FG000|Overall Study|Withdrawal by Subject|0|||
105843168|NCT02691741|365082539|FG001|Overall Study|Withdrawal by Subject|4|||
105843169|NCT02243293|365082540|FG000|Overall Study|Adverse Event|1|||
105843170|NCT02243293|365082541|FG001|Overall Study|Adverse Event|0|||
105843171|NCT02243293|365082542|FG002|Overall Study|Adverse Event|0|||
105843172|NCT02243293|365082543|FG003|Overall Study|Adverse Event|0|||
105843173|NCT02243293|365082544|FG004|Overall Study|Adverse Event|0|||
105843174|NCT02243293|365082545|FG005|Overall Study|Adverse Event|0|||
105843175|NCT02243293|365082546|FG006|Overall Study|Adverse Event|0|||
105843176|NCT02243293|365082547|FG007|Overall Study|Adverse Event|0|||
105843177|NCT02243293|365082548|FG008|Overall Study|Adverse Event|0|||
105843178|NCT02243293|365082549|FG009|Overall Study|Adverse Event|0|||
105843179|NCT02243293|365082550|FG010|Overall Study|Adverse Event|0|||
105843180|NCT02243293|365082551|FG011|Overall Study|Adverse Event|0|||
105843181|NCT02243293|365082552|FG012|Overall Study|Adverse Event|0|||
105843182|NCT02243293|365082553|FG013|Overall Study|Adverse Event|0|||
105843183|NCT02243293|365082554|FG014|Overall Study|Adverse Event|0|||
105843184|NCT02243293|365082555|FG015|Overall Study|Adverse Event|1|||
105843185|NCT02243293|365082556|FG016|Overall Study|Adverse Event|0|||
105843186|NCT02243293|365082557|FG017|Overall Study|Adverse Event|0|||
105843187|NCT02243293|365082558|FG018|Overall Study|Adverse Event|0|||
105843188|NCT02243293|365082559|FG019|Overall Study|Adverse Event|0|||
105843189|NCT02243293|365082560|FG020|Overall Study|Adverse Event|1|||
105843190|NCT02243293|365082561|FG021|Overall Study|Adverse Event|0|||
105843191|NCT02243293|365082540|FG000|Overall Study|Withdrawal by Subject|1|||
105843192|NCT02243293|365082541|FG001|Overall Study|Withdrawal by Subject|0|||
105843193|NCT02243293|365082542|FG002|Overall Study|Withdrawal by Subject|0|||
105843194|NCT02243293|365082543|FG003|Overall Study|Withdrawal by Subject|0|||
105843195|NCT02243293|365082544|FG004|Overall Study|Withdrawal by Subject|0|||
105843196|NCT02243293|365082545|FG005|Overall Study|Withdrawal by Subject|0|||
105843197|NCT02243293|365082546|FG006|Overall Study|Withdrawal by Subject|0|||
105843198|NCT02243293|365082547|FG007|Overall Study|Withdrawal by Subject|0|||
105843199|NCT02243293|365082548|FG008|Overall Study|Withdrawal by Subject|0|||
105843200|NCT02243293|365082549|FG009|Overall Study|Withdrawal by Subject|1|||
105843201|NCT02243293|365082550|FG010|Overall Study|Withdrawal by Subject|0|||
105843202|NCT02243293|365082551|FG011|Overall Study|Withdrawal by Subject|1|||
105843203|NCT02243293|365082552|FG012|Overall Study|Withdrawal by Subject|0|||
105843204|NCT02243293|365082553|FG013|Overall Study|Withdrawal by Subject|0|||
105843205|NCT02243293|365082554|FG014|Overall Study|Withdrawal by Subject|0|||
105843206|NCT02243293|365082555|FG015|Overall Study|Withdrawal by Subject|0|||
105843207|NCT02243293|365082556|FG016|Overall Study|Withdrawal by Subject|0|||
105843208|NCT02243293|365082557|FG017|Overall Study|Withdrawal by Subject|0|||
105843209|NCT02243293|365082558|FG018|Overall Study|Withdrawal by Subject|0|||
105843210|NCT02243293|365082559|FG019|Overall Study|Withdrawal by Subject|0|||
105843211|NCT02243293|365082560|FG020|Overall Study|Withdrawal by Subject|0|||
105843212|NCT02243293|365082561|FG021|Overall Study|Withdrawal by Subject|1|||
105843213|NCT02243293|365082540|FG000|Overall Study|Lost to Follow-up|0|||
105843214|NCT02243293|365082541|FG001|Overall Study|Lost to Follow-up|1|||
105843215|NCT02243293|365082542|FG002|Overall Study|Lost to Follow-up|1|||
105843216|NCT02243293|365082543|FG003|Overall Study|Lost to Follow-up|1|||
105843217|NCT02243293|365082544|FG004|Overall Study|Lost to Follow-up|0|||
105843218|NCT02243293|365082545|FG005|Overall Study|Lost to Follow-up|0|||
105843219|NCT02243293|365082546|FG006|Overall Study|Lost to Follow-up|3|||
105843220|NCT02243293|365082547|FG007|Overall Study|Lost to Follow-up|0|||
105843221|NCT02243293|365082548|FG008|Overall Study|Lost to Follow-up|0|||
105843222|NCT02243293|365082549|FG009|Overall Study|Lost to Follow-up|0|||
105843223|NCT02243293|365082550|FG010|Overall Study|Lost to Follow-up|0|||
105843224|NCT02243293|365082551|FG011|Overall Study|Lost to Follow-up|2|||
105843225|NCT02243293|365082552|FG012|Overall Study|Lost to Follow-up|0|||
105843226|NCT02243293|365082553|FG013|Overall Study|Lost to Follow-up|0|||
105843227|NCT02243293|365082554|FG014|Overall Study|Lost to Follow-up|0|||
105843228|NCT02243293|365082555|FG015|Overall Study|Lost to Follow-up|0|||
105843229|NCT02243293|365082556|FG016|Overall Study|Lost to Follow-up|3|||
105843230|NCT02243293|365082557|FG017|Overall Study|Lost to Follow-up|1|||
105843231|NCT02243293|365082558|FG018|Overall Study|Lost to Follow-up|0|||
105843232|NCT02243293|365082559|FG019|Overall Study|Lost to Follow-up|0|||
105843233|NCT02243293|365082560|FG020|Overall Study|Lost to Follow-up|1|||
105843234|NCT02243293|365082561|FG021|Overall Study|Lost to Follow-up|2|||
105843235|NCT02243293|365082540|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
105843236|NCT02243293|365082541|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
105843237|NCT02243293|365082542|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
105843238|NCT02243293|365082543|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
105843239|NCT02243293|365082544|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
105843240|NCT02243293|365082545|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
105843241|NCT02243293|365082546|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
105843242|NCT02243293|365082547|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
105843243|NCT02243293|365082548|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
105843244|NCT02243293|365082549|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
105843245|NCT02243293|365082550|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
105843246|NCT02243293|365082551|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
105843247|NCT02243293|365082552|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
105843248|NCT02243293|365082553|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
105843249|NCT02243293|365082554|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
105843250|NCT02243293|365082555|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
105843251|NCT02243293|365082556|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
105843252|NCT02243293|365082557|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
105843253|NCT02243293|365082558|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
105843254|NCT02243293|365082559|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
105314879|NCT02960490|363148698|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105314880|NCT02960490|363148699|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
105314881|NCT02960490|363148700|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105314882|NCT02960490|363148701|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105314883|NCT02960490|363148692|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
105314884|NCT02960490|363148693|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
105314885|NCT02960490|363148694|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
105314886|NCT02960490|363148695|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
105314887|NCT02960490|363148696|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
105314888|NCT02960490|363148697|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
105314889|NCT02960490|363148698|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
105314890|NCT02960490|363148699|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
105314891|NCT02960490|363148700|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
105314892|NCT02960490|363148701|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
105314893|NCT02960490|363148692|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105314894|NCT02960490|363148693|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105314895|NCT02960490|363148694|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105314896|NCT02960490|363148695|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105314897|NCT02960490|363148696|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105314898|NCT02960490|363148697|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105314899|NCT02960490|363148698|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
105314900|NCT02960490|363148699|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105314901|NCT02960490|363148700|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105314902|NCT02960490|363148701|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105314903|NCT02960490|363148692|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
105314904|NCT02960490|363148693|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
105314905|NCT02960490|363148694|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
105314906|NCT02960490|363148695|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
105314907|NCT02960490|363148696|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
105314908|NCT02960490|363148697|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
105314909|NCT02960490|363148698|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
105314910|NCT02960490|363148699|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
105314911|NCT02960490|363148700|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
105314912|NCT02960490|363148701|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
105314913|NCT02114385|363148702|FG000|Overall Study|Withdrawal by Subject|3|||
105314914|NCT02114385|363148703|FG001|Overall Study|Withdrawal by Subject|2|||
105314915|NCT02114385|363148702|FG000|Overall Study|Lost to Follow-up|0|||
105314916|NCT02114385|363148703|FG001|Overall Study|Lost to Follow-up|6|||
105314917|NCT00811928|363148708|FG000|Overall Study|AEs and SAEs Including Death|7|||
105314918|NCT00811928|363148709|FG001|Overall Study|AEs and SAEs Including Death|11|||
105314919|NCT00811928|363148708|FG000|Overall Study|Withdrawal by Subject|18|||
105314920|NCT00811928|363148709|FG001|Overall Study|Withdrawal by Subject|12|||
105314921|NCT00811928|363148708|FG000|Overall Study|Did Not Take Study Drug|3|||
105314922|NCT00811928|363148709|FG001|Overall Study|Did Not Take Study Drug|0|||
105314923|NCT00811928|363148708|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
105314924|NCT00811928|363148709|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
105314925|NCT00811928|363148708|FG000|Overall Study|Investigator Decision|2|||
105314926|NCT00811928|363148709|FG001|Overall Study|Investigator Decision|1|||
105314927|NCT00811928|363148708|FG000|Overall Study|Poor Compliance|2|||
105314928|NCT00811928|363148709|FG001|Overall Study|Poor Compliance|5|||
105314929|NCT00447876|363148710|FG000|Overall Study|Withdrawal by Subject|1|||
105314930|NCT00447876|363148711|FG001|Overall Study|Withdrawal by Subject|4|||
105314931|NCT00447876|363148710|FG000|Overall Study|Lost to Follow-up|1|||
105314932|NCT00447876|363148711|FG001|Overall Study|Lost to Follow-up|0|||
105314933|NCT00447876|363148710|FG000|Overall Study|Deterioration of symptomology|1|||
105314934|NCT00447876|363148711|FG001|Overall Study|Deterioration of symptomology|0|||
105314935|NCT02533180|363148712|FG000|Overall Study|Death|0|||
105314936|NCT02533180|363148713|FG001|Overall Study|Death|2|||
105314937|NCT02533180|363148712|FG000|Overall Study|Lost to Follow-up|0|||
105314938|NCT02533180|363148713|FG001|Overall Study|Lost to Follow-up|1|||
105314939|NCT02533180|363148712|FG000|Overall Study|Physician Decision|0|||
105314940|NCT02533180|363148713|FG001|Overall Study|Physician Decision|1|||
105314941|NCT02533180|363148712|FG000|Overall Study|Withdrawal by Subject|2|||
105843255|NCT02243293|365082560|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
105843256|NCT02243293|365082561|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
105314942|NCT02533180|363148713|FG001|Overall Study|Withdrawal by Subject|5|||
105314943|NCT02533180|363148712|FG000|Overall Study|Screen Failure|37|||
105368481|NCT00264147|363354225|FG004|Treatment I Period|Lost to Follow-up|1|||
105368482|NCT00264147|363354226|FG005|Treatment I Period|Lost to Follow-up|0|||
105368483|NCT00264147|363354221|FG000|Treatment I Period|Protocol Violation|2|||
105368484|NCT00264147|363354222|FG001|Treatment I Period|Protocol Violation|2|||
105368485|NCT00264147|363354223|FG002|Treatment I Period|Protocol Violation|0|||
105368486|NCT00264147|363354224|FG003|Treatment I Period|Protocol Violation|0|||
105368487|NCT00264147|363354225|FG004|Treatment I Period|Protocol Violation|0|||
105368488|NCT00264147|363354226|FG005|Treatment I Period|Protocol Violation|0|||
105368489|NCT00264147|363354221|FG000|Treatment I Period|Withdrawal by Subject|2|||
105368490|NCT00264147|363354222|FG001|Treatment I Period|Withdrawal by Subject|0|||
105368491|NCT00264147|363354223|FG002|Treatment I Period|Withdrawal by Subject|0|||
105368492|NCT00264147|363354224|FG003|Treatment I Period|Withdrawal by Subject|2|||
105368493|NCT00264147|363354225|FG004|Treatment I Period|Withdrawal by Subject|2|||
105368494|NCT00264147|363354226|FG005|Treatment I Period|Withdrawal by Subject|0|||
105368495|NCT00264147|363354221|FG000|Treatment I Period|Patient out of town for an extended time|0|||
105368496|NCT00264147|363354222|FG001|Treatment I Period|Patient out of town for an extended time|1|||
105368497|NCT00264147|363354223|FG002|Treatment I Period|Patient out of town for an extended time|0|||
105368498|NCT00264147|363354224|FG003|Treatment I Period|Patient out of town for an extended time|0|||
105368499|NCT00264147|363354225|FG004|Treatment I Period|Patient out of town for an extended time|0|||
105368500|NCT00264147|363354226|FG005|Treatment I Period|Patient out of town for an extended time|0|||
105368501|NCT00264147|363354221|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
105368502|NCT00264147|363354222|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
105368503|NCT00264147|363354223|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
105368504|NCT00264147|363354224|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
105368505|NCT00264147|363354225|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
105368506|NCT00264147|363354226|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
105368507|NCT00264147|363354221|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
105368508|NCT00264147|363354222|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
105368509|NCT00264147|363354223|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
105368510|NCT00264147|363354224|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
105368511|NCT00264147|363354225|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
105368512|NCT00264147|363354226|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
105368513|NCT00264147|363354221|FG000|Treatment II Period|Adverse Event|0|||
105368514|NCT00264147|363354222|FG001|Treatment II Period|Adverse Event|0|||
105368515|NCT00264147|363354223|FG002|Treatment II Period|Adverse Event|0|||
105843257|NCT02243293|365082540|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
105843258|NCT02243293|365082541|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
105843259|NCT02243293|365082542|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
105843260|NCT02243293|365082543|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
105843261|NCT02243293|365082544|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
105843262|NCT02243293|365082545|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
105843263|NCT02243293|365082546|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
105843264|NCT02243293|365082547|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
105843265|NCT02243293|365082548|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
105843266|NCT02243293|365082549|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
105843267|NCT02243293|365082550|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
105843268|NCT02243293|365082551|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
105368516|NCT00264147|363354224|FG003|Treatment II Period|Adverse Event|0|||
105368517|NCT00264147|363354225|FG004|Treatment II Period|Adverse Event|9|||
105843269|NCT02243293|365082552|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
105843270|NCT02243293|365082553|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
105843271|NCT02243293|365082554|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
105843272|NCT02243293|365082555|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
105843273|NCT02243293|365082556|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
105843274|NCT02243293|365082557|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
105843275|NCT02243293|365082558|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
105843276|NCT02243293|365082559|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
105843277|NCT02243293|365082560|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
105843278|NCT02243293|365082561|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
105843279|NCT01688726|365082562|FG000|Overall Study|Adverse Event|1|||
105843280|NCT01688726|365082563|FG001|Overall Study|Adverse Event|0|||
105843281|NCT01688726|365082562|FG000|Overall Study|Relocated abroad|0|||
105843282|NCT01688726|365082563|FG001|Overall Study|Relocated abroad|1|||
105843283|NCT00710749|365082565|FG000|First Intervention|Withdrawal by Subject|1|||
105843284|NCT00710749|365082566|FG001|First Intervention|Withdrawal by Subject|0|||
105368518|NCT00264147|363354226|FG005|Treatment II Period|Adverse Event|9|||
105368519|NCT00264147|363354221|FG000|Treatment II Period|Laboratory Adverse Event|0|||
105368520|NCT00264147|363354222|FG001|Treatment II Period|Laboratory Adverse Event|0|||
105843285|NCT04678817|365084171|FG000|Overall Study|Lost to Follow-up|28|||
105843286|NCT04678817|365084172|FG001|Overall Study|Lost to Follow-up|0|||
105368521|NCT00264147|363354223|FG002|Treatment II Period|Laboratory Adverse Event|0|||
105368522|NCT00264147|363354224|FG003|Treatment II Period|Laboratory Adverse Event|0|||
105368523|NCT00264147|363354225|FG004|Treatment II Period|Laboratory Adverse Event|0|||
105368524|NCT00264147|363354226|FG005|Treatment II Period|Laboratory Adverse Event|1|||
105368525|NCT00264147|363354221|FG000|Treatment II Period|Lack of Efficacy|0|||
105368526|NCT00264147|363354222|FG001|Treatment II Period|Lack of Efficacy|0|||
105368527|NCT00264147|363354223|FG002|Treatment II Period|Lack of Efficacy|0|||
105368528|NCT00264147|363354224|FG003|Treatment II Period|Lack of Efficacy|0|||
105368529|NCT00264147|363354225|FG004|Treatment II Period|Lack of Efficacy|20|||
105368530|NCT00264147|363354226|FG005|Treatment II Period|Lack of Efficacy|19|||
105368531|NCT00264147|363354221|FG000|Treatment II Period|Lost to Follow-up|0|||
105368532|NCT00264147|363354222|FG001|Treatment II Period|Lost to Follow-up|0|||
105368533|NCT00264147|363354223|FG002|Treatment II Period|Lost to Follow-up|0|||
105368534|NCT00264147|363354224|FG003|Treatment II Period|Lost to Follow-up|0|||
105368535|NCT00264147|363354225|FG004|Treatment II Period|Lost to Follow-up|1|||
105368536|NCT00264147|363354226|FG005|Treatment II Period|Lost to Follow-up|1|||
105368537|NCT00264147|363354221|FG000|Treatment II Period|Withdrawal by Subject|0|||
105368538|NCT00264147|363354222|FG001|Treatment II Period|Withdrawal by Subject|0|||
105368539|NCT00264147|363354223|FG002|Treatment II Period|Withdrawal by Subject|0|||
105368540|NCT00264147|363354224|FG003|Treatment II Period|Withdrawal by Subject|0|||
105368541|NCT00264147|363354225|FG004|Treatment II Period|Withdrawal by Subject|3|||
105368542|NCT00264147|363354226|FG005|Treatment II Period|Withdrawal by Subject|2|||
105368543|NCT00264147|363354221|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
105368544|NCT00264147|363354222|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
105368545|NCT00264147|363354223|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
105368546|NCT00264147|363354224|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
105368547|NCT00264147|363354225|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
105368548|NCT00264147|363354226|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
105368549|NCT03234465|363354227|FG000|Overall Study|Adverse Event|4|||
105368550|NCT03234465|363354228|FG001|Overall Study|Adverse Event|2|||
105368551|NCT03234465|363354227|FG000|Overall Study|Death|0|||
105368552|NCT03234465|363354228|FG001|Overall Study|Death|1|||
105368553|NCT03234465|363354227|FG000|Overall Study|Lost to Follow-up|1|||
105368554|NCT03234465|363354228|FG001|Overall Study|Lost to Follow-up|1|||
105368555|NCT03234465|363354227|FG000|Overall Study|Withdrawal by Subject|12|||
105368556|NCT03234465|363354228|FG001|Overall Study|Withdrawal by Subject|27|||
105368557|NCT03234465|363354227|FG000|Overall Study|Symptomatic deterioration|0|||
105368558|NCT03234465|363354228|FG001|Overall Study|Symptomatic deterioration|1|||
105368559|NCT03234465|363354227|FG000|Overall Study|Non-compliance|2|||
105368560|NCT03234465|363354228|FG001|Overall Study|Non-compliance|0|||
105368561|NCT03234465|363354227|FG000|Overall Study|Other|14|||
105368562|NCT03234465|363354228|FG001|Overall Study|Other|8|||
105368563|NCT02247466|363354236|FG000|Overall Study|Procedure changed to open surgery|0|||
105368564|NCT02247466|363354237|FG001|Overall Study|Procedure changed to open surgery|3|||
105368565|NCT00721799|363354238|FG000|Overall Study|Withdrawal by Subject|7|||
105368566|NCT00721799|363354238|FG000|Overall Study|withdraw by subject after scan 1|1|||
105368567|NCT00764790|363354241|FG000|Overall Study|Protocol Violation|0|||
105368568|NCT00764790|363354242|FG001|Overall Study|Protocol Violation|0|||
105368569|NCT00764790|363354243|FG002|Overall Study|Protocol Violation|1|||
105368570|NCT00764790|363354241|FG000|Overall Study|Withdrawal by Subject|10|||
105368571|NCT00764790|363354242|FG001|Overall Study|Withdrawal by Subject|12|||
105368572|NCT00764790|363354243|FG002|Overall Study|Withdrawal by Subject|6|||
105368573|NCT00764790|363354241|FG000|Overall Study|Lost to Follow-up|28|||
105368574|NCT00764790|363354242|FG001|Overall Study|Lost to Follow-up|29|||
105368575|NCT00764790|363354243|FG002|Overall Study|Lost to Follow-up|23|||
105368576|NCT03533751|363354244|FG000|Overall Study|Withdrawal by Subject|12|||
105368577|NCT03533751|363354245|FG001|Overall Study|Withdrawal by Subject|6|||
105368578|NCT03533751|363354246|FG002|Overall Study|Withdrawal by Subject|11|||
105368579|NCT03533751|363354247|FG003|Overall Study|Withdrawal by Subject|9|||
105490079|NCT00920829|363807451|FG001|Available for Analysis|Adverse Event|2|||
105490080|NCT00920829|363807452|FG002|Available for Analysis|Adverse Event|1|||
105490081|NCT00920829|363807453|FG003|Available for Analysis|Adverse Event|0|||
105490082|NCT00920829|363807450|FG000|Available for Analysis|Death|1|||
105368580|NCT03533751|363354248|FG004|Overall Study|Withdrawal by Subject|10|||
105368581|NCT03533751|363354244|FG000|Overall Study|Adverse Event|4|||
105368582|NCT03533751|363354245|FG001|Overall Study|Adverse Event|7|||
105368583|NCT03533751|363354246|FG002|Overall Study|Adverse Event|2|||
105368584|NCT03533751|363354247|FG003|Overall Study|Adverse Event|4|||
105368585|NCT03533751|363354248|FG004|Overall Study|Adverse Event|5|||
105368586|NCT03533751|363354244|FG000|Overall Study|Physician Decision|0|||
105368587|NCT03533751|363354245|FG001|Overall Study|Physician Decision|2|||
105368588|NCT03533751|363354246|FG002|Overall Study|Physician Decision|1|||
105368589|NCT03533751|363354247|FG003|Overall Study|Physician Decision|2|||
105368590|NCT03533751|363354248|FG004|Overall Study|Physician Decision|1|||
105368591|NCT03533751|363354244|FG000|Overall Study|Sponsor Decision|0|||
105368592|NCT03533751|363354245|FG001|Overall Study|Sponsor Decision|0|||
105368593|NCT03533751|363354246|FG002|Overall Study|Sponsor Decision|1|||
105368594|NCT03533751|363354247|FG003|Overall Study|Sponsor Decision|1|||
105314944|NCT02533180|363148713|FG001|Overall Study|Screen Failure|0|||
105314945|NCT02533180|363148712|FG000|Overall Study|Protocol Deviation|0|||
105314946|NCT02533180|363148713|FG001|Overall Study|Protocol Deviation|1|||
105314947|NCT02533180|363148712|FG000|Overall Study|Non-compliance|0|||
105314948|NCT02533180|363148713|FG001|Overall Study|Non-compliance|1|||
105314949|NCT01890434|363148714|FG000|Overall Study|Adverse Event|8|||
105314950|NCT01890434|363148714|FG000|Overall Study|PCI at external hospital|1|||
105314951|NCT01890434|363148714|FG000|Overall Study|Assessment discrepancy|1|||
105314952|NCT01890434|363148714|FG000|Overall Study|CRC didn't contact participant for FU|1|||
105314953|NCT01890434|363148714|FG000|Overall Study|Could not get whole set of images|1|||
105314954|NCT01890434|363148714|FG000|Overall Study|Decline to return for GSPECT|1|||
105314955|NCT01890434|363148714|FG000|Overall Study|GSPECT at rest was not done|1|||
105314956|NCT01890434|363148714|FG000|Overall Study|Participant didn't complete MRI|1|||
105368595|NCT03533751|363354248|FG004|Overall Study|Sponsor Decision|0|||
105314957|NCT01890434|363148714|FG000|Overall Study|Uncontactable by phone|1|||
105314958|NCT01890434|363148714|FG000|Overall Study|Moved out of position|1|||
105314959|NCT01890434|363148714|FG000|Overall Study|Unable to contact|1|||
105314960|NCT01890434|363148714|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
105314961|NCT03280381|363148716|FG000|Overall Study|Physician Decision|0|||
105314962|NCT03280381|363148717|FG001|Overall Study|Physician Decision|2|||
105314963|NCT01141205|363148718|FG000|Overall Study|Physician Decision|1|||
105314964|NCT01141205|363148719|FG001|Overall Study|Physician Decision|1|||
105314965|NCT01141205|363148718|FG000|Overall Study|Lost to Follow-up|1|||
105314966|NCT01141205|363148719|FG001|Overall Study|Lost to Follow-up|0|||
105314967|NCT01141205|363148718|FG000|Overall Study|Withdrawal by Subject|1|||
105314968|NCT01141205|363148719|FG001|Overall Study|Withdrawal by Subject|1|||
105314969|NCT01267994|363148720|FG000|Overall Study|Adverse Event|2|||
105314970|NCT02655666|363148721|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
105314971|NCT05199090|363148725|FG000|Overall Study|Adverse Event|1|||
105314972|NCT05199090|363148726|FG001|Overall Study|Adverse Event|4|||
105314973|NCT05199090|363148727|FG002|Overall Study|Adverse Event|0|||
105314974|NCT05199090|363148728|FG003|Overall Study|Adverse Event|0|||
105314975|NCT05199090|363148729|FG004|Overall Study|Adverse Event|0|||
105314976|NCT05199090|363148730|FG005|Overall Study|Adverse Event|0|||
105314977|NCT05199090|363148725|FG000|Overall Study|Lost to Follow-up|1|||
105314978|NCT05199090|363148726|FG001|Overall Study|Lost to Follow-up|0|||
105314979|NCT05199090|363148727|FG002|Overall Study|Lost to Follow-up|1|||
105314980|NCT05199090|363148728|FG003|Overall Study|Lost to Follow-up|4|||
105314981|NCT05199090|363148729|FG004|Overall Study|Lost to Follow-up|0|||
105314982|NCT05199090|363148730|FG005|Overall Study|Lost to Follow-up|5|||
105314983|NCT05199090|363148725|FG000|Overall Study|Physician Decision|0|||
105314984|NCT05199090|363148726|FG001|Overall Study|Physician Decision|0|||
105314985|NCT05199090|363148727|FG002|Overall Study|Physician Decision|0|||
105314986|NCT05199090|363148728|FG003|Overall Study|Physician Decision|0|||
105314987|NCT05199090|363148729|FG004|Overall Study|Physician Decision|0|||
105314988|NCT05199090|363148730|FG005|Overall Study|Physician Decision|1|||
105314989|NCT05199090|363148725|FG000|Overall Study|Study terminated by sponsor|0|||
105314990|NCT05199090|363148726|FG001|Overall Study|Study terminated by sponsor|6|||
105314991|NCT05199090|363148727|FG002|Overall Study|Study terminated by sponsor|0|||
105314992|NCT05199090|363148728|FG003|Overall Study|Study terminated by sponsor|0|||
105314993|NCT05199090|363148729|FG004|Overall Study|Study terminated by sponsor|0|||
105314994|NCT05199090|363148730|FG005|Overall Study|Study terminated by sponsor|5|||
105314995|NCT05199090|363148725|FG000|Overall Study|Subject decision|0|||
105314996|NCT05199090|363148726|FG001|Overall Study|Subject decision|4|||
105314997|NCT05199090|363148727|FG002|Overall Study|Subject decision|0|||
105314998|NCT05199090|363148728|FG003|Overall Study|Subject decision|2|||
105314999|NCT05199090|363148729|FG004|Overall Study|Subject decision|5|||
105315000|NCT05199090|363148730|FG005|Overall Study|Subject decision|2|||
105315001|NCT02552732|363148731|FG000|Overall Study|Lost to Follow-up|2|||
105315002|NCT02552732|363148731|FG000|Overall Study|Physician Decision|1|||
105315003|NCT02552732|363148731|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
105368596|NCT03533751|363354244|FG000|Overall Study|Lost to Follow-up|3|||
105368597|NCT03533751|363354245|FG001|Overall Study|Lost to Follow-up|7|||
105368598|NCT03533751|363354246|FG002|Overall Study|Lost to Follow-up|6|||
105368599|NCT03533751|363354247|FG003|Overall Study|Lost to Follow-up|4|||
105315004|NCT02552732|363148731|FG000|Overall Study|Withdrawal by Subject|6|||
105315005|NCT03968978|363148732|FG000|Overall Study|Adverse Event|1|||
105315006|NCT03968978|363148733|FG001|Overall Study|Adverse Event|0|||
105315007|NCT02996487|363148734|FG000|Overall Study|Lost to Follow-up|1|||
105315008|NCT02996487|363148735|FG001|Overall Study|Lost to Follow-up|1|||
105315009|NCT02996487|363148736|FG002|Overall Study|Lost to Follow-up|0|||
105315010|NCT02996487|363148734|FG000|Overall Study|Death|0|||
105315011|NCT02996487|363148735|FG001|Overall Study|Death|1|||
105576569|NCT01622348|364110217|FG002|Overall Study|Withdrawal by Subject|1|||
105315012|NCT02996487|363148736|FG002|Overall Study|Death|0|||
105315013|NCT02996487|363148734|FG000|Overall Study|Withdrawal by Subject|2|||
105368600|NCT03533751|363354248|FG004|Overall Study|Lost to Follow-up|3|||
105368601|NCT03533751|363354244|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
105368602|NCT03533751|363354245|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
105368603|NCT03533751|363354246|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
105368604|NCT03533751|363354247|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
105368605|NCT03533751|363354248|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
105368606|NCT03533751|363354244|FG000|Overall Study|Other|0|||
105368607|NCT03533751|363354245|FG001|Overall Study|Other|2|||
105368608|NCT03533751|363354246|FG002|Overall Study|Other|1|||
105368609|NCT03533751|363354247|FG003|Overall Study|Other|0|||
105843287|NCT04678817|365084173|FG002|Overall Study|Lost to Follow-up|0|||
105843288|NCT00493246|365084174|FG000|Overall Study|Withdrawal by Subject|0|||
105843289|NCT00493246|365084175|FG001|Overall Study|Withdrawal by Subject|0|||
105843290|NCT00493246|365084176|FG002|Overall Study|Withdrawal by Subject|0|||
105843291|NCT00493246|365084177|FG003|Overall Study|Withdrawal by Subject|0|||
105843292|NCT00493246|365084178|FG004|Overall Study|Withdrawal by Subject|1|||
105843293|NCT00493246|365084179|FG005|Overall Study|Withdrawal by Subject|0|||
105843294|NCT00493246|365084180|FG006|Overall Study|Withdrawal by Subject|0|||
105843295|NCT00493246|365084181|FG007|Overall Study|Withdrawal by Subject|0|||
105843296|NCT00493246|365084174|FG000|Overall Study|No access to draw blood|0|||
105843297|NCT00493246|365084175|FG001|Overall Study|No access to draw blood|0|||
105843298|NCT00493246|365084176|FG002|Overall Study|No access to draw blood|0|||
105843299|NCT00493246|365084177|FG003|Overall Study|No access to draw blood|0|||
105843300|NCT00493246|365084178|FG004|Overall Study|No access to draw blood|0|||
105843301|NCT00493246|365084179|FG005|Overall Study|No access to draw blood|1|||
105843302|NCT00493246|365084180|FG006|Overall Study|No access to draw blood|0|||
105843303|NCT00493246|365084181|FG007|Overall Study|No access to draw blood|0|||
105843304|NCT00493246|365084174|FG000|Overall Study|Lost to Follow-up|0|||
105843305|NCT00493246|365084175|FG001|Overall Study|Lost to Follow-up|0|||
105843306|NCT00493246|365084176|FG002|Overall Study|Lost to Follow-up|0|||
105843307|NCT00493246|365084177|FG003|Overall Study|Lost to Follow-up|0|||
105843308|NCT00493246|365084178|FG004|Overall Study|Lost to Follow-up|0|||
105843309|NCT00493246|365084179|FG005|Overall Study|Lost to Follow-up|0|||
105843310|NCT00493246|365084180|FG006|Overall Study|Lost to Follow-up|1|||
105843311|NCT00493246|365084181|FG007|Overall Study|Lost to Follow-up|0|||
105843312|NCT00706095|365084182|FG000|Overall Study|Progressive Disease|4|||
105843313|NCT00706095|365084183|FG001|Overall Study|Progressive Disease|5|||
105843314|NCT00706095|365084184|FG002|Overall Study|Progressive Disease|3|||
105843315|NCT00706095|365084182|FG000|Overall Study|Clinical Progression|1|||
105843316|NCT00706095|365084183|FG001|Overall Study|Clinical Progression|2|||
105843317|NCT00706095|365084184|FG002|Overall Study|Clinical Progression|2|||
105843318|NCT00706095|365084182|FG000|Overall Study|Withdrawal by Subject|1|||
105843319|NCT00706095|365084183|FG001|Overall Study|Withdrawal by Subject|0|||
105843320|NCT00706095|365084184|FG002|Overall Study|Withdrawal by Subject|0|||
105843321|NCT04109313|365084185|FG000|Overall Study|Pregnancy|1|||
105843322|NCT04109313|365084185|FG000|Overall Study|Adverse Event|11|||
105843323|NCT04109313|365084185|FG000|Overall Study|Lack of Efficacy|11|||
105843324|NCT04109313|365084185|FG000|Overall Study|Lost to Follow-up|1|||
105843325|NCT04109313|365084185|FG000|Overall Study|Physician Decision|2|||
105843326|NCT04109313|365084185|FG000|Overall Study|Subject Decision|13|||
105843327|NCT04109313|365084185|FG000|Overall Study|Covid-19 situation|2|||
105843328|NCT00655850|365084186|FG000|Overall Study|Death|2|||
105843329|NCT00655850|365084186|FG000|Overall Study|Withdrawal by Subject|1|||
105843330|NCT00140413|365084187|FG000|Overall Study|Lost to Follow-up|1|||
105843331|NCT00140413|365084188|FG001|Overall Study|Lost to Follow-up|0|||
105843332|NCT00140413|365084187|FG000|Overall Study|Withdrawal by Subject|2|||
105315014|NCT02996487|363148735|FG001|Overall Study|Withdrawal by Subject|3|||
105315015|NCT02996487|363148736|FG002|Overall Study|Withdrawal by Subject|0|||
105315016|NCT02027428|363148737|FG000|Induction|Never treated|7|||
105315017|NCT02027428|363148738|FG001|Induction|Never treated|0|||
105315018|NCT02027428|363148739|FG002|Induction|Never treated|0|||
105315019|NCT02027428|363148737|FG000|Induction|Progressive disease|77|||
105315020|NCT02027428|363148738|FG001|Induction|Progressive disease|0|||
105315021|NCT02027428|363148739|FG002|Induction|Progressive disease|0|||
105315022|NCT02027428|363148737|FG000|Induction|Adverse Event|51|||
105315023|NCT02027428|363148738|FG001|Induction|Adverse Event|0|||
105315024|NCT02027428|363148739|FG002|Induction|Adverse Event|0|||
105315025|NCT02027428|363148737|FG000|Induction|Withdrawal by Subject|22|||
105315026|NCT02027428|363148738|FG001|Induction|Withdrawal by Subject|0|||
105315027|NCT02027428|363148739|FG002|Induction|Withdrawal by Subject|0|||
105315028|NCT02027428|363148737|FG000|Induction|Death|21|||
105843333|NCT00140413|365084188|FG001|Overall Study|Withdrawal by Subject|0|||
105843334|NCT00099268|365084193|FG000|Overall Study|Withdrawal by Subject|46|||
105843335|NCT00099268|365084194|FG001|Overall Study|Withdrawal by Subject|28|||
105843336|NCT00099268|365084193|FG000|Overall Study|Adverse Event|19|||
105843337|NCT00099268|365084194|FG001|Overall Study|Adverse Event|19|||
105843338|NCT00099268|365084193|FG000|Overall Study|Protocol Violation|9|||
105843339|NCT00099268|365084194|FG001|Overall Study|Protocol Violation|8|||
105843340|NCT00099268|365084193|FG000|Overall Study|Lost to Follow-up|6|||
105843341|NCT00099268|365084194|FG001|Overall Study|Lost to Follow-up|4|||
105843342|NCT00099268|365084193|FG000|Overall Study|Lack of Efficacy|5|||
105368610|NCT03533751|363354248|FG004|Overall Study|Other|3|||
105368611|NCT01499810|363354249|FG000|Overall Study|Lost to Follow-up|10|||
105368612|NCT01499810|363354249|FG000|Overall Study|Protocol Violation|1|||
105368613|NCT01499810|363354249|FG000|Overall Study|Withdrawal by Subject|1|||
105368614|NCT05117060|363354250|FG000|Overall Study|Adverse Event|3|||
105368615|NCT05117060|363354251|FG001|Overall Study|Adverse Event|5|||
105368616|NCT05117060|363354252|FG002|Overall Study|Adverse Event|6|||
105368617|NCT05117060|363354253|FG003|Overall Study|Adverse Event|1|||
105368618|NCT05117060|363354250|FG000|Overall Study|Lost to Follow-up|0|||
105368619|NCT05117060|363354251|FG001|Overall Study|Lost to Follow-up|0|||
105368620|NCT05117060|363354252|FG002|Overall Study|Lost to Follow-up|0|||
105368621|NCT05117060|363354253|FG003|Overall Study|Lost to Follow-up|1|||
105368622|NCT05117060|363354250|FG000|Overall Study|Lack of Efficacy|4|||
105368623|NCT05117060|363354251|FG001|Overall Study|Lack of Efficacy|5|||
105368624|NCT05117060|363354252|FG002|Overall Study|Lack of Efficacy|2|||
105368625|NCT05117060|363354253|FG003|Overall Study|Lack of Efficacy|6|||
105368626|NCT05117060|363354250|FG000|Overall Study|Withdrawal by Subject|8|||
105368627|NCT05117060|363354251|FG001|Overall Study|Withdrawal by Subject|5|||
105368628|NCT05117060|363354252|FG002|Overall Study|Withdrawal by Subject|5|||
105368629|NCT05117060|363354253|FG003|Overall Study|Withdrawal by Subject|6|||
105368630|NCT05117060|363354250|FG000|Overall Study|Other|2|||
105368631|NCT05117060|363354251|FG001|Overall Study|Other|1|||
105368632|NCT05117060|363354252|FG002|Overall Study|Other|3|||
105368633|NCT05117060|363354253|FG003|Overall Study|Other|1|||
105368634|NCT04158219|363354254|FG000|Overall Study|Lost to Follow-up|1|||
105368635|NCT01324947|363354255|FG000|Overall Study|Adverse Event|7|||
105368636|NCT01324947|363354255|FG000|Overall Study|Death|10|||
105368637|NCT01324947|363354255|FG000|Overall Study|Other|3|||
105368638|NCT01324947|363354255|FG000|Overall Study|Progressive Disease|50|||
105368639|NCT01324947|363354255|FG000|Overall Study|Withdrawal by Subject|3|||
105368640|NCT01324947|363354255|FG000|Overall Study|1 discontinued before starting drug|1|||
105368641|NCT01274351|363354256|FG000|Overall Study|Lost to Follow-up|1|||
105368642|NCT01274351|363354256|FG000|Overall Study|patient not compliant with the protocol|1|||
105368643|NCT01274351|363354256|FG000|Overall Study|Pregnancy|1|||
105368644|NCT01274351|363354256|FG000|Overall Study|Death|2|||
105368645|NCT01274351|363354256|FG000|Overall Study|Withdrawal by Subject|3|||
105368646|NCT01274351|363354256|FG000|Overall Study|Adverse Event|8|||
105368647|NCT01274351|363354256|FG000|Overall Study|progression of disease|3|||
105368648|NCT01274351|363354256|FG000|Overall Study|hospitalization|1|||
105368649|NCT01655901|363356233|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
105368650|NCT01655901|363356234|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
105368651|NCT01655901|363356235|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
105368652|NCT01655901|363356236|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
105368653|NCT01655901|363356237|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
105843343|NCT00099268|365084194|FG001|Overall Study|Lack of Efficacy|18|||
105843344|NCT00099268|365084193|FG000|Overall Study|Administrative problems|4|||
105843345|NCT00099268|365084194|FG001|Overall Study|Administrative problems|4|||
105843346|NCT00099268|365084193|FG000|Overall Study|Death|3|||
105843347|NCT00099268|365084194|FG001|Overall Study|Death|1|||
105843348|NCT01360866|365084195|FG000|Overall Study|Lost to Follow-up|11|||
105843349|NCT01360866|365084196|FG001|Overall Study|Lost to Follow-up|28|||
105843350|NCT01360866|365084197|FG002|Overall Study|Lost to Follow-up|41|||
105843351|NCT01360866|365084198|FG003|Overall Study|Lost to Follow-up|0|||
105843352|NCT01360866|365084195|FG000|Overall Study|Adverse Event|56|||
105843353|NCT01360866|365084196|FG001|Overall Study|Adverse Event|61|||
105843354|NCT01360866|365084197|FG002|Overall Study|Adverse Event|134|||
105843355|NCT01360866|365084198|FG003|Overall Study|Adverse Event|6|||
105368654|NCT01655901|363356238|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
105368655|NCT00945243|363356243|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
105368656|NCT00754741|363356246|FG000|Overall Study|Died or disenrolled|57|||
105368657|NCT00754741|363356247|FG001|Overall Study|Died or disenrolled|69|||
105576570|NCT04747275|364110220|FG000|Overall Study|Study terminated|0|||
105843356|NCT01360866|365084195|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
105843357|NCT01360866|365084196|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
105843358|NCT01360866|365084197|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
105843359|NCT01360866|365084198|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
105843360|NCT01360866|365084195|FG000|Overall Study|Withdrawn by Investigator|9|||
105843361|NCT01360866|365084196|FG001|Overall Study|Withdrawn by Investigator|8|||
105843362|NCT01360866|365084197|FG002|Overall Study|Withdrawn by Investigator|31|||
105843363|NCT01360866|365084198|FG003|Overall Study|Withdrawn by Investigator|2|||
105843364|NCT01360866|365084195|FG000|Overall Study|Withdrawal by participant|79|||
105843365|NCT01360866|365084196|FG001|Overall Study|Withdrawal by participant|89|||
105368658|NCT00754741|363356248|FG002|Overall Study|Died or disenrolled|54|||
105368659|NCT00922636|363356249|FG000|Overall Study|Adverse Event|3|||
105843366|NCT01360866|365084197|FG002|Overall Study|Withdrawal by participant|168|||
105843367|NCT01360866|365084198|FG003|Overall Study|Withdrawal by participant|8|||
105843368|NCT01360866|365084195|FG000|Overall Study|Protocol Deviation|25|||
105368660|NCT00922636|363356250|FG001|Overall Study|Adverse Event|3|||
105368661|NCT00922636|363356251|FG002|Overall Study|Adverse Event|2|||
105368662|NCT00922636|363356252|FG003|Overall Study|Adverse Event|3|||
105368663|NCT00922636|363356253|FG004|Overall Study|Adverse Event|2|||
105368664|NCT00922636|363356249|FG000|Overall Study|Lack of Efficacy|1|||
105368665|NCT00922636|363356250|FG001|Overall Study|Lack of Efficacy|7|||
105368666|NCT00922636|363356251|FG002|Overall Study|Lack of Efficacy|3|||
105368667|NCT00922636|363356252|FG003|Overall Study|Lack of Efficacy|2|||
105315029|NCT02027428|363148738|FG001|Induction|Death|0|||
105315030|NCT02027428|363148739|FG002|Induction|Death|0|||
105315031|NCT02027428|363148737|FG000|Induction|Symptomatic deterioration|16|||
105315032|NCT02027428|363148738|FG001|Induction|Symptomatic deterioration|0|||
105315033|NCT02027428|363148739|FG002|Induction|Symptomatic deterioration|0|||
105315034|NCT02027428|363148737|FG000|Induction|Study terminated by sponsor|12|||
105315035|NCT02027428|363148738|FG001|Induction|Study terminated by sponsor|0|||
105315036|NCT02027428|363148739|FG002|Induction|Study terminated by sponsor|0|||
105315037|NCT02027428|363148737|FG000|Induction|Protocol Violation|1|||
105315038|NCT02027428|363148738|FG001|Induction|Protocol Violation|0|||
105315039|NCT02027428|363148739|FG002|Induction|Protocol Violation|0|||
105315040|NCT02027428|363148737|FG000|Induction|Miscellaneous|14|||
105315041|NCT02027428|363148738|FG001|Induction|Miscellaneous|0|||
105315042|NCT02027428|363148739|FG002|Induction|Miscellaneous|0|||
105315043|NCT02027428|363148737|FG000|Induction|Induction Treatment Ongoing|4|||
105315044|NCT02027428|363148738|FG001|Induction|Induction Treatment Ongoing|0|||
105315045|NCT02027428|363148739|FG002|Induction|Induction Treatment Ongoing|0|||
105315046|NCT02027428|363148737|FG000|Maintenance|Death|0|||
105315047|NCT02027428|363148738|FG001|Maintenance|Death|3|||
105315048|NCT02027428|363148739|FG002|Maintenance|Death|2|||
105315049|NCT02027428|363148737|FG000|Maintenance|Adverse Event|0|||
105368668|NCT00922636|363356253|FG004|Overall Study|Lack of Efficacy|4|||
105368669|NCT00922636|363356249|FG000|Overall Study|Sponsor Decision|0|||
105368670|NCT00922636|363356250|FG001|Overall Study|Sponsor Decision|0|||
105368671|NCT00922636|363356251|FG002|Overall Study|Sponsor Decision|2|||
105368672|NCT00922636|363356252|FG003|Overall Study|Sponsor Decision|0|||
105368673|NCT00922636|363356253|FG004|Overall Study|Sponsor Decision|0|||
105368674|NCT00922636|363356249|FG000|Overall Study|Withdrawal by Subject|0|||
105368675|NCT00922636|363356250|FG001|Overall Study|Withdrawal by Subject|0|||
105368676|NCT00922636|363356251|FG002|Overall Study|Withdrawal by Subject|5|||
105368677|NCT00922636|363356252|FG003|Overall Study|Withdrawal by Subject|2|||
105368678|NCT00922636|363356253|FG004|Overall Study|Withdrawal by Subject|4|||
105368679|NCT00922636|363356249|FG000|Overall Study|Protocol Violation|0|||
105368680|NCT00922636|363356250|FG001|Overall Study|Protocol Violation|0|||
105368681|NCT00922636|363356251|FG002|Overall Study|Protocol Violation|2|||
105368682|NCT00922636|363356252|FG003|Overall Study|Protocol Violation|2|||
105368683|NCT00922636|363356253|FG004|Overall Study|Protocol Violation|0|||
105368684|NCT00922636|363356249|FG000|Overall Study|Entry Criteria Not Met|0|||
105368685|NCT00922636|363356250|FG001|Overall Study|Entry Criteria Not Met|0|||
105368686|NCT00922636|363356251|FG002|Overall Study|Entry Criteria Not Met|1|||
105368687|NCT00922636|363356252|FG003|Overall Study|Entry Criteria Not Met|1|||
105368688|NCT00922636|363356253|FG004|Overall Study|Entry Criteria Not Met|0|||
105368689|NCT00922636|363356249|FG000|Overall Study|Parent/Caregiver Decision|2|||
105368690|NCT00922636|363356250|FG001|Overall Study|Parent/Caregiver Decision|4|||
105368691|NCT00922636|363356251|FG002|Overall Study|Parent/Caregiver Decision|3|||
105368692|NCT00922636|363356252|FG003|Overall Study|Parent/Caregiver Decision|5|||
105368693|NCT00922636|363356253|FG004|Overall Study|Parent/Caregiver Decision|2|||
105368694|NCT00922636|363356249|FG000|Overall Study|Lost to Follow-up|1|||
105368695|NCT00922636|363356250|FG001|Overall Study|Lost to Follow-up|2|||
105368696|NCT00922636|363356251|FG002|Overall Study|Lost to Follow-up|2|||
105368697|NCT00922636|363356252|FG003|Overall Study|Lost to Follow-up|2|||
105368698|NCT00922636|363356253|FG004|Overall Study|Lost to Follow-up|4|||
105368699|NCT02308046|363356258|FG000|Overall Study|Negative yeast culture at Baseline|32|||
105368700|NCT02308046|363356259|FG001|Overall Study|Negative yeast culture at Baseline|33|||
105368701|NCT02308046|363356258|FG000|Overall Study|Positive for STD at Baseline|1|||
105315050|NCT02027428|363148738|FG001|Maintenance|Adverse Event|21|||
105315051|NCT02027428|363148739|FG002|Maintenance|Adverse Event|1|||
105368702|NCT02308046|363356259|FG001|Overall Study|Positive for STD at Baseline|2|||
105315052|NCT02027428|363148737|FG000|Maintenance|Progressive disease|0|||
105315053|NCT02027428|363148738|FG001|Maintenance|Progressive disease|84|||
105368703|NCT02308046|363356258|FG000|Overall Study|Lost to Follow-up|1|||
105368704|NCT02308046|363356259|FG001|Overall Study|Lost to Follow-up|3|||
105368705|NCT01926028|363356260|FG000|Overall Study|Lost to Follow-up|7|||
105368706|NCT01926028|363356261|FG001|Overall Study|Lost to Follow-up|6|||
105368707|NCT01926028|363356262|FG002|Overall Study|Lost to Follow-up|0|||
105368708|NCT01926028|363356260|FG000|Overall Study|Physician Decision|1|||
105368709|NCT01926028|363356261|FG001|Overall Study|Physician Decision|5|||
105368710|NCT01926028|363356262|FG002|Overall Study|Physician Decision|0|||
105315054|NCT02027428|363148739|FG002|Maintenance|Progressive disease|47|||
105368711|NCT01926028|363356260|FG000|Overall Study|Withdrawal by Subject|9|||
105315055|NCT02027428|363148737|FG000|Maintenance|Symptomatic deterioration|0|||
105368712|NCT01926028|363356261|FG001|Overall Study|Withdrawal by Subject|9|||
105368713|NCT01926028|363356262|FG002|Overall Study|Withdrawal by Subject|2|||
105315056|NCT02027428|363148738|FG001|Maintenance|Symptomatic deterioration|4|||
105315057|NCT02027428|363148739|FG002|Maintenance|Symptomatic deterioration|1|||
105315058|NCT02027428|363148737|FG000|Maintenance|Withdrawal by Subject|0|||
105315059|NCT02027428|363148738|FG001|Maintenance|Withdrawal by Subject|6|||
105315060|NCT02027428|363148739|FG002|Maintenance|Withdrawal by Subject|5|||
105315061|NCT02027428|363148737|FG000|Maintenance|Protocol Violation|0|||
105315062|NCT02027428|363148738|FG001|Maintenance|Protocol Violation|0|||
105315063|NCT02027428|363148739|FG002|Maintenance|Protocol Violation|1|||
105315064|NCT02027428|363148737|FG000|Maintenance|Other|0|||
105315065|NCT02027428|363148738|FG001|Maintenance|Other|6|||
105315066|NCT02027428|363148739|FG002|Maintenance|Other|3|||
105315067|NCT02027428|363148737|FG000|Survival Follow-up|Death|0|||
105315068|NCT02027428|363148738|FG001|Survival Follow-up|Death|78|||
105315069|NCT02027428|363148739|FG002|Survival Follow-up|Death|45|||
105315070|NCT02027428|363148737|FG000|Survival Follow-up|Lost to Follow-up|0|||
105315071|NCT02027428|363148738|FG001|Survival Follow-up|Lost to Follow-up|1|||
105315072|NCT02027428|363148739|FG002|Survival Follow-up|Lost to Follow-up|1|||
105315073|NCT03017612|363148744|FG000|Overall Study|Adverse Event|2|||
105315074|NCT01320150|363148745|FG000|Overall Study|Protocol Violation|15|||
105315075|NCT01320150|363148745|FG000|Overall Study|Withdrawal by Subject|5|||
105315076|NCT01320150|363148745|FG000|Overall Study|Death|2|||
105315077|NCT01320150|363148745|FG000|Overall Study|Lost to Follow-up|44|||
105315078|NCT02759692|363148746|FG000|Period 1|Test article no longer available|1|||
105315079|NCT02759692|363148747|FG001|Period 1|Test article no longer available|1|||
105315080|NCT02759692|363148746|FG000|Period 1|No longer meets eligibility criteria.|1|||
105315081|NCT02759692|363148747|FG001|Period 1|No longer meets eligibility criteria.|0|||
105315082|NCT02759692|363148746|FG000|Period 1|Miss-Randomized|1|||
105315083|NCT02759692|363148747|FG001|Period 1|Miss-Randomized|1|||
105315084|NCT02759692|363148746|FG000|Period 2|Lost to Follow-up|1|||
105315085|NCT02759692|363148747|FG001|Period 2|Lost to Follow-up|0|||
105315086|NCT02759692|363148746|FG000|Period 2|Test article no longer available|0|||
105315087|NCT02759692|363148747|FG001|Period 2|Test article no longer available|1|||
105315088|NCT03207867|363148748|FG000|Overall Study|Adverse Event|1|||
105315089|NCT03207867|363148749|FG001|Overall Study|Adverse Event|0|||
105315090|NCT03207867|363148750|FG002|Overall Study|Adverse Event|1|||
105315091|NCT03207867|363148751|FG003|Overall Study|Adverse Event|0|||
105315092|NCT03207867|363148752|FG004|Overall Study|Adverse Event|0|||
105315093|NCT03207867|363148753|FG005|Overall Study|Adverse Event|2|||
105315094|NCT03207867|363148754|FG006|Overall Study|Adverse Event|1|||
105315095|NCT03207867|363148755|FG007|Overall Study|Adverse Event|1|||
105315096|NCT03207867|363148756|FG008|Overall Study|Adverse Event|2|||
105315097|NCT03207867|363148757|FG009|Overall Study|Adverse Event|2|||
105315098|NCT03207867|363148758|FG010|Overall Study|Adverse Event|0|||
105315099|NCT03207867|363148759|FG011|Overall Study|Adverse Event|0|||
105315100|NCT03207867|363148760|FG012|Overall Study|Adverse Event|0|||
105315101|NCT03207867|363148761|FG013|Overall Study|Adverse Event|0|||
105315102|NCT03207867|363148762|FG014|Overall Study|Adverse Event|0|||
105315103|NCT03207867|363148763|FG015|Overall Study|Adverse Event|0|||
105315104|NCT03207867|363148764|FG016|Overall Study|Adverse Event|3|||
105315105|NCT03207867|363148765|FG017|Overall Study|Adverse Event|1|||
105315106|NCT03207867|363148766|FG018|Overall Study|Adverse Event|2|||
105315107|NCT03207867|363148767|FG019|Overall Study|Adverse Event|1|||
105315108|NCT03207867|363148768|FG020|Overall Study|Adverse Event|0|||
105315109|NCT03207867|363148769|FG021|Overall Study|Adverse Event|0|||
105315110|NCT03207867|363148770|FG022|Overall Study|Adverse Event|0|||
105315111|NCT03207867|363148771|FG023|Overall Study|Adverse Event|0|||
105315112|NCT03207867|363148748|FG000|Overall Study|Death|0|||
105315113|NCT03207867|363148749|FG001|Overall Study|Death|0|||
105315114|NCT03207867|363148750|FG002|Overall Study|Death|0|||
105315115|NCT03207867|363148751|FG003|Overall Study|Death|0|||
105315116|NCT03207867|363148752|FG004|Overall Study|Death|0|||
105315117|NCT03207867|363148753|FG005|Overall Study|Death|1|||
105315118|NCT03207867|363148754|FG006|Overall Study|Death|0|||
105315119|NCT03207867|363148755|FG007|Overall Study|Death|3|||
105315120|NCT03207867|363148756|FG008|Overall Study|Death|1|||
105315121|NCT03207867|363148757|FG009|Overall Study|Death|2|||
105315122|NCT03207867|363148758|FG010|Overall Study|Death|0|||
105368714|NCT01926028|363356260|FG000|Overall Study|Non compliance or other reasons|4|||
105315123|NCT03207867|363148759|FG011|Overall Study|Death|1|||
105315124|NCT03207867|363148760|FG012|Overall Study|Death|0|||
105368715|NCT01926028|363356261|FG001|Overall Study|Non compliance or other reasons|2|||
105315125|NCT03207867|363148761|FG013|Overall Study|Death|1|||
105315126|NCT03207867|363148762|FG014|Overall Study|Death|0|||
105315127|NCT03207867|363148763|FG015|Overall Study|Death|0|||
105315128|NCT03207867|363148764|FG016|Overall Study|Death|0|||
105315129|NCT03207867|363148765|FG017|Overall Study|Death|2|||
105315130|NCT03207867|363148766|FG018|Overall Study|Death|0|||
105315131|NCT03207867|363148767|FG019|Overall Study|Death|1|||
105315132|NCT03207867|363148768|FG020|Overall Study|Death|0|||
105315133|NCT03207867|363148769|FG021|Overall Study|Death|0|||
105315134|NCT03207867|363148770|FG022|Overall Study|Death|0|||
105315135|NCT03207867|363148771|FG023|Overall Study|Death|0|||
105843369|NCT01360866|365084196|FG001|Overall Study|Protocol Deviation|33|||
105843370|NCT01360866|365084197|FG002|Overall Study|Protocol Deviation|61|||
105843371|NCT01360866|365084198|FG003|Overall Study|Protocol Deviation|2|||
105843372|NCT01360866|365084195|FG000|Overall Study|Lack of Efficacy|30|||
105843373|NCT01360866|365084196|FG001|Overall Study|Lack of Efficacy|40|||
105843374|NCT01360866|365084197|FG002|Overall Study|Lack of Efficacy|30|||
105843375|NCT01360866|365084198|FG003|Overall Study|Lack of Efficacy|4|||
105843376|NCT03702049|365084202|FG000|Overall Study|Lost to Follow-up|4|||
105843377|NCT03702049|365084202|FG000|Overall Study|Physician Decision|1|||
105843378|NCT05016622|365084203|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
105843379|NCT05016622|365084203|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
105843380|NCT03197558|365084204|FG000|Overall Study|Tubes not placed|1|||
105843381|NCT01014624|365084207|FG000|Overall Study|Adverse Event|0|||
105843382|NCT01014624|365084208|FG001|Overall Study|Adverse Event|1|||
105843383|NCT01014624|365084207|FG000|Overall Study|Protocol Violation|1|||
105843384|NCT01014624|365084208|FG001|Overall Study|Protocol Violation|0|||
105843385|NCT01014624|365084207|FG000|Overall Study|Withdrawal by Subject|1|||
105843386|NCT01014624|365084208|FG001|Overall Study|Withdrawal by Subject|0|||
105843387|NCT02954159|365084211|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
105843388|NCT02954159|365084212|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
105843389|NCT02954159|365084211|FG000|Overall Study|Withdrawal by Subject|0|||
105843390|NCT02954159|365084212|FG001|Overall Study|Withdrawal by Subject|1|||
105843391|NCT00986570|365084214|FG000|Overall Study|Lost to Follow-up|6|||
105843392|NCT00986570|365084214|FG000|Overall Study|Potential bias for objective assessment|1|||
105843393|NCT03575871|365084221|FG000|Overall Study|Adverse Event|5|||
105843394|NCT03575871|365084222|FG001|Overall Study|Adverse Event|5|||
105843395|NCT03575871|365084223|FG002|Overall Study|Adverse Event|8|||
105843396|NCT03575871|365084221|FG000|Overall Study|Death|1|||
105843397|NCT03575871|365084222|FG001|Overall Study|Death|0|||
105843398|NCT03575871|365084223|FG002|Overall Study|Death|0|||
105843399|NCT03575871|365084221|FG000|Overall Study|Lack of Efficacy|5|||
105843400|NCT03575871|365084222|FG001|Overall Study|Lack of Efficacy|4|||
105843401|NCT03575871|365084223|FG002|Overall Study|Lack of Efficacy|7|||
105843402|NCT03575871|365084221|FG000|Overall Study|Lost to Follow-up|1|||
105843403|NCT03575871|365084222|FG001|Overall Study|Lost to Follow-up|1|||
105843404|NCT03575871|365084223|FG002|Overall Study|Lost to Follow-up|1|||
105843405|NCT03575871|365084221|FG000|Overall Study|Protocol Deviation|1|||
105843406|NCT03575871|365084222|FG001|Overall Study|Protocol Deviation|1|||
105843407|NCT03575871|365084223|FG002|Overall Study|Protocol Deviation|1|||
105843408|NCT03575871|365084221|FG000|Overall Study|Withdrawal by Subject|6|||
105843409|NCT03575871|365084222|FG001|Overall Study|Withdrawal by Subject|1|||
105843410|NCT03575871|365084223|FG002|Overall Study|Withdrawal by Subject|9|||
105843411|NCT03575871|365084221|FG000|Overall Study|Other than specified|2|||
105843412|NCT03575871|365084222|FG001|Overall Study|Other than specified|2|||
105843413|NCT03575871|365084223|FG002|Overall Study|Other than specified|0|||
105843414|NCT05506358|365084224|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
105843415|NCT05506358|365084225|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
105843416|NCT05506358|365084226|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
105843417|NCT05506358|365084227|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
105843418|NCT05506358|365084228|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
105843419|NCT05506358|365084224|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
105843420|NCT05506358|365084225|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
105843421|NCT05506358|365084226|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
105843422|NCT05506358|365084227|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
105843423|NCT05506358|365084228|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
105843424|NCT05506358|365084224|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
105843425|NCT05506358|365084225|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
105843426|NCT05506358|365084226|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
105843427|NCT05506358|365084227|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
105843428|NCT05506358|365084228|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
105843429|NCT05506358|365084224|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
105315136|NCT03207867|363148748|FG000|Overall Study|Physician Decision|3|||
105843430|NCT05506358|365084225|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
105843431|NCT05506358|365084226|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
105843432|NCT05506358|365084227|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
105843433|NCT05506358|365084228|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
105315137|NCT03207867|363148749|FG001|Overall Study|Physician Decision|5|||
105315138|NCT03207867|363148750|FG002|Overall Study|Physician Decision|0|||
105843434|NCT05506358|365084224|FG000|Overall Study|HbE trait|0|||
105843435|NCT05506358|365084225|FG001|Overall Study|HbE trait|0|||
105315139|NCT03207867|363148751|FG003|Overall Study|Physician Decision|3|||
105315140|NCT03207867|363148752|FG004|Overall Study|Physician Decision|2|||
105315141|NCT03207867|363148753|FG005|Overall Study|Physician Decision|0|||
105315142|NCT03207867|363148754|FG006|Overall Study|Physician Decision|0|||
105315143|NCT03207867|363148755|FG007|Overall Study|Physician Decision|0|||
105315144|NCT03207867|363148756|FG008|Overall Study|Physician Decision|4|||
105315145|NCT03207867|363148757|FG009|Overall Study|Physician Decision|2|||
105315146|NCT03207867|363148758|FG010|Overall Study|Physician Decision|0|||
105315147|NCT03207867|363148759|FG011|Overall Study|Physician Decision|4|||
105315148|NCT03207867|363148760|FG012|Overall Study|Physician Decision|0|||
105315149|NCT03207867|363148761|FG013|Overall Study|Physician Decision|0|||
105315150|NCT03207867|363148762|FG014|Overall Study|Physician Decision|2|||
105315151|NCT03207867|363148763|FG015|Overall Study|Physician Decision|1|||
105315152|NCT03207867|363148764|FG016|Overall Study|Physician Decision|1|||
105315153|NCT03207867|363148765|FG017|Overall Study|Physician Decision|2|||
105315154|NCT03207867|363148766|FG018|Overall Study|Physician Decision|1|||
105315155|NCT03207867|363148767|FG019|Overall Study|Physician Decision|3|||
105315156|NCT03207867|363148768|FG020|Overall Study|Physician Decision|0|||
105315157|NCT03207867|363148769|FG021|Overall Study|Physician Decision|0|||
105315158|NCT03207867|363148770|FG022|Overall Study|Physician Decision|0|||
105315159|NCT03207867|363148771|FG023|Overall Study|Physician Decision|0|||
105315160|NCT03207867|363148748|FG000|Overall Study|Progressive Disease|7|||
105315161|NCT03207867|363148749|FG001|Overall Study|Progressive Disease|7|||
105315162|NCT03207867|363148750|FG002|Overall Study|Progressive Disease|9|||
105315163|NCT03207867|363148751|FG003|Overall Study|Progressive Disease|10|||
105315164|NCT03207867|363148752|FG004|Overall Study|Progressive Disease|11|||
105315165|NCT03207867|363148753|FG005|Overall Study|Progressive Disease|10|||
105315166|NCT03207867|363148754|FG006|Overall Study|Progressive Disease|9|||
105315167|NCT03207867|363148755|FG007|Overall Study|Progressive Disease|8|||
105315168|NCT03207867|363148756|FG008|Overall Study|Progressive Disease|19|||
105315169|NCT03207867|363148757|FG009|Overall Study|Progressive Disease|23|||
105315170|NCT03207867|363148758|FG010|Overall Study|Progressive Disease|2|||
105315171|NCT03207867|363148759|FG011|Overall Study|Progressive Disease|24|||
105315172|NCT03207867|363148760|FG012|Overall Study|Progressive Disease|3|||
105315173|NCT03207867|363148761|FG013|Overall Study|Progressive Disease|11|||
105315174|NCT03207867|363148762|FG014|Overall Study|Progressive Disease|9|||
105315175|NCT03207867|363148763|FG015|Overall Study|Progressive Disease|5|||
105315176|NCT03207867|363148764|FG016|Overall Study|Progressive Disease|10|||
105315177|NCT03207867|363148765|FG017|Overall Study|Progressive Disease|14|||
105315178|NCT03207867|363148766|FG018|Overall Study|Progressive Disease|13|||
105315179|NCT03207867|363148767|FG019|Overall Study|Progressive Disease|14|||
105315180|NCT03207867|363148768|FG020|Overall Study|Progressive Disease|6|||
105315181|NCT03207867|363148769|FG021|Overall Study|Progressive Disease|3|||
105315182|NCT03207867|363148770|FG022|Overall Study|Progressive Disease|3|||
105315183|NCT03207867|363148771|FG023|Overall Study|Progressive Disease|3|||
105315184|NCT03207867|363148748|FG000|Overall Study|Patient/guardian Decision|0|||
105315185|NCT03207867|363148749|FG001|Overall Study|Patient/guardian Decision|0|||
105315186|NCT03207867|363148750|FG002|Overall Study|Patient/guardian Decision|1|||
105315187|NCT03207867|363148751|FG003|Overall Study|Patient/guardian Decision|1|||
105315188|NCT03207867|363148752|FG004|Overall Study|Patient/guardian Decision|1|||
105315189|NCT03207867|363148753|FG005|Overall Study|Patient/guardian Decision|2|||
105315190|NCT03207867|363148754|FG006|Overall Study|Patient/guardian Decision|1|||
105315191|NCT03207867|363148755|FG007|Overall Study|Patient/guardian Decision|0|||
105315192|NCT03207867|363148756|FG008|Overall Study|Patient/guardian Decision|1|||
105315193|NCT03207867|363148757|FG009|Overall Study|Patient/guardian Decision|0|||
105315194|NCT03207867|363148758|FG010|Overall Study|Patient/guardian Decision|0|||
105315195|NCT03207867|363148759|FG011|Overall Study|Patient/guardian Decision|1|||
105315196|NCT03207867|363148760|FG012|Overall Study|Patient/guardian Decision|0|||
105315197|NCT03207867|363148761|FG013|Overall Study|Patient/guardian Decision|1|||
105315198|NCT03207867|363148762|FG014|Overall Study|Patient/guardian Decision|2|||
105315199|NCT03207867|363148763|FG015|Overall Study|Patient/guardian Decision|0|||
105315200|NCT03207867|363148764|FG016|Overall Study|Patient/guardian Decision|1|||
105315201|NCT03207867|363148765|FG017|Overall Study|Patient/guardian Decision|3|||
105315202|NCT03207867|363148766|FG018|Overall Study|Patient/guardian Decision|4|||
105315203|NCT03207867|363148767|FG019|Overall Study|Patient/guardian Decision|1|||
105315204|NCT03207867|363148768|FG020|Overall Study|Patient/guardian Decision|0|||
105576571|NCT04747275|364110221|FG001|Overall Study|Study terminated|1|||
105315205|NCT03207867|363148769|FG021|Overall Study|Patient/guardian Decision|0|||
105315206|NCT03207867|363148770|FG022|Overall Study|Patient/guardian Decision|0|||
105315207|NCT03207867|363148771|FG023|Overall Study|Patient/guardian Decision|0|||
105315208|NCT01371747|363150593|FG000|Overall Study|Adverse Event|4|||
105315209|NCT01371747|363150594|FG001|Overall Study|Adverse Event|2|||
105315210|NCT01371747|363150595|FG002|Overall Study|Adverse Event|7|||
105315211|NCT01371747|363150596|FG003|Overall Study|Adverse Event|2|||
105315212|NCT01371747|363150597|FG004|Overall Study|Adverse Event|2|||
105315213|NCT01371747|363150598|FG005|Overall Study|Adverse Event|2|||
105315214|NCT01371747|363150593|FG000|Overall Study|Death|1|||
105315215|NCT01371747|363150594|FG001|Overall Study|Death|0|||
105315216|NCT01371747|363150595|FG002|Overall Study|Death|4|||
105315217|NCT01371747|363150596|FG003|Overall Study|Death|1|||
105315218|NCT01371747|363150597|FG004|Overall Study|Death|2|||
105490083|NCT00920829|363807451|FG001|Available for Analysis|Death|0|||
105843436|NCT05506358|365084226|FG002|Overall Study|HbE trait|0|||
105843437|NCT05506358|365084227|FG003|Overall Study|HbE trait|1|||
105843438|NCT05506358|365084228|FG004|Overall Study|HbE trait|0|||
105843439|NCT00804141|365084232|FG000|Overall Study|Adverse Event|157|||
105843440|NCT00804141|365084232|FG000|Overall Study|Death|4|||
105843441|NCT00804141|365084232|FG000|Overall Study|Failed to return|96|||
105843442|NCT00804141|365084232|FG000|Overall Study|Investigator request|8|||
105843443|NCT00804141|365084232|FG000|Overall Study|Protocol Violation|85|||
105843444|NCT00804141|365084232|FG000|Overall Study|Withdrawal by Subject|131|||
105843445|NCT00804141|365084232|FG000|Overall Study|Lack of Efficacy|46|||
105843446|NCT00804141|365084232|FG000|Overall Study|Other than specified|30|||
105843447|NCT00804141|365084232|FG000|Overall Study|Enrolled but not treated|6|||
105843448|NCT00608517|365084233|FG000|Overall Study|Death|1|||
105843449|NCT00608517|365084234|FG001|Overall Study|Death|0|||
105843450|NCT00608517|365084235|FG002|Overall Study|Death|0|||
105843451|NCT02791893|365084236|FG000|Blinded Phase|Lost to Follow-up|2|||
105843452|NCT02791893|365084237|FG001|Blinded Phase|Lost to Follow-up|2|||
105843453|NCT02791893|365084236|FG000|Blinded Phase|Withdrawal by Subject|1|||
105843454|NCT02791893|365084237|FG001|Blinded Phase|Withdrawal by Subject|2|||
105843455|NCT02791893|365084236|FG000|Open Label Phase|Lost to Follow-up|3|||
105843456|NCT02791893|365084237|FG001|Open Label Phase|Lost to Follow-up|0|||
105843457|NCT02791893|365084236|FG000|Open Label Phase|Withdrawal by Subject|0|||
105843458|NCT02791893|365084237|FG001|Open Label Phase|Withdrawal by Subject|2|||
105843459|NCT01833533|365084238|FG000|Overall Study|Adverse Event|0|||
105843460|NCT01833533|365084239|FG001|Overall Study|Adverse Event|1|||
105843461|NCT01833533|365084238|FG000|Overall Study|Lost to Follow-up|4|||
105843462|NCT01833533|365084239|FG001|Overall Study|Lost to Follow-up|9|||
105843463|NCT01833533|365084238|FG000|Overall Study|To Enter an Extension Study|0|||
105843464|NCT01833533|365084239|FG001|Overall Study|To Enter an Extension Study|4|||
105843465|NCT01833533|365084238|FG000|Overall Study|Other|2|||
105843466|NCT01833533|365084239|FG001|Overall Study|Other|7|||
105843467|NCT01173471|365084240|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105843468|NCT01173471|365084241|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105843469|NCT01173471|365084242|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
105843470|NCT01173471|365084243|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
105843471|NCT01173471|365084240|FG000|Overall Study|Condition under investigation worsened|2|||
105843472|NCT01173471|365084241|FG001|Overall Study|Condition under investigation worsened|0|||
105843473|NCT01173471|365084242|FG002|Overall Study|Condition under investigation worsened|0|||
105843474|NCT01173471|365084243|FG003|Overall Study|Condition under investigation worsened|0|||
105843475|NCT01173471|365084240|FG000|Overall Study|Lost to Follow-up|0|||
105843476|NCT01173471|365084241|FG001|Overall Study|Lost to Follow-up|0|||
105843477|NCT01173471|365084242|FG002|Overall Study|Lost to Follow-up|1|||
105843478|NCT01173471|365084243|FG003|Overall Study|Lost to Follow-up|0|||
105843479|NCT01173471|365084240|FG000|Overall Study|Reason given as Other|0|||
105843480|NCT01173471|365084241|FG001|Overall Study|Reason given as Other|0|||
105843481|NCT01173471|365084242|FG002|Overall Study|Reason given as Other|1|||
105843482|NCT01173471|365084243|FG003|Overall Study|Reason given as Other|0|||
105843483|NCT00572039|365084244|FG000|Overall Study|Withdrawal by Subject|9|||
105843484|NCT00572039|365084245|FG001|Overall Study|Withdrawal by Subject|6|||
105843485|NCT00572039|365084244|FG000|Overall Study|Death|2|||
105843486|NCT00572039|365084245|FG001|Overall Study|Death|3|||
105843487|NCT00572039|365084244|FG000|Overall Study|Ill|5|||
105843488|NCT00572039|365084245|FG001|Overall Study|Ill|1|||
105843489|NCT00171301|365084246|FG000|Overall Study|Death|1|||
105843490|NCT00171301|365084247|FG001|Overall Study|Death|2|||
105843491|NCT00171301|365084246|FG000|Overall Study|Adverse Event|1|||
105843492|NCT00171301|365084247|FG001|Overall Study|Adverse Event|2|||
105843493|NCT00171301|365084246|FG000|Overall Study|Lost to Follow-up|6|||
105843494|NCT00171301|365084247|FG001|Overall Study|Lost to Follow-up|2|||
105843495|NCT00171301|365084246|FG000|Overall Study|Protocol Violation|0|||
105843496|NCT00171301|365084247|FG001|Overall Study|Protocol Violation|2|||
105843497|NCT00171301|365084246|FG000|Overall Study|Withdrawal by Subject|0|||
105843498|NCT00171301|365084247|FG001|Overall Study|Withdrawal by Subject|1|||
105843499|NCT03463993|365084253|FG000|Overall Study|Lost to Follow-up|7|||
105843500|NCT03463993|365084254|FG001|Overall Study|Lost to Follow-up|8|||
105843501|NCT03463993|365084253|FG000|Overall Study|Withdrawal by Subject|2|||
105843502|NCT03463993|365084254|FG001|Overall Study|Withdrawal by Subject|0|||
105843503|NCT03463993|365084253|FG000|Overall Study|Protocol Violation|4|||
105843504|NCT03463993|365084254|FG001|Overall Study|Protocol Violation|1|||
105843505|NCT03463993|365084253|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
105843506|NCT03463993|365084254|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
105843507|NCT03463993|365084253|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
105843508|NCT03463993|365084254|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
105843509|NCT05206448|365084255|FG000|Overall Study|Lost to Follow-up|2|||
105843510|NCT05206448|365084256|FG001|Overall Study|Lost to Follow-up|2|||
105843511|NCT05206448|365084255|FG000|Overall Study|Withdrawal by Subject|2|||
105315219|NCT01371747|363150598|FG005|Overall Study|Death|0|||
105315220|NCT01371747|363150593|FG000|Overall Study|Abnormal Renal Function|0|||
105315221|NCT01371747|363150594|FG001|Overall Study|Abnormal Renal Function|2|||
105315222|NCT01371747|363150595|FG002|Overall Study|Abnormal Renal Function|0|||
105315223|NCT01371747|363150596|FG003|Overall Study|Abnormal Renal Function|1|||
105315224|NCT01371747|363150597|FG004|Overall Study|Abnormal Renal Function|0|||
105315225|NCT01371747|363150598|FG005|Overall Study|Abnormal Renal Function|1|||
105315226|NCT01371747|363150593|FG000|Overall Study|High Serum Potassium Results|1|||
105315227|NCT01371747|363150594|FG001|Overall Study|High Serum Potassium Results|1|||
105315228|NCT01371747|363150595|FG002|Overall Study|High Serum Potassium Results|1|||
105315229|NCT01371747|363150596|FG003|Overall Study|High Serum Potassium Results|2|||
105315230|NCT01371747|363150597|FG004|Overall Study|High Serum Potassium Results|0|||
105315231|NCT01371747|363150598|FG005|Overall Study|High Serum Potassium Results|2|||
105315232|NCT01371747|363150593|FG000|Overall Study|Low Serum Potassium Results|1|||
105315233|NCT01371747|363150594|FG001|Overall Study|Low Serum Potassium Results|1|||
105315234|NCT01371747|363150595|FG002|Overall Study|Low Serum Potassium Results|1|||
105315235|NCT01371747|363150596|FG003|Overall Study|Low Serum Potassium Results|1|||
105315236|NCT01371747|363150597|FG004|Overall Study|Low Serum Potassium Results|0|||
105315237|NCT01371747|363150598|FG005|Overall Study|Low Serum Potassium Results|3|||
105315238|NCT01371747|363150593|FG000|Overall Study|Protocol Violation|0|||
105315239|NCT01371747|363150594|FG001|Overall Study|Protocol Violation|0|||
105315240|NCT01371747|363150595|FG002|Overall Study|Protocol Violation|1|||
105315241|NCT01371747|363150596|FG003|Overall Study|Protocol Violation|0|||
105315242|NCT01371747|363150597|FG004|Overall Study|Protocol Violation|0|||
105315243|NCT01371747|363150598|FG005|Overall Study|Protocol Violation|0|||
105315244|NCT01371747|363150593|FG000|Overall Study|Non-Compliance|3|||
105315245|NCT01371747|363150594|FG001|Overall Study|Non-Compliance|4|||
105315246|NCT01371747|363150595|FG002|Overall Study|Non-Compliance|3|||
105315247|NCT01371747|363150596|FG003|Overall Study|Non-Compliance|0|||
105315248|NCT01371747|363150597|FG004|Overall Study|Non-Compliance|0|||
105315249|NCT01371747|363150598|FG005|Overall Study|Non-Compliance|1|||
105315250|NCT01371747|363150593|FG000|Overall Study|Physician Decision|0|||
105315251|NCT01371747|363150594|FG001|Overall Study|Physician Decision|0|||
105315252|NCT01371747|363150595|FG002|Overall Study|Physician Decision|0|||
105315253|NCT01371747|363150596|FG003|Overall Study|Physician Decision|0|||
105315254|NCT01371747|363150597|FG004|Overall Study|Physician Decision|1|||
105315255|NCT01371747|363150598|FG005|Overall Study|Physician Decision|0|||
105315256|NCT01371747|363150593|FG000|Overall Study|Withdrawal by Subject|6|||
105315257|NCT01371747|363150594|FG001|Overall Study|Withdrawal by Subject|12|||
105315258|NCT01371747|363150595|FG002|Overall Study|Withdrawal by Subject|5|||
105315259|NCT01371747|363150596|FG003|Overall Study|Withdrawal by Subject|2|||
105315260|NCT01371747|363150597|FG004|Overall Study|Withdrawal by Subject|2|||
105315261|NCT01371747|363150598|FG005|Overall Study|Withdrawal by Subject|4|||
105315262|NCT01371747|363150593|FG000|Overall Study|Other Reasons|2|||
105315263|NCT01371747|363150594|FG001|Overall Study|Other Reasons|1|||
105315264|NCT01371747|363150595|FG002|Overall Study|Other Reasons|2|||
105315265|NCT01371747|363150596|FG003|Overall Study|Other Reasons|0|||
105315266|NCT01371747|363150597|FG004|Overall Study|Other Reasons|0|||
105315267|NCT01371747|363150598|FG005|Overall Study|Other Reasons|1|||
105315268|NCT03092219|363150599|FG000|Overall Study|Protocol Violation|7|||
105315269|NCT03092219|363150600|FG001|Overall Study|Protocol Violation|4|||
105315270|NCT02856555|363150603|FG000|Overall Study|Adverse Event|1|||
105315271|NCT02856555|363150604|FG001|Overall Study|Adverse Event|0|||
105315272|NCT02856555|363150605|FG002|Overall Study|Adverse Event|0|||
105315273|NCT02856555|363150603|FG000|Overall Study|Lost to Follow-up|1|||
105315274|NCT02856555|363150604|FG001|Overall Study|Lost to Follow-up|3|||
105315275|NCT02856555|363150605|FG002|Overall Study|Lost to Follow-up|0|||
105315276|NCT02856555|363150603|FG000|Overall Study|Withdrawal by Subject|3|||
105315277|NCT02856555|363150604|FG001|Overall Study|Withdrawal by Subject|0|||
105315278|NCT02856555|363150605|FG002|Overall Study|Withdrawal by Subject|0|||
105315279|NCT02856555|363150603|FG000|Overall Study|Randomized but Never Treated|0|||
105315280|NCT02856555|363150604|FG001|Overall Study|Randomized but Never Treated|1|||
105576572|NCT00531011|364110222|FG000|Overall Study|Withdrawal by Subject|2|||
105576573|NCT00531011|364110223|FG001|Overall Study|Withdrawal by Subject|4|||
105576574|NCT00531011|364110222|FG000|Overall Study|Death|1|||
105576575|NCT00531011|364110223|FG001|Overall Study|Death|0|||
105576576|NCT00531011|364110222|FG000|Overall Study|Lost to Follow-up|1|||
105576577|NCT00531011|364110223|FG001|Overall Study|Lost to Follow-up|0|||
105315281|NCT02856555|363150605|FG002|Overall Study|Randomized but Never Treated|0|||
105315282|NCT02094417|363150606|FG000|Overall Study|Adverse Event|0|||
105315283|NCT02094417|363150607|FG001|Overall Study|Adverse Event|0|||
105315284|NCT02094417|363150608|FG002|Overall Study|Adverse Event|0|||
105315285|NCT02094417|363150609|FG003|Overall Study|Adverse Event|1|||
105315286|NCT02094417|363150606|FG000|Overall Study|Eligibility criteria|0|||
105576578|NCT00531011|364110222|FG000|Overall Study|Physician Decision|0|||
105315287|NCT02094417|363150607|FG001|Overall Study|Eligibility criteria|1|||
105315288|NCT02094417|363150608|FG002|Overall Study|Eligibility criteria|0|||
105315289|NCT02094417|363150609|FG003|Overall Study|Eligibility criteria|0|||
105576579|NCT00531011|364110223|FG001|Overall Study|Physician Decision|3|||
105576580|NCT00919893|364110226|FG000|Overall Study|Protocol Violation|19|||
105576581|NCT00919893|364110227|FG001|Overall Study|Protocol Violation|9|||
105576582|NCT00197028|364110233|FG000|Overall Study|Adverse Event|2|||
105576583|NCT00197028|364110234|FG001|Overall Study|Adverse Event|2|||
105576584|NCT00197028|364110233|FG000|Overall Study|Protocol Violation|2|||
105576585|NCT00197028|364110234|FG001|Overall Study|Protocol Violation|1|||
105576586|NCT00197028|364110233|FG000|Overall Study|Withdrawal by Subject|8|||
105843512|NCT05206448|365084256|FG001|Overall Study|Withdrawal by Subject|0|||
105843513|NCT05206448|365084255|FG000|Overall Study|found ineligible after randomization|1|||
105843514|NCT05206448|365084256|FG001|Overall Study|found ineligible after randomization|1|||
105843515|NCT05206448|365084255|FG000|Overall Study|unable to complete study due to personal constraints|1|||
105843516|NCT05206448|365084256|FG001|Overall Study|unable to complete study due to personal constraints|0|||
105843517|NCT05206448|365084255|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
105843518|NCT05206448|365084256|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
105843519|NCT00754442|365084260|FG000|Overall Study|Withdrawal by Subject|5|||
105843520|NCT00754442|365084261|FG001|Overall Study|Withdrawal by Subject|3|||
105843521|NCT01557842|365084262|FG000|Overall Study|Lost to Follow-up|0|||
105843522|NCT01557842|365084263|FG001|Overall Study|Lost to Follow-up|1|||
105843523|NCT01557842|365084262|FG000|Overall Study|Death|1|||
105843524|NCT01557842|365084263|FG001|Overall Study|Death|0|||
105843525|NCT01557842|365084262|FG000|Overall Study|Lack of Efficacy|0|||
105843526|NCT01557842|365084263|FG001|Overall Study|Lack of Efficacy|1|||
105843527|NCT01557842|365084262|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
105843528|NCT01557842|365084263|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
105843529|NCT01557842|365084262|FG000|Overall Study|Study Terminated by Sponsor|3|||
105843530|NCT01557842|365084263|FG001|Overall Study|Study Terminated by Sponsor|4|||
105843531|NCT01557842|365084262|FG000|Overall Study|Not Ablated|2|||
105843532|NCT01557842|365084263|FG001|Overall Study|Not Ablated|0|||
105843533|NCT02025010|365084264|FG000|Overall Study|Symptomatic or radiographic progression|36|||
105843534|NCT02025010|365084264|FG000|Overall Study|Adverse Event|6|||
105843535|NCT02025010|365084264|FG000|Overall Study|Physician Decision|7|||
105843536|NCT02025010|365084264|FG000|Overall Study|Withdrawal by Subject|3|||
105843537|NCT02025010|365084264|FG000|Overall Study|Intercurrent illness|3|||
105843538|NCT02025010|365084264|FG000|Overall Study|Patients still on treatment|3|||
105843539|NCT02025010|365084264|FG000|Overall Study|Never initiate the treatment|2|||
105843540|NCT03005067|365084265|FG000|Overall Study|Withdrawal by Subject|3|||
105843541|NCT03005067|365084266|FG001|Overall Study|Withdrawal by Subject|2|||
105843542|NCT03005067|365084265|FG000|Overall Study|Adverse Event|4|||
105843543|NCT03005067|365084266|FG001|Overall Study|Adverse Event|3|||
105843544|NCT03005067|365084265|FG000|Overall Study|Other (reason not specified)|3|||
105315290|NCT02094417|363150606|FG000|Overall Study|No responder|4|||
105315291|NCT02094417|363150607|FG001|Overall Study|No responder|4|||
105315292|NCT02094417|363150608|FG002|Overall Study|No responder|4|||
105315293|NCT02094417|363150609|FG003|Overall Study|No responder|3|||
105315294|NCT02094417|363150606|FG000|Overall Study|Unable to conduct observations or assess|0|||
105315295|NCT02094417|363150607|FG001|Overall Study|Unable to conduct observations or assess|1|||
105315296|NCT02094417|363150608|FG002|Overall Study|Unable to conduct observations or assess|0|||
105315297|NCT02094417|363150609|FG003|Overall Study|Unable to conduct observations or assess|0|||
105315298|NCT02094417|363150606|FG000|Overall Study|Withdrawal by Subject|1|||
105315299|NCT02094417|363150607|FG001|Overall Study|Withdrawal by Subject|2|||
105315300|NCT02094417|363150608|FG002|Overall Study|Withdrawal by Subject|1|||
105315301|NCT02094417|363150609|FG003|Overall Study|Withdrawal by Subject|3|||
105315302|NCT03333941|363150610|FG000|Overall Study|Lost to Follow-up|10|||
105315303|NCT03333941|363150610|FG000|Overall Study|Death|2|||
105315304|NCT03333941|363150610|FG000|Overall Study|Adverse Event|1|||
105315305|NCT00580788|363150611|FG000|Overall Study|Adverse Event|0|||
105315306|NCT00580788|363150612|FG001|Overall Study|Adverse Event|0|||
105315307|NCT00580788|363150613|FG002|Overall Study|Adverse Event|0|||
105315308|NCT00580788|363150614|FG003|Overall Study|Adverse Event|1|||
105315309|NCT01564537|363150615|FG000|Overall Study|Site Terminated by Sponsor|1|||
105315310|NCT01564537|363150616|FG001|Overall Study|Site Terminated by Sponsor|0|||
105315311|NCT01564537|363150615|FG000|Overall Study|Withdrawal by Subject|12|||
105315312|NCT01564537|363150616|FG001|Overall Study|Withdrawal by Subject|14|||
105576587|NCT00197028|364110234|FG001|Overall Study|Withdrawal by Subject|12|||
105843545|NCT03005067|365084266|FG001|Overall Study|Other (reason not specified)|1|||
105843546|NCT03005067|365084265|FG000|Overall Study|Protocol Violation|0|||
105843547|NCT03005067|365084266|FG001|Overall Study|Protocol Violation|1|||
105315313|NCT01564537|363150615|FG000|Overall Study|Lost to Follow-up|7|||
105576588|NCT00197028|364110233|FG000|Overall Study|Lost to Follow-up|1|||
105576589|NCT00197028|364110234|FG001|Overall Study|Lost to Follow-up|0|||
105315314|NCT01564537|363150616|FG001|Overall Study|Lost to Follow-up|3|||
105315315|NCT01564537|363150615|FG000|Overall Study|Reason not specified|81|||
105315316|NCT01564537|363150616|FG001|Overall Study|Reason not specified|82|||
105576590|NCT00197028|364110233|FG000|Overall Study|Other|3|||
105843548|NCT00619359|365084267|FG000|Overall Study|Adverse Event|32|||
105843549|NCT00619359|365084268|FG001|Overall Study|Adverse Event|36|||
105843550|NCT00619359|365084267|FG000|Overall Study|Lost to Follow-up|12|||
105843551|NCT00619359|365084268|FG001|Overall Study|Lost to Follow-up|16|||
105843552|NCT00619359|365084267|FG000|Overall Study|Physician Decision|0|||
105843553|NCT00619359|365084268|FG001|Overall Study|Physician Decision|7|||
105843554|NCT00619359|365084267|FG000|Overall Study|Protocol Violation|1|||
105843555|NCT00619359|365084268|FG001|Overall Study|Protocol Violation|1|||
105843556|NCT00619359|365084267|FG000|Overall Study|Withdrawal by Subject|19|||
105843557|NCT00619359|365084268|FG001|Overall Study|Withdrawal by Subject|20|||
105843558|NCT00619359|365084267|FG000|Overall Study|Progressive Disease|3|||
105843559|NCT00619359|365084268|FG001|Overall Study|Progressive Disease|1|||
105843560|NCT01661881|365084271|FG000|Overall Study|Disease Progression|1|||
105843561|NCT01929395|365084278|FG000|Overall Study|Did not complete - non-related toxicity|1|||
105843562|NCT01929395|365084279|FG001|Overall Study|Did not complete - non-related toxicity|0|||
105843563|NCT01929395|365084280|FG002|Overall Study|Did not complete - non-related toxicity|0|||
105843564|NCT01929395|365084278|FG000|Overall Study|Withdrawal by Subject|0|||
105843565|NCT01929395|365084279|FG001|Overall Study|Withdrawal by Subject|1|||
105843566|NCT01929395|365084280|FG002|Overall Study|Withdrawal by Subject|0|||
105843567|NCT01929395|365084278|FG000|Overall Study|Screen Fail|0|||
105843568|NCT01929395|365084279|FG001|Overall Study|Screen Fail|0|||
105843569|NCT01929395|365084280|FG002|Overall Study|Screen Fail|1|||
105843570|NCT02547766|365084281|FG000|Overall Study|Withdrawal by Subject|1|||
105843571|NCT00103038|365084284|FG000|Overall Study|Withdrawal by Subject|8|||
105843572|NCT00103038|365084284|FG000|Overall Study|Screen failure|3|||
105843573|NCT00103038|365084284|FG000|Overall Study|Death|1|||
105843574|NCT00103038|365084284|FG000|Overall Study|Physician Decision|1|||
105843575|NCT03604341|365084285|FG000|Overall Study|Withdrawal by Subject|1|||
105843576|NCT03604341|365084286|FG001|Overall Study|Withdrawal by Subject|1|||
105843577|NCT03604341|365084285|FG000|Overall Study|Adverse Event|1|||
105843578|NCT03604341|365084286|FG001|Overall Study|Adverse Event|0|||
105843579|NCT03604341|365084285|FG000|Overall Study|Protocol Violation|0|||
105843580|NCT03604341|365084286|FG001|Overall Study|Protocol Violation|1|||
105843581|NCT00484419|365084287|FG000|Overall Study|Adverse Event|3|||
105843582|NCT00484419|365084288|FG001|Overall Study|Adverse Event|0|||
105843583|NCT00484419|365084289|FG002|Overall Study|Adverse Event|0|||
105843584|NCT00484419|365084287|FG000|Overall Study|Lost to Follow-up|1|||
105843585|NCT00484419|365084288|FG001|Overall Study|Lost to Follow-up|0|||
105843586|NCT00484419|365084289|FG002|Overall Study|Lost to Follow-up|2|||
105843587|NCT00484419|365084287|FG000|Overall Study|Withdrawal by Subject|3|||
105843588|NCT00484419|365084288|FG001|Overall Study|Withdrawal by Subject|1|||
105843589|NCT00484419|365084289|FG002|Overall Study|Withdrawal by Subject|1|||
105843590|NCT00484419|365084287|FG000|Overall Study|subject met discontinuation criteria|2|||
105843591|NCT00484419|365084288|FG001|Overall Study|subject met discontinuation criteria|2|||
105843592|NCT00484419|365084289|FG002|Overall Study|subject met discontinuation criteria|4|||
105843593|NCT00484419|365084287|FG000|Overall Study|required restricted medication|1|||
105843594|NCT00484419|365084288|FG001|Overall Study|required restricted medication|0|||
105843595|NCT00484419|365084289|FG002|Overall Study|required restricted medication|1|||
105843596|NCT00484419|365084287|FG000|Overall Study|Physician Decision|1|||
105843597|NCT00484419|365084288|FG001|Overall Study|Physician Decision|1|||
105843598|NCT00484419|365084289|FG002|Overall Study|Physician Decision|1|||
105843599|NCT00484419|365084287|FG000|Overall Study|subject unable to receive medication|1|||
105843600|NCT00484419|365084288|FG001|Overall Study|subject unable to receive medication|0|||
105843601|NCT00484419|365084289|FG002|Overall Study|subject unable to receive medication|0|||
105843602|NCT00484419|365084287|FG000|Overall Study|subject relocated|0|||
105843603|NCT00484419|365084288|FG001|Overall Study|subject relocated|1|||
105843604|NCT00484419|365084289|FG002|Overall Study|subject relocated|0|||
105843605|NCT00484419|365084287|FG000|Overall Study|sponsor decision, randomized in error|0|||
105843606|NCT00484419|365084288|FG001|Overall Study|sponsor decision, randomized in error|0|||
105843607|NCT00484419|365084289|FG002|Overall Study|sponsor decision, randomized in error|2|||
105843608|NCT00355472|365084294|FG000|Overall Study|Physician Decision|1|||
105843609|NCT02010255|365084297|FG000|Overall Study|Death|0|||
105843610|NCT02010255|365084298|FG001|Overall Study|Death|1|||
105843611|NCT02010255|365084299|FG002|Overall Study|Death|4|||
105843612|NCT02010255|365084300|FG003|Overall Study|Death|4|||
105315317|NCT00287586|363150618|FG000|Overall Study|Withdrew Consent|19|||
105315318|NCT00287586|363150619|FG001|Overall Study|Withdrew Consent|30|||
105315319|NCT00287586|363150618|FG000|Overall Study|Lost to Follow-up|5|||
105315320|NCT00287586|363150619|FG001|Overall Study|Lost to Follow-up|4|||
105315321|NCT00287586|363150618|FG000|Overall Study|Death|2|||
105315322|NCT00287586|363150619|FG001|Overall Study|Death|3|||
105843613|NCT02010255|365084301|FG004|Overall Study|Death|2|||
105843614|NCT02010255|365084302|FG005|Overall Study|Death|0|||
105843615|NCT02010255|365084303|FG006|Overall Study|Death|1|||
105843616|NCT02010255|365084304|FG007|Overall Study|Death|1|||
105843617|NCT02010255|365084305|FG008|Overall Study|Death|1|||
105843618|NCT02010255|365084306|FG009|Overall Study|Death|0|||
105843619|NCT02010255|365084307|FG010|Overall Study|Death|1|||
105843620|NCT02010255|365084308|FG011|Overall Study|Death|1|||
105843621|NCT02010255|365084309|FG012|Overall Study|Death|0|||
105843622|NCT02010255|365084310|FG013|Overall Study|Death|0|||
105843623|NCT02010255|365084297|FG000|Overall Study|Lack of Efficacy|4|||
105843624|NCT02010255|365084298|FG001|Overall Study|Lack of Efficacy|1|||
105843625|NCT02010255|365084299|FG002|Overall Study|Lack of Efficacy|2|||
105843626|NCT02010255|365084300|FG003|Overall Study|Lack of Efficacy|1|||
105843627|NCT02010255|365084301|FG004|Overall Study|Lack of Efficacy|1|||
105843628|NCT02010255|365084302|FG005|Overall Study|Lack of Efficacy|0|||
105843629|NCT02010255|365084303|FG006|Overall Study|Lack of Efficacy|0|||
105843630|NCT02010255|365084304|FG007|Overall Study|Lack of Efficacy|0|||
105843631|NCT02010255|365084305|FG008|Overall Study|Lack of Efficacy|0|||
105843632|NCT02010255|365084306|FG009|Overall Study|Lack of Efficacy|0|||
105843633|NCT02010255|365084307|FG010|Overall Study|Lack of Efficacy|1|||
105843634|NCT02010255|365084308|FG011|Overall Study|Lack of Efficacy|0|||
105843635|NCT02010255|365084309|FG012|Overall Study|Lack of Efficacy|0|||
105843636|NCT02010255|365084310|FG013|Overall Study|Lack of Efficacy|0|||
105843637|NCT02010255|365084297|FG000|Overall Study|Withdrew Consent|1|||
105843638|NCT02010255|365084298|FG001|Overall Study|Withdrew Consent|0|||
105843639|NCT02010255|365084299|FG002|Overall Study|Withdrew Consent|0|||
105843640|NCT02010255|365084300|FG003|Overall Study|Withdrew Consent|1|||
105843641|NCT02010255|365084301|FG004|Overall Study|Withdrew Consent|0|||
105843642|NCT02010255|365084302|FG005|Overall Study|Withdrew Consent|0|||
105843643|NCT02010255|365084303|FG006|Overall Study|Withdrew Consent|0|||
105843644|NCT02010255|365084304|FG007|Overall Study|Withdrew Consent|0|||
105843645|NCT02010255|365084305|FG008|Overall Study|Withdrew Consent|0|||
105843646|NCT02010255|365084306|FG009|Overall Study|Withdrew Consent|0|||
105843647|NCT02010255|365084307|FG010|Overall Study|Withdrew Consent|0|||
105843648|NCT02010255|365084308|FG011|Overall Study|Withdrew Consent|0|||
105843649|NCT02010255|365084309|FG012|Overall Study|Withdrew Consent|0|||
105843650|NCT02010255|365084310|FG013|Overall Study|Withdrew Consent|0|||
105843651|NCT02010255|365084297|FG000|Overall Study|Adverse Event|1|||
105843652|NCT02010255|365084298|FG001|Overall Study|Adverse Event|0|||
105843653|NCT02010255|365084299|FG002|Overall Study|Adverse Event|0|||
105843654|NCT02010255|365084300|FG003|Overall Study|Adverse Event|0|||
105843655|NCT02010255|365084301|FG004|Overall Study|Adverse Event|0|||
105843656|NCT02010255|365084302|FG005|Overall Study|Adverse Event|0|||
105843657|NCT02010255|365084303|FG006|Overall Study|Adverse Event|0|||
105843658|NCT02010255|365084304|FG007|Overall Study|Adverse Event|0|||
105843659|NCT02010255|365084305|FG008|Overall Study|Adverse Event|0|||
105843660|NCT02010255|365084306|FG009|Overall Study|Adverse Event|0|||
105843661|NCT02010255|365084307|FG010|Overall Study|Adverse Event|0|||
105843662|NCT02010255|365084308|FG011|Overall Study|Adverse Event|0|||
105843663|NCT02010255|365084309|FG012|Overall Study|Adverse Event|0|||
105843664|NCT02010255|365084310|FG013|Overall Study|Adverse Event|0|||
105843665|NCT02010255|365084297|FG000|Overall Study|Lost to Follow-up|0|||
105843666|NCT02010255|365084298|FG001|Overall Study|Lost to Follow-up|0|||
105843667|NCT02010255|365084299|FG002|Overall Study|Lost to Follow-up|1|||
105843668|NCT02010255|365084300|FG003|Overall Study|Lost to Follow-up|0|||
105843669|NCT02010255|365084301|FG004|Overall Study|Lost to Follow-up|1|||
105843670|NCT02010255|365084302|FG005|Overall Study|Lost to Follow-up|0|||
105843671|NCT02010255|365084303|FG006|Overall Study|Lost to Follow-up|0|||
105843672|NCT02010255|365084304|FG007|Overall Study|Lost to Follow-up|0|||
105843673|NCT02010255|365084305|FG008|Overall Study|Lost to Follow-up|0|||
105843674|NCT02010255|365084306|FG009|Overall Study|Lost to Follow-up|0|||
105843675|NCT02010255|365084307|FG010|Overall Study|Lost to Follow-up|0|||
105843676|NCT02010255|365084308|FG011|Overall Study|Lost to Follow-up|0|||
105843677|NCT02010255|365084309|FG012|Overall Study|Lost to Follow-up|0|||
105843678|NCT02010255|365084310|FG013|Overall Study|Lost to Follow-up|0|||
105843679|NCT02010255|365084297|FG000|Overall Study|Randomized but Not Treated|0|||
105843680|NCT02010255|365084298|FG001|Overall Study|Randomized but Not Treated|0|||
105843681|NCT02010255|365084299|FG002|Overall Study|Randomized but Not Treated|0|||
105843682|NCT02010255|365084300|FG003|Overall Study|Randomized but Not Treated|0|||
105843683|NCT02010255|365084301|FG004|Overall Study|Randomized but Not Treated|0|||
105843684|NCT02010255|365084302|FG005|Overall Study|Randomized but Not Treated|0|||
105843685|NCT02010255|365084303|FG006|Overall Study|Randomized but Not Treated|0|||
105843686|NCT02010255|365084304|FG007|Overall Study|Randomized but Not Treated|0|||
105843687|NCT02010255|365084305|FG008|Overall Study|Randomized but Not Treated|0|||
105843688|NCT02010255|365084306|FG009|Overall Study|Randomized but Not Treated|0|||
105843689|NCT02010255|365084307|FG010|Overall Study|Randomized but Not Treated|0|||
105576591|NCT00197028|364110234|FG001|Overall Study|Other|6|||
105843690|NCT02010255|365084308|FG011|Overall Study|Randomized but Not Treated|0|||
105843691|NCT02010255|365084309|FG012|Overall Study|Randomized but Not Treated|0|||
105843692|NCT02010255|365084310|FG013|Overall Study|Randomized but Not Treated|1|||
105843693|NCT01144403|365084311|FG000|Overall Study|Lost to Follow-up|3|||
105843694|NCT01144403|365084311|FG000|Overall Study|Death|1|||
105843695|NCT01144403|365084311|FG000|Overall Study|Adverse Event|1|||
105576592|NCT01763788|364110235|FG000|Overall Study|Lost to Follow-up|0|||
105843696|NCT03176784|365084312|FG000|Overall Study|Lost to Follow-up|77|||
105843697|NCT03176784|365084313|FG001|Overall Study|Lost to Follow-up|79|||
105490084|NCT00920829|363807452|FG002|Available for Analysis|Death|0|||
105843698|NCT03176784|365084314|FG002|Overall Study|Lost to Follow-up|79|||
105843699|NCT03176784|365084315|FG003|Overall Study|Lost to Follow-up|49|||
105843700|NCT03176784|365084312|FG000|Overall Study|Withdrawal by Subject|28|||
105843701|NCT03176784|365084313|FG001|Overall Study|Withdrawal by Subject|34|||
105843702|NCT03176784|365084314|FG002|Overall Study|Withdrawal by Subject|34|||
105843703|NCT03176784|365084315|FG003|Overall Study|Withdrawal by Subject|21|||
105843704|NCT01010750|365084318|FG000|Second Intervention|Adverse Event|0|||
105843705|NCT01010750|365084319|FG001|Second Intervention|Adverse Event|1|||
105843706|NCT01010750|365084320|FG002|Second Intervention|Adverse Event|0|||
105843707|NCT01010750|365084321|FG003|Second Intervention|Adverse Event|0|||
105843708|NCT01010750|365084322|FG004|Second Intervention|Adverse Event|0|||
105843709|NCT01010750|365084323|FG005|Second Intervention|Adverse Event|0|||
105843710|NCT00094094|365084333|FG000|Overall Study|Death|2|||
105843711|NCT00094094|365084333|FG000|Overall Study|Lack of Efficacy|23|||
105843712|NCT00094094|365084333|FG000|Overall Study|Adverse Event|7|||
105843713|NCT01663727|365084334|FG000|Overall Study|Death|161|||
105843714|NCT01663727|365084335|FG001|Overall Study|Death|155|||
105843715|NCT01663727|365084334|FG000|Overall Study|Lost to Follow-up|10|||
105843716|NCT01663727|365084335|FG001|Overall Study|Lost to Follow-up|8|||
105843717|NCT01663727|365084334|FG000|Overall Study|Withdrawal by Subject|18|||
105843718|NCT01663727|365084335|FG001|Overall Study|Withdrawal by Subject|25|||
105843719|NCT01663727|365084334|FG000|Overall Study|Study Terminated|51|||
105843720|NCT01663727|365084335|FG001|Overall Study|Study Terminated|50|||
105843721|NCT01663727|365084334|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
105843722|NCT01663727|365084335|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
105843723|NCT01663727|365084334|FG000|Overall Study|Withdrawal prior to dosing.|1|||
105490085|NCT00920829|363807453|FG003|Available for Analysis|Death|0|||
105490086|NCT00920829|363807450|FG000|Available for Analysis|Protocol Violation|0|||
105490087|NCT00920829|363807451|FG001|Available for Analysis|Protocol Violation|0|||
105490088|NCT00920829|363807452|FG002|Available for Analysis|Protocol Violation|1|||
105490089|NCT00920829|363807453|FG003|Available for Analysis|Protocol Violation|0|||
105490090|NCT00920829|363807450|FG000|Available for Analysis|Required more treatment|0|||
105490091|NCT00920829|363807451|FG001|Available for Analysis|Required more treatment|2|||
105490092|NCT00920829|363807452|FG002|Available for Analysis|Required more treatment|0|||
105490093|NCT00920829|363807453|FG003|Available for Analysis|Required more treatment|1|||
105490100|NCT04565236|363807462|FG000|Overall Study|Patient/Guardian Decision|0|||
105490101|NCT04565236|363807463|FG001|Overall Study|Patient/Guardian Decision|0|||
105490102|NCT04565236|363807464|FG002|Overall Study|Patient/Guardian Decision|1|||
105490103|NCT04565236|363807465|FG003|Overall Study|Patient/Guardian Decision|0|||
105490104|NCT02806973|363807466|FG000|Period 1|Withdrawal by Subject|0|||
105490105|NCT02806973|363807467|FG001|Period 1|Withdrawal by Subject|2|||
105490106|NCT02806973|363807468|FG002|Period 1|Withdrawal by Subject|1|||
105490107|NCT02806973|363807469|FG003|Period 1|Withdrawal by Subject|1|||
105490108|NCT02806973|363807466|FG000|Period 1|Adverse Event|0|||
105490109|NCT02806973|363807467|FG001|Period 1|Adverse Event|0|||
105490110|NCT02806973|363807468|FG002|Period 1|Adverse Event|0|||
105490111|NCT02806973|363807469|FG003|Period 1|Adverse Event|1|||
105490112|NCT02806973|363807466|FG000|Period 3|Withdrawal by Subject|0|||
105490113|NCT02806973|363807467|FG001|Period 3|Withdrawal by Subject|0|||
105490114|NCT02806973|363807468|FG002|Period 3|Withdrawal by Subject|0|||
105315323|NCT00287586|363150618|FG000|Overall Study|Elevated Hematocrit|3|||
105315324|NCT00287586|363150619|FG001|Overall Study|Elevated Hematocrit|0|||
105490115|NCT02806973|363807469|FG003|Period 3|Withdrawal by Subject|3|||
105490116|NCT02806973|363807466|FG000|Period 3|Adverse Event|0|||
105490117|NCT02806973|363807467|FG001|Period 3|Adverse Event|0|||
105490118|NCT02806973|363807468|FG002|Period 3|Adverse Event|1|||
105490119|NCT02806973|363807469|FG003|Period 3|Adverse Event|0|||
105490120|NCT00366340|363807473|FG000|Infant Series|Protocol Violation|3|||
105490121|NCT00366340|363807474|FG001|Infant Series|Protocol Violation|4|||
105490122|NCT00366340|363807473|FG000|Infant Series|Withdrawal by Subject|3|||
105490123|NCT00366340|363807474|FG001|Infant Series|Withdrawal by Subject|3|||
105490124|NCT00366340|363807473|FG000|Infant Series|Adverse Event|0|||
105490125|NCT00366340|363807474|FG001|Infant Series|Adverse Event|2|||
105490126|NCT00366340|363807473|FG000|Infant Series|Lost to Follow-up|1|||
105490127|NCT00366340|363807474|FG001|Infant Series|Lost to Follow-up|1|||
105490128|NCT00366340|363807473|FG000|Infant Series|Failure to return|1|||
105490129|NCT00366340|363807474|FG001|Infant Series|Failure to return|0|||
105490130|NCT00366340|363807473|FG000|After the Infant Series|Parent/legal guardian request|1|||
105843724|NCT01663727|365084335|FG001|Overall Study|Withdrawal prior to dosing.|0|||
105315325|NCT00287586|363150618|FG000|Overall Study|Rash|3|||
105843725|NCT02522403|365086659|FG000|Overall Study|Lost to Follow-up|2|||
105843726|NCT02522403|365086660|FG001|Overall Study|Lost to Follow-up|2|||
105490131|NCT00366340|363807474|FG001|After the Infant Series|Parent/legal guardian request|1|||
105490132|NCT00366340|363807473|FG000|After the Infant Series|Failed to return|0|||
105490133|NCT00366340|363807474|FG001|After the Infant Series|Failed to return|1|||
105490134|NCT00366340|363807473|FG000|After the Infant Series|Protocol Violation|2|||
105490135|NCT00366340|363807474|FG001|After the Infant Series|Protocol Violation|2|||
105490136|NCT00366340|363807473|FG000|After the Infant Series|Adverse Event|0|||
105490137|NCT00366340|363807474|FG001|After the Infant Series|Adverse Event|1|||
105490138|NCT00366340|363807473|FG000|After the Infant Series|Lost to Follow-up|0|||
105490139|NCT00366340|363807474|FG001|After the Infant Series|Lost to Follow-up|1|||
105490140|NCT00366340|363807473|FG000|Toddler Dose|Failed to return|1|||
105490141|NCT00366340|363807474|FG001|Toddler Dose|Failed to return|0|||
105490142|NCT00366340|363807473|FG000|Toddler Dose|Parent/legal guardian request|0|||
105490143|NCT00366340|363807474|FG001|Toddler Dose|Parent/legal guardian request|1|||
105490144|NCT00900601|363807475|FG000|Overall Study|Physician Decision|1|||
105490145|NCT03026088|363807476|FG000|Overall Study|Study termination|20|||
105490146|NCT01869725|363807478|FG000|Overall Study|ineligible after registration|1|||
105490147|NCT01869725|363807478|FG000|Overall Study|Death|1|||
105490148|NCT01869725|363807478|FG000|Overall Study|Lost to Follow-up|2|||
105490149|NCT01143207|363807479|FG000|Overall Study|Lost to Follow-up|2|||
105490150|NCT01025154|363807481|FG000|Overall Study|Lost to Follow-up|1|||
105490151|NCT01025154|363807481|FG000|Overall Study|Withdrawal by Subject|1|||
105490152|NCT02545075|363807482|FG000|Randomization|Lost to Follow-up|0|||
105490153|NCT02545075|363807483|FG001|Randomization|Lost to Follow-up|1|||
105490154|NCT02545075|363807482|FG000|Randomization|Withdrawal by Subject|0|||
105490155|NCT02545075|363807483|FG001|Randomization|Withdrawal by Subject|6|||
105490156|NCT02545075|363807482|FG000|Treatment|Disease progression|71|||
105490157|NCT02545075|363807483|FG001|Treatment|Disease progression|32|||
105490158|NCT02545075|363807482|FG000|Treatment|Participant dicontinued study treatment|7|||
105490159|NCT02545075|363807483|FG001|Treatment|Participant dicontinued study treatment|9|||
105490160|NCT02545075|363807482|FG000|Treatment|Withdrawal by Subject|1|||
105490161|NCT02545075|363807483|FG001|Treatment|Withdrawal by Subject|0|||
105490162|NCT02545075|363807482|FG000|Treatment|Adverse event not related to study drug|1|||
105490163|NCT02545075|363807483|FG001|Treatment|Adverse event not related to study drug|0|||
105490164|NCT02545075|363807482|FG000|Treatment|Death|1|||
105490165|NCT02545075|363807483|FG001|Treatment|Death|0|||
105490166|NCT02545075|363807482|FG000|Treatment|Participant drug toxicity|1|||
105490167|NCT02545075|363807483|FG001|Treatment|Participant drug toxicity|0|||
105490168|NCT02545075|363807482|FG000|Treatment|Completed treatment|40|||
105490169|NCT02545075|363807483|FG001|Treatment|Completed treatment|12|||
105490170|NCT00736879|363807484|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
105490171|NCT00736879|363807485|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
105490172|NCT00736879|363807486|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
105490173|NCT00736879|363807487|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
105490174|NCT00736879|363807484|FG000|Double Blind Treatment Period|Adverse Event|0|||
105490175|NCT00736879|363807485|FG001|Double Blind Treatment Period|Adverse Event|1|||
105490176|NCT00736879|363807486|FG002|Double Blind Treatment Period|Adverse Event|1|||
105490177|NCT00736879|363807487|FG003|Double Blind Treatment Period|Adverse Event|0|||
105490178|NCT00736879|363807484|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
105490179|NCT00736879|363807485|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
105490180|NCT00736879|363807486|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
105490181|NCT00736879|363807487|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
105490182|NCT00736879|363807484|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
105490183|NCT00736879|363807485|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
105490184|NCT00736879|363807486|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
105490185|NCT00736879|363807487|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
105490186|NCT00736879|363807484|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
105490187|NCT00736879|363807485|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
105490188|NCT00736879|363807486|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
105490189|NCT00736879|363807487|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
105490190|NCT00736879|363807484|FG000|Double Blind Treatment Period|No longer met criteria|0|||
105490191|NCT00736879|363807485|FG001|Double Blind Treatment Period|No longer met criteria|1|||
105490192|NCT00736879|363807486|FG002|Double Blind Treatment Period|No longer met criteria|0|||
105490193|NCT00736879|363807487|FG003|Double Blind Treatment Period|No longer met criteria|0|||
105490194|NCT00736879|363807484|FG000|Double Blind Treatment Period|non-specified|0|||
105490195|NCT00736879|363807485|FG001|Double Blind Treatment Period|non-specified|1|||
105490196|NCT00736879|363807486|FG002|Double Blind Treatment Period|non-specified|0|||
105490197|NCT00736879|363807487|FG003|Double Blind Treatment Period|non-specified|0|||
105490198|NCT00736879|363807484|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
105490199|NCT00736879|363807485|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
105490200|NCT00736879|363807486|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
105490201|NCT00736879|363807487|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
105490202|NCT00736879|363807484|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
105315326|NCT00287586|363150619|FG001|Overall Study|Rash|0|||
105315327|NCT00287586|363150618|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
105315328|NCT00287586|363150619|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
105315329|NCT00287586|363150618|FG000|Overall Study|Stroke|2|||
105315330|NCT00287586|363150619|FG001|Overall Study|Stroke|0|||
105315331|NCT00287586|363150618|FG000|Overall Study|Myocardial Infarction|1|||
105315332|NCT00287586|363150619|FG001|Overall Study|Myocardial Infarction|0|||
105315333|NCT00287586|363150618|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
105315334|NCT00287586|363150619|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
105315335|NCT00287586|363150618|FG000|Overall Study|Cognitive Impairment|1|||
105315336|NCT00287586|363150619|FG001|Overall Study|Cognitive Impairment|0|||
105315337|NCT00287586|363150618|FG000|Overall Study|Pancreatic Cancer|1|||
105315338|NCT00287586|363150619|FG001|Overall Study|Pancreatic Cancer|3|||
105315339|NCT00287586|363150618|FG000|Overall Study|Sleep Apnea|1|||
105315340|NCT00287586|363150619|FG001|Overall Study|Sleep Apnea|0|||
105315341|NCT00287586|363150618|FG000|Overall Study|Shoulder Pain|1|||
105315342|NCT00287586|363150619|FG001|Overall Study|Shoulder Pain|0|||
105315343|NCT00287586|363150618|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
105315344|NCT00287586|363150619|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
105315345|NCT00287586|363150618|FG000|Overall Study|Nonadherence|1|||
105315346|NCT00287586|363150619|FG001|Overall Study|Nonadherence|1|||
105315347|NCT00287586|363150618|FG000|Overall Study|Enrolled in Another Study|1|||
105576593|NCT01763788|364110236|FG001|Overall Study|Lost to Follow-up|0|||
105576594|NCT01763788|364110237|FG002|Overall Study|Lost to Follow-up|1|||
105576595|NCT01763788|364110238|FG003|Overall Study|Lost to Follow-up|0|||
105576596|NCT03893825|364110239|FG000|Overall Study|Death|2|||
105576597|NCT03893825|364110240|FG001|Overall Study|Death|1|||
105576598|NCT03893825|364110239|FG000|Overall Study|Adverse Event|0|||
105576599|NCT03893825|364110240|FG001|Overall Study|Adverse Event|2|||
105576600|NCT03893825|364110239|FG000|Overall Study|Withdrawal by Subject|19|||
105576601|NCT03893825|364110240|FG001|Overall Study|Withdrawal by Subject|21|||
105576602|NCT03893825|364110239|FG000|Overall Study|Protocol deviation|1|||
105576603|NCT03893825|364110240|FG001|Overall Study|Protocol deviation|0|||
105576604|NCT03893825|364110239|FG000|Overall Study|Lost to Follow-up|10|||
105576605|NCT03893825|364110240|FG001|Overall Study|Lost to Follow-up|10|||
105576606|NCT03893825|364110239|FG000|Overall Study|Other than specified|7|||
105576607|NCT03893825|364110240|FG001|Overall Study|Other than specified|6|||
105576608|NCT00390455|364110244|FG000|Overall Study|Adverse Event|17|||
105576609|NCT00390455|364110245|FG001|Overall Study|Adverse Event|3|||
105576610|NCT00390455|364110244|FG000|Overall Study|Withdrawal by Subject|8|||
105576611|NCT00390455|364110245|FG001|Overall Study|Withdrawal by Subject|8|||
105576612|NCT00390455|364110244|FG000|Overall Study|Alternate Treatment|0|||
105576613|NCT00390455|364110245|FG001|Overall Study|Alternate Treatment|1|||
105576614|NCT00390455|364110244|FG000|Overall Study|Other Medical Reasons|7|||
105576615|NCT00390455|364110245|FG001|Overall Study|Other Medical Reasons|11|||
105576616|NCT00988351|364110254|FG000|Overall Study|Withdrawal by Subject|8|||
105576617|NCT00988351|364110255|FG001|Overall Study|Withdrawal by Subject|0|||
105576618|NCT00988351|364110254|FG000|Overall Study|Lost to Follow-up|6|||
105576619|NCT00988351|364110255|FG001|Overall Study|Lost to Follow-up|9|||
105576620|NCT00988351|364110254|FG000|Overall Study|not using CPAP|5|||
105576621|NCT00988351|364110255|FG001|Overall Study|not using CPAP|3|||
105576622|NCT00734214|364110258|FG000|Overall Study|Withdrawal by Subject|3|||
105576623|NCT00734214|364110259|FG001|Overall Study|Withdrawal by Subject|4|||
105576624|NCT00734214|364110258|FG000|Overall Study|MD withdrawal|1|||
105576625|NCT00734214|364110259|FG001|Overall Study|MD withdrawal|0|||
105576626|NCT02038764|364110260|FG000|Overall Study|Adverse Event|0|||
105576627|NCT02038764|364110261|FG001|Overall Study|Adverse Event|0|||
105576628|NCT02038764|364110262|FG002|Overall Study|Adverse Event|1|||
105576629|NCT02038764|364110263|FG003|Overall Study|Adverse Event|0|||
105576630|NCT02038764|364110264|FG004|Overall Study|Adverse Event|0|||
105576631|NCT02038764|364110260|FG000|Overall Study|Lost to Follow-up|0|||
105576632|NCT02038764|364110261|FG001|Overall Study|Lost to Follow-up|1|||
105576633|NCT02038764|364110262|FG002|Overall Study|Lost to Follow-up|0|||
105843727|NCT02522403|365086659|FG000|Overall Study|Withdrawal by Subject|2|||
105843728|NCT02522403|365086660|FG001|Overall Study|Withdrawal by Subject|4|||
105843729|NCT00856973|365086661|FG000|Overall Study|Adverse Event|5|||
105843730|NCT00856973|365086662|FG001|Overall Study|Adverse Event|5|||
105576634|NCT02038764|364110263|FG003|Overall Study|Lost to Follow-up|0|||
105843731|NCT00856973|365086663|FG002|Overall Study|Adverse Event|3|||
105843732|NCT00856973|365086661|FG000|Overall Study|Lost to Follow-up|6|||
105315348|NCT00287586|363150619|FG001|Overall Study|Enrolled in Another Study|0|||
105315349|NCT00287586|363150618|FG000|Overall Study|Major Depression|0|||
105315350|NCT00287586|363150619|FG001|Overall Study|Major Depression|2|||
105315351|NCT00287586|363150618|FG000|Overall Study|Lung Cancer|0|||
105315352|NCT00287586|363150619|FG001|Overall Study|Lung Cancer|2|||
105315353|NCT00287586|363150618|FG000|Overall Study|Elevated IPSS Score|0|||
105315354|NCT00287586|363150619|FG001|Overall Study|Elevated IPSS Score|1|||
105576635|NCT02038764|364110264|FG004|Overall Study|Lost to Follow-up|0|||
105576636|NCT02038764|364110260|FG000|Overall Study|Withdrawal by Subject|0|||
105315355|NCT00287586|363150618|FG000|Overall Study|Retroperitoneal Cancer|0|||
105315356|NCT00287586|363150619|FG001|Overall Study|Retroperitoneal Cancer|1|||
105315357|NCT00287586|363150618|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
105315358|NCT00287586|363150619|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
105315359|NCT00287586|363150618|FG000|Overall Study|Mood Swings and Irritability|0|||
105315360|NCT00287586|363150619|FG001|Overall Study|Mood Swings and Irritability|1|||
105315361|NCT00287586|363150618|FG000|Overall Study|Bradycardia|0|||
105315362|NCT00287586|363150619|FG001|Overall Study|Bradycardia|1|||
105315363|NCT00287586|363150618|FG000|Overall Study|Itchy Swollen Eyes|0|||
105315364|NCT00287586|363150619|FG001|Overall Study|Itchy Swollen Eyes|1|||
105315365|NCT00287586|363150618|FG000|Overall Study|Recurrent Melanoma|0|||
105315366|NCT00287586|363150619|FG001|Overall Study|Recurrent Melanoma|1|||
105315367|NCT03743415|363150621|FG000|Overall Study|Death|5|||
105315368|NCT03743415|363150622|FG001|Overall Study|Death|3|||
105315369|NCT03743415|363150623|FG002|Overall Study|Death|1|||
105315370|NCT03743415|363150624|FG003|Overall Study|Death|4|||
105315371|NCT03743415|363150625|FG004|Overall Study|Death|0|||
105315372|NCT03743415|363150626|FG005|Overall Study|Death|0|||
105315373|NCT03743415|363150627|FG006|Overall Study|Death|0|||
105315374|NCT03743415|363150628|FG007|Overall Study|Death|0|||
105315375|NCT03743415|363150629|FG008|Overall Study|Death|1|||
105315376|NCT03743415|363150630|FG009|Overall Study|Death|0|||
105315377|NCT03743415|363150621|FG000|Overall Study|Withdrawal by Subject|1|||
105315378|NCT03743415|363150622|FG001|Overall Study|Withdrawal by Subject|0|||
105315379|NCT03743415|363150623|FG002|Overall Study|Withdrawal by Subject|4|||
105315380|NCT03743415|363150624|FG003|Overall Study|Withdrawal by Subject|5|||
105315381|NCT03743415|363150625|FG004|Overall Study|Withdrawal by Subject|5|||
105315382|NCT03743415|363150626|FG005|Overall Study|Withdrawal by Subject|2|||
105315383|NCT03743415|363150627|FG006|Overall Study|Withdrawal by Subject|2|||
105315384|NCT03743415|363150628|FG007|Overall Study|Withdrawal by Subject|5|||
105315385|NCT03743415|363150629|FG008|Overall Study|Withdrawal by Subject|9|||
105315386|NCT03743415|363150630|FG009|Overall Study|Withdrawal by Subject|10|||
105315387|NCT03743415|363150621|FG000|Overall Study|Lost to Follow-up|2|||
105315388|NCT03743415|363150622|FG001|Overall Study|Lost to Follow-up|0|||
105315389|NCT03743415|363150623|FG002|Overall Study|Lost to Follow-up|2|||
105315390|NCT03743415|363150624|FG003|Overall Study|Lost to Follow-up|1|||
105315391|NCT03743415|363150625|FG004|Overall Study|Lost to Follow-up|1|||
105315392|NCT03743415|363150626|FG005|Overall Study|Lost to Follow-up|0|||
105315393|NCT03743415|363150627|FG006|Overall Study|Lost to Follow-up|1|||
105315394|NCT03743415|363150628|FG007|Overall Study|Lost to Follow-up|4|||
105315395|NCT03743415|363150629|FG008|Overall Study|Lost to Follow-up|13|||
105315396|NCT03743415|363150630|FG009|Overall Study|Lost to Follow-up|13|||
105315397|NCT01421511|363150633|FG000|Overall Study|Lost to Follow-up|11|||
105315398|NCT01421511|363150634|FG001|Overall Study|Lost to Follow-up|14|||
105315399|NCT01421511|363150633|FG000|Overall Study|Randomized but didn't receive study drug|1|||
105315400|NCT01421511|363150634|FG001|Overall Study|Randomized but didn't receive study drug|7|||
105315401|NCT01421511|363150633|FG000|Overall Study|Physician Decision|0|||
105315402|NCT01421511|363150634|FG001|Overall Study|Physician Decision|1|||
105315403|NCT01421511|363150633|FG000|Overall Study|Withdrawal by Subject|6|||
105315404|NCT01421511|363150634|FG001|Overall Study|Withdrawal by Subject|5|||
105315405|NCT01421511|363150633|FG000|Overall Study|Death|1|||
105315406|NCT01421511|363150634|FG001|Overall Study|Death|1|||
105315407|NCT04602546|363150637|FG000|Overall Study|Training|2|||
105315408|NCT04602546|363150638|FG001|Overall Study|Training|2|||
105368716|NCT01926028|363356262|FG002|Overall Study|Non compliance or other reasons|0|||
105368717|NCT00737048|363356263|FG000|Overall Study|Physician Decision|0|||
105368718|NCT00737048|363356264|FG001|Overall Study|Physician Decision|0|||
105368719|NCT00737048|363356265|FG002|Overall Study|Physician Decision|1|||
105368720|NCT00737048|363356263|FG000|Overall Study|Adverse Event|0|||
105368721|NCT00737048|363356264|FG001|Overall Study|Adverse Event|1|||
105368722|NCT00737048|363356265|FG002|Overall Study|Adverse Event|0|||
105368723|NCT00737048|363356263|FG000|Overall Study|Worsening of the symptoms|3|||
105368724|NCT00737048|363356264|FG001|Overall Study|Worsening of the symptoms|5|||
105368725|NCT00737048|363356265|FG002|Overall Study|Worsening of the symptoms|3|||
105315409|NCT04602546|363150639|FG002|Overall Study|Training|1|||
105315410|NCT04602546|363150640|FG003|Overall Study|Training|2|||
105315411|NCT04602546|363150641|FG004|Overall Study|Training|0|||
105368726|NCT00301834|363356268|FG000|Overall Study|Death|1|||
105368727|NCT02351934|363356269|FG000|Allocation|POD weight<pre-op weight|3|||
105368728|NCT02351934|363356270|FG001|Allocation|POD weight<pre-op weight|0|||
105315412|NCT04602546|363150637|FG000|Overall Study|Randomized with disqualified data|2|||
105315413|NCT04602546|363150638|FG001|Overall Study|Randomized with disqualified data|0|||
105315414|NCT04602546|363150639|FG002|Overall Study|Randomized with disqualified data|2|||
105315415|NCT04602546|363150640|FG003|Overall Study|Randomized with disqualified data|5|||
105315416|NCT04602546|363150641|FG004|Overall Study|Randomized with disqualified data|3|||
105315417|NCT02901548|363150644|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
105368729|NCT02351934|363356269|FG000|Allocation|Hypotension preventing administration|2|||
105368730|NCT02351934|363356270|FG001|Allocation|Hypotension preventing administration|0|||
105315418|NCT02368314|363150645|FG000|Overall Study|Withdrawal by Subject|2|||
105843733|NCT00856973|365086662|FG001|Overall Study|Lost to Follow-up|3|||
105843734|NCT00856973|365086663|FG002|Overall Study|Lost to Follow-up|5|||
105843735|NCT00856973|365086661|FG000|Overall Study|Physician Decision|0|||
105843736|NCT00856973|365086662|FG001|Overall Study|Physician Decision|3|||
105843737|NCT00856973|365086663|FG002|Overall Study|Physician Decision|1|||
105843738|NCT00856973|365086661|FG000|Overall Study|Protocol Violation|1|||
105843739|NCT00856973|365086662|FG001|Overall Study|Protocol Violation|2|||
105843740|NCT00856973|365086663|FG002|Overall Study|Protocol Violation|1|||
105843741|NCT00856973|365086661|FG000|Overall Study|Withdrawal by Subject|13|||
105843742|NCT00856973|365086662|FG001|Overall Study|Withdrawal by Subject|16|||
105843743|NCT00856973|365086663|FG002|Overall Study|Withdrawal by Subject|15|||
105843744|NCT00856973|365086661|FG000|Overall Study|Other|11|||
105843745|NCT00856973|365086662|FG001|Overall Study|Other|12|||
105843746|NCT00856973|365086663|FG002|Overall Study|Other|13|||
105843747|NCT00380692|365086665|FG000|Study Period II - Double Blind|Adverse Event|1|||
105843748|NCT00380692|365086666|FG001|Study Period II - Double Blind|Adverse Event|0|||
105843749|NCT00380692|365086665|FG000|Study Period II - Double Blind|Protocol Violation|2|||
105843750|NCT00380692|365086666|FG001|Study Period II - Double Blind|Protocol Violation|2|||
105843751|NCT00380692|365086665|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
105843752|NCT00380692|365086666|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
105843753|NCT00380692|365086665|FG000|Study Period II - Double Blind|Physician Decision|0|||
105843754|NCT00380692|365086666|FG001|Study Period II - Double Blind|Physician Decision|1|||
105843755|NCT00380692|365086665|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
105843756|NCT00380692|365086666|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
105843757|NCT00380692|365086665|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
105843758|NCT00380692|365086666|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
105843759|NCT00380692|365086665|FG000|Study Period III - Open Label|Adverse Event|5|||
105843760|NCT00380692|365086666|FG001|Study Period III - Open Label|Adverse Event|3|||
105843761|NCT00380692|365086665|FG000|Study Period III - Open Label|Protocol Violation|0|||
105843762|NCT00380692|365086666|FG001|Study Period III - Open Label|Protocol Violation|0|||
105843763|NCT00380692|365086665|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
105843764|NCT00380692|365086666|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
105843765|NCT00380692|365086665|FG000|Study Period III - Open Label|Physician Decision|0|||
105843766|NCT00380692|365086666|FG001|Study Period III - Open Label|Physician Decision|3|||
105843767|NCT00380692|365086665|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
105843768|NCT00380692|365086666|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
105843769|NCT00380692|365086665|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
105843770|NCT00380692|365086666|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
105843771|NCT02698865|365086667|FG000|Overall Study|Other|11|||
105843772|NCT02698865|365086668|FG001|Overall Study|Other|11|||
105843773|NCT02698865|365086667|FG000|Overall Study|Withdrawal by Subject|20|||
105843774|NCT02698865|365086668|FG001|Overall Study|Withdrawal by Subject|16|||
105843775|NCT02698865|365086667|FG000|Overall Study|Physician Decision|0|||
105843776|NCT02698865|365086668|FG001|Overall Study|Physician Decision|4|||
105843777|NCT02698865|365086667|FG000|Overall Study|Lost to Follow-up|4|||
105843778|NCT02698865|365086668|FG001|Overall Study|Lost to Follow-up|2|||
105843779|NCT00856830|365086669|FG000|Irinotecan & Bendamustine|Death|0|||
105843780|NCT00856830|365086670|FG001|Irinotecan & Bendamustine|Death|0|||
105843781|NCT00856830|365086671|FG002|Irinotecan & Bendamustine|Death|0|||
105843782|NCT00856830|365086672|FG003|Irinotecan & Bendamustine|Death|2|||
105843783|NCT00856830|365086669|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
105843784|NCT00856830|365086670|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
105843785|NCT00856830|365086671|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
105843786|NCT00856830|365086672|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
105843787|NCT03768726|365086673|FG000|Treatment Phase|Adverse Event|2|||
105843788|NCT03768726|365086674|FG001|Treatment Phase|Adverse Event|2|||
105843789|NCT03768726|365086673|FG000|Treatment Phase|Lost to Follow-up|1|||
105843790|NCT03768726|365086674|FG001|Treatment Phase|Lost to Follow-up|0|||
105843791|NCT03768726|365086673|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
105843792|NCT03768726|365086674|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
105843793|NCT03768726|365086673|FG000|Treatment Phase|Withdrawal by Subject|3|||
105843794|NCT03768726|365086674|FG001|Treatment Phase|Withdrawal by Subject|1|||
105843795|NCT03768726|365086673|FG000|Follow-Up|Adverse Event|2|||
105843796|NCT03768726|365086674|FG001|Follow-Up|Adverse Event|2|||
105843797|NCT03768726|365086673|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
105843798|NCT03768726|365086674|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
105843799|NCT03768726|365086673|FG000|Follow-Up|Withdrawal by Subject|2|||
105843800|NCT03768726|365086674|FG001|Follow-Up|Withdrawal by Subject|0|||
105843801|NCT03768726|365086673|FG000|Follow-Up|Other|1|||
105843802|NCT03768726|365086674|FG001|Follow-Up|Other|0|||
105490203|NCT00736879|363807485|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
105843803|NCT01787279|365086675|FG000|Overall Study|Lost to Follow-up|2|||
105843804|NCT01787279|365086675|FG000|Overall Study|Lack of Efficacy|1|||
105843805|NCT01659736|365086677|FG000|Treatment Period|Adverse Event|1|||
105843806|NCT01659736|365086678|FG001|Treatment Period|Adverse Event|1|||
105843807|NCT01659736|365086677|FG000|Treatment Period|Protocol Violation|3|||
105843808|NCT01659736|365086678|FG001|Treatment Period|Protocol Violation|1|||
105843809|NCT01659736|365086677|FG000|Treatment Period|Withdrawal by Subject|1|||
105843810|NCT01659736|365086678|FG001|Treatment Period|Withdrawal by Subject|0|||
105843811|NCT01659736|365086677|FG000|3-month Follow-up|Lost to Follow-up|0|||
105843812|NCT01659736|365086678|FG001|3-month Follow-up|Lost to Follow-up|1|||
105843813|NCT02006628|365086679|FG000|Overall Study|Adverse Event|1|||
105843814|NCT02006628|365086680|FG001|Overall Study|Adverse Event|1|||
105843815|NCT02006628|365086679|FG000|Overall Study|Withdrawal by Subject|2|||
105843816|NCT02006628|365086680|FG001|Overall Study|Withdrawal by Subject|1|||
105843817|NCT03578237|365086683|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
105843818|NCT03578237|365086684|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
105843819|NCT00252174|365086685|FG000|Overall Study|Withdrawal by Subject|0|||
105843820|NCT00252174|365086686|FG001|Overall Study|Withdrawal by Subject|1|||
105843821|NCT00252174|365086687|FG002|Overall Study|Withdrawal by Subject|0|||
105490204|NCT00736879|363807486|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
105490205|NCT00736879|363807487|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
105490206|NCT00735254|363807492|FG000|Overall Study|Protocol Violation|1|||
105490207|NCT00735254|363807493|FG001|Overall Study|Protocol Violation|1|||
105490208|NCT00735254|363807494|FG002|Overall Study|Protocol Violation|1|||
105490209|NCT00735254|363807495|FG003|Overall Study|Protocol Violation|0|||
105490210|NCT00214500|363807496|FG000|Treatment Period|Adverse Event|1|||
105490211|NCT00214500|363807496|FG000|Extension Period|Withdrawal by Subject|2|||
105490212|NCT01629706|363807497|FG000|Phase 1 PureVision|Screen Failure|4|||
105490213|NCT01629706|363807497|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
105490214|NCT01629706|363807497|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
105490215|NCT01629706|363807497|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
105490216|NCT01629706|363807497|FG000|Phase 2 Habitual|Screen Failure|6|||
105490217|NCT01629706|363807497|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
105490218|NCT01629706|363807497|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
105490219|NCT01629706|363807497|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
105843822|NCT02546362|365086688|FG000|4-week Treatment Period|Lost to Follow-up|1|||
105843823|NCT02546362|365086688|FG000|4-week Treatment Period|Change in medication|2|||
105843824|NCT02546362|365086688|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
105843825|NCT02546362|365086688|FG000|12-week Treatment Period|Lost to Follow-up|2|||
105843826|NCT02546362|365086688|FG000|12-week Treatment Period|Change in medication|1|||
105843827|NCT01478828|365086689|FG000|Overall Study|Adverse Event|1|||
105843828|NCT00296491|365086690|FG000|Overall Study|Low Pollen Counts|18|||
105843829|NCT00296491|365086691|FG001|Overall Study|Low Pollen Counts|26|||
105843830|NCT00296491|365086692|FG002|Overall Study|Low Pollen Counts|25|||
105843831|NCT00296491|365086693|FG003|Overall Study|Low Pollen Counts|16|||
105843832|NCT00296491|365086690|FG000|Overall Study|Protocol Violation|4|||
105843833|NCT00296491|365086691|FG001|Overall Study|Protocol Violation|6|||
105843834|NCT00296491|365086692|FG002|Overall Study|Protocol Violation|2|||
105843835|NCT00296491|365086693|FG003|Overall Study|Protocol Violation|3|||
105843836|NCT00296491|365086690|FG000|Overall Study|Adverse Event|1|||
105843837|NCT00296491|365086691|FG001|Overall Study|Adverse Event|3|||
105843838|NCT00296491|365086692|FG002|Overall Study|Adverse Event|1|||
105843839|NCT00296491|365086693|FG003|Overall Study|Adverse Event|4|||
105843840|NCT00296491|365086690|FG000|Overall Study|Withdrawn due to Asthma|0|||
105843841|NCT00296491|365086691|FG001|Overall Study|Withdrawn due to Asthma|0|||
105843842|NCT00296491|365086692|FG002|Overall Study|Withdrawn due to Asthma|0|||
105843843|NCT00296491|365086693|FG003|Overall Study|Withdrawn due to Asthma|4|||
105843844|NCT00296491|365086690|FG000|Overall Study|Withdrawal by Subject|7|||
105843845|NCT00296491|365086691|FG001|Overall Study|Withdrawal by Subject|3|||
105843846|NCT00296491|365086692|FG002|Overall Study|Withdrawal by Subject|3|||
105843847|NCT00296491|365086693|FG003|Overall Study|Withdrawal by Subject|2|||
105843848|NCT00296491|365086690|FG000|Overall Study|Non-Compliance|12|||
105843849|NCT00296491|365086691|FG001|Overall Study|Non-Compliance|13|||
105843850|NCT00296491|365086692|FG002|Overall Study|Non-Compliance|10|||
105576637|NCT02038764|364110261|FG001|Overall Study|Withdrawal by Subject|0|||
105843851|NCT00296491|365086693|FG003|Overall Study|Non-Compliance|14|||
105843852|NCT00296491|365086690|FG000|Overall Study|Lost to Follow-up|0|||
105843853|NCT00296491|365086691|FG001|Overall Study|Lost to Follow-up|2|||
105843854|NCT00296491|365086692|FG002|Overall Study|Lost to Follow-up|2|||
105490220|NCT01629706|363807497|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
105490221|NCT02537574|363807498|FG000|Overall Study|Adverse Event|1|||
105490222|NCT02537574|363807499|FG001|Overall Study|Adverse Event|3|||
105490223|NCT02537574|363807500|FG002|Overall Study|Adverse Event|2|||
105576638|NCT02038764|364110262|FG002|Overall Study|Withdrawal by Subject|0|||
105843855|NCT00296491|365086693|FG003|Overall Study|Lost to Follow-up|0|||
105843856|NCT01300052|365086694|FG000|Overall Study|Adverse Event|3|||
105843857|NCT01300052|365086695|FG001|Overall Study|Adverse Event|0|||
105843858|NCT01300052|365086694|FG000|Overall Study|Withdrawal by Subject|2|||
105843859|NCT01300052|365086695|FG001|Overall Study|Withdrawal by Subject|2|||
105843860|NCT01300052|365086694|FG000|Overall Study|Protocol Violation|1|||
105315419|NCT02368314|363150646|FG001|Overall Study|Withdrawal by Subject|1|||
105315420|NCT02368314|363150645|FG000|Overall Study|Adverse Event|1|||
105315421|NCT02368314|363150646|FG001|Overall Study|Adverse Event|2|||
105315422|NCT01266031|363150649|FG000|Overall Study|Not treated|0|||
105315423|NCT01266031|363150650|FG001|Overall Study|Not treated|3|||
105315424|NCT01266031|363150651|FG002|Overall Study|Not treated|2|||
105315425|NCT01434810|363150652|FG000|Overall Study|Did not receive treatment|11|||
105315426|NCT01434810|363150653|FG001|Overall Study|Did not receive treatment|3|||
105315427|NCT01434810|363150652|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
105315428|NCT01434810|363150653|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
105315429|NCT01307111|363150658|FG000|IUD Insertion|Lost to Follow-up|2|||
105315430|NCT01307111|363150659|FG001|IUD Insertion|Lost to Follow-up|0|||
105315431|NCT01307111|363150658|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
105315432|NCT01307111|363150659|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
105315433|NCT01068262|363150665|FG000|Overall Study|Adverse Event|2|||
105315434|NCT01068262|363150666|FG001|Overall Study|Adverse Event|0|||
105315435|NCT01068262|363150667|FG002|Overall Study|Adverse Event|1|||
105315436|NCT01068262|363150668|FG003|Overall Study|Adverse Event|0|||
105315437|NCT01068262|363150665|FG000|Overall Study|Protocol Violation|1|||
105315438|NCT01068262|363150666|FG001|Overall Study|Protocol Violation|0|||
105315439|NCT01068262|363150667|FG002|Overall Study|Protocol Violation|0|||
105315440|NCT01068262|363150668|FG003|Overall Study|Protocol Violation|0|||
105843861|NCT01300052|365086695|FG001|Overall Study|Protocol Violation|1|||
105843862|NCT00775606|365086698|FG000|Overall Study|Study sponsor terminated funding|3|||
105843863|NCT00775606|365086699|FG001|Overall Study|Study sponsor terminated funding|0|||
105843864|NCT02278718|365086700|FG000|Overall Study|Adverse Event|1|||
105843865|NCT02278718|365086701|FG001|Overall Study|Adverse Event|0|||
105843866|NCT02278718|365086700|FG000|Overall Study|Lost to Follow-up|2|||
105843867|NCT02278718|365086701|FG001|Overall Study|Lost to Follow-up|4|||
105843868|NCT02278718|365086700|FG000|Overall Study|Withdrawal by Subject|1|||
105843869|NCT02278718|365086701|FG001|Overall Study|Withdrawal by Subject|4|||
105843870|NCT02278718|365086700|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
105843871|NCT02278718|365086701|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
105843872|NCT02278718|365086700|FG000|Overall Study|Missing|0|||
105843873|NCT02278718|365086701|FG001|Overall Study|Missing|1|||
105843874|NCT01546649|365086702|FG000|Overall Study|Adverse Event|4|||
105843875|NCT01546649|365086703|FG001|Overall Study|Adverse Event|5|||
105843876|NCT01546649|365086702|FG000|Overall Study|Protocol Violation|1|||
105843877|NCT01546649|365086703|FG001|Overall Study|Protocol Violation|0|||
105843878|NCT01546649|365086702|FG000|Overall Study|Lack of Efficacy|1|||
105843879|NCT01546649|365086703|FG001|Overall Study|Lack of Efficacy|0|||
105843880|NCT01546649|365086702|FG000|Overall Study|Recurrence|1|||
105843881|NCT01546649|365086703|FG001|Overall Study|Recurrence|1|||
105843882|NCT01546649|365086702|FG000|Overall Study|Discovery of secondary cancer|0|||
105843883|NCT01546649|365086703|FG001|Overall Study|Discovery of secondary cancer|1|||
105843884|NCT01546649|365086702|FG000|Overall Study|Withdrawal by Subject|1|||
105843885|NCT01546649|365086703|FG001|Overall Study|Withdrawal by Subject|2|||
105843886|NCT04440449|365086704|FG000|Overall Study|Lost to Follow-up|2|||
105843887|NCT04440449|365086705|FG001|Overall Study|Lost to Follow-up|0|||
105843888|NCT05212883|365086706|FG000|Overall Study|Invalid test result|125|||
105315441|NCT01068262|363150665|FG000|Overall Study|Withdrawal by Subject|0|||
105315442|NCT01068262|363150666|FG001|Overall Study|Withdrawal by Subject|1|||
105315443|NCT01068262|363150667|FG002|Overall Study|Withdrawal by Subject|0|||
105315444|NCT01068262|363150668|FG003|Overall Study|Withdrawal by Subject|0|||
105315445|NCT00195338|363150670|FG000|Overall Study|Lost to Follow-up|2|||
105315446|NCT00195338|363150670|FG000|Overall Study|Adverse Event|5|||
105315447|NCT00195338|363150670|FG000|Overall Study|Lack of Efficacy|1|||
105315448|NCT00195338|363150670|FG000|Overall Study|Early closure of the site|4|||
105315449|NCT00005957|363150675|FG000|Overall Study|No treated|3|||
105315450|NCT00005957|363150676|FG001|Overall Study|No treated|9|||
105315451|NCT00005957|363150675|FG000|Overall Study|Crossover to the other arm|5|||
105843889|NCT02502734|365086707|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
105843890|NCT02502734|365086708|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
105843891|NCT02502734|365086707|FG000|Washout Period|Adverse Event|1|||
105843892|NCT02502734|365086708|FG001|Washout Period|Adverse Event|0|||
105843893|NCT00897949|365086711|FG000|Overall Study|Adverse Event|1|||
105843894|NCT00897949|365086712|FG001|Overall Study|Adverse Event|1|||
105315452|NCT00005957|363150676|FG001|Overall Study|Crossover to the other arm|19|||
105315453|NCT02047734|363150677|FG000|Overall Study|Adverse Event|18|||
105843895|NCT00897949|365086713|FG002|Overall Study|Adverse Event|0|||
105315454|NCT02047734|363150678|FG001|Overall Study|Adverse Event|13|||
105315455|NCT02047734|363150679|FG002|Overall Study|Adverse Event|13|||
105843896|NCT00897949|365086711|FG000|Overall Study|Lost to Follow-up|0|||
105843897|NCT00897949|365086712|FG001|Overall Study|Lost to Follow-up|2|||
105843898|NCT00897949|365086713|FG002|Overall Study|Lost to Follow-up|1|||
105843899|NCT00897949|365086711|FG000|Overall Study|Protocol Violation|6|||
105843900|NCT00897949|365086712|FG001|Overall Study|Protocol Violation|3|||
105843901|NCT00897949|365086713|FG002|Overall Study|Protocol Violation|1|||
105843902|NCT00897949|365086711|FG000|Overall Study|Withdrawal by Subject|1|||
105843903|NCT00897949|365086712|FG001|Overall Study|Withdrawal by Subject|2|||
105843904|NCT00897949|365086713|FG002|Overall Study|Withdrawal by Subject|0|||
105843905|NCT00897949|365086711|FG000|Overall Study|Patient Uncoorperative|0|||
105843906|NCT00897949|365086712|FG001|Overall Study|Patient Uncoorperative|2|||
105490224|NCT02537574|363807498|FG000|Overall Study|Lost to Follow-up|40|||
105490225|NCT02537574|363807499|FG001|Overall Study|Lost to Follow-up|51|||
105490226|NCT02537574|363807500|FG002|Overall Study|Lost to Follow-up|55|||
105490227|NCT02537574|363807498|FG000|Overall Study|Noncompliance with study drug|0|||
105490228|NCT02537574|363807499|FG001|Overall Study|Noncompliance with study drug|1|||
105490229|NCT02537574|363807500|FG002|Overall Study|Noncompliance with study drug|1|||
105490230|NCT02537574|363807498|FG000|Overall Study|Physician Decision|2|||
105843907|NCT00897949|365086713|FG002|Overall Study|Patient Uncoorperative|1|||
105843908|NCT00897949|365086711|FG000|Overall Study|Lost to Follow-up|30|||
105843909|NCT00897949|365086712|FG001|Overall Study|Lost to Follow-up|23|||
105490231|NCT02537574|363807499|FG001|Overall Study|Physician Decision|0|||
105843910|NCT00897949|365086713|FG002|Overall Study|Lost to Follow-up|17|||
105843911|NCT00897949|365086711|FG000|Overall Study|Withdrawal by Subject|24|||
105843912|NCT00897949|365086712|FG001|Overall Study|Withdrawal by Subject|31|||
105843913|NCT00897949|365086713|FG002|Overall Study|Withdrawal by Subject|17|||
105843914|NCT00897949|365086711|FG000|Overall Study|Abnormal Prestudy Labs|2|||
105843915|NCT00897949|365086712|FG001|Overall Study|Abnormal Prestudy Labs|3|||
105843916|NCT00897949|365086713|FG002|Overall Study|Abnormal Prestudy Labs|4|||
105843917|NCT00897949|365086711|FG000|Overall Study|Abnormal Baseline ECG|2|||
105843918|NCT00897949|365086712|FG001|Overall Study|Abnormal Baseline ECG|2|||
105843919|NCT00897949|365086713|FG002|Overall Study|Abnormal Baseline ECG|4|||
105843920|NCT00897949|365086711|FG000|Overall Study|Need for Concom. Med.|0|||
105843921|NCT00897949|365086712|FG001|Overall Study|Need for Concom. Med.|1|||
105843922|NCT00897949|365086713|FG002|Overall Study|Need for Concom. Med.|1|||
105843923|NCT00897949|365086711|FG000|Overall Study|Lack of Migraine Attack|29|||
105843924|NCT00897949|365086712|FG001|Overall Study|Lack of Migraine Attack|30|||
105843925|NCT00897949|365086713|FG002|Overall Study|Lack of Migraine Attack|19|||
105843926|NCT00897949|365086711|FG000|Overall Study|Did not take study drug|9|||
105843927|NCT00897949|365086712|FG001|Overall Study|Did not take study drug|3|||
105843928|NCT00897949|365086713|FG002|Overall Study|Did not take study drug|4|||
105843929|NCT01763918|365086714|FG000|Overall Study|Withdrawal by Subject|2|||
105843930|NCT01763918|365086715|FG001|Overall Study|Withdrawal by Subject|1|||
105843931|NCT01763918|365086716|FG002|Overall Study|Withdrawal by Subject|1|||
105843932|NCT01763918|365086717|FG003|Overall Study|Withdrawal by Subject|2|||
105843933|NCT01763918|365086714|FG000|Overall Study|Sponsor Decision|4|||
105843934|NCT01763918|365086715|FG001|Overall Study|Sponsor Decision|0|||
105843935|NCT01763918|365086716|FG002|Overall Study|Sponsor Decision|9|||
105843936|NCT01763918|365086717|FG003|Overall Study|Sponsor Decision|0|||
105843937|NCT01553747|365086718|FG000|Overall Study|Protocol Violation|0|||
105843938|NCT01553747|365086719|FG001|Overall Study|Protocol Violation|2|||
105843939|NCT01553747|365086720|FG002|Overall Study|Protocol Violation|0|||
105843940|NCT01553747|365086718|FG000|Overall Study|Voluntarily withdrew|70|||
105843941|NCT01553747|365086719|FG001|Overall Study|Voluntarily withdrew|66|||
105843942|NCT01553747|365086720|FG002|Overall Study|Voluntarily withdrew|74|||
105843943|NCT01553747|365086718|FG000|Overall Study|Adverse event or SAE|32|||
105843944|NCT01553747|365086719|FG001|Overall Study|Adverse event or SAE|28|||
105843945|NCT01553747|365086720|FG002|Overall Study|Adverse event or SAE|19|||
105843946|NCT01553747|365086718|FG000|Overall Study|Physician decision: other|10|||
105843947|NCT01553747|365086719|FG001|Overall Study|Physician decision: other|8|||
105843948|NCT01553747|365086720|FG002|Overall Study|Physician decision: other|7|||
105843949|NCT01553747|365086718|FG000|Overall Study|Lost to Follow-up|11|||
105843950|NCT01553747|365086719|FG001|Overall Study|Lost to Follow-up|5|||
105843951|NCT01553747|365086720|FG002|Overall Study|Lost to Follow-up|6|||
105843952|NCT01553747|365086718|FG000|Overall Study|Sponsor decision, specify|7|||
105843953|NCT01553747|365086719|FG001|Overall Study|Sponsor decision, specify|5|||
105843954|NCT01553747|365086720|FG002|Overall Study|Sponsor decision, specify|0|||
105843955|NCT01553747|365086718|FG000|Overall Study|Physician decision: lack of efficacy|1|||
105843956|NCT01553747|365086719|FG001|Overall Study|Physician decision: lack of efficacy|5|||
105843957|NCT01553747|365086720|FG002|Overall Study|Physician decision: lack of efficacy|3|||
105843958|NCT03095118|365086724|FG000|Overall Study|Adverse Event|1|||
105843959|NCT03095118|365086724|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
105843960|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
105843961|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
105843962|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
105843963|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
105843964|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
105843965|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
105843966|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
105843967|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
105490232|NCT02537574|363807500|FG002|Overall Study|Physician Decision|0|||
105490233|NCT02537574|363807498|FG000|Overall Study|Protocol Violation|4|||
105843968|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
105843969|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
105843970|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
105843971|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
105843972|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
105843973|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
105843974|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
105843975|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
105843976|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
105843977|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
105843978|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
105843979|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
105843980|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
105843981|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
105843982|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
105843983|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
105843984|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
105843985|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
105843986|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
105843987|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
105843988|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Death|0|||
105843989|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Death|1|||
105843990|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Death|0|||
105843991|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Death|0|||
105843992|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
105843993|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
105843994|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
105843995|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
105843996|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
105843997|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
105843998|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
105843999|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
105844000|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Other|1|||
105844001|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Other|3|||
105844002|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Other|0|||
105844003|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Other|0|||
105844004|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
105844005|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
105844006|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
105844007|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
105844008|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Death|1|||
105844009|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Death|0|||
105844010|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Death|0|||
105844011|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Death|0|||
105844012|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
105844013|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
105844014|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
105844015|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
105844016|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
105844017|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
105844018|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
105844019|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
105844020|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
105844021|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
105844022|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
105844023|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
105844024|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
105844025|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
105315456|NCT02047734|363150677|FG000|Overall Study|Lack of Efficacy|4|||
105315457|NCT02047734|363150678|FG001|Overall Study|Lack of Efficacy|5|||
105315458|NCT02047734|363150679|FG002|Overall Study|Lack of Efficacy|1|||
105315459|NCT02047734|363150677|FG000|Overall Study|Protocol Violation|3|||
105315460|NCT02047734|363150678|FG001|Overall Study|Protocol Violation|1|||
105315461|NCT02047734|363150679|FG002|Overall Study|Protocol Violation|1|||
105315462|NCT02047734|363150677|FG000|Overall Study|Lost to Follow-up|1|||
105315463|NCT02047734|363150678|FG001|Overall Study|Lost to Follow-up|4|||
105844026|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
105844027|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
105844028|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
105844029|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
105844030|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
105315464|NCT02047734|363150679|FG002|Overall Study|Lost to Follow-up|0|||
105315465|NCT02047734|363150677|FG000|Overall Study|Death|0|||
105315466|NCT02047734|363150678|FG001|Overall Study|Death|1|||
105315467|NCT02047734|363150679|FG002|Overall Study|Death|0|||
105315468|NCT02047734|363150677|FG000|Overall Study|Withdrawal by Subject|30|||
105315469|NCT02047734|363150678|FG001|Overall Study|Withdrawal by Subject|31|||
105315470|NCT02047734|363150679|FG002|Overall Study|Withdrawal by Subject|19|||
105315471|NCT02047734|363150677|FG000|Overall Study|Physician Decision|7|||
105315472|NCT02047734|363150678|FG001|Overall Study|Physician Decision|6|||
105315473|NCT02047734|363150679|FG002|Overall Study|Physician Decision|5|||
105315474|NCT02047734|363150677|FG000|Overall Study|Miscellaneous|2|||
105315475|NCT02047734|363150678|FG001|Overall Study|Miscellaneous|4|||
105315476|NCT02047734|363150679|FG002|Overall Study|Miscellaneous|6|||
105315477|NCT02047734|363150677|FG000|Overall Study|Did Not Receive Study Drug|2|||
105315478|NCT02047734|363150678|FG001|Overall Study|Did Not Receive Study Drug|4|||
105315479|NCT02047734|363150679|FG002|Overall Study|Did Not Receive Study Drug|1|||
105844031|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
105844032|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
105844033|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
105844034|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
105844035|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
105844036|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
105315480|NCT00799825|363150680|FG000|Overall Study|Adverse Event|1|||
105315481|NCT00799825|363150680|FG000|Overall Study|Withdrawal by Subject|6|||
105315482|NCT00799825|363150680|FG000|Overall Study|Lost to Follow-up|38|||
105315483|NCT00799825|363150680|FG000|Overall Study|Pregnancy|3|||
105315484|NCT01085357|363150681|FG000|Overall Study|Adverse Event|1|||
105315485|NCT01085357|363150682|FG001|Overall Study|Adverse Event|1|||
105315486|NCT01085357|363150681|FG000|Overall Study|Subject Decision|4|||
105315487|NCT01085357|363150682|FG001|Overall Study|Subject Decision|3|||
105315488|NCT01085357|363150681|FG000|Overall Study|Investigator Decision|1|||
105844037|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
105844038|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
105844039|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
105844040|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
105844041|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
105844042|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
105844043|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
105844044|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
105844045|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
105844046|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
105844047|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
105844048|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Other|3|||
105844049|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Other|0|||
105844050|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Other|4|||
105844051|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Other|1|||
105844052|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
105844053|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
105844054|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
105844055|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
105844056|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
105844057|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
105844058|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
105844059|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
105844060|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
105844061|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
105844062|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
105844063|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
105844064|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
105844065|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
105844066|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
105844067|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
105844068|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
105844069|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
105844070|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
105315489|NCT01085357|363150682|FG001|Overall Study|Investigator Decision|1|||
105315490|NCT01085357|363150681|FG000|Overall Study|Death|11|||
105490234|NCT02537574|363807499|FG001|Overall Study|Protocol Violation|2|||
105315491|NCT01085357|363150682|FG001|Overall Study|Death|1|||
105315492|NCT01085357|363150681|FG000|Overall Study|Lost to Follow-up|2|||
105315493|NCT01085357|363150682|FG001|Overall Study|Lost to Follow-up|0|||
105315494|NCT02439970|363150687|FG000|Overall Study|Study Terminated|2|||
105490235|NCT02537574|363807500|FG002|Overall Study|Protocol Violation|3|||
105315495|NCT02439970|363150688|FG001|Overall Study|Study Terminated|3|||
105315496|NCT02289456|363150694|FG000|Induction Period|Death|2|||
105315497|NCT02289456|363150694|FG000|Induction Period|Adverse Event|11|||
105315498|NCT02289456|363150694|FG000|Induction Period|Progressive Disease (PD)|4|||
105315499|NCT02289456|363150694|FG000|Induction Period|Symptomatic Deterioration|4|||
105315500|NCT02289456|363150694|FG000|Induction Period|Withdrawal by Subject|2|||
105315501|NCT02289456|363150694|FG000|Induction Period|Miscellaneous|1|||
105315502|NCT02289456|363150694|FG000|Monotherapy Period|Death|1|||
105315503|NCT02289456|363150694|FG000|Monotherapy Period|Adverse Event|1|||
105315504|NCT02289456|363150694|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
105315505|NCT02289456|363150694|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
105315506|NCT02289456|363150694|FG000|Monotherapy Period|Withdrawal by Subject|2|||
105315507|NCT02289456|363150694|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
105315508|NCT02289456|363150694|FG000|Monotherapy Period|Miscellaneous|1|||
105315509|NCT02910011|363150695|FG000|Overall Study|Physician Decision|2|||
105315510|NCT01399658|363150696|FG000|Overall Study|Ineligible|1|||
105315511|NCT01399658|363150696|FG000|Overall Study|Machine Technical Issue|3|||
105315512|NCT01399658|363150696|FG000|Overall Study|Alternative therapy|1|||
105315513|NCT01399658|363150696|FG000|Overall Study|No reason given|1|||
105315514|NCT02460679|363150697|FG000|Overall Study|Investigator Decision|1|||
105315515|NCT02460679|363150697|FG000|Overall Study|Withdrawal by Subject|4|||
105315516|NCT00920790|363150698|FG000|Overall Study|aggravation of general condition|14|||
105315517|NCT01661062|363150699|FG000|Overall Study|Completed Treatment Off Study|3|||
105315518|NCT01661062|363150699|FG000|Overall Study|Withdrawal by Subject|2|||
105315519|NCT04411914|363150700|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
105315520|NCT04411914|363150701|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
105315521|NCT02681510|363150702|FG000|Overall Study|Withdrawal by Subject|1|||
105315522|NCT02681510|363150702|FG000|Overall Study|Lost to Follow-up|9|||
105315523|NCT04315506|363150706|FG000|Overall Study|Lost to Follow-up|74|||
105315524|NCT04315506|363150707|FG001|Overall Study|Lost to Follow-up|82|||
105315525|NCT04315506|363150706|FG000|Overall Study|Withdrawal by Subject|8|||
105315526|NCT04315506|363150707|FG001|Overall Study|Withdrawal by Subject|8|||
105315527|NCT04315506|363150706|FG000|Overall Study|Physician Decision|0|||
105315528|NCT04315506|363150707|FG001|Overall Study|Physician Decision|1|||
105315529|NCT01721317|363150708|FG000|Overall Study|Study Closed / Terminated|2|||
105315530|NCT01721317|363150709|FG001|Overall Study|Study Closed / Terminated|2|||
105315531|NCT01721317|363150708|FG000|Overall Study|Physician Decision|0|||
105315532|NCT01721317|363150709|FG001|Overall Study|Physician Decision|1|||
105315533|NCT01721317|363150708|FG000|Overall Study|Withdrawal by Subject|0|||
105315534|NCT01721317|363150709|FG001|Overall Study|Withdrawal by Subject|1|||
105315535|NCT03276078|363150714|FG000|Overall Study|Adverse Event|1|||
105315536|NCT01210612|363150716|FG000|Overall Study|Withdrawal by Subject|0|||
105315537|NCT01210612|363150717|FG001|Overall Study|Withdrawal by Subject|2|||
105315538|NCT01685840|363150721|FG000|Overall Study|Death|77|||
105315539|NCT01685840|363150722|FG001|Overall Study|Death|66|||
105315540|NCT01685840|363150721|FG000|Overall Study|Lost to Follow-up|27|||
105315541|NCT01685840|363150722|FG001|Overall Study|Lost to Follow-up|25|||
105315542|NCT01685840|363150721|FG000|Overall Study|Physician Decision|3|||
105315543|NCT01685840|363150722|FG001|Overall Study|Physician Decision|7|||
105315544|NCT01685840|363150721|FG000|Overall Study|Withdrawal by Subject|14|||
105315545|NCT01685840|363150722|FG001|Overall Study|Withdrawal by Subject|17|||
105315546|NCT01685840|363150721|FG000|Overall Study|Futility|197|||
105315547|NCT01685840|363150722|FG001|Overall Study|Futility|200|||
105315548|NCT01685840|363150721|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
105315549|NCT01685840|363150722|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
105315550|NCT00908310|363150723|FG000|Overall Study|Death|37|||
105315551|NCT00908310|363150723|FG000|Overall Study|Withdrawal by Subject|7|||
105315552|NCT00908310|363150723|FG000|Overall Study|Lost to Follow-up|7|||
105315553|NCT00908310|363150723|FG000|Overall Study|Screening failure|5|||
105315554|NCT00908310|363150723|FG000|Overall Study|Other reasons|4|||
105315555|NCT02800642|363150724|FG000|Overall Study|Death|3|||
105315556|NCT02800642|363150724|FG000|Overall Study|Other|10|||
105315557|NCT02800642|363150724|FG000|Overall Study|Physician Decision|2|||
105315558|NCT02800642|363150724|FG000|Overall Study|Adverse Event|6|||
105315559|NCT02800642|363150724|FG000|Overall Study|Withdrawal by Subject|3|||
105844071|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
105844072|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
105844073|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
105315560|NCT02800642|363150724|FG000|Overall Study|Lost to Follow-up|1|||
105315561|NCT01941498|363150725|FG000|Overall Study|Relocated out of state|1|||
105315562|NCT00447993|363150730|FG000|Overall Study|Lost to Follow-up|0|||
105315563|NCT00447993|363150731|FG001|Overall Study|Lost to Follow-up|0|||
105315564|NCT00447993|363150732|FG002|Overall Study|Lost to Follow-up|2|||
105315565|NCT00447993|363150733|FG003|Overall Study|Lost to Follow-up|2|||
105315566|NCT00447993|363150730|FG000|Overall Study|Withdrawal by Subject|0|||
105315567|NCT00447993|363150731|FG001|Overall Study|Withdrawal by Subject|0|||
105315568|NCT00447993|363150732|FG002|Overall Study|Withdrawal by Subject|2|||
105315569|NCT00447993|363150733|FG003|Overall Study|Withdrawal by Subject|2|||
105844074|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
105844075|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
105844076|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
105844077|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
105844078|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
105844079|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
105315570|NCT03390426|363150734|FG000|Overall Study|Protocol Violation|0|||
105315571|NCT03390426|363150735|FG001|Overall Study|Protocol Violation|1|||
105315572|NCT00548093|363150738|FG000|Overall Study|Death|33|||
105315573|NCT00548093|363150739|FG001|Overall Study|Death|13|||
105315574|NCT00548093|363150738|FG000|Overall Study|Lost to Follow-up|3|||
105315575|NCT00548093|363150739|FG001|Overall Study|Lost to Follow-up|1|||
105315576|NCT00548093|363150738|FG000|Overall Study|Objective progression or relapse|1|||
105315577|NCT00548093|363150739|FG001|Overall Study|Objective progression or relapse|1|||
105315578|NCT00548093|363150738|FG000|Overall Study|Other|11|||
105315579|NCT00548093|363150739|FG001|Overall Study|Other|1|||
105315580|NCT00548093|363150738|FG000|Overall Study|Withdrawal by Subject|1|||
105315581|NCT00548093|363150739|FG001|Overall Study|Withdrawal by Subject|0|||
105315582|NCT00548093|363150738|FG000|Overall Study|Completed post-treatment follow-up|1|||
105315583|NCT00548093|363150739|FG001|Overall Study|Completed post-treatment follow-up|0|||
105315584|NCT02516553|363150740|FG000|Overall Study|Progressive disease|2|||
105315585|NCT02516553|363150741|FG001|Overall Study|Progressive disease|2|||
105315586|NCT02516553|363150742|FG002|Overall Study|Progressive disease|3|||
105315587|NCT02516553|363150743|FG003|Overall Study|Progressive disease|5|||
105315588|NCT02516553|363150744|FG004|Overall Study|Progressive disease|3|||
105315589|NCT02516553|363150745|FG005|Overall Study|Progressive disease|0|||
105315590|NCT02516553|363150746|FG006|Overall Study|Progressive disease|5|||
105315591|NCT02516553|363150747|FG007|Overall Study|Progressive disease|5|||
105315592|NCT02516553|363150748|FG008|Overall Study|Progressive disease|11|||
105315593|NCT02516553|363150749|FG009|Overall Study|Progressive disease|3|||
105315594|NCT02516553|363150750|FG010|Overall Study|Progressive disease|10|||
105315595|NCT02516553|363150751|FG011|Overall Study|Progressive disease|8|||
105315596|NCT02516553|363150752|FG012|Overall Study|Progressive disease|8|||
105315597|NCT02516553|363150753|FG013|Overall Study|Progressive disease|2|||
105315598|NCT02516553|363150754|FG014|Overall Study|Progressive disease|2|||
105315599|NCT02516553|363150755|FG015|Overall Study|Progressive disease|2|||
105315600|NCT02516553|363150756|FG016|Overall Study|Progressive disease|1|||
105315601|NCT02516553|363150757|FG017|Overall Study|Progressive disease|9|||
105844080|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
105315602|NCT02516553|363150758|FG018|Overall Study|Progressive disease|12|||
105315603|NCT02516553|363150759|FG019|Overall Study|Progressive disease|7|||
105315604|NCT02516553|363150760|FG020|Overall Study|Progressive disease|16|||
105315605|NCT02516553|363150761|FG021|Overall Study|Progressive disease|18|||
105315606|NCT02516553|363150740|FG000|Overall Study|Dose limiting toxicity|0|||
105315607|NCT02516553|363150741|FG001|Overall Study|Dose limiting toxicity|0|||
105315608|NCT02516553|363150742|FG002|Overall Study|Dose limiting toxicity|0|||
105315609|NCT02516553|363150743|FG003|Overall Study|Dose limiting toxicity|0|||
105315610|NCT02516553|363150744|FG004|Overall Study|Dose limiting toxicity|3|||
105315611|NCT02516553|363150745|FG005|Overall Study|Dose limiting toxicity|1|||
105315612|NCT02516553|363150746|FG006|Overall Study|Dose limiting toxicity|1|||
105315613|NCT02516553|363150747|FG007|Overall Study|Dose limiting toxicity|0|||
105315614|NCT02516553|363150748|FG008|Overall Study|Dose limiting toxicity|1|||
105315615|NCT02516553|363150749|FG009|Overall Study|Dose limiting toxicity|0|||
105315616|NCT02516553|363150750|FG010|Overall Study|Dose limiting toxicity|0|||
105315617|NCT02516553|363150751|FG011|Overall Study|Dose limiting toxicity|1|||
105315618|NCT02516553|363150752|FG012|Overall Study|Dose limiting toxicity|0|||
105844081|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
105844082|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
105844083|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
105315619|NCT02516553|363150753|FG013|Overall Study|Dose limiting toxicity|1|||
105315620|NCT02516553|363150754|FG014|Overall Study|Dose limiting toxicity|0|||
105315621|NCT02516553|363150755|FG015|Overall Study|Dose limiting toxicity|0|||
105315622|NCT02516553|363150756|FG016|Overall Study|Dose limiting toxicity|1|||
105315623|NCT02516553|363150757|FG017|Overall Study|Dose limiting toxicity|1|||
105315624|NCT02516553|363150758|FG018|Overall Study|Dose limiting toxicity|0|||
105315625|NCT02516553|363150759|FG019|Overall Study|Dose limiting toxicity|2|||
105844084|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
105844085|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
105368731|NCT02351934|363356269|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
105368732|NCT02351934|363356270|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
105844086|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
105315626|NCT02516553|363150760|FG020|Overall Study|Dose limiting toxicity|0|||
105315627|NCT02516553|363150761|FG021|Overall Study|Dose limiting toxicity|0|||
105315628|NCT02516553|363150740|FG000|Overall Study|Other Adverse Events|0|||
105844087|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
105844088|NCT00977431|365086735|FG000|Overall Study|Other than listed|1|||
105844089|NCT00977431|365086736|FG001|Overall Study|Other than listed|0|||
105844090|NCT00977431|365086737|FG002|Overall Study|Other than listed|0|||
105844091|NCT00977431|365086738|FG003|Overall Study|Other than listed|0|||
105844092|NCT00977431|365086739|FG004|Overall Study|Other than listed|2|||
105844093|NCT00977431|365086735|FG000|Overall Study|Protocol Violation|0|||
105844094|NCT00977431|365086736|FG001|Overall Study|Protocol Violation|0|||
105844095|NCT00977431|365086737|FG002|Overall Study|Protocol Violation|1|||
105844096|NCT00977431|365086738|FG003|Overall Study|Protocol Violation|0|||
105844097|NCT00977431|365086739|FG004|Overall Study|Protocol Violation|0|||
105844098|NCT00977431|365086735|FG000|Overall Study|Adverse Event|3|||
105844099|NCT00977431|365086736|FG001|Overall Study|Adverse Event|0|||
105844100|NCT00977431|365086737|FG002|Overall Study|Adverse Event|4|||
105844101|NCT00977431|365086738|FG003|Overall Study|Adverse Event|0|||
105844102|NCT00977431|365086739|FG004|Overall Study|Adverse Event|6|||
105844103|NCT00977431|365086735|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
105844104|NCT00977431|365086736|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
105844105|NCT00977431|365086737|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
105844106|NCT00977431|365086738|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
105844107|NCT00977431|365086739|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
105844108|NCT00977431|365086735|FG000|Overall Study|Progressive disease|2|||
105844109|NCT00977431|365086736|FG001|Overall Study|Progressive disease|6|||
105844110|NCT00977431|365086737|FG002|Overall Study|Progressive disease|1|||
105844111|NCT00977431|365086738|FG003|Overall Study|Progressive disease|3|||
105844112|NCT00977431|365086739|FG004|Overall Study|Progressive disease|5|||
105844113|NCT03739138|365086742|FG000|Overall Study|Death|0|||
105844114|NCT03739138|365086743|FG001|Overall Study|Death|7|||
105844115|NCT03739138|365086744|FG002|Overall Study|Death|4|||
105844116|NCT03739138|365086745|FG003|Overall Study|Death|13|||
105844117|NCT03739138|365086746|FG004|Overall Study|Death|0|||
105844118|NCT03739138|365086742|FG000|Overall Study|Lost to Follow-up|0|||
105844119|NCT03739138|365086743|FG001|Overall Study|Lost to Follow-up|0|||
105844120|NCT03739138|365086744|FG002|Overall Study|Lost to Follow-up|1|||
105844121|NCT03739138|365086745|FG003|Overall Study|Lost to Follow-up|0|||
105844122|NCT03739138|365086746|FG004|Overall Study|Lost to Follow-up|0|||
105844123|NCT03739138|365086742|FG000|Overall Study|Study Terminated By Sponsor|0|||
105844124|NCT03739138|365086743|FG001|Overall Study|Study Terminated By Sponsor|0|||
105844125|NCT03739138|365086744|FG002|Overall Study|Study Terminated By Sponsor|0|||
105844126|NCT03739138|365086745|FG003|Overall Study|Study Terminated By Sponsor|4|||
105844127|NCT03739138|365086746|FG004|Overall Study|Study Terminated By Sponsor|0|||
105844128|NCT03739138|365086742|FG000|Overall Study|Withdrawal by Subject|0|||
105844129|NCT03739138|365086743|FG001|Overall Study|Withdrawal by Subject|0|||
105844130|NCT03739138|365086744|FG002|Overall Study|Withdrawal by Subject|0|||
105844131|NCT03739138|365086745|FG003|Overall Study|Withdrawal by Subject|1|||
105844132|NCT03739138|365086746|FG004|Overall Study|Withdrawal by Subject|0|||
105844133|NCT02654587|365086747|FG000|Overall Study|patient alive at end of study|22|||
105844134|NCT02654587|365086748|FG001|Overall Study|patient alive at end of study|8|||
105844135|NCT02654587|365086747|FG000|Overall Study|Withdrawal by Subject|1|||
105844136|NCT02654587|365086748|FG001|Overall Study|Withdrawal by Subject|7|||
105844137|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
105844138|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
105844139|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
105844140|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
105844141|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
105844142|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
105844143|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
105844144|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
105844145|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
105844146|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
105844147|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Subject decision|1|||
105844148|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Subject decision|1|||
105844149|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
105844150|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
105844151|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
105844152|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
105844153|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
105844154|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
105844155|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
105844156|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
105844157|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
105844158|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
105844159|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
105844160|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
105844161|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
105844162|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
105844163|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
105844164|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
105844165|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
105844166|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
105844167|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
105844168|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
105844169|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
105844170|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
105844171|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
105844172|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
105844173|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
105844174|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
105844175|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
105844176|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
105844177|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
105844178|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
105844179|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
105844180|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
105844181|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
105844182|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
105844183|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
105844184|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
105844185|NCT00680186|365086755|FG000|Overall Study|Adverse Event|47|||
105844186|NCT00680186|365086756|FG001|Overall Study|Adverse Event|44|||
105844187|NCT00680186|365086755|FG000|Overall Study|Protocol Violation|31|||
105844188|NCT00680186|365086756|FG001|Overall Study|Protocol Violation|26|||
105844189|NCT00680186|365086755|FG000|Overall Study|Lost to Follow-up|11|||
105844190|NCT00680186|365086756|FG001|Overall Study|Lost to Follow-up|6|||
105844191|NCT00680186|365086755|FG000|Overall Study|Withdrawal by Subject|32|||
105844192|NCT00680186|365086756|FG001|Overall Study|Withdrawal by Subject|39|||
105844193|NCT00680186|365086755|FG000|Overall Study|Other|4|||
105844194|NCT00680186|365086756|FG001|Overall Study|Other|1|||
105844195|NCT03395639|365086757|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
105844196|NCT03395639|365086758|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
105844197|NCT03395639|365086759|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
105844198|NCT03395639|365086757|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
105844199|NCT03395639|365086758|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
105844200|NCT03395639|365086759|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
105844201|NCT03395639|365086757|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
105844202|NCT03395639|365086758|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
105844203|NCT03395639|365086759|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
105844204|NCT03395639|365086757|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
105844205|NCT03395639|365086758|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
105844206|NCT03395639|365086759|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
105844207|NCT03395639|365086757|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
105844208|NCT03395639|365086758|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
105844209|NCT03395639|365086759|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
105844210|NCT00285584|365086763|FG000|Month 3|Lost to Follow-up|3|||
105844211|NCT00285584|365086764|FG001|Month 3|Lost to Follow-up|3|||
105844212|NCT00285584|365086763|FG000|Month 3|Withdrawal by Subject|1|||
105844213|NCT00285584|365086764|FG001|Month 3|Withdrawal by Subject|0|||
105844214|NCT00285584|365086763|FG000|Month 6|Lost to Follow-up|0|||
105844215|NCT00285584|365086764|FG001|Month 6|Lost to Follow-up|1|||
105844216|NCT00567476|365086765|FG000|Overall Study|Adverse Event|2|||
105844217|NCT00567476|365086766|FG001|Overall Study|Adverse Event|0|||
105844218|NCT00567476|365086765|FG000|Overall Study|Pregnancy|1|||
105844219|NCT00567476|365086766|FG001|Overall Study|Pregnancy|0|||
105844220|NCT00567476|365086765|FG000|Overall Study|Protocol Violation|4|||
105844221|NCT00567476|365086766|FG001|Overall Study|Protocol Violation|1|||
105844222|NCT00567476|365086765|FG000|Overall Study|Lost to Follow-up|0|||
105844223|NCT00567476|365086766|FG001|Overall Study|Lost to Follow-up|1|||
105844224|NCT00567476|365086765|FG000|Overall Study|Administrative issues|1|||
105844225|NCT00567476|365086766|FG001|Overall Study|Administrative issues|0|||
105844226|NCT00567476|365086765|FG000|Overall Study|Medical Decision|0|||
105844227|NCT00567476|365086766|FG001|Overall Study|Medical Decision|1|||
105844228|NCT00567476|365086765|FG000|Overall Study|Non-adherence to protocol|0|||
105844229|NCT00567476|365086766|FG001|Overall Study|Non-adherence to protocol|1|||
105368733|NCT02351934|363356269|FG000|Follow-Up|POD weight<pre-op weight|3|||
105368734|NCT02351934|363356270|FG001|Follow-Up|POD weight<pre-op weight|0|||
105368735|NCT02351934|363356269|FG000|Follow-Up|Acute Kidney Injury|1|||
105315629|NCT02516553|363150741|FG001|Overall Study|Other Adverse Events|0|||
105315630|NCT02516553|363150742|FG002|Overall Study|Other Adverse Events|0|||
105315631|NCT02516553|363150743|FG003|Overall Study|Other Adverse Events|1|||
105315632|NCT02516553|363150744|FG004|Overall Study|Other Adverse Events|0|||
105315633|NCT02516553|363150745|FG005|Overall Study|Other Adverse Events|1|||
105844230|NCT04403763|365086767|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
105844231|NCT04403763|365086768|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
105844232|NCT04403763|365086769|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
105844233|NCT04403763|365086770|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
105844234|NCT04403763|365086771|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
105844235|NCT04403763|365086772|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
105844236|NCT04403763|365086773|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
105844237|NCT04403763|365086767|FG000|Stage 1|Early termination due to PK tube failure|0|||
105844238|NCT04403763|365086768|FG001|Stage 1|Early termination due to PK tube failure|0|||
105844239|NCT04403763|365086769|FG002|Stage 1|Early termination due to PK tube failure|1|||
105844240|NCT04403763|365086770|FG003|Stage 1|Early termination due to PK tube failure|0|||
105844241|NCT04403763|365086771|FG004|Stage 1|Early termination due to PK tube failure|0|||
105844242|NCT04403763|365086772|FG005|Stage 1|Early termination due to PK tube failure|0|||
105844243|NCT04403763|365086773|FG006|Stage 1|Early termination due to PK tube failure|0|||
105844244|NCT04403763|365086767|FG000|Stage 2A|Adverse Event|0|||
105844245|NCT04403763|365086768|FG001|Stage 2A|Adverse Event|0|||
105844246|NCT04403763|365086769|FG002|Stage 2A|Adverse Event|0|||
105844247|NCT04403763|365086770|FG003|Stage 2A|Adverse Event|0|||
105844248|NCT04403763|365086771|FG004|Stage 2A|Adverse Event|0|||
105844249|NCT04403763|365086772|FG005|Stage 2A|Adverse Event|0|||
105844250|NCT04403763|365086773|FG006|Stage 2A|Adverse Event|1|||
105844251|NCT01376310|365086774|FG000|Overall Study|Study closed/terminated|1|||
105844252|NCT01376310|365086775|FG001|Overall Study|Study closed/terminated|2|||
105844253|NCT01376310|365086774|FG000|Overall Study|Withdrawal by Subject|8|||
105844254|NCT01376310|365086775|FG001|Overall Study|Withdrawal by Subject|2|||
105844255|NCT01376310|365086774|FG000|Overall Study|Physician Decision|26|||
105844256|NCT01376310|365086775|FG001|Overall Study|Physician Decision|7|||
105844257|NCT01376310|365086774|FG000|Overall Study|Lost to Follow-up|1|||
105844258|NCT01376310|365086775|FG001|Overall Study|Lost to Follow-up|0|||
105844259|NCT01523587|365086777|FG000|Overall Study|Other than listed|5|||
105844260|NCT01523587|365086778|FG001|Overall Study|Other than listed|5|||
105844261|NCT01523587|365086777|FG000|Overall Study|Worsening of underlying cancer disease|19|||
105844262|NCT01523587|365086778|FG001|Overall Study|Worsening of underlying cancer disease|34|||
105844263|NCT01523587|365086777|FG000|Overall Study|Adverse Event|68|||
105844264|NCT01523587|365086778|FG001|Overall Study|Adverse Event|52|||
105844265|NCT01523587|365086777|FG000|Overall Study|Protocol Violation|5|||
105844266|NCT01523587|365086778|FG001|Overall Study|Protocol Violation|3|||
105844267|NCT01523587|365086777|FG000|Overall Study|Lost to Follow-up|2|||
105844268|NCT01523587|365086778|FG001|Overall Study|Lost to Follow-up|2|||
105844269|NCT01523587|365086777|FG000|Overall Study|Withdrawal by Subject|28|||
105844270|NCT01523587|365086778|FG001|Overall Study|Withdrawal by Subject|20|||
105844271|NCT01523587|365086777|FG000|Overall Study|Withdrew due to Progressive disease|265|||
105844272|NCT01523587|365086778|FG001|Overall Study|Withdrew due to Progressive disease|279|||
105844273|NCT01523587|365086777|FG000|Overall Study|Randomised but bot treated|6|||
105844274|NCT01523587|365086778|FG001|Overall Study|Randomised but bot treated|2|||
105844275|NCT02903238|365086779|FG000|Overall Study|Lost to Follow-up|4|||
105315634|NCT02516553|363150746|FG006|Overall Study|Other Adverse Events|0|||
105315635|NCT02516553|363150747|FG007|Overall Study|Other Adverse Events|0|||
105315636|NCT02516553|363150748|FG008|Overall Study|Other Adverse Events|0|||
105315637|NCT02516553|363150749|FG009|Overall Study|Other Adverse Events|1|||
105315638|NCT02516553|363150750|FG010|Overall Study|Other Adverse Events|3|||
105315639|NCT02516553|363150751|FG011|Overall Study|Other Adverse Events|2|||
105315640|NCT02516553|363150752|FG012|Overall Study|Other Adverse Events|0|||
105315641|NCT02516553|363150753|FG013|Overall Study|Other Adverse Events|1|||
105315642|NCT02516553|363150754|FG014|Overall Study|Other Adverse Events|0|||
105315643|NCT02516553|363150755|FG015|Overall Study|Other Adverse Events|0|||
105315644|NCT02516553|363150756|FG016|Overall Study|Other Adverse Events|0|||
105315645|NCT02516553|363150757|FG017|Overall Study|Other Adverse Events|2|||
105315646|NCT02516553|363150758|FG018|Overall Study|Other Adverse Events|1|||
105368736|NCT02351934|363356270|FG001|Follow-Up|Acute Kidney Injury|0|||
105315647|NCT02516553|363150759|FG019|Overall Study|Other Adverse Events|2|||
105368737|NCT02351934|363356269|FG000|Follow-Up|Early dismissal|3|||
105844276|NCT01298778|365086782|FG000|Overall Study|Lost to Follow-up|2|||
105844277|NCT01298778|365086783|FG001|Overall Study|Lost to Follow-up|3|||
105844278|NCT01298778|365086782|FG000|Overall Study|Incorrect use of VAS|1|||
105844279|NCT01298778|365086783|FG001|Overall Study|Incorrect use of VAS|0|||
105844280|NCT01298778|365086782|FG000|Overall Study|Withdrawal by Subject|0|||
105844281|NCT01298778|365086783|FG001|Overall Study|Withdrawal by Subject|1|||
105844282|NCT01298778|365086782|FG000|Overall Study|Protocol Violation|0|||
105315648|NCT02516553|363150760|FG020|Overall Study|Other Adverse Events|2|||
105368738|NCT02351934|363356270|FG001|Follow-Up|Early dismissal|0|||
105844283|NCT01298778|365086783|FG001|Overall Study|Protocol Violation|1|||
105844284|NCT01298778|365086782|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
105844285|NCT01298778|365086783|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
105844286|NCT00700817|365086784|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
105844287|NCT00700817|365086785|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
105844288|NCT00700817|365086786|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
105576639|NCT02038764|364110263|FG003|Overall Study|Withdrawal by Subject|0|||
105576640|NCT02038764|364110264|FG004|Overall Study|Withdrawal by Subject|1|||
105576641|NCT02038764|364110260|FG000|Overall Study|Other|1|||
105576642|NCT02038764|364110261|FG001|Overall Study|Other|0|||
105576643|NCT02038764|364110262|FG002|Overall Study|Other|1|||
105576644|NCT02038764|364110263|FG003|Overall Study|Other|0|||
105576645|NCT02038764|364110264|FG004|Overall Study|Other|0|||
105576646|NCT02443103|364110267|FG000|Overall Study|Adverse Event|2|||
105576647|NCT02443103|364110267|FG000|Overall Study|Noncompliance|1|||
105576648|NCT01115491|364110268|FG000|Overall Study|Death|22|||
105576649|NCT01115491|364110268|FG000|Overall Study|Adverse Event|3|||
105576650|NCT01115491|364110268|FG000|Overall Study|Lost to Follow-up|3|||
105576651|NCT01115491|364110268|FG000|Overall Study|Withdrawal by Subject|1|||
105576652|NCT01115491|364110268|FG000|Overall Study|Physician Decision|1|||
105576653|NCT01913639|364110273|FG000|Overall Study|Not Eligible|3|||
105576654|NCT04297241|364110274|FG000|Overall Study|Withdrawal by Subject|1|||
105576655|NCT04297241|364110274|FG000|Overall Study|Adverse Event|1|||
105576656|NCT04297241|364110274|FG000|Overall Study|Physician Decision|3|||
105576657|NCT00630058|364110275|FG000|Overall Study|Adverse Event|1|||
105576658|NCT00630058|364110276|FG001|Overall Study|Adverse Event|1|||
105576659|NCT00630058|364110275|FG000|Overall Study|Withdrawal by Subject|0|||
105576660|NCT00630058|364110276|FG001|Overall Study|Withdrawal by Subject|1|||
105576661|NCT00630058|364110275|FG000|Overall Study|stopping criteria|3|||
105576662|NCT00630058|364110276|FG001|Overall Study|stopping criteria|2|||
105576663|NCT02141659|364110277|FG000|Overall Study|Major Protocol Deviation|0|||
105576664|NCT02141659|364110278|FG001|Overall Study|Major Protocol Deviation|1|||
105576665|NCT02141659|364110279|FG002|Overall Study|Major Protocol Deviation|0|||
105576666|NCT02141659|364110280|FG003|Overall Study|Major Protocol Deviation|0|||
105576667|NCT02141659|364110281|FG004|Overall Study|Major Protocol Deviation|0|||
105576668|NCT02141659|364110282|FG005|Overall Study|Major Protocol Deviation|0|||
105576669|NCT02141659|364110277|FG000|Overall Study|Lack of Efficacy|0|||
105576670|NCT02141659|364110278|FG001|Overall Study|Lack of Efficacy|0|||
105576671|NCT02141659|364110279|FG002|Overall Study|Lack of Efficacy|0|||
105576672|NCT02141659|364110280|FG003|Overall Study|Lack of Efficacy|0|||
105576673|NCT02141659|364110281|FG004|Overall Study|Lack of Efficacy|0|||
105576674|NCT02141659|364110282|FG005|Overall Study|Lack of Efficacy|1|||
105576675|NCT02141659|364110277|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
105576676|NCT02141659|364110278|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
105576677|NCT02141659|364110279|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
105576678|NCT02141659|364110280|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
105576679|NCT02141659|364110281|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
105576680|NCT02141659|364110282|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
105576681|NCT02471404|364110283|FG000|Overall Study|Adverse Event|7|||
105576682|NCT02471404|364110284|FG001|Overall Study|Adverse Event|1|||
105576683|NCT02471404|364110285|FG002|Overall Study|Adverse Event|2|||
105576684|NCT02471404|364110283|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
105576685|NCT02471404|364110284|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
105576686|NCT02471404|364110285|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
105576687|NCT02471404|364110283|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
105576688|NCT02471404|364110284|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
105844289|NCT00700817|365086787|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
105844290|NCT00700817|365086788|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
105844291|NCT00700817|365086784|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
105844292|NCT00700817|365086785|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
105844293|NCT00700817|365086786|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
105844294|NCT00700817|365086787|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
105844295|NCT00700817|365086788|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
105844296|NCT00700817|365086784|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
105844297|NCT00700817|365086785|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
105844298|NCT00700817|365086786|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
105844299|NCT00700817|365086787|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
105844300|NCT00700817|365086788|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
105844301|NCT00700817|365086784|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
105844302|NCT00700817|365086785|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
105576689|NCT02471404|364110285|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
105576690|NCT02471404|364110283|FG000|Overall Study|Lost to Follow-up|1|||
105576691|NCT02471404|364110284|FG001|Overall Study|Lost to Follow-up|1|||
105576692|NCT02471404|364110285|FG002|Overall Study|Lost to Follow-up|3|||
105576693|NCT02471404|364110283|FG000|Overall Study|Protocol Violation|1|||
105576694|NCT02471404|364110284|FG001|Overall Study|Protocol Violation|0|||
105844303|NCT00700817|365086786|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
105844304|NCT00700817|365086787|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
105844305|NCT00700817|365086788|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
105844306|NCT00700817|365086784|FG000|Week 0-26 (Main Period)|Unclassified|14|||
105844307|NCT00700817|365086785|FG001|Week 0-26 (Main Period)|Unclassified|4|||
105844308|NCT00700817|365086786|FG002|Week 0-26 (Main Period)|Unclassified|8|||
105844309|NCT00700817|365086787|FG003|Week 0-26 (Main Period)|Unclassified|0|||
105844310|NCT00700817|365086788|FG004|Week 0-26 (Main Period)|Unclassified|0|||
105844311|NCT00700817|365086784|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
105844312|NCT00700817|365086785|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
105844313|NCT00700817|365086786|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
105844314|NCT00700817|365086787|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
105844315|NCT00700817|365086788|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
105844316|NCT00700817|365086784|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
105844317|NCT00700817|365086785|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
105844318|NCT00700817|365086786|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
105844319|NCT00700817|365086787|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
105844320|NCT00700817|365086788|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
105844321|NCT00700817|365086784|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
105844322|NCT00700817|365086785|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
105844323|NCT00700817|365086786|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
105844324|NCT00700817|365086787|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
105844325|NCT00700817|365086788|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
105844326|NCT00700817|365086784|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
105844327|NCT00700817|365086785|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
105844328|NCT00700817|365086786|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
105844329|NCT00700817|365086787|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
105844330|NCT00700817|365086788|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
105844331|NCT00700817|365086784|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
105844332|NCT00700817|365086785|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
105844333|NCT00700817|365086786|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
105844334|NCT00700817|365086787|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
105844335|NCT00700817|365086788|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
105844336|NCT00700817|365086784|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
105844337|NCT00700817|365086785|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
105844338|NCT00700817|365086786|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
105844339|NCT00700817|365086787|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
105844340|NCT00700817|365086788|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
105844341|NCT00700817|365086784|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
105844342|NCT00700817|365086785|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
105844343|NCT00700817|365086786|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
105844344|NCT00700817|365086787|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
105844345|NCT00700817|365086788|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
105844346|NCT00700817|365086784|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
105844347|NCT00700817|365086785|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
105844348|NCT00700817|365086786|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
105844349|NCT00700817|365086787|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
105844350|NCT00700817|365086788|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
105844351|NCT00700817|365086784|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
105844352|NCT00700817|365086785|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
105844353|NCT00700817|365086786|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
105844354|NCT00700817|365086787|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
105844355|NCT00700817|365086788|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
105844356|NCT00700817|365086784|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
105844357|NCT00700817|365086785|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
105844358|NCT00700817|365086786|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
105844359|NCT00700817|365086787|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
105844360|NCT00700817|365086788|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
105844361|NCT02777918|365086789|FG000|Overall Study|Medical reasons|1|||
105844362|NCT02777918|365086790|FG001|Overall Study|Medical reasons|2|||
105844363|NCT02777918|365086789|FG000|Overall Study|Too busy / stressed|1|||
105844364|NCT02777918|365086790|FG001|Overall Study|Too busy / stressed|1|||
105844365|NCT02777918|365086789|FG000|Overall Study|Withdrawal by Subject|1|||
105844366|NCT02777918|365086790|FG001|Overall Study|Withdrawal by Subject|1|||
105844367|NCT00058214|365086791|FG000|Overall Study|Adverse Event|1|||
105844368|NCT02924376|365086798|FG000|Overall Study|Progressive Disease|4|||
105844369|NCT02924376|365086799|FG001|Overall Study|Progressive Disease|0|||
105844370|NCT02924376|365086800|FG002|Overall Study|Progressive Disease|1|||
105844371|NCT02924376|365086801|FG003|Overall Study|Progressive Disease|0|||
105368739|NCT02351934|363356269|FG000|Follow-Up|Hypotension|3|||
105315649|NCT02516553|363150761|FG021|Overall Study|Other Adverse Events|1|||
105315650|NCT02516553|363150740|FG000|Overall Study|Refused to continue trial medication|0|||
105315651|NCT02516553|363150741|FG001|Overall Study|Refused to continue trial medication|0|||
105315652|NCT02516553|363150742|FG002|Overall Study|Refused to continue trial medication|0|||
105315653|NCT02516553|363150743|FG003|Overall Study|Refused to continue trial medication|0|||
105315654|NCT02516553|363150744|FG004|Overall Study|Refused to continue trial medication|0|||
105315655|NCT02516553|363150745|FG005|Overall Study|Refused to continue trial medication|0|||
105315656|NCT02516553|363150746|FG006|Overall Study|Refused to continue trial medication|0|||
105315657|NCT02516553|363150747|FG007|Overall Study|Refused to continue trial medication|0|||
105315658|NCT02516553|363150748|FG008|Overall Study|Refused to continue trial medication|0|||
105315659|NCT02516553|363150749|FG009|Overall Study|Refused to continue trial medication|0|||
105315660|NCT02516553|363150750|FG010|Overall Study|Refused to continue trial medication|1|||
105315661|NCT02516553|363150751|FG011|Overall Study|Refused to continue trial medication|0|||
105315662|NCT02516553|363150752|FG012|Overall Study|Refused to continue trial medication|0|||
105315663|NCT02516553|363150753|FG013|Overall Study|Refused to continue trial medication|0|||
105315664|NCT02516553|363150754|FG014|Overall Study|Refused to continue trial medication|0|||
105315665|NCT02516553|363150755|FG015|Overall Study|Refused to continue trial medication|0|||
105315666|NCT02516553|363150756|FG016|Overall Study|Refused to continue trial medication|0|||
105315667|NCT02516553|363150757|FG017|Overall Study|Refused to continue trial medication|0|||
105315668|NCT02516553|363150758|FG018|Overall Study|Refused to continue trial medication|1|||
105315669|NCT02516553|363150759|FG019|Overall Study|Refused to continue trial medication|0|||
105315670|NCT02516553|363150760|FG020|Overall Study|Refused to continue trial medication|0|||
105315671|NCT02516553|363150761|FG021|Overall Study|Refused to continue trial medication|1|||
105844372|NCT02924376|365086798|FG000|Overall Study|Death|73|||
105315672|NCT02516553|363150740|FG000|Overall Study|other reasons than listed|0|||
105315673|NCT02516553|363150741|FG001|Overall Study|other reasons than listed|0|||
105315674|NCT02516553|363150742|FG002|Overall Study|other reasons than listed|0|||
105315675|NCT02516553|363150743|FG003|Overall Study|other reasons than listed|0|||
105315676|NCT02516553|363150744|FG004|Overall Study|other reasons than listed|0|||
105315677|NCT02516553|363150745|FG005|Overall Study|other reasons than listed|0|||
105315678|NCT02516553|363150746|FG006|Overall Study|other reasons than listed|0|||
105315679|NCT02516553|363150747|FG007|Overall Study|other reasons than listed|1|||
105315680|NCT02516553|363150748|FG008|Overall Study|other reasons than listed|1|||
105315681|NCT02516553|363150749|FG009|Overall Study|other reasons than listed|0|||
105315682|NCT02516553|363150750|FG010|Overall Study|other reasons than listed|1|||
105315683|NCT02516553|363150751|FG011|Overall Study|other reasons than listed|1|||
105315684|NCT02516553|363150752|FG012|Overall Study|other reasons than listed|0|||
105315685|NCT02516553|363150753|FG013|Overall Study|other reasons than listed|0|||
105315686|NCT02516553|363150754|FG014|Overall Study|other reasons than listed|0|||
105315687|NCT02516553|363150755|FG015|Overall Study|other reasons than listed|0|||
105315688|NCT02516553|363150756|FG016|Overall Study|other reasons than listed|0|||
105315689|NCT02516553|363150757|FG017|Overall Study|other reasons than listed|0|||
105315690|NCT02516553|363150758|FG018|Overall Study|other reasons than listed|0|||
105315691|NCT02516553|363150759|FG019|Overall Study|other reasons than listed|0|||
105315692|NCT02516553|363150760|FG020|Overall Study|other reasons than listed|2|||
105315693|NCT02516553|363150761|FG021|Overall Study|other reasons than listed|2|||
105844373|NCT02924376|365086799|FG001|Overall Study|Death|18|||
105844374|NCT02924376|365086800|FG002|Overall Study|Death|15|||
105844375|NCT02924376|365086801|FG003|Overall Study|Death|2|||
105844376|NCT02924376|365086798|FG000|Overall Study|Lost to Follow-up|3|||
105844377|NCT02924376|365086799|FG001|Overall Study|Lost to Follow-up|0|||
105844378|NCT02924376|365086800|FG002|Overall Study|Lost to Follow-up|0|||
105844379|NCT02924376|365086801|FG003|Overall Study|Lost to Follow-up|0|||
105844380|NCT02924376|365086798|FG000|Overall Study|Study Terminated by Sponsor|19|||
105844381|NCT02924376|365086799|FG001|Overall Study|Study Terminated by Sponsor|0|||
105844382|NCT02924376|365086800|FG002|Overall Study|Study Terminated by Sponsor|0|||
105844383|NCT02924376|365086801|FG003|Overall Study|Study Terminated by Sponsor|0|||
105844384|NCT02924376|365086798|FG000|Overall Study|Physician Decision|1|||
105844385|NCT02924376|365086799|FG001|Overall Study|Physician Decision|0|||
105844386|NCT02924376|365086800|FG002|Overall Study|Physician Decision|0|||
105844387|NCT02924376|365086801|FG003|Overall Study|Physician Decision|0|||
105844388|NCT02924376|365086798|FG000|Overall Study|Withdrawal by Subject|7|||
105844389|NCT02924376|365086799|FG001|Overall Study|Withdrawal by Subject|2|||
105315694|NCT02924727|363150762|FG000|Overall Study|Withdrawal by Subject|2|||
105315695|NCT02924727|363150763|FG001|Overall Study|Withdrawal by Subject|4|||
105315696|NCT02924727|363150762|FG000|Overall Study|Lost to Follow-up|2|||
105315697|NCT02924727|363150763|FG001|Overall Study|Lost to Follow-up|5|||
105315698|NCT02924727|363150762|FG000|Overall Study|Death|221|||
105315699|NCT02924727|363150763|FG001|Overall Study|Death|247|||
105368740|NCT02351934|363356270|FG001|Follow-Up|Hypotension|0|||
105844390|NCT02924376|365086800|FG002|Overall Study|Withdrawal by Subject|1|||
105844391|NCT02924376|365086801|FG003|Overall Study|Withdrawal by Subject|0|||
105844392|NCT02924376|365086798|FG000|Overall Study|Rolled Over to Another Study|1|||
105844393|NCT02924376|365086799|FG001|Overall Study|Rolled Over to Another Study|0|||
105315700|NCT02924727|363150762|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
105315701|NCT02924727|363150763|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
105315702|NCT03052127|363150769|FG000|Overall Study|Withdrawal by Subject|0|||
105315703|NCT03052127|363150770|FG001|Overall Study|Withdrawal by Subject|0|||
105315704|NCT03052127|363150771|FG002|Overall Study|Withdrawal by Subject|0|||
105315705|NCT03052127|363150772|FG003|Overall Study|Withdrawal by Subject|0|||
105315706|NCT03052127|363150773|FG004|Overall Study|Withdrawal by Subject|0|||
105315707|NCT03052127|363150774|FG005|Overall Study|Withdrawal by Subject|0|||
105315708|NCT03052127|363150775|FG006|Overall Study|Withdrawal by Subject|0|||
105315709|NCT03052127|363150776|FG007|Overall Study|Withdrawal by Subject|1|||
105315710|NCT03052127|363150777|FG008|Overall Study|Withdrawal by Subject|1|||
105315711|NCT03052127|363150778|FG009|Overall Study|Withdrawal by Subject|1|||
105315712|NCT03052127|363150779|FG010|Overall Study|Withdrawal by Subject|0|||
105315713|NCT03052127|363150780|FG011|Overall Study|Withdrawal by Subject|0|||
105315714|NCT03052127|363150769|FG000|Overall Study|Discontinuation by Sponsor|0|||
105315715|NCT03052127|363150770|FG001|Overall Study|Discontinuation by Sponsor|0|||
105315716|NCT03052127|363150771|FG002|Overall Study|Discontinuation by Sponsor|0|||
105315717|NCT03052127|363150772|FG003|Overall Study|Discontinuation by Sponsor|0|||
105315718|NCT03052127|363150773|FG004|Overall Study|Discontinuation by Sponsor|0|||
105315719|NCT03052127|363150774|FG005|Overall Study|Discontinuation by Sponsor|0|||
105315720|NCT03052127|363150775|FG006|Overall Study|Discontinuation by Sponsor|0|||
105315721|NCT03052127|363150776|FG007|Overall Study|Discontinuation by Sponsor|0|||
105315722|NCT03052127|363150777|FG008|Overall Study|Discontinuation by Sponsor|4|||
105315723|NCT03052127|363150778|FG009|Overall Study|Discontinuation by Sponsor|2|||
105315724|NCT03052127|363150779|FG010|Overall Study|Discontinuation by Sponsor|5|||
105315725|NCT03052127|363150780|FG011|Overall Study|Discontinuation by Sponsor|13|||
105315726|NCT03052127|363150769|FG000|Overall Study|Inability to comply with trial requirements|0|||
105315727|NCT03052127|363150770|FG001|Overall Study|Inability to comply with trial requirements|0|||
105315728|NCT03052127|363150771|FG002|Overall Study|Inability to comply with trial requirements|1|||
105315729|NCT03052127|363150772|FG003|Overall Study|Inability to comply with trial requirements|0|||
105315730|NCT03052127|363150773|FG004|Overall Study|Inability to comply with trial requirements|0|||
105315731|NCT03052127|363150774|FG005|Overall Study|Inability to comply with trial requirements|0|||
105315732|NCT03052127|363150775|FG006|Overall Study|Inability to comply with trial requirements|0|||
105315733|NCT03052127|363150776|FG007|Overall Study|Inability to comply with trial requirements|0|||
105315734|NCT03052127|363150777|FG008|Overall Study|Inability to comply with trial requirements|0|||
105315735|NCT03052127|363150778|FG009|Overall Study|Inability to comply with trial requirements|0|||
105315736|NCT03052127|363150779|FG010|Overall Study|Inability to comply with trial requirements|0|||
105315737|NCT03052127|363150780|FG011|Overall Study|Inability to comply with trial requirements|0|||
105315738|NCT03052127|363150769|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
105315739|NCT03052127|363150770|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105315740|NCT03052127|363150771|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105315741|NCT03052127|363150772|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105315742|NCT03052127|363150773|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
105315743|NCT03052127|363150774|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
105315744|NCT03052127|363150775|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
105315745|NCT03052127|363150776|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105315746|NCT03052127|363150777|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105315747|NCT03052127|363150778|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105315748|NCT03052127|363150779|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105315749|NCT03052127|363150780|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105315750|NCT03694327|363150782|FG000|Overall Study|Lost to Follow-up|13|||
105315751|NCT03694327|363150783|FG001|Overall Study|Lost to Follow-up|23|||
105315752|NCT01982812|363150788|FG000|Overall Study|Death|1|||
105315753|NCT01982812|363150789|FG001|Overall Study|Death|5|||
105315754|NCT01982812|363150788|FG000|Overall Study|Adverse Event|0|||
105315755|NCT01982812|363150789|FG001|Overall Study|Adverse Event|5|||
105315756|NCT04138043|363152557|FG000|Overall Study|Withdrawal by Subject|0|||
105315757|NCT04138043|363152558|FG001|Overall Study|Withdrawal by Subject|1|||
105315758|NCT02856802|363152559|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
105315759|NCT02856802|363152560|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
105315760|NCT02856802|363152559|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
105315761|NCT02856802|363152560|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
105315762|NCT02856802|363152559|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
105368741|NCT02351934|363356269|FG000|Follow-Up|No documentation|2|||
105368742|NCT02351934|363356270|FG001|Follow-Up|No documentation|0|||
105844394|NCT02924376|365086800|FG002|Overall Study|Rolled Over to Another Study|0|||
105315763|NCT02856802|363152560|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
105315764|NCT02856802|363152559|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
105368743|NCT02351934|363356269|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
105844395|NCT02924376|365086801|FG003|Overall Study|Rolled Over to Another Study|0|||
105315765|NCT02856802|363152560|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
105315766|NCT02856802|363152559|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
105315767|NCT02856802|363152560|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
105315768|NCT02856802|363152559|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
105315769|NCT02856802|363152560|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
105315770|NCT02755649|363152564|FG000|Overall Study|Transitioned into OLE study|99|||
105315771|NCT02755649|363152565|FG001|Overall Study|Transitioned into OLE study|98|||
105315772|NCT02755649|363152566|FG002|Overall Study|Transitioned into OLE study|100|||
105315773|NCT02755649|363152564|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
105315774|NCT02755649|363152565|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
105315775|NCT02755649|363152566|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
105315776|NCT02755649|363152564|FG000|Overall Study|Physician Decision|0|||
105315777|NCT02755649|363152565|FG001|Overall Study|Physician Decision|0|||
105315778|NCT02755649|363152566|FG002|Overall Study|Physician Decision|2|||
105315779|NCT02755649|363152564|FG000|Overall Study|Withdrawal by Subject|0|||
105315780|NCT02755649|363152565|FG001|Overall Study|Withdrawal by Subject|1|||
105315781|NCT02755649|363152566|FG002|Overall Study|Withdrawal by Subject|0|||
105315782|NCT02755649|363152564|FG000|Overall Study|Undecided|1|||
105315783|NCT02755649|363152565|FG001|Overall Study|Undecided|0|||
105315784|NCT02755649|363152566|FG002|Overall Study|Undecided|0|||
105315785|NCT01286753|363152567|FG000|Overall Study|Adverse Event|7|||
105315786|NCT01286753|363152568|FG001|Overall Study|Adverse Event|6|||
105315787|NCT01286753|363152567|FG000|Overall Study|Progression|11|||
105315788|NCT01286753|363152568|FG001|Overall Study|Progression|13|||
105315789|NCT01286753|363152567|FG000|Overall Study|Refused Treatment|1|||
105315790|NCT01286753|363152568|FG001|Overall Study|Refused Treatment|0|||
105315791|NCT01286753|363152567|FG000|Overall Study|Withdrawal of Consent|0|||
105315792|NCT01286753|363152568|FG001|Overall Study|Withdrawal of Consent|2|||
105315793|NCT01286753|363152567|FG000|Overall Study|Discontinued to Join Extension Study|6|||
105315794|NCT01286753|363152568|FG001|Overall Study|Discontinued to Join Extension Study|4|||
105315795|NCT01286753|363152567|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
105315796|NCT01286753|363152568|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
105315797|NCT03301649|363152572|FG000|Overall Study|Need alternate therapy due to live lice|17|||
105315798|NCT03301649|363152573|FG001|Overall Study|Need alternate therapy due to live lice|25|||
105315799|NCT03301649|363152574|FG002|Overall Study|Need alternate therapy due to live lice|81|||
105315800|NCT03301649|363152572|FG000|Overall Study|Lost to Follow-up|11|||
105315801|NCT03301649|363152573|FG001|Overall Study|Lost to Follow-up|11|||
105315802|NCT03301649|363152574|FG002|Overall Study|Lost to Follow-up|3|||
105315803|NCT03301649|363152572|FG000|Overall Study|Protocol Violation|0|||
105315804|NCT03301649|363152573|FG001|Overall Study|Protocol Violation|1|||
105315805|NCT03301649|363152574|FG002|Overall Study|Protocol Violation|1|||
105315806|NCT03301649|363152572|FG000|Overall Study|Withdrawal by Subject|10|||
105315807|NCT03301649|363152573|FG001|Overall Study|Withdrawal by Subject|4|||
105315808|NCT03301649|363152574|FG002|Overall Study|Withdrawal by Subject|0|||
105315809|NCT03301649|363152572|FG000|Overall Study|Other than specified|5|||
105315810|NCT03301649|363152573|FG001|Overall Study|Other than specified|3|||
105315811|NCT03301649|363152574|FG002|Overall Study|Other than specified|0|||
105315812|NCT01403051|363152575|FG000|Overall Study|Protocol Violation|2|||
105315813|NCT01403051|363152576|FG001|Overall Study|Protocol Violation|0|||
105368744|NCT02351934|363356270|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
105576695|NCT02471404|364110285|FG002|Overall Study|Protocol Violation|0|||
105844396|NCT00733369|365086802|FG000|Overall Study|Lost to Follow-up|2|||
105844397|NCT00733369|365086803|FG001|Overall Study|Lost to Follow-up|1|||
105844398|NCT00733369|365086802|FG000|Overall Study|Adverse Event|4|||
105844399|NCT00733369|365086803|FG001|Overall Study|Adverse Event|4|||
105844400|NCT00733369|365086802|FG000|Overall Study|Protocol Violation|4|||
105844401|NCT00733369|365086803|FG001|Overall Study|Protocol Violation|4|||
105844402|NCT03401073|365086804|FG000|Overall Study|Lost to Follow-up|1|||
105844403|NCT03401073|365086805|FG001|Overall Study|Lost to Follow-up|2|||
105844404|NCT02556307|365086811|FG000|Overall Study|Premature treatment interruption|11|||
105844405|NCT02556307|365086811|FG000|Overall Study|Lost to Follow-up|36|||
105844406|NCT02556307|365086811|FG000|Overall Study|Change to triple therapy|4|||
105844407|NCT02556307|365086811|FG000|Overall Study|Enrolled but not treated|2|||
105844408|NCT02139124|365086813|FG000|Overall Study|Adverse Event|2|||
105315814|NCT01403051|363152575|FG000|Overall Study|Death|1|||
105315815|NCT01403051|363152576|FG001|Overall Study|Death|0|||
105315816|NCT01403051|363152575|FG000|Overall Study|Withdrawal by Subject|2|||
105315817|NCT01403051|363152576|FG001|Overall Study|Withdrawal by Subject|1|||
105315818|NCT01403051|363152575|FG000|Overall Study|Lost to Follow-up|5|||
105315819|NCT01403051|363152576|FG001|Overall Study|Lost to Follow-up|5|||
105315820|NCT00459355|363152577|FG000|Overall Study|Subject no longer met inc criteria|20|||
105315821|NCT00459355|363152578|FG001|Overall Study|Subject no longer met inc criteria|18|||
105315822|NCT00129389|363152587|FG000|Overall Study|Adverse Event|19|||
105844409|NCT02139124|365086814|FG001|Overall Study|Adverse Event|0|||
105315823|NCT00129389|363152588|FG001|Overall Study|Adverse Event|87|||
105368745|NCT02351934|363356269|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
105368746|NCT02351934|363356270|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
105844410|NCT02139124|365086815|FG002|Overall Study|Adverse Event|1|||
105844411|NCT02139124|365086816|FG003|Overall Study|Adverse Event|2|||
105844412|NCT02139124|365086817|FG004|Overall Study|Adverse Event|5|||
105844413|NCT02139124|365086813|FG000|Overall Study|Withdrawal by Subject|2|||
105844414|NCT02139124|365086814|FG001|Overall Study|Withdrawal by Subject|2|||
105844415|NCT02139124|365086815|FG002|Overall Study|Withdrawal by Subject|2|||
105844416|NCT02139124|365086816|FG003|Overall Study|Withdrawal by Subject|2|||
105844417|NCT02139124|365086817|FG004|Overall Study|Withdrawal by Subject|3|||
105844418|NCT02139124|365086813|FG000|Overall Study|Protocol Violation|0|||
105844419|NCT02139124|365086814|FG001|Overall Study|Protocol Violation|0|||
105844420|NCT02139124|365086815|FG002|Overall Study|Protocol Violation|0|||
105844421|NCT02139124|365086816|FG003|Overall Study|Protocol Violation|1|||
105844422|NCT02139124|365086817|FG004|Overall Study|Protocol Violation|1|||
105844423|NCT02139124|365086813|FG000|Overall Study|non-compliant|1|||
105844424|NCT02139124|365086814|FG001|Overall Study|non-compliant|0|||
105844425|NCT02139124|365086815|FG002|Overall Study|non-compliant|0|||
105844426|NCT02139124|365086816|FG003|Overall Study|non-compliant|2|||
105844427|NCT02139124|365086817|FG004|Overall Study|non-compliant|0|||
105844428|NCT02139124|365086813|FG000|Overall Study|incarceration|0|||
105844429|NCT02139124|365086814|FG001|Overall Study|incarceration|0|||
105844430|NCT02139124|365086815|FG002|Overall Study|incarceration|1|||
105844431|NCT02139124|365086816|FG003|Overall Study|incarceration|0|||
105844432|NCT02139124|365086817|FG004|Overall Study|incarceration|0|||
105844433|NCT02139124|365086813|FG000|Overall Study|subject moved|1|||
105844434|NCT02139124|365086814|FG001|Overall Study|subject moved|0|||
105844435|NCT02139124|365086815|FG002|Overall Study|subject moved|0|||
105844436|NCT02139124|365086816|FG003|Overall Study|subject moved|0|||
105844437|NCT02139124|365086817|FG004|Overall Study|subject moved|0|||
105315824|NCT00129389|363152587|FG000|Overall Study|Death|0|||
105315825|NCT00129389|363152588|FG001|Overall Study|Death|1|||
105315826|NCT00129389|363152587|FG000|Overall Study|Lost to Follow-up|2|||
105315827|NCT00129389|363152588|FG001|Overall Study|Lost to Follow-up|1|||
105315828|NCT00129389|363152587|FG000|Overall Study|Physician Decision|0|||
105315829|NCT00129389|363152588|FG001|Overall Study|Physician Decision|4|||
105315830|NCT00129389|363152587|FG000|Overall Study|Protocol Violation|0|||
105315831|NCT00129389|363152588|FG001|Overall Study|Protocol Violation|6|||
105315832|NCT00129389|363152587|FG000|Overall Study|Withdrawal by Subject|9|||
105315833|NCT00129389|363152588|FG001|Overall Study|Withdrawal by Subject|23|||
105315834|NCT00129389|363152587|FG000|Overall Study|Relapse|1|||
105315835|NCT00129389|363152588|FG001|Overall Study|Relapse|0|||
105315836|NCT00129389|363152587|FG000|Overall Study|Not eligible|1|||
105315837|NCT00129389|363152588|FG001|Overall Study|Not eligible|2|||
105315838|NCT00129389|363152587|FG000|Overall Study|Crossed to the other arm|1|||
105315839|NCT00129389|363152588|FG001|Overall Study|Crossed to the other arm|16|||
105315840|NCT03760185|363152589|FG000|Overall Study|Lost to Follow-up|1|||
105315841|NCT03760185|363152590|FG001|Overall Study|Lost to Follow-up|1|||
105315842|NCT02111603|363152591|FG000|Overall Study|Withdrawal by Subject|1|||
105315843|NCT04611529|363152597|FG000|2-day Follow up|Lost to Follow-up|5|||
105315844|NCT04611529|363152598|FG001|2-day Follow up|Lost to Follow-up|6|||
105315845|NCT04611529|363152599|FG002|2-day Follow up|Lost to Follow-up|3|||
105315846|NCT01775189|363152600|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105315847|NCT01775189|363152601|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
105315848|NCT01775189|363152602|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105315849|NCT01775189|363152603|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105315850|NCT01775189|363152604|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105315851|NCT01775189|363152605|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105315852|NCT01775189|363152606|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105315853|NCT01775189|363152600|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105315854|NCT01775189|363152601|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
105315855|NCT01775189|363152602|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105844438|NCT02139124|365086813|FG000|Overall Study|Lost to Follow-up|3|||
105315856|NCT01775189|363152603|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105315857|NCT01775189|363152604|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105315858|NCT01775189|363152605|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105315859|NCT01775189|363152606|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105844439|NCT02139124|365086814|FG001|Overall Study|Lost to Follow-up|2|||
105844440|NCT02139124|365086815|FG002|Overall Study|Lost to Follow-up|0|||
105844441|NCT02139124|365086816|FG003|Overall Study|Lost to Follow-up|5|||
105844442|NCT02139124|365086817|FG004|Overall Study|Lost to Follow-up|4|||
105315860|NCT01775189|363152600|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
105315861|NCT01775189|363152601|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
105844443|NCT00854373|365086818|FG000|Overall Study|Withdrawal by Subject|1|||
105844444|NCT00854373|365086819|FG001|Overall Study|Withdrawal by Subject|3|||
105315862|NCT01775189|363152602|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
105490236|NCT02537574|363807498|FG000|Overall Study|Withdrawal by Subject|37|||
105490237|NCT02537574|363807499|FG001|Overall Study|Withdrawal by Subject|27|||
105844445|NCT00854373|365086818|FG000|Overall Study|Forgot to take study drug|1|||
105844446|NCT00854373|365086819|FG001|Overall Study|Forgot to take study drug|1|||
105844447|NCT00842530|365086820|FG000|Overall Study|Serious adverse event|0|||
105844448|NCT00842530|365086821|FG001|Overall Study|Serious adverse event|6|||
105844449|NCT00842530|365086820|FG000|Overall Study|Other adverse event|6|||
105844450|NCT00842530|365086821|FG001|Overall Study|Other adverse event|1|||
105844451|NCT00842530|365086820|FG000|Overall Study|Protocol Violation|32|||
105844452|NCT00842530|365086821|FG001|Overall Study|Protocol Violation|14|||
105844453|NCT00842530|365086820|FG000|Overall Study|Lost to Follow-up|6|||
105844454|NCT00842530|365086821|FG001|Overall Study|Lost to Follow-up|8|||
105844455|NCT00842530|365086820|FG000|Overall Study|Withdrawal by Subject|73|||
105844456|NCT00842530|365086821|FG001|Overall Study|Withdrawal by Subject|28|||
105844457|NCT00706992|365086829|FG000|Overall Study|Study termination|5|||
105844458|NCT00706992|365086830|FG001|Overall Study|Study termination|5|||
105844459|NCT00706992|365086831|FG002|Overall Study|Study termination|6|||
105844460|NCT00706992|365086832|FG003|Overall Study|Study termination|2|||
105844461|NCT00706992|365086833|FG004|Overall Study|Study termination|3|||
105844462|NCT00706992|365086834|FG005|Overall Study|Study termination|2|||
105844463|NCT00706992|365086835|FG006|Overall Study|Study termination|3|||
105844464|NCT00706992|365086829|FG000|Overall Study|Disease progression before treatment|0|||
105844465|NCT00706992|365086830|FG001|Overall Study|Disease progression before treatment|0|||
105844466|NCT00706992|365086831|FG002|Overall Study|Disease progression before treatment|0|||
105844467|NCT00706992|365086832|FG003|Overall Study|Disease progression before treatment|0|||
105844468|NCT00706992|365086833|FG004|Overall Study|Disease progression before treatment|1|||
105844469|NCT00706992|365086834|FG005|Overall Study|Disease progression before treatment|0|||
105844470|NCT00706992|365086835|FG006|Overall Study|Disease progression before treatment|0|||
105844471|NCT00518622|365086836|FG000|Overall Study|Lost to Follow-up|0|||
105844472|NCT00518622|365086837|FG001|Overall Study|Lost to Follow-up|0|||
105844473|NCT00518622|365086838|FG002|Overall Study|Lost to Follow-up|1|||
105844474|NCT00518622|365086839|FG003|Overall Study|Lost to Follow-up|0|||
105844475|NCT00518622|365086840|FG004|Overall Study|Lost to Follow-up|0|||
105844476|NCT00518622|365086841|FG005|Overall Study|Lost to Follow-up|0|||
105844477|NCT00518622|365086842|FG006|Overall Study|Lost to Follow-up|0|||
105844478|NCT00518622|365086843|FG007|Overall Study|Lost to Follow-up|0|||
105844479|NCT00518622|365086836|FG000|Overall Study|Study medication taken incorrectly|0|||
105844480|NCT00518622|365086837|FG001|Overall Study|Study medication taken incorrectly|1|||
105844481|NCT00518622|365086838|FG002|Overall Study|Study medication taken incorrectly|0|||
105844482|NCT00518622|365086839|FG003|Overall Study|Study medication taken incorrectly|0|||
105844483|NCT00518622|365086840|FG004|Overall Study|Study medication taken incorrectly|0|||
105844484|NCT00518622|365086841|FG005|Overall Study|Study medication taken incorrectly|0|||
105844485|NCT00518622|365086842|FG006|Overall Study|Study medication taken incorrectly|0|||
105844486|NCT00518622|365086843|FG007|Overall Study|Study medication taken incorrectly|0|||
105844487|NCT03499119|365086844|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
105844488|NCT03499119|365086845|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
105844489|NCT03499119|365086846|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
105844490|NCT03499119|365086847|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
105844491|NCT03499119|365086844|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
105844492|NCT03499119|365086845|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
105844493|NCT03499119|365086846|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
105844494|NCT03499119|365086847|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
105844495|NCT03499119|365086844|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
105844496|NCT03499119|365086845|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
105844497|NCT03499119|365086846|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
105844498|NCT03499119|365086847|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
105844499|NCT03499119|365086844|FG000|Optional Extension Phase|Lost to Follow-up|0|||
105844500|NCT03499119|365086845|FG001|Optional Extension Phase|Lost to Follow-up|0|||
105844501|NCT03499119|365086846|FG002|Optional Extension Phase|Lost to Follow-up|0|||
105844502|NCT03499119|365086847|FG003|Optional Extension Phase|Lost to Follow-up|1|||
105844503|NCT03499119|365086844|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
105844504|NCT03499119|365086845|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
105844505|NCT03499119|365086846|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
105844506|NCT03499119|365086847|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
105844507|NCT03499119|365086844|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
105844508|NCT03499119|365086845|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
105844509|NCT03499119|365086846|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
105844510|NCT03499119|365086847|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
105844511|NCT04553913|365086848|FG000|Overall Study|patient's block resolved prior to PACU|1|||
105844512|NCT04553913|365086848|FG000|Overall Study|did not use the device properly|5|||
105315863|NCT01775189|363152603|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
105844513|NCT04495283|365088769|FG000|Overall Study|Physician Decision|0|||
105844514|NCT04495283|365088770|FG001|Overall Study|Physician Decision|0|||
105844515|NCT04495283|365088771|FG002|Overall Study|Physician Decision|1|||
105844516|NCT04495283|365088769|FG000|Overall Study|Withdrawal by Subject|0|||
105490238|NCT02537574|363807500|FG002|Overall Study|Withdrawal by Subject|29|||
105490239|NCT02537574|363807498|FG000|Overall Study|Lack of Efficacy|14|||
105490240|NCT02537574|363807499|FG001|Overall Study|Lack of Efficacy|16|||
105490241|NCT02537574|363807500|FG002|Overall Study|Lack of Efficacy|15|||
105490242|NCT02537574|363807498|FG000|Overall Study|Duplicate Patient|1|||
105490243|NCT02537574|363807499|FG001|Overall Study|Duplicate Patient|0|||
105490244|NCT02537574|363807500|FG002|Overall Study|Duplicate Patient|0|||
105844517|NCT04495283|365088770|FG001|Overall Study|Withdrawal by Subject|1|||
105844518|NCT04495283|365088771|FG002|Overall Study|Withdrawal by Subject|1|||
105844519|NCT04495283|365088769|FG000|Overall Study|Other|1|||
105844520|NCT04495283|365088770|FG001|Overall Study|Other|0|||
105844521|NCT04495283|365088771|FG002|Overall Study|Other|1|||
105844522|NCT04718194|365088774|FG000|Overall Study|Withdrawal by Subject|3|||
105844523|NCT04718194|365088775|FG001|Overall Study|Withdrawal by Subject|0|||
105844524|NCT04718194|365088774|FG000|Overall Study|Lost to Follow-up|3|||
105844525|NCT04718194|365088775|FG001|Overall Study|Lost to Follow-up|0|||
105844526|NCT02246439|365088776|FG000|Overall Study|Adverse Event|3|||
105844527|NCT02246439|365088777|FG001|Overall Study|Adverse Event|0|||
105844528|NCT02246439|365088776|FG000|Overall Study|Lost to Follow-up|7|||
105844529|NCT02246439|365088777|FG001|Overall Study|Lost to Follow-up|5|||
105844530|NCT02246439|365088776|FG000|Overall Study|Protocol Violation|0|||
105844531|NCT02246439|365088777|FG001|Overall Study|Protocol Violation|2|||
105844532|NCT02246439|365088776|FG000|Overall Study|Physician Decision|0|||
105844533|NCT02246439|365088777|FG001|Overall Study|Physician Decision|1|||
105844534|NCT02246439|365088776|FG000|Overall Study|Unkonwn|1|||
105844535|NCT02246439|365088777|FG001|Overall Study|Unkonwn|3|||
105844536|NCT02246439|365088776|FG000|Overall Study|Withdrawal by Subject|1|||
105844537|NCT02246439|365088777|FG001|Overall Study|Withdrawal by Subject|0|||
105315864|NCT01775189|363152604|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
105315865|NCT01775189|363152605|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
105315866|NCT01775189|363152606|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
105315867|NCT01775189|363152600|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
105315868|NCT01775189|363152601|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
105315869|NCT01775189|363152602|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
105315870|NCT01775189|363152603|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
105315871|NCT01775189|363152604|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
105315872|NCT01775189|363152605|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
105315873|NCT01775189|363152606|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
105315874|NCT01775189|363152600|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
105315875|NCT01775189|363152601|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
105315876|NCT01775189|363152602|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
105315877|NCT01775189|363152603|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
105315878|NCT01775189|363152604|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
105315879|NCT01775189|363152605|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
105315880|NCT01775189|363152606|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
105315881|NCT01775189|363152600|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
105315882|NCT01775189|363152601|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
105315883|NCT01775189|363152602|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
105315884|NCT01775189|363152603|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
105315885|NCT01775189|363152604|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
105315886|NCT01775189|363152605|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
105315887|NCT01775189|363152606|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
105315888|NCT04893018|363152607|FG000|Overall Study|Lost to Follow-up|1|||
105315889|NCT04893018|363152608|FG001|Overall Study|Lost to Follow-up|0|||
105315890|NCT04893018|363152607|FG000|Overall Study|Withdrawal by Subject|2|||
105315891|NCT04893018|363152608|FG001|Overall Study|Withdrawal by Subject|0|||
105315892|NCT04893018|363152607|FG000|Overall Study|Study Terminated|1|||
105315893|NCT04893018|363152608|FG001|Overall Study|Study Terminated|2|||
105844538|NCT00743509|365088785|FG000|Overall Study|Withdrawal by Subject|2|||
105844539|NCT01386684|365088786|FG000|Overall Study|Lost to Follow-up|51|||
105844540|NCT01386684|365088786|FG000|Overall Study|Other|51|||
105315894|NCT03106987|363152609|FG000|Overall Study|Death|37|||
105315895|NCT03106987|363152610|FG001|Overall Study|Death|22|||
105315896|NCT03106987|363152611|FG002|Overall Study|Death|12|||
105315897|NCT03106987|363152612|FG003|Overall Study|Death|8|||
105315898|NCT03106987|363152609|FG000|Overall Study|Lost to Follow-up|2|||
105315899|NCT03106987|363152610|FG001|Overall Study|Lost to Follow-up|0|||
105315900|NCT03106987|363152611|FG002|Overall Study|Lost to Follow-up|2|||
105315901|NCT03106987|363152612|FG003|Overall Study|Lost to Follow-up|2|||
105315902|NCT03106987|363152609|FG000|Overall Study|Withdrawal by Subject|5|||
105490245|NCT02537574|363807498|FG000|Overall Study|Patient not Stable|0|||
105490246|NCT02537574|363807499|FG001|Overall Study|Patient not Stable|1|||
105844541|NCT01386684|365088786|FG000|Overall Study|Death|47|||
105844542|NCT01386684|365088786|FG000|Overall Study|Withdrawal of Consent|44|||
105844543|NCT01386684|365088786|FG000|Overall Study|Alternative Therapy Required|37|||
105315903|NCT03106987|363152610|FG001|Overall Study|Withdrawal by Subject|1|||
105315904|NCT03106987|363152611|FG002|Overall Study|Withdrawal by Subject|4|||
105315905|NCT03106987|363152612|FG003|Overall Study|Withdrawal by Subject|1|||
105315906|NCT01174043|363152614|FG000|Overall Study|Disease progression|5|||
105315907|NCT01174043|363152614|FG000|Overall Study|Adverse Event|3|||
105315908|NCT01174043|363152614|FG000|Overall Study|Death|1|||
105315909|NCT01174043|363152614|FG000|Overall Study|Withdrawal by Subject|2|||
105315910|NCT01333397|363152616|FG000|Overall Study|Lost to Follow-up|1|||
105315911|NCT01333397|363152617|FG001|Overall Study|Lost to Follow-up|0|||
105315912|NCT01333397|363152618|FG002|Overall Study|Lost to Follow-up|0|||
105315913|NCT01333397|363152619|FG003|Overall Study|Lost to Follow-up|1|||
105315914|NCT01333397|363152620|FG004|Overall Study|Lost to Follow-up|0|||
105315915|NCT04172597|363152621|FG000|Overall Study|Disease Progression|0|||
105315916|NCT04172597|363152622|FG001|Overall Study|Disease Progression|0|||
105315917|NCT04172597|363152623|FG002|Overall Study|Disease Progression|0|||
105315918|NCT04172597|363152624|FG003|Overall Study|Disease Progression|0|||
105315919|NCT04172597|363152625|FG004|Overall Study|Disease Progression|1|||
105315920|NCT00794339|363152626|FG000|Overall Study|Withdrawal by Subject|3|||
105315921|NCT00794339|363152626|FG000|Overall Study|Ineligible|4|||
105315922|NCT00794339|363152626|FG000|Overall Study|Tx prior to ATSM|3|||
105315923|NCT00794339|363152626|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
105315924|NCT00794339|363152626|FG000|Overall Study|Tx not per protocol|1|||
105315925|NCT01520870|363152633|FG000|Overall Study|Withdrawal by Subject|2|||
105315926|NCT05320887|363152634|FG000|Overall Study|Lost to Follow-up|0|||
105315927|NCT05320887|363152635|FG001|Overall Study|Lost to Follow-up|3|||
105315928|NCT05320887|363152636|FG002|Overall Study|Lost to Follow-up|0|||
105844544|NCT01386684|365088786|FG000|Overall Study|Disease Progression|28|||
105315929|NCT05320887|363152637|FG003|Overall Study|Lost to Follow-up|0|||
105315930|NCT02620579|363152640|FG000|Overall Study|Physician Decision|0|||
105315931|NCT02620579|363152641|FG001|Overall Study|Physician Decision|0|||
105315932|NCT02620579|363152642|FG002|Overall Study|Physician Decision|0|||
105315933|NCT02620579|363152643|FG003|Overall Study|Physician Decision|1|||
105315934|NCT02620579|363152640|FG000|Overall Study|Withdrawal by Subject|0|||
105315935|NCT02620579|363152641|FG001|Overall Study|Withdrawal by Subject|1|||
105315936|NCT02620579|363152642|FG002|Overall Study|Withdrawal by Subject|1|||
105315937|NCT02620579|363152643|FG003|Overall Study|Withdrawal by Subject|0|||
105315938|NCT00958893|363152648|FG000|Overall Study|Study prematurely terminated|4|||
105315939|NCT01524978|363152650|FG000|Overall Study|Other|16|||
105315940|NCT01524978|363152651|FG001|Overall Study|Other|2|||
105315941|NCT01524978|363152652|FG002|Overall Study|Other|1|||
105315942|NCT01524978|363152653|FG003|Overall Study|Other|2|||
105315943|NCT01524978|363152654|FG004|Overall Study|Other|1|||
105315944|NCT01524978|363152655|FG005|Overall Study|Other|3|||
105844545|NCT01386684|365088786|FG000|Overall Study|Adverse Event|20|||
105844546|NCT01386684|365088786|FG000|Overall Study|Noncompliance|8|||
105844547|NCT01386684|365088786|FG000|Overall Study|Protocol Violation|4|||
105844548|NCT01386684|365088786|FG000|Overall Study|Missing|3|||
105844549|NCT00094458|365088787|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
105844550|NCT00094458|365088788|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
105844551|NCT00094458|365088789|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
105844552|NCT00094458|365088790|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
105844553|NCT00094458|365088791|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
105844554|NCT00094458|365088792|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
105844555|NCT00094458|365088787|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
105844556|NCT00094458|365088788|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
105844557|NCT00094458|365088789|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
105844558|NCT00094458|365088790|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
105844559|NCT00094458|365088791|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
105844560|NCT00094458|365088792|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
105844561|NCT00094458|365088787|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
105844562|NCT00094458|365088788|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
105844563|NCT00094458|365088789|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
105844564|NCT00094458|365088790|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
105844565|NCT00094458|365088791|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
105844566|NCT00094458|365088792|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
105844567|NCT00094458|365088787|FG000|Main Study: Through Week 30|Adverse Event|38|||
105844568|NCT00094458|365088788|FG001|Main Study: Through Week 30|Adverse Event|20|||
105844569|NCT00094458|365088789|FG002|Main Study: Through Week 30|Adverse Event|28|||
105844570|NCT00094458|365088790|FG003|Main Study: Through Week 30|Adverse Event|0|||
105315945|NCT01524978|363152656|FG006|Overall Study|Other|17|||
105315946|NCT01524978|363152657|FG007|Overall Study|Other|1|||
105315947|NCT01524978|363152658|FG008|Overall Study|Other|2|||
105315948|NCT01524978|363152659|FG009|Overall Study|Other|2|||
105315949|NCT01524978|363152660|FG010|Overall Study|Other|5|||
105315950|NCT01524978|363152650|FG000|Overall Study|Withdrawal by Subject|12|||
105315951|NCT01524978|363152651|FG001|Overall Study|Withdrawal by Subject|0|||
105315952|NCT01524978|363152652|FG002|Overall Study|Withdrawal by Subject|1|||
105844571|NCT00094458|365088791|FG004|Main Study: Through Week 30|Adverse Event|0|||
105844572|NCT00094458|365088792|FG005|Main Study: Through Week 30|Adverse Event|0|||
105844573|NCT00094458|365088787|FG000|Main Study: Through Week 30|Death|1|||
105844574|NCT00094458|365088788|FG001|Main Study: Through Week 30|Death|0|||
105844575|NCT00094458|365088789|FG002|Main Study: Through Week 30|Death|0|||
105844576|NCT00094458|365088790|FG003|Main Study: Through Week 30|Death|0|||
105844577|NCT00094458|365088791|FG004|Main Study: Through Week 30|Death|0|||
105844578|NCT00094458|365088792|FG005|Main Study: Through Week 30|Death|0|||
105844579|NCT00094458|365088787|FG000|Main Study: Through Week 30|Other|19|||
105844580|NCT00094458|365088788|FG001|Main Study: Through Week 30|Other|16|||
105844581|NCT00094458|365088789|FG002|Main Study: Through Week 30|Other|9|||
105844582|NCT00094458|365088790|FG003|Main Study: Through Week 30|Other|0|||
105844583|NCT00094458|365088791|FG004|Main Study: Through Week 30|Other|0|||
105844584|NCT00094458|365088792|FG005|Main Study: Through Week 30|Other|0|||
105844585|NCT00094458|365088787|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
105844586|NCT00094458|365088788|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
105844587|NCT00094458|365088789|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
105844588|NCT00094458|365088790|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
105844589|NCT00094458|365088791|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
105844590|NCT00094458|365088792|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
105844591|NCT00094458|365088787|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
105844592|NCT00094458|365088788|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
105844593|NCT00094458|365088789|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
105844594|NCT00094458|365088790|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
105844595|NCT00094458|365088791|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
105844596|NCT00094458|365088792|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
105844597|NCT00094458|365088787|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
105844598|NCT00094458|365088788|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
105844599|NCT00094458|365088789|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
105844600|NCT00094458|365088790|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
105844601|NCT00094458|365088791|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
105844602|NCT00094458|365088792|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
105844603|NCT00094458|365088787|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
105844604|NCT00094458|365088788|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
105844605|NCT00094458|365088789|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
105844606|NCT00094458|365088790|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
105844607|NCT00094458|365088791|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
105844608|NCT00094458|365088792|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
105844609|NCT00094458|365088787|FG000|OLE: Open-Label Extension|Adverse Event|0|||
105844610|NCT00094458|365088788|FG001|OLE: Open-Label Extension|Adverse Event|0|||
105844611|NCT00094458|365088789|FG002|OLE: Open-Label Extension|Adverse Event|0|||
105844612|NCT00094458|365088790|FG003|OLE: Open-Label Extension|Adverse Event|0|||
105844613|NCT00094458|365088791|FG004|OLE: Open-Label Extension|Adverse Event|3|||
105844614|NCT00094458|365088792|FG005|OLE: Open-Label Extension|Adverse Event|4|||
105844615|NCT00094458|365088787|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
105844616|NCT00094458|365088788|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
105844617|NCT00094458|365088789|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
105844618|NCT00094458|365088790|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
105844619|NCT00094458|365088791|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
105844620|NCT00094458|365088792|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
105844621|NCT00094458|365088787|FG000|OLE: Open-Label Extension|Patient decision|0|||
105844622|NCT00094458|365088788|FG001|OLE: Open-Label Extension|Patient decision|0|||
105844623|NCT00094458|365088789|FG002|OLE: Open-Label Extension|Patient decision|0|||
105844624|NCT00094458|365088790|FG003|OLE: Open-Label Extension|Patient decision|0|||
105844625|NCT00094458|365088791|FG004|OLE: Open-Label Extension|Patient decision|1|||
105844626|NCT00094458|365088792|FG005|OLE: Open-Label Extension|Patient decision|0|||
105844627|NCT02119286|365088793|FG000|Overall Study|Adverse Event|9|||
105844628|NCT02119286|365088794|FG001|Overall Study|Adverse Event|7|||
105844629|NCT02119286|365088795|FG002|Overall Study|Adverse Event|2|||
105844630|NCT02119286|365088793|FG000|Overall Study|Lack of Efficacy|11|||
105844631|NCT02119286|365088794|FG001|Overall Study|Lack of Efficacy|3|||
105368747|NCT02870868|363356271|FG000|Overall Study|Withdrawal by Subject|2|||
105490247|NCT02537574|363807500|FG002|Overall Study|Patient not Stable|0|||
105844632|NCT02119286|365088795|FG002|Overall Study|Lack of Efficacy|4|||
105844633|NCT02119286|365088793|FG000|Overall Study|Lost to Follow-up|2|||
105844634|NCT02119286|365088794|FG001|Overall Study|Lost to Follow-up|0|||
105844635|NCT02119286|365088795|FG002|Overall Study|Lost to Follow-up|1|||
105844636|NCT02119286|365088793|FG000|Overall Study|Withdrawal by Subject|4|||
105490248|NCT02537574|363807498|FG000|Overall Study|Incarceration|0|||
105844637|NCT02119286|365088794|FG001|Overall Study|Withdrawal by Subject|1|||
105368748|NCT02870868|363356272|FG001|Overall Study|Withdrawal by Subject|1|||
105315953|NCT01524978|363152653|FG003|Overall Study|Withdrawal by Subject|1|||
105315954|NCT01524978|363152654|FG004|Overall Study|Withdrawal by Subject|3|||
105315955|NCT01524978|363152655|FG005|Overall Study|Withdrawal by Subject|1|||
105315956|NCT01524978|363152656|FG006|Overall Study|Withdrawal by Subject|6|||
105315957|NCT01524978|363152657|FG007|Overall Study|Withdrawal by Subject|2|||
105315958|NCT01524978|363152658|FG008|Overall Study|Withdrawal by Subject|4|||
105315959|NCT01524978|363152659|FG009|Overall Study|Withdrawal by Subject|0|||
105315960|NCT01524978|363152660|FG010|Overall Study|Withdrawal by Subject|5|||
105315961|NCT01524978|363152650|FG000|Overall Study|Lost to Follow-up|0|||
105315962|NCT01524978|363152651|FG001|Overall Study|Lost to Follow-up|0|||
105315963|NCT01524978|363152652|FG002|Overall Study|Lost to Follow-up|3|||
105315964|NCT01524978|363152653|FG003|Overall Study|Lost to Follow-up|0|||
105315965|NCT01524978|363152654|FG004|Overall Study|Lost to Follow-up|1|||
105315966|NCT01524978|363152655|FG005|Overall Study|Lost to Follow-up|1|||
105315967|NCT01524978|363152656|FG006|Overall Study|Lost to Follow-up|2|||
105315968|NCT01524978|363152657|FG007|Overall Study|Lost to Follow-up|0|||
105315969|NCT01524978|363152658|FG008|Overall Study|Lost to Follow-up|1|||
105315970|NCT01524978|363152659|FG009|Overall Study|Lost to Follow-up|1|||
105315971|NCT01524978|363152660|FG010|Overall Study|Lost to Follow-up|1|||
105315972|NCT01524978|363152650|FG000|Overall Study|Death|34|||
105315973|NCT01524978|363152651|FG001|Overall Study|Death|2|||
105315974|NCT01524978|363152652|FG002|Overall Study|Death|5|||
105315975|NCT01524978|363152653|FG003|Overall Study|Death|24|||
105315976|NCT01524978|363152654|FG004|Overall Study|Death|4|||
105315977|NCT01524978|363152655|FG005|Overall Study|Death|4|||
105315978|NCT01524978|363152656|FG006|Overall Study|Death|1|||
105315979|NCT01524978|363152657|FG007|Overall Study|Death|9|||
105315980|NCT01524978|363152658|FG008|Overall Study|Death|5|||
105315981|NCT01524978|363152659|FG009|Overall Study|Death|6|||
105315982|NCT01524978|363152660|FG010|Overall Study|Death|17|||
105315983|NCT02806024|363152661|FG000|Overall Study|Night Delivery|1|||
105315984|NCT02806024|363152662|FG001|Overall Study|Night Delivery|1|||
105315985|NCT02806024|363152661|FG000|Overall Study|DVT during antepartum admission|0|||
105315986|NCT02806024|363152662|FG001|Overall Study|DVT during antepartum admission|1|||
105315987|NCT02892149|363152663|FG000|Overall Study|Death|262|||
105315988|NCT02892149|363152664|FG001|Overall Study|Death|278|||
105315989|NCT02892149|363152663|FG000|Overall Study|Withdrawal by Subject|53|||
105315990|NCT02892149|363152664|FG001|Overall Study|Withdrawal by Subject|47|||
105315991|NCT02892149|363152663|FG000|Overall Study|Lost to Follow-up|37|||
105315992|NCT02892149|363152664|FG001|Overall Study|Lost to Follow-up|31|||
105315993|NCT03633825|363152669|FG000|Enrollment|Did not post on network|5066|||
105315994|NCT03633825|363152670|FG001|Enrollment|Did not post on network|5080|||
105315995|NCT03633825|363152669|FG000|Enrollment|Post not classified as crisis|13967|||
105368749|NCT02119299|363356273|FG000|Overall Study|Withdrawal by Subject|7|||
105368750|NCT02119299|363356273|FG000|Overall Study|Lack of Efficacy|1|||
105368751|NCT02119299|363356273|FG000|Overall Study|Pregnancy|1|||
105368752|NCT01739335|363356274|FG000|Overall Study|Lost to Follow-up|7|||
105368753|NCT01739335|363356275|FG001|Overall Study|Lost to Follow-up|4|||
105368754|NCT01739335|363356274|FG000|Overall Study|Ineligible patient randomized|0|||
105368755|NCT01739335|363356275|FG001|Overall Study|Ineligible patient randomized|1|||
105368756|NCT00288912|363356276|FG000|Overall Study|Developed exclusion criterion|4|||
105368757|NCT00288912|363356277|FG001|Overall Study|Developed exclusion criterion|6|||
105368758|NCT00288912|363356278|FG002|Overall Study|Developed exclusion criterion|7|||
105368759|NCT00288912|363356276|FG000|Overall Study|Lost to Follow-up|9|||
105368760|NCT00288912|363356277|FG001|Overall Study|Lost to Follow-up|6|||
105368761|NCT00288912|363356278|FG002|Overall Study|Lost to Follow-up|9|||
105368762|NCT00288912|363356276|FG000|Overall Study|Withdrawal by Subject|4|||
105368763|NCT00288912|363356277|FG001|Overall Study|Withdrawal by Subject|5|||
105368764|NCT00288912|363356278|FG002|Overall Study|Withdrawal by Subject|12|||
105368765|NCT03312738|363356279|FG000|Overall Study|Progressive disease|58|||
105368766|NCT03312738|363356280|FG001|Overall Study|Progressive disease|67|||
105368767|NCT03312738|363356279|FG000|Overall Study|Patient/guardian decision|13|||
105368768|NCT03312738|363356280|FG001|Overall Study|Patient/guardian decision|5|||
105315996|NCT03633825|363152670|FG001|Enrollment|Post not classified as crisis|13757|||
105315997|NCT03633825|363152669|FG000|Follow up|Lost to Follow-up|478|||
105315998|NCT03633825|363152670|FG001|Follow up|Lost to Follow-up|450|||
105315999|NCT00879411|363152671|FG000|Overall Study|lost to follow-up (non-AE)|162|||
105368769|NCT03312738|363356279|FG000|Overall Study|Adverse Event|5|||
105368770|NCT03312738|363356280|FG001|Overall Study|Adverse Event|3|||
105368771|NCT03312738|363356279|FG000|Overall Study|Protocol deviation|2|||
105316000|NCT01884337|363152672|FG000|Treatment|Adverse Event|2|||
105316001|NCT01884337|363152673|FG001|Treatment|Adverse Event|2|||
105316002|NCT01884337|363152672|FG000|Treatment|Subj. request to discont. treatment|2|||
105316003|NCT01884337|363152673|FG001|Treatment|Subj. request to discont. treatment|0|||
105316004|NCT01884337|363152672|FG000|Follow-up Period|Lost to Follow-up|1|||
105316005|NCT01884337|363152673|FG001|Follow-up Period|Lost to Follow-up|1|||
105368772|NCT03312738|363356280|FG001|Overall Study|Protocol deviation|0|||
105368773|NCT03312738|363356279|FG000|Overall Study|Technical problems|0|||
105368774|NCT03312738|363356280|FG001|Overall Study|Technical problems|1|||
105844638|NCT02119286|365088795|FG002|Overall Study|Withdrawal by Subject|0|||
105844639|NCT03856593|365088800|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
105844640|NCT03856593|365088801|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
105844641|NCT04179019|365088802|FG000|Overall Study|Lost to Follow-up|2|||
105844642|NCT04179019|365088802|FG000|Overall Study|Physician Decision|2|||
105844643|NCT04179019|365088802|FG000|Overall Study|Withdrawal by Subject|5|||
105844644|NCT04179019|365088802|FG000|Overall Study|Adverse Event|4|||
105844645|NCT02083926|365088803|FG000|Overall Study|Withdrawal by Subject|1|||
105844646|NCT02083926|365088804|FG001|Overall Study|Withdrawal by Subject|0|||
105844647|NCT03438227|365088807|FG000|Overall Study|Withdrawal by Subject|10|||
105844648|NCT03438227|365088808|FG001|Overall Study|Withdrawal by Subject|5|||
105844649|NCT02093221|365088811|FG000|Overall Study|Adverse Event|1|||
105844650|NCT02093221|365088812|FG001|Overall Study|Adverse Event|0|||
105844651|NCT02093221|365088813|FG002|Overall Study|Adverse Event|0|||
105844652|NCT02093221|365088814|FG003|Overall Study|Adverse Event|0|||
105844653|NCT02093221|365088815|FG004|Overall Study|Adverse Event|0|||
105844654|NCT02093221|365088811|FG000|Overall Study|Withdrawal by Subject|1|||
105844655|NCT02093221|365088812|FG001|Overall Study|Withdrawal by Subject|1|||
105844656|NCT02093221|365088813|FG002|Overall Study|Withdrawal by Subject|4|||
105844657|NCT02093221|365088814|FG003|Overall Study|Withdrawal by Subject|1|||
105844658|NCT02093221|365088815|FG004|Overall Study|Withdrawal by Subject|1|||
105844659|NCT02093221|365088811|FG000|Overall Study|Lost to Follow-up|2|||
105844660|NCT02093221|365088812|FG001|Overall Study|Lost to Follow-up|0|||
105844661|NCT02093221|365088813|FG002|Overall Study|Lost to Follow-up|1|||
105844662|NCT02093221|365088814|FG003|Overall Study|Lost to Follow-up|1|||
105844663|NCT02093221|365088815|FG004|Overall Study|Lost to Follow-up|0|||
105316006|NCT02455518|363152674|FG000|Overall Study|Protocol Violation|0|||
105316007|NCT02455518|363152675|FG001|Overall Study|Protocol Violation|1|||
105316008|NCT02455518|363152676|FG002|Overall Study|Protocol Violation|1|||
105316009|NCT02455518|363152677|FG003|Overall Study|Protocol Violation|3|||
105316010|NCT00428116|363152678|FG000|Overall Study|Death|1|||
105316011|NCT00428116|363152679|FG001|Overall Study|Death|0|||
105316012|NCT00428116|363152678|FG000|Overall Study|Withdrawal by Subject|1|||
105316013|NCT00428116|363152679|FG001|Overall Study|Withdrawal by Subject|0|||
105316014|NCT00428116|363152678|FG000|Overall Study|Lost to Follow-up|1|||
105316015|NCT00428116|363152679|FG001|Overall Study|Lost to Follow-up|0|||
105316016|NCT03837743|363152680|FG000|Overall Study|Adverse Event|1|||
105316017|NCT03837743|363152680|FG000|Overall Study|Withdrawal by Subject|2|||
105316018|NCT03279692|363152681|FG000|Overall Study|Withdrawal by Subject|1|||
105316019|NCT00307437|363152682|FG000|Controlled Period|Adverse Event|7|||
105316020|NCT00307437|363152683|FG001|Controlled Period|Adverse Event|2|||
105316021|NCT00307437|363152684|FG002|Controlled Period|Adverse Event|5|||
105316022|NCT00307437|363152685|FG003|Controlled Period|Adverse Event|0|||
105316023|NCT00307437|363152686|FG004|Controlled Period|Adverse Event|0|||
105316024|NCT00307437|363152687|FG005|Controlled Period|Adverse Event|0|||
105316025|NCT00307437|363152688|FG006|Controlled Period|Adverse Event|0|||
105316026|NCT00307437|363152682|FG000|Controlled Period|Death|0|||
105316027|NCT00307437|363152683|FG001|Controlled Period|Death|0|||
105316028|NCT00307437|363152684|FG002|Controlled Period|Death|1|||
105316029|NCT00307437|363152685|FG003|Controlled Period|Death|0|||
105316030|NCT00307437|363152686|FG004|Controlled Period|Death|0|||
105316031|NCT00307437|363152687|FG005|Controlled Period|Death|0|||
105316032|NCT00307437|363152688|FG006|Controlled Period|Death|0|||
105316033|NCT00307437|363152682|FG000|Controlled Period|Lack of Efficacy|2|||
105316034|NCT00307437|363152683|FG001|Controlled Period|Lack of Efficacy|0|||
105316035|NCT00307437|363152684|FG002|Controlled Period|Lack of Efficacy|0|||
105316036|NCT00307437|363152685|FG003|Controlled Period|Lack of Efficacy|0|||
105316037|NCT00307437|363152686|FG004|Controlled Period|Lack of Efficacy|0|||
105316038|NCT00307437|363152687|FG005|Controlled Period|Lack of Efficacy|0|||
105316039|NCT00307437|363152688|FG006|Controlled Period|Lack of Efficacy|0|||
105316040|NCT00307437|363152682|FG000|Controlled Period|Lost to Follow-up|2|||
105316041|NCT00307437|363152683|FG001|Controlled Period|Lost to Follow-up|3|||
105316042|NCT00307437|363152684|FG002|Controlled Period|Lost to Follow-up|0|||
105316043|NCT00307437|363152685|FG003|Controlled Period|Lost to Follow-up|0|||
105844664|NCT02093221|365088811|FG000|Overall Study|Death|0|||
105844665|NCT02093221|365088812|FG001|Overall Study|Death|1|||
105844666|NCT02093221|365088813|FG002|Overall Study|Death|0|||
105844667|NCT02093221|365088814|FG003|Overall Study|Death|0|||
105844668|NCT02093221|365088815|FG004|Overall Study|Death|0|||
105844669|NCT02093221|365088811|FG000|Overall Study|Protocol Violation|0|||
105844670|NCT02093221|365088812|FG001|Overall Study|Protocol Violation|1|||
105844671|NCT02093221|365088813|FG002|Overall Study|Protocol Violation|0|||
105316044|NCT00307437|363152686|FG004|Controlled Period|Lost to Follow-up|0|||
105316045|NCT00307437|363152687|FG005|Controlled Period|Lost to Follow-up|0|||
105316046|NCT00307437|363152688|FG006|Controlled Period|Lost to Follow-up|0|||
105316047|NCT00307437|363152682|FG000|Controlled Period|Other|5|||
105316048|NCT00307437|363152683|FG001|Controlled Period|Other|1|||
105316049|NCT00307437|363152684|FG002|Controlled Period|Other|3|||
105316050|NCT00307437|363152685|FG003|Controlled Period|Other|0|||
105844672|NCT02093221|365088814|FG003|Overall Study|Protocol Violation|0|||
105844673|NCT02093221|365088815|FG004|Overall Study|Protocol Violation|0|||
105844674|NCT02093221|365088811|FG000|Overall Study|Study termination|6|||
105844675|NCT02093221|365088812|FG001|Overall Study|Study termination|5|||
105844676|NCT02093221|365088813|FG002|Overall Study|Study termination|4|||
105844677|NCT02093221|365088814|FG003|Overall Study|Study termination|6|||
105844678|NCT02093221|365088815|FG004|Overall Study|Study termination|7|||
105844679|NCT03465436|365088816|FG000|Period 1|Protocol Violation|0|||
105844680|NCT03465436|365088817|FG001|Period 1|Protocol Violation|0|||
105844681|NCT03465436|365088818|FG002|Period 1|Protocol Violation|1|||
105844682|NCT03465436|365088819|FG003|Period 1|Protocol Violation|0|||
105844683|NCT03465436|365088816|FG000|Period 2|Protocol Violation|0|||
105844684|NCT03465436|365088817|FG001|Period 2|Protocol Violation|1|||
105844685|NCT03465436|365088818|FG002|Period 2|Protocol Violation|0|||
105844686|NCT03465436|365088819|FG003|Period 2|Protocol Violation|0|||
105844687|NCT03465436|365088816|FG000|Period 3|Protocol Violation|1|||
105844688|NCT03465436|365088817|FG001|Period 3|Protocol Violation|1|||
105844689|NCT03465436|365088818|FG002|Period 3|Protocol Violation|0|||
105844690|NCT03465436|365088819|FG003|Period 3|Protocol Violation|0|||
105844691|NCT03465436|365088816|FG000|Period 4|Protocol Violation|0|||
105844692|NCT03465436|365088817|FG001|Period 4|Protocol Violation|0|||
105844693|NCT03465436|365088818|FG002|Period 4|Protocol Violation|1|||
105844694|NCT03465436|365088819|FG003|Period 4|Protocol Violation|0|||
105844695|NCT03852459|365088820|FG000|Overall Study|Adverse Event|2|||
105844696|NCT03852459|365088821|FG001|Overall Study|Adverse Event|2|||
105844697|NCT03852459|365088820|FG000|Overall Study|Withdrawal by Subject|1|||
105844698|NCT03852459|365088821|FG001|Overall Study|Withdrawal by Subject|1|||
105844699|NCT00049842|365088822|FG000|Treatment Phase|Adverse Event|47|||
105844700|NCT00049842|365088823|FG001|Treatment Phase|Adverse Event|12|||
105844701|NCT00049842|365088822|FG000|Treatment Phase|Withdrawal by Subject|35|||
105844702|NCT00049842|365088823|FG001|Treatment Phase|Withdrawal by Subject|46|||
105844703|NCT00049842|365088822|FG000|Treatment Phase|Non-compliance with protocol|7|||
105844704|NCT00049842|365088823|FG001|Treatment Phase|Non-compliance with protocol|8|||
105844705|NCT00049842|365088822|FG000|Treatment Phase|Lost to Follow-up|4|||
105844706|NCT00049842|365088823|FG001|Treatment Phase|Lost to Follow-up|8|||
105844707|NCT00049842|365088822|FG000|Treatment Phase|Administrative|0|||
105844708|NCT00049842|365088823|FG001|Treatment Phase|Administrative|3|||
105844709|NCT00049842|365088822|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
105844710|NCT00049842|365088823|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
105844711|NCT00049842|365088822|FG000|Follow-up Phase|Adverse Event|6|||
105844712|NCT00049842|365088823|FG001|Follow-up Phase|Adverse Event|1|||
105844713|NCT00049842|365088822|FG000|Follow-up Phase|Other|1|||
105844714|NCT00049842|365088823|FG001|Follow-up Phase|Other|4|||
105844715|NCT01813071|365088824|FG000|Overall Study|Protocol Violation|0|||
105844716|NCT01813071|365088825|FG001|Overall Study|Protocol Violation|0|||
105844717|NCT01813071|365088826|FG002|Overall Study|Protocol Violation|0|||
105844718|NCT01813071|365088827|FG003|Overall Study|Protocol Violation|0|||
105844719|NCT01813071|365088828|FG004|Overall Study|Protocol Violation|1|||
105844720|NCT01813071|365088829|FG005|Overall Study|Protocol Violation|4|||
105844721|NCT01813071|365088830|FG006|Overall Study|Protocol Violation|2|||
105844722|NCT01813071|365088831|FG007|Overall Study|Protocol Violation|4|||
105844723|NCT01813071|365088832|FG008|Overall Study|Protocol Violation|2|||
105844724|NCT01813071|365088824|FG000|Overall Study|Withdrawal by Subject|0|||
105844725|NCT01813071|365088825|FG001|Overall Study|Withdrawal by Subject|0|||
105844726|NCT01813071|365088826|FG002|Overall Study|Withdrawal by Subject|0|||
105844727|NCT01813071|365088827|FG003|Overall Study|Withdrawal by Subject|0|||
105844728|NCT01813071|365088828|FG004|Overall Study|Withdrawal by Subject|0|||
105844729|NCT01813071|365088829|FG005|Overall Study|Withdrawal by Subject|1|||
105844730|NCT01813071|365088830|FG006|Overall Study|Withdrawal by Subject|0|||
105316051|NCT00307437|363152686|FG004|Controlled Period|Other|0|||
105316052|NCT00307437|363152687|FG005|Controlled Period|Other|0|||
105316053|NCT00307437|363152688|FG006|Controlled Period|Other|0|||
105316054|NCT00307437|363152682|FG000|After Controlled Period|Adverse Event|0|||
105316055|NCT00307437|363152683|FG001|After Controlled Period|Adverse Event|0|||
105316056|NCT00307437|363152684|FG002|After Controlled Period|Adverse Event|0|||
105316057|NCT00307437|363152685|FG003|After Controlled Period|Adverse Event|18|||
105844731|NCT01813071|365088831|FG007|Overall Study|Withdrawal by Subject|0|||
105844732|NCT01813071|365088832|FG008|Overall Study|Withdrawal by Subject|0|||
105844733|NCT01813071|365088824|FG000|Overall Study|Adverse Event|0|||
105844734|NCT01813071|365088825|FG001|Overall Study|Adverse Event|0|||
105844735|NCT01813071|365088826|FG002|Overall Study|Adverse Event|0|||
105844736|NCT01813071|365088827|FG003|Overall Study|Adverse Event|0|||
105316058|NCT00307437|363152686|FG004|After Controlled Period|Adverse Event|16|||
105316059|NCT00307437|363152687|FG005|After Controlled Period|Adverse Event|31|||
105490249|NCT02537574|363807499|FG001|Overall Study|Incarceration|1|||
105844737|NCT01813071|365088828|FG004|Overall Study|Adverse Event|0|||
105844738|NCT01813071|365088829|FG005|Overall Study|Adverse Event|1|||
105844739|NCT01813071|365088830|FG006|Overall Study|Adverse Event|0|||
105844740|NCT01813071|365088831|FG007|Overall Study|Adverse Event|0|||
105316060|NCT00307437|363152688|FG006|After Controlled Period|Adverse Event|40|||
105316061|NCT00307437|363152682|FG000|After Controlled Period|Death|0|||
105316062|NCT00307437|363152683|FG001|After Controlled Period|Death|0|||
105316063|NCT00307437|363152684|FG002|After Controlled Period|Death|0|||
105316064|NCT00307437|363152685|FG003|After Controlled Period|Death|3|||
105316065|NCT00307437|363152686|FG004|After Controlled Period|Death|1|||
105316066|NCT00307437|363152687|FG005|After Controlled Period|Death|1|||
105316067|NCT00307437|363152688|FG006|After Controlled Period|Death|3|||
105316068|NCT00307437|363152682|FG000|After Controlled Period|Lack of Efficacy|0|||
105316069|NCT00307437|363152683|FG001|After Controlled Period|Lack of Efficacy|0|||
105316070|NCT00307437|363152684|FG002|After Controlled Period|Lack of Efficacy|0|||
105316071|NCT00307437|363152685|FG003|After Controlled Period|Lack of Efficacy|15|||
105316072|NCT00307437|363152686|FG004|After Controlled Period|Lack of Efficacy|17|||
105316073|NCT00307437|363152687|FG005|After Controlled Period|Lack of Efficacy|37|||
105316074|NCT00307437|363152688|FG006|After Controlled Period|Lack of Efficacy|24|||
105316075|NCT00307437|363152682|FG000|After Controlled Period|Lost to Follow-up|0|||
105316076|NCT00307437|363152683|FG001|After Controlled Period|Lost to Follow-up|0|||
105316077|NCT00307437|363152684|FG002|After Controlled Period|Lost to Follow-up|0|||
105316078|NCT00307437|363152685|FG003|After Controlled Period|Lost to Follow-up|7|||
105316079|NCT00307437|363152686|FG004|After Controlled Period|Lost to Follow-up|12|||
105316080|NCT00307437|363152687|FG005|After Controlled Period|Lost to Follow-up|13|||
105316081|NCT00307437|363152688|FG006|After Controlled Period|Lost to Follow-up|18|||
105316082|NCT00307437|363152682|FG000|After Controlled Period|Other|0|||
105316083|NCT00307437|363152683|FG001|After Controlled Period|Other|0|||
105316084|NCT00307437|363152684|FG002|After Controlled Period|Other|0|||
105316085|NCT00307437|363152685|FG003|After Controlled Period|Other|15|||
105316086|NCT00307437|363152686|FG004|After Controlled Period|Other|9|||
105316087|NCT00307437|363152687|FG005|After Controlled Period|Other|40|||
105316088|NCT00307437|363152688|FG006|After Controlled Period|Other|28|||
105316089|NCT04597632|363152689|FG000|Overall Study|Withdrawal by Subject|10|||
105316090|NCT04597632|363152689|FG000|Overall Study|Lost to Follow-up|1|||
105316091|NCT04597632|363152689|FG000|Overall Study|Death|1|||
105316092|NCT04597632|363152689|FG000|Overall Study|Adverse Event|5|||
105316093|NCT01823835|363152692|FG000|Overall Study|Adverse Event|0|||
105316094|NCT01823835|363152693|FG001|Overall Study|Adverse Event|0|||
105316095|NCT01823835|363152694|FG002|Overall Study|Adverse Event|0|||
105316096|NCT01823835|363152695|FG003|Overall Study|Adverse Event|0|||
105316097|NCT01823835|363152696|FG004|Overall Study|Adverse Event|1|||
105316098|NCT01823835|363152697|FG005|Overall Study|Adverse Event|0|||
105316099|NCT01823835|363152698|FG006|Overall Study|Adverse Event|1|||
105316100|NCT01823835|363152699|FG007|Overall Study|Adverse Event|0|||
105316101|NCT01823835|363152700|FG008|Overall Study|Adverse Event|0|||
105316102|NCT01823835|363152701|FG009|Overall Study|Adverse Event|0|||
105316103|NCT01823835|363152702|FG010|Overall Study|Adverse Event|1|||
105316104|NCT01823835|363152703|FG011|Overall Study|Adverse Event|2|||
105316105|NCT01823835|363152704|FG012|Overall Study|Adverse Event|0|||
105316106|NCT01823835|363152705|FG013|Overall Study|Adverse Event|0|||
105316107|NCT01823835|363152706|FG014|Overall Study|Adverse Event|0|||
105316108|NCT01823835|363152692|FG000|Overall Study|Physician Decision|0|||
105316109|NCT01823835|363152693|FG001|Overall Study|Physician Decision|0|||
105316110|NCT01823835|363152694|FG002|Overall Study|Physician Decision|0|||
105316111|NCT01823835|363152695|FG003|Overall Study|Physician Decision|0|||
105316112|NCT01823835|363152696|FG004|Overall Study|Physician Decision|0|||
105316113|NCT01823835|363152697|FG005|Overall Study|Physician Decision|0|||
105316114|NCT01823835|363152698|FG006|Overall Study|Physician Decision|0|||
105316115|NCT01823835|363152699|FG007|Overall Study|Physician Decision|0|||
105316116|NCT01823835|363152700|FG008|Overall Study|Physician Decision|0|||
105316117|NCT01823835|363152701|FG009|Overall Study|Physician Decision|0|||
105316118|NCT01823835|363152702|FG010|Overall Study|Physician Decision|0|||
105316119|NCT01823835|363152703|FG011|Overall Study|Physician Decision|2|||
105316120|NCT01823835|363152704|FG012|Overall Study|Physician Decision|0|||
105316121|NCT01823835|363152705|FG013|Overall Study|Physician Decision|0|||
105316122|NCT01823835|363152706|FG014|Overall Study|Physician Decision|0|||
105316123|NCT01823835|363152692|FG000|Overall Study|Progressive Disease|3|||
105368775|NCT03312738|363356279|FG000|Overall Study|Physician Decision|2|||
105368776|NCT03312738|363356280|FG001|Overall Study|Physician Decision|3|||
105368777|NCT00183430|363356281|FG000|Overall Study|Adverse Event|1|||
105368778|NCT00183430|363356282|FG001|Overall Study|Adverse Event|0|||
105368779|NCT00183430|363356281|FG000|Overall Study|Lost to Follow-up|3|||
105368780|NCT00183430|363356282|FG001|Overall Study|Lost to Follow-up|0|||
105368781|NCT00183430|363356281|FG000|Overall Study|did not meet inclusion criteria|1|||
105368782|NCT00183430|363356282|FG001|Overall Study|did not meet inclusion criteria|0|||
105316124|NCT01823835|363152693|FG001|Overall Study|Progressive Disease|4|||
105316125|NCT01823835|363152694|FG002|Overall Study|Progressive Disease|3|||
105316126|NCT01823835|363152695|FG003|Overall Study|Progressive Disease|6|||
105316127|NCT01823835|363152696|FG004|Overall Study|Progressive Disease|4|||
105316128|NCT01823835|363152697|FG005|Overall Study|Progressive Disease|6|||
105316129|NCT01823835|363152698|FG006|Overall Study|Progressive Disease|5|||
105316130|NCT01823835|363152699|FG007|Overall Study|Progressive Disease|3|||
105316131|NCT01823835|363152700|FG008|Overall Study|Progressive Disease|3|||
105844741|NCT01813071|365088832|FG008|Overall Study|Adverse Event|0|||
105844742|NCT01813071|365088824|FG000|Overall Study|Physician Decision|0|||
105844743|NCT01813071|365088825|FG001|Overall Study|Physician Decision|0|||
105844744|NCT01813071|365088826|FG002|Overall Study|Physician Decision|0|||
105844745|NCT01813071|365088827|FG003|Overall Study|Physician Decision|0|||
105844746|NCT01813071|365088828|FG004|Overall Study|Physician Decision|0|||
105844747|NCT01813071|365088829|FG005|Overall Study|Physician Decision|0|||
105844748|NCT01813071|365088830|FG006|Overall Study|Physician Decision|1|||
105844749|NCT01813071|365088831|FG007|Overall Study|Physician Decision|0|||
105844750|NCT01813071|365088832|FG008|Overall Study|Physician Decision|0|||
105844751|NCT01813071|365088824|FG000|Overall Study|Met inc/exc criteria|0|||
105844752|NCT01813071|365088825|FG001|Overall Study|Met inc/exc criteria|0|||
105844753|NCT01813071|365088826|FG002|Overall Study|Met inc/exc criteria|0|||
105844754|NCT01813071|365088827|FG003|Overall Study|Met inc/exc criteria|0|||
105844755|NCT01813071|365088828|FG004|Overall Study|Met inc/exc criteria|0|||
105844756|NCT01813071|365088829|FG005|Overall Study|Met inc/exc criteria|1|||
105844757|NCT01813071|365088830|FG006|Overall Study|Met inc/exc criteria|0|||
105844758|NCT01813071|365088831|FG007|Overall Study|Met inc/exc criteria|1|||
105844759|NCT01813071|365088832|FG008|Overall Study|Met inc/exc criteria|1|||
105844760|NCT02442271|365088833|FG000|Overall Study|Adverse Event|1|||
105844761|NCT02442271|365088833|FG000|Overall Study|Withdrew Consent|1|||
105844762|NCT02442271|365088833|FG000|Overall Study|Lost to Follow-up|1|||
105844763|NCT02442271|365088833|FG000|Overall Study|Other|1|||
105844764|NCT00831623|365088835|FG000|Overall Study|Withdrawal by Subject|9|||
105844765|NCT00831623|365088835|FG000|Overall Study|Lost to Follow-up|1|||
105844766|NCT00831623|365088835|FG000|Overall Study|Not 2 years post-treatment|12|||
105844767|NCT01564459|365088836|FG000|Run-In|Adverse Event|7|||
105844768|NCT01564459|365088837|FG001|Run-In|Adverse Event|0|||
105844769|NCT01564459|365088838|FG002|Run-In|Adverse Event|0|||
105844770|NCT01564459|365088836|FG000|Run-In|Lost to Follow-up|1|||
105844771|NCT01564459|365088837|FG001|Run-In|Lost to Follow-up|0|||
105844772|NCT01564459|365088838|FG002|Run-In|Lost to Follow-up|0|||
105844773|NCT01564459|365088836|FG000|Run-In|Non-compliance with study drug|2|||
105844774|NCT01564459|365088837|FG001|Run-In|Non-compliance with study drug|0|||
105844775|NCT01564459|365088838|FG002|Run-In|Non-compliance with study drug|0|||
105844776|NCT01564459|365088836|FG000|Run-In|Protocol Violation|1|||
105844777|NCT01564459|365088837|FG001|Run-In|Protocol Violation|0|||
105844778|NCT01564459|365088838|FG002|Run-In|Protocol Violation|0|||
105844779|NCT01564459|365088836|FG000|Run-In|Withdrawal by Subject|1|||
105844780|NCT01564459|365088837|FG001|Run-In|Withdrawal by Subject|0|||
105844781|NCT01564459|365088838|FG002|Run-In|Withdrawal by Subject|0|||
105844782|NCT01564459|365088836|FG000|Double-blind Treatment|Adverse Event|0|||
105844783|NCT01564459|365088837|FG001|Double-blind Treatment|Adverse Event|0|||
105844784|NCT01564459|365088838|FG002|Double-blind Treatment|Adverse Event|1|||
105844785|NCT03629028|365088841|FG000|Overall Study|Lost to Follow-up|26|||
105844786|NCT03629028|365088842|FG001|Overall Study|Lost to Follow-up|23|||
105844787|NCT03629028|365088841|FG000|Overall Study|Pregnancy|4|||
105844788|NCT03629028|365088842|FG001|Overall Study|Pregnancy|2|||
105844789|NCT03629028|365088841|FG000|Overall Study|intolerance to examination|2|||
105844790|NCT03629028|365088842|FG001|Overall Study|intolerance to examination|0|||
105844791|NCT02427984|365088843|FG000|Overall Study|Lost to Follow-up|13|||
105844792|NCT02427984|365088844|FG001|Overall Study|Lost to Follow-up|5|||
105844793|NCT02427984|365088845|FG002|Overall Study|Lost to Follow-up|18|||
105844794|NCT03545191|365088846|FG000|Overall Study|Death|1|||
105844795|NCT03545191|365088847|FG001|Overall Study|Death|0|||
105844796|NCT03545191|365088848|FG002|Overall Study|Death|0|||
105844797|NCT03545191|365088846|FG000|Overall Study|Adverse Event|4|||
105844798|NCT03545191|365088847|FG001|Overall Study|Adverse Event|2|||
105844799|NCT03545191|365088848|FG002|Overall Study|Adverse Event|7|||
105844800|NCT03545191|365088846|FG000|Overall Study|Other reasons|3|||
105844801|NCT03545191|365088847|FG001|Overall Study|Other reasons|11|||
105844802|NCT03545191|365088848|FG002|Overall Study|Other reasons|8|||
105844803|NCT03545191|365088846|FG000|Overall Study|Withdrawal by Subject|13|||
105844804|NCT03545191|365088847|FG001|Overall Study|Withdrawal by Subject|10|||
105844805|NCT03545191|365088848|FG002|Overall Study|Withdrawal by Subject|12|||
105844806|NCT03545191|365088846|FG000|Overall Study|Lost to Follow-up|1|||
105844807|NCT03545191|365088847|FG001|Overall Study|Lost to Follow-up|2|||
105316132|NCT01823835|363152701|FG009|Overall Study|Progressive Disease|18|||
105316133|NCT01823835|363152702|FG010|Overall Study|Progressive Disease|8|||
105844808|NCT03545191|365088848|FG002|Overall Study|Lost to Follow-up|3|||
105844809|NCT01491035|365088856|FG000|Overall Study|Lost to Follow-up|0|||
105844810|NCT01491035|365088857|FG001|Overall Study|Lost to Follow-up|0|||
105844811|NCT01491035|365088858|FG002|Overall Study|Lost to Follow-up|0|||
105844812|NCT01491035|365088859|FG003|Overall Study|Lost to Follow-up|0|||
105844813|NCT01491035|365088860|FG004|Overall Study|Lost to Follow-up|1|||
105316134|NCT01823835|363152703|FG011|Overall Study|Progressive Disease|46|||
105844814|NCT01491035|365088861|FG005|Overall Study|Lost to Follow-up|0|||
105844815|NCT01491035|365088862|FG006|Overall Study|Lost to Follow-up|0|||
105844816|NCT01491035|365088863|FG007|Overall Study|Lost to Follow-up|0|||
105844817|NCT00532935|365088867|FG000|Overall Study|Adverse Event|11|||
105844818|NCT00532935|365088868|FG001|Overall Study|Adverse Event|12|||
105316135|NCT01823835|363152704|FG012|Overall Study|Progressive Disease|18|||
105316136|NCT01823835|363152705|FG013|Overall Study|Progressive Disease|4|||
105316137|NCT01823835|363152706|FG014|Overall Study|Progressive Disease|6|||
105316138|NCT01823835|363152692|FG000|Overall Study|Study Termination|0|||
105316139|NCT01823835|363152693|FG001|Overall Study|Study Termination|0|||
105316140|NCT01823835|363152694|FG002|Overall Study|Study Termination|0|||
105316141|NCT01823835|363152695|FG003|Overall Study|Study Termination|0|||
105316142|NCT01823835|363152696|FG004|Overall Study|Study Termination|1|||
105316143|NCT01823835|363152697|FG005|Overall Study|Study Termination|0|||
105316144|NCT01823835|363152698|FG006|Overall Study|Study Termination|0|||
105316145|NCT01823835|363152699|FG007|Overall Study|Study Termination|0|||
105316146|NCT01823835|363152700|FG008|Overall Study|Study Termination|0|||
105316147|NCT01823835|363152701|FG009|Overall Study|Study Termination|0|||
105316148|NCT01823835|363152702|FG010|Overall Study|Study Termination|0|||
105316149|NCT01823835|363152703|FG011|Overall Study|Study Termination|1|||
105316150|NCT01823835|363152704|FG012|Overall Study|Study Termination|0|||
105316151|NCT01823835|363152705|FG013|Overall Study|Study Termination|0|||
105316152|NCT01823835|363152706|FG014|Overall Study|Study Termination|0|||
105316153|NCT01823835|363152692|FG000|Overall Study|Withdrawal by Subject|0|||
105316154|NCT01823835|363152693|FG001|Overall Study|Withdrawal by Subject|0|||
105316155|NCT01823835|363152694|FG002|Overall Study|Withdrawal by Subject|1|||
105316156|NCT01823835|363152695|FG003|Overall Study|Withdrawal by Subject|0|||
105316157|NCT01823835|363152696|FG004|Overall Study|Withdrawal by Subject|0|||
105316158|NCT01823835|363152697|FG005|Overall Study|Withdrawal by Subject|0|||
105316159|NCT01823835|363152698|FG006|Overall Study|Withdrawal by Subject|0|||
105316160|NCT01823835|363152699|FG007|Overall Study|Withdrawal by Subject|0|||
105316161|NCT01823835|363152700|FG008|Overall Study|Withdrawal by Subject|0|||
105316162|NCT01823835|363152701|FG009|Overall Study|Withdrawal by Subject|1|||
105316163|NCT01823835|363152702|FG010|Overall Study|Withdrawal by Subject|1|||
105316164|NCT01823835|363152703|FG011|Overall Study|Withdrawal by Subject|2|||
105316165|NCT01823835|363152704|FG012|Overall Study|Withdrawal by Subject|1|||
105316166|NCT01823835|363152705|FG013|Overall Study|Withdrawal by Subject|0|||
105316167|NCT01823835|363152706|FG014|Overall Study|Withdrawal by Subject|0|||
105316168|NCT00509795|363152714|FG000|Overall Study|Adverse Event|4|||
105316169|NCT00509795|363152715|FG001|Overall Study|Adverse Event|3|||
105316170|NCT00509795|363152716|FG002|Overall Study|Adverse Event|5|||
105316171|NCT00509795|363152717|FG003|Overall Study|Adverse Event|4|||
105316172|NCT00509795|363152714|FG000|Overall Study|Death|3|||
105316173|NCT00509795|363152715|FG001|Overall Study|Death|1|||
105316174|NCT00509795|363152716|FG002|Overall Study|Death|2|||
105316175|NCT00509795|363152717|FG003|Overall Study|Death|7|||
105316176|NCT00509795|363152714|FG000|Overall Study|Lack of Efficacy|0|||
105316177|NCT00509795|363152715|FG001|Overall Study|Lack of Efficacy|0|||
105316178|NCT00509795|363152716|FG002|Overall Study|Lack of Efficacy|2|||
105316179|NCT00509795|363152717|FG003|Overall Study|Lack of Efficacy|2|||
105316180|NCT00509795|363152714|FG000|Overall Study|Lost to Follow-up|1|||
105316181|NCT00509795|363152715|FG001|Overall Study|Lost to Follow-up|2|||
105316182|NCT00509795|363152716|FG002|Overall Study|Lost to Follow-up|4|||
105316183|NCT00509795|363152717|FG003|Overall Study|Lost to Follow-up|4|||
105316184|NCT00509795|363152714|FG000|Overall Study|OTHER|1|||
105316185|NCT00509795|363152715|FG001|Overall Study|OTHER|0|||
105316186|NCT00509795|363152716|FG002|Overall Study|OTHER|4|||
105316187|NCT00509795|363152717|FG003|Overall Study|OTHER|1|||
105316188|NCT00509795|363152714|FG000|Overall Study|Protocol Violation|3|||
105316189|NCT00509795|363152715|FG001|Overall Study|Protocol Violation|0|||
105316190|NCT00509795|363152716|FG002|Overall Study|Protocol Violation|3|||
105316191|NCT00509795|363152717|FG003|Overall Study|Protocol Violation|1|||
105316192|NCT00509795|363152714|FG000|Overall Study|Withdrawal by Subject|10|||
105316193|NCT00509795|363152715|FG001|Overall Study|Withdrawal by Subject|5|||
105490250|NCT02537574|363807500|FG002|Overall Study|Incarceration|0|||
105316194|NCT00509795|363152716|FG002|Overall Study|Withdrawal by Subject|7|||
105316195|NCT00509795|363152717|FG003|Overall Study|Withdrawal by Subject|8|||
105316196|NCT00338728|363152718|FG000|Overall Study|Screen Failure|14|||
105316197|NCT00993421|363152720|FG000|Overall Study|Adverse Event|2|||
105316198|NCT00993421|363152721|FG001|Overall Study|Adverse Event|7|||
105316199|NCT00993421|363152722|FG002|Overall Study|Adverse Event|6|||
105316200|NCT00993421|363152723|FG003|Overall Study|Adverse Event|9|||
105316201|NCT00993421|363152724|FG004|Overall Study|Adverse Event|5|||
105316202|NCT00993421|363152725|FG005|Overall Study|Adverse Event|7|||
105316203|NCT00993421|363152726|FG006|Overall Study|Adverse Event|1|||
105316204|NCT00993421|363152720|FG000|Overall Study|Sponsor Decision|36|||
105316205|NCT00993421|363152721|FG001|Overall Study|Sponsor Decision|31|||
105316206|NCT00993421|363152722|FG002|Overall Study|Sponsor Decision|28|||
105316207|NCT00993421|363152723|FG003|Overall Study|Sponsor Decision|30|||
105316208|NCT00993421|363152724|FG004|Overall Study|Sponsor Decision|38|||
105316209|NCT00993421|363152725|FG005|Overall Study|Sponsor Decision|30|||
105490251|NCT02537574|363807498|FG000|Overall Study|Failed Naloxone Challenge|0|||
105316210|NCT00993421|363152726|FG006|Overall Study|Sponsor Decision|29|||
105316211|NCT00993421|363152720|FG000|Overall Study|Lost to Follow-up|3|||
105316212|NCT00993421|363152721|FG001|Overall Study|Lost to Follow-up|5|||
105844819|NCT00532935|365088867|FG000|Overall Study|Lack of Efficacy|0|||
105844820|NCT00532935|365088868|FG001|Overall Study|Lack of Efficacy|3|||
105844821|NCT00532935|365088867|FG000|Overall Study|Lost to Follow-up|10|||
105844822|NCT00532935|365088868|FG001|Overall Study|Lost to Follow-up|6|||
105844823|NCT00532935|365088867|FG000|Overall Study|Physician Decision|4|||
105844824|NCT00532935|365088868|FG001|Overall Study|Physician Decision|5|||
105844825|NCT00532935|365088867|FG000|Overall Study|Pregnancy|1|||
105844826|NCT00532935|365088868|FG001|Overall Study|Pregnancy|0|||
105844827|NCT00532935|365088867|FG000|Overall Study|Protocol Violation|4|||
105844828|NCT00532935|365088868|FG001|Overall Study|Protocol Violation|2|||
105844829|NCT00532935|365088867|FG000|Overall Study|Withdrawal by Subject|10|||
105844830|NCT00532935|365088868|FG001|Overall Study|Withdrawal by Subject|9|||
105844831|NCT00532935|365088867|FG000|Overall Study|Protocol Specific Criteria|11|||
105844832|NCT00532935|365088868|FG001|Overall Study|Protocol Specific Criteria|15|||
105844833|NCT02149121|365088872|FG000|Main Study Period|Lack of Efficacy|2|||
105844834|NCT02149121|365088873|FG001|Main Study Period|Lack of Efficacy|2|||
105844835|NCT02149121|365088874|FG002|Main Study Period|Lack of Efficacy|1|||
105844836|NCT02149121|365088875|FG003|Main Study Period|Lack of Efficacy|0|||
105844837|NCT02149121|365088876|FG004|Main Study Period|Lack of Efficacy|0|||
105844838|NCT02149121|365088877|FG005|Main Study Period|Lack of Efficacy|0|||
105844839|NCT02149121|365088878|FG006|Main Study Period|Lack of Efficacy|0|||
105844840|NCT02149121|365088872|FG000|Main Study Period|Withdrawal by Subject|9|||
105844841|NCT02149121|365088873|FG001|Main Study Period|Withdrawal by Subject|5|||
105844842|NCT02149121|365088874|FG002|Main Study Period|Withdrawal by Subject|1|||
105844843|NCT02149121|365088875|FG003|Main Study Period|Withdrawal by Subject|0|||
105844844|NCT02149121|365088876|FG004|Main Study Period|Withdrawal by Subject|0|||
105844845|NCT02149121|365088877|FG005|Main Study Period|Withdrawal by Subject|0|||
105844846|NCT02149121|365088878|FG006|Main Study Period|Withdrawal by Subject|0|||
105844847|NCT02149121|365088872|FG000|Main Study Period|Adverse Event|2|||
105844848|NCT02149121|365088873|FG001|Main Study Period|Adverse Event|5|||
105844849|NCT02149121|365088874|FG002|Main Study Period|Adverse Event|1|||
105844850|NCT02149121|365088875|FG003|Main Study Period|Adverse Event|0|||
105844851|NCT02149121|365088876|FG004|Main Study Period|Adverse Event|0|||
105844852|NCT02149121|365088877|FG005|Main Study Period|Adverse Event|0|||
105844853|NCT02149121|365088878|FG006|Main Study Period|Adverse Event|0|||
105844854|NCT02149121|365088872|FG000|Main Study Period|Protocol Violation|2|||
105844855|NCT02149121|365088873|FG001|Main Study Period|Protocol Violation|0|||
105844856|NCT02149121|365088874|FG002|Main Study Period|Protocol Violation|0|||
105844857|NCT02149121|365088875|FG003|Main Study Period|Protocol Violation|0|||
105844858|NCT02149121|365088876|FG004|Main Study Period|Protocol Violation|0|||
105844859|NCT02149121|365088877|FG005|Main Study Period|Protocol Violation|0|||
105844860|NCT02149121|365088878|FG006|Main Study Period|Protocol Violation|0|||
105844861|NCT02149121|365088872|FG000|Main Study Period|Lost to Follow-up|2|||
105844862|NCT02149121|365088873|FG001|Main Study Period|Lost to Follow-up|1|||
105844863|NCT02149121|365088874|FG002|Main Study Period|Lost to Follow-up|0|||
105844864|NCT02149121|365088875|FG003|Main Study Period|Lost to Follow-up|0|||
105844865|NCT02149121|365088876|FG004|Main Study Period|Lost to Follow-up|0|||
105844866|NCT02149121|365088877|FG005|Main Study Period|Lost to Follow-up|0|||
105844867|NCT02149121|365088878|FG006|Main Study Period|Lost to Follow-up|0|||
105844868|NCT02149121|365088872|FG000|Main Study Period|Death|1|||
105844869|NCT02149121|365088873|FG001|Main Study Period|Death|0|||
105844870|NCT02149121|365088874|FG002|Main Study Period|Death|0|||
105844871|NCT02149121|365088875|FG003|Main Study Period|Death|0|||
105844872|NCT02149121|365088876|FG004|Main Study Period|Death|0|||
105844873|NCT02149121|365088877|FG005|Main Study Period|Death|0|||
105844874|NCT02149121|365088878|FG006|Main Study Period|Death|0|||
105844875|NCT02149121|365088872|FG000|Main Study Period|Physician Decision|1|||
105844876|NCT02149121|365088873|FG001|Main Study Period|Physician Decision|0|||
105368783|NCT00183430|363356281|FG000|Overall Study|Withdrawal by Subject|1|||
105844877|NCT02149121|365088874|FG002|Main Study Period|Physician Decision|0|||
105844878|NCT02149121|365088875|FG003|Main Study Period|Physician Decision|0|||
105844879|NCT02149121|365088876|FG004|Main Study Period|Physician Decision|0|||
105844880|NCT02149121|365088877|FG005|Main Study Period|Physician Decision|0|||
105844881|NCT02149121|365088878|FG006|Main Study Period|Physician Decision|0|||
105844882|NCT02149121|365088872|FG000|Main Study Period|Developed any malignancy|0|||
105844883|NCT02149121|365088873|FG001|Main Study Period|Developed any malignancy|1|||
105844884|NCT02149121|365088874|FG002|Main Study Period|Developed any malignancy|1|||
105844885|NCT02149121|365088875|FG003|Main Study Period|Developed any malignancy|0|||
105844886|NCT02149121|365088876|FG004|Main Study Period|Developed any malignancy|0|||
105844887|NCT02149121|365088877|FG005|Main Study Period|Developed any malignancy|0|||
105844888|NCT02149121|365088878|FG006|Main Study Period|Developed any malignancy|0|||
105844889|NCT02149121|365088872|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
105844890|NCT02149121|365088873|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
105844891|NCT02149121|365088874|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
105844892|NCT02149121|365088875|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
105844893|NCT02149121|365088876|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
105844894|NCT02149121|365088877|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
105844895|NCT02149121|365088878|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
105844896|NCT02149121|365088872|FG000|Main Study Period|Disease progression|0|||
105844897|NCT02149121|365088873|FG001|Main Study Period|Disease progression|1|||
105316213|NCT00993421|363152722|FG002|Overall Study|Lost to Follow-up|5|||
105316214|NCT00993421|363152723|FG003|Overall Study|Lost to Follow-up|0|||
105316215|NCT00993421|363152724|FG004|Overall Study|Lost to Follow-up|0|||
105316216|NCT00993421|363152725|FG005|Overall Study|Lost to Follow-up|0|||
105316217|NCT00993421|363152726|FG006|Overall Study|Lost to Follow-up|6|||
105316218|NCT00993421|363152720|FG000|Overall Study|Withdrawal by Subject|3|||
105316219|NCT00993421|363152721|FG001|Overall Study|Withdrawal by Subject|2|||
105316220|NCT00993421|363152722|FG002|Overall Study|Withdrawal by Subject|3|||
105316221|NCT00993421|363152723|FG003|Overall Study|Withdrawal by Subject|3|||
105844898|NCT02149121|365088874|FG002|Main Study Period|Disease progression|0|||
105316222|NCT00993421|363152724|FG004|Overall Study|Withdrawal by Subject|3|||
105316223|NCT00993421|363152725|FG005|Overall Study|Withdrawal by Subject|5|||
105316224|NCT00993421|363152726|FG006|Overall Study|Withdrawal by Subject|3|||
105316225|NCT00993421|363152720|FG000|Overall Study|Death|0|||
105316226|NCT00993421|363152721|FG001|Overall Study|Death|0|||
105316227|NCT00993421|363152722|FG002|Overall Study|Death|0|||
105316228|NCT00993421|363152723|FG003|Overall Study|Death|0|||
105316229|NCT00993421|363152724|FG004|Overall Study|Death|0|||
105316230|NCT00993421|363152725|FG005|Overall Study|Death|0|||
105316231|NCT00993421|363152726|FG006|Overall Study|Death|1|||
105316232|NCT00993421|363152720|FG000|Overall Study|Entry Criteria Exclusion|0|||
105316233|NCT00993421|363152721|FG001|Overall Study|Entry Criteria Exclusion|0|||
105316234|NCT00993421|363152722|FG002|Overall Study|Entry Criteria Exclusion|1|||
105316235|NCT00993421|363152723|FG003|Overall Study|Entry Criteria Exclusion|3|||
105316236|NCT00993421|363152724|FG004|Overall Study|Entry Criteria Exclusion|0|||
105316237|NCT00993421|363152725|FG005|Overall Study|Entry Criteria Exclusion|1|||
105316238|NCT00993421|363152726|FG006|Overall Study|Entry Criteria Exclusion|0|||
105316239|NCT00993421|363152720|FG000|Overall Study|Physician Decision|0|||
105316240|NCT00993421|363152721|FG001|Overall Study|Physician Decision|0|||
105316241|NCT00993421|363152722|FG002|Overall Study|Physician Decision|0|||
105316242|NCT00993421|363152723|FG003|Overall Study|Physician Decision|0|||
105316243|NCT00993421|363152724|FG004|Overall Study|Physician Decision|0|||
105316244|NCT00993421|363152725|FG005|Overall Study|Physician Decision|1|||
105316245|NCT00993421|363152726|FG006|Overall Study|Physician Decision|1|||
105316246|NCT00993421|363152720|FG000|Overall Study|Protocol Violation|0|||
105316247|NCT00993421|363152721|FG001|Overall Study|Protocol Violation|0|||
105316248|NCT00993421|363152722|FG002|Overall Study|Protocol Violation|0|||
105316249|NCT00993421|363152723|FG003|Overall Study|Protocol Violation|0|||
105316250|NCT00993421|363152724|FG004|Overall Study|Protocol Violation|0|||
105316251|NCT00993421|363152725|FG005|Overall Study|Protocol Violation|2|||
105316252|NCT00993421|363152726|FG006|Overall Study|Protocol Violation|1|||
105316253|NCT02447744|363152727|FG000|Overall Study|Withdrawal by Subject|3|||
105844899|NCT02149121|365088875|FG003|Main Study Period|Disease progression|0|||
105844900|NCT02149121|365088876|FG004|Main Study Period|Disease progression|0|||
105844901|NCT02149121|365088877|FG005|Main Study Period|Disease progression|0|||
105844902|NCT02149121|365088878|FG006|Main Study Period|Disease progression|0|||
105316254|NCT02447744|363152728|FG001|Overall Study|Withdrawal by Subject|1|||
105316255|NCT02447744|363152727|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
105316256|NCT02447744|363152728|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
105316257|NCT03408639|363154651|FG000|Overall Study|Death|5|||
105316258|NCT03408639|363154652|FG001|Overall Study|Death|5|||
105316259|NCT03408639|363154651|FG000|Overall Study|Lost to Follow-up|1|||
105316260|NCT03408639|363154652|FG001|Overall Study|Lost to Follow-up|4|||
105316261|NCT03408639|363154651|FG000|Overall Study|Withdrawal by Subject|2|||
105316262|NCT03408639|363154652|FG001|Overall Study|Withdrawal by Subject|7|||
105316263|NCT03408639|363154651|FG000|Overall Study|Physician Decision|3|||
105316264|NCT03408639|363154652|FG001|Overall Study|Physician Decision|6|||
105316265|NCT01275729|363154657|FG000|Overall Study|Death|3|||
105316266|NCT01275729|363154657|FG000|Overall Study|Withdrawal by Subject|1|||
105316267|NCT02842073|363154658|FG000|Overall Study|Withdrawal by Subject|1|||
105490252|NCT02537574|363807499|FG001|Overall Study|Failed Naloxone Challenge|1|||
105490253|NCT02537574|363807500|FG002|Overall Study|Failed Naloxone Challenge|0|||
105316268|NCT03201445|363154665|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
105316269|NCT03201445|363154666|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
105316270|NCT03201445|363154665|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
105490254|NCT02537574|363807498|FG000|Overall Study|Transportation Issues|0|||
105490255|NCT02537574|363807499|FG001|Overall Study|Transportation Issues|0|||
105490256|NCT02537574|363807500|FG002|Overall Study|Transportation Issues|1|||
105490257|NCT02537574|363807498|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
105316271|NCT03201445|363154666|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
105316272|NCT03201445|363154665|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
105316273|NCT03201445|363154666|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
105844903|NCT02149121|365088872|FG000|Extension Study Period|Withdrawal by Subject|0|||
105316274|NCT03201445|363154665|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
105316275|NCT03201445|363154666|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
105316276|NCT03201445|363154665|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
105316277|NCT03201445|363154666|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
105316278|NCT03201445|363154665|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
105316279|NCT03201445|363154666|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
105316280|NCT03201445|363154665|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
105316281|NCT03201445|363154666|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
105316282|NCT03201445|363154665|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
105316283|NCT03201445|363154666|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
105316284|NCT03201445|363154665|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
105316285|NCT03201445|363154666|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
105316286|NCT03201445|363154665|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
105316287|NCT03201445|363154666|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
105316288|NCT03201445|363154665|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
105316289|NCT03201445|363154666|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
105316290|NCT03201445|363154665|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
105316291|NCT03201445|363154666|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
105316292|NCT03201445|363154665|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
105316293|NCT03201445|363154666|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
105316294|NCT03201445|363154665|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
105316295|NCT03201445|363154666|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
105316296|NCT03201445|363154665|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
105316297|NCT03201445|363154666|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
105316298|NCT03201445|363154665|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
105316299|NCT03201445|363154666|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
105316300|NCT03201445|363154665|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
105316301|NCT03201445|363154666|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
105316302|NCT03201445|363154665|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
105316303|NCT03201445|363154666|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
105316304|NCT03201445|363154665|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
105316305|NCT03201445|363154666|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
105316306|NCT03201445|363154665|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
105316307|NCT03201445|363154666|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
105316308|NCT03201445|363154665|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
105316309|NCT03201445|363154666|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
105316310|NCT02952586|363154667|FG000|Lead-In Phase (7 Days)|Death|0|||
105316311|NCT02952586|363154668|FG001|Lead-In Phase (7 Days)|Death|1|||
105316312|NCT02952586|363154667|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
105316313|NCT02952586|363154668|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
105316314|NCT02952586|363154667|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
105316315|NCT02952586|363154668|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
105316316|NCT02952586|363154667|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
105316317|NCT02952586|363154668|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
105316318|NCT02952586|363154667|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
105316319|NCT02952586|363154668|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
105316320|NCT02952586|363154667|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
105844904|NCT02149121|365088873|FG001|Extension Study Period|Withdrawal by Subject|0|||
105844905|NCT02149121|365088874|FG002|Extension Study Period|Withdrawal by Subject|0|||
105844906|NCT02149121|365088875|FG003|Extension Study Period|Withdrawal by Subject|1|||
105844907|NCT02149121|365088876|FG004|Extension Study Period|Withdrawal by Subject|0|||
105844908|NCT02149121|365088877|FG005|Extension Study Period|Withdrawal by Subject|2|||
105844909|NCT02149121|365088878|FG006|Extension Study Period|Withdrawal by Subject|0|||
105844910|NCT00766831|365088889|FG000|Overall Study|Withdrawal by Subject|4|||
105844911|NCT00766831|365088889|FG000|Overall Study|Lost to Follow-up|3|||
105844912|NCT00766831|365088889|FG000|Overall Study|Adverse Event|20|||
105844913|NCT00766831|365088889|FG000|Overall Study|Protocol Violation|15|||
105844914|NCT00766831|365088889|FG000|Overall Study|Physician Decision|5|||
105844915|NCT00766831|365088889|FG000|Overall Study|Withdrawal of consent|26|||
105844916|NCT00766831|365088889|FG000|Overall Study|Non cooperation by participants|14|||
105844917|NCT00766831|365088889|FG000|Overall Study|Other|28|||
105844918|NCT02220725|365088890|FG000|Overall Study|Lost to Follow-up|0|||
105844919|NCT02220725|365088891|FG001|Overall Study|Lost to Follow-up|0|||
105844920|NCT02220725|365088892|FG002|Overall Study|Lost to Follow-up|0|||
105844921|NCT02220725|365088893|FG003|Overall Study|Lost to Follow-up|1|||
105844922|NCT02220725|365088890|FG000|Overall Study|Withdrawal by Subject|0|||
105844923|NCT02220725|365088891|FG001|Overall Study|Withdrawal by Subject|0|||
105844924|NCT02220725|365088892|FG002|Overall Study|Withdrawal by Subject|0|||
105844925|NCT02220725|365088893|FG003|Overall Study|Withdrawal by Subject|1|||
105844926|NCT00788593|365088894|FG000|Placebo Run-in Phase|Adverse Event|2|||
105844927|NCT00788593|365088895|FG001|Placebo Run-in Phase|Adverse Event|0|||
105844928|NCT00788593|365088896|FG002|Placebo Run-in Phase|Adverse Event|0|||
105844929|NCT00788593|365088894|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
105576696|NCT02471404|364110283|FG000|Overall Study|Withdrawal by Subject|8|||
105576697|NCT02471404|364110284|FG001|Overall Study|Withdrawal by Subject|4|||
105576698|NCT02471404|364110285|FG002|Overall Study|Withdrawal by Subject|5|||
105576699|NCT02471404|364110283|FG000|Overall Study|Other reasons not specified|10|||
105576700|NCT02471404|364110284|FG001|Overall Study|Other reasons not specified|7|||
105576701|NCT02471404|364110285|FG002|Overall Study|Other reasons not specified|12|||
105576702|NCT01927731|364110286|FG000|Overall Study|Graft Failure|1|||
105576703|NCT01927731|364110287|FG001|Overall Study|Graft Failure|2|||
105576704|NCT01927731|364110286|FG000|Overall Study|Physician Decision|2|||
105576705|NCT01927731|364110287|FG001|Overall Study|Physician Decision|3|||
105576706|NCT01927731|364110286|FG000|Overall Study|Withdrawal by Subject|0|||
105576707|NCT01927731|364110287|FG001|Overall Study|Withdrawal by Subject|2|||
105576708|NCT01927731|364110286|FG000|Overall Study|Death|0|||
105576709|NCT01927731|364110287|FG001|Overall Study|Death|3|||
105576710|NCT02982720|364110288|FG000|Overall Study|Adverse Event|3|||
105844930|NCT00788593|365088895|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
105844931|NCT00788593|365088896|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
105844932|NCT00788593|365088894|FG000|Placebo Run-in Phase|Protocol Violation|2|||
105844933|NCT00788593|365088895|FG001|Placebo Run-in Phase|Protocol Violation|0|||
105844934|NCT00788593|365088896|FG002|Placebo Run-in Phase|Protocol Violation|0|||
105844935|NCT00788593|365088894|FG000|First Intervention Period|Adverse Event|0|||
105844936|NCT00788593|365088895|FG001|First Intervention Period|Adverse Event|1|||
105844937|NCT00788593|365088896|FG002|First Intervention Period|Adverse Event|0|||
105844938|NCT00788593|365088894|FG000|Second Intervention Period|Lost to Follow-up|0|||
105844939|NCT00788593|365088895|FG001|Second Intervention Period|Lost to Follow-up|1|||
105844940|NCT00788593|365088896|FG002|Second Intervention Period|Lost to Follow-up|0|||
105844941|NCT00788593|365088894|FG000|Second Intervention Period|Other|0|||
105844942|NCT00788593|365088895|FG001|Second Intervention Period|Other|0|||
105844943|NCT00788593|365088896|FG002|Second Intervention Period|Other|1|||
105844944|NCT00515034|365088897|FG000|Overall Study|Adverse Event|2|||
105844945|NCT00515034|365088898|FG001|Overall Study|Adverse Event|0|||
105844946|NCT00515034|365088899|FG002|Overall Study|Adverse Event|1|||
105844947|NCT00515034|365088900|FG003|Overall Study|Adverse Event|0|||
105844948|NCT00515034|365088897|FG000|Overall Study|Death|4|||
105844949|NCT00515034|365088898|FG001|Overall Study|Death|2|||
105844950|NCT00515034|365088899|FG002|Overall Study|Death|1|||
105844951|NCT00515034|365088900|FG003|Overall Study|Death|3|||
105844952|NCT00515034|365088897|FG000|Overall Study|Withdrawal by Subject|1|||
105844953|NCT00515034|365088898|FG001|Overall Study|Withdrawal by Subject|0|||
105844954|NCT00515034|365088899|FG002|Overall Study|Withdrawal by Subject|3|||
105844955|NCT00515034|365088900|FG003|Overall Study|Withdrawal by Subject|0|||
105844956|NCT00515034|365088897|FG000|Overall Study|Physician Decision|0|||
105844957|NCT00515034|365088898|FG001|Overall Study|Physician Decision|0|||
105844958|NCT00515034|365088899|FG002|Overall Study|Physician Decision|1|||
105844959|NCT00515034|365088900|FG003|Overall Study|Physician Decision|1|||
105844960|NCT00515034|365088897|FG000|Overall Study|Other|1|||
105844961|NCT00515034|365088898|FG001|Overall Study|Other|0|||
105844962|NCT00515034|365088899|FG002|Overall Study|Other|2|||
105844963|NCT00515034|365088900|FG003|Overall Study|Other|1|||
105844964|NCT01392326|365088903|FG000|Overall Study|Death|2|||
105844965|NCT01392326|365088904|FG001|Overall Study|Death|0|||
105844966|NCT01392326|365088905|FG002|Overall Study|Death|0|||
105844967|NCT01392326|365088903|FG000|Overall Study|Withdrawal by Subject|12|||
105844968|NCT01392326|365088904|FG001|Overall Study|Withdrawal by Subject|11|||
105844969|NCT01392326|365088905|FG002|Overall Study|Withdrawal by Subject|15|||
105844970|NCT01392326|365088903|FG000|Overall Study|Protocol Violation|2|||
105316321|NCT02952586|363154668|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
105316322|NCT02952586|363154667|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
105316323|NCT02952586|363154668|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
105316324|NCT02952586|363154667|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
105576711|NCT02982720|364110288|FG000|Overall Study|Death|1|||
105576712|NCT01388530|364110289|FG000|Overall Study|Lost to Follow-up|5|||
105576713|NCT01464255|364110292|FG000|Overall Study|unresolve corneal staining|0|||
105576714|NCT01464255|364110293|FG001|Overall Study|unresolve corneal staining|1|||
105844971|NCT01392326|365088904|FG001|Overall Study|Protocol Violation|0|||
105844972|NCT01392326|365088905|FG002|Overall Study|Protocol Violation|0|||
105844973|NCT01392326|365088903|FG000|Overall Study|Pregnancy|0|||
105844974|NCT01392326|365088904|FG001|Overall Study|Pregnancy|0|||
105844975|NCT01392326|365088905|FG002|Overall Study|Pregnancy|1|||
105844976|NCT01392326|365088903|FG000|Overall Study|Physician Decision|7|||
105844977|NCT01392326|365088904|FG001|Overall Study|Physician Decision|5|||
105844978|NCT01392326|365088905|FG002|Overall Study|Physician Decision|2|||
105844979|NCT01392326|365088903|FG000|Overall Study|Lost to Follow-up|1|||
105844980|NCT01392326|365088904|FG001|Overall Study|Lost to Follow-up|3|||
105316325|NCT02952586|363154668|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
105316326|NCT02952586|363154667|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
105490258|NCT02537574|363807499|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
105490259|NCT02537574|363807500|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
105490260|NCT02537574|363807498|FG000|Overall Study|Noncompliance with Protocol|0|||
105490261|NCT02537574|363807499|FG001|Overall Study|Noncompliance with Protocol|0|||
105844981|NCT01392326|365088905|FG002|Overall Study|Lost to Follow-up|4|||
105844982|NCT01392326|365088903|FG000|Overall Study|Lack of Efficacy|14|||
105844983|NCT01392326|365088904|FG001|Overall Study|Lack of Efficacy|10|||
105844984|NCT01392326|365088905|FG002|Overall Study|Lack of Efficacy|15|||
105844985|NCT01392326|365088903|FG000|Overall Study|Adverse Event|9|||
105844986|NCT01392326|365088904|FG001|Overall Study|Adverse Event|6|||
105844987|NCT01392326|365088905|FG002|Overall Study|Adverse Event|11|||
105844988|NCT02340221|365088910|FG000|Overall Study|Death|100|||
105844989|NCT02340221|365088911|FG001|Overall Study|Death|197|||
105844990|NCT02340221|365088910|FG000|Overall Study|Withdrawal by Participant|24|||
105844991|NCT02340221|365088911|FG001|Overall Study|Withdrawal by Participant|37|||
105844992|NCT02340221|365088910|FG000|Overall Study|Lost to Follow-up|4|||
105844993|NCT02340221|365088911|FG001|Overall Study|Lost to Follow-up|15|||
105844994|NCT02340221|365088910|FG000|Overall Study|Reason Not Specified|85|||
105844995|NCT02340221|365088911|FG001|Overall Study|Reason Not Specified|165|||
105844996|NCT02340221|365088910|FG000|Overall Study|Study Terminated by Sponsor|1|||
105844997|NCT02340221|365088911|FG001|Overall Study|Study Terminated by Sponsor|3|||
105844998|NCT00588640|365088912|FG000|Overall Study|Physician Decision|1|||
105844999|NCT00588640|365088912|FG000|Overall Study|Ineligible Patient|1|||
105845000|NCT00103402|365088913|FG000|Overall Study|Adverse Event|3|||
105845001|NCT00103402|365088914|FG001|Overall Study|Adverse Event|4|||
105845002|NCT00103402|365088913|FG000|Overall Study|Lost to Follow-up|8|||
105845003|NCT00103402|365088914|FG001|Overall Study|Lost to Follow-up|7|||
105845004|NCT00103402|365088913|FG000|Overall Study|Dissatisfied/No longer interested|6|||
105845005|NCT00103402|365088914|FG001|Overall Study|Dissatisfied/No longer interested|6|||
105845006|NCT00103402|365088913|FG000|Overall Study|Personal constraints/Other|5|||
105845007|NCT00103402|365088914|FG001|Overall Study|Personal constraints/Other|0|||
105845008|NCT01393730|365088915|FG000|Overall Study|Withdrawal by Subject|3|||
105845009|NCT01393730|365088915|FG000|Overall Study|Other|2|||
105845010|NCT01393730|365088915|FG000|Overall Study|Adverse Event|1|||
105845011|NCT01297322|365088916|FG000|Overall Study|Lost to Follow-up|1|||
105845012|NCT01297322|365088917|FG001|Overall Study|Lost to Follow-up|0|||
105845013|NCT01297322|365088916|FG000|Overall Study|Withdrawal by Subject|0|||
105845014|NCT01297322|365088917|FG001|Overall Study|Withdrawal by Subject|1|||
105845015|NCT01297322|365088916|FG000|Overall Study|Protocol Violation|0|||
105845016|NCT01297322|365088917|FG001|Overall Study|Protocol Violation|3|||
105845017|NCT01111019|365088918|FG000|Overall Study|Withdrew Prematurely|2|||
105845018|NCT01111019|365088918|FG000|Overall Study|Other|1|||
105845019|NCT01583218|365088921|FG000|Overall Study|Withdrawal by Subject|43|||
105845020|NCT01583218|365088922|FG001|Overall Study|Withdrawal by Subject|29|||
105845021|NCT01583218|365088921|FG000|Overall Study|Death|206|||
105845022|NCT01583218|365088922|FG001|Overall Study|Death|211|||
105845023|NCT01583218|365088921|FG000|Overall Study|Lost to Follow-up|11|||
105845024|NCT01583218|365088922|FG001|Overall Study|Lost to Follow-up|17|||
105845025|NCT01583218|365088921|FG000|Overall Study|Adverse event or serious adverse event|3|||
105845026|NCT01583218|365088922|FG001|Overall Study|Adverse event or serious adverse event|3|||
105845027|NCT01583218|365088921|FG000|Overall Study|Patient /Family decision|3|||
105845028|NCT01583218|365088922|FG001|Overall Study|Patient /Family decision|0|||
105845029|NCT01583218|365088921|FG000|Overall Study|Cannot contact patient directly|1|||
105845030|NCT01583218|365088922|FG001|Overall Study|Cannot contact patient directly|2|||
105845031|NCT01583218|365088921|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
105845032|NCT01583218|365088922|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
105845033|NCT01583218|365088921|FG000|Overall Study|Patient did not wish to attend visits|0|||
105845034|NCT01583218|365088922|FG001|Overall Study|Patient did not wish to attend visits|1|||
105845035|NCT01583218|365088921|FG000|Overall Study|Patient randomized but not dosed|17|||
105845036|NCT01583218|365088922|FG001|Overall Study|Patient randomized but not dosed|16|||
105845037|NCT01583218|365088921|FG000|Overall Study|Patient was assessed via phone in person|1|||
105845038|NCT01583218|365088922|FG001|Overall Study|Patient was assessed via phone in person|0|||
105845039|NCT01583218|365088921|FG000|Overall Study|Patient deemed ineligible after random|2|||
105845040|NCT01583218|365088922|FG001|Overall Study|Patient deemed ineligible after random|0|||
105845041|NCT01583218|365088921|FG000|Overall Study|Patient was early terminated from study|0|||
105845042|NCT01583218|365088922|FG001|Overall Study|Patient was early terminated from study|1|||
105845043|NCT01583218|365088921|FG000|Overall Study|Patient was randomized due to mistake|1|||
105845044|NCT01583218|365088922|FG001|Overall Study|Patient was randomized due to mistake|0|||
105845045|NCT01583218|365088921|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
105845046|NCT01583218|365088922|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
105845047|NCT01583218|365088921|FG000|Overall Study|Withdraw of consent on day of random|1|||
105845048|NCT01583218|365088922|FG001|Overall Study|Withdraw of consent on day of random|0|||
105845049|NCT01334710|365088925|FG000|Overall Study|Trial was terminated|3|||
105845050|NCT01902628|365088926|FG000|Overall Study|Withdrawal of participant's consent|7|||
105845051|NCT01902628|365088926|FG000|Overall Study|Adverse Event|41|||
105845052|NCT01902628|365088926|FG000|Overall Study|Lost to Follow-up|35|||
105845053|NCT03861481|365090746|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
105845054|NCT03861481|365090747|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
105845055|NCT03861481|365090746|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
105845056|NCT03861481|365090747|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
105845057|NCT03861481|365090746|FG000|Overall Study|Relapse|1|||
105845058|NCT03861481|365090747|FG001|Overall Study|Relapse|0|||
105845059|NCT03861481|365090746|FG000|Overall Study|Withdrawal by Subject|0|||
105845060|NCT03861481|365090747|FG001|Overall Study|Withdrawal by Subject|1|||
105845061|NCT03861481|365090746|FG000|Overall Study|Lack of Efficacy|4|||
105845062|NCT03861481|365090747|FG001|Overall Study|Lack of Efficacy|5|||
105316327|NCT02952586|363154668|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
105316328|NCT02952586|363154667|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
105316329|NCT02952586|363154668|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
105316330|NCT02952586|363154667|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
105316331|NCT02952586|363154668|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
105316332|NCT02952586|363154667|FG000|CRT for Cisplatin (63 Days)|Death|3|||
105316333|NCT02952586|363154668|FG001|CRT for Cisplatin (63 Days)|Death|8|||
105316334|NCT02952586|363154667|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
105316335|NCT02952586|363154668|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
105316336|NCT02952586|363154667|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
105316337|NCT02952586|363154668|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
105316338|NCT02952586|363154667|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
105316339|NCT02952586|363154668|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
105316340|NCT02952586|363154667|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
105316341|NCT02952586|363154668|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
105316342|NCT02952586|363154667|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
105316343|NCT02952586|363154668|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
105316344|NCT02952586|363154667|FG000|CRT for Cisplatin (63 Days)|Other|1|||
105316345|NCT02952586|363154668|FG001|CRT for Cisplatin (63 Days)|Other|1|||
105316346|NCT02952586|363154667|FG000|CRT for IMRT (63 Days)|Death|5|||
105316347|NCT02952586|363154668|FG001|CRT for IMRT (63 Days)|Death|8|||
105316348|NCT02952586|363154667|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
105316349|NCT02952586|363154668|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
105316350|NCT02952586|363154667|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
105316351|NCT02952586|363154668|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
105316352|NCT02952586|363154667|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
105316353|NCT02952586|363154668|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
105316354|NCT02952586|363154667|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
105316355|NCT02952586|363154668|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
105316356|NCT02952586|363154667|FG000|CRT for IMRT (63 Days)|Other|1|||
105316357|NCT02952586|363154668|FG001|CRT for IMRT (63 Days)|Other|0|||
105316358|NCT02952586|363154667|FG000|Maintenance Phase (12 Months)|Death|17|||
105316359|NCT02952586|363154668|FG001|Maintenance Phase (12 Months)|Death|11|||
105316360|NCT02952586|363154667|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
105316361|NCT02952586|363154668|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
105316362|NCT02952586|363154667|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
105316363|NCT02952586|363154668|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
105316364|NCT02952586|363154667|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
105316365|NCT02952586|363154668|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
105316366|NCT02952586|363154667|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
105316367|NCT02952586|363154668|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
105316368|NCT02952586|363154667|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
105316369|NCT02952586|363154668|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
105368784|NCT00183430|363356282|FG001|Overall Study|Withdrawal by Subject|0|||
105368785|NCT04539275|363356286|FG000|Overall Study|Death|2|||
105368786|NCT04539275|363356287|FG001|Overall Study|Death|4|||
105845063|NCT00773734|365090748|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
105845064|NCT00773734|365090749|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
105845065|NCT00773734|365090750|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
105845066|NCT00773734|365090751|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
105845067|NCT00773734|365090752|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
105845068|NCT00773734|365090753|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
105845069|NCT00773734|365090748|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
105845070|NCT00773734|365090749|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
105845071|NCT00773734|365090750|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
105845072|NCT00773734|365090751|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
105845073|NCT00773734|365090752|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
105845074|NCT00773734|365090753|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
105845075|NCT00773734|365090748|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
105845076|NCT00773734|365090749|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
105845077|NCT00773734|365090750|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
105845078|NCT00773734|365090751|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
105845079|NCT00773734|365090752|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
105845080|NCT00773734|365090753|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
105845081|NCT00773734|365090748|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
105845082|NCT00773734|365090749|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
105845083|NCT00773734|365090750|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
105845084|NCT00773734|365090751|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
105845085|NCT00773734|365090752|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
105845086|NCT00773734|365090753|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
105845087|NCT00773734|365090748|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
105845088|NCT00773734|365090749|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
105845089|NCT00773734|365090750|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
105845090|NCT00773734|365090751|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
105845091|NCT00773734|365090752|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
105845092|NCT00773734|365090753|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
105845093|NCT00773734|365090748|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
105845094|NCT00773734|365090749|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
105845095|NCT00773734|365090750|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
105845096|NCT00773734|365090751|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
105845097|NCT00773734|365090752|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
105845098|NCT00773734|365090753|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
105845099|NCT00773734|365090748|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
105845100|NCT00773734|365090749|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
105845101|NCT00773734|365090750|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
105845102|NCT00773734|365090751|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
105845103|NCT00773734|365090752|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
105845104|NCT00773734|365090753|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
105845105|NCT00773734|365090748|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
105845106|NCT00773734|365090749|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
105845107|NCT00773734|365090750|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
105845108|NCT00773734|365090751|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
105845109|NCT00773734|365090752|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
105845110|NCT00773734|365090753|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
105845111|NCT00773734|365090748|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
105845112|NCT00773734|365090749|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
105845113|NCT00773734|365090750|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
105845114|NCT00773734|365090751|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
105845115|NCT00773734|365090752|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
105845116|NCT00773734|365090753|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
105845117|NCT00773734|365090748|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
105845118|NCT00773734|365090749|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
105845119|NCT00773734|365090750|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
105845120|NCT00773734|365090751|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
105845121|NCT00773734|365090752|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
105845122|NCT00773734|365090753|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
105845123|NCT00773734|365090748|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
105845124|NCT00773734|365090749|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
105845125|NCT00773734|365090750|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
105845126|NCT00773734|365090751|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
105845127|NCT00773734|365090752|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
105845128|NCT00773734|365090753|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
105845129|NCT00773734|365090748|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
105845130|NCT00773734|365090749|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
105845131|NCT00773734|365090750|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
105845132|NCT00773734|365090751|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
105845133|NCT00773734|365090752|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
105845134|NCT00773734|365090753|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
105845135|NCT00773734|365090748|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
105845136|NCT00773734|365090749|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
105845137|NCT00773734|365090750|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
105316370|NCT02952586|363154667|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
105316371|NCT02952586|363154668|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
105316372|NCT02952586|363154667|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
105316373|NCT02952586|363154668|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
105316374|NCT02952586|363154667|FG000|Maintenance Phase (12 Months)|Other|2|||
105316375|NCT02952586|363154668|FG001|Maintenance Phase (12 Months)|Other|1|||
105316376|NCT02952586|363154667|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
105316377|NCT02952586|363154668|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
105316378|NCT02952586|363154667|FG000|Follow-Up Phase (90 Days)|Death|12|||
105316379|NCT02952586|363154668|FG001|Follow-Up Phase (90 Days)|Death|10|||
105316380|NCT02952586|363154667|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
105316381|NCT02952586|363154668|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
105316382|NCT02952586|363154667|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
105316383|NCT02952586|363154668|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
105316384|NCT02952586|363154667|FG000|Follow-Up Phase (90 Days)|Other|7|||
105316385|NCT02952586|363154668|FG001|Follow-Up Phase (90 Days)|Other|5|||
105316386|NCT02952586|363154667|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
105316387|NCT02952586|363154668|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
105316388|NCT02952586|363154667|FG000|LT Follow-up (up to 45 Months)|Death|51|||
105316389|NCT02952586|363154668|FG001|LT Follow-up (up to 45 Months)|Death|31|||
105316390|NCT02952586|363154667|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
105316391|NCT02952586|363154668|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
105316392|NCT02952586|363154667|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
105316393|NCT02952586|363154668|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
105316394|NCT02952586|363154667|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
105316395|NCT02952586|363154668|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
105316396|NCT02640690|363154669|FG000|Overall Study|Lost to Follow-up|7|||
105316397|NCT02640690|363154670|FG001|Overall Study|Lost to Follow-up|7|||
105316398|NCT02640690|363154669|FG000|Overall Study|Withdrawal by Subject|16|||
105845138|NCT00773734|365090751|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
105845139|NCT00773734|365090752|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
105845140|NCT00773734|365090753|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
105845141|NCT00773734|365090748|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
105845142|NCT00773734|365090749|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
105845143|NCT00773734|365090750|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
105845144|NCT00773734|365090751|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
105845145|NCT00773734|365090752|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
105845146|NCT00773734|365090753|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
105845147|NCT00773734|365090748|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
105845148|NCT00773734|365090749|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
105845149|NCT00773734|365090750|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
105845150|NCT00773734|365090751|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
105845151|NCT00773734|365090752|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
105845152|NCT00773734|365090753|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
105845153|NCT00773734|365090748|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
105845154|NCT00773734|365090749|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
105845155|NCT00773734|365090750|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
105845156|NCT00773734|365090751|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
105845157|NCT00773734|365090752|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
105845158|NCT00773734|365090753|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
105845159|NCT00773734|365090748|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
105845160|NCT00773734|365090749|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
105845161|NCT00773734|365090750|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
105845162|NCT00773734|365090751|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
105845163|NCT00773734|365090752|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
105845164|NCT00773734|365090753|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
105845165|NCT00773734|365090748|FG000|Extension: Active Treatment Week 24-52|Other|0|||
105845166|NCT00773734|365090749|FG001|Extension: Active Treatment Week 24-52|Other|0|||
105845167|NCT00773734|365090750|FG002|Extension: Active Treatment Week 24-52|Other|1|||
105845168|NCT00773734|365090751|FG003|Extension: Active Treatment Week 24-52|Other|2|||
105845169|NCT00773734|365090752|FG004|Extension: Active Treatment Week 24-52|Other|0|||
105845170|NCT00773734|365090753|FG005|Extension: Active Treatment Week 24-52|Other|1|||
105845171|NCT00773734|365090748|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
105845172|NCT00773734|365090749|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
105845173|NCT00773734|365090750|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
105845174|NCT00773734|365090751|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
105845175|NCT00773734|365090752|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
105316399|NCT02640690|363154670|FG001|Overall Study|Withdrawal by Subject|20|||
105845176|NCT00773734|365090753|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
105845177|NCT00773734|365090748|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
105845178|NCT00773734|365090749|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
105845179|NCT00773734|365090750|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
105845180|NCT00773734|365090751|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
105845181|NCT00773734|365090752|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
105845182|NCT00773734|365090753|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
105845183|NCT00773734|365090748|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
105845184|NCT00773734|365090749|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
105845185|NCT00773734|365090750|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
105845186|NCT00773734|365090751|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
105845187|NCT00773734|365090752|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
105845188|NCT00773734|365090753|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
105845189|NCT00773734|365090748|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
105845190|NCT00773734|365090749|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
105845191|NCT00773734|365090750|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
105845192|NCT00773734|365090751|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
105845193|NCT00773734|365090752|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
105845194|NCT00773734|365090753|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
105845195|NCT02054130|365090754|FG000|Overall Study|Withdrawal by Subject|4|||
105845196|NCT02054130|365090755|FG001|Overall Study|Withdrawal by Subject|4|||
105845197|NCT02054130|365090756|FG002|Overall Study|Withdrawal by Subject|7|||
105845198|NCT02054130|365090757|FG003|Overall Study|Withdrawal by Subject|10|||
105845199|NCT02054130|365090754|FG000|Overall Study|Death|0|||
105845200|NCT02054130|365090755|FG001|Overall Study|Death|1|||
105845201|NCT02054130|365090756|FG002|Overall Study|Death|0|||
105845202|NCT02054130|365090757|FG003|Overall Study|Death|0|||
105845203|NCT02054130|365090754|FG000|Overall Study|Lost to Follow-up|0|||
105845204|NCT02054130|365090755|FG001|Overall Study|Lost to Follow-up|0|||
105845205|NCT02054130|365090756|FG002|Overall Study|Lost to Follow-up|1|||
105845206|NCT02054130|365090757|FG003|Overall Study|Lost to Follow-up|2|||
105845207|NCT02054130|365090754|FG000|Overall Study|Missed dose|4|||
105845208|NCT02054130|365090755|FG001|Overall Study|Missed dose|6|||
105845209|NCT02054130|365090756|FG002|Overall Study|Missed dose|7|||
105845210|NCT02054130|365090757|FG003|Overall Study|Missed dose|10|||
105845211|NCT01304693|365090760|FG000|Overall Study|Adverse Event|0|||
105845212|NCT01304693|365090761|FG001|Overall Study|Adverse Event|0|||
105316400|NCT02640690|363154669|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
105845213|NCT01304693|365090762|FG002|Overall Study|Adverse Event|0|||
105845214|NCT01304693|365090763|FG003|Overall Study|Adverse Event|0|||
105845215|NCT01304693|365090764|FG004|Overall Study|Adverse Event|1|||
105845216|NCT01304693|365090760|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
105845217|NCT01304693|365090761|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
105845218|NCT01304693|365090762|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
105845219|NCT01304693|365090763|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
105316401|NCT02640690|363154670|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
105316402|NCT00196326|363154678|FG000|Overall Study|Did not meet protocol requirements|64|||
105316403|NCT00196326|363154678|FG000|Overall Study|Non-compliance with the protocol|81|||
105316404|NCT00196326|363154678|FG000|Overall Study|Physician Decision|3|||
105368787|NCT04539275|363356286|FG000|Overall Study|Lost to Follow-up|1|||
105368788|NCT04539275|363356287|FG001|Overall Study|Lost to Follow-up|1|||
105368789|NCT04539275|363356286|FG000|Overall Study|Withdrawal by Subject|3|||
105845220|NCT01304693|365090764|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
105845221|NCT02581163|365090776|FG000|Overall Study|Failure to return|15|||
105368790|NCT04539275|363356287|FG001|Overall Study|Withdrawal by Subject|0|||
105845222|NCT02581163|365090776|FG000|Overall Study|Insufficient virological response|3|||
105316405|NCT00196326|363154678|FG000|Overall Study|Withdrawal by Subject|225|||
105316406|NCT00196326|363154678|FG000|Overall Study|Adverse Event|253|||
105316407|NCT00196326|363154678|FG000|Overall Study|Pregnancy|34|||
105316408|NCT00196326|363154678|FG000|Overall Study|Lost to Follow-up|304|||
105316409|NCT00196326|363154678|FG000|Overall Study|Other|22|||
105316410|NCT00741338|363154679|FG000|Overall Study|Adverse Event|0|||
105316411|NCT00741338|363154680|FG001|Overall Study|Adverse Event|1|||
105316412|NCT03593395|363154681|FG000|Overall Study|Lost to Follow-up|48|||
105316413|NCT03593395|363154682|FG001|Overall Study|Lost to Follow-up|3|||
105845223|NCT02581163|365090776|FG000|Overall Study|Withdrew consent|1|||
105845224|NCT02581163|365090776|FG000|Overall Study|Death|1|||
105368791|NCT02466399|363356288|FG000|Overall Study|Adverse Event|1|||
105845225|NCT02581163|365090776|FG000|Overall Study|Other, not specified|9|||
105845226|NCT03438396|365090777|FG000|Overall Study|Reason Not Specified|9|||
105845227|NCT03438396|365090777|FG000|Overall Study|Withdrawal by Subject|5|||
105368792|NCT02466399|363356289|FG001|Overall Study|Adverse Event|0|||
105368793|NCT02466399|363356288|FG000|Overall Study|Early exit due to family emergency|1|||
105845228|NCT03438396|365090777|FG000|Overall Study|Lost to Follow-up|2|||
105845229|NCT03438396|365090777|FG000|Overall Study|Death|85|||
105845230|NCT03438396|365090777|FG000|Overall Study|Not treated|1|||
105316414|NCT03593395|363154681|FG000|Overall Study|Withdrawal by Subject|5|||
105316415|NCT03593395|363154682|FG001|Overall Study|Withdrawal by Subject|24|||
105316416|NCT03593395|363154681|FG000|Overall Study|Death|2|||
105316417|NCT03593395|363154682|FG001|Overall Study|Death|3|||
105316418|NCT03593395|363154681|FG000|Overall Study|Physician Decision|0|||
105316419|NCT03593395|363154682|FG001|Overall Study|Physician Decision|6|||
105316420|NCT03593395|363154681|FG000|Overall Study|Participant Relocated|19|||
105316421|NCT03593395|363154682|FG001|Overall Study|Participant Relocated|3|||
105316422|NCT03593395|363154681|FG000|Overall Study|No Information|1|||
105316423|NCT03593395|363154682|FG001|Overall Study|No Information|7|||
105490262|NCT02537574|363807500|FG002|Overall Study|Noncompliance with Protocol|1|||
105490263|NCT02663687|363807501|FG000|Overall Study|Adverse Event|1|||
105490264|NCT02663687|363807502|FG001|Overall Study|Adverse Event|0|||
105490265|NCT02663687|363807503|FG002|Overall Study|Adverse Event|0|||
105490266|NCT02663687|363807504|FG003|Overall Study|Adverse Event|0|||
105490267|NCT02663687|363807505|FG004|Overall Study|Adverse Event|0|||
105490268|NCT02663687|363807501|FG000|Overall Study|Other|1|||
105490269|NCT02663687|363807502|FG001|Overall Study|Other|0|||
105490270|NCT02663687|363807503|FG002|Overall Study|Other|1|||
105490271|NCT02663687|363807504|FG003|Overall Study|Other|0|||
105490272|NCT02663687|363807505|FG004|Overall Study|Other|0|||
105490273|NCT03880461|363807511|FG000|Overall Study|Determined ineligible after enrollment|45|||
105490274|NCT03880461|363807512|FG001|Overall Study|Determined ineligible after enrollment|44|||
105490275|NCT03880461|363807511|FG000|Overall Study|No weight measurement after enrollment|24|||
105490276|NCT03880461|363807512|FG001|Overall Study|No weight measurement after enrollment|17|||
105490277|NCT01822678|363807515|FG000|Overall Study|Withdrawal by Subject|5|||
105490278|NCT01822678|363807516|FG001|Overall Study|Withdrawal by Subject|4|||
105490279|NCT01822678|363807517|FG002|Overall Study|Withdrawal by Subject|4|||
105490280|NCT01822678|363807515|FG000|Overall Study|Adverse Event|4|||
105845231|NCT01388166|365090778|FG000|Overall Study|Adverse Event|16|||
105845232|NCT01388166|365090778|FG000|Overall Study|Lost to Follow-up|30|||
105845233|NCT01388166|365090778|FG000|Overall Study|Others than specified above|13|||
105845234|NCT01744093|365090782|FG000|Overall Study|Withdrawal by Subject|6|||
105845235|NCT01744093|365090783|FG001|Overall Study|Withdrawal by Subject|1|||
105845236|NCT02751359|365090788|FG000|Overall Study|Lost to Follow-up|1|||
105316424|NCT03713632|363154683|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
105316425|NCT03713632|363154684|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
105490281|NCT01822678|363807516|FG001|Overall Study|Adverse Event|3|||
105490282|NCT01822678|363807517|FG002|Overall Study|Adverse Event|1|||
105490283|NCT01822678|363807515|FG000|Overall Study|Lack of Efficacy|3|||
105845237|NCT00103311|365090789|FG000|Overall Study|Lost to Follow-up|1|||
105845238|NCT00103311|365090790|FG001|Overall Study|Lost to Follow-up|0|||
105845239|NCT00103311|365090789|FG000|Overall Study|Withdrawal by Subject|2|||
105845240|NCT00103311|365090790|FG001|Overall Study|Withdrawal by Subject|1|||
105845241|NCT00103311|365090789|FG000|Overall Study|Adverse Event|1|||
105845242|NCT00103311|365090790|FG001|Overall Study|Adverse Event|0|||
105845243|NCT02400671|365090791|FG000|Overall Study|Death|5|||
105845244|NCT02400671|365090792|FG001|Overall Study|Death|3|||
105845245|NCT02400671|365090793|FG002|Overall Study|Death|4|||
105845246|NCT02400671|365090791|FG000|Overall Study|Lost to Follow-up|20|||
105845247|NCT02400671|365090792|FG001|Overall Study|Lost to Follow-up|27|||
105845248|NCT02400671|365090793|FG002|Overall Study|Lost to Follow-up|24|||
105845249|NCT02400671|365090791|FG000|Overall Study|Withdrawal by Subject|2|||
105845250|NCT02400671|365090792|FG001|Overall Study|Withdrawal by Subject|2|||
105845251|NCT02400671|365090793|FG002|Overall Study|Withdrawal by Subject|0|||
105845252|NCT00158756|365090794|FG000|Overall Study|Withdrawal by Subject|5|||
105845253|NCT00158756|365090795|FG001|Overall Study|Withdrawal by Subject|0|||
105845254|NCT00158756|365090796|FG002|Overall Study|Withdrawal by Subject|6|||
105845255|NCT00158756|365090797|FG003|Overall Study|Withdrawal by Subject|1|||
105845256|NCT00158756|365090798|FG004|Overall Study|Withdrawal by Subject|3|||
105845257|NCT00158756|365090794|FG000|Overall Study|Adverse Event|0|||
105845258|NCT00158756|365090795|FG001|Overall Study|Adverse Event|0|||
105845259|NCT00158756|365090796|FG002|Overall Study|Adverse Event|1|||
105845260|NCT00158756|365090797|FG003|Overall Study|Adverse Event|0|||
105845261|NCT00158756|365090798|FG004|Overall Study|Adverse Event|0|||
105845262|NCT00158756|365090794|FG000|Overall Study|Serious adverse event|0|||
105845263|NCT00158756|365090795|FG001|Overall Study|Serious adverse event|0|||
105845264|NCT00158756|365090796|FG002|Overall Study|Serious adverse event|1|||
105845265|NCT00158756|365090797|FG003|Overall Study|Serious adverse event|0|||
105845266|NCT00158756|365090798|FG004|Overall Study|Serious adverse event|0|||
105845267|NCT00262041|365090799|FG000|Overall Study|Withdrawal by Subject|0|||
105845268|NCT00262041|365090800|FG001|Overall Study|Withdrawal by Subject|3|||
105845269|NCT00262041|365090801|FG002|Overall Study|Withdrawal by Subject|1|||
105490284|NCT01822678|363807516|FG001|Overall Study|Lack of Efficacy|6|||
105845270|NCT00262041|365090799|FG000|Overall Study|Lost to Follow-up|1|||
105845271|NCT00262041|365090800|FG001|Overall Study|Lost to Follow-up|1|||
105845272|NCT00262041|365090801|FG002|Overall Study|Lost to Follow-up|5|||
105845273|NCT00262041|365090799|FG000|Overall Study|Unable to classify|1|||
105845274|NCT00262041|365090800|FG001|Overall Study|Unable to classify|0|||
105845275|NCT00262041|365090801|FG002|Overall Study|Unable to classify|0|||
105845276|NCT02488330|365090804|FG000|Overall Study|Adverse Event|1|||
105845277|NCT02488330|365090804|FG000|Overall Study|Physician Decision|2|||
105845278|NCT02488330|365090804|FG000|Overall Study|Death|2|||
105845279|NCT02488330|365090804|FG000|Overall Study|Disease Progression|3|||
105845280|NCT02488330|365090804|FG000|Overall Study|Study Termination by Sponsor|4|||
105845281|NCT03052322|365090805|FG000|Overall Study|Other un-specified|1|||
105845282|NCT03052322|365090806|FG001|Overall Study|Other un-specified|2|||
105845283|NCT03052322|365090805|FG000|Overall Study|Withdrawal by Subject|10|||
105845284|NCT03052322|365090806|FG001|Overall Study|Withdrawal by Subject|9|||
105845285|NCT03052322|365090805|FG000|Overall Study|Death|0|||
105845286|NCT03052322|365090806|FG001|Overall Study|Death|2|||
105845287|NCT03052322|365090805|FG000|Overall Study|Lack of Efficacy|1|||
105845288|NCT03052322|365090806|FG001|Overall Study|Lack of Efficacy|2|||
105845289|NCT03052322|365090805|FG000|Overall Study|Protocol Violation|1|||
105845290|NCT03052322|365090806|FG001|Overall Study|Protocol Violation|0|||
105845291|NCT03052322|365090805|FG000|Overall Study|Lost to Follow-up|2|||
105845292|NCT03052322|365090806|FG001|Overall Study|Lost to Follow-up|4|||
105845293|NCT03052322|365090805|FG000|Overall Study|Adverse Event|6|||
105845294|NCT03052322|365090806|FG001|Overall Study|Adverse Event|13|||
105845295|NCT02493777|365090807|FG000|Overall Study|Lost to Follow-up|0|||
105845296|NCT02493777|365090808|FG001|Overall Study|Lost to Follow-up|1|||
105845297|NCT02370914|365090815|FG000|Overall Study|Protocol Violation|2|||
105845298|NCT03212794|365090816|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
105845299|NCT03212794|365090817|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
105845300|NCT03212794|365090816|FG000|Overall Study|Lost to Follow-up|5|||
105845301|NCT03212794|365090817|FG001|Overall Study|Lost to Follow-up|6|||
105845302|NCT03212794|365090816|FG000|Overall Study|Incarcerated; unable to participate|2|||
105845303|NCT03212794|365090817|FG001|Overall Study|Incarcerated; unable to participate|0|||
105845304|NCT03212794|365090816|FG000|Overall Study|Withdrawal by Subject|1|||
105845305|NCT03212794|365090817|FG001|Overall Study|Withdrawal by Subject|0|||
105845306|NCT03212794|365090816|FG000|Overall Study|Death|0|||
105845307|NCT03212794|365090817|FG001|Overall Study|Death|1|||
105845308|NCT03212794|365090816|FG000|Overall Study|Found to be ineligible after allocation|0|||
105845309|NCT03212794|365090817|FG001|Overall Study|Found to be ineligible after allocation|1|||
105845310|NCT03212794|365090816|FG000|Overall Study|Relocated out of area|2|||
105845311|NCT03212794|365090817|FG001|Overall Study|Relocated out of area|0|||
105845312|NCT01370213|365090818|FG000|Overall Study|Early Death|1|||
105845313|NCT01370213|365090819|FG001|Overall Study|Early Death|0|||
105845314|NCT01370213|365090820|FG002|Overall Study|Early Death|0|||
105845315|NCT01370213|365090818|FG000|Overall Study|Not evaluable|0|||
105845316|NCT01370213|365090819|FG001|Overall Study|Not evaluable|2|||
105845317|NCT01370213|365090820|FG002|Overall Study|Not evaluable|0|||
105845318|NCT02470091|365090822|FG000|Overall Study|Withdrawal by Subject|1|||
105845319|NCT02470091|365090823|FG001|Overall Study|Withdrawal by Subject|0|||
105845320|NCT02470091|365090822|FG000|Overall Study|Ineligible|0|||
105845321|NCT02470091|365090823|FG001|Overall Study|Ineligible|2|||
105845322|NCT00606502|365090824|FG000|Randomization|Randomized but not treated|3|||
105845323|NCT00606502|365090825|FG001|Randomization|Randomized but not treated|0|||
105845324|NCT00606502|365090824|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
105845325|NCT00606502|365090825|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
105845326|NCT01470612|365090829|FG000|Overall Study|Adverse Event|20|||
105845327|NCT01470612|365090830|FG001|Overall Study|Adverse Event|80|||
105845328|NCT01470612|365090829|FG000|Overall Study|Death|0|||
105845329|NCT01470612|365090830|FG001|Overall Study|Death|1|||
105845330|NCT01470612|365090829|FG000|Overall Study|Lack of Efficacy|20|||
105845331|NCT01470612|365090830|FG001|Overall Study|Lack of Efficacy|326|||
105845332|NCT01470612|365090829|FG000|Overall Study|Lost to Follow-up|2|||
105845333|NCT01470612|365090830|FG001|Overall Study|Lost to Follow-up|5|||
105845334|NCT01470612|365090829|FG000|Overall Study|Did not meet entrance criteria|0|||
105845335|NCT01470612|365090830|FG001|Overall Study|Did not meet entrance criteria|1|||
105316426|NCT03713632|363154685|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
105845336|NCT01470612|365090829|FG000|Overall Study|Pregnancy|2|||
105845337|NCT01470612|365090830|FG001|Overall Study|Pregnancy|10|||
105845338|NCT01470612|365090829|FG000|Overall Study|Protocol Violation|2|||
105845339|NCT01470612|365090830|FG001|Overall Study|Protocol Violation|7|||
105845340|NCT01470612|365090829|FG000|Overall Study|Withdrawal by Subject|24|||
105845341|NCT01470612|365090830|FG001|Overall Study|Withdrawal by Subject|79|||
105845342|NCT01470612|365090829|FG000|Overall Study|Other|14|||
105845343|NCT01470612|365090830|FG001|Overall Study|Other|156|||
105490285|NCT01822678|363807517|FG002|Overall Study|Lack of Efficacy|5|||
105845344|NCT02595008|365090838|FG000|Overall Study|Enrolled In Error|1|||
105845345|NCT02595008|365090839|FG001|Overall Study|Enrolled In Error|0|||
105845346|NCT00384176|365090845|FG000|Overall Study|Death|239|||
105845347|NCT00384176|365090846|FG001|Overall Study|Death|247|||
105845348|NCT00384176|365090847|FG002|Overall Study|Death|105|||
105845349|NCT00384176|365090845|FG000|Overall Study|Withdrawal by Subject|52|||
105845350|NCT00384176|365090846|FG001|Overall Study|Withdrawal by Subject|48|||
105845351|NCT00384176|365090847|FG002|Overall Study|Withdrawal by Subject|22|||
105845352|NCT00384176|365090845|FG000|Overall Study|Lost to Follow-up|16|||
105845353|NCT00384176|365090846|FG001|Overall Study|Lost to Follow-up|18|||
105316427|NCT03713632|363154686|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
105316428|NCT03713632|363154687|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
105316429|NCT03713632|363154683|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
105316430|NCT03713632|363154684|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
105316431|NCT03713632|363154685|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
105316432|NCT03713632|363154686|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
105316433|NCT03713632|363154687|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
105316434|NCT03713632|363154683|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
105316435|NCT03713632|363154684|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
105490286|NCT01822678|363807515|FG000|Overall Study|Lost to Follow-up|0|||
105490287|NCT01822678|363807516|FG001|Overall Study|Lost to Follow-up|2|||
105490288|NCT01822678|363807517|FG002|Overall Study|Lost to Follow-up|1|||
105490289|NCT00764504|363807518|FG000|Overall Study|Death|12|||
105316436|NCT03713632|363154685|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
105316437|NCT03713632|363154686|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
105316438|NCT03713632|363154687|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
105316439|NCT03713632|363154683|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
105490290|NCT00764504|363807519|FG001|Overall Study|Death|6|||
105490291|NCT00764504|363807520|FG002|Overall Study|Death|13|||
105490292|NCT00764504|363807518|FG000|Overall Study|Revision of Device|12|||
105490293|NCT00764504|363807519|FG001|Overall Study|Revision of Device|23|||
105845354|NCT00384176|365090847|FG002|Overall Study|Lost to Follow-up|4|||
105845355|NCT00384176|365090845|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
105845356|NCT00384176|365090846|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
105845357|NCT00384176|365090847|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
105845358|NCT00384176|365090845|FG000|Overall Study|Longer QTC as Visit 1|1|||
105845359|NCT00384176|365090846|FG001|Overall Study|Longer QTC as Visit 1|0|||
105845360|NCT00384176|365090847|FG002|Overall Study|Longer QTC as Visit 1|0|||
105845361|NCT00384176|365090845|FG000|Overall Study|Toxicity of treatment|1|||
105845362|NCT00384176|365090846|FG001|Overall Study|Toxicity of treatment|0|||
105845363|NCT00384176|365090847|FG002|Overall Study|Toxicity of treatment|0|||
105845364|NCT00384176|365090845|FG000|Overall Study|Did not receive study treatment|0|||
105845365|NCT00384176|365090846|FG001|Overall Study|Did not receive study treatment|1|||
105845366|NCT00384176|365090847|FG002|Overall Study|Did not receive study treatment|1|||
105845367|NCT00384176|365090845|FG000|Overall Study|Physician Decision|0|||
105845368|NCT00384176|365090846|FG001|Overall Study|Physician Decision|2|||
105845369|NCT00384176|365090847|FG002|Overall Study|Physician Decision|0|||
105845370|NCT00384176|365090845|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
105845371|NCT00384176|365090846|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
105845372|NCT00384176|365090847|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
105845373|NCT03078582|365090848|FG000|Overall Study|Adverse Event|0|||
105845374|NCT03078582|365090849|FG001|Overall Study|Adverse Event|8|||
105845375|NCT02458092|365090850|FG000|Overall Study|Withdrawal by Subject|1|||
105845376|NCT02458092|365090851|FG001|Overall Study|Withdrawal by Subject|0|||
105845377|NCT01843348|365090852|FG000|Overall Study|Withdrawal by Subject|4|||
105845378|NCT01843348|365090853|FG001|Overall Study|Withdrawal by Subject|16|||
105845379|NCT01843348|365090854|FG002|Overall Study|Withdrawal by Subject|18|||
105845380|NCT01843348|365090852|FG000|Overall Study|Lost to Follow-up|5|||
105845381|NCT01843348|365090853|FG001|Overall Study|Lost to Follow-up|4|||
105845382|NCT01843348|365090854|FG002|Overall Study|Lost to Follow-up|2|||
105845383|NCT01843348|365090852|FG000|Overall Study|Death|5|||
105845384|NCT01843348|365090853|FG001|Overall Study|Death|3|||
105845385|NCT01843348|365090854|FG002|Overall Study|Death|4|||
105845386|NCT01843348|365090852|FG000|Overall Study|Graft loss/retransplantation|5|||
105845387|NCT01843348|365090853|FG001|Overall Study|Graft loss/retransplantation|8|||
105845388|NCT01843348|365090854|FG002|Overall Study|Graft loss/retransplantation|11|||
105845389|NCT01843348|365090852|FG000|Overall Study|Various reasons|4|||
105845390|NCT01843348|365090853|FG001|Overall Study|Various reasons|9|||
105845391|NCT01843348|365090854|FG002|Overall Study|Various reasons|6|||
105845392|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
105845393|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
105490294|NCT00764504|363807520|FG002|Overall Study|Revision of Device|14|||
105490295|NCT00764504|363807518|FG000|Overall Study|Physician Decision|1|||
105845394|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
105845395|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
105845396|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
105845397|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
105845398|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
105845399|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
105845400|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
105316440|NCT03713632|363154684|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
105316441|NCT03713632|363154685|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
105316442|NCT03713632|363154686|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
105316443|NCT03713632|363154687|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
105316444|NCT03713632|363154683|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
105316445|NCT03713632|363154684|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
105316446|NCT03713632|363154685|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
105316447|NCT03713632|363154686|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
105316448|NCT03713632|363154687|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
105316449|NCT03713632|363154683|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
105316450|NCT03713632|363154684|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
105316451|NCT03713632|363154685|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
105316452|NCT03713632|363154686|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
105316453|NCT03713632|363154687|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
105316454|NCT03713632|363154683|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
105316455|NCT03713632|363154684|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
105316456|NCT03713632|363154685|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
105316457|NCT03713632|363154686|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
105316458|NCT03713632|363154687|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
105316459|NCT03713632|363154683|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
105316460|NCT03713632|363154684|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
105316461|NCT03713632|363154685|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
105316462|NCT03713632|363154686|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
105316463|NCT03713632|363154687|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
105316464|NCT03713632|363154683|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
105316465|NCT03713632|363154684|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
105316466|NCT03713632|363154685|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
105316467|NCT03713632|363154686|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
105316468|NCT03713632|363154687|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
105316469|NCT03713632|363154683|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
105316470|NCT03713632|363154684|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
105316471|NCT03713632|363154685|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
105316472|NCT03713632|363154686|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
105316473|NCT03713632|363154687|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
105316474|NCT03713632|363154683|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
105316475|NCT03713632|363154684|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
105316476|NCT03713632|363154685|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
105316477|NCT03713632|363154686|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
105316478|NCT03713632|363154687|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
105316479|NCT03713632|363154683|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
105316480|NCT03713632|363154684|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
105316481|NCT03713632|363154685|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
105316482|NCT03713632|363154686|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
105316483|NCT03713632|363154687|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
105316484|NCT03713632|363154683|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
105316485|NCT03713632|363154684|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
105316486|NCT03713632|363154685|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
105316487|NCT03713632|363154686|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
105316488|NCT03713632|363154687|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
105316489|NCT03713632|363154683|FG000|Treatment Period 2 (After Week 16)|Death|0|||
105316490|NCT03713632|363154684|FG001|Treatment Period 2 (After Week 16)|Death|1|||
105316491|NCT03713632|363154685|FG002|Treatment Period 2 (After Week 16)|Death|0|||
105316492|NCT03713632|363154686|FG003|Treatment Period 2 (After Week 16)|Death|0|||
105316493|NCT03713632|363154687|FG004|Treatment Period 2 (After Week 16)|Death|0|||
105316494|NCT03713632|363154683|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
105316495|NCT03713632|363154684|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
105316496|NCT03713632|363154685|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
105316497|NCT03713632|363154686|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
105316498|NCT03713632|363154687|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
105316499|NCT02685735|363154700|FG000|Overall Study|Missing construct or pain data|23|||
105316500|NCT02685735|363154701|FG001|Overall Study|Missing construct or pain data|22|||
105316501|NCT02165735|363154702|FG000|Overall Study|Lost to Follow-up|12|||
105316502|NCT02165735|363154703|FG001|Overall Study|Lost to Follow-up|10|||
105316503|NCT02165735|363154702|FG000|Overall Study|Withdrawal by Subject|3|||
105316504|NCT02165735|363154703|FG001|Overall Study|Withdrawal by Subject|0|||
105316505|NCT02165735|363154702|FG000|Overall Study|Participant indicated lack of time|1|||
105316506|NCT02165735|363154703|FG001|Overall Study|Participant indicated lack of time|3|||
105316507|NCT02165735|363154702|FG000|Overall Study|Protocol Violation|0|||
105845401|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
105845402|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
105845403|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
105845404|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
105845405|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
105845406|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
105845407|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
105845408|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
105845409|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
105845410|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
105845411|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
105845412|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
105845413|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
105845414|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
105845415|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
105845416|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
105845417|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
105845418|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
105845419|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
105845420|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
105845421|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
105845422|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
105845423|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
105845424|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
105845425|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
105845426|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
105845427|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
105845428|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
105845429|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
105845430|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
105845431|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
105845432|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
105845433|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
105845434|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
105845435|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
105845436|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
105845437|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
105845438|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
105845439|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
105845440|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
105845441|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
105845442|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
105845443|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
105845444|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
105845445|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
105845446|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
105316508|NCT02165735|363154703|FG001|Overall Study|Protocol Violation|1|||
105316509|NCT02540083|363154704|FG000|Overall Study|Withdrawal by Subject|16|||
105316510|NCT03348163|363154708|FG000|Overall Study|Withdrawal by Subject|2|||
105316511|NCT03348163|363154709|FG001|Overall Study|Withdrawal by Subject|0|||
105316512|NCT02756208|363154711|FG000|Overall Study|Withdrawal by Subject|1|||
105316513|NCT02756208|363154712|FG001|Overall Study|Withdrawal by Subject|0|||
105316514|NCT02756208|363154713|FG002|Overall Study|Withdrawal by Subject|1|||
105316515|NCT02756208|363154714|FG003|Overall Study|Withdrawal by Subject|3|||
105316516|NCT02756208|363154711|FG000|Overall Study|Lost to Follow-up|3|||
105316517|NCT02756208|363154712|FG001|Overall Study|Lost to Follow-up|1|||
105316518|NCT02756208|363154713|FG002|Overall Study|Lost to Follow-up|1|||
105316519|NCT02756208|363154714|FG003|Overall Study|Lost to Follow-up|1|||
105316520|NCT02756208|363154711|FG000|Overall Study|Physician Decision|1|||
105316521|NCT02756208|363154712|FG001|Overall Study|Physician Decision|0|||
105316522|NCT02756208|363154713|FG002|Overall Study|Physician Decision|0|||
105316523|NCT02756208|363154714|FG003|Overall Study|Physician Decision|0|||
105316524|NCT02756208|363154711|FG000|Overall Study|Protocol Violation|0|||
105316525|NCT02756208|363154712|FG001|Overall Study|Protocol Violation|1|||
105316526|NCT02756208|363154713|FG002|Overall Study|Protocol Violation|0|||
105316527|NCT02756208|363154714|FG003|Overall Study|Protocol Violation|0|||
105316528|NCT01569295|363154720|FG000|Overall Study|Progressive Disease|75|||
105316529|NCT01569295|363154721|FG001|Overall Study|Progressive Disease|139|||
105845447|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
105845448|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
105845449|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
105845450|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
105845451|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
105845452|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
105845453|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
105845454|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
105845455|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
105845456|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
105845457|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
105845458|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
105316530|NCT01569295|363154720|FG000|Overall Study|Adverse Event|39|||
105316531|NCT01569295|363154721|FG001|Overall Study|Adverse Event|14|||
105316532|NCT01569295|363154720|FG000|Overall Study|Withdrawal by Subject|25|||
105316533|NCT01569295|363154721|FG001|Overall Study|Withdrawal by Subject|12|||
105316534|NCT01569295|363154720|FG000|Overall Study|Death|19|||
105316535|NCT01569295|363154721|FG001|Overall Study|Death|15|||
105316536|NCT01569295|363154720|FG000|Overall Study|Physician Decision|13|||
105316537|NCT01569295|363154721|FG001|Overall Study|Physician Decision|18|||
105316538|NCT01569295|363154720|FG000|Overall Study|Study Terminated by Sponsor|24|||
105316539|NCT01569295|363154721|FG001|Overall Study|Study Terminated by Sponsor|2|||
105316540|NCT01569295|363154720|FG000|Overall Study|Other Reason not Specified|3|||
105316541|NCT01569295|363154721|FG001|Overall Study|Other Reason not Specified|5|||
105316542|NCT01569295|363154720|FG000|Overall Study|Non-Compliance with Study Drug|6|||
105316543|NCT01569295|363154721|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105316544|NCT01569295|363154720|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
105316545|NCT01569295|363154721|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
105316546|NCT01569295|363154720|FG000|Overall Study|Lost to Follow-up|1|||
105316547|NCT01569295|363154721|FG001|Overall Study|Lost to Follow-up|1|||
105316548|NCT01038297|363154724|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
105316549|NCT01038297|363154725|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
105316550|NCT01038297|363154726|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
105316551|NCT01973595|363154727|FG000|Washout|Withdrawal by Subject|1|||
105316552|NCT01973595|363154728|FG001|Washout|Withdrawal by Subject|0|||
105845459|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
105845460|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
105845461|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
105845462|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
105845463|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
105845464|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
105845465|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
105845466|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
105845467|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
105845468|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
105845469|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
105845470|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
105845471|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
105845472|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
105845473|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
105845474|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
105845475|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
105845476|NCT03921151|365092345|FG000|Overall Study|Withdrawal by Subject|11|||
105845477|NCT03921151|365092346|FG001|Overall Study|Withdrawal by Subject|16|||
105845478|NCT01429051|365092347|FG000|Titration Phase|Death|1|||
105316553|NCT01973595|363154729|FG002|Washout|Withdrawal by Subject|1|||
105316554|NCT01973595|363154730|FG003|Washout|Withdrawal by Subject|0|||
105316555|NCT02508935|363154731|FG000|Overall Study|Withdrawal by Subject|1|||
105316556|NCT02508935|363154731|FG000|Overall Study|Withdrawal by Caregiver|8|||
105316557|NCT02508935|363154731|FG000|Overall Study|Pain Score <4|1|||
105316558|NCT02508935|363154731|FG000|Overall Study|Emesis|3|||
105316559|NCT02508935|363154731|FG000|Overall Study|Adverse Event|3|||
105316560|NCT02508935|363154731|FG000|Overall Study|Protocol Violation|1|||
105316561|NCT02508935|363154731|FG000|Overall Study|Physician Decision|1|||
105490296|NCT00764504|363807519|FG001|Overall Study|Physician Decision|0|||
105490297|NCT00764504|363807520|FG002|Overall Study|Physician Decision|0|||
105490298|NCT00764504|363807518|FG000|Overall Study|Withdrawal by Subject|1|||
105490299|NCT00764504|363807519|FG001|Overall Study|Withdrawal by Subject|7|||
105490300|NCT00764504|363807520|FG002|Overall Study|Withdrawal by Subject|4|||
105490301|NCT00764504|363807518|FG000|Overall Study|Lost to Follow-up|40|||
105845479|NCT01429051|365092347|FG000|Titration Phase|Withdrawal by Subject|7|||
105845480|NCT01429051|365092347|FG000|Titration Phase|Physician Decision|1|||
105845481|NCT01429051|365092347|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
105845482|NCT01429051|365092347|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
105845483|NCT01429051|365092347|FG000|Efficacy Phase|Adverse Event|1|||
105845484|NCT01429051|365092347|FG000|Efficacy Phase|Death|1|||
105845485|NCT01429051|365092347|FG000|Tolerability Phase|Death|5|||
105845486|NCT01429051|365092347|FG000|Tolerability Phase|Adverse Event|2|||
105845487|NCT01429051|365092347|FG000|Tolerability Phase|Withdrawal by Subject|5|||
105845488|NCT01429051|365092347|FG000|Tolerability Phase|Physician Decision|1|||
105845489|NCT01429051|365092347|FG000|Tolerability Phase|Other|2|||
105845490|NCT01206816|365092352|FG000|Overall Study|Protocol Violation|0|||
105845491|NCT01206816|365092353|FG001|Overall Study|Protocol Violation|0|||
105845492|NCT01206816|365092354|FG002|Overall Study|Protocol Violation|1|||
105845493|NCT01206816|365092355|FG003|Overall Study|Protocol Violation|0|||
105845494|NCT01206816|365092356|FG004|Overall Study|Protocol Violation|0|||
105845495|NCT01206816|365092357|FG005|Overall Study|Protocol Violation|0|||
105845496|NCT01206816|365092358|FG006|Overall Study|Protocol Violation|0|||
105845497|NCT01206816|365092352|FG000|Overall Study|Withdrawal by Subject|0|||
105845498|NCT01206816|365092353|FG001|Overall Study|Withdrawal by Subject|0|||
105845499|NCT01206816|365092354|FG002|Overall Study|Withdrawal by Subject|1|||
105845500|NCT01206816|365092355|FG003|Overall Study|Withdrawal by Subject|0|||
105845501|NCT01206816|365092356|FG004|Overall Study|Withdrawal by Subject|0|||
105845502|NCT01206816|365092357|FG005|Overall Study|Withdrawal by Subject|0|||
105845503|NCT01206816|365092358|FG006|Overall Study|Withdrawal by Subject|0|||
105845504|NCT01206816|365092352|FG000|Overall Study|Progressive disease|3|||
105845505|NCT01206816|365092353|FG001|Overall Study|Progressive disease|3|||
105845506|NCT01206816|365092354|FG002|Overall Study|Progressive disease|13|||
105845507|NCT01206816|365092355|FG003|Overall Study|Progressive disease|3|||
105845508|NCT01206816|365092356|FG004|Overall Study|Progressive disease|3|||
105845509|NCT01206816|365092357|FG005|Overall Study|Progressive disease|16|||
105845510|NCT01206816|365092358|FG006|Overall Study|Progressive disease|3|||
105845511|NCT01206816|365092352|FG000|Overall Study|Other AE|0|||
105845512|NCT01206816|365092353|FG001|Overall Study|Other AE|0|||
105845513|NCT01206816|365092354|FG002|Overall Study|Other AE|4|||
105845514|NCT01206816|365092355|FG003|Overall Study|Other AE|0|||
105845515|NCT01206816|365092356|FG004|Overall Study|Other AE|0|||
105845516|NCT01206816|365092357|FG005|Overall Study|Other AE|3|||
105845517|NCT01206816|365092358|FG006|Overall Study|Other AE|2|||
105845518|NCT01206816|365092352|FG000|Overall Study|other than stated above|0|||
105845519|NCT01206816|365092353|FG001|Overall Study|other than stated above|0|||
105845520|NCT01206816|365092354|FG002|Overall Study|other than stated above|1|||
105845521|NCT01206816|365092355|FG003|Overall Study|other than stated above|0|||
105845522|NCT01206816|365092356|FG004|Overall Study|other than stated above|0|||
105845523|NCT01206816|365092357|FG005|Overall Study|other than stated above|0|||
105845524|NCT01206816|365092358|FG006|Overall Study|other than stated above|1|||
105845525|NCT03760250|365092359|FG000|Overall Study|Withdrawal by Subject|1|||
105845526|NCT03760250|365092359|FG000|Overall Study|Physician Decision|1|||
105845527|NCT03733210|365092360|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
105845528|NCT03733210|365092361|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
105845529|NCT02621034|365092362|FG000|Overall Study|Lost to Follow-up|3|||
105845530|NCT02621034|365092363|FG001|Overall Study|Lost to Follow-up|2|||
105845531|NCT02621034|365092364|FG002|Overall Study|Lost to Follow-up|5|||
105845532|NCT01939496|365092365|FG000|Overall Study|Adverse Event|2|||
105845533|NCT01939496|365092366|FG001|Overall Study|Adverse Event|0|||
105845534|NCT01939496|365092367|FG002|Overall Study|Adverse Event|0|||
105845535|NCT01939496|365092365|FG000|Overall Study|Lost to Follow-up|1|||
105845536|NCT01939496|365092366|FG001|Overall Study|Lost to Follow-up|1|||
105845537|NCT01939496|365092367|FG002|Overall Study|Lost to Follow-up|0|||
105845538|NCT01939496|365092365|FG000|Overall Study|Physician Decision|1|||
105845539|NCT01939496|365092366|FG001|Overall Study|Physician Decision|0|||
105845540|NCT01939496|365092367|FG002|Overall Study|Physician Decision|0|||
105845541|NCT01939496|365092365|FG000|Overall Study|Protocol Violation|3|||
105845542|NCT01939496|365092366|FG001|Overall Study|Protocol Violation|0|||
105845543|NCT01939496|365092367|FG002|Overall Study|Protocol Violation|0|||
105845544|NCT01939496|365092365|FG000|Overall Study|Withdrawal by Subject|0|||
105845545|NCT01939496|365092366|FG001|Overall Study|Withdrawal by Subject|1|||
105845546|NCT01939496|365092367|FG002|Overall Study|Withdrawal by Subject|1|||
105845547|NCT01939496|365092365|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
105845548|NCT01939496|365092366|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
105490302|NCT00764504|363807519|FG001|Overall Study|Lost to Follow-up|34|||
105490303|NCT00764504|363807520|FG002|Overall Study|Lost to Follow-up|72|||
105845549|NCT01939496|365092367|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
105845550|NCT01939496|365092365|FG000|Overall Study|Other|2|||
105845551|NCT01939496|365092366|FG001|Overall Study|Other|0|||
105845552|NCT01939496|365092367|FG002|Overall Study|Other|1|||
105845553|NCT03251963|365092368|FG000|Overall Study|inappropriate Xa level timing|6|||
105845554|NCT03251963|365092369|FG001|Overall Study|inappropriate Xa level timing|3|||
105845555|NCT03251963|365092368|FG000|Overall Study|no peak Xa level drawn|2|||
105316562|NCT02508935|363154731|FG000|Overall Study|Trial terminated by sponsor|5|||
105316563|NCT01814553|363154734|FG000|Overall Study|PD per clinical progression|6|||
105316564|NCT01814553|363154735|FG001|Overall Study|PD per clinical progression|8|||
105316565|NCT01814553|363154734|FG000|Overall Study|Other Adverse Event|4|||
105316566|NCT01814553|363154735|FG001|Overall Study|Other Adverse Event|5|||
105316567|NCT01814553|363154734|FG000|Overall Study|Withdrawal by Subject|1|||
105316568|NCT01814553|363154735|FG001|Overall Study|Withdrawal by Subject|1|||
105316569|NCT01814553|363154734|FG000|Overall Study|Other than stated|7|||
105316570|NCT01814553|363154735|FG001|Overall Study|Other than stated|8|||
105316571|NCT00086281|363154736|FG000|Phase 1|Adverse Event|0|||
105316572|NCT00086281|363154737|FG001|Phase 1|Adverse Event|0|||
105845556|NCT03251963|365092369|FG001|Overall Study|no peak Xa level drawn|0|||
105845557|NCT03251963|365092368|FG000|Overall Study|bled prior to Xa level|1|||
105845558|NCT03251963|365092369|FG001|Overall Study|bled prior to Xa level|2|||
105845559|NCT01705236|365092370|FG000|Overall Study|Lost to Follow-up|1|||
105845560|NCT01705236|365092370|FG000|Overall Study|Administrative problems|2|||
105845561|NCT01705236|365092370|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
105845562|NCT01705236|365092370|FG000|Overall Study|Protocol Violation|3|||
105845563|NCT01705236|365092370|FG000|Overall Study|Abnormal test procedure result(s)|4|||
105845564|NCT01705236|365092370|FG000|Overall Study|Abnormal laboratory value(s)|4|||
105845565|NCT01705236|365092370|FG000|Overall Study|Withdrawal by Subject|5|||
105845566|NCT01705236|365092370|FG000|Overall Study|Adverse Event|5|||
105845567|NCT03028740|365092371|FG000|Overall Study|Did not Receive Study Drug|4|||
105845568|NCT03028740|365092372|FG001|Overall Study|Did not Receive Study Drug|5|||
105845569|NCT03028740|365092371|FG000|Overall Study|Adverse Event|8|||
105845570|NCT03028740|365092372|FG001|Overall Study|Adverse Event|26|||
105845571|NCT03028740|365092371|FG000|Overall Study|Lack of Efficacy|0|||
105845572|NCT03028740|365092372|FG001|Overall Study|Lack of Efficacy|1|||
105845573|NCT03028740|365092371|FG000|Overall Study|Withdrawal by Subject|48|||
105316573|NCT00086281|363154738|FG002|Phase 1|Adverse Event|0|||
105316574|NCT00086281|363154739|FG003|Phase 1|Adverse Event|0|||
105316575|NCT00086281|363154740|FG004|Phase 1|Adverse Event|0|||
105316576|NCT00086281|363154741|FG005|Phase 1|Adverse Event|0|||
105316577|NCT00086281|363154742|FG006|Phase 1|Adverse Event|0|||
105316578|NCT00086281|363154743|FG007|Phase 1|Adverse Event|0|||
105316579|NCT00086281|363154744|FG008|Phase 1|Adverse Event|0|||
105316580|NCT00086281|363154745|FG009|Phase 1|Adverse Event|1|||
105316581|NCT00086281|363154746|FG010|Phase 1|Adverse Event|2|||
105316582|NCT00086281|363154747|FG011|Phase 1|Adverse Event|1|||
105316583|NCT00086281|363154748|FG012|Phase 1|Adverse Event|1|||
105316584|NCT00086281|363154749|FG013|Phase 1|Adverse Event|1|||
105316585|NCT00086281|363154750|FG014|Phase 1|Adverse Event|2|||
105316586|NCT00086281|363154736|FG000|Phase 1|Protocol Violation|0|||
105316587|NCT00086281|363154737|FG001|Phase 1|Protocol Violation|0|||
105316588|NCT00086281|363154738|FG002|Phase 1|Protocol Violation|0|||
105316589|NCT00086281|363154739|FG003|Phase 1|Protocol Violation|0|||
105316590|NCT00086281|363154740|FG004|Phase 1|Protocol Violation|0|||
105316591|NCT00086281|363154741|FG005|Phase 1|Protocol Violation|0|||
105316592|NCT00086281|363154742|FG006|Phase 1|Protocol Violation|0|||
105316593|NCT00086281|363154743|FG007|Phase 1|Protocol Violation|0|||
105316594|NCT00086281|363154744|FG008|Phase 1|Protocol Violation|0|||
105316595|NCT00086281|363154745|FG009|Phase 1|Protocol Violation|0|||
105316596|NCT00086281|363154746|FG010|Phase 1|Protocol Violation|1|||
105316597|NCT00086281|363154747|FG011|Phase 1|Protocol Violation|0|||
105316598|NCT00086281|363154748|FG012|Phase 1|Protocol Violation|0|||
105316599|NCT00086281|363154749|FG013|Phase 1|Protocol Violation|0|||
105845574|NCT03028740|365092372|FG001|Overall Study|Withdrawal by Subject|101|||
105845575|NCT03028740|365092371|FG000|Overall Study|Lost to Follow-up|30|||
105845576|NCT03028740|365092372|FG001|Overall Study|Lost to Follow-up|54|||
105845577|NCT03028740|365092371|FG000|Overall Study|Physician Decision|4|||
105845578|NCT03028740|365092372|FG001|Overall Study|Physician Decision|11|||
105845579|NCT03028740|365092371|FG000|Overall Study|Protocol Violation|4|||
105845580|NCT03028740|365092372|FG001|Overall Study|Protocol Violation|8|||
105316600|NCT00086281|363154750|FG014|Phase 1|Protocol Violation|0|||
105316601|NCT00086281|363154736|FG000|Phase 1|Serious Adverse Event|0|||
105316602|NCT00086281|363154737|FG001|Phase 1|Serious Adverse Event|0|||
105316603|NCT00086281|363154738|FG002|Phase 1|Serious Adverse Event|0|||
105490304|NCT01028378|363807521|FG000|Overall Study|Lost to Follow-up|12|||
105490305|NCT01028378|363807521|FG000|Overall Study|Withdrawal by Subject|1|||
105490306|NCT01028378|363807521|FG000|Overall Study|Adminstrative Reasons|4|||
105845581|NCT03028740|365092371|FG000|Overall Study|Non-compliance with Study Drug|0|||
105316604|NCT00086281|363154739|FG003|Phase 1|Serious Adverse Event|0|||
105316605|NCT00086281|363154740|FG004|Phase 1|Serious Adverse Event|0|||
105316606|NCT00086281|363154741|FG005|Phase 1|Serious Adverse Event|0|||
105316607|NCT00086281|363154742|FG006|Phase 1|Serious Adverse Event|0|||
105316608|NCT00086281|363154743|FG007|Phase 1|Serious Adverse Event|0|||
105845582|NCT03028740|365092372|FG001|Overall Study|Non-compliance with Study Drug|2|||
105845583|NCT03028740|365092371|FG000|Overall Study|Study Terminated by Sponsor|467|||
105845584|NCT03028740|365092372|FG001|Overall Study|Study Terminated by Sponsor|917|||
105845585|NCT03028740|365092371|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
105845586|NCT03028740|365092372|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
105845587|NCT03028740|365092371|FG000|Overall Study|Reason not Specified|1|||
105845588|NCT03028740|365092372|FG001|Overall Study|Reason not Specified|5|||
105845589|NCT00186888|365092374|FG000|Overall Study|Toxicity|0|||
105845590|NCT00186888|365092375|FG001|Overall Study|Toxicity|1|||
105845591|NCT00186888|365092376|FG002|Overall Study|Toxicity|0|||
105845592|NCT00186888|365092374|FG000|Overall Study|Relapse or progression of disease|4|||
105845593|NCT00186888|365092375|FG001|Overall Study|Relapse or progression of disease|2|||
105845594|NCT00186888|365092376|FG002|Overall Study|Relapse or progression of disease|0|||
105845595|NCT00289874|365092377|FG000|Overall Study|Adverse Event|1|||
105845596|NCT00289874|365092378|FG001|Overall Study|Adverse Event|5|||
105845597|NCT00289874|365092377|FG000|Overall Study|Lost to Follow-up|1|||
105845598|NCT00289874|365092378|FG001|Overall Study|Lost to Follow-up|1|||
105845599|NCT00289874|365092377|FG000|Overall Study|Protocol Violation|3|||
105845600|NCT00289874|365092378|FG001|Overall Study|Protocol Violation|2|||
105845601|NCT00289874|365092377|FG000|Overall Study|Did not meet eligibility|1|||
105845602|NCT00289874|365092378|FG001|Overall Study|Did not meet eligibility|0|||
105845603|NCT00136318|365092381|FG000|Overall Study|Adverse Event|5|||
105845604|NCT00136318|365092382|FG001|Overall Study|Adverse Event|5|||
105845605|NCT00136318|365092381|FG000|Overall Study|Withdrawal by Subject|2|||
105845606|NCT00136318|365092382|FG001|Overall Study|Withdrawal by Subject|2|||
105845607|NCT01615263|365092383|FG000|Overall Study|Post-randomization exclusion|0|||
105845608|NCT01615263|365092384|FG001|Overall Study|Post-randomization exclusion|2|||
105845609|NCT01829113|365092385|FG000|Overall Study|Disease Progression|37|||
105845610|NCT01829113|365092386|FG001|Overall Study|Disease Progression|48|||
105845611|NCT01829113|365092385|FG000|Overall Study|Adverse Event|14|||
105845612|NCT01829113|365092386|FG001|Overall Study|Adverse Event|10|||
105845613|NCT01829113|365092385|FG000|Overall Study|Withdrawal by Subject|17|||
105845614|NCT01829113|365092386|FG001|Overall Study|Withdrawal by Subject|10|||
105845615|NCT01829113|365092385|FG000|Overall Study|Death|4|||
105845616|NCT01829113|365092386|FG001|Overall Study|Death|6|||
105845617|NCT01829113|365092385|FG000|Overall Study|Sponsor Decision|1|||
105845618|NCT01829113|365092386|FG001|Overall Study|Sponsor Decision|1|||
105845619|NCT01829113|365092385|FG000|Overall Study|No Study Treatment Received|3|||
105845620|NCT01829113|365092386|FG001|Overall Study|No Study Treatment Received|2|||
105845621|NCT01829113|365092385|FG000|Overall Study|Physician Decision|1|||
105845622|NCT01829113|365092386|FG001|Overall Study|Physician Decision|1|||
105845623|NCT00942331|365092395|FG000|Overall Study|Did not start treatment|15|||
105845624|NCT00942331|365092396|FG001|Overall Study|Did not start treatment|22|||
105845625|NCT00466726|365092398|FG000|Overall Study|Not evaluable for response|14|||
105845626|NCT02696031|365092399|FG000|Up to Week 24|Adverse Event|2|||
105845627|NCT02696031|365092400|FG001|Up to Week 24|Adverse Event|4|||
105845628|NCT02696031|365092401|FG002|Up to Week 24|Adverse Event|2|||
105845629|NCT02696031|365092402|FG003|Up to Week 24|Adverse Event|0|||
105845630|NCT02696031|365092403|FG004|Up to Week 24|Adverse Event|0|||
105845631|NCT02696031|365092404|FG005|Up to Week 24|Adverse Event|0|||
105845632|NCT02696031|365092399|FG000|Up to Week 24|Lack of Efficacy|2|||
105845633|NCT02696031|365092400|FG001|Up to Week 24|Lack of Efficacy|1|||
105845634|NCT02696031|365092401|FG002|Up to Week 24|Lack of Efficacy|2|||
105845635|NCT02696031|365092402|FG003|Up to Week 24|Lack of Efficacy|0|||
105845636|NCT02696031|365092403|FG004|Up to Week 24|Lack of Efficacy|0|||
105845637|NCT02696031|365092404|FG005|Up to Week 24|Lack of Efficacy|0|||
105845638|NCT02696031|365092399|FG000|Up to Week 24|Lost to Follow-up|0|||
105845639|NCT02696031|365092400|FG001|Up to Week 24|Lost to Follow-up|1|||
105845640|NCT02696031|365092401|FG002|Up to Week 24|Lost to Follow-up|1|||
105845641|NCT02696031|365092402|FG003|Up to Week 24|Lost to Follow-up|0|||
105845642|NCT02696031|365092403|FG004|Up to Week 24|Lost to Follow-up|0|||
105845643|NCT02696031|365092404|FG005|Up to Week 24|Lost to Follow-up|0|||
105845644|NCT02696031|365092399|FG000|Up to Week 24|Physician Decision|1|||
105845645|NCT02696031|365092400|FG001|Up to Week 24|Physician Decision|0|||
105845646|NCT02696031|365092401|FG002|Up to Week 24|Physician Decision|1|||
105845647|NCT02696031|365092402|FG003|Up to Week 24|Physician Decision|0|||
105845648|NCT02696031|365092403|FG004|Up to Week 24|Physician Decision|0|||
105845649|NCT02696031|365092404|FG005|Up to Week 24|Physician Decision|0|||
105845650|NCT02696031|365092399|FG000|Up to Week 24|Protocol Violation|1|||
105845651|NCT02696031|365092400|FG001|Up to Week 24|Protocol Violation|0|||
105845652|NCT02696031|365092401|FG002|Up to Week 24|Protocol Violation|0|||
105845653|NCT02696031|365092402|FG003|Up to Week 24|Protocol Violation|0|||
105845654|NCT02696031|365092403|FG004|Up to Week 24|Protocol Violation|0|||
105845655|NCT02696031|365092404|FG005|Up to Week 24|Protocol Violation|0|||
105845656|NCT02696031|365092399|FG000|Up to Week 24|Withdrawal by Subject|4|||
105845657|NCT02696031|365092400|FG001|Up to Week 24|Withdrawal by Subject|1|||
105845658|NCT02696031|365092401|FG002|Up to Week 24|Withdrawal by Subject|5|||
105845659|NCT02696031|365092402|FG003|Up to Week 24|Withdrawal by Subject|0|||
105845660|NCT02696031|365092403|FG004|Up to Week 24|Withdrawal by Subject|0|||
105845661|NCT02696031|365092404|FG005|Up to Week 24|Withdrawal by Subject|0|||
105845662|NCT02696031|365092399|FG000|Up to Week 52|Adverse Event|4|||
105845663|NCT02696031|365092400|FG001|Up to Week 52|Adverse Event|5|||
105845664|NCT02696031|365092401|FG002|Up to Week 52|Adverse Event|3|||
105845665|NCT02696031|365092402|FG003|Up to Week 52|Adverse Event|0|||
105845666|NCT02696031|365092403|FG004|Up to Week 52|Adverse Event|0|||
105845667|NCT02696031|365092404|FG005|Up to Week 52|Adverse Event|0|||
105845668|NCT02696031|365092399|FG000|Up to Week 52|Lack of Efficacy|10|||
105845669|NCT02696031|365092400|FG001|Up to Week 52|Lack of Efficacy|7|||
105845670|NCT02696031|365092401|FG002|Up to Week 52|Lack of Efficacy|11|||
105845671|NCT02696031|365092402|FG003|Up to Week 52|Lack of Efficacy|0|||
105845672|NCT02696031|365092403|FG004|Up to Week 52|Lack of Efficacy|0|||
105845673|NCT02696031|365092404|FG005|Up to Week 52|Lack of Efficacy|0|||
105845674|NCT02696031|365092399|FG000|Up to Week 52|Lost to Follow-up|1|||
105845675|NCT02696031|365092400|FG001|Up to Week 52|Lost to Follow-up|1|||
105845676|NCT02696031|365092401|FG002|Up to Week 52|Lost to Follow-up|1|||
105845677|NCT02696031|365092402|FG003|Up to Week 52|Lost to Follow-up|0|||
105845678|NCT02696031|365092403|FG004|Up to Week 52|Lost to Follow-up|0|||
105845679|NCT02696031|365092404|FG005|Up to Week 52|Lost to Follow-up|0|||
105845680|NCT02696031|365092399|FG000|Up to Week 52|Physician Decision|1|||
105845681|NCT02696031|365092400|FG001|Up to Week 52|Physician Decision|1|||
105845682|NCT02696031|365092401|FG002|Up to Week 52|Physician Decision|2|||
105845683|NCT02696031|365092402|FG003|Up to Week 52|Physician Decision|0|||
105845684|NCT02696031|365092403|FG004|Up to Week 52|Physician Decision|0|||
105845685|NCT02696031|365092404|FG005|Up to Week 52|Physician Decision|0|||
105845686|NCT02696031|365092399|FG000|Up to Week 52|Pregnancy|0|||
105845687|NCT02696031|365092400|FG001|Up to Week 52|Pregnancy|2|||
105845688|NCT02696031|365092401|FG002|Up to Week 52|Pregnancy|0|||
105845689|NCT02696031|365092402|FG003|Up to Week 52|Pregnancy|0|||
105845690|NCT02696031|365092403|FG004|Up to Week 52|Pregnancy|0|||
105845691|NCT02696031|365092404|FG005|Up to Week 52|Pregnancy|0|||
105845692|NCT02696031|365092399|FG000|Up to Week 52|Protocol Violation|1|||
105845693|NCT02696031|365092400|FG001|Up to Week 52|Protocol Violation|0|||
105845694|NCT02696031|365092401|FG002|Up to Week 52|Protocol Violation|0|||
105845695|NCT02696031|365092402|FG003|Up to Week 52|Protocol Violation|0|||
105845696|NCT02696031|365092403|FG004|Up to Week 52|Protocol Violation|0|||
105845697|NCT02696031|365092404|FG005|Up to Week 52|Protocol Violation|0|||
105845698|NCT02696031|365092399|FG000|Up to Week 52|Withdrawal by Subject|12|||
105845699|NCT02696031|365092400|FG001|Up to Week 52|Withdrawal by Subject|3|||
105845700|NCT02696031|365092401|FG002|Up to Week 52|Withdrawal by Subject|9|||
105845701|NCT02696031|365092402|FG003|Up to Week 52|Withdrawal by Subject|0|||
105845702|NCT02696031|365092403|FG004|Up to Week 52|Withdrawal by Subject|0|||
105845703|NCT02696031|365092404|FG005|Up to Week 52|Withdrawal by Subject|0|||
105845704|NCT02696031|365092399|FG000|Up to Week 104|Pregnancy|0|||
105845705|NCT02696031|365092400|FG001|Up to Week 104|Pregnancy|2|||
105845706|NCT02696031|365092401|FG002|Up to Week 104|Pregnancy|1|||
105845707|NCT02696031|365092402|FG003|Up to Week 104|Pregnancy|0|||
105845708|NCT02696031|365092403|FG004|Up to Week 104|Pregnancy|0|||
105845709|NCT02696031|365092404|FG005|Up to Week 104|Pregnancy|0|||
105845710|NCT02696031|365092399|FG000|Up to Week 104|Withdrawal by Subject|15|||
105845711|NCT02696031|365092400|FG001|Up to Week 104|Withdrawal by Subject|10|||
105845712|NCT02696031|365092401|FG002|Up to Week 104|Withdrawal by Subject|16|||
105845713|NCT02696031|365092402|FG003|Up to Week 104|Withdrawal by Subject|0|||
105845714|NCT02696031|365092403|FG004|Up to Week 104|Withdrawal by Subject|0|||
105845715|NCT02696031|365092404|FG005|Up to Week 104|Withdrawal by Subject|0|||
105845716|NCT02696031|365092399|FG000|Up to Week 104|Protocol Violation|1|||
105845717|NCT02696031|365092400|FG001|Up to Week 104|Protocol Violation|0|||
105845718|NCT02696031|365092401|FG002|Up to Week 104|Protocol Violation|0|||
105845719|NCT02696031|365092402|FG003|Up to Week 104|Protocol Violation|0|||
105845720|NCT02696031|365092403|FG004|Up to Week 104|Protocol Violation|0|||
105845721|NCT02696031|365092404|FG005|Up to Week 104|Protocol Violation|0|||
105845722|NCT02696031|365092399|FG000|Up to Week 104|Physician Decision|1|||
105368794|NCT02466399|363356289|FG001|Overall Study|Early exit due to family emergency|0|||
105368795|NCT02669849|363356290|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
105368796|NCT02669849|363356291|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
105368797|NCT02669849|363356292|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
105368798|NCT02669849|363356290|FG000|Overall Study|Lost to Follow-up|1|||
105368799|NCT02669849|363356291|FG001|Overall Study|Lost to Follow-up|0|||
105368800|NCT02669849|363356292|FG002|Overall Study|Lost to Follow-up|3|||
105368801|NCT02669849|363356290|FG000|Overall Study|Death|1|||
105490307|NCT01465191|363807522|FG000|Overall Study|Protocol Violation|6|||
105490308|NCT01465191|363807523|FG001|Overall Study|Protocol Violation|3|||
105490309|NCT01465191|363807524|FG002|Overall Study|Protocol Violation|3|||
105490310|NCT01465191|363807522|FG000|Overall Study|Lost to Follow-up|3|||
105490311|NCT01465191|363807523|FG001|Overall Study|Lost to Follow-up|6|||
105490312|NCT01465191|363807524|FG002|Overall Study|Lost to Follow-up|4|||
105845723|NCT02696031|365092400|FG001|Up to Week 104|Physician Decision|2|||
105845724|NCT02696031|365092401|FG002|Up to Week 104|Physician Decision|3|||
105845725|NCT02696031|365092402|FG003|Up to Week 104|Physician Decision|0|||
105845726|NCT02696031|365092403|FG004|Up to Week 104|Physician Decision|0|||
105845727|NCT02696031|365092404|FG005|Up to Week 104|Physician Decision|0|||
105845728|NCT02696031|365092399|FG000|Up to Week 104|Lost to Follow-up|2|||
105845729|NCT02696031|365092400|FG001|Up to Week 104|Lost to Follow-up|3|||
105845730|NCT02696031|365092401|FG002|Up to Week 104|Lost to Follow-up|1|||
105845731|NCT02696031|365092402|FG003|Up to Week 104|Lost to Follow-up|0|||
105845732|NCT02696031|365092403|FG004|Up to Week 104|Lost to Follow-up|0|||
105845733|NCT02696031|365092404|FG005|Up to Week 104|Lost to Follow-up|0|||
105845734|NCT02696031|365092399|FG000|Up to Week 104|Lack of Efficacy|13|||
105845735|NCT02696031|365092400|FG001|Up to Week 104|Lack of Efficacy|12|||
105845736|NCT02696031|365092401|FG002|Up to Week 104|Lack of Efficacy|11|||
105845737|NCT02696031|365092402|FG003|Up to Week 104|Lack of Efficacy|0|||
105845738|NCT02696031|365092403|FG004|Up to Week 104|Lack of Efficacy|0|||
105845739|NCT02696031|365092404|FG005|Up to Week 104|Lack of Efficacy|0|||
105845740|NCT02696031|365092399|FG000|Up to Week 104|Adverse Event|7|||
105845741|NCT02696031|365092400|FG001|Up to Week 104|Adverse Event|11|||
105845742|NCT02696031|365092401|FG002|Up to Week 104|Adverse Event|5|||
105845743|NCT02696031|365092402|FG003|Up to Week 104|Adverse Event|0|||
105845744|NCT02696031|365092403|FG004|Up to Week 104|Adverse Event|0|||
105845745|NCT02696031|365092404|FG005|Up to Week 104|Adverse Event|0|||
105845746|NCT02696031|365092399|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
105845747|NCT02696031|365092400|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
105845748|NCT02696031|365092401|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
105845749|NCT02696031|365092402|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
105845750|NCT02696031|365092403|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
105845751|NCT02696031|365092404|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
105845752|NCT02696031|365092399|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
105845753|NCT02696031|365092400|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
105845754|NCT02696031|365092401|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
105845755|NCT02696031|365092402|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
105845756|NCT02696031|365092403|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
105845757|NCT02696031|365092404|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
105845758|NCT02696031|365092399|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
105845759|NCT02696031|365092400|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
105845760|NCT02696031|365092401|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
105845761|NCT02696031|365092402|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
105845762|NCT02696031|365092403|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
105845763|NCT02696031|365092404|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
105845764|NCT02696031|365092399|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
105845765|NCT02696031|365092400|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
105845766|NCT02696031|365092401|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
105845767|NCT02696031|365092402|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
105845768|NCT02696031|365092403|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
105845769|NCT02696031|365092404|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
105845770|NCT02696031|365092399|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
105845771|NCT02696031|365092400|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
105845772|NCT02696031|365092401|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
105845773|NCT02696031|365092402|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
105845774|NCT02696031|365092403|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
105845775|NCT02696031|365092404|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
105845776|NCT02696031|365092399|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
105845777|NCT02696031|365092400|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
105845778|NCT02696031|365092401|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
105845779|NCT02696031|365092402|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
105845780|NCT02696031|365092403|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
105845781|NCT02696031|365092404|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
105845782|NCT02696031|365092399|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
105845783|NCT02696031|365092400|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
105845784|NCT02696031|365092401|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
105845785|NCT02696031|365092402|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
105845786|NCT02696031|365092403|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
105845787|NCT02696031|365092404|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
105845788|NCT01901874|365092407|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
105845789|NCT01901874|365092407|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
105845790|NCT01901874|365092407|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
105845791|NCT01901874|365092407|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
105845792|NCT01901874|365092407|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
105845793|NCT01901874|365092407|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
105845794|NCT03978091|365092408|FG000|Overall Study|Lost to Follow-up|0|||
105490313|NCT01298193|363807525|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
105845795|NCT03978091|365092409|FG001|Overall Study|Lost to Follow-up|0|||
105845796|NCT03978091|365092410|FG002|Overall Study|Lost to Follow-up|1|||
105490314|NCT01298193|363807525|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
105845797|NCT03978091|365092411|FG003|Overall Study|Lost to Follow-up|0|||
105845798|NCT03978091|365092412|FG004|Overall Study|Lost to Follow-up|0|||
105845799|NCT03978091|365092413|FG005|Overall Study|Lost to Follow-up|0|||
105490315|NCT01298193|363807525|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
105316609|NCT00086281|363154744|FG008|Phase 1|Serious Adverse Event|0|||
105316610|NCT00086281|363154745|FG009|Phase 1|Serious Adverse Event|0|||
105845800|NCT03978091|365092408|FG000|Overall Study|Withdrawal by Subject|0|||
105845801|NCT03978091|365092409|FG001|Overall Study|Withdrawal by Subject|0|||
105845802|NCT03978091|365092410|FG002|Overall Study|Withdrawal by Subject|0|||
105845803|NCT03978091|365092411|FG003|Overall Study|Withdrawal by Subject|1|||
105845804|NCT03978091|365092412|FG004|Overall Study|Withdrawal by Subject|1|||
105845805|NCT03978091|365092413|FG005|Overall Study|Withdrawal by Subject|0|||
105845806|NCT02039414|365092420|FG000|Overall Study|Delivered|1|||
105845807|NCT02039414|365092421|FG001|Overall Study|Delivered|1|||
105845808|NCT02039414|365092420|FG000|Overall Study|Lost to Follow-up|2|||
105845809|NCT02039414|365092421|FG001|Overall Study|Lost to Follow-up|0|||
105845810|NCT02039414|365092420|FG000|Overall Study|Protocol Violation|3|||
105845811|NCT02039414|365092421|FG001|Overall Study|Protocol Violation|1|||
105845812|NCT02972502|365092426|FG000|Overall Study|Lost to Follow-up|3|||
105845813|NCT02972502|365092427|FG001|Overall Study|Lost to Follow-up|1|||
105316611|NCT00086281|363154746|FG010|Phase 1|Serious Adverse Event|0|||
105316612|NCT00086281|363154747|FG011|Phase 1|Serious Adverse Event|0|||
105316613|NCT00086281|363154748|FG012|Phase 1|Serious Adverse Event|0|||
105316614|NCT00086281|363154749|FG013|Phase 1|Serious Adverse Event|0|||
105845814|NCT02972502|365092426|FG000|Overall Study|Withdrawal by Subject|1|||
105845815|NCT02972502|365092427|FG001|Overall Study|Withdrawal by Subject|1|||
105845816|NCT00257920|365092430|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
105845817|NCT00257920|365092431|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
105845818|NCT00257920|365092430|FG000|Period: Second Intervention|Other|2|||
105845819|NCT00257920|365092431|FG001|Period: Second Intervention|Other|1|||
105845820|NCT03977701|365092434|FG000|Overall Study|COVID-19 pandemic|0|||
105845821|NCT03977701|365092435|FG001|Overall Study|COVID-19 pandemic|0|||
105845822|NCT03977701|365092436|FG002|Overall Study|COVID-19 pandemic|0|||
105845823|NCT03977701|365092437|FG003|Overall Study|COVID-19 pandemic|0|||
105845824|NCT03977701|365092438|FG004|Overall Study|COVID-19 pandemic|0|||
105845825|NCT03977701|365092439|FG005|Overall Study|COVID-19 pandemic|1|||
105845826|NCT03977701|365092440|FG006|Overall Study|COVID-19 pandemic|0|||
105845827|NCT03977701|365092441|FG007|Overall Study|COVID-19 pandemic|1|||
105845828|NCT03977701|365092442|FG008|Overall Study|COVID-19 pandemic|0|||
105845829|NCT03977701|365092443|FG009|Overall Study|COVID-19 pandemic|0|||
105845830|NCT01347866|365092444|FG000|Overall Study|Death|0|||
105845831|NCT01347866|365092445|FG001|Overall Study|Death|0|||
105845832|NCT01347866|365092446|FG002|Overall Study|Death|0|||
105845833|NCT01347866|365092447|FG003|Overall Study|Death|1|||
105845834|NCT01347866|365092448|FG004|Overall Study|Death|2|||
105845835|NCT01347866|365092449|FG005|Overall Study|Death|2|||
105490316|NCT01298193|363807525|FG000|Efficacy Phase (Second Cycle)|Death|1|||
105490317|NCT00107952|363807526|FG000|Overall Study|Death|75|||
105316615|NCT00086281|363154750|FG014|Phase 1|Serious Adverse Event|1|||
105316616|NCT00086281|363154736|FG000|Phase 2|Adverse Event|0|||
105316617|NCT00086281|363154737|FG001|Phase 2|Adverse Event|0|||
105316618|NCT00086281|363154738|FG002|Phase 2|Adverse Event|0|||
105316619|NCT00086281|363154739|FG003|Phase 2|Adverse Event|0|||
105316620|NCT00086281|363154740|FG004|Phase 2|Adverse Event|0|||
105845836|NCT01347866|365092450|FG006|Overall Study|Death|1|||
105845837|NCT01347866|365092451|FG007|Overall Study|Death|0|||
105845838|NCT01347866|365092452|FG008|Overall Study|Death|4|||
105490318|NCT00107952|363807527|FG001|Overall Study|Death|61|||
105490319|NCT00107952|363807526|FG000|Overall Study|Lost to Follow-up|0|||
105845839|NCT01347866|365092453|FG009|Overall Study|Death|1|||
105316621|NCT00086281|363154741|FG005|Phase 2|Adverse Event|0|||
105368802|NCT02669849|363356291|FG001|Overall Study|Death|1|||
105490320|NCT00107952|363807527|FG001|Overall Study|Lost to Follow-up|3|||
105490321|NCT00107952|363807526|FG000|Overall Study|Withdrawal by Subject|9|||
105576715|NCT02836613|364110294|FG000|Overall Study|Accidental drowning|1|||
105576716|NCT02836613|364110295|FG001|Overall Study|Accidental drowning|0|||
105576717|NCT02836613|364110294|FG000|Overall Study|Lost to Follow-up|0|||
105845840|NCT01347866|365092454|FG010|Overall Study|Death|3|||
105845841|NCT01347866|365092455|FG011|Overall Study|Death|1|||
105845842|NCT01347866|365092456|FG012|Overall Study|Death|2|||
105316622|NCT00086281|363154742|FG006|Phase 2|Adverse Event|0|||
105316623|NCT00086281|363154743|FG007|Phase 2|Adverse Event|0|||
105316624|NCT00086281|363154744|FG008|Phase 2|Adverse Event|0|||
105316625|NCT00086281|363154745|FG009|Phase 2|Adverse Event|0|||
105368803|NCT02669849|363356292|FG002|Overall Study|Death|2|||
105845843|NCT01347866|365092457|FG013|Overall Study|Death|0|||
105845844|NCT01347866|365092458|FG014|Overall Study|Death|0|||
105845845|NCT01347866|365092459|FG015|Overall Study|Death|1|||
105845846|NCT01347866|365092460|FG016|Overall Study|Death|0|||
105845847|NCT01347866|365092444|FG000|Overall Study|Lost to Follow-up|0|||
105845848|NCT01347866|365092445|FG001|Overall Study|Lost to Follow-up|0|||
105845849|NCT01347866|365092446|FG002|Overall Study|Lost to Follow-up|0|||
105845850|NCT01347866|365092447|FG003|Overall Study|Lost to Follow-up|0|||
105845851|NCT01347866|365092448|FG004|Overall Study|Lost to Follow-up|0|||
105845852|NCT01347866|365092449|FG005|Overall Study|Lost to Follow-up|0|||
105845853|NCT01347866|365092450|FG006|Overall Study|Lost to Follow-up|0|||
105845854|NCT01347866|365092451|FG007|Overall Study|Lost to Follow-up|1|||
105845855|NCT01347866|365092452|FG008|Overall Study|Lost to Follow-up|1|||
105845856|NCT01347866|365092453|FG009|Overall Study|Lost to Follow-up|0|||
105845857|NCT01347866|365092454|FG010|Overall Study|Lost to Follow-up|0|||
105845858|NCT01347866|365092455|FG011|Overall Study|Lost to Follow-up|0|||
105845859|NCT01347866|365092456|FG012|Overall Study|Lost to Follow-up|0|||
105845860|NCT01347866|365092457|FG013|Overall Study|Lost to Follow-up|0|||
105845861|NCT01347866|365092458|FG014|Overall Study|Lost to Follow-up|0|||
105576718|NCT02836613|364110295|FG001|Overall Study|Lost to Follow-up|1|||
105576719|NCT02836613|364110294|FG000|Overall Study|Withdrawal by Subject|0|||
105576720|NCT02836613|364110295|FG001|Overall Study|Withdrawal by Subject|2|||
105576721|NCT02293837|364110302|FG000|Overall Study|Lost to Follow-up|0|||
105845862|NCT01347866|365092459|FG015|Overall Study|Lost to Follow-up|0|||
105845863|NCT01347866|365092460|FG016|Overall Study|Lost to Follow-up|0|||
105845864|NCT01347866|365092444|FG000|Overall Study|Other|3|||
105845865|NCT01347866|365092445|FG001|Overall Study|Other|1|||
105845866|NCT01347866|365092446|FG002|Overall Study|Other|1|||
105845867|NCT01347866|365092447|FG003|Overall Study|Other|4|||
105845868|NCT01347866|365092448|FG004|Overall Study|Other|5|||
105845869|NCT01347866|365092449|FG005|Overall Study|Other|0|||
105845870|NCT01347866|365092450|FG006|Overall Study|Other|5|||
105845871|NCT01347866|365092451|FG007|Overall Study|Other|3|||
105845872|NCT01347866|365092452|FG008|Overall Study|Other|22|||
105845873|NCT01347866|365092453|FG009|Overall Study|Other|5|||
105845874|NCT01347866|365092454|FG010|Overall Study|Other|0|||
105845875|NCT01347866|365092455|FG011|Overall Study|Other|3|||
105845876|NCT01347866|365092456|FG012|Overall Study|Other|4|||
105845877|NCT01347866|365092457|FG013|Overall Study|Other|4|||
105845878|NCT01347866|365092458|FG014|Overall Study|Other|2|||
105845879|NCT01347866|365092459|FG015|Overall Study|Other|3|||
105845880|NCT01347866|365092460|FG016|Overall Study|Other|0|||
105845881|NCT01347866|365092444|FG000|Overall Study|Subject refused further follow-up|2|||
105845882|NCT01347866|365092445|FG001|Overall Study|Subject refused further follow-up|0|||
105845883|NCT01347866|365092446|FG002|Overall Study|Subject refused further follow-up|0|||
105845884|NCT01347866|365092447|FG003|Overall Study|Subject refused further follow-up|2|||
105845885|NCT01347866|365092448|FG004|Overall Study|Subject refused further follow-up|0|||
105845886|NCT01347866|365092449|FG005|Overall Study|Subject refused further follow-up|1|||
105845887|NCT01347866|365092450|FG006|Overall Study|Subject refused further follow-up|0|||
105845888|NCT01347866|365092451|FG007|Overall Study|Subject refused further follow-up|0|||
105845889|NCT01347866|365092452|FG008|Overall Study|Subject refused further follow-up|4|||
105845890|NCT01347866|365092453|FG009|Overall Study|Subject refused further follow-up|1|||
105845891|NCT01347866|365092454|FG010|Overall Study|Subject refused further follow-up|0|||
105845892|NCT01347866|365092455|FG011|Overall Study|Subject refused further follow-up|0|||
105845893|NCT01347866|365092456|FG012|Overall Study|Subject refused further follow-up|1|||
105845894|NCT01347866|365092457|FG013|Overall Study|Subject refused further follow-up|3|||
105845895|NCT01347866|365092458|FG014|Overall Study|Subject refused further follow-up|1|||
105845896|NCT01347866|365092459|FG015|Overall Study|Subject refused further follow-up|0|||
105845897|NCT01347866|365092460|FG016|Overall Study|Subject refused further follow-up|2|||
105845898|NCT00307931|365092462|FG000|Overall Study|Adverse Event|1|||
105845899|NCT00430950|365092463|FG000|Overall Study|Adverse Event|7|||
105845900|NCT00430950|365092464|FG001|Overall Study|Adverse Event|6|||
105845901|NCT00430950|365092463|FG000|Overall Study|Withdrawal by Subject|1|||
105845902|NCT00430950|365092464|FG001|Overall Study|Withdrawal by Subject|0|||
105845903|NCT00430950|365092463|FG000|Overall Study|concomitant medication,etc.|5|||
105845904|NCT00430950|365092464|FG001|Overall Study|concomitant medication,etc.|7|||
105845905|NCT02080832|365092471|FG000|Overall Study|Excluded from analysis by MRI|9|||
105845906|NCT02080832|365092472|FG001|Overall Study|Excluded from analysis by MRI|10|||
105845907|NCT02080832|365092473|FG002|Overall Study|Excluded from analysis by MRI|14|||
105845908|NCT02080832|365092471|FG000|Overall Study|Lost to Follow-up|0|||
105845909|NCT02080832|365092472|FG001|Overall Study|Lost to Follow-up|2|||
105845910|NCT02080832|365092473|FG002|Overall Study|Lost to Follow-up|2|||
105845911|NCT01560507|365092474|FG000|Overall Study|Lost to Follow-up|3|||
105845912|NCT01560507|365092475|FG001|Overall Study|Lost to Follow-up|1|||
105845913|NCT01560507|365092476|FG002|Overall Study|Lost to Follow-up|2|||
105845914|NCT01560507|365092474|FG000|Overall Study|Withdrawal by Subject|1|||
105845915|NCT01560507|365092475|FG001|Overall Study|Withdrawal by Subject|1|||
105576722|NCT02293837|364110303|FG001|Overall Study|Lost to Follow-up|2|||
105845916|NCT01560507|365092476|FG002|Overall Study|Withdrawal by Subject|0|||
105845917|NCT01277718|365092482|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
105576723|NCT02293837|364110304|FG002|Overall Study|Lost to Follow-up|1|||
105845918|NCT01277718|365092483|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
105845919|NCT01277718|365092482|FG000|Period 2 - Second Intervention|Physician Decision|0|||
105845920|NCT01277718|365092483|FG001|Period 2 - Second Intervention|Physician Decision|2|||
105845921|NCT01524913|365092484|FG000|Overall Study|Lost to Follow-up|4|||
105845922|NCT01524913|365092485|FG001|Overall Study|Lost to Follow-up|0|||
105845923|NCT01524913|365092486|FG002|Overall Study|Lost to Follow-up|0|||
105845924|NCT00702208|365092487|FG000|Overall Study|Lost to Follow-up|28|||
105845925|NCT00702208|365092487|FG000|Overall Study|Did not self-lavage|1|||
105845926|NCT00702208|365092487|FG000|Overall Study|Unsatisfactory colposcopy|2|||
105845927|NCT03097588|365092488|FG000|Overall Study|Adverse Event|1|||
105845928|NCT02025751|365092489|FG000|Overall Study|Lost to Follow-up|1|||
105845929|NCT02025751|365092490|FG001|Overall Study|Lost to Follow-up|0|||
105845930|NCT02025751|365092489|FG000|Overall Study|Adverse Event|0|||
105845931|NCT02025751|365092490|FG001|Overall Study|Adverse Event|1|||
105845932|NCT02025751|365092489|FG000|Overall Study|Physician Decision|0|||
105845933|NCT02025751|365092490|FG001|Overall Study|Physician Decision|1|||
105845934|NCT02025751|365092489|FG000|Overall Study|Withdrawal by Subject|0|||
105845935|NCT02025751|365092490|FG001|Overall Study|Withdrawal by Subject|1|||
105845936|NCT02687360|365092491|FG000|Overall Study|Withdrawal by Subject|3|||
105845937|NCT02687360|365092492|FG001|Overall Study|Withdrawal by Subject|0|||
105845938|NCT02989168|365092493|FG000|Overall Study|Withdrawal by Subject|2|||
105845939|NCT02989168|365092494|FG001|Overall Study|Withdrawal by Subject|0|||
105845940|NCT02989168|365092493|FG000|Overall Study|Physician Decision|0|||
105845941|NCT02989168|365092494|FG001|Overall Study|Physician Decision|1|||
105845942|NCT02989168|365092493|FG000|Overall Study|Adverse Event|1|||
105845943|NCT02989168|365092494|FG001|Overall Study|Adverse Event|2|||
105845944|NCT02989168|365092493|FG000|Overall Study|Sponsor stopped study.|1|||
105845945|NCT02989168|365092494|FG001|Overall Study|Sponsor stopped study.|0|||
105845946|NCT01030341|365094184|FG000|Overall Study|Withdrawal by Subject|1|||
105845947|NCT01030341|365094184|FG000|Overall Study|Lost to Follow-up|2|||
105845948|NCT00821873|365094185|FG000|Overall Study|Lost to Follow-up|4|||
105845949|NCT02177136|365094191|FG000|DB Phase|Withdrawal by Subject|2|||
105845950|NCT02177136|365094192|FG001|DB Phase|Withdrawal by Subject|0|||
105845951|NCT02177136|365094193|FG002|DB Phase|Withdrawal by Subject|0|||
105845952|NCT02177136|365094194|FG003|DB Phase|Withdrawal by Subject|0|||
105845953|NCT02177136|365094191|FG000|DB Phase|Discontinued Due to Pruritus|1|||
105845954|NCT02177136|365094192|FG001|DB Phase|Discontinued Due to Pruritus|3|||
105845955|NCT02177136|365094193|FG002|DB Phase|Discontinued Due to Pruritus|0|||
105845956|NCT02177136|365094194|FG003|DB Phase|Discontinued Due to Pruritus|0|||
105845957|NCT02177136|365094191|FG000|DB Phase|Adverse Event|3|||
105845958|NCT02177136|365094192|FG001|DB Phase|Adverse Event|2|||
105845959|NCT02177136|365094193|FG002|DB Phase|Adverse Event|3|||
105845960|NCT02177136|365094194|FG003|DB Phase|Adverse Event|0|||
105845961|NCT02177136|365094191|FG000|DB Phase|Protocol Violation|0|||
105845962|NCT02177136|365094192|FG001|DB Phase|Protocol Violation|0|||
105845963|NCT02177136|365094193|FG002|DB Phase|Protocol Violation|1|||
105845964|NCT02177136|365094194|FG003|DB Phase|Protocol Violation|0|||
105845965|NCT02177136|365094191|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
105845966|NCT02177136|365094192|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
105845967|NCT02177136|365094193|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
105845968|NCT02177136|365094194|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
105845969|NCT02177136|365094191|FG000|LTSE Phase|Withdrawal by Subject|0|||
105845970|NCT02177136|365094192|FG001|LTSE Phase|Withdrawal by Subject|0|||
105845971|NCT02177136|365094193|FG002|LTSE Phase|Withdrawal by Subject|0|||
105845972|NCT02177136|365094194|FG003|LTSE Phase|Withdrawal by Subject|6|||
105845973|NCT02177136|365094191|FG000|LTSE Phase|Adverse Event|0|||
105845974|NCT02177136|365094192|FG001|LTSE Phase|Adverse Event|0|||
105845975|NCT02177136|365094193|FG002|LTSE Phase|Adverse Event|0|||
105845976|NCT02177136|365094194|FG003|LTSE Phase|Adverse Event|10|||
105845977|NCT02177136|365094191|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
105845978|NCT02177136|365094192|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
105845979|NCT02177136|365094193|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
105845980|NCT02177136|365094194|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
105845981|NCT02177136|365094191|FG000|LTSE Phase|Physician Decision|0|||
105845982|NCT02177136|365094192|FG001|LTSE Phase|Physician Decision|0|||
105845983|NCT02177136|365094193|FG002|LTSE Phase|Physician Decision|0|||
105845984|NCT02177136|365094194|FG003|LTSE Phase|Physician Decision|2|||
105845985|NCT02177136|365094191|FG000|LTSE Phase|Lost to Follow-up|0|||
105845986|NCT02177136|365094192|FG001|LTSE Phase|Lost to Follow-up|0|||
105845987|NCT02177136|365094193|FG002|LTSE Phase|Lost to Follow-up|0|||
105845988|NCT02177136|365094194|FG003|LTSE Phase|Lost to Follow-up|1|||
105576724|NCT02293837|364110305|FG003|Overall Study|Lost to Follow-up|0|||
105845989|NCT02177136|365094191|FG000|LTSE Phase|Participant Moved|0|||
105845990|NCT02177136|365094192|FG001|LTSE Phase|Participant Moved|0|||
105845991|NCT02177136|365094193|FG002|LTSE Phase|Participant Moved|0|||
105845992|NCT02177136|365094194|FG003|LTSE Phase|Participant Moved|1|||
105845993|NCT00793780|365094195|FG000|Overall Study|Withdrawal by Subject|2|||
105845994|NCT00793780|365094196|FG001|Overall Study|Withdrawal by Subject|1|||
105845995|NCT01220297|365094197|FG000|Overall Study|Death|2|||
105845996|NCT01220297|365094197|FG000|Overall Study|Lost to Follow-up|1|||
105845997|NCT01287039|365094204|FG000|Overall Study|Noncompliance with study procedures|0|||
105845998|NCT01287039|365094205|FG001|Overall Study|Noncompliance with study procedures|1|||
105845999|NCT01287039|365094204|FG000|Overall Study|Change of location/residence|0|||
105846000|NCT01287039|365094205|FG001|Overall Study|Change of location/residence|3|||
105846001|NCT01287039|365094204|FG000|Overall Study|Elective surgery|0|||
105846002|NCT01287039|365094205|FG001|Overall Study|Elective surgery|1|||
105846003|NCT01287039|365094204|FG000|Overall Study|Protocol Violation|2|||
105846004|NCT01287039|365094205|FG001|Overall Study|Protocol Violation|3|||
105846005|NCT01287039|365094204|FG000|Overall Study|Excluded medication taken|1|||
105846006|NCT01287039|365094205|FG001|Overall Study|Excluded medication taken|0|||
105846007|NCT01287039|365094204|FG000|Overall Study|Noncompliance with study medication|0|||
105846008|NCT01287039|365094205|FG001|Overall Study|Noncompliance with study medication|1|||
105846009|NCT01287039|365094204|FG000|Overall Study|Problem with travel|0|||
105846010|NCT01287039|365094205|FG001|Overall Study|Problem with travel|1|||
105846011|NCT01287039|365094204|FG000|Overall Study|Death|1|||
105846012|NCT01287039|365094205|FG001|Overall Study|Death|0|||
105846013|NCT01287039|365094204|FG000|Overall Study|Change of residence|1|||
105846014|NCT01287039|365094205|FG001|Overall Study|Change of residence|0|||
105846015|NCT01287039|365094204|FG000|Overall Study|Adverse Event|7|||
105846016|NCT01287039|365094205|FG001|Overall Study|Adverse Event|4|||
105846017|NCT01287039|365094204|FG000|Overall Study|Withdrawal by Subject|14|||
105846018|NCT01287039|365094205|FG001|Overall Study|Withdrawal by Subject|11|||
105846019|NCT01287039|365094204|FG000|Overall Study|Lost to Follow-up|3|||
105846020|NCT01287039|365094205|FG001|Overall Study|Lost to Follow-up|2|||
105846021|NCT01570283|365094208|FG000|Cohort 1: Dose Level 1|Death|0|||
105846022|NCT01570283|365094209|FG001|Cohort 1: Dose Level 1|Death|1|||
105846023|NCT01570283|365094210|FG002|Cohort 1: Dose Level 1|Death|0|||
105846024|NCT01570283|365094211|FG003|Cohort 1: Dose Level 1|Death|0|||
105846025|NCT01570283|365094212|FG004|Cohort 1: Dose Level 1|Death|0|||
105846026|NCT01570283|365094213|FG005|Cohort 1: Dose Level 1|Death|0|||
105846027|NCT01570283|365094208|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
105846028|NCT01570283|365094209|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
105846029|NCT01570283|365094210|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
105846030|NCT01570283|365094211|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
105846031|NCT01570283|365094212|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
105846032|NCT01570283|365094213|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
105846033|NCT01570283|365094208|FG000|Cohort 2: Dose Level 2|Death|0|||
105846034|NCT01570283|365094209|FG001|Cohort 2: Dose Level 2|Death|0|||
105846035|NCT01570283|365094210|FG002|Cohort 2: Dose Level 2|Death|1|||
105846036|NCT01570283|365094211|FG003|Cohort 2: Dose Level 2|Death|0|||
105846037|NCT01570283|365094212|FG004|Cohort 2: Dose Level 2|Death|0|||
105846038|NCT01570283|365094213|FG005|Cohort 2: Dose Level 2|Death|0|||
105846039|NCT01570283|365094208|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
105846040|NCT01570283|365094209|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
105846041|NCT01570283|365094210|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
105846042|NCT01570283|365094211|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
105846043|NCT01570283|365094212|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
105846044|NCT01570283|365094213|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
105846045|NCT01570283|365094208|FG000|Cohort 3: Dose Level 3|Death|0|||
105846046|NCT01570283|365094209|FG001|Cohort 3: Dose Level 3|Death|0|||
105846047|NCT01570283|365094210|FG002|Cohort 3: Dose Level 3|Death|0|||
105846048|NCT01570283|365094211|FG003|Cohort 3: Dose Level 3|Death|0|||
105846049|NCT01570283|365094212|FG004|Cohort 3: Dose Level 3|Death|0|||
105846050|NCT01570283|365094213|FG005|Cohort 3: Dose Level 3|Death|1|||
105846051|NCT01570283|365094208|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
105846052|NCT01570283|365094209|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
105846053|NCT01570283|365094210|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
105846054|NCT01570283|365094211|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
105846055|NCT01570283|365094212|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
105846056|NCT01570283|365094213|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
105846057|NCT00841906|365094216|FG000|Overall Study|Withdrawal by Subject|2|||
105846058|NCT00841906|365094217|FG001|Overall Study|Withdrawal by Subject|0|||
105846059|NCT02072148|365094218|FG000|Overall Study|withdrew prior to surgery|23|||
105846060|NCT02072148|365094219|FG001|Overall Study|withdrew prior to surgery|0|||
105846061|NCT02072148|365094220|FG002|Overall Study|withdrew prior to surgery|0|||
105846062|NCT02072148|365094218|FG000|Overall Study|Death|0|||
105846063|NCT02072148|365094219|FG001|Overall Study|Death|0|||
105846064|NCT02072148|365094220|FG002|Overall Study|Death|1|||
105846065|NCT02072148|365094218|FG000|Overall Study|Withdrawal by Subject|0|||
105846066|NCT02072148|365094219|FG001|Overall Study|Withdrawal by Subject|13|||
105846067|NCT02072148|365094220|FG002|Overall Study|Withdrawal by Subject|12|||
105846068|NCT02017860|365094226|FG000|Overall Study|Adverse Event|1|||
105846069|NCT02017860|365094226|FG000|Overall Study|Withdrawal by Subject|1|||
105846070|NCT00857792|365094227|FG000|Overall Study|inadequate image quality for analysis|12|||
105846071|NCT01797835|365094231|FG000|Overall Study|Lost to Follow-up|31|||
105846072|NCT01797835|365094232|FG001|Overall Study|Lost to Follow-up|27|||
105846073|NCT02528123|365094236|FG000|Overall Study|Lost to Follow-up|1|||
105846074|NCT01195103|365094237|FG000|Overall Study|Withdrawal by Subject|1|||
105846075|NCT01195103|365094238|FG001|Overall Study|Withdrawal by Subject|0|||
105846076|NCT01195103|365094239|FG002|Overall Study|Withdrawal by Subject|0|||
105846077|NCT04421586|365094249|FG000|Overall Study|Death|0|||
105846078|NCT04421586|365094250|FG001|Overall Study|Death|1|||
105846079|NCT04421586|365094249|FG000|Overall Study|Lost to Follow-up|2|||
105846080|NCT04421586|365094250|FG001|Overall Study|Lost to Follow-up|2|||
105846081|NCT04421586|365094249|FG000|Overall Study|Withdrawn by PI|1|||
105846082|NCT04421586|365094250|FG001|Overall Study|Withdrawn by PI|0|||
105846083|NCT04421586|365094249|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
105846084|NCT04421586|365094250|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
105846085|NCT04920916|365094251|FG000|Phase IIa 60 Day Study|Death|2|||
105846086|NCT04920916|365094252|FG001|Phase IIa 60 Day Study|Death|5|||
105846087|NCT04920916|365094251|FG000|1 Year Follow up (Phone Call)|Death|1|||
105846088|NCT04920916|365094252|FG001|1 Year Follow up (Phone Call)|Death|3|||
105846089|NCT04920916|365094251|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
105846090|NCT04920916|365094252|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
105846091|NCT00973765|365094253|FG000|Overall Study|Lost to Follow-up|8|||
105846092|NCT00973765|365094254|FG001|Overall Study|Lost to Follow-up|14|||
105846093|NCT04505293|365094262|FG000|Overall Study|Lost to Follow-up|2|||
105846094|NCT04505293|365094262|FG000|Overall Study|Withdrawal by Subject|6|||
105846095|NCT04505293|365094262|FG000|Overall Study|CT scan unreadable|277|||
105846096|NCT00506129|365094263|FG000|Overall Study|Disease Progression/Relapse|15|||
105846097|NCT00506129|365094263|FG000|Overall Study|Death|7|||
105846098|NCT01642914|365094264|FG000|Overall Study|Adverse Event|11|||
105846099|NCT01642914|365094265|FG001|Overall Study|Adverse Event|7|||
105846100|NCT01642914|365094266|FG002|Overall Study|Adverse Event|15|||
105846101|NCT01642914|365094264|FG000|Overall Study|Lack of Efficacy|9|||
105846102|NCT01642914|365094265|FG001|Overall Study|Lack of Efficacy|4|||
105490322|NCT00107952|363807527|FG001|Overall Study|Withdrawal by Subject|6|||
105490323|NCT00107952|363807526|FG000|Overall Study|Other|2|||
105490324|NCT00107952|363807527|FG001|Overall Study|Other|5|||
105846103|NCT01642914|365094266|FG002|Overall Study|Lack of Efficacy|2|||
105846104|NCT01642914|365094264|FG000|Overall Study|Protocol Violation|15|||
105846105|NCT01642914|365094265|FG001|Overall Study|Protocol Violation|13|||
105846106|NCT01642914|365094266|FG002|Overall Study|Protocol Violation|6|||
105846107|NCT01642914|365094264|FG000|Overall Study|Withdrawal by Subject|5|||
105846108|NCT01642914|365094265|FG001|Overall Study|Withdrawal by Subject|5|||
105846109|NCT01642914|365094266|FG002|Overall Study|Withdrawal by Subject|10|||
105846110|NCT01642914|365094264|FG000|Overall Study|Lost to Follow-up|5|||
105846111|NCT01642914|365094265|FG001|Overall Study|Lost to Follow-up|3|||
105846112|NCT01642914|365094266|FG002|Overall Study|Lost to Follow-up|7|||
105846113|NCT01642914|365094264|FG000|Overall Study|Other Reason|1|||
105846114|NCT01642914|365094265|FG001|Overall Study|Other Reason|0|||
105846115|NCT01642914|365094266|FG002|Overall Study|Other Reason|0|||
105846116|NCT04319159|365094268|FG000|Overall Study|Screening failure|13|||
105846117|NCT04319159|365094268|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
105846118|NCT04319159|365094268|FG000|Overall Study|Withdrawal by Subject|1|||
105846119|NCT02429934|365094273|FG000|Overall Study|Withdrawal by Subject|0|||
105846120|NCT02429934|365094274|FG001|Overall Study|Withdrawal by Subject|2|||
105846121|NCT02429934|365094273|FG000|Overall Study|Adverse Event|2|||
105846122|NCT02429934|365094274|FG001|Overall Study|Adverse Event|0|||
105846123|NCT02429934|365094273|FG000|Overall Study|Lost to Follow-up|1|||
105846124|NCT02429934|365094274|FG001|Overall Study|Lost to Follow-up|1|||
105846125|NCT02429934|365094273|FG000|Overall Study|Physician Decision|1|||
105846126|NCT02429934|365094274|FG001|Overall Study|Physician Decision|0|||
105846127|NCT00869024|365094275|FG000|Overall Study|Death|2|||
105846128|NCT00869024|365094276|FG001|Overall Study|Death|3|||
105846129|NCT00869024|365094275|FG000|Overall Study|Lost to Follow-up|0|||
105846130|NCT00869024|365094276|FG001|Overall Study|Lost to Follow-up|1|||
105846131|NCT00869024|365094275|FG000|Overall Study|Protocol Violation|0|||
105846132|NCT00869024|365094276|FG001|Overall Study|Protocol Violation|1|||
105490325|NCT00107952|363807526|FG000|Overall Study|Never received study treatment|9|||
105490326|NCT00107952|363807527|FG001|Overall Study|Never received study treatment|6|||
105490327|NCT03475875|363807528|FG000|Period 1|Lost to Follow-up|1|||
105490328|NCT03475875|363807529|FG001|Period 1|Lost to Follow-up|0|||
105490329|NCT03475875|363807528|FG000|Period 1|Adverse Event|2|||
105846133|NCT00293202|365094277|FG000|Overall Study|Withdrawal by Subject|1|||
105846134|NCT00293202|365094278|FG001|Overall Study|Withdrawal by Subject|2|||
105846135|NCT00293202|365094277|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
105846136|NCT00293202|365094278|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
105846137|NCT00293202|365094277|FG000|Overall Study|on-hold due to fistula maturation time|1|||
105846138|NCT00293202|365094278|FG001|Overall Study|on-hold due to fistula maturation time|0|||
105846139|NCT00560937|365094281|FG000|Overall Study|Withdrawal by Subject|0|||
105846140|NCT00560937|365094282|FG001|Overall Study|Withdrawal by Subject|1|||
105846141|NCT00560937|365094281|FG000|Overall Study|Physician Decision|1|||
105846142|NCT00560937|365094282|FG001|Overall Study|Physician Decision|1|||
105846143|NCT01138111|365094285|FG000|Overall Study|Withdrawal by Subject|5|||
105846144|NCT01138111|365094285|FG000|Overall Study|Adverse Event|1|||
105316626|NCT00086281|363154746|FG010|Phase 2|Adverse Event|0|||
105316627|NCT00086281|363154747|FG011|Phase 2|Adverse Event|0|||
105316628|NCT00086281|363154748|FG012|Phase 2|Adverse Event|1|||
105316629|NCT00086281|363154749|FG013|Phase 2|Adverse Event|1|||
105316630|NCT00086281|363154750|FG014|Phase 2|Adverse Event|0|||
105316631|NCT01098487|363154754|FG000|Overall Study|Adverse Event|22|||
105316632|NCT01098487|363154754|FG000|Overall Study|Lack of Efficacy|11|||
105316633|NCT01098487|363154754|FG000|Overall Study|Withdrawal by Subject|7|||
105316634|NCT01098487|363154754|FG000|Overall Study|Lost to Follow-up|3|||
105316635|NCT01098487|363154754|FG000|Overall Study|Physician Decision|1|||
105316636|NCT01301729|363154755|FG000|Overall Study|Withdrawal by Subject|2|||
105316637|NCT01301729|363154755|FG000|Overall Study|Participant did not Return for Treatment|1|||
105316638|NCT01301729|363154755|FG000|Overall Study|Violated Selection Criteria|1|||
105846145|NCT01138111|365094285|FG000|Overall Study|Death|1|||
105846146|NCT01138111|365094285|FG000|Overall Study|Lost to Follow-up|2|||
105846147|NCT02377063|365094288|FG000|Overall Study|Non-compliance|5|||
105846148|NCT03456960|365094291|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
105846149|NCT03456960|365094292|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
105846150|NCT03456960|365094293|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
105846151|NCT03456960|365094294|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
105846152|NCT03456960|365094295|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
105846153|NCT03456960|365094296|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
105846154|NCT03456960|365094291|FG000|Period 2 (1 Day)|Adverse Event|1|||
105846155|NCT03456960|365094292|FG001|Period 2 (1 Day)|Adverse Event|0|||
105846156|NCT03456960|365094293|FG002|Period 2 (1 Day)|Adverse Event|0|||
105846157|NCT03456960|365094294|FG003|Period 2 (1 Day)|Adverse Event|1|||
105846158|NCT03456960|365094295|FG004|Period 2 (1 Day)|Adverse Event|0|||
105846159|NCT03456960|365094296|FG005|Period 2 (1 Day)|Adverse Event|0|||
105846160|NCT03828448|365094297|FG000|Overall Study|Sponsor's Discretion|34|||
105846161|NCT02037165|365094300|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
105846162|NCT02037165|365094301|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
105846163|NCT02037165|365094302|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
105846164|NCT02037165|365094303|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
105846165|NCT02037165|365094304|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
105846166|NCT02939014|365094305|FG000|Overall Study|Lost to Follow-up|1|||
105846167|NCT02939014|365094306|FG001|Overall Study|Lost to Follow-up|0|||
105846168|NCT02939014|365094305|FG000|Overall Study|Death|4|||
105846169|NCT02939014|365094306|FG001|Overall Study|Death|3|||
105846170|NCT00456495|365094307|FG000|Overall Study|Physician Decision|2|||
105846171|NCT02192164|365094308|FG000|Overall Study|Other|8|||
105846172|NCT02192164|365094308|FG000|Overall Study|Withdrawal by Subject|1|||
105846173|NCT02192164|365094308|FG000|Overall Study|Physician Decision|4|||
105846174|NCT02192164|365094308|FG000|Overall Study|Did not meet the exclusion criteria|1|||
105846175|NCT01300923|365094309|FG000|Overall Study|Physician Decision|0|||
105846176|NCT01300923|365094310|FG001|Overall Study|Physician Decision|2|||
105846177|NCT01568866|365094311|FG000|Overall Study|Disease Progression|208|||
105846178|NCT01568866|365094312|FG001|Overall Study|Disease Progression|183|||
105846179|NCT01568866|365094311|FG000|Overall Study|Adverse Event|94|||
105846180|NCT01568866|365094312|FG001|Overall Study|Adverse Event|96|||
105846181|NCT01568866|365094311|FG000|Overall Study|Patient Request|55|||
105846182|NCT01568866|365094312|FG001|Overall Study|Patient Request|71|||
105846183|NCT01568866|365094311|FG000|Overall Study|Physician Decision|40|||
105846184|NCT01568866|365094312|FG001|Overall Study|Physician Decision|32|||
105846185|NCT01568866|365094311|FG000|Overall Study|Withdrawal by Subject|19|||
105846186|NCT01568866|365094312|FG001|Overall Study|Withdrawal by Subject|11|||
105846187|NCT01568866|365094311|FG000|Overall Study|Death|10|||
105846188|NCT01568866|365094312|FG001|Overall Study|Death|18|||
105846189|NCT01568866|365094311|FG000|Overall Study|Protocol Non-compliance|2|||
105846190|NCT01568866|365094312|FG001|Overall Study|Protocol Non-compliance|4|||
105846191|NCT01568866|365094311|FG000|Overall Study|Lost to Follow-up|1|||
105846192|NCT01568866|365094312|FG001|Overall Study|Lost to Follow-up|0|||
105846193|NCT01568866|365094311|FG000|Overall Study|Randomized but Not Dosed|9|||
105368804|NCT02669849|363356290|FG000|Overall Study|Study terminated by sponsor|16|||
105846194|NCT01568866|365094312|FG001|Overall Study|Randomized but Not Dosed|1|||
105846195|NCT03864042|365094313|FG000|DDI Phase|Adverse Event|2|||
105846196|NCT03864042|365094314|FG001|DDI Phase|Adverse Event|0|||
105846197|NCT03864042|365094315|FG002|DDI Phase|Adverse Event|0|||
105316639|NCT05794503|363154756|FG000|Overall Study|Operation Cancelled|2|||
105316640|NCT05794503|363154757|FG001|Overall Study|Operation Cancelled|0|||
105368805|NCT02669849|363356291|FG001|Overall Study|Study terminated by sponsor|1|||
105846198|NCT03864042|365094313|FG000|DDI Phase|Physician Decision|1|||
105846199|NCT03864042|365094314|FG001|DDI Phase|Physician Decision|0|||
105846200|NCT03864042|365094315|FG002|DDI Phase|Physician Decision|0|||
105846201|NCT03864042|365094313|FG000|DDI Phase|Progressive Disease|1|||
105846202|NCT03864042|365094314|FG001|DDI Phase|Progressive Disease|0|||
105316641|NCT05794503|363154756|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
105490330|NCT03475875|363807529|FG001|Period 1|Adverse Event|1|||
105846203|NCT03864042|365094315|FG002|DDI Phase|Progressive Disease|0|||
105846204|NCT03864042|365094313|FG000|Post-DDI Phase|Adverse Event|5|||
105846205|NCT03864042|365094314|FG001|Post-DDI Phase|Adverse Event|3|||
105846206|NCT03864042|365094315|FG002|Post-DDI Phase|Adverse Event|2|||
105846207|NCT03864042|365094313|FG000|Post-DDI Phase|Progressive Disease|11|||
105846208|NCT03864042|365094314|FG001|Post-DDI Phase|Progressive Disease|6|||
105846209|NCT03864042|365094315|FG002|Post-DDI Phase|Progressive Disease|13|||
105846210|NCT03864042|365094313|FG000|Post-DDI Phase|Discretion of investigator|1|||
105846211|NCT03864042|365094314|FG001|Post-DDI Phase|Discretion of investigator|1|||
105846212|NCT03864042|365094315|FG002|Post-DDI Phase|Discretion of investigator|0|||
105846213|NCT03864042|365094313|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
105846214|NCT03864042|365094314|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
105846215|NCT03864042|365094315|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
105846216|NCT03864042|365094313|FG000|Post-DDI Phase|Withdrawal of consent|1|||
105846217|NCT03864042|365094314|FG001|Post-DDI Phase|Withdrawal of consent|2|||
105846218|NCT03864042|365094315|FG002|Post-DDI Phase|Withdrawal of consent|0|||
105846219|NCT01244061|365094316|FG000|Overall Study|Death|1|||
105846220|NCT01244061|365094317|FG001|Overall Study|Death|0|||
105846221|NCT01244061|365094316|FG000|Overall Study|Did not meet entrance criteria|1|||
105846222|NCT01244061|365094317|FG001|Overall Study|Did not meet entrance criteria|0|||
105846223|NCT01244061|365094316|FG000|Overall Study|Lack of Efficacy|1|||
105846224|NCT01244061|365094317|FG001|Overall Study|Lack of Efficacy|3|||
105846225|NCT01244061|365094316|FG000|Overall Study|Lost to Follow-up|34|||
105846226|NCT01244061|365094317|FG001|Overall Study|Lost to Follow-up|30|||
105846227|NCT01244061|365094316|FG000|Overall Study|Withdrawal by Subject|29|||
105846228|NCT01244061|365094317|FG001|Overall Study|Withdrawal by Subject|46|||
105846229|NCT01244061|365094316|FG000|Overall Study|Other|8|||
105846230|NCT01244061|365094317|FG001|Overall Study|Other|19|||
105846231|NCT01244061|365094316|FG000|Overall Study|Protocol Violation|1|||
105846232|NCT01244061|365094317|FG001|Overall Study|Protocol Violation|1|||
105846233|NCT01244061|365094316|FG000|Overall Study|Adverse Event|5|||
105846234|NCT01244061|365094317|FG001|Overall Study|Adverse Event|2|||
105846235|NCT01244061|365094316|FG000|Overall Study|Randomized but not treated|2|||
105846236|NCT01244061|365094317|FG001|Overall Study|Randomized but not treated|2|||
105846237|NCT02450526|365094320|FG000|DB Period (Cycle 1)|Adverse Event|0|||
105846238|NCT02450526|365094321|FG001|DB Period (Cycle 1)|Adverse Event|0|||
105846239|NCT02450526|365094322|FG002|DB Period (Cycle 1)|Adverse Event|2|||
105846240|NCT02450526|365094323|FG003|DB Period (Cycle 1)|Adverse Event|0|||
105846241|NCT02450526|365094324|FG004|DB Period (Cycle 1)|Adverse Event|0|||
105846242|NCT02450526|365094320|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
105846243|NCT02450526|365094321|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
105846244|NCT02450526|365094322|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
105846245|NCT02450526|365094323|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
105846246|NCT02450526|365094324|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
105846247|NCT02450526|365094320|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
105846248|NCT02450526|365094321|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
105846249|NCT02450526|365094322|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
105846250|NCT02450526|365094323|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
105846251|NCT02450526|365094324|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
105846252|NCT02450526|365094320|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
105846253|NCT02450526|365094321|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
105846254|NCT02450526|365094322|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
105846255|NCT02450526|365094323|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
105846256|NCT02450526|365094324|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
105846257|NCT02450526|365094320|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
105846258|NCT02450526|365094321|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
105846259|NCT02450526|365094322|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
105846260|NCT02450526|365094323|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
105846261|NCT02450526|365094324|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
105846262|NCT02450526|365094320|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
105846263|NCT02450526|365094321|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
105846264|NCT02450526|365094322|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
105846265|NCT02450526|365094323|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
105846266|NCT02450526|365094324|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
105846267|NCT02450526|365094320|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
105490331|NCT03475875|363807528|FG000|Period 2|Adverse Event|3|||
105490332|NCT03475875|363807529|FG001|Period 2|Adverse Event|0|||
105490333|NCT03475875|363807528|FG000|Period 2|Protocol Violation|0|||
105490334|NCT03475875|363807529|FG001|Period 2|Protocol Violation|1|||
105490335|NCT01642407|363807530|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
105490336|NCT01642407|363807530|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
105846268|NCT02450526|365094321|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
105846269|NCT02450526|365094322|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
105846270|NCT02450526|365094323|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
105576725|NCT02293837|364110302|FG000|Overall Study|Withdrawal by Subject|2|||
105846271|NCT02450526|365094324|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
105490337|NCT01642407|363807530|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
105490338|NCT04718103|363807531|FG000|Overall Study|Adverse Event|1|||
105846272|NCT02450526|365094320|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
105846273|NCT02450526|365094321|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
105846274|NCT02450526|365094322|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
105846275|NCT02450526|365094323|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
105846276|NCT02450526|365094324|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
105846277|NCT00321737|365094327|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
105846278|NCT00321737|365094328|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
105846279|NCT00321737|365094329|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
105846280|NCT00321737|365094327|FG000|Overall Study|Adverse Event|11|||
105846281|NCT00321737|365094328|FG001|Overall Study|Adverse Event|3|||
105846282|NCT00321737|365094329|FG002|Overall Study|Adverse Event|6|||
105846283|NCT00321737|365094327|FG000|Overall Study|Lost to Follow-up|5|||
105846284|NCT00321737|365094328|FG001|Overall Study|Lost to Follow-up|5|||
105846285|NCT00321737|365094329|FG002|Overall Study|Lost to Follow-up|6|||
105846286|NCT00321737|365094327|FG000|Overall Study|Withdrawal by Subject|19|||
105846287|NCT00321737|365094328|FG001|Overall Study|Withdrawal by Subject|12|||
105846288|NCT00321737|365094329|FG002|Overall Study|Withdrawal by Subject|17|||
105846289|NCT00321737|365094327|FG000|Overall Study|Protocol Violation|0|||
105846290|NCT00321737|365094328|FG001|Overall Study|Protocol Violation|0|||
105846291|NCT00321737|365094329|FG002|Overall Study|Protocol Violation|1|||
105846292|NCT00321737|365094327|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
105846293|NCT00321737|365094328|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
105846294|NCT00321737|365094329|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
105846295|NCT00321737|365094327|FG000|Overall Study|Possible Barrett's Esophagus|2|||
105846296|NCT00321737|365094328|FG001|Overall Study|Possible Barrett's Esophagus|1|||
105846297|NCT00321737|365094329|FG002|Overall Study|Possible Barrett's Esophagus|1|||
105576726|NCT02293837|364110303|FG001|Overall Study|Withdrawal by Subject|1|||
105576727|NCT02293837|364110304|FG002|Overall Study|Withdrawal by Subject|2|||
105576728|NCT02293837|364110305|FG003|Overall Study|Withdrawal by Subject|1|||
105576729|NCT02293837|364110302|FG000|Overall Study|COVID-19 Related|1|||
105576730|NCT02293837|364110303|FG001|Overall Study|COVID-19 Related|1|||
105576731|NCT02293837|364110304|FG002|Overall Study|COVID-19 Related|0|||
105846298|NCT00321737|365094327|FG000|Overall Study|Therapeutic Failure|6|||
105846299|NCT00321737|365094328|FG001|Overall Study|Therapeutic Failure|0|||
105846300|NCT00321737|365094329|FG002|Overall Study|Therapeutic Failure|2|||
105846301|NCT00321737|365094327|FG000|Overall Study|Pregnancy|0|||
105846302|NCT00321737|365094328|FG001|Overall Study|Pregnancy|2|||
105846303|NCT00321737|365094329|FG002|Overall Study|Pregnancy|0|||
105846304|NCT00321737|365094327|FG000|Overall Study|Noncompliance|2|||
105846305|NCT00321737|365094328|FG001|Overall Study|Noncompliance|0|||
105846306|NCT00321737|365094329|FG002|Overall Study|Noncompliance|0|||
105846307|NCT00321737|365094327|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
105846308|NCT00321737|365094328|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
105846309|NCT00321737|365094329|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
105846310|NCT01079832|365094330|FG000|Overall Study|Withdrawal by Subject|1|||
105846311|NCT01232491|365094331|FG000|Overall Study|Adverse Event|13|||
105846312|NCT01232491|365094332|FG001|Overall Study|Adverse Event|8|||
105846313|NCT01232491|365094331|FG000|Overall Study|Lack of Efficacy|1|||
105846314|NCT01232491|365094332|FG001|Overall Study|Lack of Efficacy|5|||
105846315|NCT01232491|365094331|FG000|Overall Study|Protocol Violation|13|||
105846316|NCT01232491|365094332|FG001|Overall Study|Protocol Violation|11|||
105846317|NCT01232491|365094331|FG000|Overall Study|Withdrawal Criteria|12|||
105846318|NCT01232491|365094332|FG001|Overall Study|Withdrawal Criteria|21|||
105846319|NCT01232491|365094331|FG000|Overall Study|Other|21|||
105846320|NCT01232491|365094332|FG001|Overall Study|Other|18|||
105846321|NCT04969861|365094333|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
105846322|NCT04969861|365094334|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
105846323|NCT02932228|365094339|FG000|Overall Study|Death|8|||
105846324|NCT02932228|365094340|FG001|Overall Study|Death|23|||
105846325|NCT02932228|365094339|FG000|Overall Study|not eligible upon chart review|2|||
105846326|NCT02932228|365094340|FG001|Overall Study|not eligible upon chart review|5|||
105846327|NCT04223778|365094341|FG000|Overall Study|Ongoing|322|||
105846328|NCT04223778|365094342|FG001|Overall Study|Ongoing|326|||
105368806|NCT02669849|363356292|FG002|Overall Study|Study terminated by sponsor|14|||
105368807|NCT02669849|363356290|FG000|Overall Study|Other|0|||
105846329|NCT04223778|365094341|FG000|Overall Study|Death|0|||
105846330|NCT04223778|365094342|FG001|Overall Study|Death|1|||
105846331|NCT04223778|365094341|FG000|Overall Study|Lost to Follow-up|1|||
105846332|NCT04223778|365094342|FG001|Overall Study|Lost to Follow-up|5|||
105846333|NCT04223778|365094341|FG000|Overall Study|Physician Decision|3|||
105846334|NCT04223778|365094342|FG001|Overall Study|Physician Decision|1|||
105846335|NCT04223778|365094341|FG000|Overall Study|Withdrawal by Subject|10|||
105846336|NCT04223778|365094342|FG001|Overall Study|Withdrawal by Subject|1|||
105846337|NCT04223778|365094341|FG000|Overall Study|Lack of Efficacy|0|||
105846338|NCT04223778|365094342|FG001|Overall Study|Lack of Efficacy|2|||
105846339|NCT04905290|365096034|FG000|Overall Study|Adverse Event|4|||
105576732|NCT02293837|364110305|FG003|Overall Study|COVID-19 Related|0|||
105846340|NCT04905290|365096034|FG000|Overall Study|Death|2|||
105846341|NCT04905290|365096034|FG000|Overall Study|Withdrawal by Subject|4|||
105846342|NCT04905290|365096034|FG000|Overall Study|Physician Decision|2|||
105846343|NCT04905290|365096034|FG000|Overall Study|Lost to Follow-up|2|||
105846344|NCT04905290|365096034|FG000|Overall Study|Screen Failure|2|||
105846345|NCT04905290|365096034|FG000|Overall Study|Unsuccessful Procedure|2|||
105846346|NCT00003138|365096035|FG000|Step 1|Reasons off treatment not documented|60|||
105846347|NCT00003138|365096036|FG001|Step 1|Reasons off treatment not documented|57|||
105846348|NCT00003138|365096035|FG000|Step 1|Never started treatment|1|||
105846349|NCT00003138|365096036|FG001|Step 1|Never started treatment|0|||
105846350|NCT00003138|365096035|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
105846351|NCT00003138|365096036|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
105846352|NCT00003138|365096035|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
105846353|NCT00003138|365096036|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
105846354|NCT00003138|365096035|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
105846355|NCT00003138|365096036|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
105846356|NCT00003138|365096035|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
105846357|NCT00003138|365096036|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
105846358|NCT04319718|365096037|FG000|Overall Study|Adverse Event|0|||
105316642|NCT05794503|363154757|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
105316643|NCT05794503|363154756|FG000|Overall Study|Protocol Violation|1|||
105316644|NCT05794503|363154757|FG001|Overall Study|Protocol Violation|0|||
105316645|NCT01885195|363154758|FG000|Overall Study|Adverse Event|29|||
105316646|NCT01885195|363154758|FG000|Overall Study|Death|1|||
105316647|NCT01885195|363154758|FG000|Overall Study|Disease Progression|67|||
105316648|NCT01885195|363154758|FG000|Overall Study|Protocol Deviation|2|||
105316649|NCT01885195|363154758|FG000|Overall Study|Physician Decision|3|||
105316650|NCT01885195|363154758|FG000|Overall Study|Patient/guardian decision|8|||
105316651|NCT01957176|363154761|FG000|Overall Study|Adverse Event|2|||
105316652|NCT01957176|363154762|FG001|Overall Study|Adverse Event|0|||
105316653|NCT01957176|363154761|FG000|Overall Study|Physician Decision|2|||
105316654|NCT01957176|363154762|FG001|Overall Study|Physician Decision|1|||
105316655|NCT01957176|363154761|FG000|Overall Study|Withdrawal by Subject|1|||
105316656|NCT01957176|363154762|FG001|Overall Study|Withdrawal by Subject|0|||
105316657|NCT01464931|363154763|FG000|Overall Study|Withdrawal by Subject|1|||
105316658|NCT01464931|363154764|FG001|Overall Study|Withdrawal by Subject|0|||
105316659|NCT00839254|363154765|FG000|Overall Study|Protocol Violation|0|||
105316660|NCT00839254|363154766|FG001|Overall Study|Protocol Violation|1|||
105316661|NCT00839254|363154767|FG002|Overall Study|Protocol Violation|1|||
105316662|NCT00839254|363154768|FG003|Overall Study|Protocol Violation|1|||
105316663|NCT00839254|363154769|FG004|Overall Study|Protocol Violation|0|||
105316664|NCT00839254|363154770|FG005|Overall Study|Protocol Violation|0|||
105316665|NCT00839254|363154771|FG006|Overall Study|Protocol Violation|1|||
105316666|NCT00839254|363154772|FG007|Overall Study|Protocol Violation|2|||
105316667|NCT00839254|363154765|FG000|Overall Study|Physician Decision|0|||
105316668|NCT00839254|363154766|FG001|Overall Study|Physician Decision|1|||
105316669|NCT00839254|363154767|FG002|Overall Study|Physician Decision|0|||
105316670|NCT00839254|363154768|FG003|Overall Study|Physician Decision|0|||
105316671|NCT00839254|363154769|FG004|Overall Study|Physician Decision|0|||
105316672|NCT00839254|363154770|FG005|Overall Study|Physician Decision|0|||
105316673|NCT00839254|363154771|FG006|Overall Study|Physician Decision|0|||
105316674|NCT00839254|363154772|FG007|Overall Study|Physician Decision|1|||
105316675|NCT00839254|363154765|FG000|Overall Study|Wrong treatment number allocation|0|||
105316676|NCT00839254|363154766|FG001|Overall Study|Wrong treatment number allocation|1|||
105316677|NCT00839254|363154767|FG002|Overall Study|Wrong treatment number allocation|0|||
105316678|NCT00839254|363154768|FG003|Overall Study|Wrong treatment number allocation|0|||
105316679|NCT00839254|363154769|FG004|Overall Study|Wrong treatment number allocation|0|||
105316680|NCT00839254|363154770|FG005|Overall Study|Wrong treatment number allocation|1|||
105316681|NCT00839254|363154771|FG006|Overall Study|Wrong treatment number allocation|0|||
105316682|NCT00839254|363154772|FG007|Overall Study|Wrong treatment number allocation|0|||
105316683|NCT00839254|363154765|FG000|Overall Study|Adverse Event|12|||
105316684|NCT00839254|363154766|FG001|Overall Study|Adverse Event|6|||
105316685|NCT00839254|363154767|FG002|Overall Study|Adverse Event|3|||
105316686|NCT00839254|363154768|FG003|Overall Study|Adverse Event|5|||
105316687|NCT00839254|363154769|FG004|Overall Study|Adverse Event|2|||
105316688|NCT00839254|363154770|FG005|Overall Study|Adverse Event|1|||
105316689|NCT00839254|363154771|FG006|Overall Study|Adverse Event|0|||
105316690|NCT00839254|363154772|FG007|Overall Study|Adverse Event|1|||
105846359|NCT04319718|365096038|FG001|Overall Study|Adverse Event|2|||
105316691|NCT00839254|363154765|FG000|Overall Study|Withdrawal by Subject|87|||
105316692|NCT00839254|363154766|FG001|Overall Study|Withdrawal by Subject|53|||
105316693|NCT00839254|363154767|FG002|Overall Study|Withdrawal by Subject|54|||
105316694|NCT00839254|363154768|FG003|Overall Study|Withdrawal by Subject|32|||
105316695|NCT00839254|363154769|FG004|Overall Study|Withdrawal by Subject|27|||
105316696|NCT00839254|363154770|FG005|Overall Study|Withdrawal by Subject|15|||
105316697|NCT00839254|363154771|FG006|Overall Study|Withdrawal by Subject|22|||
105846360|NCT04319718|365096037|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
105846361|NCT04319718|365096038|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
105846362|NCT03340064|365096039|FG000|First Period|Adverse Event, non-fatal|2|||
105846363|NCT03340064|365096040|FG001|First Period|Adverse Event, non-fatal|0|||
105846364|NCT03340064|365096039|FG000|First Period|Lack of Efficacy|3|||
105846365|NCT03340064|365096040|FG001|First Period|Lack of Efficacy|0|||
105846366|NCT03340064|365096039|FG000|Second Period|Adverse Event, non-fatal|1|||
105846367|NCT03340064|365096040|FG001|Second Period|Adverse Event, non-fatal|1|||
105846368|NCT03340064|365096039|FG000|Second Period|Lack of Efficacy|11|||
105846369|NCT03340064|365096040|FG001|Second Period|Lack of Efficacy|0|||
105846370|NCT03340064|365096039|FG000|Second Period|Physician Decision|3|||
105846371|NCT03340064|365096040|FG001|Second Period|Physician Decision|0|||
105846372|NCT03340064|365096039|FG000|Second Period|Withdrawal by Subject|2|||
105846373|NCT03340064|365096040|FG001|Second Period|Withdrawal by Subject|1|||
105846374|NCT03340064|365096039|FG000|Second Period|Approved Drug Available For Indication|1|||
105846375|NCT03340064|365096040|FG001|Second Period|Approved Drug Available For Indication|0|||
105846376|NCT03340064|365096039|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
105846377|NCT03340064|365096040|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
105846378|NCT01045421|365096041|FG000|Phase 1|Progressive Disease|0|||
105846379|NCT01045421|365096042|FG001|Phase 1|Progressive Disease|0|||
105846380|NCT01045421|365096043|FG002|Phase 1|Progressive Disease|0|||
105846381|NCT01045421|365096044|FG003|Phase 1|Progressive Disease|0|||
105846382|NCT01045421|365096045|FG004|Phase 1|Progressive Disease|1|||
105846383|NCT01045421|365096046|FG005|Phase 1|Progressive Disease|0|||
105846384|NCT01045421|365096047|FG006|Phase 1|Progressive Disease|0|||
105846385|NCT01045421|365096048|FG007|Phase 1|Progressive Disease|0|||
105846386|NCT01045421|365096049|FG008|Phase 1|Progressive Disease|0|||
105846387|NCT01045421|365096050|FG009|Phase 1|Progressive Disease|0|||
105846388|NCT01045421|365096051|FG010|Phase 1|Progressive Disease|0|||
105846389|NCT01045421|365096041|FG000|Phase 1|Withdrawal by Subject|0|||
105846390|NCT01045421|365096042|FG001|Phase 1|Withdrawal by Subject|0|||
105846391|NCT01045421|365096043|FG002|Phase 1|Withdrawal by Subject|0|||
105846392|NCT01045421|365096044|FG003|Phase 1|Withdrawal by Subject|1|||
105846393|NCT01045421|365096045|FG004|Phase 1|Withdrawal by Subject|0|||
105846394|NCT01045421|365096046|FG005|Phase 1|Withdrawal by Subject|0|||
105846395|NCT01045421|365096047|FG006|Phase 1|Withdrawal by Subject|0|||
105846396|NCT01045421|365096048|FG007|Phase 1|Withdrawal by Subject|0|||
105846397|NCT01045421|365096049|FG008|Phase 1|Withdrawal by Subject|0|||
105846398|NCT01045421|365096050|FG009|Phase 1|Withdrawal by Subject|0|||
105846399|NCT01045421|365096051|FG010|Phase 1|Withdrawal by Subject|0|||
105846400|NCT01045421|365096041|FG000|Phase 2|Progressive Disease|0|||
105846401|NCT01045421|365096042|FG001|Phase 2|Progressive Disease|0|||
105846402|NCT01045421|365096043|FG002|Phase 2|Progressive Disease|0|||
105846403|NCT01045421|365096044|FG003|Phase 2|Progressive Disease|0|||
105846404|NCT01045421|365096045|FG004|Phase 2|Progressive Disease|0|||
105846405|NCT01045421|365096046|FG005|Phase 2|Progressive Disease|0|||
105846406|NCT01045421|365096047|FG006|Phase 2|Progressive Disease|0|||
105846407|NCT01045421|365096048|FG007|Phase 2|Progressive Disease|1|||
105846408|NCT01045421|365096049|FG008|Phase 2|Progressive Disease|1|||
105846409|NCT01045421|365096050|FG009|Phase 2|Progressive Disease|1|||
105846410|NCT01045421|365096051|FG010|Phase 2|Progressive Disease|1|||
105846411|NCT01045421|365096041|FG000|Phase 2|Death|0|||
105846412|NCT01045421|365096042|FG001|Phase 2|Death|0|||
105846413|NCT01045421|365096043|FG002|Phase 2|Death|0|||
105846414|NCT01045421|365096044|FG003|Phase 2|Death|0|||
105846415|NCT01045421|365096045|FG004|Phase 2|Death|0|||
105846416|NCT01045421|365096046|FG005|Phase 2|Death|0|||
105846417|NCT01045421|365096047|FG006|Phase 2|Death|0|||
105846418|NCT01045421|365096048|FG007|Phase 2|Death|1|||
105846419|NCT01045421|365096049|FG008|Phase 2|Death|1|||
105846420|NCT01045421|365096050|FG009|Phase 2|Death|2|||
105846421|NCT01045421|365096051|FG010|Phase 2|Death|0|||
105846422|NCT01045421|365096041|FG000|Phase 2|Other|0|||
105846423|NCT01045421|365096042|FG001|Phase 2|Other|0|||
105846424|NCT01045421|365096043|FG002|Phase 2|Other|0|||
105846425|NCT01045421|365096044|FG003|Phase 2|Other|0|||
105316698|NCT00839254|363154772|FG007|Overall Study|Withdrawal by Subject|9|||
105316699|NCT00839254|363154765|FG000|Overall Study|Wrong group allocation|0|||
105846426|NCT01045421|365096045|FG004|Phase 2|Other|0|||
105316700|NCT00839254|363154766|FG001|Overall Study|Wrong group allocation|0|||
105316701|NCT00839254|363154767|FG002|Overall Study|Wrong group allocation|0|||
105316702|NCT00839254|363154768|FG003|Overall Study|Wrong group allocation|0|||
105846427|NCT01045421|365096046|FG005|Phase 2|Other|0|||
105846428|NCT01045421|365096047|FG006|Phase 2|Other|0|||
105846429|NCT01045421|365096048|FG007|Phase 2|Other|3|||
105846430|NCT01045421|365096049|FG008|Phase 2|Other|0|||
105846431|NCT01045421|365096050|FG009|Phase 2|Other|0|||
105846432|NCT01045421|365096051|FG010|Phase 2|Other|1|||
105846433|NCT02091141|365096059|FG000|Overall Study|Death|280|||
105846434|NCT02091141|365096060|FG001|Overall Study|Death|118|||
105846435|NCT02091141|365096061|FG002|Overall Study|Death|46|||
105846436|NCT02091141|365096062|FG003|Overall Study|Death|13|||
105316703|NCT00839254|363154769|FG004|Overall Study|Wrong group allocation|0|||
105316704|NCT00839254|363154770|FG005|Overall Study|Wrong group allocation|0|||
105316705|NCT00839254|363154771|FG006|Overall Study|Wrong group allocation|1|||
105316706|NCT00839254|363154772|FG007|Overall Study|Wrong group allocation|0|||
105316707|NCT00839254|363154765|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
105316708|NCT00839254|363154766|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
105316709|NCT00839254|363154767|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
105316710|NCT00839254|363154768|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
105316711|NCT00839254|363154769|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
105316712|NCT00839254|363154770|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
105316713|NCT00839254|363154771|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
105316714|NCT00839254|363154772|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
105316715|NCT00839254|363154765|FG000|Overall Study|Withdrawn due to non-compliance|2|||
105316716|NCT00839254|363154766|FG001|Overall Study|Withdrawn due to non-compliance|0|||
105316717|NCT00839254|363154767|FG002|Overall Study|Withdrawn due to non-compliance|0|||
105316718|NCT00839254|363154768|FG003|Overall Study|Withdrawn due to non-compliance|0|||
105316719|NCT00839254|363154769|FG004|Overall Study|Withdrawn due to non-compliance|0|||
105316720|NCT00839254|363154770|FG005|Overall Study|Withdrawn due to non-compliance|0|||
105316721|NCT00839254|363154771|FG006|Overall Study|Withdrawn due to non-compliance|0|||
105316722|NCT00839254|363154772|FG007|Overall Study|Withdrawn due to non-compliance|0|||
105316723|NCT00839254|363154765|FG000|Overall Study|Lost to Follow-up|51|||
105316724|NCT00839254|363154766|FG001|Overall Study|Lost to Follow-up|30|||
105316725|NCT00839254|363154767|FG002|Overall Study|Lost to Follow-up|32|||
105316726|NCT00839254|363154768|FG003|Overall Study|Lost to Follow-up|24|||
105316727|NCT00839254|363154769|FG004|Overall Study|Lost to Follow-up|8|||
105316728|NCT00839254|363154770|FG005|Overall Study|Lost to Follow-up|8|||
105316729|NCT00839254|363154771|FG006|Overall Study|Lost to Follow-up|4|||
105316730|NCT00839254|363154772|FG007|Overall Study|Lost to Follow-up|2|||
105316731|NCT02359994|363154773|FG000|Overall Population Study|Adverse Event|1|||
105316732|NCT02359994|363154774|FG001|Overall Population Study|Adverse Event|1|||
105316733|NCT02359994|363154773|FG000|Overall Population Study|Death|1|||
105316734|NCT02359994|363154774|FG001|Overall Population Study|Death|5|||
105316735|NCT02359994|363154773|FG000|Overall Population Study|Lost to Follow-up|1|||
105316736|NCT02359994|363154774|FG001|Overall Population Study|Lost to Follow-up|1|||
105316737|NCT02359994|363154773|FG000|Overall Population Study|Withdrawal by Subject|1|||
105316738|NCT02359994|363154774|FG001|Overall Population Study|Withdrawal by Subject|0|||
105316739|NCT02359994|363154773|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
105316740|NCT02359994|363154774|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
105316741|NCT02359994|363154773|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
105316742|NCT02359994|363154774|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
105316743|NCT02359994|363154773|FG000|Extended Oncology 24-Month Survival|Death|19|||
105316744|NCT02359994|363154774|FG001|Extended Oncology 24-Month Survival|Death|21|||
105316745|NCT02359994|363154773|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
105316746|NCT02359994|363154774|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
105316747|NCT00919854|363154779|FG000|Overall Study|Adverse Event|1|||
105316748|NCT02682927|363154780|FG000|Overall Study|Adverse Event|0|||
105316749|NCT02682927|363154781|FG001|Overall Study|Adverse Event|0|||
105316750|NCT02682927|363154782|FG002|Overall Study|Adverse Event|5|||
105316751|NCT02682927|363154783|FG003|Overall Study|Adverse Event|1|||
105316752|NCT02682927|363154784|FG004|Overall Study|Adverse Event|0|||
105316753|NCT02682927|363154785|FG005|Overall Study|Adverse Event|2|||
105316754|NCT02682927|363154780|FG000|Overall Study|Death|0|||
105316755|NCT02682927|363154781|FG001|Overall Study|Death|0|||
105316756|NCT02682927|363154782|FG002|Overall Study|Death|0|||
105316757|NCT02682927|363154783|FG003|Overall Study|Death|1|||
105316758|NCT02682927|363154784|FG004|Overall Study|Death|0|||
105316759|NCT02682927|363154785|FG005|Overall Study|Death|0|||
105316760|NCT02682927|363154780|FG000|Overall Study|Lack of Efficacy|1|||
105316761|NCT02682927|363154781|FG001|Overall Study|Lack of Efficacy|0|||
105316762|NCT02682927|363154782|FG002|Overall Study|Lack of Efficacy|0|||
105316763|NCT02682927|363154783|FG003|Overall Study|Lack of Efficacy|1|||
105316764|NCT02682927|363154784|FG004|Overall Study|Lack of Efficacy|0|||
105846437|NCT02091141|365096063|FG004|Overall Study|Death|31|||
105316765|NCT02682927|363154785|FG005|Overall Study|Lack of Efficacy|0|||
105316766|NCT02682927|363154780|FG000|Overall Study|Other|0|||
105316767|NCT02682927|363154781|FG001|Overall Study|Other|0|||
105316768|NCT02682927|363154782|FG002|Overall Study|Other|0|||
105316769|NCT02682927|363154783|FG003|Overall Study|Other|2|||
105316770|NCT02682927|363154784|FG004|Overall Study|Other|0|||
105316771|NCT02682927|363154785|FG005|Overall Study|Other|0|||
105316772|NCT02682927|363154780|FG000|Overall Study|Withdrawal by Subject|2|||
105316773|NCT02682927|363154781|FG001|Overall Study|Withdrawal by Subject|0|||
105316774|NCT02682927|363154782|FG002|Overall Study|Withdrawal by Subject|1|||
105316775|NCT02682927|363154783|FG003|Overall Study|Withdrawal by Subject|0|||
105846438|NCT02091141|365096064|FG005|Overall Study|Death|16|||
105490339|NCT04718103|363807532|FG001|Overall Study|Adverse Event|1|||
105490340|NCT04718103|363807531|FG000|Overall Study|Lack of Efficacy|4|||
105490341|NCT04718103|363807532|FG001|Overall Study|Lack of Efficacy|1|||
105490342|NCT04718103|363807531|FG000|Overall Study|Lost to Follow-up|2|||
105490343|NCT04718103|363807532|FG001|Overall Study|Lost to Follow-up|2|||
105490344|NCT04718103|363807531|FG000|Overall Study|Physician Decision|2|||
105846439|NCT02091141|365096065|FG006|Overall Study|Death|12|||
105846440|NCT02091141|365096059|FG000|Overall Study|Withdrawal by Subject|21|||
105846441|NCT02091141|365096060|FG001|Overall Study|Withdrawal by Subject|13|||
105846442|NCT02091141|365096061|FG002|Overall Study|Withdrawal by Subject|3|||
105846443|NCT02091141|365096062|FG003|Overall Study|Withdrawal by Subject|2|||
105846444|NCT02091141|365096063|FG004|Overall Study|Withdrawal by Subject|2|||
105846445|NCT02091141|365096064|FG005|Overall Study|Withdrawal by Subject|3|||
105846446|NCT02091141|365096065|FG006|Overall Study|Withdrawal by Subject|0|||
105846447|NCT02091141|365096059|FG000|Overall Study|Lost to Follow-up|21|||
105846448|NCT02091141|365096060|FG001|Overall Study|Lost to Follow-up|5|||
105846449|NCT02091141|365096061|FG002|Overall Study|Lost to Follow-up|1|||
105846450|NCT02091141|365096062|FG003|Overall Study|Lost to Follow-up|0|||
105846451|NCT02091141|365096063|FG004|Overall Study|Lost to Follow-up|1|||
105846452|NCT02091141|365096064|FG005|Overall Study|Lost to Follow-up|2|||
105846453|NCT02091141|365096065|FG006|Overall Study|Lost to Follow-up|0|||
105846454|NCT02091141|365096059|FG000|Overall Study|Reason Not Specified|6|||
105846455|NCT02091141|365096060|FG001|Overall Study|Reason Not Specified|5|||
105846456|NCT02091141|365096061|FG002|Overall Study|Reason Not Specified|2|||
105846457|NCT02091141|365096062|FG003|Overall Study|Reason Not Specified|0|||
105846458|NCT02091141|365096063|FG004|Overall Study|Reason Not Specified|0|||
105846459|NCT02091141|365096064|FG005|Overall Study|Reason Not Specified|0|||
105846460|NCT02091141|365096065|FG006|Overall Study|Reason Not Specified|1|||
105846461|NCT02091141|365096059|FG000|Overall Study|Study Ended by Sponsor|1|||
105846462|NCT02091141|365096060|FG001|Overall Study|Study Ended by Sponsor|9|||
105846463|NCT02091141|365096061|FG002|Overall Study|Study Ended by Sponsor|0|||
105846464|NCT02091141|365096062|FG003|Overall Study|Study Ended by Sponsor|0|||
105846465|NCT02091141|365096063|FG004|Overall Study|Study Ended by Sponsor|0|||
105846466|NCT02091141|365096064|FG005|Overall Study|Study Ended by Sponsor|0|||
105846467|NCT02091141|365096065|FG006|Overall Study|Study Ended by Sponsor|0|||
105846468|NCT02091141|365096059|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
105846469|NCT02091141|365096060|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
105846470|NCT02091141|365096061|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
105846471|NCT02091141|365096062|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
105846472|NCT02091141|365096063|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
105846473|NCT02091141|365096064|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
105846474|NCT02091141|365096065|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
105846475|NCT04556552|365096068|FG000|Overall Study|Lost to Follow-up|1|||
105846476|NCT04556552|365096069|FG001|Overall Study|Lost to Follow-up|0|||
105846477|NCT04556552|365096068|FG000|Overall Study|Claustrophobia|0|||
105846478|NCT04556552|365096069|FG001|Overall Study|Claustrophobia|1|||
105846479|NCT04556552|365096068|FG000|Overall Study|Inability to continue|0|||
105846480|NCT04556552|365096069|FG001|Overall Study|Inability to continue|1|||
105846481|NCT03439852|365096070|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
105846482|NCT03439852|365096071|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
105846483|NCT03439852|365096070|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
105846484|NCT03439852|365096071|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
105846485|NCT03439852|365096070|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
105846486|NCT03439852|365096071|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
105846487|NCT01553279|365096072|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
105846488|NCT01553279|365096073|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
105846489|NCT01553279|365096072|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
105846490|NCT01553279|365096073|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
105846491|NCT01553279|365096072|FG000|Interim Period|Withdrawal by Subject|2|||
105846492|NCT01553279|365096073|FG001|Interim Period|Withdrawal by Subject|2|||
105846493|NCT01553279|365096072|FG000|Interim Period|Lost to Follow-up|1|||
105846494|NCT01553279|365096073|FG001|Interim Period|Lost to Follow-up|0|||
105490345|NCT04718103|363807532|FG001|Overall Study|Physician Decision|0|||
105490346|NCT04718103|363807531|FG000|Overall Study|Pregnancy|0|||
105490347|NCT04718103|363807532|FG001|Overall Study|Pregnancy|1|||
105846495|NCT01553279|365096072|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
105846496|NCT01553279|365096073|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
105846497|NCT01553279|365096072|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
105846498|NCT01553279|365096073|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
105490348|NCT04718103|363807531|FG000|Overall Study|Withdrawal by Subject|10|||
105490349|NCT04718103|363807532|FG001|Overall Study|Withdrawal by Subject|6|||
105490350|NCT04718103|363807531|FG000|Overall Study|Randomized, not treated|4|||
105368808|NCT02669849|363356291|FG001|Overall Study|Other|0|||
105846499|NCT01215513|365096074|FG000|Overall Study|Not completed CS42|9|||
105846500|NCT01215513|365096074|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
105846501|NCT01215513|365096074|FG000|Overall Study|Adverse event (CS42A)|2|||
105846502|NCT01215513|365096074|FG000|Overall Study|Physician decision (CS42A)|6|||
105846503|NCT01215513|365096074|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
105846504|NCT01215513|365096074|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
105846505|NCT00605865|365096075|FG000|Overall Study|Protocol Violation|115|||
105846506|NCT03955471|365096076|FG000|Overall Study|Death|22|||
105846507|NCT03955471|365096076|FG000|Overall Study|Lost to Follow-up|1|||
105846508|NCT03955471|365096076|FG000|Overall Study|Withdrawal by Subject|6|||
105846509|NCT03955471|365096076|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
105846510|NCT01884311|365096079|FG000|Overall Study|Withdrawal by Subject|3|||
105846511|NCT01884311|365096079|FG000|Overall Study|withdrew consent due to AEs|1|||
105846512|NCT01884311|365096079|FG000|Overall Study|Precautionary measure|1|||
105846513|NCT02858492|365096085|FG000|Overall Study|Withdrawal by Subject|0|||
105846514|NCT02858492|365096086|FG001|Overall Study|Withdrawal by Subject|1|||
105846515|NCT02858492|365096087|FG002|Overall Study|Withdrawal by Subject|0|||
105846516|NCT02858492|365096088|FG003|Overall Study|Withdrawal by Subject|1|||
105846517|NCT02858492|365096085|FG000|Overall Study|Adverse Event|0|||
105846518|NCT02858492|365096086|FG001|Overall Study|Adverse Event|0|||
105846519|NCT02858492|365096087|FG002|Overall Study|Adverse Event|0|||
105846520|NCT02858492|365096088|FG003|Overall Study|Adverse Event|3|||
105846521|NCT02858492|365096085|FG000|Overall Study|Lack of Efficacy|0|||
105846522|NCT02858492|365096086|FG001|Overall Study|Lack of Efficacy|0|||
105846523|NCT02858492|365096087|FG002|Overall Study|Lack of Efficacy|0|||
105846524|NCT02858492|365096088|FG003|Overall Study|Lack of Efficacy|1|||
105846525|NCT02858492|365096085|FG000|Overall Study|Protocol defined stopping criteria|0|||
105846526|NCT02858492|365096086|FG001|Overall Study|Protocol defined stopping criteria|0|||
105846527|NCT02858492|365096087|FG002|Overall Study|Protocol defined stopping criteria|0|||
105846528|NCT02858492|365096088|FG003|Overall Study|Protocol defined stopping criteria|1|||
105846529|NCT02963441|365096092|FG000|Overall Study|Protocol violation or withdrawn|8|||
105846530|NCT02963441|365096092|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
105846531|NCT02963441|365096092|FG000|Overall Study|IDx-DR insufficient quality|33|||
105846532|NCT02011113|365096093|FG000|Overall Study|Adverse Event|4|||
105846533|NCT02011113|365096093|FG000|Overall Study|Disease Progression (DP)|16|||
105846534|NCT02011113|365096093|FG000|Overall Study|Death|1|||
105846535|NCT02011113|365096093|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
105846536|NCT02011113|365096093|FG000|Overall Study|Investigator's judgement- DP|3|||
105846537|NCT02011113|365096093|FG000|Overall Study|Study terminated by sponsor|11|||
105846538|NCT00616941|365096094|FG000|Overall Study|Progressive Disease|1|||
105846539|NCT00616941|365096095|FG001|Overall Study|Progressive Disease|2|||
105846540|NCT00616941|365096096|FG002|Overall Study|Progressive Disease|1|||
105316776|NCT02682927|363154784|FG004|Overall Study|Withdrawal by Subject|1|||
105316777|NCT02682927|363154785|FG005|Overall Study|Withdrawal by Subject|1|||
105316778|NCT00985491|363154790|FG000|Overall Study|Adverse Event|8|||
105316779|NCT00985491|363154790|FG000|Overall Study|device migration|7|||
105490351|NCT04718103|363807532|FG001|Overall Study|Randomized, not treated|1|||
105490352|NCT04718103|363807531|FG000|Overall Study|GCP violations|7|||
105490353|NCT04718103|363807532|FG001|Overall Study|GCP violations|5|||
105490354|NCT02810340|363807533|FG000|Overall Study|Withdrawal by Subject|1|||
105490355|NCT02810340|363807534|FG001|Overall Study|Withdrawal by Subject|0|||
105490356|NCT02810340|363807535|FG002|Overall Study|Withdrawal by Subject|0|||
105490357|NCT02810340|363807533|FG000|Overall Study|Incarceration|0|||
105490358|NCT02810340|363807534|FG001|Overall Study|Incarceration|1|||
105490359|NCT02810340|363807535|FG002|Overall Study|Incarceration|0|||
105490360|NCT02810340|363807533|FG000|Overall Study|Lost to Follow-up|0|||
105490361|NCT02810340|363807534|FG001|Overall Study|Lost to Follow-up|0|||
105490362|NCT02810340|363807535|FG002|Overall Study|Lost to Follow-up|1|||
105490363|NCT04795622|363807536|FG000|Overall Study|Adverse Event|1|||
105490364|NCT04795622|363807537|FG001|Overall Study|Adverse Event|0|||
105490365|NCT04795622|363807536|FG000|Overall Study|Withdrawal by Subject|3|||
105490366|NCT04795622|363807537|FG001|Overall Study|Withdrawal by Subject|3|||
105490367|NCT04795622|363807536|FG000|Overall Study|Protocol Violation|0|||
105490368|NCT04795622|363807537|FG001|Overall Study|Protocol Violation|2|||
105490369|NCT04795622|363807536|FG000|Overall Study|Lost to Follow-up|2|||
105490370|NCT04795622|363807537|FG001|Overall Study|Lost to Follow-up|3|||
105490371|NCT04795622|363807536|FG000|Overall Study|Other|7|||
105490372|NCT04795622|363807537|FG001|Overall Study|Other|8|||
105490373|NCT02017171|363807538|FG000|Overall Study|Death|10|||
105846541|NCT00616941|365096094|FG000|Overall Study|Adverse Event|0|||
105846542|NCT00616941|365096095|FG001|Overall Study|Adverse Event|1|||
105846543|NCT00616941|365096096|FG002|Overall Study|Adverse Event|1|||
105846544|NCT00616941|365096094|FG000|Overall Study|Subject Non-compliance|0|||
105846545|NCT00616941|365096095|FG001|Overall Study|Subject Non-compliance|0|||
105846546|NCT00616941|365096096|FG002|Overall Study|Subject Non-compliance|1|||
105846547|NCT00616941|365096094|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
105846548|NCT00616941|365096095|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
105846549|NCT00616941|365096096|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
105846550|NCT00616941|365096094|FG000|Overall Study|Vaccination Suspended|0|||
105846551|NCT00616941|365096095|FG001|Overall Study|Vaccination Suspended|0|||
105846552|NCT00616941|365096096|FG002|Overall Study|Vaccination Suspended|3|||
105846553|NCT02372071|365096097|FG000|Overall Study|Protocol Violation|18|||
105846554|NCT04492020|365096098|FG000|Overall Study|Adverse Event|1|||
105846555|NCT04492020|365096099|FG001|Overall Study|Adverse Event|3|||
105316780|NCT00985491|363154790|FG000|Overall Study|Withdrawal by Subject|1|||
105316781|NCT00985491|363154790|FG000|Overall Study|implant failure|3|||
105316782|NCT04386616|363154803|FG000|Overall Study|Death|22|||
105316783|NCT04386616|363154804|FG001|Overall Study|Death|22|||
105316784|NCT04386616|363154805|FG002|Overall Study|Death|21|||
105316785|NCT04386616|363154803|FG000|Overall Study|Lost to Follow-up|5|||
105316786|NCT04386616|363154804|FG001|Overall Study|Lost to Follow-up|8|||
105316787|NCT04386616|363154805|FG002|Overall Study|Lost to Follow-up|6|||
105316788|NCT04386616|363154803|FG000|Overall Study|Withdrawal by Subject|2|||
105846556|NCT04492020|365096098|FG000|Overall Study|Withdrawal by Subject|4|||
105846557|NCT04492020|365096099|FG001|Overall Study|Withdrawal by Subject|3|||
105846558|NCT04492020|365096098|FG000|Overall Study|Lost to Follow-up|4|||
105846559|NCT04492020|365096099|FG001|Overall Study|Lost to Follow-up|3|||
105846560|NCT04492020|365096098|FG000|Overall Study|Protocol Violation|5|||
105846561|NCT04492020|365096099|FG001|Overall Study|Protocol Violation|2|||
105846562|NCT04492020|365096098|FG000|Overall Study|Lack of Qualifying Event|25|||
105846563|NCT04492020|365096099|FG001|Overall Study|Lack of Qualifying Event|27|||
105846564|NCT04492020|365096098|FG000|Overall Study|Non-compliance with Study Drug|2|||
105846565|NCT04492020|365096099|FG001|Overall Study|Non-compliance with Study Drug|1|||
105846566|NCT02575911|365096103|FG000|Overall Study|Lost to Follow-up|1|||
105846567|NCT02408068|365096104|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
105846568|NCT02408068|365096105|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
105846569|NCT02408068|365096106|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
105846570|NCT02408068|365096107|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
105846571|NCT02408068|365096108|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
105846572|NCT02408068|365096109|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
105846573|NCT00629265|365096110|FG000|Overall Study|Lost to Follow-up|4|||
105846574|NCT00629265|365096111|FG001|Overall Study|Lost to Follow-up|5|||
105846575|NCT00629265|365096110|FG000|Overall Study|Withdrawal by Subject|11|||
105846576|NCT00629265|365096111|FG001|Overall Study|Withdrawal by Subject|8|||
105846577|NCT00629265|365096110|FG000|Overall Study|Death|1|||
105846578|NCT00629265|365096111|FG001|Overall Study|Death|0|||
105846579|NCT00629265|365096110|FG000|Overall Study|Adverse Event|2|||
105846580|NCT00629265|365096111|FG001|Overall Study|Adverse Event|0|||
105846581|NCT00629265|365096110|FG000|Overall Study|HNC Recurrence|4|||
105846582|NCT00629265|365096111|FG001|Overall Study|HNC Recurrence|0|||
105846583|NCT00629265|365096110|FG000|Overall Study|Other CA Requiring Treatment|1|||
105846584|NCT00629265|365096111|FG001|Overall Study|Other CA Requiring Treatment|3|||
105846585|NCT00629265|365096110|FG000|Overall Study|Needed Esophageal Dilation|4|||
105846586|NCT00629265|365096111|FG001|Overall Study|Needed Esophageal Dilation|1|||
105846587|NCT00629265|365096110|FG000|Overall Study|Unrelated Medical Complications|3|||
105846588|NCT00629265|365096111|FG001|Overall Study|Unrelated Medical Complications|1|||
105846589|NCT00629265|365096110|FG000|Overall Study|Unknown Reason|2|||
105846590|NCT00629265|365096111|FG001|Overall Study|Unknown Reason|2|||
105846591|NCT02566993|365096112|FG000|Overall Study|Randomized but not treated|5|||
105846592|NCT02566993|365096113|FG001|Overall Study|Randomized but not treated|16|||
105846593|NCT02566993|365096112|FG000|Overall Study|Progressive disease|213|||
105846594|NCT02566993|365096113|FG001|Overall Study|Progressive disease|152|||
105846595|NCT02566993|365096112|FG000|Overall Study|Withdrawal by Subject|12|||
105846596|NCT02566993|365096113|FG001|Overall Study|Withdrawal by Subject|28|||
105846597|NCT02566993|365096112|FG000|Overall Study|Death|17|||
105846598|NCT02566993|365096113|FG001|Overall Study|Death|23|||
105846599|NCT02566993|365096112|FG000|Overall Study|Physician Decision|10|||
105846600|NCT02566993|365096113|FG001|Overall Study|Physician Decision|17|||
105846601|NCT02566993|365096112|FG000|Overall Study|Study drug-related adverse event|20|||
105846602|NCT02566993|365096113|FG001|Overall Study|Study drug-related adverse event|41|||
105846603|NCT02566993|365096112|FG000|Overall Study|Non study drug-related adverse event|9|||
105316789|NCT04386616|363154804|FG001|Overall Study|Withdrawal by Subject|4|||
105490374|NCT02017171|363807539|FG001|Overall Study|Death|4|||
105490375|NCT02017171|363807538|FG000|Overall Study|Withdrawal by Subject|23|||
105846604|NCT02566993|365096113|FG001|Overall Study|Non study drug-related adverse event|9|||
105846605|NCT02566993|365096112|FG000|Overall Study|Symptomatic deterioration|9|||
105846606|NCT02566993|365096113|FG001|Overall Study|Symptomatic deterioration|16|||
105316790|NCT04386616|363154805|FG002|Overall Study|Withdrawal by Subject|1|||
105316791|NCT04386616|363154803|FG000|Overall Study|Adverse Event|1|||
105316792|NCT04386616|363154804|FG001|Overall Study|Adverse Event|1|||
105490376|NCT02017171|363807539|FG001|Overall Study|Withdrawal by Subject|17|||
105846607|NCT02566993|365096112|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
105316793|NCT04386616|363154805|FG002|Overall Study|Adverse Event|0|||
105846608|NCT02566993|365096113|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
105846609|NCT02566993|365096112|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
105846610|NCT02566993|365096113|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
105846611|NCT02566993|365096112|FG000|Overall Study|Screening failure|2|||
105846612|NCT02566993|365096113|FG001|Overall Study|Screening failure|0|||
105846613|NCT02566993|365096112|FG000|Overall Study|Lost to Follow-up|0|||
105846614|NCT02566993|365096113|FG001|Overall Study|Lost to Follow-up|1|||
105846615|NCT02566993|365096112|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
105846616|NCT02566993|365096113|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
105846617|NCT03835325|365096122|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
105846618|NCT03835325|365096122|FG000|Overall Study|Selection failure|1|||
105846619|NCT00857259|365096123|FG000|Overall Study|Protocol Violation|1|||
105846620|NCT00857259|365096124|FG001|Overall Study|Protocol Violation|0|||
105846621|NCT00857259|365096125|FG002|Overall Study|Protocol Violation|1|||
105846622|NCT02701413|365096126|FG000|Overall Study|Withdrawal by Subject|7|||
105846623|NCT02701413|365096127|FG001|Overall Study|Withdrawal by Subject|11|||
105846624|NCT02138136|365096131|FG000|Overall Study|Protocol Violation|4|||
105846625|NCT02138136|365096131|FG000|Overall Study|Physician Decision|7|||
105846626|NCT02138136|365096131|FG000|Overall Study|Lack of Efficacy|35|||
105846627|NCT02138136|365096131|FG000|Overall Study|Pregnancy|2|||
105846628|NCT02138136|365096131|FG000|Overall Study|Adverse Event|18|||
105846629|NCT02138136|365096131|FG000|Overall Study|Withdrawal by Subject|36|||
105846630|NCT02138136|365096131|FG000|Overall Study|Lost to Follow-up|32|||
105846631|NCT02138136|365096131|FG000|Overall Study|Withdrawn by Sponsor|5|||
105846632|NCT01616953|365096132|FG000|Overall Study|Lost to Follow-up|1|||
105846633|NCT01616953|365096133|FG001|Overall Study|Lost to Follow-up|0|||
105846634|NCT01616953|365096132|FG000|Overall Study|lack of bone and soft tissue|1|||
105846635|NCT01616953|365096133|FG001|Overall Study|lack of bone and soft tissue|0|||
105846636|NCT01621191|365096134|FG000|Overall Study|Adverse Event|9|||
105846637|NCT01621191|365096134|FG000|Overall Study|Withdrawal by Subject|8|||
105846638|NCT01621191|365096134|FG000|Overall Study|Lack of Efficacy|6|||
105846639|NCT01621191|365096134|FG000|Overall Study|Lost to Follow-up|1|||
105846640|NCT01621191|365096134|FG000|Overall Study|Site Removed From Study|1|||
105846641|NCT00706381|365096135|FG000|Overall Study|Lost to Follow-up|0|||
105846642|NCT00706381|365096136|FG001|Overall Study|Lost to Follow-up|1|||
105846643|NCT00706381|365096137|FG002|Overall Study|Lost to Follow-up|1|||
105846644|NCT00706381|365096138|FG003|Overall Study|Lost to Follow-up|0|||
105846645|NCT00038649|365096141|FG000|Overall Study|Adverse Event|9|||
105846646|NCT00597116|365096142|FG000|Overall Study|Adverse Event|2|||
105846647|NCT00597116|365096143|FG001|Overall Study|Adverse Event|1|||
105846648|NCT00597116|365096142|FG000|Overall Study|Withdrawal by Subject|0|||
105846649|NCT00597116|365096143|FG001|Overall Study|Withdrawal by Subject|2|||
105846650|NCT00597116|365096142|FG000|Overall Study|Physician Decision|0|||
105846651|NCT00597116|365096143|FG001|Overall Study|Physician Decision|1|||
105846652|NCT00597116|365096142|FG000|Overall Study|Death|0|||
105846653|NCT00597116|365096143|FG001|Overall Study|Death|1|||
105846654|NCT00597116|365096142|FG000|Overall Study|Lost to Follow-up|1|||
105846655|NCT00597116|365096143|FG001|Overall Study|Lost to Follow-up|0|||
105846656|NCT00597116|365096142|FG000|Overall Study|Progressive disease|11|||
105846657|NCT00597116|365096143|FG001|Overall Study|Progressive disease|6|||
105846658|NCT01355159|365096146|FG000|Overall Study|Withdrew consent|39|||
105846659|NCT01355159|365096147|FG001|Overall Study|Withdrew consent|47|||
105846660|NCT01355159|365096146|FG000|Overall Study|No primary outcome data|17|||
105846661|NCT01355159|365096147|FG001|Overall Study|No primary outcome data|11|||
105846662|NCT01355159|365096146|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
105846663|NCT01355159|365096147|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
105846664|NCT01355159|365096146|FG000|Overall Study|Early intrauterine fetal death|6|||
105846665|NCT01355159|365096147|FG001|Overall Study|Early intrauterine fetal death|6|||
105846666|NCT01338987|365096154|FG000|Overall Study|enrolled on new protocol|0|||
105846667|NCT01338987|365096155|FG001|Overall Study|enrolled on new protocol|0|||
105846668|NCT01338987|365096156|FG002|Overall Study|enrolled on new protocol|1|||
105846669|NCT01338987|365096157|FG003|Overall Study|enrolled on new protocol|0|||
105846670|NCT01338987|365096158|FG004|Overall Study|enrolled on new protocol|0|||
105846671|NCT01338987|365096154|FG000|Overall Study|Disease progression on study|2|||
105490377|NCT02017171|363807538|FG000|Overall Study|Lost to Follow-up|21|||
105490378|NCT02017171|363807539|FG001|Overall Study|Lost to Follow-up|20|||
105490379|NCT02017171|363807538|FG000|Overall Study|ESKD|6|||
105846672|NCT01338987|365096155|FG001|Overall Study|Disease progression on study|1|||
105846673|NCT01338987|365096156|FG002|Overall Study|Disease progression on study|1|||
105846674|NCT01338987|365096157|FG003|Overall Study|Disease progression on study|0|||
105846675|NCT01338987|365096158|FG004|Overall Study|Disease progression on study|0|||
105846676|NCT01640873|365096159|FG000|Overall Study|Protocol Violation|2|||
105846677|NCT01640873|365096160|FG001|Overall Study|Protocol Violation|1|||
105490380|NCT02017171|363807539|FG001|Overall Study|ESKD|2|||
105490381|NCT02017171|363807538|FG000|Overall Study|Miscellaneous|2|||
105846678|NCT03832738|365096161|FG000|Overall Study|Withdrawal by Subject|6|||
105846679|NCT03832738|365096162|FG001|Overall Study|Withdrawal by Subject|7|||
105846680|NCT03832738|365096163|FG002|Overall Study|Withdrawal by Subject|16|||
105846681|NCT03832738|365096161|FG000|Overall Study|Physician Decision|0|||
105846682|NCT03832738|365096162|FG001|Overall Study|Physician Decision|1|||
105846683|NCT03832738|365096163|FG002|Overall Study|Physician Decision|2|||
105846684|NCT03832738|365096161|FG000|Overall Study|Adverse Event|2|||
105846685|NCT03832738|365096162|FG001|Overall Study|Adverse Event|3|||
105846686|NCT03832738|365096163|FG002|Overall Study|Adverse Event|1|||
105846687|NCT03832738|365096161|FG000|Overall Study|Pregnancy|0|||
105846688|NCT03832738|365096162|FG001|Overall Study|Pregnancy|1|||
105846689|NCT03832738|365096163|FG002|Overall Study|Pregnancy|0|||
105846690|NCT00770692|365096165|FG000|Overall Study|Withdrawal by Subject|7|||
105846691|NCT00770692|365096166|FG001|Overall Study|Withdrawal by Subject|9|||
105490382|NCT02017171|363807539|FG001|Overall Study|Miscellaneous|3|||
105490383|NCT01369485|363807540|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
105490384|NCT01369485|363807541|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
105490385|NCT01369485|363807540|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
105846692|NCT00770692|365096167|FG002|Overall Study|Withdrawal by Subject|9|||
105846693|NCT00770692|365096168|FG003|Overall Study|Withdrawal by Subject|6|||
105846694|NCT00770692|365096165|FG000|Overall Study|Adverse Event|3|||
105846695|NCT00770692|365096166|FG001|Overall Study|Adverse Event|0|||
105846696|NCT00770692|365096167|FG002|Overall Study|Adverse Event|4|||
105846697|NCT00770692|365096168|FG003|Overall Study|Adverse Event|4|||
105846698|NCT00770692|365096165|FG000|Overall Study|Investigator judgment|2|||
105490386|NCT01369485|363807541|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
105490387|NCT01369485|363807540|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
105490388|NCT01369485|363807541|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
105490389|NCT01369485|363807540|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
105490390|NCT01369485|363807541|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
105490391|NCT01369485|363807540|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
105490392|NCT01369485|363807541|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
105490393|NCT01369485|363807540|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
105490394|NCT01369485|363807541|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
105490395|NCT01369485|363807540|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
105490396|NCT01369485|363807541|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
105490397|NCT01369485|363807540|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
105490398|NCT01369485|363807541|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
105490399|NCT01369485|363807540|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
105490400|NCT01369485|363807541|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
105490401|NCT01369485|363807540|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
105490402|NCT01369485|363807541|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
105490403|NCT03370289|363807542|FG000|Overall Study|Screen Failure|1|||
105490404|NCT03370289|363807542|FG000|Overall Study|Sample Size Sufficient|4|||
105490405|NCT00704808|363807544|FG000|Overall Study|Discontinued prior to starting treatment|14|||
105490406|NCT00704808|363807544|FG000|Overall Study|Death|7|||
105490407|NCT00704808|363807544|FG000|Overall Study|Tumor progression|80|||
105490408|NCT00704808|363807544|FG000|Overall Study|Patient's decision|11|||
105490409|NCT00704808|363807544|FG000|Overall Study|Early therapy discontinuation|16|||
105490410|NCT00704808|363807544|FG000|Overall Study|Adverse Event|1|||
105490411|NCT00704808|363807544|FG000|Overall Study|Lost to Follow-up|1|||
105490412|NCT00704808|363807544|FG000|Overall Study|Treatment change|1|||
105490413|NCT01309308|363807545|FG000|Overall Study|Lost to Follow-up|6|||
105490414|NCT01309308|363807546|FG001|Overall Study|Lost to Follow-up|4|||
105490415|NCT02280473|363807547|FG000|Overall Study|Adverse Event|1|||
105490416|NCT02280473|363807548|FG001|Overall Study|Adverse Event|1|||
105490417|NCT02280473|363807547|FG000|Overall Study|Lack of Efficacy|0|||
105490418|NCT02280473|363807548|FG001|Overall Study|Lack of Efficacy|1|||
105490419|NCT02280473|363807547|FG000|Overall Study|Lost to Follow-up|0|||
105490420|NCT02280473|363807548|FG001|Overall Study|Lost to Follow-up|1|||
105490421|NCT01280955|363807553|FG000|Overall Study|Death|2|||
105490422|NCT01280955|363807553|FG000|Overall Study|Withdrawal by Subject|1|||
105490423|NCT02961218|363807554|FG000|Overall Study|Lost to Follow-up|0|||
105490424|NCT02961218|363807555|FG001|Overall Study|Lost to Follow-up|2|||
105490425|NCT02961218|363807554|FG000|Overall Study|Physician Decision|0|||
105490426|NCT02961218|363807555|FG001|Overall Study|Physician Decision|2|||
105490427|NCT02961218|363807554|FG000|Overall Study|Subject/Guardian Decision|3|||
105490428|NCT02961218|363807555|FG001|Overall Study|Subject/Guardian Decision|1|||
105490429|NCT01721070|363807561|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
105846699|NCT00770692|365096166|FG001|Overall Study|Investigator judgment|0|||
105846700|NCT00770692|365096167|FG002|Overall Study|Investigator judgment|1|||
105316794|NCT03449446|363154806|FG000|Overall Study|Randomized but Never Treated|0|||
105316795|NCT03449446|363154807|FG001|Overall Study|Randomized but Never Treated|0|||
105316796|NCT03449446|363154808|FG002|Overall Study|Randomized but Never Treated|1|||
105846701|NCT00770692|365096168|FG003|Overall Study|Investigator judgment|1|||
105490430|NCT01226043|363807562|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
105490431|NCT01226043|363807563|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
105490432|NCT01226043|363807564|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
105490433|NCT01226043|363807565|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
105490434|NCT01226043|363807562|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
105846702|NCT02562482|365096169|FG000|Overall Study|Enrolled, but did not receive product|4|||
105846703|NCT02562482|365096170|FG001|Overall Study|Enrolled, but did not receive product|0|||
105846704|NCT02562482|365096169|FG000|Overall Study|Lost to Follow-up|9|||
105846705|NCT02562482|365096170|FG001|Overall Study|Lost to Follow-up|6|||
105846706|NCT02562482|365096169|FG000|Overall Study|Moved from area|2|||
105846707|NCT02562482|365096170|FG001|Overall Study|Moved from area|3|||
105846708|NCT02562482|365096169|FG000|Overall Study|Withdrawal by Subject|5|||
105846709|NCT02562482|365096170|FG001|Overall Study|Withdrawal by Subject|3|||
105846710|NCT02562482|365096169|FG000|Overall Study|Physician Decision|1|||
105846711|NCT02562482|365096170|FG001|Overall Study|Physician Decision|3|||
105846712|NCT02562482|365096169|FG000|Overall Study|Illness/Injury unrelated to product|0|||
105846713|NCT02562482|365096170|FG001|Overall Study|Illness/Injury unrelated to product|1|||
105846714|NCT01230892|365096171|FG000|Overall Study|Withdrawal by Subject|1|||
105846715|NCT01230892|365096172|FG001|Overall Study|Withdrawal by Subject|1|||
105846716|NCT01230892|365096171|FG000|Overall Study|Lost to Follow-up|2|||
105846717|NCT01230892|365096172|FG001|Overall Study|Lost to Follow-up|0|||
105846718|NCT02357342|365096177|FG000|First 6 Months|Death|2|||
105846719|NCT02357342|365096178|FG001|First 6 Months|Death|0|||
105846720|NCT01189500|365096179|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
105846721|NCT01189500|365096179|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
105846722|NCT01000493|365096180|FG000|Overall Study|Adverse Event|3|||
105846723|NCT01000493|365096181|FG001|Overall Study|Adverse Event|6|||
105846724|NCT01000493|365096180|FG000|Overall Study|Lack of Efficacy|1|||
105846725|NCT01000493|365096181|FG001|Overall Study|Lack of Efficacy|1|||
105846726|NCT01000493|365096180|FG000|Overall Study|Protocol Violation|1|||
105846727|NCT01000493|365096181|FG001|Overall Study|Protocol Violation|8|||
105846728|NCT01000493|365096180|FG000|Overall Study|Study closed/terminated|25|||
105846729|NCT01000493|365096181|FG001|Overall Study|Study closed/terminated|23|||
105846730|NCT01000493|365096180|FG000|Overall Study|Lost to Follow-up|5|||
105846731|NCT01000493|365096181|FG001|Overall Study|Lost to Follow-up|9|||
105846732|NCT01000493|365096180|FG000|Overall Study|Physician Decision|1|||
105846733|NCT01000493|365096181|FG001|Overall Study|Physician Decision|1|||
105846734|NCT01000493|365096180|FG000|Overall Study|Withdrawal by Subject|3|||
105846735|NCT01000493|365096181|FG001|Overall Study|Withdrawal by Subject|7|||
105846736|NCT04932941|365096182|FG000|Overall Study|Lost to Follow-up|3|||
105846737|NCT04932941|365096183|FG001|Overall Study|Lost to Follow-up|1|||
105846738|NCT04932941|365096182|FG000|Overall Study|Withdrawal by Subject|7|||
105846739|NCT04932941|365096183|FG001|Overall Study|Withdrawal by Subject|4|||
105846740|NCT04932941|365096182|FG000|Overall Study|Other|4|||
105846741|NCT04932941|365096183|FG001|Overall Study|Other|2|||
105846742|NCT02333487|365096184|FG000|Overall Study|Adverse Event|0|||
105846743|NCT02333487|365096185|FG001|Overall Study|Adverse Event|2|||
105846744|NCT02333487|365096186|FG002|Overall Study|Adverse Event|0|||
105846745|NCT03510182|365096187|FG000|Overall Study|Withdrawal by Subject|2|||
105846746|NCT01558297|365096189|FG000|Overall Study|Withdrawal by Subject|2|||
105846747|NCT01558297|365096190|FG001|Overall Study|Withdrawal by Subject|2|||
105846748|NCT01558297|365096191|FG002|Overall Study|Withdrawal by Subject|1|||
105846749|NCT00375492|365096192|FG000|Overall Study|Adverse Event|4|||
105846750|NCT00375492|365096193|FG001|Overall Study|Adverse Event|5|||
105846751|NCT00375492|365096192|FG000|Overall Study|Entry Criteria Not Met|0|||
105846752|NCT00375492|365096193|FG001|Overall Study|Entry Criteria Not Met|1|||
105846753|NCT00375492|365096192|FG000|Overall Study|Loss of Glucose Control|0|||
105490435|NCT01226043|363807563|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
105490436|NCT01226043|363807564|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
105490437|NCT01226043|363807565|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
105490438|NCT01226043|363807562|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
105846754|NCT00375492|365096193|FG001|Overall Study|Loss of Glucose Control|1|||
105846755|NCT00375492|365096192|FG000|Overall Study|Lost to Follow-up|10|||
105846756|NCT00375492|365096193|FG001|Overall Study|Lost to Follow-up|5|||
105846757|NCT00375492|365096192|FG000|Overall Study|Physician Decision|0|||
105846758|NCT00375492|365096193|FG001|Overall Study|Physician Decision|4|||
105490439|NCT01226043|363807563|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
105490440|NCT01226043|363807564|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
105846759|NCT00375492|365096192|FG000|Overall Study|Protocol Violation|6|||
105846760|NCT00375492|365096193|FG001|Overall Study|Protocol Violation|3|||
105846761|NCT00375492|365096192|FG000|Overall Study|Sponsor Decision|0|||
105846762|NCT00375492|365096193|FG001|Overall Study|Sponsor Decision|1|||
105846763|NCT00375492|365096192|FG000|Overall Study|Withdrawal by Subject|6|||
105846764|NCT00375492|365096193|FG001|Overall Study|Withdrawal by Subject|6|||
105846765|NCT01032018|365097641|FG000|Overall Study|Lost to Follow-up|6|||
105846766|NCT01032018|365097642|FG001|Overall Study|Lost to Follow-up|5|||
105846767|NCT01032018|365097641|FG000|Overall Study|Death|0|||
105846768|NCT01032018|365097642|FG001|Overall Study|Death|1|||
105846769|NCT03247517|365097647|FG000|Overall Study|Adverse Event|0|||
105846770|NCT03247517|365097648|FG001|Overall Study|Adverse Event|4|||
105846771|NCT03247517|365097649|FG002|Overall Study|Adverse Event|2|||
105846772|NCT03247517|365097647|FG000|Overall Study|Lost to Follow-up|2|||
105846773|NCT03247517|365097648|FG001|Overall Study|Lost to Follow-up|6|||
105846774|NCT03247517|365097649|FG002|Overall Study|Lost to Follow-up|4|||
105846775|NCT03247517|365097647|FG000|Overall Study|Consent withdrawn by caregiver|1|||
105846776|NCT03247517|365097648|FG001|Overall Study|Consent withdrawn by caregiver|4|||
105846777|NCT03247517|365097649|FG002|Overall Study|Consent withdrawn by caregiver|7|||
105846778|NCT03247517|365097647|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
105846779|NCT03247517|365097648|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
105846780|NCT03247517|365097649|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
105846781|NCT03247517|365097647|FG000|Overall Study|Protocol Violation|0|||
105846782|NCT03247517|365097648|FG001|Overall Study|Protocol Violation|2|||
105846783|NCT03247517|365097649|FG002|Overall Study|Protocol Violation|0|||
105846784|NCT03247517|365097647|FG000|Overall Study|Multiple reasons|3|||
105846785|NCT03247517|365097648|FG001|Overall Study|Multiple reasons|1|||
105846786|NCT03247517|365097649|FG002|Overall Study|Multiple reasons|0|||
105846787|NCT00619112|365097650|FG000|Overall Study|Adverse Event|1|||
105846788|NCT00619112|365097651|FG001|Overall Study|Adverse Event|2|||
105846789|NCT05855616|365097654|FG000|Overall Study|Lost to Follow-up|1|||
105846790|NCT05855616|365097655|FG001|Overall Study|Lost to Follow-up|2|||
105846791|NCT04032158|365097656|FG000|Overall Study|Study Termination|2|||
105846792|NCT04032158|365097657|FG001|Overall Study|Study Termination|1|||
105846793|NCT00059787|365097658|FG000|Overall Study|Adverse Event|13|||
105846794|NCT00059787|365097658|FG000|Overall Study|disease progression|2|||
105846795|NCT00059787|365097658|FG000|Overall Study|ineligible|1|||
105846796|NCT00059787|365097658|FG000|Overall Study|Other|4|||
105846797|NCT00652028|365097659|FG000|Overall Study|Adverse Event|1|||
105846798|NCT00652028|365097660|FG001|Overall Study|Adverse Event|0|||
105846799|NCT00652028|365097661|FG002|Overall Study|Adverse Event|0|||
105846800|NCT00652028|365097662|FG003|Overall Study|Adverse Event|0|||
105846801|NCT00652028|365097659|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
105846802|NCT00652028|365097660|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
105846803|NCT00652028|365097661|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
105846804|NCT00652028|365097662|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
105846805|NCT00652028|365097659|FG000|Overall Study|Physician Decision|0|||
105846806|NCT00652028|365097660|FG001|Overall Study|Physician Decision|0|||
105846807|NCT00652028|365097661|FG002|Overall Study|Physician Decision|1|||
105846808|NCT00652028|365097662|FG003|Overall Study|Physician Decision|0|||
105846809|NCT02072824|365097663|FG000|Overall Study|Insufficient clinical response|1|||
105846810|NCT02072824|365097664|FG001|Overall Study|Insufficient clinical response|0|||
105846811|NCT02072824|365097665|FG002|Overall Study|Insufficient clinical response|1|||
105846812|NCT02072824|365097663|FG000|Overall Study|No longer willing to participate|1|||
105846813|NCT02072824|365097664|FG001|Overall Study|No longer willing to participate|0|||
105846814|NCT02072824|365097665|FG002|Overall Study|No longer willing to participate|1|||
105846815|NCT02072824|365097663|FG000|Overall Study|Medication error|0|||
105846816|NCT02072824|365097664|FG001|Overall Study|Medication error|1|||
105846817|NCT02072824|365097665|FG002|Overall Study|Medication error|0|||
105846818|NCT02072824|365097663|FG000|Overall Study|Adverse Event|0|||
105846819|NCT02072824|365097664|FG001|Overall Study|Adverse Event|0|||
105846820|NCT02072824|365097665|FG002|Overall Study|Adverse Event|1|||
105846821|NCT00430495|365097666|FG000|Overall Study|Adverse Event|2|||
105846822|NCT00430495|365097667|FG001|Overall Study|Adverse Event|3|||
105846823|NCT00430495|365097668|FG002|Overall Study|Adverse Event|2|||
105846824|NCT00430495|365097669|FG003|Overall Study|Adverse Event|0|||
105846825|NCT00430495|365097666|FG000|Overall Study|Death|0|||
105846826|NCT00430495|365097667|FG001|Overall Study|Death|0|||
105846827|NCT00430495|365097668|FG002|Overall Study|Death|1|||
105846828|NCT00430495|365097669|FG003|Overall Study|Death|0|||
105846829|NCT00430495|365097666|FG000|Overall Study|Lost to Follow-up|0|||
105846830|NCT00430495|365097667|FG001|Overall Study|Lost to Follow-up|1|||
105846831|NCT00430495|365097668|FG002|Overall Study|Lost to Follow-up|4|||
105846832|NCT00430495|365097669|FG003|Overall Study|Lost to Follow-up|0|||
105846833|NCT00430495|365097666|FG000|Overall Study|Protocol Violation|1|||
105846834|NCT00430495|365097667|FG001|Overall Study|Protocol Violation|0|||
105846835|NCT00430495|365097668|FG002|Overall Study|Protocol Violation|1|||
105846836|NCT00430495|365097669|FG003|Overall Study|Protocol Violation|0|||
105846837|NCT00430495|365097666|FG000|Overall Study|Disease Progression|1|||
105846838|NCT00430495|365097667|FG001|Overall Study|Disease Progression|1|||
105846839|NCT00430495|365097668|FG002|Overall Study|Disease Progression|0|||
105846840|NCT00430495|365097669|FG003|Overall Study|Disease Progression|0|||
105846841|NCT00430495|365097666|FG000|Overall Study|Other|8|||
105846842|NCT00430495|365097667|FG001|Overall Study|Other|2|||
105846843|NCT00430495|365097668|FG002|Overall Study|Other|5|||
105846844|NCT00430495|365097669|FG003|Overall Study|Other|4|||
105846845|NCT00430495|365097666|FG000|Overall Study|Randomized but not Treated|2|||
105846846|NCT00430495|365097667|FG001|Overall Study|Randomized but not Treated|0|||
105846847|NCT00430495|365097668|FG002|Overall Study|Randomized but not Treated|0|||
105846848|NCT00430495|365097669|FG003|Overall Study|Randomized but not Treated|0|||
105846849|NCT00912093|365097670|FG000|The Controlled Phase|Death|0|||
105846850|NCT00912093|365097671|FG001|The Controlled Phase|Death|1|||
105846851|NCT00912093|365097672|FG002|The Controlled Phase|Death|0|||
105846852|NCT00912093|365097673|FG003|The Controlled Phase|Death|0|||
105846853|NCT00912093|365097674|FG004|The Controlled Phase|Death|0|||
105846854|NCT00912093|365097670|FG000|The Controlled Phase|Medical Condition|0|||
105846855|NCT00912093|365097671|FG001|The Controlled Phase|Medical Condition|1|||
105846856|NCT00912093|365097672|FG002|The Controlled Phase|Medical Condition|0|||
105846857|NCT00912093|365097673|FG003|The Controlled Phase|Medical Condition|0|||
105846858|NCT00912093|365097674|FG004|The Controlled Phase|Medical Condition|0|||
105846859|NCT00912093|365097670|FG000|The Controlled Phase|Lost to Follow-up|0|||
105846860|NCT00912093|365097671|FG001|The Controlled Phase|Lost to Follow-up|0|||
105846861|NCT00912093|365097672|FG002|The Controlled Phase|Lost to Follow-up|0|||
105846862|NCT00912093|365097673|FG003|The Controlled Phase|Lost to Follow-up|0|||
105846863|NCT00912093|365097674|FG004|The Controlled Phase|Lost to Follow-up|1|||
105846864|NCT01196078|365097675|FG000|Overall Study|Withdrawal by Subject|3|||
105846865|NCT01196078|365097676|FG001|Overall Study|Withdrawal by Subject|5|||
105846866|NCT01196078|365097675|FG000|Overall Study|Adverse Event|4|||
105846867|NCT01196078|365097676|FG001|Overall Study|Adverse Event|4|||
105846868|NCT01196078|365097675|FG000|Overall Study|Protocol Violation|2|||
105846869|NCT01196078|365097676|FG001|Overall Study|Protocol Violation|1|||
105846870|NCT01196078|365097675|FG000|Overall Study|Lack of Efficacy|17|||
105846871|NCT01196078|365097676|FG001|Overall Study|Lack of Efficacy|23|||
105846872|NCT01196078|365097675|FG000|Overall Study|Lost to Follow-up|1|||
105846873|NCT01196078|365097676|FG001|Overall Study|Lost to Follow-up|0|||
105846874|NCT01196078|365097675|FG000|Overall Study|Death|6|||
105846875|NCT01196078|365097676|FG001|Overall Study|Death|4|||
105846876|NCT04132336|365097678|FG000|Overall Study|Investigator Decision|0|||
105846877|NCT04132336|365097679|FG001|Overall Study|Investigator Decision|1|||
105846878|NCT04132336|365097680|FG002|Overall Study|Investigator Decision|0|||
105846879|NCT04132336|365097681|FG003|Overall Study|Investigator Decision|0|||
105846880|NCT04132336|365097682|FG004|Overall Study|Investigator Decision|0|||
105846881|NCT04132336|365097683|FG005|Overall Study|Investigator Decision|0|||
105846882|NCT04132336|365097684|FG006|Overall Study|Investigator Decision|0|||
105846883|NCT02384941|365097691|FG000|Overall Study|Adverse Event|11|||
105846884|NCT02384941|365097692|FG001|Overall Study|Adverse Event|13|||
105846885|NCT02384941|365097693|FG002|Overall Study|Adverse Event|17|||
105846886|NCT02384941|365097691|FG000|Overall Study|Lost to Follow-up|3|||
105846887|NCT02384941|365097692|FG001|Overall Study|Lost to Follow-up|2|||
105846888|NCT02384941|365097693|FG002|Overall Study|Lost to Follow-up|1|||
105846889|NCT02384941|365097691|FG000|Overall Study|Non-Compliance With Study Drug|2|||
105846890|NCT02384941|365097692|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105846891|NCT02384941|365097693|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105846892|NCT02384941|365097691|FG000|Overall Study|Physician Decision|1|||
105846893|NCT02384941|365097692|FG001|Overall Study|Physician Decision|1|||
105846894|NCT02384941|365097693|FG002|Overall Study|Physician Decision|0|||
105846895|NCT02384941|365097691|FG000|Overall Study|Protocol Violation|3|||
105846896|NCT02384941|365097692|FG001|Overall Study|Protocol Violation|0|||
105846897|NCT02384941|365097693|FG002|Overall Study|Protocol Violation|0|||
105846898|NCT02384941|365097691|FG000|Overall Study|Withdrawal by Subject|26|||
105846899|NCT02384941|365097692|FG001|Overall Study|Withdrawal by Subject|19|||
105846900|NCT02384941|365097693|FG002|Overall Study|Withdrawal by Subject|20|||
105490441|NCT01226043|363807565|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
105490442|NCT01226043|363807562|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
105490443|NCT01226043|363807563|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
105490444|NCT01226043|363807564|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
105490445|NCT01226043|363807565|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
105846901|NCT02384941|365097691|FG000|Overall Study|Pregnancy|0|||
105846902|NCT02384941|365097692|FG001|Overall Study|Pregnancy|0|||
105846903|NCT02384941|365097693|FG002|Overall Study|Pregnancy|1|||
105846904|NCT02384941|365097691|FG000|Overall Study|Other than specified above|4|||
105846905|NCT02384941|365097692|FG001|Overall Study|Other than specified above|0|||
105846906|NCT02384941|365097693|FG002|Overall Study|Other than specified above|1|||
105846907|NCT01892657|365097694|FG000|Overall Study|Withdrawal by Subject|6|||
105846908|NCT01892657|365097694|FG000|Overall Study|Protocol Violation|12|||
105846909|NCT00076804|365097697|FG000|Overall Study|Death|9|||
105846910|NCT00076804|365097698|FG001|Overall Study|Death|20|||
105846911|NCT00076804|365097697|FG000|Overall Study|Lost to Follow-up|9|||
105846912|NCT00076804|365097698|FG001|Overall Study|Lost to Follow-up|9|||
105846913|NCT00076804|365097697|FG000|Overall Study|Withdrawal by Subject|10|||
105846914|NCT00076804|365097698|FG001|Overall Study|Withdrawal by Subject|8|||
105846915|NCT00076804|365097697|FG000|Overall Study|Early study Closure|32|||
105846916|NCT00076804|365097698|FG001|Overall Study|Early study Closure|32|||
105846917|NCT01400919|365097699|FG000|Overall Study|Withdrawal by Subject|4|||
105368809|NCT02669849|363356292|FG002|Overall Study|Other|2|||
105846918|NCT01400919|365097699|FG000|Overall Study|Lost to Follow-up|2|||
105846919|NCT01400919|365097699|FG000|Overall Study|Missed visit|2|||
105846920|NCT01846273|365097714|FG000|Overall Study|Adverse Event|9|||
105846921|NCT01846273|365097715|FG001|Overall Study|Adverse Event|7|||
105846922|NCT01846273|365097716|FG002|Overall Study|Adverse Event|0|||
105846923|NCT01846273|365097714|FG000|Overall Study|Subject withdrew consent|5|||
105846924|NCT01846273|365097715|FG001|Overall Study|Subject withdrew consent|8|||
105846925|NCT01846273|365097716|FG002|Overall Study|Subject withdrew consent|0|||
105846926|NCT01846273|365097714|FG000|Overall Study|Lost to Follow-up|2|||
105846927|NCT01846273|365097715|FG001|Overall Study|Lost to Follow-up|1|||
105846928|NCT01846273|365097716|FG002|Overall Study|Lost to Follow-up|0|||
105846929|NCT01846273|365097714|FG000|Overall Study|Administrative problems|1|||
105846930|NCT01846273|365097715|FG001|Overall Study|Administrative problems|0|||
105846931|NCT01846273|365097716|FG002|Overall Study|Administrative problems|0|||
105846932|NCT01846273|365097714|FG000|Overall Study|Death|2|||
105846933|NCT01846273|365097715|FG001|Overall Study|Death|1|||
105846934|NCT01846273|365097716|FG002|Overall Study|Death|0|||
105846935|NCT01846273|365097714|FG000|Overall Study|Disease Progression|0|||
105846936|NCT01846273|365097715|FG001|Overall Study|Disease Progression|4|||
105846937|NCT01846273|365097716|FG002|Overall Study|Disease Progression|0|||
105846938|NCT01846273|365097714|FG000|Overall Study|Protocol Deviation|2|||
105846939|NCT01846273|365097715|FG001|Overall Study|Protocol Deviation|3|||
105846940|NCT01846273|365097716|FG002|Overall Study|Protocol Deviation|0|||
105846941|NCT01846273|365097714|FG000|Overall Study|Physician Decision|1|||
105846942|NCT01846273|365097715|FG001|Overall Study|Physician Decision|2|||
105846943|NCT01846273|365097716|FG002|Overall Study|Physician Decision|0|||
105846944|NCT00891839|365097717|FG000|Overall Study|Adverse Event|2|||
105846945|NCT00891839|365097717|FG000|Overall Study|Withdrawal by Subject|2|||
105846946|NCT00891839|365097717|FG000|Overall Study|Disease progression|3|||
105846947|NCT00750308|365097718|FG000|First Treatment|Adverse Event|0|||
105846948|NCT00750308|365097719|FG001|First Treatment|Adverse Event|1|||
105846949|NCT00750308|365097720|FG002|First Treatment|Adverse Event|0|||
105846950|NCT00750308|365097721|FG003|First Treatment|Adverse Event|0|||
105846951|NCT00750308|365097722|FG004|First Treatment|Adverse Event|0|||
105846952|NCT00750308|365097723|FG005|First Treatment|Adverse Event|0|||
105846953|NCT00750308|365097724|FG006|First Treatment|Adverse Event|0|||
105846954|NCT00750308|365097725|FG007|First Treatment|Adverse Event|0|||
105846955|NCT00750308|365097726|FG008|First Treatment|Adverse Event|0|||
105846956|NCT00750308|365097727|FG009|First Treatment|Adverse Event|0|||
105846957|NCT00750308|365097728|FG010|First Treatment|Adverse Event|1|||
105846958|NCT00750308|365097729|FG011|First Treatment|Adverse Event|1|||
105846959|NCT00750308|365097718|FG000|First Treatment|Withdrawal by Subject|0|||
105846960|NCT00750308|365097719|FG001|First Treatment|Withdrawal by Subject|0|||
105846961|NCT00750308|365097720|FG002|First Treatment|Withdrawal by Subject|0|||
105846962|NCT00750308|365097721|FG003|First Treatment|Withdrawal by Subject|1|||
105846963|NCT00750308|365097722|FG004|First Treatment|Withdrawal by Subject|0|||
105846964|NCT00750308|365097723|FG005|First Treatment|Withdrawal by Subject|0|||
105846965|NCT00750308|365097724|FG006|First Treatment|Withdrawal by Subject|0|||
105846966|NCT00750308|365097725|FG007|First Treatment|Withdrawal by Subject|1|||
105846967|NCT00750308|365097726|FG008|First Treatment|Withdrawal by Subject|0|||
105846968|NCT00750308|365097727|FG009|First Treatment|Withdrawal by Subject|0|||
105846969|NCT00750308|365097728|FG010|First Treatment|Withdrawal by Subject|0|||
105846970|NCT00750308|365097729|FG011|First Treatment|Withdrawal by Subject|0|||
105846971|NCT00750308|365097718|FG000|Second Treatment|Adverse Event|0|||
105846972|NCT00750308|365097719|FG001|Second Treatment|Adverse Event|0|||
105846973|NCT00750308|365097720|FG002|Second Treatment|Adverse Event|0|||
105846974|NCT00750308|365097721|FG003|Second Treatment|Adverse Event|0|||
105846975|NCT00750308|365097722|FG004|Second Treatment|Adverse Event|0|||
105846976|NCT00750308|365097723|FG005|Second Treatment|Adverse Event|1|||
105846977|NCT00750308|365097724|FG006|Second Treatment|Adverse Event|0|||
105846978|NCT00750308|365097725|FG007|Second Treatment|Adverse Event|0|||
105846979|NCT00750308|365097726|FG008|Second Treatment|Adverse Event|1|||
105368810|NCT04040439|363356299|FG000|Overall Study|Invalid registration|11|||
105846980|NCT00750308|365097727|FG009|Second Treatment|Adverse Event|0|||
105846981|NCT00750308|365097728|FG010|Second Treatment|Adverse Event|0|||
105846982|NCT00750308|365097729|FG011|Second Treatment|Adverse Event|0|||
105846983|NCT00750308|365097718|FG000|Second Treatment|Withdrawal by Subject|0|||
105846984|NCT00750308|365097719|FG001|Second Treatment|Withdrawal by Subject|0|||
105846985|NCT00750308|365097720|FG002|Second Treatment|Withdrawal by Subject|0|||
105846986|NCT00750308|365097721|FG003|Second Treatment|Withdrawal by Subject|0|||
105846987|NCT00750308|365097722|FG004|Second Treatment|Withdrawal by Subject|1|||
105846988|NCT00750308|365097723|FG005|Second Treatment|Withdrawal by Subject|0|||
105846989|NCT00750308|365097724|FG006|Second Treatment|Withdrawal by Subject|0|||
105846990|NCT00750308|365097725|FG007|Second Treatment|Withdrawal by Subject|0|||
105846991|NCT00750308|365097726|FG008|Second Treatment|Withdrawal by Subject|0|||
105846992|NCT00750308|365097727|FG009|Second Treatment|Withdrawal by Subject|0|||
105846993|NCT00750308|365097728|FG010|Second Treatment|Withdrawal by Subject|0|||
105846994|NCT00750308|365097729|FG011|Second Treatment|Withdrawal by Subject|0|||
105846995|NCT00750308|365097718|FG000|Third Treatment|Withdrawal by Subject|0|||
105316797|NCT03449446|363154809|FG003|Overall Study|Randomized but Never Treated|1|||
105316798|NCT03449446|363154810|FG004|Overall Study|Randomized but Never Treated|1|||
105316799|NCT03449446|363154811|FG005|Overall Study|Randomized but Never Treated|0|||
105316800|NCT03449446|363154812|FG006|Overall Study|Randomized but Never Treated|0|||
105316801|NCT03449446|363154806|FG000|Overall Study|Unknown Reason|33|||
105316802|NCT03449446|363154807|FG001|Overall Study|Unknown Reason|1|||
105316803|NCT03449446|363154808|FG002|Overall Study|Unknown Reason|1|||
105316804|NCT03449446|363154809|FG003|Overall Study|Unknown Reason|1|||
105316805|NCT03449446|363154810|FG004|Overall Study|Unknown Reason|2|||
105316806|NCT03449446|363154811|FG005|Overall Study|Unknown Reason|2|||
105316807|NCT03449446|363154812|FG006|Overall Study|Unknown Reason|0|||
105316808|NCT03449446|363154806|FG000|Overall Study|Withdrew Consent|1|||
105316809|NCT03449446|363154807|FG001|Overall Study|Withdrew Consent|3|||
105846996|NCT00750308|365097719|FG001|Third Treatment|Withdrawal by Subject|1|||
105846997|NCT00750308|365097720|FG002|Third Treatment|Withdrawal by Subject|0|||
105846998|NCT00750308|365097721|FG003|Third Treatment|Withdrawal by Subject|0|||
105846999|NCT00750308|365097722|FG004|Third Treatment|Withdrawal by Subject|0|||
105847000|NCT00750308|365097723|FG005|Third Treatment|Withdrawal by Subject|0|||
105847001|NCT00750308|365097724|FG006|Third Treatment|Withdrawal by Subject|0|||
105847002|NCT00750308|365097725|FG007|Third Treatment|Withdrawal by Subject|0|||
105847003|NCT00750308|365097726|FG008|Third Treatment|Withdrawal by Subject|0|||
105847004|NCT00750308|365097727|FG009|Third Treatment|Withdrawal by Subject|0|||
105847005|NCT00750308|365097728|FG010|Third Treatment|Withdrawal by Subject|0|||
105847006|NCT00750308|365097729|FG011|Third Treatment|Withdrawal by Subject|0|||
105847007|NCT01698775|365097732|FG000|Phase A|Adverse Event|2|||
105847008|NCT01698775|365097733|FG001|Phase A|Adverse Event|1|||
105847009|NCT01698775|365097732|FG000|Phase A|Death|1|||
105847010|NCT01698775|365097733|FG001|Phase A|Death|1|||
105847011|NCT01698775|365097732|FG000|Phase A|Lack of Efficacy|1|||
105847012|NCT01698775|365097733|FG001|Phase A|Lack of Efficacy|0|||
105847013|NCT01698775|365097732|FG000|Phase A|Lost to Follow-up|1|||
105847014|NCT01698775|365097733|FG001|Phase A|Lost to Follow-up|2|||
105847015|NCT01698775|365097732|FG000|Phase A|Protocol Violation|1|||
105847016|NCT01698775|365097733|FG001|Phase A|Protocol Violation|0|||
105847017|NCT01698775|365097732|FG000|Phase A|Withdrawal by Subject|3|||
105847018|NCT01698775|365097733|FG001|Phase A|Withdrawal by Subject|4|||
105847019|NCT01698775|365097732|FG000|Phase A|Kidney [transplant]|0|||
105847020|NCT01698775|365097733|FG001|Phase A|Kidney [transplant]|1|||
105847021|NCT01698775|365097732|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
105847022|NCT01698775|365097733|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
105847023|NCT01698775|365097732|FG000|Phase B|Adverse Event|6|||
105847024|NCT01698775|365097733|FG001|Phase B|Adverse Event|3|||
105847025|NCT01698775|365097732|FG000|Phase B|Death|0|||
105847026|NCT01698775|365097733|FG001|Phase B|Death|1|||
105847027|NCT01698775|365097732|FG000|Phase B|Lack of Efficacy|0|||
105847028|NCT01698775|365097733|FG001|Phase B|Lack of Efficacy|1|||
105847029|NCT01698775|365097732|FG000|Phase B|Lost to Follow-up|0|||
105847030|NCT01698775|365097733|FG001|Phase B|Lost to Follow-up|1|||
105847031|NCT01698775|365097732|FG000|Phase B|Physician Decision|1|||
105847032|NCT01698775|365097733|FG001|Phase B|Physician Decision|1|||
105847033|NCT01698775|365097732|FG000|Phase B|Protocol Violation|1|||
105847034|NCT01698775|365097733|FG001|Phase B|Protocol Violation|1|||
105847035|NCT01698775|365097732|FG000|Phase B|Withdrawal by Subject|6|||
105847036|NCT01698775|365097733|FG001|Phase B|Withdrawal by Subject|2|||
105847037|NCT00359788|365097734|FG000|Overall Study|Adverse Event|11|||
105847038|NCT00359788|365097735|FG001|Overall Study|Adverse Event|10|||
105847039|NCT00359788|365097734|FG000|Overall Study|Lack of Efficacy|1|||
105847040|NCT00359788|365097735|FG001|Overall Study|Lack of Efficacy|2|||
105847041|NCT00359788|365097734|FG000|Overall Study|Lost to Follow-up|3|||
105847042|NCT00359788|365097735|FG001|Overall Study|Lost to Follow-up|2|||
105847043|NCT00359788|365097734|FG000|Overall Study|Withdrawal by Subject|4|||
105847044|NCT00359788|365097735|FG001|Overall Study|Withdrawal by Subject|1|||
105847045|NCT00359788|365097734|FG000|Overall Study|Protocol Violation|4|||
105847046|NCT00359788|365097735|FG001|Overall Study|Protocol Violation|2|||
105847047|NCT00673933|365097738|FG000|Overall Study|Withdrawal by Subject|2|||
105847048|NCT00673933|365097738|FG000|Overall Study|Lost to Follow-up|1|||
105847049|NCT05069155|365097739|FG000|Overall Study|Withdrawal by Subject|1|||
105316810|NCT03449446|363154808|FG002|Overall Study|Withdrew Consent|1|||
105316811|NCT03449446|363154809|FG003|Overall Study|Withdrew Consent|4|||
105316812|NCT03449446|363154810|FG004|Overall Study|Withdrew Consent|4|||
105316813|NCT03449446|363154811|FG005|Overall Study|Withdrew Consent|4|||
105316814|NCT03449446|363154812|FG006|Overall Study|Withdrew Consent|1|||
105316815|NCT03449446|363154806|FG000|Overall Study|Adverse Event|1|||
105847050|NCT05069155|365097740|FG001|Overall Study|Withdrawal by Subject|3|||
105847051|NCT05816200|365097741|FG000|Overall Study|Lost to Follow-up|2|||
105847052|NCT05816200|365097742|FG001|Overall Study|Lost to Follow-up|1|||
105847053|NCT00712985|365097750|FG000|Overall Study|1 withdrew prior to start of drug|1|||
105847054|NCT00712985|365097750|FG000|Overall Study|1 patient moved out of state|1|||
105847055|NCT00712985|365097750|FG000|Overall Study|Lack of Efficacy|3|||
105847056|NCT03407430|365097753|FG000|Washout|Protocol Violation|1|||
105847057|NCT03407430|365097754|FG001|Washout|Protocol Violation|0|||
105847058|NCT01481324|365097755|FG000|Overall Study|Missing Data|0|||
105847059|NCT01481324|365097756|FG001|Overall Study|Missing Data|2|||
105847060|NCT01481324|365097757|FG002|Overall Study|Missing Data|2|||
105847061|NCT01172821|365097758|FG000|Overall Study|Adverse Event|5|||
105847062|NCT01172821|365097759|FG001|Overall Study|Adverse Event|2|||
105847063|NCT01172821|365097760|FG002|Overall Study|Adverse Event|2|||
105847064|NCT01172821|365097761|FG003|Overall Study|Adverse Event|7|||
105847065|NCT01172821|365097758|FG000|Overall Study|Protocol Violation|0|||
105847066|NCT01172821|365097759|FG001|Overall Study|Protocol Violation|2|||
105847067|NCT01172821|365097760|FG002|Overall Study|Protocol Violation|1|||
105847068|NCT01172821|365097761|FG003|Overall Study|Protocol Violation|2|||
105847069|NCT01172821|365097758|FG000|Overall Study|Lost to Follow-up|4|||
105847070|NCT01172821|365097759|FG001|Overall Study|Lost to Follow-up|1|||
105847071|NCT01172821|365097760|FG002|Overall Study|Lost to Follow-up|2|||
105847072|NCT01172821|365097761|FG003|Overall Study|Lost to Follow-up|2|||
105847073|NCT01172821|365097758|FG000|Overall Study|Withdrawal by Subject|2|||
105847074|NCT01172821|365097759|FG001|Overall Study|Withdrawal by Subject|3|||
105847075|NCT01172821|365097760|FG002|Overall Study|Withdrawal by Subject|3|||
105847076|NCT01172821|365097761|FG003|Overall Study|Withdrawal by Subject|3|||
105847077|NCT01172821|365097758|FG000|Overall Study|Other|3|||
105847078|NCT01172821|365097759|FG001|Overall Study|Other|4|||
105847079|NCT01172821|365097760|FG002|Overall Study|Other|5|||
105847080|NCT01172821|365097761|FG003|Overall Study|Other|3|||
105847081|NCT00123955|365097762|FG000|Overall Study|Adverse Event|1|||
105847082|NCT00123955|365097763|FG001|Overall Study|Adverse Event|0|||
105847083|NCT00123955|365097762|FG000|Overall Study|Withdrawal by Subject|4|||
105847084|NCT00123955|365097763|FG001|Overall Study|Withdrawal by Subject|3|||
105847085|NCT00123955|365097762|FG000|Overall Study|Death|0|||
105847086|NCT00123955|365097763|FG001|Overall Study|Death|1|||
105847087|NCT03334721|365097764|FG000|Overall Study|Withdrawal by Subject|1|||
105847088|NCT03334721|365097765|FG001|Overall Study|Withdrawal by Subject|0|||
105847089|NCT03334721|365097764|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
105847090|NCT03334721|365097765|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
105847091|NCT01769339|365097767|FG000|Overall Study|Lost to Follow-up|42|||
105847092|NCT01769339|365097767|FG000|Overall Study|Adverse Event|1|||
105847093|NCT01195272|365097768|FG000|Overall Study|Adverse Event|1|||
105847094|NCT01195272|365097768|FG000|Overall Study|Lack of Efficacy|3|||
105847095|NCT03907462|365097772|FG000|Overall Study|Physician Decision|1|||
105847096|NCT03907462|365097773|FG001|Overall Study|Physician Decision|3|||
105847097|NCT03907462|365097774|FG002|Overall Study|Physician Decision|1|||
105847098|NCT03907462|365097772|FG000|Overall Study|Withdrawal by Subject|6|||
105847099|NCT03907462|365097773|FG001|Overall Study|Withdrawal by Subject|3|||
105847100|NCT03907462|365097774|FG002|Overall Study|Withdrawal by Subject|3|||
105847101|NCT03907462|365097772|FG000|Overall Study|Pregnancy|4|||
105847102|NCT03907462|365097773|FG001|Overall Study|Pregnancy|2|||
105847103|NCT03907462|365097774|FG002|Overall Study|Pregnancy|6|||
105847104|NCT03907462|365097772|FG000|Overall Study|Lost to Follow-up|16|||
105847105|NCT03907462|365097773|FG001|Overall Study|Lost to Follow-up|18|||
105847106|NCT03907462|365097774|FG002|Overall Study|Lost to Follow-up|22|||
105847107|NCT00290251|365097775|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
105847108|NCT00290251|365097776|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
105847109|NCT00290251|365097777|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
105847110|NCT00290251|365097778|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
105847111|NCT00290251|365097779|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
105847112|NCT00290251|365097780|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
105847113|NCT00290251|365097775|FG000|Treatment 1 (Months 2-4)|headache|0|||
105847114|NCT00290251|365097776|FG001|Treatment 1 (Months 2-4)|headache|0|||
105316816|NCT03449446|363154807|FG001|Overall Study|Adverse Event|2|||
105490446|NCT01226043|363807562|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
105490447|NCT01226043|363807563|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
105847115|NCT00290251|365097777|FG002|Treatment 1 (Months 2-4)|headache|0|||
105847116|NCT00290251|365097778|FG003|Treatment 1 (Months 2-4)|headache|0|||
105847117|NCT00290251|365097779|FG004|Treatment 1 (Months 2-4)|headache|1|||
105847118|NCT00290251|365097780|FG005|Treatment 1 (Months 2-4)|headache|0|||
105847119|NCT00290251|365097775|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
105847120|NCT00290251|365097776|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
105847121|NCT00290251|365097777|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
105847122|NCT00290251|365097778|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
105847123|NCT00290251|365097779|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
105847124|NCT00290251|365097780|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
105847125|NCT02221037|365098941|FG000|Overall Study|Physician Decision|0|||
105847126|NCT02221037|365098942|FG001|Overall Study|Physician Decision|0|||
105847127|NCT02221037|365098943|FG002|Overall Study|Physician Decision|1|||
105847128|NCT02221037|365098944|FG003|Overall Study|Physician Decision|0|||
105847129|NCT01996332|365098952|FG000|Overall Study|Adverse Event|117|||
105847130|NCT01996332|365098952|FG000|Overall Study|Lack of Efficacy|1245|||
105847131|NCT01996332|365098952|FG000|Overall Study|Death|264|||
105847132|NCT01996332|365098952|FG000|Overall Study|Protocol Violation|9|||
105847133|NCT01996332|365098952|FG000|Overall Study|Withdrawal by Subject|71|||
105847134|NCT01996332|365098952|FG000|Overall Study|Other|20|||
105847135|NCT01996332|365098952|FG000|Overall Study|Clinical Deterioration|28|||
105847136|NCT01996332|365098952|FG000|Overall Study|Physician Decision|17|||
105847137|NCT01996332|365098952|FG000|Overall Study|Lost to Follow-up|34|||
105847138|NCT02113189|365098953|FG000|Overall Study|Lost to follow up|2|||
105847139|NCT02113189|365098954|FG001|Overall Study|Lost to follow up|1|||
105847140|NCT02113189|365098955|FG002|Overall Study|Lost to follow up|3|||
105847141|NCT00292188|365098956|FG000|Single-Blind|Adverse Event|14|||
105847142|NCT00292188|365098957|FG001|Single-Blind|Adverse Event|0|||
105847143|NCT00292188|365098958|FG002|Single-Blind|Adverse Event|0|||
105847144|NCT00292188|365098956|FG000|Single-Blind|Lack of Efficacy|2|||
105847145|NCT00292188|365098957|FG001|Single-Blind|Lack of Efficacy|0|||
105847146|NCT00292188|365098958|FG002|Single-Blind|Lack of Efficacy|0|||
105847147|NCT00292188|365098956|FG000|Single-Blind|Laboratory Abnormality|5|||
105847148|NCT00292188|365098957|FG001|Single-Blind|Laboratory Abnormality|0|||
105847149|NCT00292188|365098958|FG002|Single-Blind|Laboratory Abnormality|0|||
105847150|NCT00292188|365098956|FG000|Single-Blind|Lost to Follow-up|3|||
105847151|NCT00292188|365098957|FG001|Single-Blind|Lost to Follow-up|0|||
105847152|NCT00292188|365098958|FG002|Single-Blind|Lost to Follow-up|0|||
105490448|NCT01226043|363807564|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
105490449|NCT01226043|363807565|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
105490450|NCT01226043|363807562|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
105490451|NCT01226043|363807563|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
105490452|NCT01226043|363807564|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
105490453|NCT01226043|363807565|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
105490454|NCT01226043|363807562|FG000|6-week Re-randomization Phase|Adverse Event|0|||
105490455|NCT01226043|363807563|FG001|6-week Re-randomization Phase|Adverse Event|0|||
105847153|NCT00292188|365098956|FG000|Single-Blind|Other|77|||
105847154|NCT00292188|365098957|FG001|Single-Blind|Other|0|||
105847155|NCT00292188|365098958|FG002|Single-Blind|Other|0|||
105847156|NCT00292188|365098956|FG000|Single-Blind|Withdrawal by Subject|12|||
105847157|NCT00292188|365098957|FG001|Single-Blind|Withdrawal by Subject|0|||
105847158|NCT00292188|365098958|FG002|Single-Blind|Withdrawal by Subject|0|||
105847159|NCT00292188|365098956|FG000|Single-Blind|Did not receive treatment|1|||
105847160|NCT00292188|365098957|FG001|Single-Blind|Did not receive treatment|0|||
105847161|NCT00292188|365098958|FG002|Single-Blind|Did not receive treatment|0|||
105847162|NCT00292188|365098956|FG000|Double-Blind|Adverse Event|0|||
105847163|NCT00292188|365098957|FG001|Double-Blind|Adverse Event|25|||
105847164|NCT00292188|365098958|FG002|Double-Blind|Adverse Event|9|||
105847165|NCT00292188|365098956|FG000|Double-Blind|Lack of Efficacy|0|||
105847166|NCT00292188|365098957|FG001|Double-Blind|Lack of Efficacy|2|||
105847167|NCT00292188|365098958|FG002|Double-Blind|Lack of Efficacy|12|||
105847168|NCT00292188|365098956|FG000|Double-Blind|Lost to Follow-up|0|||
105847169|NCT00292188|365098957|FG001|Double-Blind|Lost to Follow-up|1|||
105847170|NCT00292188|365098958|FG002|Double-Blind|Lost to Follow-up|0|||
105847171|NCT00292188|365098956|FG000|Double-Blind|Other|0|||
105847172|NCT00292188|365098957|FG001|Double-Blind|Other|3|||
105847173|NCT00292188|365098958|FG002|Double-Blind|Other|4|||
105847174|NCT00292188|365098956|FG000|Double-Blind|Withdrawal by Subject|0|||
105847175|NCT00292188|365098957|FG001|Double-Blind|Withdrawal by Subject|0|||
105847176|NCT00292188|365098958|FG002|Double-Blind|Withdrawal by Subject|3|||
105847177|NCT00292188|365098956|FG000|Double-Blind|Laboratory Abnormality|0|||
105847178|NCT00292188|365098957|FG001|Double-Blind|Laboratory Abnormality|0|||
105847179|NCT00292188|365098958|FG002|Double-Blind|Laboratory Abnormality|1|||
105847180|NCT03084367|365098959|FG000|Overall Study|Lost to Follow-up|32|||
105847181|NCT03084367|365098959|FG000|Overall Study|Withdrawal by Subject|4|||
105847182|NCT03084367|365098959|FG000|Overall Study|Other|1|||
105847183|NCT00931268|365098962|FG000|Overall Study|Lost to Follow-up|6|||
105847184|NCT02667288|365098963|FG000|Overall Study|Protocol Violation|5|||
105847185|NCT02667288|365098963|FG000|Overall Study|Lost to Follow-up|3|||
105847186|NCT02667288|365098963|FG000|Overall Study|Withdrawal by Subject|5|||
105316817|NCT03449446|363154808|FG002|Overall Study|Adverse Event|1|||
105316818|NCT03449446|363154809|FG003|Overall Study|Adverse Event|0|||
105490456|NCT01226043|363807564|FG002|6-week Re-randomization Phase|Adverse Event|1|||
105490457|NCT01226043|363807565|FG003|6-week Re-randomization Phase|Adverse Event|1|||
105490458|NCT01226043|363807562|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
105847187|NCT02145026|365098964|FG000|Overall Study|Adverse Event|2|||
105847188|NCT02145026|365098964|FG000|Overall Study|Death|4|||
105847189|NCT02145026|365098964|FG000|Overall Study|Withdrawal by Subject|2|||
105847190|NCT02145026|365098964|FG000|Overall Study|Physician Decision|4|||
105847191|NCT00127036|365098965|FG000|Overall Study|Insufficient Data for Analysis|6|||
105847192|NCT00127036|365098966|FG001|Overall Study|Insufficient Data for Analysis|11|||
105847193|NCT00127036|365098965|FG000|Overall Study|Screen Failure|2|||
105847194|NCT00127036|365098966|FG001|Overall Study|Screen Failure|0|||
105847195|NCT03656874|365098969|FG000|Overall Study|Lost to Follow-up|3|||
105847196|NCT03656874|365098970|FG001|Overall Study|Lost to Follow-up|17|||
105847197|NCT00584844|365098971|FG000|Overall Study|Withdrawal by Subject|59|||
105847198|NCT00584844|365098971|FG000|Overall Study|Screen Failure|20|||
105847199|NCT03001219|365098973|FG000|Proof of Concept|Study Termination by Sponsor|0|||
105847200|NCT03001219|365098974|FG001|Proof of Concept|Study Termination by Sponsor|1|||
105847201|NCT03001219|365098973|FG000|Proof of Concept|Withdrawal by Subject|0|||
105847202|NCT03001219|365098974|FG001|Proof of Concept|Withdrawal by Subject|4|||
105847203|NCT03001219|365098973|FG000|Proof of Concept|Protocol Deviation|0|||
105847204|NCT03001219|365098974|FG001|Proof of Concept|Protocol Deviation|1|||
105847205|NCT03001219|365098973|FG000|Proof of Concept|Adverse Event|1|||
105847206|NCT03001219|365098974|FG001|Proof of Concept|Adverse Event|1|||
105847207|NCT03001219|365098973|FG000|Proof of Concept|Physician Decision|1|||
105847208|NCT03001219|365098974|FG001|Proof of Concept|Physician Decision|0|||
105847209|NCT03001219|365098973|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
105847210|NCT03001219|365098974|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
105847211|NCT03001219|365098973|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
105847212|NCT03001219|365098974|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
105847213|NCT03001219|365098973|FG000|Extension Period Analysis|Physician Decision|0|||
105847214|NCT03001219|365098974|FG001|Extension Period Analysis|Physician Decision|1|||
105847215|NCT03001219|365098973|FG000|Extension Period Analysis|Adverse Event|1|||
105847216|NCT03001219|365098974|FG001|Extension Period Analysis|Adverse Event|1|||
105847217|NCT03001219|365098973|FG000|Extension Period Analysis|Protocol Deviation|0|||
105847218|NCT03001219|365098974|FG001|Extension Period Analysis|Protocol Deviation|1|||
105847219|NCT03001219|365098973|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
105847220|NCT03001219|365098974|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
105847221|NCT02034058|365098977|FG000|Overall Study|Death|3|||
105847222|NCT03254602|365098978|FG000|Overall Study|Lost to Follow-up|4|||
105847223|NCT00468728|365098981|FG000|Treatment|criteria for mITT population|4|||
105847224|NCT00468728|365098982|FG001|Treatment|criteria for mITT population|11|||
105847225|NCT00468728|365098981|FG000|Follow-up|mITT failure|34|||
105847226|NCT00468728|365098982|FG001|Follow-up|mITT failure|31|||
105847227|NCT02963311|365098983|FG000|Overall Study|Withdrawal by Subject|1|||
105847228|NCT02963311|365098983|FG000|Overall Study|Screen Failure|4|||
105847229|NCT05065983|365098984|FG000|Overall Study|Lost to Follow-up|2|||
105847230|NCT01765582|365098985|FG000|Overall Study|Other|3|||
105847231|NCT01765582|365098986|FG001|Overall Study|Other|6|||
105847232|NCT01765582|365098987|FG002|Overall Study|Other|9|||
105847233|NCT01765582|365098985|FG000|Overall Study|Lost to Follow-up|2|||
105847234|NCT01765582|365098986|FG001|Overall Study|Lost to Follow-up|2|||
105847235|NCT01765582|365098987|FG002|Overall Study|Lost to Follow-up|1|||
105847236|NCT01765582|365098985|FG000|Overall Study|Death|31|||
105847237|NCT01765582|365098986|FG001|Overall Study|Death|36|||
105847238|NCT01765582|365098987|FG002|Overall Study|Death|33|||
105847239|NCT01765582|365098985|FG000|Overall Study|Sponsor Decision|46|||
105847240|NCT01765582|365098986|FG001|Overall Study|Sponsor Decision|42|||
105847241|NCT01765582|365098987|FG002|Overall Study|Sponsor Decision|42|||
105847242|NCT01765582|365098985|FG000|Overall Study|Withdrawal of Consent|11|||
105847243|NCT01765582|365098986|FG001|Overall Study|Withdrawal of Consent|6|||
105847244|NCT01765582|365098987|FG002|Overall Study|Withdrawal of Consent|10|||
105847245|NCT01691820|365098988|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
105847246|NCT01691820|365098989|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
105847247|NCT01691820|365098988|FG000|Overall Study|Migrated/moved from study area|7|||
105847248|NCT01691820|365098989|FG001|Overall Study|Migrated/moved from study area|4|||
105847249|NCT01691820|365098988|FG000|Overall Study|Lost to Follow-up|6|||
105847250|NCT01691820|365098989|FG001|Overall Study|Lost to Follow-up|17|||
105847251|NCT01691820|365098988|FG000|Overall Study|Other (unspecified)|4|||
105847252|NCT01691820|365098989|FG001|Overall Study|Other (unspecified)|1|||
105847253|NCT00714493|365099004|FG000|Overall Study|Adverse Event|11|||
105847254|NCT00714493|365099004|FG000|Overall Study|Death|3|||
105847255|NCT00714493|365099004|FG000|Overall Study|Lack of Efficacy|10|||
105847256|NCT00714493|365099004|FG000|Overall Study|Lost to Follow-up|3|||
105847257|NCT00714493|365099004|FG000|Overall Study|Protocol Violation|12|||
105847258|NCT00714493|365099004|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
105847259|NCT00714493|365099004|FG000|Overall Study|OTHER|2|||
105847260|NCT01968694|365099005|FG000|Washout (1 Month)|Lost to Follow-up|0|||
105847261|NCT01968694|365099006|FG001|Washout (1 Month)|Lost to Follow-up|1|||
105847262|NCT00354341|365099009|FG000|Overall Study|Adverse Event|1|||
105847263|NCT00354341|365099010|FG001|Overall Study|Adverse Event|0|||
105847264|NCT00354341|365099009|FG000|Overall Study|Death|0|||
105847265|NCT00354341|365099010|FG001|Overall Study|Death|2|||
105847266|NCT00354341|365099009|FG000|Overall Study|Refused treatment|1|||
105847267|NCT00354341|365099010|FG001|Overall Study|Refused treatment|2|||
105847268|NCT00354341|365099009|FG000|Overall Study|Failure to return|0|||
105847269|NCT00354341|365099010|FG001|Overall Study|Failure to return|1|||
105847270|NCT00354341|365099009|FG000|Overall Study|Other|1|||
105847271|NCT00354341|365099010|FG001|Overall Study|Other|2|||
105847272|NCT02836496|365099011|FG000|Overall Study|Adverse Event|2|||
105847273|NCT02836496|365099012|FG001|Overall Study|Adverse Event|1|||
105847274|NCT02836496|365099011|FG000|Overall Study|Withdrawal by Subject|0|||
105847275|NCT02836496|365099012|FG001|Overall Study|Withdrawal by Subject|1|||
105847276|NCT04295135|365099013|FG000|Overall Study|Withdrawal by Subject|2|||
105847277|NCT04295135|365099014|FG001|Overall Study|Withdrawal by Subject|1|||
105847278|NCT04295135|365099013|FG000|Overall Study|Subject left organization|8|||
105847279|NCT04295135|365099014|FG001|Overall Study|Subject left organization|4|||
105847280|NCT00251719|365099015|FG000|Overall Study|Adverse Event|14|||
105847281|NCT00251719|365099016|FG001|Overall Study|Adverse Event|8|||
105847282|NCT00251719|365099017|FG002|Overall Study|Adverse Event|7|||
105847283|NCT00251719|365099015|FG000|Overall Study|Protocol Violation|1|||
105847284|NCT00251719|365099016|FG001|Overall Study|Protocol Violation|1|||
105847285|NCT00251719|365099017|FG002|Overall Study|Protocol Violation|1|||
105847286|NCT00251719|365099015|FG000|Overall Study|Lost to Follow-up|5|||
105847287|NCT00251719|365099016|FG001|Overall Study|Lost to Follow-up|11|||
105847288|NCT00251719|365099017|FG002|Overall Study|Lost to Follow-up|8|||
105847289|NCT00251719|365099015|FG000|Overall Study|Withdrawal by Subject|14|||
105847290|NCT00251719|365099016|FG001|Overall Study|Withdrawal by Subject|12|||
105847291|NCT00251719|365099017|FG002|Overall Study|Withdrawal by Subject|11|||
105847292|NCT00251719|365099015|FG000|Overall Study|Lack of Efficacy|2|||
105847293|NCT00251719|365099016|FG001|Overall Study|Lack of Efficacy|1|||
105847294|NCT00251719|365099017|FG002|Overall Study|Lack of Efficacy|0|||
105847295|NCT00251719|365099015|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
105847296|NCT00251719|365099016|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
105847297|NCT00251719|365099017|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
105847298|NCT00251719|365099015|FG000|Overall Study|Investigator decision|1|||
105847299|NCT00251719|365099016|FG001|Overall Study|Investigator decision|1|||
105847300|NCT00251719|365099017|FG002|Overall Study|Investigator decision|0|||
105847301|NCT00251719|365099015|FG000|Overall Study|Noncompliance|2|||
105847302|NCT00251719|365099016|FG001|Overall Study|Noncompliance|3|||
105847303|NCT00251719|365099017|FG002|Overall Study|Noncompliance|1|||
105847304|NCT00251719|365099015|FG000|Overall Study|Barrett's esophagus|2|||
105847305|NCT00251719|365099016|FG001|Overall Study|Barrett's esophagus|2|||
105847306|NCT00251719|365099017|FG002|Overall Study|Barrett's esophagus|0|||
105847307|NCT01732874|365099021|FG000|Overall Study|Withdrawal by Subject|5|||
105847308|NCT01732874|365099022|FG001|Overall Study|Withdrawal by Subject|1|||
105847309|NCT01732874|365099021|FG000|Overall Study|Death of Infant|3|||
105847310|NCT01732874|365099022|FG001|Overall Study|Death of Infant|2|||
105847311|NCT02923674|365099023|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
105847312|NCT02923674|365099024|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
105847313|NCT02923674|365099025|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
105847314|NCT02923674|365099023|FG000|Overall Study|Lost to Follow-up|7|||
105847315|NCT02923674|365099024|FG001|Overall Study|Lost to Follow-up|12|||
105847316|NCT02923674|365099025|FG002|Overall Study|Lost to Follow-up|7|||
105847317|NCT02923674|365099023|FG000|Overall Study|Problem with intervention|2|||
105847318|NCT02923674|365099024|FG001|Overall Study|Problem with intervention|2|||
105847319|NCT02923674|365099025|FG002|Overall Study|Problem with intervention|1|||
105847320|NCT02923674|365099023|FG000|Overall Study|Adverse Event|3|||
105847321|NCT02923674|365099024|FG001|Overall Study|Adverse Event|1|||
105847322|NCT02923674|365099025|FG002|Overall Study|Adverse Event|1|||
105847323|NCT02923674|365099023|FG000|Overall Study|Withdrawal by Subject|2|||
105847324|NCT02923674|365099024|FG001|Overall Study|Withdrawal by Subject|2|||
105847325|NCT02923674|365099025|FG002|Overall Study|Withdrawal by Subject|2|||
105847326|NCT03709823|365099028|FG000|Overall Study|Adverse Event|0|||
105847327|NCT03709823|365099029|FG001|Overall Study|Adverse Event|0|||
105847328|NCT03709823|365099030|FG002|Overall Study|Adverse Event|1|||
105847329|NCT03709823|365099031|FG003|Overall Study|Adverse Event|0|||
105847330|NCT03709823|365099032|FG004|Overall Study|Adverse Event|0|||
105847331|NCT03709823|365099033|FG005|Overall Study|Adverse Event|0|||
105847332|NCT03709823|365099028|FG000|Overall Study|Lost to Follow-up|2|||
105847333|NCT03709823|365099029|FG001|Overall Study|Lost to Follow-up|2|||
105847334|NCT03709823|365099030|FG002|Overall Study|Lost to Follow-up|2|||
105847335|NCT03709823|365099031|FG003|Overall Study|Lost to Follow-up|1|||
105847336|NCT03709823|365099032|FG004|Overall Study|Lost to Follow-up|1|||
105847337|NCT03709823|365099033|FG005|Overall Study|Lost to Follow-up|0|||
105847338|NCT03709823|365099028|FG000|Overall Study|Withdrawal by Subject|1|||
105847339|NCT03709823|365099029|FG001|Overall Study|Withdrawal by Subject|3|||
105847340|NCT03709823|365099030|FG002|Overall Study|Withdrawal by Subject|0|||
105847341|NCT03709823|365099031|FG003|Overall Study|Withdrawal by Subject|0|||
105847342|NCT03709823|365099032|FG004|Overall Study|Withdrawal by Subject|0|||
105847343|NCT03709823|365099033|FG005|Overall Study|Withdrawal by Subject|0|||
105847344|NCT03709823|365099028|FG000|Overall Study|Other, Not Specified|0|||
105847345|NCT03709823|365099029|FG001|Overall Study|Other, Not Specified|0|||
105847346|NCT03709823|365099030|FG002|Overall Study|Other, Not Specified|0|||
105847347|NCT03709823|365099031|FG003|Overall Study|Other, Not Specified|1|||
105847348|NCT03709823|365099032|FG004|Overall Study|Other, Not Specified|0|||
105847349|NCT03709823|365099033|FG005|Overall Study|Other, Not Specified|0|||
105847350|NCT01055132|365099036|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
105847351|NCT01055132|365099037|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
105847352|NCT01055132|365099036|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
105847353|NCT01055132|365099037|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
105847354|NCT00557076|365099040|FG000|Overall Study|Unblinding|0|||
105847355|NCT00557076|365099041|FG001|Overall Study|Unblinding|1|||
105847356|NCT00846521|365099043|FG000|Overall Study|Withdrawal by Subject|5|||
105847357|NCT00846521|365099043|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
105847358|NCT00846521|365099043|FG000|Overall Study|Protocol Violation|1|||
105847359|NCT01246011|365099045|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
105847360|NCT01246011|365099046|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
105847361|NCT01246011|365099047|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
105847362|NCT01246011|365099045|FG000|Overall Study|Withdrawal by Subject|0|||
105847363|NCT01246011|365099046|FG001|Overall Study|Withdrawal by Subject|0|||
105847364|NCT01246011|365099047|FG002|Overall Study|Withdrawal by Subject|1|||
105847365|NCT03914950|365099052|FG000|Overall Study|Physician Decision|54|||
105847366|NCT01593696|365099053|FG000|Dose Escalation|Progressive Disease|2|||
105847367|NCT01593696|365099054|FG001|Dose Escalation|Progressive Disease|0|||
105847368|NCT01593696|365099055|FG002|Dose Escalation|Progressive Disease|0|||
105847369|NCT01593696|365099056|FG003|Dose Escalation|Progressive Disease|0|||
105847370|NCT01593696|365099053|FG000|Dose Expansion|Fungal infection|0|||
105847371|NCT01593696|365099054|FG001|Dose Expansion|Fungal infection|0|||
105847372|NCT01593696|365099055|FG002|Dose Expansion|Fungal infection|1|||
105847373|NCT01593696|365099056|FG003|Dose Expansion|Fungal infection|0|||
105847374|NCT01249365|365099066|FG000|Overall Study|Lost to Follow-up|1|||
105847375|NCT03484117|365099070|FG000|Overall Study|Lost to Follow-up|1|||
105847376|NCT03484117|365099071|FG001|Overall Study|Lost to Follow-up|3|||
105847377|NCT03484117|365099070|FG000|Overall Study|Declined participation in exit assess|1|||
105847378|NCT03484117|365099071|FG001|Overall Study|Declined participation in exit assess|1|||
105847379|NCT02712333|365099072|FG000|First Period|Withdrawal by Subject|3|||
105847380|NCT02712333|365099073|FG001|First Period|Withdrawal by Subject|2|||
105847381|NCT03052959|365099074|FG000|Overall Study|Lost to Follow-up|4|||
105847382|NCT03052959|365099075|FG001|Overall Study|Lost to Follow-up|5|||
105847383|NCT04465630|365099076|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
105847384|NCT04465630|365099076|FG000|Overall Study|Screen failure|8|||
105847385|NCT04465630|365099076|FG000|Overall Study|Baseline failure|16|||
105847386|NCT01782482|365099080|FG000|Overall Study|Adverse Event|2|||
105847387|NCT01782482|365099081|FG001|Overall Study|Adverse Event|1|||
105847388|NCT01782482|365099080|FG000|Overall Study|Lost to Follow-up|2|||
105847389|NCT01782482|365099081|FG001|Overall Study|Lost to Follow-up|3|||
105847390|NCT01782482|365099080|FG000|Overall Study|Physician Decision|1|||
105847391|NCT01782482|365099081|FG001|Overall Study|Physician Decision|0|||
105847392|NCT01782482|365099080|FG000|Overall Study|Protocol Violation|1|||
105847393|NCT01782482|365099081|FG001|Overall Study|Protocol Violation|0|||
105847394|NCT01782482|365099080|FG000|Overall Study|Withdrawal by Subject|2|||
105847395|NCT01782482|365099081|FG001|Overall Study|Withdrawal by Subject|3|||
105847396|NCT01782482|365099080|FG000|Overall Study|Randomized in Error|2|||
105847397|NCT01782482|365099081|FG001|Overall Study|Randomized in Error|2|||
105847398|NCT01782482|365099080|FG000|Overall Study|Habitually wearing toric lens OS|0|||
105847399|NCT01782482|365099081|FG001|Overall Study|Habitually wearing toric lens OS|1|||
105847400|NCT01673698|365099083|FG000|Overall Study|Lost to Follow-up|51|||
105847401|NCT01673698|365099084|FG001|Overall Study|Lost to Follow-up|13|||
105847402|NCT01288053|365101021|FG000|Overall Study|Death|1|||
105847403|NCT03188666|365101022|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
105847404|NCT03188666|365101023|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
105847405|NCT03188666|365101024|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
105847406|NCT03188666|365101025|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
105490459|NCT01226043|363807563|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
105490460|NCT01226043|363807564|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
105490461|NCT01226043|363807565|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
105490462|NCT01226043|363807562|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
105490463|NCT01226043|363807563|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
105490464|NCT01226043|363807564|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
105490465|NCT01226043|363807565|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
105847407|NCT03188666|365101022|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
105847408|NCT03188666|365101023|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
105847409|NCT03188666|365101024|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
105847410|NCT03188666|365101025|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
105847411|NCT03188666|365101022|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
105847412|NCT03188666|365101023|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
105847413|NCT03188666|365101024|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
105847414|NCT03188666|365101025|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
105847415|NCT03188666|365101022|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
105847416|NCT03188666|365101023|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
105847417|NCT03188666|365101024|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
105847418|NCT03188666|365101025|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
105847419|NCT02068092|365101026|FG000|Overall Study|Physician Decision|2|||
105847420|NCT02068092|365101026|FG000|Overall Study|Adverse Event|2|||
105847421|NCT02068092|365101026|FG000|Overall Study|Lost to Follow-up|4|||
105847422|NCT02068092|365101026|FG000|Overall Study|Withdrawal by Subject|2|||
105847423|NCT04551911|365101027|FG000|Overall Study|Lost to Follow-up|2|||
105847424|NCT04551911|365101028|FG001|Overall Study|Lost to Follow-up|1|||
105847425|NCT04551911|365101027|FG000|Overall Study|Withdrawal by Subject|10|||
105847426|NCT04551911|365101028|FG001|Overall Study|Withdrawal by Subject|10|||
105847427|NCT04551911|365101027|FG000|Overall Study|Did not receive the study drug|3|||
105847428|NCT04551911|365101028|FG001|Overall Study|Did not receive the study drug|4|||
105847429|NCT02307266|365101029|FG000|Overall Study|Adverse Event|3|||
105847430|NCT02307266|365101030|FG001|Overall Study|Adverse Event|1|||
105847431|NCT02307266|365101031|FG002|Overall Study|Adverse Event|5|||
105847432|NCT02307266|365101029|FG000|Overall Study|Withdrawal by Subject|2|||
105847433|NCT02307266|365101030|FG001|Overall Study|Withdrawal by Subject|0|||
105847434|NCT02307266|365101031|FG002|Overall Study|Withdrawal by Subject|1|||
105847435|NCT02307266|365101029|FG000|Overall Study|Lost to Follow-up|3|||
105847436|NCT02307266|365101030|FG001|Overall Study|Lost to Follow-up|0|||
105847437|NCT02307266|365101031|FG002|Overall Study|Lost to Follow-up|0|||
105847438|NCT00062010|365101032|FG000|Overall Study|Ineligible|3|||
105847439|NCT00858143|365101034|FG000|Overall Study|Adverse Event|16|||
105847440|NCT00858143|365101034|FG000|Overall Study|Lack of Efficacy|4|||
105847441|NCT00858143|365101034|FG000|Overall Study|Death|7|||
105847442|NCT00858143|365101034|FG000|Overall Study|Other|23|||
105847443|NCT01995266|365101040|FG000|Overall Study|Death|1|||
105847444|NCT01995266|365101040|FG000|Overall Study|Lack of Efficacy|6|||
105847445|NCT01995266|365101040|FG000|Overall Study|Adverse Event|2|||
105847446|NCT00852969|365101043|FG000|Overall Study|Adverse Event|0|||
105847447|NCT00852969|365101044|FG001|Overall Study|Adverse Event|1|||
105847448|NCT00852969|365101043|FG000|Overall Study|Lost to Follow-up|0|||
105847449|NCT00852969|365101044|FG001|Overall Study|Lost to Follow-up|1|||
105847450|NCT03853148|365101045|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
105847451|NCT03853148|365101046|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
105847452|NCT03853148|365101047|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
105847453|NCT03853148|365101048|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
105847454|NCT00658658|365101052|FG000|Overall Study|Withdrawal by Subject|0|||
105847455|NCT00658658|365101053|FG001|Overall Study|Withdrawal by Subject|1|||
105847456|NCT00658658|365101054|FG002|Overall Study|Withdrawal by Subject|0|||
105847457|NCT00658658|365101055|FG003|Overall Study|Withdrawal by Subject|0|||
105847458|NCT00658658|365101056|FG004|Overall Study|Withdrawal by Subject|0|||
105847459|NCT00658658|365101052|FG000|Overall Study|Death|4|||
105847460|NCT00658658|365101053|FG001|Overall Study|Death|0|||
105847461|NCT00658658|365101054|FG002|Overall Study|Death|0|||
105847462|NCT00658658|365101055|FG003|Overall Study|Death|1|||
105847463|NCT00658658|365101056|FG004|Overall Study|Death|1|||
105847464|NCT00658658|365101052|FG000|Overall Study|Disease Progression|0|||
105847465|NCT00658658|365101053|FG001|Overall Study|Disease Progression|1|||
105847466|NCT00658658|365101054|FG002|Overall Study|Disease Progression|0|||
105847467|NCT00658658|365101055|FG003|Overall Study|Disease Progression|1|||
105847468|NCT00658658|365101056|FG004|Overall Study|Disease Progression|3|||
105847469|NCT00658658|365101052|FG000|Overall Study|Protocol-specified Criteria|1|||
105847470|NCT00658658|365101053|FG001|Overall Study|Protocol-specified Criteria|0|||
105847471|NCT00658658|365101054|FG002|Overall Study|Protocol-specified Criteria|0|||
105847472|NCT00658658|365101055|FG003|Overall Study|Protocol-specified Criteria|0|||
105847473|NCT00658658|365101056|FG004|Overall Study|Protocol-specified Criteria|0|||
105847474|NCT00658658|365101052|FG000|Overall Study|Other|0|||
105847475|NCT00658658|365101053|FG001|Overall Study|Other|0|||
105847476|NCT00658658|365101054|FG002|Overall Study|Other|0|||
105847477|NCT00658658|365101055|FG003|Overall Study|Other|0|||
105847478|NCT00658658|365101056|FG004|Overall Study|Other|1|||
105847479|NCT00678041|365101057|FG000|Overall Study|Physician Decision|5|||
105847480|NCT00678041|365101058|FG001|Overall Study|Physician Decision|5|||
105847481|NCT01732484|365101061|FG000|Overall Study|Death|7|||
105847482|NCT01732484|365101061|FG000|Overall Study|Lost to Follow-up|14|||
105847483|NCT01732484|365101061|FG000|Overall Study|chronical illness|5|||
105847484|NCT02005887|365101062|FG000|Overall Study|Protocol Violation|0|||
105847485|NCT02005887|365101063|FG001|Overall Study|Protocol Violation|2|||
105847486|NCT01550744|365101064|FG000|Open-Label|Lost to Follow-up|7|||
105847487|NCT01550744|365101065|FG001|Open-Label|Lost to Follow-up|0|||
105847488|NCT01550744|365101066|FG002|Open-Label|Lost to Follow-up|0|||
105847489|NCT01550744|365101064|FG000|Open-Label|Withdrawal by Subject|13|||
105847490|NCT01550744|365101065|FG001|Open-Label|Withdrawal by Subject|0|||
105847491|NCT01550744|365101066|FG002|Open-Label|Withdrawal by Subject|0|||
105847492|NCT01550744|365101064|FG000|Open-Label|Adverse Event|11|||
105847493|NCT01550744|365101065|FG001|Open-Label|Adverse Event|0|||
105847494|NCT01550744|365101066|FG002|Open-Label|Adverse Event|0|||
105847495|NCT01550744|365101064|FG000|Open-Label|Lack of Efficacy|4|||
105847496|NCT01550744|365101065|FG001|Open-Label|Lack of Efficacy|0|||
105847497|NCT01550744|365101066|FG002|Open-Label|Lack of Efficacy|0|||
105847498|NCT01550744|365101064|FG000|Open-Label|Protocol Violation|4|||
105847499|NCT01550744|365101065|FG001|Open-Label|Protocol Violation|0|||
105847500|NCT01550744|365101066|FG002|Open-Label|Protocol Violation|0|||
105847501|NCT01550744|365101064|FG000|Open-Label|Not all 3 study drug injections received|2|||
105847502|NCT01550744|365101065|FG001|Open-Label|Not all 3 study drug injections received|0|||
105847503|NCT01550744|365101066|FG002|Open-Label|Not all 3 study drug injections received|0|||
105847504|NCT01550744|365101064|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
105847505|NCT01550744|365101065|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
105847506|NCT01550744|365101066|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
105847507|NCT01550744|365101064|FG000|Open-Label|Other|1|||
105847508|NCT01550744|365101065|FG001|Open-Label|Other|0|||
105847509|NCT01550744|365101066|FG002|Open-Label|Other|0|||
105847510|NCT01550744|365101064|FG000|Double-Blind|Lost to Follow-up|0|||
105847511|NCT01550744|365101065|FG001|Double-Blind|Lost to Follow-up|6|||
105847512|NCT01550744|365101066|FG002|Double-Blind|Lost to Follow-up|12|||
105847513|NCT01550744|365101064|FG000|Double-Blind|Withdrawal by Subject|0|||
105847514|NCT01550744|365101065|FG001|Double-Blind|Withdrawal by Subject|2|||
105847515|NCT01550744|365101066|FG002|Double-Blind|Withdrawal by Subject|15|||
105847516|NCT01550744|365101064|FG000|Double-Blind|Adverse Event|0|||
105847517|NCT01550744|365101065|FG001|Double-Blind|Adverse Event|4|||
105847518|NCT01550744|365101066|FG002|Double-Blind|Adverse Event|15|||
105847519|NCT01550744|365101064|FG000|Double-Blind|Death|0|||
105847520|NCT01550744|365101065|FG001|Double-Blind|Death|1|||
105847521|NCT01550744|365101066|FG002|Double-Blind|Death|0|||
105847522|NCT01550744|365101064|FG000|Double-Blind|Lack of Efficacy|0|||
105847523|NCT01550744|365101065|FG001|Double-Blind|Lack of Efficacy|2|||
105847524|NCT01550744|365101066|FG002|Double-Blind|Lack of Efficacy|8|||
105847525|NCT01550744|365101064|FG000|Double-Blind|Protocol Violation|0|||
105847526|NCT01550744|365101065|FG001|Double-Blind|Protocol Violation|0|||
105847527|NCT01550744|365101066|FG002|Double-Blind|Protocol Violation|4|||
105847528|NCT01550744|365101064|FG000|Double-Blind|Pregnancy|0|||
105847529|NCT01550744|365101065|FG001|Double-Blind|Pregnancy|0|||
105847530|NCT01550744|365101066|FG002|Double-Blind|Pregnancy|3|||
105847531|NCT01550744|365101064|FG000|Double-Blind|Other|0|||
105847532|NCT01550744|365101065|FG001|Double-Blind|Other|2|||
105847533|NCT01550744|365101066|FG002|Double-Blind|Other|10|||
105847534|NCT01359644|365101069|FG000|Treatment Period|Lack of Efficacy|0|||
105847535|NCT01359644|365101070|FG001|Treatment Period|Lack of Efficacy|1|||
105847536|NCT01359644|365101071|FG002|Treatment Period|Lack of Efficacy|0|||
105847537|NCT01359644|365101072|FG003|Treatment Period|Lack of Efficacy|0|||
105847538|NCT01359644|365101073|FG004|Treatment Period|Lack of Efficacy|0|||
105847539|NCT01359644|365101074|FG005|Treatment Period|Lack of Efficacy|0|||
105847540|NCT01359644|365101075|FG006|Treatment Period|Lack of Efficacy|0|||
105847541|NCT01359644|365101076|FG007|Treatment Period|Lack of Efficacy|0|||
105847542|NCT01359644|365101077|FG008|Treatment Period|Lack of Efficacy|0|||
105847543|NCT01359644|365101078|FG009|Treatment Period|Lack of Efficacy|0|||
105847544|NCT01359644|365101069|FG000|Treatment Period|Adverse Event|0|||
105847545|NCT01359644|365101070|FG001|Treatment Period|Adverse Event|0|||
105847546|NCT01359644|365101071|FG002|Treatment Period|Adverse Event|1|||
105847547|NCT01359644|365101072|FG003|Treatment Period|Adverse Event|0|||
105847548|NCT01359644|365101073|FG004|Treatment Period|Adverse Event|0|||
105847549|NCT01359644|365101074|FG005|Treatment Period|Adverse Event|1|||
105847550|NCT01359644|365101075|FG006|Treatment Period|Adverse Event|0|||
105847551|NCT01359644|365101076|FG007|Treatment Period|Adverse Event|0|||
105847552|NCT01359644|365101077|FG008|Treatment Period|Adverse Event|0|||
105847553|NCT01359644|365101078|FG009|Treatment Period|Adverse Event|0|||
105847554|NCT01359644|365101069|FG000|Treatment Period|Lost to Follow-up|0|||
105847555|NCT01359644|365101070|FG001|Treatment Period|Lost to Follow-up|0|||
105847556|NCT01359644|365101071|FG002|Treatment Period|Lost to Follow-up|0|||
105847557|NCT01359644|365101072|FG003|Treatment Period|Lost to Follow-up|0|||
105847558|NCT01359644|365101073|FG004|Treatment Period|Lost to Follow-up|0|||
105847559|NCT01359644|365101074|FG005|Treatment Period|Lost to Follow-up|1|||
105847560|NCT01359644|365101075|FG006|Treatment Period|Lost to Follow-up|0|||
105847561|NCT01359644|365101076|FG007|Treatment Period|Lost to Follow-up|0|||
105847562|NCT01359644|365101077|FG008|Treatment Period|Lost to Follow-up|0|||
105847563|NCT01359644|365101078|FG009|Treatment Period|Lost to Follow-up|0|||
105847564|NCT01359644|365101069|FG000|Follow-up Period|Withdrawal by Subject|0|||
105847565|NCT01359644|365101070|FG001|Follow-up Period|Withdrawal by Subject|0|||
105847566|NCT01359644|365101071|FG002|Follow-up Period|Withdrawal by Subject|0|||
105847567|NCT01359644|365101072|FG003|Follow-up Period|Withdrawal by Subject|0|||
105576733|NCT02293837|364110302|FG000|Overall Study|Participant ill and could not be infused|0|||
105847568|NCT01359644|365101073|FG004|Follow-up Period|Withdrawal by Subject|0|||
105847569|NCT01359644|365101074|FG005|Follow-up Period|Withdrawal by Subject|1|||
105847570|NCT01359644|365101075|FG006|Follow-up Period|Withdrawal by Subject|0|||
105847571|NCT01359644|365101076|FG007|Follow-up Period|Withdrawal by Subject|0|||
105847572|NCT01359644|365101077|FG008|Follow-up Period|Withdrawal by Subject|0|||
105847573|NCT01359644|365101078|FG009|Follow-up Period|Withdrawal by Subject|0|||
105847574|NCT01359644|365101069|FG000|Follow-up Period|Lost to Follow-up|0|||
105847575|NCT01359644|365101070|FG001|Follow-up Period|Lost to Follow-up|0|||
105316819|NCT03449446|363154810|FG004|Overall Study|Adverse Event|0|||
105316820|NCT03449446|363154811|FG005|Overall Study|Adverse Event|2|||
105316821|NCT03449446|363154812|FG006|Overall Study|Adverse Event|0|||
105316822|NCT03449446|363154806|FG000|Overall Study|Lost to Follow-up|0|||
105316823|NCT03449446|363154807|FG001|Overall Study|Lost to Follow-up|0|||
105316824|NCT03449446|363154808|FG002|Overall Study|Lost to Follow-up|2|||
105316825|NCT03449446|363154809|FG003|Overall Study|Lost to Follow-up|1|||
105316826|NCT03449446|363154810|FG004|Overall Study|Lost to Follow-up|3|||
105316827|NCT03449446|363154811|FG005|Overall Study|Lost to Follow-up|0|||
105316828|NCT03449446|363154812|FG006|Overall Study|Lost to Follow-up|0|||
105316829|NCT03449446|363154806|FG000|Overall Study|Investigator's Discretion|0|||
105316830|NCT03449446|363154807|FG001|Overall Study|Investigator's Discretion|1|||
105316831|NCT03449446|363154808|FG002|Overall Study|Investigator's Discretion|1|||
105316832|NCT03449446|363154809|FG003|Overall Study|Investigator's Discretion|2|||
105316833|NCT03449446|363154810|FG004|Overall Study|Investigator's Discretion|0|||
105316834|NCT03449446|363154811|FG005|Overall Study|Investigator's Discretion|0|||
105316835|NCT03449446|363154812|FG006|Overall Study|Investigator's Discretion|0|||
105316836|NCT03449446|363154806|FG000|Overall Study|Non Compliance with Study Drug|1|||
105316837|NCT03449446|363154807|FG001|Overall Study|Non Compliance with Study Drug|0|||
105847576|NCT01359644|365101071|FG002|Follow-up Period|Lost to Follow-up|0|||
105847577|NCT01359644|365101072|FG003|Follow-up Period|Lost to Follow-up|0|||
105847578|NCT01359644|365101073|FG004|Follow-up Period|Lost to Follow-up|0|||
105847579|NCT01359644|365101074|FG005|Follow-up Period|Lost to Follow-up|0|||
105847580|NCT01359644|365101075|FG006|Follow-up Period|Lost to Follow-up|1|||
105847581|NCT01359644|365101076|FG007|Follow-up Period|Lost to Follow-up|2|||
105847582|NCT01359644|365101077|FG008|Follow-up Period|Lost to Follow-up|0|||
105847583|NCT01359644|365101078|FG009|Follow-up Period|Lost to Follow-up|0|||
105847584|NCT02685202|365101079|FG000|Overall Study|Lost to Follow-up|9|||
105847585|NCT00160641|365101083|FG000|Overall Study|Adverse Event|102|||
105847586|NCT00160641|365101083|FG000|Overall Study|Withdrawal by Subject|87|||
105847587|NCT00160641|365101083|FG000|Overall Study|Lost to Follow-up|8|||
105847588|NCT00160641|365101083|FG000|Overall Study|Lack of Efficacy|12|||
105847589|NCT00160641|365101083|FG000|Overall Study|Protocol Violation|3|||
105847590|NCT00160641|365101083|FG000|Overall Study|Other|9|||
105847591|NCT00669071|365101086|FG000|Overall Study|Lost to Follow-up|3|||
105847592|NCT00669071|365101086|FG000|Overall Study|Final visit 40 days out of window|1|||
105847593|NCT00995085|365101087|FG000|Overall Study|Withdrawal by Subject|5|||
105847594|NCT00985712|365101088|FG000|Overall Study|Adverse Event|0|||
105847595|NCT00985712|365101089|FG001|Overall Study|Adverse Event|1|||
105847596|NCT00985712|365101088|FG000|Overall Study|Lost to Follow-up|2|||
105847597|NCT00985712|365101089|FG001|Overall Study|Lost to Follow-up|2|||
105847598|NCT00985712|365101088|FG000|Overall Study|Protocol Violation|0|||
105316838|NCT03449446|363154808|FG002|Overall Study|Non Compliance with Study Drug|0|||
105316839|NCT03449446|363154809|FG003|Overall Study|Non Compliance with Study Drug|0|||
105316840|NCT03449446|363154810|FG004|Overall Study|Non Compliance with Study Drug|0|||
105316841|NCT03449446|363154811|FG005|Overall Study|Non Compliance with Study Drug|0|||
105316842|NCT03449446|363154812|FG006|Overall Study|Non Compliance with Study Drug|0|||
105847599|NCT00985712|365101089|FG001|Overall Study|Protocol Violation|1|||
105847600|NCT00985712|365101088|FG000|Overall Study|Withdrawal by Subject|4|||
105847601|NCT00985712|365101089|FG001|Overall Study|Withdrawal by Subject|1|||
105847602|NCT00985712|365101088|FG000|Overall Study|Sponsor decision|0|||
105847603|NCT00985712|365101089|FG001|Overall Study|Sponsor decision|2|||
105847604|NCT01194973|365101090|FG000|Screening Period|Screen Failure|3|||
105316843|NCT03449446|363154806|FG000|Overall Study|Protocol Violation|0|||
105847605|NCT01194973|365101090|FG000|26 Week Treatment Period|Adverse Event|1|||
105847606|NCT01194973|365101090|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
105847607|NCT01194973|365101090|FG000|26 Week Treatment Period|Pregnancy|1|||
105847608|NCT01157897|365101091|FG000|Overall Study|Lost to Follow-up|2|||
105847609|NCT01157897|365101092|FG001|Overall Study|Lost to Follow-up|0|||
105847610|NCT01157897|365101093|FG002|Overall Study|Lost to Follow-up|0|||
105847611|NCT01157897|365101094|FG003|Overall Study|Lost to Follow-up|1|||
105847612|NCT01157897|365101091|FG000|Overall Study|Relocated|0|||
105847613|NCT01157897|365101092|FG001|Overall Study|Relocated|2|||
105847614|NCT01157897|365101093|FG002|Overall Study|Relocated|0|||
105847615|NCT01157897|365101094|FG003|Overall Study|Relocated|0|||
105316844|NCT03449446|363154807|FG001|Overall Study|Protocol Violation|0|||
105316845|NCT03449446|363154808|FG002|Overall Study|Protocol Violation|0|||
105316846|NCT03449446|363154809|FG003|Overall Study|Protocol Violation|0|||
105316847|NCT03449446|363154810|FG004|Overall Study|Protocol Violation|1|||
105316848|NCT03449446|363154811|FG005|Overall Study|Protocol Violation|1|||
105316849|NCT03449446|363154812|FG006|Overall Study|Protocol Violation|0|||
105847616|NCT03096847|365101095|FG000|Overall Study|Other|2|||
105847617|NCT03096847|365101096|FG001|Overall Study|Other|1|||
105847618|NCT03096847|365101097|FG002|Overall Study|Other|2|||
105847619|NCT03096847|365101095|FG000|Overall Study|Lost to Follow-up|1|||
105847620|NCT03096847|365101096|FG001|Overall Study|Lost to Follow-up|0|||
105847621|NCT03096847|365101097|FG002|Overall Study|Lost to Follow-up|1|||
105847622|NCT03096847|365101095|FG000|Overall Study|Death|6|||
105847623|NCT03096847|365101096|FG001|Overall Study|Death|0|||
105847624|NCT03096847|365101097|FG002|Overall Study|Death|2|||
105847625|NCT03096847|365101095|FG000|Overall Study|Protocol Violation|3|||
105847626|NCT03096847|365101096|FG001|Overall Study|Protocol Violation|0|||
105847627|NCT03096847|365101097|FG002|Overall Study|Protocol Violation|6|||
105847628|NCT03096847|365101095|FG000|Overall Study|Physician Decision|12|||
105847629|NCT03096847|365101096|FG001|Overall Study|Physician Decision|2|||
105847630|NCT03096847|365101097|FG002|Overall Study|Physician Decision|8|||
105847631|NCT03096847|365101095|FG000|Overall Study|Withdrawal by Subject|24|||
105847632|NCT03096847|365101096|FG001|Overall Study|Withdrawal by Subject|1|||
105847633|NCT03096847|365101097|FG002|Overall Study|Withdrawal by Subject|12|||
105847634|NCT03096847|365101095|FG000|Overall Study|Adverse Event|72|||
105847635|NCT03096847|365101096|FG001|Overall Study|Adverse Event|6|||
105847636|NCT03096847|365101097|FG002|Overall Study|Adverse Event|28|||
105847637|NCT03096847|365101095|FG000|Overall Study|Progressive disease|97|||
105847638|NCT03096847|365101096|FG001|Overall Study|Progressive disease|10|||
105847639|NCT03096847|365101097|FG002|Overall Study|Progressive disease|78|||
105847640|NCT03096847|365101095|FG000|Overall Study|Non-compliance with study medication|1|||
105847641|NCT03096847|365101096|FG001|Overall Study|Non-compliance with study medication|0|||
105847642|NCT03096847|365101097|FG002|Overall Study|Non-compliance with study medication|0|||
105847643|NCT03096847|365101095|FG000|Overall Study|New therapy for study indication|1|||
105847644|NCT03096847|365101096|FG001|Overall Study|New therapy for study indication|0|||
105847645|NCT03096847|365101097|FG002|Overall Study|New therapy for study indication|1|||
105847646|NCT00757848|365101098|FG000|Overall Study|Voluntary discontinuation|1|||
105847647|NCT00757848|365101099|FG001|Overall Study|Voluntary discontinuation|0|||
105847648|NCT00757848|365101098|FG000|Overall Study|Adverse Event|1|||
105847649|NCT00757848|365101099|FG001|Overall Study|Adverse Event|2|||
105847650|NCT00757848|365101098|FG000|Overall Study|Incorrect enrolment|1|||
105847651|NCT00757848|365101099|FG001|Overall Study|Incorrect enrolment|0|||
105847652|NCT00359632|365101100|FG000|Overall Study|Death|2|||
105847653|NCT00359632|365101101|FG001|Overall Study|Death|0|||
105847654|NCT00359632|365101100|FG000|Overall Study|Adverse Event|1|||
105847655|NCT00359632|365101101|FG001|Overall Study|Adverse Event|0|||
105847656|NCT00359632|365101100|FG000|Overall Study|Non-compliance with visit schedule|1|||
105847657|NCT00359632|365101101|FG001|Overall Study|Non-compliance with visit schedule|0|||
105847658|NCT01321008|365101102|FG000|Overall Study|Early Study Termination|1|||
105847659|NCT02749292|365101105|FG000|Overall Study|Physician Decision|1|||
105847660|NCT02749292|365101106|FG001|Overall Study|Physician Decision|0|||
105847661|NCT02749292|365101105|FG000|Overall Study|Withdrawal by Subject|5|||
105847662|NCT02749292|365101106|FG001|Overall Study|Withdrawal by Subject|7|||
105847663|NCT02749292|365101105|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
105847664|NCT02749292|365101106|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
105847665|NCT02749292|365101105|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
105847666|NCT02749292|365101106|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
105847667|NCT02749292|365101105|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
105847668|NCT02749292|365101106|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
105847669|NCT02749292|365101105|FG000|Overall Study|Adverse Event|4|||
105847670|NCT02749292|365101106|FG001|Overall Study|Adverse Event|1|||
105847671|NCT02749292|365101105|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
105847672|NCT02749292|365101106|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
105847673|NCT02749292|365101105|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
105490466|NCT01226043|363807562|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
105490467|NCT01226043|363807563|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
105490468|NCT01226043|363807564|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
105847674|NCT02749292|365101106|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
105847675|NCT02749292|365101105|FG000|Overall Study|Requiring glucocorticoids|0|||
105847676|NCT02749292|365101106|FG001|Overall Study|Requiring glucocorticoids|3|||
105847677|NCT02749292|365101105|FG000|Overall Study|Cancer|1|||
105847678|NCT02749292|365101106|FG001|Overall Study|Cancer|0|||
105847679|NCT00251641|365101107|FG000|Overall Study|Adverse Event|80|||
105847680|NCT00251641|365101108|FG001|Overall Study|Adverse Event|8|||
105847681|NCT00251641|365101107|FG000|Overall Study|Lack of Efficacy|2|||
105847682|NCT00251641|365101108|FG001|Overall Study|Lack of Efficacy|1|||
105847683|NCT00251641|365101107|FG000|Overall Study|Progression of Disease|0|||
105847684|NCT00251641|365101108|FG001|Overall Study|Progression of Disease|2|||
105847685|NCT00251641|365101107|FG000|Overall Study|Lost to Follow-up|3|||
105847686|NCT00251641|365101108|FG001|Overall Study|Lost to Follow-up|3|||
105847687|NCT00251641|365101107|FG000|Overall Study|Withdrawal by Subject|6|||
105847688|NCT00251641|365101108|FG001|Overall Study|Withdrawal by Subject|8|||
105847689|NCT00251641|365101107|FG000|Overall Study|Protocol Violation|10|||
105847690|NCT00251641|365101108|FG001|Overall Study|Protocol Violation|2|||
105847691|NCT00251641|365101107|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
105490469|NCT01226043|363807565|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
105490470|NCT01226043|363807562|FG000|6-week Re-randomization Phase|Physician Decision|0|||
105316850|NCT03449446|363154806|FG000|Overall Study|Death|0|||
105847692|NCT00251641|365101108|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
105847693|NCT00251641|365101107|FG000|Overall Study|Switched Treatment|9|||
105847694|NCT00251641|365101108|FG001|Overall Study|Switched Treatment|63|||
105847695|NCT00679913|365101109|FG000|Overall Study|Protocol Violation|18|||
105847696|NCT00679913|365101110|FG001|Overall Study|Protocol Violation|13|||
105847697|NCT00062751|365101111|FG000|Overall Study|Disease progression|24|||
105847698|NCT00062751|365101112|FG001|Overall Study|Disease progression|17|||
105847699|NCT00062751|365101113|FG002|Overall Study|Disease progression|24|||
105847700|NCT00062751|365101114|FG003|Overall Study|Disease progression|2|||
105847701|NCT00062751|365101115|FG004|Overall Study|Disease progression|2|||
105847702|NCT00062751|365101111|FG000|Overall Study|Adverse Event|4|||
105847703|NCT00062751|365101112|FG001|Overall Study|Adverse Event|7|||
105847704|NCT00062751|365101113|FG002|Overall Study|Adverse Event|2|||
105847705|NCT00062751|365101114|FG003|Overall Study|Adverse Event|2|||
105847706|NCT00062751|365101115|FG004|Overall Study|Adverse Event|2|||
105847707|NCT00062751|365101111|FG000|Overall Study|Other|2|||
105847708|NCT00062751|365101112|FG001|Overall Study|Other|3|||
105847709|NCT00062751|365101113|FG002|Overall Study|Other|1|||
105847710|NCT00062751|365101114|FG003|Overall Study|Other|0|||
105847711|NCT00062751|365101115|FG004|Overall Study|Other|1|||
105847712|NCT00062751|365101111|FG000|Overall Study|Withdrawal by Subject|1|||
105847713|NCT00062751|365101112|FG001|Overall Study|Withdrawal by Subject|2|||
105847714|NCT00062751|365101113|FG002|Overall Study|Withdrawal by Subject|2|||
105847715|NCT00062751|365101114|FG003|Overall Study|Withdrawal by Subject|1|||
105847716|NCT00062751|365101115|FG004|Overall Study|Withdrawal by Subject|0|||
105847717|NCT00062751|365101111|FG000|Overall Study|Symptomatic deterioration|1|||
105847718|NCT00062751|365101112|FG001|Overall Study|Symptomatic deterioration|1|||
105847719|NCT00062751|365101113|FG002|Overall Study|Symptomatic deterioration|0|||
105847720|NCT00062751|365101114|FG003|Overall Study|Symptomatic deterioration|0|||
105847721|NCT00062751|365101115|FG004|Overall Study|Symptomatic deterioration|1|||
105847722|NCT00062751|365101111|FG000|Overall Study|Death|1|||
105847723|NCT00062751|365101112|FG001|Overall Study|Death|0|||
105847724|NCT00062751|365101113|FG002|Overall Study|Death|1|||
105847725|NCT00062751|365101114|FG003|Overall Study|Death|0|||
105847726|NCT00062751|365101115|FG004|Overall Study|Death|0|||
105847727|NCT01674647|365101116|FG000|Treatment Period|Death|4|||
105847728|NCT01674647|365101117|FG001|Treatment Period|Death|1|||
105847729|NCT01674647|365101116|FG000|Treatment Period|Efficacy outcome reached|0|||
105847730|NCT01674647|365101117|FG001|Treatment Period|Efficacy outcome reached|1|||
105847731|NCT01674647|365101116|FG000|Treatment Period|Physician Decision|3|||
105847732|NCT01674647|365101117|FG001|Treatment Period|Physician Decision|1|||
105847733|NCT01674647|365101116|FG000|Treatment Period|Adverse Event|60|||
105847734|NCT01674647|365101117|FG001|Treatment Period|Adverse Event|22|||
105847735|NCT01674647|365101116|FG000|Treatment Period|Non-compliance with study drug|3|||
105847736|NCT01674647|365101117|FG001|Treatment Period|Non-compliance with study drug|0|||
105847737|NCT01674647|365101116|FG000|Treatment Period|Lost to Follow-up|1|||
105847738|NCT01674647|365101117|FG001|Treatment Period|Lost to Follow-up|1|||
105847739|NCT01674647|365101116|FG000|Treatment Period|Withdrawal by Subject|19|||
105847740|NCT01674647|365101117|FG001|Treatment Period|Withdrawal by Subject|16|||
105847741|NCT01674647|365101116|FG000|Treatment Period|Switching to other therapy|5|||
105847742|NCT01674647|365101117|FG001|Treatment Period|Switching to other therapy|2|||
105847743|NCT01674647|365101116|FG000|Treatment Period|Logistical difficulties|5|||
105847744|NCT01674647|365101117|FG001|Treatment Period|Logistical difficulties|8|||
105847745|NCT01674647|365101116|FG000|Treatment Period|Treatment failure|0|||
105847746|NCT01674647|365101117|FG001|Treatment Period|Treatment failure|14|||
105847747|NCT01674647|365101116|FG000|Treatment Period|Protocol Violation|56|||
105847748|NCT01674647|365101117|FG001|Treatment Period|Protocol Violation|36|||
105847749|NCT01674647|365101116|FG000|30-day Safety Follow-up Period|Death|3|||
105847750|NCT01674647|365101117|FG001|30-day Safety Follow-up Period|Death|2|||
105847751|NCT01674647|365101116|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
105847752|NCT01674647|365101117|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
105847753|NCT01674647|365101116|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
105847754|NCT01674647|365101117|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
105847755|NCT01674647|365101116|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
105847756|NCT01674647|365101117|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
105847757|NCT01674647|365101116|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
105847758|NCT01674647|365101117|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
105847759|NCT01674647|365101116|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
105847760|NCT01674647|365101117|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
105847761|NCT00741936|365101124|FG000|Overall Study|Lost to Follow-up|1|||
105847762|NCT00741936|365101125|FG001|Overall Study|Lost to Follow-up|1|||
105847763|NCT00741936|365101124|FG000|Overall Study|Adverse Event|3|||
105847764|NCT00741936|365101125|FG001|Overall Study|Adverse Event|4|||
105847765|NCT00741936|365101124|FG000|Overall Study|Pregnancy|0|||
105847766|NCT00741936|365101125|FG001|Overall Study|Pregnancy|1|||
105847767|NCT00741936|365101124|FG000|Overall Study|Protocol Violation|2|||
105847768|NCT00741936|365101125|FG001|Overall Study|Protocol Violation|0|||
105847769|NCT00741936|365101124|FG000|Overall Study|Lack of Efficacy|0|||
105847770|NCT00741936|365101125|FG001|Overall Study|Lack of Efficacy|2|||
105847771|NCT00741936|365101124|FG000|Overall Study|Low compliance|3|||
105847772|NCT00741936|365101125|FG001|Overall Study|Low compliance|0|||
105847773|NCT01408628|365101126|FG000|Consented|Withdrawal by Subject|12|||
105847774|NCT01408628|365101126|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
105847775|NCT01408628|365101126|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
105847776|NCT01408628|365101126|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
105847777|NCT01144364|365101127|FG000|Induction Phase|Disease progression|14|||
105847778|NCT01144364|365101128|FG001|Induction Phase|Disease progression|0|||
105847779|NCT01144364|365101129|FG002|Induction Phase|Disease progression|0|||
105847780|NCT01144364|365101127|FG000|Induction Phase|Adverse Event|9|||
105847781|NCT01144364|365101128|FG001|Induction Phase|Adverse Event|0|||
105847782|NCT01144364|365101129|FG002|Induction Phase|Adverse Event|0|||
105847783|NCT01144364|365101127|FG000|Induction Phase|Death|1|||
105847784|NCT01144364|365101128|FG001|Induction Phase|Death|0|||
105847785|NCT01144364|365101129|FG002|Induction Phase|Death|0|||
105847786|NCT01144364|365101127|FG000|Induction Phase|Withdrawal by Subject|1|||
105316851|NCT03449446|363154807|FG001|Overall Study|Death|0|||
105316852|NCT03449446|363154808|FG002|Overall Study|Death|0|||
105316853|NCT03449446|363154809|FG003|Overall Study|Death|0|||
105316854|NCT03449446|363154810|FG004|Overall Study|Death|1|||
105316855|NCT03449446|363154811|FG005|Overall Study|Death|0|||
105316856|NCT03449446|363154812|FG006|Overall Study|Death|0|||
105847787|NCT01144364|365101128|FG001|Induction Phase|Withdrawal by Subject|0|||
105847788|NCT01144364|365101129|FG002|Induction Phase|Withdrawal by Subject|0|||
105847789|NCT01144364|365101127|FG000|Induction Phase|Lost to Follow-up|2|||
105847790|NCT01144364|365101128|FG001|Induction Phase|Lost to Follow-up|0|||
105316857|NCT01377012|363154813|FG000|Core Study|Study terminated by Sponsor|47|||
105316858|NCT01377012|363154814|FG001|Core Study|Study terminated by Sponsor|54|||
105316859|NCT01377012|363154815|FG002|Core Study|Study terminated by Sponsor|46|||
105316860|NCT01377012|363154813|FG000|Core Study|Technical problems|1|||
105316861|NCT01377012|363154814|FG001|Core Study|Technical problems|0|||
105316862|NCT01377012|363154815|FG002|Core Study|Technical problems|0|||
105316863|NCT01377012|363154813|FG000|Core Study|Withdrawal by Subject|15|||
105316864|NCT01377012|363154814|FG001|Core Study|Withdrawal by Subject|23|||
105316865|NCT01377012|363154815|FG002|Core Study|Withdrawal by Subject|18|||
105316866|NCT01377012|363154813|FG000|Core Study|Protocol Violation|7|||
105316867|NCT01377012|363154814|FG001|Core Study|Protocol Violation|3|||
105847791|NCT01144364|365101129|FG002|Induction Phase|Lost to Follow-up|0|||
105847792|NCT01144364|365101127|FG000|Induction Phase|Physician Decision|1|||
105847793|NCT01144364|365101128|FG001|Induction Phase|Physician Decision|0|||
105847794|NCT01144364|365101129|FG002|Induction Phase|Physician Decision|0|||
105847795|NCT01144364|365101127|FG000|Induction Phase|Stable disease|2|||
105847796|NCT01144364|365101128|FG001|Induction Phase|Stable disease|0|||
105847797|NCT01144364|365101129|FG002|Induction Phase|Stable disease|0|||
105847798|NCT01144364|365101127|FG000|Induction Phase|Secondary neoplasia|1|||
105847799|NCT01144364|365101128|FG001|Induction Phase|Secondary neoplasia|0|||
105847800|NCT01144364|365101129|FG002|Induction Phase|Secondary neoplasia|0|||
105847801|NCT01144364|365101127|FG000|Induction Phase|Protocol Violation|1|||
105847802|NCT01144364|365101128|FG001|Induction Phase|Protocol Violation|0|||
105847803|NCT01144364|365101129|FG002|Induction Phase|Protocol Violation|0|||
105847804|NCT01144364|365101127|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
105847805|NCT01144364|365101128|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
105847806|NCT01144364|365101129|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
105847807|NCT01144364|365101127|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
105847808|NCT01144364|365101128|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
105847809|NCT01144364|365101129|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
105847810|NCT01144364|365101127|FG000|Follow-Up/Maintenance Phase|Death|0|||
105847811|NCT01144364|365101128|FG001|Follow-Up/Maintenance Phase|Death|2|||
105847812|NCT01144364|365101129|FG002|Follow-Up/Maintenance Phase|Death|0|||
105847813|NCT01144364|365101127|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
105847814|NCT01144364|365101128|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
105847815|NCT01144364|365101129|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
105847816|NCT01144364|365101127|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
105316868|NCT01377012|363154815|FG002|Core Study|Protocol Violation|2|||
105316869|NCT01377012|363154813|FG000|Core Study|Pregnancy|0|||
105316870|NCT01377012|363154814|FG001|Core Study|Pregnancy|0|||
105316871|NCT01377012|363154815|FG002|Core Study|Pregnancy|1|||
105316872|NCT01377012|363154813|FG000|Core Study|Physician Decision|5|||
105316873|NCT01377012|363154814|FG001|Core Study|Physician Decision|4|||
105316874|NCT01377012|363154815|FG002|Core Study|Physician Decision|10|||
105847817|NCT01144364|365101128|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
105847818|NCT01144364|365101129|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
105847819|NCT01144364|365101127|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
105847820|NCT01144364|365101128|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
105847821|NCT01144364|365101129|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
105847822|NCT01144364|365101127|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
105847823|NCT01144364|365101128|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
105847824|NCT01144364|365101129|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
105847825|NCT00653991|365101130|FG000|3 Month Follow-up|Participant would not respond|150|||
105847826|NCT00653991|365101131|FG001|3 Month Follow-up|Participant would not respond|157|||
105847827|NCT00653991|365101130|FG000|6 Month Follow-up|Participant would not respond|133|||
105847828|NCT00653991|365101131|FG001|6 Month Follow-up|Participant would not respond|141|||
105847829|NCT02707861|365101132|FG000|Overall Study|Went onto commercial drug|30|||
105847830|NCT02707861|365101133|FG001|Overall Study|Went onto commercial drug|23|||
105847831|NCT02707861|365101132|FG000|Overall Study|Adverse Event|2|||
105576734|NCT02293837|364110303|FG001|Overall Study|Participant ill and could not be infused|0|||
105847832|NCT02707861|365101133|FG001|Overall Study|Adverse Event|3|||
105847833|NCT02707861|365101132|FG000|Overall Study|Death|5|||
105847834|NCT02707861|365101133|FG001|Overall Study|Death|2|||
105847835|NCT02707861|365101132|FG000|Overall Study|Lack of Efficacy|0|||
105847836|NCT02707861|365101133|FG001|Overall Study|Lack of Efficacy|2|||
105847837|NCT02707861|365101132|FG000|Overall Study|Physician Decision|1|||
105847838|NCT02707861|365101133|FG001|Overall Study|Physician Decision|4|||
105847839|NCT02707861|365101132|FG000|Overall Study|Withdrawal by Subject|2|||
105847840|NCT02707861|365101133|FG001|Overall Study|Withdrawal by Subject|1|||
105847841|NCT02707861|365101132|FG000|Overall Study|Lost to Follow-up|1|||
105847842|NCT02707861|365101133|FG001|Overall Study|Lost to Follow-up|3|||
105847843|NCT01346774|365101134|FG000|Overall Study|Did not take a single dose|6|||
105847844|NCT01346774|365101135|FG001|Overall Study|Did not take a single dose|4|||
105847845|NCT01346774|365101134|FG000|Overall Study|Lost to Follow-up|3|||
105847846|NCT01346774|365101135|FG001|Overall Study|Lost to Follow-up|4|||
105847847|NCT01346774|365101134|FG000|Overall Study|Withdrawal by Subject|1|||
105847848|NCT01346774|365101135|FG001|Overall Study|Withdrawal by Subject|4|||
105847849|NCT01346774|365101134|FG000|Overall Study|Protocol Violation|2|||
105847850|NCT01346774|365101135|FG001|Overall Study|Protocol Violation|3|||
105847851|NCT01346774|365101134|FG000|Overall Study|Adverse Event|1|||
105847852|NCT01346774|365101135|FG001|Overall Study|Adverse Event|2|||
105847853|NCT01929031|365101136|FG000|Overall Study|Adverse Event|3|||
105847854|NCT01929031|365101137|FG001|Overall Study|Adverse Event|1|||
105847855|NCT01929031|365101138|FG002|Overall Study|Adverse Event|1|||
105847856|NCT01929031|365101139|FG003|Overall Study|Adverse Event|0|||
105847857|NCT01929031|365101140|FG004|Overall Study|Adverse Event|0|||
105847858|NCT01929031|365101141|FG005|Overall Study|Adverse Event|0|||
105847859|NCT01929031|365101136|FG000|Overall Study|Protocol Violation|1|||
105847860|NCT01929031|365101137|FG001|Overall Study|Protocol Violation|0|||
105847861|NCT01929031|365101138|FG002|Overall Study|Protocol Violation|0|||
105847862|NCT01929031|365101139|FG003|Overall Study|Protocol Violation|0|||
105847863|NCT01929031|365101140|FG004|Overall Study|Protocol Violation|0|||
105847864|NCT01929031|365101141|FG005|Overall Study|Protocol Violation|1|||
105847865|NCT01929031|365101136|FG000|Overall Study|Reason other than specified above|0|||
105847866|NCT01929031|365101137|FG001|Overall Study|Reason other than specified above|1|||
105847867|NCT01929031|365101138|FG002|Overall Study|Reason other than specified above|0|||
105847868|NCT01929031|365101139|FG003|Overall Study|Reason other than specified above|0|||
105847869|NCT01929031|365101140|FG004|Overall Study|Reason other than specified above|1|||
105847870|NCT01929031|365101141|FG005|Overall Study|Reason other than specified above|0|||
105847871|NCT01366443|365101144|FG000|Overall Study|Lost to Follow-up|2|||
105847872|NCT01366443|365101144|FG000|Overall Study|Under 18 yo|1|||
105847873|NCT00369382|365101145|FG000|Overall Study|Death|0|||
105847874|NCT00369382|365101146|FG001|Overall Study|Death|2|||
105847875|NCT00369382|365101145|FG000|Overall Study|Physician Decision|2|||
105847876|NCT00369382|365101146|FG001|Overall Study|Physician Decision|1|||
105847877|NCT00369382|365101145|FG000|Overall Study|Withdrawal by Subject|5|||
105847878|NCT00369382|365101146|FG001|Overall Study|Withdrawal by Subject|0|||
105847879|NCT00369382|365101145|FG000|Overall Study|Randomized, not treated|2|||
105847880|NCT00369382|365101146|FG001|Overall Study|Randomized, not treated|0|||
105847881|NCT00369382|365101145|FG000|Overall Study|Other|1|||
105847882|NCT00369382|365101146|FG001|Overall Study|Other|0|||
105847883|NCT02394730|365101147|FG000|Overall Study|Lost to Follow-up|1|||
105847884|NCT02394730|365101148|FG001|Overall Study|Lost to Follow-up|0|||
105847885|NCT02394730|365101147|FG000|Overall Study|Withdrawal by Subject|0|||
105847886|NCT02394730|365101148|FG001|Overall Study|Withdrawal by Subject|1|||
105847887|NCT03487848|365101149|FG000|Overall Study|Lost to Follow-up|1|||
105847888|NCT00502801|365101150|FG000|Treatment Period|Withdrawal by Subject|3|||
105847889|NCT00502801|365101150|FG000|Treatment Period|Adverse Event|7|||
105847890|NCT00502801|365101150|FG000|Treatment Period|Death|14|||
105847891|NCT00502801|365101150|FG000|Treatment Period|OTHER|30|||
105847892|NCT00502801|365101150|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
105847893|NCT00502801|365101150|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
105847894|NCT00502801|365101150|FG000|End of Therapy to Test of Cure|Death|3|||
105847895|NCT00502801|365101150|FG000|End of Therapy to Test of Cure|OTHER|2|||
105847896|NCT00731549|365101151|FG000|Overall Study|Lost to Follow-up|19|||
105847897|NCT00731549|365101151|FG000|Overall Study|Met withdrawal criteria|24|||
105847898|NCT00731549|365101151|FG000|Overall Study|Physician Decision|16|||
105847899|NCT00731549|365101151|FG000|Overall Study|Withdrawal by Subject|89|||
105847900|NCT00731549|365101151|FG000|Overall Study|Protocol deviation|1|||
105847901|NCT00731549|365101151|FG000|Overall Study|Adverse Event|31|||
105847902|NCT00731549|365101151|FG000|Overall Study|Lack of efficacy with AE|37|||
105847903|NCT00731549|365101151|FG000|Overall Study|Lack of efficacy without AE|6|||
105847904|NCT00507546|365101153|FG000|Overall Study|Withdrawal by Subject|1|||
105847905|NCT00507546|365101154|FG001|Overall Study|Withdrawal by Subject|0|||
105847906|NCT00507546|365101153|FG000|Overall Study|Protocol Violation|1|||
105847907|NCT00507546|365101154|FG001|Overall Study|Protocol Violation|0|||
105847908|NCT00507546|365101153|FG000|Overall Study|Physician Decision|0|||
105847909|NCT00507546|365101154|FG001|Overall Study|Physician Decision|1|||
105847910|NCT02384850|365101155|FG000|Overall Study|Withdrawal by Subject|2|||
105847911|NCT02384850|365101156|FG001|Overall Study|Withdrawal by Subject|2|||
105847912|NCT01299805|365101165|FG000|Overall Study|Adverse Event|2|||
105847913|NCT01299805|365101166|FG001|Overall Study|Adverse Event|0|||
105847914|NCT01970865|365101167|FG000|Overall Study|Death|3|||
105847915|NCT01970865|365101168|FG001|Overall Study|Death|2|||
105847916|NCT01970865|365101169|FG002|Overall Study|Death|3|||
105847917|NCT01970865|365101170|FG003|Overall Study|Death|6|||
105847918|NCT01970865|365101171|FG004|Overall Study|Death|9|||
105847919|NCT01970865|365101172|FG005|Overall Study|Death|3|||
105847920|NCT01970865|365101173|FG006|Overall Study|Death|2|||
105847921|NCT01970865|365101174|FG007|Overall Study|Death|3|||
105847922|NCT01970865|365101175|FG008|Overall Study|Death|2|||
105847923|NCT01970865|365101176|FG009|Overall Study|Death|2|||
105847924|NCT01970865|365101177|FG010|Overall Study|Death|8|||
105847925|NCT01970865|365101178|FG011|Overall Study|Death|13|||
105847926|NCT01970865|365101179|FG012|Overall Study|Death|25|||
105847927|NCT01970865|365101180|FG013|Overall Study|Death|46|||
105847928|NCT01970865|365101181|FG014|Overall Study|Death|37|||
105847929|NCT01970865|365101182|FG015|Overall Study|Death|22|||
105847930|NCT01970865|365101183|FG016|Overall Study|Death|1|||
105847931|NCT01970865|365101184|FG017|Overall Study|Death|17|||
105847932|NCT01970865|365101167|FG000|Overall Study|Lost to Follow-up|0|||
105847933|NCT01970865|365101168|FG001|Overall Study|Lost to Follow-up|0|||
105847934|NCT01970865|365101169|FG002|Overall Study|Lost to Follow-up|0|||
105847935|NCT01970865|365101170|FG003|Overall Study|Lost to Follow-up|1|||
105847936|NCT01970865|365101171|FG004|Overall Study|Lost to Follow-up|1|||
105847937|NCT01970865|365101172|FG005|Overall Study|Lost to Follow-up|0|||
105847938|NCT01970865|365101173|FG006|Overall Study|Lost to Follow-up|0|||
105847939|NCT01970865|365101174|FG007|Overall Study|Lost to Follow-up|0|||
105847940|NCT01970865|365101175|FG008|Overall Study|Lost to Follow-up|0|||
105847941|NCT01970865|365101176|FG009|Overall Study|Lost to Follow-up|0|||
105847942|NCT01970865|365101177|FG010|Overall Study|Lost to Follow-up|1|||
105847943|NCT01970865|365101178|FG011|Overall Study|Lost to Follow-up|0|||
105847944|NCT01970865|365101179|FG012|Overall Study|Lost to Follow-up|2|||
105847945|NCT01970865|365101180|FG013|Overall Study|Lost to Follow-up|0|||
105847946|NCT01970865|365101181|FG014|Overall Study|Lost to Follow-up|1|||
105847947|NCT01970865|365101182|FG015|Overall Study|Lost to Follow-up|4|||
105847948|NCT01970865|365101183|FG016|Overall Study|Lost to Follow-up|0|||
105847949|NCT01970865|365101184|FG017|Overall Study|Lost to Follow-up|1|||
105847950|NCT01970865|365101167|FG000|Overall Study|Other|0|||
105847951|NCT01970865|365101168|FG001|Overall Study|Other|1|||
105847952|NCT01970865|365101169|FG002|Overall Study|Other|0|||
105847953|NCT01970865|365101170|FG003|Overall Study|Other|1|||
105847954|NCT01970865|365101171|FG004|Overall Study|Other|1|||
105847955|NCT01970865|365101172|FG005|Overall Study|Other|0|||
105847956|NCT01970865|365101173|FG006|Overall Study|Other|1|||
105847957|NCT01970865|365101174|FG007|Overall Study|Other|0|||
105847958|NCT01970865|365101175|FG008|Overall Study|Other|0|||
105847959|NCT01970865|365101176|FG009|Overall Study|Other|0|||
105847960|NCT01970865|365101177|FG010|Overall Study|Other|2|||
105847961|NCT01970865|365101178|FG011|Overall Study|Other|3|||
105847962|NCT01970865|365101179|FG012|Overall Study|Other|8|||
105847963|NCT01970865|365101180|FG013|Overall Study|Other|3|||
105847964|NCT01970865|365101181|FG014|Overall Study|Other|2|||
105847965|NCT01970865|365101182|FG015|Overall Study|Other|3|||
105490471|NCT01226043|363807563|FG001|6-week Re-randomization Phase|Physician Decision|0|||
105847966|NCT01970865|365101183|FG016|Overall Study|Other|0|||
105847967|NCT01970865|365101184|FG017|Overall Study|Other|2|||
105847968|NCT01970865|365101167|FG000|Overall Study|Participant refused further follow-up|0|||
105490472|NCT01226043|363807564|FG002|6-week Re-randomization Phase|Physician Decision|3|||
105490473|NCT01226043|363807565|FG003|6-week Re-randomization Phase|Physician Decision|2|||
105847969|NCT01970865|365101168|FG001|Overall Study|Participant refused further follow-up|0|||
105847970|NCT01970865|365101169|FG002|Overall Study|Participant refused further follow-up|0|||
105847971|NCT01970865|365101170|FG003|Overall Study|Participant refused further follow-up|2|||
105490474|NCT01226043|363807562|FG000|6-week Re-randomization Phase|completed in error|0|||
105847972|NCT01970865|365101171|FG004|Overall Study|Participant refused further follow-up|3|||
105847973|NCT01970865|365101172|FG005|Overall Study|Participant refused further follow-up|0|||
105847974|NCT01970865|365101173|FG006|Overall Study|Participant refused further follow-up|0|||
105847975|NCT01970865|365101174|FG007|Overall Study|Participant refused further follow-up|0|||
105847976|NCT01970865|365101175|FG008|Overall Study|Participant refused further follow-up|0|||
105847977|NCT01970865|365101176|FG009|Overall Study|Participant refused further follow-up|0|||
105847978|NCT01970865|365101177|FG010|Overall Study|Participant refused further follow-up|1|||
105847979|NCT01970865|365101178|FG011|Overall Study|Participant refused further follow-up|4|||
105847980|NCT01970865|365101179|FG012|Overall Study|Participant refused further follow-up|7|||
105847981|NCT01970865|365101180|FG013|Overall Study|Participant refused further follow-up|8|||
105847982|NCT01970865|365101181|FG014|Overall Study|Participant refused further follow-up|3|||
105847983|NCT01970865|365101182|FG015|Overall Study|Participant refused further follow-up|11|||
105847984|NCT01970865|365101183|FG016|Overall Study|Participant refused further follow-up|0|||
105847985|NCT01970865|365101184|FG017|Overall Study|Participant refused further follow-up|6|||
105847986|NCT04062448|365103020|FG000|Overall Study|Lost to Follow-up|1|||
105490475|NCT01226043|363807563|FG001|6-week Re-randomization Phase|completed in error|0|||
105847987|NCT04062448|365103020|FG000|Overall Study|Withdrawal by Subject|2|||
105847988|NCT00759902|365103023|FG000|Overall Study|Adverse Event|0|||
105847989|NCT00759902|365103024|FG001|Overall Study|Adverse Event|1|||
105847990|NCT02128217|365103027|FG000|Overall Study|Lost to Follow-up|0|||
105847991|NCT02128217|365103028|FG001|Overall Study|Lost to Follow-up|1|||
105847992|NCT00541970|365103029|FG000|Month 7|Protocol Violation|9|||
105847993|NCT00541970|365103030|FG001|Month 7|Protocol Violation|13|||
105847994|NCT00541970|365103031|FG002|Month 7|Protocol Violation|11|||
105847995|NCT00541970|365103032|FG003|Month 7|Protocol Violation|5|||
105847996|NCT00541970|365103029|FG000|Month 12|Adverse Event|0|||
105847997|NCT00541970|365103030|FG001|Month 12|Adverse Event|1|||
105847998|NCT00541970|365103031|FG002|Month 12|Adverse Event|1|||
105847999|NCT00541970|365103032|FG003|Month 12|Adverse Event|1|||
105848000|NCT00541970|365103029|FG000|Month 12|Protocol Violation|12|||
105848001|NCT00541970|365103030|FG001|Month 12|Protocol Violation|21|||
105848002|NCT00541970|365103031|FG002|Month 12|Protocol Violation|20|||
105848003|NCT00541970|365103032|FG003|Month 12|Protocol Violation|15|||
105848004|NCT00541970|365103029|FG000|Month 18|Adverse Event|0|||
105848005|NCT00541970|365103030|FG001|Month 18|Adverse Event|1|||
105848006|NCT00541970|365103031|FG002|Month 18|Adverse Event|1|||
105848007|NCT00541970|365103032|FG003|Month 18|Adverse Event|1|||
105848008|NCT00541970|365103029|FG000|Month 18|Protocol Violation|14|||
105848009|NCT00541970|365103030|FG001|Month 18|Protocol Violation|23|||
105848010|NCT00541970|365103031|FG002|Month 18|Protocol Violation|24|||
105848011|NCT00541970|365103032|FG003|Month 18|Protocol Violation|16|||
105848012|NCT00541970|365103029|FG000|Month 24|Adverse Event|0|||
105848013|NCT00541970|365103030|FG001|Month 24|Adverse Event|1|||
105848014|NCT00541970|365103031|FG002|Month 24|Adverse Event|1|||
105848015|NCT00541970|365103032|FG003|Month 24|Adverse Event|1|||
105848016|NCT00541970|365103029|FG000|Month 24|Protocol Violation|29|||
105848017|NCT00541970|365103030|FG001|Month 24|Protocol Violation|31|||
105848018|NCT00541970|365103031|FG002|Month 24|Protocol Violation|31|||
105848019|NCT00541970|365103032|FG003|Month 24|Protocol Violation|21|||
105848020|NCT00541970|365103029|FG000|Month 36|Protocol Violation|61|||
105848021|NCT00541970|365103030|FG001|Month 36|Protocol Violation|66|||
105848022|NCT00541970|365103031|FG002|Month 36|Protocol Violation|66|||
105848023|NCT00541970|365103032|FG003|Month 36|Protocol Violation|60|||
105848024|NCT00541970|365103029|FG000|Month 48|Withdrawal by Subject|2|||
105848025|NCT00541970|365103030|FG001|Month 48|Withdrawal by Subject|4|||
105848026|NCT00541970|365103031|FG002|Month 48|Withdrawal by Subject|4|||
105848027|NCT00541970|365103032|FG003|Month 48|Withdrawal by Subject|2|||
105848028|NCT00541970|365103029|FG000|Month 48|Other|3|||
105848029|NCT00541970|365103030|FG001|Month 48|Other|1|||
105848030|NCT00541970|365103031|FG002|Month 48|Other|1|||
105848031|NCT00541970|365103032|FG003|Month 48|Other|0|||
105848032|NCT00541970|365103029|FG000|Month 48|Lost to Follow-up|66|||
105848033|NCT00541970|365103030|FG001|Month 48|Lost to Follow-up|68|||
105848034|NCT00541970|365103031|FG002|Month 48|Lost to Follow-up|68|||
105848035|NCT00541970|365103032|FG003|Month 48|Lost to Follow-up|73|||
105848036|NCT00541970|365103029|FG000|Month 60|Protocol Violation|78|||
105848037|NCT00541970|365103030|FG001|Month 60|Protocol Violation|77|||
105368811|NCT04040439|363356299|FG000|Overall Study|No IC* on publication of study results|2|||
105490476|NCT01226043|363807564|FG002|6-week Re-randomization Phase|completed in error|0|||
105848038|NCT00541970|365103031|FG002|Month 60|Protocol Violation|82|||
105848039|NCT00541970|365103032|FG003|Month 60|Protocol Violation|72|||
105848040|NCT02856880|365103033|FG000|Overall Study|Withdrawal of consent|1|||
105848041|NCT01183221|365103034|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
105848042|NCT01183221|365103035|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
105848043|NCT03596151|365103036|FG000|Overall Study|Withdrawal by Subject|1|||
105848044|NCT03310411|365103037|FG000|Period 1|Adverse Event|0|||
105490477|NCT01226043|363807565|FG003|6-week Re-randomization Phase|completed in error|1|||
105848045|NCT03310411|365103038|FG001|Period 1|Adverse Event|0|||
105848046|NCT03310411|365103039|FG002|Period 1|Adverse Event|0|||
105848047|NCT03310411|365103040|FG003|Period 1|Adverse Event|1|||
105848048|NCT03623386|365103044|FG000|Overall Study|Protocol Violation|3|||
105848049|NCT03623386|365103045|FG001|Overall Study|Protocol Violation|2|||
105848050|NCT03623386|365103046|FG002|Overall Study|Protocol Violation|0|||
105848051|NCT03623386|365103044|FG000|Overall Study|Physician Decision|1|||
105848052|NCT03623386|365103045|FG001|Overall Study|Physician Decision|1|||
105490478|NCT01226043|363807562|FG000|30-week Observational Phase|Adverse Event|0|||
105490479|NCT01226043|363807563|FG001|30-week Observational Phase|Adverse Event|0|||
105490480|NCT01226043|363807564|FG002|30-week Observational Phase|Adverse Event|1|||
105490481|NCT01226043|363807565|FG003|30-week Observational Phase|Adverse Event|1|||
105490482|NCT01226043|363807562|FG000|30-week Observational Phase|Protocol Violation|0|||
105490483|NCT01226043|363807563|FG001|30-week Observational Phase|Protocol Violation|0|||
105490484|NCT01226043|363807564|FG002|30-week Observational Phase|Protocol Violation|0|||
105490485|NCT01226043|363807565|FG003|30-week Observational Phase|Protocol Violation|1|||
105490486|NCT01226043|363807562|FG000|30-week Observational Phase|Lost to Follow-up|0|||
105490487|NCT01226043|363807563|FG001|30-week Observational Phase|Lost to Follow-up|0|||
105490488|NCT01226043|363807564|FG002|30-week Observational Phase|Lost to Follow-up|2|||
105490489|NCT01226043|363807565|FG003|30-week Observational Phase|Lost to Follow-up|2|||
105490490|NCT01226043|363807562|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
105490491|NCT01226043|363807563|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
105490492|NCT01226043|363807564|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
105490493|NCT01226043|363807565|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
105490494|NCT01226043|363807562|FG000|30-week Observational Phase|Physician Decision|0|||
105490495|NCT01226043|363807563|FG001|30-week Observational Phase|Physician Decision|0|||
105848053|NCT03623386|365103046|FG002|Overall Study|Physician Decision|0|||
105848054|NCT03623386|365103044|FG000|Overall Study|Lost to Follow-up|0|||
105848055|NCT03623386|365103045|FG001|Overall Study|Lost to Follow-up|2|||
105848056|NCT03623386|365103046|FG002|Overall Study|Lost to Follow-up|0|||
105848057|NCT03623386|365103044|FG000|Overall Study|COVID-19|0|||
105848058|NCT03623386|365103045|FG001|Overall Study|COVID-19|1|||
105848059|NCT03623386|365103046|FG002|Overall Study|COVID-19|0|||
105848060|NCT00729248|365103047|FG000|Overall Study|Physician Decision|2|||
105848061|NCT03222583|365103048|FG000|Overall Study|Withdrawal by Subject|3|||
105848062|NCT03222583|365103049|FG001|Overall Study|Withdrawal by Subject|3|||
105848063|NCT03222583|365103048|FG000|Overall Study|Lost to Follow-up|1|||
105848064|NCT03222583|365103049|FG001|Overall Study|Lost to Follow-up|0|||
105848065|NCT03222583|365103048|FG000|Overall Study|Other|1|||
105848066|NCT03222583|365103049|FG001|Overall Study|Other|3|||
105848067|NCT04280705|365103050|FG000|Overall Study|Enrolled but not treated|4|||
105848068|NCT04280705|365103051|FG001|Overall Study|Enrolled but not treated|10|||
105848069|NCT04280705|365103050|FG000|Overall Study|Physician Decision|1|||
105848070|NCT04280705|365103051|FG001|Overall Study|Physician Decision|0|||
105848071|NCT04280705|365103050|FG000|Overall Study|Withdrawal by Subject|7|||
105848072|NCT04280705|365103051|FG001|Overall Study|Withdrawal by Subject|9|||
105848073|NCT04280705|365103050|FG000|Overall Study|Adverse Event|0|||
105848074|NCT04280705|365103051|FG001|Overall Study|Adverse Event|4|||
105848075|NCT04280705|365103050|FG000|Overall Study|Transferred to another hospital|1|||
105848076|NCT04280705|365103051|FG001|Overall Study|Transferred to another hospital|1|||
105848077|NCT03573505|365103052|FG000|Overall Study|Adverse Event|1|||
105848078|NCT03573505|365103053|FG001|Overall Study|Adverse Event|1|||
105848079|NCT03573505|365103052|FG000|Overall Study|Consent withdrawn|0|||
105848080|NCT03573505|365103053|FG001|Overall Study|Consent withdrawn|1|||
105848081|NCT03573505|365103052|FG000|Overall Study|Disease progression|0|||
105848082|NCT03573505|365103053|FG001|Overall Study|Disease progression|1|||
105848083|NCT03573505|365103052|FG000|Overall Study|Site Terminated by Sponsor|1|||
105848084|NCT03573505|365103053|FG001|Overall Study|Site Terminated by Sponsor|1|||
105848085|NCT03573505|365103052|FG000|Overall Study|Study terminated by sponsor|50|||
105848086|NCT03573505|365103053|FG001|Overall Study|Study terminated by sponsor|45|||
105848087|NCT03573505|365103052|FG000|Overall Study|Reason not specified|0|||
105848088|NCT03573505|365103053|FG001|Overall Study|Reason not specified|1|||
105848089|NCT03573505|365103052|FG000|Overall Study|Death|0|||
105848090|NCT03573505|365103053|FG001|Overall Study|Death|4|||
105848091|NCT04271735|365103054|FG000|Overall Study|Physician Decision|2|||
105848092|NCT04271735|365103055|FG001|Overall Study|Physician Decision|0|||
105848093|NCT00515541|365103056|FG000|Overall Study|Physician Decision|0|||
105848094|NCT00515541|365103057|FG001|Overall Study|Physician Decision|2|||
105848095|NCT00515541|365103058|FG002|Overall Study|Physician Decision|0|||
105848096|NCT00515541|365103059|FG003|Overall Study|Physician Decision|1|||
105848097|NCT00515541|365103056|FG000|Overall Study|No show for appointments|0|||
105490496|NCT01226043|363807564|FG002|30-week Observational Phase|Physician Decision|2|||
105490497|NCT01226043|363807565|FG003|30-week Observational Phase|Physician Decision|2|||
105490498|NCT00910988|363807566|FG000|Overall Study|Lost to Follow-up|2|||
105490499|NCT00910988|363807567|FG001|Overall Study|Lost to Follow-up|4|||
105490500|NCT00910988|363807568|FG002|Overall Study|Lost to Follow-up|3|||
105490501|NCT00910988|363807569|FG003|Overall Study|Lost to Follow-up|0|||
105490502|NCT00973349|363807570|FG000|Overall Study|Adverse Event|0|||
105490503|NCT00973349|363807571|FG001|Overall Study|Adverse Event|0|||
105490504|NCT00973349|363807572|FG002|Overall Study|Adverse Event|0|||
105490505|NCT00973349|363807573|FG003|Overall Study|Adverse Event|0|||
105490506|NCT00973349|363807574|FG004|Overall Study|Adverse Event|1|||
105848098|NCT00515541|365103057|FG001|Overall Study|No show for appointments|1|||
105848099|NCT00515541|365103058|FG002|Overall Study|No show for appointments|0|||
105848100|NCT00515541|365103059|FG003|Overall Study|No show for appointments|2|||
105490507|NCT00973349|363807575|FG005|Overall Study|Adverse Event|0|||
105490508|NCT00973349|363807576|FG006|Overall Study|Adverse Event|0|||
105490509|NCT00973349|363807577|FG007|Overall Study|Adverse Event|0|||
105490510|NCT00973349|363807578|FG008|Overall Study|Adverse Event|1|||
105490511|NCT00973349|363807579|FG009|Overall Study|Adverse Event|0|||
105490512|NCT00973349|363807580|FG010|Overall Study|Adverse Event|0|||
105490513|NCT00973349|363807581|FG011|Overall Study|Adverse Event|0|||
105490514|NCT00973349|363807582|FG012|Overall Study|Adverse Event|0|||
105490515|NCT00973349|363807583|FG013|Overall Study|Adverse Event|0|||
105490516|NCT00973349|363807584|FG014|Overall Study|Adverse Event|1|||
105490517|NCT00973349|363807585|FG015|Overall Study|Adverse Event|0|||
105490518|NCT00973349|363807570|FG000|Overall Study|Withdrawal by Subject|1|||
105490519|NCT00973349|363807571|FG001|Overall Study|Withdrawal by Subject|2|||
105490520|NCT00973349|363807572|FG002|Overall Study|Withdrawal by Subject|2|||
105490521|NCT00973349|363807573|FG003|Overall Study|Withdrawal by Subject|3|||
105490522|NCT00973349|363807574|FG004|Overall Study|Withdrawal by Subject|2|||
105490523|NCT00973349|363807575|FG005|Overall Study|Withdrawal by Subject|0|||
105490524|NCT00973349|363807576|FG006|Overall Study|Withdrawal by Subject|2|||
105490525|NCT00973349|363807577|FG007|Overall Study|Withdrawal by Subject|2|||
105490526|NCT00973349|363807578|FG008|Overall Study|Withdrawal by Subject|0|||
105848101|NCT00515541|365103056|FG000|Overall Study|Withdrawal by Subject|0|||
105848102|NCT00515541|365103057|FG001|Overall Study|Withdrawal by Subject|2|||
105848103|NCT00515541|365103058|FG002|Overall Study|Withdrawal by Subject|0|||
105848104|NCT00515541|365103059|FG003|Overall Study|Withdrawal by Subject|2|||
105848105|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Adverse Event|9|||
105848106|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Adverse Event|4|||
105848107|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Adverse Event|5|||
105848108|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Adverse Event|9|||
105848109|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Adverse Event|8|||
105848110|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Adverse Event|0|||
105848111|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Adverse Event|0|||
105848112|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
105848113|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
105848114|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
105848115|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
105848116|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
105848117|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
105848118|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
105848119|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Death|1|||
105848120|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Death|1|||
105848121|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Death|1|||
105848122|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Death|1|||
105848123|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Death|0|||
105848124|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Death|0|||
105848125|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Death|0|||
105848126|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
105848127|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
105848128|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
105848129|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
105848130|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
105848131|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
105848132|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
105848133|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
105848134|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
105848135|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
105848136|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
105848137|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
105848138|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
105848139|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
105848140|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
105848141|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
105848142|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
105848143|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
105848144|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
105848145|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
105848146|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
105490527|NCT00973349|363807579|FG009|Overall Study|Withdrawal by Subject|2|||
105490528|NCT00973349|363807580|FG010|Overall Study|Withdrawal by Subject|0|||
105490529|NCT00973349|363807581|FG011|Overall Study|Withdrawal by Subject|1|||
105490530|NCT00973349|363807582|FG012|Overall Study|Withdrawal by Subject|0|||
105490531|NCT00973349|363807583|FG013|Overall Study|Withdrawal by Subject|0|||
105490532|NCT00973349|363807584|FG014|Overall Study|Withdrawal by Subject|0|||
105490533|NCT00973349|363807585|FG015|Overall Study|Withdrawal by Subject|0|||
105490534|NCT00973349|363807570|FG000|Overall Study|Lost to Follow-up|3|||
105316875|NCT01377012|363154813|FG000|Core Study|Non-Compliant with study treatment|0|||
105316876|NCT01377012|363154814|FG001|Core Study|Non-Compliant with study treatment|0|||
105316877|NCT01377012|363154815|FG002|Core Study|Non-Compliant with study treatment|1|||
105316878|NCT01377012|363154813|FG000|Core Study|No Longer require treatment|0|||
105316879|NCT01377012|363154814|FG001|Core Study|No Longer require treatment|0|||
105316880|NCT01377012|363154815|FG002|Core Study|No Longer require treatment|1|||
105316881|NCT01377012|363154813|FG000|Core Study|Lost to Follow-up|7|||
105316882|NCT01377012|363154814|FG001|Core Study|Lost to Follow-up|5|||
105316883|NCT01377012|363154815|FG002|Core Study|Lost to Follow-up|4|||
105316884|NCT01377012|363154813|FG000|Core Study|Lack of Efficacy|41|||
105316885|NCT01377012|363154814|FG001|Core Study|Lack of Efficacy|28|||
105316886|NCT01377012|363154815|FG002|Core Study|Lack of Efficacy|37|||
105316887|NCT01377012|363154813|FG000|Core Study|Death|1|||
105316888|NCT01377012|363154814|FG001|Core Study|Death|1|||
105316889|NCT01377012|363154815|FG002|Core Study|Death|1|||
105316890|NCT01377012|363154813|FG000|Core Study|Adverse Event|10|||
105316891|NCT01377012|363154814|FG001|Core Study|Adverse Event|14|||
105316892|NCT01377012|363154815|FG002|Core Study|Adverse Event|13|||
105316893|NCT01377012|363154813|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
105316894|NCT01377012|363154814|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
105316895|NCT01377012|363154815|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
105316896|NCT01377012|363154813|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
105316897|NCT01377012|363154814|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
105316898|NCT01377012|363154815|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
105316899|NCT01377012|363154813|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
105316900|NCT01377012|363154814|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
105316901|NCT01377012|363154815|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
105316902|NCT01377012|363154813|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
105316903|NCT01377012|363154814|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
105316904|NCT01377012|363154815|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
105316905|NCT01377012|363154813|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
105316906|NCT01377012|363154814|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
105316907|NCT01377012|363154815|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
105316908|NCT01377012|363154813|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
105316909|NCT01377012|363154814|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
105316910|NCT01377012|363154815|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
105316911|NCT00805961|363154818|FG000|Modality Therapy|Withdrawal by Subject|1|||
105316912|NCT00805961|363154818|FG000|Modality Therapy|Adverse Event|1|||
105316913|NCT00805961|363154818|FG000|Modality Therapy|Disease Progression|2|||
105316914|NCT00805961|363154818|FG000|Treatment-Free Interval|Adverse Event|3|||
105316915|NCT00805961|363154818|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
105316916|NCT00805961|363154818|FG000|Treatment-Free Interval|Physician Decision|1|||
105316917|NCT00805961|363154818|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
105316918|NCT00805961|363154818|FG000|Maintenance Treatment|Lack of Efficacy|13|||
105316919|NCT00805961|363154818|FG000|Maintenance Treatment|Intercurrent Illness|7|||
105490535|NCT00973349|363807571|FG001|Overall Study|Lost to Follow-up|1|||
105848147|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Other|2|||
105848148|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Other|9|||
105848149|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Other|9|||
105848150|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Other|3|||
105848151|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Other|2|||
105848152|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Other|0|||
105848153|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Other|0|||
105848154|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
105848155|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
105848156|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
105848157|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
105848158|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
105848159|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
105848160|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
105848161|NCT00361335|365103060|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
105848162|NCT00361335|365103061|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
105848163|NCT00361335|365103062|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
105316920|NCT00805961|363154818|FG000|Maintenance Treatment|Adverse Event|6|||
105316921|NCT00805961|363154818|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
105316922|NCT00805961|363154818|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
105316923|NCT00805961|363154818|FG000|Maintenance Treatment|Withdrawn Consent|1|||
105316924|NCT04380961|363154819|FG000|Overall Study|Lost to Follow-up|17|||
105316925|NCT04380961|363154820|FG001|Overall Study|Lost to Follow-up|11|||
105316926|NCT04380961|363154819|FG000|Overall Study|Withdrawal by Subject|3|||
105316927|NCT04380961|363154820|FG001|Overall Study|Withdrawal by Subject|0|||
105316928|NCT04380961|363154819|FG000|Overall Study|Death|22|||
105316929|NCT04380961|363154820|FG001|Overall Study|Death|16|||
105316930|NCT04380961|363154819|FG000|Overall Study|Other|1|||
105848164|NCT00361335|365103063|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
105490536|NCT00973349|363807572|FG002|Overall Study|Lost to Follow-up|2|||
105490537|NCT00973349|363807573|FG003|Overall Study|Lost to Follow-up|2|||
105490538|NCT00973349|363807574|FG004|Overall Study|Lost to Follow-up|1|||
105490539|NCT00973349|363807575|FG005|Overall Study|Lost to Follow-up|3|||
105490540|NCT00973349|363807576|FG006|Overall Study|Lost to Follow-up|0|||
105490541|NCT00973349|363807577|FG007|Overall Study|Lost to Follow-up|1|||
105490542|NCT00973349|363807578|FG008|Overall Study|Lost to Follow-up|2|||
105490543|NCT00973349|363807579|FG009|Overall Study|Lost to Follow-up|1|||
105490544|NCT00973349|363807580|FG010|Overall Study|Lost to Follow-up|0|||
105490545|NCT00973349|363807581|FG011|Overall Study|Lost to Follow-up|1|||
105490546|NCT00973349|363807582|FG012|Overall Study|Lost to Follow-up|0|||
105490547|NCT00973349|363807583|FG013|Overall Study|Lost to Follow-up|0|||
105490548|NCT00973349|363807584|FG014|Overall Study|Lost to Follow-up|0|||
105490549|NCT00973349|363807585|FG015|Overall Study|Lost to Follow-up|1|||
105490550|NCT00973349|363807570|FG000|Overall Study|Inappropriate enrolment|0|||
105490551|NCT00973349|363807571|FG001|Overall Study|Inappropriate enrolment|0|||
105490552|NCT00973349|363807572|FG002|Overall Study|Inappropriate enrolment|1|||
105490553|NCT00973349|363807573|FG003|Overall Study|Inappropriate enrolment|0|||
105848165|NCT00361335|365103064|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
105848166|NCT00361335|365103065|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
105848167|NCT00361335|365103066|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
105848168|NCT00361335|365103060|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
105848169|NCT00361335|365103061|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
105848170|NCT00361335|365103062|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
105848171|NCT00361335|365103063|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
105848172|NCT00361335|365103064|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
105848173|NCT00361335|365103065|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
105848174|NCT00361335|365103066|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
105848175|NCT00361335|365103060|FG000|SC Period: Week E0 to Week E24|Death|0|||
105848176|NCT00361335|365103061|FG001|SC Period: Week E0 to Week E24|Death|0|||
105848177|NCT00361335|365103062|FG002|SC Period: Week E0 to Week E24|Death|0|||
105848178|NCT00361335|365103063|FG003|SC Period: Week E0 to Week E24|Death|0|||
105848179|NCT00361335|365103064|FG004|SC Period: Week E0 to Week E24|Death|0|||
105848180|NCT00361335|365103065|FG005|SC Period: Week E0 to Week E24|Death|0|||
105848181|NCT00361335|365103066|FG006|SC Period: Week E0 to Week E24|Death|1|||
105848182|NCT00361335|365103060|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
105848183|NCT00361335|365103061|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
105848184|NCT00361335|365103062|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
105848185|NCT00361335|365103063|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
105848186|NCT00361335|365103064|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
105848187|NCT00361335|365103065|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
105848188|NCT00361335|365103066|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
105848189|NCT00361335|365103060|FG000|SC Period: Week E0 to Week E24|Other|1|||
105848190|NCT00361335|365103061|FG001|SC Period: Week E0 to Week E24|Other|0|||
105848191|NCT00361335|365103062|FG002|SC Period: Week E0 to Week E24|Other|0|||
105848192|NCT00361335|365103063|FG003|SC Period: Week E0 to Week E24|Other|1|||
105848193|NCT00361335|365103064|FG004|SC Period: Week E0 to Week E24|Other|0|||
105848194|NCT00361335|365103065|FG005|SC Period: Week E0 to Week E24|Other|1|||
105848195|NCT00361335|365103066|FG006|SC Period: Week E0 to Week E24|Other|2|||
105848196|NCT00361335|365103060|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
105848197|NCT00361335|365103061|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
105848198|NCT00361335|365103062|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
105848199|NCT00361335|365103063|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
105848200|NCT00361335|365103064|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
105848201|NCT00361335|365103065|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
105848202|NCT00361335|365103066|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
105848203|NCT01959035|365103067|FG000|Overall Study|Adverse Event|5|||
105848204|NCT01959035|365103067|FG000|Overall Study|Withdrawal by Subject|4|||
105848205|NCT01959035|365103067|FG000|Overall Study|Lost to Follow-up|1|||
105848206|NCT01959035|365103067|FG000|Overall Study|Other (no primary reason given)|1|||
105490554|NCT00973349|363807574|FG004|Overall Study|Inappropriate enrolment|0|||
105848207|NCT00450619|365103068|FG000|Overall Study|refused treatment after randomization|2|||
105848208|NCT00450619|365103069|FG001|Overall Study|refused treatment after randomization|0|||
105848209|NCT00450619|365103068|FG000|Overall Study|did not progress; refused further trmt|1|||
105848210|NCT00450619|365103069|FG001|Overall Study|did not progress; refused further trmt|1|||
105848211|NCT00450619|365103068|FG000|Overall Study|Adverse Event|1|||
105490555|NCT00973349|363807575|FG005|Overall Study|Inappropriate enrolment|0|||
105848212|NCT00450619|365103069|FG001|Overall Study|Adverse Event|0|||
105490556|NCT00973349|363807576|FG006|Overall Study|Inappropriate enrolment|0|||
105848213|NCT00986180|365103070|FG000|Overall Study|Adverse Event|21|||
105490557|NCT00973349|363807577|FG007|Overall Study|Inappropriate enrolment|0|||
105490558|NCT00973349|363807578|FG008|Overall Study|Inappropriate enrolment|0|||
105490559|NCT00973349|363807579|FG009|Overall Study|Inappropriate enrolment|2|||
105490560|NCT00973349|363807580|FG010|Overall Study|Inappropriate enrolment|0|||
105848214|NCT00986180|365103071|FG001|Overall Study|Adverse Event|23|||
105848215|NCT00986180|365103070|FG000|Overall Study|Lack of Efficacy|4|||
105848216|NCT00986180|365103071|FG001|Overall Study|Lack of Efficacy|3|||
105848217|NCT00986180|365103070|FG000|Overall Study|Lost to Follow-up|5|||
105848218|NCT00986180|365103071|FG001|Overall Study|Lost to Follow-up|7|||
105848219|NCT00986180|365103070|FG000|Overall Study|Physician Decision|1|||
105848220|NCT00986180|365103071|FG001|Overall Study|Physician Decision|3|||
105848221|NCT00986180|365103070|FG000|Overall Study|Protocol Violation|2|||
105848222|NCT00986180|365103071|FG001|Overall Study|Protocol Violation|0|||
105848223|NCT00986180|365103070|FG000|Overall Study|Withdrawal by Subject|1|||
105848224|NCT00986180|365103071|FG001|Overall Study|Withdrawal by Subject|9|||
105848225|NCT00986180|365103070|FG000|Overall Study|Miscellanies|10|||
105848226|NCT00986180|365103071|FG001|Overall Study|Miscellanies|11|||
105848227|NCT03822832|365103079|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
105848228|NCT03822832|365103080|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
105848229|NCT03822832|365103079|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
105848230|NCT03822832|365103080|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
105848231|NCT03822832|365103079|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
105848232|NCT03822832|365103080|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
105848233|NCT03822832|365103079|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
105848234|NCT03822832|365103080|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
105848235|NCT03822832|365103079|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
105848236|NCT03822832|365103080|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
105848237|NCT03822832|365103079|FG000|Re-allocation|Not re-allocated to open label period|2|||
105848238|NCT03822832|365103080|FG001|Re-allocation|Not re-allocated to open label period|6|||
105848239|NCT03822832|365103079|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
105848240|NCT03822832|365103080|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
105848241|NCT03822832|365103079|FG000|Period 2 - Open Label Period|Adverse Event|0|||
105848242|NCT03822832|365103080|FG001|Period 2 - Open Label Period|Adverse Event|3|||
105848243|NCT03347422|365103081|FG000|Part A (26 Weeks)|Adverse Event|3|||
105848244|NCT03347422|365103082|FG001|Part A (26 Weeks)|Adverse Event|0|||
105848245|NCT03347422|365103081|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
105848246|NCT03347422|365103082|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
105848247|NCT03347422|365103081|FG000|Part B (149 Weeks)|Adverse Event|0|||
105848248|NCT03347422|365103082|FG001|Part B (149 Weeks)|Adverse Event|1|||
105848249|NCT03347422|365103081|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
105848250|NCT03347422|365103082|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
105848251|NCT03347422|365103081|FG000|Part B (149 Weeks)|Other|1|||
105848252|NCT03347422|365103082|FG001|Part B (149 Weeks)|Other|0|||
105848253|NCT02792959|365103087|FG000|Overall Study|Protocol Violation|1|||
105848254|NCT04594707|365103088|FG000|Overall Study|Adverse Event|0|||
105490561|NCT00973349|363807581|FG011|Overall Study|Inappropriate enrolment|0|||
105490562|NCT00973349|363807582|FG012|Overall Study|Inappropriate enrolment|1|||
105490563|NCT00973349|363807583|FG013|Overall Study|Inappropriate enrolment|0|||
105490564|NCT00973349|363807584|FG014|Overall Study|Inappropriate enrolment|1|||
105490565|NCT00973349|363807585|FG015|Overall Study|Inappropriate enrolment|1|||
105490566|NCT00973349|363807570|FG000|Overall Study|Protocol Violation|0|||
105490567|NCT00973349|363807571|FG001|Overall Study|Protocol Violation|0|||
105490568|NCT00973349|363807572|FG002|Overall Study|Protocol Violation|0|||
105490569|NCT00973349|363807573|FG003|Overall Study|Protocol Violation|0|||
105490570|NCT00973349|363807574|FG004|Overall Study|Protocol Violation|0|||
105490571|NCT00973349|363807575|FG005|Overall Study|Protocol Violation|0|||
105490572|NCT00973349|363807576|FG006|Overall Study|Protocol Violation|0|||
105490573|NCT00973349|363807577|FG007|Overall Study|Protocol Violation|0|||
105490574|NCT00973349|363807578|FG008|Overall Study|Protocol Violation|1|||
105490575|NCT00973349|363807579|FG009|Overall Study|Protocol Violation|0|||
105490576|NCT00973349|363807580|FG010|Overall Study|Protocol Violation|0|||
105490577|NCT00973349|363807581|FG011|Overall Study|Protocol Violation|0|||
105490578|NCT00973349|363807582|FG012|Overall Study|Protocol Violation|0|||
105490579|NCT00973349|363807583|FG013|Overall Study|Protocol Violation|0|||
105490580|NCT00973349|363807584|FG014|Overall Study|Protocol Violation|0|||
105490581|NCT00973349|363807585|FG015|Overall Study|Protocol Violation|0|||
105490582|NCT00973349|363807570|FG000|Overall Study|Unable to classify|0|||
105490583|NCT00973349|363807571|FG001|Overall Study|Unable to classify|0|||
105490584|NCT00973349|363807572|FG002|Overall Study|Unable to classify|0|||
105490585|NCT00973349|363807573|FG003|Overall Study|Unable to classify|0|||
105490586|NCT00973349|363807574|FG004|Overall Study|Unable to classify|1|||
105576735|NCT02293837|364110304|FG002|Overall Study|Participant ill and could not be infused|1|||
105576736|NCT02293837|364110305|FG003|Overall Study|Participant ill and could not be infused|0|||
105576737|NCT04779242|364110306|FG000|Overall Study|Adverse Event|1|||
105848255|NCT04594707|365103089|FG001|Overall Study|Adverse Event|0|||
105848256|NCT04594707|365103090|FG002|Overall Study|Adverse Event|1|||
105316931|NCT04380961|363154820|FG001|Overall Study|Other|0|||
105490587|NCT00973349|363807575|FG005|Overall Study|Unable to classify|1|||
105490588|NCT00973349|363807576|FG006|Overall Study|Unable to classify|0|||
105490589|NCT00973349|363807577|FG007|Overall Study|Unable to classify|0|||
105490590|NCT00973349|363807578|FG008|Overall Study|Unable to classify|0|||
105490591|NCT00973349|363807579|FG009|Overall Study|Unable to classify|1|||
105490592|NCT00973349|363807580|FG010|Overall Study|Unable to classify|0|||
105490593|NCT00973349|363807581|FG011|Overall Study|Unable to classify|0|||
105490594|NCT00973349|363807582|FG012|Overall Study|Unable to classify|0|||
105490595|NCT00973349|363807583|FG013|Overall Study|Unable to classify|0|||
105490596|NCT00973349|363807584|FG014|Overall Study|Unable to classify|0|||
105848257|NCT04594707|365103088|FG000|Overall Study|Death|0|||
105848258|NCT04594707|365103089|FG001|Overall Study|Death|2|||
105848259|NCT04594707|365103090|FG002|Overall Study|Death|2|||
105848260|NCT04594707|365103088|FG000|Overall Study|Lung Transplant|0|||
105848261|NCT04594707|365103089|FG001|Overall Study|Lung Transplant|0|||
105848262|NCT04594707|365103090|FG002|Overall Study|Lung Transplant|1|||
105848263|NCT04594707|365103088|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
105848264|NCT04594707|365103089|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
105848265|NCT04594707|365103090|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
105848266|NCT04594707|365103088|FG000|Overall Study|Study Terminated By Sponsor|19|||
105848267|NCT04594707|365103089|FG001|Overall Study|Study Terminated By Sponsor|47|||
105848268|NCT04594707|365103090|FG002|Overall Study|Study Terminated By Sponsor|41|||
105848269|NCT04594707|365103088|FG000|Overall Study|Withdrawal by Subject|1|||
105848270|NCT04594707|365103089|FG001|Overall Study|Withdrawal by Subject|0|||
105848271|NCT04594707|365103090|FG002|Overall Study|Withdrawal by Subject|2|||
105848272|NCT04392583|365103091|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
105848273|NCT02303041|365103092|FG000|Overall Study|Adverse Event|1|||
105848274|NCT02303041|365103093|FG001|Overall Study|Adverse Event|2|||
105848275|NCT04168190|365103094|FG000|Overall Study|Lost to Follow-up|0|||
105848276|NCT04168190|365103095|FG001|Overall Study|Lost to Follow-up|1|||
105848277|NCT04168190|365103096|FG002|Overall Study|Lost to Follow-up|0|||
105848278|NCT04168190|365103097|FG003|Overall Study|Lost to Follow-up|7|||
105848279|NCT04168190|365103098|FG004|Overall Study|Lost to Follow-up|5|||
105848280|NCT04168190|365103094|FG000|Overall Study|Withdrawal by Subject|1|||
105848281|NCT04168190|365103095|FG001|Overall Study|Withdrawal by Subject|0|||
105848282|NCT04168190|365103096|FG002|Overall Study|Withdrawal by Subject|0|||
105848283|NCT04168190|365103097|FG003|Overall Study|Withdrawal by Subject|2|||
105848284|NCT04168190|365103098|FG004|Overall Study|Withdrawal by Subject|4|||
105848285|NCT04168190|365103094|FG000|Overall Study|Death|0|||
105848286|NCT04168190|365103095|FG001|Overall Study|Death|0|||
105848287|NCT04168190|365103096|FG002|Overall Study|Death|0|||
105848288|NCT04168190|365103097|FG003|Overall Study|Death|1|||
105848289|NCT04168190|365103098|FG004|Overall Study|Death|0|||
105848290|NCT01169532|365103099|FG000|Overall Study|Withdrawal by Subject|1|||
105848291|NCT02032706|365103102|FG000|Overall Study|Did not qualify|5|||
105848292|NCT02032706|365103102|FG000|Overall Study|Protocol Violation|1|||
105848293|NCT01156142|365103103|FG000|Overall Study|Withdrawal by Subject|8|||
105848294|NCT01156142|365103104|FG001|Overall Study|Withdrawal by Subject|6|||
105848295|NCT01156142|365103103|FG000|Overall Study|Ineligible|0|||
105848296|NCT01156142|365103104|FG001|Overall Study|Ineligible|1|||
105848297|NCT02731326|365103109|FG000|Overall Study|Withdrawal by Subject|4|||
105848298|NCT02731326|365103110|FG001|Overall Study|Withdrawal by Subject|1|||
105848299|NCT02731326|365103109|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
105848300|NCT02731326|365103110|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
105848301|NCT02731326|365103109|FG000|Overall Study|Discharged without AliveCor|10|||
105848302|NCT02731326|365103110|FG001|Overall Study|Discharged without AliveCor|0|||
105848303|NCT02731326|365103109|FG000|Overall Study|Duplicate Participant|1|||
105848304|NCT02731326|365103110|FG001|Overall Study|Duplicate Participant|1|||
105848305|NCT04620135|365103112|FG000|Study Completion|Adverse Event|2|||
105848306|NCT04620135|365103113|FG001|Study Completion|Adverse Event|3|||
105848307|NCT04620135|365103112|FG000|Study Completion|Withdrawal by Subject|2|||
105848308|NCT04620135|365103113|FG001|Study Completion|Withdrawal by Subject|0|||
105848309|NCT03979820|365103115|FG000|Overall Study|Protocol Violation|1|||
105848310|NCT03979820|365103116|FG001|Overall Study|Protocol Violation|0|||
105848311|NCT03979820|365103117|FG002|Overall Study|Protocol Violation|0|||
105490597|NCT00973349|363807585|FG015|Overall Study|Unable to classify|0|||
105848312|NCT03979820|365103118|FG003|Overall Study|Protocol Violation|0|||
105848313|NCT03979820|365103115|FG000|Overall Study|Withdrawal by Subject|0|||
105848314|NCT03979820|365103116|FG001|Overall Study|Withdrawal by Subject|0|||
105848315|NCT03979820|365103117|FG002|Overall Study|Withdrawal by Subject|1|||
105848316|NCT03979820|365103118|FG003|Overall Study|Withdrawal by Subject|0|||
105848317|NCT03979820|365103115|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
105848318|NCT03979820|365103116|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
105490598|NCT02734433|363807587|FG000|Overall Study|Disease progression|1|||
105848319|NCT03979820|365103117|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
105848320|NCT03979820|365103118|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
105848321|NCT02143583|365103127|FG000|Overall Study|Withdrawal by Subject|1|||
105490599|NCT02734433|363807588|FG001|Overall Study|Disease progression|5|||
105490600|NCT02734433|363807587|FG000|Overall Study|Clinical progression|0|||
105490601|NCT02734433|363807588|FG001|Overall Study|Clinical progression|1|||
105368812|NCT00547339|363356300|FG000|Overall Study|Physician Decision|0|||
105368813|NCT00547339|363356301|FG001|Overall Study|Physician Decision|0|||
105368814|NCT00547339|363356302|FG002|Overall Study|Physician Decision|1|||
105368815|NCT00547339|363356303|FG003|Overall Study|Physician Decision|0|||
105368816|NCT01935089|363356306|FG000|Overall Study|Adverse Event|2|||
105368817|NCT01935089|363356306|FG000|Overall Study|Withdrawal by Subject|1|||
105368818|NCT01309386|363356313|FG000|Overall Study|Other|2|||
105368819|NCT01309386|363356314|FG001|Overall Study|Other|0|||
105368820|NCT01309386|363356313|FG000|Overall Study|Withdrawal by Subject|2|||
105368821|NCT01309386|363356314|FG001|Overall Study|Withdrawal by Subject|0|||
105368822|NCT01309386|363356313|FG000|Overall Study|Progressive disease|9|||
105368823|NCT01309386|363356314|FG001|Overall Study|Progressive disease|11|||
105368824|NCT01309386|363356313|FG000|Overall Study|Physician Decision|1|||
105368825|NCT01309386|363356314|FG001|Overall Study|Physician Decision|1|||
105368826|NCT01309386|363356313|FG000|Overall Study|Lack of Efficacy|3|||
105368827|NCT01309386|363356314|FG001|Overall Study|Lack of Efficacy|1|||
105368828|NCT01309386|363356313|FG000|Overall Study|Adverse Event|5|||
105368829|NCT01309386|363356314|FG001|Overall Study|Adverse Event|8|||
105368830|NCT01783743|363356315|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
105368831|NCT01783743|363356316|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
105368832|NCT01783743|363356315|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
105576738|NCT04779242|364110307|FG001|Overall Study|Adverse Event|1|||
105576739|NCT04779242|364110306|FG000|Overall Study|Lost to Follow-up|2|||
105848322|NCT02143583|365103128|FG001|Overall Study|Withdrawal by Subject|0|||
105848323|NCT02143583|365103129|FG002|Overall Study|Withdrawal by Subject|1|||
105848324|NCT02143583|365103127|FG000|Overall Study|husband illness|0|||
105848325|NCT02143583|365103128|FG001|Overall Study|husband illness|0|||
105848326|NCT02143583|365103129|FG002|Overall Study|husband illness|1|||
105848327|NCT01940497|365103130|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
105848328|NCT01940497|365103131|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
105848329|NCT01940497|365103130|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
105848330|NCT01940497|365103131|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
105848331|NCT01940497|365103130|FG000|Overall Study|Violation of Entry Criteria|1|||
105848332|NCT01940497|365103131|FG001|Overall Study|Violation of Entry Criteria|1|||
105848333|NCT01940497|365103130|FG000|Overall Study|Refused Treatment|1|||
105848334|NCT01940497|365103131|FG001|Overall Study|Refused Treatment|3|||
105848335|NCT01940497|365103130|FG000|Overall Study|Withdrew Consent|6|||
105848336|NCT01940497|365103131|FG001|Overall Study|Withdrew Consent|2|||
105848337|NCT01940497|365103130|FG000|Overall Study|Administrative/Other|1|||
105848338|NCT01940497|365103131|FG001|Overall Study|Administrative/Other|1|||
105848339|NCT01641133|365103132|FG000|Overall Study|Protocol Violation|0|||
105848340|NCT01641133|365103133|FG001|Overall Study|Protocol Violation|1|||
105848341|NCT01641133|365103134|FG002|Overall Study|Protocol Violation|1|||
105848342|NCT01641133|365103132|FG000|Overall Study|Migrated/moved from study area|5|||
105848343|NCT01641133|365103133|FG001|Overall Study|Migrated/moved from study area|3|||
105848344|NCT01641133|365103134|FG002|Overall Study|Migrated/moved from study area|1|||
105848345|NCT01641133|365103132|FG000|Overall Study|Adverse Event|0|||
105848346|NCT01641133|365103133|FG001|Overall Study|Adverse Event|0|||
105848347|NCT01641133|365103134|FG002|Overall Study|Adverse Event|1|||
105368833|NCT01783743|363356316|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
105368834|NCT01783743|363356315|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
105368835|NCT01783743|363356316|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
105576740|NCT04779242|364110307|FG001|Overall Study|Lost to Follow-up|4|||
105848348|NCT01641133|365103132|FG000|Overall Study|Withdrawal by Subject|5|||
105848349|NCT01641133|365103133|FG001|Overall Study|Withdrawal by Subject|3|||
105848350|NCT01641133|365103134|FG002|Overall Study|Withdrawal by Subject|3|||
105848351|NCT01641133|365103132|FG000|Overall Study|Lost to Follow-up|0|||
105848352|NCT01641133|365103133|FG001|Overall Study|Lost to Follow-up|2|||
105848353|NCT01641133|365103134|FG002|Overall Study|Lost to Follow-up|2|||
105848354|NCT03123861|365103135|FG000|Overall Study|Protocol Violation|1|||
105848355|NCT03123861|365103136|FG001|Overall Study|Protocol Violation|1|||
105848356|NCT03123861|365103135|FG000|Overall Study|Withdrawal by Subject|2|||
105848357|NCT03123861|365103136|FG001|Overall Study|Withdrawal by Subject|2|||
105848358|NCT00513682|365103137|FG000|Washout Phase|Adverse Event|2|||
105848359|NCT02206620|365103138|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
105848360|NCT02206620|365103139|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
105848361|NCT02206620|365103138|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
105848362|NCT02206620|365103139|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
105848363|NCT04156620|365103140|FG000|Overall Study|Adverse event - TP 1|5|||
105368836|NCT01607593|363356318|FG000|Overall Study|Adverse Event|15|||
105576741|NCT04779242|364110306|FG000|Overall Study|Withdrawal by Subject|7|||
105848364|NCT04156620|365103141|FG001|Overall Study|Adverse event - TP 1|2|||
105848365|NCT04156620|365103140|FG000|Overall Study|Lost to follow-up TP 1|1|||
105848366|NCT04156620|365103141|FG001|Overall Study|Lost to follow-up TP 1|1|||
105848367|NCT04156620|365103140|FG000|Overall Study|Progressive disease - TP 1|0|||
105316932|NCT04380961|363154819|FG000|Overall Study|Randomized but Not Treated|1|||
105316933|NCT04380961|363154820|FG001|Overall Study|Randomized but Not Treated|2|||
105316934|NCT03316547|363154821|FG000|Overall Study|Death|3|||
105316935|NCT03316547|363154822|FG001|Overall Study|Death|1|||
105316936|NCT03316547|363154821|FG000|Overall Study|Lost to Follow-up|6|||
105316937|NCT03316547|363154822|FG001|Overall Study|Lost to Follow-up|6|||
105316938|NCT03316547|363154821|FG000|Overall Study|Withdrawal by Subject|3|||
105316939|NCT03316547|363154822|FG001|Overall Study|Withdrawal by Subject|2|||
105316940|NCT03316547|363154821|FG000|Overall Study|Transfer to another hospital|6|||
105316941|NCT03316547|363154822|FG001|Overall Study|Transfer to another hospital|4|||
105316942|NCT01243775|363154825|FG000|Overall Study|Withdrawal by Subject|2|||
105316943|NCT05422625|363154826|FG000|Overall Study|Withdrawal by Subject|1|||
105316944|NCT05422625|363154827|FG001|Overall Study|Withdrawal by Subject|0|||
105316945|NCT02017015|363156614|FG000|Overall Study|Adverse Event|9|||
105316946|NCT02017015|363156614|FG000|Overall Study|Withdrawal by Subject|21|||
105316947|NCT02017015|363156614|FG000|Overall Study|Death|4|||
105316948|NCT02017015|363156614|FG000|Overall Study|Progressive Disease|31|||
105316949|NCT02017015|363156614|FG000|Overall Study|Non-compliance with study drug|2|||
105316950|NCT02017015|363156614|FG000|Overall Study|Physician Decision|2|||
105316951|NCT01200069|363156615|FG000|Overall Study|Withdrawal by Subject|0|||
105316952|NCT01200069|363156616|FG001|Overall Study|Withdrawal by Subject|1|||
105316953|NCT03765788|363156624|FG000|Overall Study|Subject decision|2|||
105316954|NCT03765788|363156625|FG001|Overall Study|Subject decision|3|||
105316955|NCT03765788|363156624|FG000|Overall Study|Physician Decision|2|||
105316956|NCT03765788|363156625|FG001|Overall Study|Physician Decision|4|||
105316957|NCT03765788|363156624|FG000|Overall Study|Death|0|||
105316958|NCT03765788|363156625|FG001|Overall Study|Death|1|||
105316959|NCT03765788|363156624|FG000|Overall Study|Lost to Follow-up|1|||
105316960|NCT03765788|363156625|FG001|Overall Study|Lost to Follow-up|0|||
105316961|NCT01924754|363156626|FG000|Overall Study|Lost to Follow-up|1|||
105316962|NCT01924754|363156627|FG001|Overall Study|Lost to Follow-up|2|||
105316963|NCT01924754|363156628|FG002|Overall Study|Lost to Follow-up|1|||
105316964|NCT01924754|363156626|FG000|Overall Study|Pregnancy|0|||
105316965|NCT01924754|363156627|FG001|Overall Study|Pregnancy|1|||
105316966|NCT01924754|363156628|FG002|Overall Study|Pregnancy|2|||
105316967|NCT04778904|363156629|FG000|Overall Study|Protocol Violation|1|||
105316968|NCT04778904|363156630|FG001|Overall Study|Protocol Violation|0|||
105316969|NCT04778904|363156631|FG002|Overall Study|Protocol Violation|0|||
105316970|NCT04778904|363156632|FG003|Overall Study|Protocol Violation|0|||
105316971|NCT04778904|363156629|FG000|Overall Study|Withdrawal by Subject|0|||
105316972|NCT04778904|363156630|FG001|Overall Study|Withdrawal by Subject|0|||
105316973|NCT04778904|363156631|FG002|Overall Study|Withdrawal by Subject|1|||
105316974|NCT04778904|363156632|FG003|Overall Study|Withdrawal by Subject|0|||
105316975|NCT01582152|363156639|FG000|Overall Study|Disease Progression|4|||
105316976|NCT01582152|363156640|FG001|Overall Study|Disease Progression|5|||
105316977|NCT01582152|363156639|FG000|Overall Study|Adverse Event|2|||
105316978|NCT01582152|363156640|FG001|Overall Study|Adverse Event|1|||
105316979|NCT02794870|363156642|FG000|Overall Study|Withdrawal by Subject|2|||
105316980|NCT02794870|363156643|FG001|Overall Study|Withdrawal by Subject|0|||
105316981|NCT03336528|363156644|FG000|Overall Study|Protocol Violation|1|||
105316982|NCT03336528|363156645|FG001|Overall Study|Protocol Violation|1|||
105316983|NCT03336528|363156644|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
105316984|NCT03336528|363156645|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
105316985|NCT03336528|363156644|FG000|Overall Study|Did not receive study medication|1|||
105316986|NCT03336528|363156645|FG001|Overall Study|Did not receive study medication|2|||
105316987|NCT01753297|363156649|FG000|Overall Study|Lost to Follow-up|7|||
105316988|NCT01753297|363156650|FG001|Overall Study|Lost to Follow-up|2|||
105316989|NCT01753297|363156649|FG000|Overall Study|Withdrawal by Subject|26|||
105316990|NCT01753297|363156650|FG001|Overall Study|Withdrawal by Subject|23|||
105316991|NCT01753297|363156649|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
105316992|NCT01753297|363156650|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
105368837|NCT01607593|363356318|FG000|Overall Study|Lack of Efficacy|16|||
105368838|NCT01607593|363356318|FG000|Overall Study|Lost to Follow-up|25|||
105368839|NCT01607593|363356318|FG000|Overall Study|Continuation|33|||
105316993|NCT01753297|363156649|FG000|Overall Study|Death|0|||
105316994|NCT01753297|363156650|FG001|Overall Study|Death|2|||
105316995|NCT01753297|363156649|FG000|Overall Study|Did not attend end of study visit|7|||
105316996|NCT01753297|363156650|FG001|Overall Study|Did not attend end of study visit|8|||
105316997|NCT01611857|363156653|FG000|Overall Study|Withdrawal by Subject|0|||
105368840|NCT01607593|363356318|FG000|Overall Study|Other|4|||
105368841|NCT02062437|363356319|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
105490602|NCT02734433|363807587|FG000|Overall Study|Withdrawal by Subject|1|||
105490603|NCT02734433|363807588|FG001|Overall Study|Withdrawal by Subject|2|||
105316998|NCT01611857|363156654|FG001|Overall Study|Withdrawal by Subject|2|||
105316999|NCT04974749|363156661|FG000|Overall Study|Withdrawal by Subject|2|||
105317000|NCT04974749|363156661|FG000|Overall Study|Gestation|1|||
105317001|NCT00658879|363156662|FG000|Overall Study|Protocol Violation|1|||
105317002|NCT01118975|363156663|FG000|Overall Study|Adverse Event|0|||
105848368|NCT04156620|365103141|FG001|Overall Study|Progressive disease - TP 1|1|||
105848369|NCT04156620|365103140|FG000|Overall Study|Subject decision - TP 1|3|||
105848370|NCT04156620|365103141|FG001|Overall Study|Subject decision - TP 1|5|||
105848371|NCT04156620|365103140|FG000|Overall Study|Adverse event - TP 2|5|||
105848372|NCT04156620|365103141|FG001|Overall Study|Adverse event - TP 2|6|||
105848373|NCT04156620|365103140|FG000|Overall Study|Death - TP 2|1|||
105848374|NCT04156620|365103141|FG001|Overall Study|Death - TP 2|0|||
105848375|NCT04156620|365103140|FG000|Overall Study|Lost to follow-up - TP 2|5|||
105848376|NCT04156620|365103141|FG001|Overall Study|Lost to follow-up - TP 2|2|||
105848377|NCT04156620|365103140|FG000|Overall Study|Physician decision - TP 2|4|||
105848378|NCT04156620|365103141|FG001|Overall Study|Physician decision - TP 2|2|||
105848379|NCT04156620|365103140|FG000|Overall Study|Pregnancy - TP 2|1|||
105848380|NCT04156620|365103141|FG001|Overall Study|Pregnancy - TP 2|1|||
105848381|NCT04156620|365103140|FG000|Overall Study|Subject decision - TP 2|11|||
105848382|NCT04156620|365103141|FG001|Overall Study|Subject decision - TP 2|9|||
105848383|NCT04156620|365103140|FG000|Overall Study|New therapy for study indication - TP 2|1|||
105848384|NCT04156620|365103141|FG001|Overall Study|New therapy for study indication - TP 2|0|||
105848385|NCT03212521|365103142|FG000|Overall Study|Adverse Event|1|||
105848386|NCT03212521|365103142|FG000|Overall Study|Lost to Follow-up|4|||
105848387|NCT03212521|365103142|FG000|Overall Study|Withdrawal by Subject|1|||
105848388|NCT03212521|365103142|FG000|Overall Study|Other|1|||
105848389|NCT01121666|365103145|FG000|Overall Study|Protocol Violation|29|||
105848390|NCT01121666|365103146|FG001|Overall Study|Protocol Violation|10|||
105848391|NCT00609466|365103147|FG000|Overall Study|Withdrawal by Subject|0|||
105848392|NCT00609466|365103148|FG001|Overall Study|Withdrawal by Subject|1|||
105848393|NCT00609466|365103149|FG002|Overall Study|Withdrawal by Subject|1|||
105848394|NCT00609466|365103147|FG000|Overall Study|Adverse Event|2|||
105848395|NCT00609466|365103148|FG001|Overall Study|Adverse Event|3|||
105848396|NCT00609466|365103149|FG002|Overall Study|Adverse Event|1|||
105848397|NCT00609466|365103147|FG000|Overall Study|Lack of Efficacy|0|||
105848398|NCT00609466|365103148|FG001|Overall Study|Lack of Efficacy|2|||
105848399|NCT00609466|365103149|FG002|Overall Study|Lack of Efficacy|2|||
105848400|NCT03512262|365103152|FG000|Overall Study|Adverse Event|8|||
105848401|NCT03512262|365103153|FG001|Overall Study|Adverse Event|3|||
105848402|NCT03512262|365103152|FG000|Overall Study|Death (non-treatment emergent)|1|||
105848403|NCT03512262|365103153|FG001|Overall Study|Death (non-treatment emergent)|0|||
105848404|NCT03512262|365103152|FG000|Overall Study|Withdrawal by Subject|17|||
105848405|NCT03512262|365103153|FG001|Overall Study|Withdrawal by Subject|9|||
105848406|NCT03512262|365103152|FG000|Overall Study|Lost to Follow-up|7|||
105848407|NCT03512262|365103153|FG001|Overall Study|Lost to Follow-up|1|||
105848408|NCT03512262|365103152|FG000|Overall Study|Other than Specified|2|||
105848409|NCT03512262|365103153|FG001|Overall Study|Other than Specified|2|||
105848410|NCT02013375|365103157|FG000|Overall Study|Did not engraft|1|||
105848411|NCT02013375|365103157|FG000|Overall Study|Did not engraft|1|||
105848412|NCT02674061|365103160|FG000|Overall Study|Death|229|||
105848413|NCT02674061|365103161|FG001|Overall Study|Death|77|||
105848414|NCT02674061|365103160|FG000|Overall Study|Lost to Follow-up|3|||
105848415|NCT02674061|365103161|FG001|Overall Study|Lost to Follow-up|3|||
105848416|NCT02674061|365103160|FG000|Overall Study|Withdrawal by Subject|9|||
105848417|NCT02674061|365103161|FG001|Overall Study|Withdrawal by Subject|1|||
105848418|NCT02674061|365103160|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
105848419|NCT02674061|365103161|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
105848420|NCT01602965|365103162|FG000|Overall Study|Lost to Follow-up|4|||
105848421|NCT01602965|365103163|FG001|Overall Study|Lost to Follow-up|2|||
105848422|NCT00477295|365103164|FG000|Overall Study|Adverse Event|31|||
105848423|NCT00477295|365103165|FG001|Overall Study|Adverse Event|35|||
105848424|NCT00477295|365103164|FG000|Overall Study|Withdrawal by Subject|35|||
105848425|NCT00477295|365103165|FG001|Overall Study|Withdrawal by Subject|24|||
105848426|NCT00477295|365103164|FG000|Overall Study|Lack of Efficacy|23|||
105848427|NCT00477295|365103165|FG001|Overall Study|Lack of Efficacy|23|||
105848428|NCT00477295|365103164|FG000|Overall Study|Protocol Violation|3|||
105848429|NCT00477295|365103165|FG001|Overall Study|Protocol Violation|8|||
105848430|NCT00477295|365103164|FG000|Overall Study|Physician Decision|4|||
105317003|NCT01118975|363156664|FG001|Overall Study|Adverse Event|1|||
105317004|NCT01645787|363156665|FG000|Washout (2 Weeks)|Adverse Event|1|||
105317005|NCT01645787|363156666|FG001|Washout (2 Weeks)|Adverse Event|0|||
105317006|NCT01371539|363156667|FG000|Period One: One Week|Lost to Follow-up|0|||
105317007|NCT01371539|363156668|FG001|Period One: One Week|Lost to Follow-up|1|||
105848431|NCT00477295|365103165|FG001|Overall Study|Physician Decision|5|||
105848432|NCT00477295|365103164|FG000|Overall Study|Lost to Follow-up|21|||
105848433|NCT00477295|365103165|FG001|Overall Study|Lost to Follow-up|11|||
105848434|NCT00477295|365103164|FG000|Overall Study|Other|4|||
105848435|NCT00477295|365103165|FG001|Overall Study|Other|3|||
105848436|NCT03870477|365103166|FG000|Overall Study|Early Study Termination|1|||
105848437|NCT02283294|365103167|FG000|Overall Study|Lost to Follow-up|1|||
105848438|NCT02283294|365103168|FG001|Overall Study|Lost to Follow-up|1|||
105848439|NCT02283294|365103167|FG000|Overall Study|Withdrawal by Subject|1|||
105848440|NCT02283294|365103168|FG001|Overall Study|Withdrawal by Subject|6|||
105490604|NCT00171054|363807589|FG000|Overall Study|Protocol Violation|1|||
105490605|NCT00171054|363807590|FG001|Overall Study|Protocol Violation|2|||
105490606|NCT00171054|363807589|FG000|Overall Study|Patient withdrew consent|1|||
105490607|NCT00171054|363807590|FG001|Overall Study|Patient withdrew consent|0|||
105490608|NCT00171054|363807589|FG000|Overall Study|Lost to Follow-up|0|||
105490609|NCT00171054|363807590|FG001|Overall Study|Lost to Follow-up|1|||
105490610|NCT00171054|363807589|FG000|Overall Study|Adverse Event|8|||
105490611|NCT00171054|363807590|FG001|Overall Study|Adverse Event|8|||
105490612|NCT00171054|363807589|FG000|Overall Study|Condition no longer required study drug|0|||
105490613|NCT00171054|363807590|FG001|Overall Study|Condition no longer required study drug|1|||
105490614|NCT05597020|363807594|FG000|Washout|Forbidden medication|2|||
105848441|NCT02283294|365103167|FG000|Overall Study|Protocol Violation|1|||
105848442|NCT02283294|365103168|FG001|Overall Study|Protocol Violation|0|||
105848443|NCT02283294|365103167|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
105848444|NCT02283294|365103168|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
105848445|NCT00594646|365103169|FG000|Overall Study|Withdrawal by Subject|1|||
105848446|NCT00594646|365103169|FG000|Overall Study|Lost to Follow-up|15|||
105848447|NCT04268316|365104994|FG000|Overall Study|Withdrawal by Subject|2|||
105848448|NCT04268316|365104995|FG001|Overall Study|Withdrawal by Subject|1|||
105848449|NCT04268316|365104996|FG002|Overall Study|Withdrawal by Subject|0|||
105848450|NCT02040779|365104998|FG000|Overall Study|Adverse Event|1|||
105848451|NCT02040779|365104999|FG001|Overall Study|Adverse Event|0|||
105848452|NCT02040779|365105000|FG002|Overall Study|Adverse Event|0|||
105848453|NCT02040779|365104998|FG000|Overall Study|Withdrawal by Subject|4|||
105848454|NCT02040779|365104999|FG001|Overall Study|Withdrawal by Subject|1|||
105848455|NCT02040779|365105000|FG002|Overall Study|Withdrawal by Subject|3|||
105848456|NCT02040779|365104998|FG000|Overall Study|Non-compliance|0|||
105848457|NCT02040779|365104999|FG001|Overall Study|Non-compliance|1|||
105848458|NCT02040779|365105000|FG002|Overall Study|Non-compliance|0|||
105848459|NCT02040779|365104998|FG000|Overall Study|Protocol Violation|2|||
105848460|NCT02040779|365104999|FG001|Overall Study|Protocol Violation|1|||
105848461|NCT02040779|365105000|FG002|Overall Study|Protocol Violation|0|||
105848462|NCT02040779|365104998|FG000|Overall Study|Lost to Follow-up|1|||
105848463|NCT02040779|365104999|FG001|Overall Study|Lost to Follow-up|2|||
105848464|NCT02040779|365105000|FG002|Overall Study|Lost to Follow-up|1|||
105848465|NCT02040779|365104998|FG000|Overall Study|Lack of Efficacy|4|||
105848466|NCT02040779|365104999|FG001|Overall Study|Lack of Efficacy|2|||
105848467|NCT02040779|365105000|FG002|Overall Study|Lack of Efficacy|0|||
105848468|NCT03265288|365105001|FG000|Overall Study|Adverse Event|0|||
105848469|NCT03265288|365105002|FG001|Overall Study|Adverse Event|1|||
105848470|NCT03265288|365105001|FG000|Overall Study|Withdrawal by Subject|13|||
105848471|NCT03265288|365105002|FG001|Overall Study|Withdrawal by Subject|5|||
105848472|NCT03265288|365105001|FG000|Overall Study|Drug Withdrawn|3|||
105848473|NCT03265288|365105002|FG001|Overall Study|Drug Withdrawn|3|||
105848474|NCT03265288|365105001|FG000|Overall Study|Any Other Reason|7|||
105848475|NCT03265288|365105002|FG001|Overall Study|Any Other Reason|3|||
105848476|NCT02588950|365105011|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
105848477|NCT02588950|365105012|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
105848478|NCT02588950|365105013|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
105848479|NCT02588950|365105014|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
105848480|NCT02588950|365105011|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
105848481|NCT02588950|365105012|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
105848482|NCT02588950|365105013|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
105848483|NCT02588950|365105014|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
105848484|NCT00866658|365105015|FG000|Overall Study|Adverse Event|5|||
105848485|NCT00866658|365105016|FG001|Overall Study|Adverse Event|14|||
105848486|NCT00866658|365105015|FG000|Overall Study|Lack of Efficacy|2|||
105848487|NCT00866658|365105016|FG001|Overall Study|Lack of Efficacy|1|||
105848488|NCT00866658|365105015|FG000|Overall Study|Withdrawal by Subject|1|||
105848489|NCT00866658|365105016|FG001|Overall Study|Withdrawal by Subject|0|||
105848490|NCT00866658|365105015|FG000|Overall Study|Protocol Violation|1|||
105848491|NCT00866658|365105016|FG001|Overall Study|Protocol Violation|1|||
105848492|NCT00866658|365105015|FG000|Overall Study|Familial and Personal Reasons|4|||
105848493|NCT00866658|365105016|FG001|Overall Study|Familial and Personal Reasons|5|||
105848494|NCT03188718|365105020|FG000|Overall Study|Participant noncompliance|4|||
105848495|NCT03188718|365105020|FG000|Overall Study|Withdrawal by Subject|1|||
105848496|NCT03188718|365105020|FG000|Overall Study|Device failure|3|||
105848497|NCT04322149|365105024|FG000|Overall Study|Adverse Event|1|||
105848498|NCT04322149|365105025|FG001|Overall Study|Adverse Event|1|||
105490615|NCT05597020|363807595|FG001|Washout|Forbidden medication|0|||
105490616|NCT05597020|363807594|FG000|Treatment Period II|Advice from primary care physician|1|||
105576742|NCT04779242|364110307|FG001|Overall Study|Withdrawal by Subject|9|||
105848499|NCT04322149|365105026|FG002|Overall Study|Adverse Event|0|||
105848500|NCT04322149|365105027|FG003|Overall Study|Adverse Event|0|||
105490617|NCT05597020|363807595|FG001|Treatment Period II|Advice from primary care physician|0|||
105490618|NCT05597020|363807594|FG000|Treatment Period II|Subject lost investigational product|1|||
105490619|NCT05597020|363807595|FG001|Treatment Period II|Subject lost investigational product|0|||
105317008|NCT01371539|363156667|FG000|Period Two: One Week|Lost to Follow-up|0|||
105317009|NCT01371539|363156668|FG001|Period Two: One Week|Lost to Follow-up|1|||
105848501|NCT04322149|365105024|FG000|Overall Study|Withdrawal by Subject|0|||
105848502|NCT04322149|365105025|FG001|Overall Study|Withdrawal by Subject|0|||
105848503|NCT04322149|365105026|FG002|Overall Study|Withdrawal by Subject|0|||
105848504|NCT04322149|365105027|FG003|Overall Study|Withdrawal by Subject|2|||
105848505|NCT04322149|365105024|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
105848506|NCT04322149|365105025|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
105848507|NCT04322149|365105026|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
105848508|NCT04322149|365105027|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
105848509|NCT02238626|365105034|FG000|Overall Study|Adverse Event|3|||
105848510|NCT02238626|365105035|FG001|Overall Study|Adverse Event|5|||
105317010|NCT01371539|363156667|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
105317011|NCT01371539|363156668|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
105317012|NCT01371539|363156667|FG000|Period Two: One Week|Time/job conflict|0|||
105317013|NCT01371539|363156668|FG001|Period Two: One Week|Time/job conflict|1|||
105317014|NCT02075515|363156670|FG000|Overall Study|Serious Adverse Event|1|||
105317015|NCT02075515|363156671|FG001|Overall Study|Serious Adverse Event|1|||
105317016|NCT02075515|363156672|FG002|Overall Study|Serious Adverse Event|1|||
105317017|NCT02075515|363156670|FG000|Overall Study|Non-Serious Adverse Event|0|||
105317018|NCT02075515|363156671|FG001|Overall Study|Non-Serious Adverse Event|1|||
105317019|NCT02075515|363156672|FG002|Overall Study|Non-Serious Adverse Event|0|||
105317020|NCT02075515|363156670|FG000|Overall Study|Withdrawal by Subject|2|||
105317021|NCT02075515|363156671|FG001|Overall Study|Withdrawal by Subject|0|||
105317022|NCT02075515|363156672|FG002|Overall Study|Withdrawal by Subject|1|||
105317023|NCT02075515|363156670|FG000|Overall Study|Lost to Follow-up|1|||
105317024|NCT02075515|363156671|FG001|Overall Study|Lost to Follow-up|3|||
105317025|NCT02075515|363156672|FG002|Overall Study|Lost to Follow-up|6|||
105317026|NCT00378573|363156682|FG000|Treatment Period|Adverse Event|9|||
105317027|NCT00378573|363156682|FG000|Treatment Period|Physician Decision|1|||
105317028|NCT00378573|363156682|FG000|Treatment Period|Withdrawal by Subject|2|||
105317029|NCT00378573|363156682|FG000|Treatment Period|Disease Progression|4|||
105317030|NCT00378573|363156682|FG000|Treatment Period|Sponsor decision to close study|1|||
105317031|NCT00378573|363156682|FG000|Follow-up|Death|12|||
105317032|NCT00378573|363156682|FG000|Follow-up|Lost to Follow-up|1|||
105317033|NCT00378573|363156682|FG000|Follow-up|Withdrawal by Subject|1|||
105368842|NCT02062437|363356319|FG000|Overall Study|Patient not available for the 2y visit|18|||
105368843|NCT02062437|363356319|FG000|Overall Study|Death|2|||
105368844|NCT02062437|363356319|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
105368845|NCT02337491|363356323|FG000|Overall Study|Death|1|||
105368846|NCT02337491|363356324|FG001|Overall Study|Death|1|||
105368847|NCT02337491|363356323|FG000|Overall Study|Adverse Event|0|||
105368848|NCT02337491|363356324|FG001|Overall Study|Adverse Event|1|||
105368849|NCT02337491|363356323|FG000|Overall Study|Withdrawal by Subject|3|||
105368850|NCT02337491|363356324|FG001|Overall Study|Withdrawal by Subject|0|||
105368851|NCT02337491|363356323|FG000|Overall Study|Progressive Disease|44|||
105368852|NCT02337491|363356324|FG001|Overall Study|Progressive Disease|28|||
105368853|NCT02337491|363356323|FG000|Overall Study|On Treatment|2|||
105368854|NCT02337491|363356324|FG001|Overall Study|On Treatment|0|||
105368855|NCT00723229|363356325|FG000|First Intervention|Lost to Follow-up|7|||
105368856|NCT00723229|363356326|FG001|First Intervention|Lost to Follow-up|3|||
105368857|NCT01674725|363356327|FG000|Overall Study|Adverse Event|1|||
105368858|NCT01674725|363356328|FG001|Overall Study|Adverse Event|0|||
105368859|NCT01674725|363356327|FG000|Overall Study|Did not receive study drug|1|||
105368860|NCT01674725|363356328|FG001|Overall Study|Did not receive study drug|0|||
105368861|NCT01674725|363356327|FG000|Overall Study|Withdrawal by Subject|1|||
105368862|NCT01674725|363356328|FG001|Overall Study|Withdrawal by Subject|0|||
105368863|NCT01674725|363356327|FG000|Overall Study|Lost to Follow-up|0|||
105490620|NCT05597020|363807594|FG000|Treatment Period II|Private reasons|0|||
105490621|NCT05597020|363807595|FG001|Treatment Period II|Private reasons|1|||
105317034|NCT01098474|363156689|FG000|Active Phase|Other|0|||
105317035|NCT01098474|363156690|FG001|Active Phase|Other|0|||
105317036|NCT01098474|363156691|FG002|Active Phase|Other|3|||
105317037|NCT01098474|363156692|FG003|Active Phase|Other|0|||
105317038|NCT01098474|363156693|FG004|Active Phase|Other|0|||
105317039|NCT01098474|363156694|FG005|Active Phase|Other|0|||
105368864|NCT01674725|363356328|FG001|Overall Study|Lost to Follow-up|1|||
105368865|NCT00958074|363356329|FG000|Overall Study|Withdrawal by Subject|0|||
105490622|NCT02718300|363807598|FG000|Overall Study|Death|4|||
105317040|NCT01098474|363156689|FG000|Active Phase|Withdrawal by Subject|1|||
105317041|NCT01098474|363156690|FG001|Active Phase|Withdrawal by Subject|1|||
105317042|NCT01098474|363156691|FG002|Active Phase|Withdrawal by Subject|2|||
105317043|NCT01098474|363156692|FG003|Active Phase|Withdrawal by Subject|0|||
105368866|NCT00958074|363356330|FG001|Overall Study|Withdrawal by Subject|1|||
105368867|NCT02709746|363356331|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
105368868|NCT02709746|363356332|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
105368869|NCT02709746|363356333|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
105368870|NCT02709746|363356334|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
105368871|NCT02709746|363356335|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
105368872|NCT02709746|363356331|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
105368873|NCT02709746|363356332|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
105368874|NCT02709746|363356333|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
105368875|NCT02709746|363356334|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
105848511|NCT02238626|365105036|FG002|Overall Study|Adverse Event|0|||
105848512|NCT02238626|365105037|FG003|Overall Study|Adverse Event|3|||
105848513|NCT02238626|365105034|FG000|Overall Study|Lost to Follow-up|2|||
105848514|NCT02238626|365105035|FG001|Overall Study|Lost to Follow-up|4|||
105848515|NCT02238626|365105036|FG002|Overall Study|Lost to Follow-up|2|||
105848516|NCT02238626|365105037|FG003|Overall Study|Lost to Follow-up|2|||
105848517|NCT02238626|365105034|FG000|Overall Study|Withdrawal by Subject|0|||
105848518|NCT02238626|365105035|FG001|Overall Study|Withdrawal by Subject|3|||
105848519|NCT02238626|365105036|FG002|Overall Study|Withdrawal by Subject|0|||
105848520|NCT02238626|365105037|FG003|Overall Study|Withdrawal by Subject|1|||
105848521|NCT02238626|365105034|FG000|Overall Study|Death|0|||
105848522|NCT02238626|365105035|FG001|Overall Study|Death|0|||
105848523|NCT02238626|365105036|FG002|Overall Study|Death|1|||
105848524|NCT02238626|365105037|FG003|Overall Study|Death|1|||
105848525|NCT02238626|365105034|FG000|Overall Study|Other|0|||
105848526|NCT02238626|365105035|FG001|Overall Study|Other|2|||
105848527|NCT02238626|365105036|FG002|Overall Study|Other|0|||
105848528|NCT02238626|365105037|FG003|Overall Study|Other|0|||
105848529|NCT00270257|365105038|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
105848530|NCT00270257|365105039|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
105848531|NCT01403064|365105042|FG000|Overall Study|Death|0|||
105848532|NCT01403064|365105043|FG001|Overall Study|Death|0|||
105848533|NCT01403064|365105044|FG002|Overall Study|Death|1|||
105848534|NCT01403064|365105045|FG003|Overall Study|Death|1|||
105848535|NCT01403064|365105042|FG000|Overall Study|Withdrawal by Subject|0|||
105848536|NCT01403064|365105043|FG001|Overall Study|Withdrawal by Subject|0|||
105848537|NCT01403064|365105044|FG002|Overall Study|Withdrawal by Subject|1|||
105848538|NCT01403064|365105045|FG003|Overall Study|Withdrawal by Subject|1|||
105848539|NCT01403064|365105042|FG000|Overall Study|Other|1|||
105848540|NCT01403064|365105043|FG001|Overall Study|Other|0|||
105848541|NCT01403064|365105044|FG002|Overall Study|Other|2|||
105848542|NCT01403064|365105045|FG003|Overall Study|Other|1|||
105848543|NCT00307034|365105046|FG000|Overall Study|Adverse Event|1|||
105848544|NCT00307034|365105047|FG001|Overall Study|Adverse Event|2|||
105848545|NCT00307034|365105046|FG000|Overall Study|Withdrawal by Subject|1|||
105848546|NCT00307034|365105047|FG001|Overall Study|Withdrawal by Subject|2|||
105848547|NCT00307034|365105046|FG000|Overall Study|Lost to Follow-up|0|||
105848548|NCT00307034|365105047|FG001|Overall Study|Lost to Follow-up|3|||
105848549|NCT04688931|365105053|FG000|Overall Study|Adverse Event|4|||
105848550|NCT04688931|365105054|FG001|Overall Study|Adverse Event|1|||
105848551|NCT04688931|365105053|FG000|Overall Study|Withdrawal by Subject|5|||
105848552|NCT04688931|365105054|FG001|Overall Study|Withdrawal by Subject|16|||
105848553|NCT04688931|365105053|FG000|Overall Study|Physician Decision|3|||
105848554|NCT04688931|365105054|FG001|Overall Study|Physician Decision|5|||
105848555|NCT04688931|365105053|FG000|Overall Study|Noncompliance|0|||
105848556|NCT04688931|365105054|FG001|Overall Study|Noncompliance|1|||
105848557|NCT04688931|365105053|FG000|Overall Study|Lost to Follow-up|1|||
105848558|NCT04688931|365105054|FG001|Overall Study|Lost to Follow-up|3|||
105848559|NCT04688931|365105053|FG000|Overall Study|Randomization Error|3|||
105848560|NCT04688931|365105054|FG001|Overall Study|Randomization Error|0|||
105848561|NCT04688931|365105053|FG000|Overall Study|Not Eligible|1|||
105848562|NCT04688931|365105054|FG001|Overall Study|Not Eligible|3|||
105848563|NCT04688931|365105053|FG000|Overall Study|Disease Progression|0|||
105848564|NCT04688931|365105054|FG001|Overall Study|Disease Progression|2|||
105848565|NCT04688931|365105053|FG000|Overall Study|Sponsor Requirement|1|||
105848566|NCT04688931|365105054|FG001|Overall Study|Sponsor Requirement|1|||
105848567|NCT04688931|365105053|FG000|Overall Study|Other Reason|1|||
105848568|NCT04688931|365105054|FG001|Overall Study|Other Reason|2|||
105848569|NCT02669940|365105055|FG000|Overall Study|Failure to return|0|||
105848570|NCT02669940|365105056|FG001|Overall Study|Failure to return|3|||
105848571|NCT02669940|365105055|FG000|Overall Study|Insufficient follow-up data|1|||
105848572|NCT02669940|365105056|FG001|Overall Study|Insufficient follow-up data|0|||
105848573|NCT00974974|365105057|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
105848574|NCT00974974|365105058|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
105848575|NCT00974974|365105057|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
105848576|NCT00974974|365105058|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
105848577|NCT00974974|365105057|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
105848578|NCT00974974|365105058|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
105848579|NCT00974974|365105057|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
105317044|NCT01098474|363156693|FG004|Active Phase|Withdrawal by Subject|0|||
105317045|NCT01098474|363156694|FG005|Active Phase|Withdrawal by Subject|0|||
105317046|NCT01098474|363156689|FG000|Active Phase|Lost to Follow-up|1|||
105317047|NCT01098474|363156690|FG001|Active Phase|Lost to Follow-up|0|||
105317048|NCT01098474|363156691|FG002|Active Phase|Lost to Follow-up|0|||
105317049|NCT01098474|363156692|FG003|Active Phase|Lost to Follow-up|0|||
105317050|NCT01098474|363156693|FG004|Active Phase|Lost to Follow-up|0|||
105317051|NCT01098474|363156694|FG005|Active Phase|Lost to Follow-up|0|||
105317052|NCT01098474|363156689|FG000|Follow Up Phase|Travelled out of study area|0|||
105317053|NCT01098474|363156690|FG001|Follow Up Phase|Travelled out of study area|0|||
105317054|NCT01098474|363156691|FG002|Follow Up Phase|Travelled out of study area|0|||
105317055|NCT01098474|363156692|FG003|Follow Up Phase|Travelled out of study area|0|||
105317056|NCT01098474|363156693|FG004|Follow Up Phase|Travelled out of study area|1|||
105317057|NCT01098474|363156694|FG005|Follow Up Phase|Travelled out of study area|0|||
105848580|NCT00974974|365105058|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
105848581|NCT00974974|365105057|FG000|IR CD-LD Dose Adjustment|Various|0|||
105848582|NCT00974974|365105058|FG001|IR CD-LD Dose Adjustment|Various|9|||
105848583|NCT00974974|365105057|FG000|IPX066 Dose Conversion|Adverse Event|23|||
105848584|NCT00974974|365105058|FG001|IPX066 Dose Conversion|Adverse Event|0|||
105848585|NCT00974974|365105057|FG000|IPX066 Dose Conversion|Death|2|||
105848586|NCT00974974|365105058|FG001|IPX066 Dose Conversion|Death|0|||
105848587|NCT00974974|365105057|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
105848588|NCT00974974|365105058|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
105848589|NCT00974974|365105057|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
105848590|NCT00974974|365105058|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
105848591|NCT00974974|365105057|FG000|IPX066 Dose Conversion|Various|3|||
105848592|NCT00974974|365105058|FG001|IPX066 Dose Conversion|Various|0|||
105848593|NCT00974974|365105057|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
105848594|NCT00974974|365105058|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
105848595|NCT00974974|365105057|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
105848596|NCT00974974|365105058|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
105848597|NCT00974974|365105057|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
105848598|NCT00974974|365105058|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
105848599|NCT00974974|365105057|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
105848600|NCT00974974|365105058|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
105848601|NCT00974974|365105057|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
105848602|NCT00974974|365105058|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
105848603|NCT00974974|365105057|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
105848604|NCT00974974|365105058|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
105848605|NCT00974974|365105057|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
105848606|NCT00974974|365105058|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
105848607|NCT00974974|365105057|FG000|Maintenance - Double Blind Treatment|Various|4|||
105848608|NCT00974974|365105058|FG001|Maintenance - Double Blind Treatment|Various|0|||
105848609|NCT00667810|365105059|FG000|Overall Study|Adverse Event|13|||
105848610|NCT00667810|365105060|FG001|Overall Study|Adverse Event|14|||
105848611|NCT00667810|365105061|FG002|Overall Study|Adverse Event|19|||
105848612|NCT00667810|365105062|FG003|Overall Study|Adverse Event|1|||
105848613|NCT00667810|365105059|FG000|Overall Study|Death|1|||
105848614|NCT00667810|365105060|FG001|Overall Study|Death|1|||
105848615|NCT00667810|365105061|FG002|Overall Study|Death|3|||
105848616|NCT00667810|365105062|FG003|Overall Study|Death|0|||
105848617|NCT00667810|365105059|FG000|Overall Study|Lack of Efficacy|1|||
105848618|NCT00667810|365105060|FG001|Overall Study|Lack of Efficacy|0|||
105848619|NCT00667810|365105061|FG002|Overall Study|Lack of Efficacy|2|||
105848620|NCT00667810|365105062|FG003|Overall Study|Lack of Efficacy|0|||
105848621|NCT00667810|365105059|FG000|Overall Study|Lost to Follow-up|1|||
105848622|NCT00667810|365105060|FG001|Overall Study|Lost to Follow-up|4|||
105848623|NCT00667810|365105061|FG002|Overall Study|Lost to Follow-up|2|||
105317058|NCT01098474|363156689|FG000|Follow Up Phase|Other|0|||
105317059|NCT01098474|363156690|FG001|Follow Up Phase|Other|0|||
105317060|NCT01098474|363156691|FG002|Follow Up Phase|Other|0|||
105317061|NCT01098474|363156692|FG003|Follow Up Phase|Other|0|||
105317062|NCT01098474|363156693|FG004|Follow Up Phase|Other|0|||
105317063|NCT01098474|363156694|FG005|Follow Up Phase|Other|4|||
105317064|NCT01098474|363156689|FG000|Follow Up Phase|Withdrawal by Subject|0|||
105317065|NCT01098474|363156690|FG001|Follow Up Phase|Withdrawal by Subject|0|||
105317066|NCT01098474|363156691|FG002|Follow Up Phase|Withdrawal by Subject|0|||
105490623|NCT02718300|363807599|FG001|Overall Study|Death|5|||
105490624|NCT02718300|363807600|FG002|Overall Study|Death|17|||
105848624|NCT00667810|365105062|FG003|Overall Study|Lost to Follow-up|0|||
105848625|NCT00667810|365105059|FG000|Overall Study|Physician Decision|1|||
105848626|NCT00667810|365105060|FG001|Overall Study|Physician Decision|1|||
105317067|NCT01098474|363156692|FG003|Follow Up Phase|Withdrawal by Subject|2|||
105490625|NCT02718300|363807598|FG000|Overall Study|Lost to Follow-up|1|||
105490626|NCT02718300|363807599|FG001|Overall Study|Lost to Follow-up|0|||
105848627|NCT00667810|365105061|FG002|Overall Study|Physician Decision|2|||
105848628|NCT00667810|365105062|FG003|Overall Study|Physician Decision|0|||
105848629|NCT00667810|365105059|FG000|Overall Study|Protocol Violation|0|||
105848630|NCT00667810|365105060|FG001|Overall Study|Protocol Violation|2|||
105848631|NCT00667810|365105061|FG002|Overall Study|Protocol Violation|0|||
105848632|NCT00667810|365105062|FG003|Overall Study|Protocol Violation|0|||
105848633|NCT00667810|365105059|FG000|Overall Study|Withdrawal by Subject|14|||
105848634|NCT00667810|365105060|FG001|Overall Study|Withdrawal by Subject|20|||
105848635|NCT00667810|365105061|FG002|Overall Study|Withdrawal by Subject|29|||
105848636|NCT00667810|365105062|FG003|Overall Study|Withdrawal by Subject|1|||
105848637|NCT00667810|365105059|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
105848638|NCT00667810|365105060|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
105848639|NCT00667810|365105061|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
105848640|NCT00667810|365105062|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
105848641|NCT00667810|365105059|FG000|Overall Study|Failed to Return|0|||
105848642|NCT00667810|365105060|FG001|Overall Study|Failed to Return|0|||
105848643|NCT00667810|365105061|FG002|Overall Study|Failed to Return|2|||
105848644|NCT00667810|365105062|FG003|Overall Study|Failed to Return|0|||
105848645|NCT00667810|365105059|FG000|Overall Study|Loss of Caregiver|0|||
105317068|NCT01098474|363156693|FG004|Follow Up Phase|Withdrawal by Subject|0|||
105317069|NCT01098474|363156694|FG005|Follow Up Phase|Withdrawal by Subject|1|||
105317070|NCT01098474|363156689|FG000|Follow Up Phase|Lost to Follow-up|0|||
105317071|NCT01098474|363156690|FG001|Follow Up Phase|Lost to Follow-up|0|||
105317072|NCT01098474|363156691|FG002|Follow Up Phase|Lost to Follow-up|0|||
105317073|NCT01098474|363156692|FG003|Follow Up Phase|Lost to Follow-up|0|||
105317074|NCT01098474|363156693|FG004|Follow Up Phase|Lost to Follow-up|1|||
105848646|NCT00667810|365105060|FG001|Overall Study|Loss of Caregiver|1|||
105317075|NCT01098474|363156694|FG005|Follow Up Phase|Lost to Follow-up|0|||
105317076|NCT01994850|363156703|FG000|Overall Study|Physician Decision|1|||
105317077|NCT01994850|363156703|FG000|Overall Study|Withdrawal by Subject|1|||
105317078|NCT02481869|363156706|FG000|Overall Study|Lost to Follow-up|3|||
105317079|NCT02481869|363156707|FG001|Overall Study|Lost to Follow-up|4|||
105317080|NCT02481869|363156706|FG000|Overall Study|Withdrawal by Subject|2|||
105317081|NCT02481869|363156707|FG001|Overall Study|Withdrawal by Subject|0|||
105317082|NCT05445492|363156711|FG000|Overall Study|Physician Decision|1|||
105317083|NCT04238650|363156712|FG000|Overall Study|Withdrawal by Subject|0|||
105317084|NCT04238650|363156713|FG001|Overall Study|Withdrawal by Subject|1|||
105317085|NCT04289363|363156714|FG000|Overall Study|Lost to Follow-up|14|||
105317086|NCT04289363|363156715|FG001|Overall Study|Lost to Follow-up|0|||
105317087|NCT02585778|363156717|FG000|Overall Study|Adverse Event|17|||
105317088|NCT02585778|363156718|FG001|Overall Study|Adverse Event|4|||
105317089|NCT02585778|363156717|FG000|Overall Study|Participant did not wish to continue|9|||
105317090|NCT02585778|363156718|FG001|Overall Study|Participant did not wish to continue|4|||
105317091|NCT02585778|363156717|FG000|Overall Study|Poor compliance to study protocol|0|||
105317092|NCT02585778|363156718|FG001|Overall Study|Poor compliance to study protocol|2|||
105368876|NCT02709746|363356335|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
105368877|NCT02709746|363356331|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
105368878|NCT02709746|363356332|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
105368879|NCT02709746|363356333|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
105368880|NCT02709746|363356334|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
105368881|NCT02709746|363356335|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
105368882|NCT02709746|363356331|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
105368883|NCT02709746|363356332|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
105368884|NCT02709746|363356333|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
105368885|NCT02709746|363356334|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
105368886|NCT02709746|363356335|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
105368887|NCT02709746|363356331|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
105368888|NCT02709746|363356332|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
105368889|NCT02709746|363356333|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
105368890|NCT02709746|363356334|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
105368891|NCT02709746|363356335|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
105368892|NCT02709746|363356331|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
105368893|NCT02709746|363356332|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
105368894|NCT02709746|363356333|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
105368895|NCT02709746|363356334|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
105368896|NCT02709746|363356335|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
105576743|NCT04779242|364110306|FG000|Overall Study|Death|6|||
105848647|NCT00667810|365105061|FG002|Overall Study|Loss of Caregiver|3|||
105848648|NCT00667810|365105062|FG003|Overall Study|Loss of Caregiver|0|||
105848649|NCT00667810|365105059|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
105848650|NCT00667810|365105060|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
105317093|NCT02585778|363156717|FG000|Overall Study|Death|0|||
105317094|NCT02585778|363156718|FG001|Overall Study|Death|1|||
105317095|NCT02585778|363156717|FG000|Overall Study|Randomized but not treated|1|||
105317096|NCT02585778|363156718|FG001|Overall Study|Randomized but not treated|2|||
105317097|NCT02585778|363156717|FG000|Overall Study|Other than specified above|6|||
105317098|NCT02585778|363156718|FG001|Overall Study|Other than specified above|2|||
105317099|NCT04841577|363156719|FG000|Overall Study|Adverse Event|5|||
105317100|NCT04841577|363156720|FG001|Overall Study|Adverse Event|10|||
105317101|NCT04841577|363156719|FG000|Overall Study|Lost to Follow-up|8|||
105317102|NCT04841577|363156720|FG001|Overall Study|Lost to Follow-up|7|||
105317103|NCT04841577|363156719|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
105317104|NCT04841577|363156720|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
105317105|NCT04841577|363156719|FG000|Overall Study|Other|0|||
105317106|NCT04841577|363156720|FG001|Overall Study|Other|1|||
105317107|NCT00182325|363156721|FG000|Overall Study|Lost to Follow-up|7|||
105317108|NCT00182325|363156722|FG001|Overall Study|Lost to Follow-up|7|||
105317109|NCT00182325|363156721|FG000|Overall Study|Miscarriage|5|||
105317110|NCT00182325|363156722|FG001|Overall Study|Miscarriage|3|||
105317111|NCT00182325|363156721|FG000|Overall Study|Did not complete survey|22|||
105317112|NCT00182325|363156722|FG001|Overall Study|Did not complete survey|43|||
105317113|NCT01937871|363156723|FG000|Overall Study|Adverse Event|6|||
105317114|NCT01937871|363156724|FG001|Overall Study|Adverse Event|6|||
105317115|NCT01937871|363156725|FG002|Overall Study|Adverse Event|2|||
105317116|NCT01937871|363156723|FG000|Overall Study|Lost to Follow-up|8|||
105317117|NCT01937871|363156724|FG001|Overall Study|Lost to Follow-up|2|||
105317118|NCT01937871|363156725|FG002|Overall Study|Lost to Follow-up|4|||
105317119|NCT01937871|363156723|FG000|Overall Study|Withdrawal by Subject|9|||
105317120|NCT01937871|363156724|FG001|Overall Study|Withdrawal by Subject|6|||
105317121|NCT01937871|363156725|FG002|Overall Study|Withdrawal by Subject|4|||
105317122|NCT01937871|363156723|FG000|Overall Study|Physician Decision|0|||
105317123|NCT01937871|363156724|FG001|Overall Study|Physician Decision|1|||
105317124|NCT01937871|363156725|FG002|Overall Study|Physician Decision|0|||
105317125|NCT01937871|363156723|FG000|Overall Study|Entry Criteria Not Met|1|||
105317126|NCT01937871|363156724|FG001|Overall Study|Entry Criteria Not Met|2|||
105317127|NCT01937871|363156725|FG002|Overall Study|Entry Criteria Not Met|1|||
105317128|NCT00214383|363156726|FG000|Overall Study|Lost to Follow-up|16|||
105317129|NCT00214383|363156727|FG001|Overall Study|Lost to Follow-up|26|||
105317130|NCT02125877|363156728|FG000|Overall Study|Physician Decision|1|||
105317131|NCT02125877|363156729|FG001|Overall Study|Physician Decision|0|||
105317132|NCT02125877|363156728|FG000|Overall Study|Death|0|||
105317133|NCT02125877|363156729|FG001|Overall Study|Death|1|||
105317134|NCT02125877|363156728|FG000|Overall Study|Administrative problems|0|||
105317135|NCT02125877|363156729|FG001|Overall Study|Administrative problems|1|||
105317136|NCT02125877|363156728|FG000|Overall Study|Participant/guardian decision|0|||
105317137|NCT02125877|363156729|FG001|Overall Study|Participant/guardian decision|2|||
105317138|NCT02125877|363156728|FG000|Overall Study|Withdrawal by Subject|2|||
105317139|NCT02125877|363156729|FG001|Overall Study|Withdrawal by Subject|1|||
105317140|NCT02125877|363156728|FG000|Overall Study|Protocol deviation|4|||
105317141|NCT02125877|363156729|FG001|Overall Study|Protocol deviation|1|||
105317142|NCT02125877|363156728|FG000|Overall Study|Adverse Event|6|||
105317143|NCT02125877|363156729|FG001|Overall Study|Adverse Event|4|||
105317144|NCT00710866|363156732|FG000|Overall Study|Protocol Violation|5|||
105317145|NCT00710866|363156733|FG001|Overall Study|Protocol Violation|4|||
105317146|NCT00710866|363156732|FG000|Overall Study|Withdrawal by Subject|2|||
105317147|NCT00710866|363156733|FG001|Overall Study|Withdrawal by Subject|1|||
105317148|NCT00710866|363156732|FG000|Overall Study|Lost to Follow-up|1|||
105317149|NCT00710866|363156733|FG001|Overall Study|Lost to Follow-up|0|||
105368897|NCT02709746|363356331|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
105368898|NCT02709746|363356332|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
105368899|NCT02709746|363356333|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
105368900|NCT02709746|363356334|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
105368901|NCT02709746|363356335|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
105368902|NCT02709746|363356331|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
105368903|NCT02709746|363356332|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
105368904|NCT02709746|363356333|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
105368905|NCT02709746|363356334|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
105490627|NCT02718300|363807600|FG002|Overall Study|Lost to Follow-up|2|||
105490628|NCT02718300|363807598|FG000|Overall Study|Physician Decision|1|||
105317150|NCT00710866|363156732|FG000|Overall Study|Failed to meet eligibility|1|||
105317151|NCT00710866|363156733|FG001|Overall Study|Failed to meet eligibility|1|||
105317152|NCT02290223|363156738|FG000|6 Months|Lost to Follow-up|9|||
105317153|NCT02290223|363156739|FG001|6 Months|Lost to Follow-up|6|||
105490629|NCT02718300|363807599|FG001|Overall Study|Physician Decision|0|||
105490630|NCT02718300|363807600|FG002|Overall Study|Physician Decision|2|||
105317154|NCT02290223|363156738|FG000|6 Months|Withdrawal by Subject|5|||
105317155|NCT02290223|363156739|FG001|6 Months|Withdrawal by Subject|0|||
105317156|NCT02290223|363156738|FG000|6 Months|deceased (not related to study)|2|||
105317157|NCT02290223|363156739|FG001|6 Months|deceased (not related to study)|0|||
105317158|NCT02290223|363156738|FG000|12 Months|Lost to Follow-up|16|||
105317159|NCT02290223|363156739|FG001|12 Months|Lost to Follow-up|10|||
105317160|NCT02290223|363156738|FG000|12 Months|Refusal|0|||
105317161|NCT02290223|363156739|FG001|12 Months|Refusal|1|||
105317162|NCT02676765|363156740|FG000|Overall Study|Lost to Follow-up|0|||
105317163|NCT02676765|363156741|FG001|Overall Study|Lost to Follow-up|1|||
105368906|NCT02709746|363356335|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
105368907|NCT02709746|363356331|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
105368908|NCT02709746|363356332|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
105368909|NCT02709746|363356333|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
105368910|NCT02709746|363356334|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
105368911|NCT02709746|363356335|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
105368912|NCT02709746|363356331|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
105368913|NCT02709746|363356332|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
105368914|NCT02709746|363356333|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
105368915|NCT02709746|363356334|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
105368916|NCT02709746|363356335|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
105368917|NCT02709746|363356331|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
105368918|NCT02709746|363356332|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
105368919|NCT02709746|363356333|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
105368920|NCT02709746|363356334|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
105317164|NCT02466685|363156742|FG000|Overall Study|Adverse Event|5|||
105317165|NCT02466685|363156743|FG001|Overall Study|Adverse Event|2|||
105317166|NCT02466685|363156742|FG000|Overall Study|Lost to Follow-up|1|||
105317167|NCT02466685|363156743|FG001|Overall Study|Lost to Follow-up|1|||
105317168|NCT02466685|363156742|FG000|Overall Study|Withdrawal by Subject|1|||
105317169|NCT02466685|363156743|FG001|Overall Study|Withdrawal by Subject|0|||
105368921|NCT02709746|363356335|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
105490631|NCT02718300|363807598|FG000|Overall Study|Study Terminated by Sponsor|6|||
105490632|NCT02718300|363807599|FG001|Overall Study|Study Terminated by Sponsor|3|||
105490633|NCT02718300|363807600|FG002|Overall Study|Study Terminated by Sponsor|4|||
105490634|NCT02718300|363807598|FG000|Overall Study|Withdrawal by Subject|0|||
105490635|NCT02718300|363807599|FG001|Overall Study|Withdrawal by Subject|4|||
105490636|NCT02718300|363807600|FG002|Overall Study|Withdrawal by Subject|3|||
105490637|NCT02718300|363807598|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
105490638|NCT02718300|363807599|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
105490639|NCT02718300|363807600|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
105490640|NCT01994590|363809378|FG000|Overall Study|Adverse Event|1|||
105490641|NCT01994590|363809378|FG000|Overall Study|Trial Terminated|1|||
105490642|NCT00510874|363809379|FG000|Overall Study|Withdrawal by Subject|1|||
105490643|NCT00510874|363809380|FG001|Overall Study|Withdrawal by Subject|1|||
105490644|NCT00510874|363809381|FG002|Overall Study|Withdrawal by Subject|0|||
105490645|NCT00510874|363809382|FG003|Overall Study|Withdrawal by Subject|0|||
105490646|NCT00510874|363809383|FG004|Overall Study|Withdrawal by Subject|3|||
105490647|NCT00510874|363809384|FG005|Overall Study|Withdrawal by Subject|0|||
105490648|NCT00510874|363809385|FG006|Overall Study|Withdrawal by Subject|0|||
105490649|NCT00510874|363809379|FG000|Overall Study|Lost to Follow-up|2|||
105490650|NCT00510874|363809380|FG001|Overall Study|Lost to Follow-up|3|||
105490651|NCT00510874|363809381|FG002|Overall Study|Lost to Follow-up|1|||
105490652|NCT00510874|363809382|FG003|Overall Study|Lost to Follow-up|3|||
105490653|NCT00510874|363809383|FG004|Overall Study|Lost to Follow-up|4|||
105490654|NCT00510874|363809384|FG005|Overall Study|Lost to Follow-up|0|||
105490655|NCT00510874|363809385|FG006|Overall Study|Lost to Follow-up|1|||
105490656|NCT01739400|363809386|FG000|Overall Study|Physician Decision|3|||
105490657|NCT01739400|363809387|FG001|Overall Study|Physician Decision|0|||
105490658|NCT01739400|363809386|FG000|Overall Study|Lost to Follow-up|2|||
105490659|NCT01739400|363809387|FG001|Overall Study|Lost to Follow-up|0|||
105490660|NCT01739400|363809386|FG000|Overall Study|Death|5|||
105490661|NCT01739400|363809387|FG001|Overall Study|Death|2|||
105490662|NCT01739400|363809386|FG000|Overall Study|Withdrawal by Subject|7|||
105490663|NCT01739400|363809387|FG001|Overall Study|Withdrawal by Subject|7|||
105490664|NCT01347307|363809390|FG000|Overall Study|Death|0|||
105490665|NCT01347307|363809391|FG001|Overall Study|Death|4|||
105490666|NCT01347307|363809390|FG000|Overall Study|Physician Decision|0|||
105490667|NCT01347307|363809391|FG001|Overall Study|Physician Decision|1|||
105490668|NCT02237911|363809396|FG000|Overall Study|Withdrawal by Subject|4|||
105490669|NCT02237911|363809397|FG001|Overall Study|Withdrawal by Subject|7|||
105490670|NCT02237911|363809398|FG002|Overall Study|Withdrawal by Subject|2|||
105490671|NCT02237911|363809396|FG000|Overall Study|Lost to Follow-up|3|||
105317170|NCT02466685|363156742|FG000|Overall Study|Physician Decision|1|||
105490672|NCT02237911|363809397|FG001|Overall Study|Lost to Follow-up|1|||
105317171|NCT02466685|363156743|FG001|Overall Study|Physician Decision|1|||
105490673|NCT02237911|363809398|FG002|Overall Study|Lost to Follow-up|1|||
105490674|NCT00053365|363809399|FG000|Overall Study|Incorrect cell type|1|||
105490675|NCT00053365|363809399|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
105317172|NCT04324021|363156752|FG000|Overall Study|Adverse Event|1|||
105317173|NCT04324021|363156753|FG001|Overall Study|Adverse Event|0|||
105317174|NCT04324021|363156754|FG002|Overall Study|Adverse Event|0|||
105317175|NCT04324021|363156752|FG000|Overall Study|Lack of Efficacy|0|||
105317176|NCT04324021|363156753|FG001|Overall Study|Lack of Efficacy|0|||
105317177|NCT04324021|363156754|FG002|Overall Study|Lack of Efficacy|1|||
105317178|NCT04324021|363156752|FG000|Overall Study|Death|1|||
105317179|NCT04324021|363156753|FG001|Overall Study|Death|1|||
105317180|NCT04324021|363156754|FG002|Overall Study|Death|0|||
105317181|NCT00345631|363156755|FG000|Overall Study|Withdrawal by Subject|1|||
105317182|NCT00345631|363156756|FG001|Overall Study|Withdrawal by Subject|0|||
105317183|NCT00345631|363156757|FG002|Overall Study|Withdrawal by Subject|1|||
105317184|NCT00345631|363156755|FG000|Overall Study|Adverse Event|0|||
105317185|NCT00345631|363156756|FG001|Overall Study|Adverse Event|1|||
105317186|NCT00345631|363156757|FG002|Overall Study|Adverse Event|0|||
105317187|NCT00345631|363156755|FG000|Overall Study|Lost to Follow-up|3|||
105317188|NCT00345631|363156756|FG001|Overall Study|Lost to Follow-up|7|||
105317189|NCT00345631|363156757|FG002|Overall Study|Lost to Follow-up|4|||
105317190|NCT00345631|363156755|FG000|Overall Study|Other reasons|0|||
105317191|NCT00345631|363156756|FG001|Overall Study|Other reasons|0|||
105317192|NCT00345631|363156757|FG002|Overall Study|Other reasons|1|||
105317193|NCT01590277|363156758|FG000|Overall Study|Withdrawal by Subject|3|||
105317194|NCT01590277|363156758|FG000|Overall Study|Withdrawal by Subject|2|||
105317195|NCT01590277|363156758|FG000|Overall Study|Withdrawal by Subject|1|||
105317196|NCT01590277|363156758|FG000|Overall Study|Withdrawal by Subject|1|||
105317197|NCT01450683|363156761|FG000|Overall Study|Adverse Event|2|||
105317198|NCT02126826|363158522|FG000|Overall Study|Withdrawal by Subject|0|||
105317199|NCT02126826|363158523|FG001|Overall Study|Withdrawal by Subject|0|||
105317200|NCT02126826|363158524|FG002|Overall Study|Withdrawal by Subject|0|||
105317201|NCT02126826|363158525|FG003|Overall Study|Withdrawal by Subject|1|||
105317202|NCT02126826|363158526|FG004|Overall Study|Withdrawal by Subject|0|||
105317203|NCT02126826|363158527|FG005|Overall Study|Withdrawal by Subject|0|||
105317204|NCT02126826|363158528|FG006|Overall Study|Withdrawal by Subject|0|||
105317205|NCT02013817|363158530|FG000|Overall Study|Adverse Event|12|||
105317206|NCT02013817|363158530|FG000|Overall Study|Withdrawal by Subject|4|||
105317207|NCT02013817|363158530|FG000|Overall Study|Death|2|||
105317208|NCT02013817|363158530|FG000|Overall Study|Other|9|||
105317209|NCT02129608|363158531|FG000|Overall Study|Lost to Follow-up|0|||
105317210|NCT02129608|363158532|FG001|Overall Study|Lost to Follow-up|1|||
105317211|NCT02129608|363158533|FG002|Overall Study|Lost to Follow-up|1|||
105317212|NCT02129608|363158531|FG000|Overall Study|Withdrawal by Subject|0|||
105317213|NCT02129608|363158532|FG001|Overall Study|Withdrawal by Subject|0|||
105317214|NCT02129608|363158533|FG002|Overall Study|Withdrawal by Subject|2|||
105317215|NCT00451204|363158540|FG000|Overall Study|Adverse Event|4|||
105317216|NCT00451204|363158541|FG001|Overall Study|Adverse Event|6|||
105317217|NCT00451204|363158540|FG000|Overall Study|Lack of Efficacy|4|||
105317218|NCT00451204|363158541|FG001|Overall Study|Lack of Efficacy|4|||
105317219|NCT00451204|363158540|FG000|Overall Study|Lost to Follow-up|4|||
105317220|NCT00451204|363158541|FG001|Overall Study|Lost to Follow-up|4|||
105317221|NCT00451204|363158540|FG000|Overall Study|Protocol Violation|1|||
105317222|NCT00451204|363158541|FG001|Overall Study|Protocol Violation|0|||
105317223|NCT00451204|363158540|FG000|Overall Study|Patient refusal|8|||
105576744|NCT04779242|364110307|FG001|Overall Study|Death|6|||
105576745|NCT04779242|364110306|FG000|Overall Study|COVID-19 related reasons|2|||
105317224|NCT00451204|363158541|FG001|Overall Study|Patient refusal|4|||
105317225|NCT00451204|363158540|FG000|Overall Study|Other|1|||
105848651|NCT00667810|365105061|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
105848652|NCT00667810|365105062|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
105848653|NCT00667810|365105059|FG000|Overall Study|Other|6|||
105848654|NCT00667810|365105060|FG001|Overall Study|Other|6|||
105848655|NCT00667810|365105061|FG002|Overall Study|Other|5|||
105848656|NCT00667810|365105062|FG003|Overall Study|Other|0|||
105848657|NCT02227147|365105063|FG000|Controlled Treatment Period|Adverse Event|4|||
105848658|NCT02227147|365105064|FG001|Controlled Treatment Period|Adverse Event|3|||
105848659|NCT02227147|365105063|FG000|Controlled Treatment Period|Other|2|||
105848660|NCT02227147|365105064|FG001|Controlled Treatment Period|Other|0|||
105848661|NCT02227147|365105063|FG000|Follow-up Period|Other|3|||
105848662|NCT02227147|365105064|FG001|Follow-up Period|Other|5|||
105848663|NCT00158600|365105066|FG000|Overall Study|unable to commit time to study|0|||
105848664|NCT00158600|365105067|FG001|Overall Study|unable to commit time to study|1|||
105848665|NCT00158600|365105066|FG000|Overall Study|Adverse Event|2|||
105848666|NCT00158600|365105067|FG001|Overall Study|Adverse Event|1|||
105848667|NCT00158600|365105066|FG000|Overall Study|Death|1|||
105848668|NCT00158600|365105067|FG001|Overall Study|Death|0|||
105317226|NCT00451204|363158541|FG001|Overall Study|Other|2|||
105317227|NCT00582010|363158545|FG000|Overall Study|Death|0|||
105317228|NCT00582010|363158546|FG001|Overall Study|Death|1|||
105317229|NCT04414618|363158559|FG000|Overall Study|Death|3|||
105317230|NCT04414618|363158560|FG001|Overall Study|Death|3|||
105317231|NCT04414618|363158559|FG000|Overall Study|Withdrawal by Subject|2|||
105848669|NCT00158600|365105066|FG000|Overall Study|Withdrawal by Subject|2|||
105848670|NCT00158600|365105067|FG001|Overall Study|Withdrawal by Subject|2|||
105848671|NCT00910091|365105068|FG000|Pre-assignment|Withdrawal by Subject|0|||
105848672|NCT00910091|365105069|FG001|Pre-assignment|Withdrawal by Subject|2|||
105848673|NCT00910091|365105068|FG000|Treatment and Survival|Withdrawal by Subject|3|||
105848674|NCT00910091|365105069|FG001|Treatment and Survival|Withdrawal by Subject|4|||
105848675|NCT00910091|365105068|FG000|Treatment and Survival|Adverse Event|1|||
105848676|NCT00910091|365105069|FG001|Treatment and Survival|Adverse Event|0|||
105848677|NCT02618408|365105070|FG000|Overall Study|Withdrawal by Subject|1|||
105848678|NCT02618408|365105071|FG001|Overall Study|Withdrawal by Subject|0|||
105317232|NCT04414618|363158560|FG001|Overall Study|Withdrawal by Subject|1|||
105317233|NCT04414618|363158559|FG000|Overall Study|Lost to Follow-up|2|||
105317234|NCT04414618|363158560|FG001|Overall Study|Lost to Follow-up|3|||
105317235|NCT04414618|363158559|FG000|Overall Study|Physician Decision|1|||
105317236|NCT04414618|363158560|FG001|Overall Study|Physician Decision|0|||
105317237|NCT00362336|363158561|FG000|Overall Study|Serious Adverse Event|1|||
105317238|NCT00362336|363158562|FG001|Overall Study|Serious Adverse Event|0|||
105317239|NCT00362336|363158563|FG002|Overall Study|Serious Adverse Event|1|||
105317240|NCT00362336|363158561|FG000|Overall Study|Protocol Violation|0|||
105317241|NCT00362336|363158562|FG001|Overall Study|Protocol Violation|0|||
105317242|NCT00362336|363158563|FG002|Overall Study|Protocol Violation|1|||
105317243|NCT00362336|363158561|FG000|Overall Study|Lost to Follow-up|6|||
105317244|NCT00362336|363158562|FG001|Overall Study|Lost to Follow-up|4|||
105317245|NCT00362336|363158563|FG002|Overall Study|Lost to Follow-up|0|||
105317246|NCT00362336|363158561|FG000|Overall Study|Withdrawal by Subject|3|||
105317247|NCT00362336|363158562|FG001|Overall Study|Withdrawal by Subject|3|||
105317248|NCT00362336|363158563|FG002|Overall Study|Withdrawal by Subject|1|||
105317249|NCT02463357|363158564|FG000|Overall Study|Withdrawal by Subject|1|||
105317250|NCT02463357|363158565|FG001|Overall Study|Withdrawal by Subject|0|||
105317251|NCT02463357|363158566|FG002|Overall Study|Withdrawal by Subject|0|||
105317252|NCT02463357|363158567|FG003|Overall Study|Withdrawal by Subject|0|||
105317253|NCT02463357|363158568|FG004|Overall Study|Withdrawal by Subject|0|||
105317254|NCT02463357|363158564|FG000|Overall Study|Withdrawal by Subject|0|||
105317255|NCT02463357|363158565|FG001|Overall Study|Withdrawal by Subject|0|||
105317256|NCT02463357|363158566|FG002|Overall Study|Withdrawal by Subject|0|||
105317257|NCT02463357|363158567|FG003|Overall Study|Withdrawal by Subject|0|||
105317258|NCT02463357|363158568|FG004|Overall Study|Withdrawal by Subject|1|||
105317259|NCT01121562|363158569|FG000|Overall Study|Objective progression or relapse|8|||
105317260|NCT01121562|363158569|FG000|Overall Study|Withdrawal by Subject|1|||
105317261|NCT01121562|363158569|FG000|Overall Study|Adverse Event|1|||
105317262|NCT01121562|363158569|FG000|Overall Study|Sponsor Decision|1|||
105317263|NCT01121562|363158569|FG000|Overall Study|Met study discontinuation criteria|1|||
105317264|NCT00616421|363158574|FG000|Overall Study|Withdrawal by Subject|9|||
105317265|NCT00616421|363158575|FG001|Overall Study|Withdrawal by Subject|11|||
105368922|NCT02709746|363356331|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
105368923|NCT02709746|363356332|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
105848679|NCT02618408|365105072|FG002|Overall Study|Withdrawal by Subject|4|||
105848680|NCT02618408|365105070|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
105848681|NCT02618408|365105071|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
105848682|NCT02618408|365105072|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
105317266|NCT00616421|363158576|FG002|Overall Study|Withdrawal by Subject|8|||
105317267|NCT00616421|363158574|FG000|Overall Study|Lost to Follow-up|12|||
105368924|NCT02709746|363356333|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
105368925|NCT02709746|363356334|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
105368926|NCT02709746|363356335|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
105368927|NCT02709746|363356331|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
105368928|NCT02709746|363356332|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
105368929|NCT02709746|363356333|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
105368930|NCT02709746|363356334|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
105368931|NCT02709746|363356335|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
105368932|NCT02709746|363356331|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
105368933|NCT02709746|363356332|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
105368934|NCT02709746|363356333|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
105368935|NCT02709746|363356334|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
105490676|NCT00053365|363809399|FG000|Overall Study|Never treated|4|||
105317268|NCT00616421|363158575|FG001|Overall Study|Lost to Follow-up|26|||
105317269|NCT00616421|363158576|FG002|Overall Study|Lost to Follow-up|30|||
105317270|NCT00616421|363158574|FG000|Overall Study|Inappropriate enrollment|3|||
105317271|NCT00616421|363158575|FG001|Overall Study|Inappropriate enrollment|0|||
105317272|NCT00616421|363158576|FG002|Overall Study|Inappropriate enrollment|1|||
105848683|NCT02618408|365105070|FG000|Overall Study|Lost to Follow-up|4|||
105317273|NCT00616421|363158574|FG000|Overall Study|Administrative reason|1|||
105317274|NCT00616421|363158575|FG001|Overall Study|Administrative reason|0|||
105317275|NCT00616421|363158576|FG002|Overall Study|Administrative reason|0|||
105317276|NCT00616421|363158574|FG000|Overall Study|Protocol Violation|0|||
105317277|NCT00616421|363158575|FG001|Overall Study|Protocol Violation|1|||
105317278|NCT00616421|363158576|FG002|Overall Study|Protocol Violation|2|||
105317279|NCT00616421|363158574|FG000|Overall Study|Unable to classify|1|||
105317280|NCT00616421|363158575|FG001|Overall Study|Unable to classify|0|||
105317281|NCT00616421|363158576|FG002|Overall Study|Unable to classify|0|||
105317282|NCT01495702|363158577|FG000|Randomized Phase|Randomized But Not Treated|1|||
105317283|NCT01495702|363158578|FG001|Randomized Phase|Randomized But Not Treated|4|||
105317284|NCT01495702|363158577|FG000|Randomized Phase|Adverse Event|2|||
105317285|NCT01495702|363158578|FG001|Randomized Phase|Adverse Event|2|||
105317286|NCT01495702|363158577|FG000|Randomized Phase|Death|1|||
105317287|NCT01495702|363158578|FG001|Randomized Phase|Death|0|||
105317288|NCT01495702|363158577|FG000|Randomized Phase|Lack of Efficacy|2|||
105368936|NCT02709746|363356335|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
105368937|NCT02709746|363356331|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
105368938|NCT02709746|363356332|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
105368939|NCT02709746|363356333|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
105368940|NCT02709746|363356334|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
105368941|NCT02709746|363356335|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
105368942|NCT02709746|363356331|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
105368943|NCT02709746|363356332|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
105368944|NCT02709746|363356333|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
105368945|NCT02709746|363356334|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
105368946|NCT02709746|363356335|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
105368947|NCT02709746|363356331|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
105368948|NCT02709746|363356332|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
105368949|NCT02709746|363356333|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
105368950|NCT02709746|363356334|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
105368951|NCT02709746|363356335|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
105368952|NCT02900352|363356340|FG000|Overall Study|Lost to Follow-up|28|||
105368953|NCT02900352|363356341|FG001|Overall Study|Lost to Follow-up|17|||
105368954|NCT03074695|363356342|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
105368955|NCT03074695|363356343|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
105368956|NCT03074695|363356342|FG000|Overall Study|Research staff not available|1|||
105368957|NCT03074695|363356343|FG001|Overall Study|Research staff not available|2|||
105368958|NCT03074695|363356342|FG000|Overall Study|Did not receive neuraxial block|2|||
105368959|NCT03074695|363356343|FG001|Overall Study|Did not receive neuraxial block|2|||
105368960|NCT03191799|363356344|FG000|Overall Study|Withdrawal by Subject|4|||
105368961|NCT03191799|363356344|FG000|Overall Study|Physician Decision|2|||
105368962|NCT03191799|363356344|FG000|Overall Study|Lost to Follow-up|1|||
105368963|NCT03191799|363356344|FG000|Overall Study|Death|2|||
105368964|NCT01774981|363356345|FG000|Overall Study|Adverse Event|0|||
105368965|NCT01774981|363356346|FG001|Overall Study|Adverse Event|0|||
105368966|NCT01774981|363356347|FG002|Overall Study|Adverse Event|0|||
105368967|NCT01774981|363356348|FG003|Overall Study|Adverse Event|0|||
105368968|NCT01774981|363356349|FG004|Overall Study|Adverse Event|0|||
105368969|NCT01774981|363356350|FG005|Overall Study|Adverse Event|1|||
105368970|NCT01774981|363356351|FG006|Overall Study|Adverse Event|0|||
105368971|NCT01774981|363356352|FG007|Overall Study|Adverse Event|0|||
105368972|NCT01774981|363356345|FG000|Overall Study|Withdrawal by Subject|0|||
105368973|NCT01774981|363356346|FG001|Overall Study|Withdrawal by Subject|0|||
105368974|NCT01774981|363356347|FG002|Overall Study|Withdrawal by Subject|0|||
105576746|NCT04779242|364110307|FG001|Overall Study|COVID-19 related reasons|1|||
105576747|NCT04779242|364110306|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
105576748|NCT04779242|364110307|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
105317289|NCT01495702|363158578|FG001|Randomized Phase|Lack of Efficacy|0|||
105317290|NCT01495702|363158577|FG000|Randomized Phase|Investigators Discretion|2|||
105317291|NCT01495702|363158578|FG001|Randomized Phase|Investigators Discretion|0|||
105317292|NCT01495702|363158577|FG000|Randomized Phase|Withdrew Consent|10|||
105317293|NCT01495702|363158578|FG001|Randomized Phase|Withdrew Consent|18|||
105368975|NCT01774981|363356348|FG003|Overall Study|Withdrawal by Subject|0|||
105490677|NCT00958789|363809400|FG000|Overall Study|Death|5|||
105490678|NCT00958789|363809400|FG000|Overall Study|Lost to Follow-up|14|||
105490679|NCT00958789|363809400|FG000|Overall Study|Withdrawal by Subject|17|||
105490680|NCT00958789|363809400|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
105490681|NCT00958789|363809400|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
105490682|NCT00958789|363809400|FG000|Overall Study|Subject terminated|2|||
105490683|NCT00958789|363809400|FG000|Overall Study|Revision|7|||
105490684|NCT00478881|363809401|FG000|Overall Study|Adverse Event|31|||
105490685|NCT00478881|363809402|FG001|Overall Study|Adverse Event|12|||
105490686|NCT00478881|363809401|FG000|Overall Study|Lack of Efficacy|0|||
105490687|NCT00478881|363809402|FG001|Overall Study|Lack of Efficacy|3|||
105317294|NCT01495702|363158577|FG000|Randomized Phase|Lost to Follow-up|4|||
105317295|NCT01495702|363158578|FG001|Randomized Phase|Lost to Follow-up|3|||
105317296|NCT01495702|363158577|FG000|Randomized Phase|Participant Noncompliance|1|||
105317297|NCT01495702|363158578|FG001|Randomized Phase|Participant Noncompliance|0|||
105317298|NCT01495702|363158577|FG000|Randomized Phase|Protocol Violation|3|||
105317299|NCT01495702|363158578|FG001|Randomized Phase|Protocol Violation|1|||
105317300|NCT04152863|363158579|FG000|Overall Study|Death|13|||
105317301|NCT04152863|363158580|FG001|Overall Study|Death|12|||
105317302|NCT04152863|363158581|FG002|Overall Study|Death|7|||
105317303|NCT04152863|363158579|FG000|Overall Study|Physician Decision|1|||
105317304|NCT04152863|363158580|FG001|Overall Study|Physician Decision|1|||
105317305|NCT04152863|363158581|FG002|Overall Study|Physician Decision|1|||
105317306|NCT04152863|363158579|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
105317307|NCT04152863|363158580|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
105317308|NCT04152863|363158581|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
105317309|NCT04152863|363158579|FG000|Overall Study|Withdrawal by Subject|2|||
105317310|NCT04152863|363158580|FG001|Overall Study|Withdrawal by Subject|1|||
105317311|NCT04152863|363158581|FG002|Overall Study|Withdrawal by Subject|3|||
105317312|NCT02661217|363158586|FG000|Overall Study|Physician Decision|12|||
105317313|NCT02661217|363158587|FG001|Overall Study|Physician Decision|15|||
105317314|NCT02661217|363158586|FG000|Overall Study|Lost to Follow-up|1|||
105317315|NCT02661217|363158587|FG001|Overall Study|Lost to Follow-up|4|||
105317316|NCT02661217|363158586|FG000|Overall Study|Protocol Deviation|0|||
105317317|NCT02661217|363158587|FG001|Overall Study|Protocol Deviation|4|||
105317318|NCT02661217|363158586|FG000|Overall Study|Non-compliance with study treatment|5|||
105317319|NCT02661217|363158587|FG001|Overall Study|Non-compliance with study treatment|5|||
105317320|NCT02661217|363158586|FG000|Overall Study|Death|21|||
105317321|NCT02661217|363158587|FG001|Overall Study|Death|15|||
105317322|NCT02661217|363158586|FG000|Overall Study|Adverse Event|10|||
105317323|NCT02661217|363158587|FG001|Overall Study|Adverse Event|8|||
105317324|NCT02661217|363158586|FG000|Overall Study|Withdrawal by Subject|15|||
105317325|NCT02661217|363158587|FG001|Overall Study|Withdrawal by Subject|19|||
105317326|NCT02661217|363158586|FG000|Overall Study|Did not enter follow-up epoch|7|||
105317327|NCT02661217|363158587|FG001|Overall Study|Did not enter follow-up epoch|10|||
105317328|NCT02661217|363158586|FG000|Overall Study|Death - no study drug received|1|||
105317329|NCT02661217|363158587|FG001|Overall Study|Death - no study drug received|2|||
105317330|NCT02661217|363158586|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
105317331|NCT02661217|363158587|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
105317332|NCT01644617|363158588|FG000|Overall Study|Withdrawal by Subject|3|||
105317333|NCT01644617|363158589|FG001|Overall Study|Withdrawal by Subject|4|||
105317334|NCT01644617|363158590|FG002|Overall Study|Withdrawal by Subject|1|||
105317335|NCT01644617|363158588|FG000|Overall Study|Lost to Follow-up|0|||
105317336|NCT01644617|363158589|FG001|Overall Study|Lost to Follow-up|1|||
105317337|NCT01644617|363158590|FG002|Overall Study|Lost to Follow-up|0|||
105317338|NCT01644617|363158588|FG000|Overall Study|Adverse Event|3|||
105317339|NCT01644617|363158589|FG001|Overall Study|Adverse Event|0|||
105317340|NCT01644617|363158590|FG002|Overall Study|Adverse Event|6|||
105317341|NCT01720225|363158592|FG000|Overall Study|Withdrawal by Subject|0|||
105317342|NCT01720225|363158593|FG001|Overall Study|Withdrawal by Subject|1|||
105317343|NCT01720225|363158592|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
105317344|NCT01720225|363158593|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
105317345|NCT01372748|363158594|FG000|Overall Study|Lost to Follow-up|16|||
105317346|NCT01372748|363158595|FG001|Overall Study|Lost to Follow-up|34|||
105317347|NCT01372748|363158594|FG000|Overall Study|Withdrawal by Subject|7|||
105317348|NCT01372748|363158595|FG001|Overall Study|Withdrawal by Subject|5|||
105317349|NCT02964312|363158596|FG000|Overall Study|Lost to Follow-up|28|||
105317350|NCT02964312|363158596|FG000|Overall Study|Withdrawal by Subject|11|||
105317351|NCT02964312|363158596|FG000|Overall Study|Lack of Efficacy|10|||
105317352|NCT02964312|363158596|FG000|Overall Study|Did not consent to long-term FU|14|||
105317353|NCT02964312|363158596|FG000|Overall Study|Death|1|||
105317354|NCT00606632|363158603|FG000|Overall Study|Withdrawal by Subject|13|||
105317355|NCT00606632|363158603|FG000|Overall Study|Miscellaneous reasons|9|||
105317356|NCT00711880|363158608|FG000|Overall Study|Adverse Event|11|||
105317357|NCT00711880|363158609|FG001|Overall Study|Adverse Event|2|||
105368976|NCT01774981|363356349|FG004|Overall Study|Withdrawal by Subject|0|||
105576749|NCT04779242|364110306|FG000|Overall Study|Martial Law in Ukraine|2|||
105317358|NCT00711880|363158608|FG000|Overall Study|Patient non-compliance|1|||
105317359|NCT00711880|363158609|FG001|Overall Study|Patient non-compliance|0|||
105576750|NCT04779242|364110307|FG001|Overall Study|Martial Law in Ukraine|3|||
105576751|NCT01556763|364110313|FG000|Overall Study|Withdrawal by Subject|0|||
105317360|NCT00711880|363158608|FG000|Overall Study|Lack of Efficacy|1|||
105317361|NCT00711880|363158609|FG001|Overall Study|Lack of Efficacy|5|||
105317362|NCT02862730|363158612|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
105317363|NCT02862730|363158613|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
105848684|NCT02618408|365105071|FG001|Overall Study|Lost to Follow-up|2|||
105317364|NCT02862730|363158614|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
105317365|NCT02862730|363158615|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
105317366|NCT02862730|363158616|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
105317367|NCT02862730|363158617|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
105317368|NCT02862730|363158618|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
105317369|NCT02862730|363158612|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
105317370|NCT02862730|363158613|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
105317371|NCT02862730|363158614|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
105317372|NCT02862730|363158615|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
105317373|NCT02862730|363158616|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
105317374|NCT02862730|363158617|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
105317375|NCT02862730|363158618|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
105317376|NCT02862730|363158612|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
105317377|NCT02862730|363158613|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
105317378|NCT02862730|363158614|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
105317379|NCT02862730|363158615|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
105317380|NCT02862730|363158616|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
105317381|NCT02862730|363158617|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
105317382|NCT02862730|363158618|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
105317383|NCT02862730|363158612|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
105317384|NCT02862730|363158613|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
105317385|NCT02862730|363158614|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
105317386|NCT02862730|363158615|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
105317387|NCT02862730|363158616|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
105317388|NCT02862730|363158617|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
105317389|NCT02862730|363158618|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
105317390|NCT00704132|363158619|FG000|Overall Study|Clinical Adverse Experience|1|||
105317391|NCT00704132|363158620|FG001|Overall Study|Clinical Adverse Experience|0|||
105317392|NCT00704132|363158619|FG000|Overall Study|Lack of Efficacy|0|||
105317393|NCT00704132|363158620|FG001|Overall Study|Lack of Efficacy|1|||
105317394|NCT00704132|363158619|FG000|Overall Study|Withdrawal by Subject|0|||
105317395|NCT00704132|363158620|FG001|Overall Study|Withdrawal by Subject|1|||
105317396|NCT03908437|363158621|FG000|Overall Study|Death|0|||
105317397|NCT03908437|363158622|FG001|Overall Study|Death|1|||
105317398|NCT03908437|363158621|FG000|Overall Study|Lost to Follow-up|31|||
105317399|NCT03908437|363158622|FG001|Overall Study|Lost to Follow-up|24|||
105317400|NCT00191191|363158623|FG000|Overall Study|Entry Criteria Exclusion|2|||
105317401|NCT00191191|363158624|FG001|Overall Study|Entry Criteria Exclusion|0|||
105317402|NCT00191191|363158623|FG000|Overall Study|Treated with Another Systemic Agent|1|||
105317403|NCT00191191|363158624|FG001|Overall Study|Treated with Another Systemic Agent|1|||
105317404|NCT00191191|363158623|FG000|Overall Study|Adverse Event|11|||
105317405|NCT00191191|363158624|FG001|Overall Study|Adverse Event|21|||
105317406|NCT00191191|363158623|FG000|Overall Study|Progressive Disease|84|||
105317407|NCT00191191|363158624|FG001|Overall Study|Progressive Disease|72|||
105317408|NCT00191191|363158623|FG000|Overall Study|Toxicity After Dose Reduction|7|||
105317409|NCT00191191|363158624|FG001|Overall Study|Toxicity After Dose Reduction|8|||
105317410|NCT00191191|363158623|FG000|Overall Study|Family/Caregiver Decision|5|||
105317411|NCT00191191|363158624|FG001|Overall Study|Family/Caregiver Decision|7|||
105317412|NCT00191191|363158623|FG000|Overall Study|Lost to Follow-up|1|||
105317413|NCT00191191|363158624|FG001|Overall Study|Lost to Follow-up|0|||
105317414|NCT00191191|363158623|FG000|Overall Study|Physician Decision|3|||
105317415|NCT00191191|363158624|FG001|Overall Study|Physician Decision|2|||
105317416|NCT00191191|363158623|FG000|Overall Study|Good Clinical Practice Violation|0|||
105317417|NCT00191191|363158624|FG001|Overall Study|Good Clinical Practice Violation|1|||
105317418|NCT00442962|363158625|FG000|Overall Study|Pregnancy|1|||
105317419|NCT00442962|363158625|FG000|Overall Study|Lost to Follow-up|7|||
105317420|NCT03685344|363158626|FG000|Overall Study|Withdrawal by Subject|1|||
105317421|NCT03685344|363158627|FG001|Overall Study|Withdrawal by Subject|1|||
105317422|NCT03685344|363158628|FG002|Overall Study|Withdrawal by Subject|2|||
105317423|NCT03685344|363158629|FG003|Overall Study|Withdrawal by Subject|0|||
105317424|NCT03685344|363158626|FG000|Overall Study|Physician Decision|1|||
105317425|NCT03685344|363158627|FG001|Overall Study|Physician Decision|1|||
105368977|NCT01774981|363356350|FG005|Overall Study|Withdrawal by Subject|0|||
105368978|NCT01774981|363356351|FG006|Overall Study|Withdrawal by Subject|0|||
105576752|NCT01556763|364110314|FG001|Overall Study|Withdrawal by Subject|1|||
105317426|NCT03685344|363158628|FG002|Overall Study|Physician Decision|5|||
105317427|NCT03685344|363158629|FG003|Overall Study|Physician Decision|0|||
105368979|NCT01774981|363356352|FG007|Overall Study|Withdrawal by Subject|1|||
105576753|NCT01556763|364110315|FG002|Overall Study|Withdrawal by Subject|0|||
105368980|NCT01774981|363356345|FG000|Overall Study|Death|0|||
105368981|NCT01774981|363356346|FG001|Overall Study|Death|0|||
105368982|NCT01774981|363356347|FG002|Overall Study|Death|0|||
105576754|NCT02258464|364110316|FG000|Overall Study|Progressive disease (PD)|9|||
105576755|NCT02258464|364110317|FG001|Overall Study|Progressive disease (PD)|17|||
105576756|NCT02258464|364110316|FG000|Overall Study|Study drug never administered|1|||
105576757|NCT02258464|364110317|FG001|Overall Study|Study drug never administered|1|||
105848685|NCT02618408|365105072|FG002|Overall Study|Lost to Follow-up|6|||
105848686|NCT02618408|365105070|FG000|Overall Study|Adverse Event|4|||
105848687|NCT02618408|365105071|FG001|Overall Study|Adverse Event|0|||
105848688|NCT02618408|365105072|FG002|Overall Study|Adverse Event|10|||
105848689|NCT02618408|365105070|FG000|Overall Study|Physician Decision|1|||
105848690|NCT02618408|365105071|FG001|Overall Study|Physician Decision|1|||
105848691|NCT02618408|365105072|FG002|Overall Study|Physician Decision|2|||
105848692|NCT02618408|365105070|FG000|Overall Study|Protocol Violation|1|||
105848693|NCT02618408|365105071|FG001|Overall Study|Protocol Violation|1|||
105848694|NCT02618408|365105072|FG002|Overall Study|Protocol Violation|2|||
105848695|NCT02618408|365105070|FG000|Overall Study|Other, Multiple Categories|0|||
105848696|NCT02618408|365105071|FG001|Overall Study|Other, Multiple Categories|0|||
105848697|NCT02618408|365105072|FG002|Overall Study|Other, Multiple Categories|4|||
105848698|NCT01175811|365105075|FG000|Overall Study|Adverse Event|1|||
105848699|NCT01175811|365105076|FG001|Overall Study|Adverse Event|1|||
105848700|NCT01175811|365105075|FG000|Overall Study|Entry criteria not met|3|||
105848701|NCT01175811|365105076|FG001|Overall Study|Entry criteria not met|1|||
105848702|NCT01175811|365105075|FG000|Overall Study|Lack of Efficacy|1|||
105848703|NCT01175811|365105076|FG001|Overall Study|Lack of Efficacy|0|||
105848704|NCT01175811|365105075|FG000|Overall Study|Lost to Follow-up|3|||
105848705|NCT01175811|365105076|FG001|Overall Study|Lost to Follow-up|2|||
105848706|NCT01175811|365105075|FG000|Overall Study|Physician Decision|1|||
105848707|NCT01175811|365105076|FG001|Overall Study|Physician Decision|1|||
105848708|NCT01175811|365105075|FG000|Overall Study|Protocol Violation|1|||
105848709|NCT01175811|365105076|FG001|Overall Study|Protocol Violation|2|||
105848710|NCT01175811|365105075|FG000|Overall Study|Withdrawal by Subject|6|||
105848711|NCT01175811|365105076|FG001|Overall Study|Withdrawal by Subject|7|||
105848712|NCT01297465|365105077|FG000|Overall Study|Lack of Ovarian Response|1|||
105848713|NCT01297465|365105078|FG001|Overall Study|Lack of Ovarian Response|1|||
105848714|NCT01297465|365105077|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
105848715|NCT01297465|365105078|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
105848716|NCT01297465|365105077|FG000|Overall Study|No Oocytes Retrieved|1|||
105848717|NCT01297465|365105078|FG001|Overall Study|No Oocytes Retrieved|1|||
105848718|NCT01297465|365105077|FG000|Overall Study|Poor oocyte quality|0|||
105848719|NCT01297465|365105078|FG001|Overall Study|Poor oocyte quality|1|||
105848720|NCT01297465|365105077|FG000|Overall Study|No Fertilization|6|||
105848721|NCT01297465|365105078|FG001|Overall Study|No Fertilization|4|||
105848722|NCT01297465|365105077|FG000|Overall Study|All Embryos Discarded|0|||
105848723|NCT01297465|365105078|FG001|Overall Study|All Embryos Discarded|1|||
105848724|NCT01297465|365105077|FG000|Overall Study|Intention to Freeze all Embryos|0|||
105848725|NCT01297465|365105078|FG001|Overall Study|Intention to Freeze all Embryos|1|||
105848726|NCT03321630|365105079|FG000|Overall Study|Adverse Event|1|||
105848727|NCT03321630|365105079|FG000|Overall Study|Investigator Discretion|2|||
105848728|NCT03321630|365105079|FG000|Overall Study|Withdrawal by Subject|1|||
105848729|NCT00950963|365105080|FG000|Overall Study|Lost to Follow-up|29|||
105848730|NCT00950963|365105081|FG001|Overall Study|Lost to Follow-up|24|||
105848731|NCT01070771|365105082|FG000|Overall Study|Adverse Event|2|||
105848732|NCT01070771|365105082|FG000|Overall Study|Protocol Violation|1|||
105848733|NCT00302081|365105086|FG000|Overall Study|Adverse Event|6|||
105848734|NCT00302081|365105087|FG001|Overall Study|Adverse Event|5|||
105848735|NCT00302081|365105088|FG002|Overall Study|Adverse Event|4|||
105848736|NCT00302081|365105086|FG000|Overall Study|Lost to Follow-up|21|||
105848737|NCT00302081|365105087|FG001|Overall Study|Lost to Follow-up|18|||
105848738|NCT00302081|365105088|FG002|Overall Study|Lost to Follow-up|28|||
105848739|NCT00302081|365105086|FG000|Overall Study|Withdrawal by Subject|8|||
105848740|NCT00302081|365105087|FG001|Overall Study|Withdrawal by Subject|12|||
105848741|NCT00302081|365105088|FG002|Overall Study|Withdrawal by Subject|8|||
105848742|NCT00302081|365105086|FG000|Overall Study|Protocol Violation|5|||
105848743|NCT00302081|365105087|FG001|Overall Study|Protocol Violation|1|||
105848744|NCT00302081|365105088|FG002|Overall Study|Protocol Violation|2|||
105848745|NCT00302081|365105086|FG000|Overall Study|Lack of Efficacy|1|||
105848746|NCT00302081|365105087|FG001|Overall Study|Lack of Efficacy|0|||
105848747|NCT00302081|365105088|FG002|Overall Study|Lack of Efficacy|5|||
105848748|NCT00302081|365105086|FG000|Overall Study|Death|2|||
105848749|NCT00302081|365105087|FG001|Overall Study|Death|1|||
105848750|NCT00302081|365105088|FG002|Overall Study|Death|0|||
105848751|NCT00302081|365105086|FG000|Overall Study|Other|13|||
105848752|NCT00302081|365105087|FG001|Overall Study|Other|6|||
105848753|NCT00302081|365105088|FG002|Overall Study|Other|5|||
105848754|NCT01394952|365105089|FG000|Overall Study|Lost to Follow-up|0|||
105848755|NCT01394952|365105090|FG001|Overall Study|Lost to Follow-up|5|||
105848756|NCT01394952|365105089|FG000|Overall Study|Withdrawal by Subject|10|||
105848757|NCT01394952|365105090|FG001|Overall Study|Withdrawal by Subject|5|||
105848758|NCT01394952|365105089|FG000|Overall Study|Physician Decision|2|||
105848759|NCT01394952|365105090|FG001|Overall Study|Physician Decision|0|||
105848760|NCT01394952|365105089|FG000|Overall Study|Sponsor Decision|5|||
105848761|NCT01394952|365105090|FG001|Overall Study|Sponsor Decision|7|||
105368983|NCT01774981|363356348|FG003|Overall Study|Death|0|||
105368984|NCT01774981|363356349|FG004|Overall Study|Death|1|||
105368985|NCT01774981|363356350|FG005|Overall Study|Death|0|||
105368986|NCT01774981|363356351|FG006|Overall Study|Death|0|||
105368987|NCT01774981|363356352|FG007|Overall Study|Death|0|||
105368988|NCT01324102|363356353|FG000|Overall Study|illness|1|||
105368989|NCT01324102|363356354|FG001|Overall Study|illness|6|||
105368990|NCT00386334|363356355|FG000|Double Blind Period|Adverse Event|9|||
105368991|NCT00386334|363356356|FG001|Double Blind Period|Adverse Event|14|||
105368992|NCT00386334|363356355|FG000|Double Blind Period|Protocol Violation|1|||
105368993|NCT00386334|363356356|FG001|Double Blind Period|Protocol Violation|1|||
105368994|NCT00386334|363356355|FG000|Double Blind Period|Withdrawal by Subject|9|||
105368995|NCT00386334|363356356|FG001|Double Blind Period|Withdrawal by Subject|13|||
105368996|NCT00386334|363356355|FG000|Double Blind Period|Lack of Efficacy|20|||
105368997|NCT00386334|363356356|FG001|Double Blind Period|Lack of Efficacy|11|||
105368998|NCT00386334|363356355|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
105368999|NCT00386334|363356356|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
105369000|NCT00386334|363356355|FG000|Double Blind Period|Other|3|||
105369001|NCT00386334|363356356|FG001|Double Blind Period|Other|3|||
105369002|NCT00386334|363356355|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
105369003|NCT00386334|363356356|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
105369004|NCT00902577|363356357|FG000|Overall Study|Withdrawal by Subject|6|||
105369005|NCT00902577|363356357|FG000|Overall Study|FMISO production failure|2|||
105369006|NCT03322293|363356358|FG000|Overall Study|Lost to Follow-up|0|||
105369007|NCT03322293|363356359|FG001|Overall Study|Lost to Follow-up|0|||
105369008|NCT03322293|363356360|FG002|Overall Study|Lost to Follow-up|1|||
105369009|NCT03712280|363356361|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
105369010|NCT03712280|363356362|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
105369011|NCT03712280|363356363|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
105369012|NCT03712280|363356364|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
105369013|NCT03712280|363356361|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
105369014|NCT03712280|363356362|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
105369015|NCT03712280|363356363|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
105369016|NCT03712280|363356364|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
105369017|NCT03712280|363356361|FG000|Overall Study|Adverse Event|0|||
105369018|NCT03712280|363356362|FG001|Overall Study|Adverse Event|0|||
105369019|NCT03712280|363356363|FG002|Overall Study|Adverse Event|1|||
105369020|NCT03712280|363356364|FG003|Overall Study|Adverse Event|0|||
105369021|NCT02914834|363356365|FG000|Overall Study|Study halted due to COVID|1|||
105369022|NCT02914834|363356366|FG001|Overall Study|Study halted due to COVID|1|||
105369023|NCT02914834|363356365|FG000|Overall Study|1 subject withdrew|0|||
105369024|NCT02914834|363356366|FG001|Overall Study|1 subject withdrew|1|||
105369025|NCT02631941|363356367|FG000|Overall Study|Physician Decision|0|||
105369026|NCT02631941|363356368|FG001|Overall Study|Physician Decision|1|||
105369027|NCT02631941|363356369|FG002|Overall Study|Physician Decision|0|||
105369028|NCT02631941|363356370|FG003|Overall Study|Physician Decision|0|||
105369029|NCT02631941|363356371|FG004|Overall Study|Physician Decision|0|||
105369030|NCT02631941|363356372|FG005|Overall Study|Physician Decision|0|||
105369031|NCT02631941|363356373|FG006|Overall Study|Physician Decision|0|||
105369032|NCT02631941|363356374|FG007|Overall Study|Physician Decision|0|||
105369033|NCT02631941|363356375|FG008|Overall Study|Physician Decision|0|||
105369034|NCT02631941|363356376|FG009|Overall Study|Physician Decision|0|||
105369035|NCT02631941|363356367|FG000|Overall Study|Adverse Event|0|||
105369036|NCT02631941|363356368|FG001|Overall Study|Adverse Event|1|||
105369037|NCT02631941|363356369|FG002|Overall Study|Adverse Event|0|||
105369038|NCT02631941|363356370|FG003|Overall Study|Adverse Event|0|||
105369039|NCT02631941|363356371|FG004|Overall Study|Adverse Event|0|||
105369040|NCT02631941|363356372|FG005|Overall Study|Adverse Event|0|||
105369041|NCT02631941|363356373|FG006|Overall Study|Adverse Event|0|||
105369042|NCT02631941|363356374|FG007|Overall Study|Adverse Event|0|||
105369043|NCT02631941|363356375|FG008|Overall Study|Adverse Event|0|||
105369044|NCT02631941|363356376|FG009|Overall Study|Adverse Event|0|||
105369045|NCT02631941|363356367|FG000|Overall Study|Withdrawal by Subject|0|||
105369046|NCT02631941|363356368|FG001|Overall Study|Withdrawal by Subject|0|||
105848762|NCT03276221|365105093|FG000|Overall Study|Lost to Follow-up|6|||
105369047|NCT02631941|363356369|FG002|Overall Study|Withdrawal by Subject|0|||
105369048|NCT02631941|363356370|FG003|Overall Study|Withdrawal by Subject|0|||
105369049|NCT02631941|363356371|FG004|Overall Study|Withdrawal by Subject|1|||
105369050|NCT02631941|363356372|FG005|Overall Study|Withdrawal by Subject|0|||
105369051|NCT02631941|363356373|FG006|Overall Study|Withdrawal by Subject|0|||
105369052|NCT02631941|363356374|FG007|Overall Study|Withdrawal by Subject|1|||
105369053|NCT02631941|363356375|FG008|Overall Study|Withdrawal by Subject|0|||
105369054|NCT02631941|363356376|FG009|Overall Study|Withdrawal by Subject|0|||
105369055|NCT02631941|363356367|FG000|Overall Study|Lost to Follow-up|0|||
105369056|NCT02631941|363356368|FG001|Overall Study|Lost to Follow-up|0|||
105369057|NCT02631941|363356369|FG002|Overall Study|Lost to Follow-up|0|||
105369058|NCT02631941|363356370|FG003|Overall Study|Lost to Follow-up|0|||
105317428|NCT03685344|363158626|FG000|Overall Study|Death|1|||
105317429|NCT03685344|363158627|FG001|Overall Study|Death|1|||
105317430|NCT03685344|363158628|FG002|Overall Study|Death|0|||
105317431|NCT03685344|363158629|FG003|Overall Study|Death|0|||
105317432|NCT00261950|363158639|FG000|Overall Study|Lost to Follow-up|2|||
105317433|NCT00261950|363158639|FG000|Overall Study|Death|6|||
105317434|NCT00261950|363158639|FG000|Overall Study|Withdrawal by Subject|5|||
105317435|NCT00261950|363158639|FG000|Overall Study|Other|1|||
105317436|NCT00261950|363158639|FG000|Overall Study|Physician Decision|1|||
105317437|NCT00261950|363158639|FG000|Overall Study|Protocol specified Criteria|11|||
105317438|NCT00810511|363158644|FG000|Overall Study|Protocol Violation|0|||
105317439|NCT00810511|363158645|FG001|Overall Study|Protocol Violation|1|||
105317440|NCT00810511|363158644|FG000|Overall Study|Lack of Efficacy|9|||
105317441|NCT00810511|363158645|FG001|Overall Study|Lack of Efficacy|1|||
105317442|NCT00810511|363158644|FG000|Overall Study|death in the family|0|||
105317443|NCT00810511|363158645|FG001|Overall Study|death in the family|1|||
105317444|NCT00810511|363158644|FG000|Overall Study|Lost to Follow-up|1|||
105317445|NCT00810511|363158645|FG001|Overall Study|Lost to Follow-up|0|||
105317446|NCT00810511|363158644|FG000|Overall Study|deposits on contact lens|0|||
105317447|NCT00810511|363158645|FG001|Overall Study|deposits on contact lens|1|||
105317448|NCT00462904|363158646|FG000|Overall Study|Lost to Follow-up|1|||
105317449|NCT00652340|363158647|FG000|Overall Study|Had not progressed.|4|||
105317450|NCT00652340|363158648|FG001|Overall Study|Had not progressed.|3|||
105317451|NCT04138823|363158654|FG000|Overall Study|Clinical disease progression|0|||
105317452|NCT04138823|363158655|FG001|Overall Study|Clinical disease progression|0|||
105317453|NCT04138823|363158656|FG002|Overall Study|Clinical disease progression|1|||
105317454|NCT04138823|363158654|FG000|Overall Study|Objective disease progression|3|||
105317455|NCT04138823|363158655|FG001|Overall Study|Objective disease progression|2|||
105317456|NCT04138823|363158656|FG002|Overall Study|Objective disease progression|5|||
105369059|NCT02631941|363356371|FG004|Overall Study|Lost to Follow-up|0|||
105369060|NCT02631941|363356372|FG005|Overall Study|Lost to Follow-up|0|||
105369061|NCT02631941|363356373|FG006|Overall Study|Lost to Follow-up|0|||
105369062|NCT02631941|363356374|FG007|Overall Study|Lost to Follow-up|0|||
105369063|NCT02631941|363356375|FG008|Overall Study|Lost to Follow-up|1|||
105369064|NCT02631941|363356376|FG009|Overall Study|Lost to Follow-up|0|||
105369065|NCT02732639|363356382|FG000|Overall Study|Lost to Follow-up|1|||
105369066|NCT02133508|363356383|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
105369067|NCT02133508|363356383|FG000|Overall Study|Death|12|||
105369068|NCT02133508|363356383|FG000|Overall Study|Lost to Follow-up|2|||
105369069|NCT01159574|363356385|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
105369070|NCT01159574|363356385|FG000|Treatment Phase|Adverse Event|3|||
105369071|NCT01159574|363356385|FG000|Treatment Phase|Death|6|||
105369072|NCT01159574|363356385|FG000|Treatment Phase|Physician Decision|2|||
105369073|NCT01159574|363356385|FG000|Treatment Phase|Withdrawal by Subject|7|||
105369074|NCT01159574|363356385|FG000|Treatment Phase|still on treatment|2|||
105369075|NCT01159574|363356385|FG000|Follow Up Phase|Lost to Follow-up|2|||
105369076|NCT01159574|363356385|FG000|Follow Up Phase|still being followed for overall surviva|18|||
105369077|NCT03167242|363356388|FG000|Overall Study|Patient/Guardian Decision|0|||
105369078|NCT03167242|363356389|FG001|Overall Study|Patient/Guardian Decision|1|||
105369079|NCT03167242|363356390|FG002|Overall Study|Patient/Guardian Decision|2|||
105369080|NCT03167242|363356391|FG003|Overall Study|Patient/Guardian Decision|1|||
105369081|NCT03167242|363356392|FG004|Overall Study|Patient/Guardian Decision|1|||
105369082|NCT03167242|363356393|FG005|Overall Study|Patient/Guardian Decision|1|||
105576758|NCT02258464|364110316|FG000|Overall Study|AE not related to clinical PD|1|||
105576759|NCT02258464|364110317|FG001|Overall Study|AE not related to clinical PD|3|||
105576760|NCT02258464|364110316|FG000|Overall Study|Withdrawal by Subject|5|||
105576761|NCT02258464|364110317|FG001|Overall Study|Withdrawal by Subject|4|||
105576762|NCT02258464|364110316|FG000|Overall Study|AE related to clinical PD|1|||
105576763|NCT02258464|364110317|FG001|Overall Study|AE related to clinical PD|0|||
105317457|NCT01128543|363158662|FG000|Overall Study|Withdrawal by Subject|3|||
105369083|NCT03167242|363356394|FG006|Overall Study|Patient/Guardian Decision|0|||
105369084|NCT03167242|363356395|FG007|Overall Study|Patient/Guardian Decision|0|||
105317458|NCT01128543|363158662|FG000|Overall Study|Protocol Violation|1|||
105369085|NCT03167242|363356396|FG008|Overall Study|Patient/Guardian Decision|0|||
105369086|NCT03167242|363356397|FG009|Overall Study|Patient/Guardian Decision|0|||
105369087|NCT03167242|363356398|FG010|Overall Study|Patient/Guardian Decision|1|||
105369088|NCT03167242|363356399|FG011|Overall Study|Patient/Guardian Decision|0|||
105317459|NCT02565511|363158663|FG000|Overall Study|Study terminated by Sponsor|35|||
105317460|NCT02565511|363158664|FG001|Overall Study|Study terminated by Sponsor|22|||
105369089|NCT03167242|363356388|FG000|Overall Study|Lost to Follow-up|0|||
105317461|NCT02565511|363158665|FG002|Overall Study|Study terminated by Sponsor|235|||
105317462|NCT02565511|363158666|FG003|Overall Study|Study terminated by Sponsor|156|||
105317463|NCT02565511|363158663|FG000|Overall Study|Withdrawal by Subject|3|||
105369090|NCT03167242|363356389|FG001|Overall Study|Lost to Follow-up|0|||
105369091|NCT03167242|363356390|FG002|Overall Study|Lost to Follow-up|1|||
105369092|NCT03167242|363356391|FG003|Overall Study|Lost to Follow-up|0|||
105317464|NCT02565511|363158664|FG001|Overall Study|Withdrawal by Subject|0|||
105317465|NCT02565511|363158665|FG002|Overall Study|Withdrawal by Subject|12|||
105317466|NCT02565511|363158666|FG003|Overall Study|Withdrawal by Subject|5|||
105317467|NCT02565511|363158663|FG000|Overall Study|Adverse Event|0|||
105317468|NCT02565511|363158664|FG001|Overall Study|Adverse Event|0|||
105317469|NCT02565511|363158665|FG002|Overall Study|Adverse Event|1|||
105317470|NCT02565511|363158666|FG003|Overall Study|Adverse Event|1|||
105317471|NCT02565511|363158663|FG000|Overall Study|Lost to Follow-up|4|||
105317472|NCT02565511|363158664|FG001|Overall Study|Lost to Follow-up|1|||
105317473|NCT02565511|363158665|FG002|Overall Study|Lost to Follow-up|0|||
105317474|NCT02565511|363158666|FG003|Overall Study|Lost to Follow-up|1|||
105317475|NCT02565511|363158663|FG000|Overall Study|Physician Decision|0|||
105317476|NCT02565511|363158664|FG001|Overall Study|Physician Decision|0|||
105317477|NCT02565511|363158665|FG002|Overall Study|Physician Decision|0|||
105317478|NCT02565511|363158666|FG003|Overall Study|Physician Decision|1|||
105317479|NCT02565511|363158663|FG000|Overall Study|Protocol deviation|0|||
105317480|NCT02565511|363158664|FG001|Overall Study|Protocol deviation|0|||
105317481|NCT02565511|363158665|FG002|Overall Study|Protocol deviation|3|||
105317482|NCT02565511|363158666|FG003|Overall Study|Protocol deviation|0|||
105317483|NCT03097991|363158667|FG000|Overall Study|Didn't meet study criteria|8|||
105317484|NCT03097991|363158668|FG001|Overall Study|Didn't meet study criteria|0|||
105317485|NCT03097991|363158667|FG000|Overall Study|Withdrawal by Subject|12|||
105317486|NCT03097991|363158668|FG001|Overall Study|Withdrawal by Subject|6|||
105317487|NCT03097991|363158667|FG000|Overall Study|Death of Baby|3|||
105317488|NCT03097991|363158668|FG001|Overall Study|Death of Baby|1|||
105317489|NCT03097991|363158667|FG000|Overall Study|Lost to Follow-up|24|||
105317490|NCT03097991|363158668|FG001|Overall Study|Lost to Follow-up|38|||
105317491|NCT03097991|363158667|FG000|Overall Study|Adverse Event|3|||
105317492|NCT03097991|363158668|FG001|Overall Study|Adverse Event|5|||
105317493|NCT01755091|363158669|FG000|Overall Study|Withdrawal by Subject|6|||
105317494|NCT01755091|363158670|FG001|Overall Study|Withdrawal by Subject|1|||
105317495|NCT01755091|363158671|FG002|Overall Study|Withdrawal by Subject|3|||
105317496|NCT01755091|363158669|FG000|Overall Study|Adverse Event|1|||
105317497|NCT01755091|363158670|FG001|Overall Study|Adverse Event|1|||
105317498|NCT01755091|363158671|FG002|Overall Study|Adverse Event|1|||
105317499|NCT01755091|363158669|FG000|Overall Study|Lost to Follow-up|1|||
105317500|NCT01755091|363158670|FG001|Overall Study|Lost to Follow-up|0|||
105317501|NCT01755091|363158671|FG002|Overall Study|Lost to Follow-up|1|||
105317502|NCT01755091|363158669|FG000|Overall Study|Physician Decision|1|||
105317503|NCT01755091|363158670|FG001|Overall Study|Physician Decision|1|||
105317504|NCT01755091|363158671|FG002|Overall Study|Physician Decision|2|||
105317505|NCT03516513|363158672|FG000|Overall Study|Withdrawal by Subject|2|||
105317506|NCT03516513|363158673|FG001|Overall Study|Withdrawal by Subject|2|||
105317507|NCT03516513|363158674|FG002|Overall Study|Withdrawal by Subject|0|||
105317508|NCT03516513|363158675|FG003|Overall Study|Withdrawal by Subject|0|||
105317509|NCT01130597|363158676|FG000|Overall Study|Protocol-specified (High K+)|1|||
105317510|NCT01130597|363158676|FG000|Overall Study|Adverse Event|4|||
105317511|NCT01130597|363158676|FG000|Overall Study|Death|1|||
105317512|NCT01130597|363158676|FG000|Overall Study|Protocol Violation|1|||
105317513|NCT03071276|363158677|FG000|Overall Study|Adverse Event|1|||
105317514|NCT03071276|363158677|FG000|Overall Study|Lack of Efficacy|14|||
105317515|NCT00952731|363158683|FG000|Overall Study|Drug supply expired|1|||
105317516|NCT00952731|363158684|FG001|Overall Study|Drug supply expired|0|||
105317517|NCT04895982|363158685|FG000|Overall Study|Withdrawal by Subject|0|||
105317518|NCT04895982|363158686|FG001|Overall Study|Withdrawal by Subject|0|||
105317519|NCT04895982|363158687|FG002|Overall Study|Withdrawal by Subject|0|||
105317520|NCT04895982|363158688|FG003|Overall Study|Withdrawal by Subject|0|||
105317521|NCT04895982|363158689|FG004|Overall Study|Withdrawal by Subject|0|||
105317522|NCT04895982|363158690|FG005|Overall Study|Withdrawal by Subject|1|||
105317523|NCT04895982|363158691|FG006|Overall Study|Withdrawal by Subject|1|||
105369093|NCT03167242|363356392|FG004|Overall Study|Lost to Follow-up|0|||
105369094|NCT03167242|363356393|FG005|Overall Study|Lost to Follow-up|1|||
105369095|NCT03167242|363356394|FG006|Overall Study|Lost to Follow-up|2|||
105369096|NCT03167242|363356395|FG007|Overall Study|Lost to Follow-up|1|||
105317524|NCT04895982|363158692|FG007|Overall Study|Withdrawal by Subject|0|||
105317525|NCT04895982|363158693|FG008|Overall Study|Withdrawal by Subject|0|||
105369097|NCT03167242|363356396|FG008|Overall Study|Lost to Follow-up|0|||
105317526|NCT04895982|363158694|FG009|Overall Study|Withdrawal by Subject|1|||
105317527|NCT04895982|363158695|FG010|Overall Study|Withdrawal by Subject|0|||
105317528|NCT04895982|363158696|FG011|Overall Study|Withdrawal by Subject|1|||
105317529|NCT04895982|363158685|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105317530|NCT04895982|363158686|FG001|Overall Study|Withdrawal by parent/guardian|3|||
105369098|NCT03167242|363356397|FG009|Overall Study|Lost to Follow-up|0|||
105317531|NCT04895982|363158687|FG002|Overall Study|Withdrawal by parent/guardian|3|||
105317532|NCT04895982|363158688|FG003|Overall Study|Withdrawal by parent/guardian|1|||
105317533|NCT04895982|363158689|FG004|Overall Study|Withdrawal by parent/guardian|3|||
105317534|NCT04895982|363158690|FG005|Overall Study|Withdrawal by parent/guardian|2|||
105317535|NCT04895982|363158691|FG006|Overall Study|Withdrawal by parent/guardian|1|||
105369099|NCT03167242|363356398|FG010|Overall Study|Lost to Follow-up|1|||
105490688|NCT00478881|363809401|FG000|Overall Study|Lost to Follow-up|0|||
105490689|NCT00478881|363809402|FG001|Overall Study|Lost to Follow-up|1|||
105490690|NCT00478881|363809401|FG000|Overall Study|Protocol Violation|2|||
105490691|NCT00478881|363809402|FG001|Overall Study|Protocol Violation|2|||
105490692|NCT00478881|363809401|FG000|Overall Study|Withdrawal by Subject|6|||
105490693|NCT00478881|363809402|FG001|Overall Study|Withdrawal by Subject|2|||
105490694|NCT00478881|363809401|FG000|Overall Study|Non-Compliance with Study Medication|0|||
105490695|NCT00478881|363809402|FG001|Overall Study|Non-Compliance with Study Medication|2|||
105490696|NCT00721123|363809403|FG000|Overall Study|Adverse Event|96|||
105490697|NCT00721123|363809403|FG000|Overall Study|Death|10|||
105490698|NCT00721123|363809403|FG000|Overall Study|Insufficient Therapeutic Response|21|||
105490699|NCT00721123|363809403|FG000|Overall Study|Protocol Violation|1|||
105490700|NCT00721123|363809403|FG000|Overall Study|Refused Treatment|41|||
105490701|NCT00721123|363809403|FG000|Overall Study|Failure to Return|9|||
105490702|NCT00721123|363809403|FG000|Overall Study|Withdrawal by Subject|5|||
105490703|NCT03954041|363809407|FG000|Overall Study|Lost to Follow-up|3|||
105490704|NCT03954041|363809408|FG001|Overall Study|Lost to Follow-up|3|||
105490705|NCT03954041|363809409|FG002|Overall Study|Lost to Follow-up|6|||
105490706|NCT03954041|363809407|FG000|Overall Study|Death|4|||
105490707|NCT03954041|363809408|FG001|Overall Study|Death|0|||
105490708|NCT03954041|363809409|FG002|Overall Study|Death|1|||
105490709|NCT03954041|363809407|FG000|Overall Study|Death by neurologic criteria|0|||
105490710|NCT03954041|363809408|FG001|Overall Study|Death by neurologic criteria|0|||
105490711|NCT03954041|363809409|FG002|Overall Study|Death by neurologic criteria|1|||
105490712|NCT03954041|363809407|FG000|Overall Study|Reason not specified|7|||
105490713|NCT03954041|363809408|FG001|Overall Study|Reason not specified|4|||
105490714|NCT03954041|363809409|FG002|Overall Study|Reason not specified|2|||
105490715|NCT03954041|363809407|FG000|Overall Study|Withdrew prior to dosing|4|||
105490716|NCT03954041|363809408|FG001|Overall Study|Withdrew prior to dosing|2|||
105490717|NCT03954041|363809409|FG002|Overall Study|Withdrew prior to dosing|0|||
105490718|NCT03468985|363809410|FG000|Overall Study|Adverse Event|0|||
105490719|NCT03468985|363809411|FG001|Overall Study|Adverse Event|2|||
105490720|NCT03468985|363809412|FG002|Overall Study|Adverse Event|0|||
105490721|NCT03468985|363809413|FG003|Overall Study|Adverse Event|0|||
105490722|NCT03468985|363809410|FG000|Overall Study|Withdrawal by Subject|0|||
105490723|NCT03468985|363809411|FG001|Overall Study|Withdrawal by Subject|0|||
105490724|NCT03468985|363809412|FG002|Overall Study|Withdrawal by Subject|0|||
105490725|NCT03468985|363809413|FG003|Overall Study|Withdrawal by Subject|1|||
105490726|NCT01315236|363809414|FG000|Double-blind Phase|Death|1|||
105490727|NCT01315236|363809415|FG001|Double-blind Phase|Death|0|||
105490728|NCT01315236|363809414|FG000|Double-blind Phase|Adverse Event|1|||
105490729|NCT01315236|363809415|FG001|Double-blind Phase|Adverse Event|0|||
105490730|NCT01315236|363809414|FG000|Double-blind Phase|Withdrawal of Consent|1|||
105490731|NCT01315236|363809415|FG001|Double-blind Phase|Withdrawal of Consent|0|||
105490732|NCT01315236|363809414|FG000|Double-blind Phase|Lost to Follow-up|1|||
105490733|NCT01315236|363809415|FG001|Double-blind Phase|Lost to Follow-up|0|||
105576764|NCT02337478|364110318|FG000|Overall Study|Lack of Efficacy|5|||
105317536|NCT04895982|363158692|FG007|Overall Study|Withdrawal by parent/guardian|0|||
105317537|NCT04895982|363158693|FG008|Overall Study|Withdrawal by parent/guardian|3|||
105317538|NCT04895982|363158694|FG009|Overall Study|Withdrawal by parent/guardian|0|||
105317539|NCT04895982|363158695|FG010|Overall Study|Withdrawal by parent/guardian|0|||
105317540|NCT04895982|363158696|FG011|Overall Study|Withdrawal by parent/guardian|0|||
105317541|NCT04895982|363158685|FG000|Overall Study|Other|0|||
105317542|NCT04895982|363158686|FG001|Overall Study|Other|0|||
105317543|NCT04895982|363158687|FG002|Overall Study|Other|1|||
105317544|NCT04895982|363158688|FG003|Overall Study|Other|1|||
105317545|NCT04895982|363158689|FG004|Overall Study|Other|0|||
105317546|NCT04895982|363158690|FG005|Overall Study|Other|0|||
105317547|NCT04895982|363158691|FG006|Overall Study|Other|0|||
105317548|NCT04895982|363158692|FG007|Overall Study|Other|0|||
105317549|NCT04895982|363158693|FG008|Overall Study|Other|0|||
105490734|NCT01315236|363809414|FG000|Open-label Phase|Death|1|||
105490735|NCT01315236|363809415|FG001|Open-label Phase|Death|0|||
105490736|NCT01315236|363809414|FG000|Open-label Phase|Adverse Event|0|||
105490737|NCT01315236|363809415|FG001|Open-label Phase|Adverse Event|1|||
105490738|NCT01315236|363809414|FG000|Open-label Phase|Other|0|||
105317550|NCT04895982|363158694|FG009|Overall Study|Other|1|||
105317551|NCT04895982|363158695|FG010|Overall Study|Other|0|||
105317552|NCT04895982|363158696|FG011|Overall Study|Other|0|||
105317553|NCT04895982|363158685|FG000|Overall Study|Protocol Violation|0|||
105317554|NCT04895982|363158686|FG001|Overall Study|Protocol Violation|0|||
105490739|NCT01315236|363809415|FG001|Open-label Phase|Other|1|||
105490740|NCT01315236|363809414|FG000|12-Month Follow-up Period|Death|0|||
105490741|NCT01315236|363809415|FG001|12-Month Follow-up Period|Death|1|||
105490742|NCT01315236|363809414|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
105490743|NCT01315236|363809415|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
105490744|NCT00423670|363809417|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
105490745|NCT00423670|363809418|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
105317555|NCT04895982|363158687|FG002|Overall Study|Protocol Violation|1|||
105848763|NCT03276221|365105094|FG001|Overall Study|Lost to Follow-up|2|||
105848764|NCT03276221|365105095|FG002|Overall Study|Lost to Follow-up|0|||
105848765|NCT03276221|365105093|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
105848766|NCT03276221|365105094|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
105848767|NCT03276221|365105095|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
105848768|NCT04700280|365105099|FG000|Overall Study|Adverse Event|4|||
105317556|NCT04895982|363158688|FG003|Overall Study|Protocol Violation|1|||
105317557|NCT04895982|363158689|FG004|Overall Study|Protocol Violation|1|||
105317558|NCT04895982|363158690|FG005|Overall Study|Protocol Violation|0|||
105317559|NCT04895982|363158691|FG006|Overall Study|Protocol Violation|0|||
105317560|NCT04895982|363158692|FG007|Overall Study|Protocol Violation|1|||
105317561|NCT04895982|363158693|FG008|Overall Study|Protocol Violation|0|||
105317562|NCT04895982|363158694|FG009|Overall Study|Protocol Violation|0|||
105317563|NCT04895982|363158695|FG010|Overall Study|Protocol Violation|0|||
105317564|NCT04895982|363158696|FG011|Overall Study|Protocol Violation|0|||
105317565|NCT04895982|363158685|FG000|Overall Study|Lost to Follow-up|0|||
105317566|NCT04895982|363158686|FG001|Overall Study|Lost to Follow-up|0|||
105317567|NCT04895982|363158687|FG002|Overall Study|Lost to Follow-up|1|||
105317568|NCT04895982|363158688|FG003|Overall Study|Lost to Follow-up|0|||
105317569|NCT04895982|363158689|FG004|Overall Study|Lost to Follow-up|0|||
105317570|NCT04895982|363158690|FG005|Overall Study|Lost to Follow-up|1|||
105317571|NCT04895982|363158691|FG006|Overall Study|Lost to Follow-up|0|||
105317572|NCT04895982|363158692|FG007|Overall Study|Lost to Follow-up|0|||
105317573|NCT04895982|363158693|FG008|Overall Study|Lost to Follow-up|1|||
105317574|NCT04895982|363158694|FG009|Overall Study|Lost to Follow-up|0|||
105317575|NCT04895982|363158695|FG010|Overall Study|Lost to Follow-up|0|||
105317576|NCT04895982|363158696|FG011|Overall Study|Lost to Follow-up|0|||
105317577|NCT04895982|363158685|FG000|Overall Study|Refused further study procedures|0|||
105317578|NCT04895982|363158686|FG001|Overall Study|Refused further study procedures|0|||
105317579|NCT04895982|363158687|FG002|Overall Study|Refused further study procedures|1|||
105317580|NCT04895982|363158688|FG003|Overall Study|Refused further study procedures|0|||
105317581|NCT04895982|363158689|FG004|Overall Study|Refused further study procedures|0|||
105848769|NCT04700280|365105100|FG001|Overall Study|Adverse Event|0|||
105848770|NCT04700280|365105099|FG000|Overall Study|Lack of Efficacy|1|||
105317582|NCT04895982|363158690|FG005|Overall Study|Refused further study procedures|0|||
105317583|NCT04895982|363158691|FG006|Overall Study|Refused further study procedures|0|||
105317584|NCT04895982|363158692|FG007|Overall Study|Refused further study procedures|0|||
105317585|NCT04895982|363158693|FG008|Overall Study|Refused further study procedures|0|||
105317586|NCT04895982|363158694|FG009|Overall Study|Refused further study procedures|0|||
105317587|NCT04895982|363158695|FG010|Overall Study|Refused further study procedures|0|||
105317588|NCT04895982|363158696|FG011|Overall Study|Refused further study procedures|0|||
105317589|NCT01866098|363158701|FG000|Overall Study|Lost to Follow-up|11|||
105317590|NCT01866098|363158702|FG001|Overall Study|Lost to Follow-up|18|||
105317591|NCT01866098|363158703|FG002|Overall Study|Lost to Follow-up|13|||
105317592|NCT01866098|363158701|FG000|Overall Study|Physician Decision|0|||
105317593|NCT01866098|363158702|FG001|Overall Study|Physician Decision|1|||
105317594|NCT01866098|363158703|FG002|Overall Study|Physician Decision|2|||
105317595|NCT01866098|363158701|FG000|Overall Study|Adverse Event|1|||
105317596|NCT01866098|363158702|FG001|Overall Study|Adverse Event|5|||
105317597|NCT01866098|363158703|FG002|Overall Study|Adverse Event|4|||
105317598|NCT01866098|363158701|FG000|Overall Study|Protocol Violation|1|||
105317599|NCT01866098|363158702|FG001|Overall Study|Protocol Violation|0|||
105317600|NCT01866098|363158703|FG002|Overall Study|Protocol Violation|0|||
105317601|NCT01866098|363158701|FG000|Overall Study|Withdrawal by Subject|1|||
105317602|NCT01866098|363158702|FG001|Overall Study|Withdrawal by Subject|2|||
105317603|NCT01866098|363158703|FG002|Overall Study|Withdrawal by Subject|0|||
105317604|NCT01866098|363158701|FG000|Overall Study|Unrelated Hospitalization|2|||
105317605|NCT01866098|363158702|FG001|Overall Study|Unrelated Hospitalization|0|||
105317606|NCT01866098|363158703|FG002|Overall Study|Unrelated Hospitalization|1|||
105848771|NCT04700280|365105100|FG001|Overall Study|Lack of Efficacy|0|||
105848772|NCT04700280|365105099|FG000|Overall Study|Study terminated by sponsor|5|||
105317607|NCT01866098|363158701|FG000|Overall Study|Non-compliance|1|||
105317608|NCT01866098|363158702|FG001|Overall Study|Non-compliance|0|||
105317609|NCT01866098|363158703|FG002|Overall Study|Non-compliance|1|||
105317610|NCT01866098|363158701|FG000|Overall Study|Pregnancy|2|||
105317611|NCT01866098|363158702|FG001|Overall Study|Pregnancy|0|||
105317612|NCT01866098|363158703|FG002|Overall Study|Pregnancy|0|||
105317613|NCT01866098|363158701|FG000|Overall Study|Death|0|||
105317614|NCT01866098|363158702|FG001|Overall Study|Death|1|||
105317615|NCT01866098|363158703|FG002|Overall Study|Death|0|||
105848773|NCT04700280|365105100|FG001|Overall Study|Study terminated by sponsor|3|||
105848774|NCT04700280|365105099|FG000|Overall Study|Other than specified|1|||
105317616|NCT04239027|363158704|FG000|Overall Study|Adverse Event|4|||
105317617|NCT04239027|363158704|FG000|Overall Study|Withdrawal by Subject|9|||
105317618|NCT04239027|363158704|FG000|Overall Study|Death|1|||
105317619|NCT04239027|363158704|FG000|Overall Study|Physician Decision|9|||
105317620|NCT04239027|363158704|FG000|Overall Study|Lost to Follow-up|2|||
105848775|NCT04700280|365105100|FG001|Overall Study|Other than specified|0|||
105317621|NCT04239027|363158704|FG000|Overall Study|Lack of Efficacy|1|||
105317622|NCT04803305|363158707|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
105317623|NCT04803305|363158708|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
105317624|NCT04803305|363158707|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
105317625|NCT04803305|363158708|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
105317626|NCT04803305|363158707|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
105317627|NCT04803305|363158708|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
105317628|NCT04803305|363158707|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
105317629|NCT04803305|363158708|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
105317630|NCT04803305|363158707|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
105317631|NCT04803305|363158708|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
105317632|NCT04803305|363158707|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
105317633|NCT04803305|363158708|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
105369100|NCT03167242|363356399|FG011|Overall Study|Lost to Follow-up|1|||
105369101|NCT03167242|363356388|FG000|Overall Study|Reason not provided|0|||
105369102|NCT03167242|363356389|FG001|Overall Study|Reason not provided|0|||
105369103|NCT03167242|363356390|FG002|Overall Study|Reason not provided|0|||
105369104|NCT03167242|363356391|FG003|Overall Study|Reason not provided|0|||
105369105|NCT03167242|363356392|FG004|Overall Study|Reason not provided|0|||
105369106|NCT03167242|363356393|FG005|Overall Study|Reason not provided|0|||
105369107|NCT03167242|363356394|FG006|Overall Study|Reason not provided|0|||
105369108|NCT03167242|363356395|FG007|Overall Study|Reason not provided|0|||
105369109|NCT03167242|363356396|FG008|Overall Study|Reason not provided|1|||
105369110|NCT03167242|363356397|FG009|Overall Study|Reason not provided|0|||
105369111|NCT03167242|363356398|FG010|Overall Study|Reason not provided|0|||
105369112|NCT03167242|363356399|FG011|Overall Study|Reason not provided|0|||
105369113|NCT01791985|363356405|FG000|Overall Study|Adverse Event|7|||
105369114|NCT01791985|363356405|FG000|Overall Study|Withdrawal by Subject|1|||
105369115|NCT01687218|363356410|FG000|Overall Study|Withdrawal by Subject|2|||
105369116|NCT01687218|363356411|FG001|Overall Study|Withdrawal by Subject|3|||
105369117|NCT01687218|363356412|FG002|Overall Study|Withdrawal by Subject|0|||
105369118|NCT01687218|363356413|FG003|Overall Study|Withdrawal by Subject|1|||
105369119|NCT01687218|363356414|FG004|Overall Study|Withdrawal by Subject|1|||
105369120|NCT01687218|363356415|FG005|Overall Study|Withdrawal by Subject|0|||
105369121|NCT01687218|363356410|FG000|Overall Study|Relocated, no follow-up planned|1|||
105369122|NCT01687218|363356411|FG001|Overall Study|Relocated, no follow-up planned|0|||
105369123|NCT01687218|363356412|FG002|Overall Study|Relocated, no follow-up planned|1|||
105369124|NCT01687218|363356413|FG003|Overall Study|Relocated, no follow-up planned|1|||
105369125|NCT01687218|363356414|FG004|Overall Study|Relocated, no follow-up planned|0|||
105369126|NCT01687218|363356415|FG005|Overall Study|Relocated, no follow-up planned|0|||
105369127|NCT01973218|363356416|FG000|Overall Study|Adverse Event|1|||
105369128|NCT01973218|363356417|FG001|Overall Study|Adverse Event|0|||
105369129|NCT01973218|363356416|FG000|Overall Study|Withdrawal by Subject|1|||
105369130|NCT01973218|363356417|FG001|Overall Study|Withdrawal by Subject|0|||
105369131|NCT02997163|363358337|FG000|Overall Study|Adverse Event|1|||
105369132|NCT02997163|363358338|FG001|Overall Study|Adverse Event|0|||
105369133|NCT02997163|363358339|FG002|Overall Study|Adverse Event|0|||
105369134|NCT02997163|363358340|FG003|Overall Study|Adverse Event|1|||
105369135|NCT00329108|363358341|FG000|Overall Study|Adverse Event|2|||
105369136|NCT00329108|363358342|FG001|Overall Study|Adverse Event|2|||
105369137|NCT00329108|363358341|FG000|Overall Study|Lack of Efficacy|3|||
105369138|NCT00329108|363358342|FG001|Overall Study|Lack of Efficacy|3|||
105369139|NCT00329108|363358341|FG000|Overall Study|Withdrawal by Subject|0|||
105369140|NCT00329108|363358342|FG001|Overall Study|Withdrawal by Subject|2|||
105369141|NCT00329108|363358341|FG000|Overall Study|symptomatic deterioration|1|||
105369142|NCT00329108|363358342|FG001|Overall Study|symptomatic deterioration|1|||
105369143|NCT00329108|363358341|FG000|Overall Study|Subject no longer willing to participate|2|||
105369144|NCT00329108|363358342|FG001|Overall Study|Subject no longer willing to participate|2|||
105317634|NCT04803305|363158707|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
105317635|NCT04803305|363158708|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
105317636|NCT04803305|363158707|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
105317637|NCT04803305|363158708|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
105369145|NCT00329108|363358341|FG000|Overall Study|study terminated by sponsor|1|||
105369146|NCT00329108|363358342|FG001|Overall Study|study terminated by sponsor|0|||
105369147|NCT00329108|363358341|FG000|Overall Study|withdrew patient after SAE resolved|1|||
105369148|NCT00329108|363358342|FG001|Overall Study|withdrew patient after SAE resolved|0|||
105369149|NCT00329108|363358341|FG000|Overall Study|Protocol Violation|0|||
105369150|NCT00329108|363358342|FG001|Overall Study|Protocol Violation|2|||
105369151|NCT03256578|363358343|FG000|Overall Study|Excluded Post Randomization|66|||
105369152|NCT03256578|363358344|FG001|Overall Study|Excluded Post Randomization|56|||
105369153|NCT02371616|363358345|FG000|Overall Study|Protocol Violation|2|||
105369154|NCT02371616|363358346|FG001|Overall Study|Protocol Violation|1|||
105369155|NCT02371616|363358345|FG000|Overall Study|Adverse Event|0|||
105369156|NCT02371616|363358346|FG001|Overall Study|Adverse Event|1|||
105369157|NCT02371616|363358345|FG000|Overall Study|Withdrawal of Consent|1|||
105848776|NCT00876018|365105101|FG000|Overall Study|Lost to Follow-up|0|||
105848777|NCT00876018|365105102|FG001|Overall Study|Lost to Follow-up|1|||
105848778|NCT00876018|365105103|FG002|Overall Study|Lost to Follow-up|1|||
105848779|NCT00876018|365105101|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
105848780|NCT00876018|365105102|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
105848781|NCT00876018|365105103|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
105848782|NCT02615171|365105104|FG000|Overall Study|Lost to Follow-up|2|||
105848783|NCT02615171|365105105|FG001|Overall Study|Lost to Follow-up|1|||
105848784|NCT00725621|365105115|FG000|Overall Study|Adverse Event|25|||
105848785|NCT00725621|365105115|FG000|Overall Study|Lack of Efficacy|46|||
105848786|NCT00725621|365105115|FG000|Overall Study|Withdrawal by Subject|57|||
105848787|NCT00725621|365105115|FG000|Overall Study|Physician Decision|19|||
105848788|NCT00725621|365105115|FG000|Overall Study|Lost to Follow-up|52|||
105848789|NCT00725621|365105115|FG000|Overall Study|Non-compliance|8|||
105848790|NCT00725621|365105115|FG000|Overall Study|Continued treatment by other physician|6|||
105848791|NCT00725621|365105115|FG000|Overall Study|Switched to other study|1|||
105848792|NCT00725621|365105115|FG000|Overall Study|Switched to other drug|1|||
105848793|NCT00725621|365105115|FG000|Overall Study|Prepared for elective surgery|1|||
105848794|NCT00725621|365105115|FG000|Overall Study|Reason not specified|55|||
105848795|NCT01490866|365105119|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
105848796|NCT01490866|365105119|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
105848797|NCT01490866|365105119|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
105848798|NCT01490866|365105119|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
105848799|NCT01490866|365105119|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
105848800|NCT01490866|365105119|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
105848801|NCT01490866|365105119|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
105848802|NCT01490866|365105119|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
105848803|NCT01490866|365105119|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
105848804|NCT01490866|365105119|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
105848805|NCT01490866|365105119|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
105848806|NCT03923530|365105120|FG000|Overall Study|Withdrawal by Subject|1|||
105848807|NCT03923530|365105120|FG000|Overall Study|screen failure|3|||
105848808|NCT00407758|365105121|FG000|Overall Study|ineligible -improper prior treatment|1|||
105848809|NCT01181271|365105122|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
105848810|NCT01181271|365105122|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
105848811|NCT01181271|365105122|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
105848812|NCT01181271|365105122|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
105848813|NCT01941940|365105125|FG000|Overall Study|Adverse Event|11|||
105848814|NCT01941940|365105125|FG000|Overall Study|Lost to Follow-up|2|||
105848815|NCT01941940|365105125|FG000|Overall Study|Physician Decision|2|||
105848816|NCT01941940|365105125|FG000|Overall Study|Withdrawal by Subject|15|||
105848817|NCT01941940|365105125|FG000|Overall Study|Death|1|||
105848818|NCT01941940|365105125|FG000|Overall Study|Other|1|||
105848819|NCT01941940|365105125|FG000|Overall Study|Other|1|||
105848820|NCT01301508|365105126|FG000|Overall Study|Withdrawal by Subject|1|||
105848821|NCT01301508|365105127|FG001|Overall Study|Withdrawal by Subject|2|||
105848822|NCT01301508|365105126|FG000|Overall Study|Lost to Follow-up|0|||
105848823|NCT01301508|365105127|FG001|Overall Study|Lost to Follow-up|1|||
105848824|NCT00851643|365105128|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
105848825|NCT00851643|365105129|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
105848826|NCT00851643|365105130|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
105848827|NCT00851643|365105131|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
105848828|NCT00851643|365105132|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
105848829|NCT00851643|365105133|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
105848830|NCT00851643|365105128|FG000|Base Study (Up to 12 Months)|Other|0|||
105848831|NCT00851643|365105129|FG001|Base Study (Up to 12 Months)|Other|0|||
105369158|NCT02371616|363358346|FG001|Overall Study|Withdrawal of Consent|0|||
105369159|NCT02371616|363358345|FG000|Overall Study|Other (Not specified)|1|||
105369160|NCT02371616|363358346|FG001|Overall Study|Other (Not specified)|5|||
105369161|NCT00161213|363358356|FG000|Overall Study|Withdrawal by Subject|1|||
105369162|NCT00161213|363358356|FG000|Overall Study|Evaluable for toxicity but not response|1|||
105369163|NCT01855958|363358359|FG000|Overall Study|Withdrawal by Subject|1|||
105369164|NCT01855958|363358360|FG001|Overall Study|Withdrawal by Subject|0|||
105369165|NCT01190891|363358364|FG000|Overall Study|Protocol Violation|1|||
105369166|NCT01190891|363358365|FG001|Overall Study|Protocol Violation|0|||
105369167|NCT01190891|363358364|FG000|Overall Study|Withdrawal by Subject|5|||
105848832|NCT00851643|365105130|FG002|Base Study (Up to 12 Months)|Other|0|||
105848833|NCT00851643|365105131|FG003|Base Study (Up to 12 Months)|Other|0|||
105369168|NCT01190891|363358365|FG001|Overall Study|Withdrawal by Subject|0|||
105848834|NCT00851643|365105132|FG004|Base Study (Up to 12 Months)|Other|0|||
105848835|NCT00851643|365105133|FG005|Base Study (Up to 12 Months)|Other|1|||
105848836|NCT00851643|365105128|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
105848837|NCT00851643|365105129|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
105317638|NCT00708227|363158709|FG000|Overall Study|Physician Decision|0|||
105317639|NCT00708227|363158710|FG001|Overall Study|Physician Decision|3|||
105317640|NCT00708227|363158711|FG002|Overall Study|Physician Decision|1|||
105317641|NCT00708227|363158712|FG003|Overall Study|Physician Decision|2|||
105317642|NCT00708227|363158709|FG000|Overall Study|Withdrawal by Subject|1|||
105317643|NCT00708227|363158710|FG001|Overall Study|Withdrawal by Subject|2|||
105317644|NCT00708227|363158711|FG002|Overall Study|Withdrawal by Subject|0|||
105317645|NCT00708227|363158712|FG003|Overall Study|Withdrawal by Subject|1|||
105317646|NCT02108912|363158713|FG000|Overall Study|Lost to Follow-up|1|||
105317647|NCT02108912|363158714|FG001|Overall Study|Lost to Follow-up|1|||
105317648|NCT02108912|363158713|FG000|Overall Study|lack of transportation|1|||
105317649|NCT02108912|363158714|FG001|Overall Study|lack of transportation|0|||
105317650|NCT02108912|363158713|FG000|Overall Study|high blood pressure|1|||
105317651|NCT02108912|363158714|FG001|Overall Study|high blood pressure|0|||
105317652|NCT03203850|363160194|FG000|Overall Study|Subject/guardian decision|4|||
105317653|NCT03203850|363160195|FG001|Overall Study|Subject/guardian decision|3|||
105317654|NCT03203850|363160194|FG000|Overall Study|Adverse Event|3|||
105317655|NCT03203850|363160195|FG001|Overall Study|Adverse Event|0|||
105317656|NCT03203850|363160194|FG000|Overall Study|Death|1|||
105317657|NCT03203850|363160195|FG001|Overall Study|Death|0|||
105317658|NCT05048329|363160196|FG000|Overall Study|Withdrawal by Subject|1|||
105317659|NCT05048329|363160196|FG000|Overall Study|Screenfail|1|||
105317660|NCT01659125|363160197|FG000|Overall Study|Withdrawal by Subject|2|||
105317661|NCT01659125|363160197|FG000|Overall Study|Lost to Follow-up|7|||
105317662|NCT01659125|363160197|FG000|Overall Study|Technical Problem|1|||
105317663|NCT01659125|363160197|FG000|Overall Study|Time Constraints|2|||
105317664|NCT01659125|363160197|FG000|Overall Study|Failed to Start Treatment|2|||
105317665|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criterion #1|24|||
105317666|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criterion #1|0|||
105317667|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
105317668|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
105317669|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
105317670|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
105317671|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
105317672|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
105317673|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
105317674|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
105317675|NCT03888066|363160199|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
105317676|NCT03888066|363160200|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
105317677|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
105317678|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
105317679|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
105317680|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
105317681|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
105317682|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
105317683|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
105317684|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
105317685|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criterion #2|5|||
105317686|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criterion #2|0|||
105317687|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
105317688|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
105317689|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
105317690|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
105317691|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
105317692|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
105317693|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criterion #3|11|||
105317694|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criterion #3|0|||
105369169|NCT00266708|363358366|FG000|Overall Study|No renal function|1|||
105369170|NCT00266708|363358367|FG001|Overall Study|No renal function|1|||
105369171|NCT00266708|363358366|FG000|Overall Study|Refused biopsy|3|||
105369172|NCT00266708|363358367|FG001|Overall Study|Refused biopsy|6|||
105369173|NCT00266708|363358366|FG000|Overall Study|Asthma|0|||
105317695|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
105317696|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
105317697|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
105317698|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
105369174|NCT00266708|363358367|FG001|Overall Study|Asthma|2|||
105369175|NCT01294423|363358368|FG000|Overall Study|Adverse Event|1|||
105369176|NCT01294423|363358369|FG001|Overall Study|Adverse Event|2|||
105848838|NCT00851643|365105130|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
105848839|NCT00851643|365105131|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
105848840|NCT00851643|365105132|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
105848841|NCT00851643|365105133|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
105848842|NCT00851643|365105128|FG000|Extension Study (Up to 36 Months)|Moved|0|||
105848843|NCT00851643|365105129|FG001|Extension Study (Up to 36 Months)|Moved|2|||
105848844|NCT00851643|365105130|FG002|Extension Study (Up to 36 Months)|Moved|1|||
105848845|NCT00851643|365105131|FG003|Extension Study (Up to 36 Months)|Moved|1|||
105848846|NCT00851643|365105132|FG004|Extension Study (Up to 36 Months)|Moved|0|||
105848847|NCT00851643|365105133|FG005|Extension Study (Up to 36 Months)|Moved|1|||
105848848|NCT00444457|365105134|FG000|Infant Series|Other|0|||
105848849|NCT00444457|365105135|FG001|Infant Series|Other|1|||
105848850|NCT00444457|365105136|FG002|Infant Series|Other|0|||
105848851|NCT00444457|365105137|FG003|Infant Series|Other|0|||
105848852|NCT00444457|365105134|FG000|Infant Series|Parent or legal guardian request|18|||
105848853|NCT00444457|365105135|FG001|Infant Series|Parent or legal guardian request|29|||
105848854|NCT00444457|365105136|FG002|Infant Series|Parent or legal guardian request|34|||
105848855|NCT00444457|365105137|FG003|Infant Series|Parent or legal guardian request|14|||
105848856|NCT00444457|365105134|FG000|Infant Series|Lost to Follow-up|10|||
105848857|NCT00444457|365105135|FG001|Infant Series|Lost to Follow-up|11|||
105848858|NCT00444457|365105136|FG002|Infant Series|Lost to Follow-up|7|||
105848859|NCT00444457|365105137|FG003|Infant Series|Lost to Follow-up|6|||
105848860|NCT00444457|365105134|FG000|Infant Series|Protocol Violation|16|||
105848861|NCT00444457|365105135|FG001|Infant Series|Protocol Violation|8|||
105848862|NCT00444457|365105136|FG002|Infant Series|Protocol Violation|6|||
105848863|NCT00444457|365105137|FG003|Infant Series|Protocol Violation|3|||
105848864|NCT00444457|365105134|FG000|Infant Series|Failed to return|5|||
105848865|NCT00444457|365105135|FG001|Infant Series|Failed to return|4|||
105848866|NCT00444457|365105136|FG002|Infant Series|Failed to return|4|||
105848867|NCT00444457|365105137|FG003|Infant Series|Failed to return|2|||
105848868|NCT00444457|365105134|FG000|Infant Series|Investigator request|4|||
105848869|NCT00444457|365105135|FG001|Infant Series|Investigator request|3|||
105848870|NCT00444457|365105136|FG002|Infant Series|Investigator request|3|||
105848871|NCT00444457|365105137|FG003|Infant Series|Investigator request|2|||
105848872|NCT00444457|365105134|FG000|Infant Series|Other|0|||
105848873|NCT00444457|365105135|FG001|Infant Series|Other|2|||
105848874|NCT00444457|365105136|FG002|Infant Series|Other|4|||
105848875|NCT00444457|365105137|FG003|Infant Series|Other|0|||
105848876|NCT00444457|365105134|FG000|Infant Series|Adverse Event|1|||
105848877|NCT00444457|365105135|FG001|Infant Series|Adverse Event|2|||
105848878|NCT00444457|365105136|FG002|Infant Series|Adverse Event|2|||
105848879|NCT00444457|365105137|FG003|Infant Series|Adverse Event|0|||
105848880|NCT00444457|365105134|FG000|Infant Series|Death|0|||
105848881|NCT00444457|365105135|FG001|Infant Series|Death|1|||
105848882|NCT00444457|365105136|FG002|Infant Series|Death|1|||
105848883|NCT00444457|365105137|FG003|Infant Series|Death|1|||
105848884|NCT00444457|365105134|FG000|After Infant Series|Other|0|||
105848885|NCT00444457|365105135|FG001|After Infant Series|Other|1|||
105848886|NCT00444457|365105136|FG002|After Infant Series|Other|1|||
105848887|NCT00444457|365105137|FG003|After Infant Series|Other|1|||
105848888|NCT00444457|365105134|FG000|After Infant Series|Parent or legal guardian request|4|||
105848889|NCT00444457|365105135|FG001|After Infant Series|Parent or legal guardian request|11|||
105848890|NCT00444457|365105136|FG002|After Infant Series|Parent or legal guardian request|6|||
105848891|NCT00444457|365105137|FG003|After Infant Series|Parent or legal guardian request|3|||
105848892|NCT00444457|365105134|FG000|After Infant Series|Failed to return|7|||
105848893|NCT00444457|365105135|FG001|After Infant Series|Failed to return|6|||
105848894|NCT00444457|365105136|FG002|After Infant Series|Failed to return|5|||
105848895|NCT00444457|365105137|FG003|After Infant Series|Failed to return|1|||
105848896|NCT00444457|365105134|FG000|After Infant Series|Lost to Follow-up|5|||
105848897|NCT00444457|365105135|FG001|After Infant Series|Lost to Follow-up|5|||
105848898|NCT00444457|365105136|FG002|After Infant Series|Lost to Follow-up|5|||
105848899|NCT00444457|365105137|FG003|After Infant Series|Lost to Follow-up|2|||
105848900|NCT00444457|365105134|FG000|After Infant Series|Protocol Violation|2|||
105848901|NCT00444457|365105135|FG001|After Infant Series|Protocol Violation|4|||
105848902|NCT00444457|365105136|FG002|After Infant Series|Protocol Violation|2|||
105848903|NCT00444457|365105137|FG003|After Infant Series|Protocol Violation|2|||
105576765|NCT00932646|364110319|FG000|Overall Study|Adverse Event|2|||
105848904|NCT00444457|365105134|FG000|After Infant Series|Adverse Event|2|||
105848905|NCT00444457|365105135|FG001|After Infant Series|Adverse Event|2|||
105848906|NCT00444457|365105136|FG002|After Infant Series|Adverse Event|0|||
105848907|NCT00444457|365105137|FG003|After Infant Series|Adverse Event|0|||
105848908|NCT00444457|365105134|FG000|After Infant Series|Investigator request|0|||
105848909|NCT00444457|365105135|FG001|After Infant Series|Investigator request|0|||
105848910|NCT00444457|365105136|FG002|After Infant Series|Investigator request|0|||
105848911|NCT00444457|365105137|FG003|After Infant Series|Investigator request|1|||
105848912|NCT00444457|365105134|FG000|After Infant Series|Other|0|||
105848913|NCT00444457|365105135|FG001|After Infant Series|Other|1|||
105848914|NCT00444457|365105136|FG002|After Infant Series|Other|0|||
105848915|NCT00444457|365105137|FG003|After Infant Series|Other|0|||
105848916|NCT00444457|365105134|FG000|Toddler Dose|Lost to Follow-up|4|||
105848917|NCT00444457|365105135|FG001|Toddler Dose|Lost to Follow-up|1|||
105369177|NCT01294423|363358370|FG002|Overall Study|Adverse Event|3|||
105490746|NCT00423670|363809419|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
105490747|NCT00423670|363809420|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
105490748|NCT00423670|363809421|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
105490749|NCT00423670|363809422|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
105490750|NCT00423670|363809423|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
105490751|NCT00423670|363809424|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
105490752|NCT00423670|363809417|FG000|Treatment Period|Adverse Event|8|||
105490753|NCT00423670|363809418|FG001|Treatment Period|Adverse Event|12|||
105490754|NCT00423670|363809419|FG002|Treatment Period|Adverse Event|15|||
105490755|NCT00423670|363809420|FG003|Treatment Period|Adverse Event|20|||
105490756|NCT00423670|363809421|FG004|Treatment Period|Adverse Event|9|||
105490757|NCT00423670|363809422|FG005|Treatment Period|Adverse Event|4|||
105490758|NCT00423670|363809423|FG006|Treatment Period|Adverse Event|7|||
105490759|NCT00423670|363809424|FG007|Treatment Period|Adverse Event|2|||
105490760|NCT00423670|363809417|FG000|Treatment Period|Protocol-defined clinical event|0|||
105490761|NCT00423670|363809418|FG001|Treatment Period|Protocol-defined clinical event|7|||
105490762|NCT00423670|363809419|FG002|Treatment Period|Protocol-defined clinical event|4|||
105490763|NCT00423670|363809420|FG003|Treatment Period|Protocol-defined clinical event|12|||
105490764|NCT00423670|363809421|FG004|Treatment Period|Protocol-defined clinical event|5|||
105490765|NCT00423670|363809422|FG005|Treatment Period|Protocol-defined clinical event|4|||
105490766|NCT00423670|363809423|FG006|Treatment Period|Protocol-defined clinical event|16|||
105490767|NCT00423670|363809424|FG007|Treatment Period|Protocol-defined clinical event|15|||
105490768|NCT00423670|363809417|FG000|Treatment Period|Lost to Follow-up|2|||
105490769|NCT00423670|363809418|FG001|Treatment Period|Lost to Follow-up|1|||
105490770|NCT00423670|363809419|FG002|Treatment Period|Lost to Follow-up|3|||
105490771|NCT00423670|363809420|FG003|Treatment Period|Lost to Follow-up|1|||
105490772|NCT00423670|363809421|FG004|Treatment Period|Lost to Follow-up|6|||
105490773|NCT00423670|363809422|FG005|Treatment Period|Lost to Follow-up|0|||
105490774|NCT00423670|363809423|FG006|Treatment Period|Lost to Follow-up|3|||
105490775|NCT00423670|363809424|FG007|Treatment Period|Lost to Follow-up|1|||
105369178|NCT01294423|363358368|FG000|Overall Study|Withdrawal by Subject|1|||
105369179|NCT01294423|363358369|FG001|Overall Study|Withdrawal by Subject|2|||
105369180|NCT01294423|363358370|FG002|Overall Study|Withdrawal by Subject|2|||
105369181|NCT01294423|363358368|FG000|Overall Study|subject no longer meets study criteria|2|||
105369182|NCT01294423|363358369|FG001|Overall Study|subject no longer meets study criteria|5|||
105369183|NCT01294423|363358370|FG002|Overall Study|subject no longer meets study criteria|2|||
105369184|NCT01294423|363358368|FG000|Overall Study|poor/non-compliance|1|||
105369185|NCT01294423|363358369|FG001|Overall Study|poor/non-compliance|0|||
105369186|NCT01294423|363358370|FG002|Overall Study|poor/non-compliance|1|||
105369187|NCT00641056|363358371|FG000|Overall Study|Adverse Event|12|||
105369188|NCT00641056|363358372|FG001|Overall Study|Adverse Event|2|||
105369189|NCT00641056|363358371|FG000|Overall Study|Lost to Follow-up|2|||
105369190|NCT00641056|363358372|FG001|Overall Study|Lost to Follow-up|1|||
105369191|NCT00641056|363358371|FG000|Overall Study|Physician Decision|3|||
105369192|NCT00641056|363358372|FG001|Overall Study|Physician Decision|1|||
105369193|NCT00641056|363358371|FG000|Overall Study|Protocol Violation|2|||
105369194|NCT00641056|363358372|FG001|Overall Study|Protocol Violation|0|||
105369195|NCT00641056|363358371|FG000|Overall Study|Entry Criteria Not Met|3|||
105369196|NCT00641056|363358372|FG001|Overall Study|Entry Criteria Not Met|0|||
105369197|NCT00641056|363358371|FG000|Overall Study|Subject Decision|6|||
105369198|NCT00641056|363358372|FG001|Overall Study|Subject Decision|19|||
105369199|NCT00641056|363358371|FG000|Overall Study|Sponsor Decision|1|||
105369200|NCT00641056|363358372|FG001|Overall Study|Sponsor Decision|2|||
105369201|NCT00368251|363358373|FG000|Overall Study|SAE, non-fatal|1|||
105369202|NCT00368251|363358374|FG001|Overall Study|SAE, non-fatal|0|||
105369203|NCT00368251|363358375|FG002|Overall Study|SAE, non-fatal|0|||
105369204|NCT00368251|363358373|FG000|Overall Study|AE, non-serious non-fatal|0|||
105369205|NCT00368251|363358374|FG001|Overall Study|AE, non-serious non-fatal|0|||
105369206|NCT00368251|363358375|FG002|Overall Study|AE, non-serious non-fatal|1|||
105369207|NCT01863771|363358382|FG000|Induction Phase|Adverse Event|9|||
105490776|NCT00423670|363809417|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
105490777|NCT00423670|363809418|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
105490778|NCT00423670|363809419|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
105490779|NCT00423670|363809420|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
105490780|NCT00423670|363809421|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
105369208|NCT01863771|363358383|FG001|Induction Phase|Adverse Event|0|||
105369209|NCT01863771|363358384|FG002|Induction Phase|Adverse Event|0|||
105369210|NCT01863771|363358385|FG003|Induction Phase|Adverse Event|0|||
105369211|NCT01863771|363358382|FG000|Induction Phase|Lack of Efficacy|10|||
105490781|NCT00423670|363809422|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
105490782|NCT00423670|363809423|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
105848918|NCT00444457|365105136|FG002|Toddler Dose|Lost to Follow-up|1|||
105848919|NCT00444457|365105137|FG003|Toddler Dose|Lost to Follow-up|3|||
105848920|NCT00444457|365105134|FG000|Toddler Dose|Failed to return|2|||
105848921|NCT00444457|365105135|FG001|Toddler Dose|Failed to return|2|||
105848922|NCT00444457|365105136|FG002|Toddler Dose|Failed to return|1|||
105848923|NCT00444457|365105137|FG003|Toddler Dose|Failed to return|3|||
105848924|NCT00444457|365105134|FG000|Toddler Dose|Parent or legal guardian request|0|||
105848925|NCT00444457|365105135|FG001|Toddler Dose|Parent or legal guardian request|3|||
105848926|NCT00444457|365105136|FG002|Toddler Dose|Parent or legal guardian request|2|||
105848927|NCT00444457|365105137|FG003|Toddler Dose|Parent or legal guardian request|1|||
105848928|NCT00444457|365105134|FG000|Toddler Dose|Protocol Violation|1|||
105848929|NCT00444457|365105135|FG001|Toddler Dose|Protocol Violation|0|||
105848930|NCT00444457|365105136|FG002|Toddler Dose|Protocol Violation|0|||
105848931|NCT00444457|365105137|FG003|Toddler Dose|Protocol Violation|1|||
105848932|NCT00448136|365105140|FG000|Overall Study|Death|3|||
105848933|NCT00448136|365105141|FG001|Overall Study|Death|8|||
105848934|NCT00448136|365105140|FG000|Overall Study|Investigator's decision (progression)|1|||
105848935|NCT00448136|365105141|FG001|Overall Study|Investigator's decision (progression)|0|||
105848936|NCT03176459|365105142|FG000|Overall Study|Lost to Follow-up|5|||
105848937|NCT03176459|365105143|FG001|Overall Study|Lost to Follow-up|7|||
105848938|NCT03071094|365105144|FG000|Overall Study|Death|1|||
105848939|NCT03071094|365105145|FG001|Overall Study|Death|1|||
105848940|NCT03071094|365105144|FG000|Overall Study|Adverse Event|1|||
105848941|NCT03071094|365105145|FG001|Overall Study|Adverse Event|0|||
105848942|NCT03753763|365105147|FG000|Overall Study|Adverse Event|2|||
105848943|NCT03753763|365105148|FG001|Overall Study|Adverse Event|0|||
105848944|NCT03753763|365105147|FG000|Overall Study|Withdrawal by Subject|3|||
105848945|NCT03753763|365105148|FG001|Overall Study|Withdrawal by Subject|1|||
105848946|NCT03753763|365105147|FG000|Overall Study|clinical deterioration|1|||
105848947|NCT03753763|365105148|FG001|Overall Study|clinical deterioration|0|||
105848948|NCT00389831|365105149|FG000|Overall Study|Lack of Efficacy|0|||
105848949|NCT00389831|365105150|FG001|Overall Study|Lack of Efficacy|2|||
105848950|NCT00389831|365105149|FG000|Overall Study|Did not receive treatment.|0|||
105848951|NCT00389831|365105150|FG001|Overall Study|Did not receive treatment.|2|||
105848952|NCT00389831|365105149|FG000|Overall Study|Other reasons|0|||
105848953|NCT00389831|365105150|FG001|Overall Study|Other reasons|2|||
105848954|NCT00389831|365105149|FG000|Overall Study|Lost to Follow-up|0|||
105848955|NCT00389831|365105150|FG001|Overall Study|Lost to Follow-up|1|||
105848956|NCT03433755|365105151|FG000|Overall Study|Lost to Follow-up|1|||
105848957|NCT03433755|365105152|FG001|Overall Study|Lost to Follow-up|0|||
105848958|NCT03433755|365105153|FG002|Overall Study|Lost to Follow-up|0|||
105317699|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
105317700|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
105317701|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criterion #4|3|||
105317702|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criterion #4|0|||
105317703|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
105317704|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
105317705|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
105317706|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
105317707|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
105317708|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
105317709|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
105317710|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
105317711|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
105317712|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
105317713|NCT03888066|363160199|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
105317714|NCT03888066|363160200|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
105317715|NCT03888066|363160199|FG000|Run-in Phase|AE (Adverse Event)|17|||
105317716|NCT03888066|363160200|FG001|Run-in Phase|AE (Adverse Event)|0|||
105317717|NCT03888066|363160199|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
105317718|NCT03888066|363160200|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
105317719|NCT03888066|363160199|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
105317720|NCT03888066|363160200|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
105848959|NCT03433755|365105154|FG003|Overall Study|Lost to Follow-up|0|||
105848960|NCT03433755|365105151|FG000|Overall Study|Decision by Sponsor|1|||
105848961|NCT03433755|365105152|FG001|Overall Study|Decision by Sponsor|0|||
105848962|NCT03433755|365105153|FG002|Overall Study|Decision by Sponsor|0|||
105848963|NCT03433755|365105154|FG003|Overall Study|Decision by Sponsor|0|||
105848964|NCT04732221|365107563|FG000|Base Period|Death|2|||
105848965|NCT04732221|365107564|FG001|Base Period|Death|0|||
105848966|NCT04732221|365107565|FG002|Base Period|Death|0|||
105848967|NCT04732221|365107566|FG003|Base Period|Death|0|||
105848968|NCT04732221|365107567|FG004|Base Period|Death|0|||
105848969|NCT04732221|365107568|FG005|Base Period|Death|0|||
105848970|NCT04732221|365107569|FG006|Base Period|Death|0|||
105848971|NCT04732221|365107563|FG000|Base Period|Withdrawal by Subject|0|||
105848972|NCT04732221|365107564|FG001|Base Period|Withdrawal by Subject|1|||
105848973|NCT04732221|365107565|FG002|Base Period|Withdrawal by Subject|1|||
105848974|NCT04732221|365107566|FG003|Base Period|Withdrawal by Subject|0|||
105848975|NCT04732221|365107567|FG004|Base Period|Withdrawal by Subject|0|||
105848976|NCT04732221|365107568|FG005|Base Period|Withdrawal by Subject|0|||
105848977|NCT04732221|365107569|FG006|Base Period|Withdrawal by Subject|0|||
105848978|NCT04732221|365107563|FG000|Extension Period|Adverse Event|0|||
105848979|NCT04732221|365107564|FG001|Extension Period|Adverse Event|0|||
105848980|NCT04732221|365107565|FG002|Extension Period|Adverse Event|0|||
105848981|NCT04732221|365107566|FG003|Extension Period|Adverse Event|0|||
105848982|NCT04732221|365107567|FG004|Extension Period|Adverse Event|0|||
105317721|NCT03888066|363160199|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
105317722|NCT03888066|363160200|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
105317723|NCT03888066|363160199|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
105317724|NCT03888066|363160200|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
105317725|NCT03888066|363160199|FG000|Run-in Phase|Withdrawal by Subject|43|||
105317726|NCT03888066|363160200|FG001|Run-in Phase|Withdrawal by Subject|0|||
105317727|NCT03888066|363160199|FG000|Run-in Phase|AE; Physician Decision|1|||
105317728|NCT03888066|363160200|FG001|Run-in Phase|AE; Physician Decision|0|||
105317729|NCT03888066|363160199|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
105317730|NCT03888066|363160200|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
105317731|NCT03888066|363160199|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
105317732|NCT03888066|363160200|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
105317733|NCT03888066|363160199|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
105317734|NCT03888066|363160200|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
105317735|NCT03888066|363160199|FG000|Run-in Phase|Death|1|||
105317736|NCT03888066|363160200|FG001|Run-in Phase|Death|0|||
105317737|NCT03888066|363160199|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
105317738|NCT03888066|363160200|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
105317739|NCT03888066|363160199|FG000|Run-in Phase|Physician Decision|1|||
105317740|NCT03888066|363160200|FG001|Run-in Phase|Physician Decision|0|||
105317741|NCT03888066|363160199|FG000|Run-in Phase|Protocol Violation|13|||
105317742|NCT03888066|363160200|FG001|Run-in Phase|Protocol Violation|0|||
105317743|NCT03888066|363160199|FG000|Run-in Phase|Sponsor Request|34|||
105317744|NCT03888066|363160200|FG001|Run-in Phase|Sponsor Request|0|||
105317745|NCT03888066|363160199|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
105317746|NCT03888066|363160200|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
105317747|NCT03888066|363160199|FG000|Run-in Phase|Withdrawal Of Consent|1|||
105317748|NCT03888066|363160200|FG001|Run-in Phase|Withdrawal Of Consent|0|||
105317749|NCT03888066|363160199|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
105317750|NCT03888066|363160200|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
105317751|NCT03888066|363160199|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
105317752|NCT03888066|363160200|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
105317753|NCT03888066|363160199|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
105317754|NCT03888066|363160200|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
105317755|NCT03888066|363160199|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
105317756|NCT03888066|363160200|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
105317757|NCT03888066|363160199|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
105317758|NCT03888066|363160200|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
105317759|NCT03888066|363160199|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
105317760|NCT03888066|363160200|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
105317761|NCT03888066|363160199|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
105317762|NCT03888066|363160200|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
105317763|NCT03888066|363160199|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
105317764|NCT03888066|363160200|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
105317765|NCT03888066|363160199|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
105317766|NCT03888066|363160200|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
105317767|NCT03888066|363160199|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
105317768|NCT03888066|363160200|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
105317769|NCT03888066|363160199|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
105317770|NCT03888066|363160200|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
105317771|NCT03888066|363160199|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
105369212|NCT01863771|363358383|FG001|Induction Phase|Lack of Efficacy|0|||
105369213|NCT01863771|363358384|FG002|Induction Phase|Lack of Efficacy|0|||
105848983|NCT04732221|365107568|FG005|Extension Period|Adverse Event|1|||
105848984|NCT04732221|365107569|FG006|Extension Period|Adverse Event|0|||
105848985|NCT04732221|365107563|FG000|Extension Period|Death|0|||
105848986|NCT04732221|365107564|FG001|Extension Period|Death|0|||
105848987|NCT04732221|365107565|FG002|Extension Period|Death|0|||
105848988|NCT04732221|365107566|FG003|Extension Period|Death|0|||
105848989|NCT04732221|365107567|FG004|Extension Period|Death|1|||
105848990|NCT04732221|365107568|FG005|Extension Period|Death|0|||
105848991|NCT04732221|365107569|FG006|Extension Period|Death|2|||
105848992|NCT04732221|365107563|FG000|Extension Period|Pregnancy|0|||
105848993|NCT04732221|365107564|FG001|Extension Period|Pregnancy|0|||
105848994|NCT04732221|365107565|FG002|Extension Period|Pregnancy|0|||
105848995|NCT04732221|365107566|FG003|Extension Period|Pregnancy|0|||
105848996|NCT04732221|365107567|FG004|Extension Period|Pregnancy|1|||
105848997|NCT04732221|365107568|FG005|Extension Period|Pregnancy|0|||
105848998|NCT04732221|365107569|FG006|Extension Period|Pregnancy|0|||
105848999|NCT04732221|365107563|FG000|Extension Period|Sponsors Decision|0|||
105849000|NCT04732221|365107564|FG001|Extension Period|Sponsors Decision|0|||
105849001|NCT04732221|365107565|FG002|Extension Period|Sponsors Decision|0|||
105849002|NCT04732221|365107566|FG003|Extension Period|Sponsors Decision|0|||
105849003|NCT04732221|365107567|FG004|Extension Period|Sponsors Decision|41|||
105849004|NCT04732221|365107568|FG005|Extension Period|Sponsors Decision|40|||
105849005|NCT04732221|365107569|FG006|Extension Period|Sponsors Decision|40|||
105849006|NCT04732221|365107563|FG000|Extension Period|Withdrawal by Subject|0|||
105849007|NCT04732221|365107564|FG001|Extension Period|Withdrawal by Subject|0|||
105849008|NCT04732221|365107565|FG002|Extension Period|Withdrawal by Subject|0|||
105317772|NCT03888066|363160200|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
105317773|NCT03278626|363160201|FG000|Overall Study|Death|2|||
105317774|NCT03278626|363160201|FG000|Overall Study|Toxicity|1|||
105317775|NCT03278626|363160201|FG000|Overall Study|Disease Progression|2|||
105317776|NCT05013008|363160203|FG000|Overall Study|Exclusion from mBFAS|5|||
105317777|NCT05013008|363160204|FG001|Overall Study|Exclusion from mBFAS|25|||
105317778|NCT02717455|363160205|FG000|Overall Study|Adverse Event|1|||
105317779|NCT02717455|363160206|FG001|Overall Study|Adverse Event|0|||
105317780|NCT02717455|363160207|FG002|Overall Study|Adverse Event|0|||
105317781|NCT02717455|363160208|FG003|Overall Study|Adverse Event|2|||
105317782|NCT02717455|363160209|FG004|Overall Study|Adverse Event|2|||
105317783|NCT02717455|363160210|FG005|Overall Study|Adverse Event|2|||
105317784|NCT02717455|363160205|FG000|Overall Study|Withdrawal by Subject|1|||
105317785|NCT02717455|363160206|FG001|Overall Study|Withdrawal by Subject|1|||
105317786|NCT02717455|363160207|FG002|Overall Study|Withdrawal by Subject|0|||
105317787|NCT02717455|363160208|FG003|Overall Study|Withdrawal by Subject|2|||
105317788|NCT02717455|363160209|FG004|Overall Study|Withdrawal by Subject|2|||
105317789|NCT02717455|363160210|FG005|Overall Study|Withdrawal by Subject|1|||
105317790|NCT02717455|363160205|FG000|Overall Study|Death|1|||
105317791|NCT02717455|363160206|FG001|Overall Study|Death|0|||
105317792|NCT02717455|363160207|FG002|Overall Study|Death|0|||
105317793|NCT02717455|363160208|FG003|Overall Study|Death|0|||
105317794|NCT02717455|363160209|FG004|Overall Study|Death|1|||
105317795|NCT02717455|363160210|FG005|Overall Study|Death|0|||
105317796|NCT02717455|363160205|FG000|Overall Study|Did not receive study drug|0|||
105317797|NCT02717455|363160206|FG001|Overall Study|Did not receive study drug|0|||
105317798|NCT02717455|363160207|FG002|Overall Study|Did not receive study drug|0|||
105317799|NCT02717455|363160208|FG003|Overall Study|Did not receive study drug|1|||
105317800|NCT02717455|363160209|FG004|Overall Study|Did not receive study drug|0|||
105317801|NCT02717455|363160210|FG005|Overall Study|Did not receive study drug|1|||
105317802|NCT02717455|363160205|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
105317803|NCT02717455|363160206|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
105317804|NCT02717455|363160207|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
105317805|NCT02717455|363160208|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
105317806|NCT02717455|363160209|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
105317807|NCT02717455|363160210|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
105317808|NCT02717455|363160205|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
105317809|NCT02717455|363160206|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
105317810|NCT02717455|363160207|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
105317811|NCT02717455|363160208|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
105317812|NCT02717455|363160209|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
105317813|NCT02717455|363160210|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
105317814|NCT02207634|363160214|FG000|Overall Study|Withdrawal by Subject|21|||
105317815|NCT02207634|363160215|FG001|Overall Study|Withdrawal by Subject|31|||
105317816|NCT02207634|363160214|FG000|Overall Study|Lost to Follow-up|1|||
105317817|NCT02207634|363160215|FG001|Overall Study|Lost to Follow-up|0|||
105849009|NCT04732221|365107566|FG003|Extension Period|Withdrawal by Subject|0|||
105317818|NCT00887289|363160216|FG000|Overall Study|Lack of Efficacy|14|||
105317819|NCT00887289|363160216|FG000|Overall Study|Adverse Event|27|||
105849010|NCT04732221|365107567|FG004|Extension Period|Withdrawal by Subject|1|||
105849011|NCT04732221|365107568|FG005|Extension Period|Withdrawal by Subject|5|||
105849012|NCT04732221|365107569|FG006|Extension Period|Withdrawal by Subject|2|||
105369214|NCT01863771|363358385|FG003|Induction Phase|Lack of Efficacy|0|||
105369215|NCT01863771|363358382|FG000|Induction Phase|Withdrawal by Subject|2|||
105369216|NCT01863771|363358383|FG001|Induction Phase|Withdrawal by Subject|0|||
105369217|NCT01863771|363358384|FG002|Induction Phase|Withdrawal by Subject|0|||
105369218|NCT01863771|363358385|FG003|Induction Phase|Withdrawal by Subject|0|||
105369219|NCT01863771|363358382|FG000|Maintenance Phase|Adverse Event|0|||
105369220|NCT01863771|363358383|FG001|Maintenance Phase|Adverse Event|0|||
105849013|NCT00144781|365107570|FG000|Overall Study|Adverse Event|0|||
105849014|NCT00144781|365107571|FG001|Overall Study|Adverse Event|1|||
105849015|NCT00144781|365107572|FG002|Overall Study|Adverse Event|0|||
105369221|NCT01863771|363358384|FG002|Maintenance Phase|Adverse Event|1|||
105849016|NCT00144781|365107573|FG003|Overall Study|Adverse Event|0|||
105849017|NCT00144781|365107570|FG000|Overall Study|Non-compliant|0|||
105849018|NCT00144781|365107571|FG001|Overall Study|Non-compliant|1|||
105849019|NCT00144781|365107572|FG002|Overall Study|Non-compliant|0|||
105849020|NCT00144781|365107573|FG003|Overall Study|Non-compliant|0|||
105849021|NCT00321828|365107575|FG000|Overall Study|Ineligible|3|||
105849022|NCT00321828|365107575|FG000|Overall Study|No follow up data|1|||
105849023|NCT00112866|365107578|FG000|Overall Study|Protocol Violation|1|||
105849024|NCT00112866|365107579|FG001|Overall Study|Protocol Violation|0|||
105849025|NCT00112866|365107578|FG000|Overall Study|did not start treatment post-op|1|||
105849026|NCT00112866|365107579|FG001|Overall Study|did not start treatment post-op|2|||
105849027|NCT02944383|365107580|FG000|Overall Study|Lost to Follow-up|0|||
105849028|NCT02944383|365107581|FG001|Overall Study|Lost to Follow-up|0|||
105849029|NCT02944383|365107582|FG002|Overall Study|Lost to Follow-up|1|||
105849030|NCT02944383|365107580|FG000|Overall Study|Withdrawal by Subject|1|||
105849031|NCT02944383|365107581|FG001|Overall Study|Withdrawal by Subject|0|||
105849032|NCT02944383|365107582|FG002|Overall Study|Withdrawal by Subject|0|||
105849033|NCT02444793|365107585|FG000|Overall Study|Lost to Follow-up|2|||
105849034|NCT02444793|365107586|FG001|Overall Study|Lost to Follow-up|2|||
105849035|NCT02444793|365107587|FG002|Overall Study|Lost to Follow-up|0|||
105849036|NCT02444793|365107588|FG003|Overall Study|Lost to Follow-up|0|||
105849037|NCT02444793|365107585|FG000|Overall Study|Death|0|||
105849038|NCT02444793|365107586|FG001|Overall Study|Death|3|||
105849039|NCT02444793|365107587|FG002|Overall Study|Death|0|||
105849040|NCT02444793|365107588|FG003|Overall Study|Death|0|||
105849041|NCT02444793|365107585|FG000|Overall Study|Other|0|||
105849042|NCT02444793|365107586|FG001|Overall Study|Other|0|||
105849043|NCT02444793|365107587|FG002|Overall Study|Other|2|||
105849044|NCT02444793|365107588|FG003|Overall Study|Other|0|||
105849045|NCT02444793|365107585|FG000|Overall Study|Objective progression or relapse|9|||
105849046|NCT02444793|365107586|FG001|Overall Study|Objective progression or relapse|1|||
105849047|NCT02444793|365107587|FG002|Overall Study|Objective progression or relapse|2|||
105849048|NCT02444793|365107588|FG003|Overall Study|Objective progression or relapse|3|||
105849049|NCT02504671|365107592|FG000|Overall Study|Withdrawal by Subject|1|||
105849050|NCT02504671|365107593|FG001|Overall Study|Withdrawal by Subject|5|||
105849051|NCT02504671|365107594|FG002|Overall Study|Withdrawal by Subject|4|||
105849052|NCT02504671|365107595|FG003|Overall Study|Withdrawal by Subject|4|||
105849053|NCT02504671|365107596|FG004|Overall Study|Withdrawal by Subject|5|||
105849054|NCT02504671|365107597|FG005|Overall Study|Withdrawal by Subject|3|||
105849055|NCT02504671|365107592|FG000|Overall Study|Lack of Efficacy|1|||
105849056|NCT02504671|365107593|FG001|Overall Study|Lack of Efficacy|3|||
105369222|NCT01863771|363358385|FG003|Maintenance Phase|Adverse Event|1|||
105369223|NCT01863771|363358382|FG000|Maintenance Phase|Lack of Efficacy|0|||
105849057|NCT02504671|365107594|FG002|Overall Study|Lack of Efficacy|1|||
105849058|NCT02504671|365107595|FG003|Overall Study|Lack of Efficacy|0|||
105849059|NCT02504671|365107596|FG004|Overall Study|Lack of Efficacy|4|||
105849060|NCT02504671|365107597|FG005|Overall Study|Lack of Efficacy|4|||
105849061|NCT02504671|365107592|FG000|Overall Study|Adverse Event|1|||
105849062|NCT02504671|365107593|FG001|Overall Study|Adverse Event|1|||
105849063|NCT02504671|365107594|FG002|Overall Study|Adverse Event|0|||
105849064|NCT02504671|365107595|FG003|Overall Study|Adverse Event|1|||
105849065|NCT02504671|365107596|FG004|Overall Study|Adverse Event|0|||
105849066|NCT02504671|365107597|FG005|Overall Study|Adverse Event|2|||
105849067|NCT02504671|365107592|FG000|Overall Study|Protocol Violation|2|||
105490783|NCT00423670|363809424|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
105849068|NCT02504671|365107593|FG001|Overall Study|Protocol Violation|1|||
105369224|NCT01863771|363358383|FG001|Maintenance Phase|Lack of Efficacy|3|||
105849069|NCT02504671|365107594|FG002|Overall Study|Protocol Violation|0|||
105849070|NCT02504671|365107595|FG003|Overall Study|Protocol Violation|0|||
105849071|NCT02504671|365107596|FG004|Overall Study|Protocol Violation|0|||
105849072|NCT02504671|365107597|FG005|Overall Study|Protocol Violation|1|||
105849073|NCT02504671|365107592|FG000|Overall Study|Lost to Follow-up|0|||
105849074|NCT02504671|365107593|FG001|Overall Study|Lost to Follow-up|0|||
105849075|NCT02504671|365107594|FG002|Overall Study|Lost to Follow-up|2|||
105849076|NCT02504671|365107595|FG003|Overall Study|Lost to Follow-up|0|||
105369225|NCT01863771|363358384|FG002|Maintenance Phase|Lack of Efficacy|7|||
105849077|NCT02504671|365107596|FG004|Overall Study|Lost to Follow-up|0|||
105849078|NCT02504671|365107597|FG005|Overall Study|Lost to Follow-up|1|||
105849079|NCT02504671|365107592|FG000|Overall Study|Protocol defined stopping criteria|7|||
105849080|NCT02504671|365107593|FG001|Overall Study|Protocol defined stopping criteria|4|||
105849081|NCT02504671|365107594|FG002|Overall Study|Protocol defined stopping criteria|3|||
105849082|NCT02504671|365107595|FG003|Overall Study|Protocol defined stopping criteria|5|||
105849083|NCT02504671|365107596|FG004|Overall Study|Protocol defined stopping criteria|3|||
105849084|NCT02504671|365107597|FG005|Overall Study|Protocol defined stopping criteria|3|||
105849085|NCT00210249|365107598|FG000|Overall Study|Lost to Follow-up|5|||
105849086|NCT00210249|365107598|FG000|Overall Study|Protocol Violation|11|||
105849087|NCT02518919|365107601|FG000|Overall Study|Protocol Violation|1|||
105849088|NCT02518919|365107602|FG001|Overall Study|Protocol Violation|1|||
105849089|NCT02518919|365107603|FG002|Overall Study|Protocol Violation|2|||
105849090|NCT00599521|365107604|FG000|Overall Study|Lack of Efficacy|4|||
105849091|NCT00599521|365107605|FG001|Overall Study|Lack of Efficacy|8|||
105849092|NCT00599521|365107604|FG000|Overall Study|Adverse Event|4|||
105849093|NCT00599521|365107605|FG001|Overall Study|Adverse Event|1|||
105849094|NCT00599521|365107604|FG000|Overall Study|Withdrawal by Subject|28|||
105849095|NCT00599521|365107605|FG001|Overall Study|Withdrawal by Subject|34|||
105849096|NCT00599521|365107604|FG000|Overall Study|Protocol Violation|1|||
105849097|NCT00599521|365107605|FG001|Overall Study|Protocol Violation|1|||
105849098|NCT00599521|365107604|FG000|Overall Study|Lost to Follow-up|23|||
105849099|NCT00599521|365107605|FG001|Overall Study|Lost to Follow-up|23|||
105849100|NCT00599521|365107604|FG000|Overall Study|Pregnancy|0|||
105849101|NCT00599521|365107605|FG001|Overall Study|Pregnancy|2|||
105849102|NCT04498403|365107606|FG000|Overall Study|Adverse Event|1|||
105849103|NCT04498403|365107607|FG001|Overall Study|Adverse Event|0|||
105849104|NCT04498403|365107606|FG000|Overall Study|Study Terminated By Sponsor|29|||
105849105|NCT04498403|365107607|FG001|Overall Study|Study Terminated By Sponsor|10|||
105849106|NCT02132637|365107608|FG000|Study Period 1|Withdrawal by Subject|0|||
105849107|NCT02132637|365107609|FG001|Study Period 1|Withdrawal by Subject|4|||
105849108|NCT02132637|365107608|FG000|Study Period 1|Physician Decision|1|||
105849109|NCT02132637|365107609|FG001|Study Period 1|Physician Decision|0|||
105849110|NCT02132637|365107608|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
105849111|NCT02132637|365107609|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
105849112|NCT02132637|365107608|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
105849113|NCT02132637|365107609|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
105849114|NCT00922272|365107610|FG000|Open-label Phase|Adverse Event|5|||
105849115|NCT00922272|365107611|FG001|Open-label Phase|Adverse Event|0|||
105849116|NCT00922272|365107610|FG000|Open-label Phase|Protocol Violation|1|||
105849117|NCT00922272|365107611|FG001|Open-label Phase|Protocol Violation|0|||
105849118|NCT00922272|365107610|FG000|Open-label Phase|Withdrawal by Subject|11|||
105849119|NCT00922272|365107611|FG001|Open-label Phase|Withdrawal by Subject|0|||
105849120|NCT00922272|365107610|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
105849121|NCT00922272|365107611|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
105849122|NCT00922272|365107610|FG000|Open-label Phase|Withdrawal criteria met|5|||
105849123|NCT00922272|365107611|FG001|Open-label Phase|Withdrawal criteria met|0|||
105849124|NCT00922272|365107610|FG000|Double-blind Phase|Adverse Event|1|||
105849125|NCT00922272|365107611|FG001|Double-blind Phase|Adverse Event|1|||
105849126|NCT00922272|365107610|FG000|Double-blind Phase|Withdrawal by Subject|1|||
105849127|NCT00922272|365107611|FG001|Double-blind Phase|Withdrawal by Subject|1|||
105849128|NCT00922272|365107610|FG000|Double-blind Phase|Lost to Follow-up|2|||
105849129|NCT00922272|365107611|FG001|Double-blind Phase|Lost to Follow-up|1|||
105849130|NCT00922272|365107610|FG000|Double-blind Phase|Withdrawal criteria met|1|||
105849131|NCT00922272|365107611|FG001|Double-blind Phase|Withdrawal criteria met|1|||
105849132|NCT00922272|365107610|FG000|Double-blind Phase|Noncompliance|1|||
105849133|NCT00922272|365107611|FG001|Double-blind Phase|Noncompliance|1|||
105849134|NCT00922272|365107610|FG000|Double-blind Phase|Positive urine drug screen|1|||
105849135|NCT00922272|365107611|FG001|Double-blind Phase|Positive urine drug screen|1|||
105849136|NCT00609518|365107612|FG000|Overall Study|Death from Study Disease|32|||
105849137|NCT00609518|365107613|FG001|Overall Study|Death from Study Disease|32|||
105849138|NCT00609518|365107612|FG000|Overall Study|Withdrawal by Subject|5|||
105849139|NCT00609518|365107613|FG001|Overall Study|Withdrawal by Subject|3|||
105849140|NCT00609518|365107612|FG000|Overall Study|Lost to Follow-up|3|||
105849141|NCT00609518|365107613|FG001|Overall Study|Lost to Follow-up|0|||
105849142|NCT00609518|365107612|FG000|Overall Study|Physician Decision|1|||
105369226|NCT01863771|363358385|FG003|Maintenance Phase|Lack of Efficacy|38|||
105849143|NCT00609518|365107613|FG001|Overall Study|Physician Decision|3|||
105849144|NCT00609518|365107612|FG000|Overall Study|Death from Adverse Event|2|||
105849145|NCT00609518|365107613|FG001|Overall Study|Death from Adverse Event|2|||
105849146|NCT00824616|365107614|FG000|Overall Study|Adverse Event|2|||
105849147|NCT00824616|365107615|FG001|Overall Study|Adverse Event|1|||
105849148|NCT00824616|365107614|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
105849149|NCT00824616|365107615|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
105849150|NCT00824616|365107614|FG000|Overall Study|Hyperglycemia|1|||
105849151|NCT00824616|365107615|FG001|Overall Study|Hyperglycemia|1|||
105849152|NCT00824616|365107614|FG000|Overall Study|Lack of Efficacy|2|||
105849153|NCT00824616|365107615|FG001|Overall Study|Lack of Efficacy|1|||
105849154|NCT00824616|365107614|FG000|Overall Study|Lost to Follow-up|0|||
105317820|NCT00887289|363160216|FG000|Overall Study|Withdrawal by Subject|26|||
105317821|NCT00887289|363160216|FG000|Overall Study|Lost to Follow-up|8|||
105317822|NCT00887289|363160216|FG000|Overall Study|Other|20|||
105317823|NCT02077140|363160217|FG000|Overall Study|Lost to Follow-up|4|||
105317824|NCT02077140|363160218|FG001|Overall Study|Lost to Follow-up|1|||
105317825|NCT02077140|363160219|FG002|Overall Study|Lost to Follow-up|2|||
105317826|NCT02077140|363160220|FG003|Overall Study|Lost to Follow-up|2|||
105317827|NCT02077140|363160221|FG004|Overall Study|Lost to Follow-up|3|||
105317828|NCT02077140|363160217|FG000|Overall Study|Withdrawal by Subject|0|||
105317829|NCT02077140|363160218|FG001|Overall Study|Withdrawal by Subject|1|||
105317830|NCT02077140|363160219|FG002|Overall Study|Withdrawal by Subject|0|||
105317831|NCT02077140|363160220|FG003|Overall Study|Withdrawal by Subject|2|||
105317832|NCT02077140|363160221|FG004|Overall Study|Withdrawal by Subject|2|||
105317833|NCT00974922|363160222|FG000|Overall Study|study terminated|24|||
105317834|NCT00591773|363160223|FG000|Overall Study|Adverse Event|9|||
105317835|NCT00591773|363160224|FG001|Overall Study|Adverse Event|9|||
105317836|NCT00591773|363160225|FG002|Overall Study|Adverse Event|6|||
105317837|NCT00591773|363160223|FG000|Overall Study|Protocol Violation|2|||
105317838|NCT00591773|363160224|FG001|Overall Study|Protocol Violation|3|||
105317839|NCT00591773|363160225|FG002|Overall Study|Protocol Violation|0|||
105317840|NCT00591773|363160223|FG000|Overall Study|Lost to Follow-up|1|||
105317841|NCT00591773|363160224|FG001|Overall Study|Lost to Follow-up|4|||
105317842|NCT00591773|363160225|FG002|Overall Study|Lost to Follow-up|1|||
105317843|NCT00591773|363160223|FG000|Overall Study|Withdrawal by Subject|2|||
105317844|NCT00591773|363160224|FG001|Overall Study|Withdrawal by Subject|5|||
105317845|NCT00591773|363160225|FG002|Overall Study|Withdrawal by Subject|3|||
105317846|NCT00591773|363160223|FG000|Overall Study|Lack of Efficacy|1|||
105317847|NCT00591773|363160224|FG001|Overall Study|Lack of Efficacy|2|||
105317848|NCT00591773|363160225|FG002|Overall Study|Lack of Efficacy|2|||
105317849|NCT00591773|363160223|FG000|Overall Study|Other|1|||
105317850|NCT00591773|363160224|FG001|Overall Study|Other|1|||
105317851|NCT00591773|363160225|FG002|Overall Study|Other|4|||
105317852|NCT01009814|363160228|FG000|Overall Study|No longer met study criteria|1|||
105317853|NCT01009814|363160229|FG001|Overall Study|No longer met study criteria|1|||
105317854|NCT01009814|363160230|FG002|Overall Study|No longer met study criteria|0|||
105317855|NCT01009814|363160231|FG003|Overall Study|No longer met study criteria|0|||
105317856|NCT01009814|363160232|FG004|Overall Study|No longer met study criteria|0|||
105317857|NCT02135614|363160233|FG000|Overall Study|Randomized but Not Treated|2|||
105317858|NCT02135614|363160234|FG001|Overall Study|Randomized but Not Treated|1|||
105317859|NCT02135614|363160233|FG000|Overall Study|Adverse Event|0|||
105317860|NCT02135614|363160234|FG001|Overall Study|Adverse Event|1|||
105317861|NCT02135614|363160233|FG000|Overall Study|Death|1|||
105317862|NCT02135614|363160234|FG001|Overall Study|Death|0|||
105317863|NCT02135614|363160233|FG000|Overall Study|Investigator's Discretion|0|||
105317864|NCT02135614|363160234|FG001|Overall Study|Investigator's Discretion|1|||
105317865|NCT02135614|363160233|FG000|Overall Study|Withdrew Consent|2|||
105317866|NCT02135614|363160234|FG001|Overall Study|Withdrew Consent|2|||
105317867|NCT02135614|363160233|FG000|Overall Study|Lost to Follow-up|3|||
105317868|NCT02135614|363160234|FG001|Overall Study|Lost to Follow-up|0|||
105317869|NCT00618371|363160235|FG000|Overall Study|Withdrawal by Subject|2|||
105317870|NCT03055624|363160242|FG000|Overall Study|Study closed|9|||
105317871|NCT02437903|363160245|FG000|Overall Study|Adverse Event|1|||
105317872|NCT02437903|363160245|FG000|Overall Study|Withdrawal by Subject|1|||
105317873|NCT02437903|363160245|FG000|Overall Study|Lost to Follow-up|3|||
105317874|NCT00230178|363160246|FG000|Overall Study|Adverse Event|1|||
105317875|NCT00230178|363160247|FG001|Overall Study|Adverse Event|5|||
105317876|NCT00230178|363160248|FG002|Overall Study|Adverse Event|2|||
105317877|NCT00230178|363160246|FG000|Overall Study|Withdrawal by Subject|0|||
105317878|NCT00230178|363160247|FG001|Overall Study|Withdrawal by Subject|0|||
105317879|NCT00230178|363160248|FG002|Overall Study|Withdrawal by Subject|1|||
105317880|NCT00230178|363160246|FG000|Overall Study|Various other reasons|3|||
105317881|NCT00230178|363160247|FG001|Overall Study|Various other reasons|2|||
105317882|NCT00230178|363160248|FG002|Overall Study|Various other reasons|4|||
105317883|NCT00444587|363160253|FG000|Overall Study|Death|2|||
105317884|NCT00444587|363160254|FG001|Overall Study|Death|1|||
105317885|NCT00444587|363160253|FG000|Overall Study|Progression of the disease|73|||
105317886|NCT00444587|363160254|FG001|Overall Study|Progression of the disease|8|||
105317887|NCT00444587|363160253|FG000|Overall Study|Refused treatment/did not cooperate|4|||
105317888|NCT00444587|363160254|FG001|Overall Study|Refused treatment/did not cooperate|1|||
105317889|NCT00444587|363160253|FG000|Overall Study|Investigator decision|3|||
105317890|NCT00444587|363160254|FG001|Overall Study|Investigator decision|0|||
105317891|NCT00444587|363160253|FG000|Overall Study|Protocol Violation|1|||
105317892|NCT00444587|363160254|FG001|Overall Study|Protocol Violation|0|||
105317893|NCT00444587|363160253|FG000|Overall Study|Missing|0|||
105317894|NCT00444587|363160254|FG001|Overall Study|Missing|5|||
105317895|NCT00595309|363160255|FG000|Overall Study|Lost to Follow-up|1|||
105317896|NCT00595309|363160255|FG000|Overall Study|planned vaccination against yellow fever|1|||
105317897|NCT00595309|363160255|FG000|Overall Study|acute infection after V0|1|||
105317898|NCT00595309|363160255|FG000|Overall Study|personal reason|1|||
105369227|NCT01863771|363358382|FG000|Maintenance Phase|Physician Decision|0|||
105369228|NCT01863771|363358383|FG001|Maintenance Phase|Physician Decision|0|||
105369229|NCT01863771|363358384|FG002|Maintenance Phase|Physician Decision|2|||
105369230|NCT01863771|363358385|FG003|Maintenance Phase|Physician Decision|1|||
105369231|NCT01863771|363358382|FG000|Maintenance Phase|Pregnancy|0|||
105369232|NCT01863771|363358383|FG001|Maintenance Phase|Pregnancy|1|||
105369233|NCT01863771|363358384|FG002|Maintenance Phase|Pregnancy|0|||
105369234|NCT01863771|363358385|FG003|Maintenance Phase|Pregnancy|0|||
105369235|NCT01863771|363358382|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105369236|NCT01863771|363358383|FG001|Maintenance Phase|Withdrawal by Subject|1|||
105369237|NCT01863771|363358384|FG002|Maintenance Phase|Withdrawal by Subject|2|||
105369238|NCT01863771|363358385|FG003|Maintenance Phase|Withdrawal by Subject|3|||
105369239|NCT03499795|363358386|FG000|Overall Study|Adverse Event|1|||
105369240|NCT03499795|363358386|FG000|Overall Study|Lost to Follow-up|1|||
105369241|NCT03098979|363358391|FG000|Overall Study|Adverse Event|1|||
105576766|NCT00932646|364110320|FG001|Overall Study|Adverse Event|1|||
105849155|NCT00824616|365107615|FG001|Overall Study|Lost to Follow-up|1|||
105849156|NCT00824616|365107614|FG000|Overall Study|Withdrawal by Subject|1|||
105849157|NCT00824616|365107615|FG001|Overall Study|Withdrawal by Subject|1|||
105849158|NCT01700049|365107616|FG000|Overall Study|Withdrawal by Subject|1|||
105849159|NCT03827564|365107619|FG000|Overall Study|Discontinued due to Study Termination|1|||
105849160|NCT03827564|365107620|FG001|Overall Study|Discontinued due to Study Termination|0|||
105849161|NCT04397445|365107621|FG000|Overall Study|Withdrawal by Subject|1|||
105849162|NCT04397445|365107622|FG001|Overall Study|Withdrawal by Subject|0|||
105849163|NCT04397445|365107623|FG002|Overall Study|Withdrawal by Subject|0|||
105849164|NCT04397445|365107624|FG003|Overall Study|Withdrawal by Subject|0|||
105849165|NCT02622113|365107625|FG000|Overall Study|Adverse Event|4|||
105849166|NCT02622113|365107626|FG001|Overall Study|Adverse Event|4|||
105849167|NCT02622113|365107625|FG000|Overall Study|Physician Decision|0|||
105849168|NCT02622113|365107626|FG001|Overall Study|Physician Decision|1|||
105849169|NCT02622113|365107625|FG000|Overall Study|Withdrawal by Subject|0|||
105849170|NCT02622113|365107626|FG001|Overall Study|Withdrawal by Subject|2|||
105849171|NCT02622113|365107625|FG000|Overall Study|Stopping Criteria|1|||
105849172|NCT02622113|365107626|FG001|Overall Study|Stopping Criteria|3|||
105849173|NCT04112173|365107634|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
105849174|NCT01561430|365107635|FG000|Overall Study|Adverse Event|0|||
105849175|NCT01561430|365107636|FG001|Overall Study|Adverse Event|0|||
105849176|NCT01561430|365107637|FG002|Overall Study|Adverse Event|3|||
105849177|NCT01561430|365107638|FG003|Overall Study|Adverse Event|1|||
105849178|NCT01561430|365107635|FG000|Overall Study|Withdrawal by Subject|0|||
105849179|NCT01561430|365107636|FG001|Overall Study|Withdrawal by Subject|0|||
105849180|NCT01561430|365107637|FG002|Overall Study|Withdrawal by Subject|1|||
105849181|NCT01561430|365107638|FG003|Overall Study|Withdrawal by Subject|0|||
105849182|NCT01561430|365107635|FG000|Overall Study|Physician Decision|0|||
105849183|NCT01561430|365107636|FG001|Overall Study|Physician Decision|1|||
105849184|NCT01561430|365107637|FG002|Overall Study|Physician Decision|0|||
105849185|NCT01561430|365107638|FG003|Overall Study|Physician Decision|0|||
105849186|NCT01561430|365107635|FG000|Overall Study|Sponsor Decision|1|||
105849187|NCT01561430|365107636|FG001|Overall Study|Sponsor Decision|14|||
105849188|NCT01561430|365107637|FG002|Overall Study|Sponsor Decision|13|||
105849189|NCT01561430|365107638|FG003|Overall Study|Sponsor Decision|12|||
105849190|NCT02038907|365107639|FG000|Overall Study|Protocol Violation|0|||
105849191|NCT02038907|365107640|FG001|Overall Study|Protocol Violation|0|||
105849192|NCT02038907|365107641|FG002|Overall Study|Protocol Violation|0|||
105849193|NCT02038907|365107642|FG003|Overall Study|Protocol Violation|0|||
105849194|NCT02038907|365107643|FG004|Overall Study|Protocol Violation|0|||
105849195|NCT02038907|365107644|FG005|Overall Study|Protocol Violation|0|||
105849196|NCT02038907|365107645|FG006|Overall Study|Protocol Violation|0|||
105849197|NCT02038907|365107646|FG007|Overall Study|Protocol Violation|0|||
105849198|NCT02038907|365107647|FG008|Overall Study|Protocol Violation|0|||
105849199|NCT02038907|365107648|FG009|Overall Study|Protocol Violation|0|||
105849200|NCT02038907|365107649|FG010|Overall Study|Protocol Violation|1|||
105849201|NCT02038907|365107650|FG011|Overall Study|Protocol Violation|0|||
105849202|NCT02038907|365107651|FG012|Overall Study|Protocol Violation|0|||
105849203|NCT02038907|365107652|FG013|Overall Study|Protocol Violation|0|||
105849204|NCT02038907|365107639|FG000|Overall Study|Withdrawal by Subject|0|||
105849205|NCT02038907|365107640|FG001|Overall Study|Withdrawal by Subject|0|||
105849206|NCT02038907|365107641|FG002|Overall Study|Withdrawal by Subject|0|||
105849207|NCT02038907|365107642|FG003|Overall Study|Withdrawal by Subject|0|||
105849208|NCT02038907|365107643|FG004|Overall Study|Withdrawal by Subject|0|||
105849209|NCT02038907|365107644|FG005|Overall Study|Withdrawal by Subject|0|||
105849210|NCT02038907|365107645|FG006|Overall Study|Withdrawal by Subject|0|||
105849211|NCT02038907|365107646|FG007|Overall Study|Withdrawal by Subject|0|||
105849212|NCT02038907|365107647|FG008|Overall Study|Withdrawal by Subject|0|||
105369242|NCT03098979|363358392|FG001|Overall Study|Adverse Event|0|||
105849213|NCT02038907|365107648|FG009|Overall Study|Withdrawal by Subject|0|||
105849214|NCT02038907|365107649|FG010|Overall Study|Withdrawal by Subject|1|||
105849215|NCT02038907|365107650|FG011|Overall Study|Withdrawal by Subject|0|||
105369243|NCT03098979|363358393|FG002|Overall Study|Adverse Event|1|||
105369244|NCT03098979|363358394|FG003|Overall Study|Adverse Event|4|||
105369245|NCT03098979|363358395|FG004|Overall Study|Adverse Event|6|||
105369246|NCT03098979|363358396|FG005|Overall Study|Adverse Event|1|||
105369247|NCT03098979|363358391|FG000|Overall Study|Withdrawal by Subject|2|||
105369248|NCT03098979|363358392|FG001|Overall Study|Withdrawal by Subject|1|||
105369249|NCT03098979|363358393|FG002|Overall Study|Withdrawal by Subject|1|||
105369250|NCT03098979|363358394|FG003|Overall Study|Withdrawal by Subject|1|||
105369251|NCT03098979|363358395|FG004|Overall Study|Withdrawal by Subject|2|||
105369252|NCT03098979|363358396|FG005|Overall Study|Withdrawal by Subject|1|||
105369253|NCT03098979|363358391|FG000|Overall Study|Death|1|||
105369254|NCT03098979|363358392|FG001|Overall Study|Death|0|||
105369255|NCT03098979|363358393|FG002|Overall Study|Death|2|||
105369256|NCT03098979|363358394|FG003|Overall Study|Death|0|||
105369257|NCT03098979|363358395|FG004|Overall Study|Death|1|||
105369258|NCT03098979|363358396|FG005|Overall Study|Death|0|||
105369259|NCT03098979|363358391|FG000|Overall Study|Physician Decision|2|||
105369260|NCT03098979|363358392|FG001|Overall Study|Physician Decision|1|||
105369261|NCT03098979|363358393|FG002|Overall Study|Physician Decision|0|||
105369262|NCT03098979|363358394|FG003|Overall Study|Physician Decision|0|||
105369263|NCT03098979|363358395|FG004|Overall Study|Physician Decision|0|||
105369264|NCT03098979|363358396|FG005|Overall Study|Physician Decision|0|||
105369265|NCT03098979|363358391|FG000|Overall Study|Non-compliance|0|||
105317899|NCT00101283|363160256|FG000|Overall Study|Withdrawal by Subject|0|||
105317900|NCT00101283|363160257|FG001|Overall Study|Withdrawal by Subject|1|||
105317901|NCT00101283|363160256|FG000|Overall Study|Insurance Refusal|0|||
105317902|NCT00101283|363160257|FG001|Overall Study|Insurance Refusal|1|||
105317903|NCT00101283|363160256|FG000|Overall Study|Prostate Cancer Recurrence|0|||
105317904|NCT00101283|363160257|FG001|Overall Study|Prostate Cancer Recurrence|1|||
105317905|NCT03993379|363160258|FG000|Overall Study|The study was terminated early due to business decision.|0|||
105317906|NCT03993379|363160259|FG001|Overall Study|The study was terminated early due to business decision.|2|||
105317907|NCT03993379|363160260|FG002|Overall Study|The study was terminated early due to business decision.|0|||
105317908|NCT03993379|363160261|FG003|Overall Study|The study was terminated early due to business decision.|0|||
105317909|NCT03993379|363160258|FG000|Overall Study|Withdrawal by Subject|0|||
105317910|NCT03993379|363160259|FG001|Overall Study|Withdrawal by Subject|1|||
105317911|NCT03993379|363160260|FG002|Overall Study|Withdrawal by Subject|0|||
105317912|NCT03993379|363160261|FG003|Overall Study|Withdrawal by Subject|0|||
105317913|NCT01473407|363160262|FG000|Overall Study|Physician Decision|1|||
105317914|NCT01473407|363160263|FG001|Overall Study|Physician Decision|4|||
105317915|NCT01473407|363160262|FG000|Overall Study|Lost to Follow-up|10|||
105317916|NCT01473407|363160263|FG001|Overall Study|Lost to Follow-up|4|||
105317917|NCT01473407|363160262|FG000|Overall Study|Adverse Event|8|||
105317918|NCT01473407|363160263|FG001|Overall Study|Adverse Event|8|||
105317919|NCT01473407|363160262|FG000|Overall Study|Randomization Error|3|||
105317920|NCT01473407|363160263|FG001|Overall Study|Randomization Error|1|||
105317921|NCT01473407|363160262|FG000|Overall Study|Withdrawal by Subject|4|||
105317922|NCT01473407|363160263|FG001|Overall Study|Withdrawal by Subject|7|||
105317923|NCT01473407|363160262|FG000|Overall Study|Kidney Transplant|7|||
105317924|NCT01473407|363160263|FG001|Overall Study|Kidney Transplant|6|||
105317925|NCT01473407|363160262|FG000|Overall Study|Vacation/Travel|1|||
105317926|NCT01473407|363160263|FG001|Overall Study|Vacation/Travel|1|||
105317927|NCT01473407|363160262|FG000|Overall Study|Elevated Hemoglobin|1|||
105317928|NCT01473407|363160263|FG001|Overall Study|Elevated Hemoglobin|0|||
105369266|NCT03098979|363358392|FG001|Overall Study|Non-compliance|0|||
105369267|NCT03098979|363358393|FG002|Overall Study|Non-compliance|0|||
105369268|NCT03098979|363358394|FG003|Overall Study|Non-compliance|0|||
105369269|NCT03098979|363358395|FG004|Overall Study|Non-compliance|0|||
105369270|NCT03098979|363358396|FG005|Overall Study|Non-compliance|1|||
105317929|NCT01473407|363160262|FG000|Overall Study|Patient Received Aranesp|1|||
105317930|NCT01473407|363160263|FG001|Overall Study|Patient Received Aranesp|0|||
105317931|NCT01473407|363160262|FG000|Overall Study|Patient Lost Green Card Status|1|||
105317932|NCT01473407|363160263|FG001|Overall Study|Patient Lost Green Card Status|0|||
105317933|NCT01473407|363160262|FG000|Overall Study|Temperature Excursion|2|||
105317934|NCT01473407|363160263|FG001|Overall Study|Temperature Excursion|3|||
105317935|NCT01473407|363160262|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
105317936|NCT01473407|363160263|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
105317937|NCT01473407|363160262|FG000|Overall Study|Sponsor's Decision|10|||
105317938|NCT01473407|363160263|FG001|Overall Study|Sponsor's Decision|10|||
105317939|NCT01473407|363160262|FG000|Overall Study|Site Closure|1|||
105317940|NCT01473407|363160263|FG001|Overall Study|Site Closure|0|||
105369271|NCT03098979|363358391|FG000|Overall Study|Protocol Violation|0|||
105369272|NCT03098979|363358392|FG001|Overall Study|Protocol Violation|0|||
105317941|NCT02422797|363160264|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
105317942|NCT02422797|363160265|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
105317943|NCT02422797|363160264|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
105369273|NCT03098979|363358393|FG002|Overall Study|Protocol Violation|0|||
105369274|NCT03098979|363358394|FG003|Overall Study|Protocol Violation|0|||
105369275|NCT03098979|363358395|FG004|Overall Study|Protocol Violation|0|||
105369276|NCT03098979|363358396|FG005|Overall Study|Protocol Violation|1|||
105369277|NCT01248455|363358397|FG000|Overall Study|switched to alternate treatment|1|||
105369278|NCT01065818|363358398|FG000|Overall Study|Withdrawal by Subject|1|||
105369279|NCT01065818|363358398|FG000|Overall Study|Not a candidate for surgery|1|||
105369280|NCT00083915|363358404|FG000|Overall Study|Death|6|||
105369281|NCT00083915|363358405|FG001|Overall Study|Death|3|||
105369282|NCT00083915|363358404|FG000|Overall Study|Physician Decision|11|||
105369283|NCT00083915|363358405|FG001|Overall Study|Physician Decision|6|||
105369284|NCT00083915|363358404|FG000|Overall Study|Withdrawal by Subject|8|||
105369285|NCT00083915|363358405|FG001|Overall Study|Withdrawal by Subject|3|||
105369286|NCT00083915|363358404|FG000|Overall Study|disease progression|18|||
105369287|NCT00083915|363358405|FG001|Overall Study|disease progression|23|||
105369288|NCT00083915|363358404|FG000|Overall Study|Failure to collect|3|||
105369289|NCT00083915|363358405|FG001|Overall Study|Failure to collect|0|||
105369290|NCT00083915|363358404|FG000|Overall Study|No response|3|||
105369291|NCT00083915|363358405|FG001|Overall Study|No response|1|||
105369292|NCT00083915|363358404|FG000|Overall Study|Insurance issues|1|||
105369293|NCT00083915|363358405|FG001|Overall Study|Insurance issues|1|||
105369294|NCT01245101|363358411|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
105369295|NCT01245101|363358412|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
105369296|NCT01245101|363358411|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
105369297|NCT01245101|363358412|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
105369298|NCT01245101|363358411|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
105369299|NCT01245101|363358412|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
105369300|NCT04456686|363358413|FG000|Overall Study|Adverse Event|2|||
105369301|NCT04456686|363358414|FG001|Overall Study|Adverse Event|1|||
105369302|NCT04456686|363358413|FG000|Overall Study|Lack of Efficacy|3|||
105369303|NCT04456686|363358414|FG001|Overall Study|Lack of Efficacy|1|||
105369304|NCT04456686|363358413|FG000|Overall Study|Withdrew consent|3|||
105369305|NCT04456686|363358414|FG001|Overall Study|Withdrew consent|1|||
105369306|NCT04456686|363358413|FG000|Overall Study|Physician Decision|2|||
105369307|NCT04456686|363358414|FG001|Overall Study|Physician Decision|2|||
105369308|NCT04456686|363358413|FG000|Overall Study|Withdrawal by Subject|5|||
105369309|NCT04456686|363358414|FG001|Overall Study|Withdrawal by Subject|1|||
105369310|NCT04456686|363358413|FG000|Overall Study|Protocol Violation|0|||
105369311|NCT04456686|363358414|FG001|Overall Study|Protocol Violation|1|||
105369312|NCT01225549|363358415|FG000|Period 4 - Washout|Disallowed medication|0|||
105369313|NCT01225549|363358416|FG001|Period 4 - Washout|Disallowed medication|1|||
105369314|NCT01225549|363358417|FG002|Period 4 - Washout|Disallowed medication|0|||
105369315|NCT01225549|363358418|FG003|Period 4 - Washout|Disallowed medication|0|||
105849216|NCT02038907|365107651|FG012|Overall Study|Withdrawal by Subject|0|||
105849217|NCT02038907|365107652|FG013|Overall Study|Withdrawal by Subject|0|||
105849218|NCT00688376|365107653|FG000|Double-Blind Phase|Adverse Event|4|||
105849219|NCT00688376|365107654|FG001|Double-Blind Phase|Adverse Event|4|||
105849220|NCT00688376|365107653|FG000|Double-Blind Phase|Protocol Violation|1|||
105849221|NCT00688376|365107654|FG001|Double-Blind Phase|Protocol Violation|2|||
105849222|NCT00688376|365107653|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
105849223|NCT00688376|365107654|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
105849224|NCT00688376|365107653|FG000|Double-Blind Phase|Not treated|0|||
105849225|NCT00688376|365107654|FG001|Double-Blind Phase|Not treated|1|||
105849226|NCT00688376|365107653|FG000|Blinded Extension Phase|Adverse Event|3|||
105849227|NCT00688376|365107654|FG001|Blinded Extension Phase|Adverse Event|4|||
105849228|NCT00688376|365107653|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
105849229|NCT00688376|365107654|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
105849230|NCT00688376|365107653|FG000|Blinded Extension Phase|Physician Decision|1|||
105849231|NCT00688376|365107654|FG001|Blinded Extension Phase|Physician Decision|0|||
105849232|NCT00688376|365107653|FG000|Blinded Extension Phase|Other|1|||
105849233|NCT00688376|365107654|FG001|Blinded Extension Phase|Other|0|||
105849234|NCT03579966|365107658|FG000|Overall Study|Adverse Event|6|||
105849235|NCT03579966|365107658|FG000|Overall Study|Lost to Follow-up|4|||
105849236|NCT03579966|365107658|FG000|Overall Study|Physician Decision|10|||
105849237|NCT03579966|365107658|FG000|Overall Study|Pregnancy|1|||
105849238|NCT03579966|365107658|FG000|Overall Study|Withdrawal by Subject|16|||
105849239|NCT03579966|365107658|FG000|Overall Study|Study terminated by Sponsor|22|||
105369316|NCT01225549|363358419|FG004|Period 4 - Washout|Disallowed medication|0|||
105849240|NCT03579966|365107658|FG000|Overall Study|Protocol Violation|1|||
105849241|NCT00003875|365107659|FG000|Overall Study|Screen Failed|1|||
105849242|NCT00969540|365107660|FG000|Overall Study|Lost to Follow-up|1|||
105849243|NCT00969540|365107661|FG001|Overall Study|Lost to Follow-up|1|||
105849244|NCT01646138|365107662|FG000|Overall Study|Lost to Follow-up|0|||
105369317|NCT01225549|363358420|FG005|Period 4 - Washout|Disallowed medication|0|||
105369318|NCT01225549|363358421|FG006|Period 4 - Washout|Disallowed medication|0|||
105369319|NCT01225549|363358422|FG007|Period 4 - Washout|Disallowed medication|0|||
105369320|NCT01225549|363358423|FG008|Period 4 - Washout|Disallowed medication|0|||
105369321|NCT01225549|363358424|FG009|Period 4 - Washout|Disallowed medication|0|||
105369322|NCT01225549|363358415|FG000|Period 6 - Washout|Disallowed medication|0|||
105369323|NCT01225549|363358416|FG001|Period 6 - Washout|Disallowed medication|0|||
105317944|NCT02422797|363160265|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
105317945|NCT02422797|363160264|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
105317946|NCT02422797|363160265|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
105317947|NCT02422797|363160264|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
105317948|NCT02422797|363160265|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
105317949|NCT02422797|363160264|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
105317950|NCT02422797|363160265|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
105317951|NCT02422797|363160264|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
105317952|NCT02422797|363160265|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
105317953|NCT02422797|363160264|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
105317954|NCT02422797|363160265|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
105317955|NCT02422797|363160264|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
105317956|NCT02422797|363160265|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
105317957|NCT02422797|363160264|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
105317958|NCT02422797|363160265|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
105317959|NCT02422797|363160264|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
105317960|NCT02422797|363160265|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
105317961|NCT02422797|363160264|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
105317962|NCT02422797|363160265|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
105317963|NCT02422797|363160264|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
105317964|NCT02422797|363160265|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
105317965|NCT02422797|363160264|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
105317966|NCT02422797|363160265|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
105317967|NCT02422797|363160264|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
105317968|NCT02422797|363160265|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
105317969|NCT02422797|363160264|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
105317970|NCT02422797|363160265|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
105317971|NCT02422797|363160264|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
105317972|NCT02422797|363160265|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
105317973|NCT02422797|363160264|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
105317974|NCT02422797|363160265|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
105317975|NCT02422797|363160264|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
105317976|NCT02422797|363160265|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
105317977|NCT02422797|363160264|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
105317978|NCT02422797|363160265|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
105317979|NCT02422797|363160264|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
105317980|NCT02422797|363160265|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
105317981|NCT02422797|363160264|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
105317982|NCT02422797|363160265|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
105317983|NCT01027702|363160268|FG000|Overall Study|Received subsequent therapy|1|||
105317984|NCT01027702|363160269|FG001|Overall Study|Received subsequent therapy|2|||
105317985|NCT01027702|363160270|FG002|Overall Study|Received subsequent therapy|0|||
105317986|NCT01027702|363160271|FG003|Overall Study|Received subsequent therapy|4|||
105317987|NCT01027702|363160272|FG004|Overall Study|Received subsequent therapy|1|||
105317988|NCT01027702|363160273|FG005|Overall Study|Received subsequent therapy|0|||
105317989|NCT01027702|363160274|FG006|Overall Study|Received subsequent therapy|1|||
105317990|NCT01027702|363160268|FG000|Overall Study|Death|0|||
105317991|NCT01027702|363160269|FG001|Overall Study|Death|0|||
105317992|NCT01027702|363160270|FG002|Overall Study|Death|1|||
105317993|NCT01027702|363160271|FG003|Overall Study|Death|0|||
105369324|NCT01225549|363358417|FG002|Period 6 - Washout|Disallowed medication|0|||
105369325|NCT01225549|363358418|FG003|Period 6 - Washout|Disallowed medication|1|||
105369326|NCT01225549|363358419|FG004|Period 6 - Washout|Disallowed medication|0|||
105369327|NCT01225549|363358420|FG005|Period 6 - Washout|Disallowed medication|0|||
105369328|NCT01225549|363358421|FG006|Period 6 - Washout|Disallowed medication|0|||
105317994|NCT01027702|363160272|FG004|Overall Study|Death|0|||
105317995|NCT01027702|363160273|FG005|Overall Study|Death|0|||
105317996|NCT01027702|363160274|FG006|Overall Study|Death|0|||
105317997|NCT02301390|363160275|FG000|Overall Study|Withdrawal by Subject|3|||
105317998|NCT02301390|363160276|FG001|Overall Study|Withdrawal by Subject|5|||
105317999|NCT02301390|363160275|FG000|Overall Study|Protocol Violation|1|||
105318000|NCT02301390|363160276|FG001|Overall Study|Protocol Violation|0|||
105318001|NCT02301390|363160275|FG000|Overall Study|Physician Decision|1|||
105318002|NCT02301390|363160276|FG001|Overall Study|Physician Decision|0|||
105318003|NCT02301390|363160275|FG000|Overall Study|Lost to Follow-up|0|||
105318004|NCT02301390|363160276|FG001|Overall Study|Lost to Follow-up|1|||
105318005|NCT02301390|363160275|FG000|Overall Study|Death|2|||
105318006|NCT02301390|363160276|FG001|Overall Study|Death|2|||
105318007|NCT02301390|363160275|FG000|Overall Study|Procedure not completed|0|||
105369329|NCT01225549|363358422|FG007|Period 6 - Washout|Disallowed medication|0|||
105369330|NCT01225549|363358423|FG008|Period 6 - Washout|Disallowed medication|0|||
105369331|NCT01225549|363358424|FG009|Period 6 - Washout|Disallowed medication|0|||
105849245|NCT01646138|365107663|FG001|Overall Study|Lost to Follow-up|0|||
105849246|NCT01646138|365107664|FG002|Overall Study|Lost to Follow-up|0|||
105849247|NCT01646138|365107665|FG003|Overall Study|Lost to Follow-up|0|||
105849248|NCT01646138|365107666|FG004|Overall Study|Lost to Follow-up|2|||
105849249|NCT03551496|365107667|FG000|Overall Study|Death|11|||
105849250|NCT03551496|365107668|FG001|Overall Study|Death|7|||
105849251|NCT03551496|365107667|FG000|Overall Study|Withdrawal by Subject|4|||
105849252|NCT03551496|365107668|FG001|Overall Study|Withdrawal by Subject|3|||
105849253|NCT03551496|365107667|FG000|Overall Study|Other Reasons|1|||
105849254|NCT03551496|365107668|FG001|Overall Study|Other Reasons|0|||
105849255|NCT01780987|365107669|FG000|Overall Study|Adverse Event|0|||
105849256|NCT01780987|365107670|FG001|Overall Study|Adverse Event|4|||
105849257|NCT01780987|365107669|FG000|Overall Study|Withdrawal by Subject|2|||
105849258|NCT01780987|365107670|FG001|Overall Study|Withdrawal by Subject|0|||
105849259|NCT01780987|365107669|FG000|Overall Study|Request of Changing Hospital|0|||
105849260|NCT01780987|365107670|FG001|Overall Study|Request of Changing Hospital|1|||
105849261|NCT01780987|365107669|FG000|Overall Study|Changing Residence|1|||
105849262|NCT01780987|365107670|FG001|Overall Study|Changing Residence|0|||
105849263|NCT01780987|365107669|FG000|Overall Study|Not Receiving any Study Medication|0|||
105849264|NCT01780987|365107670|FG001|Overall Study|Not Receiving any Study Medication|1|||
105849265|NCT03560986|365107671|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
105849266|NCT03560986|365107672|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
105849267|NCT03560986|365107671|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
105849268|NCT03560986|365107672|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
105849269|NCT03560986|365107671|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
105849270|NCT03560986|365107672|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
105849271|NCT03560986|365107671|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
105849272|NCT03560986|365107672|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
105849273|NCT03560986|365107671|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
105849274|NCT03560986|365107672|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
105849275|NCT03560986|365107671|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
105849276|NCT03560986|365107672|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
105849277|NCT03560986|365107671|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
105849278|NCT03560986|365107672|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
105849279|NCT01971970|365107673|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
105849280|NCT01971970|365107674|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
105849281|NCT01971970|365107673|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
105849282|NCT01971970|365107674|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
105849283|NCT01971970|365107673|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
105849284|NCT01971970|365107674|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
105849285|NCT01971970|365107673|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
105849286|NCT01971970|365107674|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
105849287|NCT01971970|365107673|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
105849288|NCT01971970|365107674|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
105849289|NCT01971970|365107673|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
105849290|NCT01971970|365107674|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
105849291|NCT01971970|365107673|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
105849292|NCT01971970|365107674|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
105849293|NCT00848107|365107675|FG000|Overall Study|Lost to Follow-up|2|||
105849294|NCT00848107|365107675|FG000|Overall Study|Withdrawal by Subject|8|||
105849295|NCT00848107|365107675|FG000|Overall Study|Adverse Event|9|||
105849296|NCT00848107|365107675|FG000|Overall Study|Death|1|||
105849297|NCT00848107|365107675|FG000|Overall Study|Pregnancy|1|||
105849298|NCT00893737|365107676|FG000|Overall Study|Adverse Event|4|||
105849299|NCT00893737|365107676|FG000|Overall Study|Withdrawal by Subject|2|||
105849300|NCT00893737|365107676|FG000|Overall Study|Lost to Follow-up|6|||
105849301|NCT04771403|365107680|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
105849302|NCT04771403|365107681|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
105369332|NCT01122173|363358425|FG000|Overall Study|Lost to Follow-up|3|||
105369333|NCT01122173|363358425|FG000|Overall Study|Withdrawal by Subject|3|||
105369334|NCT01122173|363358425|FG000|Overall Study|Left study for other reasons|3|||
105369335|NCT02915835|363358426|FG000|Overall Study|Physician Decision|1|||
105369336|NCT02915835|363358427|FG001|Overall Study|Physician Decision|0|||
105369337|NCT02915835|363358426|FG000|Overall Study|Withdrawal by Subject|0|||
105490784|NCT00423670|363809417|FG000|Treatment Period|Investigator decision|0|||
105490785|NCT00423670|363809418|FG001|Treatment Period|Investigator decision|0|||
105490786|NCT00423670|363809419|FG002|Treatment Period|Investigator decision|0|||
105490787|NCT00423670|363809420|FG003|Treatment Period|Investigator decision|0|||
105490788|NCT00423670|363809421|FG004|Treatment Period|Investigator decision|0|||
105369338|NCT02915835|363358427|FG001|Overall Study|Withdrawal by Subject|1|||
105369339|NCT01184872|363358428|FG000|Overall Study|Adverse Event|3|||
105369340|NCT01184872|363358429|FG001|Overall Study|Adverse Event|4|||
105369341|NCT01184872|363358428|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
105369342|NCT01184872|363358429|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105369343|NCT01184872|363358428|FG000|Overall Study|Withdrawal by Subject|2|||
105369344|NCT01184872|363358429|FG001|Overall Study|Withdrawal by Subject|0|||
105369345|NCT01184872|363358428|FG000|Overall Study|Lost to Follow-up|0|||
105369346|NCT01184872|363358429|FG001|Overall Study|Lost to Follow-up|1|||
105369347|NCT01184872|363358428|FG000|Overall Study|Administrative problems|1|||
105369348|NCT01184872|363358429|FG001|Overall Study|Administrative problems|1|||
105369349|NCT01184872|363358428|FG000|Overall Study|Protocol deviation|1|||
105369350|NCT01184872|363358429|FG001|Overall Study|Protocol deviation|0|||
105369351|NCT02530385|363358430|FG000|Overall Study|Withdrawal by Subject|0|||
105369352|NCT02530385|363358431|FG001|Overall Study|Withdrawal by Subject|1|||
105369353|NCT01569022|363358433|FG000|First Intervention|Lost to Follow-up|2|||
105369354|NCT01569022|363358434|FG001|First Intervention|Lost to Follow-up|1|||
105369355|NCT01569022|363358433|FG000|Second Intervention|Lost to Follow-up|2|||
105369356|NCT01569022|363358434|FG001|Second Intervention|Lost to Follow-up|2|||
105369357|NCT03722576|363358435|FG000|Overall Study|Withdrawal by Subject|3|||
105369358|NCT03722576|363358435|FG000|Overall Study|Adverse Event|2|||
105369359|NCT03722576|363358435|FG000|Overall Study|Physician Decision|1|||
105369360|NCT03722576|363358435|FG000|Overall Study|Lost to Follow-up|1|||
105369361|NCT03426345|363358440|FG000|Overall Study|Adverse Event|4|||
105369362|NCT03426345|363358441|FG001|Overall Study|Adverse Event|4|||
105369363|NCT03426345|363358440|FG000|Overall Study|Lack of Efficacy|1|||
105369364|NCT03426345|363358441|FG001|Overall Study|Lack of Efficacy|0|||
105369365|NCT03426345|363358440|FG000|Overall Study|Withdrawal by Subject|5|||
105369366|NCT03426345|363358441|FG001|Overall Study|Withdrawal by Subject|6|||
105369367|NCT03426345|363358440|FG000|Overall Study|Lost to Follow-up|3|||
105369368|NCT03426345|363358441|FG001|Overall Study|Lost to Follow-up|1|||
105369369|NCT03426345|363358440|FG000|Overall Study|Protocol Deviation|3|||
105369370|NCT03426345|363358441|FG001|Overall Study|Protocol Deviation|4|||
105369371|NCT03426345|363358440|FG000|Overall Study|Reason Not Specified|1|||
105369372|NCT03426345|363358441|FG001|Overall Study|Reason Not Specified|2|||
105369373|NCT03426345|363358440|FG000|Overall Study|Missing Completion Status|1|||
105369374|NCT03426345|363358441|FG001|Overall Study|Missing Completion Status|0|||
105369375|NCT00116142|363358442|FG000|Overall Study|Adverse Event|8|||
105369376|NCT00116142|363358443|FG001|Overall Study|Adverse Event|7|||
105369377|NCT00116142|363358442|FG000|Overall Study|Protocol Violation|2|||
105369378|NCT00116142|363358443|FG001|Overall Study|Protocol Violation|1|||
105369379|NCT00116142|363358442|FG000|Overall Study|Withdrawal by Subject|5|||
105369380|NCT00116142|363358443|FG001|Overall Study|Withdrawal by Subject|5|||
105369381|NCT00116142|363358442|FG000|Overall Study|Physician Decision|3|||
105369382|NCT00116142|363358443|FG001|Overall Study|Physician Decision|1|||
105369383|NCT00116142|363358442|FG000|Overall Study|Delayed Radiation Therapy|1|||
105369384|NCT00116142|363358443|FG001|Overall Study|Delayed Radiation Therapy|0|||
105369385|NCT00116142|363358442|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
105369386|NCT00116142|363358443|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
105369387|NCT00116142|363358442|FG000|Overall Study|Patient stopped due to depression|0|||
105369388|NCT00116142|363358443|FG001|Overall Study|Patient stopped due to depression|1|||
105369389|NCT00116142|363358442|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
105369390|NCT00116142|363358443|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
105369391|NCT00116142|363358442|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
105369392|NCT00116142|363358443|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
105369393|NCT00116142|363358442|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
105490789|NCT00423670|363809422|FG005|Treatment Period|Investigator decision|0|||
105490790|NCT00423670|363809423|FG006|Treatment Period|Investigator decision|0|||
105490791|NCT00423670|363809424|FG007|Treatment Period|Investigator decision|1|||
105490792|NCT00423670|363809417|FG000|Treatment Period|Non-compliance with protocol|3|||
105490793|NCT00423670|363809418|FG001|Treatment Period|Non-compliance with protocol|1|||
105490794|NCT00423670|363809419|FG002|Treatment Period|Non-compliance with protocol|1|||
105369394|NCT00116142|363358443|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
105369395|NCT02446691|363358450|FG000|Overall Study|Withdrawal by Subject|2|||
105369396|NCT02446691|363358450|FG000|Overall Study|Lost to Follow-up|8|||
105369397|NCT02446691|363358450|FG000|Overall Study|Protocol Violation|1|||
105369398|NCT02497469|363358451|FG000|Overall Study|Randomized but not Treated|0|||
105369399|NCT02497469|363358452|FG001|Overall Study|Randomized but not Treated|2|||
105369400|NCT02497469|363358451|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
105369401|NCT02497469|363358452|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
105576767|NCT00932646|364110321|FG002|Overall Study|Adverse Event|1|||
105318008|NCT02301390|363160276|FG001|Overall Study|Procedure not completed|4|||
105318009|NCT02301390|363160275|FG000|Overall Study|Missed multiple visits|1|||
105318010|NCT02301390|363160276|FG001|Overall Study|Missed multiple visits|1|||
105318011|NCT02301390|363160275|FG000|Overall Study|study terminated|2|||
105318012|NCT02301390|363160276|FG001|Overall Study|study terminated|0|||
105318013|NCT00403585|363160277|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
105318014|NCT00403585|363160277|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
105318015|NCT00403585|363160277|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
105318016|NCT02604407|363160278|FG000|Overall Study|Adverse Event|0|||
105318017|NCT02604407|363160279|FG001|Overall Study|Adverse Event|7|||
105318018|NCT02604407|363160280|FG002|Overall Study|Adverse Event|5|||
105318019|NCT02604407|363160278|FG000|Overall Study|Protocol Violation|2|||
105318020|NCT02604407|363160279|FG001|Overall Study|Protocol Violation|0|||
105318021|NCT02604407|363160280|FG002|Overall Study|Protocol Violation|0|||
105318022|NCT02604407|363160278|FG000|Overall Study|Withdrawal by Subject|3|||
105318023|NCT02604407|363160279|FG001|Overall Study|Withdrawal by Subject|3|||
105318024|NCT02604407|363160280|FG002|Overall Study|Withdrawal by Subject|5|||
105318025|NCT02604407|363160278|FG000|Overall Study|Lost to Follow-up|2|||
105318026|NCT02604407|363160279|FG001|Overall Study|Lost to Follow-up|1|||
105318027|NCT02604407|363160280|FG002|Overall Study|Lost to Follow-up|2|||
105318028|NCT02604407|363160278|FG000|Overall Study|Lack of Efficacy|1|||
105318029|NCT02604407|363160279|FG001|Overall Study|Lack of Efficacy|0|||
105318030|NCT02604407|363160280|FG002|Overall Study|Lack of Efficacy|0|||
105318031|NCT02604407|363160278|FG000|Overall Study|Other|3|||
105318032|NCT02604407|363160279|FG001|Overall Study|Other|1|||
105318033|NCT02604407|363160280|FG002|Overall Study|Other|4|||
105318034|NCT00185588|363160281|FG000|Overall Study|Adverse Event|3|||
105318035|NCT00185588|363160282|FG001|Overall Study|Adverse Event|1|||
105318036|NCT00185588|363160283|FG002|Overall Study|Adverse Event|4|||
105318037|NCT00185588|363160284|FG003|Overall Study|Adverse Event|2|||
105318038|NCT00185588|363160281|FG000|Overall Study|Lost to Follow-up|0|||
105318039|NCT00185588|363160282|FG001|Overall Study|Lost to Follow-up|0|||
105318040|NCT00185588|363160283|FG002|Overall Study|Lost to Follow-up|1|||
105318041|NCT00185588|363160284|FG003|Overall Study|Lost to Follow-up|2|||
105318042|NCT00185588|363160281|FG000|Overall Study|Withdrawal by Subject|0|||
105318043|NCT00185588|363160282|FG001|Overall Study|Withdrawal by Subject|1|||
105318044|NCT00185588|363160283|FG002|Overall Study|Withdrawal by Subject|0|||
105318045|NCT00185588|363160284|FG003|Overall Study|Withdrawal by Subject|0|||
105318046|NCT00185588|363160281|FG000|Overall Study|Physician Decision|0|||
105318047|NCT00185588|363160282|FG001|Overall Study|Physician Decision|0|||
105318048|NCT00185588|363160283|FG002|Overall Study|Physician Decision|1|||
105318049|NCT00185588|363160284|FG003|Overall Study|Physician Decision|0|||
105318050|NCT03971474|363160285|FG000|Overall Study|Adverse Event|11|||
105318051|NCT03971474|363160286|FG001|Overall Study|Adverse Event|7|||
105318052|NCT03971474|363160285|FG000|Overall Study|Refusal unrelated to adverse event|5|||
105318053|NCT03971474|363160286|FG001|Overall Study|Refusal unrelated to adverse event|1|||
105318054|NCT03971474|363160285|FG000|Overall Study|Progression/relapse|40|||
105318055|NCT03971474|363160286|FG001|Overall Study|Progression/relapse|47|||
105318056|NCT03971474|363160285|FG000|Overall Study|Death|6|||
105318057|NCT03971474|363160286|FG001|Overall Study|Death|3|||
105318058|NCT03971474|363160285|FG000|Overall Study|Other - not protocol specified|5|||
105318059|NCT03971474|363160286|FG001|Overall Study|Other - not protocol specified|4|||
105318060|NCT03971474|363160285|FG000|Overall Study|On treatment|0|||
105318061|NCT03971474|363160286|FG001|Overall Study|On treatment|7|||
105318062|NCT02789137|363160287|FG000|Overall Study|Dropped out/Died|58|||
105318063|NCT01482312|363160298|FG000|Period 1, 90 Minutes of Wear|Other|1|||
105318064|NCT01482312|363160299|FG001|Period 1, 90 Minutes of Wear|Other|0|||
105318065|NCT01482312|363160300|FG002|Period 1, 90 Minutes of Wear|Other|0|||
105318066|NCT01482312|363160298|FG000|Period 2, 90 Minutes of Wear|Other|1|||
105318067|NCT01482312|363160299|FG001|Period 2, 90 Minutes of Wear|Other|0|||
105318068|NCT01482312|363160300|FG002|Period 2, 90 Minutes of Wear|Other|0|||
105318069|NCT01699815|363160301|FG000|Overall Study|Protocol Violation|4|||
105318070|NCT01699815|363160302|FG001|Overall Study|Protocol Violation|7|||
105318071|NCT01699815|363160301|FG000|Overall Study|record could not be located|1|||
105318072|NCT01699815|363160302|FG001|Overall Study|record could not be located|0|||
105318073|NCT01699815|363160301|FG000|Overall Study|Adverse Event|0|||
105318074|NCT01699815|363160302|FG001|Overall Study|Adverse Event|1|||
105318075|NCT00356525|363160308|FG000|Overall Study|Progressive Disease|8|||
105318076|NCT00356525|363160309|FG001|Overall Study|Progressive Disease|5|||
105369402|NCT02497469|363358451|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
105318077|NCT00356525|363160310|FG002|Overall Study|Progressive Disease|4|||
105318078|NCT00356525|363160311|FG003|Overall Study|Progressive Disease|2|||
105318079|NCT00356525|363160308|FG000|Overall Study|Adverse Event|1|||
105318080|NCT00356525|363160309|FG001|Overall Study|Adverse Event|3|||
105318081|NCT00356525|363160310|FG002|Overall Study|Adverse Event|1|||
105318082|NCT00356525|363160311|FG003|Overall Study|Adverse Event|1|||
105318083|NCT00356525|363160308|FG000|Overall Study|Lost to Follow-up|1|||
105318084|NCT00356525|363160309|FG001|Overall Study|Lost to Follow-up|0|||
105318085|NCT00356525|363160310|FG002|Overall Study|Lost to Follow-up|0|||
105318086|NCT00356525|363160311|FG003|Overall Study|Lost to Follow-up|0|||
105318087|NCT00356525|363160308|FG000|Overall Study|Physician Decision|2|||
105318088|NCT00356525|363160309|FG001|Overall Study|Physician Decision|2|||
105318089|NCT00356525|363160310|FG002|Overall Study|Physician Decision|2|||
105318090|NCT00356525|363160311|FG003|Overall Study|Physician Decision|1|||
105318091|NCT00356525|363160308|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
105318092|NCT00356525|363160309|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
105318093|NCT00356525|363160310|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
105318094|NCT00356525|363160311|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
105318095|NCT00356525|363160308|FG000|Overall Study|Withdrawal by Subject|1|||
105318096|NCT00356525|363160309|FG001|Overall Study|Withdrawal by Subject|1|||
105318097|NCT00356525|363160310|FG002|Overall Study|Withdrawal by Subject|0|||
105318098|NCT00356525|363160311|FG003|Overall Study|Withdrawal by Subject|3|||
105318099|NCT00356525|363160308|FG000|Overall Study|Death|0|||
105318100|NCT00356525|363160309|FG001|Overall Study|Death|0|||
105318101|NCT00356525|363160310|FG002|Overall Study|Death|0|||
105318102|NCT00356525|363160311|FG003|Overall Study|Death|1|||
105318103|NCT00356525|363160308|FG000|Overall Study|Sponsor Decision|0|||
105318104|NCT00356525|363160309|FG001|Overall Study|Sponsor Decision|0|||
105318105|NCT00356525|363160310|FG002|Overall Study|Sponsor Decision|0|||
105318106|NCT00356525|363160311|FG003|Overall Study|Sponsor Decision|1|||
105318107|NCT02932462|363160312|FG000|Overall Study|Adverse Event|1|||
105318108|NCT02932462|363160313|FG001|Overall Study|Adverse Event|2|||
105318109|NCT02932462|363160312|FG000|Overall Study|Lost to Follow-up|4|||
105318110|NCT02932462|363160313|FG001|Overall Study|Lost to Follow-up|1|||
105318111|NCT02932462|363160312|FG000|Overall Study|Protocol Violation|0|||
105318112|NCT02932462|363160313|FG001|Overall Study|Protocol Violation|5|||
105318113|NCT02932462|363160312|FG000|Overall Study|Withdrawal by Subject|1|||
105318114|NCT02932462|363160313|FG001|Overall Study|Withdrawal by Subject|4|||
105318115|NCT02932462|363160312|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105318116|NCT02932462|363160313|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105318117|NCT02932462|363160312|FG000|Overall Study|Progressive Disease|1|||
105318118|NCT02932462|363160313|FG001|Overall Study|Progressive Disease|0|||
105318119|NCT04036110|363160316|FG000|Overall Study|Lost to Follow-up|3|||
105318120|NCT04036110|363160317|FG001|Overall Study|Lost to Follow-up|2|||
105318121|NCT04036110|363160318|FG002|Overall Study|Lost to Follow-up|1|||
105318122|NCT04036110|363160316|FG000|Overall Study|Study Suspended|4|||
105318123|NCT04036110|363160317|FG001|Overall Study|Study Suspended|5|||
105318124|NCT04036110|363160318|FG002|Overall Study|Study Suspended|1|||
105318125|NCT00098774|363160325|FG000|Overall Study|Adverse Event|2|||
105318126|NCT00098774|363160325|FG000|Overall Study|Disease Progression|9|||
105318127|NCT00098774|363160325|FG000|Overall Study|Withdrawal by Subject|1|||
105318128|NCT00098774|363160325|FG000|Overall Study|Failed (to respond) during induction|4|||
105318129|NCT00098774|363160325|FG000|Overall Study|Physician Decision|2|||
105318130|NCT00879086|363160326|FG000|Overall Study|Adverse Event|3|||
105318131|NCT00879086|363160327|FG001|Overall Study|Adverse Event|15|||
105318132|NCT00879086|363160326|FG000|Overall Study|Participant choice|2|||
105318133|NCT00879086|363160327|FG001|Overall Study|Participant choice|2|||
105318134|NCT00879086|363160326|FG000|Overall Study|Progression of disease|40|||
105318135|NCT00879086|363160327|FG001|Overall Study|Progression of disease|26|||
105318136|NCT00879086|363160326|FG000|Overall Study|Withdrawal of consent|2|||
105318137|NCT00879086|363160327|FG001|Overall Study|Withdrawal of consent|1|||
105318138|NCT00879086|363160326|FG000|Overall Study|Other|4|||
105318139|NCT00879086|363160327|FG001|Overall Study|Other|6|||
105318140|NCT00879086|363160326|FG000|Overall Study|Death|1|||
105318141|NCT00879086|363160327|FG001|Overall Study|Death|2|||
105318142|NCT01487525|363160328|FG000|Overall Study|Withdrawal by Subject|0|||
105318143|NCT01487525|363160329|FG001|Overall Study|Withdrawal by Subject|1|||
105318144|NCT02296931|363160333|FG000|Overall Study|Protocol Violation|0|||
105318145|NCT02296931|363160334|FG001|Overall Study|Protocol Violation|2|||
105318146|NCT05513391|363160337|FG000|Overall Study|Adverse Event|1|||
105318147|NCT05513391|363160338|FG001|Overall Study|Adverse Event|0|||
105318148|NCT05513391|363160337|FG000|Overall Study|Protocol Deviation|0|||
105318149|NCT05513391|363160338|FG001|Overall Study|Protocol Deviation|1|||
105318150|NCT05513391|363160337|FG000|Overall Study|Withdrawal by Subject|3|||
105318151|NCT05513391|363160338|FG001|Overall Study|Withdrawal by Subject|1|||
105318152|NCT05513391|363160337|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
105318153|NCT05513391|363160338|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
105318154|NCT05513391|363160337|FG000|Overall Study|Lost to Follow-up|0|||
105318155|NCT05513391|363160338|FG001|Overall Study|Lost to Follow-up|2|||
105318156|NCT01632280|363160352|FG000|Overall Study|Withdrawal by Subject|1|||
105318157|NCT01632280|363160353|FG001|Overall Study|Withdrawal by Subject|0|||
105318158|NCT04208750|363160354|FG000|Overall Study|Lost to Follow-up|16|||
105318159|NCT04208750|363160355|FG001|Overall Study|Lost to Follow-up|15|||
105318160|NCT05022212|363160362|FG000|Overall Study|Lost to Follow-up|0|||
105318161|NCT05022212|363160363|FG001|Overall Study|Lost to Follow-up|2|||
105318162|NCT02291510|363162866|FG000|Overall Study|Adverse Event|0|||
105318163|NCT02291510|363162867|FG001|Overall Study|Adverse Event|0|||
105318164|NCT02291510|363162868|FG002|Overall Study|Adverse Event|0|||
105369403|NCT02497469|363358452|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
105369404|NCT02497469|363358451|FG000|Overall Study|Significant Protocol Deviation|4|||
105369405|NCT02497469|363358452|FG001|Overall Study|Significant Protocol Deviation|5|||
105369406|NCT02497469|363358451|FG000|Overall Study|Lost to Follow-up|14|||
105369407|NCT02497469|363358452|FG001|Overall Study|Lost to Follow-up|4|||
105369408|NCT02497469|363358451|FG000|Overall Study|Voluntary Withdrawal|39|||
105369409|NCT02497469|363358452|FG001|Overall Study|Voluntary Withdrawal|41|||
105369410|NCT02497469|363358451|FG000|Overall Study|Pregnancy|1|||
105369411|NCT02497469|363358452|FG001|Overall Study|Pregnancy|1|||
105369412|NCT02497469|363358451|FG000|Overall Study|Lack of Efficacy|86|||
105369413|NCT02497469|363358452|FG001|Overall Study|Lack of Efficacy|40|||
105369414|NCT02497469|363358451|FG000|Overall Study|Reason not Specified|6|||
105369415|NCT02497469|363358452|FG001|Overall Study|Reason not Specified|6|||
105369416|NCT03093181|363358453|FG000|Overall Study|Withdrawal by Subject|2|||
105369417|NCT03093181|363358454|FG001|Overall Study|Withdrawal by Subject|1|||
105369418|NCT03093181|363358455|FG002|Overall Study|Withdrawal by Subject|2|||
105369419|NCT03093181|363358453|FG000|Overall Study|Other (Not specified)|1|||
105369420|NCT03093181|363358454|FG001|Overall Study|Other (Not specified)|0|||
105369421|NCT03093181|363358455|FG002|Overall Study|Other (Not specified)|0|||
105369422|NCT03093181|363358453|FG000|Overall Study|Adverse Event|0|||
105369423|NCT03093181|363358454|FG001|Overall Study|Adverse Event|1|||
105369424|NCT03093181|363358455|FG002|Overall Study|Adverse Event|0|||
105369425|NCT03093181|363358453|FG000|Overall Study|Other (Protocol violation)|0|||
105369426|NCT03093181|363358454|FG001|Overall Study|Other (Protocol violation)|0|||
105369427|NCT03093181|363358455|FG002|Overall Study|Other (Protocol violation)|1|||
105369428|NCT01494818|363358463|FG000|Overall Study|Relocation|1|||
105369429|NCT01494818|363358464|FG001|Overall Study|Relocation|2|||
105369430|NCT01494818|363358463|FG000|Overall Study|Lost to Follow-up|1|||
105369431|NCT01494818|363358464|FG001|Overall Study|Lost to Follow-up|0|||
105369432|NCT00467519|363358471|FG000|Overall Study|Protocol Violation|8|||
105369433|NCT00467519|363358472|FG001|Overall Study|Protocol Violation|4|||
105369434|NCT00467519|363358471|FG000|Overall Study|Lost to Follow-up|2|||
105369435|NCT00467519|363358472|FG001|Overall Study|Lost to Follow-up|9|||
105369436|NCT00467519|363358471|FG000|Overall Study|Withdrawal by Subject|4|||
105369437|NCT00467519|363358472|FG001|Overall Study|Withdrawal by Subject|10|||
105369438|NCT00249834|363358475|FG000|Overall Study|Ovarian stimulation failed|1|||
105369439|NCT00249834|363358476|FG001|Overall Study|Ovarian stimulation failed|0|||
105369440|NCT00249834|363358477|FG002|Overall Study|Ovarian stimulation failed|0|||
105369441|NCT00249834|363358478|FG003|Overall Study|Ovarian stimulation failed|0|||
105369442|NCT00249834|363358479|FG004|Overall Study|Ovarian stimulation failed|0|||
105369443|NCT00249834|363358480|FG005|Overall Study|Ovarian stimulation failed|0|||
105369444|NCT00249834|363358481|FG006|Overall Study|Ovarian stimulation failed|0|||
105369445|NCT00249834|363358482|FG007|Overall Study|Ovarian stimulation failed|0|||
105369446|NCT00249834|363358475|FG000|Overall Study|Failure of down-regulation|0|||
105369447|NCT00249834|363358476|FG001|Overall Study|Failure of down-regulation|0|||
105369448|NCT00249834|363358477|FG002|Overall Study|Failure of down-regulation|0|||
105849303|NCT04771403|365107680|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
105849304|NCT04771403|365107681|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
105849305|NCT04771403|365107680|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
105849306|NCT04771403|365107681|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
105849307|NCT04771403|365107680|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
105849308|NCT04771403|365107681|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
105849309|NCT04771403|365107680|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
105849310|NCT04771403|365107681|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
105849311|NCT04771403|365107680|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
105849312|NCT04771403|365107681|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
105849313|NCT04771403|365107680|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
105849314|NCT04771403|365107681|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
105849315|NCT04771403|365107680|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
105369449|NCT00249834|363358478|FG003|Overall Study|Failure of down-regulation|0|||
105369450|NCT00249834|363358479|FG004|Overall Study|Failure of down-regulation|0|||
105369451|NCT00249834|363358480|FG005|Overall Study|Failure of down-regulation|0|||
105369452|NCT00249834|363358481|FG006|Overall Study|Failure of down-regulation|1|||
105369453|NCT00249834|363358482|FG007|Overall Study|Failure of down-regulation|0|||
105369454|NCT00249834|363358475|FG000|Overall Study|Protocol Violation|0|||
105369455|NCT00249834|363358476|FG001|Overall Study|Protocol Violation|19|||
105369456|NCT00249834|363358477|FG002|Overall Study|Protocol Violation|14|||
105849316|NCT04771403|365107681|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
105849317|NCT01568320|365107686|FG000|Overall Study|Death|20|||
105849318|NCT01568320|365107686|FG000|Overall Study|Lost to Follow-up|9|||
105849319|NCT01568320|365107686|FG000|Overall Study|Withdrawal by Subject|10|||
105849320|NCT01568320|365107686|FG000|Overall Study|Conversion to open repair|1|||
105849321|NCT01568320|365107686|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
105849322|NCT01660334|365107687|FG000|Overall Study|Lost to Follow-up|1|||
105849323|NCT00311311|365107689|FG000|Overall Study|Adverse Event|3|||
105849324|NCT00311311|365107690|FG001|Overall Study|Adverse Event|2|||
105849325|NCT00311311|365107689|FG000|Overall Study|Withdrawal by Subject|1|||
105849326|NCT00311311|365107690|FG001|Overall Study|Withdrawal by Subject|1|||
105849327|NCT00311311|365107689|FG000|Overall Study|Noncompliance|0|||
105849328|NCT00311311|365107690|FG001|Overall Study|Noncompliance|1|||
105849329|NCT00311311|365107689|FG000|Overall Study|Study Termination by Sponsor|3|||
105849330|NCT00311311|365107690|FG001|Overall Study|Study Termination by Sponsor|4|||
105849331|NCT00311311|365107689|FG000|Overall Study|Death|1|||
105849332|NCT00311311|365107690|FG001|Overall Study|Death|0|||
105849333|NCT00311311|365107689|FG000|Overall Study|Lack of ancillary assistance|0|||
105849334|NCT00311311|365107690|FG001|Overall Study|Lack of ancillary assistance|1|||
105849335|NCT00816361|365107691|FG000|Overall Study|Withdrawal by Subject|0|||
105849336|NCT00816361|365107692|FG001|Overall Study|Withdrawal by Subject|0|||
105849337|NCT00816361|365107693|FG002|Overall Study|Withdrawal by Subject|0|||
105849338|NCT00816361|365107694|FG003|Overall Study|Withdrawal by Subject|0|||
105849339|NCT00816361|365107695|FG004|Overall Study|Withdrawal by Subject|1|||
105849340|NCT00816361|365107696|FG005|Overall Study|Withdrawal by Subject|2|||
105849341|NCT00816361|365107697|FG006|Overall Study|Withdrawal by Subject|0|||
105849342|NCT00816361|365107698|FG007|Overall Study|Withdrawal by Subject|2|||
105849343|NCT00816361|365107699|FG008|Overall Study|Withdrawal by Subject|1|||
105849344|NCT00816361|365107691|FG000|Overall Study|Death|4|||
105849345|NCT00816361|365107692|FG001|Overall Study|Death|3|||
105849346|NCT00816361|365107693|FG002|Overall Study|Death|3|||
105849347|NCT00816361|365107694|FG003|Overall Study|Death|3|||
105849348|NCT00816361|365107695|FG004|Overall Study|Death|1|||
105849349|NCT00816361|365107696|FG005|Overall Study|Death|1|||
105849350|NCT00816361|365107697|FG006|Overall Study|Death|3|||
105849351|NCT00816361|365107698|FG007|Overall Study|Death|7|||
105849352|NCT00816361|365107699|FG008|Overall Study|Death|8|||
105849353|NCT00816361|365107691|FG000|Overall Study|Other|0|||
105849354|NCT00816361|365107692|FG001|Overall Study|Other|0|||
105849355|NCT00816361|365107693|FG002|Overall Study|Other|0|||
105849356|NCT00816361|365107694|FG003|Overall Study|Other|0|||
105849357|NCT00816361|365107695|FG004|Overall Study|Other|0|||
105849358|NCT00816361|365107696|FG005|Overall Study|Other|0|||
105849359|NCT00816361|365107697|FG006|Overall Study|Other|0|||
105849360|NCT00816361|365107698|FG007|Overall Study|Other|0|||
105849361|NCT00816361|365107699|FG008|Overall Study|Other|1|||
105849362|NCT00546572|365107700|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
105849363|NCT00546572|365107701|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
105849364|NCT00546572|365107700|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
105849365|NCT00546572|365107701|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
105849366|NCT00546572|365107700|FG000|Vax 1 / Year 0|Protocol Violation|3|||
105849367|NCT00546572|365107701|FG001|Vax 1 / Year 0|Protocol Violation|4|||
105849368|NCT00546572|365107700|FG000|Vax 1 / Year 0|Death|2|||
105849369|NCT00546572|365107701|FG001|Vax 1 / Year 0|Death|2|||
105849370|NCT00546572|365107700|FG000|Vax 1 / Year 0|Adverse Event|0|||
105849371|NCT00546572|365107701|FG001|Vax 1 / Year 0|Adverse Event|1|||
105849372|NCT00546572|365107700|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
105318165|NCT02291510|363162869|FG003|Overall Study|Adverse Event|1|||
105318166|NCT02454608|363162870|FG000|Double-Blind Period|Lack of Efficacy|0|||
105318167|NCT02454608|363162871|FG001|Double-Blind Period|Lack of Efficacy|2|||
105318168|NCT02454608|363162872|FG002|Double-Blind Period|Lack of Efficacy|0|||
105318169|NCT02454608|363162870|FG000|Open Label Period|Lost to Follow-up|0|||
105318170|NCT02454608|363162871|FG001|Open Label Period|Lost to Follow-up|0|||
105318171|NCT02454608|363162872|FG002|Open Label Period|Lost to Follow-up|11|||
105849373|NCT00546572|365107701|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
105318172|NCT02454608|363162870|FG000|Open Label Period|Withdrawal by Subject|0|||
105318173|NCT02454608|363162871|FG001|Open Label Period|Withdrawal by Subject|0|||
105318174|NCT02454608|363162872|FG002|Open Label Period|Withdrawal by Subject|8|||
105318175|NCT01433055|363162873|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
105849374|NCT00546572|365107700|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
105849375|NCT00546572|365107701|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
105849376|NCT00546572|365107700|FG000|Vax 2 / Year 1|Other|1|||
105849377|NCT00546572|365107701|FG001|Vax 2 / Year 1|Other|1|||
105849378|NCT00546572|365107700|FG000|Vax 2 / Year 1|Adverse Event|1|||
105849379|NCT00546572|365107701|FG001|Vax 2 / Year 1|Adverse Event|0|||
105849380|NCT00546572|365107700|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
105849381|NCT00546572|365107701|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
105318176|NCT01433055|363162874|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
105318177|NCT01433055|363162873|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
105318178|NCT01433055|363162874|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
105318179|NCT00233948|363162877|FG000|Overall Study|Adverse Event|1|||
105318180|NCT00233948|363162878|FG001|Overall Study|Adverse Event|0|||
105318181|NCT00233948|363162879|FG002|Overall Study|Adverse Event|0|||
105318182|NCT00233948|363162880|FG003|Overall Study|Adverse Event|0|||
105318183|NCT00233948|363162881|FG004|Overall Study|Adverse Event|0|||
105318184|NCT00233948|363162882|FG005|Overall Study|Adverse Event|0|||
105318185|NCT04981717|363162892|FG000|Overall Study|Protocol Violation|0|||
105318186|NCT04981717|363162893|FG001|Overall Study|Protocol Violation|3|||
105318187|NCT04981717|363162892|FG000|Overall Study|Adverse Event|1|||
105318188|NCT04981717|363162893|FG001|Overall Study|Adverse Event|3|||
105318189|NCT04981717|363162892|FG000|Overall Study|Pregnancy|1|||
105318190|NCT04981717|363162893|FG001|Overall Study|Pregnancy|0|||
105369457|NCT00249834|363358478|FG003|Overall Study|Protocol Violation|8|||
105369458|NCT00249834|363358479|FG004|Overall Study|Protocol Violation|5|||
105369459|NCT00249834|363358480|FG005|Overall Study|Protocol Violation|2|||
105369460|NCT00249834|363358481|FG006|Overall Study|Protocol Violation|0|||
105369461|NCT00249834|363358482|FG007|Overall Study|Protocol Violation|0|||
105369462|NCT00171249|363358483|FG000|Overall Study|Withdrawal by Subject|2|||
105369463|NCT00171249|363358484|FG001|Overall Study|Withdrawal by Subject|0|||
105369464|NCT00171249|363358485|FG002|Overall Study|Withdrawal by Subject|0|||
105369465|NCT00171249|363358486|FG003|Overall Study|Withdrawal by Subject|6|||
105369466|NCT00171249|363358487|FG004|Overall Study|Withdrawal by Subject|0|||
105369467|NCT00171249|363358488|FG005|Overall Study|Withdrawal by Subject|0|||
105369468|NCT00171249|363358489|FG006|Overall Study|Withdrawal by Subject|0|||
105369469|NCT00171249|363358483|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
105369470|NCT00171249|363358484|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
105369471|NCT00171249|363358485|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
105369472|NCT00171249|363358486|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
105369473|NCT00171249|363358487|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
105369474|NCT00171249|363358488|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
105369475|NCT00171249|363358489|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
105369476|NCT00171249|363358483|FG000|Overall Study|Death|7|||
105369477|NCT00171249|363358484|FG001|Overall Study|Death|1|||
105369478|NCT00171249|363358485|FG002|Overall Study|Death|0|||
105369479|NCT00171249|363358486|FG003|Overall Study|Death|4|||
105369480|NCT00171249|363358487|FG004|Overall Study|Death|0|||
105369481|NCT00171249|363358488|FG005|Overall Study|Death|3|||
105369482|NCT00171249|363358489|FG006|Overall Study|Death|1|||
105369483|NCT00171249|363358483|FG000|Overall Study|Other|10|||
105369484|NCT00171249|363358484|FG001|Overall Study|Other|0|||
105369485|NCT00171249|363358485|FG002|Overall Study|Other|0|||
105369486|NCT00171249|363358486|FG003|Overall Study|Other|43|||
105369487|NCT00171249|363358487|FG004|Overall Study|Other|0|||
105369488|NCT00171249|363358488|FG005|Overall Study|Other|2|||
105369489|NCT00171249|363358489|FG006|Overall Study|Other|0|||
105369490|NCT00171249|363358483|FG000|Overall Study|No Longer Requires Study Drug|4|||
105369491|NCT00171249|363358484|FG001|Overall Study|No Longer Requires Study Drug|0|||
105318191|NCT04981717|363162892|FG000|Overall Study|Physician Decision|1|||
105318192|NCT04981717|363162893|FG001|Overall Study|Physician Decision|0|||
105369492|NCT00171249|363358485|FG002|Overall Study|No Longer Requires Study Drug|0|||
105369493|NCT00171249|363358486|FG003|Overall Study|No Longer Requires Study Drug|3|||
105369494|NCT00171249|363358487|FG004|Overall Study|No Longer Requires Study Drug|0|||
105369495|NCT00171249|363358488|FG005|Overall Study|No Longer Requires Study Drug|5|||
105369496|NCT00171249|363358489|FG006|Overall Study|No Longer Requires Study Drug|0|||
105369497|NCT00171249|363358483|FG000|Overall Study|Administrative Problems|1|||
105369498|NCT00171249|363358484|FG001|Overall Study|Administrative Problems|0|||
105369499|NCT00171249|363358485|FG002|Overall Study|Administrative Problems|0|||
105849382|NCT01335997|365107702|FG000|Period I and II|Adverse Event|63|||
105849383|NCT01335997|365107703|FG001|Period I and II|Adverse Event|43|||
105318193|NCT04981717|363162892|FG000|Overall Study|Sponsor Request|157|||
105318194|NCT04981717|363162893|FG001|Overall Study|Sponsor Request|172|||
105318195|NCT04981717|363162892|FG000|Overall Study|Lost to Follow-up|4|||
105318196|NCT04981717|363162893|FG001|Overall Study|Lost to Follow-up|5|||
105318197|NCT04981717|363162892|FG000|Overall Study|Withdrawal by Subject|50|||
105318198|NCT04981717|363162893|FG001|Overall Study|Withdrawal by Subject|37|||
105369500|NCT00171249|363358486|FG003|Overall Study|Administrative Problems|2|||
105369501|NCT00171249|363358487|FG004|Overall Study|Administrative Problems|0|||
105369502|NCT00171249|363358488|FG005|Overall Study|Administrative Problems|0|||
105369503|NCT00171249|363358489|FG006|Overall Study|Administrative Problems|0|||
105369504|NCT00171249|363358483|FG000|Overall Study|Adverse Event|3|||
105369505|NCT00171249|363358484|FG001|Overall Study|Adverse Event|1|||
105369506|NCT00171249|363358485|FG002|Overall Study|Adverse Event|0|||
105318199|NCT04825912|363162894|FG000|Overall Study|Death|3|||
105318200|NCT04825912|363162894|FG000|Overall Study|Withdrawal by Subject|1|||
105318201|NCT00615199|363162895|FG000|Overall Study|Adverse Event|3|||
105369507|NCT00171249|363358486|FG003|Overall Study|Adverse Event|15|||
105369508|NCT00171249|363358487|FG004|Overall Study|Adverse Event|0|||
105369509|NCT00171249|363358488|FG005|Overall Study|Adverse Event|2|||
105369510|NCT00171249|363358489|FG006|Overall Study|Adverse Event|0|||
105369511|NCT00171249|363358483|FG000|Overall Study|Lost to Follow-up|5|||
105369512|NCT00171249|363358484|FG001|Overall Study|Lost to Follow-up|0|||
105369513|NCT00171249|363358485|FG002|Overall Study|Lost to Follow-up|0|||
105369514|NCT00171249|363358486|FG003|Overall Study|Lost to Follow-up|9|||
105369515|NCT00171249|363358487|FG004|Overall Study|Lost to Follow-up|0|||
105369516|NCT00171249|363358488|FG005|Overall Study|Lost to Follow-up|0|||
105369517|NCT00171249|363358489|FG006|Overall Study|Lost to Follow-up|0|||
105369518|NCT01041859|363358490|FG000|Open-Label Titration|Adverse Event|69|||
105369519|NCT01041859|363358491|FG001|Open-Label Titration|Adverse Event|0|||
105369520|NCT01041859|363358492|FG002|Open-Label Titration|Adverse Event|0|||
105369521|NCT01041859|363358490|FG000|Open-Label Titration|Lack of Efficacy|3|||
105369522|NCT01041859|363358491|FG001|Open-Label Titration|Lack of Efficacy|0|||
105369523|NCT01041859|363358492|FG002|Open-Label Titration|Lack of Efficacy|0|||
105369524|NCT01041859|363358490|FG000|Open-Label Titration|Lost to Follow-up|1|||
105369525|NCT01041859|363358491|FG001|Open-Label Titration|Lost to Follow-up|0|||
105369526|NCT01041859|363358492|FG002|Open-Label Titration|Lost to Follow-up|0|||
105369527|NCT01041859|363358490|FG000|Open-Label Titration|Physician Decision|1|||
105369528|NCT01041859|363358491|FG001|Open-Label Titration|Physician Decision|0|||
105369529|NCT01041859|363358492|FG002|Open-Label Titration|Physician Decision|0|||
105369530|NCT01041859|363358490|FG000|Open-Label Titration|Protocol Violation|1|||
105369531|NCT01041859|363358491|FG001|Open-Label Titration|Protocol Violation|0|||
105369532|NCT01041859|363358492|FG002|Open-Label Titration|Protocol Violation|0|||
105369533|NCT01041859|363358490|FG000|Open-Label Titration|Other|7|||
105369534|NCT01041859|363358491|FG001|Open-Label Titration|Other|0|||
105369535|NCT01041859|363358492|FG002|Open-Label Titration|Other|0|||
105369536|NCT01041859|363358490|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
105369537|NCT01041859|363358491|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
105369538|NCT01041859|363358492|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
105849384|NCT01335997|365107702|FG000|Period I and II|Noncompliance with Study Drug|1|||
105849385|NCT01335997|365107703|FG001|Period I and II|Noncompliance with Study Drug|1|||
105849386|NCT01335997|365107702|FG000|Period I and II|Lost to Follow-up|3|||
105849387|NCT01335997|365107703|FG001|Period I and II|Lost to Follow-up|5|||
105849388|NCT01335997|365107702|FG000|Period I and II|Withdrawal by Subject|9|||
105849389|NCT01335997|365107703|FG001|Period I and II|Withdrawal by Subject|4|||
105849390|NCT01335997|365107702|FG000|Period I and II|Study Terminated by Sponsor|406|||
105849391|NCT01335997|365107703|FG001|Period I and II|Study Terminated by Sponsor|415|||
105849392|NCT01335997|365107702|FG000|Period I and II|Protocol Violation|9|||
105318202|NCT00615199|363162896|FG001|Overall Study|Adverse Event|1|||
105318203|NCT00615199|363162897|FG002|Overall Study|Adverse Event|1|||
105318204|NCT00615199|363162898|FG003|Overall Study|Adverse Event|0|||
105318205|NCT00615199|363162895|FG000|Overall Study|Lack of Efficacy|2|||
105318206|NCT00615199|363162896|FG001|Overall Study|Lack of Efficacy|0|||
105318207|NCT00615199|363162897|FG002|Overall Study|Lack of Efficacy|0|||
105318208|NCT00615199|363162898|FG003|Overall Study|Lack of Efficacy|1|||
105318209|NCT00615199|363162895|FG000|Overall Study|Lost to Follow-up|1|||
105318210|NCT00615199|363162896|FG001|Overall Study|Lost to Follow-up|0|||
105318211|NCT00615199|363162897|FG002|Overall Study|Lost to Follow-up|0|||
105318212|NCT00615199|363162898|FG003|Overall Study|Lost to Follow-up|0|||
105318213|NCT00615199|363162895|FG000|Overall Study|Other|0|||
105318214|NCT00615199|363162896|FG001|Overall Study|Other|0|||
105318215|NCT00615199|363162897|FG002|Overall Study|Other|0|||
105318216|NCT00615199|363162898|FG003|Overall Study|Other|1|||
105318217|NCT00615199|363162895|FG000|Overall Study|Withdrawal by Subject|2|||
105318218|NCT00615199|363162896|FG001|Overall Study|Withdrawal by Subject|1|||
105318219|NCT00615199|363162897|FG002|Overall Study|Withdrawal by Subject|0|||
105318220|NCT00615199|363162898|FG003|Overall Study|Withdrawal by Subject|0|||
105318221|NCT02640482|363162903|FG000|Overall Study|Lost to Follow-up|3|||
105318222|NCT02640482|363162904|FG001|Overall Study|Lost to Follow-up|0|||
105318223|NCT01173120|363162905|FG000|Overall Study|Lack of Efficacy|2|||
105318224|NCT01173120|363162905|FG000|Overall Study|Lost to Follow-up|1|||
105318225|NCT01173120|363162905|FG000|Overall Study|Participant Decision|2|||
105318226|NCT01173120|363162905|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
105318227|NCT01173120|363162905|FG000|Overall Study|Switch-Participant Decision|12|||
105318228|NCT01173120|363162905|FG000|Overall Study|Switch-Difficulty With Device|12|||
105318229|NCT01207583|363162906|FG000|Overall Study|Withdrawal by Subject|0|||
105318230|NCT01207583|363162907|FG001|Overall Study|Withdrawal by Subject|3|||
105318231|NCT01207583|363162908|FG002|Overall Study|Withdrawal by Subject|1|||
105369539|NCT01041859|363358490|FG000|Open-Label Titration|Withdrawal by Subject|11|||
105369540|NCT01041859|363358491|FG001|Open-Label Titration|Withdrawal by Subject|0|||
105369541|NCT01041859|363358492|FG002|Open-Label Titration|Withdrawal by Subject|0|||
105369542|NCT01041859|363358490|FG000|Double-Blind Maintenance|Adverse Event|0|||
105369543|NCT01041859|363358491|FG001|Double-Blind Maintenance|Adverse Event|23|||
105369544|NCT01041859|363358492|FG002|Double-Blind Maintenance|Adverse Event|13|||
105318232|NCT01207583|363162906|FG000|Overall Study|Participant failed to return|1|||
105318233|NCT01207583|363162907|FG001|Overall Study|Participant failed to return|0|||
105318234|NCT01207583|363162908|FG002|Overall Study|Participant failed to return|0|||
105318235|NCT01207583|363162906|FG000|Overall Study|Lost to Follow-up|0|||
105318236|NCT01207583|363162907|FG001|Overall Study|Lost to Follow-up|2|||
105318237|NCT01207583|363162908|FG002|Overall Study|Lost to Follow-up|0|||
105318238|NCT03066258|363162909|FG000|Overall Study|Death|1|||
105318239|NCT03066258|363162910|FG001|Overall Study|Death|0|||
105318240|NCT03066258|363162911|FG002|Overall Study|Death|0|||
105318241|NCT03066258|363162912|FG003|Overall Study|Death|0|||
105318242|NCT03066258|363162913|FG004|Overall Study|Death|1|||
105318243|NCT02797171|363162916|FG000|Overall Study|Lost to Follow-up|2|||
105318244|NCT02797171|363162917|FG001|Overall Study|Lost to Follow-up|0|||
105318245|NCT02797171|363162918|FG002|Overall Study|Lost to Follow-up|2|||
105318246|NCT02797171|363162919|FG003|Overall Study|Lost to Follow-up|1|||
105318247|NCT02797171|363162920|FG004|Overall Study|Lost to Follow-up|2|||
105318248|NCT02797171|363162921|FG005|Overall Study|Lost to Follow-up|0|||
105318249|NCT02797171|363162916|FG000|Overall Study|Withdrawal by Subject|1|||
105318250|NCT02797171|363162917|FG001|Overall Study|Withdrawal by Subject|1|||
105318251|NCT02797171|363162918|FG002|Overall Study|Withdrawal by Subject|0|||
105318252|NCT02797171|363162919|FG003|Overall Study|Withdrawal by Subject|0|||
105318253|NCT02797171|363162920|FG004|Overall Study|Withdrawal by Subject|0|||
105318254|NCT02797171|363162921|FG005|Overall Study|Withdrawal by Subject|0|||
105318255|NCT02797171|363162916|FG000|Overall Study|Protocol Violation|1|||
105318256|NCT02797171|363162917|FG001|Overall Study|Protocol Violation|0|||
105318257|NCT02797171|363162918|FG002|Overall Study|Protocol Violation|0|||
105318258|NCT02797171|363162919|FG003|Overall Study|Protocol Violation|0|||
105318259|NCT02797171|363162920|FG004|Overall Study|Protocol Violation|0|||
105318260|NCT02797171|363162921|FG005|Overall Study|Protocol Violation|0|||
105318261|NCT02797171|363162916|FG000|Overall Study|Participant unable to adhere|0|||
105318262|NCT02797171|363162917|FG001|Overall Study|Participant unable to adhere|1|||
105318263|NCT02797171|363162918|FG002|Overall Study|Participant unable to adhere|0|||
105318264|NCT02797171|363162919|FG003|Overall Study|Participant unable to adhere|0|||
105318265|NCT02797171|363162920|FG004|Overall Study|Participant unable to adhere|0|||
105318266|NCT02797171|363162921|FG005|Overall Study|Participant unable to adhere|0|||
105318267|NCT02797171|363162916|FG000|Overall Study|Not Randomized|0|||
105318268|NCT02797171|363162917|FG001|Overall Study|Not Randomized|0|||
105318269|NCT02797171|363162918|FG002|Overall Study|Not Randomized|0|||
105318270|NCT02797171|363162919|FG003|Overall Study|Not Randomized|0|||
105318271|NCT02797171|363162920|FG004|Overall Study|Not Randomized|0|||
105318272|NCT02797171|363162921|FG005|Overall Study|Not Randomized|1|||
105318273|NCT00626561|363162922|FG000|Overall Study|Withdrawal by Subject|2|||
105318274|NCT00626561|363162922|FG000|Overall Study|Disease Progression|2|||
105318275|NCT04071405|363162923|FG000|Overall Study|Protocol Violation|3|||
105318276|NCT00134901|363162924|FG000|Overall Study|Lost to Follow-up|5|||
105318277|NCT00134901|363162925|FG001|Overall Study|Lost to Follow-up|5|||
105318278|NCT00134901|363162924|FG000|Overall Study|discontinued intervention|12|||
105318279|NCT00134901|363162925|FG001|Overall Study|discontinued intervention|10|||
105318280|NCT00369941|363162926|FG000|Overall Study|Never Treated|1|||
105318281|NCT00369941|363162927|FG001|Overall Study|Never Treated|2|||
105318282|NCT00369941|363162926|FG000|Overall Study|Adverse Event|14|||
105318283|NCT00369941|363162927|FG001|Overall Study|Adverse Event|28|||
105318284|NCT00369941|363162926|FG000|Overall Study|Lack of Efficacy|6|||
105318285|NCT00369941|363162927|FG001|Overall Study|Lack of Efficacy|10|||
105318286|NCT00369941|363162926|FG000|Overall Study|Lost to Follow-up|12|||
105318287|NCT00369941|363162927|FG001|Overall Study|Lost to Follow-up|22|||
105318288|NCT00369941|363162926|FG000|Overall Study|Protocol Violation|5|||
105318289|NCT00369941|363162927|FG001|Overall Study|Protocol Violation|3|||
105318290|NCT00369941|363162926|FG000|Overall Study|Withdrawal by Subject|5|||
105318291|NCT00369941|363162927|FG001|Overall Study|Withdrawal by Subject|18|||
105318292|NCT00369941|363162926|FG000|Overall Study|Pregnancy|4|||
105318293|NCT00369941|363162927|FG001|Overall Study|Pregnancy|2|||
105318294|NCT00369941|363162926|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
105318295|NCT00369941|363162927|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
105318296|NCT00369941|363162926|FG000|Overall Study|Moved|11|||
105318297|NCT00369941|363162927|FG001|Overall Study|Moved|5|||
105318298|NCT00369941|363162926|FG000|Overall Study|Treatment with Prohibited Medication|3|||
105318299|NCT00369941|363162927|FG001|Overall Study|Treatment with Prohibited Medication|1|||
105318300|NCT00369941|363162926|FG000|Overall Study|Employment Interfered with Study Visits|1|||
105318301|NCT00369941|363162927|FG001|Overall Study|Employment Interfered with Study Visits|0|||
105318302|NCT00369941|363162926|FG000|Overall Study|Study Site Terminated|2|||
105318303|NCT00369941|363162927|FG001|Overall Study|Study Site Terminated|0|||
105318304|NCT00369941|363162926|FG000|Overall Study|Miscellaneous|3|||
105318305|NCT00369941|363162927|FG001|Overall Study|Miscellaneous|3|||
105318306|NCT02370238|363162929|FG000|Overall Study|Death|42|||
105318307|NCT02370238|363162930|FG001|Overall Study|Death|35|||
105318308|NCT02370238|363162929|FG000|Overall Study|Lost to Follow-up|1|||
105318309|NCT02370238|363162930|FG001|Overall Study|Lost to Follow-up|3|||
105369545|NCT01041859|363358490|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
105369546|NCT01041859|363358491|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
105369547|NCT01041859|363358492|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
105849393|NCT01335997|365107703|FG001|Period I and II|Protocol Violation|10|||
105849394|NCT01335997|365107702|FG000|Period I and II|Physician Decision|2|||
105849395|NCT01335997|365107703|FG001|Period I and II|Physician Decision|1|||
105849396|NCT01335997|365107702|FG000|Period III|Adverse Event|0|||
105849397|NCT01335997|365107703|FG001|Period III|Adverse Event|2|||
105849398|NCT01335997|365107702|FG000|Period III|Study Terminated by Sponsor|77|||
105849399|NCT01335997|365107703|FG001|Period III|Study Terminated by Sponsor|76|||
105849400|NCT01335997|365107702|FG000|Period III|Protocol Violation|0|||
105849401|NCT01335997|365107703|FG001|Period III|Protocol Violation|1|||
105849402|NCT01335997|365107702|FG000|Period III|Lost to Follow-up|1|||
105849403|NCT01335997|365107703|FG001|Period III|Lost to Follow-up|0|||
105849404|NCT00988065|365107705|FG000|Overall Study|Adverse Event|4|||
105849405|NCT00988065|365107706|FG001|Overall Study|Adverse Event|10|||
105849406|NCT00988065|365107707|FG002|Overall Study|Adverse Event|2|||
105849407|NCT00988065|365107705|FG000|Overall Study|Lost to Follow-up|1|||
105849408|NCT00988065|365107706|FG001|Overall Study|Lost to Follow-up|2|||
105849409|NCT00988065|365107707|FG002|Overall Study|Lost to Follow-up|2|||
105849410|NCT00988065|365107705|FG000|Overall Study|Subject withdrew consent|3|||
105849411|NCT00988065|365107706|FG001|Overall Study|Subject withdrew consent|5|||
105849412|NCT00988065|365107707|FG002|Overall Study|Subject withdrew consent|2|||
105849413|NCT00988065|365107705|FG000|Overall Study|Noncompliance with protocol|5|||
105849414|NCT00988065|365107706|FG001|Overall Study|Noncompliance with protocol|6|||
105849415|NCT00988065|365107707|FG002|Overall Study|Noncompliance with protocol|9|||
105849416|NCT01229735|365107708|FG000|Overall Study|Lack of Efficacy|8|||
105849417|NCT01229735|365107709|FG001|Overall Study|Lack of Efficacy|8|||
105849418|NCT01229735|365107708|FG000|Overall Study|Protocol Violation|13|||
105849419|NCT01229735|365107709|FG001|Overall Study|Protocol Violation|8|||
105849420|NCT01229735|365107708|FG000|Overall Study|Lost to Follow-up|0|||
105849421|NCT01229735|365107709|FG001|Overall Study|Lost to Follow-up|2|||
105849422|NCT01229735|365107708|FG000|Overall Study|Withdrawal by Subject|18|||
105849423|NCT01229735|365107709|FG001|Overall Study|Withdrawal by Subject|17|||
105849424|NCT01229735|365107708|FG000|Overall Study|Other Reason|13|||
105849425|NCT01229735|365107709|FG001|Overall Study|Other Reason|10|||
105849426|NCT01229735|365107708|FG000|Overall Study|SAE, non-fatal|0|||
105849427|NCT01229735|365107709|FG001|Overall Study|SAE, non-fatal|4|||
105849428|NCT01229735|365107708|FG000|Overall Study|AE, non-serious non-fatal|13|||
105849429|NCT01229735|365107709|FG001|Overall Study|AE, non-serious non-fatal|17|||
105849430|NCT01229735|365107708|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
105849431|NCT01229735|365107709|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
105849432|NCT02130882|365107710|FG000|Overall Study|Withdrawal by Subject|0|||
105849433|NCT02130882|365107711|FG001|Overall Study|Withdrawal by Subject|1|||
105849434|NCT03734666|365107721|FG000|Overall Study|Other|7|||
105849435|NCT03734666|365107722|FG001|Overall Study|Other|4|||
105849436|NCT03734666|365107721|FG000|Overall Study|Lost to Follow-up|12|||
105849437|NCT03734666|365107722|FG001|Overall Study|Lost to Follow-up|12|||
105849438|NCT00975286|365107726|FG000|Overall Study|Adverse Event|9|||
105849439|NCT00975286|365107727|FG001|Overall Study|Adverse Event|19|||
105849440|NCT00975286|365107726|FG000|Overall Study|Protocol Violation|1|||
105849441|NCT00975286|365107727|FG001|Overall Study|Protocol Violation|2|||
105849442|NCT00975286|365107726|FG000|Overall Study|Withdrawal by Subject|0|||
105849443|NCT00975286|365107727|FG001|Overall Study|Withdrawal by Subject|2|||
105849444|NCT00975286|365107726|FG000|Overall Study|Familial and Personal Reasons|2|||
105849445|NCT00975286|365107727|FG001|Overall Study|Familial and Personal Reasons|2|||
105849446|NCT00975286|365107726|FG000|Overall Study|Poor Compliance to Protocol|0|||
105369548|NCT01041859|363358490|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
105369549|NCT01041859|363358491|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
105369550|NCT01041859|363358492|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
105369551|NCT01041859|363358490|FG000|Double-Blind Maintenance|Physician Decision|0|||
105369552|NCT01041859|363358491|FG001|Double-Blind Maintenance|Physician Decision|2|||
105369553|NCT01041859|363358492|FG002|Double-Blind Maintenance|Physician Decision|1|||
105369554|NCT01041859|363358490|FG000|Double-Blind Maintenance|Protocol Violation|0|||
105369555|NCT01041859|363358491|FG001|Double-Blind Maintenance|Protocol Violation|1|||
105849447|NCT00975286|365107727|FG001|Overall Study|Poor Compliance to Protocol|2|||
105849448|NCT00975286|365107726|FG000|Overall Study|Sponsor Decision|0|||
105849449|NCT00975286|365107727|FG001|Overall Study|Sponsor Decision|2|||
105849450|NCT02980874|365107731|FG000|Overall Study|Adverse Event|2|||
105849451|NCT02980874|365107732|FG001|Overall Study|Adverse Event|7|||
105849452|NCT02980874|365107731|FG000|Overall Study|Withdrawal by Subject|7|||
105849453|NCT02980874|365107732|FG001|Overall Study|Withdrawal by Subject|2|||
105849454|NCT02980874|365107731|FG000|Overall Study|Lost to Follow-up|5|||
105849455|NCT02980874|365107732|FG001|Overall Study|Lost to Follow-up|5|||
105369556|NCT01041859|363358492|FG002|Double-Blind Maintenance|Protocol Violation|3|||
105369557|NCT01041859|363358490|FG000|Double-Blind Maintenance|Other|0|||
105369558|NCT01041859|363358491|FG001|Double-Blind Maintenance|Other|6|||
105318310|NCT02370238|363162929|FG000|Overall Study|Withdrawal by Subject|2|||
105318311|NCT02370238|363162930|FG001|Overall Study|Withdrawal by Subject|6|||
105318312|NCT02370238|363162929|FG000|Overall Study|Other|2|||
105318313|NCT02370238|363162930|FG001|Overall Study|Other|1|||
105318314|NCT03682107|363162931|FG000|Overall Study|Withdrawal by Subject|0|||
105318315|NCT03682107|363162932|FG001|Overall Study|Withdrawal by Subject|1|||
105318316|NCT03682107|363162933|FG002|Overall Study|Withdrawal by Subject|0|||
105318317|NCT03682107|363162934|FG003|Overall Study|Withdrawal by Subject|0|||
105318318|NCT03682107|363162935|FG004|Overall Study|Withdrawal by Subject|0|||
105318319|NCT04123405|363162936|FG000|Overall Study|Adverse Event|1|||
105318320|NCT04123405|363162937|FG001|Overall Study|Adverse Event|2|||
105318321|NCT04123405|363162938|FG002|Overall Study|Adverse Event|3|||
105318322|NCT04123405|363162939|FG003|Overall Study|Adverse Event|3|||
105318323|NCT04123405|363162936|FG000|Overall Study|Exclusion criteria met|1|||
105318324|NCT04123405|363162937|FG001|Overall Study|Exclusion criteria met|2|||
105318325|NCT04123405|363162938|FG002|Overall Study|Exclusion criteria met|0|||
105318326|NCT04123405|363162939|FG003|Overall Study|Exclusion criteria met|2|||
105318327|NCT04123405|363162936|FG000|Overall Study|Withdrawal by Subject|1|||
105318328|NCT04123405|363162937|FG001|Overall Study|Withdrawal by Subject|3|||
105318329|NCT04123405|363162938|FG002|Overall Study|Withdrawal by Subject|0|||
105318330|NCT04123405|363162939|FG003|Overall Study|Withdrawal by Subject|2|||
105318331|NCT04123405|363162936|FG000|Overall Study|Contact to subject lost|0|||
105318332|NCT04123405|363162937|FG001|Overall Study|Contact to subject lost|0|||
105318333|NCT04123405|363162938|FG002|Overall Study|Contact to subject lost|0|||
105318334|NCT04123405|363162939|FG003|Overall Study|Contact to subject lost|1|||
105318335|NCT04123405|363162936|FG000|Overall Study|screening failure|1|||
105318336|NCT04123405|363162937|FG001|Overall Study|screening failure|0|||
105318337|NCT04123405|363162938|FG002|Overall Study|screening failure|0|||
105318338|NCT04123405|363162939|FG003|Overall Study|screening failure|0|||
105318339|NCT01750190|363162941|FG000|Overall Study|Adverse Event|47|||
105318340|NCT01750190|363162942|FG001|Overall Study|Adverse Event|19|||
105318341|NCT01750190|363162941|FG000|Overall Study|Death|38|||
105318342|NCT01750190|363162942|FG001|Overall Study|Death|11|||
105318343|NCT01750190|363162941|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
105318344|NCT01750190|363162942|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
105318345|NCT01750190|363162941|FG000|Overall Study|Lost to Follow-up|28|||
105318346|NCT01750190|363162942|FG001|Overall Study|Lost to Follow-up|7|||
105318347|NCT01750190|363162941|FG000|Overall Study|Physician Decision|16|||
105318348|NCT01750190|363162942|FG001|Overall Study|Physician Decision|17|||
105318349|NCT01750190|363162941|FG000|Overall Study|Protocol Violation|6|||
105318350|NCT01750190|363162942|FG001|Overall Study|Protocol Violation|5|||
105318351|NCT01750190|363162941|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
105318352|NCT01750190|363162942|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
105318353|NCT01750190|363162941|FG000|Overall Study|Withdrawal by Subject|83|||
105318354|NCT01750190|363162942|FG001|Overall Study|Withdrawal by Subject|89|||
105318355|NCT01750190|363162941|FG000|Overall Study|Kidney Transplant|8|||
105318356|NCT01750190|363162942|FG001|Overall Study|Kidney Transplant|4|||
105318357|NCT01750190|363162941|FG000|Overall Study|Dialysis|22|||
105318358|NCT01750190|363162942|FG001|Overall Study|Dialysis|8|||
105318359|NCT01750190|363162941|FG000|Overall Study|Other than Specified|13|||
105318360|NCT01750190|363162942|FG001|Overall Study|Other than Specified|4|||
105318361|NCT00911300|363162943|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
105318362|NCT00911300|363162944|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
105318363|NCT00911300|363162943|FG000|Overall Study|Death|1|||
105576768|NCT00932646|364110322|FG003|Overall Study|Adverse Event|1|||
105576769|NCT00932646|364110319|FG000|Overall Study|Lost to Follow-up|2|||
105849456|NCT02980874|365107731|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
105849457|NCT02980874|365107732|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
105849458|NCT02980874|365107731|FG000|Overall Study|Unknown study completion status|1|||
105849459|NCT02980874|365107732|FG001|Overall Study|Unknown study completion status|0|||
105849460|NCT03295318|365109523|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
105849461|NCT03295318|365109524|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
105849462|NCT03295318|365109525|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
105318364|NCT00911300|363162944|FG001|Overall Study|Death|0|||
105318365|NCT00911300|363162943|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
105318366|NCT00911300|363162944|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
105318367|NCT00911300|363162943|FG000|Overall Study|Adverse Event|14|||
105318368|NCT00911300|363162944|FG001|Overall Study|Adverse Event|6|||
105318369|NCT00911300|363162943|FG000|Overall Study|Protocol Violation|3|||
105318370|NCT00911300|363162944|FG001|Overall Study|Protocol Violation|2|||
105318371|NCT00911300|363162943|FG000|Overall Study|Consent Withdrawn|4|||
105318372|NCT00911300|363162944|FG001|Overall Study|Consent Withdrawn|12|||
105318373|NCT00911300|363162943|FG000|Overall Study|Coronary Angiography Performed|1|||
105318374|NCT00911300|363162944|FG001|Overall Study|Coronary Angiography Performed|0|||
105576770|NCT00932646|364110320|FG001|Overall Study|Lost to Follow-up|1|||
105849463|NCT03295318|365109523|FG000|Overall Study|Death|1|||
105849464|NCT03295318|365109524|FG001|Overall Study|Death|1|||
105849465|NCT03295318|365109525|FG002|Overall Study|Death|1|||
105849466|NCT03295318|365109523|FG000|Overall Study|Protocol Violation|4|||
105849467|NCT03295318|365109524|FG001|Overall Study|Protocol Violation|3|||
105849468|NCT03295318|365109525|FG002|Overall Study|Protocol Violation|3|||
105849469|NCT03295318|365109523|FG000|Overall Study|Withdrawal by Subject|0|||
105849470|NCT03295318|365109524|FG001|Overall Study|Withdrawal by Subject|0|||
105849471|NCT03295318|365109525|FG002|Overall Study|Withdrawal by Subject|1|||
105849472|NCT03295318|365109523|FG000|Overall Study|Subject discontinued due to travel|0|||
105849473|NCT03295318|365109524|FG001|Overall Study|Subject discontinued due to travel|1|||
105849474|NCT03295318|365109525|FG002|Overall Study|Subject discontinued due to travel|0|||
105849475|NCT04908683|365109526|FG000|Overall Study|Failure to meet continuation criteria|34|||
105849476|NCT04908683|365109527|FG001|Overall Study|Failure to meet continuation criteria|22|||
105849477|NCT04908683|365109526|FG000|Overall Study|Initiated prohibited medication|3|||
105849478|NCT04908683|365109527|FG001|Overall Study|Initiated prohibited medication|0|||
105849479|NCT04908683|365109526|FG000|Overall Study|Randomized by mistake|1|||
105318375|NCT00911300|363162943|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
105318376|NCT00911300|363162944|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
105318377|NCT00911300|363162943|FG000|Overall Study|Received Commercial Treatment|1|||
105318378|NCT00911300|363162944|FG001|Overall Study|Received Commercial Treatment|0|||
105318379|NCT00911300|363162943|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
105318380|NCT00911300|363162944|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
105318381|NCT00911300|363162943|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
105318382|NCT00911300|363162944|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
105318383|NCT00911300|363162943|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
105318384|NCT00911300|363162944|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
105318385|NCT00911300|363162943|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
105318386|NCT00911300|363162944|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
105318387|NCT00911300|363162943|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
105318388|NCT00911300|363162944|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
105318389|NCT00911300|363162943|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
105318390|NCT00911300|363162944|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
105318391|NCT00911300|363162943|FG000|Overall Study|International Normalized Ratio Too High|0|||
105318392|NCT00911300|363162944|FG001|Overall Study|International Normalized Ratio Too High|1|||
105318393|NCT00911300|363162943|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
105318394|NCT00911300|363162944|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
105318395|NCT00911300|363162943|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
105318396|NCT00911300|363162944|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
105318397|NCT00911300|363162943|FG000|Overall Study|Physician Decision|0|||
105318398|NCT00911300|363162944|FG001|Overall Study|Physician Decision|1|||
105318399|NCT00911300|363162943|FG000|Overall Study|Treatment Stopped by Mistake|0|||
105318400|NCT00911300|363162944|FG001|Overall Study|Treatment Stopped by Mistake|1|||
105318401|NCT00911300|363162943|FG000|Overall Study|Randomized; No Study Medication Received|0|||
105318402|NCT00911300|363162944|FG001|Overall Study|Randomized; No Study Medication Received|2|||
105318403|NCT03138655|363162946|FG000|Overall Study|Adverse Event|2|||
105318404|NCT03138655|363162947|FG001|Overall Study|Adverse Event|1|||
105318405|NCT03138655|363162948|FG002|Overall Study|Adverse Event|2|||
105318406|NCT03138655|363162949|FG003|Overall Study|Adverse Event|1|||
105318407|NCT03138655|363162950|FG004|Overall Study|Adverse Event|1|||
105318408|NCT03138655|363162951|FG005|Overall Study|Adverse Event|4|||
105318409|NCT03138655|363162952|FG006|Overall Study|Adverse Event|2|||
105318410|NCT03138655|363162953|FG007|Overall Study|Adverse Event|2|||
105318411|NCT03138655|363162946|FG000|Overall Study|Withdrawal by Subject|0|||
105318412|NCT03138655|363162947|FG001|Overall Study|Withdrawal by Subject|1|||
105318413|NCT03138655|363162948|FG002|Overall Study|Withdrawal by Subject|0|||
105318414|NCT03138655|363162949|FG003|Overall Study|Withdrawal by Subject|0|||
105318415|NCT03138655|363162950|FG004|Overall Study|Withdrawal by Subject|0|||
105318416|NCT03138655|363162951|FG005|Overall Study|Withdrawal by Subject|0|||
105318417|NCT03138655|363162952|FG006|Overall Study|Withdrawal by Subject|1|||
105318418|NCT03138655|363162953|FG007|Overall Study|Withdrawal by Subject|0|||
105318419|NCT03138655|363162946|FG000|Overall Study|Reason not Specified|1|||
105369559|NCT01041859|363358492|FG002|Double-Blind Maintenance|Other|2|||
105849480|NCT04908683|365109527|FG001|Overall Study|Randomized by mistake|0|||
105849481|NCT04908683|365109526|FG000|Overall Study|Lost to Follow-up|679|||
105849482|NCT04908683|365109527|FG001|Overall Study|Lost to Follow-up|341|||
105849483|NCT04908683|365109526|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
105849484|NCT04908683|365109527|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
105849485|NCT04908683|365109526|FG000|Overall Study|Physician Decision|44|||
105849486|NCT04908683|365109527|FG001|Overall Study|Physician Decision|35|||
105849487|NCT04908683|365109526|FG000|Overall Study|Technical problems|12|||
105849488|NCT04908683|365109527|FG001|Overall Study|Technical problems|9|||
105849489|NCT04908683|365109526|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
105849490|NCT04908683|365109527|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
105849491|NCT04908683|365109526|FG000|Overall Study|Protocol Violation|2|||
105849492|NCT04908683|365109527|FG001|Overall Study|Protocol Violation|0|||
105849493|NCT04908683|365109526|FG000|Overall Study|Withdrawal by Subject|1188|||
105849494|NCT04908683|365109527|FG001|Overall Study|Withdrawal by Subject|570|||
105849495|NCT04908683|365109526|FG000|Overall Study|Site Closure by Sponsor|6|||
105849496|NCT04908683|365109527|FG001|Overall Study|Site Closure by Sponsor|3|||
105849497|NCT04908683|365109526|FG000|Overall Study|Adverse Event|21|||
105849498|NCT04908683|365109527|FG001|Overall Study|Adverse Event|11|||
105849499|NCT04908683|365109526|FG000|Overall Study|Death|101|||
105849500|NCT04908683|365109527|FG001|Overall Study|Death|61|||
105849501|NCT04908683|365109526|FG000|Overall Study|Sponsor's decision|14398|||
105849502|NCT04908683|365109527|FG001|Overall Study|Sponsor's decision|7205|||
105849503|NCT04908683|365109526|FG000|Overall Study|Other|92|||
105849504|NCT04908683|365109527|FG001|Overall Study|Other|50|||
105849505|NCT04908683|365109526|FG000|Overall Study|Randomized not vaccinated|108|||
105849506|NCT04908683|365109527|FG001|Overall Study|Randomized not vaccinated|52|||
105849507|NCT03047473|365109529|FG000|Overall Study|Lost to Follow-up|2|||
105849508|NCT06204887|365109530|FG000|Overall Study|Lost to Follow-up|3|||
105849509|NCT06204887|365109531|FG001|Overall Study|Lost to Follow-up|4|||
105849510|NCT06204887|365109532|FG002|Overall Study|Lost to Follow-up|1|||
105849511|NCT06204887|365109533|FG003|Overall Study|Lost to Follow-up|6|||
105849512|NCT02195479|365109534|FG000|Overall Study|Lost to Follow-up|3|||
105849513|NCT02195479|365109535|FG001|Overall Study|Lost to Follow-up|0|||
105849514|NCT02195479|365109534|FG000|Overall Study|Death|48|||
105849515|NCT02195479|365109535|FG001|Overall Study|Death|45|||
105849516|NCT02195479|365109534|FG000|Overall Study|Physician Decision|1|||
105849517|NCT02195479|365109535|FG001|Overall Study|Physician Decision|0|||
105849518|NCT02195479|365109534|FG000|Overall Study|Withdrawal by Subject|11|||
105849519|NCT02195479|365109535|FG001|Overall Study|Withdrawal by Subject|6|||
105849520|NCT02195479|365109534|FG000|Overall Study|Other|2|||
105849521|NCT02195479|365109535|FG001|Overall Study|Other|2|||
105849522|NCT02195479|365109534|FG000|Overall Study|Ongoing|291|||
105849523|NCT02195479|365109535|FG001|Overall Study|Ongoing|297|||
105849524|NCT03107026|365109538|FG000|Overall Study|Adverse Event|2|||
105849525|NCT03107026|365109539|FG001|Overall Study|Adverse Event|14|||
105849526|NCT03107026|365109540|FG002|Overall Study|Adverse Event|23|||
105849527|NCT03107026|365109538|FG000|Overall Study|Lost to Follow-up|12|||
105849528|NCT03107026|365109539|FG001|Overall Study|Lost to Follow-up|12|||
105849529|NCT03107026|365109540|FG002|Overall Study|Lost to Follow-up|13|||
105849530|NCT03107026|365109538|FG000|Overall Study|Protocol Violation|1|||
105849531|NCT03107026|365109539|FG001|Overall Study|Protocol Violation|2|||
105849532|NCT03107026|365109540|FG002|Overall Study|Protocol Violation|0|||
105849533|NCT03107026|365109538|FG000|Overall Study|Pregnancy|1|||
105849534|NCT03107026|365109539|FG001|Overall Study|Pregnancy|0|||
105849535|NCT03107026|365109540|FG002|Overall Study|Pregnancy|0|||
105849536|NCT03107026|365109538|FG000|Overall Study|Withdrawal by Subject|13|||
105849537|NCT03107026|365109539|FG001|Overall Study|Withdrawal by Subject|5|||
105849538|NCT03107026|365109540|FG002|Overall Study|Withdrawal by Subject|17|||
105849539|NCT03107026|365109538|FG000|Overall Study|non compliance with study visits|1|||
105849540|NCT03107026|365109539|FG001|Overall Study|non compliance with study visits|2|||
105849541|NCT03107026|365109540|FG002|Overall Study|non compliance with study visits|0|||
105849542|NCT03107026|365109538|FG000|Overall Study|non-compliance with study drug|2|||
105849543|NCT03107026|365109539|FG001|Overall Study|non-compliance with study drug|2|||
105849544|NCT03107026|365109540|FG002|Overall Study|non-compliance with study drug|3|||
105849545|NCT03107026|365109538|FG000|Overall Study|Physician Decision|0|||
105849546|NCT03107026|365109539|FG001|Overall Study|Physician Decision|1|||
105849547|NCT03107026|365109540|FG002|Overall Study|Physician Decision|0|||
105849548|NCT00573157|365109541|FG000|Overall Study|Adverse Event|3|||
105849549|NCT00573157|365109542|FG001|Overall Study|Adverse Event|1|||
105849550|NCT00573157|365109541|FG000|Overall Study|Other|1|||
105849551|NCT00573157|365109542|FG001|Overall Study|Other|1|||
105849552|NCT02358343|365109549|FG000|Screening Intervention|Death|0|||
105849553|NCT02358343|365109550|FG001|Screening Intervention|Death|2|||
105369560|NCT01041859|363358490|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
105369561|NCT01041859|363358491|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
105849554|NCT02358343|365109551|FG002|Screening Intervention|Death|0|||
105849555|NCT02358343|365109552|FG003|Screening Intervention|Death|0|||
105849556|NCT02358343|365109553|FG004|Screening Intervention|Death|0|||
105849557|NCT02358343|365109549|FG000|Screening Intervention|Withdrawal by Subject|1|||
105849558|NCT02358343|365109550|FG001|Screening Intervention|Withdrawal by Subject|0|||
105849559|NCT02358343|365109551|FG002|Screening Intervention|Withdrawal by Subject|0|||
105849560|NCT02358343|365109552|FG003|Screening Intervention|Withdrawal by Subject|0|||
105849561|NCT02358343|365109553|FG004|Screening Intervention|Withdrawal by Subject|0|||
105849562|NCT02358343|365109549|FG000|Screening Intervention|Determined Ineligible|5|||
105849563|NCT02358343|365109550|FG001|Screening Intervention|Determined Ineligible|6|||
105849564|NCT02358343|365109551|FG002|Screening Intervention|Determined Ineligible|0|||
105849565|NCT02358343|365109552|FG003|Screening Intervention|Determined Ineligible|0|||
105318420|NCT03138655|363162947|FG001|Overall Study|Reason not Specified|0|||
105318421|NCT03138655|363162948|FG002|Overall Study|Reason not Specified|0|||
105318422|NCT03138655|363162949|FG003|Overall Study|Reason not Specified|2|||
105318423|NCT03138655|363162950|FG004|Overall Study|Reason not Specified|1|||
105318424|NCT03138655|363162951|FG005|Overall Study|Reason not Specified|1|||
105318425|NCT03138655|363162952|FG006|Overall Study|Reason not Specified|0|||
105318426|NCT03138655|363162953|FG007|Overall Study|Reason not Specified|0|||
105318427|NCT00535405|363162954|FG000|Overall Study|Adverse Event|6|||
105369562|NCT01041859|363358492|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
105369563|NCT01041859|363358490|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
105369564|NCT01041859|363358491|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
105369565|NCT01041859|363358492|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
105369566|NCT00269152|363358495|FG000|Overall Study|Adverse Event|9|||
105369567|NCT00269152|363358496|FG001|Overall Study|Adverse Event|3|||
105369568|NCT00269152|363358495|FG000|Overall Study|Withdrawal by Subject|7|||
105369569|NCT00269152|363358496|FG001|Overall Study|Withdrawal by Subject|3|||
105369570|NCT00269152|363358495|FG000|Overall Study|Physician Decision|2|||
105369571|NCT00269152|363358496|FG001|Overall Study|Physician Decision|3|||
105369572|NCT00269152|363358495|FG000|Overall Study|Protocol Violation|0|||
105369573|NCT00269152|363358496|FG001|Overall Study|Protocol Violation|1|||
105369574|NCT03368807|363358499|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
105369575|NCT03368807|363358499|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
105369576|NCT03368807|363358499|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
105369577|NCT03368807|363358499|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
105369578|NCT00885118|363358500|FG000|Overall Study|Adverse Event|1|||
105369579|NCT00885118|363358501|FG001|Overall Study|Adverse Event|0|||
105369580|NCT00885118|363358502|FG002|Overall Study|Adverse Event|0|||
105369581|NCT00885118|363358503|FG003|Overall Study|Adverse Event|0|||
105369582|NCT00885118|363358504|FG004|Overall Study|Adverse Event|0|||
105369583|NCT00885118|363358500|FG000|Overall Study|Withdrawal by Subject|0|||
105369584|NCT00885118|363358501|FG001|Overall Study|Withdrawal by Subject|0|||
105369585|NCT00885118|363358502|FG002|Overall Study|Withdrawal by Subject|0|||
105369586|NCT00885118|363358503|FG003|Overall Study|Withdrawal by Subject|0|||
105369587|NCT00885118|363358504|FG004|Overall Study|Withdrawal by Subject|1|||
105369588|NCT00885118|363358500|FG000|Overall Study|Other reason not defined above|0|||
105369589|NCT00885118|363358501|FG001|Overall Study|Other reason not defined above|0|||
105369590|NCT00885118|363358502|FG002|Overall Study|Other reason not defined above|1|||
105369591|NCT00885118|363358503|FG003|Overall Study|Other reason not defined above|0|||
105369592|NCT00885118|363358504|FG004|Overall Study|Other reason not defined above|0|||
105369593|NCT00855218|363358505|FG000|Overall Study|Adverse Event|43|||
105369594|NCT00855218|363358506|FG001|Overall Study|Adverse Event|27|||
105369595|NCT00855218|363358505|FG000|Overall Study|Withdrawal by Subject|10|||
105369596|NCT00855218|363358506|FG001|Overall Study|Withdrawal by Subject|6|||
105369597|NCT00855218|363358505|FG000|Overall Study|Physician Decision|18|||
105369598|NCT00855218|363358506|FG001|Overall Study|Physician Decision|11|||
105369599|NCT00855218|363358505|FG000|Overall Study|Lost to Follow-up|0|||
105369600|NCT00855218|363358506|FG001|Overall Study|Lost to Follow-up|1|||
105369601|NCT00855218|363358505|FG000|Overall Study|Protocol Violation|5|||
105369602|NCT00855218|363358506|FG001|Overall Study|Protocol Violation|9|||
105369603|NCT00855218|363358505|FG000|Overall Study|non-compliant with study drug|3|||
105369604|NCT00855218|363358506|FG001|Overall Study|non-compliant with study drug|1|||
105369605|NCT00855218|363358505|FG000|Overall Study|patient convenience|2|||
105369606|NCT00855218|363358506|FG001|Overall Study|patient convenience|0|||
105369607|NCT00855218|363358505|FG000|Overall Study|technical problems|2|||
105369608|NCT00855218|363358506|FG001|Overall Study|technical problems|1|||
105369609|NCT00855218|363358505|FG000|Overall Study|Still treated with study medication|0|||
105369610|NCT00855218|363358506|FG001|Overall Study|Still treated with study medication|1|||
105369611|NCT00855218|363358505|FG000|Overall Study|Untreatable disease progression|54|||
105369612|NCT00855218|363358506|FG001|Overall Study|Untreatable disease progression|67|||
105369613|NCT00855218|363358505|FG000|Overall Study|Second malignancy|0|||
105369614|NCT00855218|363358506|FG001|Overall Study|Second malignancy|1|||
105369615|NCT00855218|363358505|FG000|Overall Study|Progression measurement proven|7|||
105369616|NCT00855218|363358506|FG001|Overall Study|Progression measurement proven|15|||
105369617|NCT00855218|363358505|FG000|Overall Study|Clinical endpoint reached|10|||
105369618|NCT00855218|363358506|FG001|Overall Study|Clinical endpoint reached|13|||
105369619|NCT03191552|363358507|FG000|Overall Study|Lost to Follow-up|1|||
105369620|NCT03191552|363358508|FG001|Overall Study|Lost to Follow-up|0|||
105369621|NCT03191552|363358509|FG002|Overall Study|Lost to Follow-up|0|||
105369622|NCT03191552|363358507|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
105369623|NCT03191552|363358508|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
105318428|NCT00535405|363162955|FG001|Overall Study|Adverse Event|8|||
105369624|NCT03191552|363358509|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
105318429|NCT00535405|363162956|FG002|Overall Study|Adverse Event|3|||
105318430|NCT00535405|363162957|FG003|Overall Study|Adverse Event|8|||
105369625|NCT01441973|363358510|FG000|Overall Study|Disease progression|8|||
105318431|NCT00535405|363162958|FG004|Overall Study|Adverse Event|6|||
105849566|NCT02358343|365109553|FG004|Screening Intervention|Determined Ineligible|0|||
105849567|NCT02358343|365109549|FG000|Comparative Efficacy Trial / Observation|Death|0|||
105849568|NCT02358343|365109550|FG001|Comparative Efficacy Trial / Observation|Death|0|||
105849569|NCT02358343|365109551|FG002|Comparative Efficacy Trial / Observation|Death|2|||
105849570|NCT02358343|365109552|FG003|Comparative Efficacy Trial / Observation|Death|0|||
105369626|NCT01441973|363358511|FG001|Overall Study|Disease progression|6|||
105369627|NCT01441973|363358510|FG000|Overall Study|Adverse event unrelated to study drug|3|||
105369628|NCT01441973|363358511|FG001|Overall Study|Adverse event unrelated to study drug|2|||
105369629|NCT01441973|363358510|FG000|Overall Study|Participant request to discontinue|1|||
105369630|NCT01441973|363358511|FG001|Overall Study|Participant request to discontinue|1|||
105369631|NCT01441973|363358510|FG000|Overall Study|Poor compliance/noncompliance|0|||
105369632|NCT01441973|363358511|FG001|Overall Study|Poor compliance/noncompliance|1|||
105369633|NCT01441973|363358510|FG000|Overall Study|Administrative reason by sponsor|3|||
105369634|NCT01441973|363358511|FG001|Overall Study|Administrative reason by sponsor|5|||
105369635|NCT01441973|363358510|FG000|Overall Study|Participant withdrew consent|0|||
105369636|NCT01441973|363358511|FG001|Overall Study|Participant withdrew consent|1|||
105369637|NCT01149655|363358512|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
105369638|NCT01149655|363358513|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
105369639|NCT01149655|363358514|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
105369640|NCT01149655|363358515|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
105369641|NCT01149655|363358512|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
105369642|NCT01149655|363358513|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
105369643|NCT01149655|363358514|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
105369644|NCT01149655|363358515|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
105369645|NCT01149655|363358512|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
105369646|NCT01149655|363358513|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
105369647|NCT01149655|363358514|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
105369648|NCT01149655|363358515|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
105369649|NCT01149655|363358512|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
105369650|NCT01149655|363358513|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
105369651|NCT01149655|363358514|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
105369652|NCT01149655|363358515|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
105369653|NCT01149655|363358512|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
105369654|NCT01149655|363358513|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
105369655|NCT01149655|363358514|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
105369656|NCT01149655|363358515|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
105369657|NCT01149655|363358512|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
105369658|NCT01149655|363358513|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
105369659|NCT01149655|363358514|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
105369660|NCT01149655|363358515|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
105369661|NCT01149655|363358512|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
105369662|NCT01149655|363358513|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
105369663|NCT01149655|363358514|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
105369664|NCT01149655|363358515|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
105369665|NCT01149655|363358512|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
105369666|NCT01149655|363358513|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
105369667|NCT01149655|363358514|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
105369668|NCT01149655|363358515|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
105369669|NCT01149655|363358512|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
105369670|NCT01149655|363358513|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
105369671|NCT01149655|363358514|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
105369672|NCT01149655|363358515|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
105369673|NCT01149655|363358512|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
105369674|NCT01149655|363358513|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
105369675|NCT01149655|363358514|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
105369676|NCT01149655|363358515|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
105369677|NCT01149655|363358512|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
105369678|NCT01149655|363358513|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
105369679|NCT01149655|363358514|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
105369680|NCT01149655|363358515|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
105369681|NCT01149655|363358512|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
105490795|NCT00423670|363809420|FG003|Treatment Period|Non-compliance with protocol|3|||
105490796|NCT00423670|363809421|FG004|Treatment Period|Non-compliance with protocol|2|||
105490797|NCT00423670|363809422|FG005|Treatment Period|Non-compliance with protocol|0|||
105490798|NCT00423670|363809423|FG006|Treatment Period|Non-compliance with protocol|2|||
105490799|NCT00423670|363809424|FG007|Treatment Period|Non-compliance with protocol|2|||
105490800|NCT00423670|363809417|FG000|Follow-up Period|Lost to Follow-up|0|||
105490801|NCT00423670|363809418|FG001|Follow-up Period|Lost to Follow-up|12|||
105318432|NCT00535405|363162954|FG000|Overall Study|Lost to Follow-up|1|||
105318433|NCT00535405|363162955|FG001|Overall Study|Lost to Follow-up|3|||
105318434|NCT00535405|363162956|FG002|Overall Study|Lost to Follow-up|3|||
105318435|NCT00535405|363162957|FG003|Overall Study|Lost to Follow-up|2|||
105318436|NCT00535405|363162958|FG004|Overall Study|Lost to Follow-up|1|||
105318437|NCT00535405|363162954|FG000|Overall Study|Physician Decision|3|||
105318438|NCT00535405|363162955|FG001|Overall Study|Physician Decision|2|||
105318439|NCT00535405|363162956|FG002|Overall Study|Physician Decision|0|||
105318440|NCT00535405|363162957|FG003|Overall Study|Physician Decision|1|||
105318441|NCT00535405|363162958|FG004|Overall Study|Physician Decision|1|||
105318442|NCT00535405|363162954|FG000|Overall Study|Protocol Violation|2|||
105318443|NCT00535405|363162955|FG001|Overall Study|Protocol Violation|2|||
105318444|NCT00535405|363162956|FG002|Overall Study|Protocol Violation|2|||
105318445|NCT00535405|363162957|FG003|Overall Study|Protocol Violation|1|||
105318446|NCT00535405|363162958|FG004|Overall Study|Protocol Violation|0|||
105318447|NCT00535405|363162954|FG000|Overall Study|Withdrawal by Subject|5|||
105318448|NCT00535405|363162955|FG001|Overall Study|Withdrawal by Subject|11|||
105318449|NCT00535405|363162956|FG002|Overall Study|Withdrawal by Subject|10|||
105318450|NCT00535405|363162957|FG003|Overall Study|Withdrawal by Subject|10|||
105318451|NCT00535405|363162958|FG004|Overall Study|Withdrawal by Subject|8|||
105318452|NCT04868500|363162961|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
105318453|NCT04868500|363162962|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
105318454|NCT04868500|363162961|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
105318455|NCT04868500|363162962|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
105318456|NCT02859142|363162963|FG000|Overall Study|Adverse Event|1|||
105318457|NCT02859142|363162964|FG001|Overall Study|Adverse Event|2|||
105318458|NCT02859142|363162963|FG000|Overall Study|Lost to Follow-up|1|||
105318459|NCT02859142|363162964|FG001|Overall Study|Lost to Follow-up|4|||
105318460|NCT02859142|363162963|FG000|Overall Study|Withdrawal by Subject|2|||
105318461|NCT02859142|363162964|FG001|Overall Study|Withdrawal by Subject|0|||
105318462|NCT02859142|363162963|FG000|Overall Study|Scheduling difficulties|0|||
105318463|NCT02859142|363162964|FG001|Overall Study|Scheduling difficulties|3|||
105318464|NCT03340974|363162968|FG000|Completion of Study -Long Term Follow up|Death|8|||
105318465|NCT03340974|363162969|FG001|Completion of Study -Long Term Follow up|Death|5|||
105318466|NCT03340974|363162970|FG002|Completion of Study -Long Term Follow up|Death|5|||
105318467|NCT03340974|363162971|FG003|Completion of Study -Long Term Follow up|Death|7|||
105318468|NCT03340974|363162968|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
105318469|NCT03340974|363162969|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
105318470|NCT03340974|363162970|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
105318471|NCT03340974|363162971|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
105318472|NCT03340974|363162968|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
105318473|NCT03340974|363162969|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
105318474|NCT03340974|363162970|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
105318475|NCT03340974|363162971|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
105369682|NCT01149655|363358513|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
105369683|NCT01149655|363358514|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
105369684|NCT01149655|363358515|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
105369685|NCT01149655|363358512|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
105369686|NCT01149655|363358513|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
105369687|NCT01149655|363358514|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
105369688|NCT01149655|363358515|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
105369689|NCT01149655|363358512|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
105369690|NCT01149655|363358513|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
105369691|NCT01149655|363358514|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
105369692|NCT01149655|363358515|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
105369693|NCT01149655|363358512|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
105369694|NCT01149655|363358513|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
105369695|NCT01149655|363358514|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
105369696|NCT01149655|363358515|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
105369697|NCT01149655|363358512|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
105318476|NCT03340974|363162968|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
105318477|NCT03340974|363162969|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
105318478|NCT03340974|363162970|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
105318479|NCT03340974|363162971|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
105318480|NCT03076775|363162974|FG000|Overall Study|Lost to Follow-up|1|||
105318481|NCT03076775|363162975|FG001|Overall Study|Lost to Follow-up|0|||
105318482|NCT01332292|363162976|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
105318483|NCT01332292|363162977|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
105318484|NCT01332292|363162976|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
105318485|NCT01332292|363162977|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
105318486|NCT01332292|363162976|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
105318487|NCT01332292|363162977|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
105318488|NCT00396565|363162978|FG000|Overall Study|Physician Decision|3|||
105318489|NCT00396565|363162979|FG001|Overall Study|Physician Decision|1|||
105318490|NCT00396565|363162980|FG002|Overall Study|Physician Decision|2|||
105318491|NCT00396565|363162978|FG000|Overall Study|Adverse Event|5|||
105318492|NCT00396565|363162979|FG001|Overall Study|Adverse Event|13|||
105318493|NCT00396565|363162980|FG002|Overall Study|Adverse Event|3|||
105318494|NCT00396565|363162978|FG000|Overall Study|Withdrawal by Subject|8|||
105318495|NCT00396565|363162979|FG001|Overall Study|Withdrawal by Subject|13|||
105318496|NCT00396565|363162980|FG002|Overall Study|Withdrawal by Subject|1|||
105318497|NCT00396565|363162978|FG000|Overall Study|Lack of Efficacy|32|||
105318498|NCT00396565|363162979|FG001|Overall Study|Lack of Efficacy|64|||
105318499|NCT00396565|363162980|FG002|Overall Study|Lack of Efficacy|11|||
105318500|NCT00940316|363162981|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
105318501|NCT00940316|363162982|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
105318502|NCT00940316|363162983|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
105318503|NCT00940316|363162981|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
105318504|NCT00940316|363162982|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
105318505|NCT00940316|363162983|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
105318506|NCT00940316|363162981|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
105318507|NCT00940316|363162982|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
105318508|NCT00940316|363162983|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
105318509|NCT00940316|363162981|FG000|Treated After Cycle 5|Adverse Event|0|||
105369698|NCT01149655|363358513|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
105369699|NCT01149655|363358514|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
105369700|NCT01149655|363358515|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
105369701|NCT03054428|363358518|FG000|Overall Study|Physician Decision|0|||
105369702|NCT03054428|363358519|FG001|Overall Study|Physician Decision|1|||
105369703|NCT03054428|363358520|FG002|Overall Study|Physician Decision|1|||
105369704|NCT03054428|363358518|FG000|Overall Study|Lack of Efficacy|3|||
105369705|NCT03054428|363358519|FG001|Overall Study|Lack of Efficacy|1|||
105369706|NCT03054428|363358520|FG002|Overall Study|Lack of Efficacy|0|||
105369707|NCT03054428|363358518|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
105369708|NCT03054428|363358519|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
105369709|NCT03054428|363358520|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
105369710|NCT03054428|363358518|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
105369711|NCT03054428|363358519|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
105369712|NCT03054428|363358520|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
105369713|NCT03054428|363358518|FG000|Overall Study|Transitioned to OLE study|76|||
105369714|NCT03054428|363358519|FG001|Overall Study|Transitioned to OLE study|76|||
105369715|NCT03054428|363358520|FG002|Overall Study|Transitioned to OLE study|73|||
105369716|NCT03054428|363358518|FG000|Overall Study|Withdrawal by Subject|3|||
105369717|NCT03054428|363358519|FG001|Overall Study|Withdrawal by Subject|2|||
105369718|NCT03054428|363358520|FG002|Overall Study|Withdrawal by Subject|3|||
105369719|NCT03054428|363358518|FG000|Overall Study|Lost to Follow-up|0|||
105369720|NCT03054428|363358519|FG001|Overall Study|Lost to Follow-up|0|||
105369721|NCT03054428|363358520|FG002|Overall Study|Lost to Follow-up|1|||
105369722|NCT04356937|363358521|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
105369723|NCT04356937|363358522|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
105369724|NCT04030598|363358523|FG000|Overall Study|Voluntary Withdrawal|0|||
105369725|NCT04030598|363358524|FG001|Overall Study|Voluntary Withdrawal|1|||
105369726|NCT04030598|363358525|FG002|Overall Study|Voluntary Withdrawal|0|||
105369727|NCT01884597|363358528|FG000|Overall Study|Adverse Event|0|||
105369728|NCT01884597|363358529|FG001|Overall Study|Adverse Event|0|||
105369729|NCT01884597|363358530|FG002|Overall Study|Adverse Event|1|||
105369730|NCT01884597|363358528|FG000|Overall Study|Lack of Efficacy|1|||
105369731|NCT01884597|363358529|FG001|Overall Study|Lack of Efficacy|0|||
105369732|NCT01884597|363358530|FG002|Overall Study|Lack of Efficacy|0|||
105369733|NCT01884597|363358528|FG000|Overall Study|Death|0|||
105369734|NCT01884597|363358529|FG001|Overall Study|Death|1|||
105369735|NCT01884597|363358530|FG002|Overall Study|Death|0|||
105369736|NCT02097823|363358531|FG000|Overall Study|Withdrawal by Subject|1|||
105369737|NCT02097823|363358532|FG001|Overall Study|Withdrawal by Subject|1|||
105318510|NCT00940316|363162982|FG001|Treated After Cycle 5|Adverse Event|0|||
105318511|NCT00940316|363162983|FG002|Treated After Cycle 5|Adverse Event|1|||
105318512|NCT00940316|363162981|FG000|Treated After Cycle 5|Progressive disease|0|||
105318513|NCT00940316|363162982|FG001|Treated After Cycle 5|Progressive disease|1|||
105318514|NCT00940316|363162983|FG002|Treated After Cycle 5|Progressive disease|0|||
105318515|NCT05299528|363162984|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
105369738|NCT02074514|363358534|FG000|Overall Study|Lack of Efficacy|3|||
105369739|NCT02074514|363358535|FG001|Overall Study|Lack of Efficacy|2|||
105576771|NCT00932646|364110321|FG002|Overall Study|Lost to Follow-up|0|||
105369740|NCT02074514|363358534|FG000|Overall Study|Lost to Follow-up|0|||
105369741|NCT02074514|363358535|FG001|Overall Study|Lost to Follow-up|1|||
105849571|NCT02358343|365109553|FG004|Comparative Efficacy Trial / Observation|Death|0|||
105849572|NCT02358343|365109549|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
105849573|NCT02358343|365109550|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
105849574|NCT02358343|365109551|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
105849575|NCT02358343|365109552|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
105849576|NCT02358343|365109553|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
105849577|NCT02358343|365109549|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
105849578|NCT02358343|365109550|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
105849579|NCT02358343|365109551|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
105849580|NCT02358343|365109552|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
105849581|NCT02358343|365109553|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
105849582|NCT00090610|365109556|FG000|Overall Study|Withdrawal by Subject|1|||
105849583|NCT00090610|365109557|FG001|Overall Study|Withdrawal by Subject|1|||
105849584|NCT00807248|365109558|FG000|Overall Study|Adverse Event|1|||
105849585|NCT00807248|365109559|FG001|Overall Study|Adverse Event|2|||
105318516|NCT05299528|363162985|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
105369742|NCT02074514|363358534|FG000|Overall Study|Withdrew Consent|0|||
105490802|NCT00423670|363809419|FG002|Follow-up Period|Lost to Follow-up|8|||
105490803|NCT00423670|363809420|FG003|Follow-up Period|Lost to Follow-up|3|||
105490804|NCT00423670|363809421|FG004|Follow-up Period|Lost to Follow-up|1|||
105490805|NCT00423670|363809422|FG005|Follow-up Period|Lost to Follow-up|0|||
105490806|NCT00423670|363809423|FG006|Follow-up Period|Lost to Follow-up|5|||
105490807|NCT00423670|363809424|FG007|Follow-up Period|Lost to Follow-up|0|||
105490808|NCT00423670|363809417|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
105490809|NCT00423670|363809418|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
105490810|NCT00423670|363809419|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
105490811|NCT00423670|363809420|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
105490812|NCT00423670|363809421|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
105490813|NCT00423670|363809422|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
105490814|NCT00423670|363809423|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
105490815|NCT00423670|363809424|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
105490816|NCT00423670|363809417|FG000|Follow-up Period|Non-compliance with protocol|2|||
105490817|NCT00423670|363809418|FG001|Follow-up Period|Non-compliance with protocol|0|||
105490818|NCT00423670|363809419|FG002|Follow-up Period|Non-compliance with protocol|1|||
105490819|NCT00423670|363809420|FG003|Follow-up Period|Non-compliance with protocol|1|||
105490820|NCT00423670|363809421|FG004|Follow-up Period|Non-compliance with protocol|0|||
105490821|NCT00423670|363809422|FG005|Follow-up Period|Non-compliance with protocol|0|||
105490822|NCT00423670|363809423|FG006|Follow-up Period|Non-compliance with protocol|3|||
105490823|NCT00423670|363809424|FG007|Follow-up Period|Non-compliance with protocol|2|||
105490824|NCT00057954|363809426|FG000|Overall Study|Death|1|||
105490825|NCT00057954|363809426|FG000|Overall Study|Disease progression|1|||
105490826|NCT01251744|363809427|FG000|Overall Study|Lost to Follow-up|1|||
105490827|NCT01251744|363809428|FG001|Overall Study|Lost to Follow-up|0|||
105490828|NCT00559754|363809429|FG000|Overall Study|Disease progression|1|||
105490829|NCT00559754|363809429|FG000|Overall Study|Adverse Event|5|||
105490830|NCT00559754|363809429|FG000|Overall Study|Protocol Violation|1|||
105849586|NCT00807248|365109560|FG002|Overall Study|Adverse Event|2|||
105849587|NCT00807248|365109561|FG003|Overall Study|Adverse Event|6|||
105849588|NCT00807248|365109558|FG000|Overall Study|Lack of Efficacy|14|||
105849589|NCT00807248|365109559|FG001|Overall Study|Lack of Efficacy|4|||
105849590|NCT00807248|365109560|FG002|Overall Study|Lack of Efficacy|8|||
105849591|NCT00807248|365109561|FG003|Overall Study|Lack of Efficacy|3|||
105849592|NCT00807248|365109558|FG000|Overall Study|Protocol Violation|0|||
105849593|NCT00807248|365109559|FG001|Overall Study|Protocol Violation|1|||
105849594|NCT00807248|365109560|FG002|Overall Study|Protocol Violation|1|||
105849595|NCT00807248|365109561|FG003|Overall Study|Protocol Violation|0|||
105849596|NCT00807248|365109558|FG000|Overall Study|Withdrawal of Consent|5|||
105849597|NCT00807248|365109559|FG001|Overall Study|Withdrawal of Consent|5|||
105849598|NCT00807248|365109560|FG002|Overall Study|Withdrawal of Consent|5|||
105849599|NCT00807248|365109561|FG003|Overall Study|Withdrawal of Consent|5|||
105849600|NCT00807248|365109558|FG000|Overall Study|Lost to Follow-up|1|||
105849601|NCT00807248|365109559|FG001|Overall Study|Lost to Follow-up|0|||
105849602|NCT00807248|365109560|FG002|Overall Study|Lost to Follow-up|0|||
105849603|NCT00807248|365109561|FG003|Overall Study|Lost to Follow-up|0|||
105849604|NCT00807248|365109558|FG000|Overall Study|Other Reason|0|||
105849605|NCT00807248|365109559|FG001|Overall Study|Other Reason|0|||
105849606|NCT00807248|365109560|FG002|Overall Study|Other Reason|2|||
105849607|NCT00807248|365109561|FG003|Overall Study|Other Reason|0|||
105849608|NCT02031458|365109562|FG000|May 8, 2015 to January 11, 2019|Death|89|||
105849609|NCT02031458|365109563|FG001|May 8, 2015 to January 11, 2019|Death|193|||
105849610|NCT02031458|365109564|FG002|May 8, 2015 to January 11, 2019|Death|198|||
105849611|NCT02031458|365109562|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
105369743|NCT02074514|363358535|FG001|Overall Study|Withdrew Consent|1|||
105369744|NCT01296412|363358536|FG000|Overall Study|Adverse Event|8|||
105369745|NCT01296412|363358537|FG001|Overall Study|Adverse Event|29|||
105369746|NCT01296412|363358536|FG000|Overall Study|Lack of Efficacy|1|||
105369747|NCT01296412|363358537|FG001|Overall Study|Lack of Efficacy|0|||
105369748|NCT01296412|363358536|FG000|Overall Study|Lost to Follow-up|10|||
105369749|NCT01296412|363358537|FG001|Overall Study|Lost to Follow-up|7|||
105369750|NCT01296412|363358536|FG000|Overall Study|Non-compliance with study drug|1|||
105369751|NCT01296412|363358537|FG001|Overall Study|Non-compliance with study drug|2|||
105369752|NCT01296412|363358536|FG000|Overall Study|Other reason not specified|20|||
105369753|NCT01296412|363358537|FG001|Overall Study|Other reason not specified|15|||
105369754|NCT01296412|363358536|FG000|Overall Study|Physician Decision|1|||
105369755|NCT01296412|363358537|FG001|Overall Study|Physician Decision|3|||
105369756|NCT01296412|363358536|FG000|Overall Study|Pregnancy|0|||
105369757|NCT01296412|363358537|FG001|Overall Study|Pregnancy|1|||
105369758|NCT01296412|363358536|FG000|Overall Study|Withdrawal by Subject|10|||
105369759|NCT01296412|363358537|FG001|Overall Study|Withdrawal by Subject|13|||
105369760|NCT01181167|363360417|FG000|Overall Study|Adverse Event|11|||
105369761|NCT01181167|363360418|FG001|Overall Study|Adverse Event|21|||
105369762|NCT01181167|363360417|FG000|Overall Study|Lost to Follow-up|1|||
105369763|NCT01181167|363360418|FG001|Overall Study|Lost to Follow-up|0|||
105369764|NCT01181167|363360417|FG000|Overall Study|Physician Decision|2|||
105369765|NCT01181167|363360418|FG001|Overall Study|Physician Decision|3|||
105369766|NCT01181167|363360417|FG000|Overall Study|Protocol Violation|3|||
105369767|NCT01181167|363360418|FG001|Overall Study|Protocol Violation|0|||
105369768|NCT01181167|363360417|FG000|Overall Study|Withdrawal by Subject|6|||
105369769|NCT01181167|363360418|FG001|Overall Study|Withdrawal by Subject|8|||
105369770|NCT01145482|363360419|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
105369771|NCT01145482|363360420|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
105369772|NCT00499122|363360422|FG000|Overall Study|Withdrawal by Subject|2|||
105369773|NCT01316614|363360423|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
105369774|NCT01316614|363360423|FG000|Overall Study|Cytology slides not available for review|4|||
105369775|NCT01316614|363360423|FG000|Overall Study|Cystic lesion|5|||
105369776|NCT01316614|363360423|FG000|Overall Study|Inadequate number of passes|2|||
105369777|NCT01316614|363360423|FG000|Overall Study|Medically unstable|1|||
105369778|NCT00076570|363360424|FG000|Overall Study|Drug intolerance|8|||
105369779|NCT00076570|363360425|FG001|Overall Study|Drug intolerance|8|||
105369780|NCT01516216|363360428|FG000|Overall Study|Adverse Event|2|||
105369781|NCT01516216|363360429|FG001|Overall Study|Adverse Event|4|||
105369782|NCT01516216|363360428|FG000|Overall Study|Disease Progression|38|||
105369783|NCT01516216|363360429|FG001|Overall Study|Disease Progression|34|||
105369784|NCT01516216|363360428|FG000|Overall Study|Withdrawal by Subject|9|||
105369785|NCT01516216|363360429|FG001|Overall Study|Withdrawal by Subject|11|||
105369786|NCT01516216|363360428|FG000|Overall Study|Potentially Curative Resection|6|||
105369787|NCT01516216|363360429|FG001|Overall Study|Potentially Curative Resection|12|||
105369788|NCT01516216|363360428|FG000|Overall Study|Nonadherence|2|||
105369789|NCT01516216|363360429|FG001|Overall Study|Nonadherence|3|||
105369790|NCT01516216|363360428|FG000|Overall Study|Physician Decision|6|||
105369791|NCT01516216|363360429|FG001|Overall Study|Physician Decision|3|||
105369792|NCT01516216|363360428|FG000|Overall Study|Prolonged Treatment Delay|5|||
105369793|NCT01516216|363360429|FG001|Overall Study|Prolonged Treatment Delay|1|||
105369794|NCT01516216|363360428|FG000|Overall Study|Intercurrent Illness|1|||
105369795|NCT01516216|363360429|FG001|Overall Study|Intercurrent Illness|0|||
105369796|NCT01516216|363360428|FG000|Overall Study|Death|1|||
105369797|NCT01516216|363360429|FG001|Overall Study|Death|1|||
105369798|NCT02089347|363360430|FG000|Overall Study|Protocol Violation|1|||
105369799|NCT02089347|363360431|FG001|Overall Study|Protocol Violation|0|||
105369800|NCT02783066|363360432|FG000|Overall Study|Withdrawal by Subject|13|||
105369801|NCT00551369|363360434|FG000|Overall Study|Protocol Violation|5|||
105369802|NCT00551369|363360434|FG000|Overall Study|Withdrawal by Subject|1|||
105369803|NCT00551369|363360434|FG000|Overall Study|Not treated per protocol and re|1|||
105369804|NCT00975416|363360438|FG000|Overall Study|early discharge from tx|3|||
105369805|NCT00975416|363360439|FG001|Overall Study|early discharge from tx|5|||
105369806|NCT05379920|363360440|FG000|Overall Study|Lost to Follow-up|0|||
105369807|NCT05379920|363360441|FG001|Overall Study|Lost to Follow-up|5|||
105369808|NCT05379920|363360442|FG002|Overall Study|Lost to Follow-up|0|||
105369809|NCT05379920|363360443|FG003|Overall Study|Lost to Follow-up|0|||
105369810|NCT03176771|363360446|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
105369811|NCT03176771|363360447|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
105369812|NCT03176771|363360448|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
105369813|NCT03176771|363360449|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
105369814|NCT03176771|363360450|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
105490831|NCT00559754|363809429|FG000|Overall Study|Investigator criteria|2|||
105369815|NCT03176771|363360446|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
105369816|NCT03176771|363360447|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
105369817|NCT03176771|363360448|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
105490832|NCT00559754|363809429|FG000|Overall Study|Withdrawal by Subject|2|||
105490833|NCT01068652|363809434|FG000|Overall Study|Adverse Event|4|||
105490834|NCT01068652|363809435|FG001|Overall Study|Adverse Event|0|||
105490835|NCT01068652|363809434|FG000|Overall Study|Lack of Efficacy|0|||
105490836|NCT01068652|363809435|FG001|Overall Study|Lack of Efficacy|2|||
105490837|NCT01068652|363809434|FG000|Overall Study|Lost to Follow-up|2|||
105490838|NCT01068652|363809435|FG001|Overall Study|Lost to Follow-up|1|||
105490839|NCT01068652|363809434|FG000|Overall Study|Protocol Violation|3|||
105490840|NCT01068652|363809435|FG001|Overall Study|Protocol Violation|6|||
105490841|NCT01068652|363809434|FG000|Overall Study|Withdrawal criteria|1|||
105490842|NCT01068652|363809435|FG001|Overall Study|Withdrawal criteria|2|||
105490843|NCT01068652|363809434|FG000|Overall Study|Patient was not eligible|1|||
105490844|NCT01068652|363809435|FG001|Overall Study|Patient was not eligible|0|||
105490845|NCT01068652|363809434|FG000|Overall Study|Unclassified|7|||
105490846|NCT01068652|363809435|FG001|Overall Study|Unclassified|4|||
105490847|NCT00147251|363809436|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
105490848|NCT00147251|363809437|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
105490849|NCT02147184|363809438|FG000|Overall Study|Lost to Follow-up|28|||
105490850|NCT02147184|363809439|FG001|Overall Study|Lost to Follow-up|15|||
105490851|NCT02147184|363809438|FG000|Overall Study|Study Burden|11|||
105490852|NCT02147184|363809439|FG001|Overall Study|Study Burden|7|||
105490853|NCT02147184|363809438|FG000|Overall Study|Pregnancy|6|||
105490854|NCT02147184|363809439|FG001|Overall Study|Pregnancy|0|||
105490855|NCT02147184|363809438|FG000|Overall Study|Moved out of state|3|||
105490856|NCT02147184|363809439|FG001|Overall Study|Moved out of state|3|||
105490857|NCT02147184|363809438|FG000|Overall Study|Physician Decision|0|||
105490858|NCT02147184|363809439|FG001|Overall Study|Physician Decision|2|||
105490859|NCT02147184|363809438|FG000|Overall Study|Other|1|||
105490860|NCT02147184|363809439|FG001|Overall Study|Other|0|||
105490861|NCT03595774|363809441|FG000|Overall Study|Adverse Event|1|||
105490862|NCT03595774|363809442|FG001|Overall Study|Adverse Event|0|||
105490863|NCT03595774|363809443|FG002|Overall Study|Adverse Event|1|||
105490864|NCT03595774|363809444|FG003|Overall Study|Adverse Event|0|||
105490865|NCT03595774|363809441|FG000|Overall Study|screen failure|0|||
105490866|NCT03595774|363809442|FG001|Overall Study|screen failure|1|||
105490867|NCT03595774|363809443|FG002|Overall Study|screen failure|0|||
105849612|NCT02031458|365109563|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
105849613|NCT02031458|365109564|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
105849614|NCT02031458|365109562|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
105849615|NCT02031458|365109563|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
105318517|NCT05299528|363162986|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
105318518|NCT05299528|363162987|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
105318519|NCT05299528|363162988|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
105318520|NCT05299528|363162989|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
105318521|NCT05299528|363162990|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
105318522|NCT05299528|363162984|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
105318523|NCT05299528|363162985|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
105318524|NCT05299528|363162986|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
105318525|NCT05299528|363162987|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
105318526|NCT05299528|363162988|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
105318527|NCT05299528|363162989|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
105318528|NCT05299528|363162990|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
105318529|NCT05299528|363162984|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
105318530|NCT05299528|363162985|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
105318531|NCT05299528|363162986|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
105318532|NCT05299528|363162987|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
105318533|NCT05299528|363162988|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
105318534|NCT05299528|363162989|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
105490868|NCT03595774|363809444|FG003|Overall Study|screen failure|1|||
105490869|NCT00751621|363809445|FG000|Overall Study|Adverse Event|1|||
105849616|NCT02031458|365109564|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
105849617|NCT02031458|365109562|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
105849618|NCT02031458|365109563|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
105490870|NCT00751621|363809445|FG000|Overall Study|Withdrawal by Subject|1|||
105490871|NCT00751621|363809445|FG000|Overall Study|Subject moved to another country|1|||
105490872|NCT00751621|363809445|FG000|Overall Study|Poor adherence to asthma treatment|1|||
105490873|NCT03343067|363809446|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
105490874|NCT03343067|363809447|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
105490875|NCT03343067|363809448|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
105490876|NCT00116168|363809449|FG000|Overall Study|Lost to Follow-up|6|||
105849619|NCT02031458|365109564|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
105849620|NCT02031458|365109562|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
105849621|NCT02031458|365109563|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
105849622|NCT02031458|365109564|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
105849623|NCT02031458|365109562|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
105849624|NCT02031458|365109563|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
105849625|NCT02031458|365109564|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
105849626|NCT02031458|365109562|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
105849627|NCT02031458|365109563|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
105849628|NCT02031458|365109564|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
105849629|NCT02031458|365109562|FG000|Baseline to May 8, 2015|Death|36|||
105849630|NCT02031458|365109563|FG001|Baseline to May 8, 2015|Death|87|||
105849631|NCT02031458|365109564|FG002|Baseline to May 8, 2015|Death|100|||
105849632|NCT02031458|365109562|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
105849633|NCT02031458|365109563|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
105849634|NCT02031458|365109564|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
105849635|NCT02031458|365109562|FG000|Baseline to May 8, 2015|Physician Decision|0|||
105849636|NCT02031458|365109563|FG001|Baseline to May 8, 2015|Physician Decision|1|||
105849637|NCT02031458|365109564|FG002|Baseline to May 8, 2015|Physician Decision|0|||
105849638|NCT02031458|365109562|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
105849639|NCT02031458|365109563|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
105849640|NCT02031458|365109564|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
105849641|NCT02031458|365109562|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
105849642|NCT02031458|365109563|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
105849643|NCT02031458|365109564|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
105849644|NCT02031458|365109562|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
105849645|NCT02031458|365109563|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
105849646|NCT02031458|365109564|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
105849647|NCT02031458|365109562|FG000|Baseline to May 8, 2015|On Treatment|43|||
105849648|NCT02031458|365109563|FG001|Baseline to May 8, 2015|On Treatment|81|||
105849649|NCT02031458|365109564|FG002|Baseline to May 8, 2015|On Treatment|73|||
105849650|NCT02031458|365109562|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
105849651|NCT02031458|365109563|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
105849652|NCT02031458|365109564|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
105849653|NCT01167257|365109565|FG000|Overall Study|Lost to Follow-up|2|||
105849654|NCT01167257|365109566|FG001|Overall Study|Lost to Follow-up|2|||
105849655|NCT01167257|365109565|FG000|Overall Study|Withdrew consent|1|||
105849656|NCT01167257|365109566|FG001|Overall Study|Withdrew consent|1|||
105849657|NCT04305587|365109567|FG000|Overall Study|Withdrawal by Subject|0|||
105849658|NCT04305587|365109568|FG001|Overall Study|Withdrawal by Subject|0|||
105849659|NCT04305587|365109569|FG002|Overall Study|Withdrawal by Subject|0|||
105849660|NCT04305587|365109570|FG003|Overall Study|Withdrawal by Subject|1|||
105849661|NCT04305587|365109571|FG004|Overall Study|Withdrawal by Subject|0|||
105849662|NCT04305587|365109572|FG005|Overall Study|Withdrawal by Subject|0|||
105849663|NCT04305587|365109573|FG006|Overall Study|Withdrawal by Subject|0|||
105849664|NCT04305587|365109574|FG007|Overall Study|Withdrawal by Subject|0|||
105849665|NCT04305587|365109575|FG008|Overall Study|Withdrawal by Subject|0|||
105849666|NCT01687478|365109576|FG000|Overall Study|Adverse Event|3|||
105849667|NCT01687478|365109577|FG001|Overall Study|Adverse Event|10|||
105849668|NCT01687478|365109576|FG000|Overall Study|Lost to Follow-up|1|||
105849669|NCT01687478|365109577|FG001|Overall Study|Lost to Follow-up|3|||
105849670|NCT01687478|365109576|FG000|Overall Study|Protocol Violation|0|||
105849671|NCT01687478|365109577|FG001|Overall Study|Protocol Violation|2|||
105849672|NCT01687478|365109576|FG000|Overall Study|Withdrawal by Subject|21|||
105849673|NCT01687478|365109577|FG001|Overall Study|Withdrawal by Subject|19|||
105849674|NCT01687478|365109576|FG000|Overall Study|Physician Decision|1|||
105849675|NCT01687478|365109577|FG001|Overall Study|Physician Decision|3|||
105849676|NCT01687478|365109576|FG000|Overall Study|Entry Criteria Not Met|6|||
105849677|NCT01687478|365109577|FG001|Overall Study|Entry Criteria Not Met|2|||
105849678|NCT02049450|365109578|FG000|Overall Study|Adverse Event|2|||
105849679|NCT02049450|365109578|FG000|Overall Study|Withdrawal by Subject|1|||
105849680|NCT02049450|365109578|FG000|Overall Study|Patients/guardian decision|1|||
105849681|NCT00577395|365109579|FG000|Overall Study|Study was terminated early by Sponsor|7|||
105318535|NCT05299528|363162990|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
105318536|NCT03910673|363162991|FG000|Overall Study|Adverse Event|0|||
105318537|NCT03910673|363162992|FG001|Overall Study|Adverse Event|0|||
105318538|NCT03910673|363162993|FG002|Overall Study|Adverse Event|0|||
105318539|NCT03910673|363162994|FG003|Overall Study|Adverse Event|2|||
105318540|NCT03910673|363162995|FG004|Overall Study|Adverse Event|0|||
105318541|NCT03404674|363162996|FG000|Overall Study|Inability to Attend Future Visits|0|||
105318542|NCT03404674|363162997|FG001|Overall Study|Inability to Attend Future Visits|1|||
105318543|NCT03404674|363162998|FG002|Overall Study|Inability to Attend Future Visits|1|||
105849682|NCT00577395|365109580|FG001|Overall Study|Study was terminated early by Sponsor|6|||
105490877|NCT00116168|363809450|FG001|Overall Study|Lost to Follow-up|5|||
105369818|NCT03176771|363360449|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
105369819|NCT03176771|363360450|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
105369820|NCT03176771|363360446|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
105369821|NCT03176771|363360447|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
105369822|NCT03176771|363360448|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
105369823|NCT03176771|363360449|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
105369824|NCT03176771|363360450|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
105369825|NCT03176771|363360446|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
105369826|NCT03176771|363360447|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
105369827|NCT03176771|363360448|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
105369828|NCT03176771|363360449|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
105369829|NCT03176771|363360450|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
105369830|NCT03176771|363360446|FG000|Double-Blind Extension Period|Adverse Event|0|||
105369831|NCT03176771|363360447|FG001|Double-Blind Extension Period|Adverse Event|0|||
105369832|NCT03176771|363360448|FG002|Double-Blind Extension Period|Adverse Event|0|||
105369833|NCT03176771|363360449|FG003|Double-Blind Extension Period|Adverse Event|15|||
105369834|NCT03176771|363360450|FG004|Double-Blind Extension Period|Adverse Event|18|||
105369835|NCT03176771|363360446|FG000|Double-Blind Extension Period|Death|0|||
105369836|NCT03176771|363360447|FG001|Double-Blind Extension Period|Death|0|||
105369837|NCT03176771|363360448|FG002|Double-Blind Extension Period|Death|0|||
105369838|NCT03176771|363360449|FG003|Double-Blind Extension Period|Death|3|||
105369839|NCT03176771|363360450|FG004|Double-Blind Extension Period|Death|4|||
105369840|NCT03176771|363360446|FG000|Double-Blind Extension Period|Physician Decision|0|||
105369841|NCT03176771|363360447|FG001|Double-Blind Extension Period|Physician Decision|0|||
105849683|NCT01206101|365109585|FG000|Overall Study|Adverse Event|1|||
105849684|NCT01206101|365109586|FG001|Overall Study|Adverse Event|0|||
105849685|NCT01206101|365109585|FG000|Overall Study|Physician Decision|0|||
105849686|NCT01206101|365109586|FG001|Overall Study|Physician Decision|1|||
105849687|NCT01206101|365109585|FG000|Overall Study|Unclassified|1|||
105849688|NCT01206101|365109586|FG001|Overall Study|Unclassified|0|||
105849689|NCT01248013|365109589|FG000|Overall Study|Withdrawal by Subject|14|||
105849690|NCT01859130|365109590|FG000|Overall Study|Death|4|||
105849691|NCT01859130|365109590|FG000|Overall Study|Lost to Follow-up|16|||
105849692|NCT01859130|365109590|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
105849693|NCT01859130|365109590|FG000|Overall Study|Physician Decision|6|||
105849694|NCT01859130|365109590|FG000|Overall Study|Withdrawal by Subject|17|||
105849695|NCT01859130|365109590|FG000|Overall Study|Adverse Event|11|||
105849696|NCT04711902|365109592|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
105849697|NCT04711902|365109593|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
105849698|NCT04711902|365109594|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
105849699|NCT04711902|365109595|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
105849700|NCT04711902|365109596|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
105849701|NCT04711902|365109597|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
105849702|NCT00368979|365109598|FG000|Overall Study|Adverse Event|9|||
105849703|NCT00368979|365109599|FG001|Overall Study|Adverse Event|16|||
105849704|NCT00368979|365109598|FG000|Overall Study|Lack of Efficacy|5|||
105849705|NCT00368979|365109599|FG001|Overall Study|Lack of Efficacy|3|||
105849706|NCT00368979|365109598|FG000|Overall Study|Other|3|||
105849707|NCT00368979|365109599|FG001|Overall Study|Other|1|||
105849708|NCT00368979|365109598|FG000|Overall Study|Lost to Follow-up|1|||
105849709|NCT00368979|365109599|FG001|Overall Study|Lost to Follow-up|0|||
105849710|NCT00368979|365109598|FG000|Overall Study|Protocol Violation|2|||
105849711|NCT00368979|365109599|FG001|Overall Study|Protocol Violation|1|||
105849712|NCT00368979|365109598|FG000|Overall Study|Withdrawal by Subject|5|||
105849713|NCT00368979|365109599|FG001|Overall Study|Withdrawal by Subject|9|||
105849714|NCT01462318|365109603|FG000|Main Study / TP-DI Study|Other|2|||
105849715|NCT01462318|365109604|FG001|Main Study / TP-DI Study|Other|0|||
105849716|NCT01462318|365109605|FG002|Main Study / TP-DI Study|Other|0|||
105849717|NCT01462318|365109603|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
105849718|NCT01462318|365109604|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
105849719|NCT01462318|365109605|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
105849720|NCT01462318|365109603|FG000|Main Study / TP-DI Study|Adverse Event|4|||
105849721|NCT01462318|365109604|FG001|Main Study / TP-DI Study|Adverse Event|0|||
105369842|NCT03176771|363360448|FG002|Double-Blind Extension Period|Physician Decision|0|||
105490878|NCT00116168|363809451|FG002|Overall Study|Lost to Follow-up|0|||
105849722|NCT01462318|365109605|FG002|Main Study / TP-DI Study|Adverse Event|0|||
105849723|NCT01462318|365109603|FG000|Extension Phase|Lost to Follow-up|0|||
105369843|NCT03176771|363360449|FG003|Double-Blind Extension Period|Physician Decision|3|||
105369844|NCT03176771|363360450|FG004|Double-Blind Extension Period|Physician Decision|1|||
105369845|NCT03176771|363360446|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
105849724|NCT01462318|365109604|FG001|Extension Phase|Lost to Follow-up|0|||
105849725|NCT01462318|365109605|FG002|Extension Phase|Lost to Follow-up|1|||
105849726|NCT01462318|365109603|FG000|Extension Phase|Other|0|||
105318544|NCT03404674|363162999|FG003|Overall Study|Inability to Attend Future Visits|0|||
105318545|NCT03404674|363163000|FG004|Overall Study|Inability to Attend Future Visits|0|||
105318546|NCT03404674|363163001|FG005|Overall Study|Inability to Attend Future Visits|0|||
105318547|NCT03404674|363162996|FG000|Overall Study|Behavioral Problems|0|||
105318548|NCT03404674|363162997|FG001|Overall Study|Behavioral Problems|0|||
105318549|NCT03404674|363162998|FG002|Overall Study|Behavioral Problems|1|||
105318550|NCT03404674|363162999|FG003|Overall Study|Behavioral Problems|0|||
105318551|NCT03404674|363163000|FG004|Overall Study|Behavioral Problems|0|||
105318552|NCT03404674|363163001|FG005|Overall Study|Behavioral Problems|0|||
105318553|NCT03404674|363162996|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
105318554|NCT03404674|363162997|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
105318555|NCT03404674|363162998|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
105318556|NCT03404674|363162999|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
105318557|NCT03404674|363163000|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
105318558|NCT03404674|363163001|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
105318559|NCT04877457|363163002|FG000|Overall Study|Early termination of study due to low enrollment|2|||
105318560|NCT04877457|363163003|FG001|Overall Study|Early termination of study due to low enrollment|1|||
105318561|NCT00246324|363163004|FG000|Overall Study|Withdrawal by Subject|1|||
105318562|NCT02006732|363163005|FG000|Overall Study|Adverse Event|10|||
105318563|NCT02006732|363163006|FG001|Overall Study|Adverse Event|7|||
105318564|NCT02006732|363163007|FG002|Overall Study|Adverse Event|4|||
105318565|NCT02006732|363163008|FG003|Overall Study|Adverse Event|2|||
105318566|NCT02006732|363163005|FG000|Overall Study|Lack of Efficacy|6|||
105318567|NCT02006732|363163006|FG001|Overall Study|Lack of Efficacy|3|||
105318568|NCT02006732|363163007|FG002|Overall Study|Lack of Efficacy|1|||
105318569|NCT02006732|363163008|FG003|Overall Study|Lack of Efficacy|1|||
105318570|NCT02006732|363163005|FG000|Overall Study|Protocol Violation|1|||
105318571|NCT02006732|363163006|FG001|Overall Study|Protocol Violation|1|||
105318572|NCT02006732|363163007|FG002|Overall Study|Protocol Violation|0|||
105318573|NCT02006732|363163008|FG003|Overall Study|Protocol Violation|0|||
105318574|NCT02006732|363163005|FG000|Overall Study|Lost to Follow-up|0|||
105318575|NCT02006732|363163006|FG001|Overall Study|Lost to Follow-up|1|||
105318576|NCT02006732|363163007|FG002|Overall Study|Lost to Follow-up|0|||
105318577|NCT02006732|363163008|FG003|Overall Study|Lost to Follow-up|0|||
105318578|NCT02006732|363163005|FG000|Overall Study|Withdrawal by Subject|3|||
105318579|NCT02006732|363163006|FG001|Overall Study|Withdrawal by Subject|0|||
105318580|NCT02006732|363163007|FG002|Overall Study|Withdrawal by Subject|4|||
105318581|NCT02006732|363163008|FG003|Overall Study|Withdrawal by Subject|1|||
105318582|NCT00299130|363163009|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
105369846|NCT03176771|363360447|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
105369847|NCT03176771|363360448|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
105369848|NCT03176771|363360449|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
105369849|NCT03176771|363360450|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
105369850|NCT03530293|363360451|FG000|Pre-randomization|Adverse Event|12|||
105369851|NCT03530293|363360452|FG001|Pre-randomization|Adverse Event|0|||
105369852|NCT03530293|363360453|FG002|Pre-randomization|Adverse Event|0|||
105369853|NCT03530293|363360451|FG000|Pre-randomization|Protocol Violation|2|||
105369854|NCT03530293|363360452|FG001|Pre-randomization|Protocol Violation|0|||
105369855|NCT03530293|363360453|FG002|Pre-randomization|Protocol Violation|0|||
105369856|NCT03530293|363360451|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
105369857|NCT03530293|363360452|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
105369858|NCT03530293|363360453|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
105369859|NCT03530293|363360451|FG000|Pre-randomization|Withdrawal by Subject|5|||
105369860|NCT03530293|363360452|FG001|Pre-randomization|Withdrawal by Subject|0|||
105369861|NCT03530293|363360453|FG002|Pre-randomization|Withdrawal by Subject|0|||
105369862|NCT03530293|363360451|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
105369863|NCT03530293|363360452|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
105369864|NCT03530293|363360453|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
105369865|NCT03530293|363360451|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
105369866|NCT03530293|363360452|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
105369867|NCT03530293|363360453|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
105318583|NCT00299130|363163010|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
105318584|NCT00299130|363163011|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
105318585|NCT00299130|363163009|FG000|Treatment Period (up to 5 Years)|Death|1|||
105318586|NCT00299130|363163010|FG001|Treatment Period (up to 5 Years)|Death|3|||
105318587|NCT00299130|363163011|FG002|Treatment Period (up to 5 Years)|Death|1|||
105318588|NCT00299130|363163009|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
105318589|NCT00299130|363163010|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
105318590|NCT00299130|363163011|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
105318591|NCT00299130|363163009|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
105490879|NCT00116168|363809452|FG003|Overall Study|Lost to Follow-up|0|||
105490880|NCT00117286|363809453|FG000|Overall Study|Adverse Event|12|||
105490881|NCT00117286|363809454|FG001|Overall Study|Adverse Event|6|||
105849727|NCT01462318|365109604|FG001|Extension Phase|Other|0|||
105849728|NCT01462318|365109605|FG002|Extension Phase|Other|1|||
105849729|NCT01462318|365109603|FG000|Extension Phase|Disease Progression|0|||
105849730|NCT01462318|365109604|FG001|Extension Phase|Disease Progression|0|||
105849731|NCT01462318|365109605|FG002|Extension Phase|Disease Progression|1|||
105849732|NCT01462318|365109603|FG000|Extension Phase|Withdrawal by Subject|0|||
105849733|NCT01462318|365109604|FG001|Extension Phase|Withdrawal by Subject|0|||
105849734|NCT01462318|365109605|FG002|Extension Phase|Withdrawal by Subject|15|||
105849735|NCT01462318|365109603|FG000|Extension Phase|Investigator Decision|0|||
105849736|NCT01462318|365109604|FG001|Extension Phase|Investigator Decision|0|||
105849737|NCT01462318|365109605|FG002|Extension Phase|Investigator Decision|5|||
105849738|NCT01462318|365109603|FG000|Extension Phase|Adverse Event|0|||
105849739|NCT01462318|365109604|FG001|Extension Phase|Adverse Event|0|||
105849740|NCT01462318|365109605|FG002|Extension Phase|Adverse Event|22|||
105849741|NCT00891371|365109606|FG000|Pre-assignment|Inclusion/exclusion|5|||
105849742|NCT00891371|365109606|FG000|Pre-assignment|Consent withdrawal|1|||
105849743|NCT00891371|365109606|FG000|Treatment|Lack of Efficacy|5|||
105849744|NCT00891371|365109606|FG000|Treatment|Adverse Event|2|||
105849745|NCT00891371|365109606|FG000|Treatment|Death|1|||
105849746|NCT00891371|365109606|FG000|Treatment|Lost to Follow-up|1|||
105849747|NCT02771795|365109611|FG000|Overall Study|Withdrawal by Subject|47|||
105849748|NCT02771795|365109612|FG001|Overall Study|Withdrawal by Subject|37|||
105849749|NCT02771795|365109611|FG000|Overall Study|Termination by premature discontinuation of study|168|||
105849750|NCT02771795|365109612|FG001|Overall Study|Termination by premature discontinuation of study|185|||
105849751|NCT04442490|365109615|FG000|Overall Study|Withdrawal by Subject|18|||
105849752|NCT04442490|365109616|FG001|Overall Study|Withdrawal by Subject|10|||
105849753|NCT04442490|365109615|FG000|Overall Study|Lost to Follow-up|7|||
105849754|NCT04442490|365109616|FG001|Overall Study|Lost to Follow-up|7|||
105849755|NCT04442490|365109615|FG000|Overall Study|Adverse Event|2|||
105849756|NCT04442490|365109616|FG001|Overall Study|Adverse Event|6|||
105849757|NCT04442490|365109615|FG000|Overall Study|Noncompliance|3|||
105849758|NCT04442490|365109616|FG001|Overall Study|Noncompliance|1|||
105849759|NCT04442490|365109615|FG000|Overall Study|Physician Decision|2|||
105849760|NCT04442490|365109616|FG001|Overall Study|Physician Decision|1|||
105849761|NCT04442490|365109615|FG000|Overall Study|Reason not Specified|2|||
105849762|NCT04442490|365109616|FG001|Overall Study|Reason not Specified|1|||
105849763|NCT04442490|365109615|FG000|Overall Study|Randomized but not Treated|3|||
105849764|NCT04442490|365109616|FG001|Overall Study|Randomized but not Treated|3|||
105849765|NCT01449279|365109617|FG000|Overall Study|Lack of Efficacy|5|||
105849766|NCT01449279|365109617|FG000|Overall Study|Toxicity|2|||
105849767|NCT01345175|365109618|FG000|Overall Study|Physician Decision|0|||
105849768|NCT01345175|365109619|FG001|Overall Study|Physician Decision|1|||
105849769|NCT01345175|365109618|FG000|Overall Study|Withdrawal by Subject|1|||
105849770|NCT01345175|365109619|FG001|Overall Study|Withdrawal by Subject|1|||
105849771|NCT01345175|365109618|FG000|Overall Study|Failed to complete BFI|3|||
105849772|NCT01345175|365109619|FG001|Overall Study|Failed to complete BFI|2|||
105849773|NCT01345175|365109618|FG000|Overall Study|Stopped taking medication|2|||
105849774|NCT01345175|365109619|FG001|Overall Study|Stopped taking medication|2|||
105849775|NCT00505375|365109620|FG000|Overall Study|Death|1|||
105849776|NCT00505375|365109621|FG001|Overall Study|Death|0|||
105849777|NCT00505375|365109620|FG000|Overall Study|Withdrawal by Subject|2|||
105849778|NCT00505375|365109621|FG001|Overall Study|Withdrawal by Subject|2|||
105849779|NCT00505375|365109620|FG000|Overall Study|Lost to Follow-up|0|||
105849780|NCT00505375|365109621|FG001|Overall Study|Lost to Follow-up|2|||
105849781|NCT00505375|365109620|FG000|Overall Study|Pregnancy|1|||
105849782|NCT00505375|365109621|FG001|Overall Study|Pregnancy|0|||
105849783|NCT00505375|365109620|FG000|Overall Study|Travel issues|0|||
105849784|NCT00505375|365109621|FG001|Overall Study|Travel issues|1|||
105849785|NCT02906930|365109625|FG000|Overall Study|Withdrawal by Subject|0|||
105849786|NCT02906930|365109626|FG001|Overall Study|Withdrawal by Subject|5|||
105849787|NCT02906930|365109627|FG002|Overall Study|Withdrawal by Subject|5|||
105490882|NCT00117286|363809453|FG000|Overall Study|Lost to Follow-up|2|||
105849788|NCT02906930|365109628|FG003|Overall Study|Withdrawal by Subject|4|||
105849789|NCT02906930|365109625|FG000|Overall Study|Lost to Follow-up|5|||
105849790|NCT02906930|365109626|FG001|Overall Study|Lost to Follow-up|7|||
105849791|NCT02906930|365109627|FG002|Overall Study|Lost to Follow-up|5|||
105849792|NCT02906930|365109628|FG003|Overall Study|Lost to Follow-up|2|||
105849793|NCT02906930|365109625|FG000|Overall Study|Death|0|||
105849794|NCT02906930|365109626|FG001|Overall Study|Death|0|||
105849795|NCT02906930|365109627|FG002|Overall Study|Death|1|||
105849796|NCT02906930|365109628|FG003|Overall Study|Death|0|||
105849797|NCT02906930|365109625|FG000|Overall Study|Other|1|||
105849798|NCT02906930|365109626|FG001|Overall Study|Other|2|||
105849799|NCT02906930|365109627|FG002|Overall Study|Other|1|||
105849800|NCT02906930|365109628|FG003|Overall Study|Other|2|||
105849801|NCT02570113|365109629|FG000|Overall Study|Withdrawal by Subject|3|||
105849802|NCT02746471|365109630|FG000|Overall Study|Death|43|||
105849803|NCT02746471|365109630|FG000|Overall Study|Exited before 36 months|1119|||
105849804|NCT00987389|365109642|FG000|Overall Study|Ineligible|0|||
105318592|NCT00299130|363163010|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
105318593|NCT00299130|363163011|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
105318594|NCT00299130|363163009|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
105318595|NCT00299130|363163010|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
105318596|NCT00299130|363163011|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
105318597|NCT00299130|363163009|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
105318598|NCT00299130|363163010|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
105318599|NCT00299130|363163011|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
105318600|NCT00299130|363163009|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
105318601|NCT00299130|363163010|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
105318602|NCT00299130|363163011|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
105318603|NCT00299130|363163009|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
105318604|NCT00299130|363163010|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
105318605|NCT00299130|363163011|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
105318606|NCT00299130|363163009|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
105318607|NCT00299130|363163010|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
105318608|NCT00299130|363163011|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
105318609|NCT00299130|363163009|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
105318610|NCT00299130|363163010|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
105318611|NCT00299130|363163011|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
105318612|NCT00299130|363163009|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
105318613|NCT00299130|363163010|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
105318614|NCT00299130|363163011|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
105318615|NCT00299130|363163009|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
105318616|NCT00299130|363163010|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
105318617|NCT00299130|363163011|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
105318618|NCT00299130|363163009|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
105318619|NCT00299130|363163010|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
105318620|NCT00299130|363163011|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
105318621|NCT00299130|363163009|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
105318622|NCT00299130|363163010|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
105318623|NCT00299130|363163011|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
105318624|NCT00299130|363163009|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
105318625|NCT00299130|363163010|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
105318626|NCT00299130|363163011|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
105318627|NCT00299130|363163009|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
105318628|NCT00299130|363163010|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
105318629|NCT00299130|363163011|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
105318630|NCT00299130|363163009|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
105318631|NCT00299130|363163010|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
105318632|NCT00299130|363163011|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
105318633|NCT02211417|363163012|FG000|Overall Study|Withdrawal by Subject|11|||
105318634|NCT02211417|363163013|FG001|Overall Study|Withdrawal by Subject|8|||
105318635|NCT02211417|363163012|FG000|Overall Study|Protocol Violation|1|||
105318636|NCT02211417|363163013|FG001|Overall Study|Protocol Violation|0|||
105318637|NCT02211417|363163012|FG000|Overall Study|Pregnancy|0|||
105318638|NCT02211417|363163013|FG001|Overall Study|Pregnancy|1|||
105318639|NCT02211417|363163012|FG000|Overall Study|Lost to Follow-up|2|||
105318640|NCT02211417|363163013|FG001|Overall Study|Lost to Follow-up|3|||
105318641|NCT02211417|363163012|FG000|Overall Study|Adverse Event|1|||
105318642|NCT02211417|363163013|FG001|Overall Study|Adverse Event|4|||
105318643|NCT01198132|363163014|FG000|Overall Study|Withdrawal by Subject|4|||
105318644|NCT01198132|363163015|FG001|Overall Study|Withdrawal by Subject|5|||
105318645|NCT01198132|363163014|FG000|Overall Study|Physician Decision|5|||
105318646|NCT01198132|363163015|FG001|Overall Study|Physician Decision|4|||
105318647|NCT01198132|363163014|FG000|Overall Study|Other Unspecified|3|||
105318648|NCT01198132|363163015|FG001|Overall Study|Other Unspecified|6|||
105318649|NCT01198132|363163014|FG000|Overall Study|Lack of Efficacy|2|||
105318650|NCT01198132|363163015|FG001|Overall Study|Lack of Efficacy|3|||
105318651|NCT01198132|363163014|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
105318652|NCT01198132|363163015|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
105318653|NCT01198132|363163014|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
105318654|NCT01198132|363163015|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
105318655|NCT01198132|363163014|FG000|Overall Study|Adverse Event|0|||
105318656|NCT01198132|363163015|FG001|Overall Study|Adverse Event|1|||
105318657|NCT01198132|363163014|FG000|Overall Study|Protocol Violation|1|||
105318658|NCT01198132|363163015|FG001|Overall Study|Protocol Violation|0|||
105318659|NCT01107197|363163017|FG000|Overall Study|Death|12|||
105318660|NCT01107197|363163018|FG001|Overall Study|Death|10|||
105318661|NCT01107197|363163017|FG000|Overall Study|Lost to Follow-up|5|||
105318662|NCT01107197|363163018|FG001|Overall Study|Lost to Follow-up|8|||
105318663|NCT01107197|363163017|FG000|Overall Study|Withdrawal by Subject|3|||
105318664|NCT01107197|363163018|FG001|Overall Study|Withdrawal by Subject|5|||
105318665|NCT03548337|363163019|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
105318666|NCT03548337|363163020|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
105318667|NCT03548337|363163019|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
105318668|NCT03548337|363163020|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
105318669|NCT03548337|363163019|FG000|Infant Series|Lost to Follow-up|2|||
105318670|NCT03548337|363163020|FG001|Infant Series|Lost to Follow-up|1|||
105318671|NCT03548337|363163019|FG000|Infant Series|Adverse Event|0|||
105318672|NCT03548337|363163020|FG001|Infant Series|Adverse Event|2|||
105318673|NCT03548337|363163019|FG000|Infant Series|Randomized but Not Vaccinated|1|||
105318674|NCT03548337|363163020|FG001|Infant Series|Randomized but Not Vaccinated|0|||
105318675|NCT03548337|363163019|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
105318676|NCT03548337|363163020|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
105318677|NCT04502212|363163021|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
105318678|NCT04502212|363163021|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
105318679|NCT01911273|363163024|FG000|Overall Study|Progression of Disease|1|||
105318680|NCT01911273|363163025|FG001|Overall Study|Progression of Disease|0|||
105318681|NCT01911273|363163024|FG000|Overall Study|Withdrawal by Subject|0|||
105318682|NCT01911273|363163025|FG001|Overall Study|Withdrawal by Subject|2|||
105318683|NCT04700137|363163026|FG000|Overall Study|Lost to Follow-up|1|||
105318684|NCT04700137|363163027|FG001|Overall Study|Lost to Follow-up|6|||
105318685|NCT04700137|363163028|FG002|Overall Study|Lost to Follow-up|1|||
105318686|NCT04700137|363163029|FG003|Overall Study|Lost to Follow-up|1|||
105318687|NCT04700137|363163026|FG000|Overall Study|Withdrawal by Subject|0|||
105318688|NCT04700137|363163027|FG001|Overall Study|Withdrawal by Subject|0|||
105318689|NCT04700137|363163028|FG002|Overall Study|Withdrawal by Subject|1|||
105318690|NCT04700137|363163029|FG003|Overall Study|Withdrawal by Subject|0|||
105318691|NCT04700137|363163026|FG000|Overall Study|Death|0|||
105318692|NCT04700137|363163027|FG001|Overall Study|Death|0|||
105318693|NCT04700137|363163028|FG002|Overall Study|Death|1|||
105318694|NCT04700137|363163029|FG003|Overall Study|Death|0|||
105318695|NCT02503787|363163030|FG000|Enrollment|Withdrawal by Subject|6|||
105318696|NCT02503787|363163030|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
105318697|NCT02503787|363163030|FG000|Enrollment|Physician Decision|2|||
105318698|NCT02503787|363163030|FG000|Enrollment|Insurance issue|2|||
105318699|NCT02503787|363163030|FG000|Enrollment|Lost to Follow-up|1|||
105318700|NCT02503787|363163030|FG000|Enrollment|Study closure|1|||
105318701|NCT02503787|363163030|FG000|Enrollment|Adverse Event|1|||
105318702|NCT02503787|363163030|FG000|Enrollment|Protocol Violation|1|||
105318703|NCT02503787|363163030|FG000|Enrollment|Inability to implant system|1|||
105318704|NCT02503787|363163030|FG000|Enrollment|Unable to be programmed|1|||
105318705|NCT02503787|363163030|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
105318706|NCT02503787|363163030|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
105318707|NCT02503787|363163030|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
105318708|NCT02503787|363163030|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
105318709|NCT02503787|363163030|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
105318710|NCT02503787|363163030|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
105318711|NCT01449812|363163033|FG000|Overall Study|Migrated/moved from study area|1|||
105318712|NCT01449812|363163034|FG001|Overall Study|Migrated/moved from study area|0|||
105318713|NCT01449812|363163035|FG002|Overall Study|Migrated/moved from study area|0|||
105318714|NCT01449812|363163033|FG000|Overall Study|Withdrawal by Subject|0|||
105318715|NCT01449812|363163034|FG001|Overall Study|Withdrawal by Subject|0|||
105318716|NCT01449812|363163035|FG002|Overall Study|Withdrawal by Subject|1|||
105318717|NCT01449812|363163033|FG000|Overall Study|Lost to Follow-up|1|||
105318718|NCT01449812|363163034|FG001|Overall Study|Lost to Follow-up|0|||
105318719|NCT01449812|363163035|FG002|Overall Study|Lost to Follow-up|0|||
105318720|NCT01260701|363163050|FG000|Overall Study|Adverse Event|9|||
105318721|NCT01260701|363163050|FG000|Overall Study|Withdrawal by Subject|2|||
105318722|NCT01260701|363163050|FG000|Overall Study|Progression|53|||
105490883|NCT00117286|363809454|FG001|Overall Study|Lost to Follow-up|0|||
105490884|NCT00117286|363809453|FG000|Overall Study|Protocol Violation|3|||
105490885|NCT00117286|363809454|FG001|Overall Study|Protocol Violation|3|||
105490886|NCT00117286|363809453|FG000|Overall Study|Withdrawal by Subject|6|||
105490887|NCT00117286|363809454|FG001|Overall Study|Withdrawal by Subject|2|||
105490888|NCT00117286|363809453|FG000|Overall Study|Physician Decision|3|||
105318723|NCT01260701|363163050|FG000|Overall Study|Death|2|||
105318724|NCT01260701|363163050|FG000|Overall Study|Not protocol specified|3|||
105318725|NCT01260701|363163050|FG000|Overall Study|Under review|1|||
105318726|NCT01260701|363163050|FG000|Overall Study|Ineligible|4|||
105318727|NCT01260701|363163050|FG000|Overall Study|Did not begin protocol therapy|1|||
105318728|NCT00306995|363163053|FG000|Study Part I|Withdrawal by Subject|0|||
105318729|NCT00306995|363163054|FG001|Study Part I|Withdrawal by Subject|0|||
105318730|NCT00306995|363163055|FG002|Study Part I|Withdrawal by Subject|0|||
105490889|NCT00117286|363809454|FG001|Overall Study|Physician Decision|7|||
105318731|NCT00306995|363163056|FG003|Study Part I|Withdrawal by Subject|0|||
105318732|NCT00306995|363163057|FG004|Study Part I|Withdrawal by Subject|0|||
105318733|NCT00306995|363163058|FG005|Study Part I|Withdrawal by Subject|0|||
105318734|NCT00306995|363163059|FG006|Study Part I|Withdrawal by Subject|1|||
105318735|NCT00306995|363163053|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
105318736|NCT00306995|363163054|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
105318737|NCT00306995|363163055|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
105318738|NCT00306995|363163056|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
105318739|NCT00306995|363163057|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
105318740|NCT00306995|363163058|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
105318741|NCT00306995|363163059|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
105318742|NCT00733005|363164891|FG000|Overall Study|Adverse Event|0|||
105318743|NCT00733005|363164892|FG001|Overall Study|Adverse Event|1|||
105318744|NCT00733005|363164891|FG000|Overall Study|Treatment Failure|0|||
105318745|NCT00733005|363164892|FG001|Overall Study|Treatment Failure|1|||
105318746|NCT00733005|363164891|FG000|Overall Study|Withdrawal by Subject|0|||
105318747|NCT00733005|363164892|FG001|Overall Study|Withdrawal by Subject|1|||
105318748|NCT00733005|363164891|FG000|Overall Study|Protocol Violation|2|||
105318749|NCT00733005|363164892|FG001|Overall Study|Protocol Violation|0|||
105318750|NCT01769456|363164893|FG000|Overall Study|Lost to Follow-up|19|||
105318751|NCT01769456|363164893|FG000|Overall Study|Withdrawal by Subject|3|||
105318752|NCT01769456|363164893|FG000|Overall Study|Did not receive PCC intervention|6|||
105318753|NCT01769456|363164893|FG000|Overall Study|Moved out of the area|3|||
105318754|NCT01769456|363164893|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
105318755|NCT01769456|363164893|FG000|Overall Study|Parental request to youth to withdraw|1|||
105318756|NCT05244122|363164894|FG000|Overall Study|Withdrawal by Subject|318|||
105318757|NCT00266630|363164899|FG000|Overall Study|Adverse Event|8|||
105318758|NCT00266630|363164900|FG001|Overall Study|Adverse Event|6|||
105318759|NCT00266630|363164899|FG000|Overall Study|Lack of Efficacy|1|||
105318760|NCT00266630|363164900|FG001|Overall Study|Lack of Efficacy|4|||
105318761|NCT00266630|363164899|FG000|Overall Study|Entry Criteria not met|1|||
105318762|NCT00266630|363164900|FG001|Overall Study|Entry Criteria not met|0|||
105318763|NCT00266630|363164899|FG000|Overall Study|Protocol Violation|1|||
105318764|NCT00266630|363164900|FG001|Overall Study|Protocol Violation|3|||
105318765|NCT00266630|363164899|FG000|Overall Study|Physician Decision|1|||
105318766|NCT00266630|363164900|FG001|Overall Study|Physician Decision|2|||
105318767|NCT00266630|363164899|FG000|Overall Study|Withdrawal by Subject|10|||
105318768|NCT00266630|363164900|FG001|Overall Study|Withdrawal by Subject|2|||
105318769|NCT00266630|363164899|FG000|Overall Study|Lost to Follow-up|1|||
105318770|NCT00266630|363164900|FG001|Overall Study|Lost to Follow-up|0|||
105318771|NCT00266630|363164899|FG000|Overall Study|Other|19|||
105318772|NCT00266630|363164900|FG001|Overall Study|Other|11|||
105318773|NCT03410056|363164901|FG000|Overall Study|Decision by Sponsor|0|||
105318774|NCT03410056|363164902|FG001|Overall Study|Decision by Sponsor|0|||
105318775|NCT03410056|363164903|FG002|Overall Study|Decision by Sponsor|3|||
105318776|NCT03410056|363164904|FG003|Overall Study|Decision by Sponsor|0|||
105318777|NCT03410056|363164905|FG004|Overall Study|Decision by Sponsor|0|||
105318778|NCT03410056|363164906|FG005|Overall Study|Decision by Sponsor|0|||
105318779|NCT03410056|363164907|FG006|Overall Study|Decision by Sponsor|0|||
105318780|NCT03410056|363164901|FG000|Overall Study|Withdrawal by Subject|0|||
105318781|NCT03410056|363164902|FG001|Overall Study|Withdrawal by Subject|2|||
105318782|NCT03410056|363164903|FG002|Overall Study|Withdrawal by Subject|5|||
105318783|NCT03410056|363164904|FG003|Overall Study|Withdrawal by Subject|5|||
105318784|NCT03410056|363164905|FG004|Overall Study|Withdrawal by Subject|0|||
105318785|NCT03410056|363164906|FG005|Overall Study|Withdrawal by Subject|0|||
105318786|NCT03410056|363164907|FG006|Overall Study|Withdrawal by Subject|0|||
105318787|NCT03284723|363164908|FG000|Overall Study|Death|0|||
105318788|NCT03284723|363164909|FG001|Overall Study|Death|0|||
105318789|NCT03284723|363164910|FG002|Overall Study|Death|0|||
105318790|NCT03284723|363164911|FG003|Overall Study|Death|1|||
105318791|NCT03284723|363164912|FG004|Overall Study|Death|0|||
105318792|NCT03284723|363164913|FG005|Overall Study|Death|0|||
105318793|NCT03284723|363164914|FG006|Overall Study|Death|1|||
105318794|NCT03284723|363164915|FG007|Overall Study|Death|0|||
105318795|NCT03284723|363164916|FG008|Overall Study|Death|0|||
105318796|NCT03284723|363164917|FG009|Overall Study|Death|2|||
105318797|NCT03284723|363164918|FG010|Overall Study|Death|1|||
105318798|NCT03284723|363164919|FG011|Overall Study|Death|0|||
105490890|NCT00117286|363809453|FG000|Overall Study|Lack of Efficacy|2|||
105490891|NCT00117286|363809454|FG001|Overall Study|Lack of Efficacy|1|||
105490892|NCT00117286|363809453|FG000|Overall Study|Research site closing|0|||
105318799|NCT03284723|363164908|FG000|Overall Study|Lost to Follow-up|0|||
105318800|NCT03284723|363164909|FG001|Overall Study|Lost to Follow-up|0|||
105318801|NCT03284723|363164910|FG002|Overall Study|Lost to Follow-up|0|||
105318802|NCT03284723|363164911|FG003|Overall Study|Lost to Follow-up|0|||
105318803|NCT03284723|363164912|FG004|Overall Study|Lost to Follow-up|0|||
105318804|NCT03284723|363164913|FG005|Overall Study|Lost to Follow-up|2|||
105318805|NCT03284723|363164914|FG006|Overall Study|Lost to Follow-up|1|||
105318806|NCT03284723|363164915|FG007|Overall Study|Lost to Follow-up|0|||
105318807|NCT03284723|363164916|FG008|Overall Study|Lost to Follow-up|0|||
105318808|NCT03284723|363164917|FG009|Overall Study|Lost to Follow-up|2|||
105318809|NCT03284723|363164918|FG010|Overall Study|Lost to Follow-up|0|||
105318810|NCT03284723|363164919|FG011|Overall Study|Lost to Follow-up|0|||
105318811|NCT03284723|363164908|FG000|Overall Study|Study Terminated By Sponsor|0|||
105318812|NCT03284723|363164909|FG001|Overall Study|Study Terminated By Sponsor|0|||
105318813|NCT03284723|363164910|FG002|Overall Study|Study Terminated By Sponsor|0|||
105318814|NCT03284723|363164911|FG003|Overall Study|Study Terminated By Sponsor|0|||
105318815|NCT03284723|363164912|FG004|Overall Study|Study Terminated By Sponsor|1|||
105318816|NCT03284723|363164913|FG005|Overall Study|Study Terminated By Sponsor|0|||
105318817|NCT03284723|363164914|FG006|Overall Study|Study Terminated By Sponsor|0|||
105318818|NCT03284723|363164915|FG007|Overall Study|Study Terminated By Sponsor|0|||
105318819|NCT03284723|363164916|FG008|Overall Study|Study Terminated By Sponsor|1|||
105318820|NCT03284723|363164917|FG009|Overall Study|Study Terminated By Sponsor|1|||
105318821|NCT03284723|363164918|FG010|Overall Study|Study Terminated By Sponsor|1|||
105318822|NCT03284723|363164919|FG011|Overall Study|Study Terminated By Sponsor|1|||
105318823|NCT03284723|363164908|FG000|Overall Study|Withdrawal by Subject|0|||
105318824|NCT03284723|363164909|FG001|Overall Study|Withdrawal by Subject|0|||
105318825|NCT03284723|363164910|FG002|Overall Study|Withdrawal by Subject|0|||
105318826|NCT03284723|363164911|FG003|Overall Study|Withdrawal by Subject|0|||
105318827|NCT03284723|363164912|FG004|Overall Study|Withdrawal by Subject|5|||
105318828|NCT03284723|363164913|FG005|Overall Study|Withdrawal by Subject|3|||
105318829|NCT03284723|363164914|FG006|Overall Study|Withdrawal by Subject|1|||
105318830|NCT03284723|363164915|FG007|Overall Study|Withdrawal by Subject|0|||
105318831|NCT03284723|363164916|FG008|Overall Study|Withdrawal by Subject|6|||
105318832|NCT03284723|363164917|FG009|Overall Study|Withdrawal by Subject|0|||
105318833|NCT03284723|363164918|FG010|Overall Study|Withdrawal by Subject|3|||
105318834|NCT03284723|363164919|FG011|Overall Study|Withdrawal by Subject|1|||
105318835|NCT03284723|363164908|FG000|Overall Study|Other|1|||
105318836|NCT03284723|363164909|FG001|Overall Study|Other|0|||
105318837|NCT03284723|363164910|FG002|Overall Study|Other|1|||
105318838|NCT03284723|363164911|FG003|Overall Study|Other|0|||
105318839|NCT03284723|363164912|FG004|Overall Study|Other|1|||
105318840|NCT03284723|363164913|FG005|Overall Study|Other|0|||
105318841|NCT03284723|363164914|FG006|Overall Study|Other|0|||
105318842|NCT03284723|363164915|FG007|Overall Study|Other|0|||
105318843|NCT03284723|363164916|FG008|Overall Study|Other|0|||
105318844|NCT03284723|363164917|FG009|Overall Study|Other|0|||
105318845|NCT03284723|363164918|FG010|Overall Study|Other|1|||
105318846|NCT03284723|363164919|FG011|Overall Study|Other|0|||
105318847|NCT03284723|363164908|FG000|Overall Study|Adverse Event|0|||
105318848|NCT03284723|363164909|FG001|Overall Study|Adverse Event|0|||
105318849|NCT03284723|363164910|FG002|Overall Study|Adverse Event|0|||
105318850|NCT03284723|363164911|FG003|Overall Study|Adverse Event|0|||
105318851|NCT03284723|363164912|FG004|Overall Study|Adverse Event|0|||
105318852|NCT03284723|363164913|FG005|Overall Study|Adverse Event|0|||
105318853|NCT03284723|363164914|FG006|Overall Study|Adverse Event|0|||
105318854|NCT03284723|363164915|FG007|Overall Study|Adverse Event|0|||
105318855|NCT03284723|363164916|FG008|Overall Study|Adverse Event|1|||
105318856|NCT03284723|363164917|FG009|Overall Study|Adverse Event|0|||
105318857|NCT03284723|363164918|FG010|Overall Study|Adverse Event|0|||
105318858|NCT03284723|363164919|FG011|Overall Study|Adverse Event|0|||
105318859|NCT03022084|363164922|FG000|Overall Study|Lost to Follow-up|2|||
105318860|NCT03022084|363164923|FG001|Overall Study|Lost to Follow-up|3|||
105318861|NCT01762800|363164924|FG000|Overall Study|Adverse Event|8|||
105318862|NCT01762800|363164925|FG001|Overall Study|Adverse Event|13|||
105369868|NCT03530293|363360451|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
105369869|NCT03530293|363360452|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
105318863|NCT01762800|363164924|FG000|Overall Study|Lack of Efficacy|3|||
105318864|NCT01762800|363164925|FG001|Overall Study|Lack of Efficacy|2|||
105318865|NCT01762800|363164924|FG000|Overall Study|Study Closed/Terminated|0|||
105318866|NCT01762800|363164925|FG001|Overall Study|Study Closed/Terminated|1|||
105318867|NCT01762800|363164924|FG000|Overall Study|Physician Decision|1|||
105318868|NCT01762800|363164925|FG001|Overall Study|Physician Decision|1|||
105318869|NCT01762800|363164924|FG000|Overall Study|Withdrawal by Subject|7|||
105318870|NCT01762800|363164925|FG001|Overall Study|Withdrawal by Subject|4|||
105318871|NCT05377749|363164926|FG000|3 Weeks|Lost to Follow-up|2|||
105318872|NCT05377749|363164927|FG001|3 Weeks|Lost to Follow-up|4|||
105318873|NCT05377749|363164926|FG000|3 Weeks|Withdrawal by Subject|1|||
105318874|NCT05377749|363164927|FG001|3 Weeks|Withdrawal by Subject|1|||
105318875|NCT01383707|363164928|FG000|Overall Study|Consent withdrawal|6|||
105318876|NCT01383707|363164928|FG000|Overall Study|Death|19|||
105318877|NCT01383707|363164928|FG000|Overall Study|Other|8|||
105318878|NCT01383707|363164928|FG000|Overall Study|Sponsor's decision|2|||
105318879|NCT01383707|363164928|FG000|Overall Study|Adverse Event|14|||
105318880|NCT01383707|363164928|FG000|Overall Study|Progressive disease|23|||
105318881|NCT01625988|363164934|FG000|Overall Study|Lost to Follow-up|5|||
105318882|NCT01625988|363164935|FG001|Overall Study|Lost to Follow-up|6|||
105318883|NCT01625988|363164934|FG000|Overall Study|Withdrawal by Subject|8|||
105318884|NCT01625988|363164935|FG001|Overall Study|Withdrawal by Subject|3|||
105318885|NCT01625988|363164934|FG000|Overall Study|Adverse Event|0|||
105318886|NCT01625988|363164935|FG001|Overall Study|Adverse Event|1|||
105318887|NCT01625988|363164934|FG000|Overall Study|Lack of Efficacy|0|||
105318888|NCT01625988|363164935|FG001|Overall Study|Lack of Efficacy|1|||
105318889|NCT01625988|363164934|FG000|Overall Study|Randomized Inappropriately|1|||
105318890|NCT01625988|363164935|FG001|Overall Study|Randomized Inappropriately|0|||
105318891|NCT01625988|363164934|FG000|Overall Study|Protocol Violation|0|||
105318892|NCT01625988|363164935|FG001|Overall Study|Protocol Violation|2|||
105318893|NCT01427608|363164936|FG000|Overall Study|Death|1|||
105318894|NCT01427608|363164937|FG001|Overall Study|Death|0|||
105318895|NCT01427608|363164936|FG000|Overall Study|Withdrawal by Subject|7|||
105318896|NCT01427608|363164937|FG001|Overall Study|Withdrawal by Subject|3|||
105318897|NCT01427608|363164936|FG000|Overall Study|Relapsed-all cause|13|||
105318898|NCT01427608|363164937|FG001|Overall Study|Relapsed-all cause|34|||
105318899|NCT01427608|363164936|FG000|Overall Study|Events not attributed to study meds|0|||
105318900|NCT01427608|363164937|FG001|Overall Study|Events not attributed to study meds|1|||
105318901|NCT00661193|363164938|FG000|Overall Study|Adverse Event|2|||
105369870|NCT03530293|363360453|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
105369871|NCT03530293|363360451|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
105369872|NCT03530293|363360452|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
105369873|NCT03530293|363360453|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
105369874|NCT03530293|363360451|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
105369875|NCT03530293|363360452|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
105490893|NCT00117286|363809454|FG001|Overall Study|Research site closing|2|||
105490894|NCT00048061|363809456|FG000|Overall Study|Adverse Event|41|||
105490895|NCT00048061|363809457|FG001|Overall Study|Adverse Event|32|||
105490896|NCT00048061|363809458|FG002|Overall Study|Adverse Event|44|||
105490897|NCT00048061|363809459|FG003|Overall Study|Adverse Event|37|||
105490898|NCT00048061|363809456|FG000|Overall Study|Lost to Follow-up|3|||
105490899|NCT00048061|363809457|FG001|Overall Study|Lost to Follow-up|2|||
105490900|NCT00048061|363809458|FG002|Overall Study|Lost to Follow-up|4|||
105490901|NCT00048061|363809459|FG003|Overall Study|Lost to Follow-up|5|||
105490902|NCT00048061|363809456|FG000|Overall Study|Withdrawal by Subject|20|||
105490903|NCT00048061|363809457|FG001|Overall Study|Withdrawal by Subject|29|||
105490904|NCT00048061|363809458|FG002|Overall Study|Withdrawal by Subject|29|||
105490905|NCT00048061|363809459|FG003|Overall Study|Withdrawal by Subject|32|||
105490906|NCT00048061|363809456|FG000|Overall Study|Did not follow-up|5|||
105490907|NCT00048061|363809457|FG001|Overall Study|Did not follow-up|5|||
105490908|NCT00048061|363809458|FG002|Overall Study|Did not follow-up|4|||
105369876|NCT03530293|363360453|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
105369877|NCT00106002|363360458|FG000|Overall Study|Did not take any study drug|1|||
105369878|NCT00106002|363360458|FG000|Overall Study|Ineligible after Registration|1|||
105369879|NCT01663623|363360461|FG000|Overall Study|Adverse Event|3|||
105369880|NCT01663623|363360462|FG001|Overall Study|Adverse Event|7|||
105369881|NCT01663623|363360461|FG000|Overall Study|Lack of Efficacy|5|||
105369882|NCT01663623|363360462|FG001|Overall Study|Lack of Efficacy|6|||
105369883|NCT01663623|363360461|FG000|Overall Study|Protocol Violation|0|||
105369884|NCT01663623|363360462|FG001|Overall Study|Protocol Violation|1|||
105369885|NCT01663623|363360461|FG000|Overall Study|Other-Study closed/terminated|1|||
105369886|NCT01663623|363360462|FG001|Overall Study|Other-Study closed/terminated|1|||
105369887|NCT01663623|363360461|FG000|Overall Study|Physician Decision|1|||
105369888|NCT01663623|363360462|FG001|Overall Study|Physician Decision|4|||
105369889|NCT01663623|363360461|FG000|Overall Study|Withdrawal by Subject|2|||
105490909|NCT00048061|363809459|FG003|Overall Study|Did not follow-up|5|||
105490910|NCT00048061|363809456|FG000|Overall Study|Early improvement|6|||
105490911|NCT00048061|363809457|FG001|Overall Study|Early improvement|5|||
105490912|NCT00048061|363809458|FG002|Overall Study|Early improvement|3|||
105369890|NCT01663623|363360462|FG001|Overall Study|Withdrawal by Subject|1|||
105369891|NCT00719901|363360466|FG000|Overall Study|Adverse Event|5|||
105369892|NCT00719901|363360466|FG000|Overall Study|Withdrawal by Subject|1|||
105369893|NCT00719901|363360466|FG000|Overall Study|Alternate Treatment|1|||
105369894|NCT00719901|363360466|FG000|Overall Study|Disease Progression|3|||
105369895|NCT00719901|363360466|FG000|Overall Study|Availability of Study Drug|1|||
105490913|NCT00048061|363809459|FG003|Overall Study|Early improvement|0|||
105318902|NCT00661193|363164939|FG001|Overall Study|Adverse Event|1|||
105369896|NCT00891813|363360469|FG000|Overall Study|Adverse Event|3|||
105369897|NCT00891813|363360469|FG000|Overall Study|Withdrawal by Subject|1|||
105490914|NCT03555435|363809460|FG000|Overall Study|Lost to Follow-up|17|||
105490915|NCT03555435|363809461|FG001|Overall Study|Lost to Follow-up|19|||
105490916|NCT03555435|363809462|FG002|Overall Study|Lost to Follow-up|8|||
105490917|NCT04010539|363809463|FG000|Overall Study|Withdrawal by Subject|4|||
105318903|NCT00661193|363164938|FG000|Overall Study|Withdrawal by Subject|3|||
105318904|NCT00661193|363164939|FG001|Overall Study|Withdrawal by Subject|1|||
105318905|NCT00661193|363164938|FG000|Overall Study|Progression|27|||
105369898|NCT00891813|363360469|FG000|Overall Study|Patient Noncompliance|6|||
105490918|NCT04010539|363809464|FG001|Overall Study|Withdrawal by Subject|1|||
105369899|NCT00891813|363360469|FG000|Overall Study|Protocol Violation|2|||
105369900|NCT02858401|363360474|FG000|Overall Study|Withdrew Consent|0|||
105369901|NCT02858401|363360475|FG001|Overall Study|Withdrew Consent|0|||
105369902|NCT02858401|363360476|FG002|Overall Study|Withdrew Consent|0|||
105369903|NCT02858401|363360477|FG003|Overall Study|Withdrew Consent|0|||
105369904|NCT02858401|363360478|FG004|Overall Study|Withdrew Consent|0|||
105369905|NCT02858401|363360479|FG005|Overall Study|Withdrew Consent|1|||
105369906|NCT02858401|363360480|FG006|Overall Study|Withdrew Consent|0|||
105369907|NCT02858401|363360474|FG000|Overall Study|Lost to Follow-up|0|||
105369908|NCT02858401|363360475|FG001|Overall Study|Lost to Follow-up|1|||
105369909|NCT02858401|363360476|FG002|Overall Study|Lost to Follow-up|0|||
105369910|NCT02858401|363360477|FG003|Overall Study|Lost to Follow-up|0|||
105369911|NCT02858401|363360478|FG004|Overall Study|Lost to Follow-up|0|||
105369912|NCT02858401|363360479|FG005|Overall Study|Lost to Follow-up|0|||
105369913|NCT02858401|363360480|FG006|Overall Study|Lost to Follow-up|0|||
105369914|NCT01302899|363360481|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
105369915|NCT01302899|363360482|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
105369916|NCT01302899|363360481|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
105369917|NCT01302899|363360482|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
105369918|NCT02513550|363360483|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
105369919|NCT02513550|363360484|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
105369920|NCT02513550|363360485|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
105369921|NCT02513550|363360486|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
105369922|NCT02513550|363360487|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
105369923|NCT02513550|363360488|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
105369924|NCT02513550|363360483|FG000|Double Blind Treatment Period|Adverse Event|5|||
105369925|NCT02513550|363360484|FG001|Double Blind Treatment Period|Adverse Event|13|||
105369926|NCT02513550|363360485|FG002|Double Blind Treatment Period|Adverse Event|17|||
105369927|NCT02513550|363360486|FG003|Double Blind Treatment Period|Adverse Event|0|||
105369928|NCT02513550|363360487|FG004|Double Blind Treatment Period|Adverse Event|1|||
105369929|NCT02513550|363360488|FG005|Double Blind Treatment Period|Adverse Event|0|||
105369930|NCT02513550|363360483|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
105369931|NCT02513550|363360484|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
105369932|NCT02513550|363360485|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
105369933|NCT02513550|363360486|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
105369934|NCT02513550|363360487|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
105369935|NCT02513550|363360488|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
105369936|NCT02513550|363360483|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
105369937|NCT02513550|363360484|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
105369938|NCT02513550|363360485|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
105369939|NCT02513550|363360486|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
105369940|NCT02513550|363360487|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
105369941|NCT02513550|363360488|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
105369942|NCT02513550|363360483|FG000|Double Blind Treatment Period|Protocol Violation|1|||
105369943|NCT02513550|363360484|FG001|Double Blind Treatment Period|Protocol Violation|1|||
105369944|NCT02513550|363360485|FG002|Double Blind Treatment Period|Protocol Violation|4|||
105369945|NCT02513550|363360486|FG003|Double Blind Treatment Period|Protocol Violation|0|||
105369946|NCT02513550|363360487|FG004|Double Blind Treatment Period|Protocol Violation|0|||
105369947|NCT02513550|363360488|FG005|Double Blind Treatment Period|Protocol Violation|0|||
105369948|NCT02513550|363360483|FG000|Double Blind Treatment Period|Physician Decision|2|||
105369949|NCT02513550|363360484|FG001|Double Blind Treatment Period|Physician Decision|0|||
105369950|NCT02513550|363360485|FG002|Double Blind Treatment Period|Physician Decision|4|||
105369951|NCT02513550|363360486|FG003|Double Blind Treatment Period|Physician Decision|0|||
105369952|NCT02513550|363360487|FG004|Double Blind Treatment Period|Physician Decision|0|||
105369953|NCT02513550|363360488|FG005|Double Blind Treatment Period|Physician Decision|0|||
105369954|NCT02513550|363360483|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
105369955|NCT02513550|363360484|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
105369956|NCT02513550|363360485|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
105369957|NCT02513550|363360486|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
105369958|NCT02513550|363360487|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
105369959|NCT02513550|363360488|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
105369960|NCT02513550|363360483|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
105369961|NCT02513550|363360484|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
105369962|NCT02513550|363360485|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
105369963|NCT02513550|363360486|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
105369964|NCT02513550|363360487|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
105369965|NCT02513550|363360488|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
105369966|NCT02513550|363360483|FG000|Double Blind Treatment Period|Due to personal business|2|||
105369967|NCT02513550|363360484|FG001|Double Blind Treatment Period|Due to personal business|0|||
105576772|NCT00932646|364110322|FG003|Overall Study|Lost to Follow-up|0|||
105369968|NCT02513550|363360485|FG002|Double Blind Treatment Period|Due to personal business|1|||
105369969|NCT02513550|363360486|FG003|Double Blind Treatment Period|Due to personal business|0|||
105369970|NCT02513550|363360487|FG004|Double Blind Treatment Period|Due to personal business|0|||
105369971|NCT02513550|363360488|FG005|Double Blind Treatment Period|Due to personal business|0|||
105369972|NCT02513550|363360483|FG000|Double Blind Treatment Period|Death|1|||
105369973|NCT02513550|363360484|FG001|Double Blind Treatment Period|Death|0|||
105369974|NCT02513550|363360485|FG002|Double Blind Treatment Period|Death|2|||
105369975|NCT02513550|363360486|FG003|Double Blind Treatment Period|Death|0|||
105369976|NCT02513550|363360487|FG004|Double Blind Treatment Period|Death|0|||
105369977|NCT02513550|363360488|FG005|Double Blind Treatment Period|Death|0|||
105369978|NCT02513550|363360483|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
105369979|NCT02513550|363360484|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
105369980|NCT02513550|363360485|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
105369981|NCT02513550|363360486|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105369982|NCT02513550|363360487|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105369983|NCT02513550|363360488|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105369984|NCT02513550|363360483|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
105369985|NCT02513550|363360484|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
105369986|NCT02513550|363360485|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
105369987|NCT02513550|363360486|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
105369988|NCT02513550|363360487|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
105369989|NCT02513550|363360488|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
105369990|NCT02513550|363360483|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
105369991|NCT02513550|363360484|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
105369992|NCT02513550|363360485|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
105369993|NCT02513550|363360486|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105369994|NCT02513550|363360487|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105369995|NCT02513550|363360488|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105369996|NCT02513550|363360483|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
105369997|NCT02513550|363360484|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
105369998|NCT02513550|363360485|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
105369999|NCT02513550|363360486|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
105370000|NCT02513550|363360487|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
105370001|NCT02513550|363360488|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
105370002|NCT02513550|363360483|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
105370003|NCT02513550|363360484|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
105370004|NCT02513550|363360485|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
105370005|NCT02513550|363360486|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
105370006|NCT02513550|363360487|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
105370007|NCT02513550|363360488|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
105370008|NCT02513550|363360483|FG000|Post-Treatment Follow-up Period|Death|0|||
105370009|NCT02513550|363360484|FG001|Post-Treatment Follow-up Period|Death|0|||
105490919|NCT04010539|363809463|FG000|Overall Study|Physician Decision|0|||
105490920|NCT04010539|363809464|FG001|Overall Study|Physician Decision|2|||
105490921|NCT04010539|363809463|FG000|Overall Study|Lost to Follow-up|10|||
105490922|NCT04010539|363809464|FG001|Overall Study|Lost to Follow-up|14|||
105490923|NCT04010539|363809463|FG000|Overall Study|Adverse Event|3|||
105490924|NCT04010539|363809464|FG001|Overall Study|Adverse Event|0|||
105849805|NCT00987389|365109643|FG001|Overall Study|Ineligible|3|||
105849806|NCT00987389|365109644|FG002|Overall Study|Ineligible|0|||
105849807|NCT00987389|365109645|FG003|Overall Study|Ineligible|0|||
105849808|NCT00987389|365109642|FG000|Overall Study|Lost to Follow-up|4|||
105849809|NCT00987389|365109643|FG001|Overall Study|Lost to Follow-up|1|||
105849810|NCT00987389|365109644|FG002|Overall Study|Lost to Follow-up|3|||
105849811|NCT00987389|365109645|FG003|Overall Study|Lost to Follow-up|1|||
105849812|NCT00987389|365109642|FG000|Overall Study|Withdrawal by Subject|4|||
105849813|NCT00987389|365109643|FG001|Overall Study|Withdrawal by Subject|3|||
105849814|NCT00987389|365109644|FG002|Overall Study|Withdrawal by Subject|2|||
105849815|NCT00987389|365109645|FG003|Overall Study|Withdrawal by Subject|1|||
105370010|NCT02513550|363360485|FG002|Post-Treatment Follow-up Period|Death|1|||
105490925|NCT04010539|363809463|FG000|Overall Study|Participant Did Not Receive IP|0|||
105849816|NCT00987389|365109642|FG000|Overall Study|Withdrawn from Treatment|0|||
105370011|NCT02513550|363360486|FG003|Post-Treatment Follow-up Period|Death|0|||
105370012|NCT02513550|363360487|FG004|Post-Treatment Follow-up Period|Death|0|||
105490926|NCT04010539|363809464|FG001|Overall Study|Participant Did Not Receive IP|1|||
105490927|NCT04010539|363809463|FG000|Overall Study|Protocol Deviation|0|||
105490928|NCT04010539|363809464|FG001|Overall Study|Protocol Deviation|1|||
105490929|NCT04010539|363809463|FG000|Overall Study|Randomized in Error/ Mistake|2|||
105490930|NCT04010539|363809464|FG001|Overall Study|Randomized in Error/ Mistake|0|||
105849817|NCT00987389|365109643|FG001|Overall Study|Withdrawn from Treatment|1|||
105849818|NCT00987389|365109644|FG002|Overall Study|Withdrawn from Treatment|0|||
105370013|NCT02513550|363360488|FG005|Post-Treatment Follow-up Period|Death|0|||
105370014|NCT02513550|363360483|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
105370015|NCT02513550|363360484|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
105370016|NCT02513550|363360485|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
105370017|NCT02513550|363360486|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
105370018|NCT02513550|363360487|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
105370019|NCT02513550|363360488|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
105370020|NCT02513550|363360483|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
105370021|NCT02513550|363360484|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
105370022|NCT02513550|363360485|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
105370023|NCT02513550|363360486|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
105370024|NCT02513550|363360487|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
105370025|NCT02513550|363360488|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
105370026|NCT02513550|363360483|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
105370027|NCT02513550|363360484|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
105370028|NCT02513550|363360485|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
105370029|NCT02513550|363360486|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
105370030|NCT02513550|363360487|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
105370031|NCT02513550|363360488|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
105370032|NCT00472420|363360489|FG000|Induction Treatment Period|Physician Decision|9|||
105370033|NCT00472420|363360489|FG000|Induction Treatment Period|Adverse Event|3|||
105370034|NCT00472420|363360489|FG000|Induction Treatment Period|Non-compliance|1|||
105370035|NCT00472420|363360489|FG000|Induction Treatment Period|Death|3|||
105370036|NCT00472420|363360489|FG000|Follow-up Period|Death|5|||
105370037|NCT00472420|363360489|FG000|Follow-up Period|Physician Decision|9|||
105370038|NCT00472420|363360489|FG000|Follow-up Period|Lost to Follow-up|2|||
105370039|NCT00472420|363360489|FG000|Follow-up Period|Protocol Violation|1|||
105370040|NCT00888654|363360492|FG000|Overall Study|Problems swallowing oral meds.|1|||
105370041|NCT00888654|363360492|FG000|Overall Study|Not enough oral meds before surgery|3|||
105370042|NCT00888654|363360492|FG000|Overall Study|Surgery aborted|2|||
105370043|NCT00888654|363360492|FG000|Overall Study|Withdrawal by Subject|1|||
105370044|NCT00888654|363360492|FG000|Overall Study|Inelig. due to contraindication of med|1|||
105370045|NCT00888654|363360492|FG000|Overall Study|Change in surg date|1|||
105370046|NCT00888654|363360492|FG000|Overall Study|Stopped meds due to headaches|1|||
105370047|NCT02674516|363360493|FG000|Overall Study|Lost to Follow-up|3|||
105370048|NCT02674516|363360494|FG001|Overall Study|Lost to Follow-up|0|||
105370049|NCT02674516|363360493|FG000|Overall Study|Protocol Violation|0|||
105370050|NCT02674516|363360494|FG001|Overall Study|Protocol Violation|4|||
105370051|NCT02674516|363360493|FG000|Overall Study|Knowledge of study hypothesis|1|||
105370052|NCT02674516|363360494|FG001|Overall Study|Knowledge of study hypothesis|0|||
105370053|NCT01064479|363360495|FG000|Overall Study|Death|10|||
105370054|NCT01064479|363360496|FG001|Overall Study|Death|11|||
105370055|NCT01064479|363360495|FG000|Overall Study|Withdrawal by Subject|2|||
105370056|NCT01064479|363360496|FG001|Overall Study|Withdrawal by Subject|2|||
105370057|NCT01064479|363360495|FG000|Overall Study|Disease progression|1|||
105370058|NCT01064479|363360496|FG001|Overall Study|Disease progression|1|||
105370059|NCT01064479|363360495|FG000|Overall Study|Toxicity|1|||
105370060|NCT01064479|363360496|FG001|Overall Study|Toxicity|1|||
105370061|NCT01064479|363360495|FG000|Overall Study|Other|1|||
105370062|NCT01064479|363360496|FG001|Overall Study|Other|2|||
105490931|NCT04010539|363809463|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
105490932|NCT04010539|363809464|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
105370063|NCT04076917|363360499|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
105370064|NCT04076917|363360499|FG000|Overall Study|Study closure|13|||
105370065|NCT04076917|363360499|FG000|Overall Study|Physician Decision|3|||
105370066|NCT04076917|363360499|FG000|Overall Study|Death|1|||
105370067|NCT04076917|363360499|FG000|Overall Study|Lost to Follow-up|1|||
105370068|NCT04076917|363360499|FG000|Overall Study|Withdrawal by Subject|1|||
105370069|NCT04076917|363360499|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
105370070|NCT01787552|363360500|FG000|Overall Study|Withdrawal by Subject|2|||
105370071|NCT01787552|363360501|FG001|Overall Study|Withdrawal by Subject|0|||
105370072|NCT01787552|363360502|FG002|Overall Study|Withdrawal by Subject|0|||
105370073|NCT01787552|363360503|FG003|Overall Study|Withdrawal by Subject|4|||
105370074|NCT01787552|363360500|FG000|Overall Study|Physician Decision|2|||
105370075|NCT01787552|363360501|FG001|Overall Study|Physician Decision|2|||
105370076|NCT01787552|363360502|FG002|Overall Study|Physician Decision|1|||
105370077|NCT01787552|363360503|FG003|Overall Study|Physician Decision|2|||
105370078|NCT01787552|363360500|FG000|Overall Study|Death|0|||
105370079|NCT01787552|363360501|FG001|Overall Study|Death|0|||
105370080|NCT01787552|363360502|FG002|Overall Study|Death|0|||
105370081|NCT01787552|363360503|FG003|Overall Study|Death|1|||
105370082|NCT01787552|363360500|FG000|Overall Study|Adverse Event|2|||
105370083|NCT01787552|363360501|FG001|Overall Study|Adverse Event|5|||
105849819|NCT00987389|365109645|FG003|Overall Study|Withdrawn from Treatment|0|||
105849820|NCT00987389|365109642|FG000|Overall Study|Multiple different reasons|1|||
105849821|NCT00987389|365109643|FG001|Overall Study|Multiple different reasons|0|||
105849822|NCT00987389|365109644|FG002|Overall Study|Multiple different reasons|3|||
105849823|NCT00987389|365109645|FG003|Overall Study|Multiple different reasons|1|||
105849824|NCT00655876|365109646|FG000|Overall Study|Protocol Violation|9|||
105849825|NCT00655876|365109647|FG001|Overall Study|Protocol Violation|7|||
105849826|NCT02500641|365109648|FG000|Overall Study|Adverse Event|0|||
105849827|NCT02500641|365109649|FG001|Overall Study|Adverse Event|2|||
105849828|NCT02500641|365109648|FG000|Overall Study|Withdrawal by Subject|4|||
105849829|NCT02500641|365109649|FG001|Overall Study|Withdrawal by Subject|5|||
105849830|NCT02500641|365109648|FG000|Overall Study|Unable to follow study procedures|3|||
105849831|NCT02500641|365109649|FG001|Overall Study|Unable to follow study procedures|2|||
105849832|NCT02500641|365109648|FG000|Overall Study|Protocol Violation|1|||
105849833|NCT02500641|365109649|FG001|Overall Study|Protocol Violation|2|||
105849834|NCT02500641|365109648|FG000|Overall Study|Lost to Follow-up|1|||
105849835|NCT02500641|365109649|FG001|Overall Study|Lost to Follow-up|0|||
105849836|NCT02500641|365109648|FG000|Overall Study|Sponsor decision|1|||
105849837|NCT02500641|365109649|FG001|Overall Study|Sponsor decision|0|||
105849838|NCT02500641|365109648|FG000|Overall Study|Non compliance to study drug|0|||
105849839|NCT02500641|365109649|FG001|Overall Study|Non compliance to study drug|1|||
105318906|NCT00661193|363164939|FG001|Overall Study|Progression|24|||
105318907|NCT00661193|363164938|FG000|Overall Study|Not protocol specified|1|||
105318908|NCT00661193|363164939|FG001|Overall Study|Not protocol specified|0|||
105318909|NCT00398866|363164940|FG000|Overall Study|Adverse Event|1|||
105318910|NCT00398866|363164941|FG001|Overall Study|Adverse Event|0|||
105318911|NCT00398866|363164942|FG002|Overall Study|Adverse Event|0|||
105318912|NCT00398866|363164940|FG000|Overall Study|Lack of Efficacy|0|||
105318913|NCT00398866|363164941|FG001|Overall Study|Lack of Efficacy|0|||
105318914|NCT00398866|363164942|FG002|Overall Study|Lack of Efficacy|1|||
105318915|NCT00398866|363164940|FG000|Overall Study|Lost to Follow-up|7|||
105318916|NCT00398866|363164941|FG001|Overall Study|Lost to Follow-up|6|||
105318917|NCT00398866|363164942|FG002|Overall Study|Lost to Follow-up|4|||
105318918|NCT00398866|363164940|FG000|Overall Study|Withdrawal by Subject|5|||
105318919|NCT00398866|363164941|FG001|Overall Study|Withdrawal by Subject|1|||
105318920|NCT00398866|363164942|FG002|Overall Study|Withdrawal by Subject|2|||
105318921|NCT00398866|363164940|FG000|Overall Study|Unable to complete requirements of study|1|||
105318922|NCT00398866|363164941|FG001|Overall Study|Unable to complete requirements of study|1|||
105318923|NCT00398866|363164942|FG002|Overall Study|Unable to complete requirements of study|1|||
105318924|NCT03126435|363164943|FG000|Overall Study|Death|90|||
105318925|NCT03126435|363164944|FG001|Overall Study|Death|84|||
105318926|NCT03126435|363164943|FG000|Overall Study|Lost to Follow-up|4|||
105318927|NCT03126435|363164944|FG001|Overall Study|Lost to Follow-up|3|||
105318928|NCT03126435|363164943|FG000|Overall Study|Physician Decision|0|||
105318929|NCT03126435|363164944|FG001|Overall Study|Physician Decision|1|||
105318930|NCT03126435|363164943|FG000|Overall Study|Withdrawal by Subject|6|||
105318931|NCT03126435|363164944|FG001|Overall Study|Withdrawal by Subject|12|||
105318932|NCT03126435|363164943|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
105318933|NCT03126435|363164944|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
105318934|NCT02276807|363164947|FG000|Overall Study|Withdrawal by Subject|8|||
105318935|NCT02276807|363164948|FG001|Overall Study|Withdrawal by Subject|7|||
105318936|NCT02276807|363164947|FG000|Overall Study|Lost to Follow-up|10|||
105318937|NCT02276807|363164948|FG001|Overall Study|Lost to Follow-up|10|||
105318938|NCT01807065|363164949|FG000|Overall Study|Receive no sip-T due to IV access|1|||
105318939|NCT01807065|363164950|FG001|Overall Study|Receive no sip-T due to IV access|1|||
105318940|NCT03639779|363164959|FG000|Overall Study|Lost to Follow-up|1|||
105318941|NCT02413229|363164962|FG000|Overall Study|Adverse Event|0|||
105318942|NCT02413229|363164963|FG001|Overall Study|Adverse Event|0|||
105318943|NCT02413229|363164964|FG002|Overall Study|Adverse Event|0|||
105318944|NCT02413229|363164965|FG003|Overall Study|Adverse Event|1|||
105318945|NCT02413229|363164966|FG004|Overall Study|Adverse Event|0|||
105318946|NCT02413229|363164967|FG005|Overall Study|Adverse Event|0|||
105318947|NCT02413229|363164968|FG006|Overall Study|Adverse Event|0|||
105318948|NCT02413229|363164969|FG007|Overall Study|Adverse Event|1|||
105318949|NCT02413229|363164962|FG000|Overall Study|Lost to Follow-up|0|||
105318950|NCT02413229|363164963|FG001|Overall Study|Lost to Follow-up|0|||
105490933|NCT00249288|363809465|FG000|Overall Study|Lost to Follow-up|3|||
105318951|NCT02413229|363164964|FG002|Overall Study|Lost to Follow-up|1|||
105318952|NCT02413229|363164965|FG003|Overall Study|Lost to Follow-up|0|||
105318953|NCT02413229|363164966|FG004|Overall Study|Lost to Follow-up|2|||
105318954|NCT02413229|363164967|FG005|Overall Study|Lost to Follow-up|0|||
105318955|NCT02413229|363164968|FG006|Overall Study|Lost to Follow-up|0|||
105318956|NCT02413229|363164969|FG007|Overall Study|Lost to Follow-up|0|||
105318957|NCT02413229|363164962|FG000|Overall Study|Withdrawal by Subject|1|||
105849840|NCT04355663|365109650|FG000|Overall Study|Physician Decision|2|||
105849841|NCT04355663|365109651|FG001|Overall Study|Physician Decision|7|||
105849842|NCT04355663|365109652|FG002|Overall Study|Physician Decision|0|||
105849843|NCT04355663|365109650|FG000|Overall Study|Adverse Event|0|||
105318958|NCT02413229|363164963|FG001|Overall Study|Withdrawal by Subject|1|||
105318959|NCT02413229|363164964|FG002|Overall Study|Withdrawal by Subject|0|||
105318960|NCT02413229|363164965|FG003|Overall Study|Withdrawal by Subject|0|||
105318961|NCT02413229|363164966|FG004|Overall Study|Withdrawal by Subject|1|||
105318962|NCT02413229|363164967|FG005|Overall Study|Withdrawal by Subject|0|||
105318963|NCT02413229|363164968|FG006|Overall Study|Withdrawal by Subject|0|||
105318964|NCT02413229|363164969|FG007|Overall Study|Withdrawal by Subject|2|||
105318965|NCT02413229|363164962|FG000|Overall Study|Progressive Disease|0|||
105318966|NCT02413229|363164963|FG001|Overall Study|Progressive Disease|0|||
105318967|NCT02413229|363164964|FG002|Overall Study|Progressive Disease|0|||
105318968|NCT02413229|363164965|FG003|Overall Study|Progressive Disease|0|||
105318969|NCT02413229|363164966|FG004|Overall Study|Progressive Disease|0|||
105318970|NCT02413229|363164967|FG005|Overall Study|Progressive Disease|0|||
105318971|NCT02413229|363164968|FG006|Overall Study|Progressive Disease|0|||
105318972|NCT02413229|363164969|FG007|Overall Study|Progressive Disease|1|||
105318973|NCT00470535|363164970|FG000|Overall Study|Disease Progression|13|||
105318974|NCT00470535|363164970|FG000|Overall Study|Withdrawal by Subject|1|||
105318975|NCT00470535|363164970|FG000|Overall Study|Adverse Event|1|||
105318976|NCT00470535|363164970|FG000|Overall Study|Death|1|||
105318977|NCT00470535|363164970|FG000|Overall Study|Other|2|||
105318978|NCT05219448|363164971|FG000|Overall Study|Lost to Follow-up|9|||
105318979|NCT05219448|363164972|FG001|Overall Study|Lost to Follow-up|0|||
105318980|NCT04342819|363164973|FG000|Overall Study|Declined|4|||
105318981|NCT04342819|363164973|FG000|Overall Study|Not meeeting selection criteria|1|||
105370084|NCT01787552|363360502|FG002|Overall Study|Adverse Event|2|||
105370085|NCT01787552|363360503|FG003|Overall Study|Adverse Event|16|||
105370086|NCT01787552|363360500|FG000|Overall Study|Study terminated by Sponsor|0|||
105370087|NCT01787552|363360501|FG001|Overall Study|Study terminated by Sponsor|0|||
105370088|NCT01787552|363360502|FG002|Overall Study|Study terminated by Sponsor|1|||
105370089|NCT01787552|363360503|FG003|Overall Study|Study terminated by Sponsor|3|||
105370090|NCT01787552|363360500|FG000|Overall Study|Progressive Disease|2|||
105370091|NCT01787552|363360501|FG001|Overall Study|Progressive Disease|2|||
105370092|NCT01787552|363360502|FG002|Overall Study|Progressive Disease|1|||
105370093|NCT01787552|363360503|FG003|Overall Study|Progressive Disease|1|||
105370094|NCT01474486|363360505|FG000|Overall Study|Death|2|||
105370095|NCT01474486|363360505|FG000|Overall Study|Withdrawal by Subject|4|||
105370096|NCT01474486|363360505|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
105370097|NCT03504917|363360506|FG000|Blinded Treatment Period|Protocol Violation|1|||
105370098|NCT03504917|363360507|FG001|Blinded Treatment Period|Protocol Violation|0|||
105370099|NCT03504917|363360506|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
105370100|NCT03504917|363360507|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
105370101|NCT03504917|363360506|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
105370102|NCT03504917|363360507|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
105370103|NCT03504917|363360506|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
105370104|NCT03504917|363360507|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
105370105|NCT03504917|363360506|FG000|Blinded Treatment Period|Adverse Event|4|||
105370106|NCT03504917|363360507|FG001|Blinded Treatment Period|Adverse Event|4|||
105370107|NCT03504917|363360506|FG000|Blinded Treatment Period|Physician Decision|1|||
105370108|NCT03504917|363360507|FG001|Blinded Treatment Period|Physician Decision|0|||
105370109|NCT03504917|363360506|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
105370110|NCT03504917|363360507|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
105370111|NCT03504917|363360506|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
105370112|NCT03504917|363360507|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
105370113|NCT03504917|363360506|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
105370114|NCT03504917|363360507|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
105370115|NCT03504917|363360506|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
105370116|NCT03504917|363360507|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
105370117|NCT03504917|363360506|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
105370118|NCT03504917|363360507|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
105370119|NCT03504917|363360506|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
105370120|NCT03504917|363360507|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
105318982|NCT02955212|363164974|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
105318983|NCT02955212|363164975|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
105318984|NCT02955212|363164974|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
105318985|NCT02955212|363164975|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
105318986|NCT02955212|363164974|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
105318987|NCT02955212|363164975|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
105318988|NCT02955212|363164974|FG000|Period 1: Double-blind Treatment Period|Other|3|||
105370121|NCT03504917|363360506|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
105370122|NCT03504917|363360507|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
105370123|NCT03504917|363360506|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
105318989|NCT02955212|363164975|FG001|Period 1: Double-blind Treatment Period|Other|2|||
105318990|NCT02955212|363164974|FG000|Period 2: Open-label Extension|Adverse Event|11|||
105318991|NCT02955212|363164975|FG001|Period 2: Open-label Extension|Adverse Event|7|||
105318992|NCT02955212|363164974|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
105318993|NCT02955212|363164975|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
105318994|NCT02955212|363164974|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
105318995|NCT02955212|363164975|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
105318996|NCT02955212|363164974|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
105318997|NCT02955212|363164975|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
105318998|NCT02955212|363164974|FG000|Period 2: Open-label Extension|Other|2|||
105318999|NCT02955212|363164975|FG001|Period 2: Open-label Extension|Other|4|||
105319000|NCT00545714|363164976|FG000|Induction Phase (6 Months)|Physician Decision|3|||
105319001|NCT00545714|363164976|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
105319002|NCT00545714|363164976|FG000|Induction Phase (6 Months)|Disease Progression|1|||
105319003|NCT00545714|363164976|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
105319004|NCT00545714|363164976|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
105319005|NCT00545714|363164976|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
105319006|NCT00545714|363164976|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
105319007|NCT00545714|363164976|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
105319008|NCT00545714|363164976|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
105319009|NCT00545714|363164976|FG000|Maintenance Phase (36 Months)|Death|2|||
105319010|NCT03519087|363164982|FG000|Clinic Evaluation|Physician Decision|15|||
105319011|NCT03519087|363164983|FG001|Clinic Evaluation|Physician Decision|18|||
105370124|NCT03504917|363360507|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
105370125|NCT03504917|363360506|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
105370126|NCT03504917|363360507|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
105370127|NCT03504917|363360506|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
105370128|NCT03504917|363360507|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
105370129|NCT04219189|363360508|FG000|Overall Study|Withdrawal by Subject|1|||
105370130|NCT04219189|363360509|FG001|Overall Study|Withdrawal by Subject|2|||
105370131|NCT04219189|363360508|FG000|Overall Study|Protocol Violation|0|||
105370132|NCT04219189|363360509|FG001|Overall Study|Protocol Violation|1|||
105370133|NCT04219189|363360508|FG000|Overall Study|Lost to Follow-up|0|||
105370134|NCT04219189|363360509|FG001|Overall Study|Lost to Follow-up|1|||
105370135|NCT04219189|363360508|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
105370136|NCT04219189|363360509|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
105370137|NCT00572832|363360510|FG000|Overall Study|Lost to Follow-up|0|||
105370138|NCT00572832|363360511|FG001|Overall Study|Lost to Follow-up|11|||
105370139|NCT00572832|363360510|FG000|Overall Study|Pregnancy|0|||
105370140|NCT00572832|363360511|FG001|Overall Study|Pregnancy|1|||
105370141|NCT04079790|363360512|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
105370142|NCT04079790|363360513|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
105370143|NCT04079790|363360514|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
105370144|NCT04079790|363360515|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
105370145|NCT04079790|363360512|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
105370146|NCT04079790|363360513|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
105370147|NCT04079790|363360514|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
105370148|NCT04079790|363360515|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
105370149|NCT04079790|363360512|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
105370150|NCT04079790|363360513|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
105370151|NCT04079790|363360514|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
105370152|NCT04079790|363360515|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
105370153|NCT01253161|363360516|FG000|Overall Study|Adverse Event|1|||
105370154|NCT03101020|363360517|FG000|Overall Study|Lack of time to participate|1|||
105370155|NCT03101020|363360518|FG001|Overall Study|Lack of time to participate|0|||
105370156|NCT03101020|363360517|FG000|Overall Study|Ran over by a car|0|||
105370157|NCT03101020|363360518|FG001|Overall Study|Ran over by a car|1|||
105370158|NCT03101020|363360517|FG000|Overall Study|Withdrawal by Subject|0|||
105490934|NCT00249288|363809466|FG001|Overall Study|Lost to Follow-up|3|||
105319012|NCT03519087|363164984|FG002|Clinic Evaluation|Physician Decision|0|||
105319013|NCT03519087|363164985|FG003|Clinic Evaluation|Physician Decision|0|||
105370159|NCT03101020|363360518|FG001|Overall Study|Withdrawal by Subject|2|||
105370160|NCT00323063|363360520|FG000|Overall Study|Adverse Event|1|||
105370161|NCT00323063|363360521|FG001|Overall Study|Adverse Event|0|||
105370162|NCT00323063|363360520|FG000|Overall Study|brain mets discovered prior to treatment|1|||
105370163|NCT00323063|363360521|FG001|Overall Study|brain mets discovered prior to treatment|0|||
105370164|NCT03055936|363360522|FG000|Overall Study|Adverse Event|0|||
105370165|NCT03055936|363360523|FG001|Overall Study|Adverse Event|1|||
105370166|NCT03055936|363360524|FG002|Overall Study|Adverse Event|1|||
105370167|NCT03055936|363360525|FG003|Overall Study|Adverse Event|1|||
105849844|NCT04355663|365109651|FG001|Overall Study|Adverse Event|0|||
105319014|NCT03519087|363164986|FG004|Clinic Evaluation|Physician Decision|0|||
105319015|NCT03519087|363164982|FG000|Clinic Evaluation|Protocol Violation|1|||
105319016|NCT03519087|363164983|FG001|Clinic Evaluation|Protocol Violation|0|||
105319017|NCT03519087|363164984|FG002|Clinic Evaluation|Protocol Violation|0|||
105319018|NCT03519087|363164985|FG003|Clinic Evaluation|Protocol Violation|0|||
105319019|NCT03519087|363164986|FG004|Clinic Evaluation|Protocol Violation|0|||
105319020|NCT03519087|363164982|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
105319021|NCT03519087|363164983|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
105319022|NCT03519087|363164984|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
105849845|NCT04355663|365109652|FG002|Overall Study|Adverse Event|1|||
105849846|NCT04355663|365109650|FG000|Overall Study|Withdrawal by Subject|0|||
105849847|NCT04355663|365109651|FG001|Overall Study|Withdrawal by Subject|8|||
105849848|NCT04355663|365109652|FG002|Overall Study|Withdrawal by Subject|3|||
105849849|NCT00536263|365109653|FG000|Overall Study|Adverse Event|5|||
105319023|NCT03519087|363164985|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
105319024|NCT03519087|363164986|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
105319025|NCT03519087|363164982|FG000|Re-randomization for Treatment|Not appropriate|2|||
105319026|NCT03519087|363164983|FG001|Re-randomization for Treatment|Not appropriate|3|||
105319027|NCT03519087|363164984|FG002|Re-randomization for Treatment|Not appropriate|0|||
105319028|NCT03519087|363164985|FG003|Re-randomization for Treatment|Not appropriate|0|||
105319029|NCT03519087|363164986|FG004|Re-randomization for Treatment|Not appropriate|0|||
105319030|NCT03519087|363164982|FG000|Laboratory Testing|Lost to Follow-up|0|||
105319031|NCT03519087|363164983|FG001|Laboratory Testing|Lost to Follow-up|0|||
105319032|NCT03519087|363164984|FG002|Laboratory Testing|Lost to Follow-up|2|||
105319033|NCT03519087|363164985|FG003|Laboratory Testing|Lost to Follow-up|3|||
105319034|NCT03519087|363164986|FG004|Laboratory Testing|Lost to Follow-up|6|||
105319035|NCT03519087|363164982|FG000|Laboratory Testing|Protocol Violation|0|||
105319036|NCT03519087|363164983|FG001|Laboratory Testing|Protocol Violation|0|||
105319037|NCT03519087|363164984|FG002|Laboratory Testing|Protocol Violation|0|||
105319038|NCT03519087|363164985|FG003|Laboratory Testing|Protocol Violation|1|||
105319039|NCT03519087|363164986|FG004|Laboratory Testing|Protocol Violation|0|||
105319040|NCT02374346|363164988|FG000|Overall Study|operated or discharged during weekend|48|||
105319041|NCT04807400|363164989|FG000|Overall Study|Adverse Event|2|||
105319042|NCT04807400|363164990|FG001|Overall Study|Adverse Event|3|||
105319043|NCT04807400|363164991|FG002|Overall Study|Adverse Event|3|||
105319044|NCT04807400|363164989|FG000|Overall Study|Death|2|||
105319045|NCT04807400|363164990|FG001|Overall Study|Death|0|||
105319046|NCT04807400|363164991|FG002|Overall Study|Death|0|||
105319047|NCT04807400|363164989|FG000|Overall Study|Lost to Follow-up|8|||
105370168|NCT03055936|363360522|FG000|Overall Study|Personal reason|2|||
105370169|NCT03055936|363360523|FG001|Overall Study|Personal reason|0|||
105370170|NCT03055936|363360524|FG002|Overall Study|Personal reason|1|||
105370171|NCT03055936|363360525|FG003|Overall Study|Personal reason|0|||
105370172|NCT03087058|363360532|FG000|Overall Study|Withdrawal by Subject|2|||
105370173|NCT03087058|363360533|FG001|Overall Study|Withdrawal by Subject|0|||
105370174|NCT03087058|363360534|FG002|Overall Study|Withdrawal by Subject|0|||
105370175|NCT02577029|363360535|FG000|Overall Study|Adverse Event|1|||
105370176|NCT02577029|363360536|FG001|Overall Study|Adverse Event|0|||
105370177|NCT02577029|363360537|FG002|Overall Study|Adverse Event|2|||
105370178|NCT02577029|363360538|FG003|Overall Study|Adverse Event|0|||
105370179|NCT02577029|363360539|FG004|Overall Study|Adverse Event|1|||
105370180|NCT02577029|363360540|FG005|Overall Study|Adverse Event|0|||
105370181|NCT02577029|363360541|FG006|Overall Study|Adverse Event|0|||
105370182|NCT02577029|363360542|FG007|Overall Study|Adverse Event|0|||
105370183|NCT02577029|363360535|FG000|Overall Study|Withdrawal by Subject|0|||
105370184|NCT02577029|363360536|FG001|Overall Study|Withdrawal by Subject|0|||
105370185|NCT02577029|363360537|FG002|Overall Study|Withdrawal by Subject|0|||
105370186|NCT02577029|363360538|FG003|Overall Study|Withdrawal by Subject|0|||
105370187|NCT02577029|363360539|FG004|Overall Study|Withdrawal by Subject|0|||
105370188|NCT02577029|363360540|FG005|Overall Study|Withdrawal by Subject|1|||
105370189|NCT02577029|363360541|FG006|Overall Study|Withdrawal by Subject|0|||
105370190|NCT02577029|363360542|FG007|Overall Study|Withdrawal by Subject|0|||
105370191|NCT02577029|363360535|FG000|Overall Study|Sponsor Termination of the Study|9|||
105370192|NCT02577029|363360536|FG001|Overall Study|Sponsor Termination of the Study|2|||
105319048|NCT04807400|363164990|FG001|Overall Study|Lost to Follow-up|6|||
105319049|NCT04807400|363164991|FG002|Overall Study|Lost to Follow-up|6|||
105370193|NCT02577029|363360537|FG002|Overall Study|Sponsor Termination of the Study|5|||
105370194|NCT02577029|363360538|FG003|Overall Study|Sponsor Termination of the Study|12|||
105370195|NCT02577029|363360539|FG004|Overall Study|Sponsor Termination of the Study|10|||
105370196|NCT02577029|363360540|FG005|Overall Study|Sponsor Termination of the Study|12|||
105370197|NCT02577029|363360541|FG006|Overall Study|Sponsor Termination of the Study|12|||
105370198|NCT02577029|363360542|FG007|Overall Study|Sponsor Termination of the Study|12|||
105370199|NCT02078817|363360543|FG000|Overall Study|Withdrawal by Subject|1|||
105370200|NCT01265498|363360548|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
105849850|NCT00536263|365109654|FG001|Overall Study|Adverse Event|5|||
105319050|NCT04807400|363164989|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105319051|NCT04807400|363164990|FG001|Overall Study|Non-Compliance With Study Drug|4|||
105319052|NCT04807400|363164991|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105319053|NCT04807400|363164989|FG000|Overall Study|Participant Decision|20|||
105319054|NCT04807400|363164990|FG001|Overall Study|Participant Decision|19|||
105319055|NCT04807400|363164991|FG002|Overall Study|Participant Decision|26|||
105319056|NCT04807400|363164989|FG000|Overall Study|Physician Decision|0|||
105319057|NCT04807400|363164990|FG001|Overall Study|Physician Decision|1|||
105319058|NCT04807400|363164991|FG002|Overall Study|Physician Decision|0|||
105319059|NCT04807400|363164989|FG000|Overall Study|Protocol Violation|4|||
105319060|NCT04807400|363164990|FG001|Overall Study|Protocol Violation|3|||
105319061|NCT04807400|363164991|FG002|Overall Study|Protocol Violation|7|||
105319062|NCT04807400|363164989|FG000|Overall Study|Withdrawal by Subject|13|||
105319063|NCT04807400|363164990|FG001|Overall Study|Withdrawal by Subject|9|||
105319064|NCT04807400|363164991|FG002|Overall Study|Withdrawal by Subject|20|||
105319065|NCT04807400|363164989|FG000|Overall Study|Mis-randomized|1|||
105319066|NCT04807400|363164990|FG001|Overall Study|Mis-randomized|0|||
105319067|NCT04807400|363164991|FG002|Overall Study|Mis-randomized|0|||
105319068|NCT04194645|363164992|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105319069|NCT04194645|363164993|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105319070|NCT04194645|363164994|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105370201|NCT01265498|363360549|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
105370202|NCT01093846|363360551|FG000|Overall Study|Adverse Event|0|||
105370203|NCT01093846|363360552|FG001|Overall Study|Adverse Event|0|||
105370204|NCT01093846|363360553|FG002|Overall Study|Adverse Event|1|||
105370205|NCT01093846|363360551|FG000|Overall Study|Lack of Efficacy|0|||
105370206|NCT01093846|363360552|FG001|Overall Study|Lack of Efficacy|0|||
105370207|NCT01093846|363360553|FG002|Overall Study|Lack of Efficacy|4|||
105370208|NCT01093846|363360551|FG000|Overall Study|Condition no longer required study drug|1|||
105370209|NCT01093846|363360552|FG001|Overall Study|Condition no longer required study drug|1|||
105370210|NCT01093846|363360553|FG002|Overall Study|Condition no longer required study drug|1|||
105370211|NCT01093846|363360551|FG000|Overall Study|Administrative Problems|18|||
105370212|NCT01093846|363360552|FG001|Overall Study|Administrative Problems|17|||
105370213|NCT01093846|363360553|FG002|Overall Study|Administrative Problems|15|||
105370214|NCT03861039|363362245|FG000|Overall Study|Adverse Event|2|||
105370215|NCT03861039|363362246|FG001|Overall Study|Adverse Event|5|||
105370216|NCT03861039|363362247|FG002|Overall Study|Adverse Event|11|||
105370217|NCT03861039|363362245|FG000|Overall Study|Withdrawal by Subject|1|||
105370218|NCT03861039|363362246|FG001|Overall Study|Withdrawal by Subject|3|||
105370219|NCT03861039|363362247|FG002|Overall Study|Withdrawal by Subject|4|||
105370220|NCT03103503|363362251|FG000|Overall Study|Death|64|||
105370221|NCT03103503|363362251|FG000|Overall Study|Physician Decision|57|||
105370222|NCT03103503|363362251|FG000|Overall Study|Withdrawal by Subject|10|||
105370223|NCT03103503|363362251|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
105370224|NCT03103503|363362251|FG000|Overall Study|Lost to Follow-up|3|||
105370225|NCT03103503|363362251|FG000|Overall Study|Study Closure|757|||
105370226|NCT01384877|363362252|FG000|Treatment 2|Lost to Follow-up|2|||
105370227|NCT01384877|363362253|FG001|Treatment 2|Lost to Follow-up|2|||
105370228|NCT03630393|363362257|FG000|Overall Study|Death|1|||
105370229|NCT03630393|363362258|FG001|Overall Study|Death|0|||
105370230|NCT01586195|363362260|FG000|Overall Study|Death|11|||
105370231|NCT01586195|363362260|FG000|Overall Study|Withdrawal of Consent|5|||
105849851|NCT00536263|365109655|FG002|Overall Study|Adverse Event|7|||
105849852|NCT00536263|365109653|FG000|Overall Study|Lost to Follow-up|3|||
105849853|NCT00536263|365109654|FG001|Overall Study|Lost to Follow-up|4|||
105849854|NCT00536263|365109655|FG002|Overall Study|Lost to Follow-up|4|||
105849855|NCT00536263|365109653|FG000|Overall Study|Subject withdrew - not treatment related|2|||
105849856|NCT00536263|365109654|FG001|Overall Study|Subject withdrew - not treatment related|0|||
105849857|NCT00536263|365109655|FG002|Overall Study|Subject withdrew - not treatment related|5|||
105849858|NCT00536263|365109653|FG000|Overall Study|Subject withdrew - treatment related|0|||
105319071|NCT04194645|363164995|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105319072|NCT04194645|363164996|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105319073|NCT04194645|363164997|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105319074|NCT04194645|363164998|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105319075|NCT04194645|363164999|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105370232|NCT01586195|363362260|FG000|Overall Study|Started new anti-melanoma therapy|1|||
105370233|NCT01586195|363362260|FG000|Overall Study|Reason not specified|9|||
105370234|NCT00997334|363362261|FG000|Overall Study|still on therapy|12|||
105370235|NCT00997334|363362261|FG000|Overall Study|Adverse Event|3|||
105370236|NCT00997334|363362261|FG000|Overall Study|Patient non-compliance|1|||
105370237|NCT00997334|363362261|FG000|Overall Study|Withdrawal by Subject|3|||
105370238|NCT00997334|363362261|FG000|Overall Study|Death|2|||
105370239|NCT00997334|363362261|FG000|Overall Study|Urgent Palliative Care|2|||
105490935|NCT00249288|363809465|FG000|Overall Study|Withdrawal by Subject|2|||
105849859|NCT00536263|365109654|FG001|Overall Study|Subject withdrew - treatment related|3|||
105849860|NCT00536263|365109655|FG002|Overall Study|Subject withdrew - treatment related|2|||
105319076|NCT04194645|363165000|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105319077|NCT04194645|363165001|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
105319078|NCT04194645|363165002|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105319079|NCT04194645|363165003|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105319080|NCT04194645|363165004|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105319081|NCT04194645|363165005|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105319082|NCT04194645|363165006|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105319083|NCT00796757|363165008|FG000|Overall Study|Withdrawal by Subject|14|||
105319084|NCT00796757|363165008|FG000|Overall Study|Death|61|||
105319085|NCT00796757|363165008|FG000|Overall Study|Protocol Violation|1|||
105319086|NCT00796757|363165008|FG000|Overall Study|Participant noncompliance|1|||
105319087|NCT00796757|363165008|FG000|Overall Study|Investigator's decision|2|||
105319088|NCT00796757|363165008|FG000|Overall Study|Other|7|||
105319089|NCT00996489|363165009|FG000|Overall Study|Device failure|45|||
105319090|NCT00996489|363165009|FG000|Overall Study|Discontinued|116|||
105319091|NCT00490841|363165012|FG000|Overall Study|Death|5|||
105319092|NCT00490841|363165012|FG000|Overall Study|Withdrawal by Subject|4|||
105319093|NCT00490841|363165012|FG000|Overall Study|Lost to Follow-up|1|||
105319094|NCT00490841|363165012|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
105319095|NCT01277211|363165013|FG000|Overall Study|Adverse Event|60|||
105319096|NCT01277211|363165014|FG001|Overall Study|Adverse Event|22|||
105319097|NCT01277211|363165013|FG000|Overall Study|Pregnancy|9|||
105319098|NCT01277211|363165014|FG001|Overall Study|Pregnancy|4|||
105319099|NCT01277211|363165013|FG000|Overall Study|Lost to Follow-up|14|||
105319100|NCT01277211|363165014|FG001|Overall Study|Lost to Follow-up|9|||
105319101|NCT01277211|363165013|FG000|Overall Study|Did not wish to continue|17|||
105319102|NCT01277211|363165014|FG001|Overall Study|Did not wish to continue|0|||
105319103|NCT01277211|363165013|FG000|Overall Study|Withdrew Consent|9|||
105319104|NCT01277211|363165014|FG001|Overall Study|Withdrew Consent|9|||
105319105|NCT01277211|363165013|FG000|Overall Study|Non-compliance with protocol|13|||
105319106|NCT01277211|363165014|FG001|Overall Study|Non-compliance with protocol|4|||
105319107|NCT01277211|363165013|FG000|Overall Study|Did not meet protocol eligibility|1|||
105319108|NCT01277211|363165014|FG001|Overall Study|Did not meet protocol eligibility|0|||
105319109|NCT01277211|363165013|FG000|Overall Study|Administrative|3|||
105319110|NCT01277211|363165014|FG001|Overall Study|Administrative|0|||
105319111|NCT01277211|363165013|FG000|Overall Study|Pregnancy wish|0|||
105319112|NCT01277211|363165014|FG001|Overall Study|Pregnancy wish|2|||
105319113|NCT01277211|363165013|FG000|Overall Study|Discontinued prior to treatment|24|||
105319114|NCT01277211|363165014|FG001|Overall Study|Discontinued prior to treatment|13|||
105319115|NCT00770328|363165015|FG000|Overall Study|Adverse Event|11|||
105319116|NCT00770328|363165016|FG001|Overall Study|Adverse Event|2|||
105319117|NCT00770328|363165015|FG000|Overall Study|Lost to Follow-up|2|||
105319118|NCT00770328|363165016|FG001|Overall Study|Lost to Follow-up|2|||
105319119|NCT01130493|363165017|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
105319120|NCT01130493|363165018|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
105319121|NCT01130493|363165019|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
105319122|NCT01130493|363165017|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
105319123|NCT01130493|363165018|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
105319124|NCT01130493|363165019|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
105319125|NCT01130493|363165017|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
105319126|NCT01130493|363165018|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
105319127|NCT01130493|363165019|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
105319128|NCT01130493|363165017|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
105319129|NCT01130493|363165018|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
105319130|NCT01130493|363165019|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
105319131|NCT01130493|363165017|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
105319132|NCT01130493|363165018|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
105319133|NCT01130493|363165019|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
105319134|NCT01130493|363165017|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
105319135|NCT01130493|363165018|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
105319136|NCT01130493|363165019|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
105319137|NCT01130493|363165017|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
105370240|NCT00997334|363362261|FG000|Overall Study|No lesion amenable|1|||
105370241|NCT00997334|363362261|FG000|Overall Study|Ineligible|1|||
105319138|NCT01130493|363165018|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
105319139|NCT01130493|363165019|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
105370242|NCT02419807|363362262|FG000|Overall Study|Withdrawal by Subject|4|||
105319140|NCT01130493|363165017|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
105849861|NCT00536263|365109653|FG000|Overall Study|Noncompliance with protocol|0|||
105319141|NCT01130493|363165018|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
105370243|NCT02419807|363362262|FG000|Overall Study|Physician Decision|1|||
105370244|NCT02419807|363362262|FG000|Overall Study|Protocol Violation|5|||
105849862|NCT00536263|365109654|FG001|Overall Study|Noncompliance with protocol|0|||
105849863|NCT00536263|365109655|FG002|Overall Study|Noncompliance with protocol|1|||
105849864|NCT00536263|365109653|FG000|Overall Study|Did not meet protocol eligibility|1|||
105849865|NCT00536263|365109654|FG001|Overall Study|Did not meet protocol eligibility|2|||
105849866|NCT00536263|365109655|FG002|Overall Study|Did not meet protocol eligibility|2|||
105849867|NCT00826449|365109658|FG000|Overall Study|Disease Progression|4|||
105849868|NCT00826449|365109658|FG000|Overall Study|Withdrawal by Subject|1|||
105849869|NCT02994940|365109659|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
105849870|NCT02994940|365109660|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
105849871|NCT02994940|365109659|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
105849872|NCT02994940|365109660|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
105849873|NCT02994940|365109659|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
105849874|NCT02994940|365109660|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
105849875|NCT02196701|365109666|FG000|Overall Study|Adverse Event|1|||
105849876|NCT02196701|365109666|FG000|Overall Study|Lost to Follow-up|1|||
105849877|NCT02196701|365109666|FG000|Overall Study|Non-adherence to Protocol|1|||
105849878|NCT02317614|365109670|FG000|Overall Study|Lost to Follow-up|1|||
105849879|NCT02317614|365109671|FG001|Overall Study|Lost to Follow-up|1|||
105849880|NCT02317614|365109670|FG000|Overall Study|Withdrawal by Subject|1|||
105849881|NCT02317614|365109671|FG001|Overall Study|Withdrawal by Subject|0|||
105849882|NCT02317614|365109670|FG000|Overall Study|Death|1|||
105849883|NCT02317614|365109671|FG001|Overall Study|Death|1|||
105849884|NCT03285308|365109674|FG000|Overall Study|Adverse Event|3|||
105849885|NCT03285308|365109675|FG001|Overall Study|Adverse Event|7|||
105849886|NCT03285308|365109674|FG000|Overall Study|Withdrawal by Subject|8|||
105849887|NCT03285308|365109675|FG001|Overall Study|Withdrawal by Subject|9|||
105849888|NCT03285308|365109674|FG000|Overall Study|Lost to Follow-up|3|||
105849889|NCT03285308|365109675|FG001|Overall Study|Lost to Follow-up|1|||
105319142|NCT01130493|363165019|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
105319143|NCT01130493|363165017|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
105319144|NCT01130493|363165018|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
105319145|NCT01130493|363165019|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
105319146|NCT01130493|363165017|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
105319147|NCT01130493|363165018|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
105319148|NCT01130493|363165019|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
105319149|NCT01130493|363165017|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
105319150|NCT01130493|363165018|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
105319151|NCT01130493|363165019|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
105319152|NCT01130493|363165017|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
105319153|NCT01130493|363165018|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
105319154|NCT01130493|363165019|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
105319155|NCT01130493|363165017|FG000|Part 2: OLE|Adverse Event|0|||
105319156|NCT01130493|363165018|FG001|Part 2: OLE|Adverse Event|2|||
105319157|NCT01130493|363165019|FG002|Part 2: OLE|Adverse Event|1|||
105319158|NCT01130493|363165017|FG000|Part 2: OLE|Withdrawal by Subject|0|||
105319159|NCT01130493|363165018|FG001|Part 2: OLE|Withdrawal by Subject|1|||
105319160|NCT01130493|363165019|FG002|Part 2: OLE|Withdrawal by Subject|4|||
105319161|NCT04650204|363165025|FG000|Overall Study|Study was Terminated|2|||
105319162|NCT04650204|363165026|FG001|Overall Study|Study was Terminated|1|||
105319163|NCT02536846|363165027|FG000|Overall Study|Withdrawal by Subject|1|||
105319164|NCT00951496|363165028|FG000|Overall Study|Did not initiate study treatment|10|||
105319165|NCT00951496|363165029|FG001|Overall Study|Did not initiate study treatment|8|||
105319166|NCT00951496|363165030|FG002|Overall Study|Did not initiate study treatment|13|||
105319167|NCT02593110|363165031|FG000|Overall Study|Withdrawal by Subject|0|||
105319168|NCT02593110|363165032|FG001|Overall Study|Withdrawal by Subject|3|||
105319169|NCT02593110|363165033|FG002|Overall Study|Withdrawal by Subject|3|||
105319170|NCT02593110|363165034|FG003|Overall Study|Withdrawal by Subject|2|||
105319171|NCT02593110|363165031|FG000|Overall Study|Death|0|||
105319172|NCT02593110|363165032|FG001|Overall Study|Death|0|||
105319173|NCT02593110|363165033|FG002|Overall Study|Death|1|||
105319174|NCT02593110|363165034|FG003|Overall Study|Death|0|||
105319175|NCT02123446|363165036|FG000|Washout Period (1 Day)|Physician Decision|1|||
105319176|NCT02123446|363165037|FG001|Washout Period (1 Day)|Physician Decision|0|||
105319177|NCT02096744|363165038|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
105319178|NCT02096744|363165039|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
105319179|NCT02096744|363165038|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
105319180|NCT02096744|363165039|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
105319181|NCT02096744|363165038|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
105319182|NCT02096744|363165039|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
105849890|NCT03285308|365109674|FG000|Overall Study|Protocol Deviation|6|||
105849891|NCT03285308|365109675|FG001|Overall Study|Protocol Deviation|5|||
105849892|NCT03285308|365109674|FG000|Overall Study|Reason not Specified|0|||
105319183|NCT01893346|363165043|FG000|Overall Study|Lost to Follow-up|0|||
105849893|NCT03285308|365109675|FG001|Overall Study|Reason not Specified|1|||
105849894|NCT02787408|365109676|FG000|Overall Study|Death|16|||
105849895|NCT02787408|365109676|FG000|Overall Study|Withdrawal by Subject|1|||
105849896|NCT02787408|365109676|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
105849897|NCT00424775|365109681|FG000|Overall Study|Adverse Event|2|||
105849898|NCT00424775|365109682|FG001|Overall Study|Adverse Event|0|||
105849899|NCT00424775|365109681|FG000|Overall Study|Lack of Efficacy|1|||
105849900|NCT00424775|365109682|FG001|Overall Study|Lack of Efficacy|0|||
105849901|NCT00911807|365109684|FG000|Overall Study|Adverse Event|2|||
105849902|NCT00911807|365109685|FG001|Overall Study|Adverse Event|1|||
105849903|NCT00911807|365109686|FG002|Overall Study|Adverse Event|5|||
105849904|NCT00911807|365109684|FG000|Overall Study|Death|0|||
105849905|NCT00911807|365109685|FG001|Overall Study|Death|0|||
105849906|NCT00911807|365109686|FG002|Overall Study|Death|1|||
105849907|NCT00911807|365109684|FG000|Overall Study|Protocol Violation|6|||
105849908|NCT00911807|365109685|FG001|Overall Study|Protocol Violation|4|||
105849909|NCT00911807|365109686|FG002|Overall Study|Protocol Violation|9|||
105849910|NCT00911807|365109684|FG000|Overall Study|Withdrawal by Subject|8|||
105370245|NCT01117870|363362264|FG000|Overall Study|Inability to place needle|1|||
105370246|NCT01117870|363362265|FG001|Overall Study|Inability to place needle|0|||
105370247|NCT00095979|363362272|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
105370248|NCT01483118|363362273|FG000|Overall Study|Lost to Follow-up|12|||
105370249|NCT01483118|363362274|FG001|Overall Study|Lost to Follow-up|16|||
105370250|NCT01079780|363362277|FG000|Overall Study|Disease progression|43|||
105370251|NCT01079780|363362278|FG001|Overall Study|Disease progression|7|||
105370252|NCT01079780|363362279|FG002|Overall Study|Disease progression|31|||
105370253|NCT01079780|363362277|FG000|Overall Study|Adverse Event|13|||
105370254|NCT01079780|363362278|FG001|Overall Study|Adverse Event|5|||
105370255|NCT01079780|363362279|FG002|Overall Study|Adverse Event|7|||
105370256|NCT01079780|363362277|FG000|Overall Study|Death|2|||
105370257|NCT01079780|363362278|FG001|Overall Study|Death|0|||
105370258|NCT01079780|363362279|FG002|Overall Study|Death|2|||
105370259|NCT01079780|363362277|FG000|Overall Study|Withdrawal by Subject|6|||
105370260|NCT01079780|363362278|FG001|Overall Study|Withdrawal by Subject|4|||
105370261|NCT01079780|363362279|FG002|Overall Study|Withdrawal by Subject|4|||
105370262|NCT01079780|363362277|FG000|Overall Study|Alternative therapy|2|||
105370263|NCT01079780|363362278|FG001|Overall Study|Alternative therapy|0|||
105370264|NCT01079780|363362279|FG002|Overall Study|Alternative therapy|2|||
105370265|NCT01079780|363362277|FG000|Overall Study|Physician Decision|1|||
105370266|NCT01079780|363362278|FG001|Overall Study|Physician Decision|0|||
105370267|NCT01079780|363362279|FG002|Overall Study|Physician Decision|1|||
105370268|NCT01079780|363362277|FG000|Overall Study|Error made in lesion measurement|1|||
105370269|NCT01079780|363362278|FG001|Overall Study|Error made in lesion measurement|0|||
105370270|NCT01079780|363362279|FG002|Overall Study|Error made in lesion measurement|0|||
105370271|NCT01079780|363362277|FG000|Overall Study|Patient had surgery|1|||
105370272|NCT01079780|363362278|FG001|Overall Study|Patient had surgery|0|||
105370273|NCT01079780|363362279|FG002|Overall Study|Patient had surgery|0|||
105370274|NCT01079780|363362277|FG000|Overall Study|Treatment cycle delay|0|||
105370275|NCT01079780|363362278|FG001|Overall Study|Treatment cycle delay|0|||
105370276|NCT01079780|363362279|FG002|Overall Study|Treatment cycle delay|1|||
105370277|NCT01079780|363362277|FG000|Overall Study|Never started treatment|1|||
105370278|NCT01079780|363362278|FG001|Overall Study|Never started treatment|0|||
105370279|NCT01079780|363362279|FG002|Overall Study|Never started treatment|2|||
105370280|NCT01178294|363362280|FG000|Overall Study|Adverse Event|4|||
105370281|NCT01178294|363362280|FG000|Overall Study|Lost to Follow-up|2|||
105370282|NCT01178294|363362280|FG000|Overall Study|Lack of Efficacy|1|||
105370283|NCT01178294|363362280|FG000|Overall Study|Death|1|||
105370284|NCT01178294|363362280|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
105370285|NCT01178294|363362280|FG000|Overall Study|Subject status is terminal|1|||
105370286|NCT01178294|363362280|FG000|Overall Study|Completion status could not be verified|1|||
105370287|NCT03435055|363362281|FG000|Screening|Physician Decision|2|||
105370288|NCT03435055|363362281|FG000|Received Intervention|Did not complete nitrous administration|3|||
105370289|NCT04018066|363362282|FG000|Overall Study|participants started taking medications during the study period|3|||
105370290|NCT04018066|363362282|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
105370291|NCT00856180|363362290|FG000|Overall Study|Adverse Event|4|||
105370292|NCT00856180|363362290|FG000|Overall Study|Progressive Disease|16|||
105370293|NCT02265510|363362291|FG000|Overall Study|Withdrawal by Subject|1|||
105370294|NCT02265510|363362292|FG001|Overall Study|Withdrawal by Subject|1|||
105370295|NCT02265510|363362293|FG002|Overall Study|Withdrawal by Subject|2|||
105370296|NCT02265510|363362294|FG003|Overall Study|Withdrawal by Subject|1|||
105849911|NCT00911807|365109685|FG001|Overall Study|Withdrawal by Subject|10|||
105370297|NCT02265510|363362295|FG004|Overall Study|Withdrawal by Subject|0|||
105370298|NCT02265510|363362296|FG005|Overall Study|Withdrawal by Subject|2|||
105370299|NCT02265510|363362297|FG006|Overall Study|Withdrawal by Subject|0|||
105849912|NCT00911807|365109686|FG002|Overall Study|Withdrawal by Subject|7|||
105849913|NCT00911807|365109684|FG000|Overall Study|Organizational reasons|1|||
105849914|NCT00911807|365109685|FG001|Overall Study|Organizational reasons|3|||
105319184|NCT01893346|363165044|FG001|Overall Study|Lost to Follow-up|1|||
105319185|NCT01893346|363165045|FG002|Overall Study|Lost to Follow-up|0|||
105319186|NCT01893346|363165046|FG003|Overall Study|Lost to Follow-up|0|||
105319187|NCT01893346|363165043|FG000|Overall Study|Protocol Violation|1|||
105319188|NCT01893346|363165044|FG001|Overall Study|Protocol Violation|0|||
105319189|NCT01893346|363165045|FG002|Overall Study|Protocol Violation|0|||
105319190|NCT01893346|363165046|FG003|Overall Study|Protocol Violation|0|||
105319191|NCT01893346|363165043|FG000|Overall Study|Withdrawal by Subject|2|||
105319192|NCT01893346|363165044|FG001|Overall Study|Withdrawal by Subject|0|||
105319193|NCT01893346|363165045|FG002|Overall Study|Withdrawal by Subject|0|||
105319194|NCT01893346|363165046|FG003|Overall Study|Withdrawal by Subject|0|||
105319195|NCT01855828|363165047|FG000|Overall Study|Adverse Event|1|||
105319196|NCT01855828|363165047|FG000|Overall Study|Withdrawal by Subject|1|||
105319197|NCT03086551|363165059|FG000|First Intervention|Failure to meet inclusion criterion|1|||
105319198|NCT03086551|363165060|FG001|First Intervention|Failure to meet inclusion criterion|0|||
105319199|NCT03086551|363165059|FG000|First Intervention|Lost to Follow-up|0|||
105319200|NCT03086551|363165060|FG001|First Intervention|Lost to Follow-up|1|||
105319201|NCT03086551|363165059|FG000|Washout|Lost to Follow-up|1|||
105319202|NCT03086551|363165060|FG001|Washout|Lost to Follow-up|2|||
105319203|NCT03086551|363165059|FG000|Washout|Withdrawal by Subject|2|||
105319204|NCT03086551|363165060|FG001|Washout|Withdrawal by Subject|1|||
105319205|NCT03736031|363165061|FG000|Overall Study|Death|2|||
105319206|NCT03736031|363165062|FG001|Overall Study|Death|4|||
105319207|NCT03736031|363165061|FG000|Overall Study|Lost to Follow-up|21|||
105319208|NCT03736031|363165062|FG001|Overall Study|Lost to Follow-up|2|||
105319209|NCT03736031|363165061|FG000|Overall Study|Withdrawal by Subject|9|||
105319210|NCT03736031|363165062|FG001|Overall Study|Withdrawal by Subject|0|||
105319211|NCT00625872|363165063|FG000|Overall Study|Withdrawal by Subject|1|||
105319212|NCT00625872|363165064|FG001|Overall Study|Withdrawal by Subject|0|||
105319213|NCT00625872|363165063|FG000|Overall Study|Does not meet inclusion criteria|1|||
105319214|NCT00625872|363165064|FG001|Overall Study|Does not meet inclusion criteria|0|||
105319215|NCT00625872|363165063|FG000|Overall Study|Terminated by sponsor|2|||
105319216|NCT00625872|363165064|FG001|Overall Study|Terminated by sponsor|5|||
105319217|NCT00625872|363165063|FG000|Overall Study|Randomized but not treated|0|||
105319218|NCT00625872|363165064|FG001|Overall Study|Randomized but not treated|1|||
105319219|NCT01059786|363167302|FG000|Overall Study|Did not receive 6 cycles.|0|||
105319220|NCT01059786|363167303|FG001|Overall Study|Did not receive 6 cycles.|0|||
105319221|NCT01059786|363167304|FG002|Overall Study|Did not receive 6 cycles.|4|||
105319222|NCT01059786|363167305|FG003|Overall Study|Did not receive 6 cycles.|1|||
105319223|NCT01059786|363167306|FG004|Overall Study|Did not receive 6 cycles.|0|||
105319224|NCT01277601|363167307|FG000|Overall Study|Adverse Event|5|||
105319225|NCT01277601|363167308|FG001|Overall Study|Adverse Event|3|||
105319226|NCT01277601|363167309|FG002|Overall Study|Adverse Event|0|||
105319227|NCT01277601|363167310|FG003|Overall Study|Adverse Event|7|||
105319228|NCT01277601|363167307|FG000|Overall Study|Withdrawal by Subject|18|||
105319229|NCT01277601|363167308|FG001|Overall Study|Withdrawal by Subject|21|||
105319230|NCT01277601|363167309|FG002|Overall Study|Withdrawal by Subject|8|||
105319231|NCT01277601|363167310|FG003|Overall Study|Withdrawal by Subject|17|||
105319232|NCT01277601|363167307|FG000|Overall Study|Lost to Follow-up|7|||
105319233|NCT01277601|363167308|FG001|Overall Study|Lost to Follow-up|9|||
105319234|NCT01277601|363167309|FG002|Overall Study|Lost to Follow-up|4|||
105319235|NCT01277601|363167310|FG003|Overall Study|Lost to Follow-up|2|||
105370300|NCT02265510|363362298|FG007|Overall Study|Withdrawal by Subject|2|||
105370301|NCT02265510|363362299|FG008|Overall Study|Withdrawal by Subject|0|||
105370302|NCT02265510|363362300|FG009|Overall Study|Withdrawal by Subject|0|||
105370303|NCT02265510|363362301|FG010|Overall Study|Withdrawal by Subject|0|||
105370304|NCT02265510|363362302|FG011|Overall Study|Withdrawal by Subject|0|||
105370305|NCT02265510|363362303|FG012|Overall Study|Withdrawal by Subject|1|||
105370306|NCT02265510|363362304|FG013|Overall Study|Withdrawal by Subject|0|||
105370307|NCT02265510|363362291|FG000|Overall Study|Disease Progression|0|||
105370308|NCT02265510|363362292|FG001|Overall Study|Disease Progression|1|||
105370309|NCT02265510|363362293|FG002|Overall Study|Disease Progression|2|||
105319236|NCT01277601|363167307|FG000|Overall Study|Physician Decision|3|||
105319237|NCT01277601|363167308|FG001|Overall Study|Physician Decision|5|||
105319238|NCT01277601|363167309|FG002|Overall Study|Physician Decision|1|||
105370310|NCT02265510|363362294|FG003|Overall Study|Disease Progression|1|||
105319239|NCT01277601|363167310|FG003|Overall Study|Physician Decision|6|||
105319240|NCT01277601|363167307|FG000|Overall Study|Pregnancy|2|||
105319241|NCT01277601|363167308|FG001|Overall Study|Pregnancy|2|||
105319242|NCT01277601|363167309|FG002|Overall Study|Pregnancy|4|||
105319243|NCT01277601|363167310|FG003|Overall Study|Pregnancy|1|||
105319244|NCT01277601|363167307|FG000|Overall Study|Noncompliance with Study Drug|1|||
105319245|NCT01277601|363167308|FG001|Overall Study|Noncompliance with Study Drug|3|||
105370311|NCT02265510|363362295|FG004|Overall Study|Disease Progression|1|||
105319246|NCT01277601|363167309|FG002|Overall Study|Noncompliance with Study Drug|2|||
105319247|NCT01277601|363167310|FG003|Overall Study|Noncompliance with Study Drug|0|||
105370312|NCT02265510|363362296|FG005|Overall Study|Disease Progression|0|||
105370313|NCT02265510|363362297|FG006|Overall Study|Disease Progression|0|||
105370314|NCT02265510|363362298|FG007|Overall Study|Disease Progression|0|||
105370315|NCT02265510|363362299|FG008|Overall Study|Disease Progression|0|||
105370316|NCT02265510|363362300|FG009|Overall Study|Disease Progression|0|||
105370317|NCT02265510|363362301|FG010|Overall Study|Disease Progression|0|||
105370318|NCT02265510|363362302|FG011|Overall Study|Disease Progression|0|||
105370319|NCT02265510|363362303|FG012|Overall Study|Disease Progression|0|||
105370320|NCT02265510|363362304|FG013|Overall Study|Disease Progression|0|||
105370321|NCT02265510|363362291|FG000|Overall Study|Death|2|||
105370322|NCT02265510|363362292|FG001|Overall Study|Death|0|||
105849915|NCT00911807|365109686|FG002|Overall Study|Organizational reasons|1|||
105849916|NCT02435836|365109688|FG000|Overall Study|Lost to Follow-up|21|||
105849917|NCT02435836|365109688|FG000|Overall Study|Lack of Efficacy|1|||
105849918|NCT02435836|365109688|FG000|Overall Study|Withdrawal by Subject|236|||
105849919|NCT02435836|365109688|FG000|Overall Study|Insufficient Clinical Response|26|||
105849920|NCT02435836|365109688|FG000|Overall Study|Adverse Event|44|||
105849921|NCT02435836|365109688|FG000|Overall Study|Sponsor discontinued trial|167|||
105849922|NCT02435836|365109688|FG000|Overall Study|Noncompliance|27|||
105849923|NCT02435836|365109688|FG000|Overall Study|Protocol Violation|6|||
105849924|NCT02435836|365109688|FG000|Overall Study|Met Withdrawal Criteria|7|||
105849925|NCT02435836|365109688|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
105849926|NCT00809159|365109689|FG000|Part 1|Adverse Event|1|||
105849927|NCT00809159|365109690|FG001|Part 1|Adverse Event|1|||
105849928|NCT00809159|365109691|FG002|Part 1|Adverse Event|0|||
105849929|NCT00809159|365109692|FG003|Part 1|Adverse Event|0|||
105849930|NCT00809159|365109693|FG004|Part 1|Adverse Event|0|||
105849931|NCT00809159|365109694|FG005|Part 1|Adverse Event|0|||
105849932|NCT00809159|365109689|FG000|Part 1|Lost to Follow-up|1|||
105849933|NCT00809159|365109690|FG001|Part 1|Lost to Follow-up|0|||
105849934|NCT00809159|365109691|FG002|Part 1|Lost to Follow-up|0|||
105849935|NCT00809159|365109692|FG003|Part 1|Lost to Follow-up|0|||
105849936|NCT00809159|365109693|FG004|Part 1|Lost to Follow-up|0|||
105849937|NCT00809159|365109694|FG005|Part 1|Lost to Follow-up|0|||
105849938|NCT00809159|365109689|FG000|Part 1|Withdrawal by Subject|3|||
105849939|NCT00809159|365109690|FG001|Part 1|Withdrawal by Subject|1|||
105849940|NCT00809159|365109691|FG002|Part 1|Withdrawal by Subject|0|||
105849941|NCT00809159|365109692|FG003|Part 1|Withdrawal by Subject|0|||
105849942|NCT00809159|365109693|FG004|Part 1|Withdrawal by Subject|0|||
105849943|NCT00809159|365109694|FG005|Part 1|Withdrawal by Subject|0|||
105849944|NCT00809159|365109689|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
105849945|NCT00809159|365109690|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
105849946|NCT00809159|365109691|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
105849947|NCT00809159|365109692|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
105849948|NCT00809159|365109693|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
105849949|NCT00809159|365109694|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
105849950|NCT00809159|365109689|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
105849951|NCT00809159|365109690|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
105849952|NCT00809159|365109691|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
105849953|NCT00809159|365109692|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
105849954|NCT00809159|365109693|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
105849955|NCT00809159|365109694|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
105849956|NCT00809159|365109689|FG000|Part 1 and 2|Administrative problems|0|||
105849957|NCT00809159|365109690|FG001|Part 1 and 2|Administrative problems|0|||
105849958|NCT00809159|365109691|FG002|Part 1 and 2|Administrative problems|0|||
105849959|NCT00809159|365109692|FG003|Part 1 and 2|Administrative problems|1|||
105849960|NCT00809159|365109693|FG004|Part 1 and 2|Administrative problems|0|||
105849961|NCT00809159|365109694|FG005|Part 1 and 2|Administrative problems|0|||
105849962|NCT00809159|365109689|FG000|Part 1 and 2|Adverse Event|0|||
105849963|NCT00809159|365109690|FG001|Part 1 and 2|Adverse Event|0|||
105849964|NCT00809159|365109691|FG002|Part 1 and 2|Adverse Event|1|||
105849965|NCT00809159|365109692|FG003|Part 1 and 2|Adverse Event|0|||
105849966|NCT00809159|365109693|FG004|Part 1 and 2|Adverse Event|1|||
105849967|NCT00809159|365109694|FG005|Part 1 and 2|Adverse Event|1|||
105849968|NCT00809159|365109689|FG000|Part 1 and 2|Lost to Follow-up|0|||
105849969|NCT00809159|365109690|FG001|Part 1 and 2|Lost to Follow-up|0|||
105849970|NCT00809159|365109691|FG002|Part 1 and 2|Lost to Follow-up|1|||
105849971|NCT00809159|365109692|FG003|Part 1 and 2|Lost to Follow-up|1|||
105849972|NCT00809159|365109693|FG004|Part 1 and 2|Lost to Follow-up|0|||
105849973|NCT00809159|365109694|FG005|Part 1 and 2|Lost to Follow-up|0|||
105849974|NCT00809159|365109689|FG000|Part 1 and 2|Withdrawal by Subject|0|||
105849975|NCT00809159|365109690|FG001|Part 1 and 2|Withdrawal by Subject|0|||
105849976|NCT00809159|365109691|FG002|Part 1 and 2|Withdrawal by Subject|4|||
105370323|NCT02265510|363362293|FG002|Overall Study|Death|2|||
105370324|NCT02265510|363362294|FG003|Overall Study|Death|2|||
105370325|NCT02265510|363362295|FG004|Overall Study|Death|1|||
105370326|NCT02265510|363362296|FG005|Overall Study|Death|3|||
105849977|NCT00809159|365109692|FG003|Part 1 and 2|Withdrawal by Subject|0|||
105849978|NCT00809159|365109693|FG004|Part 1 and 2|Withdrawal by Subject|0|||
105849979|NCT00809159|365109694|FG005|Part 1 and 2|Withdrawal by Subject|1|||
105849980|NCT03201211|365109698|FG000|Overall Study|Adverse Event|1|||
105849981|NCT03201211|365109699|FG001|Overall Study|Adverse Event|0|||
105319248|NCT01277601|363167307|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
105319249|NCT01277601|363167308|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
105319250|NCT01277601|363167309|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
105319251|NCT01277601|363167310|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
105319252|NCT01277601|363167307|FG000|Overall Study|Protocol Violation|0|||
105319253|NCT01277601|363167308|FG001|Overall Study|Protocol Violation|2|||
105319254|NCT01277601|363167309|FG002|Overall Study|Protocol Violation|5|||
105319255|NCT01277601|363167310|FG003|Overall Study|Protocol Violation|0|||
105319256|NCT01277601|363167307|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
105319257|NCT01277601|363167308|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
105319258|NCT01277601|363167309|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
105319259|NCT01277601|363167310|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
105319260|NCT02243605|363167315|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
105319261|NCT02243605|363167316|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
105319262|NCT02243605|363167315|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
105319263|NCT02243605|363167316|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
105319264|NCT02243605|363167315|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
105319265|NCT02243605|363167316|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
105319266|NCT02243605|363167315|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
105319267|NCT02243605|363167316|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
105319268|NCT02243605|363167315|FG000|Stage 2 - Final Analysis Population|Progression|0|||
105319269|NCT02243605|363167316|FG001|Stage 2 - Final Analysis Population|Progression|1|||
105319270|NCT02465398|363167318|FG000|Overall Study|Death|7|||
105319271|NCT02465398|363167318|FG000|Overall Study|Revision|7|||
105319272|NCT02465398|363167318|FG000|Overall Study|did not receive study device|1|||
105319273|NCT02465398|363167318|FG000|Overall Study|Withdrawal by Subject|1|||
105319274|NCT02465398|363167318|FG000|Overall Study|Lost to Follow-up|14|||
105319275|NCT00445432|363167330|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
105319276|NCT00445432|363167331|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
105370327|NCT02265510|363362297|FG006|Overall Study|Death|2|||
105370328|NCT02265510|363362298|FG007|Overall Study|Death|1|||
105370329|NCT02265510|363362299|FG008|Overall Study|Death|3|||
105370330|NCT02265510|363362300|FG009|Overall Study|Death|3|||
105370331|NCT02265510|363362301|FG010|Overall Study|Death|4|||
105370332|NCT02265510|363362302|FG011|Overall Study|Death|12|||
105370333|NCT02265510|363362303|FG012|Overall Study|Death|7|||
105370334|NCT02265510|363362304|FG013|Overall Study|Death|6|||
105370335|NCT02265510|363362291|FG000|Overall Study|Lost to Follow-up|0|||
105370336|NCT02265510|363362292|FG001|Overall Study|Lost to Follow-up|0|||
105370337|NCT02265510|363362293|FG002|Overall Study|Lost to Follow-up|0|||
105370338|NCT02265510|363362294|FG003|Overall Study|Lost to Follow-up|0|||
105370339|NCT02265510|363362295|FG004|Overall Study|Lost to Follow-up|1|||
105370340|NCT02265510|363362296|FG005|Overall Study|Lost to Follow-up|0|||
105370341|NCT02265510|363362297|FG006|Overall Study|Lost to Follow-up|0|||
105370342|NCT02265510|363362298|FG007|Overall Study|Lost to Follow-up|0|||
105370343|NCT02265510|363362299|FG008|Overall Study|Lost to Follow-up|0|||
105370344|NCT02265510|363362300|FG009|Overall Study|Lost to Follow-up|2|||
105370345|NCT02265510|363362301|FG010|Overall Study|Lost to Follow-up|0|||
105370346|NCT02265510|363362302|FG011|Overall Study|Lost to Follow-up|0|||
105370347|NCT02265510|363362303|FG012|Overall Study|Lost to Follow-up|0|||
105370348|NCT02265510|363362304|FG013|Overall Study|Lost to Follow-up|2|||
105370349|NCT02265510|363362291|FG000|Overall Study|Other|0|||
105370350|NCT02265510|363362292|FG001|Overall Study|Other|1|||
105370351|NCT02265510|363362293|FG002|Overall Study|Other|0|||
105370352|NCT02265510|363362294|FG003|Overall Study|Other|0|||
105370353|NCT02265510|363362295|FG004|Overall Study|Other|0|||
105370354|NCT02265510|363362296|FG005|Overall Study|Other|0|||
105370355|NCT02265510|363362297|FG006|Overall Study|Other|0|||
105370356|NCT02265510|363362298|FG007|Overall Study|Other|0|||
105370357|NCT02265510|363362299|FG008|Overall Study|Other|0|||
105370358|NCT02265510|363362300|FG009|Overall Study|Other|0|||
105370359|NCT02265510|363362301|FG010|Overall Study|Other|0|||
105370360|NCT02265510|363362302|FG011|Overall Study|Other|0|||
105370361|NCT02265510|363362303|FG012|Overall Study|Other|0|||
105370362|NCT02265510|363362304|FG013|Overall Study|Other|0|||
105370363|NCT02265510|363362291|FG000|Overall Study|Study Terminated by Sponsor|0|||
105370364|NCT02265510|363362292|FG001|Overall Study|Study Terminated by Sponsor|0|||
105370365|NCT02265510|363362293|FG002|Overall Study|Study Terminated by Sponsor|0|||
105370366|NCT02265510|363362294|FG003|Overall Study|Study Terminated by Sponsor|0|||
105370367|NCT02265510|363362295|FG004|Overall Study|Study Terminated by Sponsor|0|||
105370368|NCT02265510|363362296|FG005|Overall Study|Study Terminated by Sponsor|1|||
105370369|NCT02265510|363362297|FG006|Overall Study|Study Terminated by Sponsor|1|||
105370370|NCT02265510|363362298|FG007|Overall Study|Study Terminated by Sponsor|1|||
105370371|NCT02265510|363362299|FG008|Overall Study|Study Terminated by Sponsor|1|||
105370372|NCT02265510|363362300|FG009|Overall Study|Study Terminated by Sponsor|2|||
105370373|NCT02265510|363362301|FG010|Overall Study|Study Terminated by Sponsor|1|||
105370374|NCT02265510|363362302|FG011|Overall Study|Study Terminated by Sponsor|4|||
105370375|NCT02265510|363362303|FG012|Overall Study|Study Terminated by Sponsor|1|||
105490936|NCT00249288|363809466|FG001|Overall Study|Withdrawal by Subject|2|||
105490937|NCT00381381|363809470|FG000|Overall Study|Adverse Event|3|||
105490938|NCT00381381|363809470|FG000|Overall Study|Lost to Follow-up|52|||
105490939|NCT00381381|363809470|FG000|Overall Study|Withdrawal by Subject|9|||
105490940|NCT01070043|363809486|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
105490941|NCT01070043|363809487|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
105490942|NCT01070043|363809488|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
105490943|NCT01070043|363809486|FG000|Double-Blind Treatment|Adverse Event|0|||
105490944|NCT01070043|363809487|FG001|Double-Blind Treatment|Adverse Event|0|||
105490945|NCT01070043|363809488|FG002|Double-Blind Treatment|Adverse Event|2|||
105490946|NCT01912963|363809489|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
105490947|NCT01912963|363809490|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
105490948|NCT01912963|363809491|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
105490949|NCT01912963|363809489|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
105490950|NCT01912963|363809490|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
105490951|NCT01912963|363809491|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
105319277|NCT00445432|363167332|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
105319278|NCT00445432|363167333|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
105319279|NCT00445432|363167330|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
105319280|NCT00445432|363167331|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
105319281|NCT00445432|363167332|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
105319282|NCT00445432|363167333|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
105319283|NCT00445432|363167330|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
105319284|NCT00445432|363167331|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
105319285|NCT00445432|363167332|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
105319286|NCT00445432|363167333|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
105319287|NCT00445432|363167330|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
105319288|NCT00445432|363167331|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
105319289|NCT00445432|363167332|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
105319290|NCT00445432|363167333|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
105319291|NCT00445432|363167330|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
105319292|NCT00445432|363167331|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
105319293|NCT00445432|363167332|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
105319294|NCT00445432|363167333|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
105319295|NCT00445432|363167330|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
105319296|NCT00445432|363167331|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
105319297|NCT00445432|363167332|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
105319298|NCT00445432|363167333|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
105319299|NCT00445432|363167330|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
105319300|NCT00445432|363167331|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
105490952|NCT01912963|363809489|FG000|Overall Study|Adverse Event|0|||
105490953|NCT01912963|363809490|FG001|Overall Study|Adverse Event|1|||
105490954|NCT01912963|363809491|FG002|Overall Study|Adverse Event|1|||
105490955|NCT01912963|363809489|FG000|Overall Study|Withdrawal by Subject|0|||
105319301|NCT00445432|363167332|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
105319302|NCT00445432|363167333|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
105319303|NCT00524420|363167334|FG000|Overall Study|Lack of Efficacy|1|||
105319304|NCT00524420|363167335|FG001|Overall Study|Lack of Efficacy|0|||
105319305|NCT00577863|363167336|FG000|Overall Study|Adverse Event|4|||
105319306|NCT00577863|363167337|FG001|Overall Study|Adverse Event|2|||
105319307|NCT00577863|363167336|FG000|Overall Study|Death|1|||
105319308|NCT00577863|363167337|FG001|Overall Study|Death|0|||
105319309|NCT00577863|363167336|FG000|Overall Study|Lost to Follow-up|2|||
105319310|NCT00577863|363167337|FG001|Overall Study|Lost to Follow-up|2|||
105319311|NCT00577863|363167336|FG000|Overall Study|Entry Criteria Exclusion|1|||
105319312|NCT00577863|363167337|FG001|Overall Study|Entry Criteria Exclusion|0|||
105319313|NCT00577863|363167336|FG000|Overall Study|Withdrawal by Subject|0|||
105319314|NCT00577863|363167337|FG001|Overall Study|Withdrawal by Subject|2|||
105319315|NCT00577863|363167336|FG000|Overall Study|Sponsor Decision|2|||
105319316|NCT00577863|363167337|FG001|Overall Study|Sponsor Decision|7|||
105319317|NCT00577863|363167336|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
105319318|NCT00577863|363167337|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
105319319|NCT01090414|363167338|FG000|Study 101-99|Progressive Disease|28|||
105319320|NCT01090414|363167339|FG001|Study 101-99|Progressive Disease|48|||
105319321|NCT01090414|363167340|FG002|Study 101-99|Progressive Disease|10|||
105319322|NCT01090414|363167341|FG003|Study 101-99|Progressive Disease|4|||
105490956|NCT01912963|363809490|FG001|Overall Study|Withdrawal by Subject|1|||
105490957|NCT01912963|363809491|FG002|Overall Study|Withdrawal by Subject|0|||
105490958|NCT01912963|363809489|FG000|Overall Study|Sought treatment locally|0|||
105490959|NCT01912963|363809490|FG001|Overall Study|Sought treatment locally|1|||
105490960|NCT01912963|363809491|FG002|Overall Study|Sought treatment locally|0|||
105319323|NCT01090414|363167338|FG000|Study 101-99|Adverse Event|10|||
105319324|NCT01090414|363167339|FG001|Study 101-99|Adverse Event|28|||
105490961|NCT00473746|363809492|FG000|Period 1 (Phase 1)|Adverse Event|1|||
105490962|NCT00473746|363809493|FG001|Period 1 (Phase 1)|Adverse Event|0|||
105490963|NCT00473746|363809494|FG002|Period 1 (Phase 1)|Adverse Event|0|||
105490964|NCT00473746|363809495|FG003|Period 1 (Phase 1)|Adverse Event|0|||
105319325|NCT01090414|363167340|FG002|Study 101-99|Adverse Event|18|||
105319326|NCT01090414|363167341|FG003|Study 101-99|Adverse Event|0|||
105319327|NCT01090414|363167338|FG000|Study 101-99|Investigator Request|1|||
105319328|NCT01090414|363167339|FG001|Study 101-99|Investigator Request|11|||
105490965|NCT00473746|363809496|FG004|Period 1 (Phase 1)|Adverse Event|0|||
105490966|NCT00473746|363809492|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
105490967|NCT00473746|363809493|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
105490968|NCT00473746|363809494|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
105490969|NCT00473746|363809495|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
105490970|NCT00473746|363809496|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
105490971|NCT00473746|363809492|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
105490972|NCT00473746|363809493|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
105490973|NCT00473746|363809494|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
105490974|NCT00473746|363809495|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
105490975|NCT00473746|363809496|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
105490976|NCT00473746|363809492|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
105490977|NCT00473746|363809493|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
105490978|NCT00473746|363809494|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
105490979|NCT00473746|363809495|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
105490980|NCT00473746|363809496|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
105490981|NCT00473746|363809492|FG000|Period 1 (Phase 1)|Reason not specified|0|||
105490982|NCT00473746|363809493|FG001|Period 1 (Phase 1)|Reason not specified|1|||
105319329|NCT01090414|363167340|FG002|Study 101-99|Investigator Request|4|||
105849982|NCT03201211|365109700|FG002|Overall Study|Adverse Event|0|||
105849983|NCT03201211|365109698|FG000|Overall Study|Protocol Violation|1|||
105849984|NCT03201211|365109699|FG001|Overall Study|Protocol Violation|0|||
105849985|NCT03201211|365109700|FG002|Overall Study|Protocol Violation|0|||
105319330|NCT01090414|363167341|FG003|Study 101-99|Investigator Request|0|||
105319331|NCT01090414|363167338|FG000|Study 101-99|Death|3|||
105319332|NCT01090414|363167339|FG001|Study 101-99|Death|8|||
105319333|NCT01090414|363167340|FG002|Study 101-99|Death|1|||
105319334|NCT01090414|363167341|FG003|Study 101-99|Death|0|||
105319335|NCT01090414|363167338|FG000|Study 101-99|Sponsor Discontinued Study|0|||
105319336|NCT01090414|363167339|FG001|Study 101-99|Sponsor Discontinued Study|7|||
105319337|NCT01090414|363167340|FG002|Study 101-99|Sponsor Discontinued Study|5|||
105319338|NCT01090414|363167341|FG003|Study 101-99|Sponsor Discontinued Study|0|||
105849986|NCT03201211|365109698|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105849987|NCT03201211|365109699|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105849988|NCT03201211|365109700|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
105849989|NCT03201211|365109698|FG000|Overall Study|OTHER unknown reasons|0|||
105849990|NCT03201211|365109699|FG001|Overall Study|OTHER unknown reasons|1|||
105319339|NCT01090414|363167338|FG000|Study 101-99|Other (Unknown Reasons)|3|||
105319340|NCT01090414|363167339|FG001|Study 101-99|Other (Unknown Reasons)|3|||
105319341|NCT01090414|363167340|FG002|Study 101-99|Other (Unknown Reasons)|0|||
105319342|NCT01090414|363167341|FG003|Study 101-99|Other (Unknown Reasons)|0|||
105319343|NCT01090414|363167338|FG000|Study 101-99|Withdrew Consent|0|||
105319344|NCT01090414|363167339|FG001|Study 101-99|Withdrew Consent|2|||
105319345|NCT01090414|363167340|FG002|Study 101-99|Withdrew Consent|3|||
105319346|NCT01090414|363167341|FG003|Study 101-99|Withdrew Consent|1|||
105319347|NCT01090414|363167338|FG000|Study 101-99|Participant Request|3|||
105319348|NCT01090414|363167339|FG001|Study 101-99|Participant Request|1|||
105319349|NCT01090414|363167340|FG002|Study 101-99|Participant Request|0|||
105319350|NCT01090414|363167341|FG003|Study 101-99|Participant Request|0|||
105319351|NCT02738138|363167347|FG000|Overall Study|Adverse Event|0|||
105319352|NCT02738138|363167348|FG001|Overall Study|Adverse Event|1|||
105319353|NCT02738138|363167347|FG000|Overall Study|Lost to Follow-up|2|||
105319354|NCT02738138|363167348|FG001|Overall Study|Lost to Follow-up|0|||
105319355|NCT02738138|363167347|FG000|Overall Study|Other - not further specified|1|||
105319356|NCT02738138|363167348|FG001|Overall Study|Other - not further specified|0|||
105319357|NCT02203357|363167351|FG000|Overall Study|Lost to Follow-up|58|||
105319358|NCT02203357|363167352|FG001|Overall Study|Lost to Follow-up|66|||
105319359|NCT02203357|363167353|FG002|Overall Study|Lost to Follow-up|70|||
105319360|NCT03154125|363167355|FG000|Overall Study|Lost to Follow-up|11|||
105319361|NCT03154125|363167356|FG001|Overall Study|Lost to Follow-up|11|||
105319362|NCT03154125|363167357|FG002|Overall Study|Lost to Follow-up|0|||
105319363|NCT03154125|363167355|FG000|Overall Study|Withdrawal by Subject|49|||
105319364|NCT03154125|363167356|FG001|Overall Study|Withdrawal by Subject|55|||
105319365|NCT03154125|363167357|FG002|Overall Study|Withdrawal by Subject|8|||
105319366|NCT03154125|363167355|FG000|Overall Study|Physician Decision|13|||
105319367|NCT03154125|363167356|FG001|Overall Study|Physician Decision|6|||
105319368|NCT03154125|363167357|FG002|Overall Study|Physician Decision|0|||
105319369|NCT03154125|363167355|FG000|Overall Study|Protocol Violation|3|||
105319370|NCT03154125|363167356|FG001|Overall Study|Protocol Violation|5|||
105849991|NCT03201211|365109700|FG002|Overall Study|OTHER unknown reasons|0|||
105319371|NCT03154125|363167357|FG002|Overall Study|Protocol Violation|0|||
105319372|NCT00799058|363167360|FG000|Overall Study|Withdrawal by Subject|2|||
105319373|NCT00799058|363167361|FG001|Overall Study|Withdrawal by Subject|2|||
105319374|NCT00799058|363167362|FG002|Overall Study|Withdrawal by Subject|2|||
105319375|NCT00799058|363167360|FG000|Overall Study|Lost to Follow-up|1|||
105319376|NCT00799058|363167361|FG001|Overall Study|Lost to Follow-up|2|||
105319377|NCT00799058|363167362|FG002|Overall Study|Lost to Follow-up|1|||
105319378|NCT00799058|363167360|FG000|Overall Study|Adverse Event|0|||
105319379|NCT00799058|363167361|FG001|Overall Study|Adverse Event|2|||
105319380|NCT00799058|363167362|FG002|Overall Study|Adverse Event|0|||
105319381|NCT00799058|363167360|FG000|Overall Study|Pregnancy|1|||
105319382|NCT00799058|363167361|FG001|Overall Study|Pregnancy|0|||
105319383|NCT00799058|363167362|FG002|Overall Study|Pregnancy|0|||
105319384|NCT00799058|363167360|FG000|Overall Study|Not adherent|3|||
105319385|NCT00799058|363167361|FG001|Overall Study|Not adherent|2|||
105319386|NCT00799058|363167362|FG002|Overall Study|Not adherent|1|||
105319387|NCT00799058|363167360|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
105319388|NCT00799058|363167361|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
105319389|NCT00799058|363167362|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
105319390|NCT00799058|363167360|FG000|Overall Study|IP dispensing error|1|||
105319391|NCT00799058|363167361|FG001|Overall Study|IP dispensing error|0|||
105319392|NCT00799058|363167362|FG002|Overall Study|IP dispensing error|0|||
105319393|NCT00799058|363167360|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
105319394|NCT00799058|363167361|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
105319395|NCT00799058|363167362|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
105319396|NCT00799058|363167360|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
105319397|NCT00799058|363167361|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
105319398|NCT00799058|363167362|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
105319399|NCT00799058|363167360|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
105319400|NCT00799058|363167361|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
105319401|NCT00799058|363167362|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
105319402|NCT00799058|363167360|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
105319403|NCT00799058|363167361|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
105319404|NCT00799058|363167362|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
105319405|NCT02088697|363167365|FG000|Period I|Physician Decision|1|||
105319406|NCT02088697|363167366|FG001|Period I|Physician Decision|4|||
105319407|NCT02088697|363167365|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
105319408|NCT02088697|363167366|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
105319409|NCT01295320|363167367|FG000|Overall Study|Adverse Event|2|||
105319410|NCT01295320|363167367|FG000|Overall Study|Lost to Follow-up|4|||
105319411|NCT01295320|363167367|FG000|Overall Study|Withdrawal by Subject|2|||
105319412|NCT01295320|363167367|FG000|Overall Study|Subject was bedridden|1|||
105319413|NCT01295320|363167367|FG000|Overall Study|Unable to travel|1|||
105319414|NCT01995513|363167368|FG000|Period 1: First Open Label Treatment|Other|34|||
105319415|NCT01995513|363167369|FG001|Period 1: First Open Label Treatment|Other|0|||
105319416|NCT01995513|363167370|FG002|Period 1: First Open Label Treatment|Other|0|||
105319417|NCT01995513|363167371|FG003|Period 1: First Open Label Treatment|Other|0|||
105319418|NCT01995513|363167368|FG000|Period 1: First Open Label Treatment|Death|14|||
105319419|NCT01995513|363167369|FG001|Period 1: First Open Label Treatment|Death|0|||
105319420|NCT01995513|363167370|FG002|Period 1: First Open Label Treatment|Death|0|||
105319421|NCT01995513|363167371|FG003|Period 1: First Open Label Treatment|Death|0|||
105319422|NCT01995513|363167368|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
105319423|NCT01995513|363167369|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
105319424|NCT01995513|363167370|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
105319425|NCT01995513|363167371|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
105319426|NCT01995513|363167368|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
105319427|NCT01995513|363167369|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
105319428|NCT01995513|363167370|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
105319429|NCT01995513|363167371|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
105319430|NCT01995513|363167368|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
105319431|NCT01995513|363167369|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
105319432|NCT01995513|363167370|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
105319433|NCT01995513|363167371|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
105319434|NCT01995513|363167368|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
105319435|NCT01995513|363167369|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
105319436|NCT01995513|363167370|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
105319437|NCT01995513|363167371|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
105319438|NCT01995513|363167368|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
105319439|NCT01995513|363167369|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
105319440|NCT01995513|363167370|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
105319441|NCT01995513|363167371|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
105319442|NCT01995513|363167368|FG000|Period 1: Second Open Label Treatment|Other|0|||
105319443|NCT01995513|363167369|FG001|Period 1: Second Open Label Treatment|Other|2|||
105319444|NCT01995513|363167370|FG002|Period 1: Second Open Label Treatment|Other|0|||
105319445|NCT01995513|363167371|FG003|Period 1: Second Open Label Treatment|Other|0|||
105319446|NCT01995513|363167368|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
105319447|NCT01995513|363167369|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
105319448|NCT01995513|363167370|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
105319449|NCT01995513|363167371|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
105319450|NCT01995513|363167368|FG000|Period 2: Double Blind Treatment|Death|0|||
105319451|NCT01995513|363167369|FG001|Period 2: Double Blind Treatment|Death|0|||
105319452|NCT01995513|363167370|FG002|Period 2: Double Blind Treatment|Death|0|||
105319453|NCT01995513|363167371|FG003|Period 2: Double Blind Treatment|Death|1|||
105319454|NCT01995513|363167368|FG000|Period 2: Double Blind Treatment|Other|0|||
105319455|NCT01995513|363167369|FG001|Period 2: Double Blind Treatment|Other|0|||
105319456|NCT01995513|363167370|FG002|Period 2: Double Blind Treatment|Other|3|||
105319457|NCT01995513|363167371|FG003|Period 2: Double Blind Treatment|Other|3|||
105319458|NCT01995513|363167368|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
105319459|NCT01995513|363167369|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
105319460|NCT01995513|363167370|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
105319461|NCT01995513|363167371|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
105319462|NCT01995513|363167368|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
105319463|NCT01995513|363167369|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
105319464|NCT01995513|363167370|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
105319465|NCT01995513|363167371|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
105319466|NCT01995513|363167368|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
105319467|NCT01995513|363167369|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
105319468|NCT01995513|363167370|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
105319469|NCT01995513|363167371|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
105319470|NCT01995513|363167368|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
105319471|NCT01995513|363167369|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
105319472|NCT01995513|363167370|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
105319473|NCT01995513|363167371|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
105319474|NCT02652949|363167372|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
105319475|NCT02652949|363167372|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
105319476|NCT02652949|363167372|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
105319477|NCT02652949|363167372|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
105319478|NCT02652949|363167372|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
105319479|NCT02652949|363167372|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
105319480|NCT02652949|363167372|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
105319481|NCT02652949|363167372|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
105319482|NCT02652949|363167372|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
105319483|NCT02652949|363167372|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
105319484|NCT02652949|363167372|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
105319485|NCT02652949|363167372|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
105319486|NCT02652949|363167372|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
105319487|NCT02652949|363167372|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
105319488|NCT02652949|363167372|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
105319489|NCT02652949|363167372|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
105319490|NCT02652949|363167372|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
105319491|NCT01232452|363167376|FG000|Overall Study|Adverse Event|17|||
105319492|NCT01232452|363167377|FG001|Overall Study|Adverse Event|15|||
105319493|NCT01232452|363167376|FG000|Overall Study|Withdrawal by Subject|11|||
105319494|NCT01232452|363167377|FG001|Overall Study|Withdrawal by Subject|8|||
105319495|NCT01232452|363167376|FG000|Overall Study|Physician Decision|8|||
105319496|NCT01232452|363167377|FG001|Overall Study|Physician Decision|12|||
105319497|NCT01232452|363167376|FG000|Overall Study|Protocol entry criterion not met|0|||
105319498|NCT01232452|363167377|FG001|Overall Study|Protocol entry criterion not met|2|||
105319499|NCT01232452|363167376|FG000|Overall Study|Sponsor Decision|3|||
105319500|NCT01232452|363167377|FG001|Overall Study|Sponsor Decision|1|||
105319501|NCT01232452|363167376|FG000|Overall Study|Protocol Violation|0|||
105319502|NCT01232452|363167377|FG001|Overall Study|Protocol Violation|1|||
105319503|NCT04108299|363167379|FG000|Overall Study|Not interested in participating|2|||
105319504|NCT04108299|363167380|FG001|Overall Study|Not interested in participating|1|||
105319505|NCT04108299|363167381|FG002|Overall Study|Not interested in participating|2|||
105319506|NCT04108299|363167382|FG003|Overall Study|Not interested in participating|1|||
105319507|NCT00247676|363167387|FG000|Overall Study|Death|5|||
105370376|NCT02265510|363362304|FG013|Overall Study|Study Terminated by Sponsor|2|||
105370377|NCT01668797|363362305|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
105370378|NCT01668797|363362306|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
105370379|NCT01668797|363362307|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
105370380|NCT01668797|363362308|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
105370381|NCT01668797|363362305|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
105370382|NCT01668797|363362306|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
105370383|NCT01668797|363362307|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
105370384|NCT01668797|363362308|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
105319508|NCT00247676|363167387|FG000|Overall Study|Adverse Event|11|||
105319509|NCT00247676|363167387|FG000|Overall Study|Lack of Efficacy|15|||
105319510|NCT00247676|363167387|FG000|Overall Study|Other|3|||
105319511|NCT00247676|363167387|FG000|Overall Study|Withdrawal by Subject|2|||
105319512|NCT05024747|363167388|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
105319513|NCT05024747|363167389|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
105319514|NCT05024747|363167388|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
105319515|NCT05024747|363167389|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
105319516|NCT05024747|363167388|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
105319517|NCT05024747|363167389|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
105319518|NCT00662649|363167390|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
105319519|NCT00662649|363167391|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
105319520|NCT00662649|363167392|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
105319521|NCT00662649|363167393|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
105319522|NCT00662649|363167394|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
105319523|NCT00662649|363167390|FG000|Core Study (24 Months)|Adverse Event|22|||
105319524|NCT00662649|363167391|FG001|Core Study (24 Months)|Adverse Event|13|||
105319525|NCT00662649|363167392|FG002|Core Study (24 Months)|Adverse Event|18|||
105319526|NCT00662649|363167393|FG003|Core Study (24 Months)|Adverse Event|0|||
105319527|NCT00662649|363167394|FG004|Core Study (24 Months)|Adverse Event|0|||
105319528|NCT00662649|363167390|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
105849992|NCT02478320|365109701|FG000|Overall Study|Adverse Event|2|||
105849993|NCT02478320|365109702|FG001|Overall Study|Adverse Event|0|||
105849994|NCT02478320|365109701|FG000|Overall Study|Death|1|||
105849995|NCT02478320|365109702|FG001|Overall Study|Death|0|||
105849996|NCT02478320|365109701|FG000|Overall Study|Lack of Efficacy|4|||
105849997|NCT02478320|365109702|FG001|Overall Study|Lack of Efficacy|0|||
105849998|NCT02478320|365109701|FG000|Overall Study|Withdrawal by Subject|2|||
105849999|NCT02478320|365109702|FG001|Overall Study|Withdrawal by Subject|0|||
105850000|NCT02478320|365109701|FG000|Overall Study|Screen Failure|3|||
105850001|NCT02478320|365109702|FG001|Overall Study|Screen Failure|0|||
105850002|NCT02041091|365109703|FG000|Treatment|Adverse Event|3|||
105850003|NCT02041091|365109704|FG001|Treatment|Adverse Event|3|||
105850004|NCT02041091|365109703|FG000|Treatment|Withdrawal by Subject|2|||
105850005|NCT02041091|365109704|FG001|Treatment|Withdrawal by Subject|4|||
105850006|NCT02041091|365109703|FG000|Treatment|Physician Decision|1|||
105850007|NCT02041091|365109704|FG001|Treatment|Physician Decision|0|||
105850008|NCT02041091|365109703|FG000|Treatment|Sponsor Decision|15|||
105850009|NCT02041091|365109704|FG001|Treatment|Sponsor Decision|16|||
105850010|NCT02041091|365109703|FG000|Treatment|Lost to Follow-up|1|||
105850011|NCT02041091|365109704|FG001|Treatment|Lost to Follow-up|0|||
105850012|NCT02041091|365109703|FG000|Optional Safety Extension Period|Adverse Event|4|||
105850013|NCT02041091|365109704|FG001|Optional Safety Extension Period|Adverse Event|2|||
105850014|NCT02041091|365109703|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
105850015|NCT02041091|365109704|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
105850016|NCT02041091|365109703|FG000|Optional Safety Extension Period|Protocol Violation|2|||
105850017|NCT02041091|365109704|FG001|Optional Safety Extension Period|Protocol Violation|0|||
105850018|NCT02041091|365109703|FG000|Optional Safety Extension Period|Physician Decision|2|||
105850019|NCT02041091|365109704|FG001|Optional Safety Extension Period|Physician Decision|1|||
105850020|NCT02041091|365109703|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
105850021|NCT02041091|365109704|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
105850022|NCT02041091|365109703|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
105850023|NCT02041091|365109704|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
105850024|NCT00922987|365109705|FG000|Overall Study|Insufficient clinical response|1|||
105850025|NCT00922987|365109705|FG000|Overall Study|Protocol Violation|2|||
105850026|NCT00922987|365109705|FG000|Overall Study|Adverse Event|1|||
105370385|NCT01668797|363362305|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
105370386|NCT01668797|363362306|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
105370387|NCT01668797|363362307|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
105370388|NCT01668797|363362308|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
105319529|NCT00662649|363167391|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
105850027|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
105850028|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
105850029|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850030|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850031|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850032|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850033|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850034|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850035|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850036|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850037|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850038|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850039|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850040|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850041|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
105850042|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
105850043|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850044|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850045|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850046|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850047|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850048|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850049|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850050|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850051|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850052|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850053|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850054|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850055|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
105850056|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
105850057|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850058|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850059|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850060|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850061|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850062|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850063|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850064|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850065|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850066|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850067|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850068|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850069|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
105850070|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
105850071|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850072|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850073|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850074|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850075|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850076|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850077|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850078|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850079|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850080|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850081|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850082|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850083|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
105850084|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
105850085|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850086|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850087|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850088|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850089|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850090|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850091|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850092|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850093|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850094|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105319530|NCT00662649|363167392|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
105319531|NCT00662649|363167393|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
105319532|NCT00662649|363167394|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
105319533|NCT00662649|363167390|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
105319534|NCT00662649|363167391|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
105319535|NCT00662649|363167392|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
105576773|NCT00932646|364110319|FG000|Overall Study|Withdrawal by Subject|1|||
105576774|NCT00932646|364110320|FG001|Overall Study|Withdrawal by Subject|1|||
105576775|NCT00932646|364110321|FG002|Overall Study|Withdrawal by Subject|3|||
105576776|NCT00932646|364110322|FG003|Overall Study|Withdrawal by Subject|0|||
105850095|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105319536|NCT00662649|363167393|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
105319537|NCT00662649|363167394|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
105490983|NCT00473746|363809494|FG002|Period 1 (Phase 1)|Reason not specified|0|||
105490984|NCT00473746|363809495|FG003|Period 1 (Phase 1)|Reason not specified|0|||
105319538|NCT00662649|363167390|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
105319539|NCT00662649|363167391|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
105319540|NCT00662649|363167392|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
105319541|NCT00662649|363167393|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
105319542|NCT00662649|363167394|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
105319543|NCT00662649|363167390|FG000|Core Study (24 Months)|Protocol Violation|5|||
105319544|NCT00662649|363167391|FG001|Core Study (24 Months)|Protocol Violation|5|||
105319545|NCT00662649|363167392|FG002|Core Study (24 Months)|Protocol Violation|4|||
105319546|NCT00662649|363167393|FG003|Core Study (24 Months)|Protocol Violation|0|||
105319547|NCT00662649|363167394|FG004|Core Study (24 Months)|Protocol Violation|0|||
105319548|NCT00662649|363167390|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
105319549|NCT00662649|363167391|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
105319550|NCT00662649|363167392|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
105319551|NCT00662649|363167393|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
105319552|NCT00662649|363167394|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
105319553|NCT00662649|363167390|FG000|Core Study (24 Months)|Death|1|||
105490985|NCT00473746|363809496|FG004|Period 1 (Phase 1)|Reason not specified|0|||
105490986|NCT00473746|363809492|FG000|Period 2 (Phase 2)|Adverse Event|0|||
105490987|NCT00473746|363809493|FG001|Period 2 (Phase 2)|Adverse Event|0|||
105490988|NCT00473746|363809494|FG002|Period 2 (Phase 2)|Adverse Event|0|||
105490989|NCT00473746|363809495|FG003|Period 2 (Phase 2)|Adverse Event|0|||
105490990|NCT00473746|363809496|FG004|Period 2 (Phase 2)|Adverse Event|3|||
105490991|NCT00473746|363809492|FG000|Period 2 (Phase 2)|Death|0|||
105490992|NCT00473746|363809493|FG001|Period 2 (Phase 2)|Death|0|||
105490993|NCT00473746|363809494|FG002|Period 2 (Phase 2)|Death|0|||
105490994|NCT00473746|363809495|FG003|Period 2 (Phase 2)|Death|0|||
105490995|NCT00473746|363809496|FG004|Period 2 (Phase 2)|Death|1|||
105490996|NCT00473746|363809492|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
105490997|NCT00473746|363809493|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
105490998|NCT00473746|363809494|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
105490999|NCT00473746|363809495|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
105491000|NCT00473746|363809496|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
105491001|NCT00473746|363809492|FG000|Period 2 (Phase 2)|Reason not specified|0|||
105491002|NCT00473746|363809493|FG001|Period 2 (Phase 2)|Reason not specified|0|||
105491003|NCT00473746|363809494|FG002|Period 2 (Phase 2)|Reason not specified|0|||
105491004|NCT00473746|363809495|FG003|Period 2 (Phase 2)|Reason not specified|0|||
105491005|NCT00473746|363809496|FG004|Period 2 (Phase 2)|Reason not specified|3|||
105491006|NCT00667420|363809500|FG000|Overall Study|Adverse Event|2|||
105491007|NCT00667420|363809500|FG000|Overall Study|Lack of Efficacy|5|||
105491008|NCT00667420|363809500|FG000|Overall Study|Physician Decision|1|||
105491009|NCT00667420|363809500|FG000|Overall Study|Withdrawal by Subject|2|||
105491010|NCT01982331|363809503|FG000|Received Vaccination 2|Adverse Event|1|||
105491011|NCT01982331|363809504|FG001|Received Vaccination 2|Adverse Event|2|||
105491012|NCT01982331|363809503|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
105491013|NCT01982331|363809504|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
105576777|NCT02138747|364110324|FG000|Treatment Period 1|Adverse Event|10|||
105850096|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105319554|NCT00662649|363167391|FG001|Core Study (24 Months)|Death|0|||
105491014|NCT01982331|363809503|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
105576778|NCT02138747|364110325|FG001|Treatment Period 1|Adverse Event|14|||
105319555|NCT00662649|363167392|FG002|Core Study (24 Months)|Death|2|||
105319556|NCT00662649|363167393|FG003|Core Study (24 Months)|Death|0|||
105319557|NCT00662649|363167394|FG004|Core Study (24 Months)|Death|0|||
105319558|NCT00662649|363167390|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
105319559|NCT00662649|363167391|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
105319560|NCT00662649|363167392|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
105319561|NCT00662649|363167393|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
105319562|NCT00662649|363167394|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
105850097|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
105319563|NCT00662649|363167390|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
105319564|NCT00662649|363167391|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
105850098|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
105850099|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850100|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850101|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850102|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850103|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850104|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850105|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850106|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850107|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850108|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850109|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850110|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850111|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
105850112|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
105850113|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850114|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850115|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850116|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105319565|NCT00662649|363167392|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
105319566|NCT00662649|363167393|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
105319567|NCT00662649|363167394|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
105319568|NCT00662649|363167390|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
105319569|NCT00662649|363167391|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
105319570|NCT00662649|363167392|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
105319571|NCT00662649|363167393|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
105319572|NCT00662649|363167394|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
105319573|NCT00662649|363167390|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
105319574|NCT00662649|363167391|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
105319575|NCT00662649|363167392|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
105319576|NCT00662649|363167393|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
105319577|NCT00662649|363167394|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
105319578|NCT00662649|363167390|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
105319579|NCT00662649|363167391|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
105319580|NCT00662649|363167392|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
105319581|NCT00662649|363167393|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
105319582|NCT00662649|363167394|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
105319583|NCT00662649|363167390|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
105319584|NCT00662649|363167391|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
105319585|NCT00662649|363167392|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
105319586|NCT00662649|363167393|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
105319587|NCT00662649|363167394|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
105319588|NCT00662649|363167390|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
105319589|NCT00662649|363167391|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
105319590|NCT00662649|363167392|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
105319591|NCT00662649|363167393|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
105319592|NCT00662649|363167394|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
105319593|NCT00662649|363167390|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
105319594|NCT00662649|363167391|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
105319595|NCT00662649|363167392|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
105319596|NCT00662649|363167393|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
105319597|NCT00662649|363167394|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
105319598|NCT00662649|363167390|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
105319599|NCT00662649|363167391|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
105319600|NCT00662649|363167392|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
105319601|NCT00662649|363167393|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
105319602|NCT00662649|363167394|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
105319603|NCT01026194|363167395|FG000|Period 1：Double Blind Period|Adverse Event|2|||
105319604|NCT01026194|363167396|FG001|Period 1：Double Blind Period|Adverse Event|1|||
105319605|NCT01026194|363167395|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
105850117|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850118|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105319606|NCT01026194|363167396|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
105319607|NCT01026194|363167395|FG000|Period 1：Double Blind Period|Physician Decision|0|||
105319608|NCT01026194|363167396|FG001|Period 1：Double Blind Period|Physician Decision|4|||
105319609|NCT01026194|363167395|FG000|Period 2：Open-label Period|Adverse Event|4|||
105319610|NCT01026194|363167396|FG001|Period 2：Open-label Period|Adverse Event|5|||
105319611|NCT01026194|363167395|FG000|Period 2：Open-label Period|Physician Decision|3|||
105319612|NCT01026194|363167396|FG001|Period 2：Open-label Period|Physician Decision|1|||
105319613|NCT01026194|363167395|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
105319614|NCT01026194|363167396|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
105319615|NCT02287922|363167399|FG000|Overall Study|Adverse Event|1|||
105319616|NCT02287922|363167400|FG001|Overall Study|Adverse Event|1|||
105319617|NCT02287922|363167401|FG002|Overall Study|Adverse Event|3|||
105319618|NCT02287922|363167402|FG003|Overall Study|Adverse Event|4|||
105319619|NCT02287922|363167399|FG000|Overall Study|Withdrawal by Subject|1|||
105319620|NCT02287922|363167400|FG001|Overall Study|Withdrawal by Subject|1|||
105319621|NCT02287922|363167401|FG002|Overall Study|Withdrawal by Subject|1|||
105319622|NCT02287922|363167402|FG003|Overall Study|Withdrawal by Subject|2|||
105319623|NCT02287922|363167399|FG000|Overall Study|Lost to Follow-up|0|||
105319624|NCT02287922|363167400|FG001|Overall Study|Lost to Follow-up|0|||
105319625|NCT02287922|363167401|FG002|Overall Study|Lost to Follow-up|1|||
105319626|NCT02287922|363167402|FG003|Overall Study|Lost to Follow-up|0|||
105319627|NCT02287922|363167399|FG000|Overall Study|Sponsor's decision|0|||
105319628|NCT02287922|363167400|FG001|Overall Study|Sponsor's decision|0|||
105319629|NCT02287922|363167401|FG002|Overall Study|Sponsor's decision|0|||
105319630|NCT02287922|363167402|FG003|Overall Study|Sponsor's decision|1|||
105319631|NCT02287922|363167399|FG000|Overall Study|Other|1|||
105319632|NCT02287922|363167400|FG001|Overall Study|Other|0|||
105319633|NCT02287922|363167401|FG002|Overall Study|Other|2|||
105319634|NCT02287922|363167402|FG003|Overall Study|Other|0|||
105319635|NCT04428034|363167405|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
105319636|NCT00560391|363167407|FG000|Overall Study|Still on treatment|0|||
105370389|NCT01668797|363362305|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
105370390|NCT01668797|363362306|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
105370391|NCT01668797|363362307|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
105370392|NCT01668797|363362308|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
105370393|NCT01668797|363362305|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
105370394|NCT01668797|363362306|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
105370395|NCT01668797|363362307|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
105370396|NCT01668797|363362308|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
105370397|NCT01668797|363362305|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
105370398|NCT01668797|363362306|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
105370399|NCT01668797|363362307|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
105370400|NCT01668797|363362308|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
105370401|NCT01668797|363362305|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
105370402|NCT01668797|363362306|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
105370403|NCT01668797|363362307|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
105370404|NCT01668797|363362308|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
105370405|NCT01668797|363362305|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
105370406|NCT01668797|363362306|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
105370407|NCT01668797|363362307|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
105370408|NCT01668797|363362308|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
105370409|NCT01668797|363362305|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
105370410|NCT01668797|363362306|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
105370411|NCT01668797|363362307|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
105370412|NCT01668797|363362308|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
105370413|NCT01668797|363362305|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
105370414|NCT01668797|363362306|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
105370415|NCT01668797|363362307|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
105370416|NCT01668797|363362308|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
105370417|NCT01668797|363362305|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
105370418|NCT01668797|363362306|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
105370419|NCT01668797|363362307|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
105370420|NCT01668797|363362308|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
105370421|NCT01668797|363362305|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
105576779|NCT02138747|364110326|FG002|Treatment Period 1|Adverse Event|2|||
105319637|NCT00560391|363167408|FG001|Overall Study|Still on treatment|0|||
105319638|NCT00560391|363167409|FG002|Overall Study|Still on treatment|0|||
105319639|NCT00560391|363167410|FG003|Overall Study|Still on treatment|1|||
105319640|NCT00560391|363167411|FG004|Overall Study|Still on treatment|2|||
105319641|NCT03668808|363167412|FG000|First Intervention|Withdrawal by Subject|2|||
105319642|NCT03668808|363167413|FG001|First Intervention|Withdrawal by Subject|2|||
105319643|NCT01526655|363167416|FG000|Overall Study|Withdrawal by Subject|0|||
105319644|NCT01526655|363167417|FG001|Overall Study|Withdrawal by Subject|1|||
105319645|NCT04176250|363167418|FG000|Overall Study|Adverse Event|0|||
105319646|NCT04176250|363167419|FG001|Overall Study|Adverse Event|1|||
105319647|NCT04176250|363167420|FG002|Overall Study|Adverse Event|0|||
105319648|NCT04176250|363167421|FG003|Overall Study|Adverse Event|1|||
105319649|NCT04176250|363167422|FG004|Overall Study|Adverse Event|0|||
105319650|NCT04176250|363167423|FG005|Overall Study|Adverse Event|1|||
105319651|NCT04176250|363167418|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
105319652|NCT04176250|363167419|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
105319653|NCT04176250|363167420|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
105319654|NCT04176250|363167421|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
105319655|NCT04176250|363167422|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
105319656|NCT04176250|363167423|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
105319657|NCT04176250|363167418|FG000|Overall Study|Withdrawal by Subject|0|||
105319658|NCT04176250|363167419|FG001|Overall Study|Withdrawal by Subject|0|||
105319659|NCT04176250|363167420|FG002|Overall Study|Withdrawal by Subject|0|||
105319660|NCT04176250|363167421|FG003|Overall Study|Withdrawal by Subject|0|||
105319661|NCT04176250|363167422|FG004|Overall Study|Withdrawal by Subject|0|||
105319662|NCT04176250|363167423|FG005|Overall Study|Withdrawal by Subject|1|||
105319663|NCT04176250|363167418|FG000|Overall Study|Randomized in error|0|||
105319664|NCT04176250|363167419|FG001|Overall Study|Randomized in error|0|||
105319665|NCT04176250|363167420|FG002|Overall Study|Randomized in error|0|||
105319666|NCT04176250|363167421|FG003|Overall Study|Randomized in error|0|||
105319667|NCT04176250|363167422|FG004|Overall Study|Randomized in error|1|||
105319668|NCT04176250|363167423|FG005|Overall Study|Randomized in error|0|||
105319669|NCT00344448|363167433|FG000|Screening|Withdrawal by Subject|0|||
105319670|NCT00344448|363167434|FG001|Screening|Withdrawal by Subject|1|||
105319671|NCT00344448|363167433|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
105319672|NCT00344448|363167434|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
105319673|NCT00344448|363167433|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
105319674|NCT00344448|363167434|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
105319675|NCT00344448|363167433|FG000|Open Label|Withdrawal by Subject|1|||
105319676|NCT00344448|363167434|FG001|Open Label|Withdrawal by Subject|1|||
105319677|NCT00344448|363167433|FG000|Open Label|Study terminated|1|||
105319678|NCT00344448|363167434|FG001|Open Label|Study terminated|0|||
105319679|NCT03151304|363167435|FG000|Overall Study|Termination of study by Sponsor|23|||
105319680|NCT03151304|363167435|FG000|Overall Study|missing|3|||
105319681|NCT03151304|363167435|FG000|Overall Study|Withdrawal by Subject|8|||
105319682|NCT03151304|363167435|FG000|Overall Study|multiple reasons|30|||
105319683|NCT03656744|363167436|FG000|Overall Study|Adverse Event|1|||
105319684|NCT03656744|363167437|FG001|Overall Study|Adverse Event|4|||
105319685|NCT03656744|363167438|FG002|Overall Study|Adverse Event|1|||
105319686|NCT03656744|363167436|FG000|Overall Study|Protocol Violation|1|||
105319687|NCT03656744|363167437|FG001|Overall Study|Protocol Violation|0|||
105319688|NCT03656744|363167438|FG002|Overall Study|Protocol Violation|0|||
105319689|NCT03656744|363167436|FG000|Overall Study|Lost to Follow-up|2|||
105319690|NCT03656744|363167437|FG001|Overall Study|Lost to Follow-up|2|||
105319691|NCT03656744|363167438|FG002|Overall Study|Lost to Follow-up|0|||
105319692|NCT03656744|363167436|FG000|Overall Study|Withdrawal by Subject|0|||
105319693|NCT03656744|363167437|FG001|Overall Study|Withdrawal by Subject|1|||
105319694|NCT03656744|363167438|FG002|Overall Study|Withdrawal by Subject|0|||
105319695|NCT03656744|363167436|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
105319696|NCT03656744|363167437|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
105319697|NCT03656744|363167438|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
105319698|NCT01783886|363167439|FG000|Overall Study|Lost to Follow-up|0|||
105319699|NCT01783886|363167440|FG001|Overall Study|Lost to Follow-up|3|||
105319700|NCT01783886|363167441|FG002|Overall Study|Lost to Follow-up|0|||
105319701|NCT01783886|363167439|FG000|Overall Study|Protocol deviation|0|||
105319702|NCT01783886|363167440|FG001|Overall Study|Protocol deviation|0|||
105319703|NCT01783886|363167441|FG002|Overall Study|Protocol deviation|2|||
105319704|NCT01783886|363167439|FG000|Overall Study|Withdrawal of consent by participant|1|||
105319705|NCT01783886|363167440|FG001|Overall Study|Withdrawal of consent by participant|3|||
105319706|NCT01783886|363167441|FG002|Overall Study|Withdrawal of consent by participant|4|||
105319707|NCT01783886|363167439|FG000|Overall Study|Adverse Event|4|||
105319708|NCT01783886|363167440|FG001|Overall Study|Adverse Event|5|||
105319709|NCT01783886|363167441|FG002|Overall Study|Adverse Event|4|||
105319710|NCT04542057|363167442|FG000|Overall Study|Death|3|||
105319711|NCT04542057|363167443|FG001|Overall Study|Death|1|||
105319712|NCT04542057|363167442|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
105319713|NCT04542057|363167443|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
105370422|NCT01668797|363362306|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
105319714|NCT04542057|363167442|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
105319715|NCT04542057|363167443|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
105319716|NCT04542057|363167442|FG000|Overall Study|Adverse Event|15|||
105319717|NCT04542057|363167443|FG001|Overall Study|Adverse Event|6|||
105319718|NCT04542057|363167442|FG000|Overall Study|COVID-19 adverse event|6|||
105319719|NCT04542057|363167443|FG001|Overall Study|COVID-19 adverse event|4|||
105319720|NCT04542057|363167442|FG000|Overall Study|Lack of Efficacy|2|||
105319721|NCT04542057|363167443|FG001|Overall Study|Lack of Efficacy|5|||
105319722|NCT04542057|363167442|FG000|Overall Study|Study terminated by sponsor|1|||
105319723|NCT04542057|363167443|FG001|Overall Study|Study terminated by sponsor|0|||
105319724|NCT04542057|363167442|FG000|Overall Study|Investigator discretion|2|||
105319725|NCT04542057|363167443|FG001|Overall Study|Investigator discretion|1|||
105319726|NCT04542057|363167442|FG000|Overall Study|Withdrawal by Subject|52|||
105319727|NCT04542057|363167443|FG001|Overall Study|Withdrawal by Subject|30|||
105319728|NCT04542057|363167442|FG000|Overall Study|Lost to Follow-up|8|||
105319729|NCT04542057|363167443|FG001|Overall Study|Lost to Follow-up|11|||
105319730|NCT04542057|363167442|FG000|Overall Study|Other|2|||
105319731|NCT04542057|363167443|FG001|Overall Study|Other|2|||
105319732|NCT02290405|363167444|FG000|Overall Study|Withdrawal by Subject|1|||
105319733|NCT02290405|363167445|FG001|Overall Study|Withdrawal by Subject|0|||
105319734|NCT03541317|363167446|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
105319735|NCT03541317|363167447|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
105319736|NCT03541317|363167448|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
105319737|NCT03541317|363167449|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
105319738|NCT03541317|363167450|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
105319739|NCT03541317|363167451|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
105319740|NCT02969044|363167452|FG000|Overall Study|Withdrawal by Subject|2|||
105850119|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850120|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850121|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850122|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850123|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850124|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850125|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
105850126|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
105850127|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850128|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850129|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850130|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850131|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850132|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850133|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850134|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850135|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850136|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850137|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850138|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850139|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
105850140|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
105850141|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850142|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850143|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850144|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850145|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850146|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850147|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850148|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850149|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850150|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850151|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105319741|NCT02969044|363167453|FG001|Overall Study|Withdrawal by Subject|6|||
105319742|NCT02969044|363167452|FG000|Overall Study|Adverse Event|3|||
105319743|NCT02969044|363167453|FG001|Overall Study|Adverse Event|0|||
105319744|NCT01330303|363167456|FG000|Period 1|Adverse Event|1|||
105319745|NCT01330303|363167457|FG001|Period 1|Adverse Event|0|||
105319746|NCT01330303|363167456|FG000|Period 1|Protocol Violation|0|||
105319747|NCT01330303|363167457|FG001|Period 1|Protocol Violation|1|||
105319748|NCT01330303|363167456|FG000|Period 1|Withdrawal by Subject|0|||
105319749|NCT01330303|363167457|FG001|Period 1|Withdrawal by Subject|1|||
105850152|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850153|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
105319750|NCT04604795|363167458|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
105319751|NCT04604795|363167459|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
105319752|NCT04604795|363167460|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105319753|NCT04604795|363167461|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105319754|NCT04604795|363167462|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105319755|NCT04604795|363167463|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105319756|NCT04604795|363167464|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105319757|NCT04604795|363167465|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105319758|NCT04604795|363167466|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105319759|NCT04604795|363167467|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105319760|NCT04604795|363167458|FG000|Part B: Up to Day 14|Adverse Event|0|||
105319761|NCT04604795|363167459|FG001|Part B: Up to Day 14|Adverse Event|0|||
105319762|NCT04604795|363167460|FG002|Part B: Up to Day 14|Adverse Event|0|||
105319763|NCT04604795|363167461|FG003|Part B: Up to Day 14|Adverse Event|0|||
105319764|NCT04604795|363167462|FG004|Part B: Up to Day 14|Adverse Event|2|||
105319765|NCT04604795|363167463|FG005|Part B: Up to Day 14|Adverse Event|1|||
105319766|NCT04604795|363167464|FG006|Part B: Up to Day 14|Adverse Event|0|||
105319767|NCT04604795|363167465|FG007|Part B: Up to Day 14|Adverse Event|0|||
105319768|NCT04604795|363167466|FG008|Part B: Up to Day 14|Adverse Event|0|||
105319769|NCT04604795|363167467|FG009|Part B: Up to Day 14|Adverse Event|0|||
105319770|NCT04604795|363167458|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105319771|NCT04604795|363167459|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105319772|NCT04604795|363167460|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105319773|NCT04604795|363167461|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105319774|NCT04604795|363167462|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105319775|NCT04604795|363167463|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105319776|NCT04604795|363167464|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105319777|NCT04604795|363167465|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105319778|NCT04604795|363167466|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105319779|NCT04604795|363167467|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
105319780|NCT04604795|363167458|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105319781|NCT04604795|363167459|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105319782|NCT04604795|363167460|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105319783|NCT04604795|363167461|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105319784|NCT04604795|363167462|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105319785|NCT04604795|363167463|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105319786|NCT04604795|363167464|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105319787|NCT04604795|363167465|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105319788|NCT04604795|363167466|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
105319789|NCT04604795|363167467|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105319790|NCT04604795|363167458|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105319791|NCT04604795|363167459|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105319792|NCT04604795|363167460|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105319793|NCT04604795|363167461|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105319794|NCT04604795|363167462|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105319795|NCT04604795|363167463|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105319796|NCT04604795|363167464|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105319797|NCT04604795|363167465|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105319798|NCT04604795|363167466|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
105319799|NCT04604795|363167467|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105370423|NCT01668797|363362307|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
105370424|NCT01668797|363362308|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
105370425|NCT01668797|363362305|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
105370426|NCT01668797|363362306|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
105370427|NCT01668797|363362307|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
105370428|NCT01668797|363362308|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
105370429|NCT01668797|363362305|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
105370430|NCT01668797|363362306|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
105370431|NCT01668797|363362307|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
105370432|NCT01668797|363362308|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
105370433|NCT01668797|363362305|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
105370434|NCT01668797|363362306|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
105370435|NCT01668797|363362307|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
105370436|NCT01668797|363362308|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
105576780|NCT02138747|364110327|FG003|Treatment Period 1|Adverse Event|1|||
105576781|NCT02138747|364110324|FG000|Treatment Period 1|Lost to Follow-up|0|||
105319800|NCT04604795|363167458|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
105319801|NCT04604795|363167459|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
105319802|NCT04604795|363167460|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
105319803|NCT04604795|363167461|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
105319804|NCT04604795|363167462|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
105319805|NCT04604795|363167463|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
105319806|NCT04604795|363167464|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
105319807|NCT04604795|363167465|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
105319808|NCT04604795|363167466|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
105319809|NCT04604795|363167467|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
105319810|NCT01070953|363167468|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
105319811|NCT01070953|363167468|FG000|Participants for Safety Evaluation|Off-label use|283|||
105319812|NCT01070953|363167468|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
105319813|NCT01070953|363167468|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
105319814|NCT01070953|363167468|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
105319815|NCT01070953|363167468|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
105319816|NCT01070953|363167468|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
105319817|NCT01070953|363167468|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
105319818|NCT01070953|363167468|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
105319819|NCT01070953|363167468|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
105319820|NCT02445963|363167469|FG000|Overall Study|Lost to Follow-up|1|||
105319821|NCT02445963|363167470|FG001|Overall Study|Lost to Follow-up|0|||
105319822|NCT02445963|363167471|FG002|Overall Study|Lost to Follow-up|0|||
105319823|NCT02445963|363167472|FG003|Overall Study|Lost to Follow-up|0|||
105319824|NCT02445963|363167469|FG000|Overall Study|Change in employment|1|||
105319825|NCT02445963|363167470|FG001|Overall Study|Change in employment|0|||
105319826|NCT02445963|363167471|FG002|Overall Study|Change in employment|0|||
105319827|NCT02445963|363167472|FG003|Overall Study|Change in employment|0|||
105319828|NCT02445963|363167469|FG000|Overall Study|Symptoms post-vaccination|0|||
105319829|NCT02445963|363167470|FG001|Overall Study|Symptoms post-vaccination|0|||
105319830|NCT02445963|363167471|FG002|Overall Study|Symptoms post-vaccination|1|||
105319831|NCT02445963|363167472|FG003|Overall Study|Symptoms post-vaccination|0|||
105319832|NCT02517463|363167473|FG000|Overall Study|Lost to Follow-up|5|||
105319833|NCT02517463|363167474|FG001|Overall Study|Lost to Follow-up|2|||
105319834|NCT00489827|363167475|FG000|Overall Study|Intraoperative exclusion criteria|1|||
105319835|NCT00489827|363167476|FG001|Overall Study|Intraoperative exclusion criteria|1|||
105319836|NCT00489827|363167475|FG000|Overall Study|Intraoperative exclusion criteria|1|||
105319837|NCT00489827|363167476|FG001|Overall Study|Intraoperative exclusion criteria|1|||
105319838|NCT01184079|363167479|FG000|Overall Study|Lost to Follow-up|14|||
105319839|NCT01184079|363167480|FG001|Overall Study|Lost to Follow-up|2|||
105319840|NCT01862484|363167481|FG000|Overall Study|Lack of Efficacy|1|||
105319841|NCT01862484|363167482|FG001|Overall Study|Lack of Efficacy|1|||
105319842|NCT01862484|363167481|FG000|Overall Study|Lost to Follow-up|1|||
105319843|NCT01862484|363167482|FG001|Overall Study|Lost to Follow-up|2|||
105319844|NCT01862484|363167481|FG000|Overall Study|Protocol Violation|0|||
105319845|NCT01862484|363167482|FG001|Overall Study|Protocol Violation|2|||
105319846|NCT01862484|363167481|FG000|Overall Study|Withdrawal by Subject|0|||
105319847|NCT01862484|363167482|FG001|Overall Study|Withdrawal by Subject|3|||
105319848|NCT02201277|363167484|FG000|Overall Study|Death|3|||
105319849|NCT02201277|363167485|FG001|Overall Study|Death|4|||
105319850|NCT02201277|363167484|FG000|Overall Study|Lost to Follow-up|2|||
105319851|NCT02201277|363167485|FG001|Overall Study|Lost to Follow-up|1|||
105319852|NCT02201277|363167484|FG000|Overall Study|Failed retrieval|1|||
105319853|NCT02201277|363167485|FG001|Overall Study|Failed retrieval|0|||
105319854|NCT02201277|363167484|FG000|Overall Study|Physician Decision|1|||
105319855|NCT02201277|363167485|FG001|Overall Study|Physician Decision|0|||
105319856|NCT00489255|363167486|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
105319857|NCT00489255|363167487|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
105319858|NCT00489255|363167486|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
105319859|NCT00489255|363167487|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
105319860|NCT00489255|363167486|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
105319861|NCT00489255|363167487|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
105319862|NCT00489255|363167486|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
105319863|NCT00489255|363167487|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
105319864|NCT00489255|363167486|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
105319865|NCT00489255|363167487|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
105440078|NCT05362058|363616698|FG000|Follow-Up Period|Protocol deviation|1|||
105319866|NCT00489255|363167486|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
105319867|NCT00489255|363167487|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
105319868|NCT00489255|363167486|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
105319869|NCT00489255|363167487|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
105319870|NCT00489255|363167486|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
105319871|NCT00489255|363167487|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
105319872|NCT00489255|363167486|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
105319873|NCT00489255|363167487|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
105319874|NCT00489255|363167486|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
105319875|NCT00489255|363167487|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
105319876|NCT02215967|363167490|FG000|Overall Study|Patient became ineligible for treatment|0|||
105319877|NCT02215967|363167491|FG001|Overall Study|Patient became ineligible for treatment|0|||
105319878|NCT02215967|363167492|FG002|Overall Study|Patient became ineligible for treatment|0|||
105319879|NCT02215967|363167493|FG003|Overall Study|Patient became ineligible for treatment|3|||
105319880|NCT02215967|363167490|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
105319881|NCT02215967|363167491|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
105319882|NCT02215967|363167492|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
105319883|NCT02215967|363167493|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
105319884|NCT01954745|363167494|FG000|Overall Study|Radiological Progression|11|||
105319885|NCT01954745|363167494|FG000|Overall Study|Clinical Progression|5|||
105319886|NCT01954745|363167494|FG000|Overall Study|Adverse Event|2|||
105319887|NCT01954745|363167494|FG000|Overall Study|Death|1|||
105319888|NCT00352417|363167498|FG000|Overall Study|Adverse Event|1|||
105319889|NCT00352417|363167499|FG001|Overall Study|Adverse Event|0|||
105319890|NCT00352417|363167498|FG000|Overall Study|Protocol Violation|0|||
105319891|NCT00352417|363167499|FG001|Overall Study|Protocol Violation|2|||
105319892|NCT00352417|363167498|FG000|Overall Study|Withdrawal by Subject|1|||
105319893|NCT00352417|363167499|FG001|Overall Study|Withdrawal by Subject|2|||
105319894|NCT00352417|363167498|FG000|Overall Study|Lost to Follow-up|1|||
105319895|NCT00352417|363167499|FG001|Overall Study|Lost to Follow-up|0|||
105319896|NCT00352417|363167498|FG000|Overall Study|Schedule Change|2|||
105319897|NCT00352417|363167499|FG001|Overall Study|Schedule Change|1|||
105319898|NCT00720382|363167500|FG000|Overall Study|Adverse Event|54|||
105319899|NCT00720382|363167501|FG001|Overall Study|Adverse Event|17|||
105319900|NCT00720382|363167500|FG000|Overall Study|Lack of Efficacy|18|||
105319901|NCT00720382|363167501|FG001|Overall Study|Lack of Efficacy|7|||
105319902|NCT00720382|363167500|FG000|Overall Study|Non-Compliance|15|||
105319903|NCT00720382|363167501|FG001|Overall Study|Non-Compliance|5|||
105319904|NCT00720382|363167500|FG000|Overall Study|Withdrawal by Subject|47|||
105319905|NCT00720382|363167501|FG001|Overall Study|Withdrawal by Subject|11|||
105319906|NCT00720382|363167500|FG000|Overall Study|Lost to Follow-up|28|||
105319907|NCT00720382|363167501|FG001|Overall Study|Lost to Follow-up|14|||
105319908|NCT00720382|363167500|FG000|Overall Study|administrative|14|||
105319909|NCT00720382|363167501|FG001|Overall Study|administrative|5|||
105319910|NCT04460885|363169665|FG000|Overall Study|Withdrawal by Subject|6|||
105319911|NCT04460885|363169666|FG001|Overall Study|Withdrawal by Subject|8|||
105319912|NCT04460885|363169665|FG000|Overall Study|Site closure|1|||
105319913|NCT04460885|363169666|FG001|Overall Study|Site closure|0|||
105319914|NCT04460885|363169665|FG000|Overall Study|Death|5|||
105319915|NCT04460885|363169666|FG001|Overall Study|Death|4|||
105319916|NCT04460885|363169665|FG000|Overall Study|Physician Decision|2|||
105319917|NCT04460885|363169666|FG001|Overall Study|Physician Decision|1|||
105319918|NCT04460885|363169665|FG000|Overall Study|Lost to Follow-up|4|||
105319919|NCT04460885|363169666|FG001|Overall Study|Lost to Follow-up|4|||
105319920|NCT04559347|363169667|FG000|Overall Study|Death|1|||
105319921|NCT04559347|363169668|FG001|Overall Study|Death|0|||
105319922|NCT04559347|363169667|FG000|Overall Study|Thoracotomy conversion|1|||
105319923|NCT04559347|363169668|FG001|Overall Study|Thoracotomy conversion|1|||
105319924|NCT04559347|363169667|FG000|Overall Study|Provider unavailable|2|||
105319925|NCT04559347|363169668|FG001|Overall Study|Provider unavailable|1|||
105319926|NCT04559347|363169667|FG000|Overall Study|Other|2|||
105319927|NCT04559347|363169668|FG001|Overall Study|Other|1|||
105319928|NCT04324073|363169669|FG000|Overall Study|withdrew consent|0|||
105319929|NCT04324073|363169670|FG001|Overall Study|withdrew consent|4|||
105319930|NCT04324073|363169671|FG002|Overall Study|withdrew consent|2|||
105319931|NCT04324073|363169672|FG003|Overall Study|withdrew consent|8|||
105319932|NCT02586688|363169673|FG000|Overall Study|Lost to Follow-up|2|||
105319933|NCT02586688|363169674|FG001|Overall Study|Lost to Follow-up|1|||
105319934|NCT02586688|363169673|FG000|Overall Study|Withdrawal by Subject|1|||
105319935|NCT02586688|363169674|FG001|Overall Study|Withdrawal by Subject|1|||
105319936|NCT02586688|363169673|FG000|Overall Study|Adverse Event|3|||
105319937|NCT02586688|363169674|FG001|Overall Study|Adverse Event|1|||
105319938|NCT03999996|363169675|FG000|Prior to Booster|Adverse Event|2|||
105319939|NCT03999996|363169676|FG001|Prior to Booster|Adverse Event|0|||
105319940|NCT03999996|363169677|FG002|Prior to Booster|Adverse Event|0|||
105319941|NCT03999996|363169678|FG003|Prior to Booster|Adverse Event|0|||
105319942|NCT03999996|363169675|FG000|Prior to Booster|Lost to Follow-up|17|||
105319943|NCT03999996|363169676|FG001|Prior to Booster|Lost to Follow-up|22|||
105319944|NCT03999996|363169677|FG002|Prior to Booster|Lost to Follow-up|0|||
105319945|NCT03999996|363169678|FG003|Prior to Booster|Lost to Follow-up|0|||
105319946|NCT03999996|363169675|FG000|Prior to Booster|Withdrawal of Consent|51|||
105319947|NCT03999996|363169676|FG001|Prior to Booster|Withdrawal of Consent|8|||
105319948|NCT03999996|363169677|FG002|Prior to Booster|Withdrawal of Consent|0|||
105319949|NCT03999996|363169678|FG003|Prior to Booster|Withdrawal of Consent|0|||
105319950|NCT03999996|363169675|FG000|Prior to Booster|Death|0|||
105319951|NCT03999996|363169676|FG001|Prior to Booster|Death|1|||
105319952|NCT03999996|363169677|FG002|Prior to Booster|Death|0|||
105319953|NCT03999996|363169678|FG003|Prior to Booster|Death|0|||
105319954|NCT03999996|363169675|FG000|Prior to Booster|Reason Not Specified|27|||
105319955|NCT03999996|363169676|FG001|Prior to Booster|Reason Not Specified|4|||
105319956|NCT03999996|363169677|FG002|Prior to Booster|Reason Not Specified|0|||
105319957|NCT03999996|363169678|FG003|Prior to Booster|Reason Not Specified|0|||
105319958|NCT03999996|363169675|FG000|Booster Phase|Lost to Follow-up|0|||
105319959|NCT03999996|363169676|FG001|Booster Phase|Lost to Follow-up|0|||
105319960|NCT03999996|363169677|FG002|Booster Phase|Lost to Follow-up|3|||
105319961|NCT03999996|363169678|FG003|Booster Phase|Lost to Follow-up|3|||
105319962|NCT03999996|363169675|FG000|Booster Phase|Withdrawal of Consent|0|||
105319963|NCT03999996|363169676|FG001|Booster Phase|Withdrawal of Consent|0|||
105319964|NCT03999996|363169677|FG002|Booster Phase|Withdrawal of Consent|0|||
105319965|NCT03999996|363169678|FG003|Booster Phase|Withdrawal of Consent|1|||
105319966|NCT03999996|363169675|FG000|Booster Phase|Reason Not Specified|0|||
105319967|NCT03999996|363169676|FG001|Booster Phase|Reason Not Specified|0|||
105319968|NCT03999996|363169677|FG002|Booster Phase|Reason Not Specified|0|||
105319969|NCT03999996|363169678|FG003|Booster Phase|Reason Not Specified|1|||
105319970|NCT04848480|363169681|FG000|Main Phase (26 Weeks)|Death|1|||
105319971|NCT04848480|363169682|FG001|Main Phase (26 Weeks)|Death|0|||
105319972|NCT04848480|363169681|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
105319973|NCT04848480|363169682|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
105319974|NCT04848480|363169681|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
105319975|NCT04848480|363169682|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
105319976|NCT04848480|363169681|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
105319977|NCT04848480|363169682|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
105319978|NCT04848480|363169681|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
105319979|NCT04848480|363169682|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
105319980|NCT04848480|363169681|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
105319981|NCT04848480|363169682|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
105319982|NCT03573830|363169685|FG000|Overall Study|Dropped without completing treatment|0|||
105319983|NCT03573830|363169686|FG001|Overall Study|Dropped without completing treatment|7|||
105319984|NCT03573830|363169685|FG000|Overall Study|Lost to Follow-up|4|||
105319985|NCT03573830|363169686|FG001|Overall Study|Lost to Follow-up|0|||
105319986|NCT00678210|363169689|FG000|Overall Study|Adverse Event|1|||
105319987|NCT00678210|363169690|FG001|Overall Study|Adverse Event|2|||
105319988|NCT00678210|363169691|FG002|Overall Study|Adverse Event|3|||
105319989|NCT00678210|363169692|FG003|Overall Study|Adverse Event|3|||
105319990|NCT00678210|363169689|FG000|Overall Study|Lack of Efficacy|2|||
105319991|NCT00678210|363169690|FG001|Overall Study|Lack of Efficacy|3|||
105319992|NCT00678210|363169691|FG002|Overall Study|Lack of Efficacy|1|||
105319993|NCT00678210|363169692|FG003|Overall Study|Lack of Efficacy|9|||
105319994|NCT00678210|363169689|FG000|Overall Study|Lost to Follow-up|4|||
105319995|NCT00678210|363169690|FG001|Overall Study|Lost to Follow-up|2|||
105319996|NCT00678210|363169691|FG002|Overall Study|Lost to Follow-up|0|||
105319997|NCT00678210|363169692|FG003|Overall Study|Lost to Follow-up|1|||
105319998|NCT00678210|363169689|FG000|Overall Study|Withdrawal by Subject|3|||
105319999|NCT00678210|363169690|FG001|Overall Study|Withdrawal by Subject|4|||
105320000|NCT00678210|363169691|FG002|Overall Study|Withdrawal by Subject|1|||
105320001|NCT00678210|363169692|FG003|Overall Study|Withdrawal by Subject|7|||
105320002|NCT00678210|363169689|FG000|Overall Study|Other|1|||
105320003|NCT00678210|363169690|FG001|Overall Study|Other|0|||
105320004|NCT00678210|363169691|FG002|Overall Study|Other|1|||
105320005|NCT00678210|363169692|FG003|Overall Study|Other|0|||
105320006|NCT03779334|363169693|FG000|Overall Study|Withdrawal by Subject|3|||
105320007|NCT03779334|363169694|FG001|Overall Study|Withdrawal by Subject|0|||
105320008|NCT03779334|363169695|FG002|Overall Study|Withdrawal by Subject|0|||
105320009|NCT03779334|363169693|FG000|Overall Study|Ongoing in Study|5|||
105320010|NCT03779334|363169694|FG001|Overall Study|Ongoing in Study|13|||
105320011|NCT03779334|363169695|FG002|Overall Study|Ongoing in Study|5|||
105320012|NCT02653625|363169696|FG000|Overall Study|Adverse Event|1|||
105320013|NCT02653625|363169696|FG000|Overall Study|Non-compliance with Study Drug|1|||
105320014|NCT02653625|363169696|FG000|Overall Study|Protocol Violation|1|||
105320015|NCT02653625|363169696|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
105320016|NCT00064987|363169699|FG000|Overall Study|Physician Decision|3|||
105320017|NCT00064987|363169700|FG001|Overall Study|Physician Decision|0|||
105320018|NCT02969382|363169701|FG000|Overall Study|Adverse Event|8|||
105320019|NCT02969382|363169702|FG001|Overall Study|Adverse Event|10|||
105320020|NCT02969382|363169701|FG000|Overall Study|Lack of Efficacy|4|||
105320021|NCT02969382|363169702|FG001|Overall Study|Lack of Efficacy|5|||
105320022|NCT02969382|363169701|FG000|Overall Study|Death|0|||
105320023|NCT02969382|363169702|FG001|Overall Study|Death|1|||
105320024|NCT02969382|363169701|FG000|Overall Study|PROTOCOL DEVIATION|0|||
105320025|NCT02969382|363169702|FG001|Overall Study|PROTOCOL DEVIATION|1|||
105320026|NCT02969382|363169701|FG000|Overall Study|Withdrawal by Subject|14|||
105320027|NCT02969382|363169702|FG001|Overall Study|Withdrawal by Subject|9|||
105320028|NCT00764881|363169706|FG000|Overall Study|Adverse Event|5|||
105320029|NCT00764881|363169707|FG001|Overall Study|Adverse Event|1|||
105320030|NCT00764881|363169706|FG000|Overall Study|Withdrawal by Subject|1|||
105320031|NCT00764881|363169707|FG001|Overall Study|Withdrawal by Subject|3|||
105320032|NCT00764881|363169706|FG000|Overall Study|Protocol Violation|2|||
105320033|NCT00764881|363169707|FG001|Overall Study|Protocol Violation|2|||
105320034|NCT00764881|363169706|FG000|Overall Study|Lost to Follow-up|2|||
105320035|NCT00764881|363169707|FG001|Overall Study|Lost to Follow-up|0|||
105320036|NCT00764881|363169706|FG000|Overall Study|Noncompliant|1|||
105320037|NCT00764881|363169707|FG001|Overall Study|Noncompliant|0|||
105320038|NCT00764881|363169706|FG000|Overall Study|Accidentally discontinued study drug|1|||
105320039|NCT00764881|363169707|FG001|Overall Study|Accidentally discontinued study drug|0|||
105320040|NCT00764881|363169706|FG000|Overall Study|Wished to become pregnant|1|||
105370437|NCT01668797|363362305|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
105370438|NCT01668797|363362306|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
105370439|NCT01668797|363362307|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
105370440|NCT01668797|363362308|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
105370441|NCT01668797|363362305|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
105370442|NCT01668797|363362306|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
105370443|NCT01668797|363362307|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
105370444|NCT01668797|363362308|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
105370445|NCT01668797|363362305|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
105370446|NCT01668797|363362306|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
105370447|NCT01668797|363362307|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
105370448|NCT01668797|363362308|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
105370449|NCT01668797|363362305|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
105370450|NCT01668797|363362306|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
105370451|NCT01668797|363362307|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
105370452|NCT01668797|363362308|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
105370453|NCT01668797|363362305|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
105370454|NCT01668797|363362306|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
105370455|NCT01668797|363362307|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
105370456|NCT01668797|363362308|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
105370457|NCT01668797|363362305|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
105370458|NCT01668797|363362306|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
105370459|NCT01668797|363362307|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
105370460|NCT01668797|363362308|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
105370461|NCT01668797|363362305|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
105370462|NCT01668797|363362306|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
105370463|NCT01668797|363362307|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
105370464|NCT01668797|363362308|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
105370465|NCT01668797|363362305|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
105370466|NCT01668797|363362306|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
105370467|NCT01668797|363362307|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
105370468|NCT01668797|363362308|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
105370469|NCT01668797|363362305|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
105370470|NCT01668797|363362306|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
105370471|NCT01668797|363362307|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
105370472|NCT01668797|363362308|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
105370473|NCT01668797|363362305|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
105370474|NCT01668797|363362306|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
105370475|NCT01668797|363362307|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
105370476|NCT01668797|363362308|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
105370477|NCT01004614|363362309|FG000|Washout|Withdrawal by Subject|0|||
105370478|NCT01004614|363362310|FG001|Washout|Withdrawal by Subject|1|||
105370479|NCT01004614|363362311|FG002|Washout|Withdrawal by Subject|0|||
105370480|NCT01004614|363362312|FG003|Washout|Withdrawal by Subject|0|||
105370481|NCT02111083|363362313|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
105370482|NCT02111083|363362314|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
105370483|NCT00433836|363362315|FG000|Overall Study|Adverse Event|7|||
105370484|NCT00433836|363362316|FG001|Overall Study|Adverse Event|0|||
105320041|NCT00764881|363169707|FG001|Overall Study|Wished to become pregnant|0|||
105320042|NCT00764881|363169706|FG000|Overall Study|Carcinoma detected|1|||
105320043|NCT00764881|363169707|FG001|Overall Study|Carcinoma detected|0|||
105320044|NCT00764881|363169706|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
105320045|NCT00764881|363169707|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
105850154|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
105850155|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850156|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850157|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850158|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850159|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850160|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850161|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850162|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850163|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850164|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850165|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850166|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850167|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
105850168|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
105850169|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850170|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850171|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850172|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850173|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850174|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850175|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850176|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850177|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850178|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850179|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850180|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105320046|NCT00764881|363169706|FG000|Overall Study|no treatment or no observation|2|||
105320047|NCT00764881|363169707|FG001|Overall Study|no treatment or no observation|2|||
105320048|NCT01214655|363169708|FG000|Part A|Progressive Disease|7|||
105320049|NCT01214655|363169709|FG001|Part A|Progressive Disease|0|||
105320050|NCT01214655|363169710|FG002|Part A|Progressive Disease|0|||
105320051|NCT01214655|363169708|FG000|Part A|Physician Decision|1|||
105320052|NCT01214655|363169709|FG001|Part A|Physician Decision|0|||
105320053|NCT01214655|363169710|FG002|Part A|Physician Decision|0|||
105320054|NCT01214655|363169708|FG000|Part B|Progressive disease|0|||
105320055|NCT01214655|363169709|FG001|Part B|Progressive disease|10|||
105320056|NCT01214655|363169710|FG002|Part B|Progressive disease|0|||
105320057|NCT01214655|363169708|FG000|Part B|Death|0|||
105320058|NCT01214655|363169709|FG001|Part B|Death|1|||
105320059|NCT01214655|363169710|FG002|Part B|Death|0|||
105320060|NCT01214655|363169708|FG000|Part B|Withdrawal by Subject|0|||
105320061|NCT01214655|363169709|FG001|Part B|Withdrawal by Subject|2|||
105320062|NCT01214655|363169710|FG002|Part B|Withdrawal by Subject|0|||
105320063|NCT01214655|363169708|FG000|Part C|Progressive Disease|0|||
105320064|NCT01214655|363169709|FG001|Part C|Progressive Disease|0|||
105320065|NCT01214655|363169710|FG002|Part C|Progressive Disease|5|||
105320066|NCT01214655|363169708|FG000|Part C|Death|0|||
105320067|NCT01214655|363169709|FG001|Part C|Death|0|||
105320068|NCT01214655|363169710|FG002|Part C|Death|1|||
105320069|NCT01214655|363169708|FG000|Part C|Physician Decision|0|||
105320070|NCT01214655|363169709|FG001|Part C|Physician Decision|0|||
105320071|NCT01214655|363169710|FG002|Part C|Physician Decision|1|||
105320072|NCT00113763|363169711|FG000|Overall Study|Adverse Event|5|||
105320073|NCT00113763|363169712|FG001|Overall Study|Adverse Event|2|||
105320074|NCT00113763|363169711|FG000|Overall Study|Disease Progression|28|||
105320075|NCT00113763|363169712|FG001|Overall Study|Disease Progression|14|||
105320076|NCT00113763|363169711|FG000|Overall Study|Lost to Follow-up|10|||
105320077|NCT00113763|363169712|FG001|Overall Study|Lost to Follow-up|0|||
105320078|NCT00113763|363169711|FG000|Overall Study|Withdrawal by Subject|1|||
105320079|NCT00113763|363169712|FG001|Overall Study|Withdrawal by Subject|4|||
105320080|NCT00113763|363169711|FG000|Overall Study|Other|27|||
105320081|NCT00113763|363169712|FG001|Overall Study|Other|6|||
105320082|NCT00113763|363169711|FG000|Overall Study|Non-compliance|1|||
105320083|NCT00113763|363169712|FG001|Overall Study|Non-compliance|0|||
105320084|NCT00113763|363169711|FG000|Overall Study|Ongoing|1|||
105320085|NCT00113763|363169712|FG001|Overall Study|Ongoing|0|||
105320086|NCT00517881|363169713|FG000|Overall Study|Protocol Violation|2|||
105320087|NCT00517881|363169713|FG000|Overall Study|Adverse Event|1|||
105320088|NCT00517881|363169713|FG000|Overall Study|Renal transplantation|2|||
105320089|NCT00886015|363169718|FG000|Overall Study|Death|0|||
105320090|NCT00886015|363169719|FG001|Overall Study|Death|2|||
105320091|NCT01977417|363169721|FG000|Overall Study|Adverse Event|1|||
105320092|NCT01977417|363169722|FG001|Overall Study|Adverse Event|0|||
105320093|NCT01977417|363169721|FG000|Overall Study|Withdrawal by Subject|2|||
105320094|NCT01977417|363169722|FG001|Overall Study|Withdrawal by Subject|4|||
105320095|NCT01977417|363169721|FG000|Overall Study|Female enrollment goal met|0|||
105320096|NCT01977417|363169722|FG001|Overall Study|Female enrollment goal met|2|||
105320097|NCT01692626|363169723|FG000|Overall Study|Death|0|||
105320098|NCT01692626|363169724|FG001|Overall Study|Death|1|||
105320099|NCT01692626|363169723|FG000|Overall Study|Adverse Event|2|||
105320100|NCT01692626|363169724|FG001|Overall Study|Adverse Event|3|||
105320101|NCT01692626|363169723|FG000|Overall Study|Protocol Violation|1|||
105320102|NCT01692626|363169724|FG001|Overall Study|Protocol Violation|2|||
105320103|NCT01692626|363169723|FG000|Overall Study|Withdrawal by Subject|1|||
105320104|NCT01692626|363169724|FG001|Overall Study|Withdrawal by Subject|0|||
105320105|NCT04909853|363169725|FG000|Part 1|Assigned but not treated|0|||
105320106|NCT04909853|363169726|FG001|Part 1|Assigned but not treated|0|||
105320107|NCT04909853|363169727|FG002|Part 1|Assigned but not treated|1|||
105320108|NCT04909853|363169728|FG003|Part 1|Assigned but not treated|0|||
105320109|NCT04909853|363169725|FG000|Part 2|Adverse Event|0|||
105320110|NCT04909853|363169726|FG001|Part 2|Adverse Event|0|||
105320111|NCT04909853|363169727|FG002|Part 2|Adverse Event|0|||
105320112|NCT04909853|363169728|FG003|Part 2|Adverse Event|1|||
105320113|NCT04054765|363169733|FG000|Baseline|Withdrawal by Subject|5|||
105320114|NCT04054765|363169734|FG001|Baseline|Withdrawal by Subject|3|||
105320115|NCT04054765|363169733|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
105320116|NCT04054765|363169734|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
105320117|NCT04054765|363169733|FG000|3-month Follow up|Withdrawal by Subject|0|||
105320118|NCT04054765|363169734|FG001|3-month Follow up|Withdrawal by Subject|3|||
105320119|NCT04054765|363169733|FG000|6-month Follow up|Lost to Follow-up|32|||
105320120|NCT04054765|363169734|FG001|6-month Follow up|Lost to Follow-up|32|||
105320121|NCT00855894|363169735|FG000|Overall Study|Death|31|||
105491015|NCT01982331|363809504|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
105491016|NCT01278160|363809526|FG000|Overall Study|Adverse Event|1|||
105491017|NCT01278160|363809527|FG001|Overall Study|Adverse Event|1|||
105491018|NCT01278160|363809526|FG000|Overall Study|Lost to Follow-up|0|||
105491019|NCT01278160|363809527|FG001|Overall Study|Lost to Follow-up|1|||
105491020|NCT01278160|363809526|FG000|Overall Study|Withdrawal by Subject|3|||
105491021|NCT01278160|363809527|FG001|Overall Study|Withdrawal by Subject|2|||
105491022|NCT01278160|363809526|FG000|Overall Study|Unclassified|1|||
105491023|NCT01278160|363809527|FG001|Overall Study|Unclassified|2|||
105491024|NCT02819518|363809529|FG000|Overall Study|Death|9|||
105491025|NCT02819518|363809530|FG001|Overall Study|Death|12|||
105491026|NCT02819518|363809531|FG002|Overall Study|Death|9|||
105491027|NCT02819518|363809532|FG003|Overall Study|Death|475|||
105491028|NCT02819518|363809533|FG004|Overall Study|Death|244|||
105491029|NCT02819518|363809529|FG000|Overall Study|Withdrawal by Subject|0|||
105491030|NCT02819518|363809530|FG001|Overall Study|Withdrawal by Subject|0|||
105491031|NCT02819518|363809531|FG002|Overall Study|Withdrawal by Subject|0|||
105491032|NCT02819518|363809532|FG003|Overall Study|Withdrawal by Subject|25|||
105491033|NCT02819518|363809533|FG004|Overall Study|Withdrawal by Subject|8|||
105491034|NCT02819518|363809529|FG000|Overall Study|Lost to Follow-up|0|||
105850181|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
105491035|NCT02819518|363809530|FG001|Overall Study|Lost to Follow-up|0|||
105850182|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
105850183|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850184|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850185|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850186|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850187|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105320122|NCT00855894|363169735|FG000|Overall Study|Patient's decision|1|||
105320123|NCT00855894|363169735|FG000|Overall Study|Disease progression|1|||
105320124|NCT02548156|363169738|FG000|Washout Period 1|Lost to Follow-up|0|||
105320125|NCT02548156|363169739|FG001|Washout Period 1|Lost to Follow-up|0|||
105491036|NCT02819518|363809531|FG002|Overall Study|Lost to Follow-up|0|||
105491037|NCT02819518|363809532|FG003|Overall Study|Lost to Follow-up|0|||
105491038|NCT02819518|363809533|FG004|Overall Study|Lost to Follow-up|1|||
105491039|NCT02819518|363809529|FG000|Overall Study|Sponsor Decision|1|||
105491040|NCT02819518|363809530|FG001|Overall Study|Sponsor Decision|1|||
105491041|NCT02819518|363809531|FG002|Overall Study|Sponsor Decision|0|||
105491042|NCT02819518|363809532|FG003|Overall Study|Sponsor Decision|34|||
105491043|NCT02819518|363809533|FG004|Overall Study|Sponsor Decision|17|||
105491044|NCT02819518|363809529|FG000|Overall Study|Transferred to extension study|1|||
105320126|NCT02548156|363169740|FG002|Washout Period 1|Lost to Follow-up|0|||
105320127|NCT02548156|363169741|FG003|Washout Period 1|Lost to Follow-up|0|||
105320128|NCT02548156|363169742|FG004|Washout Period 1|Lost to Follow-up|1|||
105491045|NCT02819518|363809530|FG001|Overall Study|Transferred to extension study|1|||
105491046|NCT02819518|363809531|FG002|Overall Study|Transferred to extension study|1|||
105491047|NCT02819518|363809532|FG003|Overall Study|Transferred to extension study|32|||
105491048|NCT02819518|363809533|FG004|Overall Study|Transferred to extension study|11|||
105491049|NCT00880165|363809534|FG000|Overall Study|Withdrawal by Subject|27|||
105491050|NCT00880165|363809535|FG001|Overall Study|Withdrawal by Subject|23|||
105491051|NCT00880165|363809534|FG000|Overall Study|Not diagnosed with OSA|14|||
105491052|NCT00880165|363809535|FG001|Overall Study|Not diagnosed with OSA|8|||
105491053|NCT00880165|363809534|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
105491054|NCT00880165|363809535|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
105491055|NCT00880165|363809534|FG000|Overall Study|Lost to follow|9|||
105491056|NCT00880165|363809535|FG001|Overall Study|Lost to follow|15|||
105491057|NCT00739596|363809536|FG000|Overall Study|Adverse Event|12|||
105491058|NCT00739596|363809537|FG001|Overall Study|Adverse Event|6|||
105491059|NCT00739596|363809536|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
105491060|NCT00739596|363809537|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105491061|NCT00739596|363809536|FG000|Overall Study|Patient Withdrew Consent|8|||
105491062|NCT00739596|363809537|FG001|Overall Study|Patient Withdrew Consent|8|||
105370485|NCT00433836|363362315|FG000|Overall Study|Lost to Follow-up|3|||
105370486|NCT00433836|363362316|FG001|Overall Study|Lost to Follow-up|0|||
105370487|NCT00433836|363362315|FG000|Overall Study|Withdrawal by Subject|2|||
105370488|NCT00433836|363362316|FG001|Overall Study|Withdrawal by Subject|1|||
105370489|NCT00433836|363362315|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105370490|NCT00433836|363362316|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105370491|NCT00433836|363362315|FG000|Overall Study|Protocol Violation|0|||
105491063|NCT00739596|363809536|FG000|Overall Study|Lost to Follow-up|0|||
105491064|NCT00739596|363809537|FG001|Overall Study|Lost to Follow-up|2|||
105491065|NCT00739596|363809536|FG000|Overall Study|Protocol Deviation|1|||
105491066|NCT00739596|363809537|FG001|Overall Study|Protocol Deviation|1|||
105491067|NCT00908011|363809542|FG000|Overall Study|Withdrawal by Subject|2|||
105491068|NCT00908011|363809543|FG001|Overall Study|Withdrawal by Subject|2|||
105491069|NCT02898116|363809550|FG000|Overall Study|Adverse Event|1|||
105491070|NCT02898116|363809550|FG000|Overall Study|Progressive disease|1|||
105491071|NCT02301988|363809551|FG000|Overall Study|Withdrawal by Subject|2|||
105491072|NCT02301988|363809552|FG001|Overall Study|Withdrawal by Subject|1|||
105491073|NCT02301988|363809551|FG000|Overall Study|Physician Decision|2|||
105370492|NCT00433836|363362316|FG001|Overall Study|Protocol Violation|2|||
105370493|NCT00433836|363362315|FG000|Overall Study|Condition no longer requires study drug|0|||
105370494|NCT00433836|363362316|FG001|Overall Study|Condition no longer requires study drug|1|||
105370495|NCT00433836|363362315|FG000|Overall Study|Abnormal laboratory values|0|||
105370496|NCT00433836|363362316|FG001|Overall Study|Abnormal laboratory values|1|||
105370497|NCT00644059|363362317|FG000|Overall Study|Lost to Follow-up|37|||
105491074|NCT02301988|363809552|FG001|Overall Study|Physician Decision|2|||
105491075|NCT02301988|363809551|FG000|Overall Study|Unknown Reason|1|||
105491076|NCT02301988|363809552|FG001|Overall Study|Unknown Reason|3|||
105491077|NCT02301988|363809551|FG000|Overall Study|Lack of Efficacy|3|||
105491078|NCT02301988|363809552|FG001|Overall Study|Lack of Efficacy|2|||
105491079|NCT02301988|363809551|FG000|Overall Study|Death|1|||
105491080|NCT02301988|363809552|FG001|Overall Study|Death|0|||
105491081|NCT02301988|363809551|FG000|Overall Study|Adverse Event|1|||
105491082|NCT02301988|363809552|FG001|Overall Study|Adverse Event|1|||
105491083|NCT02750943|363809563|FG000|Overall Study|Lost to Follow-up|1|||
105370498|NCT00644059|363362318|FG001|Overall Study|Lost to Follow-up|34|||
105370499|NCT00644059|363362319|FG002|Overall Study|Lost to Follow-up|16|||
105370500|NCT00644059|363362317|FG000|Overall Study|Withdrawal by Subject|52|||
105370501|NCT00644059|363362318|FG001|Overall Study|Withdrawal by Subject|60|||
105491084|NCT02750943|363809564|FG001|Overall Study|Lost to Follow-up|2|||
105491085|NCT02750943|363809563|FG000|Overall Study|Withdrawal by Subject|5|||
105491086|NCT02750943|363809564|FG001|Overall Study|Withdrawal by Subject|7|||
105491087|NCT05169567|363809566|FG000|Overall Study|On study treatment|116|||
105491088|NCT05169567|363809567|FG001|Overall Study|On study treatment|128|||
105491089|NCT05169567|363809566|FG000|Overall Study|Lost to Follow-up|1|||
105491090|NCT05169567|363809567|FG001|Overall Study|Lost to Follow-up|0|||
105491091|NCT05169567|363809566|FG000|Overall Study|Withdrawal by Subject|25|||
105491092|NCT05169567|363809567|FG001|Overall Study|Withdrawal by Subject|21|||
105491093|NCT00089284|363810645|FG000|Overall Study|Adverse event before starting treatment|0|||
105491094|NCT00089284|363810646|FG001|Overall Study|Adverse event before starting treatment|0|||
105491095|NCT00089284|363810647|FG002|Overall Study|Adverse event before starting treatment|0|||
105491096|NCT00089284|363810648|FG003|Overall Study|Adverse event before starting treatment|0|||
105491097|NCT00089284|363810649|FG004|Overall Study|Adverse event before starting treatment|0|||
105491098|NCT00089284|363810650|FG005|Overall Study|Adverse event before starting treatment|0|||
105491099|NCT00089284|363810651|FG006|Overall Study|Adverse event before starting treatment|1|||
105491100|NCT00287079|363810659|FG000|Overall Study|Qualifying relapse|12|||
105491101|NCT00287079|363810660|FG001|Overall Study|Qualifying relapse|1|||
105491102|NCT00287079|363810659|FG000|Overall Study|Non-qualifying relapse|1|||
105491103|NCT00287079|363810660|FG001|Overall Study|Non-qualifying relapse|0|||
105491104|NCT00287079|363810659|FG000|Overall Study|Adverse Event|5|||
105491105|NCT00287079|363810660|FG001|Overall Study|Adverse Event|0|||
105491106|NCT00287079|363810659|FG000|Overall Study|Protocol Violation|1|||
105491107|NCT00287079|363810660|FG001|Overall Study|Protocol Violation|0|||
105491108|NCT00287079|363810659|FG000|Overall Study|Other|3|||
105491109|NCT00287079|363810660|FG001|Overall Study|Other|0|||
105491110|NCT03282565|363810661|FG000|Overall Study|COVID-19 Research Shutdown|0|||
105491111|NCT03282565|363810662|FG001|Overall Study|COVID-19 Research Shutdown|2|||
105491112|NCT03282565|363810663|FG002|Overall Study|COVID-19 Research Shutdown|2|||
105320129|NCT02548156|363169743|FG005|Washout Period 1|Lost to Follow-up|0|||
105320130|NCT00853099|363169748|FG000|Double-blind Period|Adverse Event|7|||
105320131|NCT00853099|363169749|FG001|Double-blind Period|Adverse Event|9|||
105320132|NCT00853099|363169750|FG002|Double-blind Period|Adverse Event|13|||
105320133|NCT00853099|363169751|FG003|Double-blind Period|Adverse Event|0|||
105320134|NCT00853099|363169748|FG000|Double-blind Period|Withdrawal by Subject|2|||
105320135|NCT00853099|363169749|FG001|Double-blind Period|Withdrawal by Subject|3|||
105320136|NCT00853099|363169750|FG002|Double-blind Period|Withdrawal by Subject|0|||
105320137|NCT00853099|363169751|FG003|Double-blind Period|Withdrawal by Subject|0|||
105320138|NCT00853099|363169748|FG000|Double-blind Period|Lack of Efficacy|14|||
105320139|NCT00853099|363169749|FG001|Double-blind Period|Lack of Efficacy|17|||
105320140|NCT00853099|363169750|FG002|Double-blind Period|Lack of Efficacy|16|||
105320141|NCT00853099|363169751|FG003|Double-blind Period|Lack of Efficacy|0|||
105320142|NCT00853099|363169748|FG000|Double-blind Period|Other|0|||
105320143|NCT00853099|363169749|FG001|Double-blind Period|Other|0|||
105320144|NCT00853099|363169750|FG002|Double-blind Period|Other|1|||
105320145|NCT00853099|363169751|FG003|Double-blind Period|Other|0|||
105320146|NCT00853099|363169748|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
105320147|NCT00853099|363169749|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
105320148|NCT00853099|363169750|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
105320149|NCT00853099|363169751|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
105320150|NCT00853099|363169748|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
105320151|NCT00853099|363169749|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
105320152|NCT00853099|363169750|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
105320153|NCT00853099|363169751|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
105320154|NCT00853099|363169748|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
105320155|NCT00853099|363169749|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
105320156|NCT00853099|363169750|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
105320157|NCT00853099|363169751|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
105320158|NCT00853099|363169748|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
105320159|NCT00853099|363169749|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
105320160|NCT00853099|363169750|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
105320161|NCT00853099|363169751|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
105320162|NCT00853099|363169748|FG000|Double-blind + Open-label Periods|Other|0|||
105320163|NCT00853099|363169749|FG001|Double-blind + Open-label Periods|Other|0|||
105320164|NCT00853099|363169750|FG002|Double-blind + Open-label Periods|Other|0|||
105320165|NCT00853099|363169751|FG003|Double-blind + Open-label Periods|Other|6|||
105320166|NCT02121652|363169754|FG000|Overall Study|Lost to Follow-up|2|||
105320167|NCT02121652|363169755|FG001|Overall Study|Lost to Follow-up|1|||
105320168|NCT02121652|363169754|FG000|Overall Study|Death|1|||
105320169|NCT02121652|363169755|FG001|Overall Study|Death|0|||
105320170|NCT02121652|363169754|FG000|Overall Study|Withdrawal by Subject|3|||
105320171|NCT02121652|363169755|FG001|Overall Study|Withdrawal by Subject|3|||
105320172|NCT01811472|363169759|FG000|Overall Study|Adverse Event|1|||
105320173|NCT01811472|363169760|FG001|Overall Study|Adverse Event|0|||
105320174|NCT01811472|363169761|FG002|Overall Study|Adverse Event|4|||
105320175|NCT01811472|363169759|FG000|Overall Study|Lost to Follow-up|0|||
105320176|NCT01811472|363169760|FG001|Overall Study|Lost to Follow-up|0|||
105320177|NCT01811472|363169761|FG002|Overall Study|Lost to Follow-up|1|||
105320178|NCT01811472|363169759|FG000|Overall Study|Subject/guardian decision|1|||
105320179|NCT01811472|363169760|FG001|Overall Study|Subject/guardian decision|0|||
105320180|NCT01811472|363169761|FG002|Overall Study|Subject/guardian decision|0|||
105491113|NCT01134315|363810664|FG000|Overall Study|Adverse Event|1|||
105491114|NCT01134315|363810665|FG001|Overall Study|Adverse Event|2|||
105491115|NCT01134315|363810664|FG000|Overall Study|Other Reason|8|||
105491116|NCT01134315|363810665|FG001|Overall Study|Other Reason|17|||
105491117|NCT03960554|363810667|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
105576782|NCT02138747|364110325|FG001|Treatment Period 1|Lost to Follow-up|1|||
105576783|NCT02138747|364110326|FG002|Treatment Period 1|Lost to Follow-up|1|||
105320181|NCT03288714|363169764|FG000|Overall Study|Lost to Follow-up|2|||
105320182|NCT03288714|363169765|FG001|Overall Study|Lost to Follow-up|1|||
105320183|NCT03288714|363169764|FG000|Overall Study|Non-compliance with study schedule|2|||
105320184|NCT03288714|363169765|FG001|Overall Study|Non-compliance with study schedule|0|||
105320185|NCT03288714|363169764|FG000|Overall Study|Withdrawal by Subject|3|||
105320186|NCT03288714|363169765|FG001|Overall Study|Withdrawal by Subject|1|||
105320187|NCT03288714|363169764|FG000|Overall Study|Clinical Worsening|2|||
105491118|NCT03960554|363810668|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
105320188|NCT03288714|363169765|FG001|Overall Study|Clinical Worsening|1|||
105320189|NCT03288714|363169764|FG000|Overall Study|Adverse Event|1|||
105320190|NCT03288714|363169765|FG001|Overall Study|Adverse Event|0|||
105320191|NCT01023035|363169766|FG000|Treatment Period|Adverse Event|27|||
105320192|NCT01023035|363169767|FG001|Treatment Period|Adverse Event|32|||
105320193|NCT01023035|363169768|FG002|Treatment Period|Adverse Event|50|||
105320194|NCT01023035|363169766|FG000|Treatment Period|Non-Medical Reasons|19|||
105320195|NCT01023035|363169767|FG001|Treatment Period|Non-Medical Reasons|22|||
105320196|NCT01023035|363169768|FG002|Treatment Period|Non-Medical Reasons|44|||
105320197|NCT01023035|363169766|FG000|Treatment Period|Treatment Failure|26|||
105320198|NCT01023035|363169767|FG001|Treatment Period|Treatment Failure|31|||
105320199|NCT01023035|363169768|FG002|Treatment Period|Treatment Failure|24|||
105320200|NCT01023035|363169766|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
105320201|NCT01023035|363169767|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
105320202|NCT01023035|363169768|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
105370502|NCT00644059|363362319|FG002|Overall Study|Withdrawal by Subject|30|||
105370503|NCT00644059|363362317|FG000|Overall Study|Adverse Event|8|||
105370504|NCT00644059|363362318|FG001|Overall Study|Adverse Event|5|||
105370505|NCT00644059|363362319|FG002|Overall Study|Adverse Event|1|||
105370506|NCT00644059|363362317|FG000|Overall Study|Inappropriate Enrollment|1|||
105370507|NCT00644059|363362318|FG001|Overall Study|Inappropriate Enrollment|3|||
105370508|NCT00644059|363362319|FG002|Overall Study|Inappropriate Enrollment|0|||
105370509|NCT00644059|363362317|FG000|Overall Study|Protocol Deviation/violation|20|||
105370510|NCT00644059|363362318|FG001|Overall Study|Protocol Deviation/violation|19|||
105370511|NCT00644059|363362319|FG002|Overall Study|Protocol Deviation/violation|15|||
105370512|NCT00644059|363362317|FG000|Overall Study|Unable to classify|6|||
105370513|NCT00644059|363362318|FG001|Overall Study|Unable to classify|2|||
105370514|NCT00644059|363362319|FG002|Overall Study|Unable to classify|3|||
105370515|NCT02834975|363362324|FG000|Overall Study|Physician Decision|2|||
105370516|NCT02834975|363362324|FG000|Overall Study|Adverse Event|1|||
105370517|NCT02834975|363362324|FG000|Overall Study|Withdrawal by Subject|1|||
105370518|NCT02834975|363362324|FG000|Overall Study|Lack of Efficacy|1|||
105370519|NCT02662569|363362326|FG000|Overall Study|Withdrawal by Subject|6|||
105370520|NCT02662569|363362327|FG001|Overall Study|Withdrawal by Subject|1|||
105370521|NCT02662569|363362328|FG002|Overall Study|Withdrawal by Subject|6|||
105370522|NCT02662569|363362329|FG003|Overall Study|Withdrawal by Subject|4|||
105370523|NCT02662569|363362326|FG000|Overall Study|Lost to Follow-up|1|||
105370524|NCT02662569|363362327|FG001|Overall Study|Lost to Follow-up|0|||
105370525|NCT02662569|363362328|FG002|Overall Study|Lost to Follow-up|0|||
105370526|NCT02662569|363362329|FG003|Overall Study|Lost to Follow-up|0|||
105370527|NCT02378662|363362330|FG000|Overall Study|Early Discontinuation|2|||
105370528|NCT02378662|363362331|FG001|Overall Study|Early Discontinuation|0|||
105370529|NCT01774591|363362334|FG000|Overall Study|Physician Decision|1|||
105370530|NCT01774591|363362335|FG001|Overall Study|Physician Decision|1|||
105370531|NCT01774591|363362334|FG000|Overall Study|Withdrawal by Subject|0|||
105370532|NCT01774591|363362335|FG001|Overall Study|Withdrawal by Subject|1|||
105370533|NCT01774591|363362334|FG000|Overall Study|Adverse Event|0|||
105370534|NCT01774591|363362335|FG001|Overall Study|Adverse Event|2|||
105370535|NCT01924533|363362336|FG000|Overall Study|Death|181|||
105370536|NCT01924533|363362337|FG001|Overall Study|Death|200|||
105370537|NCT01924533|363362336|FG000|Overall Study|Lost to Follow-up|0|||
105370538|NCT01924533|363362337|FG001|Overall Study|Lost to Follow-up|1|||
105370539|NCT01924533|363362336|FG000|Overall Study|Withdrawal by Subject|7|||
105370540|NCT01924533|363362337|FG001|Overall Study|Withdrawal by Subject|3|||
105370541|NCT01924533|363362336|FG000|Overall Study|Other Eligibility criteria|1|||
105370542|NCT01924533|363362337|FG001|Overall Study|Other Eligibility criteria|1|||
105370543|NCT04275336|363362340|FG000|Overall Study|First venipuncture failed|4|||
105370544|NCT04275336|363362341|FG001|Overall Study|First venipuncture failed|6|||
105370545|NCT04275336|363362342|FG002|Overall Study|First venipuncture failed|5|||
105370546|NCT04275336|363362340|FG000|Overall Study|Unscheduled venipuncture|9|||
105370547|NCT04275336|363362341|FG001|Overall Study|Unscheduled venipuncture|13|||
105320203|NCT01023035|363169766|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
105370548|NCT04275336|363362342|FG002|Overall Study|Unscheduled venipuncture|7|||
105370549|NCT04275336|363362340|FG000|Overall Study|Failed specimen of saliva|4|||
105370550|NCT04275336|363362341|FG001|Overall Study|Failed specimen of saliva|3|||
105370551|NCT04275336|363362342|FG002|Overall Study|Failed specimen of saliva|4|||
105370552|NCT03444584|363362347|FG000|Overall Study|Withdrawal by Subject|0|||
105370553|NCT03444584|363362348|FG001|Overall Study|Withdrawal by Subject|1|||
105370554|NCT03444584|363362347|FG000|Overall Study|Other|0|||
105320204|NCT01023035|363169767|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
105320205|NCT01023035|363169768|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
105850188|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105320206|NCT03280264|363169769|FG000|Overall Study|Adverse Event|1|||
105320207|NCT03280264|363169769|FG000|Overall Study|Physician Decision|1|||
105370555|NCT03444584|363362348|FG001|Overall Study|Other|1|||
105370556|NCT00423046|363362351|FG000|Overall Study|Other|340|||
105370557|NCT00423046|363362352|FG001|Overall Study|Other|345|||
105320208|NCT03280264|363169769|FG000|Overall Study|Withdrawal by Subject|1|||
105320209|NCT01153425|363169772|FG000|Overall Study|Withdrawal by Subject|3|||
105320210|NCT01153425|363169773|FG001|Overall Study|Withdrawal by Subject|3|||
105320211|NCT00970593|363169776|FG000|Overall Study|Adverse Event|1|||
105320212|NCT00970593|363169777|FG001|Overall Study|Adverse Event|1|||
105320213|NCT00970593|363169778|FG002|Overall Study|Adverse Event|0|||
105320214|NCT00970593|363169779|FG003|Overall Study|Adverse Event|0|||
105320215|NCT00970593|363169780|FG004|Overall Study|Adverse Event|0|||
105320216|NCT00970593|363169781|FG005|Overall Study|Adverse Event|0|||
105320217|NCT00970593|363169782|FG006|Overall Study|Adverse Event|0|||
105320218|NCT00970593|363169776|FG000|Overall Study|Discontinuation of study by sponsor|0|||
105320219|NCT00970593|363169777|FG001|Overall Study|Discontinuation of study by sponsor|0|||
105320220|NCT00970593|363169778|FG002|Overall Study|Discontinuation of study by sponsor|5|||
105320221|NCT00970593|363169779|FG003|Overall Study|Discontinuation of study by sponsor|0|||
105320222|NCT00970593|363169780|FG004|Overall Study|Discontinuation of study by sponsor|0|||
105320223|NCT00970593|363169781|FG005|Overall Study|Discontinuation of study by sponsor|0|||
105320224|NCT00970593|363169782|FG006|Overall Study|Discontinuation of study by sponsor|2|||
105320225|NCT00970593|363169776|FG000|Overall Study|Withdrawal by Subject|0|||
105320226|NCT00970593|363169777|FG001|Overall Study|Withdrawal by Subject|0|||
105320227|NCT00970593|363169778|FG002|Overall Study|Withdrawal by Subject|1|||
105320228|NCT00970593|363169779|FG003|Overall Study|Withdrawal by Subject|0|||
105320229|NCT00970593|363169780|FG004|Overall Study|Withdrawal by Subject|0|||
105320230|NCT00970593|363169781|FG005|Overall Study|Withdrawal by Subject|0|||
105320231|NCT00970593|363169782|FG006|Overall Study|Withdrawal by Subject|0|||
105320232|NCT03594071|363169783|FG000|Overall Study|Re-operation|3|||
105320233|NCT03594071|363169783|FG000|Overall Study|Missed visit|2|||
105320234|NCT02009722|363169790|FG000|Overall Study|Protocol Violation|1|||
105320235|NCT02009722|363169791|FG001|Overall Study|Protocol Violation|2|||
105320236|NCT02009722|363169790|FG000|Overall Study|Did not receive intervention|0|||
105320237|NCT02009722|363169791|FG001|Overall Study|Did not receive intervention|1|||
105320238|NCT03022370|363169792|FG000|Overall Study|Death|6|||
105320239|NCT03022370|363169793|FG001|Overall Study|Death|12|||
105320240|NCT03022370|363169792|FG000|Overall Study|Lost to Follow-up|174|||
105320241|NCT03022370|363169793|FG001|Overall Study|Lost to Follow-up|109|||
105320242|NCT00668317|363169794|FG000|Overall Study|Adverse Event|2|||
105320243|NCT00699816|363169799|FG000|Overall Study|Protocol Violation|1|||
105320244|NCT00699816|363169800|FG001|Overall Study|Protocol Violation|3|||
105320245|NCT02454933|363169803|FG000|Overall Study|Progressive disease|10|||
105320246|NCT02454933|363169804|FG001|Overall Study|Progressive disease|7|||
105320247|NCT02454933|363169803|FG000|Overall Study|Adverse Event|1|||
105320248|NCT02454933|363169804|FG001|Overall Study|Adverse Event|1|||
105320249|NCT02454933|363169803|FG000|Overall Study|Withdrawal by Subject|0|||
105320250|NCT02454933|363169804|FG001|Overall Study|Withdrawal by Subject|3|||
105320251|NCT02454933|363169803|FG000|Overall Study|Lost to Follow-up|1|||
105320252|NCT02454933|363169804|FG001|Overall Study|Lost to Follow-up|0|||
105320253|NCT02790437|363169810|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
105320254|NCT02790437|363169811|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
105320255|NCT02790437|363169810|FG000|Overall Study|Adverse Event|1|||
105320256|NCT02790437|363169811|FG001|Overall Study|Adverse Event|0|||
105320257|NCT02790437|363169810|FG000|Overall Study|Withdrawal by Subject|1|||
105320258|NCT02790437|363169811|FG001|Overall Study|Withdrawal by Subject|0|||
105320259|NCT01308424|363169827|FG000|Baseline Eligibility|Screen Failures|71|||
105320260|NCT01308424|363169828|FG001|Baseline Eligibility|Screen Failures|0|||
105320261|NCT01308424|363169829|FG002|Baseline Eligibility|Screen Failures|0|||
105320262|NCT01308424|363169827|FG000|Randomization|Adverse Event|0|||
105320263|NCT01308424|363169828|FG001|Randomization|Adverse Event|1|||
105320264|NCT01308424|363169829|FG002|Randomization|Adverse Event|1|||
105320265|NCT01308424|363169827|FG000|Randomization|Lost to Follow-up|0|||
105320266|NCT01308424|363169828|FG001|Randomization|Lost to Follow-up|1|||
105320267|NCT01308424|363169829|FG002|Randomization|Lost to Follow-up|0|||
105320268|NCT01308424|363169827|FG000|Randomization|Physician Decision|0|||
105320269|NCT01308424|363169828|FG001|Randomization|Physician Decision|1|||
105320270|NCT01308424|363169829|FG002|Randomization|Physician Decision|1|||
105320271|NCT00104572|363169833|FG000|Overall Study|Withdrawal by Subject|3|||
105320272|NCT00104572|363169834|FG001|Overall Study|Withdrawal by Subject|3|||
105320273|NCT00104572|363169835|FG002|Overall Study|Withdrawal by Subject|0|||
105320274|NCT02324582|363169836|FG000|Overall Study|Screen Failures|0|||
105320275|NCT02324582|363169837|FG001|Overall Study|Screen Failures|5|||
105320276|NCT02289729|363169840|FG000|Overall Study|Lack of Efficacy|3|||
105320277|NCT02289729|363169840|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
105320278|NCT02289729|363169840|FG000|Overall Study|Withdrawal by Subject|1|||
105320279|NCT02289729|363169840|FG000|Overall Study|Death|1|||
105320280|NCT02070965|363172110|FG000|Overall Study|Lost to Follow-up|0|||
105320281|NCT02070965|363172111|FG001|Overall Study|Lost to Follow-up|1|||
105320282|NCT02070965|363172112|FG002|Overall Study|Lost to Follow-up|0|||
105320283|NCT02070965|363172110|FG000|Overall Study|Withdrawal by Subject|1|||
105320284|NCT02070965|363172111|FG001|Overall Study|Withdrawal by Subject|1|||
105320285|NCT02070965|363172112|FG002|Overall Study|Withdrawal by Subject|1|||
105370558|NCT05401565|363362353|FG000|Overall Study|Lost to Follow-up|1|||
105370559|NCT05401565|363362354|FG001|Overall Study|Lost to Follow-up|0|||
105370560|NCT05401565|363362353|FG000|Overall Study|Adverse Event|2|||
105370561|NCT05401565|363362354|FG001|Overall Study|Adverse Event|0|||
105370562|NCT00846053|363362359|FG000|Overall Study|Physician Decision|3|||
105370563|NCT00846053|363362360|FG001|Overall Study|Physician Decision|0|||
105370564|NCT00111761|363362363|FG000|Part 1|Physician Decision|0|||
105370565|NCT00111761|363362364|FG001|Part 1|Physician Decision|1|||
105370566|NCT00111761|363362363|FG000|Part 1|Death|0|||
105370567|NCT00111761|363362364|FG001|Part 1|Death|2|||
105370568|NCT00111761|363362363|FG000|Part 1|Other|0|||
105370569|NCT00111761|363362364|FG001|Part 1|Other|1|||
105370570|NCT00111761|363362363|FG000|Part 1|Withdrawal by Subject|0|||
105370571|NCT00111761|363362364|FG001|Part 1|Withdrawal by Subject|1|||
105370572|NCT00111761|363362363|FG000|Part 2|Adverse Event|1|||
105370573|NCT00111761|363362364|FG001|Part 2|Adverse Event|0|||
105370574|NCT00111761|363362363|FG000|Part 2|Physician Decision|1|||
105370575|NCT00111761|363362364|FG001|Part 2|Physician Decision|0|||
105370576|NCT00111761|363362363|FG000|Part 2|Death|1|||
105370577|NCT00111761|363362364|FG001|Part 2|Death|0|||
105370578|NCT00111761|363362363|FG000|Part 2|Disease progression|3|||
105370579|NCT00111761|363362364|FG001|Part 2|Disease progression|0|||
105370580|NCT00111761|363362363|FG000|Part 2|Protocol-specified criteria|1|||
105370581|NCT00111761|363362364|FG001|Part 2|Protocol-specified criteria|0|||
105370582|NCT00111761|363362363|FG000|Part 2|Other|1|||
105370583|NCT00111761|363362364|FG001|Part 2|Other|0|||
105370584|NCT00726609|363362365|FG000|Overall Study|Adverse Event|10|||
105370585|NCT00726609|363362365|FG000|Overall Study|Withdrawal by Subject|2|||
105370586|NCT00726609|363362365|FG000|Overall Study|Lack of Efficacy|25|||
105370587|NCT00726609|363362365|FG000|Overall Study|Other|16|||
105370588|NCT00726609|363362365|FG000|Overall Study|Missing|42|||
105370589|NCT00726609|363362365|FG000|Overall Study|Other|3|||
105370590|NCT00746551|363362366|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
105370591|NCT00746551|363362367|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
105370592|NCT00746551|363362366|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
105370593|NCT00746551|363362367|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
105370594|NCT00746551|363362366|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
105370595|NCT00746551|363362367|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
105370596|NCT02783911|363362368|FG000|Overall Study|Lost to Follow-up|3|||
105370597|NCT02783911|363362369|FG001|Overall Study|Lost to Follow-up|32|||
105370598|NCT00071981|363362370|FG000|Overall Study|Lack of Efficacy|37|||
105370599|NCT00071981|363362371|FG001|Overall Study|Lack of Efficacy|29|||
105370600|NCT00071981|363362372|FG002|Overall Study|Lack of Efficacy|30|||
105370601|NCT00071981|363362373|FG003|Overall Study|Lack of Efficacy|43|||
105370602|NCT00071981|363362370|FG000|Overall Study|Adverse Event|4|||
105370603|NCT00071981|363362371|FG001|Overall Study|Adverse Event|4|||
105491119|NCT01810432|363810671|FG000|Washout|Protocol Violation|0|||
105491120|NCT01810432|363810672|FG001|Washout|Protocol Violation|1|||
105491121|NCT01810432|363810671|FG000|Washout|Adverse Event|1|||
105491122|NCT01810432|363810672|FG001|Washout|Adverse Event|0|||
105491123|NCT01810432|363810671|FG000|Period 2|Withdrawal by Subject|2|||
105491124|NCT01810432|363810672|FG001|Period 2|Withdrawal by Subject|1|||
105491125|NCT01810432|363810671|FG000|Period 2|Physician Decision|1|||
105491126|NCT01810432|363810672|FG001|Period 2|Physician Decision|0|||
105491127|NCT01810432|363810671|FG000|Period 2|Lost to Follow-up|1|||
105491128|NCT01810432|363810672|FG001|Period 2|Lost to Follow-up|1|||
105491129|NCT02360111|363810673|FG000|Overall Study|Death|2|||
105491130|NCT01933217|363810676|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
105491131|NCT01933217|363810677|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
105491132|NCT01933217|363810676|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
105491133|NCT01933217|363810677|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
105491134|NCT03923738|363810680|FG000|Period 1|Adverse Event|1|||
105491135|NCT03923738|363810680|FG000|Period 1|Withdrawal by Subject|1|||
105491136|NCT03583164|363810682|FG000|Overall Study|Death in Main Phase|35|||
105491137|NCT03583164|363810682|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
105491138|NCT03583164|363810682|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
105491139|NCT03583164|363810682|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
105491140|NCT03583164|363810682|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
105491141|NCT03583164|363810682|FG000|Overall Study|Physician decision in Main Phase|1|||
105491142|NCT03583164|363810682|FG000|Overall Study|Physician decision in Extended Phase|2|||
105491143|NCT03583164|363810682|FG000|Overall Study|Death in Extended Phase|13|||
105491144|NCT03583164|363810682|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
105491145|NCT03583164|363810682|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
105491146|NCT03583164|363810682|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
105491147|NCT03583164|363810682|FG000|Overall Study|Treatment failure in Main Phase|2|||
105491148|NCT03583164|363810682|FG000|Overall Study|Treatment failure in Extended Phase|4|||
105370604|NCT00071981|363362372|FG002|Overall Study|Adverse Event|3|||
105370605|NCT00071981|363362373|FG003|Overall Study|Adverse Event|1|||
105370606|NCT00071981|363362370|FG000|Overall Study|Death|0|||
105491149|NCT03583164|363810682|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
105491150|NCT03583164|363810682|FG000|Overall Study|Other not specified reason in Main Phase|2|||
105491151|NCT02943460|363810686|FG000|Blinded Study Phase|Adverse Event|3|||
105370607|NCT00071981|363362371|FG001|Overall Study|Death|0|||
105370608|NCT00071981|363362372|FG002|Overall Study|Death|1|||
105370609|NCT00071981|363362373|FG003|Overall Study|Death|1|||
105370610|NCT00071981|363362370|FG000|Overall Study|Withdrawal by Subject|3|||
105370611|NCT00071981|363362371|FG001|Overall Study|Withdrawal by Subject|1|||
105370612|NCT00071981|363362372|FG002|Overall Study|Withdrawal by Subject|0|||
105370613|NCT00071981|363362373|FG003|Overall Study|Withdrawal by Subject|0|||
105370614|NCT00071981|363362370|FG000|Overall Study|No protocol therapy|2|||
105370615|NCT00071981|363362371|FG001|Overall Study|No protocol therapy|5|||
105370616|NCT00071981|363362372|FG002|Overall Study|No protocol therapy|1|||
105370617|NCT00071981|363362373|FG003|Overall Study|No protocol therapy|0|||
105370618|NCT00071981|363362370|FG000|Overall Study|others (not specified in the study)|0|||
105370619|NCT00071981|363362371|FG001|Overall Study|others (not specified in the study)|2|||
105370620|NCT00071981|363362372|FG002|Overall Study|others (not specified in the study)|2|||
105370621|NCT00071981|363362373|FG003|Overall Study|others (not specified in the study)|0|||
105370622|NCT01123655|363362378|FG000|Overall Study|Medication for RA had to be changed|1|||
105370623|NCT01123655|363362379|FG001|Overall Study|Medication for RA had to be changed|0|||
105370624|NCT01123655|363362380|FG002|Overall Study|Medication for RA had to be changed|0|||
105370625|NCT01123655|363362378|FG000|Overall Study|new illness|0|||
105370626|NCT01123655|363362379|FG001|Overall Study|new illness|1|||
105370627|NCT01123655|363362380|FG002|Overall Study|new illness|0|||
105370628|NCT01123655|363362378|FG000|Overall Study|began prohibitive drug|0|||
105370629|NCT01123655|363362379|FG001|Overall Study|began prohibitive drug|0|||
105370630|NCT01123655|363362380|FG002|Overall Study|began prohibitive drug|1|||
105370631|NCT03608826|363362383|FG000|Overall Study|Death|3|||
105370632|NCT03608826|363362383|FG000|Overall Study|Heart Transplant|3|||
105370633|NCT03608826|363362383|FG000|Overall Study|Physician Decision|4|||
105370634|NCT04609514|363362392|FG000|Overall Study|Lost to Follow-up|5|||
105370635|NCT04609514|363362393|FG001|Overall Study|Lost to Follow-up|4|||
105370636|NCT04609514|363362392|FG000|Overall Study|Withdrawal by PI|0|||
105370637|NCT04609514|363362393|FG001|Overall Study|Withdrawal by PI|2|||
105370638|NCT01677741|363362404|FG000|Overall Study|Death|0|||
105370639|NCT01677741|363362405|FG001|Overall Study|Death|0|||
105370640|NCT01677741|363362406|FG002|Overall Study|Death|0|||
105370641|NCT01677741|363362407|FG003|Overall Study|Death|1|||
105370642|NCT01677741|363362408|FG004|Overall Study|Death|0|||
105370643|NCT01677741|363362409|FG005|Overall Study|Death|1|||
105370644|NCT01677741|363362410|FG006|Overall Study|Death|0|||
105370645|NCT01677741|363362411|FG007|Overall Study|Death|0|||
105370646|NCT01677741|363362404|FG000|Overall Study|Withdrawal by Subject|2|||
105370647|NCT01677741|363362405|FG001|Overall Study|Withdrawal by Subject|7|||
105370648|NCT01677741|363362406|FG002|Overall Study|Withdrawal by Subject|5|||
105370649|NCT01677741|363362407|FG003|Overall Study|Withdrawal by Subject|4|||
105370650|NCT01677741|363362408|FG004|Overall Study|Withdrawal by Subject|11|||
105370651|NCT01677741|363362409|FG005|Overall Study|Withdrawal by Subject|20|||
105370652|NCT01677741|363362410|FG006|Overall Study|Withdrawal by Subject|4|||
105370653|NCT01677741|363362411|FG007|Overall Study|Withdrawal by Subject|2|||
105370654|NCT01677741|363362404|FG000|Overall Study|Enrolled in a rollover study|0|||
105370655|NCT01677741|363362405|FG001|Overall Study|Enrolled in a rollover study|3|||
105370656|NCT01677741|363362406|FG002|Overall Study|Enrolled in a rollover study|2|||
105370657|NCT01677741|363362407|FG003|Overall Study|Enrolled in a rollover study|1|||
105370658|NCT01677741|363362408|FG004|Overall Study|Enrolled in a rollover study|6|||
105370659|NCT01677741|363362409|FG005|Overall Study|Enrolled in a rollover study|6|||
105370660|NCT01677741|363362410|FG006|Overall Study|Enrolled in a rollover study|7|||
105370661|NCT01677741|363362411|FG007|Overall Study|Enrolled in a rollover study|0|||
105370662|NCT01677741|363362404|FG000|Overall Study|Progressive disease|1|||
105491152|NCT02943460|363810687|FG001|Blinded Study Phase|Adverse Event|0|||
105491153|NCT02943460|363810688|FG002|Blinded Study Phase|Adverse Event|0|||
105491154|NCT02943460|363810686|FG000|Blinded Study Phase|Withdrew Consent|0|||
105370663|NCT01677741|363362405|FG001|Overall Study|Progressive disease|0|||
105370664|NCT01677741|363362406|FG002|Overall Study|Progressive disease|1|||
105370665|NCT01677741|363362407|FG003|Overall Study|Progressive disease|0|||
105370666|NCT01677741|363362408|FG004|Overall Study|Progressive disease|0|||
105370667|NCT01677741|363362409|FG005|Overall Study|Progressive disease|1|||
105370668|NCT01677741|363362410|FG006|Overall Study|Progressive disease|0|||
105370669|NCT01677741|363362411|FG007|Overall Study|Progressive disease|0|||
105370670|NCT00720499|363362412|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
105370671|NCT00720499|363362413|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
105370672|NCT00720499|363362412|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
105370673|NCT00720499|363362413|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
105370674|NCT00720499|363362412|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
105370675|NCT00720499|363362413|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
105370676|NCT01326871|363362415|FG000|Overall Study|Major surgery|0|||
105370677|NCT01326871|363362416|FG001|Overall Study|Major surgery|1|||
105320286|NCT02070965|363172110|FG000|Overall Study|Subject moved|1|||
105320287|NCT02070965|363172111|FG001|Overall Study|Subject moved|0|||
105320288|NCT02070965|363172112|FG002|Overall Study|Subject moved|0|||
105320289|NCT00280735|363172113|FG000|Overall Study|Adverse Event|5|||
105320290|NCT00280735|363172113|FG000|Overall Study|Lack of Efficacy|3|||
105320291|NCT00280735|363172113|FG000|Overall Study|Withdrawal by Subject|8|||
105320292|NCT00280735|363172113|FG000|Overall Study|Intercurrent Illness|2|||
105320293|NCT04753216|363172114|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
105320294|NCT04753216|363172114|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
105320295|NCT04753216|363172114|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
105320296|NCT02001987|363172116|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
105320297|NCT02001987|363172116|FG000|Core Study Period (24 Weeks)|Death|1|||
105320298|NCT02001987|363172116|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
105320299|NCT02001987|363172116|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
105320300|NCT02001987|363172116|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
105320301|NCT02001987|363172116|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
105320302|NCT02001987|363172116|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
105320303|NCT02001987|363172116|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
105320304|NCT02001987|363172116|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
105320305|NCT02001987|363172116|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
105320306|NCT02001987|363172116|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
105320307|NCT02001987|363172116|FG000|LTE Period (52 Weeks)|Other|3|||
105320308|NCT01965860|363172117|FG000|Overall Study|Pregnancy|1|||
105320309|NCT01965860|363172118|FG001|Overall Study|Pregnancy|0|||
105320310|NCT01965860|363172119|FG002|Overall Study|Pregnancy|1|||
105320311|NCT01965860|363172117|FG000|Overall Study|Logistics|1|||
105320312|NCT01965860|363172118|FG001|Overall Study|Logistics|0|||
105320313|NCT01965860|363172119|FG002|Overall Study|Logistics|0|||
105320314|NCT01895777|363172120|FG000|Overall Study|Adverse Event|1|||
105320315|NCT01895777|363172121|FG001|Overall Study|Adverse Event|2|||
105320316|NCT01895777|363172120|FG000|Overall Study|Lost to Follow-up|2|||
105320317|NCT01895777|363172121|FG001|Overall Study|Lost to Follow-up|0|||
105320318|NCT01895777|363172120|FG000|Overall Study|Not treated|1|||
105320319|NCT01895777|363172121|FG001|Overall Study|Not treated|0|||
105320320|NCT01895777|363172120|FG000|Overall Study|Other reasons|3|||
105320321|NCT01895777|363172121|FG001|Overall Study|Other reasons|2|||
105320322|NCT01895777|363172120|FG000|Overall Study|Non-compliance with the CTP|2|||
105320323|NCT01895777|363172121|FG001|Overall Study|Non-compliance with the CTP|1|||
105320324|NCT02064296|363172128|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
105320325|NCT02064296|363172129|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
105320326|NCT02064296|363172130|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
105320327|NCT02064296|363172128|FG000|Intervention|Withdrawal by Subject|0|||
105320328|NCT02064296|363172129|FG001|Intervention|Withdrawal by Subject|1|||
105320329|NCT02064296|363172130|FG002|Intervention|Withdrawal by Subject|2|||
105320330|NCT01202175|363172137|FG000|Overall Study|Lost to Follow-up|2|||
105320331|NCT01202175|363172137|FG000|Overall Study|Withdrawal by Subject|1|||
105320332|NCT01202175|363172137|FG000|Overall Study|Adverse Event|2|||
105320333|NCT04720053|363172139|FG000|Overall Study|Lost to Follow-up|12|||
105320334|NCT03908125|363172140|FG000|Overall Study|Withdrawal by Subject|92|||
105320335|NCT03908125|363172140|FG000|Overall Study|Lost to Follow-up|8|||
105320336|NCT02815995|363172141|FG000|Overall Study|Disease Progression|3|||
105320337|NCT02815995|363172142|FG001|Overall Study|Disease Progression|7|||
105320338|NCT02815995|363172143|FG002|Overall Study|Disease Progression|2|||
105320339|NCT02815995|363172144|FG003|Overall Study|Disease Progression|4|||
105320340|NCT02815995|363172145|FG004|Overall Study|Disease Progression|3|||
105320341|NCT02815995|363172146|FG005|Overall Study|Disease Progression|9|||
105320342|NCT02815995|363172147|FG006|Overall Study|Disease Progression|3|||
105320343|NCT02815995|363172148|FG007|Overall Study|Disease Progression|1|||
105320344|NCT02815995|363172141|FG000|Overall Study|Adverse Event|1|||
105320345|NCT02815995|363172142|FG001|Overall Study|Adverse Event|2|||
105320346|NCT02815995|363172143|FG002|Overall Study|Adverse Event|2|||
105320347|NCT02815995|363172144|FG003|Overall Study|Adverse Event|0|||
105320348|NCT02815995|363172145|FG004|Overall Study|Adverse Event|0|||
105320349|NCT02815995|363172146|FG005|Overall Study|Adverse Event|1|||
105320350|NCT02815995|363172147|FG006|Overall Study|Adverse Event|0|||
105320351|NCT02815995|363172148|FG007|Overall Study|Adverse Event|0|||
105320352|NCT02815995|363172141|FG000|Overall Study|Pregnancy|0|||
105320353|NCT02815995|363172142|FG001|Overall Study|Pregnancy|0|||
105320354|NCT02815995|363172143|FG002|Overall Study|Pregnancy|0|||
105320355|NCT02815995|363172144|FG003|Overall Study|Pregnancy|0|||
105320356|NCT02815995|363172145|FG004|Overall Study|Pregnancy|0|||
105320357|NCT02815995|363172146|FG005|Overall Study|Pregnancy|0|||
105320358|NCT02815995|363172147|FG006|Overall Study|Pregnancy|1|||
105370678|NCT01326871|363362417|FG002|Overall Study|Major surgery|0|||
105320359|NCT02815995|363172148|FG007|Overall Study|Pregnancy|0|||
105320360|NCT00114140|363172149|FG000|Overall Study|Protocol Violation|7|||
105320361|NCT02942017|363172150|FG000|Overall Study|Adverse Event|0|||
105320362|NCT02942017|363172151|FG001|Overall Study|Adverse Event|1|||
105576784|NCT02138747|364110327|FG003|Treatment Period 1|Lost to Follow-up|0|||
105576785|NCT02138747|364110324|FG000|Treatment Period 1|Protocol Violation|0|||
105576786|NCT02138747|364110325|FG001|Treatment Period 1|Protocol Violation|2|||
105576787|NCT02138747|364110326|FG002|Treatment Period 1|Protocol Violation|0|||
105576788|NCT02138747|364110327|FG003|Treatment Period 1|Protocol Violation|0|||
105576789|NCT02138747|364110324|FG000|Treatment Period 1|Withdrawal by Subject|8|||
105576790|NCT02138747|364110325|FG001|Treatment Period 1|Withdrawal by Subject|4|||
105850189|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850190|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850191|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850192|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850193|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850194|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850195|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850196|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850197|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850198|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
105850199|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850200|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105370679|NCT01326871|363362415|FG000|Overall Study|SAE and death|0|||
105370680|NCT01326871|363362416|FG001|Overall Study|SAE and death|2|||
105370681|NCT01326871|363362417|FG002|Overall Study|SAE and death|0|||
105370682|NCT01326871|363362415|FG000|Overall Study|Physician decision and decreased performance status|0|||
105370683|NCT01326871|363362416|FG001|Overall Study|Physician decision and decreased performance status|1|||
105370684|NCT01326871|363362417|FG002|Overall Study|Physician decision and decreased performance status|0|||
105370685|NCT01326871|363362415|FG000|Overall Study|Disease progression|0|||
105370686|NCT01326871|363362416|FG001|Overall Study|Disease progression|11|||
105370687|NCT01326871|363362417|FG002|Overall Study|Disease progression|5|||
105370688|NCT01326871|363362415|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
105370689|NCT01326871|363362416|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
105370690|NCT01326871|363362417|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
105370691|NCT01326871|363362415|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
105370692|NCT01326871|363362416|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
105370693|NCT01326871|363362417|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
105370694|NCT01326871|363362415|FG000|Overall Study|Withdrawal by Subject|0|||
105370695|NCT01326871|363362416|FG001|Overall Study|Withdrawal by Subject|1|||
105370696|NCT01326871|363362417|FG002|Overall Study|Withdrawal by Subject|0|||
105370697|NCT01326871|363362415|FG000|Overall Study|DLT|0|||
105370698|NCT01326871|363362416|FG001|Overall Study|DLT|2|||
105370699|NCT01326871|363362417|FG002|Overall Study|DLT|0|||
105370700|NCT01326871|363362415|FG000|Overall Study|SAE, disease progression and subject decision|0|||
105370701|NCT01326871|363362416|FG001|Overall Study|SAE, disease progression and subject decision|1|||
105370702|NCT01326871|363362417|FG002|Overall Study|SAE, disease progression and subject decision|0|||
105370703|NCT01326871|363362415|FG000|Overall Study|Death|0|||
105370704|NCT01326871|363362416|FG001|Overall Study|Death|1|||
105370705|NCT01326871|363362417|FG002|Overall Study|Death|0|||
105370706|NCT01326871|363362415|FG000|Overall Study|Other|0|||
105370707|NCT01326871|363362416|FG001|Overall Study|Other|3|||
105370708|NCT01326871|363362417|FG002|Overall Study|Other|0|||
105370709|NCT01326871|363362415|FG000|Overall Study|SAE and disease progression|0|||
105370710|NCT01326871|363362416|FG001|Overall Study|SAE and disease progression|0|||
105370711|NCT01326871|363362417|FG002|Overall Study|SAE and disease progression|1|||
105370712|NCT01326871|363362415|FG000|Overall Study|SAE and physician decision|0|||
105370713|NCT01326871|363362416|FG001|Overall Study|SAE and physician decision|0|||
105370714|NCT01326871|363362417|FG002|Overall Study|SAE and physician decision|1|||
105370715|NCT01326871|363362415|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
105370716|NCT01326871|363362416|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
105370717|NCT01326871|363362417|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
105370718|NCT01326871|363362415|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
105370719|NCT01326871|363362416|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
105370720|NCT01326871|363362417|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
105370721|NCT01326871|363362415|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
105370722|NCT01326871|363362416|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
105850201|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105370723|NCT01326871|363362417|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
105370724|NCT01326871|363362415|FG000|Overall Study|Physician Decision|0|||
105370725|NCT01326871|363362416|FG001|Overall Study|Physician Decision|0|||
105576791|NCT02138747|364110326|FG002|Treatment Period 1|Withdrawal by Subject|1|||
105491155|NCT02943460|363810687|FG001|Blinded Study Phase|Withdrew Consent|1|||
105491156|NCT02943460|363810688|FG002|Blinded Study Phase|Withdrew Consent|0|||
105491157|NCT02943460|363810686|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
105491158|NCT02943460|363810687|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
105491159|NCT02943460|363810688|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
105491160|NCT02943460|363810686|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
105491161|NCT02943460|363810687|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
105491162|NCT02943460|363810688|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
105491163|NCT02943460|363810686|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
105491164|NCT02943460|363810687|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
105320363|NCT02942017|363172150|FG000|Overall Study|Withdrawal by Subject|0|||
105320364|NCT02942017|363172151|FG001|Overall Study|Withdrawal by Subject|1|||
105320365|NCT02942017|363172150|FG000|Overall Study|Lost to Follow-up|1|||
105320366|NCT02942017|363172151|FG001|Overall Study|Lost to Follow-up|1|||
105320367|NCT02942017|363172150|FG000|Overall Study|Randomized but not dosed|1|||
105320368|NCT02942017|363172151|FG001|Overall Study|Randomized but not dosed|3|||
105320369|NCT03885661|363172154|FG000|Overall Study|Withdrawal by Subject|0|||
105320370|NCT03885661|363172155|FG001|Overall Study|Withdrawal by Subject|1|||
105320371|NCT03885661|363172154|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
105320372|NCT03885661|363172155|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
105320373|NCT05211726|363172156|FG000|Overall Study|Withdrawal by Subject|2|||
105320374|NCT05211726|363172157|FG001|Overall Study|Withdrawal by Subject|3|||
105320375|NCT05211726|363172156|FG000|Overall Study|Protocol Violation|0|||
105320376|NCT05211726|363172157|FG001|Overall Study|Protocol Violation|1|||
105320377|NCT03762239|363172158|FG000|Overall Study|Appointment to the doctor|1|||
105320378|NCT03762239|363172159|FG001|Overall Study|Appointment to the doctor|1|||
105320379|NCT01137071|363172160|FG000|Overall Study|Disease Progression|11|||
105320380|NCT01137071|363172160|FG000|Overall Study|Withdrawal by Subject|2|||
105320381|NCT01137071|363172160|FG000|Overall Study|Wrongly Included|1|||
105320382|NCT03645863|363172164|FG000|Overall Study|Withdrawal by Subject|1|||
105320383|NCT03645863|363172165|FG001|Overall Study|Withdrawal by Subject|0|||
105320384|NCT03645863|363172166|FG002|Overall Study|Withdrawal by Subject|0|||
105320385|NCT02016183|363172167|FG000|Overall Study|Case Report Forms Uncollected|13|||
105320386|NCT02016183|363172167|FG000|Overall Study|Protocol Violation|52|||
105320387|NCT03142191|363172168|FG000|Placebo Controlled Period|Death|0|||
105320388|NCT03142191|363172169|FG001|Placebo Controlled Period|Death|1|||
105320389|NCT03142191|363172170|FG002|Placebo Controlled Period|Death|1|||
105320390|NCT03142191|363172171|FG003|Placebo Controlled Period|Death|0|||
105320391|NCT03142191|363172172|FG004|Placebo Controlled Period|Death|0|||
105320392|NCT03142191|363172168|FG000|Placebo Controlled Period|Adverse Event|4|||
105320393|NCT03142191|363172169|FG001|Placebo Controlled Period|Adverse Event|5|||
105320394|NCT03142191|363172170|FG002|Placebo Controlled Period|Adverse Event|1|||
105320395|NCT03142191|363172171|FG003|Placebo Controlled Period|Adverse Event|0|||
105320396|NCT03142191|363172172|FG004|Placebo Controlled Period|Adverse Event|0|||
105320397|NCT03142191|363172168|FG000|Placebo Controlled Period|Progressive Disease|1|||
105320398|NCT03142191|363172169|FG001|Placebo Controlled Period|Progressive Disease|0|||
105320399|NCT03142191|363172170|FG002|Placebo Controlled Period|Progressive Disease|1|||
105320400|NCT03142191|363172171|FG003|Placebo Controlled Period|Progressive Disease|0|||
105320401|NCT03142191|363172172|FG004|Placebo Controlled Period|Progressive Disease|0|||
105320402|NCT03142191|363172168|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
105320403|NCT03142191|363172169|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
105320404|NCT03142191|363172170|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
105320405|NCT03142191|363172171|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
105320406|NCT03142191|363172172|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
105320407|NCT03142191|363172168|FG000|Placebo Controlled Period|Other Reasons|1|||
105320408|NCT03142191|363172169|FG001|Placebo Controlled Period|Other Reasons|0|||
105320409|NCT03142191|363172170|FG002|Placebo Controlled Period|Other Reasons|0|||
105320410|NCT03142191|363172171|FG003|Placebo Controlled Period|Other Reasons|0|||
105320411|NCT03142191|363172172|FG004|Placebo Controlled Period|Other Reasons|0|||
105320412|NCT03142191|363172168|FG000|Active Treatment Extension Period|Death|2|||
105320413|NCT03142191|363172169|FG001|Active Treatment Extension Period|Death|1|||
105320414|NCT03142191|363172170|FG002|Active Treatment Extension Period|Death|1|||
105320415|NCT03142191|363172171|FG003|Active Treatment Extension Period|Death|1|||
105320416|NCT03142191|363172172|FG004|Active Treatment Extension Period|Death|0|||
105320417|NCT03142191|363172168|FG000|Active Treatment Extension Period|Adverse Event|6|||
105320418|NCT03142191|363172169|FG001|Active Treatment Extension Period|Adverse Event|5|||
105320419|NCT03142191|363172170|FG002|Active Treatment Extension Period|Adverse Event|4|||
105320420|NCT03142191|363172171|FG003|Active Treatment Extension Period|Adverse Event|1|||
105320421|NCT03142191|363172172|FG004|Active Treatment Extension Period|Adverse Event|0|||
105320422|NCT03142191|363172168|FG000|Active Treatment Extension Period|Progressive Disease|10|||
105320423|NCT03142191|363172169|FG001|Active Treatment Extension Period|Progressive Disease|5|||
105370726|NCT01326871|363362417|FG002|Overall Study|Physician Decision|1|||
105320424|NCT03142191|363172170|FG002|Active Treatment Extension Period|Progressive Disease|4|||
105850202|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850203|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850204|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850205|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850206|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850207|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850208|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850209|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850210|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850211|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
105491165|NCT02943460|363810688|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
105850212|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850213|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850214|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850215|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850216|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850217|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850218|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850219|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850220|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850221|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850222|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850223|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850224|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850225|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
105850226|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850227|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850228|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850229|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850230|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850231|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850232|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850233|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850234|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850235|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850236|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850237|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850238|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850239|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
105850240|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
105850241|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850242|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850243|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850244|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850245|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850246|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850247|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850248|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850249|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850250|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850251|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850252|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850253|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850254|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
105850255|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850256|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850257|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850258|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850259|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850260|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105491166|NCT01323946|363810689|FG000|Overall Study|Lost to Follow-up|0|||
105491167|NCT01323946|363810690|FG001|Overall Study|Lost to Follow-up|1|||
105491168|NCT01323946|363810691|FG002|Overall Study|Lost to Follow-up|0|||
105491169|NCT01323946|363810689|FG000|Overall Study|Parents refused the last blood draw|1|||
105491170|NCT01323946|363810690|FG001|Overall Study|Parents refused the last blood draw|0|||
105491171|NCT01323946|363810691|FG002|Overall Study|Parents refused the last blood draw|0|||
105491172|NCT01323946|363810689|FG000|Overall Study|Withdrawal by Subject|2|||
105491173|NCT01323946|363810690|FG001|Overall Study|Withdrawal by Subject|2|||
105491174|NCT01323946|363810691|FG002|Overall Study|Withdrawal by Subject|0|||
105491175|NCT01243671|363810694|FG000|Overall Study|Adverse Event|3|||
105491176|NCT01243671|363810694|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
105491177|NCT01243671|363810694|FG000|Overall Study|Other|1|||
105491178|NCT00925990|363810695|FG000|Overall Study|Adverse Event|1|||
105491179|NCT00925990|363810696|FG001|Overall Study|Adverse Event|3|||
105491180|NCT00925990|363810695|FG000|Overall Study|Withdrawal by Subject|2|||
105491181|NCT00925990|363810696|FG001|Overall Study|Withdrawal by Subject|2|||
105491182|NCT00925990|363810695|FG000|Overall Study|Lost to Follow-up|1|||
105491183|NCT00925990|363810696|FG001|Overall Study|Lost to Follow-up|3|||
105491184|NCT00925990|363810695|FG000|Overall Study|Physician Decision|1|||
105491185|NCT00925990|363810696|FG001|Overall Study|Physician Decision|1|||
105491186|NCT00925990|363810695|FG000|Overall Study|moved out of state, missed medication|0|||
105491187|NCT00925990|363810696|FG001|Overall Study|moved out of state, missed medication|2|||
105491188|NCT02169284|363810699|FG000|Overall Study|Physician Decision|0|||
105491189|NCT02169284|363810700|FG001|Overall Study|Physician Decision|1|||
105491190|NCT00573248|363810701|FG000|Overall Study|scheduling conflicts|15|||
105491191|NCT00573248|363810702|FG001|Overall Study|scheduling conflicts|11|||
105491192|NCT03583073|363810703|FG000|Overall Study|Lost to Follow-up|8|||
105491193|NCT03583073|363810704|FG001|Overall Study|Lost to Follow-up|12|||
105491194|NCT02495233|363810710|FG000|Overall Study|Miscellaneous|0|||
105491195|NCT02495233|363810711|FG001|Overall Study|Miscellaneous|1|||
105850261|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850262|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850263|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850264|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850265|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850266|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850267|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
105850268|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
105850269|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850270|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850271|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850272|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850273|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850274|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850275|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850276|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850277|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850278|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850279|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850280|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850281|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850282|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850283|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850284|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850285|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850286|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850287|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
105850288|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850289|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850290|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850291|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850292|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850293|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850294|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850295|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105491196|NCT05896748|363810712|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
105491197|NCT05896748|363810712|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
105491198|NCT05896748|363810712|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
105850296|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850297|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105491199|NCT05896748|363810712|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
105491200|NCT05896748|363810712|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
105491201|NCT02325791|363810714|FG000|Overall Study|Adverse Event|0|||
105370727|NCT01326871|363362415|FG000|Overall Study|SAE|0|||
105370728|NCT01326871|363362416|FG001|Overall Study|SAE|0|||
105370729|NCT01326871|363362417|FG002|Overall Study|SAE|1|||
105370730|NCT01326871|363362415|FG000|Overall Study|Disease progression and death|0|||
105370731|NCT01326871|363362416|FG001|Overall Study|Disease progression and death|0|||
105370732|NCT01326871|363362417|FG002|Overall Study|Disease progression and death|1|||
105370733|NCT01326871|363362415|FG000|Overall Study|Subject decision|0|||
105370734|NCT01326871|363362416|FG001|Overall Study|Subject decision|0|||
105370735|NCT01326871|363362417|FG002|Overall Study|Subject decision|1|||
105370736|NCT00434252|363364625|FG000|Overall Study|Lack of Efficacy|50|||
105370737|NCT00434252|363364626|FG001|Overall Study|Lack of Efficacy|100|||
105370738|NCT00434252|363364625|FG000|Overall Study|Adverse Event|6|||
105370739|NCT00434252|363364626|FG001|Overall Study|Adverse Event|13|||
105370740|NCT00434252|363364625|FG000|Overall Study|Death|1|||
105370741|NCT00434252|363364626|FG001|Overall Study|Death|2|||
105370742|NCT00434252|363364625|FG000|Overall Study|Lost to Follow-up|0|||
105370743|NCT00434252|363364626|FG001|Overall Study|Lost to Follow-up|1|||
105370744|NCT00434252|363364625|FG000|Overall Study|Physician Decision|4|||
105370745|NCT00434252|363364626|FG001|Overall Study|Physician Decision|8|||
105370746|NCT00434252|363364625|FG000|Overall Study|Withdrawal by Subject|3|||
105370747|NCT00434252|363364626|FG001|Overall Study|Withdrawal by Subject|7|||
105370748|NCT02807259|363364627|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
105370749|NCT02807259|363364628|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
105370750|NCT02807259|363364627|FG000|Midline (3 Months)|migration, refusal, not available|30|||
105370751|NCT02807259|363364628|FG001|Midline (3 Months)|migration, refusal, not available|34|||
105370752|NCT02807259|363364627|FG000|Endline (3 Months)|migration, refusal, not available|35|||
105370753|NCT02807259|363364628|FG001|Endline (3 Months)|migration, refusal, not available|87|||
105370754|NCT00720278|363364631|FG000|Overall Study|Adverse Event|5|||
105370755|NCT00720278|363364632|FG001|Overall Study|Adverse Event|3|||
105370756|NCT00720278|363364633|FG002|Overall Study|Adverse Event|4|||
105370757|NCT00720278|363364631|FG000|Overall Study|Withdrawal by Subject|0|||
105370758|NCT00720278|363364632|FG001|Overall Study|Withdrawal by Subject|1|||
105370759|NCT00720278|363364633|FG002|Overall Study|Withdrawal by Subject|0|||
105370760|NCT00720278|363364631|FG000|Overall Study|Lost to Follow-up|0|||
105370761|NCT00720278|363364632|FG001|Overall Study|Lost to Follow-up|0|||
105370762|NCT00720278|363364633|FG002|Overall Study|Lost to Follow-up|1|||
105370763|NCT00720278|363364631|FG000|Overall Study|Non-compliance|1|||
105370764|NCT00720278|363364632|FG001|Overall Study|Non-compliance|0|||
105370765|NCT00720278|363364633|FG002|Overall Study|Non-compliance|0|||
105370766|NCT00720278|363364631|FG000|Overall Study|eligibility criteria violation|1|||
105370767|NCT00720278|363364632|FG001|Overall Study|eligibility criteria violation|0|||
105370768|NCT00720278|363364633|FG002|Overall Study|eligibility criteria violation|1|||
105370769|NCT01433159|363364634|FG000|Overall Study|Adverse Event|1|||
105370770|NCT01433159|363364635|FG001|Overall Study|Adverse Event|0|||
105370771|NCT01433159|363364634|FG000|Overall Study|Physician Decision|1|||
105370772|NCT01433159|363364635|FG001|Overall Study|Physician Decision|0|||
105370773|NCT01433159|363364634|FG000|Overall Study|Protocol Violation|0|||
105370774|NCT01433159|363364635|FG001|Overall Study|Protocol Violation|1|||
105370775|NCT01287936|363364638|FG000|Overall Study|Lost to Follow-up|0|||
105370776|NCT01287936|363364639|FG001|Overall Study|Lost to Follow-up|1|||
105370777|NCT01287936|363364640|FG002|Overall Study|Lost to Follow-up|1|||
105370778|NCT00296244|363364641|FG000|Overall Study|Underwent retransplant|0|||
105370779|NCT00296244|363364642|FG001|Overall Study|Underwent retransplant|1|||
105370780|NCT00427934|363364643|FG000|Overall Study|Adverse Event|1|||
105370781|NCT00427934|363364644|FG001|Overall Study|Adverse Event|0|||
105370782|NCT00427934|363364645|FG002|Overall Study|Adverse Event|5|||
105370783|NCT00427934|363364646|FG003|Overall Study|Adverse Event|4|||
105370784|NCT00427934|363364643|FG000|Overall Study|Lack of Efficacy|0|||
105370785|NCT00427934|363364644|FG001|Overall Study|Lack of Efficacy|0|||
105370786|NCT00427934|363364645|FG002|Overall Study|Lack of Efficacy|5|||
105370787|NCT00427934|363364646|FG003|Overall Study|Lack of Efficacy|2|||
105370788|NCT00427934|363364643|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
105370789|NCT00427934|363364644|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
105370790|NCT00427934|363364645|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
105370791|NCT00427934|363364646|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
105370792|NCT00427934|363364643|FG000|Overall Study|Other|0|||
105370793|NCT00427934|363364644|FG001|Overall Study|Other|0|||
105370794|NCT00427934|363364645|FG002|Overall Study|Other|11|||
105370795|NCT00427934|363364646|FG003|Overall Study|Other|5|||
105370796|NCT00427934|363364643|FG000|Overall Study|Withdrawal by Subject|0|||
105370797|NCT00427934|363364644|FG001|Overall Study|Withdrawal by Subject|0|||
105370798|NCT00427934|363364645|FG002|Overall Study|Withdrawal by Subject|1|||
105370799|NCT00427934|363364646|FG003|Overall Study|Withdrawal by Subject|3|||
105370800|NCT01799941|363364655|FG000|Overall Study|Adverse Event|34|||
105370801|NCT01799941|363364655|FG000|Overall Study|Withdrawal by Subject|21|||
105370802|NCT01799941|363364655|FG000|Overall Study|Death|2|||
105370803|NCT01799941|363364655|FG000|Overall Study|Investigator Decision|4|||
105370804|NCT01799941|363364655|FG000|Overall Study|Lack of Efficacy|3|||
105320425|NCT03142191|363172171|FG003|Active Treatment Extension Period|Progressive Disease|1|||
105320426|NCT03142191|363172172|FG004|Active Treatment Extension Period|Progressive Disease|2|||
105320427|NCT03142191|363172168|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
105320428|NCT03142191|363172169|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
105320429|NCT03142191|363172170|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
105320430|NCT03142191|363172171|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
105320431|NCT03142191|363172172|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
105320432|NCT03142191|363172168|FG000|Active Treatment Extension Period|Physician Decision|2|||
105320433|NCT03142191|363172169|FG001|Active Treatment Extension Period|Physician Decision|0|||
105320434|NCT03142191|363172170|FG002|Active Treatment Extension Period|Physician Decision|0|||
105320435|NCT03142191|363172171|FG003|Active Treatment Extension Period|Physician Decision|0|||
105320436|NCT03142191|363172172|FG004|Active Treatment Extension Period|Physician Decision|0|||
105320437|NCT03142191|363172168|FG000|Active Treatment Extension Period|Other Reasons|3|||
105320438|NCT03142191|363172169|FG001|Active Treatment Extension Period|Other Reasons|3|||
105320439|NCT03142191|363172170|FG002|Active Treatment Extension Period|Other Reasons|3|||
105320440|NCT03142191|363172171|FG003|Active Treatment Extension Period|Other Reasons|8|||
105320441|NCT03142191|363172172|FG004|Active Treatment Extension Period|Other Reasons|3|||
105320442|NCT03142191|363172168|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
105320443|NCT03142191|363172169|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
105320444|NCT03142191|363172170|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
105320445|NCT03142191|363172171|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
105320446|NCT03142191|363172172|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
105320447|NCT00129545|363172182|FG000|Overall Study|Death|5|||
105320448|NCT00129545|363172183|FG001|Overall Study|Death|60|||
105320449|NCT00129545|363172184|FG002|Overall Study|Death|44|||
105320450|NCT00129545|363172182|FG000|Overall Study|Withdrawal by Subject|3|||
105320451|NCT00129545|363172183|FG001|Overall Study|Withdrawal by Subject|18|||
105320452|NCT00129545|363172184|FG002|Overall Study|Withdrawal by Subject|44|||
105320453|NCT00129545|363172182|FG000|Overall Study|Lost to Follow-up|2|||
105320454|NCT00129545|363172183|FG001|Overall Study|Lost to Follow-up|22|||
105320455|NCT00129545|363172184|FG002|Overall Study|Lost to Follow-up|13|||
105320456|NCT00129545|363172182|FG000|Overall Study|Physician Decision|0|||
105320457|NCT00129545|363172183|FG001|Overall Study|Physician Decision|3|||
105320458|NCT00129545|363172184|FG002|Overall Study|Physician Decision|10|||
105320459|NCT00129545|363172182|FG000|Overall Study|Device not implanted|16|||
105320460|NCT00129545|363172183|FG001|Overall Study|Device not implanted|61|||
105320461|NCT00129545|363172184|FG002|Overall Study|Device not implanted|0|||
105320462|NCT04660331|363172189|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
105320463|NCT04660331|363172190|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
105320464|NCT04660331|363172191|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
105320465|NCT01841593|363172192|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
105320466|NCT01841593|363172193|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
105320467|NCT01841593|363172192|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
105320468|NCT01841593|363172193|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
105320469|NCT00307086|363172194|FG000|Overall Study|ineligible|5|||
105320470|NCT04728802|363172197|FG000|Overall Study|Withdrawal by Subject|4|||
105320471|NCT04728802|363172198|FG001|Overall Study|Withdrawal by Subject|20|||
105320472|NCT04728802|363172197|FG000|Overall Study|Physician Decision|7|||
105320473|NCT04728802|363172198|FG001|Overall Study|Physician Decision|7|||
105320474|NCT04728802|363172197|FG000|Overall Study|Protocol Violation|10|||
105320475|NCT04728802|363172198|FG001|Overall Study|Protocol Violation|4|||
105320476|NCT04728802|363172197|FG000|Overall Study|Transfer|1|||
105320477|NCT04728802|363172198|FG001|Overall Study|Transfer|0|||
105320478|NCT04728802|363172197|FG000|Overall Study|Death|4|||
105320479|NCT04728802|363172198|FG001|Overall Study|Death|5|||
105320480|NCT04728802|363172197|FG000|Overall Study|Other|3|||
105370805|NCT01799941|363364655|FG000|Overall Study|Lost to Follow-up|17|||
105370806|NCT01799941|363364655|FG000|Overall Study|Other|15|||
105370807|NCT03408899|363364658|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
105370808|NCT04745351|363364666|FG000|Overall Study|Death|51|||
105370809|NCT04745351|363364667|FG001|Overall Study|Death|25|||
105370810|NCT04745351|363364666|FG000|Overall Study|Lost to Follow-up|9|||
105370811|NCT04745351|363364667|FG001|Overall Study|Lost to Follow-up|3|||
105320481|NCT04728802|363172198|FG001|Overall Study|Other|0|||
105320482|NCT00262028|363172199|FG000|Overall Study|Withdrawal by Subject|6|||
105320483|NCT00262028|363172200|FG001|Overall Study|Withdrawal by Subject|3|||
105320484|NCT00262028|363172201|FG002|Overall Study|Withdrawal by Subject|6|||
105370812|NCT04745351|363364666|FG000|Overall Study|Randomized but Never Treated|3|||
105370813|NCT04745351|363364667|FG001|Overall Study|Randomized but Never Treated|3|||
105320485|NCT00262028|363172202|FG003|Overall Study|Withdrawal by Subject|5|||
105320486|NCT00262028|363172203|FG004|Overall Study|Withdrawal by Subject|2|||
105370814|NCT04745351|363364666|FG000|Overall Study|Adverse Event|4|||
105370815|NCT04745351|363364667|FG001|Overall Study|Adverse Event|0|||
105320487|NCT00262028|363172204|FG005|Overall Study|Withdrawal by Subject|3|||
105320488|NCT00262028|363172205|FG006|Overall Study|Withdrawal by Subject|5|||
105320489|NCT00262028|363172206|FG007|Overall Study|Withdrawal by Subject|7|||
105320490|NCT00262028|363172207|FG008|Overall Study|Withdrawal by Subject|2|||
105320491|NCT00262028|363172199|FG000|Overall Study|Lost to Follow-up|7|||
105320492|NCT00262028|363172200|FG001|Overall Study|Lost to Follow-up|7|||
105320493|NCT00262028|363172201|FG002|Overall Study|Lost to Follow-up|5|||
105320494|NCT00262028|363172202|FG003|Overall Study|Lost to Follow-up|5|||
105320495|NCT00262028|363172203|FG004|Overall Study|Lost to Follow-up|4|||
105320496|NCT00262028|363172204|FG005|Overall Study|Lost to Follow-up|3|||
105320497|NCT00262028|363172205|FG006|Overall Study|Lost to Follow-up|3|||
105320498|NCT00262028|363172206|FG007|Overall Study|Lost to Follow-up|5|||
105320499|NCT00262028|363172207|FG008|Overall Study|Lost to Follow-up|6|||
105320500|NCT00262028|363172199|FG000|Overall Study|Administrative Reason|11|||
105320501|NCT00262028|363172200|FG001|Overall Study|Administrative Reason|14|||
105320502|NCT00262028|363172201|FG002|Overall Study|Administrative Reason|9|||
105320503|NCT00262028|363172202|FG003|Overall Study|Administrative Reason|12|||
105320504|NCT00262028|363172203|FG004|Overall Study|Administrative Reason|6|||
105370816|NCT04745351|363364666|FG000|Overall Study|Withdrew Consent|1|||
105370817|NCT04745351|363364667|FG001|Overall Study|Withdrew Consent|2|||
105370818|NCT04745351|363364666|FG000|Overall Study|Investigator's Discretion|2|||
105370819|NCT04745351|363364667|FG001|Overall Study|Investigator's Discretion|0|||
105370820|NCT04745351|363364666|FG000|Overall Study|Protocol Violation|1|||
105370821|NCT04745351|363364667|FG001|Overall Study|Protocol Violation|0|||
105370822|NCT00883181|363364668|FG000|Overall Study|Hematological Adverse Event|26|||
105370823|NCT00883181|363364668|FG000|Overall Study|Non-hematological Adverse Event|55|||
105370824|NCT00883181|363364668|FG000|Overall Study|Disease Progression|94|||
105370825|NCT00883181|363364668|FG000|Overall Study|Administrative Reason|24|||
105370826|NCT00883181|363364668|FG000|Overall Study|Withdrawal by Subject|4|||
105370827|NCT00883181|363364668|FG000|Overall Study|Death|31|||
105370828|NCT00883181|363364668|FG000|Overall Study|Other|38|||
105370829|NCT00883181|363364668|FG000|Overall Study|Protocol Deviation|3|||
105370830|NCT00883181|363364668|FG000|Overall Study|Noncompliance|3|||
105370831|NCT01715831|363364669|FG000|Overall Study|Adverse Event|1|||
105370832|NCT00426270|363364670|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
105370833|NCT00426270|363364670|FG000|Overall Study|Adverse Event|5|||
105370834|NCT01603602|363364671|FG000|Overall Study|Adverse Event|1|||
105370835|NCT01603602|363364672|FG001|Overall Study|Adverse Event|0|||
105370836|NCT01603602|363364673|FG002|Overall Study|Adverse Event|0|||
105370837|NCT01603602|363364671|FG000|Overall Study|Personal Reasons|1|||
105370838|NCT01603602|363364672|FG001|Overall Study|Personal Reasons|0|||
105370839|NCT01603602|363364673|FG002|Overall Study|Personal Reasons|1|||
105370840|NCT04748718|363364674|FG000|Overall Study|Lost to Follow-up|50|||
105370841|NCT03248037|363364676|FG000|Overall Study|Withdrawal by Subject|6|||
105370842|NCT03248037|363364677|FG001|Overall Study|Withdrawal by Subject|9|||
105370843|NCT03248037|363364676|FG000|Overall Study|Adverse Event|15|||
105370844|NCT03248037|363364677|FG001|Overall Study|Adverse Event|0|||
105370845|NCT02065557|363364683|FG000|Induction Period|Withdrawal by Subject|2|||
105370846|NCT02065557|363364684|FG001|Induction Period|Withdrawal by Subject|1|||
105370847|NCT02065557|363364685|FG002|Induction Period|Withdrawal by Subject|0|||
105370848|NCT02065557|363364686|FG003|Induction Period|Withdrawal by Subject|0|||
105370849|NCT02065557|363364687|FG004|Induction Period|Withdrawal by Subject|0|||
105370850|NCT02065557|363364688|FG005|Induction Period|Withdrawal by Subject|0|||
105370851|NCT02065557|363364683|FG000|Induction Period|Lack of Efficacy|2|||
105370852|NCT02065557|363364684|FG001|Induction Period|Lack of Efficacy|1|||
105370853|NCT02065557|363364685|FG002|Induction Period|Lack of Efficacy|1|||
105370854|NCT02065557|363364686|FG003|Induction Period|Lack of Efficacy|0|||
105370855|NCT02065557|363364687|FG004|Induction Period|Lack of Efficacy|0|||
105370856|NCT02065557|363364688|FG005|Induction Period|Lack of Efficacy|0|||
105491202|NCT02325791|363810715|FG001|Overall Study|Adverse Event|1|||
105491203|NCT02325791|363810716|FG002|Overall Study|Adverse Event|1|||
105320505|NCT00262028|363172204|FG005|Overall Study|Administrative Reason|7|||
105320506|NCT00262028|363172205|FG006|Overall Study|Administrative Reason|4|||
105370857|NCT02065557|363364683|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
105370858|NCT02065557|363364684|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
105370859|NCT02065557|363364685|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
105370860|NCT02065557|363364686|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
105370861|NCT02065557|363364687|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
105370862|NCT02065557|363364688|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
105370863|NCT02065557|363364683|FG000|Induction Period|Non-Responder at Week 8|4|||
105370864|NCT02065557|363364684|FG001|Induction Period|Non-Responder at Week 8|4|||
105320507|NCT00262028|363172206|FG007|Overall Study|Administrative Reason|6|||
105320508|NCT00262028|363172207|FG008|Overall Study|Administrative Reason|10|||
105320509|NCT00262028|363172199|FG000|Overall Study|Protocol Violation|0|||
105370865|NCT02065557|363364685|FG002|Induction Period|Non-Responder at Week 8|0|||
105370866|NCT02065557|363364686|FG003|Induction Period|Non-Responder at Week 8|0|||
105370867|NCT02065557|363364687|FG004|Induction Period|Non-Responder at Week 8|0|||
105850298|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850299|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850300|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850301|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
105850302|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850303|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850304|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850305|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850306|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850307|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850308|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850309|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850310|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850311|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850312|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850313|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850314|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850315|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
105850316|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850317|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850318|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105320510|NCT00262028|363172200|FG001|Overall Study|Protocol Violation|0|||
105320511|NCT00262028|363172201|FG002|Overall Study|Protocol Violation|0|||
105320512|NCT00262028|363172202|FG003|Overall Study|Protocol Violation|1|||
105320513|NCT00262028|363172203|FG004|Overall Study|Protocol Violation|0|||
105320514|NCT00262028|363172204|FG005|Overall Study|Protocol Violation|0|||
105320515|NCT00262028|363172205|FG006|Overall Study|Protocol Violation|0|||
105320516|NCT00262028|363172206|FG007|Overall Study|Protocol Violation|0|||
105320517|NCT00262028|363172207|FG008|Overall Study|Protocol Violation|0|||
105320518|NCT00262028|363172199|FG000|Overall Study|Unable to classify|0|||
105320519|NCT00262028|363172200|FG001|Overall Study|Unable to classify|3|||
105320520|NCT00262028|363172201|FG002|Overall Study|Unable to classify|0|||
105320521|NCT00262028|363172202|FG003|Overall Study|Unable to classify|0|||
105320522|NCT00262028|363172203|FG004|Overall Study|Unable to classify|0|||
105320523|NCT00262028|363172204|FG005|Overall Study|Unable to classify|0|||
105320524|NCT00262028|363172205|FG006|Overall Study|Unable to classify|0|||
105320525|NCT00262028|363172206|FG007|Overall Study|Unable to classify|0|||
105320526|NCT00262028|363172207|FG008|Overall Study|Unable to classify|1|||
105320527|NCT02308124|363172209|FG000|Overall Study|Lost to Follow-up|6|||
105320528|NCT02308124|363172210|FG001|Overall Study|Lost to Follow-up|6|||
105320529|NCT02308124|363172211|FG002|Overall Study|Lost to Follow-up|6|||
105320530|NCT02308124|363172209|FG000|Overall Study|Adverse Event|0|||
105320531|NCT02308124|363172210|FG001|Overall Study|Adverse Event|2|||
105320532|NCT02308124|363172211|FG002|Overall Study|Adverse Event|2|||
105320533|NCT04388553|363172212|FG000|Overall Study|Protocol Violation|1|||
105320534|NCT04388553|363172213|FG001|Overall Study|Protocol Violation|0|||
105320535|NCT02553772|363172226|FG000|Overall Study|Adverse Event|2|||
105320536|NCT02553772|363172227|FG001|Overall Study|Adverse Event|3|||
105320537|NCT02553772|363172226|FG000|Overall Study|Lost to Follow-up|2|||
105320538|NCT02553772|363172227|FG001|Overall Study|Lost to Follow-up|1|||
105320539|NCT02553772|363172226|FG000|Overall Study|Withdrawal of Consent|1|||
105320540|NCT02553772|363172227|FG001|Overall Study|Withdrawal of Consent|1|||
105320541|NCT02553772|363172226|FG000|Overall Study|Lack of Efficacy|1|||
105320542|NCT02553772|363172227|FG001|Overall Study|Lack of Efficacy|0|||
105320543|NCT02553772|363172226|FG000|Overall Study|Other Miscellaneous Reasons|0|||
105320544|NCT02553772|363172227|FG001|Overall Study|Other Miscellaneous Reasons|1|||
105320545|NCT00786409|363172228|FG000|Overall Study|Withdrawal by Subject|2|||
105320546|NCT00786409|363172228|FG000|Overall Study|Adverse Event|2|||
105320547|NCT00786409|363172228|FG000|Overall Study|Pregnancy|2|||
105320548|NCT00786409|363172228|FG000|Overall Study|Lost to Follow-up|1|||
105320549|NCT00610129|363172229|FG000|Overall Study|Not treated since patients ineligible|3|||
105320550|NCT01329900|363172232|FG000|Overall Study|Elevated creatinine/renal function|1|||
105320551|NCT03172494|363172245|FG000|Overall Study|Adverse Event|5|||
105320552|NCT03172494|363172246|FG001|Overall Study|Adverse Event|1|||
105320553|NCT03172494|363172247|FG002|Overall Study|Adverse Event|15|||
105320554|NCT03172494|363172245|FG000|Overall Study|Protocol Violation|3|||
105320555|NCT03172494|363172246|FG001|Overall Study|Protocol Violation|2|||
105320556|NCT03172494|363172247|FG002|Overall Study|Protocol Violation|1|||
105320557|NCT03172494|363172245|FG000|Overall Study|Lack of Efficacy|0|||
105320558|NCT03172494|363172246|FG001|Overall Study|Lack of Efficacy|0|||
105320559|NCT03172494|363172247|FG002|Overall Study|Lack of Efficacy|4|||
105320560|NCT03172494|363172245|FG000|Overall Study|Pregnancy|0|||
105320561|NCT03172494|363172246|FG001|Overall Study|Pregnancy|1|||
105320562|NCT03172494|363172247|FG002|Overall Study|Pregnancy|0|||
105320563|NCT03172494|363172245|FG000|Overall Study|Withdrawal by Subject|10|||
105320564|NCT03172494|363172246|FG001|Overall Study|Withdrawal by Subject|8|||
105320565|NCT03172494|363172247|FG002|Overall Study|Withdrawal by Subject|8|||
105320566|NCT03172494|363172245|FG000|Overall Study|Severe hypoglycaemic episode|0|||
105320567|NCT03172494|363172246|FG001|Overall Study|Severe hypoglycaemic episode|0|||
105320568|NCT03172494|363172247|FG002|Overall Study|Severe hypoglycaemic episode|1|||
105320569|NCT03172494|363172245|FG000|Overall Study|Non-compliance towards treatment|2|||
105320570|NCT03172494|363172246|FG001|Overall Study|Non-compliance towards treatment|0|||
105320571|NCT03172494|363172247|FG002|Overall Study|Non-compliance towards treatment|0|||
105320572|NCT00143390|363172248|FG000|Overall Study|Death|2|||
105320573|NCT00143390|363172249|FG001|Overall Study|Death|0|||
105320574|NCT00143390|363172248|FG000|Overall Study|Not meeting entry criteria|2|||
105370868|NCT02065557|363364688|FG005|Induction Period|Non-Responder at Week 8|0|||
105370869|NCT02065557|363364683|FG000|Induction Period|Adverse Event|1|||
105370870|NCT02065557|363364684|FG001|Induction Period|Adverse Event|1|||
105370871|NCT02065557|363364685|FG002|Induction Period|Adverse Event|0|||
105370872|NCT02065557|363364686|FG003|Induction Period|Adverse Event|0|||
105370873|NCT02065557|363364687|FG004|Induction Period|Adverse Event|0|||
105370874|NCT02065557|363364688|FG005|Induction Period|Adverse Event|0|||
105370875|NCT02065557|363364683|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
105370876|NCT02065557|363364684|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
105370877|NCT02065557|363364685|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
105370878|NCT02065557|363364686|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
105850319|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850320|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850321|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850322|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850323|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105370879|NCT02065557|363364687|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
105370880|NCT02065557|363364688|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
105370881|NCT02065557|363364683|FG000|Maintenance Period|Withdrawal by Subject|0|||
105850324|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105370882|NCT02065557|363364684|FG001|Maintenance Period|Withdrawal by Subject|0|||
105850325|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850326|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850327|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850328|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850329|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
105850330|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850331|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850332|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850333|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850334|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850335|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850336|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850337|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850338|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850339|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850340|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850341|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850342|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850343|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
105320575|NCT00143390|363172249|FG001|Overall Study|Not meeting entry criteria|5|||
105370883|NCT02065557|363364685|FG002|Maintenance Period|Withdrawal by Subject|0|||
105370884|NCT02065557|363364686|FG003|Maintenance Period|Withdrawal by Subject|0|||
105370885|NCT02065557|363364687|FG004|Maintenance Period|Withdrawal by Subject|2|||
105370886|NCT02065557|363364688|FG005|Maintenance Period|Withdrawal by Subject|1|||
105370887|NCT02065557|363364683|FG000|Maintenance Period|Lack of Efficacy|0|||
105370888|NCT02065557|363364684|FG001|Maintenance Period|Lack of Efficacy|0|||
105370889|NCT02065557|363364685|FG002|Maintenance Period|Lack of Efficacy|0|||
105850344|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105370890|NCT02065557|363364686|FG003|Maintenance Period|Lack of Efficacy|0|||
105370891|NCT02065557|363364687|FG004|Maintenance Period|Lack of Efficacy|5|||
105370892|NCT02065557|363364688|FG005|Maintenance Period|Lack of Efficacy|2|||
105320576|NCT00143390|363172248|FG000|Overall Study|Withdrawal by Subject|4|||
105320577|NCT00143390|363172249|FG001|Overall Study|Withdrawal by Subject|4|||
105370893|NCT02065557|363364683|FG000|Maintenance Period|Subject Non-Compliance|0|||
105370894|NCT02065557|363364684|FG001|Maintenance Period|Subject Non-Compliance|0|||
105320578|NCT00143390|363172248|FG000|Overall Study|Progressive disease|119|||
105850345|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850346|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850347|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850348|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850349|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850350|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850351|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850352|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850353|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850354|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
105850355|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105370895|NCT02065557|363364685|FG002|Maintenance Period|Subject Non-Compliance|0|||
105370896|NCT02065557|363364686|FG003|Maintenance Period|Subject Non-Compliance|0|||
105370897|NCT02065557|363364687|FG004|Maintenance Period|Subject Non-Compliance|0|||
105370898|NCT02065557|363364688|FG005|Maintenance Period|Subject Non-Compliance|1|||
105370899|NCT03154086|363364695|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105370900|NCT03154086|363364696|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105370901|NCT03154086|363364697|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105370902|NCT03154086|363364698|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
105370903|NCT03154086|363364699|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105370904|NCT03154086|363364700|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105370905|NCT03154086|363364701|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105370906|NCT03154086|363364702|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105370907|NCT03154086|363364703|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105370908|NCT03154086|363364704|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105370909|NCT03154086|363364705|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105370910|NCT03154086|363364706|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105370911|NCT03154086|363364707|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105370912|NCT03154086|363364708|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105370913|NCT03154086|363364709|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105370914|NCT03154086|363364695|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105370915|NCT03154086|363364696|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
105370916|NCT03154086|363364697|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105370917|NCT03154086|363364698|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105370918|NCT03154086|363364699|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105370919|NCT03154086|363364700|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105370920|NCT03154086|363364701|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105370921|NCT03154086|363364702|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105370922|NCT03154086|363364703|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105370923|NCT03154086|363364704|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105370924|NCT03154086|363364705|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105370925|NCT03154086|363364706|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105370926|NCT03154086|363364707|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105370927|NCT03154086|363364708|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105370928|NCT03154086|363364709|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105370929|NCT03154086|363364695|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105370930|NCT03154086|363364696|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105370931|NCT03154086|363364697|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
105370932|NCT03154086|363364698|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105370933|NCT03154086|363364699|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105370934|NCT03154086|363364700|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105370935|NCT03154086|363364701|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105370936|NCT03154086|363364702|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105370937|NCT03154086|363364703|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105370938|NCT03154086|363364704|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105370939|NCT03154086|363364705|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105370940|NCT03154086|363364706|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105370941|NCT03154086|363364707|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105370942|NCT03154086|363364708|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105370943|NCT03154086|363364709|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105370944|NCT03154086|363364695|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
105576792|NCT02138747|364110327|FG003|Treatment Period 1|Withdrawal by Subject|3|||
105370945|NCT03154086|363364696|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105370946|NCT03154086|363364697|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105491204|NCT02325791|363810717|FG003|Overall Study|Adverse Event|0|||
105491205|NCT02325791|363810714|FG000|Overall Study|Death|0|||
105491206|NCT02325791|363810715|FG001|Overall Study|Death|3|||
105491207|NCT02325791|363810716|FG002|Overall Study|Death|0|||
105320579|NCT00143390|363172249|FG001|Overall Study|Progressive disease|115|||
105320580|NCT00143390|363172248|FG000|Overall Study|Protocol Violation|2|||
105320581|NCT00143390|363172249|FG001|Overall Study|Protocol Violation|0|||
105320582|NCT00143390|363172248|FG000|Overall Study|Study termination|10|||
105320583|NCT00143390|363172249|FG001|Overall Study|Study termination|15|||
105320584|NCT00143390|363172248|FG000|Overall Study|Adverse Event|9|||
105320585|NCT00143390|363172249|FG001|Overall Study|Adverse Event|8|||
105320586|NCT00143390|363172248|FG000|Overall Study|Other|1|||
105320587|NCT00143390|363172249|FG001|Overall Study|Other|2|||
105320588|NCT00041132|363172250|FG000|Overall Study|Adverse Event|19|||
105320589|NCT00041132|363172250|FG000|Overall Study|Death|1|||
105320590|NCT00041132|363172250|FG000|Overall Study|Not Eligible|7|||
105320591|NCT00041132|363172250|FG000|Overall Study|Withdrawal by Subject|1|||
105320592|NCT00041132|363172250|FG000|Overall Study|Physician Decision|2|||
105320593|NCT02764151|363172257|FG000|Overall Study|Subject refused further follow-up|0|||
105320594|NCT02764151|363172258|FG001|Overall Study|Subject refused further follow-up|0|||
105320595|NCT02764151|363172259|FG002|Overall Study|Subject refused further follow-up|0|||
105320596|NCT02764151|363172260|FG003|Overall Study|Subject refused further follow-up|1|||
105320597|NCT02764151|363172257|FG000|Overall Study|Other|0|||
105320598|NCT02764151|363172258|FG001|Overall Study|Other|0|||
105320599|NCT02764151|363172259|FG002|Overall Study|Other|0|||
105320600|NCT02764151|363172260|FG003|Overall Study|Other|2|||
105320601|NCT00281957|363172262|FG000|Overall Study|Adverse Event|7|||
105320602|NCT00281957|363172263|FG001|Overall Study|Adverse Event|2|||
105320603|NCT00281957|363172262|FG000|Overall Study|Death|1|||
105320604|NCT00281957|363172263|FG001|Overall Study|Death|0|||
105320605|NCT00281957|363172262|FG000|Overall Study|Progression/relapse|47|||
105320606|NCT00281957|363172263|FG001|Overall Study|Progression/relapse|35|||
105491208|NCT02325791|363810717|FG003|Overall Study|Death|1|||
105491209|NCT02325791|363810714|FG000|Overall Study|Lost to Follow-up|0|||
105491210|NCT02325791|363810715|FG001|Overall Study|Lost to Follow-up|15|||
105491211|NCT02325791|363810716|FG002|Overall Study|Lost to Follow-up|14|||
105491212|NCT02325791|363810717|FG003|Overall Study|Lost to Follow-up|9|||
105491213|NCT02325791|363810714|FG000|Overall Study|Physician Decision|0|||
105491214|NCT02325791|363810715|FG001|Overall Study|Physician Decision|1|||
105491215|NCT02325791|363810716|FG002|Overall Study|Physician Decision|1|||
105491216|NCT02325791|363810717|FG003|Overall Study|Physician Decision|0|||
105491217|NCT02325791|363810714|FG000|Overall Study|Protocol Violation|0|||
105491218|NCT02325791|363810715|FG001|Overall Study|Protocol Violation|0|||
105491219|NCT02325791|363810716|FG002|Overall Study|Protocol Violation|1|||
105491220|NCT02325791|363810717|FG003|Overall Study|Protocol Violation|0|||
105491221|NCT02325791|363810714|FG000|Overall Study|Withdrawal by Subject|0|||
105491222|NCT02325791|363810715|FG001|Overall Study|Withdrawal by Subject|5|||
105491223|NCT02325791|363810716|FG002|Overall Study|Withdrawal by Subject|8|||
105491224|NCT02325791|363810717|FG003|Overall Study|Withdrawal by Subject|16|||
105491225|NCT03953183|363810718|FG000|Overall Study|Physician Decision|0|||
105491226|NCT03953183|363810719|FG001|Overall Study|Physician Decision|1|||
105491227|NCT03953183|363810718|FG000|Overall Study|Withdrawal by Subject|0|||
105491228|NCT03953183|363810719|FG001|Overall Study|Withdrawal by Subject|1|||
105491229|NCT04508140|363810720|FG000|Overall Study|Adverse Event|2|||
105491230|NCT04508140|363810721|FG001|Overall Study|Adverse Event|2|||
105491231|NCT04508140|363810720|FG000|Overall Study|Withdrawal by Subject|0|||
105491232|NCT04508140|363810721|FG001|Overall Study|Withdrawal by Subject|2|||
105491233|NCT04508140|363810720|FG000|Overall Study|progressive disease|9|||
105491234|NCT04508140|363810721|FG001|Overall Study|progressive disease|3|||
105491235|NCT01115803|363810722|FG000|Overall Study|Withdrawal by Subject|0|||
105491236|NCT01115803|363810723|FG001|Overall Study|Withdrawal by Subject|0|||
105491237|NCT01115803|363810724|FG002|Overall Study|Withdrawal by Subject|0|||
105491238|NCT01115803|363810725|FG003|Overall Study|Withdrawal by Subject|0|||
105491239|NCT01115803|363810726|FG004|Overall Study|Withdrawal by Subject|0|||
105491240|NCT01115803|363810727|FG005|Overall Study|Withdrawal by Subject|0|||
105491241|NCT01115803|363810728|FG006|Overall Study|Withdrawal by Subject|1|||
105491242|NCT01115803|363810722|FG000|Overall Study|Lost to Follow-up|0|||
105491243|NCT01115803|363810723|FG001|Overall Study|Lost to Follow-up|0|||
105491244|NCT01115803|363810724|FG002|Overall Study|Lost to Follow-up|1|||
105491245|NCT01115803|363810725|FG003|Overall Study|Lost to Follow-up|0|||
105491246|NCT01115803|363810726|FG004|Overall Study|Lost to Follow-up|0|||
105491247|NCT01115803|363810727|FG005|Overall Study|Lost to Follow-up|0|||
105491248|NCT01115803|363810728|FG006|Overall Study|Lost to Follow-up|0|||
105491249|NCT01115803|363810722|FG000|Overall Study|Progressive Disease during Cycle1|0|||
105491250|NCT01115803|363810723|FG001|Overall Study|Progressive Disease during Cycle1|0|||
105491251|NCT01115803|363810724|FG002|Overall Study|Progressive Disease during Cycle1|0|||
105491252|NCT01115803|363810725|FG003|Overall Study|Progressive Disease during Cycle1|0|||
105320607|NCT00281957|363172262|FG000|Overall Study|Not protocol specified|8|||
105491253|NCT01115803|363810726|FG004|Overall Study|Progressive Disease during Cycle1|0|||
105491254|NCT01115803|363810727|FG005|Overall Study|Progressive Disease during Cycle1|0|||
105491255|NCT01115803|363810728|FG006|Overall Study|Progressive Disease during Cycle1|1|||
105491256|NCT00943124|363810729|FG000|Period 1|Withdrawal by Subject|1|||
105850356|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
105850357|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
105850358|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850359|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850360|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850361|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850362|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850363|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850364|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850365|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850366|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850367|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850368|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850369|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850370|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850371|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
105850372|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850373|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850374|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850375|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850376|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850377|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850378|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850379|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850380|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850381|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850382|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
105850383|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850384|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
105850385|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
105850386|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850387|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850388|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850389|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850390|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850391|NCT03982199|365112496|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850392|NCT03982199|365112497|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850393|NCT03982199|365112498|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850394|NCT03982199|365112499|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850395|NCT03982199|365112500|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850396|NCT03982199|365112501|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850397|NCT03982199|365112502|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850398|NCT03982199|365112503|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850399|NCT03982199|365112504|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850400|NCT03982199|365112505|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
105850401|NCT03982199|365112506|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
105850402|NCT03982199|365112507|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
105850403|NCT03982199|365112508|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
105850404|NCT03982199|365112509|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
105850405|NCT03982199|365112496|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850406|NCT03982199|365112497|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850407|NCT03982199|365112498|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850408|NCT03982199|365112499|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850409|NCT03982199|365112500|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105491257|NCT00943124|363810730|FG001|Period 1|Withdrawal by Subject|1|||
105491258|NCT00943124|363810729|FG000|Period 1|Did Not Follow Study Procedures|1|||
105491259|NCT00943124|363810730|FG001|Period 1|Did Not Follow Study Procedures|0|||
105491260|NCT00943124|363810729|FG000|Period 1|Personal Reasons|0|||
105491261|NCT00943124|363810730|FG001|Period 1|Personal Reasons|1|||
105370947|NCT03154086|363364698|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105370948|NCT03154086|363364699|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105370949|NCT03154086|363364700|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105370950|NCT03154086|363364701|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105370951|NCT03154086|363364702|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105370952|NCT03154086|363364703|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105370953|NCT03154086|363364704|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105370954|NCT03154086|363364705|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105370955|NCT03154086|363364706|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105370956|NCT03154086|363364707|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105370957|NCT03154086|363364708|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105370958|NCT03154086|363364709|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105370959|NCT03154086|363364695|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105370960|NCT03154086|363364696|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105370961|NCT03154086|363364697|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105370962|NCT03154086|363364698|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105370963|NCT03154086|363364699|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105370964|NCT03154086|363364700|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105370965|NCT03154086|363364701|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105370966|NCT03154086|363364702|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105370967|NCT03154086|363364703|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
105370968|NCT03154086|363364704|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105370969|NCT03154086|363364705|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105370970|NCT03154086|363364706|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105370971|NCT03154086|363364707|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105370972|NCT03154086|363364708|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105370973|NCT03154086|363364709|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105370974|NCT03154086|363364695|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105370975|NCT03154086|363364696|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105370976|NCT03154086|363364697|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105370977|NCT03154086|363364698|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105370978|NCT03154086|363364699|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105370979|NCT03154086|363364700|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105370980|NCT03154086|363364701|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105370981|NCT03154086|363364702|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
105370982|NCT03154086|363364703|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105370983|NCT03154086|363364704|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105370984|NCT03154086|363364705|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105370985|NCT03154086|363364706|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105370986|NCT03154086|363364707|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105370987|NCT03154086|363364708|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105370988|NCT03154086|363364709|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105370989|NCT03154086|363364695|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
105370990|NCT03154086|363364696|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
105370991|NCT03154086|363364697|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
105370992|NCT03154086|363364698|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
105370993|NCT03154086|363364699|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
105370994|NCT03154086|363364700|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
105370995|NCT03154086|363364701|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
105370996|NCT03154086|363364702|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
105370997|NCT03154086|363364703|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
105370998|NCT03154086|363364704|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
105370999|NCT03154086|363364705|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
105371000|NCT03154086|363364706|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
105371001|NCT03154086|363364707|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
105371002|NCT03154086|363364708|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
105371003|NCT03154086|363364709|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
105371004|NCT04494646|363364712|FG000|Overall Study|Adverse Event|0|||
105371005|NCT04494646|363364713|FG001|Overall Study|Adverse Event|1|||
105371006|NCT04494646|363364712|FG000|Overall Study|Withdrawal by Subject|0|||
105371007|NCT04494646|363364713|FG001|Overall Study|Withdrawal by Subject|1|||
105371008|NCT02785939|363364716|FG000|Overall Study|Progression|25|||
105371009|NCT02785939|363364717|FG001|Overall Study|Progression|8|||
105371010|NCT02785939|363364716|FG000|Overall Study|Adverse Event|3|||
105371011|NCT02785939|363364717|FG001|Overall Study|Adverse Event|1|||
105371012|NCT02785939|363364716|FG000|Overall Study|Death|1|||
105371013|NCT02785939|363364717|FG001|Overall Study|Death|0|||
105371014|NCT02785939|363364716|FG000|Overall Study|Refusal|1|||
105371015|NCT02785939|363364717|FG001|Overall Study|Refusal|0|||
105371016|NCT02785939|363364716|FG000|Overall Study|Deteriorating health|1|||
105371017|NCT02785939|363364717|FG001|Overall Study|Deteriorating health|0|||
105371018|NCT02785939|363364716|FG000|Overall Study|Not protocol specified|0|||
105371019|NCT02785939|363364717|FG001|Overall Study|Not protocol specified|1|||
105371020|NCT02295644|363364723|FG000|Overall Study|Did not meet inclusion criterion|0|||
105371021|NCT02295644|363364724|FG001|Overall Study|Did not meet inclusion criterion|0|||
105371022|NCT02295644|363364725|FG002|Overall Study|Did not meet inclusion criterion|1|||
105850410|NCT03982199|365112501|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105371023|NCT02295644|363364726|FG003|Overall Study|Did not meet inclusion criterion|2|||
105371024|NCT01692119|363364727|FG000|Overall Study|Protocol Violation|3|||
105371025|NCT01692119|363364728|FG001|Overall Study|Protocol Violation|1|||
105371026|NCT01692119|363364727|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
105371027|NCT01692119|363364728|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
105371028|NCT01299584|363364738|FG000|Overall Study|Protocol Violation|9|||
105371029|NCT05412134|363364744|FG000|Overall Study|Lost to Follow-up|2|||
105371030|NCT05412134|363364745|FG001|Overall Study|Lost to Follow-up|0|||
105371031|NCT03307174|363364746|FG000|Overall Study|Unplanned ICU Administrion|5|||
105371032|NCT03307174|363364747|FG001|Overall Study|Unplanned ICU Administrion|3|||
105371033|NCT03307174|363364746|FG000|Overall Study|Aborted Surgery|1|||
105371034|NCT03307174|363364747|FG001|Overall Study|Aborted Surgery|2|||
105371035|NCT03307174|363364746|FG000|Overall Study|Hypotension|6|||
105371036|NCT03307174|363364747|FG001|Overall Study|Hypotension|0|||
105371037|NCT03307174|363364746|FG000|Overall Study|Nonfunctional epidural|1|||
105371038|NCT03307174|363364747|FG001|Overall Study|Nonfunctional epidural|1|||
105371039|NCT03307174|363364746|FG000|Overall Study|Planned epidural removal|1|||
105371040|NCT03307174|363364747|FG001|Overall Study|Planned epidural removal|0|||
105371041|NCT03307174|363364746|FG000|Overall Study|Intrathecal catheter placement|0|||
105371042|NCT03307174|363364747|FG001|Overall Study|Intrathecal catheter placement|1|||
105371043|NCT03704064|363364749|FG000|Overall Study|Lost to Follow-up|8|||
105371044|NCT03704064|363364750|FG001|Overall Study|Lost to Follow-up|4|||
105371045|NCT03704064|363364749|FG000|Overall Study|Withdrawal by Subject|1|||
105371046|NCT03704064|363364750|FG001|Overall Study|Withdrawal by Subject|1|||
105491262|NCT03059446|363810731|FG000|Overall Study|Adverse Event|11|||
105491263|NCT03059446|363810731|FG000|Overall Study|Withdrawal of Consent|16|||
105491264|NCT03059446|363810731|FG000|Overall Study|Lost to Follow-up|3|||
105491265|NCT03059446|363810731|FG000|Overall Study|Protocol Violation|1|||
105491266|NCT03059446|363810731|FG000|Overall Study|Study Terminated by Sponsor|131|||
105491267|NCT03059446|363810731|FG000|Overall Study|Reason not Specified|5|||
105491268|NCT04025710|363810732|FG000|Overall Study|Death|3|||
105491269|NCT04025710|363810732|FG000|Overall Study|Lost to Follow-up|5|||
105491270|NCT04025710|363810732|FG000|Overall Study|Withdrawal by Subject|1|||
105491271|NCT04025710|363810732|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
105491272|NCT04025710|363810732|FG000|Overall Study|Drop-out according to protocol|34|||
105491273|NCT02992132|363810733|FG000|Overall Study|Adverse Event|4|||
105491274|NCT02992132|363810734|FG001|Overall Study|Adverse Event|1|||
105850411|NCT03982199|365112502|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105491275|NCT02992132|363810735|FG002|Overall Study|Adverse Event|3|||
105850412|NCT03982199|365112503|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850413|NCT03982199|365112504|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850414|NCT03982199|365112505|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
105850415|NCT03982199|365112506|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850416|NCT03982199|365112507|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850417|NCT03982199|365112508|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850418|NCT03982199|365112509|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850419|NCT03982199|365112496|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850420|NCT03982199|365112497|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850421|NCT03982199|365112498|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105491276|NCT02992132|363810733|FG000|Overall Study|Lack of Efficacy|2|||
105491277|NCT02992132|363810734|FG001|Overall Study|Lack of Efficacy|0|||
105491278|NCT02992132|363810735|FG002|Overall Study|Lack of Efficacy|0|||
105491279|NCT02992132|363810733|FG000|Overall Study|Non-compliance with study drug|2|||
105491280|NCT02992132|363810734|FG001|Overall Study|Non-compliance with study drug|0|||
105491281|NCT02992132|363810735|FG002|Overall Study|Non-compliance with study drug|0|||
105371047|NCT03704064|363364749|FG000|Overall Study|No longer available for study visits|0|||
105371048|NCT03704064|363364750|FG001|Overall Study|No longer available for study visits|1|||
105371049|NCT03704064|363364749|FG000|Overall Study|Censoring event|1|||
105491282|NCT02992132|363810733|FG000|Overall Study|Progressive disease|1|||
105491283|NCT02992132|363810734|FG001|Overall Study|Progressive disease|0|||
105371050|NCT03704064|363364750|FG001|Overall Study|Censoring event|0|||
105371051|NCT00830128|363364751|FG000|Overall Study|Adverse Event|5|||
105491284|NCT02992132|363810735|FG002|Overall Study|Progressive disease|0|||
105491285|NCT02992132|363810733|FG000|Overall Study|Protocol Violation|2|||
105491286|NCT02992132|363810734|FG001|Overall Study|Protocol Violation|2|||
105491287|NCT02992132|363810735|FG002|Overall Study|Protocol Violation|0|||
105491288|NCT02992132|363810733|FG000|Overall Study|Caregiver withdrew consent|2|||
105491289|NCT02992132|363810734|FG001|Overall Study|Caregiver withdrew consent|3|||
105491290|NCT02992132|363810735|FG002|Overall Study|Caregiver withdrew consent|2|||
105491291|NCT02992132|363810733|FG000|Overall Study|Withdrawal by Subject|0|||
105491292|NCT02992132|363810734|FG001|Overall Study|Withdrawal by Subject|2|||
105491293|NCT02992132|363810735|FG002|Overall Study|Withdrawal by Subject|1|||
105320608|NCT00281957|363172263|FG001|Overall Study|Not protocol specified|1|||
105320609|NCT00281957|363172262|FG000|Overall Study|Not eligible|1|||
105320610|NCT00281957|363172263|FG001|Overall Study|Not eligible|2|||
105320611|NCT00281957|363172262|FG000|Overall Study|Did not start treatment|3|||
105491294|NCT02992132|363810733|FG000|Overall Study|Physician Decision|0|||
105320612|NCT00281957|363172263|FG001|Overall Study|Did not start treatment|1|||
105320613|NCT00281957|363172262|FG000|Overall Study|Refusal unrelated to adverse events|0|||
105320614|NCT00281957|363172263|FG001|Overall Study|Refusal unrelated to adverse events|1|||
105320615|NCT01876446|363172264|FG000|Overall Study|Death|0|||
105320616|NCT01876446|363172265|FG001|Overall Study|Death|1|||
105320617|NCT01876446|363172264|FG000|Overall Study|Withdrawal by Subject|1|||
105320618|NCT01876446|363172265|FG001|Overall Study|Withdrawal by Subject|2|||
105320619|NCT01876446|363172264|FG000|Overall Study|Physician Decision|1|||
105320620|NCT01876446|363172265|FG001|Overall Study|Physician Decision|3|||
105320621|NCT03180645|363172267|FG000|Overall Study|Adverse Event|0|||
105320622|NCT03180645|363172268|FG001|Overall Study|Adverse Event|1|||
105320623|NCT03180645|363172269|FG002|Overall Study|Adverse Event|2|||
105320624|NCT01808573|363172279|FG000|Overall Study|Death|212|||
105320625|NCT01808573|363172280|FG001|Overall Study|Death|240|||
105320626|NCT01808573|363172279|FG000|Overall Study|Withdrawal by Subject|12|||
105320627|NCT01808573|363172280|FG001|Overall Study|Withdrawal by Subject|10|||
105320628|NCT01808573|363172279|FG000|Overall Study|Lost to Follow-up|3|||
105320629|NCT01808573|363172280|FG001|Overall Study|Lost to Follow-up|0|||
105320630|NCT01808573|363172279|FG000|Overall Study|Discontinuation of study by sponsor|79|||
105320631|NCT01808573|363172280|FG001|Overall Study|Discontinuation of study by sponsor|64|||
105320632|NCT01808573|363172279|FG000|Overall Study|Randomized in Error|1|||
105320633|NCT01808573|363172280|FG001|Overall Study|Randomized in Error|0|||
105320634|NCT00995774|363172281|FG000|Training Period 2|Withdrawal by Subject|2|||
105320635|NCT00995774|363172282|FG001|Training Period 2|Withdrawal by Subject|0|||
105320636|NCT00822692|363172283|FG000|Overall Study|Lost to Follow-up|17|||
105320637|NCT00822692|363172284|FG001|Overall Study|Lost to Follow-up|25|||
105320638|NCT01256502|363172287|FG000|Overall Study|Had scaffold removed|4|||
105320639|NCT01256502|363172287|FG000|Overall Study|Personal reasons|5|||
105320640|NCT01256502|363172287|FG000|Overall Study|Protocol deviation|1|||
105320641|NCT01523002|363172288|FG000|Period 1|Withdrawal by Subject|1|||
105320642|NCT01523002|363172289|FG001|Period 1|Withdrawal by Subject|3|||
105320643|NCT01523002|363172288|FG000|Period 1|Lost to Follow-up|1|||
105320644|NCT01523002|363172289|FG001|Period 1|Lost to Follow-up|0|||
105320645|NCT01523002|363172288|FG000|Period 1|Adverse Event|0|||
105320646|NCT01523002|363172289|FG001|Period 1|Adverse Event|8|||
105320647|NCT01523002|363172288|FG000|Period 2|Withdrawal by Subject|4|||
105320648|NCT01523002|363172289|FG001|Period 2|Withdrawal by Subject|1|||
105320649|NCT01523002|363172288|FG000|Period 2|Adverse Event|2|||
105320650|NCT01523002|363172289|FG001|Period 2|Adverse Event|5|||
105320651|NCT01523002|363172288|FG000|Period 3|Withdrawal by Subject|1|||
105320652|NCT01523002|363172289|FG001|Period 3|Withdrawal by Subject|0|||
105320653|NCT01523002|363172288|FG000|Period 3|Adverse Event|3|||
105320654|NCT01523002|363172289|FG001|Period 3|Adverse Event|0|||
105320655|NCT03281876|363172290|FG000|Overall Study|Adverse Event|4|||
105320656|NCT03281876|363172291|FG001|Overall Study|Adverse Event|15|||
105320657|NCT03281876|363172290|FG000|Overall Study|Lost to Follow-up|1|||
105320658|NCT03281876|363172291|FG001|Overall Study|Lost to Follow-up|4|||
105320659|NCT03281876|363172290|FG000|Overall Study|Withdrawal by Subject|11|||
105320660|NCT03281876|363172291|FG001|Overall Study|Withdrawal by Subject|15|||
105320661|NCT03281876|363172290|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
105320662|NCT03281876|363172291|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105491295|NCT02992132|363810734|FG001|Overall Study|Physician Decision|0|||
105491296|NCT02992132|363810735|FG002|Overall Study|Physician Decision|1|||
105491297|NCT01610271|363810736|FG000|Overall Study|Surgery not complete|0|||
105320663|NCT03281876|363172290|FG000|Overall Study|OTHER|5|||
105320664|NCT03281876|363172291|FG001|Overall Study|OTHER|5|||
105320665|NCT03953612|363172292|FG000|Overall Study|Randomized but did not start|1|||
105320666|NCT03953612|363172293|FG001|Overall Study|Randomized but did not start|1|||
105320667|NCT03953612|363172294|FG002|Overall Study|Randomized but did not start|1|||
105320668|NCT03953612|363172292|FG000|Overall Study|Withdrawal by Subject|2|||
105320669|NCT03953612|363172293|FG001|Overall Study|Withdrawal by Subject|1|||
105320670|NCT03953612|363172294|FG002|Overall Study|Withdrawal by Subject|0|||
105320671|NCT00456300|363172295|FG000|Overall Study|Adverse Event|1|||
105320672|NCT00456300|363172296|FG001|Overall Study|Adverse Event|0|||
105320673|NCT03485352|363172297|FG000|Overall Study|Lost to Follow-up|9|||
105320674|NCT01478373|363172300|FG000|Treatment Phase|Protocol Violation|1|||
105320675|NCT01478373|363172300|FG000|Survival Phase|Adverse Event|8|||
105320676|NCT01478373|363172300|FG000|Survival Phase|Protocol Violation|1|||
105320677|NCT01478373|363172300|FG000|Survival Phase|crossover to another study|2|||
105320678|NCT01478373|363172300|FG000|Survival Phase|Progressive Disease|27|||
105320679|NCT02452476|363172301|FG000|Overall Study|Death|4|||
105320680|NCT02452476|363172302|FG001|Overall Study|Death|7|||
105320681|NCT02452476|363172301|FG000|Overall Study|Lost to Follow-up|1|||
105320682|NCT02452476|363172302|FG001|Overall Study|Lost to Follow-up|1|||
105320683|NCT02452476|363172301|FG000|Overall Study|Physician Decision|1|||
105320684|NCT02452476|363172302|FG001|Overall Study|Physician Decision|1|||
105320685|NCT02452476|363172301|FG000|Overall Study|Not treated|5|||
105320686|NCT02452476|363172302|FG001|Overall Study|Not treated|1|||
105320687|NCT01512160|363172303|FG000|Overall Study|Lost to Follow-up|1|||
105320688|NCT01512160|363172304|FG001|Overall Study|Lost to Follow-up|0|||
105320689|NCT01512160|363172305|FG002|Overall Study|Lost to Follow-up|0|||
105320690|NCT01512160|363172306|FG003|Overall Study|Lost to Follow-up|0|||
105320691|NCT01512160|363172303|FG000|Overall Study|Withdrawal by Subject|1|||
105320692|NCT01512160|363172304|FG001|Overall Study|Withdrawal by Subject|0|||
105320693|NCT01512160|363172305|FG002|Overall Study|Withdrawal by Subject|0|||
105320694|NCT01512160|363172306|FG003|Overall Study|Withdrawal by Subject|1|||
105320695|NCT01290302|363174825|FG000|Overall Study|Adverse Event|2|||
105320696|NCT01290302|363174826|FG001|Overall Study|Adverse Event|0|||
105320697|NCT01290302|363174825|FG000|Overall Study|Withdrawal by Subject|1|||
105320698|NCT01290302|363174826|FG001|Overall Study|Withdrawal by Subject|0|||
105320699|NCT01290302|363174825|FG000|Overall Study|Physician Decision|0|||
105320700|NCT01290302|363174826|FG001|Overall Study|Physician Decision|2|||
105320701|NCT01290302|363174825|FG000|Overall Study|Expiration of time for screening window|1|||
105320702|NCT01290302|363174826|FG001|Overall Study|Expiration of time for screening window|0|||
105320703|NCT02090725|363174827|FG000|Overall Study|Withdrawal by Subject|1|||
105320704|NCT02090725|363174827|FG000|Overall Study|participants moved from area|3|||
105320705|NCT01499095|363174828|FG000|Overall Study|Randomized But Not Treated|1|||
105320706|NCT01499095|363174829|FG001|Overall Study|Randomized But Not Treated|1|||
105320707|NCT01499095|363174828|FG000|Overall Study|Adverse Event|12|||
105320708|NCT01499095|363174829|FG001|Overall Study|Adverse Event|7|||
105320709|NCT01499095|363174828|FG000|Overall Study|Lack of Efficacy|2|||
105320710|NCT01499095|363174829|FG001|Overall Study|Lack of Efficacy|1|||
105320711|NCT01499095|363174828|FG000|Overall Study|Protocol Violation|6|||
105320712|NCT01499095|363174829|FG001|Overall Study|Protocol Violation|7|||
105320713|NCT01499095|363174828|FG000|Overall Study|Received Rescue Therapy|32|||
105320714|NCT01499095|363174829|FG001|Overall Study|Received Rescue Therapy|40|||
105320715|NCT01499095|363174828|FG000|Overall Study|Diverse Reasons|22|||
105320716|NCT01499095|363174829|FG001|Overall Study|Diverse Reasons|25|||
105320717|NCT01499095|363174828|FG000|Overall Study|Lost to Follow-up|6|||
105320718|NCT01499095|363174829|FG001|Overall Study|Lost to Follow-up|4|||
105320719|NCT01499095|363174828|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
105320720|NCT01499095|363174829|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
105320721|NCT01499095|363174828|FG000|Overall Study|Hypoglycemia|3|||
105320722|NCT01499095|363174829|FG001|Overall Study|Hypoglycemia|1|||
105320723|NCT01499095|363174828|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
105320724|NCT01499095|363174829|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
105320725|NCT01499095|363174828|FG000|Overall Study|Change in Injection Schedule|2|||
105320726|NCT01499095|363174829|FG001|Overall Study|Change in Injection Schedule|0|||
105320727|NCT01499095|363174828|FG000|Overall Study|Perceived Lack of Efficacy|1|||
105320728|NCT01499095|363174829|FG001|Overall Study|Perceived Lack of Efficacy|1|||
105320729|NCT04358081|363174833|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
105320730|NCT04358081|363174834|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
105320731|NCT04358081|363174835|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
105320732|NCT04358081|363174833|FG000|Treatment Phase of Study|Adverse Event|1|||
105320733|NCT04358081|363174834|FG001|Treatment Phase of Study|Adverse Event|0|||
105320734|NCT04358081|363174835|FG002|Treatment Phase of Study|Adverse Event|1|||
105320735|NCT04358081|363174833|FG000|Treatment Phase of Study|Physician Decision|2|||
105320736|NCT04358081|363174834|FG001|Treatment Phase of Study|Physician Decision|0|||
105320737|NCT04358081|363174835|FG002|Treatment Phase of Study|Physician Decision|1|||
105320738|NCT04358081|363174833|FG000|Treatment Phase of Study|Protocol Violation|1|||
105320739|NCT04358081|363174834|FG001|Treatment Phase of Study|Protocol Violation|0|||
105320740|NCT04358081|363174835|FG002|Treatment Phase of Study|Protocol Violation|0|||
105320741|NCT04358081|363174833|FG000|Study Completion Phase|Death|0|||
105320742|NCT04358081|363174834|FG001|Study Completion Phase|Death|0|||
105320743|NCT04358081|363174835|FG002|Study Completion Phase|Death|1|||
105320744|NCT04358081|363174833|FG000|Study Completion Phase|Lost to Follow-up|1|||
105320745|NCT04358081|363174834|FG001|Study Completion Phase|Lost to Follow-up|0|||
105320746|NCT04358081|363174835|FG002|Study Completion Phase|Lost to Follow-up|1|||
105320747|NCT03657797|363174836|FG000|Overall Study|Lost to Follow-up|0|||
105320748|NCT03657797|363174837|FG001|Overall Study|Lost to Follow-up|1|||
105320749|NCT03657797|363174838|FG002|Overall Study|Lost to Follow-up|1|||
105320750|NCT03657797|363174839|FG003|Overall Study|Lost to Follow-up|0|||
105320751|NCT03657797|363174836|FG000|Overall Study|Physician Decision|0|||
105320752|NCT03657797|363174837|FG001|Overall Study|Physician Decision|1|||
105320753|NCT03657797|363174838|FG002|Overall Study|Physician Decision|0|||
105320754|NCT03657797|363174839|FG003|Overall Study|Physician Decision|0|||
105320755|NCT03657797|363174836|FG000|Overall Study|Withdrawal by Subject|0|||
105320756|NCT03657797|363174837|FG001|Overall Study|Withdrawal by Subject|1|||
105320757|NCT03657797|363174838|FG002|Overall Study|Withdrawal by Subject|2|||
105320758|NCT03657797|363174839|FG003|Overall Study|Withdrawal by Subject|0|||
105320759|NCT03657797|363174836|FG000|Overall Study|Adverse Event|0|||
105320760|NCT03657797|363174837|FG001|Overall Study|Adverse Event|0|||
105320761|NCT03657797|363174838|FG002|Overall Study|Adverse Event|2|||
105320762|NCT03657797|363174839|FG003|Overall Study|Adverse Event|0|||
105320763|NCT00725283|363174842|FG000|Overall Study|Missing Code|3|||
105320764|NCT00725283|363174842|FG000|Overall Study|Death|5|||
105320765|NCT00725283|363174842|FG000|Overall Study|Other|6|||
105320766|NCT00725283|363174842|FG000|Overall Study|Withdrawal by Subject|10|||
105320767|NCT05256134|363174843|FG000|Overall Study|Study Terminated by Sponsor|11|||
105320768|NCT05256134|363174844|FG001|Overall Study|Study Terminated by Sponsor|10|||
105320769|NCT05256134|363174843|FG000|Overall Study|Withdrawal by Subject|1|||
105320770|NCT05256134|363174844|FG001|Overall Study|Withdrawal by Subject|3|||
105320771|NCT01130532|363174845|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
105320772|NCT01130532|363174846|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
105320773|NCT01130532|363174847|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
105320774|NCT01130532|363174848|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
105320775|NCT01130532|363174845|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
105320776|NCT01130532|363174846|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
105320777|NCT01130532|363174847|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
105320778|NCT01130532|363174848|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
105320779|NCT01130532|363174845|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
105320780|NCT01130532|363174846|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
105320781|NCT01130532|363174847|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
105320782|NCT01130532|363174848|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
105320783|NCT01130532|363174845|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
105320784|NCT01130532|363174846|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
105320785|NCT01130532|363174847|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
105320786|NCT01130532|363174848|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
105320787|NCT01130532|363174845|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
105320788|NCT01130532|363174846|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
105320789|NCT01130532|363174847|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
105320790|NCT01130532|363174848|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
105320791|NCT01130532|363174845|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
105320792|NCT01130532|363174846|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
105320793|NCT01130532|363174847|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
105320794|NCT01130532|363174848|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
105320795|NCT01130532|363174845|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
105320796|NCT01130532|363174846|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
105320797|NCT01130532|363174847|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
105320798|NCT01130532|363174848|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
105320799|NCT01130532|363174845|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
105320800|NCT01130532|363174846|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
105320801|NCT01130532|363174847|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
105320802|NCT01130532|363174848|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
105320803|NCT01130532|363174845|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
105320804|NCT01130532|363174846|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
105320805|NCT01130532|363174847|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
105320806|NCT01130532|363174848|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
105320807|NCT01130532|363174845|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
105320808|NCT01130532|363174846|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
105320809|NCT01130532|363174847|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
105320810|NCT01130532|363174848|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
105371052|NCT00830128|363364751|FG000|Overall Study|Lack of Efficacy|7|||
105576793|NCT02138747|364110324|FG000|Treatment Period 1|Other - Miscellaneous|2|||
105576794|NCT02138747|364110325|FG001|Treatment Period 1|Other - Miscellaneous|4|||
105576795|NCT02138747|364110326|FG002|Treatment Period 1|Other - Miscellaneous|0|||
105320811|NCT01130532|363174845|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
105320812|NCT01130532|363174846|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
105320813|NCT01130532|363174847|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
105320814|NCT01130532|363174848|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
105320815|NCT01567462|363174849|FG000|Overall Study|Withdrawal by Subject|4|||
105320816|NCT01567462|363174850|FG001|Overall Study|Withdrawal by Subject|7|||
105320817|NCT02847260|363174851|FG000|Overall Study|Adverse Event|3|||
105320818|NCT02847260|363174851|FG000|Overall Study|Withdrawal by Subject|2|||
105320819|NCT02847260|363174851|FG000|Overall Study|Clinical Deterioration|1|||
105320820|NCT02847260|363174851|FG000|Overall Study|Physician Decision|1|||
105320821|NCT01842438|363174859|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
105371053|NCT00830128|363364751|FG000|Overall Study|Protocol Violation|1|||
105850422|NCT03982199|365112499|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850423|NCT03982199|365112500|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850424|NCT03982199|365112501|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850425|NCT03982199|365112502|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850426|NCT03982199|365112503|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850427|NCT03982199|365112504|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850428|NCT03982199|365112505|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850429|NCT03982199|365112506|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850430|NCT03982199|365112507|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850431|NCT03982199|365112508|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850432|NCT03982199|365112509|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
105850433|NCT03982199|365112496|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105850434|NCT03982199|365112497|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105850435|NCT03982199|365112498|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105850436|NCT03982199|365112499|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105850437|NCT03982199|365112500|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105320822|NCT01842438|363174860|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
105850438|NCT03982199|365112501|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105850439|NCT03982199|365112502|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105320823|NCT01842438|363174859|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
105320824|NCT01842438|363174860|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
105320825|NCT01842438|363174859|FG000|T2: 6month Follow-up|Death|0|||
105320826|NCT01842438|363174860|FG001|T2: 6month Follow-up|Death|1|||
105320827|NCT00782626|363174864|FG000|Overall Study|Adverse Event|1|||
105320828|NCT00782626|363174864|FG000|Overall Study|Progressive Disease|5|||
105320829|NCT00782626|363174864|FG000|Overall Study|Other Complicating Disease|1|||
105320830|NCT03642262|363174865|FG000|Period 1|Withdrawal by Subject|1|||
105320831|NCT03642262|363174866|FG001|Period 1|Withdrawal by Subject|1|||
105320832|NCT03642262|363174865|FG000|Period 1|Adverse Event|0|||
105320833|NCT03642262|363174866|FG001|Period 1|Adverse Event|1|||
105320834|NCT00077207|363174867|FG000|Overall Study|Adverse Event|5|||
105320835|NCT00077207|363174867|FG000|Overall Study|Lack of Efficacy|12|||
105320836|NCT00077207|363174867|FG000|Overall Study|Physician Decision|6|||
105320837|NCT00077207|363174867|FG000|Overall Study|Withdrawal by Subject|6|||
105320838|NCT00077207|363174867|FG000|Overall Study|Ineligible|1|||
105320839|NCT01050530|363174868|FG000|Overall Study|Adverse Event|6|||
105320840|NCT01050530|363174869|FG001|Overall Study|Adverse Event|3|||
105320841|NCT01050530|363174868|FG000|Overall Study|Lack of Efficacy|1|||
105320842|NCT01050530|363174869|FG001|Overall Study|Lack of Efficacy|4|||
105320843|NCT01050530|363174868|FG000|Overall Study|Withdrawal by Subject|0|||
105320844|NCT01050530|363174869|FG001|Overall Study|Withdrawal by Subject|3|||
105320845|NCT01050530|363174868|FG000|Overall Study|Protocol Violation|1|||
105320846|NCT01050530|363174869|FG001|Overall Study|Protocol Violation|0|||
105320847|NCT00322712|363174874|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
105320848|NCT02071225|363174875|FG000|Overall Study|Withdrawal of Consent|2|||
105320849|NCT02071225|363174875|FG000|Overall Study|Protocol Deviation|1|||
105320850|NCT02071225|363174875|FG000|Overall Study|Lost to Follow-up|2|||
105320851|NCT02071225|363174875|FG000|Overall Study|Death|25|||
105320852|NCT01342081|363174882|FG000|Overall Study|Did not receive allocated intervention|0|||
105320853|NCT01342081|363174883|FG001|Overall Study|Did not receive allocated intervention|0|||
105320854|NCT01342081|363174884|FG002|Overall Study|Did not receive allocated intervention|1|||
105320855|NCT01342081|363174882|FG000|Overall Study|Adverse Event|1|||
105320856|NCT01342081|363174883|FG001|Overall Study|Adverse Event|0|||
105320857|NCT01342081|363174884|FG002|Overall Study|Adverse Event|0|||
105320858|NCT01342081|363174882|FG000|Overall Study|Physician Decision|0|||
105320859|NCT01342081|363174883|FG001|Overall Study|Physician Decision|1|||
105320860|NCT01342081|363174884|FG002|Overall Study|Physician Decision|0|||
105320861|NCT01342081|363174882|FG000|Overall Study|Withdrawal by Subject|1|||
105850440|NCT03982199|365112503|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105850441|NCT03982199|365112504|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105320862|NCT01342081|363174883|FG001|Overall Study|Withdrawal by Subject|1|||
105320863|NCT01342081|363174884|FG002|Overall Study|Withdrawal by Subject|0|||
105320864|NCT04747470|363174885|FG000|Overall Study|Death|0|||
105320865|NCT04747470|363174886|FG001|Overall Study|Death|3|||
105320866|NCT04747470|363174887|FG002|Overall Study|Death|2|||
105320867|NCT04747470|363174888|FG003|Overall Study|Death|2|||
105320868|NCT04747470|363174889|FG004|Overall Study|Death|2|||
105320869|NCT04747470|363174890|FG005|Overall Study|Death|0|||
105850442|NCT03982199|365112505|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105320870|NCT04747470|363174891|FG006|Overall Study|Death|0|||
105320871|NCT04747470|363174892|FG007|Overall Study|Death|0|||
105320872|NCT04747470|363174893|FG008|Overall Study|Death|0|||
105320873|NCT04747470|363174894|FG009|Overall Study|Death|0|||
105320874|NCT04747470|363174895|FG010|Overall Study|Death|0|||
105320875|NCT04747470|363174885|FG000|Overall Study|Withdrew Consent|0|||
105850443|NCT03982199|365112506|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
105850444|NCT03982199|365112507|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
105850445|NCT03982199|365112508|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
105850446|NCT03982199|365112509|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105850447|NCT03982199|365112496|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850448|NCT03982199|365112497|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850449|NCT03982199|365112498|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850450|NCT03982199|365112499|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850451|NCT03982199|365112500|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850452|NCT03982199|365112501|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850453|NCT03982199|365112502|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850454|NCT03982199|365112503|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850455|NCT03982199|365112504|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850456|NCT03982199|365112505|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850457|NCT03982199|365112506|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850458|NCT03982199|365112507|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850459|NCT03982199|365112508|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850460|NCT03982199|365112509|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
105850461|NCT03982199|365112496|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850462|NCT03982199|365112497|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850463|NCT03982199|365112498|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850464|NCT03982199|365112499|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850465|NCT03982199|365112500|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850466|NCT03982199|365112501|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850467|NCT03982199|365112502|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850468|NCT03982199|365112503|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850469|NCT03982199|365112504|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850470|NCT03982199|365112505|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850471|NCT03982199|365112506|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850472|NCT03982199|365112507|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850473|NCT03982199|365112508|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
105850474|NCT03982199|365112509|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
105850475|NCT03982199|365112496|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850476|NCT03982199|365112497|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850477|NCT03982199|365112498|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850478|NCT03982199|365112499|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850479|NCT03982199|365112500|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850480|NCT03982199|365112501|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850481|NCT03982199|365112502|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850482|NCT03982199|365112503|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850483|NCT03982199|365112504|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850484|NCT03982199|365112505|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850485|NCT03982199|365112506|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850486|NCT03982199|365112507|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850487|NCT03982199|365112508|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
105850488|NCT03982199|365112509|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850489|NCT03696953|365112510|FG000|Overall Study|Withdrawal by Subject|6|||
105850490|NCT03696953|365112511|FG001|Overall Study|Withdrawal by Subject|1|||
105850491|NCT03696953|365112510|FG000|Overall Study|missed GBS swabs|2|||
105850492|NCT03696953|365112511|FG001|Overall Study|missed GBS swabs|2|||
105850493|NCT03696953|365112510|FG000|Overall Study|lost study bottle containing capsules|2|||
105850494|NCT03696953|365112511|FG001|Overall Study|lost study bottle containing capsules|0|||
105850495|NCT03696953|365112510|FG000|Overall Study|Premature birth|1|||
105320876|NCT04747470|363174886|FG001|Overall Study|Withdrew Consent|0|||
105320877|NCT04747470|363174887|FG002|Overall Study|Withdrew Consent|0|||
105320878|NCT04747470|363174888|FG003|Overall Study|Withdrew Consent|1|||
105320879|NCT04747470|363174889|FG004|Overall Study|Withdrew Consent|0|||
105320880|NCT04747470|363174890|FG005|Overall Study|Withdrew Consent|0|||
105320881|NCT04747470|363174891|FG006|Overall Study|Withdrew Consent|0|||
105320882|NCT04747470|363174892|FG007|Overall Study|Withdrew Consent|0|||
105320883|NCT04747470|363174893|FG008|Overall Study|Withdrew Consent|0|||
105320884|NCT04747470|363174894|FG009|Overall Study|Withdrew Consent|0|||
105320885|NCT04747470|363174895|FG010|Overall Study|Withdrew Consent|0|||
105320886|NCT04747470|363174885|FG000|Overall Study|Study Terminated by Sponsor|0|||
105320887|NCT04747470|363174886|FG001|Overall Study|Study Terminated by Sponsor|0|||
105320888|NCT04747470|363174887|FG002|Overall Study|Study Terminated by Sponsor|1|||
105320889|NCT04747470|363174888|FG003|Overall Study|Study Terminated by Sponsor|0|||
105320890|NCT04747470|363174889|FG004|Overall Study|Study Terminated by Sponsor|2|||
105320891|NCT04747470|363174890|FG005|Overall Study|Study Terminated by Sponsor|0|||
105320892|NCT04747470|363174891|FG006|Overall Study|Study Terminated by Sponsor|0|||
105320893|NCT04747470|363174892|FG007|Overall Study|Study Terminated by Sponsor|0|||
105320894|NCT04747470|363174893|FG008|Overall Study|Study Terminated by Sponsor|0|||
105320895|NCT04747470|363174894|FG009|Overall Study|Study Terminated by Sponsor|0|||
105320896|NCT04747470|363174895|FG010|Overall Study|Study Terminated by Sponsor|0|||
105320897|NCT01960257|363174898|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
105320898|NCT01960257|363174899|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
105320899|NCT01960257|363174900|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
105320900|NCT01960257|363174898|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
105320901|NCT01960257|363174899|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
105320902|NCT01960257|363174900|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
105320903|NCT01960257|363174898|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
105320904|NCT01960257|363174899|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
105320905|NCT01960257|363174900|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
105320906|NCT02906670|363174901|FG000|Cohort 1, QW|Radiological Progression|1|||
105320907|NCT02906670|363174902|FG001|Cohort 1, QW|Radiological Progression|0|||
105320908|NCT02906670|363174903|FG002|Cohort 1, QW|Radiological Progression|0|||
105320909|NCT02906670|363174904|FG003|Cohort 1, QW|Radiological Progression|0|||
105320910|NCT02906670|363174905|FG004|Cohort 1, QW|Radiological Progression|0|||
105320911|NCT02906670|363174906|FG005|Cohort 1, QW|Radiological Progression|0|||
105320912|NCT02906670|363174907|FG006|Cohort 1, QW|Radiological Progression|0|||
105320913|NCT02906670|363174908|FG007|Cohort 1, QW|Radiological Progression|0|||
105320914|NCT02906670|363174909|FG008|Cohort 1, QW|Radiological Progression|0|||
105320915|NCT02906670|363174910|FG009|Cohort 1, QW|Radiological Progression|0|||
105320916|NCT02906670|363174901|FG000|Cohort 2, QW|Radiological Progression|0|||
105320917|NCT02906670|363174902|FG001|Cohort 2, QW|Radiological Progression|1|||
105320918|NCT02906670|363174903|FG002|Cohort 2, QW|Radiological Progression|0|||
105320919|NCT02906670|363174904|FG003|Cohort 2, QW|Radiological Progression|0|||
105320920|NCT02906670|363174905|FG004|Cohort 2, QW|Radiological Progression|0|||
105320921|NCT02906670|363174906|FG005|Cohort 2, QW|Radiological Progression|0|||
105320922|NCT02906670|363174907|FG006|Cohort 2, QW|Radiological Progression|0|||
105320923|NCT02906670|363174908|FG007|Cohort 2, QW|Radiological Progression|0|||
105320924|NCT02906670|363174909|FG008|Cohort 2, QW|Radiological Progression|0|||
105320925|NCT02906670|363174910|FG009|Cohort 2, QW|Radiological Progression|0|||
105320926|NCT02906670|363174901|FG000|Cohort 3, QW|Radiological Progression|0|||
105320927|NCT02906670|363174902|FG001|Cohort 3, QW|Radiological Progression|0|||
105320928|NCT02906670|363174903|FG002|Cohort 3, QW|Radiological Progression|2|||
105320929|NCT02906670|363174904|FG003|Cohort 3, QW|Radiological Progression|0|||
105320930|NCT02906670|363174905|FG004|Cohort 3, QW|Radiological Progression|0|||
105320931|NCT02906670|363174906|FG005|Cohort 3, QW|Radiological Progression|0|||
105320932|NCT02906670|363174907|FG006|Cohort 3, QW|Radiological Progression|0|||
105320933|NCT02906670|363174908|FG007|Cohort 3, QW|Radiological Progression|0|||
105320934|NCT02906670|363174909|FG008|Cohort 3, QW|Radiological Progression|0|||
105320935|NCT02906670|363174910|FG009|Cohort 3, QW|Radiological Progression|0|||
105320936|NCT02906670|363174901|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
105320937|NCT02906670|363174902|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
105320938|NCT02906670|363174903|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
105320939|NCT02906670|363174904|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
105320940|NCT02906670|363174905|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
105320941|NCT02906670|363174906|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
105320942|NCT02906670|363174907|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
105320943|NCT02906670|363174908|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
105320944|NCT02906670|363174909|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
105320945|NCT02906670|363174910|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
105320946|NCT02906670|363174901|FG000|Cohort 4, Q2W|Radiological Progression|0|||
105320947|NCT02906670|363174902|FG001|Cohort 4, Q2W|Radiological Progression|0|||
105320948|NCT02906670|363174903|FG002|Cohort 4, Q2W|Radiological Progression|0|||
105320949|NCT02906670|363174904|FG003|Cohort 4, Q2W|Radiological Progression|0|||
105320950|NCT02906670|363174905|FG004|Cohort 4, Q2W|Radiological Progression|0|||
105320951|NCT02906670|363174906|FG005|Cohort 4, Q2W|Radiological Progression|1|||
105320952|NCT02906670|363174907|FG006|Cohort 4, Q2W|Radiological Progression|0|||
105320953|NCT02906670|363174908|FG007|Cohort 4, Q2W|Radiological Progression|0|||
105320954|NCT02906670|363174909|FG008|Cohort 4, Q2W|Radiological Progression|0|||
105320955|NCT02906670|363174910|FG009|Cohort 4, Q2W|Radiological Progression|0|||
105320956|NCT02906670|363174901|FG000|Cohort 4, Q2W|Clinical Progression|0|||
105320957|NCT02906670|363174902|FG001|Cohort 4, Q2W|Clinical Progression|0|||
105320958|NCT02906670|363174903|FG002|Cohort 4, Q2W|Clinical Progression|0|||
105320959|NCT02906670|363174904|FG003|Cohort 4, Q2W|Clinical Progression|0|||
105320960|NCT02906670|363174905|FG004|Cohort 4, Q2W|Clinical Progression|0|||
105320961|NCT02906670|363174906|FG005|Cohort 4, Q2W|Clinical Progression|2|||
105320962|NCT02906670|363174907|FG006|Cohort 4, Q2W|Clinical Progression|0|||
105576796|NCT02138747|364110327|FG003|Treatment Period 1|Other - Miscellaneous|0|||
105320963|NCT02906670|363174908|FG007|Cohort 4, Q2W|Clinical Progression|0|||
105320964|NCT02906670|363174909|FG008|Cohort 4, Q2W|Clinical Progression|0|||
105320965|NCT02906670|363174910|FG009|Cohort 4, Q2W|Clinical Progression|0|||
105320966|NCT02906670|363174901|FG000|Cohort 5, Q2W|Radiological Progression|0|||
105320967|NCT02906670|363174902|FG001|Cohort 5, Q2W|Radiological Progression|0|||
105320968|NCT02906670|363174903|FG002|Cohort 5, Q2W|Radiological Progression|0|||
105320969|NCT02906670|363174904|FG003|Cohort 5, Q2W|Radiological Progression|0|||
105320970|NCT02906670|363174905|FG004|Cohort 5, Q2W|Radiological Progression|0|||
105320971|NCT02906670|363174906|FG005|Cohort 5, Q2W|Radiological Progression|0|||
105320972|NCT02906670|363174907|FG006|Cohort 5, Q2W|Radiological Progression|4|||
105320973|NCT02906670|363174908|FG007|Cohort 5, Q2W|Radiological Progression|0|||
105320974|NCT02906670|363174909|FG008|Cohort 5, Q2W|Radiological Progression|0|||
105320975|NCT02906670|363174910|FG009|Cohort 5, Q2W|Radiological Progression|0|||
105320976|NCT02906670|363174901|FG000|Cohort 5, Q2W|Clinical Progression|0|||
105320977|NCT02906670|363174902|FG001|Cohort 5, Q2W|Clinical Progression|0|||
105320978|NCT02906670|363174903|FG002|Cohort 5, Q2W|Clinical Progression|0|||
105320979|NCT02906670|363174904|FG003|Cohort 5, Q2W|Clinical Progression|0|||
105320980|NCT02906670|363174905|FG004|Cohort 5, Q2W|Clinical Progression|0|||
105320981|NCT02906670|363174906|FG005|Cohort 5, Q2W|Clinical Progression|0|||
105320982|NCT02906670|363174907|FG006|Cohort 5, Q2W|Clinical Progression|1|||
105320983|NCT02906670|363174908|FG007|Cohort 5, Q2W|Clinical Progression|0|||
105320984|NCT02906670|363174909|FG008|Cohort 5, Q2W|Clinical Progression|0|||
105320985|NCT02906670|363174910|FG009|Cohort 5, Q2W|Clinical Progression|0|||
105320986|NCT02906670|363174901|FG000|Cohort 5, Q2W|Adverse Event|0|||
105320987|NCT02906670|363174902|FG001|Cohort 5, Q2W|Adverse Event|0|||
105320988|NCT02906670|363174903|FG002|Cohort 5, Q2W|Adverse Event|0|||
105371054|NCT00830128|363364751|FG000|Overall Study|Withdrawal by Subject|2|||
105320989|NCT02906670|363174904|FG003|Cohort 5, Q2W|Adverse Event|0|||
105320990|NCT02906670|363174905|FG004|Cohort 5, Q2W|Adverse Event|0|||
105320991|NCT02906670|363174906|FG005|Cohort 5, Q2W|Adverse Event|0|||
105320992|NCT02906670|363174907|FG006|Cohort 5, Q2W|Adverse Event|1|||
105320993|NCT02906670|363174908|FG007|Cohort 5, Q2W|Adverse Event|0|||
105320994|NCT02906670|363174909|FG008|Cohort 5, Q2W|Adverse Event|0|||
105320995|NCT02906670|363174910|FG009|Cohort 5, Q2W|Adverse Event|0|||
105320996|NCT02906670|363174901|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105320997|NCT02906670|363174902|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105320998|NCT02906670|363174903|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105320999|NCT02906670|363174904|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105321000|NCT02906670|363174905|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105321001|NCT02906670|363174906|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105321002|NCT02906670|363174907|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
105321003|NCT02906670|363174908|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105321004|NCT02906670|363174909|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105321005|NCT02906670|363174910|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105321006|NCT02906670|363174901|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
105321007|NCT02906670|363174902|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
105321008|NCT02906670|363174903|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
105321009|NCT02906670|363174904|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
105321010|NCT02906670|363174905|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
105321011|NCT02906670|363174906|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
105371055|NCT00830128|363364751|FG000|Overall Study|Family obligation|1|||
105371056|NCT00830128|363364751|FG000|Overall Study|Relocation|1|||
105371057|NCT00830128|363364751|FG000|Overall Study|Work obligation|1|||
105371058|NCT00830128|363364751|FG000|Overall Study|Operating a vehicle|1|||
105371059|NCT00062166|363364752|FG000|Overall Study|Withdrawal by Subject|6|||
105371060|NCT03329885|363364755|FG000|Overall Study|Sponsor discontinued the study early|0|||
105371061|NCT03329885|363364756|FG001|Overall Study|Sponsor discontinued the study early|0|||
105371062|NCT03329885|363364757|FG002|Overall Study|Sponsor discontinued the study early|0|||
105371063|NCT03329885|363364758|FG003|Overall Study|Sponsor discontinued the study early|0|||
105371064|NCT03329885|363364759|FG004|Overall Study|Sponsor discontinued the study early|0|||
105371065|NCT03329885|363364760|FG005|Overall Study|Sponsor discontinued the study early|0|||
105371066|NCT03329885|363364761|FG006|Overall Study|Sponsor discontinued the study early|1|||
105371067|NCT03329885|363364762|FG007|Overall Study|Sponsor discontinued the study early|1|||
105371068|NCT03329885|363364763|FG008|Overall Study|Sponsor discontinued the study early|0|||
105371069|NCT02908347|363364764|FG000|Overall Study|Adverse Event|0|||
105491298|NCT01610271|363810737|FG001|Overall Study|Surgery not complete|1|||
105491299|NCT01610271|363810736|FG000|Overall Study|Prosthesis not implanted|2|||
105321012|NCT02906670|363174907|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
105321013|NCT02906670|363174908|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
105321014|NCT02906670|363174909|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
105321015|NCT02906670|363174910|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
105321016|NCT02906670|363174901|FG000|Cohort 5P, Q2W|Adverse Event|0|||
105321017|NCT02906670|363174902|FG001|Cohort 5P, Q2W|Adverse Event|0|||
105321018|NCT02906670|363174903|FG002|Cohort 5P, Q2W|Adverse Event|0|||
105321019|NCT02906670|363174904|FG003|Cohort 5P, Q2W|Adverse Event|0|||
105321020|NCT02906670|363174905|FG004|Cohort 5P, Q2W|Adverse Event|0|||
105321021|NCT02906670|363174906|FG005|Cohort 5P, Q2W|Adverse Event|0|||
105321022|NCT02906670|363174907|FG006|Cohort 5P, Q2W|Adverse Event|0|||
105321023|NCT02906670|363174908|FG007|Cohort 5P, Q2W|Adverse Event|1|||
105321024|NCT02906670|363174909|FG008|Cohort 5P, Q2W|Adverse Event|0|||
105321025|NCT02906670|363174910|FG009|Cohort 5P, Q2W|Adverse Event|0|||
105321026|NCT02906670|363174901|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
105321027|NCT02906670|363174902|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
105321028|NCT02906670|363174903|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
105321029|NCT02906670|363174904|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
105321030|NCT02906670|363174905|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
105321031|NCT02906670|363174906|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
105321032|NCT02906670|363174907|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
105321033|NCT02906670|363174908|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
105321034|NCT02906670|363174909|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
105321035|NCT02906670|363174910|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
105321036|NCT02906670|363174901|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
105321037|NCT02906670|363174902|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
105321038|NCT02906670|363174903|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
105321039|NCT02906670|363174904|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
105321040|NCT02906670|363174905|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
105321041|NCT02906670|363174906|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
105321042|NCT02906670|363174907|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
105321043|NCT02906670|363174908|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
105321044|NCT02906670|363174909|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
105321045|NCT02906670|363174910|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
105321046|NCT02906670|363174901|FG000|Cohort 4P, QW|Radiological Progression|0|||
105321047|NCT02906670|363174902|FG001|Cohort 4P, QW|Radiological Progression|0|||
105321048|NCT02906670|363174903|FG002|Cohort 4P, QW|Radiological Progression|0|||
105321049|NCT02906670|363174904|FG003|Cohort 4P, QW|Radiological Progression|3|||
105321050|NCT02906670|363174905|FG004|Cohort 4P, QW|Radiological Progression|0|||
105321051|NCT02906670|363174906|FG005|Cohort 4P, QW|Radiological Progression|0|||
105321052|NCT02906670|363174907|FG006|Cohort 4P, QW|Radiological Progression|0|||
105321053|NCT02906670|363174908|FG007|Cohort 4P, QW|Radiological Progression|0|||
105321054|NCT02906670|363174909|FG008|Cohort 4P, QW|Radiological Progression|0|||
105321055|NCT02906670|363174910|FG009|Cohort 4P, QW|Radiological Progression|0|||
105321056|NCT02906670|363174901|FG000|Cohort 7P, Q2W|Adverse Event|0|||
105321057|NCT02906670|363174902|FG001|Cohort 7P, Q2W|Adverse Event|0|||
105321058|NCT02906670|363174903|FG002|Cohort 7P, Q2W|Adverse Event|0|||
105321059|NCT02906670|363174904|FG003|Cohort 7P, Q2W|Adverse Event|0|||
105321060|NCT02906670|363174905|FG004|Cohort 7P, Q2W|Adverse Event|0|||
105321061|NCT02906670|363174906|FG005|Cohort 7P, Q2W|Adverse Event|0|||
105321062|NCT02906670|363174907|FG006|Cohort 7P, Q2W|Adverse Event|0|||
105321063|NCT02906670|363174908|FG007|Cohort 7P, Q2W|Adverse Event|0|||
105321064|NCT02906670|363174909|FG008|Cohort 7P, Q2W|Adverse Event|0|||
105321065|NCT02906670|363174910|FG009|Cohort 7P, Q2W|Adverse Event|1|||
105321066|NCT02906670|363174901|FG000|Cohort 7P, Q2W|Physician Decision|0|||
105321067|NCT02906670|363174902|FG001|Cohort 7P, Q2W|Physician Decision|0|||
105321068|NCT02906670|363174903|FG002|Cohort 7P, Q2W|Physician Decision|0|||
105321069|NCT02906670|363174904|FG003|Cohort 7P, Q2W|Physician Decision|0|||
105321070|NCT02906670|363174905|FG004|Cohort 7P, Q2W|Physician Decision|0|||
105321071|NCT02906670|363174906|FG005|Cohort 7P, Q2W|Physician Decision|0|||
105321072|NCT02906670|363174907|FG006|Cohort 7P, Q2W|Physician Decision|0|||
105321073|NCT02906670|363174908|FG007|Cohort 7P, Q2W|Physician Decision|0|||
105321074|NCT02906670|363174909|FG008|Cohort 7P, Q2W|Physician Decision|0|||
105321075|NCT02906670|363174910|FG009|Cohort 7P, Q2W|Physician Decision|1|||
105321076|NCT02906670|363174901|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105321077|NCT02906670|363174902|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105321078|NCT02906670|363174903|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105321079|NCT02906670|363174904|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105321080|NCT02906670|363174905|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105321081|NCT02906670|363174906|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105321082|NCT02906670|363174907|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105321083|NCT02906670|363174908|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105321084|NCT02906670|363174909|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105321085|NCT02906670|363174910|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
105321086|NCT02906670|363174901|FG000|Cohort 5P, QW|Radiological Progression|0|||
105321087|NCT02906670|363174902|FG001|Cohort 5P, QW|Radiological Progression|0|||
105321088|NCT02906670|363174903|FG002|Cohort 5P, QW|Radiological Progression|0|||
105321089|NCT02906670|363174904|FG003|Cohort 5P, QW|Radiological Progression|0|||
105321090|NCT02906670|363174905|FG004|Cohort 5P, QW|Radiological Progression|3|||
105321091|NCT02906670|363174906|FG005|Cohort 5P, QW|Radiological Progression|0|||
105321092|NCT02906670|363174907|FG006|Cohort 5P, QW|Radiological Progression|0|||
105321093|NCT02906670|363174908|FG007|Cohort 5P, QW|Radiological Progression|0|||
105321094|NCT02906670|363174909|FG008|Cohort 5P, QW|Radiological Progression|0|||
105371070|NCT02908347|363364765|FG001|Overall Study|Adverse Event|1|||
105371071|NCT02908347|363364764|FG000|Overall Study|Lost to Follow-up|1|||
105576797|NCT02138747|364110324|FG000|Treatment Period 2|Adverse Event|6|||
105321095|NCT02906670|363174910|FG009|Cohort 5P, QW|Radiological Progression|0|||
105321096|NCT00666328|363174911|FG000|Overall Study|Death|2|||
105321097|NCT00666328|363174911|FG000|Overall Study|Lost to Follow-up|2|||
105321098|NCT00666328|363174911|FG000|Overall Study|No longer met eligibility criteria|1|||
105321099|NCT02288325|363174914|FG000|Run-in Period|Adverse Event|48|||
105321100|NCT02288325|363174915|FG001|Run-in Period|Adverse Event|0|||
105321101|NCT02288325|363174916|FG002|Run-in Period|Adverse Event|0|||
105321102|NCT02288325|363174914|FG000|Run-in Period|Lack of Efficacy|16|||
105321103|NCT02288325|363174915|FG001|Run-in Period|Lack of Efficacy|0|||
105321104|NCT02288325|363174916|FG002|Run-in Period|Lack of Efficacy|0|||
105321105|NCT02288325|363174914|FG000|Run-in Period|Withdrawal of Consent|28|||
105321106|NCT02288325|363174915|FG001|Run-in Period|Withdrawal of Consent|0|||
105321107|NCT02288325|363174916|FG002|Run-in Period|Withdrawal of Consent|0|||
105321108|NCT02288325|363174914|FG000|Run-in Period|Lost to Follow-up|25|||
105321109|NCT02288325|363174915|FG001|Run-in Period|Lost to Follow-up|0|||
105321110|NCT02288325|363174916|FG002|Run-in Period|Lost to Follow-up|0|||
105371072|NCT02908347|363364765|FG001|Overall Study|Lost to Follow-up|0|||
105371073|NCT03886272|363364766|FG000|Period 1|Withdrawal by Subject|0|||
105371074|NCT03886272|363364767|FG001|Period 1|Withdrawal by Subject|0|||
105371075|NCT03886272|363364768|FG002|Period 1|Withdrawal by Subject|0|||
105371076|NCT03886272|363364769|FG003|Period 1|Withdrawal by Subject|0|||
105371077|NCT03886272|363364770|FG004|Period 1|Withdrawal by Subject|0|||
105371078|NCT03886272|363364771|FG005|Period 1|Withdrawal by Subject|1|||
105371079|NCT03886272|363364772|FG006|Period 1|Withdrawal by Subject|0|||
105371080|NCT00909870|363364781|FG000|Overall Study|Adverse Event|13|||
105371081|NCT00909870|363364782|FG001|Overall Study|Adverse Event|7|||
105371082|NCT00909870|363364781|FG000|Overall Study|Protocol Violation|1|||
105371083|NCT00909870|363364782|FG001|Overall Study|Protocol Violation|2|||
105371084|NCT00909870|363364781|FG000|Overall Study|Withdrawal by Subject|5|||
105371085|NCT00909870|363364782|FG001|Overall Study|Withdrawal by Subject|8|||
105371086|NCT00909870|363364781|FG000|Overall Study|Lost to Follow-up|3|||
105371087|NCT00909870|363364782|FG001|Overall Study|Lost to Follow-up|3|||
105371088|NCT00909870|363364781|FG000|Overall Study|Physician Decision|0|||
105371089|NCT00909870|363364782|FG001|Overall Study|Physician Decision|2|||
105371090|NCT00909870|363364781|FG000|Overall Study|Other|1|||
105371091|NCT00909870|363364782|FG001|Overall Study|Other|5|||
105371092|NCT03122171|363364783|FG000|Overall Study|Withdrawal by Subject|1|||
105371093|NCT01114724|363364784|FG000|Overall Study|Death|8|||
105371094|NCT01114724|363364784|FG000|Overall Study|Lost to Follow-up|1|||
105371095|NCT01114724|363364784|FG000|Overall Study|Withdrawal by Subject|1|||
105371096|NCT00843492|363364789|FG000|Overall Study|Adverse Event|0|||
105371097|NCT00843492|363364790|FG001|Overall Study|Adverse Event|3|||
105371098|NCT00843492|363364789|FG000|Overall Study|Lost to Follow-up|4|||
105371099|NCT00843492|363364790|FG001|Overall Study|Lost to Follow-up|4|||
105371100|NCT00843492|363364789|FG000|Overall Study|Withdrawal by Subject|0|||
105371101|NCT00843492|363364790|FG001|Overall Study|Withdrawal by Subject|4|||
105371102|NCT00843492|363364789|FG000|Overall Study|Immobilization Stopped|1|||
105371103|NCT00843492|363364790|FG001|Overall Study|Immobilization Stopped|0|||
105371104|NCT00843492|363364789|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
105371105|NCT00843492|363364790|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
105371106|NCT00843492|363364789|FG000|Overall Study|Orthopedic Surgery|0|||
105371107|NCT00843492|363364790|FG001|Overall Study|Orthopedic Surgery|2|||
105371108|NCT00843492|363364789|FG000|Overall Study|Visit Not Performed|1|||
105371109|NCT00843492|363364790|FG001|Overall Study|Visit Not Performed|0|||
105371110|NCT00843492|363364789|FG000|Overall Study|Deep-vein Thrombosis|1|||
105371111|NCT00843492|363364790|FG001|Overall Study|Deep-vein Thrombosis|0|||
105371112|NCT01200329|363364795|FG000|Overall Study|Lack of financial coverage|2|||
105371113|NCT01200329|363364795|FG000|Overall Study|Progressive disease|1|||
105371114|NCT01420536|363364799|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
105371115|NCT01420536|363364800|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
105321111|NCT02288325|363174914|FG000|Run-in Period|Protocol Violation|17|||
105321112|NCT02288325|363174915|FG001|Run-in Period|Protocol Violation|0|||
105321113|NCT02288325|363174916|FG002|Run-in Period|Protocol Violation|0|||
105371116|NCT03092752|363364802|FG000|Overall Study|Aged <40 years|14209|||
105371117|NCT03092752|363364802|FG000|Overall Study|At least one claim with T2DM|61299|||
105371118|NCT03092752|363364802|FG000|Overall Study|Having no claim of study drugs|29282|||
105371119|NCT03092752|363364802|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
105321114|NCT02288325|363174914|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
105321115|NCT02288325|363174915|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
105371120|NCT03092752|363364802|FG000|Overall Study|<6 month history|245900|||
105371121|NCT01652690|363364806|FG000|Overall Study|Withdrawal by Subject|16|||
105371122|NCT01652690|363364807|FG001|Overall Study|Withdrawal by Subject|4|||
105371123|NCT01652690|363364806|FG000|Overall Study|Other|8|||
105371124|NCT01652690|363364807|FG001|Overall Study|Other|9|||
105371125|NCT01652690|363364806|FG000|Overall Study|Lost to Follow-up|6|||
105371126|NCT01652690|363364807|FG001|Overall Study|Lost to Follow-up|6|||
105371127|NCT01652690|363364806|FG000|Overall Study|Death|5|||
105371128|NCT01652690|363364807|FG001|Overall Study|Death|2|||
105371129|NCT03225287|363364812|FG000|Overall Study|Adverse Event|0|||
105371130|NCT03225287|363364813|FG001|Overall Study|Adverse Event|0|||
105371131|NCT03225287|363364814|FG002|Overall Study|Adverse Event|1|||
105371132|NCT03225287|363364812|FG000|Overall Study|Protocol non-compliance|0|||
105371133|NCT03225287|363364813|FG001|Overall Study|Protocol non-compliance|0|||
105371134|NCT03225287|363364814|FG002|Overall Study|Protocol non-compliance|1|||
105371135|NCT03225287|363364812|FG000|Overall Study|Subject withdraws consent|3|||
105371136|NCT03225287|363364813|FG001|Overall Study|Subject withdraws consent|0|||
105371137|NCT03225287|363364814|FG002|Overall Study|Subject withdraws consent|0|||
105371138|NCT03225287|363364812|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
105371139|NCT03225287|363364813|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
105371140|NCT03225287|363364814|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
105371141|NCT03225287|363364812|FG000|Overall Study|Trial drug not effective|0|||
105371142|NCT03225287|363364813|FG001|Overall Study|Trial drug not effective|1|||
105371143|NCT03225287|363364814|FG002|Overall Study|Trial drug not effective|0|||
105371144|NCT03225287|363364812|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
105371145|NCT03225287|363364813|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
105371146|NCT03225287|363364814|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
105371147|NCT03225287|363364812|FG000|Overall Study|Stem cell transplantation|0|||
105371148|NCT03225287|363364813|FG001|Overall Study|Stem cell transplantation|1|||
105371149|NCT03225287|363364814|FG002|Overall Study|Stem cell transplantation|0|||
105371150|NCT03415178|363364815|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
105371151|NCT03415178|363364816|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
105371152|NCT03415178|363364815|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
105371153|NCT03415178|363364816|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
105371154|NCT00350545|363366727|FG000|Overall Study|Withdrawal by Subject|2|||
105371155|NCT00753519|363366728|FG000|Overall Study|Withdrawal by Subject|0|||
105371156|NCT00753519|363366729|FG001|Overall Study|Withdrawal by Subject|2|||
105371157|NCT00959751|363366730|FG000|Overall Study|Lost to Follow-up|2|||
105371158|NCT00959751|363366731|FG001|Overall Study|Lost to Follow-up|3|||
105371159|NCT00959751|363366730|FG000|Overall Study|Consent Withdrawn|0|||
105371160|NCT00959751|363366731|FG001|Overall Study|Consent Withdrawn|1|||
105371161|NCT00959751|363366730|FG000|Overall Study|Non-compliance to Study Procedures|0|||
105371162|NCT00959751|363366731|FG001|Overall Study|Non-compliance to Study Procedures|1|||
105371163|NCT00959751|363366730|FG000|Overall Study|No migraine headache without aura|7|||
105371164|NCT00959751|363366731|FG001|Overall Study|No migraine headache without aura|7|||
105371165|NCT03427892|363366736|FG000|Overall Study|Lost to Follow-up|2|||
105371166|NCT01673386|363366739|FG000|Overall Study|Study terminated by sponsor|16|||
105371167|NCT01673386|363366740|FG001|Overall Study|Study terminated by sponsor|22|||
105371168|NCT01673386|363366739|FG000|Overall Study|Adverse Event|5|||
105371169|NCT01673386|363366740|FG001|Overall Study|Adverse Event|2|||
105371170|NCT01673386|363366739|FG000|Overall Study|Progressive disease|4|||
105371171|NCT01673386|363366740|FG001|Overall Study|Progressive disease|1|||
105371172|NCT01673386|363366739|FG000|Overall Study|Withdrawal by Subject|0|||
105371173|NCT01673386|363366740|FG001|Overall Study|Withdrawal by Subject|2|||
105371174|NCT01799889|363366743|FG000|Overall Study|Adverse Event|4|||
105371175|NCT01799889|363366744|FG001|Overall Study|Adverse Event|4|||
105371176|NCT01799889|363366745|FG002|Overall Study|Adverse Event|5|||
105371177|NCT01799889|363366746|FG003|Overall Study|Adverse Event|1|||
105371178|NCT01799889|363366747|FG004|Overall Study|Adverse Event|11|||
105371179|NCT01799889|363366748|FG005|Overall Study|Adverse Event|1|||
105371180|NCT01799889|363366749|FG006|Overall Study|Adverse Event|5|||
105371181|NCT01799889|363366750|FG007|Overall Study|Adverse Event|2|||
105371182|NCT01799889|363366751|FG008|Overall Study|Adverse Event|3|||
105371183|NCT01799889|363366752|FG009|Overall Study|Adverse Event|1|||
105371184|NCT01799889|363366753|FG010|Overall Study|Adverse Event|1|||
105371185|NCT01799889|363366754|FG011|Overall Study|Adverse Event|0|||
105371186|NCT01799889|363366743|FG000|Overall Study|Death|1|||
105371187|NCT01799889|363366744|FG001|Overall Study|Death|0|||
105371188|NCT01799889|363366745|FG002|Overall Study|Death|5|||
105371189|NCT01799889|363366746|FG003|Overall Study|Death|3|||
105371190|NCT01799889|363366747|FG004|Overall Study|Death|1|||
105371191|NCT01799889|363366748|FG005|Overall Study|Death|0|||
105371192|NCT01799889|363366749|FG006|Overall Study|Death|0|||
105371193|NCT01799889|363366750|FG007|Overall Study|Death|0|||
105371194|NCT01799889|363366751|FG008|Overall Study|Death|1|||
105371195|NCT01799889|363366752|FG009|Overall Study|Death|0|||
105371196|NCT01799889|363366753|FG010|Overall Study|Death|1|||
105371197|NCT01799889|363366754|FG011|Overall Study|Death|0|||
105371198|NCT01799889|363366743|FG000|Overall Study|Lack of Efficacy|1|||
105371199|NCT01799889|363366744|FG001|Overall Study|Lack of Efficacy|1|||
105371200|NCT01799889|363366745|FG002|Overall Study|Lack of Efficacy|0|||
105371201|NCT01799889|363366746|FG003|Overall Study|Lack of Efficacy|1|||
105850496|NCT03696953|365112511|FG001|Overall Study|Premature birth|4|||
105371202|NCT01799889|363366747|FG004|Overall Study|Lack of Efficacy|2|||
105371203|NCT01799889|363366748|FG005|Overall Study|Lack of Efficacy|2|||
105371204|NCT01799889|363366749|FG006|Overall Study|Lack of Efficacy|0|||
105371205|NCT01799889|363366750|FG007|Overall Study|Lack of Efficacy|0|||
105850497|NCT03696953|365112510|FG000|Overall Study|Gestational hypertension|1|||
105321116|NCT02288325|363174916|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
105321117|NCT02288325|363174914|FG000|Run-in Period|Reason not Specified|8|||
105321118|NCT02288325|363174915|FG001|Run-in Period|Reason not Specified|0|||
105321119|NCT02288325|363174916|FG002|Run-in Period|Reason not Specified|0|||
105321120|NCT02288325|363174914|FG000|Stabilization Period|Adverse Event|13|||
105321121|NCT02288325|363174915|FG001|Stabilization Period|Adverse Event|0|||
105321122|NCT02288325|363174916|FG002|Stabilization Period|Adverse Event|0|||
105321123|NCT02288325|363174914|FG000|Stabilization Period|Lack of Efficacy|22|||
105321124|NCT02288325|363174915|FG001|Stabilization Period|Lack of Efficacy|0|||
105321125|NCT02288325|363174916|FG002|Stabilization Period|Lack of Efficacy|0|||
105321126|NCT02288325|363174914|FG000|Stabilization Period|Withdrawal of Consent|23|||
105321127|NCT02288325|363174915|FG001|Stabilization Period|Withdrawal of Consent|0|||
105321128|NCT02288325|363174916|FG002|Stabilization Period|Withdrawal of Consent|0|||
105321129|NCT02288325|363174914|FG000|Stabilization Period|Lost to Follow-up|12|||
105321130|NCT02288325|363174915|FG001|Stabilization Period|Lost to Follow-up|0|||
105321131|NCT02288325|363174916|FG002|Stabilization Period|Lost to Follow-up|0|||
105321132|NCT02288325|363174914|FG000|Stabilization Period|Protocol Violation|8|||
105321133|NCT02288325|363174915|FG001|Stabilization Period|Protocol Violation|0|||
105321134|NCT02288325|363174916|FG002|Stabilization Period|Protocol Violation|0|||
105321135|NCT02288325|363174914|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
105321136|NCT02288325|363174915|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
105321137|NCT02288325|363174916|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
105321138|NCT02288325|363174914|FG000|Stabilization Period|Reason not Specified|15|||
105850498|NCT03696953|365112511|FG001|Overall Study|Gestational hypertension|1|||
105850499|NCT03696953|365112510|FG000|Overall Study|Gestational diabetes|2|||
105850500|NCT03696953|365112511|FG001|Overall Study|Gestational diabetes|1|||
105850501|NCT03696953|365112510|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
105850502|NCT03696953|365112511|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
105850503|NCT03696953|365112510|FG000|Overall Study|Changed prenatal provider|1|||
105850504|NCT03696953|365112511|FG001|Overall Study|Changed prenatal provider|1|||
105850505|NCT05104476|365112512|FG000|Overall Study|Randomized But Not Treated|1|||
105850506|NCT05104476|365112513|FG001|Overall Study|Randomized But Not Treated|2|||
105850507|NCT05104476|365112512|FG000|Overall Study|Adverse Event|2|||
105850508|NCT05104476|365112513|FG001|Overall Study|Adverse Event|2|||
105850509|NCT05104476|365112512|FG000|Overall Study|Withdrawal by Subject|3|||
105850510|NCT05104476|365112513|FG001|Overall Study|Withdrawal by Subject|3|||
105850511|NCT05104476|365112512|FG000|Overall Study|Other Than Specified|0|||
105850512|NCT05104476|365112513|FG001|Overall Study|Other Than Specified|3|||
105850513|NCT02564211|365112514|FG000|Overall Study|Adverse Event|4|||
105321139|NCT02288325|363174915|FG001|Stabilization Period|Reason not Specified|0|||
105321140|NCT02288325|363174916|FG002|Stabilization Period|Reason not Specified|0|||
105321141|NCT02288325|363174914|FG000|Double-blind Treatment Period|Adverse Event|0|||
105321142|NCT02288325|363174915|FG001|Double-blind Treatment Period|Adverse Event|2|||
105321143|NCT02288325|363174916|FG002|Double-blind Treatment Period|Adverse Event|5|||
105321144|NCT02288325|363174914|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
105371206|NCT01799889|363366751|FG008|Overall Study|Lack of Efficacy|2|||
105371207|NCT01799889|363366752|FG009|Overall Study|Lack of Efficacy|0|||
105371208|NCT01799889|363366753|FG010|Overall Study|Lack of Efficacy|1|||
105371209|NCT01799889|363366754|FG011|Overall Study|Lack of Efficacy|0|||
105371210|NCT01799889|363366743|FG000|Overall Study|Lost to Follow-up|0|||
105371211|NCT01799889|363366744|FG001|Overall Study|Lost to Follow-up|1|||
105371212|NCT01799889|363366745|FG002|Overall Study|Lost to Follow-up|0|||
105371213|NCT01799889|363366746|FG003|Overall Study|Lost to Follow-up|0|||
105371214|NCT01799889|363366747|FG004|Overall Study|Lost to Follow-up|0|||
105371215|NCT01799889|363366748|FG005|Overall Study|Lost to Follow-up|0|||
105371216|NCT01799889|363366749|FG006|Overall Study|Lost to Follow-up|0|||
105371217|NCT01799889|363366750|FG007|Overall Study|Lost to Follow-up|0|||
105371218|NCT01799889|363366751|FG008|Overall Study|Lost to Follow-up|0|||
105371219|NCT01799889|363366752|FG009|Overall Study|Lost to Follow-up|0|||
105371220|NCT01799889|363366753|FG010|Overall Study|Lost to Follow-up|0|||
105371221|NCT01799889|363366754|FG011|Overall Study|Lost to Follow-up|0|||
105371222|NCT01799889|363366743|FG000|Overall Study|Physician Decision|3|||
105371223|NCT01799889|363366744|FG001|Overall Study|Physician Decision|2|||
105371224|NCT01799889|363366745|FG002|Overall Study|Physician Decision|4|||
105371225|NCT01799889|363366746|FG003|Overall Study|Physician Decision|4|||
105371226|NCT01799889|363366747|FG004|Overall Study|Physician Decision|5|||
105371227|NCT01799889|363366748|FG005|Overall Study|Physician Decision|5|||
105371228|NCT01799889|363366749|FG006|Overall Study|Physician Decision|5|||
105371229|NCT01799889|363366750|FG007|Overall Study|Physician Decision|2|||
105371230|NCT01799889|363366751|FG008|Overall Study|Physician Decision|6|||
105371231|NCT01799889|363366752|FG009|Overall Study|Physician Decision|0|||
105371232|NCT01799889|363366753|FG010|Overall Study|Physician Decision|0|||
105371233|NCT01799889|363366754|FG011|Overall Study|Physician Decision|1|||
105371234|NCT01799889|363366743|FG000|Overall Study|Progressive Disease|30|||
105371235|NCT01799889|363366744|FG001|Overall Study|Progressive Disease|26|||
105576798|NCT02138747|364110325|FG001|Treatment Period 2|Adverse Event|3|||
105850514|NCT00622466|365112515|FG000|Overall Study|Death|1|||
105850515|NCT00622466|365112515|FG000|Overall Study|Adverse Event|1|||
105850516|NCT00622466|365112515|FG000|Overall Study|Withdrawal by Subject|2|||
105850517|NCT01908816|365112518|FG000|Overall Study|Subject's no longer requires study drug|0|||
105850518|NCT01908816|365112519|FG001|Overall Study|Subject's no longer requires study drug|0|||
105850519|NCT01908816|365112520|FG002|Overall Study|Subject's no longer requires study drug|0|||
105850520|NCT01908816|365112521|FG003|Overall Study|Subject's no longer requires study drug|1|||
105850521|NCT01908816|365112518|FG000|Overall Study|Protocol deviation|1|||
105850522|NCT01908816|365112519|FG001|Overall Study|Protocol deviation|2|||
105850523|NCT01908816|365112520|FG002|Overall Study|Protocol deviation|1|||
105850524|NCT01908816|365112521|FG003|Overall Study|Protocol deviation|1|||
105850525|NCT01908816|365112518|FG000|Overall Study|Withdrawal by Subject|0|||
105850526|NCT01908816|365112519|FG001|Overall Study|Withdrawal by Subject|4|||
105850527|NCT01908816|365112520|FG002|Overall Study|Withdrawal by Subject|2|||
105850528|NCT01908816|365112521|FG003|Overall Study|Withdrawal by Subject|2|||
105850529|NCT01908816|365112518|FG000|Overall Study|Lost to Follow-up|3|||
105850530|NCT01908816|365112519|FG001|Overall Study|Lost to Follow-up|5|||
105850531|NCT01908816|365112520|FG002|Overall Study|Lost to Follow-up|4|||
105850532|NCT01908816|365112521|FG003|Overall Study|Lost to Follow-up|2|||
105850533|NCT01908816|365112518|FG000|Overall Study|Death|1|||
105850534|NCT01908816|365112519|FG001|Overall Study|Death|0|||
105850535|NCT01908816|365112520|FG002|Overall Study|Death|7|||
105321145|NCT02288325|363174915|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
105321146|NCT02288325|363174916|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
105321147|NCT02288325|363174914|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
105321148|NCT02288325|363174915|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
105321149|NCT02288325|363174916|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
105321150|NCT02288325|363174914|FG000|Double-blind Treatment Period|Protocol Violation|0|||
105321151|NCT02288325|363174915|FG001|Double-blind Treatment Period|Protocol Violation|1|||
105321152|NCT02288325|363174916|FG002|Double-blind Treatment Period|Protocol Violation|2|||
105321153|NCT02288325|363174914|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
105321154|NCT02288325|363174915|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
105321155|NCT02288325|363174916|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
105321156|NCT02288325|363174914|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
105321157|NCT02288325|363174915|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
105321158|NCT02288325|363174916|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
105321159|NCT02232984|363174917|FG000|Overall Study|Withdrawal by Subject|5|||
105321160|NCT02232984|363174917|FG000|Overall Study|Death|1|||
105321161|NCT02232984|363174917|FG000|Overall Study|Investigator withdrawal|10|||
105321162|NCT02232984|363174917|FG000|Overall Study|Device implant unsuccessful|53|||
105321163|NCT02232984|363174917|FG000|Overall Study|not disclosed by site|7|||
105321164|NCT02232984|363174917|FG000|Overall Study|Protocol Violation|1|||
105321165|NCT03452943|363174920|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
105321166|NCT03452943|363174921|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
105321167|NCT03452943|363174920|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
105321168|NCT03452943|363174921|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
105321169|NCT03452943|363174920|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
105321170|NCT03452943|363174921|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
105321171|NCT03452943|363174920|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
105321172|NCT03452943|363174921|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
105321173|NCT03452943|363174920|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
105321174|NCT03452943|363174921|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
105321175|NCT03452943|363174920|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
105321176|NCT03452943|363174921|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
105321177|NCT01074944|363174937|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
105321178|NCT01074944|363174938|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
105321179|NCT01074944|363174939|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
105321180|NCT01074944|363174940|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
105321181|NCT01074944|363174941|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
105321182|NCT01074944|363174937|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
105321183|NCT01074944|363174938|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
105321184|NCT01074944|363174939|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
105321185|NCT01074944|363174940|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
105321186|NCT01074944|363174941|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
105321187|NCT01074944|363174937|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
105321188|NCT01074944|363174938|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
105850536|NCT01908816|365112521|FG003|Overall Study|Death|1|||
105321189|NCT01074944|363174939|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
105321190|NCT01074944|363174940|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
105321191|NCT01074944|363174941|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
105576799|NCT02138747|364110326|FG002|Treatment Period 2|Adverse Event|1|||
105491300|NCT01610271|363810737|FG001|Overall Study|Prosthesis not implanted|3|||
105491301|NCT04223232|363810738|FG000|Overall Study|Withdrawal by Subject|1|||
105491302|NCT01927341|363812447|FG000|Phase 1b|Lost to Follow-up|1|||
105491303|NCT01927341|363812448|FG001|Phase 1b|Lost to Follow-up|0|||
105491304|NCT01927341|363812449|FG002|Phase 1b|Lost to Follow-up|0|||
105491305|NCT01927341|363812450|FG003|Phase 1b|Lost to Follow-up|0|||
105491306|NCT01927341|363812451|FG004|Phase 1b|Lost to Follow-up|0|||
105491307|NCT01927341|363812447|FG000|Phase 1b|Death|2|||
105491308|NCT01927341|363812448|FG001|Phase 1b|Death|0|||
105491309|NCT01927341|363812449|FG002|Phase 1b|Death|0|||
105321192|NCT01074944|363174937|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
105491310|NCT01927341|363812450|FG003|Phase 1b|Death|0|||
105491311|NCT01927341|363812451|FG004|Phase 1b|Death|0|||
105491312|NCT01927341|363812447|FG000|Phase 1b|Follow-up completed|7|||
105491313|NCT01927341|363812448|FG001|Phase 1b|Follow-up completed|0|||
105491314|NCT01927341|363812449|FG002|Phase 1b|Follow-up completed|0|||
105491315|NCT01927341|363812450|FG003|Phase 1b|Follow-up completed|0|||
105491316|NCT01927341|363812451|FG004|Phase 1b|Follow-up completed|0|||
105491317|NCT01927341|363812447|FG000|Phase 2|Lost to Follow-up|0|||
105491318|NCT01927341|363812448|FG001|Phase 2|Lost to Follow-up|1|||
105491319|NCT01927341|363812449|FG002|Phase 2|Lost to Follow-up|0|||
105491320|NCT01927341|363812450|FG003|Phase 2|Lost to Follow-up|0|||
105491321|NCT01927341|363812451|FG004|Phase 2|Lost to Follow-up|0|||
105491322|NCT01927341|363812447|FG000|Phase 2|Participant withdrew consent|0|||
105491323|NCT01927341|363812448|FG001|Phase 2|Participant withdrew consent|2|||
105491324|NCT01927341|363812449|FG002|Phase 2|Participant withdrew consent|1|||
105491325|NCT01927341|363812450|FG003|Phase 2|Participant withdrew consent|2|||
105491326|NCT01927341|363812451|FG004|Phase 2|Participant withdrew consent|3|||
105491327|NCT01927341|363812447|FG000|Phase 2|Death|0|||
105491328|NCT01927341|363812448|FG001|Phase 2|Death|4|||
105491329|NCT01927341|363812449|FG002|Phase 2|Death|0|||
105491330|NCT01927341|363812450|FG003|Phase 2|Death|3|||
105491331|NCT01927341|363812451|FG004|Phase 2|Death|2|||
105491332|NCT01927341|363812447|FG000|Phase 2|New cancer therapy|0|||
105491333|NCT01927341|363812448|FG001|Phase 2|New cancer therapy|1|||
105491334|NCT01927341|363812449|FG002|Phase 2|New cancer therapy|0|||
105491335|NCT01927341|363812450|FG003|Phase 2|New cancer therapy|4|||
105491336|NCT01927341|363812451|FG004|Phase 2|New cancer therapy|1|||
105491337|NCT01927341|363812447|FG000|Phase 2|Disease progression|0|||
105491338|NCT01927341|363812448|FG001|Phase 2|Disease progression|1|||
105491339|NCT01927341|363812449|FG002|Phase 2|Disease progression|1|||
105491340|NCT01927341|363812450|FG003|Phase 2|Disease progression|1|||
105491341|NCT01927341|363812451|FG004|Phase 2|Disease progression|0|||
105491342|NCT01927341|363812447|FG000|Phase 2|Follow-up completed|0|||
105491343|NCT01927341|363812448|FG001|Phase 2|Follow-up completed|6|||
105491344|NCT01927341|363812449|FG002|Phase 2|Follow-up completed|3|||
105491345|NCT01927341|363812450|FG003|Phase 2|Follow-up completed|5|||
105491346|NCT01927341|363812451|FG004|Phase 2|Follow-up completed|2|||
105491347|NCT01104701|363812452|FG000|Overall Study|Withdrawal by Subject|0|||
105491348|NCT01104701|363812453|FG001|Overall Study|Withdrawal by Subject|1|||
105491349|NCT01104701|363812454|FG002|Overall Study|Withdrawal by Subject|2|||
105491350|NCT01104701|363812455|FG003|Overall Study|Withdrawal by Subject|1|||
105491351|NCT01104701|363812452|FG000|Overall Study|Adverse Event|0|||
105491352|NCT01104701|363812453|FG001|Overall Study|Adverse Event|0|||
105491353|NCT01104701|363812454|FG002|Overall Study|Adverse Event|0|||
105491354|NCT01104701|363812455|FG003|Overall Study|Adverse Event|1|||
105491355|NCT01104701|363812452|FG000|Overall Study|Physician Decision|0|||
105491356|NCT01104701|363812453|FG001|Overall Study|Physician Decision|2|||
105491357|NCT01104701|363812454|FG002|Overall Study|Physician Decision|0|||
105491358|NCT01104701|363812455|FG003|Overall Study|Physician Decision|0|||
105491359|NCT02582255|363812456|FG000|Overall Study|Protocol Violation|0|||
105491360|NCT02582255|363812457|FG001|Overall Study|Protocol Violation|3|||
105491361|NCT02294773|363812458|FG000|Overall Study|Withdrawal by Subject|0|||
105491362|NCT02294773|363812459|FG001|Overall Study|Withdrawal by Subject|2|||
105491363|NCT01865084|363812460|FG000|Double Blind Period (DB)|Adverse Event|2|||
105491364|NCT01865084|363812461|FG001|Double Blind Period (DB)|Adverse Event|2|||
105491365|NCT01865084|363812462|FG002|Double Blind Period (DB)|Adverse Event|1|||
105321193|NCT01074944|363174938|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
105321194|NCT01074944|363174939|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
105321195|NCT01074944|363174940|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
105491366|NCT01865084|363812460|FG000|Double Blind Period (DB)|Protocol Violation|0|||
105491367|NCT01865084|363812461|FG001|Double Blind Period (DB)|Protocol Violation|0|||
105491368|NCT01865084|363812462|FG002|Double Blind Period (DB)|Protocol Violation|1|||
105491369|NCT01865084|363812460|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
105491370|NCT01865084|363812461|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
105491371|NCT01865084|363812462|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
105491372|NCT01865084|363812460|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
105491373|NCT01865084|363812461|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
105491374|NCT01865084|363812462|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
105321196|NCT01074944|363174941|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
105321197|NCT01074944|363174937|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
105321198|NCT01074944|363174938|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
105321199|NCT01074944|363174939|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
105321200|NCT01074944|363174940|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
105321201|NCT01074944|363174941|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
105321202|NCT01074944|363174937|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
105321203|NCT01074944|363174938|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
105321204|NCT01074944|363174939|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
105321205|NCT01074944|363174940|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
105321206|NCT01074944|363174941|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
105321207|NCT01074944|363174937|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
105321208|NCT01074944|363174938|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
105321209|NCT01074944|363174939|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
105321210|NCT01074944|363174940|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
105321211|NCT01074944|363174941|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
105321212|NCT01074944|363174937|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
105321213|NCT01074944|363174938|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
105321214|NCT01074944|363174939|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
105321215|NCT01074944|363174940|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
105321216|NCT01074944|363174941|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
105321217|NCT01074944|363174937|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
105321218|NCT01074944|363174938|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
105321219|NCT01074944|363174939|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
105321220|NCT01074944|363174940|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
105321221|NCT01074944|363174941|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
105321222|NCT01074944|363174937|FG000|Long Term Treatment|Adverse Event|0|||
105321223|NCT01074944|363174938|FG001|Long Term Treatment|Adverse Event|0|||
105321224|NCT01074944|363174939|FG002|Long Term Treatment|Adverse Event|0|||
105321225|NCT01074944|363174940|FG003|Long Term Treatment|Adverse Event|3|||
105321226|NCT01074944|363174941|FG004|Long Term Treatment|Adverse Event|0|||
105321227|NCT01074944|363174937|FG000|Long Term Treatment|Lost to Follow-up|0|||
105321228|NCT01074944|363174938|FG001|Long Term Treatment|Lost to Follow-up|0|||
105321229|NCT01074944|363174939|FG002|Long Term Treatment|Lost to Follow-up|0|||
105321230|NCT01074944|363174940|FG003|Long Term Treatment|Lost to Follow-up|2|||
105321231|NCT01074944|363174941|FG004|Long Term Treatment|Lost to Follow-up|0|||
105321232|NCT01074944|363174937|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
105321233|NCT01074944|363174938|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
105321234|NCT01074944|363174939|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
105321235|NCT01074944|363174940|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
105321236|NCT01074944|363174941|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
105321237|NCT01074944|363174937|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
105321238|NCT01074944|363174938|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
105321239|NCT01074944|363174939|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
105321240|NCT01074944|363174940|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
105321241|NCT01074944|363174941|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
105321242|NCT01074944|363174937|FG000|Long Term Treatment|Withdrawal by Subject|0|||
105321243|NCT01074944|363174938|FG001|Long Term Treatment|Withdrawal by Subject|0|||
105321244|NCT01074944|363174939|FG002|Long Term Treatment|Withdrawal by Subject|0|||
105321245|NCT01074944|363174940|FG003|Long Term Treatment|Withdrawal by Subject|2|||
105321246|NCT01074944|363174941|FG004|Long Term Treatment|Withdrawal by Subject|0|||
105321247|NCT01074944|363174937|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
105321248|NCT01074944|363174938|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
105321249|NCT01074944|363174939|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
105321250|NCT01074944|363174940|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
105321251|NCT01074944|363174941|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
105321252|NCT01074944|363174937|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
105321253|NCT01074944|363174938|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
105321254|NCT01074944|363174939|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
105321255|NCT01074944|363174940|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
105321256|NCT01074944|363174941|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
105321257|NCT00852202|363174942|FG000|Overall Study|Adverse Event|2|||
105321258|NCT00852202|363174943|FG001|Overall Study|Adverse Event|3|||
105321259|NCT00852202|363174944|FG002|Overall Study|Adverse Event|7|||
105371236|NCT01799889|363366745|FG002|Overall Study|Progressive Disease|25|||
105321260|NCT00852202|363174942|FG000|Overall Study|Lack of Efficacy|4|||
105371237|NCT01799889|363366746|FG003|Overall Study|Progressive Disease|30|||
105321261|NCT00852202|363174943|FG001|Overall Study|Lack of Efficacy|1|||
105321262|NCT00852202|363174944|FG002|Overall Study|Lack of Efficacy|2|||
105321263|NCT00852202|363174942|FG000|Overall Study|Protocol Violation|2|||
105321264|NCT00852202|363174943|FG001|Overall Study|Protocol Violation|2|||
105321265|NCT00852202|363174944|FG002|Overall Study|Protocol Violation|7|||
105321266|NCT00852202|363174942|FG000|Overall Study|Withdrawal by Subject|3|||
105321267|NCT00852202|363174943|FG001|Overall Study|Withdrawal by Subject|1|||
105321268|NCT00852202|363174944|FG002|Overall Study|Withdrawal by Subject|2|||
105321269|NCT00852202|363174942|FG000|Overall Study|Lost to Follow-up|5|||
105321270|NCT00852202|363174943|FG001|Overall Study|Lost to Follow-up|5|||
105850537|NCT01908816|365112518|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105850538|NCT01908816|365112519|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
105850539|NCT01908816|365112520|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
105850540|NCT01908816|365112521|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
105850541|NCT01908816|365112518|FG000|Overall Study|Early termination|87|||
105850542|NCT01908816|365112519|FG001|Overall Study|Early termination|60|||
105850543|NCT01908816|365112520|FG002|Overall Study|Early termination|43|||
105850544|NCT01908816|365112521|FG003|Overall Study|Early termination|28|||
105850545|NCT01155024|365112526|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
105850546|NCT01155024|365112527|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
105321271|NCT00852202|363174944|FG002|Overall Study|Lost to Follow-up|6|||
105321272|NCT00852202|363174942|FG000|Overall Study|pregnancy,moving away and surgery|1|||
105321273|NCT00852202|363174943|FG001|Overall Study|pregnancy,moving away and surgery|0|||
105321274|NCT00852202|363174944|FG002|Overall Study|pregnancy,moving away and surgery|2|||
105321275|NCT01408043|363174947|FG000|Overall Study|unable to collect cells|1|||
105321276|NCT01998841|363174954|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
105321277|NCT01998841|363174955|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
105321278|NCT01998841|363174956|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
105321279|NCT01998841|363174957|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
105321280|NCT01998841|363174958|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
105321281|NCT01998841|363174954|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
105321282|NCT01998841|363174955|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
105850547|NCT01155024|365112526|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
105850548|NCT01155024|365112527|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
105850549|NCT01155024|365112526|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
105850550|NCT01155024|365112527|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
105850551|NCT01936623|365112530|FG000|Overall Study|Lost to Follow-up|0|||
105850552|NCT01936623|365112531|FG001|Overall Study|Lost to Follow-up|5|||
105321283|NCT01998841|363174956|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
105321284|NCT01998841|363174957|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
105321285|NCT01998841|363174958|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
105321286|NCT03629184|363174959|FG000|Overall Study|Withdrawal by Subject|2|||
105321287|NCT03629184|363174960|FG001|Overall Study|Withdrawal by Subject|1|||
105321288|NCT03629184|363174959|FG000|Overall Study|Physician Decision|1|||
105321289|NCT03629184|363174960|FG001|Overall Study|Physician Decision|0|||
105321290|NCT02552121|363174961|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
105321291|NCT02552121|363174962|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
105321292|NCT02552121|363174963|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
105321293|NCT02552121|363174964|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
105321294|NCT02552121|363174965|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
105321295|NCT02552121|363174966|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
105321296|NCT02552121|363174967|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
105321297|NCT02552121|363174968|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
105321298|NCT02552121|363174961|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
105321299|NCT02552121|363174962|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
105321300|NCT02552121|363174963|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
105321301|NCT02552121|363174964|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
105321302|NCT02552121|363174965|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
105321303|NCT02552121|363174966|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
105321304|NCT02552121|363174967|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
105321305|NCT02552121|363174968|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
105321306|NCT02552121|363174961|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
105321307|NCT02552121|363174962|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
105321308|NCT02552121|363174963|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
105850553|NCT03201250|365112532|FG000|Overall Study|screen failures|3|||
105321309|NCT02552121|363174964|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
105321310|NCT02552121|363174965|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
105321311|NCT02552121|363174966|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
105321312|NCT02552121|363174967|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
105371238|NCT01799889|363366747|FG004|Overall Study|Progressive Disease|23|||
105491375|NCT01865084|363812460|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
105850554|NCT03201250|365112533|FG001|Overall Study|screen failures|0|||
105850555|NCT03201250|365112534|FG002|Overall Study|screen failures|0|||
105850556|NCT01383135|365112535|FG000|Overall Study|Not Scanned / Imaged|1|||
105850557|NCT01383135|365112536|FG001|Overall Study|Not Scanned / Imaged|0|||
105850558|NCT01383135|365112537|FG002|Overall Study|Not Scanned / Imaged|1|||
105850559|NCT01383135|365112538|FG003|Overall Study|Not Scanned / Imaged|0|||
105850560|NCT03167723|365112539|FG000|Overall Study|Protocol Violation|4|||
105850561|NCT03167723|365112540|FG001|Overall Study|Protocol Violation|6|||
105850562|NCT01340768|365112543|FG000|Overall Study|Lost to Follow-up|10|||
105850563|NCT01340768|365112544|FG001|Overall Study|Lost to Follow-up|4|||
105850564|NCT01340768|365112543|FG000|Overall Study|Withdrawal by Subject|5|||
105850565|NCT01340768|365112544|FG001|Overall Study|Withdrawal by Subject|1|||
105850566|NCT01340768|365112543|FG000|Overall Study|Other|2|||
105850567|NCT01340768|365112544|FG001|Overall Study|Other|0|||
105850568|NCT00415194|365112547|FG000|Overall Study|Adverse Event|37|||
105850569|NCT00415194|365112548|FG001|Overall Study|Adverse Event|32|||
105850570|NCT00415194|365112547|FG000|Overall Study|Entry Criteria Not Met|4|||
105850571|NCT00415194|365112548|FG001|Overall Study|Entry Criteria Not Met|8|||
105850572|NCT00415194|365112547|FG000|Overall Study|Lost to Follow-up|1|||
105850573|NCT00415194|365112548|FG001|Overall Study|Lost to Follow-up|0|||
105850574|NCT00415194|365112547|FG000|Overall Study|Physician Decision|10|||
105850575|NCT00415194|365112548|FG001|Overall Study|Physician Decision|16|||
105850576|NCT00415194|365112547|FG000|Overall Study|Progressive Disease|180|||
105850577|NCT00415194|365112548|FG001|Overall Study|Progressive Disease|217|||
105850578|NCT00415194|365112547|FG000|Overall Study|Protocol Violation|4|||
105850579|NCT00415194|365112548|FG001|Overall Study|Protocol Violation|2|||
105850580|NCT00415194|365112547|FG000|Overall Study|Withdrawal by Subject|28|||
105850581|NCT00415194|365112548|FG001|Overall Study|Withdrawal by Subject|21|||
105850582|NCT00415194|365112547|FG000|Overall Study|Death Due to Study Disease|26|||
105850583|NCT00415194|365112548|FG001|Overall Study|Death Due to Study Disease|29|||
105850584|NCT00415194|365112547|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
105850585|NCT00415194|365112548|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
105850586|NCT00415194|365112547|FG000|Overall Study|Death Due to Procedural Related AE|0|||
105850587|NCT00415194|365112548|FG001|Overall Study|Death Due to Procedural Related AE|1|||
105850588|NCT00415194|365112547|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
105850589|NCT00415194|365112548|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
105850590|NCT00369655|365112549|FG000|Overall Study|Refusal of further treatment|2|||
105850591|NCT01683838|365112550|FG000|Overall Study|Adverse Event|12|||
105850592|NCT01683838|365112551|FG001|Overall Study|Adverse Event|2|||
105850593|NCT01683838|365112550|FG000|Overall Study|Protocol Violation|3|||
105850594|NCT01683838|365112551|FG001|Overall Study|Protocol Violation|1|||
105850595|NCT01683838|365112550|FG000|Overall Study|Withdrawal by Subject|6|||
105850596|NCT01683838|365112551|FG001|Overall Study|Withdrawal by Subject|5|||
105850597|NCT01683838|365112550|FG000|Overall Study|Lost to Follow-up|1|||
105850598|NCT01683838|365112551|FG001|Overall Study|Lost to Follow-up|1|||
105850599|NCT01683838|365112550|FG000|Overall Study|Other|4|||
105850600|NCT01683838|365112551|FG001|Overall Study|Other|3|||
105850601|NCT04049617|365112552|FG000|Overall Study|Adverse Event|0|||
105850602|NCT04049617|365112553|FG001|Overall Study|Adverse Event|0|||
105850603|NCT04049617|365112554|FG002|Overall Study|Adverse Event|0|||
105850604|NCT04049617|365112555|FG003|Overall Study|Adverse Event|1|||
105850605|NCT04049617|365112556|FG004|Overall Study|Adverse Event|0|||
105850606|NCT04049617|365112557|FG005|Overall Study|Adverse Event|0|||
105850607|NCT04049617|365112552|FG000|Overall Study|Death|0|||
105850608|NCT04049617|365112553|FG001|Overall Study|Death|0|||
105850609|NCT04049617|365112554|FG002|Overall Study|Death|0|||
105850610|NCT04049617|365112555|FG003|Overall Study|Death|0|||
105850611|NCT04049617|365112556|FG004|Overall Study|Death|0|||
105850612|NCT04049617|365112557|FG005|Overall Study|Death|1|||
105850613|NCT04049617|365112552|FG000|Overall Study|Lost to Follow-up|0|||
105850614|NCT04049617|365112553|FG001|Overall Study|Lost to Follow-up|0|||
105850615|NCT04049617|365112554|FG002|Overall Study|Lost to Follow-up|0|||
105491376|NCT01865084|363812461|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
105850616|NCT04049617|365112555|FG003|Overall Study|Lost to Follow-up|1|||
105850617|NCT04049617|365112556|FG004|Overall Study|Lost to Follow-up|0|||
105850618|NCT04049617|365112557|FG005|Overall Study|Lost to Follow-up|0|||
105850619|NCT04049617|365112552|FG000|Overall Study|Withdrew consent|0|||
105850620|NCT04049617|365112553|FG001|Overall Study|Withdrew consent|0|||
105850621|NCT04049617|365112554|FG002|Overall Study|Withdrew consent|1|||
105850622|NCT04049617|365112555|FG003|Overall Study|Withdrew consent|0|||
105371239|NCT01799889|363366748|FG005|Overall Study|Progressive Disease|9|||
105850623|NCT04049617|365112556|FG004|Overall Study|Withdrew consent|0|||
105850624|NCT04049617|365112557|FG005|Overall Study|Withdrew consent|0|||
105850625|NCT01524679|365112558|FG000|Overall Study|Lost to Follow-up|1|||
105371240|NCT01799889|363366749|FG006|Overall Study|Progressive Disease|8|||
105371241|NCT01799889|363366750|FG007|Overall Study|Progressive Disease|13|||
105850626|NCT01524679|365112559|FG001|Overall Study|Lost to Follow-up|4|||
105850627|NCT01524679|365112558|FG000|Overall Study|Withdrawal by Subject|4|||
105850628|NCT01524679|365112559|FG001|Overall Study|Withdrawal by Subject|4|||
105850629|NCT01524679|365112558|FG000|Overall Study|Adverse Event|9|||
105850630|NCT01524679|365112559|FG001|Overall Study|Adverse Event|0|||
105850631|NCT01524679|365112558|FG000|Overall Study|Protocol Violation|1|||
105850632|NCT01524679|365112559|FG001|Overall Study|Protocol Violation|0|||
105850633|NCT01524679|365112558|FG000|Overall Study|Lack of Efficacy|2|||
105850634|NCT01524679|365112559|FG001|Overall Study|Lack of Efficacy|0|||
105850635|NCT01524679|365112558|FG000|Overall Study|e.g.wish for children, relocation|6|||
105850636|NCT01524679|365112559|FG001|Overall Study|e.g.wish for children, relocation|1|||
105850637|NCT01154816|365112560|FG000|Overall Study|Withdrawal by Subject|1|||
105850638|NCT01154816|365112561|FG001|Overall Study|Withdrawal by Subject|0|||
105850639|NCT01154816|365112562|FG002|Overall Study|Withdrawal by Subject|0|||
105850640|NCT01154816|365112563|FG003|Overall Study|Withdrawal by Subject|1|||
105850641|NCT01154816|365112564|FG004|Overall Study|Withdrawal by Subject|0|||
105850642|NCT01154816|365112565|FG005|Overall Study|Withdrawal by Subject|0|||
105850643|NCT01154816|365112566|FG006|Overall Study|Withdrawal by Subject|0|||
105850644|NCT01154816|365112567|FG007|Overall Study|Withdrawal by Subject|0|||
105850645|NCT01154816|365112568|FG008|Overall Study|Withdrawal by Subject|1|||
105850646|NCT01154816|365112569|FG009|Overall Study|Withdrawal by Subject|3|||
105850647|NCT01154816|365112570|FG010|Overall Study|Withdrawal by Subject|0|||
105850648|NCT01154816|365112571|FG011|Overall Study|Withdrawal by Subject|0|||
105850649|NCT01154816|365112560|FG000|Overall Study|Progressive Disease|13|||
105850650|NCT01154816|365112561|FG001|Overall Study|Progressive Disease|8|||
105850651|NCT01154816|365112562|FG002|Overall Study|Progressive Disease|9|||
105850652|NCT01154816|365112563|FG003|Overall Study|Progressive Disease|9|||
105850653|NCT01154816|365112564|FG004|Overall Study|Progressive Disease|8|||
105850654|NCT01154816|365112565|FG005|Overall Study|Progressive Disease|8|||
105850655|NCT01154816|365112566|FG006|Overall Study|Progressive Disease|5|||
105850656|NCT01154816|365112567|FG007|Overall Study|Progressive Disease|6|||
105371242|NCT01799889|363366751|FG008|Overall Study|Progressive Disease|18|||
105371243|NCT01799889|363366752|FG009|Overall Study|Progressive Disease|5|||
105371244|NCT01799889|363366753|FG010|Overall Study|Progressive Disease|3|||
105371245|NCT01799889|363366754|FG011|Overall Study|Progressive Disease|1|||
105371246|NCT01799889|363366743|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
105371247|NCT01799889|363366744|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
105371248|NCT01799889|363366745|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
105371249|NCT01799889|363366746|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
105371250|NCT01799889|363366747|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
105371251|NCT01799889|363366748|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
105371252|NCT01799889|363366749|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
105371253|NCT01799889|363366750|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
105371254|NCT01799889|363366751|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
105371255|NCT01799889|363366752|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
105371256|NCT01799889|363366753|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
105371257|NCT01799889|363366754|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
105371258|NCT01799889|363366743|FG000|Overall Study|Study Terminated By Sponsor|1|||
105371259|NCT01799889|363366744|FG001|Overall Study|Study Terminated By Sponsor|0|||
105371260|NCT01799889|363366745|FG002|Overall Study|Study Terminated By Sponsor|0|||
105371261|NCT01799889|363366746|FG003|Overall Study|Study Terminated By Sponsor|0|||
105371262|NCT01799889|363366747|FG004|Overall Study|Study Terminated By Sponsor|2|||
105371263|NCT01799889|363366748|FG005|Overall Study|Study Terminated By Sponsor|1|||
105371264|NCT01799889|363366749|FG006|Overall Study|Study Terminated By Sponsor|0|||
105371265|NCT01799889|363366750|FG007|Overall Study|Study Terminated By Sponsor|2|||
105371266|NCT01799889|363366751|FG008|Overall Study|Study Terminated By Sponsor|1|||
105371267|NCT01799889|363366752|FG009|Overall Study|Study Terminated By Sponsor|1|||
105371268|NCT01799889|363366753|FG010|Overall Study|Study Terminated By Sponsor|0|||
105371269|NCT01799889|363366754|FG011|Overall Study|Study Terminated By Sponsor|0|||
105371270|NCT01799889|363366743|FG000|Overall Study|Withdrawal by Subject|1|||
105371271|NCT01799889|363366744|FG001|Overall Study|Withdrawal by Subject|6|||
105371272|NCT01799889|363366745|FG002|Overall Study|Withdrawal by Subject|4|||
105371273|NCT01799889|363366746|FG003|Overall Study|Withdrawal by Subject|0|||
105371274|NCT01799889|363366747|FG004|Overall Study|Withdrawal by Subject|5|||
105371275|NCT01799889|363366748|FG005|Overall Study|Withdrawal by Subject|1|||
105850657|NCT01154816|365112568|FG008|Overall Study|Progressive Disease|8|||
105850658|NCT01154816|365112569|FG009|Overall Study|Progressive Disease|6|||
105371276|NCT01799889|363366749|FG006|Overall Study|Withdrawal by Subject|3|||
105371277|NCT01799889|363366750|FG007|Overall Study|Withdrawal by Subject|1|||
105371278|NCT01799889|363366751|FG008|Overall Study|Withdrawal by Subject|2|||
105850659|NCT01154816|365112570|FG010|Overall Study|Progressive Disease|10|||
105850660|NCT01154816|365112571|FG011|Overall Study|Progressive Disease|3|||
105371279|NCT01799889|363366752|FG009|Overall Study|Withdrawal by Subject|1|||
105371280|NCT01799889|363366753|FG010|Overall Study|Withdrawal by Subject|1|||
105371281|NCT01799889|363366754|FG011|Overall Study|Withdrawal by Subject|1|||
105371282|NCT01799889|363366743|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105850661|NCT01154816|365112560|FG000|Overall Study|Physician Decision|1|||
105850662|NCT01154816|365112561|FG001|Overall Study|Physician Decision|0|||
105321313|NCT02552121|363174968|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
105321314|NCT02552121|363174961|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
105321315|NCT02552121|363174962|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
105321316|NCT02552121|363174963|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
105321317|NCT02552121|363174964|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
105321318|NCT02552121|363174965|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
105321319|NCT02552121|363174966|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
105321320|NCT02552121|363174967|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
105321321|NCT02552121|363174968|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
105321322|NCT02552121|363174961|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
105321323|NCT02552121|363174962|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
105321324|NCT02552121|363174963|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
105321325|NCT02552121|363174964|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
105321326|NCT02552121|363174965|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
105321327|NCT02552121|363174966|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
105371283|NCT01799889|363366744|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105371284|NCT01799889|363366745|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105371285|NCT01799889|363366746|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105371286|NCT01799889|363366747|FG004|Overall Study|Non-Compliance With Study Drug|0|||
105371287|NCT01799889|363366748|FG005|Overall Study|Non-Compliance With Study Drug|1|||
105371288|NCT01799889|363366749|FG006|Overall Study|Non-Compliance With Study Drug|0|||
105371289|NCT01799889|363366750|FG007|Overall Study|Non-Compliance With Study Drug|0|||
105371290|NCT01799889|363366751|FG008|Overall Study|Non-Compliance With Study Drug|0|||
105371291|NCT01799889|363366752|FG009|Overall Study|Non-Compliance With Study Drug|0|||
105371292|NCT01799889|363366753|FG010|Overall Study|Non-Compliance With Study Drug|0|||
105371293|NCT01799889|363366754|FG011|Overall Study|Non-Compliance With Study Drug|0|||
105371294|NCT00750269|363366755|FG000|Overall Study|Protocol Violation|0|||
105371295|NCT00750269|363366756|FG001|Overall Study|Protocol Violation|1|||
105371296|NCT00750269|363366757|FG002|Overall Study|Protocol Violation|1|||
105371297|NCT00750269|363366758|FG003|Overall Study|Protocol Violation|2|||
105371298|NCT00750269|363366759|FG004|Overall Study|Protocol Violation|4|||
105371299|NCT00750269|363366755|FG000|Overall Study|Withdrawal by Subject|0|||
105371300|NCT00750269|363366756|FG001|Overall Study|Withdrawal by Subject|0|||
105371301|NCT00750269|363366757|FG002|Overall Study|Withdrawal by Subject|2|||
105371302|NCT00750269|363366758|FG003|Overall Study|Withdrawal by Subject|2|||
105371303|NCT00750269|363366759|FG004|Overall Study|Withdrawal by Subject|2|||
105371304|NCT00750269|363366755|FG000|Overall Study|Physician Decision|0|||
105371305|NCT00750269|363366756|FG001|Overall Study|Physician Decision|0|||
105371306|NCT00750269|363366757|FG002|Overall Study|Physician Decision|0|||
105371307|NCT00750269|363366758|FG003|Overall Study|Physician Decision|0|||
105371308|NCT00750269|363366759|FG004|Overall Study|Physician Decision|2|||
105371309|NCT00750269|363366755|FG000|Overall Study|Patient too large for positioning|0|||
105371310|NCT00750269|363366756|FG001|Overall Study|Patient too large for positioning|0|||
105371311|NCT00750269|363366757|FG002|Overall Study|Patient too large for positioning|1|||
105371312|NCT00750269|363366758|FG003|Overall Study|Patient too large for positioning|0|||
105371313|NCT00750269|363366759|FG004|Overall Study|Patient too large for positioning|0|||
105371314|NCT00750269|363366755|FG000|Overall Study|Site error|0|||
105371315|NCT00750269|363366756|FG001|Overall Study|Site error|0|||
105371316|NCT00750269|363366757|FG002|Overall Study|Site error|0|||
105371317|NCT00750269|363366758|FG003|Overall Study|Site error|1|||
105371318|NCT00750269|363366759|FG004|Overall Study|Site error|0|||
105371319|NCT00750269|363366755|FG000|Overall Study|SBRT plan could not be drawn|0|||
105371320|NCT00750269|363366756|FG001|Overall Study|SBRT plan could not be drawn|0|||
105371321|NCT00750269|363366757|FG002|Overall Study|SBRT plan could not be drawn|0|||
105371322|NCT00750269|363366758|FG003|Overall Study|SBRT plan could not be drawn|0|||
105491377|NCT01865084|363812462|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
105321328|NCT02552121|363174967|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
105321329|NCT02552121|363174968|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
105371323|NCT00750269|363366759|FG004|Overall Study|SBRT plan could not be drawn|1|||
105371324|NCT00750269|363366755|FG000|Overall Study|Fiducials could not be placed|0|||
105371325|NCT00750269|363366756|FG001|Overall Study|Fiducials could not be placed|0|||
105371326|NCT00750269|363366757|FG002|Overall Study|Fiducials could not be placed|0|||
105371327|NCT00750269|363366758|FG003|Overall Study|Fiducials could not be placed|0|||
105371328|NCT00750269|363366759|FG004|Overall Study|Fiducials could not be placed|1|||
105371329|NCT02934178|363366760|FG000|Received Vaccination 2|Death|0|||
105371330|NCT02934178|363366761|FG001|Received Vaccination 2|Death|1|||
105371331|NCT02934178|363366760|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
105321330|NCT02552121|363174961|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
105371332|NCT02934178|363366761|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
105371333|NCT00870727|363366763|FG000|Overall Study|Lost to Follow-up|0|||
105371334|NCT00870727|363366764|FG001|Overall Study|Lost to Follow-up|1|||
105371335|NCT00870727|363366763|FG000|Overall Study|Lack of Efficacy|1|||
105491378|NCT01865084|363812460|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
105491379|NCT01865084|363812461|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
105491380|NCT01865084|363812462|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
105491381|NCT01865084|363812460|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
105491382|NCT01865084|363812461|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
105491383|NCT01865084|363812462|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
105491384|NCT01865084|363812460|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
105491385|NCT01865084|363812461|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
105491386|NCT01865084|363812462|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
105491387|NCT01865084|363812460|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
105491388|NCT01865084|363812461|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
105850663|NCT01154816|365112562|FG002|Overall Study|Physician Decision|1|||
105850664|NCT01154816|365112563|FG003|Overall Study|Physician Decision|0|||
105850665|NCT01154816|365112564|FG004|Overall Study|Physician Decision|2|||
105850666|NCT01154816|365112565|FG005|Overall Study|Physician Decision|0|||
105850667|NCT01154816|365112566|FG006|Overall Study|Physician Decision|0|||
105850668|NCT01154816|365112567|FG007|Overall Study|Physician Decision|0|||
105850669|NCT01154816|365112568|FG008|Overall Study|Physician Decision|0|||
105850670|NCT01154816|365112569|FG009|Overall Study|Physician Decision|1|||
105850671|NCT01154816|365112570|FG010|Overall Study|Physician Decision|1|||
105850672|NCT01154816|365112571|FG011|Overall Study|Physician Decision|1|||
105850673|NCT01154816|365112560|FG000|Overall Study|Adverse Event|5|||
105850674|NCT01154816|365112561|FG001|Overall Study|Adverse Event|2|||
105850675|NCT01154816|365112562|FG002|Overall Study|Adverse Event|0|||
105850676|NCT01154816|365112563|FG003|Overall Study|Adverse Event|0|||
105371336|NCT00870727|363366764|FG001|Overall Study|Lack of Efficacy|3|||
105371337|NCT00870727|363366763|FG000|Overall Study|Adverse Event|0|||
105371338|NCT00870727|363366764|FG001|Overall Study|Adverse Event|1|||
105371339|NCT00408499|363366771|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
105371340|NCT00408499|363366772|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
105371341|NCT00408499|363366773|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
105850677|NCT01154816|365112564|FG004|Overall Study|Adverse Event|0|||
105850678|NCT01154816|365112565|FG005|Overall Study|Adverse Event|0|||
105850679|NCT01154816|365112566|FG006|Overall Study|Adverse Event|1|||
105850680|NCT01154816|365112567|FG007|Overall Study|Adverse Event|1|||
105850681|NCT01154816|365112568|FG008|Overall Study|Adverse Event|0|||
105850682|NCT01154816|365112569|FG009|Overall Study|Adverse Event|0|||
105850683|NCT01154816|365112570|FG010|Overall Study|Adverse Event|0|||
105850684|NCT01154816|365112571|FG011|Overall Study|Adverse Event|0|||
105850685|NCT00801099|365112572|FG000|Overall Study|Lost to Follow-up|101|||
105850686|NCT02534844|365112573|FG000|Part B|Withdrawal by Subject|0|||
105850687|NCT02534844|365112574|FG001|Part B|Withdrawal by Subject|0|||
105850688|NCT02534844|365112575|FG002|Part B|Withdrawal by Subject|0|||
105850689|NCT02534844|365112576|FG003|Part B|Withdrawal by Subject|0|||
105850690|NCT02534844|365112577|FG004|Part B|Withdrawal by Subject|2|||
105850691|NCT02534844|365112578|FG005|Part B|Withdrawal by Subject|1|||
105850692|NCT02393248|365112579|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105371342|NCT00408499|363366774|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
105371343|NCT00408499|363366775|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
105371344|NCT00408499|363366771|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
105371345|NCT00408499|363366772|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
105371346|NCT00408499|363366773|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
105371347|NCT00408499|363366774|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
105371348|NCT00408499|363366775|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
105371349|NCT00408499|363366771|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
105371350|NCT00408499|363366772|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
105371351|NCT00408499|363366773|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
105371352|NCT00408499|363366774|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
105371353|NCT00408499|363366775|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
105371354|NCT00408499|363366771|FG000|Phase II- MTD Expansion|Adverse Event|0|||
105371355|NCT00408499|363366772|FG001|Phase II- MTD Expansion|Adverse Event|0|||
105371356|NCT00408499|363366773|FG002|Phase II- MTD Expansion|Adverse Event|0|||
105371357|NCT00408499|363366774|FG003|Phase II- MTD Expansion|Adverse Event|0|||
105371358|NCT00408499|363366775|FG004|Phase II- MTD Expansion|Adverse Event|9|||
105371359|NCT00408499|363366771|FG000|Phase II- MTD Expansion|Death|0|||
105371360|NCT00408499|363366772|FG001|Phase II- MTD Expansion|Death|0|||
105371361|NCT00408499|363366773|FG002|Phase II- MTD Expansion|Death|0|||
105371362|NCT00408499|363366774|FG003|Phase II- MTD Expansion|Death|0|||
105371363|NCT00408499|363366775|FG004|Phase II- MTD Expansion|Death|2|||
105371364|NCT00408499|363366771|FG000|Phase II- MTD Expansion|Physician Decision|0|||
105850693|NCT02393248|365112580|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
105850694|NCT02393248|365112581|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850695|NCT02393248|365112582|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850696|NCT02393248|365112583|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105321331|NCT02552121|363174962|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
105321332|NCT02552121|363174963|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
105321333|NCT02552121|363174964|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
105321334|NCT02552121|363174965|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
105491389|NCT01865084|363812462|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
105491390|NCT03052764|363812463|FG000|Double-Blind Treatment Period|Adverse Event|2|||
105321335|NCT02552121|363174966|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
105321336|NCT02552121|363174967|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
105321337|NCT02552121|363174968|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
105321338|NCT02552121|363174961|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
105321339|NCT02552121|363174962|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
105321340|NCT02552121|363174963|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
105321341|NCT02552121|363174964|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
105321342|NCT02552121|363174965|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
105321343|NCT02552121|363174966|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
105321344|NCT02552121|363174967|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
105321345|NCT02552121|363174968|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
105321346|NCT02552121|363174961|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
105321347|NCT02552121|363174962|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
105321348|NCT02552121|363174963|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
105321349|NCT02552121|363174964|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
105321350|NCT02552121|363174965|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
105321351|NCT02552121|363174966|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
105321352|NCT02552121|363174967|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
105321353|NCT02552121|363174968|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
105321354|NCT02552121|363174961|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
105321355|NCT02552121|363174962|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
105321356|NCT02552121|363174963|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
105321357|NCT02552121|363174964|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
105321358|NCT02552121|363174965|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
105321359|NCT02552121|363174966|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
105321360|NCT02552121|363174967|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
105321361|NCT02552121|363174968|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
105321362|NCT02552121|363174961|FG000|Part 2: Cohort Expansion|Death|0|||
105321363|NCT02552121|363174962|FG001|Part 2: Cohort Expansion|Death|0|||
105321364|NCT02552121|363174963|FG002|Part 2: Cohort Expansion|Death|1|||
105321365|NCT02552121|363174964|FG003|Part 2: Cohort Expansion|Death|0|||
105321366|NCT02552121|363174965|FG004|Part 2: Cohort Expansion|Death|0|||
105321367|NCT02552121|363174966|FG005|Part 2: Cohort Expansion|Death|0|||
105321368|NCT02552121|363174967|FG006|Part 2: Cohort Expansion|Death|0|||
105321369|NCT02552121|363174968|FG007|Part 2: Cohort Expansion|Death|0|||
105321370|NCT02905032|363174969|FG000|Overall Study|Withdrawal by Subject|2|||
105321371|NCT02905032|363174970|FG001|Overall Study|Withdrawal by Subject|0|||
105321372|NCT02905032|363174971|FG002|Overall Study|Withdrawal by Subject|0|||
105321373|NCT02905032|363174969|FG000|Overall Study|Protocol Violation|6|||
105321374|NCT02905032|363174970|FG001|Overall Study|Protocol Violation|12|||
105321375|NCT02905032|363174971|FG002|Overall Study|Protocol Violation|0|||
105321376|NCT02729909|363174972|FG000|Overall Study|Lost to Follow-up|0|||
105321377|NCT02729909|363174973|FG001|Overall Study|Lost to Follow-up|1|||
105321378|NCT02729909|363174972|FG000|Overall Study|Lack of Efficacy|0|||
105321379|NCT02729909|363174973|FG001|Overall Study|Lack of Efficacy|2|||
105321380|NCT02729909|363174972|FG000|Overall Study|Significant Protocol Deviation|0|||
105321381|NCT02729909|363174973|FG001|Overall Study|Significant Protocol Deviation|2|||
105321382|NCT02729909|363174972|FG000|Overall Study|Voluntary Withdrawal|1|||
105321383|NCT02729909|363174973|FG001|Overall Study|Voluntary Withdrawal|0|||
105321384|NCT00141778|363174974|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
105321385|NCT00141778|363174975|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
105321386|NCT00141778|363174976|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
105321387|NCT00141778|363174974|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
105321388|NCT00141778|363174975|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
105321389|NCT00141778|363174976|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
105321390|NCT00141778|363174974|FG000|Started Study Medication|Withdrawal by Subject|0|||
105321391|NCT00141778|363174975|FG001|Started Study Medication|Withdrawal by Subject|2|||
105491391|NCT03052764|363812464|FG001|Double-Blind Treatment Period|Adverse Event|0|||
105491392|NCT03052764|363812463|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
105321392|NCT00141778|363174976|FG002|Started Study Medication|Withdrawal by Subject|0|||
105321393|NCT00141778|363174974|FG000|Started Study Medication|Difficulty Swallowing|0|||
105491393|NCT03052764|363812464|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
105321394|NCT00141778|363174975|FG001|Started Study Medication|Difficulty Swallowing|1|||
105321395|NCT00141778|363174976|FG002|Started Study Medication|Difficulty Swallowing|0|||
105321396|NCT00141778|363174974|FG000|Started Study Medication|Chest Discomfort|0|||
105321397|NCT00141778|363174975|FG001|Started Study Medication|Chest Discomfort|0|||
105321398|NCT00141778|363174976|FG002|Started Study Medication|Chest Discomfort|1|||
105321399|NCT05478252|363174981|FG000|Overall Study|Withdrawal by Subject|2|||
105321400|NCT05478252|363174982|FG001|Overall Study|Withdrawal by Subject|3|||
105321401|NCT05478252|363174981|FG000|Overall Study|Lost to Follow-up|4|||
105321402|NCT05478252|363174982|FG001|Overall Study|Lost to Follow-up|2|||
105321403|NCT05478252|363174981|FG000|Overall Study|Physician Decision|1|||
105321404|NCT05478252|363174982|FG001|Overall Study|Physician Decision|1|||
105321405|NCT05478252|363174981|FG000|Overall Study|Death|1|||
105321406|NCT05478252|363174982|FG001|Overall Study|Death|0|||
105321407|NCT02461160|363174983|FG000|Overall Study|Lost to Follow-up|0|||
105321408|NCT02461160|363174984|FG001|Overall Study|Lost to Follow-up|0|||
105321409|NCT02461160|363174985|FG002|Overall Study|Lost to Follow-up|0|||
105321410|NCT02461160|363174986|FG003|Overall Study|Lost to Follow-up|0|||
105321411|NCT02461160|363174987|FG004|Overall Study|Lost to Follow-up|0|||
105321412|NCT02461160|363174988|FG005|Overall Study|Lost to Follow-up|0|||
105321413|NCT02461160|363174989|FG006|Overall Study|Lost to Follow-up|0|||
105321414|NCT02461160|363174990|FG007|Overall Study|Lost to Follow-up|1|||
105321415|NCT02461160|363174991|FG008|Overall Study|Lost to Follow-up|0|||
105321416|NCT02461160|363174992|FG009|Overall Study|Lost to Follow-up|0|||
105321417|NCT02461160|363174993|FG010|Overall Study|Lost to Follow-up|0|||
105321418|NCT02461160|363174994|FG011|Overall Study|Lost to Follow-up|0|||
105321419|NCT02461160|363174995|FG012|Overall Study|Lost to Follow-up|0|||
105321420|NCT02854527|363174996|FG000|Overall Study|Adverse Event|0|||
105321421|NCT02854527|363174997|FG001|Overall Study|Adverse Event|0|||
105321422|NCT02854527|363174998|FG002|Overall Study|Adverse Event|0|||
105321423|NCT02854527|363174999|FG003|Overall Study|Adverse Event|0|||
105321424|NCT02854527|363175000|FG004|Overall Study|Adverse Event|1|||
105321425|NCT02854527|363175001|FG005|Overall Study|Adverse Event|0|||
105321426|NCT02854527|363175002|FG006|Overall Study|Adverse Event|0|||
105321427|NCT02854527|363175003|FG007|Overall Study|Adverse Event|0|||
105321428|NCT02854527|363175004|FG008|Overall Study|Adverse Event|0|||
105321429|NCT02854527|363175005|FG009|Overall Study|Adverse Event|0|||
105321430|NCT02854527|363174996|FG000|Overall Study|Lost to Follow-up|0|||
105321431|NCT02854527|363174997|FG001|Overall Study|Lost to Follow-up|0|||
105321432|NCT02854527|363174998|FG002|Overall Study|Lost to Follow-up|0|||
105321433|NCT02854527|363174999|FG003|Overall Study|Lost to Follow-up|1|||
105321434|NCT02854527|363175000|FG004|Overall Study|Lost to Follow-up|0|||
105321435|NCT02854527|363175001|FG005|Overall Study|Lost to Follow-up|0|||
105321436|NCT02854527|363175002|FG006|Overall Study|Lost to Follow-up|0|||
105321437|NCT02854527|363175003|FG007|Overall Study|Lost to Follow-up|0|||
105321438|NCT02854527|363175004|FG008|Overall Study|Lost to Follow-up|0|||
105321439|NCT02854527|363175005|FG009|Overall Study|Lost to Follow-up|0|||
105321440|NCT00193050|363175006|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
105321441|NCT00193050|363175006|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
105321442|NCT00193050|363175006|FG000|Neoadjuvant Treatment|Physician Decision|2|||
105321443|NCT00193050|363175006|FG000|Neoadjuvant Treatment|Adverse Event|2|||
105321444|NCT00193050|363175006|FG000|Adjuvant|Physician Decision|5|||
105321445|NCT00193050|363175006|FG000|Adjuvant|Intercurrent Hospitalization|3|||
105321446|NCT00193050|363175006|FG000|Adjuvant|Lack of Efficacy|2|||
105321447|NCT00061932|363175007|FG000|Overall Study|Withdrawal by Subject|13|||
105321448|NCT00061932|363175008|FG001|Overall Study|Withdrawal by Subject|4|||
105321449|NCT02899962|363175009|FG000|Open-label Phase|Adverse Event|2|||
105321450|NCT02899962|363175010|FG001|Open-label Phase|Adverse Event|0|||
105321451|NCT02899962|363175011|FG002|Open-label Phase|Adverse Event|0|||
105321452|NCT02899962|363175009|FG000|Open-label Phase|Lost to Follow-up|9|||
105321453|NCT02899962|363175010|FG001|Open-label Phase|Lost to Follow-up|0|||
105321454|NCT02899962|363175011|FG002|Open-label Phase|Lost to Follow-up|0|||
105321455|NCT02899962|363175009|FG000|Open-label Phase|Other reasons|9|||
105321456|NCT02899962|363175010|FG001|Open-label Phase|Other reasons|0|||
105321457|NCT02899962|363175011|FG002|Open-label Phase|Other reasons|0|||
105321458|NCT02899962|363175009|FG000|Open-label Phase|Withdrawal by Subject|7|||
105321459|NCT02899962|363175010|FG001|Open-label Phase|Withdrawal by Subject|0|||
105321460|NCT02899962|363175011|FG002|Open-label Phase|Withdrawal by Subject|0|||
105321461|NCT02899962|363175009|FG000|Maintenance Phase|Adverse Event|0|||
105321462|NCT02899962|363175010|FG001|Maintenance Phase|Adverse Event|2|||
105321463|NCT02899962|363175011|FG002|Maintenance Phase|Adverse Event|1|||
105321464|NCT02899962|363175009|FG000|Maintenance Phase|Death|0|||
105321465|NCT02899962|363175010|FG001|Maintenance Phase|Death|0|||
105321466|NCT02899962|363175011|FG002|Maintenance Phase|Death|1|||
105321467|NCT02899962|363175009|FG000|Maintenance Phase|Lack of Efficacy|0|||
105321468|NCT02899962|363175010|FG001|Maintenance Phase|Lack of Efficacy|20|||
105321469|NCT02899962|363175011|FG002|Maintenance Phase|Lack of Efficacy|16|||
105321470|NCT02899962|363175009|FG000|Maintenance Phase|Lost to Follow-up|0|||
105321471|NCT02899962|363175010|FG001|Maintenance Phase|Lost to Follow-up|12|||
105321472|NCT02899962|363175011|FG002|Maintenance Phase|Lost to Follow-up|14|||
105321473|NCT02899962|363175009|FG000|Maintenance Phase|Other reasons|0|||
105321474|NCT02899962|363175010|FG001|Maintenance Phase|Other reasons|9|||
105321475|NCT02899962|363175011|FG002|Maintenance Phase|Other reasons|13|||
105321476|NCT02899962|363175009|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
105321477|NCT02899962|363175010|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
105321478|NCT02899962|363175011|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
105321479|NCT02899962|363175009|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
105321480|NCT02899962|363175010|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
105321481|NCT02899962|363175011|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
105321482|NCT02899962|363175009|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105321483|NCT02899962|363175010|FG001|Maintenance Phase|Withdrawal by Subject|30|||
105321484|NCT02899962|363175011|FG002|Maintenance Phase|Withdrawal by Subject|36|||
105321485|NCT01245283|363175012|FG000|Overall Study|Lost to Follow-up|14|||
105321486|NCT01245283|363175013|FG001|Overall Study|Lost to Follow-up|11|||
105321487|NCT01245283|363175014|FG002|Overall Study|Lost to Follow-up|11|||
105321488|NCT03567980|363175023|FG000|Overall Study|Adverse Event|1|||
105321489|NCT01610492|363175024|FG000|Overall Study|Adverse Event|1|||
105321490|NCT01610492|363175024|FG000|Overall Study|Lack of Efficacy|3|||
105321491|NCT01610492|363175024|FG000|Overall Study|Other: Reached stopping criteria|1|||
105321492|NCT01610492|363175024|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
105321493|NCT01982955|363175025|FG000|Overall Study|Randomized but not treated|0|||
105321494|NCT01982955|363175026|FG001|Overall Study|Randomized but not treated|0|||
105321495|NCT01982955|363175027|FG002|Overall Study|Randomized but not treated|0|||
105321496|NCT01982955|363175028|FG003|Overall Study|Randomized but not treated|1|||
105321497|NCT01982955|363175029|FG004|Overall Study|Randomized but not treated|0|||
105321498|NCT02575833|363175033|FG000|Overall Study|Withdrawal by Subject|0|||
105321499|NCT02575833|363175034|FG001|Overall Study|Withdrawal by Subject|1|||
105321500|NCT02575833|363175033|FG000|Overall Study|Lost to Follow-up|1|||
105321501|NCT02575833|363175034|FG001|Overall Study|Lost to Follow-up|0|||
105321502|NCT01128179|363175040|FG000|Overall Study|Death|1|||
105321503|NCT01128179|363175041|FG001|Overall Study|Death|0|||
105321504|NCT01128179|363175040|FG000|Overall Study|Protocol Violation|1|||
105321505|NCT01128179|363175041|FG001|Overall Study|Protocol Violation|0|||
105321506|NCT01682811|363175042|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
105321507|NCT01682811|363175043|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
105321508|NCT01682811|363175044|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
105321509|NCT01682811|363175045|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
105321510|NCT01682811|363175046|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
105321511|NCT01682811|363175047|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
105321512|NCT01682811|363175048|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
105321513|NCT01682811|363175042|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
105321514|NCT01682811|363175043|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
105321515|NCT01682811|363175044|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
105321516|NCT01682811|363175045|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
105321517|NCT01682811|363175046|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
105321518|NCT01682811|363175047|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
105321519|NCT01682811|363175048|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
105321520|NCT01682811|363175042|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
105321521|NCT01682811|363175043|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
105321522|NCT01682811|363175044|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
105321523|NCT01682811|363175045|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
105321524|NCT01682811|363175046|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
105321525|NCT01682811|363175047|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
105321526|NCT01682811|363175048|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
105321527|NCT01682811|363175042|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
105321528|NCT01682811|363175043|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
105321529|NCT01682811|363175044|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
105321530|NCT01682811|363175045|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
105321531|NCT01682811|363175046|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
105321532|NCT01682811|363175047|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
105321533|NCT01682811|363175048|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
105321534|NCT03300817|363176902|FG000|Overall Study|Withdrawal by Subject|1|||
105321535|NCT03300817|363176902|FG000|Overall Study|Adverse Event|1|||
105371365|NCT00408499|363366772|FG001|Phase II- MTD Expansion|Physician Decision|0|||
105371366|NCT00408499|363366773|FG002|Phase II- MTD Expansion|Physician Decision|0|||
105371367|NCT00408499|363366774|FG003|Phase II- MTD Expansion|Physician Decision|0|||
105371368|NCT00408499|363366775|FG004|Phase II- MTD Expansion|Physician Decision|1|||
105371369|NCT00408499|363366771|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
105321536|NCT03300817|363176902|FG000|Overall Study|Subject Found to be Ineligible|2|||
105321537|NCT04100018|363176903|FG000|Pre-Treatment Period|Not Reported|0|||
105321538|NCT04100018|363176904|FG001|Pre-Treatment Period|Not Reported|4|||
105321539|NCT04100018|363176903|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
105321540|NCT04100018|363176904|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
105321541|NCT04100018|363176903|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
105321542|NCT04100018|363176904|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
105321543|NCT04100018|363176903|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
105321544|NCT04100018|363176904|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
105371370|NCT00408499|363366772|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
105371371|NCT00408499|363366773|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
105491394|NCT03052764|363812463|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
105491395|NCT03052764|363812464|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
105491396|NCT03052764|363812463|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
105491397|NCT03052764|363812464|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105491398|NCT03052764|363812463|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
105491399|NCT03052764|363812464|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
105491400|NCT00096954|363812468|FG000|Overall Study|Adverse Event|3|||
105491401|NCT00096954|363812469|FG001|Overall Study|Adverse Event|1|||
105321545|NCT04100018|363176903|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
105321546|NCT04100018|363176904|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
105321547|NCT04100018|363176903|FG000|Treatment Period|Ongoing Treatment|1|||
105321548|NCT04100018|363176904|FG001|Treatment Period|Ongoing Treatment|0|||
105321549|NCT04100018|363176903|FG000|Treatment Period|Other Reason|26|||
105321550|NCT04100018|363176904|FG001|Treatment Period|Other Reason|37|||
105321551|NCT04100018|363176903|FG000|Treatment Period|Completed treatment as per protocol|1|||
105321552|NCT04100018|363176904|FG001|Treatment Period|Completed treatment as per protocol|2|||
105321553|NCT04100018|363176903|FG000|Treatment Period|Maximum clinical benefit|3|||
105321554|NCT04100018|363176904|FG001|Treatment Period|Maximum clinical benefit|0|||
105321555|NCT04100018|363176903|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
105321556|NCT04100018|363176904|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
105321557|NCT04100018|363176903|FG000|Treatment Period|Study drug toxicity|67|||
105321558|NCT04100018|363176904|FG001|Treatment Period|Study drug toxicity|28|||
105321559|NCT04100018|363176903|FG000|Treatment Period|Disease Progression|284|||
105321560|NCT04100018|363176904|FG001|Treatment Period|Disease Progression|327|||
105321561|NCT04100018|363176903|FG000|Treatment Period|Administrative reasons by sponsor|16|||
105321562|NCT04100018|363176904|FG001|Treatment Period|Administrative reasons by sponsor|30|||
105321563|NCT04100018|363176903|FG000|Treatment Period|Poor/Non-Compliance|1|||
105321564|NCT04100018|363176904|FG001|Treatment Period|Poor/Non-Compliance|0|||
105321565|NCT04100018|363176903|FG000|Treatment Period|Lost to Follow-up|2|||
105321566|NCT04100018|363176904|FG001|Treatment Period|Lost to Follow-up|2|||
105321567|NCT04100018|363176903|FG000|Treatment Period|Death|16|||
105321568|NCT04100018|363176904|FG001|Treatment Period|Death|11|||
105321569|NCT04100018|363176903|FG000|Treatment Period|Participant withdrew consent|10|||
105321570|NCT04100018|363176904|FG001|Treatment Period|Participant withdrew consent|10|||
105321571|NCT04100018|363176903|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
105321572|NCT04100018|363176904|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
105321573|NCT04100018|363176903|FG000|Treatment Period|Adverse Event|14|||
105321574|NCT04100018|363176904|FG001|Treatment Period|Adverse Event|6|||
105321575|NCT04100018|363176903|FG000|Treatment Period|Lack of Efficacy|4|||
105321576|NCT04100018|363176904|FG001|Treatment Period|Lack of Efficacy|2|||
105321577|NCT02094300|363176905|FG000|Overall Study|Death|7|||
105321578|NCT02094300|363176905|FG000|Overall Study|Lost to Follow-up|10|||
105321579|NCT02094300|363176905|FG000|Overall Study|Still be eligible for follow-up|3|||
105491402|NCT00096954|363812468|FG000|Overall Study|Withdrawal by Subject|9|||
105491403|NCT00096954|363812469|FG001|Overall Study|Withdrawal by Subject|8|||
105491404|NCT00096954|363812468|FG000|Overall Study|Physician Decision|1|||
105491405|NCT00096954|363812469|FG001|Overall Study|Physician Decision|1|||
105491406|NCT00096954|363812468|FG000|Overall Study|Sponsors Decision|1|||
105576800|NCT02138747|364110327|FG003|Treatment Period 2|Adverse Event|1|||
105576801|NCT02138747|364110324|FG000|Treatment Period 2|Lost to Follow-up|2|||
105850697|NCT02393248|365112584|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
105850698|NCT02393248|365112585|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
105321580|NCT02556801|363176916|FG000|Overall Study|Lost to Follow-up|1|||
105321581|NCT02556801|363176917|FG001|Overall Study|Lost to Follow-up|0|||
105850699|NCT02393248|365112586|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850700|NCT02393248|365112587|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850701|NCT02393248|365112588|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850702|NCT02393248|365112589|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850703|NCT02393248|365112590|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850704|NCT02393248|365112591|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850705|NCT02393248|365112592|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105321582|NCT02556801|363176918|FG002|Overall Study|Lost to Follow-up|2|||
105321583|NCT02556801|363176919|FG003|Overall Study|Lost to Follow-up|0|||
105321584|NCT02556801|363176916|FG000|Overall Study|Withdrawal by Subject|1|||
105321585|NCT02556801|363176917|FG001|Overall Study|Withdrawal by Subject|1|||
105321586|NCT02556801|363176918|FG002|Overall Study|Withdrawal by Subject|1|||
105491407|NCT00096954|363812469|FG001|Overall Study|Sponsors Decision|1|||
105321587|NCT02556801|363176919|FG003|Overall Study|Withdrawal by Subject|0|||
105321588|NCT02556801|363176916|FG000|Overall Study|Protocol Violation|0|||
105321589|NCT02556801|363176917|FG001|Overall Study|Protocol Violation|3|||
105321590|NCT02556801|363176918|FG002|Overall Study|Protocol Violation|1|||
105321591|NCT02556801|363176919|FG003|Overall Study|Protocol Violation|1|||
105321592|NCT02556801|363176916|FG000|Overall Study|Adverse Event|0|||
105491408|NCT00096954|363812468|FG000|Overall Study|Pregnancy|1|||
105850706|NCT02393248|365112593|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850707|NCT02393248|365112594|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850708|NCT02393248|365112595|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850709|NCT02393248|365112596|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850710|NCT02393248|365112597|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850711|NCT02393248|365112598|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850712|NCT02393248|365112599|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850713|NCT02393248|365112600|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850714|NCT02393248|365112601|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850715|NCT02393248|365112602|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850716|NCT02393248|365112603|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850717|NCT02393248|365112579|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850718|NCT02393248|365112580|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
105850719|NCT02393248|365112581|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850720|NCT02393248|365112582|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850721|NCT02393248|365112583|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850722|NCT02393248|365112584|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850723|NCT02393248|365112585|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850724|NCT02393248|365112586|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850725|NCT02393248|365112587|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850726|NCT02393248|365112588|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850727|NCT02393248|365112589|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850728|NCT02393248|365112590|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850729|NCT02393248|365112591|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850730|NCT02393248|365112592|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850731|NCT02393248|365112593|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850732|NCT02393248|365112594|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850733|NCT02393248|365112595|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850734|NCT02393248|365112596|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850735|NCT02393248|365112597|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850736|NCT02393248|365112598|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850737|NCT02393248|365112599|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850738|NCT02393248|365112600|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850739|NCT02393248|365112601|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105491409|NCT00096954|363812469|FG001|Overall Study|Pregnancy|1|||
105491410|NCT00096954|363812468|FG000|Overall Study|Initiation of immunotherapy|1|||
105491411|NCT00096954|363812469|FG001|Overall Study|Initiation of immunotherapy|0|||
105491412|NCT00096954|363812468|FG000|Overall Study|Non-compliance|0|||
105491413|NCT00096954|363812469|FG001|Overall Study|Non-compliance|3|||
105491414|NCT00096954|363812468|FG000|Overall Study|Lost to Follow-up|8|||
105491415|NCT00096954|363812469|FG001|Overall Study|Lost to Follow-up|5|||
105491416|NCT04078178|363812470|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
105491417|NCT04078178|363812471|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
105491418|NCT04078178|363812470|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
105491419|NCT04078178|363812471|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
105491420|NCT04078178|363812470|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
105491421|NCT04078178|363812471|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
105491422|NCT04078178|363812470|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
105491423|NCT04078178|363812471|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
105491424|NCT04078178|363812470|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
105491425|NCT04078178|363812471|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
105491426|NCT02095223|363812472|FG000|Overall Study|Withdrawal by Subject|1|||
105491427|NCT02095223|363812473|FG001|Overall Study|Withdrawal by Subject|0|||
105491428|NCT03607422|363812474|FG000|Overall Study|Adverse Event|7|||
105491429|NCT03607422|363812475|FG001|Overall Study|Adverse Event|3|||
105491430|NCT03607422|363812476|FG002|Overall Study|Adverse Event|2|||
105491431|NCT03607422|363812477|FG003|Overall Study|Adverse Event|0|||
105491432|NCT03607422|363812478|FG004|Overall Study|Adverse Event|2|||
105491433|NCT03607422|363812479|FG005|Overall Study|Adverse Event|0|||
105491434|NCT03607422|363812474|FG000|Overall Study|Withdrawal by Subject|11|||
105491435|NCT03607422|363812475|FG001|Overall Study|Withdrawal by Subject|3|||
105491436|NCT03607422|363812476|FG002|Overall Study|Withdrawal by Subject|6|||
105491437|NCT03607422|363812477|FG003|Overall Study|Withdrawal by Subject|2|||
105491438|NCT03607422|363812478|FG004|Overall Study|Withdrawal by Subject|0|||
105491439|NCT03607422|363812479|FG005|Overall Study|Withdrawal by Subject|0|||
105491440|NCT03607422|363812474|FG000|Overall Study|Lost to Follow-up|0|||
105491441|NCT03607422|363812475|FG001|Overall Study|Lost to Follow-up|0|||
105491442|NCT03607422|363812476|FG002|Overall Study|Lost to Follow-up|1|||
105491443|NCT03607422|363812477|FG003|Overall Study|Lost to Follow-up|0|||
105321593|NCT02556801|363176917|FG001|Overall Study|Adverse Event|2|||
105321594|NCT02556801|363176918|FG002|Overall Study|Adverse Event|0|||
105321595|NCT02556801|363176919|FG003|Overall Study|Adverse Event|3|||
105321596|NCT02556801|363176916|FG000|Overall Study|Pregnancy|0|||
105321597|NCT02556801|363176917|FG001|Overall Study|Pregnancy|1|||
105321598|NCT02556801|363176918|FG002|Overall Study|Pregnancy|0|||
105321599|NCT02556801|363176919|FG003|Overall Study|Pregnancy|0|||
105321600|NCT02556801|363176916|FG000|Overall Study|Personal reasons patient|0|||
105321601|NCT02556801|363176917|FG001|Overall Study|Personal reasons patient|0|||
105371372|NCT00408499|363366774|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
105371373|NCT00408499|363366775|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
105371374|NCT00408499|363366771|FG000|Phase II- MTD Expansion|treatment delay|0|||
105371375|NCT00408499|363366772|FG001|Phase II- MTD Expansion|treatment delay|0|||
105371376|NCT00408499|363366773|FG002|Phase II- MTD Expansion|treatment delay|0|||
105491444|NCT03607422|363812478|FG004|Overall Study|Lost to Follow-up|0|||
105491445|NCT03607422|363812479|FG005|Overall Study|Lost to Follow-up|0|||
105491446|NCT03607422|363812474|FG000|Overall Study|Other|12|||
105491447|NCT03607422|363812475|FG001|Overall Study|Other|4|||
105491448|NCT03607422|363812476|FG002|Overall Study|Other|1|||
105491449|NCT03607422|363812477|FG003|Overall Study|Other|2|||
105491450|NCT03607422|363812478|FG004|Overall Study|Other|0|||
105491451|NCT03607422|363812479|FG005|Overall Study|Other|2|||
105491452|NCT03607422|363812474|FG000|Overall Study|Ongoing at Time of Analysis|8|||
105491453|NCT03607422|363812475|FG001|Overall Study|Ongoing at Time of Analysis|0|||
105491454|NCT03607422|363812476|FG002|Overall Study|Ongoing at Time of Analysis|2|||
105491455|NCT03607422|363812477|FG003|Overall Study|Ongoing at Time of Analysis|1|||
105491456|NCT03607422|363812478|FG004|Overall Study|Ongoing at Time of Analysis|1|||
105491457|NCT03607422|363812479|FG005|Overall Study|Ongoing at Time of Analysis|1|||
105491458|NCT04478123|363812480|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
105371377|NCT00408499|363366774|FG003|Phase II- MTD Expansion|treatment delay|0|||
105371378|NCT00408499|363366775|FG004|Phase II- MTD Expansion|treatment delay|3|||
105371379|NCT00903968|363366777|FG000|Overall Study|Adverse Event|0|||
105371380|NCT00903968|363366778|FG001|Overall Study|Adverse Event|0|||
105371381|NCT00903968|363366779|FG002|Overall Study|Adverse Event|0|||
105371382|NCT00903968|363366780|FG003|Overall Study|Adverse Event|0|||
105371383|NCT00903968|363366781|FG004|Overall Study|Adverse Event|0|||
105371384|NCT00903968|363366782|FG005|Overall Study|Adverse Event|0|||
105371385|NCT00903968|363366783|FG006|Overall Study|Adverse Event|1|||
105371386|NCT00903968|363366784|FG007|Overall Study|Adverse Event|8|||
105371387|NCT00903968|363366777|FG000|Overall Study|DLT|0|||
105371388|NCT00903968|363366778|FG001|Overall Study|DLT|0|||
105371389|NCT00903968|363366779|FG002|Overall Study|DLT|0|||
105371390|NCT00903968|363366780|FG003|Overall Study|DLT|0|||
105371391|NCT00903968|363366781|FG004|Overall Study|DLT|0|||
105371392|NCT00903968|363366782|FG005|Overall Study|DLT|0|||
105371393|NCT00903968|363366783|FG006|Overall Study|DLT|2|||
105371394|NCT00903968|363366784|FG007|Overall Study|DLT|0|||
105371395|NCT00903968|363366777|FG000|Overall Study|Withdrawal by Subject|1|||
105371396|NCT00903968|363366778|FG001|Overall Study|Withdrawal by Subject|0|||
105371397|NCT00903968|363366779|FG002|Overall Study|Withdrawal by Subject|1|||
105371398|NCT00903968|363366780|FG003|Overall Study|Withdrawal by Subject|0|||
105371399|NCT00903968|363366781|FG004|Overall Study|Withdrawal by Subject|1|||
105491459|NCT04478123|363812480|FG000|Overall Study|NE|1|||
105321602|NCT02556801|363176918|FG002|Overall Study|Personal reasons patient|0|||
105321603|NCT02556801|363176919|FG003|Overall Study|Personal reasons patient|1|||
105321604|NCT00485264|363176920|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
105321605|NCT00485264|363176921|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
105321606|NCT00485264|363176922|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
105371400|NCT00903968|363366782|FG005|Overall Study|Withdrawal by Subject|1|||
105371401|NCT00903968|363366783|FG006|Overall Study|Withdrawal by Subject|0|||
105371402|NCT00903968|363366784|FG007|Overall Study|Withdrawal by Subject|4|||
105371403|NCT00903968|363366777|FG000|Overall Study|Non-Compliance|0|||
105371404|NCT00903968|363366778|FG001|Overall Study|Non-Compliance|0|||
105371405|NCT00903968|363366779|FG002|Overall Study|Non-Compliance|0|||
105371406|NCT00903968|363366780|FG003|Overall Study|Non-Compliance|0|||
105371407|NCT00903968|363366781|FG004|Overall Study|Non-Compliance|0|||
105371408|NCT00903968|363366782|FG005|Overall Study|Non-Compliance|1|||
105371409|NCT00903968|363366783|FG006|Overall Study|Non-Compliance|0|||
105371410|NCT00903968|363366784|FG007|Overall Study|Non-Compliance|0|||
105371411|NCT00903968|363366777|FG000|Overall Study|Physician Decision|0|||
105371412|NCT00903968|363366778|FG001|Overall Study|Physician Decision|0|||
105491460|NCT01801072|363812481|FG000|Overall Study|Lost to Follow-up|17|||
105491461|NCT01801072|363812482|FG001|Overall Study|Lost to Follow-up|14|||
105491462|NCT01801072|363812481|FG000|Overall Study|Physician Decision|2|||
105491463|NCT01801072|363812482|FG001|Overall Study|Physician Decision|3|||
105491464|NCT01801072|363812481|FG000|Overall Study|Withdrawal by Subject|1|||
105491465|NCT01801072|363812482|FG001|Overall Study|Withdrawal by Subject|0|||
105321607|NCT00485264|363176923|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
105371413|NCT00903968|363366779|FG002|Overall Study|Physician Decision|0|||
105371414|NCT00903968|363366780|FG003|Overall Study|Physician Decision|0|||
105491466|NCT01801072|363812481|FG000|Overall Study|Protocol Violation|2|||
105491467|NCT01801072|363812482|FG001|Overall Study|Protocol Violation|0|||
105491468|NCT01801072|363812481|FG000|Overall Study|Death|7|||
105850740|NCT02393248|365112602|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850741|NCT02393248|365112603|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850742|NCT02393248|365112579|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
105850743|NCT02393248|365112580|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
105850744|NCT02393248|365112581|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
105850745|NCT02393248|365112582|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
105850746|NCT02393248|365112583|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
105850747|NCT02393248|365112584|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
105491469|NCT01801072|363812482|FG001|Overall Study|Death|8|||
105491470|NCT03693170|363812483|FG000|Overall Study|Disease Progression|48|||
105491471|NCT03693170|363812483|FG000|Overall Study|Adverse Event|16|||
105491472|NCT03693170|363812483|FG000|Overall Study|Physician Decision|6|||
105491473|NCT03693170|363812483|FG000|Overall Study|Protocol Violation|2|||
105491474|NCT03693170|363812483|FG000|Overall Study|Death|1|||
105491475|NCT03693170|363812483|FG000|Overall Study|Non compliance with study drug|1|||
105491476|NCT03693170|363812483|FG000|Overall Study|Withdrawal by Subject|1|||
105491477|NCT02247531|363812484|FG000|Overall Study|Adverse Event|3|||
105491478|NCT02247531|363812485|FG001|Overall Study|Adverse Event|4|||
105491479|NCT02247531|363812486|FG002|Overall Study|Adverse Event|9|||
105576802|NCT02138747|364110325|FG001|Treatment Period 2|Lost to Follow-up|0|||
105576803|NCT02138747|364110326|FG002|Treatment Period 2|Lost to Follow-up|0|||
105576804|NCT02138747|364110327|FG003|Treatment Period 2|Lost to Follow-up|0|||
105576805|NCT02138747|364110324|FG000|Treatment Period 2|Protocol Violation|1|||
105850748|NCT02393248|365112585|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
105850749|NCT02393248|365112586|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
105850750|NCT02393248|365112587|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
105576806|NCT02138747|364110325|FG001|Treatment Period 2|Protocol Violation|0|||
105576807|NCT02138747|364110326|FG002|Treatment Period 2|Protocol Violation|0|||
105576808|NCT02138747|364110327|FG003|Treatment Period 2|Protocol Violation|0|||
105576809|NCT02138747|364110324|FG000|Treatment Period 2|Withdrawal by Subject|5|||
105576810|NCT02138747|364110325|FG001|Treatment Period 2|Withdrawal by Subject|4|||
105576811|NCT02138747|364110326|FG002|Treatment Period 2|Withdrawal by Subject|1|||
105576812|NCT02138747|364110327|FG003|Treatment Period 2|Withdrawal by Subject|2|||
105576813|NCT02138747|364110324|FG000|Treatment Period 2|Other - Miscellaneous|3|||
105576814|NCT02138747|364110325|FG001|Treatment Period 2|Other - Miscellaneous|0|||
105576815|NCT02138747|364110326|FG002|Treatment Period 2|Other - Miscellaneous|0|||
105576816|NCT02138747|364110327|FG003|Treatment Period 2|Other - Miscellaneous|0|||
105576817|NCT00653263|364110328|FG000|Overall Study|Withdrawal by Subject|1|||
105576818|NCT00653263|364110328|FG000|Overall Study|Physician Decision|1|||
105576819|NCT03567993|364110332|FG000|Overall Study|Lost to Follow-up|4|||
105576820|NCT03567993|364110333|FG001|Overall Study|Lost to Follow-up|2|||
105576821|NCT03567993|364110332|FG000|Overall Study|Death|1|||
105576822|NCT03567993|364110333|FG001|Overall Study|Death|1|||
105576823|NCT03567993|364110332|FG000|Overall Study|Withdrawal by Subject|1|||
105576824|NCT03567993|364110333|FG001|Overall Study|Withdrawal by Subject|0|||
105576825|NCT00180713|364110337|FG000|Overall Study|Withdrawal by Subject|2|||
105576826|NCT00180713|364110338|FG001|Overall Study|Withdrawal by Subject|0|||
105576827|NCT00180713|364110337|FG000|Overall Study|Adverse Event|3|||
105850751|NCT02393248|365112588|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
105850752|NCT02393248|365112589|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
105850753|NCT02393248|365112590|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
105850754|NCT02393248|365112591|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
105850755|NCT02393248|365112592|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
105850756|NCT02393248|365112593|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
105850757|NCT02393248|365112594|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
105850758|NCT02393248|365112595|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
105850759|NCT02393248|365112596|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
105850760|NCT02393248|365112597|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
105850761|NCT02393248|365112598|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
105576828|NCT00180713|364110338|FG001|Overall Study|Adverse Event|3|||
105850762|NCT02393248|365112599|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
105491480|NCT02247531|363812484|FG000|Overall Study|Death|8|||
105491481|NCT02247531|363812485|FG001|Overall Study|Death|9|||
105576829|NCT02044458|364110339|FG000|Overall Study|Protocol Violation|3|||
105576830|NCT02044458|364110340|FG001|Overall Study|Protocol Violation|8|||
105576831|NCT01216293|364110341|FG000|Main Study|Adverse Event|1|||
105576832|NCT01216293|364110342|FG001|Main Study|Adverse Event|4|||
105576833|NCT01216293|364110343|FG002|Main Study|Adverse Event|2|||
105850763|NCT02393248|365112600|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
105321608|NCT00485264|363176924|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
105491482|NCT02247531|363812486|FG002|Overall Study|Death|5|||
105491483|NCT02247531|363812484|FG000|Overall Study|Lost to Follow-up|1|||
105576834|NCT01216293|364110341|FG000|Main Study|Major Protocol Deviation|1|||
105576835|NCT01216293|364110342|FG001|Main Study|Major Protocol Deviation|0|||
105576836|NCT01216293|364110343|FG002|Main Study|Major Protocol Deviation|1|||
105371415|NCT00903968|363366781|FG004|Overall Study|Physician Decision|0|||
105371416|NCT00903968|363366782|FG005|Overall Study|Physician Decision|1|||
105371417|NCT00903968|363366783|FG006|Overall Study|Physician Decision|0|||
105371418|NCT00903968|363366784|FG007|Overall Study|Physician Decision|0|||
105371419|NCT00903968|363366777|FG000|Overall Study|Progressive Disease|2|||
105371420|NCT00903968|363366778|FG001|Overall Study|Progressive Disease|3|||
105371421|NCT00903968|363366779|FG002|Overall Study|Progressive Disease|2|||
105371422|NCT00903968|363366780|FG003|Overall Study|Progressive Disease|3|||
105371423|NCT00903968|363366781|FG004|Overall Study|Progressive Disease|3|||
105371424|NCT00903968|363366782|FG005|Overall Study|Progressive Disease|3|||
105371425|NCT00903968|363366783|FG006|Overall Study|Progressive Disease|0|||
105371426|NCT00903968|363366784|FG007|Overall Study|Progressive Disease|18|||
105371427|NCT00903968|363366777|FG000|Overall Study|Lack of Efficacy|0|||
105371428|NCT00903968|363366778|FG001|Overall Study|Lack of Efficacy|0|||
105371429|NCT00903968|363366779|FG002|Overall Study|Lack of Efficacy|0|||
105371430|NCT00903968|363366780|FG003|Overall Study|Lack of Efficacy|0|||
105371431|NCT00903968|363366781|FG004|Overall Study|Lack of Efficacy|0|||
105371432|NCT00903968|363366782|FG005|Overall Study|Lack of Efficacy|0|||
105371433|NCT00903968|363366783|FG006|Overall Study|Lack of Efficacy|0|||
105371434|NCT00903968|363366784|FG007|Overall Study|Lack of Efficacy|3|||
105371435|NCT01373164|363366785|FG000|Overall Study|Lost to Follow-up|0|||
105371436|NCT01373164|363366786|FG001|Overall Study|Lost to Follow-up|0|||
105371437|NCT01373164|363366787|FG002|Overall Study|Lost to Follow-up|1|||
105371438|NCT01373164|363366788|FG003|Overall Study|Lost to Follow-up|2|||
105371439|NCT01373164|363366789|FG004|Overall Study|Lost to Follow-up|0|||
105371440|NCT01373164|363366785|FG000|Overall Study|Withdrawal by Subject|0|||
105371441|NCT01373164|363366786|FG001|Overall Study|Withdrawal by Subject|1|||
105371442|NCT01373164|363366787|FG002|Overall Study|Withdrawal by Subject|0|||
105371443|NCT01373164|363366788|FG003|Overall Study|Withdrawal by Subject|10|||
105371444|NCT01373164|363366789|FG004|Overall Study|Withdrawal by Subject|2|||
105371445|NCT00420745|363366790|FG000|Overall Study|Adverse Event|2|||
105371446|NCT00420745|363366791|FG001|Overall Study|Adverse Event|2|||
105371447|NCT00420745|363366790|FG000|Overall Study|Lost to Follow-up|10|||
105371448|NCT00420745|363366791|FG001|Overall Study|Lost to Follow-up|2|||
105371449|NCT00420745|363366790|FG000|Overall Study|Protocol Violation|1|||
105850764|NCT02393248|365112601|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
105850765|NCT02393248|365112602|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
105850766|NCT02393248|365112603|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
105850767|NCT02393248|365112579|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
105850768|NCT02393248|365112580|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850769|NCT02393248|365112581|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850770|NCT02393248|365112582|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850771|NCT02393248|365112583|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850772|NCT02393248|365112584|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850773|NCT02393248|365112585|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850774|NCT02393248|365112586|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850775|NCT02393248|365112587|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850776|NCT02393248|365112588|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850777|NCT02393248|365112589|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850778|NCT02393248|365112590|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850779|NCT02393248|365112591|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850780|NCT02393248|365112592|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850781|NCT02393248|365112593|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850782|NCT02393248|365112594|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850783|NCT02393248|365112595|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850784|NCT02393248|365112596|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850785|NCT02393248|365112597|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850786|NCT02393248|365112598|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850787|NCT02393248|365112599|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850788|NCT02393248|365112600|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850789|NCT02393248|365112601|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850790|NCT02393248|365112602|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850791|NCT02393248|365112603|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850792|NCT02393248|365112579|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850793|NCT02393248|365112580|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850794|NCT02393248|365112581|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850795|NCT02393248|365112582|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105371450|NCT00420745|363366791|FG001|Overall Study|Protocol Violation|0|||
105371451|NCT00420745|363366790|FG000|Overall Study|Physician Decision|1|||
105371452|NCT00420745|363366791|FG001|Overall Study|Physician Decision|1|||
105371453|NCT00420745|363366790|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
105371454|NCT00420745|363366791|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
105321609|NCT00485264|363176925|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
105321610|NCT00485264|363176920|FG000|Overall Study|Death|1|||
105321611|NCT00485264|363176921|FG001|Overall Study|Death|0|||
105321612|NCT00485264|363176922|FG002|Overall Study|Death|0|||
105321613|NCT00485264|363176923|FG003|Overall Study|Death|0|||
105321614|NCT00485264|363176924|FG004|Overall Study|Death|1|||
105321615|NCT00485264|363176925|FG005|Overall Study|Death|0|||
105321616|NCT00485264|363176920|FG000|Overall Study|Adverse Event|1|||
105321617|NCT00485264|363176921|FG001|Overall Study|Adverse Event|0|||
105321618|NCT00485264|363176922|FG002|Overall Study|Adverse Event|2|||
105321619|NCT00485264|363176923|FG003|Overall Study|Adverse Event|3|||
105321620|NCT00485264|363176924|FG004|Overall Study|Adverse Event|1|||
105321621|NCT00485264|363176925|FG005|Overall Study|Adverse Event|3|||
105321622|NCT00485264|363176920|FG000|Overall Study|Pregnancy|4|||
105321623|NCT00485264|363176921|FG001|Overall Study|Pregnancy|0|||
105321624|NCT00485264|363176922|FG002|Overall Study|Pregnancy|0|||
105321625|NCT00485264|363176923|FG003|Overall Study|Pregnancy|0|||
105321626|NCT00485264|363176924|FG004|Overall Study|Pregnancy|0|||
105321627|NCT00485264|363176925|FG005|Overall Study|Pregnancy|0|||
105321628|NCT00485264|363176920|FG000|Overall Study|Disallowed Medication|0|||
105321629|NCT00485264|363176921|FG001|Overall Study|Disallowed Medication|0|||
105321630|NCT00485264|363176922|FG002|Overall Study|Disallowed Medication|0|||
105321631|NCT00485264|363176923|FG003|Overall Study|Disallowed Medication|0|||
105321632|NCT00485264|363176924|FG004|Overall Study|Disallowed Medication|0|||
105321633|NCT00485264|363176925|FG005|Overall Study|Disallowed Medication|1|||
105321634|NCT00485264|363176920|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
105321635|NCT00485264|363176921|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
105321636|NCT00485264|363176922|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
105321637|NCT00485264|363176923|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
105321638|NCT00485264|363176924|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
105321639|NCT00485264|363176925|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
105321640|NCT00485264|363176920|FG000|Overall Study|Lack of Efficacy|0|||
105321641|NCT00485264|363176921|FG001|Overall Study|Lack of Efficacy|1|||
105321642|NCT00485264|363176922|FG002|Overall Study|Lack of Efficacy|0|||
105321643|NCT00485264|363176923|FG003|Overall Study|Lack of Efficacy|0|||
105321644|NCT00485264|363176924|FG004|Overall Study|Lack of Efficacy|0|||
105321645|NCT00485264|363176925|FG005|Overall Study|Lack of Efficacy|0|||
105321646|NCT00485264|363176920|FG000|Overall Study|Guardian Consent Withdrawn|1|||
105321647|NCT00485264|363176921|FG001|Overall Study|Guardian Consent Withdrawn|0|||
105321648|NCT00485264|363176922|FG002|Overall Study|Guardian Consent Withdrawn|0|||
105321649|NCT00485264|363176923|FG003|Overall Study|Guardian Consent Withdrawn|0|||
105321650|NCT00485264|363176924|FG004|Overall Study|Guardian Consent Withdrawn|1|||
105321651|NCT00485264|363176925|FG005|Overall Study|Guardian Consent Withdrawn|0|||
105321652|NCT00485264|363176920|FG000|Overall Study|Physician Decision|0|||
105321653|NCT00485264|363176921|FG001|Overall Study|Physician Decision|2|||
105321654|NCT00485264|363176922|FG002|Overall Study|Physician Decision|0|||
105321655|NCT00485264|363176923|FG003|Overall Study|Physician Decision|0|||
105321656|NCT00485264|363176924|FG004|Overall Study|Physician Decision|0|||
105321657|NCT00485264|363176925|FG005|Overall Study|Physician Decision|0|||
105321658|NCT00485264|363176920|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
105321659|NCT00485264|363176921|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
105321660|NCT00485264|363176922|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
105321661|NCT00485264|363176923|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
105321662|NCT00485264|363176924|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
105321663|NCT00485264|363176925|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
105321664|NCT00485264|363176920|FG000|Overall Study|Not Able to Attend Clinic|5|||
105321665|NCT00485264|363176921|FG001|Overall Study|Not Able to Attend Clinic|0|||
105321666|NCT00485264|363176922|FG002|Overall Study|Not Able to Attend Clinic|0|||
105321667|NCT00485264|363176923|FG003|Overall Study|Not Able to Attend Clinic|1|||
105321668|NCT00485264|363176924|FG004|Overall Study|Not Able to Attend Clinic|1|||
105321669|NCT00485264|363176925|FG005|Overall Study|Not Able to Attend Clinic|2|||
105321670|NCT00485264|363176920|FG000|Overall Study|Non-Compliant|17|||
105321671|NCT00485264|363176921|FG001|Overall Study|Non-Compliant|2|||
105321672|NCT00485264|363176922|FG002|Overall Study|Non-Compliant|1|||
105321673|NCT00485264|363176923|FG003|Overall Study|Non-Compliant|0|||
105321674|NCT00485264|363176924|FG004|Overall Study|Non-Compliant|1|||
105321675|NCT00485264|363176925|FG005|Overall Study|Non-Compliant|0|||
105371455|NCT00420745|363366790|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
105371456|NCT00420745|363366791|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
105321676|NCT00485264|363176920|FG000|Overall Study|Lost to Follow-up|2|||
105321677|NCT00485264|363176921|FG001|Overall Study|Lost to Follow-up|1|||
105321678|NCT00485264|363176922|FG002|Overall Study|Lost to Follow-up|1|||
105321679|NCT00485264|363176923|FG003|Overall Study|Lost to Follow-up|0|||
105321680|NCT00485264|363176924|FG004|Overall Study|Lost to Follow-up|0|||
105321681|NCT00485264|363176925|FG005|Overall Study|Lost to Follow-up|1|||
105321682|NCT00485264|363176920|FG000|Overall Study|Other Reason|3|||
105321683|NCT00485264|363176921|FG001|Overall Study|Other Reason|0|||
105321684|NCT00485264|363176922|FG002|Overall Study|Other Reason|0|||
105321685|NCT00485264|363176923|FG003|Overall Study|Other Reason|0|||
105321686|NCT00485264|363176924|FG004|Overall Study|Other Reason|0|||
105321687|NCT00485264|363176925|FG005|Overall Study|Other Reason|0|||
105321688|NCT02515331|363176931|FG000|Overall Study|Withdrawal by Subject|0|||
105321689|NCT02515331|363176932|FG001|Overall Study|Withdrawal by Subject|0|||
105321690|NCT02515331|363176933|FG002|Overall Study|Withdrawal by Subject|1|||
105321691|NCT02515331|363176931|FG000|Overall Study|Protocol deviation|0|||
105321692|NCT02515331|363176932|FG001|Overall Study|Protocol deviation|0|||
105371457|NCT04889040|363366792|FG000|Overall Study|Withdrawal by Subject|3|||
105371458|NCT04889040|363366793|FG001|Overall Study|Withdrawal by Subject|3|||
105371459|NCT04889040|363366792|FG000|Overall Study|Lost to Follow-up|0|||
105371460|NCT04889040|363366793|FG001|Overall Study|Lost to Follow-up|1|||
105371461|NCT04889040|363366792|FG000|Overall Study|Adverse Event|2|||
105371462|NCT04889040|363366793|FG001|Overall Study|Adverse Event|1|||
105371463|NCT02014272|363366794|FG000|Intervention Period 1|Withdrawal by Subject|1|||
105371464|NCT02014272|363366795|FG001|Intervention Period 1|Withdrawal by Subject|0|||
105371465|NCT02014272|363366794|FG000|Intervention Period 1|Adverse Event|0|||
105371466|NCT02014272|363366795|FG001|Intervention Period 1|Adverse Event|1|||
105371467|NCT01240746|363366796|FG000|Overall Study|Adverse Event|2|||
105371468|NCT01240746|363366797|FG001|Overall Study|Adverse Event|0|||
105371469|NCT01240746|363366798|FG002|Overall Study|Adverse Event|10|||
105371470|NCT01240746|363366796|FG000|Overall Study|Lost to Follow-up|23|||
105371471|NCT01240746|363366797|FG001|Overall Study|Lost to Follow-up|20|||
105371472|NCT01240746|363366798|FG002|Overall Study|Lost to Follow-up|102|||
105371473|NCT01240746|363366796|FG000|Overall Study|Protocol Violation|24|||
105850796|NCT02393248|365112583|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850797|NCT02393248|365112584|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
105850798|NCT02393248|365112585|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
105850799|NCT02393248|365112586|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850800|NCT02393248|365112587|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850801|NCT02393248|365112588|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
105850802|NCT02393248|365112589|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850803|NCT02393248|365112590|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850804|NCT02393248|365112591|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850805|NCT02393248|365112592|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850806|NCT02393248|365112593|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850807|NCT02393248|365112594|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850808|NCT02393248|365112595|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850809|NCT02393248|365112596|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850810|NCT02393248|365112597|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850811|NCT02393248|365112598|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850812|NCT02393248|365112599|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850813|NCT02393248|365112600|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850814|NCT02393248|365112601|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850815|NCT02393248|365112602|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850816|NCT02393248|365112603|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850817|NCT02393248|365112579|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850818|NCT02393248|365112580|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850819|NCT02393248|365112581|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850820|NCT02393248|365112582|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850821|NCT02393248|365112583|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850822|NCT02393248|365112584|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850823|NCT02393248|365112585|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
105850824|NCT02393248|365112586|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850825|NCT02393248|365112587|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850826|NCT02393248|365112588|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850827|NCT02393248|365112589|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105321693|NCT02515331|363176933|FG002|Overall Study|Protocol deviation|3|||
105321694|NCT02515331|363176931|FG000|Overall Study|Adverse Event|2|||
105321695|NCT02515331|363176932|FG001|Overall Study|Adverse Event|0|||
105321696|NCT02515331|363176933|FG002|Overall Study|Adverse Event|0|||
105321697|NCT00124748|363176934|FG000|Overall Study|Adverse Event|8|||
105371474|NCT01240746|363366797|FG001|Overall Study|Protocol Violation|15|||
105371475|NCT01240746|363366798|FG002|Overall Study|Protocol Violation|72|||
105371476|NCT01240746|363366796|FG000|Overall Study|Withdrawal by Subject|10|||
105371477|NCT01240746|363366797|FG001|Overall Study|Withdrawal by Subject|13|||
105371478|NCT01240746|363366798|FG002|Overall Study|Withdrawal by Subject|59|||
105371479|NCT03636256|363366799|FG000|Overall Study|Lost to Follow-up|3|||
105321698|NCT00124748|363176935|FG001|Overall Study|Adverse Event|39|||
105321699|NCT00124748|363176934|FG000|Overall Study|Abnormal laboratory Value|2|||
105321700|NCT00124748|363176935|FG001|Overall Study|Abnormal laboratory Value|2|||
105321701|NCT00124748|363176934|FG000|Overall Study|Abnormal Procedure|0|||
105321702|NCT00124748|363176935|FG001|Overall Study|Abnormal Procedure|1|||
105321703|NCT00124748|363176934|FG000|Overall Study|Lack of Efficacy|20|||
105321704|NCT00124748|363176935|FG001|Overall Study|Lack of Efficacy|41|||
105321705|NCT00124748|363176934|FG000|Overall Study|No longer requires study drug|1|||
105321706|NCT00124748|363176935|FG001|Overall Study|No longer requires study drug|1|||
105321707|NCT00124748|363176934|FG000|Overall Study|Protocol Violation|3|||
105321708|NCT00124748|363176935|FG001|Overall Study|Protocol Violation|1|||
105321709|NCT00124748|363176934|FG000|Overall Study|Withdrawal by Subject|5|||
105321710|NCT00124748|363176935|FG001|Overall Study|Withdrawal by Subject|15|||
105321711|NCT00124748|363176934|FG000|Overall Study|Lost to Follow-up|2|||
105321712|NCT00124748|363176935|FG001|Overall Study|Lost to Follow-up|7|||
105321713|NCT00124748|363176934|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
105321714|NCT00124748|363176935|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
105321715|NCT00124748|363176934|FG000|Overall Study|Death|1|||
105321716|NCT00124748|363176935|FG001|Overall Study|Death|3|||
105321717|NCT01514461|363176936|FG000|Overall Study|Adverse Event|2|||
105321718|NCT01514461|363176937|FG001|Overall Study|Adverse Event|1|||
105321719|NCT01514461|363176938|FG002|Overall Study|Adverse Event|3|||
105321720|NCT01514461|363176936|FG000|Overall Study|Physician Decision|1|||
105321721|NCT01514461|363176937|FG001|Overall Study|Physician Decision|1|||
105321722|NCT01514461|363176938|FG002|Overall Study|Physician Decision|0|||
105321723|NCT01514461|363176936|FG000|Overall Study|Patient/guardian decision|1|||
105321724|NCT01514461|363176937|FG001|Overall Study|Patient/guardian decision|1|||
105321725|NCT01514461|363176938|FG002|Overall Study|Patient/guardian decision|1|||
105321726|NCT01514461|363176936|FG000|Overall Study|Death|1|||
105321727|NCT01514461|363176937|FG001|Overall Study|Death|0|||
105321728|NCT01514461|363176938|FG002|Overall Study|Death|0|||
105321729|NCT03889886|363176940|FG000|Overall Study|Other|0|||
105321730|NCT03889886|363176941|FG001|Overall Study|Other|1|||
105321731|NCT03889886|363176942|FG002|Overall Study|Other|0|||
105321732|NCT03889886|363176943|FG003|Overall Study|Other|1|||
105321733|NCT03889886|363176940|FG000|Overall Study|Withdrawal by Subject|0|||
105321734|NCT03889886|363176941|FG001|Overall Study|Withdrawal by Subject|0|||
105321735|NCT03889886|363176942|FG002|Overall Study|Withdrawal by Subject|1|||
105321736|NCT03889886|363176943|FG003|Overall Study|Withdrawal by Subject|0|||
105321737|NCT03889886|363176940|FG000|Overall Study|Adverse Event|0|||
105321738|NCT03889886|363176941|FG001|Overall Study|Adverse Event|0|||
105321739|NCT03889886|363176942|FG002|Overall Study|Adverse Event|0|||
105321740|NCT03889886|363176943|FG003|Overall Study|Adverse Event|6|||
105321741|NCT00758524|363176946|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
105321742|NCT00758524|363176947|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
105321743|NCT00758524|363176948|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
105321744|NCT00758524|363176949|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105321745|NCT00758524|363176950|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
105321746|NCT00758524|363176951|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
105321747|NCT00758524|363176952|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105321748|NCT00758524|363176953|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105321749|NCT00758524|363176954|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105321750|NCT00758524|363176955|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105321751|NCT00758524|363176956|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105321752|NCT00758524|363176957|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105321753|NCT00758524|363176958|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105321754|NCT00758524|363176959|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105321755|NCT00758524|363176960|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105321756|NCT00758524|363176961|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105321757|NCT00758524|363176962|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105321758|NCT00758524|363176946|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
105321759|NCT00758524|363176947|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105321760|NCT00758524|363176948|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
105321761|NCT00758524|363176949|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
105321762|NCT00758524|363176950|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
105321763|NCT00758524|363176951|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
105321764|NCT00758524|363176952|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105321765|NCT00758524|363176953|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105321766|NCT00758524|363176954|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105321767|NCT00758524|363176955|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105321768|NCT00758524|363176956|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105371480|NCT03636256|363366800|FG001|Overall Study|Lost to Follow-up|0|||
105321769|NCT00758524|363176957|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105321770|NCT00758524|363176958|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105371481|NCT03636256|363366801|FG002|Overall Study|Lost to Follow-up|2|||
105371482|NCT03636256|363366802|FG003|Overall Study|Lost to Follow-up|1|||
105371483|NCT03636256|363366803|FG004|Overall Study|Lost to Follow-up|0|||
105371484|NCT03636256|363366804|FG005|Overall Study|Lost to Follow-up|4|||
105371485|NCT03636256|363366805|FG006|Overall Study|Lost to Follow-up|2|||
105371486|NCT03636256|363366806|FG007|Overall Study|Lost to Follow-up|0|||
105371487|NCT03636256|363366807|FG008|Overall Study|Lost to Follow-up|4|||
105371488|NCT03636256|363366799|FG000|Overall Study|Withdrawal by Subject|0|||
105371489|NCT03636256|363366800|FG001|Overall Study|Withdrawal by Subject|0|||
105371490|NCT03636256|363366801|FG002|Overall Study|Withdrawal by Subject|0|||
105371491|NCT03636256|363366802|FG003|Overall Study|Withdrawal by Subject|0|||
105371492|NCT03636256|363366803|FG004|Overall Study|Withdrawal by Subject|0|||
105371493|NCT03636256|363366804|FG005|Overall Study|Withdrawal by Subject|0|||
105371494|NCT03636256|363366805|FG006|Overall Study|Withdrawal by Subject|0|||
105371495|NCT03636256|363366806|FG007|Overall Study|Withdrawal by Subject|0|||
105371496|NCT03636256|363366807|FG008|Overall Study|Withdrawal by Subject|1|||
105371497|NCT02369653|363366808|FG000|Overall Study|Lost to Follow-up|0|||
105371498|NCT02369653|363366809|FG001|Overall Study|Lost to Follow-up|1|||
105371499|NCT02369653|363366808|FG000|Overall Study|Administrative reason by sponsor|0|||
105371500|NCT02369653|363366809|FG001|Overall Study|Administrative reason by sponsor|1|||
105371501|NCT02369653|363366808|FG000|Overall Study|Death|1|||
105371502|NCT02369653|363366809|FG001|Overall Study|Death|2|||
105371503|NCT02369653|363366808|FG000|Overall Study|Participant withdrew consent|13|||
105371504|NCT02369653|363366809|FG001|Overall Study|Participant withdrew consent|3|||
105371505|NCT03587636|363366812|FG000|Overall Study|Lost to Follow-up|2|||
105371506|NCT03587636|363366813|FG001|Overall Study|Lost to Follow-up|5|||
105371507|NCT01458587|363366814|FG000|Overall Study|Withdrawal by Subject|1|||
105371508|NCT01458587|363366815|FG001|Overall Study|Withdrawal by Subject|0|||
105371509|NCT00726453|363366816|FG000|Primary Enrollment Group|Death|18|||
105371510|NCT00726453|363366817|FG001|Primary Enrollment Group|Death|0|||
105371511|NCT00726453|363366816|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
105371512|NCT00726453|363366817|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
105371513|NCT00726453|363366816|FG000|38 mm Length Group|Death|0|||
105371514|NCT00726453|363366817|FG001|38 mm Length Group|Death|3|||
105371515|NCT02152007|363366822|FG000|Overall Study|Withdrawal by Subject|1|||
105371516|NCT03558516|363366825|FG000|Overall Study|Protocol Violation|2|||
105371517|NCT03558516|363366826|FG001|Overall Study|Protocol Violation|2|||
105371518|NCT02714153|363366828|FG000|Overall Study|Death|1|||
105371519|NCT00686972|363366829|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
105371520|NCT01901185|363366830|FG000|Overall Study|Withdrawal by Subject|2|||
105371521|NCT01462942|363366832|FG000|Overall Study|Adverse Event|7|||
105371522|NCT01462942|363366833|FG001|Overall Study|Adverse Event|12|||
105371523|NCT01462942|363366834|FG002|Overall Study|Adverse Event|10|||
105371524|NCT01462942|363366835|FG003|Overall Study|Adverse Event|11|||
105371525|NCT01462942|363366836|FG004|Overall Study|Adverse Event|11|||
105371526|NCT01462942|363366832|FG000|Overall Study|Other, including COPD exacerbation|3|||
105371527|NCT01462942|363366833|FG001|Overall Study|Other, including COPD exacerbation|5|||
105371528|NCT01462942|363366834|FG002|Overall Study|Other, including COPD exacerbation|2|||
105371529|NCT01462942|363366835|FG003|Overall Study|Other, including COPD exacerbation|8|||
105371530|NCT01462942|363366836|FG004|Overall Study|Other, including COPD exacerbation|5|||
105371531|NCT01462942|363366832|FG000|Overall Study|Withdrawal by Subject|14|||
105371532|NCT01462942|363366833|FG001|Overall Study|Withdrawal by Subject|10|||
105576837|NCT01216293|364110341|FG000|Main Study|Lost to Follow-up|3|||
105850828|NCT02393248|365112590|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850829|NCT02393248|365112591|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850830|NCT02393248|365112592|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850831|NCT02393248|365112593|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850832|NCT02393248|365112594|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850833|NCT02393248|365112595|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850834|NCT02393248|365112596|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850835|NCT02393248|365112597|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850836|NCT02393248|365112598|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105371533|NCT01462942|363366834|FG002|Overall Study|Withdrawal by Subject|14|||
105371534|NCT01462942|363366835|FG003|Overall Study|Withdrawal by Subject|16|||
105371535|NCT01462942|363366836|FG004|Overall Study|Withdrawal by Subject|19|||
105371536|NCT01462942|363366832|FG000|Overall Study|Lack of Efficacy|6|||
105371537|NCT01462942|363366833|FG001|Overall Study|Lack of Efficacy|0|||
105371538|NCT01462942|363366834|FG002|Overall Study|Lack of Efficacy|4|||
105371539|NCT01462942|363366835|FG003|Overall Study|Lack of Efficacy|5|||
105371540|NCT01462942|363366836|FG004|Overall Study|Lack of Efficacy|3|||
105371541|NCT01462942|363366832|FG000|Overall Study|Lost to Follow-up|0|||
105371542|NCT01462942|363366833|FG001|Overall Study|Lost to Follow-up|1|||
105371543|NCT01462942|363366834|FG002|Overall Study|Lost to Follow-up|1|||
105850837|NCT02393248|365112599|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850838|NCT02393248|365112600|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850839|NCT02393248|365112601|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850840|NCT02393248|365112602|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850841|NCT02393248|365112603|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850842|NCT02393248|365112579|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850843|NCT02393248|365112580|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850844|NCT02393248|365112581|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850845|NCT02393248|365112582|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850846|NCT02393248|365112583|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850847|NCT02393248|365112584|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850848|NCT02393248|365112585|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850849|NCT02393248|365112586|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850850|NCT02393248|365112587|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850851|NCT02393248|365112588|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850852|NCT02393248|365112589|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850853|NCT02393248|365112590|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
105850854|NCT02393248|365112591|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
105850855|NCT02393248|365112592|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
105850856|NCT02393248|365112593|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
105850857|NCT02393248|365112594|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850858|NCT02393248|365112595|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850859|NCT02393248|365112596|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850860|NCT02393248|365112597|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850861|NCT02393248|365112598|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850862|NCT02393248|365112599|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850863|NCT02393248|365112600|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850864|NCT02393248|365112601|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850865|NCT02393248|365112602|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850866|NCT02393248|365112603|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850867|NCT02393248|365112579|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850868|NCT02393248|365112580|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850869|NCT02393248|365112581|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850870|NCT02393248|365112582|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850871|NCT02393248|365112583|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850872|NCT02393248|365112584|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850873|NCT02393248|365112585|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850874|NCT02393248|365112586|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850875|NCT02393248|365112587|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850876|NCT02393248|365112588|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850877|NCT02393248|365112589|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
105850878|NCT02393248|365112590|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
105850879|NCT02393248|365112591|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105321771|NCT00758524|363176959|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105321772|NCT00758524|363176960|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105321773|NCT00758524|363176961|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105321774|NCT00758524|363176962|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105321775|NCT00758524|363176946|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
105321776|NCT00758524|363176947|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
105321777|NCT00758524|363176948|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
105321778|NCT00758524|363176949|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
105321779|NCT00758524|363176950|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
105321780|NCT00758524|363176951|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
105321781|NCT00758524|363176952|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105321782|NCT00758524|363176953|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105321783|NCT00758524|363176954|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105321784|NCT00758524|363176955|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105321785|NCT00758524|363176956|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105321786|NCT00758524|363176957|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105321787|NCT00758524|363176958|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105321788|NCT00758524|363176959|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105321789|NCT00758524|363176960|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105321790|NCT00758524|363176961|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105321791|NCT00758524|363176962|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105321792|NCT00758524|363176946|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105321793|NCT00758524|363176947|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
105321794|NCT00758524|363176948|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
105321795|NCT00758524|363176949|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105321796|NCT00758524|363176950|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
105321797|NCT00758524|363176951|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
105321798|NCT00758524|363176952|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105321799|NCT00758524|363176953|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105321800|NCT00758524|363176954|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105321801|NCT00758524|363176955|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105321802|NCT00758524|363176956|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105321803|NCT00758524|363176957|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105321804|NCT00758524|363176958|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105321805|NCT00758524|363176959|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105321806|NCT00758524|363176960|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105321807|NCT00758524|363176961|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105321808|NCT00758524|363176962|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105321809|NCT00758524|363176946|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105321810|NCT00758524|363176947|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105321811|NCT00758524|363176948|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
105321812|NCT00758524|363176949|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
105321813|NCT00758524|363176950|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105321814|NCT00758524|363176951|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105321815|NCT00758524|363176952|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105321816|NCT00758524|363176953|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105321817|NCT00758524|363176954|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105321818|NCT00758524|363176955|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105321819|NCT00758524|363176956|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105321820|NCT00758524|363176957|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105321821|NCT00758524|363176958|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105321822|NCT00758524|363176959|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105321823|NCT00758524|363176960|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105321824|NCT00758524|363176961|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105321825|NCT00758524|363176962|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105321826|NCT00758524|363176946|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321827|NCT00758524|363176947|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321828|NCT00758524|363176948|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321829|NCT00758524|363176949|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321830|NCT00758524|363176950|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
105321831|NCT00758524|363176951|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321832|NCT00758524|363176952|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321833|NCT00758524|363176953|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321834|NCT00758524|363176954|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321835|NCT00758524|363176955|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321836|NCT00758524|363176956|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321837|NCT00758524|363176957|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321838|NCT00758524|363176958|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321839|NCT00758524|363176959|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321840|NCT00758524|363176960|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321841|NCT00758524|363176961|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321842|NCT00758524|363176962|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105321843|NCT00758524|363176946|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105321844|NCT00758524|363176947|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
105321845|NCT00758524|363176948|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105321846|NCT00758524|363176949|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105321847|NCT00758524|363176950|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105321848|NCT00758524|363176951|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105321849|NCT00758524|363176952|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105321850|NCT00758524|363176953|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105321851|NCT00758524|363176954|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105321852|NCT00758524|363176955|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105321853|NCT00758524|363176956|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105321854|NCT00758524|363176957|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105321855|NCT00758524|363176958|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105321856|NCT00758524|363176959|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105371544|NCT01462942|363366835|FG003|Overall Study|Lost to Follow-up|1|||
105491484|NCT02247531|363812485|FG001|Overall Study|Lost to Follow-up|8|||
105850880|NCT02393248|365112592|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850881|NCT02393248|365112593|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850882|NCT02393248|365112594|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850883|NCT02393248|365112595|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850884|NCT02393248|365112596|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850885|NCT02393248|365112597|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850886|NCT02393248|365112598|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850887|NCT02393248|365112599|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850888|NCT02393248|365112600|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850889|NCT02393248|365112601|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850890|NCT02393248|365112602|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850891|NCT02393248|365112603|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850892|NCT02393248|365112579|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
105850893|NCT02393248|365112580|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
105850894|NCT02393248|365112581|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
105850895|NCT02393248|365112582|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
105850896|NCT02393248|365112583|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
105850897|NCT02393248|365112584|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
105850898|NCT02393248|365112585|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
105850899|NCT02393248|365112586|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
105850900|NCT02393248|365112587|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
105850901|NCT02393248|365112588|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
105850902|NCT02393248|365112589|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
105850903|NCT02393248|365112590|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
105850904|NCT02393248|365112591|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
105850905|NCT02393248|365112592|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
105850906|NCT02393248|365112593|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
105850907|NCT02393248|365112594|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
105850908|NCT02393248|365112595|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
105850909|NCT02393248|365112596|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
105850910|NCT02393248|365112597|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
105850911|NCT02393248|365112598|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
105850912|NCT02393248|365112599|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
105850913|NCT02393248|365112600|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
105850914|NCT02393248|365112601|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
105850915|NCT02393248|365112602|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
105850916|NCT02393248|365112603|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
105850917|NCT02393248|365112579|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850918|NCT02393248|365112580|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850919|NCT02393248|365112581|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850920|NCT02393248|365112582|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850921|NCT02393248|365112583|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850922|NCT02393248|365112584|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850923|NCT02393248|365112585|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105491485|NCT02247531|363812486|FG002|Overall Study|Lost to Follow-up|3|||
105491486|NCT02247531|363812484|FG000|Overall Study|Non-compliance|2|||
105491487|NCT02247531|363812485|FG001|Overall Study|Non-compliance|2|||
105491488|NCT02247531|363812486|FG002|Overall Study|Non-compliance|0|||
105491489|NCT02247531|363812484|FG000|Overall Study|Withdrawal by Subject|26|||
105491490|NCT02247531|363812485|FG001|Overall Study|Withdrawal by Subject|31|||
105850924|NCT02393248|365112586|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850925|NCT02393248|365112587|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850926|NCT02393248|365112588|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850927|NCT02393248|365112589|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105321857|NCT00758524|363176960|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105321858|NCT00758524|363176961|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105321859|NCT00758524|363176962|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105321860|NCT00758524|363176946|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105321861|NCT00758524|363176947|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
105321862|NCT00758524|363176948|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105321863|NCT00758524|363176949|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105321864|NCT00758524|363176950|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105321865|NCT00758524|363176951|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105491491|NCT02247531|363812486|FG002|Overall Study|Withdrawal by Subject|25|||
105491492|NCT02247531|363812484|FG000|Overall Study|Study Terminated by Sponsor|64|||
105491493|NCT02247531|363812485|FG001|Overall Study|Study Terminated by Sponsor|66|||
105850928|NCT02393248|365112590|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
105850929|NCT02393248|365112591|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850930|NCT02393248|365112592|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
105321866|NCT00758524|363176952|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105321867|NCT00758524|363176953|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105321868|NCT00758524|363176954|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105321869|NCT00758524|363176955|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105321870|NCT00758524|363176956|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105321871|NCT00758524|363176957|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105321872|NCT00758524|363176958|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105321873|NCT00758524|363176959|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105321874|NCT00758524|363176960|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105321875|NCT00758524|363176961|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105321876|NCT00758524|363176962|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105321877|NCT00758524|363176946|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321878|NCT00758524|363176947|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321879|NCT00758524|363176948|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321880|NCT00758524|363176949|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321881|NCT00758524|363176950|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321882|NCT00758524|363176951|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321883|NCT00758524|363176952|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321884|NCT00758524|363176953|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321885|NCT00758524|363176954|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
105321886|NCT00758524|363176955|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321887|NCT00758524|363176956|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321888|NCT00758524|363176957|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321889|NCT00758524|363176958|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321890|NCT00758524|363176959|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321891|NCT00758524|363176960|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321892|NCT00758524|363176961|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321893|NCT00758524|363176962|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105321894|NCT00758524|363176946|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321895|NCT00758524|363176947|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321896|NCT00758524|363176948|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321897|NCT00758524|363176949|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321898|NCT00758524|363176950|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321899|NCT00758524|363176951|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321900|NCT00758524|363176952|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
105321901|NCT00758524|363176953|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321902|NCT00758524|363176954|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321903|NCT00758524|363176955|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321904|NCT00758524|363176956|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321905|NCT00758524|363176957|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321906|NCT00758524|363176958|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321907|NCT00758524|363176959|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321908|NCT00758524|363176960|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321909|NCT00758524|363176961|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321910|NCT00758524|363176962|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105321911|NCT00276484|363176963|FG000|Overall Study|Adverse Event|4|||
105321912|NCT00276484|363176964|FG001|Overall Study|Adverse Event|7|||
105321913|NCT00276484|363176963|FG000|Overall Study|Lost to Follow-up|1|||
105321914|NCT00276484|363176964|FG001|Overall Study|Lost to Follow-up|1|||
105321915|NCT00276484|363176963|FG000|Overall Study|Protocol Violation|0|||
105321916|NCT00276484|363176964|FG001|Overall Study|Protocol Violation|1|||
105321917|NCT00276484|363176963|FG000|Overall Study|Withdrawal by Subject|4|||
105321918|NCT00276484|363176964|FG001|Overall Study|Withdrawal by Subject|3|||
105321919|NCT00276484|363176963|FG000|Overall Study|Could not take time off work|0|||
105321920|NCT00276484|363176964|FG001|Overall Study|Could not take time off work|1|||
105321921|NCT02440464|363176965|FG000|Overall Study|Withdrawal by Subject|3|||
105321922|NCT02440464|363176966|FG001|Overall Study|Withdrawal by Subject|2|||
105371545|NCT01462942|363366836|FG004|Overall Study|Lost to Follow-up|1|||
105371546|NCT01462942|363366832|FG000|Overall Study|Protocol Violation|4|||
105371547|NCT01462942|363366833|FG001|Overall Study|Protocol Violation|6|||
105371548|NCT01462942|363366834|FG002|Overall Study|Protocol Violation|9|||
105321923|NCT01626690|363176970|FG000|Overall Study|Protocol Violation|1|||
105321924|NCT01626690|363176971|FG001|Overall Study|Protocol Violation|0|||
105321925|NCT01626690|363176970|FG000|Overall Study|Adverse Event|1|||
105321926|NCT01626690|363176971|FG001|Overall Study|Adverse Event|0|||
105321927|NCT01942993|363176977|FG000|Overall Study|Lost to Follow-up|1|||
105371549|NCT01462942|363366835|FG003|Overall Study|Protocol Violation|9|||
105321928|NCT01942993|363176977|FG000|Overall Study|Physician Decision|1|||
105321929|NCT01350271|363176978|FG000|Overall Study|Lost to Follow-up|21|||
105321930|NCT01350271|363176979|FG001|Overall Study|Lost to Follow-up|17|||
105321931|NCT01350271|363176980|FG002|Overall Study|Lost to Follow-up|26|||
105321932|NCT01349192|363176981|FG000|Overall Study|Protocol Violation|0|||
105321933|NCT01349192|363176982|FG001|Overall Study|Protocol Violation|1|||
105321934|NCT01349192|363176981|FG000|Overall Study|Withdrawal by Subject|0|||
105321935|NCT01349192|363176982|FG001|Overall Study|Withdrawal by Subject|2|||
105321936|NCT01349192|363176981|FG000|Overall Study|Lost to Follow-up|1|||
105321937|NCT01349192|363176982|FG001|Overall Study|Lost to Follow-up|3|||
105321938|NCT01349192|363176981|FG000|Overall Study|Failure to adhere to Protocol|2|||
105321939|NCT01349192|363176982|FG001|Overall Study|Failure to adhere to Protocol|0|||
105321940|NCT02038010|363176983|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
105321941|NCT02038010|363176984|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
105321942|NCT02038010|363176985|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
105321943|NCT02038010|363176986|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
105321944|NCT02038010|363176983|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
105321945|NCT02038010|363176984|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
105321946|NCT02038010|363176985|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
105321947|NCT02038010|363176986|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
105321948|NCT02038010|363176983|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
105321949|NCT02038010|363176984|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
105321950|NCT02038010|363176985|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
105321951|NCT02038010|363176986|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
105321952|NCT02038010|363176983|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
105321953|NCT02038010|363176984|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
105321954|NCT02038010|363176985|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
105321955|NCT02038010|363176986|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
105321956|NCT02038010|363176983|FG000|Follow Up|Death|4|||
105321957|NCT02038010|363176984|FG001|Follow Up|Death|3|||
105321958|NCT02038010|363176985|FG002|Follow Up|Death|0|||
105321959|NCT02038010|363176986|FG003|Follow Up|Death|0|||
105321960|NCT02038010|363176983|FG000|Follow Up|Other|3|||
105321961|NCT02038010|363176984|FG001|Follow Up|Other|0|||
105321962|NCT02038010|363176985|FG002|Follow Up|Other|0|||
105321963|NCT02038010|363176986|FG003|Follow Up|Other|0|||
105321964|NCT00769379|363176989|FG000|Overall Study|No follow up data mapped to Other.|3|||
105321965|NCT00769379|363176990|FG001|Overall Study|No follow up data mapped to Other.|13|||
105321966|NCT03735121|363176991|FG000|Overall Study|Death|3|||
105321967|NCT03735121|363176992|FG001|Overall Study|Death|6|||
105321968|NCT03735121|363176993|FG002|Overall Study|Death|8|||
105321969|NCT03735121|363176994|FG003|Overall Study|Death|37|||
105321970|NCT03735121|363176995|FG004|Overall Study|Death|86|||
105321971|NCT03735121|363176991|FG000|Overall Study|Withdrawal by Subject|1|||
105321972|NCT03735121|363176992|FG001|Overall Study|Withdrawal by Subject|1|||
105321973|NCT03735121|363176993|FG002|Overall Study|Withdrawal by Subject|3|||
105321974|NCT03735121|363176994|FG003|Overall Study|Withdrawal by Subject|4|||
105321975|NCT03735121|363176995|FG004|Overall Study|Withdrawal by Subject|2|||
105850931|NCT02393248|365112593|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850932|NCT02393248|365112594|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850933|NCT02393248|365112595|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850934|NCT02393248|365112596|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850935|NCT02393248|365112597|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850936|NCT02393248|365112598|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850937|NCT02393248|365112599|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850938|NCT02393248|365112600|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850939|NCT02393248|365112601|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850940|NCT02393248|365112602|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850941|NCT02393248|365112603|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850942|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850943|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850944|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850945|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105321976|NCT03735121|363176991|FG000|Overall Study|Progressive Disease|0|||
105321977|NCT03735121|363176992|FG001|Overall Study|Progressive Disease|0|||
105321978|NCT03735121|363176993|FG002|Overall Study|Progressive Disease|1|||
105321979|NCT03735121|363176994|FG003|Overall Study|Progressive Disease|0|||
105321980|NCT03735121|363176995|FG004|Overall Study|Progressive Disease|0|||
105321981|NCT03735121|363176991|FG000|Overall Study|Lost to Follow-up|0|||
105321982|NCT03735121|363176992|FG001|Overall Study|Lost to Follow-up|0|||
105321983|NCT03735121|363176993|FG002|Overall Study|Lost to Follow-up|0|||
105321984|NCT03735121|363176994|FG003|Overall Study|Lost to Follow-up|0|||
105321985|NCT03735121|363176995|FG004|Overall Study|Lost to Follow-up|1|||
105321986|NCT03735121|363176991|FG000|Overall Study|Ongoing|3|||
105321987|NCT03735121|363176992|FG001|Overall Study|Ongoing|3|||
105321988|NCT03735121|363176993|FG002|Overall Study|Ongoing|26|||
105321989|NCT03735121|363176994|FG003|Overall Study|Ongoing|83|||
105321990|NCT03735121|363176995|FG004|Overall Study|Ongoing|158|||
105321991|NCT04870710|363176999|FG000|Overall Study|Lost to Follow-up|3|||
105321992|NCT00111241|363177000|FG000|Overall Study|Lost to Follow-up|1|||
105321993|NCT00111241|363177001|FG001|Overall Study|Lost to Follow-up|0|||
105321994|NCT00111241|363177000|FG000|Overall Study|Withdrawal by Subject|4|||
105321995|NCT00111241|363177001|FG001|Overall Study|Withdrawal by Subject|0|||
105321996|NCT00111241|363177000|FG000|Overall Study|Protocol Violation|9|||
105321997|NCT00111241|363177001|FG001|Overall Study|Protocol Violation|8|||
105321998|NCT00111241|363177000|FG000|Overall Study|Adverse Event|1|||
105321999|NCT00111241|363177001|FG001|Overall Study|Adverse Event|0|||
105322000|NCT04338022|363177002|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
105322001|NCT04338022|363177003|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
105322002|NCT04338022|363177002|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
105322003|NCT04338022|363177003|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
105322004|NCT04338022|363177002|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
105322005|NCT04338022|363177003|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
105322006|NCT04338022|363177002|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
105322007|NCT04338022|363177003|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
105322008|NCT04338022|363177002|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
105322009|NCT04338022|363177003|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
105322010|NCT04338022|363177002|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
105322011|NCT04338022|363177003|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
105322012|NCT04338022|363177002|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
105322013|NCT04338022|363177003|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
105322014|NCT04338022|363177002|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
105322015|NCT04338022|363177003|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
105322016|NCT04338022|363177002|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
105322017|NCT04338022|363177003|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
105322018|NCT04338022|363177002|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
105322019|NCT04338022|363177003|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
105322020|NCT04338022|363177002|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
105322021|NCT04338022|363177003|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
105322022|NCT04338022|363177002|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
105322023|NCT04338022|363177003|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
105322024|NCT04338022|363177002|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
105322025|NCT04338022|363177003|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
105322026|NCT04338022|363177002|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
105322027|NCT04338022|363177003|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
105322028|NCT01042093|363177007|FG000|Overall Study|Protocol Violation|2|||
105322029|NCT01042093|363177008|FG001|Overall Study|Protocol Violation|2|||
105322030|NCT01042093|363177009|FG002|Overall Study|Protocol Violation|2|||
105322031|NCT01042093|363177010|FG003|Overall Study|Protocol Violation|3|||
105322032|NCT01042093|363177007|FG000|Overall Study|Withdrawal by Subject|0|||
105322033|NCT01042093|363177008|FG001|Overall Study|Withdrawal by Subject|0|||
105322034|NCT01042093|363177009|FG002|Overall Study|Withdrawal by Subject|0|||
105322035|NCT01042093|363177010|FG003|Overall Study|Withdrawal by Subject|1|||
105322036|NCT02208089|363177015|FG000|Overall Study|Withdrawal by Subject|1|||
105322037|NCT02208089|363177016|FG001|Overall Study|Withdrawal by Subject|0|||
105322038|NCT02208089|363177015|FG000|Overall Study|Lost to Follow-up|6|||
105322039|NCT02208089|363177016|FG001|Overall Study|Lost to Follow-up|0|||
105322040|NCT03200717|363177021|FG000|Overall Study|Progressive disease|24|||
105322041|NCT03200717|363177022|FG001|Overall Study|Progressive disease|5|||
105322042|NCT03200717|363177021|FG000|Overall Study|Adverse Event|11|||
105322043|NCT03200717|363177022|FG001|Overall Study|Adverse Event|8|||
105322044|NCT03200717|363177021|FG000|Overall Study|Physician Decision|3|||
105322045|NCT03200717|363177022|FG001|Overall Study|Physician Decision|2|||
105322046|NCT03200717|363177021|FG000|Overall Study|Death|2|||
105322047|NCT03200717|363177022|FG001|Overall Study|Death|0|||
105322048|NCT03200717|363177021|FG000|Overall Study|Subject/Guardian Decision|1|||
105371550|NCT01462942|363366836|FG004|Overall Study|Protocol Violation|6|||
105371551|NCT01670292|363366839|FG000|Overall Study|Lost to Follow-up|14|||
105371552|NCT01603277|363366845|FG000|Overall Study|Adverse Event|1|||
105322049|NCT03200717|363177022|FG001|Overall Study|Subject/Guardian Decision|0|||
105322050|NCT02586155|363177023|FG000|Overall Study|Adverse Event|2|||
105322051|NCT02586155|363177024|FG001|Overall Study|Adverse Event|3|||
105322052|NCT02586155|363177023|FG000|Overall Study|Withdrawal by Subject|31|||
105322053|NCT02586155|363177024|FG001|Overall Study|Withdrawal by Subject|24|||
105322054|NCT02586155|363177023|FG000|Overall Study|Lost to Follow-up|7|||
105371553|NCT01603277|363366846|FG001|Overall Study|Adverse Event|2|||
105322055|NCT02586155|363177024|FG001|Overall Study|Lost to Follow-up|13|||
105322056|NCT02586155|363177023|FG000|Overall Study|Death|61|||
105322057|NCT02586155|363177024|FG001|Overall Study|Death|72|||
105322058|NCT02586155|363177023|FG000|Overall Study|Other reasons|26|||
105322059|NCT02586155|363177024|FG001|Overall Study|Other reasons|15|||
105322060|NCT00739063|363177027|FG000|Overall Study|Screen failures|8|||
105322061|NCT05101343|363177028|FG000|Overall Study|Withdrawal by Subject|2|||
105322062|NCT05101343|363177029|FG001|Overall Study|Withdrawal by Subject|1|||
105322063|NCT03447743|363177030|FG000|Overall Study|Withdrawal by Subject|2|||
105322064|NCT03447743|363177030|FG000|Overall Study|Lost to Follow-up|3|||
105322065|NCT03447743|363177030|FG000|Overall Study|Adverse Event|1|||
105322066|NCT03447743|363177030|FG000|Overall Study|Did not meet criteria to continue|1|||
105322067|NCT02046603|363177031|FG000|Overall Study|Other|11|||
105322068|NCT02046603|363177032|FG001|Overall Study|Other|66|||
105322069|NCT02046603|363177031|FG000|Overall Study|Protocol Violation|0|||
105322070|NCT02046603|363177032|FG001|Overall Study|Protocol Violation|1|||
105322071|NCT02046603|363177031|FG000|Overall Study|Participant/legal guardian decision|1|||
105322072|NCT02046603|363177032|FG001|Overall Study|Participant/legal guardian decision|3|||
105322073|NCT02046603|363177031|FG000|Overall Study|Physician Decision|2|||
105322074|NCT02046603|363177032|FG001|Overall Study|Physician Decision|1|||
105322075|NCT02046603|363177031|FG000|Overall Study|Lost to Follow-up|1|||
105322076|NCT02046603|363177032|FG001|Overall Study|Lost to Follow-up|2|||
105322077|NCT02046603|363177031|FG000|Overall Study|Death|0|||
105322078|NCT02046603|363177032|FG001|Overall Study|Death|1|||
105322079|NCT02046603|363177031|FG000|Overall Study|Adverse Event|0|||
105322080|NCT02046603|363177032|FG001|Overall Study|Adverse Event|1|||
105371554|NCT01603277|363366845|FG000|Overall Study|Physician Decision|0|||
105371555|NCT01603277|363366846|FG001|Overall Study|Physician Decision|1|||
105371556|NCT01603277|363366845|FG000|Overall Study|Protocol Violation|6|||
105371557|NCT01603277|363366846|FG001|Overall Study|Protocol Violation|10|||
105371558|NCT01603277|363366845|FG000|Overall Study|Withdrawal by Subject|5|||
105371559|NCT01603277|363366846|FG001|Overall Study|Withdrawal by Subject|4|||
105371560|NCT01603277|363366845|FG000|Overall Study|Non-Compliance|2|||
105371561|NCT01603277|363366846|FG001|Overall Study|Non-Compliance|1|||
105371562|NCT00087178|363366847|FG000|Overall Study|No follow up data|5|||
105371563|NCT00087178|363366848|FG001|Overall Study|No follow up data|15|||
105371564|NCT00087178|363366847|FG000|Overall Study|No clinical assessment|1|||
105371565|NCT00087178|363366848|FG001|Overall Study|No clinical assessment|2|||
105371566|NCT00087178|363366847|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
105850946|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850947|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105371567|NCT00087178|363366848|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
105371568|NCT00630916|363366849|FG000|Overall Study|Death|110|||
105371569|NCT00630916|363366849|FG000|Overall Study|Explant|8|||
105371570|NCT00630916|363366849|FG000|Overall Study|Lost to Follow-up|5|||
105371571|NCT00630916|363366849|FG000|Overall Study|Withdrawal by Subject|30|||
105371572|NCT00630916|363366849|FG000|Overall Study|Protocol Violation|7|||
105371573|NCT00630916|363366849|FG000|Overall Study|Physician Decision|47|||
105371574|NCT00630916|363366849|FG000|Overall Study|Lack of Efficacy|3|||
105371575|NCT00324155|363366850|FG000|Enrolled and Randomized|No longer met study criteria|3|||
105371576|NCT00324155|363366851|FG001|Enrolled and Randomized|No longer met study criteria|0|||
105491494|NCT02247531|363812486|FG002|Overall Study|Study Terminated by Sponsor|62|||
105322081|NCT02072980|363177033|FG000|Period 2, Second Wear|Adverse Event|0|||
105322082|NCT02072980|363177034|FG001|Period 2, Second Wear|Adverse Event|1|||
105322083|NCT03093259|363177035|FG000|Overall Study|Adverse Event|1|||
105322084|NCT03093259|363177036|FG001|Overall Study|Adverse Event|0|||
105322085|NCT03093259|363177035|FG000|Overall Study|Withdrawal by Subject|1|||
105322086|NCT03093259|363177036|FG001|Overall Study|Withdrawal by Subject|0|||
105322087|NCT00866359|363177040|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
105322088|NCT00866359|363177041|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
105322089|NCT00866359|363177042|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
105322090|NCT00866359|363177043|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
105371577|NCT00324155|363366850|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
105371578|NCT00324155|363366851|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
105371579|NCT00324155|363366850|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
105371580|NCT00324155|363366851|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
105371581|NCT00324155|363366850|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
105371582|NCT00324155|363366851|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
105371583|NCT00324155|363366850|FG000|Received Treatment in Induction Phase|Death|8|||
105371584|NCT00324155|363366851|FG001|Received Treatment in Induction Phase|Death|15|||
105850948|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850949|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105371585|NCT00324155|363366850|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
105491495|NCT02247531|363812484|FG000|Overall Study|Physician Decision|0|||
105322091|NCT00866359|363177040|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
105322092|NCT00866359|363177041|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
105371586|NCT00324155|363366851|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
105371587|NCT00324155|363366850|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
105371588|NCT00324155|363366851|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
105371589|NCT00324155|363366850|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
105371590|NCT00324155|363366851|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
105371591|NCT00324155|363366850|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
105371592|NCT00324155|363366851|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
105371593|NCT00324155|363366850|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
105371594|NCT00324155|363366851|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
105371595|NCT00324155|363366850|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
105371596|NCT00324155|363366851|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
105371597|NCT00324155|363366850|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
105371598|NCT00324155|363366851|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
105371599|NCT00324155|363366850|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
105371600|NCT00324155|363366851|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
105371601|NCT00324155|363366850|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
105371602|NCT00324155|363366851|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
105371603|NCT00324155|363366850|FG000|Follow-up Phase|On-going participants still on drug|11|||
105371604|NCT00324155|363366851|FG001|Follow-up Phase|On-going participants still on drug|6|||
105371605|NCT00390689|363366852|FG000|Overall Study|Adverse Event|2|||
105371606|NCT00390689|363366853|FG001|Overall Study|Adverse Event|5|||
105371607|NCT00390689|363366854|FG002|Overall Study|Adverse Event|2|||
105371608|NCT00390689|363366852|FG000|Overall Study|Lack of Efficacy|0|||
105371609|NCT00390689|363366853|FG001|Overall Study|Lack of Efficacy|0|||
105371610|NCT00390689|363366854|FG002|Overall Study|Lack of Efficacy|1|||
105371611|NCT00390689|363366852|FG000|Overall Study|Protocol Violation|1|||
105371612|NCT00390689|363366853|FG001|Overall Study|Protocol Violation|0|||
105371613|NCT00390689|363366854|FG002|Overall Study|Protocol Violation|0|||
105371614|NCT00390689|363366852|FG000|Overall Study|Investigator's judgement|2|||
105371615|NCT00390689|363366853|FG001|Overall Study|Investigator's judgement|0|||
105371616|NCT00390689|363366854|FG002|Overall Study|Investigator's judgement|0|||
105371617|NCT02747927|363366855|FG000|Overall Study|Adverse Event|5|||
105371618|NCT02747927|363366856|FG001|Overall Study|Adverse Event|14|||
105371619|NCT02747927|363366855|FG000|Overall Study|Lost to Follow-up|22|||
105371620|NCT02747927|363366856|FG001|Overall Study|Lost to Follow-up|43|||
105371621|NCT02747927|363366855|FG000|Overall Study|Pregnancy|34|||
105371622|NCT02747927|363366856|FG001|Overall Study|Pregnancy|66|||
105371623|NCT02747927|363366855|FG000|Overall Study|Protocol Violation|2|||
105371624|NCT02747927|363366856|FG001|Overall Study|Protocol Violation|4|||
105371625|NCT02747927|363366855|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
105371626|NCT02747927|363366856|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
105371627|NCT02747927|363366855|FG000|Overall Study|Reason not Specified|11|||
105371628|NCT02747927|363366856|FG001|Overall Study|Reason not Specified|27|||
105371629|NCT03451045|363366860|FG000|Overall Study|Lack of Efficacy|3|||
105371630|NCT03451045|363366861|FG001|Overall Study|Lack of Efficacy|2|||
105371631|NCT03451045|363366862|FG002|Overall Study|Lack of Efficacy|2|||
105371632|NCT03451045|363366860|FG000|Overall Study|Physician Decision|1|||
105371633|NCT03451045|363366861|FG001|Overall Study|Physician Decision|1|||
105371634|NCT03451045|363366862|FG002|Overall Study|Physician Decision|1|||
105371635|NCT03451045|363366860|FG000|Overall Study|Withdrawal by Subject|4|||
105371636|NCT03451045|363366861|FG001|Overall Study|Withdrawal by Subject|0|||
105371637|NCT03451045|363366862|FG002|Overall Study|Withdrawal by Subject|5|||
105371638|NCT03451045|363366860|FG000|Overall Study|Pregnancy|0|||
105371639|NCT03451045|363366861|FG001|Overall Study|Pregnancy|0|||
105371640|NCT03451045|363366862|FG002|Overall Study|Pregnancy|2|||
105371641|NCT03451045|363366860|FG000|Overall Study|Adverse Event|7|||
105850950|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850951|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850952|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850953|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850954|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850955|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105371642|NCT03451045|363366861|FG001|Overall Study|Adverse Event|1|||
105371643|NCT03451045|363366862|FG002|Overall Study|Adverse Event|3|||
105371644|NCT03451045|363366860|FG000|Overall Study|Non-compliance with study|2|||
105371645|NCT03451045|363366861|FG001|Overall Study|Non-compliance with study|0|||
105371646|NCT03451045|363366862|FG002|Overall Study|Non-compliance with study|1|||
105371647|NCT03451045|363366860|FG000|Overall Study|any other reason|10|||
105371648|NCT03451045|363366861|FG001|Overall Study|any other reason|2|||
105371649|NCT03451045|363366862|FG002|Overall Study|any other reason|13|||
105371650|NCT00863707|363366865|FG000|Overall Study|Randomized, but drug not received|4|||
105371651|NCT00863707|363366866|FG001|Overall Study|Randomized, but drug not received|3|||
105322093|NCT00866359|363177042|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
105491496|NCT02247531|363812485|FG001|Overall Study|Physician Decision|2|||
105491497|NCT02247531|363812486|FG002|Overall Study|Physician Decision|2|||
105491498|NCT02247531|363812484|FG000|Overall Study|Unspecified Reason|2|||
105491499|NCT02247531|363812485|FG001|Overall Study|Unspecified Reason|3|||
105491500|NCT02247531|363812486|FG002|Overall Study|Unspecified Reason|4|||
105491501|NCT04123665|363812487|FG000|Overall Study|Withdrawal by Subject|7|||
105491502|NCT04123665|363812488|FG001|Overall Study|Withdrawal by Subject|0|||
105491503|NCT04123665|363812487|FG000|Overall Study|Lost to Follow-up|1|||
105491504|NCT04123665|363812488|FG001|Overall Study|Lost to Follow-up|0|||
105491505|NCT03646643|363812495|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
105491506|NCT03646643|363812496|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
105491507|NCT03646643|363812495|FG000|Overall Study|Lost to Follow-up|0|||
105491508|NCT03646643|363812496|FG001|Overall Study|Lost to Follow-up|1|||
105491509|NCT04521777|363812497|FG000|Overall Study|Death|2|||
105491510|NCT04521777|363812497|FG000|Overall Study|Withdrawal by Subject|2|||
105491511|NCT00145600|363812500|FG000|Overall Study|Death|1|||
105491512|NCT00145600|363812501|FG001|Overall Study|Death|2|||
105850956|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105322094|NCT00866359|363177043|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
105322095|NCT00866359|363177040|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
105322096|NCT00866359|363177041|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
105322097|NCT00866359|363177042|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
105322098|NCT00866359|363177043|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
105322099|NCT00866359|363177040|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
105322100|NCT00866359|363177041|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
105322101|NCT00866359|363177042|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
105322102|NCT00866359|363177043|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
105322103|NCT00866359|363177040|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
105322104|NCT00866359|363177041|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
105322105|NCT00866359|363177042|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
105322106|NCT00866359|363177043|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
105322107|NCT00866359|363177040|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
105322108|NCT00866359|363177041|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
105322109|NCT00866359|363177042|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
105322110|NCT00866359|363177043|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
105322111|NCT00550459|363177044|FG000|Overall Study|Adverse Event|0|||
105322112|NCT00550459|363177045|FG001|Overall Study|Adverse Event|2|||
105322113|NCT00550459|363177044|FG000|Overall Study|Withdrawal by Subject|1|||
105322114|NCT00550459|363177045|FG001|Overall Study|Withdrawal by Subject|1|||
105850957|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850958|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105322115|NCT01742897|363177046|FG000|Overall Study|Adverse Event|3|||
105322116|NCT01742897|363177046|FG000|Overall Study|Withdrawal by Subject|1|||
105322117|NCT01742897|363177046|FG000|Overall Study|Other|1|||
105322118|NCT02404805|363177047|FG000|Overall Study|Withdrawal by Subject|1|||
105322119|NCT02404805|363177048|FG001|Overall Study|Withdrawal by Subject|0|||
105322120|NCT02404805|363177049|FG002|Overall Study|Withdrawal by Subject|0|||
105322121|NCT02404805|363177050|FG003|Overall Study|Withdrawal by Subject|0|||
105322122|NCT02404805|363177051|FG004|Overall Study|Withdrawal by Subject|0|||
105322123|NCT02404805|363177052|FG005|Overall Study|Withdrawal by Subject|0|||
105322124|NCT01625091|363177053|FG000|Intervention|Death|1|||
105850959|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105322125|NCT01625091|363177054|FG001|Intervention|Death|1|||
105322126|NCT01625091|363177053|FG000|Intervention|Withdrawal by Subject|4|||
105322127|NCT01625091|363177054|FG001|Intervention|Withdrawal by Subject|1|||
105322128|NCT01625091|363177053|FG000|Intervention|Adverse Event|0|||
105322129|NCT01625091|363177054|FG001|Intervention|Adverse Event|2|||
105322130|NCT01625091|363177053|FG000|Intervention|Lost to Follow-up|4|||
105322131|NCT01625091|363177054|FG001|Intervention|Lost to Follow-up|4|||
105322132|NCT01625091|363177053|FG000|Intervention|Study termination|2|||
105322133|NCT01625091|363177054|FG001|Intervention|Study termination|3|||
105322134|NCT01625091|363177053|FG000|Post-intervention|Death|0|||
105322135|NCT01625091|363177054|FG001|Post-intervention|Death|1|||
105322136|NCT01625091|363177053|FG000|Post-intervention|Lost to Follow-up|2|||
105322137|NCT01625091|363177054|FG001|Post-intervention|Lost to Follow-up|0|||
105322138|NCT01625091|363177053|FG000|Post-intervention|Study termination|2|||
105322139|NCT01625091|363177054|FG001|Post-intervention|Study termination|1|||
105322140|NCT02163057|363177055|FG000|Overall Study|Participant Refusal to Continue|2|||
105322141|NCT02163057|363177056|FG001|Overall Study|Participant Refusal to Continue|2|||
105322142|NCT02163057|363177055|FG000|Overall Study|Participant Significant Noncompliance|0|||
105322143|NCT02163057|363177056|FG001|Overall Study|Participant Significant Noncompliance|1|||
105322144|NCT02163057|363177055|FG000|Overall Study|Progression of Disease|1|||
105322145|NCT02163057|363177056|FG001|Overall Study|Progression of Disease|2|||
105322146|NCT00768248|363177057|FG000|Overall Study|Research coordinator didn't collect data|1|||
105322147|NCT00768248|363177058|FG001|Overall Study|Research coordinator didn't collect data|1|||
105322148|NCT01547390|363177059|FG000|Overall Study|Withdrawal by Subject|10|||
105322149|NCT01547390|363177060|FG001|Overall Study|Withdrawal by Subject|7|||
105322150|NCT01547390|363177059|FG000|Overall Study|termination of pregnancy|0|||
105322151|NCT01547390|363177060|FG001|Overall Study|termination of pregnancy|1|||
105322152|NCT01547390|363177059|FG000|Overall Study|Lost to Follow-up|0|||
105322153|NCT01547390|363177060|FG001|Overall Study|Lost to Follow-up|2|||
105322154|NCT01547390|363177059|FG000|Overall Study|Adverse Event|3|||
105322155|NCT01547390|363177060|FG001|Overall Study|Adverse Event|0|||
105371652|NCT01218802|363366867|FG000|Overall Study|Lost to Follow-up|5|||
105371653|NCT01218802|363366868|FG001|Overall Study|Lost to Follow-up|6|||
105371654|NCT01218802|363366867|FG000|Overall Study|Withdrawal by Subject|3|||
105371655|NCT01218802|363366868|FG001|Overall Study|Withdrawal by Subject|10|||
105371656|NCT01218802|363366867|FG000|Overall Study|Adverse Event|0|||
105371657|NCT01218802|363366868|FG001|Overall Study|Adverse Event|2|||
105371658|NCT01218802|363366867|FG000|Overall Study|Incarcerated|2|||
105371659|NCT01218802|363366868|FG001|Overall Study|Incarcerated|0|||
105371660|NCT00833755|363366871|FG000|Overall Study|Physician Decision|4|||
105371661|NCT00833755|363366872|FG001|Overall Study|Physician Decision|4|||
105371662|NCT00833755|363366873|FG002|Overall Study|Physician Decision|2|||
105371663|NCT00833755|363366874|FG003|Overall Study|Physician Decision|6|||
105371664|NCT00833755|363366871|FG000|Overall Study|Subject had scheduling issues|0|||
105371665|NCT00833755|363366872|FG001|Overall Study|Subject had scheduling issues|1|||
105371666|NCT00833755|363366873|FG002|Overall Study|Subject had scheduling issues|0|||
105371667|NCT00833755|363366874|FG003|Overall Study|Subject had scheduling issues|0|||
105371668|NCT01776554|363366877|FG000|Overall Study|Adverse Event|1|||
105850960|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
105850961|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850962|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
105850963|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
105850964|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850965|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
105850966|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850967|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Death|0|||
105850968|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Death|0|||
105850969|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Death|0|||
105850970|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Death|0|||
105850971|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Death|0|||
105850972|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Death|0|||
105850973|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Death|0|||
105850974|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Death|0|||
105850975|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Death|0|||
105850976|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Death|0|||
105850977|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Death|0|||
105850978|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Death|0|||
105850979|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Death|0|||
105850980|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Death|0|||
105850981|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Death|0|||
105850982|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Death|1|||
105850983|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Death|7|||
105850984|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Death|5|||
105850985|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Death|5|||
105850986|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Death|3|||
105850987|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Death|7|||
105850988|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Death|5|||
105850989|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Death|6|||
105850990|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Death|3|||
105850991|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Death|0|||
105322156|NCT02601014|363177061|FG000|Overall Study|Adverse Event|3|||
105371669|NCT01776554|363366878|FG001|Overall Study|Adverse Event|0|||
105371670|NCT01776554|363366877|FG000|Overall Study|Withdrawal by Subject|3|||
105371671|NCT01776554|363366878|FG001|Overall Study|Withdrawal by Subject|8|||
105371672|NCT01776554|363366877|FG000|Overall Study|Lost to Follow-up|6|||
105371673|NCT01776554|363366878|FG001|Overall Study|Lost to Follow-up|9|||
105371674|NCT01776554|363366877|FG000|Overall Study|Administrative Reason|2|||
105371675|NCT01776554|363366878|FG001|Overall Study|Administrative Reason|5|||
105371676|NCT01776554|363366877|FG000|Overall Study|Protocol Violation|1|||
105371677|NCT01776554|363366878|FG001|Overall Study|Protocol Violation|0|||
105371678|NCT01776554|363366877|FG000|Overall Study|Unclassified|4|||
105371679|NCT01776554|363366878|FG001|Overall Study|Unclassified|1|||
105371680|NCT02814526|363366879|FG000|Overall Study|Adverse Event|4|||
105371681|NCT02814526|363366880|FG001|Overall Study|Adverse Event|3|||
105850992|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105371682|NCT02814526|363366879|FG000|Overall Study|Death|1|||
105371683|NCT02814526|363366880|FG001|Overall Study|Death|1|||
105850993|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105850994|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105850995|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105322157|NCT02601014|363177062|FG001|Overall Study|Adverse Event|3|||
105322158|NCT02601014|363177061|FG000|Overall Study|Death|3|||
105322159|NCT02601014|363177062|FG001|Overall Study|Death|1|||
105322160|NCT02601014|363177061|FG000|Overall Study|Disease progression|4|||
105322161|NCT02601014|363177062|FG001|Overall Study|Disease progression|8|||
105322162|NCT04211831|363177063|FG000|Overall Study|Withdrawal by Subject|4|||
105322163|NCT04211831|363177064|FG001|Overall Study|Withdrawal by Subject|1|||
105322164|NCT04211831|363177065|FG002|Overall Study|Withdrawal by Subject|1|||
105322165|NCT04211831|363177063|FG000|Overall Study|Protocol Violation|0|||
105322166|NCT04211831|363177064|FG001|Overall Study|Protocol Violation|0|||
105322167|NCT04211831|363177065|FG002|Overall Study|Protocol Violation|1|||
105322168|NCT04211831|363177063|FG000|Overall Study|Adverse Event|0|||
105322169|NCT04211831|363177064|FG001|Overall Study|Adverse Event|1|||
105322170|NCT04211831|363177065|FG002|Overall Study|Adverse Event|0|||
105371684|NCT02814526|363366879|FG000|Overall Study|Lost to Follow-up|3|||
105371685|NCT02814526|363366880|FG001|Overall Study|Lost to Follow-up|4|||
105371686|NCT02814526|363366879|FG000|Overall Study|non site physician decision|1|||
105371687|NCT02814526|363366880|FG001|Overall Study|non site physician decision|0|||
105371688|NCT02814526|363366879|FG000|Overall Study|participant noncompliance|1|||
105371689|NCT02814526|363366880|FG001|Overall Study|participant noncompliance|1|||
105371690|NCT02814526|363366879|FG000|Overall Study|Withdrawal by Subject|20|||
105371691|NCT02814526|363366880|FG001|Overall Study|Withdrawal by Subject|14|||
105371692|NCT02814526|363366879|FG000|Overall Study|safety risk|2|||
105371693|NCT02814526|363366880|FG001|Overall Study|safety risk|1|||
105371694|NCT02814526|363366879|FG000|Overall Study|early termination-study terminated|1|||
105371695|NCT02814526|363366880|FG001|Overall Study|early termination-study terminated|2|||
105371696|NCT02814526|363366879|FG000|Overall Study|Other|0|||
105371697|NCT02814526|363366880|FG001|Overall Study|Other|4|||
105371698|NCT00251758|363366883|FG000|Overall Study|Adverse Event|7|||
105371699|NCT00251758|363366884|FG001|Overall Study|Adverse Event|9|||
105371700|NCT00251758|363366885|FG002|Overall Study|Adverse Event|11|||
105371701|NCT00251758|363366883|FG000|Overall Study|Lost to Follow-up|4|||
105371702|NCT00251758|363366884|FG001|Overall Study|Lost to Follow-up|2|||
105371703|NCT00251758|363366885|FG002|Overall Study|Lost to Follow-up|5|||
105371704|NCT00251758|363366883|FG000|Overall Study|Withdrawal by Subject|13|||
105371705|NCT00251758|363366884|FG001|Overall Study|Withdrawal by Subject|7|||
105371706|NCT00251758|363366885|FG002|Overall Study|Withdrawal by Subject|3|||
105371707|NCT00251758|363366883|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
105371708|NCT00251758|363366884|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
105371709|NCT00251758|363366885|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
105371710|NCT00251758|363366883|FG000|Overall Study|Lack of Efficacy|3|||
105371711|NCT00251758|363366884|FG001|Overall Study|Lack of Efficacy|0|||
105371712|NCT00251758|363366885|FG002|Overall Study|Lack of Efficacy|0|||
105371713|NCT00251758|363366883|FG000|Overall Study|Noncompliant|0|||
105371714|NCT00251758|363366884|FG001|Overall Study|Noncompliant|2|||
105371715|NCT00251758|363366885|FG002|Overall Study|Noncompliant|2|||
105371716|NCT00251758|363366883|FG000|Overall Study|Pregnancy|0|||
105371717|NCT00251758|363366884|FG001|Overall Study|Pregnancy|1|||
105371718|NCT00251758|363366885|FG002|Overall Study|Pregnancy|0|||
105371719|NCT00251758|363366883|FG000|Overall Study|Per Subject Request|0|||
105371720|NCT00251758|363366884|FG001|Overall Study|Per Subject Request|0|||
105371721|NCT00251758|363366885|FG002|Overall Study|Per Subject Request|1|||
105371722|NCT00251758|363366883|FG000|Overall Study|Per Investigator Request|1|||
105371723|NCT00251758|363366884|FG001|Overall Study|Per Investigator Request|0|||
105371724|NCT00251758|363366885|FG002|Overall Study|Per Investigator Request|0|||
105371725|NCT01981616|363366890|FG000|Overall Study|Adverse Event|0|||
105371726|NCT01981616|363366891|FG001|Overall Study|Adverse Event|1|||
105371727|NCT01981616|363366890|FG000|Overall Study|Protocol Violation|1|||
105371728|NCT01981616|363366891|FG001|Overall Study|Protocol Violation|0|||
105371729|NCT03642990|363366894|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
105322171|NCT04211831|363177063|FG000|Overall Study|Lack of Efficacy|0|||
105371730|NCT03642990|363366894|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
105576838|NCT01216293|364110342|FG001|Main Study|Lost to Follow-up|1|||
105322172|NCT04211831|363177064|FG001|Overall Study|Lack of Efficacy|0|||
105371731|NCT00617279|363366895|FG000|Overall Study|Study terminated by Sponsor|10|||
105371732|NCT00617279|363366896|FG001|Overall Study|Study terminated by Sponsor|15|||
105371733|NCT00617279|363366895|FG000|Overall Study|Graft abandonment|2|||
105371734|NCT00617279|363366896|FG001|Overall Study|Graft abandonment|0|||
105576839|NCT01216293|364110343|FG002|Main Study|Lost to Follow-up|0|||
105322173|NCT04211831|363177065|FG002|Overall Study|Lack of Efficacy|1|||
105576840|NCT01216293|364110341|FG000|Main Study|Voluntary Withdrawal|2|||
105322174|NCT04211831|363177063|FG000|Overall Study|Lost to Follow-up|0|||
105322175|NCT04211831|363177064|FG001|Overall Study|Lost to Follow-up|0|||
105371735|NCT00617279|363366895|FG000|Overall Study|Lost to Follow-up|1|||
105371736|NCT00617279|363366896|FG001|Overall Study|Lost to Follow-up|0|||
105371737|NCT00617279|363366895|FG000|Overall Study|Death|1|||
105371738|NCT00617279|363366896|FG001|Overall Study|Death|2|||
105371739|NCT00921024|363366899|FG000|Overall Study|Lost to Follow-up|2|||
105371740|NCT00921024|363366900|FG001|Overall Study|Lost to Follow-up|0|||
105576841|NCT01216293|364110342|FG001|Main Study|Voluntary Withdrawal|2|||
105322176|NCT04211831|363177065|FG002|Overall Study|Lost to Follow-up|2|||
105322177|NCT04211831|363177063|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
105322178|NCT04211831|363177064|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
105322179|NCT04211831|363177065|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
105322180|NCT04211831|363177063|FG000|Overall Study|Other|0|||
105322181|NCT04211831|363177064|FG001|Overall Study|Other|1|||
105322182|NCT04211831|363177065|FG002|Overall Study|Other|0|||
105322183|NCT01168427|363177066|FG000|Overall Study|Patient exited prior to implant|1|||
105322184|NCT00397514|363177069|FG000|Overall Study|Withdrawal by Subject|1|||
105322185|NCT00397514|363177069|FG000|Overall Study|Pacing wire malfunction|1|||
105322186|NCT00397514|363177069|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
105322187|NCT00397514|363177069|FG000|Overall Study|early extubation|2|||
105322188|NCT00397514|363177069|FG000|Overall Study|poor echocardiographic windows|1|||
105322189|NCT00445146|363177070|FG000|Overall Study|Withdrew Consent|29|||
105322190|NCT00445146|363177070|FG000|Overall Study|Lack of Efficacy|28|||
105322191|NCT00445146|363177070|FG000|Overall Study|Investigator's Discretion|22|||
105322192|NCT00445146|363177070|FG000|Overall Study|Adverse Event|13|||
105322193|NCT00445146|363177070|FG000|Overall Study|Lost to Follow-up|13|||
105322194|NCT00445146|363177070|FG000|Overall Study|Death|9|||
105322195|NCT00445146|363177070|FG000|Overall Study|Protocol Violation|4|||
105322196|NCT00445146|363177070|FG000|Overall Study|Pregnancy|1|||
105322197|NCT01256879|363177071|FG000|Overall Study|Withdrawal by Subject|1|||
105322198|NCT00640315|363177072|FG000|Overall Study|Withdrawal by Subject|0|||
105322199|NCT00640315|363177073|FG001|Overall Study|Withdrawal by Subject|1|||
105322200|NCT00967330|363177074|FG000|Overall Study|Protocol Violation|3|||
105322201|NCT00967330|363177075|FG001|Overall Study|Protocol Violation|4|||
105322202|NCT00967330|363177074|FG000|Overall Study|Regular|10|||
105322203|NCT00967330|363177075|FG001|Overall Study|Regular|3|||
105322204|NCT00967330|363177074|FG000|Overall Study|Withdrawal by Subject|6|||
105322205|NCT00967330|363177075|FG001|Overall Study|Withdrawal by Subject|0|||
105322206|NCT00967330|363177074|FG000|Overall Study|Lost to Follow-up|1|||
105322207|NCT00967330|363177075|FG001|Overall Study|Lost to Follow-up|1|||
105322208|NCT00967330|363177074|FG000|Overall Study|Death|102|||
105322209|NCT00967330|363177075|FG001|Overall Study|Death|51|||
105322210|NCT00967330|363177074|FG000|Overall Study|Severe protocol deviation|0|||
105322211|NCT00967330|363177075|FG001|Overall Study|Severe protocol deviation|1|||
105322212|NCT01959295|363177078|FG000|Overall Study|Adverse Event|2|||
105322213|NCT01959295|363177079|FG001|Overall Study|Adverse Event|0|||
105322214|NCT01959295|363177078|FG000|Overall Study|Lost to Follow-up|0|||
105322215|NCT01959295|363177079|FG001|Overall Study|Lost to Follow-up|2|||
105322216|NCT01959295|363177078|FG000|Overall Study|Physician Decision|2|||
105322217|NCT01959295|363177079|FG001|Overall Study|Physician Decision|3|||
105322218|NCT01959295|363177078|FG000|Overall Study|Protocol Violation|16|||
105322219|NCT01959295|363177079|FG001|Overall Study|Protocol Violation|5|||
105491513|NCT00145600|363812502|FG002|Overall Study|Death|2|||
105491514|NCT00145600|363812503|FG003|Overall Study|Death|6|||
105491515|NCT00145600|363812500|FG000|Overall Study|Ineligible|3|||
105491516|NCT00145600|363812501|FG001|Overall Study|Ineligible|0|||
105491517|NCT00145600|363812502|FG002|Overall Study|Ineligible|1|||
105491518|NCT00145600|363812503|FG003|Overall Study|Ineligible|5|||
105491519|NCT00145600|363812500|FG000|Overall Study|Lost to Follow-up|2|||
105491520|NCT00145600|363812501|FG001|Overall Study|Lost to Follow-up|6|||
105491521|NCT00145600|363812502|FG002|Overall Study|Lost to Follow-up|2|||
105491522|NCT00145600|363812503|FG003|Overall Study|Lost to Follow-up|4|||
105491523|NCT00145600|363812500|FG000|Overall Study|Noncompliance|1|||
105491524|NCT00145600|363812501|FG001|Overall Study|Noncompliance|0|||
105491525|NCT00145600|363812502|FG002|Overall Study|Noncompliance|0|||
105491526|NCT00145600|363812503|FG003|Overall Study|Noncompliance|0|||
105322220|NCT01959295|363177078|FG000|Overall Study|Withdrawal by Subject|3|||
105322221|NCT01959295|363177079|FG001|Overall Study|Withdrawal by Subject|1|||
105322222|NCT01959295|363177078|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
105322223|NCT01959295|363177079|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
105322224|NCT00955617|363177081|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
105322225|NCT00955617|363177082|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
105322226|NCT00955617|363177081|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
105322227|NCT00955617|363177082|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
105491527|NCT00145600|363812500|FG000|Overall Study|Withdrawal by Subject|1|||
105491528|NCT00145600|363812501|FG001|Overall Study|Withdrawal by Subject|2|||
105491529|NCT00145600|363812502|FG002|Overall Study|Withdrawal by Subject|0|||
105322228|NCT00955617|363177081|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
105322229|NCT00955617|363177082|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
105322230|NCT00955617|363177081|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
105322231|NCT00955617|363177082|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
105322232|NCT02694328|363177083|FG000|Overall Study|Adverse Event|27|||
105491530|NCT00145600|363812503|FG003|Overall Study|Withdrawal by Subject|1|||
105491531|NCT05128773|363812506|FG000|Overall Study|Sponsor decision to terminate study|3|||
105850996|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105850997|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105850998|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105850999|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851000|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851001|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851002|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851003|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851004|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851005|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851006|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851007|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851008|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851009|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
105851010|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
105851011|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851012|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
105851013|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
105851014|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
105851015|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
105851016|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
105851017|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Disease Progression|0|||
105851018|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Disease Progression|0|||
105851019|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Disease Progression|0|||
105851020|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Disease Progression|0|||
105851021|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Disease Progression|0|||
105851022|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Disease Progression|0|||
105851023|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Disease Progression|0|||
105851024|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Disease Progression|0|||
105851025|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Disease Progression|0|||
105851026|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Disease Progression|0|||
105851027|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Disease Progression|0|||
105851028|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Disease Progression|0|||
105851029|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Disease Progression|0|||
105851030|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Disease Progression|0|||
105851031|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Disease Progression|0|||
105851032|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Disease Progression|0|||
105851033|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Disease Progression|0|||
105851034|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Disease Progression|0|||
105851035|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Disease Progression|0|||
105851036|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Disease Progression|0|||
105851037|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Disease Progression|2|||
105322233|NCT02694328|363177084|FG001|Overall Study|Adverse Event|33|||
105322234|NCT02694328|363177083|FG000|Overall Study|Withdrawal by Subject|27|||
105322235|NCT02694328|363177084|FG001|Overall Study|Withdrawal by Subject|23|||
105322236|NCT02694328|363177083|FG000|Overall Study|Lost to Follow-up|26|||
105322237|NCT02694328|363177084|FG001|Overall Study|Lost to Follow-up|22|||
105322238|NCT02694328|363177083|FG000|Overall Study|Noncompliant with study drug|11|||
105322239|NCT02694328|363177084|FG001|Overall Study|Noncompliant with study drug|8|||
105322240|NCT02694328|363177083|FG000|Overall Study|Incarceration|1|||
105322241|NCT02694328|363177084|FG001|Overall Study|Incarceration|1|||
105322242|NCT02694328|363177083|FG000|Overall Study|Lack of Efficacy|1|||
105322243|NCT02694328|363177084|FG001|Overall Study|Lack of Efficacy|2|||
105322244|NCT02694328|363177083|FG000|Overall Study|Pregnancy|1|||
105322245|NCT02694328|363177084|FG001|Overall Study|Pregnancy|1|||
105322246|NCT02694328|363177083|FG000|Overall Study|Protocol Violation|6|||
105322247|NCT02694328|363177084|FG001|Overall Study|Protocol Violation|5|||
105322248|NCT02694328|363177083|FG000|Overall Study|Abnormal Laboratory Value|0|||
105322249|NCT02694328|363177084|FG001|Overall Study|Abnormal Laboratory Value|3|||
105322250|NCT03493685|363179088|FG000|Overall Study|Death|4|||
105322251|NCT03493685|363179089|FG001|Overall Study|Death|3|||
105322252|NCT03493685|363179088|FG000|Overall Study|Lost to Follow-up|3|||
105322253|NCT03493685|363179089|FG001|Overall Study|Lost to Follow-up|2|||
105322254|NCT03493685|363179088|FG000|Overall Study|Physician Decision|2|||
105322255|NCT03493685|363179089|FG001|Overall Study|Physician Decision|0|||
105576842|NCT01216293|364110343|FG002|Main Study|Voluntary Withdrawal|2|||
105851038|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Disease Progression|1|||
105322256|NCT03493685|363179088|FG000|Overall Study|Withdrawal by Subject|7|||
105322257|NCT03493685|363179089|FG001|Overall Study|Withdrawal by Subject|11|||
105322258|NCT04147234|363179090|FG000|Overall Study|Clinical deterioration|0|||
105322259|NCT04147234|363179091|FG001|Overall Study|Clinical deterioration|0|||
105322260|NCT04147234|363179092|FG002|Overall Study|Clinical deterioration|1|||
105851039|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Disease Progression|0|||
105851040|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Disease Progression|0|||
105851041|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Disease Progression|0|||
105851042|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851043|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851044|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851045|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851046|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851047|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851048|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851049|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851050|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851051|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851052|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851053|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851054|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
105322261|NCT04147234|363179093|FG003|Overall Study|Clinical deterioration|0|||
105322262|NCT04147234|363179094|FG004|Overall Study|Clinical deterioration|0|||
105322263|NCT04147234|363179095|FG005|Overall Study|Clinical deterioration|0|||
105322264|NCT04147234|363179096|FG006|Overall Study|Clinical deterioration|0|||
105322265|NCT04147234|363179090|FG000|Overall Study|Withdrawal by Subject|0|||
105322266|NCT04147234|363179091|FG001|Overall Study|Withdrawal by Subject|1|||
105322267|NCT04147234|363179092|FG002|Overall Study|Withdrawal by Subject|1|||
105322268|NCT04147234|363179093|FG003|Overall Study|Withdrawal by Subject|0|||
105322269|NCT04147234|363179094|FG004|Overall Study|Withdrawal by Subject|0|||
105322270|NCT04147234|363179095|FG005|Overall Study|Withdrawal by Subject|0|||
105322271|NCT04147234|363179096|FG006|Overall Study|Withdrawal by Subject|0|||
105322272|NCT04147234|363179090|FG000|Overall Study|Clinical disease progression|1|||
105322273|NCT04147234|363179091|FG001|Overall Study|Clinical disease progression|3|||
105322274|NCT04147234|363179092|FG002|Overall Study|Clinical disease progression|1|||
105322275|NCT04147234|363179093|FG003|Overall Study|Clinical disease progression|1|||
105322276|NCT04147234|363179094|FG004|Overall Study|Clinical disease progression|0|||
105322277|NCT04147234|363179095|FG005|Overall Study|Clinical disease progression|1|||
105322278|NCT04147234|363179096|FG006|Overall Study|Clinical disease progression|0|||
105322279|NCT04147234|363179090|FG000|Overall Study|Objective disease progression|6|||
105322280|NCT04147234|363179091|FG001|Overall Study|Objective disease progression|4|||
105322281|NCT04147234|363179092|FG002|Overall Study|Objective disease progression|3|||
105322282|NCT04147234|363179093|FG003|Overall Study|Objective disease progression|3|||
105322283|NCT04147234|363179094|FG004|Overall Study|Objective disease progression|5|||
105322284|NCT04147234|363179095|FG005|Overall Study|Objective disease progression|2|||
105322285|NCT04147234|363179096|FG006|Overall Study|Objective disease progression|3|||
105322286|NCT04147234|363179090|FG000|Overall Study|Adverse Event|0|||
105322287|NCT04147234|363179091|FG001|Overall Study|Adverse Event|0|||
105322288|NCT04147234|363179092|FG002|Overall Study|Adverse Event|0|||
105322289|NCT04147234|363179093|FG003|Overall Study|Adverse Event|0|||
105322290|NCT04147234|363179094|FG004|Overall Study|Adverse Event|1|||
105322291|NCT04147234|363179095|FG005|Overall Study|Adverse Event|0|||
105322292|NCT04147234|363179096|FG006|Overall Study|Adverse Event|0|||
105322293|NCT00001521|363179101|FG000|Overall Study|Withdrawal by Subject|3|||
105322294|NCT00001521|363179102|FG001|Overall Study|Withdrawal by Subject|3|||
105322295|NCT00001521|363179101|FG000|Overall Study|Physician Decision|1|||
105322296|NCT00001521|363179102|FG001|Overall Study|Physician Decision|1|||
105322297|NCT00001521|363179101|FG000|Overall Study|Noncompliant|6|||
105322298|NCT00001521|363179102|FG001|Overall Study|Noncompliant|3|||
105322299|NCT01557504|363179103|FG000|Overall Study|Physician Decision|1|||
105322300|NCT01557504|363179104|FG001|Overall Study|Physician Decision|0|||
105322301|NCT02366689|363179113|FG000|Overall Study|Withdrawal by Subject|1|||
105322302|NCT02366689|363179114|FG001|Overall Study|Withdrawal by Subject|0|||
105322303|NCT02366689|363179115|FG002|Overall Study|Withdrawal by Subject|1|||
105322304|NCT02366689|363179113|FG000|Overall Study|Lost to Follow-up|3|||
105322305|NCT02366689|363179114|FG001|Overall Study|Lost to Follow-up|2|||
105851055|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851056|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851057|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851058|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
105322306|NCT02366689|363179115|FG002|Overall Study|Lost to Follow-up|0|||
105322307|NCT02366689|363179113|FG000|Overall Study|Pregnancy|0|||
105322308|NCT02366689|363179114|FG001|Overall Study|Pregnancy|1|||
105322309|NCT02366689|363179115|FG002|Overall Study|Pregnancy|1|||
105322310|NCT04882241|363179116|FG000|Overall Study|Ongoing in study|46|||
105322311|NCT04882241|363179117|FG001|Overall Study|Ongoing in study|48|||
105322312|NCT04882241|363179118|FG002|Overall Study|Ongoing in study|0|||
105322313|NCT04882241|363179119|FG003|Overall Study|Ongoing in study|0|||
105322314|NCT04882241|363179116|FG000|Overall Study|Death|13|||
105322315|NCT04882241|363179117|FG001|Overall Study|Death|13|||
105322316|NCT04882241|363179118|FG002|Overall Study|Death|0|||
105322317|NCT04882241|363179119|FG003|Overall Study|Death|0|||
105322318|NCT02439216|363179128|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
105322319|NCT02439216|363179129|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105322320|NCT02439216|363179130|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105322321|NCT02439216|363179131|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105322322|NCT02439216|363179132|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105322323|NCT02439216|363179133|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105322324|NCT02439216|363179134|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105322325|NCT02439216|363179135|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105322326|NCT02439216|363179136|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105322327|NCT02439216|363179128|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105322328|NCT02439216|363179129|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105322329|NCT02439216|363179130|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105322330|NCT02439216|363179131|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105322331|NCT02439216|363179132|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105322332|NCT02439216|363179133|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105322333|NCT02439216|363179134|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105322334|NCT02439216|363179135|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
105322335|NCT02439216|363179136|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105322336|NCT02439216|363179128|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
105322337|NCT02439216|363179129|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
105322338|NCT02439216|363179130|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
105322339|NCT02439216|363179131|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
105322340|NCT02439216|363179132|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
105322341|NCT02439216|363179133|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
105322342|NCT02439216|363179134|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
105322343|NCT02439216|363179135|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
105322344|NCT02439216|363179136|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
105322345|NCT02439216|363179128|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105322346|NCT02439216|363179129|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105322347|NCT02439216|363179130|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105322348|NCT02439216|363179131|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105322349|NCT02439216|363179132|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105322350|NCT02439216|363179133|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105322351|NCT02439216|363179134|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105322352|NCT02439216|363179135|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105322353|NCT02439216|363179136|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
105322354|NCT02439216|363179128|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
105322355|NCT02439216|363179129|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
105322356|NCT02439216|363179130|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
105322357|NCT02439216|363179131|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
105322358|NCT02439216|363179132|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
105371741|NCT00921024|363366899|FG000|Overall Study|Received concomittant therapy|2|||
105371742|NCT00921024|363366900|FG001|Overall Study|Received concomittant therapy|0|||
105371743|NCT00921024|363366899|FG000|Overall Study|Withdrawal by Subject|0|||
105371744|NCT00921024|363366900|FG001|Overall Study|Withdrawal by Subject|3|||
105371745|NCT03573297|363366905|FG000|Open Label Treatment Period|Adverse Event|67|||
105371746|NCT03573297|363366906|FG001|Open Label Treatment Period|Adverse Event|0|||
105371747|NCT03573297|363366907|FG002|Open Label Treatment Period|Adverse Event|0|||
105371748|NCT03573297|363366908|FG003|Open Label Treatment Period|Adverse Event|0|||
105371749|NCT03573297|363366905|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
105371750|NCT03573297|363366906|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
105371751|NCT03573297|363366907|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
105371752|NCT03573297|363366908|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
105371753|NCT03573297|363366905|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
105371754|NCT03573297|363366906|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
105371755|NCT03573297|363366907|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
105371756|NCT03573297|363366908|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
105371757|NCT03573297|363366905|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
105322359|NCT02439216|363179133|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
105322360|NCT02439216|363179134|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
105322361|NCT02439216|363179135|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
105371758|NCT03573297|363366906|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
105371759|NCT03573297|363366907|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
105491532|NCT02476422|363812507|FG000|Overall Study|Subject/guardian decision|0|||
105491533|NCT02476422|363812508|FG001|Overall Study|Subject/guardian decision|1|||
105491534|NCT00760214|363812509|FG000|Overall Study|Adverse Event|8|||
105491535|NCT00760214|363812510|FG001|Overall Study|Adverse Event|9|||
105491536|NCT00760214|363812511|FG002|Overall Study|Adverse Event|12|||
105491537|NCT00760214|363812509|FG000|Overall Study|Protocol Violation|3|||
105491538|NCT00760214|363812510|FG001|Overall Study|Protocol Violation|0|||
105491539|NCT00760214|363812511|FG002|Overall Study|Protocol Violation|3|||
105491540|NCT00760214|363812509|FG000|Overall Study|Lost to Follow-up|0|||
105491541|NCT00760214|363812510|FG001|Overall Study|Lost to Follow-up|0|||
105491542|NCT00760214|363812511|FG002|Overall Study|Lost to Follow-up|1|||
105491543|NCT00760214|363812509|FG000|Overall Study|Withdrawal by Subject|12|||
105491544|NCT00760214|363812510|FG001|Overall Study|Withdrawal by Subject|14|||
105491545|NCT00760214|363812511|FG002|Overall Study|Withdrawal by Subject|13|||
105491546|NCT00760214|363812509|FG000|Overall Study|Lack of Efficacy|3|||
105491547|NCT00760214|363812510|FG001|Overall Study|Lack of Efficacy|2|||
105491548|NCT00760214|363812511|FG002|Overall Study|Lack of Efficacy|4|||
105491549|NCT00760214|363812509|FG000|Overall Study|Pregnancy|0|||
105491550|NCT00760214|363812510|FG001|Overall Study|Pregnancy|0|||
105491551|NCT00760214|363812511|FG002|Overall Study|Pregnancy|1|||
105491552|NCT00760214|363812509|FG000|Overall Study|Physician Decision|1|||
105491553|NCT00760214|363812510|FG001|Overall Study|Physician Decision|1|||
105491554|NCT00760214|363812511|FG002|Overall Study|Physician Decision|1|||
105491555|NCT00760214|363812509|FG000|Overall Study|Other|3|||
105491556|NCT00760214|363812510|FG001|Overall Study|Other|4|||
105491557|NCT00760214|363812511|FG002|Overall Study|Other|6|||
105491558|NCT02694523|363812515|FG000|Part A|Adverse Event|7|||
105491559|NCT02694523|363812516|FG001|Part A|Adverse Event|3|||
105491560|NCT02694523|363812517|FG002|Part A|Adverse Event|0|||
105491561|NCT02694523|363812518|FG003|Part A|Adverse Event|0|||
105491562|NCT02694523|363812519|FG004|Part A|Adverse Event|0|||
105491563|NCT02694523|363812520|FG005|Part A|Adverse Event|0|||
105491564|NCT02694523|363812521|FG006|Part A|Adverse Event|0|||
105491565|NCT02694523|363812515|FG000|Part A|Protocol Violation|1|||
105491566|NCT02694523|363812516|FG001|Part A|Protocol Violation|0|||
105491567|NCT02694523|363812517|FG002|Part A|Protocol Violation|0|||
105491568|NCT02694523|363812518|FG003|Part A|Protocol Violation|0|||
105491569|NCT02694523|363812519|FG004|Part A|Protocol Violation|0|||
105491570|NCT02694523|363812520|FG005|Part A|Protocol Violation|0|||
105491571|NCT02694523|363812521|FG006|Part A|Protocol Violation|0|||
105491572|NCT02694523|363812515|FG000|Part A|Lost to Follow-up|1|||
105491573|NCT02694523|363812516|FG001|Part A|Lost to Follow-up|2|||
105491574|NCT02694523|363812517|FG002|Part A|Lost to Follow-up|0|||
105491575|NCT02694523|363812518|FG003|Part A|Lost to Follow-up|0|||
105491576|NCT02694523|363812519|FG004|Part A|Lost to Follow-up|0|||
105491577|NCT02694523|363812520|FG005|Part A|Lost to Follow-up|0|||
105491578|NCT02694523|363812521|FG006|Part A|Lost to Follow-up|0|||
105491579|NCT02694523|363812515|FG000|Part A|Withdrawal by Subject|3|||
105491580|NCT02694523|363812516|FG001|Part A|Withdrawal by Subject|1|||
105491581|NCT02694523|363812517|FG002|Part A|Withdrawal by Subject|0|||
105851059|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851060|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851061|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851062|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
105851063|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
105851064|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851065|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851066|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851067|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851068|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851069|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851070|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851071|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851072|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851073|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851074|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851075|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851076|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105491582|NCT02694523|363812518|FG003|Part A|Withdrawal by Subject|0|||
105491583|NCT02694523|363812519|FG004|Part A|Withdrawal by Subject|0|||
105491584|NCT02694523|363812520|FG005|Part A|Withdrawal by Subject|0|||
105491585|NCT02694523|363812521|FG006|Part A|Withdrawal by Subject|0|||
105491586|NCT02694523|363812515|FG000|Part A|Other|1|||
105491587|NCT02694523|363812516|FG001|Part A|Other|1|||
105491588|NCT02694523|363812517|FG002|Part A|Other|0|||
105491589|NCT02694523|363812518|FG003|Part A|Other|0|||
105491590|NCT02694523|363812519|FG004|Part A|Other|0|||
105491591|NCT02694523|363812520|FG005|Part A|Other|0|||
105491592|NCT02694523|363812521|FG006|Part A|Other|0|||
105491593|NCT02694523|363812515|FG000|Part B|Adverse Event|0|||
105491594|NCT02694523|363812516|FG001|Part B|Adverse Event|0|||
105491595|NCT02694523|363812517|FG002|Part B|Adverse Event|7|||
105491596|NCT02694523|363812518|FG003|Part B|Adverse Event|1|||
105491597|NCT02694523|363812519|FG004|Part B|Adverse Event|1|||
105491598|NCT02694523|363812520|FG005|Part B|Adverse Event|2|||
105491599|NCT02694523|363812521|FG006|Part B|Adverse Event|0|||
105491600|NCT02694523|363812515|FG000|Part B|Protocol Violation|0|||
105491601|NCT02694523|363812516|FG001|Part B|Protocol Violation|0|||
105491602|NCT02694523|363812517|FG002|Part B|Protocol Violation|1|||
105491603|NCT02694523|363812518|FG003|Part B|Protocol Violation|0|||
105491604|NCT02694523|363812519|FG004|Part B|Protocol Violation|0|||
105491605|NCT02694523|363812520|FG005|Part B|Protocol Violation|0|||
105491606|NCT02694523|363812521|FG006|Part B|Protocol Violation|0|||
105491607|NCT02694523|363812515|FG000|Part B|Lost to Follow-up|0|||
105491608|NCT02694523|363812516|FG001|Part B|Lost to Follow-up|0|||
105491609|NCT02694523|363812517|FG002|Part B|Lost to Follow-up|2|||
105491610|NCT02694523|363812518|FG003|Part B|Lost to Follow-up|3|||
105491611|NCT02694523|363812519|FG004|Part B|Lost to Follow-up|2|||
105491612|NCT02694523|363812520|FG005|Part B|Lost to Follow-up|0|||
105491613|NCT02694523|363812521|FG006|Part B|Lost to Follow-up|1|||
105491614|NCT02694523|363812515|FG000|Part B|Withdrawal by Subject|0|||
105491615|NCT02694523|363812516|FG001|Part B|Withdrawal by Subject|0|||
105491616|NCT02694523|363812517|FG002|Part B|Withdrawal by Subject|9|||
105491617|NCT02694523|363812518|FG003|Part B|Withdrawal by Subject|0|||
105491618|NCT02694523|363812519|FG004|Part B|Withdrawal by Subject|1|||
105491619|NCT02694523|363812520|FG005|Part B|Withdrawal by Subject|3|||
105491620|NCT02694523|363812521|FG006|Part B|Withdrawal by Subject|0|||
105491621|NCT02694523|363812515|FG000|Part B|Other|0|||
105851077|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851078|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851079|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851080|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851081|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851082|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851083|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851084|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851085|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851086|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851087|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
105851088|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851089|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851090|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851091|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851092|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Adverse Event|0|||
105851093|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Adverse Event|0|||
105851094|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Adverse Event|0|||
105851095|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Adverse Event|0|||
105851096|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Adverse Event|0|||
105851097|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Adverse Event|0|||
105851098|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Adverse Event|0|||
105851099|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Adverse Event|0|||
105851100|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Adverse Event|0|||
105851101|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Adverse Event|0|||
105851102|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Adverse Event|0|||
105491622|NCT02694523|363812516|FG001|Part B|Other|0|||
105491623|NCT02694523|363812517|FG002|Part B|Other|1|||
105491624|NCT02694523|363812518|FG003|Part B|Other|0|||
105491625|NCT02694523|363812519|FG004|Part B|Other|0|||
105491626|NCT02694523|363812520|FG005|Part B|Other|0|||
105491627|NCT02694523|363812521|FG006|Part B|Other|1|||
105491628|NCT01272661|363812523|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
105491629|NCT01272661|363812524|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
105491630|NCT01272661|363812525|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
105491631|NCT04137224|363812526|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
105491632|NCT04137224|363812527|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
105491633|NCT04137224|363812526|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
105491634|NCT04137224|363812527|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
105851103|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Adverse Event|0|||
105851104|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Adverse Event|0|||
105851105|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Adverse Event|0|||
105851106|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Adverse Event|0|||
105851107|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Adverse Event|0|||
105851108|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Adverse Event|0|||
105851109|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Adverse Event|0|||
105851110|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Adverse Event|0|||
105851111|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Adverse Event|0|||
105851112|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Adverse Event|0|||
105851113|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Adverse Event|0|||
105851114|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Adverse Event|0|||
105851115|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Adverse Event|1|||
105851116|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Adverse Event|0|||
105851117|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851118|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851119|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851120|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851121|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851122|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851123|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851124|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851125|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851126|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851127|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851128|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851129|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851130|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851131|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851132|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851133|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851134|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851135|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851136|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105322362|NCT02439216|363179136|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
105322363|NCT01276041|363179141|FG000|Overall Study|Adverse Event|2|||
105322364|NCT01276041|363179141|FG000|Overall Study|Protocol Violation|1|||
105322365|NCT05767905|363179149|FG000|Overall Study|Adverse Event|0|||
105322366|NCT05767905|363179150|FG001|Overall Study|Adverse Event|0|||
105322367|NCT05767905|363179151|FG002|Overall Study|Adverse Event|1|||
105322368|NCT04471428|363179152|FG000|Overall Study|Withdrawal by Subject|29|||
105322369|NCT04471428|363179153|FG001|Overall Study|Withdrawal by Subject|1|||
105322370|NCT04471428|363179152|FG000|Overall Study|Physician Decision|0|||
105322371|NCT04471428|363179153|FG001|Overall Study|Physician Decision|1|||
105322372|NCT04471428|363179152|FG000|Overall Study|Reason Not Specified|0|||
105322373|NCT04471428|363179153|FG001|Overall Study|Reason Not Specified|2|||
105322374|NCT04471428|363179152|FG000|Overall Study|Death|106|||
105322375|NCT04471428|363179153|FG001|Overall Study|Death|114|||
105322376|NCT04471428|363179152|FG000|Overall Study|Ongoing in the study|45|||
105322377|NCT04471428|363179153|FG001|Overall Study|Ongoing in the study|68|||
105322378|NCT03624192|363179156|FG000|Overall Study|Lost to Follow-up|1|||
105322379|NCT03624192|363179157|FG001|Overall Study|Lost to Follow-up|1|||
105322380|NCT06071754|363179172|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
105322381|NCT02273388|363179173|FG000|Overall Study|Adverse Event|0|||
105322382|NCT02273388|363179174|FG001|Overall Study|Adverse Event|0|||
105322383|NCT02273388|363179175|FG002|Overall Study|Adverse Event|0|||
105322384|NCT02273388|363179176|FG003|Overall Study|Adverse Event|0|||
105322385|NCT02273388|363179177|FG004|Overall Study|Adverse Event|0|||
105322386|NCT02273388|363179178|FG005|Overall Study|Adverse Event|0|||
105322387|NCT02273388|363179179|FG006|Overall Study|Adverse Event|1|||
105322388|NCT02273388|363179180|FG007|Overall Study|Adverse Event|2|||
105322389|NCT02273388|363179181|FG008|Overall Study|Adverse Event|0|||
105322390|NCT02273388|363179182|FG009|Overall Study|Adverse Event|0|||
105322391|NCT02273388|363179183|FG010|Overall Study|Adverse Event|0|||
105322392|NCT02273388|363179184|FG011|Overall Study|Adverse Event|0|||
105322393|NCT02273388|363179173|FG000|Overall Study|Adverse Event study disease worse|4|||
105322394|NCT02273388|363179174|FG001|Overall Study|Adverse Event study disease worse|3|||
105322395|NCT02273388|363179175|FG002|Overall Study|Adverse Event study disease worse|3|||
105322396|NCT02273388|363179176|FG003|Overall Study|Adverse Event study disease worse|2|||
105322397|NCT02273388|363179177|FG004|Overall Study|Adverse Event study disease worse|4|||
105322398|NCT02273388|363179178|FG005|Overall Study|Adverse Event study disease worse|3|||
105322399|NCT02273388|363179179|FG006|Overall Study|Adverse Event study disease worse|14|||
105322400|NCT02273388|363179180|FG007|Overall Study|Adverse Event study disease worse|6|||
105322401|NCT02273388|363179181|FG008|Overall Study|Adverse Event study disease worse|6|||
105322402|NCT02273388|363179182|FG009|Overall Study|Adverse Event study disease worse|5|||
105322403|NCT02273388|363179183|FG010|Overall Study|Adverse Event study disease worse|10|||
105491635|NCT04137224|363812526|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
105491636|NCT04137224|363812527|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
105491637|NCT01646073|363812530|FG000|Period A (12 Weeks)|Adverse Event|0|||
105491638|NCT01646073|363812531|FG001|Period A (12 Weeks)|Adverse Event|2|||
105491639|NCT01646073|363812530|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
105491640|NCT01646073|363812531|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
105491641|NCT01646073|363812530|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
105491642|NCT01646073|363812531|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
105491643|NCT01646073|363812530|FG000|Period A (12 Weeks)|Protocol Violation|0|||
105491644|NCT01646073|363812531|FG001|Period A (12 Weeks)|Protocol Violation|1|||
105491645|NCT01646073|363812530|FG000|Period A (12 Weeks)|Other|0|||
105491646|NCT01646073|363812531|FG001|Period A (12 Weeks)|Other|1|||
105491647|NCT01646073|363812530|FG000|Period B (12 Weeks)|Adverse Event|0|||
105491648|NCT01646073|363812531|FG001|Period B (12 Weeks)|Adverse Event|7|||
105491649|NCT01646073|363812530|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
105491650|NCT01646073|363812531|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
105491651|NCT01646073|363812530|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
105322404|NCT02273388|363179184|FG011|Overall Study|Adverse Event study disease worse|1|||
105322405|NCT02273388|363179173|FG000|Overall Study|Sponsor decision|0|||
105322406|NCT02273388|363179174|FG001|Overall Study|Sponsor decision|0|||
105322407|NCT02273388|363179175|FG002|Overall Study|Sponsor decision|0|||
105322408|NCT02273388|363179176|FG003|Overall Study|Sponsor decision|0|||
105322409|NCT02273388|363179177|FG004|Overall Study|Sponsor decision|0|||
105322410|NCT02273388|363179178|FG005|Overall Study|Sponsor decision|0|||
105322411|NCT02273388|363179179|FG006|Overall Study|Sponsor decision|0|||
105322412|NCT02273388|363179180|FG007|Overall Study|Sponsor decision|0|||
105322413|NCT02273388|363179181|FG008|Overall Study|Sponsor decision|0|||
105322414|NCT02273388|363179182|FG009|Overall Study|Sponsor decision|0|||
105322415|NCT02273388|363179183|FG010|Overall Study|Sponsor decision|0|||
105322416|NCT02273388|363179184|FG011|Overall Study|Sponsor decision|1|||
105322417|NCT04331808|363179185|FG000|Overall Study|Withdrew consent|1|||
105322418|NCT04331808|363179186|FG001|Overall Study|Withdrew consent|0|||
105322419|NCT04331808|363179187|FG002|Overall Study|Withdrew consent|2|||
105322420|NCT04331808|363179188|FG003|Overall Study|Withdrew consent|3|||
105322421|NCT04233073|363179189|FG000|Overall Study|Death|5|||
105322422|NCT02198963|363179190|FG000|Overall Study|Adverse Event|1|||
105322423|NCT02198963|363179190|FG000|Overall Study|Withdrawal by Subject|6|||
105322424|NCT00243412|363179192|FG000|Overall Study|Death|0|||
105322425|NCT00243412|363179193|FG001|Overall Study|Death|1|||
105322426|NCT00243412|363179192|FG000|Overall Study|Adverse Event|4|||
105322427|NCT00243412|363179193|FG001|Overall Study|Adverse Event|2|||
105322428|NCT00243412|363179192|FG000|Overall Study|Lost to Follow-up|0|||
105322429|NCT00243412|363179193|FG001|Overall Study|Lost to Follow-up|1|||
105322430|NCT00243412|363179192|FG000|Overall Study|Physician Decision|1|||
105322431|NCT00243412|363179193|FG001|Overall Study|Physician Decision|1|||
105322432|NCT00243412|363179192|FG000|Overall Study|Withdrawal by Subject|4|||
105322433|NCT00243412|363179193|FG001|Overall Study|Withdrawal by Subject|5|||
105322434|NCT00243412|363179192|FG000|Overall Study|Other|1|||
105322435|NCT00243412|363179193|FG001|Overall Study|Other|1|||
105322436|NCT02443740|363179196|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
105491652|NCT01646073|363812531|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
105322437|NCT02443740|363179197|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
105322438|NCT02443740|363179198|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
105322439|NCT02443740|363179199|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
105322440|NCT02443740|363179200|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
105322441|NCT02443740|363179201|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
105322442|NCT02443740|363179202|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
105322443|NCT02443740|363179203|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
105322444|NCT02443740|363179204|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
105322445|NCT02443740|363179205|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
105322446|NCT02443740|363179206|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
105322447|NCT02443740|363179196|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
105322448|NCT02443740|363179197|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105322449|NCT02443740|363179198|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105322450|NCT02443740|363179199|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105322451|NCT02443740|363179200|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105322452|NCT02443740|363179201|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105322453|NCT02443740|363179202|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
105322454|NCT02443740|363179203|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105322455|NCT02443740|363179204|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105322456|NCT02443740|363179205|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105322457|NCT02443740|363179206|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105322458|NCT02443740|363179196|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105322459|NCT02443740|363179197|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105322460|NCT02443740|363179198|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105322461|NCT02443740|363179199|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105322462|NCT02443740|363179200|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105322463|NCT02443740|363179201|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
105322464|NCT02443740|363179202|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105322465|NCT02443740|363179203|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105322466|NCT02443740|363179204|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105322467|NCT02443740|363179205|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105322468|NCT02443740|363179206|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105322469|NCT01964976|363179207|FG000|Overall Study|Protocol Violation|31|||
105322470|NCT00683657|363179211|FG000|Overall Study|Adverse Event|0|||
105322471|NCT00683657|363179212|FG001|Overall Study|Adverse Event|1|||
105322472|NCT00683657|363179211|FG000|Overall Study|Subject Withdrew Consent|1|||
105322473|NCT00683657|363179212|FG001|Overall Study|Subject Withdrew Consent|0|||
105322474|NCT02348112|363179215|FG000|Overall Study|Withdrawal by Subject|32|||
105322475|NCT02348112|363179216|FG001|Overall Study|Withdrawal by Subject|29|||
105322476|NCT02348112|363179215|FG000|Overall Study|Lost to Follow-up|24|||
105322477|NCT02348112|363179216|FG001|Overall Study|Lost to Follow-up|20|||
105322478|NCT02348112|363179215|FG000|Overall Study|Physician Decision|17|||
105322479|NCT02348112|363179216|FG001|Overall Study|Physician Decision|15|||
105322480|NCT02348112|363179215|FG000|Overall Study|Site closed due to PI leaving|0|||
105322481|NCT02348112|363179216|FG001|Overall Study|Site closed due to PI leaving|30|||
105322482|NCT02348112|363179215|FG000|Overall Study|Sponsor withdrawal|0|||
105322483|NCT02348112|363179216|FG001|Overall Study|Sponsor withdrawal|7|||
105322484|NCT02348112|363179215|FG000|Overall Study|Death|0|||
105322485|NCT02348112|363179216|FG001|Overall Study|Death|1|||
105322486|NCT00972595|363179220|FG000|Period 1|Adverse Event|1|||
105322487|NCT00972595|363179221|FG001|Period 1|Adverse Event|0|||
105322488|NCT01461538|363179223|FG000|Overall Study|Death|15|||
105851137|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851138|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851139|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851140|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
105851141|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851142|NCT04765384|365112604|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
105851143|NCT04765384|365112605|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
105851144|NCT04765384|365112606|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
105851145|NCT04765384|365112607|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
105851146|NCT04765384|365112608|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
105851147|NCT04765384|365112609|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
105851148|NCT04765384|365112604|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
105851149|NCT04765384|365112605|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
105851150|NCT04765384|365112606|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
105322489|NCT01461538|363179224|FG001|Overall Study|Death|6|||
105371760|NCT03573297|363366908|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
105576843|NCT01216293|364110341|FG000|Main Study|Other Reason Not Specified|0|||
105576844|NCT01216293|364110342|FG001|Main Study|Other Reason Not Specified|1|||
105576845|NCT01216293|364110343|FG002|Main Study|Other Reason Not Specified|1|||
105576846|NCT01216293|364110341|FG000|Main Study|Randomized, Not Treated|1|||
105576847|NCT01216293|364110342|FG001|Main Study|Randomized, Not Treated|0|||
105576848|NCT01216293|364110343|FG002|Main Study|Randomized, Not Treated|0|||
105576849|NCT01216293|364110341|FG000|Calcium Absorption Substudy|Adverse Event|0|||
105576850|NCT01216293|364110342|FG001|Calcium Absorption Substudy|Adverse Event|2|||
105576851|NCT01216293|364110343|FG002|Calcium Absorption Substudy|Adverse Event|0|||
105576852|NCT01216293|364110341|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
105576853|NCT01216293|364110342|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
105576854|NCT01216293|364110343|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
105851151|NCT04765384|365112607|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
105322490|NCT01461538|363179225|FG002|Overall Study|Death|2|||
105322491|NCT01461538|363179223|FG000|Overall Study|Study Stopped by Sponsor|2|||
105322492|NCT01461538|363179224|FG001|Overall Study|Study Stopped by Sponsor|1|||
105322493|NCT01461538|363179225|FG002|Overall Study|Study Stopped by Sponsor|0|||
105322494|NCT01461538|363179223|FG000|Overall Study|Withdrawal by Subject|1|||
105322495|NCT01461538|363179224|FG001|Overall Study|Withdrawal by Subject|1|||
105322496|NCT01461538|363179225|FG002|Overall Study|Withdrawal by Subject|0|||
105322497|NCT02201784|363179226|FG000|Overall Study|Failure to achieve adequate block|2|||
105371761|NCT03573297|363366905|FG000|Open Label Treatment Period|Pregnancy|1|||
105851152|NCT04765384|365112608|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
105851153|NCT04765384|365112609|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
105851154|NCT04765384|365112604|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
105851155|NCT04765384|365112605|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
105851156|NCT04765384|365112606|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
105851157|NCT04765384|365112607|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
105851158|NCT04765384|365112608|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
105851159|NCT04765384|365112609|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
105851160|NCT04765384|365112604|FG000|Post-natal: Neonates and Infants|Death|0|||
105851161|NCT04765384|365112605|FG001|Post-natal: Neonates and Infants|Death|0|||
105851162|NCT04765384|365112606|FG002|Post-natal: Neonates and Infants|Death|0|||
105851163|NCT04765384|365112607|FG003|Post-natal: Neonates and Infants|Death|1|||
105851164|NCT04765384|365112608|FG004|Post-natal: Neonates and Infants|Death|0|||
105851165|NCT04765384|365112609|FG005|Post-natal: Neonates and Infants|Death|0|||
105851166|NCT04765384|365112604|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
105851167|NCT04765384|365112605|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
105851168|NCT04765384|365112606|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
105851169|NCT04765384|365112607|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
105851170|NCT04765384|365112608|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
105851171|NCT04765384|365112609|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
105851172|NCT02335983|365112610|FG000|Overall Study|Sponsor Decision|0|||
105851173|NCT02335983|365112611|FG001|Overall Study|Sponsor Decision|0|||
105851174|NCT02335983|365112612|FG002|Overall Study|Sponsor Decision|1|||
105851175|NCT02335983|365112613|FG003|Overall Study|Sponsor Decision|1|||
105851176|NCT02335983|365112614|FG004|Overall Study|Sponsor Decision|0|||
105322498|NCT02201784|363179227|FG001|Overall Study|Failure to achieve adequate block|0|||
105322499|NCT04779879|363179228|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
105851177|NCT02335983|365112615|FG005|Overall Study|Sponsor Decision|1|||
105851178|NCT02335983|365112610|FG000|Overall Study|Withdrawal by Subject|3|||
105851179|NCT02335983|365112611|FG001|Overall Study|Withdrawal by Subject|2|||
105851180|NCT02335983|365112612|FG002|Overall Study|Withdrawal by Subject|2|||
105851181|NCT02335983|365112613|FG003|Overall Study|Withdrawal by Subject|1|||
105851182|NCT02335983|365112614|FG004|Overall Study|Withdrawal by Subject|3|||
105851183|NCT02335983|365112615|FG005|Overall Study|Withdrawal by Subject|9|||
105851184|NCT02335983|365112610|FG000|Overall Study|Death|0|||
105851185|NCT02335983|365112611|FG001|Overall Study|Death|0|||
105851186|NCT02335983|365112612|FG002|Overall Study|Death|2|||
105851187|NCT02335983|365112613|FG003|Overall Study|Death|0|||
105851188|NCT02335983|365112614|FG004|Overall Study|Death|0|||
105851189|NCT02335983|365112615|FG005|Overall Study|Death|0|||
105851190|NCT02335983|365112610|FG000|Overall Study|Lost to Follow-up|0|||
105851191|NCT02335983|365112611|FG001|Overall Study|Lost to Follow-up|0|||
105851192|NCT02335983|365112612|FG002|Overall Study|Lost to Follow-up|0|||
105851193|NCT02335983|365112613|FG003|Overall Study|Lost to Follow-up|0|||
105851194|NCT02335983|365112614|FG004|Overall Study|Lost to Follow-up|0|||
105322500|NCT04779879|363179229|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
105322501|NCT04779879|363179230|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
105322502|NCT04779879|363179231|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
105322503|NCT04779879|363179232|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
105322504|NCT04779879|363179233|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
105322505|NCT04779879|363179228|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
105322506|NCT04779879|363179229|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
105322507|NCT04779879|363179230|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
105322508|NCT04779879|363179231|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
105322509|NCT04779879|363179232|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
105322510|NCT04779879|363179233|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
105322511|NCT04779879|363179228|FG000|Part C: Up to Week 36|Death|0|||
105322512|NCT04779879|363179229|FG001|Part C: Up to Week 36|Death|0|||
105322513|NCT04779879|363179230|FG002|Part C: Up to Week 36|Death|0|||
105322514|NCT04779879|363179231|FG003|Part C: Up to Week 36|Death|0|||
105322515|NCT04779879|363179232|FG004|Part C: Up to Week 36|Death|0|||
105322516|NCT04779879|363179233|FG005|Part C: Up to Week 36|Death|1|||
105322517|NCT04779879|363179228|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
105322518|NCT04779879|363179229|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
105322519|NCT04779879|363179230|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
105322520|NCT04779879|363179231|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
105322521|NCT04779879|363179232|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
105322522|NCT04779879|363179233|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
105322523|NCT02431364|363179234|FG000|Overall Study|Adverse Event|0|||
105322524|NCT02431364|363179235|FG001|Overall Study|Adverse Event|1|||
105322525|NCT02431364|363179236|FG002|Overall Study|Adverse Event|0|||
105322526|NCT02431364|363179237|FG003|Overall Study|Adverse Event|0|||
105322527|NCT02431364|363179238|FG004|Overall Study|Adverse Event|0|||
105322528|NCT02431364|363179234|FG000|Overall Study|Randomized but never treated|0|||
105322529|NCT02431364|363179235|FG001|Overall Study|Randomized but never treated|0|||
105322530|NCT02431364|363179236|FG002|Overall Study|Randomized but never treated|0|||
105322531|NCT02431364|363179237|FG003|Overall Study|Randomized but never treated|1|||
105322532|NCT02431364|363179238|FG004|Overall Study|Randomized but never treated|0|||
105322533|NCT02633787|363179239|FG000|Overall Study|Withdrawal by Subject|1|||
105322534|NCT01459783|363179243|FG000|Baseline to 6 Months|Death|1|||
105322535|NCT01459783|363179244|FG001|Baseline to 6 Months|Death|0|||
105322536|NCT01459783|363179243|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
105322537|NCT01459783|363179244|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
105322538|NCT01459783|363179243|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
105322539|NCT01459783|363179244|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
105322540|NCT01459783|363179243|FG000|6 Months to 12 Months|Death|0|||
105322541|NCT01459783|363179244|FG001|6 Months to 12 Months|Death|1|||
105322542|NCT01459783|363179243|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
105322543|NCT01459783|363179244|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
105322544|NCT01459783|363179243|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
105322545|NCT01459783|363179244|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
105322546|NCT01459783|363179243|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
105322547|NCT01459783|363179244|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
105322548|NCT00625820|363179245|FG000|Overall Study|Withdrawal by Subject|1|||
105322549|NCT02623725|363179248|FG000|Overall Study|Non compliance with protocol|9|||
105322550|NCT02623725|363179249|FG001|Overall Study|Non compliance with protocol|3|||
105322551|NCT02623725|363179248|FG000|Overall Study|Serious adverse event|0|||
105322552|NCT02623725|363179249|FG001|Overall Study|Serious adverse event|2|||
105322553|NCT02623725|363179248|FG000|Overall Study|Withdrawal by Subject|7|||
105322554|NCT02623725|363179249|FG001|Overall Study|Withdrawal by Subject|1|||
105322555|NCT02456740|363179251|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
105322556|NCT02456740|363179252|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
105322557|NCT02456740|363179253|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
105322558|NCT02456740|363179254|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
105322559|NCT02456740|363179255|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
105322560|NCT02456740|363179256|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
105322561|NCT02456740|363179257|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
105322562|NCT02456740|363179258|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
105322563|NCT02456740|363179259|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
105322564|NCT02456740|363179251|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
105322565|NCT02456740|363179252|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
105322566|NCT02456740|363179253|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
105322567|NCT02456740|363179254|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
105322568|NCT02456740|363179255|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
105322569|NCT02456740|363179256|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
105322570|NCT02456740|363179257|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
105322571|NCT02456740|363179258|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
105322572|NCT02456740|363179259|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
105322573|NCT02456740|363179251|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
105322574|NCT02456740|363179252|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
105322575|NCT02456740|363179253|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
105322576|NCT02456740|363179254|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
105322577|NCT02456740|363179255|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
105322578|NCT02456740|363179256|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
105322579|NCT02456740|363179257|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
105322580|NCT02456740|363179258|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
105322581|NCT02456740|363179259|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
105322582|NCT02456740|363179251|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
105322583|NCT02456740|363179252|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
105322584|NCT02456740|363179253|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
105322585|NCT02456740|363179254|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
105322586|NCT02456740|363179255|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
105371762|NCT03573297|363366906|FG001|Open Label Treatment Period|Pregnancy|0|||
105371763|NCT03573297|363366907|FG002|Open Label Treatment Period|Pregnancy|0|||
105371764|NCT03573297|363366908|FG003|Open Label Treatment Period|Pregnancy|0|||
105322587|NCT02456740|363179256|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
105322588|NCT02456740|363179257|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
105322589|NCT02456740|363179258|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
105371765|NCT03573297|363366905|FG000|Open Label Treatment Period|Protocol Violation|17|||
105851195|NCT02335983|365112615|FG005|Overall Study|Lost to Follow-up|1|||
105371766|NCT03573297|363366906|FG001|Open Label Treatment Period|Protocol Violation|0|||
105371767|NCT03573297|363366907|FG002|Open Label Treatment Period|Protocol Violation|0|||
105371768|NCT03573297|363366908|FG003|Open Label Treatment Period|Protocol Violation|0|||
105371769|NCT03573297|363366905|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
105371770|NCT03573297|363366906|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
105371771|NCT03573297|363366907|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
105851196|NCT02335983|365112610|FG000|Overall Study|Protocol Specified Criteria|5|||
105851197|NCT02335983|365112611|FG001|Overall Study|Protocol Specified Criteria|7|||
105851198|NCT02335983|365112612|FG002|Overall Study|Protocol Specified Criteria|27|||
105851199|NCT02335983|365112613|FG003|Overall Study|Protocol Specified Criteria|7|||
105851200|NCT02335983|365112614|FG004|Overall Study|Protocol Specified Criteria|5|||
105851201|NCT02335983|365112615|FG005|Overall Study|Protocol Specified Criteria|21|||
105851202|NCT01831765|365112616|FG000|Overall Study|Lack of Efficacy|1|||
105851203|NCT01831765|365112617|FG001|Overall Study|Lack of Efficacy|0|||
105851204|NCT01831765|365112618|FG002|Overall Study|Lack of Efficacy|0|||
105851205|NCT01831765|365112616|FG000|Overall Study|Other, sponsor withdrew subject|0|||
105851206|NCT01831765|365112617|FG001|Overall Study|Other, sponsor withdrew subject|1|||
105851207|NCT01831765|365112618|FG002|Overall Study|Other, sponsor withdrew subject|0|||
105851208|NCT01831765|365112616|FG000|Overall Study|Pregnancy|1|||
105851209|NCT01831765|365112617|FG001|Overall Study|Pregnancy|1|||
105851210|NCT01831765|365112618|FG002|Overall Study|Pregnancy|2|||
105851211|NCT01831765|365112616|FG000|Overall Study|Death|0|||
105851212|NCT01831765|365112617|FG001|Overall Study|Death|1|||
105851213|NCT01831765|365112618|FG002|Overall Study|Death|1|||
105851214|NCT01831765|365112616|FG000|Overall Study|Other, site closed|1|||
105851215|NCT01831765|365112617|FG001|Overall Study|Other, site closed|1|||
105851216|NCT01831765|365112618|FG002|Overall Study|Other, site closed|0|||
105851217|NCT01831765|365112616|FG000|Overall Study|Adverse Event|5|||
105851218|NCT01831765|365112617|FG001|Overall Study|Adverse Event|3|||
105851219|NCT01831765|365112618|FG002|Overall Study|Adverse Event|3|||
105851220|NCT01831765|365112616|FG000|Overall Study|Withdrawal by Subject|22|||
105851221|NCT01831765|365112617|FG001|Overall Study|Withdrawal by Subject|7|||
105371772|NCT03573297|363366908|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
105371773|NCT03573297|363366905|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
105371774|NCT03573297|363366906|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
105371775|NCT03573297|363366907|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
105371776|NCT03573297|363366908|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
105371777|NCT03573297|363366905|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
105371778|NCT03573297|363366906|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
105371779|NCT03573297|363366907|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
105371780|NCT03573297|363366908|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
105371781|NCT03573297|363366905|FG000|Open Label Treatment Period|Other, Not Specified|7|||
105371782|NCT03573297|363366906|FG001|Open Label Treatment Period|Other, Not Specified|0|||
105371783|NCT03573297|363366907|FG002|Open Label Treatment Period|Other, Not Specified|0|||
105371784|NCT03573297|363366908|FG003|Open Label Treatment Period|Other, Not Specified|0|||
105371785|NCT03573297|363366905|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
105371786|NCT03573297|363366906|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
105371787|NCT03573297|363366907|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
105371788|NCT03573297|363366908|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
105371789|NCT03573297|363366905|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105371790|NCT03573297|363366906|FG001|Double-Blind Treatment Period|Adverse Event|1|||
105371791|NCT03573297|363366907|FG002|Double-Blind Treatment Period|Adverse Event|5|||
105371792|NCT03573297|363366908|FG003|Double-Blind Treatment Period|Adverse Event|1|||
105371793|NCT03573297|363366905|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
105371794|NCT03573297|363366906|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
105371795|NCT03573297|363366907|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
105371796|NCT03573297|363366908|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
105371797|NCT03573297|363366905|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105371798|NCT03573297|363366906|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
105371799|NCT03573297|363366907|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
105371800|NCT03573297|363366908|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
105371801|NCT03573297|363366905|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105371802|NCT03573297|363366906|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
105851222|NCT01831765|365112618|FG002|Overall Study|Withdrawal by Subject|17|||
105851223|NCT01831765|365112616|FG000|Overall Study|Withdrawal criteria|12|||
105851224|NCT01831765|365112617|FG001|Overall Study|Withdrawal criteria|10|||
105851225|NCT01831765|365112618|FG002|Overall Study|Withdrawal criteria|16|||
105851226|NCT01831765|365112616|FG000|Overall Study|Lost to Follow-up|2|||
105851227|NCT01831765|365112617|FG001|Overall Study|Lost to Follow-up|3|||
105851228|NCT01831765|365112618|FG002|Overall Study|Lost to Follow-up|3|||
105322590|NCT02456740|363179259|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
105322591|NCT02456740|363179251|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
105322592|NCT02456740|363179252|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
105322593|NCT02456740|363179253|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
105322594|NCT02456740|363179254|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
105322595|NCT02456740|363179255|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
105322596|NCT02456740|363179256|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
105322597|NCT02456740|363179257|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
105322598|NCT02456740|363179258|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
105322599|NCT02456740|363179259|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
105322600|NCT02456740|363179251|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105322601|NCT02456740|363179252|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105322602|NCT02456740|363179253|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105322603|NCT02456740|363179254|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105322604|NCT02456740|363179255|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105322605|NCT02456740|363179256|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105322606|NCT02456740|363179257|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105322607|NCT02456740|363179258|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
105322608|NCT02456740|363179259|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105322609|NCT02456740|363179251|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
105322610|NCT02456740|363179252|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
105322611|NCT02456740|363179253|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
105371803|NCT03573297|363366907|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
105371804|NCT03573297|363366908|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
105371805|NCT03573297|363366905|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
105371806|NCT03573297|363366906|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
105371807|NCT03573297|363366907|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
105371808|NCT03573297|363366908|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
105371809|NCT03573297|363366905|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
105371810|NCT03573297|363366906|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
105371811|NCT03573297|363366907|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
105851229|NCT00507130|365112619|FG000|Overall Study|Lost to Follow-up|0|||
105851230|NCT00507130|365112620|FG001|Overall Study|Lost to Follow-up|0|||
105851231|NCT00507130|365112621|FG002|Overall Study|Lost to Follow-up|1|||
105851232|NCT00507130|365112622|FG003|Overall Study|Lost to Follow-up|1|||
105851233|NCT00507130|365112619|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
105851234|NCT00507130|365112620|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
105851235|NCT00507130|365112621|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
105851236|NCT00507130|365112622|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
105851237|NCT00080938|365112627|FG000|Overall Study|Adverse Event|3|||
105851238|NCT00080938|365112627|FG000|Overall Study|Withdrawal by Subject|6|||
105851239|NCT00080938|365112627|FG000|Overall Study|Death|2|||
105851240|NCT00080938|365112627|FG000|Overall Study|Lack of Efficacy|7|||
105851241|NCT00080938|365112627|FG000|Overall Study|other disease|1|||
105851242|NCT00080938|365112627|FG000|Overall Study|Not started protocol therapy|1|||
105851243|NCT00080938|365112627|FG000|Overall Study|Ineligible|4|||
105851244|NCT00706511|365112630|FG000|Overall Study|Withdrawal by Subject|1|||
105851245|NCT00706511|365112631|FG001|Overall Study|Withdrawal by Subject|0|||
105851246|NCT00706511|365112632|FG002|Overall Study|Withdrawal by Subject|0|||
105851247|NCT00706511|365112633|FG003|Overall Study|Withdrawal by Subject|0|||
105851248|NCT02605993|365112634|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
105851249|NCT02605993|365112635|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
105851250|NCT02605993|365112636|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
105851251|NCT02605993|365112637|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
105851252|NCT01868893|365112639|FG000|Overall Study|Adverse Event|2|||
105851253|NCT01868893|365112639|FG000|Overall Study|Commercial availability of study drug|17|||
105851254|NCT01868893|365112639|FG000|Overall Study|Neutropenia|1|||
105851255|NCT03127644|365112649|FG000|Overall Study|Study-specific withdrawal criteria|0|||
105851256|NCT03127644|365112650|FG001|Overall Study|Study-specific withdrawal criteria|0|||
105851257|NCT03127644|365112651|FG002|Overall Study|Study-specific withdrawal criteria|2|||
105851258|NCT00928707|365112652|FG000|Overall Study|Protocol Violation|1|||
105851259|NCT00928707|365112653|FG001|Overall Study|Protocol Violation|0|||
105851260|NCT02140411|365112654|FG000|Overall Study|Adverse Event|1|||
105851261|NCT03981419|365112655|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
105322612|NCT02456740|363179254|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
105322613|NCT02456740|363179255|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
105371812|NCT03573297|363366908|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
105851262|NCT03981419|365112656|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
105322614|NCT02456740|363179256|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
105322615|NCT02456740|363179257|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
105322616|NCT02456740|363179258|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
105322617|NCT02456740|363179259|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
105322618|NCT03759392|363179260|FG000|Overall Study|Adverse Event|12|||
105322619|NCT03759392|363179261|FG001|Overall Study|Adverse Event|4|||
105322620|NCT03759392|363179260|FG000|Overall Study|Death|2|||
105322621|NCT03759392|363179261|FG001|Overall Study|Death|1|||
105322622|NCT03759392|363179260|FG000|Overall Study|Withdrawal by Subject|2|||
105322623|NCT03759392|363179261|FG001|Overall Study|Withdrawal by Subject|0|||
105322624|NCT03759392|363179260|FG000|Overall Study|Protocol Violation|2|||
105322625|NCT03759392|363179261|FG001|Overall Study|Protocol Violation|0|||
105322626|NCT03759392|363179260|FG000|Overall Study|Physician Decision|0|||
105322627|NCT03759392|363179261|FG001|Overall Study|Physician Decision|1|||
105322628|NCT03759392|363179260|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
105322629|NCT03759392|363179261|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
105322630|NCT03759392|363179260|FG000|Overall Study|No longer able to take medicines|1|||
105322631|NCT03759392|363179261|FG001|Overall Study|No longer able to take medicines|0|||
105322632|NCT03759392|363179260|FG000|Overall Study|Stopped taking study drug|1|||
105322633|NCT03759392|363179261|FG001|Overall Study|Stopped taking study drug|0|||
105322634|NCT02548143|363179263|FG000|Overall Study|Adverse Event|1|||
105322635|NCT02548143|363179264|FG001|Overall Study|Adverse Event|0|||
105322636|NCT02548143|363179263|FG000|Overall Study|Withdrawal by Subject|0|||
105322637|NCT02548143|363179264|FG001|Overall Study|Withdrawal by Subject|1|||
105322638|NCT02603146|363181561|FG000|Overall Study|Lost to Follow-up|5|||
105322639|NCT02603146|363181562|FG001|Overall Study|Lost to Follow-up|6|||
105322640|NCT02603146|363181561|FG000|Overall Study|Withdrawal by Subject|8|||
105322641|NCT02603146|363181562|FG001|Overall Study|Withdrawal by Subject|10|||
105322642|NCT02603146|363181561|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
105322643|NCT02603146|363181562|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
105322644|NCT02603146|363181561|FG000|Overall Study|Participant moved|2|||
105322645|NCT02603146|363181562|FG001|Overall Study|Participant moved|0|||
105322646|NCT02603146|363181561|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
105322647|NCT02603146|363181562|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
105322648|NCT03620708|363181566|FG000|Overall Study|Lost to Follow-up|1|||
105322649|NCT03620708|363181567|FG001|Overall Study|Lost to Follow-up|1|||
105322650|NCT03620708|363181568|FG002|Overall Study|Lost to Follow-up|2|||
105371813|NCT03573297|363366905|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
105322651|NCT03620708|363181566|FG000|Overall Study|Withdrawal by Subject|0|||
105322652|NCT03620708|363181567|FG001|Overall Study|Withdrawal by Subject|0|||
105322653|NCT03620708|363181568|FG002|Overall Study|Withdrawal by Subject|1|||
105322654|NCT06082843|363181569|FG000|Overall Study|Withdrawal by Subject|0|||
105322655|NCT06082843|363181570|FG001|Overall Study|Withdrawal by Subject|2|||
105322656|NCT06082843|363181569|FG000|Overall Study|Study terminated by sponsor|12|||
105322657|NCT06082843|363181570|FG001|Overall Study|Study terminated by sponsor|8|||
105322658|NCT02848001|363181571|FG000|Overall Study|other reasons|0|||
105322659|NCT02848001|363181572|FG001|Overall Study|other reasons|0|||
105322660|NCT02848001|363181573|FG002|Overall Study|other reasons|1|||
105322661|NCT02848001|363181574|FG003|Overall Study|other reasons|0|||
105322662|NCT02848001|363181575|FG004|Overall Study|other reasons|4|||
105322663|NCT02848001|363181576|FG005|Overall Study|other reasons|1|||
105322664|NCT02848001|363181577|FG006|Overall Study|other reasons|0|||
105322665|NCT02848001|363181578|FG007|Overall Study|other reasons|2|||
105322666|NCT02848001|363181579|FG008|Overall Study|other reasons|2|||
105371814|NCT03573297|363366906|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
105371815|NCT03573297|363366907|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
105371816|NCT03573297|363366908|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
105371817|NCT00666237|363366913|FG000|Overall Study|Death|5|||
105371818|NCT00666237|363366914|FG001|Overall Study|Death|5|||
105322667|NCT02848001|363181580|FG009|Overall Study|other reasons|3|||
105322668|NCT02848001|363181581|FG010|Overall Study|other reasons|0|||
105322669|NCT02848001|363181582|FG011|Overall Study|other reasons|1|||
105322670|NCT02848001|363181583|FG012|Overall Study|other reasons|1|||
105322671|NCT02848001|363181584|FG013|Overall Study|other reasons|0|||
105322672|NCT02848001|363181585|FG014|Overall Study|other reasons|0|||
105322673|NCT02848001|363181586|FG015|Overall Study|other reasons|2|||
105322674|NCT02848001|363181587|FG016|Overall Study|other reasons|1|||
105322675|NCT02848001|363181571|FG000|Overall Study|Lack of Efficacy|0|||
105322676|NCT02848001|363181572|FG001|Overall Study|Lack of Efficacy|1|||
105322677|NCT02848001|363181573|FG002|Overall Study|Lack of Efficacy|1|||
105322678|NCT02848001|363181574|FG003|Overall Study|Lack of Efficacy|2|||
105322679|NCT02848001|363181575|FG004|Overall Study|Lack of Efficacy|3|||
105322680|NCT02848001|363181576|FG005|Overall Study|Lack of Efficacy|0|||
105322681|NCT02848001|363181577|FG006|Overall Study|Lack of Efficacy|1|||
105322682|NCT02848001|363181578|FG007|Overall Study|Lack of Efficacy|0|||
105371819|NCT00666237|363366913|FG000|Overall Study|Lost to Follow-up|29|||
105322683|NCT02848001|363181579|FG008|Overall Study|Lack of Efficacy|0|||
105322684|NCT02848001|363181580|FG009|Overall Study|Lack of Efficacy|1|||
105322685|NCT02848001|363181581|FG010|Overall Study|Lack of Efficacy|0|||
105322686|NCT02848001|363181582|FG011|Overall Study|Lack of Efficacy|2|||
105322687|NCT02848001|363181583|FG012|Overall Study|Lack of Efficacy|0|||
105322688|NCT02848001|363181584|FG013|Overall Study|Lack of Efficacy|2|||
105322689|NCT02848001|363181585|FG014|Overall Study|Lack of Efficacy|2|||
105322690|NCT02848001|363181586|FG015|Overall Study|Lack of Efficacy|0|||
105322691|NCT02848001|363181587|FG016|Overall Study|Lack of Efficacy|0|||
105322692|NCT02848001|363181571|FG000|Overall Study|Progressive Disease|2|||
105322693|NCT02848001|363181572|FG001|Overall Study|Progressive Disease|1|||
105322694|NCT02848001|363181573|FG002|Overall Study|Progressive Disease|0|||
105322695|NCT02848001|363181574|FG003|Overall Study|Progressive Disease|4|||
105322696|NCT02848001|363181575|FG004|Overall Study|Progressive Disease|3|||
105322697|NCT02848001|363181576|FG005|Overall Study|Progressive Disease|0|||
105322698|NCT02848001|363181577|FG006|Overall Study|Progressive Disease|4|||
105322699|NCT02848001|363181578|FG007|Overall Study|Progressive Disease|1|||
105322700|NCT02848001|363181579|FG008|Overall Study|Progressive Disease|0|||
105322701|NCT02848001|363181580|FG009|Overall Study|Progressive Disease|2|||
105322702|NCT02848001|363181581|FG010|Overall Study|Progressive Disease|3|||
105322703|NCT02848001|363181582|FG011|Overall Study|Progressive Disease|2|||
105322704|NCT02848001|363181583|FG012|Overall Study|Progressive Disease|1|||
105322705|NCT02848001|363181584|FG013|Overall Study|Progressive Disease|0|||
105322706|NCT02848001|363181585|FG014|Overall Study|Progressive Disease|2|||
105322707|NCT02848001|363181586|FG015|Overall Study|Progressive Disease|4|||
105322708|NCT02848001|363181587|FG016|Overall Study|Progressive Disease|0|||
105322709|NCT02848001|363181571|FG000|Overall Study|Adverse Event|0|||
105322710|NCT02848001|363181572|FG001|Overall Study|Adverse Event|0|||
105322711|NCT02848001|363181573|FG002|Overall Study|Adverse Event|0|||
105322712|NCT02848001|363181574|FG003|Overall Study|Adverse Event|0|||
105322713|NCT02848001|363181575|FG004|Overall Study|Adverse Event|2|||
105322714|NCT02848001|363181576|FG005|Overall Study|Adverse Event|0|||
105322715|NCT02848001|363181577|FG006|Overall Study|Adverse Event|0|||
105322716|NCT02848001|363181578|FG007|Overall Study|Adverse Event|0|||
105322717|NCT02848001|363181579|FG008|Overall Study|Adverse Event|0|||
105322718|NCT02848001|363181580|FG009|Overall Study|Adverse Event|1|||
105371820|NCT00666237|363366914|FG001|Overall Study|Lost to Follow-up|25|||
105371821|NCT01075048|363369213|FG000|Overall Study|Death|4|||
105371822|NCT01075048|363369214|FG001|Overall Study|Death|17|||
105371823|NCT01075048|363369215|FG002|Overall Study|Death|12|||
105851263|NCT02272634|365112663|FG000|Overall Study|Adverse Event|1|||
105851264|NCT02272634|365112664|FG001|Overall Study|Adverse Event|0|||
105851265|NCT02272634|365112665|FG002|Overall Study|Adverse Event|0|||
105851266|NCT02272634|365112663|FG000|Overall Study|Protocol Violation|0|||
105851267|NCT02272634|365112664|FG001|Overall Study|Protocol Violation|0|||
105851268|NCT02272634|365112665|FG002|Overall Study|Protocol Violation|1|||
105851269|NCT02272634|365112663|FG000|Overall Study|Withdrawal by Subject|0|||
105851270|NCT02272634|365112664|FG001|Overall Study|Withdrawal by Subject|1|||
105851271|NCT02272634|365112665|FG002|Overall Study|Withdrawal by Subject|0|||
105851272|NCT01437943|365112667|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
105851273|NCT01437943|365112668|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
105851274|NCT01437943|365112667|FG000|Overall Study|Subject expressed pregnancy plans|1|||
105851275|NCT01437943|365112668|FG001|Overall Study|Subject expressed pregnancy plans|0|||
105851276|NCT01437943|365112667|FG000|Overall Study|Adverse Event|2|||
105851277|NCT01437943|365112668|FG001|Overall Study|Adverse Event|0|||
105851278|NCT05788289|365112669|FG000|Overall Study|Death|3|||
105851279|NCT00762437|365112670|FG000|Overall Study|Lost to Follow-up|7|||
105851280|NCT00762437|365112670|FG000|Overall Study|Missed final study visit|11|||
105851281|NCT00762437|365112670|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
105851282|NCT01986010|365112676|FG000|Overall Study|Adverse Event|0|||
105851283|NCT01986010|365112677|FG001|Overall Study|Adverse Event|1|||
105851284|NCT01986010|365112678|FG002|Overall Study|Adverse Event|0|||
105851285|NCT01986010|365112679|FG003|Overall Study|Adverse Event|0|||
105851286|NCT01986010|365112680|FG004|Overall Study|Adverse Event|0|||
105851287|NCT01986010|365112681|FG005|Overall Study|Adverse Event|0|||
105851288|NCT01986010|365112682|FG006|Overall Study|Adverse Event|0|||
105322719|NCT02848001|363181581|FG010|Overall Study|Adverse Event|0|||
105371824|NCT01075048|363369213|FG000|Overall Study|Start of other or new therapy|4|||
105371825|NCT01075048|363369214|FG001|Overall Study|Start of other or new therapy|36|||
105851289|NCT01986010|365112683|FG007|Overall Study|Adverse Event|0|||
105851290|NCT01986010|365112684|FG008|Overall Study|Adverse Event|0|||
105851291|NCT01986010|365112685|FG009|Overall Study|Adverse Event|0|||
105851292|NCT01986010|365112686|FG010|Overall Study|Adverse Event|0|||
105322720|NCT02848001|363181582|FG011|Overall Study|Adverse Event|1|||
105322721|NCT02848001|363181583|FG012|Overall Study|Adverse Event|1|||
105322722|NCT02848001|363181584|FG013|Overall Study|Adverse Event|0|||
105322723|NCT02848001|363181585|FG014|Overall Study|Adverse Event|2|||
105851293|NCT01986010|365112687|FG011|Overall Study|Adverse Event|0|||
105851294|NCT01986010|365112688|FG012|Overall Study|Adverse Event|0|||
105851295|NCT01986010|365112689|FG013|Overall Study|Adverse Event|0|||
105322724|NCT02848001|363181586|FG015|Overall Study|Adverse Event|0|||
105322725|NCT02848001|363181587|FG016|Overall Study|Adverse Event|0|||
105322726|NCT02848001|363181571|FG000|Overall Study|Death|0|||
105322727|NCT02848001|363181572|FG001|Overall Study|Death|0|||
105322728|NCT02848001|363181573|FG002|Overall Study|Death|0|||
105322729|NCT02848001|363181574|FG003|Overall Study|Death|1|||
105322730|NCT02848001|363181575|FG004|Overall Study|Death|3|||
105322731|NCT02848001|363181576|FG005|Overall Study|Death|1|||
105322732|NCT02848001|363181577|FG006|Overall Study|Death|2|||
105322733|NCT02848001|363181578|FG007|Overall Study|Death|3|||
105322734|NCT02848001|363181579|FG008|Overall Study|Death|4|||
105322735|NCT02848001|363181580|FG009|Overall Study|Death|1|||
105322736|NCT02848001|363181581|FG010|Overall Study|Death|0|||
105322737|NCT02848001|363181582|FG011|Overall Study|Death|1|||
105322738|NCT02848001|363181583|FG012|Overall Study|Death|3|||
105322739|NCT02848001|363181584|FG013|Overall Study|Death|0|||
105322740|NCT02848001|363181585|FG014|Overall Study|Death|2|||
105322741|NCT02848001|363181586|FG015|Overall Study|Death|3|||
105322742|NCT02848001|363181587|FG016|Overall Study|Death|0|||
105322743|NCT02848001|363181571|FG000|Overall Study|Physician Decision|0|||
105322744|NCT02848001|363181572|FG001|Overall Study|Physician Decision|0|||
105322745|NCT02848001|363181573|FG002|Overall Study|Physician Decision|0|||
105322746|NCT02848001|363181574|FG003|Overall Study|Physician Decision|0|||
105322747|NCT02848001|363181575|FG004|Overall Study|Physician Decision|0|||
105322748|NCT02848001|363181576|FG005|Overall Study|Physician Decision|0|||
105322749|NCT02848001|363181577|FG006|Overall Study|Physician Decision|0|||
105322750|NCT02848001|363181578|FG007|Overall Study|Physician Decision|0|||
105322751|NCT02848001|363181579|FG008|Overall Study|Physician Decision|1|||
105322752|NCT02848001|363181580|FG009|Overall Study|Physician Decision|1|||
105322753|NCT02848001|363181581|FG010|Overall Study|Physician Decision|0|||
105322754|NCT02848001|363181582|FG011|Overall Study|Physician Decision|0|||
105322755|NCT02848001|363181583|FG012|Overall Study|Physician Decision|2|||
105322756|NCT02848001|363181584|FG013|Overall Study|Physician Decision|0|||
105322757|NCT02848001|363181585|FG014|Overall Study|Physician Decision|0|||
105322758|NCT02848001|363181586|FG015|Overall Study|Physician Decision|0|||
105322759|NCT02848001|363181587|FG016|Overall Study|Physician Decision|0|||
105322760|NCT02848001|363181571|FG000|Overall Study|Withdrawal by Subject|0|||
105322761|NCT02848001|363181572|FG001|Overall Study|Withdrawal by Subject|0|||
105322762|NCT02848001|363181573|FG002|Overall Study|Withdrawal by Subject|0|||
105322763|NCT02848001|363181574|FG003|Overall Study|Withdrawal by Subject|0|||
105322764|NCT02848001|363181575|FG004|Overall Study|Withdrawal by Subject|0|||
105491653|NCT00566501|363812532|FG000|Overall Study|Adverse Event|68|||
105491654|NCT00566501|363812533|FG001|Overall Study|Adverse Event|59|||
105322765|NCT02848001|363181576|FG005|Overall Study|Withdrawal by Subject|1|||
105322766|NCT02848001|363181577|FG006|Overall Study|Withdrawal by Subject|1|||
105322767|NCT02848001|363181578|FG007|Overall Study|Withdrawal by Subject|1|||
105322768|NCT02848001|363181579|FG008|Overall Study|Withdrawal by Subject|0|||
105322769|NCT02848001|363181580|FG009|Overall Study|Withdrawal by Subject|0|||
105322770|NCT02848001|363181581|FG010|Overall Study|Withdrawal by Subject|0|||
105322771|NCT02848001|363181582|FG011|Overall Study|Withdrawal by Subject|0|||
105322772|NCT02848001|363181583|FG012|Overall Study|Withdrawal by Subject|0|||
105322773|NCT02848001|363181584|FG013|Overall Study|Withdrawal by Subject|0|||
105322774|NCT02848001|363181585|FG014|Overall Study|Withdrawal by Subject|0|||
105322775|NCT02848001|363181586|FG015|Overall Study|Withdrawal by Subject|0|||
105322776|NCT02848001|363181587|FG016|Overall Study|Withdrawal by Subject|0|||
105322777|NCT03989102|363181591|FG000|Year 1|Withdrawal by Subject|6|||
105322778|NCT03989102|363181592|FG001|Year 1|Withdrawal by Subject|2|||
105322779|NCT03989102|363181593|FG002|Year 1|Withdrawal by Subject|7|||
105322780|NCT03989102|363181591|FG000|Year 1|Lost to Follow-up|5|||
105322781|NCT03989102|363181592|FG001|Year 1|Lost to Follow-up|2|||
105322782|NCT03989102|363181593|FG002|Year 1|Lost to Follow-up|5|||
105322783|NCT03989102|363181591|FG000|Year 1|Subject met withdrawal criteria|1|||
105322784|NCT03989102|363181592|FG001|Year 1|Subject met withdrawal criteria|0|||
105322785|NCT03989102|363181593|FG002|Year 1|Subject met withdrawal criteria|1|||
105322786|NCT03989102|363181591|FG000|Year 2|Lost to Follow-up|7|||
105322787|NCT03989102|363181592|FG001|Year 2|Lost to Follow-up|3|||
105322788|NCT03989102|363181593|FG002|Year 2|Lost to Follow-up|4|||
105322789|NCT03989102|363181591|FG000|Year 2|Withdrawal by Subject|3|||
105322790|NCT03989102|363181592|FG001|Year 2|Withdrawal by Subject|1|||
105322791|NCT03989102|363181593|FG002|Year 2|Withdrawal by Subject|2|||
105322792|NCT03989102|363181591|FG000|Year 2|Subject non-compliant|3|||
105322793|NCT03989102|363181592|FG001|Year 2|Subject non-compliant|2|||
105491655|NCT00566501|363812532|FG000|Overall Study|Medication Non-compliance|5|||
105491656|NCT00566501|363812533|FG001|Overall Study|Medication Non-compliance|0|||
105322794|NCT03989102|363181593|FG002|Year 2|Subject non-compliant|0|||
105322795|NCT03989102|363181591|FG000|Year 2|Travel|1|||
105322796|NCT03989102|363181592|FG001|Year 2|Travel|0|||
105322797|NCT03989102|363181593|FG002|Year 2|Travel|1|||
105322798|NCT03989102|363181591|FG000|Year 2|P16 missing|4|||
105322799|NCT03989102|363181592|FG001|Year 2|P16 missing|2|||
105322800|NCT03989102|363181593|FG002|Year 2|P16 missing|1|||
105322801|NCT03989102|363181591|FG000|Year 2|P11 missing|1|||
105576855|NCT01216293|364110341|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
105576856|NCT01216293|364110342|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
105576857|NCT01216293|364110343|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
105576858|NCT01671748|364110344|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
105851296|NCT01986010|365112690|FG014|Overall Study|Adverse Event|0|||
105851297|NCT01986010|365112691|FG015|Overall Study|Adverse Event|1|||
105851298|NCT01986010|365112692|FG016|Overall Study|Adverse Event|0|||
105851299|NCT01986010|365112676|FG000|Overall Study|Lost to Follow-up|2|||
105851300|NCT01986010|365112677|FG001|Overall Study|Lost to Follow-up|1|||
105851301|NCT01986010|365112678|FG002|Overall Study|Lost to Follow-up|2|||
105851302|NCT01986010|365112679|FG003|Overall Study|Lost to Follow-up|2|||
105851303|NCT01986010|365112680|FG004|Overall Study|Lost to Follow-up|2|||
105851304|NCT01986010|365112681|FG005|Overall Study|Lost to Follow-up|2|||
105851305|NCT01986010|365112682|FG006|Overall Study|Lost to Follow-up|0|||
105851306|NCT01986010|365112683|FG007|Overall Study|Lost to Follow-up|0|||
105851307|NCT01986010|365112684|FG008|Overall Study|Lost to Follow-up|4|||
105851308|NCT01986010|365112685|FG009|Overall Study|Lost to Follow-up|2|||
105851309|NCT01986010|365112686|FG010|Overall Study|Lost to Follow-up|0|||
105851310|NCT01986010|365112687|FG011|Overall Study|Lost to Follow-up|1|||
105851311|NCT01986010|365112688|FG012|Overall Study|Lost to Follow-up|1|||
105322802|NCT03989102|363181592|FG001|Year 2|P11 missing|3|||
105371826|NCT01075048|363369215|FG002|Overall Study|Start of other or new therapy|46|||
105371827|NCT01075048|363369213|FG000|Overall Study|Withdrawal by Subject|1|||
105371828|NCT01075048|363369214|FG001|Overall Study|Withdrawal by Subject|6|||
105371829|NCT01075048|363369215|FG002|Overall Study|Withdrawal by Subject|3|||
105371830|NCT01075048|363369213|FG000|Overall Study|Lost to Follow-up|0|||
105371831|NCT01075048|363369214|FG001|Overall Study|Lost to Follow-up|1|||
105371832|NCT01075048|363369215|FG002|Overall Study|Lost to Follow-up|1|||
105576859|NCT01671748|364110345|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
105851312|NCT01986010|365112689|FG013|Overall Study|Lost to Follow-up|1|||
105851313|NCT01986010|365112690|FG014|Overall Study|Lost to Follow-up|2|||
105851314|NCT01986010|365112691|FG015|Overall Study|Lost to Follow-up|0|||
105322803|NCT03989102|363181593|FG002|Year 2|P11 missing|7|||
105322804|NCT03989102|363181591|FG000|Year 2|Definitive displacement outside the study site|0|||
105322805|NCT03989102|363181592|FG001|Year 2|Definitive displacement outside the study site|1|||
105322806|NCT03989102|363181593|FG002|Year 2|Definitive displacement outside the study site|0|||
105322807|NCT03989102|363181591|FG000|Year 2|Subject missed last study visit|0|||
105322808|NCT03989102|363181592|FG001|Year 2|Subject missed last study visit|1|||
105322809|NCT03989102|363181593|FG002|Year 2|Subject missed last study visit|0|||
105322810|NCT03989102|363181591|FG000|Year 2|Death|0|||
105322811|NCT03989102|363181592|FG001|Year 2|Death|1|||
105322812|NCT03989102|363181593|FG002|Year 2|Death|0|||
105322813|NCT03989102|363181591|FG000|Year 2|Subject not reachable|0|||
105322814|NCT03989102|363181592|FG001|Year 2|Subject not reachable|0|||
105322815|NCT03989102|363181593|FG002|Year 2|Subject not reachable|1|||
105322816|NCT03989102|363181591|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
105322817|NCT03989102|363181592|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
105322818|NCT03989102|363181593|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
105322819|NCT03989102|363181591|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
105322820|NCT03989102|363181592|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
105322821|NCT03989102|363181593|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
105322822|NCT03989102|363181591|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
105322823|NCT03989102|363181592|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
105322824|NCT03989102|363181593|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
105322825|NCT03989102|363181591|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
105322826|NCT03989102|363181592|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
105322827|NCT03989102|363181593|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
105322828|NCT03989102|363181591|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
105322829|NCT03989102|363181592|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
105322830|NCT03989102|363181593|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
105322831|NCT03989102|363181591|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
105322832|NCT03989102|363181592|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
105322833|NCT03989102|363181593|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
105322834|NCT01962103|363181596|FG000|Phase 1|Adverse Event|4|||
105322835|NCT01962103|363181597|FG001|Phase 1|Adverse Event|0|||
105322836|NCT01962103|363181598|FG002|Phase 1|Adverse Event|2|||
105322837|NCT01962103|363181599|FG003|Phase 1|Adverse Event|1|||
105322838|NCT01962103|363181600|FG004|Phase 1|Adverse Event|2|||
105322839|NCT01962103|363181601|FG005|Phase 1|Adverse Event|2|||
105322840|NCT01962103|363181602|FG006|Phase 1|Adverse Event|0|||
105322841|NCT01962103|363181603|FG007|Phase 1|Adverse Event|0|||
105322842|NCT01962103|363181604|FG008|Phase 1|Adverse Event|0|||
105322843|NCT01962103|363181596|FG000|Phase 1|Progressive Disease|8|||
105851315|NCT01986010|365112692|FG016|Overall Study|Lost to Follow-up|0|||
105851316|NCT01986010|365112676|FG000|Overall Study|Physician Decision|0|||
105322844|NCT01962103|363181597|FG001|Phase 1|Progressive Disease|6|||
105322845|NCT01962103|363181598|FG002|Phase 1|Progressive Disease|8|||
105322846|NCT01962103|363181599|FG003|Phase 1|Progressive Disease|4|||
105322847|NCT01962103|363181600|FG004|Phase 1|Progressive Disease|5|||
105322848|NCT01962103|363181601|FG005|Phase 1|Progressive Disease|4|||
105322849|NCT01962103|363181602|FG006|Phase 1|Progressive Disease|0|||
105322850|NCT01962103|363181603|FG007|Phase 1|Progressive Disease|0|||
105322851|NCT01962103|363181604|FG008|Phase 1|Progressive Disease|0|||
105322852|NCT01962103|363181596|FG000|Phase 1|Withdrawal by Subject|0|||
105322853|NCT01962103|363181597|FG001|Phase 1|Withdrawal by Subject|0|||
105322854|NCT01962103|363181598|FG002|Phase 1|Withdrawal by Subject|0|||
105322855|NCT01962103|363181599|FG003|Phase 1|Withdrawal by Subject|2|||
105322856|NCT01962103|363181600|FG004|Phase 1|Withdrawal by Subject|0|||
105322857|NCT01962103|363181601|FG005|Phase 1|Withdrawal by Subject|0|||
105322858|NCT01962103|363181602|FG006|Phase 1|Withdrawal by Subject|0|||
105322859|NCT01962103|363181603|FG007|Phase 1|Withdrawal by Subject|0|||
105322860|NCT01962103|363181604|FG008|Phase 1|Withdrawal by Subject|0|||
105322861|NCT01962103|363181596|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
105322862|NCT01962103|363181597|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
105322863|NCT01962103|363181598|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
105322864|NCT01962103|363181599|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
105322865|NCT01962103|363181600|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
105322866|NCT01962103|363181601|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
105322867|NCT01962103|363181602|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
105322868|NCT01962103|363181603|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
105322869|NCT01962103|363181604|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
105322870|NCT01962103|363181596|FG000|Phase 1|Physician Decision|0|||
105322871|NCT01962103|363181597|FG001|Phase 1|Physician Decision|0|||
105322872|NCT01962103|363181598|FG002|Phase 1|Physician Decision|0|||
105322873|NCT01962103|363181599|FG003|Phase 1|Physician Decision|1|||
105322874|NCT01962103|363181600|FG004|Phase 1|Physician Decision|0|||
105322875|NCT01962103|363181601|FG005|Phase 1|Physician Decision|0|||
105322876|NCT01962103|363181602|FG006|Phase 1|Physician Decision|0|||
105322877|NCT01962103|363181603|FG007|Phase 1|Physician Decision|0|||
105322878|NCT01962103|363181604|FG008|Phase 1|Physician Decision|0|||
105322879|NCT01962103|363181596|FG000|Phase 1|Symptomatic Deterioration|3|||
105322880|NCT01962103|363181597|FG001|Phase 1|Symptomatic Deterioration|2|||
105322881|NCT01962103|363181598|FG002|Phase 1|Symptomatic Deterioration|2|||
105322882|NCT01962103|363181599|FG003|Phase 1|Symptomatic Deterioration|2|||
105322883|NCT01962103|363181600|FG004|Phase 1|Symptomatic Deterioration|1|||
105322884|NCT01962103|363181601|FG005|Phase 1|Symptomatic Deterioration|1|||
105322885|NCT01962103|363181602|FG006|Phase 1|Symptomatic Deterioration|0|||
105322886|NCT01962103|363181603|FG007|Phase 1|Symptomatic Deterioration|0|||
105322887|NCT01962103|363181604|FG008|Phase 1|Symptomatic Deterioration|0|||
105322888|NCT01962103|363181596|FG000|Phase 1|Miscellaneous|1|||
105322889|NCT01962103|363181597|FG001|Phase 1|Miscellaneous|0|||
105322890|NCT01962103|363181598|FG002|Phase 1|Miscellaneous|0|||
105322891|NCT01962103|363181599|FG003|Phase 1|Miscellaneous|0|||
105322892|NCT01962103|363181600|FG004|Phase 1|Miscellaneous|0|||
105322893|NCT01962103|363181601|FG005|Phase 1|Miscellaneous|0|||
105322894|NCT01962103|363181602|FG006|Phase 1|Miscellaneous|0|||
105322895|NCT01962103|363181603|FG007|Phase 1|Miscellaneous|0|||
105322896|NCT01962103|363181604|FG008|Phase 1|Miscellaneous|0|||
105322897|NCT01962103|363181596|FG000|Phase 2|Adverse Event|0|||
105322898|NCT01962103|363181597|FG001|Phase 2|Adverse Event|0|||
105322899|NCT01962103|363181598|FG002|Phase 2|Adverse Event|0|||
105322900|NCT01962103|363181599|FG003|Phase 2|Adverse Event|0|||
105322901|NCT01962103|363181600|FG004|Phase 2|Adverse Event|0|||
105322902|NCT01962103|363181601|FG005|Phase 2|Adverse Event|0|||
105322903|NCT01962103|363181602|FG006|Phase 2|Adverse Event|1|||
105322904|NCT01962103|363181603|FG007|Phase 2|Adverse Event|0|||
105322905|NCT01962103|363181604|FG008|Phase 2|Adverse Event|3|||
105322906|NCT01962103|363181596|FG000|Phase 2|Progressive Disease|0|||
105322907|NCT01962103|363181597|FG001|Phase 2|Progressive Disease|0|||
105371833|NCT02791269|363369216|FG000|Overall Study|Lost to Follow-up|0|||
105371834|NCT02791269|363369217|FG001|Overall Study|Lost to Follow-up|1|||
105371835|NCT01649765|363369218|FG000|Overall Study|Adverse Event|5|||
105371836|NCT01649765|363369219|FG001|Overall Study|Adverse Event|3|||
105371837|NCT01649765|363369218|FG000|Overall Study|Lack of Efficacy|1|||
105371838|NCT01649765|363369219|FG001|Overall Study|Lack of Efficacy|1|||
105371839|NCT01649765|363369218|FG000|Overall Study|Physician Decision|0|||
105322908|NCT01962103|363181598|FG002|Phase 2|Progressive Disease|0|||
105322909|NCT01962103|363181599|FG003|Phase 2|Progressive Disease|0|||
105322910|NCT01962103|363181600|FG004|Phase 2|Progressive Disease|0|||
105322911|NCT01962103|363181601|FG005|Phase 2|Progressive Disease|0|||
105322912|NCT01962103|363181602|FG006|Phase 2|Progressive Disease|11|||
105322913|NCT01962103|363181603|FG007|Phase 2|Progressive Disease|12|||
105322914|NCT01962103|363181604|FG008|Phase 2|Progressive Disease|11|||
105322915|NCT01962103|363181596|FG000|Phase 2|Symptomatic Deterioration|0|||
105322916|NCT01962103|363181597|FG001|Phase 2|Symptomatic Deterioration|0|||
105322917|NCT01962103|363181598|FG002|Phase 2|Symptomatic Deterioration|0|||
105322918|NCT01962103|363181599|FG003|Phase 2|Symptomatic Deterioration|0|||
105322919|NCT01962103|363181600|FG004|Phase 2|Symptomatic Deterioration|0|||
105371840|NCT01649765|363369219|FG001|Overall Study|Physician Decision|3|||
105371841|NCT01649765|363369218|FG000|Overall Study|Protocol Violation|1|||
105371842|NCT01649765|363369219|FG001|Overall Study|Protocol Violation|0|||
105371843|NCT01649765|363369218|FG000|Overall Study|Withdrawal by Subject|2|||
105371844|NCT01649765|363369219|FG001|Overall Study|Withdrawal by Subject|1|||
105371845|NCT03427411|363369220|FG000|Overall Study|Screen failure - platelets too low|0|||
105371846|NCT03427411|363369221|FG001|Overall Study|Screen failure - platelets too low|1|||
105371847|NCT02472405|363369222|FG000|Overall Study|Lost to Follow-up|9|||
105371848|NCT02472405|363369222|FG000|Overall Study|Adverse Event|1|||
105371849|NCT00900562|363369223|FG000|Overall Study|Progressive disease|9|||
105371850|NCT00900562|363369224|FG001|Overall Study|Progressive disease|5|||
105371851|NCT00900562|363369223|FG000|Overall Study|Toxicity|1|||
105371852|NCT00900562|363369224|FG001|Overall Study|Toxicity|0|||
105371853|NCT00900562|363369223|FG000|Overall Study|Death|1|||
105371854|NCT00900562|363369224|FG001|Overall Study|Death|1|||
105371855|NCT00900562|363369223|FG000|Overall Study|Withdrawal by Subject|0|||
105371856|NCT00900562|363369224|FG001|Overall Study|Withdrawal by Subject|1|||
105371857|NCT00900562|363369223|FG000|Overall Study|Unrelated adverse event|1|||
105371858|NCT00900562|363369224|FG001|Overall Study|Unrelated adverse event|0|||
105371859|NCT02426684|363369225|FG000|Overall Study|Physician Decision|1|||
105371860|NCT03736967|363369226|FG000|Overall Study|Withdrawal by Subject|26|||
105371861|NCT03736967|363369227|FG001|Overall Study|Withdrawal by Subject|25|||
105371862|NCT03736967|363369228|FG002|Overall Study|Withdrawal by Subject|23|||
105371863|NCT03736967|363369229|FG003|Overall Study|Withdrawal by Subject|26|||
105371864|NCT03736967|363369226|FG000|Overall Study|Lost to Follow-up|3|||
105371865|NCT03736967|363369227|FG001|Overall Study|Lost to Follow-up|2|||
105371866|NCT03736967|363369228|FG002|Overall Study|Lost to Follow-up|1|||
105371867|NCT03736967|363369229|FG003|Overall Study|Lost to Follow-up|1|||
105576860|NCT01671748|364110344|FG000|4 Week run-in Phase|Adverse Event|1|||
105371868|NCT03736967|363369226|FG000|Overall Study|Physician Decision|1|||
105371869|NCT03736967|363369227|FG001|Overall Study|Physician Decision|0|||
105371870|NCT03736967|363369228|FG002|Overall Study|Physician Decision|0|||
105371871|NCT03736967|363369229|FG003|Overall Study|Physician Decision|1|||
105371872|NCT03736967|363369226|FG000|Overall Study|Adverse Event|0|||
105371873|NCT03736967|363369227|FG001|Overall Study|Adverse Event|1|||
105371874|NCT03736967|363369228|FG002|Overall Study|Adverse Event|0|||
105371875|NCT03736967|363369229|FG003|Overall Study|Adverse Event|1|||
105371876|NCT03736967|363369226|FG000|Overall Study|Death|0|||
105371877|NCT03736967|363369227|FG001|Overall Study|Death|0|||
105371878|NCT03736967|363369228|FG002|Overall Study|Death|0|||
105371879|NCT03736967|363369229|FG003|Overall Study|Death|1|||
105851317|NCT01986010|365112677|FG001|Overall Study|Physician Decision|0|||
105851318|NCT01986010|365112678|FG002|Overall Study|Physician Decision|0|||
105851319|NCT01986010|365112679|FG003|Overall Study|Physician Decision|0|||
105851320|NCT01986010|365112680|FG004|Overall Study|Physician Decision|0|||
105851321|NCT01986010|365112681|FG005|Overall Study|Physician Decision|0|||
105851322|NCT01986010|365112682|FG006|Overall Study|Physician Decision|0|||
105851323|NCT01986010|365112683|FG007|Overall Study|Physician Decision|0|||
105851324|NCT01986010|365112684|FG008|Overall Study|Physician Decision|0|||
105851325|NCT01986010|365112685|FG009|Overall Study|Physician Decision|0|||
105851326|NCT01986010|365112686|FG010|Overall Study|Physician Decision|0|||
105851327|NCT01986010|365112687|FG011|Overall Study|Physician Decision|0|||
105851328|NCT01986010|365112688|FG012|Overall Study|Physician Decision|0|||
105851329|NCT01986010|365112689|FG013|Overall Study|Physician Decision|0|||
105851330|NCT01986010|365112690|FG014|Overall Study|Physician Decision|1|||
105851331|NCT01986010|365112691|FG015|Overall Study|Physician Decision|0|||
105851332|NCT01986010|365112692|FG016|Overall Study|Physician Decision|0|||
105851333|NCT01986010|365112676|FG000|Overall Study|Withdrawal by Subject|2|||
105851334|NCT01986010|365112677|FG001|Overall Study|Withdrawal by Subject|2|||
105851335|NCT01986010|365112678|FG002|Overall Study|Withdrawal by Subject|3|||
105851336|NCT01986010|365112679|FG003|Overall Study|Withdrawal by Subject|0|||
105851337|NCT01986010|365112680|FG004|Overall Study|Withdrawal by Subject|2|||
105851338|NCT01986010|365112681|FG005|Overall Study|Withdrawal by Subject|4|||
105851339|NCT01986010|365112682|FG006|Overall Study|Withdrawal by Subject|0|||
105851340|NCT01986010|365112683|FG007|Overall Study|Withdrawal by Subject|0|||
105851341|NCT01986010|365112684|FG008|Overall Study|Withdrawal by Subject|0|||
105371880|NCT03736967|363369226|FG000|Overall Study|Randomized but never treated|1|||
105371881|NCT03736967|363369227|FG001|Overall Study|Randomized but never treated|0|||
105371882|NCT03736967|363369228|FG002|Overall Study|Randomized but never treated|0|||
105371883|NCT03736967|363369229|FG003|Overall Study|Randomized but never treated|0|||
105371884|NCT02897349|363369230|FG000|Overall Study|Lost to Follow-up|2|||
105851342|NCT01986010|365112685|FG009|Overall Study|Withdrawal by Subject|0|||
105851343|NCT01986010|365112686|FG010|Overall Study|Withdrawal by Subject|0|||
105851344|NCT01986010|365112687|FG011|Overall Study|Withdrawal by Subject|2|||
105851345|NCT01986010|365112688|FG012|Overall Study|Withdrawal by Subject|0|||
105851346|NCT01986010|365112689|FG013|Overall Study|Withdrawal by Subject|1|||
105851347|NCT01986010|365112690|FG014|Overall Study|Withdrawal by Subject|2|||
105851348|NCT01986010|365112691|FG015|Overall Study|Withdrawal by Subject|0|||
105851349|NCT01986010|365112692|FG016|Overall Study|Withdrawal by Subject|0|||
105851350|NCT01986010|365112676|FG000|Overall Study|Status Not Recorded|2|||
105851351|NCT01986010|365112677|FG001|Overall Study|Status Not Recorded|4|||
105851352|NCT01986010|365112678|FG002|Overall Study|Status Not Recorded|2|||
105851353|NCT01986010|365112679|FG003|Overall Study|Status Not Recorded|0|||
105851354|NCT01986010|365112680|FG004|Overall Study|Status Not Recorded|1|||
105851355|NCT01986010|365112681|FG005|Overall Study|Status Not Recorded|2|||
105851356|NCT01986010|365112682|FG006|Overall Study|Status Not Recorded|0|||
105851357|NCT01986010|365112683|FG007|Overall Study|Status Not Recorded|0|||
105851358|NCT01986010|365112684|FG008|Overall Study|Status Not Recorded|2|||
105851359|NCT01986010|365112685|FG009|Overall Study|Status Not Recorded|1|||
105322920|NCT01962103|363181601|FG005|Phase 2|Symptomatic Deterioration|0|||
105322921|NCT01962103|363181602|FG006|Phase 2|Symptomatic Deterioration|2|||
105322922|NCT01962103|363181603|FG007|Phase 2|Symptomatic Deterioration|2|||
105322923|NCT01962103|363181604|FG008|Phase 2|Symptomatic Deterioration|0|||
105322924|NCT01321749|363181605|FG000|Overall Study|Lost to Follow-up|4|||
105322925|NCT01321749|363181606|FG001|Overall Study|Lost to Follow-up|11|||
105322926|NCT01321749|363181605|FG000|Overall Study|Protocol Violation|4|||
105322927|NCT01321749|363181606|FG001|Overall Study|Protocol Violation|7|||
105322928|NCT01321749|363181605|FG000|Overall Study|Withdrawal by Subject|5|||
105322929|NCT01321749|363181606|FG001|Overall Study|Withdrawal by Subject|4|||
105322930|NCT01290068|363181609|FG000|Overall Study|Adverse Event|1|||
105322931|NCT01290068|363181610|FG001|Overall Study|Adverse Event|3|||
105322932|NCT01290068|363181609|FG000|Overall Study|Lost to Follow-up|3|||
105322933|NCT01290068|363181610|FG001|Overall Study|Lost to Follow-up|0|||
105322934|NCT01290068|363181609|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
105322935|NCT01290068|363181610|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
105322936|NCT01290068|363181609|FG000|Overall Study|Other|3|||
105322937|NCT01290068|363181610|FG001|Overall Study|Other|1|||
105322938|NCT03718832|363181611|FG000|Analysis Sample|Withdrawal by Subject|18|||
105322939|NCT03718832|363181612|FG001|Analysis Sample|Withdrawal by Subject|15|||
105322940|NCT03718832|363181611|FG000|Analysis Sample|Legal hold on data|1|||
105322941|NCT03718832|363181612|FG001|Analysis Sample|Legal hold on data|0|||
105322942|NCT03718832|363181611|FG000|Analysis Sample|Participant from treated household|0|||
105322943|NCT03718832|363181612|FG001|Analysis Sample|Participant from treated household|1|||
105322944|NCT03718832|363181611|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
105322945|NCT03718832|363181612|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
105322946|NCT03375320|363181613|FG000|Overall Study|Adverse Event|34|||
105322947|NCT03375320|363181614|FG001|Overall Study|Adverse Event|9|||
105322948|NCT03375320|363181615|FG002|Overall Study|Adverse Event|10|||
105322949|NCT03375320|363181616|FG003|Overall Study|Adverse Event|0|||
105322950|NCT03375320|363181613|FG000|Overall Study|Death|6|||
105322951|NCT03375320|363181614|FG001|Overall Study|Death|3|||
105322952|NCT03375320|363181615|FG002|Overall Study|Death|0|||
105322953|NCT03375320|363181616|FG003|Overall Study|Death|0|||
105322954|NCT03375320|363181613|FG000|Overall Study|Withdrawal by Subject|7|||
105322955|NCT03375320|363181614|FG001|Overall Study|Withdrawal by Subject|4|||
105322956|NCT03375320|363181615|FG002|Overall Study|Withdrawal by Subject|5|||
105322957|NCT03375320|363181616|FG003|Overall Study|Withdrawal by Subject|4|||
105322958|NCT03375320|363181613|FG000|Overall Study|Progressive disease|55|||
105322959|NCT03375320|363181614|FG001|Overall Study|Progressive disease|41|||
105322960|NCT03375320|363181615|FG002|Overall Study|Progressive disease|29|||
105322961|NCT03375320|363181616|FG003|Overall Study|Progressive disease|24|||
105322962|NCT03375320|363181613|FG000|Overall Study|Alternative treatment|6|||
105322963|NCT03375320|363181614|FG001|Overall Study|Alternative treatment|1|||
105322964|NCT03375320|363181615|FG002|Overall Study|Alternative treatment|1|||
105322965|NCT03375320|363181616|FG003|Overall Study|Alternative treatment|0|||
105322966|NCT03375320|363181613|FG000|Overall Study|Other disease|1|||
105322967|NCT03375320|363181614|FG001|Overall Study|Other disease|1|||
105322968|NCT03375320|363181615|FG002|Overall Study|Other disease|3|||
105322969|NCT03375320|363181616|FG003|Overall Study|Other disease|0|||
105322970|NCT03375320|363181613|FG000|Overall Study|Withdrawal prior to initiation|2|||
105322971|NCT03375320|363181614|FG001|Overall Study|Withdrawal prior to initiation|2|||
105576861|NCT01671748|364110345|FG001|4 Week run-in Phase|Adverse Event|0|||
105322972|NCT03375320|363181615|FG002|Overall Study|Withdrawal prior to initiation|1|||
105322973|NCT03375320|363181616|FG003|Overall Study|Withdrawal prior to initiation|0|||
105322974|NCT03375320|363181613|FG000|Overall Study|Physician Decision|1|||
105322975|NCT03375320|363181614|FG001|Overall Study|Physician Decision|1|||
105322976|NCT03375320|363181615|FG002|Overall Study|Physician Decision|1|||
105322977|NCT03375320|363181616|FG003|Overall Study|Physician Decision|1|||
105322978|NCT03375320|363181613|FG000|Overall Study|Non-compliance|1|||
105322979|NCT03375320|363181614|FG001|Overall Study|Non-compliance|0|||
105322980|NCT03375320|363181615|FG002|Overall Study|Non-compliance|0|||
105322981|NCT03375320|363181616|FG003|Overall Study|Non-compliance|0|||
105576862|NCT01671748|364110344|FG000|4 Week run-in Phase|Not eligible|9|||
105322982|NCT01866826|363181617|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
105322983|NCT01866826|363181618|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
105851360|NCT01986010|365112686|FG010|Overall Study|Status Not Recorded|7|||
105851361|NCT01986010|365112687|FG011|Overall Study|Status Not Recorded|7|||
105322984|NCT01866826|363181617|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
105322985|NCT01866826|363181618|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
105322986|NCT01866826|363181617|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
105322987|NCT01866826|363181618|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
105322988|NCT02288312|363181619|FG000|Overall Study|Pregnancy|1|||
105322989|NCT02288312|363181620|FG001|Overall Study|Pregnancy|0|||
105322990|NCT02288312|363181621|FG002|Overall Study|Pregnancy|0|||
105322991|NCT00742209|363181624|FG000|Overall Study|Adverse Event|11|||
105322992|NCT00742209|363181625|FG001|Overall Study|Adverse Event|4|||
105322993|NCT00742209|363181626|FG002|Overall Study|Adverse Event|17|||
105322994|NCT00742209|363181627|FG003|Overall Study|Adverse Event|16|||
105322995|NCT00742209|363181628|FG004|Overall Study|Adverse Event|13|||
105322996|NCT00742209|363181624|FG000|Overall Study|Participant Withdrew Consent|8|||
105322997|NCT00742209|363181625|FG001|Overall Study|Participant Withdrew Consent|4|||
105322998|NCT00742209|363181626|FG002|Overall Study|Participant Withdrew Consent|14|||
105322999|NCT00742209|363181627|FG003|Overall Study|Participant Withdrew Consent|7|||
105323000|NCT00742209|363181628|FG004|Overall Study|Participant Withdrew Consent|4|||
105323001|NCT00742209|363181624|FG000|Overall Study|Protocol Violation|6|||
105323002|NCT00742209|363181625|FG001|Overall Study|Protocol Violation|5|||
105323003|NCT00742209|363181626|FG002|Overall Study|Protocol Violation|4|||
105323004|NCT00742209|363181627|FG003|Overall Study|Protocol Violation|5|||
105323005|NCT00742209|363181628|FG004|Overall Study|Protocol Violation|3|||
105323006|NCT00742209|363181624|FG000|Overall Study|Lost to Follow-up|3|||
105323007|NCT00742209|363181625|FG001|Overall Study|Lost to Follow-up|4|||
105323008|NCT00742209|363181626|FG002|Overall Study|Lost to Follow-up|5|||
105323009|NCT00742209|363181627|FG003|Overall Study|Lost to Follow-up|5|||
105323010|NCT00742209|363181628|FG004|Overall Study|Lost to Follow-up|3|||
105323011|NCT00742209|363181624|FG000|Overall Study|Lack of Efficacy|6|||
105323012|NCT00742209|363181625|FG001|Overall Study|Lack of Efficacy|1|||
105323013|NCT00742209|363181626|FG002|Overall Study|Lack of Efficacy|1|||
105323014|NCT00742209|363181627|FG003|Overall Study|Lack of Efficacy|3|||
105323015|NCT00742209|363181628|FG004|Overall Study|Lack of Efficacy|1|||
105323016|NCT00742209|363181624|FG000|Overall Study|Investigator Discretion|0|||
105323017|NCT00742209|363181625|FG001|Overall Study|Investigator Discretion|0|||
105323018|NCT00742209|363181626|FG002|Overall Study|Investigator Discretion|5|||
105323019|NCT00742209|363181627|FG003|Overall Study|Investigator Discretion|1|||
105323020|NCT00742209|363181628|FG004|Overall Study|Investigator Discretion|1|||
105323021|NCT00725491|363181629|FG000|Overall Study|Adverse Event|3|||
105323022|NCT00725491|363181630|FG001|Overall Study|Adverse Event|2|||
105323023|NCT00725491|363181629|FG000|Overall Study|Pregnancy|0|||
105323024|NCT00725491|363181630|FG001|Overall Study|Pregnancy|3|||
105323025|NCT00725491|363181629|FG000|Overall Study|Risk for hyperstimulation|2|||
105323026|NCT00725491|363181630|FG001|Overall Study|Risk for hyperstimulation|9|||
105323027|NCT00725491|363181629|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
105323028|NCT00725491|363181630|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
105323029|NCT00725491|363181629|FG000|Overall Study|Fertilization failure|0|||
105323030|NCT00725491|363181630|FG001|Overall Study|Fertilization failure|1|||
105323031|NCT00725491|363181629|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
105323032|NCT00725491|363181630|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
105323033|NCT01495000|363181635|FG000|Overall Study|Lost to Follow-up|2|||
105323034|NCT01495000|363181636|FG001|Overall Study|Lost to Follow-up|2|||
105323035|NCT01495000|363181635|FG000|Overall Study|Protocol Violation|1|||
105323036|NCT01495000|363181636|FG001|Overall Study|Protocol Violation|0|||
105323037|NCT01495000|363181635|FG000|Overall Study|Withdrawal by Subject|10|||
105323038|NCT01495000|363181636|FG001|Overall Study|Withdrawal by Subject|10|||
105323039|NCT01431079|363181637|FG000|Overall Study|Lost to Follow-up|35|||
105323040|NCT01431079|363181638|FG001|Overall Study|Lost to Follow-up|39|||
105323041|NCT02968576|363181639|FG000|Overall Study|Pregnancy|0|||
105323042|NCT02968576|363181640|FG001|Overall Study|Pregnancy|1|||
105323043|NCT03345420|363181643|FG000|Overall Study|Withdrawal by Subject|1|||
105323044|NCT04688671|363181647|FG000|Overall Study|Adverse Event|3|||
105323045|NCT04688671|363181648|FG001|Overall Study|Adverse Event|1|||
105323046|NCT04688671|363181647|FG000|Overall Study|Withdrawal by Subject|3|||
105323047|NCT04688671|363181648|FG001|Overall Study|Withdrawal by Subject|1|||
105323048|NCT04688671|363181647|FG000|Overall Study|Lack of Efficacy|1|||
105323049|NCT04688671|363181648|FG001|Overall Study|Lack of Efficacy|1|||
105371885|NCT02897349|363369231|FG001|Overall Study|Lost to Follow-up|2|||
105371886|NCT02897349|363369230|FG000|Overall Study|Adverse Event|3|||
105323050|NCT04688671|363181647|FG000|Overall Study|Protocol Violation|1|||
105323051|NCT04688671|363181648|FG001|Overall Study|Protocol Violation|0|||
105323052|NCT04688671|363181647|FG000|Overall Study|Lost to Follow-up|0|||
105323053|NCT04688671|363181648|FG001|Overall Study|Lost to Follow-up|1|||
105323054|NCT03359850|363181653|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
105323055|NCT03359850|363181654|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
105323056|NCT03359850|363181653|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
105323057|NCT03359850|363181654|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
105323058|NCT03359850|363181653|FG000|Extension Phase (Up to 28 Months)|Death|2|||
105371887|NCT02897349|363369231|FG001|Overall Study|Adverse Event|3|||
105323059|NCT03359850|363181654|FG001|Extension Phase (Up to 28 Months)|Death|4|||
105323060|NCT03359850|363181653|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
105323061|NCT03359850|363181654|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
105323062|NCT03359850|363181653|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
105323063|NCT03359850|363181654|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
105323064|NCT00942357|363181670|FG000|Overall Study|Ineligible|37|||
105323065|NCT00942357|363181671|FG001|Overall Study|Ineligible|40|||
105323066|NCT02002221|363181674|FG000|Overall Study|Adverse Event|2|||
105323067|NCT02002221|363181675|FG001|Overall Study|Adverse Event|1|||
105323068|NCT02002221|363181674|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105323069|NCT02002221|363181675|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105323070|NCT02002221|363181674|FG000|Overall Study|Patient withdrew consent|0|||
105323071|NCT02002221|363181675|FG001|Overall Study|Patient withdrew consent|1|||
105323072|NCT03749330|363181679|FG000|Overall Study|Clinicians left work in the CICU|0|||
105323073|NCT03749330|363181680|FG001|Overall Study|Clinicians left work in the CICU|2|||
105323074|NCT03749330|363181681|FG002|Overall Study|Clinicians left work in the CICU|0|||
105323075|NCT03749330|363181682|FG003|Overall Study|Clinicians left work in the CICU|0|||
105323076|NCT03749330|363181683|FG004|Overall Study|Clinicians left work in the CICU|0|||
105323077|NCT03749330|363181684|FG005|Overall Study|Clinicians left work in the CICU|0|||
105323078|NCT01973439|363181685|FG000|Overall Study|Lost samples from one PK Day|2|||
105323079|NCT01973439|363181685|FG000|Overall Study|Vomiting after commencing once daily|1|||
105323080|NCT01973439|363181685|FG000|Overall Study|PK curve incomplete|2|||
105323081|NCT02262325|363181690|FG000|Overall Study|Death|16|||
105323082|NCT02262325|363181690|FG000|Overall Study|Lost to Follow-up|1|||
105323083|NCT01071915|363181694|FG000|Overall Study|Adverse Event|3|||
105323084|NCT01071915|363181694|FG000|Overall Study|Physician Decision|2|||
105323085|NCT01071915|363181694|FG000|Overall Study|Withdrawal by Subject|2|||
105323086|NCT01071915|363181694|FG000|Overall Study|Miscellaneous Reasons|2|||
105323087|NCT01518322|363181696|FG000|Overall Study|FeNO measurement was missing|13|||
105323088|NCT03571828|363181697|FG000|Overall Study|Withdrawal by Subject|1|||
105323089|NCT03571828|363181698|FG001|Overall Study|Withdrawal by Subject|0|||
105323090|NCT03571828|363181697|FG000|Overall Study|Decision by sponsor|5|||
105323091|NCT03571828|363181698|FG001|Overall Study|Decision by sponsor|1|||
105323092|NCT03571828|363181697|FG000|Overall Study|Death|2|||
105323093|NCT03571828|363181698|FG001|Overall Study|Death|0|||
105323094|NCT00245466|363181699|FG000|Overall Study|Adverse Event|2|||
105323095|NCT00245466|363181700|FG001|Overall Study|Adverse Event|8|||
105323096|NCT00245466|363181701|FG002|Overall Study|Adverse Event|4|||
105323097|NCT00245466|363181699|FG000|Overall Study|Low prostate specific antigen suppr|16|||
105323098|NCT00245466|363181700|FG001|Overall Study|Low prostate specific antigen suppr|14|||
105323099|NCT00245466|363181701|FG002|Overall Study|Low prostate specific antigen suppr|5|||
105323100|NCT00245466|363181699|FG000|Overall Study|Insufficient testosterone suppr|12|||
105323101|NCT00245466|363181700|FG001|Overall Study|Insufficient testosterone suppr|12|||
105323102|NCT00245466|363181701|FG002|Overall Study|Insufficient testosterone suppr|21|||
105323103|NCT00245466|363181699|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
105323104|NCT00245466|363181700|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
105323105|NCT00245466|363181701|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
105323106|NCT00245466|363181699|FG000|Overall Study|Withdrawal by Subject|2|||
105323107|NCT00245466|363181700|FG001|Overall Study|Withdrawal by Subject|2|||
105323108|NCT00245466|363181701|FG002|Overall Study|Withdrawal by Subject|1|||
105323109|NCT00245466|363181699|FG000|Overall Study|Lost to Follow-up|3|||
105323110|NCT00245466|363181700|FG001|Overall Study|Lost to Follow-up|0|||
105323111|NCT00245466|363181701|FG002|Overall Study|Lost to Follow-up|0|||
105323112|NCT00245466|363181699|FG000|Overall Study|Disease progression|0|||
105323113|NCT00245466|363181700|FG001|Overall Study|Disease progression|3|||
105323114|NCT00245466|363181701|FG002|Overall Study|Disease progression|1|||
105323115|NCT00245466|363181699|FG000|Overall Study|Protocol Violation|1|||
105323116|NCT00245466|363181700|FG001|Overall Study|Protocol Violation|2|||
105323117|NCT00245466|363181701|FG002|Overall Study|Protocol Violation|2|||
105323118|NCT00245466|363181699|FG000|Overall Study|Death|0|||
105323119|NCT00245466|363181700|FG001|Overall Study|Death|2|||
105323120|NCT00245466|363181701|FG002|Overall Study|Death|0|||
105323121|NCT00245466|363181699|FG000|Overall Study|Administrative reasons|0|||
105323122|NCT00245466|363181700|FG001|Overall Study|Administrative reasons|1|||
105323123|NCT00245466|363181701|FG002|Overall Study|Administrative reasons|0|||
105323124|NCT05064397|363181702|FG000|Overall Study|Adverse Event|4|||
105323125|NCT05064397|363181702|FG000|Overall Study|Lack of Efficacy|12|||
105323126|NCT05064397|363181702|FG000|Overall Study|Withdrawal by Subject|3|||
105323127|NCT05064397|363181702|FG000|Overall Study|Lost to Follow-up|1|||
105323128|NCT05064397|363181702|FG000|Overall Study|Other reasons|3|||
105323129|NCT01958437|363181703|FG000|Overall Study|Incidental MRI findings|0|||
105323130|NCT01958437|363181704|FG001|Overall Study|Incidental MRI findings|0|||
105323131|NCT01958437|363181705|FG002|Overall Study|Incidental MRI findings|1|||
105323132|NCT01958437|363181706|FG003|Overall Study|Incidental MRI findings|1|||
105323133|NCT01928472|363181709|FG000|Overall Study|Death|0|||
105323134|NCT01928472|363181710|FG001|Overall Study|Death|0|||
105491657|NCT00566501|363812532|FG000|Overall Study|Protocol Violation|2|||
105491658|NCT00566501|363812533|FG001|Overall Study|Protocol Violation|2|||
105491659|NCT00566501|363812532|FG000|Overall Study|Request of Investigator or Sponsor|6|||
105491660|NCT00566501|363812533|FG001|Overall Study|Request of Investigator or Sponsor|7|||
105851362|NCT01986010|365112688|FG012|Overall Study|Status Not Recorded|9|||
105323135|NCT01928472|363181711|FG002|Overall Study|Death|1|||
105323136|NCT01928472|363181712|FG003|Overall Study|Death|0|||
105323137|NCT01928472|363181709|FG000|Overall Study|Withdrawal by Subject|4|||
105323138|NCT01928472|363181710|FG001|Overall Study|Withdrawal by Subject|4|||
105323139|NCT01928472|363181711|FG002|Overall Study|Withdrawal by Subject|1|||
105323140|NCT01928472|363181712|FG003|Overall Study|Withdrawal by Subject|2|||
105323141|NCT01928472|363181709|FG000|Overall Study|Lost to Follow-up|2|||
105323142|NCT01928472|363181710|FG001|Overall Study|Lost to Follow-up|3|||
105323143|NCT01928472|363181711|FG002|Overall Study|Lost to Follow-up|4|||
105323144|NCT01928472|363181712|FG003|Overall Study|Lost to Follow-up|0|||
105323145|NCT01928472|363181709|FG000|Overall Study|Administrative Reason|2|||
105323146|NCT01928472|363181710|FG001|Overall Study|Administrative Reason|1|||
105323147|NCT01928472|363181711|FG002|Overall Study|Administrative Reason|0|||
105323148|NCT01928472|363181712|FG003|Overall Study|Administrative Reason|0|||
105323149|NCT01928472|363181709|FG000|Overall Study|Unclassified|0|||
105323150|NCT01928472|363181710|FG001|Overall Study|Unclassified|0|||
105323151|NCT01928472|363181711|FG002|Overall Study|Unclassified|1|||
105323152|NCT01928472|363181712|FG003|Overall Study|Unclassified|0|||
105323153|NCT06481709|363181714|FG000|Overall Study|Withdrawal by Subject|0|||
105323154|NCT06481709|363181715|FG001|Overall Study|Withdrawal by Subject|0|||
105323155|NCT06481709|363181716|FG002|Overall Study|Withdrawal by Subject|2|||
105323156|NCT06481709|363181717|FG003|Overall Study|Withdrawal by Subject|0|||
105323157|NCT00948155|363181718|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
105323158|NCT00948155|363181719|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
105323159|NCT00948155|363181718|FG000|Washout 14 Days|Lost to Follow-up|1|||
105323160|NCT00948155|363181719|FG001|Washout 14 Days|Lost to Follow-up|2|||
105323161|NCT03473925|363181723|FG000|Overall Study|Death|48|||
105323162|NCT03473925|363181724|FG001|Overall Study|Death|44|||
105323163|NCT03473925|363181723|FG000|Overall Study|Sponsor Decision|2|||
105323164|NCT03473925|363181724|FG001|Overall Study|Sponsor Decision|7|||
105323165|NCT03473925|363181723|FG000|Overall Study|Withdrawal by Subject|1|||
105323166|NCT03473925|363181724|FG001|Overall Study|Withdrawal by Subject|3|||
105323167|NCT03473925|363181723|FG000|Overall Study|Not Treated|1|||
105323168|NCT03473925|363181724|FG001|Overall Study|Not Treated|1|||
105323169|NCT05198518|363181729|FG000|Screening Visit|Deemed unable to participate|58|||
105323170|NCT05198518|363181730|FG001|Screening Visit|Deemed unable to participate|0|||
105323171|NCT05198518|363181731|FG002|Screening Visit|Deemed unable to participate|0|||
105323172|NCT02224157|363181732|FG000|Overall Study|Severe non-compliance to protocol|2|||
105323173|NCT02224157|363181733|FG001|Overall Study|Severe non-compliance to protocol|2|||
105323174|NCT02224157|363181732|FG000|Overall Study|Other|13|||
105323175|NCT02224157|363181733|FG001|Overall Study|Other|10|||
105323176|NCT02224157|363181732|FG000|Overall Study|Subject decision|58|||
105323177|NCT02224157|363181733|FG001|Overall Study|Subject decision|50|||
105323178|NCT02224157|363181732|FG000|Overall Study|Prematurely closed site|4|||
105323179|NCT02224157|363181733|FG001|Overall Study|Prematurely closed site|2|||
105323180|NCT02224157|363181732|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
105323181|NCT02224157|363181733|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
105323182|NCT02224157|363181732|FG000|Overall Study|Lost to Follow-up|27|||
105323183|NCT02224157|363181733|FG001|Overall Study|Lost to Follow-up|35|||
105323184|NCT02224157|363181732|FG000|Overall Study|Death|1|||
105323185|NCT02224157|363181733|FG001|Overall Study|Death|1|||
105323186|NCT02224157|363181732|FG000|Overall Study|Adverse Event|1|||
105323187|NCT02224157|363181733|FG001|Overall Study|Adverse Event|3|||
105323188|NCT02766335|363181736|FG000|Initial Registration|Adverse Event|6|||
105323189|NCT02766335|363181737|FG001|Initial Registration|Adverse Event|3|||
105323190|NCT02766335|363181738|FG002|Initial Registration|Adverse Event|0|||
105323191|NCT02766335|363181736|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
105323192|NCT02766335|363181737|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
105323193|NCT02766335|363181738|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
105323194|NCT02766335|363181736|FG000|Initial Registration|Progression/relapse|49|||
105323195|NCT02766335|363181737|FG001|Initial Registration|Progression/relapse|15|||
105323196|NCT02766335|363181738|FG002|Initial Registration|Progression/relapse|0|||
105323197|NCT02766335|363181736|FG000|Initial Registration|Death|1|||
105323198|NCT02766335|363181737|FG001|Initial Registration|Death|3|||
105323199|NCT02766335|363181738|FG002|Initial Registration|Death|0|||
105323200|NCT02766335|363181736|FG000|Initial Registration|not protocol specified|1|||
105323201|NCT02766335|363181737|FG001|Initial Registration|not protocol specified|9|||
105323202|NCT02766335|363181738|FG002|Initial Registration|not protocol specified|0|||
105323203|NCT02766335|363181736|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
105323204|NCT02766335|363181737|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
105323205|NCT02766335|363181738|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
105323206|NCT02766335|363181736|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
105323207|NCT02766335|363181737|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
105323208|NCT02766335|363181738|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
105323209|NCT01176513|363181746|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
105323210|NCT02286843|363181747|FG000|Overall Study|Not Treated|4|||
105323211|NCT02286843|363181747|FG000|Overall Study|Protocol Violation|1|||
105323212|NCT02286843|363181747|FG000|Overall Study|Withdrawal by Subject|1|||
105323213|NCT00613171|363181748|FG000|Overall Study|Adverse Event|7|||
105323214|NCT00613171|363181748|FG000|Overall Study|Withdrawal by Subject|3|||
105323215|NCT00613171|363181748|FG000|Overall Study|Reason not Specified|4|||
105323216|NCT01526057|363181749|FG000|Overall Study|Withdrawal by Subject|3|||
105323217|NCT01526057|363181750|FG001|Overall Study|Withdrawal by Subject|2|||
105323218|NCT01526057|363181751|FG002|Overall Study|Withdrawal by Subject|2|||
105323219|NCT01526057|363181749|FG000|Overall Study|Adverse Event|3|||
105323220|NCT01526057|363181750|FG001|Overall Study|Adverse Event|1|||
105323221|NCT01526057|363181751|FG002|Overall Study|Adverse Event|1|||
105323222|NCT01526057|363181749|FG000|Overall Study|Death|1|||
105323223|NCT01526057|363181750|FG001|Overall Study|Death|0|||
105323224|NCT01526057|363181751|FG002|Overall Study|Death|0|||
105323225|NCT01526057|363181749|FG000|Overall Study|Lost to Follow-up|1|||
105323226|NCT01526057|363181750|FG001|Overall Study|Lost to Follow-up|0|||
105323227|NCT01526057|363181751|FG002|Overall Study|Lost to Follow-up|1|||
105323228|NCT01526057|363181749|FG000|Overall Study|Other|1|||
105323229|NCT01526057|363181750|FG001|Overall Study|Other|0|||
105323230|NCT01526057|363181751|FG002|Overall Study|Other|1|||
105323231|NCT01526057|363181749|FG000|Overall Study|Protocol Violation|0|||
105323232|NCT01526057|363181750|FG001|Overall Study|Protocol Violation|0|||
105323233|NCT01526057|363181751|FG002|Overall Study|Protocol Violation|1|||
105323234|NCT01169350|363181752|FG000|Overall Study|Physician Decision|3|||
105323235|NCT01169350|363181752|FG000|Overall Study|Lost to Follow-up|2|||
105323236|NCT04871776|363181755|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
105323237|NCT04871776|363181756|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
105323238|NCT04871776|363181757|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
105323239|NCT04871776|363181755|FG000|Overall Study|Did not meet eligibility criteria|1|||
105323240|NCT04871776|363181756|FG001|Overall Study|Did not meet eligibility criteria|1|||
105323241|NCT04871776|363181757|FG002|Overall Study|Did not meet eligibility criteria|1|||
105323242|NCT05620082|363181759|FG000|Overall Study|Discharged before study end|1|||
105323243|NCT05620082|363181760|FG001|Overall Study|Discharged before study end|4|||
105323244|NCT05620082|363181761|FG002|Overall Study|Discharged before study end|0|||
105323245|NCT05620082|363181759|FG000|Overall Study|Moved to a different ward|1|||
105323246|NCT05620082|363181760|FG001|Overall Study|Moved to a different ward|0|||
105323247|NCT05620082|363181761|FG002|Overall Study|Moved to a different ward|0|||
105323248|NCT05620082|363181759|FG000|Overall Study|Feeling too unwell|1|||
105323249|NCT05620082|363181760|FG001|Overall Study|Feeling too unwell|0|||
105323250|NCT05620082|363181761|FG002|Overall Study|Feeling too unwell|0|||
105323251|NCT01368497|363183005|FG000|Overall Study|Lost to Follow-up|2|||
105323252|NCT02762929|363183006|FG000|Overall Study|Adverse Event|0|||
105323253|NCT02762929|363183007|FG001|Overall Study|Adverse Event|0|||
105323254|NCT02762929|363183008|FG002|Overall Study|Adverse Event|0|||
105323255|NCT02762929|363183009|FG003|Overall Study|Adverse Event|1|||
105323256|NCT02762929|363183010|FG004|Overall Study|Adverse Event|0|||
105323257|NCT02762929|363183011|FG005|Overall Study|Adverse Event|0|||
105323258|NCT02762929|363183006|FG000|Overall Study|Lost to Follow-up|1|||
105323259|NCT02762929|363183007|FG001|Overall Study|Lost to Follow-up|2|||
105323260|NCT02762929|363183008|FG002|Overall Study|Lost to Follow-up|0|||
105371888|NCT02897349|363369230|FG000|Overall Study|Other than listed above|0|||
105371889|NCT02897349|363369231|FG001|Overall Study|Other than listed above|1|||
105323261|NCT02762929|363183009|FG003|Overall Study|Lost to Follow-up|1|||
105323262|NCT02762929|363183010|FG004|Overall Study|Lost to Follow-up|0|||
105323263|NCT02762929|363183011|FG005|Overall Study|Lost to Follow-up|0|||
105323264|NCT02762929|363183006|FG000|Overall Study|Withdrawal by Subject|0|||
105323265|NCT02762929|363183007|FG001|Overall Study|Withdrawal by Subject|1|||
105323266|NCT02762929|363183008|FG002|Overall Study|Withdrawal by Subject|0|||
105323267|NCT02762929|363183009|FG003|Overall Study|Withdrawal by Subject|0|||
105323268|NCT02762929|363183010|FG004|Overall Study|Withdrawal by Subject|0|||
105323269|NCT02762929|363183011|FG005|Overall Study|Withdrawal by Subject|0|||
105323270|NCT02762929|363183006|FG000|Overall Study|exclusionary medication disclosed late|0|||
105323271|NCT02762929|363183007|FG001|Overall Study|exclusionary medication disclosed late|0|||
105323272|NCT02762929|363183008|FG002|Overall Study|exclusionary medication disclosed late|0|||
105323273|NCT02762929|363183009|FG003|Overall Study|exclusionary medication disclosed late|1|||
105371890|NCT03817528|363369232|FG000|Overall Study|Withdrawal by Subject|1|||
105323274|NCT02762929|363183010|FG004|Overall Study|exclusionary medication disclosed late|0|||
105323275|NCT02762929|363183011|FG005|Overall Study|exclusionary medication disclosed late|0|||
105323276|NCT00118157|363183012|FG000|Overall Study|Adverse Event|2|||
105323277|NCT00118157|363183012|FG000|Overall Study|Death|8|||
105323278|NCT00118157|363183012|FG000|Overall Study|Withdrawal by Subject|2|||
105323279|NCT02656303|363183013|FG000|Overall Study|Adverse Event|3|||
105323280|NCT02656303|363183014|FG001|Overall Study|Adverse Event|2|||
105323281|NCT02656303|363183015|FG002|Overall Study|Adverse Event|0|||
105323282|NCT02656303|363183013|FG000|Overall Study|Death|12|||
105323283|NCT02656303|363183014|FG001|Overall Study|Death|4|||
105323284|NCT02656303|363183015|FG002|Overall Study|Death|1|||
105323285|NCT02656303|363183013|FG000|Overall Study|Lack of Efficacy|1|||
105323286|NCT02656303|363183014|FG001|Overall Study|Lack of Efficacy|0|||
105323287|NCT02656303|363183015|FG002|Overall Study|Lack of Efficacy|0|||
105323288|NCT02656303|363183013|FG000|Overall Study|Non-Compliance with Study|1|||
105323289|NCT02656303|363183014|FG001|Overall Study|Non-Compliance with Study|1|||
105323290|NCT02656303|363183015|FG002|Overall Study|Non-Compliance with Study|0|||
105323291|NCT02656303|363183013|FG000|Overall Study|Investigator Decision|2|||
105323292|NCT02656303|363183014|FG001|Overall Study|Investigator Decision|1|||
105323293|NCT02656303|363183015|FG002|Overall Study|Investigator Decision|0|||
105323294|NCT02656303|363183013|FG000|Overall Study|Progressive Disease|25|||
105371891|NCT03817528|363369232|FG000|Overall Study|Adverse Event|2|||
105371892|NCT02349386|363369233|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
105371893|NCT02349386|363369234|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
105371894|NCT02349386|363369235|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
105371895|NCT02349386|363369236|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
105371896|NCT02349386|363369233|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
105371897|NCT02349386|363369234|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
105371898|NCT02349386|363369235|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
105371899|NCT02349386|363369236|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
105371900|NCT02349386|363369233|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
105371901|NCT02349386|363369234|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
105371902|NCT02349386|363369235|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
105371903|NCT02349386|363369236|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
105371904|NCT02349386|363369233|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
105371905|NCT02349386|363369234|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
105371906|NCT02349386|363369235|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
105371907|NCT02349386|363369236|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
105371908|NCT02349386|363369233|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
105371909|NCT02349386|363369234|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
105371910|NCT02349386|363369235|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
105371911|NCT02349386|363369236|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
105371912|NCT02349386|363369233|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
105371913|NCT02349386|363369234|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
105371914|NCT02349386|363369235|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
105371915|NCT02349386|363369236|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
105371916|NCT01712178|363369239|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
105371917|NCT01712178|363369240|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
105371918|NCT01712178|363369239|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
105371919|NCT01712178|363369240|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
105371920|NCT01712178|363369239|FG000|Overall Study|Lost to Follow-up|0|||
105371921|NCT01712178|363369240|FG001|Overall Study|Lost to Follow-up|1|||
105371922|NCT00091819|363369241|FG000|Overall Study|Adverse Event|1|||
105371923|NCT00091819|363369242|FG001|Overall Study|Adverse Event|1|||
105371924|NCT00091819|363369241|FG000|Overall Study|Death|4|||
105371925|NCT00091819|363369242|FG001|Overall Study|Death|5|||
105371926|NCT00091819|363369241|FG000|Overall Study|Lost to Follow-up|26|||
105371927|NCT00091819|363369242|FG001|Overall Study|Lost to Follow-up|23|||
105371928|NCT00091819|363369241|FG000|Overall Study|Withdrawal by Subject|5|||
105371929|NCT00091819|363369242|FG001|Overall Study|Withdrawal by Subject|8|||
105371930|NCT00091819|363369241|FG000|Overall Study|Protocol Violation|1|||
105371931|NCT00091819|363369242|FG001|Overall Study|Protocol Violation|2|||
105371932|NCT00091819|363369241|FG000|Overall Study|Other|2|||
105371933|NCT00091819|363369242|FG001|Overall Study|Other|3|||
105371934|NCT00091819|363369241|FG000|Overall Study|Never received study treatment|3|||
105371935|NCT00091819|363369242|FG001|Overall Study|Never received study treatment|4|||
105371936|NCT02471339|363369243|FG000|Overall Study|Did not provide follow-up data|2|||
105371937|NCT02471339|363369244|FG001|Overall Study|Did not provide follow-up data|0|||
105323295|NCT02656303|363183014|FG001|Overall Study|Progressive Disease|14|||
105323296|NCT02656303|363183015|FG002|Overall Study|Progressive Disease|10|||
105323297|NCT02656303|363183013|FG000|Overall Study|Study Terminated by Sponsor|20|||
105323298|NCT02656303|363183014|FG001|Overall Study|Study Terminated by Sponsor|7|||
105323299|NCT02656303|363183015|FG002|Overall Study|Study Terminated by Sponsor|5|||
105323300|NCT02656303|363183013|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
105323301|NCT02656303|363183014|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
105323302|NCT02656303|363183015|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
105323303|NCT02656303|363183013|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
105323304|NCT02656303|363183014|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
105323305|NCT02656303|363183015|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
105323306|NCT02656303|363183013|FG000|Overall Study|Reason not Specified|1|||
105323307|NCT02656303|363183014|FG001|Overall Study|Reason not Specified|1|||
105323308|NCT02656303|363183015|FG002|Overall Study|Reason not Specified|2|||
105323309|NCT05989672|363183018|FG000|Overall Study|Adverse Event|3|||
105323310|NCT05989672|363183019|FG001|Overall Study|Adverse Event|0|||
105323311|NCT05989672|363183020|FG002|Overall Study|Adverse Event|0|||
105323312|NCT00696423|363183021|FG000|Overall Study|Lost to Follow-up|0|||
105323313|NCT00696423|363183022|FG001|Overall Study|Lost to Follow-up|5|||
105323314|NCT00443729|363183023|FG000|Overall Study|Never Treated|0|||
105323315|NCT00443729|363183024|FG001|Overall Study|Never Treated|1|||
105323316|NCT00443729|363183023|FG000|Overall Study|Lack of Efficacy|4|||
105323317|NCT00443729|363183024|FG001|Overall Study|Lack of Efficacy|2|||
105323318|NCT00443729|363183023|FG000|Overall Study|Lost to Follow-up|0|||
105851363|NCT01986010|365112689|FG013|Overall Study|Status Not Recorded|9|||
105851364|NCT01986010|365112690|FG014|Overall Study|Status Not Recorded|5|||
105851365|NCT01986010|365112691|FG015|Overall Study|Status Not Recorded|10|||
105371938|NCT03451071|363369249|FG000|First Vaccine|Withdrawal by Subject|1|||
105371939|NCT03451071|363369249|FG000|Second Vaccine|Lost to Follow-up|19|||
105371940|NCT03451071|363369249|FG000|Third Vaccine|Lost to Follow-up|22|||
105371941|NCT03451071|363369249|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
105371942|NCT03363906|363369250|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
105371943|NCT03363906|363369251|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
105371944|NCT03363906|363369250|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
105371945|NCT03363906|363369251|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
105371946|NCT03363906|363369250|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
105371947|NCT03363906|363369251|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
105323319|NCT00443729|363183024|FG001|Overall Study|Lost to Follow-up|1|||
105323320|NCT00443729|363183023|FG000|Overall Study|Physician Decision|2|||
105323321|NCT00443729|363183024|FG001|Overall Study|Physician Decision|1|||
105323322|NCT00443729|363183023|FG000|Overall Study|Protocol Violation|1|||
105323323|NCT00443729|363183024|FG001|Overall Study|Protocol Violation|1|||
105323324|NCT00443729|363183023|FG000|Overall Study|Withdrawal by Subject|3|||
105323325|NCT00443729|363183024|FG001|Overall Study|Withdrawal by Subject|1|||
105323326|NCT00086684|363183028|FG000|Overall Study|Adverse Event|12|||
105323327|NCT00086684|363183029|FG001|Overall Study|Adverse Event|17|||
105323328|NCT00086684|363183030|FG002|Overall Study|Adverse Event|14|||
105323329|NCT00086684|363183028|FG000|Overall Study|Lack of Efficacy|6|||
105323330|NCT00086684|363183029|FG001|Overall Study|Lack of Efficacy|6|||
105323331|NCT00086684|363183030|FG002|Overall Study|Lack of Efficacy|5|||
105323332|NCT00086684|363183028|FG000|Overall Study|Lost to Follow-up|15|||
105323333|NCT00086684|363183029|FG001|Overall Study|Lost to Follow-up|8|||
105323334|NCT00086684|363183030|FG002|Overall Study|Lost to Follow-up|10|||
105323335|NCT00086684|363183028|FG000|Overall Study|Protocol Violation|8|||
105323336|NCT00086684|363183029|FG001|Overall Study|Protocol Violation|3|||
105323337|NCT00086684|363183030|FG002|Overall Study|Protocol Violation|0|||
105323338|NCT00086684|363183028|FG000|Overall Study|Withdrawal by Subject|0|||
105323339|NCT00086684|363183029|FG001|Overall Study|Withdrawal by Subject|4|||
105323340|NCT00086684|363183030|FG002|Overall Study|Withdrawal by Subject|10|||
105323341|NCT00086684|363183028|FG000|Overall Study|NONCOMPLIANCE|5|||
105323342|NCT00086684|363183029|FG001|Overall Study|NONCOMPLIANCE|7|||
105323343|NCT00086684|363183030|FG002|Overall Study|NONCOMPLIANCE|6|||
105323344|NCT00086684|363183028|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105323345|NCT00086684|363183029|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
105323346|NCT00086684|363183030|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105323347|NCT00086684|363183028|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
105323348|NCT00086684|363183029|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
105323349|NCT00086684|363183030|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
105323350|NCT00086684|363183028|FG000|Overall Study|Other|4|||
105323351|NCT00086684|363183029|FG001|Overall Study|Other|2|||
105323352|NCT00086684|363183030|FG002|Overall Study|Other|3|||
105323353|NCT00654095|363183031|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
105323354|NCT00654095|363183031|FG000|Overall Study|Elevated triglyceride level (2)|1|||
105323355|NCT00654095|363183031|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
105323356|NCT00654095|363183031|FG000|Overall Study|Adverse Event|11|||
105323357|NCT00654095|363183031|FG000|Overall Study|Withdrawal by Subject|5|||
105323358|NCT00654095|363183031|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
105323359|NCT00654095|363183031|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
105323360|NCT00654095|363183031|FG000|Overall Study|Did not meet inclusion criteria|1|||
105323361|NCT02502149|363183032|FG000|Intermediate|Discontinued prematurely|1|||
105323362|NCT02502149|363183033|FG001|Intermediate|Discontinued prematurely|0|||
105323363|NCT02502149|363183034|FG002|Intermediate|Discontinued prematurely|0|||
105323364|NCT02502149|363183035|FG003|Intermediate|Discontinued prematurely|0|||
105323365|NCT02502149|363183036|FG004|Intermediate|Discontinued prematurely|0|||
105323366|NCT02548832|363183037|FG000|Overall Study|Lost to Follow-up|2|||
105323367|NCT02548832|363183038|FG001|Overall Study|Lost to Follow-up|2|||
105323368|NCT02548832|363183039|FG002|Overall Study|Lost to Follow-up|2|||
105323369|NCT03565900|363183042|FG000|Overall Study|Disposition Unknown|4|||
105323370|NCT03565900|363183043|FG001|Overall Study|Disposition Unknown|1|||
105323371|NCT03565900|363183042|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
105323372|NCT03565900|363183043|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
105323373|NCT03565900|363183042|FG000|Overall Study|Withdrawal by Subject|4|||
105323374|NCT03565900|363183043|FG001|Overall Study|Withdrawal by Subject|5|||
105323375|NCT03565900|363183042|FG000|Overall Study|Randomized By Mistake|0|||
105323376|NCT03565900|363183043|FG001|Overall Study|Randomized By Mistake|2|||
105323377|NCT03565900|363183042|FG000|Overall Study|Physician Decision|7|||
105323378|NCT03565900|363183043|FG001|Overall Study|Physician Decision|11|||
105323379|NCT03565900|363183042|FG000|Overall Study|Death|9|||
105323380|NCT03565900|363183043|FG001|Overall Study|Death|7|||
105323381|NCT00958828|363183046|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
105323382|NCT00958828|363183047|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
105323383|NCT00958828|363183046|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
105323384|NCT00958828|363183047|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
105323385|NCT03305848|363183048|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
105323386|NCT03305848|363183048|FG000|Overall Study|Physician Decision|2|||
105323387|NCT02756611|363183049|FG000|Overall Study|Death|70|||
105323388|NCT02756611|363183049|FG000|Overall Study|Withdrawal by Subject|2|||
105323389|NCT02756611|363183049|FG000|Overall Study|Lost to Follow-up|3|||
105323390|NCT02756611|363183049|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
105323391|NCT02756611|363183049|FG000|Overall Study|Other|10|||
105323392|NCT03125798|363183050|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
105323393|NCT03125798|363183051|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
105323394|NCT03125798|363183050|FG000|Overall Study|Conversion to thoracotomy|7|||
105323395|NCT03125798|363183051|FG001|Overall Study|Conversion to thoracotomy|7|||
105323396|NCT02635984|363183053|FG000|Overall Study|Lost to Follow-up|2|||
105323397|NCT02635984|363183054|FG001|Overall Study|Lost to Follow-up|4|||
105323398|NCT02635984|363183053|FG000|Overall Study|Study Arm Closed|1|||
105323399|NCT02635984|363183054|FG001|Overall Study|Study Arm Closed|0|||
105323400|NCT01640249|363183057|FG000|Period 1|Withdrawal by Subject|1|||
105323401|NCT01640249|363183058|FG001|Period 1|Withdrawal by Subject|0|||
105323402|NCT01640249|363183059|FG002|Period 1|Withdrawal by Subject|0|||
105323403|NCT01640249|363183060|FG003|Period 1|Withdrawal by Subject|0|||
105323404|NCT01640249|363183061|FG004|Period 1|Withdrawal by Subject|0|||
105323405|NCT01640249|363183062|FG005|Period 1|Withdrawal by Subject|1|||
105323406|NCT01640249|363183063|FG006|Period 1|Withdrawal by Subject|0|||
105323407|NCT01870778|363183067|FG000|Overall Study|Withdrawal by Subject|8|||
105323408|NCT01870778|363183068|FG001|Overall Study|Withdrawal by Subject|7|||
105323409|NCT01870778|363183067|FG000|Overall Study|Lost to Follow-up|0|||
105323410|NCT01870778|363183068|FG001|Overall Study|Lost to Follow-up|2|||
105323411|NCT00065156|363183069|FG000|Overall Study|Adverse Event|37|||
105323412|NCT00065156|363183069|FG000|Overall Study|Lack of Efficacy|52|||
105323413|NCT00065156|363183069|FG000|Overall Study|Withdrawal by Subject|8|||
105323414|NCT00065156|363183069|FG000|Overall Study|Lost to Follow-up|1|||
105323415|NCT00065156|363183069|FG000|Overall Study|Death|11|||
105323416|NCT00065156|363183069|FG000|Overall Study|Study Closed by Sponsor|2|||
105323417|NCT00065156|363183069|FG000|Overall Study|Disease Progression|7|||
105323418|NCT00065156|363183069|FG000|Overall Study|Investigator Decision|2|||
105323419|NCT00065156|363183069|FG000|Overall Study|Non-Compliance|2|||
105323420|NCT00065156|363183069|FG000|Overall Study|Loss of Response|1|||
105323421|NCT00065156|363183069|FG000|Overall Study|Secondary Malign Disease|1|||
105323422|NCT00312338|363183070|FG000|Overall Study|Adverse Event|7|||
105323423|NCT00312338|363183071|FG001|Overall Study|Adverse Event|2|||
105323424|NCT00312338|363183070|FG000|Overall Study|Lost to Follow-up|9|||
105323425|NCT00312338|363183071|FG001|Overall Study|Lost to Follow-up|1|||
105323426|NCT00312338|363183070|FG000|Overall Study|Withdrawal by Subject|4|||
105323427|NCT00312338|363183071|FG001|Overall Study|Withdrawal by Subject|0|||
105323428|NCT00312338|363183070|FG000|Overall Study|Subsequent infection|2|||
105323429|NCT00312338|363183071|FG001|Overall Study|Subsequent infection|0|||
105323430|NCT00100828|363183072|FG000|Overall Study|Physician Decision|6|||
105323431|NCT04583735|363183073|FG000|Double-masked Treatment Period|Adverse Event|0|||
105323432|NCT04583735|363183074|FG001|Double-masked Treatment Period|Adverse Event|1|||
105323433|NCT04583735|363183073|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
105323434|NCT04583735|363183074|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
105323435|NCT04583735|363183073|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
105323436|NCT04583735|363183074|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
105371948|NCT03363906|363369250|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
105371949|NCT03363906|363369251|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
105323437|NCT04583735|363183073|FG000|Open-label Treatment Period|Adverse Event|1|||
105323438|NCT04583735|363183074|FG001|Open-label Treatment Period|Adverse Event|1|||
105323439|NCT04583735|363183073|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
105323440|NCT04583735|363183074|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
105323441|NCT04583735|363183073|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
105323442|NCT04583735|363183074|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
105323443|NCT00124917|363183075|FG000|Overall Study|Physician Decision|3|||
105323444|NCT03518008|363183076|FG000|Period 2, Second Week of Wear|Family emergency|0|||
105323445|NCT03518008|363183077|FG001|Period 2, Second Week of Wear|Family emergency|1|||
105323446|NCT01215136|363183078|FG000|Overall Study|Adverse Event|2|||
105323447|NCT01215136|363183079|FG001|Overall Study|Adverse Event|9|||
105323448|NCT01215136|363183078|FG000|Overall Study|Disease Progression|3|||
105323449|NCT01215136|363183079|FG001|Overall Study|Disease Progression|14|||
105323450|NCT01215136|363183078|FG000|Overall Study|Symptomatic Deterioration|1|||
105323451|NCT01215136|363183079|FG001|Overall Study|Symptomatic Deterioration|1|||
105323452|NCT01215136|363183078|FG000|Overall Study|Death|0|||
105323453|NCT01215136|363183079|FG001|Overall Study|Death|2|||
105323454|NCT01215136|363183078|FG000|Overall Study|Withdrawal by Subject|0|||
105323455|NCT01215136|363183079|FG001|Overall Study|Withdrawal by Subject|1|||
105323456|NCT01197911|363183081|FG000|Overall Study|Adverse Event|0|||
105323457|NCT01197911|363183082|FG001|Overall Study|Adverse Event|0|||
105323458|NCT01197911|363183083|FG002|Overall Study|Adverse Event|1|||
105323459|NCT01320293|363183086|FG000|Overall Study|Lack of Efficacy|1|||
105323460|NCT01320293|363183086|FG000|Overall Study|Adverse Event|1|||
105323461|NCT03483012|363183090|FG000|Overall Study|Lack of Efficacy|6|||
105323462|NCT00476190|363183091|FG000|Overall Study|Ineligible|1|||
105323463|NCT00476190|363183092|FG001|Overall Study|Ineligible|1|||
105323464|NCT00476190|363183091|FG000|Overall Study|Induction Death|2|||
105323465|NCT00476190|363183092|FG001|Overall Study|Induction Death|0|||
105323466|NCT00476190|363183091|FG000|Overall Study|Induction Failure|2|||
105323467|NCT00476190|363183092|FG001|Overall Study|Induction Failure|4|||
105323468|NCT00476190|363183091|FG000|Overall Study|Lost to Follow-up|1|||
105323469|NCT00476190|363183092|FG001|Overall Study|Lost to Follow-up|0|||
105323470|NCT00476190|363183091|FG000|Overall Study|Relapse/Progression|5|||
105371950|NCT00819039|363369252|FG000|Overall Study|Physician Decision|1|||
105371951|NCT00819039|363369253|FG001|Overall Study|Physician Decision|0|||
105371952|NCT00819039|363369254|FG002|Overall Study|Physician Decision|1|||
105371953|NCT00819039|363369252|FG000|Overall Study|Protocol Violation|1|||
105576863|NCT01671748|364110345|FG001|4 Week run-in Phase|Not eligible|0|||
105323471|NCT00476190|363183092|FG001|Overall Study|Relapse/Progression|2|||
105323472|NCT00476190|363183091|FG000|Overall Study|Remission Death|0|||
105323473|NCT00476190|363183092|FG001|Overall Study|Remission Death|1|||
105323474|NCT00476190|363183091|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
105323475|NCT00476190|363183092|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
105323476|NCT00476190|363183091|FG000|Overall Study|Withdrawal by Subject|6|||
105323477|NCT00476190|363183092|FG001|Overall Study|Withdrawal by Subject|2|||
105323478|NCT00476190|363183091|FG000|Overall Study|Other|9|||
105323479|NCT00476190|363183092|FG001|Overall Study|Other|10|||
105323480|NCT01147068|363183093|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
105323481|NCT01147068|363183094|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
105323482|NCT01147068|363183095|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
105323483|NCT01147068|363183096|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
105323484|NCT01147068|363183097|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
105323485|NCT01147068|363183098|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
105323486|NCT01147068|363183099|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
105323487|NCT01147068|363183093|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
105323488|NCT01147068|363183094|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
105323489|NCT01147068|363183095|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
105323490|NCT01147068|363183096|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
105323491|NCT01147068|363183097|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
105323492|NCT01147068|363183098|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
105323493|NCT01147068|363183099|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
105323494|NCT01147068|363183093|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
105323495|NCT01147068|363183094|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
105323496|NCT01147068|363183095|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
105323497|NCT01147068|363183096|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
105323498|NCT01147068|363183097|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
105323499|NCT01147068|363183098|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
105323500|NCT01147068|363183099|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
105323501|NCT01147068|363183093|FG000|Subjects That Received 2nd Dose|Other|0|||
105323502|NCT01147068|363183094|FG001|Subjects That Received 2nd Dose|Other|3|||
105323503|NCT01147068|363183095|FG002|Subjects That Received 2nd Dose|Other|3|||
105323504|NCT01147068|363183096|FG003|Subjects That Received 2nd Dose|Other|0|||
105371954|NCT00819039|363369253|FG001|Overall Study|Protocol Violation|0|||
105371955|NCT00819039|363369254|FG002|Overall Study|Protocol Violation|0|||
105851366|NCT01986010|365112692|FG016|Overall Study|Status Not Recorded|4|||
105851367|NCT04740814|365112695|FG000|Overall Study|Adverse Event|3|||
105851368|NCT04740814|365112695|FG000|Overall Study|Protocol Violation|2|||
105851369|NCT04740814|365112695|FG000|Overall Study|Lost to Follow-up|2|||
105851370|NCT04740814|365112695|FG000|Overall Study|Withdrawal by Subject|3|||
105851371|NCT02440568|365112698|FG000|Overall Study|Death|1|||
105851372|NCT02440568|365112699|FG001|Overall Study|Death|3|||
105851373|NCT02440568|365112700|FG002|Overall Study|Death|4|||
105851374|NCT02440568|365112701|FG003|Overall Study|Death|2|||
105851375|NCT02440568|365112698|FG000|Overall Study|Lack of Efficacy|2|||
105851376|NCT02440568|365112699|FG001|Overall Study|Lack of Efficacy|0|||
105851377|NCT02440568|365112700|FG002|Overall Study|Lack of Efficacy|1|||
105851378|NCT02440568|365112701|FG003|Overall Study|Lack of Efficacy|0|||
105851379|NCT02440568|365112698|FG000|Overall Study|Lost to Follow-up|1|||
105851380|NCT02440568|365112699|FG001|Overall Study|Lost to Follow-up|0|||
105851381|NCT02440568|365112700|FG002|Overall Study|Lost to Follow-up|0|||
105851382|NCT02440568|365112701|FG003|Overall Study|Lost to Follow-up|0|||
105851383|NCT03233230|365112704|FG000|Overall Study|Adverse Event|6|||
105851384|NCT03233230|365112705|FG001|Overall Study|Adverse Event|3|||
105851385|NCT03233230|365112706|FG002|Overall Study|Adverse Event|6|||
105851386|NCT03233230|365112707|FG003|Overall Study|Adverse Event|3|||
105851387|NCT03233230|365112704|FG000|Overall Study|Protocol Violation|1|||
105851388|NCT03233230|365112705|FG001|Overall Study|Protocol Violation|2|||
105851389|NCT03233230|365112706|FG002|Overall Study|Protocol Violation|1|||
105851390|NCT03233230|365112707|FG003|Overall Study|Protocol Violation|1|||
105851391|NCT03233230|365112704|FG000|Overall Study|Lack of Efficacy|1|||
105851392|NCT03233230|365112705|FG001|Overall Study|Lack of Efficacy|0|||
105851393|NCT03233230|365112706|FG002|Overall Study|Lack of Efficacy|0|||
105851394|NCT03233230|365112707|FG003|Overall Study|Lack of Efficacy|0|||
105851395|NCT03233230|365112704|FG000|Overall Study|Other|5|||
105851396|NCT03233230|365112705|FG001|Overall Study|Other|5|||
105851397|NCT03233230|365112706|FG002|Overall Study|Other|5|||
105851398|NCT03233230|365112707|FG003|Overall Study|Other|3|||
105851399|NCT03233230|365112704|FG000|Overall Study|Withdrawal by Subject|2|||
105851400|NCT03233230|365112705|FG001|Overall Study|Withdrawal by Subject|2|||
105851401|NCT03233230|365112706|FG002|Overall Study|Withdrawal by Subject|0|||
105851402|NCT03233230|365112707|FG003|Overall Study|Withdrawal by Subject|1|||
105851403|NCT03233230|365112704|FG000|Overall Study|Lost to Follow-up|0|||
105851404|NCT03233230|365112705|FG001|Overall Study|Lost to Follow-up|3|||
105851405|NCT03233230|365112706|FG002|Overall Study|Lost to Follow-up|0|||
105851406|NCT03233230|365112707|FG003|Overall Study|Lost to Follow-up|0|||
105851407|NCT02331368|365112708|FG000|Overall Study|Withdrawal by Subject|3|||
105851408|NCT04126213|365112716|FG000|Overall Study|Lost to Follow-up|9|||
105851409|NCT04126213|365112717|FG001|Overall Study|Lost to Follow-up|1|||
105851410|NCT04126213|365112718|FG002|Overall Study|Lost to Follow-up|5|||
105851411|NCT04126213|365112719|FG003|Overall Study|Lost to Follow-up|10|||
105851412|NCT04126213|365112720|FG004|Overall Study|Lost to Follow-up|4|||
105851413|NCT04126213|365112721|FG005|Overall Study|Lost to Follow-up|7|||
105851414|NCT04126213|365112716|FG000|Overall Study|Withdrawal by Subject|3|||
105851415|NCT04126213|365112717|FG001|Overall Study|Withdrawal by Subject|2|||
105851416|NCT04126213|365112718|FG002|Overall Study|Withdrawal by Subject|1|||
105851417|NCT04126213|365112719|FG003|Overall Study|Withdrawal by Subject|1|||
105851418|NCT04126213|365112720|FG004|Overall Study|Withdrawal by Subject|1|||
105851419|NCT04126213|365112721|FG005|Overall Study|Withdrawal by Subject|1|||
105851420|NCT04126213|365112716|FG000|Overall Study|Other|0|||
105851421|NCT04126213|365112717|FG001|Overall Study|Other|0|||
105851422|NCT04126213|365112718|FG002|Overall Study|Other|2|||
105851423|NCT04126213|365112719|FG003|Overall Study|Other|2|||
105851424|NCT04126213|365112720|FG004|Overall Study|Other|0|||
105851425|NCT04126213|365112721|FG005|Overall Study|Other|1|||
105851426|NCT04126213|365112716|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105851427|NCT04126213|365112717|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
105851428|NCT04126213|365112718|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105851429|NCT04126213|365112719|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105851430|NCT04126213|365112720|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105851431|NCT04126213|365112721|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
105851432|NCT02853370|365112724|FG000|Overall Study|Physician Decision|1|||
105851433|NCT02853370|365112724|FG000|Overall Study|Lack of Efficacy|2|||
105851434|NCT02853370|365112724|FG000|Overall Study|Death|1|||
105851435|NCT02853370|365112724|FG000|Overall Study|Adverse Event|4|||
105851436|NCT02853370|365112724|FG000|Overall Study|Withdrawal by Subject|3|||
105851437|NCT02302859|365112725|FG000|Overall Study|Lost Phone|1|||
105851438|NCT02302859|365112726|FG001|Overall Study|Lost Phone|1|||
105576864|NCT02781506|364112068|FG000|Overall Study|Adverse Event|5|||
105851439|NCT02302859|365112725|FG000|Overall Study|Withdrawal by Subject|0|||
105851440|NCT02302859|365112726|FG001|Overall Study|Withdrawal by Subject|1|||
105851441|NCT02912650|365112727|FG000|Overall Study|Withdrawal by Subject|1|||
105851442|NCT02912650|365112728|FG001|Overall Study|Withdrawal by Subject|0|||
105851443|NCT02912650|365112729|FG002|Overall Study|Withdrawal by Subject|1|||
105851444|NCT02912650|365112730|FG003|Overall Study|Withdrawal by Subject|5|||
105323505|NCT01147068|363183097|FG004|Subjects That Received 2nd Dose|Other|1|||
105323506|NCT01147068|363183098|FG005|Subjects That Received 2nd Dose|Other|0|||
105323507|NCT01147068|363183099|FG006|Subjects That Received 2nd Dose|Other|0|||
105323508|NCT01147068|363183093|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
105323509|NCT01147068|363183094|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
105323510|NCT01147068|363183095|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
105323511|NCT01147068|363183096|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
105323512|NCT01147068|363183097|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
105323513|NCT01147068|363183098|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
105323514|NCT01147068|363183099|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
105323515|NCT01147068|363183093|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
105323516|NCT01147068|363183094|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
105323517|NCT01147068|363183095|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
105323518|NCT01147068|363183096|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
105323519|NCT01147068|363183097|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
105323520|NCT01147068|363183098|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
105323521|NCT01147068|363183099|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
105323522|NCT01147068|363183093|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
105323523|NCT01147068|363183094|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
105323524|NCT01147068|363183095|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
105323525|NCT01147068|363183096|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
105323526|NCT01147068|363183097|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
105323527|NCT01147068|363183098|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
105323528|NCT01147068|363183099|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
105323529|NCT04782076|363183100|FG000|Overall Study|Family Emergency|1|||
105323530|NCT02860546|363183107|FG000|Overall Study|Clinical Progression|6|||
105323531|NCT02860546|363183107|FG000|Overall Study|Radiological Progression|12|||
105323532|NCT02466321|363183112|FG000|Overall Study|Death|26|||
105323533|NCT02466321|363183112|FG000|Overall Study|Revision|6|||
105323534|NCT02466321|363183112|FG000|Overall Study|Lost to Follow-up|60|||
105323535|NCT02466321|363183112|FG000|Overall Study|Did not receive study device|1|||
105323536|NCT02189837|363183116|FG000|Overall Study|Withdrawal by Subject|2|||
105323537|NCT02189837|363183117|FG001|Overall Study|Withdrawal by Subject|1|||
105323538|NCT02189837|363183118|FG002|Overall Study|Withdrawal by Subject|3|||
105323539|NCT02189837|363183119|FG003|Overall Study|Withdrawal by Subject|1|||
105323540|NCT02189837|363183116|FG000|Overall Study|Sponsor Decision|0|||
105323541|NCT02189837|363183117|FG001|Overall Study|Sponsor Decision|0|||
105323542|NCT02189837|363183118|FG002|Overall Study|Sponsor Decision|0|||
105323543|NCT02189837|363183119|FG003|Overall Study|Sponsor Decision|1|||
105323544|NCT01821807|363183121|FG000|Overall Study|Lost to Follow-up|3|||
105323545|NCT01821807|363183122|FG001|Overall Study|Lost to Follow-up|1|||
105323546|NCT00265759|363184325|FG000|Overall Study|Withdrawal by Subject|0|||
105323547|NCT00265759|363184326|FG001|Overall Study|Withdrawal by Subject|1|||
105323548|NCT00265759|363184327|FG002|Overall Study|Withdrawal by Subject|2|||
105323549|NCT00265759|363184328|FG003|Overall Study|Withdrawal by Subject|2|||
105323550|NCT00265759|363184325|FG000|Overall Study|Cancel|0|||
105323551|NCT00265759|363184326|FG001|Overall Study|Cancel|0|||
105323552|NCT00265759|363184327|FG002|Overall Study|Cancel|0|||
105323553|NCT00265759|363184328|FG003|Overall Study|Cancel|3|||
105323554|NCT00265759|363184325|FG000|Overall Study|Ineligible|0|||
105323555|NCT00265759|363184326|FG001|Overall Study|Ineligible|0|||
105323556|NCT00265759|363184327|FG002|Overall Study|Ineligible|0|||
105323557|NCT00265759|363184328|FG003|Overall Study|Ineligible|1|||
105323558|NCT00265759|363184325|FG000|Overall Study|Bilateral disease|0|||
105323559|NCT00265759|363184326|FG001|Overall Study|Bilateral disease|0|||
105323560|NCT00265759|363184327|FG002|Overall Study|Bilateral disease|0|||
105323561|NCT00265759|363184328|FG003|Overall Study|Bilateral disease|2|||
105323562|NCT00265759|363184325|FG000|Overall Study|Discontinued due to intolerability|0|||
105323563|NCT00265759|363184326|FG001|Overall Study|Discontinued due to intolerability|0|||
105323564|NCT00265759|363184327|FG002|Overall Study|Discontinued due to intolerability|0|||
105323565|NCT00265759|363184328|FG003|Overall Study|Discontinued due to intolerability|1|||
105323566|NCT00711243|363184332|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
105323567|NCT00711243|363184333|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
105323568|NCT00711243|363184334|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
105323569|NCT00711243|363184335|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
105323570|NCT00711243|363184336|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
105323571|NCT00711243|363184337|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
105323572|NCT00711243|363184332|FG000|Reached First Response/4 Cycles|Death|0|||
105323573|NCT00711243|363184333|FG001|Reached First Response/4 Cycles|Death|0|||
105323574|NCT00711243|363184334|FG002|Reached First Response/4 Cycles|Death|0|||
105323575|NCT00711243|363184335|FG003|Reached First Response/4 Cycles|Death|0|||
105323576|NCT00711243|363184336|FG004|Reached First Response/4 Cycles|Death|0|||
105323577|NCT00711243|363184337|FG005|Reached First Response/4 Cycles|Death|2|||
105323578|NCT00711243|363184332|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
105323579|NCT00711243|363184333|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
105323580|NCT00711243|363184334|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
105323581|NCT00711243|363184335|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
105323582|NCT00711243|363184336|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
105323583|NCT00711243|363184337|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
105323584|NCT00711243|363184332|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
105323585|NCT00711243|363184333|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
105323586|NCT00711243|363184334|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
105323587|NCT00711243|363184335|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
105323588|NCT00711243|363184336|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
105323589|NCT00711243|363184337|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
105323590|NCT00711243|363184332|FG000|Treated Cycle 5 After First Response|Death|0|||
105323591|NCT00711243|363184333|FG001|Treated Cycle 5 After First Response|Death|0|||
105323592|NCT00711243|363184334|FG002|Treated Cycle 5 After First Response|Death|0|||
105323593|NCT00711243|363184335|FG003|Treated Cycle 5 After First Response|Death|0|||
105323594|NCT00711243|363184336|FG004|Treated Cycle 5 After First Response|Death|0|||
105323595|NCT00711243|363184337|FG005|Treated Cycle 5 After First Response|Death|2|||
105323596|NCT00711243|363184332|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
105323597|NCT00711243|363184333|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
105323598|NCT00711243|363184334|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
105323599|NCT00711243|363184335|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
105323600|NCT00711243|363184336|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
105323601|NCT00711243|363184337|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
105323602|NCT00711243|363184332|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
105323603|NCT00711243|363184333|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
105323604|NCT00711243|363184334|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
105323605|NCT00711243|363184335|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
105323606|NCT00711243|363184336|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
105323607|NCT00711243|363184337|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
105323608|NCT01402570|363184338|FG000|Overall Study|Adverse Event|1|||
105323609|NCT02750618|363184339|FG000|Overall Study|Withdrawal by Subject|1|||
105323610|NCT02157935|363184345|FG000|Overall Study|Withdrawal by Subject|25|||
105323611|NCT02157935|363184346|FG001|Overall Study|Withdrawal by Subject|39|||
105323612|NCT02157935|363184345|FG000|Overall Study|Screen failure|1|||
105323613|NCT02157935|363184346|FG001|Overall Study|Screen failure|2|||
105371956|NCT00929669|363369255|FG000|Overall Study|elevated glucose levels|1|||
105371957|NCT01240694|363369256|FG000|Overall Study|Adverse Event|9|||
105371958|NCT01240694|363369256|FG000|Overall Study|Lack of Efficacy|6|||
105371959|NCT01240694|363369256|FG000|Overall Study|Withdrawal by Subject|6|||
105371960|NCT01240694|363369256|FG000|Overall Study|Protocol Violation|2|||
105371961|NCT01240694|363369256|FG000|Overall Study|Lost to Follow-up|2|||
105371962|NCT01240694|363369256|FG000|Overall Study|Other than specified|3|||
105371963|NCT01240694|363369256|FG000|Overall Study|Withdrawn due to early study termination|107|||
105371964|NCT01881425|363369257|FG000|Overall Study|Death|5|||
105371965|NCT01881425|363369258|FG001|Overall Study|Death|1|||
105371966|NCT01881425|363369257|FG000|Overall Study|Withdrawal by Subject|8|||
105371967|NCT01881425|363369258|FG001|Overall Study|Withdrawal by Subject|3|||
105371968|NCT01881425|363369257|FG000|Overall Study|Physician Decision|2|||
105371969|NCT01881425|363369258|FG001|Overall Study|Physician Decision|1|||
105371970|NCT01881425|363369257|FG000|Overall Study|Adverse Event|3|||
105371971|NCT01881425|363369258|FG001|Overall Study|Adverse Event|0|||
105371972|NCT01881425|363369257|FG000|Overall Study|General Anesthesia panic attack|0|||
105371973|NCT01881425|363369258|FG001|Overall Study|General Anesthesia panic attack|1|||
105371974|NCT01881425|363369257|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
105371975|NCT01881425|363369258|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
105371976|NCT01881425|363369257|FG000|Overall Study|Lost to Follow-up|7|||
105323614|NCT02157935|363184345|FG000|Overall Study|Protocol Violation|1|||
105323615|NCT02157935|363184346|FG001|Overall Study|Protocol Violation|0|||
105323616|NCT02157935|363184345|FG000|Overall Study|Progressive disease|0|||
105323617|NCT02157935|363184346|FG001|Overall Study|Progressive disease|2|||
105323618|NCT02157935|363184345|FG000|Overall Study|Other|5|||
105323619|NCT02157935|363184346|FG001|Overall Study|Other|12|||
105323620|NCT02157935|363184345|FG000|Overall Study|Lack of Efficacy|0|||
105371977|NCT01881425|363369258|FG001|Overall Study|Lost to Follow-up|2|||
105371978|NCT00250588|363369259|FG000|Overall Study|Withdrawal by Subject|3|||
105371979|NCT00250588|363369260|FG001|Overall Study|Withdrawal by Subject|6|||
105371980|NCT00250588|363369261|FG002|Overall Study|Withdrawal by Subject|0|||
105371981|NCT00250588|363369259|FG000|Overall Study|Lost to Follow-up|6|||
105323621|NCT02157935|363184346|FG001|Overall Study|Lack of Efficacy|1|||
105323622|NCT02157935|363184345|FG000|Overall Study|Death|4|||
105323623|NCT02157935|363184346|FG001|Overall Study|Death|4|||
105323624|NCT02157935|363184345|FG000|Overall Study|Adverse Event|3|||
105323625|NCT02157935|363184346|FG001|Overall Study|Adverse Event|5|||
105323626|NCT03283566|363184347|FG000|Overall Study|Lost to Follow-up|1|||
105323627|NCT03283566|363184348|FG001|Overall Study|Lost to Follow-up|2|||
105323628|NCT04515147|363184350|FG000|Overall Study|Withdrawal by Subject|1|||
105323629|NCT04515147|363184351|FG001|Overall Study|Withdrawal by Subject|0|||
105323630|NCT04515147|363184352|FG002|Overall Study|Withdrawal by Subject|10|||
105323631|NCT04515147|363184353|FG003|Overall Study|Withdrawal by Subject|18|||
105323632|NCT04515147|363184354|FG004|Overall Study|Withdrawal by Subject|1|||
105323633|NCT04515147|363184355|FG005|Overall Study|Withdrawal by Subject|8|||
105323634|NCT04515147|363184350|FG000|Overall Study|Lost to Follow-up|0|||
105323635|NCT04515147|363184351|FG001|Overall Study|Lost to Follow-up|1|||
105323636|NCT04515147|363184352|FG002|Overall Study|Lost to Follow-up|5|||
105323637|NCT04515147|363184353|FG003|Overall Study|Lost to Follow-up|6|||
105323638|NCT04515147|363184354|FG004|Overall Study|Lost to Follow-up|2|||
105323639|NCT04515147|363184355|FG005|Overall Study|Lost to Follow-up|1|||
105323640|NCT04515147|363184350|FG000|Overall Study|Adverse Event|0|||
105323641|NCT04515147|363184351|FG001|Overall Study|Adverse Event|0|||
105323642|NCT04515147|363184352|FG002|Overall Study|Adverse Event|0|||
105323643|NCT04515147|363184353|FG003|Overall Study|Adverse Event|2|||
105323644|NCT04515147|363184354|FG004|Overall Study|Adverse Event|0|||
105323645|NCT04515147|363184355|FG005|Overall Study|Adverse Event|0|||
105323646|NCT04515147|363184350|FG000|Overall Study|Miscellaneous|0|||
105323647|NCT04515147|363184351|FG001|Overall Study|Miscellaneous|0|||
105323648|NCT04515147|363184352|FG002|Overall Study|Miscellaneous|0|||
105323649|NCT04515147|363184353|FG003|Overall Study|Miscellaneous|1|||
105323650|NCT04515147|363184354|FG004|Overall Study|Miscellaneous|0|||
105323651|NCT04515147|363184355|FG005|Overall Study|Miscellaneous|1|||
105323652|NCT01269918|363184356|FG000|Overall Study|Did not receive study drug|0|||
105323653|NCT01269918|363184357|FG001|Overall Study|Did not receive study drug|3|||
105323654|NCT03743051|363184361|FG000|Overall Study|Adverse Event|5|||
105323655|NCT03743051|363184362|FG001|Overall Study|Adverse Event|9|||
105323656|NCT03743051|363184361|FG000|Overall Study|Death|27|||
105323657|NCT03743051|363184362|FG001|Overall Study|Death|26|||
105323658|NCT03743051|363184361|FG000|Overall Study|Lost to Follow-up|4|||
105323659|NCT03743051|363184362|FG001|Overall Study|Lost to Follow-up|8|||
105323660|NCT03743051|363184361|FG000|Overall Study|Withdrawal by Subject|32|||
105323661|NCT03743051|363184362|FG001|Overall Study|Withdrawal by Subject|19|||
105323662|NCT03743051|363184361|FG000|Overall Study|Physician Decision|10|||
105323663|NCT03743051|363184362|FG001|Overall Study|Physician Decision|15|||
105323664|NCT03743051|363184361|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
105323665|NCT03743051|363184362|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
105323666|NCT02137252|363184365|FG000|Overall Study|trial terminated early|2|||
105323667|NCT02137252|363184366|FG001|Overall Study|trial terminated early|1|||
105323668|NCT00711087|363184367|FG000|Overall Study|Lost to Follow-up|1|||
105323669|NCT00711087|363184368|FG001|Overall Study|Lost to Follow-up|0|||
105323670|NCT00856193|363184369|FG000|Period 2|Abnormal test procedure results|0|||
105323671|NCT00856193|363184370|FG001|Period 2|Abnormal test procedure results|1|||
105323672|NCT00856193|363184369|FG000|Period 2|Lost to Follow-up|0|||
105323673|NCT00856193|363184370|FG001|Period 2|Lost to Follow-up|1|||
105323674|NCT00840749|363184371|FG000|Overall Study|Death|1|||
105323675|NCT00840749|363184372|FG001|Overall Study|Death|2|||
105323676|NCT00840749|363184371|FG000|Overall Study|not treated on study arm|11|||
105323677|NCT00840749|363184372|FG001|Overall Study|not treated on study arm|11|||
105323678|NCT00840749|363184371|FG000|Overall Study|study closed|19|||
105323679|NCT00840749|363184372|FG001|Overall Study|study closed|14|||
105323680|NCT03534687|363184375|FG000|Overall Study|Lost to Follow-up|7|||
105323681|NCT03534687|363184376|FG001|Overall Study|Lost to Follow-up|2|||
105323682|NCT02569801|363184377|FG000|Overall Study|Withdrawal by Subject|9|||
105323683|NCT02569801|363184378|FG001|Overall Study|Withdrawal by Subject|9|||
105323684|NCT02569801|363184377|FG000|Overall Study|Sponsor Decision|13|||
105323685|NCT02569801|363184378|FG001|Overall Study|Sponsor Decision|14|||
105323686|NCT02569801|363184377|FG000|Overall Study|Progressive Disease|2|||
105323687|NCT02569801|363184378|FG001|Overall Study|Progressive Disease|7|||
105323688|NCT02569801|363184377|FG000|Overall Study|Lost to Follow-up|0|||
105323689|NCT02569801|363184378|FG001|Overall Study|Lost to Follow-up|1|||
105323690|NCT02569801|363184377|FG000|Overall Study|Death|12|||
105323691|NCT02569801|363184378|FG001|Overall Study|Death|4|||
105323692|NCT00428246|363184379|FG000|Overall Study|Withdrawal by Subject|0|||
105323693|NCT00428246|363184380|FG001|Overall Study|Withdrawal by Subject|0|||
105323694|NCT00428246|363184381|FG002|Overall Study|Withdrawal by Subject|1|||
105323695|NCT00428246|363184379|FG000|Overall Study|Adverse Event|1|||
105323696|NCT00428246|363184380|FG001|Overall Study|Adverse Event|0|||
105323697|NCT00428246|363184381|FG002|Overall Study|Adverse Event|0|||
105323698|NCT03776357|363184384|FG000|Overall Study|Lost to Follow-up|3|||
105323699|NCT00235755|363184392|FG000|4-Week Titration Phase|Adverse Event|6|||
105323700|NCT00235755|363184393|FG001|4-Week Titration Phase|Adverse Event|14|||
105323701|NCT00235755|363184394|FG002|4-Week Titration Phase|Adverse Event|20|||
105323702|NCT00235755|363184392|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
105323703|NCT00235755|363184393|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
105323704|NCT00235755|363184394|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
105323705|NCT00235755|363184392|FG000|4-Week Titration Phase|Protocol Violation|2|||
105323706|NCT00235755|363184393|FG001|4-Week Titration Phase|Protocol Violation|2|||
105323707|NCT00235755|363184394|FG002|4-Week Titration Phase|Protocol Violation|1|||
105323708|NCT00235755|363184392|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
105323709|NCT00235755|363184393|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
105323710|NCT00235755|363184394|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
105323711|NCT00235755|363184392|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
105323712|NCT00235755|363184393|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
105323713|NCT00235755|363184394|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
105323714|NCT00235755|363184392|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
105323715|NCT00235755|363184393|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
105323716|NCT00235755|363184394|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
105323717|NCT00235755|363184392|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
105323718|NCT00235755|363184393|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
105323719|NCT00235755|363184394|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
105323720|NCT00235755|363184392|FG000|12-Week Maintenance Phase|Adverse Event|8|||
105323721|NCT00235755|363184393|FG001|12-Week Maintenance Phase|Adverse Event|12|||
105323722|NCT00235755|363184394|FG002|12-Week Maintenance Phase|Adverse Event|26|||
105323723|NCT00235755|363184392|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
105323724|NCT00235755|363184393|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
105323725|NCT00235755|363184394|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
105323726|NCT00235755|363184392|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
105323727|NCT00235755|363184393|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
105323728|NCT00235755|363184394|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
105323729|NCT00235755|363184392|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
105323730|NCT00235755|363184393|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
105323731|NCT00235755|363184394|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
105323732|NCT00235755|363184392|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
105323733|NCT00235755|363184393|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
105323734|NCT00235755|363184394|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
105323735|NCT00235755|363184392|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
105323736|NCT00235755|363184393|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
105323737|NCT00235755|363184394|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
105323738|NCT01125917|363184395|FG000|Overall Study|Adverse Event|43|||
105323739|NCT01125917|363184395|FG000|Overall Study|Lost to Follow-up|23|||
105323740|NCT01125917|363184395|FG000|Overall Study|Withdrawal by Subject|31|||
105323741|NCT01125917|363184395|FG000|Overall Study|Administrative|223|||
105323742|NCT01125917|363184395|FG000|Overall Study|Lack of Efficacy|19|||
105323743|NCT00838526|363184404|FG000|Overall Study|Adverse Event|3|||
105323744|NCT00838526|363184405|FG001|Overall Study|Adverse Event|12|||
105323745|NCT00838526|363184404|FG000|Overall Study|Lost to Follow-up|4|||
105323746|NCT00838526|363184405|FG001|Overall Study|Lost to Follow-up|12|||
105323747|NCT00838526|363184404|FG000|Overall Study|Withdrawal by Subject|4|||
105323748|NCT00838526|363184405|FG001|Overall Study|Withdrawal by Subject|5|||
105323749|NCT00838526|363184404|FG000|Overall Study|Lack of Efficacy|2|||
105323750|NCT00838526|363184405|FG001|Overall Study|Lack of Efficacy|3|||
105323751|NCT00838526|363184404|FG000|Overall Study|Other|11|||
105323752|NCT00838526|363184405|FG001|Overall Study|Other|7|||
105323753|NCT00931411|363184408|FG000|First Intervention - 42 Days|Adverse Event|2|||
105323754|NCT00931411|363184409|FG001|First Intervention - 42 Days|Adverse Event|3|||
105323755|NCT00931411|363184408|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
105323756|NCT00931411|363184409|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
105323757|NCT00931411|363184408|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
105323758|NCT00931411|363184409|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
105323759|NCT00470470|363184410|FG000|Overall Study|Adverse Event|2|||
105323760|NCT00470470|363184410|FG000|Overall Study|Death|2|||
105323761|NCT00470470|363184410|FG000|Overall Study|Not treated|1|||
105323762|NCT01149863|363184416|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
105323763|NCT01306305|363184417|FG000|Overall Study|Lost to Follow-up|1|||
105323764|NCT01306305|363184418|FG001|Overall Study|Lost to Follow-up|0|||
105323765|NCT01306305|363184417|FG000|Overall Study|Withdrew consent|1|||
105323766|NCT01306305|363184418|FG001|Overall Study|Withdrew consent|0|||
105323767|NCT00699998|363184419|FG000|Overall Study|Withdrawal by Subject|194|||
105323768|NCT00699998|363184420|FG001|Overall Study|Withdrawal by Subject|83|||
105323769|NCT00699998|363184421|FG002|Overall Study|Withdrawal by Subject|202|||
105323770|NCT00699998|363184422|FG003|Overall Study|Withdrawal by Subject|80|||
105323771|NCT00699998|363184419|FG000|Overall Study|Physician Decision|3|||
105323772|NCT00699998|363184420|FG001|Overall Study|Physician Decision|2|||
105323773|NCT00699998|363184421|FG002|Overall Study|Physician Decision|1|||
105323774|NCT00699998|363184422|FG003|Overall Study|Physician Decision|1|||
105323775|NCT00699998|363184419|FG000|Overall Study|Lost to Follow-up|2|||
105323776|NCT00699998|363184420|FG001|Overall Study|Lost to Follow-up|1|||
105323777|NCT00699998|363184421|FG002|Overall Study|Lost to Follow-up|3|||
105323778|NCT00699998|363184422|FG003|Overall Study|Lost to Follow-up|1|||
105323779|NCT04052620|363184423|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
105323780|NCT04052620|363184424|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
105323781|NCT04052620|363184423|FG000|Overall Study|Withdrawal by Subject|1|||
105323782|NCT04052620|363184424|FG001|Overall Study|Withdrawal by Subject|0|||
105323783|NCT04052620|363184423|FG000|Overall Study|Lost to Follow-up|1|||
105323784|NCT04052620|363184424|FG001|Overall Study|Lost to Follow-up|1|||
105323785|NCT04052620|363184423|FG000|Overall Study|Adverse Event|1|||
105323786|NCT04052620|363184424|FG001|Overall Study|Adverse Event|0|||
105323787|NCT04052620|363184423|FG000|Overall Study|Subject did not meet study Criteria|0|||
105576865|NCT00581113|364112069|FG000|Overall Study|Withdrawal by Subject|0|||
105576866|NCT00581113|364112070|FG001|Overall Study|Withdrawal by Subject|1|||
105576867|NCT01818141|364112071|FG000|Overall Study|Withdrawal by Subject|2|||
105576868|NCT01818141|364112072|FG001|Overall Study|Withdrawal by Subject|0|||
105576869|NCT01818141|364112071|FG000|Overall Study|No baseline C.diff colonies|1|||
105576870|NCT01818141|364112072|FG001|Overall Study|No baseline C.diff colonies|1|||
105576871|NCT01818141|364112071|FG000|Overall Study|Lost to Follow-up|0|||
105576872|NCT01818141|364112072|FG001|Overall Study|Lost to Follow-up|2|||
105576873|NCT01091428|364112073|FG000|Phase 1|Progressive Disease|24|||
105576874|NCT01091428|364112074|FG001|Phase 1|Progressive Disease|8|||
105576875|NCT01091428|364112075|FG002|Phase 1|Progressive Disease|0|||
105576876|NCT01091428|364112076|FG003|Phase 1|Progressive Disease|0|||
105576877|NCT01091428|364112073|FG000|Phase 1|Symptomatic Deterioration|3|||
105576878|NCT01091428|364112074|FG001|Phase 1|Symptomatic Deterioration|2|||
105851445|NCT02912650|365112727|FG000|Overall Study|Adverse Event|0|||
105851446|NCT02912650|365112728|FG001|Overall Study|Adverse Event|0|||
105576879|NCT01091428|364112075|FG002|Phase 1|Symptomatic Deterioration|0|||
105576880|NCT01091428|364112076|FG003|Phase 1|Symptomatic Deterioration|0|||
105576881|NCT01091428|364112073|FG000|Phase 1|Adverse Event|2|||
105576882|NCT01091428|364112074|FG001|Phase 1|Adverse Event|0|||
105576883|NCT01091428|364112075|FG002|Phase 1|Adverse Event|0|||
105576884|NCT01091428|364112076|FG003|Phase 1|Adverse Event|0|||
105576885|NCT01091428|364112073|FG000|Phase 1|Withdrawal by Subject|7|||
105576886|NCT01091428|364112074|FG001|Phase 1|Withdrawal by Subject|0|||
105576887|NCT01091428|364112075|FG002|Phase 1|Withdrawal by Subject|0|||
105576888|NCT01091428|364112076|FG003|Phase 1|Withdrawal by Subject|0|||
105576889|NCT01091428|364112073|FG000|Phase 1|Reason not specified|0|||
105851447|NCT02912650|365112729|FG002|Overall Study|Adverse Event|1|||
105851448|NCT02912650|365112730|FG003|Overall Study|Adverse Event|0|||
105851449|NCT01791153|365112731|FG000|Part 1: Blinded Period|Adverse Event|7|||
105851450|NCT01791153|365112732|FG001|Part 1: Blinded Period|Adverse Event|3|||
105851451|NCT01791153|365112733|FG002|Part 1: Blinded Period|Adverse Event|2|||
105851452|NCT01791153|365112734|FG003|Part 1: Blinded Period|Adverse Event|0|||
105851453|NCT01791153|365112735|FG004|Part 1: Blinded Period|Adverse Event|0|||
105851454|NCT01791153|365112736|FG005|Part 1: Blinded Period|Adverse Event|0|||
105851455|NCT01791153|365112737|FG006|Part 1: Blinded Period|Adverse Event|0|||
105851456|NCT01791153|365112738|FG007|Part 1: Blinded Period|Adverse Event|0|||
105851457|NCT01791153|365112731|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
105851458|NCT01791153|365112732|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
105851459|NCT01791153|365112733|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
105851460|NCT01791153|365112734|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
105851461|NCT01791153|365112735|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
105851462|NCT01791153|365112736|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
105851463|NCT01791153|365112737|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
105851464|NCT01791153|365112738|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
105851465|NCT01791153|365112731|FG000|Part 1: Blinded Period|Non-Compliance|1|||
105851466|NCT01791153|365112732|FG001|Part 1: Blinded Period|Non-Compliance|0|||
105851467|NCT01791153|365112733|FG002|Part 1: Blinded Period|Non-Compliance|0|||
105851468|NCT01791153|365112734|FG003|Part 1: Blinded Period|Non-Compliance|0|||
105851469|NCT01791153|365112735|FG004|Part 1: Blinded Period|Non-Compliance|0|||
105851470|NCT01791153|365112736|FG005|Part 1: Blinded Period|Non-Compliance|0|||
105851471|NCT01791153|365112737|FG006|Part 1: Blinded Period|Non-Compliance|0|||
105851472|NCT01791153|365112738|FG007|Part 1: Blinded Period|Non-Compliance|0|||
105576890|NCT01091428|364112074|FG001|Phase 1|Reason not specified|1|||
105576891|NCT01091428|364112075|FG002|Phase 1|Reason not specified|0|||
105851473|NCT01791153|365112731|FG000|Part 1: Blinded Period|Physician Decision|0|||
105851474|NCT01791153|365112732|FG001|Part 1: Blinded Period|Physician Decision|0|||
105576892|NCT01091428|364112076|FG003|Phase 1|Reason not specified|0|||
105851475|NCT01791153|365112733|FG002|Part 1: Blinded Period|Physician Decision|0|||
105851476|NCT01791153|365112734|FG003|Part 1: Blinded Period|Physician Decision|1|||
105851477|NCT01791153|365112735|FG004|Part 1: Blinded Period|Physician Decision|0|||
105851478|NCT01791153|365112736|FG005|Part 1: Blinded Period|Physician Decision|0|||
105851479|NCT01791153|365112737|FG006|Part 1: Blinded Period|Physician Decision|0|||
105371982|NCT00250588|363369260|FG001|Overall Study|Lost to Follow-up|13|||
105323788|NCT04052620|363184424|FG001|Overall Study|Subject did not meet study Criteria|1|||
105323789|NCT04052620|363184423|FG000|Overall Study|Screened failure, randomized by mistake|0|||
105323790|NCT04052620|363184424|FG001|Overall Study|Screened failure, randomized by mistake|1|||
105323791|NCT04052620|363184423|FG000|Overall Study|Personal reasons|2|||
105323792|NCT04052620|363184424|FG001|Overall Study|Personal reasons|4|||
105323793|NCT04052620|363184423|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
105323794|NCT04052620|363184424|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
105323795|NCT00473590|363184425|FG000|Overall Study|Adverse Event|3|||
105323796|NCT00473590|363184426|FG001|Overall Study|Adverse Event|3|||
105323797|NCT00473590|363184425|FG000|Overall Study|Death|4|||
105323798|NCT00473590|363184426|FG001|Overall Study|Death|2|||
105323799|NCT00473590|363184425|FG000|Overall Study|Progression not resulting in death|24|||
105323800|NCT00473590|363184426|FG001|Overall Study|Progression not resulting in death|20|||
105323801|NCT00473590|363184425|FG000|Overall Study|Non-protocol-specified therapy|7|||
105323802|NCT00473590|363184426|FG001|Overall Study|Non-protocol-specified therapy|5|||
105323803|NCT00473590|363184425|FG000|Overall Study|Physician Decision|2|||
105323804|NCT00473590|363184426|FG001|Overall Study|Physician Decision|4|||
105323805|NCT00473590|363184425|FG000|Overall Study|Withdrawal by Subject|5|||
105323806|NCT00473590|363184426|FG001|Overall Study|Withdrawal by Subject|3|||
105323807|NCT00473590|363184425|FG000|Overall Study|Other|0|||
105323808|NCT00473590|363184426|FG001|Overall Study|Other|1|||
105323809|NCT01757275|363184427|FG000|Overall Study|Lost to Follow-up|1|||
105323810|NCT01757275|363184428|FG001|Overall Study|Lost to Follow-up|2|||
105323811|NCT01757275|363184427|FG000|Overall Study|Adverse Event|3|||
105323812|NCT01757275|363184428|FG001|Overall Study|Adverse Event|3|||
105323813|NCT01757275|363184427|FG000|Overall Study|Withdrawal by Subject|2|||
105323814|NCT01757275|363184428|FG001|Overall Study|Withdrawal by Subject|4|||
105323815|NCT01757275|363184427|FG000|Overall Study|Not treated|3|||
105323816|NCT01757275|363184428|FG001|Overall Study|Not treated|4|||
105323817|NCT00858273|363184429|FG000|Overall Study|Protocol Violation|3|||
105323818|NCT00858273|363184430|FG001|Overall Study|Protocol Violation|5|||
105323819|NCT01326845|363184432|FG000|Overall Study|Administrative Problems|5|||
105323820|NCT01326845|363184433|FG001|Overall Study|Administrative Problems|2|||
105323821|NCT01326845|363184432|FG000|Overall Study|Adverse Event|1|||
105851480|NCT01791153|365112738|FG007|Part 1: Blinded Period|Physician Decision|0|||
105851481|NCT01791153|365112731|FG000|Part 1: Blinded Period|Protocol Violation|0|||
105851482|NCT01791153|365112732|FG001|Part 1: Blinded Period|Protocol Violation|0|||
105851483|NCT01791153|365112733|FG002|Part 1: Blinded Period|Protocol Violation|0|||
105851484|NCT01791153|365112734|FG003|Part 1: Blinded Period|Protocol Violation|1|||
105851485|NCT01791153|365112735|FG004|Part 1: Blinded Period|Protocol Violation|0|||
105851486|NCT01791153|365112736|FG005|Part 1: Blinded Period|Protocol Violation|0|||
105851487|NCT01791153|365112737|FG006|Part 1: Blinded Period|Protocol Violation|0|||
105323822|NCT01326845|363184433|FG001|Overall Study|Adverse Event|0|||
105576893|NCT01091428|364112073|FG000|Phase 1|Single-Patient IND|2|||
105576894|NCT01091428|364112074|FG001|Phase 1|Single-Patient IND|0|||
105323823|NCT01326845|363184432|FG000|Overall Study|Misisng|1|||
105323824|NCT01326845|363184433|FG001|Overall Study|Misisng|3|||
105323825|NCT00982657|363184434|FG000|Overall Study|Death|1|||
105323826|NCT00982657|363184435|FG001|Overall Study|Death|0|||
105323827|NCT00982657|363184436|FG002|Overall Study|Death|1|||
105323828|NCT00982657|363184437|FG003|Overall Study|Death|1|||
105323829|NCT00982657|363184434|FG000|Overall Study|Withdrawal by Subject|0|||
105323830|NCT00982657|363184435|FG001|Overall Study|Withdrawal by Subject|0|||
105323831|NCT00982657|363184436|FG002|Overall Study|Withdrawal by Subject|1|||
105323832|NCT00982657|363184437|FG003|Overall Study|Withdrawal by Subject|3|||
105323833|NCT00982657|363184434|FG000|Overall Study|Other|0|||
105323834|NCT00982657|363184435|FG001|Overall Study|Other|0|||
105323835|NCT00982657|363184436|FG002|Overall Study|Other|0|||
105323836|NCT00982657|363184437|FG003|Overall Study|Other|4|||
105323837|NCT00982657|363184434|FG000|Overall Study|On going at date of cut-off|0|||
105323838|NCT00982657|363184435|FG001|Overall Study|On going at date of cut-off|0|||
105323839|NCT00982657|363184436|FG002|Overall Study|On going at date of cut-off|0|||
105323840|NCT00982657|363184437|FG003|Overall Study|On going at date of cut-off|1|||
105323841|NCT02964247|363184438|FG000|Overall Study|Lost to Follow-up|2|||
105323842|NCT02964247|363184439|FG001|Overall Study|Lost to Follow-up|0|||
105323843|NCT02964247|363184438|FG000|Overall Study|Withdrawal by Subject|1|||
105576895|NCT01091428|364112075|FG002|Phase 1|Single-Patient IND|0|||
105576896|NCT01091428|364112076|FG003|Phase 1|Single-Patient IND|0|||
105576897|NCT01091428|364112073|FG000|Phase 2|Progressive Disease|0|||
105851488|NCT01791153|365112738|FG007|Part 1: Blinded Period|Protocol Violation|0|||
105323844|NCT02964247|363184439|FG001|Overall Study|Withdrawal by Subject|2|||
105323845|NCT01891864|363184440|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
105323846|NCT01891864|363184441|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
105323847|NCT01891864|363184442|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
105323848|NCT01891864|363184443|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
105323849|NCT01891864|363184444|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
105323850|NCT01891864|363184445|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
105323851|NCT01891864|363184440|FG000|Treatment Period 1|Physician Decision|0|||
105323852|NCT01891864|363184441|FG001|Treatment Period 1|Physician Decision|1|||
105323853|NCT01891864|363184442|FG002|Treatment Period 1|Physician Decision|0|||
105323854|NCT01891864|363184443|FG003|Treatment Period 1|Physician Decision|0|||
105323855|NCT01891864|363184444|FG004|Treatment Period 1|Physician Decision|0|||
105323856|NCT01891864|363184445|FG005|Treatment Period 1|Physician Decision|0|||
105323857|NCT01891864|363184440|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
105323858|NCT01891864|363184441|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
105323859|NCT01891864|363184442|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
105323860|NCT01891864|363184443|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
105323861|NCT01891864|363184444|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
105323862|NCT01891864|363184445|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
105323863|NCT01891864|363184440|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
105323864|NCT01891864|363184441|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
105323865|NCT01891864|363184442|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
105323866|NCT01891864|363184443|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
105323867|NCT01891864|363184444|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
105323868|NCT01891864|363184445|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
105323869|NCT01891864|363184440|FG000|Treatment Period 1|Withdrawal by Subject|2|||
105323870|NCT01891864|363184441|FG001|Treatment Period 1|Withdrawal by Subject|5|||
105323871|NCT01891864|363184442|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105323872|NCT01891864|363184443|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105323873|NCT01891864|363184444|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105323874|NCT01891864|363184445|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105323875|NCT01891864|363184440|FG000|Treatment Period 1|Lost to Follow-up|1|||
105323876|NCT01891864|363184441|FG001|Treatment Period 1|Lost to Follow-up|0|||
105323877|NCT01891864|363184442|FG002|Treatment Period 1|Lost to Follow-up|0|||
105323878|NCT01891864|363184443|FG003|Treatment Period 1|Lost to Follow-up|0|||
105323879|NCT01891864|363184444|FG004|Treatment Period 1|Lost to Follow-up|0|||
105323880|NCT01891864|363184445|FG005|Treatment Period 1|Lost to Follow-up|0|||
105323881|NCT01891864|363184440|FG000|Treatment Period 2|Protocol Violation|0|||
105323882|NCT01891864|363184441|FG001|Treatment Period 2|Protocol Violation|0|||
105323883|NCT01891864|363184442|FG002|Treatment Period 2|Protocol Violation|0|||
105323884|NCT01891864|363184443|FG003|Treatment Period 2|Protocol Violation|1|||
105323885|NCT01891864|363184444|FG004|Treatment Period 2|Protocol Violation|0|||
105323886|NCT01891864|363184445|FG005|Treatment Period 2|Protocol Violation|0|||
105323887|NCT01891864|363184440|FG000|Treatment Period 2|Physician Decision|0|||
105323888|NCT01891864|363184441|FG001|Treatment Period 2|Physician Decision|0|||
105323889|NCT01891864|363184442|FG002|Treatment Period 2|Physician Decision|1|||
105323890|NCT01891864|363184443|FG003|Treatment Period 2|Physician Decision|0|||
105323891|NCT01891864|363184444|FG004|Treatment Period 2|Physician Decision|0|||
105323892|NCT01891864|363184445|FG005|Treatment Period 2|Physician Decision|0|||
105323893|NCT01891864|363184440|FG000|Treatment Period 2|Site Termination|0|||
105323894|NCT01891864|363184441|FG001|Treatment Period 2|Site Termination|0|||
105323895|NCT01891864|363184442|FG002|Treatment Period 2|Site Termination|1|||
105323896|NCT01891864|363184443|FG003|Treatment Period 2|Site Termination|2|||
105323897|NCT01891864|363184444|FG004|Treatment Period 2|Site Termination|0|||
105323898|NCT01891864|363184445|FG005|Treatment Period 2|Site Termination|0|||
105323899|NCT01891864|363184440|FG000|Treatment Period 2|Lack of Efficacy|0|||
105323900|NCT01891864|363184441|FG001|Treatment Period 2|Lack of Efficacy|0|||
105323901|NCT01891864|363184442|FG002|Treatment Period 2|Lack of Efficacy|1|||
105323902|NCT01891864|363184443|FG003|Treatment Period 2|Lack of Efficacy|0|||
105323903|NCT01891864|363184444|FG004|Treatment Period 2|Lack of Efficacy|1|||
105323904|NCT01891864|363184445|FG005|Treatment Period 2|Lack of Efficacy|0|||
105323905|NCT01891864|363184440|FG000|Treatment Period 2|Adverse Event|0|||
105323906|NCT01891864|363184441|FG001|Treatment Period 2|Adverse Event|0|||
105323907|NCT01891864|363184442|FG002|Treatment Period 2|Adverse Event|1|||
105323908|NCT01891864|363184443|FG003|Treatment Period 2|Adverse Event|2|||
105323909|NCT01891864|363184444|FG004|Treatment Period 2|Adverse Event|0|||
105323910|NCT01891864|363184445|FG005|Treatment Period 2|Adverse Event|4|||
105323911|NCT01891864|363184440|FG000|Treatment Period 2|Termination of Site|0|||
105323912|NCT01891864|363184441|FG001|Treatment Period 2|Termination of Site|0|||
105323913|NCT01891864|363184442|FG002|Treatment Period 2|Termination of Site|0|||
105323914|NCT01891864|363184443|FG003|Treatment Period 2|Termination of Site|0|||
105323915|NCT01891864|363184444|FG004|Treatment Period 2|Termination of Site|2|||
105323916|NCT01891864|363184445|FG005|Treatment Period 2|Termination of Site|0|||
105323917|NCT01891864|363184440|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105323918|NCT01891864|363184441|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105323919|NCT01891864|363184442|FG002|Treatment Period 2|Withdrawal by Subject|3|||
105323920|NCT01891864|363184443|FG003|Treatment Period 2|Withdrawal by Subject|4|||
105323921|NCT01891864|363184444|FG004|Treatment Period 2|Withdrawal by Subject|1|||
105323922|NCT01891864|363184445|FG005|Treatment Period 2|Withdrawal by Subject|1|||
105323923|NCT01891864|363184440|FG000|Extension Period|Lack of Efficacy|0|||
105323924|NCT01891864|363184441|FG001|Extension Period|Lack of Efficacy|0|||
105323925|NCT01891864|363184442|FG002|Extension Period|Lack of Efficacy|0|||
105323926|NCT01891864|363184443|FG003|Extension Period|Lack of Efficacy|1|||
105323927|NCT01891864|363184444|FG004|Extension Period|Lack of Efficacy|1|||
105323928|NCT01891864|363184445|FG005|Extension Period|Lack of Efficacy|0|||
105323929|NCT01891864|363184440|FG000|Extension Period|Pregnancy|0|||
105323930|NCT01891864|363184441|FG001|Extension Period|Pregnancy|0|||
105323931|NCT01891864|363184442|FG002|Extension Period|Pregnancy|1|||
105323932|NCT01891864|363184443|FG003|Extension Period|Pregnancy|0|||
105323933|NCT01891864|363184444|FG004|Extension Period|Pregnancy|0|||
105323934|NCT01891864|363184445|FG005|Extension Period|Pregnancy|0|||
105323935|NCT01891864|363184440|FG000|Extension Period|Adverse Event|0|||
105323936|NCT01891864|363184441|FG001|Extension Period|Adverse Event|0|||
105323937|NCT01891864|363184442|FG002|Extension Period|Adverse Event|4|||
105323938|NCT01891864|363184443|FG003|Extension Period|Adverse Event|2|||
105323939|NCT01891864|363184444|FG004|Extension Period|Adverse Event|2|||
105323940|NCT01891864|363184445|FG005|Extension Period|Adverse Event|0|||
105323941|NCT01891864|363184440|FG000|Extension Period|Withdrawal by Subject|0|||
105323942|NCT01891864|363184441|FG001|Extension Period|Withdrawal by Subject|0|||
105323943|NCT01891864|363184442|FG002|Extension Period|Withdrawal by Subject|1|||
105323944|NCT01891864|363184443|FG003|Extension Period|Withdrawal by Subject|2|||
105323945|NCT01891864|363184444|FG004|Extension Period|Withdrawal by Subject|4|||
105323946|NCT01891864|363184445|FG005|Extension Period|Withdrawal by Subject|0|||
105323947|NCT01891864|363184440|FG000|Extension Period|Lost to Follow-up|0|||
105323948|NCT01891864|363184441|FG001|Extension Period|Lost to Follow-up|0|||
105323949|NCT01891864|363184442|FG002|Extension Period|Lost to Follow-up|2|||
105323950|NCT01891864|363184443|FG003|Extension Period|Lost to Follow-up|0|||
105323951|NCT01891864|363184444|FG004|Extension Period|Lost to Follow-up|0|||
105323952|NCT01891864|363184445|FG005|Extension Period|Lost to Follow-up|0|||
105323953|NCT05373108|363184446|FG000|Overall Study|Withdrawal by Subject|2|||
105323954|NCT02892331|363184447|FG000|Overall Study|Withdrawal by Subject|0|||
105323955|NCT02892331|363184448|FG001|Overall Study|Withdrawal by Subject|1|||
105323956|NCT02892331|363184449|FG002|Overall Study|Withdrawal by Subject|1|||
105323957|NCT02892331|363184447|FG000|Overall Study|Sick family member|0|||
105323958|NCT02892331|363184448|FG001|Overall Study|Sick family member|0|||
105323959|NCT02892331|363184449|FG002|Overall Study|Sick family member|1|||
105323960|NCT02892331|363184447|FG000|Overall Study|Corona virus pandemic|1|||
105323961|NCT02892331|363184448|FG001|Overall Study|Corona virus pandemic|0|||
105323962|NCT02892331|363184449|FG002|Overall Study|Corona virus pandemic|1|||
105323963|NCT02892331|363184447|FG000|Overall Study|Lost to Follow-up|1|||
105323964|NCT02892331|363184448|FG001|Overall Study|Lost to Follow-up|0|||
105323965|NCT02892331|363184449|FG002|Overall Study|Lost to Follow-up|1|||
105323966|NCT02892331|363184447|FG000|Overall Study|Blood pressure was too elevated|0|||
105323967|NCT02892331|363184448|FG001|Overall Study|Blood pressure was too elevated|1|||
105323968|NCT02892331|363184449|FG002|Overall Study|Blood pressure was too elevated|0|||
105323969|NCT02892331|363184447|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
105323970|NCT02892331|363184448|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
105323971|NCT02892331|363184449|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
105323972|NCT01133067|363184450|FG000|Overall Study|Death|136|||
105323973|NCT01133067|363184450|FG000|Overall Study|Lost to Follow-up|3|||
105323974|NCT00752128|363184453|FG000|Overall Study|Withdrawal by Subject|4|||
105323975|NCT02166333|363184454|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
105323976|NCT02166333|363184455|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
105323977|NCT02166333|363184456|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
105323978|NCT02166333|363184457|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
105323979|NCT02166333|363184458|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
105371983|NCT00250588|363369261|FG002|Overall Study|Lost to Follow-up|13|||
105371984|NCT00706797|363369262|FG000|Overall Study|Lack of Efficacy|3|||
105371985|NCT00706797|363369263|FG001|Overall Study|Lack of Efficacy|0|||
105371986|NCT00706797|363369262|FG000|Overall Study|Adverse Event|0|||
105371987|NCT00706797|363369263|FG001|Overall Study|Adverse Event|3|||
105576898|NCT01091428|364112074|FG001|Phase 2|Progressive Disease|0|||
105576899|NCT01091428|364112075|FG002|Phase 2|Progressive Disease|44|||
105323980|NCT02166333|363184459|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
105323981|NCT02166333|363184454|FG000|Stage 1|Death|4|||
105323982|NCT02166333|363184455|FG001|Stage 1|Death|0|||
105576900|NCT01091428|364112076|FG003|Phase 2|Progressive Disease|46|||
105576901|NCT01091428|364112073|FG000|Phase 2|Symptomatic Deterioration|0|||
105576902|NCT01091428|364112074|FG001|Phase 2|Symptomatic Deterioration|0|||
105576903|NCT01091428|364112075|FG002|Phase 2|Symptomatic Deterioration|1|||
105371988|NCT00706797|363369262|FG000|Overall Study|Withdrawal by Subject|8|||
105576904|NCT01091428|364112076|FG003|Phase 2|Symptomatic Deterioration|6|||
105323983|NCT02166333|363184456|FG002|Stage 1|Death|2|||
105323984|NCT02166333|363184457|FG003|Stage 1|Death|0|||
105576905|NCT01091428|364112073|FG000|Phase 2|Adverse Event|0|||
105323985|NCT02166333|363184458|FG004|Stage 1|Death|3|||
105323986|NCT02166333|363184459|FG005|Stage 1|Death|2|||
105323987|NCT02166333|363184454|FG000|Stage 1|Lost to Follow-up|12|||
105323988|NCT02166333|363184455|FG001|Stage 1|Lost to Follow-up|0|||
105323989|NCT02166333|363184456|FG002|Stage 1|Lost to Follow-up|6|||
105323990|NCT02166333|363184457|FG003|Stage 1|Lost to Follow-up|0|||
105323991|NCT02166333|363184458|FG004|Stage 1|Lost to Follow-up|3|||
105323992|NCT02166333|363184459|FG005|Stage 1|Lost to Follow-up|3|||
105323993|NCT02166333|363184454|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
105323994|NCT02166333|363184455|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
105323995|NCT02166333|363184456|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
105323996|NCT02166333|363184457|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
105323997|NCT02166333|363184458|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
105323998|NCT02166333|363184459|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
105323999|NCT02166333|363184454|FG000|Stage 2|Death|4|||
105324000|NCT02166333|363184455|FG001|Stage 2|Death|2|||
105324001|NCT02166333|363184456|FG002|Stage 2|Death|1|||
105324002|NCT02166333|363184457|FG003|Stage 2|Death|0|||
105324003|NCT02166333|363184458|FG004|Stage 2|Death|0|||
105324004|NCT02166333|363184459|FG005|Stage 2|Death|1|||
105324005|NCT02166333|363184454|FG000|Stage 2|Lost to Follow-up|23|||
105324006|NCT02166333|363184455|FG001|Stage 2|Lost to Follow-up|4|||
105324007|NCT02166333|363184456|FG002|Stage 2|Lost to Follow-up|11|||
105324008|NCT02166333|363184457|FG003|Stage 2|Lost to Follow-up|9|||
105324009|NCT02166333|363184458|FG004|Stage 2|Lost to Follow-up|3|||
105324010|NCT02166333|363184459|FG005|Stage 2|Lost to Follow-up|6|||
105324011|NCT02286713|363184460|FG000|One Week Follow-Up|Death|1|||
105324012|NCT02286713|363184461|FG001|One Week Follow-Up|Death|0|||
105324013|NCT02286713|363184460|FG000|One Week Follow-Up|Lost to Follow-up|17|||
105324014|NCT02286713|363184461|FG001|One Week Follow-Up|Lost to Follow-up|21|||
105324015|NCT02286713|363184460|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
105324016|NCT02286713|363184461|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
105324017|NCT02286713|363184460|FG000|Three Month Follow-Up|Death|1|||
105324018|NCT02286713|363184461|FG001|Three Month Follow-Up|Death|1|||
105324019|NCT02286713|363184460|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
105324020|NCT02286713|363184461|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
105324021|NCT02286713|363184460|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
105324022|NCT02286713|363184461|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
105324023|NCT02286713|363184460|FG000|Six Month Follow-Up|Death|2|||
105324024|NCT02286713|363184461|FG001|Six Month Follow-Up|Death|0|||
105324025|NCT02286713|363184460|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
105324026|NCT02286713|363184461|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
105324027|NCT04314037|363184462|FG000|Treatment Period 2|Adverse Event|1|||
105324028|NCT04314037|363184463|FG001|Treatment Period 2|Adverse Event|0|||
105324029|NCT04314037|363184462|FG000|Treatment Period 3|Protocol Violation|1|||
105324030|NCT04314037|363184463|FG001|Treatment Period 3|Protocol Violation|0|||
105324031|NCT04314037|363184462|FG000|Treatment Period 3|Adverse Event|0|||
105324032|NCT04314037|363184463|FG001|Treatment Period 3|Adverse Event|1|||
105324033|NCT02654054|363184464|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
105324034|NCT02654054|363184465|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
105324035|NCT02654054|363184466|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
105324036|NCT02654054|363184464|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
105324037|NCT02654054|363184465|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105324038|NCT02654054|363184466|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
105324039|NCT02654054|363184464|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
105324040|NCT02654054|363184465|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
105324041|NCT02654054|363184466|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
105324042|NCT02654054|363184464|FG000|Post-Treatment Follow-Up Period|Other|1|||
105324043|NCT02654054|363184465|FG001|Post-Treatment Follow-Up Period|Other|0|||
105371989|NCT00706797|363369263|FG001|Overall Study|Withdrawal by Subject|1|||
105371990|NCT00706797|363369262|FG000|Overall Study|Death|1|||
105371991|NCT00706797|363369263|FG001|Overall Study|Death|0|||
105371992|NCT00706797|363369262|FG000|Overall Study|Discontinuation of study by sponsor|52|||
105371993|NCT00706797|363369263|FG001|Overall Study|Discontinuation of study by sponsor|63|||
105371994|NCT00706797|363369262|FG000|Overall Study|Protocol Violation|3|||
105371995|NCT00706797|363369263|FG001|Overall Study|Protocol Violation|2|||
105371996|NCT00706797|363369262|FG000|Overall Study|Lost to Follow-up|1|||
105371997|NCT00706797|363369263|FG001|Overall Study|Lost to Follow-up|2|||
105371998|NCT00706797|363369262|FG000|Overall Study|Other|1|||
105371999|NCT00706797|363369263|FG001|Overall Study|Other|0|||
105324044|NCT02654054|363184466|FG002|Post-Treatment Follow-Up Period|Other|4|||
105324045|NCT02654054|363184464|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
105372000|NCT00297167|363369265|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
105372001|NCT00297167|363369266|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
105324046|NCT02654054|363184465|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
105576906|NCT01091428|364112074|FG001|Phase 2|Adverse Event|0|||
105324047|NCT02654054|363184466|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
105324048|NCT00420420|363184467|FG000|Overall Study|Adverse Event|5|||
105324049|NCT00420420|363184468|FG001|Overall Study|Adverse Event|3|||
105324050|NCT00420420|363184467|FG000|Overall Study|Protocol Violation|1|||
105851489|NCT01791153|365112731|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
105851490|NCT01791153|365112732|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
105851491|NCT01791153|365112733|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
105851492|NCT01791153|365112734|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
105851493|NCT01791153|365112735|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
105851494|NCT01791153|365112736|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
105851495|NCT01791153|365112737|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
105851496|NCT01791153|365112738|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
105851497|NCT01791153|365112731|FG000|Part 2: Open-label Period|Adverse Event|0|||
105851498|NCT01791153|365112732|FG001|Part 2: Open-label Period|Adverse Event|0|||
105851499|NCT01791153|365112733|FG002|Part 2: Open-label Period|Adverse Event|0|||
105851500|NCT01791153|365112734|FG003|Part 2: Open-label Period|Adverse Event|0|||
105851501|NCT01791153|365112735|FG004|Part 2: Open-label Period|Adverse Event|0|||
105851502|NCT01791153|365112736|FG005|Part 2: Open-label Period|Adverse Event|1|||
105851503|NCT01791153|365112737|FG006|Part 2: Open-label Period|Adverse Event|1|||
105851504|NCT01791153|365112738|FG007|Part 2: Open-label Period|Adverse Event|2|||
105851505|NCT01791153|365112731|FG000|Part 2: Open-label Period|Death|0|||
105851506|NCT01791153|365112732|FG001|Part 2: Open-label Period|Death|0|||
105851507|NCT01791153|365112733|FG002|Part 2: Open-label Period|Death|0|||
105851508|NCT01791153|365112734|FG003|Part 2: Open-label Period|Death|0|||
105851509|NCT01791153|365112735|FG004|Part 2: Open-label Period|Death|0|||
105851510|NCT01791153|365112736|FG005|Part 2: Open-label Period|Death|1|||
105851511|NCT01791153|365112737|FG006|Part 2: Open-label Period|Death|1|||
105324051|NCT00420420|363184468|FG001|Overall Study|Protocol Violation|1|||
105324052|NCT00420420|363184467|FG000|Overall Study|Withdrawal by Subject|1|||
105324053|NCT00420420|363184468|FG001|Overall Study|Withdrawal by Subject|0|||
105324054|NCT00420420|363184467|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
105324055|NCT00420420|363184468|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
105324056|NCT00856492|363184473|FG000|Overall Study|Ineligible or withdrew consent|1|||
105324057|NCT00856492|363184474|FG001|Overall Study|Ineligible or withdrew consent|1|||
105324058|NCT00856492|363184475|FG002|Overall Study|Ineligible or withdrew consent|2|||
105324059|NCT00931528|363186247|FG000|Overall Study|Protocol Violation|9|||
105324060|NCT00931528|363186248|FG001|Overall Study|Protocol Violation|12|||
105324061|NCT00931528|363186247|FG000|Overall Study|Withdrawal by Subject|4|||
105324062|NCT00931528|363186248|FG001|Overall Study|Withdrawal by Subject|12|||
105324063|NCT00931528|363186247|FG000|Overall Study|Lost to Follow-up|6|||
105324064|NCT00931528|363186248|FG001|Overall Study|Lost to Follow-up|13|||
105324065|NCT00931528|363186247|FG000|Overall Study|Assessment outside of Time Frame|22|||
105324066|NCT00931528|363186248|FG001|Overall Study|Assessment outside of Time Frame|23|||
105324067|NCT04173507|363186249|FG000|Overall Study|On Treatment|3|||
105324068|NCT04173507|363186249|FG000|Overall Study|Adverse Event|3|||
105324069|NCT04173507|363186249|FG000|Overall Study|Progression/Relapse|34|||
105324070|NCT04173507|363186249|FG000|Overall Study|Death|2|||
105324071|NCT01823328|363186250|FG000|Overall Study|Withdrawal by Subject|8|||
105324072|NCT01823328|363186251|FG001|Overall Study|Withdrawal by Subject|6|||
105324073|NCT04179838|363186254|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
105324074|NCT04179838|363186255|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
105324075|NCT04179838|363186254|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
105324076|NCT04179838|363186255|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
105324077|NCT02572570|363186258|FG000|Overall Study|Study Terminated|27|||
105324078|NCT02763046|363186259|FG000|Overall Study|Adverse Event|5|||
105324079|NCT02763046|363186260|FG001|Overall Study|Adverse Event|4|||
105324080|NCT02763046|363186261|FG002|Overall Study|Adverse Event|0|||
105324081|NCT02763046|363186259|FG000|Overall Study|Lack of Efficacy|1|||
105324082|NCT02763046|363186260|FG001|Overall Study|Lack of Efficacy|1|||
105324083|NCT02763046|363186261|FG002|Overall Study|Lack of Efficacy|3|||
105324084|NCT02763046|363186259|FG000|Overall Study|Physician Decision|1|||
105324085|NCT02763046|363186260|FG001|Overall Study|Physician Decision|0|||
105324086|NCT02763046|363186261|FG002|Overall Study|Physician Decision|1|||
105324087|NCT02763046|363186259|FG000|Overall Study|Subject/guardian decision|2|||
105324088|NCT02763046|363186260|FG001|Overall Study|Subject/guardian decision|0|||
105324089|NCT02763046|363186261|FG002|Overall Study|Subject/guardian decision|4|||
105324090|NCT00513695|363186262|FG000|Overall Study|Discontinued therapy|2|||
105324091|NCT00513695|363186262|FG000|Overall Study|Progression prior to surgery|3|||
105324092|NCT01417156|363186268|FG000|Overall Study|Adverse Event|12|||
105324093|NCT01417156|363186268|FG000|Overall Study|Protocol Violation|2|||
105324094|NCT02764762|363186271|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
105324095|NCT02764762|363186271|FG000|Overall Study|Lost to Follow-up|4|||
105324096|NCT02764762|363186271|FG000|Overall Study|Voluntary Withdrawal|8|||
105372002|NCT00297167|363369267|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
105372003|NCT00297167|363369265|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
105324097|NCT02764762|363186271|FG000|Overall Study|Site Termination|1|||
105324098|NCT02764762|363186271|FG000|Overall Study|Lack of Efficacy|16|||
105324099|NCT02764762|363186271|FG000|Overall Study|Reason not Specified|1|||
105324100|NCT03052751|363186272|FG000|Dosing Period 1|Adverse Event|0|||
105324101|NCT03052751|363186273|FG001|Dosing Period 1|Adverse Event|1|||
105324102|NCT03052751|363186274|FG002|Dosing Period 1|Adverse Event|0|||
105324103|NCT03052751|363186275|FG003|Dosing Period 1|Adverse Event|0|||
105324104|NCT03052751|363186276|FG004|Dosing Period 1|Adverse Event|0|||
105324105|NCT03052751|363186277|FG005|Dosing Period 1|Adverse Event|0|||
105324106|NCT03052751|363186272|FG000|Dosing Period 2|Adverse Event|0|||
105324107|NCT03052751|363186273|FG001|Dosing Period 2|Adverse Event|0|||
105324108|NCT03052751|363186274|FG002|Dosing Period 2|Adverse Event|3|||
105324109|NCT03052751|363186275|FG003|Dosing Period 2|Adverse Event|0|||
105324110|NCT03052751|363186276|FG004|Dosing Period 2|Adverse Event|0|||
105324111|NCT03052751|363186277|FG005|Dosing Period 2|Adverse Event|0|||
105324112|NCT03052751|363186272|FG000|Observation Period|Adverse Event|0|||
105324113|NCT03052751|363186273|FG001|Observation Period|Adverse Event|0|||
105324114|NCT03052751|363186274|FG002|Observation Period|Adverse Event|0|||
105324115|NCT03052751|363186275|FG003|Observation Period|Adverse Event|0|||
105324116|NCT03052751|363186276|FG004|Observation Period|Adverse Event|1|||
105324117|NCT03052751|363186277|FG005|Observation Period|Adverse Event|0|||
105324118|NCT01173523|363186278|FG000|Overall Study|Clinical Progression|1|||
105324119|NCT01173523|363186279|FG001|Overall Study|Clinical Progression|1|||
105324120|NCT01173523|363186278|FG000|Overall Study|Progressive Disease|10|||
105324121|NCT01173523|363186279|FG001|Overall Study|Progressive Disease|8|||
105324122|NCT01173523|363186278|FG000|Overall Study|Other|2|||
105324123|NCT01173523|363186279|FG001|Overall Study|Other|3|||
105324124|NCT01067105|363186282|FG000|Overall Study|Adverse Event|14|||
105324125|NCT01067105|363186282|FG000|Overall Study|Protocol Violation|48|||
105324126|NCT01067105|363186282|FG000|Overall Study|Withdrawal by Subject|36|||
105324127|NCT01067105|363186282|FG000|Overall Study|Lost to Follow-up|6|||
105324128|NCT01067105|363186282|FG000|Overall Study|Physician Decision|6|||
105324129|NCT01067105|363186282|FG000|Overall Study|Other|31|||
105324130|NCT02760004|363186284|FG000|Overall Study|Lost to Follow-up|13|||
105324131|NCT02760004|363186285|FG001|Overall Study|Lost to Follow-up|22|||
105324132|NCT02719184|363186288|FG000|Overall Study|Other than listed|1|||
105324133|NCT02719184|363186289|FG001|Overall Study|Other than listed|12|||
105324134|NCT02719184|363186290|FG002|Overall Study|Other than listed|13|||
105324135|NCT02719184|363186291|FG003|Overall Study|Other than listed|22|||
105324136|NCT02719184|363186292|FG004|Overall Study|Other than listed|9|||
105324137|NCT02719184|363186288|FG000|Overall Study|Withdrawal by Subject|5|||
105851512|NCT01791153|365112738|FG007|Part 2: Open-label Period|Death|1|||
105851513|NCT01791153|365112731|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
105851514|NCT01791153|365112732|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
105851515|NCT01791153|365112733|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
105851516|NCT01791153|365112734|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
105851517|NCT01791153|365112735|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
105851518|NCT01791153|365112736|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
105851519|NCT01791153|365112737|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
105851520|NCT01791153|365112738|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
105851521|NCT01791153|365112731|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
105851522|NCT01791153|365112732|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
105851523|NCT01791153|365112733|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
105851524|NCT01791153|365112734|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
105851525|NCT01791153|365112735|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
105851526|NCT01791153|365112736|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
105851527|NCT01791153|365112737|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
105851528|NCT01791153|365112738|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
105851529|NCT01791153|365112731|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
105851530|NCT01791153|365112732|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
105851531|NCT01791153|365112733|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
105851532|NCT01791153|365112734|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
105324138|NCT02719184|363186289|FG001|Overall Study|Withdrawal by Subject|3|||
105851533|NCT01791153|365112735|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
105851534|NCT01791153|365112736|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
105324139|NCT02719184|363186290|FG002|Overall Study|Withdrawal by Subject|6|||
105324140|NCT02719184|363186291|FG003|Overall Study|Withdrawal by Subject|6|||
105324141|NCT02719184|363186292|FG004|Overall Study|Withdrawal by Subject|0|||
105324142|NCT02719184|363186288|FG000|Overall Study|Lost to Follow-up|0|||
105324143|NCT02719184|363186289|FG001|Overall Study|Lost to Follow-up|4|||
105324144|NCT02719184|363186290|FG002|Overall Study|Lost to Follow-up|1|||
105324145|NCT02719184|363186291|FG003|Overall Study|Lost to Follow-up|3|||
105324146|NCT02719184|363186292|FG004|Overall Study|Lost to Follow-up|0|||
105324147|NCT02719184|363186288|FG000|Overall Study|Protocol Violation|0|||
105324148|NCT02719184|363186289|FG001|Overall Study|Protocol Violation|3|||
105324149|NCT02719184|363186290|FG002|Overall Study|Protocol Violation|0|||
105324150|NCT02719184|363186291|FG003|Overall Study|Protocol Violation|2|||
105324151|NCT02719184|363186292|FG004|Overall Study|Protocol Violation|0|||
105324152|NCT02719184|363186288|FG000|Overall Study|Adverse Event|0|||
105324153|NCT02719184|363186289|FG001|Overall Study|Adverse Event|0|||
105324154|NCT02719184|363186290|FG002|Overall Study|Adverse Event|0|||
105324155|NCT02719184|363186291|FG003|Overall Study|Adverse Event|3|||
105324156|NCT02719184|363186292|FG004|Overall Study|Adverse Event|0|||
105324157|NCT01439802|363186293|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
105324158|NCT01439802|363186293|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
105324159|NCT00324987|363186297|FG000|Overall Study|Adverse Event|2|||
105324160|NCT00324987|363186298|FG001|Overall Study|Adverse Event|1|||
105324161|NCT00324987|363186297|FG000|Overall Study|Withdrawal by Subject|1|||
105324162|NCT00324987|363186298|FG001|Overall Study|Withdrawal by Subject|1|||
105324163|NCT00324987|363186297|FG000|Overall Study|Progression|1|||
105324164|NCT00324987|363186298|FG001|Overall Study|Progression|1|||
105324165|NCT00324987|363186297|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
105324166|NCT00324987|363186298|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
105324167|NCT02058069|363186299|FG000|Overall Study|Exclusion due to implant size|5|||
105324168|NCT02058069|363186299|FG000|Overall Study|Withdrawal by Subject|6|||
105324169|NCT00897715|363186307|FG000|Overall Study|Lost to Follow-up|0|||
105324170|NCT00897715|363186308|FG001|Overall Study|Lost to Follow-up|1|||
105324171|NCT00897715|363186307|FG000|Overall Study|Physician Decision|1|||
105324172|NCT00897715|363186308|FG001|Overall Study|Physician Decision|0|||
105324173|NCT00897715|363186307|FG000|Overall Study|increased risk of infection|1|||
105324174|NCT00897715|363186308|FG001|Overall Study|increased risk of infection|0|||
105324175|NCT00707239|363186309|FG000|Overall Study|Adverse Event|5|||
105324176|NCT00707239|363186310|FG001|Overall Study|Adverse Event|3|||
105324177|NCT00707239|363186311|FG002|Overall Study|Adverse Event|2|||
105324178|NCT00707239|363186309|FG000|Overall Study|Death|3|||
105324179|NCT00707239|363186310|FG001|Overall Study|Death|1|||
105324180|NCT00707239|363186311|FG002|Overall Study|Death|3|||
105324181|NCT00707239|363186309|FG000|Overall Study|Physician Decision|1|||
105324182|NCT00707239|363186310|FG001|Overall Study|Physician Decision|1|||
105324183|NCT00707239|363186311|FG002|Overall Study|Physician Decision|2|||
105324184|NCT00707239|363186309|FG000|Overall Study|Protocol Violation|0|||
105324185|NCT00707239|363186310|FG001|Overall Study|Protocol Violation|0|||
105324186|NCT00707239|363186311|FG002|Overall Study|Protocol Violation|1|||
105324187|NCT00707239|363186309|FG000|Overall Study|Lack of Efficacy|1|||
105324188|NCT00707239|363186310|FG001|Overall Study|Lack of Efficacy|2|||
105324189|NCT00707239|363186311|FG002|Overall Study|Lack of Efficacy|0|||
105324190|NCT00707239|363186309|FG000|Overall Study|Randomized, but not treated|1|||
105324191|NCT00707239|363186310|FG001|Overall Study|Randomized, but not treated|1|||
105324192|NCT00707239|363186311|FG002|Overall Study|Randomized, but not treated|1|||
105324193|NCT00707239|363186309|FG000|Overall Study|Other|8|||
105324194|NCT00707239|363186310|FG001|Overall Study|Other|3|||
105324195|NCT00707239|363186311|FG002|Overall Study|Other|5|||
105324196|NCT03472014|363186313|FG000|Overall Study|Lost to Follow-up|4|||
105324197|NCT00110396|363186314|FG000|Overall Study|Adverse Event|15|||
105324198|NCT00110396|363186314|FG000|Overall Study|Lost to Follow-up|1|||
105324199|NCT00110396|363186314|FG000|Overall Study|Administration of plasmapheresis|1|||
105324200|NCT00110396|363186314|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
105324201|NCT00110396|363186314|FG000|Overall Study|Lack of Efficacy|1|||
105324202|NCT00110396|363186314|FG000|Overall Study|Decided not to continue treatment|1|||
105324203|NCT00110396|363186314|FG000|Overall Study|Patient non-compliance|1|||
105324204|NCT00110396|363186314|FG000|Overall Study|Patient refused to continue|1|||
105372004|NCT00297167|363369266|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
105372005|NCT00297167|363369267|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
105372006|NCT00296335|363369268|FG000|Overall Study|Recurrence|3|||
105372007|NCT00296335|363369269|FG001|Overall Study|Recurrence|51|||
105372008|NCT00296335|363369268|FG000|Overall Study|Adverse Event|17|||
105372009|NCT00296335|363369269|FG001|Overall Study|Adverse Event|27|||
105372010|NCT00296335|363369268|FG000|Overall Study|Lost to Follow-up|7|||
105372011|NCT00296335|363369269|FG001|Overall Study|Lost to Follow-up|33|||
105372012|NCT00296335|363369268|FG000|Overall Study|Physician Decision|3|||
105372013|NCT00296335|363369269|FG001|Overall Study|Physician Decision|11|||
105324205|NCT00110396|363186314|FG000|Overall Study|Patient refused to participate|1|||
105324206|NCT00110396|363186314|FG000|Overall Study|Patient will|1|||
105324207|NCT00110396|363186314|FG000|Overall Study|Patient's decision|1|||
105324208|NCT00110396|363186314|FG000|Overall Study|Participation in MS vaccine study|1|||
105324209|NCT00110396|363186314|FG000|Overall Study|Pregnancy|1|||
105324210|NCT00110396|363186314|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
105324211|NCT00110396|363186314|FG000|Overall Study|Protocol Violation|2|||
105324212|NCT00110396|363186314|FG000|Overall Study|Patient refused to come back|1|||
105324213|NCT00110396|363186314|FG000|Overall Study|The patient has refused|2|||
105324214|NCT00110396|363186314|FG000|Overall Study|The patient has refused to visit site|1|||
105324215|NCT00110396|363186314|FG000|Overall Study|Patient is to be administered copaxone|1|||
105324216|NCT02792517|363186315|FG000|Overall Study|Withdrawal by Subject|10|||
105324217|NCT02792517|363186315|FG000|Overall Study|Decision by Sponsor|7|||
105324218|NCT02792517|363186315|FG000|Overall Study|Lost to Follow-up|3|||
105324219|NCT00882518|363186316|FG000|Overall Study|Adverse Event|9|||
105324220|NCT00882518|363186317|FG001|Overall Study|Adverse Event|18|||
105324221|NCT00882518|363186316|FG000|Overall Study|Withdrawal by Subject|9|||
105491661|NCT00566501|363812532|FG000|Overall Study|Withdrawal by Subject|33|||
105491662|NCT00566501|363812533|FG001|Overall Study|Withdrawal by Subject|30|||
105491663|NCT00566501|363812532|FG000|Overall Study|Lack of Efficacy|8|||
105491664|NCT00566501|363812533|FG001|Overall Study|Lack of Efficacy|3|||
105491665|NCT00566501|363812532|FG000|Overall Study|Other|25|||
105491666|NCT00566501|363812533|FG001|Overall Study|Other|21|||
105491667|NCT00679055|363812537|FG000|Overall Study|Adverse Event|0|||
105491668|NCT00679055|363812538|FG001|Overall Study|Adverse Event|1|||
105491669|NCT00679055|363812537|FG000|Overall Study|Other|0|||
105491670|NCT00679055|363812538|FG001|Overall Study|Other|3|||
105491671|NCT00679055|363812537|FG000|Overall Study|Study Terminated|2|||
105491672|NCT00679055|363812538|FG001|Overall Study|Study Terminated|1|||
105491673|NCT01400815|363812539|FG000|Overall Study|Adverse Event|3|||
105491674|NCT01400815|363812540|FG001|Overall Study|Adverse Event|0|||
105491675|NCT01400815|363812539|FG000|Overall Study|Death|0|||
105491676|NCT01400815|363812540|FG001|Overall Study|Death|1|||
105491677|NCT01400815|363812539|FG000|Overall Study|Lost to Follow-up|18|||
105491678|NCT01400815|363812540|FG001|Overall Study|Lost to Follow-up|11|||
105491679|NCT01400815|363812539|FG000|Overall Study|Protocol Violation|0|||
105491680|NCT01400815|363812540|FG001|Overall Study|Protocol Violation|1|||
105491681|NCT01400815|363812539|FG000|Overall Study|Physician Decision|1|||
105491682|NCT01400815|363812540|FG001|Overall Study|Physician Decision|0|||
105491683|NCT01400815|363812539|FG000|Overall Study|Withdrawal by Subject|15|||
105491684|NCT01400815|363812540|FG001|Overall Study|Withdrawal by Subject|8|||
105491685|NCT01400815|363812539|FG000|Overall Study|Subject in jail|1|||
105491686|NCT01400815|363812540|FG001|Overall Study|Subject in jail|0|||
105491687|NCT04950166|363812550|FG000|Overall Study|Withdrawal by Subject|1|||
105491688|NCT01199731|363812551|FG000|Overall Study|Adverse Event|0|||
105491689|NCT01199731|363812552|FG001|Overall Study|Adverse Event|1|||
105491690|NCT01199731|363812553|FG002|Overall Study|Adverse Event|0|||
105491691|NCT01199731|363812551|FG000|Overall Study|Study closed/terminated|7|||
105491692|NCT01199731|363812552|FG001|Overall Study|Study closed/terminated|9|||
105491693|NCT01199731|363812553|FG002|Overall Study|Study closed/terminated|7|||
105491694|NCT01199731|363812551|FG000|Overall Study|Lost to Follow-up|0|||
105491695|NCT01199731|363812552|FG001|Overall Study|Lost to Follow-up|0|||
105324222|NCT00882518|363186317|FG001|Overall Study|Withdrawal by Subject|13|||
105324223|NCT00882518|363186316|FG000|Overall Study|Lack of Efficacy|12|||
105324224|NCT00882518|363186317|FG001|Overall Study|Lack of Efficacy|9|||
105324225|NCT00882518|363186316|FG000|Overall Study|Severe non-compliance to protocol|3|||
105324226|NCT00882518|363186317|FG001|Overall Study|Severe non-compliance to protocol|1|||
105324227|NCT00882518|363186316|FG000|Overall Study|Incorrect enrolment|4|||
105324228|NCT00882518|363186317|FG001|Overall Study|Incorrect enrolment|2|||
105324229|NCT00882518|363186316|FG000|Overall Study|Central lab closure for National day|1|||
105324230|NCT00882518|363186317|FG001|Overall Study|Central lab closure for National day|0|||
105324231|NCT00882518|363186316|FG000|Overall Study|Allocating random number by mistake|0|||
105324232|NCT00882518|363186317|FG001|Overall Study|Allocating random number by mistake|1|||
105324233|NCT02414958|363186318|FG000|Overall Study|Adverse Event|6|||
105324234|NCT02414958|363186319|FG001|Overall Study|Adverse Event|6|||
105324235|NCT02414958|363186320|FG002|Overall Study|Adverse Event|3|||
105324236|NCT02414958|363186318|FG000|Overall Study|Protocol Violation|10|||
105324237|NCT02414958|363186319|FG001|Overall Study|Protocol Violation|3|||
105324238|NCT02414958|363186320|FG002|Overall Study|Protocol Violation|1|||
105372014|NCT01027845|363369270|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
105372015|NCT01027845|363369271|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
105372016|NCT01027845|363369272|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
105372017|NCT01027845|363369273|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
105372018|NCT01027845|363369270|FG000|Primary Vaccination Phase|Adverse Event|1|||
105372019|NCT01027845|363369271|FG001|Primary Vaccination Phase|Adverse Event|0|||
105372020|NCT01027845|363369272|FG002|Primary Vaccination Phase|Adverse Event|0|||
105372021|NCT01027845|363369273|FG003|Primary Vaccination Phase|Adverse Event|0|||
105372022|NCT01027845|363369270|FG000|Primary Vaccination Phase|Protocol Violation|1|||
105372023|NCT01027845|363369271|FG001|Primary Vaccination Phase|Protocol Violation|0|||
105372024|NCT01027845|363369272|FG002|Primary Vaccination Phase|Protocol Violation|0|||
105324239|NCT02414958|363186318|FG000|Overall Study|Lost to Follow-up|7|||
105324240|NCT02414958|363186319|FG001|Overall Study|Lost to Follow-up|4|||
105324241|NCT02414958|363186320|FG002|Overall Study|Lost to Follow-up|0|||
105324242|NCT02414958|363186318|FG000|Overall Study|Withdrawal by Subject|5|||
105324243|NCT02414958|363186319|FG001|Overall Study|Withdrawal by Subject|3|||
105491696|NCT01199731|363812553|FG002|Overall Study|Lost to Follow-up|2|||
105491697|NCT01199731|363812551|FG000|Overall Study|Physician Decision|0|||
105491698|NCT01199731|363812552|FG001|Overall Study|Physician Decision|1|||
105491699|NCT01199731|363812553|FG002|Overall Study|Physician Decision|1|||
105324244|NCT02414958|363186320|FG002|Overall Study|Withdrawal by Subject|5|||
105491700|NCT01199731|363812551|FG000|Overall Study|Withdrawal by Subject|2|||
105491701|NCT01199731|363812552|FG001|Overall Study|Withdrawal by Subject|0|||
105324245|NCT02414958|363186318|FG000|Overall Study|Other than specified|4|||
105324246|NCT02414958|363186319|FG001|Overall Study|Other than specified|4|||
105324247|NCT02414958|363186320|FG002|Overall Study|Other than specified|5|||
105324248|NCT02059135|363186321|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
105324249|NCT02059135|363186322|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
105324250|NCT02059135|363186321|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
105324251|NCT02059135|363186322|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
105324252|NCT02059135|363186321|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
105324253|NCT02059135|363186322|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
105324254|NCT02059135|363186321|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
105324255|NCT02059135|363186322|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
105324256|NCT02059135|363186321|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
105324257|NCT02059135|363186322|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
105324258|NCT02059135|363186321|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
105324259|NCT02059135|363186322|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
105324260|NCT02059135|363186321|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
105324261|NCT02059135|363186322|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
105324262|NCT02059135|363186321|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
105324263|NCT02059135|363186322|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
105324264|NCT03335475|363186323|FG000|Overall Study|Did not wear accelerometer|4|||
105324265|NCT03335475|363186324|FG001|Overall Study|Did not wear accelerometer|0|||
105324266|NCT03335475|363186323|FG000|Overall Study|Withdrawal by Subject|0|||
105324267|NCT03335475|363186324|FG001|Overall Study|Withdrawal by Subject|1|||
105324268|NCT04620746|363186325|FG000|Overall Study|Adverse Event|2|||
105324269|NCT04620746|363186326|FG001|Overall Study|Adverse Event|0|||
105324270|NCT04620746|363186325|FG000|Overall Study|Uniterpretable skin test|1|||
105324271|NCT04620746|363186326|FG001|Overall Study|Uniterpretable skin test|0|||
105324272|NCT04620746|363186325|FG000|Overall Study|Withdrawal by Subject|0|||
105324273|NCT04620746|363186326|FG001|Overall Study|Withdrawal by Subject|1|||
105324274|NCT00789854|363186327|FG000|Overall Study|Adverse Event|28|||
105324275|NCT00789854|363186328|FG001|Overall Study|Adverse Event|23|||
105324276|NCT00789854|363186329|FG002|Overall Study|Adverse Event|18|||
105324277|NCT00789854|363186327|FG000|Overall Study|Lost to Follow-up|1|||
105324278|NCT00789854|363186328|FG001|Overall Study|Lost to Follow-up|1|||
105324279|NCT00789854|363186329|FG002|Overall Study|Lost to Follow-up|4|||
105324280|NCT00789854|363186327|FG000|Overall Study|Withdrawal by Subject|9|||
105324281|NCT00789854|363186328|FG001|Overall Study|Withdrawal by Subject|6|||
105324282|NCT00789854|363186329|FG002|Overall Study|Withdrawal by Subject|17|||
105324283|NCT00789854|363186327|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
105324284|NCT00789854|363186328|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
105324285|NCT00789854|363186329|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
105324286|NCT00789854|363186327|FG000|Overall Study|Severe non-compliance to the protocol|3|||
105324287|NCT00789854|363186328|FG001|Overall Study|Severe non-compliance to the protocol|0|||
105324288|NCT00789854|363186329|FG002|Overall Study|Severe non-compliance to the protocol|0|||
105324289|NCT00789854|363186327|FG000|Overall Study|Safety reasons|0|||
105324290|NCT00789854|363186328|FG001|Overall Study|Safety reasons|0|||
105324291|NCT00789854|363186329|FG002|Overall Study|Safety reasons|2|||
105324292|NCT00789854|363186327|FG000|Overall Study|Other|6|||
105324293|NCT00789854|363186328|FG001|Overall Study|Other|0|||
105324294|NCT00789854|363186329|FG002|Overall Study|Other|5|||
105324295|NCT03411863|363186330|FG000|Overall Study|Withdrawal by Subject|3|||
105324296|NCT03411863|363186331|FG001|Overall Study|Withdrawal by Subject|1|||
105324297|NCT03411863|363186330|FG000|Overall Study|Physician Decision|0|||
105324298|NCT03411863|363186331|FG001|Overall Study|Physician Decision|1|||
105324299|NCT04578535|363186332|FG000|Overall Study|Lost to Follow-up|1|||
105324300|NCT04578535|363186333|FG001|Overall Study|Lost to Follow-up|0|||
105324301|NCT04578535|363186334|FG002|Overall Study|Lost to Follow-up|0|||
105324302|NCT04578535|363186335|FG003|Overall Study|Lost to Follow-up|1|||
105324303|NCT04578535|363186336|FG004|Overall Study|Lost to Follow-up|0|||
105324304|NCT04578535|363186337|FG005|Overall Study|Lost to Follow-up|2|||
105324305|NCT04578535|363186332|FG000|Overall Study|Pregnancy|1|||
105372025|NCT01027845|363369273|FG003|Primary Vaccination Phase|Protocol Violation|0|||
105372026|NCT01027845|363369270|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
105372027|NCT01027845|363369271|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
105324306|NCT04578535|363186333|FG001|Overall Study|Pregnancy|0|||
105372028|NCT01027845|363369272|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
105324307|NCT04578535|363186334|FG002|Overall Study|Pregnancy|0|||
105324308|NCT04578535|363186335|FG003|Overall Study|Pregnancy|0|||
105324309|NCT04578535|363186336|FG004|Overall Study|Pregnancy|0|||
105324310|NCT04578535|363186337|FG005|Overall Study|Pregnancy|0|||
105324311|NCT04578535|363186332|FG000|Overall Study|Withdrawal by Subject|0|||
105324312|NCT04578535|363186333|FG001|Overall Study|Withdrawal by Subject|0|||
105324313|NCT04578535|363186334|FG002|Overall Study|Withdrawal by Subject|0|||
105324314|NCT04578535|363186335|FG003|Overall Study|Withdrawal by Subject|1|||
105372029|NCT01027845|363369273|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
105372030|NCT01027845|363369270|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
105372031|NCT01027845|363369271|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
105372032|NCT01027845|363369272|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
105372033|NCT01027845|363369273|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
105372034|NCT01027845|363369270|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
105372035|NCT01027845|363369271|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
105372036|NCT01027845|363369272|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
105372037|NCT01027845|363369273|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
105372038|NCT00368550|363369274|FG000|Overall Study|Adverse Event|7|||
105372039|NCT00368550|363369275|FG001|Overall Study|Adverse Event|4|||
105372040|NCT00368550|363369274|FG000|Overall Study|Lack of Efficacy|4|||
105372041|NCT00368550|363369275|FG001|Overall Study|Lack of Efficacy|9|||
105372042|NCT00368550|363369274|FG000|Overall Study|Withdrawal by Subject|17|||
105372043|NCT00368550|363369275|FG001|Overall Study|Withdrawal by Subject|10|||
105372044|NCT01401322|363369276|FG000|Overall Study|Withdrawal by Subject|1|||
105372045|NCT01401322|363369276|FG000|Overall Study|Physician Decision|1|||
105372046|NCT00486044|363369277|FG000|Overall Study|Withdrawal by Subject|2|||
105372047|NCT00486044|363369278|FG001|Overall Study|Withdrawal by Subject|1|||
105372048|NCT00486044|363369277|FG000|Overall Study|Adverse Event|0|||
105372049|NCT00486044|363369278|FG001|Overall Study|Adverse Event|1|||
105372050|NCT00486044|363369277|FG000|Overall Study|Lost to Follow-up|0|||
105372051|NCT00486044|363369278|FG001|Overall Study|Lost to Follow-up|1|||
105372052|NCT02737722|363369280|FG000|Overall Study|Physician Decision|0|||
105372053|NCT02737722|363369281|FG001|Overall Study|Physician Decision|0|||
105372054|NCT02737722|363369282|FG002|Overall Study|Physician Decision|1|||
105372055|NCT02737722|363369283|FG003|Overall Study|Physician Decision|0|||
105372056|NCT01026493|363369284|FG000|Overall Study|Protocol Violation|0|||
105372057|NCT01026493|363369285|FG001|Overall Study|Protocol Violation|1|||
105372058|NCT01026493|363369286|FG002|Overall Study|Protocol Violation|0|||
105372059|NCT01026493|363369287|FG003|Overall Study|Protocol Violation|0|||
105372060|NCT01026493|363369288|FG004|Overall Study|Protocol Violation|2|||
105372061|NCT01026493|363369289|FG005|Overall Study|Protocol Violation|3|||
105372062|NCT01026493|363369290|FG006|Overall Study|Protocol Violation|4|||
105372063|NCT01026493|363369291|FG007|Overall Study|Protocol Violation|1|||
105372064|NCT01206764|363369292|FG000|Overall Study|Adverse Event|20|||
105372065|NCT01206764|363369292|FG000|Overall Study|Abnormal laboratory value|2|||
105372066|NCT01206764|363369292|FG000|Overall Study|Abnormal test procedure result|1|||
105372067|NCT01206764|363369292|FG000|Overall Study|Patient withdrew consent|5|||
105372068|NCT01206764|363369292|FG000|Overall Study|Lost to Follow-up|6|||
105372069|NCT01206764|363369292|FG000|Overall Study|Death|11|||
105372070|NCT01206764|363369292|FG000|Overall Study|New cancer therapy|2|||
105372071|NCT01206764|363369292|FG000|Overall Study|Disease progression|88|||
105372072|NCT01206764|363369292|FG000|Overall Study|Protocol deviation|3|||
105372073|NCT01186770|363369295|FG000|Overall Study|Ineligibility|0|||
105372074|NCT01186770|363369296|FG001|Overall Study|Ineligibility|0|||
105372075|NCT01186770|363369297|FG002|Overall Study|Ineligibility|2|||
105372076|NCT01186770|363369298|FG003|Overall Study|Ineligibility|0|||
105372077|NCT01186770|363369295|FG000|Overall Study|Protocol Violation|7|||
105372078|NCT01186770|363369296|FG001|Overall Study|Protocol Violation|9|||
105372079|NCT01186770|363369297|FG002|Overall Study|Protocol Violation|12|||
105372080|NCT01186770|363369298|FG003|Overall Study|Protocol Violation|14|||
105372081|NCT01186770|363369295|FG000|Overall Study|Adverse Event|2|||
105372082|NCT01186770|363369296|FG001|Overall Study|Adverse Event|9|||
105372083|NCT01186770|363369297|FG002|Overall Study|Adverse Event|7|||
105372084|NCT01186770|363369298|FG003|Overall Study|Adverse Event|9|||
105372085|NCT01186770|363369295|FG000|Overall Study|Withdrawal by Subject|15|||
105372086|NCT01186770|363369296|FG001|Overall Study|Withdrawal by Subject|13|||
105372087|NCT01186770|363369297|FG002|Overall Study|Withdrawal by Subject|11|||
105372088|NCT01186770|363369298|FG003|Overall Study|Withdrawal by Subject|17|||
105372089|NCT01186770|363369295|FG000|Overall Study|Lost to Follow-up|10|||
105372090|NCT01186770|363369296|FG001|Overall Study|Lost to Follow-up|6|||
105372091|NCT01186770|363369297|FG002|Overall Study|Lost to Follow-up|14|||
105372092|NCT01186770|363369298|FG003|Overall Study|Lost to Follow-up|9|||
105372093|NCT01186770|363369295|FG000|Overall Study|Insufficient response to treatment|7|||
105372094|NCT01186770|363369296|FG001|Overall Study|Insufficient response to treatment|8|||
105372095|NCT01186770|363369297|FG002|Overall Study|Insufficient response to treatment|5|||
105372096|NCT01186770|363369298|FG003|Overall Study|Insufficient response to treatment|7|||
105372097|NCT01186770|363369295|FG000|Overall Study|Other than specified|0|||
105372098|NCT01186770|363369296|FG001|Overall Study|Other than specified|1|||
105372099|NCT01186770|363369297|FG002|Overall Study|Other than specified|1|||
105372100|NCT01186770|363369298|FG003|Overall Study|Other than specified|2|||
105372101|NCT01033136|363369313|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
105372102|NCT01033136|363369314|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
105372103|NCT00701363|363369318|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
105372104|NCT00701363|363369319|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
105576907|NCT01091428|364112075|FG002|Phase 2|Adverse Event|12|||
105324315|NCT04578535|363186336|FG004|Overall Study|Withdrawal by Subject|1|||
105324316|NCT04578535|363186337|FG005|Overall Study|Withdrawal by Subject|5|||
105324317|NCT04578535|363186332|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
105324318|NCT04578535|363186333|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
105324319|NCT04578535|363186334|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
105324320|NCT04578535|363186335|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
105324321|NCT04578535|363186336|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
105324322|NCT04578535|363186337|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
105324323|NCT05317312|363186338|FG000|Overall Study|Withdrawal by Subject|0|||
105324324|NCT05317312|363186339|FG001|Overall Study|Withdrawal by Subject|1|||
105324325|NCT05317312|363186340|FG002|Overall Study|Withdrawal by Subject|0|||
105324326|NCT05317312|363186341|FG003|Overall Study|Withdrawal by Subject|0|||
105324327|NCT05317312|363186338|FG000|Overall Study|Lost to Follow-up|0|||
105491702|NCT01199731|363812553|FG002|Overall Study|Withdrawal by Subject|0|||
105491703|NCT02448810|363812554|FG000|Overall Study|Adverse Event|0|||
105491704|NCT02448810|363812555|FG001|Overall Study|Adverse Event|0|||
105491705|NCT02448810|363812556|FG002|Overall Study|Adverse Event|1|||
105491706|NCT02448810|363812557|FG003|Overall Study|Adverse Event|0|||
105491707|NCT02448810|363812558|FG004|Overall Study|Adverse Event|0|||
105491708|NCT02448810|363812559|FG005|Overall Study|Adverse Event|0|||
105491709|NCT02448810|363812560|FG006|Overall Study|Adverse Event|0|||
105491710|NCT02448810|363812561|FG007|Overall Study|Adverse Event|0|||
105491711|NCT02448810|363812554|FG000|Overall Study|Withdrawal by Subject|0|||
105491712|NCT02448810|363812555|FG001|Overall Study|Withdrawal by Subject|0|||
105491713|NCT02448810|363812556|FG002|Overall Study|Withdrawal by Subject|1|||
105491714|NCT02448810|363812557|FG003|Overall Study|Withdrawal by Subject|0|||
105491715|NCT02448810|363812558|FG004|Overall Study|Withdrawal by Subject|3|||
105491716|NCT02448810|363812559|FG005|Overall Study|Withdrawal by Subject|5|||
105491717|NCT02448810|363812560|FG006|Overall Study|Withdrawal by Subject|0|||
105491718|NCT02448810|363812561|FG007|Overall Study|Withdrawal by Subject|2|||
105491719|NCT02448810|363812554|FG000|Overall Study|Other (study terminated by sponsor)|0|||
105491720|NCT02448810|363812555|FG001|Overall Study|Other (study terminated by sponsor)|0|||
105491721|NCT02448810|363812556|FG002|Overall Study|Other (study terminated by sponsor)|0|||
105491722|NCT02448810|363812557|FG003|Overall Study|Other (study terminated by sponsor)|0|||
105491723|NCT02448810|363812558|FG004|Overall Study|Other (study terminated by sponsor)|4|||
105491724|NCT02448810|363812559|FG005|Overall Study|Other (study terminated by sponsor)|2|||
105491725|NCT02448810|363812560|FG006|Overall Study|Other (study terminated by sponsor)|2|||
105491726|NCT02448810|363812561|FG007|Overall Study|Other (study terminated by sponsor)|1|||
105491727|NCT02448810|363812554|FG000|Overall Study|Death|1|||
105491728|NCT02448810|363812555|FG001|Overall Study|Death|0|||
105491729|NCT02448810|363812556|FG002|Overall Study|Death|1|||
105491730|NCT02448810|363812557|FG003|Overall Study|Death|0|||
105491731|NCT02448810|363812558|FG004|Overall Study|Death|1|||
105491732|NCT02448810|363812559|FG005|Overall Study|Death|0|||
105491733|NCT02448810|363812560|FG006|Overall Study|Death|0|||
105491734|NCT02448810|363812561|FG007|Overall Study|Death|0|||
105491735|NCT02448810|363812554|FG000|Overall Study|Other (Progressive disease)|2|||
105491736|NCT02448810|363812555|FG001|Overall Study|Other (Progressive disease)|2|||
105491737|NCT02448810|363812556|FG002|Overall Study|Other (Progressive disease)|0|||
105491738|NCT02448810|363812557|FG003|Overall Study|Other (Progressive disease)|3|||
105491739|NCT02448810|363812558|FG004|Overall Study|Other (Progressive disease)|23|||
105324328|NCT05317312|363186339|FG001|Overall Study|Lost to Follow-up|0|||
105324329|NCT05317312|363186340|FG002|Overall Study|Lost to Follow-up|0|||
105324330|NCT05317312|363186341|FG003|Overall Study|Lost to Follow-up|1|||
105324331|NCT05317312|363186338|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
105324332|NCT05317312|363186339|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
105324333|NCT05317312|363186340|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
105324334|NCT05317312|363186341|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
105324335|NCT03839628|363186342|FG000|Overall Study|Withdrawal by Subject|1|||
105324336|NCT03164551|363186343|FG000|Overall Study|Imaging discontinued prior completion|8|||
105324337|NCT03164551|363186344|FG001|Overall Study|Imaging discontinued prior completion|0|||
105324338|NCT03164551|363186343|FG000|Overall Study|Participant was non-compliant|1|||
105372105|NCT00701363|363369320|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
105491740|NCT02448810|363812559|FG005|Overall Study|Other (Progressive disease)|9|||
105491741|NCT02448810|363812560|FG006|Overall Study|Other (Progressive disease)|14|||
105491742|NCT02448810|363812561|FG007|Overall Study|Other (Progressive disease)|5|||
105491743|NCT02448810|363812554|FG000|Overall Study|Lost to Follow-up|0|||
105491744|NCT02448810|363812555|FG001|Overall Study|Lost to Follow-up|1|||
105372106|NCT00701363|363369321|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
105491745|NCT02448810|363812556|FG002|Overall Study|Lost to Follow-up|0|||
105491746|NCT02448810|363812557|FG003|Overall Study|Lost to Follow-up|0|||
105491747|NCT02448810|363812558|FG004|Overall Study|Lost to Follow-up|0|||
105491748|NCT02448810|363812559|FG005|Overall Study|Lost to Follow-up|0|||
105324339|NCT03164551|363186344|FG001|Overall Study|Participant was non-compliant|0|||
105324340|NCT03164551|363186343|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
105324341|NCT03164551|363186344|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
105324342|NCT03164551|363186343|FG000|Overall Study|Other|8|||
105324343|NCT03164551|363186344|FG001|Overall Study|Other|2|||
105324344|NCT02314026|363186351|FG000|Overall Study|Protocol Violation|28|||
105324345|NCT04421131|363186352|FG000|Overall Study|Lost to Follow-up|1|||
105324346|NCT04421131|363186352|FG000|Overall Study|Protocol Violation|2|||
105324347|NCT04421131|363186352|FG000|Overall Study|App crashed|5|||
105324348|NCT01532934|363186354|FG000|Overall Study|Lost to Follow-up|11|||
105372107|NCT00701363|363369318|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
105372108|NCT00701363|363369319|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
105372109|NCT00701363|363369320|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
105372110|NCT00701363|363369321|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
105372111|NCT00701363|363369318|FG000|Treatment Phase 1|Adverse Event|7|||
105372112|NCT00701363|363369319|FG001|Treatment Phase 1|Adverse Event|0|||
105372113|NCT00701363|363369320|FG002|Treatment Phase 1|Adverse Event|0|||
105372114|NCT00701363|363369321|FG003|Treatment Phase 1|Adverse Event|0|||
105372115|NCT00701363|363369318|FG000|Treatment Phase 1|Protocol Violation|1|||
105372116|NCT00701363|363369319|FG001|Treatment Phase 1|Protocol Violation|0|||
105372117|NCT00701363|363369320|FG002|Treatment Phase 1|Protocol Violation|0|||
105372118|NCT00701363|363369321|FG003|Treatment Phase 1|Protocol Violation|0|||
105372119|NCT00701363|363369318|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
105372120|NCT00701363|363369319|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
105372121|NCT00701363|363369320|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
105372122|NCT00701363|363369321|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
105372123|NCT00701363|363369318|FG000|Treatment Phase 1|Lack of Efficacy|1|||
105372124|NCT00701363|363369319|FG001|Treatment Phase 1|Lack of Efficacy|0|||
105372125|NCT00701363|363369320|FG002|Treatment Phase 1|Lack of Efficacy|0|||
105372126|NCT00701363|363369321|FG003|Treatment Phase 1|Lack of Efficacy|0|||
105372127|NCT00701363|363369318|FG000|Treatment Phase 2|Adverse Event|0|||
105372128|NCT00701363|363369319|FG001|Treatment Phase 2|Adverse Event|0|||
105372129|NCT00701363|363369320|FG002|Treatment Phase 2|Adverse Event|1|||
105372130|NCT00701363|363369321|FG003|Treatment Phase 2|Adverse Event|0|||
105372131|NCT00701363|363369318|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
105372132|NCT00701363|363369319|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
105372133|NCT00701363|363369320|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
105372134|NCT00701363|363369321|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
105372135|NCT02722967|363369322|FG000|Overall Study|Adverse Event|1|||
105372136|NCT02722967|363369323|FG001|Overall Study|Adverse Event|0|||
105372137|NCT02722967|363369324|FG002|Overall Study|Adverse Event|0|||
105372138|NCT02722967|363369322|FG000|Overall Study|Lost to Follow-up|0|||
105372139|NCT02722967|363369323|FG001|Overall Study|Lost to Follow-up|1|||
105372140|NCT02722967|363369324|FG002|Overall Study|Lost to Follow-up|0|||
105372141|NCT02722967|363369322|FG000|Overall Study|Non-compliance with patch wearing|2|||
105372142|NCT02722967|363369323|FG001|Overall Study|Non-compliance with patch wearing|1|||
105372143|NCT02722967|363369324|FG002|Overall Study|Non-compliance with patch wearing|1|||
105372144|NCT02722967|363369322|FG000|Overall Study|Withdrawal by Subject|1|||
105372145|NCT02722967|363369323|FG001|Overall Study|Withdrawal by Subject|0|||
105372146|NCT02722967|363369324|FG002|Overall Study|Withdrawal by Subject|1|||
105372147|NCT02722967|363369322|FG000|Overall Study|Physician Decision|1|||
105372148|NCT02722967|363369323|FG001|Overall Study|Physician Decision|0|||
105372149|NCT02722967|363369324|FG002|Overall Study|Physician Decision|0|||
105372150|NCT02722967|363369322|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
105372151|NCT02722967|363369323|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
105372152|NCT02722967|363369324|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
105372153|NCT02391337|363369325|FG000|6 Months Follow-up|Death|5|||
105372154|NCT02391337|363369326|FG001|6 Months Follow-up|Death|4|||
105372155|NCT02391337|363369325|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
105372156|NCT02391337|363369326|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
105372157|NCT02391337|363369325|FG000|12 Months Follow-up|Death|2|||
105372158|NCT02391337|363369326|FG001|12 Months Follow-up|Death|0|||
105372159|NCT02391337|363369325|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
105372160|NCT02391337|363369326|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
105372161|NCT02391337|363369325|FG000|12 Months Follow-up|Lost to Follow-up|0|||
105372162|NCT02391337|363369326|FG001|12 Months Follow-up|Lost to Follow-up|2|||
105372163|NCT00465517|363369327|FG000|Overall Study|Adverse Event|7|||
105372164|NCT00465517|363369328|FG001|Overall Study|Adverse Event|3|||
105372165|NCT00465517|363369327|FG000|Overall Study|Lost to Follow-up|1|||
105372166|NCT00465517|363369328|FG001|Overall Study|Lost to Follow-up|0|||
105372167|NCT00465517|363369327|FG000|Overall Study|Withdrawal by Subject|4|||
105372168|NCT00465517|363369328|FG001|Overall Study|Withdrawal by Subject|1|||
105372169|NCT00289276|363369333|FG000|Second Part of FAST Study (Expansion)|Death|0|||
105372170|NCT00289276|363369334|FG001|Second Part of FAST Study (Expansion)|Death|2|||
105372171|NCT00289276|363369333|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
105372172|NCT00289276|363369334|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
105491749|NCT02448810|363812560|FG006|Overall Study|Lost to Follow-up|0|||
105324349|NCT01532934|363186355|FG001|Overall Study|Lost to Follow-up|11|||
105324350|NCT01532934|363186354|FG000|Overall Study|In controlled environment|3|||
105324351|NCT01532934|363186355|FG001|Overall Study|In controlled environment|2|||
105324352|NCT00729937|363186356|FG000|Overall Study|Lost to Follow-up|49|||
105324353|NCT00729937|363186357|FG001|Overall Study|Lost to Follow-up|58|||
105324354|NCT00729937|363186358|FG002|Overall Study|Lost to Follow-up|18|||
105324355|NCT00729937|363186359|FG003|Overall Study|Lost to Follow-up|33|||
105324356|NCT00729937|363186360|FG004|Overall Study|Lost to Follow-up|18|||
105324357|NCT00729937|363186361|FG005|Overall Study|Lost to Follow-up|23|||
105324358|NCT00729937|363186356|FG000|Overall Study|Physician Decision|7|||
105324359|NCT00729937|363186357|FG001|Overall Study|Physician Decision|16|||
105324360|NCT00729937|363186358|FG002|Overall Study|Physician Decision|2|||
105372173|NCT03040726|363369335|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
105372174|NCT03040726|363369336|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
105372175|NCT03040726|363369335|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
105372176|NCT03040726|363369336|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
105372177|NCT03040726|363369335|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
105372178|NCT03040726|363369336|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
105372179|NCT03040726|363369335|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
105372180|NCT03040726|363369336|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
105372181|NCT03040726|363369335|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
105372182|NCT03040726|363369336|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
105372183|NCT04682301|363369338|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
105372184|NCT04682301|363369338|FG000|Overall Study|Death|2|||
105372185|NCT01654276|363369339|FG000|Overall Study|Lack of Efficacy|1|||
105372186|NCT01654276|363369339|FG000|Overall Study|Lost to Follow-up|4|||
105372187|NCT01654276|363369339|FG000|Overall Study|Withdrawal by Subject|1|||
105372188|NCT00315445|363369340|FG000|Overall Study|Adverse Event|7|||
105372189|NCT00315445|363369341|FG001|Overall Study|Adverse Event|12|||
105372190|NCT00315445|363369342|FG002|Overall Study|Adverse Event|15|||
105372191|NCT00315445|363369340|FG000|Overall Study|Lack of Efficacy|16|||
105372192|NCT00315445|363369341|FG001|Overall Study|Lack of Efficacy|1|||
105372193|NCT00315445|363369342|FG002|Overall Study|Lack of Efficacy|7|||
105372194|NCT00315445|363369340|FG000|Overall Study|Lost to Follow-up|1|||
105372195|NCT00315445|363369341|FG001|Overall Study|Lost to Follow-up|0|||
105372196|NCT00315445|363369342|FG002|Overall Study|Lost to Follow-up|1|||
105372197|NCT00315445|363369340|FG000|Overall Study|Protocol Violation|2|||
105372198|NCT00315445|363369341|FG001|Overall Study|Protocol Violation|0|||
105372199|NCT00315445|363369342|FG002|Overall Study|Protocol Violation|1|||
105372200|NCT00315445|363369340|FG000|Overall Study|Other|1|||
105372201|NCT00315445|363369341|FG001|Overall Study|Other|3|||
105372202|NCT00315445|363369342|FG002|Overall Study|Other|0|||
105372203|NCT02966834|363369343|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
105372204|NCT02966834|363369344|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
105372205|NCT02966834|363369345|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
105372206|NCT02966834|363369346|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
105372207|NCT02966834|363369347|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
105372208|NCT02966834|363369348|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
105372209|NCT02966834|363369343|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
105372210|NCT02966834|363369344|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105372211|NCT02966834|363369345|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105372212|NCT02966834|363369346|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105372213|NCT02966834|363369347|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105372214|NCT02966834|363369348|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105372215|NCT02966834|363369343|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
105372216|NCT02966834|363369344|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
105372217|NCT02966834|363369345|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
105372218|NCT02966834|363369346|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
105372219|NCT02966834|363369347|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
105372220|NCT02966834|363369348|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
105372221|NCT02966834|363369343|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
105372222|NCT02966834|363369344|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
105372223|NCT02966834|363369345|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
105372224|NCT02966834|363369346|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
105372225|NCT02966834|363369347|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
105372226|NCT02966834|363369348|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
105372227|NCT02966834|363369343|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
105372228|NCT02966834|363369344|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
105372229|NCT02966834|363369345|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
105324361|NCT00729937|363186359|FG003|Overall Study|Physician Decision|0|||
105324362|NCT00729937|363186360|FG004|Overall Study|Physician Decision|5|||
105324363|NCT00729937|363186361|FG005|Overall Study|Physician Decision|8|||
105324364|NCT00729937|363186356|FG000|Overall Study|Death|1|||
105324365|NCT00729937|363186357|FG001|Overall Study|Death|0|||
105324366|NCT00729937|363186358|FG002|Overall Study|Death|1|||
105324367|NCT00729937|363186359|FG003|Overall Study|Death|0|||
105324368|NCT00729937|363186360|FG004|Overall Study|Death|0|||
105324369|NCT00729937|363186361|FG005|Overall Study|Death|1|||
105372230|NCT02966834|363369346|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
105372231|NCT02966834|363369347|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
105372232|NCT02966834|363369348|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
105372233|NCT02966834|363369343|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
105372234|NCT02966834|363369344|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
105372235|NCT02966834|363369345|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
105372236|NCT02966834|363369346|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
105372237|NCT02966834|363369347|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
105372238|NCT02966834|363369348|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
105372239|NCT01155570|363369351|FG000|Overall Study|Adverse Event|39|||
105372240|NCT01155570|363369351|FG000|Overall Study|Lack of Efficacy|46|||
105372241|NCT01155570|363369351|FG000|Overall Study|Participant's Economic Reasons|17|||
105372242|NCT01155570|363369351|FG000|Overall Study|No Hospital Visits|7|||
105372243|NCT01155570|363369351|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
105372244|NCT01155570|363369351|FG000|Overall Study|Adverse Event + Other Reasons|7|||
105372245|NCT01155570|363369351|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
105372246|NCT01155570|363369351|FG000|Overall Study|Other Reasons|23|||
105372247|NCT01020123|363369352|FG000|Main Period|Withdrawal by Subject|6|||
105372248|NCT01020123|363369353|FG001|Main Period|Withdrawal by Subject|5|||
105372249|NCT01020123|363369354|FG002|Main Period|Withdrawal by Subject|3|||
105372250|NCT01020123|363369355|FG003|Main Period|Withdrawal by Subject|1|||
105372251|NCT01020123|363369356|FG004|Main Period|Withdrawal by Subject|6|||
105372252|NCT01020123|363369357|FG005|Main Period|Withdrawal by Subject|3|||
105372253|NCT01020123|363369358|FG006|Main Period|Withdrawal by Subject|2|||
105372254|NCT01020123|363369352|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
105372255|NCT01020123|363369353|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
105372256|NCT01020123|363369354|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
105372257|NCT01020123|363369355|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
105372258|NCT01020123|363369356|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
105372259|NCT01020123|363369357|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
105372260|NCT01020123|363369358|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
105372261|NCT01020123|363369352|FG000|Main Period|Adverse Event|5|||
105372262|NCT01020123|363369353|FG001|Main Period|Adverse Event|2|||
105372263|NCT01020123|363369354|FG002|Main Period|Adverse Event|2|||
105372264|NCT01020123|363369355|FG003|Main Period|Adverse Event|1|||
105372265|NCT01020123|363369356|FG004|Main Period|Adverse Event|1|||
105372266|NCT01020123|363369357|FG005|Main Period|Adverse Event|2|||
105372267|NCT01020123|363369358|FG006|Main Period|Adverse Event|1|||
105372268|NCT01020123|363369352|FG000|Main Period|Protocol Violation|4|||
105372269|NCT01020123|363369353|FG001|Main Period|Protocol Violation|4|||
105372270|NCT01020123|363369354|FG002|Main Period|Protocol Violation|2|||
105372271|NCT01020123|363369355|FG003|Main Period|Protocol Violation|5|||
105372272|NCT01020123|363369356|FG004|Main Period|Protocol Violation|2|||
105372273|NCT01020123|363369357|FG005|Main Period|Protocol Violation|3|||
105491750|NCT02448810|363812561|FG007|Overall Study|Lost to Follow-up|0|||
105491751|NCT02448810|363812554|FG000|Overall Study|Other (unspecified)|0|||
105491752|NCT02448810|363812555|FG001|Overall Study|Other (unspecified)|0|||
105491753|NCT02448810|363812556|FG002|Overall Study|Other (unspecified)|0|||
105324370|NCT00729937|363186356|FG000|Overall Study|Withdrawal by Subject|3|||
105324371|NCT00729937|363186357|FG001|Overall Study|Withdrawal by Subject|5|||
105324372|NCT00729937|363186358|FG002|Overall Study|Withdrawal by Subject|6|||
105324373|NCT00729937|363186359|FG003|Overall Study|Withdrawal by Subject|0|||
105324374|NCT00729937|363186360|FG004|Overall Study|Withdrawal by Subject|4|||
105324375|NCT00729937|363186361|FG005|Overall Study|Withdrawal by Subject|2|||
105324376|NCT00729937|363186356|FG000|Overall Study|Randomized but not treated|12|||
105324377|NCT00729937|363186357|FG001|Overall Study|Randomized but not treated|6|||
105324378|NCT00729937|363186358|FG002|Overall Study|Randomized but not treated|1|||
105324379|NCT00729937|363186359|FG003|Overall Study|Randomized but not treated|0|||
105372274|NCT01020123|363369358|FG006|Main Period|Protocol Violation|2|||
105372275|NCT01020123|363369352|FG000|Main Period|Lost to Follow-up|0|||
105491754|NCT02448810|363812557|FG003|Overall Study|Other (unspecified)|0|||
105372276|NCT01020123|363369353|FG001|Main Period|Lost to Follow-up|2|||
105491755|NCT02448810|363812558|FG004|Overall Study|Other (unspecified)|0|||
105372277|NCT01020123|363369354|FG002|Main Period|Lost to Follow-up|0|||
105372278|NCT01020123|363369355|FG003|Main Period|Lost to Follow-up|0|||
105491756|NCT02448810|363812559|FG005|Overall Study|Other (unspecified)|0|||
105324380|NCT00729937|363186360|FG004|Overall Study|Randomized but not treated|1|||
105324381|NCT00729937|363186361|FG005|Overall Study|Randomized but not treated|3|||
105324382|NCT00729937|363186356|FG000|Overall Study|Did not meet eligibility criteria|2|||
105372279|NCT01020123|363369356|FG004|Main Period|Lost to Follow-up|0|||
105372280|NCT01020123|363369357|FG005|Main Period|Lost to Follow-up|0|||
105372281|NCT01020123|363369358|FG006|Main Period|Lost to Follow-up|0|||
105324383|NCT00729937|363186357|FG001|Overall Study|Did not meet eligibility criteria|1|||
105324384|NCT00729937|363186358|FG002|Overall Study|Did not meet eligibility criteria|0|||
105324385|NCT00729937|363186359|FG003|Overall Study|Did not meet eligibility criteria|0|||
105324386|NCT00729937|363186360|FG004|Overall Study|Did not meet eligibility criteria|0|||
105324387|NCT00729937|363186361|FG005|Overall Study|Did not meet eligibility criteria|0|||
105324388|NCT00729937|363186356|FG000|Overall Study|Incarcerated|0|||
105324389|NCT00729937|363186357|FG001|Overall Study|Incarcerated|2|||
105324390|NCT00729937|363186358|FG002|Overall Study|Incarcerated|1|||
105324391|NCT00729937|363186359|FG003|Overall Study|Incarcerated|1|||
105324392|NCT00729937|363186360|FG004|Overall Study|Incarcerated|0|||
105372282|NCT01020123|363369352|FG000|Main Period|Unclasified|2|||
105372283|NCT01020123|363369353|FG001|Main Period|Unclasified|0|||
105372284|NCT01020123|363369354|FG002|Main Period|Unclasified|1|||
105324393|NCT00729937|363186361|FG005|Overall Study|Incarcerated|0|||
105324394|NCT01522456|363186362|FG000|Overall Study|Adverse Event|2|||
105324395|NCT01522456|363186362|FG000|Overall Study|Lost to Follow-up|2|||
105324396|NCT01522456|363186362|FG000|Overall Study|Withdrawal by Subject|2|||
105324397|NCT01522456|363186362|FG000|Overall Study|Pregnancy|1|||
105324398|NCT01522456|363186362|FG000|Overall Study|Tolerability Assessment|1|||
105324399|NCT01406574|363186363|FG000|Overall Study|Adverse Event|0|||
105324400|NCT01406574|363186364|FG001|Overall Study|Adverse Event|0|||
105324401|NCT01406574|363186365|FG002|Overall Study|Adverse Event|1|||
105324402|NCT01406574|363186366|FG003|Overall Study|Adverse Event|3|||
105324403|NCT01406574|363186363|FG000|Overall Study|Physician Decision|0|||
105324404|NCT01406574|363186364|FG001|Overall Study|Physician Decision|0|||
105324405|NCT01406574|363186365|FG002|Overall Study|Physician Decision|0|||
105324406|NCT01406574|363186366|FG003|Overall Study|Physician Decision|1|||
105324407|NCT01406574|363186363|FG000|Overall Study|Withdrawal by Subject|0|||
105324408|NCT01406574|363186364|FG001|Overall Study|Withdrawal by Subject|1|||
105324409|NCT01406574|363186365|FG002|Overall Study|Withdrawal by Subject|0|||
105324410|NCT01406574|363186366|FG003|Overall Study|Withdrawal by Subject|0|||
105324411|NCT01406574|363186363|FG000|Overall Study|Definite progression of primary disease|1|||
105324412|NCT01406574|363186364|FG001|Overall Study|Definite progression of primary disease|0|||
105324413|NCT01406574|363186365|FG002|Overall Study|Definite progression of primary disease|0|||
105324414|NCT01406574|363186366|FG003|Overall Study|Definite progression of primary disease|0|||
105324415|NCT03552380|363186367|FG000|Study Treatment|Disease Progression|3|||
105324416|NCT03552380|363186368|FG001|Study Treatment|Disease Progression|4|||
105324417|NCT03552380|363186367|FG000|Study Treatment|Adverse Event|2|||
105324418|NCT03552380|363186368|FG001|Study Treatment|Adverse Event|2|||
105324419|NCT03552380|363186367|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
105324420|NCT03552380|363186368|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
105324421|NCT03552380|363186367|FG000|Follow up|Death|3|||
105324422|NCT03552380|363186368|FG001|Follow up|Death|4|||
105324423|NCT03552380|363186367|FG000|Follow up|Site IRB terminated|0|||
105324424|NCT03552380|363186368|FG001|Follow up|Site IRB terminated|1|||
105324425|NCT00916383|363186373|FG000|Overall Study|Adverse Event|1|||
105324426|NCT00916383|363186373|FG000|Overall Study|Death|1|||
105324427|NCT00916383|363186373|FG000|Overall Study|Protocol Violation|1|||
105324428|NCT03367819|363186377|FG000|Overall Study|Adverse Event|4|||
105324429|NCT03367819|363186378|FG001|Overall Study|Adverse Event|4|||
105324430|NCT03367819|363186377|FG000|Overall Study|Progressive Disease|15|||
105324431|NCT03367819|363186378|FG001|Overall Study|Progressive Disease|13|||
105324432|NCT03367819|363186377|FG000|Overall Study|Withdrawal by Subject|1|||
105324433|NCT03367819|363186378|FG001|Overall Study|Withdrawal by Subject|0|||
105324434|NCT03367819|363186377|FG000|Overall Study|Other|4|||
105324435|NCT03367819|363186378|FG001|Overall Study|Other|2|||
105324436|NCT01565889|363186379|FG000|Part A|Withdrawal by Subject|1|||
105372285|NCT01020123|363369355|FG003|Main Period|Unclasified|0|||
105372286|NCT01020123|363369356|FG004|Main Period|Unclasified|1|||
105372287|NCT01020123|363369357|FG005|Main Period|Unclasified|3|||
105324437|NCT01565889|363186380|FG001|Part A|Withdrawal by Subject|0|||
105324438|NCT01565889|363186381|FG002|Part A|Withdrawal by Subject|0|||
105372288|NCT01020123|363369358|FG006|Main Period|Unclasified|6|||
105372289|NCT01020123|363369352|FG000|Extention Period|Withdrawal by Subject|2|||
105372290|NCT01020123|363369353|FG001|Extention Period|Withdrawal by Subject|1|||
105576908|NCT01091428|364112076|FG003|Phase 2|Adverse Event|5|||
105324439|NCT01565889|363186382|FG003|Part A|Withdrawal by Subject|0|||
105324440|NCT01565889|363186383|FG004|Part A|Withdrawal by Subject|0|||
105324441|NCT01565889|363186384|FG005|Part A|Withdrawal by Subject|0|||
105324442|NCT01565889|363186379|FG000|Part B|Withdrawal by Subject|0|||
105324443|NCT01565889|363186380|FG001|Part B|Withdrawal by Subject|0|||
105324444|NCT01565889|363186381|FG002|Part B|Withdrawal by Subject|0|||
105324445|NCT01565889|363186382|FG003|Part B|Withdrawal by Subject|0|||
105324446|NCT01565889|363186383|FG004|Part B|Withdrawal by Subject|0|||
105576909|NCT01091428|364112073|FG000|Phase 2|Withdrawal by Subject|0|||
105324447|NCT01565889|363186384|FG005|Part B|Withdrawal by Subject|1|||
105324448|NCT01565889|363186379|FG000|Part B|Lack of Efficacy|0|||
105324449|NCT01565889|363186380|FG001|Part B|Lack of Efficacy|0|||
105324450|NCT01565889|363186381|FG002|Part B|Lack of Efficacy|0|||
105324451|NCT01565889|363186382|FG003|Part B|Lack of Efficacy|0|||
105324452|NCT01565889|363186383|FG004|Part B|Lack of Efficacy|0|||
105324453|NCT01565889|363186384|FG005|Part B|Lack of Efficacy|2|||
105324454|NCT01565889|363186379|FG000|Part B|Lost to Follow-up|0|||
105324455|NCT01565889|363186380|FG001|Part B|Lost to Follow-up|0|||
105324456|NCT01565889|363186381|FG002|Part B|Lost to Follow-up|0|||
105324457|NCT01565889|363186382|FG003|Part B|Lost to Follow-up|0|||
105324458|NCT01565889|363186383|FG004|Part B|Lost to Follow-up|0|||
105324459|NCT01565889|363186384|FG005|Part B|Lost to Follow-up|1|||
105324460|NCT02524847|363186387|FG000|Overall Study|Adverse Event|4|||
105324461|NCT02524847|363186387|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
105324462|NCT02524847|363186387|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
105324463|NCT02524847|363186387|FG000|Overall Study|Death|1|||
105324464|NCT02524847|363186387|FG000|Overall Study|Reason not Specified|1|||
105324465|NCT04352101|363186388|FG000|Overall Study|Physician Decision|2|||
105324466|NCT04352101|363186389|FG001|Overall Study|Physician Decision|1|||
105324467|NCT00725920|363186390|FG000|Overall Study|Lack of Efficacy|3|||
105372291|NCT01020123|363369354|FG002|Extention Period|Withdrawal by Subject|1|||
105372292|NCT01020123|363369355|FG003|Extention Period|Withdrawal by Subject|0|||
105372293|NCT01020123|363369356|FG004|Extention Period|Withdrawal by Subject|0|||
105372294|NCT01020123|363369357|FG005|Extention Period|Withdrawal by Subject|0|||
105372295|NCT01020123|363369358|FG006|Extention Period|Withdrawal by Subject|0|||
105372296|NCT01020123|363369352|FG000|Extention Period|Adverse Event|0|||
105372297|NCT01020123|363369353|FG001|Extention Period|Adverse Event|0|||
105372298|NCT01020123|363369354|FG002|Extention Period|Adverse Event|0|||
105372299|NCT01020123|363369355|FG003|Extention Period|Adverse Event|1|||
105372300|NCT01020123|363369356|FG004|Extention Period|Adverse Event|0|||
105372301|NCT01020123|363369357|FG005|Extention Period|Adverse Event|0|||
105372302|NCT01020123|363369358|FG006|Extention Period|Adverse Event|0|||
105372303|NCT01020123|363369352|FG000|Extention Period|Protocol Violation|1|||
105372304|NCT01020123|363369353|FG001|Extention Period|Protocol Violation|1|||
105372305|NCT01020123|363369354|FG002|Extention Period|Protocol Violation|1|||
105372306|NCT01020123|363369355|FG003|Extention Period|Protocol Violation|0|||
105372307|NCT01020123|363369356|FG004|Extention Period|Protocol Violation|0|||
105372308|NCT01020123|363369357|FG005|Extention Period|Protocol Violation|0|||
105372309|NCT01020123|363369358|FG006|Extention Period|Protocol Violation|1|||
105372310|NCT01020123|363369352|FG000|Extention Period|Lost to Follow-up|0|||
105372311|NCT01020123|363369353|FG001|Extention Period|Lost to Follow-up|0|||
105372312|NCT01020123|363369354|FG002|Extention Period|Lost to Follow-up|0|||
105372313|NCT01020123|363369355|FG003|Extention Period|Lost to Follow-up|0|||
105372314|NCT01020123|363369356|FG004|Extention Period|Lost to Follow-up|0|||
105372315|NCT01020123|363369357|FG005|Extention Period|Lost to Follow-up|2|||
105372316|NCT01020123|363369358|FG006|Extention Period|Lost to Follow-up|0|||
105372317|NCT02318940|363369359|FG000|Overall Study|lost the record|1|||
105372318|NCT02318940|363369360|FG001|Overall Study|lost the record|0|||
105372319|NCT03082729|363369363|FG000|Overall Study|Lost to Follow-up|7|||
105372320|NCT03082729|363369363|FG000|Overall Study|Physician Decision|2|||
105372321|NCT03082729|363369363|FG000|Overall Study|Withdrawal by Subject|1|||
105372322|NCT03082729|363369363|FG000|Overall Study|Lack of Efficacy|9|||
105372323|NCT03082729|363369363|FG000|Overall Study|Adverse Event|4|||
105372324|NCT03082729|363369363|FG000|Overall Study|Protocol Violation|6|||
105372325|NCT03082729|363369363|FG000|Overall Study|Fear of study procedure|1|||
105372326|NCT03082729|363369363|FG000|Overall Study|Scheduling conflict|1|||
105372327|NCT02781324|363369367|FG000|Overall Study|Withdrawal by Subject|1|||
105372328|NCT02781324|363369368|FG001|Overall Study|Withdrawal by Subject|0|||
105372329|NCT02781324|363369367|FG000|Overall Study|Physician Decision|1|||
105372330|NCT02781324|363369368|FG001|Overall Study|Physician Decision|2|||
105372331|NCT02160626|363369369|FG000|Overall Study|Adverse Event|1|||
105372332|NCT02160626|363369370|FG001|Overall Study|Adverse Event|0|||
105372333|NCT02160626|363369371|FG002|Overall Study|Adverse Event|0|||
105372334|NCT02160626|363369369|FG000|Overall Study|Schedule not conducive to study visits|0|||
105372335|NCT02160626|363369370|FG001|Overall Study|Schedule not conducive to study visits|0|||
105372336|NCT02160626|363369371|FG002|Overall Study|Schedule not conducive to study visits|1|||
105372337|NCT02160626|363369369|FG000|Overall Study|Withdrawal by Subject|0|||
105372338|NCT02160626|363369370|FG001|Overall Study|Withdrawal by Subject|1|||
105372339|NCT02160626|363369371|FG002|Overall Study|Withdrawal by Subject|0|||
105851535|NCT01791153|365112737|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
105372340|NCT03074500|363369372|FG000|Overall Study|Lost to Follow-up|1|||
105324468|NCT00725920|363186391|FG001|Overall Study|Lack of Efficacy|6|||
105324469|NCT03918629|363186395|FG000|Overall Study|Adverse Event|19|||
105324470|NCT03918629|363186396|FG001|Overall Study|Adverse Event|20|||
105324471|NCT03918629|363186395|FG000|Overall Study|Death|14|||
105372341|NCT03074500|363369373|FG001|Overall Study|Lost to Follow-up|0|||
105372342|NCT03074500|363369374|FG002|Overall Study|Lost to Follow-up|0|||
105324472|NCT03918629|363186396|FG001|Overall Study|Death|7|||
105324473|NCT03918629|363186395|FG000|Overall Study|Lost to Follow-up|36|||
105324474|NCT03918629|363186396|FG001|Overall Study|Lost to Follow-up|28|||
105372343|NCT03074500|363369372|FG000|Overall Study|Lack of Efficacy|0|||
105372344|NCT03074500|363369373|FG001|Overall Study|Lack of Efficacy|1|||
105324475|NCT03918629|363186395|FG000|Overall Study|Physician Decision|1|||
105324476|NCT03918629|363186396|FG001|Overall Study|Physician Decision|0|||
105324477|NCT03918629|363186395|FG000|Overall Study|Protocol Violation|7|||
105324478|NCT03918629|363186396|FG001|Overall Study|Protocol Violation|4|||
105324479|NCT03918629|363186395|FG000|Overall Study|Withdrawal by Subject|47|||
105324480|NCT03918629|363186396|FG001|Overall Study|Withdrawal by Subject|47|||
105324481|NCT03918629|363186395|FG000|Overall Study|Other|7|||
105324482|NCT03918629|363186396|FG001|Overall Study|Other|11|||
105324483|NCT03918629|363186395|FG000|Overall Study|Randomized but not vaccinated|2|||
105324484|NCT03918629|363186396|FG001|Overall Study|Randomized but not vaccinated|1|||
105324485|NCT04135937|363186403|FG000|Overall Study|Lost to Follow-up|2|||
105324486|NCT04135937|363186403|FG000|Overall Study|Withdrawal by Subject|1|||
105324487|NCT03832686|363186404|FG000|Overall Study|Lost to Follow-up|6|||
105324488|NCT03832686|363186405|FG001|Overall Study|Lost to Follow-up|9|||
105324489|NCT03832686|363186404|FG000|Overall Study|Discontinued Intervention|5|||
105324490|NCT03832686|363186405|FG001|Overall Study|Discontinued Intervention|4|||
105324491|NCT04447027|363186406|FG000|Dose Escalation|Withdrawal by Subject|1|||
105372345|NCT03074500|363369374|FG002|Overall Study|Lack of Efficacy|0|||
105372346|NCT03074500|363369372|FG000|Overall Study|Adverse Event|0|||
105372347|NCT03074500|363369373|FG001|Overall Study|Adverse Event|0|||
105372348|NCT03074500|363369374|FG002|Overall Study|Adverse Event|1|||
105372349|NCT04239924|363369377|FG000|Overall Study|Lost to Follow-up|2|||
105372350|NCT03321721|363369380|FG000|Overall Study|Lost to Follow-up|4|||
105372351|NCT03321721|363369381|FG001|Overall Study|Lost to Follow-up|8|||
105372352|NCT03321721|363369382|FG002|Overall Study|Lost to Follow-up|11|||
105372353|NCT01416571|363369385|FG000|Overall Study|Lost to Follow-up|2|||
105372354|NCT03353220|363369386|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
105372355|NCT03353220|363369387|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
105372356|NCT01712516|363370633|FG000|Overall Study|Technical problems|0|||
105372357|NCT01712516|363370634|FG001|Overall Study|Technical problems|0|||
105372358|NCT01712516|363370635|FG002|Overall Study|Technical problems|0|||
105372359|NCT01712516|363370636|FG003|Overall Study|Technical problems|2|||
105372360|NCT01712516|363370633|FG000|Overall Study|Lost to Follow-up|0|||
105372361|NCT01712516|363370634|FG001|Overall Study|Lost to Follow-up|0|||
105372362|NCT01712516|363370635|FG002|Overall Study|Lost to Follow-up|2|||
105372363|NCT01712516|363370636|FG003|Overall Study|Lost to Follow-up|1|||
105372364|NCT01712516|363370633|FG000|Overall Study|Death|0|||
105372365|NCT01712516|363370634|FG001|Overall Study|Death|1|||
105372366|NCT01712516|363370635|FG002|Overall Study|Death|0|||
105372367|NCT01712516|363370636|FG003|Overall Study|Death|0|||
105372368|NCT01712516|363370633|FG000|Overall Study|Protocol deviation|1|||
105372369|NCT01712516|363370634|FG001|Overall Study|Protocol deviation|0|||
105372370|NCT01712516|363370635|FG002|Overall Study|Protocol deviation|1|||
105372371|NCT01712516|363370636|FG003|Overall Study|Protocol deviation|0|||
105372372|NCT01712516|363370633|FG000|Overall Study|Physician Decision|2|||
105372373|NCT01712516|363370634|FG001|Overall Study|Physician Decision|0|||
105372374|NCT01712516|363370635|FG002|Overall Study|Physician Decision|0|||
105372375|NCT01712516|363370636|FG003|Overall Study|Physician Decision|1|||
105372376|NCT01712516|363370633|FG000|Overall Study|Withdrawal by Subject|3|||
105372377|NCT01712516|363370634|FG001|Overall Study|Withdrawal by Subject|9|||
105372378|NCT01712516|363370635|FG002|Overall Study|Withdrawal by Subject|3|||
105372379|NCT01712516|363370636|FG003|Overall Study|Withdrawal by Subject|9|||
105372380|NCT01721798|363370637|FG000|Overall Study|Death|0|||
105372381|NCT01721798|363370638|FG001|Overall Study|Death|0|||
105372382|NCT01721798|363370639|FG002|Overall Study|Death|1|||
105372383|NCT01721798|363370640|FG003|Overall Study|Death|1|||
105372384|NCT01721798|363370637|FG000|Overall Study|Lost to Follow-up|2|||
105372385|NCT01721798|363370638|FG001|Overall Study|Lost to Follow-up|2|||
105491757|NCT02448810|363812560|FG006|Overall Study|Other (unspecified)|2|||
105491758|NCT02448810|363812561|FG007|Overall Study|Other (unspecified)|0|||
105324492|NCT04447027|363186407|FG001|Dose Escalation|Withdrawal by Subject|4|||
105324493|NCT04447027|363186408|FG002|Dose Escalation|Withdrawal by Subject|3|||
105324494|NCT04447027|363186409|FG003|Dose Escalation|Withdrawal by Subject|3|||
105324495|NCT04447027|363186410|FG004|Dose Escalation|Withdrawal by Subject|1|||
105324496|NCT04447027|363186411|FG005|Dose Escalation|Withdrawal by Subject|0|||
105324497|NCT04447027|363186412|FG006|Dose Escalation|Withdrawal by Subject|0|||
105324498|NCT04447027|363186413|FG007|Dose Escalation|Withdrawal by Subject|0|||
105324499|NCT04447027|363186414|FG008|Dose Escalation|Withdrawal by Subject|0|||
105324500|NCT04447027|363186406|FG000|Dose Escalation|Refused further treatment|0|||
105324501|NCT04447027|363186407|FG001|Dose Escalation|Refused further treatment|1|||
105372386|NCT01721798|363370639|FG002|Overall Study|Lost to Follow-up|9|||
105372387|NCT01721798|363370640|FG003|Overall Study|Lost to Follow-up|9|||
105372388|NCT01721798|363370637|FG000|Overall Study|Pregnancy|0|||
105372389|NCT01721798|363370638|FG001|Overall Study|Pregnancy|0|||
105372390|NCT01721798|363370639|FG002|Overall Study|Pregnancy|1|||
105372391|NCT01721798|363370640|FG003|Overall Study|Pregnancy|1|||
105372392|NCT01721798|363370637|FG000|Overall Study|Withdrawal by Subject|1|||
105372393|NCT01721798|363370638|FG001|Overall Study|Withdrawal by Subject|0|||
105372394|NCT01721798|363370639|FG002|Overall Study|Withdrawal by Subject|2|||
105372395|NCT01721798|363370640|FG003|Overall Study|Withdrawal by Subject|1|||
105372396|NCT01721798|363370637|FG000|Overall Study|Not eligible for 24 month visit|1|||
105372397|NCT01721798|363370638|FG001|Overall Study|Not eligible for 24 month visit|0|||
105372398|NCT01721798|363370639|FG002|Overall Study|Not eligible for 24 month visit|8|||
105372399|NCT01721798|363370640|FG003|Overall Study|Not eligible for 24 month visit|7|||
105372400|NCT00715208|363370641|FG000|Overall Study|Withdrawal by Subject|1|||
105372401|NCT00715208|363370642|FG001|Overall Study|Withdrawal by Subject|1|||
105372402|NCT00715208|363370641|FG000|Overall Study|Adverse Event|0|||
105372403|NCT00715208|363370642|FG001|Overall Study|Adverse Event|6|||
105372404|NCT00715208|363370641|FG000|Overall Study|Lack of Efficacy|0|||
105372405|NCT00715208|363370642|FG001|Overall Study|Lack of Efficacy|2|||
105372406|NCT01294046|363370643|FG000|Overall Study|Infection and surgical explant|1|||
105372407|NCT01294046|363370643|FG000|Overall Study|Eligibility criteria expanded|1|||
105372408|NCT01294046|363370643|FG000|Overall Study|Stimulation response inadqequate|1|||
105372409|NCT00607893|363370644|FG000|Overall Study|Lost to Follow-up|4|||
105372410|NCT00607893|363370645|FG001|Overall Study|Lost to Follow-up|0|||
105372411|NCT00607893|363370644|FG000|Overall Study|withdrew due to loss of interest|0|||
105372412|NCT00607893|363370645|FG001|Overall Study|withdrew due to loss of interest|1|||
105372413|NCT00607893|363370644|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
105372414|NCT00607893|363370645|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
105372415|NCT00607893|363370644|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
105372416|NCT00607893|363370645|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
105372417|NCT00607893|363370644|FG000|Overall Study|Declined to be treated|1|||
105372418|NCT00607893|363370645|FG001|Overall Study|Declined to be treated|0|||
105372419|NCT00607893|363370644|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
105372420|NCT00607893|363370645|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
105372421|NCT01125930|363370646|FG000|Overall Study|Adverse Event|0|||
105372422|NCT01125930|363370647|FG001|Overall Study|Adverse Event|1|||
105372423|NCT01125930|363370646|FG000|Overall Study|Withdrawal by Subject|1|||
105372424|NCT01125930|363370647|FG001|Overall Study|Withdrawal by Subject|6|||
105372425|NCT01125930|363370646|FG000|Overall Study|Protocol Violation|0|||
105372426|NCT01125930|363370647|FG001|Overall Study|Protocol Violation|1|||
105372427|NCT01125930|363370646|FG000|Overall Study|Lost to Follow-up|0|||
105372428|NCT01125930|363370647|FG001|Overall Study|Lost to Follow-up|2|||
105372429|NCT02566005|363370652|FG000|Overall Study|vaginal bleeding|0|||
105372430|NCT02566005|363370653|FG001|Overall Study|vaginal bleeding|1|||
105372431|NCT02566005|363370652|FG000|Overall Study|received foley|8|||
105372432|NCT02566005|363370653|FG001|Overall Study|received foley|0|||
105372433|NCT02566005|363370652|FG000|Overall Study|did not receive foley|0|||
105372434|NCT02566005|363370653|FG001|Overall Study|did not receive foley|1|||
105372435|NCT02566005|363370652|FG000|Overall Study|labor after randomization|0|||
105372436|NCT02566005|363370653|FG001|Overall Study|labor after randomization|4|||
105372437|NCT02058095|363370654|FG000|Overall Study|Adverse Event|1|||
105372438|NCT02058095|363370655|FG001|Overall Study|Adverse Event|0|||
105372439|NCT02251275|363370658|FG000|Overall Study|Adverse Event|23|||
105372440|NCT02251275|363370659|FG001|Overall Study|Adverse Event|60|||
105372441|NCT02251275|363370660|FG002|Overall Study|Adverse Event|28|||
105372442|NCT02251275|363370661|FG003|Overall Study|Adverse Event|0|||
105372443|NCT02251275|363370662|FG004|Overall Study|Adverse Event|0|||
105372444|NCT02251275|363370658|FG000|Overall Study|Lost to Follow-up|5|||
105372445|NCT02251275|363370659|FG001|Overall Study|Lost to Follow-up|6|||
105372446|NCT02251275|363370660|FG002|Overall Study|Lost to Follow-up|4|||
105372447|NCT02251275|363370661|FG003|Overall Study|Lost to Follow-up|0|||
105372448|NCT02251275|363370662|FG004|Overall Study|Lost to Follow-up|0|||
105372449|NCT02251275|363370658|FG000|Overall Study|Physician Decision|19|||
105851536|NCT01791153|365112738|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
105851537|NCT01791153|365112731|FG000|Part 2: Open-label Period|Physician Decision|0|||
105851538|NCT01791153|365112732|FG001|Part 2: Open-label Period|Physician Decision|0|||
105851539|NCT01791153|365112733|FG002|Part 2: Open-label Period|Physician Decision|0|||
105851540|NCT01791153|365112734|FG003|Part 2: Open-label Period|Physician Decision|0|||
105851541|NCT01791153|365112735|FG004|Part 2: Open-label Period|Physician Decision|1|||
105851542|NCT01791153|365112736|FG005|Part 2: Open-label Period|Physician Decision|1|||
105851543|NCT01791153|365112737|FG006|Part 2: Open-label Period|Physician Decision|0|||
105851544|NCT01791153|365112738|FG007|Part 2: Open-label Period|Physician Decision|0|||
105851545|NCT04135196|365112741|FG000|Overall Study|Lost to Follow-up|8|||
105372450|NCT02251275|363370659|FG001|Overall Study|Physician Decision|30|||
105851546|NCT04135196|365112742|FG001|Overall Study|Lost to Follow-up|7|||
105372451|NCT02251275|363370660|FG002|Overall Study|Physician Decision|26|||
105372452|NCT02251275|363370661|FG003|Overall Study|Physician Decision|0|||
105372453|NCT02251275|363370662|FG004|Overall Study|Physician Decision|1|||
105372454|NCT02251275|363370658|FG000|Overall Study|Protocol Deviation|0|||
105491759|NCT00568685|363812571|FG000|Overall Study|Adverse Event|2|||
105491760|NCT00568685|363812572|FG001|Overall Study|Adverse Event|3|||
105851547|NCT04135196|365112743|FG002|Overall Study|Lost to Follow-up|8|||
105372455|NCT02251275|363370659|FG001|Overall Study|Protocol Deviation|0|||
105372456|NCT02251275|363370660|FG002|Overall Study|Protocol Deviation|1|||
105576910|NCT01091428|364112074|FG001|Phase 2|Withdrawal by Subject|0|||
105576911|NCT01091428|364112075|FG002|Phase 2|Withdrawal by Subject|9|||
105576912|NCT01091428|364112076|FG003|Phase 2|Withdrawal by Subject|8|||
105576913|NCT01091428|364112073|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
105576914|NCT01091428|364112074|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
105576915|NCT01091428|364112075|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
105576916|NCT01091428|364112076|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
105576917|NCT01091428|364112073|FG000|Phase 2|Reason not specified|0|||
105576918|NCT01091428|364112074|FG001|Phase 2|Reason not specified|0|||
105576919|NCT01091428|364112075|FG002|Phase 2|Reason not specified|4|||
105576920|NCT01091428|364112076|FG003|Phase 2|Reason not specified|3|||
105576921|NCT01091428|364112073|FG000|Phase 2|Physician Decision|0|||
105576922|NCT01091428|364112074|FG001|Phase 2|Physician Decision|0|||
105324502|NCT04447027|363186408|FG002|Dose Escalation|Refused further treatment|1|||
105324503|NCT04447027|363186409|FG003|Dose Escalation|Refused further treatment|0|||
105324504|NCT04447027|363186410|FG004|Dose Escalation|Refused further treatment|0|||
105324505|NCT04447027|363186411|FG005|Dose Escalation|Refused further treatment|0|||
105324506|NCT04447027|363186412|FG006|Dose Escalation|Refused further treatment|0|||
105324507|NCT04447027|363186413|FG007|Dose Escalation|Refused further treatment|0|||
105324508|NCT04447027|363186414|FG008|Dose Escalation|Refused further treatment|0|||
105324509|NCT04447027|363186406|FG000|Dose Expansion|Withdrawal by Subject|0|||
105324510|NCT04447027|363186407|FG001|Dose Expansion|Withdrawal by Subject|0|||
105324511|NCT04447027|363186408|FG002|Dose Expansion|Withdrawal by Subject|0|||
105324512|NCT04447027|363186409|FG003|Dose Expansion|Withdrawal by Subject|0|||
105324513|NCT04447027|363186410|FG004|Dose Expansion|Withdrawal by Subject|0|||
105324514|NCT04447027|363186411|FG005|Dose Expansion|Withdrawal by Subject|2|||
105324515|NCT04447027|363186412|FG006|Dose Expansion|Withdrawal by Subject|0|||
105324516|NCT04447027|363186413|FG007|Dose Expansion|Withdrawal by Subject|2|||
105324517|NCT04447027|363186414|FG008|Dose Expansion|Withdrawal by Subject|0|||
105324518|NCT02235454|363186415|FG000|Overall Study|Withdrawal by Subject|2|||
105324519|NCT03641469|363186416|FG000|Overall Study|Ineligible|2|||
105324520|NCT03641469|363186416|FG000|Overall Study|Withdrawal by Subject|5|||
105324521|NCT03641469|363186416|FG000|Overall Study|Physician Decision|1|||
105324522|NCT03641469|363186416|FG000|Overall Study|Protocol Violation|1|||
105324523|NCT03641469|363186416|FG000|Overall Study|Lost to Follow-up|2|||
105324524|NCT05479435|363186417|FG000|Overall Study|Withdrawal by Subject|1|||
105324525|NCT05479435|363186418|FG001|Overall Study|Withdrawal by Subject|0|||
105324526|NCT05479435|363186419|FG002|Overall Study|Withdrawal by Subject|0|||
105324527|NCT05479435|363186417|FG000|Overall Study|Covid 19|0|||
105324528|NCT05479435|363186418|FG001|Overall Study|Covid 19|0|||
105324529|NCT05479435|363186419|FG002|Overall Study|Covid 19|2|||
105324530|NCT00868530|363186420|FG000|Overall Study|Adverse Event|3|||
105324531|NCT00868530|363186420|FG000|Overall Study|Lost to Follow-up|1|||
105324532|NCT05966584|363186421|FG000|Overall Study|Lost to Follow-up|1|||
105324533|NCT00709995|363188267|FG000|Overall Study|Adverse Event|4|||
105324534|NCT00709995|363188268|FG001|Overall Study|Adverse Event|2|||
105324535|NCT00709995|363188267|FG000|Overall Study|Withdrawal by Subject|1|||
105324536|NCT00709995|363188268|FG001|Overall Study|Withdrawal by Subject|3|||
105324537|NCT00638508|363188276|FG000|Overall Study|Physician Decision|5|||
105324538|NCT00638508|363188277|FG001|Overall Study|Physician Decision|2|||
105324539|NCT03499067|363188278|FG000|First Intervention|Physician Decision|2|||
105324540|NCT03499067|363188279|FG001|First Intervention|Physician Decision|1|||
105324541|NCT03499067|363188278|FG000|First Intervention|Withdrawal by Subject|3|||
105324542|NCT03499067|363188279|FG001|First Intervention|Withdrawal by Subject|6|||
105324543|NCT02222922|363188280|FG000|Overall Study|Death|0|||
105324544|NCT02222922|363188281|FG001|Overall Study|Death|0|||
105324545|NCT02222922|363188282|FG002|Overall Study|Death|0|||
105372457|NCT02251275|363370661|FG003|Overall Study|Protocol Deviation|0|||
105372458|NCT02251275|363370662|FG004|Overall Study|Protocol Deviation|0|||
105372459|NCT02251275|363370658|FG000|Overall Study|Withdrawal by Subject|25|||
105372460|NCT02251275|363370659|FG001|Overall Study|Withdrawal by Subject|51|||
105576923|NCT01091428|364112075|FG002|Phase 2|Physician Decision|2|||
105576924|NCT01091428|364112076|FG003|Phase 2|Physician Decision|0|||
105324546|NCT02222922|363188283|FG003|Overall Study|Death|0|||
105324547|NCT02222922|363188284|FG004|Overall Study|Death|13|||
105324548|NCT02222922|363188285|FG005|Overall Study|Death|0|||
105324549|NCT02222922|363188286|FG006|Overall Study|Death|0|||
105324550|NCT02222922|363188287|FG007|Overall Study|Death|0|||
105324551|NCT02222922|363188288|FG008|Overall Study|Death|2|||
105324552|NCT02222922|363188280|FG000|Overall Study|Lost to Follow-up|0|||
105324553|NCT02222922|363188281|FG001|Overall Study|Lost to Follow-up|0|||
105324554|NCT02222922|363188282|FG002|Overall Study|Lost to Follow-up|1|||
105372461|NCT02251275|363370660|FG002|Overall Study|Withdrawal by Subject|35|||
105324555|NCT02222922|363188283|FG003|Overall Study|Lost to Follow-up|0|||
105324556|NCT02222922|363188284|FG004|Overall Study|Lost to Follow-up|9|||
105324557|NCT02222922|363188285|FG005|Overall Study|Lost to Follow-up|1|||
105324558|NCT02222922|363188286|FG006|Overall Study|Lost to Follow-up|0|||
105324559|NCT02222922|363188287|FG007|Overall Study|Lost to Follow-up|0|||
105576925|NCT03518658|364112077|FG000|Overall Study|Other|51|||
105324560|NCT02222922|363188288|FG008|Overall Study|Lost to Follow-up|0|||
105324561|NCT02222922|363188280|FG000|Overall Study|Other|0|||
105324562|NCT02222922|363188281|FG001|Overall Study|Other|0|||
105324563|NCT02222922|363188282|FG002|Overall Study|Other|0|||
105324564|NCT02222922|363188283|FG003|Overall Study|Other|2|||
105324565|NCT02222922|363188284|FG004|Overall Study|Other|10|||
105324566|NCT02222922|363188285|FG005|Overall Study|Other|2|||
105324567|NCT02222922|363188286|FG006|Overall Study|Other|2|||
105324568|NCT02222922|363188287|FG007|Overall Study|Other|4|||
105324569|NCT02222922|363188288|FG008|Overall Study|Other|1|||
105324570|NCT02222922|363188280|FG000|Overall Study|Participant refused further follow-up|1|||
105324571|NCT02222922|363188281|FG001|Overall Study|Participant refused further follow-up|0|||
105324572|NCT02222922|363188282|FG002|Overall Study|Participant refused further follow-up|0|||
105324573|NCT02222922|363188283|FG003|Overall Study|Participant refused further follow-up|1|||
105324574|NCT02222922|363188284|FG004|Overall Study|Participant refused further follow-up|6|||
105324575|NCT02222922|363188285|FG005|Overall Study|Participant refused further follow-up|0|||
105324576|NCT02222922|363188286|FG006|Overall Study|Participant refused further follow-up|0|||
105324577|NCT02222922|363188287|FG007|Overall Study|Participant refused further follow-up|0|||
105324578|NCT02222922|363188288|FG008|Overall Study|Participant refused further follow-up|3|||
105324579|NCT01254643|363188289|FG000|Overall Study|Withdrawal by Subject|1|||
105324580|NCT03347110|363188290|FG000|Overall Study|Other (Participant is incarcerated)|1|||
105324581|NCT03347110|363188290|FG000|Overall Study|Withdrawal by Subject|9|||
105324582|NCT03347110|363188290|FG000|Overall Study|Lost to Follow-up|1|||
105324583|NCT03347110|363188290|FG000|Overall Study|Lack of Efficacy|2|||
105372462|NCT02251275|363370661|FG003|Overall Study|Withdrawal by Subject|1|||
105372463|NCT02251275|363370662|FG004|Overall Study|Withdrawal by Subject|0|||
105372464|NCT01259245|363370663|FG000|Overall Study|Withdrawal by Subject|27|||
105372465|NCT01259245|363370664|FG001|Overall Study|Withdrawal by Subject|24|||
105372466|NCT01259245|363370663|FG000|Overall Study|Death|1|||
105372467|NCT01259245|363370664|FG001|Overall Study|Death|2|||
105372468|NCT00676143|363370669|FG000|Overall Study|Adverse Event|34|||
105372469|NCT00676143|363370670|FG001|Overall Study|Adverse Event|60|||
105372470|NCT00676143|363370669|FG000|Overall Study|Death|4|||
105372471|NCT00676143|363370670|FG001|Overall Study|Death|4|||
105372472|NCT00676143|363370669|FG000|Overall Study|Lack of Efficacy|0|||
105372473|NCT00676143|363370670|FG001|Overall Study|Lack of Efficacy|6|||
105372474|NCT00676143|363370669|FG000|Overall Study|Lost to Follow-up|0|||
105372475|NCT00676143|363370670|FG001|Overall Study|Lost to Follow-up|13|||
105372476|NCT00676143|363370669|FG000|Overall Study|Physician Decision|5|||
105372477|NCT00676143|363370670|FG001|Overall Study|Physician Decision|8|||
105372478|NCT00676143|363370669|FG000|Overall Study|Protocol Violation|4|||
105372479|NCT00676143|363370670|FG001|Overall Study|Protocol Violation|8|||
105372480|NCT00676143|363370669|FG000|Overall Study|Withdrawal by Subject|24|||
105372481|NCT00676143|363370670|FG001|Overall Study|Withdrawal by Subject|42|||
105372482|NCT00676143|363370669|FG000|Overall Study|Discontinuation of study by sponsor|65|||
105372483|NCT00676143|363370670|FG001|Overall Study|Discontinuation of study by sponsor|88|||
105372484|NCT00676143|363370669|FG000|Overall Study|Failed to return|2|||
105372485|NCT00676143|363370670|FG001|Overall Study|Failed to return|1|||
105372486|NCT00676143|363370669|FG000|Overall Study|Loss of caregiver|5|||
105372487|NCT00676143|363370670|FG001|Overall Study|Loss of caregiver|3|||
105372488|NCT00676143|363370669|FG000|Overall Study|Other|11|||
105372489|NCT00676143|363370670|FG001|Overall Study|Other|20|||
105372490|NCT00676143|363370669|FG000|Overall Study|Participant participation unknown|1|||
105372491|NCT00676143|363370670|FG001|Overall Study|Participant participation unknown|4|||
105372492|NCT00676143|363370669|FG000|Overall Study|Vasogenic edema recurrence|1|||
105372493|NCT00676143|363370670|FG001|Overall Study|Vasogenic edema recurrence|3|||
105372494|NCT03502798|363370673|FG000|Overall Study|equipment failure|0|||
105372495|NCT03502798|363370674|FG001|Overall Study|equipment failure|7|||
105372496|NCT00485303|363370675|FG000|Overall Study|Adverse Event|5|||
105372497|NCT00485303|363370675|FG000|Overall Study|Progressive Disease|44|||
105372498|NCT00485303|363370675|FG000|Overall Study|Other|3|||
105372499|NCT00485303|363370675|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
105372500|NCT00485303|363370675|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
105372501|NCT02410629|363370676|FG000|Overall Study|Family cannot commit to the study|2|||
105372502|NCT02410629|363370677|FG001|Overall Study|Family cannot commit to the study|1|||
105372503|NCT02410629|363370676|FG000|Overall Study|Subject returned to work|1|||
105372504|NCT02410629|363370677|FG001|Overall Study|Subject returned to work|0|||
105324584|NCT03347110|363188290|FG000|Overall Study|Adverse Event, non-fatal|9|||
105324585|NCT02105467|363188291|FG000|Period 1|Lost to Follow-up|1|||
105324586|NCT02105467|363188292|FG001|Period 1|Lost to Follow-up|0|||
105324587|NCT02105467|363188291|FG000|Period 1|Death|1|||
105324588|NCT02105467|363188292|FG001|Period 1|Death|0|||
105324589|NCT02105467|363188291|FG000|Period 2|Lost to Follow-up|1|||
105324590|NCT02105467|363188292|FG001|Period 2|Lost to Follow-up|0|||
105324591|NCT02105467|363188291|FG000|Period 2|Death|1|||
105324592|NCT02105467|363188292|FG001|Period 2|Death|0|||
105372505|NCT02410629|363370676|FG000|Overall Study|Subject moved back to home country|0|||
105576926|NCT03518658|364112078|FG001|Overall Study|Other|0|||
105324593|NCT02105467|363188291|FG000|Period 2|Withdrawal by Subject|0|||
105324594|NCT02105467|363188292|FG001|Period 2|Withdrawal by Subject|2|||
105324595|NCT02105467|363188291|FG000|Period 3|Lost to Follow-up|0|||
105324596|NCT02105467|363188292|FG001|Period 3|Lost to Follow-up|1|||
105324597|NCT01125189|363188300|FG000|Treatment Period|Lack of Efficacy|15|||
105324598|NCT01125189|363188301|FG001|Treatment Period|Lack of Efficacy|18|||
105324599|NCT01125189|363188302|FG002|Treatment Period|Lack of Efficacy|25|||
105324600|NCT01125189|363188300|FG000|Treatment Period|Adverse Event|7|||
105324601|NCT01125189|363188301|FG001|Treatment Period|Adverse Event|8|||
105324602|NCT01125189|363188302|FG002|Treatment Period|Adverse Event|8|||
105324603|NCT01125189|363188300|FG000|Treatment Period|Withdrawal by Subject|3|||
105324604|NCT01125189|363188301|FG001|Treatment Period|Withdrawal by Subject|1|||
105324605|NCT01125189|363188302|FG002|Treatment Period|Withdrawal by Subject|1|||
105324606|NCT01125189|363188300|FG000|Treatment Period|Death|1|||
105324607|NCT01125189|363188301|FG001|Treatment Period|Death|0|||
105324608|NCT01125189|363188302|FG002|Treatment Period|Death|0|||
105324609|NCT01125189|363188300|FG000|Treatment Period|Lost to Follow-up|1|||
105324610|NCT01125189|363188301|FG001|Treatment Period|Lost to Follow-up|2|||
105324611|NCT01125189|363188302|FG002|Treatment Period|Lost to Follow-up|1|||
105324612|NCT01125189|363188300|FG000|Treatment Period|Poor compliance/noncompliance|0|||
105324613|NCT01125189|363188301|FG001|Treatment Period|Poor compliance/noncompliance|1|||
105324614|NCT01125189|363188302|FG002|Treatment Period|Poor compliance/noncompliance|0|||
105324615|NCT01125189|363188300|FG000|Treatment Period|Participants requested to discontinue|1|||
105324616|NCT01125189|363188301|FG001|Treatment Period|Participants requested to discontinue|3|||
105324617|NCT01125189|363188302|FG002|Treatment Period|Participants requested to discontinue|4|||
105324618|NCT01125189|363188300|FG000|Treatment Period|Other reasons|1|||
105324619|NCT01125189|363188301|FG001|Treatment Period|Other reasons|1|||
105324620|NCT01125189|363188302|FG002|Treatment Period|Other reasons|0|||
105324621|NCT01125189|363188300|FG000|Treatment Period|Completed 24 week treatment period only|2|||
105324622|NCT01125189|363188301|FG001|Treatment Period|Completed 24 week treatment period only|1|||
105324623|NCT01125189|363188302|FG002|Treatment Period|Completed 24 week treatment period only|2|||
105324624|NCT01125189|363188300|FG000|Follow up Period|Withdrawal by Subject|3|||
105324625|NCT01125189|363188301|FG001|Follow up Period|Withdrawal by Subject|2|||
105324626|NCT01125189|363188302|FG002|Follow up Period|Withdrawal by Subject|5|||
105324627|NCT01125189|363188300|FG000|Follow up Period|Death|1|||
105324628|NCT01125189|363188301|FG001|Follow up Period|Death|0|||
105324629|NCT01125189|363188302|FG002|Follow up Period|Death|0|||
105324630|NCT01125189|363188300|FG000|Follow up Period|Lost to Follow-up|12|||
105324631|NCT01125189|363188301|FG001|Follow up Period|Lost to Follow-up|9|||
105324632|NCT01125189|363188302|FG002|Follow up Period|Lost to Follow-up|6|||
105324633|NCT01125189|363188300|FG000|Follow up Period|Other reasons|4|||
105324634|NCT01125189|363188301|FG001|Follow up Period|Other reasons|4|||
105324635|NCT01125189|363188302|FG002|Follow up Period|Other reasons|5|||
105324636|NCT02088177|363188306|FG000|Overall Study|Lost to Follow-up|3|||
105324637|NCT01641640|363188307|FG000|Overall Study|Enrolled but not treated|1|||
105324638|NCT01641640|363188307|FG000|Overall Study|Efficacy failure|29|||
105324639|NCT01641640|363188307|FG000|Overall Study|Lost to Follow-up|3|||
105324640|NCT01641640|363188307|FG000|Overall Study|Withdrawal by Subject|2|||
105324641|NCT01641640|363188307|FG000|Overall Study|Adverse Event|1|||
105324642|NCT00289848|363188312|FG000|Overall Study|Adverse Event|6|||
105324643|NCT00289848|363188313|FG001|Overall Study|Adverse Event|4|||
105324644|NCT00289848|363188312|FG000|Overall Study|Death|1|||
105324645|NCT00289848|363188313|FG001|Overall Study|Death|0|||
105324646|NCT00289848|363188312|FG000|Overall Study|Lack of Efficacy|20|||
105372506|NCT02410629|363370677|FG001|Overall Study|Subject moved back to home country|1|||
105491761|NCT00568685|363812573|FG002|Overall Study|Adverse Event|3|||
105491762|NCT00568685|363812571|FG000|Overall Study|Withdrawal by Subject|7|||
105324647|NCT00289848|363188313|FG001|Overall Study|Lack of Efficacy|24|||
105324648|NCT00289848|363188312|FG000|Overall Study|Lost to Follow-up|3|||
105324649|NCT00289848|363188313|FG001|Overall Study|Lost to Follow-up|1|||
105324650|NCT00289848|363188312|FG000|Overall Study|Protocol Violation|5|||
105324651|NCT00289848|363188313|FG001|Overall Study|Protocol Violation|2|||
105324652|NCT00289848|363188312|FG000|Overall Study|Withdrawal by Subject|5|||
105324653|NCT00289848|363188313|FG001|Overall Study|Withdrawal by Subject|11|||
105324654|NCT00289848|363188312|FG000|Overall Study|Patient Moved|6|||
105324655|NCT00289848|363188313|FG001|Overall Study|Patient Moved|2|||
105324656|NCT00289848|363188312|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
105324657|NCT00289848|363188313|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
105324658|NCT01234350|363188315|FG000|Overall Study|Adverse Event|277|||
105324659|NCT01234350|363188316|FG001|Overall Study|Adverse Event|92|||
105324660|NCT01234350|363188315|FG000|Overall Study|Withdrawal by Subject|61|||
105324661|NCT01234350|363188316|FG001|Overall Study|Withdrawal by Subject|36|||
105324662|NCT01234350|363188315|FG000|Overall Study|Lost to Follow-up|115|||
105324663|NCT01234350|363188316|FG001|Overall Study|Lost to Follow-up|47|||
105324664|NCT01234350|363188315|FG000|Overall Study|Covers a diverse set of reasons|234|||
105324665|NCT01234350|363188316|FG001|Overall Study|Covers a diverse set of reasons|92|||
105324666|NCT01199939|363188317|FG000|Overall Study|Adverse Event|4|||
105324667|NCT01199939|363188317|FG000|Overall Study|Protocol Violation|3|||
105324668|NCT01199939|363188317|FG000|Overall Study|Lost to Follow-up|2|||
105324669|NCT01199939|363188317|FG000|Overall Study|Reached a virologic endpoint|4|||
105324670|NCT01836471|363188328|FG000|Overall Study|Pregnancy|1|||
105324671|NCT01836471|363188329|FG001|Overall Study|Pregnancy|0|||
105324672|NCT01836471|363188330|FG002|Overall Study|Pregnancy|0|||
105324673|NCT01836471|363188331|FG003|Overall Study|Pregnancy|0|||
105324674|NCT01836471|363188332|FG004|Overall Study|Pregnancy|0|||
105324675|NCT01836471|363188328|FG000|Overall Study|Withdrawal by Subject|3|||
105324676|NCT01836471|363188329|FG001|Overall Study|Withdrawal by Subject|4|||
105324677|NCT01836471|363188330|FG002|Overall Study|Withdrawal by Subject|1|||
105324678|NCT01836471|363188331|FG003|Overall Study|Withdrawal by Subject|0|||
105324679|NCT01836471|363188332|FG004|Overall Study|Withdrawal by Subject|2|||
105324680|NCT01836471|363188328|FG000|Overall Study|Physician Decision|0|||
105324681|NCT01836471|363188329|FG001|Overall Study|Physician Decision|1|||
105324682|NCT01836471|363188330|FG002|Overall Study|Physician Decision|0|||
105324683|NCT01836471|363188331|FG003|Overall Study|Physician Decision|0|||
105324684|NCT01836471|363188332|FG004|Overall Study|Physician Decision|0|||
105324685|NCT01836471|363188328|FG000|Overall Study|Lost to Follow-up|0|||
105324686|NCT01836471|363188329|FG001|Overall Study|Lost to Follow-up|0|||
105324687|NCT01836471|363188330|FG002|Overall Study|Lost to Follow-up|0|||
105324688|NCT01836471|363188331|FG003|Overall Study|Lost to Follow-up|1|||
105324689|NCT01836471|363188332|FG004|Overall Study|Lost to Follow-up|1|||
105324690|NCT01836471|363188328|FG000|Overall Study|Adverse Event|6|||
105324691|NCT01836471|363188329|FG001|Overall Study|Adverse Event|3|||
105324692|NCT01836471|363188330|FG002|Overall Study|Adverse Event|1|||
105324693|NCT01836471|363188331|FG003|Overall Study|Adverse Event|1|||
105324694|NCT01836471|363188332|FG004|Overall Study|Adverse Event|2|||
105324695|NCT01836471|363188328|FG000|Overall Study|Non compliance with tx|1|||
105324696|NCT01836471|363188329|FG001|Overall Study|Non compliance with tx|1|||
105324697|NCT01836471|363188330|FG002|Overall Study|Non compliance with tx|0|||
105324698|NCT01836471|363188331|FG003|Overall Study|Non compliance with tx|0|||
105324699|NCT01836471|363188332|FG004|Overall Study|Non compliance with tx|0|||
105324700|NCT01960413|363188334|FG000|Overall Study|Withdrawal by Subject|1|||
105324701|NCT01960413|363188335|FG001|Overall Study|Withdrawal by Subject|1|||
105324702|NCT01960413|363188334|FG000|Overall Study|Physician Decision|1|||
105324703|NCT01960413|363188335|FG001|Overall Study|Physician Decision|0|||
105324704|NCT01960413|363188334|FG000|Overall Study|Lost to Follow-up|2|||
105324705|NCT01960413|363188335|FG001|Overall Study|Lost to Follow-up|0|||
105324706|NCT01283464|363188337|FG000|Overall Study|Lost to Follow-up|0|||
105324707|NCT01283464|363188338|FG001|Overall Study|Lost to Follow-up|1|||
105324708|NCT01283464|363188337|FG000|Overall Study|Withdrawal by Subject|1|||
105324709|NCT01283464|363188338|FG001|Overall Study|Withdrawal by Subject|0|||
105324710|NCT01283464|363188337|FG000|Overall Study|Physician Decision|1|||
105324711|NCT01283464|363188338|FG001|Overall Study|Physician Decision|0|||
105324712|NCT03051100|363188339|FG000|Overall Study|Withdrawal by Subject|1|||
105324713|NCT03051100|363188340|FG001|Overall Study|Withdrawal by Subject|0|||
105324714|NCT02105987|363188343|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
105324715|NCT02105987|363188344|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
105324716|NCT02105987|363188345|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
105324717|NCT02105987|363188346|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
105324718|NCT02105987|363188347|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
105324719|NCT02105987|363188348|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
105324720|NCT02105987|363188343|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
105324721|NCT02105987|363188344|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
105324722|NCT02105987|363188345|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
105324723|NCT02105987|363188346|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
105324724|NCT02105987|363188347|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
105324725|NCT02105987|363188348|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
105324726|NCT02105987|363188343|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
105324727|NCT02105987|363188344|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
105324728|NCT02105987|363188345|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105372507|NCT02410629|363370676|FG000|Overall Study|Subject underwent heart surgery|0|||
105372508|NCT02410629|363370677|FG001|Overall Study|Subject underwent heart surgery|1|||
105372509|NCT04465422|363370678|FG000|Overall Study|Lost to Follow-up|0|||
105324729|NCT02105987|363188346|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105324730|NCT02105987|363188347|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105324731|NCT02105987|363188348|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105324732|NCT02105987|363188343|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
105324733|NCT02105987|363188344|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
105324734|NCT02105987|363188345|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105324735|NCT02105987|363188346|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105324736|NCT02105987|363188347|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105324737|NCT02105987|363188348|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105324738|NCT02105987|363188343|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
105324739|NCT02105987|363188344|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
105324740|NCT02105987|363188345|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
105324741|NCT02105987|363188346|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
105324742|NCT02105987|363188347|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
105324743|NCT02105987|363188348|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
105324744|NCT02105987|363188343|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
105324745|NCT02105987|363188344|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
105324746|NCT02105987|363188345|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
105324747|NCT02105987|363188346|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
105324748|NCT02105987|363188347|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
105324749|NCT02105987|363188348|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
105324750|NCT02105987|363188343|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
105324751|NCT02105987|363188344|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
105324752|NCT02105987|363188345|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
105324753|NCT02105987|363188346|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
105324754|NCT02105987|363188347|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
105324755|NCT02105987|363188348|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
105324756|NCT02105987|363188343|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
105324757|NCT02105987|363188344|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
105324758|NCT02105987|363188345|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
105324759|NCT02105987|363188346|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
105324760|NCT02105987|363188347|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
105491763|NCT00568685|363812572|FG001|Overall Study|Withdrawal by Subject|2|||
105324761|NCT02105987|363188348|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
105491764|NCT00568685|363812573|FG002|Overall Study|Withdrawal by Subject|2|||
105491765|NCT00568685|363812571|FG000|Overall Study|Protocol Violation|1|||
105491766|NCT00568685|363812572|FG001|Overall Study|Protocol Violation|0|||
105491767|NCT00568685|363812573|FG002|Overall Study|Protocol Violation|0|||
105491768|NCT01462227|363812574|FG000|Second Assignment|Lost to Follow-up|1|||
105491769|NCT01462227|363812575|FG001|Second Assignment|Lost to Follow-up|0|||
105491770|NCT01462227|363812576|FG002|Second Assignment|Lost to Follow-up|0|||
105491771|NCT01462227|363812577|FG003|Second Assignment|Lost to Follow-up|0|||
105491772|NCT01462227|363812574|FG000|Second Assignment|Protocol Violation|0|||
105491773|NCT01462227|363812575|FG001|Second Assignment|Protocol Violation|1|||
105491774|NCT01462227|363812576|FG002|Second Assignment|Protocol Violation|1|||
105491775|NCT01462227|363812577|FG003|Second Assignment|Protocol Violation|0|||
105491776|NCT02393690|363812578|FG000|Overall Study|Ineligible|0|||
105576927|NCT00312858|364112086|FG000|Overall Study|Adverse Event|0|||
105324762|NCT02105987|363188343|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105324763|NCT02105987|363188344|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105324764|NCT02105987|363188345|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
105491777|NCT02393690|363812579|FG001|Overall Study|Ineligible|1|||
105491778|NCT00591266|363812580|FG000|Overall Study|Adverse Event|2|||
105491779|NCT00591266|363812581|FG001|Overall Study|Adverse Event|2|||
105576928|NCT00312858|364112087|FG001|Overall Study|Adverse Event|1|||
105851548|NCT04135196|365112744|FG003|Overall Study|Lost to Follow-up|9|||
105324765|NCT02105987|363188346|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
105324766|NCT02105987|363188347|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105324767|NCT02105987|363188348|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105324768|NCT02105987|363188343|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105324769|NCT02105987|363188344|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105324770|NCT02105987|363188345|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
105324771|NCT02105987|363188346|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
105324772|NCT02105987|363188347|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105324773|NCT02105987|363188348|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105324774|NCT02105987|363188343|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
105324775|NCT02105987|363188344|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
105324776|NCT02105987|363188345|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
105324777|NCT02105987|363188346|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
105324778|NCT02105987|363188347|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
105324779|NCT02105987|363188348|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
105324780|NCT02105987|363188343|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
105324781|NCT02105987|363188344|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
105324782|NCT02105987|363188345|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
105324783|NCT02105987|363188346|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
105324784|NCT02105987|363188347|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
105324785|NCT02105987|363188348|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
105324786|NCT02105987|363188343|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
105324787|NCT02105987|363188344|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
105491780|NCT00591266|363812582|FG002|Overall Study|Adverse Event|3|||
105576929|NCT00312858|364112086|FG000|Overall Study|Lost to Follow-up|25|||
105324788|NCT02105987|363188345|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
105324789|NCT02105987|363188346|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
105324790|NCT02105987|363188347|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
105324791|NCT02105987|363188348|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
105324792|NCT02105987|363188343|FG000|Continuation Phase|Protocol Violation|0|||
105324793|NCT02105987|363188344|FG001|Continuation Phase|Protocol Violation|0|||
105324794|NCT02105987|363188345|FG002|Continuation Phase|Protocol Violation|0|||
105324795|NCT02105987|363188346|FG003|Continuation Phase|Protocol Violation|0|||
105372510|NCT04465422|363370679|FG001|Overall Study|Lost to Follow-up|2|||
105372511|NCT00142415|363370680|FG000|Overall Study|Physician Decision|0|||
105372512|NCT00142415|363370681|FG001|Overall Study|Physician Decision|0|||
105372513|NCT00142415|363370682|FG002|Overall Study|Physician Decision|0|||
105372514|NCT00142415|363370683|FG003|Overall Study|Physician Decision|0|||
105372515|NCT00142415|363370684|FG004|Overall Study|Physician Decision|1|||
105372516|NCT00142415|363370685|FG005|Overall Study|Physician Decision|2|||
105372517|NCT02147626|363370691|FG000|Overall Study|Lost to Follow-up|4|||
105372518|NCT02147626|363370692|FG001|Overall Study|Lost to Follow-up|4|||
105372519|NCT02147626|363370691|FG000|Overall Study|Pregnancy|1|||
105372520|NCT02147626|363370692|FG001|Overall Study|Pregnancy|2|||
105372521|NCT02147626|363370691|FG000|Overall Study|Withdrawal by Subject|0|||
105372522|NCT02147626|363370692|FG001|Overall Study|Withdrawal by Subject|1|||
105372523|NCT00997893|363370693|FG000|Overall Study|Adverse Event|1|||
105372524|NCT00997893|363370694|FG001|Overall Study|Adverse Event|0|||
105372525|NCT00997893|363370695|FG002|Overall Study|Adverse Event|0|||
105372526|NCT00997893|363370693|FG000|Overall Study|Unable to meet study timelines|1|||
105372527|NCT00997893|363370694|FG001|Overall Study|Unable to meet study timelines|0|||
105372528|NCT00997893|363370695|FG002|Overall Study|Unable to meet study timelines|0|||
105372529|NCT00997893|363370693|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
105372530|NCT00997893|363370694|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
105372531|NCT00997893|363370695|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
105372532|NCT01286129|363370696|FG000|Overall Study|Withdrawal by Subject|4|||
105372533|NCT01286129|363370697|FG001|Overall Study|Withdrawal by Subject|1|||
105372534|NCT01286129|363370696|FG000|Overall Study|Could not comply with study requirements|4|||
105372535|NCT01286129|363370697|FG001|Overall Study|Could not comply with study requirements|4|||
105372536|NCT03805841|363370699|FG000|Overall Study|Clinical Progression|2|||
105372537|NCT03805841|363370700|FG001|Overall Study|Clinical Progression|0|||
105372538|NCT03805841|363370701|FG002|Overall Study|Clinical Progression|0|||
105372539|NCT03805841|363370699|FG000|Overall Study|Death|0|||
105372540|NCT03805841|363370700|FG001|Overall Study|Death|3|||
105372541|NCT03805841|363370701|FG002|Overall Study|Death|1|||
105372542|NCT03805841|363370699|FG000|Overall Study|Lost to Follow-up|0|||
105372543|NCT03805841|363370700|FG001|Overall Study|Lost to Follow-up|0|||
105372544|NCT03805841|363370701|FG002|Overall Study|Lost to Follow-up|1|||
105372545|NCT03805841|363370699|FG000|Overall Study|Withdrawal by Subject|2|||
105372546|NCT03805841|363370700|FG001|Overall Study|Withdrawal by Subject|3|||
105372547|NCT03805841|363370701|FG002|Overall Study|Withdrawal by Subject|0|||
105372548|NCT03805841|363370699|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
105372549|NCT03805841|363370700|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
105372550|NCT03805841|363370701|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
105372551|NCT00465179|363370702|FG000|Overall Study|Adverse Event|4|||
105372552|NCT00465179|363370702|FG000|Overall Study|Withdrawal by Subject|2|||
105372553|NCT00465179|363370702|FG000|Overall Study|Progression of Disease|47|||
105372554|NCT01933594|363370703|FG000|Overall Study|Lost to Follow-up|1|||
105372555|NCT01933594|363370704|FG001|Overall Study|Lost to Follow-up|0|||
105372556|NCT01933594|363370705|FG002|Overall Study|Lost to Follow-up|0|||
105372557|NCT01933594|363370706|FG003|Overall Study|Lost to Follow-up|0|||
105372558|NCT01933594|363370707|FG004|Overall Study|Lost to Follow-up|1|||
105372559|NCT01933594|363370708|FG005|Overall Study|Lost to Follow-up|0|||
105372560|NCT01933594|363370703|FG000|Overall Study|Ineligible for subsequent study step|0|||
105372561|NCT01933594|363370704|FG001|Overall Study|Ineligible for subsequent study step|0|||
105372562|NCT01933594|363370705|FG002|Overall Study|Ineligible for subsequent study step|0|||
105372563|NCT01933594|363370706|FG003|Overall Study|Ineligible for subsequent study step|0|||
105372564|NCT01933594|363370707|FG004|Overall Study|Ineligible for subsequent study step|1|||
105491781|NCT00591266|363812580|FG000|Overall Study|Lost to Follow-up|0|||
105491782|NCT00591266|363812581|FG001|Overall Study|Lost to Follow-up|1|||
105491783|NCT00591266|363812582|FG002|Overall Study|Lost to Follow-up|0|||
105491784|NCT00591266|363812580|FG000|Overall Study|Protocol Violation|0|||
105491785|NCT00591266|363812581|FG001|Overall Study|Protocol Violation|0|||
105491786|NCT00591266|363812582|FG002|Overall Study|Protocol Violation|1|||
105324796|NCT02105987|363188347|FG004|Continuation Phase|Protocol Violation|1|||
105372565|NCT01933594|363370708|FG005|Overall Study|Ineligible for subsequent study step|0|||
105372566|NCT02121210|363370719|FG000|Overall Study|Adverse Event|5|||
105372567|NCT02121210|363370720|FG001|Overall Study|Adverse Event|7|||
105372568|NCT02121210|363370719|FG000|Overall Study|Lack of Efficacy|2|||
105491787|NCT00591266|363812580|FG000|Overall Study|Withdrawal by Subject|6|||
105324797|NCT02105987|363188348|FG005|Continuation Phase|Protocol Violation|0|||
105324798|NCT00837148|363188349|FG000|Overall Study|Adverse Event|1|||
105324799|NCT00837148|363188349|FG000|Overall Study|Death|1|||
105324800|NCT02301169|363188350|FG000|Overall Study|Adverse Event|1|||
105324801|NCT02301169|363188351|FG001|Overall Study|Adverse Event|0|||
105324802|NCT00380874|363188352|FG000|Overall Study|Adverse Event|7|||
105324803|NCT00380874|363188353|FG001|Overall Study|Adverse Event|7|||
105324804|NCT00380874|363188352|FG000|Overall Study|Death|1|||
105324805|NCT00380874|363188353|FG001|Overall Study|Death|0|||
105324806|NCT00380874|363188352|FG000|Overall Study|Withdrawal by Subject|2|||
105324807|NCT00380874|363188353|FG001|Overall Study|Withdrawal by Subject|1|||
105324808|NCT00380874|363188352|FG000|Overall Study|Not related to study drug|3|||
105324809|NCT00380874|363188353|FG001|Overall Study|Not related to study drug|2|||
105324810|NCT01515423|363188354|FG000|Open Label Phase|Adverse Event|57|||
105324811|NCT01515423|363188355|FG001|Open Label Phase|Adverse Event|0|||
105324812|NCT01515423|363188356|FG002|Open Label Phase|Adverse Event|0|||
105324813|NCT01515423|363188354|FG000|Open Label Phase|Death|2|||
105324814|NCT01515423|363188355|FG001|Open Label Phase|Death|0|||
105324815|NCT01515423|363188356|FG002|Open Label Phase|Death|0|||
105324816|NCT01515423|363188354|FG000|Open Label Phase|Lack of Efficacy|117|||
105324817|NCT01515423|363188355|FG001|Open Label Phase|Lack of Efficacy|0|||
105324818|NCT01515423|363188356|FG002|Open Label Phase|Lack of Efficacy|0|||
105324819|NCT01515423|363188354|FG000|Open Label Phase|Lost to Follow-up|21|||
105324820|NCT01515423|363188355|FG001|Open Label Phase|Lost to Follow-up|0|||
105324821|NCT01515423|363188356|FG002|Open Label Phase|Lost to Follow-up|0|||
105324822|NCT01515423|363188354|FG000|Open Label Phase|Withdrawal by Subject|118|||
105324823|NCT01515423|363188355|FG001|Open Label Phase|Withdrawal by Subject|0|||
105324824|NCT01515423|363188356|FG002|Open Label Phase|Withdrawal by Subject|0|||
105324825|NCT01515423|363188354|FG000|Open Label Phase|excluded from DB Phase|70|||
105324826|NCT01515423|363188355|FG001|Open Label Phase|excluded from DB Phase|0|||
105324827|NCT01515423|363188356|FG002|Open Label Phase|excluded from DB Phase|0|||
105324828|NCT01515423|363188354|FG000|Open Label Phase|Other|28|||
105324829|NCT01515423|363188355|FG001|Open Label Phase|Other|0|||
105324830|NCT01515423|363188356|FG002|Open Label Phase|Other|0|||
105324831|NCT01515423|363188354|FG000|DOUBLE BLIND|Adverse Event|0|||
105324832|NCT01515423|363188355|FG001|DOUBLE BLIND|Adverse Event|15|||
105324833|NCT01515423|363188356|FG002|DOUBLE BLIND|Adverse Event|13|||
105324834|NCT01515423|363188354|FG000|DOUBLE BLIND|Death|0|||
105324835|NCT01515423|363188355|FG001|DOUBLE BLIND|Death|1|||
105324836|NCT01515423|363188356|FG002|DOUBLE BLIND|Death|2|||
105324837|NCT01515423|363188354|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
105324838|NCT01515423|363188355|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
105324839|NCT01515423|363188356|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
105324840|NCT01515423|363188354|FG000|DOUBLE BLIND|Pregnancy|0|||
105324841|NCT01515423|363188355|FG001|DOUBLE BLIND|Pregnancy|2|||
105324842|NCT01515423|363188356|FG002|DOUBLE BLIND|Pregnancy|0|||
105324843|NCT01515423|363188354|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
105324844|NCT01515423|363188355|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
105324845|NCT01515423|363188356|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
105324846|NCT01515423|363188354|FG000|DOUBLE BLIND|Other|0|||
105324847|NCT01515423|363188355|FG001|DOUBLE BLIND|Other|6|||
105324848|NCT01515423|363188356|FG002|DOUBLE BLIND|Other|12|||
105324849|NCT01515423|363188354|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
105324850|NCT01515423|363188355|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
105324851|NCT01515423|363188356|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
105324852|NCT01707290|363188361|FG000|Overall Study|Adverse event (AE)|1|||
105324853|NCT01707290|363188362|FG001|Overall Study|Adverse event (AE)|0|||
105324854|NCT01707290|363188361|FG000|Overall Study|Physician Decision|1|||
105324855|NCT01707290|363188362|FG001|Overall Study|Physician Decision|0|||
105324856|NCT01707290|363188361|FG000|Overall Study|Lost to Follow-up|3|||
105324857|NCT01707290|363188362|FG001|Overall Study|Lost to Follow-up|0|||
105324858|NCT01707290|363188361|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
105324859|NCT01707290|363188362|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
105324860|NCT01707290|363188361|FG000|Overall Study|Commercial drug available|60|||
105491788|NCT00591266|363812581|FG001|Overall Study|Withdrawal by Subject|2|||
105324861|NCT01707290|363188362|FG001|Overall Study|Commercial drug available|1|||
105324862|NCT01707290|363188361|FG000|Overall Study|Other unspecified|17|||
105324863|NCT01707290|363188362|FG001|Overall Study|Other unspecified|0|||
105324864|NCT02949973|363188365|FG000|Overall Study|Physician Decision|1|||
105324865|NCT02501928|363188366|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
105491789|NCT00591266|363812582|FG002|Overall Study|Withdrawal by Subject|5|||
105324866|NCT02501928|363188367|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
105324867|NCT02501928|363188368|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
105324868|NCT02501928|363188369|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
105324869|NCT02501928|363188370|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
105324870|NCT02501928|363188371|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
105324871|NCT02291237|363188372|FG000|Overall Study|Study Terminated by Sponsor|72|||
105324872|NCT02291237|363188373|FG001|Overall Study|Study Terminated by Sponsor|67|||
105324873|NCT02291237|363188372|FG000|Overall Study|Adverse Event|1|||
105372569|NCT02121210|363370720|FG001|Overall Study|Lack of Efficacy|0|||
105372570|NCT02121210|363370719|FG000|Overall Study|Other than specified above|0|||
105372571|NCT02121210|363370720|FG001|Overall Study|Other than specified above|2|||
105372572|NCT00830765|363370721|FG000|Overall Study|Protocol Violation|3|||
105372573|NCT00830765|363370722|FG001|Overall Study|Protocol Violation|2|||
105372574|NCT00402831|363370723|FG000|Overall Study|Lost to Follow-up|1|||
105372575|NCT00402831|363370724|FG001|Overall Study|Lost to Follow-up|2|||
105372576|NCT00402831|363370723|FG000|Overall Study|Non-compliance with protocol|0|||
105372577|NCT00402831|363370724|FG001|Overall Study|Non-compliance with protocol|1|||
105372578|NCT00671788|363370727|FG000|Overall Study|Adverse Event|8|||
105372579|NCT00671788|363370727|FG000|Overall Study|Refused further treatment|3|||
105372580|NCT00671788|363370727|FG000|Overall Study|Ineligible|1|||
105372581|NCT00671788|363370727|FG000|Overall Study|MD Decision|1|||
105372582|NCT00671788|363370727|FG000|Overall Study|Other|1|||
105372583|NCT01299909|363370728|FG000|Overall Study|Lost to Follow-up|22|||
105372584|NCT01299909|363370729|FG001|Overall Study|Lost to Follow-up|18|||
105372585|NCT01299909|363370730|FG002|Overall Study|Lost to Follow-up|17|||
105372586|NCT02792504|363370733|FG000|Overall Study|Lost to Follow-up|24|||
105372587|NCT02792504|363370733|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
105372588|NCT01035138|363370734|FG000|Overall Study|Adverse Event|4|||
105372589|NCT01035138|363370735|FG001|Overall Study|Adverse Event|0|||
105372590|NCT01035138|363370736|FG002|Overall Study|Adverse Event|2|||
105372591|NCT01035138|363370734|FG000|Overall Study|Caregiver Decision|2|||
105372592|NCT01035138|363370735|FG001|Overall Study|Caregiver Decision|0|||
105372593|NCT01035138|363370736|FG002|Overall Study|Caregiver Decision|1|||
105372594|NCT01035138|363370734|FG000|Overall Study|Withdrawal by Subject|1|||
105372595|NCT01035138|363370735|FG001|Overall Study|Withdrawal by Subject|0|||
105372596|NCT01035138|363370736|FG002|Overall Study|Withdrawal by Subject|0|||
105372597|NCT01035138|363370734|FG000|Overall Study|Physician Decision|0|||
105372598|NCT01035138|363370735|FG001|Overall Study|Physician Decision|0|||
105372599|NCT01035138|363370736|FG002|Overall Study|Physician Decision|1|||
105372600|NCT01035138|363370734|FG000|Overall Study|Sponsor Decision|66|||
105372601|NCT01035138|363370735|FG001|Overall Study|Sponsor Decision|60|||
105372602|NCT01035138|363370736|FG002|Overall Study|Sponsor Decision|42|||
105372603|NCT01035138|363370734|FG000|Overall Study|Lost to Follow-up|0|||
105372604|NCT01035138|363370735|FG001|Overall Study|Lost to Follow-up|0|||
105372605|NCT01035138|363370736|FG002|Overall Study|Lost to Follow-up|1|||
105372606|NCT01811238|363370737|FG000|Overall Study|Withdrawal by Subject|42|||
105372607|NCT01811238|363370737|FG000|Overall Study|Adverse Event|25|||
105372608|NCT01811238|363370737|FG000|Overall Study|Protocol Violation|4|||
105372609|NCT01811238|363370737|FG000|Overall Study|Lack of Efficacy|4|||
105372610|NCT01811238|363370737|FG000|Overall Study|subject refused study medication|6|||
105372611|NCT00848497|363370744|FG000|Overall Study|Screen failure|2|||
105372612|NCT00848497|363370745|FG001|Overall Study|Screen failure|0|||
105372613|NCT00848497|363370744|FG000|Overall Study|Withdrawal by Subject|0|||
105372614|NCT00848497|363370745|FG001|Overall Study|Withdrawal by Subject|1|||
105372615|NCT01832766|363370746|FG000|Washout|Lost to Follow-up|0|||
105372616|NCT01832766|363370747|FG001|Washout|Lost to Follow-up|1|||
105372617|NCT02340949|363370748|FG000|Overall Study|Adverse Event|4|||
105372618|NCT02340949|363370749|FG001|Overall Study|Adverse Event|2|||
105372619|NCT02340949|363370748|FG000|Overall Study|Withdrawal by Subject|2|||
105372620|NCT02340949|363370749|FG001|Overall Study|Withdrawal by Subject|0|||
105372621|NCT02340949|363370748|FG000|Overall Study|Progression disease|6|||
105372622|NCT02340949|363370749|FG001|Overall Study|Progression disease|2|||
105372623|NCT02340949|363370748|FG000|Overall Study|Death|3|||
105372624|NCT02340949|363370749|FG001|Overall Study|Death|0|||
105372625|NCT02340949|363370748|FG000|Overall Study|Physician Decision|1|||
105372626|NCT02340949|363370749|FG001|Overall Study|Physician Decision|0|||
105491790|NCT00591266|363812580|FG000|Overall Study|Lack of Efficacy|0|||
105491791|NCT00591266|363812581|FG001|Overall Study|Lack of Efficacy|2|||
105491792|NCT00591266|363812582|FG002|Overall Study|Lack of Efficacy|0|||
105491793|NCT00591266|363812580|FG000|Overall Study|Other|1|||
105851549|NCT04135196|365112745|FG004|Overall Study|Lost to Follow-up|1|||
105372627|NCT03883386|363370750|FG000|First Assignment|Lost to Follow-up|1|||
105372628|NCT03883386|363370751|FG001|First Assignment|Lost to Follow-up|0|||
105372629|NCT03883386|363370750|FG000|First Assignment|Withdrawal by Subject|1|||
105372630|NCT03883386|363370751|FG001|First Assignment|Withdrawal by Subject|1|||
105372631|NCT04711005|363370754|FG000|Overall Study|Withdrawal by Subject|0|||
105372632|NCT04711005|363370755|FG001|Overall Study|Withdrawal by Subject|0|||
105372633|NCT04711005|363370756|FG002|Overall Study|Withdrawal by Subject|0|||
105372634|NCT04711005|363370757|FG003|Overall Study|Withdrawal by Subject|0|||
105372635|NCT04711005|363370758|FG004|Overall Study|Withdrawal by Subject|0|||
105372636|NCT04711005|363370759|FG005|Overall Study|Withdrawal by Subject|0|||
105372637|NCT04711005|363370760|FG006|Overall Study|Withdrawal by Subject|0|||
105372638|NCT04711005|363370761|FG007|Overall Study|Withdrawal by Subject|1|||
105372639|NCT04711005|363370762|FG008|Overall Study|Withdrawal by Subject|0|||
105372640|NCT04711005|363370763|FG009|Overall Study|Withdrawal by Subject|0|||
105491794|NCT00591266|363812581|FG001|Overall Study|Other|4|||
105491795|NCT00591266|363812582|FG002|Overall Study|Other|5|||
105372641|NCT04711005|363370754|FG000|Overall Study|Physician Decision|0|||
105372642|NCT04711005|363370755|FG001|Overall Study|Physician Decision|0|||
105372643|NCT04711005|363370756|FG002|Overall Study|Physician Decision|0|||
105372644|NCT04711005|363370757|FG003|Overall Study|Physician Decision|0|||
105372645|NCT04711005|363370758|FG004|Overall Study|Physician Decision|0|||
105372646|NCT04711005|363370759|FG005|Overall Study|Physician Decision|0|||
105372647|NCT04711005|363370760|FG006|Overall Study|Physician Decision|0|||
105372648|NCT04711005|363370761|FG007|Overall Study|Physician Decision|2|||
105372649|NCT04711005|363370762|FG008|Overall Study|Physician Decision|1|||
105372650|NCT04711005|363370763|FG009|Overall Study|Physician Decision|0|||
105372651|NCT02337764|363372426|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
105372652|NCT02337764|363372426|FG000|Overall Study|Voluntary Withdrawal|12|||
105372653|NCT02337764|363372426|FG000|Overall Study|Lack of Efficacy|2|||
105372654|NCT02034006|363372427|FG000|Overall Study|Withdrawal by Subject|7|||
105372655|NCT02034006|363372427|FG000|Overall Study|Lost to Follow-up|5|||
105372656|NCT02034006|363372427|FG000|Overall Study|Death|1|||
105372657|NCT02034006|363372427|FG000|Overall Study|Pregnancy|1|||
105372658|NCT01140906|363372443|FG000|Overall Study|Adverse Event|7|||
105372659|NCT01140906|363372444|FG001|Overall Study|Adverse Event|10|||
105372660|NCT01140906|363372445|FG002|Overall Study|Adverse Event|17|||
105372661|NCT01140906|363372446|FG003|Overall Study|Adverse Event|7|||
105372662|NCT01140906|363372443|FG000|Overall Study|Lack of Efficacy|6|||
105372663|NCT01140906|363372444|FG001|Overall Study|Lack of Efficacy|8|||
105372664|NCT01140906|363372445|FG002|Overall Study|Lack of Efficacy|2|||
105372665|NCT01140906|363372446|FG003|Overall Study|Lack of Efficacy|1|||
105372666|NCT01140906|363372443|FG000|Overall Study|Non-compliance|0|||
105372667|NCT01140906|363372444|FG001|Overall Study|Non-compliance|1|||
105372668|NCT01140906|363372445|FG002|Overall Study|Non-compliance|0|||
105372669|NCT01140906|363372446|FG003|Overall Study|Non-compliance|1|||
105372670|NCT01140906|363372443|FG000|Overall Study|Protocol Violation|5|||
105372671|NCT01140906|363372444|FG001|Overall Study|Protocol Violation|3|||
105372672|NCT01140906|363372445|FG002|Overall Study|Protocol Violation|2|||
105372673|NCT01140906|363372446|FG003|Overall Study|Protocol Violation|1|||
105372674|NCT01140906|363372443|FG000|Overall Study|Withdrawal of consent|6|||
105372675|NCT01140906|363372444|FG001|Overall Study|Withdrawal of consent|6|||
105372676|NCT01140906|363372445|FG002|Overall Study|Withdrawal of consent|2|||
105372677|NCT01140906|363372446|FG003|Overall Study|Withdrawal of consent|2|||
105372678|NCT01140906|363372443|FG000|Overall Study|Lost to Follow-up|1|||
105372679|NCT01140906|363372444|FG001|Overall Study|Lost to Follow-up|1|||
105372680|NCT01140906|363372445|FG002|Overall Study|Lost to Follow-up|0|||
105372681|NCT01140906|363372446|FG003|Overall Study|Lost to Follow-up|2|||
105372682|NCT01140906|363372443|FG000|Overall Study|Administrative or other reason|0|||
105372683|NCT01140906|363372444|FG001|Overall Study|Administrative or other reason|5|||
105372684|NCT01140906|363372445|FG002|Overall Study|Administrative or other reason|3|||
105372685|NCT01140906|363372446|FG003|Overall Study|Administrative or other reason|2|||
105372686|NCT00336544|363372447|FG000|Overall Study|Lack of Efficacy|8|||
105372687|NCT00336544|363372448|FG001|Overall Study|Lack of Efficacy|5|||
105372688|NCT00336544|363372447|FG000|Overall Study|Adverse Event|4|||
105372689|NCT00336544|363372448|FG001|Overall Study|Adverse Event|9|||
105372690|NCT00336544|363372447|FG000|Overall Study|Withdrawal by Subject|4|||
105372691|NCT00336544|363372448|FG001|Overall Study|Withdrawal by Subject|3|||
105372692|NCT00336544|363372447|FG000|Overall Study|Other|3|||
105372693|NCT00336544|363372448|FG001|Overall Study|Other|5|||
105372694|NCT01294514|363372451|FG000|Overall Study|Excluded due to Arrhythmia|1|||
105372695|NCT01715298|363372452|FG000|Overall Study|Lost to Follow-up|0|||
105372696|NCT01715298|363372453|FG001|Overall Study|Lost to Follow-up|2|||
105372697|NCT01715298|363372452|FG000|Overall Study|Patient/guardian decision|7|||
105372698|NCT01715298|363372453|FG001|Overall Study|Patient/guardian decision|9|||
105372699|NCT03157089|363372456|FG000|Overall Study|Treated only with pembrolizumab|1|||
105372700|NCT03157089|363372457|FG001|Overall Study|Treated only with pembrolizumab|0|||
105372701|NCT03157089|363372456|FG000|Overall Study|Adverse Event|5|||
105372702|NCT03157089|363372457|FG001|Overall Study|Adverse Event|4|||
105372703|NCT03157089|363372456|FG000|Overall Study|Progressive disease|6|||
105372704|NCT03157089|363372457|FG001|Overall Study|Progressive disease|8|||
105372705|NCT02932943|363372458|FG000|Overall Study|Lost to Follow-up|0|||
105372706|NCT02932943|363372459|FG001|Overall Study|Lost to Follow-up|2|||
105372707|NCT02932943|363372458|FG000|Overall Study|Adverse Event|2|||
105372708|NCT02932943|363372459|FG001|Overall Study|Adverse Event|2|||
105372709|NCT02932943|363372458|FG000|Overall Study|Withdrawal by Subject|3|||
105372710|NCT02932943|363372459|FG001|Overall Study|Withdrawal by Subject|3|||
105372711|NCT01454284|363372460|FG000|Overall Study|Adverse Event|20|||
105372712|NCT01454284|363372461|FG001|Overall Study|Adverse Event|7|||
105372713|NCT01454284|363372460|FG000|Overall Study|Death|0|||
105372714|NCT01454284|363372461|FG001|Overall Study|Death|3|||
105372715|NCT01454284|363372460|FG000|Overall Study|Lost to Follow-up|13|||
105372716|NCT01454284|363372461|FG001|Overall Study|Lost to Follow-up|8|||
105372717|NCT01454284|363372460|FG000|Overall Study|Protocol Violation|9|||
105372718|NCT01454284|363372461|FG001|Overall Study|Protocol Violation|6|||
105372719|NCT01454284|363372460|FG000|Overall Study|Withdrawal by Subject|58|||
105851550|NCT04135196|365112741|FG000|Overall Study|Pregnancy|0|||
105851551|NCT04135196|365112742|FG001|Overall Study|Pregnancy|0|||
105851552|NCT04135196|365112743|FG002|Overall Study|Pregnancy|1|||
105851553|NCT04135196|365112744|FG003|Overall Study|Pregnancy|0|||
105324874|NCT02291237|363188373|FG001|Overall Study|Adverse Event|3|||
105324875|NCT02291237|363188372|FG000|Overall Study|Investigator's Discretion|0|||
105324876|NCT02291237|363188373|FG001|Overall Study|Investigator's Discretion|3|||
105324877|NCT02291237|363188372|FG000|Overall Study|Withdrew Consent|11|||
105324878|NCT02291237|363188373|FG001|Overall Study|Withdrew Consent|11|||
105324879|NCT02291237|363188372|FG000|Overall Study|Lost to Follow-up|0|||
105324880|NCT02291237|363188373|FG001|Overall Study|Lost to Follow-up|2|||
105324881|NCT02291237|363188372|FG000|Overall Study|Subject Required Prohibited Medication|2|||
105324882|NCT02291237|363188373|FG001|Overall Study|Subject Required Prohibited Medication|0|||
105324883|NCT00258960|363188374|FG000|Overall Study|Death|2|||
105324884|NCT00258960|363188374|FG000|Overall Study|Disease Progression|7|||
105324885|NCT00258960|363188374|FG000|Overall Study|Adverse Event|4|||
105324886|NCT00258960|363188374|FG000|Overall Study|Physician Decision|1|||
105324887|NCT00258960|363188374|FG000|Overall Study|Withdrawal by Subject|1|||
105324888|NCT00258960|363188374|FG000|Overall Study|Mistake|2|||
105324889|NCT01112059|363188377|FG000|Overall Study|Withdrawal by Subject|1|||
105324890|NCT01112059|363188378|FG001|Overall Study|Withdrawal by Subject|0|||
105324891|NCT01401452|363188381|FG000|Overall Study|Adverse reaction|9|||
105324892|NCT01401452|363188381|FG000|Overall Study|Lost to Follow-up|12|||
105324893|NCT01401452|363188381|FG000|Overall Study|Lack of Efficacy|30|||
105324894|NCT01401452|363188381|FG000|Overall Study|Participant developed breast cancer|1|||
105324895|NCT01401452|363188381|FG000|Overall Study|Tx stopped due to financial reasons|1|||
105372720|NCT01454284|363372461|FG001|Overall Study|Withdrawal by Subject|36|||
105372721|NCT01454284|363372460|FG000|Overall Study|Physician Decision|16|||
105372722|NCT01454284|363372461|FG001|Overall Study|Physician Decision|11|||
105372723|NCT01454284|363372460|FG000|Overall Study|Sponsor Decision|0|||
105372724|NCT01454284|363372461|FG001|Overall Study|Sponsor Decision|2|||
105372725|NCT02665117|363372466|FG000|Overall Study|Physician Decision|1|||
105372726|NCT02665117|363372467|FG001|Overall Study|Physician Decision|0|||
105372727|NCT00977197|363372468|FG000|Overall Study|Withdrawal by Subject|3|||
105372728|NCT00977197|363372469|FG001|Overall Study|Withdrawal by Subject|4|||
105372729|NCT00977197|363372468|FG000|Overall Study|Adverse Event|3|||
105372730|NCT00977197|363372469|FG001|Overall Study|Adverse Event|1|||
105372731|NCT00977197|363372468|FG000|Overall Study|Lack of Efficacy|1|||
105372732|NCT00977197|363372469|FG001|Overall Study|Lack of Efficacy|0|||
105372733|NCT00977197|363372468|FG000|Overall Study|Lost to Follow-up|1|||
105372734|NCT00977197|363372469|FG001|Overall Study|Lost to Follow-up|3|||
105372735|NCT00977197|363372468|FG000|Overall Study|Nonadherence|1|||
105372736|NCT00977197|363372469|FG001|Overall Study|Nonadherence|1|||
105372737|NCT00784875|363372472|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
105372738|NCT00784875|363372473|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
105372739|NCT00784875|363372474|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
105372740|NCT00784875|363372475|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
105372741|NCT00784875|363372472|FG000|Period A - Baseline|Adverse Event|0|||
105372742|NCT00784875|363372473|FG001|Period A - Baseline|Adverse Event|0|||
105372743|NCT00784875|363372474|FG002|Period A - Baseline|Adverse Event|0|||
105372744|NCT00784875|363372475|FG003|Period A - Baseline|Adverse Event|8|||
105372745|NCT00784875|363372472|FG000|Period A - Baseline|Protocol Violation|0|||
105372746|NCT00784875|363372473|FG001|Period A - Baseline|Protocol Violation|0|||
105372747|NCT00784875|363372474|FG002|Period A - Baseline|Protocol Violation|0|||
105372748|NCT00784875|363372475|FG003|Period A - Baseline|Protocol Violation|25|||
105372749|NCT00784875|363372472|FG000|Period A - Baseline|Withdrawal by Subject|0|||
105372750|NCT00784875|363372473|FG001|Period A - Baseline|Withdrawal by Subject|0|||
105372751|NCT00784875|363372474|FG002|Period A - Baseline|Withdrawal by Subject|0|||
105372752|NCT00784875|363372475|FG003|Period A - Baseline|Withdrawal by Subject|27|||
105372753|NCT00784875|363372472|FG000|Period A - Baseline|Physician Decision|0|||
105372754|NCT00784875|363372473|FG001|Period A - Baseline|Physician Decision|0|||
105372755|NCT00784875|363372474|FG002|Period A - Baseline|Physician Decision|0|||
105372756|NCT00784875|363372475|FG003|Period A - Baseline|Physician Decision|2|||
105372757|NCT00784875|363372472|FG000|Period A - Baseline|Sponsor Decision|0|||
105372758|NCT00784875|363372473|FG001|Period A - Baseline|Sponsor Decision|0|||
105372759|NCT00784875|363372474|FG002|Period A - Baseline|Sponsor Decision|0|||
105372760|NCT00784875|363372475|FG003|Period A - Baseline|Sponsor Decision|113|||
105372761|NCT00784875|363372472|FG000|Period A - Baseline|Lost to Follow-up|0|||
105372762|NCT00784875|363372473|FG001|Period A - Baseline|Lost to Follow-up|0|||
105372763|NCT00784875|363372474|FG002|Period A - Baseline|Lost to Follow-up|0|||
105372764|NCT00784875|363372475|FG003|Period A - Baseline|Lost to Follow-up|2|||
105372765|NCT00784875|363372472|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
105491796|NCT00901927|363812585|FG000|Overall Study|Lack of Efficacy|1|||
105324896|NCT01401452|363188381|FG000|Overall Study|Tx stopped by psychiatrist|1|||
105324897|NCT01401452|363188381|FG000|Overall Study|No more visits within the 36 wk followup|4|||
105324898|NCT01401452|363188381|FG000|Overall Study|Subject did not come to follow up visits|2|||
105324899|NCT01401452|363188381|FG000|Overall Study|Subject didn't return for routine visits|1|||
105851554|NCT04135196|365112745|FG004|Overall Study|Pregnancy|0|||
105851555|NCT04135196|365112741|FG000|Overall Study|Withdrawal by Subject|0|||
105851556|NCT04135196|365112742|FG001|Overall Study|Withdrawal by Subject|0|||
105851557|NCT04135196|365112743|FG002|Overall Study|Withdrawal by Subject|0|||
105851558|NCT04135196|365112744|FG003|Overall Study|Withdrawal by Subject|0|||
105851559|NCT04135196|365112745|FG004|Overall Study|Withdrawal by Subject|1|||
105851560|NCT00073021|365112746|FG000|Overall Study|Protocol Violation|2|||
105372766|NCT00784875|363372473|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
105372767|NCT00784875|363372474|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
105372768|NCT00784875|363372475|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
105372769|NCT00784875|363372472|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
105372770|NCT00784875|363372473|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
105372771|NCT00784875|363372474|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
105372772|NCT00784875|363372475|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
105372773|NCT00784875|363372472|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
105372774|NCT00784875|363372473|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
105372775|NCT00784875|363372474|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
105372776|NCT00784875|363372475|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
105372777|NCT00784875|363372472|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
105372778|NCT00784875|363372473|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
105372779|NCT00784875|363372474|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
105372780|NCT00784875|363372475|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
105372781|NCT00784875|363372472|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
105372782|NCT00784875|363372473|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
105372783|NCT00784875|363372474|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
105372784|NCT00784875|363372475|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
105372785|NCT00784875|363372472|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
105372786|NCT00784875|363372473|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
105372787|NCT00784875|363372474|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
105372788|NCT00784875|363372475|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
105372789|NCT00784875|363372472|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
105372790|NCT00784875|363372473|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
105372791|NCT00784875|363372474|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
105372792|NCT00784875|363372475|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
105372793|NCT00784875|363372472|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
105372794|NCT00784875|363372473|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
105372795|NCT00784875|363372474|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
105372796|NCT00784875|363372475|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
105372797|NCT00784875|363372472|FG000|Period C|Adverse Event|1|||
105372798|NCT00784875|363372473|FG001|Period C|Adverse Event|0|||
105372799|NCT00784875|363372474|FG002|Period C|Adverse Event|4|||
105372800|NCT00784875|363372475|FG003|Period C|Adverse Event|2|||
105372801|NCT00784875|363372472|FG000|Period C|Protocol Violation|0|||
105372802|NCT00784875|363372473|FG001|Period C|Protocol Violation|0|||
105372803|NCT00784875|363372474|FG002|Period C|Protocol Violation|1|||
105372804|NCT00784875|363372475|FG003|Period C|Protocol Violation|2|||
105372805|NCT00784875|363372472|FG000|Period C|Lack of Efficacy|0|||
105372806|NCT00784875|363372473|FG001|Period C|Lack of Efficacy|0|||
105372807|NCT00784875|363372474|FG002|Period C|Lack of Efficacy|1|||
105372808|NCT00784875|363372475|FG003|Period C|Lack of Efficacy|0|||
105372809|NCT00784875|363372472|FG000|Period C|Withdrawal by Subject|1|||
105372810|NCT00784875|363372473|FG001|Period C|Withdrawal by Subject|1|||
105372811|NCT00784875|363372474|FG002|Period C|Withdrawal by Subject|2|||
105372812|NCT00784875|363372475|FG003|Period C|Withdrawal by Subject|0|||
105851561|NCT00073021|365112747|FG001|Overall Study|Protocol Violation|1|||
105372813|NCT00784875|363372472|FG000|Period C|Physician Decision|0|||
105372814|NCT00784875|363372473|FG001|Period C|Physician Decision|0|||
105372815|NCT00784875|363372474|FG002|Period C|Physician Decision|1|||
105372816|NCT00784875|363372475|FG003|Period C|Physician Decision|1|||
105372817|NCT00784875|363372472|FG000|Period C|Sponsor Decision|5|||
105372818|NCT00784875|363372473|FG001|Period C|Sponsor Decision|5|||
105372819|NCT00784875|363372474|FG002|Period C|Sponsor Decision|4|||
105372820|NCT00784875|363372475|FG003|Period C|Sponsor Decision|2|||
105372821|NCT00784875|363372472|FG000|Period D|Adverse Event|0|||
105372822|NCT00784875|363372473|FG001|Period D|Adverse Event|2|||
105372823|NCT00784875|363372474|FG002|Period D|Adverse Event|2|||
105372824|NCT00784875|363372475|FG003|Period D|Adverse Event|0|||
105372825|NCT00784875|363372472|FG000|Period D|Protocol Violation|1|||
105372826|NCT00784875|363372473|FG001|Period D|Protocol Violation|0|||
105491797|NCT00901927|363812585|FG000|Overall Study|Protocol Violation|3|||
105491798|NCT00901927|363812585|FG000|Overall Study|Withdrawal by Subject|2|||
105491799|NCT00586846|363812586|FG000|Overall Study|Physician Decision|1|||
105851562|NCT00073021|365112746|FG000|Overall Study|Adverse Event|4|||
105372827|NCT00784875|363372474|FG002|Period D|Protocol Violation|0|||
105372828|NCT00784875|363372475|FG003|Period D|Protocol Violation|0|||
105372829|NCT00784875|363372472|FG000|Period D|Withdrawal by Subject|2|||
105491800|NCT00586846|363812586|FG000|Overall Study|Death|1|||
105372830|NCT00784875|363372473|FG001|Period D|Withdrawal by Subject|0|||
105372831|NCT00784875|363372474|FG002|Period D|Withdrawal by Subject|2|||
105372832|NCT00784875|363372475|FG003|Period D|Withdrawal by Subject|0|||
105372833|NCT00784875|363372472|FG000|Period D|Physician Decision|0|||
105372834|NCT00784875|363372473|FG001|Period D|Physician Decision|1|||
105372835|NCT00784875|363372474|FG002|Period D|Physician Decision|0|||
105372836|NCT00784875|363372475|FG003|Period D|Physician Decision|0|||
105372837|NCT00784875|363372472|FG000|Period D|Sponsor Decision|1|||
105372838|NCT00784875|363372473|FG001|Period D|Sponsor Decision|1|||
105372839|NCT00784875|363372474|FG002|Period D|Sponsor Decision|1|||
105372840|NCT00784875|363372475|FG003|Period D|Sponsor Decision|0|||
105372841|NCT00784875|363372472|FG000|Period D|Lost to Follow-up|1|||
105372842|NCT00784875|363372473|FG001|Period D|Lost to Follow-up|0|||
105372843|NCT00784875|363372474|FG002|Period D|Lost to Follow-up|1|||
105372844|NCT00784875|363372475|FG003|Period D|Lost to Follow-up|1|||
105372845|NCT01432951|363372476|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
105372846|NCT03286504|363372477|FG000|Overall Study|Lost to Follow-up|19|||
105372847|NCT03286504|363372478|FG001|Overall Study|Lost to Follow-up|16|||
105372848|NCT02842866|363372481|FG000|Overall Study|Serious Adverse Event|0|||
105372849|NCT02842866|363372482|FG001|Overall Study|Serious Adverse Event|1|||
105372850|NCT02842866|363372481|FG000|Overall Study|Protocol Violation|4|||
105372851|NCT02842866|363372482|FG001|Overall Study|Protocol Violation|2|||
105372852|NCT02842866|363372481|FG000|Overall Study|Lost to Follow-up|2|||
105372853|NCT02842866|363372482|FG001|Overall Study|Lost to Follow-up|0|||
105372854|NCT02842866|363372481|FG000|Overall Study|Withdrawal by Subject|1|||
105372855|NCT02842866|363372482|FG001|Overall Study|Withdrawal by Subject|0|||
105372856|NCT00941928|363372487|FG000|Overall Study|Withdrawal by Subject|1|||
105372857|NCT00941928|363372487|FG000|Overall Study|Disease Progression|1|||
105372858|NCT02300610|363372488|FG000|Overall Study|Withdrawal by Subject|1|||
105372859|NCT02300610|363372489|FG001|Overall Study|Withdrawal by Subject|0|||
105372860|NCT02300610|363372490|FG002|Overall Study|Withdrawal by Subject|1|||
105372861|NCT00141921|363372491|FG000|Overall Study|Remain on Study|28|||
105372862|NCT00141921|363372491|FG000|Overall Study|Withdrawal by Subject|42|||
105372863|NCT00141921|363372491|FG000|Overall Study|Lost to Follow-up|19|||
105372864|NCT00141921|363372491|FG000|Overall Study|Noncompliance|17|||
105372865|NCT00141921|363372491|FG000|Overall Study|Disease Progression|7|||
105372866|NCT00141921|363372491|FG000|Overall Study|Protocol Deviation|7|||
105372867|NCT00141921|363372491|FG000|Overall Study|Adverse Event|5|||
105372868|NCT00141921|363372491|FG000|Overall Study|Administrative Decision|2|||
105372869|NCT00141921|363372491|FG000|Overall Study|Pregnancy|4|||
105372870|NCT00141921|363372491|FG000|Overall Study|Ineligibility Determined|2|||
105372871|NCT00141921|363372491|FG000|Overall Study|Other|8|||
105372872|NCT03743194|363372493|FG000|Overall Study|Protocol Violation|7|||
105372873|NCT03743194|363372494|FG001|Overall Study|Protocol Violation|7|||
105372874|NCT03743194|363372493|FG000|Overall Study|Physician Decision|0|||
105372875|NCT03743194|363372494|FG001|Overall Study|Physician Decision|2|||
105372876|NCT01829347|363372495|FG000|VTI-210|Death|5|||
105372877|NCT01829347|363372496|FG001|VTI-210|Death|3|||
105372878|NCT01829347|363372495|FG000|VTI-210|Withdrawal by Subject|1|||
105372879|NCT01829347|363372496|FG001|VTI-210|Withdrawal by Subject|0|||
105372880|NCT01829347|363372495|FG000|VTI-210E|Death|2|||
105372881|NCT01829347|363372496|FG001|VTI-210E|Death|1|||
105372882|NCT01829347|363372495|FG000|VTI-210E|Study terminated prematurely|1|||
105372883|NCT01829347|363372496|FG001|VTI-210E|Study terminated prematurely|5|||
105372884|NCT02765035|363372509|FG000|First Intervention (90 Days)|Adverse Event|1|||
105491801|NCT00586846|363812586|FG000|Overall Study|Evaluable for Toxicity Only|4|||
105491802|NCT01697358|363812590|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
105491803|NCT01697358|363812591|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
105372885|NCT02765035|363372510|FG001|First Intervention (90 Days)|Adverse Event|1|||
105372886|NCT02765035|363372509|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
105372887|NCT02765035|363372510|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
105372888|NCT02110693|363372512|FG000|Overall Study|Withdrawal by Subject|6|||
105372889|NCT02110693|363372513|FG001|Overall Study|Withdrawal by Subject|7|||
105372890|NCT02110693|363372512|FG000|Overall Study|skipped assessment|15|||
105372891|NCT02110693|363372513|FG001|Overall Study|skipped assessment|18|||
105372892|NCT02110693|363372512|FG000|Overall Study|technical difficulties|6|||
105372893|NCT02110693|363372513|FG001|Overall Study|technical difficulties|4|||
105372894|NCT02110693|363372512|FG000|Overall Study|Other|1|||
105372895|NCT02110693|363372513|FG001|Overall Study|Other|0|||
105372896|NCT02765165|363372521|FG000|Treatment Period|Progressive disease|3|||
105372897|NCT02765165|363372522|FG001|Treatment Period|Progressive disease|2|||
105372898|NCT02765165|363372523|FG002|Treatment Period|Progressive disease|3|||
105372899|NCT02765165|363372524|FG003|Treatment Period|Progressive disease|3|||
105372900|NCT02765165|363372525|FG004|Treatment Period|Progressive disease|4|||
105372901|NCT02765165|363372526|FG005|Treatment Period|Progressive disease|2|||
105372902|NCT02765165|363372527|FG006|Treatment Period|Progressive disease|2|||
105372903|NCT02765165|363372521|FG000|Treatment Period|Physician Decision|0|||
105372904|NCT02765165|363372522|FG001|Treatment Period|Physician Decision|1|||
105372905|NCT02765165|363372523|FG002|Treatment Period|Physician Decision|0|||
105324900|NCT01401452|363188381|FG000|Overall Study|Subject moved to another city|1|||
105324901|NCT01401452|363188381|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
105324902|NCT01401452|363188381|FG000|Overall Study|Psoriatic arthritis|1|||
105324903|NCT01401452|363188381|FG000|Overall Study|Participant stopped Tx|2|||
105324904|NCT01401452|363188381|FG000|Overall Study|Discontinuation for personal reasons|1|||
105324905|NCT01401452|363188381|FG000|Overall Study|Treatment failure|1|||
105324906|NCT01401452|363188381|FG000|Overall Study|Unsatisfactory output|1|||
105324907|NCT01401452|363188381|FG000|Overall Study|Subject withdrew because of Tx success|1|||
105324908|NCT01401452|363188381|FG000|Overall Study|Subject chose to discontinue treatment|1|||
105324909|NCT01401452|363188381|FG000|Overall Study|Participant withdrew consent|1|||
105324910|NCT00584454|363188382|FG000|Overall Study|Adverse Event|1|||
105324911|NCT00584454|363188382|FG000|Overall Study|Relocation|1|||
105324912|NCT00584454|363188382|FG000|Overall Study|Clinical Hold|2|||
105324913|NCT02723344|363188384|FG000|Overall Study|Lost to Follow-up|0|||
105324914|NCT02723344|363188385|FG001|Overall Study|Lost to Follow-up|4|||
105324915|NCT01530464|363188390|FG000|Washout (24h)|Withdrawal by Subject|1|||
105324916|NCT01530464|363188391|FG001|Washout (24h)|Withdrawal by Subject|0|||
105324917|NCT01530464|363188390|FG000|Washout (24h)|Withdrawal by Subject|0|||
105324918|NCT01530464|363188391|FG001|Washout (24h)|Withdrawal by Subject|1|||
105324919|NCT01709500|363188392|FG000|Overall Study|Randomized but not treated|0|||
105324920|NCT01709500|363188393|FG001|Overall Study|Randomized but not treated|1|||
105324921|NCT01709500|363188392|FG000|Overall Study|Adverse Event|5|||
105324922|NCT01709500|363188393|FG001|Overall Study|Adverse Event|1|||
105324923|NCT01709500|363188392|FG000|Overall Study|Poor compliance to protocol|2|||
105324924|NCT01709500|363188393|FG001|Overall Study|Poor compliance to protocol|1|||
105324925|NCT01709500|363188392|FG000|Overall Study|Other|3|||
105324926|NCT01709500|363188393|FG001|Overall Study|Other|1|||
105324927|NCT01709500|363188392|FG000|Overall Study|Related to IMP administration|1|||
105324928|NCT01709500|363188393|FG001|Overall Study|Related to IMP administration|0|||
105324929|NCT01709500|363188392|FG000|Overall Study|Treatment ongoing|156|||
105324930|NCT01709500|363188393|FG001|Overall Study|Treatment ongoing|78|||
105324931|NCT04720105|363188394|FG000|Overall Study|Lack of Efficacy|1|||
105324932|NCT04720105|363188394|FG000|Overall Study|Lost to Follow-up|1|||
105324933|NCT04720105|363188394|FG000|Overall Study|Withdrawal by Subject|3|||
105324934|NCT02387840|363188395|FG000|Overall Study|Death|0|||
105324935|NCT02387840|363188396|FG001|Overall Study|Death|0|||
105324936|NCT02387840|363188397|FG002|Overall Study|Death|0|||
105324937|NCT02387840|363188398|FG003|Overall Study|Death|0|||
105324938|NCT02387840|363188399|FG004|Overall Study|Death|0|||
105324939|NCT02387840|363188400|FG005|Overall Study|Death|1|||
105324940|NCT02698163|363188401|FG000|Overall Study|Lost to Follow-up|0|||
105324941|NCT02698163|363188402|FG001|Overall Study|Lost to Follow-up|1|||
105324942|NCT00740636|363188409|FG000|Overall Study|Adverse Event|0|||
105324943|NCT00740636|363188410|FG001|Overall Study|Adverse Event|2|||
105324944|NCT00740636|363188409|FG000|Overall Study|Patient Ineligible|0|||
105324945|NCT00740636|363188410|FG001|Overall Study|Patient Ineligible|1|||
105324946|NCT00740636|363188409|FG000|Overall Study|Patient Not Treated|0|||
105324947|NCT00740636|363188410|FG001|Overall Study|Patient Not Treated|1|||
105324948|NCT00740636|363188409|FG000|Overall Study|Progressive Disease|1|||
105324949|NCT00740636|363188410|FG001|Overall Study|Progressive Disease|0|||
105324950|NCT00740636|363188409|FG000|Overall Study|Death|1|||
105324951|NCT00740636|363188410|FG001|Overall Study|Death|0|||
105324952|NCT03539302|363188411|FG000|Overall Study|Spontaneous cardio version|0|||
105324953|NCT03539302|363188412|FG001|Overall Study|Spontaneous cardio version|0|||
105324954|NCT03539302|363188413|FG002|Overall Study|Spontaneous cardio version|0|||
105324955|NCT03539302|363188414|FG003|Overall Study|Spontaneous cardio version|0|||
105324956|NCT03539302|363188415|FG004|Overall Study|Spontaneous cardio version|0|||
105324957|NCT03539302|363188416|FG005|Overall Study|Spontaneous cardio version|1|||
105324958|NCT03539302|363188417|FG006|Overall Study|Spontaneous cardio version|1|||
105324959|NCT00349973|363188421|FG000|Overall Study|Adverse Event|3|||
105324960|NCT00349973|363188422|FG001|Overall Study|Adverse Event|3|||
105324961|NCT00349973|363188421|FG000|Overall Study|Withdrawal by Subject|1|||
105324962|NCT00349973|363188422|FG001|Overall Study|Withdrawal by Subject|0|||
105324963|NCT00071110|363188425|FG000|Overall Study|Protocol Violation|0|||
105491804|NCT01697358|363812590|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
105491805|NCT01697358|363812591|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
105324964|NCT00071110|363188426|FG001|Overall Study|Protocol Violation|4|||
105324965|NCT00273182|363188429|FG000|Overall Study|Death|450|||
105324966|NCT00273182|363188429|FG000|Overall Study|Lost to Follow-up|88|||
105324967|NCT00273182|363188429|FG000|Overall Study|Withdrawal by Subject|257|||
105324968|NCT00273182|363188429|FG000|Overall Study|Device/System Explant|154|||
105324969|NCT00273182|363188429|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
105324970|NCT03805412|363188430|FG000|Overall Study|Lost to Follow-up|0|||
105324971|NCT03805412|363188431|FG001|Overall Study|Lost to Follow-up|1|||
105324972|NCT01622673|363188432|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105324973|NCT01622673|363188433|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105324974|NCT01622673|363188434|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105324975|NCT01622673|363188435|FG003|Treatment Period 1|Withdrawal by Subject|1|||
105491806|NCT01697358|363812590|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
105491807|NCT01697358|363812591|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
105491808|NCT01697358|363812590|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
105491809|NCT01697358|363812591|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
105491810|NCT01697358|363812590|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
105491811|NCT01697358|363812591|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
105491812|NCT01697358|363812590|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
105491813|NCT01697358|363812591|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
105491814|NCT01697358|363812590|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
105491815|NCT01697358|363812591|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
105491816|NCT01697358|363812590|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
105491817|NCT01697358|363812591|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
105491818|NCT01697358|363812590|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
105491819|NCT01697358|363812591|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
105491820|NCT01697358|363812590|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
105491821|NCT01697358|363812591|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
105491822|NCT03538431|363812592|FG000|Overall Study|Physician Decision|0|||
105491823|NCT03538431|363812593|FG001|Overall Study|Physician Decision|1|||
105491824|NCT03538431|363812592|FG000|Overall Study|Withdrawal by Subject|1|||
105491825|NCT03538431|363812593|FG001|Overall Study|Withdrawal by Subject|0|||
105491826|NCT00620464|363812594|FG000|Overall Study|Adverse Event|15|||
105491827|NCT00620464|363812595|FG001|Overall Study|Adverse Event|17|||
105491828|NCT00620464|363812594|FG000|Overall Study|Lost to Follow-up|1|||
105491829|NCT00620464|363812595|FG001|Overall Study|Lost to Follow-up|1|||
105491830|NCT00620464|363812594|FG000|Overall Study|Planning Pregnancy|1|||
105491831|NCT00620464|363812595|FG001|Overall Study|Planning Pregnancy|4|||
105491832|NCT00620464|363812594|FG000|Overall Study|Personal|2|||
105491833|NCT00620464|363812595|FG001|Overall Study|Personal|2|||
105491834|NCT00620464|363812594|FG000|Overall Study|Used prohibited medication|1|||
105491835|NCT00620464|363812595|FG001|Overall Study|Used prohibited medication|0|||
105491836|NCT00586066|363812596|FG000|Overall Study|Lost to Follow-up|6|||
105491837|NCT00586066|363812597|FG001|Overall Study|Lost to Follow-up|3|||
105491838|NCT00586066|363812596|FG000|Overall Study|Lack of Efficacy|5|||
105491839|NCT00586066|363812597|FG001|Overall Study|Lack of Efficacy|3|||
105491840|NCT00586066|363812596|FG000|Overall Study|Adverse Event|2|||
105491841|NCT00586066|363812597|FG001|Overall Study|Adverse Event|2|||
105491842|NCT00586066|363812596|FG000|Overall Study|Physician Decision|1|||
105491843|NCT00586066|363812597|FG001|Overall Study|Physician Decision|0|||
105491844|NCT00586066|363812596|FG000|Overall Study|Withdrawal of consent|4|||
105491845|NCT00586066|363812597|FG001|Overall Study|Withdrawal of consent|2|||
105491846|NCT00410202|363812600|FG000|On-Treatment|Continuing treatment|69|||
105491847|NCT00410202|363812601|FG001|On-Treatment|Continuing treatment|71|||
105491848|NCT00410202|363812602|FG002|On-Treatment|Continuing treatment|66|||
105491849|NCT00410202|363812600|FG000|On-Treatment|Adverse Event|1|||
105491850|NCT00410202|363812601|FG001|On-Treatment|Adverse Event|3|||
105491851|NCT00410202|363812602|FG002|On-Treatment|Adverse Event|2|||
105491852|NCT00410202|363812600|FG000|On-Treatment|Death|1|||
105491853|NCT00410202|363812601|FG001|On-Treatment|Death|0|||
105491854|NCT00410202|363812602|FG002|On-Treatment|Death|0|||
105491855|NCT00410202|363812600|FG000|On-Treatment|Lost to Follow-up|1|||
105491856|NCT00410202|363812601|FG001|On-Treatment|Lost to Follow-up|0|||
105491857|NCT00410202|363812602|FG002|On-Treatment|Lost to Follow-up|1|||
105491858|NCT00410202|363812600|FG000|On-Treatment|Lack of Efficacy|1|||
105491859|NCT00410202|363812601|FG001|On-Treatment|Lack of Efficacy|4|||
105491860|NCT00410202|363812602|FG002|On-Treatment|Lack of Efficacy|0|||
105851563|NCT00073021|365112747|FG001|Overall Study|Adverse Event|4|||
105491861|NCT00410202|363812600|FG000|On-Treatment|Withdrawal by Subject|2|||
105576930|NCT00312858|364112087|FG001|Overall Study|Lost to Follow-up|42|||
105576931|NCT00312858|364112086|FG000|Overall Study|Protocol Violation|3|||
105576932|NCT00312858|364112087|FG001|Overall Study|Protocol Violation|8|||
105576933|NCT00312858|364112086|FG000|Overall Study|Withdraw by Participant|20|||
105491862|NCT00410202|363812601|FG001|On-Treatment|Withdrawal by Subject|1|||
105491863|NCT00410202|363812602|FG002|On-Treatment|Withdrawal by Subject|1|||
105491864|NCT00410202|363812600|FG000|On-Treatment|Other Reason|0|||
105491865|NCT00410202|363812601|FG001|On-Treatment|Other Reason|0|||
105491866|NCT00410202|363812602|FG002|On-Treatment|Other Reason|1|||
105491867|NCT00410202|363812600|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
105491868|NCT00410202|363812601|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
105576934|NCT00312858|364112087|FG001|Overall Study|Withdraw by Participant|20|||
105851564|NCT00073021|365112746|FG000|Overall Study|Withdrawal by Subject|6|||
105851565|NCT00073021|365112747|FG001|Overall Study|Withdrawal by Subject|5|||
105491869|NCT00410202|363812602|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
105491870|NCT00410202|363812600|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
105491871|NCT00410202|363812601|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
105576935|NCT00312858|364112086|FG000|Overall Study|Participant Moved|11|||
105324976|NCT01622673|363188436|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105324977|NCT01622673|363188437|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105324978|NCT01622673|363188432|FG000|Treatment Period 1|Protocol Violation|0|||
105324979|NCT01622673|363188433|FG001|Treatment Period 1|Protocol Violation|1|||
105324980|NCT01622673|363188434|FG002|Treatment Period 1|Protocol Violation|0|||
105324981|NCT01622673|363188435|FG003|Treatment Period 1|Protocol Violation|0|||
105324982|NCT01622673|363188436|FG004|Treatment Period 1|Protocol Violation|0|||
105324983|NCT01622673|363188437|FG005|Treatment Period 1|Protocol Violation|0|||
105324984|NCT01622673|363188432|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105324985|NCT01622673|363188433|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105324986|NCT01622673|363188434|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105324987|NCT01622673|363188435|FG003|Treatment Period 2|Withdrawal by Subject|1|||
105324988|NCT01622673|363188436|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105324989|NCT01622673|363188437|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105324990|NCT01622673|363188432|FG000|Treatment Period 3|Protocol Violation|0|||
105324991|NCT01622673|363188433|FG001|Treatment Period 3|Protocol Violation|1|||
105324992|NCT01622673|363188434|FG002|Treatment Period 3|Protocol Violation|0|||
105324993|NCT01622673|363188435|FG003|Treatment Period 3|Protocol Violation|0|||
105324994|NCT01622673|363188436|FG004|Treatment Period 3|Protocol Violation|0|||
105324995|NCT01622673|363188437|FG005|Treatment Period 3|Protocol Violation|0|||
105324996|NCT05085834|363189970|FG000|Overall Study|Lost to Follow-up|9|||
105324997|NCT05085834|363189971|FG001|Overall Study|Lost to Follow-up|2|||
105324998|NCT05085834|363189970|FG000|Overall Study|Adverse Event|6|||
105324999|NCT05085834|363189971|FG001|Overall Study|Adverse Event|0|||
105325000|NCT05085834|363189970|FG000|Overall Study|Death|1|||
105325001|NCT05085834|363189971|FG001|Overall Study|Death|0|||
105325002|NCT05085834|363189970|FG000|Overall Study|Inability to swallow the pill|0|||
105325003|NCT05085834|363189971|FG001|Overall Study|Inability to swallow the pill|1|||
105325004|NCT00413699|363189972|FG000|Initial Period|Death|25|||
105325005|NCT00413699|363189973|FG001|Initial Period|Death|30|||
105325006|NCT00413699|363189974|FG002|Initial Period|Death|0|||
105325007|NCT00413699|363189972|FG000|Initial Period|Lack of Efficacy|59|||
105325008|NCT00413699|363189973|FG001|Initial Period|Lack of Efficacy|115|||
105325009|NCT00413699|363189974|FG002|Initial Period|Lack of Efficacy|0|||
105325010|NCT00413699|363189972|FG000|Initial Period|Lost to Follow-up|31|||
105325011|NCT00413699|363189973|FG001|Initial Period|Lost to Follow-up|101|||
105325012|NCT00413699|363189974|FG002|Initial Period|Lost to Follow-up|0|||
105325013|NCT00413699|363189972|FG000|Initial Period|Protocol Violation|38|||
105325014|NCT00413699|363189973|FG001|Initial Period|Protocol Violation|89|||
105325015|NCT00413699|363189974|FG002|Initial Period|Protocol Violation|0|||
105325016|NCT00413699|363189972|FG000|Initial Period|Pregnancy|10|||
105325017|NCT00413699|363189973|FG001|Initial Period|Pregnancy|8|||
105325018|NCT00413699|363189974|FG002|Initial Period|Pregnancy|0|||
105325019|NCT00413699|363189972|FG000|Initial Period|Did not meet entrance criteria|2|||
105325020|NCT00413699|363189973|FG001|Initial Period|Did not meet entrance criteria|2|||
105325021|NCT00413699|363189974|FG002|Initial Period|Did not meet entrance criteria|0|||
105325022|NCT00413699|363189972|FG000|Initial Period|Medication error without adverse event|0|||
105325023|NCT00413699|363189973|FG001|Initial Period|Medication error without adverse event|1|||
105325024|NCT00413699|363189974|FG002|Initial Period|Medication error without adverse event|0|||
105325025|NCT00413699|363189972|FG000|Initial Period|Study terminated by Sponsor|0|||
105325026|NCT00413699|363189973|FG001|Initial Period|Study terminated by Sponsor|1|||
105325027|NCT00413699|363189974|FG002|Initial Period|Study terminated by Sponsor|0|||
105325028|NCT00413699|363189972|FG000|Initial Period|Other|67|||
105325029|NCT00413699|363189973|FG001|Initial Period|Other|211|||
105325030|NCT00413699|363189974|FG002|Initial Period|Other|0|||
105325031|NCT00413699|363189972|FG000|Initial Period|Adverse event related to study drug|178|||
105325032|NCT00413699|363189973|FG001|Initial Period|Adverse event related to study drug|527|||
105325033|NCT00413699|363189974|FG002|Initial Period|Adverse event related to study drug|0|||
105325034|NCT00413699|363189972|FG000|Initial Period|Adverse event not related to study drug|113|||
105325035|NCT00413699|363189973|FG001|Initial Period|Adverse event not related to study drug|248|||
105325036|NCT00413699|363189974|FG002|Initial Period|Adverse event not related to study drug|0|||
105325037|NCT00413699|363189972|FG000|Initial Period|Missing end of study page|0|||
105325038|NCT00413699|363189973|FG001|Initial Period|Missing end of study page|4|||
105325039|NCT00413699|363189974|FG002|Initial Period|Missing end of study page|0|||
105325040|NCT00413699|363189972|FG000|Initial Period|No longer willing to participate|116|||
105325041|NCT00413699|363189973|FG001|Initial Period|No longer willing to participate|368|||
105325042|NCT00413699|363189974|FG002|Initial Period|No longer willing to participate|0|||
105325043|NCT00413699|363189972|FG000|Extension Period|No Longer Willing to Participate|0|||
105325044|NCT00413699|363189973|FG001|Extension Period|No Longer Willing to Participate|0|||
105325045|NCT00413699|363189974|FG002|Extension Period|No Longer Willing to Participate|2|||
105325046|NCT00413699|363189972|FG000|Extension Period|Protocol Violation|0|||
105325047|NCT00413699|363189973|FG001|Extension Period|Protocol Violation|0|||
105325048|NCT00413699|363189974|FG002|Extension Period|Protocol Violation|1|||
105325049|NCT00413699|363189972|FG000|Extension Period|Adverse Event|0|||
105325050|NCT00413699|363189973|FG001|Extension Period|Adverse Event|0|||
105325051|NCT00413699|363189974|FG002|Extension Period|Adverse Event|2|||
105325052|NCT02115269|363189975|FG000|Overall Study|Lost to Follow-up|43|||
105325053|NCT02115269|363189975|FG000|Overall Study|Did not complete patient diary|3|||
105325054|NCT02115269|363189975|FG000|Overall Study|Moved to another city|7|||
105325055|NCT02115269|363189975|FG000|Overall Study|Withdrawal by Subject|2|||
105325056|NCT02115269|363189975|FG000|Overall Study|Didn't take study drug|2|||
105325057|NCT02810457|363189976|FG000|Overall Study|Randomised but no treatment received|2|||
105325058|NCT02810457|363189977|FG001|Overall Study|Randomised but no treatment received|1|||
105325059|NCT02810457|363189976|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
105325060|NCT02810457|363189977|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
105325061|NCT02810457|363189976|FG000|Overall Study|Adverse Event|37|||
105325062|NCT02810457|363189977|FG001|Overall Study|Adverse Event|43|||
105325063|NCT02810457|363189976|FG000|Overall Study|Patient decision|31|||
105325064|NCT02810457|363189977|FG001|Overall Study|Patient decision|35|||
105325065|NCT02810457|363189976|FG000|Overall Study|Patient lost to follow-up|2|||
105325066|NCT02810457|363189977|FG001|Overall Study|Patient lost to follow-up|2|||
105325067|NCT02810457|363189976|FG000|Overall Study|Death|39|||
105325068|NCT02810457|363189977|FG001|Overall Study|Death|28|||
105325069|NCT02810457|363189976|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
105325070|NCT02810457|363189977|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
105325071|NCT02810457|363189976|FG000|Overall Study|Clinical progression|15|||
105325072|NCT02810457|363189977|FG001|Overall Study|Clinical progression|16|||
105325073|NCT02810457|363189976|FG000|Overall Study|Investigator decision|3|||
105325074|NCT02810457|363189977|FG001|Overall Study|Investigator decision|2|||
105325075|NCT02810457|363189976|FG000|Overall Study|Patient ineligibility|3|||
105325076|NCT02810457|363189977|FG001|Overall Study|Patient ineligibility|0|||
105325077|NCT02810457|363189976|FG000|Overall Study|Miscalculated PD|1|||
105325078|NCT02810457|363189977|FG001|Overall Study|Miscalculated PD|0|||
105325079|NCT02810457|363189976|FG000|Overall Study|Physician Decision|0|||
105325080|NCT02810457|363189977|FG001|Overall Study|Physician Decision|1|||
105325081|NCT00818766|363189978|FG000|Overall Study|Could not be Contacted on Day 28|11|||
105325082|NCT00818766|363189979|FG001|Overall Study|Could not be Contacted on Day 28|10|||
105325083|NCT00818766|363189978|FG000|Overall Study|Death|1|||
105325084|NCT00818766|363189979|FG001|Overall Study|Death|0|||
105325085|NCT00818766|363189978|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
105325086|NCT00818766|363189979|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
105325087|NCT01996241|363189980|FG000|Overall Study|Lost to Follow-up|252|||
105325088|NCT01996241|363189981|FG001|Overall Study|Lost to Follow-up|235|||
105325089|NCT01103180|363189986|FG000|Overall Study|Withdrawal by Subject|8|||
105325090|NCT01103180|363189987|FG001|Overall Study|Withdrawal by Subject|13|||
105325091|NCT01103180|363189986|FG000|Overall Study|Lost to Follow-up|13|||
105325092|NCT01103180|363189987|FG001|Overall Study|Lost to Follow-up|7|||
105325093|NCT01103180|363189986|FG000|Overall Study|Physician Decision|1|||
105325094|NCT01103180|363189987|FG001|Overall Study|Physician Decision|0|||
105325095|NCT01103180|363189986|FG000|Overall Study|Protocol Violation|0|||
105325096|NCT01103180|363189987|FG001|Overall Study|Protocol Violation|1|||
105325097|NCT02717507|363189992|FG000|Overall Study|Lost to Follow-up|5|||
105325098|NCT02717507|363189993|FG001|Overall Study|Lost to Follow-up|8|||
105325099|NCT02717507|363189992|FG000|Overall Study|Pregnancy|1|||
105325100|NCT02717507|363189993|FG001|Overall Study|Pregnancy|1|||
105325101|NCT02717507|363189992|FG000|Overall Study|Protocol Violation|2|||
105325102|NCT02717507|363189993|FG001|Overall Study|Protocol Violation|2|||
105325103|NCT02717507|363189992|FG000|Overall Study|Withdrawal by Subject|20|||
105325104|NCT02717507|363189993|FG001|Overall Study|Withdrawal by Subject|20|||
105325105|NCT02717507|363189992|FG000|Overall Study|Relapse|1|||
105325106|NCT02717507|363189993|FG001|Overall Study|Relapse|1|||
105325107|NCT02717507|363189992|FG000|Overall Study|Cardiac Event|2|||
105325108|NCT02717507|363189993|FG001|Overall Study|Cardiac Event|6|||
105325109|NCT02493660|363189995|FG000|Overall Study|Physician Decision|0|||
105372906|NCT02765165|363372524|FG003|Treatment Period|Physician Decision|0|||
105372907|NCT02765165|363372525|FG004|Treatment Period|Physician Decision|0|||
105372908|NCT02765165|363372526|FG005|Treatment Period|Physician Decision|0|||
105372909|NCT02765165|363372527|FG006|Treatment Period|Physician Decision|0|||
105372910|NCT02765165|363372521|FG000|Treatment Period|Adverse Event|0|||
105372911|NCT02765165|363372522|FG001|Treatment Period|Adverse Event|1|||
105372912|NCT02765165|363372523|FG002|Treatment Period|Adverse Event|0|||
105325110|NCT02493660|363189996|FG001|Overall Study|Physician Decision|1|||
105325111|NCT02493660|363189995|FG000|Overall Study|Adverse Event|4|||
105325112|NCT02493660|363189996|FG001|Overall Study|Adverse Event|2|||
105325113|NCT02493660|363189995|FG000|Overall Study|Withdrawal by Subject|2|||
105325114|NCT02493660|363189996|FG001|Overall Study|Withdrawal by Subject|3|||
105325115|NCT02493660|363189995|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
105325116|NCT02493660|363189996|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
105325117|NCT02493660|363189995|FG000|Overall Study|Protocol Violation|0|||
105325118|NCT02493660|363189996|FG001|Overall Study|Protocol Violation|1|||
105325119|NCT02493660|363189995|FG000|Overall Study|Death|0|||
105325120|NCT02493660|363189996|FG001|Overall Study|Death|1|||
105325121|NCT02493660|363189995|FG000|Overall Study|Lost to Follow-up|2|||
105325122|NCT02493660|363189996|FG001|Overall Study|Lost to Follow-up|4|||
105325123|NCT00370552|363189998|FG000|Overall Study|Adverse Event|2|||
105325124|NCT00370552|363189999|FG001|Overall Study|Adverse Event|2|||
105325125|NCT00370552|363190000|FG002|Overall Study|Adverse Event|2|||
105325126|NCT00370552|363189998|FG000|Overall Study|Disease progression|23|||
105325127|NCT00370552|363189999|FG001|Overall Study|Disease progression|23|||
105325128|NCT00370552|363190000|FG002|Overall Study|Disease progression|15|||
105325129|NCT00370552|363189998|FG000|Overall Study|Maximum clinical benefit|3|||
105325130|NCT00370552|363189999|FG001|Overall Study|Maximum clinical benefit|5|||
105325131|NCT00370552|363190000|FG002|Overall Study|Maximum clinical benefit|5|||
105325132|NCT00370552|363189998|FG000|Overall Study|Poor or noncompliance|0|||
105325133|NCT00370552|363189999|FG001|Overall Study|Poor or noncompliance|0|||
105325134|NCT00370552|363190000|FG002|Overall Study|Poor or noncompliance|1|||
105325135|NCT00370552|363189998|FG000|Overall Study|Study drug toxicity|11|||
105325136|NCT00370552|363189999|FG001|Overall Study|Study drug toxicity|8|||
105325137|NCT00370552|363190000|FG002|Overall Study|Study drug toxicity|6|||
105325138|NCT00370552|363189998|FG000|Overall Study|Withdrawal by Subject|2|||
105325139|NCT00370552|363189999|FG001|Overall Study|Withdrawal by Subject|0|||
105325140|NCT00370552|363190000|FG002|Overall Study|Withdrawal by Subject|1|||
105325141|NCT00370552|363189998|FG000|Overall Study|Still on treatment|1|||
105325142|NCT00370552|363189999|FG001|Overall Study|Still on treatment|3|||
105325143|NCT00370552|363190000|FG002|Overall Study|Still on treatment|2|||
105325144|NCT00370552|363189998|FG000|Overall Study|Never treated|1|||
105325145|NCT00370552|363189999|FG001|Overall Study|Never treated|0|||
105325146|NCT00370552|363190000|FG002|Overall Study|Never treated|0|||
105325147|NCT00370552|363189998|FG000|Overall Study|Physician Decision|1|||
105325148|NCT00370552|363189999|FG001|Overall Study|Physician Decision|1|||
105325149|NCT00370552|363190000|FG002|Overall Study|Physician Decision|0|||
105325150|NCT00370552|363189998|FG000|Overall Study|Investigator decision|2|||
105325151|NCT00370552|363189999|FG001|Overall Study|Investigator decision|1|||
105325152|NCT00370552|363190000|FG002|Overall Study|Investigator decision|0|||
105325153|NCT00370552|363189998|FG000|Overall Study|High risk of allergic reaction|0|||
105325154|NCT00370552|363189999|FG001|Overall Study|High risk of allergic reaction|1|||
105325155|NCT00370552|363190000|FG002|Overall Study|High risk of allergic reaction|0|||
105325156|NCT00370552|363189998|FG000|Overall Study|Planned radiation for palliation|0|||
105325157|NCT00370552|363189999|FG001|Overall Study|Planned radiation for palliation|1|||
105325158|NCT00370552|363190000|FG002|Overall Study|Planned radiation for palliation|0|||
105325159|NCT03500198|363190001|FG000|Overall Study|Lost to Follow-up|0|||
105325160|NCT03500198|363190002|FG001|Overall Study|Lost to Follow-up|1|||
105325161|NCT00595621|363190008|FG000|Open Label Run in|Adverse Event|1|||
105325162|NCT00595621|363190009|FG001|Open Label Run in|Adverse Event|0|||
105325163|NCT00595621|363190008|FG000|Open Label Run in|Physician Decision|1|||
105325164|NCT00595621|363190009|FG001|Open Label Run in|Physician Decision|0|||
105325165|NCT00595621|363190008|FG000|Open Label Run in|Withdrawal by Subject|1|||
105325166|NCT00595621|363190009|FG001|Open Label Run in|Withdrawal by Subject|0|||
105325167|NCT00595621|363190008|FG000|Randomization and Study|Adverse Event|2|||
105325168|NCT00595621|363190009|FG001|Randomization and Study|Adverse Event|0|||
105325169|NCT00595621|363190008|FG000|Randomization and Study|Withdrawal by Subject|0|||
105325170|NCT00595621|363190009|FG001|Randomization and Study|Withdrawal by Subject|1|||
105325171|NCT03817125|363190012|FG000|Overall Study|Adverse Event|1|||
105325172|NCT03817125|363190013|FG001|Overall Study|Adverse Event|0|||
105325173|NCT03817125|363190012|FG000|Overall Study|Physician Decision|0|||
105325174|NCT03817125|363190013|FG001|Overall Study|Physician Decision|1|||
105325175|NCT03817125|363190012|FG000|Overall Study|Lack of Efficacy|1|||
105325176|NCT03817125|363190013|FG001|Overall Study|Lack of Efficacy|5|||
105325177|NCT01062425|363190014|FG000|Overall Study|Protocol Violation|3|||
105325178|NCT01062425|363190015|FG001|Overall Study|Protocol Violation|6|||
105325179|NCT01998919|363190017|FG000|Overall Study|Death|2|||
105325180|NCT01998919|363190018|FG001|Overall Study|Death|2|||
105325181|NCT01998919|363190017|FG000|Overall Study|Adverse Event|0|||
105325182|NCT01998919|363190018|FG001|Overall Study|Adverse Event|5|||
105325183|NCT01998919|363190017|FG000|Overall Study|Disease progression|31|||
105325184|NCT01998919|363190018|FG001|Overall Study|Disease progression|22|||
105325185|NCT01998919|363190017|FG000|Overall Study|Withdrawal by Subject|2|||
105325186|NCT01998919|363190018|FG001|Overall Study|Withdrawal by Subject|4|||
105325187|NCT01998919|363190017|FG000|Overall Study|Lost to Follow-up|2|||
105325188|NCT01998919|363190018|FG001|Overall Study|Lost to Follow-up|0|||
105325189|NCT01998919|363190017|FG000|Overall Study|Other|5|||
105325190|NCT01998919|363190018|FG001|Overall Study|Other|2|||
105325191|NCT00116779|363190019|FG000|Overall Study|Adverse Event|4|||
105325192|NCT00116779|363190020|FG001|Overall Study|Adverse Event|2|||
105325193|NCT00116779|363190019|FG000|Overall Study|Protocol Violation|1|||
105325194|NCT00116779|363190020|FG001|Overall Study|Protocol Violation|4|||
105325195|NCT00116779|363190019|FG000|Overall Study|Withdrawal by Subject|4|||
105325196|NCT00116779|363190020|FG001|Overall Study|Withdrawal by Subject|1|||
105325197|NCT00116779|363190019|FG000|Overall Study|Inadequate testosterone suppression|7|||
105325198|NCT00116779|363190020|FG001|Overall Study|Inadequate testosterone suppression|9|||
105325199|NCT00116779|363190019|FG000|Overall Study|Physician Decision|3|||
105491872|NCT00410202|363812602|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
105491873|NCT00410202|363812600|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
105491874|NCT00410202|363812601|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
105491875|NCT00410202|363812602|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
105491876|NCT03139279|363812603|FG000|Overall Study|Physician Decision|2|||
105491877|NCT03139279|363812604|FG001|Overall Study|Physician Decision|0|||
105325200|NCT00116779|363190020|FG001|Overall Study|Physician Decision|1|||
105325201|NCT00116779|363190019|FG000|Overall Study|Elevated PSA levels|2|||
105325202|NCT00116779|363190020|FG001|Overall Study|Elevated PSA levels|2|||
105325203|NCT02383017|363190021|FG000|Overall Study|Injury Sustained Outside Study|1|||
105325204|NCT02383017|363190022|FG001|Overall Study|Injury Sustained Outside Study|0|||
105325205|NCT02383017|363190021|FG000|Overall Study|Compliance|3|||
105325206|NCT02383017|363190022|FG001|Overall Study|Compliance|2|||
105325207|NCT02383017|363190021|FG000|Overall Study|Found to be Hypogonadal|1|||
105325208|NCT02383017|363190022|FG001|Overall Study|Found to be Hypogonadal|0|||
105325209|NCT01037218|363190023|FG000|Overall Study|Adverse Event|4|||
105325210|NCT01037218|363190024|FG001|Overall Study|Adverse Event|2|||
105325211|NCT01037218|363190025|FG002|Overall Study|Adverse Event|2|||
105325212|NCT01037218|363190026|FG003|Overall Study|Adverse Event|1|||
105325213|NCT01037218|363190023|FG000|Overall Study|Lack of Efficacy|0|||
105325214|NCT01037218|363190024|FG001|Overall Study|Lack of Efficacy|2|||
105325215|NCT01037218|363190025|FG002|Overall Study|Lack of Efficacy|1|||
105325216|NCT01037218|363190026|FG003|Overall Study|Lack of Efficacy|5|||
105325217|NCT01037218|363190023|FG000|Overall Study|Lost to Follow-up|3|||
105325218|NCT01037218|363190024|FG001|Overall Study|Lost to Follow-up|5|||
105325219|NCT01037218|363190025|FG002|Overall Study|Lost to Follow-up|4|||
105325220|NCT01037218|363190026|FG003|Overall Study|Lost to Follow-up|2|||
105325221|NCT01037218|363190023|FG000|Overall Study|Withdrawal by Subject|6|||
105325222|NCT01037218|363190024|FG001|Overall Study|Withdrawal by Subject|7|||
105325223|NCT01037218|363190025|FG002|Overall Study|Withdrawal by Subject|7|||
105325224|NCT01037218|363190026|FG003|Overall Study|Withdrawal by Subject|4|||
105325225|NCT01037218|363190023|FG000|Overall Study|Partner Withdrew Consent|0|||
105325226|NCT01037218|363190024|FG001|Overall Study|Partner Withdrew Consent|3|||
105325227|NCT01037218|363190025|FG002|Overall Study|Partner Withdrew Consent|2|||
105325228|NCT01037218|363190026|FG003|Overall Study|Partner Withdrew Consent|1|||
105325229|NCT01037218|363190023|FG000|Overall Study|Protocol Violation|0|||
105325230|NCT01037218|363190024|FG001|Overall Study|Protocol Violation|0|||
105325231|NCT01037218|363190025|FG002|Overall Study|Protocol Violation|2|||
105325232|NCT01037218|363190026|FG003|Overall Study|Protocol Violation|2|||
105325233|NCT01037218|363190023|FG000|Overall Study|Various|3|||
105325234|NCT01037218|363190024|FG001|Overall Study|Various|2|||
105325235|NCT01037218|363190025|FG002|Overall Study|Various|3|||
105325236|NCT01037218|363190026|FG003|Overall Study|Various|1|||
105325237|NCT01068860|363190027|FG000|Overall Study|Withdrawal by Subject|0|||
105325238|NCT01068860|363190028|FG001|Overall Study|Withdrawal by Subject|0|||
105325239|NCT01068860|363190029|FG002|Overall Study|Withdrawal by Subject|0|||
105325240|NCT01068860|363190030|FG003|Overall Study|Withdrawal by Subject|0|||
105325241|NCT01068860|363190031|FG004|Overall Study|Withdrawal by Subject|0|||
105325242|NCT01068860|363190032|FG005|Overall Study|Withdrawal by Subject|2|||
105325243|NCT01068860|363190033|FG006|Overall Study|Withdrawal by Subject|0|||
105325244|NCT01068860|363190034|FG007|Overall Study|Withdrawal by Subject|0|||
105325245|NCT01068860|363190035|FG008|Overall Study|Withdrawal by Subject|0|||
105325246|NCT01068860|363190036|FG009|Overall Study|Withdrawal by Subject|3|||
105325247|NCT01068860|363190027|FG000|Overall Study|Administrative problems; misrandomized|0|||
105325248|NCT01068860|363190028|FG001|Overall Study|Administrative problems; misrandomized|0|||
105325249|NCT01068860|363190029|FG002|Overall Study|Administrative problems; misrandomized|0|||
105325250|NCT01068860|363190030|FG003|Overall Study|Administrative problems; misrandomized|1|||
105325251|NCT01068860|363190031|FG004|Overall Study|Administrative problems; misrandomized|0|||
105325252|NCT01068860|363190032|FG005|Overall Study|Administrative problems; misrandomized|0|||
105325253|NCT01068860|363190033|FG006|Overall Study|Administrative problems; misrandomized|0|||
105325254|NCT01068860|363190034|FG007|Overall Study|Administrative problems; misrandomized|0|||
105325255|NCT01068860|363190035|FG008|Overall Study|Administrative problems; misrandomized|0|||
105325256|NCT01068860|363190036|FG009|Overall Study|Administrative problems; misrandomized|1|||
105325257|NCT01068860|363190027|FG000|Overall Study|Lost to Follow-up|0|||
105325258|NCT01068860|363190028|FG001|Overall Study|Lost to Follow-up|1|||
105325259|NCT01068860|363190029|FG002|Overall Study|Lost to Follow-up|0|||
105325260|NCT01068860|363190030|FG003|Overall Study|Lost to Follow-up|0|||
105325261|NCT01068860|363190031|FG004|Overall Study|Lost to Follow-up|0|||
105325262|NCT01068860|363190032|FG005|Overall Study|Lost to Follow-up|0|||
105325263|NCT01068860|363190033|FG006|Overall Study|Lost to Follow-up|0|||
105325264|NCT01068860|363190034|FG007|Overall Study|Lost to Follow-up|0|||
105325265|NCT01068860|363190035|FG008|Overall Study|Lost to Follow-up|0|||
105325266|NCT01068860|363190036|FG009|Overall Study|Lost to Follow-up|0|||
105325267|NCT02676882|363190037|FG000|Overall Study|Adverse Event|1|||
105325268|NCT02676882|363190038|FG001|Overall Study|Adverse Event|0|||
105491878|NCT03139279|363812603|FG000|Overall Study|Protocol Violation|5|||
105325269|NCT02676882|363190037|FG000|Overall Study|Lost to Follow-up|1|||
105372913|NCT02765165|363372524|FG003|Treatment Period|Adverse Event|0|||
105372914|NCT02765165|363372525|FG004|Treatment Period|Adverse Event|0|||
105372915|NCT02765165|363372526|FG005|Treatment Period|Adverse Event|0|||
105372916|NCT02765165|363372527|FG006|Treatment Period|Adverse Event|0|||
105372917|NCT02765165|363372521|FG000|Treatment Period|Withdrawal by Subject|0|||
105372918|NCT02765165|363372522|FG001|Treatment Period|Withdrawal by Subject|0|||
105372919|NCT02765165|363372523|FG002|Treatment Period|Withdrawal by Subject|0|||
105372920|NCT02765165|363372524|FG003|Treatment Period|Withdrawal by Subject|0|||
105372921|NCT02765165|363372525|FG004|Treatment Period|Withdrawal by Subject|2|||
105576936|NCT00312858|364112087|FG001|Overall Study|Participant Moved|10|||
105576937|NCT00312858|364112086|FG000|Overall Study|Other|9|||
105576938|NCT00312858|364112087|FG001|Overall Study|Other|12|||
105576939|NCT00802659|364112089|FG000|Overall Study|Physician Decision|0|||
105576940|NCT00802659|364112090|FG001|Overall Study|Physician Decision|1|||
105325270|NCT02676882|363190038|FG001|Overall Study|Lost to Follow-up|0|||
105325271|NCT02676882|363190037|FG000|Overall Study|Withdrawal by Subject|1|||
105325272|NCT02676882|363190038|FG001|Overall Study|Withdrawal by Subject|2|||
105325273|NCT02568072|363190039|FG000|Overall Study|Unavailable for appointment|23|||
105325274|NCT02568072|363190039|FG000|Overall Study|Unable to contact|3|||
105325275|NCT02568072|363190039|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
105325276|NCT02568072|363190039|FG000|Overall Study|Withdrawal by Subject|1|||
105325277|NCT02568072|363190039|FG000|Overall Study|Sustained injury, marathon not run|24|||
105325278|NCT00460603|363190040|FG000|Phase 1|Death|1|||
105325279|NCT00460603|363190041|FG001|Phase 1|Death|0|||
105325280|NCT00460603|363190042|FG002|Phase 1|Death|0|||
105325281|NCT00460603|363190043|FG003|Phase 1|Death|2|||
105325282|NCT00460603|363190044|FG004|Phase 1|Death|0|||
105325283|NCT00460603|363190045|FG005|Phase 1|Death|0|||
105325284|NCT00460603|363190046|FG006|Phase 1|Death|0|||
105325285|NCT00460603|363190047|FG007|Phase 1|Death|0|||
105325286|NCT00460603|363190048|FG008|Phase 1|Death|1|||
105325287|NCT00460603|363190049|FG009|Phase 1|Death|0|||
105325288|NCT00460603|363190050|FG010|Phase 1|Death|0|||
105325289|NCT00460603|363190051|FG011|Phase 1|Death|0|||
105325290|NCT00460603|363190040|FG000|Phase 1|Adverse Event|3|||
105325291|NCT00460603|363190041|FG001|Phase 1|Adverse Event|1|||
105325292|NCT00460603|363190042|FG002|Phase 1|Adverse Event|1|||
105325293|NCT00460603|363190043|FG003|Phase 1|Adverse Event|2|||
105325294|NCT00460603|363190044|FG004|Phase 1|Adverse Event|0|||
105325295|NCT00460603|363190045|FG005|Phase 1|Adverse Event|0|||
105325296|NCT00460603|363190046|FG006|Phase 1|Adverse Event|3|||
105325297|NCT00460603|363190047|FG007|Phase 1|Adverse Event|0|||
105325298|NCT00460603|363190048|FG008|Phase 1|Adverse Event|4|||
105325299|NCT00460603|363190049|FG009|Phase 1|Adverse Event|0|||
105325300|NCT00460603|363190050|FG010|Phase 1|Adverse Event|0|||
105325301|NCT00460603|363190051|FG011|Phase 1|Adverse Event|0|||
105325302|NCT00460603|363190040|FG000|Phase 1|Lack of Efficacy|1|||
105325303|NCT00460603|363190041|FG001|Phase 1|Lack of Efficacy|0|||
105325304|NCT00460603|363190042|FG002|Phase 1|Lack of Efficacy|1|||
105325305|NCT00460603|363190043|FG003|Phase 1|Lack of Efficacy|2|||
105325306|NCT00460603|363190044|FG004|Phase 1|Lack of Efficacy|2|||
105325307|NCT00460603|363190045|FG005|Phase 1|Lack of Efficacy|2|||
105325308|NCT00460603|363190046|FG006|Phase 1|Lack of Efficacy|2|||
105325309|NCT00460603|363190047|FG007|Phase 1|Lack of Efficacy|2|||
105325310|NCT00460603|363190048|FG008|Phase 1|Lack of Efficacy|11|||
105325311|NCT00460603|363190049|FG009|Phase 1|Lack of Efficacy|0|||
105325312|NCT00460603|363190050|FG010|Phase 1|Lack of Efficacy|0|||
105325313|NCT00460603|363190051|FG011|Phase 1|Lack of Efficacy|0|||
105325314|NCT00460603|363190040|FG000|Phase 1|Withdrawal by Subject|1|||
105325315|NCT00460603|363190041|FG001|Phase 1|Withdrawal by Subject|2|||
105325316|NCT00460603|363190042|FG002|Phase 1|Withdrawal by Subject|1|||
105325317|NCT00460603|363190043|FG003|Phase 1|Withdrawal by Subject|1|||
105325318|NCT00460603|363190044|FG004|Phase 1|Withdrawal by Subject|3|||
105325319|NCT00460603|363190045|FG005|Phase 1|Withdrawal by Subject|0|||
105325320|NCT00460603|363190046|FG006|Phase 1|Withdrawal by Subject|1|||
105325321|NCT00460603|363190047|FG007|Phase 1|Withdrawal by Subject|0|||
105325322|NCT00460603|363190048|FG008|Phase 1|Withdrawal by Subject|2|||
105325323|NCT00460603|363190049|FG009|Phase 1|Withdrawal by Subject|0|||
105325324|NCT00460603|363190050|FG010|Phase 1|Withdrawal by Subject|0|||
105325325|NCT00460603|363190051|FG011|Phase 1|Withdrawal by Subject|0|||
105325326|NCT00460603|363190040|FG000|Phase 1|Other|0|||
105372922|NCT02765165|363372526|FG005|Treatment Period|Withdrawal by Subject|0|||
105325327|NCT00460603|363190041|FG001|Phase 1|Other|3|||
105325328|NCT00460603|363190042|FG002|Phase 1|Other|1|||
105325329|NCT00460603|363190043|FG003|Phase 1|Other|1|||
105325330|NCT00460603|363190044|FG004|Phase 1|Other|1|||
105325331|NCT00460603|363190045|FG005|Phase 1|Other|2|||
105325332|NCT00460603|363190046|FG006|Phase 1|Other|0|||
105325333|NCT00460603|363190047|FG007|Phase 1|Other|1|||
105325334|NCT00460603|363190048|FG008|Phase 1|Other|0|||
105325335|NCT00460603|363190049|FG009|Phase 1|Other|0|||
105325336|NCT00460603|363190050|FG010|Phase 1|Other|0|||
105325337|NCT00460603|363190051|FG011|Phase 1|Other|0|||
105325338|NCT00460603|363190040|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105325339|NCT00460603|363190041|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105576941|NCT00802659|364112091|FG002|Overall Study|Physician Decision|0|||
105325340|NCT00460603|363190042|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105325341|NCT00460603|363190043|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105325342|NCT00460603|363190044|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105325343|NCT00460603|363190045|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105325344|NCT00460603|363190046|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105325345|NCT00460603|363190047|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105325346|NCT00460603|363190048|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105372923|NCT02765165|363372527|FG006|Treatment Period|Withdrawal by Subject|0|||
105372924|NCT02765165|363372521|FG000|Treatment Period|Study terminated|0|||
105372925|NCT02765165|363372522|FG001|Treatment Period|Study terminated|0|||
105372926|NCT02765165|363372523|FG002|Treatment Period|Study terminated|0|||
105372927|NCT02765165|363372524|FG003|Treatment Period|Study terminated|0|||
105372928|NCT02765165|363372525|FG004|Treatment Period|Study terminated|0|||
105372929|NCT02765165|363372526|FG005|Treatment Period|Study terminated|1|||
105372930|NCT02765165|363372527|FG006|Treatment Period|Study terminated|2|||
105372931|NCT02765165|363372521|FG000|Post-treatment Follow-up|Death|1|||
105372932|NCT02765165|363372522|FG001|Post-treatment Follow-up|Death|2|||
105372933|NCT02765165|363372523|FG002|Post-treatment Follow-up|Death|1|||
105372934|NCT02765165|363372524|FG003|Post-treatment Follow-up|Death|1|||
105372935|NCT02765165|363372525|FG004|Post-treatment Follow-up|Death|1|||
105372936|NCT02765165|363372526|FG005|Post-treatment Follow-up|Death|1|||
105372937|NCT02765165|363372527|FG006|Post-treatment Follow-up|Death|0|||
105372938|NCT02765165|363372521|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
105372939|NCT02765165|363372522|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
105372940|NCT02765165|363372523|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
105576942|NCT00802659|364112092|FG003|Overall Study|Physician Decision|0|||
105325347|NCT00460603|363190049|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
105325348|NCT00460603|363190050|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105325349|NCT00460603|363190051|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105325350|NCT00460603|363190040|FG000|Phase 2|Adverse Event|0|||
105325351|NCT00460603|363190041|FG001|Phase 2|Adverse Event|0|||
105325352|NCT00460603|363190042|FG002|Phase 2|Adverse Event|0|||
105325353|NCT00460603|363190043|FG003|Phase 2|Adverse Event|0|||
105325354|NCT00460603|363190044|FG004|Phase 2|Adverse Event|0|||
105325355|NCT00460603|363190045|FG005|Phase 2|Adverse Event|0|||
105325356|NCT00460603|363190046|FG006|Phase 2|Adverse Event|0|||
105325357|NCT00460603|363190047|FG007|Phase 2|Adverse Event|0|||
105325358|NCT00460603|363190048|FG008|Phase 2|Adverse Event|0|||
105325359|NCT00460603|363190049|FG009|Phase 2|Adverse Event|12|||
105325360|NCT00460603|363190050|FG010|Phase 2|Adverse Event|9|||
105325361|NCT00460603|363190051|FG011|Phase 2|Adverse Event|10|||
105325362|NCT00460603|363190040|FG000|Phase 2|Death|0|||
105325363|NCT00460603|363190041|FG001|Phase 2|Death|0|||
105325364|NCT00460603|363190042|FG002|Phase 2|Death|0|||
105325365|NCT00460603|363190043|FG003|Phase 2|Death|0|||
105325366|NCT00460603|363190044|FG004|Phase 2|Death|0|||
105325367|NCT00460603|363190045|FG005|Phase 2|Death|0|||
105325368|NCT00460603|363190046|FG006|Phase 2|Death|0|||
105325369|NCT00460603|363190047|FG007|Phase 2|Death|0|||
105325370|NCT00460603|363190048|FG008|Phase 2|Death|0|||
105325371|NCT00460603|363190049|FG009|Phase 2|Death|4|||
105325372|NCT00460603|363190050|FG010|Phase 2|Death|2|||
105325373|NCT00460603|363190051|FG011|Phase 2|Death|2|||
105325374|NCT00460603|363190040|FG000|Phase 2|Protocol Violation|0|||
105325375|NCT00460603|363190041|FG001|Phase 2|Protocol Violation|0|||
105325376|NCT00460603|363190042|FG002|Phase 2|Protocol Violation|0|||
105325377|NCT00460603|363190043|FG003|Phase 2|Protocol Violation|0|||
105325378|NCT00460603|363190044|FG004|Phase 2|Protocol Violation|0|||
105325379|NCT00460603|363190045|FG005|Phase 2|Protocol Violation|0|||
105325380|NCT00460603|363190046|FG006|Phase 2|Protocol Violation|0|||
105325381|NCT00460603|363190047|FG007|Phase 2|Protocol Violation|0|||
105372941|NCT02765165|363372524|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
105576943|NCT00289770|364112093|FG000|Year 15|Withdrawal by Subject|1|||
105576944|NCT00154063|364112094|FG000|Overall Study|Adverse Event|4|||
105325382|NCT00460603|363190048|FG008|Phase 2|Protocol Violation|0|||
105325383|NCT00460603|363190049|FG009|Phase 2|Protocol Violation|1|||
105325384|NCT00460603|363190050|FG010|Phase 2|Protocol Violation|1|||
105325385|NCT00460603|363190051|FG011|Phase 2|Protocol Violation|0|||
105325386|NCT00460603|363190040|FG000|Phase 2|Lost to Follow-up|0|||
105325387|NCT00460603|363190041|FG001|Phase 2|Lost to Follow-up|0|||
105325388|NCT00460603|363190042|FG002|Phase 2|Lost to Follow-up|0|||
105325389|NCT00460603|363190043|FG003|Phase 2|Lost to Follow-up|0|||
105325390|NCT00460603|363190044|FG004|Phase 2|Lost to Follow-up|0|||
105325391|NCT00460603|363190045|FG005|Phase 2|Lost to Follow-up|0|||
105325392|NCT00460603|363190046|FG006|Phase 2|Lost to Follow-up|0|||
105325393|NCT00460603|363190047|FG007|Phase 2|Lost to Follow-up|0|||
105372942|NCT02765165|363372525|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
105372943|NCT02765165|363372526|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
105372944|NCT02765165|363372527|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
105372945|NCT02765165|363372521|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
105372946|NCT02765165|363372522|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
105491879|NCT03139279|363812604|FG001|Overall Study|Protocol Violation|4|||
105491880|NCT03139279|363812603|FG000|Overall Study|Withdrawal by Subject|0|||
105491881|NCT03139279|363812604|FG001|Overall Study|Withdrawal by Subject|2|||
105491882|NCT01369615|363812605|FG000|Overall Study|Withdrawal by Subject|0|||
105491883|NCT01369615|363812606|FG001|Overall Study|Withdrawal by Subject|1|||
105491884|NCT01369615|363812605|FG000|Overall Study|Lost to Follow-up|0|||
105491885|NCT01369615|363812606|FG001|Overall Study|Lost to Follow-up|1|||
105491886|NCT04263454|363812607|FG000|Overall Study|Adverse Event|0|||
105491887|NCT04263454|363812608|FG001|Overall Study|Adverse Event|2|||
105491888|NCT04263454|363812607|FG000|Overall Study|Physician Decision|3|||
105491889|NCT04263454|363812608|FG001|Overall Study|Physician Decision|5|||
105576945|NCT00154063|364112095|FG001|Overall Study|Adverse Event|8|||
105576946|NCT00154063|364112094|FG000|Overall Study|Protocol Violation|1|||
105576947|NCT00154063|364112095|FG001|Overall Study|Protocol Violation|1|||
105576948|NCT00154063|364112094|FG000|Overall Study|Investigator or Sponsor Request|0|||
105576949|NCT00154063|364112095|FG001|Overall Study|Investigator or Sponsor Request|1|||
105576950|NCT00154063|364112094|FG000|Overall Study|Withdrawal by Subject|4|||
105576951|NCT00154063|364112095|FG001|Overall Study|Withdrawal by Subject|9|||
105576952|NCT00154063|364112094|FG000|Overall Study|Other|3|||
105576953|NCT00154063|364112095|FG001|Overall Study|Other|3|||
105576954|NCT01804673|364112096|FG000|Overall Study|Adverse Event|4|||
105576955|NCT01804673|364112096|FG000|Overall Study|Withdrawal by Subject|1|||
105576956|NCT01804673|364112096|FG000|Overall Study|Lack of Efficacy|9|||
105576957|NCT01804673|364112096|FG000|Overall Study|Change to Oral Therapy|37|||
105576958|NCT01804673|364112096|FG000|Overall Study|No Further Therapy Required|84|||
105576959|NCT01804673|364112096|FG000|Overall Study|Use of Prohibited Medication|1|||
105576960|NCT01804673|364112096|FG000|Overall Study|Other|4|||
105576961|NCT04012814|364112103|FG000|Overall Study|Lost to Follow-up|4|||
105576962|NCT04012814|364112103|FG000|Overall Study|Withdrawal by Subject|2|||
105576963|NCT04012814|364112103|FG000|Overall Study|Protocol Violation|1|||
105576964|NCT04012814|364112103|FG000|Overall Study|Adverse Event|1|||
105576965|NCT04397523|364112104|FG000|Overall Study|Lost to Follow-up|3|||
105576966|NCT04397523|364112104|FG000|Overall Study|Transfer from/to other hospital|8|||
105576967|NCT04076020|364112111|FG000|Overall Study|Death|4|||
105576968|NCT04076020|364112112|FG001|Overall Study|Death|6|||
105576969|NCT04076020|364112111|FG000|Overall Study|Withdrawal by Subject|12|||
105851566|NCT00073021|365112746|FG000|Overall Study|Physician Decision|3|||
105576970|NCT04076020|364112112|FG001|Overall Study|Withdrawal by Subject|8|||
105576971|NCT02406261|364112113|FG000|Period 1|Lost to Follow-up|2|||
105576972|NCT02406261|364112114|FG001|Period 1|Lost to Follow-up|0|||
105851567|NCT00073021|365112747|FG001|Overall Study|Physician Decision|1|||
105851568|NCT00073021|365112746|FG000|Overall Study|Lack of Efficacy|11|||
105851569|NCT00073021|365112747|FG001|Overall Study|Lack of Efficacy|5|||
105851570|NCT01753336|365112748|FG000|Overall Study|Patient decision|12|||
105851571|NCT01753336|365112748|FG000|Overall Study|Lost to Follow-up|3|||
105325394|NCT00460603|363190048|FG008|Phase 2|Lost to Follow-up|0|||
105325395|NCT00460603|363190049|FG009|Phase 2|Lost to Follow-up|1|||
105325396|NCT00460603|363190050|FG010|Phase 2|Lost to Follow-up|0|||
105325397|NCT00460603|363190051|FG011|Phase 2|Lost to Follow-up|0|||
105325398|NCT00460603|363190040|FG000|Phase 2|Other|0|||
105325399|NCT00460603|363190041|FG001|Phase 2|Other|0|||
105325400|NCT00460603|363190042|FG002|Phase 2|Other|0|||
105325401|NCT00460603|363190043|FG003|Phase 2|Other|0|||
105325402|NCT00460603|363190044|FG004|Phase 2|Other|0|||
105325403|NCT00460603|363190045|FG005|Phase 2|Other|0|||
105325404|NCT00460603|363190046|FG006|Phase 2|Other|0|||
105325405|NCT00460603|363190047|FG007|Phase 2|Other|0|||
105325406|NCT00460603|363190048|FG008|Phase 2|Other|0|||
105325407|NCT00460603|363190049|FG009|Phase 2|Other|6|||
105325408|NCT00460603|363190050|FG010|Phase 2|Other|16|||
105325409|NCT00460603|363190051|FG011|Phase 2|Other|7|||
105325410|NCT00460603|363190040|FG000|Phase 2|Objective Progression or Relapse|0|||
105325411|NCT00460603|363190041|FG001|Phase 2|Objective Progression or Relapse|0|||
105325412|NCT00460603|363190042|FG002|Phase 2|Objective Progression or Relapse|0|||
105325413|NCT00460603|363190043|FG003|Phase 2|Objective Progression or Relapse|0|||
105325414|NCT00460603|363190044|FG004|Phase 2|Objective Progression or Relapse|0|||
105325415|NCT00460603|363190045|FG005|Phase 2|Objective Progression or Relapse|0|||
105325416|NCT00460603|363190046|FG006|Phase 2|Objective Progression or Relapse|0|||
105325417|NCT00460603|363190047|FG007|Phase 2|Objective Progression or Relapse|0|||
105491890|NCT04263454|363812607|FG000|Overall Study|Poor Data Quality|0|||
105491891|NCT04263454|363812608|FG001|Overall Study|Poor Data Quality|1|||
105491892|NCT02676466|363812609|FG000|Overall Study|Death|0|||
105491893|NCT02676466|363812610|FG001|Overall Study|Death|2|||
105491894|NCT02676466|363812611|FG002|Overall Study|Death|1|||
105491895|NCT02676466|363812612|FG003|Overall Study|Death|0|||
105576973|NCT02406261|364112113|FG000|Period 1|Adverse Event|1|||
105576974|NCT02406261|364112114|FG001|Period 1|Adverse Event|0|||
105576975|NCT02406261|364112113|FG000|Period 2|Physician Decision|0|||
105576976|NCT02406261|364112114|FG001|Period 2|Physician Decision|1|||
105576977|NCT02406261|364112113|FG000|Period 2|Protocol Violation|0|||
105576978|NCT02406261|364112114|FG001|Period 2|Protocol Violation|1|||
105576979|NCT02406261|364112113|FG000|Period 2|Withdrawal by Subject|0|||
105325418|NCT00460603|363190048|FG008|Phase 2|Objective Progression or Relapse|0|||
105325419|NCT00460603|363190049|FG009|Phase 2|Objective Progression or Relapse|9|||
105325420|NCT00460603|363190050|FG010|Phase 2|Objective Progression or Relapse|10|||
105325421|NCT00460603|363190051|FG011|Phase 2|Objective Progression or Relapse|17|||
105325422|NCT00460603|363190040|FG000|Phase 2|Global Deterioration of Health Status|0|||
105325423|NCT00460603|363190041|FG001|Phase 2|Global Deterioration of Health Status|0|||
105576980|NCT02406261|364112114|FG001|Period 2|Withdrawal by Subject|1|||
105576981|NCT02572817|364112115|FG000|Overall Study|Death|6|||
105576982|NCT02572817|364112116|FG001|Overall Study|Death|3|||
105576983|NCT02572817|364112115|FG000|Overall Study|Lost to Follow-up|3|||
105576984|NCT02572817|364112116|FG001|Overall Study|Lost to Follow-up|3|||
105576985|NCT01394250|364112117|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
105576986|NCT01394250|364112118|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
105576987|NCT01394250|364112117|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
105576988|NCT01394250|364112118|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
105576989|NCT02310126|364112121|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
105576990|NCT02310126|364112122|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
105851572|NCT01753336|365112748|FG000|Overall Study|Physician Decision|2|||
105851573|NCT01753336|365112748|FG000|Overall Study|Sponsor's decision|2|||
105851574|NCT01753336|365112748|FG000|Overall Study|Withdrawal by Subject|1|||
105851575|NCT00914459|365112749|FG000|Overall Study|Protocol Violation|0|||
105851576|NCT00914459|365112750|FG001|Overall Study|Protocol Violation|1|||
105851577|NCT00914459|365112749|FG000|Overall Study|Parent/Legal guardian request|1|||
105851578|NCT00914459|365112750|FG001|Overall Study|Parent/Legal guardian request|0|||
105851579|NCT01661179|365112753|FG000|Overall Study|Death|1|||
105851580|NCT01661179|365112753|FG000|Overall Study|Withdrawal by Subject|1|||
105851581|NCT01661179|365112753|FG000|Overall Study|Other Eligibility criteria|4|||
105851582|NCT01083810|365112754|FG000|Overall Study|Lost to Follow-up|23|||
105851583|NCT01083810|365112755|FG001|Overall Study|Lost to Follow-up|11|||
105576991|NCT02310126|364112121|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
105576992|NCT02310126|364112122|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
105576993|NCT01744496|364112132|FG000|Titration Period|Adverse Event|2|||
105576994|NCT01744496|364112133|FG001|Titration Period|Adverse Event|1|||
105576995|NCT01744496|364112132|FG000|Titration Period|Personal reasons|0|||
105576996|NCT01744496|364112133|FG001|Titration Period|Personal reasons|1|||
105576997|NCT01744496|364112132|FG000|Maintenance Period|Adverse Event|1|||
105576998|NCT01744496|364112133|FG001|Maintenance Period|Adverse Event|3|||
105576999|NCT01744496|364112132|FG000|Maintenance Period|Protocol Violation|1|||
105577000|NCT01744496|364112133|FG001|Maintenance Period|Protocol Violation|0|||
105577001|NCT01744496|364112132|FG000|Maintenance Period|Withdrawal by Subject|1|||
105577002|NCT01744496|364112133|FG001|Maintenance Period|Withdrawal by Subject|1|||
105577003|NCT01744496|364112132|FG000|Maintenance Period|Subject left town|1|||
105577004|NCT01744496|364112133|FG001|Maintenance Period|Subject left town|0|||
105577005|NCT03537261|364112135|FG000|Overall Study|Lost to Follow-up|4|||
105577006|NCT03537261|364112136|FG001|Overall Study|Lost to Follow-up|5|||
105577007|NCT03537261|364112135|FG000|Overall Study|Withdrawal by Subject|4|||
105577008|NCT03537261|364112136|FG001|Overall Study|Withdrawal by Subject|6|||
105577009|NCT03537261|364112135|FG000|Overall Study|Did not return study questionnaires|0|||
105577010|NCT03537261|364112136|FG001|Overall Study|Did not return study questionnaires|1|||
105577011|NCT02500979|364112139|FG000|Period 1|Hyperglycemia|1|||
105577012|NCT02500979|364112140|FG001|Period 1|Hyperglycemia|0|||
105577013|NCT02500979|364112139|FG000|Period 1|Severe non-compliance to protocol|0|||
105577014|NCT02500979|364112140|FG001|Period 1|Severe non-compliance to protocol|1|||
105577015|NCT02500979|364112139|FG000|Period 1|Adverse Event|1|||
105577016|NCT02500979|364112140|FG001|Period 1|Adverse Event|0|||
105577017|NCT02500979|364112139|FG000|Period 1|Subject decision|2|||
105577018|NCT02500979|364112140|FG001|Period 1|Subject decision|0|||
105577019|NCT02500979|364112139|FG000|Period 2|Change in risk|1|||
105577020|NCT02500979|364112140|FG001|Period 2|Change in risk|0|||
105325424|NCT00460603|363190042|FG002|Phase 2|Global Deterioration of Health Status|0|||
105325425|NCT00460603|363190043|FG003|Phase 2|Global Deterioration of Health Status|0|||
105325426|NCT00460603|363190044|FG004|Phase 2|Global Deterioration of Health Status|0|||
105325427|NCT00460603|363190045|FG005|Phase 2|Global Deterioration of Health Status|0|||
105325428|NCT00460603|363190046|FG006|Phase 2|Global Deterioration of Health Status|0|||
105325429|NCT00460603|363190047|FG007|Phase 2|Global Deterioration of Health Status|0|||
105325430|NCT00460603|363190048|FG008|Phase 2|Global Deterioration of Health Status|0|||
105325431|NCT00460603|363190049|FG009|Phase 2|Global Deterioration of Health Status|0|||
105577021|NCT01380990|364112145|FG000|Overall Study|Treatment Failure|1|||
105577022|NCT01380990|364112146|FG001|Overall Study|Treatment Failure|0|||
105577023|NCT01380990|364112145|FG000|Overall Study|Death|0|||
105577024|NCT01380990|364112146|FG001|Overall Study|Death|1|||
105577025|NCT00672958|364112147|FG000|Overall Study|Adverse Event|11|||
105577026|NCT00672958|364112148|FG001|Overall Study|Adverse Event|9|||
105577027|NCT00672958|364112147|FG000|Overall Study|Lack of Efficacy|6|||
105851584|NCT01083810|365112756|FG002|Overall Study|Lost to Follow-up|4|||
105851585|NCT01083810|365112754|FG000|Overall Study|Adverse Event|15|||
105851586|NCT01083810|365112755|FG001|Overall Study|Adverse Event|11|||
105372947|NCT02765165|363372523|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
105372948|NCT02765165|363372524|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
105372949|NCT02765165|363372525|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
105372950|NCT02765165|363372526|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
105372951|NCT02765165|363372527|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
105372952|NCT02765165|363372521|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
105372953|NCT02765165|363372522|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
105372954|NCT02765165|363372523|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
105372955|NCT02765165|363372524|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
105372956|NCT02765165|363372525|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
105372957|NCT02765165|363372526|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
105372958|NCT02765165|363372527|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
105372959|NCT02765165|363372521|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
105372960|NCT02765165|363372522|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
105372961|NCT02765165|363372523|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
105372962|NCT02765165|363372524|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
105372963|NCT02765165|363372525|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
105372964|NCT02765165|363372526|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
105372965|NCT02765165|363372527|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
105372966|NCT02765165|363372521|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
105577028|NCT00672958|364112148|FG001|Overall Study|Lack of Efficacy|11|||
105851587|NCT01083810|365112756|FG002|Overall Study|Adverse Event|4|||
105372967|NCT02765165|363372522|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
105372968|NCT02765165|363372523|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
105372969|NCT02765165|363372524|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
105372970|NCT02765165|363372525|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
105491896|NCT02676466|363812613|FG004|Overall Study|Death|0|||
105491897|NCT02676466|363812614|FG005|Overall Study|Death|0|||
105491898|NCT02676466|363812615|FG006|Overall Study|Death|0|||
105491899|NCT02676466|363812616|FG007|Overall Study|Death|0|||
105491900|NCT02676466|363812609|FG000|Overall Study|Withdrawal by Subject|4|||
105491901|NCT02676466|363812610|FG001|Overall Study|Withdrawal by Subject|3|||
105491902|NCT02676466|363812611|FG002|Overall Study|Withdrawal by Subject|1|||
105491903|NCT02676466|363812612|FG003|Overall Study|Withdrawal by Subject|0|||
105491904|NCT02676466|363812613|FG004|Overall Study|Withdrawal by Subject|3|||
105491905|NCT02676466|363812614|FG005|Overall Study|Withdrawal by Subject|1|||
105491906|NCT02676466|363812615|FG006|Overall Study|Withdrawal by Subject|1|||
105491907|NCT02676466|363812616|FG007|Overall Study|Withdrawal by Subject|1|||
105491908|NCT01178073|363812618|FG000|Overall Study|Adverse Event|34|||
105491909|NCT01178073|363812619|FG001|Overall Study|Adverse Event|27|||
105491910|NCT01178073|363812620|FG002|Overall Study|Adverse Event|24|||
105491911|NCT01178073|363812618|FG000|Overall Study|Protocol Violation|1|||
105491912|NCT01178073|363812619|FG001|Overall Study|Protocol Violation|1|||
105491913|NCT01178073|363812620|FG002|Overall Study|Protocol Violation|1|||
105491914|NCT01178073|363812618|FG000|Overall Study|Lost to Follow-up|2|||
105491915|NCT01178073|363812619|FG001|Overall Study|Lost to Follow-up|0|||
105491916|NCT01178073|363812620|FG002|Overall Study|Lost to Follow-up|3|||
105491917|NCT01178073|363812618|FG000|Overall Study|Physician Decision|14|||
105491918|NCT01178073|363812619|FG001|Overall Study|Physician Decision|10|||
105491919|NCT01178073|363812620|FG002|Overall Study|Physician Decision|10|||
105491920|NCT01178073|363812618|FG000|Overall Study|Withdrawal by Subject|10|||
105491921|NCT01178073|363812619|FG001|Overall Study|Withdrawal by Subject|6|||
105491922|NCT01178073|363812620|FG002|Overall Study|Withdrawal by Subject|8|||
105491923|NCT01178073|363812618|FG000|Overall Study|Missing Completion Status|1|||
105491924|NCT01178073|363812619|FG001|Overall Study|Missing Completion Status|0|||
105491925|NCT01178073|363812620|FG002|Overall Study|Missing Completion Status|0|||
105491926|NCT03187756|363812623|FG000|Overall Study|Termination of study|4|||
105491927|NCT00084838|363813907|FG000|Overall Study|Death|1|||
105491928|NCT00084838|363813907|FG000|Overall Study|Adverse Event|2|||
105491929|NCT00084838|363813907|FG000|Overall Study|Withdrawal by Subject|1|||
105491930|NCT00084838|363813907|FG000|Overall Study|Progressive Disease|4|||
105491931|NCT00084838|363813907|FG000|Overall Study|Pt Non-Compliance|1|||
105491932|NCT00084838|363813907|FG000|Overall Study|Ineligible|4|||
105491933|NCT00122278|363813908|FG000|Overall Study|Lost to Follow-up|2|||
105491934|NCT00122278|363813909|FG001|Overall Study|Lost to Follow-up|0|||
105491935|NCT01002482|363813910|FG000|Overall Study|Withdrawal by Subject|14|||
105491936|NCT01002482|363813911|FG001|Overall Study|Withdrawal by Subject|21|||
105491937|NCT01002482|363813910|FG000|Overall Study|Included twice|1|||
105491938|NCT01002482|363813911|FG001|Overall Study|Included twice|0|||
105491939|NCT05108922|363813915|FG000|Overall Study|Adverse Event|2|||
105491940|NCT05108922|363813916|FG001|Overall Study|Adverse Event|3|||
105491941|NCT05108922|363813915|FG000|Overall Study|Lost to Follow-up|2|||
105491942|NCT05108922|363813916|FG001|Overall Study|Lost to Follow-up|1|||
105325432|NCT00460603|363190050|FG010|Phase 2|Global Deterioration of Health Status|1|||
105325433|NCT00460603|363190051|FG011|Phase 2|Global Deterioration of Health Status|0|||
105325434|NCT00460603|363190040|FG000|Phase 2|Withdrawal by Subject|0|||
105325435|NCT00460603|363190041|FG001|Phase 2|Withdrawal by Subject|0|||
105325436|NCT00460603|363190042|FG002|Phase 2|Withdrawal by Subject|0|||
105325437|NCT00460603|363190043|FG003|Phase 2|Withdrawal by Subject|0|||
105325438|NCT00460603|363190044|FG004|Phase 2|Withdrawal by Subject|0|||
105325439|NCT00460603|363190045|FG005|Phase 2|Withdrawal by Subject|0|||
105325440|NCT00460603|363190046|FG006|Phase 2|Withdrawal by Subject|0|||
105325441|NCT00460603|363190047|FG007|Phase 2|Withdrawal by Subject|0|||
105325442|NCT00460603|363190048|FG008|Phase 2|Withdrawal by Subject|0|||
105325443|NCT00460603|363190049|FG009|Phase 2|Withdrawal by Subject|5|||
105325444|NCT00460603|363190050|FG010|Phase 2|Withdrawal by Subject|4|||
105325445|NCT00460603|363190051|FG011|Phase 2|Withdrawal by Subject|5|||
105325446|NCT00460603|363190040|FG000|Phase 2|Randomized, but not treated|0|||
105325447|NCT00460603|363190041|FG001|Phase 2|Randomized, but not treated|0|||
105325448|NCT00460603|363190042|FG002|Phase 2|Randomized, but not treated|0|||
105325449|NCT00460603|363190043|FG003|Phase 2|Randomized, but not treated|0|||
105325450|NCT00460603|363190044|FG004|Phase 2|Randomized, but not treated|0|||
105325451|NCT00460603|363190045|FG005|Phase 2|Randomized, but not treated|0|||
105325452|NCT00460603|363190046|FG006|Phase 2|Randomized, but not treated|0|||
105325453|NCT00460603|363190047|FG007|Phase 2|Randomized, but not treated|0|||
105325454|NCT00460603|363190048|FG008|Phase 2|Randomized, but not treated|0|||
105325455|NCT00460603|363190049|FG009|Phase 2|Randomized, but not treated|3|||
105325456|NCT00460603|363190050|FG010|Phase 2|Randomized, but not treated|0|||
105325457|NCT00460603|363190051|FG011|Phase 2|Randomized, but not treated|0|||
105325458|NCT01321879|363190055|FG000|Overall Study|Lack of Efficacy|5|||
105325459|NCT01321879|363190055|FG000|Overall Study|Adverse Event|5|||
105325460|NCT01321879|363190055|FG000|Overall Study|Death|3|||
105325461|NCT01321879|363190055|FG000|Overall Study|Withdrawal by Subject|1|||
105325462|NCT02687451|363190056|FG000|Overall Study|Withdrawal by Subject|1|||
105325463|NCT02687451|363190057|FG001|Overall Study|Withdrawal by Subject|0|||
105325464|NCT02687451|363190058|FG002|Overall Study|Withdrawal by Subject|0|||
105325465|NCT02687451|363190059|FG003|Overall Study|Withdrawal by Subject|0|||
105325466|NCT02687451|363190060|FG004|Overall Study|Withdrawal by Subject|0|||
105325467|NCT02687451|363190061|FG005|Overall Study|Withdrawal by Subject|1|||
105325468|NCT00927589|363190062|FG000|Overall Study|Death|1|||
105325469|NCT00927589|363190062|FG000|Overall Study|Physician Decision|1|||
105325470|NCT00927589|363190062|FG000|Overall Study|Withdrawal by Subject|3|||
105325471|NCT00927589|363190062|FG000|Overall Study|Adverse Event|2|||
105325472|NCT00927589|363190062|FG000|Overall Study|Disease Progression|8|||
105325473|NCT00927589|363190062|FG000|Overall Study|Non-compliance|1|||
105325474|NCT01651117|363190067|FG000|Overall Study|Death|2|||
105325475|NCT01651117|363190068|FG001|Overall Study|Death|3|||
105325476|NCT01651117|363190069|FG002|Overall Study|Death|2|||
105325477|NCT01651117|363190070|FG003|Overall Study|Death|2|||
105325478|NCT02714218|363190071|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105325479|NCT02714218|363190072|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
105325480|NCT02714218|363190073|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105325481|NCT02714218|363190071|FG000|Pre-Treatment Period|Other reasons|0|||
105325482|NCT02714218|363190072|FG001|Pre-Treatment Period|Other reasons|1|||
105325483|NCT02714218|363190073|FG002|Pre-Treatment Period|Other reasons|0|||
105325484|NCT02714218|363190071|FG000|Treatment Period|Disease Progression|55|||
105325485|NCT02714218|363190072|FG001|Treatment Period|Disease Progression|52|||
105325486|NCT02714218|363190073|FG002|Treatment Period|Disease Progression|14|||
105325487|NCT02714218|363190071|FG000|Treatment Period|Study drug toxicity|46|||
105325488|NCT02714218|363190072|FG001|Treatment Period|Study drug toxicity|70|||
105325489|NCT02714218|363190073|FG002|Treatment Period|Study drug toxicity|6|||
105325490|NCT02714218|363190071|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
105325491|NCT02714218|363190072|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
105325492|NCT02714218|363190073|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
105325493|NCT02714218|363190071|FG000|Treatment Period|Request to discontinue treatment|1|||
105325494|NCT02714218|363190072|FG001|Treatment Period|Request to discontinue treatment|4|||
105325495|NCT02714218|363190073|FG002|Treatment Period|Request to discontinue treatment|1|||
105325496|NCT02714218|363190071|FG000|Treatment Period|Participant withdrew consent|2|||
105325497|NCT02714218|363190072|FG001|Treatment Period|Participant withdrew consent|2|||
105325498|NCT02714218|363190073|FG002|Treatment Period|Participant withdrew consent|0|||
105325499|NCT02714218|363190071|FG000|Treatment Period|Maximum clinical benefit|4|||
105491943|NCT05108922|363813915|FG000|Overall Study|Inadvertent enrollment|0|||
105325500|NCT02714218|363190072|FG001|Treatment Period|Maximum clinical benefit|2|||
105325501|NCT02714218|363190073|FG002|Treatment Period|Maximum clinical benefit|0|||
105325502|NCT02714218|363190071|FG000|Treatment Period|Administrative reason by sponsor|2|||
105325503|NCT02714218|363190072|FG001|Treatment Period|Administrative reason by sponsor|1|||
105325504|NCT02714218|363190073|FG002|Treatment Period|Administrative reason by sponsor|0|||
105325505|NCT02714218|363190071|FG000|Treatment Period|Other reasons|6|||
105491944|NCT05108922|363813916|FG001|Overall Study|Inadvertent enrollment|1|||
105325506|NCT02714218|363190072|FG001|Treatment Period|Other reasons|6|||
105325507|NCT02714218|363190073|FG002|Treatment Period|Other reasons|0|||
105325508|NCT02714218|363190071|FG000|Treatment Period|Completed treatment as per protocol|36|||
105325509|NCT02714218|363190072|FG001|Treatment Period|Completed treatment as per protocol|27|||
105325510|NCT02714218|363190073|FG002|Treatment Period|Completed treatment as per protocol|3|||
105325511|NCT02714218|363190071|FG000|Treatment Period|Not reported|9|||
105325512|NCT02714218|363190072|FG001|Treatment Period|Not reported|6|||
105325513|NCT02714218|363190073|FG002|Treatment Period|Not reported|0|||
105325514|NCT01778530|363190074|FG000|Overall Study|Progression on study|1|||
105325515|NCT01778530|363190074|FG000|Overall Study|Adverse event/side effect|1|||
105325516|NCT00811733|363190077|FG000|Overall Study|Investigator Discretion|10|||
105325517|NCT00811733|363190078|FG001|Overall Study|Investigator Discretion|8|||
105325518|NCT00811733|363190077|FG000|Overall Study|Withdrawal by Subject|1|||
105325519|NCT00811733|363190078|FG001|Overall Study|Withdrawal by Subject|2|||
105325520|NCT00793871|363190079|FG000|Overall Study|Death|50|||
105325521|NCT00793871|363190079|FG000|Overall Study|Lost to Follow-up|3|||
105325522|NCT00793871|363190079|FG000|Overall Study|Study terminated by the Sponsor|7|||
105325523|NCT02500589|363190080|FG000|Overall Study|Withdrawal by Subject|11|||
105325524|NCT02500589|363190081|FG001|Overall Study|Withdrawal by Subject|14|||
105325525|NCT02500589|363190080|FG000|Overall Study|Lost to Follow-up|10|||
105325526|NCT02500589|363190081|FG001|Overall Study|Lost to Follow-up|12|||
105325527|NCT02500589|363190080|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
105325528|NCT02500589|363190081|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
105325529|NCT02500589|363190080|FG000|Overall Study|Death|7|||
105325530|NCT02500589|363190081|FG001|Overall Study|Death|5|||
105325531|NCT04341363|363190083|FG000|Overall Study|Adverse Event|1|||
105325532|NCT04341363|363190083|FG000|Overall Study|Withdrawal by Subject|1|||
105325533|NCT03652051|363190084|FG000|Stage 1|Adverse Event|0|||
105325534|NCT03652051|363190085|FG001|Stage 1|Adverse Event|5|||
105325535|NCT03652051|363190086|FG002|Stage 1|Adverse Event|7|||
105325536|NCT03652051|363190087|FG003|Stage 1|Adverse Event|1|||
105325537|NCT03652051|363190084|FG000|Stage 1|Withdrawal by Subject|0|||
105325538|NCT03652051|363190085|FG001|Stage 1|Withdrawal by Subject|0|||
105325539|NCT03652051|363190086|FG002|Stage 1|Withdrawal by Subject|1|||
105325540|NCT03652051|363190087|FG003|Stage 1|Withdrawal by Subject|0|||
105325541|NCT03652051|363190084|FG000|Stage 2|Adverse Event|0|||
105325542|NCT03652051|363190085|FG001|Stage 2|Adverse Event|2|||
105325543|NCT03652051|363190086|FG002|Stage 2|Adverse Event|1|||
105325544|NCT03652051|363190087|FG003|Stage 2|Adverse Event|0|||
105325545|NCT03652051|363190084|FG000|Stage 2|Protocol Violation|0|||
105325546|NCT03652051|363190085|FG001|Stage 2|Protocol Violation|1|||
105325547|NCT03652051|363190086|FG002|Stage 2|Protocol Violation|6|||
105325548|NCT03652051|363190087|FG003|Stage 2|Protocol Violation|0|||
105325549|NCT03652051|363190084|FG000|Stage 2|Lost to Follow-up|0|||
105325550|NCT03652051|363190085|FG001|Stage 2|Lost to Follow-up|2|||
105325551|NCT03652051|363190086|FG002|Stage 2|Lost to Follow-up|0|||
105325552|NCT03652051|363190087|FG003|Stage 2|Lost to Follow-up|3|||
105325553|NCT03652051|363190084|FG000|Stage 2|Withdrawal by Subject|0|||
105325554|NCT03652051|363190085|FG001|Stage 2|Withdrawal by Subject|11|||
105325555|NCT03652051|363190086|FG002|Stage 2|Withdrawal by Subject|9|||
105325556|NCT03652051|363190087|FG003|Stage 2|Withdrawal by Subject|3|||
105325557|NCT01051960|363190088|FG000|Overall Study|Adverse Event|1|||
105325558|NCT02394600|363190089|FG000|Overall Study|Adverse Event|3|||
105325559|NCT02394600|363190090|FG001|Overall Study|Adverse Event|0|||
105325560|NCT02394600|363190089|FG000|Overall Study|Lost to Follow-up|0|||
105325561|NCT02394600|363190090|FG001|Overall Study|Lost to Follow-up|1|||
105325562|NCT02394600|363190089|FG000|Overall Study|Withdrawal by Subject|0|||
105372971|NCT02765165|363372526|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
105372972|NCT02765165|363372527|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
105325563|NCT02394600|363190090|FG001|Overall Study|Withdrawal by Subject|1|||
105325564|NCT02394600|363190089|FG000|Overall Study|Protocol Violation|1|||
105325565|NCT02394600|363190090|FG001|Overall Study|Protocol Violation|0|||
105325566|NCT00395629|363190091|FG000|Core Study|Adverse Event|0|||
105325567|NCT00395629|363190092|FG001|Core Study|Adverse Event|3|||
105325568|NCT00395629|363190093|FG002|Core Study|Adverse Event|4|||
105325569|NCT00395629|363190091|FG000|Core Study|Abnormal laboratory value(s)|0|||
105325570|NCT00395629|363190092|FG001|Core Study|Abnormal laboratory value(s)|0|||
105325571|NCT00395629|363190093|FG002|Core Study|Abnormal laboratory value(s)|1|||
105325572|NCT00395629|363190091|FG000|Core Study|Protocol Violation|1|||
105325573|NCT00395629|363190092|FG001|Core Study|Protocol Violation|0|||
105325574|NCT00395629|363190093|FG002|Core Study|Protocol Violation|0|||
105325575|NCT00395629|363190091|FG000|Core Study|Withdrawal by Subject|0|||
105325576|NCT00395629|363190092|FG001|Core Study|Withdrawal by Subject|1|||
105325577|NCT00395629|363190093|FG002|Core Study|Withdrawal by Subject|1|||
105325578|NCT00395629|363190091|FG000|Core Study|Lost to Follow-up|0|||
105325579|NCT00395629|363190092|FG001|Core Study|Lost to Follow-up|0|||
105325580|NCT00395629|363190093|FG002|Core Study|Lost to Follow-up|1|||
105325581|NCT00395629|363190091|FG000|Extension Study|Adverse Event|0|||
105325582|NCT00395629|363190092|FG001|Extension Study|Adverse Event|0|||
105325583|NCT00395629|363190093|FG002|Extension Study|Adverse Event|2|||
105372973|NCT00321763|363372528|FG000|Overall Study|Adverse Event|1|||
105372974|NCT00321763|363372529|FG001|Overall Study|Adverse Event|1|||
105372975|NCT00321763|363372530|FG002|Overall Study|Adverse Event|0|||
105372976|NCT00321763|363372531|FG003|Overall Study|Adverse Event|1|||
105372977|NCT00321763|363372528|FG000|Overall Study|Withdrawal by Subject|2|||
105372978|NCT00321763|363372529|FG001|Overall Study|Withdrawal by Subject|0|||
105372979|NCT00321763|363372530|FG002|Overall Study|Withdrawal by Subject|1|||
105372980|NCT00321763|363372531|FG003|Overall Study|Withdrawal by Subject|0|||
105372981|NCT00321763|363372528|FG000|Overall Study|Lost to Follow-up|3|||
105372982|NCT00321763|363372529|FG001|Overall Study|Lost to Follow-up|1|||
105372983|NCT00321763|363372530|FG002|Overall Study|Lost to Follow-up|5|||
105577029|NCT00672958|364112147|FG000|Overall Study|Non-compliance with study drug|2|||
105577030|NCT00672958|364112148|FG001|Overall Study|Non-compliance with study drug|3|||
105577031|NCT00672958|364112147|FG000|Overall Study|Protocol deviations|11|||
105577032|NCT00672958|364112148|FG001|Overall Study|Protocol deviations|5|||
105577033|NCT00672958|364112147|FG000|Overall Study|Voluntary withdrawal|12|||
105577034|NCT00672958|364112148|FG001|Overall Study|Voluntary withdrawal|8|||
105577035|NCT00672958|364112147|FG000|Overall Study|Lost to Follow-up|22|||
105577036|NCT00672958|364112148|FG001|Overall Study|Lost to Follow-up|17|||
105577037|NCT00672958|364112147|FG000|Overall Study|Reason not specified|0|||
105577038|NCT00672958|364112148|FG001|Overall Study|Reason not specified|3|||
105577039|NCT04844918|364112149|FG000|Overall Study|Adverse Event|7|||
105577040|NCT04844918|364112150|FG001|Overall Study|Adverse Event|8|||
105577041|NCT04844918|364112151|FG002|Overall Study|Adverse Event|5|||
105577042|NCT04844918|364112149|FG000|Overall Study|Physician Decision|0|||
105577043|NCT04844918|364112150|FG001|Overall Study|Physician Decision|1|||
105577044|NCT04844918|364112151|FG002|Overall Study|Physician Decision|0|||
105577045|NCT04844918|364112149|FG000|Overall Study|Withdrawal by Subject|6|||
105577046|NCT04844918|364112150|FG001|Overall Study|Withdrawal by Subject|3|||
105577047|NCT04844918|364112151|FG002|Overall Study|Withdrawal by Subject|3|||
105577048|NCT04844918|364112149|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
105577049|NCT04844918|364112150|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
105577050|NCT04844918|364112151|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
105577051|NCT01630590|364112158|FG000|Overall Study|Adverse Event|9|||
105577052|NCT01630590|364112158|FG000|Overall Study|Lack of Efficacy|37|||
105577053|NCT01630590|364112158|FG000|Overall Study|Withdrawal by Subject|4|||
105577054|NCT01630590|364112158|FG000|Overall Study|2nd primary tumor|2|||
105577055|NCT01630590|364112158|FG000|Overall Study|Automobile accident|1|||
105577056|NCT01630590|364112158|FG000|Overall Study|Maximum benefit|4|||
105577057|NCT02366936|364112160|FG000|Overall Study|Withdrawal by Subject|2|||
105577058|NCT02366936|364112160|FG000|Overall Study|Lost to Follow-up|4|||
105577059|NCT02366936|364112160|FG000|Overall Study|Physician Decision|2|||
105577060|NCT00849680|364112164|FG000|Overall Study|Adverse Event|0|||
105577061|NCT00849680|364112165|FG001|Overall Study|Adverse Event|0|||
105577062|NCT00849680|364112166|FG002|Overall Study|Adverse Event|0|||
105577063|NCT00849680|364112167|FG003|Overall Study|Adverse Event|0|||
105577064|NCT00849680|364112168|FG004|Overall Study|Adverse Event|0|||
105577065|NCT00849680|364112169|FG005|Overall Study|Adverse Event|0|||
105577066|NCT00849680|364112170|FG006|Overall Study|Adverse Event|2|||
105577067|NCT00849680|364112171|FG007|Overall Study|Adverse Event|0|||
105577068|NCT00849680|364112164|FG000|Overall Study|Lost to Follow-up|7|||
105372984|NCT00321763|363372531|FG003|Overall Study|Lost to Follow-up|4|||
105372985|NCT00410163|363372532|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
105372986|NCT00410163|363372533|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
105372987|NCT00410163|363372532|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
105372988|NCT00410163|363372533|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
105577069|NCT00849680|364112165|FG001|Overall Study|Lost to Follow-up|3|||
105577070|NCT00849680|364112166|FG002|Overall Study|Lost to Follow-up|12|||
105577071|NCT00849680|364112167|FG003|Overall Study|Lost to Follow-up|11|||
105577072|NCT00849680|364112168|FG004|Overall Study|Lost to Follow-up|8|||
105577073|NCT00849680|364112169|FG005|Overall Study|Lost to Follow-up|11|||
105577074|NCT00849680|364112170|FG006|Overall Study|Lost to Follow-up|12|||
105577075|NCT00849680|364112171|FG007|Overall Study|Lost to Follow-up|5|||
105577076|NCT00849680|364112164|FG000|Overall Study|Subject moved|1|||
105851588|NCT01083810|365112754|FG000|Overall Study|Withdrawal by Subject|7|||
105851589|NCT01083810|365112755|FG001|Overall Study|Withdrawal by Subject|2|||
105851590|NCT01083810|365112756|FG002|Overall Study|Withdrawal by Subject|4|||
105851591|NCT01083810|365112754|FG000|Overall Study|Reason not reported|6|||
105851592|NCT01083810|365112755|FG001|Overall Study|Reason not reported|1|||
105851593|NCT01083810|365112756|FG002|Overall Study|Reason not reported|1|||
105851594|NCT01083810|365112754|FG000|Overall Study|Non-compliance|4|||
105851595|NCT01083810|365112755|FG001|Overall Study|Non-compliance|7|||
105851596|NCT01083810|365112756|FG002|Overall Study|Non-compliance|2|||
105851597|NCT01083810|365112754|FG000|Overall Study|Simplification|4|||
105851598|NCT01083810|365112755|FG001|Overall Study|Simplification|1|||
105372989|NCT00410163|363372532|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
105372990|NCT00410163|363372533|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
105851599|NCT01083810|365112756|FG002|Overall Study|Simplification|0|||
105851600|NCT01083810|365112754|FG000|Overall Study|Death|2|||
105851601|NCT01083810|365112755|FG001|Overall Study|Death|2|||
105851602|NCT01083810|365112756|FG002|Overall Study|Death|3|||
105851603|NCT01083810|365112754|FG000|Overall Study|Co-morbidities|1|||
105851604|NCT01083810|365112755|FG001|Overall Study|Co-morbidities|0|||
105851605|NCT01083810|365112756|FG002|Overall Study|Co-morbidities|0|||
105851606|NCT01083810|365112754|FG000|Overall Study|Participation in study|1|||
105851607|NCT01083810|365112755|FG001|Overall Study|Participation in study|0|||
105851608|NCT01083810|365112756|FG002|Overall Study|Participation in study|0|||
105851609|NCT01083810|365112754|FG000|Overall Study|Therapy break|1|||
105851610|NCT01083810|365112755|FG001|Overall Study|Therapy break|2|||
105851611|NCT01083810|365112756|FG002|Overall Study|Therapy break|2|||
105851612|NCT01083810|365112754|FG000|Overall Study|Virologic failure|1|||
105851613|NCT01083810|365112755|FG001|Overall Study|Virologic failure|8|||
105851614|NCT01083810|365112756|FG002|Overall Study|Virologic failure|0|||
105851615|NCT01855074|365112758|FG000|Overall Study|Adverse Event|1|||
105851616|NCT01855074|365112758|FG000|Overall Study|Lost to Follow-up|4|||
105851617|NCT01855074|365112758|FG000|Overall Study|Withdrawal by Subject|8|||
105851618|NCT01855074|365112758|FG000|Overall Study|Started but not treated|1|||
105851619|NCT03118570|365112759|FG000|Overall Study|Adverse Event|2|||
105851620|NCT03118570|365112760|FG001|Overall Study|Adverse Event|0|||
105851621|NCT03118570|365112761|FG002|Overall Study|Adverse Event|0|||
105851622|NCT03118570|365112762|FG003|Overall Study|Adverse Event|0|||
105851623|NCT03118570|365112763|FG004|Overall Study|Adverse Event|3|||
105851624|NCT03118570|365112759|FG000|Overall Study|Withdrawal by Subject|0|||
105851625|NCT03118570|365112760|FG001|Overall Study|Withdrawal by Subject|1|||
105851626|NCT03118570|365112761|FG002|Overall Study|Withdrawal by Subject|4|||
105851627|NCT03118570|365112762|FG003|Overall Study|Withdrawal by Subject|0|||
105851628|NCT03118570|365112763|FG004|Overall Study|Withdrawal by Subject|1|||
105851629|NCT03118570|365112759|FG000|Overall Study|Lost to Follow-up|2|||
105851630|NCT03118570|365112760|FG001|Overall Study|Lost to Follow-up|3|||
105851631|NCT03118570|365112761|FG002|Overall Study|Lost to Follow-up|1|||
105851632|NCT03118570|365112762|FG003|Overall Study|Lost to Follow-up|0|||
105851633|NCT03118570|365112763|FG004|Overall Study|Lost to Follow-up|1|||
105851634|NCT03118570|365112759|FG000|Overall Study|Other, Not Specified|1|||
105851635|NCT03118570|365112760|FG001|Overall Study|Other, Not Specified|3|||
105851636|NCT03118570|365112761|FG002|Overall Study|Other, Not Specified|0|||
105851637|NCT03118570|365112762|FG003|Overall Study|Other, Not Specified|0|||
105851638|NCT03118570|365112763|FG004|Overall Study|Other, Not Specified|0|||
105851639|NCT02304458|365112766|FG000|Overall Study|Adverse Event|0|||
105851640|NCT02304458|365112767|FG001|Overall Study|Adverse Event|0|||
105851641|NCT02304458|365112768|FG002|Overall Study|Adverse Event|7|||
105851642|NCT02304458|365112769|FG003|Overall Study|Adverse Event|0|||
105851643|NCT02304458|365112770|FG004|Overall Study|Adverse Event|0|||
105851644|NCT02304458|365112771|FG005|Overall Study|Adverse Event|0|||
105851645|NCT02304458|365112772|FG006|Overall Study|Adverse Event|3|||
105851646|NCT02304458|365112773|FG007|Overall Study|Adverse Event|4|||
105851647|NCT02304458|365112766|FG000|Overall Study|Death|0|||
105851648|NCT02304458|365112767|FG001|Overall Study|Death|0|||
105851649|NCT02304458|365112768|FG002|Overall Study|Death|2|||
105851650|NCT02304458|365112769|FG003|Overall Study|Death|0|||
105851651|NCT02304458|365112770|FG004|Overall Study|Death|0|||
105851652|NCT02304458|365112771|FG005|Overall Study|Death|0|||
105851653|NCT02304458|365112772|FG006|Overall Study|Death|1|||
105851654|NCT02304458|365112773|FG007|Overall Study|Death|0|||
105325584|NCT00395629|363190091|FG000|Extension Study|Administrative problems|0|||
105325585|NCT00395629|363190092|FG001|Extension Study|Administrative problems|0|||
105325586|NCT00395629|363190093|FG002|Extension Study|Administrative problems|1|||
105325587|NCT02285361|363190097|FG000|Overall Study|Protocol Violation|43|||
105325588|NCT02285361|363190097|FG000|Overall Study|Lost to Follow-up|5|||
105325589|NCT02285361|363190097|FG000|Overall Study|Not taken GIOTRIF|2|||
105325590|NCT02285361|363190097|FG000|Overall Study|Consented prior to the contract date|1|||
105325591|NCT00031590|363190098|FG000|Overall Study|Adverse Event|1|||
105325592|NCT00031590|363190098|FG000|Overall Study|Withdrawal by parents|2|||
105325593|NCT03442751|363190102|FG000|Overall Study|Withdrawal by Subject|3|||
105851655|NCT02304458|365112766|FG000|Overall Study|Lack of Efficacy|4|||
105325594|NCT03442751|363190103|FG001|Overall Study|Withdrawal by Subject|1|||
105325595|NCT03442751|363190102|FG000|Overall Study|Lost to Follow-up|3|||
105372991|NCT00410163|363372532|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
105491945|NCT05108922|363813915|FG000|Overall Study|Physician Decision|2|||
105851656|NCT02304458|365112767|FG001|Overall Study|Lack of Efficacy|6|||
105851657|NCT02304458|365112768|FG002|Overall Study|Lack of Efficacy|38|||
105851658|NCT02304458|365112769|FG003|Overall Study|Lack of Efficacy|5|||
105851659|NCT02304458|365112770|FG004|Overall Study|Lack of Efficacy|6|||
105851660|NCT02304458|365112771|FG005|Overall Study|Lack of Efficacy|6|||
105851661|NCT02304458|365112772|FG006|Overall Study|Lack of Efficacy|21|||
105851662|NCT02304458|365112773|FG007|Overall Study|Lack of Efficacy|4|||
105851663|NCT02304458|365112766|FG000|Overall Study|Physician Decision|2|||
105851664|NCT02304458|365112767|FG001|Overall Study|Physician Decision|0|||
105325596|NCT03442751|363190103|FG001|Overall Study|Lost to Follow-up|0|||
105325597|NCT01546025|363190104|FG000|Overall Study|Lost to Follow-up|0|||
105325598|NCT01546025|363190105|FG001|Overall Study|Lost to Follow-up|1|||
105325599|NCT04199104|363192089|FG000|Overall Study|Death|148|||
105325600|NCT04199104|363192090|FG001|Overall Study|Death|134|||
105325601|NCT04199104|363192089|FG000|Overall Study|Lost to Follow-up|1|||
105325602|NCT04199104|363192090|FG001|Overall Study|Lost to Follow-up|1|||
105325603|NCT04199104|363192089|FG000|Overall Study|Withdrawal by Subject|4|||
105325604|NCT04199104|363192090|FG001|Overall Study|Withdrawal by Subject|4|||
105325605|NCT04199104|363192089|FG000|Overall Study|Participants Ongoing|103|||
105325606|NCT04199104|363192090|FG001|Overall Study|Participants Ongoing|116|||
105325607|NCT03238651|363192091|FG000|Overall Study|Other|0|||
105325608|NCT03238651|363192092|FG001|Overall Study|Other|0|||
105325609|NCT03238651|363192093|FG002|Overall Study|Other|0|||
105325610|NCT03238651|363192094|FG003|Overall Study|Other|0|||
105325611|NCT03238651|363192095|FG004|Overall Study|Other|1|||
105325612|NCT03238651|363192091|FG000|Overall Study|Progressive Disease|2|||
105325613|NCT03238651|363192092|FG001|Overall Study|Progressive Disease|2|||
105325614|NCT03238651|363192093|FG002|Overall Study|Progressive Disease|2|||
105325615|NCT03238651|363192094|FG003|Overall Study|Progressive Disease|2|||
105325616|NCT03238651|363192095|FG004|Overall Study|Progressive Disease|0|||
105325617|NCT03238651|363192091|FG000|Overall Study|Withdrawal by Subject|0|||
105325618|NCT03238651|363192092|FG001|Overall Study|Withdrawal by Subject|1|||
105325619|NCT03238651|363192093|FG002|Overall Study|Withdrawal by Subject|0|||
105372992|NCT00410163|363372533|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
105372993|NCT00410163|363372532|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
105372994|NCT00410163|363372533|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
105372995|NCT00410163|363372532|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
105372996|NCT00410163|363372533|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
105372997|NCT00410163|363372532|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
105372998|NCT00410163|363372533|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
105372999|NCT00410163|363372532|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
105373000|NCT00410163|363372533|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
105373001|NCT00410163|363372532|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
105373002|NCT00410163|363372533|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
105373003|NCT00410163|363372532|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
105373004|NCT00410163|363372533|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
105373005|NCT00410163|363372532|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
105373006|NCT00410163|363372533|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
105373007|NCT00410163|363372532|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
105373008|NCT00410163|363372533|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
105373009|NCT00410163|363372532|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
105373010|NCT00410163|363372533|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
105373011|NCT00410163|363372532|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
105373012|NCT00410163|363372533|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
105373013|NCT02309359|363372535|FG000|Overall Study|Adverse Event|4|||
105373014|NCT02309359|363372536|FG001|Overall Study|Adverse Event|5|||
105373015|NCT02309359|363372537|FG002|Overall Study|Adverse Event|5|||
105373016|NCT02309359|363372538|FG003|Overall Study|Adverse Event|4|||
105373017|NCT02309359|363372539|FG004|Overall Study|Adverse Event|4|||
105373018|NCT02309359|363372535|FG000|Overall Study|Death|1|||
105373019|NCT02309359|363372536|FG001|Overall Study|Death|0|||
105373020|NCT02309359|363372537|FG002|Overall Study|Death|0|||
105373021|NCT02309359|363372538|FG003|Overall Study|Death|0|||
105373022|NCT02309359|363372539|FG004|Overall Study|Death|0|||
105373023|NCT02309359|363372535|FG000|Overall Study|Withdrawal by Subject|2|||
105373024|NCT02309359|363372536|FG001|Overall Study|Withdrawal by Subject|2|||
105373025|NCT02309359|363372537|FG002|Overall Study|Withdrawal by Subject|4|||
105373026|NCT02309359|363372538|FG003|Overall Study|Withdrawal by Subject|4|||
105373027|NCT02309359|363372539|FG004|Overall Study|Withdrawal by Subject|0|||
105373028|NCT02309359|363372535|FG000|Overall Study|Lack of Efficacy|3|||
105373029|NCT02309359|363372536|FG001|Overall Study|Lack of Efficacy|1|||
105373030|NCT02309359|363372537|FG002|Overall Study|Lack of Efficacy|0|||
105373031|NCT02309359|363372538|FG003|Overall Study|Lack of Efficacy|0|||
105373032|NCT02309359|363372539|FG004|Overall Study|Lack of Efficacy|3|||
105491946|NCT05108922|363813916|FG001|Overall Study|Physician Decision|3|||
105491947|NCT05108922|363813915|FG000|Overall Study|Protocol deviation|1|||
105325620|NCT03238651|363192094|FG003|Overall Study|Withdrawal by Subject|1|||
105325621|NCT03238651|363192095|FG004|Overall Study|Withdrawal by Subject|0|||
105325622|NCT03238651|363192091|FG000|Overall Study|Adverse Event|1|||
105325623|NCT03238651|363192092|FG001|Overall Study|Adverse Event|3|||
105373033|NCT02309359|363372535|FG000|Overall Study|Lost to Follow-up|0|||
105373034|NCT02309359|363372536|FG001|Overall Study|Lost to Follow-up|0|||
105491948|NCT05108922|363813916|FG001|Overall Study|Protocol deviation|0|||
105491949|NCT05108922|363813915|FG000|Overall Study|Screen failure|1|||
105491950|NCT05108922|363813916|FG001|Overall Study|Screen failure|0|||
105491951|NCT05108922|363813915|FG000|Overall Study|Withdrawal by Subject|11|||
105491952|NCT05108922|363813916|FG001|Overall Study|Withdrawal by Subject|8|||
105491953|NCT04444895|363813917|FG000|Overall Study|Adverse Event|2|||
105491954|NCT04444895|363813917|FG000|Overall Study|Lost to Follow-up|2|||
105491955|NCT04444895|363813917|FG000|Overall Study|Withdrawal by Subject|5|||
105491956|NCT01854658|363813918|FG000|Overall Study|Protocol Violation|6|||
105491957|NCT01854658|363813919|FG001|Overall Study|Protocol Violation|2|||
105491958|NCT01854658|363813920|FG002|Overall Study|Protocol Violation|2|||
105491959|NCT01854658|363813921|FG003|Overall Study|Protocol Violation|1|||
105491960|NCT01854658|363813918|FG000|Overall Study|Physician Decision|7|||
105491961|NCT01854658|363813919|FG001|Overall Study|Physician Decision|5|||
105577077|NCT00849680|364112165|FG001|Overall Study|Subject moved|0|||
105851665|NCT02304458|365112768|FG002|Overall Study|Physician Decision|16|||
105851666|NCT02304458|365112769|FG003|Overall Study|Physician Decision|1|||
105851667|NCT02304458|365112770|FG004|Overall Study|Physician Decision|0|||
105325624|NCT03238651|363192093|FG002|Overall Study|Adverse Event|2|||
105373035|NCT02309359|363372537|FG002|Overall Study|Lost to Follow-up|0|||
105373036|NCT02309359|363372538|FG003|Overall Study|Lost to Follow-up|1|||
105373037|NCT02309359|363372539|FG004|Overall Study|Lost to Follow-up|0|||
105373038|NCT02309359|363372535|FG000|Overall Study|Other|2|||
105373039|NCT02309359|363372536|FG001|Overall Study|Other|0|||
105373040|NCT02309359|363372537|FG002|Overall Study|Other|2|||
105373041|NCT02309359|363372538|FG003|Overall Study|Other|3|||
105373042|NCT02309359|363372539|FG004|Overall Study|Other|2|||
105373043|NCT00284856|363372540|FG000|Overall Study|Adverse Event|3|||
105373044|NCT00284856|363372541|FG001|Overall Study|Adverse Event|3|||
105373045|NCT00284856|363372542|FG002|Overall Study|Adverse Event|3|||
105373046|NCT00284856|363372540|FG000|Overall Study|Lack of Efficacy|2|||
105373047|NCT00284856|363372541|FG001|Overall Study|Lack of Efficacy|1|||
105373048|NCT00284856|363372542|FG002|Overall Study|Lack of Efficacy|8|||
105373049|NCT00284856|363372540|FG000|Overall Study|Lost to Follow-up|25|||
105373050|NCT00284856|363372541|FG001|Overall Study|Lost to Follow-up|21|||
105373051|NCT00284856|363372542|FG002|Overall Study|Lost to Follow-up|22|||
105373052|NCT00284856|363372540|FG000|Overall Study|Protocol Violation|5|||
105373053|NCT00284856|363372541|FG001|Overall Study|Protocol Violation|4|||
105373054|NCT00284856|363372542|FG002|Overall Study|Protocol Violation|5|||
105373055|NCT00284856|363372540|FG000|Overall Study|Withdrawal by Subject|12|||
105373056|NCT00284856|363372541|FG001|Overall Study|Withdrawal by Subject|16|||
105373057|NCT00284856|363372542|FG002|Overall Study|Withdrawal by Subject|18|||
105373058|NCT00284856|363372540|FG000|Overall Study|Other|4|||
105373059|NCT00284856|363372541|FG001|Overall Study|Other|5|||
105373060|NCT00284856|363372542|FG002|Overall Study|Other|4|||
105373061|NCT01192815|363372543|FG000|Overall Study|Withdrawal by Subject|1|||
105373062|NCT01192815|363372543|FG000|Overall Study|Lack of Efficacy|1|||
105373063|NCT01142336|363372544|FG000|Overall Study|Adverse Event|1|||
105325625|NCT03238651|363192094|FG003|Overall Study|Adverse Event|0|||
105325626|NCT03238651|363192095|FG004|Overall Study|Adverse Event|0|||
105325627|NCT02550561|363192096|FG000|Overall Study|Lost to Follow-up|5|||
105325628|NCT02550561|363192096|FG000|Overall Study|Withdrawal by Subject|1|||
105325629|NCT01113892|363192101|FG000|Overall Study|Lost to Follow-up|2|||
105325630|NCT01113892|363192102|FG001|Overall Study|Lost to Follow-up|2|||
105325631|NCT01113892|363192101|FG000|Overall Study|Withdrawal by Subject|1|||
105325632|NCT01113892|363192102|FG001|Overall Study|Withdrawal by Subject|1|||
105325633|NCT01113892|363192101|FG000|Overall Study|Death|2|||
105325634|NCT01113892|363192102|FG001|Overall Study|Death|4|||
105325635|NCT01113892|363192101|FG000|Overall Study|Graft no longer evaluable|9|||
105325636|NCT01113892|363192102|FG001|Overall Study|Graft no longer evaluable|9|||
105325637|NCT05506046|363192107|FG000|Overall Study|Lost to Follow-up|89|||
105325638|NCT05506046|363192108|FG001|Overall Study|Lost to Follow-up|101|||
105325639|NCT05506046|363192109|FG002|Overall Study|Lost to Follow-up|102|||
105325640|NCT05506046|363192110|FG003|Overall Study|Lost to Follow-up|99|||
105325641|NCT00191477|363192111|FG000|Overall Study|Tumor Recurrence|49|||
105325642|NCT00191477|363192112|FG001|Overall Study|Tumor Recurrence|48|||
105325643|NCT00191477|363192111|FG000|Overall Study|Death, Study Disease|1|||
105325644|NCT00191477|363192112|FG001|Overall Study|Death, Study Disease|1|||
105325645|NCT00191477|363192111|FG000|Overall Study|Death, Other Cause|3|||
105373064|NCT01142336|363372545|FG001|Overall Study|Adverse Event|1|||
105373065|NCT01142336|363372544|FG000|Overall Study|Lost to Follow-up|0|||
105373066|NCT01142336|363372545|FG001|Overall Study|Lost to Follow-up|1|||
105373067|NCT01604785|363372546|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
105373068|NCT01604785|363372547|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
105373069|NCT00869960|363372548|FG000|Overall Study|Lost to Follow-up|2|||
105491962|NCT01854658|363813920|FG002|Overall Study|Physician Decision|2|||
105491963|NCT01854658|363813921|FG003|Overall Study|Physician Decision|4|||
105491964|NCT01854658|363813918|FG000|Overall Study|Lost to Follow-up|8|||
105491965|NCT01854658|363813919|FG001|Overall Study|Lost to Follow-up|9|||
105491966|NCT01854658|363813920|FG002|Overall Study|Lost to Follow-up|8|||
105491967|NCT01854658|363813921|FG003|Overall Study|Lost to Follow-up|4|||
105851668|NCT02304458|365112771|FG005|Overall Study|Physician Decision|0|||
105851669|NCT02304458|365112772|FG006|Overall Study|Physician Decision|3|||
105851670|NCT02304458|365112773|FG007|Overall Study|Physician Decision|0|||
105851671|NCT02304458|365112766|FG000|Overall Study|Protocol Violation|0|||
105851672|NCT02304458|365112767|FG001|Overall Study|Protocol Violation|0|||
105851673|NCT02304458|365112768|FG002|Overall Study|Protocol Violation|1|||
105851674|NCT02304458|365112769|FG003|Overall Study|Protocol Violation|0|||
105851675|NCT02304458|365112770|FG004|Overall Study|Protocol Violation|0|||
105851676|NCT02304458|365112771|FG005|Overall Study|Protocol Violation|0|||
105851677|NCT02304458|365112772|FG006|Overall Study|Protocol Violation|0|||
105851678|NCT02304458|365112773|FG007|Overall Study|Protocol Violation|0|||
105851679|NCT02304458|365112766|FG000|Overall Study|Withdrawal by Subject|1|||
105851680|NCT02304458|365112767|FG001|Overall Study|Withdrawal by Subject|0|||
105851681|NCT02304458|365112768|FG002|Overall Study|Withdrawal by Subject|7|||
105851682|NCT02304458|365112769|FG003|Overall Study|Withdrawal by Subject|0|||
105851683|NCT02304458|365112770|FG004|Overall Study|Withdrawal by Subject|0|||
105851684|NCT02304458|365112771|FG005|Overall Study|Withdrawal by Subject|0|||
105851685|NCT02304458|365112772|FG006|Overall Study|Withdrawal by Subject|1|||
105851686|NCT02304458|365112773|FG007|Overall Study|Withdrawal by Subject|0|||
105851687|NCT01214915|365112778|FG000|Overall Study|Adverse Event|8|||
105851688|NCT01214915|365112778|FG000|Overall Study|Lack of Efficacy|3|||
105851689|NCT04024462|365115907|FG000|Overall Study|Withdrawal by Subject|6|||
105851690|NCT04024462|365115908|FG001|Overall Study|Withdrawal by Subject|7|||
105851691|NCT04024462|365115907|FG000|Overall Study|Progressive Disease|0|||
105851692|NCT04024462|365115908|FG001|Overall Study|Progressive Disease|1|||
105851693|NCT04024462|365115907|FG000|Overall Study|Adverse Event|0|||
105851694|NCT04024462|365115908|FG001|Overall Study|Adverse Event|1|||
105851695|NCT04024462|365115907|FG000|Overall Study|Death|0|||
105851696|NCT04024462|365115908|FG001|Overall Study|Death|1|||
105851697|NCT04024462|365115907|FG000|Overall Study|Lost to Follow-up|1|||
105851698|NCT04024462|365115908|FG001|Overall Study|Lost to Follow-up|0|||
105851699|NCT04024462|365115907|FG000|Overall Study|Ongoing in the Study|94|||
105851700|NCT04024462|365115908|FG001|Overall Study|Ongoing in the Study|89|||
105851701|NCT05101486|365115909|FG000|Overall Study|Death|1|||
105851702|NCT05101486|365115910|FG001|Overall Study|Death|0|||
105851703|NCT05101486|365115911|FG002|Overall Study|Death|1|||
105851704|NCT05101486|365115909|FG000|Overall Study|Lost to Follow-up|12|||
105851705|NCT05101486|365115910|FG001|Overall Study|Lost to Follow-up|8|||
105851706|NCT05101486|365115911|FG002|Overall Study|Lost to Follow-up|17|||
105851707|NCT05101486|365115909|FG000|Overall Study|Physician Decision|1|||
105851708|NCT05101486|365115910|FG001|Overall Study|Physician Decision|0|||
105851709|NCT05101486|365115911|FG002|Overall Study|Physician Decision|0|||
105851710|NCT05101486|365115909|FG000|Overall Study|Protocol Violation|0|||
105851711|NCT05101486|365115910|FG001|Overall Study|Protocol Violation|0|||
105851712|NCT05101486|365115911|FG002|Overall Study|Protocol Violation|1|||
105851713|NCT05101486|365115909|FG000|Overall Study|Withdrawal by Subject|5|||
105851714|NCT05101486|365115910|FG001|Overall Study|Withdrawal by Subject|2|||
105851715|NCT05101486|365115911|FG002|Overall Study|Withdrawal by Subject|4|||
105851716|NCT05101486|365115909|FG000|Overall Study|Randomized but not vaccinated|1|||
105851717|NCT05101486|365115910|FG001|Overall Study|Randomized but not vaccinated|1|||
105851718|NCT05101486|365115911|FG002|Overall Study|Randomized but not vaccinated|1|||
105851719|NCT03747601|365115912|FG000|Overall Study|COVID halt to visits|4|||
105851720|NCT02788045|365115913|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
105851721|NCT02788045|365115914|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
105851722|NCT02788045|365115915|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
105851723|NCT02788045|365115913|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
105851724|NCT02788045|365115914|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
105851725|NCT02788045|365115915|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
105851726|NCT02788045|365115913|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
105325646|NCT00191477|363192112|FG001|Overall Study|Death, Other Cause|6|||
105325647|NCT00191477|363192111|FG000|Overall Study|Lost to Follow-up|23|||
105851727|NCT02788045|365115914|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
105851728|NCT02788045|365115915|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
105851729|NCT02788045|365115913|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
105851730|NCT02788045|365115914|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
105851731|NCT02788045|365115915|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
105851732|NCT02788045|365115913|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
105851733|NCT02788045|365115914|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
105851734|NCT02788045|365115915|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
105851735|NCT02788045|365115913|FG000|Main Study (Up to Week 72)|Other|3|||
105851736|NCT02788045|365115914|FG001|Main Study (Up to Week 72)|Other|0|||
105851737|NCT02788045|365115915|FG002|Main Study (Up to Week 72)|Other|0|||
105851738|NCT02788045|365115913|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
105851739|NCT02788045|365115914|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
105851740|NCT02788045|365115915|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
105851741|NCT02788045|365115913|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
105851742|NCT02788045|365115914|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
105325648|NCT00191477|363192112|FG001|Overall Study|Lost to Follow-up|21|||
105325649|NCT00191477|363192111|FG000|Overall Study|Protocol Violation|1|||
105325650|NCT00191477|363192112|FG001|Overall Study|Protocol Violation|1|||
105325651|NCT00191477|363192111|FG000|Overall Study|Treatment Change|2|||
105325652|NCT00191477|363192112|FG001|Overall Study|Treatment Change|0|||
105325653|NCT00191477|363192111|FG000|Overall Study|Withdrawal by Subject|2|||
105325654|NCT00191477|363192112|FG001|Overall Study|Withdrawal by Subject|0|||
105325655|NCT00191477|363192111|FG000|Overall Study|Other|2|||
105325656|NCT00191477|363192112|FG001|Overall Study|Other|0|||
105325657|NCT00191477|363192111|FG000|Overall Study|Not Eligible|41|||
105325658|NCT00191477|363192112|FG001|Overall Study|Not Eligible|38|||
105325659|NCT00191477|363192111|FG000|Overall Study|Pathological Specimen Lost|1|||
105325660|NCT00191477|363192112|FG001|Overall Study|Pathological Specimen Lost|0|||
105325661|NCT00191477|363192111|FG000|Overall Study|Discontinued Prior to Instillation|13|||
105325662|NCT00191477|363192112|FG001|Overall Study|Discontinued Prior to Instillation|14|||
105325663|NCT00658723|363192127|FG000|Overall Study|Lost to Follow-up|0|||
105325664|NCT00658723|363192128|FG001|Overall Study|Lost to Follow-up|2|||
105325665|NCT00658723|363192129|FG002|Overall Study|Lost to Follow-up|2|||
105325666|NCT00658723|363192127|FG000|Overall Study|Death|2|||
105325667|NCT00658723|363192128|FG001|Overall Study|Death|1|||
105325668|NCT00658723|363192129|FG002|Overall Study|Death|4|||
105325669|NCT00658723|363192127|FG000|Overall Study|Scheduling Issue|1|||
105325670|NCT00658723|363192128|FG001|Overall Study|Scheduling Issue|1|||
105325671|NCT00658723|363192129|FG002|Overall Study|Scheduling Issue|0|||
105325672|NCT00658723|363192127|FG000|Overall Study|Withdrawal by Subject|1|||
105325673|NCT00658723|363192128|FG001|Overall Study|Withdrawal by Subject|0|||
105325674|NCT00658723|363192129|FG002|Overall Study|Withdrawal by Subject|1|||
105325675|NCT01108718|363192135|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
105325676|NCT01108718|363192136|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
105325677|NCT01060072|363192137|FG000|Overall Study|Adverse Event|1|||
105325678|NCT01060072|363192138|FG001|Overall Study|Adverse Event|1|||
105325679|NCT01060072|363192137|FG000|Overall Study|Physician Decision|0|||
105325680|NCT01060072|363192138|FG001|Overall Study|Physician Decision|2|||
105325681|NCT01060072|363192137|FG000|Overall Study|Protocol Violation|0|||
105325682|NCT01060072|363192138|FG001|Overall Study|Protocol Violation|1|||
105325683|NCT01060072|363192137|FG000|Overall Study|Acute cholecystitis|1|||
105325684|NCT01060072|363192138|FG001|Overall Study|Acute cholecystitis|0|||
105325685|NCT01060072|363192137|FG000|Overall Study|Excluded Medications|0|||
105325686|NCT01060072|363192138|FG001|Overall Study|Excluded Medications|1|||
105325687|NCT01262872|363192139|FG000|Step 2|Death|0|||
105325688|NCT01262872|363192140|FG001|Step 2|Death|0|||
105325689|NCT01262872|363192141|FG002|Step 2|Death|0|||
105325690|NCT01262872|363192142|FG003|Step 2|Death|1|||
105325691|NCT01262872|363192143|FG004|Step 2|Death|0|||
105325692|NCT01262872|363192144|FG005|Step 2|Death|2|||
105325693|NCT01262872|363192145|FG006|Step 2|Death|2|||
105325694|NCT01262872|363192146|FG007|Step 2|Death|1|||
105325695|NCT01262872|363192139|FG000|Step 2|Protocol Violation|0|||
105325696|NCT01262872|363192140|FG001|Step 2|Protocol Violation|0|||
105325697|NCT01262872|363192141|FG002|Step 2|Protocol Violation|1|||
105325698|NCT01262872|363192142|FG003|Step 2|Protocol Violation|0|||
105325699|NCT01262872|363192143|FG004|Step 2|Protocol Violation|0|||
105325700|NCT01262872|363192144|FG005|Step 2|Protocol Violation|0|||
105325701|NCT01262872|363192145|FG006|Step 2|Protocol Violation|3|||
105325702|NCT01262872|363192146|FG007|Step 2|Protocol Violation|1|||
105325703|NCT01262872|363192139|FG000|Step 2|Withdrawal by Subject|0|||
105325704|NCT01262872|363192140|FG001|Step 2|Withdrawal by Subject|0|||
105325705|NCT01262872|363192141|FG002|Step 2|Withdrawal by Subject|4|||
105325706|NCT01262872|363192142|FG003|Step 2|Withdrawal by Subject|6|||
105325707|NCT01262872|363192143|FG004|Step 2|Withdrawal by Subject|3|||
105325708|NCT01262872|363192144|FG005|Step 2|Withdrawal by Subject|1|||
105325709|NCT01262872|363192145|FG006|Step 2|Withdrawal by Subject|2|||
105325710|NCT01262872|363192146|FG007|Step 2|Withdrawal by Subject|1|||
105577078|NCT00849680|364112166|FG002|Overall Study|Subject moved|3|||
105325711|NCT01262872|363192139|FG000|Step 2|Migrated/moved from study area|0|||
105325712|NCT01262872|363192140|FG001|Step 2|Migrated/moved from study area|0|||
105325713|NCT01262872|363192141|FG002|Step 2|Migrated/moved from study area|4|||
105325714|NCT01262872|363192142|FG003|Step 2|Migrated/moved from study area|3|||
105325715|NCT01262872|363192143|FG004|Step 2|Migrated/moved from study area|2|||
105325716|NCT01262872|363192144|FG005|Step 2|Migrated/moved from study area|6|||
105325717|NCT01262872|363192145|FG006|Step 2|Migrated/moved from study area|2|||
105325718|NCT01262872|363192146|FG007|Step 2|Migrated/moved from study area|3|||
105325719|NCT03380429|363192149|FG000|Overall Study|Physician Decision|0|||
105325720|NCT03380429|363192150|FG001|Overall Study|Physician Decision|1|||
105325721|NCT03380429|363192151|FG002|Overall Study|Physician Decision|0|||
105325722|NCT03380429|363192152|FG003|Overall Study|Physician Decision|1|||
105325723|NCT03380429|363192153|FG004|Overall Study|Physician Decision|1|||
105325724|NCT03380429|363192149|FG000|Overall Study|Withdrawal by Subject|3|||
105325725|NCT03380429|363192150|FG001|Overall Study|Withdrawal by Subject|3|||
105325726|NCT03380429|363192151|FG002|Overall Study|Withdrawal by Subject|5|||
105325727|NCT03380429|363192152|FG003|Overall Study|Withdrawal by Subject|2|||
105325728|NCT03380429|363192153|FG004|Overall Study|Withdrawal by Subject|1|||
105325729|NCT03380429|363192149|FG000|Overall Study|Lost to Follow-up|0|||
105325730|NCT03380429|363192150|FG001|Overall Study|Lost to Follow-up|2|||
105325731|NCT03380429|363192151|FG002|Overall Study|Lost to Follow-up|4|||
105325732|NCT03380429|363192152|FG003|Overall Study|Lost to Follow-up|3|||
105325733|NCT03380429|363192153|FG004|Overall Study|Lost to Follow-up|1|||
105325734|NCT03380429|363192149|FG000|Overall Study|Protocol Violation|1|||
105325735|NCT03380429|363192150|FG001|Overall Study|Protocol Violation|0|||
105325736|NCT03380429|363192151|FG002|Overall Study|Protocol Violation|1|||
105325737|NCT03380429|363192152|FG003|Overall Study|Protocol Violation|0|||
105325738|NCT03380429|363192153|FG004|Overall Study|Protocol Violation|1|||
105325739|NCT03380429|363192149|FG000|Overall Study|Lack of Efficacy|0|||
105325740|NCT03380429|363192150|FG001|Overall Study|Lack of Efficacy|0|||
105325741|NCT03380429|363192151|FG002|Overall Study|Lack of Efficacy|0|||
105325742|NCT03380429|363192152|FG003|Overall Study|Lack of Efficacy|2|||
105325743|NCT03380429|363192153|FG004|Overall Study|Lack of Efficacy|1|||
105325744|NCT03380429|363192149|FG000|Overall Study|Adverse Event|1|||
105325745|NCT03380429|363192150|FG001|Overall Study|Adverse Event|1|||
105325746|NCT03380429|363192151|FG002|Overall Study|Adverse Event|1|||
105325747|NCT03380429|363192152|FG003|Overall Study|Adverse Event|2|||
105325748|NCT03380429|363192153|FG004|Overall Study|Adverse Event|0|||
105325749|NCT01198470|363192154|FG000|Overall Study|Adverse Event|2|||
105325750|NCT00765102|363192157|FG000|Overall Study|Progressive disease|18|||
105325751|NCT00765102|363192157|FG000|Overall Study|Adverse Event|6|||
105325752|NCT00765102|363192157|FG000|Overall Study|Physician Decision|4|||
105325753|NCT00765102|363192157|FG000|Overall Study|Withdrawal by Subject|2|||
105325754|NCT00765102|363192157|FG000|Overall Study|Protocol Violation|1|||
105325755|NCT01787292|363192158|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
105325756|NCT01787292|363192159|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
105325757|NCT01787292|363192158|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
105325758|NCT01787292|363192159|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
105325759|NCT03181633|363192160|FG000|Overall Study|Withdrawal by Subject|1|||
105325760|NCT03181633|363192160|FG000|Overall Study|Missing follow-up visit|1|||
105325761|NCT02962648|363192161|FG000|Overall Study|Withdrawal by Subject|3|||
105325762|NCT02962648|363192161|FG000|Overall Study|Lost to Follow-up|3|||
105325763|NCT02962648|363192161|FG000|Overall Study|Physician Decision|1|||
105325764|NCT02962648|363192161|FG000|Overall Study|Subject had problems with transportation|2|||
105325765|NCT01924689|363192162|FG000|Overall Study|Death|0|||
105325766|NCT01924689|363192163|FG001|Overall Study|Death|1|||
105325767|NCT01924689|363192164|FG002|Overall Study|Death|0|||
105325768|NCT01924689|363192165|FG003|Overall Study|Death|1|||
105325769|NCT01924689|363192166|FG004|Overall Study|Death|0|||
105325770|NCT01924689|363192167|FG005|Overall Study|Death|0|||
105325771|NCT01924689|363192162|FG000|Overall Study|Disease progression|0|||
105325772|NCT01924689|363192163|FG001|Overall Study|Disease progression|0|||
105325773|NCT01924689|363192164|FG002|Overall Study|Disease progression|2|||
105325774|NCT01924689|363192165|FG003|Overall Study|Disease progression|0|||
105325775|NCT01924689|363192166|FG004|Overall Study|Disease progression|3|||
105325776|NCT01924689|363192167|FG005|Overall Study|Disease progression|2|||
105325777|NCT01924689|363192162|FG000|Overall Study|New therapy or study|3|||
105325778|NCT01924689|363192163|FG001|Overall Study|New therapy or study|2|||
105325779|NCT01924689|363192164|FG002|Overall Study|New therapy or study|1|||
105325780|NCT01924689|363192165|FG003|Overall Study|New therapy or study|4|||
105325781|NCT01924689|363192166|FG004|Overall Study|New therapy or study|2|||
105325782|NCT01924689|363192167|FG005|Overall Study|New therapy or study|0|||
105325783|NCT01924689|363192162|FG000|Overall Study|Withdrawal of consent|0|||
105325784|NCT01924689|363192163|FG001|Overall Study|Withdrawal of consent|0|||
105373070|NCT00314145|363372557|FG000|Overall Study|Withdrawal by Subject|8|||
105373071|NCT00314145|363372558|FG001|Overall Study|Withdrawal by Subject|10|||
105373072|NCT00314145|363372557|FG000|Overall Study|Lost to Follow-up|5|||
105373073|NCT00314145|363372558|FG001|Overall Study|Lost to Follow-up|12|||
105325785|NCT01924689|363192164|FG002|Overall Study|Withdrawal of consent|1|||
105325786|NCT01924689|363192165|FG003|Overall Study|Withdrawal of consent|1|||
105325787|NCT01924689|363192166|FG004|Overall Study|Withdrawal of consent|0|||
105325788|NCT01924689|363192167|FG005|Overall Study|Withdrawal of consent|0|||
105325789|NCT01924689|363192162|FG000|Overall Study|Other|0|||
105325790|NCT01924689|363192163|FG001|Overall Study|Other|0|||
105325791|NCT01924689|363192164|FG002|Overall Study|Other|0|||
105325792|NCT01924689|363192165|FG003|Overall Study|Other|0|||
105325793|NCT01924689|363192166|FG004|Overall Study|Other|1|||
105373074|NCT00314145|363372557|FG000|Overall Study|Physician Decision|3|||
105325794|NCT01924689|363192167|FG005|Overall Study|Other|0|||
105325795|NCT01597778|363192169|FG000|Overall Study|Death|7|||
105325796|NCT01597778|363192170|FG001|Overall Study|Death|10|||
105325797|NCT01597778|363192169|FG000|Overall Study|Withdrawal by Subject|3|||
105325798|NCT01597778|363192170|FG001|Overall Study|Withdrawal by Subject|4|||
105325799|NCT01597778|363192169|FG000|Overall Study|Adverse Event|1|||
105325800|NCT01597778|363192170|FG001|Overall Study|Adverse Event|1|||
105325801|NCT01597778|363192169|FG000|Overall Study|Protocol Violation|1|||
105373075|NCT00314145|363372558|FG001|Overall Study|Physician Decision|4|||
105373076|NCT00314145|363372557|FG000|Overall Study|Adverse Event|0|||
105373077|NCT00314145|363372558|FG001|Overall Study|Adverse Event|3|||
105373078|NCT00314145|363372557|FG000|Overall Study|Protocol Violation|3|||
105373079|NCT00314145|363372558|FG001|Overall Study|Protocol Violation|0|||
105373080|NCT00314145|363372557|FG000|Overall Study|Sponsor Decision|2|||
105373081|NCT00314145|363372558|FG001|Overall Study|Sponsor Decision|0|||
105373082|NCT02029417|363372561|FG000|Overall Study|Death|1|||
105373083|NCT02029417|363372561|FG000|Overall Study|Adverse Event|1|||
105373084|NCT00639509|363372562|FG000|Overall Study|Death|1|||
105373085|NCT00141817|363372565|FG000|Overall Study|Protocol Violation|0|||
105373086|NCT00141817|363372566|FG001|Overall Study|Protocol Violation|0|||
105373087|NCT00141817|363372567|FG002|Overall Study|Protocol Violation|1|||
105373088|NCT00141817|363372568|FG003|Overall Study|Protocol Violation|0|||
105373089|NCT00141817|363372565|FG000|Overall Study|Parent request|1|||
105851743|NCT02788045|365115915|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
105851744|NCT02788045|365115913|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
105851745|NCT02788045|365115914|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
105851746|NCT02788045|365115915|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
105851747|NCT03303625|365115916|FG000|Overall Study|Withdrawal by Subject|2|||
105851748|NCT03303625|365115917|FG001|Overall Study|Withdrawal by Subject|0|||
105851749|NCT03303625|365115918|FG002|Overall Study|Withdrawal by Subject|0|||
105851750|NCT03303625|365115919|FG003|Overall Study|Withdrawal by Subject|0|||
105851751|NCT03502707|365115920|FG000|Overall Study|Adverse Event|0|||
105851752|NCT03502707|365115921|FG001|Overall Study|Adverse Event|0|||
105851753|NCT03502707|365115922|FG002|Overall Study|Adverse Event|0|||
105851754|NCT03502707|365115923|FG003|Overall Study|Adverse Event|0|||
105851755|NCT03502707|365115924|FG004|Overall Study|Adverse Event|0|||
105851756|NCT03502707|365115925|FG005|Overall Study|Adverse Event|0|||
105851757|NCT03502707|365115926|FG006|Overall Study|Adverse Event|0|||
105851758|NCT03502707|365115927|FG007|Overall Study|Adverse Event|0|||
105851759|NCT03502707|365115928|FG008|Overall Study|Adverse Event|0|||
105851760|NCT03502707|365115929|FG009|Overall Study|Adverse Event|0|||
105851761|NCT03502707|365115930|FG010|Overall Study|Adverse Event|0|||
105851762|NCT03502707|365115931|FG011|Overall Study|Adverse Event|0|||
105851763|NCT03502707|365115932|FG012|Overall Study|Adverse Event|0|||
105851764|NCT03502707|365115933|FG013|Overall Study|Adverse Event|0|||
105851765|NCT03502707|365115934|FG014|Overall Study|Adverse Event|0|||
105851766|NCT03502707|365115935|FG015|Overall Study|Adverse Event|1|||
105851767|NCT03502707|365115936|FG016|Overall Study|Adverse Event|5|||
105851768|NCT03502707|365115937|FG017|Overall Study|Adverse Event|0|||
105851769|NCT03502707|365115920|FG000|Overall Study|Death|0|||
105851770|NCT03502707|365115921|FG001|Overall Study|Death|0|||
105851771|NCT03502707|365115922|FG002|Overall Study|Death|0|||
105851772|NCT03502707|365115923|FG003|Overall Study|Death|1|||
105851773|NCT03502707|365115924|FG004|Overall Study|Death|0|||
105851774|NCT03502707|365115925|FG005|Overall Study|Death|0|||
105851775|NCT03502707|365115926|FG006|Overall Study|Death|0|||
105851776|NCT03502707|365115927|FG007|Overall Study|Death|0|||
105851777|NCT03502707|365115928|FG008|Overall Study|Death|1|||
105851778|NCT03502707|365115929|FG009|Overall Study|Death|1|||
105851779|NCT03502707|365115930|FG010|Overall Study|Death|0|||
105851780|NCT03502707|365115931|FG011|Overall Study|Death|0|||
105851781|NCT03502707|365115932|FG012|Overall Study|Death|1|||
105851782|NCT03502707|365115933|FG013|Overall Study|Death|0|||
105851783|NCT03502707|365115934|FG014|Overall Study|Death|0|||
105851784|NCT03502707|365115935|FG015|Overall Study|Death|1|||
105851785|NCT03502707|365115936|FG016|Overall Study|Death|0|||
105851786|NCT03502707|365115937|FG017|Overall Study|Death|0|||
105851787|NCT03502707|365115920|FG000|Overall Study|Lost to Follow-up|0|||
105851788|NCT03502707|365115921|FG001|Overall Study|Lost to Follow-up|0|||
105851789|NCT03502707|365115922|FG002|Overall Study|Lost to Follow-up|0|||
105851790|NCT03502707|365115923|FG003|Overall Study|Lost to Follow-up|0|||
105851791|NCT03502707|365115924|FG004|Overall Study|Lost to Follow-up|0|||
105851792|NCT03502707|365115925|FG005|Overall Study|Lost to Follow-up|0|||
105851793|NCT03502707|365115926|FG006|Overall Study|Lost to Follow-up|0|||
105851794|NCT03502707|365115927|FG007|Overall Study|Lost to Follow-up|5|||
105851795|NCT03502707|365115928|FG008|Overall Study|Lost to Follow-up|0|||
105851796|NCT03502707|365115929|FG009|Overall Study|Lost to Follow-up|2|||
105851797|NCT03502707|365115930|FG010|Overall Study|Lost to Follow-up|1|||
105373090|NCT00141817|363372566|FG001|Overall Study|Parent request|0|||
105373091|NCT00141817|363372567|FG002|Overall Study|Parent request|0|||
105851798|NCT03502707|365115931|FG011|Overall Study|Lost to Follow-up|2|||
105851799|NCT03502707|365115932|FG012|Overall Study|Lost to Follow-up|1|||
105851800|NCT03502707|365115933|FG013|Overall Study|Lost to Follow-up|1|||
105851801|NCT03502707|365115934|FG014|Overall Study|Lost to Follow-up|0|||
105851802|NCT03502707|365115935|FG015|Overall Study|Lost to Follow-up|4|||
105851803|NCT03502707|365115936|FG016|Overall Study|Lost to Follow-up|9|||
105373092|NCT00141817|363372568|FG003|Overall Study|Parent request|0|||
105851804|NCT03502707|365115937|FG017|Overall Study|Lost to Follow-up|2|||
105851805|NCT03502707|365115920|FG000|Overall Study|Physician Decision|0|||
105373093|NCT00127803|363372573|FG000|Overall Study|Adverse Event|2|||
105373094|NCT00127803|363372574|FG001|Overall Study|Adverse Event|0|||
105325802|NCT01597778|363192170|FG001|Overall Study|Protocol Violation|11|||
105325803|NCT01597778|363192169|FG000|Overall Study|Transplanted off protocol|2|||
105325804|NCT01597778|363192170|FG001|Overall Study|Transplanted off protocol|3|||
105325805|NCT04030299|363192172|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
105325806|NCT04030299|363192172|FG000|Overall Study|Withdrawal by Subject|3|||
105325807|NCT04616612|363192173|FG000|Overall Study|Lost to Follow-up|6|||
105325808|NCT04616612|363192174|FG001|Overall Study|Lost to Follow-up|3|||
105325809|NCT01597973|363192175|FG000|Overall Study|Found ineligible before study medication started|4|||
105325810|NCT01597973|363192176|FG001|Overall Study|Found ineligible before study medication started|2|||
105325811|NCT01597973|363192175|FG000|Overall Study|Eligible pathogen not confirmed|14|||
105325812|NCT01597973|363192176|FG001|Overall Study|Eligible pathogen not confirmed|15|||
105325813|NCT01597973|363192175|FG000|Overall Study|LAR not authorized to consent|0|||
105325814|NCT01597973|363192176|FG001|Overall Study|LAR not authorized to consent|1|||
105325815|NCT01597973|363192175|FG000|Overall Study|Ineligible due to early seizures|1|||
105325816|NCT01597973|363192176|FG001|Overall Study|Ineligible due to early seizures|0|||
105325817|NCT01597973|363192175|FG000|Overall Study|Ineligible due to non-target infection|1|||
105325818|NCT01597973|363192176|FG001|Overall Study|Ineligible due to non-target infection|1|||
105325819|NCT01288079|363192179|FG000|Overall Study|Withdrawal by Subject|2|||
105325820|NCT01288079|363192180|FG001|Overall Study|Withdrawal by Subject|4|||
105325821|NCT01288079|363192181|FG002|Overall Study|Withdrawal by Subject|1|||
105325822|NCT01288079|363192182|FG003|Overall Study|Withdrawal by Subject|0|||
105325823|NCT01288079|363192179|FG000|Overall Study|Adverse Event|2|||
105325824|NCT01288079|363192180|FG001|Overall Study|Adverse Event|1|||
105325825|NCT01288079|363192181|FG002|Overall Study|Adverse Event|2|||
105325826|NCT01288079|363192182|FG003|Overall Study|Adverse Event|3|||
105325827|NCT01288079|363192179|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
105325828|NCT01288079|363192180|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
105325829|NCT01288079|363192181|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
105325830|NCT01288079|363192182|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
105325831|NCT01288079|363192179|FG000|Overall Study|Condition under Investigation Worsened|0|||
105325832|NCT01288079|363192180|FG001|Overall Study|Condition under Investigation Worsened|0|||
105325833|NCT01288079|363192181|FG002|Overall Study|Condition under Investigation Worsened|0|||
105325834|NCT01288079|363192182|FG003|Overall Study|Condition under Investigation Worsened|1|||
105325835|NCT01288079|363192179|FG000|Overall Study|Lack of Efficacy|2|||
105325836|NCT01288079|363192180|FG001|Overall Study|Lack of Efficacy|2|||
105325837|NCT01288079|363192181|FG002|Overall Study|Lack of Efficacy|0|||
105325838|NCT01288079|363192182|FG003|Overall Study|Lack of Efficacy|2|||
105325839|NCT01288079|363192179|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
105325840|NCT01288079|363192180|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
105325841|NCT01288079|363192181|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
105325842|NCT01288079|363192182|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
105325843|NCT01288079|363192179|FG000|Overall Study|Lost to Follow-up|1|||
105325844|NCT01288079|363192180|FG001|Overall Study|Lost to Follow-up|1|||
105325845|NCT01288079|363192181|FG002|Overall Study|Lost to Follow-up|1|||
105325846|NCT01288079|363192182|FG003|Overall Study|Lost to Follow-up|0|||
105325847|NCT01288079|363192179|FG000|Overall Study|Other or Study Termination|11|||
105325848|NCT01288079|363192180|FG001|Overall Study|Other or Study Termination|15|||
105325849|NCT01288079|363192181|FG002|Overall Study|Other or Study Termination|14|||
105325850|NCT01288079|363192182|FG003|Overall Study|Other or Study Termination|8|||
105325851|NCT00908544|363192183|FG000|Overall Study|Withdrawal by Subject|2|||
105325852|NCT00908544|363192184|FG001|Overall Study|Withdrawal by Subject|4|||
105325853|NCT00908544|363192183|FG000|Overall Study|Lack of Efficacy|0|||
105851806|NCT03502707|365115921|FG001|Overall Study|Physician Decision|0|||
105851807|NCT03502707|365115922|FG002|Overall Study|Physician Decision|0|||
105325854|NCT00908544|363192184|FG001|Overall Study|Lack of Efficacy|1|||
105325855|NCT00908544|363192183|FG000|Overall Study|Pregnancy|1|||
105325856|NCT00908544|363192184|FG001|Overall Study|Pregnancy|0|||
105325857|NCT00908544|363192183|FG000|Overall Study|Relocation abroad|1|||
105325858|NCT00908544|363192184|FG001|Overall Study|Relocation abroad|1|||
105325859|NCT00908544|363192183|FG000|Overall Study|Unable to visit sutdy center|1|||
105325860|NCT00908544|363192184|FG001|Overall Study|Unable to visit sutdy center|0|||
105325861|NCT03170544|363192185|FG000|Part 1|Lost to Follow-up|1|||
105325862|NCT03170544|363192186|FG001|Part 1|Lost to Follow-up|0|||
105851808|NCT03502707|365115923|FG003|Overall Study|Physician Decision|0|||
105325863|NCT03170544|363192187|FG002|Part 1|Lost to Follow-up|0|||
105325864|NCT03170544|363192188|FG003|Part 1|Lost to Follow-up|0|||
105325865|NCT03170544|363192189|FG004|Part 1|Lost to Follow-up|0|||
105325866|NCT03170544|363192190|FG005|Part 1|Lost to Follow-up|0|||
105325867|NCT03170544|363192191|FG006|Part 1|Lost to Follow-up|0|||
105325868|NCT03170544|363192192|FG007|Part 1|Lost to Follow-up|0|||
105325869|NCT03170544|363192193|FG008|Part 1|Lost to Follow-up|0|||
105325870|NCT03170544|363192194|FG009|Part 1|Lost to Follow-up|0|||
105325871|NCT03170544|363192195|FG010|Part 1|Lost to Follow-up|0|||
105325872|NCT03170544|363192196|FG011|Part 1|Lost to Follow-up|0|||
105325873|NCT03170544|363192185|FG000|Part 1|Not treated|0|||
105325874|NCT03170544|363192186|FG001|Part 1|Not treated|0|||
105325875|NCT03170544|363192187|FG002|Part 1|Not treated|0|||
105851809|NCT03502707|365115924|FG004|Overall Study|Physician Decision|0|||
105851810|NCT03502707|365115925|FG005|Overall Study|Physician Decision|0|||
105851811|NCT03502707|365115926|FG006|Overall Study|Physician Decision|0|||
105851812|NCT03502707|365115927|FG007|Overall Study|Physician Decision|0|||
105851813|NCT03502707|365115928|FG008|Overall Study|Physician Decision|2|||
105851814|NCT03502707|365115929|FG009|Overall Study|Physician Decision|1|||
105851815|NCT03502707|365115930|FG010|Overall Study|Physician Decision|0|||
105851816|NCT03502707|365115931|FG011|Overall Study|Physician Decision|0|||
105851817|NCT03502707|365115932|FG012|Overall Study|Physician Decision|0|||
105851818|NCT03502707|365115933|FG013|Overall Study|Physician Decision|0|||
105851819|NCT03502707|365115934|FG014|Overall Study|Physician Decision|1|||
105851820|NCT03502707|365115935|FG015|Overall Study|Physician Decision|3|||
105851821|NCT03502707|365115936|FG016|Overall Study|Physician Decision|0|||
105851822|NCT03502707|365115937|FG017|Overall Study|Physician Decision|0|||
105851823|NCT03502707|365115920|FG000|Overall Study|Protocol Violation|0|||
105851824|NCT03502707|365115921|FG001|Overall Study|Protocol Violation|0|||
105851825|NCT03502707|365115922|FG002|Overall Study|Protocol Violation|0|||
105851826|NCT03502707|365115923|FG003|Overall Study|Protocol Violation|0|||
105851827|NCT03502707|365115924|FG004|Overall Study|Protocol Violation|0|||
105851828|NCT03502707|365115925|FG005|Overall Study|Protocol Violation|0|||
105851829|NCT03502707|365115926|FG006|Overall Study|Protocol Violation|0|||
105851830|NCT03502707|365115927|FG007|Overall Study|Protocol Violation|0|||
105851831|NCT03502707|365115928|FG008|Overall Study|Protocol Violation|0|||
105851832|NCT03502707|365115929|FG009|Overall Study|Protocol Violation|0|||
105851833|NCT03502707|365115930|FG010|Overall Study|Protocol Violation|0|||
105851834|NCT03502707|365115931|FG011|Overall Study|Protocol Violation|0|||
105851835|NCT03502707|365115932|FG012|Overall Study|Protocol Violation|0|||
105851836|NCT03502707|365115933|FG013|Overall Study|Protocol Violation|0|||
105851837|NCT03502707|365115934|FG014|Overall Study|Protocol Violation|0|||
105851838|NCT03502707|365115935|FG015|Overall Study|Protocol Violation|1|||
105851839|NCT03502707|365115936|FG016|Overall Study|Protocol Violation|0|||
105851840|NCT03502707|365115937|FG017|Overall Study|Protocol Violation|0|||
105851841|NCT03502707|365115920|FG000|Overall Study|Withdrawal by Subject|1|||
105851842|NCT03502707|365115921|FG001|Overall Study|Withdrawal by Subject|1|||
105851843|NCT03502707|365115922|FG002|Overall Study|Withdrawal by Subject|0|||
105851844|NCT03502707|365115923|FG003|Overall Study|Withdrawal by Subject|0|||
105851845|NCT03502707|365115924|FG004|Overall Study|Withdrawal by Subject|0|||
105851846|NCT03502707|365115925|FG005|Overall Study|Withdrawal by Subject|2|||
105851847|NCT03502707|365115926|FG006|Overall Study|Withdrawal by Subject|0|||
105851848|NCT03502707|365115927|FG007|Overall Study|Withdrawal by Subject|3|||
105851849|NCT03502707|365115928|FG008|Overall Study|Withdrawal by Subject|1|||
105851850|NCT03502707|365115929|FG009|Overall Study|Withdrawal by Subject|2|||
105851851|NCT03502707|365115930|FG010|Overall Study|Withdrawal by Subject|12|||
105851852|NCT03502707|365115931|FG011|Overall Study|Withdrawal by Subject|23|||
105851853|NCT03502707|365115932|FG012|Overall Study|Withdrawal by Subject|5|||
105851854|NCT03502707|365115933|FG013|Overall Study|Withdrawal by Subject|3|||
105851855|NCT03502707|365115934|FG014|Overall Study|Withdrawal by Subject|3|||
105851856|NCT03502707|365115935|FG015|Overall Study|Withdrawal by Subject|43|||
105851857|NCT03502707|365115936|FG016|Overall Study|Withdrawal by Subject|44|||
105851858|NCT03502707|365115937|FG017|Overall Study|Withdrawal by Subject|18|||
105851859|NCT03502707|365115920|FG000|Overall Study|Sponsor's Decision|1|||
105851860|NCT03502707|365115921|FG001|Overall Study|Sponsor's Decision|0|||
105851861|NCT03502707|365115922|FG002|Overall Study|Sponsor's Decision|0|||
105851862|NCT03502707|365115923|FG003|Overall Study|Sponsor's Decision|0|||
105851863|NCT03502707|365115924|FG004|Overall Study|Sponsor's Decision|0|||
105851864|NCT03502707|365115925|FG005|Overall Study|Sponsor's Decision|0|||
105325876|NCT03170544|363192188|FG003|Part 1|Not treated|1|||
105325877|NCT03170544|363192189|FG004|Part 1|Not treated|0|||
105325878|NCT03170544|363192190|FG005|Part 1|Not treated|0|||
105325879|NCT03170544|363192191|FG006|Part 1|Not treated|0|||
105325880|NCT03170544|363192192|FG007|Part 1|Not treated|0|||
105325881|NCT03170544|363192193|FG008|Part 1|Not treated|0|||
105325882|NCT03170544|363192194|FG009|Part 1|Not treated|0|||
105325883|NCT03170544|363192195|FG010|Part 1|Not treated|0|||
105325884|NCT03170544|363192196|FG011|Part 1|Not treated|0|||
105373095|NCT00127803|363372575|FG002|Overall Study|Adverse Event|0|||
105373096|NCT00127803|363372576|FG003|Overall Study|Adverse Event|0|||
105373097|NCT00127803|363372573|FG000|Overall Study|Withdrawal by Subject|1|||
105373098|NCT00127803|363372574|FG001|Overall Study|Withdrawal by Subject|0|||
105373099|NCT00127803|363372575|FG002|Overall Study|Withdrawal by Subject|0|||
105373100|NCT00127803|363372576|FG003|Overall Study|Withdrawal by Subject|0|||
105373101|NCT00127803|363372573|FG000|Overall Study|Lost to Follow-up|0|||
105491968|NCT01854658|363813918|FG000|Overall Study|Withdrawal by Subject|28|||
105851865|NCT03502707|365115926|FG006|Overall Study|Sponsor's Decision|0|||
105851866|NCT03502707|365115927|FG007|Overall Study|Sponsor's Decision|0|||
105325885|NCT01213966|363192197|FG000|Overall Study|Protocol Violation|1|||
105851867|NCT03502707|365115928|FG008|Overall Study|Sponsor's Decision|0|||
105851868|NCT03502707|365115929|FG009|Overall Study|Sponsor's Decision|1|||
105325886|NCT01213966|363192198|FG001|Overall Study|Protocol Violation|0|||
105373102|NCT00127803|363372574|FG001|Overall Study|Lost to Follow-up|0|||
105325887|NCT01213966|363192199|FG002|Overall Study|Protocol Violation|3|||
105325888|NCT01213966|363192200|FG003|Overall Study|Protocol Violation|1|||
105325889|NCT02174627|363192206|FG000|Overall Study|Missing|0|||
105325890|NCT02174627|363192207|FG001|Overall Study|Missing|1|||
105325891|NCT02174627|363192206|FG000|Overall Study|Incorrect enrolment before randomization|0|||
105325892|NCT02174627|363192207|FG001|Overall Study|Incorrect enrolment before randomization|1|||
105325893|NCT02174627|363192206|FG000|Overall Study|Participant decision|84|||
105325894|NCT02174627|363192207|FG001|Overall Study|Participant decision|128|||
105325895|NCT03591874|363192208|FG000|Overall Study|Adverse Event|4|||
105325896|NCT03591874|363192209|FG001|Overall Study|Adverse Event|0|||
105325897|NCT03591874|363192208|FG000|Overall Study|Withdrawal by Subject|2|||
105325898|NCT03591874|363192209|FG001|Overall Study|Withdrawal by Subject|1|||
105325899|NCT03591874|363192208|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
105325900|NCT03591874|363192209|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
105325901|NCT03591874|363192208|FG000|Overall Study|On Study at Time of Study Termination|12|||
105325902|NCT03591874|363192209|FG001|Overall Study|On Study at Time of Study Termination|6|||
105325903|NCT04564092|363192210|FG000|Overall Study|Withdrawal by Subject|1|||
105325904|NCT02269098|363192213|FG000|Overall Study|Lost to Follow-up|14|||
105325905|NCT02269098|363192214|FG001|Overall Study|Lost to Follow-up|9|||
105325906|NCT04495829|363192218|FG000|Overall Study|Lost to Follow-up|2|||
105325907|NCT04495829|363192218|FG000|Overall Study|Inclusion criterion not met|3|||
105325908|NCT02107131|363192221|FG000|Overall Study|Lost to Follow-up|4|||
105325909|NCT02107131|363192222|FG001|Overall Study|Lost to Follow-up|4|||
105325910|NCT02107131|363192221|FG000|Overall Study|Physician Decision|1|||
105325911|NCT02107131|363192222|FG001|Overall Study|Physician Decision|0|||
105325912|NCT02107131|363192221|FG000|Overall Study|Withdrawal by Subject|2|||
105325913|NCT02107131|363192222|FG001|Overall Study|Withdrawal by Subject|0|||
105325914|NCT02107131|363192221|FG000|Overall Study|mental instability|1|||
105325915|NCT02107131|363192222|FG001|Overall Study|mental instability|0|||
105325916|NCT02107131|363192221|FG000|Overall Study|Death|0|||
105325917|NCT02107131|363192222|FG001|Overall Study|Death|1|||
105325918|NCT02107131|363192221|FG000|Overall Study|Protocol Violation|0|||
105325919|NCT02107131|363192222|FG001|Overall Study|Protocol Violation|4|||
105325920|NCT00682786|363192223|FG000|Overall Study|Withdrawal by Subject|2|||
105325921|NCT00682786|363192224|FG001|Overall Study|Withdrawal by Subject|2|||
105325922|NCT00682786|363192223|FG000|Overall Study|Did not receive irinotecan|0|||
105325923|NCT00682786|363192224|FG001|Overall Study|Did not receive irinotecan|1|||
105325924|NCT02747108|363192225|FG000|Overall Study|Death|2|||
105325925|NCT02747108|363192226|FG001|Overall Study|Death|2|||
105325926|NCT02747108|363192225|FG000|Overall Study|Withdrawal by Subject|1|||
105325927|NCT02747108|363192226|FG001|Overall Study|Withdrawal by Subject|0|||
105325928|NCT02747108|363192225|FG000|Overall Study|Protocol Violation|2|||
105325929|NCT02747108|363192226|FG001|Overall Study|Protocol Violation|0|||
105325930|NCT01991743|363192228|FG000|Overall Study|external cephalic version not performed|0|||
105325931|NCT01991743|363192229|FG001|Overall Study|external cephalic version not performed|0|||
105325932|NCT01991743|363192230|FG002|Overall Study|external cephalic version not performed|1|||
105325933|NCT01991743|363192231|FG003|Overall Study|external cephalic version not performed|0|||
105325934|NCT03830333|363192233|FG000|Overall Study|Death|0|||
105325935|NCT03830333|363192234|FG001|Overall Study|Death|1|||
105325936|NCT03830333|363192233|FG000|Overall Study|Withdrawal by Subject|5|||
105325937|NCT03830333|363192234|FG001|Overall Study|Withdrawal by Subject|1|||
105325938|NCT03830333|363192233|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
105325939|NCT03830333|363192234|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
105325940|NCT04390113|363192242|FG000|Overall Study|Not Treated|0|||
105325941|NCT04390113|363192243|FG001|Overall Study|Not Treated|1|||
105325942|NCT04390113|363192242|FG000|Overall Study|Adverse Event|1|||
105325943|NCT04390113|363192243|FG001|Overall Study|Adverse Event|0|||
105325944|NCT04390113|363192242|FG000|Overall Study|Death|2|||
105325945|NCT04390113|363192243|FG001|Overall Study|Death|1|||
105325946|NCT04390113|363192242|FG000|Overall Study|Physician Decision|1|||
105325947|NCT04390113|363192243|FG001|Overall Study|Physician Decision|3|||
105325948|NCT04390113|363192242|FG000|Overall Study|Study Terminated by Sponsor|5|||
105325949|NCT04390113|363192243|FG001|Overall Study|Study Terminated by Sponsor|3|||
105325950|NCT04390113|363192242|FG000|Overall Study|Withdrawal by Subject|10|||
105325951|NCT04390113|363192243|FG001|Overall Study|Withdrawal by Subject|5|||
105325952|NCT04390113|363192242|FG000|Overall Study|Other|1|||
105325953|NCT04390113|363192243|FG001|Overall Study|Other|0|||
105325954|NCT04390113|363192242|FG000|Overall Study|Missing|0|||
105325955|NCT04390113|363192243|FG001|Overall Study|Missing|1|||
105373103|NCT00127803|363372575|FG002|Overall Study|Lost to Follow-up|0|||
105325956|NCT02389829|363192244|FG000|Overall Study|Lost to Follow-up|0|||
105325957|NCT02389829|363192245|FG001|Overall Study|Lost to Follow-up|1|||
105325958|NCT02362360|363192246|FG000|Period 1|Lack of Efficacy|1|||
105325959|NCT02362360|363192247|FG001|Period 1|Lack of Efficacy|0|||
105325960|NCT02362360|363192246|FG000|Period 1|Withdrawal by Subject|2|||
105325961|NCT02362360|363192247|FG001|Period 1|Withdrawal by Subject|1|||
105325962|NCT03817190|363192250|FG000|Overall Study|Early Termination|13|||
105851869|NCT03502707|365115930|FG010|Overall Study|Sponsor's Decision|0|||
105851870|NCT03502707|365115931|FG011|Overall Study|Sponsor's Decision|0|||
105851871|NCT03502707|365115932|FG012|Overall Study|Sponsor's Decision|0|||
105851872|NCT03502707|365115933|FG013|Overall Study|Sponsor's Decision|0|||
105851873|NCT03502707|365115934|FG014|Overall Study|Sponsor's Decision|0|||
105851874|NCT03502707|365115935|FG015|Overall Study|Sponsor's Decision|2|||
105851875|NCT03502707|365115936|FG016|Overall Study|Sponsor's Decision|1|||
105851876|NCT03502707|365115937|FG017|Overall Study|Sponsor's Decision|0|||
105851877|NCT03502707|365115920|FG000|Overall Study|Initiated Prohibited Medication|0|||
105851878|NCT03502707|365115921|FG001|Overall Study|Initiated Prohibited Medication|0|||
105851879|NCT03502707|365115922|FG002|Overall Study|Initiated Prohibited Medication|0|||
105851880|NCT03502707|365115923|FG003|Overall Study|Initiated Prohibited Medication|0|||
105851881|NCT03502707|365115924|FG004|Overall Study|Initiated Prohibited Medication|0|||
105851882|NCT03502707|365115925|FG005|Overall Study|Initiated Prohibited Medication|0|||
105851883|NCT03502707|365115926|FG006|Overall Study|Initiated Prohibited Medication|0|||
105851884|NCT03502707|365115927|FG007|Overall Study|Initiated Prohibited Medication|0|||
105851885|NCT03502707|365115928|FG008|Overall Study|Initiated Prohibited Medication|0|||
105851886|NCT03502707|365115929|FG009|Overall Study|Initiated Prohibited Medication|0|||
105851887|NCT03502707|365115930|FG010|Overall Study|Initiated Prohibited Medication|0|||
105851888|NCT03502707|365115931|FG011|Overall Study|Initiated Prohibited Medication|0|||
105851889|NCT03502707|365115932|FG012|Overall Study|Initiated Prohibited Medication|0|||
105851890|NCT03502707|365115933|FG013|Overall Study|Initiated Prohibited Medication|0|||
105851891|NCT03502707|365115934|FG014|Overall Study|Initiated Prohibited Medication|0|||
105851892|NCT03502707|365115935|FG015|Overall Study|Initiated Prohibited Medication|0|||
105851893|NCT03502707|365115936|FG016|Overall Study|Initiated Prohibited Medication|1|||
105851894|NCT03502707|365115937|FG017|Overall Study|Initiated Prohibited Medication|0|||
105851895|NCT03502707|365115920|FG000|Overall Study|Other|0|||
105851896|NCT03502707|365115921|FG001|Overall Study|Other|0|||
105851897|NCT03502707|365115922|FG002|Overall Study|Other|0|||
105851898|NCT03502707|365115923|FG003|Overall Study|Other|0|||
105851899|NCT03502707|365115924|FG004|Overall Study|Other|0|||
105851900|NCT03502707|365115925|FG005|Overall Study|Other|0|||
105851901|NCT03502707|365115926|FG006|Overall Study|Other|0|||
105851902|NCT03502707|365115927|FG007|Overall Study|Other|0|||
105851903|NCT03502707|365115928|FG008|Overall Study|Other|1|||
105851904|NCT03502707|365115929|FG009|Overall Study|Other|1|||
105851905|NCT03502707|365115930|FG010|Overall Study|Other|2|||
105851906|NCT03502707|365115931|FG011|Overall Study|Other|0|||
105851907|NCT03502707|365115932|FG012|Overall Study|Other|0|||
105851908|NCT03502707|365115933|FG013|Overall Study|Other|0|||
105851909|NCT03502707|365115934|FG014|Overall Study|Other|0|||
105851910|NCT03502707|365115935|FG015|Overall Study|Other|4|||
105851911|NCT03502707|365115936|FG016|Overall Study|Other|1|||
105851912|NCT03502707|365115937|FG017|Overall Study|Other|0|||
105851913|NCT03502707|365115920|FG000|Overall Study|Randomized but not vaccinated|0|||
105851914|NCT03502707|365115921|FG001|Overall Study|Randomized but not vaccinated|0|||
105851915|NCT03502707|365115922|FG002|Overall Study|Randomized but not vaccinated|0|||
105851916|NCT03502707|365115923|FG003|Overall Study|Randomized but not vaccinated|0|||
105851917|NCT03502707|365115924|FG004|Overall Study|Randomized but not vaccinated|0|||
105851918|NCT03502707|365115925|FG005|Overall Study|Randomized but not vaccinated|0|||
105851919|NCT03502707|365115926|FG006|Overall Study|Randomized but not vaccinated|0|||
105851920|NCT03502707|365115927|FG007|Overall Study|Randomized but not vaccinated|0|||
105851921|NCT03502707|365115928|FG008|Overall Study|Randomized but not vaccinated|0|||
105851922|NCT03502707|365115929|FG009|Overall Study|Randomized but not vaccinated|0|||
105851923|NCT03502707|365115930|FG010|Overall Study|Randomized but not vaccinated|0|||
105851924|NCT03502707|365115931|FG011|Overall Study|Randomized but not vaccinated|1|||
105851925|NCT03502707|365115932|FG012|Overall Study|Randomized but not vaccinated|0|||
105851926|NCT03502707|365115933|FG013|Overall Study|Randomized but not vaccinated|0|||
105851927|NCT03502707|365115934|FG014|Overall Study|Randomized but not vaccinated|0|||
105851928|NCT03502707|365115935|FG015|Overall Study|Randomized but not vaccinated|0|||
105851929|NCT03502707|365115936|FG016|Overall Study|Randomized but not vaccinated|0|||
105851930|NCT03502707|365115937|FG017|Overall Study|Randomized but not vaccinated|1|||
105851931|NCT02511106|365115938|FG000|Overall Study|Lost to Follow-up|6|||
105851932|NCT02511106|365115939|FG001|Overall Study|Lost to Follow-up|4|||
105851933|NCT02511106|365115938|FG000|Overall Study|Withdrawal by Subject|24|||
105851934|NCT02511106|365115939|FG001|Overall Study|Withdrawal by Subject|21|||
105851935|NCT02511106|365115938|FG000|Overall Study|Death|42|||
105851936|NCT02511106|365115939|FG001|Overall Study|Death|82|||
105851937|NCT02511106|365115938|FG000|Overall Study|Ongoing study at data cut-off|3|||
105851938|NCT02511106|365115939|FG001|Overall Study|Ongoing study at data cut-off|2|||
105851939|NCT02511106|365115938|FG000|Overall Study|Without specified reason|3|||
105851940|NCT02511106|365115939|FG001|Overall Study|Without specified reason|0|||
105851941|NCT02935686|365115940|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
105851942|NCT02935686|365115941|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
105851943|NCT02935686|365115942|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
105851944|NCT02935686|365115943|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
105325963|NCT03817190|363192251|FG001|Overall Study|Early Termination|20|||
105325964|NCT03817190|363192250|FG000|Overall Study|Adverse Event|10|||
105325965|NCT03817190|363192251|FG001|Overall Study|Adverse Event|17|||
105325966|NCT03817190|363192250|FG000|Overall Study|Withdrawal by Subject|12|||
105325967|NCT03817190|363192251|FG001|Overall Study|Withdrawal by Subject|8|||
105325968|NCT03817190|363192250|FG000|Overall Study|Lost to Follow-up|11|||
105325969|NCT03817190|363192251|FG001|Overall Study|Lost to Follow-up|7|||
105325970|NCT03817190|363192250|FG000|Overall Study|Lack of Efficacy|7|||
105325971|NCT03817190|363192251|FG001|Overall Study|Lack of Efficacy|5|||
105325972|NCT03817190|363192250|FG000|Overall Study|Investigator Decision|5|||
105325973|NCT03817190|363192251|FG001|Overall Study|Investigator Decision|1|||
105325974|NCT03817190|363192250|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
105325975|NCT03817190|363192251|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
105325976|NCT03817190|363192250|FG000|Overall Study|Lack of Contact|1|||
105325977|NCT03817190|363192251|FG001|Overall Study|Lack of Contact|0|||
105325978|NCT03817190|363192250|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
105325979|NCT03817190|363192251|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
105325980|NCT04146012|363192252|FG000|Overall Study|Study Terminated|30|||
105325981|NCT04146012|363192253|FG001|Overall Study|Study Terminated|15|||
105325982|NCT03323398|363192254|FG000|Overall Study|Other than Specified|0|||
105325983|NCT03323398|363192255|FG001|Overall Study|Other than Specified|1|||
105325984|NCT03323398|363192256|FG002|Overall Study|Other than Specified|2|||
105325985|NCT03323398|363192257|FG003|Overall Study|Other than Specified|0|||
105325986|NCT03323398|363192258|FG004|Overall Study|Other than Specified|0|||
105325987|NCT03323398|363192259|FG005|Overall Study|Other than Specified|0|||
105325988|NCT03323398|363192260|FG006|Overall Study|Other than Specified|1|||
105325989|NCT03323398|363192261|FG007|Overall Study|Other than Specified|0|||
105325990|NCT03323398|363192262|FG008|Overall Study|Other than Specified|2|||
105325991|NCT03323398|363192254|FG000|Overall Study|Lost to Follow-up|1|||
105325992|NCT03323398|363192255|FG001|Overall Study|Lost to Follow-up|2|||
105325993|NCT03323398|363192256|FG002|Overall Study|Lost to Follow-up|1|||
105325994|NCT03323398|363192257|FG003|Overall Study|Lost to Follow-up|0|||
105325995|NCT03323398|363192258|FG004|Overall Study|Lost to Follow-up|0|||
105325996|NCT03323398|363192259|FG005|Overall Study|Lost to Follow-up|0|||
105325997|NCT03323398|363192260|FG006|Overall Study|Lost to Follow-up|0|||
105325998|NCT03323398|363192261|FG007|Overall Study|Lost to Follow-up|0|||
105325999|NCT03323398|363192262|FG008|Overall Study|Lost to Follow-up|0|||
105326000|NCT03323398|363192254|FG000|Overall Study|Death|4|||
105326001|NCT03323398|363192255|FG001|Overall Study|Death|6|||
105326002|NCT03323398|363192256|FG002|Overall Study|Death|2|||
105326003|NCT03323398|363192257|FG003|Overall Study|Death|2|||
105326004|NCT03323398|363192258|FG004|Overall Study|Death|1|||
105326005|NCT03323398|363192259|FG005|Overall Study|Death|2|||
105326006|NCT03323398|363192260|FG006|Overall Study|Death|0|||
105326007|NCT03323398|363192261|FG007|Overall Study|Death|0|||
105326008|NCT03323398|363192262|FG008|Overall Study|Death|6|||
105326009|NCT03323398|363192254|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
105326010|NCT03323398|363192255|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
105326011|NCT03323398|363192256|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
105851945|NCT02935686|365115944|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
105851946|NCT02935686|365115940|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
105851947|NCT02935686|365115941|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
105851948|NCT02935686|365115942|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
105851949|NCT02935686|365115943|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
105851950|NCT02935686|365115944|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
105851951|NCT02935686|365115940|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
105851952|NCT02935686|365115941|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
105851953|NCT02935686|365115942|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
105851954|NCT02935686|365115943|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
105851955|NCT02935686|365115944|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
105851956|NCT02935686|365115940|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
105326012|NCT03323398|363192257|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
105373104|NCT00127803|363372576|FG003|Overall Study|Lost to Follow-up|1|||
105373105|NCT00362232|363374026|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
105577079|NCT00849680|364112167|FG003|Overall Study|Subject moved|1|||
105326013|NCT03323398|363192258|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
105326014|NCT03323398|363192259|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
105326015|NCT03323398|363192260|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
105326016|NCT03323398|363192261|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
105326017|NCT03323398|363192262|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
105326018|NCT03323398|363192254|FG000|Overall Study|Withdrawal by Subject|2|||
105326019|NCT03323398|363192255|FG001|Overall Study|Withdrawal by Subject|1|||
105373106|NCT00362232|363374027|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
105326020|NCT03323398|363192256|FG002|Overall Study|Withdrawal by Subject|3|||
105326021|NCT03323398|363192257|FG003|Overall Study|Withdrawal by Subject|0|||
105326022|NCT03323398|363192258|FG004|Overall Study|Withdrawal by Subject|0|||
105326023|NCT03323398|363192259|FG005|Overall Study|Withdrawal by Subject|1|||
105326024|NCT03323398|363192260|FG006|Overall Study|Withdrawal by Subject|0|||
105326025|NCT03323398|363192261|FG007|Overall Study|Withdrawal by Subject|0|||
105326026|NCT03323398|363192262|FG008|Overall Study|Withdrawal by Subject|0|||
105326027|NCT03323398|363192254|FG000|Overall Study|Participant was Put on Hospice|0|||
105326028|NCT03323398|363192255|FG001|Overall Study|Participant was Put on Hospice|0|||
105326029|NCT03323398|363192256|FG002|Overall Study|Participant was Put on Hospice|0|||
105326030|NCT03323398|363192257|FG003|Overall Study|Participant was Put on Hospice|0|||
105326031|NCT03323398|363192258|FG004|Overall Study|Participant was Put on Hospice|0|||
105326032|NCT03323398|363192259|FG005|Overall Study|Participant was Put on Hospice|0|||
105326033|NCT03323398|363192260|FG006|Overall Study|Participant was Put on Hospice|1|||
105326034|NCT03323398|363192261|FG007|Overall Study|Participant was Put on Hospice|0|||
105326035|NCT03323398|363192262|FG008|Overall Study|Participant was Put on Hospice|0|||
105326036|NCT03323398|363192254|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
105326037|NCT03323398|363192255|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
105326038|NCT03323398|363192256|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
105326039|NCT03323398|363192257|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
105326040|NCT03323398|363192258|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
105326041|NCT03323398|363192259|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
105326042|NCT03323398|363192260|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
105326043|NCT03323398|363192261|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
105326044|NCT03323398|363192262|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
105326045|NCT02729025|363192263|FG000|Overall Study|Sponsor Decision|0|||
105326046|NCT02729025|363192264|FG001|Overall Study|Sponsor Decision|1|||
105326047|NCT01609790|363192268|FG000|Overall Study|Protocol Violation|1|||
105326048|NCT01609790|363192269|FG001|Overall Study|Protocol Violation|7|||
105326049|NCT01609790|363192270|FG002|Overall Study|Protocol Violation|8|||
105326050|NCT00679211|363194750|FG000|Overall Study|Progressive disease|82|||
105326051|NCT00679211|363194750|FG000|Overall Study|Adverse Event|7|||
105326052|NCT00679211|363194750|FG000|Overall Study|Withdrawal by Subject|2|||
105326053|NCT00679211|363194750|FG000|Overall Study|Physician Decision|5|||
105326054|NCT00679211|363194750|FG000|Overall Study|Refused to undergo protocol procedures|1|||
105326055|NCT00679211|363194750|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
105326056|NCT00679211|363194750|FG000|Overall Study|Other|1|||
105326057|NCT01730053|363194751|FG000|Overall Study|Participant moved|0|||
105326058|NCT01730053|363194752|FG001|Overall Study|Participant moved|0|||
105326059|NCT01730053|363194753|FG002|Overall Study|Participant moved|1|||
105326060|NCT01730053|363194754|FG003|Overall Study|Participant moved|0|||
105326061|NCT01730053|363194755|FG004|Overall Study|Participant moved|0|||
105326062|NCT01730053|363194756|FG005|Overall Study|Participant moved|0|||
105326063|NCT01730053|363194751|FG000|Overall Study|Physician Decision|0|||
105326064|NCT01730053|363194752|FG001|Overall Study|Physician Decision|0|||
105326065|NCT01730053|363194753|FG002|Overall Study|Physician Decision|0|||
105326066|NCT01730053|363194754|FG003|Overall Study|Physician Decision|1|||
105326067|NCT01730053|363194755|FG004|Overall Study|Physician Decision|0|||
105326068|NCT01730053|363194756|FG005|Overall Study|Physician Decision|0|||
105373107|NCT00362232|363374026|FG000|Treatment (12 +/- 2 Days)|Death|1|||
105373108|NCT00362232|363374027|FG001|Treatment (12 +/- 2 Days)|Death|3|||
105373109|NCT00362232|363374026|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
105373110|NCT00362232|363374027|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
105373111|NCT00362232|363374026|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
105373112|NCT00362232|363374027|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
105373113|NCT00362232|363374026|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
105373114|NCT00362232|363374027|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
105373115|NCT00362232|363374026|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
105373116|NCT00362232|363374027|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
105373117|NCT00362232|363374026|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
105373118|NCT00362232|363374027|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
105373119|NCT00362232|363374026|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
105326069|NCT01730053|363194751|FG000|Overall Study|Adverse Event|2|||
105326070|NCT01730053|363194752|FG001|Overall Study|Adverse Event|6|||
105326071|NCT01730053|363194753|FG002|Overall Study|Adverse Event|3|||
105326072|NCT01730053|363194754|FG003|Overall Study|Adverse Event|3|||
105326073|NCT01730053|363194755|FG004|Overall Study|Adverse Event|2|||
105326074|NCT01730053|363194756|FG005|Overall Study|Adverse Event|2|||
105326075|NCT01730053|363194751|FG000|Overall Study|Poor compliance to protocol|1|||
105326076|NCT01730053|363194752|FG001|Overall Study|Poor compliance to protocol|2|||
105326077|NCT01730053|363194753|FG002|Overall Study|Poor compliance to protocol|2|||
105326078|NCT01730053|363194754|FG003|Overall Study|Poor compliance to protocol|0|||
105326079|NCT01730053|363194755|FG004|Overall Study|Poor compliance to protocol|0|||
105851957|NCT02935686|365115941|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
105851958|NCT02935686|365115942|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
105851959|NCT02935686|365115943|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
105851960|NCT02935686|365115944|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
105851961|NCT02935686|365115940|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
105851962|NCT02935686|365115941|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
105851963|NCT02935686|365115942|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
105851964|NCT02935686|365115943|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
105851965|NCT02935686|365115944|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
105851966|NCT02935686|365115940|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
105851967|NCT02935686|365115941|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
105851968|NCT02935686|365115942|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
105851969|NCT02935686|365115943|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
105851970|NCT02935686|365115944|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
105851971|NCT02935686|365115940|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
105851972|NCT02935686|365115941|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
105851973|NCT02935686|365115942|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
105851974|NCT02935686|365115943|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
105851975|NCT02935686|365115944|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
105851976|NCT02935686|365115940|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
105851977|NCT02935686|365115941|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
105851978|NCT02935686|365115942|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
105851979|NCT02935686|365115943|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
105851980|NCT02935686|365115944|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
105851981|NCT02935686|365115940|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
105851982|NCT02935686|365115941|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
105851983|NCT02935686|365115942|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
105851984|NCT02935686|365115943|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
105851985|NCT02935686|365115944|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
105851986|NCT02935686|365115940|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
105851987|NCT02935686|365115941|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
105851988|NCT02935686|365115942|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
105851989|NCT02935686|365115943|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
105851990|NCT02935686|365115944|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
105851991|NCT02935686|365115940|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
105851992|NCT02935686|365115941|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
105851993|NCT02935686|365115942|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
105851994|NCT02935686|365115943|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
105851995|NCT02935686|365115944|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
105851996|NCT05071313|365115945|FG000|Overall Study|Lost to Follow-up|17|||
105851997|NCT05071313|365115946|FG001|Overall Study|Lost to Follow-up|10|||
105851998|NCT05071313|365115945|FG000|Overall Study|Physician Decision|1|||
105851999|NCT05071313|365115946|FG001|Overall Study|Physician Decision|6|||
105852000|NCT05071313|365115945|FG000|Overall Study|Death|1|||
105852001|NCT05071313|365115946|FG001|Overall Study|Death|0|||
105852002|NCT05071313|365115945|FG000|Overall Study|Withdrawal by Subject|10|||
105852003|NCT05071313|365115946|FG001|Overall Study|Withdrawal by Subject|15|||
105852004|NCT05071313|365115945|FG000|Overall Study|Other|1|||
105852005|NCT05071313|365115946|FG001|Overall Study|Other|0|||
105852006|NCT05071313|365115945|FG000|Overall Study|Randomized but not vaccinated|4|||
105852007|NCT05071313|365115946|FG001|Overall Study|Randomized but not vaccinated|2|||
105852008|NCT01951885|365115948|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
105852009|NCT01951885|365115949|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
105852010|NCT01951885|365115948|FG000|Overall Study|Adverse Event|1|||
105852011|NCT01951885|365115949|FG001|Overall Study|Adverse Event|0|||
105852012|NCT01951885|365115948|FG000|Overall Study|Withdrawal by Subject|0|||
105852013|NCT01951885|365115949|FG001|Overall Study|Withdrawal by Subject|1|||
105852014|NCT01951885|365115948|FG000|Overall Study|ineligible due to a change in donor|0|||
105326080|NCT01730053|363194756|FG005|Overall Study|Poor compliance to protocol|2|||
105326081|NCT01730053|363194751|FG000|Overall Study|Other than specified|2|||
105852015|NCT01951885|365115949|FG001|Overall Study|ineligible due to a change in donor|1|||
105852016|NCT01951885|365115948|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
105852017|NCT01951885|365115949|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
105326082|NCT01730053|363194752|FG001|Overall Study|Other than specified|6|||
105852018|NCT01293539|365115950|FG000|Overall Study|Physician Decision|1|||
105852019|NCT01367665|365115951|FG000|Overall Study|Death|102|||
105852020|NCT01367665|365115952|FG001|Overall Study|Death|19|||
105852021|NCT01367665|365115951|FG000|Overall Study|Lost to Follow-up|222|||
105852022|NCT01367665|365115952|FG001|Overall Study|Lost to Follow-up|22|||
105852023|NCT01367665|365115951|FG000|Overall Study|Not Done|118|||
105852024|NCT01367665|365115952|FG001|Overall Study|Not Done|14|||
105373120|NCT00362232|363374027|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
105852025|NCT02752906|365115953|FG000|Overall Study|Protocol Violation|2|||
105852026|NCT02752906|365115954|FG001|Overall Study|Protocol Violation|1|||
105852027|NCT02752906|365115953|FG000|Overall Study|Withdrawal by Subject|2|||
105852028|NCT02752906|365115954|FG001|Overall Study|Withdrawal by Subject|2|||
105852029|NCT02752906|365115953|FG000|Overall Study|Lost to Follow-up|3|||
105852030|NCT02752906|365115954|FG001|Overall Study|Lost to Follow-up|2|||
105852031|NCT02492880|365115955|FG000|Overall Study|Lost to Follow-up|1|||
105852032|NCT02492880|365115955|FG000|Overall Study|Protocol Violation|1|||
105852033|NCT04462471|365115956|FG000|Overall Study|Adverse Event|0|||
105852034|NCT04462471|365115957|FG001|Overall Study|Adverse Event|1|||
105852035|NCT04462471|365115958|FG002|Overall Study|Adverse Event|0|||
105852036|NCT04462471|365115959|FG003|Overall Study|Adverse Event|0|||
105852037|NCT04462471|365115956|FG000|Overall Study|Disease progression|1|||
105852038|NCT04462471|365115957|FG001|Overall Study|Disease progression|0|||
105852039|NCT04462471|365115958|FG002|Overall Study|Disease progression|0|||
105852040|NCT04462471|365115959|FG003|Overall Study|Disease progression|0|||
105852041|NCT01200992|365115960|FG000|Overall Study|Study terminated early|35|||
105852042|NCT01200992|365115961|FG001|Overall Study|Study terminated early|41|||
105852043|NCT01200992|365115960|FG000|Overall Study|Randomized but not treated|2|||
105852044|NCT01200992|365115961|FG001|Overall Study|Randomized but not treated|0|||
105852045|NCT00554190|365115962|FG000|Overall Study|Termination forms not completed|10|||
105852046|NCT03514641|365115964|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
105852047|NCT03514641|365115965|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
105852048|NCT03514641|365115966|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
105852049|NCT03514641|365115967|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
105852050|NCT03514641|365115964|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
105852051|NCT03514641|365115965|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
105852052|NCT03514641|365115966|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
105852053|NCT03514641|365115967|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
105852054|NCT03514641|365115964|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
105852055|NCT03514641|365115965|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
105852056|NCT03514641|365115966|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
105852057|NCT03514641|365115967|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
105852058|NCT03514641|365115964|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
105852059|NCT03514641|365115965|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
105852060|NCT03514641|365115966|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
105852061|NCT03514641|365115967|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
105852062|NCT03514641|365115964|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
105852063|NCT03514641|365115965|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
105852064|NCT03514641|365115966|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
105852065|NCT03514641|365115967|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
105852066|NCT03514641|365115964|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
105852067|NCT03514641|365115965|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
105852068|NCT03514641|365115966|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
105852069|NCT03514641|365115967|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
105852070|NCT03514641|365115964|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
105852071|NCT03514641|365115965|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
105852072|NCT03514641|365115966|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
105852073|NCT03514641|365115967|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
105852074|NCT03514641|365115964|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
105852075|NCT03514641|365115965|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
105852076|NCT03514641|365115966|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
105852077|NCT03514641|365115967|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
105852078|NCT03514641|365115964|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
105852079|NCT03514641|365115965|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
105373121|NCT00362232|363374026|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
105373122|NCT00362232|363374027|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
105373123|NCT00362232|363374026|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
105373124|NCT00362232|363374027|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
105852080|NCT03514641|365115966|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
105852081|NCT03514641|365115967|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
105852082|NCT03514641|365115964|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
105852083|NCT03514641|365115965|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
105852084|NCT03514641|365115966|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
105852085|NCT03514641|365115967|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
105852086|NCT03514641|365115964|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
105852087|NCT03514641|365115965|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
105852088|NCT03514641|365115966|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
105852089|NCT03514641|365115967|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
105852090|NCT03514641|365115964|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
105852091|NCT03514641|365115965|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
105852092|NCT03514641|365115966|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
105852093|NCT03514641|365115967|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
105852094|NCT00114166|365115977|FG000|Overall Study|Wrong primary|0|||
105852095|NCT00114166|365115978|FG001|Overall Study|Wrong primary|1|||
105852096|NCT02397408|365115979|FG000|Overall Study|Physician Decision|4|||
105852097|NCT02397408|365115979|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
105852098|NCT03397771|365115982|FG000|Overall Study|2 erroneously randomized, never treated|3|||
105852099|NCT03397771|365115983|FG001|Overall Study|2 erroneously randomized, never treated|1|||
105852100|NCT03397771|365115982|FG000|Overall Study|Withdrawal by Subject|1|||
105852101|NCT03397771|365115983|FG001|Overall Study|Withdrawal by Subject|3|||
105852102|NCT03397771|365115982|FG000|Overall Study|Protocol Violation|2|||
105852103|NCT03397771|365115983|FG001|Overall Study|Protocol Violation|2|||
105852104|NCT03397771|365115982|FG000|Overall Study|Adverse Event|2|||
105852105|NCT03397771|365115983|FG001|Overall Study|Adverse Event|1|||
105852106|NCT04078126|365115987|FG000|Washout|Study put on hold due to COVID-19|0|||
105852107|NCT04078126|365115988|FG001|Washout|Study put on hold due to COVID-19|2|||
105852108|NCT04078126|365115987|FG000|Period 2|Study put on hold due to COVID-19|1|||
105852109|NCT04078126|365115988|FG001|Period 2|Study put on hold due to COVID-19|1|||
105852110|NCT00140426|365115989|FG000|Overall Study|Withdrawal by Subject|0|||
105852111|NCT00140426|365115990|FG001|Overall Study|Withdrawal by Subject|3|||
105852112|NCT02669758|365115991|FG000|Overall Study|Withdrawal by Subject|43|||
105852113|NCT02669758|365115991|FG000|Overall Study|Lost to Follow-up|19|||
105852114|NCT02669758|365115991|FG000|Overall Study|Adverse Event|16|||
105852115|NCT02669758|365115991|FG000|Overall Study|Non-Compliance with Study Drug|8|||
105852116|NCT02669758|365115991|FG000|Overall Study|Lack of Efficacy|5|||
105852117|NCT02669758|365115991|FG000|Overall Study|Pregnancy|1|||
105852118|NCT02669758|365115991|FG000|Overall Study|Study noncompliance|1|||
105852119|NCT02669758|365115991|FG000|Overall Study|Protocol Violation|1|||
105852120|NCT02149108|365115992|FG000|Overall Study|Not treated|1|||
105852121|NCT02149108|365115993|FG001|Overall Study|Not treated|2|||
105852122|NCT02149108|365115992|FG000|Overall Study|Progressive Disease (PD)|324|||
105852123|NCT02149108|365115993|FG001|Overall Study|Progressive Disease (PD)|318|||
105852124|NCT02149108|365115992|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
105852125|NCT02149108|365115993|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
105852126|NCT02149108|365115992|FG000|Overall Study|Other Adverse Event (AE)|8|||
105852127|NCT02149108|365115993|FG001|Overall Study|Other Adverse Event (AE)|18|||
105852128|NCT02149108|365115992|FG000|Overall Study|Other not defined above|0|||
105852129|NCT02149108|365115993|FG001|Overall Study|Other not defined above|2|||
105852130|NCT02149108|365115992|FG000|Overall Study|Refusal to continue trial medication|15|||
105852131|NCT02149108|365115993|FG001|Overall Study|Refusal to continue trial medication|11|||
105852132|NCT02149108|365115992|FG000|Overall Study|Lost to Follow-up|1|||
105852133|NCT02149108|365115993|FG001|Overall Study|Lost to Follow-up|0|||
105852134|NCT00806286|365115994|FG000|Overall Study|Adverse Event|5|||
105852135|NCT00806286|365115995|FG001|Overall Study|Adverse Event|2|||
105852136|NCT00806286|365115996|FG002|Overall Study|Adverse Event|0|||
105852137|NCT00806286|365115994|FG000|Overall Study|Disease progression|31|||
105852138|NCT00806286|365115995|FG001|Overall Study|Disease progression|38|||
105852139|NCT00806286|365115996|FG002|Overall Study|Disease progression|1|||
105852140|NCT00806286|365115994|FG000|Overall Study|Death|1|||
105852141|NCT00806286|365115995|FG001|Overall Study|Death|6|||
105852142|NCT00806286|365115996|FG002|Overall Study|Death|0|||
105852143|NCT00806286|365115994|FG000|Overall Study|Lost to Follow-up|0|||
105852144|NCT00806286|365115995|FG001|Overall Study|Lost to Follow-up|1|||
105852145|NCT00806286|365115996|FG002|Overall Study|Lost to Follow-up|0|||
105852146|NCT00806286|365115994|FG000|Overall Study|Withdrawal by Subject|8|||
105852147|NCT00806286|365115995|FG001|Overall Study|Withdrawal by Subject|3|||
105852148|NCT00806286|365115996|FG002|Overall Study|Withdrawal by Subject|1|||
105852149|NCT00806286|365115994|FG000|Overall Study|Physician Decision|2|||
105852150|NCT00806286|365115995|FG001|Overall Study|Physician Decision|2|||
105852151|NCT00806286|365115996|FG002|Overall Study|Physician Decision|0|||
105373125|NCT00362232|363374026|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
105373126|NCT00362232|363374027|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
105852152|NCT00806286|365115994|FG000|Overall Study|Due to a variety of reasons|7|||
105852153|NCT00806286|365115995|FG001|Overall Study|Due to a variety of reasons|2|||
105852154|NCT00806286|365115996|FG002|Overall Study|Due to a variety of reasons|1|||
105852155|NCT02455050|365115997|FG000|Treatment Period 1|Lost to Follow-up|1|||
105373127|NCT00362232|363374026|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
105852156|NCT02455050|365115998|FG001|Treatment Period 1|Lost to Follow-up|1|||
105852157|NCT02455050|365115999|FG002|Treatment Period 1|Lost to Follow-up|1|||
105852158|NCT02455050|365116000|FG003|Treatment Period 1|Lost to Follow-up|2|||
105852159|NCT02455050|365115997|FG000|Treatment Period 2|Lost to Follow-up|1|||
105852160|NCT02455050|365115998|FG001|Treatment Period 2|Lost to Follow-up|0|||
105852161|NCT02455050|365115999|FG002|Treatment Period 2|Lost to Follow-up|2|||
105852162|NCT02455050|365116000|FG003|Treatment Period 2|Lost to Follow-up|1|||
105852163|NCT03402750|365116001|FG000|Overall Study|Lost to Follow-up|2|||
105326083|NCT01730053|363194753|FG002|Overall Study|Other than specified|5|||
105326084|NCT01730053|363194754|FG003|Overall Study|Other than specified|4|||
105326085|NCT01730053|363194755|FG004|Overall Study|Other than specified|7|||
105326086|NCT01730053|363194756|FG005|Overall Study|Other than specified|9|||
105326087|NCT03511105|363194757|FG000|Overall Study|Adverse Event|1|||
105326088|NCT03511105|363194758|FG001|Overall Study|Adverse Event|0|||
105326089|NCT03511105|363194757|FG000|Overall Study|Withdrew consent|1|||
105326090|NCT03511105|363194758|FG001|Overall Study|Withdrew consent|0|||
105326091|NCT02832687|363194759|FG000|Overall Study|Adverse Event|0|||
105326092|NCT02832687|363194760|FG001|Overall Study|Adverse Event|2|||
105326093|NCT04231825|363194761|FG000|Overall Study|Protocol Violation|3|||
105326094|NCT04231825|363194762|FG001|Overall Study|Protocol Violation|3|||
105326095|NCT04231825|363194761|FG000|Overall Study|Lost to Follow-up|0|||
105326096|NCT04231825|363194762|FG001|Overall Study|Lost to Follow-up|1|||
105326097|NCT02019472|363194763|FG000|Overall Study|Adverse Event|14|||
105326098|NCT02019472|363194764|FG001|Overall Study|Adverse Event|23|||
105326099|NCT02019472|363194765|FG002|Overall Study|Adverse Event|17|||
105326100|NCT02019472|363194763|FG000|Overall Study|Death|0|||
105326101|NCT02019472|363194764|FG001|Overall Study|Death|1|||
105326102|NCT02019472|363194765|FG002|Overall Study|Death|1|||
105326103|NCT02019472|363194763|FG000|Overall Study|Lack of Efficacy|7|||
105326104|NCT02019472|363194764|FG001|Overall Study|Lack of Efficacy|4|||
105326105|NCT02019472|363194765|FG002|Overall Study|Lack of Efficacy|4|||
105326106|NCT02019472|363194763|FG000|Overall Study|Lost to Follow-up|0|||
105326107|NCT02019472|363194764|FG001|Overall Study|Lost to Follow-up|2|||
105326108|NCT02019472|363194765|FG002|Overall Study|Lost to Follow-up|1|||
105326109|NCT02019472|363194763|FG000|Overall Study|Physician Decision|1|||
105326110|NCT02019472|363194764|FG001|Overall Study|Physician Decision|2|||
105326111|NCT02019472|363194765|FG002|Overall Study|Physician Decision|0|||
105326112|NCT02019472|363194763|FG000|Overall Study|Pregnancy|1|||
105326113|NCT02019472|363194764|FG001|Overall Study|Pregnancy|2|||
105326114|NCT02019472|363194765|FG002|Overall Study|Pregnancy|2|||
105326115|NCT02019472|363194763|FG000|Overall Study|Withdrawal by Subject|11|||
105326116|NCT02019472|363194764|FG001|Overall Study|Withdrawal by Subject|10|||
105326117|NCT02019472|363194765|FG002|Overall Study|Withdrawal by Subject|11|||
105326118|NCT02019472|363194763|FG000|Overall Study|Other|3|||
105326119|NCT02019472|363194764|FG001|Overall Study|Other|8|||
105326120|NCT02019472|363194765|FG002|Overall Study|Other|6|||
105326121|NCT01662635|363194766|FG000|Overall Study|scarce samples for evaluation|30|||
105326122|NCT04570670|363194769|FG000|Overall Study|Withdrawal by Subject|1|||
105326123|NCT04570670|363194770|FG001|Overall Study|Withdrawal by Subject|0|||
105326124|NCT01002989|363194771|FG000|Overall Study|exclusion criteria, no consent|5|||
105326125|NCT02547428|363194778|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
105326126|NCT02547428|363194779|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
105326127|NCT02547428|363194778|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
105326128|NCT02547428|363194779|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
105326129|NCT02547428|363194778|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
105326130|NCT02547428|363194779|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
105326131|NCT02547428|363194778|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
105326132|NCT02547428|363194779|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
105326133|NCT02547428|363194778|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
105852164|NCT03402750|365116002|FG001|Overall Study|Lost to Follow-up|1|||
105852165|NCT02628743|365116004|FG000|Overall Study|Other|3|||
105852166|NCT02628743|365116004|FG000|Overall Study|Withdrawal by Subject|50|||
105852167|NCT02628743|365116004|FG000|Overall Study|Study Terminated by Sponsor|76|||
105852168|NCT02628743|365116004|FG000|Overall Study|Physician Decision|2|||
105852169|NCT02981303|365116005|FG000|Overall Study|Progressive Disease|17|||
105852170|NCT02981303|365116006|FG001|Overall Study|Progressive Disease|37|||
105852171|NCT02981303|365116005|FG000|Overall Study|Adverse Event|1|||
105852172|NCT02981303|365116006|FG001|Overall Study|Adverse Event|4|||
105852173|NCT02981303|365116005|FG000|Overall Study|Withdrawal by Subject|0|||
105326134|NCT02547428|363194779|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
105326135|NCT02547428|363194778|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
105326136|NCT02547428|363194779|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
105326137|NCT02547428|363194778|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
105373128|NCT00362232|363374027|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
105326138|NCT02547428|363194779|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
105373129|NCT00362232|363374026|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
105373130|NCT00362232|363374027|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
105326139|NCT02547428|363194778|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
105326140|NCT02547428|363194779|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
105373131|NCT03255187|363374028|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
105852174|NCT02981303|365116006|FG001|Overall Study|Withdrawal by Subject|1|||
105326141|NCT01479465|363194780|FG000|Overall Study|Disease Progression|9|||
105852175|NCT02325518|365116007|FG000|Overall Study|Adverse Event|4|||
105326142|NCT01479465|363194781|FG001|Overall Study|Disease Progression|61|||
105326143|NCT01479465|363194782|FG002|Overall Study|Disease Progression|65|||
105326144|NCT01479465|363194783|FG003|Overall Study|Disease Progression|70|||
105326145|NCT01479465|363194780|FG000|Overall Study|Study Discontinued by Sponsor|0|||
105326146|NCT01479465|363194781|FG001|Overall Study|Study Discontinued by Sponsor|7|||
105326147|NCT01479465|363194782|FG002|Overall Study|Study Discontinued by Sponsor|5|||
105326148|NCT01479465|363194783|FG003|Overall Study|Study Discontinued by Sponsor|3|||
105326149|NCT01479465|363194780|FG000|Overall Study|Adverse Event|0|||
105326150|NCT01479465|363194781|FG001|Overall Study|Adverse Event|3|||
105326151|NCT01479465|363194782|FG002|Overall Study|Adverse Event|6|||
105326152|NCT01479465|363194783|FG003|Overall Study|Adverse Event|4|||
105326153|NCT01479465|363194780|FG000|Overall Study|Investigator Discretion|1|||
105326154|NCT01479465|363194781|FG001|Overall Study|Investigator Discretion|4|||
105326155|NCT01479465|363194782|FG002|Overall Study|Investigator Discretion|2|||
105326156|NCT01479465|363194783|FG003|Overall Study|Investigator Discretion|4|||
105326157|NCT01479465|363194780|FG000|Overall Study|Subject Request|1|||
105326158|NCT01479465|363194781|FG001|Overall Study|Subject Request|3|||
105326159|NCT01479465|363194782|FG002|Overall Study|Subject Request|4|||
105326160|NCT01479465|363194783|FG003|Overall Study|Subject Request|2|||
105326161|NCT01479465|363194780|FG000|Overall Study|Subject Withdrew Consent|0|||
105326162|NCT01479465|363194781|FG001|Overall Study|Subject Withdrew Consent|5|||
105326163|NCT01479465|363194782|FG002|Overall Study|Subject Withdrew Consent|2|||
105326164|NCT01479465|363194783|FG003|Overall Study|Subject Withdrew Consent|1|||
105326165|NCT01479465|363194780|FG000|Overall Study|Protocol Violation|0|||
105326166|NCT01479465|363194781|FG001|Overall Study|Protocol Violation|1|||
105326167|NCT01479465|363194782|FG002|Overall Study|Protocol Violation|1|||
105326168|NCT01479465|363194783|FG003|Overall Study|Protocol Violation|0|||
105326169|NCT01479465|363194780|FG000|Overall Study|Death|0|||
105326170|NCT01479465|363194781|FG001|Overall Study|Death|0|||
105326171|NCT01479465|363194782|FG002|Overall Study|Death|0|||
105326172|NCT01479465|363194783|FG003|Overall Study|Death|1|||
105326173|NCT01479465|363194780|FG000|Overall Study|Lost to Follow-up|0|||
105326174|NCT01479465|363194781|FG001|Overall Study|Lost to Follow-up|0|||
105326175|NCT01479465|363194782|FG002|Overall Study|Lost to Follow-up|1|||
105326176|NCT01479465|363194783|FG003|Overall Study|Lost to Follow-up|0|||
105326177|NCT02392481|363194786|FG000|Overall Study|Adverse Event|0|||
105326178|NCT02392481|363194787|FG001|Overall Study|Adverse Event|0|||
105326179|NCT02392481|363194788|FG002|Overall Study|Adverse Event|1|||
105326180|NCT02392481|363194789|FG003|Overall Study|Adverse Event|2|||
105326181|NCT02392481|363194786|FG000|Overall Study|Withdrawal by Subject|0|||
105326182|NCT02392481|363194787|FG001|Overall Study|Withdrawal by Subject|0|||
105326183|NCT02392481|363194788|FG002|Overall Study|Withdrawal by Subject|1|||
105326184|NCT02392481|363194789|FG003|Overall Study|Withdrawal by Subject|0|||
105326185|NCT03334435|363194790|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
105326186|NCT03334435|363194791|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
105373132|NCT03255187|363374029|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
105373133|NCT03255187|363374028|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
105373134|NCT03255187|363374029|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
105373135|NCT00375752|363374030|FG000|Overall Study|Lack of Efficacy|4|||
105373136|NCT00375752|363374031|FG001|Overall Study|Lack of Efficacy|4|||
105373137|NCT00375752|363374030|FG000|Overall Study|Adverse Event|1|||
105373138|NCT00375752|363374031|FG001|Overall Study|Adverse Event|6|||
105373139|NCT00375752|363374030|FG000|Overall Study|Withdrawal by Subject|6|||
105373140|NCT00375752|363374031|FG001|Overall Study|Withdrawal by Subject|1|||
105373141|NCT00375752|363374030|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
105373142|NCT00375752|363374031|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
105373143|NCT00375752|363374030|FG000|Overall Study|Protocol Violation|0|||
105373144|NCT00375752|363374031|FG001|Overall Study|Protocol Violation|2|||
105326187|NCT03334435|363194792|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
105326188|NCT03334435|363194793|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
105326189|NCT03334435|363194794|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
105326190|NCT03334435|363194795|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105326191|NCT03334435|363194796|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105373145|NCT00375752|363374030|FG000|Overall Study|Administrative Problems|0|||
105373146|NCT00375752|363374031|FG001|Overall Study|Administrative Problems|1|||
105373147|NCT01898078|363374036|FG000|Overall Study|Progressive Disease|1|||
105373148|NCT01898078|363374037|FG001|Overall Study|Progressive Disease|5|||
105373149|NCT01898078|363374036|FG000|Overall Study|Adverse Event|2|||
105373150|NCT01898078|363374037|FG001|Overall Study|Adverse Event|1|||
105326192|NCT03334435|363194797|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105852176|NCT02325518|365116008|FG001|Overall Study|Adverse Event|1|||
105852177|NCT02325518|365116007|FG000|Overall Study|Physician Decision|0|||
105852178|NCT02325518|365116008|FG001|Overall Study|Physician Decision|1|||
105852179|NCT02325518|365116007|FG000|Overall Study|Withdrawal by Subject|0|||
105852180|NCT02325518|365116008|FG001|Overall Study|Withdrawal by Subject|1|||
105852181|NCT04715932|365116009|FG000|Overall Study|Lost to Follow-up|1|||
105852182|NCT04715932|365116010|FG001|Overall Study|Lost to Follow-up|0|||
105852183|NCT02740699|365116023|FG000|Overall Study|Lost to Follow-up|5|||
105852184|NCT02740699|365116023|FG000|Overall Study|Withdrawal by Subject|14|||
105852185|NCT02740699|365116023|FG000|Overall Study|Physician Decision|5|||
105852186|NCT03393806|365116024|FG000|Overall Study|Physician Decision|1|||
105852187|NCT03393806|365116025|FG001|Overall Study|Physician Decision|0|||
105852188|NCT00886288|365116026|FG000|Overall Study|no respect of the 12 weeks period|657|||
105852189|NCT00886288|365116027|FG001|Overall Study|no respect of the 12 weeks period|227|||
105852190|NCT00886288|365116026|FG000|Overall Study|Lost to Follow-up|86|||
105852191|NCT00886288|365116027|FG001|Overall Study|Lost to Follow-up|0|||
105852192|NCT01259115|365116028|FG000|Period 1|Adverse Event|1|||
105852193|NCT01259115|365116029|FG001|Period 1|Adverse Event|0|||
105852194|NCT01259115|365116028|FG000|Period 1|Protocol Violation|2|||
105852195|NCT01259115|365116029|FG001|Period 1|Protocol Violation|0|||
105852196|NCT01259115|365116028|FG000|Period 1|Lost to Follow-up|0|||
105852197|NCT01259115|365116029|FG001|Period 1|Lost to Follow-up|1|||
105852198|NCT01259115|365116028|FG000|Period 2|Adverse Event|1|||
105852199|NCT01259115|365116029|FG001|Period 2|Adverse Event|0|||
105852200|NCT01675661|365116030|FG000|Overall Study|Lost to Follow-up|22|||
105852201|NCT01675661|365116031|FG001|Overall Study|Lost to Follow-up|23|||
105852202|NCT01675661|365116030|FG000|Overall Study|Practical problems|9|||
105852203|NCT01675661|365116031|FG001|Overall Study|Practical problems|5|||
105852204|NCT01675661|365116030|FG000|Overall Study|Moved away|5|||
105852205|NCT01675661|365116031|FG001|Overall Study|Moved away|6|||
105852206|NCT01675661|365116030|FG000|Overall Study|Withdrawal by Subject|3|||
105852207|NCT01675661|365116031|FG001|Overall Study|Withdrawal by Subject|7|||
105852208|NCT01675661|365116030|FG000|Overall Study|Physician Decision|0|||
105852209|NCT01675661|365116031|FG001|Overall Study|Physician Decision|2|||
105852210|NCT01675661|365116030|FG000|Overall Study|Death|0|||
105852211|NCT01675661|365116031|FG001|Overall Study|Death|1|||
105852212|NCT01675661|365116030|FG000|Overall Study|Other reason|1|||
105852213|NCT01675661|365116031|FG001|Overall Study|Other reason|2|||
105852214|NCT00326963|365116032|FG000|Overall Study|Adverse Event|2|||
105852215|NCT00326963|365116032|FG000|Overall Study|Injection site reaction|1|||
105852216|NCT00326963|365116032|FG000|Overall Study|Death|1|||
105852217|NCT00326963|365116032|FG000|Overall Study|Failure to return|10|||
105852218|NCT00326963|365116032|FG000|Overall Study|Withdrawal by Subject|10|||
105852219|NCT00326963|365116032|FG000|Overall Study|Refused treatment / did not cooperate|5|||
105852220|NCT00326963|365116032|FG000|Overall Study|Violation of selection criteria at entry|2|||
105852221|NCT00326963|365116032|FG000|Overall Study|Other protocol violation|1|||
105852222|NCT00326963|365116032|FG000|Overall Study|Administrative / other|1|||
105852223|NCT00859586|365116033|FG000|Overall Study|Donors|4|||
105852224|NCT01783548|365116035|FG000|Overall Study|Adverse Event|8|||
105852225|NCT01783548|365116036|FG001|Overall Study|Adverse Event|4|||
105852226|NCT01783548|365116035|FG000|Overall Study|Withdrawal by Subject|11|||
105852227|NCT01783548|365116036|FG001|Overall Study|Withdrawal by Subject|8|||
105852228|NCT01783548|365116035|FG000|Overall Study|Non-compliance|4|||
105852229|NCT01783548|365116036|FG001|Overall Study|Non-compliance|0|||
105852230|NCT01783548|365116035|FG000|Overall Study|Protocol Violation|2|||
105852231|NCT01783548|365116036|FG001|Overall Study|Protocol Violation|2|||
105852232|NCT01783548|365116035|FG000|Overall Study|Lost to Follow-up|8|||
105852233|NCT01783548|365116036|FG001|Overall Study|Lost to Follow-up|3|||
105852234|NCT01783548|365116035|FG000|Overall Study|Lack of Efficacy|1|||
105852235|NCT01783548|365116036|FG001|Overall Study|Lack of Efficacy|1|||
105373151|NCT01898078|363374036|FG000|Overall Study|Withdrawal by Subject|1|||
105852236|NCT02992418|365116037|FG000|Overall Study|Withdrawal by Subject|11|||
105852237|NCT02992418|365116038|FG001|Overall Study|Withdrawal by Subject|12|||
105373152|NCT01898078|363374037|FG001|Overall Study|Withdrawal by Subject|1|||
105373153|NCT01898078|363374036|FG000|Overall Study|Symptomatic Deterioration|2|||
105373154|NCT01898078|363374037|FG001|Overall Study|Symptomatic Deterioration|0|||
105852238|NCT02992418|365116037|FG000|Overall Study|Non-compliance with the protocol|308|||
105852239|NCT02992418|365116038|FG001|Overall Study|Non-compliance with the protocol|308|||
105852240|NCT02992418|365116037|FG000|Overall Study|Lost to Follow-up|27|||
105852241|NCT02992418|365116038|FG001|Overall Study|Lost to Follow-up|22|||
105852242|NCT03246126|365116043|FG000|Overall Study|Withdrawal by Subject|0|||
105852243|NCT03246126|365116044|FG001|Overall Study|Withdrawal by Subject|1|||
105852244|NCT01460901|365116050|FG000|Overall Study|Withdrawal by Subject|2|||
105852245|NCT01006135|365116053|FG000|Overall Study|Adverse Event|22|||
105852246|NCT01006135|365116053|FG000|Overall Study|Protocol Violation|14|||
105852247|NCT01006135|365116053|FG000|Overall Study|Lost to Follow-up|32|||
105852248|NCT01006135|365116053|FG000|Overall Study|Other|72|||
105852249|NCT02387983|365116063|FG000|Overall Study|Adverse Event|4|||
105852250|NCT02387983|365116063|FG000|Overall Study|Protocol Violation|1|||
105326193|NCT03334435|363194798|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105326194|NCT03334435|363194799|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105326195|NCT03334435|363194800|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105326196|NCT03334435|363194801|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105326197|NCT03334435|363194802|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105326198|NCT03334435|363194803|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105326199|NCT03334435|363194804|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105326200|NCT03334435|363194790|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
105326201|NCT03334435|363194791|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
105326202|NCT03334435|363194792|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
105326203|NCT03334435|363194793|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
105326204|NCT03334435|363194794|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
105326205|NCT03334435|363194795|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105326206|NCT03334435|363194796|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105326207|NCT03334435|363194797|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105326208|NCT03334435|363194798|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105326209|NCT03334435|363194799|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105326210|NCT03334435|363194800|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105326211|NCT03334435|363194801|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105326212|NCT03334435|363194802|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105326213|NCT03334435|363194803|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105326214|NCT03334435|363194804|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105326215|NCT03334435|363194790|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
105326216|NCT03334435|363194791|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
105326217|NCT03334435|363194792|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
105326218|NCT03334435|363194793|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
105326219|NCT03334435|363194794|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
105326220|NCT03334435|363194795|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105326221|NCT03334435|363194796|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105326222|NCT03334435|363194797|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105326223|NCT03334435|363194798|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105326224|NCT03334435|363194799|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105326225|NCT03334435|363194800|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105326226|NCT03334435|363194801|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105326227|NCT03334435|363194802|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105326228|NCT03334435|363194803|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105326229|NCT03334435|363194804|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105326230|NCT03334435|363194790|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
105326231|NCT03334435|363194791|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
105326232|NCT03334435|363194792|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
105326233|NCT03334435|363194793|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
105326234|NCT03334435|363194794|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
105326235|NCT03334435|363194795|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105326236|NCT03334435|363194796|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105326237|NCT03334435|363194797|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105326238|NCT03334435|363194798|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105326239|NCT03334435|363194799|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105326240|NCT03334435|363194800|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105326241|NCT03334435|363194801|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105326242|NCT03334435|363194802|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105326243|NCT03334435|363194803|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105326244|NCT03334435|363194804|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105326245|NCT03334435|363194790|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
105326246|NCT03334435|363194791|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105326247|NCT03334435|363194792|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
105326248|NCT03334435|363194793|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
105326249|NCT03334435|363194794|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
105326250|NCT03334435|363194795|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105326251|NCT03334435|363194796|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105326252|NCT03334435|363194797|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105852251|NCT02387983|365116063|FG000|Overall Study|Withdrawal by Subject|2|||
105852252|NCT00423319|365116066|FG000|Overall Study|Death|2|||
105852253|NCT00423319|365116067|FG001|Overall Study|Death|0|||
105852254|NCT00423319|365116066|FG000|Overall Study|Adverse Event|93|||
105852255|NCT00423319|365116067|FG001|Overall Study|Adverse Event|112|||
105852256|NCT00423319|365116066|FG000|Overall Study|Withdrawal by Subject|86|||
105852257|NCT00423319|365116067|FG001|Overall Study|Withdrawal by Subject|99|||
105852258|NCT00423319|365116066|FG000|Overall Study|Lost to Follow-up|4|||
105852259|NCT00423319|365116067|FG001|Overall Study|Lost to Follow-up|3|||
105852260|NCT00423319|365116066|FG000|Overall Study|Poor compliance or noncompliance|1|||
105852261|NCT00423319|365116067|FG001|Overall Study|Poor compliance or noncompliance|1|||
105852262|NCT00423319|365116066|FG000|Overall Study|No longer meets study criteria|15|||
105852263|NCT00423319|365116067|FG001|Overall Study|No longer meets study criteria|15|||
105852264|NCT00423319|365116066|FG000|Overall Study|Other|23|||
105852265|NCT00423319|365116067|FG001|Overall Study|Other|22|||
105852266|NCT01763684|365116068|FG000|Overall Study|Study terminated early due to low enrollment|126|||
105852267|NCT01763684|365116069|FG001|Overall Study|Study terminated early due to low enrollment|127|||
105852268|NCT01763684|365116068|FG000|Overall Study|Study surgery not performed|7|||
105852269|NCT01763684|365116069|FG001|Overall Study|Study surgery not performed|6|||
105852270|NCT02283983|365116070|FG000|Overall Study|Inclusion criteria not met|0|||
105852271|NCT02283983|365116071|FG001|Overall Study|Inclusion criteria not met|1|||
105852272|NCT02283983|365116070|FG000|Overall Study|Withdrawal by Subject|4|||
105852273|NCT02283983|365116071|FG001|Overall Study|Withdrawal by Subject|2|||
105852274|NCT02283983|365116070|FG000|Overall Study|Protocol Violation|0|||
105852275|NCT02283983|365116071|FG001|Overall Study|Protocol Violation|4|||
105852276|NCT02283983|365116070|FG000|Overall Study|Physician Decision|2|||
105852277|NCT02283983|365116071|FG001|Overall Study|Physician Decision|4|||
105852278|NCT02283983|365116070|FG000|Overall Study|Death|1|||
105852279|NCT02283983|365116071|FG001|Overall Study|Death|0|||
105852280|NCT02283983|365116070|FG000|Overall Study|Adverse Event|1|||
105852281|NCT02283983|365116071|FG001|Overall Study|Adverse Event|0|||
105852282|NCT02283983|365116070|FG000|Overall Study|Lost to Follow-up|9|||
105852283|NCT02283983|365116071|FG001|Overall Study|Lost to Follow-up|8|||
105852284|NCT02283983|365116070|FG000|Overall Study|Relapse|1|||
105852285|NCT02283983|365116071|FG001|Overall Study|Relapse|0|||
105852286|NCT01898650|365116074|FG000|Overall Study|the subject would not lie still for imaging|1|||
105852287|NCT01822275|365116075|FG000|Overall Study|Withdrawal by Subject|3|||
105852288|NCT01822275|365116075|FG000|Overall Study|Adverse Event|3|||
105852289|NCT01822275|365116075|FG000|Overall Study|Progression|14|||
105852290|NCT01822275|365116075|FG000|Overall Study|Physician Decision|2|||
105852291|NCT03970837|365116076|FG000|Overall Study|Adverse Event|23|||
105852292|NCT03970837|365116077|FG001|Overall Study|Adverse Event|20|||
105852293|NCT03970837|365116078|FG002|Overall Study|Adverse Event|16|||
105852294|NCT03970837|365116079|FG003|Overall Study|Adverse Event|6|||
105852295|NCT03970837|365116080|FG004|Overall Study|Adverse Event|4|||
105852296|NCT03970837|365116081|FG005|Overall Study|Adverse Event|5|||
105852297|NCT03970837|365116082|FG006|Overall Study|Adverse Event|1|||
105852298|NCT03970837|365116083|FG007|Overall Study|Adverse Event|5|||
105852299|NCT03970837|365116084|FG008|Overall Study|Adverse Event|0|||
105852300|NCT03970837|365116085|FG009|Overall Study|Adverse Event|0|||
105852301|NCT03970837|365116086|FG010|Overall Study|Adverse Event|1|||
105852302|NCT03970837|365116087|FG011|Overall Study|Adverse Event|1|||
105326253|NCT03334435|363194798|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105326254|NCT03334435|363194799|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105326255|NCT03334435|363194800|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105326256|NCT03334435|363194801|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105326257|NCT03334435|363194802|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105326258|NCT03334435|363194803|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105326259|NCT03334435|363194804|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105326260|NCT03334435|363194790|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
105326261|NCT03334435|363194791|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
105326262|NCT03334435|363194792|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
105326263|NCT03334435|363194793|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
105326264|NCT03334435|363194794|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
105326265|NCT03334435|363194795|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
105852303|NCT03970837|365116076|FG000|Overall Study|Lack of Efficacy|14|||
105852304|NCT03970837|365116077|FG001|Overall Study|Lack of Efficacy|12|||
105852305|NCT03970837|365116078|FG002|Overall Study|Lack of Efficacy|1|||
105852306|NCT03970837|365116079|FG003|Overall Study|Lack of Efficacy|2|||
105852307|NCT03970837|365116080|FG004|Overall Study|Lack of Efficacy|3|||
105852308|NCT03970837|365116081|FG005|Overall Study|Lack of Efficacy|4|||
105852309|NCT03970837|365116082|FG006|Overall Study|Lack of Efficacy|6|||
105852310|NCT03970837|365116083|FG007|Overall Study|Lack of Efficacy|1|||
105852311|NCT03970837|365116084|FG008|Overall Study|Lack of Efficacy|1|||
105852312|NCT03970837|365116085|FG009|Overall Study|Lack of Efficacy|0|||
105852313|NCT03970837|365116086|FG010|Overall Study|Lack of Efficacy|0|||
105852314|NCT03970837|365116087|FG011|Overall Study|Lack of Efficacy|0|||
105326266|NCT03334435|363194796|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
105326267|NCT03334435|363194797|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
105326268|NCT03334435|363194798|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
105326269|NCT03334435|363194799|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
105326270|NCT03334435|363194800|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
105326271|NCT03334435|363194801|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
105326272|NCT03334435|363194802|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
105326273|NCT03334435|363194803|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
105326274|NCT03334435|363194804|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
105326275|NCT03334435|363194790|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
105326276|NCT03334435|363194791|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
105326277|NCT03334435|363194792|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
105326278|NCT03334435|363194793|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
105326279|NCT03334435|363194794|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
105326280|NCT03334435|363194795|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
105326281|NCT03334435|363194796|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
105326282|NCT03334435|363194797|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
105326283|NCT03334435|363194798|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
105326284|NCT03334435|363194799|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
105326285|NCT03334435|363194800|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
105326286|NCT03334435|363194801|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
105326287|NCT03334435|363194802|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
105326288|NCT03334435|363194803|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
105326289|NCT03334435|363194804|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
105326290|NCT03334435|363194790|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
105326291|NCT03334435|363194791|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
105326292|NCT03334435|363194792|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
105326293|NCT03334435|363194793|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
105326294|NCT03334435|363194794|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
105326295|NCT03334435|363194795|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
105326296|NCT03334435|363194796|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
105326297|NCT03334435|363194797|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
105326298|NCT03334435|363194798|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
105326299|NCT03334435|363194799|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
105326300|NCT03334435|363194800|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
105326301|NCT03334435|363194801|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
105326302|NCT03334435|363194802|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
105326303|NCT03334435|363194803|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
105326304|NCT03334435|363194804|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
105326305|NCT03334435|363194790|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
105326306|NCT03334435|363194791|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
105326307|NCT03334435|363194792|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
105326308|NCT03334435|363194793|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
105326309|NCT03334435|363194794|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
105326310|NCT03334435|363194795|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
105326311|NCT03334435|363194796|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
105326312|NCT03334435|363194797|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
105326313|NCT03334435|363194798|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
105326314|NCT03334435|363194799|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
105326315|NCT03334435|363194800|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
105326316|NCT03334435|363194801|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
105326317|NCT03334435|363194802|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
105326318|NCT03334435|363194803|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
105326319|NCT03334435|363194804|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
105326320|NCT03334435|363194790|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
105326321|NCT03334435|363194791|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
105326322|NCT03334435|363194792|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
105326323|NCT03334435|363194793|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
105326324|NCT03334435|363194794|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
105326325|NCT03334435|363194795|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
105326326|NCT03334435|363194796|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
105326327|NCT03334435|363194797|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
105326328|NCT03334435|363194798|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
105326329|NCT03334435|363194799|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
105577080|NCT00849680|364112168|FG004|Overall Study|Subject moved|0|||
105852315|NCT03970837|365116076|FG000|Overall Study|Lost to Follow-up|6|||
105852316|NCT03970837|365116077|FG001|Overall Study|Lost to Follow-up|5|||
105852317|NCT03970837|365116078|FG002|Overall Study|Lost to Follow-up|5|||
105852318|NCT03970837|365116079|FG003|Overall Study|Lost to Follow-up|1|||
105852319|NCT03970837|365116080|FG004|Overall Study|Lost to Follow-up|0|||
105852320|NCT03970837|365116081|FG005|Overall Study|Lost to Follow-up|2|||
105852321|NCT03970837|365116082|FG006|Overall Study|Lost to Follow-up|0|||
105852322|NCT03970837|365116083|FG007|Overall Study|Lost to Follow-up|0|||
105852323|NCT03970837|365116084|FG008|Overall Study|Lost to Follow-up|0|||
105852324|NCT03970837|365116085|FG009|Overall Study|Lost to Follow-up|0|||
105852325|NCT03970837|365116086|FG010|Overall Study|Lost to Follow-up|0|||
105852326|NCT03970837|365116087|FG011|Overall Study|Lost to Follow-up|0|||
105852327|NCT03970837|365116076|FG000|Overall Study|Protocol Violation|1|||
105326330|NCT03334435|363194800|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
105326331|NCT03334435|363194801|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
105326332|NCT03334435|363194802|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
105326333|NCT03334435|363194803|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
105852328|NCT03970837|365116077|FG001|Overall Study|Protocol Violation|0|||
105852329|NCT03970837|365116078|FG002|Overall Study|Protocol Violation|0|||
105852330|NCT03970837|365116079|FG003|Overall Study|Protocol Violation|0|||
105852331|NCT03970837|365116080|FG004|Overall Study|Protocol Violation|0|||
105852332|NCT03970837|365116081|FG005|Overall Study|Protocol Violation|0|||
105852333|NCT03970837|365116082|FG006|Overall Study|Protocol Violation|0|||
105852334|NCT03970837|365116083|FG007|Overall Study|Protocol Violation|0|||
105852335|NCT03970837|365116084|FG008|Overall Study|Protocol Violation|0|||
105852336|NCT03970837|365116085|FG009|Overall Study|Protocol Violation|0|||
105852337|NCT03970837|365116086|FG010|Overall Study|Protocol Violation|0|||
105852338|NCT03970837|365116087|FG011|Overall Study|Protocol Violation|0|||
105852339|NCT03970837|365116076|FG000|Overall Study|Physician Decision|5|||
105852340|NCT03970837|365116077|FG001|Overall Study|Physician Decision|8|||
105852341|NCT03970837|365116078|FG002|Overall Study|Physician Decision|4|||
105852342|NCT03970837|365116079|FG003|Overall Study|Physician Decision|1|||
105852343|NCT03970837|365116080|FG004|Overall Study|Physician Decision|5|||
105852344|NCT03970837|365116081|FG005|Overall Study|Physician Decision|2|||
105852345|NCT03970837|365116082|FG006|Overall Study|Physician Decision|4|||
105852346|NCT03970837|365116083|FG007|Overall Study|Physician Decision|5|||
105852347|NCT03970837|365116084|FG008|Overall Study|Physician Decision|0|||
105852348|NCT03970837|365116085|FG009|Overall Study|Physician Decision|1|||
105852349|NCT03970837|365116086|FG010|Overall Study|Physician Decision|0|||
105852350|NCT03970837|365116087|FG011|Overall Study|Physician Decision|0|||
105852351|NCT03970837|365116076|FG000|Overall Study|Withdrawal by Subject|32|||
105852352|NCT03970837|365116077|FG001|Overall Study|Withdrawal by Subject|35|||
105852353|NCT03970837|365116078|FG002|Overall Study|Withdrawal by Subject|12|||
105852354|NCT03970837|365116079|FG003|Overall Study|Withdrawal by Subject|8|||
105852355|NCT03970837|365116080|FG004|Overall Study|Withdrawal by Subject|6|||
105852356|NCT03970837|365116081|FG005|Overall Study|Withdrawal by Subject|8|||
105852357|NCT03970837|365116082|FG006|Overall Study|Withdrawal by Subject|2|||
105852358|NCT03970837|365116083|FG007|Overall Study|Withdrawal by Subject|3|||
105852359|NCT03970837|365116084|FG008|Overall Study|Withdrawal by Subject|0|||
105852360|NCT03970837|365116085|FG009|Overall Study|Withdrawal by Subject|0|||
105852361|NCT03970837|365116086|FG010|Overall Study|Withdrawal by Subject|0|||
105852362|NCT03970837|365116087|FG011|Overall Study|Withdrawal by Subject|1|||
105852363|NCT03970837|365116076|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
105852364|NCT03970837|365116077|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
105852365|NCT03970837|365116078|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
105852366|NCT03970837|365116079|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
105852367|NCT03970837|365116080|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
105852368|NCT03970837|365116081|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
105852369|NCT03970837|365116082|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
105852370|NCT03970837|365116083|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
105852371|NCT03970837|365116084|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
105852372|NCT03970837|365116085|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
105852373|NCT03970837|365116086|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
105326334|NCT03334435|363194804|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
105326335|NCT03334435|363194790|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
105326336|NCT03334435|363194791|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
105326337|NCT03334435|363194792|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
105326338|NCT03334435|363194793|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
105326339|NCT03334435|363194794|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
105326340|NCT03334435|363194795|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
105326341|NCT03334435|363194796|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
105326342|NCT03334435|363194797|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
105326343|NCT03334435|363194798|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
105326344|NCT03334435|363194799|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
105326345|NCT03334435|363194800|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
105326346|NCT03334435|363194801|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
105326347|NCT03334435|363194802|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
105326348|NCT03334435|363194803|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
105326349|NCT03334435|363194804|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
105326350|NCT03334435|363194790|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
105326351|NCT03334435|363194791|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
105326352|NCT03334435|363194792|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
105326353|NCT03334435|363194793|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
105326354|NCT03334435|363194794|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
105326355|NCT03334435|363194795|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
105326356|NCT03334435|363194796|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
105326357|NCT03334435|363194797|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
105326358|NCT03334435|363194798|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
105326359|NCT03334435|363194799|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
105326360|NCT03334435|363194800|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
105326361|NCT03334435|363194801|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
105326362|NCT03334435|363194802|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
105326363|NCT03334435|363194803|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
105326364|NCT03334435|363194804|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
105326365|NCT03334435|363194790|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105326366|NCT03334435|363194791|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105326367|NCT03334435|363194792|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105326368|NCT03334435|363194793|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105326369|NCT03334435|363194794|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105326370|NCT03334435|363194795|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105326371|NCT03334435|363194796|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105326372|NCT03334435|363194797|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105326373|NCT03334435|363194798|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105326374|NCT03334435|363194799|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105326375|NCT03334435|363194800|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105326376|NCT03334435|363194801|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
105326377|NCT03334435|363194802|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105326378|NCT03334435|363194803|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
105326379|NCT03334435|363194804|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105326380|NCT03334435|363194790|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
105326381|NCT03334435|363194791|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
105326382|NCT03334435|363194792|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
105326383|NCT03334435|363194793|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
105326384|NCT03334435|363194794|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
105326385|NCT03334435|363194795|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
105326386|NCT03334435|363194796|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
105326387|NCT03334435|363194797|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
105326388|NCT03334435|363194798|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
105326389|NCT03334435|363194799|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
105326390|NCT03334435|363194800|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
105326391|NCT03334435|363194801|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
105326392|NCT03334435|363194802|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
105326393|NCT03334435|363194803|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
105326394|NCT03334435|363194804|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
105326395|NCT03334435|363194790|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105326396|NCT03334435|363194791|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105326397|NCT03334435|363194792|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105326398|NCT03334435|363194793|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105326399|NCT03334435|363194794|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105326400|NCT03334435|363194795|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
105326401|NCT03334435|363194796|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
105326402|NCT03334435|363194797|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
105326403|NCT03334435|363194798|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
105326404|NCT03334435|363194799|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
105326405|NCT03334435|363194800|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
105326406|NCT03334435|363194801|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
105373155|NCT01898078|363374036|FG000|Overall Study|Reason not Specified|0|||
105373156|NCT01898078|363374037|FG001|Overall Study|Reason not Specified|1|||
105373157|NCT00703534|363374038|FG000|Overall Study|Adverse Event|14|||
105373158|NCT00703534|363374039|FG001|Overall Study|Adverse Event|3|||
105373159|NCT00703534|363374038|FG000|Overall Study|Withdrawal by Subject|8|||
105373160|NCT00703534|363374039|FG001|Overall Study|Withdrawal by Subject|7|||
105373161|NCT00703534|363374038|FG000|Overall Study|Incorrect Enrollment|6|||
105373162|NCT00703534|363374039|FG001|Overall Study|Incorrect Enrollment|6|||
105373163|NCT00703534|363374038|FG000|Overall Study|Lost to Follow-up|1|||
105373164|NCT00703534|363374039|FG001|Overall Study|Lost to Follow-up|4|||
105373165|NCT00703534|363374038|FG000|Overall Study|Severe Non Compliance|1|||
105373166|NCT00703534|363374039|FG001|Overall Study|Severe Non Compliance|5|||
105373167|NCT00089648|363374040|FG000|Overall Study|Adverse Event|7|||
105373168|NCT00089648|363374040|FG000|Overall Study|Withdrawal by Subject|1|||
105373169|NCT00089648|363374040|FG000|Overall Study|Lack of Efficacy|33|||
105373170|NCT00300053|363374042|FG000|Overall Study|Patient/Caregiver Preference|2|||
105373171|NCT00300053|363374043|FG001|Overall Study|Patient/Caregiver Preference|2|||
105373172|NCT00300053|363374044|FG002|Overall Study|Patient/Caregiver Preference|3|||
105373173|NCT00300053|363374042|FG000|Overall Study|Death|0|||
105373174|NCT00300053|363374043|FG001|Overall Study|Death|0|||
105373175|NCT00300053|363374044|FG002|Overall Study|Death|3|||
105373176|NCT00300053|363374042|FG000|Overall Study|Lost to Follow-up|0|||
105373177|NCT00300053|363374043|FG001|Overall Study|Lost to Follow-up|1|||
105373178|NCT00300053|363374044|FG002|Overall Study|Lost to Follow-up|0|||
105373179|NCT03183908|363374047|FG000|Overall Study|Missing Symptom Diary Data|0|||
105373180|NCT03183908|363374048|FG001|Overall Study|Missing Symptom Diary Data|2|||
105373181|NCT01134042|363374056|FG000|Overall Study|Adverse Event|3|||
105373182|NCT01134042|363374057|FG001|Overall Study|Adverse Event|7|||
105373183|NCT01134042|363374058|FG002|Overall Study|Adverse Event|2|||
105373184|NCT01134042|363374056|FG000|Overall Study|Lack of Efficacy|21|||
105373185|NCT01134042|363374057|FG001|Overall Study|Lack of Efficacy|6|||
105373186|NCT01134042|363374058|FG002|Overall Study|Lack of Efficacy|18|||
105373187|NCT01134042|363374056|FG000|Overall Study|Protocol Violation|5|||
105373188|NCT01134042|363374057|FG001|Overall Study|Protocol Violation|3|||
105373189|NCT01134042|363374058|FG002|Overall Study|Protocol Violation|5|||
105373190|NCT01134042|363374056|FG000|Overall Study|Lost to Follow-up|2|||
105373191|NCT01134042|363374057|FG001|Overall Study|Lost to Follow-up|0|||
105373192|NCT01134042|363374058|FG002|Overall Study|Lost to Follow-up|1|||
105326407|NCT03334435|363194802|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105852374|NCT03970837|365116087|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
105852375|NCT03970837|365116076|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105852376|NCT03970837|365116077|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105852377|NCT03970837|365116078|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105852378|NCT03970837|365116079|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105852379|NCT03970837|365116080|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105852380|NCT03970837|365116081|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105852381|NCT03970837|365116082|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
105852382|NCT03970837|365116083|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
105852383|NCT03970837|365116084|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
105852384|NCT03970837|365116085|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
105852385|NCT03970837|365116086|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
105852386|NCT03970837|365116087|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
105852387|NCT05327816|365117986|FG000|Overall Study|Lost to Follow-up|1|||
105852388|NCT05327816|365117987|FG001|Overall Study|Lost to Follow-up|0|||
105326408|NCT03334435|363194803|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105326409|NCT03334435|363194804|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105326410|NCT03334435|363194790|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105326411|NCT03334435|363194791|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105326412|NCT03334435|363194792|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105326413|NCT03334435|363194793|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105326414|NCT03334435|363194794|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105326415|NCT03334435|363194795|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
105326416|NCT03334435|363194796|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
105326417|NCT03334435|363194797|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105326418|NCT03334435|363194798|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105373193|NCT01134042|363374056|FG000|Overall Study|Physician Decision|4|||
105373194|NCT01134042|363374057|FG001|Overall Study|Physician Decision|8|||
105373195|NCT01134042|363374058|FG002|Overall Study|Physician Decision|1|||
105852389|NCT05327816|365117988|FG002|Overall Study|Lost to Follow-up|0|||
105373196|NCT01134042|363374056|FG000|Overall Study|Withdrawal by Subject|13|||
105373197|NCT01134042|363374057|FG001|Overall Study|Withdrawal by Subject|4|||
105373198|NCT01134042|363374058|FG002|Overall Study|Withdrawal by Subject|7|||
105852390|NCT05327816|365117989|FG003|Overall Study|Lost to Follow-up|0|||
105852391|NCT05327816|365117990|FG004|Overall Study|Lost to Follow-up|0|||
105852392|NCT05327816|365117991|FG005|Overall Study|Lost to Follow-up|0|||
105852393|NCT05327816|365117992|FG006|Overall Study|Lost to Follow-up|0|||
105852394|NCT05327816|365117993|FG007|Overall Study|Lost to Follow-up|0|||
105852395|NCT05327816|365117994|FG008|Overall Study|Lost to Follow-up|0|||
105852396|NCT05327816|365117995|FG009|Overall Study|Lost to Follow-up|1|||
105852397|NCT05327816|365117996|FG010|Overall Study|Lost to Follow-up|0|||
105852398|NCT05327816|365117986|FG000|Overall Study|Withdrawal by Subject|0|||
105852399|NCT05327816|365117987|FG001|Overall Study|Withdrawal by Subject|0|||
105852400|NCT05327816|365117988|FG002|Overall Study|Withdrawal by Subject|0|||
105852401|NCT05327816|365117989|FG003|Overall Study|Withdrawal by Subject|0|||
105852402|NCT05327816|365117990|FG004|Overall Study|Withdrawal by Subject|1|||
105852403|NCT05327816|365117991|FG005|Overall Study|Withdrawal by Subject|1|||
105852404|NCT05327816|365117992|FG006|Overall Study|Withdrawal by Subject|0|||
105852405|NCT05327816|365117993|FG007|Overall Study|Withdrawal by Subject|0|||
105852406|NCT05327816|365117994|FG008|Overall Study|Withdrawal by Subject|0|||
105852407|NCT05327816|365117995|FG009|Overall Study|Withdrawal by Subject|0|||
105852408|NCT05327816|365117996|FG010|Overall Study|Withdrawal by Subject|0|||
105852409|NCT05327816|365117986|FG000|Overall Study|Study Terminated by Sponsor|11|||
105852410|NCT05327816|365117987|FG001|Overall Study|Study Terminated by Sponsor|12|||
105852411|NCT05327816|365117988|FG002|Overall Study|Study Terminated by Sponsor|12|||
105852412|NCT05327816|365117989|FG003|Overall Study|Study Terminated by Sponsor|12|||
105852413|NCT05327816|365117990|FG004|Overall Study|Study Terminated by Sponsor|11|||
105852414|NCT05327816|365117991|FG005|Overall Study|Study Terminated by Sponsor|11|||
105852415|NCT05327816|365117992|FG006|Overall Study|Study Terminated by Sponsor|11|||
105852416|NCT05327816|365117993|FG007|Overall Study|Study Terminated by Sponsor|11|||
105852417|NCT05327816|365117994|FG008|Overall Study|Study Terminated by Sponsor|11|||
105852418|NCT05327816|365117995|FG009|Overall Study|Study Terminated by Sponsor|11|||
105852419|NCT05327816|365117996|FG010|Overall Study|Study Terminated by Sponsor|12|||
105852420|NCT05327816|365117986|FG000|Overall Study|Randomized but not treated|0|||
105852421|NCT05327816|365117987|FG001|Overall Study|Randomized but not treated|0|||
105852422|NCT05327816|365117988|FG002|Overall Study|Randomized but not treated|0|||
105852423|NCT05327816|365117989|FG003|Overall Study|Randomized but not treated|0|||
105852424|NCT05327816|365117990|FG004|Overall Study|Randomized but not treated|0|||
105852425|NCT05327816|365117991|FG005|Overall Study|Randomized but not treated|0|||
105852426|NCT05327816|365117992|FG006|Overall Study|Randomized but not treated|1|||
105852427|NCT05327816|365117993|FG007|Overall Study|Randomized but not treated|1|||
105852428|NCT05327816|365117994|FG008|Overall Study|Randomized but not treated|1|||
105852429|NCT05327816|365117995|FG009|Overall Study|Randomized but not treated|0|||
105852430|NCT05327816|365117996|FG010|Overall Study|Randomized but not treated|0|||
105852431|NCT00792935|365117997|FG000|Overall Study|Adverse Event|2|||
105852432|NCT00792935|365117998|FG001|Overall Study|Adverse Event|1|||
105852433|NCT00792935|365117997|FG000|Overall Study|Lost to Follow-up|0|||
105852434|NCT00792935|365117998|FG001|Overall Study|Lost to Follow-up|1|||
105852435|NCT00792935|365117997|FG000|Overall Study|Protocol Violation|2|||
105852436|NCT00792935|365117998|FG001|Overall Study|Protocol Violation|0|||
105852437|NCT00792935|365117997|FG000|Overall Study|Withdrawal by Subject|0|||
105852438|NCT00792935|365117998|FG001|Overall Study|Withdrawal by Subject|1|||
105852439|NCT03665441|365117999|FG000|Overall Study|survival follow up ongoing|23|||
105852440|NCT03665441|365118000|FG001|Overall Study|survival follow up ongoing|0|||
105852441|NCT03665441|365117999|FG000|Overall Study|Patients ongoing on treatment|9|||
105852442|NCT03665441|365118000|FG001|Overall Study|Patients ongoing on treatment|6|||
105852443|NCT03665441|365117999|FG000|Overall Study|Randomized but not treated|7|||
105852444|NCT03665441|365118000|FG001|Overall Study|Randomized but not treated|11|||
105852445|NCT02213510|365118001|FG000|Overall Study|Death|0|||
105852446|NCT02213510|365118002|FG001|Overall Study|Death|1|||
105852447|NCT02213510|365118001|FG000|Overall Study|Lost to Follow-up|1|||
105852448|NCT02213510|365118002|FG001|Overall Study|Lost to Follow-up|0|||
105852449|NCT04325204|365118004|FG000|Overall Study|Death|0|||
105852450|NCT04325204|365118005|FG001|Overall Study|Death|1|||
105852451|NCT04325204|365118004|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
105852452|NCT04325204|365118005|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
105852453|NCT04325204|365118004|FG000|Overall Study|Lost to Follow-up|8|||
105852454|NCT04325204|365118005|FG001|Overall Study|Lost to Follow-up|8|||
105852455|NCT04325204|365118004|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
105852456|NCT04325204|365118005|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
105852457|NCT04234984|365118006|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
105852458|NCT04234984|365118006|FG000|Follow-up at the Second Time Point|Death|1|||
105852459|NCT04234984|365118006|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
105852460|NCT05183217|365118007|FG000|Overall Study|Withdrawal by Subject|1|||
105852461|NCT05183217|365118008|FG001|Overall Study|Withdrawal by Subject|1|||
105852462|NCT02524730|365118010|FG000|Overall Study|Lost to Follow-up|5|||
105852463|NCT02524730|365118010|FG000|Overall Study|Withdrawal by Subject|18|||
105852464|NCT02524730|365118010|FG000|Overall Study|Death|10|||
105852465|NCT02524730|365118010|FG000|Overall Study|Adverse Event|8|||
105852466|NCT02524730|365118010|FG000|Overall Study|Protocol Violation|1|||
105326419|NCT03334435|363194799|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105326420|NCT03334435|363194800|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105326421|NCT03334435|363194801|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
105852467|NCT02524730|365118010|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
105852468|NCT03783039|365118011|FG000|Overall Study|Death|2|||
105852469|NCT03783039|365118012|FG001|Overall Study|Death|1|||
105852470|NCT00977379|365118013|FG000|Overall Study|Withdrawal by Subject|1|||
105852471|NCT00977379|365118014|FG001|Overall Study|Withdrawal by Subject|1|||
105852472|NCT00977379|365118013|FG000|Overall Study|Death|7|||
105852473|NCT00977379|365118014|FG001|Overall Study|Death|9|||
105852474|NCT00977379|365118013|FG000|Overall Study|Premature Study Termination|4|||
105852475|NCT00977379|365118014|FG001|Overall Study|Premature Study Termination|0|||
105852476|NCT00977379|365118013|FG000|Overall Study|Participant Moving House|0|||
105852477|NCT00977379|365118014|FG001|Overall Study|Participant Moving House|1|||
105852478|NCT00977379|365118013|FG000|Overall Study|Randomization Error|0|||
105852479|NCT00977379|365118014|FG001|Overall Study|Randomization Error|1|||
105852480|NCT02603393|365118017|FG000|Overall Study|Patient/guardian decision|32|||
105852481|NCT02603393|365118018|FG001|Overall Study|Patient/guardian decision|18|||
105852482|NCT02603393|365118017|FG000|Overall Study|Adverse Event|17|||
105852483|NCT02603393|365118018|FG001|Overall Study|Adverse Event|15|||
105852484|NCT02603393|365118017|FG000|Overall Study|Technical problems|4|||
105852485|NCT02603393|365118018|FG001|Overall Study|Technical problems|7|||
105852486|NCT02603393|365118017|FG000|Overall Study|Lack of Efficacy|7|||
105852487|NCT02603393|365118018|FG001|Overall Study|Lack of Efficacy|2|||
105852488|NCT02603393|365118017|FG000|Overall Study|Death|3|||
105852489|NCT02603393|365118018|FG001|Overall Study|Death|4|||
105852490|NCT02603393|365118017|FG000|Overall Study|Physician Decision|3|||
105852491|NCT02603393|365118018|FG001|Overall Study|Physician Decision|3|||
105852492|NCT02603393|365118017|FG000|Overall Study|Protocol deviation|2|||
105852493|NCT02603393|365118018|FG001|Overall Study|Protocol deviation|3|||
105852494|NCT02603393|365118017|FG000|Overall Study|Lost to Follow-up|1|||
105852495|NCT02603393|365118018|FG001|Overall Study|Lost to Follow-up|2|||
105852496|NCT02603393|365118017|FG000|Overall Study|Non-compliance with study treatment|1|||
105852497|NCT02603393|365118018|FG001|Overall Study|Non-compliance with study treatment|0|||
105852498|NCT02603393|365118017|FG000|Overall Study|Sponsor decision|1|||
105852499|NCT02603393|365118018|FG001|Overall Study|Sponsor decision|0|||
105852500|NCT01359969|365118019|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
105852501|NCT00593736|365118022|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
105852502|NCT00593736|365118023|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
105852503|NCT00593736|365118024|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
105852504|NCT00593736|365118025|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
105852505|NCT00593736|365118022|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
105852506|NCT00593736|365118023|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
105852507|NCT00593736|365118024|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
105852508|NCT00593736|365118025|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
105852509|NCT00593736|365118022|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
105852510|NCT00593736|365118023|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
105852511|NCT00593736|365118024|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
105852512|NCT00593736|365118025|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
105852513|NCT00593736|365118022|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
105852514|NCT00593736|365118023|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
105852515|NCT00593736|365118024|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
105852516|NCT00593736|365118025|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
105852517|NCT00593736|365118022|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
105852518|NCT00593736|365118023|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
105852519|NCT00593736|365118024|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
105852520|NCT00593736|365118025|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
105852521|NCT00593736|365118022|FG000|Screening Period and Placebo Run-in|Various|0|||
105852522|NCT00593736|365118023|FG001|Screening Period and Placebo Run-in|Various|0|||
105852523|NCT00593736|365118024|FG002|Screening Period and Placebo Run-in|Various|0|||
105852524|NCT00593736|365118025|FG003|Screening Period and Placebo Run-in|Various|25|||
105852525|NCT00593736|365118022|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
105852526|NCT00593736|365118023|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
105852527|NCT00593736|365118024|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
105852528|NCT00593736|365118025|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
105852529|NCT00593736|365118022|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
105852530|NCT00593736|365118023|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
105852531|NCT00593736|365118024|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
105852532|NCT00593736|365118025|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
105852533|NCT00593736|365118022|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
105326422|NCT03334435|363194802|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
105852534|NCT00593736|365118023|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
105852535|NCT00593736|365118024|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
105852536|NCT00593736|365118025|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
105852537|NCT00593736|365118022|FG000|Treatment Period and Placebo Run-out|Various|1|||
105852538|NCT00593736|365118023|FG001|Treatment Period and Placebo Run-out|Various|1|||
105852539|NCT00593736|365118024|FG002|Treatment Period and Placebo Run-out|Various|1|||
105852540|NCT00593736|365118025|FG003|Treatment Period and Placebo Run-out|Various|0|||
105852541|NCT01857271|365118026|FG000|Overall Study|Lost to Follow-up|1|||
105852542|NCT04645966|365118027|FG000|Vaccination Phase|Adverse Event|1|||
105852543|NCT04645966|365118028|FG001|Vaccination Phase|Adverse Event|0|||
105852544|NCT04645966|365118029|FG002|Vaccination Phase|Adverse Event|0|||
105852545|NCT04645966|365118030|FG003|Vaccination Phase|Adverse Event|0|||
105852546|NCT04645966|365118031|FG004|Vaccination Phase|Adverse Event|0|||
105326423|NCT03334435|363194803|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
105852547|NCT04645966|365118032|FG005|Vaccination Phase|Adverse Event|0|||
105852548|NCT04645966|365118033|FG006|Vaccination Phase|Adverse Event|1|||
105852549|NCT04645966|365118034|FG007|Vaccination Phase|Adverse Event|0|||
105852550|NCT04645966|365118035|FG008|Vaccination Phase|Adverse Event|0|||
105852551|NCT04645966|365118027|FG000|Vaccination Phase|Death|0|||
105852552|NCT04645966|365118028|FG001|Vaccination Phase|Death|0|||
105852553|NCT04645966|365118029|FG002|Vaccination Phase|Death|0|||
105852554|NCT04645966|365118030|FG003|Vaccination Phase|Death|0|||
105852555|NCT04645966|365118031|FG004|Vaccination Phase|Death|0|||
105852556|NCT04645966|365118032|FG005|Vaccination Phase|Death|1|||
105852557|NCT04645966|365118033|FG006|Vaccination Phase|Death|0|||
105852558|NCT04645966|365118034|FG007|Vaccination Phase|Death|0|||
105852559|NCT04645966|365118035|FG008|Vaccination Phase|Death|0|||
105852560|NCT04645966|365118027|FG000|Vaccination Phase|Protocol Violation|0|||
105852561|NCT04645966|365118028|FG001|Vaccination Phase|Protocol Violation|0|||
105852562|NCT04645966|365118029|FG002|Vaccination Phase|Protocol Violation|0|||
105852563|NCT04645966|365118030|FG003|Vaccination Phase|Protocol Violation|0|||
105852564|NCT04645966|365118031|FG004|Vaccination Phase|Protocol Violation|1|||
105852565|NCT04645966|365118032|FG005|Vaccination Phase|Protocol Violation|0|||
105852566|NCT04645966|365118033|FG006|Vaccination Phase|Protocol Violation|0|||
105852567|NCT04645966|365118034|FG007|Vaccination Phase|Protocol Violation|0|||
105852568|NCT04645966|365118035|FG008|Vaccination Phase|Protocol Violation|0|||
105852569|NCT04645966|365118027|FG000|Vaccination Phase|Study terminated by sponsor|0|||
105852570|NCT04645966|365118028|FG001|Vaccination Phase|Study terminated by sponsor|0|||
105852571|NCT04645966|365118029|FG002|Vaccination Phase|Study terminated by sponsor|14|||
105852572|NCT04645966|365118030|FG003|Vaccination Phase|Study terminated by sponsor|15|||
105852573|NCT04645966|365118031|FG004|Vaccination Phase|Study terminated by sponsor|47|||
105852574|NCT04645966|365118032|FG005|Vaccination Phase|Study terminated by sponsor|43|||
105852575|NCT04645966|365118033|FG006|Vaccination Phase|Study terminated by sponsor|29|||
105852576|NCT04645966|365118034|FG007|Vaccination Phase|Study terminated by sponsor|29|||
105852577|NCT04645966|365118035|FG008|Vaccination Phase|Study terminated by sponsor|12|||
105852578|NCT04645966|365118027|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
105852579|NCT04645966|365118028|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
105852580|NCT04645966|365118029|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
105852581|NCT04645966|365118030|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
105852582|NCT04645966|365118031|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
105852583|NCT04645966|365118032|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
105852584|NCT04645966|365118033|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
105852585|NCT04645966|365118034|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
105852586|NCT04645966|365118035|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
105852587|NCT04645966|365118027|FG000|Vaccination Phase|Other|0|||
105852588|NCT04645966|365118028|FG001|Vaccination Phase|Other|0|||
105852589|NCT04645966|365118029|FG002|Vaccination Phase|Other|0|||
105852590|NCT04645966|365118030|FG003|Vaccination Phase|Other|0|||
105852591|NCT04645966|365118031|FG004|Vaccination Phase|Other|0|||
105852592|NCT04645966|365118032|FG005|Vaccination Phase|Other|2|||
105852593|NCT04645966|365118033|FG006|Vaccination Phase|Other|0|||
105852594|NCT04645966|365118034|FG007|Vaccination Phase|Other|0|||
105852595|NCT04645966|365118035|FG008|Vaccination Phase|Other|0|||
105852596|NCT04645966|365118027|FG000|Vaccination Phase|Lost to Follow-up|0|||
105852597|NCT04645966|365118028|FG001|Vaccination Phase|Lost to Follow-up|0|||
105852598|NCT04645966|365118029|FG002|Vaccination Phase|Lost to Follow-up|0|||
105852599|NCT04645966|365118030|FG003|Vaccination Phase|Lost to Follow-up|0|||
105852600|NCT04645966|365118031|FG004|Vaccination Phase|Lost to Follow-up|0|||
105852601|NCT04645966|365118032|FG005|Vaccination Phase|Lost to Follow-up|0|||
105852602|NCT04645966|365118033|FG006|Vaccination Phase|Lost to Follow-up|0|||
105326424|NCT03334435|363194804|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
105326425|NCT03334435|363194790|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105852603|NCT04645966|365118034|FG007|Vaccination Phase|Lost to Follow-up|1|||
105852604|NCT04645966|365118035|FG008|Vaccination Phase|Lost to Follow-up|0|||
105852605|NCT04645966|365118027|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
105373199|NCT01118299|363374059|FG000|Overall Study|Death|7|||
105373200|NCT01118299|363374060|FG001|Overall Study|Death|5|||
105373201|NCT01118299|363374059|FG000|Overall Study|Withdrawal by Subject|8|||
105373202|NCT01118299|363374060|FG001|Overall Study|Withdrawal by Subject|8|||
105373203|NCT01118299|363374059|FG000|Overall Study|Lost to Follow-up|2|||
105373204|NCT01118299|363374060|FG001|Overall Study|Lost to Follow-up|1|||
105373205|NCT01118299|363374059|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
105373206|NCT01118299|363374060|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
105373207|NCT04459338|363374061|FG000|Overall Study|Loss of IV during study|1|||
105373208|NCT04459338|363374062|FG001|Overall Study|Loss of IV during study|0|||
105373209|NCT02690727|363374063|FG000|Overall Study|Adverse Event|2|||
105373210|NCT02690727|363374064|FG001|Overall Study|Adverse Event|2|||
105373211|NCT01983930|363374065|FG000|Overall Study|Withdrawal by Subject|9|||
105373212|NCT01983930|363374066|FG001|Overall Study|Withdrawal by Subject|8|||
105373213|NCT01983930|363374065|FG000|Overall Study|Adverse Event|0|||
105373214|NCT01983930|363374066|FG001|Overall Study|Adverse Event|1|||
105373215|NCT00656617|363374069|FG000|Overall Study|Adverse Event|1|||
105373216|NCT00656617|363374069|FG000|Overall Study|Death|2|||
105373217|NCT00656617|363374069|FG000|Overall Study|Insurance Issues|2|||
105373218|NCT00656617|363374069|FG000|Overall Study|Move to different clinical trial|2|||
105373219|NCT00671749|363374070|FG000|Overall Study|Adverse Event|2|||
105373220|NCT00671749|363374070|FG000|Overall Study|Withdrawal by Subject|4|||
105373221|NCT00671749|363374070|FG000|Overall Study|Protocol Violation|1|||
105373222|NCT00671749|363374070|FG000|Overall Study|Lost to Follow-up|1|||
105373223|NCT02515227|363374071|FG000|Overall Study|Adverse Event|0|||
105373224|NCT02515227|363374072|FG001|Overall Study|Adverse Event|2|||
105373225|NCT02515227|363374071|FG000|Overall Study|Progressive disease|2|||
105373226|NCT02515227|363374072|FG001|Overall Study|Progressive disease|9|||
105373227|NCT03473197|363374073|FG000|Overall Study|Adverse Event|4|||
105373228|NCT03473197|363374073|FG000|Overall Study|Lost to Follow-up|1|||
105373229|NCT03473197|363374073|FG000|Overall Study|Withdrawal by Subject|5|||
105373230|NCT00785629|363374074|FG000|Overall Study|Adverse Event|2|||
105373231|NCT00785629|363374075|FG001|Overall Study|Adverse Event|1|||
105373232|NCT00785629|363374076|FG002|Overall Study|Adverse Event|1|||
105373233|NCT00785629|363374077|FG003|Overall Study|Adverse Event|5|||
105373234|NCT00785629|363374074|FG000|Overall Study|Protocol Violation|1|||
105373235|NCT00785629|363374075|FG001|Overall Study|Protocol Violation|2|||
105373236|NCT00785629|363374076|FG002|Overall Study|Protocol Violation|4|||
105373237|NCT00785629|363374077|FG003|Overall Study|Protocol Violation|5|||
105373238|NCT00785629|363374074|FG000|Overall Study|administrative decision|5|||
105373239|NCT00785629|363374075|FG001|Overall Study|administrative decision|1|||
105373240|NCT00785629|363374076|FG002|Overall Study|administrative decision|3|||
105373241|NCT00785629|363374077|FG003|Overall Study|administrative decision|4|||
105373242|NCT00785629|363374074|FG000|Overall Study|Withdrawal by Subject|0|||
105373243|NCT00785629|363374075|FG001|Overall Study|Withdrawal by Subject|1|||
105373244|NCT00785629|363374076|FG002|Overall Study|Withdrawal by Subject|2|||
105373245|NCT00785629|363374077|FG003|Overall Study|Withdrawal by Subject|2|||
105373246|NCT00634504|363374079|FG000|Overall Study|Protocol Violation|1|||
105373247|NCT00634504|363374080|FG001|Overall Study|Protocol Violation|0|||
105373248|NCT03482024|363374081|FG000|Overall Study|Physician Decision|1|||
105373249|NCT03482024|363374082|FG001|Overall Study|Physician Decision|0|||
105373250|NCT03482024|363374083|FG002|Overall Study|Physician Decision|0|||
105373251|NCT03482024|363374084|FG003|Overall Study|Physician Decision|0|||
105373252|NCT03482024|363374085|FG004|Overall Study|Physician Decision|0|||
105373253|NCT02736617|363374086|FG000|Treatment|Adverse Event|1|||
105373254|NCT02736617|363374086|FG000|Treatment|Lack of Efficacy|1|||
105373255|NCT02736617|363374086|FG000|Treatment|Withdrawal by Subject|1|||
105373256|NCT02736617|363374086|FG000|Maintenance|Lack of Efficacy|4|||
105373257|NCT02736617|363374086|FG000|Maintenance|Physician Decision|1|||
105373258|NCT02469857|363374089|FG000|Overall Study|Death|24|||
105373259|NCT02469857|363374090|FG001|Overall Study|Death|29|||
105373260|NCT02469857|363374089|FG000|Overall Study|Discontinuation|1|||
105373261|NCT02469857|363374090|FG001|Overall Study|Discontinuation|3|||
105373262|NCT00147238|363374091|FG000|Overall Study|Inevaluable|8|||
105373263|NCT04424901|363374092|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
105373264|NCT04424901|363374093|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
105373265|NCT00537277|363374094|FG000|Overall Study|Adverse Event|1|||
105373266|NCT00537277|363374094|FG000|Overall Study|Lack of Efficacy|2|||
105373267|NCT00537277|363374094|FG000|Overall Study|Lost to Follow-up|12|||
105373268|NCT00537277|363374094|FG000|Overall Study|Protocol Violation|11|||
105373269|NCT00537277|363374094|FG000|Overall Study|Unclassified|4|||
105373270|NCT00537277|363374094|FG000|Overall Study|Inability to tolerate trial medication|4|||
105373271|NCT00537277|363374094|FG000|Overall Study|Non-compliance with trial procedures|15|||
105373272|NCT04009837|363374095|FG000|Overall Study|Withdrawal by Subject|5|||
105373273|NCT04009837|363374096|FG001|Overall Study|Withdrawal by Subject|4|||
105373274|NCT04009837|363374095|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
105373275|NCT04009837|363374096|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
105373276|NCT00112957|363374099|FG000|Overall Study|Progressive disease|18|||
105491969|NCT01854658|363813919|FG001|Overall Study|Withdrawal by Subject|21|||
105491970|NCT01854658|363813920|FG002|Overall Study|Withdrawal by Subject|29|||
105491971|NCT01854658|363813921|FG003|Overall Study|Withdrawal by Subject|15|||
105491972|NCT01854658|363813918|FG000|Overall Study|Protocol-specified criteria|15|||
105491973|NCT01854658|363813919|FG001|Overall Study|Protocol-specified criteria|15|||
105491974|NCT01854658|363813920|FG002|Overall Study|Protocol-specified criteria|10|||
105491975|NCT01854658|363813921|FG003|Overall Study|Protocol-specified criteria|7|||
105491976|NCT01854658|363813918|FG000|Overall Study|Lack of Efficacy|3|||
105491977|NCT01854658|363813919|FG001|Overall Study|Lack of Efficacy|8|||
105491978|NCT01854658|363813920|FG002|Overall Study|Lack of Efficacy|4|||
105491979|NCT01854658|363813921|FG003|Overall Study|Lack of Efficacy|7|||
105491980|NCT01854658|363813918|FG000|Overall Study|Adverse Event|21|||
105491981|NCT01854658|363813919|FG001|Overall Study|Adverse Event|14|||
105491982|NCT01854658|363813920|FG002|Overall Study|Adverse Event|23|||
105491983|NCT01854658|363813921|FG003|Overall Study|Adverse Event|19|||
105491984|NCT01854658|363813918|FG000|Overall Study|Administrative reasons|5|||
105491985|NCT01854658|363813919|FG001|Overall Study|Administrative reasons|1|||
105491986|NCT01854658|363813920|FG002|Overall Study|Administrative reasons|2|||
105491987|NCT01854658|363813921|FG003|Overall Study|Administrative reasons|2|||
105491988|NCT01795638|363813922|FG000|Overall Study|Death|0|||
105491989|NCT01795638|363813923|FG001|Overall Study|Death|3|||
105491990|NCT01795638|363813922|FG000|Overall Study|transferred to quaternary hospital|2|||
105491991|NCT01795638|363813923|FG001|Overall Study|transferred to quaternary hospital|3|||
105491992|NCT01795638|363813922|FG000|Overall Study|Protocol Violation|3|||
105491993|NCT01795638|363813923|FG001|Overall Study|Protocol Violation|0|||
105491994|NCT01795638|363813922|FG000|Overall Study|discharged from hospital|7|||
105491995|NCT01795638|363813923|FG001|Overall Study|discharged from hospital|5|||
105491996|NCT01795638|363813922|FG000|Overall Study|Withdrawal by Subject|1|||
105491997|NCT01795638|363813923|FG001|Overall Study|Withdrawal by Subject|0|||
105491998|NCT03875118|363813924|FG000|Overall Study|Withdrawal by Subject|4|||
105491999|NCT03875118|363813925|FG001|Overall Study|Withdrawal by Subject|4|||
105492000|NCT01442038|363813926|FG000|Overall Study|Death|35|||
105492001|NCT01442038|363813927|FG001|Overall Study|Death|29|||
105492002|NCT01442038|363813926|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
105492003|NCT01442038|363813927|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
105492004|NCT01442038|363813926|FG000|Overall Study|Participant Withdrew Consent|137|||
105492005|NCT01442038|363813927|FG001|Overall Study|Participant Withdrew Consent|102|||
105492006|NCT01442038|363813926|FG000|Overall Study|Lost to Follow-up|37|||
105577081|NCT00849680|364112169|FG005|Overall Study|Subject moved|2|||
105852606|NCT04645966|365118028|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
105852607|NCT04645966|365118029|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
105852608|NCT04645966|365118030|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
105852609|NCT04645966|365118031|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
105852610|NCT04645966|365118032|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
105852611|NCT04645966|365118033|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
105326426|NCT03334435|363194791|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105373277|NCT00112957|363374099|FG000|Overall Study|Physician Decision|1|||
105373278|NCT00797563|363374100|FG000|Overall Study|Adverse Event|1|||
105373279|NCT00961415|363374103|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
105373280|NCT00961415|363374104|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
105373281|NCT00961415|363374105|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
105373282|NCT00961415|363374103|FG000|Induction Treatment Phase|Death|77|||
105373283|NCT00961415|363374104|FG001|Induction Treatment Phase|Death|0|||
105373284|NCT00961415|363374105|FG002|Induction Treatment Phase|Death|0|||
105373285|NCT00961415|363374103|FG000|Induction Treatment Phase|Protocol Violation|1|||
105373286|NCT00961415|363374104|FG001|Induction Treatment Phase|Protocol Violation|0|||
105373287|NCT00961415|363374105|FG002|Induction Treatment Phase|Protocol Violation|0|||
105373288|NCT00961415|363374103|FG000|Induction Treatment Phase|Physician Decision|2|||
105373289|NCT00961415|363374104|FG001|Induction Treatment Phase|Physician Decision|0|||
105577082|NCT00849680|364112170|FG006|Overall Study|Subject moved|2|||
105326427|NCT03334435|363194792|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105326428|NCT03334435|363194793|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105326429|NCT03334435|363194794|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105326430|NCT03334435|363194795|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
105326431|NCT03334435|363194796|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105326432|NCT03334435|363194797|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105326433|NCT03334435|363194798|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105326434|NCT03334435|363194799|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105492007|NCT01442038|363813927|FG001|Overall Study|Lost to Follow-up|51|||
105492008|NCT01442038|363813926|FG000|Overall Study|Adverse Event|26|||
105492009|NCT01442038|363813927|FG001|Overall Study|Adverse Event|15|||
105492010|NCT01442038|363813926|FG000|Overall Study|Protocol Deviation|9|||
105492011|NCT01442038|363813927|FG001|Overall Study|Protocol Deviation|20|||
105373290|NCT00961415|363374105|FG002|Induction Treatment Phase|Physician Decision|0|||
105373291|NCT00961415|363374103|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
105373292|NCT00961415|363374104|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
105373293|NCT00961415|363374105|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
105373294|NCT00961415|363374103|FG000|Induction Treatment Phase|Other Reason|5|||
105852612|NCT04645966|365118034|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
105852613|NCT04645966|365118035|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
105852614|NCT04645966|365118027|FG000|Follow-up Phase|Lost to Follow-up|0|||
105852615|NCT04645966|365118028|FG001|Follow-up Phase|Lost to Follow-up|0|||
105852616|NCT04645966|365118029|FG002|Follow-up Phase|Lost to Follow-up|0|||
105852617|NCT04645966|365118030|FG003|Follow-up Phase|Lost to Follow-up|0|||
105852618|NCT04645966|365118031|FG004|Follow-up Phase|Lost to Follow-up|0|||
105852619|NCT04645966|365118032|FG005|Follow-up Phase|Lost to Follow-up|0|||
105852620|NCT04645966|365118033|FG006|Follow-up Phase|Lost to Follow-up|0|||
105852621|NCT04645966|365118034|FG007|Follow-up Phase|Lost to Follow-up|1|||
105852622|NCT04645966|365118035|FG008|Follow-up Phase|Lost to Follow-up|0|||
105852623|NCT03825341|365118036|FG000|Overall Study|Withdrawal by Subject|0|||
105852624|NCT03825341|365118037|FG001|Overall Study|Withdrawal by Subject|1|||
105852625|NCT01735955|365118038|FG000|Overall Study|Administrative problems|1|||
105852626|NCT01735955|365118038|FG000|Overall Study|Patient/guardian decision|1|||
105852627|NCT01735955|365118038|FG000|Overall Study|Patient withdrew consent|2|||
105852628|NCT01735955|365118038|FG000|Overall Study|Physician Decision|4|||
105852629|NCT01735955|365118038|FG000|Overall Study|Disease progression|24|||
105852630|NCT01735955|365118038|FG000|Overall Study|Adverse Event|5|||
105852631|NCT01330459|365118039|FG000|Overall Study|Physician Decision|0|||
105852632|NCT01330459|365118040|FG001|Overall Study|Physician Decision|2|||
105852633|NCT00895947|365118041|FG000|Overall Study|Adverse Event|3|||
105852634|NCT00895947|365118042|FG001|Overall Study|Adverse Event|4|||
105852635|NCT00895947|365118041|FG000|Overall Study|Lost to Follow-up|3|||
105852636|NCT00895947|365118042|FG001|Overall Study|Lost to Follow-up|4|||
105852637|NCT00895947|365118041|FG000|Overall Study|Protocol Violation|4|||
105852638|NCT00895947|365118042|FG001|Overall Study|Protocol Violation|2|||
105852639|NCT00895947|365118041|FG000|Overall Study|Withdrawal by Subject|2|||
105852640|NCT00895947|365118042|FG001|Overall Study|Withdrawal by Subject|0|||
105852641|NCT04562155|365118045|FG000|Overall Study|COVID-19 pandemic|0|||
105852642|NCT04562155|365118046|FG001|Overall Study|COVID-19 pandemic|0|||
105852643|NCT04562155|365118047|FG002|Overall Study|COVID-19 pandemic|0|||
105852644|NCT04562155|365118048|FG003|Overall Study|COVID-19 pandemic|1|||
105852645|NCT04562155|365118045|FG000|Overall Study|Adverse Event|7|||
105852646|NCT04562155|365118046|FG001|Overall Study|Adverse Event|3|||
105852647|NCT04562155|365118047|FG002|Overall Study|Adverse Event|8|||
105852648|NCT04562155|365118048|FG003|Overall Study|Adverse Event|1|||
105852649|NCT04562155|365118045|FG000|Overall Study|Withdrawal by Subject|3|||
105852650|NCT04562155|365118046|FG001|Overall Study|Withdrawal by Subject|6|||
105852651|NCT04562155|365118047|FG002|Overall Study|Withdrawal by Subject|3|||
105852652|NCT04562155|365118048|FG003|Overall Study|Withdrawal by Subject|3|||
105326435|NCT03334435|363194800|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
105326436|NCT03334435|363194801|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105326437|NCT03334435|363194802|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105326438|NCT03334435|363194803|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105326439|NCT03334435|363194804|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
105326440|NCT03334435|363194790|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105326441|NCT03334435|363194791|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105326442|NCT03334435|363194792|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105326443|NCT03334435|363194793|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105326444|NCT03334435|363194794|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105326445|NCT03334435|363194795|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105326446|NCT03334435|363194796|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105326447|NCT03334435|363194797|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
105326448|NCT03334435|363194798|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
105326449|NCT03334435|363194799|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105326450|NCT03334435|363194800|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
105326451|NCT03334435|363194801|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
105326452|NCT03334435|363194802|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
105326453|NCT03334435|363194803|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105326454|NCT03334435|363194804|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105326455|NCT03334435|363194790|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105852653|NCT04562155|365118045|FG000|Overall Study|Participant personal reason|1|||
105852654|NCT04562155|365118046|FG001|Overall Study|Participant personal reason|0|||
105852655|NCT04562155|365118047|FG002|Overall Study|Participant personal reason|2|||
105852656|NCT04562155|365118048|FG003|Overall Study|Participant personal reason|1|||
105373295|NCT00961415|363374104|FG001|Induction Treatment Phase|Other Reason|0|||
105577083|NCT00849680|364112171|FG007|Overall Study|Subject moved|2|||
105326456|NCT03334435|363194791|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105326457|NCT03334435|363194792|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105326458|NCT03334435|363194793|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105326459|NCT03334435|363194794|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105326460|NCT03334435|363194795|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105326461|NCT03334435|363194796|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105326462|NCT03334435|363194797|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105326463|NCT03334435|363194798|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105326464|NCT03334435|363194799|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105326465|NCT03334435|363194800|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105326466|NCT03334435|363194801|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
105326467|NCT03334435|363194802|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105326468|NCT03334435|363194803|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
105326469|NCT03334435|363194804|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
105326470|NCT03922321|363194805|FG000|Overall Study|Participant Moved|1|||
105326471|NCT03922321|363194805|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
105326472|NCT03597295|363194813|FG000|Overall Study|Death|70|||
105326473|NCT03597295|363194813|FG000|Overall Study|Lost to Follow-up|7|||
105326474|NCT04067050|363194814|FG000|One Month|Lost to Follow-up|4|||
105326475|NCT04067050|363194815|FG001|One Month|Lost to Follow-up|0|||
105326476|NCT04067050|363194814|FG000|Two Month|Lost to Follow-up|1|||
105326477|NCT04067050|363194815|FG001|Two Month|Lost to Follow-up|0|||
105326478|NCT04067050|363194814|FG000|Two Month|Adverse Event|1|||
105326479|NCT04067050|363194815|FG001|Two Month|Adverse Event|0|||
105326480|NCT03270657|363194826|FG000|Overall Study|Withdrawal by Subject|1|||
105326481|NCT00513240|363194827|FG000|Overall Study|Did not have intended surgery|3|||
105326482|NCT00513240|363194828|FG001|Overall Study|Did not have intended surgery|0|||
105326483|NCT00513240|363194827|FG000|Overall Study|Death|3|||
105326484|NCT00513240|363194828|FG001|Overall Study|Death|3|||
105326485|NCT00513240|363194827|FG000|Overall Study|Withdrawal by Subject|7|||
105326486|NCT00513240|363194828|FG001|Overall Study|Withdrawal by Subject|4|||
105326487|NCT00162981|363194829|FG000|Overall Study|Adverse Event|2|||
105326488|NCT00162981|363194830|FG001|Overall Study|Adverse Event|5|||
105326489|NCT00162981|363194829|FG000|Overall Study|Withdrawal by Subject|1|||
105326490|NCT00162981|363194830|FG001|Overall Study|Withdrawal by Subject|1|||
105326491|NCT00162981|363194829|FG000|Overall Study|Physician Decision|1|||
105326492|NCT00162981|363194830|FG001|Overall Study|Physician Decision|0|||
105326493|NCT03871543|363194832|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
105326494|NCT03871543|363194832|FG000|Period 1|Investigator Error|1|||
105326495|NCT03871543|363194832|FG000|Period 1|Protocol Violation|2|||
105326496|NCT03871543|363194832|FG000|Period 1|COVID-19 Related|1|||
105326497|NCT03871543|363194832|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
105326498|NCT03871543|363194832|FG000|Period 1|Withdrawal by Subject|10|||
105326499|NCT03871543|363194832|FG000|Period 2|Adverse Event|1|||
105326500|NCT03871543|363194832|FG000|Period 2|Withdrawal by Subject|1|||
105326501|NCT01894919|363194839|FG000|Overall Study|Withdrawal by Subject|1|||
105326502|NCT01894919|363194840|FG001|Overall Study|Withdrawal by Subject|0|||
105326503|NCT01894919|363194841|FG002|Overall Study|Withdrawal by Subject|0|||
105326504|NCT01894919|363194842|FG003|Overall Study|Withdrawal by Subject|0|||
105326505|NCT01894919|363194843|FG004|Overall Study|Withdrawal by Subject|1|||
105326506|NCT01894919|363194844|FG005|Overall Study|Withdrawal by Subject|0|||
105326507|NCT01894919|363194845|FG006|Overall Study|Withdrawal by Subject|0|||
105326508|NCT01894919|363194846|FG007|Overall Study|Withdrawal by Subject|0|||
105326509|NCT01894919|363194847|FG008|Overall Study|Withdrawal by Subject|0|||
105326510|NCT01894919|363194848|FG009|Overall Study|Withdrawal by Subject|1|||
105326511|NCT01894919|363194849|FG010|Overall Study|Withdrawal by Subject|1|||
105326512|NCT01894919|363194850|FG011|Overall Study|Withdrawal by Subject|0|||
105326513|NCT01894919|363194851|FG012|Overall Study|Withdrawal by Subject|0|||
105326514|NCT01894919|363194839|FG000|Overall Study|Adverse Event|0|||
105326515|NCT01894919|363194840|FG001|Overall Study|Adverse Event|0|||
105326516|NCT01894919|363194841|FG002|Overall Study|Adverse Event|0|||
105326517|NCT01894919|363194842|FG003|Overall Study|Adverse Event|0|||
105326518|NCT01894919|363194843|FG004|Overall Study|Adverse Event|0|||
105373296|NCT00961415|363374105|FG002|Induction Treatment Phase|Other Reason|0|||
105373297|NCT00961415|363374103|FG000|Maintenance Treatment Phase|Death|0|||
105326519|NCT01894919|363194844|FG005|Overall Study|Adverse Event|0|||
105326520|NCT01894919|363194845|FG006|Overall Study|Adverse Event|0|||
105326521|NCT01894919|363194846|FG007|Overall Study|Adverse Event|0|||
105326522|NCT01894919|363194847|FG008|Overall Study|Adverse Event|0|||
105373298|NCT00961415|363374104|FG001|Maintenance Treatment Phase|Death|42|||
105373299|NCT00961415|363374105|FG002|Maintenance Treatment Phase|Death|34|||
105326523|NCT01894919|363194848|FG009|Overall Study|Adverse Event|0|||
105326524|NCT01894919|363194849|FG010|Overall Study|Adverse Event|1|||
105326525|NCT01894919|363194850|FG011|Overall Study|Adverse Event|0|||
105326526|NCT01894919|363194851|FG012|Overall Study|Adverse Event|0|||
105326527|NCT01894919|363194839|FG000|Overall Study|Other-Unspecified|1|||
105373300|NCT00961415|363374103|FG000|Maintenance Treatment Phase|Investigators decision|0|||
105326528|NCT01894919|363194840|FG001|Overall Study|Other-Unspecified|0|||
105326529|NCT01894919|363194841|FG002|Overall Study|Other-Unspecified|0|||
105326530|NCT01894919|363194842|FG003|Overall Study|Other-Unspecified|0|||
105326531|NCT01894919|363194843|FG004|Overall Study|Other-Unspecified|0|||
105326532|NCT01894919|363194844|FG005|Overall Study|Other-Unspecified|0|||
105326533|NCT01894919|363194845|FG006|Overall Study|Other-Unspecified|0|||
105326534|NCT01894919|363194846|FG007|Overall Study|Other-Unspecified|0|||
105326535|NCT01894919|363194847|FG008|Overall Study|Other-Unspecified|0|||
105326536|NCT01894919|363194848|FG009|Overall Study|Other-Unspecified|0|||
105326537|NCT01894919|363194849|FG010|Overall Study|Other-Unspecified|0|||
105326538|NCT01894919|363194850|FG011|Overall Study|Other-Unspecified|0|||
105326539|NCT01894919|363194851|FG012|Overall Study|Other-Unspecified|0|||
105326540|NCT01894919|363194839|FG000|Overall Study|Lost to Follow-up|0|||
105326541|NCT01894919|363194840|FG001|Overall Study|Lost to Follow-up|0|||
105326542|NCT01894919|363194841|FG002|Overall Study|Lost to Follow-up|0|||
105326543|NCT01894919|363194842|FG003|Overall Study|Lost to Follow-up|0|||
105326544|NCT01894919|363194843|FG004|Overall Study|Lost to Follow-up|2|||
105326545|NCT01894919|363194844|FG005|Overall Study|Lost to Follow-up|0|||
105326546|NCT01894919|363194845|FG006|Overall Study|Lost to Follow-up|0|||
105326547|NCT01894919|363194846|FG007|Overall Study|Lost to Follow-up|0|||
105326548|NCT01894919|363194847|FG008|Overall Study|Lost to Follow-up|0|||
105326549|NCT01894919|363194848|FG009|Overall Study|Lost to Follow-up|0|||
105326550|NCT01894919|363194849|FG010|Overall Study|Lost to Follow-up|0|||
105326551|NCT01894919|363194850|FG011|Overall Study|Lost to Follow-up|0|||
105326552|NCT01894919|363194851|FG012|Overall Study|Lost to Follow-up|0|||
105326553|NCT02075203|363194852|FG000|Overall Study|Withdrawal by Subject|1|||
105326554|NCT02075203|363194853|FG001|Overall Study|Withdrawal by Subject|0|||
105326555|NCT02075203|363194854|FG002|Overall Study|Withdrawal by Subject|1|||
105326556|NCT02075203|363194852|FG000|Overall Study|Adverse Event|1|||
105326557|NCT02075203|363194853|FG001|Overall Study|Adverse Event|0|||
105326558|NCT02075203|363194854|FG002|Overall Study|Adverse Event|0|||
105326559|NCT02075203|363194852|FG000|Overall Study|participant refused to use contraception|1|||
105326560|NCT02075203|363194853|FG001|Overall Study|participant refused to use contraception|0|||
105326561|NCT02075203|363194854|FG002|Overall Study|participant refused to use contraception|0|||
105326562|NCT00350207|363194857|FG000|Overall Study|Adverse Event|5|||
105326563|NCT00350207|363194858|FG001|Overall Study|Adverse Event|2|||
105326564|NCT00350207|363194859|FG002|Overall Study|Adverse Event|2|||
105326565|NCT00350207|363194857|FG000|Overall Study|Lack of Efficacy|1|||
105326566|NCT00350207|363194858|FG001|Overall Study|Lack of Efficacy|0|||
105326567|NCT00350207|363194859|FG002|Overall Study|Lack of Efficacy|2|||
105326568|NCT00350207|363194857|FG000|Overall Study|Lost to Follow-up|1|||
105326569|NCT00350207|363194858|FG001|Overall Study|Lost to Follow-up|0|||
105326570|NCT00350207|363194859|FG002|Overall Study|Lost to Follow-up|1|||
105326571|NCT00350207|363194857|FG000|Overall Study|Withdrawal by Subject|0|||
105326572|NCT00350207|363194858|FG001|Overall Study|Withdrawal by Subject|1|||
105326573|NCT00350207|363194859|FG002|Overall Study|Withdrawal by Subject|1|||
105326574|NCT00350207|363194857|FG000|Overall Study|Other|1|||
105326575|NCT00350207|363194858|FG001|Overall Study|Other|3|||
105326576|NCT00350207|363194859|FG002|Overall Study|Other|1|||
105326577|NCT03711188|363194860|FG000|Overall Study|Disease progression|11|||
105326578|NCT03711188|363194860|FG000|Overall Study|Adverse Event|1|||
105326579|NCT03922308|363194864|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
105326580|NCT03922308|363194865|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
105326581|NCT03922308|363194866|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
105326582|NCT03922308|363194864|FG000|Overall Study|Lost to Follow-up|1|||
105373301|NCT00961415|363374104|FG001|Maintenance Treatment Phase|Investigators decision|2|||
105373302|NCT00961415|363374105|FG002|Maintenance Treatment Phase|Investigators decision|0|||
105373303|NCT00961415|363374103|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
105373304|NCT00961415|363374104|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
105373305|NCT00961415|363374105|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
105373306|NCT00961415|363374103|FG000|Maintenance Treatment Phase|Other reason|0|||
105373307|NCT00961415|363374104|FG001|Maintenance Treatment Phase|Other reason|1|||
105373308|NCT00961415|363374105|FG002|Maintenance Treatment Phase|Other reason|3|||
105373309|NCT00207740|363374111|FG000|Overall Study|Adverse Event|4|||
105373310|NCT00207740|363374112|FG001|Overall Study|Adverse Event|14|||
105373311|NCT00207740|363374113|FG002|Overall Study|Adverse Event|14|||
105492012|NCT01442038|363813926|FG000|Overall Study|Investigator's Discretion|13|||
105492013|NCT01442038|363813927|FG001|Overall Study|Investigator's Discretion|16|||
105326583|NCT03922308|363194865|FG001|Overall Study|Lost to Follow-up|0|||
105326584|NCT03922308|363194866|FG002|Overall Study|Lost to Follow-up|0|||
105326585|NCT03922308|363194864|FG000|Overall Study|Reason not Specified|0|||
105326586|NCT03922308|363194865|FG001|Overall Study|Reason not Specified|2|||
105326587|NCT03922308|363194866|FG002|Overall Study|Reason not Specified|1|||
105326588|NCT05005507|363194867|FG000|Overall Study|Premature termination of study|1|||
105326589|NCT02755103|363194868|FG000|Overall Study|Lost to Follow-up|17|||
105326590|NCT02755103|363194869|FG001|Overall Study|Lost to Follow-up|15|||
105326591|NCT02755103|363194868|FG000|Overall Study|Death|0|||
105326592|NCT02755103|363194869|FG001|Overall Study|Death|1|||
105326593|NCT02755103|363194868|FG000|Overall Study|Physician Decision|0|||
105326594|NCT02755103|363194869|FG001|Overall Study|Physician Decision|1|||
105326595|NCT02755103|363194868|FG000|Overall Study|Pregnancy|0|||
105326596|NCT02755103|363194869|FG001|Overall Study|Pregnancy|1|||
105326597|NCT02755103|363194868|FG000|Overall Study|Withdrawal by Subject|3|||
105326598|NCT02755103|363194869|FG001|Overall Study|Withdrawal by Subject|0|||
105326599|NCT02172664|363194878|FG000|Overall Study|Lost to Follow-up|4|||
105326600|NCT02172664|363194879|FG001|Overall Study|Lost to Follow-up|4|||
105326601|NCT02172664|363194878|FG000|Overall Study|Death|1|||
105326602|NCT02172664|363194879|FG001|Overall Study|Death|1|||
105326603|NCT02172664|363194878|FG000|Overall Study|Moved out of area|1|||
105326604|NCT02172664|363194879|FG001|Overall Study|Moved out of area|1|||
105326605|NCT00586703|363194884|FG000|Overall Study|Death|12|||
105326606|NCT01422213|363194885|FG000|Overall Study|Adverse Event|8|||
105326607|NCT01422213|363194886|FG001|Overall Study|Adverse Event|7|||
105326608|NCT01422213|363194887|FG002|Overall Study|Adverse Event|11|||
105326609|NCT01422213|363194885|FG000|Overall Study|Lack of Efficacy|10|||
105326610|NCT01422213|363194886|FG001|Overall Study|Lack of Efficacy|2|||
105326611|NCT01422213|363194887|FG002|Overall Study|Lack of Efficacy|2|||
105326612|NCT01422213|363194885|FG000|Overall Study|Non-compliance with study drug|0|||
105326613|NCT01422213|363194886|FG001|Overall Study|Non-compliance with study drug|1|||
105326614|NCT01422213|363194887|FG002|Overall Study|Non-compliance with study drug|0|||
105326615|NCT01422213|363194885|FG000|Overall Study|Protocol Violation|0|||
105326616|NCT01422213|363194886|FG001|Overall Study|Protocol Violation|2|||
105326617|NCT01422213|363194887|FG002|Overall Study|Protocol Violation|4|||
105326618|NCT01422213|363194885|FG000|Overall Study|Withdrawal of Consent|7|||
105326619|NCT01422213|363194886|FG001|Overall Study|Withdrawal of Consent|3|||
105326620|NCT01422213|363194887|FG002|Overall Study|Withdrawal of Consent|5|||
105326621|NCT01422213|363194885|FG000|Overall Study|Lost to Follow-up|3|||
105326622|NCT01422213|363194886|FG001|Overall Study|Lost to Follow-up|3|||
105326623|NCT01422213|363194887|FG002|Overall Study|Lost to Follow-up|5|||
105326624|NCT01422213|363194885|FG000|Overall Study|Administrative or Other Reason(s)|5|||
105326625|NCT01422213|363194886|FG001|Overall Study|Administrative or Other Reason(s)|4|||
105326626|NCT01422213|363194887|FG002|Overall Study|Administrative or Other Reason(s)|2|||
105326627|NCT01882985|363194890|FG000|Overall Study|Lost to Follow-up|1|||
105326628|NCT01882985|363194890|FG000|Overall Study|Withdrawal by Subject|1|||
105326629|NCT02857816|363194891|FG000|Overall Study|Screen Failure|33|||
105492014|NCT01442038|363813926|FG000|Overall Study|Study Terminated By Sponsor|2|||
105492015|NCT01442038|363813927|FG001|Overall Study|Study Terminated By Sponsor|3|||
105326630|NCT02857816|363194891|FG000|Overall Study|Withdrawal by Subject|4|||
105326631|NCT02857816|363194891|FG000|Overall Study|Lost to Follow-up|1|||
105326632|NCT01383174|363194898|FG000|3 Month Assessment|Death|0|||
105326633|NCT01383174|363194899|FG001|3 Month Assessment|Death|1|||
105326634|NCT01383174|363194898|FG000|3 Month Assessment|Lost to Follow-up|2|||
105326635|NCT01383174|363194899|FG001|3 Month Assessment|Lost to Follow-up|0|||
105326636|NCT01383174|363194898|FG000|3 Month Assessment|Refused to complete|4|||
105326637|NCT01383174|363194899|FG001|3 Month Assessment|Refused to complete|0|||
105326638|NCT01383174|363194898|FG000|6 Month Assessment|Lost to Follow-up|1|||
105326639|NCT01383174|363194899|FG001|6 Month Assessment|Lost to Follow-up|1|||
105326640|NCT01383174|363194898|FG000|6 Month Assessment|Refused to complete|4|||
105326641|NCT01383174|363194899|FG001|6 Month Assessment|Refused to complete|0|||
105326642|NCT05271175|363194900|FG000|One Week Follow up|Lost to Follow-up|10|||
105326643|NCT05271175|363194901|FG001|One Week Follow up|Lost to Follow-up|7|||
105326644|NCT05271175|363194902|FG002|One Week Follow up|Lost to Follow-up|5|||
105326645|NCT05271175|363194900|FG000|One Month Follow up|Lost to Follow-up|12|||
105326646|NCT05271175|363194901|FG001|One Month Follow up|Lost to Follow-up|7|||
105326647|NCT05271175|363194902|FG002|One Month Follow up|Lost to Follow-up|9|||
105326648|NCT05271175|363194900|FG000|Six Months Follow up|Lost to Follow-up|8|||
105326649|NCT05271175|363194901|FG001|Six Months Follow up|Lost to Follow-up|2|||
105326650|NCT05271175|363194902|FG002|Six Months Follow up|Lost to Follow-up|2|||
105326651|NCT03296527|363194903|FG000|Overall Study|Adverse Event|15|||
105326652|NCT03296527|363194904|FG001|Overall Study|Adverse Event|33|||
105326653|NCT03296527|363194903|FG000|Overall Study|Protocol Deviation|4|||
105326654|NCT03296527|363194904|FG001|Overall Study|Protocol Deviation|0|||
105326655|NCT03296527|363194903|FG000|Overall Study|Participant withdrew consent|3|||
105326656|NCT03296527|363194904|FG001|Overall Study|Participant withdrew consent|1|||
105326657|NCT03296527|363194903|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
105326658|NCT03296527|363194904|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
105326659|NCT03296527|363194903|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
105326660|NCT03296527|363194904|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
105326661|NCT03296527|363194903|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
105326662|NCT03296527|363194904|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
105326663|NCT03296527|363194903|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
105326664|NCT03296527|363194904|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
105492016|NCT04622735|363813931|FG000|Overall Study|Lost to Follow-up|1|||
105852657|NCT05070546|365118049|FG000|Overall Study|Death|0|||
105852658|NCT05070546|365118050|FG001|Overall Study|Death|0|||
105852659|NCT05070546|365118051|FG002|Overall Study|Death|0|||
105852660|NCT05070546|365118052|FG003|Overall Study|Death|0|||
105852661|NCT05070546|365118053|FG004|Overall Study|Death|0|||
105852662|NCT05070546|365118054|FG005|Overall Study|Death|1|||
105852663|NCT05070546|365118049|FG000|Overall Study|Lost to Follow-up|8|||
105852664|NCT05070546|365118050|FG001|Overall Study|Lost to Follow-up|2|||
105852665|NCT05070546|365118051|FG002|Overall Study|Lost to Follow-up|7|||
105852666|NCT05070546|365118052|FG003|Overall Study|Lost to Follow-up|1|||
105852667|NCT05070546|365118053|FG004|Overall Study|Lost to Follow-up|2|||
105852668|NCT05070546|365118054|FG005|Overall Study|Lost to Follow-up|0|||
105852669|NCT05070546|365118049|FG000|Overall Study|Withdrawal by Subject|1|||
105852670|NCT05070546|365118050|FG001|Overall Study|Withdrawal by Subject|1|||
105852671|NCT05070546|365118051|FG002|Overall Study|Withdrawal by Subject|3|||
105852672|NCT05070546|365118052|FG003|Overall Study|Withdrawal by Subject|0|||
105852673|NCT05070546|365118053|FG004|Overall Study|Withdrawal by Subject|0|||
105852674|NCT05070546|365118054|FG005|Overall Study|Withdrawal by Subject|0|||
105852675|NCT05070546|365118049|FG000|Overall Study|Other|0|||
105852676|NCT05070546|365118050|FG001|Overall Study|Other|0|||
105852677|NCT05070546|365118051|FG002|Overall Study|Other|0|||
105852678|NCT05070546|365118052|FG003|Overall Study|Other|0|||
105852679|NCT05070546|365118053|FG004|Overall Study|Other|3|||
105852680|NCT05070546|365118054|FG005|Overall Study|Other|0|||
105852681|NCT05070546|365118049|FG000|Overall Study|Randomized but not vaccinated|1|||
105852682|NCT05070546|365118050|FG001|Overall Study|Randomized but not vaccinated|0|||
105852683|NCT05070546|365118051|FG002|Overall Study|Randomized but not vaccinated|1|||
105852684|NCT05070546|365118052|FG003|Overall Study|Randomized but not vaccinated|1|||
105852685|NCT05070546|365118053|FG004|Overall Study|Randomized but not vaccinated|3|||
105852686|NCT05070546|365118054|FG005|Overall Study|Randomized but not vaccinated|0|||
105852687|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
105852688|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
105852689|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
105852690|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
105852691|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
105852692|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
105852693|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
105852694|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
105852695|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
105852696|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852697|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
105852698|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852699|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852700|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852701|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852702|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852703|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852704|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852705|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852706|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
105852707|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852708|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
105852709|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852710|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852711|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852712|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852713|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852714|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
105852715|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
105852716|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
105373312|NCT00207740|363374114|FG003|Overall Study|Adverse Event|11|||
105373313|NCT00207740|363374111|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105373314|NCT00207740|363374112|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105373315|NCT00207740|363374113|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
105852717|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
105852718|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
105373316|NCT00207740|363374114|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
105373317|NCT00207740|363374111|FG000|Overall Study|Lost to Follow-up|0|||
105852719|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
105852720|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
105373318|NCT00207740|363374112|FG001|Overall Study|Lost to Follow-up|2|||
105492017|NCT04622735|363813932|FG001|Overall Study|Lost to Follow-up|2|||
105492018|NCT04622735|363813933|FG002|Overall Study|Lost to Follow-up|1|||
105492019|NCT04622735|363813931|FG000|Overall Study|Adverse Event|0|||
105492020|NCT04622735|363813932|FG001|Overall Study|Adverse Event|0|||
105492021|NCT04622735|363813933|FG002|Overall Study|Adverse Event|1|||
105492022|NCT04622735|363813931|FG000|Overall Study|Protocol Violation|1|||
105492023|NCT04622735|363813932|FG001|Overall Study|Protocol Violation|0|||
105492024|NCT04622735|363813933|FG002|Overall Study|Protocol Violation|0|||
105492025|NCT05007717|363813934|FG000|Overall Study|Death|3|||
105492026|NCT05007717|363813935|FG001|Overall Study|Death|2|||
105492027|NCT05314478|363813936|FG000|Overall Study|Physician Decision|1|||
105492028|NCT04060862|363813939|FG000|Overall Study|Symptomatic Deterioration|1|||
105492029|NCT04060862|363813939|FG000|Overall Study|Un-specified|6|||
105492030|NCT04060862|363813939|FG000|Overall Study|Progressive disease|12|||
105492031|NCT04060862|363813939|FG000|Overall Study|Physician Decision|1|||
105492032|NCT01325623|363813940|FG000|Overall Study|Withdrawal by Subject|3|||
105492033|NCT03875768|363813943|FG000|Overall Study|Lost to Follow-up|16|||
105492034|NCT03875768|363813944|FG001|Overall Study|Lost to Follow-up|13|||
105492035|NCT03875768|363813943|FG000|Overall Study|Withdrawal by Subject|10|||
105492036|NCT03875768|363813944|FG001|Overall Study|Withdrawal by Subject|21|||
105492037|NCT03875768|363813943|FG000|Overall Study|Did not complete assessment|21|||
105492038|NCT03875768|363813944|FG001|Overall Study|Did not complete assessment|12|||
105492039|NCT03875768|363813943|FG000|Overall Study|Became ineligible|1|||
105492040|NCT03875768|363813944|FG001|Overall Study|Became ineligible|0|||
105492041|NCT00777205|363813945|FG000|Overall Study|Lost to Follow-up|25|||
105492042|NCT00777205|363813946|FG001|Overall Study|Lost to Follow-up|9|||
105492043|NCT00777205|363813945|FG000|Overall Study|Withdrawal by Subject|6|||
105492044|NCT00777205|363813946|FG001|Overall Study|Withdrawal by Subject|4|||
105492045|NCT00777205|363813945|FG000|Overall Study|Death|0|||
105492046|NCT00777205|363813946|FG001|Overall Study|Death|2|||
105492047|NCT00777205|363813945|FG000|Overall Study|Protocol Violation|0|||
105492048|NCT00777205|363813946|FG001|Overall Study|Protocol Violation|56|||
105492049|NCT01130103|363813950|FG000|Randomized Treatment|Adverse Event|1|||
105492050|NCT01130103|363813951|FG001|Randomized Treatment|Adverse Event|1|||
105492051|NCT01130103|363813950|FG000|Randomized Treatment|Lost to Follow-up|1|||
105492052|NCT01130103|363813951|FG001|Randomized Treatment|Lost to Follow-up|0|||
105492053|NCT01130103|363813950|FG000|Randomized Treatment|Protocol Violation|3|||
105492054|NCT01130103|363813951|FG001|Randomized Treatment|Protocol Violation|2|||
105492055|NCT01130103|363813950|FG000|Randomized Treatment|Withdrawal by Subject|1|||
105492056|NCT01130103|363813951|FG001|Randomized Treatment|Withdrawal by Subject|2|||
105492057|NCT01130103|363813950|FG000|Maintenance Treatment|Lack of Efficacy|0|||
105492058|NCT01130103|363813951|FG001|Maintenance Treatment|Lack of Efficacy|1|||
105492059|NCT01130103|363813950|FG000|Maintenance Treatment|Lost to Follow-up|1|||
105492060|NCT01130103|363813951|FG001|Maintenance Treatment|Lost to Follow-up|1|||
105492061|NCT01130103|363813950|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
105492062|NCT01130103|363813951|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
105492063|NCT01916967|363813953|FG000|Overall Study|Adverse Event|0|||
105492064|NCT01916967|363813954|FG001|Overall Study|Adverse Event|0|||
105492065|NCT01916967|363813955|FG002|Overall Study|Adverse Event|2|||
105492066|NCT01916967|363813953|FG000|Overall Study|Lack of Efficacy|0|||
105492067|NCT01916967|363813954|FG001|Overall Study|Lack of Efficacy|0|||
105326665|NCT03296527|363194903|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
105326666|NCT03296527|363194904|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
105326667|NCT01129557|363194906|FG000|Overall Study|Adverse Event|1|||
105326668|NCT01129557|363194907|FG001|Overall Study|Adverse Event|2|||
105326669|NCT01129557|363194908|FG002|Overall Study|Adverse Event|2|||
105326670|NCT01129557|363194906|FG000|Overall Study|Novartis terminated study early|3|||
105326671|NCT01129557|363194907|FG001|Overall Study|Novartis terminated study early|3|||
105326672|NCT01129557|363194908|FG002|Overall Study|Novartis terminated study early|2|||
105326673|NCT01445730|363194909|FG000|Overall Study|Adverse Event|1|||
105326674|NCT01445730|363194909|FG000|Overall Study|For the advice of a dentist|1|||
105326675|NCT01445730|363194909|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
105326676|NCT01167140|363194910|FG000|Overall Study|Withdrawal by Subject|1|||
105326677|NCT02872714|363194915|FG000|Overall Study|Progressive Disease|1|||
105852721|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
105326678|NCT02872714|363194916|FG001|Overall Study|Progressive Disease|2|||
105326679|NCT02872714|363194917|FG002|Overall Study|Progressive Disease|0|||
105326680|NCT02872714|363194918|FG003|Overall Study|Progressive Disease|0|||
105326681|NCT02872714|363194919|FG004|Overall Study|Progressive Disease|0|||
105326682|NCT02872714|363194915|FG000|Overall Study|Death|87|||
105326683|NCT02872714|363194916|FG001|Overall Study|Death|36|||
105326684|NCT02872714|363194917|FG002|Overall Study|Death|8|||
105326685|NCT02872714|363194918|FG003|Overall Study|Death|81|||
105326686|NCT02872714|363194919|FG004|Overall Study|Death|2|||
105492068|NCT01916967|363813955|FG002|Overall Study|Lack of Efficacy|6|||
105492069|NCT01916967|363813953|FG000|Overall Study|Physician Decision|0|||
105492070|NCT01916967|363813954|FG001|Overall Study|Physician Decision|0|||
105852722|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
105852723|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
105852724|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
105852725|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
105852726|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852727|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
105852728|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852729|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852730|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852731|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852732|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852733|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
105852734|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852735|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852736|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852737|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852738|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852739|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852740|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852741|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852742|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852743|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852744|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
105852745|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852746|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852747|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852748|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852749|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852750|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
105852751|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
105852752|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
105852753|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
105852754|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
105852755|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
105852756|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
105852757|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
105852758|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
105852759|NCT03893565|365118055|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
105852760|NCT03893565|365118056|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
105852761|NCT03893565|365118057|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
105852762|NCT03893565|365118058|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
105852763|NCT03893565|365118059|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
105852764|NCT03893565|365118060|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
105852765|NCT03893565|365118061|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
105852766|NCT03893565|365118062|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
105852767|NCT03893565|365118063|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
105852768|NCT03893565|365118055|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852769|NCT03893565|365118056|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852770|NCT03893565|365118057|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852771|NCT03893565|365118058|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852772|NCT03893565|365118059|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852773|NCT03893565|365118060|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852774|NCT03893565|365118061|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
105852775|NCT03893565|365118062|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852776|NCT03893565|365118063|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852777|NCT03893565|365118055|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
105852778|NCT03893565|365118056|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
105852779|NCT03893565|365118057|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
105852780|NCT03893565|365118058|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
105852781|NCT03893565|365118059|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
105852782|NCT03893565|365118060|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
105852783|NCT03893565|365118061|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
105852784|NCT03893565|365118062|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
105852785|NCT03893565|365118063|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
105852786|NCT03893565|365118055|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
105852787|NCT03893565|365118056|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
105852788|NCT03893565|365118057|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
105852789|NCT03893565|365118058|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
105852790|NCT03893565|365118059|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
105852791|NCT03893565|365118060|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
105852792|NCT03893565|365118061|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
105852793|NCT03893565|365118062|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
105852794|NCT03893565|365118063|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
105852795|NCT03893565|365118055|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852796|NCT03893565|365118056|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852797|NCT03893565|365118057|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852798|NCT03893565|365118058|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852799|NCT03893565|365118059|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852800|NCT03893565|365118060|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852801|NCT03893565|365118061|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852802|NCT03893565|365118062|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
105852803|NCT03893565|365118063|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852804|NCT03893565|365118055|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852805|NCT03893565|365118056|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852806|NCT03893565|365118057|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852807|NCT03893565|365118058|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852808|NCT03893565|365118059|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852809|NCT03893565|365118060|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852810|NCT03893565|365118061|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852811|NCT03893565|365118062|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
105852812|NCT03893565|365118063|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852813|NCT03893565|365118055|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852814|NCT03893565|365118056|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852815|NCT03893565|365118057|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852816|NCT03893565|365118058|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852817|NCT03893565|365118059|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852818|NCT03893565|365118060|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852819|NCT03893565|365118061|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852820|NCT03893565|365118062|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
105852821|NCT03893565|365118063|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852822|NCT03893565|365118055|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852823|NCT03893565|365118056|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852824|NCT03893565|365118057|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852825|NCT03893565|365118058|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852826|NCT03893565|365118059|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852827|NCT03893565|365118060|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852828|NCT03893565|365118061|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852829|NCT03893565|365118062|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852830|NCT03893565|365118063|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
105852831|NCT01715571|365118064|FG000|Overall Study|Lost to Follow-up|8|||
105852832|NCT04076059|365118065|FG000|Double Blind Phase|Progressive disease|22|||
105852833|NCT04076059|365118066|FG001|Double Blind Phase|Progressive disease|26|||
105852834|NCT04076059|365118067|FG002|Double Blind Phase|Progressive disease|0|||
105852835|NCT04076059|365118065|FG000|Double Blind Phase|Withdrawal by Subject|4|||
105852836|NCT04076059|365118066|FG001|Double Blind Phase|Withdrawal by Subject|11|||
105852837|NCT04076059|365118067|FG002|Double Blind Phase|Withdrawal by Subject|0|||
105852838|NCT04076059|365118065|FG000|Double Blind Phase|Death|1|||
105852839|NCT04076059|365118066|FG001|Double Blind Phase|Death|1|||
105852840|NCT04076059|365118067|FG002|Double Blind Phase|Death|0|||
105852841|NCT04076059|365118065|FG000|Double Blind Phase|Lost to Follow-up|1|||
105852842|NCT04076059|365118066|FG001|Double Blind Phase|Lost to Follow-up|0|||
105852843|NCT04076059|365118067|FG002|Double Blind Phase|Lost to Follow-up|0|||
105852844|NCT04076059|365118065|FG000|Double Blind Phase|Adverse Event|5|||
105577084|NCT00849680|364112164|FG000|Overall Study|Withdrawal by Subject|2|||
105577085|NCT00849680|364112165|FG001|Overall Study|Withdrawal by Subject|0|||
105577086|NCT00849680|364112166|FG002|Overall Study|Withdrawal by Subject|0|||
105577087|NCT00849680|364112167|FG003|Overall Study|Withdrawal by Subject|2|||
105852845|NCT04076059|365118066|FG001|Double Blind Phase|Adverse Event|1|||
105852846|NCT04076059|365118067|FG002|Double Blind Phase|Adverse Event|0|||
105852847|NCT04076059|365118065|FG000|Double Blind Phase|Ongoing Participants|82|||
105852848|NCT04076059|365118066|FG001|Double Blind Phase|Ongoing Participants|18|||
105852849|NCT04076059|365118067|FG002|Double Blind Phase|Ongoing Participants|0|||
105852850|NCT04076059|365118065|FG000|Double Blind Phase|Miscellaneous|3|||
105852851|NCT04076059|365118066|FG001|Double Blind Phase|Miscellaneous|1|||
105852852|NCT04076059|365118067|FG002|Double Blind Phase|Miscellaneous|0|||
105852853|NCT04076059|365118065|FG000|Double Blind Phase|Protocol Deviation|1|||
105852854|NCT04076059|365118066|FG001|Double Blind Phase|Protocol Deviation|1|||
105852855|NCT04076059|365118067|FG002|Double Blind Phase|Protocol Deviation|0|||
105852856|NCT04076059|365118065|FG000|Double Blind Phase|Did not take study drug|1|||
105852857|NCT04076059|365118066|FG001|Double Blind Phase|Did not take study drug|1|||
105852858|NCT04076059|365118067|FG002|Double Blind Phase|Did not take study drug|0|||
105852859|NCT04076059|365118065|FG000|Open Label Phase|Progressive disease|0|||
105852860|NCT04076059|365118066|FG001|Open Label Phase|Progressive disease|0|||
105326687|NCT02872714|363194915|FG000|Overall Study|Lost to Follow-up|2|||
105326688|NCT02872714|363194916|FG001|Overall Study|Lost to Follow-up|1|||
105326689|NCT02872714|363194917|FG002|Overall Study|Lost to Follow-up|0|||
105326690|NCT02872714|363194918|FG003|Overall Study|Lost to Follow-up|3|||
105326691|NCT02872714|363194919|FG004|Overall Study|Lost to Follow-up|0|||
105326692|NCT02872714|363194915|FG000|Overall Study|Physician Decision|0|||
105326693|NCT02872714|363194916|FG001|Overall Study|Physician Decision|0|||
105326694|NCT02872714|363194917|FG002|Overall Study|Physician Decision|0|||
105326695|NCT02872714|363194918|FG003|Overall Study|Physician Decision|1|||
105326696|NCT02872714|363194919|FG004|Overall Study|Physician Decision|0|||
105326697|NCT02872714|363194915|FG000|Overall Study|Withdrawal by Subject|1|||
105326698|NCT02872714|363194916|FG001|Overall Study|Withdrawal by Subject|3|||
105326699|NCT02872714|363194917|FG002|Overall Study|Withdrawal by Subject|0|||
105326700|NCT02872714|363194918|FG003|Overall Study|Withdrawal by Subject|2|||
105326701|NCT02872714|363194919|FG004|Overall Study|Withdrawal by Subject|0|||
105852861|NCT04076059|365118067|FG002|Open Label Phase|Progressive disease|7|||
105852862|NCT04076059|365118065|FG000|Open Label Phase|Withdrawal by Subject|0|||
105852863|NCT04076059|365118066|FG001|Open Label Phase|Withdrawal by Subject|0|||
105852864|NCT04076059|365118067|FG002|Open Label Phase|Withdrawal by Subject|3|||
105852865|NCT04076059|365118065|FG000|Open Label Phase|Death|0|||
105852866|NCT04076059|365118066|FG001|Open Label Phase|Death|0|||
105852867|NCT04076059|365118067|FG002|Open Label Phase|Death|2|||
105852868|NCT04076059|365118065|FG000|Open Label Phase|Ongoing Participants|0|||
105852869|NCT04076059|365118066|FG001|Open Label Phase|Ongoing Participants|0|||
105852870|NCT04076059|365118067|FG002|Open Label Phase|Ongoing Participants|11|||
105852871|NCT06354998|365118068|FG000|Overall Study|Withdrawal by Subject|3|||
105852872|NCT06354998|365118069|FG001|Overall Study|Withdrawal by Subject|0|||
105852873|NCT03819049|365118070|FG000|Overall Study|Lost to Follow-up|1|||
105326702|NCT02872714|363194915|FG000|Overall Study|Captured as Other|2|||
105326703|NCT02872714|363194916|FG001|Overall Study|Captured as Other|0|||
105326704|NCT02872714|363194917|FG002|Overall Study|Captured as Other|0|||
105326705|NCT02872714|363194918|FG003|Overall Study|Captured as Other|1|||
105326706|NCT02872714|363194919|FG004|Overall Study|Captured as Other|0|||
105326707|NCT02576847|363194925|FG000|Overall Study|Adverse Event|27|||
105326708|NCT02576847|363194925|FG000|Overall Study|Lost to Follow-up|22|||
105326709|NCT02576847|363194925|FG000|Overall Study|Physician Decision|1|||
105326710|NCT02576847|363194925|FG000|Overall Study|Pregnancy|1|||
105326711|NCT02576847|363194925|FG000|Overall Study|Protocol Violation|3|||
105326712|NCT02576847|363194925|FG000|Overall Study|Withdrawal by Subject|78|||
105326713|NCT02576847|363194925|FG000|Overall Study|Other|5|||
105326714|NCT05016960|363196423|FG000|Overall Study|Withdrawal by Subject|1|||
105326715|NCT05016960|363196424|FG001|Overall Study|Withdrawal by Subject|9|||
105326716|NCT00739882|363196425|FG000|Double-blind Period|Adverse Event|1|||
105326717|NCT00739882|363196426|FG001|Double-blind Period|Adverse Event|2|||
105326718|NCT00739882|363196425|FG000|Double-blind Period|Protocol Violation|1|||
105326719|NCT00739882|363196426|FG001|Double-blind Period|Protocol Violation|0|||
105326720|NCT00739882|363196425|FG000|Double-blind Period|Lack of Efficacy|1|||
105326721|NCT00739882|363196426|FG001|Double-blind Period|Lack of Efficacy|1|||
105326722|NCT00739882|363196425|FG000|Double-blind Period|Other|16|||
105852874|NCT03819049|365118071|FG001|Overall Study|Lost to Follow-up|2|||
105852875|NCT03819049|365118072|FG002|Overall Study|Lost to Follow-up|9|||
105852876|NCT03819049|365118073|FG003|Overall Study|Lost to Follow-up|0|||
105852877|NCT03819049|365118074|FG004|Overall Study|Lost to Follow-up|3|||
105326723|NCT00739882|363196426|FG001|Double-blind Period|Other|8|||
105326724|NCT00739882|363196425|FG000|Open-label Period|Adverse Event|1|||
105326725|NCT00739882|363196426|FG001|Open-label Period|Adverse Event|0|||
105852878|NCT03819049|365118075|FG005|Overall Study|Lost to Follow-up|1|||
105852879|NCT03819049|365118076|FG006|Overall Study|Lost to Follow-up|0|||
105326726|NCT00739882|363196425|FG000|Open-label Period|Other|9|||
105326727|NCT00739882|363196426|FG001|Open-label Period|Other|5|||
105326728|NCT01168232|363196427|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
105852880|NCT03819049|365118070|FG000|Overall Study|Withdrawal by Subject|0|||
105852881|NCT03819049|365118071|FG001|Overall Study|Withdrawal by Subject|0|||
105852882|NCT03819049|365118072|FG002|Overall Study|Withdrawal by Subject|18|||
105852883|NCT03819049|365118073|FG003|Overall Study|Withdrawal by Subject|0|||
105852884|NCT03819049|365118074|FG004|Overall Study|Withdrawal by Subject|10|||
105852885|NCT03819049|365118075|FG005|Overall Study|Withdrawal by Subject|9|||
105852886|NCT03819049|365118076|FG006|Overall Study|Withdrawal by Subject|1|||
105852887|NCT03819049|365118070|FG000|Overall Study|Ongoing|0|||
105852888|NCT03819049|365118071|FG001|Overall Study|Ongoing|0|||
105852889|NCT03819049|365118072|FG002|Overall Study|Ongoing|75|||
105852890|NCT03819049|365118073|FG003|Overall Study|Ongoing|0|||
105852891|NCT03819049|365118074|FG004|Overall Study|Ongoing|41|||
105852892|NCT03819049|365118075|FG005|Overall Study|Ongoing|0|||
105852893|NCT03819049|365118076|FG006|Overall Study|Ongoing|0|||
105852894|NCT03819049|365118070|FG000|Overall Study|Other|0|||
105852895|NCT03819049|365118071|FG001|Overall Study|Other|0|||
105852896|NCT03819049|365118072|FG002|Overall Study|Other|2|||
105852897|NCT03819049|365118073|FG003|Overall Study|Other|0|||
105852898|NCT03819049|365118074|FG004|Overall Study|Other|0|||
105852899|NCT03819049|365118075|FG005|Overall Study|Other|0|||
105852900|NCT03819049|365118076|FG006|Overall Study|Other|0|||
105852901|NCT03819049|365118070|FG000|Overall Study|Randomized but not vaccinated|0|||
105852902|NCT03819049|365118071|FG001|Overall Study|Randomized but not vaccinated|0|||
105852903|NCT03819049|365118072|FG002|Overall Study|Randomized but not vaccinated|0|||
105852904|NCT03819049|365118073|FG003|Overall Study|Randomized but not vaccinated|1|||
105852905|NCT03819049|365118074|FG004|Overall Study|Randomized but not vaccinated|0|||
105852906|NCT03819049|365118075|FG005|Overall Study|Randomized but not vaccinated|2|||
105852907|NCT03819049|365118076|FG006|Overall Study|Randomized but not vaccinated|1|||
105852908|NCT03819049|365118070|FG000|Overall Study|Physician Decision|0|||
105852909|NCT03819049|365118071|FG001|Overall Study|Physician Decision|0|||
105852910|NCT03819049|365118072|FG002|Overall Study|Physician Decision|0|||
105852911|NCT03819049|365118073|FG003|Overall Study|Physician Decision|0|||
105852912|NCT03819049|365118074|FG004|Overall Study|Physician Decision|0|||
105852913|NCT03819049|365118075|FG005|Overall Study|Physician Decision|0|||
105852914|NCT03819049|365118076|FG006|Overall Study|Physician Decision|1|||
105852915|NCT01103466|365118077|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
105852916|NCT01103466|365118078|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
105852917|NCT01103466|365118079|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
105852918|NCT01103466|365118077|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
105852919|NCT01103466|365118078|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
105852920|NCT01103466|365118079|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
105852921|NCT01103466|365118077|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
105852922|NCT01103466|365118078|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
105852923|NCT01103466|365118079|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
105852924|NCT01103466|365118077|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
105852925|NCT01103466|365118078|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
105852926|NCT01103466|365118079|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
105852927|NCT01103466|365118077|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
105852928|NCT01103466|365118078|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
105852929|NCT01103466|365118079|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
105852930|NCT01103466|365118077|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
105852931|NCT01103466|365118078|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
105852932|NCT01103466|365118079|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
105852933|NCT02987959|365118084|FG000|Overall Study|Grantor stopped supply of drugs|6|||
105852934|NCT00643565|365118086|FG000|Overall Study|Death|12|||
105852935|NCT00643565|365118087|FG001|Overall Study|Death|11|||
105852936|NCT00643565|365118086|FG000|Overall Study|Withdrawal by Subject|4|||
105852937|NCT00643565|365118087|FG001|Overall Study|Withdrawal by Subject|1|||
105852938|NCT00643565|365118086|FG000|Overall Study|Lost to Follow-up|0|||
105326729|NCT01168232|363196427|FG000|Overall Study|Ineligible- Wrong cell type|6|||
105326730|NCT01168232|363196427|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
105852939|NCT00643565|365118087|FG001|Overall Study|Lost to Follow-up|6|||
105852940|NCT00643565|365118086|FG000|Overall Study|Other|7|||
105852941|NCT00643565|365118087|FG001|Overall Study|Other|8|||
105852942|NCT00643565|365118086|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
105852943|NCT00643565|365118087|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
105852944|NCT00643565|365118086|FG000|Overall Study|Recurrence of Disease|2|||
105326731|NCT01415518|363196428|FG000|Overall Study|Withdrawal by Subject|2|||
105326732|NCT01415518|363196429|FG001|Overall Study|Withdrawal by Subject|12|||
105326733|NCT01415518|363196428|FG000|Overall Study|Protocol Violation|6|||
105326734|NCT01415518|363196429|FG001|Overall Study|Protocol Violation|8|||
105326735|NCT01415518|363196428|FG000|Overall Study|Lost to Follow-up|3|||
105326736|NCT01415518|363196429|FG001|Overall Study|Lost to Follow-up|5|||
105326737|NCT01415518|363196428|FG000|Overall Study|Adverse Event|3|||
105326738|NCT01415518|363196429|FG001|Overall Study|Adverse Event|4|||
105326739|NCT01415518|363196428|FG000|Overall Study|Death|1|||
105852945|NCT00643565|365118087|FG001|Overall Study|Recurrence of Disease|1|||
105852946|NCT00643565|365118086|FG000|Overall Study|Progression of Disease|18|||
105852947|NCT00643565|365118087|FG001|Overall Study|Progression of Disease|14|||
105373319|NCT00207740|363374113|FG002|Overall Study|Lost to Follow-up|1|||
105373320|NCT00207740|363374114|FG003|Overall Study|Lost to Follow-up|1|||
105373321|NCT00207740|363374111|FG000|Overall Study|Death|0|||
105373322|NCT00207740|363374112|FG001|Overall Study|Death|0|||
105326740|NCT01415518|363196429|FG001|Overall Study|Death|1|||
105326741|NCT01415518|363196428|FG000|Overall Study|Condition under Investigation Worsened|1|||
105326742|NCT01415518|363196429|FG001|Overall Study|Condition under Investigation Worsened|1|||
105326743|NCT01749826|363196430|FG000|Overall Study|Study Terminated|20|||
105326744|NCT01749826|363196431|FG001|Overall Study|Study Terminated|0|||
105326745|NCT01470248|363196434|FG000|Overall Study|Withdrawal by Subject|1|||
105326746|NCT03192488|363196435|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
105326747|NCT03192488|363196436|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
105326748|NCT03192488|363196437|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
105326749|NCT03192488|363196438|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
105326750|NCT03192488|363196439|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
105326751|NCT03192488|363196440|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
105326752|NCT03192488|363196435|FG000|Third Intervention (d1)|Adverse Event|0|||
105326753|NCT03192488|363196436|FG001|Third Intervention (d1)|Adverse Event|0|||
105326754|NCT03192488|363196437|FG002|Third Intervention (d1)|Adverse Event|0|||
105326755|NCT03192488|363196438|FG003|Third Intervention (d1)|Adverse Event|0|||
105326756|NCT03192488|363196439|FG004|Third Intervention (d1)|Adverse Event|1|||
105326757|NCT03192488|363196440|FG005|Third Intervention (d1)|Adverse Event|0|||
105326758|NCT02549859|363196445|FG000|Long-term 60 Hz DBS|Study Closed|1|||
105326759|NCT05140915|363196446|FG000|Overall Study|Lost to Follow-up|2|||
105326760|NCT05140915|363196447|FG001|Overall Study|Lost to Follow-up|1|||
105326761|NCT03664232|363196450|FG000|Overall Study|Withdrawal by Subject|0|||
105326762|NCT03664232|363196451|FG001|Overall Study|Withdrawal by Subject|1|||
105326763|NCT03664232|363196452|FG002|Overall Study|Withdrawal by Subject|0|||
105326764|NCT03664232|363196453|FG003|Overall Study|Withdrawal by Subject|1|||
105326765|NCT03664232|363196450|FG000|Overall Study|Adverse Event|0|||
105326766|NCT03664232|363196451|FG001|Overall Study|Adverse Event|0|||
105326767|NCT03664232|363196452|FG002|Overall Study|Adverse Event|1|||
105326768|NCT03664232|363196453|FG003|Overall Study|Adverse Event|0|||
105326769|NCT03664232|363196450|FG000|Overall Study|Other-Non-compliance with study drug|0|||
105326770|NCT03664232|363196451|FG001|Overall Study|Other-Non-compliance with study drug|1|||
105326771|NCT03664232|363196452|FG002|Overall Study|Other-Non-compliance with study drug|0|||
105326772|NCT03664232|363196453|FG003|Overall Study|Other-Non-compliance with study drug|2|||
105326773|NCT03664232|363196450|FG000|Overall Study|Other-Unspecified|0|||
105326774|NCT03664232|363196451|FG001|Overall Study|Other-Unspecified|3|||
105326775|NCT03664232|363196452|FG002|Overall Study|Other-Unspecified|0|||
105326776|NCT03664232|363196453|FG003|Overall Study|Other-Unspecified|1|||
105326777|NCT03664232|363196450|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
105326778|NCT03664232|363196451|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
105326779|NCT03664232|363196452|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
105326780|NCT03664232|363196453|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
105326781|NCT00942084|363196454|FG000|Overall Study|Death|2|||
105326782|NCT02342678|363196455|FG000|Overall Study|Lost to Follow-up|0|||
105326783|NCT02342678|363196456|FG001|Overall Study|Lost to Follow-up|1|||
105326784|NCT02342678|363196455|FG000|Overall Study|Too busy to complete study|0|||
105326785|NCT02342678|363196456|FG001|Overall Study|Too busy to complete study|2|||
105326786|NCT02342678|363196455|FG000|Overall Study|Family illness/emergency|0|||
105326787|NCT02342678|363196456|FG001|Overall Study|Family illness/emergency|1|||
105326788|NCT02342678|363196455|FG000|Overall Study|Illness/medical reason|1|||
105326789|NCT02342678|363196456|FG001|Overall Study|Illness/medical reason|1|||
105326790|NCT00455403|363196466|FG000|Overall Study|Lost to Follow-up|2|||
105326791|NCT00455403|363196467|FG001|Overall Study|Lost to Follow-up|1|||
105326792|NCT00455403|363196466|FG000|Overall Study|Withdrawal by Subject|1|||
105326793|NCT00455403|363196467|FG001|Overall Study|Withdrawal by Subject|3|||
105326794|NCT00455403|363196466|FG000|Overall Study|Protocol Violation|0|||
105326795|NCT00455403|363196467|FG001|Overall Study|Protocol Violation|2|||
105326796|NCT01433471|363196470|FG000|Overall Study|Withdrawal by Subject|0|||
105326797|NCT01433471|363196471|FG001|Overall Study|Withdrawal by Subject|1|||
105326798|NCT00495391|363196472|FG000|Overall Study|Lack of Efficacy|34|||
105326799|NCT00495391|363196473|FG001|Overall Study|Lack of Efficacy|18|||
105326800|NCT00495391|363196472|FG000|Overall Study|Withdrawal by Subject|2|||
105326801|NCT00495391|363196473|FG001|Overall Study|Withdrawal by Subject|3|||
105326802|NCT03875508|363196474|FG000|Overall Study|Adverse Event|1|||
105326803|NCT03875508|363196474|FG000|Overall Study|Lost to Follow-up|8|||
105326804|NCT03875508|363196474|FG000|Overall Study|Lack of Efficacy|1|||
105326805|NCT03875508|363196474|FG000|Overall Study|Other, not specified|2|||
105326806|NCT03214224|363196475|FG000|Overall Study|Protocol Violation|1|||
105326807|NCT03214224|363196475|FG000|Overall Study|Withdrawal by Subject|2|||
105326808|NCT03214224|363196475|FG000|Overall Study|Practice controls or therapists|6|||
105326809|NCT03802825|363196484|FG000|Overall Study|Lost to follow-up for intervention|12|||
105326810|NCT03802825|363196485|FG001|Overall Study|Lost to follow-up for intervention|3|||
105326811|NCT03802825|363196484|FG000|Overall Study|Received only 1 component of intervention|0|||
105326812|NCT03802825|363196485|FG001|Overall Study|Received only 1 component of intervention|13|||
105326813|NCT00568451|363196486|FG000|Overall Study|Disease Progression|0|||
105326814|NCT00568451|363196487|FG001|Overall Study|Disease Progression|0|||
105326815|NCT00568451|363196488|FG002|Overall Study|Disease Progression|2|||
105326816|NCT00568451|363196489|FG003|Overall Study|Disease Progression|7|||
105326817|NCT01930162|363196490|FG000|Overall Study|Abnormal test procedure result(s)|4|||
105492071|NCT01916967|363813955|FG002|Overall Study|Physician Decision|1|||
105492072|NCT01916967|363813953|FG000|Overall Study|Protocol Violation|0|||
105492073|NCT01916967|363813954|FG001|Overall Study|Protocol Violation|1|||
105492074|NCT01916967|363813955|FG002|Overall Study|Protocol Violation|0|||
105492075|NCT01437878|363813962|FG000|Overall Study|Withdrawal by Subject|1|||
105492076|NCT01437878|363813963|FG001|Overall Study|Withdrawal by Subject|0|||
105492077|NCT01528215|363813966|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
105492078|NCT01528215|363813967|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
105492079|NCT01528215|363813966|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
105492080|NCT01528215|363813967|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
105492081|NCT01528215|363813966|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
105492082|NCT01528215|363813967|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
105492083|NCT01528215|363813966|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
105492084|NCT01528215|363813967|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
105492085|NCT01147172|363813968|FG000|Overall Study|Withdrawal by Subject|2|||
105492086|NCT01147172|363813968|FG000|Overall Study|Lost to Follow-up|2|||
105492087|NCT03488927|363813969|FG000|Overall Study|Withdrawal by Subject|44|||
105492088|NCT03488927|363813970|FG001|Overall Study|Withdrawal by Subject|118|||
105492089|NCT03488927|363813971|FG002|Overall Study|Withdrawal by Subject|217|||
105492090|NCT02927262|363813974|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
105492091|NCT02927262|363813975|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
105492092|NCT02927262|363813974|FG000|Treatment Period (Up to 744 Days)|Death|1|||
105492093|NCT02927262|363813975|FG001|Treatment Period (Up to 744 Days)|Death|0|||
105492094|NCT02927262|363813974|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
105492095|NCT02927262|363813975|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
105492096|NCT02927262|363813974|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
105492097|NCT02927262|363813975|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
105492098|NCT02927262|363813974|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
105492099|NCT02927262|363813975|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
105492100|NCT02927262|363813974|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
105492101|NCT02927262|363813975|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
105492102|NCT02927262|363813974|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
105492103|NCT02927262|363813975|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
105492104|NCT02927262|363813974|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
105492105|NCT02927262|363813975|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
105492106|NCT02927262|363813974|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
105492107|NCT02927262|363813975|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
105852948|NCT00643565|365118086|FG000|Overall Study|Protocol Violation|3|||
105852949|NCT00643565|365118087|FG001|Overall Study|Protocol Violation|0|||
105852950|NCT00643565|365118086|FG000|Overall Study|Did Not Cooperate|0|||
105852951|NCT00643565|365118087|FG001|Overall Study|Did Not Cooperate|1|||
105852952|NCT00643565|365118086|FG000|Overall Study|Administrative|22|||
105852953|NCT00643565|365118087|FG001|Overall Study|Administrative|16|||
105852954|NCT00643565|365118086|FG000|Overall Study|Adverse Event|5|||
105852955|NCT00643565|365118087|FG001|Overall Study|Adverse Event|8|||
105852956|NCT00311402|365118089|FG000|Overall Study|Adverse Event|118|||
105852957|NCT00311402|365118090|FG001|Overall Study|Adverse Event|105|||
105852958|NCT00311402|365118089|FG000|Overall Study|Lost to Follow-up|0|||
105852959|NCT00311402|365118090|FG001|Overall Study|Lost to Follow-up|3|||
105852960|NCT00311402|365118089|FG000|Overall Study|Withdrawal by Subject|17|||
105852961|NCT00311402|365118090|FG001|Overall Study|Withdrawal by Subject|18|||
105852962|NCT00311402|365118089|FG000|Overall Study|Lack of Efficacy|58|||
105852963|NCT00311402|365118090|FG001|Overall Study|Lack of Efficacy|42|||
105852964|NCT00311402|365118089|FG000|Overall Study|Protocol Violation|7|||
105852965|NCT00311402|365118090|FG001|Overall Study|Protocol Violation|6|||
105852966|NCT00311402|365118089|FG000|Overall Study|IRB's rejection etc.|10|||
105852967|NCT00311402|365118090|FG001|Overall Study|IRB's rejection etc.|3|||
105852968|NCT03275064|365118095|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
105852969|NCT03275064|365118096|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
105852970|NCT03275064|365118097|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
105326818|NCT01930162|363196490|FG000|Overall Study|Death|1|||
105852971|NCT03275064|365118098|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
105852972|NCT03275064|365118099|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
105852973|NCT03275064|365118095|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
105852974|NCT03275064|365118096|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
105852975|NCT03275064|365118097|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
105852976|NCT03275064|365118098|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
105852977|NCT03275064|365118099|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
105852978|NCT03275064|365118095|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
105852979|NCT03275064|365118096|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
105852980|NCT03275064|365118097|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
105852981|NCT03275064|365118098|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
105852982|NCT03275064|365118099|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
105852983|NCT03275064|365118095|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
105852984|NCT03275064|365118096|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
105852985|NCT03275064|365118097|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
105852986|NCT03275064|365118098|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
105852987|NCT03275064|365118099|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
105852988|NCT03275064|365118095|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
105852989|NCT03275064|365118096|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
105852990|NCT03275064|365118097|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
105852991|NCT03275064|365118098|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
105852992|NCT03275064|365118099|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
105852993|NCT04159935|365118100|FG000|Overall Study|Study terminated due to COVID-19|1|||
105852994|NCT04159935|365118101|FG001|Overall Study|Study terminated due to COVID-19|3|||
105852995|NCT02348723|365118102|FG000|Overall Study|No ablation|21|||
105852996|NCT02348723|365118103|FG001|Overall Study|No ablation|20|||
105852997|NCT02348723|365118102|FG000|Overall Study|Non-compliant with Protocol|1|||
105852998|NCT02348723|365118103|FG001|Overall Study|Non-compliant with Protocol|0|||
105852999|NCT02348723|365118102|FG000|Overall Study|Lost to Follow-up|1|||
105853000|NCT02348723|365118103|FG001|Overall Study|Lost to Follow-up|1|||
105853001|NCT02348723|365118102|FG000|Overall Study|Consent withdrawn|1|||
105853002|NCT02348723|365118103|FG001|Overall Study|Consent withdrawn|3|||
105853003|NCT02348723|365118102|FG000|Overall Study|Reason other than specified|1|||
105853004|NCT02348723|365118103|FG001|Overall Study|Reason other than specified|1|||
105853005|NCT02348723|365118102|FG000|Overall Study|Adverse Event|3|||
105853006|NCT02348723|365118103|FG001|Overall Study|Adverse Event|1|||
105853007|NCT00724048|365118104|FG000|Overall Study|Adverse Event|1|||
105853008|NCT00724048|365118105|FG001|Overall Study|Adverse Event|1|||
105853009|NCT00724048|365118106|FG002|Overall Study|Adverse Event|1|||
105853010|NCT00724048|365118107|FG003|Overall Study|Adverse Event|0|||
105853011|NCT00724048|365118104|FG000|Overall Study|Lost to Follow-up|0|||
105853012|NCT00724048|365118105|FG001|Overall Study|Lost to Follow-up|1|||
105853013|NCT00724048|365118106|FG002|Overall Study|Lost to Follow-up|0|||
105853014|NCT00724048|365118107|FG003|Overall Study|Lost to Follow-up|0|||
105853015|NCT00724048|365118104|FG000|Overall Study|Withdrawal by Subject|1|||
105853016|NCT00724048|365118105|FG001|Overall Study|Withdrawal by Subject|2|||
105853017|NCT00724048|365118106|FG002|Overall Study|Withdrawal by Subject|1|||
105853018|NCT00724048|365118107|FG003|Overall Study|Withdrawal by Subject|2|||
105853019|NCT00724048|365118104|FG000|Overall Study|Investigator decision|0|||
105853020|NCT00724048|365118105|FG001|Overall Study|Investigator decision|0|||
105853021|NCT00724048|365118106|FG002|Overall Study|Investigator decision|1|||
105853022|NCT00724048|365118107|FG003|Overall Study|Investigator decision|0|||
105853023|NCT00724048|365118104|FG000|Overall Study|Did not tolerate study drug|0|||
105853024|NCT00724048|365118105|FG001|Overall Study|Did not tolerate study drug|0|||
105853025|NCT00724048|365118106|FG002|Overall Study|Did not tolerate study drug|0|||
105853026|NCT00724048|365118107|FG003|Overall Study|Did not tolerate study drug|1|||
105853027|NCT00724048|365118104|FG000|Overall Study|Other than specified|1|||
105326819|NCT03428152|363196492|FG000|Overall Study|Physician Decision|4|||
105326820|NCT03428152|363196493|FG001|Overall Study|Physician Decision|2|||
105326821|NCT03428152|363196492|FG000|Overall Study|Protocol Violation|3|||
105326822|NCT03428152|363196493|FG001|Overall Study|Protocol Violation|5|||
105326823|NCT03428152|363196492|FG000|Overall Study|Lack of Efficacy|0|||
105853028|NCT00724048|365118105|FG001|Overall Study|Other than specified|1|||
105853029|NCT00724048|365118106|FG002|Overall Study|Other than specified|0|||
105853030|NCT00724048|365118107|FG003|Overall Study|Other than specified|0|||
105853031|NCT00681590|365118108|FG000|Overall Study|Withdrawal by Subject|2|||
105853032|NCT00681590|365118109|FG001|Overall Study|Withdrawal by Subject|12|||
105326824|NCT03428152|363196493|FG001|Overall Study|Lack of Efficacy|4|||
105326825|NCT01686373|363196494|FG000|Overall Study|Lost to Follow-up|3|||
105326826|NCT01686373|363196495|FG001|Overall Study|Lost to Follow-up|0|||
105853033|NCT02722148|365118122|FG000|Overall Study|Lost to Follow-up|2|||
105853034|NCT02722148|365118122|FG000|Overall Study|Non compliant with treatment regimen|3|||
105853035|NCT01946191|365118123|FG000|Allocation|Did not complete orientation|1|||
105853036|NCT01946191|365118124|FG001|Allocation|Did not complete orientation|1|||
105853037|NCT01946191|365118123|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
105853038|NCT01946191|365118124|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
105853039|NCT01946191|365118123|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
105853040|NCT01946191|365118124|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
105853041|NCT01946191|365118123|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
105853042|NCT01946191|365118124|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
105853043|NCT01629966|365118125|FG000|Overall Study|Pregnancy|0|||
105853044|NCT01629966|365118126|FG001|Overall Study|Pregnancy|1|||
105853045|NCT01629966|365118127|FG002|Overall Study|Pregnancy|0|||
105853046|NCT01629966|365118125|FG000|Overall Study|Lost to Follow-up|10|||
105853047|NCT01629966|365118126|FG001|Overall Study|Lost to Follow-up|13|||
105853048|NCT01629966|365118127|FG002|Overall Study|Lost to Follow-up|9|||
105853049|NCT01629966|365118125|FG000|Overall Study|Withdrawal by Subject|8|||
105853050|NCT01629966|365118126|FG001|Overall Study|Withdrawal by Subject|9|||
105853051|NCT01629966|365118127|FG002|Overall Study|Withdrawal by Subject|16|||
105853052|NCT01629966|365118125|FG000|Overall Study|Protocol Violation|7|||
105853053|NCT01629966|365118126|FG001|Overall Study|Protocol Violation|9|||
105853054|NCT01629966|365118127|FG002|Overall Study|Protocol Violation|7|||
105373323|NCT00207740|363374113|FG002|Overall Study|Death|0|||
105373324|NCT00207740|363374114|FG003|Overall Study|Death|1|||
105373325|NCT00207740|363374111|FG000|Overall Study|Sponsor Directive|22|||
105373326|NCT00207740|363374112|FG001|Overall Study|Sponsor Directive|15|||
105373327|NCT00207740|363374113|FG002|Overall Study|Sponsor Directive|16|||
105373328|NCT00207740|363374114|FG003|Overall Study|Sponsor Directive|21|||
105373329|NCT00207740|363374111|FG000|Overall Study|Other|2|||
105373330|NCT00207740|363374112|FG001|Overall Study|Other|10|||
105373331|NCT00207740|363374113|FG002|Overall Study|Other|7|||
105373332|NCT00207740|363374114|FG003|Overall Study|Other|5|||
105373333|NCT02592824|363374115|FG000|Overall Study|Protocol Violation|5|||
105373334|NCT02592824|363374116|FG001|Overall Study|Protocol Violation|3|||
105373335|NCT02592824|363374115|FG000|Overall Study|Lost to Follow-up|2|||
105373336|NCT02592824|363374116|FG001|Overall Study|Lost to Follow-up|1|||
105373337|NCT01704261|363374117|FG000|Overall Study|Withdrawal by Subject|12|||
105373338|NCT01704261|363374118|FG001|Overall Study|Withdrawal by Subject|15|||
105373339|NCT01704261|363374117|FG000|Overall Study|Lost to Follow-up|1|||
105373340|NCT01704261|363374118|FG001|Overall Study|Lost to Follow-up|0|||
105373341|NCT00924898|363374119|FG000|Overall Study|Withdrawal by Subject|2|||
105373342|NCT01285518|363374120|FG000|Overall Study|Lost to Follow-up|0|||
105373343|NCT01285518|363374121|FG001|Overall Study|Lost to Follow-up|0|||
105373344|NCT01285518|363374122|FG002|Overall Study|Lost to Follow-up|0|||
105373345|NCT01285518|363374123|FG003|Overall Study|Lost to Follow-up|0|||
105373346|NCT01285518|363374124|FG004|Overall Study|Lost to Follow-up|0|||
105373347|NCT01285518|363374125|FG005|Overall Study|Lost to Follow-up|1|||
105373348|NCT01285518|363374126|FG006|Overall Study|Lost to Follow-up|0|||
105373349|NCT01285518|363374127|FG007|Overall Study|Lost to Follow-up|0|||
105373350|NCT00879658|363374130|FG000|Overall Study|Abnormal laboratory value(s)|3|||
105373351|NCT00879658|363374131|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105373352|NCT00879658|363374132|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105373353|NCT00879658|363374133|FG003|Overall Study|Abnormal laboratory value(s)|1|||
105373354|NCT00879658|363374134|FG004|Overall Study|Abnormal laboratory value(s)|0|||
105373355|NCT00879658|363374135|FG005|Overall Study|Abnormal laboratory value(s)|0|||
105373356|NCT00879658|363374136|FG006|Overall Study|Abnormal laboratory value(s)|0|||
105373357|NCT00879658|363374130|FG000|Overall Study|Administrative problems|2|||
105373358|NCT00879658|363374131|FG001|Overall Study|Administrative problems|1|||
105373359|NCT00879658|363374132|FG002|Overall Study|Administrative problems|0|||
105373360|NCT00879658|363374133|FG003|Overall Study|Administrative problems|1|||
105373361|NCT00879658|363374134|FG004|Overall Study|Administrative problems|0|||
105373362|NCT00879658|363374135|FG005|Overall Study|Administrative problems|0|||
105373363|NCT00879658|363374136|FG006|Overall Study|Administrative problems|0|||
105373364|NCT00879658|363374130|FG000|Overall Study|Adverse Event|6|||
105373365|NCT00879658|363374131|FG001|Overall Study|Adverse Event|4|||
105373366|NCT00879658|363374132|FG002|Overall Study|Adverse Event|3|||
105373367|NCT00879658|363374133|FG003|Overall Study|Adverse Event|1|||
105373368|NCT00879658|363374134|FG004|Overall Study|Adverse Event|2|||
105853055|NCT01629966|365118125|FG000|Overall Study|Lack of Efficacy|5|||
105853056|NCT01629966|365118126|FG001|Overall Study|Lack of Efficacy|2|||
105853057|NCT01629966|365118127|FG002|Overall Study|Lack of Efficacy|4|||
105853058|NCT01629966|365118125|FG000|Overall Study|Adverse Event|11|||
105853059|NCT01629966|365118126|FG001|Overall Study|Adverse Event|18|||
105853060|NCT01629966|365118127|FG002|Overall Study|Adverse Event|30|||
105373369|NCT00879658|363374135|FG005|Overall Study|Adverse Event|0|||
105373370|NCT00879658|363374136|FG006|Overall Study|Adverse Event|0|||
105373371|NCT00879658|363374130|FG000|Overall Study|Protocol Violation|1|||
105373372|NCT00879658|363374131|FG001|Overall Study|Protocol Violation|0|||
105853061|NCT01150890|365118128|FG000|Overall Study|Other|0|||
105853062|NCT01150890|365118129|FG001|Overall Study|Other|1|||
105853063|NCT01150890|365118130|FG002|Overall Study|Other|0|||
105853064|NCT01150890|365118131|FG003|Overall Study|Other|2|||
105853065|NCT01150890|365118128|FG000|Overall Study|Pregnancy|0|||
105853066|NCT01150890|365118129|FG001|Overall Study|Pregnancy|0|||
105853067|NCT01150890|365118130|FG002|Overall Study|Pregnancy|0|||
105853068|NCT01150890|365118131|FG003|Overall Study|Pregnancy|1|||
105853069|NCT01150890|365118128|FG000|Overall Study|Administrative Decision|4|||
105853070|NCT01150890|365118129|FG001|Overall Study|Administrative Decision|4|||
105853071|NCT01150890|365118130|FG002|Overall Study|Administrative Decision|5|||
105853072|NCT01150890|365118131|FG003|Overall Study|Administrative Decision|6|||
105853073|NCT01150890|365118128|FG000|Overall Study|Ineligibility determined|0|||
105853074|NCT01150890|365118129|FG001|Overall Study|Ineligibility determined|1|||
105853075|NCT01150890|365118130|FG002|Overall Study|Ineligibility determined|0|||
105853076|NCT01150890|365118131|FG003|Overall Study|Ineligibility determined|0|||
105853077|NCT01150890|365118128|FG000|Overall Study|Adverse Event|0|||
105853078|NCT01150890|365118129|FG001|Overall Study|Adverse Event|0|||
105853079|NCT01150890|365118130|FG002|Overall Study|Adverse Event|2|||
105853080|NCT01150890|365118131|FG003|Overall Study|Adverse Event|0|||
105853081|NCT01150890|365118128|FG000|Overall Study|Withdrawal by Subject|0|||
105853082|NCT01150890|365118129|FG001|Overall Study|Withdrawal by Subject|0|||
105853083|NCT01150890|365118130|FG002|Overall Study|Withdrawal by Subject|2|||
105853084|NCT01150890|365118131|FG003|Overall Study|Withdrawal by Subject|1|||
105853085|NCT01150890|365118128|FG000|Overall Study|Disease progression|0|||
105853086|NCT01150890|365118129|FG001|Overall Study|Disease progression|7|||
105853087|NCT01150890|365118130|FG002|Overall Study|Disease progression|3|||
105853088|NCT01150890|365118131|FG003|Overall Study|Disease progression|7|||
105853089|NCT04568031|365118134|FG000|Overall Study|Lost to Follow-up|1|||
105853090|NCT04568031|365118135|FG001|Overall Study|Lost to Follow-up|0|||
105853091|NCT04568031|365118136|FG002|Overall Study|Lost to Follow-up|0|||
105853092|NCT04568031|365118137|FG003|Overall Study|Lost to Follow-up|0|||
105853093|NCT04568031|365118134|FG000|Overall Study|Physician Decision|1|||
105853094|NCT04568031|365118135|FG001|Overall Study|Physician Decision|0|||
105853095|NCT04568031|365118136|FG002|Overall Study|Physician Decision|1|||
105853096|NCT04568031|365118137|FG003|Overall Study|Physician Decision|0|||
105853097|NCT04568031|365118134|FG000|Overall Study|Withdrawal by Subject|1|||
105853098|NCT04568031|365118135|FG001|Overall Study|Withdrawal by Subject|0|||
105326827|NCT01686373|363196494|FG000|Overall Study|Withdrawal by Subject|0|||
105326828|NCT01686373|363196495|FG001|Overall Study|Withdrawal by Subject|1|||
105326829|NCT01686373|363196494|FG000|Overall Study|Adverse Event|0|||
105326830|NCT01686373|363196495|FG001|Overall Study|Adverse Event|1|||
105326831|NCT00360282|363196496|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
105326832|NCT00360282|363196497|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
105326833|NCT00360282|363196498|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
105326834|NCT00360282|363196499|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
105326835|NCT00360282|363196496|FG000|Second Intervention|Adverse Event|0|||
105326836|NCT00360282|363196497|FG001|Second Intervention|Adverse Event|1|||
105326837|NCT00360282|363196498|FG002|Second Intervention|Adverse Event|0|||
105373373|NCT00879658|363374132|FG002|Overall Study|Protocol Violation|0|||
105373374|NCT00879658|363374133|FG003|Overall Study|Protocol Violation|0|||
105373375|NCT00879658|363374134|FG004|Overall Study|Protocol Violation|0|||
105373376|NCT00879658|363374135|FG005|Overall Study|Protocol Violation|0|||
105373377|NCT00879658|363374136|FG006|Overall Study|Protocol Violation|0|||
105373378|NCT00879658|363374130|FG000|Overall Study|Withdrawal by Subject|3|||
105373379|NCT00879658|363374131|FG001|Overall Study|Withdrawal by Subject|0|||
105373380|NCT00879658|363374132|FG002|Overall Study|Withdrawal by Subject|2|||
105373381|NCT00879658|363374133|FG003|Overall Study|Withdrawal by Subject|0|||
105373382|NCT00879658|363374134|FG004|Overall Study|Withdrawal by Subject|0|||
105373383|NCT00879658|363374135|FG005|Overall Study|Withdrawal by Subject|1|||
105373384|NCT00879658|363374136|FG006|Overall Study|Withdrawal by Subject|0|||
105373385|NCT00879658|363374130|FG000|Overall Study|Lack of Efficacy|0|||
105373386|NCT00879658|363374131|FG001|Overall Study|Lack of Efficacy|0|||
105853099|NCT04568031|365118136|FG002|Overall Study|Withdrawal by Subject|4|||
105853100|NCT04568031|365118137|FG003|Overall Study|Withdrawal by Subject|1|||
105853101|NCT01425723|365118138|FG000|Overall Study|Lack of Efficacy|0|||
105853102|NCT01425723|365118139|FG001|Overall Study|Lack of Efficacy|1|||
105853103|NCT01425723|365118138|FG000|Overall Study|Withdrawal by Subject|1|||
105853104|NCT01425723|365118139|FG001|Overall Study|Withdrawal by Subject|4|||
105853105|NCT01425723|365118138|FG000|Overall Study|Lost to Follow-up|0|||
105853106|NCT01425723|365118139|FG001|Overall Study|Lost to Follow-up|3|||
105326838|NCT00360282|363196499|FG003|Second Intervention|Adverse Event|0|||
105853107|NCT01425723|365118138|FG000|Overall Study|Physician Decision|2|||
105853108|NCT01425723|365118139|FG001|Overall Study|Physician Decision|0|||
105373387|NCT00879658|363374132|FG002|Overall Study|Lack of Efficacy|2|||
105373388|NCT00879658|363374133|FG003|Overall Study|Lack of Efficacy|0|||
105373389|NCT00879658|363374134|FG004|Overall Study|Lack of Efficacy|0|||
105853109|NCT01425723|365118138|FG000|Overall Study|Other|1|||
105853110|NCT01425723|365118139|FG001|Overall Study|Other|10|||
105853111|NCT00186043|365118140|FG000|Overall Study|Lack of Efficacy|1|||
105853112|NCT00186043|365118141|FG001|Overall Study|Lack of Efficacy|3|||
105853113|NCT00186043|365118140|FG000|Overall Study|Lost to Follow-up|4|||
105853114|NCT00186043|365118141|FG001|Overall Study|Lost to Follow-up|6|||
105853115|NCT00186043|365118140|FG000|Overall Study|Withdrawal by Subject|1|||
105853116|NCT00186043|365118141|FG001|Overall Study|Withdrawal by Subject|0|||
105853117|NCT00186043|365118140|FG000|Overall Study|Adverse Event|7|||
105853118|NCT00186043|365118141|FG001|Overall Study|Adverse Event|3|||
105853119|NCT00186043|365118140|FG000|Overall Study|Protocol Violation|2|||
105853120|NCT00186043|365118141|FG001|Overall Study|Protocol Violation|1|||
105853121|NCT02312063|365118147|FG000|Overall Study|Withdrawal by Subject|0|||
105853122|NCT02312063|365118148|FG001|Overall Study|Withdrawal by Subject|1|||
105853123|NCT00228423|365118149|FG000|Overall Study|Adverse Event|2|||
105853124|NCT00228423|365118150|FG001|Overall Study|Adverse Event|5|||
105853125|NCT00228423|365118149|FG000|Overall Study|Withdrawal by Subject|7|||
105853126|NCT00228423|365118150|FG001|Overall Study|Withdrawal by Subject|3|||
105853127|NCT00228423|365118149|FG000|Overall Study|Protocol Violation|1|||
105853128|NCT00228423|365118150|FG001|Overall Study|Protocol Violation|3|||
105853129|NCT00228423|365118149|FG000|Overall Study|Physician Decision|0|||
105853130|NCT00228423|365118150|FG001|Overall Study|Physician Decision|1|||
105853131|NCT03258853|365118160|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
105853132|NCT03258853|365118161|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
105853133|NCT00620659|365118166|FG000|Treatment Period 1|Adverse Event|1|||
105853134|NCT00620659|365118167|FG001|Treatment Period 1|Adverse Event|0|||
105853135|NCT00620659|365118168|FG002|Treatment Period 1|Adverse Event|0|||
105853136|NCT00620659|365118169|FG003|Treatment Period 1|Adverse Event|3|||
105853137|NCT00620659|365118170|FG004|Treatment Period 1|Adverse Event|0|||
105853138|NCT00620659|365118171|FG005|Treatment Period 1|Adverse Event|0|||
105853139|NCT00620659|365118166|FG000|Treatment Period 1|Protocol Violation|1|||
105853140|NCT00620659|365118167|FG001|Treatment Period 1|Protocol Violation|0|||
105853141|NCT00620659|365118168|FG002|Treatment Period 1|Protocol Violation|0|||
105853142|NCT00620659|365118169|FG003|Treatment Period 1|Protocol Violation|0|||
105853143|NCT00620659|365118170|FG004|Treatment Period 1|Protocol Violation|0|||
105853144|NCT00620659|365118171|FG005|Treatment Period 1|Protocol Violation|0|||
105853145|NCT00620659|365118166|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105853146|NCT00620659|365118167|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105853147|NCT00620659|365118168|FG002|Treatment Period 1|Withdrawal by Subject|1|||
105853148|NCT00620659|365118169|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105853149|NCT00620659|365118170|FG004|Treatment Period 1|Withdrawal by Subject|1|||
105853150|NCT00620659|365118171|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105853151|NCT00620659|365118166|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
105853152|NCT00620659|365118167|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
105853153|NCT00620659|365118168|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
105853154|NCT00620659|365118169|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
105853155|NCT00620659|365118170|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
105853156|NCT00620659|365118171|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
105853157|NCT00620659|365118166|FG000|Treatment Period 2|Adverse Event|0|||
105853158|NCT00620659|365118167|FG001|Treatment Period 2|Adverse Event|3|||
105853159|NCT00620659|365118168|FG002|Treatment Period 2|Adverse Event|0|||
105853160|NCT00620659|365118169|FG003|Treatment Period 2|Adverse Event|0|||
105853161|NCT00620659|365118170|FG004|Treatment Period 2|Adverse Event|2|||
105853162|NCT00620659|365118171|FG005|Treatment Period 2|Adverse Event|0|||
105853163|NCT00620659|365118166|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105853164|NCT00620659|365118167|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105853165|NCT00620659|365118168|FG002|Treatment Period 2|Withdrawal by Subject|1|||
105853166|NCT00620659|365118169|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105853167|NCT00620659|365118170|FG004|Treatment Period 2|Withdrawal by Subject|3|||
105373390|NCT00879658|363374135|FG005|Overall Study|Lack of Efficacy|0|||
105853168|NCT00620659|365118171|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105853169|NCT00620659|365118166|FG000|Placebo Washout Period 2|Adverse Event|2|||
105373391|NCT00879658|363374136|FG006|Overall Study|Lack of Efficacy|0|||
105373392|NCT00879658|363374130|FG000|Overall Study|misrandomized (never received study med)|0|||
105373393|NCT00879658|363374131|FG001|Overall Study|misrandomized (never received study med)|0|||
105853170|NCT00620659|365118167|FG001|Placebo Washout Period 2|Adverse Event|0|||
105853171|NCT00620659|365118168|FG002|Placebo Washout Period 2|Adverse Event|0|||
105853172|NCT00620659|365118169|FG003|Placebo Washout Period 2|Adverse Event|0|||
105853173|NCT00620659|365118170|FG004|Placebo Washout Period 2|Adverse Event|0|||
105853174|NCT00620659|365118171|FG005|Placebo Washout Period 2|Adverse Event|0|||
105853175|NCT00620659|365118166|FG000|Treatment Period 3|Adverse Event|0|||
105853176|NCT00620659|365118167|FG001|Treatment Period 3|Adverse Event|2|||
105853177|NCT00620659|365118168|FG002|Treatment Period 3|Adverse Event|0|||
105853178|NCT00620659|365118169|FG003|Treatment Period 3|Adverse Event|0|||
105853179|NCT00620659|365118170|FG004|Treatment Period 3|Adverse Event|0|||
105853180|NCT00620659|365118171|FG005|Treatment Period 3|Adverse Event|0|||
105853181|NCT00620659|365118166|FG000|Treatment Period 3|Withdrawal by Subject|0|||
105853182|NCT00620659|365118167|FG001|Treatment Period 3|Withdrawal by Subject|0|||
105853183|NCT00620659|365118168|FG002|Treatment Period 3|Withdrawal by Subject|0|||
105853184|NCT00620659|365118169|FG003|Treatment Period 3|Withdrawal by Subject|1|||
105326839|NCT04537078|363196500|FG000|Overall Study|Protocol Violation|3|||
105326840|NCT04537078|363196501|FG001|Overall Study|Protocol Violation|2|||
105326841|NCT04537078|363196500|FG000|Overall Study|Lost to Follow-up|1|||
105326842|NCT04537078|363196501|FG001|Overall Study|Lost to Follow-up|0|||
105326843|NCT04537078|363196500|FG000|Overall Study|Withdrawal by Subject|0|||
105326844|NCT04537078|363196501|FG001|Overall Study|Withdrawal by Subject|1|||
105326845|NCT01568892|363196502|FG000|Open-label Phase|Adverse Event|2|||
105326846|NCT01568892|363196503|FG001|Open-label Phase|Adverse Event|0|||
105326847|NCT01568892|363196502|FG000|Open-label Phase|Lack of Efficacy|4|||
105326848|NCT01568892|363196503|FG001|Open-label Phase|Lack of Efficacy|2|||
105326849|NCT01568892|363196502|FG000|Open-label Phase|Lost to Follow-up|0|||
105326850|NCT01568892|363196503|FG001|Open-label Phase|Lost to Follow-up|1|||
105326851|NCT01697748|363196508|FG000|Overall Study|ineligible skin incision|1|||
105326852|NCT01697748|363196509|FG001|Overall Study|ineligible skin incision|2|||
105326853|NCT01697748|363196508|FG000|Overall Study|ineligible uterine incision|4|||
105326854|NCT01697748|363196509|FG001|Overall Study|ineligible uterine incision|1|||
105326855|NCT01697748|363196508|FG000|Overall Study|Lost to Follow-up|53|||
105326856|NCT01697748|363196509|FG001|Overall Study|Lost to Follow-up|65|||
105326857|NCT01058642|363196510|FG000|Treatment Period 1|Adverse Event|0|||
105326858|NCT01058642|363196511|FG001|Treatment Period 1|Adverse Event|1|||
105326859|NCT01058642|363196512|FG002|Treatment Period 1|Adverse Event|1|||
105326860|NCT01058642|363196513|FG003|Treatment Period 1|Adverse Event|0|||
105326861|NCT01058642|363196510|FG000|Treatment Period 1|Physician Decision|0|||
105326862|NCT01058642|363196511|FG001|Treatment Period 1|Physician Decision|0|||
105326863|NCT01058642|363196512|FG002|Treatment Period 1|Physician Decision|1|||
105326864|NCT01058642|363196513|FG003|Treatment Period 1|Physician Decision|0|||
105326865|NCT01058642|363196510|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105326866|NCT01058642|363196511|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105326867|NCT01058642|363196512|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105326868|NCT01058642|363196513|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105326869|NCT01058642|363196510|FG000|Treatment Period 1|Lack of Efficacy|0|||
105326870|NCT01058642|363196511|FG001|Treatment Period 1|Lack of Efficacy|0|||
105326871|NCT01058642|363196512|FG002|Treatment Period 1|Lack of Efficacy|0|||
105326872|NCT01058642|363196513|FG003|Treatment Period 1|Lack of Efficacy|1|||
105326873|NCT01058642|363196510|FG000|Treatment Period 1|Protocol Violation|0|||
105326874|NCT01058642|363196511|FG001|Treatment Period 1|Protocol Violation|0|||
105326875|NCT01058642|363196512|FG002|Treatment Period 1|Protocol Violation|0|||
105326876|NCT01058642|363196513|FG003|Treatment Period 1|Protocol Violation|1|||
105326877|NCT01058642|363196510|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
105326878|NCT01058642|363196511|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
105326879|NCT01058642|363196512|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
105326880|NCT01058642|363196513|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
105326881|NCT01256450|363196514|FG000|Open-label Titration|Adverse Event|39|||
105326882|NCT01256450|363196515|FG001|Open-label Titration|Adverse Event|0|||
105326883|NCT01256450|363196516|FG002|Open-label Titration|Adverse Event|0|||
105326884|NCT01256450|363196514|FG000|Open-label Titration|Lost to Follow-up|7|||
105326885|NCT01256450|363196515|FG001|Open-label Titration|Lost to Follow-up|0|||
105326886|NCT01256450|363196516|FG002|Open-label Titration|Lost to Follow-up|0|||
105326887|NCT01256450|363196514|FG000|Open-label Titration|Lack of analgesic effect|30|||
105326888|NCT01256450|363196515|FG001|Open-label Titration|Lack of analgesic effect|0|||
105326889|NCT01256450|363196516|FG002|Open-label Titration|Lack of analgesic effect|0|||
105326890|NCT01256450|363196514|FG000|Open-label Titration|Non-compliance|9|||
105326891|NCT01256450|363196515|FG001|Open-label Titration|Non-compliance|0|||
105326892|NCT01256450|363196516|FG002|Open-label Titration|Non-compliance|0|||
105326893|NCT01256450|363196514|FG000|Open-label Titration|Screen failure|1|||
105326894|NCT01256450|363196515|FG001|Open-label Titration|Screen failure|0|||
105326895|NCT01256450|363196516|FG002|Open-label Titration|Screen failure|0|||
105326896|NCT01256450|363196514|FG000|Open-label Titration|Other|13|||
105326897|NCT01256450|363196515|FG001|Open-label Titration|Other|0|||
105326898|NCT01256450|363196516|FG002|Open-label Titration|Other|0|||
105326899|NCT01256450|363196514|FG000|Double-blind Treatment|Adverse Event|0|||
105326900|NCT01256450|363196515|FG001|Double-blind Treatment|Adverse Event|8|||
105326901|NCT01256450|363196516|FG002|Double-blind Treatment|Adverse Event|6|||
105326902|NCT01256450|363196514|FG000|Double-blind Treatment|Lost to Follow-up|0|||
105326903|NCT01256450|363196515|FG001|Double-blind Treatment|Lost to Follow-up|1|||
105326904|NCT01256450|363196516|FG002|Double-blind Treatment|Lost to Follow-up|7|||
105326905|NCT01256450|363196514|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
105326906|NCT01256450|363196515|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
105326907|NCT01256450|363196516|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
105326908|NCT01256450|363196514|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
105326909|NCT01256450|363196515|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
105326910|NCT01256450|363196516|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
105326911|NCT01256450|363196514|FG000|Double-blind Treatment|Non-compliance|0|||
105326912|NCT01256450|363196515|FG001|Double-blind Treatment|Non-compliance|5|||
105326913|NCT01256450|363196516|FG002|Double-blind Treatment|Non-compliance|4|||
105853185|NCT00620659|365118170|FG004|Treatment Period 3|Withdrawal by Subject|0|||
105853186|NCT00620659|365118171|FG005|Treatment Period 3|Withdrawal by Subject|0|||
105853187|NCT02352779|365118174|FG000|Overall Study|Personal Issues|1|||
105853188|NCT02352779|365118175|FG001|Overall Study|Personal Issues|1|||
105853189|NCT02352779|365118176|FG002|Overall Study|Personal Issues|0|||
105853190|NCT02352779|365118174|FG000|Overall Study|Too Many Forms|2|||
105853191|NCT02352779|365118175|FG001|Overall Study|Too Many Forms|0|||
105853192|NCT02352779|365118176|FG002|Overall Study|Too Many Forms|0|||
105853193|NCT02352779|365118174|FG000|Overall Study|Feeling Overwhelmed|1|||
105853194|NCT02352779|365118175|FG001|Overall Study|Feeling Overwhelmed|0|||
105853195|NCT02352779|365118176|FG002|Overall Study|Feeling Overwhelmed|0|||
105853196|NCT02352779|365118174|FG000|Overall Study|Disliked Intervention|1|||
105853197|NCT02352779|365118175|FG001|Overall Study|Disliked Intervention|0|||
105853198|NCT02352779|365118176|FG002|Overall Study|Disliked Intervention|0|||
105853199|NCT02352779|365118174|FG000|Overall Study|Changed Mind|1|||
105853200|NCT02352779|365118175|FG001|Overall Study|Changed Mind|0|||
105853201|NCT02352779|365118176|FG002|Overall Study|Changed Mind|0|||
105853202|NCT02352779|365118174|FG000|Overall Study|Study Related Symptoms|1|||
105853203|NCT02352779|365118175|FG001|Overall Study|Study Related Symptoms|0|||
105853204|NCT02352779|365118176|FG002|Overall Study|Study Related Symptoms|0|||
105853205|NCT02352779|365118174|FG000|Overall Study|Absence of Symptoms|1|||
105853206|NCT02352779|365118175|FG001|Overall Study|Absence of Symptoms|0|||
105853207|NCT02352779|365118176|FG002|Overall Study|Absence of Symptoms|0|||
105853208|NCT02352779|365118174|FG000|Overall Study|Other Medical Reason|0|||
105853209|NCT02352779|365118175|FG001|Overall Study|Other Medical Reason|0|||
105853210|NCT02352779|365118176|FG002|Overall Study|Other Medical Reason|1|||
105853211|NCT02352779|365118174|FG000|Overall Study|No Reason|0|||
105853212|NCT02352779|365118175|FG001|Overall Study|No Reason|0|||
105853213|NCT02352779|365118176|FG002|Overall Study|No Reason|1|||
105853214|NCT01104779|365118181|FG000|Overall Study|Protocol Violation|1|||
105853215|NCT01104779|365118182|FG001|Overall Study|Protocol Violation|2|||
105853216|NCT01104779|365118183|FG002|Overall Study|Protocol Violation|2|||
105853217|NCT01104779|365118181|FG000|Overall Study|Lack of Efficacy|26|||
105853218|NCT01104779|365118182|FG001|Overall Study|Lack of Efficacy|12|||
105853219|NCT01104779|365118183|FG002|Overall Study|Lack of Efficacy|13|||
105853220|NCT01104779|365118181|FG000|Overall Study|Adverse Event|13|||
105853221|NCT01104779|365118182|FG001|Overall Study|Adverse Event|14|||
105853222|NCT01104779|365118183|FG002|Overall Study|Adverse Event|13|||
105853223|NCT01104779|365118181|FG000|Overall Study|Did not meet inc/exc criteria|1|||
105853224|NCT01104779|365118182|FG001|Overall Study|Did not meet inc/exc criteria|1|||
105853225|NCT01104779|365118183|FG002|Overall Study|Did not meet inc/exc criteria|1|||
105853226|NCT01104779|365118181|FG000|Overall Study|Other reasons|0|||
105853227|NCT01104779|365118182|FG001|Overall Study|Other reasons|1|||
105853228|NCT01104779|365118183|FG002|Overall Study|Other reasons|0|||
105853229|NCT01104779|365118181|FG000|Overall Study|Lost to Follow-up|2|||
105853230|NCT01104779|365118182|FG001|Overall Study|Lost to Follow-up|0|||
105853231|NCT01104779|365118183|FG002|Overall Study|Lost to Follow-up|1|||
105853232|NCT01104779|365118181|FG000|Overall Study|Withdrawal by Subject|16|||
105853233|NCT01104779|365118182|FG001|Overall Study|Withdrawal by Subject|25|||
105853234|NCT01104779|365118183|FG002|Overall Study|Withdrawal by Subject|32|||
105853235|NCT02968849|365118184|FG000|Overall Study|Death|8|||
105853236|NCT02968849|365118185|FG001|Overall Study|Death|10|||
105853237|NCT02968849|365118184|FG000|Overall Study|Lost to Follow-up|31|||
105853238|NCT02968849|365118185|FG001|Overall Study|Lost to Follow-up|29|||
105853239|NCT02968849|365118184|FG000|Overall Study|Withdrawal by Subject|73|||
105853240|NCT02968849|365118185|FG001|Overall Study|Withdrawal by Subject|64|||
105853241|NCT02968849|365118184|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
105853242|NCT02968849|365118185|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
105853243|NCT02968849|365118184|FG000|Overall Study|Physician Decision|6|||
105853244|NCT02968849|365118185|FG001|Overall Study|Physician Decision|9|||
105853245|NCT02968849|365118184|FG000|Overall Study|Other|16|||
105853246|NCT02968849|365118185|FG001|Overall Study|Other|10|||
105853247|NCT02201290|365118186|FG000|Overall Study|Withdrawal by Subject|2|||
105853248|NCT02201290|365118186|FG000|Overall Study|Lack of Efficacy|2|||
105853249|NCT02201290|365118186|FG000|Overall Study|Adverse Event|1|||
105853250|NCT00871741|365118187|FG000|Overall Study|Premature study termination|9|||
105853251|NCT00871741|365118188|FG001|Overall Study|Premature study termination|7|||
105853252|NCT01565850|365118193|FG000|Overall Study|Adverse Event|0|||
105853253|NCT01565850|365118194|FG001|Overall Study|Adverse Event|1|||
105853254|NCT01565850|365118193|FG000|Overall Study|Lost to Follow-up|12|||
105373394|NCT00879658|363374132|FG002|Overall Study|misrandomized (never received study med)|0|||
105853255|NCT01565850|365118194|FG001|Overall Study|Lost to Follow-up|4|||
105853256|NCT01565850|365118193|FG000|Overall Study|Investigator's Discretion|2|||
105853257|NCT01565850|365118194|FG001|Overall Study|Investigator's Discretion|1|||
105853258|NCT01565850|365118193|FG000|Overall Study|Participant noncompliance|2|||
105853259|NCT01565850|365118194|FG001|Overall Study|Participant noncompliance|0|||
105853260|NCT01565850|365118193|FG000|Overall Study|Withdrew Consent|4|||
105853261|NCT01565850|365118194|FG001|Overall Study|Withdrew Consent|2|||
105853262|NCT00704730|365118195|FG000|Overall Study|Adverse Event|35|||
105853263|NCT00704730|365118196|FG001|Overall Study|Adverse Event|9|||
105373395|NCT00879658|363374133|FG003|Overall Study|misrandomized (never received study med)|1|||
105373396|NCT00879658|363374134|FG004|Overall Study|misrandomized (never received study med)|0|||
105373397|NCT00879658|363374135|FG005|Overall Study|misrandomized (never received study med)|0|||
105373398|NCT00879658|363374136|FG006|Overall Study|misrandomized (never received study med)|0|||
105373399|NCT01143324|363374143|FG000|Overall Study|Lost to Follow-up|11|||
105373400|NCT01143324|363374143|FG000|Overall Study|Withdrawal by Subject|4|||
105373401|NCT01143324|363374143|FG000|Overall Study|Explant of the device|4|||
105373402|NCT02916927|363374144|FG000|Overall Study|Discharged prior to study drug receipt|0|||
105373403|NCT02916927|363374145|FG001|Overall Study|Discharged prior to study drug receipt|2|||
105373404|NCT02916927|363374144|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
105373405|NCT02916927|363374145|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
105373406|NCT02916927|363374144|FG000|Overall Study|Withdrawal before first time point|1|||
105373407|NCT02916927|363374145|FG001|Overall Study|Withdrawal before first time point|0|||
105373408|NCT01387269|363374146|FG000|Overall Study|Death|38|||
105373409|NCT01387269|363374147|FG001|Overall Study|Death|20|||
105373410|NCT01387269|363374146|FG000|Overall Study|Other|8|||
105373411|NCT01387269|363374147|FG001|Overall Study|Other|7|||
105373412|NCT01387269|363374146|FG000|Overall Study|Unrelated AE|12|||
105373413|NCT01387269|363374147|FG001|Overall Study|Unrelated AE|3|||
105373414|NCT01387269|363374146|FG000|Overall Study|Withdrawal by patient|32|||
105373415|NCT01387269|363374147|FG001|Overall Study|Withdrawal by patient|10|||
105373416|NCT01387269|363374146|FG000|Overall Study|Study drug-related AE|1|||
105373417|NCT01387269|363374147|FG001|Overall Study|Study drug-related AE|0|||
105373418|NCT01387269|363374146|FG000|Overall Study|Lost to Follow-up|1|||
105373419|NCT01387269|363374147|FG001|Overall Study|Lost to Follow-up|0|||
105492108|NCT02927262|363813974|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
105492109|NCT02927262|363813975|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
105492110|NCT02927262|363813974|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
105492111|NCT02927262|363813975|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
105326914|NCT01256450|363196514|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
105326915|NCT01256450|363196515|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
105326916|NCT01256450|363196516|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
105326917|NCT01256450|363196514|FG000|Double-blind Treatment|Other|0|||
105326918|NCT01256450|363196515|FG001|Double-blind Treatment|Other|9|||
105326919|NCT01256450|363196516|FG002|Double-blind Treatment|Other|12|||
105326920|NCT03866512|363196517|FG000|Overall Study|Lost to Follow-up|1|||
105326921|NCT03866512|363196518|FG001|Overall Study|Lost to Follow-up|2|||
105326922|NCT03866512|363196519|FG002|Overall Study|Lost to Follow-up|1|||
105326923|NCT03866512|363196517|FG000|Overall Study|Cannulation issues|0|||
105326924|NCT03866512|363196518|FG001|Overall Study|Cannulation issues|1|||
105326925|NCT03866512|363196519|FG002|Overall Study|Cannulation issues|2|||
105326926|NCT00997373|363196520|FG000|Overall Study|Withdrawal by Subject|5|||
105326927|NCT00997373|363196521|FG001|Overall Study|Withdrawal by Subject|0|||
105326928|NCT00997373|363196520|FG000|Overall Study|wrong tumor type|4|||
105326929|NCT00997373|363196521|FG001|Overall Study|wrong tumor type|0|||
105326930|NCT00997373|363196520|FG000|Overall Study|could not have hysterectomy|6|||
105326931|NCT00997373|363196521|FG001|Overall Study|could not have hysterectomy|0|||
105326932|NCT03809663|363196522|FG000|Overall Study|Decision by sponsor|24|||
105326933|NCT03809663|363196523|FG001|Overall Study|Decision by sponsor|18|||
105326934|NCT03809663|363196524|FG002|Overall Study|Decision by sponsor|20|||
105326935|NCT03809663|363196525|FG003|Overall Study|Decision by sponsor|20|||
105853264|NCT00704730|365118195|FG000|Overall Study|Death|11|||
105853265|NCT00704730|365118196|FG001|Overall Study|Death|5|||
105853266|NCT00704730|365118195|FG000|Overall Study|Physician Decision|2|||
105853267|NCT00704730|365118196|FG001|Overall Study|Physician Decision|0|||
105853268|NCT00704730|365118195|FG000|Overall Study|Did not receive drug|5|||
105853269|NCT00704730|365118196|FG001|Overall Study|Did not receive drug|2|||
105853270|NCT00704730|365118195|FG000|Overall Study|Disease progression per PI|58|||
105853271|NCT00704730|365118196|FG001|Overall Study|Disease progression per PI|67|||
105853272|NCT00704730|365118195|FG000|Overall Study|data unavailable|1|||
105853273|NCT00704730|365118196|FG001|Overall Study|data unavailable|0|||
105326936|NCT03809663|363196526|FG004|Overall Study|Decision by sponsor|0|||
105326937|NCT03809663|363196527|FG005|Overall Study|Decision by sponsor|0|||
105326938|NCT03809663|363196522|FG000|Overall Study|Withdrawal by Subject|26|||
105853274|NCT00704730|365118195|FG000|Overall Study|Withdrawal by Subject|9|||
105853275|NCT00704730|365118196|FG001|Overall Study|Withdrawal by Subject|13|||
105853276|NCT02551666|365118197|FG000|Overall Study|Withdrawal by Subject|1|||
105853277|NCT02551666|365118198|FG001|Overall Study|Withdrawal by Subject|3|||
105853278|NCT01142388|365121445|FG000|Overall Study|Lack of Efficacy|21|||
105373420|NCT01047319|363374152|FG000|Overall Study|Teva requested participant withdrawal|3|||
105853279|NCT01142388|365121446|FG001|Overall Study|Lack of Efficacy|31|||
105853280|NCT01142388|365121445|FG000|Overall Study|Adverse Event|9|||
105326939|NCT03809663|363196523|FG001|Overall Study|Withdrawal by Subject|22|||
105326940|NCT03809663|363196524|FG002|Overall Study|Withdrawal by Subject|27|||
105326941|NCT03809663|363196525|FG003|Overall Study|Withdrawal by Subject|26|||
105853281|NCT01142388|365121446|FG001|Overall Study|Adverse Event|5|||
105853282|NCT01142388|365121445|FG000|Overall Study|Death|3|||
105853283|NCT01142388|365121446|FG001|Overall Study|Death|2|||
105853284|NCT01142388|365121445|FG000|Overall Study|Withdrawal by Subject|5|||
105853285|NCT01142388|365121446|FG001|Overall Study|Withdrawal by Subject|3|||
105853286|NCT01142388|365121445|FG000|Overall Study|Alternative therapy|1|||
105853287|NCT01142388|365121446|FG001|Overall Study|Alternative therapy|0|||
105853288|NCT01142388|365121445|FG000|Overall Study|Other complications|0|||
105853289|NCT01142388|365121446|FG001|Overall Study|Other complications|2|||
105853290|NCT01142388|365121445|FG000|Overall Study|Other|1|||
105853291|NCT01142388|365121446|FG001|Overall Study|Other|1|||
105853292|NCT01142388|365121445|FG000|Overall Study|Never started therapy|7|||
105853293|NCT01142388|365121446|FG001|Overall Study|Never started therapy|3|||
105853294|NCT01274338|365121447|FG000|Overall Study|Lack of Efficacy|72|||
105853295|NCT01274338|365121448|FG001|Overall Study|Lack of Efficacy|108|||
105853296|NCT01274338|365121449|FG002|Overall Study|Lack of Efficacy|116|||
105853297|NCT01274338|365121450|FG003|Overall Study|Lack of Efficacy|0|||
105853298|NCT01274338|365121451|FG004|Overall Study|Lack of Efficacy|0|||
105853299|NCT01274338|365121452|FG005|Overall Study|Lack of Efficacy|0|||
105853300|NCT01274338|365121447|FG000|Overall Study|Adverse Event|272|||
105853301|NCT01274338|365121448|FG001|Overall Study|Adverse Event|105|||
105853302|NCT01274338|365121449|FG002|Overall Study|Adverse Event|180|||
105853303|NCT01274338|365121450|FG003|Overall Study|Adverse Event|1|||
105853304|NCT01274338|365121451|FG004|Overall Study|Adverse Event|0|||
105853305|NCT01274338|365121452|FG005|Overall Study|Adverse Event|0|||
105853306|NCT01274338|365121447|FG000|Overall Study|Death|8|||
105853307|NCT01274338|365121448|FG001|Overall Study|Death|1|||
105853308|NCT01274338|365121449|FG002|Overall Study|Death|0|||
105853309|NCT01274338|365121450|FG003|Overall Study|Death|0|||
105853310|NCT01274338|365121451|FG004|Overall Study|Death|0|||
105853311|NCT01274338|365121452|FG005|Overall Study|Death|0|||
105853312|NCT01274338|365121447|FG000|Overall Study|Withdrawal by Subject|27|||
105853313|NCT01274338|365121448|FG001|Overall Study|Withdrawal by Subject|99|||
105853314|NCT01274338|365121449|FG002|Overall Study|Withdrawal by Subject|17|||
105853315|NCT01274338|365121450|FG003|Overall Study|Withdrawal by Subject|0|||
105853316|NCT01274338|365121451|FG004|Overall Study|Withdrawal by Subject|0|||
105853317|NCT01274338|365121452|FG005|Overall Study|Withdrawal by Subject|0|||
105853318|NCT01274338|365121447|FG000|Overall Study|Did not start treatment|8|||
105853319|NCT01274338|365121448|FG001|Overall Study|Did not start treatment|116|||
105853320|NCT01274338|365121449|FG002|Overall Study|Did not start treatment|7|||
105853321|NCT01274338|365121450|FG003|Overall Study|Did not start treatment|0|||
105853322|NCT01274338|365121451|FG004|Overall Study|Did not start treatment|0|||
105853323|NCT01274338|365121452|FG005|Overall Study|Did not start treatment|0|||
105853324|NCT01274338|365121447|FG000|Overall Study|Alternative therapy|0|||
105853325|NCT01274338|365121448|FG001|Overall Study|Alternative therapy|1|||
105853326|NCT01274338|365121449|FG002|Overall Study|Alternative therapy|0|||
105853327|NCT01274338|365121450|FG003|Overall Study|Alternative therapy|0|||
105853328|NCT01274338|365121451|FG004|Overall Study|Alternative therapy|0|||
105853329|NCT01274338|365121452|FG005|Overall Study|Alternative therapy|0|||
105853330|NCT01274338|365121447|FG000|Overall Study|Other complicating diseases|0|||
105853331|NCT01274338|365121448|FG001|Overall Study|Other complicating diseases|3|||
105853332|NCT01274338|365121449|FG002|Overall Study|Other complicating diseases|1|||
105853333|NCT01274338|365121450|FG003|Overall Study|Other complicating diseases|0|||
105853334|NCT01274338|365121451|FG004|Overall Study|Other complicating diseases|0|||
105853335|NCT01274338|365121452|FG005|Overall Study|Other complicating diseases|0|||
105853336|NCT01274338|365121447|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
105853337|NCT01274338|365121448|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
105853338|NCT01274338|365121449|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
105853339|NCT01274338|365121450|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
105853340|NCT01274338|365121451|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
105853341|NCT01274338|365121452|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
105853342|NCT01274338|365121447|FG000|Overall Study|Pregnancy|0|||
105853343|NCT01274338|365121448|FG001|Overall Study|Pregnancy|0|||
105853344|NCT01274338|365121449|FG002|Overall Study|Pregnancy|1|||
105853345|NCT01274338|365121450|FG003|Overall Study|Pregnancy|0|||
105853346|NCT01274338|365121451|FG004|Overall Study|Pregnancy|0|||
105853347|NCT01274338|365121452|FG005|Overall Study|Pregnancy|0|||
105853348|NCT01274338|365121447|FG000|Overall Study|Reason not reported|12|||
105853349|NCT01274338|365121448|FG001|Overall Study|Reason not reported|21|||
105853350|NCT01274338|365121449|FG002|Overall Study|Reason not reported|3|||
105853351|NCT01274338|365121450|FG003|Overall Study|Reason not reported|0|||
105853352|NCT01274338|365121451|FG004|Overall Study|Reason not reported|1|||
105853353|NCT01274338|365121452|FG005|Overall Study|Reason not reported|0|||
105853354|NCT01386385|365121453|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
105853355|NCT01386385|365121454|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
105853356|NCT01386385|365121455|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
105853357|NCT01386385|365121456|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
105853358|NCT01386385|365121457|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
105853359|NCT01386385|365121458|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
105853360|NCT01386385|365121459|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
105853361|NCT01386385|365121460|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
105326942|NCT03809663|363196526|FG004|Overall Study|Withdrawal by Subject|0|||
105326943|NCT03809663|363196527|FG005|Overall Study|Withdrawal by Subject|0|||
105853362|NCT01386385|365121453|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
105853363|NCT01386385|365121454|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
105853364|NCT01386385|365121455|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
105853365|NCT01386385|365121456|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
105853366|NCT01386385|365121457|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
105853367|NCT01386385|365121458|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
105853368|NCT01386385|365121459|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
105853369|NCT01386385|365121460|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
105853370|NCT01386385|365121453|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
105853371|NCT01386385|365121454|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
105853372|NCT01386385|365121455|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
105853373|NCT01386385|365121456|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
105853374|NCT01386385|365121457|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
105853375|NCT01386385|365121458|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
105853376|NCT01386385|365121459|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
105853377|NCT01386385|365121460|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
105853378|NCT01386385|365121453|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
105853379|NCT01386385|365121454|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
105853380|NCT01386385|365121455|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
105853381|NCT01386385|365121456|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
105853382|NCT01386385|365121457|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
105853383|NCT01386385|365121458|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
105853384|NCT01386385|365121459|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
105853385|NCT01386385|365121460|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
105853386|NCT01386385|365121453|FG000|Phase II Concurrent CRT|Adverse Event|0|||
105853387|NCT01386385|365121454|FG001|Phase II Concurrent CRT|Adverse Event|0|||
105853388|NCT01386385|365121455|FG002|Phase II Concurrent CRT|Adverse Event|0|||
105853389|NCT01386385|365121456|FG003|Phase II Concurrent CRT|Adverse Event|0|||
105853390|NCT01386385|365121457|FG004|Phase II Concurrent CRT|Adverse Event|0|||
105853391|NCT01386385|365121458|FG005|Phase II Concurrent CRT|Adverse Event|0|||
105853392|NCT01386385|365121459|FG006|Phase II Concurrent CRT|Adverse Event|3|||
105853393|NCT01386385|365121460|FG007|Phase II Concurrent CRT|Adverse Event|3|||
105853394|NCT01386385|365121453|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
105853395|NCT01386385|365121454|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
105853396|NCT01386385|365121455|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
105853397|NCT01386385|365121456|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
105853398|NCT01386385|365121457|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
105853399|NCT01386385|365121458|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
105853400|NCT01386385|365121459|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
105853401|NCT01386385|365121460|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
105853402|NCT01386385|365121453|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
105853403|NCT01386385|365121454|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
105853404|NCT01386385|365121455|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
105853405|NCT01386385|365121456|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
105853406|NCT01386385|365121457|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
105853407|NCT01386385|365121458|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
105853408|NCT01386385|365121459|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
105853409|NCT01386385|365121460|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
105853410|NCT01386385|365121453|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
105853411|NCT01386385|365121454|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
105853412|NCT01386385|365121455|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
105853413|NCT01386385|365121456|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
105853414|NCT01386385|365121457|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
105853415|NCT01386385|365121458|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
105326944|NCT03809663|363196522|FG000|Overall Study|Lost to Follow-up|1|||
105326945|NCT03809663|363196523|FG001|Overall Study|Lost to Follow-up|4|||
105326946|NCT03809663|363196524|FG002|Overall Study|Lost to Follow-up|1|||
105326947|NCT03809663|363196525|FG003|Overall Study|Lost to Follow-up|1|||
105326948|NCT03809663|363196526|FG004|Overall Study|Lost to Follow-up|0|||
105326949|NCT03809663|363196527|FG005|Overall Study|Lost to Follow-up|0|||
105326950|NCT02275819|363196530|FG000|Overall Study|Adverse Event|0|||
105326951|NCT02275819|363196531|FG001|Overall Study|Adverse Event|1|||
105326952|NCT00777296|363196535|FG000|Overall Study|Adverse Event|0|||
105326953|NCT00777296|363196536|FG001|Overall Study|Adverse Event|1|||
105326954|NCT00777296|363196537|FG002|Overall Study|Adverse Event|0|||
105853416|NCT01386385|365121459|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
105853417|NCT01386385|365121460|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
105853418|NCT01386385|365121453|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
105326955|NCT00777296|363196538|FG003|Overall Study|Adverse Event|1|||
105326956|NCT00777296|363196535|FG000|Overall Study|Withdrawal by Subject|1|||
105326957|NCT00777296|363196536|FG001|Overall Study|Withdrawal by Subject|0|||
105326958|NCT00777296|363196537|FG002|Overall Study|Withdrawal by Subject|0|||
105326959|NCT00777296|363196538|FG003|Overall Study|Withdrawal by Subject|0|||
105326960|NCT00777296|363196535|FG000|Overall Study|CRF form not completed|0|||
105326961|NCT00777296|363196536|FG001|Overall Study|CRF form not completed|0|||
105326962|NCT00777296|363196537|FG002|Overall Study|CRF form not completed|2|||
105326963|NCT00777296|363196538|FG003|Overall Study|CRF form not completed|0|||
105326964|NCT00931255|363196539|FG000|Overall Study|Follow up biopsy not done|2|||
105326965|NCT00931255|363196540|FG001|Overall Study|Follow up biopsy not done|3|||
105326966|NCT05000164|363196542|FG000|Overall Study|Adverse Event|1|||
105326967|NCT05000164|363196542|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
105326968|NCT05000164|363196542|FG000|Overall Study|Lens Discomfort|3|||
105326969|NCT05000164|363196542|FG000|Overall Study|Withdrew Consent during Study|2|||
105492112|NCT02927262|363813974|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
105492113|NCT02927262|363813975|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
105492114|NCT02927262|363813974|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
105492115|NCT02927262|363813975|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
105492116|NCT02927262|363813974|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
105492117|NCT02927262|363813975|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
105492118|NCT02927262|363813974|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
105492119|NCT02927262|363813975|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
105492120|NCT02927262|363813974|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
105492121|NCT02927262|363813975|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
105492122|NCT00923936|363813976|FG000|Overall Study|progressive disease on study|2|||
105492123|NCT00923936|363813977|FG001|Overall Study|progressive disease on study|1|||
105492124|NCT00923936|363813976|FG000|Overall Study|Adverse Event|2|||
105492125|NCT00923936|363813977|FG001|Overall Study|Adverse Event|1|||
105492126|NCT00923936|363813976|FG000|Overall Study|Lost to follow up|2|||
105492127|NCT00923936|363813977|FG001|Overall Study|Lost to follow up|0|||
105492128|NCT00923936|363813976|FG000|Overall Study|Continuing in follow up period|2|||
105492129|NCT00923936|363813977|FG001|Overall Study|Continuing in follow up period|1|||
105492130|NCT05298306|363813980|FG000|Overall Study|Physician Decision|0|||
105492131|NCT05298306|363813981|FG001|Overall Study|Physician Decision|0|||
105492132|NCT05298306|363813982|FG002|Overall Study|Physician Decision|0|||
105492133|NCT05298306|363813983|FG003|Overall Study|Physician Decision|1|||
105492134|NCT05298306|363813984|FG004|Overall Study|Physician Decision|0|||
105492135|NCT05298306|363813985|FG005|Overall Study|Physician Decision|0|||
105492136|NCT00467610|363813989|FG000|Overall Study|Withdrawal by Subject|1|||
105492137|NCT00986479|363813990|FG000|Period 1|Improved mood|1|||
105492138|NCT00986479|363813991|FG001|Period 1|Improved mood|0|||
105492139|NCT00986479|363813990|FG000|Period 1|Administrative reasons|1|||
105577088|NCT00849680|364112168|FG004|Overall Study|Withdrawal by Subject|2|||
105577089|NCT00849680|364112169|FG005|Overall Study|Withdrawal by Subject|2|||
105853419|NCT01386385|365121454|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
105853420|NCT01386385|365121455|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
105853421|NCT01386385|365121456|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
105853422|NCT01386385|365121457|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
105853423|NCT01386385|365121458|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
105853424|NCT01386385|365121459|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
105853425|NCT01386385|365121460|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
105853426|NCT04179175|365121462|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
105853427|NCT04179175|365121463|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
105853428|NCT04179175|365121464|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
105853429|NCT04179175|365121465|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
105853430|NCT04179175|365121466|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
105853431|NCT04179175|365121467|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
105577090|NCT00849680|364112170|FG006|Overall Study|Withdrawal by Subject|1|||
105577091|NCT00849680|364112171|FG007|Overall Study|Withdrawal by Subject|1|||
105326970|NCT05000164|363196542|FG000|Overall Study|Subject Withdrawn by PI|2|||
105326971|NCT05000164|363196542|FG000|Overall Study|Other Fractured Test Article|1|||
105577092|NCT00849680|364112164|FG000|Overall Study|Subject unable to comply with protocol|1|||
105492140|NCT00986479|363813991|FG001|Period 1|Administrative reasons|0|||
105492141|NCT01702571|363814001|FG000|Overall Study|Death|1067|||
105492142|NCT01702571|363814002|FG001|Overall Study|Death|76|||
105326972|NCT03493854|363196543|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
105853432|NCT04179175|365121462|FG000|Overall Study|Adverse Event|5|||
105853433|NCT04179175|365121463|FG001|Overall Study|Adverse Event|3|||
105853434|NCT04179175|365121464|FG002|Overall Study|Adverse Event|3|||
105853435|NCT04179175|365121465|FG003|Overall Study|Adverse Event|4|||
105853436|NCT04179175|365121466|FG004|Overall Study|Adverse Event|6|||
105853437|NCT04179175|365121467|FG005|Overall Study|Adverse Event|6|||
105853438|NCT04179175|365121462|FG000|Overall Study|Lack of Efficacy|5|||
105853439|NCT04179175|365121463|FG001|Overall Study|Lack of Efficacy|1|||
105853440|NCT04179175|365121464|FG002|Overall Study|Lack of Efficacy|3|||
105577093|NCT00849680|364112165|FG001|Overall Study|Subject unable to comply with protocol|0|||
105577094|NCT00849680|364112166|FG002|Overall Study|Subject unable to comply with protocol|0|||
105577095|NCT00849680|364112167|FG003|Overall Study|Subject unable to comply with protocol|0|||
105577096|NCT00849680|364112168|FG004|Overall Study|Subject unable to comply with protocol|0|||
105577097|NCT00849680|364112169|FG005|Overall Study|Subject unable to comply with protocol|0|||
105577098|NCT00849680|364112170|FG006|Overall Study|Subject unable to comply with protocol|0|||
105577099|NCT00849680|364112171|FG007|Overall Study|Subject unable to comply with protocol|0|||
105577100|NCT01265823|364112172|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
105577101|NCT01265823|364112172|FG000|Overall Study|Failure to Return|4|||
105577102|NCT01265823|364112172|FG000|Overall Study|Protocol Violation|1|||
105577103|NCT01265823|364112172|FG000|Overall Study|Participant Request|1|||
105577104|NCT04170296|364112173|FG000|Overall Study|Adverse Event|1|||
105577105|NCT04170296|364112174|FG001|Overall Study|Adverse Event|0|||
105577106|NCT04170296|364112173|FG000|Overall Study|Withdrawal by Subject|3|||
105577107|NCT04170296|364112174|FG001|Overall Study|Withdrawal by Subject|2|||
105577108|NCT04170296|364112173|FG000|Overall Study|Lost to Follow-up|4|||
105853441|NCT04179175|365121465|FG003|Overall Study|Lack of Efficacy|2|||
105853442|NCT04179175|365121466|FG004|Overall Study|Lack of Efficacy|18|||
105853443|NCT04179175|365121467|FG005|Overall Study|Lack of Efficacy|7|||
105853444|NCT04179175|365121462|FG000|Overall Study|Lost to Follow-up|5|||
105853445|NCT04179175|365121463|FG001|Overall Study|Lost to Follow-up|3|||
105853446|NCT04179175|365121464|FG002|Overall Study|Lost to Follow-up|2|||
105853447|NCT04179175|365121465|FG003|Overall Study|Lost to Follow-up|2|||
105853448|NCT04179175|365121466|FG004|Overall Study|Lost to Follow-up|4|||
105853449|NCT04179175|365121467|FG005|Overall Study|Lost to Follow-up|5|||
105853450|NCT04179175|365121462|FG000|Overall Study|Physician Decision|2|||
105853451|NCT04179175|365121463|FG001|Overall Study|Physician Decision|0|||
105853452|NCT04179175|365121464|FG002|Overall Study|Physician Decision|2|||
105853453|NCT04179175|365121465|FG003|Overall Study|Physician Decision|3|||
105853454|NCT04179175|365121466|FG004|Overall Study|Physician Decision|1|||
105853455|NCT04179175|365121467|FG005|Overall Study|Physician Decision|1|||
105853456|NCT04179175|365121462|FG000|Overall Study|Pregnancy|3|||
105853457|NCT04179175|365121463|FG001|Overall Study|Pregnancy|0|||
105853458|NCT04179175|365121464|FG002|Overall Study|Pregnancy|3|||
105853459|NCT04179175|365121465|FG003|Overall Study|Pregnancy|0|||
105853460|NCT04179175|365121466|FG004|Overall Study|Pregnancy|1|||
105853461|NCT04179175|365121467|FG005|Overall Study|Pregnancy|2|||
105853462|NCT04179175|365121462|FG000|Overall Study|Withdrawal by Subject|22|||
105853463|NCT04179175|365121463|FG001|Overall Study|Withdrawal by Subject|10|||
105853464|NCT04179175|365121464|FG002|Overall Study|Withdrawal by Subject|12|||
105853465|NCT04179175|365121465|FG003|Overall Study|Withdrawal by Subject|8|||
105853466|NCT04179175|365121466|FG004|Overall Study|Withdrawal by Subject|23|||
105853467|NCT04179175|365121467|FG005|Overall Study|Withdrawal by Subject|31|||
105373421|NCT01047319|363374153|FG001|Overall Study|Teva requested participant withdrawal|0|||
105373422|NCT01047319|363374154|FG002|Overall Study|Teva requested participant withdrawal|1|||
105373423|NCT01047319|363374152|FG000|Overall Study|Protocol Violation|3|||
105373424|NCT01047319|363374153|FG001|Overall Study|Protocol Violation|2|||
105373425|NCT01047319|363374154|FG002|Overall Study|Protocol Violation|4|||
105373426|NCT01047319|363374152|FG000|Overall Study|Lack of Efficacy|4|||
105373427|NCT01047319|363374153|FG001|Overall Study|Lack of Efficacy|3|||
105373428|NCT01047319|363374154|FG002|Overall Study|Lack of Efficacy|3|||
105853468|NCT04179175|365121462|FG000|Overall Study|Technical problems|0|||
105853469|NCT04179175|365121463|FG001|Overall Study|Technical problems|0|||
105853470|NCT04179175|365121464|FG002|Overall Study|Technical problems|1|||
105853471|NCT04179175|365121465|FG003|Overall Study|Technical problems|1|||
105853472|NCT04179175|365121466|FG004|Overall Study|Technical problems|0|||
105853473|NCT04179175|365121467|FG005|Overall Study|Technical problems|0|||
105853474|NCT06025396|365121470|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
105373429|NCT01047319|363374152|FG000|Overall Study|Death|5|||
105373430|NCT01047319|363374153|FG001|Overall Study|Death|1|||
105373431|NCT01047319|363374154|FG002|Overall Study|Death|5|||
105853475|NCT06025396|365121471|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
105853476|NCT06025396|365121472|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
105577109|NCT04170296|364112174|FG001|Overall Study|Lost to Follow-up|2|||
105577110|NCT00556374|364112178|FG000|Overall Study|Withdrawal by Subject|235|||
105577111|NCT00556374|364112179|FG001|Overall Study|Withdrawal by Subject|205|||
105373432|NCT01047319|363374152|FG000|Overall Study|Pregnancy|13|||
105577112|NCT00556374|364112178|FG000|Overall Study|Death|158|||
105853477|NCT06025396|365121473|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
105853478|NCT06025396|365121474|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
105853479|NCT06025396|365121470|FG000|Overall Study|Withdrawal by Subject|0|||
105853480|NCT06025396|365121471|FG001|Overall Study|Withdrawal by Subject|1|||
105853481|NCT06025396|365121472|FG002|Overall Study|Withdrawal by Subject|1|||
105853482|NCT06025396|365121473|FG003|Overall Study|Withdrawal by Subject|0|||
105853483|NCT06025396|365121474|FG004|Overall Study|Withdrawal by Subject|0|||
105853484|NCT02775851|365121475|FG000|Overall Study|Adverse Event|1|||
105853485|NCT02775851|365121476|FG001|Overall Study|Adverse Event|10|||
105853486|NCT02775851|365121475|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
105853487|NCT02775851|365121476|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
105853488|NCT02775851|365121475|FG000|Overall Study|Progression/Relapse|0|||
105577113|NCT00556374|364112179|FG001|Overall Study|Death|127|||
105577114|NCT00556374|364112178|FG000|Overall Study|Lost to Follow-up|24|||
105577115|NCT00556374|364112179|FG001|Overall Study|Lost to Follow-up|17|||
105577116|NCT00556374|364112178|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
105577117|NCT00556374|364112179|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
105577118|NCT00544544|364112180|FG000|Overall Study|Withdrawal by Subject|1|||
105577119|NCT00544544|364112180|FG000|Overall Study|Adverse Event|1|||
105577120|NCT00544544|364112180|FG000|Overall Study|Lost to Follow-up|1|||
105577121|NCT01291225|364112182|FG000|Overall Study|Lost to Follow-up|85|||
105577122|NCT01291225|364112183|FG001|Overall Study|Lost to Follow-up|39|||
105577123|NCT02855164|364112190|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
105853489|NCT02775851|365121476|FG001|Overall Study|Progression/Relapse|4|||
105853490|NCT02775851|365121475|FG000|Overall Study|Other - Not Protocol Specified|0|||
105853491|NCT02775851|365121476|FG001|Overall Study|Other - Not Protocol Specified|7|||
105853492|NCT02775851|365121475|FG000|Overall Study|Withdrawal by Subject|1|||
105853493|NCT02775851|365121476|FG001|Overall Study|Withdrawal by Subject|0|||
105853494|NCT03938324|365121478|FG000|Overall Study|Lost to Follow-up|42|||
105853495|NCT03938324|365121479|FG001|Overall Study|Lost to Follow-up|21|||
105853496|NCT03938324|365121478|FG000|Overall Study|Withdrawal by Subject|6|||
105853497|NCT03938324|365121479|FG001|Overall Study|Withdrawal by Subject|1|||
105853498|NCT05691829|365121480|FG000|Overall Study|Physician Decision|2|||
105853499|NCT05691829|365121480|FG000|Overall Study|Eligibility criteria not met|3|||
105853500|NCT02769962|365121481|FG000|Overall Study|Physician Decision|0|||
105853501|NCT02769962|365121482|FG001|Overall Study|Physician Decision|0|||
105853502|NCT02769962|365121483|FG002|Overall Study|Physician Decision|0|||
105853503|NCT02769962|365121484|FG003|Overall Study|Physician Decision|0|||
105853504|NCT02769962|365121485|FG004|Overall Study|Physician Decision|0|||
105853505|NCT02769962|365121486|FG005|Overall Study|Physician Decision|1|||
105853506|NCT02769962|365121487|FG006|Overall Study|Physician Decision|0|||
105853507|NCT02769962|365121488|FG007|Overall Study|Physician Decision|1|||
105853508|NCT02769962|365121481|FG000|Overall Study|Refused further treatment|0|||
105853509|NCT02769962|365121482|FG001|Overall Study|Refused further treatment|0|||
105853510|NCT02769962|365121483|FG002|Overall Study|Refused further treatment|0|||
105853511|NCT02769962|365121484|FG003|Overall Study|Refused further treatment|0|||
105853512|NCT02769962|365121485|FG004|Overall Study|Refused further treatment|0|||
105853513|NCT02769962|365121486|FG005|Overall Study|Refused further treatment|1|||
105853514|NCT02769962|365121487|FG006|Overall Study|Refused further treatment|1|||
105853515|NCT02769962|365121488|FG007|Overall Study|Refused further treatment|0|||
105853516|NCT03737994|365121489|FG000|Overall Study|Withdrawal by Subject|0|||
105853517|NCT03737994|365121490|FG001|Overall Study|Withdrawal by Subject|0|||
105853518|NCT03737994|365121491|FG002|Overall Study|Withdrawal by Subject|0|||
105853519|NCT03737994|365121492|FG003|Overall Study|Withdrawal by Subject|0|||
105853520|NCT03737994|365121493|FG004|Overall Study|Withdrawal by Subject|0|||
105853521|NCT03737994|365121494|FG005|Overall Study|Withdrawal by Subject|0|||
105853522|NCT03737994|365121495|FG006|Overall Study|Withdrawal by Subject|1|||
105853523|NCT03548207|365121496|FG000|Overall Study|Death|10|||
105853524|NCT03548207|365121497|FG001|Overall Study|Death|23|||
105853525|NCT03548207|365121498|FG002|Overall Study|Death|3|||
105853526|NCT03548207|365121496|FG000|Overall Study|Lost to Follow-up|0|||
105853527|NCT03548207|365121497|FG001|Overall Study|Lost to Follow-up|2|||
105853528|NCT03548207|365121498|FG002|Overall Study|Lost to Follow-up|0|||
105853529|NCT03548207|365121496|FG000|Overall Study|Withdrawal by Subject|0|||
105853530|NCT03548207|365121497|FG001|Overall Study|Withdrawal by Subject|3|||
105853531|NCT03548207|365121498|FG002|Overall Study|Withdrawal by Subject|0|||
105853532|NCT03548207|365121496|FG000|Overall Study|Sponsor decision|19|||
105853533|NCT03548207|365121497|FG001|Overall Study|Sponsor decision|40|||
105853534|NCT03548207|365121498|FG002|Overall Study|Sponsor decision|6|||
105853535|NCT03548207|365121496|FG000|Overall Study|Randomized but not treated|6|||
105853536|NCT03548207|365121497|FG001|Overall Study|Randomized but not treated|10|||
105853537|NCT03548207|365121498|FG002|Overall Study|Randomized but not treated|4|||
105853538|NCT01286272|365121503|FG000|Overall Study|Ineligible after beginning treatment|1|||
105853539|NCT01286272|365121504|FG001|Overall Study|Ineligible after beginning treatment|3|||
105577124|NCT02855164|364112191|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
105577125|NCT02855164|364112192|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
105853540|NCT00937937|365121507|FG000|Overall Study|Adverse Event|6|||
105373433|NCT01047319|363374153|FG001|Overall Study|Pregnancy|8|||
105373434|NCT01047319|363374154|FG002|Overall Study|Pregnancy|8|||
105373435|NCT01047319|363374152|FG000|Overall Study|Physician Decision|12|||
105373436|NCT01047319|363374153|FG001|Overall Study|Physician Decision|9|||
105373437|NCT01047319|363374154|FG002|Overall Study|Physician Decision|10|||
105373438|NCT01047319|363374152|FG000|Overall Study|Lost to Follow-up|14|||
105373439|NCT01047319|363374153|FG001|Overall Study|Lost to Follow-up|10|||
105373440|NCT01047319|363374154|FG002|Overall Study|Lost to Follow-up|10|||
105373441|NCT01047319|363374152|FG000|Overall Study|Adverse Event|16|||
105373442|NCT01047319|363374153|FG001|Overall Study|Adverse Event|27|||
105373443|NCT01047319|363374154|FG002|Overall Study|Adverse Event|21|||
105373444|NCT01047319|363374152|FG000|Overall Study|Withdrawal by Subject|77|||
105373445|NCT01047319|363374153|FG001|Overall Study|Withdrawal by Subject|75|||
105373446|NCT01047319|363374154|FG002|Overall Study|Withdrawal by Subject|87|||
105373447|NCT01047319|363374152|FG000|Overall Study|Study terminated by Sponsor|198|||
105373448|NCT01047319|363374153|FG001|Overall Study|Study terminated by Sponsor|215|||
105373449|NCT01047319|363374154|FG002|Overall Study|Study terminated by Sponsor|203|||
105373450|NCT02273167|363374160|FG000|Overall Study|Adverse Event|1|||
105373451|NCT02273167|363374161|FG001|Overall Study|Adverse Event|0|||
105373452|NCT02273167|363374162|FG002|Overall Study|Adverse Event|0|||
105373453|NCT02273167|363374160|FG000|Overall Study|Protocol Violation|3|||
105373454|NCT02273167|363374161|FG001|Overall Study|Protocol Violation|1|||
105373455|NCT02273167|363374162|FG002|Overall Study|Protocol Violation|1|||
105373456|NCT02273167|363374160|FG000|Overall Study|Lost to Follow-up|0|||
105373457|NCT02273167|363374161|FG001|Overall Study|Lost to Follow-up|1|||
105373458|NCT02273167|363374162|FG002|Overall Study|Lost to Follow-up|1|||
105373459|NCT02273167|363374160|FG000|Overall Study|Withdrawal by Subject|10|||
105373460|NCT02273167|363374161|FG001|Overall Study|Withdrawal by Subject|12|||
105373461|NCT02273167|363374162|FG002|Overall Study|Withdrawal by Subject|11|||
105373462|NCT02273167|363374160|FG000|Overall Study|Various|10|||
105373463|NCT02273167|363374161|FG001|Overall Study|Various|9|||
105373464|NCT02273167|363374162|FG002|Overall Study|Various|8|||
105373465|NCT01157845|363374163|FG000|Overall Study|Lost to Follow-up|5|||
105373466|NCT01157845|363374163|FG000|Overall Study|Withdrawal by Subject|12|||
105373467|NCT01157845|363374163|FG000|Overall Study|Physician Decision|3|||
105373468|NCT01157845|363374163|FG000|Overall Study|Protocol Violation|13|||
105373469|NCT01157845|363374163|FG000|Overall Study|Study was ended|1|||
105373470|NCT01157845|363374163|FG000|Overall Study|Device malfunction|1|||
105373471|NCT00834041|363374165|FG000|Overall Study|Withdrawal by Subject|1|||
105373472|NCT00834041|363374166|FG001|Overall Study|Withdrawal by Subject|0|||
105373473|NCT00834041|363374165|FG000|Overall Study|Lost to Follow-up|0|||
105373474|NCT00834041|363374166|FG001|Overall Study|Lost to Follow-up|1|||
105373475|NCT00849056|363376221|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
105373476|NCT00849056|363376222|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
105373477|NCT00849056|363376221|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
105373478|NCT00849056|363376222|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
105373479|NCT00849056|363376221|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
105373480|NCT00849056|363376222|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
105373481|NCT00849056|363376221|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
105373482|NCT00849056|363376222|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
105373483|NCT00849056|363376221|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
105373484|NCT00849056|363376222|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
105373485|NCT00849056|363376221|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
105373486|NCT00849056|363376222|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
105373487|NCT00849056|363376221|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
105373488|NCT00849056|363376222|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
105373489|NCT00849056|363376221|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
105373490|NCT00849056|363376222|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
105373491|NCT00849056|363376221|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
105492143|NCT01702571|363814001|FG000|Overall Study|Lost to Follow-up|144|||
105492144|NCT01702571|363814002|FG001|Overall Study|Lost to Follow-up|10|||
105492145|NCT01702571|363814001|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
105492146|NCT01702571|363814002|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
105492147|NCT01702571|363814001|FG000|Overall Study|Investigator Decision|5|||
105492148|NCT01702571|363814002|FG001|Overall Study|Investigator Decision|0|||
105492149|NCT01702571|363814001|FG000|Overall Study|Not Classifiable|1|||
105492150|NCT01702571|363814002|FG001|Overall Study|Not Classifiable|0|||
105492151|NCT01702571|363814001|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
105853541|NCT00937937|365121507|FG000|Overall Study|Withdrawal by Subject|2|||
105373492|NCT00849056|363376222|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
105373493|NCT00849056|363376221|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
105492152|NCT01702571|363814002|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
105373494|NCT00849056|363376222|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
105373495|NCT00849056|363376221|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
105373496|NCT00849056|363376222|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
105853542|NCT00937937|365121507|FG000|Overall Study|Progression/relapse|61|||
105853543|NCT00937937|365121507|FG000|Overall Study|Death|1|||
105853544|NCT00937937|365121507|FG000|Overall Study|Other|2|||
105853545|NCT03563716|365121508|FG000|Overall Study|Death|20|||
105853546|NCT03563716|365121509|FG001|Overall Study|Death|14|||
105853547|NCT03563716|365121508|FG000|Overall Study|Withdrawal by Subject|3|||
105853548|NCT03563716|365121509|FG001|Overall Study|Withdrawal by Subject|3|||
105853549|NCT03563716|365121508|FG000|Overall Study|Still on Study|45|||
105853550|NCT03563716|365121509|FG001|Overall Study|Still on Study|50|||
105326973|NCT03493854|363196544|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
105326974|NCT03493854|363196543|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
105326975|NCT03493854|363196544|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
105326976|NCT03493854|363196543|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
105326977|NCT03493854|363196544|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
105326978|NCT03493854|363196543|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
105326979|NCT03493854|363196544|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
105326980|NCT03493854|363196543|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
105326981|NCT03493854|363196544|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
105326982|NCT03493854|363196543|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
105326983|NCT03493854|363196544|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
105326984|NCT03493854|363196543|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
105326985|NCT03493854|363196544|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
105326986|NCT03493854|363196543|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
105326987|NCT03493854|363196544|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
105326988|NCT03493854|363196543|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
105326989|NCT03493854|363196544|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
105326990|NCT03493854|363196543|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
105326991|NCT03493854|363196544|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
105326992|NCT03493854|363196543|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
105326993|NCT03493854|363196544|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
105326994|NCT03493854|363196543|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
105326995|NCT03493854|363196544|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
105326996|NCT03493854|363196543|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
105326997|NCT03493854|363196544|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
105326998|NCT03493854|363196543|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
105326999|NCT03493854|363196544|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
105327000|NCT03493854|363196543|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
105327001|NCT03493854|363196544|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
105327002|NCT03493854|363196543|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
105327003|NCT03493854|363196544|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
105327004|NCT03493854|363196543|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
105327005|NCT03493854|363196544|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
105327006|NCT03493854|363196543|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
105327007|NCT03493854|363196544|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
105327008|NCT01753570|363196545|FG000|Overall Study|Adverse Event|1|||
105327009|NCT01753570|363196546|FG001|Overall Study|Adverse Event|0|||
105327010|NCT01753570|363196547|FG002|Overall Study|Adverse Event|1|||
105327011|NCT01753570|363196545|FG000|Overall Study|Physician Decision|0|||
105327012|NCT01753570|363196546|FG001|Overall Study|Physician Decision|1|||
105327013|NCT01753570|363196547|FG002|Overall Study|Physician Decision|0|||
105327014|NCT01753570|363196545|FG000|Overall Study|Withdrawal by Subject|1|||
105327015|NCT01753570|363196546|FG001|Overall Study|Withdrawal by Subject|4|||
105327016|NCT01753570|363196547|FG002|Overall Study|Withdrawal by Subject|0|||
105327017|NCT01000155|363196548|FG000|Overall Study|Withdrawal by Subject|1|||
105327018|NCT01000155|363196548|FG000|Overall Study|Adverse Event|1|||
105327019|NCT00720213|363196553|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
105327020|NCT00720213|363196554|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
105327021|NCT00720213|363196555|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
105327022|NCT01808066|363196557|FG000|Overall Study|Withdrawal by Subject|15|||
105327023|NCT00806403|363196562|FG000|Overall Study|Death|4|||
105327024|NCT00806403|363196563|FG001|Overall Study|Death|3|||
105327025|NCT00884117|363196564|FG000|Overall Study|Adverse Event|2|||
105327026|NCT00884117|363196564|FG000|Overall Study|Withdrawal by Subject|89|||
105327027|NCT00884117|363196564|FG000|Overall Study|Death|3|||
105327028|NCT00884117|363196564|FG000|Overall Study|Lost to Follow-up|143|||
105327029|NCT00884117|363196564|FG000|Overall Study|Other|12|||
105373497|NCT00849056|363376221|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
105373498|NCT00849056|363376222|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
105373499|NCT00849056|363376221|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
105373500|NCT00849056|363376222|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
105853551|NCT02783170|365121510|FG000|Overall Study|Randomized but not Vaccinated|1|||
105853552|NCT02783170|365121511|FG001|Overall Study|Randomized but not Vaccinated|0|||
105853553|NCT06422377|365121512|FG000|Overall Study|Study Terminated by Sponsor|1|||
105853554|NCT03104699|365121513|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
105853555|NCT03104699|365121514|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
105853556|NCT03104699|365121515|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
105853557|NCT03104699|365121516|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
105853558|NCT03104699|365121517|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
105853559|NCT03104699|365121518|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
105853560|NCT03104699|365121513|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
105853561|NCT03104699|365121514|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
105853562|NCT03104699|365121515|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
105853563|NCT03104699|365121516|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
105853564|NCT03104699|365121517|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
105853565|NCT03104699|365121518|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
105853566|NCT03104699|365121513|FG000|Phase 1: Dose Escalation|Death|6|||
105853567|NCT03104699|365121514|FG001|Phase 1: Dose Escalation|Death|3|||
105853568|NCT03104699|365121515|FG002|Phase 1: Dose Escalation|Death|0|||
105853569|NCT03104699|365121516|FG003|Phase 1: Dose Escalation|Death|1|||
105853570|NCT03104699|365121517|FG004|Phase 1: Dose Escalation|Death|1|||
105853571|NCT03104699|365121518|FG005|Phase 1: Dose Escalation|Death|0|||
105853572|NCT03104699|365121513|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
105853573|NCT03104699|365121514|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
105853574|NCT03104699|365121515|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
105853575|NCT03104699|365121516|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
105853576|NCT03104699|365121517|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
105853577|NCT03104699|365121518|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
105853578|NCT03104699|365121513|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
105853579|NCT03104699|365121514|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
105853580|NCT03104699|365121515|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
105853581|NCT03104699|365121516|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
105853582|NCT03104699|365121517|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
105853583|NCT03104699|365121518|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
105853584|NCT03104699|365121513|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
105853585|NCT03104699|365121514|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
105853586|NCT03104699|365121515|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
105853587|NCT03104699|365121516|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
105853588|NCT03104699|365121517|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
105853589|NCT03104699|365121518|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
105853590|NCT03104699|365121513|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
105853591|NCT03104699|365121514|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
105853592|NCT03104699|365121515|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
105853593|NCT03104699|365121516|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
105853594|NCT03104699|365121517|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
105853595|NCT03104699|365121518|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
105853596|NCT03104699|365121513|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
105853597|NCT03104699|365121514|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
105853598|NCT03104699|365121515|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
105853599|NCT03104699|365121516|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
105853600|NCT03104699|365121517|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
105853601|NCT03104699|365121518|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
105853602|NCT03104699|365121513|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
105853603|NCT03104699|365121514|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
105853604|NCT03104699|365121515|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
105853605|NCT03104699|365121516|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
105853606|NCT03104699|365121517|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
105853607|NCT03104699|365121518|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
105853608|NCT03104699|365121513|FG000|Phase 2: Dose Expansion|Death|0|||
105853609|NCT03104699|365121514|FG001|Phase 2: Dose Expansion|Death|0|||
105853610|NCT03104699|365121515|FG002|Phase 2: Dose Expansion|Death|0|||
105853611|NCT03104699|365121516|FG003|Phase 2: Dose Expansion|Death|0|||
105853612|NCT03104699|365121517|FG004|Phase 2: Dose Expansion|Death|0|||
105853613|NCT03104699|365121518|FG005|Phase 2: Dose Expansion|Death|107|||
105853614|NCT03104699|365121513|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
105853615|NCT03104699|365121514|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
105853616|NCT03104699|365121515|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
105853617|NCT03104699|365121516|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
105853618|NCT03104699|365121517|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
105853619|NCT03104699|365121518|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
105853620|NCT03104699|365121513|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
105853621|NCT03104699|365121514|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
105853622|NCT03104699|365121515|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
105853623|NCT03104699|365121516|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
105853624|NCT03104699|365121517|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
105853625|NCT03104699|365121518|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
105853626|NCT03104699|365121513|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105853627|NCT03104699|365121514|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105853628|NCT03104699|365121515|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105853629|NCT03104699|365121516|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105853630|NCT03104699|365121517|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105853631|NCT03104699|365121518|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
105853632|NCT03104699|365121513|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
105853633|NCT03104699|365121514|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
105853634|NCT03104699|365121515|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
105853635|NCT03104699|365121516|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
105853636|NCT03104699|365121517|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
105853637|NCT03104699|365121518|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
105853638|NCT01171898|365121521|FG000|Overall Study|Death|0|||
105853639|NCT01171898|365121522|FG001|Overall Study|Death|0|||
105853640|NCT01171898|365121523|FG002|Overall Study|Death|2|||
105853641|NCT01171898|365121524|FG003|Overall Study|Death|0|||
105853642|NCT01171898|365121521|FG000|Overall Study|Lost to Follow-up|0|||
105853643|NCT01171898|365121522|FG001|Overall Study|Lost to Follow-up|1|||
105853644|NCT01171898|365121523|FG002|Overall Study|Lost to Follow-up|1|||
105853645|NCT01171898|365121524|FG003|Overall Study|Lost to Follow-up|1|||
105853646|NCT01171898|365121521|FG000|Overall Study|Withdrawal by Subject|1|||
105853647|NCT01171898|365121522|FG001|Overall Study|Withdrawal by Subject|4|||
105853648|NCT01171898|365121523|FG002|Overall Study|Withdrawal by Subject|6|||
105853649|NCT01171898|365121524|FG003|Overall Study|Withdrawal by Subject|3|||
105853650|NCT01171898|365121521|FG000|Overall Study|Terminated by Sponsor|1|||
105853651|NCT01171898|365121522|FG001|Overall Study|Terminated by Sponsor|0|||
105853652|NCT01171898|365121523|FG002|Overall Study|Terminated by Sponsor|0|||
105853653|NCT01171898|365121524|FG003|Overall Study|Terminated by Sponsor|0|||
105853654|NCT01171898|365121521|FG000|Overall Study|Ongoing|1|||
105853655|NCT01171898|365121522|FG001|Overall Study|Ongoing|9|||
105853656|NCT01171898|365121523|FG002|Overall Study|Ongoing|3|||
105853657|NCT01171898|365121524|FG003|Overall Study|Ongoing|0|||
105853658|NCT01171898|365121521|FG000|Overall Study|Other|1|||
105853659|NCT01171898|365121522|FG001|Overall Study|Other|5|||
105853660|NCT01171898|365121523|FG002|Overall Study|Other|0|||
105853661|NCT01171898|365121524|FG003|Overall Study|Other|2|||
105327030|NCT01753310|363196565|FG000|Overall Study|Entered into open label extension study|25|||
105327031|NCT01753310|363196566|FG001|Overall Study|Entered into open label extension study|22|||
105327032|NCT01753310|363196565|FG000|Overall Study|Adverse Event|1|||
105327033|NCT01753310|363196566|FG001|Overall Study|Adverse Event|0|||
105327034|NCT01753310|363196565|FG000|Overall Study|Lost to Follow-up|2|||
105327035|NCT01753310|363196566|FG001|Overall Study|Lost to Follow-up|0|||
105327036|NCT01753310|363196565|FG000|Overall Study|Subject decision|2|||
105327037|NCT01753310|363196566|FG001|Overall Study|Subject decision|2|||
105853662|NCT03055013|365121526|FG000|Overall Study|Adverse Event|78|||
105853663|NCT03055013|365121527|FG001|Overall Study|Adverse Event|0|||
105853664|NCT03055013|365121526|FG000|Overall Study|Death|6|||
105327038|NCT01753310|363196565|FG000|Overall Study|Sponsor decision|1|||
105327039|NCT01753310|363196566|FG001|Overall Study|Sponsor decision|0|||
105327040|NCT01753310|363196565|FG000|Overall Study|Withdrawal by Subject|1|||
105327041|NCT01753310|363196566|FG001|Overall Study|Withdrawal by Subject|0|||
105327042|NCT02946463|363196567|FG000|Primary Evaluation Period|Physician Decision|0|||
105327043|NCT02946463|363196568|FG001|Primary Evaluation Period|Physician Decision|1|||
105327044|NCT02946463|363196569|FG002|Primary Evaluation Period|Physician Decision|0|||
105327045|NCT02946463|363196570|FG003|Primary Evaluation Period|Physician Decision|0|||
105327046|NCT02946463|363196567|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
105327047|NCT02946463|363196568|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
105327048|NCT02946463|363196569|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
105327049|NCT02946463|363196570|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
105327050|NCT02946463|363196567|FG000|Extension Period|Death|4|||
105327051|NCT02946463|363196568|FG001|Extension Period|Death|4|||
105327052|NCT02946463|363196569|FG002|Extension Period|Death|0|||
105327053|NCT02946463|363196570|FG003|Extension Period|Death|0|||
105373501|NCT00849056|363376221|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
105373502|NCT00849056|363376222|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
105373503|NCT00849056|363376221|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
105373504|NCT00849056|363376222|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
105373505|NCT00849056|363376221|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
105853665|NCT03055013|365121527|FG001|Overall Study|Death|0|||
105327054|NCT02946463|363196567|FG000|Extension Period|Withdrawal by Subject|4|||
105853666|NCT03055013|365121526|FG000|Overall Study|Disease relapse|33|||
105853667|NCT03055013|365121527|FG001|Overall Study|Disease relapse|0|||
105853668|NCT03055013|365121526|FG000|Overall Study|Withdrawal by Subject|28|||
105853669|NCT03055013|365121527|FG001|Overall Study|Withdrawal by Subject|0|||
105853670|NCT03055013|365121526|FG000|Overall Study|Other complicating disease|5|||
105853671|NCT03055013|365121527|FG001|Overall Study|Other complicating disease|0|||
105853672|NCT03055013|365121526|FG000|Overall Study|Physician Decision|1|||
105853673|NCT03055013|365121527|FG001|Overall Study|Physician Decision|0|||
105853674|NCT03055013|365121526|FG000|Overall Study|Benign mass/non-RCC|4|||
105853675|NCT03055013|365121527|FG001|Overall Study|Benign mass/non-RCC|0|||
105853676|NCT03055013|365121526|FG000|Overall Study|Enrolled in another trial|1|||
105853677|NCT03055013|365121527|FG001|Overall Study|Enrolled in another trial|0|||
105853678|NCT03055013|365121526|FG000|Overall Study|Non-protocol therapy|1|||
105853679|NCT03055013|365121527|FG001|Overall Study|Non-protocol therapy|0|||
105853680|NCT03055013|365121526|FG000|Overall Study|Incompliance|1|||
105853681|NCT03055013|365121527|FG001|Overall Study|Incompliance|0|||
105853682|NCT03055013|365121526|FG000|Overall Study|Insurance issues|1|||
105853683|NCT03055013|365121527|FG001|Overall Study|Insurance issues|0|||
105853684|NCT03055013|365121526|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
105853685|NCT03055013|365121527|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
105853686|NCT03055013|365121526|FG000|Overall Study|Did not receive nivolumab|10|||
105853687|NCT03055013|365121527|FG001|Overall Study|Did not receive nivolumab|0|||
105853688|NCT03055013|365121526|FG000|Overall Study|Did not receive surgery|0|||
105853689|NCT03055013|365121527|FG001|Overall Study|Did not receive surgery|28|||
105853690|NCT02506153|365121531|FG000|Overall Study|Adverse Event|359|||
105853691|NCT02506153|365121532|FG001|Overall Study|Adverse Event|114|||
105853692|NCT02506153|365121531|FG000|Overall Study|Refused unrelated to adverse event|127|||
105853693|NCT02506153|365121532|FG001|Overall Study|Refused unrelated to adverse event|18|||
105853694|NCT02506153|365121531|FG000|Overall Study|Progression/relapse|91|||
105853695|NCT02506153|365121532|FG001|Overall Study|Progression/relapse|136|||
105853696|NCT02506153|365121531|FG000|Overall Study|Death|2|||
105853697|NCT02506153|365121532|FG001|Overall Study|Death|1|||
105853698|NCT02506153|365121531|FG000|Overall Study|Other - not protocol specified|23|||
105853699|NCT02506153|365121532|FG001|Overall Study|Other - not protocol specified|12|||
105853700|NCT03395197|365121533|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
105853701|NCT03395197|365121534|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
105853702|NCT03395197|365121535|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
105853703|NCT03395197|365121536|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
105853704|NCT03395197|365121537|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
105853705|NCT03395197|365121538|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
105853706|NCT03395197|365121533|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
105853707|NCT03395197|365121534|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
105373506|NCT00849056|363376222|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
105373507|NCT02711137|363376223|FG000|Overall Study|Death|1|||
105373508|NCT02711137|363376224|FG001|Overall Study|Death|4|||
105373509|NCT02711137|363376225|FG002|Overall Study|Death|5|||
105373510|NCT02711137|363376226|FG003|Overall Study|Death|5|||
105373511|NCT02711137|363376227|FG004|Overall Study|Death|3|||
105373512|NCT02711137|363376228|FG005|Overall Study|Death|1|||
105373513|NCT02711137|363376229|FG006|Overall Study|Death|61|||
105373514|NCT02711137|363376230|FG007|Overall Study|Death|3|||
105373515|NCT02711137|363376231|FG008|Overall Study|Death|0|||
105373516|NCT02711137|363376232|FG009|Overall Study|Death|1|||
105373517|NCT02711137|363376233|FG010|Overall Study|Death|1|||
105373518|NCT02711137|363376234|FG011|Overall Study|Death|1|||
105373519|NCT02711137|363376235|FG012|Overall Study|Death|0|||
105373520|NCT02711137|363376236|FG013|Overall Study|Death|0|||
105373521|NCT02711137|363376237|FG014|Overall Study|Death|0|||
105373522|NCT02711137|363376223|FG000|Overall Study|Study Terminated by Sponsor|0|||
105373523|NCT02711137|363376224|FG001|Overall Study|Study Terminated by Sponsor|0|||
105373524|NCT02711137|363376225|FG002|Overall Study|Study Terminated by Sponsor|1|||
105373525|NCT02711137|363376226|FG003|Overall Study|Study Terminated by Sponsor|0|||
105373526|NCT02711137|363376227|FG004|Overall Study|Study Terminated by Sponsor|0|||
105577126|NCT02855164|364112193|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
105577127|NCT02855164|364112194|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
105373527|NCT02711137|363376228|FG005|Overall Study|Study Terminated by Sponsor|0|||
105577128|NCT02855164|364112195|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
105853708|NCT03395197|365121535|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
105853709|NCT03395197|365121536|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
105853710|NCT03395197|365121537|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
105853711|NCT03395197|365121538|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
105853712|NCT03395197|365121533|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
105853713|NCT03395197|365121534|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
105577129|NCT02855164|364112196|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
105853714|NCT03395197|365121535|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
105373528|NCT02711137|363376229|FG006|Overall Study|Study Terminated by Sponsor|1|||
105853715|NCT03395197|365121536|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
105853716|NCT03395197|365121537|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
105853717|NCT03395197|365121538|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
105853718|NCT03395197|365121533|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
105853719|NCT03395197|365121534|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
105853720|NCT03395197|365121535|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
105853721|NCT03395197|365121536|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
105853722|NCT03395197|365121537|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
105853723|NCT03395197|365121538|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
105853724|NCT03395197|365121533|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
105853725|NCT03395197|365121534|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
105853726|NCT03395197|365121535|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
105853727|NCT03395197|365121536|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
105853728|NCT03395197|365121537|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
105853729|NCT03395197|365121538|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
105853730|NCT03395197|365121533|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
105853731|NCT03395197|365121534|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
105853732|NCT03395197|365121535|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
105853733|NCT03395197|365121536|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
105853734|NCT03395197|365121537|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
105853735|NCT03395197|365121538|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
105853736|NCT03395197|365121533|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
105853737|NCT03395197|365121534|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
105853738|NCT03395197|365121535|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
105853739|NCT03395197|365121536|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
105853740|NCT03395197|365121537|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
105853741|NCT03395197|365121538|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
105853742|NCT03395197|365121533|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
105853743|NCT03395197|365121534|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
105853744|NCT03395197|365121535|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
105853745|NCT03395197|365121536|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
105853746|NCT03395197|365121537|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
105853747|NCT03395197|365121538|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
105853748|NCT03395197|365121533|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
105853749|NCT03395197|365121534|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
105853750|NCT03395197|365121535|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
105853751|NCT03395197|365121536|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
105853752|NCT03395197|365121537|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
105853753|NCT03395197|365121538|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
105853754|NCT03395197|365121533|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
105853755|NCT03395197|365121534|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
105853756|NCT03395197|365121535|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
105853757|NCT03395197|365121536|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
105853758|NCT03395197|365121537|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
105853759|NCT03395197|365121538|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
105853760|NCT03395197|365121533|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
105853761|NCT03395197|365121534|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
105853762|NCT03395197|365121535|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
105853763|NCT03395197|365121536|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
105853764|NCT03395197|365121537|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
105853765|NCT03395197|365121538|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
105853766|NCT03395197|365121533|FG000|Analysis for DDR-Deficient Participants|Death|0|||
105853767|NCT03395197|365121534|FG001|Analysis for DDR-Deficient Participants|Death|0|||
105853768|NCT03395197|365121535|FG002|Analysis for DDR-Deficient Participants|Death|0|||
105853769|NCT03395197|365121536|FG003|Analysis for DDR-Deficient Participants|Death|0|||
105853770|NCT03395197|365121537|FG004|Analysis for DDR-Deficient Participants|Death|1|||
105853771|NCT03395197|365121538|FG005|Analysis for DDR-Deficient Participants|Death|4|||
105853772|NCT03395197|365121533|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
105853773|NCT03395197|365121534|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
105853774|NCT03395197|365121535|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
105853775|NCT03395197|365121536|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
105853776|NCT03395197|365121537|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
105853777|NCT03395197|365121538|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
105853778|NCT03395197|365121533|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
105853779|NCT03395197|365121534|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
105853780|NCT03395197|365121535|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
105853781|NCT03395197|365121536|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
105373529|NCT02711137|363376230|FG007|Overall Study|Study Terminated by Sponsor|0|||
105373530|NCT02711137|363376231|FG008|Overall Study|Study Terminated by Sponsor|0|||
105373531|NCT02711137|363376232|FG009|Overall Study|Study Terminated by Sponsor|0|||
105373532|NCT02711137|363376233|FG010|Overall Study|Study Terminated by Sponsor|0|||
105373533|NCT02711137|363376234|FG011|Overall Study|Study Terminated by Sponsor|0|||
105373534|NCT02711137|363376235|FG012|Overall Study|Study Terminated by Sponsor|0|||
105373535|NCT02711137|363376236|FG013|Overall Study|Study Terminated by Sponsor|0|||
105373536|NCT02711137|363376237|FG014|Overall Study|Study Terminated by Sponsor|0|||
105373537|NCT02711137|363376223|FG000|Overall Study|Physician Decision|1|||
105373538|NCT02711137|363376224|FG001|Overall Study|Physician Decision|0|||
105373539|NCT02711137|363376225|FG002|Overall Study|Physician Decision|2|||
105373540|NCT02711137|363376226|FG003|Overall Study|Physician Decision|1|||
105373541|NCT02711137|363376227|FG004|Overall Study|Physician Decision|1|||
105373542|NCT02711137|363376228|FG005|Overall Study|Physician Decision|0|||
105373543|NCT02711137|363376229|FG006|Overall Study|Physician Decision|12|||
105373544|NCT02711137|363376230|FG007|Overall Study|Physician Decision|2|||
105373545|NCT02711137|363376231|FG008|Overall Study|Physician Decision|1|||
105373546|NCT02711137|363376232|FG009|Overall Study|Physician Decision|1|||
105373547|NCT02711137|363376233|FG010|Overall Study|Physician Decision|3|||
105373548|NCT02711137|363376234|FG011|Overall Study|Physician Decision|2|||
105373549|NCT02711137|363376235|FG012|Overall Study|Physician Decision|1|||
105373550|NCT02711137|363376236|FG013|Overall Study|Physician Decision|1|||
105373551|NCT02711137|363376237|FG014|Overall Study|Physician Decision|2|||
105373552|NCT02711137|363376223|FG000|Overall Study|Other|0|||
105373553|NCT02711137|363376224|FG001|Overall Study|Other|1|||
105373554|NCT02711137|363376225|FG002|Overall Study|Other|0|||
105853782|NCT03395197|365121537|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
105853783|NCT03395197|365121538|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
105853784|NCT03395197|365121533|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
105373555|NCT02711137|363376226|FG003|Overall Study|Other|0|||
105373556|NCT02711137|363376227|FG004|Overall Study|Other|0|||
105373557|NCT02711137|363376228|FG005|Overall Study|Other|0|||
105853785|NCT03395197|365121534|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
105853786|NCT03395197|365121535|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
105853787|NCT03395197|365121536|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
105853788|NCT03395197|365121537|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
105853789|NCT03395197|365121538|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
105853790|NCT03395197|365121533|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
105853791|NCT03395197|365121534|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
105853792|NCT03395197|365121535|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
105853793|NCT03395197|365121536|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
105853794|NCT03395197|365121537|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
105853795|NCT03395197|365121538|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
105853796|NCT03395197|365121533|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
105853797|NCT03395197|365121534|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
105853798|NCT03395197|365121535|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
105853799|NCT03395197|365121536|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
105853800|NCT03395197|365121537|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
105853801|NCT03395197|365121538|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
105853802|NCT03395197|365121533|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
105853803|NCT03395197|365121534|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
105853804|NCT03395197|365121535|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
105373558|NCT02711137|363376229|FG006|Overall Study|Other|3|||
105373559|NCT02711137|363376230|FG007|Overall Study|Other|0|||
105373560|NCT02711137|363376231|FG008|Overall Study|Other|0|||
105492153|NCT01702571|363814001|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
105492154|NCT01702571|363814002|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
105492155|NCT01702571|363814001|FG000|Overall Study|Progressive Disease|3|||
105373561|NCT02711137|363376232|FG009|Overall Study|Other|0|||
105373562|NCT02711137|363376233|FG010|Overall Study|Other|0|||
105492156|NCT01702571|363814002|FG001|Overall Study|Progressive Disease|0|||
105492157|NCT01702571|363814001|FG000|Overall Study|Protocol Violation|2|||
105373563|NCT02711137|363376234|FG011|Overall Study|Other|0|||
105373564|NCT02711137|363376235|FG012|Overall Study|Other|0|||
105373565|NCT02711137|363376236|FG013|Overall Study|Other|0|||
105373566|NCT02711137|363376237|FG014|Overall Study|Other|1|||
105853805|NCT03395197|365121536|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
105853806|NCT03395197|365121537|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
105853807|NCT03395197|365121538|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
105853808|NCT03395197|365121533|FG000|Analysis for DDR-Deficient Participants|Other|0|||
105853809|NCT03395197|365121534|FG001|Analysis for DDR-Deficient Participants|Other|0|||
105853810|NCT03395197|365121535|FG002|Analysis for DDR-Deficient Participants|Other|0|||
105853811|NCT03395197|365121536|FG003|Analysis for DDR-Deficient Participants|Other|0|||
105853812|NCT03395197|365121537|FG004|Analysis for DDR-Deficient Participants|Other|3|||
105853813|NCT03395197|365121538|FG005|Analysis for DDR-Deficient Participants|Other|3|||
105853814|NCT03395197|365121533|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
105853815|NCT03395197|365121534|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
105853816|NCT03395197|365121535|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
105853817|NCT03395197|365121536|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
105853818|NCT03395197|365121537|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
105853819|NCT03395197|365121538|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
105853820|NCT00861705|365121539|FG000|Overall Study|Never Began Treatment|7|||
105853821|NCT00861705|365121540|FG001|Overall Study|Never Began Treatment|3|||
105853822|NCT00861705|365121541|FG002|Overall Study|Never Began Treatment|0|||
105853823|NCT00861705|365121542|FG003|Overall Study|Never Began Treatment|1|||
105853824|NCT00433511|365121554|FG000|Step 1|Adverse Event|50|||
105853825|NCT00433511|365121555|FG001|Step 1|Adverse Event|157|||
105853826|NCT00433511|365121556|FG002|Step 1|Adverse Event|153|||
105853827|NCT00433511|365121554|FG000|Step 1|Withdrawal by Subject|45|||
105853828|NCT00433511|365121555|FG001|Step 1|Withdrawal by Subject|143|||
105853829|NCT00433511|365121556|FG002|Step 1|Withdrawal by Subject|154|||
105853830|NCT00433511|365121554|FG000|Step 1|Death|3|||
105853831|NCT00433511|365121555|FG001|Step 1|Death|1|||
105853832|NCT00433511|365121556|FG002|Step 1|Death|1|||
105853833|NCT00433511|365121554|FG000|Step 1|Physician Decision|1|||
105853834|NCT00433511|365121555|FG001|Step 1|Physician Decision|4|||
105853835|NCT00433511|365121556|FG002|Step 1|Physician Decision|3|||
105853836|NCT00433511|365121554|FG000|Step 1|Never started protocol therapy|28|||
105853837|NCT00433511|365121555|FG001|Step 1|Never started protocol therapy|64|||
105853838|NCT00433511|365121556|FG002|Step 1|Never started protocol therapy|66|||
105853839|NCT00433511|365121554|FG000|Step 1|Alternative therapy|2|||
105853840|NCT00433511|365121555|FG001|Step 1|Alternative therapy|1|||
105853841|NCT00433511|365121556|FG002|Step 1|Alternative therapy|3|||
105853842|NCT00433511|365121554|FG000|Step 1|Disease progression, relapse|5|||
105853843|NCT00433511|365121555|FG001|Step 1|Disease progression, relapse|3|||
105853844|NCT00433511|365121556|FG002|Step 1|Disease progression, relapse|3|||
105853845|NCT00433511|365121554|FG000|Step 1|Other complicating disease|2|||
105853846|NCT00433511|365121555|FG001|Step 1|Other complicating disease|6|||
105853847|NCT00433511|365121556|FG002|Step 1|Other complicating disease|3|||
105853848|NCT00433511|365121554|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
105853849|NCT00433511|365121555|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
105853850|NCT00433511|365121556|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
105853851|NCT00433511|365121554|FG000|Step 1|Suspected recurrence|0|||
105853852|NCT00433511|365121555|FG001|Step 1|Suspected recurrence|1|||
105853853|NCT00433511|365121556|FG002|Step 1|Suspected recurrence|0|||
105853854|NCT00433511|365121554|FG000|Step 1|Insurance/drug distribution issues|0|||
105853855|NCT00433511|365121555|FG001|Step 1|Insurance/drug distribution issues|1|||
105853856|NCT00433511|365121556|FG002|Step 1|Insurance/drug distribution issues|2|||
105853857|NCT00433511|365121554|FG000|Step 1|Patient moved|0|||
105853858|NCT00433511|365121555|FG001|Step 1|Patient moved|0|||
105853859|NCT00433511|365121556|FG002|Step 1|Patient moved|1|||
105853860|NCT00433511|365121554|FG000|Step 2 (Arm D)|Adverse Event|0|||
105853861|NCT00433511|365121555|FG001|Step 2 (Arm D)|Adverse Event|0|||
105853862|NCT00433511|365121556|FG002|Step 2 (Arm D)|Adverse Event|135|||
105853863|NCT00433511|365121554|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
105853864|NCT00433511|365121555|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
105492158|NCT01702571|363814002|FG001|Overall Study|Protocol Violation|0|||
105853865|NCT00433511|365121556|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
105853866|NCT00433511|365121554|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
105327055|NCT02946463|363196568|FG001|Extension Period|Withdrawal by Subject|3|||
105327056|NCT02946463|363196569|FG002|Extension Period|Withdrawal by Subject|0|||
105327057|NCT02946463|363196570|FG003|Extension Period|Withdrawal by Subject|0|||
105327058|NCT02946463|363196567|FG000|Extension Period|Other than specified|2|||
105327059|NCT02946463|363196568|FG001|Extension Period|Other than specified|3|||
105327060|NCT02946463|363196569|FG002|Extension Period|Other than specified|2|||
105327061|NCT02946463|363196570|FG003|Extension Period|Other than specified|0|||
105853867|NCT00433511|365121555|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
105853868|NCT00433511|365121556|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
105853869|NCT00433511|365121554|FG000|Step 2 (Arm D)|Physician Decision|0|||
105853870|NCT00433511|365121555|FG001|Step 2 (Arm D)|Physician Decision|0|||
105853871|NCT00433511|365121556|FG002|Step 2 (Arm D)|Physician Decision|9|||
105853872|NCT00433511|365121554|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
105853873|NCT00433511|365121555|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
105853874|NCT00433511|365121556|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
105853875|NCT00433511|365121554|FG000|Step 2 (Arm D)|Other complicating disease|0|||
105853876|NCT00433511|365121555|FG001|Step 2 (Arm D)|Other complicating disease|0|||
105853877|NCT00433511|365121556|FG002|Step 2 (Arm D)|Other complicating disease|3|||
105853878|NCT00433511|365121554|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
105853879|NCT00433511|365121555|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
105853880|NCT00433511|365121556|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
105853881|NCT00433511|365121554|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
105853882|NCT00433511|365121555|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
105853883|NCT00433511|365121556|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
105853884|NCT00433511|365121554|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
105853885|NCT00433511|365121555|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
105853886|NCT00433511|365121556|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
105853887|NCT00433511|365121554|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
105853888|NCT00433511|365121555|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
105853889|NCT00433511|365121556|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
105853890|NCT02595879|365121557|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
105853891|NCT02595879|365121558|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
105853892|NCT05383209|365121559|FG000|Overall Study|Adverse Event: Non-ocular|0|||
105853893|NCT05383209|365121560|FG001|Overall Study|Adverse Event: Non-ocular|1|||
105853894|NCT05383209|365121561|FG002|Overall Study|Adverse Event: Non-ocular|0|||
105853895|NCT05383209|365121559|FG000|Overall Study|Lost to Follow-up|2|||
105853896|NCT05383209|365121560|FG001|Overall Study|Lost to Follow-up|1|||
105853897|NCT05383209|365121561|FG002|Overall Study|Lost to Follow-up|4|||
105853898|NCT05383209|365121559|FG000|Overall Study|Withdrawal by Subject|2|||
105853899|NCT05383209|365121560|FG001|Overall Study|Withdrawal by Subject|0|||
105853900|NCT05383209|365121561|FG002|Overall Study|Withdrawal by Subject|1|||
105853901|NCT05383209|365121559|FG000|Overall Study|Death|1|||
105853902|NCT05383209|365121560|FG001|Overall Study|Death|0|||
105853903|NCT05383209|365121561|FG002|Overall Study|Death|0|||
105853904|NCT05383209|365121559|FG000|Overall Study|Other|0|||
105853905|NCT05383209|365121560|FG001|Overall Study|Other|1|||
105853906|NCT05383209|365121561|FG002|Overall Study|Other|0|||
105853907|NCT00602641|365121562|FG000|Overall Study|Never started protocol therapy|6|||
105853908|NCT00602641|365121563|FG001|Overall Study|Never started protocol therapy|2|||
105853909|NCT00602641|365121562|FG000|Overall Study|Still on treatment at time of analysis|8|||
105853910|NCT00602641|365121563|FG001|Overall Study|Still on treatment at time of analysis|15|||
105853911|NCT00602641|365121562|FG000|Overall Study|Adverse Event|62|||
105853912|NCT00602641|365121563|FG001|Overall Study|Adverse Event|53|||
105853913|NCT00602641|365121562|FG000|Overall Study|Disease progression|38|||
105853914|NCT00602641|365121563|FG001|Overall Study|Disease progression|55|||
105853915|NCT00602641|365121562|FG000|Overall Study|Death|6|||
105853916|NCT00602641|365121563|FG001|Overall Study|Death|5|||
105853917|NCT00602641|365121562|FG000|Overall Study|Withdrawal by Subject|15|||
105853918|NCT00602641|365121563|FG001|Overall Study|Withdrawal by Subject|12|||
105853919|NCT00602641|365121562|FG000|Overall Study|Alternative therapy|5|||
105853920|NCT00602641|365121563|FG001|Overall Study|Alternative therapy|2|||
105853921|NCT00602641|365121562|FG000|Overall Study|Other Complicating Disease|5|||
105853922|NCT00602641|365121563|FG001|Overall Study|Other Complicating Disease|2|||
105853923|NCT00602641|365121562|FG000|Overall Study|Physician Decision|5|||
105853924|NCT00602641|365121563|FG001|Overall Study|Physician Decision|4|||
105853925|NCT00602641|365121562|FG000|Overall Study|Administrative Closure|1|||
105853926|NCT00602641|365121563|FG001|Overall Study|Administrative Closure|1|||
105853927|NCT00602641|365121562|FG000|Overall Study|Other|3|||
105853928|NCT00602641|365121563|FG001|Overall Study|Other|1|||
105853929|NCT03896503|365121566|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
105853930|NCT03896503|365121567|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
105853931|NCT03896503|365121568|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
105853932|NCT03896503|365121569|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
105853933|NCT03896503|365121570|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
105373567|NCT02711137|363376223|FG000|Overall Study|Withdrawal by Subject|1|||
105853934|NCT03896503|365121571|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
105853935|NCT03896503|365121572|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
105853936|NCT03896503|365121573|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
105853937|NCT03896503|365121566|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
105853938|NCT03896503|365121567|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
105853939|NCT03896503|365121568|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
105853940|NCT03896503|365121569|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
105853941|NCT03896503|365121570|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
105853942|NCT03896503|365121571|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
105373568|NCT02711137|363376224|FG001|Overall Study|Withdrawal by Subject|0|||
105853943|NCT03896503|365121572|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
105853944|NCT03896503|365121573|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
105853945|NCT03896503|365121566|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
105853946|NCT03896503|365121567|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
105853947|NCT03896503|365121568|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
105853948|NCT03896503|365121569|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
105853949|NCT03896503|365121570|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
105853950|NCT03896503|365121571|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
105853951|NCT03896503|365121572|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
105853952|NCT03896503|365121573|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
105853953|NCT03896503|365121566|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
105853954|NCT03896503|365121567|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
105853955|NCT03896503|365121568|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
105853956|NCT03896503|365121569|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
105853957|NCT03896503|365121570|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
105853958|NCT03896503|365121571|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
105853959|NCT03896503|365121572|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
105853960|NCT03896503|365121573|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
105853961|NCT03896503|365121566|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
105853962|NCT03896503|365121567|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
105853963|NCT03896503|365121568|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
105853964|NCT03896503|365121569|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
105853965|NCT03896503|365121570|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
105853966|NCT03896503|365121571|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
105853967|NCT03896503|365121572|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
105853968|NCT03896503|365121573|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
105853969|NCT03896503|365121566|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
105853970|NCT03896503|365121567|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
105853971|NCT03896503|365121568|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
105853972|NCT03896503|365121569|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
105853973|NCT03896503|365121570|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
105853974|NCT03896503|365121571|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
105853975|NCT03896503|365121572|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
105853976|NCT03896503|365121573|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
105853977|NCT03896503|365121566|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
105492159|NCT01702571|363814001|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
105492160|NCT01702571|363814002|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
105327062|NCT02946463|363196567|FG000|Extension Period|Physician Decision|1|||
105327063|NCT02946463|363196568|FG001|Extension Period|Physician Decision|4|||
105327064|NCT02946463|363196569|FG002|Extension Period|Physician Decision|0|||
105327065|NCT02946463|363196570|FG003|Extension Period|Physician Decision|0|||
105327066|NCT02946463|363196567|FG000|Extension Period|Pregnancy|3|||
105327067|NCT02946463|363196568|FG001|Extension Period|Pregnancy|1|||
105327068|NCT02946463|363196569|FG002|Extension Period|Pregnancy|0|||
105327069|NCT02946463|363196570|FG003|Extension Period|Pregnancy|0|||
105327070|NCT02946463|363196567|FG000|Extension Period|Adverse Event|1|||
105327071|NCT02946463|363196568|FG001|Extension Period|Adverse Event|2|||
105327072|NCT02946463|363196569|FG002|Extension Period|Adverse Event|0|||
105327073|NCT02946463|363196570|FG003|Extension Period|Adverse Event|0|||
105327074|NCT02946463|363196567|FG000|Extension Period|Lost to Follow-up|1|||
105327075|NCT02946463|363196568|FG001|Extension Period|Lost to Follow-up|0|||
105327076|NCT02946463|363196569|FG002|Extension Period|Lost to Follow-up|0|||
105327077|NCT02946463|363196570|FG003|Extension Period|Lost to Follow-up|0|||
105327078|NCT01956773|363196571|FG000|Overall Study|Lost to Follow-up|628|||
105327079|NCT01956773|363196572|FG001|Overall Study|Lost to Follow-up|1|||
105327080|NCT03267212|363196575|FG000|First Intervention|Lost to Follow-up|0|||
105327081|NCT03267212|363196576|FG001|First Intervention|Lost to Follow-up|2|||
105327082|NCT03267212|363196575|FG000|First Intervention|Withdrawal by Subject|1|||
105327083|NCT03267212|363196576|FG001|First Intervention|Withdrawal by Subject|1|||
105327084|NCT03267212|363196575|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
105327085|NCT03267212|363196576|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
105327086|NCT02907177|363196577|FG000|Overall Study|Death|0|||
105327087|NCT02907177|363196578|FG001|Overall Study|Death|1|||
105327088|NCT02907177|363196577|FG000|Overall Study|Physician Decision|3|||
105327089|NCT02907177|363196578|FG001|Overall Study|Physician Decision|3|||
105327090|NCT02907177|363196577|FG000|Overall Study|Withdrawal by Subject|15|||
105373569|NCT02711137|363376225|FG002|Overall Study|Withdrawal by Subject|0|||
105373570|NCT02711137|363376226|FG003|Overall Study|Withdrawal by Subject|1|||
105373571|NCT02711137|363376227|FG004|Overall Study|Withdrawal by Subject|1|||
105492161|NCT01702571|363814001|FG000|Overall Study|Termination By Sponsor|4|||
105492162|NCT01702571|363814002|FG001|Overall Study|Termination By Sponsor|0|||
105492163|NCT01702571|363814001|FG000|Overall Study|Withdrawal by Subject|177|||
105492164|NCT01702571|363814002|FG001|Overall Study|Withdrawal by Subject|29|||
105492165|NCT03004443|363814003|FG000|Overall Study|Pregnancy|0|||
105492166|NCT03004443|363814004|FG001|Overall Study|Pregnancy|1|||
105492167|NCT00828854|363814005|FG000|Overall Study|Disease Progression|17|||
105492168|NCT00828854|363814005|FG000|Overall Study|Adverse Event|9|||
105492169|NCT00828854|363814005|FG000|Overall Study|Reason not Specified|1|||
105492170|NCT03971071|363814007|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
105492171|NCT03971071|363814008|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
105492172|NCT03971071|363814009|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
105492173|NCT03971071|363814010|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
105492174|NCT03971071|363814011|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
105492175|NCT03971071|363814007|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
105492176|NCT03971071|363814008|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
105492177|NCT03971071|363814009|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
105492178|NCT03971071|363814010|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
105492179|NCT03971071|363814011|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
105492180|NCT03971071|363814007|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
105492181|NCT03971071|363814008|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
105492182|NCT03971071|363814009|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
105492183|NCT03971071|363814010|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
105492184|NCT03971071|363814011|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
105492185|NCT03971071|363814007|FG000|Open-label Treatment Period|Sponsor decision|0|||
105492186|NCT03971071|363814008|FG001|Open-label Treatment Period|Sponsor decision|0|||
105492187|NCT03971071|363814009|FG002|Open-label Treatment Period|Sponsor decision|0|||
105492188|NCT03971071|363814010|FG003|Open-label Treatment Period|Sponsor decision|0|||
105492189|NCT03971071|363814011|FG004|Open-label Treatment Period|Sponsor decision|1|||
105492190|NCT03971071|363814007|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
105492191|NCT03971071|363814008|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
105492192|NCT03971071|363814009|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
105492193|NCT03971071|363814010|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
105492194|NCT03971071|363814011|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
105492195|NCT03971071|363814007|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
105327091|NCT02907177|363196578|FG001|Overall Study|Withdrawal by Subject|7|||
105327092|NCT02907177|363196577|FG000|Overall Study|Sponsor's Decision|50|||
105327093|NCT02907177|363196578|FG001|Overall Study|Sponsor's Decision|57|||
105327094|NCT02505217|363196579|FG000|Overall Study|Withdrawal by Subject|1|||
105327095|NCT02505217|363196580|FG001|Overall Study|Withdrawal by Subject|2|||
105327096|NCT01289678|363196581|FG000|Overall Study|Physician Decision|6|||
105327097|NCT00991887|363196582|FG000|Overall Study|Lost to Follow-up|2|||
105327098|NCT00991887|363196583|FG001|Overall Study|Lost to Follow-up|1|||
105327099|NCT00468819|363196584|FG000|Overall Study|Withdrawal by Subject|4|||
105327100|NCT00468819|363196585|FG001|Overall Study|Withdrawal by Subject|0|||
105327101|NCT00468819|363196586|FG002|Overall Study|Withdrawal by Subject|1|||
105327102|NCT00468819|363196584|FG000|Overall Study|Lost to Follow-up|0|||
105327103|NCT00468819|363196585|FG001|Overall Study|Lost to Follow-up|0|||
105327104|NCT00468819|363196586|FG002|Overall Study|Lost to Follow-up|1|||
105327105|NCT00468819|363196584|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
105327106|NCT00468819|363196585|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
105327107|NCT00468819|363196586|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
105327108|NCT00946920|363196587|FG000|Overall Study|Withdrawal by Subject|28|||
105327109|NCT00946920|363196588|FG001|Overall Study|Withdrawal by Subject|15|||
105327110|NCT00946920|363196587|FG000|Overall Study|Lost to Follow-up|2|||
105327111|NCT00946920|363196588|FG001|Overall Study|Lost to Follow-up|2|||
105327112|NCT00946920|363196587|FG000|Overall Study|Physician Decision|5|||
105327113|NCT00946920|363196588|FG001|Overall Study|Physician Decision|2|||
105327114|NCT00946920|363196587|FG000|Overall Study|Adverse Event|41|||
105327115|NCT00946920|363196588|FG001|Overall Study|Adverse Event|14|||
105327116|NCT00946920|363196587|FG000|Overall Study|Protocol Violation|16|||
105327117|NCT00946920|363196588|FG001|Overall Study|Protocol Violation|8|||
105327118|NCT00946920|363196587|FG000|Overall Study|Miscellaneous reasons|18|||
105327119|NCT00946920|363196588|FG001|Overall Study|Miscellaneous reasons|3|||
105327120|NCT02492867|363196591|FG000|Overall Study|Alternate therapy|1|||
105327121|NCT02492867|363196591|FG000|Overall Study|Withdrawal by Subject|2|||
105327122|NCT02492867|363196591|FG000|Overall Study|Disease progression after treatment started|1|||
105327123|NCT02492867|363196591|FG000|Overall Study|Death|1|||
105327124|NCT00153179|363196594|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
105327125|NCT00153179|363196595|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
105853978|NCT03896503|365121567|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
105853979|NCT03896503|365121568|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
105853980|NCT03896503|365121569|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
105853981|NCT03896503|365121570|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
105853982|NCT03896503|365121571|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
105853983|NCT03896503|365121572|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
105853984|NCT03896503|365121573|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
105853985|NCT03896503|365121566|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
105853986|NCT03896503|365121567|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
105853987|NCT03896503|365121568|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
105853988|NCT03896503|365121569|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
105373572|NCT02711137|363376228|FG005|Overall Study|Withdrawal by Subject|0|||
105373573|NCT02711137|363376229|FG006|Overall Study|Withdrawal by Subject|7|||
105373574|NCT02711137|363376230|FG007|Overall Study|Withdrawal by Subject|0|||
105373575|NCT02711137|363376231|FG008|Overall Study|Withdrawal by Subject|0|||
105373576|NCT02711137|363376232|FG009|Overall Study|Withdrawal by Subject|0|||
105373577|NCT02711137|363376233|FG010|Overall Study|Withdrawal by Subject|0|||
105373578|NCT02711137|363376234|FG011|Overall Study|Withdrawal by Subject|0|||
105373579|NCT02711137|363376235|FG012|Overall Study|Withdrawal by Subject|0|||
105373580|NCT02711137|363376236|FG013|Overall Study|Withdrawal by Subject|1|||
105373581|NCT02711137|363376237|FG014|Overall Study|Withdrawal by Subject|0|||
105373582|NCT02711137|363376223|FG000|Overall Study|Lost to Follow-up|1|||
105373583|NCT02711137|363376224|FG001|Overall Study|Lost to Follow-up|0|||
105373584|NCT02711137|363376225|FG002|Overall Study|Lost to Follow-up|0|||
105373585|NCT02711137|363376226|FG003|Overall Study|Lost to Follow-up|0|||
105373586|NCT02711137|363376227|FG004|Overall Study|Lost to Follow-up|0|||
105373587|NCT02711137|363376228|FG005|Overall Study|Lost to Follow-up|0|||
105373588|NCT02711137|363376229|FG006|Overall Study|Lost to Follow-up|2|||
105373589|NCT02711137|363376230|FG007|Overall Study|Lost to Follow-up|0|||
105373590|NCT02711137|363376231|FG008|Overall Study|Lost to Follow-up|0|||
105373591|NCT02711137|363376232|FG009|Overall Study|Lost to Follow-up|0|||
105373592|NCT02711137|363376233|FG010|Overall Study|Lost to Follow-up|0|||
105373593|NCT02711137|363376234|FG011|Overall Study|Lost to Follow-up|0|||
105373594|NCT02711137|363376235|FG012|Overall Study|Lost to Follow-up|0|||
105373595|NCT02711137|363376236|FG013|Overall Study|Lost to Follow-up|0|||
105373596|NCT02711137|363376237|FG014|Overall Study|Lost to Follow-up|0|||
105373597|NCT01113749|363376238|FG000|Overall Study|Lost to Follow-up|1|||
105373598|NCT01113749|363376239|FG001|Overall Study|Lost to Follow-up|2|||
105373599|NCT00109343|363376242|FG000|Overall Study|Adverse Event|1|||
105373600|NCT00109343|363376243|FG001|Overall Study|Adverse Event|0|||
105373601|NCT00109343|363376244|FG002|Overall Study|Adverse Event|2|||
105373602|NCT00109343|363376242|FG000|Overall Study|Lack of Efficacy|1|||
105373603|NCT00109343|363376243|FG001|Overall Study|Lack of Efficacy|0|||
105373604|NCT00109343|363376244|FG002|Overall Study|Lack of Efficacy|0|||
105373605|NCT00109343|363376242|FG000|Overall Study|Lost to Follow-up|35|||
105373606|NCT00109343|363376243|FG001|Overall Study|Lost to Follow-up|20|||
105373607|NCT00109343|363376244|FG002|Overall Study|Lost to Follow-up|14|||
105373608|NCT00109343|363376242|FG000|Overall Study|Protocol Violation|1|||
105373609|NCT00109343|363376243|FG001|Overall Study|Protocol Violation|2|||
105373610|NCT00109343|363376244|FG002|Overall Study|Protocol Violation|2|||
105373611|NCT00109343|363376242|FG000|Overall Study|Withdrawal by Subject|15|||
105373612|NCT00109343|363376243|FG001|Overall Study|Withdrawal by Subject|11|||
105373613|NCT00109343|363376244|FG002|Overall Study|Withdrawal by Subject|10|||
105373614|NCT00109343|363376242|FG000|Overall Study|Subject Moved|6|||
105373615|NCT00109343|363376243|FG001|Overall Study|Subject Moved|2|||
105373616|NCT00109343|363376244|FG002|Overall Study|Subject Moved|1|||
105373617|NCT00109343|363376242|FG000|Overall Study|Other|5|||
105373618|NCT00109343|363376243|FG001|Overall Study|Other|2|||
105373619|NCT00109343|363376244|FG002|Overall Study|Other|1|||
105373620|NCT02194465|363376245|FG000|Overall Study|Adverse Event|6|||
105373621|NCT02194465|363376246|FG001|Overall Study|Adverse Event|1|||
105373622|NCT02194465|363376247|FG002|Overall Study|Adverse Event|4|||
105373623|NCT02194465|363376248|FG003|Overall Study|Adverse Event|4|||
105373624|NCT02194465|363376249|FG004|Overall Study|Adverse Event|4|||
105373625|NCT02194465|363376250|FG005|Overall Study|Adverse Event|2|||
105373626|NCT02194465|363376251|FG006|Overall Study|Adverse Event|0|||
105373627|NCT02194465|363376245|FG000|Overall Study|Lost to Follow-up|0|||
105373628|NCT02194465|363376246|FG001|Overall Study|Lost to Follow-up|0|||
105373629|NCT02194465|363376247|FG002|Overall Study|Lost to Follow-up|0|||
105373630|NCT02194465|363376248|FG003|Overall Study|Lost to Follow-up|1|||
105373631|NCT02194465|363376249|FG004|Overall Study|Lost to Follow-up|0|||
105373632|NCT02194465|363376250|FG005|Overall Study|Lost to Follow-up|1|||
105373633|NCT02194465|363376251|FG006|Overall Study|Lost to Follow-up|0|||
105373634|NCT02194465|363376245|FG000|Overall Study|Physician Decision|1|||
105373635|NCT02194465|363376246|FG001|Overall Study|Physician Decision|0|||
105373636|NCT02194465|363376247|FG002|Overall Study|Physician Decision|0|||
105373637|NCT02194465|363376248|FG003|Overall Study|Physician Decision|0|||
105373638|NCT02194465|363376249|FG004|Overall Study|Physician Decision|0|||
105373639|NCT02194465|363376250|FG005|Overall Study|Physician Decision|0|||
105373640|NCT02194465|363376251|FG006|Overall Study|Physician Decision|0|||
105373641|NCT02194465|363376245|FG000|Overall Study|Protocol Violation|1|||
105373642|NCT02194465|363376246|FG001|Overall Study|Protocol Violation|1|||
105373643|NCT02194465|363376247|FG002|Overall Study|Protocol Violation|2|||
105373644|NCT02194465|363376248|FG003|Overall Study|Protocol Violation|1|||
105373645|NCT02194465|363376249|FG004|Overall Study|Protocol Violation|1|||
105373646|NCT02194465|363376250|FG005|Overall Study|Protocol Violation|0|||
105373647|NCT02194465|363376251|FG006|Overall Study|Protocol Violation|0|||
105373648|NCT02194465|363376245|FG000|Overall Study|Withdrawal by Subject|1|||
105373649|NCT02194465|363376246|FG001|Overall Study|Withdrawal by Subject|3|||
105373650|NCT02194465|363376247|FG002|Overall Study|Withdrawal by Subject|1|||
105373651|NCT02194465|363376248|FG003|Overall Study|Withdrawal by Subject|2|||
105373652|NCT02194465|363376249|FG004|Overall Study|Withdrawal by Subject|2|||
105373653|NCT02194465|363376250|FG005|Overall Study|Withdrawal by Subject|1|||
105373654|NCT02194465|363376251|FG006|Overall Study|Withdrawal by Subject|2|||
105373655|NCT02194465|363376245|FG000|Overall Study|Discontinued follow-up period|0|||
105373656|NCT02194465|363376246|FG001|Overall Study|Discontinued follow-up period|2|||
105492196|NCT03971071|363814008|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
105492197|NCT03971071|363814009|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
105492198|NCT03971071|363814010|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
105492199|NCT03971071|363814011|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
105492200|NCT00292318|363814012|FG000|Overall Study|Study terminated by officials|2|||
105492201|NCT00292318|363814013|FG001|Overall Study|Study terminated by officials|1|||
105492202|NCT00771316|363814014|FG000|Overall Study|Adverse Event|0|||
105492203|NCT00771316|363814015|FG001|Overall Study|Adverse Event|1|||
105492204|NCT00771316|363814014|FG000|Overall Study|Patient withdrew consent|1|||
105492205|NCT00771316|363814015|FG001|Overall Study|Patient withdrew consent|0|||
105492206|NCT00771316|363814014|FG000|Overall Study|Discontinued due to early termination|1|||
105492207|NCT00771316|363814015|FG001|Overall Study|Discontinued due to early termination|0|||
105492208|NCT01626495|363814016|FG000|Overall Study|Adverse Event|3|||
105492209|NCT01626495|363814016|FG000|Overall Study|Disease progression|27|||
105492210|NCT01626495|363814016|FG000|Overall Study|Withdrawal by Subject|1|||
105492211|NCT01626495|363814016|FG000|Overall Study|Administrative problem|1|||
105492212|NCT01626495|363814016|FG000|Overall Study|Death|2|||
105492213|NCT01626495|363814016|FG000|Overall Study|Physician Decision|1|||
105492214|NCT01626495|363814016|FG000|Overall Study|New cancer therapy|16|||
105492215|NCT01626495|363814016|FG000|Overall Study|Manufacturing failure|1|||
105492216|NCT00445978|363814017|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
105492217|NCT00445978|363814017|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
105492218|NCT00445978|363814017|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
105492219|NCT00445978|363814017|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
105492220|NCT00445978|363814017|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
105492221|NCT00445978|363814017|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
105492222|NCT00445978|363814017|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
105492223|NCT00445978|363814017|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
105492224|NCT00445978|363814017|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
105492225|NCT03438383|363814021|FG000|Overall Study|Protocol Violation|9|||
105492226|NCT03438383|363814022|FG001|Overall Study|Protocol Violation|3|||
105492227|NCT00843726|363814023|FG000|Overall Study|Death|1|||
105492228|NCT00843726|363814024|FG001|Overall Study|Death|0|||
105492229|NCT00843726|363814023|FG000|Overall Study|Withdrawal by Subject|0|||
105492230|NCT00843726|363814024|FG001|Overall Study|Withdrawal by Subject|1|||
105492231|NCT00667602|363814025|FG000|Overall Study|Withdrawal by Subject|4|||
105492232|NCT00667602|363814026|FG001|Overall Study|Withdrawal by Subject|9|||
105492233|NCT00667602|363814027|FG002|Overall Study|Withdrawal by Subject|10|||
105492234|NCT00667602|363814025|FG000|Overall Study|Lost to Follow-up|4|||
105492235|NCT00667602|363814026|FG001|Overall Study|Lost to Follow-up|5|||
105853989|NCT03896503|365121570|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
105853990|NCT03896503|365121571|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
105853991|NCT03896503|365121572|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
105373657|NCT02194465|363376247|FG002|Overall Study|Discontinued follow-up period|1|||
105492236|NCT00667602|363814027|FG002|Overall Study|Lost to Follow-up|6|||
105492237|NCT00667602|363814025|FG000|Overall Study|Administrative reason|0|||
105492238|NCT00667602|363814026|FG001|Overall Study|Administrative reason|0|||
105492239|NCT00667602|363814027|FG002|Overall Study|Administrative reason|2|||
105492240|NCT00667602|363814025|FG000|Overall Study|Protocol Violation|0|||
105492241|NCT00667602|363814026|FG001|Overall Study|Protocol Violation|1|||
105492242|NCT00667602|363814027|FG002|Overall Study|Protocol Violation|0|||
105373658|NCT02194465|363376248|FG003|Overall Study|Discontinued follow-up period|0|||
105373659|NCT02194465|363376249|FG004|Overall Study|Discontinued follow-up period|2|||
105373660|NCT02194465|363376250|FG005|Overall Study|Discontinued follow-up period|0|||
105577130|NCT02855164|364112197|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
105577131|NCT02855164|364112190|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
105853992|NCT03896503|365121573|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
105853993|NCT03896503|365121566|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
105853994|NCT03896503|365121567|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
105853995|NCT03896503|365121568|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
105853996|NCT03896503|365121569|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
105853997|NCT03896503|365121570|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
105853998|NCT03896503|365121571|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
105853999|NCT03896503|365121572|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
105854000|NCT03896503|365121573|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
105854001|NCT03896503|365121566|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
105854002|NCT03896503|365121567|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
105854003|NCT03896503|365121568|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
105854004|NCT03896503|365121569|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
105854005|NCT03896503|365121570|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
105854006|NCT03896503|365121571|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
105854007|NCT03896503|365121572|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
105854008|NCT03896503|365121573|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
105854009|NCT03896503|365121566|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
105854010|NCT03896503|365121567|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
105854011|NCT03896503|365121568|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
105854012|NCT03896503|365121569|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
105854013|NCT03896503|365121570|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
105854014|NCT03896503|365121571|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
105854015|NCT03896503|365121572|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
105854016|NCT03896503|365121573|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
105854017|NCT04037254|365121574|FG000|Overall Study|Protocol Violation|1|||
105854018|NCT04037254|365121575|FG001|Overall Study|Protocol Violation|0|||
105854019|NCT04037254|365121576|FG002|Overall Study|Protocol Violation|0|||
105854020|NCT04037254|365121577|FG003|Overall Study|Protocol Violation|0|||
105854021|NCT04037254|365121578|FG004|Overall Study|Protocol Violation|0|||
105854022|NCT04037254|365121574|FG000|Overall Study|Withdrawal by Subject|0|||
105854023|NCT04037254|365121575|FG001|Overall Study|Withdrawal by Subject|0|||
105854024|NCT04037254|365121576|FG002|Overall Study|Withdrawal by Subject|1|||
105854025|NCT04037254|365121577|FG003|Overall Study|Withdrawal by Subject|0|||
105854026|NCT04037254|365121578|FG004|Overall Study|Withdrawal by Subject|0|||
105854027|NCT04037254|365121574|FG000|Overall Study|Delayed or incomplete treatment|0|||
105854028|NCT04037254|365121575|FG001|Overall Study|Delayed or incomplete treatment|2|||
105854029|NCT04037254|365121576|FG002|Overall Study|Delayed or incomplete treatment|1|||
105854030|NCT04037254|365121577|FG003|Overall Study|Delayed or incomplete treatment|0|||
105854031|NCT04037254|365121578|FG004|Overall Study|Delayed or incomplete treatment|0|||
105854032|NCT04918147|365121579|FG000|Overall Study|Disease flare as defined in protocol|0|||
105854033|NCT04918147|365121580|FG001|Overall Study|Disease flare as defined in protocol|2|||
105854034|NCT05355818|365121587|FG000|Overall Study|Adverse Event|1|||
105854035|NCT05355818|365121588|FG001|Overall Study|Adverse Event|1|||
105854036|NCT05355818|365121587|FG000|Overall Study|Lack of Efficacy|2|||
105854037|NCT05355818|365121588|FG001|Overall Study|Lack of Efficacy|1|||
105854038|NCT05355818|365121587|FG000|Overall Study|Lost to Follow-up|0|||
105854039|NCT05355818|365121588|FG001|Overall Study|Lost to Follow-up|1|||
105854040|NCT01375114|365121592|FG000|Overall Study|Lost to Follow-up|1|||
105854041|NCT01375114|365121593|FG001|Overall Study|Lost to Follow-up|0|||
105854042|NCT01375114|365121594|FG002|Overall Study|Lost to Follow-up|1|||
105854043|NCT01375114|365121592|FG000|Overall Study|Disease Progression|3|||
105854044|NCT01375114|365121593|FG001|Overall Study|Disease Progression|2|||
105854045|NCT01375114|365121594|FG002|Overall Study|Disease Progression|2|||
105854046|NCT01375114|365121592|FG000|Overall Study|Patient Changed Mind|0|||
105854047|NCT01375114|365121593|FG001|Overall Study|Patient Changed Mind|0|||
105854048|NCT01375114|365121594|FG002|Overall Study|Patient Changed Mind|2|||
105854049|NCT01375114|365121592|FG000|Overall Study|Pruritus|0|||
105854050|NCT01375114|365121593|FG001|Overall Study|Pruritus|0|||
105854051|NCT01375114|365121594|FG002|Overall Study|Pruritus|1|||
105854052|NCT01375114|365121592|FG000|Overall Study|Restlessness|0|||
105854053|NCT01375114|365121593|FG001|Overall Study|Restlessness|0|||
105854054|NCT01375114|365121594|FG002|Overall Study|Restlessness|1|||
105854055|NCT01375114|365121592|FG000|Overall Study|Diarrhea|0|||
105854056|NCT01375114|365121593|FG001|Overall Study|Diarrhea|0|||
105854057|NCT01375114|365121594|FG002|Overall Study|Diarrhea|1|||
105854058|NCT01375114|365121592|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
105492243|NCT00406718|363814028|FG000|Overall Study|Withdrawal by Subject|2|||
105492244|NCT00406718|363814029|FG001|Overall Study|Withdrawal by Subject|9|||
105492245|NCT00406718|363814030|FG002|Overall Study|Withdrawal by Subject|4|||
105492246|NCT00406718|363814028|FG000|Overall Study|Lost to Follow-up|2|||
105854059|NCT01375114|365121593|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
105854060|NCT01375114|365121594|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
105854061|NCT01375114|365121592|FG000|Overall Study|Nausea|0|||
105854062|NCT01375114|365121593|FG001|Overall Study|Nausea|1|||
105854063|NCT01375114|365121594|FG002|Overall Study|Nausea|0|||
105854064|NCT01375114|365121592|FG000|Overall Study|Increased AST/ALT|0|||
105854065|NCT01375114|365121593|FG001|Overall Study|Increased AST/ALT|1|||
105854066|NCT01375114|365121594|FG002|Overall Study|Increased AST/ALT|0|||
105327126|NCT00153179|363196596|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
105327127|NCT00153179|363196597|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
105327128|NCT04563754|363199394|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
105327129|NCT04563754|363199395|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
105327130|NCT04563754|363199396|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
105327131|NCT04563754|363199394|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
105327132|NCT04563754|363199395|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
105327133|NCT04563754|363199396|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
105327134|NCT04563754|363199394|FG000|Follow up|Lost to Follow-up|61|||
105327135|NCT04563754|363199395|FG001|Follow up|Lost to Follow-up|23|||
105327136|NCT04563754|363199396|FG002|Follow up|Lost to Follow-up|5|||
105327137|NCT04563754|363199394|FG000|Follow up|Death|0|||
105327138|NCT04563754|363199395|FG001|Follow up|Death|2|||
105327139|NCT04563754|363199396|FG002|Follow up|Death|0|||
105327140|NCT04563754|363199394|FG000|Follow up|Ongoing|0|||
105327141|NCT04563754|363199395|FG001|Follow up|Ongoing|28|||
105327142|NCT04563754|363199396|FG002|Follow up|Ongoing|0|||
105327143|NCT04075825|363199399|FG000|Overall Study|Withdrawal by Subject|6|||
105327144|NCT04075825|363199400|FG001|Overall Study|Withdrawal by Subject|8|||
105327145|NCT04075825|363199399|FG000|Overall Study|Physician Decision|3|||
105327146|NCT04075825|363199400|FG001|Overall Study|Physician Decision|1|||
105327147|NCT04075825|363199399|FG000|Overall Study|Lost to Follow-up|5|||
105327148|NCT04075825|363199400|FG001|Overall Study|Lost to Follow-up|1|||
105327149|NCT04075825|363199399|FG000|Overall Study|Participation in New Clinical Trial|1|||
105327150|NCT04075825|363199400|FG001|Overall Study|Participation in New Clinical Trial|1|||
105327151|NCT04075825|363199399|FG000|Overall Study|Reason Not Specified|2|||
105327152|NCT04075825|363199400|FG001|Overall Study|Reason Not Specified|2|||
105327153|NCT02513160|363199401|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
105327154|NCT02513160|363199402|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
105327155|NCT02513160|363199403|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
105327156|NCT02513160|363199404|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
105327157|NCT02513160|363199401|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
105327158|NCT02513160|363199402|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
105327159|NCT02513160|363199403|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
105327160|NCT02513160|363199404|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
105327161|NCT02513160|363199401|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
105327162|NCT02513160|363199402|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
105327163|NCT02513160|363199403|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
105327164|NCT02513160|363199404|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
105327165|NCT02513160|363199401|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
105327166|NCT02513160|363199402|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
105327167|NCT02513160|363199403|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
105327168|NCT02513160|363199404|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
105327169|NCT02513160|363199401|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
105327170|NCT02513160|363199402|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
105327171|NCT02513160|363199403|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
105327172|NCT02513160|363199404|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
105327173|NCT02513160|363199401|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
105327174|NCT02513160|363199402|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
105327175|NCT02513160|363199403|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
105327176|NCT02513160|363199404|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
105327177|NCT02513160|363199401|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
105327178|NCT02513160|363199402|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
105373661|NCT02194465|363376251|FG006|Overall Study|Discontinued follow-up period|0|||
105492247|NCT00406718|363814029|FG001|Overall Study|Lost to Follow-up|5|||
105854067|NCT01375114|365121592|FG000|Overall Study|Vaginal Hemorrhage|0|||
105854068|NCT01375114|365121593|FG001|Overall Study|Vaginal Hemorrhage|1|||
105854069|NCT01375114|365121594|FG002|Overall Study|Vaginal Hemorrhage|0|||
105492248|NCT00406718|363814030|FG002|Overall Study|Lost to Follow-up|4|||
105492249|NCT00072176|363814031|FG000|Overall Study|Withdrawal by Subject|1|||
105492250|NCT00072176|363814032|FG001|Overall Study|Withdrawal by Subject|0|||
105492251|NCT00072176|363814031|FG000|Overall Study|Protocol Violation|0|||
105492252|NCT00072176|363814032|FG001|Overall Study|Protocol Violation|1|||
105492253|NCT02891161|363814035|FG000|Study Treatment|Disease Progression|2|||
105492254|NCT02891161|363814036|FG001|Study Treatment|Disease Progression|4|||
105492255|NCT02891161|363814035|FG000|Study Treatment|AE/Side Effects/Complications|1|||
105492256|NCT02891161|363814036|FG001|Study Treatment|AE/Side Effects/Complications|5|||
105492257|NCT02891161|363814035|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
105492258|NCT02891161|363814036|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
105492259|NCT02891161|363814035|FG000|Follow up|Death|4|||
105492260|NCT02891161|363814036|FG001|Follow up|Death|8|||
105492261|NCT02891161|363814035|FG000|Follow up|Refused to Follow up|0|||
105492262|NCT02891161|363814036|FG001|Follow up|Refused to Follow up|2|||
105492263|NCT02891161|363814035|FG000|Follow up|Symptomatic deterioration|0|||
105492264|NCT02891161|363814036|FG001|Follow up|Symptomatic deterioration|1|||
105492265|NCT02891161|363814035|FG000|Follow up|Study terminated|0|||
105492266|NCT02891161|363814036|FG001|Follow up|Study terminated|6|||
105492267|NCT05069259|363814037|FG000|Overall Study|Withdrawal by Subject|1|||
105492268|NCT05069259|363814037|FG000|Overall Study|Sponsor decision|1|||
105492269|NCT00215683|363815694|FG000|Overall Study|Adverse Event|15|||
105492270|NCT00215683|363815695|FG001|Overall Study|Adverse Event|16|||
105492271|NCT00215683|363815696|FG002|Overall Study|Adverse Event|15|||
105492272|NCT00215683|363815694|FG000|Overall Study|Lack of Efficacy|5|||
105492273|NCT00215683|363815695|FG001|Overall Study|Lack of Efficacy|1|||
105492274|NCT00215683|363815696|FG002|Overall Study|Lack of Efficacy|2|||
105492275|NCT00215683|363815694|FG000|Overall Study|Lost to Follow-up|0|||
105492276|NCT00215683|363815695|FG001|Overall Study|Lost to Follow-up|2|||
105492277|NCT00215683|363815696|FG002|Overall Study|Lost to Follow-up|1|||
105492278|NCT00215683|363815694|FG000|Overall Study|Withdrawal by Subject|9|||
105492279|NCT00215683|363815695|FG001|Overall Study|Withdrawal by Subject|4|||
105492280|NCT00215683|363815696|FG002|Overall Study|Withdrawal by Subject|13|||
105492281|NCT00215683|363815694|FG000|Overall Study|Physician Decision|0|||
105492282|NCT00215683|363815695|FG001|Overall Study|Physician Decision|0|||
105492283|NCT00215683|363815696|FG002|Overall Study|Physician Decision|1|||
105492284|NCT00215683|363815694|FG000|Overall Study|Difficult to attend visits|0|||
105492285|NCT00215683|363815695|FG001|Overall Study|Difficult to attend visits|1|||
105492286|NCT00215683|363815696|FG002|Overall Study|Difficult to attend visits|0|||
105492287|NCT00215683|363815694|FG000|Overall Study|No study drug available|0|||
105492288|NCT00215683|363815695|FG001|Overall Study|No study drug available|1|||
105492289|NCT00215683|363815696|FG002|Overall Study|No study drug available|0|||
105492290|NCT00215683|363815694|FG000|Overall Study|Intermittent therapy required|0|||
105492291|NCT00215683|363815695|FG001|Overall Study|Intermittent therapy required|1|||
105492292|NCT00215683|363815696|FG002|Overall Study|Intermittent therapy required|0|||
105492293|NCT00422097|363815703|FG000|Dose Level 2|Still on treatment|0|||
105492294|NCT00422097|363815704|FG001|Dose Level 2|Still on treatment|1|||
105492295|NCT00422097|363815705|FG002|Dose Level 2|Still on treatment|0|||
105492296|NCT00422097|363815706|FG003|Dose Level 2|Still on treatment|0|||
105492297|NCT00422097|363815707|FG004|Dose Level 2|Still on treatment|0|||
105492298|NCT00422097|363815708|FG005|Dose Level 2|Still on treatment|0|||
105492299|NCT00422097|363815709|FG006|Dose Level 2|Still on treatment|0|||
105492300|NCT00422097|363815710|FG007|Dose Level 2|Still on treatment|0|||
105492301|NCT02923427|363815711|FG000|Overall Study|convert to laparatomy|2|||
105492302|NCT02923427|363815712|FG001|Overall Study|convert to laparatomy|2|||
105492303|NCT02923427|363815711|FG000|Overall Study|destaturation|1|||
105492304|NCT02923427|363815712|FG001|Overall Study|destaturation|0|||
105492305|NCT02923427|363815711|FG000|Overall Study|can not replace LMA|1|||
105492306|NCT02923427|363815712|FG001|Overall Study|can not replace LMA|0|||
105492307|NCT01229397|363815713|FG000|Overall Study|Withdrawal by Subject|3|||
105492308|NCT01229397|363815714|FG001|Overall Study|Withdrawal by Subject|3|||
105492309|NCT01229397|363815713|FG000|Overall Study|Lost to Follow-up|7|||
105492310|NCT01229397|363815714|FG001|Overall Study|Lost to Follow-up|6|||
105492311|NCT01229397|363815713|FG000|Overall Study|Migrated/moved from study area|1|||
105492312|NCT01229397|363815714|FG001|Overall Study|Migrated/moved from study area|0|||
105492313|NCT00950911|363815715|FG000|Overall Study|Adverse Event|0|||
105492314|NCT00950911|363815716|FG001|Overall Study|Adverse Event|2|||
105492315|NCT00950911|363815715|FG000|Overall Study|Death|4|||
105492316|NCT00950911|363815716|FG001|Overall Study|Death|6|||
105492317|NCT00950911|363815715|FG000|Overall Study|Disease progression|2|||
105492318|NCT00950911|363815716|FG001|Overall Study|Disease progression|2|||
105492319|NCT00950911|363815715|FG000|Overall Study|Consent withdrawn|1|||
105492320|NCT00950911|363815716|FG001|Overall Study|Consent withdrawn|3|||
105492321|NCT00950911|363815715|FG000|Overall Study|Administrative decision|3|||
105492322|NCT00950911|363815716|FG001|Overall Study|Administrative decision|1|||
105492323|NCT00950911|363815715|FG000|Overall Study|Ineligibility determined|1|||
105492324|NCT00950911|363815716|FG001|Overall Study|Ineligibility determined|0|||
105492325|NCT00950911|363815715|FG000|Overall Study|Noncompliance|1|||
105854070|NCT01375114|365121592|FG000|Overall Study|Family problem|0|||
105854071|NCT01375114|365121593|FG001|Overall Study|Family problem|1|||
105854072|NCT01375114|365121594|FG002|Overall Study|Family problem|0|||
105854073|NCT01375114|365121592|FG000|Overall Study|Protocol Violation|2|||
105854074|NCT01375114|365121593|FG001|Overall Study|Protocol Violation|0|||
105854075|NCT01375114|365121594|FG002|Overall Study|Protocol Violation|0|||
105854076|NCT02769832|365121595|FG000|Overall Study|Death|30|||
105854077|NCT00070499|365121598|FG000|Overall Study|Adverse Event|6|||
105854078|NCT00070499|365121599|FG001|Overall Study|Adverse Event|6|||
105854079|NCT00070499|365121600|FG002|Overall Study|Adverse Event|19|||
105854080|NCT00070499|365121601|FG003|Overall Study|Adverse Event|15|||
105854081|NCT00070499|365121598|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
105854082|NCT00070499|365121599|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
105854083|NCT00070499|365121600|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
105854084|NCT00070499|365121601|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
105854085|NCT00070499|365121598|FG000|Overall Study|Progression/relapse|4|||
105854086|NCT00070499|365121599|FG001|Overall Study|Progression/relapse|2|||
105854087|NCT00070499|365121600|FG002|Overall Study|Progression/relapse|1|||
105854088|NCT00070499|365121601|FG003|Overall Study|Progression/relapse|4|||
105854089|NCT00070499|365121598|FG000|Overall Study|Death|1|||
105854090|NCT00070499|365121599|FG001|Overall Study|Death|1|||
105854091|NCT00070499|365121600|FG002|Overall Study|Death|1|||
105854092|NCT00070499|365121601|FG003|Overall Study|Death|2|||
105854093|NCT00070499|365121598|FG000|Overall Study|Other - not protocol specified|7|||
105854094|NCT00070499|365121599|FG001|Overall Study|Other - not protocol specified|3|||
105854095|NCT00070499|365121600|FG002|Overall Study|Other - not protocol specified|12|||
105854096|NCT00070499|365121601|FG003|Overall Study|Other - not protocol specified|20|||
105854097|NCT00070499|365121598|FG000|Overall Study|Still on protocol treatment|10|||
105854098|NCT00070499|365121599|FG001|Overall Study|Still on protocol treatment|4|||
105854099|NCT00070499|365121600|FG002|Overall Study|Still on protocol treatment|79|||
105854100|NCT00070499|365121601|FG003|Overall Study|Still on protocol treatment|57|||
105854101|NCT00070499|365121598|FG000|Overall Study|Did not start treatment|1|||
105854102|NCT00070499|365121599|FG001|Overall Study|Did not start treatment|0|||
105854103|NCT00070499|365121600|FG002|Overall Study|Did not start treatment|0|||
105854104|NCT00070499|365121601|FG003|Overall Study|Did not start treatment|2|||
105854105|NCT00070499|365121598|FG000|Overall Study|Not eligible|2|||
105854106|NCT00070499|365121599|FG001|Overall Study|Not eligible|5|||
105854107|NCT00070499|365121600|FG002|Overall Study|Not eligible|3|||
105854108|NCT00070499|365121601|FG003|Overall Study|Not eligible|2|||
105854109|NCT06134180|365121602|FG000|Overall Study|Lost to Follow-up|4|||
105854110|NCT04512976|365121603|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
105854111|NCT04512976|365121604|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
105854112|NCT04512976|365121605|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
105854113|NCT04512976|365121606|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
105854114|NCT04512976|365121607|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
105854115|NCT04512976|365121608|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
105854116|NCT02152982|365121609|FG000|Overall Study|Ineligible|4|||
105854117|NCT02152982|365121610|FG001|Overall Study|Ineligible|4|||
105854118|NCT02152982|365121609|FG000|Overall Study|Did not start treatment|12|||
105854119|NCT02152982|365121610|FG001|Overall Study|Did not start treatment|6|||
105854120|NCT01169337|365121611|FG000|Overall Study|Lack of Efficacy|5|||
105854121|NCT01169337|365121612|FG001|Overall Study|Lack of Efficacy|7|||
105854122|NCT01169337|365121613|FG002|Overall Study|Lack of Efficacy|0|||
105854123|NCT01169337|365121611|FG000|Overall Study|Adverse Event|12|||
105854124|NCT01169337|365121612|FG001|Overall Study|Adverse Event|18|||
105854125|NCT01169337|365121613|FG002|Overall Study|Adverse Event|0|||
105854126|NCT01169337|365121611|FG000|Overall Study|Death|2|||
105854127|NCT01169337|365121612|FG001|Overall Study|Death|0|||
105854128|NCT01169337|365121613|FG002|Overall Study|Death|0|||
105854129|NCT01169337|365121611|FG000|Overall Study|Withdrawal by Subject|11|||
105854130|NCT01169337|365121612|FG001|Overall Study|Withdrawal by Subject|11|||
105854131|NCT01169337|365121613|FG002|Overall Study|Withdrawal by Subject|6|||
105492326|NCT00950911|363815716|FG001|Overall Study|Noncompliance|0|||
105854132|NCT01169337|365121611|FG000|Overall Study|Noncompliance|2|||
105854133|NCT01169337|365121612|FG001|Overall Study|Noncompliance|0|||
105854134|NCT01169337|365121613|FG002|Overall Study|Noncompliance|0|||
105854135|NCT01169337|365121611|FG000|Overall Study|Other complicating disease|1|||
105854136|NCT01169337|365121612|FG001|Overall Study|Other complicating disease|1|||
105854137|NCT01169337|365121613|FG002|Overall Study|Other complicating disease|0|||
105854138|NCT01169337|365121611|FG000|Overall Study|Physician Decision|1|||
105854139|NCT01169337|365121612|FG001|Overall Study|Physician Decision|5|||
105854140|NCT01169337|365121613|FG002|Overall Study|Physician Decision|0|||
105854141|NCT01169337|365121611|FG000|Overall Study|Alternative therapy|0|||
105854142|NCT01169337|365121612|FG001|Overall Study|Alternative therapy|2|||
105854143|NCT01169337|365121613|FG002|Overall Study|Alternative therapy|0|||
105854144|NCT01169337|365121611|FG000|Overall Study|Changed hospital|0|||
105854145|NCT01169337|365121612|FG001|Overall Study|Changed hospital|1|||
105854146|NCT01169337|365121613|FG002|Overall Study|Changed hospital|0|||
105854147|NCT01169337|365121611|FG000|Overall Study|Never started treatment|0|||
105854148|NCT01169337|365121612|FG001|Overall Study|Never started treatment|2|||
105854149|NCT01169337|365121613|FG002|Overall Study|Never started treatment|0|||
105854150|NCT01169337|365121611|FG000|Overall Study|Reason not reported|1|||
105854151|NCT01169337|365121612|FG001|Overall Study|Reason not reported|0|||
105854152|NCT01169337|365121613|FG002|Overall Study|Reason not reported|0|||
105854153|NCT01169337|365121611|FG000|Overall Study|Continuing lenalidomide|9|||
105854154|NCT01169337|365121612|FG001|Overall Study|Continuing lenalidomide|43|||
105854155|NCT01169337|365121613|FG002|Overall Study|Continuing lenalidomide|0|||
105854156|NCT01134614|365121614|FG000|Overall Study|Still on treatment as of March 2013|21|||
105854157|NCT01134614|365121615|FG001|Overall Study|Still on treatment as of March 2013|13|||
105854158|NCT01134614|365121614|FG000|Overall Study|Progressive disease|60|||
105854159|NCT01134614|365121615|FG001|Overall Study|Progressive disease|54|||
105854160|NCT01134614|365121614|FG000|Overall Study|Adverse Event|26|||
105854161|NCT01134614|365121615|FG001|Overall Study|Adverse Event|39|||
105854162|NCT01134614|365121614|FG000|Overall Study|Death|5|||
105854163|NCT01134614|365121615|FG001|Overall Study|Death|8|||
105854164|NCT01134614|365121614|FG000|Overall Study|Withdrawal by Subject|3|||
105854165|NCT01134614|365121615|FG001|Overall Study|Withdrawal by Subject|2|||
105854166|NCT01134614|365121614|FG000|Overall Study|Alternative therapy|2|||
105854167|NCT01134614|365121615|FG001|Overall Study|Alternative therapy|0|||
105854168|NCT01134614|365121614|FG000|Overall Study|Complicating disease|2|||
105854169|NCT01134614|365121615|FG001|Overall Study|Complicating disease|1|||
105854170|NCT01134614|365121614|FG000|Overall Study|Physician's decision|0|||
105854171|NCT01134614|365121615|FG001|Overall Study|Physician's decision|1|||
105854172|NCT01134614|365121614|FG000|Overall Study|Never started treatment|4|||
105854173|NCT01134614|365121615|FG001|Overall Study|Never started treatment|1|||
105854174|NCT01134614|365121614|FG000|Overall Study|Pt received tx not allowed on study|0|||
105854175|NCT01134614|365121615|FG001|Overall Study|Pt received tx not allowed on study|1|||
105854176|NCT01134614|365121614|FG000|Overall Study|Symptomatic deterioration|0|||
105854177|NCT01134614|365121615|FG001|Overall Study|Symptomatic deterioration|1|||
105854178|NCT01134614|365121614|FG000|Overall Study|Patient in hospice care|0|||
105854179|NCT01134614|365121615|FG001|Overall Study|Patient in hospice care|1|||
105854180|NCT04034927|365121618|FG000|Overall Study|Adverse Event|4|||
105854181|NCT04034927|365121619|FG001|Overall Study|Adverse Event|9|||
105854182|NCT04034927|365121618|FG000|Overall Study|Death|0|||
105854183|NCT04034927|365121619|FG001|Overall Study|Death|1|||
105854184|NCT04034927|365121618|FG000|Overall Study|Withdrawal by Subject|0|||
105854185|NCT04034927|365121619|FG001|Overall Study|Withdrawal by Subject|3|||
105854186|NCT04034927|365121618|FG000|Overall Study|Still on Treatment|2|||
105854187|NCT04034927|365121619|FG001|Overall Study|Still on Treatment|1|||
105854188|NCT04034927|365121618|FG000|Overall Study|Other|1|||
105854189|NCT04034927|365121619|FG001|Overall Study|Other|1|||
105854190|NCT03997383|365121622|FG000|Double-blind Treatment Period|Adverse Event|4|||
105854191|NCT03997383|365121623|FG001|Double-blind Treatment Period|Adverse Event|3|||
105854192|NCT03997383|365121622|FG000|Double-blind Treatment Period|Death|4|||
105854193|NCT03997383|365121623|FG001|Double-blind Treatment Period|Death|4|||
105854194|NCT03997383|365121622|FG000|Double-blind Treatment Period|Physician Decision|2|||
105854195|NCT03997383|365121623|FG001|Double-blind Treatment Period|Physician Decision|0|||
105854196|NCT03997383|365121622|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
105854197|NCT03997383|365121623|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
105854198|NCT03997383|365121622|FG000|Open-label Extension Period|Ongoing|148|||
105854199|NCT03997383|365121623|FG001|Open-label Extension Period|Ongoing|151|||
105854200|NCT03997383|365121622|FG000|Open-label Extension Period|Adverse Event|4|||
105854201|NCT03997383|365121623|FG001|Open-label Extension Period|Adverse Event|1|||
105854202|NCT03997383|365121622|FG000|Open-label Extension Period|Death|8|||
105854203|NCT03997383|365121623|FG001|Open-label Extension Period|Death|9|||
105854204|NCT03997383|365121622|FG000|Open-label Extension Period|Physician Decision|1|||
105854205|NCT03997383|365121623|FG001|Open-label Extension Period|Physician Decision|1|||
105854206|NCT03997383|365121622|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
105854207|NCT03997383|365121623|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
105854208|NCT03997383|365121622|FG000|Open-label Extension Period|Reason Not Specified|2|||
105854209|NCT03997383|365121623|FG001|Open-label Extension Period|Reason Not Specified|0|||
105854210|NCT02306161|365121624|FG000|Overall Study|Death|1|||
105854211|NCT02306161|365121625|FG001|Overall Study|Death|3|||
105854212|NCT02306161|365121624|FG000|Overall Study|Lack of Efficacy|20|||
105854213|NCT02306161|365121625|FG001|Overall Study|Lack of Efficacy|43|||
105854214|NCT02306161|365121624|FG000|Overall Study|Physician Decision|30|||
105854215|NCT02306161|365121625|FG001|Overall Study|Physician Decision|18|||
105373662|NCT00961064|363376252|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
105492327|NCT00950911|363815715|FG000|Overall Study|Poor performance status|0|||
105854216|NCT02306161|365121624|FG000|Overall Study|Withdrawal by Subject|4|||
105854217|NCT02306161|365121625|FG001|Overall Study|Withdrawal by Subject|0|||
105854218|NCT02306161|365121624|FG000|Overall Study|Ineligible|9|||
105854219|NCT02306161|365121625|FG001|Overall Study|Ineligible|5|||
105854220|NCT03909152|365121626|FG000|Overall Study|Adverse Event|14|||
105854221|NCT03909152|365121627|FG001|Overall Study|Adverse Event|5|||
105854222|NCT03909152|365121628|FG002|Overall Study|Adverse Event|1|||
105854223|NCT03909152|365121629|FG003|Overall Study|Adverse Event|14|||
105854224|NCT03880019|365121630|FG000|Overall Study|Competing disease|1|||
105854225|NCT05905601|365121631|FG000|Overall Study|Lost to Follow-up|1|||
105854226|NCT05905601|365121632|FG001|Overall Study|Lost to Follow-up|3|||
105854227|NCT03583606|365121633|FG000|Overall Study|Lost to Follow-up|0|||
105854228|NCT03583606|365121634|FG001|Overall Study|Lost to Follow-up|1|||
105854229|NCT03583606|365121635|FG002|Overall Study|Lost to Follow-up|0|||
105854230|NCT03583606|365121633|FG000|Overall Study|Ineligible at baseline|1|||
105854231|NCT03583606|365121634|FG001|Overall Study|Ineligible at baseline|0|||
105854232|NCT03583606|365121635|FG002|Overall Study|Ineligible at baseline|0|||
105854233|NCT03362502|365121640|FG000|Overall Study|Death|0|||
105854234|NCT03362502|365121641|FG001|Overall Study|Death|0|||
105854235|NCT03362502|365121642|FG002|Overall Study|Death|1|||
105854236|NCT03338829|365121643|FG000|Overall Study|Lost to Follow-up|4|||
105854237|NCT03338829|365121644|FG001|Overall Study|Lost to Follow-up|2|||
105854238|NCT03338829|365121645|FG002|Overall Study|Lost to Follow-up|4|||
105854239|NCT03338829|365121643|FG000|Overall Study|Pregnancy loss|1|||
105854240|NCT03338829|365121644|FG001|Overall Study|Pregnancy loss|1|||
105854241|NCT03338829|365121645|FG002|Overall Study|Pregnancy loss|0|||
105854242|NCT03338829|365121643|FG000|Overall Study|Protocol Violation|0|||
105854243|NCT03338829|365121644|FG001|Overall Study|Protocol Violation|1|||
105854244|NCT03338829|365121645|FG002|Overall Study|Protocol Violation|0|||
105854245|NCT02498613|365121646|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
105854246|NCT02498613|365121647|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
105854247|NCT02498613|365121648|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
105327179|NCT02513160|363199403|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
105327180|NCT02513160|363199404|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
105327181|NCT02513160|363199401|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
105327182|NCT02513160|363199402|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
105327183|NCT02513160|363199403|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
105327184|NCT02513160|363199404|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
105327185|NCT02513160|363199401|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
105327186|NCT02513160|363199402|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
105327187|NCT02513160|363199403|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
105327188|NCT02513160|363199404|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
105327189|NCT02513160|363199401|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
105327190|NCT02513160|363199402|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
105327191|NCT02513160|363199403|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
105327192|NCT02513160|363199404|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
105327193|NCT02513160|363199401|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
105327194|NCT02513160|363199402|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
105327195|NCT02513160|363199403|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
105327196|NCT02513160|363199404|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
105327197|NCT02513160|363199401|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
105327198|NCT02513160|363199402|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
105327199|NCT02513160|363199403|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
105327200|NCT02513160|363199404|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
105327201|NCT04021914|363199405|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
105327202|NCT02844543|363199406|FG000|Overall Study|Withdrawal by Subject|4|||
105327203|NCT02844543|363199406|FG000|Overall Study|Did not meet eligibility criteria|1|||
105327204|NCT00485732|363199411|FG000|Overall Study|Protocol Violation|1|||
105327205|NCT00485732|363199412|FG001|Overall Study|Protocol Violation|3|||
105327206|NCT00485732|363199411|FG000|Overall Study|Withdrawal by Subject|5|||
105327207|NCT00485732|363199412|FG001|Overall Study|Withdrawal by Subject|4|||
105327208|NCT00485732|363199411|FG000|Overall Study|Lost to Follow-up|2|||
105327209|NCT00485732|363199412|FG001|Overall Study|Lost to Follow-up|2|||
105373663|NCT00961064|363376252|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
105373664|NCT00961064|363376252|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
105373665|NCT00961064|363376252|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
105373666|NCT00961064|363376252|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
105373667|NCT00961064|363376252|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
105854248|NCT02498613|365121649|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
105854249|NCT02498613|365121646|FG000|Overall Study|Withdrawal by Subject|3|||
105854250|NCT02498613|365121647|FG001|Overall Study|Withdrawal by Subject|1|||
105854251|NCT02498613|365121648|FG002|Overall Study|Withdrawal by Subject|0|||
105854252|NCT02498613|365121649|FG003|Overall Study|Withdrawal by Subject|0|||
105854253|NCT05063539|365121650|FG000|Overall Study|Adverse Event|1|||
105854254|NCT05063539|365121651|FG001|Overall Study|Adverse Event|2|||
105854255|NCT05063539|365121652|FG002|Overall Study|Adverse Event|1|||
105854256|NCT05063539|365121650|FG000|Overall Study|Death|0|||
105854257|NCT05063539|365121651|FG001|Overall Study|Death|1|||
105854258|NCT05063539|365121652|FG002|Overall Study|Death|1|||
105854259|NCT05063539|365121650|FG000|Overall Study|Lost to Follow-up|0|||
105854260|NCT05063539|365121651|FG001|Overall Study|Lost to Follow-up|1|||
105854261|NCT05063539|365121652|FG002|Overall Study|Lost to Follow-up|0|||
105373668|NCT00961064|363376252|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
105373669|NCT00961064|363376252|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
105373670|NCT01648764|363376253|FG000|Overall Study|Progressive Disease|0|||
105373671|NCT01648764|363376254|FG001|Overall Study|Progressive Disease|1|||
105373672|NCT01648764|363376255|FG002|Overall Study|Progressive Disease|0|||
105373673|NCT01648764|363376256|FG003|Overall Study|Progressive Disease|0|||
105373674|NCT01648764|363376257|FG004|Overall Study|Progressive Disease|0|||
105373675|NCT01648764|363376258|FG005|Overall Study|Progressive Disease|1|||
105373676|NCT01648764|363376259|FG006|Overall Study|Progressive Disease|1|||
105373677|NCT01648764|363376260|FG007|Overall Study|Progressive Disease|0|||
105373678|NCT01648764|363376261|FG008|Overall Study|Progressive Disease|0|||
105373679|NCT01648764|363376262|FG009|Overall Study|Progressive Disease|2|||
105373680|NCT01648764|363376263|FG010|Overall Study|Progressive Disease|0|||
105373681|NCT01648764|363376264|FG011|Overall Study|Progressive Disease|1|||
105373682|NCT01648764|363376265|FG012|Overall Study|Progressive Disease|2|||
105373683|NCT01648764|363376266|FG013|Overall Study|Progressive Disease|1|||
105373684|NCT01648764|363376253|FG000|Overall Study|Adverse Event|0|||
105373685|NCT01648764|363376254|FG001|Overall Study|Adverse Event|0|||
105373686|NCT01648764|363376255|FG002|Overall Study|Adverse Event|0|||
105373687|NCT01648764|363376256|FG003|Overall Study|Adverse Event|0|||
105373688|NCT01648764|363376257|FG004|Overall Study|Adverse Event|0|||
105373689|NCT01648764|363376258|FG005|Overall Study|Adverse Event|1|||
105373690|NCT01648764|363376259|FG006|Overall Study|Adverse Event|0|||
105373691|NCT01648764|363376260|FG007|Overall Study|Adverse Event|0|||
105373692|NCT01648764|363376261|FG008|Overall Study|Adverse Event|0|||
105373693|NCT01648764|363376262|FG009|Overall Study|Adverse Event|1|||
105373694|NCT01648764|363376263|FG010|Overall Study|Adverse Event|0|||
105373695|NCT01648764|363376264|FG011|Overall Study|Adverse Event|3|||
105373696|NCT01648764|363376265|FG012|Overall Study|Adverse Event|1|||
105373697|NCT01648764|363376266|FG013|Overall Study|Adverse Event|1|||
105373698|NCT01648764|363376253|FG000|Overall Study|Death|0|||
105373699|NCT01648764|363376254|FG001|Overall Study|Death|0|||
105373700|NCT01648764|363376255|FG002|Overall Study|Death|0|||
105373701|NCT01648764|363376256|FG003|Overall Study|Death|0|||
105373702|NCT01648764|363376257|FG004|Overall Study|Death|0|||
105373703|NCT01648764|363376258|FG005|Overall Study|Death|0|||
105373704|NCT01648764|363376259|FG006|Overall Study|Death|1|||
105373705|NCT01648764|363376260|FG007|Overall Study|Death|0|||
105373706|NCT01648764|363376261|FG008|Overall Study|Death|0|||
105373707|NCT01648764|363376262|FG009|Overall Study|Death|0|||
105373708|NCT01648764|363376263|FG010|Overall Study|Death|0|||
105373709|NCT01648764|363376264|FG011|Overall Study|Death|0|||
105373710|NCT01648764|363376265|FG012|Overall Study|Death|0|||
105373711|NCT01648764|363376266|FG013|Overall Study|Death|1|||
105373712|NCT01648764|363376253|FG000|Overall Study|Withdrawal by Subject|0|||
105373713|NCT01648764|363376254|FG001|Overall Study|Withdrawal by Subject|0|||
105373714|NCT01648764|363376255|FG002|Overall Study|Withdrawal by Subject|0|||
105373715|NCT01648764|363376256|FG003|Overall Study|Withdrawal by Subject|0|||
105373716|NCT01648764|363376257|FG004|Overall Study|Withdrawal by Subject|0|||
105373717|NCT01648764|363376258|FG005|Overall Study|Withdrawal by Subject|0|||
105373718|NCT01648764|363376259|FG006|Overall Study|Withdrawal by Subject|2|||
105373719|NCT01648764|363376260|FG007|Overall Study|Withdrawal by Subject|0|||
105854262|NCT05063539|365121650|FG000|Overall Study|Physician Decision|4|||
105854263|NCT05063539|365121651|FG001|Overall Study|Physician Decision|3|||
105854264|NCT05063539|365121652|FG002|Overall Study|Physician Decision|1|||
105854265|NCT05063539|365121650|FG000|Overall Study|Progressive Disease|0|||
105373720|NCT01648764|363376261|FG008|Overall Study|Withdrawal by Subject|0|||
105373721|NCT01648764|363376262|FG009|Overall Study|Withdrawal by Subject|0|||
105373722|NCT01648764|363376263|FG010|Overall Study|Withdrawal by Subject|0|||
105373723|NCT01648764|363376264|FG011|Overall Study|Withdrawal by Subject|0|||
105373724|NCT01648764|363376265|FG012|Overall Study|Withdrawal by Subject|1|||
105373725|NCT01648764|363376266|FG013|Overall Study|Withdrawal by Subject|0|||
105373726|NCT01648764|363376253|FG000|Overall Study|Investigator Decision|0|||
105373727|NCT01648764|363376254|FG001|Overall Study|Investigator Decision|0|||
105373728|NCT01648764|363376255|FG002|Overall Study|Investigator Decision|0|||
105373729|NCT01648764|363376256|FG003|Overall Study|Investigator Decision|0|||
105373730|NCT01648764|363376257|FG004|Overall Study|Investigator Decision|0|||
105373731|NCT01648764|363376258|FG005|Overall Study|Investigator Decision|0|||
105373732|NCT01648764|363376259|FG006|Overall Study|Investigator Decision|1|||
105373733|NCT01648764|363376260|FG007|Overall Study|Investigator Decision|0|||
105373734|NCT01648764|363376261|FG008|Overall Study|Investigator Decision|0|||
105373735|NCT01648764|363376262|FG009|Overall Study|Investigator Decision|0|||
105373736|NCT01648764|363376263|FG010|Overall Study|Investigator Decision|0|||
105854266|NCT05063539|365121651|FG001|Overall Study|Progressive Disease|2|||
105854267|NCT05063539|365121652|FG002|Overall Study|Progressive Disease|0|||
105492328|NCT00950911|363815716|FG001|Overall Study|Poor performance status|1|||
105492329|NCT02180165|363815721|FG000|Overall Study|Not Treated|0|||
105492330|NCT02180165|363815722|FG001|Overall Study|Not Treated|0|||
105492331|NCT02180165|363815723|FG002|Overall Study|Not Treated|1|||
105492332|NCT02180165|363815724|FG003|Overall Study|Not Treated|0|||
105492333|NCT02180165|363815721|FG000|Overall Study|Adverse Event|7|||
105492334|NCT02180165|363815722|FG001|Overall Study|Adverse Event|0|||
105492335|NCT02180165|363815723|FG002|Overall Study|Adverse Event|18|||
105492336|NCT02180165|363815724|FG003|Overall Study|Adverse Event|3|||
105492337|NCT02180165|363815721|FG000|Overall Study|Lack of Efficacy|0|||
105492338|NCT02180165|363815722|FG001|Overall Study|Lack of Efficacy|1|||
105492339|NCT02180165|363815723|FG002|Overall Study|Lack of Efficacy|3|||
105492340|NCT02180165|363815724|FG003|Overall Study|Lack of Efficacy|2|||
105373737|NCT01648764|363376264|FG011|Overall Study|Investigator Decision|1|||
105373738|NCT01648764|363376265|FG012|Overall Study|Investigator Decision|0|||
105373739|NCT01648764|363376266|FG013|Overall Study|Investigator Decision|0|||
105373740|NCT00947544|363376267|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
105373741|NCT00947544|363376268|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
105373742|NCT00761319|363376269|FG000|Overall Study|Protocol Violation|21|||
105373743|NCT00761319|363376270|FG001|Overall Study|Protocol Violation|14|||
105373744|NCT00761319|363376269|FG000|Overall Study|Adverse Event|11|||
105492341|NCT02180165|363815721|FG000|Overall Study|Physician Decision|1|||
105492342|NCT02180165|363815722|FG001|Overall Study|Physician Decision|0|||
105492343|NCT02180165|363815723|FG002|Overall Study|Physician Decision|5|||
105373745|NCT00761319|363376270|FG001|Overall Study|Adverse Event|7|||
105373746|NCT00761319|363376269|FG000|Overall Study|Withdrawal by Subject|8|||
105492344|NCT02180165|363815724|FG003|Overall Study|Physician Decision|0|||
105492345|NCT02180165|363815721|FG000|Overall Study|Withdrawal by Subject|3|||
105492346|NCT02180165|363815722|FG001|Overall Study|Withdrawal by Subject|0|||
105327210|NCT04796909|363199414|FG000|Overall Study|Withdrawal by Subject|1|||
105327211|NCT04796909|363199415|FG001|Overall Study|Withdrawal by Subject|1|||
105327212|NCT04162847|363199416|FG000|Overall Study|Withdrawal by Subject|7|||
105327213|NCT04162847|363199417|FG001|Overall Study|Withdrawal by Subject|1|||
105327214|NCT03428958|363199418|FG000|Overall Study|Adverse Event|0|||
105327215|NCT03428958|363199419|FG001|Overall Study|Adverse Event|0|||
105327216|NCT03428958|363199420|FG002|Overall Study|Adverse Event|0|||
105327217|NCT03428958|363199421|FG003|Overall Study|Adverse Event|1|||
105327218|NCT03428958|363199422|FG004|Overall Study|Adverse Event|0|||
105327219|NCT03428958|363199423|FG005|Overall Study|Adverse Event|2|||
105327220|NCT03428958|363199424|FG006|Overall Study|Adverse Event|1|||
105327221|NCT03428958|363199425|FG007|Overall Study|Adverse Event|0|||
105327222|NCT03428958|363199426|FG008|Overall Study|Adverse Event|0|||
105327223|NCT03428958|363199427|FG009|Overall Study|Adverse Event|0|||
105327224|NCT03428958|363199428|FG010|Overall Study|Adverse Event|0|||
105327225|NCT03428958|363199429|FG011|Overall Study|Adverse Event|0|||
105327226|NCT03428958|363199430|FG012|Overall Study|Adverse Event|0|||
105327227|NCT03428958|363199431|FG013|Overall Study|Adverse Event|0|||
105327228|NCT03428958|363199432|FG014|Overall Study|Adverse Event|0|||
105327229|NCT03428958|363199433|FG015|Overall Study|Adverse Event|0|||
105327230|NCT03428958|363199434|FG016|Overall Study|Adverse Event|0|||
105327231|NCT03428958|363199418|FG000|Overall Study|Clinical Progression|2|||
105327232|NCT03428958|363199419|FG001|Overall Study|Clinical Progression|3|||
105327233|NCT03428958|363199420|FG002|Overall Study|Clinical Progression|2|||
105854268|NCT05063539|365121650|FG000|Overall Study|Withdrawal by Subject|17|||
105854269|NCT05063539|365121651|FG001|Overall Study|Withdrawal by Subject|26|||
105854270|NCT05063539|365121652|FG002|Overall Study|Withdrawal by Subject|14|||
105854271|NCT05063539|365121650|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
105854272|NCT05063539|365121651|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
105854273|NCT05063539|365121652|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
105854274|NCT05063539|365121650|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
105854275|NCT05063539|365121651|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
105854276|NCT05063539|365121652|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
105854277|NCT05063539|365121650|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
105373747|NCT00761319|363376270|FG001|Overall Study|Withdrawal by Subject|7|||
105373748|NCT00761319|363376269|FG000|Overall Study|Noncompliance|4|||
105327234|NCT03428958|363199421|FG003|Overall Study|Clinical Progression|1|||
105327235|NCT03428958|363199422|FG004|Overall Study|Clinical Progression|0|||
105327236|NCT03428958|363199423|FG005|Overall Study|Clinical Progression|2|||
105327237|NCT03428958|363199424|FG006|Overall Study|Clinical Progression|0|||
105327238|NCT03428958|363199425|FG007|Overall Study|Clinical Progression|0|||
105327239|NCT03428958|363199426|FG008|Overall Study|Clinical Progression|0|||
105327240|NCT03428958|363199427|FG009|Overall Study|Clinical Progression|0|||
105327241|NCT03428958|363199428|FG010|Overall Study|Clinical Progression|0|||
105327242|NCT03428958|363199429|FG011|Overall Study|Clinical Progression|0|||
105327243|NCT03428958|363199430|FG012|Overall Study|Clinical Progression|0|||
105854278|NCT05063539|365121651|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
105854279|NCT05063539|365121652|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
105854280|NCT05063539|365121650|FG000|Overall Study|Discontinued due to Common Close Design|0|||
105854281|NCT05063539|365121651|FG001|Overall Study|Discontinued due to Common Close Design|1|||
105373749|NCT00761319|363376270|FG001|Overall Study|Noncompliance|3|||
105373750|NCT00761319|363376269|FG000|Overall Study|Lost to Follow-up|1|||
105373751|NCT00761319|363376270|FG001|Overall Study|Lost to Follow-up|1|||
105373752|NCT00761319|363376269|FG000|Overall Study|Nonspecified|2|||
105373753|NCT00761319|363376270|FG001|Overall Study|Nonspecified|2|||
105373754|NCT00761319|363376269|FG000|Overall Study|Missing|1|||
105373755|NCT00761319|363376270|FG001|Overall Study|Missing|0|||
105373756|NCT03261401|363376274|FG000|Overall Study|Withdrawal by Subject|0|||
105373757|NCT03261401|363376275|FG001|Overall Study|Withdrawal by Subject|0|||
105373758|NCT03261401|363376276|FG002|Overall Study|Withdrawal by Subject|0|||
105373759|NCT03261401|363376277|FG003|Overall Study|Withdrawal by Subject|0|||
105373760|NCT03261401|363376278|FG004|Overall Study|Withdrawal by Subject|0|||
105373761|NCT03261401|363376279|FG005|Overall Study|Withdrawal by Subject|1|||
105373762|NCT03261401|363376280|FG006|Overall Study|Withdrawal by Subject|0|||
105373763|NCT03261401|363376281|FG007|Overall Study|Withdrawal by Subject|0|||
105373764|NCT03261401|363376282|FG008|Overall Study|Withdrawal by Subject|0|||
105373765|NCT03261401|363376283|FG009|Overall Study|Withdrawal by Subject|0|||
105373766|NCT03261401|363376284|FG010|Overall Study|Withdrawal by Subject|0|||
105373767|NCT03261401|363376285|FG011|Overall Study|Withdrawal by Subject|0|||
105373768|NCT03261401|363376286|FG012|Overall Study|Withdrawal by Subject|0|||
105373769|NCT03261401|363376274|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
105373770|NCT03261401|363376275|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
105373771|NCT03261401|363376276|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
105373772|NCT03261401|363376277|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
105373773|NCT03261401|363376278|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
105373774|NCT03261401|363376279|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
105373775|NCT03261401|363376280|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
105373776|NCT03261401|363376281|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
105373777|NCT03261401|363376282|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
105373778|NCT03261401|363376283|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
105373779|NCT03261401|363376284|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
105854282|NCT05063539|365121652|FG002|Overall Study|Discontinued due to Common Close Design|0|||
105854283|NCT05063539|365121650|FG000|Overall Study|Participant not co-operative|0|||
105854284|NCT05063539|365121651|FG001|Overall Study|Participant not co-operative|1|||
105854285|NCT05063539|365121652|FG002|Overall Study|Participant not co-operative|0|||
105854286|NCT05063539|365121650|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
105854287|NCT05063539|365121651|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
105373780|NCT03261401|363376285|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
105373781|NCT03261401|363376286|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
105373782|NCT00998946|363376287|FG000|Overall Study|Lost to Follow-up|1|||
105373783|NCT00998946|363376287|FG000|Overall Study|Withdrawal by Subject|1|||
105373784|NCT00998946|363376287|FG000|Overall Study|Death|2|||
105373785|NCT00998946|363376287|FG000|Overall Study|Reason Unspecified|3|||
105373786|NCT00998946|363376287|FG000|Overall Study|Enrolled but not Dosed|2|||
105373787|NCT00853385|363376288|FG000|Overall Study|Death|0|||
105373788|NCT00853385|363376289|FG001|Overall Study|Death|0|||
105373789|NCT00853385|363376290|FG002|Overall Study|Death|0|||
105373790|NCT00853385|363376291|FG003|Overall Study|Death|0|||
105373791|NCT00853385|363376292|FG004|Overall Study|Death|1|||
105373792|NCT00853385|363376288|FG000|Overall Study|Adverse Event|24|||
105373793|NCT00853385|363376289|FG001|Overall Study|Adverse Event|24|||
105373794|NCT00853385|363376290|FG002|Overall Study|Adverse Event|2|||
105373795|NCT00853385|363376291|FG003|Overall Study|Adverse Event|5|||
105373796|NCT00853385|363376292|FG004|Overall Study|Adverse Event|22|||
105373797|NCT00853385|363376288|FG000|Overall Study|Lack of Efficacy|6|||
105373798|NCT00853385|363376289|FG001|Overall Study|Lack of Efficacy|7|||
105854288|NCT05063539|365121652|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
105854289|NCT05063539|365121650|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
105373799|NCT00853385|363376290|FG002|Overall Study|Lack of Efficacy|3|||
105373800|NCT00853385|363376291|FG003|Overall Study|Lack of Efficacy|3|||
105373801|NCT00853385|363376292|FG004|Overall Study|Lack of Efficacy|6|||
105373802|NCT00853385|363376288|FG000|Overall Study|Lost to Follow-up|2|||
105373803|NCT00853385|363376289|FG001|Overall Study|Lost to Follow-up|1|||
105373804|NCT00853385|363376290|FG002|Overall Study|Lost to Follow-up|0|||
105373805|NCT00853385|363376291|FG003|Overall Study|Lost to Follow-up|0|||
105373806|NCT00853385|363376292|FG004|Overall Study|Lost to Follow-up|0|||
105373807|NCT00853385|363376288|FG000|Overall Study|Withdrawal by Subject|4|||
105373808|NCT00853385|363376289|FG001|Overall Study|Withdrawal by Subject|2|||
105854290|NCT05063539|365121651|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
105854291|NCT05063539|365121652|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
105854292|NCT03250377|365121653|FG000|Overall Study|Adverse Event|2|||
105854293|NCT03250377|365121654|FG001|Overall Study|Adverse Event|4|||
105854294|NCT03250377|365121655|FG002|Overall Study|Adverse Event|0|||
105854295|NCT03250377|365121656|FG003|Overall Study|Adverse Event|4|||
105854296|NCT03250377|365121653|FG000|Overall Study|Lack of Efficacy|5|||
105854297|NCT03250377|365121654|FG001|Overall Study|Lack of Efficacy|14|||
105854298|NCT03250377|365121655|FG002|Overall Study|Lack of Efficacy|1|||
105854299|NCT03250377|365121656|FG003|Overall Study|Lack of Efficacy|3|||
105854300|NCT03250377|365121653|FG000|Overall Study|Protocol Violation|0|||
105854301|NCT03250377|365121654|FG001|Overall Study|Protocol Violation|2|||
105854302|NCT03250377|365121655|FG002|Overall Study|Protocol Violation|0|||
105854303|NCT03250377|365121656|FG003|Overall Study|Protocol Violation|1|||
105854304|NCT03250377|365121653|FG000|Overall Study|Lost to Follow-up|0|||
105854305|NCT03250377|365121654|FG001|Overall Study|Lost to Follow-up|1|||
105854306|NCT03250377|365121655|FG002|Overall Study|Lost to Follow-up|0|||
105854307|NCT03250377|365121656|FG003|Overall Study|Lost to Follow-up|0|||
105854308|NCT03250377|365121653|FG000|Overall Study|Withdrawal by Subject|7|||
105373809|NCT00853385|363376290|FG002|Overall Study|Withdrawal by Subject|0|||
105373810|NCT00853385|363376291|FG003|Overall Study|Withdrawal by Subject|1|||
105373811|NCT00853385|363376292|FG004|Overall Study|Withdrawal by Subject|1|||
105373812|NCT00853385|363376288|FG000|Overall Study|Other|18|||
105373813|NCT00853385|363376289|FG001|Overall Study|Other|9|||
105373814|NCT00853385|363376290|FG002|Overall Study|Other|4|||
105373815|NCT00853385|363376291|FG003|Overall Study|Other|4|||
105373816|NCT00853385|363376292|FG004|Overall Study|Other|12|||
105373817|NCT01461551|363376303|FG000|Overall Study|Physician Decision|2|||
105373818|NCT01461551|363376304|FG001|Overall Study|Physician Decision|1|||
105373819|NCT01461551|363376305|FG002|Overall Study|Physician Decision|2|||
105373820|NCT01155141|363376306|FG000|Overall Study|Withdrawal by Subject|1|||
105373821|NCT01155141|363376306|FG000|Overall Study|Screen Failure|1|||
105373822|NCT02020941|363376307|FG000|Overall Study|Adverse Event|1|||
105373823|NCT02020941|363376307|FG000|Overall Study|Physician Decision|2|||
105373824|NCT02020941|363376307|FG000|Overall Study|Withdrawal by Subject|1|||
105373825|NCT02020941|363376307|FG000|Overall Study|Disease Progression|4|||
105373826|NCT03530696|363376312|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
105373827|NCT03530696|363376313|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
105373828|NCT01838876|363376314|FG000|Overall Study|Adverse Event|49|||
105373829|NCT01838876|363376314|FG000|Overall Study|Insufficient Therapeutic Response|10|||
105373830|NCT01838876|363376314|FG000|Overall Study|Protocol Violation|34|||
105373831|NCT01838876|363376314|FG000|Overall Study|Withdrawal of Consent|33|||
105373832|NCT01838876|363376314|FG000|Overall Study|Lost to Follow-up|21|||
105373833|NCT01838876|363376314|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
105373834|NCT01838876|363376314|FG000|Overall Study|Reason not Specified|7|||
105373835|NCT01838876|363376314|FG000|Overall Study|Did not meet eligibility criteria|78|||
105373836|NCT00226655|363376317|FG000|Overall Study|Death|13|||
105373837|NCT00226655|363376317|FG000|Overall Study|Withdrawal by Subject|15|||
105373838|NCT00226655|363376317|FG000|Overall Study|Adverse Event|35|||
105373839|NCT00226655|363376317|FG000|Overall Study|Physician Decision|6|||
105373840|NCT00226655|363376317|FG000|Overall Study|Clinical deterioration|10|||
105373841|NCT03188822|363376325|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
105373842|NCT03188822|363376325|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
105373843|NCT02550795|363376329|FG000|Overall Study|Physician Decision|0|||
105373844|NCT02550795|363376330|FG001|Overall Study|Physician Decision|1|||
105373845|NCT02550795|363376331|FG002|Overall Study|Physician Decision|0|||
105373846|NCT02187783|363376334|FG000|Overall Study|Adverse Event|8|||
105373847|NCT02187783|363376334|FG000|Overall Study|Death|3|||
105373848|NCT02187783|363376334|FG000|Overall Study|Progressive disease|80|||
105373849|NCT02187783|363376334|FG000|Overall Study|Protocol Violation|3|||
105373850|NCT02187783|363376334|FG000|Overall Study|Physician Decision|2|||
105373851|NCT02187783|363376334|FG000|Overall Study|Withdrawal by Subject|9|||
105373852|NCT02187783|363376334|FG000|Overall Study|Study terminated by sponsor|1|||
105373853|NCT00471497|363376335|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
105373854|NCT00471497|363376336|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
105373855|NCT00471497|363376337|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
105373856|NCT00471497|363376335|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
105373857|NCT00471497|363376336|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
105373858|NCT00471497|363376337|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
105373859|NCT00471497|363376335|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
105854309|NCT03250377|365121654|FG001|Overall Study|Withdrawal by Subject|7|||
105854310|NCT03250377|365121655|FG002|Overall Study|Withdrawal by Subject|0|||
105854311|NCT03250377|365121656|FG003|Overall Study|Withdrawal by Subject|4|||
105373860|NCT00471497|363376336|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
105854312|NCT03250377|365121653|FG000|Overall Study|Investigator's Judgment|1|||
105854313|NCT03250377|365121654|FG001|Overall Study|Investigator's Judgment|0|||
105854314|NCT03250377|365121655|FG002|Overall Study|Investigator's Judgment|0|||
105854315|NCT03250377|365121656|FG003|Overall Study|Investigator's Judgment|0|||
105854316|NCT03250377|365121653|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
105854317|NCT03250377|365121654|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
105854318|NCT03250377|365121655|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
105854319|NCT03250377|365121656|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
105854320|NCT03250377|365121653|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
105854321|NCT03250377|365121654|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
105854322|NCT03250377|365121655|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
105854323|NCT03250377|365121656|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
105854324|NCT03250377|365121653|FG000|Overall Study|Epilepsy Surgery|0|||
105854325|NCT03250377|365121654|FG001|Overall Study|Epilepsy Surgery|1|||
105854326|NCT03250377|365121655|FG002|Overall Study|Epilepsy Surgery|2|||
105854327|NCT03250377|365121656|FG003|Overall Study|Epilepsy Surgery|0|||
105854328|NCT03250377|365121653|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
105854329|NCT03250377|365121654|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
105854330|NCT03250377|365121655|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
105854331|NCT03250377|365121656|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
105854332|NCT03250377|365121653|FG000|Overall Study|Request From The Sponsor|0|||
105854333|NCT03250377|365121654|FG001|Overall Study|Request From The Sponsor|1|||
105854334|NCT03250377|365121655|FG002|Overall Study|Request From The Sponsor|0|||
105854335|NCT03250377|365121656|FG003|Overall Study|Request From The Sponsor|0|||
105854336|NCT03250377|365121653|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
105854337|NCT03250377|365121654|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
105854338|NCT03250377|365121655|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
105854339|NCT03250377|365121656|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
105854340|NCT03250377|365121653|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
105854341|NCT03250377|365121654|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
105854342|NCT03250377|365121655|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
105854343|NCT03250377|365121656|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
105854344|NCT03250377|365121653|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
105854345|NCT03250377|365121654|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
105854346|NCT03250377|365121655|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
105854347|NCT03250377|365121656|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
105854348|NCT03250377|365121653|FG000|Overall Study|Pregnancy Event|0|||
105854349|NCT03250377|365121654|FG001|Overall Study|Pregnancy Event|1|||
105854350|NCT03250377|365121655|FG002|Overall Study|Pregnancy Event|0|||
105854351|NCT03250377|365121656|FG003|Overall Study|Pregnancy Event|0|||
105854352|NCT03250377|365121653|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
105854353|NCT03250377|365121654|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
105854354|NCT03250377|365121655|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
105854355|NCT03250377|365121656|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
105854356|NCT03250377|365121653|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
105854357|NCT03250377|365121654|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
105854358|NCT03250377|365121655|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
105854359|NCT03250377|365121656|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
105854360|NCT03250377|365121653|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
105854361|NCT03250377|365121654|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
105854362|NCT03250377|365121655|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
105854363|NCT03250377|365121656|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
105854364|NCT03250377|365121653|FG000|Overall Study|Patient requested to change hospital|0|||
105854365|NCT03250377|365121654|FG001|Overall Study|Patient requested to change hospital|0|||
105854366|NCT03250377|365121655|FG002|Overall Study|Patient requested to change hospital|0|||
105854367|NCT03250377|365121656|FG003|Overall Study|Patient requested to change hospital|1|||
105854368|NCT03250377|365121653|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
105854369|NCT03250377|365121654|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
105854370|NCT03250377|365121655|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
105854371|NCT03250377|365121656|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
105373861|NCT00471497|363376337|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
105373862|NCT00471497|363376335|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
105373863|NCT00471497|363376336|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
105373864|NCT00471497|363376337|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
105854372|NCT01708941|365121666|FG000|Overall Study|Adverse Event|4|||
105854373|NCT01708941|365121667|FG001|Overall Study|Adverse Event|6|||
105854374|NCT01708941|365121668|FG002|Overall Study|Adverse Event|1|||
105854375|NCT01708941|365121669|FG003|Overall Study|Adverse Event|0|||
105373865|NCT00471497|363376335|FG000|Core Treatment Phase|Lost to Follow-up|6|||
105373866|NCT00471497|363376336|FG001|Core Treatment Phase|Lost to Follow-up|6|||
105373867|NCT00471497|363376337|FG002|Core Treatment Phase|Lost to Follow-up|3|||
105373868|NCT00471497|363376335|FG000|Core Treatment Phase|Death|3|||
105373869|NCT00471497|363376336|FG001|Core Treatment Phase|Death|9|||
105373870|NCT00471497|363376337|FG002|Core Treatment Phase|Death|3|||
105373871|NCT00471497|363376335|FG000|Core Treatment Phase|Disease Progression|10|||
105373872|NCT00471497|363376336|FG001|Core Treatment Phase|Disease Progression|2|||
105373873|NCT00471497|363376337|FG002|Core Treatment Phase|Disease Progression|4|||
105373874|NCT00471497|363376335|FG000|Core Treatment Phase|Protocol Violation|6|||
105373875|NCT00471497|363376336|FG001|Core Treatment Phase|Protocol Violation|15|||
105373876|NCT00471497|363376337|FG002|Core Treatment Phase|Protocol Violation|11|||
105373877|NCT00471497|363376335|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
105373878|NCT00471497|363376336|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
105373879|NCT00471497|363376337|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
105373880|NCT00471497|363376335|FG000|Core Treatment Phase|Administrative problems|14|||
105373881|NCT00471497|363376336|FG001|Core Treatment Phase|Administrative problems|14|||
105373882|NCT00471497|363376337|FG002|Core Treatment Phase|Administrative problems|12|||
105373883|NCT00471497|363376335|FG000|Core Treatment Phase|Adverse Event|43|||
105373884|NCT00471497|363376336|FG001|Core Treatment Phase|Adverse Event|53|||
105373885|NCT00471497|363376337|FG002|Core Treatment Phase|Adverse Event|89|||
105373886|NCT00471497|363376335|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
105373887|NCT00471497|363376336|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
105373888|NCT00471497|363376337|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
105373889|NCT00471497|363376335|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
105373890|NCT00471497|363376336|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
105373891|NCT00471497|363376337|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
105373892|NCT00471497|363376335|FG000|Extension Phase|Adverse Event|9|||
105373893|NCT00471497|363376336|FG001|Extension Phase|Adverse Event|5|||
105373894|NCT00471497|363376337|FG002|Extension Phase|Adverse Event|1|||
105373895|NCT00471497|363376335|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
105373896|NCT00471497|363376336|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
105373897|NCT00471497|363376337|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
105373898|NCT00471497|363376335|FG000|Extension Phase|Withdrawal by Subject|3|||
105373899|NCT00471497|363376336|FG001|Extension Phase|Withdrawal by Subject|1|||
105373900|NCT00471497|363376337|FG002|Extension Phase|Withdrawal by Subject|0|||
105373901|NCT00471497|363376335|FG000|Extension Phase|Lost to Follow-up|2|||
105373902|NCT00471497|363376336|FG001|Extension Phase|Lost to Follow-up|0|||
105373903|NCT00471497|363376337|FG002|Extension Phase|Lost to Follow-up|0|||
105373904|NCT00471497|363376335|FG000|Extension Phase|Death|1|||
105373905|NCT00471497|363376336|FG001|Extension Phase|Death|0|||
105373906|NCT00471497|363376337|FG002|Extension Phase|Death|0|||
105373907|NCT00471497|363376335|FG000|Extension Phase|Disease progression|2|||
105373908|NCT00471497|363376336|FG001|Extension Phase|Disease progression|0|||
105373909|NCT00471497|363376337|FG002|Extension Phase|Disease progression|0|||
105373910|NCT00471497|363376335|FG000|Extension Phase|Protocol Violation|2|||
105373911|NCT00471497|363376336|FG001|Extension Phase|Protocol Violation|2|||
105373912|NCT00471497|363376337|FG002|Extension Phase|Protocol Violation|0|||
105373913|NCT01232283|363376338|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
105373914|NCT01232283|363376339|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
105373915|NCT01232283|363376340|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105373916|NCT01232283|363376341|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105373917|NCT01232283|363376342|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105373918|NCT01232283|363376343|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105373919|NCT01232283|363376344|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105373920|NCT01232283|363376345|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105373921|NCT01232283|363376346|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105373922|NCT01232283|363376347|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105373923|NCT01232283|363376338|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
105373924|NCT01232283|363376339|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
105373925|NCT01232283|363376340|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105373926|NCT01232283|363376341|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105373927|NCT01232283|363376342|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105373928|NCT01232283|363376343|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105373929|NCT01232283|363376344|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105373930|NCT01232283|363376345|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105373931|NCT01232283|363376346|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105373932|NCT01232283|363376347|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105373933|NCT01232283|363376338|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
105373934|NCT01232283|363376339|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105854376|NCT01708941|365121666|FG000|Overall Study|Death|1|||
105327244|NCT03428958|363199431|FG013|Overall Study|Clinical Progression|0|||
105327245|NCT03428958|363199432|FG014|Overall Study|Clinical Progression|0|||
105327246|NCT03428958|363199433|FG015|Overall Study|Clinical Progression|0|||
105327247|NCT03428958|363199434|FG016|Overall Study|Clinical Progression|0|||
105327248|NCT03428958|363199418|FG000|Overall Study|Progression per RECIST|6|||
105327249|NCT03428958|363199419|FG001|Overall Study|Progression per RECIST|6|||
105327250|NCT03428958|363199420|FG002|Overall Study|Progression per RECIST|7|||
105327251|NCT03428958|363199421|FG003|Overall Study|Progression per RECIST|4|||
105327252|NCT03428958|363199422|FG004|Overall Study|Progression per RECIST|0|||
105327253|NCT03428958|363199423|FG005|Overall Study|Progression per RECIST|7|||
105327254|NCT03428958|363199424|FG006|Overall Study|Progression per RECIST|8|||
105327255|NCT03428958|363199425|FG007|Overall Study|Progression per RECIST|0|||
105327256|NCT03428958|363199426|FG008|Overall Study|Progression per RECIST|0|||
105327257|NCT03428958|363199427|FG009|Overall Study|Progression per RECIST|0|||
105327258|NCT03428958|363199428|FG010|Overall Study|Progression per RECIST|0|||
105327259|NCT03428958|363199429|FG011|Overall Study|Progression per RECIST|0|||
105327260|NCT03428958|363199430|FG012|Overall Study|Progression per RECIST|1|||
105327261|NCT03428958|363199431|FG013|Overall Study|Progression per RECIST|0|||
105327262|NCT03428958|363199432|FG014|Overall Study|Progression per RECIST|0|||
105327263|NCT03428958|363199433|FG015|Overall Study|Progression per RECIST|0|||
105327264|NCT03428958|363199434|FG016|Overall Study|Progression per RECIST|0|||
105327265|NCT03428958|363199418|FG000|Overall Study|Death|2|||
105327266|NCT03428958|363199419|FG001|Overall Study|Death|2|||
105327267|NCT03428958|363199420|FG002|Overall Study|Death|0|||
105327268|NCT03428958|363199421|FG003|Overall Study|Death|0|||
105327269|NCT03428958|363199422|FG004|Overall Study|Death|0|||
105327270|NCT03428958|363199423|FG005|Overall Study|Death|7|||
105327271|NCT03428958|363199424|FG006|Overall Study|Death|9|||
105327272|NCT03428958|363199425|FG007|Overall Study|Death|6|||
105327273|NCT03428958|363199426|FG008|Overall Study|Death|0|||
105327274|NCT03428958|363199427|FG009|Overall Study|Death|0|||
105327275|NCT03428958|363199428|FG010|Overall Study|Death|3|||
105327276|NCT03428958|363199429|FG011|Overall Study|Death|0|||
105327277|NCT03428958|363199430|FG012|Overall Study|Death|4|||
105327278|NCT03428958|363199431|FG013|Overall Study|Death|0|||
105327279|NCT03428958|363199432|FG014|Overall Study|Death|0|||
105327280|NCT03428958|363199433|FG015|Overall Study|Death|0|||
105327281|NCT03428958|363199434|FG016|Overall Study|Death|0|||
105327282|NCT03428958|363199418|FG000|Overall Study|Lost to Follow-up|0|||
105327283|NCT03428958|363199419|FG001|Overall Study|Lost to Follow-up|0|||
105327284|NCT03428958|363199420|FG002|Overall Study|Lost to Follow-up|0|||
105327285|NCT03428958|363199421|FG003|Overall Study|Lost to Follow-up|0|||
105327286|NCT03428958|363199422|FG004|Overall Study|Lost to Follow-up|0|||
105327287|NCT03428958|363199423|FG005|Overall Study|Lost to Follow-up|1|||
105327288|NCT03428958|363199424|FG006|Overall Study|Lost to Follow-up|1|||
105327289|NCT03428958|363199425|FG007|Overall Study|Lost to Follow-up|0|||
105327290|NCT03428958|363199426|FG008|Overall Study|Lost to Follow-up|0|||
105327291|NCT03428958|363199427|FG009|Overall Study|Lost to Follow-up|0|||
105327292|NCT03428958|363199428|FG010|Overall Study|Lost to Follow-up|0|||
105327293|NCT03428958|363199429|FG011|Overall Study|Lost to Follow-up|0|||
105327294|NCT03428958|363199430|FG012|Overall Study|Lost to Follow-up|0|||
105327295|NCT03428958|363199431|FG013|Overall Study|Lost to Follow-up|0|||
105327296|NCT03428958|363199432|FG014|Overall Study|Lost to Follow-up|0|||
105327297|NCT03428958|363199433|FG015|Overall Study|Lost to Follow-up|0|||
105327298|NCT03428958|363199434|FG016|Overall Study|Lost to Follow-up|0|||
105327299|NCT03428958|363199418|FG000|Overall Study|Physician/Sponsor Decision|1|||
105327300|NCT03428958|363199419|FG001|Overall Study|Physician/Sponsor Decision|0|||
105327301|NCT03428958|363199420|FG002|Overall Study|Physician/Sponsor Decision|1|||
105327302|NCT03428958|363199421|FG003|Overall Study|Physician/Sponsor Decision|0|||
105327303|NCT03428958|363199422|FG004|Overall Study|Physician/Sponsor Decision|0|||
105327304|NCT03428958|363199423|FG005|Overall Study|Physician/Sponsor Decision|2|||
105327305|NCT03428958|363199424|FG006|Overall Study|Physician/Sponsor Decision|2|||
105327306|NCT03428958|363199425|FG007|Overall Study|Physician/Sponsor Decision|2|||
105327307|NCT03428958|363199426|FG008|Overall Study|Physician/Sponsor Decision|0|||
105327308|NCT03428958|363199427|FG009|Overall Study|Physician/Sponsor Decision|0|||
105327309|NCT03428958|363199428|FG010|Overall Study|Physician/Sponsor Decision|2|||
105327310|NCT03428958|363199429|FG011|Overall Study|Physician/Sponsor Decision|0|||
105327311|NCT03428958|363199430|FG012|Overall Study|Physician/Sponsor Decision|4|||
105327312|NCT03428958|363199431|FG013|Overall Study|Physician/Sponsor Decision|0|||
105327313|NCT03428958|363199432|FG014|Overall Study|Physician/Sponsor Decision|0|||
105327314|NCT03428958|363199433|FG015|Overall Study|Physician/Sponsor Decision|0|||
105327315|NCT03428958|363199434|FG016|Overall Study|Physician/Sponsor Decision|0|||
105327316|NCT03428958|363199418|FG000|Overall Study|Withdrawal by Subject|0|||
105327317|NCT03428958|363199419|FG001|Overall Study|Withdrawal by Subject|0|||
105327318|NCT03428958|363199420|FG002|Overall Study|Withdrawal by Subject|2|||
105327319|NCT03428958|363199421|FG003|Overall Study|Withdrawal by Subject|0|||
105327320|NCT03428958|363199422|FG004|Overall Study|Withdrawal by Subject|0|||
105327321|NCT03428958|363199423|FG005|Overall Study|Withdrawal by Subject|2|||
105327322|NCT03428958|363199424|FG006|Overall Study|Withdrawal by Subject|4|||
105854377|NCT01708941|365121667|FG001|Overall Study|Death|1|||
105854378|NCT01708941|365121668|FG002|Overall Study|Death|2|||
105854379|NCT01708941|365121669|FG003|Overall Study|Death|14|||
105854380|NCT01708941|365121666|FG000|Overall Study|Withdrawal by Subject|1|||
105854381|NCT01708941|365121667|FG001|Overall Study|Withdrawal by Subject|0|||
105854382|NCT01708941|365121668|FG002|Overall Study|Withdrawal by Subject|3|||
105854383|NCT01708941|365121669|FG003|Overall Study|Withdrawal by Subject|4|||
105854384|NCT01708941|365121666|FG000|Overall Study|Disease progression|9|||
105854385|NCT01708941|365121667|FG001|Overall Study|Disease progression|10|||
105854386|NCT01708941|365121668|FG002|Overall Study|Disease progression|8|||
105854387|NCT01708941|365121669|FG003|Overall Study|Disease progression|0|||
105854388|NCT01708941|365121666|FG000|Overall Study|Alternative therapy|0|||
105854389|NCT01708941|365121667|FG001|Overall Study|Alternative therapy|0|||
105854390|NCT01708941|365121668|FG002|Overall Study|Alternative therapy|2|||
105854391|NCT01708941|365121669|FG003|Overall Study|Alternative therapy|0|||
105854392|NCT01708941|365121666|FG000|Overall Study|Ineligible and never started treatment|1|||
105854393|NCT01708941|365121667|FG001|Overall Study|Ineligible and never started treatment|0|||
105854394|NCT01708941|365121668|FG002|Overall Study|Ineligible and never started treatment|1|||
105854395|NCT01708941|365121669|FG003|Overall Study|Ineligible and never started treatment|0|||
105854396|NCT01708941|365121666|FG000|Overall Study|Never started treatment|2|||
105854397|NCT01708941|365121667|FG001|Overall Study|Never started treatment|1|||
105854398|NCT01708941|365121668|FG002|Overall Study|Never started treatment|0|||
105854399|NCT01708941|365121669|FG003|Overall Study|Never started treatment|0|||
105854400|NCT01708941|365121666|FG000|Overall Study|Ineligible|0|||
105854401|NCT01708941|365121667|FG001|Overall Study|Ineligible|0|||
105854402|NCT01708941|365121668|FG002|Overall Study|Ineligible|2|||
105854403|NCT01708941|365121669|FG003|Overall Study|Ineligible|0|||
105854404|NCT01575548|365121670|FG000|Overall Study|Adverse Event|15|||
105854405|NCT01575548|365121671|FG001|Overall Study|Adverse Event|2|||
105854406|NCT01575548|365121670|FG000|Overall Study|Disease progression|12|||
105854407|NCT01575548|365121671|FG001|Overall Study|Disease progression|25|||
105854408|NCT01575548|365121670|FG000|Overall Study|Death|1|||
105854409|NCT01575548|365121671|FG001|Overall Study|Death|0|||
105854410|NCT01575548|365121670|FG000|Overall Study|Other complicating disease|1|||
105854411|NCT01575548|365121671|FG001|Overall Study|Other complicating disease|0|||
105854412|NCT01575548|365121670|FG000|Overall Study|Withdrawal by Subject|7|||
105854413|NCT01575548|365121671|FG001|Overall Study|Withdrawal by Subject|3|||
105854414|NCT01575548|365121670|FG000|Overall Study|Noncompliance|1|||
105854415|NCT01575548|365121671|FG001|Overall Study|Noncompliance|0|||
105854416|NCT01575548|365121670|FG000|Overall Study|Anticipated surgery|0|||
105854417|NCT01575548|365121671|FG001|Overall Study|Anticipated surgery|1|||
105854418|NCT01575548|365121670|FG000|Overall Study|Never started protocol therapy|3|||
105854419|NCT01575548|365121671|FG001|Overall Study|Never started protocol therapy|2|||
105854420|NCT04116073|365121672|FG000|Overall Study|Withdrawal by Subject|2|||
105854421|NCT04116073|365121672|FG000|Overall Study|failed to maintained eligibility|1|||
105854422|NCT02615691|365121673|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
105854423|NCT02615691|365121673|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
105854424|NCT02615691|365121673|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
105854425|NCT02615691|365121673|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
105854426|NCT02048813|365121677|FG000|Overall Study|Still on treatment|279|||
105854427|NCT02048813|365121678|FG001|Overall Study|Still on treatment|0|||
105854428|NCT02048813|365121677|FG000|Overall Study|Adverse Event|40|||
105854429|NCT02048813|365121678|FG001|Overall Study|Adverse Event|38|||
105854430|NCT02048813|365121677|FG000|Overall Study|Disease progression|13|||
105854431|NCT02048813|365121678|FG001|Overall Study|Disease progression|3|||
105854432|NCT02048813|365121677|FG000|Overall Study|Withdrawal by Subject|7|||
105854433|NCT02048813|365121678|FG001|Overall Study|Withdrawal by Subject|8|||
105854434|NCT02048813|365121677|FG000|Overall Study|Death|2|||
105854435|NCT02048813|365121678|FG001|Overall Study|Death|1|||
105854436|NCT02048813|365121677|FG000|Overall Study|Complication|2|||
105854437|NCT02048813|365121678|FG001|Overall Study|Complication|2|||
105854438|NCT02048813|365121677|FG000|Overall Study|Non-protocol therapy|0|||
105854439|NCT02048813|365121678|FG001|Overall Study|Non-protocol therapy|1|||
105854440|NCT02048813|365121677|FG000|Overall Study|Second primary cancer|2|||
105854441|NCT02048813|365121678|FG001|Overall Study|Second primary cancer|0|||
105854442|NCT02048813|365121677|FG000|Overall Study|Insurance|2|||
105854443|NCT02048813|365121678|FG001|Overall Study|Insurance|0|||
105854444|NCT02048813|365121677|FG000|Overall Study|Wound infection/healing|2|||
105854445|NCT02048813|365121678|FG001|Overall Study|Wound infection/healing|0|||
105854446|NCT02048813|365121677|FG000|Overall Study|Missed appointment|3|||
105854447|NCT02048813|365121678|FG001|Overall Study|Missed appointment|0|||
105854448|NCT02048813|365121677|FG000|Overall Study|Never started treatment|2|||
105854449|NCT02048813|365121678|FG001|Overall Study|Never started treatment|17|||
105854450|NCT00972478|365121679|FG000|Overall Study|Adverse Event|3|||
105854451|NCT00972478|365121680|FG001|Overall Study|Adverse Event|16|||
105854452|NCT00972478|365121679|FG000|Overall Study|Withdrawal by Subject|1|||
105854453|NCT00972478|365121680|FG001|Overall Study|Withdrawal by Subject|8|||
105854454|NCT00972478|365121679|FG000|Overall Study|Progression/Relapse|0|||
105854455|NCT00972478|365121680|FG001|Overall Study|Progression/Relapse|2|||
105854456|NCT00972478|365121679|FG000|Overall Study|Death|0|||
105854457|NCT00972478|365121680|FG001|Overall Study|Death|2|||
105854458|NCT00972478|365121679|FG000|Overall Study|Not protocol specified|1|||
105854459|NCT00972478|365121680|FG001|Overall Study|Not protocol specified|1|||
105854460|NCT00972478|365121679|FG000|Overall Study|Ineligible|1|||
105854461|NCT00972478|365121680|FG001|Overall Study|Ineligible|7|||
105854462|NCT00972478|365121679|FG000|Overall Study|Not start protocol treatment|1|||
105854463|NCT00972478|365121680|FG001|Overall Study|Not start protocol treatment|2|||
105854464|NCT01708954|365121681|FG000|Step 1|Disease progression|26|||
105854465|NCT01708954|365121682|FG001|Step 1|Disease progression|17|||
105854466|NCT01708954|365121683|FG002|Step 1|Disease progression|14|||
105854467|NCT01708954|365121681|FG000|Step 1|Adverse Event|3|||
105854468|NCT01708954|365121682|FG001|Step 1|Adverse Event|11|||
105854469|NCT01708954|365121683|FG002|Step 1|Adverse Event|13|||
105854470|NCT01708954|365121681|FG000|Step 1|Death|3|||
105854471|NCT01708954|365121682|FG001|Step 1|Death|2|||
105854472|NCT01708954|365121683|FG002|Step 1|Death|3|||
105854473|NCT01708954|365121681|FG000|Step 1|Withdrawal by Subject|2|||
105854474|NCT01708954|365121682|FG001|Step 1|Withdrawal by Subject|5|||
105854475|NCT01708954|365121683|FG002|Step 1|Withdrawal by Subject|3|||
105854476|NCT01708954|365121681|FG000|Step 1|Other complicating disease|0|||
105854477|NCT01708954|365121682|FG001|Step 1|Other complicating disease|2|||
105854478|NCT01708954|365121683|FG002|Step 1|Other complicating disease|0|||
105854479|NCT01708954|365121681|FG000|Step 1|Crossed over to Step 2|2|||
105854480|NCT01708954|365121682|FG001|Step 1|Crossed over to Step 2|0|||
105854481|NCT01708954|365121683|FG002|Step 1|Crossed over to Step 2|0|||
105854482|NCT01708954|365121681|FG000|Step 1|Symptomatic deterioration|1|||
105854483|NCT01708954|365121682|FG001|Step 1|Symptomatic deterioration|0|||
105854484|NCT01708954|365121683|FG002|Step 1|Symptomatic deterioration|1|||
105854485|NCT01708954|365121681|FG000|Step 1|Off-treatment reason not submitted|1|||
105854486|NCT01708954|365121682|FG001|Step 1|Off-treatment reason not submitted|1|||
105854487|NCT01708954|365121683|FG002|Step 1|Off-treatment reason not submitted|1|||
105854488|NCT01708954|365121681|FG000|Step 1|Ineligible or never received treatment|4|||
105854489|NCT01708954|365121682|FG001|Step 1|Ineligible or never received treatment|2|||
105854490|NCT01708954|365121683|FG002|Step 1|Ineligible or never received treatment|8|||
105854491|NCT01708954|365121681|FG000|Step 2|Disease progression|9|||
105854492|NCT01708954|365121682|FG001|Step 2|Disease progression|4|||
105854493|NCT01708954|365121683|FG002|Step 2|Disease progression|0|||
105854494|NCT01708954|365121681|FG000|Step 2|Adverse Event|3|||
105854495|NCT01708954|365121682|FG001|Step 2|Adverse Event|2|||
105854496|NCT01708954|365121683|FG002|Step 2|Adverse Event|0|||
105854497|NCT01708954|365121681|FG000|Step 2|Withdrawal by Subject|1|||
105854498|NCT01708954|365121682|FG001|Step 2|Withdrawal by Subject|1|||
105854499|NCT01708954|365121683|FG002|Step 2|Withdrawal by Subject|0|||
105854500|NCT04201093|365121684|FG000|Overall Study|Adverse Event|6|||
105327323|NCT03428958|363199425|FG007|Overall Study|Withdrawal by Subject|1|||
105327324|NCT03428958|363199426|FG008|Overall Study|Withdrawal by Subject|0|||
105327325|NCT03428958|363199427|FG009|Overall Study|Withdrawal by Subject|0|||
105327326|NCT03428958|363199428|FG010|Overall Study|Withdrawal by Subject|0|||
105327327|NCT03428958|363199429|FG011|Overall Study|Withdrawal by Subject|0|||
105327328|NCT03428958|363199430|FG012|Overall Study|Withdrawal by Subject|0|||
105327329|NCT03428958|363199431|FG013|Overall Study|Withdrawal by Subject|0|||
105327330|NCT03428958|363199432|FG014|Overall Study|Withdrawal by Subject|0|||
105327331|NCT03428958|363199433|FG015|Overall Study|Withdrawal by Subject|0|||
105327332|NCT03428958|363199434|FG016|Overall Study|Withdrawal by Subject|0|||
105327333|NCT05258773|363199435|FG000|Overall Study|Screen Failure|1|||
105327334|NCT05258773|363199436|FG001|Overall Study|Screen Failure|1|||
105327335|NCT05258773|363199435|FG000|Overall Study|Adverse Event|1|||
105327336|NCT05258773|363199436|FG001|Overall Study|Adverse Event|0|||
105327337|NCT05258773|363199435|FG000|Overall Study|Withdrawal by Subject|0|||
105327338|NCT05258773|363199436|FG001|Overall Study|Withdrawal by Subject|1|||
105854501|NCT04201093|365121685|FG001|Overall Study|Adverse Event|29|||
105854502|NCT04201093|365121686|FG002|Overall Study|Adverse Event|35|||
105854503|NCT04201093|365121684|FG000|Overall Study|Death|2|||
105854504|NCT04201093|365121685|FG001|Overall Study|Death|1|||
105854505|NCT04201093|365121686|FG002|Overall Study|Death|0|||
105854506|NCT04201093|365121684|FG000|Overall Study|Lack of Efficacy|5|||
105854507|NCT04201093|365121685|FG001|Overall Study|Lack of Efficacy|1|||
105854508|NCT04201093|365121686|FG002|Overall Study|Lack of Efficacy|2|||
105854509|NCT04201093|365121684|FG000|Overall Study|Lost to Follow-up|0|||
105854510|NCT04201093|365121685|FG001|Overall Study|Lost to Follow-up|0|||
105854511|NCT04201093|365121686|FG002|Overall Study|Lost to Follow-up|1|||
105327339|NCT01127256|363199437|FG000|Overall Study|Adverse Event|13|||
105327340|NCT01127256|363199438|FG001|Overall Study|Adverse Event|13|||
105327341|NCT01127256|363199437|FG000|Overall Study|Lack of Efficacy|4|||
105854512|NCT04201093|365121684|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
105854513|NCT04201093|365121685|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
105854514|NCT04201093|365121686|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
105854515|NCT04201093|365121684|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
105854516|NCT04201093|365121685|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
105854517|NCT04201093|365121686|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
105854518|NCT04201093|365121684|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
105854519|NCT04201093|365121685|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
105854520|NCT04201093|365121686|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
105854521|NCT04201093|365121684|FG000|Overall Study|Physician Decision|1|||
105854522|NCT04201093|365121685|FG001|Overall Study|Physician Decision|0|||
105854523|NCT04201093|365121686|FG002|Overall Study|Physician Decision|0|||
105854524|NCT04201093|365121684|FG000|Overall Study|Protocol Deviation|1|||
105854525|NCT04201093|365121685|FG001|Overall Study|Protocol Deviation|0|||
105854526|NCT04201093|365121686|FG002|Overall Study|Protocol Deviation|0|||
105854527|NCT04201093|365121684|FG000|Overall Study|Site Terminated by Sponsor|5|||
105327342|NCT01127256|363199438|FG001|Overall Study|Lack of Efficacy|0|||
105327343|NCT01127256|363199437|FG000|Overall Study|Lost to Follow-up|16|||
105327344|NCT01127256|363199438|FG001|Overall Study|Lost to Follow-up|17|||
105327345|NCT01127256|363199437|FG000|Overall Study|Withdrawal by Subject|5|||
105327346|NCT01127256|363199438|FG001|Overall Study|Withdrawal by Subject|9|||
105327347|NCT01127256|363199437|FG000|Overall Study|Protocol Violation|1|||
105327348|NCT01127256|363199438|FG001|Overall Study|Protocol Violation|0|||
105327349|NCT01922037|363199439|FG000|Overall Study|Withdrawal by Subject|2|||
105327350|NCT01922037|363199440|FG001|Overall Study|Withdrawal by Subject|44|||
105327351|NCT01922037|363199439|FG000|Overall Study|Adverse Event|1|||
105327352|NCT01922037|363199440|FG001|Overall Study|Adverse Event|7|||
105327353|NCT01922037|363199439|FG000|Overall Study|Death|0|||
105327354|NCT01922037|363199440|FG001|Overall Study|Death|5|||
105327355|NCT01922037|363199439|FG000|Overall Study|Pregnancy|0|||
105327356|NCT01922037|363199440|FG001|Overall Study|Pregnancy|2|||
105327357|NCT01922037|363199439|FG000|Overall Study|Participant non-compliance|4|||
105327358|NCT01922037|363199440|FG001|Overall Study|Participant non-compliance|46|||
105327359|NCT01922037|363199439|FG000|Overall Study|Investigator/Sponsor decision|1|||
105327360|NCT01922037|363199440|FG001|Overall Study|Investigator/Sponsor decision|4|||
105327361|NCT01922037|363199439|FG000|Overall Study|Other unspecified|2|||
105327362|NCT01922037|363199440|FG001|Overall Study|Other unspecified|66|||
105327363|NCT02068508|363199441|FG000|Overall Study|Case report forms uncollected|27|||
105327364|NCT02068508|363199441|FG000|Overall Study|Patient did not visit the study site|1|||
105327365|NCT02068508|363199441|FG000|Overall Study|Protocol Violation|4|||
105327366|NCT00813150|363199442|FG000|Treatment Period|Adverse Event|16|||
105327367|NCT00813150|363199443|FG001|Treatment Period|Adverse Event|15|||
105327368|NCT00813150|363199442|FG000|Treatment Period|Death|2|||
105327369|NCT00813150|363199443|FG001|Treatment Period|Death|0|||
105327370|NCT00813150|363199442|FG000|Treatment Period|Progressive disease|1|||
105327371|NCT00813150|363199443|FG001|Treatment Period|Progressive disease|0|||
105327372|NCT00813150|363199442|FG000|Treatment Period|Complete response|0|||
105327373|NCT00813150|363199443|FG001|Treatment Period|Complete response|1|||
105327374|NCT00813150|363199442|FG000|Treatment Period|Stable disease|1|||
105327375|NCT00813150|363199443|FG001|Treatment Period|Stable disease|2|||
105327376|NCT00813150|363199442|FG000|Treatment Period|Protocol Violation|3|||
105327377|NCT00813150|363199443|FG001|Treatment Period|Protocol Violation|4|||
105327378|NCT00813150|363199442|FG000|Treatment Period|Withdrawal by Subject|5|||
105327379|NCT00813150|363199443|FG001|Treatment Period|Withdrawal by Subject|3|||
105327380|NCT00813150|363199442|FG000|Treatment Period|Non compliance|0|||
105327381|NCT00813150|363199443|FG001|Treatment Period|Non compliance|1|||
105327382|NCT00813150|363199442|FG000|Treatment Period|Reason not specified|3|||
105327383|NCT00813150|363199443|FG001|Treatment Period|Reason not specified|4|||
105327384|NCT00813150|363199442|FG000|Treatment Period|Data not available|1|||
105854528|NCT04201093|365121685|FG001|Overall Study|Site Terminated by Sponsor|3|||
105854529|NCT04201093|365121686|FG002|Overall Study|Site Terminated by Sponsor|1|||
105327385|NCT00813150|363199443|FG001|Treatment Period|Data not available|2|||
105327386|NCT00813150|363199442|FG000|Long Term Follow-up|Death|0|||
105327387|NCT00813150|363199443|FG001|Long Term Follow-up|Death|4|||
105327388|NCT00813150|363199442|FG000|Long Term Follow-up|Other|0|||
105327389|NCT00813150|363199443|FG001|Long Term Follow-up|Other|3|||
105373935|NCT01232283|363376340|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105373936|NCT01232283|363376341|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105854530|NCT04201093|365121684|FG000|Overall Study|Withdrawal by Subject|7|||
105854531|NCT04201093|365121685|FG001|Overall Study|Withdrawal by Subject|8|||
105327390|NCT00813150|363199442|FG000|Long Term Follow-up|Lost to Follow-up|2|||
105327391|NCT00813150|363199443|FG001|Long Term Follow-up|Lost to Follow-up|0|||
105327392|NCT00813150|363199442|FG000|Long Term Follow-up|Progression/Relapse|22|||
105327393|NCT00813150|363199443|FG001|Long Term Follow-up|Progression/Relapse|24|||
105327394|NCT03103087|363199448|FG000|Overall Study|Did not receive any study drug|1|||
105327395|NCT03103087|363199449|FG001|Overall Study|Did not receive any study drug|0|||
105327396|NCT03103087|363199450|FG002|Overall Study|Did not receive any study drug|0|||
105327397|NCT03103087|363199448|FG000|Overall Study|Protocol Violation|1|||
105327398|NCT03103087|363199449|FG001|Overall Study|Protocol Violation|2|||
105327399|NCT03103087|363199450|FG002|Overall Study|Protocol Violation|1|||
105327400|NCT03103087|363199448|FG000|Overall Study|Lack of Efficacy|2|||
105327401|NCT03103087|363199449|FG001|Overall Study|Lack of Efficacy|1|||
105327402|NCT03103087|363199450|FG002|Overall Study|Lack of Efficacy|1|||
105327403|NCT03103087|363199448|FG000|Overall Study|Pregnancy|0|||
105327404|NCT03103087|363199449|FG001|Overall Study|Pregnancy|0|||
105327405|NCT03103087|363199450|FG002|Overall Study|Pregnancy|1|||
105327406|NCT03103087|363199448|FG000|Overall Study|Adverse Event|2|||
105327407|NCT03103087|363199449|FG001|Overall Study|Adverse Event|15|||
105327408|NCT03103087|363199450|FG002|Overall Study|Adverse Event|6|||
105327409|NCT03103087|363199448|FG000|Overall Study|Withdrawal by Subject|13|||
105327410|NCT03103087|363199449|FG001|Overall Study|Withdrawal by Subject|6|||
105327411|NCT03103087|363199450|FG002|Overall Study|Withdrawal by Subject|6|||
105327412|NCT03103087|363199448|FG000|Overall Study|Lost to Follow-up|4|||
105327413|NCT03103087|363199449|FG001|Overall Study|Lost to Follow-up|2|||
105327414|NCT03103087|363199450|FG002|Overall Study|Lost to Follow-up|7|||
105327415|NCT03103087|363199448|FG000|Overall Study|Other reason not reported|1|||
105327416|NCT03103087|363199449|FG001|Overall Study|Other reason not reported|3|||
105327417|NCT03103087|363199450|FG002|Overall Study|Other reason not reported|5|||
105327418|NCT00075816|363199451|FG000|Overall Study|Did not undergo transplantation|14|||
105327419|NCT00075816|363199452|FG001|Overall Study|Did not undergo transplantation|11|||
105327420|NCT01467713|363199453|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
105327421|NCT01467713|363199454|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
105327422|NCT01467713|363199455|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
105327423|NCT01467713|363199456|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
105327424|NCT01467713|363199453|FG000|Overall Study|Major Protocol Deviation|2|||
105327425|NCT01467713|363199454|FG001|Overall Study|Major Protocol Deviation|4|||
105327426|NCT01467713|363199455|FG002|Overall Study|Major Protocol Deviation|4|||
105327427|NCT01467713|363199456|FG003|Overall Study|Major Protocol Deviation|1|||
105327428|NCT01467713|363199453|FG000|Overall Study|Lost to Follow-up|9|||
105327429|NCT01467713|363199454|FG001|Overall Study|Lost to Follow-up|12|||
105327430|NCT01467713|363199455|FG002|Overall Study|Lost to Follow-up|6|||
105373937|NCT01232283|363376342|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105373938|NCT01232283|363376343|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105373939|NCT01232283|363376344|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105373940|NCT01232283|363376345|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105373941|NCT01232283|363376346|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105373942|NCT01232283|363376347|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105373943|NCT01232283|363376338|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
105373944|NCT01232283|363376339|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
105373945|NCT01232283|363376340|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105373946|NCT01232283|363376341|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105373947|NCT01232283|363376342|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105373948|NCT01232283|363376343|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105373949|NCT01232283|363376344|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105373950|NCT01232283|363376345|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105373951|NCT01232283|363376346|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105373952|NCT01232283|363376347|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105373953|NCT01232283|363376338|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
105373954|NCT01232283|363376339|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
105373955|NCT01232283|363376340|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
105373956|NCT01232283|363376341|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
105373957|NCT01232283|363376342|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
105373958|NCT01232283|363376343|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
105373959|NCT01232283|363376344|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
105373960|NCT01232283|363376345|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
105373961|NCT01232283|363376346|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
105373962|NCT01232283|363376347|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
105373963|NCT01232283|363376338|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
105373964|NCT01232283|363376339|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
105373965|NCT01232283|363376340|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105373966|NCT01232283|363376341|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105327431|NCT01467713|363199456|FG003|Overall Study|Lost to Follow-up|9|||
105327432|NCT01467713|363199453|FG000|Overall Study|Voluntary Withdrawal|18|||
105327433|NCT01467713|363199454|FG001|Overall Study|Voluntary Withdrawal|14|||
105373967|NCT01232283|363376342|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105327434|NCT01467713|363199455|FG002|Overall Study|Voluntary Withdrawal|21|||
105327435|NCT01467713|363199456|FG003|Overall Study|Voluntary Withdrawal|20|||
105327436|NCT01467713|363199453|FG000|Overall Study|Study Termination|23|||
105327437|NCT01467713|363199454|FG001|Overall Study|Study Termination|33|||
105327438|NCT01467713|363199455|FG002|Overall Study|Study Termination|28|||
105327439|NCT01467713|363199456|FG003|Overall Study|Study Termination|29|||
105327440|NCT01467713|363199453|FG000|Overall Study|Pregnancy|0|||
105327441|NCT01467713|363199454|FG001|Overall Study|Pregnancy|1|||
105327442|NCT01467713|363199455|FG002|Overall Study|Pregnancy|1|||
105854532|NCT04201093|365121686|FG002|Overall Study|Withdrawal by Subject|15|||
105854533|NCT04201093|365121684|FG000|Overall Study|Other|0|||
105854534|NCT04201093|365121685|FG001|Overall Study|Other|1|||
105854535|NCT04201093|365121686|FG002|Overall Study|Other|2|||
105854536|NCT04256512|365121687|FG000|Overall Study|Withdrawal by Subject|1|||
105854537|NCT01522976|365121694|FG000|Overall Study|Ineligible|4|||
105854538|NCT01522976|365121695|FG001|Overall Study|Ineligible|0|||
105854539|NCT01522976|365121696|FG002|Overall Study|Ineligible|1|||
105854540|NCT01522976|365121694|FG000|Overall Study|Death|7|||
105854541|NCT01522976|365121695|FG001|Overall Study|Death|6|||
105854542|NCT01522976|365121696|FG002|Overall Study|Death|2|||
105854543|NCT01522976|365121694|FG000|Overall Study|Still on treatment|9|||
105327443|NCT01467713|363199456|FG003|Overall Study|Pregnancy|3|||
105327444|NCT01467713|363199453|FG000|Overall Study|Relapse|35|||
105327445|NCT01467713|363199454|FG001|Overall Study|Relapse|25|||
105327446|NCT01467713|363199455|FG002|Overall Study|Relapse|28|||
105327447|NCT01467713|363199456|FG003|Overall Study|Relapse|35|||
105327448|NCT01467713|363199453|FG000|Overall Study|Reason not Specified|6|||
105327449|NCT01467713|363199454|FG001|Overall Study|Reason not Specified|11|||
105327450|NCT01467713|363199455|FG002|Overall Study|Reason not Specified|8|||
105327451|NCT01467713|363199456|FG003|Overall Study|Reason not Specified|7|||
105327452|NCT02445248|363199461|FG000|Overall Study|Death|45|||
105327453|NCT02445248|363199462|FG001|Overall Study|Death|12|||
105327454|NCT02445248|363199461|FG000|Overall Study|Progressive disease|13|||
105327455|NCT02445248|363199462|FG001|Overall Study|Progressive disease|1|||
105327456|NCT02445248|363199461|FG000|Overall Study|Subject decision|8|||
105327457|NCT02445248|363199462|FG001|Overall Study|Subject decision|0|||
105327458|NCT02445248|363199461|FG000|Overall Study|Physician Decision|5|||
105327459|NCT02445248|363199462|FG001|Overall Study|Physician Decision|0|||
105327460|NCT02445248|363199461|FG000|Overall Study|Adverse Event|1|||
105327461|NCT02445248|363199462|FG001|Overall Study|Adverse Event|0|||
105327462|NCT02445248|363199461|FG000|Overall Study|Lost to Follow-up|1|||
105327463|NCT02445248|363199462|FG001|Overall Study|Lost to Follow-up|0|||
105327464|NCT02596971|363199465|FG000|Overall Study|Death|5|||
105327465|NCT02596971|363199466|FG001|Overall Study|Death|1|||
105327466|NCT02596971|363199467|FG002|Overall Study|Death|5|||
105327467|NCT02596971|363199465|FG000|Overall Study|Withdrawal by Subject|5|||
105327468|NCT02596971|363199466|FG001|Overall Study|Withdrawal by Subject|1|||
105327469|NCT02596971|363199467|FG002|Overall Study|Withdrawal by Subject|4|||
105327470|NCT01401361|363199468|FG000|Overall Study|Withdrawal by Subject|16|||
105327471|NCT01401361|363199468|FG000|Overall Study|Lack of Efficacy|6|||
105327472|NCT01401361|363199468|FG000|Overall Study|Physician Decision|1|||
105327473|NCT01401361|363199468|FG000|Overall Study|Lost to Follow-up|3|||
105327474|NCT01401361|363199468|FG000|Overall Study|Subject/family decision post procedure|2|||
105327475|NCT00595920|363199471|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
105327476|NCT03048747|363199472|FG000|Overall Study|Adverse Event|2|||
105327477|NCT03048747|363199472|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
105327478|NCT03048747|363199472|FG000|Overall Study|Physician Decision|1|||
105327479|NCT00824772|363199473|FG000|Overall Study|Withdrawal by Subject|8|||
105327480|NCT00611923|363199474|FG000|Overall Study|Withdrawal by Subject|2|||
105327481|NCT00611923|363199475|FG001|Overall Study|Withdrawal by Subject|2|||
105327482|NCT03588910|363199476|FG000|Overall Study|Withdrawal by Subject|1|||
105327483|NCT03588910|363199477|FG001|Overall Study|Withdrawal by Subject|0|||
105327484|NCT03588910|363199476|FG000|Overall Study|Allergy|2|||
105327485|NCT03588910|363199477|FG001|Overall Study|Allergy|0|||
105327486|NCT03588910|363199476|FG000|Overall Study|Protocol Violation|0|||
105327487|NCT03588910|363199477|FG001|Overall Study|Protocol Violation|3|||
105327488|NCT03588910|363199476|FG000|Overall Study|Did not complete Day 1 Survey|5|||
105327489|NCT03588910|363199477|FG001|Overall Study|Did not complete Day 1 Survey|10|||
105327490|NCT03588910|363199476|FG000|Overall Study|Did not complete Day 7 Survey|5|||
105327491|NCT03588910|363199477|FG001|Overall Study|Did not complete Day 7 Survey|2|||
105327492|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
105327493|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
105327494|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
105327495|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
105327496|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
105327497|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
105327498|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
105327499|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
105327500|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
105327501|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
105327502|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
105327503|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
105327504|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
105854544|NCT01522976|365121695|FG001|Overall Study|Still on treatment|9|||
105854545|NCT01522976|365121696|FG002|Overall Study|Still on treatment|6|||
105854546|NCT01522976|365121694|FG000|Overall Study|Disease progression|28|||
105854547|NCT01522976|365121695|FG001|Overall Study|Disease progression|30|||
105854548|NCT01522976|365121696|FG002|Overall Study|Disease progression|25|||
105854549|NCT01522976|365121694|FG000|Overall Study|Adverse Event|17|||
105854550|NCT01522976|365121695|FG001|Overall Study|Adverse Event|7|||
105854551|NCT01522976|365121696|FG002|Overall Study|Adverse Event|18|||
105854552|NCT01522976|365121694|FG000|Overall Study|Refusal unrelated to adverse event|10|||
105327505|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
105327506|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
105327507|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
105327508|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
105327509|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
105327510|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
105327511|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
105327512|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
105327513|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
105327514|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
105327515|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
105854553|NCT01522976|365121695|FG001|Overall Study|Refusal unrelated to adverse event|13|||
105854554|NCT01522976|365121696|FG002|Overall Study|Refusal unrelated to adverse event|14|||
105854555|NCT01522976|365121694|FG000|Overall Study|Not protocol specified|22|||
105854556|NCT01522976|365121695|FG001|Overall Study|Not protocol specified|27|||
105854557|NCT01522976|365121696|FG002|Overall Study|Not protocol specified|27|||
105854558|NCT01013649|365121697|FG000|First Step|Withdrawal by Subject|36|||
105854559|NCT01013649|365121698|FG001|First Step|Withdrawal by Subject|19|||
105854560|NCT01013649|365121699|FG002|First Step|Withdrawal by Subject|0|||
105854561|NCT01013649|365121700|FG003|First Step|Withdrawal by Subject|0|||
105854562|NCT01013649|365121697|FG000|First Step|Progression|58|||
105854563|NCT01013649|365121698|FG001|First Step|Progression|23|||
105854564|NCT01013649|365121699|FG002|First Step|Progression|0|||
105854565|NCT01013649|365121700|FG003|First Step|Progression|0|||
105854566|NCT01013649|365121697|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
105854567|NCT01013649|365121698|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
105854568|NCT01013649|365121699|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
105577132|NCT02855164|364112191|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
105577133|NCT02855164|364112192|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
105577134|NCT02855164|364112193|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
105577135|NCT02855164|364112194|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
105577136|NCT02855164|364112195|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
105577137|NCT02855164|364112196|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
105577138|NCT02855164|364112197|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
105854569|NCT01013649|365121700|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
105854570|NCT01013649|365121697|FG000|First Step|Death|3|||
105854571|NCT01013649|365121698|FG001|First Step|Death|4|||
105854572|NCT01013649|365121699|FG002|First Step|Death|0|||
105854573|NCT01013649|365121700|FG003|First Step|Death|0|||
105854574|NCT01013649|365121697|FG000|First Step|Adverse Event|9|||
105854575|NCT01013649|365121698|FG001|First Step|Adverse Event|5|||
105854576|NCT01013649|365121699|FG002|First Step|Adverse Event|0|||
105854577|NCT01013649|365121700|FG003|First Step|Adverse Event|0|||
105854578|NCT01013649|365121697|FG000|First Step|Other|4|||
105854579|NCT01013649|365121698|FG001|First Step|Other|6|||
105854580|NCT01013649|365121699|FG002|First Step|Other|0|||
105854581|NCT01013649|365121700|FG003|First Step|Other|0|||
105854582|NCT02684006|365121704|FG000|Overall Study|Other|18|||
105854583|NCT02684006|365121705|FG001|Overall Study|Other|6|||
105854584|NCT02684006|365121704|FG000|Overall Study|Protocol Violation|2|||
105854585|NCT02684006|365121705|FG001|Overall Study|Protocol Violation|1|||
105854586|NCT02684006|365121704|FG000|Overall Study|Non-compliance with study drug|1|||
105854587|NCT02684006|365121705|FG001|Overall Study|Non-compliance with study drug|1|||
105854588|NCT02684006|365121704|FG000|Overall Study|No longer met eligibility criteria|6|||
105327516|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
105327517|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
105854589|NCT02684006|365121705|FG001|Overall Study|No longer met eligibility criteria|2|||
105854590|NCT02684006|365121704|FG000|Overall Study|Lost to Follow-up|0|||
105854591|NCT02684006|365121705|FG001|Overall Study|Lost to Follow-up|1|||
105854592|NCT02684006|365121704|FG000|Overall Study|Death|25|||
105854593|NCT02684006|365121705|FG001|Overall Study|Death|22|||
105854594|NCT02684006|365121704|FG000|Overall Study|Global deterioration of health status|18|||
105854595|NCT02684006|365121705|FG001|Overall Study|Global deterioration of health status|20|||
105854596|NCT02684006|365121704|FG000|Overall Study|Physician Decision|15|||
105854597|NCT02684006|365121705|FG001|Overall Study|Physician Decision|8|||
105854598|NCT02684006|365121704|FG000|Overall Study|Adverse Event|86|||
105854599|NCT02684006|365121705|FG001|Overall Study|Adverse Event|65|||
105854600|NCT02684006|365121704|FG000|Overall Study|Withdrawal by Subject|29|||
105854601|NCT02684006|365121705|FG001|Overall Study|Withdrawal by Subject|43|||
105854602|NCT02684006|365121704|FG000|Overall Study|Progressive disease|236|||
105854603|NCT02684006|365121705|FG001|Overall Study|Progressive disease|266|||
105854604|NCT02684006|365121704|FG000|Overall Study|Participation terminated by sponsor|6|||
105854605|NCT02684006|365121705|FG001|Overall Study|Participation terminated by sponsor|9|||
105854606|NCT04397263|365121706|FG000|Overall Study|Withdrawal by Subject|2|||
105854607|NCT02883049|365121707|FG000|Induction|Adverse Event|52|||
105854608|NCT02883049|365121708|FG001|Induction|Adverse Event|2|||
105854609|NCT02883049|365121709|FG002|Induction|Adverse Event|0|||
105854610|NCT02883049|365121710|FG003|Induction|Adverse Event|0|||
105854611|NCT02883049|365121711|FG004|Induction|Adverse Event|0|||
105854612|NCT02883049|365121712|FG005|Induction|Adverse Event|0|||
105854613|NCT02883049|365121713|FG006|Induction|Adverse Event|0|||
105854614|NCT02883049|365121714|FG007|Induction|Adverse Event|0|||
105854615|NCT02883049|365121715|FG008|Induction|Adverse Event|0|||
105854616|NCT02883049|365121716|FG009|Induction|Adverse Event|0|||
105327518|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
105854617|NCT02883049|365121717|FG010|Induction|Adverse Event|0|||
105327519|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
105327520|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
105327521|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
105327522|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
105327523|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
105327524|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
105327525|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
105327526|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
105327527|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
105327528|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
105327529|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
105327530|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
105327531|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
105327532|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
105327533|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
105327534|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
105327535|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
105327536|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
105327537|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
105327538|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
105327539|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
105327540|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
105327541|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
105327542|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
105327543|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
105327544|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Site closed|0|||
105327545|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Site closed|0|||
105327546|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Site closed|1|||
105327547|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Site closed|0|||
105327548|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
105327549|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
105327550|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
105327551|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
105327552|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
105327553|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
105327554|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
105327555|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
105327556|NCT00838903|363199478|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
105327557|NCT00838903|363199479|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
105327558|NCT00838903|363199480|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
105327559|NCT00838903|363199481|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
105327560|NCT00838903|363199478|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
105327561|NCT00838903|363199479|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
105327562|NCT00838903|363199480|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
105327563|NCT00838903|363199481|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
105327564|NCT00838903|363199478|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
105327565|NCT00838903|363199479|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
105327566|NCT00838903|363199480|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
105327567|NCT00838903|363199481|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
105854618|NCT02883049|365121718|FG011|Induction|Adverse Event|0|||
105854619|NCT02883049|365121719|FG012|Induction|Adverse Event|0|||
105854620|NCT02883049|365121720|FG013|Induction|Adverse Event|0|||
105373968|NCT01232283|363376343|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105373969|NCT01232283|363376344|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105373970|NCT01232283|363376345|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105373971|NCT01232283|363376346|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105373972|NCT01232283|363376347|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105373973|NCT01232283|363376338|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
105373974|NCT01232283|363376339|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
105373975|NCT01232283|363376340|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105373976|NCT01232283|363376341|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105373977|NCT01232283|363376342|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105373978|NCT01232283|363376343|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105373979|NCT01232283|363376344|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105373980|NCT01232283|363376345|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105373981|NCT01232283|363376346|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105373982|NCT01232283|363376347|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105373983|NCT01232283|363376338|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105373984|NCT01232283|363376339|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105373985|NCT01232283|363376340|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
105373986|NCT01232283|363376341|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
105373987|NCT01232283|363376342|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105373988|NCT01232283|363376343|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105373989|NCT01232283|363376344|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105373990|NCT01232283|363376345|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105373991|NCT01232283|363376346|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105373992|NCT01232283|363376347|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105373993|NCT01232283|363376338|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105373994|NCT01232283|363376339|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105373995|NCT01232283|363376340|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
105373996|NCT01232283|363376341|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
105373997|NCT01232283|363376342|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105373998|NCT01232283|363376343|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105373999|NCT01232283|363376344|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105374000|NCT01232283|363376345|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105374001|NCT01232283|363376346|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105374002|NCT01232283|363376347|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105374003|NCT01232283|363376338|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105374004|NCT01232283|363376339|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105374005|NCT01232283|363376340|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
105374006|NCT01232283|363376341|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105374007|NCT01232283|363376342|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105374008|NCT01232283|363376343|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105374009|NCT01232283|363376344|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105374010|NCT01232283|363376345|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105374011|NCT01232283|363376346|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105374012|NCT01232283|363376347|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105327568|NCT00838903|363199478|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
105327569|NCT00838903|363199479|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
105327570|NCT00838903|363199480|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
105327571|NCT00838903|363199481|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
105327572|NCT00838903|363199478|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
105327573|NCT00838903|363199479|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
105327574|NCT00838903|363199480|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
105374013|NCT01232283|363376338|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
105374014|NCT01232283|363376339|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
105374015|NCT01232283|363376340|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
105374016|NCT01232283|363376341|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
105374017|NCT01232283|363376342|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
105374018|NCT01232283|363376343|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
105374019|NCT01232283|363376344|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
105374020|NCT01232283|363376345|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
105374021|NCT01232283|363376346|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
105374022|NCT01232283|363376347|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
105374023|NCT01232283|363376338|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
105374024|NCT01232283|363376339|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
105374025|NCT01232283|363376340|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
105854621|NCT02883049|365121721|FG014|Induction|Adverse Event|0|||
105327575|NCT00838903|363199481|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
105374026|NCT01232283|363376341|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
105374027|NCT01232283|363376342|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
105374028|NCT01232283|363376343|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
105374029|NCT01232283|363376344|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
105374030|NCT01232283|363376345|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
105374031|NCT01232283|363376346|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
105374032|NCT01232283|363376347|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
105374033|NCT01232283|363376338|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
105374034|NCT01232283|363376339|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
105374035|NCT01232283|363376340|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
105374036|NCT01232283|363376341|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
105374037|NCT01232283|363376342|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
105374038|NCT01232283|363376343|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
105374039|NCT01232283|363376344|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
105374040|NCT01232283|363376345|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
105374041|NCT01232283|363376346|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
105374042|NCT01232283|363376347|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
105327576|NCT00838903|363199478|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
105327577|NCT00838903|363199479|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
105327578|NCT00838903|363199480|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
105327579|NCT00838903|363199481|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
105327580|NCT00838903|363199478|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
105327581|NCT00838903|363199479|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
105374043|NCT01232283|363376338|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
105374044|NCT01232283|363376339|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
105374045|NCT01232283|363376340|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
105374046|NCT01232283|363376341|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
105374047|NCT01232283|363376342|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
105374048|NCT01232283|363376343|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
105374049|NCT01232283|363376344|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
105374050|NCT01232283|363376345|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
105374051|NCT01232283|363376346|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
105374052|NCT01232283|363376347|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
105577139|NCT02855164|364112190|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
105577140|NCT02855164|364112191|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
105577141|NCT02855164|364112192|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
105577142|NCT02855164|364112193|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
105577143|NCT02855164|364112194|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
105577144|NCT02855164|364112195|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
105577145|NCT02855164|364112196|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
105577146|NCT02855164|364112197|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
105327582|NCT00838903|363199480|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
105327583|NCT00838903|363199481|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
105327584|NCT00838903|363199478|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
105327585|NCT00838903|363199479|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
105327586|NCT00838903|363199480|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
105327587|NCT00838903|363199481|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
105327588|NCT00838903|363199478|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
105327589|NCT00838903|363199479|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
105327590|NCT00838903|363199480|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
105327591|NCT00838903|363199481|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
105327592|NCT00838903|363199478|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
105577147|NCT02855164|364112190|FG000|Part C (Randomized Set)|Adverse Event|0|||
105577148|NCT02855164|364112191|FG001|Part C (Randomized Set)|Adverse Event|0|||
105577149|NCT02855164|364112192|FG002|Part C (Randomized Set)|Adverse Event|0|||
105577150|NCT02855164|364112193|FG003|Part C (Randomized Set)|Adverse Event|0|||
105577151|NCT02855164|364112194|FG004|Part C (Randomized Set)|Adverse Event|0|||
105577152|NCT02855164|364112195|FG005|Part C (Randomized Set)|Adverse Event|5|||
105577153|NCT02855164|364112196|FG006|Part C (Randomized Set)|Adverse Event|9|||
105577154|NCT02855164|364112197|FG007|Part C (Randomized Set)|Adverse Event|2|||
105577155|NCT02855164|364112190|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
105374053|NCT01232283|363376338|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
105374054|NCT01232283|363376339|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
105374055|NCT01232283|363376340|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
105374056|NCT01232283|363376341|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
105374057|NCT01232283|363376342|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
105374058|NCT01232283|363376343|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
105374059|NCT01232283|363376344|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
105327593|NCT00838903|363199479|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
105374060|NCT01232283|363376345|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
105374061|NCT01232283|363376346|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
105374062|NCT01232283|363376347|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
105374063|NCT01232283|363376338|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
105374064|NCT01232283|363376339|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
105374065|NCT01232283|363376340|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
105374066|NCT01232283|363376341|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
105374067|NCT01232283|363376342|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
105327594|NCT00838903|363199480|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
105327595|NCT00838903|363199481|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
105327596|NCT00838903|363199478|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
105327597|NCT00838903|363199479|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
105327598|NCT00838903|363199480|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
105374068|NCT01232283|363376343|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
105374069|NCT01232283|363376344|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
105374070|NCT01232283|363376345|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
105374071|NCT01232283|363376346|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
105374072|NCT01232283|363376347|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
105374073|NCT01232283|363376338|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105374074|NCT01232283|363376339|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105327599|NCT00838903|363199481|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
105327600|NCT00838903|363199478|FG000|Follow-up Period (8 Weeks)|Missing|1|||
105327601|NCT00838903|363199479|FG001|Follow-up Period (8 Weeks)|Missing|2|||
105327602|NCT00838903|363199480|FG002|Follow-up Period (8 Weeks)|Missing|1|||
105327603|NCT00838903|363199481|FG003|Follow-up Period (8 Weeks)|Missing|1|||
105327604|NCT04565145|363199482|FG000|Overall Study|Withdrawal by Subject|1|||
105327605|NCT04565145|363199483|FG001|Overall Study|Withdrawal by Subject|1|||
105327606|NCT03096314|363199484|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
105327607|NCT03096314|363199485|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
105327608|NCT00536939|363199486|FG000|Overall Study|Withdrawal by Subject|1|||
105327609|NCT00536939|363199487|FG001|Overall Study|Withdrawal by Subject|0|||
105327610|NCT00536939|363199486|FG000|Overall Study|Other Complicating Disease|1|||
105327611|NCT00536939|363199487|FG001|Overall Study|Other Complicating Disease|0|||
105327612|NCT02512302|363199488|FG000|Period 1|Adverse Event|0|||
105327613|NCT02512302|363199489|FG001|Period 1|Adverse Event|1|||
105327614|NCT02512302|363199490|FG002|Period 1|Adverse Event|0|||
105327615|NCT02512302|363199491|FG003|Period 1|Adverse Event|0|||
105327616|NCT02512302|363199492|FG004|Period 1|Adverse Event|0|||
105327617|NCT02512302|363199493|FG005|Period 1|Adverse Event|0|||
105327618|NCT02512302|363199494|FG006|Period 1|Adverse Event|0|||
105327619|NCT02512302|363199495|FG007|Period 1|Adverse Event|0|||
105327620|NCT02512302|363199496|FG008|Period 1|Adverse Event|0|||
105327621|NCT02512302|363199497|FG009|Period 1|Adverse Event|0|||
105327622|NCT02512302|363199488|FG000|Period 2|Adverse Event|0|||
105374075|NCT01232283|363376340|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105374076|NCT01232283|363376341|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105374077|NCT01232283|363376342|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
105374078|NCT01232283|363376343|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105374079|NCT01232283|363376344|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105374080|NCT01232283|363376345|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105374081|NCT01232283|363376346|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105327623|NCT02512302|363199489|FG001|Period 2|Adverse Event|0|||
105327624|NCT02512302|363199490|FG002|Period 2|Adverse Event|0|||
105327625|NCT02512302|363199491|FG003|Period 2|Adverse Event|0|||
105374082|NCT01232283|363376347|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105374083|NCT01232283|363376338|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
105374084|NCT01232283|363376339|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
105374085|NCT01232283|363376340|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
105374086|NCT01232283|363376341|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
105374087|NCT01232283|363376342|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
105374088|NCT01232283|363376343|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
105374089|NCT01232283|363376344|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
105374090|NCT01232283|363376345|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
105374091|NCT01232283|363376346|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
105374092|NCT01232283|363376347|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
105374093|NCT01232283|363376338|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105374094|NCT01232283|363376339|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105327626|NCT02512302|363199492|FG004|Period 2|Adverse Event|0|||
105327627|NCT02512302|363199493|FG005|Period 2|Adverse Event|0|||
105327628|NCT02512302|363199494|FG006|Period 2|Adverse Event|0|||
105327629|NCT02512302|363199495|FG007|Period 2|Adverse Event|0|||
105327630|NCT02512302|363199496|FG008|Period 2|Adverse Event|0|||
105327631|NCT02512302|363199497|FG009|Period 2|Adverse Event|1|||
105327632|NCT02512302|363199488|FG000|Period 3|Lost to Follow-up|0|||
105327633|NCT02512302|363199489|FG001|Period 3|Lost to Follow-up|0|||
105327634|NCT02512302|363199490|FG002|Period 3|Lost to Follow-up|1|||
105327635|NCT02512302|363199491|FG003|Period 3|Lost to Follow-up|0|||
105327636|NCT02512302|363199492|FG004|Period 3|Lost to Follow-up|0|||
105327637|NCT02512302|363199493|FG005|Period 3|Lost to Follow-up|0|||
105327638|NCT02512302|363199494|FG006|Period 3|Lost to Follow-up|0|||
105327639|NCT02512302|363199495|FG007|Period 3|Lost to Follow-up|0|||
105327640|NCT02512302|363199496|FG008|Period 3|Lost to Follow-up|0|||
105327641|NCT02512302|363199497|FG009|Period 3|Lost to Follow-up|0|||
105327642|NCT02512302|363199488|FG000|Period 4|Adverse Event|0|||
105327643|NCT02512302|363199489|FG001|Period 4|Adverse Event|0|||
105327644|NCT02512302|363199490|FG002|Period 4|Adverse Event|0|||
105327645|NCT02512302|363199491|FG003|Period 4|Adverse Event|0|||
105327646|NCT02512302|363199492|FG004|Period 4|Adverse Event|0|||
105327647|NCT02512302|363199493|FG005|Period 4|Adverse Event|0|||
105327648|NCT02512302|363199494|FG006|Period 4|Adverse Event|1|||
105327649|NCT02512302|363199495|FG007|Period 4|Adverse Event|0|||
105327650|NCT02512302|363199496|FG008|Period 4|Adverse Event|0|||
105327651|NCT02512302|363199497|FG009|Period 4|Adverse Event|0|||
105327652|NCT00471822|363199498|FG000|Overall Study|Protocol Violation|2|||
105327653|NCT04168112|363199503|FG000|Overall Study|Lost to Follow-up|1|||
105327654|NCT04168112|363199504|FG001|Overall Study|Lost to Follow-up|0|||
105374095|NCT01232283|363376340|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105374096|NCT01232283|363376341|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105374097|NCT01232283|363376342|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105374098|NCT01232283|363376343|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105374099|NCT01232283|363376344|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105374100|NCT01232283|363376345|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
105374101|NCT01232283|363376346|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105374102|NCT01232283|363376347|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105374103|NCT01232283|363376338|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105374104|NCT01232283|363376339|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105374105|NCT01232283|363376340|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105374106|NCT01232283|363376341|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105374107|NCT01232283|363376342|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105374108|NCT01232283|363376343|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
105374109|NCT01232283|363376344|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105374110|NCT01232283|363376345|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105374111|NCT01232283|363376346|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105374112|NCT01232283|363376347|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105374113|NCT01232283|363376338|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105374114|NCT01232283|363376339|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105374115|NCT01232283|363376340|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105374116|NCT01232283|363376341|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105374117|NCT01232283|363376342|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105374118|NCT01232283|363376343|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105374119|NCT01232283|363376344|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105374120|NCT01232283|363376345|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105374121|NCT01232283|363376346|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
105374122|NCT01232283|363376347|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
105374123|NCT01232283|363376338|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105374124|NCT01232283|363376339|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105374125|NCT01232283|363376340|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105374126|NCT01232283|363376341|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105374127|NCT01232283|363376342|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105374128|NCT01232283|363376343|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105577156|NCT02855164|364112191|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
105577157|NCT02855164|364112192|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
105577158|NCT02855164|364112193|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
105577159|NCT02855164|364112194|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
105327655|NCT04168112|363199503|FG000|Overall Study|Withdrawal by Subject|1|||
105327656|NCT04168112|363199504|FG001|Overall Study|Withdrawal by Subject|0|||
105327657|NCT01735916|363199505|FG000|Overall Study|Subject not eligible to be randomized|11|||
105327658|NCT01735916|363199506|FG001|Overall Study|Subject not eligible to be randomized|0|||
105327659|NCT01735916|363199507|FG002|Overall Study|Subject not eligible to be randomized|0|||
105327660|NCT01735916|363199505|FG000|Overall Study|Early termination of study by sponsor|4|||
105327661|NCT01735916|363199506|FG001|Overall Study|Early termination of study by sponsor|19|||
105327662|NCT01735916|363199507|FG002|Overall Study|Early termination of study by sponsor|7|||
105374129|NCT01232283|363376344|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105374130|NCT01232283|363376345|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105374131|NCT01232283|363376346|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
105374132|NCT01232283|363376347|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
105374133|NCT01232283|363376338|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105374134|NCT01232283|363376339|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105374135|NCT01232283|363376340|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105374136|NCT01232283|363376341|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105854622|NCT02883049|365121722|FG015|Induction|Adverse Event|0|||
105854623|NCT02883049|365121707|FG000|Induction|Death|76|||
105854624|NCT02883049|365121708|FG001|Induction|Death|8|||
105854625|NCT02883049|365121709|FG002|Induction|Death|0|||
105327663|NCT01735916|363199505|FG000|Overall Study|Withdrawal by Subject|3|||
105327664|NCT01735916|363199506|FG001|Overall Study|Withdrawal by Subject|0|||
105327665|NCT01735916|363199507|FG002|Overall Study|Withdrawal by Subject|0|||
105327666|NCT02955355|363199513|FG000|Overall Study|Adverse Event|4|||
105327667|NCT02955355|363199513|FG000|Overall Study|Death|1|||
105327668|NCT02955355|363199513|FG000|Overall Study|Physician Decision|21|||
105327669|NCT02955355|363199513|FG000|Overall Study|Site Terminated by Sponsor|35|||
105327670|NCT02955355|363199513|FG000|Overall Study|Withdrawal by Subject|19|||
105327671|NCT02955355|363199513|FG000|Overall Study|Reason Not Specified|5|||
105327672|NCT02612623|363199514|FG000|Overall Study|Withdrawal by Subject|0|||
105327673|NCT02612623|363199515|FG001|Overall Study|Withdrawal by Subject|1|||
105327674|NCT02612623|363199516|FG002|Overall Study|Withdrawal by Subject|0|||
105327675|NCT02612623|363199517|FG003|Overall Study|Withdrawal by Subject|0|||
105327676|NCT02612623|363199514|FG000|Overall Study|Adverse Event|1|||
105327677|NCT02612623|363199515|FG001|Overall Study|Adverse Event|0|||
105327678|NCT02612623|363199516|FG002|Overall Study|Adverse Event|1|||
105327679|NCT02612623|363199517|FG003|Overall Study|Adverse Event|0|||
105327680|NCT00333983|363199518|FG000|Overall Study|Lost to Follow-up|2|||
105327681|NCT00333983|363199519|FG001|Overall Study|Lost to Follow-up|1|||
105327682|NCT00333983|363199520|FG002|Overall Study|Lost to Follow-up|0|||
105327683|NCT00333983|363199518|FG000|Overall Study|Adverse Event|1|||
105374137|NCT01232283|363376342|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105374138|NCT01232283|363376343|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105374139|NCT01232283|363376344|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105854626|NCT02883049|365121710|FG003|Induction|Death|0|||
105327684|NCT00333983|363199519|FG001|Overall Study|Adverse Event|1|||
105327685|NCT00333983|363199520|FG002|Overall Study|Adverse Event|1|||
105327686|NCT00333983|363199518|FG000|Overall Study|Withdrawal by Subject|0|||
105327687|NCT00333983|363199519|FG001|Overall Study|Withdrawal by Subject|3|||
105327688|NCT00333983|363199520|FG002|Overall Study|Withdrawal by Subject|1|||
105327689|NCT04227197|363199521|FG000|Randomization|Protocol Violation|1|||
105327690|NCT04227197|363199522|FG001|Randomization|Protocol Violation|0|||
105327691|NCT04227197|363199521|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
105327692|NCT04227197|363199522|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
105327693|NCT04227197|363199521|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
105327694|NCT04227197|363199522|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
105327695|NCT04227197|363199521|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
105327696|NCT04227197|363199522|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
105327697|NCT04227197|363199521|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
105327698|NCT04227197|363199522|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
105327699|NCT04227197|363199521|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
105327700|NCT04227197|363199522|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
105327701|NCT04227197|363199521|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
105327702|NCT04227197|363199522|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
105327703|NCT00833105|363199523|FG000|Overall Study|Withdrawal by Subject|1|||
105327704|NCT00833105|363199523|FG000|Overall Study|Adverse Event|2|||
105327705|NCT03656068|363199528|FG000|Overall Study|Withdrawal by Subject|4|||
105327706|NCT03656068|363199528|FG000|Overall Study|Adverse Event|1|||
105327707|NCT04335123|363199529|FG000|Overall Study|Withdrawal by Subject|2|||
105327708|NCT04335123|363199530|FG001|Overall Study|Withdrawal by Subject|0|||
105327709|NCT04335123|363199529|FG000|Overall Study|Physician Decision|2|||
105327710|NCT04335123|363199530|FG001|Overall Study|Physician Decision|0|||
105327711|NCT02712320|363199531|FG000|Overall Study|Lost to Follow-up|1|||
105327712|NCT02712320|363199531|FG000|Overall Study|Withdrawal by Subject|1|||
105327713|NCT02712320|363199531|FG000|Overall Study|Transferred to another facility|1|||
105327714|NCT02712320|363199531|FG000|Overall Study|Treating with the prohibited medications|2|||
105327715|NCT00063934|363199534|FG000|Overall Study|Ineligible|1|||
105327716|NCT05266053|363199535|FG000|Overall Study|Withdrawal by Subject|8|||
105854627|NCT02883049|365121711|FG004|Induction|Death|0|||
105854628|NCT02883049|365121712|FG005|Induction|Death|0|||
105327717|NCT05266053|363199536|FG001|Overall Study|Withdrawal by Subject|4|||
105854629|NCT02883049|365121713|FG006|Induction|Death|0|||
105854630|NCT02883049|365121714|FG007|Induction|Death|0|||
105577160|NCT02855164|364112195|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
105327718|NCT01343043|363199538|FG000|Overall Study|Disease progression before treatment|1|||
105327719|NCT01343043|363199539|FG001|Overall Study|Disease progression before treatment|0|||
105327720|NCT01343043|363199540|FG002|Overall Study|Disease progression before treatment|0|||
105327721|NCT01343043|363199541|FG003|Overall Study|Disease progression before treatment|0|||
105327722|NCT01343043|363199538|FG000|Overall Study|Withdrawal by Subject|1|||
105327723|NCT01343043|363199539|FG001|Overall Study|Withdrawal by Subject|0|||
105327724|NCT01343043|363199540|FG002|Overall Study|Withdrawal by Subject|0|||
105327725|NCT01343043|363199541|FG003|Overall Study|Withdrawal by Subject|0|||
105327726|NCT01343043|363199538|FG000|Overall Study|Death|1|||
105327727|NCT01343043|363199539|FG001|Overall Study|Death|1|||
105327728|NCT01343043|363199540|FG002|Overall Study|Death|0|||
105327729|NCT01343043|363199541|FG003|Overall Study|Death|1|||
105327730|NCT01017874|363199542|FG000|Overall Study|Withdrawal by Subject|23|||
105327731|NCT01017874|363199543|FG001|Overall Study|Withdrawal by Subject|20|||
105327732|NCT01017874|363199542|FG000|Overall Study|Sponsor decision|3|||
105327733|NCT01017874|363199543|FG001|Overall Study|Sponsor decision|1|||
105327734|NCT01017874|363199542|FG000|Overall Study|Lost to Follow-up|3|||
105327735|NCT01017874|363199543|FG001|Overall Study|Lost to Follow-up|2|||
105327736|NCT01017874|363199542|FG000|Overall Study|Physician Decision|1|||
105327737|NCT01017874|363199543|FG001|Overall Study|Physician Decision|3|||
105327738|NCT00925704|363199544|FG000|First Intervention|Withdrew consent|0|||
105327739|NCT00925704|363199545|FG001|First Intervention|Withdrew consent|0|||
105327740|NCT00925704|363199546|FG002|First Intervention|Withdrew consent|0|||
105327741|NCT00925704|363199547|FG003|First Intervention|Withdrew consent|1|||
105327742|NCT00925704|363199548|FG004|First Intervention|Withdrew consent|1|||
105327743|NCT00925704|363199549|FG005|First Intervention|Withdrew consent|0|||
105327744|NCT00925704|363199544|FG000|Second Intervention|Withdrawal by Subject|1|||
105327745|NCT00925704|363199545|FG001|Second Intervention|Withdrawal by Subject|0|||
105327746|NCT00925704|363199546|FG002|Second Intervention|Withdrawal by Subject|0|||
105327747|NCT00925704|363199547|FG003|Second Intervention|Withdrawal by Subject|0|||
105327748|NCT00925704|363199548|FG004|Second Intervention|Withdrawal by Subject|1|||
105327749|NCT00925704|363199549|FG005|Second Intervention|Withdrawal by Subject|0|||
105327750|NCT00925704|363199544|FG000|Third Intervention|Withdrew consent|0|||
105327751|NCT00925704|363199545|FG001|Third Intervention|Withdrew consent|0|||
105327752|NCT00925704|363199546|FG002|Third Intervention|Withdrew consent|0|||
105327753|NCT00925704|363199547|FG003|Third Intervention|Withdrew consent|0|||
105327754|NCT00925704|363199548|FG004|Third Intervention|Withdrew consent|0|||
105327755|NCT00925704|363199549|FG005|Third Intervention|Withdrew consent|1|||
105327756|NCT02996968|363199550|FG000|Overall Study|Withdrawal by Subject|1|||
105327757|NCT02996968|363199551|FG001|Overall Study|Withdrawal by Subject|0|||
105327758|NCT00502242|363199552|FG000|Overall Study|Lack of Efficacy|1|||
105327759|NCT00502242|363199553|FG001|Overall Study|Lack of Efficacy|11|||
105327760|NCT00502242|363199552|FG000|Overall Study|Adverse Event|31|||
105327761|NCT00502242|363199553|FG001|Overall Study|Adverse Event|20|||
105327762|NCT00502242|363199552|FG000|Overall Study|Physician Decision|2|||
105327763|NCT00502242|363199553|FG001|Overall Study|Physician Decision|3|||
105327764|NCT00502242|363199552|FG000|Overall Study|Other - Unspecified|8|||
105327765|NCT00502242|363199553|FG001|Overall Study|Other - Unspecified|14|||
105327766|NCT00502242|363199552|FG000|Overall Study|Protocol Violation|3|||
105327767|NCT00502242|363199553|FG001|Overall Study|Protocol Violation|1|||
105327768|NCT00502242|363199552|FG000|Overall Study|Withdrawal by Subject|6|||
105327769|NCT00502242|363199553|FG001|Overall Study|Withdrawal by Subject|7|||
105327770|NCT03817853|363199554|FG000|Induction Phase|Adverse Event|5|||
105327771|NCT03817853|363199555|FG001|Induction Phase|Adverse Event|0|||
105327772|NCT03817853|363199556|FG002|Induction Phase|Adverse Event|0|||
105327773|NCT03817853|363199554|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
105327774|NCT03817853|363199555|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
105327775|NCT03817853|363199556|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
105327776|NCT03817853|363199554|FG000|Induction Phase|Physician Decision|2|||
105327777|NCT03817853|363199555|FG001|Induction Phase|Physician Decision|0|||
105327778|NCT03817853|363199556|FG002|Induction Phase|Physician Decision|0|||
105327779|NCT03817853|363199554|FG000|Induction Phase|Progressive Disease|6|||
105327780|NCT03817853|363199555|FG001|Induction Phase|Progressive Disease|0|||
105327781|NCT03817853|363199556|FG002|Induction Phase|Progressive Disease|0|||
105327782|NCT03817853|363199554|FG000|Induction Phase|Withdrawal by Subject|4|||
105327783|NCT03817853|363199555|FG001|Induction Phase|Withdrawal by Subject|0|||
105327784|NCT03817853|363199556|FG002|Induction Phase|Withdrawal by Subject|0|||
105327785|NCT03817853|363199554|FG000|Maintenance Phase|Adverse Event|0|||
105327786|NCT03817853|363199555|FG001|Maintenance Phase|Adverse Event|8|||
105327787|NCT03817853|363199556|FG002|Maintenance Phase|Adverse Event|0|||
105327788|NCT03817853|363199554|FG000|Maintenance Phase|Death|0|||
105327789|NCT03817853|363199555|FG001|Maintenance Phase|Death|5|||
105327790|NCT03817853|363199556|FG002|Maintenance Phase|Death|0|||
105327791|NCT03817853|363199554|FG000|Maintenance Phase|Progressive Disease|0|||
105374140|NCT01232283|363376345|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105374141|NCT01232283|363376346|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
105374142|NCT01232283|363376347|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
105374143|NCT01232283|363376338|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105374144|NCT01232283|363376339|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105374145|NCT01232283|363376340|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105374146|NCT01232283|363376341|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105374147|NCT01232283|363376342|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105374148|NCT01232283|363376343|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105374149|NCT01232283|363376344|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105374150|NCT01232283|363376345|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105854631|NCT02883049|365121715|FG008|Induction|Death|0|||
105854632|NCT02883049|365121716|FG009|Induction|Death|0|||
105854633|NCT02883049|365121717|FG010|Induction|Death|0|||
105854634|NCT02883049|365121718|FG011|Induction|Death|0|||
105854635|NCT02883049|365121719|FG012|Induction|Death|0|||
105854636|NCT02883049|365121720|FG013|Induction|Death|0|||
105854637|NCT02883049|365121721|FG014|Induction|Death|0|||
105854638|NCT02883049|365121722|FG015|Induction|Death|0|||
105854639|NCT02883049|365121707|FG000|Induction|Lost to Follow-up|2|||
105854640|NCT02883049|365121708|FG001|Induction|Lost to Follow-up|0|||
105854641|NCT02883049|365121709|FG002|Induction|Lost to Follow-up|0|||
105854642|NCT02883049|365121710|FG003|Induction|Lost to Follow-up|0|||
105854643|NCT02883049|365121711|FG004|Induction|Lost to Follow-up|0|||
105854644|NCT02883049|365121712|FG005|Induction|Lost to Follow-up|0|||
105854645|NCT02883049|365121713|FG006|Induction|Lost to Follow-up|0|||
105854646|NCT02883049|365121714|FG007|Induction|Lost to Follow-up|0|||
105854647|NCT02883049|365121715|FG008|Induction|Lost to Follow-up|0|||
105854648|NCT02883049|365121716|FG009|Induction|Lost to Follow-up|0|||
105854649|NCT02883049|365121717|FG010|Induction|Lost to Follow-up|0|||
105854650|NCT02883049|365121718|FG011|Induction|Lost to Follow-up|0|||
105854651|NCT02883049|365121719|FG012|Induction|Lost to Follow-up|0|||
105854652|NCT02883049|365121720|FG013|Induction|Lost to Follow-up|0|||
105854653|NCT02883049|365121721|FG014|Induction|Lost to Follow-up|0|||
105854654|NCT02883049|365121722|FG015|Induction|Lost to Follow-up|0|||
105854655|NCT02883049|365121707|FG000|Induction|Physician Decision|1407|||
105854656|NCT02883049|365121708|FG001|Induction|Physician Decision|8|||
105854657|NCT02883049|365121709|FG002|Induction|Physician Decision|0|||
105854658|NCT02883049|365121710|FG003|Induction|Physician Decision|0|||
105854659|NCT02883049|365121711|FG004|Induction|Physician Decision|0|||
105854660|NCT02883049|365121712|FG005|Induction|Physician Decision|0|||
105854661|NCT02883049|365121713|FG006|Induction|Physician Decision|0|||
105854662|NCT02883049|365121714|FG007|Induction|Physician Decision|0|||
105854663|NCT02883049|365121715|FG008|Induction|Physician Decision|0|||
105854664|NCT02883049|365121716|FG009|Induction|Physician Decision|0|||
105854665|NCT02883049|365121717|FG010|Induction|Physician Decision|0|||
105854666|NCT02883049|365121718|FG011|Induction|Physician Decision|0|||
105854667|NCT02883049|365121719|FG012|Induction|Physician Decision|0|||
105854668|NCT02883049|365121720|FG013|Induction|Physician Decision|0|||
105854669|NCT02883049|365121721|FG014|Induction|Physician Decision|0|||
105854670|NCT02883049|365121722|FG015|Induction|Physician Decision|0|||
105854671|NCT02883049|365121707|FG000|Induction|Protocol Violation|6|||
105854672|NCT02883049|365121708|FG001|Induction|Protocol Violation|0|||
105854673|NCT02883049|365121709|FG002|Induction|Protocol Violation|0|||
105854674|NCT02883049|365121710|FG003|Induction|Protocol Violation|0|||
105854675|NCT02883049|365121711|FG004|Induction|Protocol Violation|0|||
105854676|NCT02883049|365121712|FG005|Induction|Protocol Violation|0|||
105854677|NCT02883049|365121713|FG006|Induction|Protocol Violation|0|||
105374151|NCT01232283|363376346|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
105577161|NCT02855164|364112196|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
105577162|NCT02855164|364112197|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
105854678|NCT02883049|365121714|FG007|Induction|Protocol Violation|0|||
105854679|NCT02883049|365121715|FG008|Induction|Protocol Violation|0|||
105854680|NCT02883049|365121716|FG009|Induction|Protocol Violation|0|||
105854681|NCT02883049|365121717|FG010|Induction|Protocol Violation|0|||
105854682|NCT02883049|365121718|FG011|Induction|Protocol Violation|0|||
105854683|NCT02883049|365121719|FG012|Induction|Protocol Violation|0|||
105854684|NCT02883049|365121720|FG013|Induction|Protocol Violation|0|||
105854685|NCT02883049|365121721|FG014|Induction|Protocol Violation|0|||
105854686|NCT02883049|365121722|FG015|Induction|Protocol Violation|0|||
105854687|NCT02883049|365121707|FG000|Induction|Withdrawal by Subject|6|||
105854688|NCT02883049|365121708|FG001|Induction|Withdrawal by Subject|0|||
105854689|NCT02883049|365121709|FG002|Induction|Withdrawal by Subject|0|||
105854690|NCT02883049|365121710|FG003|Induction|Withdrawal by Subject|0|||
105854691|NCT02883049|365121711|FG004|Induction|Withdrawal by Subject|0|||
105854692|NCT02883049|365121712|FG005|Induction|Withdrawal by Subject|0|||
105854693|NCT02883049|365121713|FG006|Induction|Withdrawal by Subject|0|||
105854694|NCT02883049|365121714|FG007|Induction|Withdrawal by Subject|0|||
105854695|NCT02883049|365121715|FG008|Induction|Withdrawal by Subject|0|||
105327792|NCT03817853|363199555|FG001|Maintenance Phase|Progressive Disease|7|||
105327793|NCT03817853|363199556|FG002|Maintenance Phase|Progressive Disease|0|||
105327794|NCT03817853|363199554|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105327795|NCT03817853|363199555|FG001|Maintenance Phase|Withdrawal by Subject|2|||
105327796|NCT03817853|363199556|FG002|Maintenance Phase|Withdrawal by Subject|0|||
105327797|NCT03817853|363199554|FG000|Maintenance Phase|Physician Decision|0|||
105327798|NCT03817853|363199555|FG001|Maintenance Phase|Physician Decision|1|||
105327799|NCT03817853|363199556|FG002|Maintenance Phase|Physician Decision|0|||
105327800|NCT03817853|363199554|FG000|Maintenance Phase|Various reasons|0|||
105327801|NCT03817853|363199555|FG001|Maintenance Phase|Various reasons|4|||
105327802|NCT03817853|363199556|FG002|Maintenance Phase|Various reasons|0|||
105327803|NCT03817853|363199554|FG000|Maintenance Phase|Protocol Deviation|0|||
105327804|NCT03817853|363199555|FG001|Maintenance Phase|Protocol Deviation|1|||
105327805|NCT03817853|363199556|FG002|Maintenance Phase|Protocol Deviation|0|||
105327806|NCT03817853|363199554|FG000|Follow-up Phase|Adverse Event|0|||
105327807|NCT03817853|363199555|FG001|Follow-up Phase|Adverse Event|0|||
105327808|NCT03817853|363199556|FG002|Follow-up Phase|Adverse Event|2|||
105327809|NCT03817853|363199554|FG000|Follow-up Phase|Death|0|||
105327810|NCT03817853|363199555|FG001|Follow-up Phase|Death|0|||
105327811|NCT03817853|363199556|FG002|Follow-up Phase|Death|1|||
105327812|NCT03817853|363199554|FG000|Follow-up Phase|Progressive Disease|0|||
105327813|NCT03817853|363199555|FG001|Follow-up Phase|Progressive Disease|0|||
105327814|NCT03817853|363199556|FG002|Follow-up Phase|Progressive Disease|3|||
105327815|NCT03817853|363199554|FG000|Follow-up Phase|Withdrawal by Subject|0|||
105327816|NCT03817853|363199555|FG001|Follow-up Phase|Withdrawal by Subject|0|||
105327817|NCT03817853|363199556|FG002|Follow-up Phase|Withdrawal by Subject|1|||
105327818|NCT01293695|363199563|FG000|Overall Study|Withdrawal by Subject|7|||
105327819|NCT01293695|363199564|FG001|Overall Study|Withdrawal by Subject|1|||
105327820|NCT01293695|363199563|FG000|Overall Study|Lost to Follow-up|8|||
105327821|NCT01293695|363199564|FG001|Overall Study|Lost to Follow-up|6|||
105327822|NCT02570308|363199565|FG000|Overall Study|Death|1|||
105327823|NCT02570308|363199566|FG001|Overall Study|Death|5|||
105327824|NCT02570308|363199567|FG002|Overall Study|Death|4|||
105327825|NCT02570308|363199568|FG003|Overall Study|Death|4|||
105327826|NCT02570308|363199569|FG004|Overall Study|Death|69|||
105327827|NCT02570308|363199565|FG000|Overall Study|Lost to Follow-up|0|||
105327828|NCT02570308|363199566|FG001|Overall Study|Lost to Follow-up|0|||
105327829|NCT02570308|363199567|FG002|Overall Study|Lost to Follow-up|0|||
105327830|NCT02570308|363199568|FG003|Overall Study|Lost to Follow-up|0|||
105327831|NCT02570308|363199569|FG004|Overall Study|Lost to Follow-up|2|||
105327832|NCT02570308|363199565|FG000|Overall Study|Withdrawal by Subject|0|||
105327833|NCT02570308|363199566|FG001|Overall Study|Withdrawal by Subject|0|||
105327834|NCT02570308|363199567|FG002|Overall Study|Withdrawal by Subject|0|||
105327835|NCT02570308|363199568|FG003|Overall Study|Withdrawal by Subject|0|||
105327836|NCT02570308|363199569|FG004|Overall Study|Withdrawal by Subject|1|||
105327837|NCT02570308|363199565|FG000|Overall Study|Other|0|||
105327838|NCT02570308|363199566|FG001|Overall Study|Other|0|||
105327839|NCT02570308|363199567|FG002|Overall Study|Other|0|||
105327840|NCT02570308|363199568|FG003|Overall Study|Other|0|||
105327841|NCT02570308|363199569|FG004|Overall Study|Other|2|||
105374152|NCT01232283|363376347|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
105327842|NCT00314340|363199570|FG000|Overall Study|lost interest|1|||
105327843|NCT01620138|363199573|FG000|Overall Study|Withdrawal by Subject|3|||
105327844|NCT01620138|363199574|FG001|Overall Study|Withdrawal by Subject|0|||
105327845|NCT01620138|363199573|FG000|Overall Study|Lack of Efficacy|1|||
105327846|NCT01620138|363199574|FG001|Overall Study|Lack of Efficacy|0|||
105327847|NCT01620138|363199573|FG000|Overall Study|Adverse Event|2|||
105327848|NCT01620138|363199574|FG001|Overall Study|Adverse Event|0|||
105327849|NCT02069015|363199575|FG000|Overall Study|Lost to Follow-up|39|||
105327850|NCT02069015|363199576|FG001|Overall Study|Lost to Follow-up|32|||
105327851|NCT02069015|363199575|FG000|Overall Study|Withdrawal by Subject|1|||
105327852|NCT02069015|363199576|FG001|Overall Study|Withdrawal by Subject|1|||
105327853|NCT01082328|363199577|FG000|Overall Study|Adverse Event|1|||
105327854|NCT00791778|363199578|FG000|Double-blind Treatment|Adverse Event|49|||
105327855|NCT00791778|363199579|FG001|Double-blind Treatment|Adverse Event|9|||
105327856|NCT00791778|363199578|FG000|Double-blind Treatment|Physician Decision|6|||
105374153|NCT01232283|363376338|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105327857|NCT00791778|363199579|FG001|Double-blind Treatment|Physician Decision|26|||
105327858|NCT00791778|363199578|FG000|Double-blind Treatment|Protocol Violation|0|||
105374154|NCT01232283|363376339|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105327859|NCT00791778|363199579|FG001|Double-blind Treatment|Protocol Violation|4|||
105327860|NCT00791778|363199578|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
105327861|NCT00791778|363199579|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
105327862|NCT00791778|363199578|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
105327863|NCT00791778|363199579|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
105327864|NCT00791778|363199578|FG000|Follow-up|Withdrawal by Subject|3|||
105327865|NCT00791778|363199579|FG001|Follow-up|Withdrawal by Subject|0|||
105327866|NCT00791778|363199578|FG000|Follow-up|Lost to Follow-up|2|||
105374155|NCT01232283|363376340|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105374156|NCT01232283|363376341|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105374157|NCT01232283|363376342|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105374158|NCT01232283|363376343|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105374159|NCT01232283|363376344|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105374160|NCT01232283|363376345|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105374161|NCT01232283|363376346|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
105374162|NCT01232283|363376347|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
105374163|NCT01232283|363376338|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105374164|NCT01232283|363376339|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105374165|NCT01232283|363376340|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105374166|NCT01232283|363376341|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105374167|NCT01232283|363376342|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105374168|NCT01232283|363376343|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105374169|NCT01232283|363376344|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105374170|NCT01232283|363376345|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105374171|NCT01232283|363376346|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
105854696|NCT02883049|365121716|FG009|Induction|Withdrawal by Subject|0|||
105854697|NCT02883049|365121717|FG010|Induction|Withdrawal by Subject|0|||
105854698|NCT02883049|365121718|FG011|Induction|Withdrawal by Subject|0|||
105854699|NCT02883049|365121719|FG012|Induction|Withdrawal by Subject|0|||
105854700|NCT02883049|365121720|FG013|Induction|Withdrawal by Subject|0|||
105854701|NCT02883049|365121721|FG014|Induction|Withdrawal by Subject|0|||
105854702|NCT02883049|365121722|FG015|Induction|Withdrawal by Subject|0|||
105854703|NCT02883049|365121707|FG000|Induction|Ineligible|35|||
105854704|NCT02883049|365121708|FG001|Induction|Ineligible|1|||
105854705|NCT02883049|365121709|FG002|Induction|Ineligible|0|||
105854706|NCT02883049|365121710|FG003|Induction|Ineligible|0|||
105854707|NCT02883049|365121711|FG004|Induction|Ineligible|0|||
105854708|NCT02883049|365121712|FG005|Induction|Ineligible|0|||
105854709|NCT02883049|365121713|FG006|Induction|Ineligible|0|||
105854710|NCT02883049|365121714|FG007|Induction|Ineligible|0|||
105854711|NCT02883049|365121715|FG008|Induction|Ineligible|0|||
105854712|NCT02883049|365121716|FG009|Induction|Ineligible|0|||
105854713|NCT02883049|365121717|FG010|Induction|Ineligible|0|||
105854714|NCT02883049|365121718|FG011|Induction|Ineligible|0|||
105854715|NCT02883049|365121719|FG012|Induction|Ineligible|0|||
105854716|NCT02883049|365121720|FG013|Induction|Ineligible|0|||
105854717|NCT02883049|365121721|FG014|Induction|Ineligible|0|||
105854718|NCT02883049|365121722|FG015|Induction|Ineligible|0|||
105854719|NCT02883049|365121707|FG000|Induction|Refusal of further protocol therapy|466|||
105854720|NCT02883049|365121708|FG001|Induction|Refusal of further protocol therapy|2|||
105854721|NCT02883049|365121709|FG002|Induction|Refusal of further protocol therapy|0|||
105854722|NCT02883049|365121710|FG003|Induction|Refusal of further protocol therapy|0|||
105854723|NCT02883049|365121711|FG004|Induction|Refusal of further protocol therapy|0|||
105854724|NCT02883049|365121712|FG005|Induction|Refusal of further protocol therapy|0|||
105854725|NCT02883049|365121713|FG006|Induction|Refusal of further protocol therapy|0|||
105854726|NCT02883049|365121714|FG007|Induction|Refusal of further protocol therapy|0|||
105854727|NCT02883049|365121715|FG008|Induction|Refusal of further protocol therapy|0|||
105854728|NCT02883049|365121716|FG009|Induction|Refusal of further protocol therapy|0|||
105327867|NCT00791778|363199579|FG001|Follow-up|Lost to Follow-up|1|||
105327868|NCT00957801|363199582|FG000|Overall Study|Withdrawal by Subject|0|||
105327869|NCT00957801|363199583|FG001|Overall Study|Withdrawal by Subject|0|||
105327870|NCT00957801|363199584|FG002|Overall Study|Withdrawal by Subject|0|||
105327871|NCT00957801|363199585|FG003|Overall Study|Withdrawal by Subject|1|||
105327872|NCT02841995|363199590|FG000|Overall Study|Disease progression|5|||
105327873|NCT02841995|363199591|FG001|Overall Study|Disease progression|11|||
105327874|NCT02841995|363199592|FG002|Overall Study|Disease progression|8|||
105327875|NCT02841995|363199590|FG000|Overall Study|Withdrawal by Subject|2|||
105327876|NCT02841995|363199591|FG001|Overall Study|Withdrawal by Subject|4|||
105327877|NCT02841995|363199592|FG002|Overall Study|Withdrawal by Subject|4|||
105327878|NCT02841995|363199590|FG000|Overall Study|Adverse Event|2|||
105327879|NCT02841995|363199591|FG001|Overall Study|Adverse Event|0|||
105327880|NCT02841995|363199592|FG002|Overall Study|Adverse Event|1|||
105327881|NCT02841995|363199590|FG000|Overall Study|Investigator decision|2|||
105327882|NCT02841995|363199591|FG001|Overall Study|Investigator decision|0|||
105327883|NCT02841995|363199592|FG002|Overall Study|Investigator decision|1|||
105327884|NCT02841995|363199590|FG000|Overall Study|Death|0|||
105327885|NCT02841995|363199591|FG001|Overall Study|Death|0|||
105327886|NCT02841995|363199592|FG002|Overall Study|Death|2|||
105327887|NCT02841995|363199590|FG000|Overall Study|Noncompliance to protocol|1|||
105327888|NCT02841995|363199591|FG001|Overall Study|Noncompliance to protocol|0|||
105327889|NCT02841995|363199592|FG002|Overall Study|Noncompliance to protocol|0|||
105327890|NCT02841995|363199590|FG000|Overall Study|Sponsor decision|1|||
105327891|NCT02841995|363199591|FG001|Overall Study|Sponsor decision|0|||
105854729|NCT02883049|365121717|FG010|Induction|Refusal of further protocol therapy|0|||
105854730|NCT02883049|365121718|FG011|Induction|Refusal of further protocol therapy|0|||
105854731|NCT02883049|365121719|FG012|Induction|Refusal of further protocol therapy|0|||
105854732|NCT02883049|365121720|FG013|Induction|Refusal of further protocol therapy|0|||
105854733|NCT02883049|365121721|FG014|Induction|Refusal of further protocol therapy|0|||
105854734|NCT02883049|365121722|FG015|Induction|Refusal of further protocol therapy|0|||
105854735|NCT02883049|365121707|FG000|Induction|Identified as Ph+ patients|279|||
105854736|NCT02883049|365121708|FG001|Induction|Identified as Ph+ patients|1|||
105854737|NCT02883049|365121709|FG002|Induction|Identified as Ph+ patients|0|||
105854738|NCT02883049|365121710|FG003|Induction|Identified as Ph+ patients|0|||
105854739|NCT02883049|365121711|FG004|Induction|Identified as Ph+ patients|0|||
105854740|NCT02883049|365121712|FG005|Induction|Identified as Ph+ patients|0|||
105854741|NCT02883049|365121713|FG006|Induction|Identified as Ph+ patients|0|||
105854742|NCT02883049|365121714|FG007|Induction|Identified as Ph+ patients|0|||
105854743|NCT02883049|365121715|FG008|Induction|Identified as Ph+ patients|0|||
105854744|NCT02883049|365121716|FG009|Induction|Identified as Ph+ patients|0|||
105854745|NCT02883049|365121717|FG010|Induction|Identified as Ph+ patients|0|||
105854746|NCT02883049|365121718|FG011|Induction|Identified as Ph+ patients|0|||
105854747|NCT02883049|365121719|FG012|Induction|Identified as Ph+ patients|0|||
105854748|NCT02883049|365121720|FG013|Induction|Identified as Ph+ patients|0|||
105854749|NCT02883049|365121721|FG014|Induction|Identified as Ph+ patients|0|||
105854750|NCT02883049|365121722|FG015|Induction|Identified as Ph+ patients|0|||
105854751|NCT02883049|365121707|FG000|Induction|M3 Marrow at Day29|8|||
105854752|NCT02883049|365121708|FG001|Induction|M3 Marrow at Day29|1|||
105854753|NCT02883049|365121709|FG002|Induction|M3 Marrow at Day29|0|||
105854754|NCT02883049|365121710|FG003|Induction|M3 Marrow at Day29|0|||
105854755|NCT02883049|365121711|FG004|Induction|M3 Marrow at Day29|0|||
105854756|NCT02883049|365121712|FG005|Induction|M3 Marrow at Day29|0|||
105854757|NCT02883049|365121713|FG006|Induction|M3 Marrow at Day29|0|||
105854758|NCT02883049|365121714|FG007|Induction|M3 Marrow at Day29|0|||
105854759|NCT02883049|365121715|FG008|Induction|M3 Marrow at Day29|0|||
105854760|NCT02883049|365121716|FG009|Induction|M3 Marrow at Day29|0|||
105854761|NCT02883049|365121717|FG010|Induction|M3 Marrow at Day29|0|||
105854762|NCT02883049|365121718|FG011|Induction|M3 Marrow at Day29|0|||
105854763|NCT02883049|365121719|FG012|Induction|M3 Marrow at Day29|0|||
105854764|NCT02883049|365121720|FG013|Induction|M3 Marrow at Day29|0|||
105854765|NCT02883049|365121721|FG014|Induction|M3 Marrow at Day29|0|||
105854766|NCT02883049|365121722|FG015|Induction|M3 Marrow at Day29|0|||
105854767|NCT02883049|365121707|FG000|Induction|Inevaluable|33|||
105854768|NCT02883049|365121708|FG001|Induction|Inevaluable|1|||
105854769|NCT02883049|365121709|FG002|Induction|Inevaluable|0|||
105854770|NCT02883049|365121710|FG003|Induction|Inevaluable|0|||
105854771|NCT02883049|365121711|FG004|Induction|Inevaluable|0|||
105854772|NCT02883049|365121712|FG005|Induction|Inevaluable|0|||
105854773|NCT02883049|365121713|FG006|Induction|Inevaluable|0|||
105854774|NCT02883049|365121714|FG007|Induction|Inevaluable|0|||
105854775|NCT02883049|365121715|FG008|Induction|Inevaluable|0|||
105854776|NCT02883049|365121716|FG009|Induction|Inevaluable|0|||
105854777|NCT02883049|365121717|FG010|Induction|Inevaluable|0|||
105854778|NCT02883049|365121718|FG011|Induction|Inevaluable|0|||
105854779|NCT02883049|365121719|FG012|Induction|Inevaluable|0|||
105854780|NCT02883049|365121720|FG013|Induction|Inevaluable|0|||
105854781|NCT02883049|365121721|FG014|Induction|Inevaluable|0|||
105854782|NCT02883049|365121722|FG015|Induction|Inevaluable|0|||
105854783|NCT02883049|365121707|FG000|Induction|Identified as VHR at end of Induction|244|||
105854784|NCT02883049|365121708|FG001|Induction|Identified as VHR at end of Induction|0|||
105854785|NCT02883049|365121709|FG002|Induction|Identified as VHR at end of Induction|0|||
105854786|NCT02883049|365121710|FG003|Induction|Identified as VHR at end of Induction|0|||
105854787|NCT02883049|365121711|FG004|Induction|Identified as VHR at end of Induction|0|||
105854788|NCT02883049|365121712|FG005|Induction|Identified as VHR at end of Induction|0|||
105854789|NCT02883049|365121713|FG006|Induction|Identified as VHR at end of Induction|0|||
105854790|NCT02883049|365121714|FG007|Induction|Identified as VHR at end of Induction|0|||
105854791|NCT02883049|365121715|FG008|Induction|Identified as VHR at end of Induction|0|||
105854792|NCT02883049|365121716|FG009|Induction|Identified as VHR at end of Induction|0|||
105854793|NCT02883049|365121717|FG010|Induction|Identified as VHR at end of Induction|0|||
105854794|NCT02883049|365121718|FG011|Induction|Identified as VHR at end of Induction|0|||
105854795|NCT02883049|365121719|FG012|Induction|Identified as VHR at end of Induction|0|||
105854796|NCT02883049|365121720|FG013|Induction|Identified as VHR at end of Induction|0|||
105854797|NCT02883049|365121721|FG014|Induction|Identified as VHR at end of Induction|0|||
105854798|NCT02883049|365121722|FG015|Induction|Identified as VHR at end of Induction|0|||
105854799|NCT02883049|365121707|FG000|Induction|Moved to another non-COG institution|3|||
105854800|NCT02883049|365121708|FG001|Induction|Moved to another non-COG institution|0|||
105854801|NCT02883049|365121709|FG002|Induction|Moved to another non-COG institution|0|||
105854802|NCT02883049|365121710|FG003|Induction|Moved to another non-COG institution|0|||
105854803|NCT02883049|365121711|FG004|Induction|Moved to another non-COG institution|0|||
105854804|NCT02883049|365121712|FG005|Induction|Moved to another non-COG institution|0|||
105854805|NCT02883049|365121713|FG006|Induction|Moved to another non-COG institution|0|||
105327892|NCT02841995|363199592|FG002|Overall Study|Sponsor decision|0|||
105327893|NCT02841995|363199590|FG000|Overall Study|Other|4|||
105327894|NCT02841995|363199591|FG001|Overall Study|Other|1|||
105327895|NCT02841995|363199592|FG002|Overall Study|Other|5|||
105327896|NCT00630825|363199593|FG000|Overall Study|Adverse Event|4|||
105327897|NCT00630825|363199594|FG001|Overall Study|Adverse Event|4|||
105327898|NCT00630825|363199595|FG002|Overall Study|Adverse Event|3|||
105327899|NCT00630825|363199596|FG003|Overall Study|Adverse Event|1|||
105327900|NCT00630825|363199593|FG000|Overall Study|Entry Criteria Not Met|1|||
105327901|NCT00630825|363199594|FG001|Overall Study|Entry Criteria Not Met|0|||
105327902|NCT00630825|363199595|FG002|Overall Study|Entry Criteria Not Met|2|||
105327903|NCT00630825|363199596|FG003|Overall Study|Entry Criteria Not Met|1|||
105327904|NCT00630825|363199593|FG000|Overall Study|Lost to Follow-up|1|||
105327905|NCT00630825|363199594|FG001|Overall Study|Lost to Follow-up|1|||
105327906|NCT00630825|363199595|FG002|Overall Study|Lost to Follow-up|1|||
105327907|NCT00630825|363199596|FG003|Overall Study|Lost to Follow-up|1|||
105327908|NCT00630825|363199593|FG000|Overall Study|Physician Decision|1|||
105327909|NCT00630825|363199594|FG001|Overall Study|Physician Decision|0|||
105327910|NCT00630825|363199595|FG002|Overall Study|Physician Decision|0|||
105327911|NCT00630825|363199596|FG003|Overall Study|Physician Decision|0|||
105327912|NCT00630825|363199593|FG000|Overall Study|Withdrawal by Subject|2|||
105327913|NCT00630825|363199594|FG001|Overall Study|Withdrawal by Subject|2|||
105327914|NCT00630825|363199595|FG002|Overall Study|Withdrawal by Subject|2|||
105327915|NCT00630825|363199596|FG003|Overall Study|Withdrawal by Subject|3|||
105327916|NCT02042014|363199597|FG000|Overall Study|Adverse Event|1|||
105327917|NCT02042014|363199597|FG000|Overall Study|Physician Decision|7|||
105327918|NCT03762265|363199598|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
105327919|NCT03762265|363199599|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
105327920|NCT03762265|363199598|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
105327921|NCT03762265|363199599|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
105327922|NCT03762265|363199598|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
105327923|NCT03762265|363199599|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
105327924|NCT03762265|363199598|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
105327925|NCT03762265|363199599|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
105327926|NCT03762265|363199598|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
105327927|NCT03762265|363199599|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
105327928|NCT03762265|363199598|FG000|BT Period: Weeks 1 to 37|Other|0|||
105327929|NCT03762265|363199599|FG001|BT Period: Weeks 1 to 37|Other|1|||
105327930|NCT03762265|363199598|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
105327931|NCT03762265|363199599|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
105327932|NCT03762265|363199598|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
105327933|NCT03762265|363199599|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
105327934|NCT03762265|363199598|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
105327935|NCT03762265|363199599|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
105327936|NCT03762265|363199598|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
105327937|NCT03762265|363199599|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
105327938|NCT03762265|363199598|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
105327939|NCT03762265|363199599|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
105327940|NCT03762265|363199598|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
105327941|NCT03762265|363199599|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
105327942|NCT03762265|363199598|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
105327943|NCT03762265|363199599|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
105327944|NCT03762265|363199598|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
105327945|NCT03762265|363199599|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
105327946|NCT03762265|363199598|FG000|LTE Period: Weeks 61 to 109|Other|1|||
105327947|NCT03762265|363199599|FG001|LTE Period: Weeks 61 to 109|Other|0|||
105327948|NCT00226499|363199609|FG000|Overall Study|Adverse Event|10|||
105327949|NCT00226499|363199610|FG001|Overall Study|Adverse Event|6|||
105327950|NCT00226499|363199611|FG002|Overall Study|Adverse Event|3|||
105327951|NCT00226499|363199609|FG000|Overall Study|Others|1064|||
105327952|NCT00226499|363199610|FG001|Overall Study|Others|1066|||
105327953|NCT00226499|363199611|FG002|Overall Study|Others|356|||
105327954|NCT03644342|363199613|FG000|Overall Study|Adverse Event|2|||
105327955|NCT03644342|363199614|FG001|Overall Study|Adverse Event|0|||
105327956|NCT03644342|363199613|FG000|Overall Study|Protocol Violation|0|||
105327957|NCT03644342|363199614|FG001|Overall Study|Protocol Violation|1|||
105327958|NCT00359424|363199615|FG000|Overall Study|Death|99|||
105327959|NCT00359424|363199616|FG001|Overall Study|Death|58|||
105327960|NCT00359424|363199615|FG000|Overall Study|Lost to Follow-up|19|||
105327961|NCT00359424|363199616|FG001|Overall Study|Lost to Follow-up|7|||
105327962|NCT00359424|363199615|FG000|Overall Study|Withdrawal by Subject|10|||
105327963|NCT00359424|363199616|FG001|Overall Study|Withdrawal by Subject|2|||
105327964|NCT00359424|363199615|FG000|Overall Study|follow up not conducted|2|||
105327965|NCT00359424|363199616|FG001|Overall Study|follow up not conducted|0|||
105327966|NCT03194542|363199617|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
105327967|NCT03194542|363199618|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
105854806|NCT02883049|365121714|FG007|Induction|Moved to another non-COG institution|0|||
105854807|NCT02883049|365121715|FG008|Induction|Moved to another non-COG institution|0|||
105854808|NCT02883049|365121716|FG009|Induction|Moved to another non-COG institution|0|||
105854809|NCT02883049|365121717|FG010|Induction|Moved to another non-COG institution|0|||
105854810|NCT02883049|365121718|FG011|Induction|Moved to another non-COG institution|0|||
105854811|NCT02883049|365121719|FG012|Induction|Moved to another non-COG institution|0|||
105854812|NCT02883049|365121720|FG013|Induction|Moved to another non-COG institution|0|||
105854813|NCT02883049|365121721|FG014|Induction|Moved to another non-COG institution|0|||
105854814|NCT02883049|365121722|FG015|Induction|Moved to another non-COG institution|0|||
105854815|NCT02883049|365121707|FG000|Induction|Randomization closed|41|||
105854816|NCT02883049|365121708|FG001|Induction|Randomization closed|0|||
105854817|NCT02883049|365121709|FG002|Induction|Randomization closed|0|||
105854818|NCT02883049|365121710|FG003|Induction|Randomization closed|0|||
105854819|NCT02883049|365121711|FG004|Induction|Randomization closed|0|||
105854820|NCT02883049|365121712|FG005|Induction|Randomization closed|0|||
105854821|NCT02883049|365121713|FG006|Induction|Randomization closed|0|||
105854822|NCT02883049|365121714|FG007|Induction|Randomization closed|0|||
105327968|NCT03194542|363199619|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
105327969|NCT03194542|363199620|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
105327970|NCT03194542|363199617|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
105327971|NCT03194542|363199618|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
105327972|NCT03194542|363199619|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
105327973|NCT03194542|363199620|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
105327974|NCT03194542|363199617|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
105327975|NCT03194542|363199618|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
105327976|NCT03194542|363199619|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
105327977|NCT03194542|363199620|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
105327978|NCT03194542|363199617|FG000|Overall Study|Loss of Response|4|||
105327979|NCT03194542|363199618|FG001|Overall Study|Loss of Response|2|||
105327980|NCT03194542|363199619|FG002|Overall Study|Loss of Response|3|||
105327981|NCT03194542|363199620|FG003|Overall Study|Loss of Response|4|||
105327982|NCT03194542|363199617|FG000|Overall Study|Physician Decision|0|||
105327983|NCT03194542|363199618|FG001|Overall Study|Physician Decision|1|||
105327984|NCT03194542|363199619|FG002|Overall Study|Physician Decision|0|||
105327985|NCT03194542|363199620|FG003|Overall Study|Physician Decision|0|||
105327986|NCT03194542|363199617|FG000|Overall Study|Lack of Efficacy|2|||
105327987|NCT03194542|363199618|FG001|Overall Study|Lack of Efficacy|2|||
105327988|NCT03194542|363199619|FG002|Overall Study|Lack of Efficacy|2|||
105327989|NCT03194542|363199620|FG003|Overall Study|Lack of Efficacy|6|||
105327990|NCT03194542|363199617|FG000|Overall Study|Withdrawal by Subject|2|||
105327991|NCT03194542|363199618|FG001|Overall Study|Withdrawal by Subject|1|||
105327992|NCT03194542|363199619|FG002|Overall Study|Withdrawal by Subject|5|||
105327993|NCT03194542|363199620|FG003|Overall Study|Withdrawal by Subject|4|||
105327994|NCT03194542|363199617|FG000|Overall Study|Progressive Disease|1|||
105327995|NCT03194542|363199618|FG001|Overall Study|Progressive Disease|0|||
105327996|NCT03194542|363199619|FG002|Overall Study|Progressive Disease|1|||
105327997|NCT03194542|363199620|FG003|Overall Study|Progressive Disease|1|||
105327998|NCT03194542|363199617|FG000|Overall Study|Adverse Event|1|||
105327999|NCT03194542|363199618|FG001|Overall Study|Adverse Event|2|||
105328000|NCT03194542|363199619|FG002|Overall Study|Adverse Event|0|||
105328001|NCT03194542|363199620|FG003|Overall Study|Adverse Event|5|||
105328002|NCT03194542|363199617|FG000|Overall Study|Death|1|||
105328003|NCT03194542|363199618|FG001|Overall Study|Death|2|||
105328004|NCT03194542|363199619|FG002|Overall Study|Death|0|||
105328005|NCT03194542|363199620|FG003|Overall Study|Death|5|||
105328006|NCT03194542|363199617|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
105328007|NCT03194542|363199618|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
105328008|NCT03194542|363199619|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
105328009|NCT03194542|363199620|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
105328010|NCT01662492|363199621|FG000|Overall Study|Other miscellaneous reasons.|1|||
105328011|NCT01662492|363199622|FG001|Overall Study|Other miscellaneous reasons.|0|||
105328012|NCT01662492|363199623|FG002|Overall Study|Other miscellaneous reasons.|1|||
105328013|NCT01662492|363199621|FG000|Overall Study|Withdrawal by Subject|0|||
105328014|NCT01662492|363199622|FG001|Overall Study|Withdrawal by Subject|0|||
105328015|NCT01662492|363199623|FG002|Overall Study|Withdrawal by Subject|1|||
105328016|NCT01662492|363199621|FG000|Overall Study|Protocol Violation|1|||
105328017|NCT01662492|363199622|FG001|Overall Study|Protocol Violation|0|||
105328018|NCT01662492|363199623|FG002|Overall Study|Protocol Violation|0|||
105328019|NCT01662492|363199621|FG000|Overall Study|Lost to Follow-up|0|||
105328020|NCT01662492|363199622|FG001|Overall Study|Lost to Follow-up|0|||
105328021|NCT01662492|363199623|FG002|Overall Study|Lost to Follow-up|2|||
105854823|NCT02883049|365121715|FG008|Induction|Randomization closed|0|||
105854824|NCT02883049|365121716|FG009|Induction|Randomization closed|0|||
105854825|NCT02883049|365121717|FG010|Induction|Randomization closed|0|||
105854826|NCT02883049|365121718|FG011|Induction|Randomization closed|0|||
105854827|NCT02883049|365121719|FG012|Induction|Randomization closed|0|||
105854828|NCT02883049|365121720|FG013|Induction|Randomization closed|0|||
105854829|NCT02883049|365121721|FG014|Induction|Randomization closed|0|||
105854830|NCT02883049|365121722|FG015|Induction|Randomization closed|0|||
105854831|NCT02883049|365121707|FG000|Induction|MRD negative|36|||
105854832|NCT02883049|365121708|FG001|Induction|MRD negative|0|||
105854833|NCT02883049|365121709|FG002|Induction|MRD negative|0|||
105854834|NCT02883049|365121710|FG003|Induction|MRD negative|0|||
105854835|NCT02883049|365121711|FG004|Induction|MRD negative|0|||
105854836|NCT02883049|365121712|FG005|Induction|MRD negative|0|||
105854837|NCT02883049|365121713|FG006|Induction|MRD negative|0|||
105854838|NCT02883049|365121714|FG007|Induction|MRD negative|0|||
105854839|NCT02883049|365121715|FG008|Induction|MRD negative|0|||
105854840|NCT02883049|365121716|FG009|Induction|MRD negative|0|||
105854841|NCT02883049|365121717|FG010|Induction|MRD negative|0|||
105854842|NCT02883049|365121718|FG011|Induction|MRD negative|0|||
105854843|NCT02883049|365121719|FG012|Induction|MRD negative|0|||
105854844|NCT02883049|365121720|FG013|Induction|MRD negative|0|||
105854845|NCT02883049|365121721|FG014|Induction|MRD negative|0|||
105854846|NCT02883049|365121722|FG015|Induction|MRD negative|0|||
105854847|NCT02883049|365121707|FG000|Induction|Identified as HR patients|165|||
105854848|NCT02883049|365121708|FG001|Induction|Identified as HR patients|0|||
105854849|NCT02883049|365121709|FG002|Induction|Identified as HR patients|0|||
105854850|NCT02883049|365121710|FG003|Induction|Identified as HR patients|0|||
105854851|NCT02883049|365121711|FG004|Induction|Identified as HR patients|0|||
105854852|NCT02883049|365121712|FG005|Induction|Identified as HR patients|0|||
105854853|NCT02883049|365121713|FG006|Induction|Identified as HR patients|0|||
105854854|NCT02883049|365121714|FG007|Induction|Identified as HR patients|0|||
105854855|NCT02883049|365121715|FG008|Induction|Identified as HR patients|0|||
105854856|NCT02883049|365121716|FG009|Induction|Identified as HR patients|0|||
105854857|NCT02883049|365121717|FG010|Induction|Identified as HR patients|0|||
105854858|NCT02883049|365121718|FG011|Induction|Identified as HR patients|0|||
105854859|NCT02883049|365121719|FG012|Induction|Identified as HR patients|0|||
105854860|NCT02883049|365121720|FG013|Induction|Identified as HR patients|0|||
105854861|NCT02883049|365121721|FG014|Induction|Identified as HR patients|0|||
105854862|NCT02883049|365121722|FG015|Induction|Identified as HR patients|0|||
105854863|NCT02883049|365121707|FG000|Induction|Developed SMN|0|||
105854864|NCT02883049|365121708|FG001|Induction|Developed SMN|1|||
105854865|NCT02883049|365121709|FG002|Induction|Developed SMN|0|||
105854866|NCT02883049|365121710|FG003|Induction|Developed SMN|0|||
105854867|NCT02883049|365121711|FG004|Induction|Developed SMN|0|||
105854868|NCT02883049|365121712|FG005|Induction|Developed SMN|0|||
105854869|NCT02883049|365121713|FG006|Induction|Developed SMN|0|||
105854870|NCT02883049|365121714|FG007|Induction|Developed SMN|0|||
105854871|NCT02883049|365121715|FG008|Induction|Developed SMN|0|||
105854872|NCT02883049|365121716|FG009|Induction|Developed SMN|0|||
105854873|NCT02883049|365121717|FG010|Induction|Developed SMN|0|||
105854874|NCT02883049|365121718|FG011|Induction|Developed SMN|0|||
105854875|NCT02883049|365121719|FG012|Induction|Developed SMN|0|||
105854876|NCT02883049|365121720|FG013|Induction|Developed SMN|0|||
105854877|NCT02883049|365121721|FG014|Induction|Developed SMN|0|||
105854878|NCT02883049|365121722|FG015|Induction|Developed SMN|0|||
105854879|NCT02883049|365121707|FG000|Induction|Enrolled onto another COG study|72|||
105854880|NCT02883049|365121708|FG001|Induction|Enrolled onto another COG study|0|||
105854881|NCT02883049|365121709|FG002|Induction|Enrolled onto another COG study|0|||
105854882|NCT02883049|365121710|FG003|Induction|Enrolled onto another COG study|0|||
105854883|NCT02883049|365121711|FG004|Induction|Enrolled onto another COG study|0|||
105854884|NCT02883049|365121712|FG005|Induction|Enrolled onto another COG study|0|||
105854885|NCT02883049|365121713|FG006|Induction|Enrolled onto another COG study|0|||
105854886|NCT02883049|365121714|FG007|Induction|Enrolled onto another COG study|0|||
105328022|NCT01662492|363199621|FG000|Overall Study|Lack of Efficacy|1|||
105328023|NCT01662492|363199622|FG001|Overall Study|Lack of Efficacy|1|||
105328024|NCT01662492|363199623|FG002|Overall Study|Lack of Efficacy|2|||
105328025|NCT00318474|363200716|FG000|Overall Study|Adverse Event|1|||
105328026|NCT00318474|363200717|FG001|Overall Study|Adverse Event|1|||
105854887|NCT02883049|365121715|FG008|Induction|Enrolled onto another COG study|0|||
105854888|NCT02883049|365121716|FG009|Induction|Enrolled onto another COG study|0|||
105854889|NCT02883049|365121717|FG010|Induction|Enrolled onto another COG study|0|||
105854890|NCT02883049|365121718|FG011|Induction|Enrolled onto another COG study|0|||
105854891|NCT02883049|365121719|FG012|Induction|Enrolled onto another COG study|0|||
105854892|NCT02883049|365121720|FG013|Induction|Enrolled onto another COG study|0|||
105328027|NCT00318474|363200716|FG000|Overall Study|Lost to Follow-up|0|||
105328028|NCT00318474|363200717|FG001|Overall Study|Lost to Follow-up|1|||
105854893|NCT02883049|365121721|FG014|Induction|Enrolled onto another COG study|0|||
105854894|NCT02883049|365121722|FG015|Induction|Enrolled onto another COG study|0|||
105854895|NCT02883049|365121707|FG000|Induction|Incomplete induction data|17|||
105854896|NCT02883049|365121708|FG001|Induction|Incomplete induction data|0|||
105854897|NCT02883049|365121709|FG002|Induction|Incomplete induction data|0|||
105854898|NCT02883049|365121710|FG003|Induction|Incomplete induction data|0|||
105854899|NCT02883049|365121711|FG004|Induction|Incomplete induction data|0|||
105328029|NCT00318474|363200716|FG000|Overall Study|Pregnancy|0|||
105328030|NCT00318474|363200717|FG001|Overall Study|Pregnancy|2|||
105328031|NCT00318474|363200716|FG000|Overall Study|Protocol Violation|1|||
105328032|NCT00318474|363200717|FG001|Overall Study|Protocol Violation|0|||
105328033|NCT00318474|363200716|FG000|Overall Study|Withdrawal by Subject|3|||
105328034|NCT00318474|363200717|FG001|Overall Study|Withdrawal by Subject|2|||
105328035|NCT00318474|363200716|FG000|Overall Study|Fall in GFR|3|||
105328036|NCT00318474|363200717|FG001|Overall Study|Fall in GFR|3|||
105328037|NCT00318474|363200716|FG000|Overall Study|Post-therapy hyperflycemia|0|||
105328038|NCT00318474|363200717|FG001|Overall Study|Post-therapy hyperflycemia|1|||
105328039|NCT00318474|363200716|FG000|Overall Study|Trial terminated|10|||
105328040|NCT00318474|363200717|FG001|Overall Study|Trial terminated|7|||
105328041|NCT01611935|363200718|FG000|Overall Study|Family Declined Participation|1|||
105328042|NCT01611935|363200719|FG001|Overall Study|Family Declined Participation|0|||
105328043|NCT00570141|363200720|FG000|Overall Study|Adverse Event|1|||
105328044|NCT00570141|363200720|FG000|Overall Study|Missed visits|1|||
105328045|NCT00570141|363200720|FG000|Overall Study|Lost to Follow-up|1|||
105328046|NCT00712712|363200724|FG000|Overall Study|Protocol Violation|11|||
105328047|NCT00712712|363200724|FG000|Overall Study|Radiofrequency not done|3|||
105328048|NCT00712712|363200724|FG000|Overall Study|Death|8|||
105328049|NCT00712712|363200724|FG000|Overall Study|Withdrawal by Subject|1|||
105328050|NCT02044302|363200725|FG000|Overall Study|study terminated|2|||
105328051|NCT02044302|363200726|FG001|Overall Study|study terminated|0|||
105328052|NCT03207815|363200731|FG000|Overall Study|Protocol Violation|3|||
105328053|NCT03207815|363200732|FG001|Overall Study|Protocol Violation|1|||
105328054|NCT03207815|363200731|FG000|Overall Study|Adverse Event|1|||
105328055|NCT03207815|363200732|FG001|Overall Study|Adverse Event|2|||
105328056|NCT03207815|363200731|FG000|Overall Study|Lost to Follow-up|1|||
105328057|NCT03207815|363200732|FG001|Overall Study|Lost to Follow-up|2|||
105328058|NCT03207815|363200731|FG000|Overall Study|Investigator's Discretion|1|||
105328059|NCT03207815|363200732|FG001|Overall Study|Investigator's Discretion|1|||
105328060|NCT03207815|363200731|FG000|Overall Study|Lack of Efficacy|0|||
105328061|NCT03207815|363200732|FG001|Overall Study|Lack of Efficacy|1|||
105328062|NCT03207815|363200731|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
105328063|NCT03207815|363200732|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
105328064|NCT03207815|363200731|FG000|Overall Study|Withdrew Consent|1|||
105328065|NCT03207815|363200732|FG001|Overall Study|Withdrew Consent|0|||
105328066|NCT01671007|363200733|FG000|Overall Study|Other reasons than listed|166|||
105328067|NCT01671007|363200734|FG001|Overall Study|Other reasons than listed|373|||
105328068|NCT01671007|363200735|FG002|Overall Study|Other reasons than listed|197|||
105328069|NCT01671007|363200736|FG003|Overall Study|Other reasons than listed|228|||
105328070|NCT01671007|363200737|FG004|Overall Study|Other reasons than listed|14|||
105328071|NCT01671007|363200738|FG005|Overall Study|Other reasons than listed|71|||
105328072|NCT01671007|363200739|FG006|Overall Study|Other reasons than listed|17|||
105328073|NCT01671007|363200740|FG007|Overall Study|Other reasons than listed|66|||
105328074|NCT01671007|363200741|FG008|Overall Study|Other reasons than listed|0|||
105328075|NCT01671007|363200733|FG000|Overall Study|Withdrawal by Subject|36|||
105328076|NCT01671007|363200734|FG001|Overall Study|Withdrawal by Subject|59|||
105328077|NCT01671007|363200735|FG002|Overall Study|Withdrawal by Subject|53|||
105328078|NCT01671007|363200736|FG003|Overall Study|Withdrawal by Subject|58|||
105328079|NCT01671007|363200737|FG004|Overall Study|Withdrawal by Subject|4|||
105328080|NCT01671007|363200738|FG005|Overall Study|Withdrawal by Subject|15|||
105328081|NCT01671007|363200739|FG006|Overall Study|Withdrawal by Subject|1|||
105328082|NCT01671007|363200740|FG007|Overall Study|Withdrawal by Subject|19|||
105328083|NCT01671007|363200741|FG008|Overall Study|Withdrawal by Subject|0|||
105328084|NCT01671007|363200733|FG000|Overall Study|Lost to Follow-up|93|||
105328085|NCT01671007|363200734|FG001|Overall Study|Lost to Follow-up|142|||
105328086|NCT01671007|363200735|FG002|Overall Study|Lost to Follow-up|91|||
105328087|NCT01671007|363200736|FG003|Overall Study|Lost to Follow-up|63|||
105328088|NCT01671007|363200737|FG004|Overall Study|Lost to Follow-up|7|||
105328089|NCT01671007|363200738|FG005|Overall Study|Lost to Follow-up|20|||
105328090|NCT01671007|363200739|FG006|Overall Study|Lost to Follow-up|2|||
105328091|NCT01671007|363200740|FG007|Overall Study|Lost to Follow-up|28|||
105328092|NCT01671007|363200741|FG008|Overall Study|Lost to Follow-up|0|||
105328093|NCT01671007|363200733|FG000|Overall Study|No end of study case report form|3|||
105328094|NCT01671007|363200734|FG001|Overall Study|No end of study case report form|1|||
105328095|NCT01671007|363200735|FG002|Overall Study|No end of study case report form|0|||
105328096|NCT01671007|363200736|FG003|Overall Study|No end of study case report form|2|||
105328097|NCT01671007|363200737|FG004|Overall Study|No end of study case report form|0|||
105328098|NCT01671007|363200738|FG005|Overall Study|No end of study case report form|0|||
105328099|NCT01671007|363200739|FG006|Overall Study|No end of study case report form|0|||
105328100|NCT01671007|363200740|FG007|Overall Study|No end of study case report form|0|||
105328101|NCT01671007|363200741|FG008|Overall Study|No end of study case report form|0|||
105328102|NCT01671007|363200733|FG000|Overall Study|Not eligible|23|||
105328103|NCT01671007|363200734|FG001|Overall Study|Not eligible|76|||
105328104|NCT01671007|363200735|FG002|Overall Study|Not eligible|25|||
105328105|NCT01671007|363200736|FG003|Overall Study|Not eligible|17|||
105328106|NCT01671007|363200737|FG004|Overall Study|Not eligible|0|||
105854900|NCT02883049|365121712|FG005|Induction|Incomplete induction data|0|||
105854901|NCT02883049|365121713|FG006|Induction|Incomplete induction data|0|||
105854902|NCT02883049|365121714|FG007|Induction|Incomplete induction data|0|||
105854903|NCT02883049|365121715|FG008|Induction|Incomplete induction data|0|||
105854904|NCT02883049|365121716|FG009|Induction|Incomplete induction data|0|||
105854905|NCT02883049|365121717|FG010|Induction|Incomplete induction data|0|||
105854906|NCT02883049|365121718|FG011|Induction|Incomplete induction data|0|||
105328107|NCT01671007|363200738|FG005|Overall Study|Not eligible|6|||
105328108|NCT01671007|363200739|FG006|Overall Study|Not eligible|1|||
105328109|NCT01671007|363200740|FG007|Overall Study|Not eligible|19|||
105328110|NCT01671007|363200741|FG008|Overall Study|Not eligible|0|||
105328111|NCT01286467|363200742|FG000|Overall Study|Death|1|||
105328112|NCT01286467|363200743|FG001|Overall Study|Death|1|||
105328113|NCT01286467|363200744|FG002|Overall Study|Death|1|||
105328114|NCT01286467|363200745|FG003|Overall Study|Death|0|||
105328115|NCT01286467|363200742|FG000|Overall Study|Lost to Follow-up|0|||
105328116|NCT01286467|363200743|FG001|Overall Study|Lost to Follow-up|0|||
105328117|NCT01286467|363200744|FG002|Overall Study|Lost to Follow-up|0|||
105328118|NCT01286467|363200745|FG003|Overall Study|Lost to Follow-up|1|||
105328119|NCT01286467|363200742|FG000|Overall Study|Withdrawal by Subject|0|||
105328120|NCT01286467|363200743|FG001|Overall Study|Withdrawal by Subject|0|||
105328121|NCT01286467|363200744|FG002|Overall Study|Withdrawal by Subject|1|||
105328122|NCT01286467|363200745|FG003|Overall Study|Withdrawal by Subject|0|||
105328123|NCT01286467|363200742|FG000|Overall Study|Physician Decision|0|||
105328124|NCT01286467|363200743|FG001|Overall Study|Physician Decision|0|||
105328125|NCT01286467|363200744|FG002|Overall Study|Physician Decision|0|||
105328126|NCT01286467|363200745|FG003|Overall Study|Physician Decision|1|||
105328127|NCT01286467|363200742|FG000|Overall Study|Disease progression|3|||
105328128|NCT01286467|363200743|FG001|Overall Study|Disease progression|2|||
105328129|NCT01286467|363200744|FG002|Overall Study|Disease progression|2|||
105328130|NCT01286467|363200745|FG003|Overall Study|Disease progression|3|||
105328131|NCT01286467|363200742|FG000|Overall Study|Adverse Event|0|||
105328132|NCT01286467|363200743|FG001|Overall Study|Adverse Event|1|||
105328133|NCT01286467|363200744|FG002|Overall Study|Adverse Event|2|||
105328134|NCT01286467|363200745|FG003|Overall Study|Adverse Event|3|||
105328135|NCT01286467|363200742|FG000|Overall Study|Study drug stop longer than 14 days|0|||
105328136|NCT01286467|363200743|FG001|Overall Study|Study drug stop longer than 14 days|0|||
105328137|NCT01286467|363200744|FG002|Overall Study|Study drug stop longer than 14 days|1|||
105328138|NCT01286467|363200745|FG003|Overall Study|Study drug stop longer than 14 days|0|||
105328139|NCT00442897|363200746|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
105328140|NCT00442897|363200747|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
105328141|NCT00442897|363200746|FG000|Base Study (12 Week Follow-up)|Death|0|||
105328142|NCT00442897|363200747|FG001|Base Study (12 Week Follow-up)|Death|1|||
105328143|NCT00442897|363200746|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
105328144|NCT00442897|363200747|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
105328145|NCT00442897|363200746|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
105328146|NCT00442897|363200747|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
105328147|NCT00442897|363200746|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
105328148|NCT00442897|363200747|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
105328149|NCT00442897|363200746|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
105328150|NCT00442897|363200747|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
105328151|NCT00442897|363200746|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
105328152|NCT00442897|363200747|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
105328153|NCT00442897|363200746|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
105328154|NCT00442897|363200747|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
105328155|NCT02182843|363200748|FG000|Overall Study|Withdrawal by Subject|7|||
105328156|NCT02182843|363200748|FG000|Overall Study|Lost to Follow-up|2|||
105328157|NCT02182843|363200748|FG000|Overall Study|Adverse Event|1|||
105328158|NCT04548193|363200754|FG000|Overall Study|Lost to Follow-up|0|||
105328159|NCT04548193|363200755|FG001|Overall Study|Lost to Follow-up|1|||
105328160|NCT04548193|363200754|FG000|Overall Study|Death|0|||
105328161|NCT04548193|363200755|FG001|Overall Study|Death|1|||
105328162|NCT04548193|363200754|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
105328163|NCT04548193|363200755|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
105328164|NCT04548193|363200754|FG000|Overall Study|Withdrawal by Subject|2|||
105328165|NCT04548193|363200755|FG001|Overall Study|Withdrawal by Subject|2|||
105854907|NCT02883049|365121719|FG012|Induction|Incomplete induction data|0|||
105328166|NCT03889418|363200763|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
105328167|NCT03889418|363200764|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105328168|NCT03889418|363200765|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105328169|NCT03889418|363200766|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105328170|NCT03889418|363200767|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105328171|NCT03889418|363200768|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105328172|NCT03889418|363200769|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105328173|NCT03889418|363200770|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105374172|NCT01232283|363376347|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105374173|NCT01232283|363376338|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105374174|NCT01232283|363376339|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105374175|NCT01232283|363376340|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105374176|NCT01232283|363376341|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105374177|NCT01232283|363376342|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105374178|NCT01232283|363376343|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105374179|NCT01232283|363376344|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105374180|NCT01232283|363376345|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105374181|NCT01232283|363376346|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
105374182|NCT01232283|363376347|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105374183|NCT01232283|363376338|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105374184|NCT01232283|363376339|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105374185|NCT01232283|363376340|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105374186|NCT01232283|363376341|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105374187|NCT01232283|363376342|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105374188|NCT01232283|363376343|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105374189|NCT01232283|363376344|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105374190|NCT01232283|363376345|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105374191|NCT01232283|363376346|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
105374192|NCT01232283|363376347|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
105374193|NCT01192178|363376348|FG000|Overall Study|Withdrawal by Subject|6|||
105374194|NCT01192178|363376349|FG001|Overall Study|Withdrawal by Subject|10|||
105374195|NCT01192178|363376348|FG000|Overall Study|Protocol Violation|10|||
105374196|NCT01192178|363376349|FG001|Overall Study|Protocol Violation|3|||
105374197|NCT01192178|363376348|FG000|Overall Study|Physician Decision|2|||
105374198|NCT01192178|363376349|FG001|Overall Study|Physician Decision|4|||
105374199|NCT01192178|363376348|FG000|Overall Study|Lost to Follow-up|3|||
105374200|NCT01192178|363376349|FG001|Overall Study|Lost to Follow-up|3|||
105374201|NCT01192178|363376348|FG000|Overall Study|Adverse Event|2|||
105374202|NCT01192178|363376349|FG001|Overall Study|Adverse Event|1|||
105374203|NCT01192178|363376348|FG000|Overall Study|Lack of Efficacy|1|||
105374204|NCT01192178|363376349|FG001|Overall Study|Lack of Efficacy|2|||
105374205|NCT02460289|363376352|FG000|Overall Study|Adverse Event|1|||
105374206|NCT02460289|363376352|FG000|Overall Study|Withdrawal by Subject|8|||
105374207|NCT02460289|363376352|FG000|Overall Study|Lost to Follow-up|1|||
105328174|NCT03889418|363200771|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105328175|NCT03889418|363200772|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105328176|NCT03889418|363200763|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105328177|NCT03889418|363200764|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
105328178|NCT03889418|363200765|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
105328179|NCT03889418|363200766|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105328180|NCT03889418|363200767|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105328181|NCT03889418|363200768|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105328182|NCT03889418|363200769|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105328183|NCT03889418|363200770|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105328184|NCT03889418|363200771|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105328185|NCT03889418|363200772|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105328186|NCT03889418|363200763|FG000|October-December 2019 (Month 7-9)|Death|0|||
105328187|NCT03889418|363200764|FG001|October-December 2019 (Month 7-9)|Death|0|||
105328188|NCT03889418|363200765|FG002|October-December 2019 (Month 7-9)|Death|0|||
105328189|NCT03889418|363200766|FG003|October-December 2019 (Month 7-9)|Death|0|||
105328190|NCT03889418|363200767|FG004|October-December 2019 (Month 7-9)|Death|0|||
105328191|NCT03889418|363200768|FG005|October-December 2019 (Month 7-9)|Death|0|||
105328192|NCT03889418|363200769|FG006|October-December 2019 (Month 7-9)|Death|0|||
105328193|NCT03889418|363200770|FG007|October-December 2019 (Month 7-9)|Death|0|||
105854908|NCT02883049|365121720|FG013|Induction|Incomplete induction data|0|||
105374208|NCT02164916|363376353|FG000|Overall Study|Adverse Event|3|||
105374209|NCT02164916|363376354|FG001|Overall Study|Adverse Event|8|||
105374210|NCT02164916|363376353|FG000|Overall Study|Death|1|||
105374211|NCT02164916|363376354|FG001|Overall Study|Death|1|||
105374212|NCT02164916|363376353|FG000|Overall Study|Refusal unrelated to adverse event|3|||
105374213|NCT02164916|363376354|FG001|Overall Study|Refusal unrelated to adverse event|7|||
105374214|NCT02164916|363376353|FG000|Overall Study|Progression|37|||
105374215|NCT02164916|363376354|FG001|Overall Study|Progression|26|||
105374216|NCT02164916|363376353|FG000|Overall Study|Not protocol specified|5|||
105374217|NCT02164916|363376354|FG001|Overall Study|Not protocol specified|1|||
105374218|NCT02164916|363376353|FG000|Overall Study|Reason under review|1|||
105374219|NCT02164916|363376354|FG001|Overall Study|Reason under review|6|||
105328194|NCT03889418|363200771|FG008|October-December 2019 (Month 7-9)|Death|1|||
105328195|NCT03889418|363200772|FG009|October-December 2019 (Month 7-9)|Death|0|||
105328196|NCT03889418|363200763|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105328197|NCT03889418|363200764|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105328198|NCT03889418|363200765|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105328199|NCT03889418|363200766|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
105328200|NCT03889418|363200767|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105328201|NCT03889418|363200768|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105328202|NCT03889418|363200769|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105328203|NCT03889418|363200770|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
105328204|NCT03889418|363200771|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105328205|NCT03889418|363200772|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105328206|NCT03889418|363200763|FG000|April - June 2020 (Month 13-15)|Death|0|||
105328207|NCT03889418|363200764|FG001|April - June 2020 (Month 13-15)|Death|1|||
105328208|NCT03889418|363200765|FG002|April - June 2020 (Month 13-15)|Death|0|||
105328209|NCT03889418|363200766|FG003|April - June 2020 (Month 13-15)|Death|0|||
105328210|NCT03889418|363200767|FG004|April - June 2020 (Month 13-15)|Death|0|||
105328211|NCT03889418|363200768|FG005|April - June 2020 (Month 13-15)|Death|0|||
105328212|NCT03889418|363200769|FG006|April - June 2020 (Month 13-15)|Death|0|||
105328213|NCT03889418|363200770|FG007|April - June 2020 (Month 13-15)|Death|0|||
105328214|NCT03889418|363200771|FG008|April - June 2020 (Month 13-15)|Death|0|||
105328215|NCT03889418|363200772|FG009|April - June 2020 (Month 13-15)|Death|0|||
105328216|NCT03889418|363200763|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105328217|NCT03889418|363200764|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105328218|NCT03889418|363200765|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105328219|NCT03889418|363200766|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
105328220|NCT03889418|363200767|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105328221|NCT03889418|363200768|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105328222|NCT03889418|363200769|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105328223|NCT03889418|363200770|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105328224|NCT03889418|363200771|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105328225|NCT03889418|363200772|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105328226|NCT03889418|363200763|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
105328227|NCT03889418|363200764|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
105374220|NCT02164916|363376353|FG000|Overall Study|Not eligible|2|||
105328228|NCT03889418|363200765|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
105854909|NCT02883049|365121721|FG014|Induction|Incomplete induction data|0|||
105854910|NCT02883049|365121722|FG015|Induction|Incomplete induction data|0|||
105854911|NCT02883049|365121707|FG000|Post Induction|Adverse Event|0|||
105854912|NCT02883049|365121708|FG001|Post Induction|Adverse Event|0|||
105854913|NCT02883049|365121709|FG002|Post Induction|Adverse Event|0|||
105854914|NCT02883049|365121710|FG003|Post Induction|Adverse Event|7|||
105854915|NCT02883049|365121711|FG004|Post Induction|Adverse Event|8|||
105854916|NCT02883049|365121712|FG005|Post Induction|Adverse Event|3|||
105854917|NCT02883049|365121713|FG006|Post Induction|Adverse Event|4|||
105854918|NCT02883049|365121714|FG007|Post Induction|Adverse Event|5|||
105854919|NCT02883049|365121715|FG008|Post Induction|Adverse Event|6|||
105854920|NCT02883049|365121716|FG009|Post Induction|Adverse Event|7|||
105854921|NCT02883049|365121717|FG010|Post Induction|Adverse Event|2|||
105854922|NCT02883049|365121718|FG011|Post Induction|Adverse Event|2|||
105854923|NCT02883049|365121719|FG012|Post Induction|Adverse Event|0|||
105854924|NCT02883049|365121720|FG013|Post Induction|Adverse Event|0|||
105854925|NCT02883049|365121721|FG014|Post Induction|Adverse Event|5|||
105854926|NCT02883049|365121722|FG015|Post Induction|Adverse Event|2|||
105854927|NCT02883049|365121707|FG000|Post Induction|Death|0|||
105854928|NCT02883049|365121708|FG001|Post Induction|Death|0|||
105854929|NCT02883049|365121709|FG002|Post Induction|Death|0|||
105854930|NCT02883049|365121710|FG003|Post Induction|Death|9|||
105854931|NCT02883049|365121711|FG004|Post Induction|Death|9|||
105328229|NCT03889418|363200766|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
105328230|NCT03889418|363200767|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
105328231|NCT03889418|363200768|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
105328232|NCT03889418|363200769|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
105328233|NCT03889418|363200770|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
105328234|NCT03889418|363200771|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
105328235|NCT03889418|363200772|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
105328236|NCT03889418|363200763|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
105374221|NCT02164916|363376354|FG001|Overall Study|Not eligible|5|||
105854932|NCT02883049|365121712|FG005|Post Induction|Death|0|||
105854933|NCT02883049|365121713|FG006|Post Induction|Death|1|||
105854934|NCT02883049|365121714|FG007|Post Induction|Death|6|||
105854935|NCT02883049|365121715|FG008|Post Induction|Death|5|||
105854936|NCT02883049|365121716|FG009|Post Induction|Death|3|||
105854937|NCT02883049|365121717|FG010|Post Induction|Death|1|||
105854938|NCT02883049|365121718|FG011|Post Induction|Death|0|||
105854939|NCT02883049|365121719|FG012|Post Induction|Death|1|||
105854940|NCT02883049|365121720|FG013|Post Induction|Death|1|||
105854941|NCT02883049|365121721|FG014|Post Induction|Death|10|||
105854942|NCT02883049|365121722|FG015|Post Induction|Death|2|||
105854943|NCT02883049|365121707|FG000|Post Induction|Lost to Follow-up|0|||
105854944|NCT02883049|365121708|FG001|Post Induction|Lost to Follow-up|0|||
105854945|NCT02883049|365121709|FG002|Post Induction|Lost to Follow-up|0|||
105854946|NCT02883049|365121710|FG003|Post Induction|Lost to Follow-up|0|||
105854947|NCT02883049|365121711|FG004|Post Induction|Lost to Follow-up|1|||
105854948|NCT02883049|365121712|FG005|Post Induction|Lost to Follow-up|1|||
105854949|NCT02883049|365121713|FG006|Post Induction|Lost to Follow-up|0|||
105854950|NCT02883049|365121714|FG007|Post Induction|Lost to Follow-up|0|||
105854951|NCT02883049|365121715|FG008|Post Induction|Lost to Follow-up|3|||
105854952|NCT02883049|365121716|FG009|Post Induction|Lost to Follow-up|0|||
105854953|NCT02883049|365121717|FG010|Post Induction|Lost to Follow-up|1|||
105854954|NCT02883049|365121718|FG011|Post Induction|Lost to Follow-up|0|||
105854955|NCT02883049|365121719|FG012|Post Induction|Lost to Follow-up|0|||
105854956|NCT02883049|365121720|FG013|Post Induction|Lost to Follow-up|0|||
105854957|NCT02883049|365121721|FG014|Post Induction|Lost to Follow-up|0|||
105854958|NCT02883049|365121722|FG015|Post Induction|Lost to Follow-up|0|||
105854959|NCT02883049|365121707|FG000|Post Induction|Physician Decision|0|||
105854960|NCT02883049|365121708|FG001|Post Induction|Physician Decision|0|||
105854961|NCT02883049|365121709|FG002|Post Induction|Physician Decision|0|||
105854962|NCT02883049|365121710|FG003|Post Induction|Physician Decision|27|||
105854963|NCT02883049|365121711|FG004|Post Induction|Physician Decision|27|||
105854964|NCT02883049|365121712|FG005|Post Induction|Physician Decision|23|||
105854965|NCT02883049|365121713|FG006|Post Induction|Physician Decision|30|||
105854966|NCT02883049|365121714|FG007|Post Induction|Physician Decision|56|||
105854967|NCT02883049|365121715|FG008|Post Induction|Physician Decision|85|||
105854968|NCT02883049|365121716|FG009|Post Induction|Physician Decision|12|||
105854969|NCT02883049|365121717|FG010|Post Induction|Physician Decision|5|||
105854970|NCT02883049|365121718|FG011|Post Induction|Physician Decision|14|||
105854971|NCT02883049|365121719|FG012|Post Induction|Physician Decision|1|||
105854972|NCT02883049|365121720|FG013|Post Induction|Physician Decision|11|||
105854973|NCT02883049|365121721|FG014|Post Induction|Physician Decision|19|||
105854974|NCT02883049|365121722|FG015|Post Induction|Physician Decision|5|||
105854975|NCT02883049|365121707|FG000|Post Induction|Protocol Violation|0|||
105854976|NCT02883049|365121708|FG001|Post Induction|Protocol Violation|0|||
105854977|NCT02883049|365121709|FG002|Post Induction|Protocol Violation|0|||
105854978|NCT02883049|365121710|FG003|Post Induction|Protocol Violation|0|||
105854979|NCT02883049|365121711|FG004|Post Induction|Protocol Violation|0|||
105854980|NCT02883049|365121712|FG005|Post Induction|Protocol Violation|0|||
105854981|NCT02883049|365121713|FG006|Post Induction|Protocol Violation|0|||
105854982|NCT02883049|365121714|FG007|Post Induction|Protocol Violation|1|||
105854983|NCT02883049|365121715|FG008|Post Induction|Protocol Violation|0|||
105854984|NCT02883049|365121716|FG009|Post Induction|Protocol Violation|0|||
105854985|NCT02883049|365121717|FG010|Post Induction|Protocol Violation|0|||
105854986|NCT02883049|365121718|FG011|Post Induction|Protocol Violation|0|||
105854987|NCT02883049|365121719|FG012|Post Induction|Protocol Violation|0|||
105854988|NCT02883049|365121720|FG013|Post Induction|Protocol Violation|0|||
105854989|NCT02883049|365121721|FG014|Post Induction|Protocol Violation|0|||
105854990|NCT02883049|365121722|FG015|Post Induction|Protocol Violation|0|||
105854991|NCT02883049|365121707|FG000|Post Induction|Withdrawal by Subject|0|||
105854992|NCT02883049|365121708|FG001|Post Induction|Withdrawal by Subject|0|||
105854993|NCT02883049|365121709|FG002|Post Induction|Withdrawal by Subject|0|||
105854994|NCT02883049|365121710|FG003|Post Induction|Withdrawal by Subject|5|||
105854995|NCT02883049|365121711|FG004|Post Induction|Withdrawal by Subject|2|||
105854996|NCT02883049|365121712|FG005|Post Induction|Withdrawal by Subject|1|||
105854997|NCT02883049|365121713|FG006|Post Induction|Withdrawal by Subject|0|||
105854998|NCT02883049|365121714|FG007|Post Induction|Withdrawal by Subject|0|||
105854999|NCT02883049|365121715|FG008|Post Induction|Withdrawal by Subject|2|||
105855000|NCT02883049|365121716|FG009|Post Induction|Withdrawal by Subject|0|||
105855001|NCT02883049|365121717|FG010|Post Induction|Withdrawal by Subject|1|||
105374222|NCT00296517|363376355|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
105855002|NCT02883049|365121718|FG011|Post Induction|Withdrawal by Subject|1|||
105855003|NCT02883049|365121719|FG012|Post Induction|Withdrawal by Subject|0|||
105855004|NCT02883049|365121720|FG013|Post Induction|Withdrawal by Subject|0|||
105855005|NCT02883049|365121721|FG014|Post Induction|Withdrawal by Subject|1|||
105855006|NCT02883049|365121722|FG015|Post Induction|Withdrawal by Subject|0|||
105855007|NCT02883049|365121707|FG000|Post Induction|Ineligible|0|||
105374223|NCT00296517|363376356|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
105855008|NCT02883049|365121708|FG001|Post Induction|Ineligible|0|||
105855009|NCT02883049|365121709|FG002|Post Induction|Ineligible|2|||
105855010|NCT02883049|365121710|FG003|Post Induction|Ineligible|0|||
105855011|NCT02883049|365121711|FG004|Post Induction|Ineligible|0|||
105855012|NCT02883049|365121712|FG005|Post Induction|Ineligible|0|||
105855013|NCT02883049|365121713|FG006|Post Induction|Ineligible|1|||
105855014|NCT02883049|365121714|FG007|Post Induction|Ineligible|0|||
105855015|NCT02883049|365121715|FG008|Post Induction|Ineligible|0|||
105855016|NCT02883049|365121716|FG009|Post Induction|Ineligible|0|||
105855017|NCT02883049|365121717|FG010|Post Induction|Ineligible|1|||
105855018|NCT02883049|365121718|FG011|Post Induction|Ineligible|0|||
105855019|NCT02883049|365121719|FG012|Post Induction|Ineligible|0|||
105374224|NCT00296517|363376355|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
105374225|NCT00296517|363376356|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
105374226|NCT00296517|363376355|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
105374227|NCT00296517|363376356|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
105374228|NCT00296517|363376355|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
105374229|NCT00296517|363376356|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
105374230|NCT00296517|363376355|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
105374231|NCT00296517|363376356|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
105374232|NCT00296517|363376355|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
105374233|NCT00296517|363376356|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
105374234|NCT00296517|363376355|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
105374235|NCT00296517|363376356|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
105374236|NCT00296517|363376355|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
105374237|NCT00296517|363376356|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
105374238|NCT00296517|363376355|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
105374239|NCT00296517|363376356|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
105374240|NCT01922934|363376360|FG000|Eligible Patients|Death|0|||
105374241|NCT01922934|363376361|FG001|Eligible Patients|Death|7|||
105374242|NCT01922934|363376360|FG000|Eligible Patients|Physician Decision|17|||
105374243|NCT01922934|363376361|FG001|Eligible Patients|Physician Decision|0|||
105374244|NCT01922934|363376360|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
105374245|NCT01922934|363376361|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
105374246|NCT01922934|363376360|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
105374247|NCT01922934|363376361|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
105374248|NCT01922934|363376360|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
105374249|NCT01922934|363376361|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
105374250|NCT01922934|363376360|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
105374251|NCT01922934|363376361|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
105374252|NCT01349595|363376370|FG000|Overall Study|Lack of funding|2|||
105374253|NCT01349595|363376371|FG001|Overall Study|Lack of funding|2|||
105374254|NCT00094445|363376372|FG000|Overall Study|Withdrawal by Subject|3|||
105374255|NCT00094445|363376372|FG000|Overall Study|Lost to Follow-up|1|||
105374256|NCT00094445|363376372|FG000|Overall Study|Progressive Disease|2|||
105374257|NCT03479905|363376375|FG000|Overall Study|Other airway method used|4|||
105374258|NCT03479905|363376376|FG001|Overall Study|Other airway method used|5|||
105374259|NCT03479905|363376377|FG002|Overall Study|Other airway method used|5|||
105374260|NCT00862992|363376382|FG000|Overall Study|Adverse Event|2|||
105374261|NCT00862992|363376383|FG001|Overall Study|Adverse Event|1|||
105374262|NCT00862992|363376384|FG002|Overall Study|Adverse Event|1|||
105374263|NCT00862992|363376382|FG000|Overall Study|Physician Decision|1|||
105328237|NCT03889418|363200764|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
105328238|NCT03889418|363200765|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
105328239|NCT03889418|363200766|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
105328240|NCT03889418|363200767|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
105328241|NCT03889418|363200768|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
105328242|NCT03889418|363200769|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
105328243|NCT03889418|363200770|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
105328244|NCT03889418|363200771|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
105328245|NCT03889418|363200772|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
105328246|NCT01139125|363200776|FG000|Overall Study|Withdrawal by Subject|1|||
105328247|NCT03751098|363200777|FG000|Overall Study|Withdrawal by Subject|0|||
105328248|NCT03751098|363200778|FG001|Overall Study|Withdrawal by Subject|1|||
105328249|NCT02220764|363200781|FG000|Overall Study|Lost to Follow-up|3|||
105328250|NCT02220764|363200782|FG001|Overall Study|Lost to Follow-up|1|||
105328251|NCT02220764|363200781|FG000|Overall Study|Death|1|||
105328252|NCT02220764|363200782|FG001|Overall Study|Death|0|||
105328253|NCT00739661|363200783|FG000|Overall Study|Adverse Event|2|||
105328254|NCT00739661|363200784|FG001|Overall Study|Adverse Event|0|||
105328255|NCT00739661|363200783|FG000|Overall Study|Physician decision to withdraw patient|1|||
105328256|NCT00739661|363200784|FG001|Overall Study|Physician decision to withdraw patient|0|||
105374264|NCT00862992|363376383|FG001|Overall Study|Physician Decision|0|||
105374265|NCT00862992|363376384|FG002|Overall Study|Physician Decision|0|||
105374266|NCT00862992|363376382|FG000|Overall Study|Withdrawal by Subject|0|||
105374267|NCT00862992|363376383|FG001|Overall Study|Withdrawal by Subject|0|||
105374268|NCT00862992|363376384|FG002|Overall Study|Withdrawal by Subject|2|||
105374269|NCT00720759|363376385|FG000|Overall Study|Lost to Follow-up|0|||
105374270|NCT00720759|363376386|FG001|Overall Study|Lost to Follow-up|1|||
105374271|NCT00720759|363376387|FG002|Overall Study|Lost to Follow-up|1|||
105374272|NCT00720759|363376388|FG003|Overall Study|Lost to Follow-up|0|||
105328257|NCT00739661|363200783|FG000|Overall Study|Patient decision to withdraw|9|||
105374273|NCT00769561|363376389|FG000|Overall Study|Withdrawal by Subject|2|||
105374274|NCT00769561|363376390|FG001|Overall Study|Withdrawal by Subject|2|||
105374275|NCT00769561|363376389|FG000|Overall Study|Lost to Follow-up|1|||
105374276|NCT00769561|363376390|FG001|Overall Study|Lost to Follow-up|3|||
105374277|NCT02696798|363376400|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
105374278|NCT02696798|363376401|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
105374279|NCT02696798|363376402|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
105374280|NCT02696798|363376400|FG000|Blinded Treatment Dosing Period|Death|0|||
105374281|NCT02696798|363376401|FG001|Blinded Treatment Dosing Period|Death|0|||
105374282|NCT02696798|363376402|FG002|Blinded Treatment Dosing Period|Death|1|||
105374283|NCT02696798|363376400|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
105374284|NCT02696798|363376401|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
105374285|NCT02696798|363376402|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
105577163|NCT02855164|364112190|FG000|Part C (Randomized Set)|Physician Decision|0|||
105855020|NCT02883049|365121720|FG013|Post Induction|Ineligible|0|||
105855021|NCT02883049|365121721|FG014|Post Induction|Ineligible|0|||
105328258|NCT00739661|363200784|FG001|Overall Study|Patient decision to withdraw|4|||
105328259|NCT00739661|363200783|FG000|Overall Study|Disease progression, radiographic|33|||
105328260|NCT00739661|363200784|FG001|Overall Study|Disease progression, radiographic|37|||
105328261|NCT00739661|363200783|FG000|Overall Study|Reason for discontinuation not available|1|||
105328262|NCT00739661|363200784|FG001|Overall Study|Reason for discontinuation not available|1|||
105328263|NCT02198664|363200785|FG000|Overall Study|Adverse Event|2|||
105328264|NCT02198664|363200786|FG001|Overall Study|Adverse Event|0|||
105328265|NCT02198664|363200785|FG000|Overall Study|Withdrawal by Subject|11|||
105328266|NCT02198664|363200786|FG001|Overall Study|Withdrawal by Subject|8|||
105328267|NCT02198664|363200785|FG000|Overall Study|Failure to tolerate|2|||
105328268|NCT02198664|363200786|FG001|Overall Study|Failure to tolerate|0|||
105328269|NCT02198664|363200785|FG000|Overall Study|Not stated|1|||
105328270|NCT02198664|363200786|FG001|Overall Study|Not stated|0|||
105328271|NCT05343364|363200789|FG000|Overall Study|Miscellaneous|0|||
105328272|NCT05343364|363200790|FG001|Overall Study|Miscellaneous|1|||
105328273|NCT01252095|363200793|FG000|Overall Study|Disease progression|1|||
105328274|NCT01252095|363200794|FG001|Overall Study|Disease progression|0|||
105328275|NCT01139775|363200795|FG000|Overall Study|Adverse Event|0|||
105328276|NCT01139775|363200796|FG001|Overall Study|Adverse Event|6|||
105328277|NCT01139775|363200797|FG002|Overall Study|Adverse Event|2|||
105328278|NCT01139775|363200795|FG000|Overall Study|Protocol Violation|0|||
105328279|NCT01139775|363200796|FG001|Overall Study|Protocol Violation|5|||
105328280|NCT01139775|363200797|FG002|Overall Study|Protocol Violation|0|||
105328281|NCT01139775|363200795|FG000|Overall Study|Withdrawal by Subject|1|||
105328282|NCT01139775|363200796|FG001|Overall Study|Withdrawal by Subject|0|||
105328283|NCT01139775|363200797|FG002|Overall Study|Withdrawal by Subject|2|||
105328284|NCT01139775|363200795|FG000|Overall Study|Physician Decision|0|||
105328285|NCT01139775|363200796|FG001|Overall Study|Physician Decision|2|||
105328286|NCT01139775|363200797|FG002|Overall Study|Physician Decision|2|||
105328287|NCT00594165|363200800|FG000|Overall Study|Major protocol violation|1|||
105328288|NCT00594165|363200800|FG000|Overall Study|Lack of Efficacy|12|||
105328289|NCT00594165|363200800|FG000|Overall Study|Adverse Event|52|||
105328290|NCT00594165|363200800|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
105328291|NCT00594165|363200800|FG000|Overall Study|Subject withdrew consent|27|||
105328292|NCT00594165|363200800|FG000|Overall Study|Study ended per sponsor|102|||
105328293|NCT00594165|363200800|FG000|Overall Study|Lost to Follow-up|4|||
105328294|NCT00594165|363200800|FG000|Overall Study|Other: PI discretion|5|||
105328295|NCT00594165|363200800|FG000|Overall Study|Other: Subject moving|3|||
105328296|NCT00594165|363200800|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
105328297|NCT00594165|363200800|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
105328298|NCT00594165|363200800|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
105328299|NCT00594165|363200800|FG000|Overall Study|Other: Site terminated participation|2|||
105328300|NCT03193853|363200801|FG000|Overall Study|Death|6|||
105328301|NCT04739800|363200804|FG000|Overall Study|Adverse Event|2|||
105328302|NCT04739800|363200805|FG001|Overall Study|Adverse Event|1|||
105328303|NCT04739800|363200806|FG002|Overall Study|Adverse Event|4|||
105374286|NCT02696798|363376400|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
105855022|NCT02883049|365121722|FG015|Post Induction|Ineligible|1|||
105855023|NCT02883049|365121707|FG000|Post Induction|Refusal of further protocol therapy|0|||
105855024|NCT02883049|365121708|FG001|Post Induction|Refusal of further protocol therapy|0|||
105328304|NCT04739800|363200807|FG003|Overall Study|Adverse Event|5|||
105328305|NCT04739800|363200804|FG000|Overall Study|Never Treated|2|||
105328306|NCT04739800|363200805|FG001|Overall Study|Never Treated|0|||
105328307|NCT04739800|363200806|FG002|Overall Study|Never Treated|1|||
105328308|NCT04739800|363200807|FG003|Overall Study|Never Treated|1|||
105328309|NCT04739800|363200804|FG000|Overall Study|On Treatment|5|||
105328310|NCT04739800|363200805|FG001|Overall Study|On Treatment|9|||
105328311|NCT04739800|363200806|FG002|Overall Study|On Treatment|9|||
105328312|NCT04739800|363200807|FG003|Overall Study|On Treatment|9|||
105328313|NCT04739800|363200804|FG000|Overall Study|Symptomatic Deterioration|1|||
105328314|NCT04739800|363200805|FG001|Overall Study|Symptomatic Deterioration|1|||
105328315|NCT04739800|363200806|FG002|Overall Study|Symptomatic Deterioration|3|||
105328316|NCT04739800|363200807|FG003|Overall Study|Symptomatic Deterioration|0|||
105855025|NCT02883049|365121709|FG002|Post Induction|Refusal of further protocol therapy|0|||
105855026|NCT02883049|365121710|FG003|Post Induction|Refusal of further protocol therapy|11|||
105855027|NCT02883049|365121711|FG004|Post Induction|Refusal of further protocol therapy|15|||
105855028|NCT02883049|365121712|FG005|Post Induction|Refusal of further protocol therapy|9|||
105855029|NCT02883049|365121713|FG006|Post Induction|Refusal of further protocol therapy|13|||
105855030|NCT02883049|365121714|FG007|Post Induction|Refusal of further protocol therapy|5|||
105855031|NCT02883049|365121715|FG008|Post Induction|Refusal of further protocol therapy|21|||
105855032|NCT02883049|365121716|FG009|Post Induction|Refusal of further protocol therapy|7|||
105855033|NCT02883049|365121717|FG010|Post Induction|Refusal of further protocol therapy|0|||
105855034|NCT02883049|365121718|FG011|Post Induction|Refusal of further protocol therapy|7|||
105855035|NCT02883049|365121719|FG012|Post Induction|Refusal of further protocol therapy|3|||
105855036|NCT02883049|365121720|FG013|Post Induction|Refusal of further protocol therapy|0|||
105855037|NCT02883049|365121721|FG014|Post Induction|Refusal of further protocol therapy|4|||
105855038|NCT02883049|365121722|FG015|Post Induction|Refusal of further protocol therapy|1|||
105855039|NCT02883049|365121707|FG000|Post Induction|Inevaluable|0|||
105855040|NCT02883049|365121708|FG001|Post Induction|Inevaluable|0|||
105855041|NCT02883049|365121709|FG002|Post Induction|Inevaluable|0|||
105855042|NCT02883049|365121710|FG003|Post Induction|Inevaluable|1|||
105328317|NCT04739800|363200804|FG000|Overall Study|Withdrawal by Subject|1|||
105328318|NCT04739800|363200805|FG001|Overall Study|Withdrawal by Subject|2|||
105328319|NCT04739800|363200806|FG002|Overall Study|Withdrawal by Subject|1|||
105328320|NCT04739800|363200807|FG003|Overall Study|Withdrawal by Subject|3|||
105328321|NCT04739800|363200804|FG000|Overall Study|Other Reason|1|||
105328322|NCT04739800|363200805|FG001|Overall Study|Other Reason|3|||
105328323|NCT04739800|363200806|FG002|Overall Study|Other Reason|5|||
105328324|NCT04739800|363200807|FG003|Overall Study|Other Reason|4|||
105328325|NCT00450437|363200810|FG000|Overall Study|Withdrawal by Subject|10|||
105328326|NCT00450437|363200811|FG001|Overall Study|Withdrawal by Subject|2|||
105328327|NCT00450437|363200812|FG002|Overall Study|Withdrawal by Subject|0|||
105328328|NCT00450437|363200813|FG003|Overall Study|Withdrawal by Subject|1|||
105328329|NCT00450437|363200810|FG000|Overall Study|Lost to Follow-up|31|||
105328330|NCT00450437|363200811|FG001|Overall Study|Lost to Follow-up|12|||
105328331|NCT00450437|363200812|FG002|Overall Study|Lost to Follow-up|19|||
105328332|NCT00450437|363200813|FG003|Overall Study|Lost to Follow-up|9|||
105328333|NCT00450437|363200810|FG000|Overall Study|Protocol Violation|0|||
105328334|NCT00450437|363200811|FG001|Overall Study|Protocol Violation|1|||
105328335|NCT00450437|363200812|FG002|Overall Study|Protocol Violation|0|||
105328336|NCT00450437|363200813|FG003|Overall Study|Protocol Violation|1|||
105328337|NCT00450437|363200810|FG000|Overall Study|Inappropriate enrollment|4|||
105328338|NCT00450437|363200811|FG001|Overall Study|Inappropriate enrollment|1|||
105328339|NCT00450437|363200812|FG002|Overall Study|Inappropriate enrollment|3|||
105328340|NCT00450437|363200813|FG003|Overall Study|Inappropriate enrollment|0|||
105328341|NCT00450437|363200810|FG000|Overall Study|Administrative reason|0|||
105328342|NCT00450437|363200811|FG001|Overall Study|Administrative reason|0|||
105328343|NCT00450437|363200812|FG002|Overall Study|Administrative reason|1|||
105328344|NCT00450437|363200813|FG003|Overall Study|Administrative reason|0|||
105328345|NCT00450437|363200810|FG000|Overall Study|Unable to Classify|1|||
105328346|NCT00450437|363200811|FG001|Overall Study|Unable to Classify|0|||
105328347|NCT00450437|363200812|FG002|Overall Study|Unable to Classify|1|||
105328348|NCT00450437|363200813|FG003|Overall Study|Unable to Classify|0|||
105328349|NCT01827111|363200814|FG000|Overall Study|Disease Progression|1|||
105328350|NCT02169271|363200815|FG000|Overall Study|Protocol Violation|1|||
105328351|NCT02169271|363200816|FG001|Overall Study|Protocol Violation|2|||
105328352|NCT00122382|363200820|FG000|Double-Blind Study|Adverse Event|9|||
105328353|NCT00122382|363200821|FG001|Double-Blind Study|Adverse Event|11|||
105328354|NCT00122382|363200822|FG002|Double-Blind Study|Adverse Event|0|||
105328355|NCT00122382|363200820|FG000|Double-Blind Study|Death|2|||
105328356|NCT00122382|363200821|FG001|Double-Blind Study|Death|2|||
105328357|NCT00122382|363200822|FG002|Double-Blind Study|Death|0|||
105328358|NCT00122382|363200820|FG000|Double-Blind Study|Lack of Efficacy|0|||
105328359|NCT00122382|363200821|FG001|Double-Blind Study|Lack of Efficacy|8|||
105855043|NCT02883049|365121711|FG004|Post Induction|Inevaluable|1|||
105855044|NCT02883049|365121712|FG005|Post Induction|Inevaluable|2|||
105328360|NCT00122382|363200822|FG002|Double-Blind Study|Lack of Efficacy|0|||
105328361|NCT00122382|363200820|FG000|Double-Blind Study|Lost to Follow-up|2|||
105328362|NCT00122382|363200821|FG001|Double-Blind Study|Lost to Follow-up|1|||
105328363|NCT00122382|363200822|FG002|Double-Blind Study|Lost to Follow-up|0|||
105328364|NCT00122382|363200820|FG000|Double-Blind Study|Pregnancy|2|||
105328365|NCT00122382|363200821|FG001|Double-Blind Study|Pregnancy|0|||
105328366|NCT00122382|363200822|FG002|Double-Blind Study|Pregnancy|0|||
105328367|NCT00122382|363200820|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
105328368|NCT00122382|363200821|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
105328369|NCT00122382|363200822|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
105328370|NCT00122382|363200820|FG000|Double-Blind Study|Withdrawal of Consent|7|||
105328371|NCT00122382|363200821|FG001|Double-Blind Study|Withdrawal of Consent|3|||
105328372|NCT00122382|363200822|FG002|Double-Blind Study|Withdrawal of Consent|0|||
105328373|NCT00122382|363200820|FG000|Double-Blind Study|Protocol Violation|1|||
105328374|NCT00122382|363200821|FG001|Double-Blind Study|Protocol Violation|0|||
105328375|NCT00122382|363200822|FG002|Double-Blind Study|Protocol Violation|0|||
105328376|NCT00122382|363200820|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
105328377|NCT00122382|363200821|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
105328378|NCT00122382|363200822|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
105328379|NCT00122382|363200820|FG000|Double-Blind Study|Randomized but not treated|0|||
105328380|NCT00122382|363200821|FG001|Double-Blind Study|Randomized but not treated|2|||
105328381|NCT00122382|363200822|FG002|Double-Blind Study|Randomized but not treated|0|||
105328382|NCT00122382|363200820|FG000|Open-Label Study|Adverse Event|0|||
105328383|NCT00122382|363200821|FG001|Open-Label Study|Adverse Event|0|||
105328384|NCT00122382|363200822|FG002|Open-Label Study|Adverse Event|11|||
105328385|NCT00122382|363200820|FG000|Open-Label Study|Death|0|||
105328386|NCT00122382|363200821|FG001|Open-Label Study|Death|0|||
105328387|NCT00122382|363200822|FG002|Open-Label Study|Death|2|||
105328388|NCT00122382|363200820|FG000|Open-Label Study|Lack of Efficacy|0|||
105328389|NCT00122382|363200821|FG001|Open-Label Study|Lack of Efficacy|0|||
105328390|NCT00122382|363200822|FG002|Open-Label Study|Lack of Efficacy|3|||
105328391|NCT00122382|363200820|FG000|Open-Label Study|Lost to Follow-up|0|||
105328392|NCT00122382|363200821|FG001|Open-Label Study|Lost to Follow-up|0|||
105328393|NCT00122382|363200822|FG002|Open-Label Study|Lost to Follow-up|3|||
105328394|NCT00122382|363200820|FG000|Open-Label Study|Pregnancy|0|||
105328395|NCT00122382|363200821|FG001|Open-Label Study|Pregnancy|0|||
105328396|NCT00122382|363200822|FG002|Open-Label Study|Pregnancy|2|||
105328397|NCT00122382|363200820|FG000|Open-Label Study|Poor/Non-Compliance|0|||
105328398|NCT00122382|363200821|FG001|Open-Label Study|Poor/Non-Compliance|0|||
105328399|NCT00122382|363200822|FG002|Open-Label Study|Poor/Non-Compliance|1|||
105855045|NCT02883049|365121713|FG006|Post Induction|Inevaluable|7|||
105855046|NCT02883049|365121714|FG007|Post Induction|Inevaluable|6|||
105855047|NCT02883049|365121715|FG008|Post Induction|Inevaluable|4|||
105855048|NCT02883049|365121716|FG009|Post Induction|Inevaluable|4|||
105855049|NCT02883049|365121717|FG010|Post Induction|Inevaluable|1|||
105855050|NCT02883049|365121718|FG011|Post Induction|Inevaluable|1|||
105855051|NCT02883049|365121719|FG012|Post Induction|Inevaluable|2|||
105855052|NCT02883049|365121720|FG013|Post Induction|Inevaluable|0|||
105855053|NCT02883049|365121721|FG014|Post Induction|Inevaluable|0|||
105855054|NCT02883049|365121722|FG015|Post Induction|Inevaluable|1|||
105855055|NCT02883049|365121707|FG000|Post Induction|Moved to another non-COG institution|0|||
105855056|NCT02883049|365121708|FG001|Post Induction|Moved to another non-COG institution|0|||
105855057|NCT02883049|365121709|FG002|Post Induction|Moved to another non-COG institution|0|||
105855058|NCT02883049|365121710|FG003|Post Induction|Moved to another non-COG institution|0|||
105855059|NCT02883049|365121711|FG004|Post Induction|Moved to another non-COG institution|0|||
105855060|NCT02883049|365121712|FG005|Post Induction|Moved to another non-COG institution|0|||
105855061|NCT02883049|365121713|FG006|Post Induction|Moved to another non-COG institution|0|||
105855062|NCT02883049|365121714|FG007|Post Induction|Moved to another non-COG institution|2|||
105855063|NCT02883049|365121715|FG008|Post Induction|Moved to another non-COG institution|2|||
105855064|NCT02883049|365121716|FG009|Post Induction|Moved to another non-COG institution|0|||
105855065|NCT02883049|365121717|FG010|Post Induction|Moved to another non-COG institution|0|||
105855066|NCT02883049|365121718|FG011|Post Induction|Moved to another non-COG institution|1|||
105855067|NCT02883049|365121719|FG012|Post Induction|Moved to another non-COG institution|0|||
105855068|NCT02883049|365121720|FG013|Post Induction|Moved to another non-COG institution|0|||
105855069|NCT02883049|365121721|FG014|Post Induction|Moved to another non-COG institution|0|||
105328400|NCT00122382|363200820|FG000|Open-Label Study|Withdrawal of Consent|0|||
105328401|NCT00122382|363200821|FG001|Open-Label Study|Withdrawal of Consent|0|||
105328402|NCT00122382|363200822|FG002|Open-Label Study|Withdrawal of Consent|4|||
105328403|NCT02040805|363200824|FG000|Overall Study|Lost to Follow-up|14|||
105328404|NCT02040805|363200825|FG001|Overall Study|Lost to Follow-up|9|||
105328405|NCT02040805|363200824|FG000|Overall Study|Withdrawal by Subject|28|||
105328406|NCT02040805|363200825|FG001|Overall Study|Withdrawal by Subject|41|||
105328407|NCT00503698|363200826|FG000|Overall Study|Protocol Violation|5|||
105328408|NCT00503698|363200827|FG001|Overall Study|Protocol Violation|6|||
105328409|NCT00503698|363200826|FG000|Overall Study|Adverse Event|52|||
105328410|NCT00503698|363200827|FG001|Overall Study|Adverse Event|41|||
105328411|NCT00503698|363200826|FG000|Overall Study|Death|1|||
105328412|NCT00503698|363200827|FG001|Overall Study|Death|0|||
105328413|NCT00503698|363200826|FG000|Overall Study|Lack of Efficacy|3|||
105328414|NCT00503698|363200827|FG001|Overall Study|Lack of Efficacy|4|||
105328415|NCT00503698|363200826|FG000|Overall Study|Trial terminated|216|||
105328416|NCT00503698|363200827|FG001|Overall Study|Trial terminated|253|||
105328417|NCT00503698|363200826|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
105328418|NCT00503698|363200827|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
105328419|NCT00503698|363200826|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
105328420|NCT00503698|363200827|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
105328421|NCT00503698|363200826|FG000|Overall Study|Any condition in exclusion criteria|4|||
105855070|NCT02883049|365121722|FG015|Post Induction|Moved to another non-COG institution|0|||
105855071|NCT02883049|365121707|FG000|Post Induction|Randomization closed|0|||
105328422|NCT00503698|363200827|FG001|Overall Study|Any condition in exclusion criteria|6|||
105328423|NCT00503698|363200826|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
105328424|NCT00503698|363200827|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
105328425|NCT00503698|363200826|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
105328426|NCT00503698|363200827|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
105328427|NCT00503698|363200826|FG000|Overall Study|Critically ill|2|||
105328428|NCT00503698|363200827|FG001|Overall Study|Critically ill|0|||
105328429|NCT00503698|363200826|FG000|Overall Study|Unclassified|48|||
105328430|NCT00503698|363200827|FG001|Overall Study|Unclassified|32|||
105328431|NCT00503698|363200826|FG000|Overall Study|Not exposed to trial drug|11|||
105328432|NCT00503698|363200827|FG001|Overall Study|Not exposed to trial drug|6|||
105328433|NCT01591096|363200833|FG000|Overall Study|Adverse Event|1|||
105328434|NCT01831635|363200834|FG000|Overall Study|Withdrawal by Subject|0|||
105328435|NCT01831635|363200835|FG001|Overall Study|Withdrawal by Subject|2|||
105328436|NCT01831635|363200836|FG002|Overall Study|Withdrawal by Subject|0|||
105328437|NCT01408303|363200839|FG000|Overall Study|Adverse Event|3|||
105328438|NCT01408303|363200840|FG001|Overall Study|Adverse Event|7|||
105328439|NCT01408303|363200841|FG002|Overall Study|Adverse Event|2|||
105328440|NCT01408303|363200839|FG000|Overall Study|Lost to Follow-up|0|||
105328441|NCT01408303|363200840|FG001|Overall Study|Lost to Follow-up|1|||
105328442|NCT01408303|363200841|FG002|Overall Study|Lost to Follow-up|2|||
105328443|NCT01408303|363200839|FG000|Overall Study|Withdrawal by Subject|2|||
105328444|NCT01408303|363200840|FG001|Overall Study|Withdrawal by Subject|3|||
105328445|NCT01408303|363200841|FG002|Overall Study|Withdrawal by Subject|1|||
105328446|NCT01408303|363200839|FG000|Overall Study|Protocol Violation|0|||
105328447|NCT01408303|363200840|FG001|Overall Study|Protocol Violation|1|||
105328448|NCT01408303|363200841|FG002|Overall Study|Protocol Violation|0|||
105328449|NCT01408303|363200839|FG000|Overall Study|Noncompliance|1|||
105328450|NCT01408303|363200840|FG001|Overall Study|Noncompliance|0|||
105328451|NCT01408303|363200841|FG002|Overall Study|Noncompliance|1|||
105328452|NCT01367886|363200842|FG000|Overall Study|Lost to Follow-up|4|||
105328453|NCT01367886|363200842|FG000|Overall Study|Lack of Efficacy|2|||
105328454|NCT01367886|363200842|FG000|Overall Study|Death|1|||
105328455|NCT04577404|363200843|FG000|Overall Study|Adverse Event|31|||
105328456|NCT04577404|363200843|FG000|Overall Study|Death|1|||
105328457|NCT04577404|363200843|FG000|Overall Study|Lack of Efficacy|3|||
105328458|NCT04577404|363200843|FG000|Overall Study|Physician Decision|7|||
105328459|NCT04577404|363200843|FG000|Overall Study|Withdrawal by Subject|21|||
105328460|NCT04577404|363200843|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
105328461|NCT01611883|363200844|FG000|Overall Study|Adverse Event|1|||
105328462|NCT01611883|363200845|FG001|Overall Study|Adverse Event|1|||
105328463|NCT06868654|363200846|FG000|Overall Study|Death|4|||
105328464|NCT06868654|363200847|FG001|Overall Study|Death|14|||
105328465|NCT06868654|363200846|FG000|Overall Study|Lost to Follow-up|0|||
105328466|NCT06868654|363200847|FG001|Overall Study|Lost to Follow-up|1|||
105328467|NCT06868654|363200846|FG000|Overall Study|Withdrawal by Subject|5|||
105328468|NCT06868654|363200847|FG001|Overall Study|Withdrawal by Subject|3|||
105328469|NCT06868654|363200846|FG000|Overall Study|Physician Decision|0|||
105328470|NCT06868654|363200847|FG001|Overall Study|Physician Decision|1|||
105328471|NCT06868654|363200846|FG000|Overall Study|Ongoing|23|||
105328472|NCT06868654|363200847|FG001|Overall Study|Ongoing|21|||
105328473|NCT03349060|363203501|FG000|Overall Study|Adverse Event|9|||
105328474|NCT03349060|363203502|FG001|Overall Study|Adverse Event|9|||
105577164|NCT02855164|364112191|FG001|Part C (Randomized Set)|Physician Decision|0|||
105855072|NCT02883049|365121708|FG001|Post Induction|Randomization closed|0|||
105855073|NCT02883049|365121709|FG002|Post Induction|Randomization closed|0|||
105855074|NCT02883049|365121710|FG003|Post Induction|Randomization closed|0|||
105855075|NCT02883049|365121711|FG004|Post Induction|Randomization closed|0|||
105855076|NCT02883049|365121712|FG005|Post Induction|Randomization closed|0|||
105855077|NCT02883049|365121713|FG006|Post Induction|Randomization closed|0|||
105855078|NCT02883049|365121714|FG007|Post Induction|Randomization closed|20|||
105855079|NCT02883049|365121715|FG008|Post Induction|Randomization closed|0|||
105855080|NCT02883049|365121716|FG009|Post Induction|Randomization closed|0|||
105328475|NCT03349060|363203503|FG002|Overall Study|Adverse Event|7|||
105328476|NCT03349060|363203501|FG000|Overall Study|Lack of Efficacy|1|||
105328477|NCT03349060|363203502|FG001|Overall Study|Lack of Efficacy|0|||
105328478|NCT03349060|363203503|FG002|Overall Study|Lack of Efficacy|2|||
105328479|NCT03349060|363203501|FG000|Overall Study|Lost to Follow-up|2|||
105328480|NCT03349060|363203502|FG001|Overall Study|Lost to Follow-up|1|||
105328481|NCT03349060|363203503|FG002|Overall Study|Lost to Follow-up|1|||
105328482|NCT03349060|363203501|FG000|Overall Study|Protocol Violation|2|||
105855081|NCT02883049|365121717|FG010|Post Induction|Randomization closed|0|||
105328483|NCT03349060|363203502|FG001|Overall Study|Protocol Violation|2|||
105328484|NCT03349060|363203503|FG002|Overall Study|Protocol Violation|1|||
105328485|NCT03349060|363203501|FG000|Overall Study|Withdrawal by Subject|5|||
105577165|NCT02855164|364112192|FG002|Part C (Randomized Set)|Physician Decision|0|||
105855082|NCT02883049|365121718|FG011|Post Induction|Randomization closed|0|||
105855083|NCT02883049|365121719|FG012|Post Induction|Randomization closed|0|||
105855084|NCT02883049|365121720|FG013|Post Induction|Randomization closed|0|||
105855085|NCT02883049|365121721|FG014|Post Induction|Randomization closed|0|||
105855086|NCT02883049|365121722|FG015|Post Induction|Randomization closed|0|||
105855087|NCT02883049|365121707|FG000|Post Induction|MRD negative|0|||
105855088|NCT02883049|365121708|FG001|Post Induction|MRD negative|0|||
105855089|NCT02883049|365121709|FG002|Post Induction|MRD negative|0|||
105855090|NCT02883049|365121710|FG003|Post Induction|MRD negative|0|||
105855091|NCT02883049|365121711|FG004|Post Induction|MRD negative|0|||
105855092|NCT02883049|365121712|FG005|Post Induction|MRD negative|0|||
105855093|NCT02883049|365121713|FG006|Post Induction|MRD negative|0|||
105855094|NCT02883049|365121714|FG007|Post Induction|MRD negative|11|||
105855095|NCT02883049|365121715|FG008|Post Induction|MRD negative|0|||
105855096|NCT02883049|365121716|FG009|Post Induction|MRD negative|0|||
105855097|NCT02883049|365121717|FG010|Post Induction|MRD negative|0|||
105855098|NCT02883049|365121718|FG011|Post Induction|MRD negative|0|||
105855099|NCT02883049|365121719|FG012|Post Induction|MRD negative|0|||
105855100|NCT02883049|365121720|FG013|Post Induction|MRD negative|0|||
105855101|NCT02883049|365121721|FG014|Post Induction|MRD negative|0|||
105855102|NCT02883049|365121722|FG015|Post Induction|MRD negative|0|||
105855103|NCT02883049|365121707|FG000|Post Induction|Developed SMN|0|||
105855104|NCT02883049|365121708|FG001|Post Induction|Developed SMN|0|||
105855105|NCT02883049|365121709|FG002|Post Induction|Developed SMN|0|||
105855106|NCT02883049|365121710|FG003|Post Induction|Developed SMN|0|||
105855107|NCT02883049|365121711|FG004|Post Induction|Developed SMN|1|||
105855108|NCT02883049|365121712|FG005|Post Induction|Developed SMN|0|||
105855109|NCT02883049|365121713|FG006|Post Induction|Developed SMN|1|||
105855110|NCT02883049|365121714|FG007|Post Induction|Developed SMN|0|||
105855111|NCT02883049|365121715|FG008|Post Induction|Developed SMN|0|||
105328486|NCT03349060|363203502|FG001|Overall Study|Withdrawal by Subject|3|||
105328487|NCT03349060|363203503|FG002|Overall Study|Withdrawal by Subject|4|||
105328488|NCT03349060|363203501|FG000|Overall Study|Medication error,no linked adverse event|0|||
105328489|NCT03349060|363203502|FG001|Overall Study|Medication error,no linked adverse event|0|||
105328490|NCT03349060|363203503|FG002|Overall Study|Medication error,no linked adverse event|1|||
105328491|NCT03349060|363203501|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
105328492|NCT03349060|363203502|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
105328493|NCT03349060|363203503|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
105328494|NCT03349060|363203501|FG000|Overall Study|Other|2|||
105328495|NCT03349060|363203502|FG001|Overall Study|Other|1|||
105328496|NCT03349060|363203503|FG002|Overall Study|Other|0|||
105328497|NCT02861586|363203504|FG000|Overall Study|Withdrawal by Subject|1|||
105328498|NCT02861586|363203505|FG001|Overall Study|Withdrawal by Subject|2|||
105328499|NCT02861586|363203506|FG002|Overall Study|Withdrawal by Subject|0|||
105328500|NCT02861586|363203507|FG003|Overall Study|Withdrawal by Subject|0|||
105328501|NCT02861586|363203508|FG004|Overall Study|Withdrawal by Subject|0|||
105328502|NCT02861586|363203509|FG005|Overall Study|Withdrawal by Subject|1|||
105328503|NCT02861586|363203510|FG006|Overall Study|Withdrawal by Subject|1|||
105328504|NCT02861586|363203511|FG007|Overall Study|Withdrawal by Subject|0|||
105328505|NCT02861586|363203504|FG000|Overall Study|Lost to Follow-up|3|||
105328506|NCT02861586|363203505|FG001|Overall Study|Lost to Follow-up|1|||
105328507|NCT02861586|363203506|FG002|Overall Study|Lost to Follow-up|1|||
105328508|NCT02861586|363203507|FG003|Overall Study|Lost to Follow-up|0|||
105328509|NCT02861586|363203508|FG004|Overall Study|Lost to Follow-up|0|||
105328510|NCT02861586|363203509|FG005|Overall Study|Lost to Follow-up|3|||
105328511|NCT02861586|363203510|FG006|Overall Study|Lost to Follow-up|0|||
105328512|NCT02861586|363203511|FG007|Overall Study|Lost to Follow-up|0|||
105328513|NCT02861586|363203504|FG000|Overall Study|Adverse Event|0|||
105328514|NCT02861586|363203505|FG001|Overall Study|Adverse Event|0|||
105328515|NCT02861586|363203506|FG002|Overall Study|Adverse Event|0|||
105328516|NCT02861586|363203507|FG003|Overall Study|Adverse Event|0|||
105328517|NCT02861586|363203508|FG004|Overall Study|Adverse Event|0|||
105328518|NCT02861586|363203509|FG005|Overall Study|Adverse Event|1|||
105328519|NCT02861586|363203510|FG006|Overall Study|Adverse Event|0|||
105328520|NCT02861586|363203511|FG007|Overall Study|Adverse Event|0|||
105328521|NCT00955409|363203512|FG000|Overall Study|Lack of Efficacy|1|||
105328522|NCT00955409|363203513|FG001|Overall Study|Lack of Efficacy|0|||
105328523|NCT00955409|363203514|FG002|Overall Study|Lack of Efficacy|0|||
105328524|NCT00955409|363203515|FG003|Overall Study|Lack of Efficacy|0|||
105328525|NCT00955409|363203516|FG004|Overall Study|Lack of Efficacy|0|||
105855112|NCT02883049|365121716|FG009|Post Induction|Developed SMN|0|||
105855113|NCT02883049|365121717|FG010|Post Induction|Developed SMN|1|||
105855114|NCT02883049|365121718|FG011|Post Induction|Developed SMN|1|||
105328526|NCT00955409|363203517|FG005|Overall Study|Lack of Efficacy|0|||
105328527|NCT00955409|363203518|FG006|Overall Study|Lack of Efficacy|0|||
105328528|NCT00955409|363203519|FG007|Overall Study|Lack of Efficacy|0|||
105328529|NCT00955409|363203520|FG008|Overall Study|Lack of Efficacy|0|||
105328530|NCT00955409|363203521|FG009|Overall Study|Lack of Efficacy|0|||
105855115|NCT02883049|365121719|FG012|Post Induction|Developed SMN|0|||
105855116|NCT02883049|365121720|FG013|Post Induction|Developed SMN|0|||
105855117|NCT02883049|365121721|FG014|Post Induction|Developed SMN|1|||
105855118|NCT02883049|365121722|FG015|Post Induction|Developed SMN|0|||
105855119|NCT02883049|365121707|FG000|Post Induction|Enrolled onto another COG study|0|||
105855120|NCT02883049|365121708|FG001|Post Induction|Enrolled onto another COG study|0|||
105855121|NCT02883049|365121709|FG002|Post Induction|Enrolled onto another COG study|0|||
105855122|NCT02883049|365121710|FG003|Post Induction|Enrolled onto another COG study|1|||
105855123|NCT02883049|365121711|FG004|Post Induction|Enrolled onto another COG study|1|||
105855124|NCT02883049|365121712|FG005|Post Induction|Enrolled onto another COG study|0|||
105855125|NCT02883049|365121713|FG006|Post Induction|Enrolled onto another COG study|0|||
105855126|NCT02883049|365121714|FG007|Post Induction|Enrolled onto another COG study|4|||
105855127|NCT02883049|365121715|FG008|Post Induction|Enrolled onto another COG study|0|||
105855128|NCT02883049|365121716|FG009|Post Induction|Enrolled onto another COG study|0|||
105855129|NCT02883049|365121717|FG010|Post Induction|Enrolled onto another COG study|0|||
105855130|NCT02883049|365121718|FG011|Post Induction|Enrolled onto another COG study|2|||
105855131|NCT02883049|365121719|FG012|Post Induction|Enrolled onto another COG study|0|||
105855132|NCT02883049|365121720|FG013|Post Induction|Enrolled onto another COG study|1|||
105855133|NCT02883049|365121721|FG014|Post Induction|Enrolled onto another COG study|0|||
105855134|NCT02883049|365121722|FG015|Post Induction|Enrolled onto another COG study|0|||
105855135|NCT02883049|365121707|FG000|Post Induction|Recurrent leukemia|0|||
105855136|NCT02883049|365121708|FG001|Post Induction|Recurrent leukemia|0|||
105855137|NCT02883049|365121709|FG002|Post Induction|Recurrent leukemia|0|||
105855138|NCT02883049|365121710|FG003|Post Induction|Recurrent leukemia|17|||
105855139|NCT02883049|365121711|FG004|Post Induction|Recurrent leukemia|12|||
105855140|NCT02883049|365121712|FG005|Post Induction|Recurrent leukemia|4|||
105855141|NCT02883049|365121713|FG006|Post Induction|Recurrent leukemia|1|||
105855142|NCT02883049|365121714|FG007|Post Induction|Recurrent leukemia|13|||
105855143|NCT02883049|365121715|FG008|Post Induction|Recurrent leukemia|27|||
105855144|NCT02883049|365121716|FG009|Post Induction|Recurrent leukemia|5|||
105855145|NCT02883049|365121717|FG010|Post Induction|Recurrent leukemia|3|||
105855146|NCT02883049|365121718|FG011|Post Induction|Recurrent leukemia|12|||
105855147|NCT02883049|365121719|FG012|Post Induction|Recurrent leukemia|1|||
105855148|NCT02883049|365121720|FG013|Post Induction|Recurrent leukemia|1|||
105855149|NCT02883049|365121721|FG014|Post Induction|Recurrent leukemia|9|||
105855150|NCT02883049|365121722|FG015|Post Induction|Recurrent leukemia|3|||
105855151|NCT02883049|365121707|FG000|Post Induction|Induction Failure|0|||
105855152|NCT02883049|365121708|FG001|Post Induction|Induction Failure|0|||
105855153|NCT02883049|365121709|FG002|Post Induction|Induction Failure|0|||
105855154|NCT02883049|365121710|FG003|Post Induction|Induction Failure|0|||
105855155|NCT02883049|365121711|FG004|Post Induction|Induction Failure|0|||
105855156|NCT02883049|365121712|FG005|Post Induction|Induction Failure|0|||
105855157|NCT02883049|365121713|FG006|Post Induction|Induction Failure|0|||
105855158|NCT02883049|365121714|FG007|Post Induction|Induction Failure|2|||
105855159|NCT02883049|365121715|FG008|Post Induction|Induction Failure|2|||
105855160|NCT02883049|365121716|FG009|Post Induction|Induction Failure|0|||
105855161|NCT02883049|365121717|FG010|Post Induction|Induction Failure|0|||
105855162|NCT02883049|365121718|FG011|Post Induction|Induction Failure|0|||
105855163|NCT02883049|365121719|FG012|Post Induction|Induction Failure|0|||
105855164|NCT02883049|365121720|FG013|Post Induction|Induction Failure|2|||
105855165|NCT02883049|365121721|FG014|Post Induction|Induction Failure|0|||
105855166|NCT02883049|365121722|FG015|Post Induction|Induction Failure|0|||
105855167|NCT03698994|365121723|FG000|Overall Study|Adverse Event|2|||
105855168|NCT03698994|365121723|FG000|Overall Study|Death|1|||
105855169|NCT03698994|365121723|FG000|Overall Study|Physician Decision|1|||
105855170|NCT03698994|365121723|FG000|Overall Study|Withdrawal by Subject|3|||
105855171|NCT03698994|365121723|FG000|Overall Study|Progressive Disease|12|||
105855172|NCT02567435|365121727|FG000|Overall Study|Death|1|||
105855173|NCT02567435|365121728|FG001|Overall Study|Death|1|||
105855174|NCT02567435|365121729|FG002|Overall Study|Death|0|||
105855175|NCT02567435|365121730|FG003|Overall Study|Death|0|||
105855176|NCT02567435|365121727|FG000|Overall Study|Ineligible|1|||
105855177|NCT02567435|365121728|FG001|Overall Study|Ineligible|3|||
105855178|NCT02567435|365121729|FG002|Overall Study|Ineligible|0|||
105328531|NCT00955409|363203512|FG000|Overall Study|Withdrawal by Subject|1|||
105855179|NCT02567435|365121730|FG003|Overall Study|Ineligible|0|||
105855180|NCT02567435|365121727|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
105855181|NCT02567435|365121728|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
105855182|NCT02567435|365121729|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
105855183|NCT02567435|365121730|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
105855184|NCT02166463|365121731|FG000|Overall Study|Lost to Follow-up|0|||
105328532|NCT00955409|363203513|FG001|Overall Study|Withdrawal by Subject|0|||
105328533|NCT00955409|363203514|FG002|Overall Study|Withdrawal by Subject|5|||
105855185|NCT02166463|365121732|FG001|Overall Study|Lost to Follow-up|1|||
105855186|NCT02166463|365121731|FG000|Overall Study|Physician Decision|10|||
105855187|NCT02166463|365121732|FG001|Overall Study|Physician Decision|10|||
105855188|NCT02166463|365121731|FG000|Overall Study|Ineligible|11|||
105855189|NCT02166463|365121732|FG001|Overall Study|Ineligible|2|||
105855190|NCT02166463|365121731|FG000|Overall Study|Progressive Disease|9|||
105328534|NCT00955409|363203515|FG003|Overall Study|Withdrawal by Subject|2|||
105328535|NCT00955409|363203516|FG004|Overall Study|Withdrawal by Subject|0|||
105328536|NCT00955409|363203517|FG005|Overall Study|Withdrawal by Subject|0|||
105328537|NCT00955409|363203518|FG006|Overall Study|Withdrawal by Subject|2|||
105328538|NCT00955409|363203519|FG007|Overall Study|Withdrawal by Subject|0|||
105328539|NCT00955409|363203520|FG008|Overall Study|Withdrawal by Subject|1|||
105328540|NCT00955409|363203521|FG009|Overall Study|Withdrawal by Subject|0|||
105328541|NCT00955409|363203512|FG000|Overall Study|Caregiver Request|2|||
105328542|NCT00955409|363203513|FG001|Overall Study|Caregiver Request|0|||
105328543|NCT00955409|363203514|FG002|Overall Study|Caregiver Request|6|||
105328544|NCT00955409|363203515|FG003|Overall Study|Caregiver Request|5|||
105328545|NCT00955409|363203516|FG004|Overall Study|Caregiver Request|0|||
105328546|NCT00955409|363203517|FG005|Overall Study|Caregiver Request|2|||
105328547|NCT00955409|363203518|FG006|Overall Study|Caregiver Request|3|||
105328548|NCT00955409|363203519|FG007|Overall Study|Caregiver Request|1|||
105328549|NCT00955409|363203520|FG008|Overall Study|Caregiver Request|3|||
105328550|NCT00955409|363203521|FG009|Overall Study|Caregiver Request|0|||
105328551|NCT00955409|363203512|FG000|Overall Study|Investigator Request|0|||
105328552|NCT00955409|363203513|FG001|Overall Study|Investigator Request|0|||
105328553|NCT00955409|363203514|FG002|Overall Study|Investigator Request|1|||
105328554|NCT00955409|363203515|FG003|Overall Study|Investigator Request|0|||
105328555|NCT00955409|363203516|FG004|Overall Study|Investigator Request|0|||
105328556|NCT00955409|363203517|FG005|Overall Study|Investigator Request|0|||
105328557|NCT00955409|363203518|FG006|Overall Study|Investigator Request|0|||
105328558|NCT00955409|363203519|FG007|Overall Study|Investigator Request|0|||
105328559|NCT00955409|363203520|FG008|Overall Study|Investigator Request|0|||
105328560|NCT00955409|363203521|FG009|Overall Study|Investigator Request|0|||
105328561|NCT00955409|363203512|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
105328562|NCT00955409|363203513|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
105328563|NCT00955409|363203514|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
105328564|NCT00955409|363203515|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
105328565|NCT00955409|363203516|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
105328566|NCT00955409|363203517|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
105328567|NCT00955409|363203518|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
105328568|NCT00955409|363203519|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
105328569|NCT00955409|363203520|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
105328570|NCT00955409|363203521|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
105328571|NCT00955409|363203512|FG000|Overall Study|Lost to Follow-up|0|||
105328572|NCT00955409|363203513|FG001|Overall Study|Lost to Follow-up|0|||
105328573|NCT00955409|363203514|FG002|Overall Study|Lost to Follow-up|1|||
105328574|NCT00955409|363203515|FG003|Overall Study|Lost to Follow-up|0|||
105328575|NCT00955409|363203516|FG004|Overall Study|Lost to Follow-up|0|||
105328576|NCT00955409|363203517|FG005|Overall Study|Lost to Follow-up|0|||
105328577|NCT00955409|363203518|FG006|Overall Study|Lost to Follow-up|1|||
105328578|NCT00955409|363203519|FG007|Overall Study|Lost to Follow-up|0|||
105328579|NCT00955409|363203520|FG008|Overall Study|Lost to Follow-up|0|||
105328580|NCT00955409|363203521|FG009|Overall Study|Lost to Follow-up|0|||
105328581|NCT00955409|363203512|FG000|Overall Study|Failed to Return|2|||
105328582|NCT00955409|363203513|FG001|Overall Study|Failed to Return|0|||
105328583|NCT00955409|363203514|FG002|Overall Study|Failed to Return|0|||
105328584|NCT00955409|363203515|FG003|Overall Study|Failed to Return|0|||
105328585|NCT00955409|363203516|FG004|Overall Study|Failed to Return|0|||
105328586|NCT00955409|363203517|FG005|Overall Study|Failed to Return|0|||
105328587|NCT00955409|363203518|FG006|Overall Study|Failed to Return|0|||
105328588|NCT00955409|363203519|FG007|Overall Study|Failed to Return|2|||
105328589|NCT00955409|363203520|FG008|Overall Study|Failed to Return|0|||
105328590|NCT00955409|363203521|FG009|Overall Study|Failed to Return|0|||
105328591|NCT00955409|363203512|FG000|Overall Study|Adverse Event (AE)|2|||
105328592|NCT00955409|363203513|FG001|Overall Study|Adverse Event (AE)|0|||
105328593|NCT00955409|363203514|FG002|Overall Study|Adverse Event (AE)|0|||
105328594|NCT00955409|363203515|FG003|Overall Study|Adverse Event (AE)|0|||
105328595|NCT00955409|363203516|FG004|Overall Study|Adverse Event (AE)|0|||
105328596|NCT00955409|363203517|FG005|Overall Study|Adverse Event (AE)|1|||
105328597|NCT00955409|363203518|FG006|Overall Study|Adverse Event (AE)|2|||
105328598|NCT00955409|363203519|FG007|Overall Study|Adverse Event (AE)|0|||
105328599|NCT00955409|363203520|FG008|Overall Study|Adverse Event (AE)|2|||
105328600|NCT00955409|363203521|FG009|Overall Study|Adverse Event (AE)|0|||
105328601|NCT00955409|363203512|FG000|Overall Study|Reason not Specified|2|||
105328602|NCT00955409|363203513|FG001|Overall Study|Reason not Specified|1|||
105328603|NCT00955409|363203514|FG002|Overall Study|Reason not Specified|13|||
105328604|NCT00955409|363203515|FG003|Overall Study|Reason not Specified|1|||
105328605|NCT00955409|363203516|FG004|Overall Study|Reason not Specified|2|||
105328606|NCT00955409|363203517|FG005|Overall Study|Reason not Specified|0|||
105328607|NCT00955409|363203518|FG006|Overall Study|Reason not Specified|16|||
105328608|NCT00955409|363203519|FG007|Overall Study|Reason not Specified|0|||
105328609|NCT00955409|363203520|FG008|Overall Study|Reason not Specified|8|||
105328610|NCT00955409|363203521|FG009|Overall Study|Reason not Specified|1|||
105328611|NCT00570687|363203524|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328612|NCT00570687|363203525|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328613|NCT00570687|363203526|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328614|NCT00570687|363203527|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328615|NCT00570687|363203528|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
105328616|NCT00570687|363203529|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
105328617|NCT00570687|363203530|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
105328618|NCT00570687|363203531|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
105328619|NCT00570687|363203532|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
105328620|NCT00570687|363203533|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
105328621|NCT00570687|363203524|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328622|NCT00570687|363203525|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328623|NCT00570687|363203526|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328624|NCT00570687|363203527|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328625|NCT00570687|363203528|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328626|NCT00570687|363203529|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105374287|NCT02696798|363376401|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
105374288|NCT02696798|363376402|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
105374289|NCT02696798|363376400|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
105374290|NCT02696798|363376401|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
105374291|NCT02696798|363376402|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
105855191|NCT02166463|365121732|FG001|Overall Study|Progressive Disease|6|||
105855192|NCT02166463|365121731|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
105855193|NCT02166463|365121732|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
105855194|NCT02166463|365121731|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
105855195|NCT02166463|365121732|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
105855196|NCT02166463|365121731|FG000|Overall Study|Refusal of further protocol therapy|5|||
105855197|NCT02166463|365121732|FG001|Overall Study|Refusal of further protocol therapy|6|||
105855198|NCT03641313|365121733|FG000|Overall Study|Death|1|||
105855199|NCT03641313|365121733|FG000|Overall Study|Withdrawal by Subject|2|||
105855200|NCT03641313|365121733|FG000|Overall Study|Declining health|1|||
105855201|NCT03641313|365121733|FG000|Overall Study|Adverse Event|1|||
105855202|NCT04642898|365121734|FG000|Overall Study|Withdrawal by Subject|2|||
105855203|NCT04642898|365121735|FG001|Overall Study|Withdrawal by Subject|4|||
105855204|NCT04642898|365121736|FG002|Overall Study|Withdrawal by Subject|4|||
105855205|NCT04642898|365121737|FG003|Overall Study|Withdrawal by Subject|6|||
105855206|NCT04642898|365121738|FG004|Overall Study|Withdrawal by Subject|2|||
105855207|NCT04642898|365121739|FG005|Overall Study|Withdrawal by Subject|6|||
105855208|NCT04642898|365121734|FG000|Overall Study|Lost to Follow-up|0|||
105855209|NCT04642898|365121735|FG001|Overall Study|Lost to Follow-up|0|||
105855210|NCT04642898|365121736|FG002|Overall Study|Lost to Follow-up|0|||
105855211|NCT04642898|365121737|FG003|Overall Study|Lost to Follow-up|2|||
105855212|NCT04642898|365121738|FG004|Overall Study|Lost to Follow-up|0|||
105855213|NCT04642898|365121739|FG005|Overall Study|Lost to Follow-up|1|||
105855214|NCT04642898|365121734|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
105855215|NCT04642898|365121735|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
105855216|NCT04642898|365121736|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
105855217|NCT04642898|365121737|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
105855218|NCT04642898|365121738|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
105855219|NCT04642898|365121739|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
105855220|NCT04642898|365121734|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
105855221|NCT04642898|365121735|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
105855222|NCT04642898|365121736|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
105855223|NCT04642898|365121737|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
105855224|NCT04642898|365121738|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
105855225|NCT04642898|365121739|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
105328627|NCT00570687|363203530|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328628|NCT00570687|363203531|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328629|NCT00570687|363203532|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
105328630|NCT00570687|363203533|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105374292|NCT02696798|363376400|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
105374293|NCT02696798|363376401|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
105374294|NCT02696798|363376402|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
105855226|NCT03033225|365121740|FG000|Overall Study|Withdrawal by Subject|5|||
105855227|NCT05856227|365121741|FG000|Overall Study|Adverse Event|0|||
105374295|NCT02696798|363376400|FG000|Extended Treatment Period|Adverse Event|1|||
105328631|NCT00570687|363203524|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328632|NCT00570687|363203525|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328633|NCT00570687|363203526|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328634|NCT00570687|363203527|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328635|NCT00570687|363203528|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328636|NCT00570687|363203529|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105374296|NCT02696798|363376401|FG001|Extended Treatment Period|Adverse Event|4|||
105374297|NCT02696798|363376402|FG002|Extended Treatment Period|Adverse Event|5|||
105374298|NCT02696798|363376400|FG000|Extended Treatment Period|Lack of Efficacy|7|||
105374299|NCT02696798|363376401|FG001|Extended Treatment Period|Lack of Efficacy|2|||
105374300|NCT02696798|363376402|FG002|Extended Treatment Period|Lack of Efficacy|2|||
105374301|NCT02696798|363376400|FG000|Extended Treatment Period|Lost to Follow-up|1|||
105374302|NCT02696798|363376401|FG001|Extended Treatment Period|Lost to Follow-up|0|||
105374303|NCT02696798|363376402|FG002|Extended Treatment Period|Lost to Follow-up|0|||
105374304|NCT02696798|363376400|FG000|Extended Treatment Period|Physician Decision|0|||
105374305|NCT02696798|363376401|FG001|Extended Treatment Period|Physician Decision|1|||
105374306|NCT02696798|363376402|FG002|Extended Treatment Period|Physician Decision|0|||
105374307|NCT02696798|363376400|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
105374308|NCT02696798|363376401|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
105374309|NCT02696798|363376402|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
105374310|NCT02696798|363376400|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
105328637|NCT00570687|363203530|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
105328638|NCT00570687|363203531|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328639|NCT00570687|363203532|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328640|NCT00570687|363203533|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105328641|NCT03055338|363203534|FG000|Overall Study|Lost to Follow-up|9|||
105328642|NCT03055338|363203535|FG001|Overall Study|Lost to Follow-up|2|||
105374311|NCT02696798|363376401|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
105374312|NCT02696798|363376402|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
105374313|NCT02696798|363376400|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
105374314|NCT02696798|363376401|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
105374315|NCT02696798|363376402|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
105374316|NCT02696798|363376400|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
105374317|NCT02696798|363376401|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
105374318|NCT02696798|363376402|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
105374319|NCT02696798|363376400|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
105374320|NCT02696798|363376401|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
105374321|NCT02696798|363376402|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
105374322|NCT02696798|363376400|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
105374323|NCT02696798|363376401|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
105374324|NCT02696798|363376402|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
105374325|NCT02696798|363376400|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
105374326|NCT02696798|363376401|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
105374327|NCT02696798|363376402|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
105374328|NCT00857389|363376403|FG000|Overall Study|Did not proceed to transplant|2|||
105374329|NCT03311555|363376405|FG000|Overall Study|Adverse Event|1|||
105855228|NCT05856227|365121742|FG001|Overall Study|Adverse Event|1|||
105855229|NCT05856227|365121741|FG000|Overall Study|Due to Investigator absence|1|||
105855230|NCT05856227|365121742|FG001|Overall Study|Due to Investigator absence|0|||
105855231|NCT05856227|365121741|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
105855232|NCT05856227|365121742|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
105855233|NCT03434678|365121744|FG000|Overall Study|Withdrawal by Subject|13|||
105855234|NCT03434678|365121745|FG001|Overall Study|Withdrawal by Subject|13|||
105328643|NCT03055338|363203536|FG002|Overall Study|Lost to Follow-up|3|||
105328644|NCT03055338|363203534|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
105328645|NCT03055338|363203535|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
105328646|NCT03055338|363203536|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
105374330|NCT03069989|363376407|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
105374331|NCT03069989|363376408|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
105374332|NCT03846479|363377639|FG000|Overall Study|Death|8|||
105374333|NCT03846479|363377639|FG000|Overall Study|Lost to Follow-up|1|||
105374334|NCT01171534|363377642|FG000|Overall Study|Lost to Follow-up|0|||
105374335|NCT01171534|363377643|FG001|Overall Study|Lost to Follow-up|2|||
105374336|NCT01171534|363377642|FG000|Overall Study|screen failure|0|||
105374337|NCT01171534|363377643|FG001|Overall Study|screen failure|1|||
105374338|NCT00548327|363377644|FG000|Overall Study|Adverse Event|0|||
105328647|NCT03055338|363203534|FG000|Overall Study|Physician Decision|0|||
105374339|NCT00548327|363377645|FG001|Overall Study|Adverse Event|1|||
105374340|NCT00274456|363377646|FG000|Overall Study|Still on treatment|2|||
105374341|NCT00274456|363377647|FG001|Overall Study|Still on treatment|3|||
105855235|NCT03434678|365121744|FG000|Overall Study|Found to be ineligible post randomization|2|||
105855236|NCT03434678|365121745|FG001|Overall Study|Found to be ineligible post randomization|1|||
105855237|NCT05011058|365121746|FG000|Overall Study|Sponsor Decision|2|||
105855238|NCT05011058|365121747|FG001|Overall Study|Sponsor Decision|0|||
105855239|NCT05011058|365121748|FG002|Overall Study|Sponsor Decision|14|||
105855240|NCT05011058|365121749|FG003|Overall Study|Sponsor Decision|0|||
105855241|NCT05011058|365121750|FG004|Overall Study|Sponsor Decision|0|||
105855242|NCT05011058|365121751|FG005|Overall Study|Sponsor Decision|1|||
105855243|NCT05011058|365121752|FG006|Overall Study|Sponsor Decision|0|||
105855244|NCT05011058|365121753|FG007|Overall Study|Sponsor Decision|5|||
105855245|NCT06060457|365121758|FG000|Overall Study|Adverse Event|1|||
105855246|NCT06060457|365121759|FG001|Overall Study|Adverse Event|1|||
105855247|NCT06060457|365121758|FG000|Overall Study|Death|2|||
105855248|NCT06060457|365121759|FG001|Overall Study|Death|2|||
105855249|NCT06060457|365121758|FG000|Overall Study|Lost to Follow-up|17|||
105855250|NCT06060457|365121759|FG001|Overall Study|Lost to Follow-up|19|||
105855251|NCT06060457|365121758|FG000|Overall Study|Physician Decision|0|||
105855252|NCT06060457|365121759|FG001|Overall Study|Physician Decision|1|||
105855253|NCT06060457|365121758|FG000|Overall Study|Protocol Violation|1|||
105855254|NCT06060457|365121759|FG001|Overall Study|Protocol Violation|1|||
105855255|NCT06060457|365121758|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
105855256|NCT06060457|365121759|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
105855257|NCT06060457|365121758|FG000|Overall Study|Withdrawal by Subject|12|||
105855258|NCT06060457|365121759|FG001|Overall Study|Withdrawal by Subject|15|||
105855259|NCT06060457|365121758|FG000|Overall Study|Other Than Specified|2|||
105855260|NCT06060457|365121759|FG001|Overall Study|Other Than Specified|1|||
105328648|NCT03055338|363203535|FG001|Overall Study|Physician Decision|0|||
105328649|NCT03055338|363203536|FG002|Overall Study|Physician Decision|2|||
105328650|NCT03055338|363203534|FG000|Overall Study|Withdrawal by Subject|9|||
105328651|NCT03055338|363203535|FG001|Overall Study|Withdrawal by Subject|8|||
105328652|NCT03055338|363203536|FG002|Overall Study|Withdrawal by Subject|7|||
105328653|NCT00803790|363203537|FG000|Period 1|Adverse Event|0|||
105328654|NCT00803790|363203538|FG001|Period 1|Adverse Event|1|||
105328655|NCT00803790|363203539|FG002|Period 1|Adverse Event|0|||
105328656|NCT00803790|363203540|FG003|Period 1|Adverse Event|0|||
105328657|NCT00803790|363203537|FG000|Period 1|Lost to Follow-up|1|||
105328658|NCT00803790|363203538|FG001|Period 1|Lost to Follow-up|2|||
105328659|NCT00803790|363203539|FG002|Period 1|Lost to Follow-up|0|||
105328660|NCT00803790|363203540|FG003|Period 1|Lost to Follow-up|0|||
105328661|NCT00803790|363203537|FG000|Period 1|Withdrawal by Subject|8|||
105328662|NCT00803790|363203538|FG001|Period 1|Withdrawal by Subject|6|||
105328663|NCT00803790|363203539|FG002|Period 1|Withdrawal by Subject|0|||
105328664|NCT00803790|363203540|FG003|Period 1|Withdrawal by Subject|0|||
105328665|NCT00803790|363203537|FG000|Period 1|positive drug screen or personal reasons|0|||
105328666|NCT00803790|363203538|FG001|Period 1|positive drug screen or personal reasons|3|||
105328667|NCT00803790|363203539|FG002|Period 1|positive drug screen or personal reasons|0|||
105328668|NCT00803790|363203540|FG003|Period 1|positive drug screen or personal reasons|4|||
105328669|NCT00803790|363203537|FG000|Period 1|Protocol Violation|0|||
105328670|NCT00803790|363203538|FG001|Period 1|Protocol Violation|0|||
105328671|NCT00803790|363203539|FG002|Period 1|Protocol Violation|1|||
105328672|NCT00803790|363203540|FG003|Period 1|Protocol Violation|0|||
105328673|NCT00803790|363203537|FG000|Period 2|Adverse Event|0|||
105328674|NCT00803790|363203538|FG001|Period 2|Adverse Event|0|||
105328675|NCT00803790|363203539|FG002|Period 2|Adverse Event|1|||
105328676|NCT00803790|363203540|FG003|Period 2|Adverse Event|1|||
105328677|NCT00803790|363203537|FG000|Period 2|Withdrawal by Subject|1|||
105328678|NCT00803790|363203538|FG001|Period 2|Withdrawal by Subject|0|||
105328679|NCT00803790|363203539|FG002|Period 2|Withdrawal by Subject|0|||
105328680|NCT00803790|363203540|FG003|Period 2|Withdrawal by Subject|0|||
105328681|NCT00803790|363203537|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
105328682|NCT00803790|363203538|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
105328683|NCT00803790|363203539|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
105328684|NCT00803790|363203540|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
105328685|NCT02151851|363203543|FG000|Overall Study|Lack of Efficacy|67|||
105328686|NCT02151851|363203544|FG001|Overall Study|Lack of Efficacy|94|||
105328687|NCT02151851|363203543|FG000|Overall Study|Protocol Violation|0|||
105328688|NCT02151851|363203544|FG001|Overall Study|Protocol Violation|1|||
105328689|NCT02151851|363203543|FG000|Overall Study|Withdrawal by Subject|2|||
105328690|NCT02151851|363203544|FG001|Overall Study|Withdrawal by Subject|5|||
105328691|NCT02151851|363203543|FG000|Overall Study|Medical impairment|1|||
105328692|NCT02151851|363203544|FG001|Overall Study|Medical impairment|0|||
105328693|NCT02151851|363203543|FG000|Overall Study|Low compliance to study visits|0|||
105374342|NCT00274456|363377648|FG002|Overall Study|Still on treatment|5|||
105855261|NCT02003222|365121760|FG000|Induction|Never started treatment|0|||
105855262|NCT02003222|365121761|FG001|Induction|Never started treatment|0|||
105855263|NCT02003222|365121762|FG002|Induction|Never started treatment|0|||
105855264|NCT02003222|365121763|FG003|Induction|Never started treatment|0|||
105855265|NCT02003222|365121764|FG004|Induction|Never started treatment|8|||
105328694|NCT02151851|363203544|FG001|Overall Study|Low compliance to study visits|1|||
105328695|NCT02151851|363203543|FG000|Overall Study|Subject entered into study in error|0|||
105328696|NCT02151851|363203544|FG001|Overall Study|Subject entered into study in error|1|||
105328697|NCT02151851|363203543|FG000|Overall Study|Adverse Event|6|||
105328698|NCT02151851|363203544|FG001|Overall Study|Adverse Event|28|||
105328699|NCT02159053|363203545|FG000|Overall Study|Death|2|||
105328700|NCT02159053|363203546|FG001|Overall Study|Death|0|||
105328701|NCT02159053|363203547|FG002|Overall Study|Death|1|||
105328702|NCT02159053|363203545|FG000|Overall Study|Physician Decision|0|||
105328703|NCT02159053|363203546|FG001|Overall Study|Physician Decision|1|||
105328704|NCT02159053|363203547|FG002|Overall Study|Physician Decision|1|||
105328705|NCT02159053|363203545|FG000|Overall Study|Lack of Efficacy|3|||
105328706|NCT02159053|363203546|FG001|Overall Study|Lack of Efficacy|4|||
105328707|NCT02159053|363203547|FG002|Overall Study|Lack of Efficacy|7|||
105328708|NCT02159053|363203545|FG000|Overall Study|Adverse Event|7|||
105328709|NCT02159053|363203546|FG001|Overall Study|Adverse Event|6|||
105328710|NCT02159053|363203547|FG002|Overall Study|Adverse Event|5|||
105328711|NCT02159053|363203545|FG000|Overall Study|Participants/guardian decision|8|||
105328712|NCT02159053|363203546|FG001|Overall Study|Participants/guardian decision|10|||
105328713|NCT02159053|363203547|FG002|Overall Study|Participants/guardian decision|6|||
105328714|NCT01540487|363203554|FG000|Overall Study|Protocol Violation|1|||
105328715|NCT01540487|363203555|FG001|Overall Study|Protocol Violation|0|||
105328716|NCT04846569|363203563|FG000|Overall Study|Withdrawal by Subject|3|||
105328717|NCT04846569|363203564|FG001|Overall Study|Withdrawal by Subject|1|||
105328718|NCT01217112|363203565|FG000|Overall Study|Adverse Event|0|||
105328719|NCT01217112|363203566|FG001|Overall Study|Adverse Event|2|||
105328720|NCT01217112|363203567|FG002|Overall Study|Adverse Event|0|||
105328721|NCT01217112|363203568|FG003|Overall Study|Adverse Event|2|||
105328722|NCT01217112|363203569|FG004|Overall Study|Adverse Event|0|||
105328723|NCT01217112|363203565|FG000|Overall Study|Withdrawal by Subject|0|||
105328724|NCT01217112|363203566|FG001|Overall Study|Withdrawal by Subject|0|||
105328725|NCT01217112|363203567|FG002|Overall Study|Withdrawal by Subject|1|||
105328726|NCT01217112|363203568|FG003|Overall Study|Withdrawal by Subject|0|||
105328727|NCT01217112|363203569|FG004|Overall Study|Withdrawal by Subject|0|||
105328728|NCT01217112|363203565|FG000|Overall Study|Physician Decision|0|||
105328729|NCT01217112|363203566|FG001|Overall Study|Physician Decision|0|||
105328730|NCT01217112|363203567|FG002|Overall Study|Physician Decision|0|||
105328731|NCT01217112|363203568|FG003|Overall Study|Physician Decision|0|||
105328732|NCT01217112|363203569|FG004|Overall Study|Physician Decision|1|||
105328733|NCT00351468|363203570|FG000|Overall Study|Adverse Event|42|||
105328734|NCT00351468|363203570|FG000|Overall Study|Withdrawal by Subject|39|||
105328735|NCT00351468|363203570|FG000|Overall Study|Various -follow up w clinical team|39|||
105328736|NCT00351468|363203570|FG000|Overall Study|Lack of Efficacy|32|||
105328737|NCT00351468|363203570|FG000|Overall Study|Non-compliance|8|||
105328738|NCT00351468|363203570|FG000|Overall Study|Lost to Follow-up|4|||
105328739|NCT00351468|363203570|FG000|Overall Study|Protocol Violation|3|||
105328740|NCT01894841|363203571|FG000|Overall Study|Withdrawal by Subject|9|||
105328741|NCT01894841|363203572|FG001|Overall Study|Withdrawal by Subject|4|||
105328742|NCT01894841|363203571|FG000|Overall Study|Withdrawn by investigator|2|||
105328743|NCT01894841|363203572|FG001|Overall Study|Withdrawn by investigator|2|||
105328744|NCT01894841|363203571|FG000|Overall Study|Lost to Follow-up|7|||
105328745|NCT01894841|363203572|FG001|Overall Study|Lost to Follow-up|3|||
105328746|NCT00683618|363203575|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
105328747|NCT00683618|363203576|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
105328748|NCT00683618|363203577|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
105328749|NCT00683618|363203575|FG000|Randomised Treatment Period|Protocol Violation|0|||
105328750|NCT00683618|363203576|FG001|Randomised Treatment Period|Protocol Violation|1|||
105328751|NCT00683618|363203577|FG002|Randomised Treatment Period|Protocol Violation|0|||
105328752|NCT00683618|363203575|FG000|Randomised Treatment Period|Adverse Event|2|||
105328753|NCT00683618|363203576|FG001|Randomised Treatment Period|Adverse Event|0|||
105328754|NCT00683618|363203577|FG002|Randomised Treatment Period|Adverse Event|2|||
105328755|NCT00683618|363203575|FG000|Randomised Treatment Period|Reason not provided|0|||
105328756|NCT00683618|363203576|FG001|Randomised Treatment Period|Reason not provided|0|||
105328757|NCT00683618|363203577|FG002|Randomised Treatment Period|Reason not provided|2|||
105328758|NCT00683618|363203575|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
105328759|NCT00683618|363203576|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
105328760|NCT00683618|363203577|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
105328761|NCT00683618|363203575|FG000|Extension Treatment Period|Adverse Event|1|||
105328762|NCT00683618|363203576|FG001|Extension Treatment Period|Adverse Event|0|||
105328763|NCT00683618|363203577|FG002|Extension Treatment Period|Adverse Event|0|||
105328764|NCT00683618|363203575|FG000|Extension Treatment Period|Protocol Violation|1|||
105328765|NCT00683618|363203576|FG001|Extension Treatment Period|Protocol Violation|0|||
105328766|NCT00683618|363203577|FG002|Extension Treatment Period|Protocol Violation|0|||
105328767|NCT00529087|363203578|FG000|Overall Study|Adverse Event|10|||
105328768|NCT00529087|363203579|FG001|Overall Study|Adverse Event|13|||
105328769|NCT00529087|363203580|FG002|Overall Study|Adverse Event|4|||
105855266|NCT02003222|365121760|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
105855267|NCT02003222|365121761|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
105855268|NCT02003222|365121762|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
105855269|NCT02003222|365121763|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
105855270|NCT02003222|365121764|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
105855271|NCT02003222|365121760|FG000|Induction|Adverse Event|0|||
105855272|NCT02003222|365121761|FG001|Induction|Adverse Event|0|||
105855273|NCT02003222|365121762|FG002|Induction|Adverse Event|0|||
105855274|NCT02003222|365121763|FG003|Induction|Adverse Event|0|||
105855275|NCT02003222|365121764|FG004|Induction|Adverse Event|13|||
105855276|NCT02003222|365121760|FG000|Induction|Alternative therapy|0|||
105855277|NCT02003222|365121761|FG001|Induction|Alternative therapy|0|||
105855278|NCT02003222|365121762|FG002|Induction|Alternative therapy|0|||
105855279|NCT02003222|365121763|FG003|Induction|Alternative therapy|0|||
105855280|NCT02003222|365121764|FG004|Induction|Alternative therapy|12|||
105855281|NCT02003222|365121760|FG000|Induction|Disease progression|0|||
105855282|NCT02003222|365121761|FG001|Induction|Disease progression|0|||
105855283|NCT02003222|365121762|FG002|Induction|Disease progression|0|||
105855284|NCT02003222|365121763|FG003|Induction|Disease progression|0|||
105855285|NCT02003222|365121764|FG004|Induction|Disease progression|22|||
105855286|NCT02003222|365121760|FG000|Induction|Death|0|||
105855287|NCT02003222|365121761|FG001|Induction|Death|0|||
105855288|NCT02003222|365121762|FG002|Induction|Death|0|||
105855289|NCT02003222|365121763|FG003|Induction|Death|0|||
105855290|NCT02003222|365121764|FG004|Induction|Death|3|||
105855291|NCT02003222|365121760|FG000|Induction|Withdrawal by Subject|0|||
105855292|NCT02003222|365121761|FG001|Induction|Withdrawal by Subject|0|||
105855293|NCT02003222|365121762|FG002|Induction|Withdrawal by Subject|0|||
105855294|NCT02003222|365121763|FG003|Induction|Withdrawal by Subject|0|||
105855295|NCT02003222|365121764|FG004|Induction|Withdrawal by Subject|8|||
105855296|NCT02003222|365121760|FG000|Induction|Other reasons|0|||
105855297|NCT02003222|365121761|FG001|Induction|Other reasons|0|||
105855298|NCT02003222|365121762|FG002|Induction|Other reasons|0|||
105855299|NCT02003222|365121763|FG003|Induction|Other reasons|0|||
105855300|NCT02003222|365121764|FG004|Induction|Other reasons|22|||
105855301|NCT02003222|365121760|FG000|Intensification|Never started treatment|0|||
105855302|NCT02003222|365121761|FG001|Intensification|Never started treatment|0|||
105855303|NCT02003222|365121762|FG002|Intensification|Never started treatment|0|||
105855304|NCT02003222|365121763|FG003|Intensification|Never started treatment|0|||
105855305|NCT02003222|365121764|FG004|Intensification|Never started treatment|2|||
105855306|NCT02003222|365121760|FG000|Intensification|Adverse Event|0|||
105855307|NCT02003222|365121761|FG001|Intensification|Adverse Event|0|||
105855308|NCT02003222|365121762|FG002|Intensification|Adverse Event|0|||
105855309|NCT02003222|365121763|FG003|Intensification|Adverse Event|0|||
105855310|NCT02003222|365121764|FG004|Intensification|Adverse Event|6|||
105855311|NCT02003222|365121760|FG000|Intensification|Alternative therapy|0|||
105855312|NCT02003222|365121761|FG001|Intensification|Alternative therapy|0|||
105855313|NCT02003222|365121762|FG002|Intensification|Alternative therapy|0|||
105855314|NCT02003222|365121763|FG003|Intensification|Alternative therapy|0|||
105855315|NCT02003222|365121764|FG004|Intensification|Alternative therapy|8|||
105855316|NCT02003222|365121760|FG000|Intensification|Disease progression|0|||
105855317|NCT02003222|365121761|FG001|Intensification|Disease progression|0|||
105855318|NCT02003222|365121762|FG002|Intensification|Disease progression|0|||
105855319|NCT02003222|365121763|FG003|Intensification|Disease progression|0|||
105855320|NCT02003222|365121764|FG004|Intensification|Disease progression|18|||
105855321|NCT02003222|365121760|FG000|Intensification|Withdrawal by Subject|0|||
105855322|NCT02003222|365121761|FG001|Intensification|Withdrawal by Subject|0|||
105855323|NCT02003222|365121762|FG002|Intensification|Withdrawal by Subject|0|||
105855324|NCT02003222|365121763|FG003|Intensification|Withdrawal by Subject|0|||
105855325|NCT02003222|365121764|FG004|Intensification|Withdrawal by Subject|5|||
105855326|NCT02003222|365121760|FG000|Intensification|Other reasons|0|||
105374343|NCT00274456|363377649|FG003|Overall Study|Still on treatment|1|||
105374344|NCT00274456|363377646|FG000|Overall Study|Unacceptable toxicity|10|||
105374345|NCT00274456|363377647|FG001|Overall Study|Unacceptable toxicity|5|||
105855327|NCT02003222|365121761|FG001|Intensification|Other reasons|0|||
105855328|NCT02003222|365121762|FG002|Intensification|Other reasons|0|||
105855329|NCT02003222|365121763|FG003|Intensification|Other reasons|0|||
105855330|NCT02003222|365121764|FG004|Intensification|Other reasons|8|||
105374346|NCT00274456|363377648|FG002|Overall Study|Unacceptable toxicity|12|||
105374347|NCT00274456|363377649|FG003|Overall Study|Unacceptable toxicity|16|||
105374348|NCT00274456|363377646|FG000|Overall Study|Adverse Event|0|||
105855331|NCT01886872|365121766|FG000|Overall Study|Ineligible|7|||
105855332|NCT01886872|365121767|FG001|Overall Study|Ineligible|4|||
105855333|NCT01886872|365121768|FG002|Overall Study|Ineligible|12|||
105855334|NCT05163522|365121769|FG000|Overall Study|Withdrawal by Subject|0|||
105855335|NCT05163522|365121770|FG001|Overall Study|Withdrawal by Subject|0|||
105855336|NCT05163522|365121771|FG002|Overall Study|Withdrawal by Subject|1|||
105855337|NCT05163522|365121772|FG003|Overall Study|Withdrawal by Subject|0|||
105374349|NCT00274456|363377647|FG001|Overall Study|Adverse Event|1|||
105374350|NCT00274456|363377648|FG002|Overall Study|Adverse Event|2|||
105855338|NCT05163522|365121773|FG004|Overall Study|Withdrawal by Subject|0|||
105855339|NCT05163522|365121774|FG005|Overall Study|Withdrawal by Subject|0|||
105855340|NCT05163522|365121775|FG006|Overall Study|Withdrawal by Subject|0|||
105855341|NCT05163522|365121776|FG007|Overall Study|Withdrawal by Subject|0|||
105855342|NCT05163522|365121777|FG008|Overall Study|Withdrawal by Subject|0|||
105855343|NCT05163522|365121778|FG009|Overall Study|Withdrawal by Subject|0|||
105855344|NCT05163522|365121779|FG010|Overall Study|Withdrawal by Subject|0|||
105855345|NCT03939637|365121793|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
105855346|NCT03939637|365121794|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
105855347|NCT03939637|365121793|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
105855348|NCT03939637|365121794|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
105855349|NCT03412396|365121795|FG000|Overall Study|Withdrawal by Subject|2|||
105855350|NCT03412396|365121795|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
105855351|NCT03412396|365121795|FG000|Overall Study|Did not undergo RP|2|||
105855352|NCT05224076|365121801|FG000|Overall Study|Lost to Follow-up|24|||
105855353|NCT03698019|365121802|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
105855354|NCT03698019|365121803|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
105855355|NCT03698019|365121802|FG000|Step 1: Registration|Withdrawal by Subject|7|||
105855356|NCT03698019|365121803|FG001|Step 1: Registration|Withdrawal by Subject|2|||
105855357|NCT03698019|365121802|FG000|Step 1: Registration|Toxicity|0|||
105855358|NCT03698019|365121803|FG001|Step 1: Registration|Toxicity|1|||
105855359|NCT03698019|365121802|FG000|Step 1: Registration|Disease Progression|0|||
105855360|NCT03698019|365121803|FG001|Step 1: Registration|Disease Progression|12|||
105855361|NCT03698019|365121802|FG000|Step 1: Registration|Co-morbidities|0|||
105855362|NCT03698019|365121803|FG001|Step 1: Registration|Co-morbidities|1|||
105855363|NCT03698019|365121802|FG000|Step 1: Registration|Scheduling Issues|1|||
105855364|NCT03698019|365121803|FG001|Step 1: Registration|Scheduling Issues|0|||
105855365|NCT03698019|365121802|FG000|Step 1: Registration|Participant Refusal|0|||
105855366|NCT03698019|365121803|FG001|Step 1: Registration|Participant Refusal|1|||
105855367|NCT03698019|365121802|FG000|Step 2: Surgery|Participant Refusal|2|||
105855368|NCT03698019|365121803|FG001|Step 2: Surgery|Participant Refusal|1|||
105855369|NCT03698019|365121802|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
105855370|NCT03698019|365121803|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
105855371|NCT03698019|365121802|FG000|Step 2: Surgery|Metastatic Disease|16|||
105855372|NCT03698019|365121803|FG001|Step 2: Surgery|Metastatic Disease|9|||
105855373|NCT03698019|365121802|FG000|Step 2: Surgery|Residual Disease|2|||
105855374|NCT03698019|365121803|FG001|Step 2: Surgery|Residual Disease|1|||
105855375|NCT03698019|365121802|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
105855376|NCT03698019|365121803|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
105855377|NCT03698019|365121802|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
105855378|NCT03698019|365121803|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
105855379|NCT03698019|365121802|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
105855380|NCT03698019|365121803|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
105855381|NCT03698019|365121802|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
105855382|NCT03698019|365121803|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
105855383|NCT03698019|365121802|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
105855384|NCT03698019|365121803|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
105855385|NCT03698019|365121802|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
105855386|NCT03698019|365121803|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
105855387|NCT03698019|365121802|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
105855388|NCT03698019|365121803|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
105855389|NCT03698019|365121802|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
105855390|NCT03698019|365121803|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
105855391|NCT00588770|365121804|FG000|Overall Study|Disease progression|85|||
105855392|NCT00588770|365121805|FG001|Overall Study|Disease progression|68|||
105855393|NCT00588770|365121804|FG000|Overall Study|Adverse Event|29|||
105374351|NCT00274456|363377649|FG003|Overall Study|Adverse Event|2|||
105374352|NCT00274456|363377646|FG000|Overall Study|Physician Decision|7|||
105374353|NCT00274456|363377647|FG001|Overall Study|Physician Decision|5|||
105855394|NCT00588770|365121805|FG001|Overall Study|Adverse Event|58|||
105855395|NCT00588770|365121804|FG000|Overall Study|Death|13|||
105855396|NCT00588770|365121805|FG001|Overall Study|Death|22|||
105855397|NCT00588770|365121804|FG000|Overall Study|Withdrawal by Subject|15|||
105855398|NCT00588770|365121805|FG001|Overall Study|Withdrawal by Subject|25|||
105855399|NCT00588770|365121804|FG000|Overall Study|Alternative therapy|2|||
105855400|NCT00588770|365121805|FG001|Overall Study|Alternative therapy|4|||
105374354|NCT00274456|363377648|FG002|Overall Study|Physician Decision|6|||
105374355|NCT00274456|363377649|FG003|Overall Study|Physician Decision|13|||
105855401|NCT00588770|365121804|FG000|Overall Study|Other complicating disease|3|||
105374356|NCT00274456|363377646|FG000|Overall Study|Lost to Follow-up|0|||
105328770|NCT00529087|363203578|FG000|Overall Study|Lost to Follow-up|6|||
105328771|NCT00529087|363203579|FG001|Overall Study|Lost to Follow-up|4|||
105328772|NCT00529087|363203580|FG002|Overall Study|Lost to Follow-up|1|||
105328773|NCT00529087|363203578|FG000|Overall Study|Protocol Violation|8|||
105328774|NCT00529087|363203579|FG001|Overall Study|Protocol Violation|7|||
105328775|NCT00529087|363203580|FG002|Overall Study|Protocol Violation|6|||
105328776|NCT00529087|363203578|FG000|Overall Study|Withdrawal by Subject|3|||
105328777|NCT00529087|363203579|FG001|Overall Study|Withdrawal by Subject|3|||
105328778|NCT00529087|363203580|FG002|Overall Study|Withdrawal by Subject|3|||
105328779|NCT00529087|363203578|FG000|Overall Study|Protocol deviation|1|||
105328780|NCT00529087|363203579|FG001|Overall Study|Protocol deviation|1|||
105328781|NCT00529087|363203580|FG002|Overall Study|Protocol deviation|2|||
105328782|NCT00457002|363203585|FG000|Overall Study|Death|40|||
105328783|NCT00457002|363203586|FG001|Overall Study|Death|47|||
105328784|NCT00457002|363203585|FG000|Overall Study|Adverse Event|284|||
105328785|NCT00457002|363203586|FG001|Overall Study|Adverse Event|260|||
105328786|NCT00457002|363203585|FG000|Overall Study|Withdrawal by Subject|299|||
105374357|NCT00274456|363377647|FG001|Overall Study|Lost to Follow-up|0|||
105374358|NCT00274456|363377648|FG002|Overall Study|Lost to Follow-up|1|||
105374359|NCT00274456|363377649|FG003|Overall Study|Lost to Follow-up|0|||
105374360|NCT00274456|363377646|FG000|Overall Study|Withdrawal by Subject|18|||
105374361|NCT00274456|363377647|FG001|Overall Study|Withdrawal by Subject|13|||
105374362|NCT00274456|363377648|FG002|Overall Study|Withdrawal by Subject|9|||
105374363|NCT00274456|363377649|FG003|Overall Study|Withdrawal by Subject|13|||
105374364|NCT03617588|363377657|FG000|Overall Study|Withdrawal by Subject|1|||
105374365|NCT03617588|363377658|FG001|Overall Study|Withdrawal by Subject|0|||
105374366|NCT01126424|363377661|FG000|Overall Study|Adverse Event|0|||
105328787|NCT00457002|363203586|FG001|Overall Study|Withdrawal by Subject|271|||
105328788|NCT00457002|363203585|FG000|Overall Study|Lost to Follow-up|72|||
105328789|NCT00457002|363203586|FG001|Overall Study|Lost to Follow-up|71|||
105328790|NCT00457002|363203585|FG000|Overall Study|Poor/Non-compliance|46|||
105374367|NCT01126424|363377662|FG001|Overall Study|Adverse Event|0|||
105374368|NCT01126424|363377663|FG002|Overall Study|Adverse Event|0|||
105328791|NCT00457002|363203586|FG001|Overall Study|Poor/Non-compliance|33|||
105328792|NCT00457002|363203585|FG000|Overall Study|No longer met criteria|41|||
105328793|NCT00457002|363203586|FG001|Overall Study|No longer met criteria|37|||
105328794|NCT00457002|363203585|FG000|Overall Study|Administrative reason by Sponsor|1|||
105328795|NCT00457002|363203586|FG001|Overall Study|Administrative reason by Sponsor|0|||
105328796|NCT00457002|363203585|FG000|Overall Study|non-specified|29|||
105328797|NCT00457002|363203586|FG001|Overall Study|non-specified|38|||
105328798|NCT00457002|363203585|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
105328799|NCT00457002|363203586|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
105328800|NCT03318861|363203594|FG000|Overall Study|Death|2|||
105328801|NCT03318861|363203595|FG001|Overall Study|Death|3|||
105328802|NCT03318861|363203596|FG002|Overall Study|Death|3|||
105328803|NCT03318861|363203597|FG003|Overall Study|Death|2|||
105328804|NCT03318861|363203598|FG004|Overall Study|Death|2|||
105328805|NCT03318861|363203594|FG000|Overall Study|Enrolled But Never Treated|0|||
105328806|NCT03318861|363203595|FG001|Overall Study|Enrolled But Never Treated|1|||
105328807|NCT03318861|363203596|FG002|Overall Study|Enrolled But Never Treated|0|||
105328808|NCT03318861|363203597|FG003|Overall Study|Enrolled But Never Treated|1|||
105328809|NCT03318861|363203598|FG004|Overall Study|Enrolled But Never Treated|1|||
105328810|NCT03318861|363203594|FG000|Overall Study|Informed Consent Withdraw|0|||
105328811|NCT03318861|363203595|FG001|Overall Study|Informed Consent Withdraw|0|||
105328812|NCT03318861|363203596|FG002|Overall Study|Informed Consent Withdraw|0|||
105328813|NCT03318861|363203597|FG003|Overall Study|Informed Consent Withdraw|1|||
105328814|NCT03318861|363203598|FG004|Overall Study|Informed Consent Withdraw|0|||
105328815|NCT03318861|363203594|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
105328816|NCT03318861|363203595|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
105328817|NCT03318861|363203596|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
105328818|NCT03318861|363203597|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
105328819|NCT03318861|363203598|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
105328820|NCT00917852|363203599|FG000|Overall Study|Death|6|||
105328821|NCT02283268|363203601|FG000|Overall Study|Withdrawal by Subject|1|||
105328822|NCT00454246|363203602|FG000|Overall Study|Adverse Event|2|||
105374369|NCT01126424|363377664|FG003|Overall Study|Adverse Event|0|||
105374370|NCT01126424|363377665|FG004|Overall Study|Adverse Event|1|||
105374371|NCT01126424|363377666|FG005|Overall Study|Adverse Event|0|||
105374372|NCT01126424|363377661|FG000|Overall Study|Withdrawal by Subject|0|||
105374373|NCT01126424|363377662|FG001|Overall Study|Withdrawal by Subject|0|||
105374374|NCT01126424|363377663|FG002|Overall Study|Withdrawal by Subject|1|||
105328823|NCT00454246|363203603|FG001|Overall Study|Adverse Event|2|||
105328824|NCT00454246|363203604|FG002|Overall Study|Adverse Event|0|||
105328825|NCT00454246|363203602|FG000|Overall Study|Violation of selection criteria at entry|6|||
105328826|NCT00454246|363203603|FG001|Overall Study|Violation of selection criteria at entry|0|||
105328827|NCT00454246|363203604|FG002|Overall Study|Violation of selection criteria at entry|0|||
105328828|NCT00454246|363203602|FG000|Overall Study|Protocol Violation|1|||
105374375|NCT01126424|363377664|FG003|Overall Study|Withdrawal by Subject|3|||
105374376|NCT01126424|363377665|FG004|Overall Study|Withdrawal by Subject|1|||
105374377|NCT01126424|363377666|FG005|Overall Study|Withdrawal by Subject|0|||
105374378|NCT01006629|363377669|FG000|Overall Study|Adverse Event|1|||
105374379|NCT01006629|363377669|FG000|Overall Study|Parent refused to continue participation|1|||
105374380|NCT01006629|363377669|FG000|Overall Study|Parent unable to perform site visit|4|||
105855402|NCT00588770|365121805|FG001|Overall Study|Other complicating disease|2|||
105855403|NCT00588770|365121804|FG000|Overall Study|Not start protocol therapy|0|||
105855404|NCT00588770|365121805|FG001|Overall Study|Not start protocol therapy|9|||
105855405|NCT00588770|365121804|FG000|Overall Study|Lack of Efficacy|8|||
105855406|NCT00588770|365121805|FG001|Overall Study|Lack of Efficacy|10|||
105855407|NCT00588770|365121804|FG000|Overall Study|Physician discretion|2|||
105855408|NCT00588770|365121805|FG001|Overall Study|Physician discretion|0|||
105855409|NCT00588770|365121804|FG000|Overall Study|Patient non-compliance|2|||
105855410|NCT00588770|365121805|FG001|Overall Study|Patient non-compliance|2|||
105855411|NCT00569127|365121806|FG000|Overall Study|Adverse Event|57|||
105855412|NCT00569127|365121807|FG001|Overall Study|Adverse Event|47|||
105855413|NCT00569127|365121806|FG000|Overall Study|Withdrawal by Subject|13|||
105855414|NCT00569127|365121807|FG001|Overall Study|Withdrawal by Subject|27|||
105855415|NCT00569127|365121806|FG000|Overall Study|Progression|99|||
105855416|NCT00569127|365121807|FG001|Overall Study|Progression|100|||
105855417|NCT00569127|365121806|FG000|Overall Study|Death|4|||
105855418|NCT00569127|365121807|FG001|Overall Study|Death|3|||
105855419|NCT00569127|365121806|FG000|Overall Study|Other|20|||
105855420|NCT00569127|365121807|FG001|Overall Study|Other|19|||
105855421|NCT00569127|365121806|FG000|Overall Study|Lost to Follow-up|0|||
105855422|NCT00569127|365121807|FG001|Overall Study|Lost to Follow-up|3|||
105855423|NCT00569127|365121806|FG000|Overall Study|Not Eligible|14|||
105855424|NCT00569127|365121807|FG001|Overall Study|Not Eligible|11|||
105855425|NCT00569127|365121806|FG000|Overall Study|Still on Treatment|7|||
105855426|NCT00569127|365121807|FG001|Overall Study|Still on Treatment|3|||
105855427|NCT03517969|365121808|FG000|Overall Study|Never started protocol treatment|3|||
105855428|NCT03517969|365121809|FG001|Overall Study|Never started protocol treatment|5|||
105855429|NCT03517969|365121808|FG000|Overall Study|Disease progression|11|||
105855430|NCT03517969|365121809|FG001|Overall Study|Disease progression|16|||
105855431|NCT03517969|365121808|FG000|Overall Study|PSA progression|8|||
105855432|NCT03517969|365121809|FG001|Overall Study|PSA progression|1|||
105855433|NCT03517969|365121808|FG000|Overall Study|Clinical progression|4|||
105855434|NCT03517969|365121809|FG001|Overall Study|Clinical progression|2|||
105855435|NCT03517969|365121808|FG000|Overall Study|Adverse Event|5|||
105855436|NCT03517969|365121809|FG001|Overall Study|Adverse Event|4|||
105855437|NCT03517969|365121808|FG000|Overall Study|Intercurrent illness|1|||
105855438|NCT03517969|365121809|FG001|Overall Study|Intercurrent illness|2|||
105855439|NCT03517969|365121808|FG000|Overall Study|Death|1|||
105855440|NCT03517969|365121809|FG001|Overall Study|Death|1|||
105855441|NCT03517969|365121808|FG000|Overall Study|Withdrawal by Subject|1|||
105855442|NCT03517969|365121809|FG001|Overall Study|Withdrawal by Subject|2|||
105855443|NCT03517969|365121808|FG000|Overall Study|Physician Decision|1|||
105855444|NCT03517969|365121809|FG001|Overall Study|Physician Decision|1|||
105855445|NCT03517969|365121808|FG000|Overall Study|No clinical benefit|1|||
105855446|NCT03517969|365121809|FG001|Overall Study|No clinical benefit|0|||
105855447|NCT03517969|365121808|FG000|Overall Study|Delayed treatment for dental treatment|1|||
105855448|NCT03517969|365121809|FG001|Overall Study|Delayed treatment for dental treatment|0|||
105855449|NCT03517969|365121808|FG000|Overall Study|Difficult to maintain appointment|0|||
105855450|NCT03517969|365121809|FG001|Overall Study|Difficult to maintain appointment|1|||
105855451|NCT03517969|365121808|FG000|Overall Study|Protocol Violation|0|||
105855452|NCT03517969|365121809|FG001|Overall Study|Protocol Violation|1|||
105855453|NCT01856192|365121810|FG000|Overall Study|Adverse Event|12|||
105855454|NCT01856192|365121811|FG001|Overall Study|Adverse Event|4|||
105855455|NCT01856192|365121810|FG000|Overall Study|Alternative therapy|0|||
105374381|NCT01499511|363377670|FG000|Overall Study|Death|1|||
105855456|NCT01856192|365121811|FG001|Overall Study|Alternative therapy|3|||
105855457|NCT01856192|365121810|FG000|Overall Study|Death|3|||
105855458|NCT01856192|365121811|FG001|Overall Study|Death|5|||
105855459|NCT01856192|365121810|FG000|Overall Study|Lack of Efficacy|0|||
105855460|NCT01856192|365121811|FG001|Overall Study|Lack of Efficacy|5|||
105374382|NCT01499511|363377671|FG001|Overall Study|Death|0|||
105374383|NCT00316004|363377672|FG000|Overall Study|Subject was not given study fluid.|14|||
105855461|NCT01856192|365121810|FG000|Overall Study|Withdrawal by Subject|1|||
105374384|NCT00316004|363377673|FG001|Overall Study|Subject was not given study fluid.|14|||
105855462|NCT01856192|365121811|FG001|Overall Study|Withdrawal by Subject|1|||
105855463|NCT01856192|365121810|FG000|Overall Study|Other diseases|1|||
105855464|NCT01856192|365121811|FG001|Overall Study|Other diseases|0|||
105855465|NCT01856192|365121810|FG000|Overall Study|Never started treatment|7|||
105855466|NCT01856192|365121811|FG001|Overall Study|Never started treatment|5|||
105855467|NCT01856192|365121810|FG000|Overall Study|Path ineligible|20|||
105855468|NCT01856192|365121811|FG001|Overall Study|Path ineligible|34|||
105855469|NCT01856192|365121810|FG000|Overall Study|Non-path ineligible|2|||
105855470|NCT01856192|365121811|FG001|Overall Study|Non-path ineligible|2|||
105328829|NCT00454246|363203603|FG001|Overall Study|Protocol Violation|0|||
105855471|NCT01856192|365121810|FG000|Overall Study|Physician Decision|1|||
105855472|NCT01856192|365121811|FG001|Overall Study|Physician Decision|1|||
105855473|NCT01856192|365121810|FG000|Overall Study|Suspicion of progressive disease|1|||
105855474|NCT01856192|365121811|FG001|Overall Study|Suspicion of progressive disease|0|||
105855475|NCT01856192|365121810|FG000|Overall Study|Non-compliance|1|||
105855476|NCT01856192|365121811|FG001|Overall Study|Non-compliance|0|||
105855477|NCT04428151|365121812|FG000|Overall Study|Death|100|||
105855478|NCT04428151|365121813|FG001|Overall Study|Death|86|||
105855479|NCT04428151|365121814|FG002|Overall Study|Death|57|||
105855480|NCT04428151|365121812|FG000|Overall Study|Lost to Follow-up|1|||
105855481|NCT04428151|365121813|FG001|Overall Study|Lost to Follow-up|1|||
105855482|NCT04428151|365121814|FG002|Overall Study|Lost to Follow-up|0|||
105855483|NCT04428151|365121812|FG000|Overall Study|Withdrawal by Subject|2|||
105855484|NCT04428151|365121813|FG001|Overall Study|Withdrawal by Subject|2|||
105855485|NCT04428151|365121814|FG002|Overall Study|Withdrawal by Subject|3|||
105855486|NCT04428151|365121812|FG000|Overall Study|Participant Ongoing in Study|41|||
105855487|NCT04428151|365121813|FG001|Overall Study|Participant Ongoing in Study|53|||
105855488|NCT04428151|365121814|FG002|Overall Study|Participant Ongoing in Study|28|||
105855489|NCT02642042|365121818|FG000|Overall Study|Adverse Event|22|||
105855490|NCT02642042|365121818|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
105855491|NCT02642042|365121818|FG000|Overall Study|Progression/Relapse|28|||
105855492|NCT02642042|365121818|FG000|Overall Study|Death|1|||
105855493|NCT02642042|365121818|FG000|Overall Study|Not Protocol Specified|2|||
105855494|NCT04268004|365121825|FG000|Overall Study|Excluded from analyses|0|||
105855495|NCT04268004|365121826|FG001|Overall Study|Excluded from analyses|1|||
105855496|NCT03348631|365121827|FG000|Overall Study|Not Eligible, No treatment|0|||
105855497|NCT03348631|365121828|FG001|Overall Study|Not Eligible, No treatment|1|||
105855498|NCT03348631|365121827|FG000|Overall Study|Not Eligible, Treated|2|||
105328830|NCT00454246|363203604|FG002|Overall Study|Protocol Violation|0|||
105328831|NCT00454246|363203602|FG000|Overall Study|Refused Treatment|1|||
105328832|NCT00454246|363203603|FG001|Overall Study|Refused Treatment|1|||
105328833|NCT00454246|363203604|FG002|Overall Study|Refused Treatment|0|||
105328834|NCT00454246|363203602|FG000|Overall Study|Failure to return|1|||
105328835|NCT00454246|363203603|FG001|Overall Study|Failure to return|0|||
105328836|NCT00454246|363203604|FG002|Overall Study|Failure to return|0|||
105328837|NCT00454246|363203602|FG000|Overall Study|Early termination of study|62|||
105328838|NCT00454246|363203603|FG001|Overall Study|Early termination of study|26|||
105328839|NCT00454246|363203604|FG002|Overall Study|Early termination of study|9|||
105328840|NCT00729612|363203613|FG000|Overall Study|Non evaluable for response|10|||
105328841|NCT05344560|363203616|FG000|Period 1|Subject out of visit window|1|||
105328842|NCT05344560|363203617|FG001|Period 1|Subject out of visit window|1|||
105328843|NCT05344560|363203616|FG000|Period 2|Covid-19 Related|1|||
105328844|NCT05344560|363203617|FG001|Period 2|Covid-19 Related|0|||
105328845|NCT05344560|363203616|FG000|Period 2|Adverse Event|1|||
105328846|NCT05344560|363203617|FG001|Period 2|Adverse Event|0|||
105328847|NCT05344560|363203616|FG000|Period 2|Subject out of visit window|1|||
105328848|NCT05344560|363203617|FG001|Period 2|Subject out of visit window|1|||
105328849|NCT05344560|363203616|FG000|Period 3|Subject out of visit window|1|||
105328850|NCT05344560|363203617|FG001|Period 3|Subject out of visit window|0|||
105328851|NCT01704495|363203626|FG000|Subjects Randomized|Other Reason|3|||
105328852|NCT01704495|363203627|FG001|Subjects Randomized|Other Reason|2|||
105328853|NCT01704495|363203628|FG002|Subjects Randomized|Other Reason|3|||
105328854|NCT01704495|363203629|FG003|Subjects Randomized|Other Reason|2|||
105328855|NCT01704495|363203626|FG000|Subjects Randomized|Discontinuation criteria met|4|||
105328856|NCT01704495|363203627|FG001|Subjects Randomized|Discontinuation criteria met|2|||
105328857|NCT01704495|363203628|FG002|Subjects Randomized|Discontinuation criteria met|2|||
105328858|NCT01704495|363203629|FG003|Subjects Randomized|Discontinuation criteria met|0|||
105328859|NCT01704495|363203626|FG000|Subjects Randomized|Adverse Event|8|||
105328860|NCT01704495|363203627|FG001|Subjects Randomized|Adverse Event|2|||
105328861|NCT01704495|363203628|FG002|Subjects Randomized|Adverse Event|0|||
105328862|NCT01704495|363203629|FG003|Subjects Randomized|Adverse Event|7|||
105328863|NCT01704495|363203626|FG000|Subjects Randomized|Withdrawal by Subject|5|||
105328864|NCT01704495|363203627|FG001|Subjects Randomized|Withdrawal by Subject|5|||
105328865|NCT01704495|363203628|FG002|Subjects Randomized|Withdrawal by Subject|5|||
105328866|NCT01704495|363203629|FG003|Subjects Randomized|Withdrawal by Subject|5|||
105328867|NCT01704495|363203626|FG000|Subjects Randomized|Protocol Violation|1|||
105328868|NCT01704495|363203627|FG001|Subjects Randomized|Protocol Violation|1|||
105328869|NCT01704495|363203628|FG002|Subjects Randomized|Protocol Violation|2|||
105328870|NCT01704495|363203629|FG003|Subjects Randomized|Protocol Violation|0|||
105328871|NCT01704495|363203626|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
105855499|NCT03348631|365121828|FG001|Overall Study|Not Eligible, Treated|0|||
105855500|NCT03348631|365121827|FG000|Overall Study|Eligible, No Treatment|1|||
105855501|NCT03348631|365121828|FG001|Overall Study|Eligible, No Treatment|0|||
105855502|NCT04099511|365121829|FG000|Overall Study|Lost to Follow-up|2|||
105328872|NCT01704495|363203627|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
105328873|NCT01704495|363203628|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
105328874|NCT01704495|363203629|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
105328875|NCT01704495|363203626|FG000|Optional Safety Extension|Adverse Event|0|||
105328876|NCT01704495|363203627|FG001|Optional Safety Extension|Adverse Event|4|||
105328877|NCT01704495|363203628|FG002|Optional Safety Extension|Adverse Event|0|||
105328878|NCT01704495|363203629|FG003|Optional Safety Extension|Adverse Event|1|||
105328879|NCT01704495|363203626|FG000|Optional Safety Extension|Other reason|27|||
105328880|NCT01704495|363203627|FG001|Optional Safety Extension|Other reason|29|||
105328881|NCT01704495|363203628|FG002|Optional Safety Extension|Other reason|30|||
105328882|NCT01704495|363203629|FG003|Optional Safety Extension|Other reason|28|||
105328883|NCT01704495|363203626|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
105328884|NCT01704495|363203627|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
105328885|NCT01704495|363203628|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
105328886|NCT01704495|363203629|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
105328887|NCT02375971|363203630|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
105328888|NCT02375971|363203631|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
105328889|NCT02375971|363203632|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
105328890|NCT02375971|363203630|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
105328891|NCT02375971|363203631|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
105328892|NCT02375971|363203632|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
105328893|NCT02375971|363203630|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
105328894|NCT02375971|363203631|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
105328895|NCT02375971|363203632|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
105328896|NCT02375971|363203630|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
105328897|NCT02375971|363203631|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
105328898|NCT02375971|363203632|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
105328899|NCT02375971|363203630|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
105328900|NCT02375971|363203631|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
105328901|NCT02375971|363203632|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
105328902|NCT02375971|363203630|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
105328903|NCT02375971|363203631|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
105328904|NCT02375971|363203632|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
105328905|NCT02375971|363203630|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
105328906|NCT02375971|363203631|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
105328907|NCT02375971|363203632|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
105328908|NCT02375971|363203630|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
105328909|NCT02375971|363203631|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
105328910|NCT02375971|363203632|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
105328911|NCT02259010|363203633|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
105328912|NCT02462603|363203634|FG000|Overall Study|Investigator Decision|1|||
105328913|NCT02462603|363203634|FG000|Overall Study|Non-Compliance|1|||
105328914|NCT02462603|363203634|FG000|Overall Study|Withdrawal by Subject|2|||
105328915|NCT04762160|363203635|FG000|Overall Study|Study terminated early due to business reasons|5|||
105328916|NCT01537042|363203639|FG000|Overall Study|Adverse Event|0|||
105328917|NCT01537042|363203640|FG001|Overall Study|Adverse Event|2|||
105328918|NCT01537042|363203639|FG000|Overall Study|Lack of Efficacy|0|||
105328919|NCT01537042|363203640|FG001|Overall Study|Lack of Efficacy|1|||
105328920|NCT01537042|363203639|FG000|Overall Study|Protocol Violation|0|||
105328921|NCT01537042|363203640|FG001|Overall Study|Protocol Violation|1|||
105328922|NCT01537042|363203639|FG000|Overall Study|Other|0|||
105328923|NCT01537042|363203640|FG001|Overall Study|Other|1|||
105328924|NCT03655405|363203641|FG000|Overall Study|Death after initial data collection|4|||
105328925|NCT03655405|363203642|FG001|Overall Study|Death after initial data collection|2|||
105328926|NCT03655405|363203641|FG000|Overall Study|Died before initial data collection|1|||
105328927|NCT03655405|363203642|FG001|Overall Study|Died before initial data collection|2|||
105328928|NCT03655405|363203641|FG000|Overall Study|Protocol Violation|0|||
105328929|NCT03655405|363203642|FG001|Overall Study|Protocol Violation|1|||
105328930|NCT01779440|363203643|FG000|Overall Study|Withdrawal by Subject|3|||
105328931|NCT01779440|363203644|FG001|Overall Study|Withdrawal by Subject|5|||
105328932|NCT01205269|363203645|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
105328933|NCT01205269|363203646|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
105374385|NCT00316004|363377674|FG002|Overall Study|Subject was not given study fluid.|21|||
105374386|NCT02326883|363377677|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
105374387|NCT02326883|363377678|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
105328934|NCT01205269|363203647|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
105328935|NCT01205269|363203648|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
105328936|NCT01205269|363203649|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
105328937|NCT01205269|363203650|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
105328938|NCT01804946|363203651|FG000|Overall Study|Protocol Violation|1|||
105374388|NCT02326883|363377679|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
105328939|NCT01804946|363203652|FG001|Overall Study|Protocol Violation|0|||
105374389|NCT02911116|363377680|FG000|Overall Study|Insufficient Therapeutic Response|1|||
105374390|NCT02911116|363377681|FG001|Overall Study|Insufficient Therapeutic Response|0|||
105374391|NCT02911116|363377680|FG000|Overall Study|Lost to Follow-up|0|||
105374392|NCT02911116|363377681|FG001|Overall Study|Lost to Follow-up|1|||
105374393|NCT01513590|363377682|FG000|Overall Study|Adverse Event|2|||
105374394|NCT01513590|363377683|FG001|Overall Study|Adverse Event|3|||
105374395|NCT01513590|363377682|FG000|Overall Study|Withdrawal Criteria|3|||
105374396|NCT01513590|363377683|FG001|Overall Study|Withdrawal Criteria|0|||
105374397|NCT01513590|363377682|FG000|Overall Study|Unclassified|5|||
105374398|NCT01513590|363377683|FG001|Overall Study|Unclassified|10|||
105374399|NCT02701634|363377684|FG000|Overall Study|Adverse Event|2|||
105374400|NCT02701634|363377685|FG001|Overall Study|Adverse Event|3|||
105374401|NCT02701634|363377684|FG000|Overall Study|Death|1|||
105374402|NCT02701634|363377685|FG001|Overall Study|Death|0|||
105374403|NCT02701634|363377684|FG000|Overall Study|Investigator's Discretion|7|||
105374404|NCT02701634|363377685|FG001|Overall Study|Investigator's Discretion|4|||
105374405|NCT02701634|363377684|FG000|Overall Study|Study terminated by Sponsor|15|||
105374406|NCT02701634|363377685|FG001|Overall Study|Study terminated by Sponsor|17|||
105374407|NCT02701634|363377684|FG000|Overall Study|Withdrew Consent|6|||
105374408|NCT02701634|363377685|FG001|Overall Study|Withdrew Consent|7|||
105374409|NCT02701634|363377684|FG000|Overall Study|Randomized but not treated|1|||
105374410|NCT02701634|363377685|FG001|Overall Study|Randomized but not treated|0|||
105374411|NCT02178956|363377688|FG000|Overall Study|Lost to Follow-up|4|||
105374412|NCT02178956|363377689|FG001|Overall Study|Lost to Follow-up|4|||
105374413|NCT02178956|363377688|FG000|Overall Study|Sponsor terminated study|49|||
105374414|NCT02178956|363377689|FG001|Overall Study|Sponsor terminated study|58|||
105374415|NCT02178956|363377688|FG000|Overall Study|Withdrawal by Subject|15|||
105374416|NCT02178956|363377689|FG001|Overall Study|Withdrawal by Subject|11|||
105855503|NCT04099511|365121830|FG001|Overall Study|Lost to Follow-up|2|||
105855504|NCT04099511|365121829|FG000|Overall Study|Withdrawal by Subject|8|||
105855505|NCT04099511|365121830|FG001|Overall Study|Withdrawal by Subject|4|||
105855506|NCT03783442|365124323|FG000|Overall Study|Death|252|||
105855507|NCT03783442|365124324|FG001|Overall Study|Death|268|||
105855508|NCT03783442|365124323|FG000|Overall Study|Withdrawal by Subject|19|||
105855509|NCT03783442|365124324|FG001|Overall Study|Withdrawal by Subject|21|||
105855510|NCT03783442|365124323|FG000|Overall Study|Lost to Follow-up|7|||
105855511|NCT03783442|365124324|FG001|Overall Study|Lost to Follow-up|6|||
105855512|NCT03783442|365124323|FG000|Overall Study|Sponsor Ended Study|48|||
105855513|NCT03783442|365124324|FG001|Overall Study|Sponsor Ended Study|28|||
105855514|NCT01570868|365124325|FG000|Overall Study|Adverse Event|8|||
105855515|NCT01570868|365124326|FG001|Overall Study|Adverse Event|1|||
105855516|NCT01570868|365124325|FG000|Overall Study|FDA Recommendation|23|||
105855517|NCT01570868|365124326|FG001|Overall Study|FDA Recommendation|3|||
105855518|NCT01570868|365124325|FG000|Overall Study|Physician Decision|10|||
105855519|NCT01570868|365124326|FG001|Overall Study|Physician Decision|4|||
105855520|NCT01570868|365124325|FG000|Overall Study|Lost to Follow-up|1|||
105855521|NCT01570868|365124326|FG001|Overall Study|Lost to Follow-up|0|||
105855522|NCT01570868|365124325|FG000|Overall Study|Withdrawal by Subject|1|||
105855523|NCT01570868|365124326|FG001|Overall Study|Withdrawal by Subject|0|||
105855524|NCT05194267|365124327|FG000|Overall Study|Withdrawal by Subject|2|||
105855525|NCT00098475|365124333|FG000|Step 1|Progressive disease|33|||
105855526|NCT00098475|365124334|FG001|Step 1|Progressive disease|35|||
105855527|NCT00098475|365124335|FG002|Step 1|Progressive disease|2|||
105855528|NCT00098475|365124336|FG003|Step 1|Progressive disease|1|||
105855529|NCT00098475|365124333|FG000|Step 1|Adverse Event|56|||
105855530|NCT00098475|365124334|FG001|Step 1|Adverse Event|37|||
105855531|NCT00098475|365124335|FG002|Step 1|Adverse Event|0|||
105855532|NCT00098475|365124336|FG003|Step 1|Adverse Event|1|||
105855533|NCT00098475|365124333|FG000|Step 1|Death|8|||
105855534|NCT00098475|365124334|FG001|Step 1|Death|5|||
105855535|NCT00098475|365124335|FG002|Step 1|Death|0|||
105855536|NCT00098475|365124336|FG003|Step 1|Death|1|||
105855537|NCT00098475|365124333|FG000|Step 1|Withdrawal by Subject|14|||
105374417|NCT02178956|363377688|FG000|Overall Study|Various Reasons|3|||
105855538|NCT00098475|365124334|FG001|Step 1|Withdrawal by Subject|11|||
105855539|NCT00098475|365124335|FG002|Step 1|Withdrawal by Subject|0|||
105374418|NCT02178956|363377689|FG001|Overall Study|Various Reasons|5|||
105374419|NCT01056536|363377691|FG000|Overall Study|Lost to Follow-up|202|||
105374420|NCT01056536|363377692|FG001|Overall Study|Lost to Follow-up|116|||
105855540|NCT00098475|365124336|FG003|Step 1|Withdrawal by Subject|0|||
105855541|NCT00098475|365124333|FG000|Step 1|Physician Decision|5|||
105855542|NCT00098475|365124334|FG001|Step 1|Physician Decision|2|||
105855543|NCT00098475|365124335|FG002|Step 1|Physician Decision|0|||
105374421|NCT01056536|363377693|FG002|Overall Study|Lost to Follow-up|248|||
105374422|NCT03839641|363377694|FG000|Overall Study|Withdrawal by Subject|1|||
105374423|NCT03839641|363377695|FG001|Overall Study|Withdrawal by Subject|1|||
105374424|NCT00294658|363377701|FG000|Overall Study|Death|0|||
105374425|NCT00294658|363377702|FG001|Overall Study|Death|1|||
105855544|NCT00098475|365124336|FG003|Step 1|Physician Decision|0|||
105855545|NCT00098475|365124333|FG000|Step 1|Alternative therapy|31|||
105855546|NCT00098475|365124334|FG001|Step 1|Alternative therapy|43|||
105328940|NCT01804946|363203651|FG000|Overall Study|Adverse Event|0|||
105328941|NCT01804946|363203652|FG001|Overall Study|Adverse Event|1|||
105328942|NCT01804946|363203651|FG000|Overall Study|Insufficient data available|0|||
105328943|NCT01804946|363203652|FG001|Overall Study|Insufficient data available|1|||
105328944|NCT01804946|363203651|FG000|Overall Study|Do not meet inclusion criteria|1|||
105328945|NCT01804946|363203652|FG001|Overall Study|Do not meet inclusion criteria|2|||
105328946|NCT01207687|363203653|FG000|Overall Study|Adverse Event|1|||
105328947|NCT01207687|363203653|FG000|Overall Study|Withdrawal by Subject|1|||
105328948|NCT02859337|363203654|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
105328949|NCT02859337|363203655|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
105328950|NCT02859337|363203656|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
105328951|NCT02859337|363203654|FG000|Overall Study|Withdrawal by Subject|3|||
105328952|NCT02859337|363203655|FG001|Overall Study|Withdrawal by Subject|1|||
105328953|NCT02859337|363203656|FG002|Overall Study|Withdrawal by Subject|0|||
105328954|NCT02859337|363203654|FG000|Overall Study|Lost to Follow-up|1|||
105328955|NCT02859337|363203655|FG001|Overall Study|Lost to Follow-up|0|||
105328956|NCT02859337|363203656|FG002|Overall Study|Lost to Follow-up|0|||
105328957|NCT00722137|363203657|FG000|Overall Study|Overt Disease Progression|5|||
105328958|NCT00722137|363203658|FG001|Overall Study|Overt Disease Progression|4|||
105328959|NCT00722137|363203657|FG000|Overall Study|Adverse Event|17|||
105328960|NCT00722137|363203658|FG001|Overall Study|Adverse Event|21|||
105328961|NCT00722137|363203657|FG000|Overall Study|Death|12|||
105374426|NCT00294658|363377701|FG000|Overall Study|Lost to Follow-up|4|||
105374427|NCT00294658|363377702|FG001|Overall Study|Lost to Follow-up|0|||
105374428|NCT00294658|363377701|FG000|Overall Study|Physician Decision|1|||
105374429|NCT00294658|363377702|FG001|Overall Study|Physician Decision|2|||
105374430|NCT00294658|363377701|FG000|Overall Study|Pregnancy|0|||
105374431|NCT00294658|363377702|FG001|Overall Study|Pregnancy|1|||
105374432|NCT00294658|363377701|FG000|Overall Study|Withdrawal by Subject|0|||
105374433|NCT00294658|363377702|FG001|Overall Study|Withdrawal by Subject|4|||
105374434|NCT00294658|363377701|FG000|Overall Study|Found to have invasive thymoma|1|||
105374435|NCT00294658|363377702|FG001|Overall Study|Found to have invasive thymoma|0|||
105374436|NCT00294658|363377701|FG000|Overall Study|Patient and family were not satisfied|0|||
105374437|NCT00294658|363377702|FG001|Overall Study|Patient and family were not satisfied|1|||
105374438|NCT01910441|363377703|FG000|Overall Study|Sponsor decision|0|||
105374439|NCT01910441|363377704|FG001|Overall Study|Sponsor decision|2|||
105374440|NCT01910441|363377703|FG000|Overall Study|Lost to Follow-up|6|||
105374441|NCT01910441|363377704|FG001|Overall Study|Lost to Follow-up|5|||
105374442|NCT01910441|363377703|FG000|Overall Study|Withdrawal by Subject|0|||
105374443|NCT01910441|363377704|FG001|Overall Study|Withdrawal by Subject|1|||
105374444|NCT01910441|363377703|FG000|Overall Study|Non-compliance|0|||
105374445|NCT01910441|363377704|FG001|Overall Study|Non-compliance|1|||
105374446|NCT01910441|363377703|FG000|Overall Study|Adverse Event|1|||
105374447|NCT01910441|363377704|FG001|Overall Study|Adverse Event|0|||
105374448|NCT01910441|363377703|FG000|Overall Study|Physician Decision|0|||
105374449|NCT01910441|363377704|FG001|Overall Study|Physician Decision|1|||
105374450|NCT00262925|363377705|FG000|Overall Study|Lack of Efficacy|3|||
105374451|NCT00262925|363377705|FG000|Overall Study|Adverse Event|4|||
105374452|NCT00262925|363377705|FG000|Overall Study|Death|2|||
105374453|NCT00262925|363377705|FG000|Overall Study|alternative therapy|1|||
105374454|NCT00262925|363377705|FG000|Overall Study|Other|1|||
105374455|NCT00392223|363377707|FG000|Overall Study|Adverse Event|5|||
105374456|NCT00392223|363377708|FG001|Overall Study|Adverse Event|4|||
105374457|NCT00392223|363377707|FG000|Overall Study|Lost to Follow-up|1|||
105374458|NCT00392223|363377708|FG001|Overall Study|Lost to Follow-up|4|||
105374459|NCT00392223|363377707|FG000|Overall Study|Protocol Violation|0|||
105374460|NCT00392223|363377708|FG001|Overall Study|Protocol Violation|3|||
105328962|NCT00722137|363203658|FG001|Overall Study|Death|7|||
105328963|NCT00722137|363203657|FG000|Overall Study|Withdrawal by Subject|6|||
105328964|NCT00722137|363203658|FG001|Overall Study|Withdrawal by Subject|9|||
105328965|NCT00722137|363203657|FG000|Overall Study|Other Reason Unknown|3|||
105328966|NCT00722137|363203658|FG001|Overall Study|Other Reason Unknown|4|||
105374461|NCT00392223|363377707|FG000|Overall Study|Withdrawal by Subject|3|||
105374462|NCT00392223|363377708|FG001|Overall Study|Withdrawal by Subject|2|||
105374463|NCT03462680|363377709|FG000|Overall Study|Withdrawal by Subject|3|||
105374464|NCT03462680|363377710|FG001|Overall Study|Withdrawal by Subject|5|||
105374465|NCT02246777|363377712|FG000|Overall Study|Adverse Event|2|||
105374466|NCT02246777|363377712|FG000|Overall Study|Change of residence|1|||
105328967|NCT00722137|363203657|FG000|Overall Study|Randomized But Not Treated|2|||
105328968|NCT00722137|363203658|FG001|Overall Study|Randomized But Not Treated|3|||
105328969|NCT01486446|363203659|FG000|Overall Study|Adverse Event|1|||
105328970|NCT01486446|363203660|FG001|Overall Study|Adverse Event|0|||
105374467|NCT01991795|363377713|FG000|Overall Study|Lost to Follow-up|6|||
105374468|NCT01991795|363377714|FG001|Overall Study|Lost to Follow-up|4|||
105374469|NCT01991795|363377713|FG000|Overall Study|Withdrawal by Subject|117|||
105374470|NCT01991795|363377714|FG001|Overall Study|Withdrawal by Subject|94|||
105374471|NCT01991795|363377713|FG000|Overall Study|Site prematurely closed by sponsor|26|||
105374472|NCT01991795|363377714|FG001|Overall Study|Site prematurely closed by sponsor|25|||
105328971|NCT01801865|363203661|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
105328972|NCT01801865|363203661|FG000|Overall Study|Physician Decision|7|||
105328973|NCT00523848|363203662|FG000|Overall Study|Adverse Event|11|||
105328974|NCT00523848|363203662|FG000|Overall Study|Withdrawal by Subject|2|||
105328975|NCT00523848|363203662|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
105328976|NCT00523848|363203662|FG000|Overall Study|Disease Progression|5|||
105328977|NCT00523848|363203662|FG000|Overall Study|Other, unspecified|4|||
105328978|NCT00985504|363203671|FG000|Acute Treatment Period|Adverse Event|3|||
105328979|NCT00985504|363203672|FG001|Acute Treatment Period|Adverse Event|4|||
105328980|NCT00985504|363203671|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
105328981|NCT00985504|363203672|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
105328982|NCT00985504|363203671|FG000|Acute Treatment Period|Protocol Violation|2|||
105328983|NCT00985504|363203672|FG001|Acute Treatment Period|Protocol Violation|0|||
105328984|NCT00985504|363203671|FG000|Acute Treatment Period|Sponsor Decision|0|||
105328985|NCT00985504|363203672|FG001|Acute Treatment Period|Sponsor Decision|1|||
105328986|NCT00985504|363203671|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
105328987|NCT00985504|363203672|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
105328988|NCT00985504|363203671|FG000|Optimization Period|Adverse Event|7|||
105328989|NCT00985504|363203672|FG001|Optimization Period|Adverse Event|9|||
105328990|NCT00985504|363203671|FG000|Optimization Period|Death|0|||
105328991|NCT00985504|363203672|FG001|Optimization Period|Death|1|||
105328992|NCT00985504|363203671|FG000|Optimization Period|Lack of Efficacy|5|||
105328993|NCT00985504|363203672|FG001|Optimization Period|Lack of Efficacy|3|||
105328994|NCT00985504|363203671|FG000|Optimization Period|Lost to Follow-up|0|||
105328995|NCT00985504|363203672|FG001|Optimization Period|Lost to Follow-up|1|||
105328996|NCT00985504|363203671|FG000|Optimization Period|Physician Decision|1|||
105328997|NCT00985504|363203672|FG001|Optimization Period|Physician Decision|0|||
105328998|NCT00985504|363203671|FG000|Optimization Period|Protocol Violation|3|||
105328999|NCT00985504|363203672|FG001|Optimization Period|Protocol Violation|1|||
105329000|NCT00985504|363203671|FG000|Optimization Period|Withdrawal by Subject|10|||
105329001|NCT00985504|363203672|FG001|Optimization Period|Withdrawal by Subject|8|||
105329002|NCT03711786|363203673|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
105329003|NCT03711786|363203674|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
105329004|NCT03711786|363203673|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
105329005|NCT03711786|363203674|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
105329006|NCT03711786|363203673|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
105329007|NCT03711786|363203674|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
105329008|NCT03711786|363203673|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
105329009|NCT03711786|363203674|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
105374473|NCT02401230|363377720|FG000|Overall Study|Adverse Event|3|||
105374474|NCT02401230|363377721|FG001|Overall Study|Adverse Event|2|||
105374475|NCT02401230|363377722|FG002|Overall Study|Adverse Event|0|||
105374476|NCT02401230|363377720|FG000|Overall Study|Withdrawal by Subject|2|||
105374477|NCT02401230|363377721|FG001|Overall Study|Withdrawal by Subject|1|||
105374478|NCT02401230|363377722|FG002|Overall Study|Withdrawal by Subject|1|||
105374479|NCT02401230|363377720|FG000|Overall Study|Lost to Follow-up|1|||
105374480|NCT02401230|363377721|FG001|Overall Study|Lost to Follow-up|3|||
105374481|NCT02401230|363377722|FG002|Overall Study|Lost to Follow-up|3|||
105374482|NCT01316575|363377723|FG000|Overall Study|Withdrawal by Subject|2|||
105374483|NCT01316575|363377724|FG001|Overall Study|Withdrawal by Subject|0|||
105329010|NCT03711786|363203673|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
105855547|NCT00098475|365124335|FG002|Step 1|Alternative therapy|1|||
105855548|NCT00098475|365124336|FG003|Step 1|Alternative therapy|0|||
105855549|NCT00098475|365124333|FG000|Step 1|Other disease|2|||
105855550|NCT00098475|365124334|FG001|Step 1|Other disease|1|||
105855551|NCT00098475|365124335|FG002|Step 1|Other disease|1|||
105855552|NCT00098475|365124336|FG003|Step 1|Other disease|0|||
105855553|NCT00098475|365124333|FG000|Step 1|Never started treatment|0|||
105855554|NCT00098475|365124334|FG001|Step 1|Never started treatment|2|||
105855555|NCT00098475|365124335|FG002|Step 1|Never started treatment|0|||
105329011|NCT03711786|363203674|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
105329012|NCT03711786|363203673|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
105374484|NCT01316575|363377723|FG000|Overall Study|Required alternate treatment|0|||
105374485|NCT01316575|363377724|FG001|Overall Study|Required alternate treatment|1|||
105374486|NCT01977846|363377725|FG000|Total Study - Prospective|Death|0|||
105329013|NCT03711786|363203674|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
105329014|NCT00669669|363203676|FG000|Overall Study|To late to start treatment|1|||
105329015|NCT00848718|363203677|FG000|Overall Study|Adverse Event|2|||
105329016|NCT00848718|363203678|FG001|Overall Study|Adverse Event|2|||
105329017|NCT00848718|363203679|FG002|Overall Study|Adverse Event|1|||
105329018|NCT00848718|363203680|FG003|Overall Study|Adverse Event|1|||
105329019|NCT00848718|363203681|FG004|Overall Study|Adverse Event|1|||
105374487|NCT01977846|363377726|FG001|Total Study - Prospective|Death|1|||
105855556|NCT00098475|365124336|FG003|Step 1|Never started treatment|0|||
105855557|NCT00098475|365124333|FG000|Step 1|Still on treatment as of this analysis|14|||
105374488|NCT01977846|363377725|FG000|Total Study - Prospective|Lost to Follow-up|0|||
105374489|NCT01977846|363377726|FG001|Total Study - Prospective|Lost to Follow-up|8|||
105374490|NCT01977846|363377725|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
105374491|NCT01977846|363377726|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
105374492|NCT01977846|363377725|FG000|Total Study - Prospective|Not available at time of visit|0|||
105374493|NCT01977846|363377726|FG001|Total Study - Prospective|Not available at time of visit|5|||
105374494|NCT01977846|363377725|FG000|Total Study - Prospective|No show|0|||
105374495|NCT01977846|363377726|FG001|Total Study - Prospective|No show|1|||
105374496|NCT01977846|363377725|FG000|Total Study - Prospective|Protocol Violation|0|||
105374497|NCT01977846|363377726|FG001|Total Study - Prospective|Protocol Violation|1|||
105374498|NCT00964782|363377727|FG000|Overall Study|Lost to Follow-up|1|||
105374499|NCT00964782|363377728|FG001|Overall Study|Lost to Follow-up|0|||
105374500|NCT03122106|363377731|FG000|Overall Study|Not enough tissue|1|||
105374501|NCT03122106|363377731|FG000|Overall Study|Disease progression during screening|2|||
105374502|NCT03122106|363377731|FG000|Overall Study|Poor RNA quality for vaccine|1|||
105374503|NCT00596635|363377732|FG000|Overall Study|Lost to Follow-up|0|||
105374504|NCT00596635|363377733|FG001|Overall Study|Lost to Follow-up|2|||
105374505|NCT00596635|363377734|FG002|Overall Study|Lost to Follow-up|0|||
105374506|NCT00596635|363377732|FG000|Overall Study|Treatment for symptomatic UTI|4|||
105374507|NCT00596635|363377733|FG001|Overall Study|Treatment for symptomatic UTI|6|||
105374508|NCT00596635|363377734|FG002|Overall Study|Treatment for symptomatic UTI|3|||
105374509|NCT00596635|363377732|FG000|Overall Study|Hip fracture|2|||
105374510|NCT00596635|363377733|FG001|Overall Study|Hip fracture|3|||
105329020|NCT00848718|363203682|FG005|Overall Study|Adverse Event|0|||
105329021|NCT00848718|363203683|FG006|Overall Study|Adverse Event|0|||
105329022|NCT00848718|363203684|FG007|Overall Study|Adverse Event|1|||
105329023|NCT00848718|363203685|FG008|Overall Study|Adverse Event|1|||
105329024|NCT00848718|363203686|FG009|Overall Study|Adverse Event|0|||
105329025|NCT00848718|363203687|FG010|Overall Study|Adverse Event|0|||
105329026|NCT00848718|363203688|FG011|Overall Study|Adverse Event|0|||
105329027|NCT00848718|363203689|FG012|Overall Study|Adverse Event|2|||
105329028|NCT00848718|363203677|FG000|Overall Study|Lack of Efficacy|0|||
105329029|NCT00848718|363203678|FG001|Overall Study|Lack of Efficacy|0|||
105329030|NCT00848718|363203679|FG002|Overall Study|Lack of Efficacy|1|||
105329031|NCT00848718|363203680|FG003|Overall Study|Lack of Efficacy|0|||
105329032|NCT00848718|363203681|FG004|Overall Study|Lack of Efficacy|0|||
105329033|NCT00848718|363203682|FG005|Overall Study|Lack of Efficacy|0|||
105329034|NCT00848718|363203683|FG006|Overall Study|Lack of Efficacy|1|||
105329035|NCT00848718|363203684|FG007|Overall Study|Lack of Efficacy|0|||
105329036|NCT00848718|363203685|FG008|Overall Study|Lack of Efficacy|0|||
105374511|NCT00596635|363377734|FG002|Overall Study|Hip fracture|3|||
105374512|NCT00596635|363377732|FG000|Overall Study|Could not provide urine specimen|1|||
105374513|NCT00596635|363377733|FG001|Overall Study|Could not provide urine specimen|2|||
105374514|NCT00596635|363377734|FG002|Overall Study|Could not provide urine specimen|2|||
105374515|NCT01101178|363377737|FG000|Period 1|Withdrawal by Subject|1|||
105329037|NCT00848718|363203686|FG009|Overall Study|Lack of Efficacy|0|||
105855558|NCT00098475|365124334|FG001|Step 1|Still on treatment as of this analysis|27|||
105855559|NCT00098475|365124335|FG002|Step 1|Still on treatment as of this analysis|0|||
105855560|NCT00098475|365124336|FG003|Step 1|Still on treatment as of this analysis|0|||
105855561|NCT00098475|365124333|FG000|Step 1|Knee surgery|1|||
105855562|NCT00098475|365124334|FG001|Step 1|Knee surgery|0|||
105855563|NCT00098475|365124335|FG002|Step 1|Knee surgery|0|||
105329038|NCT00848718|363203687|FG010|Overall Study|Lack of Efficacy|0|||
105329039|NCT00848718|363203688|FG011|Overall Study|Lack of Efficacy|0|||
105329040|NCT00848718|363203689|FG012|Overall Study|Lack of Efficacy|0|||
105374516|NCT01101178|363377738|FG001|Period 1|Withdrawal by Subject|2|||
105374517|NCT01101178|363377737|FG000|Period 1|Positive drug screen|1|||
105374518|NCT01101178|363377738|FG001|Period 1|Positive drug screen|1|||
105374519|NCT01101178|363377737|FG000|Period 1|Adverse Event|2|||
105374520|NCT01101178|363377738|FG001|Period 1|Adverse Event|1|||
105374521|NCT01101178|363377737|FG000|Period 2|Withdrawal by Subject|0|||
105374522|NCT01101178|363377738|FG001|Period 2|Withdrawal by Subject|1|||
105329041|NCT00848718|363203677|FG000|Overall Study|Physician Decision|0|||
105329042|NCT00848718|363203678|FG001|Overall Study|Physician Decision|1|||
105374523|NCT01850641|363377739|FG000|Overall Study|Physician Decision|1|||
105374524|NCT01850641|363377739|FG000|Overall Study|Decrease in serum phosphorus|1|||
105374525|NCT01850641|363377739|FG000|Overall Study|Decrease in serum calcium|2|||
105374526|NCT01850641|363377739|FG000|Overall Study|Increase in serum ferritin|1|||
105374527|NCT02774889|363377749|FG000|Overall Study|Lost to Follow-up|2|||
105329043|NCT00848718|363203679|FG002|Overall Study|Physician Decision|0|||
105329044|NCT00848718|363203680|FG003|Overall Study|Physician Decision|0|||
105329045|NCT00848718|363203681|FG004|Overall Study|Physician Decision|1|||
105855564|NCT00098475|365124336|FG003|Step 1|Knee surgery|0|||
105329046|NCT00848718|363203682|FG005|Overall Study|Physician Decision|1|||
105329047|NCT00848718|363203683|FG006|Overall Study|Physician Decision|0|||
105329048|NCT00848718|363203684|FG007|Overall Study|Physician Decision|0|||
105329049|NCT00848718|363203685|FG008|Overall Study|Physician Decision|1|||
105374528|NCT02774889|363377750|FG001|Overall Study|Lost to Follow-up|1|||
105577166|NCT02855164|364112193|FG003|Part C (Randomized Set)|Physician Decision|0|||
105329050|NCT00848718|363203686|FG009|Overall Study|Physician Decision|2|||
105329051|NCT00848718|363203687|FG010|Overall Study|Physician Decision|0|||
105329052|NCT00848718|363203688|FG011|Overall Study|Physician Decision|0|||
105329053|NCT00848718|363203689|FG012|Overall Study|Physician Decision|1|||
105329054|NCT00848718|363203677|FG000|Overall Study|Progressive disease before treatment|1|||
105329055|NCT00848718|363203678|FG001|Overall Study|Progressive disease before treatment|5|||
105329056|NCT00848718|363203679|FG002|Overall Study|Progressive disease before treatment|1|||
105329057|NCT00848718|363203680|FG003|Overall Study|Progressive disease before treatment|3|||
105329058|NCT00848718|363203681|FG004|Overall Study|Progressive disease before treatment|4|||
105329059|NCT00848718|363203682|FG005|Overall Study|Progressive disease before treatment|4|||
105329060|NCT00848718|363203683|FG006|Overall Study|Progressive disease before treatment|2|||
105329061|NCT00848718|363203684|FG007|Overall Study|Progressive disease before treatment|1|||
105329062|NCT00848718|363203685|FG008|Overall Study|Progressive disease before treatment|2|||
105329063|NCT00848718|363203686|FG009|Overall Study|Progressive disease before treatment|7|||
105329064|NCT00848718|363203687|FG010|Overall Study|Progressive disease before treatment|3|||
105329065|NCT00848718|363203688|FG011|Overall Study|Progressive disease before treatment|6|||
105329066|NCT00848718|363203689|FG012|Overall Study|Progressive disease before treatment|2|||
105329067|NCT00848718|363203677|FG000|Overall Study|Protocol Violation|0|||
105329068|NCT00848718|363203678|FG001|Overall Study|Protocol Violation|1|||
105329069|NCT00848718|363203679|FG002|Overall Study|Protocol Violation|0|||
105329070|NCT00848718|363203680|FG003|Overall Study|Protocol Violation|0|||
105329071|NCT00848718|363203681|FG004|Overall Study|Protocol Violation|0|||
105329072|NCT00848718|363203682|FG005|Overall Study|Protocol Violation|0|||
105329073|NCT00848718|363203683|FG006|Overall Study|Protocol Violation|0|||
105329074|NCT00848718|363203684|FG007|Overall Study|Protocol Violation|1|||
105329075|NCT00848718|363203685|FG008|Overall Study|Protocol Violation|0|||
105329076|NCT00848718|363203686|FG009|Overall Study|Protocol Violation|0|||
105329077|NCT00848718|363203687|FG010|Overall Study|Protocol Violation|0|||
105329078|NCT00848718|363203688|FG011|Overall Study|Protocol Violation|0|||
105329079|NCT00848718|363203689|FG012|Overall Study|Protocol Violation|1|||
105329080|NCT00848718|363203677|FG000|Overall Study|Withdrawal by Subject|1|||
105329081|NCT00848718|363203678|FG001|Overall Study|Withdrawal by Subject|0|||
105329082|NCT00848718|363203679|FG002|Overall Study|Withdrawal by Subject|0|||
105329083|NCT00848718|363203680|FG003|Overall Study|Withdrawal by Subject|1|||
105329084|NCT00848718|363203681|FG004|Overall Study|Withdrawal by Subject|0|||
105329085|NCT00848718|363203682|FG005|Overall Study|Withdrawal by Subject|0|||
105329086|NCT00848718|363203683|FG006|Overall Study|Withdrawal by Subject|0|||
105329087|NCT00848718|363203684|FG007|Overall Study|Withdrawal by Subject|0|||
105329088|NCT00848718|363203685|FG008|Overall Study|Withdrawal by Subject|0|||
105329089|NCT00848718|363203686|FG009|Overall Study|Withdrawal by Subject|0|||
105329090|NCT00848718|363203687|FG010|Overall Study|Withdrawal by Subject|1|||
105329091|NCT00848718|363203688|FG011|Overall Study|Withdrawal by Subject|0|||
105329092|NCT00848718|363203689|FG012|Overall Study|Withdrawal by Subject|0|||
105329093|NCT00848718|363203677|FG000|Overall Study|Progressive disease during treatment|3|||
105329094|NCT00848718|363203678|FG001|Overall Study|Progressive disease during treatment|0|||
105329095|NCT00848718|363203679|FG002|Overall Study|Progressive disease during treatment|3|||
105329096|NCT00848718|363203680|FG003|Overall Study|Progressive disease during treatment|0|||
105329097|NCT00848718|363203681|FG004|Overall Study|Progressive disease during treatment|0|||
105329098|NCT00848718|363203682|FG005|Overall Study|Progressive disease during treatment|0|||
105329099|NCT00848718|363203683|FG006|Overall Study|Progressive disease during treatment|0|||
105329100|NCT00848718|363203684|FG007|Overall Study|Progressive disease during treatment|2|||
105329101|NCT00848718|363203685|FG008|Overall Study|Progressive disease during treatment|0|||
105329102|NCT00848718|363203686|FG009|Overall Study|Progressive disease during treatment|0|||
105329103|NCT00848718|363203687|FG010|Overall Study|Progressive disease during treatment|0|||
105329104|NCT00848718|363203688|FG011|Overall Study|Progressive disease during treatment|0|||
105329105|NCT00848718|363203689|FG012|Overall Study|Progressive disease during treatment|2|||
105329106|NCT04200651|363203690|FG000|Overall Study|Moved to another country during follow-up|2|||
105329107|NCT04200651|363203691|FG001|Overall Study|Moved to another country during follow-up|2|||
105329108|NCT04200651|363203690|FG000|Overall Study|Lost to Follow-up|1|||
105329109|NCT04200651|363203691|FG001|Overall Study|Lost to Follow-up|3|||
105329110|NCT00030901|363203695|FG000|Initial Registration|Ineligible|167|||
105329111|NCT00030901|363203696|FG001|Initial Registration|Ineligible|0|||
105329112|NCT00030901|363203697|FG002|Initial Registration|Ineligible|0|||
105329113|NCT00030901|363203695|FG000|Randomization|Adverse Event|0|||
105329114|NCT00030901|363203696|FG001|Randomization|Adverse Event|11|||
105329115|NCT00030901|363203697|FG002|Randomization|Adverse Event|7|||
105329116|NCT00030901|363203695|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
105329117|NCT00030901|363203696|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
105329118|NCT00030901|363203697|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
105329119|NCT00030901|363203695|FG000|Randomization|Progression/Relapse|0|||
105329120|NCT00030901|363203696|FG001|Randomization|Progression/Relapse|22|||
105329121|NCT00030901|363203697|FG002|Randomization|Progression/Relapse|21|||
105855565|NCT00098475|365124333|FG000|Step 1|Complications|1|||
105855566|NCT00098475|365124334|FG001|Step 1|Complications|0|||
105855567|NCT00098475|365124335|FG002|Step 1|Complications|0|||
105855568|NCT00098475|365124336|FG003|Step 1|Complications|0|||
105855569|NCT00098475|365124333|FG000|Step 1|Cannot comply due to other tx|0|||
105855570|NCT00098475|365124334|FG001|Step 1|Cannot comply due to other tx|1|||
105855571|NCT00098475|365124335|FG002|Step 1|Cannot comply due to other tx|0|||
105855572|NCT00098475|365124336|FG003|Step 1|Cannot comply due to other tx|0|||
105855573|NCT00098475|365124333|FG000|Step 1|Both patient and physician's decision|2|||
105855574|NCT00098475|365124334|FG001|Step 1|Both patient and physician's decision|1|||
105855575|NCT00098475|365124335|FG002|Step 1|Both patient and physician's decision|0|||
105855576|NCT00098475|365124336|FG003|Step 1|Both patient and physician's decision|0|||
105855577|NCT00098475|365124333|FG000|Step 1|Incorrect disease assessment|2|||
105855578|NCT00098475|365124334|FG001|Step 1|Incorrect disease assessment|0|||
105855579|NCT00098475|365124335|FG002|Step 1|Incorrect disease assessment|0|||
105855580|NCT00098475|365124336|FG003|Step 1|Incorrect disease assessment|0|||
105855581|NCT00098475|365124333|FG000|Step 1|Off treatment for > specified timeframe|1|||
105855582|NCT00098475|365124334|FG001|Step 1|Off treatment for > specified timeframe|1|||
105855583|NCT00098475|365124335|FG002|Step 1|Off treatment for > specified timeframe|0|||
105855584|NCT00098475|365124336|FG003|Step 1|Off treatment for > specified timeframe|0|||
105855585|NCT00098475|365124333|FG000|Step 1|Declining performance status|0|||
105329122|NCT00030901|363203695|FG000|Randomization|Death|0|||
105329123|NCT00030901|363203696|FG001|Randomization|Death|1|||
105329124|NCT00030901|363203697|FG002|Randomization|Death|3|||
105329125|NCT00030901|363203695|FG000|Randomization|Other|0|||
105329126|NCT00030901|363203696|FG001|Randomization|Other|36|||
105329127|NCT00030901|363203697|FG002|Randomization|Other|33|||
105329128|NCT00030901|363203695|FG000|Randomization|Ineligible|0|||
105329129|NCT00030901|363203696|FG001|Randomization|Ineligible|15|||
105329130|NCT00030901|363203697|FG002|Randomization|Ineligible|14|||
105329131|NCT01806051|363203698|FG000|Overall Study|Withdrawal by Subject|6|||
105329132|NCT01205776|363203699|FG000|Overall Study|Lost to Follow-up|53|||
105329133|NCT01205776|363203700|FG001|Overall Study|Lost to Follow-up|61|||
105329134|NCT01205776|363203699|FG000|Overall Study|Withdrawal by Subject|11|||
105329135|NCT01205776|363203700|FG001|Overall Study|Withdrawal by Subject|34|||
105329136|NCT03225105|363203705|FG000|Overall Study|Withdrawal by Subject|1|||
105329137|NCT03225105|363203706|FG001|Overall Study|Withdrawal by Subject|0|||
105329138|NCT03225105|363203707|FG002|Overall Study|Withdrawal by Subject|0|||
105329139|NCT03225105|363203708|FG003|Overall Study|Withdrawal by Subject|0|||
105329140|NCT03225105|363203705|FG000|Overall Study|Death|0|||
105329141|NCT03225105|363203706|FG001|Overall Study|Death|4|||
105329142|NCT03225105|363203707|FG002|Overall Study|Death|2|||
105329143|NCT03225105|363203708|FG003|Overall Study|Death|0|||
105329144|NCT03225105|363203705|FG000|Overall Study|Study termination per Sponsor Decision|2|||
105329145|NCT03225105|363203706|FG001|Overall Study|Study termination per Sponsor Decision|0|||
105329146|NCT03225105|363203707|FG002|Overall Study|Study termination per Sponsor Decision|3|||
105329147|NCT03225105|363203708|FG003|Overall Study|Study termination per Sponsor Decision|3|||
105329148|NCT04031846|363203709|FG000|Overall Study|Lost to Follow-up|4|||
105329149|NCT04031846|363203710|FG001|Overall Study|Lost to Follow-up|4|||
105329150|NCT04031846|363203709|FG000|Overall Study|Physician Decision|0|||
105329151|NCT04031846|363203710|FG001|Overall Study|Physician Decision|1|||
105329152|NCT04031846|363203709|FG000|Overall Study|Protocol Violation|1|||
105329153|NCT04031846|363203710|FG001|Overall Study|Protocol Violation|1|||
105329154|NCT04031846|363203709|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
105329155|NCT04031846|363203710|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
105329156|NCT02431676|363203711|FG000|Overall Study|no lab obtained|0|||
105329157|NCT02431676|363203712|FG001|Overall Study|no lab obtained|1|||
105329158|NCT02431676|363203713|FG002|Overall Study|no lab obtained|2|||
105329159|NCT00571727|363203714|FG000|Overall Study|Did not enter in this study|1|||
105329160|NCT00571727|363203714|FG000|Overall Study|Non-compliance|4|||
105329161|NCT00571727|363203714|FG000|Overall Study|Lost to Follow-up|30|||
105329162|NCT00571727|363203714|FG000|Overall Study|Poor growth|1|||
105329163|NCT00571727|363203714|FG000|Overall Study|Parent/patient decision|2|||
105577167|NCT02855164|364112194|FG004|Part C (Randomized Set)|Physician Decision|0|||
105855586|NCT00098475|365124334|FG001|Step 1|Declining performance status|1|||
105855587|NCT00098475|365124335|FG002|Step 1|Declining performance status|0|||
105329164|NCT00571727|363203714|FG000|Overall Study|Participant transferred to commercial drug|14|||
105329165|NCT00571727|363203714|FG000|Overall Study|Unable to provide study drug|6|||
105329166|NCT00571727|363203714|FG000|Overall Study|On-treatment at end of study|8|||
105329167|NCT01777282|363203715|FG000|Overall Study|Persistent Hyperglycemia|0|||
105329168|NCT01777282|363203716|FG001|Overall Study|Persistent Hyperglycemia|0|||
105329169|NCT01777282|363203717|FG002|Overall Study|Persistent Hyperglycemia|1|||
105329170|NCT01777282|363203718|FG003|Overall Study|Persistent Hyperglycemia|0|||
105329171|NCT01777282|363203719|FG004|Overall Study|Persistent Hyperglycemia|0|||
105329172|NCT01777282|363203715|FG000|Overall Study|New Antidiabetic Medication|0|||
105855588|NCT00098475|365124336|FG003|Step 1|Declining performance status|0|||
105855589|NCT00098475|365124333|FG000|Step 1|Insurance issue|0|||
105329173|NCT01777282|363203716|FG001|Overall Study|New Antidiabetic Medication|0|||
105329174|NCT01777282|363203717|FG002|Overall Study|New Antidiabetic Medication|1|||
105329175|NCT01777282|363203718|FG003|Overall Study|New Antidiabetic Medication|0|||
105329176|NCT01777282|363203719|FG004|Overall Study|New Antidiabetic Medication|0|||
105329177|NCT01777282|363203715|FG000|Overall Study|Adverse Event|4|||
105329178|NCT01777282|363203716|FG001|Overall Study|Adverse Event|4|||
105329179|NCT01777282|363203717|FG002|Overall Study|Adverse Event|2|||
105329180|NCT01777282|363203718|FG003|Overall Study|Adverse Event|1|||
105329181|NCT01777282|363203719|FG004|Overall Study|Adverse Event|3|||
105329182|NCT01777282|363203715|FG000|Overall Study|Withdrawal by Subject|4|||
105329183|NCT01777282|363203716|FG001|Overall Study|Withdrawal by Subject|0|||
105329184|NCT01777282|363203717|FG002|Overall Study|Withdrawal by Subject|0|||
105329185|NCT01777282|363203718|FG003|Overall Study|Withdrawal by Subject|1|||
105329186|NCT01777282|363203719|FG004|Overall Study|Withdrawal by Subject|2|||
105329187|NCT01777282|363203715|FG000|Overall Study|Protocol Violation|2|||
105329188|NCT01777282|363203716|FG001|Overall Study|Protocol Violation|0|||
105329189|NCT01777282|363203717|FG002|Overall Study|Protocol Violation|1|||
105329190|NCT01777282|363203718|FG003|Overall Study|Protocol Violation|0|||
105329191|NCT01777282|363203719|FG004|Overall Study|Protocol Violation|2|||
105329192|NCT01777282|363203715|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
105329193|NCT01777282|363203716|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
105329194|NCT01777282|363203717|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
105329195|NCT01777282|363203718|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
105329196|NCT01777282|363203719|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
105329197|NCT00764660|363203723|FG000|Overall Study|Adverse Event|6|||
105329198|NCT00764660|363203724|FG001|Overall Study|Adverse Event|3|||
105329199|NCT00764660|363203723|FG000|Overall Study|Lost to Follow-up|3|||
105329200|NCT00764660|363203724|FG001|Overall Study|Lost to Follow-up|4|||
105329201|NCT00764660|363203723|FG000|Overall Study|Withdrawal by Subject|7|||
105329202|NCT00764660|363203724|FG001|Overall Study|Withdrawal by Subject|3|||
105329203|NCT00764660|363203723|FG000|Overall Study|Noncompliance With Protocol|5|||
105329204|NCT00764660|363203724|FG001|Overall Study|Noncompliance With Protocol|1|||
105329205|NCT00764660|363203723|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
105329206|NCT00764660|363203724|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
105329207|NCT01131455|363203725|FG000|Overall Study|Death of PI|6|||
105329208|NCT01131455|363203726|FG001|Overall Study|Death of PI|4|||
105329209|NCT01131455|363203727|FG002|Overall Study|Death of PI|0|||
105329210|NCT01120184|363205677|FG000|Overall Study|Adverse Event|0|||
105329211|NCT01120184|363205678|FG001|Overall Study|Adverse Event|1|||
105329212|NCT01120184|363205679|FG002|Overall Study|Adverse Event|0|||
105329213|NCT01120184|363205677|FG000|Overall Study|Lost to Follow-up|13|||
105329214|NCT01120184|363205678|FG001|Overall Study|Lost to Follow-up|13|||
105329215|NCT01120184|363205679|FG002|Overall Study|Lost to Follow-up|11|||
105329216|NCT01120184|363205677|FG000|Overall Study|Physician Decision|9|||
105329217|NCT01120184|363205678|FG001|Overall Study|Physician Decision|1|||
105329218|NCT01120184|363205679|FG002|Overall Study|Physician Decision|3|||
105329219|NCT01120184|363205677|FG000|Overall Study|Reason not Specified|8|||
105329220|NCT01120184|363205678|FG001|Overall Study|Reason not Specified|3|||
105329221|NCT01120184|363205679|FG002|Overall Study|Reason not Specified|12|||
105329222|NCT01120184|363205677|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
105329223|NCT01120184|363205678|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
105329224|NCT01120184|363205679|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
105329225|NCT01120184|363205677|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
105329226|NCT01120184|363205678|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
105329227|NCT01120184|363205679|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
105329228|NCT01120184|363205677|FG000|Overall Study|Death|170|||
105329229|NCT01120184|363205678|FG001|Overall Study|Death|176|||
105329230|NCT01120184|363205679|FG002|Overall Study|Death|169|||
105329231|NCT02525783|363205680|FG000|Overall Study|Lost to Follow-up|10|||
105329232|NCT04003636|363205681|FG000|Overall Study|Death|409|||
105329233|NCT04003636|363205682|FG001|Overall Study|Death|443|||
105329234|NCT04003636|363205681|FG000|Overall Study|Lost to Follow-up|0|||
105329235|NCT04003636|363205682|FG001|Overall Study|Lost to Follow-up|1|||
105329236|NCT04003636|363205681|FG000|Overall Study|Withdrawal by Subject|5|||
105329237|NCT04003636|363205682|FG001|Overall Study|Withdrawal by Subject|2|||
105329238|NCT04003636|363205681|FG000|Overall Study|Participant On-going|119|||
105329239|NCT04003636|363205682|FG001|Overall Study|Participant On-going|90|||
105329240|NCT00866281|363205683|FG000|Overall Study|Adverse Event|1|||
105329241|NCT00866281|363205684|FG001|Overall Study|Adverse Event|0|||
105329242|NCT00866281|363205683|FG000|Overall Study|Withdrawal by participants|3|||
105329243|NCT00866281|363205684|FG001|Overall Study|Withdrawal by participants|0|||
105329244|NCT00866281|363205683|FG000|Overall Study|Disease progression|3|||
105329245|NCT00866281|363205684|FG001|Overall Study|Disease progression|11|||
105329246|NCT00866281|363205683|FG000|Overall Study|New cancer therapy|0|||
105329247|NCT00866281|363205684|FG001|Overall Study|New cancer therapy|4|||
105329248|NCT01100086|363205685|FG000|Period 1|Withdrawal by Subject|1|||
105329249|NCT01100086|363205686|FG001|Period 1|Withdrawal by Subject|0|||
105329250|NCT02954601|363205688|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
105329251|NCT02954601|363205689|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
105329252|NCT02954601|363205690|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
105329253|NCT02954601|363205691|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
105329254|NCT00471081|363205692|FG000|Active Phase|Protocol Violation|1|||
105329255|NCT00471081|363205693|FG001|Active Phase|Protocol Violation|1|||
105329256|NCT00471081|363205692|FG000|Active Phase|Withdrawal by Subject|0|||
105329257|NCT00471081|363205693|FG001|Active Phase|Withdrawal by Subject|3|||
105329258|NCT00471081|363205692|FG000|Active Phase|Lost to Follow-up|0|||
105329259|NCT00471081|363205693|FG001|Active Phase|Lost to Follow-up|1|||
105329260|NCT00471081|363205692|FG000|Active Phase|Lost health plan/insurance|1|||
105329261|NCT00471081|363205693|FG001|Active Phase|Lost health plan/insurance|8|||
105329262|NCT00471081|363205692|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
105329263|NCT00471081|363205693|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
105329264|NCT00471081|363205692|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
105329265|NCT00471081|363205693|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
105329266|NCT00471081|363205692|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
105329267|NCT00471081|363205693|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
105329268|NCT02844933|363205694|FG000|Overall Study|Discontinued due to premature termination of study|3|||
105329269|NCT02844933|363205695|FG001|Overall Study|Discontinued due to premature termination of study|2|||
105329270|NCT02275546|363205699|FG000|Treatment Period 2|Withdrawal by Subject|2|||
105329271|NCT02275546|363205700|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105329272|NCT02275546|363205699|FG000|Treatment Period 2|Protocol Violation|0|||
105329273|NCT02275546|363205700|FG001|Treatment Period 2|Protocol Violation|1|||
105329274|NCT01609010|363205703|FG000|Overall Study|Stable disease (SD)|22|||
105329275|NCT01609010|363205704|FG001|Overall Study|Stable disease (SD)|16|||
105329276|NCT01609010|363205703|FG000|Overall Study|Progressive disease (PD)|8|||
105329277|NCT01609010|363205704|FG001|Overall Study|Progressive disease (PD)|10|||
105329278|NCT01609010|363205703|FG000|Overall Study|Adverse Event|3|||
105329279|NCT01609010|363205704|FG001|Overall Study|Adverse Event|6|||
105329280|NCT01609010|363205703|FG000|Overall Study|Withdrawal by Subject|2|||
105329281|NCT01609010|363205704|FG001|Overall Study|Withdrawal by Subject|2|||
105329282|NCT01609010|363205703|FG000|Overall Study|Other|2|||
105329283|NCT01609010|363205704|FG001|Overall Study|Other|0|||
105329284|NCT01609010|363205703|FG000|Overall Study|Other malignancy|1|||
105329285|NCT01609010|363205704|FG001|Overall Study|Other malignancy|0|||
105329286|NCT01609010|363205703|FG000|Overall Study|Pathology review|2|||
105329287|NCT01609010|363205704|FG001|Overall Study|Pathology review|1|||
105329288|NCT01609010|363205703|FG000|Overall Study|Protocol Violation|1|||
105329289|NCT01609010|363205704|FG001|Overall Study|Protocol Violation|1|||
105329290|NCT01609010|363205703|FG000|Overall Study|New cancer|1|||
105329291|NCT01609010|363205704|FG001|Overall Study|New cancer|0|||
105329292|NCT01609010|363205703|FG000|Overall Study|Lost to Follow-up|1|||
105329293|NCT01609010|363205704|FG001|Overall Study|Lost to Follow-up|1|||
105329294|NCT05486091|363205705|FG000|Overall Study|Withdrawal by Subject|1|||
105329295|NCT05486091|363205705|FG000|Overall Study|Lost to Follow-up|2|||
105329296|NCT02626026|363205706|FG000|Overall Study|Randomized but Never Treated|0|||
105329297|NCT02626026|363205707|FG001|Overall Study|Randomized but Never Treated|0|||
105329298|NCT02626026|363205708|FG002|Overall Study|Randomized but Never Treated|0|||
105855590|NCT00098475|365124334|FG001|Step 1|Insurance issue|1|||
105855591|NCT00098475|365124335|FG002|Step 1|Insurance issue|0|||
105855592|NCT00098475|365124336|FG003|Step 1|Insurance issue|0|||
105855593|NCT00098475|365124333|FG000|Step 1|Rising paraprotein|0|||
105855594|NCT00098475|365124334|FG001|Step 1|Rising paraprotein|1|||
105855595|NCT00098475|365124335|FG002|Step 1|Rising paraprotein|0|||
105855596|NCT00098475|365124336|FG003|Step 1|Rising paraprotein|0|||
105855597|NCT00098475|365124333|FG000|Step 1|Referred to other physicians|0|||
105855598|NCT00098475|365124334|FG001|Step 1|Referred to other physicians|1|||
105855599|NCT00098475|365124335|FG002|Step 1|Referred to other physicians|0|||
105855600|NCT00098475|365124336|FG003|Step 1|Referred to other physicians|0|||
105855601|NCT00098475|365124333|FG000|Step 1|Criteria to continue treatment not met|0|||
105855602|NCT00098475|365124334|FG001|Step 1|Criteria to continue treatment not met|1|||
105855603|NCT00098475|365124335|FG002|Step 1|Criteria to continue treatment not met|0|||
105855604|NCT00098475|365124336|FG003|Step 1|Criteria to continue treatment not met|0|||
105329299|NCT02626026|363205709|FG003|Overall Study|Randomized but Never Treated|0|||
105329300|NCT02626026|363205710|FG004|Overall Study|Randomized but Never Treated|1|||
105329301|NCT02626026|363205711|FG005|Overall Study|Randomized but Never Treated|0|||
105329302|NCT04630002|363205712|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
105329303|NCT04630002|363205713|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
105329304|NCT04630002|363205714|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
105329305|NCT04630002|363205712|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
105855605|NCT00098475|365124333|FG000|Step 1|Misinterpretation of lab data|0|||
105329306|NCT04630002|363205713|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
105855606|NCT00098475|365124334|FG001|Step 1|Misinterpretation of lab data|1|||
105855607|NCT00098475|365124335|FG002|Step 1|Misinterpretation of lab data|0|||
105577168|NCT02855164|364112195|FG005|Part C (Randomized Set)|Physician Decision|1|||
105329307|NCT04630002|363205714|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
105329308|NCT04630002|363205712|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
105329309|NCT04630002|363205713|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
105329310|NCT04630002|363205714|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
105329311|NCT04630002|363205712|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
105329312|NCT04630002|363205713|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
105329313|NCT04630002|363205714|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
105329314|NCT04630002|363205712|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
105329315|NCT04630002|363205713|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
105329316|NCT04630002|363205714|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
105329317|NCT04630002|363205712|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
105329318|NCT04630002|363205713|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
105329319|NCT04630002|363205714|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
105329320|NCT04630002|363205712|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
105329321|NCT04630002|363205713|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
105329322|NCT04630002|363205714|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
105329323|NCT04630002|363205712|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
105329324|NCT04630002|363205713|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
105329325|NCT04630002|363205714|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
105329326|NCT00891020|363205719|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
105329327|NCT00891020|363205720|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
105329328|NCT00891020|363205721|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
105329329|NCT00891020|363205719|FG000|24 Week Treatment Period|Death|0|||
105329330|NCT00891020|363205720|FG001|24 Week Treatment Period|Death|2|||
105329331|NCT00891020|363205721|FG002|24 Week Treatment Period|Death|0|||
105329332|NCT00891020|363205719|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
105329333|NCT00891020|363205720|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
105329334|NCT00891020|363205721|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
105329335|NCT00891020|363205719|FG000|24 Week Treatment Period|Failure to return|4|||
105329336|NCT00891020|363205720|FG001|24 Week Treatment Period|Failure to return|5|||
105329337|NCT00891020|363205721|FG002|24 Week Treatment Period|Failure to return|5|||
105329338|NCT00891020|363205719|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
105329339|NCT00891020|363205720|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
105329340|NCT00891020|363205721|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
105329341|NCT00891020|363205719|FG000|24 Week Treatment Period|Other protocol violation|1|||
105329342|NCT00891020|363205720|FG001|24 Week Treatment Period|Other protocol violation|1|||
105329343|NCT00891020|363205721|FG002|24 Week Treatment Period|Other protocol violation|2|||
105329344|NCT00891020|363205719|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
105329345|NCT00891020|363205720|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
105329346|NCT00891020|363205721|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
105329347|NCT00891020|363205719|FG000|24 Week Treatment Period|Withdrew consent|6|||
105329348|NCT00891020|363205720|FG001|24 Week Treatment Period|Withdrew consent|3|||
105329349|NCT00891020|363205721|FG002|24 Week Treatment Period|Withdrew consent|15|||
105329350|NCT00891020|363205719|FG000|24 Week Treatment Period|Administrative/Other|5|||
105329351|NCT00891020|363205720|FG001|24 Week Treatment Period|Administrative/Other|6|||
105329352|NCT00891020|363205721|FG002|24 Week Treatment Period|Administrative/Other|1|||
105329353|NCT00891020|363205719|FG000|Long-term Extension Period|Adverse Event|1|||
105329354|NCT00891020|363205720|FG001|Long-term Extension Period|Adverse Event|11|||
105329355|NCT00891020|363205721|FG002|Long-term Extension Period|Adverse Event|10|||
105329356|NCT00891020|363205719|FG000|Long-term Extension Period|Death|0|||
105329357|NCT00891020|363205720|FG001|Long-term Extension Period|Death|0|||
105329358|NCT00891020|363205721|FG002|Long-term Extension Period|Death|1|||
105329359|NCT00891020|363205719|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
105329360|NCT00891020|363205720|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
105329361|NCT00891020|363205721|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
105329362|NCT00891020|363205719|FG000|Long-term Extension Period|Protocol Violation|0|||
105329363|NCT00891020|363205720|FG001|Long-term Extension Period|Protocol Violation|1|||
105329364|NCT00891020|363205721|FG002|Long-term Extension Period|Protocol Violation|1|||
105329365|NCT00891020|363205719|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
105329366|NCT00891020|363205720|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
105329367|NCT00891020|363205721|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
105329368|NCT00891020|363205719|FG000|Long-term Extension Period|Failure to return|0|||
105329369|NCT00891020|363205720|FG001|Long-term Extension Period|Failure to return|2|||
105329370|NCT00891020|363205721|FG002|Long-term Extension Period|Failure to return|3|||
105329371|NCT00891020|363205719|FG000|Long-term Extension Period|Administrative|1|||
105329372|NCT00891020|363205720|FG001|Long-term Extension Period|Administrative|2|||
105374529|NCT00858988|363377753|FG000|Analysis|Lactulose unable to be detected in urine|2|||
105374530|NCT00858988|363377754|FG001|Analysis|Lactulose unable to be detected in urine|1|||
105374531|NCT00846365|363377755|FG000|Overall Study|Adverse Event|20|||
105374532|NCT00846365|363377756|FG001|Overall Study|Adverse Event|30|||
105374533|NCT00846365|363377757|FG002|Overall Study|Adverse Event|11|||
105374534|NCT00846365|363377755|FG000|Overall Study|Protocol Violation|5|||
105855608|NCT00098475|365124336|FG003|Step 1|Misinterpretation of lab data|0|||
105855609|NCT00098475|365124333|FG000|Step 1|Patient fell with fracture|1|||
105855610|NCT00098475|365124334|FG001|Step 1|Patient fell with fracture|0|||
105855611|NCT00098475|365124335|FG002|Step 1|Patient fell with fracture|0|||
105855612|NCT00098475|365124336|FG003|Step 1|Patient fell with fracture|0|||
105855613|NCT00098475|365124333|FG000|Step 1|Not documented|0|||
105855614|NCT00098475|365124334|FG001|Step 1|Not documented|1|||
105855615|NCT00098475|365124335|FG002|Step 1|Not documented|0|||
105855616|NCT00098475|365124336|FG003|Step 1|Not documented|0|||
105855617|NCT00098475|365124333|FG000|Step 2|Disease progression|1|||
105855618|NCT00098475|365124334|FG001|Step 2|Disease progression|4|||
105855619|NCT00098475|365124335|FG002|Step 2|Disease progression|0|||
105855620|NCT00098475|365124336|FG003|Step 2|Disease progression|0|||
105855621|NCT00098475|365124333|FG000|Step 2|Adverse Event|2|||
105855622|NCT00098475|365124334|FG001|Step 2|Adverse Event|0|||
105855623|NCT00098475|365124335|FG002|Step 2|Adverse Event|0|||
105855624|NCT00098475|365124336|FG003|Step 2|Adverse Event|0|||
105855625|NCT00098475|365124333|FG000|Step 2|Withdrawal by Subject|0|||
105855626|NCT00098475|365124334|FG001|Step 2|Withdrawal by Subject|2|||
105855627|NCT00098475|365124335|FG002|Step 2|Withdrawal by Subject|0|||
105855628|NCT00098475|365124336|FG003|Step 2|Withdrawal by Subject|0|||
105855629|NCT00098475|365124333|FG000|Step 2|Physician Decision|0|||
105855630|NCT00098475|365124334|FG001|Step 2|Physician Decision|1|||
105855631|NCT00098475|365124335|FG002|Step 2|Physician Decision|0|||
105855632|NCT00098475|365124336|FG003|Step 2|Physician Decision|0|||
105855633|NCT00098475|365124333|FG000|Step 2|Alternative therapy|1|||
105855634|NCT00098475|365124334|FG001|Step 2|Alternative therapy|2|||
105855635|NCT00098475|365124335|FG002|Step 2|Alternative therapy|0|||
105855636|NCT00098475|365124336|FG003|Step 2|Alternative therapy|0|||
105855637|NCT00098475|365124333|FG000|Step 2|Never started treatment|1|||
105855638|NCT00098475|365124334|FG001|Step 2|Never started treatment|1|||
105855639|NCT00098475|365124335|FG002|Step 2|Never started treatment|0|||
105855640|NCT00098475|365124336|FG003|Step 2|Never started treatment|0|||
105855641|NCT06151288|365124337|FG000|Overall Study|Lost to Follow-up|4|||
105855642|NCT06151288|365124338|FG001|Overall Study|Lost to Follow-up|2|||
105855643|NCT06151288|365124339|FG002|Overall Study|Lost to Follow-up|4|||
105855644|NCT06151288|365124340|FG003|Overall Study|Lost to Follow-up|3|||
105855645|NCT06151288|365124337|FG000|Overall Study|Withdrawal by Subject|4|||
105855646|NCT06151288|365124338|FG001|Overall Study|Withdrawal by Subject|5|||
105855647|NCT06151288|365124339|FG002|Overall Study|Withdrawal by Subject|1|||
105855648|NCT06151288|365124340|FG003|Overall Study|Withdrawal by Subject|1|||
105855649|NCT05722015|365124341|FG000|Overall Study|Death|57|||
105855650|NCT05722015|365124342|FG001|Overall Study|Death|37|||
105855651|NCT05722015|365124341|FG000|Overall Study|Lost to Follow-up|1|||
105855652|NCT05722015|365124342|FG001|Overall Study|Lost to Follow-up|0|||
105855653|NCT05722015|365124341|FG000|Overall Study|Withdrawal by Subject|5|||
105855654|NCT05722015|365124342|FG001|Overall Study|Withdrawal by Subject|1|||
105855655|NCT05722015|365124341|FG000|Overall Study|Participants Ongoing|188|||
105855656|NCT05722015|365124342|FG001|Overall Study|Participants Ongoing|88|||
105855657|NCT04542018|365124343|FG000|Overall Study|Withdrawal by Subject|0|||
105374535|NCT00846365|363377756|FG001|Overall Study|Protocol Violation|4|||
105374536|NCT00846365|363377757|FG002|Overall Study|Protocol Violation|0|||
105374537|NCT00846365|363377755|FG000|Overall Study|Lost to Follow-up|8|||
105374538|NCT00846365|363377756|FG001|Overall Study|Lost to Follow-up|2|||
105374539|NCT00846365|363377757|FG002|Overall Study|Lost to Follow-up|5|||
105374540|NCT00846365|363377755|FG000|Overall Study|Withdrawal by Subject|11|||
105374541|NCT00846365|363377756|FG001|Overall Study|Withdrawal by Subject|11|||
105374542|NCT00846365|363377757|FG002|Overall Study|Withdrawal by Subject|9|||
105374543|NCT00846365|363377755|FG000|Overall Study|Pregnancy|1|||
105374544|NCT00846365|363377756|FG001|Overall Study|Pregnancy|0|||
105374545|NCT00846365|363377757|FG002|Overall Study|Pregnancy|0|||
105374546|NCT00846365|363377755|FG000|Overall Study|Lack of Efficacy|1|||
105855658|NCT04542018|365124344|FG001|Overall Study|Withdrawal by Subject|0|||
105855659|NCT04542018|365124345|FG002|Overall Study|Withdrawal by Subject|4|||
105374547|NCT00846365|363377756|FG001|Overall Study|Lack of Efficacy|1|||
105374548|NCT00846365|363377757|FG002|Overall Study|Lack of Efficacy|2|||
105855660|NCT04542018|365124343|FG000|Overall Study|Protocol Violation|0|||
105855661|NCT04542018|365124344|FG001|Overall Study|Protocol Violation|0|||
105855662|NCT04542018|365124345|FG002|Overall Study|Protocol Violation|2|||
105374549|NCT00846365|363377755|FG000|Overall Study|Other|9|||
105855663|NCT04181827|365124350|FG000|Overall Study|Ongoing|124|||
105855664|NCT04181827|365124351|FG001|Overall Study|Ongoing|157|||
105855665|NCT04181827|365124350|FG000|Overall Study|Death|82|||
105855666|NCT04181827|365124351|FG001|Overall Study|Death|50|||
105855667|NCT04181827|365124350|FG000|Overall Study|Lost to Follow-up|0|||
105329373|NCT00891020|363205721|FG002|Long-term Extension Period|Administrative|2|||
105329374|NCT04177095|363205726|FG000|Overall Study|Withdrawal by Subject|3|||
105329375|NCT04177095|363205726|FG000|Overall Study|Screen Failure|3|||
105329376|NCT04177095|363205726|FG000|Overall Study|Problems with the Trugraf assay|1|||
105329377|NCT02211209|363205730|FG000|Overall Study|Investigator judgment|0|||
105329378|NCT02211209|363205731|FG001|Overall Study|Investigator judgment|1|||
105329379|NCT02211209|363205730|FG000|Overall Study|Voluntary withdrawal|1|||
105329380|NCT02211209|363205731|FG001|Overall Study|Voluntary withdrawal|4|||
105329381|NCT02211209|363205730|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
105329382|NCT02211209|363205731|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
105329383|NCT02211209|363205730|FG000|Overall Study|Reason Not Specified|1|||
105329384|NCT02211209|363205731|FG001|Overall Study|Reason Not Specified|0|||
105329385|NCT00558467|363205734|FG000|Overall Study|Adverse Event|1|||
105329386|NCT00558467|363205735|FG001|Overall Study|Adverse Event|2|||
105329387|NCT00558467|363205734|FG000|Overall Study|Lack of Efficacy|0|||
105329388|NCT00558467|363205735|FG001|Overall Study|Lack of Efficacy|1|||
105329389|NCT00558467|363205734|FG000|Overall Study|Patient moving out of state|0|||
105329390|NCT00558467|363205735|FG001|Overall Study|Patient moving out of state|1|||
105329391|NCT01372995|363205736|FG000|Overall Study|Spouse withdrew participant from study|0|||
105329392|NCT01372995|363205737|FG001|Overall Study|Spouse withdrew participant from study|1|||
105329393|NCT01372995|363205738|FG002|Overall Study|Spouse withdrew participant from study|0|||
105329394|NCT01372995|363205736|FG000|Overall Study|Physician Decision|0|||
105329395|NCT01372995|363205737|FG001|Overall Study|Physician Decision|0|||
105329396|NCT01372995|363205738|FG002|Overall Study|Physician Decision|1|||
105329397|NCT03103152|363205739|FG000|Overall Study|Physician Decision|5|||
105329398|NCT03103152|363205740|FG001|Overall Study|Physician Decision|2|||
105329399|NCT03103152|363205741|FG002|Overall Study|Physician Decision|6|||
105329400|NCT03103152|363205742|FG003|Overall Study|Physician Decision|3|||
105329401|NCT03103152|363205743|FG004|Overall Study|Physician Decision|3|||
105329402|NCT03103152|363205744|FG005|Overall Study|Physician Decision|1|||
105329403|NCT03103152|363205739|FG000|Overall Study|Protocol Violation|2|||
105329404|NCT03103152|363205740|FG001|Overall Study|Protocol Violation|2|||
105329405|NCT03103152|363205741|FG002|Overall Study|Protocol Violation|1|||
105329406|NCT03103152|363205742|FG003|Overall Study|Protocol Violation|2|||
105329407|NCT03103152|363205743|FG004|Overall Study|Protocol Violation|1|||
105329408|NCT03103152|363205744|FG005|Overall Study|Protocol Violation|1|||
105329409|NCT03103152|363205739|FG000|Overall Study|Inter-current illness|0|||
105329410|NCT03103152|363205740|FG001|Overall Study|Inter-current illness|0|||
105329411|NCT03103152|363205741|FG002|Overall Study|Inter-current illness|1|||
105329412|NCT03103152|363205742|FG003|Overall Study|Inter-current illness|0|||
105329413|NCT03103152|363205743|FG004|Overall Study|Inter-current illness|0|||
105329414|NCT03103152|363205744|FG005|Overall Study|Inter-current illness|0|||
105329415|NCT03103152|363205739|FG000|Overall Study|Death|0|||
105329416|NCT03103152|363205740|FG001|Overall Study|Death|1|||
105329417|NCT03103152|363205741|FG002|Overall Study|Death|0|||
105329418|NCT03103152|363205742|FG003|Overall Study|Death|0|||
105329419|NCT03103152|363205743|FG004|Overall Study|Death|0|||
105329420|NCT03103152|363205744|FG005|Overall Study|Death|0|||
105329421|NCT03103152|363205739|FG000|Overall Study|Adverse Event|0|||
105329422|NCT03103152|363205740|FG001|Overall Study|Adverse Event|0|||
105329423|NCT03103152|363205741|FG002|Overall Study|Adverse Event|1|||
105329424|NCT03103152|363205742|FG003|Overall Study|Adverse Event|0|||
105329425|NCT03103152|363205743|FG004|Overall Study|Adverse Event|0|||
105329426|NCT03103152|363205744|FG005|Overall Study|Adverse Event|1|||
105329427|NCT03103152|363205739|FG000|Overall Study|Withdrawal by Subject|1|||
105329428|NCT03103152|363205740|FG001|Overall Study|Withdrawal by Subject|0|||
105329429|NCT03103152|363205741|FG002|Overall Study|Withdrawal by Subject|1|||
105374550|NCT00846365|363377756|FG001|Overall Study|Other|1|||
105374551|NCT00846365|363377757|FG002|Overall Study|Other|6|||
105374552|NCT00724945|363377758|FG000|Period 1|non-compliance|1|||
105374553|NCT00724945|363377759|FG001|Period 1|non-compliance|0|||
105374554|NCT00724945|363377758|FG000|Period 1|Adverse Event|1|||
105329430|NCT03103152|363205742|FG003|Overall Study|Withdrawal by Subject|1|||
105329431|NCT03103152|363205743|FG004|Overall Study|Withdrawal by Subject|1|||
105329432|NCT03103152|363205744|FG005|Overall Study|Withdrawal by Subject|1|||
105374555|NCT00724945|363377759|FG001|Period 1|Adverse Event|1|||
105374556|NCT00724945|363377758|FG000|Period 1|Lost to Follow-up|1|||
105374557|NCT00724945|363377759|FG001|Period 1|Lost to Follow-up|0|||
105577169|NCT02855164|364112196|FG006|Part C (Randomized Set)|Physician Decision|0|||
105577170|NCT02855164|364112197|FG007|Part C (Randomized Set)|Physician Decision|1|||
105329433|NCT03103152|363205739|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
105329434|NCT03103152|363205740|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
105329435|NCT03103152|363205741|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
105577171|NCT02855164|364112190|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
105329436|NCT03103152|363205742|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
105329437|NCT03103152|363205743|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
105374558|NCT00724945|363377758|FG000|Period 2|lens comfort issue|3|||
105855668|NCT04181827|365124351|FG001|Overall Study|Lost to Follow-up|1|||
105855669|NCT04181827|365124350|FG000|Overall Study|Withdrawal by Subject|5|||
105855670|NCT04181827|365124351|FG001|Overall Study|Withdrawal by Subject|0|||
105855671|NCT04588389|365124352|FG000|Overall Study|Issues with anesthesia during surgery|2|||
105855672|NCT04588389|365124353|FG001|Overall Study|Issues with anesthesia during surgery|0|||
105855673|NCT04588389|365124354|FG002|Overall Study|Issues with anesthesia during surgery|0|||
105855674|NCT04190186|365124357|FG000|Overall Study|ILR is no longer functioning|0|||
105855675|NCT04190186|365124358|FG001|Overall Study|ILR is no longer functioning|1|||
105855676|NCT04190186|365124357|FG000|Overall Study|Lost to Follow-up|0|||
105855677|NCT04190186|365124358|FG001|Overall Study|Lost to Follow-up|1|||
105855678|NCT04190186|365124357|FG000|Overall Study|Withdrawal by Subject|2|||
105855679|NCT04190186|365124358|FG001|Overall Study|Withdrawal by Subject|0|||
105855680|NCT04190186|365124357|FG000|Overall Study|Subject choice to explant|1|||
105855681|NCT04190186|365124358|FG001|Overall Study|Subject choice to explant|0|||
105855682|NCT04190186|365124357|FG000|Overall Study|Physician Decision|0|||
105855683|NCT04190186|365124358|FG001|Overall Study|Physician Decision|1|||
105855684|NCT04190186|365124357|FG000|Overall Study|Study was stopped|4|||
105855685|NCT04190186|365124358|FG001|Overall Study|Study was stopped|5|||
105855686|NCT04068610|365124359|FG000|Overall Study|Death|4|||
105855687|NCT04068610|365124360|FG001|Overall Study|Death|8|||
105855688|NCT04068610|365124361|FG002|Overall Study|Death|13|||
105855689|NCT04068610|365124359|FG000|Overall Study|Lost to Follow-up|0|||
105855690|NCT04068610|365124360|FG001|Overall Study|Lost to Follow-up|2|||
105855691|NCT04068610|365124361|FG002|Overall Study|Lost to Follow-up|0|||
105855692|NCT04068610|365124359|FG000|Overall Study|Withdrawal by Subject|0|||
105855693|NCT04068610|365124360|FG001|Overall Study|Withdrawal by Subject|4|||
105855694|NCT04068610|365124361|FG002|Overall Study|Withdrawal by Subject|2|||
105855695|NCT04068610|365124359|FG000|Overall Study|Other|3|||
105855696|NCT04068610|365124360|FG001|Overall Study|Other|12|||
105855697|NCT04068610|365124361|FG002|Overall Study|Other|11|||
105855698|NCT03194646|365124362|FG000|Overall Study|Adverse Event|24|||
105855699|NCT03194646|365124363|FG001|Overall Study|Adverse Event|25|||
105855700|NCT03194646|365124364|FG002|Overall Study|Adverse Event|14|||
105855701|NCT03194646|365124365|FG003|Overall Study|Adverse Event|17|||
105855702|NCT03194646|365124362|FG000|Overall Study|Lack of Efficacy|4|||
105855703|NCT03194646|365124363|FG001|Overall Study|Lack of Efficacy|2|||
105855704|NCT03194646|365124364|FG002|Overall Study|Lack of Efficacy|2|||
105855705|NCT03194646|365124365|FG003|Overall Study|Lack of Efficacy|12|||
105855706|NCT03194646|365124362|FG000|Overall Study|Lost to Follow-up|30|||
105855707|NCT03194646|365124363|FG001|Overall Study|Lost to Follow-up|22|||
105855708|NCT03194646|365124364|FG002|Overall Study|Lost to Follow-up|12|||
105855709|NCT03194646|365124365|FG003|Overall Study|Lost to Follow-up|35|||
105855710|NCT03194646|365124362|FG000|Overall Study|Non-compliance with study drug|4|||
105855711|NCT03194646|365124363|FG001|Overall Study|Non-compliance with study drug|0|||
105855712|NCT03194646|365124364|FG002|Overall Study|Non-compliance with study drug|1|||
105855713|NCT03194646|365124365|FG003|Overall Study|Non-compliance with study drug|1|||
105855714|NCT03194646|365124362|FG000|Overall Study|Other|89|||
105855715|NCT03194646|365124363|FG001|Overall Study|Other|68|||
105855716|NCT03194646|365124364|FG002|Overall Study|Other|34|||
105855717|NCT03194646|365124365|FG003|Overall Study|Other|31|||
105855718|NCT03194646|365124362|FG000|Overall Study|Physician Decision|7|||
105855719|NCT03194646|365124363|FG001|Overall Study|Physician Decision|9|||
105855720|NCT03194646|365124364|FG002|Overall Study|Physician Decision|5|||
105855721|NCT03194646|365124365|FG003|Overall Study|Physician Decision|4|||
105855722|NCT03194646|365124362|FG000|Overall Study|Pregnancy|4|||
105855723|NCT03194646|365124363|FG001|Overall Study|Pregnancy|5|||
105855724|NCT03194646|365124364|FG002|Overall Study|Pregnancy|1|||
105855725|NCT03194646|365124365|FG003|Overall Study|Pregnancy|2|||
105855726|NCT03194646|365124362|FG000|Overall Study|Protocol Violation|4|||
105855727|NCT03194646|365124363|FG001|Overall Study|Protocol Violation|2|||
105855728|NCT03194646|365124364|FG002|Overall Study|Protocol Violation|1|||
105855729|NCT03194646|365124365|FG003|Overall Study|Protocol Violation|1|||
105855730|NCT03194646|365124362|FG000|Overall Study|Site terminated by sponsor|0|||
105855731|NCT03194646|365124363|FG001|Overall Study|Site terminated by sponsor|0|||
105855732|NCT03194646|365124364|FG002|Overall Study|Site terminated by sponsor|2|||
105855733|NCT03194646|365124365|FG003|Overall Study|Site terminated by sponsor|0|||
105855734|NCT03194646|365124362|FG000|Overall Study|Study terminated by sponsor|62|||
105855735|NCT03194646|365124363|FG001|Overall Study|Study terminated by sponsor|61|||
105855736|NCT03194646|365124364|FG002|Overall Study|Study terminated by sponsor|30|||
105855737|NCT03194646|365124365|FG003|Overall Study|Study terminated by sponsor|34|||
105855738|NCT03194646|365124362|FG000|Overall Study|Withdrawal by Subject|75|||
105855739|NCT03194646|365124363|FG001|Overall Study|Withdrawal by Subject|74|||
105855740|NCT03194646|365124364|FG002|Overall Study|Withdrawal by Subject|36|||
105855741|NCT03194646|365124365|FG003|Overall Study|Withdrawal by Subject|131|||
105855742|NCT03194646|365124362|FG000|Overall Study|Missing|1|||
105855743|NCT03194646|365124363|FG001|Overall Study|Missing|0|||
105855744|NCT03194646|365124364|FG002|Overall Study|Missing|1|||
105855745|NCT03194646|365124365|FG003|Overall Study|Missing|12|||
105855746|NCT00843882|365124366|FG000|Step 1|Lack of Efficacy|14|||
105374559|NCT00724945|363377759|FG001|Period 2|lens comfort issue|0|||
105374560|NCT00724945|363377758|FG000|Period 2|lens physiology issue|1|||
105374561|NCT00724945|363377759|FG001|Period 2|lens physiology issue|0|||
105374562|NCT01925417|363377760|FG000|Overall Study|Withdrawal by Subject|2|||
105374563|NCT01925417|363377760|FG000|Overall Study|Death|1|||
105374564|NCT00655889|363377761|FG000|Overall Study|Inadequate cell growth|1|||
105374565|NCT00655889|363377761|FG000|Overall Study|Protocol Violation|1|||
105374566|NCT01277861|363377762|FG000|Overall Study|Physician Decision|2|||
105329438|NCT03103152|363205744|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
105329439|NCT03103152|363205739|FG000|Overall Study|Unacceptable side effects|0|||
105329440|NCT03103152|363205740|FG001|Overall Study|Unacceptable side effects|0|||
105329441|NCT03103152|363205741|FG002|Overall Study|Unacceptable side effects|0|||
105329442|NCT03103152|363205742|FG003|Overall Study|Unacceptable side effects|0|||
105329443|NCT03103152|363205743|FG004|Overall Study|Unacceptable side effects|0|||
105329444|NCT03103152|363205744|FG005|Overall Study|Unacceptable side effects|1|||
105329445|NCT03103152|363205739|FG000|Overall Study|Lost to Follow-up|0|||
105329446|NCT03103152|363205740|FG001|Overall Study|Lost to Follow-up|1|||
105329447|NCT03103152|363205741|FG002|Overall Study|Lost to Follow-up|0|||
105329448|NCT03103152|363205742|FG003|Overall Study|Lost to Follow-up|1|||
105329449|NCT03103152|363205743|FG004|Overall Study|Lost to Follow-up|0|||
105329450|NCT03103152|363205744|FG005|Overall Study|Lost to Follow-up|1|||
105329451|NCT03103152|363205739|FG000|Overall Study|Testicular pain|0|||
105374567|NCT01277861|363377763|FG001|Overall Study|Physician Decision|2|||
105329452|NCT03103152|363205740|FG001|Overall Study|Testicular pain|0|||
105329453|NCT03103152|363205741|FG002|Overall Study|Testicular pain|0|||
105329454|NCT03103152|363205742|FG003|Overall Study|Testicular pain|1|||
105329455|NCT03103152|363205743|FG004|Overall Study|Testicular pain|0|||
105374568|NCT02145390|363377770|FG000|Overall Study|Withdrawal by Subject|1|||
105374569|NCT01288430|363379126|FG000|Part 1|Progressive disease|2|||
105374570|NCT01288430|363379127|FG001|Part 1|Progressive disease|1|||
105374571|NCT01288430|363379128|FG002|Part 1|Progressive disease|1|||
105374572|NCT01288430|363379129|FG003|Part 1|Progressive disease|6|||
105374573|NCT01288430|363379130|FG004|Part 1|Progressive disease|2|||
105374574|NCT01288430|363379131|FG005|Part 1|Progressive disease|4|||
105374575|NCT01288430|363379132|FG006|Part 1|Progressive disease|2|||
105374576|NCT01288430|363379133|FG007|Part 1|Progressive disease|0|||
105374577|NCT01288430|363379134|FG008|Part 1|Progressive disease|0|||
105374578|NCT01288430|363379135|FG009|Part 1|Progressive disease|0|||
105374579|NCT01288430|363379126|FG000|Part 1|Clinical disease progression|0|||
105374580|NCT01288430|363379127|FG001|Part 1|Clinical disease progression|0|||
105374581|NCT01288430|363379128|FG002|Part 1|Clinical disease progression|1|||
105374582|NCT01288430|363379129|FG003|Part 1|Clinical disease progression|0|||
105374583|NCT01288430|363379130|FG004|Part 1|Clinical disease progression|0|||
105374584|NCT01288430|363379131|FG005|Part 1|Clinical disease progression|2|||
105374585|NCT01288430|363379132|FG006|Part 1|Clinical disease progression|2|||
105374586|NCT01288430|363379133|FG007|Part 1|Clinical disease progression|0|||
105374587|NCT01288430|363379134|FG008|Part 1|Clinical disease progression|0|||
105374588|NCT01288430|363379135|FG009|Part 1|Clinical disease progression|0|||
105374589|NCT01288430|363379126|FG000|Part 1|Death due to disease progression|0|||
105374590|NCT01288430|363379127|FG001|Part 1|Death due to disease progression|0|||
105374591|NCT01288430|363379128|FG002|Part 1|Death due to disease progression|0|||
105374592|NCT01288430|363379129|FG003|Part 1|Death due to disease progression|0|||
105374593|NCT01288430|363379130|FG004|Part 1|Death due to disease progression|1|||
105374594|NCT01288430|363379131|FG005|Part 1|Death due to disease progression|0|||
105374595|NCT01288430|363379132|FG006|Part 1|Death due to disease progression|0|||
105374596|NCT01288430|363379133|FG007|Part 1|Death due to disease progression|0|||
105329456|NCT03103152|363205744|FG005|Overall Study|Testicular pain|0|||
105329457|NCT00092118|363205745|FG000|Overall Study|Adverse Event|35|||
105329458|NCT00092118|363205746|FG001|Overall Study|Adverse Event|32|||
105329459|NCT00092118|363205745|FG000|Overall Study|Lack of Efficacy|12|||
105329460|NCT00092118|363205746|FG001|Overall Study|Lack of Efficacy|14|||
105329461|NCT00092118|363205745|FG000|Overall Study|Lost to Follow-up|4|||
105374597|NCT01288430|363379134|FG008|Part 1|Death due to disease progression|0|||
105374598|NCT01288430|363379135|FG009|Part 1|Death due to disease progression|0|||
105374599|NCT01288430|363379126|FG000|Part 1|Adverse Event|0|||
105374600|NCT01288430|363379127|FG001|Part 1|Adverse Event|0|||
105374601|NCT01288430|363379128|FG002|Part 1|Adverse Event|3|||
105374602|NCT01288430|363379129|FG003|Part 1|Adverse Event|1|||
105374603|NCT01288430|363379130|FG004|Part 1|Adverse Event|0|||
105374604|NCT01288430|363379131|FG005|Part 1|Adverse Event|0|||
105374605|NCT01288430|363379132|FG006|Part 1|Adverse Event|2|||
105374606|NCT01288430|363379133|FG007|Part 1|Adverse Event|0|||
105374607|NCT01288430|363379134|FG008|Part 1|Adverse Event|0|||
105329462|NCT00092118|363205746|FG001|Overall Study|Lost to Follow-up|3|||
105329463|NCT00092118|363205745|FG000|Overall Study|Protocol Violation|23|||
105329464|NCT00092118|363205746|FG001|Overall Study|Protocol Violation|25|||
105374608|NCT01288430|363379135|FG009|Part 1|Adverse Event|0|||
105374609|NCT01288430|363379126|FG000|Part 1|Other|0|||
105374610|NCT01288430|363379127|FG001|Part 1|Other|2|||
105374611|NCT01288430|363379128|FG002|Part 1|Other|0|||
105855747|NCT00843882|365124367|FG001|Step 1|Lack of Efficacy|10|||
105855748|NCT00843882|365124368|FG002|Step 1|Lack of Efficacy|21|||
105855749|NCT00843882|365124366|FG000|Step 1|Adverse Event|8|||
105855750|NCT00843882|365124367|FG001|Step 1|Adverse Event|17|||
105855751|NCT00843882|365124368|FG002|Step 1|Adverse Event|20|||
105855752|NCT00843882|365124366|FG000|Step 1|Death|1|||
105855753|NCT00843882|365124367|FG001|Step 1|Death|2|||
105855754|NCT00843882|365124368|FG002|Step 1|Death|4|||
105855755|NCT00843882|365124366|FG000|Step 1|Withdrawal by Subject|6|||
105855756|NCT00843882|365124367|FG001|Step 1|Withdrawal by Subject|12|||
105855757|NCT00843882|365124368|FG002|Step 1|Withdrawal by Subject|9|||
105855758|NCT00843882|365124366|FG000|Step 1|Physician Decision|0|||
105855759|NCT00843882|365124367|FG001|Step 1|Physician Decision|5|||
105855760|NCT00843882|365124368|FG002|Step 1|Physician Decision|1|||
105855761|NCT00843882|365124366|FG000|Step 1|Patient and physician's decision|0|||
105855762|NCT00843882|365124367|FG001|Step 1|Patient and physician's decision|0|||
105855763|NCT00843882|365124368|FG002|Step 1|Patient and physician's decision|1|||
105855764|NCT00843882|365124366|FG000|Step 1|Other complicating disease|1|||
105855765|NCT00843882|365124367|FG001|Step 1|Other complicating disease|3|||
105855766|NCT00843882|365124368|FG002|Step 1|Other complicating disease|4|||
105855767|NCT00843882|365124366|FG000|Step 1|Alternative therapy|0|||
105855768|NCT00843882|365124367|FG001|Step 1|Alternative therapy|1|||
105855769|NCT00843882|365124368|FG002|Step 1|Alternative therapy|1|||
105855770|NCT00843882|365124366|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
105855771|NCT00843882|365124367|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
105855772|NCT00843882|365124368|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
105855773|NCT00843882|365124366|FG000|Step 1|Off treatment reason unknown|0|||
105855774|NCT00843882|365124367|FG001|Step 1|Off treatment reason unknown|1|||
105855775|NCT00843882|365124368|FG002|Step 1|Off treatment reason unknown|4|||
105855776|NCT00843882|365124366|FG000|Step 1|Never started treatment|2|||
105855777|NCT00843882|365124367|FG001|Step 1|Never started treatment|0|||
105855778|NCT00843882|365124368|FG002|Step 1|Never started treatment|0|||
105855779|NCT00843882|365124366|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
105855780|NCT00843882|365124367|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
105855781|NCT00843882|365124368|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
105855782|NCT00843882|365124366|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
105855783|NCT00843882|365124367|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
105855784|NCT00843882|365124368|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
105855785|NCT00843882|365124366|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
105855786|NCT00843882|365124367|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
105855787|NCT00843882|365124368|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
105855788|NCT00843882|365124366|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
105855789|NCT00843882|365124367|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
105855790|NCT00843882|365124368|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
105855791|NCT00843882|365124366|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
105855792|NCT00843882|365124367|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
105855793|NCT00843882|365124368|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
105855794|NCT00843882|365124366|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
105855795|NCT00843882|365124367|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
105855796|NCT00843882|365124368|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
105855797|NCT00843882|365124366|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
105855798|NCT00843882|365124367|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
105855799|NCT00843882|365124368|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
105855800|NCT02115282|365124369|FG000|Overall Study|Disease progression during treatment|216|||
105855801|NCT02115282|365124370|FG001|Overall Study|Disease progression during treatment|229|||
105855802|NCT02115282|365124369|FG000|Overall Study|Adverse Event|49|||
105855803|NCT02115282|365124370|FG001|Overall Study|Adverse Event|23|||
105855804|NCT02115282|365124369|FG000|Overall Study|Death|1|||
105855805|NCT02115282|365124370|FG001|Overall Study|Death|3|||
105855806|NCT02115282|365124369|FG000|Overall Study|Alternative therapy|1|||
105855807|NCT02115282|365124370|FG001|Overall Study|Alternative therapy|1|||
105855808|NCT02115282|365124369|FG000|Overall Study|Complicating disease|0|||
105855809|NCT02115282|365124370|FG001|Overall Study|Complicating disease|3|||
105855810|NCT02115282|365124369|FG000|Overall Study|Withdrawal by Subject|12|||
105855811|NCT02115282|365124370|FG001|Overall Study|Withdrawal by Subject|10|||
105855812|NCT02115282|365124369|FG000|Overall Study|Symptomatic progression/deterioration|7|||
105855813|NCT02115282|365124370|FG001|Overall Study|Symptomatic progression/deterioration|18|||
105855814|NCT02115282|365124369|FG000|Overall Study|Non-compliance|5|||
105855815|NCT02115282|365124370|FG001|Overall Study|Non-compliance|1|||
105855816|NCT02115282|365124369|FG000|Overall Study|Protocol Violation|2|||
105855817|NCT02115282|365124370|FG001|Overall Study|Protocol Violation|2|||
105855818|NCT02115282|365124369|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
105855819|NCT02115282|365124370|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
105855820|NCT02115282|365124369|FG000|Overall Study|Not start protocol therapy|9|||
105855821|NCT02115282|365124370|FG001|Overall Study|Not start protocol therapy|10|||
105329465|NCT00092118|363205745|FG000|Overall Study|Withdrawal by Subject|4|||
105329466|NCT00092118|363205746|FG001|Overall Study|Withdrawal by Subject|10|||
105329467|NCT00092118|363205745|FG000|Overall Study|Other|6|||
105329468|NCT00092118|363205746|FG001|Overall Study|Other|5|||
105329469|NCT03123393|363205752|FG000|Overall Study|Study Terminated by Sponsor|6|||
105329470|NCT03123393|363205753|FG001|Overall Study|Study Terminated by Sponsor|9|||
105329471|NCT03123393|363205752|FG000|Overall Study|Withdrawal by Subject|2|||
105329472|NCT03123393|363205753|FG001|Overall Study|Withdrawal by Subject|1|||
105374612|NCT01288430|363379129|FG003|Part 1|Other|0|||
105374613|NCT01288430|363379130|FG004|Part 1|Other|0|||
105374614|NCT01288430|363379131|FG005|Part 1|Other|0|||
105374615|NCT01288430|363379132|FG006|Part 1|Other|1|||
105374616|NCT01288430|363379133|FG007|Part 1|Other|0|||
105374617|NCT01288430|363379134|FG008|Part 1|Other|0|||
105374618|NCT01288430|363379135|FG009|Part 1|Other|0|||
105374619|NCT01288430|363379126|FG000|Part 2|Progressive disease|0|||
105374620|NCT01288430|363379127|FG001|Part 2|Progressive disease|0|||
105374621|NCT01288430|363379128|FG002|Part 2|Progressive disease|0|||
105374622|NCT01288430|363379129|FG003|Part 2|Progressive disease|0|||
105374623|NCT01288430|363379130|FG004|Part 2|Progressive disease|0|||
105374624|NCT01288430|363379131|FG005|Part 2|Progressive disease|0|||
105374625|NCT01288430|363379132|FG006|Part 2|Progressive disease|0|||
105374626|NCT01288430|363379133|FG007|Part 2|Progressive disease|8|||
105374627|NCT01288430|363379134|FG008|Part 2|Progressive disease|7|||
105374628|NCT01288430|363379135|FG009|Part 2|Progressive disease|2|||
105374629|NCT01288430|363379126|FG000|Part 2|Clinical disease progression|0|||
105374630|NCT01288430|363379127|FG001|Part 2|Clinical disease progression|0|||
105374631|NCT01288430|363379128|FG002|Part 2|Clinical disease progression|0|||
105374632|NCT01288430|363379129|FG003|Part 2|Clinical disease progression|0|||
105374633|NCT01288430|363379130|FG004|Part 2|Clinical disease progression|0|||
105374634|NCT01288430|363379131|FG005|Part 2|Clinical disease progression|0|||
105374635|NCT01288430|363379132|FG006|Part 2|Clinical disease progression|0|||
105374636|NCT01288430|363379133|FG007|Part 2|Clinical disease progression|2|||
105374637|NCT01288430|363379134|FG008|Part 2|Clinical disease progression|0|||
105374638|NCT01288430|363379135|FG009|Part 2|Clinical disease progression|0|||
105374639|NCT01288430|363379126|FG000|Part 2|Withdrawal by Subject|0|||
105374640|NCT01288430|363379127|FG001|Part 2|Withdrawal by Subject|0|||
105374641|NCT01288430|363379128|FG002|Part 2|Withdrawal by Subject|0|||
105374642|NCT01288430|363379129|FG003|Part 2|Withdrawal by Subject|0|||
105374643|NCT01288430|363379130|FG004|Part 2|Withdrawal by Subject|0|||
105374644|NCT01288430|363379131|FG005|Part 2|Withdrawal by Subject|0|||
105374645|NCT01288430|363379132|FG006|Part 2|Withdrawal by Subject|0|||
105374646|NCT01288430|363379133|FG007|Part 2|Withdrawal by Subject|1|||
105374647|NCT01288430|363379134|FG008|Part 2|Withdrawal by Subject|4|||
105374648|NCT01288430|363379135|FG009|Part 2|Withdrawal by Subject|0|||
105374649|NCT01288430|363379126|FG000|Part 2|Adverse Event|0|||
105374650|NCT01288430|363379127|FG001|Part 2|Adverse Event|0|||
105374651|NCT01288430|363379128|FG002|Part 2|Adverse Event|0|||
105374652|NCT01288430|363379129|FG003|Part 2|Adverse Event|0|||
105374653|NCT01288430|363379130|FG004|Part 2|Adverse Event|0|||
105374654|NCT01288430|363379131|FG005|Part 2|Adverse Event|0|||
105374655|NCT01288430|363379132|FG006|Part 2|Adverse Event|0|||
105374656|NCT01288430|363379133|FG007|Part 2|Adverse Event|1|||
105374657|NCT01288430|363379134|FG008|Part 2|Adverse Event|1|||
105374658|NCT01288430|363379135|FG009|Part 2|Adverse Event|0|||
105374659|NCT01288430|363379126|FG000|Part 2|Other|0|||
105374660|NCT01288430|363379127|FG001|Part 2|Other|0|||
105374661|NCT01288430|363379128|FG002|Part 2|Other|0|||
105374662|NCT01288430|363379129|FG003|Part 2|Other|0|||
105374663|NCT01288430|363379130|FG004|Part 2|Other|0|||
105374664|NCT01288430|363379131|FG005|Part 2|Other|0|||
105374665|NCT01288430|363379132|FG006|Part 2|Other|0|||
105374666|NCT01288430|363379133|FG007|Part 2|Other|0|||
105374667|NCT01288430|363379134|FG008|Part 2|Other|0|||
105374668|NCT01288430|363379135|FG009|Part 2|Other|1|||
105374669|NCT02233413|363379136|FG000|Overall Study|Lost to Follow-up|7|||
105374670|NCT02233413|363379137|FG001|Overall Study|Lost to Follow-up|9|||
105329473|NCT03123393|363205752|FG000|Overall Study|Reason not Specified|13|||
105374671|NCT02233413|363379136|FG000|Overall Study|Withdrawal by Subject|4|||
105374672|NCT02233413|363379137|FG001|Overall Study|Withdrawal by Subject|5|||
105374673|NCT02100631|363379138|FG000|Overall Study|Withdrawal by Subject|1|||
105374674|NCT02100631|363379139|FG001|Overall Study|Withdrawal by Subject|0|||
105374675|NCT02100631|363379140|FG002|Overall Study|Withdrawal by Subject|0|||
105577172|NCT02855164|364112191|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
105329474|NCT03123393|363205753|FG001|Overall Study|Reason not Specified|13|||
105329475|NCT00558701|363205754|FG000|Overall Study|Protocol Deviations|1|||
105374676|NCT02100631|363379138|FG000|Overall Study|Lost to Follow-up|3|||
105374677|NCT02100631|363379139|FG001|Overall Study|Lost to Follow-up|4|||
105374678|NCT02100631|363379140|FG002|Overall Study|Lost to Follow-up|0|||
105374679|NCT02100631|363379138|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
105374680|NCT02100631|363379139|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
105329476|NCT00558701|363205755|FG001|Overall Study|Protocol Deviations|4|||
105374681|NCT02100631|363379140|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
105374682|NCT01408641|363379143|FG000|Overall Study|Physician Decision|1|||
105374683|NCT01408641|363379144|FG001|Overall Study|Physician Decision|0|||
105374684|NCT00576758|363379145|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
105374685|NCT00576758|363379146|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
105374686|NCT00576758|363379145|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
105374687|NCT00576758|363379146|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
105374688|NCT00576758|363379145|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
105329477|NCT00427648|363205756|FG000|Overall Study|Protocol Violation|1|||
105329478|NCT00427648|363205757|FG001|Overall Study|Protocol Violation|2|||
105855822|NCT00644228|365124371|FG000|Randomization & Eligibility|Ineligible|31|||
105855823|NCT00644228|365124372|FG001|Randomization & Eligibility|Ineligible|21|||
105329479|NCT00427648|363205756|FG000|Overall Study|Adverse Event|0|||
105329480|NCT00427648|363205757|FG001|Overall Study|Adverse Event|1|||
105329481|NCT01297517|363205761|FG000|Overall Study|Adverse Event|21|||
105329482|NCT01297517|363205762|FG001|Overall Study|Adverse Event|7|||
105329483|NCT01297517|363205763|FG002|Overall Study|Adverse Event|16|||
105329484|NCT01297517|363205761|FG000|Overall Study|Lost to Follow-up|1|||
105329485|NCT01297517|363205762|FG001|Overall Study|Lost to Follow-up|0|||
105329486|NCT01297517|363205763|FG002|Overall Study|Lost to Follow-up|1|||
105329487|NCT01297517|363205761|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
105329488|NCT01297517|363205762|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
105329489|NCT01297517|363205763|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
105374689|NCT00576758|363379146|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
105374690|NCT00576758|363379145|FG000|Induction Treatment Period|Death|1|||
105855824|NCT00644228|365124371|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
105329490|NCT01297517|363205761|FG000|Overall Study|Noncompliance|1|||
105855825|NCT00644228|365124372|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
105855826|NCT00644228|365124371|FG000|Randomization & Eligibility|Invalid Consent|0|||
105855827|NCT00644228|365124372|FG001|Randomization & Eligibility|Invalid Consent|1|||
105855828|NCT00644228|365124371|FG000|Induction Therapy|Adverse Event|22|||
105855829|NCT00644228|365124372|FG001|Induction Therapy|Adverse Event|55|||
105855830|NCT00644228|365124371|FG000|Induction Therapy|Withdrawal by Subject|10|||
105855831|NCT00644228|365124372|FG001|Induction Therapy|Withdrawal by Subject|3|||
105855832|NCT00644228|365124371|FG000|Induction Therapy|Progression/Relapse|24|||
105855833|NCT00644228|365124372|FG001|Induction Therapy|Progression/Relapse|12|||
105855834|NCT00644228|365124371|FG000|Induction Therapy|Death|3|||
105855835|NCT00644228|365124372|FG001|Induction Therapy|Death|7|||
105855836|NCT00644228|365124371|FG000|Induction Therapy|Not Protocol-Specified|24|||
105855837|NCT00644228|365124372|FG001|Induction Therapy|Not Protocol-Specified|28|||
105855838|NCT00644228|365124371|FG000|Maintenance|Adverse Event|27|||
105855839|NCT00644228|365124372|FG001|Maintenance|Adverse Event|31|||
105855840|NCT00644228|365124371|FG000|Maintenance|Withdrawal by Subject|6|||
105855841|NCT00644228|365124372|FG001|Maintenance|Withdrawal by Subject|4|||
105855842|NCT00644228|365124371|FG000|Maintenance|Progression/Relapse|67|||
105855843|NCT00644228|365124372|FG001|Maintenance|Progression/Relapse|42|||
105855844|NCT00644228|365124371|FG000|Maintenance|Death|3|||
105855845|NCT00644228|365124372|FG001|Maintenance|Death|3|||
105855846|NCT00644228|365124371|FG000|Maintenance|Not Protocol-Specified|14|||
105855847|NCT00644228|365124372|FG001|Maintenance|Not Protocol-Specified|15|||
105855848|NCT00644228|365124371|FG000|Maintenance|On Treatment|26|||
105855849|NCT00644228|365124372|FG001|Maintenance|On Treatment|40|||
105855850|NCT00658814|365124373|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
105855851|NCT00658814|365124374|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
105855852|NCT00658814|365124373|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
105855853|NCT00658814|365124374|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
105855854|NCT00658814|365124373|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
105855855|NCT00658814|365124374|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
105855856|NCT00658814|365124373|FG000|Remission Induction Chemotherapy|Death|1|||
105855857|NCT00658814|365124374|FG001|Remission Induction Chemotherapy|Death|4|||
105855858|NCT00658814|365124373|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
105855859|NCT00658814|365124374|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
105855860|NCT00658814|365124373|FG000|Remission Induction Chemotherapy|Not eligible|1|||
105855861|NCT00658814|365124374|FG001|Remission Induction Chemotherapy|Not eligible|2|||
105855862|NCT00658814|365124373|FG000|Consolidation Therapy|Not protocol specified|0|||
105329491|NCT01297517|363205762|FG001|Overall Study|Noncompliance|0|||
105329492|NCT01297517|363205763|FG002|Overall Study|Noncompliance|0|||
105329493|NCT01297517|363205761|FG000|Overall Study|Protocol Violation|1|||
105329494|NCT01297517|363205762|FG001|Overall Study|Protocol Violation|1|||
105855863|NCT00658814|365124374|FG001|Consolidation Therapy|Not protocol specified|1|||
105329495|NCT01297517|363205763|FG002|Overall Study|Protocol Violation|1|||
105329496|NCT01297517|363205761|FG000|Overall Study|Inadequate Control of IOP|1|||
105329497|NCT01297517|363205762|FG001|Overall Study|Inadequate Control of IOP|1|||
105374691|NCT00576758|363379146|FG001|Induction Treatment Period|Death|0|||
105374692|NCT00576758|363379145|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
105374693|NCT00576758|363379146|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
105374694|NCT00576758|363379145|FG000|Induction Treatment Period|Withdrew consent|1|||
105374695|NCT00576758|363379146|FG001|Induction Treatment Period|Withdrew consent|0|||
105374696|NCT00576758|363379145|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
105855864|NCT00658814|365124373|FG000|Consolidation Therapy|Not eligible|2|||
105855865|NCT00658814|365124374|FG001|Consolidation Therapy|Not eligible|2|||
105855866|NCT00658814|365124373|FG000|Maintenance Therapy|Adverse Event|1|||
105855867|NCT00658814|365124374|FG001|Maintenance Therapy|Adverse Event|1|||
105855868|NCT00658814|365124373|FG000|Maintenance Therapy|Not protocol specified|1|||
105855869|NCT00658814|365124374|FG001|Maintenance Therapy|Not protocol specified|0|||
105855870|NCT00658814|365124373|FG000|Maintenance Therapy|Not eligible|1|||
105855871|NCT00658814|365124374|FG001|Maintenance Therapy|Not eligible|0|||
105855872|NCT02911142|365124375|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
105855873|NCT02911142|365124375|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
105855874|NCT02911142|365124375|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
105855875|NCT02911142|365124375|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
105855876|NCT03260894|365124376|FG000|Overall Study|Death|6|||
105855877|NCT03260894|365124377|FG001|Overall Study|Death|8|||
105855878|NCT03260894|365124376|FG000|Overall Study|Withdrawal by Subject|4|||
105855879|NCT03260894|365124377|FG001|Overall Study|Withdrawal by Subject|11|||
105855880|NCT03260894|365124376|FG000|Overall Study|On-going at clinical cut off date|36|||
105855881|NCT03260894|365124377|FG001|Overall Study|On-going at clinical cut off date|31|||
105855882|NCT04755283|365124378|FG000|Overall Study|Withdrawal by Subject|14|||
105855883|NCT04755283|365124379|FG001|Overall Study|Withdrawal by Subject|3|||
105855884|NCT04755283|365124380|FG002|Overall Study|Withdrawal by Subject|6|||
105855885|NCT04755283|365124378|FG000|Overall Study|Lost to Follow-up|0|||
105855886|NCT04755283|365124379|FG001|Overall Study|Lost to Follow-up|0|||
105855887|NCT04755283|365124380|FG002|Overall Study|Lost to Follow-up|1|||
105855888|NCT04755283|365124378|FG000|Overall Study|Death|31|||
105855889|NCT04755283|365124379|FG001|Overall Study|Death|36|||
105855890|NCT04755283|365124380|FG002|Overall Study|Death|34|||
105855891|NCT02446600|365124381|FG000|Overall Study|Never treated|20|||
105855892|NCT02446600|365124382|FG001|Overall Study|Never treated|2|||
105855893|NCT02446600|365124383|FG002|Overall Study|Never treated|6|||
105855894|NCT02446600|365124384|FG003|Overall Study|Never treated|0|||
105855895|NCT02446600|365124381|FG000|Overall Study|Withdrawal by Subject|19|||
105855896|NCT02446600|365124382|FG001|Overall Study|Withdrawal by Subject|5|||
105855897|NCT02446600|365124383|FG002|Overall Study|Withdrawal by Subject|17|||
105855898|NCT02446600|365124384|FG003|Overall Study|Withdrawal by Subject|0|||
105855899|NCT02446600|365124381|FG000|Overall Study|Ineligible|1|||
105855900|NCT02446600|365124382|FG001|Overall Study|Ineligible|4|||
105855901|NCT02446600|365124383|FG002|Overall Study|Ineligible|4|||
105855902|NCT02446600|365124384|FG003|Overall Study|Ineligible|1|||
105855903|NCT02446600|365124381|FG000|Overall Study|Duplicate Enrollment|0|||
105855904|NCT02446600|365124382|FG001|Overall Study|Duplicate Enrollment|1|||
105855905|NCT02446600|365124383|FG002|Overall Study|Duplicate Enrollment|0|||
105855906|NCT02446600|365124384|FG003|Overall Study|Duplicate Enrollment|0|||
105855907|NCT05007392|365124385|FG000|Overall Study|Randomized but not treated|1|||
105855908|NCT05007392|365124386|FG001|Overall Study|Randomized but not treated|2|||
105855909|NCT05007392|365124385|FG000|Overall Study|Other|5|||
105855910|NCT05007392|365124386|FG001|Overall Study|Other|4|||
105855911|NCT05007392|365124385|FG000|Overall Study|Lost to Follow-up|1|||
105855912|NCT05007392|365124386|FG001|Overall Study|Lost to Follow-up|2|||
105855913|NCT05007392|365124385|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
105855914|NCT05007392|365124386|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
105855915|NCT05007392|365124385|FG000|Overall Study|Use of prohibited concomitant drug|1|||
105855916|NCT05007392|365124386|FG001|Overall Study|Use of prohibited concomitant drug|1|||
105855917|NCT05007392|365124385|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
105855918|NCT05007392|365124386|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
105855919|NCT05007392|365124385|FG000|Overall Study|Adverse Event|10|||
105855920|NCT05007392|365124386|FG001|Overall Study|Adverse Event|6|||
105855921|NCT05007392|365124385|FG000|Overall Study|Participant choice|5|||
105374697|NCT00576758|363379146|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
105855922|NCT05007392|365124386|FG001|Overall Study|Participant choice|10|||
105855923|NCT05007392|365124385|FG000|Overall Study|Withdrawal of consent|5|||
105855924|NCT05007392|365124386|FG001|Overall Study|Withdrawal of consent|4|||
105374698|NCT00576758|363379145|FG000|Extension Treatment Period|Death|1|||
105855925|NCT03228537|365124387|FG000|Neoadjuvant|Adverse Event|2|||
105855926|NCT03228537|365124387|FG000|Neoadjuvant|Progression/Relapse|4|||
105855927|NCT03228537|365124387|FG000|Neoadjuvant|Death|1|||
105855928|NCT03228537|365124387|FG000|Surgery|Death|1|||
105855929|NCT03228537|365124387|FG000|Surgery|Other - Not Protocol Specified|2|||
105855930|NCT03228537|365124387|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
105855931|NCT03228537|365124387|FG000|Maintenance|Progression/Relapse|10|||
105855932|NCT02466971|365124388|FG000|Overall Study|eligible and never treated|14|||
105855933|NCT02466971|365124389|FG001|Overall Study|eligible and never treated|20|||
105374699|NCT00576758|363379146|FG001|Extension Treatment Period|Death|1|||
105374700|NCT00576758|363379145|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
105374701|NCT00576758|363379146|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
105374702|NCT00576758|363379145|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
105374703|NCT00576758|363379146|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
105374704|NCT00576758|363379145|FG000|Extension Treatment Period|Administrative/Other|3|||
105374705|NCT00576758|363379146|FG001|Extension Treatment Period|Administrative/Other|1|||
105374706|NCT00576758|363379145|FG000|Follow-up Period|Administrative/Other|6|||
105374707|NCT00576758|363379146|FG001|Follow-up Period|Administrative/Other|8|||
105374708|NCT00576758|363379145|FG000|Follow-up Period|Death|3|||
105577173|NCT02855164|364112192|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
105855934|NCT02466971|365124388|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
105855935|NCT02466971|365124389|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
105855936|NCT02466971|365124388|FG000|Overall Study|ineligible and treated|1|||
105855937|NCT02466971|365124389|FG001|Overall Study|ineligible and treated|0|||
105855938|NCT02466971|365124388|FG000|Overall Study|ineligible and never treated|0|||
105855939|NCT02466971|365124389|FG001|Overall Study|ineligible and never treated|1|||
105855940|NCT06213701|365124390|FG000|Overall Study|Withdrawal by Subject|2|||
105855941|NCT06213701|365124391|FG001|Overall Study|Withdrawal by Subject|1|||
105855942|NCT06213701|365124392|FG002|Overall Study|Withdrawal by Subject|0|||
105855943|NCT05014542|365124393|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
105855944|NCT05014542|365124394|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
105855945|NCT05014542|365124393|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
105855946|NCT05014542|365124394|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
105855947|NCT05014542|365124393|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
105855948|NCT05014542|365124394|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
105855949|NCT05014542|365124393|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
105855950|NCT05014542|365124394|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
105855951|NCT05507580|365124395|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105855952|NCT05507580|365124396|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
105855953|NCT05507580|365124397|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
105855954|NCT05507580|365124398|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
105855955|NCT05507580|365124399|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
105855956|NCT05507580|365124400|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
105855957|NCT05507580|365124395|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
105855958|NCT05507580|365124396|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105855959|NCT05507580|365124397|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105855960|NCT05507580|365124398|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105855961|NCT05507580|365124399|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105855962|NCT05507580|365124400|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105855963|NCT05507580|365124395|FG000|Double-Blind Treatment Period|Other, not specified|5|||
105855964|NCT05507580|365124396|FG001|Double-Blind Treatment Period|Other, not specified|4|||
105855965|NCT05507580|365124397|FG002|Double-Blind Treatment Period|Other, not specified|0|||
105855966|NCT05507580|365124398|FG003|Double-Blind Treatment Period|Other, not specified|0|||
105855967|NCT05507580|365124399|FG004|Double-Blind Treatment Period|Other, not specified|0|||
105855968|NCT05507580|365124400|FG005|Double-Blind Treatment Period|Other, not specified|0|||
105855969|NCT05507580|365124395|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
105855970|NCT05507580|365124396|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
105374709|NCT00576758|363379146|FG001|Follow-up Period|Death|3|||
105855971|NCT05507580|365124397|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
105855972|NCT05507580|365124398|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
105855973|NCT05507580|365124399|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
105855974|NCT05507580|365124400|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
105855975|NCT05507580|365124395|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
105855976|NCT05507580|365124396|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
105855977|NCT05507580|365124397|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
105855978|NCT05507580|365124398|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
105855979|NCT05507580|365124399|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
105855980|NCT05507580|365124400|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
105855981|NCT05507580|365124395|FG000|Single-Blind Treatment Period|Other, not specified|0|||
105374710|NCT00576758|363379145|FG000|Follow-up Period|Insufficient therapeutic response|16|||
105577174|NCT02855164|364112193|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
105577175|NCT02855164|364112194|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
105855982|NCT05507580|365124396|FG001|Single-Blind Treatment Period|Other, not specified|0|||
105374711|NCT00576758|363379146|FG001|Follow-up Period|Insufficient therapeutic response|5|||
105374712|NCT00576758|363379145|FG000|Follow-up Period|Withdrew consent|2|||
105374713|NCT00576758|363379146|FG001|Follow-up Period|Withdrew consent|1|||
105374714|NCT03979313|363379147|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
105374715|NCT03979313|363379148|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
105374716|NCT03979313|363379147|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
105374717|NCT03979313|363379148|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
105329498|NCT01297517|363205763|FG002|Overall Study|Inadequate Control of IOP|2|||
105329499|NCT00386360|363205764|FG000|Overall Study|Adverse Event|4|||
105329500|NCT00386360|363205765|FG001|Overall Study|Adverse Event|2|||
105329501|NCT00386360|363205764|FG000|Overall Study|Physician Decision|2|||
105855983|NCT05507580|365124397|FG002|Single-Blind Treatment Period|Other, not specified|2|||
105855984|NCT05507580|365124398|FG003|Single-Blind Treatment Period|Other, not specified|7|||
105855985|NCT05507580|365124399|FG004|Single-Blind Treatment Period|Other, not specified|3|||
105855986|NCT05507580|365124400|FG005|Single-Blind Treatment Period|Other, not specified|5|||
105855987|NCT06000501|365124406|FG000|Overall Study|Screen failure|3|||
105855988|NCT06000501|365124406|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
105855989|NCT06000501|365124406|FG000|Overall Study|Physician Decision|4|||
105855990|NCT06000501|365124406|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
105855991|NCT06000501|365124406|FG000|Overall Study|Scheduling issues|2|||
105855992|NCT03496662|365124408|FG000|Overall Study|Adverse Event|0|||
105855993|NCT03496662|365124409|FG001|Overall Study|Adverse Event|0|||
105855994|NCT03496662|365124410|FG002|Overall Study|Adverse Event|4|||
105855995|NCT03496662|365124408|FG000|Overall Study|Withdrawal by Subject|1|||
105855996|NCT03496662|365124409|FG001|Overall Study|Withdrawal by Subject|0|||
105855997|NCT03496662|365124410|FG002|Overall Study|Withdrawal by Subject|2|||
105855998|NCT03496662|365124408|FG000|Overall Study|Death|0|||
105855999|NCT03496662|365124409|FG001|Overall Study|Death|0|||
105856000|NCT03496662|365124410|FG002|Overall Study|Death|2|||
105856001|NCT03496662|365124408|FG000|Overall Study|Noncompliance|0|||
105856002|NCT03496662|365124409|FG001|Overall Study|Noncompliance|0|||
105329502|NCT00386360|363205765|FG001|Overall Study|Physician Decision|2|||
105329503|NCT00386360|363205764|FG000|Overall Study|Lost to Follow-up|0|||
105329504|NCT00386360|363205765|FG001|Overall Study|Lost to Follow-up|2|||
105329505|NCT00386360|363205764|FG000|Overall Study|Protocol Violation|0|||
105329506|NCT00386360|363205765|FG001|Overall Study|Protocol Violation|3|||
105329507|NCT00386360|363205764|FG000|Overall Study|Withdrawal by Subject|3|||
105329508|NCT00386360|363205765|FG001|Overall Study|Withdrawal by Subject|6|||
105329509|NCT00386360|363205764|FG000|Overall Study|Did not take any study medication|0|||
105329510|NCT00386360|363205765|FG001|Overall Study|Did not take any study medication|2|||
105329511|NCT02025725|363205768|FG000|Overall Study|Adverse Event|5|||
105329512|NCT02025725|363205769|FG001|Overall Study|Adverse Event|0|||
105329513|NCT02025725|363205768|FG000|Overall Study|Lost to Follow-up|2|||
105329514|NCT02025725|363205769|FG001|Overall Study|Lost to Follow-up|0|||
105329515|NCT02025725|363205768|FG000|Overall Study|Protocol Violation|1|||
105856003|NCT03496662|365124410|FG002|Overall Study|Noncompliance|1|||
105856004|NCT03210714|365124415|FG000|Overall Study|Adverse Event|6|||
105856005|NCT03210714|365124415|FG000|Overall Study|Physician Decision|1|||
105856006|NCT03210714|365124415|FG000|Overall Study|Progressive disease|11|||
105856007|NCT03210714|365124415|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
105856008|NCT02883062|365124416|FG000|Overall Study|Withdrawal by Subject|6|||
105856009|NCT02883062|365124417|FG001|Overall Study|Withdrawal by Subject|0|||
105856010|NCT04051827|365124418|FG000|Overall Study|Death|1|||
105856011|NCT04051827|365124418|FG000|Overall Study|Withdrawal by Subject|4|||
105329516|NCT02025725|363205769|FG001|Overall Study|Protocol Violation|1|||
105329517|NCT02025725|363205768|FG000|Overall Study|Withdrawal by Subject|3|||
105329518|NCT02025725|363205769|FG001|Overall Study|Withdrawal by Subject|2|||
105329519|NCT02025725|363205768|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
105374718|NCT03979313|363379147|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
105329520|NCT02025725|363205769|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
105374719|NCT03979313|363379148|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
105374720|NCT03979313|363379147|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
105856012|NCT04051827|365124418|FG000|Overall Study|Progressive disease|16|||
105856013|NCT04051827|365124418|FG000|Overall Study|Physician Decision|1|||
105856014|NCT04051827|365124418|FG000|Overall Study|Other|4|||
105856015|NCT02888743|365124419|FG000|Overall Study|Withdrawal by Subject|1|||
105329521|NCT02677922|363205778|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
105329522|NCT02677922|363205779|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
105329523|NCT02677922|363205780|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
105329524|NCT02677922|363205781|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
105329525|NCT02677922|363205782|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
105329526|NCT02677922|363205783|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
105856016|NCT02888743|365124420|FG001|Overall Study|Withdrawal by Subject|2|||
105856017|NCT02888743|365124421|FG002|Overall Study|Withdrawal by Subject|2|||
105856018|NCT02888743|365124422|FG003|Overall Study|Withdrawal by Subject|0|||
105577176|NCT02855164|364112195|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
105577177|NCT02855164|364112196|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
105856019|NCT02888743|365124423|FG004|Overall Study|Withdrawal by Subject|1|||
105856020|NCT02888743|365124419|FG000|Overall Study|Disease progression before treatment|2|||
105856021|NCT02888743|365124420|FG001|Overall Study|Disease progression before treatment|0|||
105856022|NCT02888743|365124421|FG002|Overall Study|Disease progression before treatment|2|||
105856023|NCT02888743|365124422|FG003|Overall Study|Disease progression before treatment|0|||
105856024|NCT02888743|365124423|FG004|Overall Study|Disease progression before treatment|0|||
105856025|NCT02888743|365124419|FG000|Overall Study|Patient ineligible|1|||
105856026|NCT02888743|365124420|FG001|Overall Study|Patient ineligible|2|||
105856027|NCT02888743|365124421|FG002|Overall Study|Patient ineligible|0|||
105856028|NCT02888743|365124422|FG003|Overall Study|Patient ineligible|0|||
105856029|NCT02888743|365124423|FG004|Overall Study|Patient ineligible|0|||
105856030|NCT05779007|365124427|FG000|Overall Study|not meeting eligibility criteria|3517|||
105856031|NCT05779007|365124428|FG001|Overall Study|not meeting eligibility criteria|2009|||
105856032|NCT04589650|365124429|FG000|Overall Study|Subject decision|6|||
105856033|NCT04589650|365124430|FG001|Overall Study|Subject decision|2|||
105856034|NCT04589650|365124431|FG002|Overall Study|Subject decision|2|||
105856035|NCT04589650|365124432|FG003|Overall Study|Subject decision|0|||
105856036|NCT04589650|365124433|FG004|Overall Study|Subject decision|0|||
105856037|NCT04589650|365124434|FG005|Overall Study|Subject decision|0|||
105856038|NCT04589650|365124429|FG000|Overall Study|Adverse Event|3|||
105856039|NCT04589650|365124430|FG001|Overall Study|Adverse Event|1|||
105856040|NCT04589650|365124431|FG002|Overall Study|Adverse Event|1|||
105856041|NCT04589650|365124432|FG003|Overall Study|Adverse Event|1|||
105856042|NCT04589650|365124433|FG004|Overall Study|Adverse Event|0|||
105856043|NCT04589650|365124434|FG005|Overall Study|Adverse Event|1|||
105856044|NCT04589650|365124429|FG000|Overall Study|Physician Decision|1|||
105856045|NCT04589650|365124430|FG001|Overall Study|Physician Decision|1|||
105856046|NCT04589650|365124431|FG002|Overall Study|Physician Decision|0|||
105856047|NCT04589650|365124432|FG003|Overall Study|Physician Decision|0|||
105856048|NCT04589650|365124433|FG004|Overall Study|Physician Decision|0|||
105856049|NCT04589650|365124434|FG005|Overall Study|Physician Decision|0|||
105856050|NCT04589650|365124429|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105856051|NCT04589650|365124430|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105856052|NCT04589650|365124431|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105856053|NCT04589650|365124432|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
105856054|NCT04589650|365124433|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
105856055|NCT04589650|365124434|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
105856056|NCT04589650|365124429|FG000|Overall Study|Death|0|||
105856057|NCT04589650|365124430|FG001|Overall Study|Death|0|||
105856058|NCT04589650|365124431|FG002|Overall Study|Death|0|||
105856059|NCT04589650|365124432|FG003|Overall Study|Death|1|||
105856060|NCT04589650|365124433|FG004|Overall Study|Death|0|||
105856061|NCT04589650|365124434|FG005|Overall Study|Death|0|||
105856062|NCT04589650|365124429|FG000|Overall Study|Guardian Decision|0|||
105856063|NCT04589650|365124430|FG001|Overall Study|Guardian Decision|0|||
105856064|NCT04589650|365124431|FG002|Overall Study|Guardian Decision|0|||
105856065|NCT04589650|365124432|FG003|Overall Study|Guardian Decision|1|||
105856066|NCT04589650|365124433|FG004|Overall Study|Guardian Decision|0|||
105856067|NCT04589650|365124434|FG005|Overall Study|Guardian Decision|0|||
105856068|NCT00902694|365124437|FG000|Overall Study|Death|1|||
105856069|NCT00902694|365124438|FG001|Overall Study|Death|3|||
105856070|NCT00902694|365124437|FG000|Overall Study|Lost to Follow-up|1|||
105329527|NCT02677922|363205778|FG000|Treatment Period|Adverse Event|0|||
105329528|NCT02677922|363205779|FG001|Treatment Period|Adverse Event|0|||
105329529|NCT02677922|363205780|FG002|Treatment Period|Adverse Event|1|||
105329530|NCT02677922|363205781|FG003|Treatment Period|Adverse Event|3|||
105329531|NCT02677922|363205782|FG004|Treatment Period|Adverse Event|5|||
105329532|NCT02677922|363205783|FG005|Treatment Period|Adverse Event|2|||
105329533|NCT02677922|363205778|FG000|Treatment Period|Progressive Disease|1|||
105329534|NCT02677922|363205779|FG001|Treatment Period|Progressive Disease|1|||
105577178|NCT02855164|364112197|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
105577179|NCT01370603|364112204|FG000|Period 1|Adverse Event|5|||
105577180|NCT01370603|364112205|FG001|Period 1|Adverse Event|3|||
105577181|NCT01370603|364112204|FG000|Period 1|Lost to Follow-up|2|||
105856071|NCT00902694|365124438|FG001|Overall Study|Lost to Follow-up|0|||
105856072|NCT00902694|365124437|FG000|Overall Study|Censored per protocol|3|||
105856073|NCT00902694|365124438|FG001|Overall Study|Censored per protocol|1|||
105856074|NCT00902694|365124437|FG000|Overall Study|Pregnancy|1|||
105856075|NCT00902694|365124438|FG001|Overall Study|Pregnancy|1|||
105856076|NCT00902694|365124437|FG000|Overall Study|Incarceration|1|||
105856077|NCT00902694|365124438|FG001|Overall Study|Incarceration|0|||
105856078|NCT04017962|365124439|FG000|Overall Study|Death|2|||
105856079|NCT04017962|365124440|FG001|Overall Study|Death|0|||
105856080|NCT04017962|365124439|FG000|Overall Study|Lost to Follow-up|2|||
105856081|NCT04017962|365124440|FG001|Overall Study|Lost to Follow-up|0|||
105856082|NCT04017962|365124439|FG000|Overall Study|Physician Decision|1|||
105856083|NCT04017962|365124440|FG001|Overall Study|Physician Decision|0|||
105856084|NCT04017962|365124439|FG000|Overall Study|Discontinued LTV|5|||
105856085|NCT04017962|365124440|FG001|Overall Study|Discontinued LTV|0|||
105856086|NCT04969263|365124441|FG000|Overall Study|Death|1|||
105856087|NCT04969263|365124441|FG000|Overall Study|Lost to Follow-up|2|||
105856088|NCT04969263|365124441|FG000|Overall Study|Withdrawal by Subject|5|||
105856089|NCT04969263|365124441|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
105856090|NCT05489081|365124443|FG000|Overall Study|student left classroom|0|||
105856091|NCT05489081|365124444|FG001|Overall Study|student left classroom|1|||
105856092|NCT05489081|365124443|FG000|Overall Study|teacher left school|0|||
105329535|NCT02677922|363205780|FG002|Treatment Period|Progressive Disease|0|||
105329536|NCT02677922|363205781|FG003|Treatment Period|Progressive Disease|0|||
105329537|NCT02677922|363205782|FG004|Treatment Period|Progressive Disease|8|||
105329538|NCT02677922|363205783|FG005|Treatment Period|Progressive Disease|7|||
105329539|NCT02677922|363205778|FG000|Treatment Period|Lack of Efficacy|0|||
105329540|NCT02677922|363205779|FG001|Treatment Period|Lack of Efficacy|0|||
105329541|NCT02677922|363205780|FG002|Treatment Period|Lack of Efficacy|0|||
105329542|NCT02677922|363205781|FG003|Treatment Period|Lack of Efficacy|1|||
105329543|NCT02677922|363205782|FG004|Treatment Period|Lack of Efficacy|1|||
105856093|NCT05489081|365124444|FG001|Overall Study|teacher left school|2|||
105856094|NCT04816721|365124452|FG000|Overall Study|Withdrawal by Subject|0|||
105329544|NCT02677922|363205783|FG005|Treatment Period|Lack of Efficacy|6|||
105329545|NCT02677922|363205778|FG000|Treatment Period|Withdrawal by Subject|0|||
105329546|NCT02677922|363205779|FG001|Treatment Period|Withdrawal by Subject|0|||
105856095|NCT04816721|365124453|FG001|Overall Study|Withdrawal by Subject|2|||
105856096|NCT04816721|365124454|FG002|Overall Study|Withdrawal by Subject|0|||
105856097|NCT04816721|365124455|FG003|Overall Study|Withdrawal by Subject|1|||
105856098|NCT04816721|365124456|FG004|Overall Study|Withdrawal by Subject|1|||
105856099|NCT04816721|365124457|FG005|Overall Study|Withdrawal by Subject|0|||
105856100|NCT04816721|365124458|FG006|Overall Study|Withdrawal by Subject|0|||
105856101|NCT04816721|365124459|FG007|Overall Study|Withdrawal by Subject|0|||
105856102|NCT04816721|365124452|FG000|Overall Study|Miscellaneous|0|||
105856103|NCT04816721|365124453|FG001|Overall Study|Miscellaneous|0|||
105856104|NCT04816721|365124454|FG002|Overall Study|Miscellaneous|0|||
105856105|NCT04816721|365124455|FG003|Overall Study|Miscellaneous|0|||
105856106|NCT04816721|365124456|FG004|Overall Study|Miscellaneous|0|||
105856107|NCT04816721|365124457|FG005|Overall Study|Miscellaneous|1|||
105856108|NCT04816721|365124458|FG006|Overall Study|Miscellaneous|0|||
105856109|NCT04816721|365124459|FG007|Overall Study|Miscellaneous|0|||
105856110|NCT04816721|365124452|FG000|Overall Study|Lost to Follow-up|0|||
105856111|NCT04816721|365124453|FG001|Overall Study|Lost to Follow-up|0|||
105856112|NCT04816721|365124454|FG002|Overall Study|Lost to Follow-up|0|||
105856113|NCT04816721|365124455|FG003|Overall Study|Lost to Follow-up|1|||
105856114|NCT04816721|365124456|FG004|Overall Study|Lost to Follow-up|0|||
105856115|NCT04816721|365124457|FG005|Overall Study|Lost to Follow-up|0|||
105856116|NCT04816721|365124458|FG006|Overall Study|Lost to Follow-up|0|||
105856117|NCT04816721|365124459|FG007|Overall Study|Lost to Follow-up|0|||
105856118|NCT02257528|365124460|FG000|Overall Study|Never received study treatment|1|||
105856119|NCT01371981|365124461|FG000|Overall Study|Adverse Event|12|||
105856120|NCT01371981|365124462|FG001|Overall Study|Adverse Event|17|||
105856121|NCT01371981|365124463|FG002|Overall Study|Adverse Event|0|||
105856122|NCT01371981|365124464|FG003|Overall Study|Adverse Event|4|||
105856123|NCT01371981|365124465|FG004|Overall Study|Adverse Event|1|||
105856124|NCT01371981|365124466|FG005|Overall Study|Adverse Event|0|||
105329547|NCT02677922|363205780|FG002|Treatment Period|Withdrawal by Subject|1|||
105329548|NCT02677922|363205781|FG003|Treatment Period|Withdrawal by Subject|3|||
105329549|NCT02677922|363205782|FG004|Treatment Period|Withdrawal by Subject|5|||
105329550|NCT02677922|363205783|FG005|Treatment Period|Withdrawal by Subject|5|||
105329551|NCT02677922|363205778|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
105329552|NCT02677922|363205779|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
105329553|NCT02677922|363205780|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
105856125|NCT01371981|365124461|FG000|Overall Study|Death|22|||
105329554|NCT02677922|363205781|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
105329555|NCT02677922|363205782|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
105329556|NCT02677922|363205783|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
105329557|NCT02677922|363205778|FG000|Treatment Period|Disease Relapse|0|||
105329558|NCT02677922|363205779|FG001|Treatment Period|Disease Relapse|0|||
105856126|NCT01371981|365124462|FG001|Overall Study|Death|16|||
105856127|NCT01371981|365124463|FG002|Overall Study|Death|0|||
105329559|NCT02677922|363205780|FG002|Treatment Period|Disease Relapse|0|||
105329560|NCT02677922|363205781|FG003|Treatment Period|Disease Relapse|3|||
105329561|NCT02677922|363205782|FG004|Treatment Period|Disease Relapse|6|||
105577182|NCT01370603|364112205|FG001|Period 1|Lost to Follow-up|0|||
105856128|NCT01371981|365124464|FG003|Overall Study|Death|0|||
105856129|NCT01371981|365124465|FG004|Overall Study|Death|2|||
105856130|NCT01371981|365124466|FG005|Overall Study|Death|2|||
105856131|NCT01371981|365124461|FG000|Overall Study|Lack of Efficacy|69|||
105856132|NCT01371981|365124462|FG001|Overall Study|Lack of Efficacy|61|||
105856133|NCT01371981|365124463|FG002|Overall Study|Lack of Efficacy|4|||
105856134|NCT01371981|365124464|FG003|Overall Study|Lack of Efficacy|8|||
105856135|NCT01371981|365124465|FG004|Overall Study|Lack of Efficacy|5|||
105856136|NCT01371981|365124466|FG005|Overall Study|Lack of Efficacy|0|||
105856137|NCT01371981|365124461|FG000|Overall Study|Physician Decision|48|||
105856138|NCT01371981|365124462|FG001|Overall Study|Physician Decision|63|||
105856139|NCT01371981|365124463|FG002|Overall Study|Physician Decision|1|||
105856140|NCT01371981|365124464|FG003|Overall Study|Physician Decision|7|||
105856141|NCT01371981|365124465|FG004|Overall Study|Physician Decision|14|||
105856142|NCT01371981|365124466|FG005|Overall Study|Physician Decision|3|||
105856143|NCT01371981|365124461|FG000|Overall Study|Withdrawal by Subject|12|||
105856144|NCT01371981|365124462|FG001|Overall Study|Withdrawal by Subject|19|||
105856145|NCT01371981|365124463|FG002|Overall Study|Withdrawal by Subject|1|||
105856146|NCT01371981|365124464|FG003|Overall Study|Withdrawal by Subject|2|||
105856147|NCT01371981|365124465|FG004|Overall Study|Withdrawal by Subject|10|||
105856148|NCT01371981|365124466|FG005|Overall Study|Withdrawal by Subject|3|||
105856149|NCT01371981|365124461|FG000|Overall Study|Ineligible|19|||
105856150|NCT01371981|365124462|FG001|Overall Study|Ineligible|13|||
105856151|NCT01371981|365124463|FG002|Overall Study|Ineligible|0|||
105856152|NCT01371981|365124464|FG003|Overall Study|Ineligible|0|||
105856153|NCT01371981|365124465|FG004|Overall Study|Ineligible|0|||
105856154|NCT01371981|365124466|FG005|Overall Study|Ineligible|4|||
105856155|NCT01371981|365124461|FG000|Overall Study|Did not start treatment|2|||
105856156|NCT01371981|365124462|FG001|Overall Study|Did not start treatment|3|||
105856157|NCT01371981|365124463|FG002|Overall Study|Did not start treatment|0|||
105856158|NCT01371981|365124464|FG003|Overall Study|Did not start treatment|0|||
105856159|NCT01371981|365124465|FG004|Overall Study|Did not start treatment|0|||
105856160|NCT01371981|365124466|FG005|Overall Study|Did not start treatment|2|||
105856161|NCT00026312|365124467|FG000|Overall Study|Adverse Event|0|||
105856162|NCT00026312|365124468|FG001|Overall Study|Adverse Event|32|||
105856163|NCT00026312|365124467|FG000|Overall Study|Death|1|||
105856164|NCT00026312|365124468|FG001|Overall Study|Death|7|||
105856165|NCT00026312|365124467|FG000|Overall Study|Lack of Efficacy|19|||
105856166|NCT00026312|365124468|FG001|Overall Study|Lack of Efficacy|114|||
105856167|NCT00026312|365124467|FG000|Overall Study|Lost to Follow-up|0|||
105856168|NCT00026312|365124468|FG001|Overall Study|Lost to Follow-up|5|||
105374721|NCT03979313|363379148|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
105374722|NCT03979313|363379147|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
105374723|NCT03979313|363379148|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
105374724|NCT03979313|363379147|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
105374725|NCT03979313|363379148|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
105374726|NCT03979313|363379147|FG000|All Subjects|Any Other Reason|16|||
105374727|NCT03979313|363379148|FG001|All Subjects|Any Other Reason|23|||
105374728|NCT03979313|363379147|FG000|All Subjects|Covid-19|1|||
105374729|NCT03979313|363379148|FG001|All Subjects|Covid-19|3|||
105374730|NCT03979313|363379147|FG000|All Subjects|Withdrawal by Subject|35|||
105374731|NCT03979313|363379148|FG001|All Subjects|Withdrawal by Subject|44|||
105374732|NCT03979313|363379147|FG000|All Subjects|Death|0|||
105374733|NCT03979313|363379148|FG001|All Subjects|Death|5|||
105374734|NCT03979313|363379147|FG000|All Subjects|Lost to Follow-up|28|||
105856169|NCT00026312|365124467|FG000|Overall Study|Physician Decision|1|||
105856170|NCT00026312|365124468|FG001|Overall Study|Physician Decision|37|||
105856171|NCT00026312|365124467|FG000|Overall Study|Protocol Violation|0|||
105856172|NCT00026312|365124468|FG001|Overall Study|Protocol Violation|3|||
105856173|NCT00026312|365124467|FG000|Overall Study|Withdrawal by Subject|1|||
105856174|NCT00026312|365124468|FG001|Overall Study|Withdrawal by Subject|6|||
105856175|NCT00026312|365124467|FG000|Overall Study|Ineligible|4|||
105329562|NCT02677922|363205783|FG005|Treatment Period|Disease Relapse|1|||
105329563|NCT02677922|363205778|FG000|Treatment Period|Allogeneic HSCT|1|||
105329564|NCT02677922|363205779|FG001|Treatment Period|Allogeneic HSCT|0|||
105329565|NCT02677922|363205780|FG002|Treatment Period|Allogeneic HSCT|0|||
105329566|NCT02677922|363205781|FG003|Treatment Period|Allogeneic HSCT|1|||
105329567|NCT02677922|363205782|FG004|Treatment Period|Allogeneic HSCT|4|||
105329568|NCT02677922|363205783|FG005|Treatment Period|Allogeneic HSCT|1|||
105329569|NCT02677922|363205778|FG000|Treatment Period|Other Reasons|0|||
105329570|NCT02677922|363205779|FG001|Treatment Period|Other Reasons|0|||
105329571|NCT02677922|363205780|FG002|Treatment Period|Other Reasons|0|||
105374735|NCT03979313|363379148|FG001|All Subjects|Lost to Follow-up|61|||
105856176|NCT00026312|365124468|FG001|Overall Study|Ineligible|5|||
105856177|NCT00026312|365124467|FG000|Overall Study|Entry onto another COG study|0|||
105856178|NCT00026312|365124468|FG001|Overall Study|Entry onto another COG study|1|||
105856179|NCT00026312|365124467|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
105329572|NCT02677922|363205781|FG003|Treatment Period|Other Reasons|1|||
105329573|NCT02677922|363205782|FG004|Treatment Period|Other Reasons|3|||
105329574|NCT02677922|363205783|FG005|Treatment Period|Other Reasons|5|||
105329575|NCT02677922|363205778|FG000|Treatment Period|Death|0|||
105374736|NCT00423605|363379149|FG000|Overall Study|Adverse Event|129|||
105856180|NCT00026312|365124468|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
105856181|NCT02101853|365124469|FG000|Block 1 Induction|Adverse Event|11|||
105856182|NCT02101853|365124470|FG001|Block 1 Induction|Adverse Event|0|||
105856183|NCT02101853|365124471|FG002|Block 1 Induction|Adverse Event|0|||
105856184|NCT02101853|365124472|FG003|Block 1 Induction|Adverse Event|0|||
105856185|NCT02101853|365124473|FG004|Block 1 Induction|Adverse Event|0|||
105856186|NCT02101853|365124474|FG005|Block 1 Induction|Adverse Event|0|||
105856187|NCT02101853|365124469|FG000|Block 1 Induction|Death|20|||
105856188|NCT02101853|365124470|FG001|Block 1 Induction|Death|0|||
105856189|NCT02101853|365124471|FG002|Block 1 Induction|Death|0|||
105856190|NCT02101853|365124472|FG003|Block 1 Induction|Death|0|||
105856191|NCT02101853|365124473|FG004|Block 1 Induction|Death|0|||
105856192|NCT02101853|365124474|FG005|Block 1 Induction|Death|0|||
105856193|NCT02101853|365124469|FG000|Block 1 Induction|Lack of Efficacy|6|||
105856194|NCT02101853|365124470|FG001|Block 1 Induction|Lack of Efficacy|0|||
105856195|NCT02101853|365124471|FG002|Block 1 Induction|Lack of Efficacy|0|||
105856196|NCT02101853|365124472|FG003|Block 1 Induction|Lack of Efficacy|0|||
105856197|NCT02101853|365124473|FG004|Block 1 Induction|Lack of Efficacy|0|||
105856198|NCT02101853|365124474|FG005|Block 1 Induction|Lack of Efficacy|0|||
105856199|NCT02101853|365124469|FG000|Block 1 Induction|Physician Decision|61|||
105856200|NCT02101853|365124470|FG001|Block 1 Induction|Physician Decision|0|||
105856201|NCT02101853|365124471|FG002|Block 1 Induction|Physician Decision|0|||
105856202|NCT02101853|365124472|FG003|Block 1 Induction|Physician Decision|0|||
105856203|NCT02101853|365124473|FG004|Block 1 Induction|Physician Decision|0|||
105856204|NCT02101853|365124474|FG005|Block 1 Induction|Physician Decision|0|||
105856205|NCT02101853|365124469|FG000|Block 1 Induction|Protocol Violation|2|||
105856206|NCT02101853|365124470|FG001|Block 1 Induction|Protocol Violation|0|||
105856207|NCT02101853|365124471|FG002|Block 1 Induction|Protocol Violation|0|||
105856208|NCT02101853|365124472|FG003|Block 1 Induction|Protocol Violation|0|||
105856209|NCT02101853|365124473|FG004|Block 1 Induction|Protocol Violation|0|||
105856210|NCT02101853|365124474|FG005|Block 1 Induction|Protocol Violation|0|||
105856211|NCT02101853|365124469|FG000|Block 1 Induction|Withdrawal by Subject|65|||
105856212|NCT02101853|365124470|FG001|Block 1 Induction|Withdrawal by Subject|0|||
105856213|NCT02101853|365124471|FG002|Block 1 Induction|Withdrawal by Subject|0|||
105856214|NCT02101853|365124472|FG003|Block 1 Induction|Withdrawal by Subject|0|||
105856215|NCT02101853|365124473|FG004|Block 1 Induction|Withdrawal by Subject|0|||
105856216|NCT02101853|365124474|FG005|Block 1 Induction|Withdrawal by Subject|0|||
105856217|NCT02101853|365124469|FG000|Block 1 Induction|Ineligible|8|||
105856218|NCT02101853|365124470|FG001|Block 1 Induction|Ineligible|0|||
105856219|NCT02101853|365124471|FG002|Block 1 Induction|Ineligible|0|||
105856220|NCT02101853|365124472|FG003|Block 1 Induction|Ineligible|0|||
105856221|NCT02101853|365124473|FG004|Block 1 Induction|Ineligible|0|||
105856222|NCT02101853|365124474|FG005|Block 1 Induction|Ineligible|0|||
105856223|NCT02101853|365124469|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
105856224|NCT02101853|365124470|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
105856225|NCT02101853|365124471|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
105856226|NCT02101853|365124472|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
105856227|NCT02101853|365124473|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
105856228|NCT02101853|365124474|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
105856229|NCT02101853|365124469|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
105856230|NCT02101853|365124470|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
105856231|NCT02101853|365124471|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
105856232|NCT02101853|365124472|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
105856233|NCT02101853|365124473|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
105856234|NCT02101853|365124474|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
105329576|NCT02677922|363205779|FG001|Treatment Period|Death|0|||
105329577|NCT02677922|363205780|FG002|Treatment Period|Death|0|||
105329578|NCT02677922|363205781|FG003|Treatment Period|Death|0|||
105329579|NCT02677922|363205782|FG004|Treatment Period|Death|12|||
105329580|NCT02677922|363205783|FG005|Treatment Period|Death|1|||
105329581|NCT02677922|363205778|FG000|Treatment Period|Non-compliance with Study Drug|0|||
105329582|NCT02677922|363205779|FG001|Treatment Period|Non-compliance with Study Drug|0|||
105329583|NCT02677922|363205780|FG002|Treatment Period|Non-compliance with Study Drug|0|||
105329584|NCT02677922|363205781|FG003|Treatment Period|Non-compliance with Study Drug|0|||
105329585|NCT02677922|363205782|FG004|Treatment Period|Non-compliance with Study Drug|1|||
105329586|NCT02677922|363205783|FG005|Treatment Period|Non-compliance with Study Drug|0|||
105329587|NCT02677922|363205778|FG000|Treatment Period|Physician Decision|0|||
105329588|NCT02677922|363205779|FG001|Treatment Period|Physician Decision|0|||
105329589|NCT02677922|363205780|FG002|Treatment Period|Physician Decision|0|||
105329590|NCT02677922|363205781|FG003|Treatment Period|Physician Decision|0|||
105329591|NCT02677922|363205782|FG004|Treatment Period|Physician Decision|0|||
105329592|NCT02677922|363205783|FG005|Treatment Period|Physician Decision|1|||
105856235|NCT02101853|365124469|FG000|Post Induction Randomization|Adverse Event|0|||
105856236|NCT02101853|365124470|FG001|Post Induction Randomization|Adverse Event|3|||
105856237|NCT02101853|365124471|FG002|Post Induction Randomization|Adverse Event|8|||
105856238|NCT02101853|365124472|FG003|Post Induction Randomization|Adverse Event|4|||
105856239|NCT02101853|365124473|FG004|Post Induction Randomization|Adverse Event|4|||
105856240|NCT02101853|365124474|FG005|Post Induction Randomization|Adverse Event|0|||
105856241|NCT02101853|365124469|FG000|Post Induction Randomization|Death|0|||
105856242|NCT02101853|365124470|FG001|Post Induction Randomization|Death|9|||
105856243|NCT02101853|365124471|FG002|Post Induction Randomization|Death|2|||
105856244|NCT02101853|365124472|FG003|Post Induction Randomization|Death|2|||
105856245|NCT02101853|365124473|FG004|Post Induction Randomization|Death|0|||
105856246|NCT02101853|365124474|FG005|Post Induction Randomization|Death|0|||
105856247|NCT02101853|365124469|FG000|Post Induction Randomization|Lack of Efficacy|0|||
105856248|NCT02101853|365124470|FG001|Post Induction Randomization|Lack of Efficacy|14|||
105856249|NCT02101853|365124471|FG002|Post Induction Randomization|Lack of Efficacy|23|||
105856250|NCT02101853|365124472|FG003|Post Induction Randomization|Lack of Efficacy|18|||
105856251|NCT02101853|365124473|FG004|Post Induction Randomization|Lack of Efficacy|21|||
105856252|NCT02101853|365124474|FG005|Post Induction Randomization|Lack of Efficacy|0|||
105856253|NCT02101853|365124469|FG000|Post Induction Randomization|Physician Decision|0|||
105856254|NCT02101853|365124470|FG001|Post Induction Randomization|Physician Decision|43|||
105856255|NCT02101853|365124471|FG002|Post Induction Randomization|Physician Decision|23|||
105856256|NCT02101853|365124472|FG003|Post Induction Randomization|Physician Decision|14|||
105856257|NCT02101853|365124473|FG004|Post Induction Randomization|Physician Decision|14|||
105856258|NCT02101853|365124474|FG005|Post Induction Randomization|Physician Decision|0|||
105856259|NCT02101853|365124469|FG000|Post Induction Randomization|Protocol Violation|0|||
105856260|NCT02101853|365124470|FG001|Post Induction Randomization|Protocol Violation|3|||
105856261|NCT02101853|365124471|FG002|Post Induction Randomization|Protocol Violation|0|||
105856262|NCT02101853|365124472|FG003|Post Induction Randomization|Protocol Violation|0|||
105856263|NCT02101853|365124473|FG004|Post Induction Randomization|Protocol Violation|0|||
105856264|NCT02101853|365124474|FG005|Post Induction Randomization|Protocol Violation|0|||
105856265|NCT02101853|365124469|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
105856266|NCT02101853|365124470|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
105856267|NCT02101853|365124471|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
105856268|NCT02101853|365124472|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
105856269|NCT02101853|365124473|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
105856270|NCT02101853|365124474|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
105856271|NCT02101853|365124469|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
105856272|NCT02101853|365124470|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
105856273|NCT02101853|365124471|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
105856274|NCT02101853|365124472|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
105856275|NCT02101853|365124473|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
105856276|NCT02101853|365124474|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
105856277|NCT02101853|365124469|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
105856278|NCT02101853|365124470|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
105856279|NCT02101853|365124471|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
105856280|NCT02101853|365124472|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
105856281|NCT02101853|365124473|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
105856282|NCT02101853|365124474|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
105856283|NCT02101853|365124469|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
105856284|NCT02101853|365124470|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
105856285|NCT02101853|365124471|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
105856286|NCT02101853|365124472|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
105856287|NCT02101853|365124473|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
105856288|NCT02101853|365124474|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
105856289|NCT02101853|365124469|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
105856290|NCT02101853|365124470|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
105856291|NCT02101853|365124471|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
105329593|NCT02677922|363205778|FG000|Treatment Period|Symptomatic Deterioration|0|||
105329594|NCT02677922|363205779|FG001|Treatment Period|Symptomatic Deterioration|0|||
105329595|NCT02677922|363205780|FG002|Treatment Period|Symptomatic Deterioration|0|||
105329596|NCT02677922|363205781|FG003|Treatment Period|Symptomatic Deterioration|0|||
105329597|NCT02677922|363205782|FG004|Treatment Period|Symptomatic Deterioration|1|||
105329598|NCT02677922|363205783|FG005|Treatment Period|Symptomatic Deterioration|0|||
105374737|NCT00423605|363379149|FG000|Overall Study|Withdrawal by Subject|36|||
105374738|NCT00423605|363379149|FG000|Overall Study|Lost to Follow-up|15|||
105374739|NCT00423605|363379149|FG000|Overall Study|Lack of Efficacy|38|||
105374740|NCT00423605|363379149|FG000|Overall Study|Sponsor Decision|3|||
105374741|NCT00423605|363379149|FG000|Overall Study|Physician Decision|8|||
105374742|NCT00423605|363379149|FG000|Overall Study|Protocol Violation|7|||
105374743|NCT00423605|363379149|FG000|Overall Study|Not one of the pre-specified options|5|||
105374744|NCT03738696|363379150|FG000|Overall Study|Withdrawal by Subject|0|||
105374745|NCT03738696|363379151|FG001|Overall Study|Withdrawal by Subject|1|||
105374746|NCT03738696|363379150|FG000|Overall Study|Lost to Follow-up|8|||
105374747|NCT03738696|363379151|FG001|Overall Study|Lost to Follow-up|14|||
105374748|NCT03095287|363379153|FG000|Overall Study|Treatment Failure|1|||
105374749|NCT03095287|363379153|FG000|Overall Study|Adverse Event|1|||
105374750|NCT01136954|363379159|FG000|Overall Study|Adverse Event|3|||
105374751|NCT01136954|363379160|FG001|Overall Study|Adverse Event|2|||
105374752|NCT01136954|363379159|FG000|Overall Study|Withdrawal by Subject|6|||
105374753|NCT01136954|363379160|FG001|Overall Study|Withdrawal by Subject|2|||
105374754|NCT01136954|363379159|FG000|Overall Study|Lack of Efficacy|14|||
105374755|NCT01136954|363379160|FG001|Overall Study|Lack of Efficacy|13|||
105374756|NCT01136954|363379159|FG000|Overall Study|Physician Decision|0|||
105374757|NCT01136954|363379160|FG001|Overall Study|Physician Decision|1|||
105374758|NCT01136954|363379159|FG000|Overall Study|Other|1|||
105374759|NCT01136954|363379160|FG001|Overall Study|Other|3|||
105374760|NCT03345004|363379162|FG000|Overall Study|Physician Decision|1|||
105374761|NCT03345004|363379163|FG001|Overall Study|Physician Decision|0|||
105374762|NCT03345004|363379162|FG000|Overall Study|Withdrawal by Subject|0|||
105374763|NCT03345004|363379163|FG001|Overall Study|Withdrawal by Subject|1|||
105374764|NCT00393367|363379164|FG000|Overall Study|Protocol Violation|2|||
105374765|NCT00393367|363379165|FG001|Overall Study|Protocol Violation|5|||
105374766|NCT00393367|363379164|FG000|Overall Study|Withdrawal by Subject|0|||
105374767|NCT00393367|363379165|FG001|Overall Study|Withdrawal by Subject|2|||
105374768|NCT00764517|363379169|FG000|Overall Study|Adverse Event|9|||
105374769|NCT00764517|363379170|FG001|Overall Study|Adverse Event|3|||
105374770|NCT00764517|363379169|FG000|Overall Study|Death|3|||
105374771|NCT00764517|363379170|FG001|Overall Study|Death|11|||
105374772|NCT00764517|363379169|FG000|Overall Study|Physician Decision|3|||
105374773|NCT00764517|363379170|FG001|Overall Study|Physician Decision|0|||
105374774|NCT00915525|363379172|FG000|Overall Study|Protocol Violation|9|||
105374775|NCT00915525|363379173|FG001|Overall Study|Protocol Violation|4|||
105374776|NCT00915525|363379172|FG000|Overall Study|Withdrawal by Subject|59|||
105374777|NCT00915525|363379173|FG001|Overall Study|Withdrawal by Subject|21|||
105374778|NCT00915525|363379172|FG000|Overall Study|Lost to Follow-up|27|||
105374779|NCT00915525|363379173|FG001|Overall Study|Lost to Follow-up|16|||
105374780|NCT00915525|363379172|FG000|Overall Study|Pregnancy|2|||
105374781|NCT00915525|363379173|FG001|Overall Study|Pregnancy|0|||
105374782|NCT00915525|363379172|FG000|Overall Study|Lack of Efficacy|15|||
105374783|NCT00915525|363379173|FG001|Overall Study|Lack of Efficacy|32|||
105374784|NCT00915525|363379172|FG000|Overall Study|Adverse Event|29|||
105374785|NCT00915525|363379173|FG001|Overall Study|Adverse Event|13|||
105374786|NCT00915525|363379172|FG000|Overall Study|Missing|12|||
105374787|NCT00915525|363379173|FG001|Overall Study|Missing|1|||
105374788|NCT00915525|363379172|FG000|Overall Study|Other Reason|35|||
105374789|NCT00915525|363379173|FG001|Overall Study|Other Reason|12|||
105374790|NCT00915525|363379172|FG000|Overall Study|Site Closed|27|||
105374791|NCT00915525|363379173|FG001|Overall Study|Site Closed|9|||
105374792|NCT00915525|363379172|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
105374793|NCT00915525|363379173|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
105374794|NCT00915525|363379172|FG000|Overall Study|Study Burden|28|||
105374795|NCT00915525|363379173|FG001|Overall Study|Study Burden|12|||
105374796|NCT00915525|363379172|FG000|Overall Study|Non-Compliance|3|||
105374797|NCT00915525|363379173|FG001|Overall Study|Non-Compliance|1|||
105374798|NCT00915525|363379172|FG000|Overall Study|Patient Moved|15|||
105374799|NCT00915525|363379173|FG001|Overall Study|Patient Moved|9|||
105374800|NCT05350423|363379174|FG000|Overall Study|Lost to Follow-up|3|||
105374801|NCT05350423|363379175|FG001|Overall Study|Lost to Follow-up|3|||
105374802|NCT05350423|363379174|FG000|Overall Study|screen failure|5|||
105374803|NCT05350423|363379175|FG001|Overall Study|screen failure|6|||
105374804|NCT01027949|363379183|FG000|Overall Study|Death|174|||
105374805|NCT01027949|363379183|FG000|Overall Study|Progressive Disease|163|||
105374806|NCT01027949|363379183|FG000|Overall Study|Adverse Event|172|||
105374807|NCT01027949|363379183|FG000|Overall Study|Withdrawal by Subject|113|||
105374808|NCT01027949|363379183|FG000|Overall Study|Lost to Follow-up|17|||
105374809|NCT01027949|363379183|FG000|Overall Study|Protocol Violation|13|||
105374810|NCT01027949|363379183|FG000|Overall Study|PI Decision|8|||
105374811|NCT01027949|363379183|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
105374812|NCT01027949|363379183|FG000|Overall Study|Non-compliance with Study Procedures|7|||
105374813|NCT01027949|363379183|FG000|Overall Study|Lung Transplant|5|||
105374814|NCT01027949|363379183|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
105374815|NCT01027949|363379183|FG000|Overall Study|Use of Excluded Medication|2|||
105374816|NCT01027949|363379183|FG000|Overall Study|Patient Self-discontinuation|1|||
105856292|NCT02101853|365124472|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
105856293|NCT02101853|365124473|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
105856294|NCT02101853|365124474|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
105856295|NCT02101853|365124469|FG000|Blinatumomab Salvage Therapy|Death|0|||
105856296|NCT02101853|365124470|FG001|Blinatumomab Salvage Therapy|Death|0|||
105856297|NCT02101853|365124471|FG002|Blinatumomab Salvage Therapy|Death|0|||
105856298|NCT02101853|365124472|FG003|Blinatumomab Salvage Therapy|Death|0|||
105856299|NCT02101853|365124473|FG004|Blinatumomab Salvage Therapy|Death|0|||
105856300|NCT02101853|365124474|FG005|Blinatumomab Salvage Therapy|Death|2|||
105856301|NCT02101853|365124469|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
105329599|NCT01791894|363205787|FG000|Overall Study|Adverse Event|1|||
105329600|NCT01420068|363205792|FG000|Overall Study|Administrative problems|1|||
105329601|NCT01420068|363205793|FG001|Overall Study|Administrative problems|3|||
105329602|NCT01420068|363205792|FG000|Overall Study|Withdrawal by Subject|1|||
105329603|NCT01420068|363205793|FG001|Overall Study|Withdrawal by Subject|2|||
105329604|NCT02268916|363205796|FG000|Overall Study|Lost to Follow-up|1|||
105329605|NCT02268916|363205797|FG001|Overall Study|Lost to Follow-up|1|||
105329606|NCT02268916|363205796|FG000|Overall Study|Withdrawal by Subject|6|||
105329607|NCT02268916|363205797|FG001|Overall Study|Withdrawal by Subject|5|||
105329608|NCT02268916|363205796|FG000|Overall Study|Participant did not have diabetes|1|||
105329609|NCT02268916|363205797|FG001|Overall Study|Participant did not have diabetes|0|||
105329610|NCT02268916|363205796|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
105329611|NCT02268916|363205797|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
105329612|NCT00365794|363205798|FG000|Overall Study|Withdrawal by Subject|2|||
105329613|NCT03926117|363205799|FG000|Overall Study|Unclassified|1|||
105329614|NCT03926117|363205800|FG001|Overall Study|Unclassified|4|||
105329615|NCT03926117|363205801|FG002|Overall Study|Unclassified|1|||
105329616|NCT03926117|363205802|FG003|Overall Study|Unclassified|4|||
105329617|NCT03926117|363205799|FG000|Overall Study|Withdrawal by Subject|3|||
105329618|NCT03926117|363205800|FG001|Overall Study|Withdrawal by Subject|0|||
105329619|NCT03926117|363205801|FG002|Overall Study|Withdrawal by Subject|1|||
105856302|NCT02101853|365124470|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
105856303|NCT02101853|365124471|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
105329620|NCT03926117|363205802|FG003|Overall Study|Withdrawal by Subject|1|||
105329621|NCT03926117|363205799|FG000|Overall Study|Lost to Follow-up|0|||
105329622|NCT03926117|363205800|FG001|Overall Study|Lost to Follow-up|2|||
105329623|NCT03926117|363205801|FG002|Overall Study|Lost to Follow-up|1|||
105329624|NCT03926117|363205802|FG003|Overall Study|Lost to Follow-up|0|||
105329625|NCT03926117|363205799|FG000|Overall Study|Adverse Event|1|||
105329626|NCT03926117|363205800|FG001|Overall Study|Adverse Event|2|||
105329627|NCT03926117|363205801|FG002|Overall Study|Adverse Event|3|||
105329628|NCT03926117|363205802|FG003|Overall Study|Adverse Event|1|||
105329629|NCT03926117|363205799|FG000|Overall Study|Randomized but not treated|1|||
105329630|NCT03926117|363205800|FG001|Overall Study|Randomized but not treated|1|||
105329631|NCT03926117|363205801|FG002|Overall Study|Randomized but not treated|0|||
105329632|NCT03926117|363205802|FG003|Overall Study|Randomized but not treated|1|||
105329633|NCT02554682|363205803|FG000|Overall Study|Lost to Follow-up|11|||
105329634|NCT02554682|363205804|FG001|Overall Study|Lost to Follow-up|9|||
105329635|NCT02554682|363205805|FG002|Overall Study|Lost to Follow-up|4|||
105329636|NCT02554682|363205806|FG003|Overall Study|Lost to Follow-up|3|||
105329637|NCT02554682|363205807|FG004|Overall Study|Lost to Follow-up|2|||
105329638|NCT02554682|363205808|FG005|Overall Study|Lost to Follow-up|1|||
105374817|NCT01027949|363379183|FG000|Overall Study|Pregnancy|1|||
105374818|NCT01027949|363379183|FG000|Overall Study|Surgery|1|||
105374819|NCT00984867|363379190|FG000|Overall Study|Adverse Event|3|||
105374820|NCT00984867|363379191|FG001|Overall Study|Adverse Event|7|||
105374821|NCT00984867|363379190|FG000|Overall Study|Death|1|||
105374822|NCT00984867|363379191|FG001|Overall Study|Death|0|||
105374823|NCT00984867|363379190|FG000|Overall Study|Withdrawal by Subject|13|||
105374824|NCT00984867|363379191|FG001|Overall Study|Withdrawal by Subject|4|||
105374825|NCT00984867|363379190|FG000|Overall Study|Lost to Follow-up|3|||
105374826|NCT00984867|363379191|FG001|Overall Study|Lost to Follow-up|4|||
105374827|NCT00984867|363379190|FG000|Overall Study|Poor/non-compliance|0|||
105374828|NCT00984867|363379191|FG001|Overall Study|Poor/non-compliance|1|||
105856304|NCT02101853|365124472|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
105856305|NCT02101853|365124473|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
105856306|NCT02101853|365124474|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
105329639|NCT02554682|363205809|FG006|Overall Study|Lost to Follow-up|6|||
105329640|NCT02554682|363205810|FG007|Overall Study|Lost to Follow-up|6|||
105329641|NCT02554682|363205811|FG008|Overall Study|Lost to Follow-up|2|||
105329642|NCT02554682|363205812|FG009|Overall Study|Lost to Follow-up|2|||
105329643|NCT02554682|363205803|FG000|Overall Study|Withdrawal by Subject|2|||
105374829|NCT00984867|363379190|FG000|Overall Study|Subject no longer meets study criteria|1|||
105374830|NCT00984867|363379191|FG001|Overall Study|Subject no longer meets study criteria|1|||
105374831|NCT00984867|363379190|FG000|Overall Study|site closing|1|||
105374832|NCT00984867|363379191|FG001|Overall Study|site closing|0|||
105374833|NCT00984867|363379190|FG000|Overall Study|lack of efficacy and subject compliance|1|||
105374834|NCT00984867|363379191|FG001|Overall Study|lack of efficacy and subject compliance|0|||
105374835|NCT01541748|363379192|FG000|Overall Study|Lost to Follow-up|17|||
105374836|NCT01541748|363379192|FG000|Overall Study|Moved out of state|1|||
105374837|NCT01541748|363379192|FG000|Overall Study|Withdrawal by Subject|7|||
105374838|NCT01541748|363379192|FG000|Overall Study|Screen failure|5|||
105374839|NCT01541748|363379192|FG000|Overall Study|Did not receive study device|1|||
105374840|NCT00626639|363379200|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
105374841|NCT00626639|363379201|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
105374842|NCT00827567|363379202|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
105374843|NCT00303186|363379203|FG000|Overall Study|Other|52|||
105374844|NCT00851591|363379207|FG000|Overall Study|Withdrawal by Subject|2|||
105374845|NCT00851591|363379208|FG001|Overall Study|Withdrawal by Subject|0|||
105374846|NCT05001620|363379211|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
105374847|NCT05001620|363379212|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
105374848|NCT00481676|363379213|FG000|Overall Study|Adverse Event|0|||
105374849|NCT00481676|363379214|FG001|Overall Study|Adverse Event|1|||
105329644|NCT02554682|363205804|FG001|Overall Study|Withdrawal by Subject|1|||
105329645|NCT02554682|363205805|FG002|Overall Study|Withdrawal by Subject|0|||
105329646|NCT02554682|363205806|FG003|Overall Study|Withdrawal by Subject|0|||
105329647|NCT02554682|363205807|FG004|Overall Study|Withdrawal by Subject|0|||
105329648|NCT02554682|363205808|FG005|Overall Study|Withdrawal by Subject|0|||
105329649|NCT02554682|363205809|FG006|Overall Study|Withdrawal by Subject|0|||
105329650|NCT02554682|363205810|FG007|Overall Study|Withdrawal by Subject|0|||
105329651|NCT02554682|363205811|FG008|Overall Study|Withdrawal by Subject|0|||
105329652|NCT02554682|363205812|FG009|Overall Study|Withdrawal by Subject|0|||
105329653|NCT02554682|363205803|FG000|Overall Study|Physician Decision|2|||
105329654|NCT02554682|363205804|FG001|Overall Study|Physician Decision|2|||
105329655|NCT02554682|363205805|FG002|Overall Study|Physician Decision|0|||
105329656|NCT02554682|363205806|FG003|Overall Study|Physician Decision|0|||
105329657|NCT02554682|363205807|FG004|Overall Study|Physician Decision|0|||
105329658|NCT02554682|363205808|FG005|Overall Study|Physician Decision|0|||
105329659|NCT02554682|363205809|FG006|Overall Study|Physician Decision|0|||
105329660|NCT02554682|363205810|FG007|Overall Study|Physician Decision|0|||
105329661|NCT02554682|363205811|FG008|Overall Study|Physician Decision|0|||
105329662|NCT02554682|363205812|FG009|Overall Study|Physician Decision|0|||
105329663|NCT04830969|363205816|FG000|Overall Study|Withdrawal by Subject|6|||
105329664|NCT04830969|363205817|FG001|Overall Study|Withdrawal by Subject|2|||
105329665|NCT04830969|363205816|FG000|Overall Study|Protocol Violation|3|||
105329666|NCT04830969|363205817|FG001|Overall Study|Protocol Violation|9|||
105329667|NCT04830969|363205816|FG000|Overall Study|Lost to Follow-up|4|||
105329668|NCT04830969|363205817|FG001|Overall Study|Lost to Follow-up|4|||
105329669|NCT02929589|363205818|FG000|Overall Study|Withdrawal by Subject|1|||
105329670|NCT02929589|363205819|FG001|Overall Study|Withdrawal by Subject|0|||
105329671|NCT02929589|363205820|FG002|Overall Study|Withdrawal by Subject|0|||
105329672|NCT02929589|363205821|FG003|Overall Study|Withdrawal by Subject|0|||
105329673|NCT02929589|363205818|FG000|Overall Study|Physician Decision|2|||
105329674|NCT02929589|363205819|FG001|Overall Study|Physician Decision|0|||
105329675|NCT02929589|363205820|FG002|Overall Study|Physician Decision|0|||
105329676|NCT02929589|363205821|FG003|Overall Study|Physician Decision|0|||
105329677|NCT01786993|363205822|FG000|Overall Study|Death|6|||
105329678|NCT01786993|363205823|FG001|Overall Study|Death|7|||
105329679|NCT01786993|363205822|FG000|Overall Study|Withdrawal by Subject|3|||
105329680|NCT01786993|363205823|FG001|Overall Study|Withdrawal by Subject|2|||
105329681|NCT01786993|363205822|FG000|Overall Study|Lost to Follow-up|0|||
105329682|NCT01786993|363205823|FG001|Overall Study|Lost to Follow-up|1|||
105329683|NCT01786993|363205822|FG000|Overall Study|Subject Non-Compliance|1|||
105329684|NCT01786993|363205823|FG001|Overall Study|Subject Non-Compliance|0|||
105329685|NCT01786993|363205822|FG000|Overall Study|System Explant|1|||
105329686|NCT01786993|363205823|FG001|Overall Study|System Explant|0|||
105329687|NCT01786993|363205822|FG000|Overall Study|Hospice Admission|1|||
105329688|NCT01786993|363205823|FG001|Overall Study|Hospice Admission|0|||
105329689|NCT03564119|363205831|FG000|Overall Study|Adverse Event|4|||
105329690|NCT03564119|363205832|FG001|Overall Study|Adverse Event|0|||
105329691|NCT03564119|363205831|FG000|Overall Study|Lost to Follow-up|1|||
105329692|NCT03564119|363205832|FG001|Overall Study|Lost to Follow-up|4|||
105329693|NCT03564119|363205831|FG000|Overall Study|Protocol Violation|1|||
105329694|NCT03564119|363205832|FG001|Overall Study|Protocol Violation|0|||
105329695|NCT03564119|363205831|FG000|Overall Study|Withdrawal by Subject|9|||
105329696|NCT03564119|363205832|FG001|Overall Study|Withdrawal by Subject|4|||
105329697|NCT03564119|363205831|FG000|Overall Study|Other Than Specified|0|||
105329698|NCT03564119|363205832|FG001|Overall Study|Other Than Specified|1|||
105329699|NCT00634036|363205833|FG000|Overall Study|Lost to Follow-up|1|||
105329700|NCT00634036|363205834|FG001|Overall Study|Lost to Follow-up|1|||
105329701|NCT00634036|363205833|FG000|Overall Study|Withdrawal by Subject|1|||
105329702|NCT00634036|363205834|FG001|Overall Study|Withdrawal by Subject|1|||
105329703|NCT03896022|363205837|FG000|Overall Study|Withdrawal by Subject|1|||
105329704|NCT03896022|363205838|FG001|Overall Study|Withdrawal by Subject|0|||
105329705|NCT03896022|363205839|FG002|Overall Study|Withdrawal by Subject|0|||
105329706|NCT03896022|363205837|FG000|Overall Study|Did not have procedure|3|||
105329707|NCT03896022|363205838|FG001|Overall Study|Did not have procedure|0|||
105329708|NCT03896022|363205839|FG002|Overall Study|Did not have procedure|0|||
105329709|NCT03859427|363205849|FG000|Overall Study|Withdrawal by Subject|4|||
105329710|NCT03859427|363205850|FG001|Overall Study|Withdrawal by Subject|7|||
105329711|NCT03859427|363205849|FG000|Overall Study|Decision by sponsor|0|||
105329712|NCT03859427|363205850|FG001|Overall Study|Decision by sponsor|3|||
105329713|NCT03859427|363205849|FG000|Overall Study|Lost to Follow-up|3|||
105329714|NCT03859427|363205850|FG001|Overall Study|Lost to Follow-up|2|||
105329715|NCT03859427|363205849|FG000|Overall Study|Death|22|||
105329716|NCT03859427|363205850|FG001|Overall Study|Death|25|||
105329717|NCT02503540|363205851|FG000|Overall Study|Death|2|||
105329718|NCT02503540|363205851|FG000|Overall Study|Withdrawal by Subject|1|||
105329719|NCT00979654|363205854|FG000|Overall Study|Lost to Follow-up|1|||
105329720|NCT00979654|363205854|FG000|Overall Study|Withdrawal by Subject|22|||
105329721|NCT00979654|363205854|FG000|Overall Study|Death|1|||
105856307|NCT02101853|365124469|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
105856308|NCT02101853|365124470|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
105856309|NCT02101853|365124471|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
105856310|NCT02101853|365124472|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
105856311|NCT02101853|365124473|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
105856312|NCT02101853|365124474|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
105329722|NCT00979654|363205854|FG000|Overall Study|Lack of Efficacy|6|||
105329723|NCT00979654|363205854|FG000|Overall Study|Adverse Event|1|||
105329724|NCT00979654|363205854|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
105329725|NCT00979654|363205854|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
105329726|NCT00979654|363205854|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
105329727|NCT00979654|363205854|FG000|Overall Study|Serious Adverse Event|1|||
105329728|NCT00979654|363205854|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
105374850|NCT00481676|363379213|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105856313|NCT02101853|365124469|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
105856314|NCT02101853|365124470|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
105856315|NCT02101853|365124471|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
105856316|NCT02101853|365124472|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
105856317|NCT02101853|365124473|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
105856318|NCT02101853|365124474|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
105856319|NCT02112916|365124475|FG000|Overall Study|Adverse Event|6|||
105856320|NCT02112916|365124476|FG001|Overall Study|Adverse Event|9|||
105856321|NCT02112916|365124477|FG002|Overall Study|Adverse Event|3|||
105856322|NCT02112916|365124478|FG003|Overall Study|Adverse Event|2|||
105856323|NCT02112916|365124475|FG000|Overall Study|Death|9|||
105856324|NCT02112916|365124476|FG001|Overall Study|Death|9|||
105856325|NCT02112916|365124477|FG002|Overall Study|Death|3|||
105856326|NCT02112916|365124478|FG003|Overall Study|Death|4|||
105856327|NCT02112916|365124475|FG000|Overall Study|Lost to Follow-up|1|||
105856328|NCT02112916|365124476|FG001|Overall Study|Lost to Follow-up|0|||
105856329|NCT02112916|365124477|FG002|Overall Study|Lost to Follow-up|0|||
105856330|NCT02112916|365124478|FG003|Overall Study|Lost to Follow-up|0|||
105856331|NCT02112916|365124475|FG000|Overall Study|Physician Decision|94|||
105856332|NCT02112916|365124476|FG001|Overall Study|Physician Decision|72|||
105856333|NCT02112916|365124477|FG002|Overall Study|Physician Decision|24|||
105856334|NCT02112916|365124478|FG003|Overall Study|Physician Decision|15|||
105856335|NCT02112916|365124475|FG000|Overall Study|Withdrawal by Subject|5|||
105856336|NCT02112916|365124476|FG001|Overall Study|Withdrawal by Subject|3|||
105856337|NCT02112916|365124477|FG002|Overall Study|Withdrawal by Subject|1|||
105856338|NCT02112916|365124478|FG003|Overall Study|Withdrawal by Subject|1|||
105856339|NCT02112916|365124475|FG000|Overall Study|Ineligible|4|||
105856340|NCT02112916|365124476|FG001|Overall Study|Ineligible|8|||
105856341|NCT02112916|365124477|FG002|Overall Study|Ineligible|3|||
105856342|NCT02112916|365124478|FG003|Overall Study|Ineligible|8|||
105374851|NCT00481676|363379214|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
105374852|NCT00481676|363379213|FG000|Overall Study|Administrative problem|1|||
105856343|NCT02112916|365124475|FG000|Overall Study|Inevaluable|6|||
105856344|NCT02112916|365124476|FG001|Overall Study|Inevaluable|4|||
105856345|NCT02112916|365124477|FG002|Overall Study|Inevaluable|5|||
105856346|NCT02112916|365124478|FG003|Overall Study|Inevaluable|5|||
105856347|NCT02112916|365124475|FG000|Overall Study|Refusal of further protocol therapy|19|||
105856348|NCT02112916|365124476|FG001|Overall Study|Refusal of further protocol therapy|16|||
105856349|NCT02112916|365124477|FG002|Overall Study|Refusal of further protocol therapy|1|||
105374853|NCT00481676|363379214|FG001|Overall Study|Administrative problem|0|||
105374854|NCT03937778|363379215|FG000|Overall Study|Withdrawal by Subject|1|||
105577183|NCT01370603|364112204|FG000|Period 1|Protocol Violation|2|||
105856350|NCT02112916|365124478|FG003|Overall Study|Refusal of further protocol therapy|7|||
105856351|NCT02112916|365124475|FG000|Overall Study|Development of SMN|1|||
105856352|NCT02112916|365124476|FG001|Overall Study|Development of SMN|0|||
105856353|NCT02112916|365124477|FG002|Overall Study|Development of SMN|0|||
105856354|NCT02112916|365124478|FG003|Overall Study|Development of SMN|1|||
105856355|NCT02112916|365124475|FG000|Overall Study|Relapse/Progression|10|||
105856356|NCT02112916|365124476|FG001|Overall Study|Relapse/Progression|18|||
105856357|NCT02112916|365124477|FG002|Overall Study|Relapse/Progression|15|||
105856358|NCT02112916|365124478|FG003|Overall Study|Relapse/Progression|2|||
105856359|NCT02112916|365124475|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
105856360|NCT02112916|365124476|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
105856361|NCT02112916|365124477|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
105856362|NCT02112916|365124478|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
105856363|NCT02112916|365124475|FG000|Overall Study|Still on Therapy|44|||
105856364|NCT02112916|365124476|FG001|Overall Study|Still on Therapy|47|||
105856365|NCT02112916|365124477|FG002|Overall Study|Still on Therapy|3|||
105856366|NCT02112916|365124478|FG003|Overall Study|Still on Therapy|2|||
105856367|NCT02112916|365124475|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
105856368|NCT02112916|365124476|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
105856369|NCT02112916|365124477|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
105856370|NCT02112916|365124478|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
105856371|NCT02112916|365124475|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
105856372|NCT02112916|365124476|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
105856373|NCT02112916|365124477|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
105856374|NCT02112916|365124478|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
105856375|NCT05067452|365124479|FG000|Overall Study|Lost to Follow-up|0|||
105856376|NCT05067452|365124480|FG001|Overall Study|Lost to Follow-up|4|||
105856377|NCT01638546|365124491|FG000|Overall Study|Adverse Event|1|||
105856378|NCT01638546|365124492|FG001|Overall Study|Adverse Event|3|||
105856379|NCT05147662|365124501|FG000|Overall Study|Withdrawal by parent/guardian|3|||
105856380|NCT05147662|365124501|FG000|Overall Study|Assigned to treatment but never treated|1|||
105856381|NCT03779906|365124506|FG000|Overall Study|Lost to Follow-up|7|||
105856382|NCT03779906|365124506|FG000|Overall Study|COVID pandemic|1|||
105856383|NCT03907488|365124507|FG000|Overall Study|Adverse Event|20|||
105856384|NCT03907488|365124508|FG001|Overall Study|Adverse Event|20|||
105856385|NCT03907488|365124507|FG000|Overall Study|Withdrawal by Subject|9|||
105856386|NCT03907488|365124508|FG001|Overall Study|Withdrawal by Subject|13|||
105856387|NCT03907488|365124507|FG000|Overall Study|Lack of Efficacy|0|||
105856388|NCT03907488|365124508|FG001|Overall Study|Lack of Efficacy|9|||
105856389|NCT03907488|365124507|FG000|Overall Study|Death|3|||
105856390|NCT03907488|365124508|FG001|Overall Study|Death|8|||
105856391|NCT03907488|365124507|FG000|Overall Study|not protocol specified|5|||
105856392|NCT03907488|365124508|FG001|Overall Study|not protocol specified|8|||
105856393|NCT03907488|365124507|FG000|Overall Study|Ineligible|9|||
105856394|NCT03907488|365124508|FG001|Overall Study|Ineligible|15|||
105856395|NCT03444376|365124509|FG000|Part A|Disease relapse or Progression|1|||
105856396|NCT03444376|365124509|FG000|Part A|Withdrawal by Subject|2|||
105856397|NCT03444376|365124509|FG000|Part A|Adverse Event|1|||
105856398|NCT03444376|365124509|FG000|Part B|Disease relapse or Progression|18|||
105856399|NCT03444376|365124509|FG000|Part B|Withdrawal by Subject|2|||
105856400|NCT03444376|365124509|FG000|Part B|Adverse Event|2|||
105856401|NCT03444376|365124509|FG000|Part B|Physician Decision|1|||
105856402|NCT03444376|365124509|FG000|Part C|Disease relapse or Progression|43|||
105856403|NCT03444376|365124509|FG000|Part C|Withdrawal by Subject|5|||
105856404|NCT03444376|365124509|FG000|Part C|Adverse Event|2|||
105856405|NCT03444376|365124509|FG000|Part C|Physician Decision|2|||
105856406|NCT03444376|365124509|FG000|Part C|Death|1|||
105856407|NCT03307629|365124510|FG000|Overall Study|Withdrawal by Subject|0|||
105856408|NCT03307629|365124511|FG001|Overall Study|Withdrawal by Subject|0|||
105856409|NCT03307629|365124512|FG002|Overall Study|Withdrawal by Subject|0|||
105856410|NCT03307629|365124513|FG003|Overall Study|Withdrawal by Subject|2|||
105856411|NCT03307629|365124510|FG000|Overall Study|Disease Progression|0|||
105856412|NCT03307629|365124511|FG001|Overall Study|Disease Progression|0|||
105856413|NCT03307629|365124512|FG002|Overall Study|Disease Progression|0|||
105856414|NCT03307629|365124513|FG003|Overall Study|Disease Progression|3|||
105856415|NCT03307629|365124510|FG000|Overall Study|Death|0|||
105856416|NCT03307629|365124511|FG001|Overall Study|Death|3|||
105856417|NCT03307629|365124512|FG002|Overall Study|Death|0|||
105856418|NCT03307629|365124513|FG003|Overall Study|Death|1|||
105856419|NCT00977574|365124514|FG000|Overall Study|Never Treated|4|||
105856420|NCT00977574|365124515|FG001|Overall Study|Never Treated|2|||
105856421|NCT00977574|365124516|FG002|Overall Study|Never Treated|4|||
105856422|NCT02553460|365124517|FG000|Overall Study|Death|3|||
105856423|NCT02553460|365124517|FG000|Overall Study|Withdrawal by Subject|1|||
105856424|NCT02553460|365124517|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
105856425|NCT02553460|365124517|FG000|Overall Study|Relapse or Transplant|14|||
105856426|NCT02553460|365124517|FG000|Overall Study|No response to treatment|2|||
105856427|NCT02553460|365124517|FG000|Overall Study|CAR T cells|2|||
105856428|NCT02839707|365124518|FG000|Phase I|Not eligible for analysis|9|||
105856429|NCT02839707|365124519|FG001|Phase I|Not eligible for analysis|0|||
105856430|NCT02839707|365124520|FG002|Phase I|Not eligible for analysis|0|||
105856431|NCT02839707|365124518|FG000|Phase II|Not treated according to protocol|4|||
105856432|NCT02839707|365124519|FG001|Phase II|Not treated according to protocol|0|||
105856433|NCT02839707|365124520|FG002|Phase II|Not treated according to protocol|2|||
105856434|NCT02839707|365124518|FG000|Phase III|Not treated according to protocol|0|||
105856435|NCT02839707|365124519|FG001|Phase III|Not treated according to protocol|0|||
105856436|NCT02839707|365124520|FG002|Phase III|Not treated according to protocol|4|||
105856437|NCT02890355|365124521|FG000|Overall Study|Adverse Event|5|||
105856438|NCT02890355|365124522|FG001|Overall Study|Adverse Event|5|||
105856439|NCT02890355|365124521|FG000|Overall Study|Refusal unrelated to adverse event|5|||
105856440|NCT02890355|365124522|FG001|Overall Study|Refusal unrelated to adverse event|10|||
105856441|NCT02890355|365124521|FG000|Overall Study|Progression/relapse|46|||
105856442|NCT02890355|365124522|FG001|Overall Study|Progression/relapse|39|||
105856443|NCT02890355|365124521|FG000|Overall Study|Not protocol specified|3|||
105856444|NCT02890355|365124522|FG001|Overall Study|Not protocol specified|4|||
105856445|NCT03862131|365124527|FG000|Overall Study|Lost to Follow-up|1|||
105856446|NCT03862131|365124528|FG001|Overall Study|Lost to Follow-up|0|||
105856447|NCT03862131|365124529|FG002|Overall Study|Lost to Follow-up|1|||
105856448|NCT03862131|365124527|FG000|Overall Study|Determined to be ineligible|0|||
105856449|NCT03862131|365124528|FG001|Overall Study|Determined to be ineligible|0|||
105856450|NCT03862131|365124529|FG002|Overall Study|Determined to be ineligible|5|||
105856451|NCT03862131|365124527|FG000|Overall Study|Death|4|||
105856452|NCT03862131|365124528|FG001|Overall Study|Death|4|||
105856453|NCT03862131|365124529|FG002|Overall Study|Death|0|||
105856454|NCT03862131|365124527|FG000|Overall Study|Withdrawal by Subject|5|||
105856455|NCT03862131|365124528|FG001|Overall Study|Withdrawal by Subject|3|||
105856456|NCT03862131|365124529|FG002|Overall Study|Withdrawal by Subject|0|||
105856457|NCT03862131|365124527|FG000|Overall Study|Physician Decision|0|||
105856458|NCT03862131|365124528|FG001|Overall Study|Physician Decision|1|||
105856459|NCT03862131|365124529|FG002|Overall Study|Physician Decision|0|||
105856460|NCT04814368|365125066|FG000|Overall Study|Study Terminated by Sponsor|0|||
105856461|NCT04814368|365125067|FG001|Overall Study|Study Terminated by Sponsor|3|||
105856462|NCT04814368|365125068|FG002|Overall Study|Study Terminated by Sponsor|0|||
105329729|NCT00734994|363205857|FG000|Overall Study|Withdrawal by Subject|1|||
105329730|NCT04509076|363207381|FG000|Overall Study|Withdrawal by Subject|1|||
105329731|NCT04509076|363207382|FG001|Overall Study|Withdrawal by Subject|2|||
105329732|NCT04509076|363207381|FG000|Overall Study|Lost to Follow-up|1|||
105329733|NCT04509076|363207382|FG001|Overall Study|Lost to Follow-up|2|||
105329734|NCT00449865|363207383|FG000|Overall Study|Withdrawal by Subject|110|||
105329735|NCT00449865|363207384|FG001|Overall Study|Withdrawal by Subject|110|||
105329736|NCT00449865|363207383|FG000|Overall Study|Lost to Follow-up|36|||
105329737|NCT00449865|363207384|FG001|Overall Study|Lost to Follow-up|37|||
105329738|NCT00449865|363207383|FG000|Overall Study|Physician Decision|13|||
105329739|NCT00449865|363207384|FG001|Overall Study|Physician Decision|12|||
105329740|NCT00449865|363207383|FG000|Overall Study|Death|31|||
105329741|NCT00449865|363207384|FG001|Overall Study|Death|40|||
105329742|NCT00449865|363207383|FG000|Overall Study|Protocol Violation|8|||
105329743|NCT00449865|363207384|FG001|Overall Study|Protocol Violation|7|||
105329744|NCT00449865|363207383|FG000|Overall Study|Study was stopped|324|||
105329745|NCT00449865|363207384|FG001|Overall Study|Study was stopped|328|||
105329746|NCT01778855|363207385|FG000|Overall Study|Death|0|||
105329747|NCT01778855|363207386|FG001|Overall Study|Death|1|||
105329748|NCT00444535|363207387|FG000|Overall Study|Withdrawal by Subject|5|||
105329749|NCT00444535|363207387|FG000|Overall Study|Physician Decision|5|||
105329750|NCT00444535|363207387|FG000|Overall Study|progressive disease|1|||
105329751|NCT00444535|363207387|FG000|Overall Study|Adverse Event|2|||
105329752|NCT00171210|363207395|FG000|Overall Study|Adverse Event|16|||
105329753|NCT00171210|363207396|FG001|Overall Study|Adverse Event|27|||
105329754|NCT00171210|363207395|FG000|Overall Study|Abnormal laboratory value(s)|6|||
105329755|NCT00171210|363207396|FG001|Overall Study|Abnormal laboratory value(s)|3|||
105329756|NCT00171210|363207395|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105329757|NCT00171210|363207396|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105329758|NCT00171210|363207395|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
105329759|NCT00171210|363207396|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
105329760|NCT00171210|363207395|FG000|Overall Study|Protocol Violation|0|||
105329761|NCT00171210|363207396|FG001|Overall Study|Protocol Violation|2|||
105329762|NCT00171210|363207395|FG000|Overall Study|Withdrawal by Subject|32|||
105329763|NCT00171210|363207396|FG001|Overall Study|Withdrawal by Subject|30|||
105329764|NCT00171210|363207395|FG000|Overall Study|Lost to Follow-up|1|||
105329765|NCT00171210|363207396|FG001|Overall Study|Lost to Follow-up|0|||
105329766|NCT00171210|363207395|FG000|Overall Study|Administrative problems|1|||
105329767|NCT00171210|363207396|FG001|Overall Study|Administrative problems|1|||
105329768|NCT00171210|363207395|FG000|Overall Study|Death|2|||
105329769|NCT00171210|363207396|FG001|Overall Study|Death|3|||
105856463|NCT04814368|365125069|FG003|Overall Study|Study Terminated by Sponsor|2|||
105856464|NCT04814368|365125066|FG000|Overall Study|Subject Decision|1|||
105856465|NCT04814368|365125067|FG001|Overall Study|Subject Decision|2|||
105856466|NCT04814368|365125068|FG002|Overall Study|Subject Decision|0|||
105856467|NCT04814368|365125069|FG003|Overall Study|Subject Decision|0|||
105856468|NCT00980460|365125070|FG000|Overall Study|Death|0|||
105856469|NCT00980460|365125071|FG001|Overall Study|Death|0|||
105856470|NCT00980460|365125072|FG002|Overall Study|Death|1|||
105856471|NCT00980460|365125073|FG003|Overall Study|Death|2|||
105856472|NCT00980460|365125074|FG004|Overall Study|Death|1|||
105856473|NCT00980460|365125070|FG000|Overall Study|Lack of Efficacy|0|||
105856474|NCT00980460|365125071|FG001|Overall Study|Lack of Efficacy|0|||
105856475|NCT00980460|365125072|FG002|Overall Study|Lack of Efficacy|10|||
105856476|NCT00980460|365125073|FG003|Overall Study|Lack of Efficacy|6|||
105856477|NCT00980460|365125074|FG004|Overall Study|Lack of Efficacy|8|||
105856478|NCT00980460|365125070|FG000|Overall Study|Lost to Follow-up|0|||
105856479|NCT00980460|365125071|FG001|Overall Study|Lost to Follow-up|0|||
105856480|NCT00980460|365125072|FG002|Overall Study|Lost to Follow-up|0|||
105856481|NCT00980460|365125073|FG003|Overall Study|Lost to Follow-up|1|||
105856482|NCT00980460|365125074|FG004|Overall Study|Lost to Follow-up|0|||
105856483|NCT00980460|365125070|FG000|Overall Study|Physician Decision|0|||
105856484|NCT00980460|365125071|FG001|Overall Study|Physician Decision|0|||
105856485|NCT00980460|365125072|FG002|Overall Study|Physician Decision|11|||
105856486|NCT00980460|365125073|FG003|Overall Study|Physician Decision|5|||
105856487|NCT00980460|365125074|FG004|Overall Study|Physician Decision|3|||
105856488|NCT00980460|365125070|FG000|Overall Study|Withdrawal by Subject|0|||
105856489|NCT00980460|365125071|FG001|Overall Study|Withdrawal by Subject|0|||
105856490|NCT00980460|365125072|FG002|Overall Study|Withdrawal by Subject|1|||
105856491|NCT00980460|365125073|FG003|Overall Study|Withdrawal by Subject|0|||
105856492|NCT00980460|365125074|FG004|Overall Study|Withdrawal by Subject|0|||
105856493|NCT00980460|365125070|FG000|Overall Study|Ineligible|0|||
105329770|NCT00171210|363207395|FG000|Overall Study|Stopped at end of core|0|||
105329771|NCT00171210|363207396|FG001|Overall Study|Stopped at end of core|32|||
105329772|NCT00171210|363207395|FG000|Overall Study|Stopped at end of extension 1|0|||
105329773|NCT00171210|363207396|FG001|Overall Study|Stopped at end of extension 1|1|||
105856494|NCT00980460|365125071|FG001|Overall Study|Ineligible|2|||
105856495|NCT00980460|365125072|FG002|Overall Study|Ineligible|3|||
105856496|NCT00980460|365125073|FG003|Overall Study|Ineligible|1|||
105856497|NCT00980460|365125074|FG004|Overall Study|Ineligible|4|||
105856498|NCT00980460|365125070|FG000|Overall Study|Refusal of further therapy|0|||
105856499|NCT00980460|365125071|FG001|Overall Study|Refusal of further therapy|2|||
105856500|NCT00980460|365125072|FG002|Overall Study|Refusal of further therapy|3|||
105856501|NCT00980460|365125073|FG003|Overall Study|Refusal of further therapy|2|||
105856502|NCT00980460|365125074|FG004|Overall Study|Refusal of further therapy|0|||
105856503|NCT00980460|365125070|FG000|Overall Study|No therapy within 42 days of resection|0|||
105856504|NCT00980460|365125071|FG001|Overall Study|No therapy within 42 days of resection|0|||
105856505|NCT00980460|365125072|FG002|Overall Study|No therapy within 42 days of resection|3|||
105856506|NCT00980460|365125073|FG003|Overall Study|No therapy within 42 days of resection|1|||
105856507|NCT00980460|365125074|FG004|Overall Study|No therapy within 42 days of resection|0|||
105856508|NCT00980460|365125070|FG000|Overall Study|No transplant by protocol timepoints|0|||
105856509|NCT00980460|365125071|FG001|Overall Study|No transplant by protocol timepoints|0|||
105856510|NCT00980460|365125072|FG002|Overall Study|No transplant by protocol timepoints|3|||
105856511|NCT00980460|365125073|FG003|Overall Study|No transplant by protocol timepoints|0|||
105856512|NCT00980460|365125074|FG004|Overall Study|No transplant by protocol timepoints|0|||
105856513|NCT01950390|365125079|FG000|Overall Study|Never started treatment|3|||
105856514|NCT01950390|365125080|FG001|Overall Study|Never started treatment|2|||
105856515|NCT01950390|365125079|FG000|Overall Study|Disease progression|45|||
105856516|NCT01950390|365125080|FG001|Overall Study|Disease progression|52|||
105856517|NCT01950390|365125079|FG000|Overall Study|Adverse Event|22|||
105856518|NCT01950390|365125080|FG001|Overall Study|Adverse Event|16|||
105856519|NCT01950390|365125079|FG000|Overall Study|Death|5|||
105856520|NCT01950390|365125080|FG001|Overall Study|Death|3|||
105856521|NCT01950390|365125079|FG000|Overall Study|Withdrawal by Subject|5|||
105856522|NCT01950390|365125080|FG001|Overall Study|Withdrawal by Subject|1|||
105856523|NCT01950390|365125079|FG000|Overall Study|Alternative therapy|0|||
105329774|NCT04498182|363207401|FG000|Overall Study|Adverse Event|2|||
105329775|NCT04498182|363207402|FG001|Overall Study|Adverse Event|3|||
105329776|NCT04498182|363207403|FG002|Overall Study|Adverse Event|2|||
105329777|NCT04498182|363207401|FG000|Overall Study|Withdrawal of Consent|3|||
105329778|NCT04498182|363207402|FG001|Overall Study|Withdrawal of Consent|4|||
105329779|NCT04498182|363207403|FG002|Overall Study|Withdrawal of Consent|3|||
105329780|NCT04498182|363207401|FG000|Overall Study|Non-Compliant|1|||
105329781|NCT04498182|363207402|FG001|Overall Study|Non-Compliant|0|||
105329782|NCT04498182|363207403|FG002|Overall Study|Non-Compliant|1|||
105329783|NCT04498182|363207401|FG000|Overall Study|Lost to Follow-up|0|||
105329784|NCT04498182|363207402|FG001|Overall Study|Lost to Follow-up|0|||
105329785|NCT04498182|363207403|FG002|Overall Study|Lost to Follow-up|1|||
105374855|NCT03937778|363379215|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
105374856|NCT01056276|363379216|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
105374857|NCT01056276|363379217|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
105374858|NCT01056276|363379216|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
105374859|NCT01056276|363379217|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
105374860|NCT01056276|363379216|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
105374861|NCT01056276|363379217|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
105374862|NCT01056276|363379216|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
105374863|NCT01056276|363379217|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
105374864|NCT01056276|363379216|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
105374865|NCT01056276|363379217|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
105374866|NCT01056276|363379216|FG000|Treatment Period-Cycles 1-8|Death|3|||
105374867|NCT01056276|363379217|FG001|Treatment Period-Cycles 1-8|Death|1|||
105374868|NCT01056276|363379216|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
105856524|NCT01950390|365125080|FG001|Overall Study|Alternative therapy|3|||
105329786|NCT04498182|363207401|FG000|Overall Study|Investigator Decision|0|||
105329787|NCT04498182|363207402|FG001|Overall Study|Investigator Decision|0|||
105329788|NCT04498182|363207403|FG002|Overall Study|Investigator Decision|1|||
105329789|NCT04498182|363207401|FG000|Overall Study|Protocol Violation|1|||
105329790|NCT04498182|363207402|FG001|Overall Study|Protocol Violation|0|||
105329791|NCT04498182|363207403|FG002|Overall Study|Protocol Violation|2|||
105329792|NCT00320710|363207412|FG000|Overall Study|Disease progression|24|||
105329793|NCT00320710|363207413|FG001|Overall Study|Disease progression|19|||
105329794|NCT00320710|363207414|FG002|Overall Study|Disease progression|2|||
105329795|NCT00320710|363207412|FG000|Overall Study|Death|10|||
105329796|NCT00320710|363207413|FG001|Overall Study|Death|7|||
105329797|NCT00320710|363207414|FG002|Overall Study|Death|1|||
105329798|NCT00320710|363207412|FG000|Overall Study|Administrative problems|1|||
105329799|NCT00320710|363207413|FG001|Overall Study|Administrative problems|2|||
105329800|NCT00320710|363207414|FG002|Overall Study|Administrative problems|0|||
105329801|NCT00320710|363207412|FG000|Overall Study|Withdrawal by Subject|20|||
105329802|NCT00320710|363207413|FG001|Overall Study|Withdrawal by Subject|26|||
105329803|NCT00320710|363207414|FG002|Overall Study|Withdrawal by Subject|1|||
105329804|NCT00320710|363207412|FG000|Overall Study|Protocol Violation|6|||
105329805|NCT00320710|363207413|FG001|Overall Study|Protocol Violation|5|||
105329806|NCT00320710|363207414|FG002|Overall Study|Protocol Violation|0|||
105329807|NCT00320710|363207412|FG000|Overall Study|Abnormal test procedure result(s)|2|||
105329808|NCT00320710|363207413|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105329809|NCT00320710|363207414|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105329810|NCT00320710|363207412|FG000|Overall Study|Abnormal laboratory value(s)|12|||
105329811|NCT00320710|363207413|FG001|Overall Study|Abnormal laboratory value(s)|3|||
105329812|NCT00320710|363207414|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105329813|NCT00320710|363207412|FG000|Overall Study|Adverse Event|18|||
105329814|NCT00320710|363207413|FG001|Overall Study|Adverse Event|14|||
105329815|NCT00320710|363207414|FG002|Overall Study|Adverse Event|1|||
105329816|NCT00320710|363207412|FG000|Overall Study|Lost to Follow-up|1|||
105329817|NCT00320710|363207413|FG001|Overall Study|Lost to Follow-up|0|||
105329818|NCT00320710|363207414|FG002|Overall Study|Lost to Follow-up|0|||
105329819|NCT03448419|363207415|FG000|Overall Study|Adverse Event|10|||
105329820|NCT03448419|363207416|FG001|Overall Study|Adverse Event|9|||
105329821|NCT03448419|363207415|FG000|Overall Study|Lost to Follow-up|0|||
105329822|NCT03448419|363207416|FG001|Overall Study|Lost to Follow-up|2|||
105329823|NCT03448419|363207415|FG000|Overall Study|Withdrawal by Subject|3|||
105329824|NCT03448419|363207416|FG001|Overall Study|Withdrawal by Subject|1|||
105329825|NCT03448419|363207415|FG000|Overall Study|Not treated|0|||
105329826|NCT03448419|363207416|FG001|Overall Study|Not treated|1|||
105329827|NCT03448419|363207415|FG000|Overall Study|Patient did not attend all visits|0|||
105329828|NCT03448419|363207416|FG001|Overall Study|Patient did not attend all visits|2|||
105329829|NCT03448419|363207415|FG000|Overall Study|Withdrawn by Sponsor|0|||
105329830|NCT03448419|363207416|FG001|Overall Study|Withdrawn by Sponsor|1|||
105329831|NCT00832455|363207417|FG000|Overall Study|Adverse Event|13|||
105329832|NCT00832455|363207417|FG000|Overall Study|Lost to Follow-up|26|||
105329833|NCT00832455|363207417|FG000|Overall Study|Protocol Violation|4|||
105329834|NCT00832455|363207417|FG000|Overall Study|Withdrawal by Subject|17|||
105329835|NCT00832455|363207417|FG000|Overall Study|Screening Failure|2|||
105329836|NCT00832455|363207417|FG000|Overall Study|Stopped Medication|4|||
105329837|NCT00832455|363207417|FG000|Overall Study|Parent misunderstood study|1|||
105329838|NCT00832455|363207417|FG000|Overall Study|Parent dissatisfied|1|||
105329839|NCT00832455|363207417|FG000|Overall Study|No improvement|3|||
105329840|NCT00832455|363207417|FG000|Overall Study|Patient moved|1|||
105329841|NCT04578457|363207418|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
105329842|NCT04578457|363207418|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
105329843|NCT04578457|363207418|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
105329844|NCT04578457|363207418|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
105374869|NCT01056276|363379217|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
105374870|NCT01056276|363379216|FG000|Maintenance Therapy|Toxicity|0|||
105374871|NCT01056276|363379217|FG001|Maintenance Therapy|Toxicity|2|||
105374872|NCT01056276|363379216|FG000|Maintenance Therapy|Progressive Disease|0|||
105374873|NCT01056276|363379217|FG001|Maintenance Therapy|Progressive Disease|9|||
105856525|NCT01950390|365125079|FG000|Overall Study|Complicating disease|1|||
105856526|NCT01950390|365125080|FG001|Overall Study|Complicating disease|0|||
105856527|NCT01950390|365125079|FG000|Overall Study|On treatment|1|||
105856528|NCT01950390|365125080|FG001|Overall Study|On treatment|0|||
105856529|NCT01950390|365125079|FG000|Overall Study|Symptomatic deterioration|2|||
105856530|NCT01950390|365125080|FG001|Overall Study|Symptomatic deterioration|1|||
105856531|NCT01950390|365125079|FG000|Overall Study|Physician Decision|0|||
105374874|NCT01056276|363379216|FG000|Maintenance Therapy|Physician Decision|0|||
105374875|NCT01056276|363379217|FG001|Maintenance Therapy|Physician Decision|1|||
105374876|NCT01056276|363379216|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
105374877|NCT01056276|363379217|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
105374878|NCT01056276|363379216|FG000|Maintenance Therapy|Intercurrent Illness|0|||
105374879|NCT01056276|363379217|FG001|Maintenance Therapy|Intercurrent Illness|1|||
105374880|NCT01056276|363379216|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
105577184|NCT01370603|364112205|FG001|Period 1|Protocol Violation|2|||
105577185|NCT01370603|364112204|FG000|Period 1|Withdrawal by Subject|5|||
105374881|NCT01056276|363379217|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
105374882|NCT00937950|363379218|FG000|Overall Study|Withdrawal by Subject|23|||
105374883|NCT00937950|363379218|FG000|Overall Study|Migrated/moved from study area|27|||
105374884|NCT00937950|363379218|FG000|Overall Study|Lost to Follow-up|144|||
105374885|NCT00937950|363379218|FG000|Overall Study|Missing confirmed|4|||
105374886|NCT00937950|363379218|FG000|Overall Study|Other|18|||
105374887|NCT01137786|363379220|FG000|Overall Study|Lost to Follow-up|0|||
105374888|NCT01137786|363379221|FG001|Overall Study|Lost to Follow-up|2|||
105374889|NCT01137786|363379220|FG000|Overall Study|Withdrawal by Subject|1|||
105374890|NCT01137786|363379221|FG001|Overall Study|Withdrawal by Subject|1|||
105374891|NCT01200355|363379224|FG000|Overall Study|Death|7|||
105374892|NCT01200355|363379225|FG001|Overall Study|Death|2|||
105374893|NCT01970371|363379226|FG000|Overall Study|Death|8|||
105374894|NCT01970371|363379227|FG001|Overall Study|Death|13|||
105374895|NCT01970371|363379228|FG002|Overall Study|Death|12|||
105374896|NCT01970371|363379226|FG000|Overall Study|Lost to Follow-up|0|||
105374897|NCT01970371|363379227|FG001|Overall Study|Lost to Follow-up|0|||
105374898|NCT01970371|363379228|FG002|Overall Study|Lost to Follow-up|1|||
105374899|NCT01348269|363379230|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
105374900|NCT01348269|363379231|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
105374901|NCT01348269|363379230|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
105374902|NCT01348269|363379231|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
105374903|NCT01348269|363379230|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
105374904|NCT01348269|363379231|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
105374905|NCT03834350|363379232|FG000|Overall Study|Withdrawal by Subject|1|||
105374906|NCT01572792|363379233|FG000|Lead-in Study|Lost to Follow-up|5|||
105374907|NCT01572792|363379234|FG001|Lead-in Study|Lost to Follow-up|9|||
105374908|NCT01572792|363379235|FG002|Lead-in Study|Lost to Follow-up|4|||
105374909|NCT01572792|363379236|FG003|Lead-in Study|Lost to Follow-up|2|||
105374910|NCT01572792|363379237|FG004|Lead-in Study|Lost to Follow-up|4|||
105374911|NCT01572792|363379233|FG000|Lead-in Study|Withdrawal by Subject|22|||
105374912|NCT01572792|363379234|FG001|Lead-in Study|Withdrawal by Subject|11|||
105374913|NCT01572792|363379235|FG002|Lead-in Study|Withdrawal by Subject|12|||
105374914|NCT01572792|363379236|FG003|Lead-in Study|Withdrawal by Subject|24|||
105374915|NCT01572792|363379237|FG004|Lead-in Study|Withdrawal by Subject|11|||
105374916|NCT01572792|363379233|FG000|Lead-in Study|Protocol Violation|19|||
105374917|NCT01572792|363379234|FG001|Lead-in Study|Protocol Violation|10|||
105374918|NCT01572792|363379235|FG002|Lead-in Study|Protocol Violation|12|||
105374919|NCT01572792|363379236|FG003|Lead-in Study|Protocol Violation|13|||
105374920|NCT01572792|363379237|FG004|Lead-in Study|Protocol Violation|21|||
105374921|NCT01572792|363379233|FG000|Lead-in Study|Lack of Efficacy|20|||
105374922|NCT01572792|363379234|FG001|Lead-in Study|Lack of Efficacy|5|||
105374923|NCT01572792|363379235|FG002|Lead-in Study|Lack of Efficacy|4|||
105374924|NCT01572792|363379236|FG003|Lead-in Study|Lack of Efficacy|8|||
105374925|NCT01572792|363379237|FG004|Lead-in Study|Lack of Efficacy|10|||
105374926|NCT01572792|363379233|FG000|Lead-in Study|Adverse Event|21|||
105374927|NCT01572792|363379234|FG001|Lead-in Study|Adverse Event|21|||
105374928|NCT01572792|363379235|FG002|Lead-in Study|Adverse Event|22|||
105374929|NCT01572792|363379236|FG003|Lead-in Study|Adverse Event|16|||
105374930|NCT01572792|363379237|FG004|Lead-in Study|Adverse Event|14|||
105374931|NCT01572792|363379233|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
105374932|NCT01572792|363379234|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
105374933|NCT01572792|363379235|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
105577186|NCT01370603|364112205|FG001|Period 1|Withdrawal by Subject|5|||
105856532|NCT01950390|365125080|FG001|Overall Study|Physician Decision|4|||
105856533|NCT01950390|365125079|FG000|Overall Study|Lack of clinical benefit|0|||
105374934|NCT01572792|363379236|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
105374935|NCT01572792|363379237|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
105374936|NCT01572792|363379233|FG000|Extension Study|Lost to Follow-up|6|||
105374937|NCT01572792|363379234|FG001|Extension Study|Lost to Follow-up|2|||
105374938|NCT01572792|363379235|FG002|Extension Study|Lost to Follow-up|0|||
105374939|NCT01572792|363379236|FG003|Extension Study|Lost to Follow-up|3|||
105374940|NCT01572792|363379237|FG004|Extension Study|Lost to Follow-up|3|||
105374941|NCT01572792|363379233|FG000|Extension Study|Withdrawal by Subject|7|||
105374942|NCT01572792|363379234|FG001|Extension Study|Withdrawal by Subject|6|||
105374943|NCT01572792|363379235|FG002|Extension Study|Withdrawal by Subject|11|||
105374944|NCT01572792|363379236|FG003|Extension Study|Withdrawal by Subject|8|||
105374945|NCT01572792|363379237|FG004|Extension Study|Withdrawal by Subject|14|||
105374946|NCT01572792|363379233|FG000|Extension Study|Protocol Violation|0|||
105374947|NCT01572792|363379234|FG001|Extension Study|Protocol Violation|4|||
105374948|NCT01572792|363379235|FG002|Extension Study|Protocol Violation|3|||
105374949|NCT01572792|363379236|FG003|Extension Study|Protocol Violation|4|||
105374950|NCT01572792|363379237|FG004|Extension Study|Protocol Violation|3|||
105374951|NCT01572792|363379233|FG000|Extension Study|Lack of Efficacy|2|||
105374952|NCT01572792|363379234|FG001|Extension Study|Lack of Efficacy|3|||
105374953|NCT01572792|363379235|FG002|Extension Study|Lack of Efficacy|3|||
105374954|NCT01572792|363379236|FG003|Extension Study|Lack of Efficacy|2|||
105374955|NCT01572792|363379237|FG004|Extension Study|Lack of Efficacy|2|||
105374956|NCT01572792|363379233|FG000|Extension Study|Adverse Event|7|||
105374957|NCT01572792|363379234|FG001|Extension Study|Adverse Event|6|||
105374958|NCT01572792|363379235|FG002|Extension Study|Adverse Event|5|||
105374959|NCT01572792|363379236|FG003|Extension Study|Adverse Event|6|||
105374960|NCT01572792|363379237|FG004|Extension Study|Adverse Event|4|||
105374961|NCT01572792|363379233|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
105374962|NCT01572792|363379234|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
105374963|NCT01572792|363379235|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
105856534|NCT01950390|365125080|FG001|Overall Study|Lack of clinical benefit|1|||
105856535|NCT01950390|365125079|FG000|Overall Study|Maintained PR and moved to observation only|0|||
105856536|NCT01950390|365125080|FG001|Overall Study|Maintained PR and moved to observation only|1|||
105856537|NCT02180867|365125083|FG000|Overall Study|Adverse Event|3|||
105856538|NCT02180867|365125084|FG001|Overall Study|Adverse Event|4|||
105856539|NCT02180867|365125085|FG002|Overall Study|Adverse Event|1|||
105856540|NCT02180867|365125086|FG003|Overall Study|Adverse Event|5|||
105856541|NCT02180867|365125087|FG004|Overall Study|Adverse Event|0|||
105856542|NCT02180867|365125088|FG005|Overall Study|Adverse Event|0|||
105856543|NCT02180867|365125089|FG006|Overall Study|Adverse Event|0|||
105856544|NCT02180867|365125083|FG000|Overall Study|Death|0|||
105856545|NCT02180867|365125084|FG001|Overall Study|Death|0|||
105856546|NCT02180867|365125085|FG002|Overall Study|Death|0|||
105856547|NCT02180867|365125086|FG003|Overall Study|Death|0|||
105856548|NCT02180867|365125087|FG004|Overall Study|Death|1|||
105856549|NCT02180867|365125088|FG005|Overall Study|Death|0|||
105856550|NCT02180867|365125089|FG006|Overall Study|Death|0|||
105856551|NCT02180867|365125083|FG000|Overall Study|Lack of Efficacy|0|||
105856552|NCT02180867|365125084|FG001|Overall Study|Lack of Efficacy|2|||
105856553|NCT02180867|365125085|FG002|Overall Study|Lack of Efficacy|0|||
105856554|NCT02180867|365125086|FG003|Overall Study|Lack of Efficacy|1|||
105856555|NCT02180867|365125087|FG004|Overall Study|Lack of Efficacy|6|||
105856556|NCT02180867|365125088|FG005|Overall Study|Lack of Efficacy|0|||
105856557|NCT02180867|365125089|FG006|Overall Study|Lack of Efficacy|1|||
105856558|NCT02180867|365125083|FG000|Overall Study|Physician Decision|1|||
105856559|NCT02180867|365125084|FG001|Overall Study|Physician Decision|3|||
105856560|NCT02180867|365125085|FG002|Overall Study|Physician Decision|1|||
105856561|NCT02180867|365125086|FG003|Overall Study|Physician Decision|10|||
105856562|NCT02180867|365125087|FG004|Overall Study|Physician Decision|9|||
105856563|NCT02180867|365125088|FG005|Overall Study|Physician Decision|3|||
105856564|NCT02180867|365125089|FG006|Overall Study|Physician Decision|4|||
105856565|NCT02180867|365125083|FG000|Overall Study|Withdrawal by Subject|0|||
105856566|NCT02180867|365125084|FG001|Overall Study|Withdrawal by Subject|0|||
105856567|NCT02180867|365125085|FG002|Overall Study|Withdrawal by Subject|0|||
105856568|NCT02180867|365125086|FG003|Overall Study|Withdrawal by Subject|1|||
105856569|NCT02180867|365125087|FG004|Overall Study|Withdrawal by Subject|1|||
105856570|NCT02180867|365125088|FG005|Overall Study|Withdrawal by Subject|0|||
105374964|NCT01572792|363379236|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
105374965|NCT01572792|363379237|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
105374966|NCT00844519|363379243|FG000|Overall Study|Withdrawal by Subject|1|||
105374967|NCT00844519|363379244|FG001|Overall Study|Withdrawal by Subject|1|||
105374968|NCT00844519|363379243|FG000|Overall Study|Adverse Event|1|||
105856571|NCT02180867|365125089|FG006|Overall Study|Withdrawal by Subject|0|||
105374969|NCT00844519|363379244|FG001|Overall Study|Adverse Event|0|||
105374970|NCT01564407|363379254|FG000|Overall Study|Lost to Follow-up|0|||
105856572|NCT02180867|365125083|FG000|Overall Study|Ineligible|1|||
105856573|NCT02180867|365125084|FG001|Overall Study|Ineligible|2|||
105856574|NCT02180867|365125085|FG002|Overall Study|Ineligible|0|||
105374971|NCT01564407|363379255|FG001|Overall Study|Lost to Follow-up|1|||
105374972|NCT01564407|363379256|FG002|Overall Study|Lost to Follow-up|0|||
105374973|NCT01564407|363379257|FG003|Overall Study|Lost to Follow-up|0|||
105374974|NCT01564407|363379258|FG004|Overall Study|Lost to Follow-up|0|||
105374975|NCT01564407|363379254|FG000|Overall Study|Withdrawal by Subject|0|||
105374976|NCT01564407|363379255|FG001|Overall Study|Withdrawal by Subject|1|||
105374977|NCT01564407|363379256|FG002|Overall Study|Withdrawal by Subject|0|||
105374978|NCT01564407|363379257|FG003|Overall Study|Withdrawal by Subject|0|||
105374979|NCT01564407|363379258|FG004|Overall Study|Withdrawal by Subject|0|||
105374980|NCT01564407|363379254|FG000|Overall Study|funding lost, study ended|0|||
105374981|NCT01564407|363379255|FG001|Overall Study|funding lost, study ended|0|||
105374982|NCT01564407|363379256|FG002|Overall Study|funding lost, study ended|0|||
105374983|NCT01564407|363379257|FG003|Overall Study|funding lost, study ended|1|||
105374984|NCT01564407|363379258|FG004|Overall Study|funding lost, study ended|0|||
105374985|NCT01163617|363379261|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
105374986|NCT01163617|363379262|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
105374987|NCT01163617|363379263|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
105374988|NCT01163617|363379264|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
105374989|NCT01163617|363379265|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
105374990|NCT01163617|363379266|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
105374991|NCT01163617|363379267|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
105374992|NCT01163617|363379268|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
105374993|NCT01163617|363379261|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
105374994|NCT01163617|363379262|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
105374995|NCT01163617|363379263|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
105374996|NCT01163617|363379264|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
105374997|NCT01163617|363379265|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
105374998|NCT01163617|363379266|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
105374999|NCT01163617|363379267|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
105375000|NCT01163617|363379268|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
105375001|NCT01163617|363379261|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
105375002|NCT01163617|363379262|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
105375003|NCT01163617|363379263|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
105375004|NCT01163617|363379264|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
105856575|NCT02180867|365125086|FG003|Overall Study|Ineligible|3|||
105856576|NCT02180867|365125087|FG004|Overall Study|Ineligible|5|||
105856577|NCT02180867|365125088|FG005|Overall Study|Ineligible|0|||
105856578|NCT02180867|365125089|FG006|Overall Study|Ineligible|0|||
105856579|NCT02180867|365125083|FG000|Overall Study|Repeat Eligibility Studies|0|||
105856580|NCT02180867|365125084|FG001|Overall Study|Repeat Eligibility Studies|0|||
105856581|NCT02180867|365125085|FG002|Overall Study|Repeat Eligibility Studies|0|||
105856582|NCT02180867|365125086|FG003|Overall Study|Repeat Eligibility Studies|0|||
105856583|NCT02180867|365125087|FG004|Overall Study|Repeat Eligibility Studies|1|||
105856584|NCT02180867|365125088|FG005|Overall Study|Repeat Eligibility Studies|0|||
105856585|NCT02180867|365125089|FG006|Overall Study|Repeat Eligibility Studies|0|||
105856586|NCT02180867|365125083|FG000|Overall Study|Refusal of further protocol therapy|1|||
105856587|NCT02180867|365125084|FG001|Overall Study|Refusal of further protocol therapy|0|||
105856588|NCT02180867|365125085|FG002|Overall Study|Refusal of further protocol therapy|2|||
105856589|NCT02180867|365125086|FG003|Overall Study|Refusal of further protocol therapy|6|||
105856590|NCT02180867|365125087|FG004|Overall Study|Refusal of further protocol therapy|4|||
105329845|NCT03376789|363207426|FG000|Overall Study|Withdrawal by Subject|3|||
105329846|NCT03376789|363207427|FG001|Overall Study|Withdrawal by Subject|5|||
105329847|NCT03376789|363207426|FG000|Overall Study|Protocol Violation|0|||
105329848|NCT03376789|363207427|FG001|Overall Study|Protocol Violation|1|||
105329849|NCT03376789|363207426|FG000|Overall Study|Adverse Event|0|||
105329850|NCT03376789|363207427|FG001|Overall Study|Adverse Event|1|||
105329851|NCT03376789|363207426|FG000|Overall Study|Lost to Follow-up|1|||
105329852|NCT03376789|363207427|FG001|Overall Study|Lost to Follow-up|1|||
105329853|NCT03376789|363207426|FG000|Overall Study|Per sponsor due to noncompliance|1|||
105329854|NCT03376789|363207427|FG001|Overall Study|Per sponsor due to noncompliance|0|||
105329855|NCT03376789|363207426|FG000|Overall Study|Subject off study medication|0|||
105329856|NCT03376789|363207427|FG001|Overall Study|Subject off study medication|1|||
105329857|NCT03337113|363207428|FG000|Overall Study|Adverse Event|1|||
105329858|NCT03337113|363207429|FG001|Overall Study|Adverse Event|1|||
105329859|NCT03337113|363207430|FG002|Overall Study|Adverse Event|0|||
105329860|NCT03337113|363207431|FG003|Overall Study|Adverse Event|1|||
105329861|NCT03337113|363207428|FG000|Overall Study|Physician Decision|0|||
105329862|NCT03337113|363207429|FG001|Overall Study|Physician Decision|2|||
105329863|NCT03337113|363207430|FG002|Overall Study|Physician Decision|0|||
105329864|NCT03337113|363207431|FG003|Overall Study|Physician Decision|1|||
105856591|NCT02180867|365125088|FG005|Overall Study|Refusal of further protocol therapy|0|||
105856592|NCT02180867|365125089|FG006|Overall Study|Refusal of further protocol therapy|0|||
105856593|NCT01251861|365125090|FG000|Overall Study|Disease progression|6|||
105856594|NCT01251861|365125091|FG001|Overall Study|Disease progression|6|||
105856595|NCT01251861|365125090|FG000|Overall Study|Adverse Event|2|||
105856596|NCT01251861|365125091|FG001|Overall Study|Adverse Event|17|||
105856597|NCT01251861|365125090|FG000|Overall Study|Withdrawal by Subject|2|||
105856598|NCT01251861|365125091|FG001|Overall Study|Withdrawal by Subject|2|||
105856599|NCT01251861|365125090|FG000|Overall Study|Alternative therapy|1|||
105856600|NCT01251861|365125091|FG001|Overall Study|Alternative therapy|0|||
105856601|NCT01251861|365125090|FG000|Overall Study|Other complicating disease|0|||
105856602|NCT01251861|365125091|FG001|Overall Study|Other complicating disease|1|||
105856603|NCT01251861|365125090|FG000|Overall Study|Physician Decision|1|||
105856604|NCT01251861|365125091|FG001|Overall Study|Physician Decision|0|||
105856605|NCT01251861|365125090|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
105856606|NCT01251861|365125091|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
105856607|NCT01251861|365125090|FG000|Overall Study|Other|1|||
105856608|NCT01251861|365125091|FG001|Overall Study|Other|0|||
105856609|NCT01251861|365125090|FG000|Overall Study|Never started therapy|4|||
105856610|NCT01251861|365125091|FG001|Overall Study|Never started therapy|1|||
105856611|NCT01251861|365125090|FG000|Overall Study|Potential interaction of drugs|0|||
105856612|NCT01251861|365125091|FG001|Overall Study|Potential interaction of drugs|1|||
105856613|NCT05222555|365125092|FG000|Overall Study|Ongoing|2|||
105856614|NCT05222555|365125093|FG001|Overall Study|Ongoing|18|||
105856615|NCT05222555|365125092|FG000|Overall Study|Adverse Event|1|||
105856616|NCT05222555|365125093|FG001|Overall Study|Adverse Event|1|||
105856617|NCT05222555|365125092|FG000|Overall Study|Death|0|||
105856618|NCT05222555|365125093|FG001|Overall Study|Death|6|||
105856619|NCT05222555|365125092|FG000|Overall Study|Withdrawal by Subject|0|||
105856620|NCT05222555|365125093|FG001|Overall Study|Withdrawal by Subject|11|||
105856621|NCT03581292|365125094|FG000|Overall Study|Physician Decision|9|||
105856622|NCT03581292|365125095|FG001|Overall Study|Physician Decision|5|||
105856623|NCT03581292|365125094|FG000|Overall Study|Withdrawal by Subject|3|||
105856624|NCT03581292|365125095|FG001|Overall Study|Withdrawal by Subject|0|||
105856625|NCT03581292|365125094|FG000|Overall Study|Withdrawal before Therapy Start|1|||
105856626|NCT03581292|365125095|FG001|Overall Study|Withdrawal before Therapy Start|0|||
105856627|NCT04284774|365125096|FG000|Overall Study|Progressive disease|5|||
105856628|NCT03578887|365125097|FG000|Overall Study|Withdrawal by Subject|7|||
105856629|NCT03578887|365125098|FG001|Overall Study|Withdrawal by Subject|2|||
105856630|NCT03578887|365125099|FG002|Overall Study|Withdrawal by Subject|1|||
105856631|NCT03578887|365125097|FG000|Overall Study|Lost to Follow-up|13|||
105856632|NCT03578887|365125098|FG001|Overall Study|Lost to Follow-up|1|||
105856633|NCT03578887|365125099|FG002|Overall Study|Lost to Follow-up|4|||
105856634|NCT03578887|365125097|FG000|Overall Study|Physician Decision|0|||
105856635|NCT03578887|365125098|FG001|Overall Study|Physician Decision|1|||
105856636|NCT03578887|365125099|FG002|Overall Study|Physician Decision|1|||
105856637|NCT04922554|365125101|FG000|Overall Study|Adverse Event|4|||
105856638|NCT04922554|365125102|FG001|Overall Study|Adverse Event|0|||
105856639|NCT04922554|365125101|FG000|Overall Study|Withdrawal by Subject|1|||
105856640|NCT04922554|365125102|FG001|Overall Study|Withdrawal by Subject|0|||
105375005|NCT01163617|363379265|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
105375006|NCT01163617|363379266|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
105375007|NCT01163617|363379267|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
105375008|NCT01163617|363379268|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
105375009|NCT02394756|363379269|FG000|Period 1|Lens Discomfort|0|||
105375010|NCT02394756|363379270|FG001|Period 1|Lens Discomfort|0|||
105375011|NCT02394756|363379271|FG002|Period 1|Lens Discomfort|0|||
105375012|NCT02394756|363379272|FG003|Period 1|Lens Discomfort|0|||
105375013|NCT02394756|363379273|FG004|Period 1|Lens Discomfort|0|||
105375014|NCT02394756|363379274|FG005|Period 1|Lens Discomfort|1|||
105375015|NCT02394756|363379269|FG000|Period 1|Withdrawal by Subject|0|||
105375016|NCT02394756|363379270|FG001|Period 1|Withdrawal by Subject|1|||
105375017|NCT02394756|363379271|FG002|Period 1|Withdrawal by Subject|1|||
105329865|NCT03337113|363207428|FG000|Overall Study|Withdrawal by Subject|0|||
105329866|NCT03337113|363207429|FG001|Overall Study|Withdrawal by Subject|0|||
105329867|NCT03337113|363207430|FG002|Overall Study|Withdrawal by Subject|1|||
105329868|NCT03337113|363207431|FG003|Overall Study|Withdrawal by Subject|0|||
105329869|NCT02556775|363207433|FG000|Overall Study|Withdrawal by Subject|1|||
105375018|NCT02394756|363379272|FG003|Period 1|Withdrawal by Subject|1|||
105375019|NCT02394756|363379273|FG004|Period 1|Withdrawal by Subject|0|||
105375020|NCT02394756|363379274|FG005|Period 1|Withdrawal by Subject|0|||
105375021|NCT02394756|363379269|FG000|Period 2|Unsatisfactory Visual Response|0|||
105375022|NCT02394756|363379270|FG001|Period 2|Unsatisfactory Visual Response|0|||
105375023|NCT02394756|363379271|FG002|Period 2|Unsatisfactory Visual Response|0|||
105375024|NCT02394756|363379272|FG003|Period 2|Unsatisfactory Visual Response|0|||
105375025|NCT02394756|363379273|FG004|Period 2|Unsatisfactory Visual Response|1|||
105375026|NCT02394756|363379274|FG005|Period 2|Unsatisfactory Visual Response|0|||
105375027|NCT03801252|363381527|FG000|Overall Study|Protocol Violation|1|||
105375028|NCT03801252|363381528|FG001|Overall Study|Protocol Violation|2|||
105375029|NCT02471183|363381529|FG000|Main Treatment Period|Adverse Event|1|||
105375030|NCT02471183|363381529|FG000|Main Treatment Period|Withdrawal by Subject|1|||
105375031|NCT02471183|363381529|FG000|Extended Treatment Period|Lack of Efficacy|1|||
105329870|NCT02556775|363207434|FG001|Overall Study|Withdrawal by Subject|0|||
105329871|NCT02556775|363207435|FG002|Overall Study|Withdrawal by Subject|1|||
105375032|NCT01013753|363381531|FG000|Overall Study|Adverse Event|8|||
105375033|NCT01013753|363381531|FG000|Overall Study|Protocol Violation|3|||
105329872|NCT02556775|363207436|FG003|Overall Study|Withdrawal by Subject|0|||
105329873|NCT02556775|363207433|FG000|Overall Study|Lost to Follow-up|1|||
105329874|NCT02556775|363207434|FG001|Overall Study|Lost to Follow-up|0|||
105329875|NCT02556775|363207435|FG002|Overall Study|Lost to Follow-up|0|||
105375034|NCT01013753|363381531|FG000|Overall Study|Lost to Follow-up|1|||
105375035|NCT01013753|363381531|FG000|Overall Study|Withdrawal by Subject|2|||
105375036|NCT01013753|363381531|FG000|Overall Study|Other|2|||
105375037|NCT01432327|363381532|FG000|Posttest 3 Months|depression|3|||
105375038|NCT01432327|363381533|FG001|Posttest 3 Months|depression|0|||
105375039|NCT01432327|363381534|FG002|Posttest 3 Months|depression|0|||
105375040|NCT01432327|363381535|FG003|Posttest 3 Months|depression|0|||
105375041|NCT01432327|363381532|FG000|Posttest 3 Months|Lost to Follow-up|1|||
105375042|NCT01432327|363381533|FG001|Posttest 3 Months|Lost to Follow-up|0|||
105375043|NCT01432327|363381534|FG002|Posttest 3 Months|Lost to Follow-up|2|||
105375044|NCT01432327|363381535|FG003|Posttest 3 Months|Lost to Follow-up|1|||
105375045|NCT01432327|363381532|FG000|Posttest 3 Months|Allergic reaction|0|||
105375046|NCT01432327|363381533|FG001|Posttest 3 Months|Allergic reaction|2|||
105375047|NCT01432327|363381534|FG002|Posttest 3 Months|Allergic reaction|0|||
105375048|NCT01432327|363381535|FG003|Posttest 3 Months|Allergic reaction|0|||
105375049|NCT01432327|363381532|FG000|Posttest 6 Months|Lost to Follow-up|0|||
105375050|NCT01432327|363381533|FG001|Posttest 6 Months|Lost to Follow-up|0|||
105375051|NCT01432327|363381534|FG002|Posttest 6 Months|Lost to Follow-up|3|||
105375052|NCT01432327|363381535|FG003|Posttest 6 Months|Lost to Follow-up|2|||
105375053|NCT01432327|363381532|FG000|Posttest 6 Months|Allergic reaction|0|||
105375054|NCT01432327|363381533|FG001|Posttest 6 Months|Allergic reaction|0|||
105375055|NCT01432327|363381534|FG002|Posttest 6 Months|Allergic reaction|1|||
105375056|NCT01432327|363381535|FG003|Posttest 6 Months|Allergic reaction|0|||
105375057|NCT01432327|363381532|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
105375058|NCT01432327|363381533|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
105375059|NCT01432327|363381534|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
105375060|NCT01432327|363381535|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
105375061|NCT01432327|363381532|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
105375062|NCT01432327|363381533|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
105375063|NCT01432327|363381534|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
105375064|NCT01432327|363381535|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
105375065|NCT01432327|363381532|FG000|Posttest 1 Year|Lost to Follow-up|0|||
105375066|NCT01432327|363381533|FG001|Posttest 1 Year|Lost to Follow-up|0|||
105375067|NCT01432327|363381534|FG002|Posttest 1 Year|Lost to Follow-up|4|||
105375068|NCT01432327|363381535|FG003|Posttest 1 Year|Lost to Follow-up|2|||
105375069|NCT01432327|363381532|FG000|Posttest 1 Year|Allergic reaction|0|||
105375070|NCT01432327|363381533|FG001|Posttest 1 Year|Allergic reaction|0|||
105375071|NCT01432327|363381534|FG002|Posttest 1 Year|Allergic reaction|1|||
105375072|NCT01432327|363381535|FG003|Posttest 1 Year|Allergic reaction|1|||
105375073|NCT02097277|363381537|FG000|Overall Study|Subject no longer meets study criteria|0|||
105375074|NCT02097277|363381538|FG001|Overall Study|Subject no longer meets study criteria|1|||
105375075|NCT02097277|363381539|FG002|Overall Study|Subject no longer meets study criteria|0|||
105375076|NCT02097277|363381540|FG003|Overall Study|Subject no longer meets study criteria|1|||
105375077|NCT02097277|363381541|FG004|Overall Study|Subject no longer meets study criteria|0|||
105375078|NCT02097277|363381537|FG000|Overall Study|Subject request to discontinue treatment|0|||
105375079|NCT02097277|363381538|FG001|Overall Study|Subject request to discontinue treatment|0|||
105375080|NCT02097277|363381539|FG002|Overall Study|Subject request to discontinue treatment|0|||
105375081|NCT02097277|363381540|FG003|Overall Study|Subject request to discontinue treatment|0|||
105375082|NCT02097277|363381541|FG004|Overall Study|Subject request to discontinue treatment|1|||
105375083|NCT02097277|363381537|FG000|Overall Study|Lost to Follow-up|0|||
105375084|NCT02097277|363381538|FG001|Overall Study|Lost to Follow-up|1|||
105375085|NCT02097277|363381539|FG002|Overall Study|Lost to Follow-up|1|||
105375086|NCT02097277|363381540|FG003|Overall Study|Lost to Follow-up|0|||
105329876|NCT02556775|363207436|FG003|Overall Study|Lost to Follow-up|0|||
105329877|NCT02792062|363207437|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
105329878|NCT02792062|363207438|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
105329879|NCT02792062|363207439|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
105329880|NCT02792062|363207440|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
105329881|NCT02792062|363207441|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
105329882|NCT02792062|363207442|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
105329883|NCT03309943|363207443|FG000|Overall Study|Withdrawal by Subject|0|||
105329884|NCT03309943|363207444|FG001|Overall Study|Withdrawal by Subject|1|||
105329885|NCT03309943|363207443|FG000|Overall Study|Inappropriate behavior towards staff|0|||
105329886|NCT03309943|363207444|FG001|Overall Study|Inappropriate behavior towards staff|1|||
105329887|NCT03876743|363207445|FG000|Overall Study|Lost to Follow-up|6|||
105329888|NCT03876743|363207446|FG001|Overall Study|Lost to Follow-up|4|||
105329889|NCT03876743|363207447|FG002|Overall Study|Lost to Follow-up|4|||
105329890|NCT03876743|363207448|FG003|Overall Study|Lost to Follow-up|7|||
105329891|NCT02019264|363207449|FG000|Overall Study|Not treated|6|||
105329892|NCT02019264|363207450|FG001|Overall Study|Not treated|4|||
105329893|NCT02019264|363207449|FG000|Overall Study|Lost to Follow-up|50|||
105329894|NCT02019264|363207450|FG001|Overall Study|Lost to Follow-up|47|||
105329895|NCT02019264|363207449|FG000|Overall Study|Withdrawal by Subject|142|||
105329896|NCT02019264|363207450|FG001|Overall Study|Withdrawal by Subject|117|||
105329897|NCT02019264|363207449|FG000|Overall Study|Administrative reason|36|||
105329898|NCT02019264|363207450|FG001|Overall Study|Administrative reason|28|||
105375087|NCT02097277|363381541|FG004|Overall Study|Lost to Follow-up|0|||
105375088|NCT02097277|363381537|FG000|Overall Study|Withdrawal by Subject|2|||
105375089|NCT02097277|363381538|FG001|Overall Study|Withdrawal by Subject|1|||
105375090|NCT02097277|363381539|FG002|Overall Study|Withdrawal by Subject|0|||
105375091|NCT02097277|363381540|FG003|Overall Study|Withdrawal by Subject|1|||
105375092|NCT02097277|363381541|FG004|Overall Study|Withdrawal by Subject|0|||
105375093|NCT02097277|363381537|FG000|Overall Study|Adverse Event|0|||
105375094|NCT02097277|363381538|FG001|Overall Study|Adverse Event|0|||
105375095|NCT02097277|363381539|FG002|Overall Study|Adverse Event|1|||
105329899|NCT02019264|363207449|FG000|Overall Study|Missing|14|||
105329900|NCT02019264|363207450|FG001|Overall Study|Missing|11|||
105375096|NCT02097277|363381540|FG003|Overall Study|Adverse Event|2|||
105375097|NCT02097277|363381541|FG004|Overall Study|Adverse Event|0|||
105375098|NCT00577408|363381547|FG000|Overall Study|Stopped attending study visits|9|||
105375099|NCT00577408|363381548|FG001|Overall Study|Stopped attending study visits|11|||
105375100|NCT00577408|363381547|FG000|Overall Study|Continued opioid use|3|||
105375101|NCT00577408|363381548|FG001|Overall Study|Continued opioid use|2|||
105375102|NCT00577408|363381547|FG000|Overall Study|Non-compliance with study meds|0|||
105375103|NCT00577408|363381548|FG001|Overall Study|Non-compliance with study meds|3|||
105375104|NCT00577408|363381547|FG000|Overall Study|Refused Oral Naltrexone|0|||
105375105|NCT00577408|363381548|FG001|Overall Study|Refused Oral Naltrexone|1|||
105375106|NCT00577408|363381547|FG000|Overall Study|Moved out of state|0|||
105375107|NCT00577408|363381548|FG001|Overall Study|Moved out of state|1|||
105375108|NCT00577408|363381547|FG000|Overall Study|Scheduling Issues|0|||
105375109|NCT00577408|363381548|FG001|Overall Study|Scheduling Issues|3|||
105375110|NCT00577408|363381547|FG000|Overall Study|Death|0|||
105375111|NCT00577408|363381548|FG001|Overall Study|Death|1|||
105375112|NCT00577408|363381547|FG000|Overall Study|Psychiatric hospitalization|0|||
105375113|NCT00577408|363381548|FG001|Overall Study|Psychiatric hospitalization|1|||
105375114|NCT01091259|363381549|FG000|Overall Study|Adverse Event|3|||
105375115|NCT01091259|363381549|FG000|Overall Study|Lack of Efficacy|2|||
105375116|NCT03320369|363381550|FG000|Overall Study|Adverse Event|1|||
105375117|NCT03320369|363381550|FG000|Overall Study|Withdrawal by Subject|2|||
105375118|NCT02239328|363381555|FG000|Overall Study|Benign disease noted at time of surgery|6|||
105375119|NCT02239328|363381555|FG000|Overall Study|Equipment or website malfunction|2|||
105375120|NCT02412657|363381560|FG000|Overall Study|Lost to Follow-up|1|||
105375121|NCT02412657|363381561|FG001|Overall Study|Lost to Follow-up|0|||
105375122|NCT02412657|363381562|FG002|Overall Study|Lost to Follow-up|0|||
105375123|NCT02412657|363381560|FG000|Overall Study|Protocol Violation|0|||
105375124|NCT02412657|363381561|FG001|Overall Study|Protocol Violation|2|||
105375125|NCT02412657|363381562|FG002|Overall Study|Protocol Violation|3|||
105375126|NCT00460798|363381563|FG000|Overall Study|Death|59|||
105329901|NCT03321968|363207456|FG000|Overall Study|Withdrawal by Subject|1|||
105329902|NCT03321968|363207457|FG001|Overall Study|Withdrawal by Subject|2|||
105329903|NCT03321968|363207458|FG002|Overall Study|Withdrawal by Subject|1|||
105329904|NCT03321968|363207456|FG000|Overall Study|Lost to Follow-up|2|||
105329905|NCT03321968|363207457|FG001|Overall Study|Lost to Follow-up|0|||
105329906|NCT03321968|363207458|FG002|Overall Study|Lost to Follow-up|1|||
105329907|NCT03321968|363207456|FG000|Overall Study|Other than specified|0|||
105329908|NCT03321968|363207457|FG001|Overall Study|Other than specified|0|||
105329909|NCT03321968|363207458|FG002|Overall Study|Other than specified|1|||
105329910|NCT01737710|363207459|FG000|Overall Study|Lost to Follow-up|0|||
105329911|NCT01737710|363207460|FG001|Overall Study|Lost to Follow-up|2|||
105329912|NCT01737710|363207461|FG002|Overall Study|Lost to Follow-up|2|||
105329913|NCT01737710|363207462|FG003|Overall Study|Lost to Follow-up|0|||
105329914|NCT01737710|363207463|FG004|Overall Study|Lost to Follow-up|0|||
105329915|NCT01737710|363207459|FG000|Overall Study|Withdrawal by Subject|1|||
105329916|NCT01737710|363207460|FG001|Overall Study|Withdrawal by Subject|1|||
105329917|NCT01737710|363207461|FG002|Overall Study|Withdrawal by Subject|1|||
105329918|NCT01737710|363207462|FG003|Overall Study|Withdrawal by Subject|0|||
105329919|NCT01737710|363207463|FG004|Overall Study|Withdrawal by Subject|0|||
105329920|NCT01737710|363207459|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
105329921|NCT01737710|363207460|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
105329922|NCT01737710|363207461|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
105329923|NCT01737710|363207462|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
105329924|NCT01737710|363207463|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
105329925|NCT02155283|363207465|FG000|Overall Study|Lost to Follow-up|3|||
105577187|NCT01370603|364112204|FG000|Crossover Washout|Adverse Event|2|||
105577188|NCT01370603|364112205|FG001|Crossover Washout|Adverse Event|1|||
105577189|NCT01370603|364112204|FG000|Crossover Washout|Lost to Follow-up|2|||
105577190|NCT01370603|364112205|FG001|Crossover Washout|Lost to Follow-up|0|||
105577191|NCT01370603|364112204|FG000|Crossover Washout|Protocol Violation|1|||
105577192|NCT01370603|364112205|FG001|Crossover Washout|Protocol Violation|0|||
105577193|NCT01370603|364112204|FG000|Crossover Washout|Withdrawal by Subject|4|||
105577194|NCT01370603|364112205|FG001|Crossover Washout|Withdrawal by Subject|1|||
105577195|NCT01370603|364112204|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
105577196|NCT01370603|364112205|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
105577197|NCT01370603|364112204|FG000|Period 2|Adverse Event|1|||
105577198|NCT01370603|364112205|FG001|Period 2|Adverse Event|4|||
105577199|NCT01370603|364112204|FG000|Period 2|Lost to Follow-up|1|||
105577200|NCT01370603|364112205|FG001|Period 2|Lost to Follow-up|0|||
105577201|NCT01370603|364112204|FG000|Period 2|Withdrawal by Subject|1|||
105577202|NCT01370603|364112205|FG001|Period 2|Withdrawal by Subject|0|||
105577203|NCT00127413|364112206|FG000|Overall Study|Lost to Follow-up|6|||
105577204|NCT00127413|364112207|FG001|Overall Study|Lost to Follow-up|4|||
105577205|NCT00127413|364112208|FG002|Overall Study|Lost to Follow-up|8|||
105577206|NCT00127413|364112209|FG003|Overall Study|Lost to Follow-up|2|||
105577207|NCT05221749|364112210|FG000|Overall Study|Lost to Follow-up|2|||
105577208|NCT05221749|364112211|FG001|Overall Study|Lost to Follow-up|3|||
105577209|NCT01254890|364112213|FG000|Overall Study|Ineligible|0|||
105577210|NCT01254890|364112214|FG001|Overall Study|Ineligible|3|||
105577211|NCT01254890|364112213|FG000|Overall Study|Withdrawal by Subject|1|||
105577212|NCT01254890|364112214|FG001|Overall Study|Withdrawal by Subject|2|||
105577213|NCT01254890|364112213|FG000|Overall Study|Disease Progression|0|||
105577214|NCT01254890|364112214|FG001|Overall Study|Disease Progression|5|||
105577215|NCT04039503|364112216|FG000|Overall Study|Adverse Event|3|||
105577216|NCT04039503|364112217|FG001|Overall Study|Adverse Event|0|||
105577217|NCT04039503|364112218|FG002|Overall Study|Adverse Event|2|||
105577218|NCT04039503|364112219|FG003|Overall Study|Adverse Event|0|||
105577219|NCT04039503|364112216|FG000|Overall Study|Lost to Follow-up|0|||
105577220|NCT04039503|364112217|FG001|Overall Study|Lost to Follow-up|0|||
105577221|NCT04039503|364112218|FG002|Overall Study|Lost to Follow-up|1|||
105577222|NCT04039503|364112219|FG003|Overall Study|Lost to Follow-up|0|||
105577223|NCT04039503|364112216|FG000|Overall Study|Protocol Violation|0|||
105577224|NCT04039503|364112217|FG001|Overall Study|Protocol Violation|1|||
105577225|NCT04039503|364112218|FG002|Overall Study|Protocol Violation|2|||
105577226|NCT04039503|364112219|FG003|Overall Study|Protocol Violation|1|||
105577227|NCT04039503|364112216|FG000|Overall Study|Withdrawal by Subject|4|||
105577228|NCT04039503|364112217|FG001|Overall Study|Withdrawal by Subject|3|||
105577229|NCT04039503|364112218|FG002|Overall Study|Withdrawal by Subject|5|||
105577230|NCT04039503|364112219|FG003|Overall Study|Withdrawal by Subject|2|||
105577231|NCT02023879|364112220|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
105577232|NCT02023879|364112221|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
105577233|NCT02023879|364112222|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
105577234|NCT02023879|364112220|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
105577235|NCT02023879|364112221|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
105577236|NCT02023879|364112222|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
105577237|NCT02023879|364112220|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
105577238|NCT02023879|364112221|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
105375127|NCT00460798|363381563|FG000|Overall Study|Adverse Event|27|||
105375128|NCT00460798|363381563|FG000|Overall Study|Lost to Follow-up|19|||
105375129|NCT00460798|363381563|FG000|Overall Study|Progressive Disease|99|||
105375130|NCT00460798|363381563|FG000|Overall Study|Other|27|||
105375131|NCT00460798|363381563|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
105375132|NCT00460798|363381563|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
105375133|NCT00920816|363381564|FG000|Overall Study|Death|116|||
105375134|NCT00920816|363381565|FG001|Overall Study|Death|63|||
105375135|NCT00920816|363381566|FG002|Overall Study|Death|8|||
105375136|NCT00920816|363381567|FG003|Overall Study|Death|3|||
105375137|NCT00920816|363381564|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
105375138|NCT00920816|363381565|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
105375139|NCT00920816|363381566|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
105375140|NCT00920816|363381567|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
105375141|NCT00920816|363381564|FG000|Overall Study|Global deterioration of health status|2|||
105375142|NCT00920816|363381565|FG001|Overall Study|Global deterioration of health status|0|||
105375143|NCT00920816|363381566|FG002|Overall Study|Global deterioration of health status|0|||
105375144|NCT00920816|363381567|FG003|Overall Study|Global deterioration of health status|0|||
105375145|NCT00920816|363381564|FG000|Overall Study|Objective progression or relapse|6|||
105375146|NCT00920816|363381565|FG001|Overall Study|Objective progression or relapse|2|||
105375147|NCT00920816|363381566|FG002|Overall Study|Objective progression or relapse|0|||
105375148|NCT00920816|363381567|FG003|Overall Study|Objective progression or relapse|0|||
105375149|NCT00920816|363381564|FG000|Overall Study|Other|26|||
105375150|NCT00920816|363381565|FG001|Overall Study|Other|15|||
105375151|NCT00920816|363381566|FG002|Overall Study|Other|1|||
105375152|NCT00920816|363381567|FG003|Overall Study|Other|2|||
105375153|NCT00920816|363381564|FG000|Overall Study|Lost to Follow-up|11|||
105375154|NCT00920816|363381565|FG001|Overall Study|Lost to Follow-up|2|||
105375155|NCT00920816|363381566|FG002|Overall Study|Lost to Follow-up|0|||
105375156|NCT00920816|363381567|FG003|Overall Study|Lost to Follow-up|0|||
105375157|NCT00920816|363381564|FG000|Overall Study|Adverse Event|1|||
105375158|NCT00920816|363381565|FG001|Overall Study|Adverse Event|1|||
105375159|NCT00920816|363381566|FG002|Overall Study|Adverse Event|1|||
105375160|NCT00920816|363381567|FG003|Overall Study|Adverse Event|0|||
105375161|NCT00920816|363381564|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
105375162|NCT00920816|363381565|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
105375163|NCT00920816|363381566|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
105375164|NCT00920816|363381567|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
105375165|NCT00920816|363381564|FG000|Overall Study|Randomized but not treated|3|||
105375166|NCT00920816|363381565|FG001|Overall Study|Randomized but not treated|0|||
105375167|NCT00920816|363381566|FG002|Overall Study|Randomized but not treated|0|||
105375168|NCT00920816|363381567|FG003|Overall Study|Randomized but not treated|0|||
105375169|NCT01180777|363381572|FG000|Overall Study|Protocol Violation|6|||
105375170|NCT01180777|363381572|FG000|Overall Study|Poor lens fit|4|||
105375171|NCT01180777|363381572|FG000|Overall Study|Lost to Follow-up|1|||
105375172|NCT01180777|363381572|FG000|Overall Study|Adverse Event|1|||
105375173|NCT01281306|363381573|FG000|Overall Study|Lack of Efficacy|0|||
105375174|NCT01281306|363381574|FG001|Overall Study|Lack of Efficacy|1|||
105375175|NCT01281306|363381575|FG002|Overall Study|Lack of Efficacy|3|||
105375176|NCT01281306|363381576|FG003|Overall Study|Lack of Efficacy|0|||
105375177|NCT01281306|363381577|FG004|Overall Study|Lack of Efficacy|2|||
105375178|NCT01281306|363381578|FG005|Overall Study|Lack of Efficacy|0|||
105375179|NCT01281306|363381579|FG006|Overall Study|Lack of Efficacy|1|||
105375180|NCT01281306|363381573|FG000|Overall Study|Withdrawal by Subject|1|||
105375181|NCT01281306|363381574|FG001|Overall Study|Withdrawal by Subject|0|||
105375182|NCT01281306|363381575|FG002|Overall Study|Withdrawal by Subject|2|||
105375183|NCT01281306|363381576|FG003|Overall Study|Withdrawal by Subject|4|||
105375184|NCT01281306|363381577|FG004|Overall Study|Withdrawal by Subject|1|||
105375185|NCT01281306|363381578|FG005|Overall Study|Withdrawal by Subject|3|||
105375186|NCT01281306|363381579|FG006|Overall Study|Withdrawal by Subject|1|||
105375187|NCT01281306|363381573|FG000|Overall Study|Protocol deviation|0|||
105375188|NCT01281306|363381574|FG001|Overall Study|Protocol deviation|1|||
105375189|NCT01281306|363381575|FG002|Overall Study|Protocol deviation|1|||
105375190|NCT01281306|363381576|FG003|Overall Study|Protocol deviation|1|||
105375191|NCT01281306|363381577|FG004|Overall Study|Protocol deviation|1|||
105375192|NCT01281306|363381578|FG005|Overall Study|Protocol deviation|0|||
105375193|NCT01281306|363381579|FG006|Overall Study|Protocol deviation|0|||
105375194|NCT01281306|363381573|FG000|Overall Study|Condition no longer requires study drug|1|||
105375195|NCT01281306|363381574|FG001|Overall Study|Condition no longer requires study drug|0|||
105375196|NCT01281306|363381575|FG002|Overall Study|Condition no longer requires study drug|0|||
105375197|NCT01281306|363381576|FG003|Overall Study|Condition no longer requires study drug|0|||
105375198|NCT01281306|363381577|FG004|Overall Study|Condition no longer requires study drug|0|||
105375199|NCT01281306|363381578|FG005|Overall Study|Condition no longer requires study drug|1|||
105375200|NCT01281306|363381579|FG006|Overall Study|Condition no longer requires study drug|1|||
105375201|NCT01281306|363381573|FG000|Overall Study|Lost to Follow-up|1|||
105375202|NCT01281306|363381574|FG001|Overall Study|Lost to Follow-up|0|||
105375203|NCT01281306|363381575|FG002|Overall Study|Lost to Follow-up|0|||
105375204|NCT01281306|363381576|FG003|Overall Study|Lost to Follow-up|2|||
105375205|NCT01281306|363381577|FG004|Overall Study|Lost to Follow-up|0|||
105375206|NCT01281306|363381578|FG005|Overall Study|Lost to Follow-up|0|||
105375207|NCT01281306|363381579|FG006|Overall Study|Lost to Follow-up|1|||
105375208|NCT01281306|363381573|FG000|Overall Study|Death|1|||
105375209|NCT01281306|363381574|FG001|Overall Study|Death|0|||
105375210|NCT01281306|363381575|FG002|Overall Study|Death|0|||
105375211|NCT01281306|363381576|FG003|Overall Study|Death|0|||
105375212|NCT01281306|363381577|FG004|Overall Study|Death|0|||
105375213|NCT01281306|363381578|FG005|Overall Study|Death|0|||
105375214|NCT01281306|363381579|FG006|Overall Study|Death|0|||
105375215|NCT01281306|363381573|FG000|Overall Study|Adverse Event|3|||
105375216|NCT01281306|363381574|FG001|Overall Study|Adverse Event|2|||
105375217|NCT01281306|363381575|FG002|Overall Study|Adverse Event|2|||
105375218|NCT01281306|363381576|FG003|Overall Study|Adverse Event|3|||
105375219|NCT01281306|363381577|FG004|Overall Study|Adverse Event|5|||
105375220|NCT01281306|363381578|FG005|Overall Study|Adverse Event|3|||
105375221|NCT01281306|363381579|FG006|Overall Study|Adverse Event|3|||
105375222|NCT01281306|363381573|FG000|Overall Study|Randomized in error|1|||
105375223|NCT01281306|363381574|FG001|Overall Study|Randomized in error|0|||
105375224|NCT01281306|363381575|FG002|Overall Study|Randomized in error|0|||
105375225|NCT01281306|363381576|FG003|Overall Study|Randomized in error|1|||
105375226|NCT01281306|363381577|FG004|Overall Study|Randomized in error|0|||
105375227|NCT01281306|363381578|FG005|Overall Study|Randomized in error|0|||
105375228|NCT01281306|363381579|FG006|Overall Study|Randomized in error|0|||
105375229|NCT04115059|363381580|FG000|Overall Study|Withdrawal by Subject|1|||
105375230|NCT04115059|363381580|FG000|Overall Study|Lack of Efficacy|2|||
105375231|NCT04167462|363381586|FG000|Overall Study|Other reasons|3|||
105375232|NCT04167462|363381587|FG001|Overall Study|Other reasons|2|||
105375233|NCT04167462|363381586|FG000|Overall Study|Withdrawal by Subject|6|||
105375234|NCT04167462|363381587|FG001|Overall Study|Withdrawal by Subject|7|||
105375235|NCT04167462|363381586|FG000|Overall Study|Adverse Event|4|||
105577239|NCT02023879|364112222|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
105577240|NCT02023879|364112220|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
105577241|NCT02023879|364112221|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
105577242|NCT02023879|364112222|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
105577243|NCT02023879|364112220|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
105577244|NCT02023879|364112221|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
105577245|NCT02023879|364112222|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
105577246|NCT02023879|364112220|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
105577247|NCT02023879|364112221|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
105577248|NCT02023879|364112222|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
105577249|NCT02023879|364112220|FG000|Extension Open Label Treatment|Adverse Event|1|||
105577250|NCT02023879|364112221|FG001|Extension Open Label Treatment|Adverse Event|7|||
105577251|NCT02023879|364112222|FG002|Extension Open Label Treatment|Adverse Event|3|||
105577252|NCT02023879|364112220|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
105375236|NCT04167462|363381587|FG001|Overall Study|Adverse Event|0|||
105375237|NCT04167462|363381586|FG000|Overall Study|Pregnancy|1|||
105375238|NCT04167462|363381587|FG001|Overall Study|Pregnancy|0|||
105375239|NCT04167462|363381586|FG000|Overall Study|Lack of Efficacy|0|||
105375240|NCT04167462|363381587|FG001|Overall Study|Lack of Efficacy|1|||
105375241|NCT03331562|363381588|FG000|Overall Study|Adverse Event|2|||
105375242|NCT03331562|363381589|FG001|Overall Study|Adverse Event|0|||
105375243|NCT03331562|363381588|FG000|Overall Study|Death|1|||
105375244|NCT03331562|363381589|FG001|Overall Study|Death|0|||
105375245|NCT03718000|363381590|FG000|Overall Study|Relocation|2|||
105375246|NCT03718000|363381591|FG001|Overall Study|Relocation|4|||
105375247|NCT03718000|363381590|FG000|Overall Study|Pregnancy|0|||
105375248|NCT03718000|363381591|FG001|Overall Study|Pregnancy|1|||
105375249|NCT00630292|363381594|FG000|Overall Study|Withdrawal by Subject|1|||
105375250|NCT01582451|363381595|FG000|Overall Study|Adverse Event|1|||
105375251|NCT01582451|363381596|FG001|Overall Study|Adverse Event|3|||
105375252|NCT01582451|363381595|FG000|Overall Study|Death|3|||
105375253|NCT01582451|363381596|FG001|Overall Study|Death|3|||
105375254|NCT01582451|363381595|FG000|Overall Study|Lost to Follow-up|0|||
105375255|NCT01582451|363381596|FG001|Overall Study|Lost to Follow-up|2|||
105375256|NCT01582451|363381595|FG000|Overall Study|Protocol Violation|11|||
105375257|NCT01582451|363381596|FG001|Overall Study|Protocol Violation|3|||
105375258|NCT01582451|363381595|FG000|Overall Study|Withdrawal by Subject|13|||
105375259|NCT01582451|363381596|FG001|Overall Study|Withdrawal by Subject|9|||
105375260|NCT01582451|363381595|FG000|Overall Study|Physician Decision|3|||
105375261|NCT01582451|363381596|FG001|Overall Study|Physician Decision|0|||
105375262|NCT01582451|363381595|FG000|Overall Study|Sponsor Decision|1|||
105375263|NCT01582451|363381596|FG001|Overall Study|Sponsor Decision|0|||
105375264|NCT03620162|363381597|FG000|Overall Study|Physician Decision|4|||
105375265|NCT03620162|363381598|FG001|Overall Study|Physician Decision|0|||
105375266|NCT03620162|363381599|FG002|Overall Study|Physician Decision|1|||
105375267|NCT03620162|363381600|FG003|Overall Study|Physician Decision|0|||
105375268|NCT03620162|363381601|FG004|Overall Study|Physician Decision|2|||
105375269|NCT03620162|363381597|FG000|Overall Study|Lost to Follow-up|2|||
105375270|NCT03620162|363381598|FG001|Overall Study|Lost to Follow-up|6|||
105375271|NCT03620162|363381599|FG002|Overall Study|Lost to Follow-up|7|||
105375272|NCT03620162|363381600|FG003|Overall Study|Lost to Follow-up|3|||
105375273|NCT03620162|363381601|FG004|Overall Study|Lost to Follow-up|2|||
105375274|NCT03620162|363381597|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
105375275|NCT03620162|363381598|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
105375276|NCT03620162|363381599|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
105375277|NCT03620162|363381600|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
105375278|NCT03620162|363381601|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
105375279|NCT00487188|363381604|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
105375280|NCT00487188|363381605|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
105375281|NCT00487188|363381606|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
105375282|NCT00487188|363381604|FG000|Induction Phase|Adverse Event|5|||
105375283|NCT00487188|363381605|FG001|Induction Phase|Adverse Event|0|||
105375284|NCT00487188|363381606|FG002|Induction Phase|Adverse Event|0|||
105375285|NCT00487188|363381604|FG000|Induction Phase|Lack of Efficacy|0|||
105375286|NCT00487188|363381605|FG001|Induction Phase|Lack of Efficacy|1|||
105375287|NCT00487188|363381606|FG002|Induction Phase|Lack of Efficacy|0|||
105375288|NCT00487188|363381604|FG000|Induction Phase|Protocol Violation|1|||
105375289|NCT00487188|363381605|FG001|Induction Phase|Protocol Violation|0|||
105375290|NCT00487188|363381606|FG002|Induction Phase|Protocol Violation|0|||
105375291|NCT00487188|363381604|FG000|Induction Phase|Refused Treatment|1|||
105375292|NCT00487188|363381605|FG001|Induction Phase|Refused Treatment|2|||
105375293|NCT00487188|363381606|FG002|Induction Phase|Refused Treatment|0|||
105375294|NCT00487188|363381604|FG000|Induction Phase|Lost to Follow-up|2|||
105375295|NCT00487188|363381605|FG001|Induction Phase|Lost to Follow-up|2|||
105577253|NCT02023879|364112221|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
105577254|NCT02023879|364112222|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
105577255|NCT02023879|364112220|FG000|Extension Open Label Treatment|Participant moved|1|||
105577256|NCT02023879|364112221|FG001|Extension Open Label Treatment|Participant moved|2|||
105577257|NCT02023879|364112222|FG002|Extension Open Label Treatment|Participant moved|0|||
105577258|NCT02023879|364112220|FG000|Extension Open Label Treatment|Other than specified above|2|||
105577259|NCT02023879|364112221|FG001|Extension Open Label Treatment|Other than specified above|7|||
105577260|NCT02023879|364112222|FG002|Extension Open Label Treatment|Other than specified above|2|||
105577261|NCT03363659|364112223|FG000|Overall Study|Adverse Event|1|||
105577262|NCT03363659|364112223|FG000|Overall Study|Screen fail|1|||
105577263|NCT03363659|364112223|FG000|Overall Study|Withdrawal by Subject|1|||
105577264|NCT03857841|364112224|FG000|Overall Study|Death|1|||
105577265|NCT03857841|364112225|FG001|Overall Study|Death|0|||
105577266|NCT03857841|364112226|FG002|Overall Study|Death|0|||
105577267|NCT03857841|364112227|FG003|Overall Study|Death|0|||
105577268|NCT03857841|364112224|FG000|Overall Study|Study Terminated by Sponsor|1|||
105577269|NCT03857841|364112225|FG001|Overall Study|Study Terminated by Sponsor|0|||
105577270|NCT03857841|364112226|FG002|Overall Study|Study Terminated by Sponsor|0|||
105577271|NCT03857841|364112227|FG003|Overall Study|Study Terminated by Sponsor|0|||
105577272|NCT04249336|364114398|FG000|Overall Study|Lost to Follow-up|3|||
105577273|NCT04249336|364114399|FG001|Overall Study|Lost to Follow-up|3|||
105577274|NCT04249336|364114400|FG002|Overall Study|Lost to Follow-up|3|||
105577275|NCT04249336|364114401|FG003|Overall Study|Lost to Follow-up|3|||
105577276|NCT01242176|364114402|FG000|Washout Period of 7 Days|Adverse Event|0|||
105577277|NCT01242176|364114403|FG001|Washout Period of 7 Days|Adverse Event|2|||
105577278|NCT01242176|364114402|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
105375296|NCT00487188|363381606|FG002|Induction Phase|Lost to Follow-up|0|||
105375297|NCT00487188|363381604|FG000|Induction Phase|Administrative|0|||
105375298|NCT00487188|363381605|FG001|Induction Phase|Administrative|1|||
105375299|NCT00487188|363381606|FG002|Induction Phase|Administrative|0|||
105375300|NCT00487188|363381604|FG000|Maintenance Phase|Adverse Event|1|||
105375301|NCT00487188|363381605|FG001|Maintenance Phase|Adverse Event|0|||
105577279|NCT01242176|364114403|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
105577280|NCT00744237|364114405|FG000|Overall Study|Lack of Efficacy|1|||
105577281|NCT00744237|364114406|FG001|Overall Study|Lack of Efficacy|1|||
105577282|NCT00744237|364114407|FG002|Overall Study|Lack of Efficacy|0|||
105577283|NCT00744237|364114405|FG000|Overall Study|Withdrawal by Subject|9|||
105577284|NCT00744237|364114406|FG001|Overall Study|Withdrawal by Subject|5|||
105577285|NCT00744237|364114407|FG002|Overall Study|Withdrawal by Subject|3|||
105577286|NCT00744237|364114405|FG000|Overall Study|Lost to Follow-up|1|||
105577287|NCT00744237|364114406|FG001|Overall Study|Lost to Follow-up|1|||
105329926|NCT02155283|363207465|FG000|Overall Study|Withdrawal by Subject|1|||
105329927|NCT02155283|363207465|FG000|Overall Study|Protocol Violation|3|||
105329928|NCT00954941|363207467|FG000|Overall Study|Received treatment at home|1|||
105329929|NCT00954941|363207468|FG001|Overall Study|Received treatment at home|0|||
105329930|NCT00954941|363207467|FG000|Overall Study|Withdrawal by Subject|1|||
105329931|NCT00954941|363207468|FG001|Overall Study|Withdrawal by Subject|0|||
105329932|NCT00954941|363207467|FG000|Overall Study|Insurance Denial|2|||
105577288|NCT00744237|364114407|FG002|Overall Study|Lost to Follow-up|1|||
105577289|NCT00744237|364114405|FG000|Overall Study|Protocol Violation|3|||
105577290|NCT00744237|364114406|FG001|Overall Study|Protocol Violation|4|||
105577291|NCT00744237|364114407|FG002|Overall Study|Protocol Violation|3|||
105577292|NCT00744237|364114405|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
105577293|NCT00744237|364114406|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
105577294|NCT00744237|364114407|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
105577295|NCT00744237|364114405|FG000|Overall Study|Dosing Error|1|||
105577296|NCT00744237|364114406|FG001|Overall Study|Dosing Error|0|||
105577297|NCT00744237|364114407|FG002|Overall Study|Dosing Error|1|||
105577298|NCT00744237|364114405|FG000|Overall Study|Study Drug Error|1|||
105577299|NCT00744237|364114406|FG001|Overall Study|Study Drug Error|0|||
105577300|NCT00744237|364114407|FG002|Overall Study|Study Drug Error|0|||
105577301|NCT00744237|364114405|FG000|Overall Study|Prohibited Concomitant Medication|0|||
105577302|NCT00744237|364114406|FG001|Overall Study|Prohibited Concomitant Medication|0|||
105577303|NCT00744237|364114407|FG002|Overall Study|Prohibited Concomitant Medication|1|||
105577304|NCT00744237|364114405|FG000|Overall Study|Poor Compliance|0|||
105577305|NCT00744237|364114406|FG001|Overall Study|Poor Compliance|2|||
105577306|NCT00744237|364114407|FG002|Overall Study|Poor Compliance|0|||
105577307|NCT00744237|364114405|FG000|Overall Study|Administrative. Site Closed|1|||
105577308|NCT00744237|364114406|FG001|Overall Study|Administrative. Site Closed|1|||
105577309|NCT00744237|364114407|FG002|Overall Study|Administrative. Site Closed|1|||
105577310|NCT00744237|364114405|FG000|Overall Study|Adverse Event|9|||
105577311|NCT00744237|364114406|FG001|Overall Study|Adverse Event|13|||
105577312|NCT00744237|364114407|FG002|Overall Study|Adverse Event|5|||
105577313|NCT01995357|364114408|FG000|Period 5|Lack of Efficacy|1|||
105577314|NCT01995357|364114409|FG001|Period 5|Lack of Efficacy|0|||
105577315|NCT01995357|364114410|FG002|Period 5|Lack of Efficacy|0|||
105577316|NCT01995357|364114411|FG003|Period 5|Lack of Efficacy|0|||
105577317|NCT01995357|364114412|FG004|Period 5|Lack of Efficacy|0|||
105577318|NCT01995357|364114413|FG005|Period 5|Lack of Efficacy|0|||
105577319|NCT01995357|364114408|FG000|Period 5|Adverse Event|1|||
105577320|NCT01995357|364114409|FG001|Period 5|Adverse Event|0|||
105577321|NCT01995357|364114410|FG002|Period 5|Adverse Event|1|||
105577322|NCT01995357|364114411|FG003|Period 5|Adverse Event|0|||
105577323|NCT01995357|364114412|FG004|Period 5|Adverse Event|0|||
105577324|NCT01995357|364114413|FG005|Period 5|Adverse Event|0|||
105577325|NCT01807221|364114415|FG000|Overall Study|Progressive disease|1|||
105577326|NCT01807221|364114416|FG001|Overall Study|Progressive disease|0|||
105577327|NCT01807221|364114417|FG002|Overall Study|Progressive disease|1|||
105329933|NCT00954941|363207468|FG001|Overall Study|Insurance Denial|2|||
105375302|NCT00487188|363381606|FG002|Maintenance Phase|Adverse Event|0|||
105375303|NCT00487188|363381604|FG000|Maintenance Phase|Death|1|||
105375304|NCT00487188|363381605|FG001|Maintenance Phase|Death|0|||
105375305|NCT00487188|363381606|FG002|Maintenance Phase|Death|0|||
105375306|NCT00487188|363381604|FG000|Maintenance Phase|Lost to Follow-up|1|||
105375307|NCT00487188|363381605|FG001|Maintenance Phase|Lost to Follow-up|0|||
105375308|NCT00487188|363381606|FG002|Maintenance Phase|Lost to Follow-up|0|||
105375309|NCT00487188|363381604|FG000|Maintenance Phase|Administrative|0|||
105375310|NCT00487188|363381605|FG001|Maintenance Phase|Administrative|0|||
105375311|NCT00487188|363381606|FG002|Maintenance Phase|Administrative|1|||
105375312|NCT02472353|363381608|FG000|Overall Study|Lost to Follow-up|1|||
105375313|NCT02472353|363381609|FG001|Overall Study|Lost to Follow-up|1|||
105375314|NCT02472353|363381608|FG000|Overall Study|Withdrawal by Subject|2|||
105375315|NCT02472353|363381609|FG001|Overall Study|Withdrawal by Subject|1|||
105375316|NCT02472353|363381608|FG000|Overall Study|Study Termination|1|||
105375317|NCT02472353|363381609|FG001|Overall Study|Study Termination|4|||
105375318|NCT02101294|363381610|FG000|Overall Study|Withdrawal by Subject|5|||
105375319|NCT02101294|363381610|FG000|Overall Study|Lost to Follow-up|6|||
105375320|NCT03416179|363381611|FG000|Overall Study|Death|90|||
105329934|NCT00954941|363207467|FG000|Overall Study|Physician Decision|2|||
105329935|NCT00954941|363207468|FG001|Overall Study|Physician Decision|2|||
105329936|NCT00954941|363207467|FG000|Overall Study|Ineligible|2|||
105375321|NCT03416179|363381612|FG001|Overall Study|Death|87|||
105329937|NCT00954941|363207468|FG001|Overall Study|Ineligible|2|||
105375322|NCT03416179|363381613|FG002|Overall Study|Death|117|||
105375323|NCT03416179|363381614|FG003|Overall Study|Death|113|||
105577328|NCT01807221|364114418|FG003|Overall Study|Progressive disease|0|||
105577329|NCT01807221|364114419|FG004|Overall Study|Progressive disease|0|||
105577330|NCT01807221|364114420|FG005|Overall Study|Progressive disease|0|||
105577331|NCT01807221|364114415|FG000|Overall Study|Death|7|||
105577332|NCT01807221|364114416|FG001|Overall Study|Death|9|||
105577333|NCT01807221|364114417|FG002|Overall Study|Death|4|||
105577334|NCT01807221|364114418|FG003|Overall Study|Death|2|||
105375324|NCT03416179|363381611|FG000|Overall Study|Withdrawal by Subject|15|||
105375325|NCT03416179|363381612|FG001|Overall Study|Withdrawal by Subject|20|||
105375326|NCT03416179|363381613|FG002|Overall Study|Withdrawal by Subject|6|||
105375327|NCT03416179|363381614|FG003|Overall Study|Withdrawal by Subject|9|||
105577335|NCT01807221|364114419|FG004|Overall Study|Death|1|||
105577336|NCT01807221|364114420|FG005|Overall Study|Death|6|||
105577337|NCT01807221|364114415|FG000|Overall Study|Physician Decision|2|||
105577338|NCT01807221|364114416|FG001|Overall Study|Physician Decision|1|||
105577339|NCT01807221|364114417|FG002|Overall Study|Physician Decision|0|||
105577340|NCT01807221|364114418|FG003|Overall Study|Physician Decision|0|||
105577341|NCT01807221|364114419|FG004|Overall Study|Physician Decision|0|||
105577342|NCT01807221|364114420|FG005|Overall Study|Physician Decision|0|||
105577343|NCT01807221|364114415|FG000|Overall Study|Adverse Event|33|||
105577344|NCT01807221|364114416|FG001|Overall Study|Adverse Event|22|||
105577345|NCT01807221|364114417|FG002|Overall Study|Adverse Event|26|||
105577346|NCT01807221|364114418|FG003|Overall Study|Adverse Event|25|||
105577347|NCT01807221|364114419|FG004|Overall Study|Adverse Event|18|||
105577348|NCT01807221|364114420|FG005|Overall Study|Adverse Event|21|||
105577349|NCT01807221|364114415|FG000|Overall Study|Protocol Violation|0|||
105577350|NCT01807221|364114416|FG001|Overall Study|Protocol Violation|2|||
105577351|NCT01807221|364114417|FG002|Overall Study|Protocol Violation|1|||
105577352|NCT01807221|364114418|FG003|Overall Study|Protocol Violation|2|||
105577353|NCT01807221|364114419|FG004|Overall Study|Protocol Violation|0|||
105577354|NCT01807221|364114420|FG005|Overall Study|Protocol Violation|1|||
105577355|NCT01807221|364114415|FG000|Overall Study|Non-compliance|1|||
105577356|NCT01807221|364114416|FG001|Overall Study|Non-compliance|2|||
105577357|NCT01807221|364114417|FG002|Overall Study|Non-compliance|0|||
105577358|NCT01807221|364114418|FG003|Overall Study|Non-compliance|1|||
105577359|NCT01807221|364114419|FG004|Overall Study|Non-compliance|0|||
105577360|NCT01807221|364114420|FG005|Overall Study|Non-compliance|0|||
105577361|NCT01807221|364114415|FG000|Overall Study|Logistical difficulties|0|||
105577362|NCT01807221|364114416|FG001|Overall Study|Logistical difficulties|1|||
105577363|NCT01807221|364114417|FG002|Overall Study|Logistical difficulties|0|||
105577364|NCT01807221|364114418|FG003|Overall Study|Logistical difficulties|0|||
105577365|NCT01807221|364114419|FG004|Overall Study|Logistical difficulties|1|||
105577366|NCT01807221|364114420|FG005|Overall Study|Logistical difficulties|0|||
105577367|NCT01807221|364114415|FG000|Overall Study|Withdrawal by Subject|33|||
105577368|NCT01807221|364114416|FG001|Overall Study|Withdrawal by Subject|15|||
105577369|NCT01807221|364114417|FG002|Overall Study|Withdrawal by Subject|8|||
105577370|NCT01807221|364114418|FG003|Overall Study|Withdrawal by Subject|14|||
105577371|NCT01807221|364114419|FG004|Overall Study|Withdrawal by Subject|16|||
105577372|NCT01807221|364114420|FG005|Overall Study|Withdrawal by Subject|13|||
105577373|NCT01807221|364114415|FG000|Overall Study|Sponsor decision|2|||
105577374|NCT01807221|364114416|FG001|Overall Study|Sponsor decision|0|||
105577375|NCT01807221|364114417|FG002|Overall Study|Sponsor decision|1|||
105577376|NCT01807221|364114418|FG003|Overall Study|Sponsor decision|1|||
105577377|NCT01807221|364114419|FG004|Overall Study|Sponsor decision|0|||
105577378|NCT01807221|364114420|FG005|Overall Study|Sponsor decision|0|||
105577379|NCT01807221|364114415|FG000|Overall Study|Lost to Follow-up|1|||
105577380|NCT01807221|364114416|FG001|Overall Study|Lost to Follow-up|0|||
105577381|NCT01807221|364114417|FG002|Overall Study|Lost to Follow-up|2|||
105577382|NCT01807221|364114418|FG003|Overall Study|Lost to Follow-up|1|||
105577383|NCT01807221|364114419|FG004|Overall Study|Lost to Follow-up|0|||
105577384|NCT01807221|364114420|FG005|Overall Study|Lost to Follow-up|0|||
105577385|NCT02609659|364114421|FG000|Overall Study|Adverse Event|1|||
105577386|NCT02609659|364114421|FG000|Overall Study|Lost to Follow-up|6|||
105577387|NCT02609659|364114421|FG000|Overall Study|Other|1|||
105577388|NCT03545113|364114422|FG000|Overall Study|Surgery Cancelled|1|||
105577389|NCT03545113|364114423|FG001|Overall Study|Surgery Cancelled|0|||
105577390|NCT03545113|364114422|FG000|Overall Study|Death|1|||
105577391|NCT03545113|364114423|FG001|Overall Study|Death|0|||
105577392|NCT03545113|364114422|FG000|Overall Study|Adverse Event|2|||
105577393|NCT03545113|364114423|FG001|Overall Study|Adverse Event|0|||
105577394|NCT03545113|364114422|FG000|Overall Study|Received different surgery|1|||
105577395|NCT03545113|364114423|FG001|Overall Study|Received different surgery|0|||
105375328|NCT03416179|363381611|FG000|Overall Study|Lost to Follow-up|1|||
105577396|NCT01017120|364114428|FG000|Overall Study|Adverse Event|9|||
105375329|NCT03416179|363381612|FG001|Overall Study|Lost to Follow-up|1|||
105375330|NCT03416179|363381613|FG002|Overall Study|Lost to Follow-up|0|||
105375331|NCT03416179|363381614|FG003|Overall Study|Lost to Follow-up|3|||
105577397|NCT01017120|364114429|FG001|Overall Study|Adverse Event|0|||
105577398|NCT01017120|364114428|FG000|Overall Study|Lost to Follow-up|13|||
105577399|NCT01017120|364114429|FG001|Overall Study|Lost to Follow-up|11|||
105577400|NCT01017120|364114428|FG000|Overall Study|Lack of Efficacy|1|||
105577401|NCT01017120|364114429|FG001|Overall Study|Lack of Efficacy|0|||
105577402|NCT01017120|364114428|FG000|Overall Study|Withdrawal by Subject|39|||
105577403|NCT01017120|364114429|FG001|Overall Study|Withdrawal by Subject|21|||
105577404|NCT01017120|364114428|FG000|Overall Study|Pregnancy|1|||
105577405|NCT01017120|364114429|FG001|Overall Study|Pregnancy|1|||
105577406|NCT01017120|364114428|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
105577407|NCT01017120|364114429|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
105577408|NCT01017120|364114428|FG000|Overall Study|Relocated Out of Town|0|||
105577409|NCT01017120|364114429|FG001|Overall Study|Relocated Out of Town|2|||
105577410|NCT01017120|364114428|FG000|Overall Study|Protocol Violation|1|||
105577411|NCT01017120|364114429|FG001|Overall Study|Protocol Violation|0|||
105577412|NCT01017120|364114428|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
105577413|NCT01017120|364114429|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
105577414|NCT00432835|364114432|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
105577415|NCT00432835|364114433|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
105577416|NCT02091869|364114441|FG000|Overall Study|Withdrawal by Subject|0|||
105577417|NCT02091869|364114442|FG001|Overall Study|Withdrawal by Subject|3|||
105577418|NCT01024959|364114450|FG000|Overall Study|ineligible|12|||
105577419|NCT01024959|364114450|FG000|Overall Study|results not evaluable|12|||
105577420|NCT01024959|364114450|FG000|Overall Study|missing results required for analysis|17|||
105577421|NCT00594906|364114457|FG000|Overall Study|Physician Decision|1|||
105577422|NCT00594906|364114458|FG001|Overall Study|Physician Decision|0|||
105577423|NCT00594906|364114457|FG000|Overall Study|Physician Decision|0|||
105577424|NCT00594906|364114458|FG001|Overall Study|Physician Decision|1|||
105577425|NCT00594906|364114457|FG000|Overall Study|Death|0|||
105577426|NCT00594906|364114458|FG001|Overall Study|Death|1|||
105577427|NCT00839917|364114459|FG000|Overall Study|Lost to Follow-up|1|||
105577428|NCT00839917|364114460|FG001|Overall Study|Lost to Follow-up|0|||
105577429|NCT00839917|364114459|FG000|Overall Study|Did not receive vaccine|0|||
105577430|NCT00839917|364114460|FG001|Overall Study|Did not receive vaccine|1|||
105577431|NCT01129336|364114461|FG000|Overall Study|Protocol Violation|1|||
105577432|NCT01129336|364114462|FG001|Overall Study|Protocol Violation|0|||
105577433|NCT01129336|364114461|FG000|Overall Study|Disease Progression|1|||
105577434|NCT01129336|364114462|FG001|Overall Study|Disease Progression|4|||
105577435|NCT01129336|364114461|FG000|Overall Study|Lost to Follow-up|1|||
105577436|NCT01129336|364114462|FG001|Overall Study|Lost to Follow-up|0|||
105577437|NCT01129336|364114461|FG000|Overall Study|Withdrawal by Subject|7|||
105577438|NCT01129336|364114462|FG001|Overall Study|Withdrawal by Subject|4|||
105577439|NCT01129336|364114461|FG000|Overall Study|Adverse Event|0|||
105577440|NCT01129336|364114462|FG001|Overall Study|Adverse Event|1|||
105577441|NCT01129336|364114461|FG000|Overall Study|Missing Study Completion Status|2|||
105577442|NCT01129336|364114462|FG001|Overall Study|Missing Study Completion Status|3|||
105577443|NCT01129336|364114461|FG000|Overall Study|Death|0|||
105577444|NCT01129336|364114462|FG001|Overall Study|Death|4|||
105577445|NCT01950273|364114463|FG000|Overall Study|Protocol Violation|1|||
105577446|NCT01950273|364114464|FG001|Overall Study|Protocol Violation|0|||
105577447|NCT01950273|364114463|FG000|Overall Study|Withdrawal by Subject|2|||
105577448|NCT01950273|364114464|FG001|Overall Study|Withdrawal by Subject|0|||
105577449|NCT01950273|364114463|FG000|Overall Study|Other not defined above|1|||
105577450|NCT01950273|364114464|FG001|Overall Study|Other not defined above|0|||
105577451|NCT00472186|364114465|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
105577452|NCT00472186|364114466|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
105577453|NCT01254565|364114467|FG000|Overall Study|Non-compliance to Study Procedures|0|||
105577454|NCT01254565|364114468|FG001|Overall Study|Non-compliance to Study Procedures|0|||
105577455|NCT01254565|364114469|FG002|Overall Study|Non-compliance to Study Procedures|0|||
105577456|NCT01254565|364114470|FG003|Overall Study|Non-compliance to Study Procedures|0|||
105577457|NCT01254565|364114471|FG004|Overall Study|Non-compliance to Study Procedures|1|||
105577458|NCT01254565|364114472|FG005|Overall Study|Non-compliance to Study Procedures|0|||
105577459|NCT01254565|364114467|FG000|Overall Study|Did not Receive Treatment|1|||
105577460|NCT01254565|364114468|FG001|Overall Study|Did not Receive Treatment|1|||
105577461|NCT01254565|364114469|FG002|Overall Study|Did not Receive Treatment|0|||
105577462|NCT01254565|364114470|FG003|Overall Study|Did not Receive Treatment|0|||
105577463|NCT01254565|364114471|FG004|Overall Study|Did not Receive Treatment|3|||
105577464|NCT01254565|364114472|FG005|Overall Study|Did not Receive Treatment|4|||
105577465|NCT01254565|364114467|FG000|Overall Study|Other|0|||
105577466|NCT01254565|364114468|FG001|Overall Study|Other|0|||
105577467|NCT01254565|364114469|FG002|Overall Study|Other|0|||
105577468|NCT01254565|364114470|FG003|Overall Study|Other|1|||
105577469|NCT01254565|364114471|FG004|Overall Study|Other|0|||
105577470|NCT01254565|364114472|FG005|Overall Study|Other|0|||
105577471|NCT00179010|364114473|FG000|Overall Study|Muscle probe defective|1|||
105577472|NCT00179010|364114474|FG001|Overall Study|Muscle probe defective|1|||
105329938|NCT00954941|363207467|FG000|Overall Study|Adverse Event|0|||
105329939|NCT00954941|363207468|FG001|Overall Study|Adverse Event|1|||
105329940|NCT00529308|363207470|FG000|Overall Study|Withdrawal by Subject|1|||
105329941|NCT00529308|363207471|FG001|Overall Study|Withdrawal by Subject|1|||
105329942|NCT00745901|363207476|FG000|Overall Study|Adverse Event|3|||
105329943|NCT00745901|363207477|FG001|Overall Study|Adverse Event|4|||
105329944|NCT00745901|363207476|FG000|Overall Study|Protocol Violation|0|||
105329945|NCT00745901|363207477|FG001|Overall Study|Protocol Violation|1|||
105375332|NCT03416179|363381611|FG000|Overall Study|Study participation terminated by Sponsor|93|||
105375333|NCT03416179|363381612|FG001|Overall Study|Study participation terminated by Sponsor|91|||
105375334|NCT03416179|363381613|FG002|Overall Study|Study participation terminated by Sponsor|26|||
105375335|NCT03416179|363381614|FG003|Overall Study|Study participation terminated by Sponsor|31|||
105375336|NCT03416179|363381611|FG000|Overall Study|Other|2|||
105375337|NCT03416179|363381612|FG001|Overall Study|Other|3|||
105375338|NCT03416179|363381613|FG002|Overall Study|Other|1|||
105375339|NCT03416179|363381614|FG003|Overall Study|Other|0|||
105375340|NCT01682031|363381617|FG000|Overall Study|Withdrawal by Subject|0|||
105375341|NCT01682031|363381618|FG001|Overall Study|Withdrawal by Subject|1|||
105375342|NCT01682031|363381617|FG000|Overall Study|Adverse Event|0|||
105375343|NCT01682031|363381618|FG001|Overall Study|Adverse Event|2|||
105375344|NCT01682031|363381617|FG000|Overall Study|MRI results indicate increased nodul|0|||
105375345|NCT01682031|363381618|FG001|Overall Study|MRI results indicate increased nodul|1|||
105375346|NCT01682031|363381617|FG000|Overall Study|Patient could not swallow tablets|1|||
105375347|NCT01682031|363381618|FG001|Overall Study|Patient could not swallow tablets|0|||
105375348|NCT01682031|363381617|FG000|Overall Study|Patient stopped selenium on his own|0|||
105375349|NCT01682031|363381618|FG001|Overall Study|Patient stopped selenium on his own|1|||
105375350|NCT01129128|363381621|FG000|Overall Study|Lost to Follow-up|2|||
105375351|NCT01129128|363381622|FG001|Overall Study|Lost to Follow-up|2|||
105375352|NCT01129128|363381623|FG002|Overall Study|Lost to Follow-up|1|||
105375353|NCT01129128|363381621|FG000|Overall Study|Protocol Violation|0|||
105375354|NCT01129128|363381622|FG001|Overall Study|Protocol Violation|1|||
105375355|NCT01129128|363381623|FG002|Overall Study|Protocol Violation|0|||
105375356|NCT01129128|363381621|FG000|Overall Study|Withdrawal by Subject|0|||
105375357|NCT01129128|363381622|FG001|Overall Study|Withdrawal by Subject|1|||
105375358|NCT01129128|363381623|FG002|Overall Study|Withdrawal by Subject|3|||
105375359|NCT01129128|363381621|FG000|Overall Study|Physician Decision|1|||
105375360|NCT01129128|363381622|FG001|Overall Study|Physician Decision|0|||
105375361|NCT01129128|363381623|FG002|Overall Study|Physician Decision|0|||
105375362|NCT04666298|363381625|FG000|Overall Study|Subject decision|1|||
105375363|NCT04666298|363381626|FG001|Overall Study|Subject decision|0|||
105375364|NCT04666298|363381627|FG002|Overall Study|Subject decision|0|||
105375365|NCT04666298|363381628|FG003|Overall Study|Subject decision|2|||
105375366|NCT04666298|363381625|FG000|Overall Study|Death|1|||
105375367|NCT04666298|363381626|FG001|Overall Study|Death|0|||
105375368|NCT04666298|363381627|FG002|Overall Study|Death|0|||
105375369|NCT04666298|363381628|FG003|Overall Study|Death|0|||
105375370|NCT04666298|363381625|FG000|Overall Study|Lost to Follow-up|0|||
105375371|NCT04666298|363381626|FG001|Overall Study|Lost to Follow-up|0|||
105375372|NCT04666298|363381627|FG002|Overall Study|Lost to Follow-up|0|||
105375373|NCT04666298|363381628|FG003|Overall Study|Lost to Follow-up|1|||
105375374|NCT04666298|363381625|FG000|Overall Study|Physician Decision|0|||
105375375|NCT04666298|363381626|FG001|Overall Study|Physician Decision|0|||
105375376|NCT04666298|363381627|FG002|Overall Study|Physician Decision|0|||
105375377|NCT04666298|363381628|FG003|Overall Study|Physician Decision|1|||
105375378|NCT04666298|363381625|FG000|Overall Study|Protocol deviation|0|||
105375379|NCT04666298|363381626|FG001|Overall Study|Protocol deviation|0|||
105375380|NCT04666298|363381627|FG002|Overall Study|Protocol deviation|1|||
105375381|NCT04666298|363381628|FG003|Overall Study|Protocol deviation|0|||
105329946|NCT00745901|363207476|FG000|Overall Study|Withdrawal by Subject|1|||
105329947|NCT00745901|363207477|FG001|Overall Study|Withdrawal by Subject|0|||
105329948|NCT00745901|363207476|FG000|Overall Study|Lost to Follow-up|7|||
105329949|NCT00745901|363207477|FG001|Overall Study|Lost to Follow-up|4|||
105329950|NCT00745901|363207476|FG000|Overall Study|Pregnancy|2|||
105329951|NCT00745901|363207477|FG001|Overall Study|Pregnancy|4|||
105329952|NCT00745901|363207476|FG000|Overall Study|Lack of compliance|2|||
105329953|NCT00745901|363207477|FG001|Overall Study|Lack of compliance|2|||
105329954|NCT00745901|363207476|FG000|Overall Study|Patient's next menses did not start with|1|||
105329955|NCT00745901|363207477|FG001|Overall Study|Patient's next menses did not start with|0|||
105329956|NCT00745901|363207476|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
105329957|NCT00745901|363207477|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
105329958|NCT00745901|363207476|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
105329959|NCT00745901|363207477|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
105329960|NCT00745901|363207476|FG000|Overall Study|Patient didn't take any study medication|7|||
105375382|NCT01995201|363381629|FG000|From Baseline Until Week 24|Adverse Event|4|||
105375383|NCT01995201|363381630|FG001|From Baseline Until Week 24|Adverse Event|15|||
105375384|NCT01995201|363381631|FG002|From Baseline Until Week 24|Adverse Event|0|||
105375385|NCT01995201|363381632|FG003|From Baseline Until Week 24|Adverse Event|0|||
105375386|NCT01995201|363381633|FG004|From Baseline Until Week 24|Adverse Event|0|||
105375387|NCT01995201|363381634|FG005|From Baseline Until Week 24|Adverse Event|0|||
105375388|NCT01995201|363381635|FG006|From Baseline Until Week 24|Adverse Event|0|||
105375389|NCT01995201|363381629|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
105375390|NCT01995201|363381630|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
105375391|NCT01995201|363381631|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
105577473|NCT00179010|364114473|FG000|Overall Study|Failure to place arterial line|0|||
105577474|NCT00179010|364114474|FG001|Overall Study|Failure to place arterial line|1|||
105577475|NCT03249376|364114475|FG000|Overall Study|Adverse Event|11|||
105577476|NCT03249376|364114476|FG001|Overall Study|Adverse Event|5|||
105577477|NCT03249376|364114475|FG000|Overall Study|Lack of Efficacy|2|||
105577478|NCT03249376|364114476|FG001|Overall Study|Lack of Efficacy|4|||
105577479|NCT03249376|364114475|FG000|Overall Study|Protocol Violation|3|||
105577480|NCT03249376|364114476|FG001|Overall Study|Protocol Violation|2|||
105577481|NCT03249376|364114475|FG000|Overall Study|Physician Decision|0|||
105577482|NCT03249376|364114476|FG001|Overall Study|Physician Decision|2|||
105577483|NCT03249376|364114475|FG000|Overall Study|Withdrawal by Subject|3|||
105577484|NCT03249376|364114476|FG001|Overall Study|Withdrawal by Subject|9|||
105577485|NCT03249376|364114475|FG000|Overall Study|LTFU|2|||
105577486|NCT03249376|364114476|FG001|Overall Study|LTFU|1|||
105577487|NCT02139982|364114486|FG000|Overall Study|Lack of Efficacy|0|||
105577488|NCT02139982|364114487|FG001|Overall Study|Lack of Efficacy|1|||
105577489|NCT02139982|364114488|FG002|Overall Study|Lack of Efficacy|0|||
105577490|NCT02139982|364114489|FG003|Overall Study|Lack of Efficacy|1|||
105577491|NCT02139982|364114490|FG004|Overall Study|Lack of Efficacy|0|||
105577492|NCT02139982|364114491|FG005|Overall Study|Lack of Efficacy|0|||
105577493|NCT02139982|364114492|FG006|Overall Study|Lack of Efficacy|0|||
105577494|NCT02139982|364114493|FG007|Overall Study|Lack of Efficacy|0|||
105577495|NCT02139982|364114494|FG008|Overall Study|Lack of Efficacy|0|||
105577496|NCT02139982|364114495|FG009|Overall Study|Lack of Efficacy|0|||
105577497|NCT04254679|364114518|FG000|Overall Study|Protocol Violation|1|||
105577498|NCT04254679|364114519|FG001|Overall Study|Protocol Violation|1|||
105577499|NCT04254679|364114518|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
105577500|NCT04254679|364114519|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
105577501|NCT00794820|364114524|FG000|Overall Study|Adverse Event|11|||
105577502|NCT00794820|364114524|FG000|Overall Study|Secondary Malignancies|2|||
105577503|NCT00794820|364114524|FG000|Overall Study|Resistant Disease|2|||
105577504|NCT00794820|364114524|FG000|Overall Study|Ineligible/Screen Failure|1|||
105577505|NCT01591460|364114534|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
105577506|NCT01591460|364114534|FG000|Overall Study|Futility Rule (Week 12)|7|||
105577507|NCT01591460|364114534|FG000|Overall Study|Futility Rule (Week 24)|3|||
105577508|NCT01591460|364114534|FG000|Overall Study|Rebound or Breakthrough|3|||
105577509|NCT01591460|364114534|FG000|Overall Study|Treatment Discontinued by Error|1|||
105577510|NCT01591460|364114534|FG000|Overall Study|Lost to Follow-up|1|||
105577511|NCT01591460|364114534|FG000|Overall Study|Noncompliance|1|||
105577512|NCT01591460|364114534|FG000|Overall Study|Participant Refusal|3|||
105577513|NCT01591460|364114534|FG000|Overall Study|Withdrawal by Subject|1|||
105577514|NCT01591460|364114534|FG000|Overall Study|Protocol Violation|1|||
105577515|NCT03230864|364114535|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
105577516|NCT03230864|364114536|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
105577517|NCT03230864|364114537|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
105577518|NCT03230864|364114538|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
105577519|NCT03230864|364114535|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
105577520|NCT03230864|364114536|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
105577521|NCT03230864|364114537|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
105577522|NCT03230864|364114538|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
105577523|NCT03230864|364114535|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
105577524|NCT03230864|364114536|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
105577525|NCT03230864|364114537|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
105577526|NCT03230864|364114538|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
105577527|NCT03230864|364114535|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
105577528|NCT03230864|364114536|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
105577529|NCT03230864|364114537|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
105577530|NCT03230864|364114538|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
105577531|NCT03230864|364114535|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
105577532|NCT03230864|364114536|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
105577533|NCT03230864|364114537|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
105577534|NCT03230864|364114538|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
105577535|NCT03230864|364114535|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
105577536|NCT03230864|364114536|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
105577537|NCT03230864|364114537|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
105577538|NCT03230864|364114538|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
105577539|NCT03230864|364114535|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
105577540|NCT03230864|364114536|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
105577541|NCT03230864|364114537|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
105577542|NCT03230864|364114538|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
105577543|NCT03230864|364114535|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
105375392|NCT01995201|363381632|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
105375393|NCT01995201|363381633|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
105375394|NCT01995201|363381634|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
105375395|NCT01995201|363381635|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
105375396|NCT01995201|363381629|FG000|From Baseline Until Week 24|Death|0|||
105375397|NCT01995201|363381630|FG001|From Baseline Until Week 24|Death|1|||
105375398|NCT01995201|363381631|FG002|From Baseline Until Week 24|Death|0|||
105375399|NCT01995201|363381632|FG003|From Baseline Until Week 24|Death|0|||
105375400|NCT01995201|363381633|FG004|From Baseline Until Week 24|Death|0|||
105375401|NCT01995201|363381634|FG005|From Baseline Until Week 24|Death|0|||
105375402|NCT01995201|363381635|FG006|From Baseline Until Week 24|Death|0|||
105375403|NCT01995201|363381629|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
105375404|NCT01995201|363381630|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
105375405|NCT01995201|363381631|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
105375406|NCT01995201|363381632|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
105375407|NCT01995201|363381633|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
105375408|NCT01995201|363381634|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
105375409|NCT01995201|363381635|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
105375410|NCT01995201|363381629|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
105375411|NCT01995201|363381630|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
105375412|NCT01995201|363381631|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
105375413|NCT01995201|363381632|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
105375414|NCT01995201|363381633|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
105375415|NCT01995201|363381634|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
105375416|NCT01995201|363381635|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
105375417|NCT01995201|363381629|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
105375418|NCT01995201|363381630|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
105375419|NCT01995201|363381631|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
105375420|NCT01995201|363381632|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
105375421|NCT01995201|363381633|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
105375422|NCT01995201|363381634|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
105375423|NCT01995201|363381635|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
105375424|NCT01995201|363381629|FG000|From Baseline Until Week 24|Physician Decision|0|||
105375425|NCT01995201|363381630|FG001|From Baseline Until Week 24|Physician Decision|2|||
105375426|NCT01995201|363381631|FG002|From Baseline Until Week 24|Physician Decision|0|||
105375427|NCT01995201|363381632|FG003|From Baseline Until Week 24|Physician Decision|0|||
105375428|NCT01995201|363381633|FG004|From Baseline Until Week 24|Physician Decision|0|||
105375429|NCT01995201|363381634|FG005|From Baseline Until Week 24|Physician Decision|0|||
105375430|NCT01995201|363381635|FG006|From Baseline Until Week 24|Physician Decision|0|||
105375431|NCT01995201|363381629|FG000|From Baseline Until Week 24|Protocol Violation|0|||
105375432|NCT01995201|363381630|FG001|From Baseline Until Week 24|Protocol Violation|9|||
105375433|NCT01995201|363381631|FG002|From Baseline Until Week 24|Protocol Violation|0|||
105375434|NCT01995201|363381632|FG003|From Baseline Until Week 24|Protocol Violation|0|||
105375435|NCT01995201|363381633|FG004|From Baseline Until Week 24|Protocol Violation|0|||
105375436|NCT01995201|363381634|FG005|From Baseline Until Week 24|Protocol Violation|0|||
105375437|NCT01995201|363381635|FG006|From Baseline Until Week 24|Protocol Violation|0|||
105375438|NCT01995201|363381629|FG000|From Week 24 Until Week 48|Adverse Event|0|||
105375439|NCT01995201|363381630|FG001|From Week 24 Until Week 48|Adverse Event|0|||
105375440|NCT01995201|363381631|FG002|From Week 24 Until Week 48|Adverse Event|2|||
105577544|NCT03230864|364114536|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
105577545|NCT03230864|364114537|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
105577546|NCT03230864|364114538|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
105577547|NCT03230864|364114535|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
105577548|NCT03230864|364114536|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
105577549|NCT03230864|364114537|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
105577550|NCT03230864|364114538|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
105577551|NCT03230864|364114535|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
105577552|NCT03230864|364114536|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
105375441|NCT01995201|363381632|FG003|From Week 24 Until Week 48|Adverse Event|1|||
105375442|NCT01995201|363381633|FG004|From Week 24 Until Week 48|Adverse Event|1|||
105375443|NCT01995201|363381634|FG005|From Week 24 Until Week 48|Adverse Event|3|||
105375444|NCT01995201|363381635|FG006|From Week 24 Until Week 48|Adverse Event|1|||
105375445|NCT01995201|363381629|FG000|From Week 24 Until Week 48|Death|0|||
105375446|NCT01995201|363381630|FG001|From Week 24 Until Week 48|Death|0|||
105375447|NCT01995201|363381631|FG002|From Week 24 Until Week 48|Death|0|||
105375448|NCT01995201|363381632|FG003|From Week 24 Until Week 48|Death|0|||
105375449|NCT01995201|363381633|FG004|From Week 24 Until Week 48|Death|0|||
105375450|NCT01995201|363381634|FG005|From Week 24 Until Week 48|Death|2|||
105375451|NCT01995201|363381635|FG006|From Week 24 Until Week 48|Death|0|||
105375452|NCT01995201|363381629|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
105375453|NCT01995201|363381630|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
105375454|NCT01995201|363381631|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
105375455|NCT01995201|363381632|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
105375456|NCT01995201|363381633|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
105375457|NCT01995201|363381634|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
105375458|NCT01995201|363381635|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
105375459|NCT01995201|363381629|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
105375460|NCT01995201|363381630|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
105375461|NCT01995201|363381631|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
105375462|NCT01995201|363381632|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
105375463|NCT01995201|363381633|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
105375464|NCT01995201|363381634|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
105375465|NCT01995201|363381635|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
105375466|NCT01995201|363381629|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
105375467|NCT01995201|363381630|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
105375468|NCT01995201|363381631|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
105375469|NCT01995201|363381632|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
105375470|NCT01995201|363381633|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
105375471|NCT01995201|363381634|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
105375472|NCT01995201|363381635|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
105375473|NCT01995201|363381629|FG000|From Week 24 Until Week 48|Physician Decision|0|||
105375474|NCT01995201|363381630|FG001|From Week 24 Until Week 48|Physician Decision|0|||
105375475|NCT01995201|363381631|FG002|From Week 24 Until Week 48|Physician Decision|0|||
105375476|NCT01995201|363381632|FG003|From Week 24 Until Week 48|Physician Decision|0|||
105375477|NCT01995201|363381633|FG004|From Week 24 Until Week 48|Physician Decision|1|||
105375478|NCT01995201|363381634|FG005|From Week 24 Until Week 48|Physician Decision|0|||
105375479|NCT01995201|363381635|FG006|From Week 24 Until Week 48|Physician Decision|0|||
105375480|NCT01995201|363381629|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
105375481|NCT01995201|363381630|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
105375482|NCT01995201|363381631|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
105375483|NCT01995201|363381632|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
105375484|NCT01995201|363381633|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
105375485|NCT01995201|363381634|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
105375486|NCT01995201|363381635|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
105375487|NCT03329001|363381636|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
105329961|NCT00745901|363207477|FG001|Overall Study|Patient didn't take any study medication|3|||
105329962|NCT04526288|363207482|FG000|Overall Study|Disease Progression|1|||
105329963|NCT04526288|363207483|FG001|Overall Study|Disease Progression|0|||
105329964|NCT00984542|363207486|FG000|Overall Study|disease progression|19|||
105329965|NCT00984542|363207486|FG000|Overall Study|toxicity|7|||
105329966|NCT00984542|363207486|FG000|Overall Study|Death|7|||
105329967|NCT00984542|363207486|FG000|Overall Study|complicating disease|3|||
105329968|NCT00984542|363207486|FG000|Overall Study|Withdrawal by Subject|3|||
105329969|NCT00984542|363207486|FG000|Overall Study|clinical deterioration|2|||
105329970|NCT01422889|363207520|FG000|Overall Study|No Data Entered for Study Stent|9|||
105329971|NCT02343939|363207521|FG000|Overall Study|Death|0|||
105329972|NCT02343939|363207522|FG001|Overall Study|Death|15|||
105329973|NCT02343939|363207523|FG002|Overall Study|Death|4|||
105329974|NCT02343939|363207524|FG003|Overall Study|Death|2|||
105329975|NCT02343939|363207525|FG004|Overall Study|Death|5|||
105329976|NCT02343939|363207526|FG005|Overall Study|Death|11|||
105329977|NCT02343939|363207527|FG006|Overall Study|Death|8|||
105329978|NCT02343939|363207528|FG007|Overall Study|Death|22|||
105329979|NCT02343939|363207529|FG008|Overall Study|Death|1|||
105329980|NCT02343939|363207521|FG000|Overall Study|Study terminated by sponsor|0|||
105329981|NCT02343939|363207522|FG001|Overall Study|Study terminated by sponsor|27|||
105329982|NCT02343939|363207523|FG002|Overall Study|Study terminated by sponsor|0|||
105577553|NCT03230864|364114537|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
105577554|NCT03230864|364114538|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
105577555|NCT00432679|364114541|FG000|Overall Study|Adverse Event|2|||
105577556|NCT00432679|364114542|FG001|Overall Study|Adverse Event|1|||
105577557|NCT00432679|364114541|FG000|Overall Study|Withdrawal by Subject|3|||
105577558|NCT00432679|364114542|FG001|Overall Study|Withdrawal by Subject|2|||
105577559|NCT00502996|364114543|FG000|Overall Study|Lost to Follow-up|9|||
105577560|NCT00502996|364114543|FG000|Overall Study|Protocol Violation|2|||
105577561|NCT00502996|364114543|FG000|Overall Study|Treatment failure|25|||
105577562|NCT00502996|364114543|FG000|Overall Study|Withdrawal Informed Consent|6|||
105577563|NCT00502996|364114543|FG000|Overall Study|Adverse Event|2|||
105577564|NCT01729728|364114544|FG000|Overall Study|Adverse Event|0|||
105577565|NCT01729728|364114545|FG001|Overall Study|Adverse Event|6|||
105577566|NCT01729728|364114546|FG002|Overall Study|Adverse Event|0|||
105577567|NCT01729728|364114544|FG000|Overall Study|Protocol Violation|1|||
105375488|NCT03329001|363381637|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
105375489|NCT03329001|363381638|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
105375490|NCT03329001|363381639|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
105375491|NCT03329001|363381640|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
105375492|NCT03329001|363381641|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
105375493|NCT03329001|363381642|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
105375494|NCT03329001|363381643|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
105375495|NCT03329001|363381636|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
105375496|NCT03329001|363381637|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
105375497|NCT03329001|363381638|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
105375498|NCT03329001|363381639|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
105375499|NCT03329001|363381640|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
105329983|NCT02343939|363207524|FG003|Overall Study|Study terminated by sponsor|1|||
105577568|NCT01729728|364114545|FG001|Overall Study|Protocol Violation|0|||
105577569|NCT01729728|364114546|FG002|Overall Study|Protocol Violation|1|||
105577570|NCT04267614|364114548|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
105577571|NCT04267614|364114548|FG000|Overall Study|Lost to Follow-up|115|||
105329984|NCT02343939|363207525|FG004|Overall Study|Study terminated by sponsor|1|||
105329985|NCT02343939|363207526|FG005|Overall Study|Study terminated by sponsor|5|||
105329986|NCT02343939|363207527|FG006|Overall Study|Study terminated by sponsor|3|||
105329987|NCT02343939|363207528|FG007|Overall Study|Study terminated by sponsor|4|||
105329988|NCT02343939|363207529|FG008|Overall Study|Study terminated by sponsor|0|||
105577572|NCT01284140|364114549|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
105577573|NCT01284140|364114550|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
105375500|NCT03329001|363381641|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
105375501|NCT03329001|363381642|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
105375502|NCT03329001|363381643|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
105375503|NCT03329001|363381636|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
105375504|NCT03329001|363381637|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
105375505|NCT03329001|363381638|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
105375506|NCT03329001|363381639|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
105375507|NCT03329001|363381640|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
105375508|NCT03329001|363381641|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
105375509|NCT03329001|363381642|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
105375510|NCT03329001|363381643|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
105375511|NCT03329001|363381636|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
105375512|NCT03329001|363381637|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
105375513|NCT03329001|363381638|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
105375514|NCT03329001|363381639|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
105375515|NCT03329001|363381640|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
105375516|NCT03329001|363381641|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
105375517|NCT03329001|363381642|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
105375518|NCT03329001|363381643|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
105375519|NCT03329001|363381636|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
105375520|NCT03329001|363381637|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
105375521|NCT03329001|363381638|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
105375522|NCT03329001|363381639|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
105375523|NCT03329001|363381640|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
105375524|NCT03329001|363381641|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
105375525|NCT03329001|363381642|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
105375526|NCT03329001|363381643|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
105375527|NCT03329001|363381636|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
105375528|NCT03329001|363381637|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
105375529|NCT03329001|363381638|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
105375530|NCT03329001|363381639|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
105375531|NCT03329001|363381640|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
105375532|NCT03329001|363381641|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
105375533|NCT03329001|363381642|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
105375534|NCT03329001|363381643|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
105375535|NCT03329001|363381636|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
105375536|NCT03329001|363381637|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
105375537|NCT03329001|363381638|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
105375538|NCT03329001|363381639|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
105375539|NCT03329001|363381640|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
105375540|NCT03329001|363381641|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
105375541|NCT03329001|363381642|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
105375542|NCT03329001|363381643|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
105375543|NCT03329001|363381636|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
105375544|NCT03329001|363381637|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
105375545|NCT03329001|363381638|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
105375546|NCT03329001|363381639|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
105375547|NCT03329001|363381640|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
105375548|NCT03329001|363381641|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
105375549|NCT03329001|363381642|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
105375550|NCT03329001|363381643|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
105375551|NCT03329001|363381636|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
105375552|NCT03329001|363381637|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
105375553|NCT03329001|363381638|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
105375554|NCT03329001|363381639|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
105375555|NCT03329001|363381640|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
105375556|NCT03329001|363381641|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
105375557|NCT03329001|363381642|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
105375558|NCT03329001|363381643|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
105375559|NCT03329001|363381636|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
105375560|NCT03329001|363381637|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
105375561|NCT03329001|363381638|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
105375562|NCT03329001|363381639|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
105375563|NCT03329001|363381640|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
105375564|NCT03329001|363381641|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
105375565|NCT03329001|363381642|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
105375566|NCT03329001|363381643|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
105375567|NCT03329001|363381636|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
105375568|NCT03329001|363381637|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
105375569|NCT03329001|363381638|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
105375570|NCT03329001|363381639|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
105375571|NCT03329001|363381640|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
105375572|NCT03329001|363381641|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
105375573|NCT03329001|363381642|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
105375574|NCT03329001|363381643|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
105375575|NCT03329001|363381636|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
105375576|NCT03329001|363381637|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
105375577|NCT03329001|363381638|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
105375578|NCT03329001|363381639|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
105375579|NCT03329001|363381640|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
105375580|NCT03329001|363381641|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
105375581|NCT03329001|363381642|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
105375582|NCT03329001|363381643|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
105375583|NCT03329001|363381636|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
105375584|NCT03329001|363381637|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
105375585|NCT03329001|363381638|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
105375586|NCT03329001|363381639|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
105375587|NCT03329001|363381640|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
105375588|NCT03329001|363381641|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
105375589|NCT03329001|363381642|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
105375590|NCT03329001|363381643|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
105375591|NCT03329001|363381636|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
105375592|NCT03329001|363381637|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
105375593|NCT03329001|363381638|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
105375594|NCT03329001|363381639|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
105375595|NCT03329001|363381640|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
105375596|NCT03329001|363381641|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
105375597|NCT03329001|363381642|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
105375598|NCT03329001|363381643|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
105375599|NCT03329001|363381636|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
105375600|NCT03329001|363381637|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
105375601|NCT03329001|363381638|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
105375602|NCT03329001|363381639|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
105375603|NCT03329001|363381640|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
105375604|NCT03329001|363381641|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
105375605|NCT03329001|363381642|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
105375606|NCT03329001|363381643|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
105375607|NCT03329001|363381636|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
105375608|NCT03329001|363381637|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
105375609|NCT03329001|363381638|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
105577574|NCT01284140|364114549|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
105577575|NCT01284140|364114550|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
105577576|NCT04827134|364114551|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
105577577|NCT04827134|364114552|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
105577578|NCT04827134|364114553|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
105577579|NCT04827134|364114554|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
105577580|NCT01009047|364114555|FG000|Overall Study|Adverse Event|5|||
105577581|NCT01009047|364114556|FG001|Overall Study|Adverse Event|0|||
105577582|NCT01009047|364114555|FG000|Overall Study|Lost to Follow-up|0|||
105577583|NCT01009047|364114556|FG001|Overall Study|Lost to Follow-up|2|||
105577584|NCT01009047|364114555|FG000|Overall Study|Lack of Efficacy|4|||
105577585|NCT01009047|364114556|FG001|Overall Study|Lack of Efficacy|11|||
105577586|NCT01009047|364114555|FG000|Overall Study|Withdrawal by consent|16|||
105577587|NCT01009047|364114556|FG001|Overall Study|Withdrawal by consent|11|||
105577588|NCT01009047|364114555|FG000|Overall Study|Other|3|||
105577589|NCT01009047|364114556|FG001|Overall Study|Other|2|||
105577590|NCT03881059|364114559|FG000|Treatment Period - Part A|Adverse Event|1|||
105577591|NCT03881059|364114560|FG001|Treatment Period - Part A|Adverse Event|3|||
105577592|NCT03881059|364114561|FG002|Treatment Period - Part A|Adverse Event|4|||
105577593|NCT03881059|364114559|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
105577594|NCT03881059|364114560|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
105577595|NCT03881059|364114561|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
105577596|NCT03881059|364114559|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
105375610|NCT03329001|363381639|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
105375611|NCT03329001|363381640|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
105375612|NCT03329001|363381641|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
105375613|NCT03329001|363381642|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
105375614|NCT03329001|363381643|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
105375615|NCT03329001|363381636|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
105375616|NCT03329001|363381637|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
105375617|NCT03329001|363381638|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
105375618|NCT03329001|363381639|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
105375619|NCT03329001|363381640|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
105375620|NCT03329001|363381641|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
105375621|NCT03329001|363381642|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
105375622|NCT03329001|363381643|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
105375623|NCT03329001|363381636|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
105375624|NCT03329001|363381637|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
105375625|NCT03329001|363381638|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
105375626|NCT03329001|363381639|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
105375627|NCT03329001|363381640|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
105375628|NCT03329001|363381641|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
105375629|NCT03329001|363381642|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
105375630|NCT03329001|363381643|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
105375631|NCT03329001|363381636|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
105375632|NCT03329001|363381637|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
105375633|NCT03329001|363381638|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
105375634|NCT03329001|363381639|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
105375635|NCT03329001|363381640|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
105375636|NCT03329001|363381641|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
105375637|NCT03329001|363381642|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
105375638|NCT03329001|363381643|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
105375639|NCT03329001|363381636|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
105375640|NCT03329001|363381637|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
105375641|NCT03329001|363381638|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
105375642|NCT03329001|363381639|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
105375643|NCT03329001|363381640|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
105375644|NCT03329001|363381641|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
105375645|NCT03329001|363381642|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
105577597|NCT03881059|364114560|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
105577598|NCT03881059|364114561|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
105577599|NCT03881059|364114559|FG000|Treatment Period - Part A|Other reasons|2|||
105577600|NCT03881059|364114560|FG001|Treatment Period - Part A|Other reasons|1|||
105577601|NCT03881059|364114561|FG002|Treatment Period - Part A|Other reasons|0|||
105375646|NCT03329001|363381643|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
105375647|NCT03329001|363381636|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
105375648|NCT03329001|363381637|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
105375649|NCT03329001|363381638|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
105375650|NCT03329001|363381639|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
105375651|NCT03329001|363381640|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
105375652|NCT03329001|363381641|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
105375653|NCT03329001|363381642|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
105375654|NCT03329001|363381643|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
105375655|NCT03329001|363381636|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
105375656|NCT03329001|363381637|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
105375657|NCT03329001|363381638|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
105375658|NCT03329001|363381639|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
105375659|NCT03329001|363381640|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
105375660|NCT03329001|363381641|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
105375661|NCT03329001|363381642|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
105375662|NCT03329001|363381643|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
105375663|NCT03329001|363381636|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
105375664|NCT03329001|363381637|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
105375665|NCT03329001|363381638|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
105375666|NCT03329001|363381639|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
105375667|NCT03329001|363381640|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
105375668|NCT03329001|363381641|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
105375669|NCT03329001|363381642|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
105375670|NCT03329001|363381643|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
105375671|NCT03329001|363381636|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
105375672|NCT03329001|363381637|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
105375673|NCT03329001|363381638|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
105375674|NCT03329001|363381639|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
105375675|NCT03329001|363381640|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
105375676|NCT03329001|363381641|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
105375677|NCT03329001|363381642|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
105375678|NCT03329001|363381643|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
105375679|NCT03329001|363381636|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
105375680|NCT03329001|363381637|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
105375681|NCT03329001|363381638|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
105375682|NCT03329001|363381639|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
105375683|NCT03329001|363381640|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
105375684|NCT03329001|363381641|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
105375685|NCT03329001|363381642|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
105375686|NCT03329001|363381643|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
105375687|NCT03329001|363381636|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
105375688|NCT03329001|363381637|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
105375689|NCT03329001|363381638|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
105375690|NCT03329001|363381639|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
105375691|NCT03329001|363381640|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
105375692|NCT03329001|363381641|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
105375693|NCT03329001|363381642|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
105375694|NCT03329001|363381643|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
105375695|NCT03329001|363381636|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
105375696|NCT03329001|363381637|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
105375697|NCT03329001|363381638|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
105375698|NCT03329001|363381639|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
105375699|NCT03329001|363381640|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
105375700|NCT03329001|363381641|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
105375701|NCT03329001|363381642|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
105375702|NCT03329001|363381643|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
105375703|NCT03329001|363381636|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
105375704|NCT03329001|363381637|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
105375705|NCT03329001|363381638|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
105375706|NCT03329001|363381639|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
105375707|NCT03329001|363381640|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
105577602|NCT03881059|364114559|FG000|Treatment Period - Part B|Adverse Event|0|||
105577603|NCT03881059|364114560|FG001|Treatment Period - Part B|Adverse Event|0|||
105577604|NCT03881059|364114561|FG002|Treatment Period - Part B|Adverse Event|3|||
105577605|NCT03881059|364114559|FG000|Treatment Period - Part B|Death|0|||
105577606|NCT03881059|364114560|FG001|Treatment Period - Part B|Death|1|||
105577607|NCT03881059|364114561|FG002|Treatment Period - Part B|Death|1|||
105577608|NCT03881059|364114559|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
105577609|NCT03881059|364114560|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
105577610|NCT03881059|364114561|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
105577611|NCT03881059|364114559|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
105577612|NCT03881059|364114560|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
105577613|NCT03881059|364114561|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
105577614|NCT03881059|364114559|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
105577615|NCT03881059|364114560|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
105577616|NCT03881059|364114561|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
105577617|NCT03881059|364114559|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
105577618|NCT03881059|364114560|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
105577619|NCT03881059|364114561|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
105577620|NCT03881059|364114559|FG000|Treatment Period - Part B|Other reasons|4|||
105577621|NCT03881059|364114560|FG001|Treatment Period - Part B|Other reasons|3|||
105577622|NCT03881059|364114561|FG002|Treatment Period - Part B|Other reasons|3|||
105577623|NCT02065570|364114562|FG000|Induction Study|Adverse Event|5|||
105577624|NCT02065570|364114563|FG001|Induction Study|Adverse Event|12|||
105577625|NCT02065570|364114564|FG002|Induction Study|Adverse Event|0|||
105577626|NCT02065570|364114565|FG003|Induction Study|Adverse Event|0|||
105577627|NCT02065570|364114562|FG000|Induction Study|Withdrawal by Subject|2|||
105577628|NCT02065570|364114563|FG001|Induction Study|Withdrawal by Subject|3|||
105577629|NCT02065570|364114564|FG002|Induction Study|Withdrawal by Subject|0|||
105577630|NCT02065570|364114565|FG003|Induction Study|Withdrawal by Subject|0|||
105577631|NCT02065570|364114562|FG000|Induction Study|Lost to Follow-up|1|||
105577632|NCT02065570|364114563|FG001|Induction Study|Lost to Follow-up|1|||
105329989|NCT02343939|363207521|FG000|Overall Study|Withdrew consent|3|||
105329990|NCT02343939|363207522|FG001|Overall Study|Withdrew consent|6|||
105329991|NCT02343939|363207523|FG002|Overall Study|Withdrew consent|1|||
105329992|NCT02343939|363207524|FG003|Overall Study|Withdrew consent|2|||
105329993|NCT02343939|363207525|FG004|Overall Study|Withdrew consent|2|||
105329994|NCT02343939|363207526|FG005|Overall Study|Withdrew consent|0|||
105329995|NCT02343939|363207527|FG006|Overall Study|Withdrew consent|0|||
105329996|NCT02343939|363207528|FG007|Overall Study|Withdrew consent|8|||
105329997|NCT02343939|363207529|FG008|Overall Study|Withdrew consent|6|||
105329998|NCT02343939|363207521|FG000|Overall Study|Treatment failure|0|||
105329999|NCT02343939|363207522|FG001|Overall Study|Treatment failure|0|||
105330000|NCT02343939|363207523|FG002|Overall Study|Treatment failure|0|||
105330001|NCT02343939|363207524|FG003|Overall Study|Treatment failure|0|||
105330002|NCT02343939|363207525|FG004|Overall Study|Treatment failure|0|||
105330003|NCT02343939|363207526|FG005|Overall Study|Treatment failure|0|||
105330004|NCT02343939|363207527|FG006|Overall Study|Treatment failure|2|||
105330005|NCT02343939|363207528|FG007|Overall Study|Treatment failure|1|||
105330006|NCT02343939|363207529|FG008|Overall Study|Treatment failure|0|||
105330007|NCT02343939|363207521|FG000|Overall Study|Investigator's discretion|0|||
105330008|NCT02343939|363207522|FG001|Overall Study|Investigator's discretion|0|||
105330009|NCT02343939|363207523|FG002|Overall Study|Investigator's discretion|0|||
105330010|NCT02343939|363207524|FG003|Overall Study|Investigator's discretion|1|||
105330011|NCT02343939|363207525|FG004|Overall Study|Investigator's discretion|0|||
105330012|NCT02343939|363207526|FG005|Overall Study|Investigator's discretion|0|||
105330013|NCT02343939|363207527|FG006|Overall Study|Investigator's discretion|1|||
105330014|NCT02343939|363207528|FG007|Overall Study|Investigator's discretion|0|||
105330015|NCT02343939|363207529|FG008|Overall Study|Investigator's discretion|0|||
105330016|NCT02343939|363207521|FG000|Overall Study|Adverse Event|0|||
105330017|NCT02343939|363207522|FG001|Overall Study|Adverse Event|0|||
105330018|NCT02343939|363207523|FG002|Overall Study|Adverse Event|0|||
105330019|NCT02343939|363207524|FG003|Overall Study|Adverse Event|0|||
105330020|NCT02343939|363207525|FG004|Overall Study|Adverse Event|0|||
105330021|NCT02343939|363207526|FG005|Overall Study|Adverse Event|1|||
105330022|NCT02343939|363207527|FG006|Overall Study|Adverse Event|0|||
105330023|NCT02343939|363207528|FG007|Overall Study|Adverse Event|0|||
105330024|NCT02343939|363207529|FG008|Overall Study|Adverse Event|0|||
105330025|NCT02343939|363207521|FG000|Overall Study|Never Treated With ENTO|0|||
105330026|NCT02343939|363207522|FG001|Overall Study|Never Treated With ENTO|0|||
105330027|NCT02343939|363207523|FG002|Overall Study|Never Treated With ENTO|0|||
105330028|NCT02343939|363207524|FG003|Overall Study|Never Treated With ENTO|0|||
105330029|NCT02343939|363207525|FG004|Overall Study|Never Treated With ENTO|0|||
105330030|NCT02343939|363207526|FG005|Overall Study|Never Treated With ENTO|0|||
105330031|NCT02343939|363207527|FG006|Overall Study|Never Treated With ENTO|1|||
105330032|NCT02343939|363207528|FG007|Overall Study|Never Treated With ENTO|2|||
105375708|NCT03329001|363381641|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
105375709|NCT03329001|363381642|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
105375710|NCT03329001|363381643|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
105375711|NCT03329001|363381636|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
105375712|NCT03329001|363381637|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
105375713|NCT03329001|363381638|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
105375714|NCT03329001|363381639|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
105375715|NCT03329001|363381640|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
105375716|NCT03329001|363381641|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
105375717|NCT03329001|363381642|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
105375718|NCT03329001|363381643|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
105375719|NCT02709369|363381645|FG000|Overall Study|Lost to Follow-up|15|||
105375720|NCT02709369|363381645|FG000|Overall Study|Withdrawal by Subject|10|||
105375721|NCT02709369|363381645|FG000|Overall Study|Did not received intervention|2|||
105375722|NCT00963235|363381646|FG000|Overall Study|Withdrawal by Subject|22|||
105375723|NCT00963235|363381646|FG000|Overall Study|Lost to Follow-up|14|||
105375724|NCT00963235|363381646|FG000|Overall Study|Failed to return|9|||
105375725|NCT00963235|363381646|FG000|Overall Study|Protocol Violation|7|||
105375726|NCT00963235|363381646|FG000|Overall Study|Adverse Event|5|||
105375727|NCT00963235|363381646|FG000|Overall Study|Physician Decision|2|||
105375728|NCT00963235|363381646|FG000|Overall Study|Other|1|||
105375729|NCT01311661|363381647|FG000|Overall Study|Adverse Event|2|||
105375730|NCT01311661|363381647|FG000|Overall Study|Protocol Violation|3|||
105375731|NCT01311661|363381647|FG000|Overall Study|Withdrawal by Subject|2|||
105375732|NCT01900314|363381648|FG000|Overall Study|Lost to Follow-up|1|||
105375733|NCT01900314|363381649|FG001|Overall Study|Lost to Follow-up|0|||
105375734|NCT01900314|363381648|FG000|Overall Study|Protocol Violation|0|||
105375735|NCT01900314|363381649|FG001|Overall Study|Protocol Violation|1|||
105375736|NCT01900314|363381648|FG000|Overall Study|Withdrawal by Subject|3|||
105375737|NCT01900314|363381649|FG001|Overall Study|Withdrawal by Subject|3|||
105375738|NCT01104766|363381651|FG000|Overall Study|Did not meet inc/exc criteria|1|||
105375739|NCT01104766|363381652|FG001|Overall Study|Did not meet inc/exc criteria|0|||
105375740|NCT01104766|363381653|FG002|Overall Study|Did not meet inc/exc criteria|0|||
105375741|NCT01104766|363381654|FG003|Overall Study|Did not meet inc/exc criteria|0|||
105375742|NCT01104766|363381651|FG000|Overall Study|Adverse Event|17|||
105375743|NCT01104766|363381652|FG001|Overall Study|Adverse Event|15|||
105375744|NCT01104766|363381653|FG002|Overall Study|Adverse Event|20|||
105375745|NCT01104766|363381654|FG003|Overall Study|Adverse Event|14|||
105375746|NCT01104766|363381651|FG000|Overall Study|Lack of Efficacy|20|||
105375747|NCT01104766|363381652|FG001|Overall Study|Lack of Efficacy|15|||
105375748|NCT01104766|363381653|FG002|Overall Study|Lack of Efficacy|14|||
105375749|NCT01104766|363381654|FG003|Overall Study|Lack of Efficacy|8|||
105375750|NCT01104766|363381651|FG000|Overall Study|Protocol Violation|2|||
105375751|NCT01104766|363381652|FG001|Overall Study|Protocol Violation|0|||
105375752|NCT01104766|363381653|FG002|Overall Study|Protocol Violation|0|||
105375753|NCT01104766|363381654|FG003|Overall Study|Protocol Violation|0|||
105375754|NCT01104766|363381651|FG000|Overall Study|Withdrawal by Subject|17|||
105375755|NCT01104766|363381652|FG001|Overall Study|Withdrawal by Subject|19|||
105375756|NCT01104766|363381653|FG002|Overall Study|Withdrawal by Subject|25|||
105330033|NCT02343939|363207529|FG008|Overall Study|Never Treated With ENTO|0|||
105330034|NCT01890122|363207538|FG000|Overall Study|Adverse Event|1|||
105330035|NCT01890122|363207539|FG001|Overall Study|Adverse Event|1|||
105330036|NCT01890122|363207540|FG002|Overall Study|Adverse Event|1|||
105330037|NCT01890122|363207541|FG003|Overall Study|Adverse Event|2|||
105330038|NCT01890122|363207538|FG000|Overall Study|Major Protocol Deviation|3|||
105330039|NCT01890122|363207539|FG001|Overall Study|Major Protocol Deviation|1|||
105375757|NCT01104766|363381654|FG003|Overall Study|Withdrawal by Subject|15|||
105375758|NCT01104766|363381651|FG000|Overall Study|Lost to Follow-up|1|||
105375759|NCT01104766|363381652|FG001|Overall Study|Lost to Follow-up|2|||
105375760|NCT01104766|363381653|FG002|Overall Study|Lost to Follow-up|1|||
105375761|NCT01104766|363381654|FG003|Overall Study|Lost to Follow-up|1|||
105375762|NCT01341470|363381655|FG000|Overall Study|Sponsor decision|0|||
105375763|NCT01341470|363381656|FG001|Overall Study|Sponsor decision|0|||
105375764|NCT01341470|363381657|FG002|Overall Study|Sponsor decision|1|||
105375765|NCT01341470|363381658|FG003|Overall Study|Sponsor decision|1|||
105375766|NCT01341470|363381659|FG004|Overall Study|Sponsor decision|0|||
105375767|NCT01341470|363381660|FG005|Overall Study|Sponsor decision|1|||
105375768|NCT01136915|363381661|FG000|Overall Study|Lost to Follow-up|2|||
105375769|NCT01136915|363381662|FG001|Overall Study|Lost to Follow-up|0|||
105375770|NCT01136915|363381661|FG000|Overall Study|Exclusion criterion met|0|||
105375771|NCT01136915|363381662|FG001|Overall Study|Exclusion criterion met|1|||
105375772|NCT01756235|363381663|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
105375773|NCT01044498|363381664|FG000|Overall Study|Withdrew consent|1|||
105330040|NCT01890122|363207540|FG002|Overall Study|Major Protocol Deviation|0|||
105330041|NCT01890122|363207541|FG003|Overall Study|Major Protocol Deviation|1|||
105330042|NCT01890122|363207538|FG000|Overall Study|Lost to Follow-up|0|||
105577633|NCT02065570|364114564|FG002|Induction Study|Lost to Follow-up|0|||
105577634|NCT02065570|364114565|FG003|Induction Study|Lost to Follow-up|0|||
105577635|NCT02065570|364114562|FG000|Induction Study|Other, Not Specified|6|||
105577636|NCT02065570|364114563|FG001|Induction Study|Other, Not Specified|5|||
105577637|NCT02065570|364114564|FG002|Induction Study|Other, Not Specified|0|||
105577638|NCT02065570|364114565|FG003|Induction Study|Other, Not Specified|0|||
105577639|NCT02065570|364114562|FG000|Maintenance Study|Adverse Event|0|||
105577640|NCT02065570|364114563|FG001|Maintenance Study|Adverse Event|0|||
105577641|NCT02065570|364114564|FG002|Maintenance Study|Adverse Event|8|||
105577642|NCT02065570|364114565|FG003|Maintenance Study|Adverse Event|8|||
105577643|NCT02065570|364114562|FG000|Maintenance Study|Withdrawal by Subject|0|||
105577644|NCT02065570|364114563|FG001|Maintenance Study|Withdrawal by Subject|0|||
105577645|NCT02065570|364114564|FG002|Maintenance Study|Withdrawal by Subject|1|||
105577646|NCT02065570|364114565|FG003|Maintenance Study|Withdrawal by Subject|4|||
105577647|NCT02065570|364114562|FG000|Maintenance Study|Lost to Follow-up|0|||
105577648|NCT02065570|364114563|FG001|Maintenance Study|Lost to Follow-up|0|||
105577649|NCT02065570|364114564|FG002|Maintenance Study|Lost to Follow-up|2|||
105577650|NCT02065570|364114565|FG003|Maintenance Study|Lost to Follow-up|2|||
105577651|NCT02065570|364114562|FG000|Maintenance Study|Other, Not Specified|0|||
105577652|NCT02065570|364114563|FG001|Maintenance Study|Other, Not Specified|0|||
105577653|NCT02065570|364114564|FG002|Maintenance Study|Other, Not Specified|11|||
105577654|NCT02065570|364114565|FG003|Maintenance Study|Other, Not Specified|5|||
105577655|NCT02207374|364114568|FG000|Overall Study|Withdrawal by Subject|5|||
105577656|NCT02207374|364114569|FG001|Overall Study|Withdrawal by Subject|9|||
105577657|NCT02207374|364114570|FG002|Overall Study|Withdrawal by Subject|4|||
105577658|NCT02207374|364114568|FG000|Overall Study|Death|1|||
105577659|NCT02207374|364114569|FG001|Overall Study|Death|0|||
105577660|NCT02207374|364114570|FG002|Overall Study|Death|1|||
105577661|NCT02207374|364114568|FG000|Overall Study|Missing follow-up information|0|||
105577662|NCT02207374|364114569|FG001|Overall Study|Missing follow-up information|1|||
105577663|NCT02207374|364114570|FG002|Overall Study|Missing follow-up information|1|||
105577664|NCT02087150|364114571|FG000|Overall Study|Death|0|||
105577665|NCT02087150|364114572|FG001|Overall Study|Death|1|||
105577666|NCT02087150|364114573|FG002|Overall Study|Death|0|||
105577667|NCT02087150|364114571|FG000|Overall Study|Lost to Follow-up|6|||
105577668|NCT02087150|364114572|FG001|Overall Study|Lost to Follow-up|13|||
105577669|NCT02087150|364114573|FG002|Overall Study|Lost to Follow-up|7|||
105577670|NCT02087150|364114571|FG000|Overall Study|Withdrawal by Subject|2|||
105577671|NCT02087150|364114572|FG001|Overall Study|Withdrawal by Subject|5|||
105577672|NCT02087150|364114573|FG002|Overall Study|Withdrawal by Subject|3|||
105577673|NCT02087150|364114571|FG000|Overall Study|Physician Decision|0|||
105577674|NCT02087150|364114572|FG001|Overall Study|Physician Decision|1|||
105577675|NCT02087150|364114573|FG002|Overall Study|Physician Decision|0|||
105577676|NCT02087150|364114571|FG000|Overall Study|Procedure not done|1|||
105577677|NCT02087150|364114572|FG001|Overall Study|Procedure not done|13|||
105577678|NCT02087150|364114573|FG002|Overall Study|Procedure not done|0|||
105577679|NCT02087150|364114571|FG000|Overall Study|F/U not completed w/in study window|0|||
105577680|NCT02087150|364114572|FG001|Overall Study|F/U not completed w/in study window|0|||
105577681|NCT02087150|364114573|FG002|Overall Study|F/U not completed w/in study window|1|||
105577682|NCT02087150|364114571|FG000|Overall Study|Other|1|||
105577683|NCT02087150|364114572|FG001|Overall Study|Other|0|||
105577684|NCT02087150|364114573|FG002|Overall Study|Other|0|||
105577685|NCT02087150|364114571|FG000|Overall Study|Pt moved out of town|0|||
105577686|NCT02087150|364114572|FG001|Overall Study|Pt moved out of town|1|||
105577687|NCT02087150|364114573|FG002|Overall Study|Pt moved out of town|0|||
105577688|NCT03382600|364114576|FG000|Overall Study|Adverse Event|3|||
105577689|NCT03382600|364114577|FG001|Overall Study|Adverse Event|3|||
105577690|NCT03382600|364114576|FG000|Overall Study|Clinical Disease Progression|2|||
105577691|NCT03382600|364114577|FG001|Overall Study|Clinical Disease Progression|4|||
105577692|NCT03382600|364114576|FG000|Overall Study|Radiological Progression|40|||
105577693|NCT03382600|364114577|FG001|Overall Study|Radiological Progression|31|||
105375774|NCT01044498|363381665|FG001|Overall Study|Withdrew consent|1|||
105577694|NCT03382600|364114576|FG000|Overall Study|Withdrawal by Subject|0|||
105577695|NCT03382600|364114577|FG001|Overall Study|Withdrawal by Subject|1|||
105577696|NCT03382600|364114576|FG000|Overall Study|Other|9|||
105577697|NCT03382600|364114577|FG001|Overall Study|Other|7|||
105577698|NCT01000376|364114580|FG000|Cycle 1 Day 1|Adverse Event|1|||
105577699|NCT01000376|364114581|FG001|Cycle 1 Day 1|Adverse Event|0|||
105577700|NCT01000376|364114580|FG000|Cycle 1 Day 1|Progressive Disease|1|||
105577701|NCT01000376|364114581|FG001|Cycle 1 Day 1|Progressive Disease|0|||
105577702|NCT00064025|364114582|FG000|Overall Study|Ineligible|4|||
105577703|NCT00064025|364114582|FG000|Overall Study|Inevaluable|3|||
105375775|NCT01044498|363381664|FG000|Overall Study|Adverse Event|1|||
105375776|NCT01044498|363381665|FG001|Overall Study|Adverse Event|1|||
105330043|NCT01890122|363207539|FG001|Overall Study|Lost to Follow-up|1|||
105330044|NCT01890122|363207540|FG002|Overall Study|Lost to Follow-up|2|||
105330045|NCT01890122|363207541|FG003|Overall Study|Lost to Follow-up|2|||
105330046|NCT01890122|363207538|FG000|Overall Study|Voluntary Withdrawal|8|||
105375777|NCT01044498|363381664|FG000|Overall Study|Other|1|||
105375778|NCT01044498|363381665|FG001|Overall Study|Other|0|||
105375779|NCT00390013|363381666|FG000|Phase 1|tired|0|||
105375780|NCT00390013|363381667|FG001|Phase 1|tired|0|||
105375781|NCT00390013|363381668|FG002|Phase 1|tired|0|||
105375782|NCT00390013|363381669|FG003|Phase 1|tired|1|||
105375783|NCT00390013|363381666|FG000|Phase 2 First Treatment|tired|1|||
105330047|NCT01890122|363207539|FG001|Overall Study|Voluntary Withdrawal|8|||
105330048|NCT01890122|363207540|FG002|Overall Study|Voluntary Withdrawal|2|||
105330049|NCT01890122|363207541|FG003|Overall Study|Voluntary Withdrawal|11|||
105330050|NCT01890122|363207538|FG000|Overall Study|Lack of Efficacy|14|||
105577704|NCT02468934|364114583|FG000|Overall Study|Withdrawal by Subject|4|||
105577705|NCT02468934|364114583|FG000|Overall Study|Screen Failure|3|||
105577706|NCT00519636|364114588|FG000|Treatment Period 1|Adverse Event|1|||
105577707|NCT00519636|364114589|FG001|Treatment Period 1|Adverse Event|0|||
105577708|NCT00519636|364114590|FG002|Treatment Period 1|Adverse Event|1|||
105577709|NCT00519636|364114591|FG003|Treatment Period 1|Adverse Event|0|||
105577710|NCT00519636|364114588|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
105577711|NCT00519636|364114589|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
105577712|NCT00519636|364114590|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
105577713|NCT00519636|364114591|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
105577714|NCT00519636|364114588|FG000|Washout Period|Adverse Event|2|||
105577715|NCT00519636|364114589|FG001|Washout Period|Adverse Event|1|||
105577716|NCT00519636|364114590|FG002|Washout Period|Adverse Event|1|||
105577717|NCT00519636|364114591|FG003|Washout Period|Adverse Event|0|||
105577718|NCT00519636|364114588|FG000|Washout Period|Lost to Follow-up|1|||
105577719|NCT00519636|364114589|FG001|Washout Period|Lost to Follow-up|0|||
105577720|NCT00519636|364114590|FG002|Washout Period|Lost to Follow-up|0|||
105577721|NCT00519636|364114591|FG003|Washout Period|Lost to Follow-up|0|||
105577722|NCT00519636|364114588|FG000|Washout Period|Protocol Violation|0|||
105577723|NCT00519636|364114589|FG001|Washout Period|Protocol Violation|0|||
105577724|NCT00519636|364114590|FG002|Washout Period|Protocol Violation|1|||
105577725|NCT00519636|364114591|FG003|Washout Period|Protocol Violation|2|||
105577726|NCT00519636|364114588|FG000|Washout Period|Withdrawal by Subject|1|||
105577727|NCT00519636|364114589|FG001|Washout Period|Withdrawal by Subject|0|||
105577728|NCT00519636|364114590|FG002|Washout Period|Withdrawal by Subject|1|||
105577729|NCT00519636|364114591|FG003|Washout Period|Withdrawal by Subject|0|||
105577730|NCT00519636|364114588|FG000|Washout Period|Failed to meet continuation criteria|14|||
105577731|NCT00519636|364114589|FG001|Washout Period|Failed to meet continuation criteria|11|||
105577732|NCT00519636|364114590|FG002|Washout Period|Failed to meet continuation criteria|9|||
105577733|NCT00519636|364114591|FG003|Washout Period|Failed to meet continuation criteria|3|||
105577734|NCT00519636|364114588|FG000|Washout Period|Out of pollen area > 48 hours|1|||
105577735|NCT00519636|364114589|FG001|Washout Period|Out of pollen area > 48 hours|0|||
105577736|NCT00519636|364114590|FG002|Washout Period|Out of pollen area > 48 hours|0|||
105375784|NCT00390013|363381667|FG001|Phase 2 First Treatment|tired|0|||
105375785|NCT00390013|363381668|FG002|Phase 2 First Treatment|tired|0|||
105375786|NCT00390013|363381669|FG003|Phase 2 First Treatment|tired|0|||
105375787|NCT00390013|363381666|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
105375788|NCT00390013|363381667|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
105375789|NCT00390013|363381668|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
105375790|NCT00390013|363381669|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
105375791|NCT03034967|363381672|FG000|Overall Study|Withdrawal by Subject|9|||
105375792|NCT03034967|363381673|FG001|Overall Study|Withdrawal by Subject|2|||
105375793|NCT03034967|363381674|FG002|Overall Study|Withdrawal by Subject|6|||
105375794|NCT03034967|363381675|FG003|Overall Study|Withdrawal by Subject|6|||
105375795|NCT03034967|363381676|FG004|Overall Study|Withdrawal by Subject|9|||
105375796|NCT03034967|363381677|FG005|Overall Study|Withdrawal by Subject|2|||
105375797|NCT03034967|363381672|FG000|Overall Study|Physician Decision|1|||
105375798|NCT03034967|363381673|FG001|Overall Study|Physician Decision|0|||
105375799|NCT03034967|363381674|FG002|Overall Study|Physician Decision|1|||
105375800|NCT03034967|363381675|FG003|Overall Study|Physician Decision|1|||
105375801|NCT03034967|363381676|FG004|Overall Study|Physician Decision|1|||
105375802|NCT03034967|363381677|FG005|Overall Study|Physician Decision|0|||
105375803|NCT03034967|363381672|FG000|Overall Study|Lost to Follow-up|0|||
105375804|NCT03034967|363381673|FG001|Overall Study|Lost to Follow-up|0|||
105330051|NCT01890122|363207539|FG001|Overall Study|Lack of Efficacy|24|||
105330052|NCT01890122|363207540|FG002|Overall Study|Lack of Efficacy|7|||
105577737|NCT00519636|364114591|FG003|Washout Period|Out of pollen area > 48 hours|0|||
105375805|NCT03034967|363381674|FG002|Overall Study|Lost to Follow-up|0|||
105375806|NCT03034967|363381675|FG003|Overall Study|Lost to Follow-up|1|||
105375807|NCT03034967|363381676|FG004|Overall Study|Lost to Follow-up|0|||
105330053|NCT01890122|363207541|FG003|Overall Study|Lack of Efficacy|41|||
105330054|NCT01890122|363207538|FG000|Overall Study|Reason not Specified|0|||
105330055|NCT01890122|363207539|FG001|Overall Study|Reason not Specified|1|||
105330056|NCT01890122|363207540|FG002|Overall Study|Reason not Specified|1|||
105330057|NCT01890122|363207541|FG003|Overall Study|Reason not Specified|2|||
105330058|NCT01890122|363207538|FG000|Overall Study|Randomized but not Treated|1|||
105330059|NCT01890122|363207539|FG001|Overall Study|Randomized but not Treated|1|||
105330060|NCT01890122|363207540|FG002|Overall Study|Randomized but not Treated|0|||
105330061|NCT01890122|363207541|FG003|Overall Study|Randomized but not Treated|0|||
105330062|NCT02062450|363207542|FG000|Overall Study|No follow-up visit|124|||
105330063|NCT00298272|363209794|FG000|Double-blind Phase|Adverse Event|2|||
105330064|NCT00298272|363209795|FG001|Double-blind Phase|Adverse Event|0|||
105330065|NCT00298272|363209794|FG000|Double-blind Phase|Failure to Return|2|||
105330066|NCT00298272|363209795|FG001|Double-blind Phase|Failure to Return|0|||
105330067|NCT00298272|363209794|FG000|Double-blind Phase|Protocol Violation|2|||
105330068|NCT00298272|363209795|FG001|Double-blind Phase|Protocol Violation|0|||
105330069|NCT00298272|363209794|FG000|Double-blind Phase|Withdrawal by Subject|2|||
105330070|NCT00298272|363209795|FG001|Double-blind Phase|Withdrawal by Subject|0|||
105330071|NCT00298272|363209794|FG000|Open Label Retreatment Phase|Adverse Event|1|||
105330072|NCT00298272|363209795|FG001|Open Label Retreatment Phase|Adverse Event|2|||
105330073|NCT00298272|363209794|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
105330074|NCT00298272|363209795|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
105330075|NCT00298272|363209794|FG000|Open Label Retreatment Phase|Failure to Return|1|||
105330076|NCT00298272|363209795|FG001|Open Label Retreatment Phase|Failure to Return|0|||
105330077|NCT00298272|363209794|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
105330078|NCT00298272|363209795|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
105330079|NCT00298272|363209794|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
105330080|NCT00298272|363209795|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
105330081|NCT00298272|363209794|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
105330082|NCT00298272|363209795|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
105330083|NCT00298272|363209794|FG000|Safety Follow-up Phase|Failure to Return|1|||
105330084|NCT00298272|363209795|FG001|Safety Follow-up Phase|Failure to Return|1|||
105330085|NCT00298272|363209794|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
105330086|NCT00298272|363209795|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
105330087|NCT00298272|363209794|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
105330088|NCT00298272|363209795|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
105330089|NCT02898597|363209798|FG000|Overall Study|Protocol Violation|4|||
105330090|NCT02898597|363209799|FG001|Overall Study|Protocol Violation|2|||
105330091|NCT02898597|363209798|FG000|Overall Study|Lost to Follow-up|0|||
105330092|NCT02898597|363209799|FG001|Overall Study|Lost to Follow-up|9|||
105330093|NCT02898597|363209798|FG000|Overall Study|Death|0|||
105330094|NCT02898597|363209799|FG001|Overall Study|Death|1|||
105330095|NCT05326529|363209800|FG000|Overall Study|Lack of Efficacy|0|||
105330096|NCT05326529|363209801|FG001|Overall Study|Lack of Efficacy|1|||
105330097|NCT05326529|363209802|FG002|Overall Study|Lack of Efficacy|0|||
105330098|NCT05326529|363209800|FG000|Overall Study|Physician Decision|0|||
105330099|NCT05326529|363209801|FG001|Overall Study|Physician Decision|0|||
105330100|NCT05326529|363209802|FG002|Overall Study|Physician Decision|2|||
105330101|NCT01344824|363209805|FG000|Overall Study|Adverse Event|15|||
105330102|NCT01344824|363209805|FG000|Overall Study|Withdrawal by Subject|6|||
105330103|NCT01344824|363209805|FG000|Overall Study|Other complicating disease|1|||
105330104|NCT01344824|363209805|FG000|Overall Study|Progression|15|||
105330105|NCT01754129|363209809|FG000|Overall Study|Death|13|||
105330106|NCT01754129|363209809|FG000|Overall Study|Duodopa discontinuation|9|||
105330107|NCT01754129|363209809|FG000|Overall Study|Lost to Follow-up|7|||
105330108|NCT01754129|363209809|FG000|Overall Study|Withdrew consent|1|||
105330109|NCT01754129|363209809|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
105330110|NCT00708552|363209810|FG000|Overall Study|Adverse Event|10|||
105330111|NCT00708552|363209811|FG001|Overall Study|Adverse Event|3|||
105330112|NCT00708552|363209812|FG002|Overall Study|Adverse Event|4|||
105330113|NCT00708552|363209813|FG003|Overall Study|Adverse Event|6|||
105330114|NCT00708552|363209810|FG000|Overall Study|Lack of Efficacy|0|||
105330115|NCT00708552|363209811|FG001|Overall Study|Lack of Efficacy|4|||
105330116|NCT00708552|363209812|FG002|Overall Study|Lack of Efficacy|1|||
105330117|NCT00708552|363209813|FG003|Overall Study|Lack of Efficacy|0|||
105330118|NCT00708552|363209810|FG000|Overall Study|Protocol Violation|0|||
105330119|NCT00708552|363209811|FG001|Overall Study|Protocol Violation|0|||
105330120|NCT00708552|363209812|FG002|Overall Study|Protocol Violation|2|||
105330121|NCT00708552|363209813|FG003|Overall Study|Protocol Violation|4|||
105330122|NCT00708552|363209810|FG000|Overall Study|Lost to Follow-up|4|||
105330123|NCT00708552|363209811|FG001|Overall Study|Lost to Follow-up|2|||
105330124|NCT00708552|363209812|FG002|Overall Study|Lost to Follow-up|0|||
105330125|NCT00708552|363209813|FG003|Overall Study|Lost to Follow-up|1|||
105330126|NCT00708552|363209810|FG000|Overall Study|Physician Decision|1|||
105375808|NCT03034967|363381677|FG005|Overall Study|Lost to Follow-up|2|||
105375809|NCT03034967|363381672|FG000|Overall Study|Liver function test abnormality|0|||
105375810|NCT03034967|363381673|FG001|Overall Study|Liver function test abnormality|0|||
105375811|NCT03034967|363381674|FG002|Overall Study|Liver function test abnormality|1|||
105375812|NCT03034967|363381675|FG003|Overall Study|Liver function test abnormality|0|||
105375813|NCT03034967|363381676|FG004|Overall Study|Liver function test abnormality|0|||
105375814|NCT03034967|363381677|FG005|Overall Study|Liver function test abnormality|0|||
105375815|NCT03034967|363381672|FG000|Overall Study|Protocol Violation|1|||
105375816|NCT03034967|363381673|FG001|Overall Study|Protocol Violation|0|||
105375817|NCT03034967|363381674|FG002|Overall Study|Protocol Violation|0|||
105375818|NCT03034967|363381675|FG003|Overall Study|Protocol Violation|0|||
105375819|NCT03034967|363381676|FG004|Overall Study|Protocol Violation|0|||
105375820|NCT03034967|363381677|FG005|Overall Study|Protocol Violation|2|||
105375821|NCT03034967|363381672|FG000|Overall Study|Lack of Efficacy|0|||
105375822|NCT03034967|363381673|FG001|Overall Study|Lack of Efficacy|1|||
105375823|NCT03034967|363381674|FG002|Overall Study|Lack of Efficacy|2|||
105375824|NCT03034967|363381675|FG003|Overall Study|Lack of Efficacy|1|||
105375825|NCT03034967|363381676|FG004|Overall Study|Lack of Efficacy|1|||
105375826|NCT03034967|363381677|FG005|Overall Study|Lack of Efficacy|0|||
105375827|NCT03034967|363381672|FG000|Overall Study|Adverse Event, non-fatal|3|||
105375828|NCT03034967|363381673|FG001|Overall Study|Adverse Event, non-fatal|1|||
105375829|NCT03034967|363381674|FG002|Overall Study|Adverse Event, non-fatal|2|||
105375830|NCT03034967|363381675|FG003|Overall Study|Adverse Event, non-fatal|0|||
105375831|NCT03034967|363381676|FG004|Overall Study|Adverse Event, non-fatal|2|||
105375832|NCT03034967|363381677|FG005|Overall Study|Adverse Event, non-fatal|8|||
105375833|NCT03034967|363381672|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
105375834|NCT03034967|363381673|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
105375835|NCT03034967|363381674|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
105375836|NCT03034967|363381675|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
105375837|NCT03034967|363381676|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
105375838|NCT03034967|363381677|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
105375839|NCT02225587|363381680|FG000|Overall Study|Adverse Event|5|||
105375840|NCT02225587|363381681|FG001|Overall Study|Adverse Event|5|||
105375841|NCT02225587|363381680|FG000|Overall Study|Lost to Follow-up|5|||
105375842|NCT02225587|363381681|FG001|Overall Study|Lost to Follow-up|5|||
105375843|NCT02225587|363381680|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105375844|NCT02225587|363381681|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105375845|NCT02225587|363381680|FG000|Overall Study|Physician Decision|2|||
105375846|NCT02225587|363381681|FG001|Overall Study|Physician Decision|0|||
105375847|NCT02225587|363381680|FG000|Overall Study|Protocol Violation|1|||
105375848|NCT02225587|363381681|FG001|Overall Study|Protocol Violation|0|||
105375849|NCT02225587|363381680|FG000|Overall Study|Participant Moved|1|||
105375850|NCT02225587|363381681|FG001|Overall Study|Participant Moved|0|||
105375851|NCT02225587|363381680|FG000|Overall Study|Withdrawal by Subject|13|||
105375852|NCT02225587|363381681|FG001|Overall Study|Withdrawal by Subject|28|||
105375853|NCT01551173|363381687|FG000|Overall Study|Withdrawal by Subject|11|||
105375854|NCT01551173|363381688|FG001|Overall Study|Withdrawal by Subject|16|||
105375855|NCT01551173|363381687|FG000|Overall Study|Adverse Event|7|||
105375856|NCT01551173|363381688|FG001|Overall Study|Adverse Event|6|||
105375857|NCT01551173|363381687|FG000|Overall Study|Lost to Follow-up|5|||
105375858|NCT01551173|363381688|FG001|Overall Study|Lost to Follow-up|7|||
105375859|NCT01551173|363381687|FG000|Overall Study|Other|5|||
105375860|NCT01551173|363381688|FG001|Overall Study|Other|3|||
105375861|NCT04167670|363383352|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
105375862|NCT04167670|363383353|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
105375863|NCT04167670|363383354|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
105375864|NCT04167670|363383352|FG000|Overall Study|Significant protocol deviation|3|||
105375865|NCT04167670|363383353|FG001|Overall Study|Significant protocol deviation|1|||
105375866|NCT04167670|363383354|FG002|Overall Study|Significant protocol deviation|0|||
105375867|NCT04167670|363383352|FG000|Overall Study|Lost to Follow-up|0|||
105375868|NCT04167670|363383353|FG001|Overall Study|Lost to Follow-up|3|||
105375869|NCT04167670|363383354|FG002|Overall Study|Lost to Follow-up|3|||
105375870|NCT04167670|363383352|FG000|Overall Study|Voluntary Withdrawal|0|||
105375871|NCT04167670|363383353|FG001|Overall Study|Voluntary Withdrawal|1|||
105375872|NCT04167670|363383354|FG002|Overall Study|Voluntary Withdrawal|1|||
105375873|NCT04167670|363383352|FG000|Overall Study|Withdrawal of Consent|4|||
105375874|NCT04167670|363383353|FG001|Overall Study|Withdrawal of Consent|1|||
105375875|NCT04167670|363383354|FG002|Overall Study|Withdrawal of Consent|3|||
105375876|NCT04167670|363383352|FG000|Overall Study|Miscellaneous|7|||
105375877|NCT04167670|363383353|FG001|Overall Study|Miscellaneous|5|||
105375878|NCT04167670|363383354|FG002|Overall Study|Miscellaneous|3|||
105375879|NCT01127061|363383355|FG000|Overall Study|Lost to Follow-up|7|||
105375880|NCT01127061|363383356|FG001|Overall Study|Lost to Follow-up|10|||
105375881|NCT01127061|363383355|FG000|Overall Study|Physician Decision|3|||
105375882|NCT01127061|363383356|FG001|Overall Study|Physician Decision|3|||
105375883|NCT03595748|363383357|FG000|Overall Study|Death|11|||
105375884|NCT03595748|363383358|FG001|Overall Study|Death|12|||
105375885|NCT03595748|363383357|FG000|Overall Study|Withdrawal by Subject|28|||
105375886|NCT03595748|363383358|FG001|Overall Study|Withdrawal by Subject|29|||
105375887|NCT03595748|363383357|FG000|Overall Study|Protocol Violation|0|||
105375888|NCT03595748|363383358|FG001|Overall Study|Protocol Violation|1|||
105375889|NCT00549055|363383359|FG000|Overall Study|Adverse Event|4|||
105375890|NCT00549055|363383359|FG000|Overall Study|Lack of Efficacy|18|||
105375891|NCT00549055|363383359|FG000|Overall Study|Stabilization|5|||
105375892|NCT00549055|363383359|FG000|Overall Study|Progression to fibrosis|2|||
105375893|NCT00549055|363383359|FG000|Overall Study|Decrease of size|1|||
105375894|NCT00549055|363383359|FG000|Overall Study|Active choroidal neovascula increased|1|||
105577738|NCT00519636|364114588|FG000|Washout Period|Participating in study at another site|1|||
105577739|NCT00519636|364114589|FG001|Washout Period|Participating in study at another site|0|||
105577740|NCT00519636|364114590|FG002|Washout Period|Participating in study at another site|0|||
105577741|NCT00519636|364114591|FG003|Washout Period|Participating in study at another site|0|||
105577742|NCT00519636|364114588|FG000|Washout Period|Non-compliant|0|||
105577743|NCT00519636|364114589|FG001|Washout Period|Non-compliant|1|||
105577744|NCT00519636|364114590|FG002|Washout Period|Non-compliant|0|||
105577745|NCT00519636|364114591|FG003|Washout Period|Non-compliant|0|||
105577746|NCT00519636|364114588|FG000|Washout Period|Per doctors request|0|||
105577747|NCT00519636|364114589|FG001|Washout Period|Per doctors request|1|||
105577748|NCT00519636|364114590|FG002|Washout Period|Per doctors request|0|||
105577749|NCT00519636|364114591|FG003|Washout Period|Per doctors request|0|||
105577750|NCT00519636|364114588|FG000|Washout Period|Subject randomized in error|0|||
105577751|NCT00519636|364114589|FG001|Washout Period|Subject randomized in error|0|||
105577752|NCT00519636|364114590|FG002|Washout Period|Subject randomized in error|1|||
105577753|NCT00519636|364114591|FG003|Washout Period|Subject randomized in error|0|||
105577754|NCT00519636|364114588|FG000|Washout Period|Prohibited medications|0|||
105577755|NCT00519636|364114589|FG001|Washout Period|Prohibited medications|0|||
105577756|NCT00519636|364114590|FG002|Washout Period|Prohibited medications|1|||
105577757|NCT00519636|364114591|FG003|Washout Period|Prohibited medications|0|||
105577758|NCT00519636|364114588|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
105577759|NCT00519636|364114589|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
105577760|NCT00519636|364114590|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
105577761|NCT00519636|364114591|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
105577762|NCT00519636|364114588|FG000|Treatment Period 2|Subject randomized in error|0|||
105577763|NCT00519636|364114589|FG001|Treatment Period 2|Subject randomized in error|1|||
105577764|NCT00519636|364114590|FG002|Treatment Period 2|Subject randomized in error|0|||
105577765|NCT00519636|364114591|FG003|Treatment Period 2|Subject randomized in error|0|||
105577766|NCT00519636|364114588|FG000|Treatment Period 2|Per doctors request|0|||
105577767|NCT00519636|364114589|FG001|Treatment Period 2|Per doctors request|0|||
105577768|NCT00519636|364114590|FG002|Treatment Period 2|Per doctors request|1|||
105577769|NCT00519636|364114591|FG003|Treatment Period 2|Per doctors request|0|||
105577770|NCT00519636|364114588|FG000|Treatment Period 2|Subject misrandomized|0|||
105577771|NCT00519636|364114589|FG001|Treatment Period 2|Subject misrandomized|0|||
105577772|NCT00519636|364114590|FG002|Treatment Period 2|Subject misrandomized|0|||
105577773|NCT00519636|364114591|FG003|Treatment Period 2|Subject misrandomized|1|||
105577774|NCT00519636|364114588|FG000|Post Study Period|Subject randomized in error|0|||
105577775|NCT00519636|364114589|FG001|Post Study Period|Subject randomized in error|0|||
105577776|NCT00519636|364114590|FG002|Post Study Period|Subject randomized in error|0|||
105577777|NCT00519636|364114591|FG003|Post Study Period|Subject randomized in error|1|||
105577778|NCT02404493|364114592|FG000|Overall Study|Adverse Event|1|||
105577779|NCT02404493|364114593|FG001|Overall Study|Adverse Event|1|||
105577780|NCT02133924|364114598|FG000|Overall Study|Death|38|||
105577781|NCT02133924|364114598|FG000|Overall Study|Physician Decision|1|||
105577782|NCT02133924|364114598|FG000|Overall Study|Withdrawal by Subject|3|||
105577783|NCT01644474|364114599|FG000|Overall Study|Poor compliance to protocol|1|||
105577784|NCT01644474|364114600|FG001|Overall Study|Poor compliance to protocol|0|||
105577785|NCT01644474|364114599|FG000|Overall Study|Consent withdrawn by participant|0|||
105375895|NCT00549055|363383359|FG000|Overall Study|Vitreous hemorrhage|1|||
105375896|NCT00549055|363383359|FG000|Overall Study|Growth choroidal neovascularisation|1|||
105375897|NCT00549055|363383359|FG000|Overall Study|Choroidal neovascularization|1|||
105577786|NCT01644474|364114600|FG001|Overall Study|Consent withdrawn by participant|1|||
105577787|NCT01644474|364114599|FG000|Overall Study|Participant moved|0|||
105577788|NCT01644474|364114600|FG001|Overall Study|Participant moved|1|||
105577789|NCT01644474|364114599|FG000|Overall Study|Adverse Event|4|||
105577790|NCT01644474|364114600|FG001|Overall Study|Adverse Event|5|||
105577791|NCT01644474|364114599|FG000|Overall Study|Site scheduling error|1|||
105577792|NCT01644474|364114600|FG001|Overall Study|Site scheduling error|1|||
105577793|NCT01644474|364114599|FG000|Overall Study|Protocol Violation|1|||
105577794|NCT01644474|364114600|FG001|Overall Study|Protocol Violation|0|||
105375898|NCT00549055|363383359|FG000|Overall Study|Very low visual acuity (VA)|1|||
105375899|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
105375900|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
105375901|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
105375902|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
105375903|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
105375904|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
105375905|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
105375906|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
105375907|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
105375908|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
105375909|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
105375910|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
105375911|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
105375912|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
105375913|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
105375914|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
105375915|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
105375916|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
105375917|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
105375918|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
105375919|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
105375920|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
105375921|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
105375922|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
105375923|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
105375924|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
105375925|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
105375926|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
105375927|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
105375928|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
105375929|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
105375930|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
105375931|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
105375932|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
105375933|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
105375934|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
105375935|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
105375936|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
105375937|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
105375938|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
105375939|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
105375940|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
105375941|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
105375942|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
105375943|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
105375944|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
105375945|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
105375946|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
105375947|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
105375948|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
105375949|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
105375950|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
105375951|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
105375952|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
105375953|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
105375954|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
105375955|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
105375956|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
105375957|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
105375958|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
105375959|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
105577795|NCT00386308|364116583|FG000|Overall Study|Adverse Event|3|||
105577796|NCT00386308|364116584|FG001|Overall Study|Adverse Event|3|||
105577797|NCT00386308|364116583|FG000|Overall Study|Protocol Violation|2|||
105577798|NCT00386308|364116584|FG001|Overall Study|Protocol Violation|5|||
105577799|NCT00386308|364116583|FG000|Overall Study|Lack of Efficacy|0|||
105577800|NCT00386308|364116584|FG001|Overall Study|Lack of Efficacy|2|||
105577801|NCT00386308|364116583|FG000|Overall Study|Lost to Follow-up|10|||
105577802|NCT00386308|364116584|FG001|Overall Study|Lost to Follow-up|6|||
105577803|NCT00386308|364116583|FG000|Overall Study|Withdrawal by Subject|6|||
105577804|NCT00386308|364116584|FG001|Overall Study|Withdrawal by Subject|2|||
105577805|NCT00386308|364116583|FG000|Overall Study|Other Event|8|||
105577806|NCT00386308|364116584|FG001|Overall Study|Other Event|1|||
105577807|NCT00445601|364116585|FG000|Overall Study|Withdrawal by Subject|11|||
105577808|NCT00445601|364116586|FG001|Overall Study|Withdrawal by Subject|11|||
105577809|NCT00445601|364116585|FG000|Overall Study|TURBT Complication|12|||
105577810|NCT00445601|364116586|FG001|Overall Study|TURBT Complication|8|||
105577811|NCT00445601|364116585|FG000|Overall Study|Incorrect Disease Status|6|||
105577812|NCT00445601|364116586|FG001|Overall Study|Incorrect Disease Status|6|||
105577813|NCT00445601|364116585|FG000|Overall Study|Drug Delivery Issue|2|||
105577814|NCT00445601|364116586|FG001|Overall Study|Drug Delivery Issue|2|||
105577815|NCT00445601|364116585|FG000|Overall Study|Adverse Event|2|||
105577816|NCT00445601|364116586|FG001|Overall Study|Adverse Event|0|||
105577817|NCT00445601|364116585|FG000|Overall Study|Death prior to TURBT|0|||
105577818|NCT00445601|364116586|FG001|Overall Study|Death prior to TURBT|1|||
105577819|NCT04781647|364116591|FG000|Overall Study|Study terminated by Sponsor|11|||
105577820|NCT04781647|364116592|FG001|Overall Study|Study terminated by Sponsor|9|||
105577821|NCT04781647|364116593|FG002|Overall Study|Study terminated by Sponsor|9|||
105577822|NCT04781647|364116591|FG000|Overall Study|Withdrawal by Subject|1|||
105577823|NCT04781647|364116592|FG001|Overall Study|Withdrawal by Subject|2|||
105577824|NCT04781647|364116593|FG002|Overall Study|Withdrawal by Subject|0|||
105577825|NCT04781647|364116591|FG000|Overall Study|Adverse Event|0|||
105577826|NCT04781647|364116592|FG001|Overall Study|Adverse Event|1|||
105577827|NCT04781647|364116593|FG002|Overall Study|Adverse Event|1|||
105577828|NCT04781647|364116591|FG000|Overall Study|Protocol Violation|1|||
105577829|NCT04781647|364116592|FG001|Overall Study|Protocol Violation|0|||
105577830|NCT04781647|364116593|FG002|Overall Study|Protocol Violation|0|||
105577831|NCT04781647|364116591|FG000|Overall Study|Pregnancy|0|||
105577832|NCT04781647|364116592|FG001|Overall Study|Pregnancy|0|||
105577833|NCT04781647|364116593|FG002|Overall Study|Pregnancy|1|||
105577834|NCT04781647|364116591|FG000|Overall Study|Virology rebounded|1|||
105577835|NCT04781647|364116592|FG001|Overall Study|Virology rebounded|0|||
105577836|NCT04781647|364116593|FG002|Overall Study|Virology rebounded|0|||
105577837|NCT02531295|364116594|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
105577838|NCT02531295|364116595|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
105577839|NCT02531295|364116596|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
105577840|NCT02531295|364116597|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
105577841|NCT02531295|364116598|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
105577842|NCT02531295|364116599|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
105577843|NCT04213989|364116600|FG000|Overall Study|Withdrawal by Subject|3|||
105330127|NCT00708552|363209811|FG001|Overall Study|Physician Decision|2|||
105330128|NCT00708552|363209812|FG002|Overall Study|Physician Decision|0|||
105330129|NCT00708552|363209813|FG003|Overall Study|Physician Decision|0|||
105330130|NCT00708552|363209810|FG000|Overall Study|Withdrawal by Subject|12|||
105330131|NCT00708552|363209811|FG001|Overall Study|Withdrawal by Subject|7|||
105330132|NCT00708552|363209812|FG002|Overall Study|Withdrawal by Subject|8|||
105330133|NCT00708552|363209813|FG003|Overall Study|Withdrawal by Subject|10|||
105330134|NCT02126579|363209814|FG000|Overall Study|disease progression|0|||
105330135|NCT02126579|363209815|FG001|Overall Study|disease progression|0|||
105330136|NCT02126579|363209816|FG002|Overall Study|disease progression|0|||
105330137|NCT02126579|363209817|FG003|Overall Study|disease progression|1|||
105330138|NCT02126579|363209818|FG004|Overall Study|disease progression|0|||
105330139|NCT02126579|363209819|FG005|Overall Study|disease progression|0|||
105330140|NCT02126579|363209820|FG006|Overall Study|disease progression|1|||
105330141|NCT00808210|363209824|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
105330142|NCT00808210|363209825|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
105330143|NCT00808210|363209824|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
105330144|NCT00808210|363209825|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
105330145|NCT00808210|363209824|FG000|Double-Blind TX Period|Adverse Event|0|||
105330146|NCT00808210|363209825|FG001|Double-Blind TX Period|Adverse Event|1|||
105330147|NCT00808210|363209824|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
105330148|NCT00808210|363209825|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
105330149|NCT00808210|363209824|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
105330150|NCT00808210|363209825|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
105330151|NCT00808210|363209824|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
105330152|NCT00808210|363209825|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
105330153|NCT00391768|363209826|FG000|Overall Study|Withdrawal by Subject|0|||
105577844|NCT04213989|364116601|FG001|Overall Study|Withdrawal by Subject|2|||
105577845|NCT04213989|364116600|FG000|Overall Study|Physician Decision|1|||
105577846|NCT04213989|364116601|FG001|Overall Study|Physician Decision|0|||
105577847|NCT04213989|364116600|FG000|Overall Study|Lost to Follow-up|0|||
105577848|NCT04213989|364116601|FG001|Overall Study|Lost to Follow-up|4|||
105577849|NCT02105636|364116604|FG000|Pre-Treatment|Disease Progression|1|||
105577850|NCT02105636|364116605|FG001|Pre-Treatment|Disease Progression|0|||
105577851|NCT02105636|364116604|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
105577852|NCT02105636|364116605|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
105577853|NCT02105636|364116604|FG000|Pre-Treatment|Participant withdrew consent|0|||
105577854|NCT02105636|364116605|FG001|Pre-Treatment|Participant withdrew consent|6|||
105577855|NCT02105636|364116604|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
105577856|NCT02105636|364116605|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
105577857|NCT02105636|364116604|FG000|Treatment|Study Drug Toxicity|14|||
105577858|NCT02105636|364116605|FG001|Treatment|Study Drug Toxicity|10|||
105577859|NCT02105636|364116604|FG000|Treatment|Adverse event unrelated to study drug|19|||
105577860|NCT02105636|364116605|FG001|Treatment|Adverse event unrelated to study drug|3|||
105577861|NCT02105636|364116604|FG000|Treatment|Participant request to discontinue study treatment|8|||
105577862|NCT02105636|364116605|FG001|Treatment|Participant request to discontinue study treatment|6|||
105577863|NCT02105636|364116604|FG000|Treatment|Participant withdrew consent|5|||
105577864|NCT02105636|364116605|FG001|Treatment|Participant withdrew consent|1|||
105577865|NCT02105636|364116604|FG000|Treatment|Lost to Follow-up|1|||
105577866|NCT02105636|364116605|FG001|Treatment|Lost to Follow-up|0|||
105577867|NCT02105636|364116604|FG000|Treatment|Maximum Clinical Benefit|1|||
105577868|NCT02105636|364116605|FG001|Treatment|Maximum Clinical Benefit|3|||
105577869|NCT02105636|364116604|FG000|Treatment|Poor/Non-compliance|0|||
105577870|NCT02105636|364116605|FG001|Treatment|Poor/Non-compliance|1|||
105577871|NCT02105636|364116604|FG000|Treatment|Participant no longer meets study criteria|1|||
105577872|NCT02105636|364116605|FG001|Treatment|Participant no longer meets study criteria|0|||
105577873|NCT02105636|364116604|FG000|Treatment|Other reasons|1|||
105330154|NCT00391768|363209827|FG001|Overall Study|Withdrawal by Subject|0|||
105330155|NCT00391768|363209828|FG002|Overall Study|Withdrawal by Subject|1|||
105577874|NCT02105636|364116605|FG001|Treatment|Other reasons|0|||
105577875|NCT02105636|364116604|FG000|Treatment|Disease Progression|185|||
105577876|NCT02105636|364116605|FG001|Treatment|Disease Progression|87|||
105577877|NCT03390036|364116606|FG000|Overall Study|Lost to Follow-up|1|||
105577878|NCT03390036|364116607|FG001|Overall Study|Lost to Follow-up|0|||
105577879|NCT03390036|364116608|FG002|Overall Study|Lost to Follow-up|0|||
105577880|NCT03390036|364116606|FG000|Overall Study|Lack of Efficacy|1|||
105577881|NCT03390036|364116607|FG001|Overall Study|Lack of Efficacy|0|||
105577882|NCT03390036|364116608|FG002|Overall Study|Lack of Efficacy|0|||
105375960|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
105375961|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
105375962|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
105375963|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
105375964|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
105375965|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
105375966|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
105375967|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
105375968|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
105375969|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
105375970|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
105375971|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
105375972|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
105577883|NCT00358215|364116611|FG000|Overall Study|Ineligibility determined|4|||
105577884|NCT00358215|364116612|FG001|Overall Study|Ineligibility determined|3|||
105577885|NCT00358215|364116611|FG000|Overall Study|Adverse Event|83|||
105577886|NCT00358215|364116612|FG001|Overall Study|Adverse Event|65|||
105577887|NCT00358215|364116611|FG000|Overall Study|Withdrawal by Subject|111|||
105577888|NCT00358215|364116612|FG001|Overall Study|Withdrawal by Subject|102|||
105577889|NCT00358215|364116611|FG000|Overall Study|Participant request|65|||
105577890|NCT00358215|364116612|FG001|Overall Study|Participant request|64|||
105577891|NCT00358215|364116611|FG000|Overall Study|Physician Decision|47|||
105577892|NCT00358215|364116612|FG001|Overall Study|Physician Decision|39|||
105577893|NCT00358215|364116611|FG000|Overall Study|Lost to Follow-up|16|||
105577894|NCT00358215|364116612|FG001|Overall Study|Lost to Follow-up|22|||
105577895|NCT00358215|364116611|FG000|Overall Study|Death|265|||
105577896|NCT00358215|364116612|FG001|Overall Study|Death|281|||
105577897|NCT00358215|364116611|FG000|Overall Study|Protocol Violation|64|||
105577898|NCT00358215|364116612|FG001|Overall Study|Protocol Violation|59|||
105577899|NCT00358215|364116611|FG000|Overall Study|Pregnancy|1|||
105375973|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
105375974|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
105375975|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
105375976|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
105375977|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
105375978|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
105375979|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
105375980|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
105375981|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
105375982|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
105375983|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
105375984|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
105375985|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
105375986|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
105375987|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
105375988|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
105375989|NCT00090103|363383362|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
105375990|NCT00090103|363383363|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
105375991|NCT00090103|363383364|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
105375992|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
105375993|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
105375994|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
105375995|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
105375996|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
105375997|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
105375998|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
105375999|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
105376000|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
105376001|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
105577900|NCT00358215|364116612|FG001|Overall Study|Pregnancy|0|||
105577901|NCT00358215|364116611|FG000|Overall Study|Other|21|||
105577902|NCT00358215|364116612|FG001|Overall Study|Other|14|||
105577903|NCT00358215|364116611|FG000|Overall Study|Did not receive investigational product|2|||
105577904|NCT00358215|364116612|FG001|Overall Study|Did not receive investigational product|3|||
105577905|NCT02291289|364116613|FG000|Induction Treatment|Withdrawal by Subject|0|||
105577906|NCT02291289|364116614|FG001|Induction Treatment|Withdrawal by Subject|0|||
105577907|NCT02291289|364116615|FG002|Induction Treatment|Withdrawal by Subject|0|||
105577908|NCT02291289|364116616|FG003|Induction Treatment|Withdrawal by Subject|24|||
105577909|NCT02291289|364116617|FG004|Induction Treatment|Withdrawal by Subject|0|||
105577910|NCT02291289|364116618|FG005|Induction Treatment|Withdrawal by Subject|0|||
105577911|NCT02291289|364116619|FG006|Induction Treatment|Withdrawal by Subject|0|||
105577912|NCT02291289|364116620|FG007|Induction Treatment|Withdrawal by Subject|0|||
105577913|NCT02291289|364116621|FG008|Induction Treatment|Withdrawal by Subject|0|||
105577914|NCT02291289|364116622|FG009|Induction Treatment|Withdrawal by Subject|18|||
105577915|NCT02291289|364116623|FG010|Induction Treatment|Withdrawal by Subject|0|||
105577916|NCT02291289|364116624|FG011|Induction Treatment|Withdrawal by Subject|0|||
105577917|NCT02291289|364116625|FG012|Induction Treatment|Withdrawal by Subject|0|||
105577918|NCT02291289|364116613|FG000|Induction Treatment|Adverse Event|0|||
105577919|NCT02291289|364116614|FG001|Induction Treatment|Adverse Event|0|||
105577920|NCT02291289|364116615|FG002|Induction Treatment|Adverse Event|0|||
105577921|NCT02291289|364116616|FG003|Induction Treatment|Adverse Event|3|||
105577922|NCT02291289|364116617|FG004|Induction Treatment|Adverse Event|0|||
105577923|NCT02291289|364116618|FG005|Induction Treatment|Adverse Event|0|||
105577924|NCT02291289|364116619|FG006|Induction Treatment|Adverse Event|0|||
105577925|NCT02291289|364116620|FG007|Induction Treatment|Adverse Event|0|||
105577926|NCT02291289|364116621|FG008|Induction Treatment|Adverse Event|0|||
105577927|NCT02291289|364116622|FG009|Induction Treatment|Adverse Event|1|||
105577928|NCT02291289|364116623|FG010|Induction Treatment|Adverse Event|0|||
105577929|NCT02291289|364116624|FG011|Induction Treatment|Adverse Event|0|||
105577930|NCT02291289|364116625|FG012|Induction Treatment|Adverse Event|0|||
105577931|NCT02291289|364116613|FG000|Induction Treatment|Death|25|||
105577932|NCT02291289|364116614|FG001|Induction Treatment|Death|0|||
105577933|NCT02291289|364116615|FG002|Induction Treatment|Death|0|||
105577934|NCT02291289|364116616|FG003|Induction Treatment|Death|111|||
105577935|NCT02291289|364116617|FG004|Induction Treatment|Death|0|||
105577936|NCT02291289|364116618|FG005|Induction Treatment|Death|0|||
105577937|NCT02291289|364116619|FG006|Induction Treatment|Death|1|||
105577938|NCT02291289|364116620|FG007|Induction Treatment|Death|0|||
105577939|NCT02291289|364116621|FG008|Induction Treatment|Death|0|||
105577940|NCT02291289|364116622|FG009|Induction Treatment|Death|82|||
105577941|NCT02291289|364116623|FG010|Induction Treatment|Death|0|||
105577942|NCT02291289|364116624|FG011|Induction Treatment|Death|0|||
105577943|NCT02291289|364116625|FG012|Induction Treatment|Death|0|||
105577944|NCT02291289|364116613|FG000|Induction Treatment|Lost to Follow-up|1|||
105577945|NCT02291289|364116614|FG001|Induction Treatment|Lost to Follow-up|0|||
105577946|NCT02291289|364116615|FG002|Induction Treatment|Lost to Follow-up|0|||
105577947|NCT02291289|364116616|FG003|Induction Treatment|Lost to Follow-up|12|||
105577948|NCT02291289|364116617|FG004|Induction Treatment|Lost to Follow-up|0|||
105577949|NCT02291289|364116618|FG005|Induction Treatment|Lost to Follow-up|0|||
105577950|NCT02291289|364116619|FG006|Induction Treatment|Lost to Follow-up|0|||
105577951|NCT02291289|364116620|FG007|Induction Treatment|Lost to Follow-up|0|||
105577952|NCT02291289|364116621|FG008|Induction Treatment|Lost to Follow-up|0|||
105577953|NCT02291289|364116622|FG009|Induction Treatment|Lost to Follow-up|9|||
105577954|NCT02291289|364116623|FG010|Induction Treatment|Lost to Follow-up|0|||
105577955|NCT02291289|364116624|FG011|Induction Treatment|Lost to Follow-up|0|||
105577956|NCT02291289|364116625|FG012|Induction Treatment|Lost to Follow-up|0|||
105577957|NCT02291289|364116613|FG000|Induction Treatment|Non-Compliance|0|||
105577958|NCT02291289|364116614|FG001|Induction Treatment|Non-Compliance|0|||
105577959|NCT02291289|364116615|FG002|Induction Treatment|Non-Compliance|0|||
105577960|NCT02291289|364116616|FG003|Induction Treatment|Non-Compliance|1|||
105577961|NCT02291289|364116617|FG004|Induction Treatment|Non-Compliance|0|||
105330156|NCT00391768|363209829|FG003|Overall Study|Withdrawal by Subject|0|||
105330157|NCT00391768|363209830|FG004|Overall Study|Withdrawal by Subject|0|||
105330158|NCT00391768|363209831|FG005|Overall Study|Withdrawal by Subject|1|||
105330159|NCT00391768|363209832|FG006|Overall Study|Withdrawal by Subject|1|||
105330160|NCT00391768|363209826|FG000|Overall Study|Lost to Follow-up|0|||
105330161|NCT00391768|363209827|FG001|Overall Study|Lost to Follow-up|0|||
105330162|NCT00391768|363209828|FG002|Overall Study|Lost to Follow-up|0|||
105330163|NCT00391768|363209829|FG003|Overall Study|Lost to Follow-up|1|||
105330164|NCT00391768|363209830|FG004|Overall Study|Lost to Follow-up|2|||
105330165|NCT00391768|363209831|FG005|Overall Study|Lost to Follow-up|2|||
105330166|NCT00391768|363209832|FG006|Overall Study|Lost to Follow-up|3|||
105330167|NCT00406367|363209833|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
105330168|NCT00406367|363209834|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
105330169|NCT00406367|363209833|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
105330170|NCT00406367|363209834|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
105577962|NCT02291289|364116618|FG005|Induction Treatment|Non-Compliance|0|||
105577963|NCT02291289|364116619|FG006|Induction Treatment|Non-Compliance|0|||
105577964|NCT02291289|364116620|FG007|Induction Treatment|Non-Compliance|0|||
105577965|NCT02291289|364116621|FG008|Induction Treatment|Non-Compliance|0|||
105577966|NCT02291289|364116622|FG009|Induction Treatment|Non-Compliance|1|||
105577967|NCT02291289|364116623|FG010|Induction Treatment|Non-Compliance|0|||
105577968|NCT02291289|364116624|FG011|Induction Treatment|Non-Compliance|0|||
105577969|NCT02291289|364116625|FG012|Induction Treatment|Non-Compliance|0|||
105577970|NCT02291289|364116613|FG000|Induction Treatment|Reason Not Specified|0|||
105577971|NCT02291289|364116614|FG001|Induction Treatment|Reason Not Specified|0|||
105376002|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
105376003|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
105376004|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
105376005|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
105376006|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
105376007|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
105376008|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
105376009|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
105376010|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
105376011|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
105376012|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
105376013|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
105376014|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
105376015|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
105376016|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
105376017|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
105376018|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
105376019|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
105376020|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
105376021|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
105376022|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
105376023|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
105376024|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
105376025|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
105376026|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
105376027|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
105376028|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
105376029|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
105376030|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
105376031|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
105376032|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
105376033|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
105376034|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
105376035|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
105376036|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
105376037|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
105376038|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
105376039|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
105376040|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Death|1|||
105376041|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Death|0|||
105376042|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Death|1|||
105376043|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
105376044|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
105376045|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
105376046|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
105376047|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
105376048|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
105376049|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
105376050|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
105376051|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
105376052|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
105376053|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
105577972|NCT02291289|364116615|FG002|Induction Treatment|Reason Not Specified|0|||
105577973|NCT02291289|364116616|FG003|Induction Treatment|Reason Not Specified|4|||
105577974|NCT02291289|364116617|FG004|Induction Treatment|Reason Not Specified|0|||
105577975|NCT02291289|364116618|FG005|Induction Treatment|Reason Not Specified|0|||
105577976|NCT02291289|364116619|FG006|Induction Treatment|Reason Not Specified|0|||
105577977|NCT02291289|364116620|FG007|Induction Treatment|Reason Not Specified|0|||
105577978|NCT02291289|364116621|FG008|Induction Treatment|Reason Not Specified|0|||
105577979|NCT02291289|364116622|FG009|Induction Treatment|Reason Not Specified|7|||
105577980|NCT02291289|364116623|FG010|Induction Treatment|Reason Not Specified|0|||
105577981|NCT02291289|364116624|FG011|Induction Treatment|Reason Not Specified|0|||
105577982|NCT02291289|364116625|FG012|Induction Treatment|Reason Not Specified|0|||
105577983|NCT02291289|364116613|FG000|Induction Treatment|Physician Decision|0|||
105577984|NCT02291289|364116614|FG001|Induction Treatment|Physician Decision|0|||
105577985|NCT02291289|364116615|FG002|Induction Treatment|Physician Decision|0|||
105577986|NCT02291289|364116616|FG003|Induction Treatment|Physician Decision|3|||
105577987|NCT02291289|364116617|FG004|Induction Treatment|Physician Decision|0|||
105577988|NCT02291289|364116618|FG005|Induction Treatment|Physician Decision|0|||
105577989|NCT02291289|364116619|FG006|Induction Treatment|Physician Decision|0|||
105577990|NCT02291289|364116620|FG007|Induction Treatment|Physician Decision|0|||
105577991|NCT02291289|364116621|FG008|Induction Treatment|Physician Decision|0|||
105577992|NCT02291289|364116622|FG009|Induction Treatment|Physician Decision|1|||
105577993|NCT02291289|364116623|FG010|Induction Treatment|Physician Decision|0|||
105577994|NCT02291289|364116624|FG011|Induction Treatment|Physician Decision|0|||
105577995|NCT02291289|364116625|FG012|Induction Treatment|Physician Decision|0|||
105577996|NCT02291289|364116613|FG000|Induction Treatment|Protocol Violation|0|||
105577997|NCT02291289|364116614|FG001|Induction Treatment|Protocol Violation|0|||
105577998|NCT02291289|364116615|FG002|Induction Treatment|Protocol Violation|0|||
105577999|NCT02291289|364116616|FG003|Induction Treatment|Protocol Violation|3|||
105578000|NCT02291289|364116617|FG004|Induction Treatment|Protocol Violation|0|||
105578001|NCT02291289|364116618|FG005|Induction Treatment|Protocol Violation|0|||
105578002|NCT02291289|364116619|FG006|Induction Treatment|Protocol Violation|0|||
105578003|NCT02291289|364116620|FG007|Induction Treatment|Protocol Violation|0|||
105578004|NCT02291289|364116621|FG008|Induction Treatment|Protocol Violation|0|||
105578005|NCT02291289|364116622|FG009|Induction Treatment|Protocol Violation|2|||
105578006|NCT02291289|364116623|FG010|Induction Treatment|Protocol Violation|0|||
105578007|NCT02291289|364116624|FG011|Induction Treatment|Protocol Violation|0|||
105578008|NCT02291289|364116625|FG012|Induction Treatment|Protocol Violation|0|||
105578009|NCT02291289|364116613|FG000|Induction Treatment|Missing|4|||
105578010|NCT02291289|364116614|FG001|Induction Treatment|Missing|0|||
105578011|NCT02291289|364116615|FG002|Induction Treatment|Missing|0|||
105578012|NCT02291289|364116616|FG003|Induction Treatment|Missing|14|||
105578013|NCT02291289|364116617|FG004|Induction Treatment|Missing|0|||
105578014|NCT02291289|364116618|FG005|Induction Treatment|Missing|0|||
105578015|NCT02291289|364116619|FG006|Induction Treatment|Missing|0|||
105578016|NCT02291289|364116620|FG007|Induction Treatment|Missing|0|||
105578017|NCT02291289|364116621|FG008|Induction Treatment|Missing|0|||
105578018|NCT02291289|364116622|FG009|Induction Treatment|Missing|54|||
105578019|NCT02291289|364116623|FG010|Induction Treatment|Missing|0|||
105578020|NCT02291289|364116624|FG011|Induction Treatment|Missing|0|||
105578021|NCT02291289|364116625|FG012|Induction Treatment|Missing|0|||
105578022|NCT02291289|364116613|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
105578023|NCT02291289|364116614|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
105578024|NCT02291289|364116615|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
105578025|NCT02291289|364116616|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
105578026|NCT02291289|364116617|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
105578027|NCT02291289|364116618|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
105578028|NCT02291289|364116619|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
105578029|NCT02291289|364116620|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
105578030|NCT02291289|364116621|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
105578031|NCT02291289|364116622|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
105578032|NCT02291289|364116623|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
105578033|NCT02291289|364116624|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
105578034|NCT02291289|364116625|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
105578035|NCT02291289|364116613|FG000|Maintenance Treatment Phase|Death|0|||
105578036|NCT02291289|364116614|FG001|Maintenance Treatment Phase|Death|29|||
105578037|NCT02291289|364116615|FG002|Maintenance Treatment Phase|Death|16|||
105578038|NCT02291289|364116616|FG003|Maintenance Treatment Phase|Death|0|||
105578039|NCT02291289|364116617|FG004|Maintenance Treatment Phase|Death|188|||
105578040|NCT02291289|364116618|FG005|Maintenance Treatment Phase|Death|107|||
105578041|NCT02291289|364116619|FG006|Maintenance Treatment Phase|Death|0|||
105578042|NCT02291289|364116620|FG007|Maintenance Treatment Phase|Death|1|||
105578043|NCT02291289|364116621|FG008|Maintenance Treatment Phase|Death|1|||
105578044|NCT02291289|364116622|FG009|Maintenance Treatment Phase|Death|0|||
105578045|NCT02291289|364116623|FG010|Maintenance Treatment Phase|Death|46|||
105578046|NCT02291289|364116624|FG011|Maintenance Treatment Phase|Death|19|||
105578047|NCT02291289|364116625|FG012|Maintenance Treatment Phase|Death|0|||
105578048|NCT02291289|364116613|FG000|Maintenance Treatment Phase|Adverse Event|0|||
105578049|NCT02291289|364116614|FG001|Maintenance Treatment Phase|Adverse Event|0|||
105578050|NCT02291289|364116615|FG002|Maintenance Treatment Phase|Adverse Event|0|||
105578051|NCT02291289|364116616|FG003|Maintenance Treatment Phase|Adverse Event|0|||
105578052|NCT02291289|364116617|FG004|Maintenance Treatment Phase|Adverse Event|1|||
105578053|NCT02291289|364116618|FG005|Maintenance Treatment Phase|Adverse Event|1|||
105578054|NCT02291289|364116619|FG006|Maintenance Treatment Phase|Adverse Event|0|||
105578055|NCT02291289|364116620|FG007|Maintenance Treatment Phase|Adverse Event|0|||
105578056|NCT02291289|364116621|FG008|Maintenance Treatment Phase|Adverse Event|0|||
105578057|NCT02291289|364116622|FG009|Maintenance Treatment Phase|Adverse Event|0|||
105578058|NCT02291289|364116623|FG010|Maintenance Treatment Phase|Adverse Event|0|||
105578059|NCT02291289|364116624|FG011|Maintenance Treatment Phase|Adverse Event|0|||
105578060|NCT02291289|364116625|FG012|Maintenance Treatment Phase|Adverse Event|0|||
105578061|NCT02291289|364116613|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
105578062|NCT02291289|364116614|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
105578063|NCT02291289|364116615|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
105578064|NCT02291289|364116616|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
105578065|NCT02291289|364116617|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
105578066|NCT02291289|364116618|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
105578067|NCT02291289|364116619|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
105578068|NCT02291289|364116620|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
105578069|NCT02291289|364116621|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
105578070|NCT02291289|364116622|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
105578071|NCT02291289|364116623|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
105578072|NCT02291289|364116624|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
105578073|NCT02291289|364116625|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
105578074|NCT02291289|364116613|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
105578075|NCT02291289|364116614|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
105578076|NCT02291289|364116615|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
105578077|NCT02291289|364116616|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
105578078|NCT02291289|364116617|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
105578079|NCT02291289|364116618|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
105578080|NCT02291289|364116619|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
105578081|NCT02291289|364116620|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
105578082|NCT02291289|364116621|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
105578083|NCT02291289|364116622|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
105578084|NCT02291289|364116623|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
105578085|NCT02291289|364116624|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
105578086|NCT02291289|364116625|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
105578087|NCT02291289|364116613|FG000|Maintenance Treatment Phase|Physician Decision|0|||
105578088|NCT02291289|364116614|FG001|Maintenance Treatment Phase|Physician Decision|2|||
105578089|NCT02291289|364116615|FG002|Maintenance Treatment Phase|Physician Decision|0|||
105578090|NCT02291289|364116616|FG003|Maintenance Treatment Phase|Physician Decision|0|||
105578091|NCT02291289|364116617|FG004|Maintenance Treatment Phase|Physician Decision|3|||
105578092|NCT02291289|364116618|FG005|Maintenance Treatment Phase|Physician Decision|0|||
105578093|NCT02291289|364116619|FG006|Maintenance Treatment Phase|Physician Decision|0|||
105578094|NCT02291289|364116620|FG007|Maintenance Treatment Phase|Physician Decision|0|||
105578095|NCT02291289|364116621|FG008|Maintenance Treatment Phase|Physician Decision|0|||
105578096|NCT02291289|364116622|FG009|Maintenance Treatment Phase|Physician Decision|0|||
105578097|NCT02291289|364116623|FG010|Maintenance Treatment Phase|Physician Decision|1|||
105578098|NCT02291289|364116624|FG011|Maintenance Treatment Phase|Physician Decision|3|||
105578099|NCT02291289|364116625|FG012|Maintenance Treatment Phase|Physician Decision|0|||
105578100|NCT02291289|364116613|FG000|Maintenance Treatment Phase|Not Treated|0|||
105578101|NCT02291289|364116614|FG001|Maintenance Treatment Phase|Not Treated|0|||
105578102|NCT02291289|364116615|FG002|Maintenance Treatment Phase|Not Treated|2|||
105578103|NCT02291289|364116616|FG003|Maintenance Treatment Phase|Not Treated|0|||
105578104|NCT02291289|364116617|FG004|Maintenance Treatment Phase|Not Treated|0|||
105578105|NCT02291289|364116618|FG005|Maintenance Treatment Phase|Not Treated|0|||
105578106|NCT02291289|364116619|FG006|Maintenance Treatment Phase|Not Treated|0|||
105578107|NCT02291289|364116620|FG007|Maintenance Treatment Phase|Not Treated|0|||
105578108|NCT02291289|364116621|FG008|Maintenance Treatment Phase|Not Treated|0|||
105578109|NCT02291289|364116622|FG009|Maintenance Treatment Phase|Not Treated|0|||
105578110|NCT02291289|364116623|FG010|Maintenance Treatment Phase|Not Treated|0|||
105578111|NCT02291289|364116624|FG011|Maintenance Treatment Phase|Not Treated|0|||
105578112|NCT02291289|364116625|FG012|Maintenance Treatment Phase|Not Treated|0|||
105578113|NCT02291289|364116613|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
105578114|NCT02291289|364116614|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
105578115|NCT02291289|364116615|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
105376054|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
105376055|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
105376056|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
105376057|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
105376058|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
105376059|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
105376060|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
105376061|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
105376062|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
105376063|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
105376064|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Depression|0|||
105376065|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Depression|1|||
105376066|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Depression|0|||
105376067|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
105376068|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
105376069|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
105376070|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Jailed|0|||
105376071|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Jailed|1|||
105376072|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Jailed|0|||
105376073|NCT00090103|363383362|FG000|16-Week Safety Follow-up Period|Other|0|||
105376074|NCT00090103|363383363|FG001|16-Week Safety Follow-up Period|Other|1|||
105376075|NCT00090103|363383364|FG002|16-Week Safety Follow-up Period|Other|0|||
105376076|NCT01787838|363383367|FG000|Overall Study|refused|1413|||
105376077|NCT01431976|363383368|FG000|Overall Study|Adverse Event|6|||
105376078|NCT01431976|363383368|FG000|Overall Study|Lack of Efficacy|2|||
105376079|NCT01431976|363383368|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
105376080|NCT01431976|363383368|FG000|Overall Study|Physician Decision|1|||
105376081|NCT01431976|363383368|FG000|Overall Study|Withdrawal by Subject|1|||
105376082|NCT01963611|363383369|FG000|Overall Study|Adverse Event|1|||
105376083|NCT01963611|363383370|FG001|Overall Study|Adverse Event|1|||
105376084|NCT01963611|363383371|FG002|Overall Study|Adverse Event|3|||
105376085|NCT01963611|363383372|FG003|Overall Study|Adverse Event|4|||
105578116|NCT02291289|364116616|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
105578117|NCT02291289|364116617|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
105330171|NCT00406367|363209833|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
105330172|NCT00406367|363209834|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
105330173|NCT00406367|363209833|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
105330174|NCT00406367|363209834|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
105330175|NCT00406367|363209833|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
105376086|NCT01963611|363383373|FG004|Overall Study|Adverse Event|3|||
105376087|NCT01963611|363383369|FG000|Overall Study|Protocol Violation|0|||
105376088|NCT01963611|363383370|FG001|Overall Study|Protocol Violation|0|||
105376089|NCT01963611|363383371|FG002|Overall Study|Protocol Violation|0|||
105376090|NCT01963611|363383372|FG003|Overall Study|Protocol Violation|1|||
105376091|NCT01963611|363383373|FG004|Overall Study|Protocol Violation|0|||
105376092|NCT01963611|363383369|FG000|Overall Study|Lack of Efficacy|0|||
105376093|NCT01963611|363383370|FG001|Overall Study|Lack of Efficacy|0|||
105376094|NCT01963611|363383371|FG002|Overall Study|Lack of Efficacy|0|||
105376095|NCT01963611|363383372|FG003|Overall Study|Lack of Efficacy|1|||
105376096|NCT01963611|363383373|FG004|Overall Study|Lack of Efficacy|0|||
105376097|NCT01963611|363383369|FG000|Overall Study|Withdrawal by Subject|3|||
105376098|NCT01963611|363383370|FG001|Overall Study|Withdrawal by Subject|2|||
105376099|NCT01963611|363383371|FG002|Overall Study|Withdrawal by Subject|1|||
105376100|NCT01963611|363383372|FG003|Overall Study|Withdrawal by Subject|1|||
105376101|NCT01963611|363383373|FG004|Overall Study|Withdrawal by Subject|3|||
105376102|NCT01963611|363383369|FG000|Overall Study|Other|47|||
105376103|NCT01963611|363383370|FG001|Overall Study|Other|46|||
105376104|NCT01963611|363383371|FG002|Overall Study|Other|48|||
105330176|NCT00406367|363209834|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
105330177|NCT00406367|363209833|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
105330178|NCT00406367|363209834|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
105330179|NCT00406367|363209833|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
105330180|NCT00406367|363209834|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
105330181|NCT00406367|363209833|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
105330182|NCT00406367|363209834|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
105330183|NCT00406367|363209833|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
105330184|NCT00406367|363209834|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
105330185|NCT00406367|363209833|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
105330186|NCT00406367|363209834|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
105330187|NCT00406367|363209833|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
105330188|NCT00406367|363209834|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
105376105|NCT01963611|363383372|FG003|Overall Study|Other|45|||
105330189|NCT00406367|363209833|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
105330190|NCT00406367|363209834|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
105330191|NCT01812109|363209838|FG000|Overall Study|research personnel delay|16|||
105330192|NCT01812109|363209838|FG000|Overall Study|NIRS Unattainable|17|||
105330193|NCT03313180|363209839|FG000|Overall Study|Adverse Event|120|||
105330194|NCT03313180|363209839|FG000|Overall Study|Lost to Follow-up|3|||
105330195|NCT03313180|363209839|FG000|Overall Study|Withdrawal by Subject|39|||
105330196|NCT03313180|363209839|FG000|Overall Study|Other than listed above|15|||
105330197|NCT03313180|363209839|FG000|Overall Study|Covid-19 related|2|||
105330198|NCT02588612|363209845|FG000|Overall Study|Physician Decision|1|||
105330199|NCT02588612|363209845|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
105330200|NCT02588612|363209845|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
105330201|NCT02588612|363209845|FG000|Overall Study|Death prior to T-cell infusion|1|||
105330202|NCT01609296|363209852|FG000|Overall Study|Death|253|||
105330203|NCT01609296|363209852|FG000|Overall Study|Withdrawal by Subject|151|||
105376106|NCT01963611|363383373|FG004|Overall Study|Other|45|||
105376107|NCT02394275|363383379|FG000|Overall Study|Adverse Event|22|||
105376108|NCT02394275|363383379|FG000|Overall Study|Lost to Follow-up|7|||
105376109|NCT00782067|363383382|FG000|Overall Study|Adverse Event|35|||
105376110|NCT00782067|363383382|FG000|Overall Study|Subject withdrew consent|11|||
105376111|NCT00782067|363383382|FG000|Overall Study|Lost to Follow-up|2|||
105376112|NCT00782067|363383382|FG000|Overall Study|Administrative problems|14|||
105376113|NCT00782067|363383382|FG000|Overall Study|Death|9|||
105376114|NCT00782067|363383382|FG000|Overall Study|Disease progression|43|||
105376115|NCT00782067|363383382|FG000|Overall Study|Protocol deviation|2|||
105376116|NCT00614393|363383384|FG000|Overall Study|Adverse Event|20|||
105376117|NCT00614393|363383385|FG001|Overall Study|Adverse Event|2|||
105376118|NCT00614393|363383386|FG002|Overall Study|Adverse Event|3|||
105376119|NCT00614393|363383387|FG003|Overall Study|Adverse Event|13|||
105376120|NCT00614393|363383388|FG004|Overall Study|Adverse Event|21|||
105376121|NCT00614393|363383384|FG000|Overall Study|Lost to Follow-up|0|||
105376122|NCT00614393|363383385|FG001|Overall Study|Lost to Follow-up|0|||
105376123|NCT00614393|363383386|FG002|Overall Study|Lost to Follow-up|0|||
105330204|NCT01609296|363209852|FG000|Overall Study|Lost to Follow-up|21|||
105330205|NCT01609296|363209852|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
105330206|NCT01609296|363209852|FG000|Overall Study|missed visit but known to be alive|28|||
105330207|NCT00628212|363209853|FG000|Overall Study|Adverse Event|2|||
105330208|NCT00628212|363209854|FG001|Overall Study|Adverse Event|0|||
105330209|NCT00628212|363209855|FG002|Overall Study|Adverse Event|1|||
105376124|NCT00614393|363383387|FG003|Overall Study|Lost to Follow-up|1|||
105376125|NCT00614393|363383388|FG004|Overall Study|Lost to Follow-up|2|||
105376126|NCT00614393|363383384|FG000|Overall Study|Physician Decision|17|||
105376127|NCT00614393|363383385|FG001|Overall Study|Physician Decision|0|||
105376128|NCT00614393|363383386|FG002|Overall Study|Physician Decision|1|||
105376129|NCT00614393|363383387|FG003|Overall Study|Physician Decision|8|||
105376130|NCT00614393|363383388|FG004|Overall Study|Physician Decision|9|||
105376131|NCT00614393|363383384|FG000|Overall Study|Progressive Disease|118|||
105376132|NCT00614393|363383385|FG001|Overall Study|Progressive Disease|5|||
105376133|NCT00614393|363383386|FG002|Overall Study|Progressive Disease|5|||
105376134|NCT00614393|363383387|FG003|Overall Study|Progressive Disease|138|||
105376135|NCT00614393|363383388|FG004|Overall Study|Progressive Disease|130|||
105376136|NCT00614393|363383384|FG000|Overall Study|Protocol Violation|1|||
105376137|NCT00614393|363383385|FG001|Overall Study|Protocol Violation|0|||
105330210|NCT00628212|363209856|FG003|Overall Study|Adverse Event|2|||
105330211|NCT00628212|363209853|FG000|Overall Study|Physician Decision|1|||
105330212|NCT00628212|363209854|FG001|Overall Study|Physician Decision|1|||
105330213|NCT00628212|363209855|FG002|Overall Study|Physician Decision|2|||
105330214|NCT00628212|363209856|FG003|Overall Study|Physician Decision|3|||
105330215|NCT01592786|363209857|FG000|Overall Study|Adverse Event|60|||
105330216|NCT01592786|363209857|FG000|Overall Study|Lack of Efficacy|19|||
105330217|NCT01592786|363209857|FG000|Overall Study|Protocol Violation|14|||
105330218|NCT01592786|363209857|FG000|Overall Study|Withdrawal by Subject|23|||
105330219|NCT01592786|363209857|FG000|Overall Study|Lost to Follow-up|19|||
105376138|NCT00614393|363383386|FG002|Overall Study|Protocol Violation|0|||
105376139|NCT00614393|363383387|FG003|Overall Study|Protocol Violation|0|||
105330220|NCT01592786|363209857|FG000|Overall Study|Other|3|||
105330221|NCT05047211|363209858|FG000|Overall Study|Lost to Follow-up|8|||
105376140|NCT00614393|363383388|FG004|Overall Study|Protocol Violation|0|||
105376141|NCT00614393|363383384|FG000|Overall Study|Terminated by Sponsor|0|||
105376142|NCT00614393|363383385|FG001|Overall Study|Terminated by Sponsor|0|||
105376143|NCT00614393|363383386|FG002|Overall Study|Terminated by Sponsor|0|||
105330222|NCT05047211|363209859|FG001|Overall Study|Lost to Follow-up|5|||
105330223|NCT01575834|363209860|FG000|Overall Study|Withdrawal by Subject|352|||
105330224|NCT01575834|363209861|FG001|Overall Study|Withdrawal by Subject|390|||
105330225|NCT01575834|363209860|FG000|Overall Study|Death|81|||
105330226|NCT01575834|363209861|FG001|Overall Study|Death|74|||
105376144|NCT00614393|363383387|FG003|Overall Study|Terminated by Sponsor|0|||
105376145|NCT00614393|363383388|FG004|Overall Study|Terminated by Sponsor|1|||
105578118|NCT02291289|364116618|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
105578119|NCT02291289|364116619|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
105578120|NCT02291289|364116620|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
105578121|NCT02291289|364116621|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
105578122|NCT02291289|364116622|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
105578123|NCT02291289|364116623|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
105578124|NCT02291289|364116624|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
105578125|NCT02291289|364116625|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
105578126|NCT02291289|364116613|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
105578127|NCT02291289|364116614|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
105578128|NCT02291289|364116615|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
105578129|NCT02291289|364116616|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
105578130|NCT02291289|364116617|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
105578131|NCT02291289|364116618|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
105578132|NCT02291289|364116619|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
105578133|NCT02291289|364116620|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
105578134|NCT02291289|364116621|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
105578135|NCT02291289|364116622|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
105578136|NCT02291289|364116623|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
105578137|NCT02291289|364116624|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
105578138|NCT02291289|364116625|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
105578139|NCT02291289|364116613|FG000|Early Disease Progression|Death|0|||
105578140|NCT02291289|364116614|FG001|Early Disease Progression|Death|0|||
105578141|NCT02291289|364116615|FG002|Early Disease Progression|Death|0|||
105578142|NCT02291289|364116616|FG003|Early Disease Progression|Death|0|||
105578143|NCT02291289|364116617|FG004|Early Disease Progression|Death|0|||
105578144|NCT02291289|364116618|FG005|Early Disease Progression|Death|0|||
105578145|NCT02291289|364116619|FG006|Early Disease Progression|Death|0|||
105578146|NCT02291289|364116620|FG007|Early Disease Progression|Death|0|||
105578147|NCT02291289|364116621|FG008|Early Disease Progression|Death|0|||
105578148|NCT02291289|364116622|FG009|Early Disease Progression|Death|0|||
105578149|NCT02291289|364116623|FG010|Early Disease Progression|Death|0|||
105578150|NCT02291289|364116624|FG011|Early Disease Progression|Death|0|||
105578151|NCT02291289|364116625|FG012|Early Disease Progression|Death|10|||
105578152|NCT02291289|364116613|FG000|Early Disease Progression|Lost to Follow-up|0|||
105578153|NCT02291289|364116614|FG001|Early Disease Progression|Lost to Follow-up|0|||
105578154|NCT02291289|364116615|FG002|Early Disease Progression|Lost to Follow-up|0|||
105578155|NCT02291289|364116616|FG003|Early Disease Progression|Lost to Follow-up|0|||
105578156|NCT02291289|364116617|FG004|Early Disease Progression|Lost to Follow-up|0|||
105578157|NCT02291289|364116618|FG005|Early Disease Progression|Lost to Follow-up|0|||
105578158|NCT02291289|364116619|FG006|Early Disease Progression|Lost to Follow-up|0|||
105578159|NCT02291289|364116620|FG007|Early Disease Progression|Lost to Follow-up|0|||
105578160|NCT02291289|364116621|FG008|Early Disease Progression|Lost to Follow-up|0|||
105578161|NCT02291289|364116622|FG009|Early Disease Progression|Lost to Follow-up|0|||
105578162|NCT02291289|364116623|FG010|Early Disease Progression|Lost to Follow-up|0|||
105578163|NCT02291289|364116624|FG011|Early Disease Progression|Lost to Follow-up|0|||
105578164|NCT02291289|364116625|FG012|Early Disease Progression|Lost to Follow-up|1|||
105578165|NCT01087723|364116628|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
105578166|NCT01087723|364116629|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
105578167|NCT01087723|364116628|FG000|Overall Study|Withdrawal by Subject|10|||
105578168|NCT01087723|364116629|FG001|Overall Study|Withdrawal by Subject|13|||
105578169|NCT01087723|364116628|FG000|Overall Study|Physician Decision|2|||
105578170|NCT01087723|364116629|FG001|Overall Study|Physician Decision|0|||
105578171|NCT01087723|364116628|FG000|Overall Study|Lost to Follow-up|1|||
105578172|NCT01087723|364116629|FG001|Overall Study|Lost to Follow-up|4|||
105578173|NCT01087723|364116628|FG000|Overall Study|Reason Not Specified|1|||
105578174|NCT01087723|364116629|FG001|Overall Study|Reason Not Specified|2|||
105578175|NCT00806624|364116632|FG000|Overall Study|Adverse Event|2|||
105578176|NCT00806624|364116633|FG001|Overall Study|Adverse Event|8|||
105578177|NCT00806624|364116634|FG002|Overall Study|Adverse Event|0|||
105578178|NCT00806624|364116632|FG000|Overall Study|Death|0|||
105578179|NCT00806624|364116633|FG001|Overall Study|Death|1|||
105376146|NCT00614393|363383384|FG000|Overall Study|Withdrawal by Subject|20|||
105376147|NCT00614393|363383385|FG001|Overall Study|Withdrawal by Subject|1|||
105376148|NCT00614393|363383386|FG002|Overall Study|Withdrawal by Subject|1|||
105376149|NCT00614393|363383387|FG003|Overall Study|Withdrawal by Subject|16|||
105578180|NCT00806624|364116634|FG002|Overall Study|Death|1|||
105578181|NCT00806624|364116632|FG000|Overall Study|Lost to Follow-up|1|||
105578182|NCT00806624|364116633|FG001|Overall Study|Lost to Follow-up|0|||
105376150|NCT00614393|363383388|FG004|Overall Study|Withdrawal by Subject|13|||
105376151|NCT00614393|363383384|FG000|Overall Study|Other|4|||
105376152|NCT00614393|363383385|FG001|Overall Study|Other|0|||
105376153|NCT00614393|363383386|FG002|Overall Study|Other|0|||
105376154|NCT00614393|363383387|FG003|Overall Study|Other|4|||
105376155|NCT00614393|363383388|FG004|Overall Study|Other|2|||
105376156|NCT00614393|363383384|FG000|Overall Study|Not Treated|0|||
105376157|NCT00614393|363383385|FG001|Overall Study|Not Treated|0|||
105376158|NCT00614393|363383386|FG002|Overall Study|Not Treated|0|||
105376159|NCT00614393|363383387|FG003|Overall Study|Not Treated|0|||
105376160|NCT00614393|363383388|FG004|Overall Study|Not Treated|2|||
105376161|NCT02328105|363383389|FG000|Overall Study|Death|6|||
105376162|NCT02328105|363383389|FG000|Overall Study|Withdrawal by Subject|1|||
105376163|NCT02328105|363383389|FG000|Overall Study|Still On Study in Follow-Up|4|||
105376164|NCT01588509|363383392|FG000|Overall Study|Lost to Follow-up|1|||
105376165|NCT01588509|363383393|FG001|Overall Study|Lost to Follow-up|0|||
105376166|NCT00855582|363383394|FG000|Overall Study|Adverse Event|2|||
105376167|NCT00855582|363383395|FG001|Overall Study|Adverse Event|6|||
105376168|NCT00855582|363383396|FG002|Overall Study|Adverse Event|3|||
105376169|NCT00855582|363383394|FG000|Overall Study|Death|1|||
105376170|NCT00855582|363383395|FG001|Overall Study|Death|0|||
105376171|NCT00855582|363383396|FG002|Overall Study|Death|0|||
105376172|NCT00855582|363383394|FG000|Overall Study|Lack of Efficacy|1|||
105376173|NCT00855582|363383395|FG001|Overall Study|Lack of Efficacy|3|||
105376174|NCT00855582|363383396|FG002|Overall Study|Lack of Efficacy|8|||
105376175|NCT00855582|363383394|FG000|Overall Study|Lost to Follow-up|1|||
105376176|NCT00855582|363383395|FG001|Overall Study|Lost to Follow-up|3|||
105376177|NCT00855582|363383396|FG002|Overall Study|Lost to Follow-up|1|||
105376178|NCT00855582|363383394|FG000|Overall Study|Physician Decision|0|||
105376179|NCT00855582|363383395|FG001|Overall Study|Physician Decision|0|||
105376180|NCT00855582|363383396|FG002|Overall Study|Physician Decision|1|||
105376181|NCT00855582|363383394|FG000|Overall Study|Protocol Violation|6|||
105376182|NCT00855582|363383395|FG001|Overall Study|Protocol Violation|2|||
105376183|NCT00855582|363383396|FG002|Overall Study|Protocol Violation|6|||
105376184|NCT00855582|363383394|FG000|Overall Study|Entry Criteria Not Met|8|||
105376185|NCT00855582|363383395|FG001|Overall Study|Entry Criteria Not Met|6|||
105376186|NCT00855582|363383396|FG002|Overall Study|Entry Criteria Not Met|3|||
105376187|NCT00855582|363383394|FG000|Overall Study|Withdrawal by Subject|7|||
105376188|NCT00855582|363383395|FG001|Overall Study|Withdrawal by Subject|4|||
105376189|NCT00855582|363383396|FG002|Overall Study|Withdrawal by Subject|8|||
105376190|NCT00620542|363383400|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
105376191|NCT00620542|363383401|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
105376192|NCT00620542|363383402|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
105376193|NCT00620542|363383403|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
105376194|NCT00620542|363383400|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
105376195|NCT00620542|363383401|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
105376196|NCT00620542|363383402|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
105376197|NCT00620542|363383403|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
105376198|NCT00620542|363383400|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
105376199|NCT00620542|363383401|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
105376200|NCT00620542|363383402|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
105376201|NCT00620542|363383403|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
105376202|NCT00620542|363383400|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
105376203|NCT00620542|363383401|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
105376204|NCT00620542|363383402|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
105376205|NCT00620542|363383403|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
105376206|NCT00620542|363383400|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
105376207|NCT00620542|363383401|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
105376208|NCT00620542|363383402|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
105376209|NCT00620542|363383403|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
105376210|NCT00620542|363383400|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
105376211|NCT00620542|363383401|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
105376212|NCT00620542|363383402|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
105376213|NCT00620542|363383403|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
105376214|NCT00620542|363383400|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
105578183|NCT00806624|364116634|FG002|Overall Study|Lost to Follow-up|1|||
105578184|NCT00806624|364116632|FG000|Overall Study|Withdrawal by Subject|6|||
105578185|NCT00806624|364116633|FG001|Overall Study|Withdrawal by Subject|3|||
105578186|NCT00806624|364116634|FG002|Overall Study|Withdrawal by Subject|3|||
105376215|NCT00620542|363383401|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
105376216|NCT00620542|363383402|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
105376217|NCT00620542|363383403|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
105376218|NCT00620542|363383400|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
105376219|NCT00620542|363383401|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
105376220|NCT00620542|363383402|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
105578187|NCT00806624|364116632|FG000|Overall Study|discontinued before start of treatment|0|||
105376221|NCT00620542|363383403|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
105376222|NCT00620542|363383400|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
105578188|NCT00806624|364116633|FG001|Overall Study|discontinued before start of treatment|0|||
105578189|NCT00806624|364116634|FG002|Overall Study|discontinued before start of treatment|1|||
105578190|NCT01702428|364116635|FG000|Overall Study|Adverse Event|2|||
105578191|NCT01702428|364116636|FG001|Overall Study|Adverse Event|0|||
105578192|NCT01702428|364116637|FG002|Overall Study|Adverse Event|0|||
105578193|NCT01702428|364116638|FG003|Overall Study|Adverse Event|0|||
105578194|NCT01702428|364116635|FG000|Overall Study|Lost to Follow-up|33|||
105578195|NCT01702428|364116636|FG001|Overall Study|Lost to Follow-up|41|||
105578196|NCT01702428|364116637|FG002|Overall Study|Lost to Follow-up|37|||
105578197|NCT01702428|364116638|FG003|Overall Study|Lost to Follow-up|44|||
105578198|NCT01702428|364116635|FG000|Overall Study|Parents cannot assist to site|1|||
105578199|NCT01702428|364116636|FG001|Overall Study|Parents cannot assist to site|0|||
105578200|NCT01702428|364116637|FG002|Overall Study|Parents cannot assist to site|1|||
105578201|NCT01702428|364116638|FG003|Overall Study|Parents cannot assist to site|0|||
105578202|NCT01702428|364116635|FG000|Overall Study|Lost Coverage|0|||
105578203|NCT01702428|364116636|FG001|Overall Study|Lost Coverage|0|||
105578204|NCT01702428|364116637|FG002|Overall Study|Lost Coverage|0|||
105578205|NCT01702428|364116638|FG003|Overall Study|Lost Coverage|1|||
105578206|NCT01702428|364116635|FG000|Overall Study|Lost Health Plan|3|||
105578207|NCT01702428|364116636|FG001|Overall Study|Lost Health Plan|5|||
105578208|NCT01702428|364116637|FG002|Overall Study|Lost Health Plan|0|||
105578209|NCT01702428|364116638|FG003|Overall Study|Lost Health Plan|2|||
105578210|NCT01702428|364116635|FG000|Overall Study|Mother transferred care|0|||
105578211|NCT01702428|364116636|FG001|Overall Study|Mother transferred care|1|||
105578212|NCT01702428|364116637|FG002|Overall Study|Mother transferred care|0|||
105578213|NCT01702428|364116638|FG003|Overall Study|Mother transferred care|0|||
105578214|NCT01702428|364116635|FG000|Overall Study|Parents too busy|1|||
105578215|NCT01702428|364116636|FG001|Overall Study|Parents too busy|0|||
105578216|NCT01702428|364116637|FG002|Overall Study|Parents too busy|0|||
105578217|NCT01702428|364116638|FG003|Overall Study|Parents too busy|0|||
105578218|NCT01702428|364116635|FG000|Overall Study|Protocol Violation|3|||
105578219|NCT01702428|364116636|FG001|Overall Study|Protocol Violation|0|||
105578220|NCT01702428|364116637|FG002|Overall Study|Protocol Violation|1|||
105578221|NCT01702428|364116638|FG003|Overall Study|Protocol Violation|0|||
105578222|NCT01702428|364116635|FG000|Overall Study|Withdrawal by Subject|21|||
105578223|NCT01702428|364116636|FG001|Overall Study|Withdrawal by Subject|23|||
105578224|NCT01702428|364116637|FG002|Overall Study|Withdrawal by Subject|14|||
105578225|NCT01702428|364116638|FG003|Overall Study|Withdrawal by Subject|10|||
105578226|NCT00709592|364116639|FG000|Overall Study|Unable to proceed to transplant|0|||
105578227|NCT00709592|364116640|FG001|Overall Study|Unable to proceed to transplant|1|||
105578228|NCT03268590|364116647|FG000|Overall Study|Previously unknown exclusion criteria|1|||
105578229|NCT02080520|364116648|FG000|Overall Study|Self-reported symptoms|5|||
105578230|NCT02080520|364116649|FG001|Overall Study|Self-reported symptoms|6|||
105578231|NCT02080520|364116648|FG000|Overall Study|Unable to contact|2|||
105578232|NCT02080520|364116649|FG001|Overall Study|Unable to contact|1|||
105578233|NCT02080520|364116648|FG000|Overall Study|Initiated aspirin|2|||
105578234|NCT02080520|364116649|FG001|Overall Study|Initiated aspirin|0|||
105578235|NCT02080520|364116648|FG000|Overall Study|Atrial fibrillation|1|||
105578236|NCT02080520|364116649|FG001|Overall Study|Atrial fibrillation|1|||
105578237|NCT02080520|364116648|FG000|Overall Study|Cancer|1|||
105578238|NCT02080520|364116649|FG001|Overall Study|Cancer|2|||
105578239|NCT02080520|364116648|FG000|Overall Study|Not interested in study|1|||
105578240|NCT02080520|364116649|FG001|Overall Study|Not interested in study|3|||
105578241|NCT02080520|364116648|FG000|Overall Study|Too busy|1|||
105578242|NCT02080520|364116649|FG001|Overall Study|Too busy|1|||
105578243|NCT02080520|364116648|FG000|Overall Study|Work-related injury|1|||
105578244|NCT02080520|364116649|FG001|Overall Study|Work-related injury|0|||
105578245|NCT02080520|364116648|FG000|Overall Study|Personal reasons|0|||
105578246|NCT02080520|364116649|FG001|Overall Study|Personal reasons|3|||
105578247|NCT00109928|364116656|FG000|Overall Study|Adverse Event|2|||
105578248|NCT00109928|364116656|FG000|Overall Study|Progression|6|||
105578249|NCT00109928|364116656|FG000|Overall Study|Death|2|||
105578250|NCT00109928|364116656|FG000|Overall Study|not protocol specified|2|||
105578251|NCT00109928|364116656|FG000|Overall Study|not eligible|1|||
105578252|NCT01196104|364116657|FG000|Overall Study|Lost to Follow-up|1|||
105578253|NCT01196104|364116658|FG001|Overall Study|Lost to Follow-up|0|||
105578254|NCT01196104|364116657|FG000|Overall Study|Physician Decision|0|||
105578255|NCT01196104|364116658|FG001|Overall Study|Physician Decision|1|||
105578256|NCT01196104|364116657|FG000|Overall Study|Withdrawal by Subject|3|||
105578257|NCT01196104|364116658|FG001|Overall Study|Withdrawal by Subject|3|||
105578258|NCT01196104|364116657|FG000|Overall Study|Various|0|||
105578259|NCT01196104|364116658|FG001|Overall Study|Various|1|||
105578260|NCT00610675|364116659|FG000|Overall Study|Untreated|4|||
105578261|NCT00610675|364116659|FG000|Overall Study|Adverse Event|67|||
105578262|NCT00610675|364116659|FG000|Overall Study|Insufficient Effect|31|||
105376223|NCT00620542|363383401|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
105578263|NCT00610675|364116659|FG000|Overall Study|Withdrawal by Subject|28|||
105578264|NCT00610675|364116659|FG000|Overall Study|Reasons unrelated to trial|27|||
105578265|NCT00610675|364116659|FG000|Overall Study|Lack of Compliance|7|||
105578266|NCT00610675|364116659|FG000|Overall Study|Lost to Follow-up|31|||
105578267|NCT00610675|364116659|FG000|Overall Study|Other reason (not specified)|25|||
105578268|NCT01316692|364116660|FG000|Overall Study|Adverse Event|5|||
105578269|NCT01316692|364116660|FG000|Overall Study|Disease Progression|7|||
105578270|NCT01536145|364116667|FG000|Overall Study|Progressive disease|3|||
105578271|NCT01536145|364116668|FG001|Overall Study|Progressive disease|4|||
105578272|NCT01536145|364116669|FG002|Overall Study|Progressive disease|1|||
105578273|NCT01536145|364116670|FG003|Overall Study|Progressive disease|2|||
105578274|NCT01536145|364116671|FG004|Overall Study|Progressive disease|1|||
105578275|NCT01536145|364116672|FG005|Overall Study|Progressive disease|2|||
105578276|NCT01536145|364116673|FG006|Overall Study|Progressive disease|1|||
105578277|NCT01536145|364116674|FG007|Overall Study|Progressive disease|2|||
105578278|NCT01536145|364116675|FG008|Overall Study|Progressive disease|1|||
105578279|NCT01536145|364116676|FG009|Overall Study|Progressive disease|3|||
105578280|NCT01536145|364116677|FG010|Overall Study|Progressive disease|3|||
105578281|NCT01536145|364116667|FG000|Overall Study|Withdrawal by Subject|0|||
105578282|NCT01536145|364116668|FG001|Overall Study|Withdrawal by Subject|0|||
105578283|NCT01536145|364116669|FG002|Overall Study|Withdrawal by Subject|1|||
105578284|NCT01536145|364116670|FG003|Overall Study|Withdrawal by Subject|0|||
105578285|NCT01536145|364116671|FG004|Overall Study|Withdrawal by Subject|0|||
105578286|NCT01536145|364116672|FG005|Overall Study|Withdrawal by Subject|1|||
105578287|NCT01536145|364116673|FG006|Overall Study|Withdrawal by Subject|0|||
105578288|NCT01536145|364116674|FG007|Overall Study|Withdrawal by Subject|0|||
105578289|NCT01536145|364116675|FG008|Overall Study|Withdrawal by Subject|2|||
105578290|NCT01536145|364116676|FG009|Overall Study|Withdrawal by Subject|0|||
105578291|NCT01536145|364116677|FG010|Overall Study|Withdrawal by Subject|2|||
105578292|NCT01536145|364116667|FG000|Overall Study|Other|0|||
105578293|NCT01536145|364116668|FG001|Overall Study|Other|0|||
105578294|NCT01536145|364116669|FG002|Overall Study|Other|0|||
105578295|NCT01536145|364116670|FG003|Overall Study|Other|0|||
105578296|NCT01536145|364116671|FG004|Overall Study|Other|1|||
105578297|NCT01536145|364116672|FG005|Overall Study|Other|0|||
105578298|NCT01536145|364116673|FG006|Overall Study|Other|0|||
105578299|NCT01536145|364116674|FG007|Overall Study|Other|0|||
105578300|NCT01536145|364116675|FG008|Overall Study|Other|0|||
105578301|NCT01536145|364116676|FG009|Overall Study|Other|3|||
105578302|NCT01536145|364116677|FG010|Overall Study|Other|2|||
105578303|NCT01536145|364116667|FG000|Overall Study|Death|0|||
105578304|NCT01536145|364116668|FG001|Overall Study|Death|0|||
105578305|NCT01536145|364116669|FG002|Overall Study|Death|0|||
105578306|NCT01536145|364116670|FG003|Overall Study|Death|0|||
105578307|NCT01536145|364116671|FG004|Overall Study|Death|0|||
105578308|NCT01536145|364116672|FG005|Overall Study|Death|0|||
105578309|NCT01536145|364116673|FG006|Overall Study|Death|1|||
105578310|NCT01536145|364116674|FG007|Overall Study|Death|0|||
105578311|NCT01536145|364116675|FG008|Overall Study|Death|0|||
105578312|NCT01536145|364116676|FG009|Overall Study|Death|0|||
105578313|NCT01536145|364116677|FG010|Overall Study|Death|0|||
105578314|NCT01536145|364116667|FG000|Overall Study|Adverse Event|0|||
105578315|NCT01536145|364116668|FG001|Overall Study|Adverse Event|0|||
105578316|NCT01536145|364116669|FG002|Overall Study|Adverse Event|0|||
105578317|NCT01536145|364116670|FG003|Overall Study|Adverse Event|0|||
105578318|NCT01536145|364116671|FG004|Overall Study|Adverse Event|0|||
105578319|NCT01536145|364116672|FG005|Overall Study|Adverse Event|0|||
105578320|NCT01536145|364116673|FG006|Overall Study|Adverse Event|0|||
105578321|NCT01536145|364116674|FG007|Overall Study|Adverse Event|2|||
105376224|NCT00620542|363383402|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
105376225|NCT00620542|363383403|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
105376226|NCT00620542|363383400|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
105578322|NCT01536145|364116675|FG008|Overall Study|Adverse Event|0|||
105578323|NCT01536145|364116676|FG009|Overall Study|Adverse Event|0|||
105376227|NCT00620542|363383401|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
105376228|NCT00620542|363383402|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
105376229|NCT00620542|363383403|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
105376230|NCT00620542|363383400|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
105376231|NCT00620542|363383401|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
105376232|NCT00620542|363383402|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
105578324|NCT01536145|364116677|FG010|Overall Study|Adverse Event|3|||
105578325|NCT02001974|364116678|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
105578326|NCT02001974|364116679|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
105578327|NCT02001974|364116680|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
105578328|NCT02001974|364116678|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
105578329|NCT02001974|364116679|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
105578330|NCT02001974|364116680|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
105578331|NCT02001974|364116678|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
105578332|NCT02001974|364116679|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
105578333|NCT02001974|364116680|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
105578334|NCT02001974|364116678|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
105376233|NCT00620542|363383403|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
105376234|NCT00620542|363383400|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
105376235|NCT00620542|363383401|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
105376236|NCT00620542|363383402|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
105376237|NCT00620542|363383403|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
105376238|NCT00620542|363383400|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
105376239|NCT00620542|363383401|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
105376240|NCT00620542|363383402|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
105376241|NCT00620542|363383403|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
105376242|NCT00620542|363383400|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
105376243|NCT00620542|363383401|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
105376244|NCT00620542|363383402|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
105376245|NCT00620542|363383403|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
105376246|NCT00620542|363383400|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
105376247|NCT00620542|363383401|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
105376248|NCT00620542|363383402|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
105376249|NCT00620542|363383403|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
105376250|NCT02453048|363383408|FG000|Overall Study|Only part of initial 6 mo. study|0|||
105376251|NCT02453048|363383409|FG001|Overall Study|Only part of initial 6 mo. study|0|||
105376252|NCT02453048|363383410|FG002|Overall Study|Only part of initial 6 mo. study|0|||
105376253|NCT02453048|363383411|FG003|Overall Study|Only part of initial 6 mo. study|0|||
105376254|NCT02453048|363383412|FG004|Overall Study|Only part of initial 6 mo. study|6|||
105376255|NCT02453048|363383408|FG000|Overall Study|Lost to Follow-up|0|||
105376256|NCT02453048|363383409|FG001|Overall Study|Lost to Follow-up|1|||
105376257|NCT02453048|363383410|FG002|Overall Study|Lost to Follow-up|2|||
105376258|NCT02453048|363383411|FG003|Overall Study|Lost to Follow-up|0|||
105376259|NCT02453048|363383412|FG004|Overall Study|Lost to Follow-up|0|||
105376260|NCT01283386|363383413|FG000|Overall Study|Death|2|||
105376261|NCT01283386|363383414|FG001|Overall Study|Death|0|||
105376262|NCT01283386|363383413|FG000|Overall Study|Withdrawal by Subject|2|||
105376263|NCT01283386|363383414|FG001|Overall Study|Withdrawal by Subject|1|||
105376264|NCT01283386|363383413|FG000|Overall Study|Relapse of underlying disease|1|||
105376265|NCT01283386|363383414|FG001|Overall Study|Relapse of underlying disease|3|||
105376266|NCT01283386|363383413|FG000|Overall Study|Progression of underlying disease|2|||
105376267|NCT01283386|363383414|FG001|Overall Study|Progression of underlying disease|7|||
105376268|NCT01283386|363383413|FG000|Overall Study|Reason not specified|1|||
105376269|NCT01283386|363383414|FG001|Overall Study|Reason not specified|0|||
105376270|NCT01283386|363383413|FG000|Overall Study|Protocol Violation|0|||
105376271|NCT01283386|363383414|FG001|Overall Study|Protocol Violation|1|||
105376272|NCT04796415|363383417|FG000|Overall Study|not interested|12|||
105376273|NCT04796415|363383417|FG000|Overall Study|health issue|8|||
105376274|NCT04796415|363383417|FG000|Overall Study|Other|4|||
105376275|NCT04796415|363383417|FG000|Overall Study|discharged from home health service|3|||
105376276|NCT04796415|363383417|FG000|Overall Study|re-hospitalization|2|||
105376277|NCT04796415|363383417|FG000|Overall Study|moving to nursing home|1|||
105376278|NCT04796415|363383417|FG000|Overall Study|lost contact|1|||
105376279|NCT01481779|363383419|FG000|Overall Study|Adverse Event|23|||
105376280|NCT01481779|363383420|FG001|Overall Study|Adverse Event|5|||
105376281|NCT01481779|363383419|FG000|Overall Study|Lost to Follow-up|3|||
105376282|NCT01481779|363383420|FG001|Overall Study|Lost to Follow-up|2|||
105376283|NCT01481779|363383419|FG000|Overall Study|Protocol Violation|2|||
105376284|NCT01481779|363383420|FG001|Overall Study|Protocol Violation|3|||
105376285|NCT01481779|363383419|FG000|Overall Study|Withdrawal by Subject|26|||
105376286|NCT01481779|363383420|FG001|Overall Study|Withdrawal by Subject|13|||
105376287|NCT01481779|363383419|FG000|Overall Study|Physician Decision|13|||
105376288|NCT01481779|363383420|FG001|Overall Study|Physician Decision|4|||
105376289|NCT01481779|363383419|FG000|Overall Study|Sponsor Decision|3|||
105376290|NCT01481779|363383420|FG001|Overall Study|Sponsor Decision|1|||
105376291|NCT02378181|363383421|FG000|Overall Study|Lost to Follow-up|2|||
105376292|NCT02378181|363383422|FG001|Overall Study|Lost to Follow-up|5|||
105376293|NCT02378181|363383421|FG000|Overall Study|Withdrawal by Subject|1|||
105376294|NCT02378181|363383422|FG001|Overall Study|Withdrawal by Subject|1|||
105376295|NCT02378181|363383421|FG000|Overall Study|Incarcerated|0|||
105376296|NCT02378181|363383422|FG001|Overall Study|Incarcerated|1|||
105376297|NCT00805532|363383426|FG000|Overall Study|invalid data|0|||
105376298|NCT00805532|363383427|FG001|Overall Study|invalid data|1|||
105376299|NCT01859741|363383428|FG000|Overall Study|Death|3|||
105376300|NCT01859741|363383429|FG001|Overall Study|Death|2|||
105376301|NCT01859741|363383430|FG002|Overall Study|Death|4|||
105376302|NCT01859741|363383431|FG003|Overall Study|Death|3|||
105376303|NCT01859741|363383432|FG004|Overall Study|Death|5|||
105376304|NCT01859741|363383433|FG005|Overall Study|Death|4|||
105376305|NCT01859741|363383434|FG006|Overall Study|Death|51|||
105376306|NCT01859741|363383435|FG007|Overall Study|Death|51|||
105376307|NCT01859741|363383428|FG000|Overall Study|Lost to Follow-up|0|||
105376308|NCT01859741|363383429|FG001|Overall Study|Lost to Follow-up|0|||
105376309|NCT01859741|363383430|FG002|Overall Study|Lost to Follow-up|0|||
105376310|NCT01859741|363383431|FG003|Overall Study|Lost to Follow-up|0|||
105376311|NCT01859741|363383432|FG004|Overall Study|Lost to Follow-up|0|||
105376312|NCT01859741|363383433|FG005|Overall Study|Lost to Follow-up|1|||
105376313|NCT01859741|363383434|FG006|Overall Study|Lost to Follow-up|0|||
105376314|NCT01859741|363383435|FG007|Overall Study|Lost to Follow-up|4|||
105376315|NCT01859741|363383428|FG000|Overall Study|Withdrawal by Subject|0|||
105376316|NCT01859741|363383429|FG001|Overall Study|Withdrawal by Subject|1|||
105376317|NCT01859741|363383430|FG002|Overall Study|Withdrawal by Subject|2|||
105376318|NCT01859741|363383431|FG003|Overall Study|Withdrawal by Subject|0|||
105376319|NCT01859741|363383432|FG004|Overall Study|Withdrawal by Subject|0|||
105376320|NCT01859741|363383433|FG005|Overall Study|Withdrawal by Subject|1|||
105376321|NCT01859741|363383434|FG006|Overall Study|Withdrawal by Subject|1|||
105376322|NCT01859741|363383435|FG007|Overall Study|Withdrawal by Subject|1|||
105376323|NCT01859741|363383428|FG000|Overall Study|Study Terminated by Sponsor|0|||
105376324|NCT01859741|363383429|FG001|Overall Study|Study Terminated by Sponsor|0|||
105376325|NCT01859741|363383430|FG002|Overall Study|Study Terminated by Sponsor|0|||
105376326|NCT01859741|363383431|FG003|Overall Study|Study Terminated by Sponsor|0|||
105376327|NCT01859741|363383432|FG004|Overall Study|Study Terminated by Sponsor|1|||
105376328|NCT01859741|363383433|FG005|Overall Study|Study Terminated by Sponsor|0|||
105376329|NCT01859741|363383434|FG006|Overall Study|Study Terminated by Sponsor|16|||
105376330|NCT01859741|363383435|FG007|Overall Study|Study Terminated by Sponsor|14|||
105376331|NCT01859741|363383428|FG000|Overall Study|Other|0|||
105376332|NCT01859741|363383429|FG001|Overall Study|Other|0|||
105376333|NCT01859741|363383430|FG002|Overall Study|Other|0|||
105376334|NCT01859741|363383431|FG003|Overall Study|Other|0|||
105376335|NCT01859741|363383432|FG004|Overall Study|Other|0|||
105376336|NCT01859741|363383433|FG005|Overall Study|Other|0|||
105376337|NCT01859741|363383434|FG006|Overall Study|Other|2|||
105376338|NCT01859741|363383435|FG007|Overall Study|Other|0|||
105376339|NCT02320396|363383438|FG000|Overall Study|Adverse Event|2|||
105376340|NCT02320396|363383439|FG001|Overall Study|Adverse Event|2|||
105376341|NCT02320396|363383438|FG000|Overall Study|Pregnancy|0|||
105376342|NCT02320396|363383439|FG001|Overall Study|Pregnancy|1|||
105376343|NCT02320396|363383438|FG000|Overall Study|Protocol Violation|0|||
105376344|NCT02320396|363383439|FG001|Overall Study|Protocol Violation|1|||
105376345|NCT02320396|363383438|FG000|Overall Study|Withdrawal by Subject|2|||
105376346|NCT02320396|363383439|FG001|Overall Study|Withdrawal by Subject|0|||
105330227|NCT01575834|363209860|FG000|Overall Study|Other|70|||
105330228|NCT01575834|363209861|FG001|Overall Study|Other|70|||
105330229|NCT01575834|363209860|FG000|Overall Study|Adverse Event|63|||
105330230|NCT01575834|363209861|FG001|Overall Study|Adverse Event|61|||
105330231|NCT01575834|363209860|FG000|Overall Study|Lost to Follow-up|55|||
105330232|NCT01575834|363209861|FG001|Overall Study|Lost to Follow-up|68|||
105330233|NCT01575834|363209860|FG000|Overall Study|Noncompliance|52|||
105330234|NCT01575834|363209861|FG001|Overall Study|Noncompliance|27|||
105330235|NCT01575834|363209860|FG000|Overall Study|Administrative decision|15|||
105330236|NCT01575834|363209861|FG001|Overall Study|Administrative decision|33|||
105330237|NCT01575834|363209860|FG000|Overall Study|Ineligibility Determined|5|||
105330238|NCT01575834|363209861|FG001|Overall Study|Ineligibility Determined|8|||
105330239|NCT01575834|363209860|FG000|Overall Study|Protocol Deviation|4|||
105330240|NCT01575834|363209861|FG001|Overall Study|Protocol Deviation|3|||
105330241|NCT01575834|363209860|FG000|Overall Study|Requirement for Alternative Therapy|2|||
105330242|NCT01575834|363209861|FG001|Overall Study|Requirement for Alternative Therapy|4|||
105330243|NCT01741688|363209863|FG000|Overall Study|Lack of insurance coverage|2|||
105330244|NCT01741688|363209863|FG000|Overall Study|Withdrawal by Subject|1|||
105330245|NCT00463047|363209867|FG000|Titration Period 1|Adverse Event|10|||
105330246|NCT00463047|363209868|FG001|Titration Period 1|Adverse Event|8|||
105330247|NCT00463047|363209867|FG000|Titration Period 1|Lack of Efficacy|10|||
105330248|NCT00463047|363209868|FG001|Titration Period 1|Lack of Efficacy|4|||
105330249|NCT00463047|363209867|FG000|Titration Period 1|Lost to Follow-up|2|||
105330250|NCT00463047|363209868|FG001|Titration Period 1|Lost to Follow-up|0|||
105330251|NCT00463047|363209867|FG000|Titration Period 1|Non-compliance with study medication|3|||
105330252|NCT00463047|363209868|FG001|Titration Period 1|Non-compliance with study medication|5|||
105330253|NCT00463047|363209867|FG000|Titration Period 1|Protocol Violation|5|||
105330254|NCT00463047|363209868|FG001|Titration Period 1|Protocol Violation|5|||
105330255|NCT00463047|363209867|FG000|Titration Period 1|Withdrawal by Subject|3|||
105330256|NCT00463047|363209868|FG001|Titration Period 1|Withdrawal by Subject|5|||
105330257|NCT00463047|363209867|FG000|Titration Period 1|Non-compliance procedures|4|||
105330258|NCT00463047|363209868|FG001|Titration Period 1|Non-compliance procedures|10|||
105330259|NCT00463047|363209867|FG000|Titration Period 1|Other|0|||
105330260|NCT00463047|363209868|FG001|Titration Period 1|Other|2|||
105330261|NCT00463047|363209867|FG000|Titration Period 2|Adverse Event|9|||
105330262|NCT00463047|363209868|FG001|Titration Period 2|Adverse Event|9|||
105330263|NCT00463047|363209867|FG000|Titration Period 2|Lack of Efficacy|6|||
105330264|NCT00463047|363209868|FG001|Titration Period 2|Lack of Efficacy|4|||
105330265|NCT00463047|363209867|FG000|Titration Period 2|Withdrawal by Subject|1|||
105376347|NCT02441283|363383441|FG000|Overall Study|Withdrew consent|15|||
105376348|NCT02441283|363383441|FG000|Overall Study|Lost to Follow-up|42|||
105376349|NCT02441283|363383441|FG000|Overall Study|Death|1|||
105376350|NCT02441283|363383441|FG000|Overall Study|Other, not specified|32|||
105376351|NCT01189266|363383442|FG000|Overall Study|Adverse Event|1|||
105376352|NCT01189266|363383443|FG001|Overall Study|Adverse Event|0|||
105376353|NCT01189266|363383444|FG002|Overall Study|Adverse Event|5|||
105376354|NCT01189266|363383442|FG000|Overall Study|Death|0|||
105376355|NCT01189266|363383443|FG001|Overall Study|Death|0|||
105376356|NCT01189266|363383444|FG002|Overall Study|Death|5|||
105376357|NCT01189266|363383442|FG000|Overall Study|Lack of Efficacy|4|||
105376358|NCT01189266|363383443|FG001|Overall Study|Lack of Efficacy|5|||
105376359|NCT01189266|363383444|FG002|Overall Study|Lack of Efficacy|44|||
105376360|NCT01189266|363383442|FG000|Overall Study|Physician Decision|0|||
105376361|NCT01189266|363383443|FG001|Overall Study|Physician Decision|0|||
105376362|NCT01189266|363383444|FG002|Overall Study|Physician Decision|1|||
105376363|NCT01189266|363383442|FG000|Overall Study|Protocol Violation|0|||
105376364|NCT01189266|363383443|FG001|Overall Study|Protocol Violation|1|||
105376365|NCT01189266|363383444|FG002|Overall Study|Protocol Violation|1|||
105376366|NCT01189266|363383442|FG000|Overall Study|Withdrawal by Subject|0|||
105376367|NCT01189266|363383443|FG001|Overall Study|Withdrawal by Subject|0|||
105376368|NCT01189266|363383444|FG002|Overall Study|Withdrawal by Subject|1|||
105376369|NCT01189266|363383442|FG000|Overall Study|Patient refuses further therapy|1|||
105376370|NCT01189266|363383443|FG001|Overall Study|Patient refuses further therapy|0|||
105376371|NCT01189266|363383444|FG002|Overall Study|Patient refuses further therapy|7|||
105376372|NCT01189266|363383442|FG000|Overall Study|No treatment|0|||
105376373|NCT01189266|363383443|FG001|Overall Study|No treatment|0|||
105376374|NCT01189266|363383444|FG002|Overall Study|No treatment|1|||
105376375|NCT03881371|363383445|FG000|Overall Study|Adverse Event|8|||
105376376|NCT03881371|363383446|FG001|Overall Study|Adverse Event|9|||
105376377|NCT03881371|363383445|FG000|Overall Study|Death|1|||
105376378|NCT03881371|363383446|FG001|Overall Study|Death|0|||
105376379|NCT03881371|363383445|FG000|Overall Study|Lost to Follow-up|1|||
105376380|NCT03881371|363383446|FG001|Overall Study|Lost to Follow-up|0|||
105376381|NCT03881371|363383445|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105376382|NCT03881371|363383446|FG001|Overall Study|Non-Compliance with Study Drug|2|||
105376383|NCT03881371|363383445|FG000|Overall Study|Physician Decision|3|||
105376384|NCT03881371|363383446|FG001|Overall Study|Physician Decision|3|||
105376385|NCT03881371|363383445|FG000|Overall Study|Withdrawal by Subject|2|||
105376386|NCT03881371|363383446|FG001|Overall Study|Withdrawal by Subject|10|||
105376387|NCT03881371|363383445|FG000|Overall Study|Discontinuation from Study|1|||
105376388|NCT03881371|363383446|FG001|Overall Study|Discontinuation from Study|0|||
105376389|NCT00933933|363383447|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
105376390|NCT00933933|363383448|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
105376391|NCT00933933|363383449|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
105376392|NCT00933933|363383447|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
105376393|NCT00933933|363383448|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
105376394|NCT00933933|363383449|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
105376395|NCT03822416|363383450|FG000|Overall Study|Lost to Follow-up|1|||
105376396|NCT03822416|363383451|FG001|Overall Study|Lost to Follow-up|0|||
105376397|NCT03822416|363383450|FG000|Overall Study|Withdrawal by Subject|0|||
105376398|NCT03822416|363383451|FG001|Overall Study|Withdrawal by Subject|1|||
105376399|NCT00976027|363383452|FG000|Overall Study|Serious Adverse Event|36|||
105376400|NCT00976027|363383453|FG001|Overall Study|Serious Adverse Event|17|||
105376401|NCT00976027|363383452|FG000|Overall Study|Adverse Event|0|||
105376402|NCT00976027|363383453|FG001|Overall Study|Adverse Event|2|||
105376403|NCT00976027|363383452|FG000|Overall Study|Protocol Violation|60|||
105376404|NCT00976027|363383453|FG001|Overall Study|Protocol Violation|27|||
105578335|NCT02001974|364116679|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
105578336|NCT02001974|364116680|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
105578337|NCT02374593|364116681|FG000|Overall Study|non-compliant|2|||
105578338|NCT02374593|364116682|FG001|Overall Study|non-compliant|0|||
105376405|NCT00976027|363383452|FG000|Overall Study|Lost to Follow-up|208|||
105376406|NCT00976027|363383453|FG001|Overall Study|Lost to Follow-up|103|||
105376407|NCT00976027|363383452|FG000|Overall Study|Withdrawal by Subject|107|||
105376408|NCT00976027|363383453|FG001|Overall Study|Withdrawal by Subject|66|||
105376409|NCT01402700|363383458|FG000|Overall Study|Death|3|||
105376410|NCT01402700|363383458|FG000|Overall Study|Withdrawal by Subject|3|||
105376411|NCT01402700|363383458|FG000|Overall Study|Missed Visit|1|||
105376412|NCT01160614|363383459|FG000|Overall Study|Withdrawal by Subject|0|||
105376413|NCT01160614|363383460|FG001|Overall Study|Withdrawal by Subject|2|||
105376414|NCT03506477|363383462|FG000|Overall Study|Withdrawal by Subject|1|||
105376415|NCT03506477|363383463|FG001|Overall Study|Withdrawal by Subject|0|||
105376416|NCT00927472|363383464|FG000|Overall Study|Withdrawal by Subject|10|||
105376417|NCT00927472|363383465|FG001|Overall Study|Withdrawal by Subject|11|||
105578339|NCT00210119|364116683|FG000|Overall Study|Protocol Violation|1|||
105330266|NCT00463047|363209868|FG001|Titration Period 2|Withdrawal by Subject|0|||
105330267|NCT00463047|363209867|FG000|Titration Period 2|Protocol Violation|2|||
105330268|NCT00463047|363209868|FG001|Titration Period 2|Protocol Violation|3|||
105330269|NCT00463047|363209867|FG000|Titration Period 2|Lost to Follow-up|1|||
105578340|NCT00210119|364116683|FG000|Overall Study|Withdrawal by Subject|1|||
105578341|NCT04716881|364116688|FG000|Overall Study|Adverse Event|1|||
105376418|NCT00927472|363383464|FG000|Overall Study|Lost to Follow-up|1|||
105376419|NCT00927472|363383465|FG001|Overall Study|Lost to Follow-up|6|||
105376420|NCT00927472|363383464|FG000|Overall Study|Protocol Violation|0|||
105376421|NCT00927472|363383465|FG001|Overall Study|Protocol Violation|1|||
105376422|NCT00927472|363383464|FG000|Overall Study|Post treatment Assessment out of window|0|||
105376423|NCT00927472|363383465|FG001|Overall Study|Post treatment Assessment out of window|4|||
105376424|NCT00433537|363383466|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
105376425|NCT00433537|363383467|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
105376426|NCT00433537|363383468|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
105376427|NCT00433537|363383466|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
105376428|NCT00433537|363383467|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
105376429|NCT00433537|363383468|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
105376430|NCT00433537|363383466|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
105376431|NCT00433537|363383467|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
105376432|NCT00433537|363383468|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
105376433|NCT00433537|363383466|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
105376434|NCT00433537|363383467|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
105376435|NCT00433537|363383468|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
105376436|NCT00433537|363383466|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
105376437|NCT00433537|363383467|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
105376438|NCT00433537|363383468|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
105376439|NCT00433537|363383466|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
105376440|NCT00433537|363383467|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
105376441|NCT00433537|363383468|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
105376442|NCT00433537|363383466|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
105376443|NCT00433537|363383467|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
105376444|NCT00433537|363383468|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
105376445|NCT00433537|363383466|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
105376446|NCT00433537|363383467|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
105376447|NCT00433537|363383468|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
105376448|NCT00433537|363383466|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
105376449|NCT00433537|363383467|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
105376450|NCT00433537|363383468|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
105376451|NCT00831844|363383469|FG000|Overall Study|Adverse Event|2|||
105376452|NCT00831844|363383470|FG001|Overall Study|Adverse Event|0|||
105376453|NCT00831844|363383471|FG002|Overall Study|Adverse Event|0|||
105376454|NCT00831844|363383472|FG003|Overall Study|Adverse Event|0|||
105376455|NCT00831844|363383473|FG004|Overall Study|Adverse Event|1|||
105376456|NCT00831844|363383474|FG005|Overall Study|Adverse Event|1|||
105376457|NCT00831844|363383475|FG006|Overall Study|Adverse Event|2|||
105376458|NCT00831844|363383476|FG007|Overall Study|Adverse Event|0|||
105376459|NCT00831844|363383477|FG008|Overall Study|Adverse Event|0|||
105376460|NCT00831844|363383478|FG009|Overall Study|Adverse Event|0|||
105376461|NCT00831844|363383469|FG000|Overall Study|Death|0|||
105376462|NCT00831844|363383470|FG001|Overall Study|Death|0|||
105376463|NCT00831844|363383471|FG002|Overall Study|Death|0|||
105376464|NCT00831844|363383472|FG003|Overall Study|Death|1|||
105376465|NCT00831844|363383473|FG004|Overall Study|Death|0|||
105376466|NCT00831844|363383474|FG005|Overall Study|Death|0|||
105330270|NCT00463047|363209868|FG001|Titration Period 2|Lost to Follow-up|2|||
105330271|NCT00463047|363209867|FG000|Titration Period 2|Non-compliance study medication|4|||
105330272|NCT00463047|363209868|FG001|Titration Period 2|Non-compliance study medication|2|||
105330273|NCT00463047|363209867|FG000|Titration Period 2|Non-compliance procedures|4|||
105330274|NCT00463047|363209868|FG001|Titration Period 2|Non-compliance procedures|1|||
105330275|NCT00463047|363209867|FG000|Titration Period 2|Other|3|||
105330276|NCT00463047|363209868|FG001|Titration Period 2|Other|2|||
105330277|NCT00463047|363209867|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
105330278|NCT00463047|363209868|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
105330279|NCT00463047|363209867|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
105330280|NCT00463047|363209868|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
105330281|NCT00463047|363209867|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
105330282|NCT00463047|363209868|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
105330283|NCT00463047|363209867|FG000|Double-Blind Treatment Period 1|Other|1|||
105330284|NCT00463047|363209868|FG001|Double-Blind Treatment Period 1|Other|0|||
105330285|NCT00463047|363209867|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
105376467|NCT00831844|363383475|FG006|Overall Study|Death|0|||
105376468|NCT00831844|363383476|FG007|Overall Study|Death|0|||
105376469|NCT00831844|363383477|FG008|Overall Study|Death|0|||
105376470|NCT00831844|363383478|FG009|Overall Study|Death|0|||
105376471|NCT00831844|363383469|FG000|Overall Study|Lack of Efficacy|8|||
105376472|NCT00831844|363383470|FG001|Overall Study|Lack of Efficacy|10|||
105376473|NCT00831844|363383471|FG002|Overall Study|Lack of Efficacy|15|||
105376474|NCT00831844|363383472|FG003|Overall Study|Lack of Efficacy|8|||
105376475|NCT00831844|363383473|FG004|Overall Study|Lack of Efficacy|11|||
105376476|NCT00831844|363383474|FG005|Overall Study|Lack of Efficacy|17|||
105376477|NCT00831844|363383475|FG006|Overall Study|Lack of Efficacy|8|||
105376478|NCT00831844|363383476|FG007|Overall Study|Lack of Efficacy|9|||
105376479|NCT00831844|363383477|FG008|Overall Study|Lack of Efficacy|7|||
105376480|NCT00831844|363383478|FG009|Overall Study|Lack of Efficacy|0|||
105376481|NCT00831844|363383469|FG000|Overall Study|Physician Decision|0|||
105376482|NCT00831844|363383470|FG001|Overall Study|Physician Decision|1|||
105376483|NCT00831844|363383471|FG002|Overall Study|Physician Decision|3|||
105376484|NCT00831844|363383472|FG003|Overall Study|Physician Decision|1|||
105376485|NCT00831844|363383473|FG004|Overall Study|Physician Decision|1|||
105376486|NCT00831844|363383474|FG005|Overall Study|Physician Decision|1|||
105376487|NCT00831844|363383475|FG006|Overall Study|Physician Decision|0|||
105376488|NCT00831844|363383476|FG007|Overall Study|Physician Decision|0|||
105376489|NCT00831844|363383477|FG008|Overall Study|Physician Decision|1|||
105376490|NCT00831844|363383478|FG009|Overall Study|Physician Decision|0|||
105376491|NCT00831844|363383469|FG000|Overall Study|Withdrawal by Subject|0|||
105376492|NCT00831844|363383470|FG001|Overall Study|Withdrawal by Subject|0|||
105376493|NCT00831844|363383471|FG002|Overall Study|Withdrawal by Subject|1|||
105376494|NCT00831844|363383472|FG003|Overall Study|Withdrawal by Subject|0|||
105376495|NCT00831844|363383473|FG004|Overall Study|Withdrawal by Subject|0|||
105376496|NCT00831844|363383474|FG005|Overall Study|Withdrawal by Subject|0|||
105376497|NCT00831844|363383475|FG006|Overall Study|Withdrawal by Subject|0|||
105376498|NCT00831844|363383476|FG007|Overall Study|Withdrawal by Subject|1|||
105376499|NCT00831844|363383477|FG008|Overall Study|Withdrawal by Subject|1|||
105376500|NCT00831844|363383478|FG009|Overall Study|Withdrawal by Subject|0|||
105376501|NCT00831844|363383469|FG000|Overall Study|Ineligible|0|||
105376502|NCT00831844|363383470|FG001|Overall Study|Ineligible|1|||
105376503|NCT00831844|363383471|FG002|Overall Study|Ineligible|1|||
105376504|NCT00831844|363383472|FG003|Overall Study|Ineligible|0|||
105376505|NCT00831844|363383473|FG004|Overall Study|Ineligible|1|||
105376506|NCT00831844|363383474|FG005|Overall Study|Ineligible|0|||
105376507|NCT00831844|363383475|FG006|Overall Study|Ineligible|0|||
105376508|NCT00831844|363383476|FG007|Overall Study|Ineligible|0|||
105376509|NCT00831844|363383477|FG008|Overall Study|Ineligible|0|||
105376510|NCT00831844|363383478|FG009|Overall Study|Ineligible|0|||
105376511|NCT03980223|363383481|FG000|Overall Study|Lost to Follow-up|3|||
105376512|NCT03980223|363383482|FG001|Overall Study|Lost to Follow-up|7|||
105376513|NCT03980223|363383483|FG002|Overall Study|Lost to Follow-up|10|||
105376514|NCT03980223|363383484|FG003|Overall Study|Lost to Follow-up|8|||
105376515|NCT03980223|363383481|FG000|Overall Study|Withdrawal by Subject|0|||
105376516|NCT03980223|363383482|FG001|Overall Study|Withdrawal by Subject|0|||
105376517|NCT03980223|363383483|FG002|Overall Study|Withdrawal by Subject|1|||
105376518|NCT03980223|363383484|FG003|Overall Study|Withdrawal by Subject|2|||
105376519|NCT03980223|363383481|FG000|Overall Study|Physician Decision|0|||
105376520|NCT03980223|363383482|FG001|Overall Study|Physician Decision|0|||
105376521|NCT03980223|363383483|FG002|Overall Study|Physician Decision|1|||
105376522|NCT03980223|363383484|FG003|Overall Study|Physician Decision|0|||
105376523|NCT03980223|363383481|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
105376524|NCT03980223|363383482|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
105376525|NCT03980223|363383483|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
105376526|NCT03980223|363383484|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
105376527|NCT01937299|363383488|FG000|Overall Study|Adverse Event|13|||
105376528|NCT01937299|363383489|FG001|Overall Study|Adverse Event|0|||
105376529|NCT01937299|363383488|FG000|Overall Study|Lack of Efficacy|0|||
105376530|NCT01937299|363383489|FG001|Overall Study|Lack of Efficacy|4|||
105376531|NCT01937299|363383488|FG000|Overall Study|Withdrawal by Subject|1|||
105578342|NCT04716881|364116688|FG000|Overall Study|Lost to Follow-up|1|||
105376532|NCT01937299|363383489|FG001|Overall Study|Withdrawal by Subject|0|||
105376533|NCT00385840|363383490|FG000|Overall Study|Adverse Event|1|||
105376534|NCT00385840|363383491|FG001|Overall Study|Adverse Event|1|||
105376535|NCT00385840|363383490|FG000|Overall Study|Lost to Follow-up|3|||
105376536|NCT00385840|363383491|FG001|Overall Study|Lost to Follow-up|13|||
105376537|NCT05172570|363383493|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
105376538|NCT05172570|363383494|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
105376539|NCT05172570|363383495|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
105376540|NCT05172570|363383493|FG000|Overall Study|PI Decision due to equipment shortages|0|||
105376541|NCT05172570|363383494|FG001|Overall Study|PI Decision due to equipment shortages|0|||
105578343|NCT01313923|364116691|FG000|Overall Study|Physician Decision|3|||
105578344|NCT03358329|364116696|FG000|Overall Study|Lost to Follow-up|2|||
105578345|NCT03358329|364116696|FG000|Overall Study|Withdrawal by Subject|2|||
105578346|NCT03875911|364116699|FG000|Overall Study|Lost to Follow-up|3|||
105578347|NCT03875911|364116700|FG001|Overall Study|Lost to Follow-up|6|||
105578348|NCT03875911|364116701|FG002|Overall Study|Lost to Follow-up|2|||
105578349|NCT03875911|364116699|FG000|Overall Study|Surgery cancelled|1|||
105578350|NCT03875911|364116700|FG001|Overall Study|Surgery cancelled|0|||
105578351|NCT03875911|364116701|FG002|Overall Study|Surgery cancelled|1|||
105578352|NCT03875911|364116699|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
105578353|NCT03875911|364116700|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
105578354|NCT03875911|364116701|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
105578355|NCT00305864|364116702|FG000|Overall Study|Ineligible / No protocol treatment|0|||
105578356|NCT00305864|364116703|FG001|Overall Study|Ineligible / No protocol treatment|1|||
105578357|NCT00305864|364116704|FG002|Overall Study|Ineligible / No protocol treatment|1|||
105578358|NCT00305864|364116705|FG003|Overall Study|Ineligible / No protocol treatment|13|||
105578359|NCT01734850|364116708|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
105578360|NCT01734850|364116709|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
105578361|NCT01734850|364116710|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
105578362|NCT01734850|364116708|FG000|Overall Study|Not infused due to manufacturing failure|0|||
105578363|NCT01734850|364116709|FG001|Overall Study|Not infused due to manufacturing failure|0|||
105578364|NCT01734850|364116710|FG002|Overall Study|Not infused due to manufacturing failure|1|||
105578365|NCT00750893|364116711|FG000|Overall Study|Adverse Event|5|||
105578366|NCT00750893|364116711|FG000|Overall Study|Withdrawal by Subject|10|||
105578367|NCT00750893|364116711|FG000|Overall Study|Lost to Follow-up|510|||
105578368|NCT00750893|364116711|FG000|Overall Study|Other|17|||
105578369|NCT03824938|364116712|FG000|Overall Study|Withdrawal by Subject|2|||
105578370|NCT03824938|364116713|FG001|Overall Study|Withdrawal by Subject|1|||
105578371|NCT03824938|364116714|FG002|Overall Study|Withdrawal by Subject|0|||
105578372|NCT03824938|364116715|FG003|Overall Study|Withdrawal by Subject|2|||
105578373|NCT03824938|364116716|FG004|Overall Study|Withdrawal by Subject|0|||
105578374|NCT03824938|364116717|FG005|Overall Study|Withdrawal by Subject|1|||
105578375|NCT03824938|364116712|FG000|Overall Study|Lost to Follow-up|0|||
105578376|NCT03824938|364116713|FG001|Overall Study|Lost to Follow-up|1|||
105578377|NCT03824938|364116714|FG002|Overall Study|Lost to Follow-up|0|||
105578378|NCT03824938|364116715|FG003|Overall Study|Lost to Follow-up|0|||
105578379|NCT03824938|364116716|FG004|Overall Study|Lost to Follow-up|1|||
105578380|NCT03824938|364116717|FG005|Overall Study|Lost to Follow-up|0|||
105578381|NCT01990300|364116721|FG000|Overall Study|Case Report Forms Uncollected|89|||
105578382|NCT01990300|364116721|FG000|Overall Study|Protocol Deviation|53|||
105578383|NCT00287469|364116724|FG000|Overall Study|serious adverse event|1|||
105578384|NCT00287469|364116725|FG001|Overall Study|serious adverse event|6|||
105578385|NCT00287469|364116724|FG000|Overall Study|Adverse Event|1|||
105578386|NCT00287469|364116725|FG001|Overall Study|Adverse Event|1|||
105578387|NCT00287469|364116724|FG000|Overall Study|moved from area|144|||
105578388|NCT00287469|364116725|FG001|Overall Study|moved from area|138|||
105578389|NCT00287469|364116724|FG000|Overall Study|Lost to Follow-up|74|||
105578390|NCT00287469|364116725|FG001|Overall Study|Lost to Follow-up|69|||
105578391|NCT01225835|364116726|FG000|Overall Study|Completed protocol|2|||
105578392|NCT01225835|364116727|FG001|Overall Study|Completed protocol|1|||
105578393|NCT01225835|364116726|FG000|Overall Study|Did not meet hCG criterion|2|||
105578394|NCT01225835|364116727|FG001|Overall Study|Did not meet hCG criterion|0|||
105578395|NCT01225835|364116726|FG000|Overall Study|Adverse Event|2|||
105578396|NCT01225835|364116727|FG001|Overall Study|Adverse Event|1|||
105578397|NCT01225835|364116726|FG000|Overall Study|Other|1|||
105578398|NCT01225835|364116727|FG001|Overall Study|Other|1|||
105578399|NCT01266993|364116728|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
105578400|NCT01266993|364116729|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
105578401|NCT01266993|364116728|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
105578402|NCT01266993|364116729|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
105578403|NCT03285113|364116732|FG000|Overall Study|Unable to implant leads|2|||
105578404|NCT02942004|364116733|FG000|Overall Study|Withdrawal by Subject|0|||
105578405|NCT02942004|364116734|FG001|Overall Study|Withdrawal by Subject|2|||
105578406|NCT02942004|364116735|FG002|Overall Study|Withdrawal by Subject|3|||
105578407|NCT02942004|364116733|FG000|Overall Study|Lost to Follow-up|1|||
105578408|NCT02942004|364116734|FG001|Overall Study|Lost to Follow-up|1|||
105578409|NCT02942004|364116735|FG002|Overall Study|Lost to Follow-up|2|||
105578410|NCT02942004|364116733|FG000|Overall Study|Randomized but not dosed|3|||
105578411|NCT02942004|364116734|FG001|Overall Study|Randomized but not dosed|9|||
105578412|NCT02942004|364116735|FG002|Overall Study|Randomized but not dosed|4|||
105578413|NCT01544491|364116736|FG000|Overall Study|Withdrawal by Subject|3|||
105578414|NCT01544491|364116737|FG001|Overall Study|Withdrawal by Subject|2|||
105376542|NCT05172570|363383495|FG002|Overall Study|PI Decision due to equipment shortages|1|||
105376543|NCT01260948|363383506|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
105376544|NCT01260948|363383507|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
105376545|NCT01260948|363383506|FG000|Second Intervention|Emesis|0|||
105376546|NCT01260948|363383507|FG001|Second Intervention|Emesis|1|||
105376547|NCT00640289|363383508|FG000|Overall Study|Death|3|||
105376548|NCT00640289|363383508|FG000|Overall Study|Withdrawal by Subject|1|||
105376549|NCT00640289|363383508|FG000|Overall Study|Lost to Follow-up|1|||
105376550|NCT00640289|363383508|FG000|Overall Study|Data collected under different amendment|2|||
105376551|NCT00640289|363383508|FG000|Overall Study|Transferred to another center|1|||
105376552|NCT00640289|363383508|FG000|Overall Study|Missing status|5|||
105376553|NCT00462462|363383509|FG000|Overall Study|Physician Decision|0|||
105376554|NCT00462462|363383510|FG001|Overall Study|Physician Decision|1|||
105376555|NCT00765076|363383511|FG000|Overall Study|Adverse Event|1|||
105376556|NCT00765076|363383512|FG001|Overall Study|Adverse Event|0|||
105376557|NCT00765076|363383513|FG002|Overall Study|Adverse Event|0|||
105376558|NCT00765076|363383511|FG000|Overall Study|Withdrawal by Subject|0|||
105376559|NCT00765076|363383512|FG001|Overall Study|Withdrawal by Subject|0|||
105376560|NCT00765076|363383513|FG002|Overall Study|Withdrawal by Subject|1|||
105376561|NCT01685437|363383514|FG000|Overall Study|Withdrawal by Subject|22|||
105376562|NCT01685437|363383514|FG000|Overall Study|Lost to Follow-up|3|||
105376563|NCT01685437|363383514|FG000|Overall Study|Adverse Event|1|||
105376564|NCT01685437|363383514|FG000|Overall Study|Protocol Violation|4|||
105376565|NCT01685437|363383514|FG000|Overall Study|Unable to make visits due to work|1|||
105376566|NCT00768053|363383515|FG000|Overall Study|Adverse Event|10|||
105376567|NCT00768053|363383515|FG000|Overall Study|Lost to Follow-up|1|||
105376568|NCT04584788|363383522|FG000|Overall Study|Physician Decision|8|||
105376569|NCT04584788|363383522|FG000|Overall Study|Withdrawal by Subject|1|||
105376570|NCT04584788|363383522|FG000|Overall Study|Adverse Event|3|||
105376571|NCT02207608|363383523|FG000|Overall Study|Adverse Event|1|||
105376572|NCT02207608|363383524|FG001|Overall Study|Adverse Event|0|||
105376573|NCT00632359|363383527|FG000|Overall Study|Withdrawal by Subject|2|||
105376574|NCT01732692|363385348|FG000|Overall Study|Adverse Event|0|||
105376575|NCT01732692|363385349|FG001|Overall Study|Adverse Event|1|||
105376576|NCT02030600|363385350|FG000|Treatment Period 1|Adverse Event|5|||
105376577|NCT02030600|363385351|FG001|Treatment Period 1|Adverse Event|7|||
105376578|NCT02030600|363385350|FG000|Treatment Period 1|Lack of Efficacy|0|||
105376579|NCT02030600|363385351|FG001|Treatment Period 1|Lack of Efficacy|1|||
105376580|NCT02030600|363385350|FG000|Treatment Period 1|Lost to Follow-up|11|||
105376581|NCT02030600|363385351|FG001|Treatment Period 1|Lost to Follow-up|3|||
105376582|NCT02030600|363385350|FG000|Treatment Period 1|Protocol Violation|22|||
105376583|NCT02030600|363385351|FG001|Treatment Period 1|Protocol Violation|17|||
105376584|NCT02030600|363385350|FG000|Treatment Period 1|Withdrawal by Subject|13|||
105376585|NCT02030600|363385351|FG001|Treatment Period 1|Withdrawal by Subject|17|||
105376586|NCT02030600|363385350|FG000|Treatment Period 1|Casebook Unsigned|1|||
105376587|NCT02030600|363385351|FG001|Treatment Period 1|Casebook Unsigned|0|||
105376588|NCT02030600|363385350|FG000|Treatment Period 1|Unclassified|1|||
105376589|NCT02030600|363385351|FG001|Treatment Period 1|Unclassified|0|||
105376590|NCT02030600|363385350|FG000|Treatment Period 2|Adverse Event|4|||
105376591|NCT02030600|363385351|FG001|Treatment Period 2|Adverse Event|4|||
105376592|NCT02030600|363385350|FG000|Treatment Period 2|Lack of Efficacy|2|||
105376593|NCT02030600|363385351|FG001|Treatment Period 2|Lack of Efficacy|1|||
105376594|NCT02030600|363385350|FG000|Treatment Period 2|Lost to Follow-up|4|||
105376595|NCT02030600|363385351|FG001|Treatment Period 2|Lost to Follow-up|2|||
105376596|NCT02030600|363385350|FG000|Treatment Period 2|Protocol Violation|1|||
105376597|NCT02030600|363385351|FG001|Treatment Period 2|Protocol Violation|2|||
105376598|NCT02030600|363385350|FG000|Treatment Period 2|Withdrawal by Subject|13|||
105578415|NCT01544491|364116736|FG000|Overall Study|Lost to Follow-up|0|||
105578416|NCT01544491|364116737|FG001|Overall Study|Lost to Follow-up|1|||
105578417|NCT01544491|364116736|FG000|Overall Study|administrative problems|2|||
105578418|NCT01544491|364116737|FG001|Overall Study|administrative problems|0|||
105578419|NCT01448044|364116738|FG000|Treatment Period|Adverse Event|4|||
105376599|NCT02030600|363385351|FG001|Treatment Period 2|Withdrawal by Subject|9|||
105376600|NCT02030600|363385350|FG000|Treatment Period 2|Unclassified|1|||
105376601|NCT02030600|363385351|FG001|Treatment Period 2|Unclassified|0|||
105376602|NCT01155323|363385352|FG000|First Intervention|exclusion criteria|1|||
105376603|NCT01155323|363385353|FG001|First Intervention|exclusion criteria|1|||
105376604|NCT01155323|363385352|FG000|Second Intervention|Lost to Follow-up|1|||
105376605|NCT01155323|363385353|FG001|Second Intervention|Lost to Follow-up|1|||
105376606|NCT01208051|363385356|FG000|Total Enrollment|Withdrawal by Subject|0|||
105376607|NCT01208051|363385357|FG001|Total Enrollment|Withdrawal by Subject|1|||
105376608|NCT01208051|363385358|FG002|Total Enrollment|Withdrawal by Subject|0|||
105376609|NCT01208051|363385359|FG003|Total Enrollment|Withdrawal by Subject|0|||
105376610|NCT01208051|363385360|FG004|Total Enrollment|Withdrawal by Subject|2|||
105376611|NCT01208051|363385356|FG000|Total Enrollment|Brain metastases|0|||
105376612|NCT01208051|363385357|FG001|Total Enrollment|Brain metastases|0|||
105376613|NCT01208051|363385358|FG002|Total Enrollment|Brain metastases|1|||
105376614|NCT01208051|363385359|FG003|Total Enrollment|Brain metastases|0|||
105376615|NCT01208051|363385360|FG004|Total Enrollment|Brain metastases|0|||
105578420|NCT01448044|364116739|FG001|Treatment Period|Adverse Event|3|||
105578421|NCT01448044|364116738|FG000|Treatment Period|Lack of Efficacy|5|||
105376616|NCT00973973|363385366|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
105376617|NCT00973973|363385367|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
105376618|NCT00973973|363385366|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
105376619|NCT00973973|363385367|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
105376620|NCT00973973|363385366|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
105376621|NCT00973973|363385367|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
105376622|NCT00973973|363385366|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
105376623|NCT00973973|363385367|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
105376624|NCT00973973|363385366|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
105376625|NCT00973973|363385367|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
105376626|NCT00973973|363385366|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
105376627|NCT00973973|363385367|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
105376628|NCT00973973|363385366|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
105376629|NCT00973973|363385367|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
105376630|NCT00973973|363385366|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
105376631|NCT00973973|363385367|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
105376632|NCT00973973|363385366|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
105376633|NCT00973973|363385367|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
105376634|NCT00973973|363385366|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
105376635|NCT00973973|363385367|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
105376636|NCT00973973|363385366|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
105376637|NCT00973973|363385367|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
105376638|NCT00973973|363385366|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
105376639|NCT00973973|363385367|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
105376640|NCT00671060|363385368|FG000|Overall Study|Protocol Violation|1|||
105376641|NCT00671060|363385369|FG001|Overall Study|Protocol Violation|0|||
105376642|NCT00671060|363385368|FG000|Overall Study|Physician Decision|0|||
105376643|NCT00671060|363385369|FG001|Overall Study|Physician Decision|1|||
105376644|NCT02832037|363385370|FG000|Overall Study|Administrative reasons|0|||
105376645|NCT02832037|363385371|FG001|Overall Study|Administrative reasons|0|||
105376646|NCT02832037|363385372|FG002|Overall Study|Administrative reasons|1|||
105376647|NCT02832037|363385373|FG003|Overall Study|Administrative reasons|0|||
105376648|NCT02832037|363385374|FG004|Overall Study|Administrative reasons|0|||
105376649|NCT02832037|363385370|FG000|Overall Study|Protocol Violation|3|||
105376650|NCT02832037|363385371|FG001|Overall Study|Protocol Violation|0|||
105376651|NCT02832037|363385372|FG002|Overall Study|Protocol Violation|4|||
105376652|NCT02832037|363385373|FG003|Overall Study|Protocol Violation|1|||
105376653|NCT02832037|363385374|FG004|Overall Study|Protocol Violation|2|||
105376654|NCT02832037|363385370|FG000|Overall Study|Lost to Follow-up|2|||
105376655|NCT02832037|363385371|FG001|Overall Study|Lost to Follow-up|0|||
105376656|NCT02832037|363385372|FG002|Overall Study|Lost to Follow-up|3|||
105376657|NCT02832037|363385373|FG003|Overall Study|Lost to Follow-up|0|||
105376658|NCT02832037|363385374|FG004|Overall Study|Lost to Follow-up|5|||
105376659|NCT02832037|363385370|FG000|Overall Study|Withdrawal by Subject|9|||
105376660|NCT02832037|363385371|FG001|Overall Study|Withdrawal by Subject|8|||
105376661|NCT02832037|363385372|FG002|Overall Study|Withdrawal by Subject|0|||
105376662|NCT02832037|363385373|FG003|Overall Study|Withdrawal by Subject|4|||
105376663|NCT02832037|363385374|FG004|Overall Study|Withdrawal by Subject|8|||
105376664|NCT02832037|363385370|FG000|Overall Study|Adverse Event|5|||
105376665|NCT02832037|363385371|FG001|Overall Study|Adverse Event|4|||
105376666|NCT02832037|363385372|FG002|Overall Study|Adverse Event|0|||
105376667|NCT02832037|363385373|FG003|Overall Study|Adverse Event|2|||
105376668|NCT02832037|363385374|FG004|Overall Study|Adverse Event|4|||
105376669|NCT02107898|363385377|FG000|Overall Study|Adverse Event|4|||
105376670|NCT02107898|363385378|FG001|Overall Study|Adverse Event|7|||
105376671|NCT02107898|363385377|FG000|Overall Study|Poor compliance to protocol|0|||
105376672|NCT02107898|363385378|FG001|Overall Study|Poor compliance to protocol|1|||
105376673|NCT02107898|363385377|FG000|Overall Study|Participant moved|0|||
105376674|NCT02107898|363385378|FG001|Overall Study|Participant moved|2|||
105376675|NCT02107898|363385377|FG000|Overall Study|Consent withdrawn by participant|2|||
105376676|NCT02107898|363385378|FG001|Overall Study|Consent withdrawn by participant|1|||
105376677|NCT02107898|363385377|FG000|Overall Study|Randomized but not treated|0|||
105376678|NCT02107898|363385378|FG001|Overall Study|Randomized but not treated|1|||
105376679|NCT01531153|363385381|FG000|Overall Study|Withdrawal by Subject|10|||
105376680|NCT01531153|363385382|FG001|Overall Study|Withdrawal by Subject|9|||
105376681|NCT01531153|363385383|FG002|Overall Study|Withdrawal by Subject|15|||
105376682|NCT03483103|363385384|FG000|Pre-Treatment Phase|Other reasons|1|||
105376683|NCT03483103|363385384|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
105376684|NCT03483103|363385384|FG000|Pre-Treatment Phase|Disease-related complications|1|||
105376685|NCT03483103|363385384|FG000|Pre-Treatment Phase|Death|5|||
105376686|NCT03483103|363385384|FG000|Treatment Phase|Withdrawal by Subject|7|||
105376687|NCT03483103|363385384|FG000|Treatment Phase|Other reasons|1|||
105376688|NCT03483103|363385384|FG000|Treatment Phase|Death|23|||
105376689|NCT03483103|363385384|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
105376690|NCT03483103|363385384|FG000|Treatment Phase|Received nonconforming product|1|||
105376691|NCT04810962|363385385|FG000|Overall Study|Adverse Event|0|||
105376692|NCT04810962|363385386|FG001|Overall Study|Adverse Event|1|||
105376693|NCT04810962|363385385|FG000|Overall Study|Lost to Follow-up|2|||
105376694|NCT04810962|363385386|FG001|Overall Study|Lost to Follow-up|1|||
105376695|NCT04810962|363385385|FG000|Overall Study|Physician Decision|1|||
105376696|NCT04810962|363385386|FG001|Overall Study|Physician Decision|0|||
105376697|NCT04810962|363385385|FG000|Overall Study|Withdrawal by Subject|1|||
105376698|NCT04810962|363385386|FG001|Overall Study|Withdrawal by Subject|3|||
105376699|NCT04810962|363385385|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
105376700|NCT04810962|363385386|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
105376701|NCT00770367|363385387|FG000|First Intervention|Withdrawal by Subject|0|||
105376702|NCT00770367|363385388|FG001|First Intervention|Withdrawal by Subject|2|||
105376703|NCT00770367|363385387|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
105376704|NCT00770367|363385388|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
105376705|NCT00770367|363385387|FG000|Second Intervention|Lost to Follow-up|2|||
105376706|NCT00770367|363385388|FG001|Second Intervention|Lost to Follow-up|0|||
105376707|NCT00435942|363385389|FG000|Overall Study|Death|17|||
105376708|NCT00435942|363385390|FG001|Overall Study|Death|10|||
105376709|NCT00435942|363385389|FG000|Overall Study|Withdrawal by Subject|2|||
105376710|NCT00435942|363385390|FG001|Overall Study|Withdrawal by Subject|0|||
105376711|NCT00435942|363385389|FG000|Overall Study|Lost to Follow-up|0|||
105376712|NCT00435942|363385390|FG001|Overall Study|Lost to Follow-up|16|||
105376713|NCT00435942|363385389|FG000|Overall Study|Conversion to Open Repair|1|||
105376714|NCT00435942|363385390|FG001|Overall Study|Conversion to Open Repair|0|||
105376715|NCT00435942|363385389|FG000|Overall Study|Technical Failure|3|||
105376716|NCT00435942|363385390|FG001|Overall Study|Technical Failure|0|||
105376717|NCT00435942|363385389|FG000|Overall Study|Other|0|||
105376718|NCT00435942|363385390|FG001|Overall Study|Other|1|||
105376719|NCT04727749|363385391|FG000|Overall Study|Lost to Follow-up|10|||
105376720|NCT04727749|363385392|FG001|Overall Study|Lost to Follow-up|3|||
105376721|NCT01898130|363385393|FG000|Treatment|Withdrawal by Subject|2|||
105376722|NCT01898130|363385393|FG000|Treatment|Progressive Disease|4|||
105376723|NCT01898130|363385393|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
105376724|NCT04491994|363385397|FG000|Overall Study|Withdrawal by Subject|10|||
105376725|NCT04491994|363385398|FG001|Overall Study|Withdrawal by Subject|5|||
105376726|NCT04491994|363385397|FG000|Overall Study|developed fever > 3 days|4|||
105376727|NCT04491994|363385398|FG001|Overall Study|developed fever > 3 days|1|||
105376728|NCT04491994|363385397|FG000|Overall Study|Protocol Violation|11|||
105376729|NCT04491994|363385398|FG001|Overall Study|Protocol Violation|2|||
105376730|NCT04491994|363385397|FG000|Overall Study|Lost to Follow-up|4|||
105376731|NCT04491994|363385398|FG001|Overall Study|Lost to Follow-up|3|||
105376732|NCT00505921|363385399|FG000|Overall Study|Ineligible|1|||
105376733|NCT00505921|363385399|FG000|Overall Study|Failed to Mobilize|8|||
105376734|NCT02382939|363385405|FG000|Overall Study|Adverse Event|1|||
105376735|NCT02382939|363385406|FG001|Overall Study|Adverse Event|1|||
105376736|NCT02382939|363385405|FG000|Overall Study|Withdrawal by Subject|2|||
105376737|NCT02382939|363385406|FG001|Overall Study|Withdrawal by Subject|2|||
105376738|NCT00717886|363385409|FG000|Overall Study|Withdrawal by Subject|3|||
105376739|NCT00717886|363385409|FG000|Overall Study|Treatment Failure|1|||
105376740|NCT01369433|363385410|FG000|Overall Study|Adverse Event|31|||
105376741|NCT01369433|363385411|FG001|Overall Study|Adverse Event|1|||
105376742|NCT01369433|363385410|FG000|Overall Study|Required significant surgical procedure|1|||
105376743|NCT01369433|363385411|FG001|Overall Study|Required significant surgical procedure|0|||
105376744|NCT01369433|363385410|FG000|Overall Study|Non-compliance|1|||
105376745|NCT01369433|363385411|FG001|Overall Study|Non-compliance|0|||
105376746|NCT01369433|363385410|FG000|Overall Study|Withdrawal by Subject|5|||
105376747|NCT01369433|363385411|FG001|Overall Study|Withdrawal by Subject|2|||
105376748|NCT01369433|363385410|FG000|Overall Study|Study terminated by Sponsor|67|||
105376749|NCT01369433|363385411|FG001|Overall Study|Study terminated by Sponsor|0|||
105376750|NCT01369433|363385410|FG000|Overall Study|Lost to Follow-up|1|||
105376751|NCT01369433|363385411|FG001|Overall Study|Lost to Follow-up|0|||
105578422|NCT01448044|364116739|FG001|Treatment Period|Lack of Efficacy|12|||
105376752|NCT01369433|363385410|FG000|Overall Study|Death|5|||
105376753|NCT01369433|363385411|FG001|Overall Study|Death|0|||
105376754|NCT01369433|363385410|FG000|Overall Study|Investigator discretion|6|||
105376755|NCT01369433|363385411|FG001|Overall Study|Investigator discretion|1|||
105376756|NCT01369433|363385410|FG000|Overall Study|Progressive Disease|92|||
105376757|NCT01369433|363385411|FG001|Overall Study|Progressive Disease|12|||
105376758|NCT01553851|363385412|FG000|Overall Study|Adverse Event|2|||
105376759|NCT01553851|363385412|FG000|Overall Study|constipation|1|||
105376760|NCT01303419|363385415|FG000|Overall Study|Discontinuation of study|60|||
105376761|NCT01303419|363385415|FG000|Overall Study|Did not complete both imaging methods|5|||
105376762|NCT01303419|363385415|FG000|Overall Study|Did not meet all I/E after screening|31|||
105376763|NCT00303628|363385419|FG000|Overall Study|Disease progression|0|||
105376764|NCT00303628|363385420|FG001|Overall Study|Disease progression|1|||
105376765|NCT00303628|363385419|FG000|Overall Study|Adverse Event|26|||
105376766|NCT00303628|363385420|FG001|Overall Study|Adverse Event|36|||
105376767|NCT00303628|363385419|FG000|Overall Study|Death|0|||
105376768|NCT00303628|363385420|FG001|Overall Study|Death|1|||
105376769|NCT00303628|363385419|FG000|Overall Study|Withdrawal by Subject|11|||
105376770|NCT00303628|363385420|FG001|Overall Study|Withdrawal by Subject|20|||
105376771|NCT00303628|363385419|FG000|Overall Study|Alternative therapy|2|||
105376772|NCT00303628|363385420|FG001|Overall Study|Alternative therapy|0|||
105376773|NCT00303628|363385419|FG000|Overall Study|Other complicating disease|0|||
105376774|NCT00303628|363385420|FG001|Overall Study|Other complicating disease|1|||
105376775|NCT00303628|363385419|FG000|Overall Study|Not start protocol therapy|3|||
105376776|NCT00303628|363385420|FG001|Overall Study|Not start protocol therapy|5|||
105376777|NCT00303628|363385419|FG000|Overall Study|Other|8|||
105376778|NCT00303628|363385420|FG001|Overall Study|Other|9|||
105376779|NCT00376506|363385421|FG000|Overall Study|Death|0|||
105376780|NCT00376506|363385422|FG001|Overall Study|Death|2|||
105376781|NCT00311168|363385423|FG000|First Intervention|Withdrawal by Subject|2|||
105376782|NCT00311168|363385424|FG001|First Intervention|Withdrawal by Subject|2|||
105376783|NCT00311168|363385423|FG000|First Intervention|Lost to Follow-up|1|||
105376784|NCT00311168|363385424|FG001|First Intervention|Lost to Follow-up|1|||
105376785|NCT00311168|363385423|FG000|First Intervention|Protocol Violation|1|||
105376786|NCT00311168|363385424|FG001|First Intervention|Protocol Violation|1|||
105376787|NCT00311168|363385423|FG000|First Intervention|Adverse Event|1|||
105376788|NCT00311168|363385424|FG001|First Intervention|Adverse Event|0|||
105376789|NCT00311168|363385423|FG000|First Intervention|Other|2|||
105376790|NCT00311168|363385424|FG001|First Intervention|Other|2|||
105376791|NCT00311168|363385423|FG000|Second Intervention|Lost to Follow-up|9|||
105376792|NCT00311168|363385424|FG001|Second Intervention|Lost to Follow-up|2|||
105376793|NCT00311168|363385423|FG000|Second Intervention|Withdrawal by Subject|0|||
105376794|NCT00311168|363385424|FG001|Second Intervention|Withdrawal by Subject|1|||
105376795|NCT00311168|363385423|FG000|Second Intervention|Other|1|||
105376796|NCT00311168|363385424|FG001|Second Intervention|Other|1|||
105376797|NCT01697579|363385428|FG000|Base Study-Cycle 1|Adverse Event|1|||
105376798|NCT01697579|363385429|FG001|Base Study-Cycle 1|Adverse Event|0|||
105376799|NCT01697579|363385430|FG002|Base Study-Cycle 1|Adverse Event|0|||
105376800|NCT01697579|363385431|FG003|Base Study-Cycle 1|Adverse Event|0|||
105376801|NCT01697579|363385432|FG004|Base Study-Cycle 1|Adverse Event|0|||
105376802|NCT01697579|363385433|FG005|Base Study-Cycle 1|Adverse Event|0|||
105376803|NCT01697579|363385434|FG006|Base Study-Cycle 1|Adverse Event|0|||
105376804|NCT01697579|363385428|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
105376805|NCT01697579|363385429|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
105376806|NCT01697579|363385430|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
105376807|NCT01697579|363385431|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
105376808|NCT01697579|363385432|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
105376809|NCT01697579|363385433|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
105376810|NCT01697579|363385434|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
105376811|NCT01697579|363385428|FG000|Base Study-Cycle 1|Protocol Violation|0|||
105376812|NCT01697579|363385429|FG001|Base Study-Cycle 1|Protocol Violation|0|||
105376813|NCT01697579|363385430|FG002|Base Study-Cycle 1|Protocol Violation|0|||
105376814|NCT01697579|363385431|FG003|Base Study-Cycle 1|Protocol Violation|0|||
105376815|NCT01697579|363385432|FG004|Base Study-Cycle 1|Protocol Violation|3|||
105376816|NCT01697579|363385433|FG005|Base Study-Cycle 1|Protocol Violation|0|||
105376817|NCT01697579|363385434|FG006|Base Study-Cycle 1|Protocol Violation|0|||
105376818|NCT01697579|363385428|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
105376819|NCT01697579|363385429|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
105376820|NCT01697579|363385430|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
105376821|NCT01697579|363385431|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
105376822|NCT01697579|363385432|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
105376823|NCT01697579|363385433|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
105376824|NCT01697579|363385434|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
105376825|NCT01697579|363385428|FG000|Base Study-Cycle 1|Technical Problems|0|||
105376826|NCT01697579|363385429|FG001|Base Study-Cycle 1|Technical Problems|0|||
105376827|NCT01697579|363385430|FG002|Base Study-Cycle 1|Technical Problems|1|||
105376828|NCT01697579|363385431|FG003|Base Study-Cycle 1|Technical Problems|1|||
105376829|NCT01697579|363385432|FG004|Base Study-Cycle 1|Technical Problems|0|||
105376830|NCT01697579|363385433|FG005|Base Study-Cycle 1|Technical Problems|0|||
105376831|NCT01697579|363385434|FG006|Base Study-Cycle 1|Technical Problems|0|||
105578423|NCT01448044|364116738|FG000|Treatment Period|Subject requested discontinue study drug|1|||
105376832|NCT01697579|363385428|FG000|Optional Extension-Cycles 2-6|Death|0|||
105376833|NCT01697579|363385429|FG001|Optional Extension-Cycles 2-6|Death|0|||
105376834|NCT01697579|363385430|FG002|Optional Extension-Cycles 2-6|Death|0|||
105376835|NCT01697579|363385431|FG003|Optional Extension-Cycles 2-6|Death|0|||
105376836|NCT01697579|363385432|FG004|Optional Extension-Cycles 2-6|Death|0|||
105376837|NCT01697579|363385433|FG005|Optional Extension-Cycles 2-6|Death|0|||
105376838|NCT01697579|363385434|FG006|Optional Extension-Cycles 2-6|Death|2|||
105376839|NCT01697579|363385428|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
105376840|NCT01697579|363385429|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
105376841|NCT01697579|363385430|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
105376842|NCT01697579|363385431|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
105376843|NCT01697579|363385432|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
105376844|NCT01697579|363385433|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
105376845|NCT01697579|363385434|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
105376846|NCT01697579|363385428|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
105376847|NCT01697579|363385429|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
105376848|NCT01697579|363385430|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
105376849|NCT01697579|363385431|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
105376850|NCT01697579|363385432|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
105376851|NCT01697579|363385433|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
105376852|NCT01697579|363385434|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
105376853|NCT01697579|363385428|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
105376854|NCT01697579|363385429|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
105376855|NCT01697579|363385430|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
105376856|NCT01697579|363385431|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
105376857|NCT01697579|363385432|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
105376858|NCT01697579|363385433|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
105376859|NCT01697579|363385434|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
105376860|NCT01697579|363385428|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
105376861|NCT01697579|363385429|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
105376862|NCT01697579|363385430|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
105376863|NCT01697579|363385431|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
105376864|NCT01697579|363385432|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
105376865|NCT01697579|363385433|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
105376866|NCT01697579|363385434|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
105376867|NCT01697579|363385428|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
105376868|NCT01697579|363385429|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
105376869|NCT01697579|363385430|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
105376870|NCT01697579|363385431|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
105376871|NCT01697579|363385432|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
105376872|NCT01697579|363385433|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
105376873|NCT01697579|363385434|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
105376874|NCT01697579|363385428|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
105376875|NCT01697579|363385429|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
105376876|NCT01697579|363385430|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
105376877|NCT01697579|363385431|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
105376878|NCT01697579|363385432|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
105376879|NCT01697579|363385433|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
105330286|NCT00463047|363209868|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
105330287|NCT00463047|363209867|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
105330288|NCT00463047|363209868|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
105330289|NCT00463047|363209867|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
105330290|NCT00463047|363209868|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
105330291|NCT03363776|363209872|FG000|Overall Study|Progressive disease|2|||
105330292|NCT03363776|363209873|FG001|Overall Study|Progressive disease|3|||
105330293|NCT03363776|363209874|FG002|Overall Study|Progressive disease|1|||
105330294|NCT03363776|363209872|FG000|Overall Study|Study drug toxicity|0|||
105330295|NCT03363776|363209873|FG001|Overall Study|Study drug toxicity|0|||
105330296|NCT03363776|363209874|FG002|Overall Study|Study drug toxicity|1|||
105330297|NCT03363776|363209872|FG000|Overall Study|Death|1|||
105330298|NCT03363776|363209873|FG001|Overall Study|Death|0|||
105330299|NCT03363776|363209874|FG002|Overall Study|Death|0|||
105330300|NCT02418949|363209883|FG000|Overall Study|Withdrawal by Subject|1|||
105330301|NCT02418949|363209884|FG001|Overall Study|Withdrawal by Subject|0|||
105330302|NCT02418949|363209885|FG002|Overall Study|Withdrawal by Subject|1|||
105330303|NCT02418949|363209886|FG003|Overall Study|Withdrawal by Subject|1|||
105330304|NCT02418949|363209883|FG000|Overall Study|Lost to Follow-up|1|||
105330305|NCT02418949|363209884|FG001|Overall Study|Lost to Follow-up|0|||
105330306|NCT02418949|363209885|FG002|Overall Study|Lost to Follow-up|1|||
105330307|NCT02418949|363209886|FG003|Overall Study|Lost to Follow-up|0|||
105330308|NCT02418949|363209883|FG000|Overall Study|Physician Decision|1|||
105330309|NCT02418949|363209884|FG001|Overall Study|Physician Decision|1|||
105330310|NCT02418949|363209885|FG002|Overall Study|Physician Decision|1|||
105330311|NCT02418949|363209886|FG003|Overall Study|Physician Decision|0|||
105330312|NCT01303172|363209888|FG000|Overall Study|Physician Decision|9|||
105578424|NCT01448044|364116739|FG001|Treatment Period|Subject requested discontinue study drug|0|||
105578425|NCT01448044|364116738|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
105578426|NCT01448044|364116739|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
105578427|NCT01448044|364116738|FG000|Treatment Period|Participant does not meet study criteria|1|||
105578428|NCT01448044|364116739|FG001|Treatment Period|Participant does not meet study criteria|0|||
105578429|NCT01448044|364116738|FG000|Treatment Period|Lost to Follow-up|2|||
105578430|NCT01448044|364116739|FG001|Treatment Period|Lost to Follow-up|1|||
105578431|NCT01448044|364116738|FG000|Treatment Period|Other reason|2|||
105578432|NCT01448044|364116739|FG001|Treatment Period|Other reason|0|||
105578433|NCT01448044|364116738|FG000|Follow Up Period|Withdrawal by Subject|1|||
105578434|NCT01448044|364116739|FG001|Follow Up Period|Withdrawal by Subject|1|||
105578435|NCT01448044|364116738|FG000|Follow Up Period|Lost to Follow-up|6|||
105578436|NCT01448044|364116739|FG001|Follow Up Period|Lost to Follow-up|2|||
105578437|NCT01448044|364116738|FG000|Follow Up Period|Other|5|||
105578438|NCT01448044|364116739|FG001|Follow Up Period|Other|11|||
105578439|NCT00681187|364116740|FG000|Overall Study|Withdrawal by Subject|1|||
105578440|NCT00681187|364116741|FG001|Overall Study|Withdrawal by Subject|0|||
105578441|NCT00681187|364116740|FG000|Overall Study|Death|0|||
105578442|NCT00681187|364116741|FG001|Overall Study|Death|1|||
105578443|NCT00681187|364116740|FG000|Overall Study|Adverse Event|0|||
105578444|NCT00681187|364116741|FG001|Overall Study|Adverse Event|1|||
105578445|NCT00896454|364116742|FG000|Overall Study|Death|10|||
105578446|NCT00896454|364116742|FG000|Overall Study|Adverse Event|8|||
105578447|NCT00896454|364116742|FG000|Overall Study|Disease Progression|5|||
105578448|NCT00896454|364116742|FG000|Overall Study|Other|4|||
105578449|NCT00896454|364116742|FG000|Overall Study|Requirement for alternative therapy|3|||
105578450|NCT00896454|364116742|FG000|Overall Study|Ongoing in study|2|||
105578451|NCT00896454|364116742|FG000|Overall Study|Withdrawal by Subject|1|||
105578452|NCT03688711|364116745|FG000|Overall Study|Withdrawal by Subject|0|||
105578453|NCT03688711|364116746|FG001|Overall Study|Withdrawal by Subject|1|||
105578454|NCT00219141|364116747|FG000|Overall Study|Adverse Event|4|||
105578455|NCT00219141|364116748|FG001|Overall Study|Adverse Event|10|||
105578456|NCT00219141|364116749|FG002|Overall Study|Adverse Event|5|||
105578457|NCT00219141|364116747|FG000|Overall Study|Lack of Efficacy|3|||
105578458|NCT00219141|364116748|FG001|Overall Study|Lack of Efficacy|2|||
105578459|NCT00219141|364116749|FG002|Overall Study|Lack of Efficacy|0|||
105578460|NCT00219141|364116747|FG000|Overall Study|Administrative problems|0|||
105578461|NCT00219141|364116748|FG001|Overall Study|Administrative problems|1|||
105578462|NCT00219141|364116749|FG002|Overall Study|Administrative problems|0|||
105578463|NCT00219141|364116747|FG000|Overall Study|Lost to Follow-up|2|||
105578464|NCT00219141|364116748|FG001|Overall Study|Lost to Follow-up|4|||
105578465|NCT00219141|364116749|FG002|Overall Study|Lost to Follow-up|1|||
105578466|NCT00219141|364116747|FG000|Overall Study|Protocol Violation|3|||
105578467|NCT00219141|364116748|FG001|Overall Study|Protocol Violation|1|||
105578468|NCT00219141|364116749|FG002|Overall Study|Protocol Violation|1|||
105578469|NCT00219141|364116747|FG000|Overall Study|Withdrawal by Subject|1|||
105578470|NCT00219141|364116748|FG001|Overall Study|Withdrawal by Subject|3|||
105578471|NCT00219141|364116749|FG002|Overall Study|Withdrawal by Subject|5|||
105578472|NCT00219141|364116747|FG000|Overall Study|Condition no longer requires study drug|1|||
105578473|NCT00219141|364116748|FG001|Overall Study|Condition no longer requires study drug|0|||
105578474|NCT00219141|364116749|FG002|Overall Study|Condition no longer requires study drug|0|||
105578475|NCT00972179|364116750|FG000|Overall Study|Noncompliance|1|||
105578476|NCT00972179|364116751|FG001|Overall Study|Noncompliance|0|||
105578477|NCT00972179|364116752|FG002|Overall Study|Noncompliance|0|||
105578478|NCT00972179|364116753|FG003|Overall Study|Noncompliance|0|||
105578479|NCT00972179|364116754|FG004|Overall Study|Noncompliance|1|||
105578480|NCT00972179|364116755|FG005|Overall Study|Noncompliance|0|||
105578481|NCT00972179|364116756|FG006|Overall Study|Noncompliance|1|||
105578482|NCT00972179|364116750|FG000|Overall Study|Withdrawal by Subject|0|||
105578483|NCT00972179|364116751|FG001|Overall Study|Withdrawal by Subject|3|||
105578484|NCT00972179|364116752|FG002|Overall Study|Withdrawal by Subject|0|||
105578485|NCT00972179|364116753|FG003|Overall Study|Withdrawal by Subject|1|||
105578486|NCT00972179|364116754|FG004|Overall Study|Withdrawal by Subject|0|||
105578487|NCT00972179|364116755|FG005|Overall Study|Withdrawal by Subject|0|||
105578488|NCT00972179|364116756|FG006|Overall Study|Withdrawal by Subject|2|||
105578489|NCT00972179|364116750|FG000|Overall Study|Administrative Decision|0|||
105578490|NCT00972179|364116751|FG001|Overall Study|Administrative Decision|0|||
105578491|NCT00972179|364116752|FG002|Overall Study|Administrative Decision|0|||
105578492|NCT00972179|364116753|FG003|Overall Study|Administrative Decision|0|||
105578493|NCT00972179|364116754|FG004|Overall Study|Administrative Decision|1|||
105578494|NCT00972179|364116755|FG005|Overall Study|Administrative Decision|0|||
105578495|NCT00972179|364116756|FG006|Overall Study|Administrative Decision|0|||
105578496|NCT00972179|364116750|FG000|Overall Study|Lost to Follow-up|0|||
105578497|NCT00972179|364116751|FG001|Overall Study|Lost to Follow-up|0|||
105578498|NCT00972179|364116752|FG002|Overall Study|Lost to Follow-up|1|||
105578499|NCT00972179|364116753|FG003|Overall Study|Lost to Follow-up|0|||
105578500|NCT00972179|364116754|FG004|Overall Study|Lost to Follow-up|0|||
105330313|NCT01303172|363209889|FG001|Overall Study|Physician Decision|6|||
105330314|NCT01303172|363209888|FG000|Overall Study|Adverse Event|5|||
105330315|NCT01303172|363209889|FG001|Overall Study|Adverse Event|2|||
105376880|NCT01697579|363385434|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
105376881|NCT01697579|363385428|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
105376882|NCT01697579|363385429|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
105376883|NCT01697579|363385430|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
105376884|NCT01697579|363385431|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
105376885|NCT01697579|363385432|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
105376886|NCT01697579|363385433|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
105376887|NCT01697579|363385434|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
105376888|NCT01697579|363385428|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
105376889|NCT01697579|363385429|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
105376890|NCT01697579|363385430|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
105376891|NCT01697579|363385431|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
105376892|NCT01697579|363385432|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
105376893|NCT01697579|363385433|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
105376894|NCT01697579|363385434|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
105376895|NCT01697579|363385428|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
105376896|NCT01697579|363385429|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
105376897|NCT01697579|363385430|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
105376898|NCT01697579|363385431|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
105376899|NCT01697579|363385432|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
105376900|NCT01697579|363385433|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
105376901|NCT01697579|363385434|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
105376902|NCT01697579|363385428|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
105376903|NCT01697579|363385429|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
105376904|NCT01697579|363385430|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
105376905|NCT01697579|363385431|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
105376906|NCT01697579|363385432|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
105376907|NCT01697579|363385433|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
105376908|NCT01697579|363385434|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
105578501|NCT00972179|364116755|FG005|Overall Study|Lost to Follow-up|3|||
105330316|NCT01303172|363209888|FG000|Overall Study|Withdrawal by Subject|4|||
105330317|NCT01303172|363209889|FG001|Overall Study|Withdrawal by Subject|2|||
105330318|NCT01303172|363209888|FG000|Overall Study|Death|20|||
105330319|NCT01303172|363209889|FG001|Overall Study|Death|7|||
105330320|NCT01303172|363209888|FG000|Overall Study|Lack of Efficacy|25|||
105330321|NCT01303172|363209889|FG001|Overall Study|Lack of Efficacy|17|||
105330322|NCT02684097|363209892|FG000|Overall Study|Lack of Efficacy|13|||
105330323|NCT02684097|363209893|FG001|Overall Study|Lack of Efficacy|6|||
105330324|NCT02593097|363209894|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
105330325|NCT02593097|363209895|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
105330326|NCT02593097|363209894|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
105330327|NCT02593097|363209895|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
105330328|NCT02593097|363209894|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
105330329|NCT02593097|363209895|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
105330330|NCT02593097|363209894|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
105330331|NCT02593097|363209895|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
105330332|NCT02593097|363209894|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
105330333|NCT02593097|363209895|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
105330334|NCT02630251|363209899|FG000|Overall Study|Physician Decision|0|||
105330335|NCT02630251|363209900|FG001|Overall Study|Physician Decision|0|||
105330336|NCT02630251|363209901|FG002|Overall Study|Physician Decision|1|||
105330337|NCT02630251|363209902|FG003|Overall Study|Physician Decision|0|||
105330338|NCT00570063|363209905|FG000|Overall Study|Adverse Event|4|||
105330339|NCT00570063|363209906|FG001|Overall Study|Adverse Event|1|||
105330340|NCT00570063|363209905|FG000|Overall Study|Lack of Efficacy|0|||
105330341|NCT00570063|363209906|FG001|Overall Study|Lack of Efficacy|1|||
105330342|NCT00570063|363209905|FG000|Overall Study|Withdrawal by Subject|4|||
105330343|NCT00570063|363209906|FG001|Overall Study|Withdrawal by Subject|3|||
105330344|NCT00570063|363209905|FG000|Overall Study|Sponsor's Decision|7|||
105330345|NCT00570063|363209906|FG001|Overall Study|Sponsor's Decision|3|||
105330346|NCT00697463|363209907|FG000|Overall Study|Withdrawal by Subject|1|||
105330347|NCT03307252|363209908|FG000|Part 2, Period 1|Treatment not received|0|||
105330348|NCT03307252|363209909|FG001|Part 2, Period 1|Treatment not received|0|||
105330349|NCT03307252|363209910|FG002|Part 2, Period 1|Treatment not received|0|||
105330350|NCT03307252|363209911|FG003|Part 2, Period 1|Treatment not received|0|||
105330351|NCT03307252|363209912|FG004|Part 2, Period 1|Treatment not received|0|||
105330352|NCT03307252|363209913|FG005|Part 2, Period 1|Treatment not received|1|||
105330353|NCT03307252|363209914|FG006|Part 2, Period 1|Treatment not received|0|||
105330354|NCT03307252|363209915|FG007|Part 2, Period 1|Treatment not received|0|||
105578502|NCT00972179|364116756|FG006|Overall Study|Lost to Follow-up|1|||
105578503|NCT04285229|364116757|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
105578504|NCT04285229|364116758|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105578505|NCT04285229|364116759|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105578506|NCT04285229|364116760|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105578507|NCT04285229|364116761|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105578508|NCT04285229|364116762|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105578509|NCT04285229|364116757|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
105578510|NCT04285229|364116758|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
105578511|NCT04285229|364116759|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
105578512|NCT04285229|364116760|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
105578513|NCT04285229|364116761|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
105578514|NCT04285229|364116762|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
105578515|NCT04285229|364116757|FG000|Extended Treatment Period|Adverse Event|0|||
105578516|NCT04285229|364116758|FG001|Extended Treatment Period|Adverse Event|0|||
105578517|NCT04285229|364116759|FG002|Extended Treatment Period|Adverse Event|0|||
105578518|NCT04285229|364116760|FG003|Extended Treatment Period|Adverse Event|1|||
105578519|NCT04285229|364116761|FG004|Extended Treatment Period|Adverse Event|0|||
105578520|NCT04285229|364116762|FG005|Extended Treatment Period|Adverse Event|0|||
105578521|NCT04285229|364116757|FG000|Extended Treatment Period|Physician Decision|0|||
105578522|NCT04285229|364116758|FG001|Extended Treatment Period|Physician Decision|0|||
105578523|NCT04285229|364116759|FG002|Extended Treatment Period|Physician Decision|1|||
105578524|NCT04285229|364116760|FG003|Extended Treatment Period|Physician Decision|0|||
105578525|NCT04285229|364116761|FG004|Extended Treatment Period|Physician Decision|0|||
105578526|NCT04285229|364116762|FG005|Extended Treatment Period|Physician Decision|0|||
105578527|NCT04285229|364116757|FG000|Follow-up Period|Adverse Event|0|||
105578528|NCT04285229|364116758|FG001|Follow-up Period|Adverse Event|0|||
105578529|NCT04285229|364116759|FG002|Follow-up Period|Adverse Event|0|||
105578530|NCT04285229|364116760|FG003|Follow-up Period|Adverse Event|0|||
105578531|NCT04285229|364116761|FG004|Follow-up Period|Adverse Event|1|||
105578532|NCT04285229|364116762|FG005|Follow-up Period|Adverse Event|4|||
105578533|NCT04285229|364116757|FG000|Follow-up Period|Withdrawal by Subject|0|||
105578534|NCT04285229|364116758|FG001|Follow-up Period|Withdrawal by Subject|0|||
105578535|NCT04285229|364116759|FG002|Follow-up Period|Withdrawal by Subject|0|||
105578536|NCT04285229|364116760|FG003|Follow-up Period|Withdrawal by Subject|0|||
105578537|NCT04285229|364116761|FG004|Follow-up Period|Withdrawal by Subject|0|||
105578538|NCT04285229|364116762|FG005|Follow-up Period|Withdrawal by Subject|5|||
105578539|NCT04285229|364116757|FG000|Follow-up Period|Covid-19|0|||
105578540|NCT04285229|364116758|FG001|Follow-up Period|Covid-19|0|||
105578541|NCT04285229|364116759|FG002|Follow-up Period|Covid-19|0|||
105578542|NCT04285229|364116760|FG003|Follow-up Period|Covid-19|0|||
105578543|NCT04285229|364116761|FG004|Follow-up Period|Covid-19|0|||
105578544|NCT04285229|364116762|FG005|Follow-up Period|Covid-19|2|||
105578545|NCT04285229|364116757|FG000|Follow-up Period|Physician Decision|0|||
105578546|NCT04285229|364116758|FG001|Follow-up Period|Physician Decision|0|||
105578547|NCT04285229|364116759|FG002|Follow-up Period|Physician Decision|0|||
105578548|NCT04285229|364116760|FG003|Follow-up Period|Physician Decision|0|||
105578549|NCT04285229|364116761|FG004|Follow-up Period|Physician Decision|0|||
105578550|NCT04285229|364116762|FG005|Follow-up Period|Physician Decision|1|||
105578551|NCT02061761|364116763|FG000|Overall Study|Disease progression|2|||
105578552|NCT02061761|364116764|FG001|Overall Study|Disease progression|8|||
105578553|NCT02061761|364116765|FG002|Overall Study|Disease progression|4|||
105578554|NCT02061761|364116766|FG003|Overall Study|Disease progression|5|||
105578555|NCT02061761|364116767|FG004|Overall Study|Disease progression|9|||
105578556|NCT02061761|364116768|FG005|Overall Study|Disease progression|3|||
105330355|NCT03307252|363209916|FG008|Part 2, Period 1|Treatment not received|0|||
105578557|NCT02061761|364116769|FG006|Overall Study|Disease progression|1|||
105578558|NCT02061761|364116770|FG007|Overall Study|Disease progression|2|||
105578559|NCT02061761|364116771|FG008|Overall Study|Disease progression|28|||
105578560|NCT02061761|364116763|FG000|Overall Study|Study Drug toxicity|0|||
105578561|NCT02061761|364116764|FG001|Overall Study|Study Drug toxicity|0|||
105578562|NCT02061761|364116765|FG002|Overall Study|Study Drug toxicity|0|||
105578563|NCT02061761|364116766|FG003|Overall Study|Study Drug toxicity|0|||
105578564|NCT02061761|364116767|FG004|Overall Study|Study Drug toxicity|0|||
105330356|NCT03307252|363209917|FG009|Part 2, Period 1|Treatment not received|0|||
105330357|NCT03307252|363209918|FG010|Part 2, Period 1|Treatment not received|0|||
105330358|NCT03307252|363209908|FG000|Part 2, Period 3|Other than listed|0|||
105330359|NCT03307252|363209909|FG001|Part 2, Period 3|Other than listed|0|||
105330360|NCT03307252|363209910|FG002|Part 2, Period 3|Other than listed|0|||
105330361|NCT03307252|363209911|FG003|Part 2, Period 3|Other than listed|0|||
105330362|NCT03307252|363209912|FG004|Part 2, Period 3|Other than listed|1|||
105330363|NCT03307252|363209913|FG005|Part 2, Period 3|Other than listed|0|||
105330364|NCT03307252|363209914|FG006|Part 2, Period 3|Other than listed|0|||
105330365|NCT03307252|363209915|FG007|Part 2, Period 3|Other than listed|0|||
105376909|NCT01697579|363385428|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
105376910|NCT01697579|363385429|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
105376911|NCT01697579|363385430|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
105376912|NCT01697579|363385431|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
105376913|NCT01697579|363385432|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
105376914|NCT01697579|363385433|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
105376915|NCT01697579|363385434|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
105376916|NCT01697579|363385428|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
105376917|NCT01697579|363385429|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
105376918|NCT01697579|363385430|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
105376919|NCT01697579|363385431|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
105376920|NCT01697579|363385432|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
105376921|NCT01697579|363385433|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
105376922|NCT01697579|363385434|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
105376923|NCT02452190|363385435|FG000|Overall Study|Withdrawal by Sponsor|1|||
105376924|NCT02452190|363385436|FG001|Overall Study|Withdrawal by Sponsor|3|||
105376925|NCT02452190|363385435|FG000|Overall Study|Pregnancy|1|||
105376926|NCT02452190|363385436|FG001|Overall Study|Pregnancy|0|||
105376927|NCT02452190|363385435|FG000|Overall Study|Investigator's Decision|2|||
105376928|NCT02452190|363385436|FG001|Overall Study|Investigator's Decision|0|||
105376929|NCT02452190|363385435|FG000|Overall Study|Lack of Efficacy|3|||
105376930|NCT02452190|363385436|FG001|Overall Study|Lack of Efficacy|1|||
105376931|NCT02452190|363385435|FG000|Overall Study|Lost to Follow-up|4|||
105376932|NCT02452190|363385436|FG001|Overall Study|Lost to Follow-up|3|||
105376933|NCT02452190|363385435|FG000|Overall Study|Adverse Event|2|||
105376934|NCT02452190|363385436|FG001|Overall Study|Adverse Event|5|||
105376935|NCT02452190|363385435|FG000|Overall Study|Withdrawal by Subject|20|||
105376936|NCT02452190|363385436|FG001|Overall Study|Withdrawal by Subject|11|||
105376937|NCT02452190|363385435|FG000|Overall Study|Noncompliance with study drug|1|||
105376938|NCT02452190|363385436|FG001|Overall Study|Noncompliance with study drug|0|||
105376939|NCT02452190|363385435|FG000|Overall Study|Participant traveled abroad|1|||
105376940|NCT02452190|363385436|FG001|Overall Study|Participant traveled abroad|0|||
105376941|NCT02452190|363385435|FG000|Overall Study|Death|0|||
105376942|NCT02452190|363385436|FG001|Overall Study|Death|1|||
105376943|NCT02948400|363385437|FG000|Overall Study|Withdrawal by Subject|17|||
105376944|NCT02948400|363385438|FG001|Overall Study|Withdrawal by Subject|10|||
105376945|NCT02948400|363385437|FG000|Overall Study|failed to attend appointments|47|||
105376946|NCT02948400|363385438|FG001|Overall Study|failed to attend appointments|34|||
105376947|NCT02948400|363385437|FG000|Overall Study|COVID-related closure|6|||
105376948|NCT02948400|363385438|FG001|Overall Study|COVID-related closure|2|||
105376949|NCT02948400|363385437|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
105376950|NCT02948400|363385438|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
105376951|NCT02948400|363385437|FG000|Overall Study|motion sickness in virtual reality|2|||
105376952|NCT02948400|363385438|FG001|Overall Study|motion sickness in virtual reality|0|||
105376953|NCT02403271|363385439|FG000|Period 1|Other varied reasons|1|||
105376954|NCT02403271|363385440|FG001|Period 1|Other varied reasons|0|||
105376955|NCT02403271|363385439|FG000|Period 2|Withdrawal by Subject|0|||
105376956|NCT02403271|363385440|FG001|Period 2|Withdrawal by Subject|14|||
105376957|NCT02403271|363385439|FG000|Period 2|Death|0|||
105376958|NCT02403271|363385440|FG001|Period 2|Death|84|||
105376959|NCT02403271|363385439|FG000|Period 2|Lost to Follow-up|0|||
105376960|NCT02403271|363385440|FG001|Period 2|Lost to Follow-up|2|||
105376961|NCT02403271|363385439|FG000|Period 2|Study Terminated by Sponsor|0|||
105376962|NCT02403271|363385440|FG001|Period 2|Study Terminated by Sponsor|14|||
105376963|NCT02403271|363385439|FG000|Period 2|Other varied reasons|0|||
105376964|NCT02403271|363385440|FG001|Period 2|Other varied reasons|10|||
105376965|NCT00975923|363385448|FG000|Overall Study|Withdrawal by Subject|0|||
105376966|NCT00975923|363385449|FG001|Overall Study|Withdrawal by Subject|1|||
105330366|NCT03307252|363209916|FG008|Part 2, Period 3|Other than listed|0|||
105330367|NCT03307252|363209917|FG009|Part 2, Period 3|Other than listed|0|||
105330368|NCT03307252|363209918|FG010|Part 2, Period 3|Other than listed|0|||
105330369|NCT03307252|363209908|FG000|Part 2, Period 4|Other than listed|0|||
105330370|NCT03307252|363209909|FG001|Part 2, Period 4|Other than listed|0|||
105330371|NCT03307252|363209910|FG002|Part 2, Period 4|Other than listed|0|||
105330372|NCT03307252|363209911|FG003|Part 2, Period 4|Other than listed|0|||
105330373|NCT03307252|363209912|FG004|Part 2, Period 4|Other than listed|0|||
105376967|NCT00695019|363385451|FG000|Overall Study|Withdrawal by Subject|8|||
105376968|NCT00695019|363385452|FG001|Overall Study|Withdrawal by Subject|6|||
105376969|NCT00695019|363385453|FG002|Overall Study|Withdrawal by Subject|4|||
105376970|NCT00695019|363385451|FG000|Overall Study|Protocol Violation|1|||
105376971|NCT00695019|363385452|FG001|Overall Study|Protocol Violation|3|||
105376972|NCT00695019|363385453|FG002|Overall Study|Protocol Violation|1|||
105376973|NCT00695019|363385451|FG000|Overall Study|Lack of Efficacy|0|||
105376974|NCT00695019|363385452|FG001|Overall Study|Lack of Efficacy|0|||
105376975|NCT00695019|363385453|FG002|Overall Study|Lack of Efficacy|1|||
105578565|NCT02061761|364116768|FG005|Overall Study|Study Drug toxicity|1|||
105578566|NCT02061761|364116769|FG006|Overall Study|Study Drug toxicity|0|||
105578567|NCT02061761|364116770|FG007|Overall Study|Study Drug toxicity|2|||
105578568|NCT02061761|364116771|FG008|Overall Study|Study Drug toxicity|6|||
105578569|NCT02061761|364116763|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
105578570|NCT02061761|364116764|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
105578571|NCT02061761|364116765|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
105578572|NCT02061761|364116766|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
105578573|NCT02061761|364116767|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
105578574|NCT02061761|364116768|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
105578575|NCT02061761|364116769|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
105578576|NCT02061761|364116770|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
105578577|NCT02061761|364116771|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
105578578|NCT02061761|364116763|FG000|Overall Study|Participant request to discontinue study treatment|0|||
105578579|NCT02061761|364116764|FG001|Overall Study|Participant request to discontinue study treatment|0|||
105578580|NCT02061761|364116765|FG002|Overall Study|Participant request to discontinue study treatment|2|||
105578581|NCT02061761|364116766|FG003|Overall Study|Participant request to discontinue study treatment|2|||
105578582|NCT02061761|364116767|FG004|Overall Study|Participant request to discontinue study treatment|0|||
105578583|NCT02061761|364116768|FG005|Overall Study|Participant request to discontinue study treatment|1|||
105578584|NCT02061761|364116769|FG006|Overall Study|Participant request to discontinue study treatment|0|||
105578585|NCT02061761|364116770|FG007|Overall Study|Participant request to discontinue study treatment|0|||
105578586|NCT02061761|364116771|FG008|Overall Study|Participant request to discontinue study treatment|2|||
105578587|NCT02061761|364116763|FG000|Overall Study|Withdrawal by Subject|0|||
105578588|NCT02061761|364116764|FG001|Overall Study|Withdrawal by Subject|0|||
105578589|NCT02061761|364116765|FG002|Overall Study|Withdrawal by Subject|0|||
105578590|NCT02061761|364116766|FG003|Overall Study|Withdrawal by Subject|0|||
105578591|NCT02061761|364116767|FG004|Overall Study|Withdrawal by Subject|0|||
105578592|NCT02061761|364116768|FG005|Overall Study|Withdrawal by Subject|0|||
105578593|NCT02061761|364116769|FG006|Overall Study|Withdrawal by Subject|0|||
105578594|NCT02061761|364116770|FG007|Overall Study|Withdrawal by Subject|0|||
105578595|NCT02061761|364116771|FG008|Overall Study|Withdrawal by Subject|2|||
105578596|NCT02061761|364116763|FG000|Overall Study|Maximum clinical benefit|0|||
105578597|NCT02061761|364116764|FG001|Overall Study|Maximum clinical benefit|0|||
105578598|NCT02061761|364116765|FG002|Overall Study|Maximum clinical benefit|0|||
105578599|NCT02061761|364116766|FG003|Overall Study|Maximum clinical benefit|1|||
105578600|NCT02061761|364116767|FG004|Overall Study|Maximum clinical benefit|0|||
105578601|NCT02061761|364116768|FG005|Overall Study|Maximum clinical benefit|0|||
105578602|NCT02061761|364116769|FG006|Overall Study|Maximum clinical benefit|0|||
105578603|NCT02061761|364116770|FG007|Overall Study|Maximum clinical benefit|0|||
105578604|NCT02061761|364116771|FG008|Overall Study|Maximum clinical benefit|6|||
105578605|NCT02061761|364116763|FG000|Overall Study|Participant no longer meets study criteria|0|||
105578606|NCT02061761|364116764|FG001|Overall Study|Participant no longer meets study criteria|0|||
105578607|NCT02061761|364116765|FG002|Overall Study|Participant no longer meets study criteria|0|||
105578608|NCT02061761|364116766|FG003|Overall Study|Participant no longer meets study criteria|0|||
105578609|NCT02061761|364116767|FG004|Overall Study|Participant no longer meets study criteria|0|||
105578610|NCT02061761|364116768|FG005|Overall Study|Participant no longer meets study criteria|0|||
105578611|NCT02061761|364116769|FG006|Overall Study|Participant no longer meets study criteria|0|||
105578612|NCT02061761|364116770|FG007|Overall Study|Participant no longer meets study criteria|0|||
105578613|NCT02061761|364116771|FG008|Overall Study|Participant no longer meets study criteria|1|||
105578614|NCT02061761|364116763|FG000|Overall Study|Other reasons|0|||
105578615|NCT02061761|364116764|FG001|Overall Study|Other reasons|0|||
105578616|NCT02061761|364116765|FG002|Overall Study|Other reasons|0|||
105578617|NCT02061761|364116766|FG003|Overall Study|Other reasons|0|||
105578618|NCT02061761|364116767|FG004|Overall Study|Other reasons|2|||
105578619|NCT02061761|364116768|FG005|Overall Study|Other reasons|0|||
105578620|NCT02061761|364116769|FG006|Overall Study|Other reasons|0|||
105578621|NCT02061761|364116770|FG007|Overall Study|Other reasons|0|||
105578622|NCT02061761|364116771|FG008|Overall Study|Other reasons|6|||
105578623|NCT01932996|364116777|FG000|Overall Study|Protocol Violation|2|||
105578624|NCT01932996|364116778|FG001|Overall Study|Protocol Violation|0|||
105578625|NCT02500316|364116779|FG000|Overall Study|Adverse Event|3|||
105578626|NCT02500316|364116779|FG000|Overall Study|Lost to Follow-up|2|||
105578627|NCT02500316|364116779|FG000|Overall Study|Protocol Violation|1|||
105578628|NCT02500316|364116779|FG000|Overall Study|Withdrawal by Subject|15|||
105578629|NCT02500316|364116779|FG000|Overall Study|Final height achieved|5|||
105578630|NCT02500316|364116779|FG000|Overall Study|Due to war activity|1|||
105578631|NCT01406717|364116780|FG000|Overall Study|Subject non-compliance|4|||
105578632|NCT01406717|364116781|FG001|Overall Study|Subject non-compliance|3|||
105578633|NCT01406717|364116780|FG000|Overall Study|Protocol Violation|5|||
105376976|NCT00695019|363385451|FG000|Overall Study|Various|4|||
105578634|NCT01406717|364116781|FG001|Overall Study|Protocol Violation|1|||
105376977|NCT00695019|363385452|FG001|Overall Study|Various|5|||
105376978|NCT00695019|363385453|FG002|Overall Study|Various|4|||
105376979|NCT02278354|363385459|FG000|Overall Study|Lost to Follow-up|2|||
105376980|NCT02278354|363385460|FG001|Overall Study|Lost to Follow-up|2|||
105376981|NCT02278354|363385459|FG000|Overall Study|Withdrawal by Subject|0|||
105376982|NCT02278354|363385460|FG001|Overall Study|Withdrawal by Subject|1|||
105376983|NCT02278354|363385459|FG000|Overall Study|<10 professional fights|2|||
105376984|NCT02278354|363385460|FG001|Overall Study|<10 professional fights|0|||
105376985|NCT01901562|363385462|FG000|Overall Study|Protocol Violation|5|||
105376986|NCT01901562|363385462|FG000|Overall Study|Excluded intraoperatively|4|||
105376987|NCT03197129|363385463|FG000|Overall Study|did not answer the VPT: shyness|4|||
105376988|NCT03197129|363385464|FG001|Overall Study|did not answer the VPT: shyness|5|||
105376989|NCT02572167|363385466|FG000|Overall Study|Withdrawal by Subject|0|||
105376990|NCT02572167|363385467|FG001|Overall Study|Withdrawal by Subject|3|||
105376991|NCT02572167|363385468|FG002|Overall Study|Withdrawal by Subject|0|||
105376992|NCT02572167|363385466|FG000|Overall Study|Lost to Follow-up|2|||
105376993|NCT02572167|363385467|FG001|Overall Study|Lost to Follow-up|5|||
105376994|NCT02572167|363385468|FG002|Overall Study|Lost to Follow-up|3|||
105376995|NCT02572167|363385466|FG000|Overall Study|Death|0|||
105376996|NCT02572167|363385467|FG001|Overall Study|Death|8|||
105376997|NCT02572167|363385468|FG002|Overall Study|Death|3|||
105376998|NCT02572167|363385466|FG000|Overall Study|Did not meet inclusion criteria|0|||
105376999|NCT02572167|363385467|FG001|Overall Study|Did not meet inclusion criteria|0|||
105377000|NCT02572167|363385468|FG002|Overall Study|Did not meet inclusion criteria|1|||
105377001|NCT02572167|363385466|FG000|Overall Study|Study closure by Sponsor|4|||
105377002|NCT02572167|363385467|FG001|Overall Study|Study closure by Sponsor|40|||
105377003|NCT02572167|363385468|FG002|Overall Study|Study closure by Sponsor|24|||
105377004|NCT00005047|363385469|FG000|Overall Study|Withdrawal by Subject|12|||
105377005|NCT00005047|363385470|FG001|Overall Study|Withdrawal by Subject|0|||
105377006|NCT00005047|363385471|FG002|Overall Study|Withdrawal by Subject|0|||
105377007|NCT00005047|363385472|FG003|Overall Study|Withdrawal by Subject|0|||
105377008|NCT00005047|363385469|FG000|Overall Study|Adverse Event|5|||
105377009|NCT00005047|363385470|FG001|Overall Study|Adverse Event|0|||
105377010|NCT00005047|363385471|FG002|Overall Study|Adverse Event|0|||
105377011|NCT00005047|363385472|FG003|Overall Study|Adverse Event|0|||
105377012|NCT00005047|363385469|FG000|Overall Study|Lost to Follow-up|1|||
105377013|NCT00005047|363385470|FG001|Overall Study|Lost to Follow-up|0|||
105377014|NCT00005047|363385471|FG002|Overall Study|Lost to Follow-up|0|||
105377015|NCT00005047|363385472|FG003|Overall Study|Lost to Follow-up|0|||
105377016|NCT00005047|363385469|FG000|Overall Study|Lack of Efficacy|1|||
105377017|NCT00005047|363385470|FG001|Overall Study|Lack of Efficacy|0|||
105377018|NCT00005047|363385471|FG002|Overall Study|Lack of Efficacy|0|||
105377019|NCT00005047|363385472|FG003|Overall Study|Lack of Efficacy|0|||
105377020|NCT00580840|363385473|FG000|Run-in|Adverse Event|17|||
105377021|NCT00580840|363385474|FG001|Run-in|Adverse Event|0|||
105377022|NCT00580840|363385475|FG002|Run-in|Adverse Event|0|||
105377023|NCT00580840|363385476|FG003|Run-in|Adverse Event|0|||
105377024|NCT00580840|363385473|FG000|Run-in|Lack of Efficacy|93|||
105377025|NCT00580840|363385474|FG001|Run-in|Lack of Efficacy|0|||
105377026|NCT00580840|363385475|FG002|Run-in|Lack of Efficacy|0|||
105377027|NCT00580840|363385476|FG003|Run-in|Lack of Efficacy|0|||
105377028|NCT00580840|363385473|FG000|Run-in|Loss of Efficacy|1|||
105377029|NCT00580840|363385474|FG001|Run-in|Loss of Efficacy|0|||
105377030|NCT00580840|363385475|FG002|Run-in|Loss of Efficacy|0|||
105377031|NCT00580840|363385476|FG003|Run-in|Loss of Efficacy|0|||
105377032|NCT00580840|363385473|FG000|Run-in|Lost to Follow-up|4|||
105377033|NCT00580840|363385474|FG001|Run-in|Lost to Follow-up|0|||
105377034|NCT00580840|363385475|FG002|Run-in|Lost to Follow-up|0|||
105377035|NCT00580840|363385476|FG003|Run-in|Lost to Follow-up|0|||
105377036|NCT00580840|363385473|FG000|Run-in|Withdrawal by Subject|5|||
105377037|NCT00580840|363385474|FG001|Run-in|Withdrawal by Subject|0|||
105377038|NCT00580840|363385475|FG002|Run-in|Withdrawal by Subject|0|||
105377039|NCT00580840|363385476|FG003|Run-in|Withdrawal by Subject|0|||
105377040|NCT00580840|363385473|FG000|Run-in|Other: Per Sponsor Request|2|||
105377041|NCT00580840|363385474|FG001|Run-in|Other: Per Sponsor Request|0|||
105377042|NCT00580840|363385475|FG002|Run-in|Other: Per Sponsor Request|0|||
105377043|NCT00580840|363385476|FG003|Run-in|Other: Per Sponsor Request|0|||
105377044|NCT00580840|363385473|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
105377045|NCT00580840|363385474|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
105377046|NCT00580840|363385475|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
105377047|NCT00580840|363385476|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
105377048|NCT00580840|363385473|FG000|Run-in|Other: Exclusionary Lab Value|1|||
105377049|NCT00580840|363385474|FG001|Run-in|Other: Exclusionary Lab Value|0|||
105377050|NCT00580840|363385475|FG002|Run-in|Other: Exclusionary Lab Value|0|||
105377051|NCT00580840|363385476|FG003|Run-in|Other: Exclusionary Lab Value|0|||
105377052|NCT00580840|363385473|FG000|Double-Blind|Adverse Event|0|||
105377053|NCT00580840|363385474|FG001|Double-Blind|Adverse Event|3|||
105377054|NCT00580840|363385475|FG002|Double-Blind|Adverse Event|4|||
105377055|NCT00580840|363385476|FG003|Double-Blind|Adverse Event|1|||
105377056|NCT00580840|363385473|FG000|Double-Blind|Loss of Efficacy|0|||
105377057|NCT00580840|363385474|FG001|Double-Blind|Loss of Efficacy|1|||
105377058|NCT00580840|363385475|FG002|Double-Blind|Loss of Efficacy|2|||
105377059|NCT00580840|363385476|FG003|Double-Blind|Loss of Efficacy|10|||
105377060|NCT00580840|363385473|FG000|Double-Blind|Lost to Follow-up|0|||
105377061|NCT00580840|363385474|FG001|Double-Blind|Lost to Follow-up|1|||
105377062|NCT00580840|363385475|FG002|Double-Blind|Lost to Follow-up|0|||
105377063|NCT00580840|363385476|FG003|Double-Blind|Lost to Follow-up|2|||
105377064|NCT00580840|363385473|FG000|Double-Blind|Withdrawal by Subject|0|||
105377065|NCT00580840|363385474|FG001|Double-Blind|Withdrawal by Subject|1|||
105377066|NCT00580840|363385475|FG002|Double-Blind|Withdrawal by Subject|2|||
105377067|NCT00580840|363385476|FG003|Double-Blind|Withdrawal by Subject|2|||
105377068|NCT00580840|363385473|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
105377069|NCT00580840|363385474|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
105377070|NCT00580840|363385475|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
105377071|NCT00580840|363385476|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
105377072|NCT00580840|363385473|FG000|Double-Blind|Other: Forbidden Medication|0|||
105377073|NCT00580840|363385474|FG001|Double-Blind|Other: Forbidden Medication|0|||
105377074|NCT00580840|363385475|FG002|Double-Blind|Other: Forbidden Medication|1|||
105377075|NCT00580840|363385476|FG003|Double-Blind|Other: Forbidden Medication|0|||
105377076|NCT00088153|363385477|FG000|Overall Study|Physician Decision|3|||
105377077|NCT00088153|363385478|FG001|Overall Study|Physician Decision|3|||
105377078|NCT00088153|363385477|FG000|Overall Study|Withdrawal by Subject|10|||
105377079|NCT00088153|363385478|FG001|Overall Study|Withdrawal by Subject|10|||
105377080|NCT00088153|363385477|FG000|Overall Study|Lost to Follow-up|11|||
105377081|NCT00088153|363385478|FG001|Overall Study|Lost to Follow-up|12|||
105377082|NCT01757847|363385483|FG000|Overall Study|Withdrawal by Subject|3|||
105377083|NCT01757847|363385484|FG001|Overall Study|Withdrawal by Subject|4|||
105377084|NCT02324153|363385485|FG000|Overall Study|Withdrawal by Subject|4|||
105377085|NCT02324153|363385486|FG001|Overall Study|Withdrawal by Subject|1|||
105377086|NCT02324153|363385485|FG000|Overall Study|Surgery postponed after randomization|3|||
105377087|NCT02324153|363385486|FG001|Overall Study|Surgery postponed after randomization|0|||
105377088|NCT02324153|363385485|FG000|Overall Study|Developed delirium preoperatively|1|||
105377089|NCT02324153|363385486|FG001|Overall Study|Developed delirium preoperatively|0|||
105377090|NCT01069939|363385492|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
105377091|NCT01069939|363385493|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
105377092|NCT01069939|363385492|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
105377093|NCT01069939|363385493|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
105377094|NCT01069939|363385492|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
105377095|NCT01069939|363385493|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
105377096|NCT01069939|363385492|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
105377097|NCT01069939|363385493|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
105377098|NCT01069939|363385492|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
105377099|NCT01069939|363385493|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
105377100|NCT01069939|363385492|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
105377101|NCT01069939|363385493|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
105377102|NCT01069939|363385492|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
105377103|NCT01069939|363385493|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
105377104|NCT01069939|363385492|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
105377105|NCT01069939|363385493|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
105377106|NCT01069939|363385492|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
105377107|NCT01069939|363385493|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
105377108|NCT01069939|363385492|FG000|Randomised and Included in the Analyses|Removal|1|||
105377109|NCT01069939|363385493|FG001|Randomised and Included in the Analyses|Removal|0|||
105377110|NCT05166876|363385494|FG000|Overall Study|Withdrawal by Subject|1|||
105377111|NCT05166876|363385495|FG001|Overall Study|Withdrawal by Subject|0|||
105377112|NCT05166876|363385496|FG002|Overall Study|Withdrawal by Subject|0|||
105377113|NCT00658528|363385497|FG000|Overall Study|Adverse Event|5|||
105377114|NCT00658528|363385498|FG001|Overall Study|Adverse Event|7|||
105377115|NCT00658528|363385497|FG000|Overall Study|Lost to Follow-up|14|||
105377116|NCT00658528|363385498|FG001|Overall Study|Lost to Follow-up|22|||
105377117|NCT00658528|363385497|FG000|Overall Study|Withdrawal by Subject|8|||
105377118|NCT00658528|363385498|FG001|Overall Study|Withdrawal by Subject|6|||
105377119|NCT00658528|363385497|FG000|Overall Study|Withdrawal of consent|5|||
105377120|NCT00658528|363385498|FG001|Overall Study|Withdrawal of consent|6|||
105377121|NCT00658528|363385497|FG000|Overall Study|Other|8|||
105377122|NCT00658528|363385498|FG001|Overall Study|Other|4|||
105377123|NCT01913353|363385499|FG000|Overall Study|Adverse Event|2|||
105377124|NCT01913353|363385500|FG001|Overall Study|Adverse Event|0|||
105377125|NCT01913353|363385499|FG000|Overall Study|Physician Decision|0|||
105377126|NCT01913353|363385500|FG001|Overall Study|Physician Decision|2|||
105377127|NCT01913353|363385499|FG000|Overall Study|Withdrawal by Subject|20|||
105578635|NCT01406717|364116780|FG000|Overall Study|Lost to Follow-up|14|||
105578636|NCT01406717|364116781|FG001|Overall Study|Lost to Follow-up|8|||
105578637|NCT01406717|364116780|FG000|Overall Study|Withdrawal by Subject|19|||
105578638|NCT01406717|364116781|FG001|Overall Study|Withdrawal by Subject|15|||
105578639|NCT01406717|364116780|FG000|Overall Study|Adverse Event|1|||
105578640|NCT01406717|364116781|FG001|Overall Study|Adverse Event|2|||
105578641|NCT01406717|364116780|FG000|Overall Study|Lack of Efficacy|0|||
105578642|NCT01406717|364116781|FG001|Overall Study|Lack of Efficacy|1|||
105578643|NCT01406717|364116780|FG000|Overall Study|Non-completion of visit activity|0|||
105578644|NCT01406717|364116781|FG001|Overall Study|Non-completion of visit activity|1|||
105578645|NCT03257995|364116782|FG000|Overall Study|Adverse Event|0|||
105578646|NCT03257995|364116783|FG001|Overall Study|Adverse Event|1|||
105578647|NCT03257995|364116784|FG002|Overall Study|Adverse Event|0|||
105578648|NCT03257995|364116785|FG003|Overall Study|Adverse Event|0|||
105578649|NCT03257995|364116786|FG004|Overall Study|Adverse Event|0|||
105578650|NCT03257995|364116787|FG005|Overall Study|Adverse Event|0|||
105578651|NCT03257995|364116782|FG000|Overall Study|Protocol deviation|0|||
105578652|NCT03257995|364116783|FG001|Overall Study|Protocol deviation|0|||
105578653|NCT03257995|364116784|FG002|Overall Study|Protocol deviation|0|||
105578654|NCT03257995|364116785|FG003|Overall Study|Protocol deviation|0|||
105578655|NCT03257995|364116786|FG004|Overall Study|Protocol deviation|0|||
105578656|NCT03257995|364116787|FG005|Overall Study|Protocol deviation|2|||
105578657|NCT01680458|364116791|FG000|Overall Study|Protocol Violation|3|||
105578658|NCT01018563|364116792|FG000|Overall Study|Termination of the study by Sponsor|2|||
105578659|NCT01018563|364116793|FG001|Overall Study|Termination of the study by Sponsor|1|||
105578660|NCT03864926|364118577|FG000|Overall Study|Death|0|||
105578661|NCT03864926|364118578|FG001|Overall Study|Death|2|||
105578662|NCT03918239|364118582|FG000|Overall Study|Lost to Follow-up|3|||
105578663|NCT03918239|364118583|FG001|Overall Study|Lost to Follow-up|1|||
105578664|NCT03918239|364118582|FG000|Overall Study|Pregnancy|0|||
105578665|NCT03918239|364118583|FG001|Overall Study|Pregnancy|2|||
105578666|NCT03918239|364118582|FG000|Overall Study|Withdrawal by Subject|3|||
105578667|NCT03918239|364118583|FG001|Overall Study|Withdrawal by Subject|3|||
105578668|NCT03918239|364118582|FG000|Overall Study|positive urine drug screening results|4|||
105578669|NCT03918239|364118583|FG001|Overall Study|positive urine drug screening results|1|||
105578670|NCT03699124|364118584|FG000|Overall Study|Adverse Event|6|||
105578671|NCT03699124|364118585|FG001|Overall Study|Adverse Event|5|||
105578672|NCT03699124|364118586|FG002|Overall Study|Adverse Event|2|||
105578673|NCT03699124|364118584|FG000|Overall Study|Death|0|||
105578674|NCT03699124|364118585|FG001|Overall Study|Death|2|||
105578675|NCT03699124|364118586|FG002|Overall Study|Death|0|||
105578676|NCT03699124|364118584|FG000|Overall Study|Lost to Follow-up|20|||
105578677|NCT03699124|364118585|FG001|Overall Study|Lost to Follow-up|16|||
105578678|NCT03699124|364118586|FG002|Overall Study|Lost to Follow-up|15|||
105578679|NCT03699124|364118584|FG000|Overall Study|Protocol Violation|1|||
105578680|NCT03699124|364118585|FG001|Overall Study|Protocol Violation|0|||
105578681|NCT03699124|364118586|FG002|Overall Study|Protocol Violation|0|||
105578682|NCT03699124|364118584|FG000|Overall Study|Withdrawal by Subject|13|||
105578683|NCT03699124|364118585|FG001|Overall Study|Withdrawal by Subject|14|||
105578684|NCT03699124|364118586|FG002|Overall Study|Withdrawal by Subject|13|||
105578685|NCT03699124|364118584|FG000|Overall Study|Other reasons|5|||
105578686|NCT03699124|364118585|FG001|Overall Study|Other reasons|3|||
105578687|NCT03699124|364118586|FG002|Overall Study|Other reasons|10|||
105578688|NCT00999661|364118587|FG000|Overall Study|Lost to Follow-up|59|||
105578689|NCT00999661|364118587|FG000|Overall Study|Adverse Event|1|||
105578690|NCT00999661|364118587|FG000|Overall Study|Withdrawal by Subject|1|||
105377128|NCT01913353|363385500|FG001|Overall Study|Withdrawal by Subject|6|||
105377129|NCT01913353|363385499|FG000|Overall Study|multiple reasons|10|||
105578691|NCT00999661|364118587|FG000|Overall Study|Not meeting eligibility criteria|9|||
105578692|NCT01238575|364118588|FG000|Overall Study|Lack of Efficacy|2|||
105578693|NCT01238575|364118589|FG001|Overall Study|Lack of Efficacy|4|||
105578694|NCT01238575|364118588|FG000|Overall Study|Adverse Event|2|||
105578695|NCT01238575|364118589|FG001|Overall Study|Adverse Event|0|||
105578696|NCT00593554|364118590|FG000|Overall Study|Death|1|||
105578697|NCT00593554|364118591|FG001|Overall Study|Death|2|||
105578698|NCT00593554|364118590|FG000|Overall Study|Physician Decision|0|||
105578699|NCT00593554|364118591|FG001|Overall Study|Physician Decision|1|||
105578700|NCT00593554|364118590|FG000|Overall Study|Withdrawal by Subject|1|||
105578701|NCT00593554|364118591|FG001|Overall Study|Withdrawal by Subject|0|||
105377130|NCT01913353|363385500|FG001|Overall Study|multiple reasons|7|||
105578702|NCT00593554|364118590|FG000|Overall Study|Disease Progression|1|||
105578703|NCT00593554|364118591|FG001|Overall Study|Disease Progression|2|||
105578704|NCT03638635|364118596|FG000|Initial Hospitalization|Study terminated prematurely|0|||
105578705|NCT03638635|364118597|FG001|Initial Hospitalization|Study terminated prematurely|1|||
105578706|NCT03638635|364118596|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
105578707|NCT03638635|364118597|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
105578708|NCT03638635|364118596|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
105578709|NCT03638635|364118597|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
105578710|NCT00962585|364118607|FG000|Overall Study|Adverse Event|0|||
105578711|NCT00962585|364118608|FG001|Overall Study|Adverse Event|2|||
105377131|NCT02555878|363385502|FG000|Overall Study|Lost to Follow-up|2|||
105377132|NCT02555878|363385503|FG001|Overall Study|Lost to Follow-up|3|||
105377133|NCT02555878|363385502|FG000|Overall Study|Withdrawal by Subject|48|||
105377134|NCT02555878|363385503|FG001|Overall Study|Withdrawal by Subject|48|||
105377135|NCT02555878|363385502|FG000|Overall Study|Adverse Event|12|||
105377136|NCT02555878|363385503|FG001|Overall Study|Adverse Event|8|||
105377137|NCT02555878|363385502|FG000|Overall Study|Death|74|||
105377138|NCT02555878|363385503|FG001|Overall Study|Death|59|||
105377139|NCT02555878|363385502|FG000|Overall Study|Protocol Violation|1|||
105377140|NCT02555878|363385503|FG001|Overall Study|Protocol Violation|2|||
105377141|NCT02555878|363385502|FG000|Overall Study|Physician Decision|12|||
105377142|NCT02555878|363385503|FG001|Overall Study|Physician Decision|13|||
105377143|NCT02555878|363385502|FG000|Overall Study|Other|17|||
105377144|NCT02555878|363385503|FG001|Overall Study|Other|17|||
105377145|NCT02875080|363385504|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
105377146|NCT02875080|363385505|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
105377147|NCT02875080|363385506|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
105377148|NCT01164475|363385507|FG000|Overall Study|Lack of Efficacy|1|||
105377149|NCT01164475|363385508|FG001|Overall Study|Lack of Efficacy|0|||
105377150|NCT01164475|363385507|FG000|Overall Study|Other|0|||
105377151|NCT01164475|363385508|FG001|Overall Study|Other|1|||
105377152|NCT01164475|363385507|FG000|Overall Study|Progressive disease|0|||
105377153|NCT01164475|363385508|FG001|Overall Study|Progressive disease|1|||
105377154|NCT01164475|363385507|FG000|Overall Study|Protocol Violation|1|||
105377155|NCT01164475|363385508|FG001|Overall Study|Protocol Violation|0|||
105377156|NCT02335944|363385509|FG000|Treatment Phase|Progressive Disease|2|||
105377157|NCT02335944|363385510|FG001|Treatment Phase|Progressive Disease|5|||
105377158|NCT02335944|363385511|FG002|Treatment Phase|Progressive Disease|2|||
105377159|NCT02335944|363385512|FG003|Treatment Phase|Progressive Disease|11|||
105377160|NCT02335944|363385513|FG004|Treatment Phase|Progressive Disease|4|||
105377161|NCT02335944|363385514|FG005|Treatment Phase|Progressive Disease|25|||
105377162|NCT02335944|363385515|FG006|Treatment Phase|Progressive Disease|2|||
105377163|NCT02335944|363385516|FG007|Treatment Phase|Progressive Disease|30|||
105377164|NCT02335944|363385517|FG008|Treatment Phase|Progressive Disease|27|||
105377165|NCT02335944|363385518|FG009|Treatment Phase|Progressive Disease|0|||
105377166|NCT02335944|363385509|FG000|Treatment Phase|Adverse Event|2|||
105377167|NCT02335944|363385510|FG001|Treatment Phase|Adverse Event|0|||
105377168|NCT02335944|363385511|FG002|Treatment Phase|Adverse Event|0|||
105377169|NCT02335944|363385512|FG003|Treatment Phase|Adverse Event|2|||
105377170|NCT02335944|363385513|FG004|Treatment Phase|Adverse Event|1|||
105377171|NCT02335944|363385514|FG005|Treatment Phase|Adverse Event|15|||
105377172|NCT02335944|363385515|FG006|Treatment Phase|Adverse Event|0|||
105377173|NCT02335944|363385516|FG007|Treatment Phase|Adverse Event|5|||
105377174|NCT02335944|363385517|FG008|Treatment Phase|Adverse Event|7|||
105377175|NCT02335944|363385518|FG009|Treatment Phase|Adverse Event|0|||
105377176|NCT02335944|363385509|FG000|Treatment Phase|Physician Decision|0|||
105377177|NCT02335944|363385510|FG001|Treatment Phase|Physician Decision|0|||
105377178|NCT02335944|363385511|FG002|Treatment Phase|Physician Decision|0|||
105377179|NCT02335944|363385512|FG003|Treatment Phase|Physician Decision|1|||
105377180|NCT02335944|363385513|FG004|Treatment Phase|Physician Decision|0|||
105377181|NCT02335944|363385514|FG005|Treatment Phase|Physician Decision|6|||
105377182|NCT02335944|363385515|FG006|Treatment Phase|Physician Decision|1|||
105377183|NCT02335944|363385516|FG007|Treatment Phase|Physician Decision|2|||
105377184|NCT02335944|363385517|FG008|Treatment Phase|Physician Decision|1|||
105377185|NCT02335944|363385518|FG009|Treatment Phase|Physician Decision|0|||
105377186|NCT02335944|363385509|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
105377187|NCT02335944|363385510|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
105377188|NCT02335944|363385511|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
105377189|NCT02335944|363385512|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
105377190|NCT02335944|363385513|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
105377191|NCT02335944|363385514|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
105377192|NCT02335944|363385515|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
105377193|NCT02335944|363385516|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
105377194|NCT02335944|363385517|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
105377195|NCT02335944|363385518|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
105377196|NCT02335944|363385509|FG000|Treatment Phase|Subject/Guardian Decision|0|||
105377197|NCT02335944|363385510|FG001|Treatment Phase|Subject/Guardian Decision|0|||
105377198|NCT02335944|363385511|FG002|Treatment Phase|Subject/Guardian Decision|1|||
105377199|NCT02335944|363385512|FG003|Treatment Phase|Subject/Guardian Decision|0|||
105377200|NCT02335944|363385513|FG004|Treatment Phase|Subject/Guardian Decision|0|||
105377201|NCT02335944|363385514|FG005|Treatment Phase|Subject/Guardian Decision|1|||
105377202|NCT02335944|363385515|FG006|Treatment Phase|Subject/Guardian Decision|0|||
105377203|NCT02335944|363385516|FG007|Treatment Phase|Subject/Guardian Decision|4|||
105377204|NCT02335944|363385517|FG008|Treatment Phase|Subject/Guardian Decision|0|||
105377205|NCT02335944|363385518|FG009|Treatment Phase|Subject/Guardian Decision|0|||
105377206|NCT02335944|363385509|FG000|Post-treatment Follow-up|Progressive Disease|0|||
105377207|NCT02335944|363385510|FG001|Post-treatment Follow-up|Progressive Disease|0|||
105377208|NCT02335944|363385511|FG002|Post-treatment Follow-up|Progressive Disease|0|||
105377209|NCT02335944|363385512|FG003|Post-treatment Follow-up|Progressive Disease|1|||
105377210|NCT02335944|363385513|FG004|Post-treatment Follow-up|Progressive Disease|0|||
105377211|NCT02335944|363385514|FG005|Post-treatment Follow-up|Progressive Disease|9|||
105377212|NCT02335944|363385515|FG006|Post-treatment Follow-up|Progressive Disease|0|||
105377213|NCT02335944|363385516|FG007|Post-treatment Follow-up|Progressive Disease|2|||
105377214|NCT02335944|363385517|FG008|Post-treatment Follow-up|Progressive Disease|3|||
105377215|NCT02335944|363385518|FG009|Post-treatment Follow-up|Progressive Disease|0|||
105377216|NCT02335944|363385509|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105377217|NCT02335944|363385510|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105578712|NCT00962585|364118609|FG002|Overall Study|Adverse Event|1|||
105578713|NCT00962585|364118610|FG003|Overall Study|Adverse Event|0|||
105578714|NCT00962585|364118607|FG000|Overall Study|Lost to Follow-up|3|||
105578715|NCT00962585|364118608|FG001|Overall Study|Lost to Follow-up|0|||
105578716|NCT00962585|364118609|FG002|Overall Study|Lost to Follow-up|1|||
105578717|NCT00962585|364118610|FG003|Overall Study|Lost to Follow-up|0|||
105578718|NCT00962585|364118607|FG000|Overall Study|Protocol Violation|0|||
105578719|NCT00962585|364118608|FG001|Overall Study|Protocol Violation|0|||
105578720|NCT00962585|364118609|FG002|Overall Study|Protocol Violation|1|||
105578721|NCT00962585|364118610|FG003|Overall Study|Protocol Violation|0|||
105578722|NCT00962585|364118607|FG000|Overall Study|Withdrawal by Subject|1|||
105578723|NCT00962585|364118608|FG001|Overall Study|Withdrawal by Subject|0|||
105578724|NCT00962585|364118609|FG002|Overall Study|Withdrawal by Subject|0|||
105578725|NCT00962585|364118610|FG003|Overall Study|Withdrawal by Subject|0|||
105578726|NCT00962585|364118607|FG000|Overall Study|Withdrew Consent|2|||
105578727|NCT00962585|364118608|FG001|Overall Study|Withdrew Consent|0|||
105578728|NCT00962585|364118609|FG002|Overall Study|Withdrew Consent|0|||
105578729|NCT00962585|364118610|FG003|Overall Study|Withdrew Consent|0|||
105578730|NCT00867490|364118611|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
105578731|NCT00867490|364118611|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
105578732|NCT00867490|364118611|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
105578733|NCT00867490|364118611|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
105578734|NCT00867490|364118611|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
105578735|NCT04668989|364118616|FG000|First Intervention|Covid-19 related self-isolation|0|||
105578736|NCT04668989|364118617|FG001|First Intervention|Covid-19 related self-isolation|1|||
105578737|NCT04668989|364118616|FG000|Second Intervention|Adverse Event|0|||
105578738|NCT04668989|364118617|FG001|Second Intervention|Adverse Event|1|||
105578739|NCT02564055|364118632|FG000|Overall Study|Adverse Event|1|||
105578740|NCT02564055|364118633|FG001|Overall Study|Adverse Event|0|||
105578741|NCT02564055|364118634|FG002|Overall Study|Adverse Event|4|||
105578742|NCT02564055|364118635|FG003|Overall Study|Adverse Event|1|||
105578743|NCT02564055|364118636|FG004|Overall Study|Adverse Event|4|||
105578744|NCT02564055|364118637|FG005|Overall Study|Adverse Event|1|||
105578745|NCT02564055|364118632|FG000|Overall Study|Protocol Violation|1|||
105578746|NCT02564055|364118633|FG001|Overall Study|Protocol Violation|0|||
105578747|NCT02564055|364118634|FG002|Overall Study|Protocol Violation|0|||
105578748|NCT02564055|364118635|FG003|Overall Study|Protocol Violation|0|||
105578749|NCT02564055|364118636|FG004|Overall Study|Protocol Violation|0|||
105578750|NCT02564055|364118637|FG005|Overall Study|Protocol Violation|0|||
105578751|NCT02564055|364118632|FG000|Overall Study|Reached stopping criteria|0|||
105578752|NCT02564055|364118633|FG001|Overall Study|Reached stopping criteria|0|||
105578753|NCT02564055|364118634|FG002|Overall Study|Reached stopping criteria|0|||
105578754|NCT02564055|364118635|FG003|Overall Study|Reached stopping criteria|0|||
105377218|NCT02335944|363385511|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105377219|NCT02335944|363385512|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105377220|NCT02335944|363385513|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105578755|NCT02564055|364118636|FG004|Overall Study|Reached stopping criteria|0|||
105578756|NCT02564055|364118637|FG005|Overall Study|Reached stopping criteria|1|||
105578757|NCT02564055|364118632|FG000|Overall Study|Lost to Follow-up|0|||
105578758|NCT02564055|364118633|FG001|Overall Study|Lost to Follow-up|1|||
105578759|NCT02564055|364118634|FG002|Overall Study|Lost to Follow-up|4|||
105377221|NCT02335944|363385514|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
105578760|NCT02564055|364118635|FG003|Overall Study|Lost to Follow-up|2|||
105578761|NCT02564055|364118636|FG004|Overall Study|Lost to Follow-up|1|||
105578762|NCT02564055|364118637|FG005|Overall Study|Lost to Follow-up|0|||
105578763|NCT02564055|364118632|FG000|Overall Study|Physician Decision|0|||
105578764|NCT02564055|364118633|FG001|Overall Study|Physician Decision|0|||
105578765|NCT02564055|364118634|FG002|Overall Study|Physician Decision|1|||
105578766|NCT02564055|364118635|FG003|Overall Study|Physician Decision|0|||
105578767|NCT02564055|364118636|FG004|Overall Study|Physician Decision|0|||
105578768|NCT02564055|364118637|FG005|Overall Study|Physician Decision|0|||
105578769|NCT02564055|364118632|FG000|Overall Study|Withdrawal by Subject|4|||
105578770|NCT02564055|364118633|FG001|Overall Study|Withdrawal by Subject|4|||
105578771|NCT02564055|364118634|FG002|Overall Study|Withdrawal by Subject|3|||
105578772|NCT02564055|364118635|FG003|Overall Study|Withdrawal by Subject|3|||
105578773|NCT02564055|364118636|FG004|Overall Study|Withdrawal by Subject|10|||
105578774|NCT02564055|364118637|FG005|Overall Study|Withdrawal by Subject|10|||
105578775|NCT01375959|364118638|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
105578776|NCT01375959|364118639|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
105578777|NCT01375959|364118638|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
105578778|NCT01375959|364118639|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
105578779|NCT01375959|364118638|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
105578780|NCT01375959|364118639|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
105578781|NCT01349907|364118646|FG000|Overall Study|Adverse Event|37|||
105578782|NCT01349907|364118647|FG001|Overall Study|Adverse Event|11|||
105578783|NCT01349907|364118646|FG000|Overall Study|Treatment failure|13|||
105578784|NCT01349907|364118647|FG001|Overall Study|Treatment failure|4|||
105578785|NCT01349907|364118646|FG000|Overall Study|Lost to Follow-up|25|||
105578786|NCT01349907|364118647|FG001|Overall Study|Lost to Follow-up|6|||
105578787|NCT01349907|364118646|FG000|Overall Study|Withdrawal by Subject|30|||
105578788|NCT01349907|364118647|FG001|Overall Study|Withdrawal by Subject|8|||
105578789|NCT01349907|364118646|FG000|Overall Study|Protocol Violation|33|||
105578790|NCT01349907|364118647|FG001|Overall Study|Protocol Violation|13|||
105578791|NCT01349907|364118646|FG000|Overall Study|Administrative|1|||
105578792|NCT01349907|364118647|FG001|Overall Study|Administrative|1|||
105578793|NCT03237013|364118652|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
105578794|NCT03237013|364118653|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
105578795|NCT03237013|364118654|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
105578796|NCT01567163|364118655|FG000|Overall Study|Progressive Disease|2|||
105578797|NCT01567163|364118655|FG000|Overall Study|Lost to Follow-up|2|||
105578798|NCT03405662|364118657|FG000|Overall Study|COVID-19 restriction|1|||
105578799|NCT03405662|364118658|FG001|Overall Study|COVID-19 restriction|0|||
105578800|NCT03405662|364118657|FG000|Overall Study|unblinding|0|||
105578801|NCT03405662|364118658|FG001|Overall Study|unblinding|1|||
105578802|NCT03405662|364118657|FG000|Overall Study|placement in memory care facility|0|||
105377222|NCT02335944|363385515|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105377223|NCT02335944|363385516|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105377224|NCT02335944|363385517|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105377225|NCT02335944|363385518|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105377226|NCT02335944|363385509|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
105377227|NCT02335944|363385510|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
105377228|NCT02335944|363385511|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
105377229|NCT02335944|363385512|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
105377230|NCT02335944|363385513|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
105377231|NCT02335944|363385514|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
105377232|NCT02335944|363385515|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
105377233|NCT02335944|363385516|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
105377234|NCT02335944|363385517|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
105377235|NCT02335944|363385518|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
105377236|NCT02335944|363385509|FG000|Post-treatment Follow-up|Adverse Event|0|||
105377237|NCT02335944|363385510|FG001|Post-treatment Follow-up|Adverse Event|0|||
105377238|NCT02335944|363385511|FG002|Post-treatment Follow-up|Adverse Event|0|||
105377239|NCT02335944|363385512|FG003|Post-treatment Follow-up|Adverse Event|0|||
105377240|NCT02335944|363385513|FG004|Post-treatment Follow-up|Adverse Event|0|||
105377241|NCT02335944|363385514|FG005|Post-treatment Follow-up|Adverse Event|1|||
105578803|NCT03405662|364118658|FG001|Overall Study|placement in memory care facility|2|||
105578804|NCT02761629|364118659|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
105578805|NCT02761629|364118660|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
105578806|NCT02761629|364118659|FG000|Overall Study|Insufficient Therapeutic Response|2|||
105578807|NCT02761629|364118660|FG001|Overall Study|Insufficient Therapeutic Response|7|||
105578808|NCT02761629|364118659|FG000|Overall Study|Failure to Return|2|||
105578809|NCT02761629|364118660|FG001|Overall Study|Failure to Return|4|||
105377242|NCT02335944|363385515|FG006|Post-treatment Follow-up|Adverse Event|0|||
105377243|NCT02335944|363385516|FG007|Post-treatment Follow-up|Adverse Event|0|||
105578810|NCT02761629|364118659|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
105377244|NCT02335944|363385517|FG008|Post-treatment Follow-up|Adverse Event|0|||
105578811|NCT02761629|364118660|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
105578812|NCT02761629|364118659|FG000|Overall Study|Protocol Violation|2|||
105578813|NCT02761629|364118660|FG001|Overall Study|Protocol Violation|2|||
105578814|NCT02761629|364118659|FG000|Overall Study|Withdrawal by Subject|0|||
105578815|NCT02761629|364118660|FG001|Overall Study|Withdrawal by Subject|3|||
105578816|NCT02761629|364118659|FG000|Overall Study|Other|0|||
105578817|NCT02761629|364118660|FG001|Overall Study|Other|2|||
105578818|NCT02761629|364118659|FG000|Overall Study|Lost to Follow-up|4|||
105578819|NCT02761629|364118660|FG001|Overall Study|Lost to Follow-up|1|||
105578820|NCT02761629|364118659|FG000|Overall Study|Randomized But Not Treated|8|||
105578821|NCT02761629|364118660|FG001|Overall Study|Randomized But Not Treated|4|||
105578822|NCT00393094|364118663|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
105578823|NCT00393094|364118663|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
105578824|NCT00507026|364118666|FG000|Overall Study|Lack of Efficacy|6|||
105578825|NCT00507026|364118667|FG001|Overall Study|Lack of Efficacy|4|||
105578826|NCT00507026|364118668|FG002|Overall Study|Lack of Efficacy|21|||
105578827|NCT00507026|364118666|FG000|Overall Study|Withdrawal by Subject|2|||
105578828|NCT00507026|364118667|FG001|Overall Study|Withdrawal by Subject|0|||
105578829|NCT00507026|364118668|FG002|Overall Study|Withdrawal by Subject|0|||
105578830|NCT00507026|364118666|FG000|Overall Study|Investigator Decision|1|||
105578831|NCT00507026|364118667|FG001|Overall Study|Investigator Decision|0|||
105578832|NCT00507026|364118668|FG002|Overall Study|Investigator Decision|0|||
105578833|NCT00507026|364118666|FG000|Overall Study|Adverse Event|2|||
105578834|NCT00507026|364118667|FG001|Overall Study|Adverse Event|0|||
105578835|NCT00507026|364118668|FG002|Overall Study|Adverse Event|0|||
105578836|NCT00507026|364118666|FG000|Overall Study|Protocol Violation|1|||
105578837|NCT00507026|364118667|FG001|Overall Study|Protocol Violation|0|||
105578838|NCT00507026|364118668|FG002|Overall Study|Protocol Violation|0|||
105578839|NCT00507026|364118666|FG000|Overall Study|Other|1|||
105578840|NCT00507026|364118667|FG001|Overall Study|Other|0|||
105578841|NCT00507026|364118668|FG002|Overall Study|Other|0|||
105578842|NCT02372058|364118669|FG000|Overall Study|Withdrawal by Subject|3|||
105578843|NCT02788006|364118670|FG000|Overall Study|Patient not treated|1|||
105578844|NCT03050398|364118671|FG000|Overall Study|Study terminated by sponsor|8|||
105578845|NCT00598481|364118672|FG000|Treatment|Physician Decision|1|||
105578846|NCT01461993|364118673|FG000|Overall Study|Withdrawal by Subject|60|||
105578847|NCT01461993|364118674|FG001|Overall Study|Withdrawal by Subject|53|||
105578848|NCT01461993|364118675|FG002|Overall Study|Withdrawal by Subject|16|||
105578849|NCT01461993|364118673|FG000|Overall Study|Lost to Follow-up|44|||
105578850|NCT01461993|364118674|FG001|Overall Study|Lost to Follow-up|48|||
105578851|NCT01461993|364118675|FG002|Overall Study|Lost to Follow-up|22|||
105578852|NCT01461993|364118673|FG000|Overall Study|Protocol Violation|10|||
105578853|NCT01461993|364118674|FG001|Overall Study|Protocol Violation|9|||
105578854|NCT01461993|364118675|FG002|Overall Study|Protocol Violation|7|||
105578855|NCT01461993|364118673|FG000|Overall Study|Adverse Event|9|||
105578856|NCT01461993|364118674|FG001|Overall Study|Adverse Event|11|||
105578857|NCT01461993|364118675|FG002|Overall Study|Adverse Event|3|||
105578858|NCT01461993|364118673|FG000|Overall Study|No longer met eligibility criteria|13|||
105578859|NCT01461993|364118674|FG001|Overall Study|No longer met eligibility criteria|18|||
105578860|NCT01461993|364118675|FG002|Overall Study|No longer met eligibility criteria|10|||
105578861|NCT01461993|364118673|FG000|Overall Study|Did not meet entrance criteria|2|||
105578862|NCT01461993|364118674|FG001|Overall Study|Did not meet entrance criteria|3|||
105578863|NCT01461993|364118675|FG002|Overall Study|Did not meet entrance criteria|0|||
105578864|NCT01461993|364118673|FG000|Overall Study|Other|13|||
105578865|NCT01461993|364118674|FG001|Overall Study|Other|15|||
105578866|NCT01461993|364118675|FG002|Overall Study|Other|6|||
105578867|NCT03018106|364118676|FG000|Overall Study|Lost to Follow-up|0|||
105578868|NCT03018106|364118677|FG001|Overall Study|Lost to Follow-up|1|||
105578869|NCT03055832|364118678|FG000|Week 2|Withdrawal by Subject|1|||
105578870|NCT03055832|364118679|FG001|Week 2|Withdrawal by Subject|0|||
105578871|NCT01152554|364118680|FG000|Overall Study|Withdrawal by Subject|73|||
105578872|NCT01152554|364118681|FG001|Overall Study|Withdrawal by Subject|28|||
105578873|NCT01152554|364118680|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
105377245|NCT02335944|363385518|FG009|Post-treatment Follow-up|Adverse Event|0|||
105377246|NCT02335944|363385509|FG000|Post-treatment Follow-up|Death|0|||
105377247|NCT02335944|363385510|FG001|Post-treatment Follow-up|Death|0|||
105377248|NCT02335944|363385511|FG002|Post-treatment Follow-up|Death|0|||
105377249|NCT02335944|363385512|FG003|Post-treatment Follow-up|Death|1|||
105377250|NCT02335944|363385513|FG004|Post-treatment Follow-up|Death|0|||
105377251|NCT02335944|363385514|FG005|Post-treatment Follow-up|Death|1|||
105377252|NCT02335944|363385515|FG006|Post-treatment Follow-up|Death|0|||
105377253|NCT02335944|363385516|FG007|Post-treatment Follow-up|Death|0|||
105377254|NCT02335944|363385517|FG008|Post-treatment Follow-up|Death|0|||
105377255|NCT02335944|363385518|FG009|Post-treatment Follow-up|Death|0|||
105377256|NCT02335944|363385509|FG000|Post-treatment Follow-up|Physician Decision|1|||
105377257|NCT02335944|363385510|FG001|Post-treatment Follow-up|Physician Decision|0|||
105377258|NCT02335944|363385511|FG002|Post-treatment Follow-up|Physician Decision|0|||
105377259|NCT02335944|363385512|FG003|Post-treatment Follow-up|Physician Decision|0|||
105377260|NCT02335944|363385513|FG004|Post-treatment Follow-up|Physician Decision|0|||
105377261|NCT02335944|363385514|FG005|Post-treatment Follow-up|Physician Decision|0|||
105377262|NCT02335944|363385515|FG006|Post-treatment Follow-up|Physician Decision|0|||
105377263|NCT02335944|363385516|FG007|Post-treatment Follow-up|Physician Decision|1|||
105377264|NCT02335944|363385517|FG008|Post-treatment Follow-up|Physician Decision|0|||
105377265|NCT02335944|363385518|FG009|Post-treatment Follow-up|Physician Decision|0|||
105377266|NCT01202591|363385524|FG000|Overall Study|Adverse Event|2|||
105377267|NCT01202591|363385525|FG001|Overall Study|Adverse Event|1|||
105377268|NCT01202591|363385526|FG002|Overall Study|Adverse Event|4|||
105377269|NCT01202591|363385527|FG003|Overall Study|Adverse Event|4|||
105377270|NCT01202591|363385528|FG004|Overall Study|Adverse Event|0|||
105377271|NCT01202591|363385529|FG005|Overall Study|Adverse Event|0|||
105377272|NCT01202591|363385524|FG000|Overall Study|Other reason as per investigator|3|||
105377273|NCT01202591|363385525|FG001|Overall Study|Other reason as per investigator|4|||
105377274|NCT01202591|363385526|FG002|Overall Study|Other reason as per investigator|7|||
105377275|NCT01202591|363385527|FG003|Overall Study|Other reason as per investigator|3|||
105377276|NCT01202591|363385528|FG004|Overall Study|Other reason as per investigator|1|||
105377277|NCT01202591|363385529|FG005|Overall Study|Other reason as per investigator|3|||
105377278|NCT01202591|363385524|FG000|Overall Study|Withdrawal by Subject|0|||
105377279|NCT01202591|363385525|FG001|Overall Study|Withdrawal by Subject|0|||
105377280|NCT01202591|363385526|FG002|Overall Study|Withdrawal by Subject|0|||
105377281|NCT01202591|363385527|FG003|Overall Study|Withdrawal by Subject|0|||
105377282|NCT01202591|363385528|FG004|Overall Study|Withdrawal by Subject|2|||
105377283|NCT01202591|363385529|FG005|Overall Study|Withdrawal by Subject|1|||
105377284|NCT01202591|363385524|FG000|Overall Study|Objective Disease Progression|0|||
105377285|NCT01202591|363385525|FG001|Overall Study|Objective Disease Progression|0|||
105377286|NCT01202591|363385526|FG002|Overall Study|Objective Disease Progression|0|||
105377287|NCT01202591|363385527|FG003|Overall Study|Objective Disease Progression|0|||
105377288|NCT01202591|363385528|FG004|Overall Study|Objective Disease Progression|2|||
105377289|NCT01202591|363385529|FG005|Overall Study|Objective Disease Progression|0|||
105377290|NCT03018938|363385530|FG000|Overall Study|Death|0|||
105377291|NCT03018938|363385531|FG001|Overall Study|Death|1|||
105377292|NCT03018938|363385530|FG000|Overall Study|Lost to Follow-up|21|||
105377293|NCT03018938|363385531|FG001|Overall Study|Lost to Follow-up|32|||
105377294|NCT03018938|363385530|FG000|Overall Study|Withdrawal by Subject|38|||
105377295|NCT03018938|363385531|FG001|Overall Study|Withdrawal by Subject|45|||
105377296|NCT03018938|363385530|FG000|Overall Study|Physician Decision|3|||
105377297|NCT03018938|363385531|FG001|Overall Study|Physician Decision|2|||
105377298|NCT03018938|363385530|FG000|Overall Study|Sponsor Decision|0|||
105377299|NCT03018938|363385531|FG001|Overall Study|Sponsor Decision|1|||
105377300|NCT03018938|363385530|FG000|Overall Study|Screen failure-After randomization|4|||
105377301|NCT03018938|363385531|FG001|Overall Study|Screen failure-After randomization|2|||
105377302|NCT03018938|363385530|FG000|Overall Study|Not recorded|0|||
105377303|NCT03018938|363385531|FG001|Overall Study|Not recorded|2|||
105377304|NCT00191100|363385534|FG000|Overall Study|Adverse Event|18|||
105377305|NCT00191100|363385535|FG001|Overall Study|Adverse Event|1|||
105377306|NCT00191100|363385534|FG000|Overall Study|Lost to Follow-up|2|||
105377307|NCT00191100|363385535|FG001|Overall Study|Lost to Follow-up|0|||
105377308|NCT00191100|363385534|FG000|Overall Study|Patient Moved|0|||
105377309|NCT00191100|363385535|FG001|Overall Study|Patient Moved|1|||
105377310|NCT00191100|363385534|FG000|Overall Study|Withdrawal by Subject|9|||
105377311|NCT00191100|363385535|FG001|Overall Study|Withdrawal by Subject|3|||
105377312|NCT00191100|363385534|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
105377313|NCT00191100|363385535|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
105377314|NCT00191100|363385534|FG000|Overall Study|Clinical Relapse|2|||
105377315|NCT00191100|363385535|FG001|Overall Study|Clinical Relapse|1|||
105377316|NCT00191100|363385534|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
105377317|NCT00191100|363385535|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
105377318|NCT00191100|363385534|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
105377319|NCT00191100|363385535|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
105377320|NCT00191100|363385534|FG000|Overall Study|Physician Decision|3|||
105377321|NCT00191100|363385535|FG001|Overall Study|Physician Decision|1|||
105377322|NCT00191100|363385534|FG000|Overall Study|Death from Study Drug Toxicity|2|||
105377323|NCT00191100|363385535|FG001|Overall Study|Death from Study Drug Toxicity|0|||
105377324|NCT00191100|363385534|FG000|Overall Study|Protocol Violation|1|||
105377325|NCT00191100|363385535|FG001|Overall Study|Protocol Violation|1|||
105377326|NCT00191100|363385534|FG000|Overall Study|Death from Other Cause|1|||
105377327|NCT00191100|363385535|FG001|Overall Study|Death from Other Cause|0|||
105377328|NCT00191100|363385534|FG000|Overall Study|Reason Not Specified|0|||
105377329|NCT00191100|363385535|FG001|Overall Study|Reason Not Specified|1|||
105377330|NCT02811159|363385536|FG000|Treatment Course 1|Lost to Follow-up|1|||
105377331|NCT00003456|363387116|FG000|Overall Study|Not evaluable|8|||
105377332|NCT00479232|363387117|FG000|Overall Study|Adverse Event|0|||
105377333|NCT00479232|363387118|FG001|Overall Study|Adverse Event|0|||
105377334|NCT00479232|363387119|FG002|Overall Study|Adverse Event|5|||
105377335|NCT00479232|363387120|FG003|Overall Study|Adverse Event|0|||
105377336|NCT00479232|363387121|FG004|Overall Study|Adverse Event|0|||
105377337|NCT00479232|363387122|FG005|Overall Study|Adverse Event|10|||
105377338|NCT00479232|363387117|FG000|Overall Study|Deviation from Protocol|0|||
105377339|NCT00479232|363387118|FG001|Overall Study|Deviation from Protocol|0|||
105377340|NCT00479232|363387119|FG002|Overall Study|Deviation from Protocol|1|||
105377341|NCT00479232|363387120|FG003|Overall Study|Deviation from Protocol|0|||
105377342|NCT00479232|363387121|FG004|Overall Study|Deviation from Protocol|0|||
105377343|NCT00479232|363387122|FG005|Overall Study|Deviation from Protocol|0|||
105377344|NCT00479232|363387117|FG000|Overall Study|Lack of Efficacy|0|||
105377345|NCT00479232|363387118|FG001|Overall Study|Lack of Efficacy|0|||
105377346|NCT00479232|363387119|FG002|Overall Study|Lack of Efficacy|2|||
105377347|NCT00479232|363387120|FG003|Overall Study|Lack of Efficacy|0|||
105377348|NCT00479232|363387121|FG004|Overall Study|Lack of Efficacy|0|||
105377349|NCT00479232|363387122|FG005|Overall Study|Lack of Efficacy|4|||
105377350|NCT00479232|363387117|FG000|Overall Study|Physician Decision|0|||
105377351|NCT00479232|363387118|FG001|Overall Study|Physician Decision|0|||
105377352|NCT00479232|363387119|FG002|Overall Study|Physician Decision|2|||
105377353|NCT00479232|363387120|FG003|Overall Study|Physician Decision|0|||
105377354|NCT00479232|363387121|FG004|Overall Study|Physician Decision|0|||
105377355|NCT00479232|363387122|FG005|Overall Study|Physician Decision|1|||
105377356|NCT00479232|363387117|FG000|Overall Study|Progressive Disease|3|||
105377357|NCT00479232|363387118|FG001|Overall Study|Progressive Disease|1|||
105377358|NCT00479232|363387119|FG002|Overall Study|Progressive Disease|12|||
105377359|NCT00479232|363387120|FG003|Overall Study|Progressive Disease|3|||
105377360|NCT00479232|363387121|FG004|Overall Study|Progressive Disease|3|||
105377361|NCT00479232|363387122|FG005|Overall Study|Progressive Disease|12|||
105377362|NCT00479232|363387117|FG000|Overall Study|Withdrew Consent|0|||
105377363|NCT00479232|363387118|FG001|Overall Study|Withdrew Consent|2|||
105377364|NCT00479232|363387119|FG002|Overall Study|Withdrew Consent|6|||
105377365|NCT00479232|363387120|FG003|Overall Study|Withdrew Consent|0|||
105377366|NCT00479232|363387121|FG004|Overall Study|Withdrew Consent|1|||
105377367|NCT00479232|363387122|FG005|Overall Study|Withdrew Consent|3|||
105377368|NCT01373229|363387123|FG000|Overall Study|Death|3|||
105377369|NCT01373229|363387123|FG000|Overall Study|Physician Decision|3|||
105377370|NCT01991314|363387127|FG000|Overall Study|Adverse Event|5|||
105377371|NCT01991314|363387128|FG001|Overall Study|Adverse Event|1|||
105377372|NCT01991314|363387127|FG000|Overall Study|Lost to Follow-up|6|||
105377373|NCT01991314|363387128|FG001|Overall Study|Lost to Follow-up|10|||
105377374|NCT00970944|363387129|FG000|Overall Study|Death|1|||
105377375|NCT00970944|363387130|FG001|Overall Study|Death|0|||
105377376|NCT00970944|363387129|FG000|Overall Study|Physician Decision|0|||
105377377|NCT00970944|363387130|FG001|Overall Study|Physician Decision|2|||
105377378|NCT05177094|363387131|FG000|Overall Study|Adverse Event|5|||
105377379|NCT05177094|363387132|FG001|Overall Study|Adverse Event|5|||
105377380|NCT05177094|363387131|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
105330374|NCT03307252|363209913|FG005|Part 2, Period 4|Other than listed|0|||
105330375|NCT03307252|363209914|FG006|Part 2, Period 4|Other than listed|1|||
105330376|NCT03307252|363209915|FG007|Part 2, Period 4|Other than listed|0|||
105330377|NCT03307252|363209916|FG008|Part 2, Period 4|Other than listed|0|||
105330378|NCT03307252|363209917|FG009|Part 2, Period 4|Other than listed|0|||
105330379|NCT03307252|363209918|FG010|Part 2, Period 4|Other than listed|0|||
105330380|NCT03307252|363209908|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105330381|NCT03307252|363209909|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105330382|NCT03307252|363209910|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105330383|NCT03307252|363209911|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105330384|NCT03307252|363209912|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105330385|NCT03307252|363209913|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105330386|NCT03307252|363209914|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105330387|NCT03307252|363209915|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105330388|NCT03307252|363209916|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105330389|NCT03307252|363209917|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105330390|NCT03307252|363209918|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
105330391|NCT03517540|363209919|FG000|Overall Study|Protocol Violation|2|||
105330392|NCT03517540|363209920|FG001|Overall Study|Protocol Violation|0|||
105330393|NCT03517540|363209921|FG002|Overall Study|Protocol Violation|0|||
105330394|NCT03517540|363209922|FG003|Overall Study|Protocol Violation|1|||
105330395|NCT03517540|363209919|FG000|Overall Study|Adverse Event|9|||
105330396|NCT03517540|363209920|FG001|Overall Study|Adverse Event|3|||
105330397|NCT03517540|363209921|FG002|Overall Study|Adverse Event|8|||
105330398|NCT03517540|363209922|FG003|Overall Study|Adverse Event|1|||
105330399|NCT03517540|363209919|FG000|Overall Study|Withdrawal by Subject|3|||
105330400|NCT03517540|363209920|FG001|Overall Study|Withdrawal by Subject|4|||
105330401|NCT03517540|363209921|FG002|Overall Study|Withdrawal by Subject|1|||
105330402|NCT03517540|363209922|FG003|Overall Study|Withdrawal by Subject|3|||
105330403|NCT02568189|363209923|FG000|Overall Study|Protocol Violation|0|||
105330404|NCT02568189|363209924|FG001|Overall Study|Protocol Violation|0|||
105330405|NCT02568189|363209925|FG002|Overall Study|Protocol Violation|19|||
105330406|NCT02568189|363209926|FG003|Overall Study|Protocol Violation|18|||
105330407|NCT02712554|363209927|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
105330408|NCT02712554|363209928|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
105330409|NCT02712554|363209927|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
105330410|NCT02712554|363209928|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
105330411|NCT02712554|363209927|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
105330412|NCT02712554|363209928|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
105330413|NCT02712554|363209927|FG000|Part B: Qualification Phase|Adverse Event|0|||
105330414|NCT02712554|363209928|FG001|Part B: Qualification Phase|Adverse Event|1|||
105330415|NCT02712554|363209927|FG000|Part B: Treatment Phase|Adverse Event|0|||
105330416|NCT02712554|363209928|FG001|Part B: Treatment Phase|Adverse Event|1|||
105330417|NCT02712554|363209927|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
105330418|NCT02712554|363209928|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
105330419|NCT02712554|363209927|FG000|Part B: Treatment Phase|Other|0|||
105330420|NCT02712554|363209928|FG001|Part B: Treatment Phase|Other|1|||
105330421|NCT01554527|363209929|FG000|Overall Study|Withdrawal by Subject|1|||
105330422|NCT01554527|363209930|FG001|Overall Study|Withdrawal by Subject|0|||
105330423|NCT01554527|363209931|FG002|Overall Study|Withdrawal by Subject|3|||
105330424|NCT01554527|363209929|FG000|Overall Study|Lost to Follow-up|0|||
105330425|NCT01554527|363209930|FG001|Overall Study|Lost to Follow-up|0|||
105330426|NCT01554527|363209931|FG002|Overall Study|Lost to Follow-up|4|||
105330427|NCT01554527|363209929|FG000|Overall Study|Physician Decision|0|||
105330428|NCT01554527|363209930|FG001|Overall Study|Physician Decision|0|||
105330429|NCT01554527|363209931|FG002|Overall Study|Physician Decision|1|||
105330430|NCT01052480|363209932|FG000|Overall Study|Lost to Follow-up|3|||
105330431|NCT01052480|363209933|FG001|Overall Study|Lost to Follow-up|3|||
105330432|NCT01052480|363209932|FG000|Overall Study|Protocol Violation|1|||
105330433|NCT01052480|363209933|FG001|Overall Study|Protocol Violation|0|||
105330434|NCT01052480|363209932|FG000|Overall Study|Withdrawal by Subject|3|||
105330435|NCT01052480|363209933|FG001|Overall Study|Withdrawal by Subject|7|||
105330436|NCT01052480|363209932|FG000|Overall Study|Physician Decision|0|||
105330437|NCT01052480|363209933|FG001|Overall Study|Physician Decision|2|||
105330438|NCT01052480|363209932|FG000|Overall Study|Death|1|||
105330439|NCT01052480|363209933|FG001|Overall Study|Death|5|||
105330440|NCT02157376|363209934|FG000|Overall Study|Death|10|||
105377381|NCT05177094|363387132|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
105377382|NCT05177094|363387131|FG000|Overall Study|Protocol Deviation|3|||
105377383|NCT05177094|363387132|FG001|Overall Study|Protocol Deviation|0|||
105377384|NCT05177094|363387131|FG000|Overall Study|Withdrawal by Subject|6|||
105377385|NCT05177094|363387132|FG001|Overall Study|Withdrawal by Subject|3|||
105377386|NCT05177094|363387131|FG000|Overall Study|Participant could not tolerate long study visits|1|||
105377387|NCT05177094|363387132|FG001|Overall Study|Participant could not tolerate long study visits|0|||
105377388|NCT04307394|363387135|FG000|Overall Study|Lost to Follow-up|3|||
105377389|NCT04307394|363387135|FG000|Overall Study|Withdrawal by Subject|2|||
105377390|NCT01121926|363387136|FG000|First Intervention Period|Adverse Event|1|||
105377391|NCT01121926|363387137|FG001|First Intervention Period|Adverse Event|0|||
105377392|NCT01121926|363387136|FG000|Washout Period|Adverse Event|0|||
105377393|NCT01121926|363387137|FG001|Washout Period|Adverse Event|1|||
105377394|NCT01121926|363387136|FG000|Washout Period|Positive pregnancy test|0|||
105377395|NCT01121926|363387137|FG001|Washout Period|Positive pregnancy test|1|||
105377396|NCT02536794|363387140|FG000|Reached 1st Response Assessment|Adverse Event|2|||
105377397|NCT02536794|363387140|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
105377398|NCT02536794|363387140|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
105377399|NCT02536794|363387140|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
105377400|NCT02536794|363387140|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
105377401|NCT02536794|363387140|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
105377402|NCT00416949|363387141|FG000|Overall Study|Patients refused to participate|5|||
105377403|NCT01410604|363387143|FG000|Overall Study|Adverse Event|2|||
105377404|NCT01410604|363387144|FG001|Overall Study|Adverse Event|1|||
105377405|NCT01410604|363387143|FG000|Overall Study|Lost to Follow-up|1|||
105377406|NCT01410604|363387144|FG001|Overall Study|Lost to Follow-up|0|||
105377407|NCT01410604|363387143|FG000|Overall Study|Physician Decision|0|||
105377408|NCT01410604|363387144|FG001|Overall Study|Physician Decision|1|||
105377409|NCT00356590|363387145|FG000|Overall Study|Adverse Event|54|||
105377410|NCT00356590|363387145|FG000|Overall Study|Death|10|||
105377411|NCT00356590|363387145|FG000|Overall Study|Lost to Follow-up|35|||
105377412|NCT00356590|363387145|FG000|Overall Study|Physician Decision|46|||
105377413|NCT00356590|363387145|FG000|Overall Study|Withdrawal by Subject|41|||
105377414|NCT00356590|363387145|FG000|Overall Study|Completed month 12 only|2|||
105377415|NCT00356590|363387145|FG000|Overall Study|Protocol issues|6|||
105377416|NCT00356590|363387145|FG000|Overall Study|Response status|28|||
105377417|NCT00356590|363387145|FG000|Overall Study|Other|52|||
105377418|NCT01496456|363387152|FG000|Overall Study|Protocol Violation|1|||
105377419|NCT01496456|363387152|FG000|Overall Study|Lost to Follow-up|7|||
105377420|NCT00407511|363387153|FG000|Overall Study|Adverse Event|9|||
105377421|NCT00407511|363387153|FG000|Overall Study|Lost to Follow-up|4|||
105377422|NCT00407511|363387153|FG000|Overall Study|Other|5|||
105377423|NCT00407511|363387153|FG000|Overall Study|Withdrawal by Subject|4|||
105377424|NCT00712920|363387154|FG000|Overall Study|Adverse Event|3|||
105377425|NCT00712920|363387155|FG001|Overall Study|Adverse Event|4|||
105377426|NCT00712920|363387156|FG002|Overall Study|Adverse Event|7|||
105377427|NCT00712920|363387154|FG000|Overall Study|Withdrawal by Subject|4|||
105377428|NCT00712920|363387155|FG001|Overall Study|Withdrawal by Subject|2|||
105377429|NCT00712920|363387156|FG002|Overall Study|Withdrawal by Subject|1|||
105377430|NCT00712920|363387154|FG000|Overall Study|Lost to Follow-up|1|||
105377431|NCT00712920|363387155|FG001|Overall Study|Lost to Follow-up|4|||
105377432|NCT00712920|363387156|FG002|Overall Study|Lost to Follow-up|0|||
105377433|NCT00712920|363387154|FG000|Overall Study|Lack of Efficacy|1|||
105377434|NCT00712920|363387155|FG001|Overall Study|Lack of Efficacy|0|||
105377435|NCT00712920|363387156|FG002|Overall Study|Lack of Efficacy|1|||
105377436|NCT00712920|363387154|FG000|Overall Study|Other|5|||
105578874|NCT01152554|364118681|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
105578875|NCT01152554|364118680|FG000|Overall Study|Adverse Event|67|||
105578876|NCT01152554|364118681|FG001|Overall Study|Adverse Event|14|||
105578877|NCT01152554|364118680|FG000|Overall Study|Severe non-compliance to protocol|36|||
105578878|NCT01152554|364118681|FG001|Overall Study|Severe non-compliance to protocol|14|||
105578879|NCT01152554|364118680|FG000|Overall Study|Condition under investigation worsened|5|||
105377437|NCT00712920|363387155|FG001|Overall Study|Other|7|||
105377438|NCT00712920|363387156|FG002|Overall Study|Other|3|||
105377439|NCT00712920|363387154|FG000|Overall Study|Non-compliance|3|||
105377440|NCT00712920|363387155|FG001|Overall Study|Non-compliance|0|||
105377441|NCT00712920|363387156|FG002|Overall Study|Non-compliance|0|||
105377442|NCT03329989|363387159|FG000|Overall Study|Withdrawal by Subject|9|||
105377443|NCT03329989|363387159|FG000|Overall Study|Lost to Follow-up|8|||
105377444|NCT03329989|363387159|FG000|Overall Study|Adverse Event|5|||
105377445|NCT03329989|363387159|FG000|Overall Study|Protocol Violation|1|||
105377446|NCT01732783|363387160|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
105377447|NCT01732783|363387161|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
105377448|NCT01732783|363387162|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
105377449|NCT01732783|363387160|FG000|Overall Study|Death|13|||
105377450|NCT01732783|363387161|FG001|Overall Study|Death|4|||
105377451|NCT01732783|363387162|FG002|Overall Study|Death|1|||
105377452|NCT01732783|363387160|FG000|Overall Study|Lost to Follow-up|7|||
105377453|NCT01732783|363387161|FG001|Overall Study|Lost to Follow-up|1|||
105377454|NCT01732783|363387162|FG002|Overall Study|Lost to Follow-up|1|||
105377455|NCT01732783|363387160|FG000|Overall Study|Administrative Decision|8|||
105377456|NCT01732783|363387161|FG001|Overall Study|Administrative Decision|2|||
105377457|NCT01732783|363387162|FG002|Overall Study|Administrative Decision|1|||
105377458|NCT01732783|363387160|FG000|Overall Study|Withdrawal by Subject|1|||
105377459|NCT01732783|363387161|FG001|Overall Study|Withdrawal by Subject|0|||
105377460|NCT01732783|363387162|FG002|Overall Study|Withdrawal by Subject|0|||
105377461|NCT02313155|363387163|FG000|Overall Study|Lost to Follow-up|0|||
105377462|NCT02313155|363387164|FG001|Overall Study|Lost to Follow-up|1|||
105377463|NCT00876343|363387171|FG000|Overall Study|Adverse Event|7|||
105377464|NCT00876343|363387172|FG001|Overall Study|Adverse Event|8|||
105377465|NCT00876343|363387173|FG002|Overall Study|Adverse Event|2|||
105377466|NCT00876343|363387171|FG000|Overall Study|Withdrawal by Subject|4|||
105377467|NCT00876343|363387172|FG001|Overall Study|Withdrawal by Subject|4|||
105377468|NCT00876343|363387173|FG002|Overall Study|Withdrawal by Subject|3|||
105377469|NCT00876343|363387171|FG000|Overall Study|Lack of Efficacy|0|||
105377470|NCT00876343|363387172|FG001|Overall Study|Lack of Efficacy|0|||
105377471|NCT00876343|363387173|FG002|Overall Study|Lack of Efficacy|1|||
105377472|NCT00876343|363387171|FG000|Overall Study|Protocol Violation|4|||
105377473|NCT00876343|363387172|FG001|Overall Study|Protocol Violation|1|||
105377474|NCT00876343|363387173|FG002|Overall Study|Protocol Violation|1|||
105377475|NCT00876343|363387171|FG000|Overall Study|Physician Decision|0|||
105377476|NCT00876343|363387172|FG001|Overall Study|Physician Decision|1|||
105377477|NCT00876343|363387173|FG002|Overall Study|Physician Decision|1|||
105377478|NCT00876343|363387171|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
105377479|NCT00876343|363387172|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
105377480|NCT00876343|363387173|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
105377481|NCT00876343|363387171|FG000|Overall Study|Change of residence or other commitments|2|||
105377482|NCT00876343|363387172|FG001|Overall Study|Change of residence or other commitments|2|||
105377483|NCT00876343|363387173|FG002|Overall Study|Change of residence or other commitments|3|||
105377484|NCT02989389|363387174|FG000|Period 1|Lost to Follow-up|0|||
105377485|NCT02989389|363387175|FG001|Period 1|Lost to Follow-up|1|||
105377486|NCT02989389|363387176|FG002|Period 1|Lost to Follow-up|0|||
105377487|NCT02989389|363387177|FG003|Period 1|Lost to Follow-up|0|||
105377488|NCT02989389|363387178|FG004|Period 1|Lost to Follow-up|0|||
105377489|NCT02989389|363387179|FG005|Period 1|Lost to Follow-up|0|||
105377490|NCT02989389|363387180|FG006|Period 1|Lost to Follow-up|0|||
105377491|NCT02989389|363387181|FG007|Period 1|Lost to Follow-up|0|||
105377492|NCT02989389|363387182|FG008|Period 1|Lost to Follow-up|0|||
105377493|NCT02989389|363387183|FG009|Period 1|Lost to Follow-up|0|||
105377494|NCT02989389|363387174|FG000|Period 1|Physician Decision|0|||
105377495|NCT02989389|363387175|FG001|Period 1|Physician Decision|0|||
105377496|NCT02989389|363387176|FG002|Period 1|Physician Decision|0|||
105377497|NCT02989389|363387177|FG003|Period 1|Physician Decision|0|||
105377498|NCT02989389|363387178|FG004|Period 1|Physician Decision|0|||
105377499|NCT02989389|363387179|FG005|Period 1|Physician Decision|0|||
105377500|NCT02989389|363387180|FG006|Period 1|Physician Decision|0|||
105377501|NCT02989389|363387181|FG007|Period 1|Physician Decision|0|||
105377502|NCT02989389|363387182|FG008|Period 1|Physician Decision|1|||
105377503|NCT02989389|363387183|FG009|Period 1|Physician Decision|0|||
105377504|NCT00374868|363387184|FG000|Overall Study|Adverse Event|12|||
105377505|NCT00374868|363387184|FG000|Overall Study|Progressive Disease|7|||
105377506|NCT00374868|363387184|FG000|Overall Study|Physician Decision|13|||
105377507|NCT00374868|363387184|FG000|Overall Study|Lost to Follow-up|1|||
105377508|NCT00374868|363387184|FG000|Overall Study|Death|2|||
105377509|NCT00374868|363387184|FG000|Overall Study|Other - Not Specified|1|||
105377510|NCT04470427|363387185|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
105377511|NCT04470427|363387186|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
105377512|NCT04470427|363387187|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
105377513|NCT04470427|363387188|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
105377514|NCT04470427|363387189|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
105377515|NCT04470427|363387190|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
105377516|NCT04470427|363387185|FG000|Part B :Open-label|Other than specified|0|||
105377517|NCT04470427|363387186|FG001|Part B :Open-label|Other than specified|0|||
105377518|NCT04470427|363387187|FG002|Part B :Open-label|Other than specified|788|||
105377519|NCT04470427|363387188|FG003|Part B :Open-label|Other than specified|0|||
105377520|NCT04470427|363387189|FG004|Part B :Open-label|Other than specified|523|||
105377521|NCT04470427|363387190|FG005|Part B :Open-label|Other than specified|0|||
105377522|NCT04470427|363387185|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
105377523|NCT04470427|363387186|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
105377524|NCT04470427|363387187|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
105377525|NCT04470427|363387188|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
105377526|NCT04470427|363387189|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
105377527|NCT04470427|363387190|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
105377528|NCT04470427|363387185|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
105377529|NCT04470427|363387186|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
105377530|NCT04470427|363387187|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
105377531|NCT04470427|363387188|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
105377532|NCT04470427|363387189|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
105377533|NCT04470427|363387190|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
105377534|NCT02802228|363387191|FG000|Overall Study|Withdrawal by Subject|2|||
105377535|NCT02802228|363387192|FG001|Overall Study|Withdrawal by Subject|0|||
105377536|NCT02802228|363387191|FG000|Overall Study|Lost to Follow-up|1|||
105377537|NCT02802228|363387192|FG001|Overall Study|Lost to Follow-up|0|||
105377538|NCT02802228|363387191|FG000|Overall Study|Adverse Event|1|||
105377539|NCT02802228|363387192|FG001|Overall Study|Adverse Event|0|||
105377540|NCT02802228|363387191|FG000|Overall Study|Physician Decision|1|||
105377541|NCT02802228|363387192|FG001|Overall Study|Physician Decision|0|||
105377542|NCT01018979|363387193|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
105377543|NCT01018979|363387194|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
105377544|NCT01018979|363387193|FG000|Overall Study|Not received at least one dose|0|||
105377545|NCT01018979|363387194|FG001|Overall Study|Not received at least one dose|1|||
105377546|NCT01925794|363387195|FG000|180 Days|Death|2|||
105377547|NCT01925794|363387195|FG000|180 Days|Withdrawal by Subject|2|||
105377548|NCT01925794|363387195|FG000|270 Days|Death|2|||
105377549|NCT01925794|363387195|FG000|270 Days|Protocol Violation|3|||
105377550|NCT03301714|363387196|FG000|Overall Study|Lost to Follow-up|10|||
105377551|NCT03301714|363387197|FG001|Overall Study|Lost to Follow-up|4|||
105377552|NCT03301714|363387198|FG002|Overall Study|Lost to Follow-up|4|||
105377553|NCT03301714|363387196|FG000|Overall Study|Did not receive allocated intervention|0|||
105377554|NCT03301714|363387197|FG001|Overall Study|Did not receive allocated intervention|2|||
105377555|NCT03301714|363387198|FG002|Overall Study|Did not receive allocated intervention|3|||
105377556|NCT03188185|363387199|FG000|Stage 1|Adverse Event|4|||
105377557|NCT03188185|363387200|FG001|Stage 1|Adverse Event|12|||
105377558|NCT03188185|363387201|FG002|Stage 1|Adverse Event|0|||
105377559|NCT03188185|363387202|FG003|Stage 1|Adverse Event|0|||
105377560|NCT03188185|363387199|FG000|Stage 1|Lack of Efficacy|0|||
105377561|NCT03188185|363387200|FG001|Stage 1|Lack of Efficacy|2|||
105377562|NCT03188185|363387201|FG002|Stage 1|Lack of Efficacy|0|||
105377563|NCT03188185|363387202|FG003|Stage 1|Lack of Efficacy|0|||
105377564|NCT03188185|363387199|FG000|Stage 1|Lost to Follow-up|6|||
105377565|NCT03188185|363387200|FG001|Stage 1|Lost to Follow-up|1|||
105377566|NCT03188185|363387201|FG002|Stage 1|Lost to Follow-up|0|||
105377567|NCT03188185|363387202|FG003|Stage 1|Lost to Follow-up|0|||
105377568|NCT03188185|363387199|FG000|Stage 1|Withdrawal by Subject|9|||
105377569|NCT03188185|363387200|FG001|Stage 1|Withdrawal by Subject|0|||
105377570|NCT03188185|363387201|FG002|Stage 1|Withdrawal by Subject|0|||
105377571|NCT03188185|363387202|FG003|Stage 1|Withdrawal by Subject|0|||
105377572|NCT03188185|363387199|FG000|Stage 1|Identified as a professional patient|0|||
105377573|NCT03188185|363387200|FG001|Stage 1|Identified as a professional patient|1|||
105377574|NCT03188185|363387201|FG002|Stage 1|Identified as a professional patient|0|||
105377575|NCT03188185|363387202|FG003|Stage 1|Identified as a professional patient|0|||
105377576|NCT03188185|363387199|FG000|Stage 2|Adverse Event|0|||
105377577|NCT03188185|363387200|FG001|Stage 2|Adverse Event|0|||
105377578|NCT03188185|363387201|FG002|Stage 2|Adverse Event|2|||
105377579|NCT03188185|363387202|FG003|Stage 2|Adverse Event|4|||
105377580|NCT03188185|363387199|FG000|Stage 2|Lack of Efficacy|0|||
105377581|NCT03188185|363387200|FG001|Stage 2|Lack of Efficacy|0|||
105377582|NCT03188185|363387201|FG002|Stage 2|Lack of Efficacy|3|||
105377583|NCT03188185|363387202|FG003|Stage 2|Lack of Efficacy|0|||
105377584|NCT03188185|363387199|FG000|Stage 2|Lost to Follow-up|0|||
105377585|NCT03188185|363387200|FG001|Stage 2|Lost to Follow-up|0|||
105377586|NCT03188185|363387201|FG002|Stage 2|Lost to Follow-up|1|||
105377587|NCT03188185|363387202|FG003|Stage 2|Lost to Follow-up|0|||
105377588|NCT03188185|363387199|FG000|Stage 2|Physician Decision|0|||
105377589|NCT03188185|363387200|FG001|Stage 2|Physician Decision|0|||
105377590|NCT03188185|363387201|FG002|Stage 2|Physician Decision|0|||
105377591|NCT03188185|363387202|FG003|Stage 2|Physician Decision|1|||
105377592|NCT03188185|363387199|FG000|Stage 2|Withdrawal by Subject|0|||
105377593|NCT03188185|363387200|FG001|Stage 2|Withdrawal by Subject|0|||
105377594|NCT03188185|363387201|FG002|Stage 2|Withdrawal by Subject|3|||
105377595|NCT03188185|363387202|FG003|Stage 2|Withdrawal by Subject|1|||
105377596|NCT00790036|363387203|FG000|Overall Study|Abnormal lab values|3|||
105377597|NCT00790036|363387204|FG001|Overall Study|Abnormal lab values|2|||
105377598|NCT00790036|363387203|FG000|Overall Study|Administrative problems|5|||
105377599|NCT00790036|363387204|FG001|Overall Study|Administrative problems|9|||
105377600|NCT00790036|363387203|FG000|Overall Study|Adverse Event|113|||
105377601|NCT00790036|363387204|FG001|Overall Study|Adverse Event|44|||
105377602|NCT00790036|363387203|FG000|Overall Study|Death|1|||
105377603|NCT00790036|363387204|FG001|Overall Study|Death|0|||
105377604|NCT00790036|363387203|FG000|Overall Study|Disease progression|24|||
105578880|NCT01152554|364118681|FG001|Overall Study|Condition under investigation worsened|2|||
105578881|NCT01152554|364118680|FG000|Overall Study|Lack of Efficacy|20|||
105578882|NCT01152554|364118681|FG001|Overall Study|Lack of Efficacy|3|||
105578883|NCT01152554|364118680|FG000|Overall Study|Study-specific withdrawal criteria|17|||
105578884|NCT01152554|364118681|FG001|Overall Study|Study-specific withdrawal criteria|8|||
105578885|NCT01152554|364118680|FG000|Overall Study|Lost to Follow-up|87|||
105578886|NCT01152554|364118681|FG001|Overall Study|Lost to Follow-up|32|||
105578887|NCT01152554|364118680|FG000|Overall Study|Other|28|||
105578888|NCT01152554|364118681|FG001|Overall Study|Other|8|||
105578889|NCT01152554|364118680|FG000|Overall Study|Death|1|||
105578890|NCT01152554|364118681|FG001|Overall Study|Death|1|||
105578891|NCT01818700|364118684|FG000|Overall Study|Adverse Event|67|||
105578892|NCT01818700|364118684|FG000|Overall Study|Lack of Efficacy|2|||
105578893|NCT01818700|364118684|FG000|Overall Study|Lost to Follow-up|5|||
105578894|NCT01818700|364118684|FG000|Overall Study|Withdrawal by Subject|27|||
105578895|NCT01818700|364118684|FG000|Overall Study|Protocol Violation|2|||
105578896|NCT01818700|364118684|FG000|Overall Study|Other|1|||
105578897|NCT02213055|364118685|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
105578898|NCT02213055|364118686|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
105578899|NCT02213055|364118685|FG000|Overall Study|Protocol was not Followed during Study|1|||
105578900|NCT02213055|364118686|FG001|Overall Study|Protocol was not Followed during Study|0|||
105578901|NCT02213055|364118685|FG000|Overall Study|Documentation Issue at Enrollment|1|||
105578902|NCT02213055|364118686|FG001|Overall Study|Documentation Issue at Enrollment|0|||
105578903|NCT02213055|364118685|FG000|Overall Study|Documentation Issue during Study|10|||
105578904|NCT02213055|364118686|FG001|Overall Study|Documentation Issue during Study|0|||
105578905|NCT02213055|364118685|FG000|Overall Study|Did not have Live Lice|8|||
105578906|NCT02213055|364118686|FG001|Overall Study|Did not have Live Lice|0|||
105578907|NCT02213055|364118685|FG000|Overall Study|Had another Treatment during the Study|3|||
105578908|NCT02213055|364118686|FG001|Overall Study|Had another Treatment during the Study|0|||
105578909|NCT02213055|364118685|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
105578910|NCT02213055|364118686|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
105578911|NCT02213055|364118685|FG000|Overall Study|Did not Return to School|5|||
105578912|NCT02213055|364118686|FG001|Overall Study|Did not Return to School|0|||
105578913|NCT01848834|364118688|FG000|Overall Study|Adverse Event|3|||
105578914|NCT01848834|364118689|FG001|Overall Study|Adverse Event|11|||
105578915|NCT01848834|364118690|FG002|Overall Study|Adverse Event|3|||
105578916|NCT01848834|364118691|FG003|Overall Study|Adverse Event|5|||
105578917|NCT01848834|364118692|FG004|Overall Study|Adverse Event|9|||
105578918|NCT01848834|364118688|FG000|Overall Study|Death|2|||
105578919|NCT01848834|364118689|FG001|Overall Study|Death|11|||
105578920|NCT01848834|364118690|FG002|Overall Study|Death|1|||
105578921|NCT01848834|364118691|FG003|Overall Study|Death|8|||
105578922|NCT01848834|364118692|FG004|Overall Study|Death|27|||
105578923|NCT01848834|364118688|FG000|Overall Study|Excluded Medication|5|||
105578924|NCT01848834|364118689|FG001|Overall Study|Excluded Medication|4|||
105578925|NCT01848834|364118690|FG002|Overall Study|Excluded Medication|3|||
105578926|NCT01848834|364118691|FG003|Overall Study|Excluded Medication|6|||
105377605|NCT00790036|363387204|FG001|Overall Study|Disease progression|48|||
105578927|NCT01848834|364118692|FG004|Overall Study|Excluded Medication|6|||
105578928|NCT01848834|364118688|FG000|Overall Study|Lost to Follow-up|5|||
105578929|NCT01848834|364118689|FG001|Overall Study|Lost to Follow-up|5|||
105377606|NCT00790036|363387203|FG000|Overall Study|Lost to Follow-up|1|||
105377607|NCT00790036|363387204|FG001|Overall Study|Lost to Follow-up|2|||
105377608|NCT00790036|363387203|FG000|Overall Study|Protocol Violation|10|||
105578930|NCT01848834|364118690|FG002|Overall Study|Lost to Follow-up|3|||
105578931|NCT01848834|364118691|FG003|Overall Study|Lost to Follow-up|0|||
105578932|NCT01848834|364118692|FG004|Overall Study|Lost to Follow-up|3|||
105377609|NCT00790036|363387204|FG001|Overall Study|Protocol Violation|2|||
105377610|NCT00790036|363387203|FG000|Overall Study|Withdrawal by Subject|18|||
105377611|NCT00790036|363387204|FG001|Overall Study|Withdrawal by Subject|7|||
105377612|NCT00790036|363387203|FG000|Overall Study|Subject/guardian decision|20|||
105377613|NCT00790036|363387204|FG001|Overall Study|Subject/guardian decision|7|||
105377614|NCT02612155|363387205|FG000|Overall Study|Death|1|||
105377615|NCT02612155|363387206|FG001|Overall Study|Death|1|||
105377616|NCT02612155|363387205|FG000|Overall Study|Lost to Follow-up|2|||
105377617|NCT02612155|363387206|FG001|Overall Study|Lost to Follow-up|2|||
105377618|NCT01179516|363387207|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
105377619|NCT01179516|363387208|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
105377620|NCT01179516|363387209|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
105377621|NCT01179516|363387207|FG000|Overall Study|Lack of Efficacy|4|||
105377622|NCT01179516|363387208|FG001|Overall Study|Lack of Efficacy|2|||
105377623|NCT01179516|363387209|FG002|Overall Study|Lack of Efficacy|0|||
105377624|NCT01179516|363387207|FG000|Overall Study|Noncompliance with Study Drug|2|||
105377625|NCT01179516|363387208|FG001|Overall Study|Noncompliance with Study Drug|0|||
105377626|NCT01179516|363387209|FG002|Overall Study|Noncompliance with Study Drug|1|||
105377627|NCT01179516|363387207|FG000|Overall Study|Protocol Deviations|4|||
105377628|NCT01179516|363387208|FG001|Overall Study|Protocol Deviations|3|||
105377629|NCT01179516|363387209|FG002|Overall Study|Protocol Deviations|3|||
105377630|NCT01179516|363387207|FG000|Overall Study|Withdrawal of Consent|2|||
105377631|NCT01179516|363387208|FG001|Overall Study|Withdrawal of Consent|6|||
105377632|NCT01179516|363387209|FG002|Overall Study|Withdrawal of Consent|10|||
105377633|NCT01179516|363387207|FG000|Overall Study|Lost to Follow-up|7|||
105377634|NCT01179516|363387208|FG001|Overall Study|Lost to Follow-up|7|||
105377635|NCT01179516|363387209|FG002|Overall Study|Lost to Follow-up|3|||
105377636|NCT01179516|363387207|FG000|Overall Study|Other|2|||
105377637|NCT01179516|363387208|FG001|Overall Study|Other|0|||
105377638|NCT01179516|363387209|FG002|Overall Study|Other|2|||
105377639|NCT05073315|363387214|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
105377640|NCT05073315|363387215|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
105377641|NCT05073315|363387216|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
105377642|NCT05073315|363387214|FG000|Period 1 (Lead-in Period)|Death|1|||
105377643|NCT05073315|363387215|FG001|Period 1 (Lead-in Period)|Death|0|||
105377644|NCT05073315|363387216|FG002|Period 1 (Lead-in Period)|Death|0|||
105377645|NCT05073315|363387214|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
105377646|NCT05073315|363387215|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
105377647|NCT05073315|363387216|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
105377648|NCT05073315|363387214|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
105377649|NCT05073315|363387215|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
105377650|NCT05073315|363387216|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
105377651|NCT05073315|363387214|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
105377652|NCT05073315|363387215|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
105377653|NCT05073315|363387216|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
105377654|NCT05073315|363387214|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
105377655|NCT05073315|363387215|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
105377656|NCT05073315|363387216|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
105377657|NCT05073315|363387214|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
105377658|NCT05073315|363387215|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
105377659|NCT05073315|363387216|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
105377660|NCT05073315|363387214|FG000|Period 2|Adverse Event|0|||
105377661|NCT05073315|363387215|FG001|Period 2|Adverse Event|3|||
105377662|NCT05073315|363387216|FG002|Period 2|Adverse Event|6|||
105377663|NCT05073315|363387214|FG000|Period 2|Lost to Follow-up|0|||
105377664|NCT05073315|363387215|FG001|Period 2|Lost to Follow-up|5|||
105377665|NCT05073315|363387216|FG002|Period 2|Lost to Follow-up|5|||
105377666|NCT05073315|363387214|FG000|Period 2|Withdrawal by Subject|0|||
105578933|NCT01848834|364118688|FG000|Overall Study|Physician Decision|1|||
105578934|NCT01848834|364118689|FG001|Overall Study|Physician Decision|3|||
105377667|NCT05073315|363387215|FG001|Period 2|Withdrawal by Subject|4|||
105377668|NCT05073315|363387216|FG002|Period 2|Withdrawal by Subject|9|||
105377669|NCT05073315|363387214|FG000|Period 2|Protocol Violation|0|||
105377670|NCT05073315|363387215|FG001|Period 2|Protocol Violation|0|||
105377671|NCT05073315|363387216|FG002|Period 2|Protocol Violation|1|||
105377672|NCT01695746|363387217|FG000|Overall Study|Adverse Event|1|||
105377673|NCT01695746|363387217|FG000|Overall Study|Non-compliance by the participant|3|||
105377674|NCT01695746|363387217|FG000|Overall Study|Protocol Violation|5|||
105377675|NCT01695746|363387217|FG000|Overall Study|Participant not willing to participate|3|||
105377676|NCT02232698|363387218|FG000|Overall Study|Pregnancy|1|||
105377677|NCT02232698|363387219|FG001|Overall Study|Pregnancy|1|||
105377678|NCT02232698|363387218|FG000|Overall Study|Met exclusion criteria|1|||
105377679|NCT02232698|363387219|FG001|Overall Study|Met exclusion criteria|1|||
105377680|NCT02232698|363387218|FG000|Overall Study|Had device-associated symptoms|7|||
105377681|NCT02232698|363387219|FG001|Overall Study|Had device-associated symptoms|0|||
105377682|NCT02232698|363387218|FG000|Overall Study|Non-compliance with study device|1|||
105578935|NCT01848834|364118690|FG002|Overall Study|Physician Decision|4|||
105578936|NCT01848834|364118691|FG003|Overall Study|Physician Decision|0|||
105578937|NCT01848834|364118692|FG004|Overall Study|Physician Decision|11|||
105578938|NCT01848834|364118688|FG000|Overall Study|Protocol Violation|0|||
105578939|NCT01848834|364118689|FG001|Overall Study|Protocol Violation|0|||
105578940|NCT01848834|364118690|FG002|Overall Study|Protocol Violation|0|||
105578941|NCT01848834|364118691|FG003|Overall Study|Protocol Violation|0|||
105578942|NCT01848834|364118692|FG004|Overall Study|Protocol Violation|1|||
105578943|NCT01848834|364118688|FG000|Overall Study|Sponsor Decision|1|||
105578944|NCT01848834|364118689|FG001|Overall Study|Sponsor Decision|1|||
105578945|NCT01848834|364118690|FG002|Overall Study|Sponsor Decision|0|||
105578946|NCT01848834|364118691|FG003|Overall Study|Sponsor Decision|1|||
105578947|NCT01848834|364118692|FG004|Overall Study|Sponsor Decision|1|||
105578948|NCT01848834|364118688|FG000|Overall Study|Withdrawal by Subject|2|||
105578949|NCT01848834|364118689|FG001|Overall Study|Withdrawal by Subject|13|||
105578950|NCT01848834|364118690|FG002|Overall Study|Withdrawal by Subject|10|||
105578951|NCT01848834|364118691|FG003|Overall Study|Withdrawal by Subject|6|||
105578952|NCT01848834|364118692|FG004|Overall Study|Withdrawal by Subject|36|||
105578953|NCT02040090|364118695|FG000|Overall Study|Adverse Event|2|||
105578954|NCT02040090|364118696|FG001|Overall Study|Adverse Event|0|||
105578955|NCT02040090|364118695|FG000|Overall Study|Physician Decision|1|||
105578956|NCT02040090|364118696|FG001|Overall Study|Physician Decision|0|||
105578957|NCT02040090|364118695|FG000|Overall Study|Withdrawal by Subject|0|||
105578958|NCT02040090|364118696|FG001|Overall Study|Withdrawal by Subject|1|||
105578959|NCT02040090|364118695|FG000|Overall Study|Lost to Follow-up|0|||
105578960|NCT02040090|364118696|FG001|Overall Study|Lost to Follow-up|1|||
105578961|NCT02550873|364118697|FG000|Randomized Double Blind|Adverse Event|3|||
105578962|NCT02550873|364118698|FG001|Randomized Double Blind|Adverse Event|1|||
105578963|NCT02550873|364118699|FG002|Randomized Double Blind|Adverse Event|0|||
105578964|NCT02550873|364118697|FG000|Randomized Double Blind|Disease progression|1|||
105578965|NCT02550873|364118698|FG001|Randomized Double Blind|Disease progression|1|||
105578966|NCT02550873|364118699|FG002|Randomized Double Blind|Disease progression|0|||
105578967|NCT02550873|364118697|FG000|Open Label Extension|Study ongoing|0|||
105578968|NCT02550873|364118698|FG001|Open Label Extension|Study ongoing|0|||
105578969|NCT02550873|364118699|FG002|Open Label Extension|Study ongoing|111|||
105578970|NCT00776100|364118707|FG000|Overall Study|Disease Progression|1|||
105578971|NCT00776100|364118708|FG001|Overall Study|Disease Progression|0|||
105578972|NCT02102464|364118713|FG000|Randomized Study|Withdrawal by Subject|0|||
105578973|NCT02102464|364118714|FG001|Randomized Study|Withdrawal by Subject|1|||
105578974|NCT02102464|364118715|FG002|Randomized Study|Withdrawal by Subject|0|||
105578975|NCT01163747|364118716|FG000|Overall Study|Adverse Event|0|||
105578976|NCT01163747|364118717|FG001|Overall Study|Adverse Event|5|||
105578977|NCT01163747|364118716|FG000|Overall Study|Insufficient Therapeutic Response|0|||
105578978|NCT01163747|364118717|FG001|Overall Study|Insufficient Therapeutic Response|1|||
105578979|NCT01163747|364118716|FG000|Overall Study|Protocol Violation|0|||
105578980|NCT01163747|364118717|FG001|Overall Study|Protocol Violation|1|||
105578981|NCT01163747|364118716|FG000|Overall Study|Refused Treatment|6|||
105578982|NCT01163747|364118717|FG001|Overall Study|Refused Treatment|4|||
105578983|NCT02846558|364118723|FG000|Overall Study|Adverse Event|1|||
105578984|NCT02846558|364118724|FG001|Overall Study|Adverse Event|0|||
105578985|NCT02846558|364118725|FG002|Overall Study|Adverse Event|0|||
105578986|NCT02846558|364118726|FG003|Overall Study|Adverse Event|0|||
105578987|NCT02846558|364118723|FG000|Overall Study|Withdrawal by Subject|5|||
105578988|NCT02846558|364118724|FG001|Overall Study|Withdrawal by Subject|4|||
105578989|NCT02846558|364118725|FG002|Overall Study|Withdrawal by Subject|2|||
105578990|NCT02846558|364118726|FG003|Overall Study|Withdrawal by Subject|2|||
105578991|NCT02846558|364118723|FG000|Overall Study|Lost to Follow-up|2|||
105578992|NCT02846558|364118724|FG001|Overall Study|Lost to Follow-up|0|||
105578993|NCT02846558|364118725|FG002|Overall Study|Lost to Follow-up|0|||
105578994|NCT02846558|364118726|FG003|Overall Study|Lost to Follow-up|0|||
105578995|NCT01189890|364120213|FG000|Overall Study|Adverse Event|3|||
105377683|NCT02232698|363387219|FG001|Overall Study|Non-compliance with study device|4|||
105377684|NCT02232698|363387218|FG000|Overall Study|Allocated to control group|0|||
105377685|NCT02232698|363387219|FG001|Overall Study|Allocated to control group|3|||
105377686|NCT02232698|363387218|FG000|Overall Study|Withdrawal by Subject|0|||
105377687|NCT02232698|363387219|FG001|Overall Study|Withdrawal by Subject|11|||
105377688|NCT00157755|363387220|FG000|Overall Study|Death|2|||
105377689|NCT00157755|363387221|FG001|Overall Study|Death|3|||
105377690|NCT00157755|363387222|FG002|Overall Study|Death|3|||
105578996|NCT01189890|364120214|FG001|Overall Study|Adverse Event|4|||
105578997|NCT01189890|364120213|FG000|Overall Study|Lack of Efficacy|7|||
105578998|NCT01189890|364120214|FG001|Overall Study|Lack of Efficacy|2|||
105578999|NCT01189890|364120213|FG000|Overall Study|Lost to Follow-up|1|||
105377691|NCT00157755|363387223|FG003|Overall Study|Death|2|||
105579000|NCT01189890|364120214|FG001|Overall Study|Lost to Follow-up|7|||
105579001|NCT01189890|364120213|FG000|Overall Study|Protocol Violation|1|||
105579002|NCT01189890|364120214|FG001|Overall Study|Protocol Violation|5|||
105579003|NCT01189890|364120213|FG000|Overall Study|Withdrawal by Subject|15|||
105579004|NCT01189890|364120214|FG001|Overall Study|Withdrawal by Subject|11|||
105377692|NCT00157755|363387224|FG004|Overall Study|Death|0|||
105579005|NCT01189890|364120213|FG000|Overall Study|Non Compliance|0|||
105579006|NCT01189890|364120214|FG001|Overall Study|Non Compliance|1|||
105579007|NCT01189890|364120213|FG000|Overall Study|Physician Decision|5|||
105579008|NCT01189890|364120214|FG001|Overall Study|Physician Decision|4|||
105579009|NCT01189890|364120213|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
105579010|NCT01189890|364120214|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
105579011|NCT02802319|364120215|FG000|Overall Study|Physician Decision|2|||
105579012|NCT02802319|364120216|FG001|Overall Study|Physician Decision|1|||
105579013|NCT02802319|364120215|FG000|Overall Study|Lost to Follow-up|0|||
105579014|NCT02802319|364120216|FG001|Overall Study|Lost to Follow-up|4|||
105579015|NCT01155388|364120217|FG000|Overall Study|Adverse Event|1|||
105579016|NCT01155388|364120218|FG001|Overall Study|Adverse Event|0|||
105579017|NCT04329104|364120219|FG000|Efficacy Study|Withdrawal by Subject|0|||
105579018|NCT04329104|364120220|FG001|Efficacy Study|Withdrawal by Subject|0|||
105579019|NCT04329104|364120221|FG002|Efficacy Study|Withdrawal by Subject|0|||
105579020|NCT04329104|364120222|FG003|Efficacy Study|Withdrawal by Subject|5|||
105579021|NCT04329104|364120223|FG004|Efficacy Study|Withdrawal by Subject|6|||
105579022|NCT04329104|364120224|FG005|Efficacy Study|Withdrawal by Subject|8|||
105579023|NCT03884231|364120225|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
105579024|NCT03884231|364120225|FG000|Overall Study|Subject Withdrew Consent|1|||
105579025|NCT03884231|364120225|FG000|Overall Study|MRI Scan Not Performed|1|||
105579026|NCT01500226|364120232|FG000|Overall Study|Adverse Event|31|||
105579027|NCT01500226|364120233|FG001|Overall Study|Adverse Event|38|||
105579028|NCT01500226|364120232|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
105579029|NCT01500226|364120233|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
105579030|NCT01500226|364120232|FG000|Overall Study|Withdrawal by Subject|93|||
105579031|NCT01500226|364120233|FG001|Overall Study|Withdrawal by Subject|96|||
105579032|NCT01500226|364120232|FG000|Overall Study|Death|12|||
105579033|NCT01500226|364120233|FG001|Overall Study|Death|4|||
105579034|NCT01500226|364120232|FG000|Overall Study|Disease Progression|16|||
105579035|NCT01500226|364120233|FG001|Overall Study|Disease Progression|14|||
105579036|NCT01500226|364120232|FG000|Overall Study|Protocol Violation|53|||
105579037|NCT01500226|364120233|FG001|Overall Study|Protocol Violation|39|||
105579038|NCT01500226|364120232|FG000|Overall Study|Physician Decision|17|||
105579039|NCT01500226|364120233|FG001|Overall Study|Physician Decision|15|||
105579040|NCT01500226|364120232|FG000|Overall Study|Lack of Efficacy|14|||
105579041|NCT01500226|364120233|FG001|Overall Study|Lack of Efficacy|30|||
105579042|NCT01500226|364120232|FG000|Overall Study|Lost to Follow-up|9|||
105579043|NCT01500226|364120233|FG001|Overall Study|Lost to Follow-up|5|||
105579044|NCT01500226|364120232|FG000|Overall Study|Other Reasons|19|||
105579045|NCT01500226|364120233|FG001|Overall Study|Other Reasons|16|||
105579046|NCT01023308|364120234|FG000|Overall Study|Abnormal test proceedure results|3|||
105579047|NCT01023308|364120235|FG001|Overall Study|Abnormal test proceedure results|8|||
105579048|NCT01023308|364120234|FG000|Overall Study|Administrative problems|2|||
105579049|NCT01023308|364120235|FG001|Overall Study|Administrative problems|1|||
105579050|NCT01023308|364120234|FG000|Overall Study|Adverse Event|130|||
105579051|NCT01023308|364120235|FG001|Overall Study|Adverse Event|66|||
105579052|NCT01023308|364120234|FG000|Overall Study|Death|21|||
105579053|NCT01023308|364120235|FG001|Overall Study|Death|17|||
105579054|NCT01023308|364120234|FG000|Overall Study|Disease progression|82|||
105579055|NCT01023308|364120235|FG001|Overall Study|Disease progression|153|||
105579056|NCT01023308|364120234|FG000|Overall Study|New Cancer therapy|4|||
105579057|NCT01023308|364120235|FG001|Overall Study|New Cancer therapy|7|||
105579058|NCT01023308|364120234|FG000|Overall Study|Protocol Violation|3|||
105579059|NCT01023308|364120235|FG001|Overall Study|Protocol Violation|4|||
105579060|NCT01023308|364120234|FG000|Overall Study|Untreated|5|||
105579061|NCT01023308|364120235|FG001|Overall Study|Untreated|5|||
105579062|NCT01023308|364120234|FG000|Overall Study|Lost to Follow-up|1|||
105579063|NCT01023308|364120235|FG001|Overall Study|Lost to Follow-up|0|||
105579064|NCT01023308|364120234|FG000|Overall Study|Withdrawal by Subject|34|||
105579065|NCT01023308|364120235|FG001|Overall Study|Withdrawal by Subject|18|||
105579066|NCT03354637|364120236|FG000|Double-blind Period|Protocol Violation|2|||
105330441|NCT02157376|363209935|FG001|Overall Study|Death|4|||
105330442|NCT02157376|363209934|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105330443|NCT02157376|363209935|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
105330444|NCT02157376|363209934|FG000|Overall Study|Withdrawal by Subject|3|||
105330445|NCT02157376|363209935|FG001|Overall Study|Withdrawal by Subject|8|||
105330446|NCT02157376|363209934|FG000|Overall Study|Not treated|8|||
105330447|NCT02157376|363209935|FG001|Overall Study|Not treated|3|||
105330448|NCT02157376|363209934|FG000|Overall Study|Investigator's misjudgement|1|||
105330449|NCT02157376|363209935|FG001|Overall Study|Investigator's misjudgement|2|||
105330450|NCT00529373|363209936|FG000|Base Study|Adverse Event|525|||
105330451|NCT00529373|363209937|FG001|Base Study|Adverse Event|470|||
105330452|NCT00529373|363209936|FG000|Base Study|Lack of Efficacy|16|||
105330453|NCT00529373|363209937|FG001|Base Study|Lack of Efficacy|75|||
105330454|NCT00529373|363209936|FG000|Base Study|Lost to Follow-up|221|||
105330455|NCT00529373|363209937|FG001|Base Study|Lost to Follow-up|208|||
105330456|NCT00529373|363209936|FG000|Base Study|Other Protocol Specified Criteria|19|||
105579067|NCT03354637|364120237|FG001|Double-blind Period|Protocol Violation|0|||
105579068|NCT03354637|364120238|FG002|Double-blind Period|Protocol Violation|0|||
105579069|NCT03354637|364120236|FG000|Double-blind Period|Adverse Event|1|||
105579070|NCT03354637|364120237|FG001|Double-blind Period|Adverse Event|2|||
105579071|NCT03354637|364120238|FG002|Double-blind Period|Adverse Event|0|||
105579072|NCT03354637|364120236|FG000|Double-blind Period|Lost to Follow-up|3|||
105579073|NCT03354637|364120237|FG001|Double-blind Period|Lost to Follow-up|4|||
105579074|NCT03354637|364120238|FG002|Double-blind Period|Lost to Follow-up|3|||
105579075|NCT03354637|364120236|FG000|Double-blind Period|Withdrawal by Subject|10|||
105579076|NCT03354637|364120237|FG001|Double-blind Period|Withdrawal by Subject|6|||
105579077|NCT03354637|364120238|FG002|Double-blind Period|Withdrawal by Subject|4|||
105579078|NCT03354637|364120236|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
105579079|NCT03354637|364120237|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
105579080|NCT03354637|364120238|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
105579081|NCT03354637|364120236|FG000|Open Label Extension|Adverse Event|0|||
105579082|NCT03354637|364120237|FG001|Open Label Extension|Adverse Event|0|||
105579083|NCT03354637|364120238|FG002|Open Label Extension|Adverse Event|1|||
105579084|NCT03354637|364120236|FG000|Open Label Extension|Lost to Follow-up|0|||
105579085|NCT03354637|364120237|FG001|Open Label Extension|Lost to Follow-up|0|||
105579086|NCT03354637|364120238|FG002|Open Label Extension|Lost to Follow-up|2|||
105579087|NCT03354637|364120236|FG000|Open Label Extension|Withdrawal by Subject|0|||
105579088|NCT03354637|364120237|FG001|Open Label Extension|Withdrawal by Subject|0|||
105579089|NCT03354637|364120238|FG002|Open Label Extension|Withdrawal by Subject|5|||
105579090|NCT03354637|364120236|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
105579091|NCT03354637|364120237|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
105579092|NCT03354637|364120238|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
105579093|NCT03354637|364120236|FG000|Open Label Extension|Subject Noncompliance|0|||
105579094|NCT03354637|364120237|FG001|Open Label Extension|Subject Noncompliance|0|||
105579095|NCT03354637|364120238|FG002|Open Label Extension|Subject Noncompliance|1|||
105579096|NCT03354637|364120236|FG000|Open Label Extension|Lack of Efficacy|0|||
105579097|NCT03354637|364120237|FG001|Open Label Extension|Lack of Efficacy|0|||
105579098|NCT03354637|364120238|FG002|Open Label Extension|Lack of Efficacy|1|||
105579099|NCT03354637|364120236|FG000|Open Label Extension|Physician Decision|0|||
105579100|NCT03354637|364120237|FG001|Open Label Extension|Physician Decision|0|||
105579101|NCT03354637|364120238|FG002|Open Label Extension|Physician Decision|1|||
105579102|NCT02726399|364120241|FG000|Overall Study|Participant Non-Compliance|1|||
105579103|NCT02726399|364120241|FG000|Overall Study|Adverse Event|2|||
105579104|NCT02726399|364120241|FG000|Overall Study|Progression of disease|4|||
105579105|NCT03685708|364120242|FG000|Overall Study|Withdrawal by Subject|0|||
105579106|NCT03685708|364120243|FG001|Overall Study|Withdrawal by Subject|0|||
105579107|NCT03685708|364120244|FG002|Overall Study|Withdrawal by Subject|1|||
105579108|NCT03685708|364120242|FG000|Overall Study|Screen Fail|0|||
105579109|NCT03685708|364120243|FG001|Overall Study|Screen Fail|1|||
105579110|NCT03685708|364120244|FG002|Overall Study|Screen Fail|1|||
105579111|NCT03685708|364120242|FG000|Overall Study|COVID 19 Pandemic|1|||
105579112|NCT03685708|364120243|FG001|Overall Study|COVID 19 Pandemic|1|||
105579113|NCT03685708|364120244|FG002|Overall Study|COVID 19 Pandemic|6|||
105579114|NCT03685708|364120242|FG000|Overall Study|Disease Progression|0|||
105579115|NCT03685708|364120243|FG001|Overall Study|Disease Progression|0|||
105579116|NCT03685708|364120244|FG002|Overall Study|Disease Progression|1|||
105579117|NCT04430335|364120245|FG000|Overall Study|Withdrawal by Subject|1|||
105377693|NCT00157755|363387225|FG005|Overall Study|Death|0|||
105377694|NCT00157755|363387220|FG000|Overall Study|Lost to Follow-up|0|||
105377695|NCT00157755|363387221|FG001|Overall Study|Lost to Follow-up|0|||
105377696|NCT00157755|363387222|FG002|Overall Study|Lost to Follow-up|1|||
105377697|NCT00157755|363387223|FG003|Overall Study|Lost to Follow-up|0|||
105377698|NCT00157755|363387224|FG004|Overall Study|Lost to Follow-up|0|||
105377699|NCT00157755|363387225|FG005|Overall Study|Lost to Follow-up|0|||
105377700|NCT00157755|363387220|FG000|Overall Study|Withdrawal by Subject|0|||
105377701|NCT00157755|363387221|FG001|Overall Study|Withdrawal by Subject|0|||
105377702|NCT00157755|363387222|FG002|Overall Study|Withdrawal by Subject|1|||
105377703|NCT00157755|363387223|FG003|Overall Study|Withdrawal by Subject|1|||
105377704|NCT00157755|363387224|FG004|Overall Study|Withdrawal by Subject|1|||
105377705|NCT00157755|363387225|FG005|Overall Study|Withdrawal by Subject|2|||
105377706|NCT00157755|363387220|FG000|Overall Study|Explant due to infection|0|||
105377707|NCT00157755|363387221|FG001|Overall Study|Explant due to infection|0|||
105377708|NCT00157755|363387222|FG002|Overall Study|Explant due to infection|1|||
105377709|NCT00157755|363387223|FG003|Overall Study|Explant due to infection|0|||
105377710|NCT00157755|363387224|FG004|Overall Study|Explant due to infection|0|||
105377711|NCT00157755|363387225|FG005|Overall Study|Explant due to infection|0|||
105377712|NCT00157755|363387220|FG000|Overall Study|Medical reason|0|||
105377713|NCT00157755|363387221|FG001|Overall Study|Medical reason|0|||
105377714|NCT00157755|363387222|FG002|Overall Study|Medical reason|1|||
105377715|NCT00157755|363387223|FG003|Overall Study|Medical reason|1|||
105377716|NCT00157755|363387224|FG004|Overall Study|Medical reason|0|||
105377717|NCT00157755|363387225|FG005|Overall Study|Medical reason|0|||
105377718|NCT00157755|363387220|FG000|Overall Study|Study site closure|0|||
105377719|NCT00157755|363387221|FG001|Overall Study|Study site closure|1|||
105377720|NCT00157755|363387222|FG002|Overall Study|Study site closure|0|||
105377721|NCT00157755|363387223|FG003|Overall Study|Study site closure|0|||
105377722|NCT00157755|363387224|FG004|Overall Study|Study site closure|0|||
105377723|NCT00157755|363387225|FG005|Overall Study|Study site closure|0|||
105377724|NCT00157755|363387220|FG000|Overall Study|Subject non-compliance|0|||
105377725|NCT00157755|363387221|FG001|Overall Study|Subject non-compliance|0|||
105377726|NCT00157755|363387222|FG002|Overall Study|Subject non-compliance|0|||
105377727|NCT00157755|363387223|FG003|Overall Study|Subject non-compliance|0|||
105377728|NCT00157755|363387224|FG004|Overall Study|Subject non-compliance|0|||
105377729|NCT00157755|363387225|FG005|Overall Study|Subject non-compliance|1|||
105377730|NCT00157755|363387220|FG000|Overall Study|Study completion|0|||
105377731|NCT00157755|363387221|FG001|Overall Study|Study completion|0|||
105377732|NCT00157755|363387222|FG002|Overall Study|Study completion|0|||
105377733|NCT00157755|363387223|FG003|Overall Study|Study completion|0|||
105377734|NCT00157755|363387224|FG004|Overall Study|Study completion|1|||
105377735|NCT00157755|363387225|FG005|Overall Study|Study completion|2|||
105377736|NCT00325416|363387228|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
105377737|NCT00325416|363387229|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
105377738|NCT00325416|363387228|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
105377739|NCT00325416|363387229|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
105377740|NCT00325416|363387228|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
105377741|NCT00325416|363387229|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
105377742|NCT00325416|363387228|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
105377743|NCT00325416|363387229|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
105377744|NCT00325416|363387228|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
105377745|NCT00325416|363387229|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
105377746|NCT00325416|363387228|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
105377747|NCT00325416|363387229|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
105377748|NCT03010501|363387237|FG000|Study Week 1|Withdrawal by Subject|2|||
105377749|NCT03010501|363387238|FG001|Study Week 1|Withdrawal by Subject|1|||
105377750|NCT03010501|363387239|FG002|Study Week 1|Withdrawal by Subject|0|||
105377751|NCT03010501|363387240|FG003|Study Week 1|Withdrawal by Subject|2|||
105377752|NCT03010501|363387241|FG004|Study Week 1|Withdrawal by Subject|0|||
105377753|NCT03010501|363387242|FG005|Study Week 1|Withdrawal by Subject|0|||
105377754|NCT03010501|363387237|FG000|Study Week 3|Withdrawal by Subject|0|||
105377755|NCT03010501|363387238|FG001|Study Week 3|Withdrawal by Subject|0|||
105377756|NCT03010501|363387239|FG002|Study Week 3|Withdrawal by Subject|0|||
105377757|NCT03010501|363387240|FG003|Study Week 3|Withdrawal by Subject|1|||
105377758|NCT03010501|363387241|FG004|Study Week 3|Withdrawal by Subject|0|||
105377759|NCT03010501|363387242|FG005|Study Week 3|Withdrawal by Subject|0|||
105377760|NCT01147458|363387243|FG000|First Intervention|Study terminated by sponsor|8|||
105377761|NCT01147458|363387244|FG001|First Intervention|Study terminated by sponsor|8|||
105377762|NCT01147458|363387245|FG002|First Intervention|Study terminated by sponsor|7|||
105377763|NCT01147458|363387246|FG003|First Intervention|Study terminated by sponsor|8|||
105377764|NCT01147458|363387243|FG000|First Intervention|Protocol Violation|2|||
105377765|NCT01147458|363387244|FG001|First Intervention|Protocol Violation|3|||
105377766|NCT01147458|363387245|FG002|First Intervention|Protocol Violation|2|||
105377767|NCT01147458|363387246|FG003|First Intervention|Protocol Violation|3|||
105377768|NCT01147458|363387243|FG000|First Intervention|Withdrawal by Subject|3|||
105377769|NCT01147458|363387244|FG001|First Intervention|Withdrawal by Subject|0|||
105377770|NCT01147458|363387245|FG002|First Intervention|Withdrawal by Subject|1|||
105377771|NCT01147458|363387246|FG003|First Intervention|Withdrawal by Subject|0|||
105377772|NCT01147458|363387243|FG000|First Intervention|Adverse Event|0|||
105377773|NCT01147458|363387244|FG001|First Intervention|Adverse Event|3|||
105377774|NCT01147458|363387245|FG002|First Intervention|Adverse Event|2|||
105579118|NCT01592695|364120251|FG000|Overall Study|Lost to Follow-up|8|||
105377775|NCT01147458|363387246|FG003|First Intervention|Adverse Event|3|||
105377776|NCT01147458|363387243|FG000|First Intervention|Other|1|||
105377777|NCT01147458|363387244|FG001|First Intervention|Other|2|||
105377778|NCT01147458|363387245|FG002|First Intervention|Other|0|||
105377779|NCT01147458|363387246|FG003|First Intervention|Other|0|||
105377780|NCT01147458|363387243|FG000|Second Intervention|Study terminated by sponsor|7|||
105377781|NCT01147458|363387244|FG001|Second Intervention|Study terminated by sponsor|5|||
105377782|NCT01147458|363387245|FG002|Second Intervention|Study terminated by sponsor|5|||
105377783|NCT01147458|363387246|FG003|Second Intervention|Study terminated by sponsor|3|||
105377784|NCT01147458|363387243|FG000|Second Intervention|Protocol Violation|0|||
105377785|NCT01147458|363387244|FG001|Second Intervention|Protocol Violation|1|||
105377786|NCT01147458|363387245|FG002|Second Intervention|Protocol Violation|1|||
105377787|NCT01147458|363387246|FG003|Second Intervention|Protocol Violation|0|||
105377788|NCT01147458|363387243|FG000|Second Intervention|Withdrawal by Subject|0|||
105377789|NCT01147458|363387244|FG001|Second Intervention|Withdrawal by Subject|1|||
105377790|NCT01147458|363387245|FG002|Second Intervention|Withdrawal by Subject|0|||
105377791|NCT01147458|363387246|FG003|Second Intervention|Withdrawal by Subject|0|||
105377792|NCT01147458|363387243|FG000|Second Intervention|Adverse Event|2|||
105377793|NCT01147458|363387244|FG001|Second Intervention|Adverse Event|0|||
105377794|NCT01147458|363387245|FG002|Second Intervention|Adverse Event|1|||
105377795|NCT01147458|363387246|FG003|Second Intervention|Adverse Event|1|||
105377796|NCT01147458|363387243|FG000|Second Intervention|Other|0|||
105377797|NCT01147458|363387244|FG001|Second Intervention|Other|0|||
105377798|NCT01147458|363387245|FG002|Second Intervention|Other|1|||
105377799|NCT01147458|363387246|FG003|Second Intervention|Other|0|||
105377800|NCT03550209|363387247|FG000|Overall Study|Lost to Follow-up|1|||
105377801|NCT03550209|363387248|FG001|Overall Study|Lost to Follow-up|0|||
105377802|NCT03550209|363387249|FG002|Overall Study|Lost to Follow-up|1|||
105377803|NCT03550209|363387250|FG003|Overall Study|Lost to Follow-up|0|||
105377804|NCT03550209|363387247|FG000|Overall Study|Withdrawal by Subject|0|||
105377805|NCT03550209|363387248|FG001|Overall Study|Withdrawal by Subject|3|||
105377806|NCT03550209|363387249|FG002|Overall Study|Withdrawal by Subject|1|||
105377807|NCT03550209|363387250|FG003|Overall Study|Withdrawal by Subject|2|||
105377808|NCT03550209|363387247|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
105377809|NCT03550209|363387248|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
105377810|NCT03550209|363387249|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
105377811|NCT03550209|363387250|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
105377812|NCT00832975|363387251|FG000|Overall Study|Lost to Follow-up|7|||
105377813|NCT00832975|363387251|FG000|Overall Study|Protocol Violation|6|||
105377814|NCT00832975|363387251|FG000|Overall Study|Death|5|||
105377815|NCT00832975|363387251|FG000|Overall Study|Physician Decision|4|||
105377816|NCT00832975|363387251|FG000|Overall Study|Withdrawal by Subject|3|||
105377817|NCT00832975|363387251|FG000|Overall Study|Other reasons|14|||
105377818|NCT01706328|363387252|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
105377819|NCT01706328|363387253|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
105377820|NCT01706328|363387254|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
105377821|NCT01706328|363387252|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
105377822|NCT01706328|363387253|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
105377823|NCT01706328|363387254|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
105377824|NCT01706328|363387252|FG000|2-week Run-in Period|Physician Decision|4|||
105377825|NCT01706328|363387253|FG001|2-week Run-in Period|Physician Decision|0|||
105377826|NCT01706328|363387254|FG002|2-week Run-in Period|Physician Decision|0|||
105377827|NCT01706328|363387252|FG000|2-week Run-in Period|Adverse Event|4|||
105377828|NCT01706328|363387253|FG001|2-week Run-in Period|Adverse Event|0|||
105377829|NCT01706328|363387254|FG002|2-week Run-in Period|Adverse Event|0|||
105377830|NCT01706328|363387252|FG000|2-week Run-in Period|Lost to Follow-up|2|||
105377831|NCT01706328|363387253|FG001|2-week Run-in Period|Lost to Follow-up|0|||
105377832|NCT01706328|363387254|FG002|2-week Run-in Period|Lost to Follow-up|0|||
105377833|NCT01706328|363387252|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
105377834|NCT01706328|363387253|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
105377835|NCT01706328|363387254|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
105377836|NCT01706328|363387252|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
105377837|NCT01706328|363387253|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
105377838|NCT01706328|363387254|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
105377839|NCT01706328|363387252|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
105377840|NCT01706328|363387253|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
105377841|NCT01706328|363387254|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
105377842|NCT01706328|363387252|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
105377843|NCT01706328|363387253|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
105377844|NCT01706328|363387254|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
105377845|NCT01706328|363387252|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
105377846|NCT01706328|363387253|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
105377847|NCT01706328|363387254|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
105377848|NCT01706328|363387252|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
105377849|NCT01706328|363387253|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
105377850|NCT01706328|363387254|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
105377851|NCT01706328|363387252|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
105377852|NCT01706328|363387253|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
105377853|NCT01706328|363387254|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
105377854|NCT00433290|363387256|FG000|Overall Study|Adverse Event|24|||
105377855|NCT00433290|363387257|FG001|Overall Study|Adverse Event|7|||
105377856|NCT00433290|363387256|FG000|Overall Study|Lack of Efficacy|1|||
105377857|NCT00433290|363387257|FG001|Overall Study|Lack of Efficacy|5|||
105377858|NCT00433290|363387256|FG000|Overall Study|Withdrawal by Subject|4|||
105377859|NCT00433290|363387257|FG001|Overall Study|Withdrawal by Subject|2|||
105377860|NCT00433290|363387256|FG000|Overall Study|Protocol Violation|3|||
105377861|NCT00433290|363387257|FG001|Overall Study|Protocol Violation|2|||
105377862|NCT00433290|363387256|FG000|Overall Study|Physician Decision|2|||
105377863|NCT00433290|363387257|FG001|Overall Study|Physician Decision|0|||
105377864|NCT00433290|363387256|FG000|Overall Study|Entry Criteria Not Met|0|||
105377865|NCT00433290|363387257|FG001|Overall Study|Entry Criteria Not Met|1|||
105377866|NCT00433290|363387256|FG000|Overall Study|Lost to Follow-up|1|||
105377867|NCT00433290|363387257|FG001|Overall Study|Lost to Follow-up|0|||
105377868|NCT01397747|363387260|FG000|Overall Study|Multitarget DNA test excluded|689|||
105377869|NCT01397747|363387260|FG000|Overall Study|Colonoscopy excluded|304|||
105579119|NCT01592695|364120252|FG001|Overall Study|Lost to Follow-up|4|||
105377870|NCT01397747|363387260|FG000|Overall Study|FIT excluded|34|||
105377871|NCT02406612|363387261|FG000|Overall Study|Screening Failure|3|||
105377872|NCT02406612|363387262|FG001|Overall Study|Screening Failure|0|||
105377873|NCT02406612|363387261|FG000|Overall Study|Intra-procedural Exclusion|1|||
105377874|NCT02406612|363387262|FG001|Overall Study|Intra-procedural Exclusion|3|||
105377875|NCT02406612|363387261|FG000|Overall Study|Guidewire Failure|0|||
105377876|NCT02406612|363387262|FG001|Overall Study|Guidewire Failure|1|||
105377877|NCT02830087|363387267|FG000|Overall Study|No study staff to follow-up patients|4|||
105377878|NCT02830087|363387268|FG001|Overall Study|No study staff to follow-up patients|4|||
105579120|NCT00627042|364120253|FG000|Overall Study|Withdrawal by Subject|2|||
105377879|NCT02830087|363387269|FG002|Overall Study|No study staff to follow-up patients|4|||
105377880|NCT02830087|363387270|FG003|Overall Study|No study staff to follow-up patients|3|||
105377881|NCT02830087|363387271|FG004|Overall Study|No study staff to follow-up patients|3|||
105377882|NCT02830087|363387272|FG005|Overall Study|No study staff to follow-up patients|3|||
105377883|NCT01525589|363387273|FG000|Overall Study|Non-treatment-related AE|1|||
105377884|NCT01525589|363387274|FG001|Overall Study|Non-treatment-related AE|0|||
105377885|NCT01525589|363387275|FG002|Overall Study|Non-treatment-related AE|0|||
105377886|NCT01525589|363387273|FG000|Overall Study|Progressive disease|48|||
105377887|NCT01525589|363387274|FG001|Overall Study|Progressive disease|15|||
105377888|NCT01525589|363387275|FG002|Overall Study|Progressive disease|29|||
105377889|NCT01525589|363387273|FG000|Overall Study|Never treated|2|||
105377890|NCT01525589|363387274|FG001|Overall Study|Never treated|0|||
105377891|NCT01525589|363387275|FG002|Overall Study|Never treated|0|||
105377892|NCT01525589|363387273|FG000|Overall Study|Physician Decision|4|||
105377893|NCT01525589|363387274|FG001|Overall Study|Physician Decision|2|||
105377894|NCT01525589|363387275|FG002|Overall Study|Physician Decision|2|||
105377895|NCT01525589|363387273|FG000|Overall Study|Death|0|||
105377896|NCT01525589|363387274|FG001|Overall Study|Death|0|||
105377897|NCT01525589|363387275|FG002|Overall Study|Death|2|||
105377898|NCT01525589|363387273|FG000|Overall Study|Treatment-related AE|1|||
105377899|NCT01525589|363387274|FG001|Overall Study|Treatment-related AE|1|||
105377900|NCT01525589|363387275|FG002|Overall Study|Treatment-related AE|2|||
105377901|NCT01525589|363387273|FG000|Overall Study|Other reasons|0|||
105377902|NCT01525589|363387274|FG001|Overall Study|Other reasons|1|||
105377903|NCT01525589|363387275|FG002|Overall Study|Other reasons|0|||
105377904|NCT01525589|363387273|FG000|Overall Study|Withdrawal by Subject|0|||
105377905|NCT01525589|363387274|FG001|Overall Study|Withdrawal by Subject|1|||
105377906|NCT01525589|363387275|FG002|Overall Study|Withdrawal by Subject|0|||
105377907|NCT02583269|363387278|FG000|Overall Study|Patient hospitalized prior to start|1|||
105377908|NCT02583269|363387279|FG001|Overall Study|Patient hospitalized prior to start|0|||
105377909|NCT02583269|363387280|FG002|Overall Study|Patient hospitalized prior to start|0|||
105377910|NCT02583269|363387281|FG003|Overall Study|Patient hospitalized prior to start|0|||
105579121|NCT00178256|364120254|FG000|Overall Study|Adverse Event|2|||
105377911|NCT02583269|363387282|FG004|Overall Study|Patient hospitalized prior to start|0|||
105377912|NCT02332707|363388956|FG000|Overall Study|Adverse Event|0|||
105377913|NCT02332707|363388957|FG001|Overall Study|Adverse Event|0|||
105377914|NCT02332707|363388958|FG002|Overall Study|Adverse Event|0|||
105579122|NCT00178256|364120255|FG001|Overall Study|Adverse Event|0|||
105579123|NCT00178256|364120256|FG002|Overall Study|Adverse Event|0|||
105579124|NCT00178256|364120257|FG003|Overall Study|Adverse Event|0|||
105579125|NCT00178256|364120254|FG000|Overall Study|Death|0|||
105579126|NCT00178256|364120255|FG001|Overall Study|Death|1|||
105579127|NCT00178256|364120256|FG002|Overall Study|Death|0|||
105579128|NCT00178256|364120257|FG003|Overall Study|Death|1|||
105579129|NCT00178256|364120254|FG000|Overall Study|Cancer progression|2|||
105579130|NCT00178256|364120255|FG001|Overall Study|Cancer progression|0|||
105579131|NCT00178256|364120256|FG002|Overall Study|Cancer progression|0|||
105579132|NCT00178256|364120257|FG003|Overall Study|Cancer progression|1|||
105579133|NCT00478608|364120258|FG000|Overall Study|Adverse Event|1|||
105579134|NCT00478608|364120258|FG000|Overall Study|Serious Adverse Event|14|||
105579135|NCT00478608|364120258|FG000|Overall Study|Withdrawal by Subject|2|||
105579136|NCT00478608|364120258|FG000|Overall Study|Protocol Violation|3|||
105579137|NCT05199233|364120260|FG000|Overall Study|Lack of Efficacy|1|||
105579138|NCT01555021|364120261|FG000|Overall Study|Lost to Follow-up|1|||
105579139|NCT01555021|364120262|FG001|Overall Study|Lost to Follow-up|2|||
105579140|NCT00065468|364120264|FG000|Overall Study|Death|172|||
105579141|NCT00065468|364120265|FG001|Overall Study|Death|169|||
105579142|NCT00065468|364120266|FG002|Overall Study|Death|171|||
105579143|NCT00065468|364120264|FG000|Overall Study|Withdrawal by Subject|3|||
105579144|NCT00065468|364120265|FG001|Overall Study|Withdrawal by Subject|4|||
105579145|NCT00065468|364120266|FG002|Overall Study|Withdrawal by Subject|5|||
105579146|NCT00065468|364120264|FG000|Overall Study|Lost to Follow-up|5|||
105579147|NCT00065468|364120265|FG001|Overall Study|Lost to Follow-up|3|||
105579148|NCT00065468|364120266|FG002|Overall Study|Lost to Follow-up|2|||
105579149|NCT00065468|364120264|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
105579150|NCT00065468|364120265|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
105579151|NCT00065468|364120266|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
105579152|NCT00065468|364120264|FG000|Overall Study|Disease progression|0|||
105579153|NCT00065468|364120265|FG001|Overall Study|Disease progression|0|||
105579154|NCT00065468|364120266|FG002|Overall Study|Disease progression|1|||
105579155|NCT00065468|364120264|FG000|Overall Study|Other|14|||
105579156|NCT00065468|364120265|FG001|Overall Study|Other|24|||
105579157|NCT00065468|364120266|FG002|Overall Study|Other|18|||
105579158|NCT01058863|364120268|FG000|Overall Study|Lost to Follow-up|1|||
105579159|NCT01058863|364120268|FG000|Overall Study|Withdrawal by Subject|1|||
105579160|NCT01058863|364120268|FG000|Overall Study|Sponsor requested withdrawal|1|||
105579161|NCT01058863|364120268|FG000|Overall Study|Randomized in error|1|||
105579162|NCT03653416|364120269|FG000|Overall Study|Protocol Violation|6|||
105579163|NCT03653416|364120270|FG001|Overall Study|Protocol Violation|1|||
105579164|NCT02269943|364120272|FG000|Treatment Period|Death|0|||
105579165|NCT02269943|364120273|FG001|Treatment Period|Death|1|||
105579166|NCT02269943|364120272|FG000|Treatment Period|Adverse Event|1|||
105579167|NCT02269943|364120273|FG001|Treatment Period|Adverse Event|10|||
105579168|NCT02269943|364120272|FG000|Treatment Period|Progressive Disease|5|||
105579169|NCT02269943|364120273|FG001|Treatment Period|Progressive Disease|17|||
105579170|NCT02269943|364120272|FG000|Treatment Period|Symptomatic Deterioration|0|||
105579171|NCT02269943|364120273|FG001|Treatment Period|Symptomatic Deterioration|2|||
105579172|NCT02269943|364120272|FG000|Follow-Up Survival Period|Death|3|||
105579173|NCT02269943|364120273|FG001|Follow-Up Survival Period|Death|16|||
105579174|NCT02269943|364120272|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
105579175|NCT02269943|364120273|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
105579176|NCT02269943|364120272|FG000|Follow-Up Survival Period|Alive|2|||
105579177|NCT02269943|364120273|FG001|Follow-Up Survival Period|Alive|8|||
105579178|NCT03541642|364120276|FG000|Overall Study|Withdrawal by Subject|1|||
105579179|NCT03541642|364120277|FG001|Overall Study|Withdrawal by Subject|2|||
105579180|NCT03541642|364120276|FG000|Overall Study|Lost to Follow-up|16|||
105579181|NCT03541642|364120277|FG001|Overall Study|Lost to Follow-up|12|||
105579182|NCT03541642|364120276|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
105579183|NCT03541642|364120277|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
105579184|NCT01951092|364120278|FG000|Overall Study|Lost to Follow-up|10|||
105579185|NCT01951092|364120278|FG000|Overall Study|Incarceration|1|||
105579186|NCT01951092|364120278|FG000|Overall Study|Transfer of Care|1|||
105579187|NCT02025205|364120281|FG000|Overall Study|Withdrawal by Subject|1|||
105579188|NCT02025205|364120282|FG001|Overall Study|Withdrawal by Subject|1|||
105377915|NCT02332707|363388959|FG003|Overall Study|Adverse Event|0|||
105579189|NCT02025205|364120281|FG000|Overall Study|Protocol Violation|2|||
105579190|NCT02025205|364120282|FG001|Overall Study|Protocol Violation|1|||
105579191|NCT02025205|364120281|FG000|Overall Study|Death|0|||
105579192|NCT02025205|364120282|FG001|Overall Study|Death|1|||
105579193|NCT01767129|364120283|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
105579194|NCT01767129|364120284|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
105377916|NCT02332707|363388960|FG004|Overall Study|Adverse Event|0|||
105579195|NCT01024751|364120288|FG000|Enrolled Participants|Ineligible at baseline|3|||
105579196|NCT01024751|364120289|FG001|Enrolled Participants|Ineligible at baseline|4|||
105579197|NCT01024751|364120288|FG000|Eligible Participants|Withdrawal by Subject|0|||
105579198|NCT01024751|364120289|FG001|Eligible Participants|Withdrawal by Subject|1|||
105579199|NCT01024751|364120288|FG000|Eligible Participants|Lost to Follow-up|0|||
105579200|NCT01024751|364120289|FG001|Eligible Participants|Lost to Follow-up|1|||
105579201|NCT01024751|364120288|FG000|Eligible Participants|Ineligible|0|||
105377917|NCT02332707|363388961|FG005|Overall Study|Adverse Event|0|||
105377918|NCT02332707|363388962|FG006|Overall Study|Adverse Event|0|||
105377919|NCT02332707|363388963|FG007|Overall Study|Adverse Event|0|||
105377920|NCT02332707|363388964|FG008|Overall Study|Adverse Event|0|||
105377921|NCT02332707|363388965|FG009|Overall Study|Adverse Event|0|||
105377922|NCT02332707|363388966|FG010|Overall Study|Adverse Event|0|||
105377923|NCT02332707|363388967|FG011|Overall Study|Adverse Event|0|||
105377924|NCT02332707|363388968|FG012|Overall Study|Adverse Event|1|||
105377925|NCT02332707|363388969|FG013|Overall Study|Adverse Event|0|||
105377926|NCT02332707|363388970|FG014|Overall Study|Adverse Event|0|||
105377927|NCT02332707|363388971|FG015|Overall Study|Adverse Event|0|||
105377928|NCT02332707|363388972|FG016|Overall Study|Adverse Event|0|||
105377929|NCT02332707|363388973|FG017|Overall Study|Adverse Event|0|||
105377930|NCT02332707|363388956|FG000|Overall Study|Lost to Follow-up|0|||
105377931|NCT02332707|363388957|FG001|Overall Study|Lost to Follow-up|0|||
105377932|NCT02332707|363388958|FG002|Overall Study|Lost to Follow-up|0|||
105377933|NCT02332707|363388959|FG003|Overall Study|Lost to Follow-up|0|||
105377934|NCT02332707|363388960|FG004|Overall Study|Lost to Follow-up|0|||
105377935|NCT02332707|363388961|FG005|Overall Study|Lost to Follow-up|1|||
105377936|NCT02332707|363388962|FG006|Overall Study|Lost to Follow-up|0|||
105377937|NCT02332707|363388963|FG007|Overall Study|Lost to Follow-up|0|||
105377938|NCT02332707|363388964|FG008|Overall Study|Lost to Follow-up|0|||
105377939|NCT02332707|363388965|FG009|Overall Study|Lost to Follow-up|0|||
105377940|NCT02332707|363388966|FG010|Overall Study|Lost to Follow-up|2|||
105377941|NCT02332707|363388967|FG011|Overall Study|Lost to Follow-up|0|||
105377942|NCT02332707|363388968|FG012|Overall Study|Lost to Follow-up|3|||
105377943|NCT02332707|363388969|FG013|Overall Study|Lost to Follow-up|0|||
105377944|NCT02332707|363388970|FG014|Overall Study|Lost to Follow-up|0|||
105377945|NCT02332707|363388971|FG015|Overall Study|Lost to Follow-up|0|||
105377946|NCT02332707|363388972|FG016|Overall Study|Lost to Follow-up|0|||
105377947|NCT02332707|363388973|FG017|Overall Study|Lost to Follow-up|0|||
105377948|NCT02332707|363388956|FG000|Overall Study|Physician Decision|0|||
105377949|NCT02332707|363388957|FG001|Overall Study|Physician Decision|0|||
105377950|NCT02332707|363388958|FG002|Overall Study|Physician Decision|0|||
105377951|NCT02332707|363388959|FG003|Overall Study|Physician Decision|1|||
105377952|NCT02332707|363388960|FG004|Overall Study|Physician Decision|0|||
105377953|NCT02332707|363388961|FG005|Overall Study|Physician Decision|0|||
105377954|NCT02332707|363388962|FG006|Overall Study|Physician Decision|0|||
105377955|NCT02332707|363388963|FG007|Overall Study|Physician Decision|0|||
105377956|NCT02332707|363388964|FG008|Overall Study|Physician Decision|0|||
105377957|NCT02332707|363388965|FG009|Overall Study|Physician Decision|0|||
105377958|NCT02332707|363388966|FG010|Overall Study|Physician Decision|0|||
105377959|NCT02332707|363388967|FG011|Overall Study|Physician Decision|0|||
105377960|NCT02332707|363388968|FG012|Overall Study|Physician Decision|1|||
105377961|NCT02332707|363388969|FG013|Overall Study|Physician Decision|0|||
105377962|NCT02332707|363388970|FG014|Overall Study|Physician Decision|0|||
105377963|NCT02332707|363388971|FG015|Overall Study|Physician Decision|0|||
105377964|NCT02332707|363388972|FG016|Overall Study|Physician Decision|0|||
105377965|NCT02332707|363388973|FG017|Overall Study|Physician Decision|0|||
105377966|NCT02332707|363388956|FG000|Overall Study|Withdrawal by Subject|0|||
105377967|NCT02332707|363388957|FG001|Overall Study|Withdrawal by Subject|0|||
105377968|NCT02332707|363388958|FG002|Overall Study|Withdrawal by Subject|1|||
105377969|NCT02332707|363388959|FG003|Overall Study|Withdrawal by Subject|0|||
105377970|NCT02332707|363388960|FG004|Overall Study|Withdrawal by Subject|0|||
105377971|NCT02332707|363388961|FG005|Overall Study|Withdrawal by Subject|0|||
105377972|NCT02332707|363388962|FG006|Overall Study|Withdrawal by Subject|0|||
105377973|NCT02332707|363388963|FG007|Overall Study|Withdrawal by Subject|0|||
105377974|NCT02332707|363388964|FG008|Overall Study|Withdrawal by Subject|0|||
105377975|NCT02332707|363388965|FG009|Overall Study|Withdrawal by Subject|3|||
105377976|NCT02332707|363388966|FG010|Overall Study|Withdrawal by Subject|0|||
105377977|NCT02332707|363388967|FG011|Overall Study|Withdrawal by Subject|0|||
105377978|NCT02332707|363388968|FG012|Overall Study|Withdrawal by Subject|0|||
105377979|NCT02332707|363388969|FG013|Overall Study|Withdrawal by Subject|0|||
105377980|NCT02332707|363388970|FG014|Overall Study|Withdrawal by Subject|0|||
105377981|NCT02332707|363388971|FG015|Overall Study|Withdrawal by Subject|0|||
105377982|NCT02332707|363388972|FG016|Overall Study|Withdrawal by Subject|0|||
105377983|NCT02332707|363388973|FG017|Overall Study|Withdrawal by Subject|0|||
105377984|NCT05399771|363388974|FG000|Overall Study|Physician Decision|3|||
105377985|NCT05399771|363388974|FG000|Overall Study|Adverse Event|1|||
105377986|NCT02293499|363388984|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
105377987|NCT02293499|363388985|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
105377988|NCT02293499|363388986|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
105377989|NCT02293499|363388984|FG000|Intervention - Camp|Withdrawal by Subject|3|||
105377990|NCT02293499|363388985|FG001|Intervention - Camp|Withdrawal by Subject|6|||
105377991|NCT02293499|363388986|FG002|Intervention - Camp|Withdrawal by Subject|2|||
105377992|NCT02293499|363388984|FG000|Intervention - Camp|these are those not showing up at camp|24|||
105579202|NCT01024751|364120289|FG001|Eligible Participants|Ineligible|1|||
105377993|NCT02293499|363388985|FG001|Intervention - Camp|these are those not showing up at camp|28|||
105377994|NCT02293499|363388986|FG002|Intervention - Camp|these are those not showing up at camp|4|||
105377995|NCT02293499|363388984|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
105377996|NCT02293499|363388985|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
105377997|NCT02293499|363388986|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
105377998|NCT02293499|363388984|FG000|3 Month Follow Up|Lost to Follow-up|14|||
105377999|NCT02293499|363388985|FG001|3 Month Follow Up|Lost to Follow-up|15|||
105378000|NCT02293499|363388986|FG002|3 Month Follow Up|Lost to Follow-up|6|||
105378001|NCT02293499|363388984|FG000|6 Month Follow Up|Lost to Follow-up|17|||
105378002|NCT02293499|363388985|FG001|6 Month Follow Up|Lost to Follow-up|27|||
105378003|NCT02293499|363388986|FG002|6 Month Follow Up|Lost to Follow-up|6|||
105378004|NCT02293499|363388984|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
105378005|NCT02293499|363388985|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
105378006|NCT02293499|363388986|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
105378007|NCT02293499|363388984|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
105378008|NCT02293499|363388985|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
105378009|NCT02293499|363388986|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
105378010|NCT02293499|363388984|FG000|9 Month Follow Up|Lost to Follow-up|24|||
105378011|NCT02293499|363388985|FG001|9 Month Follow Up|Lost to Follow-up|28|||
105378012|NCT02293499|363388986|FG002|9 Month Follow Up|Lost to Follow-up|4|||
105378013|NCT02293499|363388984|FG000|12 Month Follow Up|Lost to Follow-up|26|||
105378014|NCT02293499|363388985|FG001|12 Month Follow Up|Lost to Follow-up|25|||
105378015|NCT02293499|363388986|FG002|12 Month Follow Up|Lost to Follow-up|6|||
105378016|NCT02293499|363388984|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
105378017|NCT02293499|363388985|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
105378018|NCT02293499|363388986|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
105378019|NCT02293499|363388984|FG000|15 Month Follow Up|Lost to Follow-up|22|||
105378020|NCT02293499|363388985|FG001|15 Month Follow Up|Lost to Follow-up|22|||
105378021|NCT02293499|363388986|FG002|15 Month Follow Up|Lost to Follow-up|7|||
105378022|NCT00729586|363388989|FG000|Overall Study|Ineligible|0|||
105378023|NCT00729586|363388990|FG001|Overall Study|Ineligible|1|||
105378024|NCT00729586|363388989|FG000|Overall Study|never treated|1|||
105378025|NCT00729586|363388990|FG001|Overall Study|never treated|0|||
105378026|NCT00662259|363388991|FG000|Overall Study|Adverse Event|2|||
105378027|NCT00662259|363388992|FG001|Overall Study|Adverse Event|0|||
105378028|NCT01033942|363388993|FG000|Overall Study|Withdrawal by Subject|1|||
105378029|NCT01033942|363388994|FG001|Overall Study|Withdrawal by Subject|1|||
105378030|NCT01033942|363388995|FG002|Overall Study|Withdrawal by Subject|1|||
105378031|NCT01033942|363388993|FG000|Overall Study|Lost to Follow-up|1|||
105378032|NCT01033942|363388994|FG001|Overall Study|Lost to Follow-up|0|||
105378033|NCT01033942|363388995|FG002|Overall Study|Lost to Follow-up|0|||
105378034|NCT01033942|363388993|FG000|Overall Study|Enrolled in Extension Study|0|||
105378035|NCT01033942|363388994|FG001|Overall Study|Enrolled in Extension Study|3|||
105378036|NCT01033942|363388995|FG002|Overall Study|Enrolled in Extension Study|0|||
105378037|NCT02737618|363388996|FG000|Overall Study|Withdrawal by Subject|9|||
105378038|NCT02397837|363389008|FG000|Overall Study|Withdrawal by Subject|6|||
105378039|NCT02397837|363389009|FG001|Overall Study|Withdrawal by Subject|5|||
105378040|NCT02397837|363389008|FG000|Overall Study|Physician Decision|1|||
105378041|NCT02397837|363389009|FG001|Overall Study|Physician Decision|1|||
105378042|NCT01771913|363389012|FG000|Overall Study|Withdrawal by Subject|1|||
105378043|NCT01771913|363389013|FG001|Overall Study|Withdrawal by Subject|0|||
105378044|NCT02782468|363389014|FG000|Overall Study|Progressive Disease|2|||
105378045|NCT02782468|363389015|FG001|Overall Study|Progressive Disease|5|||
105378046|NCT02782468|363389016|FG002|Overall Study|Progressive Disease|0|||
105378047|NCT02782468|363389017|FG003|Overall Study|Progressive Disease|4|||
105378048|NCT02782468|363389014|FG000|Overall Study|Adverse Event|0|||
105378049|NCT02782468|363389015|FG001|Overall Study|Adverse Event|2|||
105378050|NCT02782468|363389016|FG002|Overall Study|Adverse Event|2|||
105378051|NCT02782468|363389017|FG003|Overall Study|Adverse Event|3|||
105378052|NCT02782468|363389014|FG000|Overall Study|Other|0|||
105378053|NCT02782468|363389015|FG001|Overall Study|Other|0|||
105378054|NCT02782468|363389016|FG002|Overall Study|Other|1|||
105378055|NCT02782468|363389017|FG003|Overall Study|Other|1|||
105378056|NCT02782468|363389014|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
105378057|NCT02782468|363389015|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
105378058|NCT02782468|363389016|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
105378059|NCT02782468|363389017|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
105378060|NCT02782468|363389014|FG000|Overall Study|Symptomatic Deterioration|0|||
105378061|NCT02782468|363389015|FG001|Overall Study|Symptomatic Deterioration|0|||
105378062|NCT02782468|363389016|FG002|Overall Study|Symptomatic Deterioration|0|||
105378063|NCT02782468|363389017|FG003|Overall Study|Symptomatic Deterioration|1|||
105378064|NCT02782468|363389014|FG000|Overall Study|Withdrawal by Subject|1|||
105378065|NCT02782468|363389015|FG001|Overall Study|Withdrawal by Subject|0|||
105378066|NCT02782468|363389016|FG002|Overall Study|Withdrawal by Subject|0|||
105378067|NCT02782468|363389017|FG003|Overall Study|Withdrawal by Subject|0|||
105378068|NCT00817063|363389020|FG000|Overall Study|Adverse Event|32|||
105378069|NCT00817063|363389021|FG001|Overall Study|Adverse Event|13|||
105378070|NCT00817063|363389020|FG000|Overall Study|Death|1|||
105378071|NCT00817063|363389021|FG001|Overall Study|Death|1|||
105378072|NCT00817063|363389020|FG000|Overall Study|Lack of Efficacy|33|||
105378073|NCT00817063|363389021|FG001|Overall Study|Lack of Efficacy|86|||
105378074|NCT00817063|363389020|FG000|Overall Study|Failure to Return|13|||
105378075|NCT00817063|363389021|FG001|Overall Study|Failure to Return|12|||
105378076|NCT00817063|363389020|FG000|Overall Study|Violation of Selection at Entry|7|||
105378077|NCT00817063|363389021|FG001|Overall Study|Violation of Selection at Entry|4|||
105378078|NCT00817063|363389020|FG000|Overall Study|Protocol Violation|3|||
105378079|NCT00817063|363389021|FG001|Overall Study|Protocol Violation|8|||
105378080|NCT00817063|363389020|FG000|Overall Study|Withdrawal by Subject|17|||
105378081|NCT00817063|363389021|FG001|Overall Study|Withdrawal by Subject|37|||
105378082|NCT00817063|363389020|FG000|Overall Study|Early Improvement|19|||
105378083|NCT00817063|363389021|FG001|Overall Study|Early Improvement|4|||
105378084|NCT00817063|363389020|FG000|Overall Study|Administrative|10|||
105378085|NCT00817063|363389021|FG001|Overall Study|Administrative|4|||
105378086|NCT00817063|363389020|FG000|Overall Study|Abnormality of Laboratory Test|2|||
105378087|NCT00817063|363389021|FG001|Overall Study|Abnormality of Laboratory Test|1|||
105378088|NCT00529035|363389022|FG000|Overall Study|Withdrawal by Subject|1|||
105378089|NCT03439514|363389023|FG000|Double-Blind Treatment Period|Other|4|||
105378090|NCT03439514|363389024|FG001|Double-Blind Treatment Period|Other|1|||
105378091|NCT03439514|363389023|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
105378092|NCT03439514|363389024|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
105378093|NCT03439514|363389023|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
105378094|NCT03439514|363389024|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
105378095|NCT03439514|363389023|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
105378096|NCT03439514|363389024|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
105378097|NCT03439514|363389023|FG000|Double-Blind Treatment Period|Death|1|||
105378098|NCT03439514|363389024|FG001|Double-Blind Treatment Period|Death|2|||
105378099|NCT01521364|363389025|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
105378100|NCT01521364|363389025|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
105378101|NCT02696616|363389028|FG000|Overall Study|Adverse Event|0|||
105378102|NCT02696616|363389029|FG001|Overall Study|Adverse Event|1|||
105378103|NCT02696616|363389030|FG002|Overall Study|Adverse Event|0|||
105378104|NCT02696616|363389031|FG003|Overall Study|Adverse Event|0|||
105378105|NCT02696616|363389032|FG004|Overall Study|Adverse Event|0|||
105378106|NCT02696616|363389033|FG005|Overall Study|Adverse Event|0|||
105378107|NCT02696616|363389034|FG006|Overall Study|Adverse Event|0|||
105378108|NCT01500083|363389035|FG000|Overall Study|Adverse Event|4|||
105378109|NCT01500083|363389036|FG001|Overall Study|Adverse Event|17|||
105378110|NCT01500083|363389035|FG000|Overall Study|Death|0|||
105378111|NCT01500083|363389036|FG001|Overall Study|Death|2|||
105378112|NCT01500083|363389035|FG000|Overall Study|Lost to Follow-up|1|||
105378113|NCT01500083|363389036|FG001|Overall Study|Lost to Follow-up|0|||
105378114|NCT01500083|363389035|FG000|Overall Study|Withdrawal of Consent|0|||
105378115|NCT01500083|363389036|FG001|Overall Study|Withdrawal of Consent|1|||
105378116|NCT01500083|363389035|FG000|Overall Study|Disease Progression|2|||
105378117|NCT01500083|363389036|FG001|Overall Study|Disease Progression|10|||
105378118|NCT01500083|363389035|FG000|Overall Study|Investigator Discretion|3|||
105378119|NCT01500083|363389036|FG001|Overall Study|Investigator Discretion|8|||
105378120|NCT01500083|363389035|FG000|Overall Study|Other Reasons|2|||
105378121|NCT01500083|363389036|FG001|Overall Study|Other Reasons|5|||
105378122|NCT01555931|363389037|FG000|Overall Study|Lost to Follow-up|2|||
105378123|NCT01555931|363389038|FG001|Overall Study|Lost to Follow-up|5|||
105378124|NCT04871113|363389039|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105378125|NCT04871113|363389040|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105378126|NCT04871113|363389041|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105378127|NCT04871113|363389042|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105378128|NCT04871113|363389043|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105378129|NCT04871113|363389044|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
105378130|NCT04871113|363389045|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105378131|NCT04871113|363389046|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105378132|NCT04871113|363389047|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105378133|NCT04871113|363389048|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105378134|NCT04871113|363389039|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
105378135|NCT04871113|363389040|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
105378136|NCT04871113|363389041|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
105378137|NCT04871113|363389042|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
105378138|NCT04871113|363389043|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
105378139|NCT04871113|363389044|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
105378140|NCT04871113|363389045|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
105378141|NCT04871113|363389046|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
105378142|NCT04871113|363389047|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
105378143|NCT04871113|363389048|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
105378144|NCT02299167|363389049|FG000|Overall Study|patients were excluded from the study|11|||
105378145|NCT02606253|363389052|FG000|Overall Study|Adverse Event|2|||
105378146|NCT02606253|363389053|FG001|Overall Study|Adverse Event|0|||
105378147|NCT02606253|363389054|FG002|Overall Study|Adverse Event|0|||
105378148|NCT02606253|363389052|FG000|Overall Study|Protocol Violation|2|||
105378149|NCT02606253|363389053|FG001|Overall Study|Protocol Violation|1|||
105378150|NCT02606253|363389054|FG002|Overall Study|Protocol Violation|0|||
105378151|NCT02606253|363389052|FG000|Overall Study|Physician Decision|1|||
105378152|NCT02606253|363389053|FG001|Overall Study|Physician Decision|1|||
105378153|NCT02606253|363389054|FG002|Overall Study|Physician Decision|0|||
105378154|NCT00689936|363389060|FG000|Active Treatment Phase|Adverse Event|68|||
105378155|NCT00689936|363389061|FG001|Active Treatment Phase|Adverse Event|71|||
105378156|NCT00689936|363389062|FG002|Active Treatment Phase|Adverse Event|76|||
105378157|NCT00689936|363389060|FG000|Active Treatment Phase|Disease Progression|273|||
105378158|NCT00689936|363389061|FG001|Active Treatment Phase|Disease Progression|362|||
105378159|NCT00689936|363389062|FG002|Active Treatment Phase|Disease Progression|339|||
105378160|NCT00689936|363389060|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
105378161|NCT00689936|363389061|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
105378162|NCT00689936|363389062|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
105378163|NCT00689936|363389060|FG000|Active Treatment Phase|Death|60|||
105378164|NCT00689936|363389061|FG001|Active Treatment Phase|Death|28|||
105378165|NCT00689936|363389062|FG002|Active Treatment Phase|Death|37|||
105378166|NCT00689936|363389060|FG000|Active Treatment Phase|Lost to Follow-up|0|||
105378167|NCT00689936|363389061|FG001|Active Treatment Phase|Lost to Follow-up|2|||
105378168|NCT00689936|363389062|FG002|Active Treatment Phase|Lost to Follow-up|2|||
105378169|NCT00689936|363389060|FG000|Active Treatment Phase|Protocol Violation|2|||
105378170|NCT00689936|363389061|FG001|Active Treatment Phase|Protocol Violation|2|||
105378171|NCT00689936|363389062|FG002|Active Treatment Phase|Protocol Violation|4|||
105378172|NCT00689936|363389060|FG000|Active Treatment Phase|Study Close Out|64|||
105378173|NCT00689936|363389061|FG001|Active Treatment Phase|Study Close Out|26|||
105378174|NCT00689936|363389062|FG002|Active Treatment Phase|Study Close Out|21|||
105378175|NCT00689936|363389060|FG000|Active Treatment Phase|Miscellaneous|52|||
105378176|NCT00689936|363389061|FG001|Active Treatment Phase|Miscellaneous|34|||
105378177|NCT00689936|363389062|FG002|Active Treatment Phase|Miscellaneous|47|||
105378178|NCT00689936|363389060|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
105378179|NCT00689936|363389061|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
105378180|NCT00689936|363389062|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
105378181|NCT01138046|363389063|FG000|Overall Study|Withdrawal due to death|6|||
105378182|NCT02836769|363389064|FG000|Overall Study|Lost to Follow-up|10|||
105378183|NCT02836769|363389064|FG000|Overall Study|Medical withdrawal|2|||
105330457|NCT00529373|363209937|FG001|Base Study|Other Protocol Specified Criteria|20|||
105330458|NCT00529373|363209936|FG000|Base Study|Physician Decision|60|||
105330459|NCT00529373|363209937|FG001|Base Study|Physician Decision|52|||
105330460|NCT00529373|363209936|FG000|Base Study|Protocol Violation|48|||
105330461|NCT00529373|363209937|FG001|Base Study|Protocol Violation|38|||
105330462|NCT00529373|363209936|FG000|Base Study|Withdrawal by Subject|1062|||
105330463|NCT00529373|363209937|FG001|Base Study|Withdrawal by Subject|967|||
105330464|NCT00529373|363209936|FG000|Base Study|Did not continue into Extension|1795|||
105330465|NCT00529373|363209937|FG001|Base Study|Did not continue into Extension|2238|||
105330466|NCT00529373|363209936|FG000|First Extension Study|Adverse Event|162|||
105330467|NCT00529373|363209937|FG001|First Extension Study|Adverse Event|142|||
105330468|NCT00529373|363209936|FG000|First Extension Study|Lack of Efficacy|65|||
105330469|NCT00529373|363209937|FG001|First Extension Study|Lack of Efficacy|427|||
105330470|NCT00529373|363209936|FG000|First Extension Study|Lost to Follow-up|41|||
105330471|NCT00529373|363209937|FG001|First Extension Study|Lost to Follow-up|37|||
105330472|NCT00529373|363209936|FG000|First Extension Study|Other|27|||
105330473|NCT00529373|363209937|FG001|First Extension Study|Other|47|||
105330474|NCT00529373|363209936|FG000|First Extension Study|Physician Decision|50|||
105330475|NCT00529373|363209937|FG001|First Extension Study|Physician Decision|45|||
105330476|NCT00529373|363209936|FG000|First Extension Study|Protocol Violation|16|||
105330477|NCT00529373|363209937|FG001|First Extension Study|Protocol Violation|13|||
105330478|NCT00529373|363209936|FG000|First Extension Study|Withdrawal by Subject|296|||
105330479|NCT00529373|363209937|FG001|First Extension Study|Withdrawal by Subject|287|||
105330480|NCT00529373|363209936|FG000|First Extension Study|Disposition record non-existing|0|||
105330481|NCT00529373|363209937|FG001|First Extension Study|Disposition record non-existing|1|||
105330482|NCT00529373|363209936|FG000|First Extension Study|Discontinued after 5 years completion|208|||
105330483|NCT00529373|363209937|FG001|First Extension Study|Discontinued after 5 years completion|346|||
105330484|NCT00529373|363209936|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
105330485|NCT00529373|363209937|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
105330486|NCT00529373|363209936|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
105579203|NCT01163149|364120290|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
105579204|NCT01163149|364120291|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
105579205|NCT01163149|364120292|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
105579206|NCT01163149|364120290|FG000|Extension Treatment Period|Adverse Event|0|||
105579207|NCT01163149|364120291|FG001|Extension Treatment Period|Adverse Event|1|||
105579208|NCT01163149|364120292|FG002|Extension Treatment Period|Adverse Event|0|||
105579209|NCT01163149|364120290|FG000|Extension Treatment Period|Noncompliance|0|||
105579210|NCT01163149|364120291|FG001|Extension Treatment Period|Noncompliance|0|||
105579211|NCT01163149|364120292|FG002|Extension Treatment Period|Noncompliance|1|||
105579212|NCT01822353|364120293|FG000|Overall Study|Adverse Event|1|||
105579213|NCT01822353|364120294|FG001|Overall Study|Adverse Event|3|||
105579214|NCT01822353|364120295|FG002|Overall Study|Adverse Event|1|||
105579215|NCT01822353|364120293|FG000|Overall Study|Pregnancy|0|||
105579216|NCT01822353|364120294|FG001|Overall Study|Pregnancy|1|||
105579217|NCT01822353|364120295|FG002|Overall Study|Pregnancy|0|||
105579218|NCT01822353|364120293|FG000|Overall Study|Withdrawal by Subject|3|||
105579219|NCT01822353|364120294|FG001|Overall Study|Withdrawal by Subject|1|||
105579220|NCT01822353|364120295|FG002|Overall Study|Withdrawal by Subject|0|||
105579221|NCT02431533|364120302|FG000|Overall Study|Withdrawal by Subject|1|||
105579222|NCT02431533|364120303|FG001|Overall Study|Withdrawal by Subject|3|||
105579223|NCT02431533|364120302|FG000|Overall Study|Developed Exclusionary criteria|1|||
105579224|NCT02431533|364120303|FG001|Overall Study|Developed Exclusionary criteria|0|||
105579225|NCT02107443|364120308|FG000|Overall Study|Death|42|||
105579226|NCT02107443|364120309|FG001|Overall Study|Death|30|||
105579227|NCT02107443|364120308|FG000|Overall Study|Study Protocol Violation|3|||
105579228|NCT02107443|364120309|FG001|Overall Study|Study Protocol Violation|1|||
105579229|NCT02107443|364120308|FG000|Overall Study|Registered but Not Eligible|0|||
105579230|NCT02107443|364120309|FG001|Overall Study|Registered but Not Eligible|1|||
105579231|NCT02107443|364120308|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
105579232|NCT02107443|364120309|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
105579233|NCT02107443|364120308|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
105579234|NCT02107443|364120309|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
105579235|NCT02107443|364120308|FG000|Overall Study|Withdrawal: Changed Mind|2|||
105579236|NCT02107443|364120309|FG001|Overall Study|Withdrawal: Changed Mind|0|||
105579237|NCT02107443|364120308|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
105579238|NCT02107443|364120309|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
105579239|NCT02107443|364120308|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
105579240|NCT02107443|364120309|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
105579241|NCT02107443|364120308|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
105579242|NCT02107443|364120309|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
105579243|NCT02107443|364120308|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
105579244|NCT02107443|364120309|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
105579245|NCT02107443|364120308|FG000|Overall Study|Withdrawal: Other Medical|9|||
105579246|NCT02107443|364120309|FG001|Overall Study|Withdrawal: Other Medical|5|||
105579247|NCT02107443|364120308|FG000|Overall Study|Withdrawal: Disease Progression|4|||
105579248|NCT02107443|364120309|FG001|Overall Study|Withdrawal: Disease Progression|2|||
105579249|NCT02107443|364120308|FG000|Overall Study|Withdrawal: Personal Issues|0|||
105579250|NCT02107443|364120309|FG001|Overall Study|Withdrawal: Personal Issues|3|||
105579251|NCT02285595|364120314|FG000|Overall Study|Lost to Follow-up|14|||
105579252|NCT02285595|364120314|FG000|Overall Study|Withdrawal by Subject|1|||
105579253|NCT01987830|364120315|FG000|Overall Study|Never received baseline scan|1|||
105579254|NCT03990363|364120316|FG000|Overall Study|Withdrawal by Subject|10|||
105579255|NCT03990363|364120317|FG001|Overall Study|Withdrawal by Subject|9|||
105579256|NCT03990363|364120318|FG002|Overall Study|Withdrawal by Subject|18|||
105579257|NCT03990363|364120319|FG003|Overall Study|Withdrawal by Subject|11|||
105579258|NCT03990363|364120320|FG004|Overall Study|Withdrawal by Subject|9|||
105579259|NCT03990363|364120316|FG000|Overall Study|Physician Decision|1|||
105579260|NCT03990363|364120317|FG001|Overall Study|Physician Decision|0|||
105579261|NCT03990363|364120318|FG002|Overall Study|Physician Decision|0|||
105579262|NCT03990363|364120319|FG003|Overall Study|Physician Decision|0|||
105579263|NCT03990363|364120320|FG004|Overall Study|Physician Decision|0|||
105579264|NCT03990363|364120316|FG000|Overall Study|Adverse Event|1|||
105579265|NCT03990363|364120317|FG001|Overall Study|Adverse Event|3|||
105579266|NCT03990363|364120318|FG002|Overall Study|Adverse Event|2|||
105579267|NCT03990363|364120319|FG003|Overall Study|Adverse Event|2|||
105579268|NCT03990363|364120320|FG004|Overall Study|Adverse Event|0|||
105579269|NCT03990363|364120316|FG000|Overall Study|Death|14|||
105579270|NCT03990363|364120317|FG001|Overall Study|Death|8|||
105579271|NCT03990363|364120318|FG002|Overall Study|Death|14|||
105579272|NCT03990363|364120319|FG003|Overall Study|Death|10|||
105579273|NCT03990363|364120320|FG004|Overall Study|Death|11|||
105579274|NCT03990363|364120316|FG000|Overall Study|Failure to meet randomization criteria|0|||
105579275|NCT03990363|364120317|FG001|Overall Study|Failure to meet randomization criteria|1|||
105579276|NCT03990363|364120318|FG002|Overall Study|Failure to meet randomization criteria|1|||
105579277|NCT03990363|364120319|FG003|Overall Study|Failure to meet randomization criteria|0|||
105579278|NCT03990363|364120320|FG004|Overall Study|Failure to meet randomization criteria|0|||
105579279|NCT03990363|364120316|FG000|Overall Study|Lost to Follow-up|0|||
105579280|NCT03990363|364120317|FG001|Overall Study|Lost to Follow-up|0|||
105579281|NCT03990363|364120318|FG002|Overall Study|Lost to Follow-up|0|||
105579282|NCT03990363|364120319|FG003|Overall Study|Lost to Follow-up|1|||
105579283|NCT03990363|364120320|FG004|Overall Study|Lost to Follow-up|2|||
105579284|NCT03990363|364120316|FG000|Overall Study|Non-compliance with study drug|2|||
105579285|NCT03990363|364120317|FG001|Overall Study|Non-compliance with study drug|1|||
105579286|NCT03990363|364120318|FG002|Overall Study|Non-compliance with study drug|2|||
105579287|NCT03990363|364120319|FG003|Overall Study|Non-compliance with study drug|0|||
105579288|NCT03990363|364120320|FG004|Overall Study|Non-compliance with study drug|0|||
105579289|NCT03990363|364120316|FG000|Overall Study|Study terminated by sponsor|0|||
105579290|NCT03990363|364120317|FG001|Overall Study|Study terminated by sponsor|1|||
105579291|NCT03990363|364120318|FG002|Overall Study|Study terminated by sponsor|0|||
105579292|NCT03990363|364120319|FG003|Overall Study|Study terminated by sponsor|0|||
105579293|NCT03990363|364120320|FG004|Overall Study|Study terminated by sponsor|0|||
105579294|NCT03990363|364120316|FG000|Overall Study|Site terminated by sponsor|2|||
105579295|NCT03990363|364120317|FG001|Overall Study|Site terminated by sponsor|1|||
105579296|NCT03990363|364120318|FG002|Overall Study|Site terminated by sponsor|2|||
105579297|NCT03990363|364120319|FG003|Overall Study|Site terminated by sponsor|0|||
105579298|NCT03990363|364120320|FG004|Overall Study|Site terminated by sponsor|2|||
105378184|NCT02836769|363389064|FG000|Overall Study|Withdrawal by Subject|3|||
105378185|NCT02755090|363389069|FG000|Overall Study|equipment malfunction|1|||
105378186|NCT02755090|363389070|FG001|Overall Study|equipment malfunction|0|||
105378187|NCT00221104|363389071|FG000|Overall Study|Adverse Event|1|||
105378188|NCT00221104|363389072|FG001|Overall Study|Adverse Event|0|||
105378189|NCT00221104|363389071|FG000|Overall Study|Physician Decision|1|||
105378190|NCT00221104|363389072|FG001|Overall Study|Physician Decision|0|||
105378191|NCT00221104|363389071|FG000|Overall Study|Protocol Violation|2|||
105378192|NCT00221104|363389072|FG001|Overall Study|Protocol Violation|0|||
105378193|NCT00221104|363389071|FG000|Overall Study|Withdrawal by Subject|42|||
105378194|NCT00221104|363389072|FG001|Overall Study|Withdrawal by Subject|29|||
105378195|NCT00221104|363389071|FG000|Overall Study|Others|37|||
105378196|NCT00221104|363389072|FG001|Overall Study|Others|47|||
105378197|NCT03349515|363389073|FG000|Overall Study|Lack of Efficacy|2|||
105378198|NCT03349515|363389074|FG001|Overall Study|Lack of Efficacy|0|||
105378199|NCT03349515|363389073|FG000|Overall Study|Physician Decision|3|||
105378200|NCT03349515|363389074|FG001|Overall Study|Physician Decision|1|||
105378201|NCT01860989|363389086|FG000|Overall Study|Unsatisfactory therapeutic|5|||
105378202|NCT00700635|363389089|FG000|Overall Study|Adverse Event|1|||
105378203|NCT00700635|363389090|FG001|Overall Study|Adverse Event|0|||
105378204|NCT00700635|363389091|FG002|Overall Study|Adverse Event|0|||
105378205|NCT00700635|363389089|FG000|Overall Study|Lost to Follow-up|1|||
105378206|NCT00700635|363389090|FG001|Overall Study|Lost to Follow-up|3|||
105378207|NCT00700635|363389091|FG002|Overall Study|Lost to Follow-up|0|||
105378208|NCT00700635|363389089|FG000|Overall Study|Protocol Violation|2|||
105378209|NCT00700635|363389090|FG001|Overall Study|Protocol Violation|2|||
105378210|NCT00700635|363389091|FG002|Overall Study|Protocol Violation|0|||
105378211|NCT00700635|363389089|FG000|Overall Study|Withdrawal by Subject|7|||
105378212|NCT00700635|363389090|FG001|Overall Study|Withdrawal by Subject|3|||
105378213|NCT00700635|363389091|FG002|Overall Study|Withdrawal by Subject|1|||
105378214|NCT02347787|363389094|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
105378215|NCT02347787|363389095|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
105378216|NCT02347787|363389094|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
105378217|NCT02347787|363389095|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
105579299|NCT03990363|364120316|FG000|Overall Study|Not categorized|5|||
105378218|NCT02347787|363389094|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
105579300|NCT03990363|364120317|FG001|Overall Study|Not categorized|5|||
105378219|NCT02347787|363389095|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
105378220|NCT02347787|363389094|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
105579301|NCT03990363|364120318|FG002|Overall Study|Not categorized|3|||
105579302|NCT03990363|364120319|FG003|Overall Study|Not categorized|2|||
105579303|NCT03990363|364120320|FG004|Overall Study|Not categorized|2|||
105579304|NCT01349660|364120321|FG000|Overall Study|Still Receiving Study Treatment|0|||
105378221|NCT02347787|363389095|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
105378222|NCT01179399|363389108|FG000|Overall Study|Adverse Event|1|||
105378223|NCT01179399|363389108|FG000|Overall Study|Lack of Efficacy|30|||
105378224|NCT01179399|363389108|FG000|Overall Study|Withdrawal by Subject|1|||
105378225|NCT00770809|363390739|FG000|Overall Study|Adverse Event|9|||
105378226|NCT00770809|363390740|FG001|Overall Study|Adverse Event|1|||
105378227|NCT00770809|363390741|FG002|Overall Study|Adverse Event|12|||
105378228|NCT00770809|363390739|FG000|Overall Study|Death|1|||
105378229|NCT00770809|363390740|FG001|Overall Study|Death|0|||
105378230|NCT00770809|363390741|FG002|Overall Study|Death|0|||
105378231|NCT00770809|363390739|FG000|Overall Study|Withdrawal by Subject|3|||
105378232|NCT00770809|363390740|FG001|Overall Study|Withdrawal by Subject|3|||
105378233|NCT00770809|363390741|FG002|Overall Study|Withdrawal by Subject|7|||
105378234|NCT00770809|363390739|FG000|Overall Study|Progression|2|||
105378235|NCT00770809|363390740|FG001|Overall Study|Progression|2|||
105378236|NCT00770809|363390741|FG002|Overall Study|Progression|0|||
105378237|NCT00770809|363390739|FG000|Overall Study|Complicating illness|0|||
105378238|NCT00770809|363390740|FG001|Overall Study|Complicating illness|0|||
105378239|NCT00770809|363390741|FG002|Overall Study|Complicating illness|1|||
105378240|NCT00770809|363390739|FG000|Overall Study|Other Medical Reasons|2|||
105378241|NCT00770809|363390740|FG001|Overall Study|Other Medical Reasons|4|||
105378242|NCT00770809|363390741|FG002|Overall Study|Other Medical Reasons|3|||
105378243|NCT00143507|363390744|FG000|Overall Study|Death|572|||
105378244|NCT00143507|363390745|FG001|Overall Study|Death|547|||
105378245|NCT00143507|363390744|FG000|Overall Study|Withdrawal by Subject|114|||
105378246|NCT00143507|363390745|FG001|Overall Study|Withdrawal by Subject|102|||
105378247|NCT00143507|363390744|FG000|Overall Study|Lost to Follow-up|1|||
105378248|NCT00143507|363390745|FG001|Overall Study|Lost to Follow-up|0|||
105378249|NCT00143507|363390744|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
105378250|NCT00143507|363390745|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
105378251|NCT00587457|363390746|FG000|Overall Study|Adverse Event|1|||
105378252|NCT00587457|363390747|FG001|Overall Study|Adverse Event|2|||
105378253|NCT00587457|363390748|FG002|Overall Study|Adverse Event|1|||
105378254|NCT00587457|363390746|FG000|Overall Study|Disease progression|2|||
105378255|NCT00587457|363390747|FG001|Overall Study|Disease progression|0|||
105378256|NCT00587457|363390748|FG002|Overall Study|Disease progression|2|||
105378257|NCT00587457|363390746|FG000|Overall Study|Initiation of alternative therapy|0|||
105378258|NCT00587457|363390747|FG001|Overall Study|Initiation of alternative therapy|1|||
105378259|NCT00587457|363390748|FG002|Overall Study|Initiation of alternative therapy|0|||
105378260|NCT00587457|363390746|FG000|Overall Study|Undefined|0|||
105378261|NCT00587457|363390747|FG001|Overall Study|Undefined|0|||
105378262|NCT00587457|363390748|FG002|Overall Study|Undefined|1|||
105378263|NCT00587457|363390746|FG000|Overall Study|Development of neutralizing Abs|0|||
105378264|NCT00587457|363390747|FG001|Overall Study|Development of neutralizing Abs|0|||
105378265|NCT00587457|363390748|FG002|Overall Study|Development of neutralizing Abs|1|||
105378266|NCT00484159|363390749|FG000|Overall Study|Lost to Follow-up|1|||
105378267|NCT00484159|363390750|FG001|Overall Study|Lost to Follow-up|1|||
105378268|NCT00484159|363390751|FG002|Overall Study|Lost to Follow-up|0|||
105378269|NCT00177671|363390752|FG000|Overall Study|Withdrawal by Subject|5|||
105378270|NCT00177671|363390753|FG001|Overall Study|Withdrawal by Subject|6|||
105378271|NCT00177671|363390752|FG000|Overall Study|medical complications|2|||
105378272|NCT00177671|363390753|FG001|Overall Study|medical complications|0|||
105378273|NCT00177671|363390752|FG000|Overall Study|Adverse Event|6|||
105378274|NCT00177671|363390753|FG001|Overall Study|Adverse Event|0|||
105378275|NCT00177671|363390752|FG000|Overall Study|Physician Decision|12|||
105378276|NCT00177671|363390753|FG001|Overall Study|Physician Decision|8|||
105378277|NCT00690898|363390754|FG000|SCREENING|Screen failure|18|||
105378278|NCT00690898|363390754|FG000|TREATMENT|Adverse Event|3|||
105378279|NCT00690898|363390754|FG000|TREATMENT|Lack of Efficacy|18|||
105378280|NCT00690898|363390754|FG000|TREATMENT|Withdrawal by Subject|4|||
105378281|NCT00690898|363390754|FG000|TREATMENT|Other (not otherwise specified)|1|||
105378282|NCT00541229|363390755|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
105378283|NCT00541229|363390756|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
105378284|NCT00541229|363390757|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
105378285|NCT00541229|363390758|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
105378286|NCT00541229|363390759|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
105378287|NCT00541229|363390760|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
105378288|NCT00541229|363390755|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
105579305|NCT01349660|364120322|FG001|Overall Study|Still Receiving Study Treatment|0|||
105579306|NCT01349660|364120323|FG002|Overall Study|Still Receiving Study Treatment|1|||
105378289|NCT00541229|363390756|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
105378290|NCT00541229|363390757|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
105378291|NCT00541229|363390758|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
105378292|NCT00541229|363390759|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
105378293|NCT00541229|363390760|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
105378294|NCT00541229|363390755|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
105378295|NCT00541229|363390756|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
105378296|NCT00541229|363390757|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
105378297|NCT00541229|363390758|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
105579307|NCT01349660|364120321|FG000|Overall Study|Disease Progression|2|||
105579308|NCT01349660|364120322|FG001|Overall Study|Disease Progression|4|||
105579309|NCT01349660|364120323|FG002|Overall Study|Disease Progression|50|||
105579310|NCT01349660|364120321|FG000|Overall Study|Adverse Event|1|||
105579311|NCT01349660|364120322|FG001|Overall Study|Adverse Event|1|||
105579312|NCT01349660|364120323|FG002|Overall Study|Adverse Event|12|||
105579313|NCT01349660|364120321|FG000|Overall Study|Withdrawal by Subject|2|||
105579314|NCT01349660|364120322|FG001|Overall Study|Withdrawal by Subject|0|||
105579315|NCT01349660|364120323|FG002|Overall Study|Withdrawal by Subject|9|||
105579316|NCT01349660|364120321|FG000|Overall Study|Death|1|||
105579317|NCT01349660|364120322|FG001|Overall Study|Death|1|||
105579318|NCT01349660|364120323|FG002|Overall Study|Death|0|||
105579319|NCT01349660|364120321|FG000|Overall Study|Non-Permitted Interventions|0|||
105579320|NCT01349660|364120322|FG001|Overall Study|Non-Permitted Interventions|0|||
105579321|NCT01349660|364120323|FG002|Overall Study|Non-Permitted Interventions|2|||
105579322|NCT01349660|364120321|FG000|Overall Study|Study Compliance|0|||
105579323|NCT01349660|364120322|FG001|Overall Study|Study Compliance|0|||
105579324|NCT01349660|364120323|FG002|Overall Study|Study Compliance|1|||
105579325|NCT01349660|364120321|FG000|Overall Study|Declining Performance Status|0|||
105579326|NCT01349660|364120322|FG001|Overall Study|Declining Performance Status|0|||
105579327|NCT01349660|364120323|FG002|Overall Study|Declining Performance Status|1|||
105579328|NCT05764239|364120325|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
105579329|NCT05764239|364120325|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
105579330|NCT05764239|364120325|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
105579331|NCT05764239|364120325|FG000|DEP (Part 1)|Adverse Event|1|||
105579332|NCT05764239|364120325|FG000|DEP (Part 1)|Lost to Follow-up|1|||
105579333|NCT05764239|364120325|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
105579334|NCT05764239|364120325|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
105579335|NCT05764239|364120325|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
105579336|NCT05764239|364120325|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
105579337|NCT00057811|364120326|FG000|Overall Study|Lack of Efficacy|1|||
105579338|NCT00057811|364120327|FG001|Overall Study|Lack of Efficacy|4|||
105579339|NCT00057811|364120326|FG000|Overall Study|Physician Decision|1|||
105579340|NCT00057811|364120327|FG001|Overall Study|Physician Decision|0|||
105579341|NCT00057811|364120326|FG000|Overall Study|Withdrawal by Subject|3|||
105579342|NCT00057811|364120327|FG001|Overall Study|Withdrawal by Subject|4|||
105579343|NCT00057811|364120326|FG000|Overall Study|Ineligible|4|||
105579344|NCT00057811|364120327|FG001|Overall Study|Ineligible|2|||
105579345|NCT00057811|364120326|FG000|Overall Study|Inevaluable|1|||
105579346|NCT00057811|364120327|FG001|Overall Study|Inevaluable|2|||
105579347|NCT00663962|364120330|FG000|Overall Study|somnolence|1|||
105579348|NCT00663962|364120331|FG001|Overall Study|somnolence|0|||
105579349|NCT02218489|364120332|FG000|Overall Study|Withdrawal by Subject|4|||
105579350|NCT02218489|364120333|FG001|Overall Study|Withdrawal by Subject|3|||
105579351|NCT02218489|364120332|FG000|Overall Study|Lost to Follow-up|1|||
105579352|NCT02218489|364120333|FG001|Overall Study|Lost to Follow-up|0|||
105579353|NCT01815736|364120334|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
105579354|NCT01815736|364120335|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
105378298|NCT00541229|363390759|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
105378299|NCT00541229|363390760|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
105378300|NCT00541229|363390755|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
105378301|NCT00541229|363390756|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
105378302|NCT00541229|363390757|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
105378303|NCT00541229|363390758|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
105378304|NCT00541229|363390759|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
105378305|NCT00541229|363390760|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
105378306|NCT00541229|363390755|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
105378307|NCT00541229|363390756|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
105378308|NCT00541229|363390757|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
105378309|NCT00541229|363390758|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
105579355|NCT01815736|364120334|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
105579356|NCT01815736|364120335|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
105579357|NCT01815736|364120334|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
105579358|NCT01815736|364120335|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
105579359|NCT01815736|364120334|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
105579360|NCT01815736|364120335|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
105579361|NCT01815736|364120334|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
105579362|NCT01815736|364120335|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
105579363|NCT01815736|364120334|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
105579364|NCT01815736|364120335|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
105579365|NCT01815736|364120334|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
105579366|NCT01815736|364120335|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
105579367|NCT01815736|364120334|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
105378310|NCT00541229|363390759|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
105378311|NCT00541229|363390760|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
105378312|NCT00541229|363390755|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
105378313|NCT00541229|363390756|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
105378314|NCT00541229|363390757|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
105378315|NCT00541229|363390758|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
105378316|NCT00541229|363390759|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
105579368|NCT01815736|364120335|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
105579369|NCT01815736|364120334|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
105579370|NCT01815736|364120335|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
105579371|NCT01815736|364120334|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
105579372|NCT01815736|364120335|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
105579373|NCT01815736|364120334|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
105579374|NCT01815736|364120335|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
105579375|NCT01815736|364120334|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
105579376|NCT01815736|364120335|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
105579377|NCT01815736|364120334|FG000|Extension Treatment Phase- After Week 96|Death|1|||
105579378|NCT01815736|364120335|FG001|Extension Treatment Phase- After Week 96|Death|0|||
105579379|NCT03040687|364120336|FG000|Overall Study|Withdrawal by Subject|1|||
105579380|NCT03040687|364120337|FG001|Overall Study|Withdrawal by Subject|0|||
105579381|NCT03040687|364120338|FG002|Overall Study|Withdrawal by Subject|0|||
105579382|NCT00550173|364120339|FG000|Overall Study|Death|45|||
105579383|NCT00550173|364120340|FG001|Overall Study|Death|38|||
105579384|NCT00550173|364120341|FG002|Overall Study|Death|50|||
105579385|NCT00550173|364120339|FG000|Overall Study|Physician Decision|1|||
105579386|NCT00550173|364120340|FG001|Overall Study|Physician Decision|2|||
105579387|NCT00550173|364120341|FG002|Overall Study|Physician Decision|2|||
105579388|NCT00550173|364120339|FG000|Overall Study|Withdrawal by Subject|9|||
105579389|NCT00550173|364120340|FG001|Overall Study|Withdrawal by Subject|12|||
105579390|NCT00550173|364120341|FG002|Overall Study|Withdrawal by Subject|17|||
105579391|NCT00550173|364120339|FG000|Overall Study|Sponsor Decision|13|||
105579392|NCT00550173|364120340|FG001|Overall Study|Sponsor Decision|7|||
105579393|NCT00550173|364120341|FG002|Overall Study|Sponsor Decision|1|||
105579394|NCT00550173|364120339|FG000|Overall Study|Lost to Follow-up|4|||
105579395|NCT00550173|364120340|FG001|Overall Study|Lost to Follow-up|4|||
105579396|NCT00550173|364120341|FG002|Overall Study|Lost to Follow-up|3|||
105579397|NCT00810641|364120342|FG000|Overall Study|Withdrawal by Subject|0|||
105579398|NCT00810641|364120343|FG001|Overall Study|Withdrawal by Subject|1|||
105579399|NCT00810641|364120344|FG002|Overall Study|Withdrawal by Subject|2|||
105579400|NCT02325713|364120345|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
105579401|NCT02325713|364120346|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
105579402|NCT02325713|364120347|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
105579403|NCT02325713|364120348|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
105579404|NCT02325713|364120349|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
105579405|NCT02325713|364120350|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
105579406|NCT02325713|364120351|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
105579407|NCT02325713|364120352|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
105579408|NCT02325713|364120353|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
105378317|NCT00541229|363390760|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
105378318|NCT00541229|363390755|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
105378319|NCT00541229|363390756|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
105378320|NCT00541229|363390757|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
105378321|NCT00541229|363390758|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
105378322|NCT00541229|363390759|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
105378323|NCT00541229|363390760|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
105378324|NCT00541229|363390755|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
105378325|NCT00541229|363390756|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
105378326|NCT00541229|363390757|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
105378327|NCT00541229|363390758|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
105579409|NCT02325713|364120354|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
105579410|NCT02325713|364120355|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
105579411|NCT02325713|364120356|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
105579412|NCT02325713|364120357|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
105579413|NCT02325713|364120358|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
105579414|NCT02325713|364120359|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
105579415|NCT02325713|364120360|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
105579416|NCT02325713|364120345|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
105579417|NCT02325713|364120346|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105579418|NCT02325713|364120347|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105378328|NCT00541229|363390759|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
105378329|NCT00541229|363390760|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
105378330|NCT00541229|363390755|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
105378331|NCT00541229|363390756|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
105378332|NCT00541229|363390757|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
105378333|NCT00541229|363390758|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
105378334|NCT00541229|363390759|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
105378335|NCT00541229|363390760|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
105378336|NCT00541229|363390755|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
105378337|NCT00541229|363390756|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
105378338|NCT00541229|363390757|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
105492347|NCT02180165|363815723|FG002|Overall Study|Withdrawal by Subject|2|||
105579419|NCT02325713|364120348|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105579420|NCT02325713|364120349|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105579421|NCT02325713|364120350|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105579422|NCT02325713|364120351|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105579423|NCT02325713|364120352|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105579424|NCT02325713|364120353|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105579425|NCT02325713|364120354|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105579426|NCT02325713|364120355|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105579427|NCT02325713|364120356|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105579428|NCT02325713|364120357|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105579429|NCT02325713|364120358|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105579430|NCT02325713|364120359|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105579431|NCT02325713|364120360|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105579432|NCT02325713|364120345|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
105579433|NCT02325713|364120346|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
105579434|NCT02325713|364120347|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
105579435|NCT02325713|364120348|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
105579436|NCT02325713|364120349|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
105579437|NCT02325713|364120350|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
105579438|NCT02325713|364120351|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
105579439|NCT02325713|364120352|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
105579440|NCT02325713|364120353|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
105579441|NCT02325713|364120354|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
105579442|NCT02325713|364120355|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
105579443|NCT02325713|364120356|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
105579444|NCT02325713|364120357|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
105579445|NCT02325713|364120358|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
105579446|NCT02325713|364120359|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
105579447|NCT02325713|364120360|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
105579448|NCT01213173|364120362|FG000|Overall Study|Protocol Violation|2|||
105579449|NCT01213173|364120363|FG001|Overall Study|Protocol Violation|0|||
105579450|NCT01213173|364120362|FG000|Overall Study|Adverse Event|4|||
105579451|NCT01213173|364120363|FG001|Overall Study|Adverse Event|8|||
105579452|NCT01213173|364120362|FG000|Overall Study|Withdrawal by Subject|5|||
105579453|NCT01213173|364120363|FG001|Overall Study|Withdrawal by Subject|5|||
105579454|NCT01213173|364120362|FG000|Overall Study|Incorrect Enrollment|1|||
105579455|NCT01213173|364120363|FG001|Overall Study|Incorrect Enrollment|3|||
105579456|NCT02353832|364120366|FG000|Overall Study|Ineligible after enrollment|1|||
105579457|NCT02353832|364120366|FG000|Overall Study|Lost to Follow-up|1|||
105579458|NCT02684903|364120367|FG000|Overall Study|COVID-19 shutdown of lab|4|||
105579459|NCT02684903|364120368|FG001|Overall Study|COVID-19 shutdown of lab|6|||
105579460|NCT02684903|364120367|FG000|Overall Study|Lost to Follow-up|31|||
105579461|NCT02684903|364120368|FG001|Overall Study|Lost to Follow-up|41|||
105579462|NCT00904150|364120369|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
105579463|NCT00904150|364120370|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
105579464|NCT00904150|364120369|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
105579465|NCT00904150|364120370|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
105579466|NCT04880161|364120371|FG000|Overall Study|Withdrawal by Subject|1|||
105579467|NCT04880161|364120372|FG001|Overall Study|Withdrawal by Subject|0|||
105579468|NCT04880161|364120371|FG000|Overall Study|Lack of Compliance|1|||
105579469|NCT04880161|364120372|FG001|Overall Study|Lack of Compliance|1|||
105579470|NCT04880161|364120371|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
105579471|NCT04880161|364120372|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
105579472|NCT04880161|364120371|FG000|Overall Study|Screen Failure|0|||
105579473|NCT04880161|364120372|FG001|Overall Study|Screen Failure|1|||
105579474|NCT01354106|364120373|FG000|Overall Study|Withdrawal by Subject|2|||
105579475|NCT01040780|364122275|FG000|Overall Study|Protocol Violation|1|||
105579476|NCT01040780|364122276|FG001|Overall Study|Protocol Violation|3|||
105579477|NCT03681639|364122277|FG000|Overall Study|Death|4|||
105378339|NCT00541229|363390758|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
105378340|NCT00541229|363390759|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
105378341|NCT00541229|363390760|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
105378342|NCT00541229|363390755|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
105378343|NCT00541229|363390756|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
105378344|NCT00541229|363390757|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
105378345|NCT00541229|363390758|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
105378346|NCT00541229|363390759|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
105378347|NCT00541229|363390760|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
105378348|NCT00541229|363390755|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
105378349|NCT00541229|363390756|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
105378350|NCT00541229|363390757|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
105378351|NCT00541229|363390758|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
105378352|NCT00541229|363390759|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
105378353|NCT00541229|363390760|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
105378354|NCT00541229|363390755|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
105378355|NCT00541229|363390756|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
105378356|NCT00541229|363390757|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
105378357|NCT00541229|363390758|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
105378358|NCT00541229|363390759|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
105378359|NCT00541229|363390760|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
105378360|NCT00541229|363390755|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
105378361|NCT00541229|363390756|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
105378362|NCT00541229|363390757|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
105378363|NCT00541229|363390758|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
105378364|NCT00541229|363390759|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
105378365|NCT00541229|363390760|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
105378366|NCT00541229|363390755|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
105378367|NCT00541229|363390756|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
105378368|NCT00541229|363390757|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
105378369|NCT00541229|363390758|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
105378370|NCT00541229|363390759|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
105378371|NCT00541229|363390760|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
105378372|NCT00541229|363390755|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
105378373|NCT00541229|363390756|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
105378374|NCT00541229|363390757|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
105378375|NCT00541229|363390758|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
105378376|NCT00541229|363390759|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
105378377|NCT00541229|363390760|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
105378378|NCT03439839|363390761|FG000|Overall Study|Death|3|||
105378379|NCT03439839|363390762|FG001|Overall Study|Death|0|||
105378380|NCT03807843|363390763|FG000|Overall Study|Lost to Follow-up|1|||
105378381|NCT03807843|363390764|FG001|Overall Study|Lost to Follow-up|0|||
105378382|NCT01312129|363390765|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
105378383|NCT01312129|363390766|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
105378384|NCT01847209|363390767|FG000|Overall Study|Withdrawal by Subject|1|||
105378385|NCT01847209|363390767|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
105378386|NCT02008370|363390788|FG000|Overall Study|Lost to Follow-up|7|||
105378387|NCT00972738|363390789|FG000|Overall Study|Adverse Event|7|||
105378388|NCT00972738|363390790|FG001|Overall Study|Adverse Event|1|||
105378389|NCT00972738|363390791|FG002|Overall Study|Adverse Event|8|||
105378390|NCT00972738|363390789|FG000|Overall Study|Protocol Violation|2|||
105378391|NCT00972738|363390790|FG001|Overall Study|Protocol Violation|1|||
105378392|NCT00972738|363390791|FG002|Overall Study|Protocol Violation|3|||
105378393|NCT00972738|363390789|FG000|Overall Study|Lost to Follow-up|1|||
105378394|NCT00972738|363390790|FG001|Overall Study|Lost to Follow-up|0|||
105378395|NCT00972738|363390791|FG002|Overall Study|Lost to Follow-up|1|||
105378396|NCT00972738|363390789|FG000|Overall Study|Lack of Efficacy|5|||
105378397|NCT00972738|363390790|FG001|Overall Study|Lack of Efficacy|1|||
105579478|NCT03681639|364122277|FG000|Overall Study|Lost to Follow-up|2|||
105579479|NCT03681639|364122277|FG000|Overall Study|Withdrawal by Subject|1|||
105579480|NCT03681639|364122277|FG000|Overall Study|Adverse Event|2|||
105579481|NCT00654940|364122278|FG000|Period 1|Adverse Event|0|||
105579482|NCT00654940|364122279|FG001|Period 1|Adverse Event|1|||
105579483|NCT00654940|364122278|FG000|Period 1|Intolerable Pain Level|1|||
105579484|NCT00654940|364122279|FG001|Period 1|Intolerable Pain Level|0|||
105579485|NCT00802737|364122280|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
105579486|NCT00802737|364122281|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
105378398|NCT00972738|363390791|FG002|Overall Study|Lack of Efficacy|11|||
105378399|NCT00972738|363390789|FG000|Overall Study|Withdrawal by Subject|5|||
105579487|NCT00802737|364122282|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
105579488|NCT00802737|364122280|FG000|Overall Study|Death|6|||
105579489|NCT00802737|364122281|FG001|Overall Study|Death|5|||
105579490|NCT00802737|364122282|FG002|Overall Study|Death|1|||
105579491|NCT00802737|364122280|FG000|Overall Study|Adverse Event|1|||
105579492|NCT00802737|364122281|FG001|Overall Study|Adverse Event|0|||
105579493|NCT00802737|364122282|FG002|Overall Study|Adverse Event|0|||
105579494|NCT00802737|364122280|FG000|Overall Study|Received Prohibited Therapy|1|||
105579495|NCT00802737|364122281|FG001|Overall Study|Received Prohibited Therapy|0|||
105579496|NCT00802737|364122282|FG002|Overall Study|Received Prohibited Therapy|0|||
105378400|NCT00972738|363390790|FG001|Overall Study|Withdrawal by Subject|1|||
105378401|NCT00972738|363390791|FG002|Overall Study|Withdrawal by Subject|4|||
105378402|NCT00972738|363390789|FG000|Overall Study|Moved|0|||
105378403|NCT00972738|363390790|FG001|Overall Study|Moved|0|||
105378404|NCT00972738|363390791|FG002|Overall Study|Moved|1|||
105378405|NCT00972738|363390789|FG000|Overall Study|Other|1|||
105378406|NCT00972738|363390790|FG001|Overall Study|Other|2|||
105378407|NCT00972738|363390791|FG002|Overall Study|Other|1|||
105378408|NCT03915067|363390794|FG000|Overall Study|Adverse Event|0|||
105378409|NCT03915067|363390795|FG001|Overall Study|Adverse Event|0|||
105378410|NCT03915067|363390796|FG002|Overall Study|Adverse Event|1|||
105378411|NCT03915067|363390794|FG000|Overall Study|Withdrawal by Subject|4|||
105378412|NCT03915067|363390795|FG001|Overall Study|Withdrawal by Subject|3|||
105378413|NCT03915067|363390796|FG002|Overall Study|Withdrawal by Subject|0|||
105378414|NCT03915067|363390794|FG000|Overall Study|Lost to Follow-up|3|||
105378415|NCT03915067|363390795|FG001|Overall Study|Lost to Follow-up|2|||
105378416|NCT03915067|363390796|FG002|Overall Study|Lost to Follow-up|0|||
105378417|NCT03915067|363390794|FG000|Overall Study|Protocol Deviation|0|||
105378418|NCT03915067|363390795|FG001|Overall Study|Protocol Deviation|0|||
105378419|NCT03915067|363390796|FG002|Overall Study|Protocol Deviation|1|||
105378420|NCT03915067|363390794|FG000|Overall Study|Covid-19 Related Issues|2|||
105378421|NCT03915067|363390795|FG001|Overall Study|Covid-19 Related Issues|4|||
105378422|NCT03915067|363390796|FG002|Overall Study|Covid-19 Related Issues|4|||
105378423|NCT03915067|363390794|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
105378424|NCT03915067|363390795|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
105378425|NCT03915067|363390796|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
105378426|NCT03317496|363390797|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
105378427|NCT03317496|363390798|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
105378428|NCT03317496|363390799|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
105378429|NCT03317496|363390800|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
105378430|NCT03317496|363390801|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
105378431|NCT03317496|363390797|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
105378432|NCT03317496|363390798|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
105378433|NCT03317496|363390799|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
105378434|NCT03317496|363390800|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
105378435|NCT03317496|363390801|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
105378436|NCT03317496|363390797|FG000|Phase 1b Lead-in: Treatment|Death|0|||
105378437|NCT03317496|363390798|FG001|Phase 1b Lead-in: Treatment|Death|0|||
105378438|NCT03317496|363390799|FG002|Phase 1b Lead-in: Treatment|Death|1|||
105378439|NCT03317496|363390800|FG003|Phase 1b Lead-in: Treatment|Death|0|||
105378440|NCT03317496|363390801|FG004|Phase 1b Lead-in: Treatment|Death|0|||
105378441|NCT03317496|363390797|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
105378442|NCT03317496|363390798|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
105378443|NCT03317496|363390799|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
105378444|NCT03317496|363390800|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
105378445|NCT03317496|363390801|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
105378446|NCT03317496|363390797|FG000|Phase 1b Lead-in: Treatment|Other|2|||
105378447|NCT03317496|363390798|FG001|Phase 1b Lead-in: Treatment|Other|1|||
105378448|NCT03317496|363390799|FG002|Phase 1b Lead-in: Treatment|Other|0|||
105378449|NCT03317496|363390800|FG003|Phase 1b Lead-in: Treatment|Other|0|||
105378450|NCT03317496|363390801|FG004|Phase 1b Lead-in: Treatment|Other|0|||
105378451|NCT03317496|363390797|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
105378452|NCT03317496|363390798|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
105378453|NCT03317496|363390799|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
105378454|NCT03317496|363390800|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
105378455|NCT03317496|363390801|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
105378456|NCT03317496|363390797|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
105378457|NCT03317496|363390798|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
105378458|NCT03317496|363390799|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
105378459|NCT03317496|363390800|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
105378460|NCT03317496|363390801|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
105378461|NCT03317496|363390797|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
105378462|NCT03317496|363390798|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
105579497|NCT00802737|364122280|FG000|Overall Study|Ongoing CLL-Treatment|0|||
105579498|NCT00802737|364122281|FG001|Overall Study|Ongoing CLL-Treatment|1|||
105579499|NCT00802737|364122282|FG002|Overall Study|Ongoing CLL-Treatment|0|||
105378463|NCT03317496|363390799|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
105378464|NCT03317496|363390800|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
105378465|NCT03317496|363390801|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
105378466|NCT03317496|363390797|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
105378467|NCT03317496|363390798|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
105378468|NCT03317496|363390799|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
105378469|NCT03317496|363390800|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
105378470|NCT03317496|363390801|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
105378471|NCT03317496|363390797|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
105378472|NCT03317496|363390798|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
105378473|NCT03317496|363390799|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
105378474|NCT03317496|363390800|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
105378475|NCT03317496|363390801|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
105378476|NCT03317496|363390797|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
105378477|NCT03317496|363390798|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
105579500|NCT00802737|364122280|FG000|Overall Study|Participant too Unwell|0|||
105579501|NCT00802737|364122281|FG001|Overall Study|Participant too Unwell|2|||
105579502|NCT00802737|364122282|FG002|Overall Study|Participant too Unwell|0|||
105579503|NCT02906683|364122283|FG000|Overall Study|Adverse Event|0|||
105579504|NCT02906683|364122284|FG001|Overall Study|Adverse Event|1|||
105579505|NCT02906683|364122285|FG002|Overall Study|Adverse Event|0|||
105579506|NCT02906683|364122283|FG000|Overall Study|Physician Decision|0|||
105579507|NCT02906683|364122284|FG001|Overall Study|Physician Decision|1|||
105579508|NCT02906683|364122285|FG002|Overall Study|Physician Decision|1|||
105579509|NCT02906683|364122283|FG000|Overall Study|Withdrawal by Subject|0|||
105579510|NCT02906683|364122284|FG001|Overall Study|Withdrawal by Subject|2|||
105579511|NCT02906683|364122285|FG002|Overall Study|Withdrawal by Subject|1|||
105579512|NCT02906683|364122283|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
105579513|NCT02906683|364122284|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
105579514|NCT02906683|364122285|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
105579515|NCT02906683|364122283|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
105579516|NCT02906683|364122284|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
105579517|NCT02906683|364122285|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
105579518|NCT04714216|364122286|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
105579519|NCT04714216|364122286|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
105579520|NCT00619476|364122289|FG000|Overall Study|Adverse Event|12|||
105579521|NCT00619476|364122290|FG001|Overall Study|Adverse Event|6|||
105579522|NCT00619476|364122291|FG002|Overall Study|Adverse Event|12|||
105579523|NCT00619476|364122292|FG003|Overall Study|Adverse Event|16|||
105579524|NCT00619476|364122289|FG000|Overall Study|Lack of Efficacy|6|||
105579525|NCT00619476|364122290|FG001|Overall Study|Lack of Efficacy|1|||
105579526|NCT00619476|364122291|FG002|Overall Study|Lack of Efficacy|1|||
105378478|NCT03317496|363390799|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
105378479|NCT03317496|363390800|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
105378480|NCT03317496|363390801|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
105378481|NCT03317496|363390797|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
105378482|NCT03317496|363390798|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
105378483|NCT03317496|363390799|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
105378484|NCT03317496|363390800|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
105330487|NCT00529373|363209937|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
105330488|NCT00529373|363209936|FG000|Second Extension Study|Adverse Event|101|||
105330489|NCT00529373|363209937|FG001|Second Extension Study|Adverse Event|51|||
105330490|NCT00529373|363209936|FG000|Second Extension Study|Lack of Efficacy|7|||
105330491|NCT00529373|363209937|FG001|Second Extension Study|Lack of Efficacy|15|||
105330492|NCT00529373|363209936|FG000|Second Extension Study|Lost to Follow-up|18|||
105330493|NCT00529373|363209937|FG001|Second Extension Study|Lost to Follow-up|12|||
105330494|NCT00529373|363209936|FG000|Second Extension Study|Other|7|||
105330495|NCT00529373|363209937|FG001|Second Extension Study|Other|12|||
105330496|NCT00529373|363209936|FG000|Second Extension Study|Physician Decision|63|||
105330497|NCT00529373|363209937|FG001|Second Extension Study|Physician Decision|26|||
105330498|NCT00529373|363209936|FG000|Second Extension Study|Protocol Violation|2|||
105330499|NCT00529373|363209937|FG001|Second Extension Study|Protocol Violation|1|||
105330500|NCT00529373|363209936|FG000|Second Extension Study|Withdrawal by Subject|97|||
105330501|NCT00529373|363209937|FG001|Second Extension Study|Withdrawal by Subject|75|||
105330502|NCT00529373|363209936|FG000|Second Extension Study|Status Missing|5|||
105330503|NCT00529373|363209937|FG001|Second Extension Study|Status Missing|5|||
105330504|NCT01863667|363209944|FG000|Overall Study|Adverse Event|1|||
105330505|NCT01863667|363209945|FG001|Overall Study|Adverse Event|0|||
105330506|NCT01863667|363209944|FG000|Overall Study|Study terminated by Sponsor|30|||
105330507|NCT01863667|363209945|FG001|Overall Study|Study terminated by Sponsor|30|||
105330508|NCT01863667|363209944|FG000|Overall Study|Withdrawal by Subject|2|||
105330509|NCT01863667|363209945|FG001|Overall Study|Withdrawal by Subject|2|||
105330510|NCT00615550|363209946|FG000|Overall Study|Lost to Follow-up|6|||
105330511|NCT00615550|363209947|FG001|Overall Study|Lost to Follow-up|1|||
105330512|NCT02741076|363209948|FG000|Overall Study|Adverse Event|0|||
105330513|NCT02741076|363209949|FG001|Overall Study|Adverse Event|1|||
105330514|NCT02741076|363209950|FG002|Overall Study|Adverse Event|1|||
105330515|NCT02741076|363209951|FG003|Overall Study|Adverse Event|0|||
105330516|NCT02741076|363209948|FG000|Overall Study|Lack of Efficacy|1|||
105330517|NCT02741076|363209949|FG001|Overall Study|Lack of Efficacy|0|||
105330518|NCT02741076|363209950|FG002|Overall Study|Lack of Efficacy|0|||
105330519|NCT02741076|363209951|FG003|Overall Study|Lack of Efficacy|0|||
105330520|NCT02741076|363209948|FG000|Overall Study|Withdrawal by Subject|0|||
105330521|NCT02741076|363209949|FG001|Overall Study|Withdrawal by Subject|1|||
105330522|NCT02741076|363209950|FG002|Overall Study|Withdrawal by Subject|0|||
105330523|NCT02741076|363209951|FG003|Overall Study|Withdrawal by Subject|0|||
105330524|NCT02741076|363209948|FG000|Overall Study|Sponsor Request|2|||
105330525|NCT02741076|363209949|FG001|Overall Study|Sponsor Request|3|||
105330526|NCT02741076|363209950|FG002|Overall Study|Sponsor Request|0|||
105330527|NCT02741076|363209951|FG003|Overall Study|Sponsor Request|1|||
105330528|NCT02741076|363209948|FG000|Overall Study|No additional information available|0|||
105330529|NCT02741076|363209949|FG001|Overall Study|No additional information available|0|||
105330530|NCT02741076|363209950|FG002|Overall Study|No additional information available|1|||
105330531|NCT02741076|363209951|FG003|Overall Study|No additional information available|1|||
105330532|NCT00315458|363209952|FG000|Overall Study|Administrative|0|||
105330533|NCT00315458|363209953|FG001|Overall Study|Administrative|3|||
105330534|NCT00315458|363209954|FG002|Overall Study|Administrative|8|||
105330535|NCT00315458|363209955|FG003|Overall Study|Administrative|21|||
105330536|NCT00315458|363209952|FG000|Overall Study|Adverse Event|2|||
105330537|NCT00315458|363209953|FG001|Overall Study|Adverse Event|4|||
105330538|NCT00315458|363209954|FG002|Overall Study|Adverse Event|23|||
105330539|NCT00315458|363209955|FG003|Overall Study|Adverse Event|3|||
105330540|NCT00315458|363209952|FG000|Overall Study|Lost to Follow-up|1|||
105330541|NCT00315458|363209953|FG001|Overall Study|Lost to Follow-up|2|||
105330542|NCT00315458|363209954|FG002|Overall Study|Lost to Follow-up|0|||
105330543|NCT00315458|363209955|FG003|Overall Study|Lost to Follow-up|2|||
105330544|NCT00315458|363209952|FG000|Overall Study|Withdrawal by Subject|0|||
105330545|NCT00315458|363209953|FG001|Overall Study|Withdrawal by Subject|3|||
105330546|NCT00315458|363209954|FG002|Overall Study|Withdrawal by Subject|0|||
105330547|NCT00315458|363209955|FG003|Overall Study|Withdrawal by Subject|2|||
105330548|NCT00315458|363209952|FG000|Overall Study|Lack of Efficacy|0|||
105330549|NCT00315458|363209953|FG001|Overall Study|Lack of Efficacy|0|||
105330550|NCT00315458|363209954|FG002|Overall Study|Lack of Efficacy|20|||
105330551|NCT00315458|363209955|FG003|Overall Study|Lack of Efficacy|1|||
105378485|NCT03317496|363390801|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
105378486|NCT03317496|363390797|FG000|Phase 2: Treatment|Adverse Event|0|||
105378487|NCT03317496|363390798|FG001|Phase 2: Treatment|Adverse Event|0|||
105579527|NCT00619476|364122292|FG003|Overall Study|Lack of Efficacy|4|||
105579528|NCT00619476|364122289|FG000|Overall Study|Protocol Violation|5|||
105579529|NCT00619476|364122290|FG001|Overall Study|Protocol Violation|4|||
105579530|NCT00619476|364122291|FG002|Overall Study|Protocol Violation|4|||
105579531|NCT00619476|364122292|FG003|Overall Study|Protocol Violation|9|||
105579532|NCT00619476|364122289|FG000|Overall Study|Lost to Follow-up|1|||
105579533|NCT00619476|364122290|FG001|Overall Study|Lost to Follow-up|2|||
105579534|NCT00619476|364122291|FG002|Overall Study|Lost to Follow-up|0|||
105579535|NCT00619476|364122292|FG003|Overall Study|Lost to Follow-up|1|||
105579536|NCT00619476|364122289|FG000|Overall Study|Investigator Discretion|2|||
105579537|NCT00619476|364122290|FG001|Overall Study|Investigator Discretion|2|||
105579538|NCT00619476|364122291|FG002|Overall Study|Investigator Discretion|2|||
105579539|NCT00619476|364122292|FG003|Overall Study|Investigator Discretion|0|||
105378488|NCT03317496|363390799|FG002|Phase 2: Treatment|Adverse Event|0|||
105378489|NCT03317496|363390800|FG003|Phase 2: Treatment|Adverse Event|0|||
105378490|NCT03317496|363390801|FG004|Phase 2: Treatment|Adverse Event|6|||
105378491|NCT03317496|363390797|FG000|Phase 2: Treatment|Progressive disease|0|||
105378492|NCT03317496|363390798|FG001|Phase 2: Treatment|Progressive disease|0|||
105378493|NCT03317496|363390799|FG002|Phase 2: Treatment|Progressive disease|0|||
105378494|NCT03317496|363390800|FG003|Phase 2: Treatment|Progressive disease|0|||
105378495|NCT03317496|363390801|FG004|Phase 2: Treatment|Progressive disease|22|||
105378496|NCT03317496|363390797|FG000|Phase 2: Treatment|Other|0|||
105378497|NCT03317496|363390798|FG001|Phase 2: Treatment|Other|0|||
105378498|NCT03317496|363390799|FG002|Phase 2: Treatment|Other|0|||
105378499|NCT03317496|363390800|FG003|Phase 2: Treatment|Other|0|||
105378500|NCT03317496|363390801|FG004|Phase 2: Treatment|Other|4|||
105378501|NCT03317496|363390797|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
105378502|NCT03317496|363390798|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
105378503|NCT03317496|363390799|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
105378504|NCT03317496|363390800|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
105378505|NCT03317496|363390801|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
105378506|NCT03317496|363390797|FG000|Phase 2: Treatment|Physician Decision|0|||
105378507|NCT03317496|363390798|FG001|Phase 2: Treatment|Physician Decision|0|||
105378508|NCT03317496|363390799|FG002|Phase 2: Treatment|Physician Decision|0|||
105378509|NCT03317496|363390800|FG003|Phase 2: Treatment|Physician Decision|0|||
105378510|NCT03317496|363390801|FG004|Phase 2: Treatment|Physician Decision|1|||
105378511|NCT03317496|363390797|FG000|Phase 2: Treatment|Death|0|||
105378512|NCT03317496|363390798|FG001|Phase 2: Treatment|Death|0|||
105378513|NCT03317496|363390799|FG002|Phase 2: Treatment|Death|0|||
105378514|NCT03317496|363390800|FG003|Phase 2: Treatment|Death|0|||
105378515|NCT03317496|363390801|FG004|Phase 2: Treatment|Death|1|||
105378516|NCT03317496|363390797|FG000|Phase 2: Follow-up|Death|0|||
105378517|NCT03317496|363390798|FG001|Phase 2: Follow-up|Death|0|||
105378518|NCT03317496|363390799|FG002|Phase 2: Follow-up|Death|0|||
105378519|NCT03317496|363390800|FG003|Phase 2: Follow-up|Death|0|||
105378520|NCT03317496|363390801|FG004|Phase 2: Follow-up|Death|24|||
105378521|NCT03317496|363390797|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
105378522|NCT03317496|363390798|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
105378523|NCT03317496|363390799|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
105378524|NCT03317496|363390800|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
105378525|NCT03317496|363390801|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
105378526|NCT03317496|363390797|FG000|Phase 2: Follow-up|Other|0|||
105378527|NCT03317496|363390798|FG001|Phase 2: Follow-up|Other|0|||
105378528|NCT03317496|363390799|FG002|Phase 2: Follow-up|Other|0|||
105378529|NCT03317496|363390800|FG003|Phase 2: Follow-up|Other|0|||
105378530|NCT03317496|363390801|FG004|Phase 2: Follow-up|Other|1|||
105378531|NCT03317496|363390797|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
105579540|NCT00619476|364122289|FG000|Overall Study|Withdrawal by Subject|5|||
105378532|NCT03317496|363390798|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
105579541|NCT00619476|364122290|FG001|Overall Study|Withdrawal by Subject|7|||
105579542|NCT00619476|364122291|FG002|Overall Study|Withdrawal by Subject|5|||
105579543|NCT00619476|364122292|FG003|Overall Study|Withdrawal by Subject|4|||
105579544|NCT03204695|364122295|FG000|Overall Study|Death|1|||
105378533|NCT03317496|363390799|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
105579545|NCT03204695|364122295|FG000|Overall Study|Participant was treated with another device|1|||
105378534|NCT03317496|363390800|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
105378535|NCT03317496|363390801|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
105378536|NCT02693418|363390802|FG000|Overall Study|Lost to Follow-up|1|||
105378537|NCT02693418|363390803|FG001|Overall Study|Lost to Follow-up|2|||
105378538|NCT02693418|363390804|FG002|Overall Study|Lost to Follow-up|0|||
105378539|NCT02693418|363390805|FG003|Overall Study|Lost to Follow-up|0|||
105378540|NCT02693418|363390806|FG004|Overall Study|Lost to Follow-up|0|||
105378541|NCT02693418|363390802|FG000|Overall Study|Menses during study period|0|||
105378542|NCT02693418|363390803|FG001|Overall Study|Menses during study period|0|||
105378543|NCT02693418|363390804|FG002|Overall Study|Menses during study period|2|||
105378544|NCT02693418|363390805|FG003|Overall Study|Menses during study period|0|||
105378545|NCT02693418|363390806|FG004|Overall Study|Menses during study period|0|||
105378546|NCT02513199|363390807|FG000|Treatment|Death|1|||
105378547|NCT02513199|363390807|FG000|Treatment|Lost to Follow-up|1|||
105378548|NCT02513199|363390807|FG000|Follow-Up|Death|11|||
105378549|NCT01750346|363390809|FG000|Overall Study|Adverse Event|1|||
105378550|NCT01750346|363390810|FG001|Overall Study|Adverse Event|0|||
105378551|NCT01750346|363390811|FG002|Overall Study|Adverse Event|0|||
105378552|NCT01001104|363390812|FG000|Overall Study|Adverse Event|2|||
105378553|NCT01001104|363390813|FG001|Overall Study|Adverse Event|1|||
105378554|NCT01001104|363390814|FG002|Overall Study|Adverse Event|0|||
105378555|NCT01001104|363390815|FG003|Overall Study|Adverse Event|0|||
105378556|NCT01001104|363390812|FG000|Overall Study|Lost to Follow-up|0|||
105378557|NCT01001104|363390813|FG001|Overall Study|Lost to Follow-up|0|||
105378558|NCT01001104|363390814|FG002|Overall Study|Lost to Follow-up|1|||
105378559|NCT01001104|363390815|FG003|Overall Study|Lost to Follow-up|0|||
105378560|NCT01001104|363390812|FG000|Overall Study|Entry Criteria Not Met|0|||
105579546|NCT03204695|364122295|FG000|Overall Study|Physician Decision|2|||
105378561|NCT01001104|363390813|FG001|Overall Study|Entry Criteria Not Met|0|||
105378562|NCT01001104|363390814|FG002|Overall Study|Entry Criteria Not Met|0|||
105378563|NCT01001104|363390815|FG003|Overall Study|Entry Criteria Not Met|1|||
105378564|NCT01001104|363390812|FG000|Overall Study|Withdrawal by Subject|0|||
105378565|NCT01001104|363390813|FG001|Overall Study|Withdrawal by Subject|0|||
105378566|NCT01001104|363390814|FG002|Overall Study|Withdrawal by Subject|0|||
105378567|NCT01001104|363390815|FG003|Overall Study|Withdrawal by Subject|2|||
105378568|NCT02034591|363390817|FG000|Overall Study|Withdrawal by Subject|0|||
105378569|NCT02034591|363390818|FG001|Overall Study|Withdrawal by Subject|0|||
105378570|NCT02034591|363390819|FG002|Overall Study|Withdrawal by Subject|0|||
105378571|NCT02034591|363390820|FG003|Overall Study|Withdrawal by Subject|0|||
105378572|NCT02034591|363390821|FG004|Overall Study|Withdrawal by Subject|1|||
105378573|NCT02034591|363390822|FG005|Overall Study|Withdrawal by Subject|0|||
105378574|NCT00599313|363390825|FG000|Overall Study|Adverse Event|19|||
105378575|NCT00599313|363390825|FG000|Overall Study|Disease Progression|12|||
105378576|NCT00599313|363390825|FG000|Overall Study|Patient Request|4|||
105378577|NCT00599313|363390825|FG000|Overall Study|Ineligible|1|||
105378578|NCT01793935|363390826|FG000|Overall Study|Pregnancy|1|||
105378579|NCT01793935|363390827|FG001|Overall Study|Pregnancy|0|||
105378580|NCT01793935|363390826|FG000|Overall Study|Protocol Violation|2|||
105378581|NCT01793935|363390827|FG001|Overall Study|Protocol Violation|1|||
105378582|NCT01793935|363390826|FG000|Overall Study|Adverse Event|2|||
105378583|NCT01793935|363390827|FG001|Overall Study|Adverse Event|0|||
105378584|NCT01793935|363390826|FG000|Overall Study|Patient did not take study medication|1|||
105378585|NCT01793935|363390827|FG001|Overall Study|Patient did not take study medication|1|||
105378586|NCT01793935|363390826|FG000|Overall Study|Lost to Follow-up|0|||
105378587|NCT01793935|363390827|FG001|Overall Study|Lost to Follow-up|1|||
105378588|NCT04137887|363390831|FG000|Overall Study|Death|102|||
105378589|NCT04137887|363390832|FG001|Overall Study|Death|92|||
105378590|NCT04137887|363390831|FG000|Overall Study|Withdrawal by Subject|2|||
105378591|NCT04137887|363390832|FG001|Overall Study|Withdrawal by Subject|3|||
105378592|NCT04137887|363390831|FG000|Overall Study|Randomized but not treated|0|||
105579547|NCT04834362|364122296|FG000|Overall Study|Death|1|||
105378593|NCT04137887|363390832|FG001|Overall Study|Randomized but not treated|1|||
105378594|NCT00313170|363390834|FG000|Overall Study|Death|2|||
105378595|NCT00313170|363390835|FG001|Overall Study|Death|4|||
105378596|NCT00313170|363390836|FG002|Overall Study|Death|2|||
105378597|NCT00313170|363390834|FG000|Overall Study|Adverse Event|1|||
105378598|NCT00313170|363390835|FG001|Overall Study|Adverse Event|2|||
105378599|NCT00313170|363390836|FG002|Overall Study|Adverse Event|0|||
105378600|NCT00313170|363390834|FG000|Overall Study|Disease progression|31|||
105378601|NCT00313170|363390835|FG001|Overall Study|Disease progression|26|||
105378602|NCT00313170|363390836|FG002|Overall Study|Disease progression|27|||
105378603|NCT00313170|363390834|FG000|Overall Study|Withdrawal by Subject|1|||
105378604|NCT00313170|363390835|FG001|Overall Study|Withdrawal by Subject|0|||
105378605|NCT00313170|363390836|FG002|Overall Study|Withdrawal by Subject|1|||
105378606|NCT00313170|363390834|FG000|Overall Study|Incorrect enrollment|0|||
105378607|NCT00313170|363390835|FG001|Overall Study|Incorrect enrollment|2|||
105378608|NCT00313170|363390836|FG002|Overall Study|Incorrect enrollment|1|||
105378609|NCT00313170|363390834|FG000|Overall Study|Lost to Follow-up|0|||
105378610|NCT00313170|363390835|FG001|Overall Study|Lost to Follow-up|0|||
105330552|NCT00315458|363209952|FG000|Overall Study|Did not qualify|0|||
105330553|NCT00315458|363209953|FG001|Overall Study|Did not qualify|0|||
105330554|NCT00315458|363209954|FG002|Overall Study|Did not qualify|1|||
105330555|NCT00315458|363209955|FG003|Overall Study|Did not qualify|0|||
105330556|NCT02748213|363209956|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
105330557|NCT02748213|363209957|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
105330558|NCT02748213|363209956|FG000|Overall Study|Abnormal Laboratory Test|1|||
105330559|NCT02748213|363209957|FG001|Overall Study|Abnormal Laboratory Test|0|||
105330560|NCT02748213|363209956|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
105330561|NCT02748213|363209957|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
105330562|NCT02748213|363209956|FG000|Overall Study|Death|5|||
105330563|NCT02748213|363209957|FG001|Overall Study|Death|3|||
105330564|NCT02748213|363209956|FG000|Overall Study|Insufficient Therapeutic Response|56|||
105330565|NCT02748213|363209957|FG001|Overall Study|Insufficient Therapeutic Response|57|||
105330566|NCT02748213|363209956|FG000|Overall Study|Violation of Selection Criteria|2|||
105330567|NCT02748213|363209957|FG001|Overall Study|Violation of Selection Criteria|0|||
105330568|NCT02748213|363209956|FG000|Overall Study|Protocol Violation|6|||
105330569|NCT02748213|363209957|FG001|Overall Study|Protocol Violation|4|||
105330570|NCT02748213|363209956|FG000|Overall Study|Refused Treatment*|6|||
105330571|NCT02748213|363209957|FG001|Overall Study|Refused Treatment*|6|||
105330572|NCT02748213|363209956|FG000|Overall Study|Failure to Return|1|||
105330573|NCT02748213|363209957|FG001|Overall Study|Failure to Return|0|||
105330574|NCT02748213|363209956|FG000|Overall Study|Other|30|||
105330575|NCT02748213|363209957|FG001|Overall Study|Other|29|||
105330576|NCT02418182|363209963|FG000|Overall Study|Unable to re-consent|18|||
105330577|NCT02418182|363209964|FG001|Overall Study|Unable to re-consent|15|||
105330578|NCT02418182|363209963|FG000|Overall Study|Lost to Follow-up|0|||
105330579|NCT02418182|363209964|FG001|Overall Study|Lost to Follow-up|2|||
105330580|NCT03668119|363211250|FG000|Pre-treatment|Disease Progression|1|||
105330581|NCT03668119|363211251|FG001|Pre-treatment|Disease Progression|0|||
105330582|NCT03668119|363211250|FG000|Treatment|Disease Progression|76|||
105330583|NCT03668119|363211251|FG001|Treatment|Disease Progression|57|||
105330584|NCT03668119|363211250|FG000|Treatment|Study drug toxicity|19|||
105330585|NCT03668119|363211251|FG001|Treatment|Study drug toxicity|1|||
105330586|NCT03668119|363211250|FG000|Treatment|Death|3|||
105330587|NCT03668119|363211251|FG001|Treatment|Death|0|||
105330588|NCT03668119|363211250|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
105330589|NCT03668119|363211251|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
105330590|NCT03668119|363211250|FG000|Treatment|Withdrawal by Subject|1|||
105330591|NCT03668119|363211251|FG001|Treatment|Withdrawal by Subject|1|||
105330592|NCT03668119|363211250|FG000|Treatment|Participant request to discontinue study treatment|3|||
105330593|NCT03668119|363211251|FG001|Treatment|Participant request to discontinue study treatment|1|||
105330594|NCT03668119|363211250|FG000|Treatment|Maximum Clinical Benefit|0|||
105330595|NCT03668119|363211251|FG001|Treatment|Maximum Clinical Benefit|1|||
105330596|NCT03668119|363211250|FG000|Treatment|Participants completed treatment|27|||
105330597|NCT03668119|363211251|FG001|Treatment|Participants completed treatment|11|||
105330598|NCT03668119|363211250|FG000|Treatment|Other reasons|2|||
105330599|NCT03668119|363211251|FG001|Treatment|Other reasons|1|||
105330600|NCT01068678|363211252|FG000|Overall Study|Lack of Efficacy|3|||
105330601|NCT01068678|363211253|FG001|Overall Study|Lack of Efficacy|2|||
105330602|NCT01068678|363211252|FG000|Overall Study|Protocol Violation|5|||
105330603|NCT01068678|363211253|FG001|Overall Study|Protocol Violation|1|||
105330604|NCT01068678|363211252|FG000|Overall Study|Withdrawal criteria|12|||
105330605|NCT01068678|363211253|FG001|Overall Study|Withdrawal criteria|6|||
105330606|NCT01068678|363211252|FG000|Overall Study|Unclassified|18|||
105330607|NCT01068678|363211253|FG001|Overall Study|Unclassified|15|||
105330608|NCT00347958|363211254|FG000|Overall Study|Adverse Event|1|||
105330609|NCT00347958|363211254|FG000|Overall Study|Protocol Violation|2|||
105330610|NCT00347958|363211254|FG000|Overall Study|Withdrawal by Subject|1|||
105330611|NCT00754234|363211255|FG000|Overall Study|Withdrawal by Subject|3|||
105330612|NCT00975611|363211258|FG000|Overall Study|Screen Fail|16|||
105330613|NCT00975611|363211258|FG000|Overall Study|Physician Decision|1|||
105330614|NCT01102257|363211262|FG000|Overall Study|Adverse Event|1|||
105330615|NCT01102257|363211263|FG001|Overall Study|Adverse Event|0|||
105330616|NCT01102257|363211262|FG000|Overall Study|Adverse Event|1|||
105330617|NCT01102257|363211263|FG001|Overall Study|Adverse Event|0|||
105330618|NCT02530125|363211264|FG000|Completed Treatment|Early termination of study|1|||
105330619|NCT02530125|363211264|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
105330620|NCT01379768|363211265|FG000|Overall Study|Adverse Event|1|||
105330621|NCT01379768|363211266|FG001|Overall Study|Adverse Event|1|||
105330622|NCT01379768|363211267|FG002|Overall Study|Adverse Event|0|||
105330623|NCT01379768|363211265|FG000|Overall Study|Lost to Follow-up|2|||
105330624|NCT01379768|363211266|FG001|Overall Study|Lost to Follow-up|0|||
105330625|NCT01379768|363211267|FG002|Overall Study|Lost to Follow-up|0|||
105330626|NCT00566020|363211271|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
105378611|NCT00313170|363390836|FG002|Overall Study|Lost to Follow-up|1|||
105378612|NCT00313170|363390834|FG000|Overall Study|Progression (investigators opinion)|1|||
105378613|NCT00313170|363390835|FG001|Overall Study|Progression (investigators opinion)|0|||
105378614|NCT00313170|363390836|FG002|Overall Study|Progression (investigators opinion)|0|||
105378615|NCT00898807|363390844|FG000|Overall Study|Withdrawal by Subject|5|||
105378616|NCT00898807|363390845|FG001|Overall Study|Withdrawal by Subject|3|||
105579548|NCT04834362|364122297|FG001|Overall Study|Death|2|||
105579549|NCT03095599|364122300|FG000|Overall Study|Withdrawal by Subject|1|||
105579550|NCT03095599|364122301|FG001|Overall Study|Withdrawal by Subject|0|||
105579551|NCT03095599|364122300|FG000|Overall Study|Lost to Follow-up|1|||
105579552|NCT03095599|364122301|FG001|Overall Study|Lost to Follow-up|0|||
105579553|NCT03095599|364122300|FG000|Overall Study|Withdrawal prior to vaccination|1|||
105579554|NCT03095599|364122301|FG001|Overall Study|Withdrawal prior to vaccination|0|||
105579555|NCT02959138|364122302|FG000|Overall Study|Enrolled but Never Treated|0|||
105579556|NCT02959138|364122303|FG001|Overall Study|Enrolled but Never Treated|1|||
105579557|NCT02959138|364122304|FG002|Overall Study|Enrolled but Never Treated|0|||
105579558|NCT02391038|364122305|FG000|Overall Study|Progressive disease|3|||
105579559|NCT02391038|364122306|FG001|Overall Study|Progressive disease|3|||
105579560|NCT02391038|364122307|FG002|Overall Study|Progressive disease|6|||
105579561|NCT01811563|364122313|FG000|Overall Study|Lost to Follow-up|5|||
105579562|NCT01811563|364122314|FG001|Overall Study|Lost to Follow-up|2|||
105579563|NCT01811563|364122313|FG000|Overall Study|Incorrect Randomization procedure|0|||
105579564|NCT01811563|364122314|FG001|Overall Study|Incorrect Randomization procedure|1|||
105579565|NCT02930122|364122317|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
105579566|NCT02930122|364122318|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
105579567|NCT01004250|364122319|FG000|Induction Therapy Period|Adverse Event|10|||
105579568|NCT01004250|364122319|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
105579569|NCT01004250|364122319|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
105579570|NCT01004250|364122319|FG000|Induction Therapy Period|Physician Decision|2|||
105579571|NCT01004250|364122319|FG000|Maintenance Therapy Period|Adverse Event|15|||
105579572|NCT01004250|364122319|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
105579573|NCT01004250|364122319|FG000|Maintenance Therapy Period|Protocol Violation|1|||
105579574|NCT01004250|364122319|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
105579575|NCT01004250|364122319|FG000|Maintenance Therapy Period|Physician Decision|4|||
105579576|NCT01004250|364122319|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
105579577|NCT01853254|364122320|FG000|Overall Study|Abnormal Laboratory Test|1|||
105579578|NCT01853254|364122320|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
105579579|NCT01853254|364122320|FG000|Overall Study|Death|1|||
105579580|NCT01853254|364122320|FG000|Overall Study|Failure to Return|43|||
105579581|NCT01853254|364122320|FG000|Overall Study|Insufficient Therapeutic Response|22|||
105579582|NCT01853254|364122320|FG000|Overall Study|Refusal of Treatment|1|||
105579583|NCT01853254|364122320|FG000|Overall Study|Other Protocol Violation|1|||
105579584|NCT01853254|364122320|FG000|Overall Study|Withdrawal of Consent|16|||
105579585|NCT01853254|364122320|FG000|Overall Study|Administrative/Other|16|||
105579586|NCT00373295|364122321|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
105579587|NCT00373295|364122322|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
105579588|NCT00373295|364122323|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
105579589|NCT00373295|364122324|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
105579590|NCT00373295|364122325|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
105579591|NCT00373295|364122326|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
105579592|NCT00506285|364122333|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
105579593|NCT00506285|364122334|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
105579594|NCT00506285|364122333|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
105579595|NCT00506285|364122334|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
105579596|NCT00506285|364122333|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
105579597|NCT00506285|364122334|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
105579598|NCT00506285|364122333|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
105378617|NCT00898807|363390844|FG000|Overall Study|Family pressure to discontinue|2|||
105378618|NCT00898807|363390845|FG001|Overall Study|Family pressure to discontinue|2|||
105579599|NCT00506285|364122334|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
105579600|NCT00506285|364122333|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
105579601|NCT00506285|364122334|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
105579602|NCT01089556|364122335|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
105579603|NCT01089556|364122336|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
105579604|NCT01089556|364122337|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
105579605|NCT01089556|364122338|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
105579606|NCT01089556|364122339|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
105579607|NCT01089556|364122340|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
105579608|NCT01089556|364122335|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
105579609|NCT01089556|364122336|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
105378619|NCT00898807|363390844|FG000|Overall Study|Lost to Follow-up|1|||
105378620|NCT00898807|363390845|FG001|Overall Study|Lost to Follow-up|3|||
105378621|NCT00898807|363390844|FG000|Overall Study|Death|0|||
105378622|NCT00898807|363390845|FG001|Overall Study|Death|1|||
105378623|NCT04919161|363390846|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
105378624|NCT04919161|363390847|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
105378625|NCT04919161|363390846|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
105378626|NCT04919161|363390847|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
105378627|NCT04919161|363390846|FG000|Overall Study|Acute ankle sprain after session 1|0|||
105378628|NCT04919161|363390847|FG001|Overall Study|Acute ankle sprain after session 1|1|||
105378629|NCT02489773|363390848|FG000|Overall Study|Lost to Follow-up|4|||
105378630|NCT02489773|363390849|FG001|Overall Study|Lost to Follow-up|1|||
105378631|NCT02489773|363390848|FG000|Overall Study|Physician Decision|1|||
105378632|NCT02489773|363390849|FG001|Overall Study|Physician Decision|0|||
105378633|NCT02489773|363390848|FG000|Overall Study|Withdrawal by Subject|1|||
105378634|NCT02489773|363390849|FG001|Overall Study|Withdrawal by Subject|0|||
105378635|NCT02489773|363390848|FG000|Overall Study|Leave the country or the state|1|||
105378636|NCT02489773|363390849|FG001|Overall Study|Leave the country or the state|1|||
105378637|NCT02362451|363390850|FG000|Overall Study|Withdrawal by Subject|0|||
105378638|NCT02362451|363390851|FG001|Overall Study|Withdrawal by Subject|1|||
105378639|NCT02362451|363390850|FG000|Overall Study|Lack of Efficacy|2|||
105378640|NCT02362451|363390851|FG001|Overall Study|Lack of Efficacy|0|||
105378641|NCT02362451|363390850|FG000|Overall Study|Progression|1|||
105378642|NCT02362451|363390851|FG001|Overall Study|Progression|0|||
105378643|NCT02362451|363390850|FG000|Overall Study|Participant chose other therapy.|1|||
105378644|NCT02362451|363390851|FG001|Overall Study|Participant chose other therapy.|0|||
105378645|NCT01879852|363390854|FG000|Overall Study|Withdrawal by Subject|2|||
105378646|NCT01879852|363390855|FG001|Overall Study|Withdrawal by Subject|0|||
105378647|NCT02115386|363390856|FG000|Overall Study|Protocol Violation|1|||
105378648|NCT02115386|363390856|FG000|Overall Study|Administrative - trial was terminated|6|||
105378649|NCT02493855|363390857|FG000|Overall Study|Non-compliance|1|||
105378650|NCT02493855|363390858|FG001|Overall Study|Non-compliance|0|||
105378651|NCT02493855|363390859|FG002|Overall Study|Non-compliance|0|||
105378652|NCT02493855|363390857|FG000|Overall Study|Adverse Event|0|||
105378653|NCT02493855|363390858|FG001|Overall Study|Adverse Event|1|||
105378654|NCT02493855|363390859|FG002|Overall Study|Adverse Event|0|||
105378655|NCT02493855|363390857|FG000|Overall Study|Withdrawal by Subject|1|||
105378656|NCT02493855|363390858|FG001|Overall Study|Withdrawal by Subject|0|||
105378657|NCT02493855|363390859|FG002|Overall Study|Withdrawal by Subject|0|||
105378658|NCT04398134|363390864|FG000|Overall Study|Adverse Event|0|||
105378659|NCT04398134|363390865|FG001|Overall Study|Adverse Event|0|||
105378660|NCT04398134|363390866|FG002|Overall Study|Adverse Event|1|||
105378661|NCT04398134|363390867|FG003|Overall Study|Adverse Event|0|||
105378662|NCT04398134|363390864|FG000|Overall Study|Withdrawal by Subject|2|||
105378663|NCT04398134|363390865|FG001|Overall Study|Withdrawal by Subject|0|||
105378664|NCT04398134|363390866|FG002|Overall Study|Withdrawal by Subject|0|||
105378665|NCT04398134|363390867|FG003|Overall Study|Withdrawal by Subject|1|||
105378666|NCT04398134|363390864|FG000|Overall Study|Study Terminated by Sponsor|30|||
105378667|NCT04398134|363390865|FG001|Overall Study|Study Terminated by Sponsor|11|||
105378668|NCT04398134|363390866|FG002|Overall Study|Study Terminated by Sponsor|32|||
105378669|NCT04398134|363390867|FG003|Overall Study|Study Terminated by Sponsor|11|||
105378670|NCT01946802|363390873|FG000|Overall Study|Death|1|||
105378671|NCT01946802|363390873|FG000|Overall Study|Withdrawal by Subject|2|||
105378672|NCT01946802|363390873|FG000|Overall Study|Combined septic shock|1|||
105378673|NCT01946802|363390873|FG000|Overall Study|Protocol Violation|1|||
105378674|NCT03097315|363390874|FG000|Overall Study|Withdrawal by Subject|1|||
105378675|NCT01334515|363390875|FG000|Overall Study|Adverse Event|1|||
105378676|NCT01334515|363390876|FG001|Overall Study|Adverse Event|6|||
105378677|NCT01334515|363390875|FG000|Overall Study|Death|1|||
105378678|NCT01334515|363390876|FG001|Overall Study|Death|0|||
105378679|NCT01334515|363390875|FG000|Overall Study|Lack of Efficacy|8|||
105378680|NCT01334515|363390876|FG001|Overall Study|Lack of Efficacy|21|||
105378681|NCT01334515|363390875|FG000|Overall Study|Physician Decision|1|||
105378682|NCT01334515|363390876|FG001|Overall Study|Physician Decision|1|||
105378683|NCT01334515|363390875|FG000|Overall Study|Withdrawal by Subject|1|||
105378684|NCT01334515|363390876|FG001|Overall Study|Withdrawal by Subject|1|||
105378685|NCT04327271|363390877|FG000|Overall Study|Death|1|||
105378686|NCT04327271|363390878|FG001|Overall Study|Death|0|||
105378687|NCT04327271|363390877|FG000|Overall Study|Withdrawal by Subject|1|||
105378688|NCT04327271|363390878|FG001|Overall Study|Withdrawal by Subject|0|||
105378689|NCT04327271|363390877|FG000|Overall Study|randomization error (data capture)|4|||
105378690|NCT04327271|363390878|FG001|Overall Study|randomization error (data capture)|3|||
105378691|NCT03637374|363390879|FG000|Overall Study|Death|2|||
105378692|NCT03637374|363390880|FG001|Overall Study|Death|0|||
105378693|NCT01132755|363390884|FG000|Overall Study|Procedure not done due to medical reason|23|||
105378694|NCT01132755|363390884|FG000|Overall Study|Protocol Violation|15|||
105579610|NCT01089556|364122337|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
105579611|NCT01089556|364122338|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
105579612|NCT01089556|364122339|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
105579613|NCT01089556|364122340|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
105579614|NCT01089556|364122335|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
105579615|NCT01089556|364122336|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
105579616|NCT01089556|364122337|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
105378695|NCT01132755|363390884|FG000|Overall Study|Withdrawal by Subject|4|||
105378696|NCT04069520|363390886|FG000|Overall Study|Lost to Follow-up|0|||
105378697|NCT04069520|363390887|FG001|Overall Study|Lost to Follow-up|2|||
105378698|NCT04069520|363390886|FG000|Overall Study|Withdrawal by Subject|0|||
105378699|NCT04069520|363390887|FG001|Overall Study|Withdrawal by Subject|1|||
105579617|NCT01089556|364122338|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
105579618|NCT01089556|364122339|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
105579619|NCT01089556|364122340|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
105579620|NCT01089556|364122335|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
105579621|NCT01089556|364122336|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
105579622|NCT01089556|364122337|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
105579623|NCT01089556|364122338|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
105579624|NCT01089556|364122339|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
105579625|NCT01089556|364122340|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
105579626|NCT01089556|364122335|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
105579627|NCT01089556|364122336|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
105579628|NCT01089556|364122337|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
105579629|NCT01089556|364122338|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
105579630|NCT01089556|364122339|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
105579631|NCT01089556|364122340|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
105579632|NCT01089556|364122335|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
105579633|NCT01089556|364122336|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
105579634|NCT01089556|364122337|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
105579635|NCT01089556|364122338|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
105579636|NCT01089556|364122339|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
105579637|NCT01089556|364122340|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
105579638|NCT01089556|364122335|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
105579639|NCT01089556|364122336|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
105579640|NCT01089556|364122337|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
105579641|NCT01089556|364122338|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
105579642|NCT01089556|364122339|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
105579643|NCT01089556|364122340|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
105579644|NCT01089556|364122335|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
105579645|NCT01089556|364122336|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
105579646|NCT01089556|364122337|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
105579647|NCT01089556|364122338|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
105579648|NCT01089556|364122339|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
105579649|NCT01089556|364122340|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
105579650|NCT01089556|364122335|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
105579651|NCT01089556|364122336|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
105579652|NCT01089556|364122337|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
105579653|NCT01089556|364122338|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
105579654|NCT01089556|364122339|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
105579655|NCT01089556|364122340|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
105579656|NCT01089556|364122335|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
105579657|NCT01089556|364122336|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
105579658|NCT01089556|364122337|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
105579659|NCT01089556|364122338|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
105579660|NCT01089556|364122339|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
105579661|NCT01089556|364122340|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
105579662|NCT01089556|364122335|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
105579663|NCT01089556|364122336|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
105579664|NCT01089556|364122337|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
105579665|NCT01089556|364122338|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
105579666|NCT01089556|364122339|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
105378700|NCT04069520|363390886|FG000|Overall Study|Prior Injury|1|||
105579667|NCT01089556|364122340|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
105579668|NCT01089556|364122335|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
105378701|NCT04069520|363390887|FG001|Overall Study|Prior Injury|0|||
105378702|NCT04069520|363390886|FG000|Overall Study|Orthodontia|1|||
105378703|NCT04069520|363390887|FG001|Overall Study|Orthodontia|0|||
105378704|NCT04069520|363390886|FG000|Overall Study|Cut from team|0|||
105378705|NCT04069520|363390887|FG001|Overall Study|Cut from team|2|||
105378706|NCT00849472|363390888|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
105378707|NCT00849472|363390888|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
105378708|NCT00849472|363390888|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
105378709|NCT00849472|363390888|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
105378710|NCT00849472|363390888|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
105378711|NCT00849472|363390888|FG000|Weekly Paclitaxel|Disease Progression|1|||
105378712|NCT00849472|363390888|FG000|Weekly Paclitaxel|Adverse Event|11|||
105378713|NCT00849472|363390888|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
105378714|NCT00849472|363390888|FG000|Weekly Paclitaxel|Physician Decision|3|||
105378715|NCT00849472|363390888|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
105378716|NCT00849472|363390888|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
105378717|NCT00849472|363390888|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
105378718|NCT00849472|363390888|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
105378719|NCT00849472|363390888|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
105378720|NCT00849472|363390888|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
105378721|NCT00849472|363390888|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
105378722|NCT00849472|363390888|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
105378723|NCT02691572|363390889|FG000|Overall Study|Withdrawal by Subject|1|||
105378724|NCT02691572|363390890|FG001|Overall Study|Withdrawal by Subject|0|||
105378725|NCT02691572|363390889|FG000|Overall Study|Protocol Violation|0|||
105378726|NCT02691572|363390890|FG001|Overall Study|Protocol Violation|1|||
105378727|NCT04615507|363390891|FG000|Period 1|Covid-19 exposure|2|||
105330627|NCT00566020|363211272|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
105330628|NCT00566020|363211271|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
105330629|NCT00566020|363211272|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
105330630|NCT00566020|363211271|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
105330631|NCT00566020|363211272|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
105330632|NCT00566020|363211271|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
105330633|NCT00566020|363211272|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
105330634|NCT00566020|363211271|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
105330635|NCT00566020|363211272|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
105330636|NCT00566020|363211271|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
105330637|NCT00566020|363211272|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
105330638|NCT02393950|363211273|FG000|Overall Study|Adverse Event|1|||
105330639|NCT02393950|363211274|FG001|Overall Study|Adverse Event|0|||
105330640|NCT02393950|363211273|FG000|Overall Study|Withdrawal by Subject|0|||
105330641|NCT02393950|363211274|FG001|Overall Study|Withdrawal by Subject|1|||
105330642|NCT01295671|363211275|FG000|Overall Study|Lost to Follow-up|4|||
105330643|NCT01295671|363211276|FG001|Overall Study|Lost to Follow-up|6|||
105330644|NCT01295671|363211277|FG002|Overall Study|Lost to Follow-up|3|||
105330645|NCT01295671|363211275|FG000|Overall Study|Withdrawal by Subject|3|||
105330646|NCT01295671|363211276|FG001|Overall Study|Withdrawal by Subject|1|||
105330647|NCT01295671|363211277|FG002|Overall Study|Withdrawal by Subject|0|||
105330648|NCT02058537|363211278|FG000|Overall Study|Withdrawal by Subject|1|||
105330649|NCT01085630|363211279|FG000|Overall Study|Insufficient data|1|||
105330650|NCT01085630|363211280|FG001|Overall Study|Insufficient data|0|||
105330651|NCT01085630|363211279|FG000|Overall Study|Ineligible|3|||
105330652|NCT01085630|363211280|FG001|Overall Study|Ineligible|0|||
105330653|NCT03351608|363211281|FG000|Overall Study|Lost to Follow-up|0|||
105330654|NCT03351608|363211282|FG001|Overall Study|Lost to Follow-up|1|||
105330655|NCT03351608|363211283|FG002|Overall Study|Lost to Follow-up|1|||
105330656|NCT03351608|363211284|FG003|Overall Study|Lost to Follow-up|1|||
105330657|NCT03351608|363211285|FG004|Overall Study|Lost to Follow-up|1|||
105330658|NCT03351608|363211281|FG000|Overall Study|Physician Decision|1|||
105330659|NCT03351608|363211282|FG001|Overall Study|Physician Decision|0|||
105330660|NCT03351608|363211283|FG002|Overall Study|Physician Decision|0|||
105330661|NCT03351608|363211284|FG003|Overall Study|Physician Decision|2|||
105330662|NCT03351608|363211285|FG004|Overall Study|Physician Decision|1|||
105330663|NCT03351608|363211281|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
105330664|NCT03351608|363211282|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
105330665|NCT03351608|363211283|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
105330666|NCT03351608|363211284|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
105330667|NCT03351608|363211285|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
105330668|NCT03351608|363211281|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105330669|NCT03351608|363211282|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105330670|NCT03351608|363211283|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105330671|NCT03351608|363211284|FG003|Overall Study|Withdrawal by parent/guardian|1|||
105330672|NCT03351608|363211285|FG004|Overall Study|Withdrawal by parent/guardian|0|||
105330673|NCT03351608|363211281|FG000|Overall Study|Other|0|||
105330674|NCT03351608|363211282|FG001|Overall Study|Other|1|||
105330675|NCT03351608|363211283|FG002|Overall Study|Other|1|||
105378728|NCT04615507|363390892|FG001|Period 1|Covid-19 exposure|1|||
105378729|NCT04615507|363390891|FG000|Period 2|Covid-19 exposure|0|||
105378730|NCT04615507|363390892|FG001|Period 2|Covid-19 exposure|1|||
105378731|NCT04615507|363390891|FG000|Period 2|Protocol Violation|1|||
105378732|NCT04615507|363390892|FG001|Period 2|Protocol Violation|0|||
105378733|NCT04615507|363390891|FG000|Period 2|Withdrawal by Subject|1|||
105378734|NCT04615507|363390892|FG001|Period 2|Withdrawal by Subject|0|||
105378735|NCT04615507|363390891|FG000|Period 2|Adverse Event|0|||
105378736|NCT04615507|363390892|FG001|Period 2|Adverse Event|1|||
105378737|NCT04615507|363390891|FG000|Period 3|Covid-19 exposure|0|||
105378738|NCT04615507|363390892|FG001|Period 3|Covid-19 exposure|1|||
105378739|NCT00699751|363390893|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
105378740|NCT00699751|363390894|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
105378741|NCT00699751|363390893|FG000|Period 1: Without/Before Drug Switch|Death|28|||
105378742|NCT00699751|363390894|FG001|Period 1: Without/Before Drug Switch|Death|29|||
105378743|NCT00699751|363390893|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
105378744|NCT00699751|363390894|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
105378745|NCT00699751|363390893|FG000|Period 1: Without/Before Drug Switch|Other|30|||
105378746|NCT00699751|363390894|FG001|Period 1: Without/Before Drug Switch|Other|20|||
105378747|NCT00699751|363390893|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
105378748|NCT00699751|363390894|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
105378749|NCT00699751|363390893|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
105378750|NCT00699751|363390894|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
105378751|NCT00699751|363390893|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
105378752|NCT00699751|363390894|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
105378753|NCT00699751|363390893|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
105378754|NCT00699751|363390894|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
105378755|NCT02965833|363390897|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
105378756|NCT02965833|363390898|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
105378757|NCT02965833|363390897|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
105378758|NCT02965833|363390898|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
105378759|NCT02965833|363390897|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
105378760|NCT02965833|363390898|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
105378761|NCT02965833|363390897|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
105378762|NCT02965833|363390898|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
105378763|NCT02965833|363390897|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
105378764|NCT02965833|363390898|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
105378765|NCT03370302|363390899|FG000|Dose Escalation Phase|Other|0|||
105378766|NCT03370302|363390900|FG001|Dose Escalation Phase|Other|1|||
105378767|NCT03370302|363390901|FG002|Dose Escalation Phase|Other|1|||
105378768|NCT03370302|363390902|FG003|Dose Escalation Phase|Other|0|||
105378769|NCT03370302|363390903|FG004|Dose Escalation Phase|Other|0|||
105378770|NCT03370302|363390904|FG005|Dose Escalation Phase|Other|0|||
105378771|NCT03370302|363390899|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
105378772|NCT03370302|363390900|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
105378773|NCT03370302|363390901|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
105378774|NCT03370302|363390902|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
105378775|NCT03370302|363390903|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
105378776|NCT03370302|363390904|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
105378777|NCT03370302|363390899|FG000|Dose Escalation Phase|Adverse Event|1|||
105378778|NCT03370302|363390900|FG001|Dose Escalation Phase|Adverse Event|0|||
105378779|NCT03370302|363390901|FG002|Dose Escalation Phase|Adverse Event|2|||
105378780|NCT03370302|363390902|FG003|Dose Escalation Phase|Adverse Event|0|||
105378781|NCT03370302|363390903|FG004|Dose Escalation Phase|Adverse Event|0|||
105378782|NCT03370302|363390904|FG005|Dose Escalation Phase|Adverse Event|0|||
105378783|NCT03370302|363390899|FG000|Dose Escalation Phase|Progressive Disease|2|||
105378784|NCT03370302|363390900|FG001|Dose Escalation Phase|Progressive Disease|4|||
105378785|NCT03370302|363390901|FG002|Dose Escalation Phase|Progressive Disease|2|||
105378786|NCT03370302|363390902|FG003|Dose Escalation Phase|Progressive Disease|0|||
105378787|NCT03370302|363390903|FG004|Dose Escalation Phase|Progressive Disease|3|||
105378788|NCT03370302|363390904|FG005|Dose Escalation Phase|Progressive Disease|1|||
105378789|NCT03370302|363390899|FG000|Dose Expansion Phase|Progressive Disease|0|||
105378790|NCT03370302|363390900|FG001|Dose Expansion Phase|Progressive Disease|0|||
105378791|NCT03370302|363390901|FG002|Dose Expansion Phase|Progressive Disease|0|||
105378792|NCT03370302|363390902|FG003|Dose Expansion Phase|Progressive Disease|6|||
105378793|NCT03370302|363390903|FG004|Dose Expansion Phase|Progressive Disease|0|||
105492348|NCT02180165|363815724|FG003|Overall Study|Withdrawal by Subject|1|||
105378794|NCT03370302|363390904|FG005|Dose Expansion Phase|Progressive Disease|0|||
105378795|NCT01214720|363390910|FG000|Overall Study|Alive and still on treatment|34|||
105378796|NCT01214720|363390911|FG001|Overall Study|Alive and still on treatment|18|||
105378797|NCT01214720|363390910|FG000|Overall Study|Alive and in follow-up|45|||
105378798|NCT01214720|363390911|FG001|Overall Study|Alive and in follow-up|48|||
105378799|NCT01214720|363390910|FG000|Overall Study|Lost to Follow-up|6|||
105378800|NCT01214720|363390911|FG001|Overall Study|Lost to Follow-up|2|||
105378801|NCT00544882|363390912|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
105378802|NCT00544882|363390913|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
105378803|NCT00544882|363390914|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
105378804|NCT00544882|363390912|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
105378805|NCT00544882|363390913|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
105378806|NCT00544882|363390914|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
105378807|NCT00544882|363390912|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
105378808|NCT00544882|363390913|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
105378809|NCT00544882|363390914|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
105378810|NCT00544882|363390912|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
105378811|NCT00544882|363390913|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
105378812|NCT00544882|363390914|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
105378813|NCT00544882|363390912|FG000|Cycle 3: Follow-up|Noncompliance|0|||
105378814|NCT00544882|363390913|FG001|Cycle 3: Follow-up|Noncompliance|1|||
105378815|NCT00544882|363390914|FG002|Cycle 3: Follow-up|Noncompliance|0|||
105378816|NCT00544882|363390912|FG000|Cycle 3: Follow-up|Pregnancy|0|||
105378817|NCT00544882|363390913|FG001|Cycle 3: Follow-up|Pregnancy|1|||
105378818|NCT00544882|363390914|FG002|Cycle 3: Follow-up|Pregnancy|0|||
105378819|NCT01039675|363390917|FG000|Overall Study|Adverse Event|0|||
105378820|NCT01039675|363390918|FG001|Overall Study|Adverse Event|2|||
105378821|NCT01039675|363390917|FG000|Overall Study|Lack of Efficacy|0|||
105378822|NCT01039675|363390918|FG001|Overall Study|Lack of Efficacy|2|||
105378823|NCT01039675|363390917|FG000|Overall Study|Withdrawal by Subject|0|||
105378824|NCT01039675|363390918|FG001|Overall Study|Withdrawal by Subject|1|||
105378825|NCT01039675|363390917|FG000|Overall Study|Lost to Follow-up|0|||
105378826|NCT01039675|363390918|FG001|Overall Study|Lost to Follow-up|1|||
105378827|NCT01039675|363390917|FG000|Overall Study|Physician Decision|0|||
105378828|NCT01039675|363390918|FG001|Overall Study|Physician Decision|1|||
105378829|NCT00876395|363392419|FG000|Overall Study|Untreated|8|||
105378830|NCT00876395|363392420|FG001|Overall Study|Untreated|1|||
105378831|NCT00876395|363392419|FG000|Overall Study|Adverse Event|63|||
105378832|NCT00876395|363392420|FG001|Overall Study|Adverse Event|11|||
105378833|NCT00876395|363392419|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105378834|NCT00876395|363392420|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105378835|NCT00876395|363392419|FG000|Overall Study|Disease progression|259|||
105378836|NCT00876395|363392420|FG001|Overall Study|Disease progression|162|||
105378837|NCT00876395|363392419|FG000|Overall Study|New cancer therapy|25|||
105378838|NCT00876395|363392420|FG001|Overall Study|New cancer therapy|7|||
105378839|NCT00876395|363392419|FG000|Overall Study|Protocol Violation|5|||
105378840|NCT00876395|363392420|FG001|Overall Study|Protocol Violation|2|||
105378841|NCT00876395|363392419|FG000|Overall Study|Withdrawal by Subject|66|||
105378842|NCT00876395|363392420|FG001|Overall Study|Withdrawal by Subject|33|||
105378843|NCT00876395|363392419|FG000|Overall Study|Lost to Follow-up|2|||
105378844|NCT00876395|363392420|FG001|Overall Study|Lost to Follow-up|0|||
105378845|NCT00876395|363392419|FG000|Overall Study|Administrative problems|39|||
105378846|NCT00876395|363392420|FG001|Overall Study|Administrative problems|23|||
105378847|NCT00876395|363392419|FG000|Overall Study|Death|12|||
105378848|NCT00876395|363392420|FG001|Overall Study|Death|0|||
105378849|NCT03720847|363392421|FG000|Washout|Physician Decision|1|||
105378850|NCT03720847|363392422|FG001|Washout|Physician Decision|2|||
105378851|NCT01239680|363392427|FG000|Overall Study|Withdrawal by Subject|2|||
105378852|NCT01239680|363392428|FG001|Overall Study|Withdrawal by Subject|0|||
105378853|NCT03033901|363392429|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
105378854|NCT03033901|363392429|FG000|Overall Study|Refused PSG|23|||
105378855|NCT03033901|363392429|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
105378856|NCT03033901|363392429|FG000|Overall Study|Missing Oximetry Data|3|||
105378857|NCT00924651|363392432|FG000|Overall Study|Chemo started too soon|2|||
105378858|NCT00924651|363392433|FG001|Overall Study|Chemo started too soon|3|||
105378859|NCT00924651|363392432|FG000|Overall Study|No Reason|3|||
105378860|NCT00924651|363392433|FG001|Overall Study|No Reason|7|||
105378861|NCT00924651|363392432|FG000|Overall Study|Overwhelmed|6|||
105378862|NCT00924651|363392433|FG001|Overall Study|Overwhelmed|6|||
105378863|NCT00924651|363392432|FG000|Overall Study|Noncompliant|1|||
105378864|NCT00924651|363392433|FG001|Overall Study|Noncompliant|4|||
105378865|NCT00924651|363392432|FG000|Overall Study|Medical|1|||
105378866|NCT00924651|363392433|FG001|Overall Study|Medical|3|||
105378867|NCT00924651|363392432|FG000|Overall Study|Changed Mind|10|||
105378868|NCT00924651|363392433|FG001|Overall Study|Changed Mind|1|||
105378869|NCT00924651|363392432|FG000|Overall Study|Incomplete Form|2|||
105378870|NCT00924651|363392433|FG001|Overall Study|Incomplete Form|1|||
105378871|NCT02260986|363392436|FG000|Overall Study|Adverse Event|24|||
105378872|NCT02260986|363392437|FG001|Overall Study|Adverse Event|0|||
105378873|NCT02260986|363392438|FG002|Overall Study|Adverse Event|11|||
105378874|NCT02260986|363392436|FG000|Overall Study|Lack of Efficacy|27|||
105378875|NCT02260986|363392437|FG001|Overall Study|Lack of Efficacy|3|||
105378876|NCT02260986|363392438|FG002|Overall Study|Lack of Efficacy|0|||
105378877|NCT02260986|363392436|FG000|Overall Study|Protocol Violation|14|||
105378878|NCT02260986|363392437|FG001|Overall Study|Protocol Violation|5|||
105378879|NCT02260986|363392438|FG002|Overall Study|Protocol Violation|16|||
105378880|NCT02260986|363392436|FG000|Overall Study|Car accident|0|||
105378881|NCT02260986|363392437|FG001|Overall Study|Car accident|0|||
105378882|NCT02260986|363392438|FG002|Overall Study|Car accident|1|||
105378883|NCT02260986|363392436|FG000|Overall Study|Withdrawal by Subject|17|||
105378884|NCT02260986|363392437|FG001|Overall Study|Withdrawal by Subject|4|||
105378885|NCT02260986|363392438|FG002|Overall Study|Withdrawal by Subject|9|||
105378886|NCT02260986|363392436|FG000|Overall Study|Incorrect randomization|0|||
105378887|NCT02260986|363392437|FG001|Overall Study|Incorrect randomization|1|||
105378888|NCT02260986|363392438|FG002|Overall Study|Incorrect randomization|0|||
105378889|NCT02260986|363392436|FG000|Overall Study|Lack of investigation product supply|2|||
105378890|NCT02260986|363392437|FG001|Overall Study|Lack of investigation product supply|0|||
105378891|NCT02260986|363392438|FG002|Overall Study|Lack of investigation product supply|1|||
105378892|NCT02260986|363392436|FG000|Overall Study|Lost to Follow-up|4|||
105378893|NCT02260986|363392437|FG001|Overall Study|Lost to Follow-up|0|||
105378894|NCT02260986|363392438|FG002|Overall Study|Lost to Follow-up|3|||
105378895|NCT02260986|363392436|FG000|Overall Study|Pregnancy|2|||
105378896|NCT02260986|363392437|FG001|Overall Study|Pregnancy|0|||
105378897|NCT02260986|363392438|FG002|Overall Study|Pregnancy|0|||
105378898|NCT02175758|363392439|FG000|Treatment Phase|Lost to Follow-up|0|||
105378899|NCT02175758|363392440|FG001|Treatment Phase|Lost to Follow-up|1|||
105378900|NCT02175758|363392441|FG002|Treatment Phase|Lost to Follow-up|0|||
105378901|NCT02175758|363392442|FG003|Treatment Phase|Lost to Follow-up|0|||
105378902|NCT02175758|363392443|FG004|Treatment Phase|Lost to Follow-up|0|||
105378903|NCT02175758|363392444|FG005|Treatment Phase|Lost to Follow-up|0|||
105378904|NCT02175758|363392439|FG000|Treatment Phase|Adverse Event|0|||
105378905|NCT02175758|363392440|FG001|Treatment Phase|Adverse Event|0|||
105378906|NCT02175758|363392441|FG002|Treatment Phase|Adverse Event|0|||
105378907|NCT02175758|363392442|FG003|Treatment Phase|Adverse Event|0|||
105378908|NCT02175758|363392443|FG004|Treatment Phase|Adverse Event|1|||
105378909|NCT02175758|363392444|FG005|Treatment Phase|Adverse Event|0|||
105378910|NCT01482221|363392449|FG000|Overall Study|Lack of Efficacy|1|||
105378911|NCT01482221|363392450|FG001|Overall Study|Lack of Efficacy|0|||
105378912|NCT01482221|363392451|FG002|Overall Study|Lack of Efficacy|1|||
105378913|NCT01482221|363392449|FG000|Overall Study|Lost to Follow-up|3|||
105378914|NCT01482221|363392450|FG001|Overall Study|Lost to Follow-up|2|||
105378915|NCT01482221|363392451|FG002|Overall Study|Lost to Follow-up|1|||
105378916|NCT01482221|363392449|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
105378917|NCT01482221|363392450|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
105378918|NCT01482221|363392451|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
105378919|NCT01482221|363392449|FG000|Overall Study|Condition under Investigation Worsened|3|||
105378920|NCT01482221|363392450|FG001|Overall Study|Condition under Investigation Worsened|2|||
105378921|NCT01482221|363392451|FG002|Overall Study|Condition under Investigation Worsened|4|||
105378922|NCT01482221|363392449|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
105378923|NCT01482221|363392450|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
105378924|NCT01482221|363392451|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
105378925|NCT01482221|363392449|FG000|Overall Study|Adverse Event|1|||
105378926|NCT01482221|363392450|FG001|Overall Study|Adverse Event|7|||
105378927|NCT01482221|363392451|FG002|Overall Study|Adverse Event|3|||
105378928|NCT01482221|363392449|FG000|Overall Study|Withdrawal by Subject|10|||
105378929|NCT01482221|363392450|FG001|Overall Study|Withdrawal by Subject|7|||
105378930|NCT01482221|363392451|FG002|Overall Study|Withdrawal by Subject|12|||
105378931|NCT01482221|363392449|FG000|Overall Study|Incorrect randomization|0|||
105378932|NCT01482221|363392450|FG001|Overall Study|Incorrect randomization|1|||
105378933|NCT01482221|363392451|FG002|Overall Study|Incorrect randomization|0|||
105378934|NCT01482221|363392449|FG000|Overall Study|Physician Decision|0|||
105378935|NCT01482221|363392450|FG001|Overall Study|Physician Decision|1|||
105378936|NCT01482221|363392451|FG002|Overall Study|Physician Decision|0|||
105378937|NCT03086343|363392452|FG000|Period 1|Adverse Event|7|||
105378938|NCT03086343|363392453|FG001|Period 1|Adverse Event|7|||
105378939|NCT03086343|363392454|FG002|Period 1|Adverse Event|0|||
105378940|NCT03086343|363392455|FG003|Period 1|Adverse Event|1|||
105378941|NCT03086343|363392452|FG000|Period 1|Withdrawal by Subject|6|||
105378942|NCT03086343|363392453|FG001|Period 1|Withdrawal by Subject|10|||
105378943|NCT03086343|363392454|FG002|Period 1|Withdrawal by Subject|0|||
105378944|NCT03086343|363392455|FG003|Period 1|Withdrawal by Subject|0|||
105378945|NCT03086343|363392452|FG000|Period 1|Lost to Follow-up|1|||
105378946|NCT03086343|363392453|FG001|Period 1|Lost to Follow-up|3|||
105378947|NCT03086343|363392454|FG002|Period 1|Lost to Follow-up|1|||
105378948|NCT03086343|363392455|FG003|Period 1|Lost to Follow-up|0|||
105378949|NCT03086343|363392452|FG000|Period 1|Other, Not Specified|10|||
105378950|NCT03086343|363392453|FG001|Period 1|Other, Not Specified|12|||
105378951|NCT03086343|363392454|FG002|Period 1|Other, Not Specified|2|||
105378952|NCT03086343|363392455|FG003|Period 1|Other, Not Specified|1|||
105378953|NCT03086343|363392452|FG000|Period 1|Missing|1|||
105378954|NCT03086343|363392453|FG001|Period 1|Missing|0|||
105378955|NCT03086343|363392454|FG002|Period 1|Missing|0|||
105378956|NCT03086343|363392455|FG003|Period 1|Missing|0|||
105378957|NCT03086343|363392452|FG000|Period 2|Adverse Event|20|||
105378958|NCT03086343|363392453|FG001|Period 2|Adverse Event|11|||
105378959|NCT03086343|363392454|FG002|Period 2|Adverse Event|1|||
105378960|NCT03086343|363392455|FG003|Period 2|Adverse Event|2|||
105378961|NCT03086343|363392452|FG000|Period 2|Withdrawal by Subject|15|||
105378962|NCT03086343|363392453|FG001|Period 2|Withdrawal by Subject|25|||
105378963|NCT03086343|363392454|FG002|Period 2|Withdrawal by Subject|2|||
105378964|NCT03086343|363392455|FG003|Period 2|Withdrawal by Subject|2|||
105378965|NCT03086343|363392452|FG000|Period 2|Lost to Follow-up|6|||
105378966|NCT03086343|363392453|FG001|Period 2|Lost to Follow-up|11|||
105378967|NCT03086343|363392454|FG002|Period 2|Lost to Follow-up|1|||
105378968|NCT03086343|363392455|FG003|Period 2|Lost to Follow-up|0|||
105378969|NCT03086343|363392452|FG000|Period 2|COVID-19 Infection|5|||
105378970|NCT03086343|363392453|FG001|Period 2|COVID-19 Infection|0|||
105378971|NCT03086343|363392454|FG002|Period 2|COVID-19 Infection|0|||
105378972|NCT03086343|363392455|FG003|Period 2|COVID-19 Infection|0|||
105378973|NCT03086343|363392452|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
105378974|NCT03086343|363392453|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
105378975|NCT03086343|363392454|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
105378976|NCT03086343|363392455|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
105378977|NCT03086343|363392452|FG000|Period 2|Other, Not Specified|23|||
105378978|NCT03086343|363392453|FG001|Period 2|Other, Not Specified|22|||
105378979|NCT03086343|363392454|FG002|Period 2|Other, Not Specified|2|||
105378980|NCT03086343|363392455|FG003|Period 2|Other, Not Specified|4|||
105378981|NCT04900272|363392456|FG000|Overall Study|Lost to Follow-up|2|||
105378982|NCT04900272|363392456|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
105378983|NCT04900272|363392456|FG000|Overall Study|Withdrawal by Subject|1|||
105378984|NCT01047501|363392457|FG000|Overall Study|Adverse Event|7|||
105378985|NCT01047501|363392458|FG001|Overall Study|Adverse Event|8|||
105378986|NCT01047501|363392459|FG002|Overall Study|Adverse Event|5|||
105378987|NCT01047501|363392457|FG000|Overall Study|Withdrew Consent|6|||
105378988|NCT01047501|363392458|FG001|Overall Study|Withdrew Consent|2|||
105378989|NCT01047501|363392459|FG002|Overall Study|Withdrew Consent|4|||
105378990|NCT01047501|363392457|FG000|Overall Study|Lost to Follow-up|0|||
105378991|NCT01047501|363392458|FG001|Overall Study|Lost to Follow-up|1|||
105378992|NCT01047501|363392459|FG002|Overall Study|Lost to Follow-up|1|||
105378993|NCT01047501|363392457|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
105378994|NCT01047501|363392458|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
105378995|NCT01047501|363392459|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
105378996|NCT01047501|363392457|FG000|Overall Study|Death|1|||
105378997|NCT01047501|363392458|FG001|Overall Study|Death|0|||
105378998|NCT01047501|363392459|FG002|Overall Study|Death|0|||
105378999|NCT01047501|363392457|FG000|Overall Study|Other discontinuation|1|||
105379000|NCT01047501|363392458|FG001|Overall Study|Other discontinuation|0|||
105379001|NCT01047501|363392459|FG002|Overall Study|Other discontinuation|1|||
105379002|NCT01047501|363392457|FG000|Overall Study|Investigator judgement|0|||
105379003|NCT01047501|363392458|FG001|Overall Study|Investigator judgement|0|||
105379004|NCT01047501|363392459|FG002|Overall Study|Investigator judgement|1|||
105379005|NCT05607043|363392460|FG000|Overall Study|Lost to Follow-up|2|||
105379006|NCT00741611|363392461|FG000|Overall Study|Death|0|||
105379007|NCT00741611|363392462|FG001|Overall Study|Death|0|||
105379008|NCT00741611|363392463|FG002|Overall Study|Death|1|||
105379009|NCT00741611|363392461|FG000|Overall Study|Withdrawal by Subject|0|||
105379010|NCT00741611|363392462|FG001|Overall Study|Withdrawal by Subject|2|||
105379011|NCT00741611|363392463|FG002|Overall Study|Withdrawal by Subject|2|||
105379012|NCT00800540|363392471|FG000|Period One: 6 Weeks|Noncompliance|1|||
105379013|NCT00800540|363392472|FG001|Period One: 6 Weeks|Noncompliance|0|||
105379014|NCT00800540|363392471|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
105379015|NCT00800540|363392472|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
105579669|NCT01089556|364122336|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
105579670|NCT01089556|364122337|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
105379016|NCT00800540|363392471|FG000|Period 2: 6 Weeks|Adverse Event|0|||
105579671|NCT01089556|364122338|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
105579672|NCT01089556|364122339|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
105579673|NCT01089556|364122340|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
105579674|NCT01089556|364122335|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
105379017|NCT00800540|363392472|FG001|Period 2: 6 Weeks|Adverse Event|1|||
105379018|NCT00429299|363392475|FG000|Overall Study|Disease Progression|1|||
105379019|NCT00429299|363392476|FG001|Overall Study|Disease Progression|1|||
105379020|NCT00429299|363392477|FG002|Overall Study|Disease Progression|0|||
105379021|NCT00429299|363392475|FG000|Overall Study|Adverse Event|2|||
105379022|NCT00429299|363392476|FG001|Overall Study|Adverse Event|5|||
105379023|NCT00429299|363392477|FG002|Overall Study|Adverse Event|1|||
105379024|NCT00429299|363392475|FG000|Overall Study|Protocol Violation|1|||
105379025|NCT00429299|363392476|FG001|Overall Study|Protocol Violation|0|||
105379026|NCT00429299|363392477|FG002|Overall Study|Protocol Violation|0|||
105379027|NCT00429299|363392475|FG000|Overall Study|Withdrawal by Subject|0|||
105379028|NCT00429299|363392476|FG001|Overall Study|Withdrawal by Subject|1|||
105579675|NCT01089556|364122336|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
105579676|NCT01089556|364122337|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
105579677|NCT01089556|364122338|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
105579678|NCT01089556|364122339|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
105579679|NCT01089556|364122340|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
105579680|NCT01089556|364122335|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
105579681|NCT01089556|364122336|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
105579682|NCT01089556|364122337|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
105579683|NCT01089556|364122338|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
105579684|NCT01089556|364122339|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
105579685|NCT01089556|364122340|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
105579686|NCT01089556|364122335|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
105579687|NCT01089556|364122336|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
105579688|NCT01089556|364122337|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
105579689|NCT01089556|364122338|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
105579690|NCT01089556|364122339|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
105579691|NCT01089556|364122340|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
105579692|NCT00551213|364122341|FG000|Overall Study|Adverse Event|6|||
105579693|NCT00551213|364122342|FG001|Overall Study|Adverse Event|3|||
105579694|NCT00551213|364122341|FG000|Overall Study|Progressive Disease|41|||
105579695|NCT00551213|364122342|FG001|Overall Study|Progressive Disease|12|||
105579696|NCT00551213|364122341|FG000|Overall Study|Withdrawal by Subject|2|||
105579697|NCT00551213|364122342|FG001|Overall Study|Withdrawal by Subject|0|||
105579698|NCT00551213|364122341|FG000|Overall Study|Not Treated|1|||
105579699|NCT00551213|364122342|FG001|Overall Study|Not Treated|2|||
105579700|NCT01383993|364122343|FG000|Overall Study|Adverse Event|1|||
105579701|NCT01383993|364122344|FG001|Overall Study|Adverse Event|1|||
105579702|NCT01383993|364122345|FG002|Overall Study|Adverse Event|0|||
105579703|NCT01383993|364122343|FG000|Overall Study|Withdrawal by Subject|0|||
105579704|NCT01383993|364122344|FG001|Overall Study|Withdrawal by Subject|0|||
105579705|NCT01383993|364122345|FG002|Overall Study|Withdrawal by Subject|1|||
105579706|NCT01383993|364122343|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
105579707|NCT01383993|364122344|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
105579708|NCT01383993|364122345|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
105579709|NCT03525574|364122350|FG000|Overall Study|Adverse Event|15|||
105579710|NCT03525574|364122351|FG001|Overall Study|Adverse Event|0|||
105579711|NCT03525574|364122350|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
105579712|NCT03525574|364122351|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
105579713|NCT03525574|364122350|FG000|Overall Study|Lost to Follow-up|4|||
105579714|NCT03525574|364122351|FG001|Overall Study|Lost to Follow-up|0|||
105579715|NCT03525574|364122350|FG000|Overall Study|Commercial drug is Available for participant|48|||
105579716|NCT03525574|364122351|FG001|Overall Study|Commercial drug is Available for participant|0|||
105579717|NCT03525574|364122350|FG000|Overall Study|Death|1|||
105579718|NCT03525574|364122351|FG001|Overall Study|Death|0|||
105579719|NCT03525574|364122350|FG000|Overall Study|Other non-compliance|2|||
105579720|NCT03525574|364122351|FG001|Overall Study|Other non-compliance|0|||
105579721|NCT03525574|364122350|FG000|Overall Study|Physician Decision|6|||
105579722|NCT03525574|364122351|FG001|Overall Study|Physician Decision|0|||
105579723|NCT03525574|364122350|FG000|Overall Study|Other|58|||
105579724|NCT03525574|364122351|FG001|Overall Study|Other|0|||
105579725|NCT03525574|364122350|FG000|Overall Study|Enrolled but never dosed|1|||
105579726|NCT03525574|364122351|FG001|Overall Study|Enrolled but never dosed|0|||
105579727|NCT03525574|364122350|FG000|Overall Study|Not enrolled in 105 study|0|||
105579728|NCT03525574|364122351|FG001|Overall Study|Not enrolled in 105 study|3|||
105579729|NCT03772314|364122361|FG000|Overall Study|Adverse Event|7|||
105579730|NCT03772314|364122362|FG001|Overall Study|Adverse Event|2|||
105579731|NCT00579982|364122365|FG000|Overall Study|Adverse Event|4|||
105579732|NCT00579982|364122365|FG000|Overall Study|Protocol Violation|4|||
105579733|NCT00088205|364122366|FG000|Overall Study|Adverse Event|4|||
105579734|NCT00088205|364122366|FG000|Overall Study|Progressive Disease|51|||
105379029|NCT00429299|363392477|FG002|Overall Study|Withdrawal by Subject|3|||
105379030|NCT01510756|363392478|FG000|Overall Study|Death|1|||
105379031|NCT01510756|363392478|FG000|Overall Study|Lack of Efficacy|2|||
105579735|NCT00088205|364122366|FG000|Overall Study|Physician Decision|1|||
105579736|NCT00088205|364122366|FG000|Overall Study|Death Due to Study Disease|4|||
105579737|NCT03192215|364122367|FG000|Overall Study|Death|28|||
105579738|NCT03192215|364122368|FG001|Overall Study|Death|23|||
105579739|NCT03192215|364122367|FG000|Overall Study|Lost to Follow-up|10|||
105579740|NCT03192215|364122368|FG001|Overall Study|Lost to Follow-up|15|||
105579741|NCT03192215|364122367|FG000|Overall Study|Withdrawal by Subject|49|||
105579742|NCT03192215|364122368|FG001|Overall Study|Withdrawal by Subject|48|||
105579743|NCT03192215|364122367|FG000|Overall Study|Other as reported in analysis|4|||
105579744|NCT03192215|364122368|FG001|Overall Study|Other as reported in analysis|1|||
105579745|NCT01364727|364122373|FG000|Overall Study|Not Eligible|2|||
105579746|NCT01676220|364122375|FG000|Overall Study|Randomized But Not Treated|4|||
105579747|NCT01676220|364122376|FG001|Overall Study|Randomized But Not Treated|1|||
105579748|NCT01676220|364122375|FG000|Overall Study|Adverse Event|10|||
105579749|NCT01676220|364122376|FG001|Overall Study|Adverse Event|8|||
105579750|NCT01676220|364122375|FG000|Overall Study|Lack of Efficacy|2|||
105579751|NCT01676220|364122376|FG001|Overall Study|Lack of Efficacy|5|||
105579752|NCT01676220|364122375|FG000|Overall Study|Protocol Violation|11|||
105579753|NCT01676220|364122376|FG001|Overall Study|Protocol Violation|12|||
105579754|NCT01676220|364122375|FG000|Overall Study|Received Rescue Therapy|14|||
105579755|NCT01676220|364122376|FG001|Overall Study|Received Rescue Therapy|22|||
105579756|NCT01676220|364122375|FG000|Overall Study|Personal Reason|34|||
105579757|NCT01676220|364122376|FG001|Overall Study|Personal Reason|45|||
105579758|NCT01676220|364122375|FG000|Overall Study|Lost to Follow-up|11|||
105579759|NCT01676220|364122376|FG001|Overall Study|Lost to Follow-up|18|||
105579760|NCT01676220|364122375|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
105579761|NCT01676220|364122376|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
105579762|NCT01676220|364122375|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
105579763|NCT01676220|364122376|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
105579764|NCT01676220|364122375|FG000|Overall Study|Perceived Lack of Efficacy|3|||
105579765|NCT01676220|364122376|FG001|Overall Study|Perceived Lack of Efficacy|1|||
105579766|NCT01676220|364122375|FG000|Overall Study|Non Serious Hypoglycemia|2|||
105579767|NCT01676220|364122376|FG001|Overall Study|Non Serious Hypoglycemia|0|||
105579768|NCT01676220|364122375|FG000|Overall Study|No More Need of Insulin|1|||
105579769|NCT01676220|364122376|FG001|Overall Study|No More Need of Insulin|0|||
105579770|NCT01558674|364122377|FG000|Part 1|Study Terminated by Sponsor|10|||
105579771|NCT01558674|364122378|FG001|Part 1|Study Terminated by Sponsor|0|||
105579772|NCT01558674|364122377|FG000|Part 1|Withdrawal by Subject|1|||
105579773|NCT01558674|364122378|FG001|Part 1|Withdrawal by Subject|0|||
105579774|NCT04147260|364122379|FG000|Overall Study|Adverse Event|1|||
105579775|NCT04147260|364122380|FG001|Overall Study|Adverse Event|0|||
105579776|NCT04147260|364122381|FG002|Overall Study|Adverse Event|1|||
105579777|NCT04147260|364122382|FG003|Overall Study|Adverse Event|2|||
105579778|NCT04147260|364122383|FG004|Overall Study|Adverse Event|0|||
105579779|NCT04147260|364122379|FG000|Overall Study|Withdrawal by Subject|0|||
105579780|NCT04147260|364122380|FG001|Overall Study|Withdrawal by Subject|0|||
105579781|NCT04147260|364122381|FG002|Overall Study|Withdrawal by Subject|1|||
105579782|NCT04147260|364122382|FG003|Overall Study|Withdrawal by Subject|1|||
105579783|NCT04147260|364122383|FG004|Overall Study|Withdrawal by Subject|0|||
105579784|NCT02411591|364122384|FG000|Overall Study|Adverse Event|0|||
105579785|NCT02411591|364122385|FG001|Overall Study|Adverse Event|4|||
105579786|NCT02411591|364122386|FG002|Overall Study|Adverse Event|2|||
105579787|NCT02411591|364122384|FG000|Overall Study|Withdrawal by Subject|0|||
105579788|NCT02411591|364122385|FG001|Overall Study|Withdrawal by Subject|3|||
105579789|NCT02411591|364122386|FG002|Overall Study|Withdrawal by Subject|0|||
105579790|NCT02411591|364122384|FG000|Overall Study|Physician Decision|0|||
105579791|NCT02411591|364122385|FG001|Overall Study|Physician Decision|3|||
105579792|NCT02411591|364122386|FG002|Overall Study|Physician Decision|1|||
105579793|NCT02954575|364122387|FG000|Overall Study|Withdrawal by Subject|2|||
105579794|NCT02954575|364122387|FG000|Overall Study|Adverse Event|1|||
105579795|NCT01734382|364122392|FG000|Part 1|Adverse Event|2|||
105579796|NCT01734382|364122393|FG001|Part 1|Adverse Event|0|||
105579797|NCT01734382|364122394|FG002|Part 1|Adverse Event|0|||
105579798|NCT01734382|364122392|FG000|Part 2|Adverse Event|0|||
105579799|NCT01734382|364122393|FG001|Part 2|Adverse Event|0|||
105579800|NCT01734382|364122394|FG002|Part 2|Adverse Event|1|||
105579801|NCT01734382|364122392|FG000|Part 2|Lack of Efficacy|0|||
105579802|NCT01734382|364122393|FG001|Part 2|Lack of Efficacy|1|||
105579803|NCT01734382|364122394|FG002|Part 2|Lack of Efficacy|1|||
105579804|NCT01734382|364122392|FG000|Part 2|Other|0|||
105579805|NCT01734382|364122393|FG001|Part 2|Other|0|||
105579806|NCT01734382|364122394|FG002|Part 2|Other|1|||
105579807|NCT01734382|364122392|FG000|Part 2|Physician Decision|0|||
105579808|NCT01734382|364122393|FG001|Part 2|Physician Decision|0|||
105579809|NCT01734382|364122394|FG002|Part 2|Physician Decision|3|||
105579810|NCT01734382|364122392|FG000|Part 2|Protocol Violation|0|||
105579811|NCT01734382|364122393|FG001|Part 2|Protocol Violation|1|||
105579812|NCT01734382|364122394|FG002|Part 2|Protocol Violation|0|||
105579813|NCT01734382|364122392|FG000|Part 2|Withdrawal by Subject|0|||
105579814|NCT01734382|364122393|FG001|Part 2|Withdrawal by Subject|0|||
105579815|NCT01734382|364122394|FG002|Part 2|Withdrawal by Subject|1|||
105579816|NCT02420327|364122395|FG000|Overall Study|Adverse Event|7|||
105579817|NCT02420327|364122395|FG000|Overall Study|Pregnancy|1|||
105579818|NCT02420327|364122395|FG000|Overall Study|Withdrawal by Subject|6|||
105579819|NCT02420327|364122395|FG000|Overall Study|Lost to Follow-up|1|||
105579820|NCT02420327|364122395|FG000|Overall Study|Protocol Violation|1|||
105579821|NCT02204293|364122396|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
105579822|NCT02204293|364122397|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
105579823|NCT02204293|364122398|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
105579824|NCT02204293|364122399|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
105579825|NCT02204293|364122400|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
105379032|NCT01510756|363392478|FG000|Overall Study|Physician Decision|1|||
105579826|NCT02204293|364122401|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
105579827|NCT02204293|364122396|FG000|Core Study Part I|Adverse Event|1|||
105579828|NCT02204293|364122397|FG001|Core Study Part I|Adverse Event|0|||
105579829|NCT02204293|364122398|FG002|Core Study Part I|Adverse Event|0|||
105579830|NCT02204293|364122399|FG003|Core Study Part I|Adverse Event|0|||
105579831|NCT02204293|364122400|FG004|Core Study Part I|Adverse Event|0|||
105579832|NCT02204293|364122401|FG005|Core Study Part I|Adverse Event|0|||
105579833|NCT02204293|364122396|FG000|Core Study Part I|Physician Decision|0|||
105579834|NCT02204293|364122397|FG001|Core Study Part I|Physician Decision|3|||
105579835|NCT02204293|364122398|FG002|Core Study Part I|Physician Decision|0|||
105579836|NCT02204293|364122399|FG003|Core Study Part I|Physician Decision|0|||
105579837|NCT02204293|364122400|FG004|Core Study Part I|Physician Decision|0|||
105579838|NCT02204293|364122401|FG005|Core Study Part I|Physician Decision|0|||
105579839|NCT02204293|364122396|FG000|LTE Phase|Study Suspended|0|||
105579840|NCT02204293|364122397|FG001|LTE Phase|Study Suspended|0|||
105579841|NCT02204293|364122398|FG002|LTE Phase|Study Suspended|0|||
105579842|NCT02204293|364122399|FG003|LTE Phase|Study Suspended|0|||
105579843|NCT02204293|364122400|FG004|LTE Phase|Study Suspended|0|||
105579844|NCT02204293|364122401|FG005|LTE Phase|Study Suspended|7|||
105579845|NCT02589392|364122409|FG000|Overall Study|Adverse Event|1|||
105579846|NCT02589392|364122410|FG001|Overall Study|Adverse Event|1|||
105579847|NCT02589392|364122409|FG000|Overall Study|Withdrawal by Subject|1|||
105579848|NCT02589392|364122410|FG001|Overall Study|Withdrawal by Subject|2|||
105579849|NCT02589392|364122409|FG000|Overall Study|Protocol Violation|1|||
105579850|NCT02589392|364122410|FG001|Overall Study|Protocol Violation|1|||
105579851|NCT02589392|364122409|FG000|Overall Study|Lost to Follow-up|2|||
105579852|NCT02589392|364122410|FG001|Overall Study|Lost to Follow-up|2|||
105579853|NCT02589392|364122409|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
105579854|NCT02589392|364122410|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
105579855|NCT04230980|364122413|FG000|Overall Study|Lost to Follow-up|1|||
105579856|NCT04230980|364122414|FG001|Overall Study|Lost to Follow-up|2|||
105579857|NCT04230980|364122413|FG000|Overall Study|Adverse Event|0|||
105579858|NCT04230980|364122414|FG001|Overall Study|Adverse Event|1|||
105579859|NCT01232556|364122417|FG000|Overall Study|Withdrawal by Subject|21|||
105579860|NCT01232556|364122418|FG001|Overall Study|Withdrawal by Subject|17|||
105379033|NCT01922011|363392479|FG000|Overall Study|Protocol Violation|0|||
105379034|NCT01922011|363392480|FG001|Overall Study|Protocol Violation|1|||
105579861|NCT01232556|364122417|FG000|Overall Study|Death|97|||
105579862|NCT01232556|364122418|FG001|Overall Study|Death|97|||
105579863|NCT01232556|364122417|FG000|Overall Study|Lost to Follow-up|0|||
105579864|NCT01232556|364122418|FG001|Overall Study|Lost to Follow-up|2|||
105579865|NCT01232556|364122417|FG000|Overall Study|Terminated by Sponsor|35|||
105579866|NCT01232556|364122418|FG001|Overall Study|Terminated by Sponsor|51|||
105579867|NCT01232556|364122417|FG000|Overall Study|Other|6|||
105579868|NCT01232556|364122418|FG001|Overall Study|Other|4|||
105579869|NCT01141660|364122420|FG000|Overall Study|Physician Decision|0|||
105579870|NCT01141660|364122421|FG001|Overall Study|Physician Decision|12|||
105579871|NCT00209027|364122422|FG000|Overall Study|study terminated|10|||
105579872|NCT00209027|364122423|FG001|Overall Study|study terminated|0|||
105579873|NCT04894903|364122430|FG000|Overall Study|Death|1|||
105579874|NCT04894903|364122431|FG001|Overall Study|Death|0|||
105579875|NCT04894903|364122430|FG000|Overall Study|Pregnancy|1|||
105579876|NCT04894903|364122431|FG001|Overall Study|Pregnancy|0|||
105579877|NCT04894903|364122430|FG000|Overall Study|Withdrawal by Subject|1|||
105579878|NCT04894903|364122431|FG001|Overall Study|Withdrawal by Subject|1|||
105579879|NCT04894903|364122430|FG000|Overall Study|moved or exited health system|1|||
105579880|NCT04894903|364122431|FG001|Overall Study|moved or exited health system|3|||
105579881|NCT04320615|364122432|FG000|Overall Study|Withdrawal by Subject|4|||
105579882|NCT04320615|364122433|FG001|Overall Study|Withdrawal by Subject|10|||
105579883|NCT04320615|364122432|FG000|Overall Study|Physician Decision|2|||
105579884|NCT04320615|364122433|FG001|Overall Study|Physician Decision|0|||
105579885|NCT04320615|364122432|FG000|Overall Study|Other|2|||
105579886|NCT04320615|364122433|FG001|Overall Study|Other|0|||
105379035|NCT01922011|363392479|FG000|Overall Study|Physician Decision|0|||
105579887|NCT04320615|364122432|FG000|Overall Study|Lost to Follow-up|5|||
105579888|NCT04320615|364122433|FG001|Overall Study|Lost to Follow-up|23|||
105579889|NCT04320615|364122432|FG000|Overall Study|Death|35|||
105579890|NCT04320615|364122433|FG001|Overall Study|Death|71|||
105579891|NCT00895843|364122434|FG000|Overall Study|Protocol Violation|12|||
105579892|NCT00895843|364122435|FG001|Overall Study|Protocol Violation|12|||
105579893|NCT04963062|364122436|FG000|Overall Study|withdrew by the study team|4|||
105579894|NCT04963062|364122437|FG001|Overall Study|withdrew by the study team|2|||
105579895|NCT01857323|364122438|FG000|Overall Study|Adverse Event|1|||
105579896|NCT01857323|364122438|FG000|Overall Study|Withdrawal by Subject|3|||
105579897|NCT01857323|364122438|FG000|Overall Study|Non-compliance|1|||
105579898|NCT01857323|364122438|FG000|Overall Study|Protocol Violation|6|||
105579899|NCT01857323|364122438|FG000|Overall Study|Lost to Follow-up|1|||
105579900|NCT01857323|364122438|FG000|Overall Study|Other|4|||
105579901|NCT01857323|364122438|FG000|Overall Study|Did not complete 180 doses|48|||
105579902|NCT01475786|364122439|FG000|Overall Study|Adverse Event|0|||
105579903|NCT01475786|364122440|FG001|Overall Study|Adverse Event|1|||
105579904|NCT01475786|364122441|FG002|Overall Study|Adverse Event|0|||
105579905|NCT01475786|364122439|FG000|Overall Study|Lost to Follow-up|1|||
105579906|NCT01475786|364122440|FG001|Overall Study|Lost to Follow-up|2|||
105579907|NCT01475786|364122441|FG002|Overall Study|Lost to Follow-up|1|||
105579908|NCT01475786|364122439|FG000|Overall Study|Withdrawal by Subject|0|||
105579909|NCT01475786|364122440|FG001|Overall Study|Withdrawal by Subject|1|||
105579910|NCT01475786|364122441|FG002|Overall Study|Withdrawal by Subject|1|||
105579911|NCT01475786|364122439|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
105579912|NCT01475786|364122440|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
105579913|NCT01475786|364122441|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
105579914|NCT01349829|364124164|FG000|Overall Study|Lost to Follow-up|4|||
105579915|NCT01349829|364124165|FG001|Overall Study|Lost to Follow-up|8|||
105579916|NCT01349829|364124164|FG000|Overall Study|Consent withdrawal|3|||
105579917|NCT01349829|364124165|FG001|Overall Study|Consent withdrawal|8|||
105579918|NCT01349829|364124164|FG000|Overall Study|Migrated/moved|2|||
105579919|NCT01349829|364124165|FG001|Overall Study|Migrated/moved|7|||
105579920|NCT02555371|364124166|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
105579921|NCT02555371|364124167|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
105579922|NCT02555371|364124168|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
105579923|NCT02555371|364124169|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
105579924|NCT02555371|364124170|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
105579925|NCT02555371|364124166|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
105579926|NCT02555371|364124167|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
105579927|NCT02555371|364124168|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
105579928|NCT02555371|364124169|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
105579929|NCT02555371|364124170|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
105579930|NCT02555371|364124166|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
105579931|NCT02555371|364124167|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
105579932|NCT02555371|364124168|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
105579933|NCT02555371|364124169|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
105579934|NCT02555371|364124170|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
105579935|NCT02555371|364124166|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
105579936|NCT02555371|364124167|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
105579937|NCT02555371|364124168|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
105579938|NCT02555371|364124169|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
105579939|NCT02555371|364124170|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
105579940|NCT02555371|364124166|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
105579941|NCT02555371|364124167|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
105579942|NCT02555371|364124168|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
105579943|NCT02555371|364124169|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
105579944|NCT02555371|364124170|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
105579945|NCT02555371|364124166|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
105579946|NCT02555371|364124167|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
105579947|NCT02555371|364124168|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
105579948|NCT02555371|364124169|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
105579949|NCT02555371|364124170|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
105579950|NCT02555371|364124166|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
105579951|NCT02555371|364124167|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
105579952|NCT02555371|364124168|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
105579953|NCT02555371|364124169|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
105579954|NCT02555371|364124170|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
105579955|NCT02555371|364124166|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
105579956|NCT02555371|364124167|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
105579957|NCT02555371|364124168|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
105579958|NCT02555371|364124169|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
105579959|NCT02555371|364124170|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
105579960|NCT02555371|364124166|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
105579961|NCT02555371|364124167|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
105379036|NCT01922011|363392480|FG001|Overall Study|Physician Decision|1|||
105379037|NCT01922011|363392479|FG000|Overall Study|Parent/Guardian Decision|3|||
105379038|NCT01922011|363392480|FG001|Overall Study|Parent/Guardian Decision|0|||
105379039|NCT01922011|363392479|FG000|Overall Study|Lost to Follow-up|0|||
105379040|NCT01922011|363392480|FG001|Overall Study|Lost to Follow-up|1|||
105579962|NCT02555371|364124168|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
105579963|NCT02555371|364124169|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
105579964|NCT02555371|364124170|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
105579965|NCT02555371|364124166|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
105579966|NCT02555371|364124167|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
105579967|NCT02555371|364124168|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
105579968|NCT02555371|364124169|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
105579969|NCT02555371|364124170|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
105579970|NCT02555371|364124166|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
105579971|NCT02555371|364124167|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
105579972|NCT02555371|364124168|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
105579973|NCT02555371|364124169|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
105579974|NCT02555371|364124170|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
105579975|NCT02555371|364124166|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
105579976|NCT02555371|364124167|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
105579977|NCT02555371|364124168|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
105579978|NCT02555371|364124169|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
105579979|NCT02555371|364124170|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
105579980|NCT02555371|364124166|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
105579981|NCT02555371|364124167|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
105579982|NCT02555371|364124168|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
105579983|NCT02555371|364124169|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
105579984|NCT02555371|364124170|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
105579985|NCT02555371|364124166|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
105579986|NCT02555371|364124167|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
105579987|NCT02555371|364124168|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
105579988|NCT02555371|364124169|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
105579989|NCT02555371|364124170|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
105579990|NCT00513019|364124172|FG000|Overall Study|Adverse Event|1|||
105579991|NCT00513019|364124173|FG001|Overall Study|Adverse Event|0|||
105579992|NCT00513019|364124172|FG000|Overall Study|Withdrawal by Subject|4|||
105579993|NCT00513019|364124173|FG001|Overall Study|Withdrawal by Subject|5|||
105579994|NCT01625910|364124174|FG000|Overall Study|Lost to Follow-up|3|||
105579995|NCT01625910|364124175|FG001|Overall Study|Lost to Follow-up|4|||
105579996|NCT01327547|364124176|FG000|Overall Study|Adverse Event|4|||
105579997|NCT01327547|364124177|FG001|Overall Study|Adverse Event|1|||
105579998|NCT01327547|364124176|FG000|Overall Study|Death|1|||
105579999|NCT01327547|364124177|FG001|Overall Study|Death|2|||
105580000|NCT01327547|364124176|FG000|Overall Study|Lost to Follow-up|6|||
105580001|NCT01327547|364124177|FG001|Overall Study|Lost to Follow-up|6|||
105580002|NCT01327547|364124176|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
105580003|NCT01327547|364124177|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
105580004|NCT01327547|364124176|FG000|Overall Study|Withdrawal by Subject|3|||
105580005|NCT01327547|364124177|FG001|Overall Study|Withdrawal by Subject|7|||
105580006|NCT01327547|364124176|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
105580007|NCT01327547|364124177|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
105580008|NCT01327547|364124176|FG000|Overall Study|Protocol Violation|1|||
105580009|NCT01327547|364124177|FG001|Overall Study|Protocol Violation|0|||
105580010|NCT01327547|364124176|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
105580011|NCT01327547|364124177|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
105580012|NCT01327547|364124176|FG000|Overall Study|Required prohibited medication|2|||
105580013|NCT01327547|364124177|FG001|Overall Study|Required prohibited medication|0|||
105580014|NCT01327547|364124176|FG000|Overall Study|Non-compliance with study procedures|1|||
105580015|NCT01327547|364124177|FG001|Overall Study|Non-compliance with study procedures|0|||
105580016|NCT01327547|364124176|FG000|Overall Study|By investigator in subject's interest|0|||
105580017|NCT01327547|364124177|FG001|Overall Study|By investigator in subject's interest|1|||
105580018|NCT03943589|364124181|FG000|Overall Study|Death|1|||
105379041|NCT01922011|363392479|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
105580019|NCT03943589|364124181|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
105580020|NCT00900627|364124182|FG000|Overall Study|Condition under investigation worsened|4|||
105580021|NCT00900627|364124183|FG001|Overall Study|Condition under investigation worsened|0|||
105580022|NCT00900627|364124184|FG002|Overall Study|Condition under investigation worsened|5|||
105379042|NCT01922011|363392480|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
105379043|NCT01922011|363392479|FG000|Overall Study|Not Treated|1|||
105379044|NCT01922011|363392480|FG001|Overall Study|Not Treated|0|||
105580023|NCT00900627|364124185|FG003|Overall Study|Condition under investigation worsened|3|||
105580024|NCT00900627|364124186|FG004|Overall Study|Condition under investigation worsened|0|||
105580025|NCT00900627|364124187|FG005|Overall Study|Condition under investigation worsened|0|||
105580026|NCT00900627|364124182|FG000|Overall Study|Withdrawal by Subject|1|||
105580027|NCT00900627|364124183|FG001|Overall Study|Withdrawal by Subject|0|||
105580028|NCT00900627|364124184|FG002|Overall Study|Withdrawal by Subject|1|||
105580029|NCT00900627|364124185|FG003|Overall Study|Withdrawal by Subject|0|||
105580030|NCT00900627|364124186|FG004|Overall Study|Withdrawal by Subject|1|||
105580031|NCT00900627|364124187|FG005|Overall Study|Withdrawal by Subject|2|||
105580032|NCT00900627|364124182|FG000|Overall Study|Adverse Event|1|||
105580033|NCT00900627|364124183|FG001|Overall Study|Adverse Event|2|||
105580034|NCT00900627|364124184|FG002|Overall Study|Adverse Event|0|||
105580035|NCT00900627|364124185|FG003|Overall Study|Adverse Event|3|||
105580036|NCT00900627|364124186|FG004|Overall Study|Adverse Event|0|||
105580037|NCT00900627|364124187|FG005|Overall Study|Adverse Event|0|||
105580038|NCT00900627|364124182|FG000|Overall Study|Death|0|||
105580039|NCT00900627|364124183|FG001|Overall Study|Death|0|||
105580040|NCT00900627|364124184|FG002|Overall Study|Death|0|||
105580041|NCT00900627|364124185|FG003|Overall Study|Death|0|||
105580042|NCT00900627|364124186|FG004|Overall Study|Death|28|||
105580043|NCT00900627|364124187|FG005|Overall Study|Death|24|||
105580044|NCT03583541|364124188|FG000|Overall Study|Lost to Follow-up|31|||
105580045|NCT03583541|364124189|FG001|Overall Study|Lost to Follow-up|65|||
105580046|NCT04102540|364124190|FG000|Overall Study|Withdrawn by PI|2|||
105580047|NCT04102540|364124190|FG000|Overall Study|Lost to Follow-up|6|||
105580048|NCT01477749|364124193|FG000|Overall Study|Physician Decision|4|||
105580049|NCT00280293|364124194|FG000|Overall Study|Protocol Violation|3|||
105580050|NCT00280293|364124195|FG001|Overall Study|Protocol Violation|0|||
105580051|NCT00280293|364124194|FG000|Overall Study|Physician Decision|5|||
105580052|NCT00280293|364124195|FG001|Overall Study|Physician Decision|4|||
105580053|NCT00280293|364124194|FG000|Overall Study|Lost to Follow-up|14|||
105580054|NCT00280293|364124195|FG001|Overall Study|Lost to Follow-up|12|||
105580055|NCT00280293|364124194|FG000|Overall Study|Withdrawal by Subject|3|||
105580056|NCT00280293|364124195|FG001|Overall Study|Withdrawal by Subject|5|||
105580057|NCT00280293|364124194|FG000|Overall Study|Incarceration/Legal Reasons|1|||
105580058|NCT00280293|364124195|FG001|Overall Study|Incarceration/Legal Reasons|1|||
105580059|NCT00280293|364124194|FG000|Overall Study|Adverse Event|0|||
105580060|NCT00280293|364124195|FG001|Overall Study|Adverse Event|1|||
105379045|NCT01922011|363392479|FG000|Overall Study|Lack of willing home health agency|1|||
105379046|NCT01922011|363392480|FG001|Overall Study|Lack of willing home health agency|0|||
105379047|NCT01922011|363392479|FG000|Overall Study|Randomized in error|1|||
105379048|NCT01922011|363392480|FG001|Overall Study|Randomized in error|0|||
105379049|NCT02447029|363392484|FG000|Overall Study|Withdrawal by Subject|3|||
105379050|NCT02447029|363392485|FG001|Overall Study|Withdrawal by Subject|2|||
105379051|NCT00726557|363392486|FG000|Overall Study|Screening failure|4|||
105379052|NCT00726557|363392486|FG000|Overall Study|No end of treatment documentation|37|||
105379053|NCT00726557|363392486|FG000|Overall Study|No follow-up documentation available|55|||
105379054|NCT00726557|363392486|FG000|Overall Study|Treatment less than 3 months|17|||
105379055|NCT00726557|363392486|FG000|Overall Study|Inclusion criteria not met|15|||
105379056|NCT01239745|363392487|FG000|Overall Study|Study terminated by sponsor|45|||
105379057|NCT01239745|363392487|FG000|Overall Study|Adverse Event|1|||
105379058|NCT01257542|363392488|FG000|Overall Study|Protocol Violation|3|||
105379059|NCT01257542|363392489|FG001|Overall Study|Protocol Violation|5|||
105379060|NCT01257542|363392488|FG000|Overall Study|Withdrawal by Subject|0|||
105379061|NCT01257542|363392489|FG001|Overall Study|Withdrawal by Subject|2|||
105379062|NCT00081458|363392491|FG000|Overall Study|Adverse Event|1|||
105379063|NCT00081458|363392492|FG001|Overall Study|Adverse Event|5|||
105379064|NCT00081458|363392493|FG002|Overall Study|Adverse Event|2|||
105379065|NCT00081458|363392491|FG000|Overall Study|Withdrawal by Subject|0|||
105379066|NCT00081458|363392492|FG001|Overall Study|Withdrawal by Subject|3|||
105379067|NCT00081458|363392493|FG002|Overall Study|Withdrawal by Subject|1|||
105379068|NCT00081458|363392491|FG000|Overall Study|Randomized but not dosed|0|||
105379069|NCT00081458|363392492|FG001|Overall Study|Randomized but not dosed|0|||
105379070|NCT00081458|363392493|FG002|Overall Study|Randomized but not dosed|1|||
105379071|NCT03600428|363392494|FG000|Overall Study|Not eligible|0|||
105379072|NCT03600428|363392495|FG001|Overall Study|Not eligible|1|||
105580061|NCT01177813|364124196|FG000|Overall Study|Adverse Event|8|||
105580062|NCT01177813|364124197|FG001|Overall Study|Adverse Event|2|||
105580063|NCT01177813|364124198|FG002|Overall Study|Adverse Event|4|||
105580064|NCT01177813|364124199|FG003|Overall Study|Adverse Event|6|||
105580065|NCT01177813|364124200|FG004|Overall Study|Adverse Event|3|||
105379073|NCT03600428|363392494|FG000|Overall Study|Lost to Follow-up|5|||
105379074|NCT03600428|363392495|FG001|Overall Study|Lost to Follow-up|4|||
105379075|NCT00770484|363392496|FG000|Overall Study|Withdrawal by Subject|1|||
105379076|NCT00770484|363392497|FG001|Overall Study|Withdrawal by Subject|0|||
105379077|NCT00894647|363392498|FG000|Overall Study|Adverse Event|5|||
105379078|NCT00894647|363392499|FG001|Overall Study|Adverse Event|4|||
105580066|NCT01177813|364124196|FG000|Overall Study|Lack of Efficacy|1|||
105379079|NCT00894647|363392498|FG000|Overall Study|Withdrawal by Subject|4|||
105379080|NCT00894647|363392499|FG001|Overall Study|Withdrawal by Subject|4|||
105379081|NCT00894647|363392498|FG000|Overall Study|Lost to Follow-up|0|||
105379082|NCT00894647|363392499|FG001|Overall Study|Lost to Follow-up|2|||
105379083|NCT00894647|363392498|FG000|Overall Study|Non-compliance with study procedures|0|||
105379084|NCT00894647|363392499|FG001|Overall Study|Non-compliance with study procedures|2|||
105379085|NCT00894647|363392498|FG000|Overall Study|Other, not due to AE|1|||
105379086|NCT00894647|363392499|FG001|Overall Study|Other, not due to AE|2|||
105379087|NCT02153827|363392505|FG000|Overall Study|Lost to Follow-up|3|||
105379088|NCT02153827|363392506|FG001|Overall Study|Lost to Follow-up|9|||
105379089|NCT00153920|363392507|FG000|Overall Study|Adverse Event|9|||
105379090|NCT00153920|363392507|FG000|Overall Study|Progressive Disease|9|||
105379091|NCT00153920|363392507|FG000|Overall Study|Physician Decision|3|||
105379092|NCT00153920|363392507|FG000|Overall Study|Lack of Response|3|||
105379093|NCT00153920|363392507|FG000|Overall Study|Death|2|||
105379094|NCT00153920|363392507|FG000|Overall Study|Withdrawal by Subject|1|||
105379095|NCT00153920|363392507|FG000|Overall Study|Non-Protocol Therapy|1|||
105379096|NCT00153920|363392507|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
105379097|NCT00153920|363392507|FG000|Overall Study|Progressive Disease before Trt|1|||
105379098|NCT02541903|363392510|FG000|Overall Study|Death|1|||
105379099|NCT01479530|363392513|FG000|Overall Study|Adverse Event|5|||
105379100|NCT01479530|363392514|FG001|Overall Study|Adverse Event|6|||
105379101|NCT01479530|363392513|FG000|Overall Study|Lack of Efficacy|0|||
105379102|NCT01479530|363392514|FG001|Overall Study|Lack of Efficacy|1|||
105379103|NCT01479530|363392513|FG000|Overall Study|Protocol Violation|2|||
105379104|NCT01479530|363392514|FG001|Overall Study|Protocol Violation|3|||
105379105|NCT01479530|363392513|FG000|Overall Study|Withdrawal of Consent|3|||
105379106|NCT01479530|363392514|FG001|Overall Study|Withdrawal of Consent|2|||
105379107|NCT04795323|363392515|FG000|Overall Study|Did not interact with TARA|1|||
105379108|NCT04795323|363392516|FG001|Overall Study|Did not interact with TARA|0|||
105379109|NCT02691663|363392518|FG000|Overall Study|Screen failure after baseline|2|||
105379110|NCT02691663|363392519|FG001|Overall Study|Screen failure after baseline|2|||
105379111|NCT02691663|363392518|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
105379112|NCT02691663|363392519|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
105379113|NCT02691663|363392518|FG000|Overall Study|Withdrawn after Follow up 2|1|||
105379114|NCT02691663|363392519|FG001|Overall Study|Withdrawn after Follow up 2|1|||
105379115|NCT02691663|363392518|FG000|Overall Study|Lost to Follow-up|3|||
105379116|NCT02691663|363392519|FG001|Overall Study|Lost to Follow-up|2|||
105379117|NCT03142750|363392520|FG000|Overall Study|Lost to Follow-up|4|||
105379118|NCT03142750|363392521|FG001|Overall Study|Lost to Follow-up|1|||
105379119|NCT05561140|363392522|FG000|Randomized Treatment Period|Adverse Event|1|||
105379120|NCT05561140|363392523|FG001|Randomized Treatment Period|Adverse Event|0|||
105379121|NCT05561140|363392522|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
105379122|NCT05561140|363392523|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
105379123|NCT05561140|363392522|FG000|Open Label Treatment Period|Adverse Event|6|||
105379124|NCT05561140|363392523|FG001|Open Label Treatment Period|Adverse Event|4|||
105379125|NCT05561140|363392522|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
105379126|NCT05561140|363392523|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
105379127|NCT05561140|363392522|FG000|Open Label Treatment Period|Physician Decision|0|||
105379128|NCT05561140|363392523|FG001|Open Label Treatment Period|Physician Decision|1|||
105379129|NCT05561140|363392522|FG000|Open Label Treatment Period|Pregnancy|1|||
105379130|NCT05561140|363392523|FG001|Open Label Treatment Period|Pregnancy|0|||
105379131|NCT05561140|363392522|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
105379132|NCT05561140|363392523|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
105379133|NCT05561140|363392522|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
105379134|NCT05561140|363392523|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
105379135|NCT05561140|363392522|FG000|Open Label Treatment Period|Other|1|||
105379136|NCT05561140|363392523|FG001|Open Label Treatment Period|Other|0|||
105379137|NCT03487445|363392524|FG000|Randomization|Not treated for administrative reasons|1|||
105379138|NCT03487445|363392525|FG001|Randomization|Not treated for administrative reasons|0|||
105379139|NCT01666652|363392530|FG000|Overall Study|Serious Adverse Event|0|||
105379140|NCT01666652|363392531|FG001|Overall Study|Serious Adverse Event|0|||
105379141|NCT01666652|363392532|FG002|Overall Study|Serious Adverse Event|0|||
105379142|NCT01666652|363392533|FG003|Overall Study|Serious Adverse Event|1|||
105379143|NCT01666652|363392534|FG004|Overall Study|Serious Adverse Event|0|||
105379144|NCT01666652|363392530|FG000|Overall Study|Withdrawal by Subject|0|||
105379145|NCT01666652|363392531|FG001|Overall Study|Withdrawal by Subject|0|||
105379146|NCT01666652|363392532|FG002|Overall Study|Withdrawal by Subject|0|||
105379147|NCT01666652|363392533|FG003|Overall Study|Withdrawal by Subject|0|||
105379148|NCT01666652|363392534|FG004|Overall Study|Withdrawal by Subject|1|||
105379149|NCT01666652|363392530|FG000|Overall Study|Moved from study area|1|||
105379150|NCT01666652|363392531|FG001|Overall Study|Moved from study area|0|||
105379151|NCT01666652|363392532|FG002|Overall Study|Moved from study area|0|||
105379152|NCT01666652|363392533|FG003|Overall Study|Moved from study area|2|||
105379153|NCT01666652|363392534|FG004|Overall Study|Moved from study area|0|||
105580067|NCT01177813|364124197|FG001|Overall Study|Lack of Efficacy|0|||
105580068|NCT01177813|364124198|FG002|Overall Study|Lack of Efficacy|0|||
105580069|NCT01177813|364124199|FG003|Overall Study|Lack of Efficacy|0|||
105580070|NCT01177813|364124200|FG004|Overall Study|Lack of Efficacy|0|||
105580071|NCT01177813|364124196|FG000|Overall Study|Protocol Violation|3|||
105580072|NCT01177813|364124197|FG001|Overall Study|Protocol Violation|2|||
105580073|NCT01177813|364124198|FG002|Overall Study|Protocol Violation|2|||
105580074|NCT01177813|364124199|FG003|Overall Study|Protocol Violation|0|||
105580075|NCT01177813|364124200|FG004|Overall Study|Protocol Violation|1|||
105580076|NCT01177813|364124196|FG000|Overall Study|Lost to Follow-up|12|||
105580077|NCT01177813|364124197|FG001|Overall Study|Lost to Follow-up|5|||
105379154|NCT01666652|363392530|FG000|Overall Study|Lost to Follow-up|1|||
105379155|NCT01666652|363392531|FG001|Overall Study|Lost to Follow-up|1|||
105379156|NCT01666652|363392532|FG002|Overall Study|Lost to Follow-up|1|||
105379157|NCT01666652|363392533|FG003|Overall Study|Lost to Follow-up|1|||
105379158|NCT01666652|363392534|FG004|Overall Study|Lost to Follow-up|0|||
105379159|NCT03325439|363392535|FG000|Overall Study|Ineligibility|3|||
105379160|NCT00866320|363392537|FG000|Overall Study|Withdrawal by Subject|4|||
105379161|NCT00866320|363392537|FG000|Overall Study|Death|2|||
105379162|NCT03412890|363392540|FG000|Overall Study|Adverse Event|5|||
105379163|NCT03412890|363392541|FG001|Overall Study|Adverse Event|5|||
105379164|NCT03412890|363392542|FG002|Overall Study|Adverse Event|9|||
105379165|NCT03412890|363392540|FG000|Overall Study|Protocol deviation|2|||
105379166|NCT03412890|363392541|FG001|Overall Study|Protocol deviation|1|||
105379167|NCT03412890|363392542|FG002|Overall Study|Protocol deviation|2|||
105379168|NCT03412890|363392540|FG000|Overall Study|Lost to Follow-up|7|||
105379169|NCT03412890|363392541|FG001|Overall Study|Lost to Follow-up|10|||
105379170|NCT03412890|363392542|FG002|Overall Study|Lost to Follow-up|10|||
105379171|NCT03412890|363392540|FG000|Overall Study|Withdrawal by Subject|9|||
105379172|NCT03412890|363392541|FG001|Overall Study|Withdrawal by Subject|12|||
105379173|NCT03412890|363392542|FG002|Overall Study|Withdrawal by Subject|11|||
105379174|NCT03412890|363392540|FG000|Overall Study|Lack of Efficacy|2|||
105379175|NCT03412890|363392541|FG001|Overall Study|Lack of Efficacy|7|||
105379176|NCT03412890|363392542|FG002|Overall Study|Lack of Efficacy|5|||
105379177|NCT03412890|363392540|FG000|Overall Study|Other|5|||
105379178|NCT03412890|363392541|FG001|Overall Study|Other|6|||
105379179|NCT03412890|363392542|FG002|Overall Study|Other|5|||
105379180|NCT03412890|363392540|FG000|Overall Study|Participants who did not receive any study drug|0|||
105379181|NCT03412890|363392541|FG001|Overall Study|Participants who did not receive any study drug|1|||
105379182|NCT03412890|363392542|FG002|Overall Study|Participants who did not receive any study drug|0|||
105379183|NCT02315625|363392543|FG000|First Intervention|Disease Progression|1|||
105379184|NCT02315625|363392544|FG001|First Intervention|Disease Progression|0|||
105379185|NCT02315625|363392543|FG000|Second Intervention|Physician Decision|2|||
105379186|NCT02315625|363392544|FG001|Second Intervention|Physician Decision|1|||
105379187|NCT02315625|363392543|FG000|Second Intervention|Study closure|1|||
105379188|NCT02315625|363392544|FG001|Second Intervention|Study closure|0|||
105379189|NCT02315625|363392543|FG000|Second Intervention|Disease Progression|1|||
105379190|NCT02315625|363392544|FG001|Second Intervention|Disease Progression|0|||
105379191|NCT00021255|363392547|FG000|Overall Study|Death|1|||
105379192|NCT00021255|363392548|FG001|Overall Study|Death|0|||
105379193|NCT00021255|363392549|FG002|Overall Study|Death|2|||
105379194|NCT00021255|363392547|FG000|Overall Study|Breast cancer relapse|5|||
105379195|NCT00021255|363392548|FG001|Overall Study|Breast cancer relapse|18|||
105379196|NCT00021255|363392549|FG002|Overall Study|Breast cancer relapse|11|||
105379197|NCT00021255|363392547|FG000|Overall Study|Second primary malignancy|0|||
105379198|NCT00021255|363392548|FG001|Overall Study|Second primary malignancy|4|||
105379199|NCT00021255|363392549|FG002|Overall Study|Second primary malignancy|1|||
105379200|NCT00021255|363392547|FG000|Overall Study|Withdrawal by Subject|41|||
105379201|NCT00021255|363392548|FG001|Overall Study|Withdrawal by Subject|64|||
105379202|NCT00021255|363392549|FG002|Overall Study|Withdrawal by Subject|26|||
105379203|NCT00021255|363392547|FG000|Overall Study|Lost to Follow-up|0|||
105379204|NCT00021255|363392548|FG001|Overall Study|Lost to Follow-up|2|||
105379205|NCT00021255|363392549|FG002|Overall Study|Lost to Follow-up|3|||
105379206|NCT00021255|363392547|FG000|Overall Study|Cardiac toxicity|0|||
105379207|NCT00021255|363392548|FG001|Overall Study|Cardiac toxicity|61|||
105379208|NCT00021255|363392549|FG002|Overall Study|Cardiac toxicity|32|||
105379209|NCT00021255|363392547|FG000|Overall Study|Herceptin toxicity|0|||
105379210|NCT00021255|363392548|FG001|Overall Study|Herceptin toxicity|22|||
105379211|NCT00021255|363392549|FG002|Overall Study|Herceptin toxicity|6|||
105379212|NCT00021255|363392547|FG000|Overall Study|Adverse Event|46|||
105379213|NCT00021255|363392548|FG001|Overall Study|Adverse Event|30|||
105379214|NCT00021255|363392549|FG002|Overall Study|Adverse Event|18|||
105580078|NCT01177813|364124198|FG002|Overall Study|Lost to Follow-up|6|||
105379215|NCT00021255|363392547|FG000|Overall Study|Protocol Violation|0|||
105379216|NCT00021255|363392548|FG001|Overall Study|Protocol Violation|2|||
105379217|NCT00021255|363392549|FG002|Overall Study|Protocol Violation|0|||
105379218|NCT00021255|363392547|FG000|Overall Study|Other than specified above|0|||
105580079|NCT01177813|364124199|FG003|Overall Study|Lost to Follow-up|3|||
105580080|NCT01177813|364124200|FG004|Overall Study|Lost to Follow-up|0|||
105580081|NCT01177813|364124196|FG000|Overall Study|Withdrawal by Subject|12|||
105580082|NCT01177813|364124197|FG001|Overall Study|Withdrawal by Subject|7|||
105580083|NCT01177813|364124198|FG002|Overall Study|Withdrawal by Subject|6|||
105580084|NCT01177813|364124199|FG003|Overall Study|Withdrawal by Subject|5|||
105580085|NCT01177813|364124200|FG004|Overall Study|Withdrawal by Subject|3|||
105580086|NCT01177813|364124196|FG000|Overall Study|Other reason not defined above|5|||
105580087|NCT01177813|364124197|FG001|Overall Study|Other reason not defined above|2|||
105330676|NCT03351608|363211284|FG003|Overall Study|Other|3|||
105330677|NCT03351608|363211285|FG004|Overall Study|Other|0|||
105330678|NCT03150719|363211286|FG000|Overall Study|Adverse Event|0|||
105330679|NCT03150719|363211287|FG001|Overall Study|Adverse Event|1|||
105379219|NCT00021255|363392548|FG001|Overall Study|Other than specified above|38|||
105379220|NCT00021255|363392549|FG002|Overall Study|Other than specified above|19|||
105379221|NCT00021255|363392547|FG000|Overall Study|Missing|0|||
105379222|NCT00021255|363392548|FG001|Overall Study|Missing|27|||
105379223|NCT00021255|363392549|FG002|Overall Study|Missing|13|||
105379224|NCT00021255|363392547|FG000|Overall Study|Randomized but not treated|28|||
105379225|NCT00021255|363392548|FG001|Overall Study|Randomized but not treated|2|||
105379226|NCT00021255|363392549|FG002|Overall Study|Randomized but not treated|18|||
105379227|NCT00387127|363392552|FG000|Overall Study|Lost to Follow-up|0|||
105379228|NCT00387127|363392553|FG001|Overall Study|Lost to Follow-up|4|||
105379229|NCT00387127|363392552|FG000|Overall Study|Death|16|||
105379230|NCT00387127|363392553|FG001|Overall Study|Death|16|||
105379231|NCT00387127|363392552|FG000|Overall Study|Physician Decision|0|||
105379232|NCT00387127|363392553|FG001|Overall Study|Physician Decision|1|||
105379233|NCT00387127|363392552|FG000|Overall Study|Withdrawal by Subject|3|||
105379234|NCT00387127|363392553|FG001|Overall Study|Withdrawal by Subject|2|||
105379235|NCT00387127|363392552|FG000|Overall Study|Required by Protocol Amendment #4|12|||
105379236|NCT00387127|363392553|FG001|Overall Study|Required by Protocol Amendment #4|10|||
105379237|NCT00387127|363392552|FG000|Overall Study|Serious Adverse Event|1|||
105379238|NCT00387127|363392553|FG001|Overall Study|Serious Adverse Event|1|||
105580088|NCT01177813|364124198|FG002|Overall Study|Other reason not defined above|2|||
105580089|NCT01177813|364124199|FG003|Overall Study|Other reason not defined above|3|||
105580090|NCT01177813|364124200|FG004|Overall Study|Other reason not defined above|2|||
105580091|NCT02056119|364124205|FG000|Overall Study|Death|1|||
105580092|NCT02056119|364124206|FG001|Overall Study|Death|2|||
105580093|NCT02056119|364124205|FG000|Overall Study|Intubated for less than 24 hrs|2|||
105580094|NCT02056119|364124206|FG001|Overall Study|Intubated for less than 24 hrs|7|||
105580095|NCT02056119|364124205|FG000|Overall Study|No aerosol treatments were given.|3|||
105580096|NCT02056119|364124206|FG001|Overall Study|No aerosol treatments were given.|2|||
105580097|NCT02056119|364124205|FG000|Overall Study|Received Metaneb treatment|0|||
105580098|NCT02056119|364124206|FG001|Overall Study|Received Metaneb treatment|2|||
105580099|NCT02056119|364124205|FG000|Overall Study|Protocol Violation|4|||
105580100|NCT02056119|364124206|FG001|Overall Study|Protocol Violation|7|||
105580101|NCT01348854|364124207|FG000|Overall Study|Lost to Follow-up|2|||
105580102|NCT01348854|364124208|FG001|Overall Study|Lost to Follow-up|1|||
105580103|NCT01348854|364124207|FG000|Overall Study|Withdrawal by Subject|1|||
105580104|NCT01348854|364124208|FG001|Overall Study|Withdrawal by Subject|0|||
105330680|NCT03150719|363211286|FG000|Overall Study|Death|0|||
105330681|NCT03150719|363211287|FG001|Overall Study|Death|1|||
105330682|NCT03150719|363211286|FG000|Overall Study|Other|1|||
105330683|NCT03150719|363211287|FG001|Overall Study|Other|0|||
105330684|NCT01790984|363211288|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
105330685|NCT01790984|363211289|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
105330686|NCT01790984|363211290|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
105330687|NCT01790984|363211291|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
105330688|NCT03187301|363211292|FG000|Titration Period|Adverse Event|0|||
105330689|NCT03187301|363211293|FG001|Titration Period|Adverse Event|0|||
105330690|NCT03187301|363211294|FG002|Titration Period|Adverse Event|0|||
105330691|NCT03187301|363211295|FG003|Titration Period|Adverse Event|0|||
105330692|NCT03187301|363211296|FG004|Titration Period|Adverse Event|0|||
105330693|NCT03187301|363211297|FG005|Titration Period|Adverse Event|0|||
105330694|NCT03187301|363211298|FG006|Titration Period|Adverse Event|5|||
105330695|NCT03187301|363211292|FG000|Titration Period|Withdrawal by Subject|0|||
105330696|NCT03187301|363211293|FG001|Titration Period|Withdrawal by Subject|0|||
105330697|NCT03187301|363211294|FG002|Titration Period|Withdrawal by Subject|0|||
105330698|NCT03187301|363211295|FG003|Titration Period|Withdrawal by Subject|0|||
105330699|NCT03187301|363211296|FG004|Titration Period|Withdrawal by Subject|0|||
105330700|NCT03187301|363211297|FG005|Titration Period|Withdrawal by Subject|0|||
105330701|NCT03187301|363211298|FG006|Titration Period|Withdrawal by Subject|1|||
105330702|NCT03187301|363211292|FG000|Titration Period|Exclusion Criteria Met|0|||
105330703|NCT03187301|363211293|FG001|Titration Period|Exclusion Criteria Met|0|||
105330704|NCT03187301|363211294|FG002|Titration Period|Exclusion Criteria Met|0|||
105330705|NCT03187301|363211295|FG003|Titration Period|Exclusion Criteria Met|0|||
105330706|NCT03187301|363211296|FG004|Titration Period|Exclusion Criteria Met|0|||
105330707|NCT03187301|363211297|FG005|Titration Period|Exclusion Criteria Met|0|||
105379239|NCT00387127|363392552|FG000|Overall Study|Sponsor Unblinded|1|||
105379240|NCT00387127|363392553|FG001|Overall Study|Sponsor Unblinded|0|||
105379241|NCT01947933|363392554|FG000|Overall Study|Withdrawal by Subject|0|||
105379242|NCT01947933|363392555|FG001|Overall Study|Withdrawal by Subject|0|||
105379243|NCT01947933|363392556|FG002|Overall Study|Withdrawal by Subject|1|||
105379244|NCT01947933|363392557|FG003|Overall Study|Withdrawal by Subject|0|||
105379245|NCT01947933|363392558|FG004|Overall Study|Withdrawal by Subject|0|||
105379246|NCT01947933|363392559|FG005|Overall Study|Withdrawal by Subject|0|||
105379247|NCT01947933|363392560|FG006|Overall Study|Withdrawal by Subject|0|||
105379248|NCT01947933|363392561|FG007|Overall Study|Withdrawal by Subject|0|||
105379249|NCT01947933|363392562|FG008|Overall Study|Withdrawal by Subject|0|||
105379250|NCT01947933|363392554|FG000|Overall Study|Lost to Follow-up|0|||
105379251|NCT01947933|363392555|FG001|Overall Study|Lost to Follow-up|0|||
105379252|NCT01947933|363392556|FG002|Overall Study|Lost to Follow-up|0|||
105379253|NCT01947933|363392557|FG003|Overall Study|Lost to Follow-up|0|||
105379254|NCT01947933|363392558|FG004|Overall Study|Lost to Follow-up|0|||
105379255|NCT01947933|363392559|FG005|Overall Study|Lost to Follow-up|0|||
105379256|NCT01947933|363392560|FG006|Overall Study|Lost to Follow-up|0|||
105330708|NCT03187301|363211298|FG006|Titration Period|Exclusion Criteria Met|1|||
105330709|NCT03187301|363211292|FG000|Pre-Intervention|Withdrawal by Subject|1|||
105330710|NCT03187301|363211293|FG001|Pre-Intervention|Withdrawal by Subject|0|||
105330711|NCT03187301|363211294|FG002|Pre-Intervention|Withdrawal by Subject|0|||
105330712|NCT03187301|363211295|FG003|Pre-Intervention|Withdrawal by Subject|0|||
105330713|NCT03187301|363211296|FG004|Pre-Intervention|Withdrawal by Subject|0|||
105330714|NCT03187301|363211297|FG005|Pre-Intervention|Withdrawal by Subject|0|||
105330715|NCT03187301|363211298|FG006|Pre-Intervention|Withdrawal by Subject|0|||
105330716|NCT01966120|363211299|FG000|Overall Study|Withdrawal by Subject|0|||
105330717|NCT01966120|363211300|FG001|Overall Study|Withdrawal by Subject|5|||
105330718|NCT01966120|363211299|FG000|Overall Study|Lost to Follow-up|1|||
105330719|NCT01966120|363211300|FG001|Overall Study|Lost to Follow-up|1|||
105330720|NCT00561392|363211302|FG000|Overall Study|Adverse Event|38|||
105330721|NCT00561392|363211302|FG000|Overall Study|Lack of Efficacy|2|||
105330722|NCT00561392|363211302|FG000|Overall Study|Protocol Violation|1|||
105330723|NCT00561392|363211302|FG000|Overall Study|Withdrawal by Subject|8|||
105330724|NCT00561392|363211302|FG000|Overall Study|Administrative problems|4|||
105330725|NCT02861807|363211303|FG000|Overall Study|Lost to Follow-up|7|||
105330726|NCT02861807|363211304|FG001|Overall Study|Lost to Follow-up|6|||
105330727|NCT02861807|363211303|FG000|Overall Study|Withdrawal by Subject|5|||
105330728|NCT02861807|363211304|FG001|Overall Study|Withdrawal by Subject|8|||
105330729|NCT00410813|363211305|FG000|Overall Study|Adverse Event|6|||
105330730|NCT00410813|363211306|FG001|Overall Study|Adverse Event|11|||
105330731|NCT00410813|363211305|FG000|Overall Study|Progression|32|||
105330732|NCT00410813|363211306|FG001|Overall Study|Progression|21|||
105330733|NCT00410813|363211305|FG000|Overall Study|Not protocol specified|3|||
105330734|NCT00410813|363211306|FG001|Overall Study|Not protocol specified|4|||
105330735|NCT00410813|363211305|FG000|Overall Study|Ineligible|2|||
105330736|NCT00410813|363211306|FG001|Overall Study|Ineligible|4|||
105330737|NCT00410813|363211305|FG000|Overall Study|Death|0|||
105330738|NCT00410813|363211306|FG001|Overall Study|Death|2|||
105330739|NCT05027451|363211307|FG000|Overall Study|Lost to Follow-up|1|||
105330740|NCT05027451|363211308|FG001|Overall Study|Lost to Follow-up|1|||
105330741|NCT05310071|363211309|FG000|Overall Study|Death|0|||
105330742|NCT05310071|363211310|FG001|Overall Study|Death|3|||
105330743|NCT05310071|363211309|FG000|Overall Study|Adverse Event|4|||
105330744|NCT05310071|363211310|FG001|Overall Study|Adverse Event|31|||
105330745|NCT05310071|363211309|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
105330746|NCT05310071|363211310|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
105330747|NCT05310071|363211309|FG000|Overall Study|Protocol Deviation|2|||
105330748|NCT05310071|363211310|FG001|Overall Study|Protocol Deviation|0|||
105330749|NCT05310071|363211309|FG000|Overall Study|Randomized by Mistake|0|||
105330750|NCT05310071|363211310|FG001|Overall Study|Randomized by Mistake|1|||
105330751|NCT05310071|363211309|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
105330752|NCT05310071|363211310|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
105330753|NCT05310071|363211309|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
105330754|NCT05310071|363211310|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
105330755|NCT05310071|363211309|FG000|Overall Study|Site Terminated by Sponsor|0|||
105330756|NCT05310071|363211310|FG001|Overall Study|Site Terminated by Sponsor|2|||
105330757|NCT05310071|363211309|FG000|Overall Study|Study Terminated by Sponsor|282|||
105330758|NCT05310071|363211310|FG001|Overall Study|Study Terminated by Sponsor|559|||
105330759|NCT05310071|363211309|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
105330760|NCT05310071|363211310|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
105330761|NCT05310071|363211309|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
105330762|NCT05310071|363211310|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
105580105|NCT03220737|364124209|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
105580106|NCT03220737|364124210|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
105580107|NCT03220737|364124211|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
105580108|NCT03220737|364124212|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
105580109|NCT03220737|364124213|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
105580110|NCT03220737|364124214|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
105580111|NCT03220737|364124215|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
105580112|NCT03220737|364124209|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
105580113|NCT03220737|364124210|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
105580114|NCT03220737|364124211|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
105580115|NCT03220737|364124212|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
105580116|NCT03220737|364124213|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
105580117|NCT03220737|364124214|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
105580118|NCT03220737|364124215|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
105580119|NCT03220737|364124209|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
105580120|NCT03220737|364124210|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
105580121|NCT03220737|364124211|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
105580122|NCT03220737|364124212|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
105580123|NCT03220737|364124213|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
105580124|NCT03220737|364124214|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
105580125|NCT03220737|364124215|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
105580126|NCT03220737|364124209|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
105580127|NCT03220737|364124210|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
105580128|NCT03220737|364124211|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
105580129|NCT03220737|364124212|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
105580130|NCT03220737|364124213|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
105580131|NCT03220737|364124214|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
105580132|NCT03220737|364124215|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
105580133|NCT03220737|364124209|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
105580134|NCT03220737|364124210|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
105580135|NCT03220737|364124211|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
105580136|NCT03220737|364124212|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
105580137|NCT03220737|364124213|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
105580138|NCT03220737|364124214|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
105580139|NCT03220737|364124215|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
105580140|NCT03220737|364124209|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
105580141|NCT03220737|364124210|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
105580142|NCT03220737|364124211|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
105580143|NCT03220737|364124212|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
105580144|NCT03220737|364124213|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
105580145|NCT03220737|364124214|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
105580146|NCT03220737|364124215|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
105580147|NCT03220737|364124209|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
105379257|NCT01947933|363392561|FG007|Overall Study|Lost to Follow-up|0|||
105379258|NCT01947933|363392562|FG008|Overall Study|Lost to Follow-up|1|||
105379259|NCT03407482|363392563|FG000|Overall Study|Adverse Event|12|||
105379260|NCT03407482|363392563|FG000|Overall Study|Disease Relapse|1|||
105379261|NCT03407482|363392563|FG000|Overall Study|Lost to Follow-up|1|||
105379262|NCT03407482|363392563|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105379263|NCT03407482|363392563|FG000|Overall Study|Pregnancy|2|||
105379264|NCT03407482|363392563|FG000|Overall Study|Protocol Violation|1|||
105379265|NCT03407482|363392563|FG000|Overall Study|Study Terminated By Sponsor|106|||
105379266|NCT03407482|363392563|FG000|Overall Study|Withdrawal by Subject|6|||
105379267|NCT03407482|363392563|FG000|Overall Study|Data Entry Error|1|||
105379268|NCT01928771|363392566|FG000|Overall Study|Adverse Event|6|||
105379269|NCT01928771|363392567|FG001|Overall Study|Adverse Event|5|||
105379270|NCT01928771|363392568|FG002|Overall Study|Adverse Event|1|||
105379271|NCT01928771|363392566|FG000|Overall Study|Death|2|||
105379272|NCT01928771|363392567|FG001|Overall Study|Death|2|||
105379273|NCT01928771|363392568|FG002|Overall Study|Death|2|||
105379274|NCT01928771|363392566|FG000|Overall Study|Lost to Follow-up|5|||
105379275|NCT01928771|363392567|FG001|Overall Study|Lost to Follow-up|6|||
105379276|NCT01928771|363392568|FG002|Overall Study|Lost to Follow-up|3|||
105379277|NCT01928771|363392566|FG000|Overall Study|Withdrawal by Subject|20|||
105379278|NCT01928771|363392567|FG001|Overall Study|Withdrawal by Subject|15|||
105379279|NCT01928771|363392568|FG002|Overall Study|Withdrawal by Subject|17|||
105379280|NCT01928771|363392566|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
105379281|NCT01928771|363392567|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
105379282|NCT01928771|363392568|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
105379283|NCT01928771|363392566|FG000|Overall Study|Other Reasons|9|||
105379284|NCT01928771|363392567|FG001|Overall Study|Other Reasons|9|||
105379285|NCT01928771|363392568|FG002|Overall Study|Other Reasons|14|||
105379286|NCT01928771|363392566|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
105379287|NCT01928771|363392567|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
105379288|NCT01928771|363392568|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
105379289|NCT04827446|363393684|FG000|Overall Study|Lost to Follow-up|1|||
105379290|NCT04827446|363393685|FG001|Overall Study|Lost to Follow-up|1|||
105379291|NCT04827446|363393684|FG000|Overall Study|Death|2|||
105379292|NCT04827446|363393685|FG001|Overall Study|Death|0|||
105379293|NCT04827446|363393684|FG000|Overall Study|Withdrawal by Subject|2|||
105379294|NCT04827446|363393685|FG001|Overall Study|Withdrawal by Subject|2|||
105379295|NCT05638737|363393688|FG000|Overall Study|Withdrawal by Subject|4|||
105379296|NCT05638737|363393689|FG001|Overall Study|Withdrawal by Subject|7|||
105580148|NCT03220737|364124210|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
105580149|NCT03220737|364124211|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
105580150|NCT03220737|364124212|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
105580151|NCT03220737|364124213|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
105580152|NCT03220737|364124214|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
105580153|NCT03220737|364124215|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
105580154|NCT03220737|364124209|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
105580155|NCT03220737|364124210|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
105580156|NCT03220737|364124211|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
105580157|NCT03220737|364124212|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
105580158|NCT03220737|364124213|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
105379297|NCT03234881|363393690|FG000|Overall Study|Lost to Follow-up|9|||
105379298|NCT03234881|363393691|FG001|Overall Study|Lost to Follow-up|3|||
105379299|NCT00845182|363393692|FG000|Overall Study|Lost to Follow-up|3|||
105379300|NCT00845182|363393693|FG001|Overall Study|Lost to Follow-up|3|||
105379301|NCT00845182|363393694|FG002|Overall Study|Lost to Follow-up|4|||
105379302|NCT00845182|363393692|FG000|Overall Study|Adverse Event|0|||
105379303|NCT00845182|363393693|FG001|Overall Study|Adverse Event|1|||
105379304|NCT00845182|363393694|FG002|Overall Study|Adverse Event|1|||
105379305|NCT00845182|363393692|FG000|Overall Study|Physician Decision|0|||
105379306|NCT00845182|363393693|FG001|Overall Study|Physician Decision|0|||
105379307|NCT00845182|363393694|FG002|Overall Study|Physician Decision|1|||
105379308|NCT01297244|363393695|FG000|Overall Study|Progressive disease|22|||
105379309|NCT01297244|363393696|FG001|Overall Study|Progressive disease|3|||
105379310|NCT01297244|363393695|FG000|Overall Study|Adverse Event|9|||
105379311|NCT01297244|363393696|FG001|Overall Study|Adverse Event|1|||
105379312|NCT01297244|363393695|FG000|Overall Study|Death|1|||
105379313|NCT01297244|363393696|FG001|Overall Study|Death|1|||
105379314|NCT01297244|363393695|FG000|Overall Study|Clinical progression|1|||
105379315|NCT01297244|363393696|FG001|Overall Study|Clinical progression|1|||
105379316|NCT01297244|363393695|FG000|Overall Study|Withdrawal by Subject|2|||
105379317|NCT01297244|363393696|FG001|Overall Study|Withdrawal by Subject|0|||
105379318|NCT00549328|363393697|FG000|Overall Study|Adverse Event|2|||
105379319|NCT00549328|363393697|FG000|Overall Study|Disease Progression|10|||
105379320|NCT00549328|363393697|FG000|Overall Study|Death|1|||
105379321|NCT00549328|363393697|FG000|Overall Study|Use of Prohibited Medication|1|||
105379322|NCT05161936|363393698|FG000|Overall Study|Study terminated by Sponsor|1|||
105379323|NCT05161936|363393699|FG001|Overall Study|Study terminated by Sponsor|0|||
105379324|NCT05161936|363393700|FG002|Overall Study|Study terminated by Sponsor|0|||
105379325|NCT05161936|363393698|FG000|Overall Study|Withdrawal by Subject|0|||
105379326|NCT05161936|363393699|FG001|Overall Study|Withdrawal by Subject|0|||
105379327|NCT05161936|363393700|FG002|Overall Study|Withdrawal by Subject|1|||
105379328|NCT00776997|363393711|FG000|Overall Study|Adverse Event|2|||
105330763|NCT05310071|363211309|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
105330764|NCT05310071|363211310|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
105330765|NCT05310071|363211309|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
105330766|NCT05310071|363211310|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
105330767|NCT05310071|363211309|FG000|Overall Study|Withdrawal by Participant - Other|25|||
105330768|NCT05310071|363211310|FG001|Overall Study|Withdrawal by Participant - Other|30|||
105330769|NCT05310071|363211309|FG000|Overall Study|Lost to Follow-up|2|||
105330770|NCT05310071|363211310|FG001|Overall Study|Lost to Follow-up|4|||
105330771|NCT05310071|363211309|FG000|Overall Study|Reason Not Specified|1|||
105330772|NCT05310071|363211310|FG001|Overall Study|Reason Not Specified|3|||
105330773|NCT02091089|363211312|FG000|Overall Study|Lost to Follow-up|2|||
105330774|NCT00462709|363211313|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
105330775|NCT00462709|363211313|FG000|Overall Study|Lost to Follow-up|10|||
105330776|NCT00462709|363211313|FG000|Overall Study|Withdrawal by Subject|8|||
105330777|NCT00462709|363211313|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
105330778|NCT00462709|363211313|FG000|Overall Study|Death|2|||
105330779|NCT00462709|363211313|FG000|Overall Study|Logistical reasons|2|||
105330780|NCT00462709|363211313|FG000|Overall Study|Physician Decision|1|||
105330781|NCT00462709|363211313|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
105330782|NCT02097745|363211314|FG000|Overall Study|Adverse Event|25|||
105330783|NCT02097745|363211314|FG000|Overall Study|Death|16|||
105330784|NCT02097745|363211314|FG000|Overall Study|Failure to Return|14|||
105330785|NCT02097745|363211314|FG000|Overall Study|Administrative/Other|27|||
105330786|NCT02097745|363211314|FG000|Overall Study|Reason Not Specified|96|||
105330787|NCT00425750|363211315|FG000|Overall Study|Death|1|||
105330788|NCT00425750|363211315|FG000|Overall Study|Withdrawal by Subject|3|||
105330789|NCT00425750|363211315|FG000|Overall Study|Adverse Event|3|||
105330790|NCT00425750|363211315|FG000|Overall Study|Progression of disease|18|||
105330791|NCT03515811|363211316|FG000|Overall Study|Lost to Follow-up|2|||
105330792|NCT03515811|363211317|FG001|Overall Study|Lost to Follow-up|1|||
105330793|NCT03515811|363211316|FG000|Overall Study|Protocol Violation|1|||
105330794|NCT03515811|363211317|FG001|Overall Study|Protocol Violation|1|||
105330795|NCT03515811|363211316|FG000|Overall Study|Death|1|||
105330796|NCT03515811|363211317|FG001|Overall Study|Death|1|||
105330797|NCT03515811|363211316|FG000|Overall Study|Withdrawal by Subject|0|||
105330798|NCT03515811|363211317|FG001|Overall Study|Withdrawal by Subject|2|||
105330799|NCT03515811|363211316|FG000|Overall Study|Technical Problems|1|||
105330800|NCT03515811|363211317|FG001|Overall Study|Technical Problems|0|||
105330801|NCT03515811|363211316|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
105330802|NCT03515811|363211317|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
105330803|NCT03515811|363211316|FG000|Overall Study|COVID-19|0|||
105330804|NCT03515811|363211317|FG001|Overall Study|COVID-19|1|||
105379329|NCT06377488|363393712|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
105379330|NCT06377488|363393712|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
105379331|NCT06377488|363393712|FG000|Overall Study|Protocol Violation|1|||
105379332|NCT06377488|363393712|FG000|Overall Study|Lost to Follow-up|1|||
105379333|NCT06377488|363393712|FG000|Overall Study|Incorrect Lens Dispensed|2|||
105379334|NCT02112552|363393717|FG000|Overall Study|Withdrawal by Subject|1|||
105379335|NCT02112552|363393717|FG000|Overall Study|Adverse Event|1|||
105379336|NCT00774748|363393718|FG000|Overall Study|Lost to Follow-up|3|||
105379337|NCT02503865|363393719|FG000|Overall Study|Moved out of area|1|||
105379338|NCT02503865|363393720|FG001|Overall Study|Moved out of area|8|||
105379339|NCT02503865|363393721|FG002|Overall Study|Moved out of area|0|||
105379340|NCT02503865|363393719|FG000|Overall Study|Refused treatment|4|||
105379341|NCT02503865|363393720|FG001|Overall Study|Refused treatment|39|||
105330805|NCT04331067|363211318|FG000|Overall Study|Adverse Event|1|||
105330806|NCT04331067|363211319|FG001|Overall Study|Adverse Event|3|||
105330807|NCT04331067|363211320|FG002|Overall Study|Adverse Event|1|||
105330808|NCT04331067|363211318|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
105330809|NCT04331067|363211319|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
105330810|NCT04331067|363211320|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
105330811|NCT04339062|363211321|FG000|Overall Study|Death|0|||
105330812|NCT04339062|363211322|FG001|Overall Study|Death|1|||
105330813|NCT05870371|363211323|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
105330814|NCT05870371|363211324|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
105330815|NCT01197534|363211325|FG000|Overall Study|Not reported|16|||
105330816|NCT01197534|363211326|FG001|Overall Study|Not reported|10|||
105330817|NCT01197534|363211327|FG002|Overall Study|Not reported|16|||
105330818|NCT01197534|363211325|FG000|Overall Study|Enrolment in long term extension|57|||
105330819|NCT01197534|363211326|FG001|Overall Study|Enrolment in long term extension|66|||
105330820|NCT01197534|363211327|FG002|Overall Study|Enrolment in long term extension|119|||
105330821|NCT01197534|363211325|FG000|Overall Study|Severe non-compliance to protocol|3|||
105330822|NCT01197534|363211326|FG001|Overall Study|Severe non-compliance to protocol|4|||
105330823|NCT01197534|363211327|FG002|Overall Study|Severe non-compliance to protocol|1|||
105330824|NCT01197534|363211325|FG000|Overall Study|Lack of therapeutic response|9|||
105330825|NCT01197534|363211326|FG001|Overall Study|Lack of therapeutic response|4|||
105330826|NCT01197534|363211327|FG002|Overall Study|Lack of therapeutic response|9|||
105330827|NCT01197534|363211325|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
105330828|NCT01197534|363211326|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
105330829|NCT01197534|363211327|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
105330830|NCT01197534|363211325|FG000|Overall Study|Lost to Follow-up|1|||
105330831|NCT01197534|363211326|FG001|Overall Study|Lost to Follow-up|4|||
105330832|NCT01197534|363211327|FG002|Overall Study|Lost to Follow-up|2|||
105330833|NCT01197534|363211325|FG000|Overall Study|Adverse Event|35|||
105330834|NCT01197534|363211326|FG001|Overall Study|Adverse Event|36|||
105330835|NCT01197534|363211327|FG002|Overall Study|Adverse Event|24|||
105330836|NCT01153815|363211330|FG000|Overall Study|Adverse Event|3|||
105330837|NCT01153815|363211331|FG001|Overall Study|Adverse Event|1|||
105330838|NCT01153815|363211330|FG000|Overall Study|Withdrawal by Subject|6|||
105330839|NCT01153815|363211331|FG001|Overall Study|Withdrawal by Subject|4|||
105330840|NCT00708461|363211334|FG000|Overall Study|Lost to Follow-up|18|||
105330841|NCT00708461|363211335|FG001|Overall Study|Lost to Follow-up|11|||
105330842|NCT00708461|363211334|FG000|Overall Study|Withdrawal by Subject|8|||
105330843|NCT00708461|363211335|FG001|Overall Study|Withdrawal by Subject|9|||
105330844|NCT00708461|363211334|FG000|Overall Study|left workforce|115|||
105330845|NCT00708461|363211335|FG001|Overall Study|left workforce|180|||
105330846|NCT02968173|363211338|FG000|Overall Study|Withdrawal by Subject|1|||
105330847|NCT02670525|363211339|FG000|Overall Study|Death|94|||
105330848|NCT02670525|363211340|FG001|Overall Study|Death|14|||
105330849|NCT02670525|363211339|FG000|Overall Study|Lost to Follow-up|4|||
105330850|NCT02670525|363211340|FG001|Overall Study|Lost to Follow-up|1|||
105330851|NCT02670525|363211339|FG000|Overall Study|Subject withdrew consent|1|||
105330852|NCT02670525|363211340|FG001|Overall Study|Subject withdrew consent|0|||
105330853|NCT02670525|363211339|FG000|Overall Study|Unknown, data entry delayed|123|||
105330854|NCT02670525|363211340|FG001|Overall Study|Unknown, data entry delayed|78|||
105330855|NCT01796392|363211341|FG000|Overall Study|Withdrawal by Subject|2|||
105330856|NCT01796392|363211342|FG001|Overall Study|Withdrawal by Subject|0|||
105330857|NCT01796392|363211341|FG000|Overall Study|Death|5|||
105330858|NCT01796392|363211342|FG001|Overall Study|Death|1|||
105330859|NCT01796392|363211341|FG000|Overall Study|Excluded for medical reasons|1|||
105330860|NCT01796392|363211342|FG001|Overall Study|Excluded for medical reasons|2|||
105330861|NCT01796392|363211341|FG000|Overall Study|Lost to Follow-up|1|||
105330862|NCT01796392|363211342|FG001|Overall Study|Lost to Follow-up|0|||
105330863|NCT03627546|363211347|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
105330864|NCT03627546|363211348|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
105330865|NCT03627546|363211349|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
105330866|NCT03627546|363211347|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
105330867|NCT03627546|363211348|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
105330868|NCT03627546|363211349|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
105330869|NCT01134939|363211351|FG000|Overall Study|Adverse Event|9|||
105330870|NCT01134939|363211352|FG001|Overall Study|Adverse Event|3|||
105330871|NCT01134939|363211353|FG002|Overall Study|Adverse Event|4|||
105330872|NCT01134939|363211354|FG003|Overall Study|Adverse Event|5|||
105330873|NCT01134939|363211355|FG004|Overall Study|Adverse Event|5|||
105330874|NCT01134939|363211356|FG005|Overall Study|Adverse Event|5|||
105330875|NCT01134939|363211357|FG006|Overall Study|Adverse Event|1|||
105330876|NCT01134939|363211358|FG007|Overall Study|Adverse Event|0|||
105330877|NCT01134939|363211351|FG000|Overall Study|Lack of Efficacy|2|||
105330878|NCT01134939|363211352|FG001|Overall Study|Lack of Efficacy|5|||
105330879|NCT01134939|363211353|FG002|Overall Study|Lack of Efficacy|1|||
105330880|NCT01134939|363211354|FG003|Overall Study|Lack of Efficacy|0|||
105330881|NCT01134939|363211355|FG004|Overall Study|Lack of Efficacy|3|||
105330882|NCT01134939|363211356|FG005|Overall Study|Lack of Efficacy|0|||
105330883|NCT01134939|363211357|FG006|Overall Study|Lack of Efficacy|1|||
105330884|NCT01134939|363211358|FG007|Overall Study|Lack of Efficacy|0|||
105330885|NCT01134939|363211351|FG000|Overall Study|Lost to Follow-up|2|||
105330886|NCT01134939|363211352|FG001|Overall Study|Lost to Follow-up|3|||
105330887|NCT01134939|363211353|FG002|Overall Study|Lost to Follow-up|0|||
105330888|NCT01134939|363211354|FG003|Overall Study|Lost to Follow-up|1|||
105330889|NCT01134939|363211355|FG004|Overall Study|Lost to Follow-up|2|||
105330890|NCT01134939|363211356|FG005|Overall Study|Lost to Follow-up|1|||
105330891|NCT01134939|363211357|FG006|Overall Study|Lost to Follow-up|0|||
105330892|NCT01134939|363211358|FG007|Overall Study|Lost to Follow-up|0|||
105330893|NCT01134939|363211351|FG000|Overall Study|Death|0|||
105330894|NCT01134939|363211352|FG001|Overall Study|Death|1|||
105330895|NCT01134939|363211353|FG002|Overall Study|Death|0|||
105330896|NCT01134939|363211354|FG003|Overall Study|Death|0|||
105330897|NCT01134939|363211355|FG004|Overall Study|Death|0|||
105330898|NCT01134939|363211356|FG005|Overall Study|Death|0|||
105330899|NCT01134939|363211357|FG006|Overall Study|Death|0|||
105330900|NCT01134939|363211358|FG007|Overall Study|Death|0|||
105330901|NCT01134939|363211351|FG000|Overall Study|Termination page not available|4|||
105330902|NCT01134939|363211352|FG001|Overall Study|Termination page not available|6|||
105330903|NCT01134939|363211353|FG002|Overall Study|Termination page not available|5|||
105330904|NCT01134939|363211354|FG003|Overall Study|Termination page not available|8|||
105330905|NCT01134939|363211355|FG004|Overall Study|Termination page not available|0|||
105330906|NCT01134939|363211356|FG005|Overall Study|Termination page not available|3|||
105330907|NCT01134939|363211357|FG006|Overall Study|Termination page not available|7|||
105379342|NCT02503865|363393721|FG002|Overall Study|Refused treatment|2|||
105379343|NCT01529268|363393722|FG000|Overall Study|Lost to Follow-up|9|||
105379344|NCT01529268|363393723|FG001|Overall Study|Lost to Follow-up|3|||
105379345|NCT01529268|363393722|FG000|Overall Study|Moved|3|||
105379346|NCT01529268|363393723|FG001|Overall Study|Moved|0|||
105379347|NCT00303953|363393724|FG000|Overall Study|Ineligible|1|||
105379348|NCT00303953|363393724|FG000|Overall Study|Death|1|||
105379349|NCT00303953|363393724|FG000|Overall Study|Adverse Event|4|||
105379350|NCT00303953|363393724|FG000|Overall Study|Lack of Efficacy|12|||
105379351|NCT00303953|363393724|FG000|Overall Study|Physician Decision|1|||
105379352|NCT02393755|363393725|FG000|Overall Study|Withdrawal by Subject|0|||
105379353|NCT02393755|363393726|FG001|Overall Study|Withdrawal by Subject|3|||
105379354|NCT02393755|363393725|FG000|Overall Study|Adverse Event|0|||
105379355|NCT02393755|363393726|FG001|Overall Study|Adverse Event|2|||
105379356|NCT02393755|363393725|FG000|Overall Study|Physician Decision|0|||
105379357|NCT02393755|363393726|FG001|Overall Study|Physician Decision|2|||
105379358|NCT02337946|363393729|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
105379359|NCT02337946|363393730|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
105379360|NCT02337946|363393731|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
105379361|NCT02337946|363393729|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
105379362|NCT02337946|363393730|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
105379363|NCT02337946|363393731|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
105379364|NCT02337946|363393729|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
105379365|NCT02337946|363393730|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
105379366|NCT02337946|363393731|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
105379367|NCT02337946|363393729|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
105379368|NCT02337946|363393730|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
105379369|NCT02337946|363393731|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
105379370|NCT02337946|363393729|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
105379371|NCT02337946|363393730|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
105379372|NCT02337946|363393731|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
105379373|NCT02337946|363393729|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
105379374|NCT02337946|363393730|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
105379375|NCT02337946|363393731|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
105379376|NCT02337946|363393729|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
105379377|NCT02337946|363393730|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
105379378|NCT02337946|363393731|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
105379379|NCT02337946|363393729|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
105379380|NCT02337946|363393730|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
105379381|NCT02337946|363393731|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
105379382|NCT02337946|363393729|FG000|In-between Period|Without Informed Consent|1|||
105379383|NCT02337946|363393730|FG001|In-between Period|Without Informed Consent|0|||
105379384|NCT02337946|363393731|FG002|In-between Period|Without Informed Consent|0|||
105379385|NCT02337946|363393729|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
105379386|NCT02337946|363393730|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
105379387|NCT02337946|363393731|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
105379388|NCT02337946|363393729|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
105379389|NCT02337946|363393730|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
105379390|NCT02337946|363393731|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
105379391|NCT02337946|363393729|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
105379392|NCT02337946|363393730|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
105379393|NCT02337946|363393731|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
105379394|NCT02337946|363393729|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
105379395|NCT02337946|363393730|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
105379396|NCT02337946|363393731|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
105379397|NCT02337946|363393729|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
105379398|NCT02337946|363393730|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
105379399|NCT02337946|363393731|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
105379400|NCT02337946|363393729|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
105379401|NCT02337946|363393730|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
105379402|NCT02337946|363393731|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
105379403|NCT01327703|363393732|FG000|Second Treatment Period|Adverse Event|1|||
105379404|NCT01327703|363393733|FG001|Second Treatment Period|Adverse Event|1|||
105379405|NCT01327703|363393732|FG000|Second Treatment Period|Protocol Violation|0|||
105379406|NCT01327703|363393733|FG001|Second Treatment Period|Protocol Violation|1|||
105379407|NCT01786109|363393734|FG000|Overall Study|fail manometry barostat tube placement|1|||
105379408|NCT01786109|363393735|FG001|Overall Study|fail manometry barostat tube placement|0|||
105379409|NCT01786109|363393736|FG002|Overall Study|fail manometry barostat tube placement|0|||
105379410|NCT01786109|363393734|FG000|Overall Study|unrelated illness|0|||
105379411|NCT01786109|363393735|FG001|Overall Study|unrelated illness|0|||
105379412|NCT01786109|363393736|FG002|Overall Study|unrelated illness|1|||
105379413|NCT01786109|363393734|FG000|Overall Study|adverse effects colon preparation|0|||
105379414|NCT01786109|363393735|FG001|Overall Study|adverse effects colon preparation|0|||
105379415|NCT01786109|363393736|FG002|Overall Study|adverse effects colon preparation|1|||
105379416|NCT02949934|363393739|FG000|Natural Drinking Period|Adverse Event|1|||
105379417|NCT02949934|363393740|FG001|Natural Drinking Period|Adverse Event|0|||
105379418|NCT02949934|363393741|FG002|Natural Drinking Period|Adverse Event|0|||
105379419|NCT02949934|363393742|FG003|Natural Drinking Period|Adverse Event|1|||
105379420|NCT02949934|363393743|FG004|Natural Drinking Period|Adverse Event|0|||
105379421|NCT02949934|363393744|FG005|Natural Drinking Period|Adverse Event|0|||
105379422|NCT02949934|363393739|FG000|Natural Drinking Period|Lost to Follow-up|0|||
105379423|NCT02949934|363393740|FG001|Natural Drinking Period|Lost to Follow-up|0|||
105379424|NCT02949934|363393741|FG002|Natural Drinking Period|Lost to Follow-up|0|||
105379425|NCT02949934|363393742|FG003|Natural Drinking Period|Lost to Follow-up|0|||
105379426|NCT02949934|363393743|FG004|Natural Drinking Period|Lost to Follow-up|1|||
105379427|NCT02949934|363393744|FG005|Natural Drinking Period|Lost to Follow-up|0|||
105379428|NCT02949934|363393739|FG000|Neuroimaging|Protocol Violation|2|||
105379429|NCT02949934|363393740|FG001|Neuroimaging|Protocol Violation|0|||
105379430|NCT02949934|363393741|FG002|Neuroimaging|Protocol Violation|0|||
105379431|NCT02949934|363393742|FG003|Neuroimaging|Protocol Violation|0|||
105379432|NCT02949934|363393743|FG004|Neuroimaging|Protocol Violation|1|||
105379433|NCT02949934|363393744|FG005|Neuroimaging|Protocol Violation|0|||
105379434|NCT02949934|363393739|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
105379435|NCT02949934|363393740|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
105379436|NCT02949934|363393741|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
105379437|NCT02949934|363393742|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
105379438|NCT02949934|363393743|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
105379439|NCT02949934|363393744|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
105379440|NCT02949934|363393739|FG000|Neuroimaging|Not scanned|0|||
105379441|NCT02949934|363393740|FG001|Neuroimaging|Not scanned|0|||
105379442|NCT02949934|363393741|FG002|Neuroimaging|Not scanned|1|||
105379443|NCT02949934|363393742|FG003|Neuroimaging|Not scanned|0|||
105379444|NCT02949934|363393743|FG004|Neuroimaging|Not scanned|0|||
105379445|NCT02949934|363393744|FG005|Neuroimaging|Not scanned|2|||
105379446|NCT02949934|363393739|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
105379447|NCT02949934|363393740|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
105379448|NCT02949934|363393741|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
105379449|NCT02949934|363393742|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
105379450|NCT02949934|363393743|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
105379451|NCT02949934|363393744|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
105379452|NCT02949934|363393739|FG000|Bar Laboratory|Adverse Event|1|||
105379453|NCT02949934|363393740|FG001|Bar Laboratory|Adverse Event|0|||
105379454|NCT02949934|363393741|FG002|Bar Laboratory|Adverse Event|2|||
105379455|NCT02949934|363393742|FG003|Bar Laboratory|Adverse Event|0|||
105379456|NCT02949934|363393743|FG004|Bar Laboratory|Adverse Event|1|||
105379457|NCT02949934|363393744|FG005|Bar Laboratory|Adverse Event|0|||
105379458|NCT02949934|363393739|FG000|Bar Laboratory|Protocol Violation|0|||
105379459|NCT02949934|363393740|FG001|Bar Laboratory|Protocol Violation|0|||
105379460|NCT02949934|363393741|FG002|Bar Laboratory|Protocol Violation|0|||
105379461|NCT02949934|363393742|FG003|Bar Laboratory|Protocol Violation|1|||
105379462|NCT02949934|363393743|FG004|Bar Laboratory|Protocol Violation|0|||
105379463|NCT02949934|363393744|FG005|Bar Laboratory|Protocol Violation|0|||
105379464|NCT01068912|363393745|FG000|Overall Study|Adverse Event|2|||
105379465|NCT01068912|363393746|FG001|Overall Study|Adverse Event|3|||
105379466|NCT01068912|363393747|FG002|Overall Study|Adverse Event|2|||
105379467|NCT01068912|363393745|FG000|Overall Study|Withdrawal by Subject|5|||
105379468|NCT01068912|363393746|FG001|Overall Study|Withdrawal by Subject|6|||
105379469|NCT01068912|363393747|FG002|Overall Study|Withdrawal by Subject|6|||
105379470|NCT01068912|363393745|FG000|Overall Study|Lost to Follow-up|3|||
105379471|NCT01068912|363393746|FG001|Overall Study|Lost to Follow-up|7|||
105379472|NCT01068912|363393747|FG002|Overall Study|Lost to Follow-up|3|||
105379473|NCT01068912|363393745|FG000|Overall Study|Protocol Violation|0|||
105379474|NCT01068912|363393746|FG001|Overall Study|Protocol Violation|2|||
105379475|NCT01068912|363393747|FG002|Overall Study|Protocol Violation|0|||
105379476|NCT01068912|363393745|FG000|Overall Study|aggravation influenza|1|||
105379477|NCT01068912|363393746|FG001|Overall Study|aggravation influenza|1|||
105379478|NCT01068912|363393747|FG002|Overall Study|aggravation influenza|1|||
105379479|NCT01068912|363393745|FG000|Overall Study|other underlying illness|0|||
105379480|NCT01068912|363393746|FG001|Overall Study|other underlying illness|3|||
105379481|NCT01068912|363393747|FG002|Overall Study|other underlying illness|3|||
105379482|NCT00294398|363393753|FG000|Overall Study|Lost to Follow-up|21|||
105379483|NCT00294398|363393754|FG001|Overall Study|Lost to Follow-up|26|||
105379484|NCT01428128|363393759|FG000|Overall Study|Withdrawal by Subject|4|||
105379485|NCT01428128|363393759|FG000|Overall Study|Screen failure by p53|10|||
105379486|NCT01428128|363393759|FG000|Overall Study|Received Neulasta in one cycle|2|||
105379487|NCT01428128|363393759|FG000|Overall Study|Adverse Event|1|||
105379488|NCT00985790|363393760|FG000|Overall Study|Withdrawal by Subject|1|||
105379489|NCT00985790|363393761|FG001|Overall Study|Withdrawal by Subject|1|||
105379490|NCT00985790|363393760|FG000|Overall Study|Lost to Follow-up|6|||
105379491|NCT00985790|363393761|FG001|Overall Study|Lost to Follow-up|7|||
105379492|NCT03442569|363393763|FG000|Overall Study|Subject was ineligible after enrollment|1|||
105379493|NCT05089357|363393764|FG000|Overall Study|Withdrawal by Subject|23|||
105379494|NCT05089357|363393764|FG000|Overall Study|Lost to Follow-up|6|||
105379495|NCT05089357|363393764|FG000|Overall Study|Medical reason|1|||
105379496|NCT05089357|363393764|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
105379497|NCT05089357|363393764|FG000|Overall Study|Pregnancy|2|||
105379498|NCT00424008|363393765|FG000|Overall Study|Adverse Event|8|||
105379499|NCT00424008|363393766|FG001|Overall Study|Adverse Event|6|||
105379500|NCT00424008|363393765|FG000|Overall Study|Lack of Efficacy|40|||
105379501|NCT00424008|363393766|FG001|Overall Study|Lack of Efficacy|34|||
105379502|NCT00424008|363393765|FG000|Overall Study|Lost to Follow-up|1|||
105379503|NCT00424008|363393766|FG001|Overall Study|Lost to Follow-up|2|||
105379504|NCT00424008|363393765|FG000|Overall Study|Withdrawal by Subject|5|||
105379505|NCT00424008|363393766|FG001|Overall Study|Withdrawal by Subject|8|||
105379506|NCT00424008|363393765|FG000|Overall Study|Noncompliance with protocol|13|||
105379507|NCT00424008|363393766|FG001|Overall Study|Noncompliance with protocol|7|||
105379508|NCT00424008|363393765|FG000|Overall Study|Did not meet protocol eligibility|16|||
105379509|NCT00424008|363393766|FG001|Overall Study|Did not meet protocol eligibility|21|||
105379510|NCT00424008|363393765|FG000|Overall Study|Administrative|266|||
105379511|NCT00424008|363393766|FG001|Overall Study|Administrative|257|||
105379512|NCT03828383|363393773|FG000|Overall Study|Lost to Follow-up|3|||
105379513|NCT03828383|363393774|FG001|Overall Study|Lost to Follow-up|2|||
105379514|NCT03828383|363393773|FG000|Overall Study|Withdrawal by Subject|4|||
105379515|NCT03828383|363393774|FG001|Overall Study|Withdrawal by Subject|5|||
105379516|NCT00504309|363393775|FG000|Overall Study|Death|0|||
105379517|NCT00504309|363393776|FG001|Overall Study|Death|0|||
105379518|NCT00504309|363393777|FG002|Overall Study|Death|0|||
105379519|NCT00504309|363393778|FG003|Overall Study|Death|0|||
105379520|NCT00504309|363393779|FG004|Overall Study|Death|1|||
105379521|NCT00504309|363393780|FG005|Overall Study|Death|0|||
105379522|NCT00504309|363393775|FG000|Overall Study|Withdrawal by Subject|0|||
105379523|NCT00504309|363393776|FG001|Overall Study|Withdrawal by Subject|0|||
105379524|NCT00504309|363393777|FG002|Overall Study|Withdrawal by Subject|1|||
105379525|NCT00504309|363393778|FG003|Overall Study|Withdrawal by Subject|0|||
105379526|NCT00504309|363393779|FG004|Overall Study|Withdrawal by Subject|0|||
105379527|NCT00504309|363393780|FG005|Overall Study|Withdrawal by Subject|0|||
105379528|NCT00308685|363393781|FG000|Overall Study|Lost to Follow-up|1|||
105379529|NCT00308685|363393782|FG001|Overall Study|Lost to Follow-up|0|||
105379530|NCT00308685|363393781|FG000|Overall Study|Need to administer prohibited medication|1|||
105379531|NCT00308685|363393782|FG001|Overall Study|Need to administer prohibited medication|2|||
105379532|NCT00308685|363393781|FG000|Overall Study|Other than specified|1|||
105379533|NCT00308685|363393782|FG001|Overall Study|Other than specified|3|||
105379534|NCT03770455|363393783|FG000|Overall Study|Screen failures|3|||
105379535|NCT03345095|363393784|FG000|Overall Study|Lack of Efficacy|184|||
105379536|NCT03345095|363393785|FG001|Overall Study|Lack of Efficacy|156|||
105379537|NCT03345095|363393784|FG000|Overall Study|Adverse Event|36|||
105379538|NCT03345095|363393785|FG001|Overall Study|Adverse Event|118|||
105379539|NCT03345095|363393784|FG000|Overall Study|Withdrawal by Subject|22|||
105379540|NCT03345095|363393785|FG001|Overall Study|Withdrawal by Subject|59|||
105379541|NCT03345095|363393784|FG000|Overall Study|Physician Decision|3|||
105379542|NCT03345095|363393785|FG001|Overall Study|Physician Decision|18|||
105379543|NCT03345095|363393784|FG000|Overall Study|Death|2|||
105379544|NCT03345095|363393785|FG001|Overall Study|Death|4|||
105379545|NCT03345095|363393784|FG000|Overall Study|Other reasons|2|||
105379546|NCT03345095|363393785|FG001|Overall Study|Other reasons|11|||
105379547|NCT03345095|363393784|FG000|Overall Study|Protocol Violation|0|||
105379548|NCT03345095|363393785|FG001|Overall Study|Protocol Violation|1|||
105379549|NCT01121575|363393786|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
105379550|NCT01121575|363393787|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
105379551|NCT01121575|363393788|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
105379552|NCT01121575|363393789|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
105379553|NCT01121575|363393790|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
105379554|NCT01121575|363393791|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
105379555|NCT01121575|363393786|FG000|Overall Study|Unspecified Reasons|8|||
105379556|NCT01121575|363393787|FG001|Overall Study|Unspecified Reasons|6|||
105379557|NCT01121575|363393788|FG002|Overall Study|Unspecified Reasons|7|||
105379558|NCT01121575|363393789|FG003|Overall Study|Unspecified Reasons|5|||
105379559|NCT01121575|363393790|FG004|Overall Study|Unspecified Reasons|13|||
105379560|NCT01121575|363393791|FG005|Overall Study|Unspecified Reasons|10|||
105379561|NCT01121575|363393786|FG000|Overall Study|Death|6|||
105379562|NCT01121575|363393787|FG001|Overall Study|Death|0|||
105379563|NCT01121575|363393788|FG002|Overall Study|Death|0|||
105379564|NCT01121575|363393789|FG003|Overall Study|Death|1|||
105379565|NCT01121575|363393790|FG004|Overall Study|Death|7|||
105379566|NCT01121575|363393791|FG005|Overall Study|Death|1|||
105379567|NCT01350973|363393792|FG000|Overall Study|Adverse Event|4|||
105379568|NCT01350973|363393793|FG001|Overall Study|Adverse Event|7|||
105379569|NCT01350973|363393794|FG002|Overall Study|Adverse Event|7|||
105379570|NCT01350973|363393792|FG000|Overall Study|Voluntary Withdrawal|2|||
105379571|NCT01350973|363393793|FG001|Overall Study|Voluntary Withdrawal|1|||
105379572|NCT01350973|363393794|FG002|Overall Study|Voluntary Withdrawal|1|||
105379573|NCT01695772|363393798|FG000|Overall Study|Withdrawal by Subject|18|||
105379574|NCT01695772|363393798|FG000|Overall Study|Progressive Disease|8|||
105379575|NCT01695772|363393798|FG000|Overall Study|Investigator Decision|5|||
105379576|NCT01695772|363393798|FG000|Overall Study|Lost to Follow-up|4|||
105379577|NCT01695772|363393798|FG000|Overall Study|Protocol Violation|2|||
105379578|NCT01695772|363393798|FG000|Overall Study|Unspecified Reason|1|||
105379579|NCT00134719|363395326|FG000|Primary Vaccination Phase|Adverse Event|4|||
105379580|NCT00134719|363395327|FG001|Primary Vaccination Phase|Adverse Event|0|||
105379581|NCT00134719|363395328|FG002|Primary Vaccination Phase|Adverse Event|0|||
105379582|NCT00134719|363395326|FG000|Primary Vaccination Phase|Protocol Violation|1|||
105379583|NCT00134719|363395327|FG001|Primary Vaccination Phase|Protocol Violation|0|||
105379584|NCT00134719|363395328|FG002|Primary Vaccination Phase|Protocol Violation|0|||
105379585|NCT00134719|363395326|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
105379586|NCT00134719|363395327|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
105379587|NCT00134719|363395328|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
105379588|NCT00134719|363395326|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
105379589|NCT00134719|363395327|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
105379590|NCT00134719|363395328|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
105379591|NCT00134719|363395326|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
105379592|NCT00134719|363395327|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
105379593|NCT00134719|363395328|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
105379594|NCT00134719|363395326|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
105379595|NCT00134719|363395327|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
105379596|NCT00134719|363395328|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
105379597|NCT00639379|363395331|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
105379598|NCT00639379|363395332|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
105379599|NCT00639379|363395331|FG000|Period 1 - 2 Weeks|lens issue|3|||
105379600|NCT00639379|363395332|FG001|Period 1 - 2 Weeks|lens issue|0|||
105379601|NCT00263562|363395334|FG000|Overall Study|Protocol Violation|3|||
105379602|NCT00263562|363395335|FG001|Overall Study|Protocol Violation|0|||
105379603|NCT05059080|363395336|FG000|Overall Study|Withdrawal by Subject|3|||
105379604|NCT05059080|363395336|FG000|Overall Study|Study Terminated by Sponsor|64|||
105379605|NCT03927157|363395337|FG000|Overall Study|Adverse Event|1|||
105379606|NCT03927157|363395338|FG001|Overall Study|Adverse Event|3|||
105379607|NCT03927157|363395337|FG000|Overall Study|Protocol Violation|1|||
105379608|NCT03927157|363395338|FG001|Overall Study|Protocol Violation|2|||
105379609|NCT03927157|363395337|FG000|Overall Study|Withdrawal by Subject|8|||
105379610|NCT03927157|363395338|FG001|Overall Study|Withdrawal by Subject|21|||
105379611|NCT03927157|363395337|FG000|Overall Study|Due to COVID-19 pandemic|5|||
105379612|NCT03927157|363395338|FG001|Overall Study|Due to COVID-19 pandemic|2|||
105379613|NCT03927157|363395337|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
105379614|NCT03927157|363395338|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
105379615|NCT03927157|363395337|FG000|Overall Study|Other than above|0|||
105379616|NCT03927157|363395338|FG001|Overall Study|Other than above|1|||
105379617|NCT00875667|363395342|FG000|Overall Study|Adverse Event|29|||
105379618|NCT00875667|363395343|FG001|Overall Study|Adverse Event|10|||
105379619|NCT00875667|363395342|FG000|Overall Study|Withdrawal by Subject|17|||
105379620|NCT00875667|363395343|FG001|Overall Study|Withdrawal by Subject|5|||
105379621|NCT00875667|363395342|FG000|Overall Study|Death|7|||
105379622|NCT00875667|363395343|FG001|Overall Study|Death|2|||
105379623|NCT00875667|363395342|FG000|Overall Study|Protocol Violation|2|||
105379624|NCT00875667|363395343|FG001|Overall Study|Protocol Violation|0|||
105379625|NCT00875667|363395342|FG000|Overall Study|Disease Progression|100|||
105379626|NCT00875667|363395343|FG001|Overall Study|Disease Progression|49|||
105379627|NCT00875667|363395342|FG000|Overall Study|Miscellaneous|12|||
105379628|NCT00875667|363395343|FG001|Overall Study|Miscellaneous|6|||
105379629|NCT00875667|363395342|FG000|Overall Study|Randomized but no Study Drug Given|3|||
105379630|NCT00875667|363395343|FG001|Overall Study|Randomized but no Study Drug Given|1|||
105379631|NCT01158404|363395346|FG000|Overall Study|Withdrawal by Subject|0|||
105379632|NCT01158404|363395347|FG001|Overall Study|Withdrawal by Subject|1|||
105379633|NCT01158404|363395348|FG002|Overall Study|Withdrawal by Subject|0|||
105379634|NCT01158404|363395349|FG003|Overall Study|Withdrawal by Subject|0|||
105379635|NCT01158404|363395350|FG004|Overall Study|Withdrawal by Subject|3|||
105379636|NCT01158404|363395351|FG005|Overall Study|Withdrawal by Subject|1|||
105379637|NCT01158404|363395352|FG006|Overall Study|Withdrawal by Subject|0|||
105379638|NCT01158404|363395353|FG007|Overall Study|Withdrawal by Subject|1|||
105379639|NCT01158404|363395346|FG000|Overall Study|Physician Decision|0|||
105379640|NCT01158404|363395347|FG001|Overall Study|Physician Decision|0|||
105379641|NCT01158404|363395348|FG002|Overall Study|Physician Decision|0|||
105379642|NCT01158404|363395349|FG003|Overall Study|Physician Decision|0|||
105379643|NCT01158404|363395350|FG004|Overall Study|Physician Decision|0|||
105379644|NCT01158404|363395351|FG005|Overall Study|Physician Decision|0|||
105379645|NCT01158404|363395352|FG006|Overall Study|Physician Decision|0|||
105379646|NCT01158404|363395353|FG007|Overall Study|Physician Decision|1|||
105379647|NCT01158404|363395346|FG000|Overall Study|Progressive Disease|0|||
105379648|NCT01158404|363395347|FG001|Overall Study|Progressive Disease|0|||
105379649|NCT01158404|363395348|FG002|Overall Study|Progressive Disease|0|||
105379650|NCT01158404|363395349|FG003|Overall Study|Progressive Disease|0|||
105379651|NCT01158404|363395350|FG004|Overall Study|Progressive Disease|0|||
105379652|NCT01158404|363395351|FG005|Overall Study|Progressive Disease|0|||
105379653|NCT01158404|363395352|FG006|Overall Study|Progressive Disease|1|||
105379654|NCT01158404|363395353|FG007|Overall Study|Progressive Disease|0|||
105379655|NCT03384966|363395356|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
105379656|NCT03384966|363395357|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
105379657|NCT03384966|363395358|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
105379658|NCT03384966|363395356|FG000|Follow-up Period|Adverse Event|1|||
105379659|NCT03384966|363395357|FG001|Follow-up Period|Adverse Event|0|||
105379660|NCT03384966|363395358|FG002|Follow-up Period|Adverse Event|0|||
105379661|NCT05762679|363395361|FG000|Overall Study|Withdrawal by Subject|1|||
105379662|NCT05762679|363395361|FG000|Overall Study|No analyzable imaging data|1|||
105379663|NCT01716156|363395362|FG000|Overall Study|Protocol Violation|1|||
105379664|NCT01716156|363395363|FG001|Overall Study|Protocol Violation|0|||
105379665|NCT01716156|363395364|FG002|Overall Study|Protocol Violation|0|||
105379666|NCT01716156|363395362|FG000|Overall Study|Withdrawal by Subject|0|||
105379667|NCT01716156|363395363|FG001|Overall Study|Withdrawal by Subject|1|||
105379668|NCT01716156|363395364|FG002|Overall Study|Withdrawal by Subject|2|||
105379669|NCT01716156|363395362|FG000|Overall Study|Lost to Follow-up|1|||
105379670|NCT01716156|363395363|FG001|Overall Study|Lost to Follow-up|0|||
105379671|NCT01716156|363395364|FG002|Overall Study|Lost to Follow-up|0|||
105379672|NCT03925220|363395367|FG000|Overall Study|Withdrawal by Subject|4|||
105379673|NCT03925220|363395368|FG001|Overall Study|Withdrawal by Subject|4|||
105379674|NCT03925220|363395369|FG002|Overall Study|Withdrawal by Subject|4|||
105379675|NCT03925220|363395370|FG003|Overall Study|Withdrawal by Subject|4|||
105379676|NCT03925220|363395367|FG000|Overall Study|Lost to Follow-up|40|||
105379677|NCT03925220|363395368|FG001|Overall Study|Lost to Follow-up|46|||
105379678|NCT03925220|363395369|FG002|Overall Study|Lost to Follow-up|37|||
105379679|NCT03925220|363395370|FG003|Overall Study|Lost to Follow-up|38|||
105379680|NCT01944774|363395373|FG000|Overall Study|Withdrawal by Subject|2|||
105379681|NCT01944774|363395374|FG001|Overall Study|Withdrawal by Subject|3|||
105379682|NCT01944774|363395375|FG002|Overall Study|Withdrawal by Subject|3|||
105379683|NCT01944774|363395373|FG000|Overall Study|Adverse Event|3|||
105379684|NCT01944774|363395374|FG001|Overall Study|Adverse Event|2|||
105379685|NCT01944774|363395375|FG002|Overall Study|Adverse Event|3|||
105379686|NCT01944774|363395373|FG000|Overall Study|Lack of Efficacy|1|||
105379687|NCT01944774|363395374|FG001|Overall Study|Lack of Efficacy|2|||
105379688|NCT01944774|363395375|FG002|Overall Study|Lack of Efficacy|2|||
105379689|NCT01944774|363395373|FG000|Overall Study|Lost to Follow-up|0|||
105379690|NCT01944774|363395374|FG001|Overall Study|Lost to Follow-up|1|||
105379691|NCT01944774|363395375|FG002|Overall Study|Lost to Follow-up|0|||
105379692|NCT05324371|363395378|FG000|Overall Study|Withdrawal by Subject|1|||
105330908|NCT01134939|363211358|FG007|Overall Study|Termination page not available|0|||
105330909|NCT02887183|363211359|FG000|Overall Study|Adverse Event|44|||
105330910|NCT02887183|363211359|FG000|Overall Study|Death|30|||
105330911|NCT02887183|363211359|FG000|Overall Study|Pregnancy|1|||
105330912|NCT02887183|363211359|FG000|Overall Study|Protocol Violation|6|||
105330913|NCT02887183|363211359|FG000|Overall Study|Technical Problems|2|||
105330914|NCT02887183|363211359|FG000|Overall Study|Lost to Follow-up|13|||
105330915|NCT02887183|363211359|FG000|Overall Study|Physician Decision|10|||
105330916|NCT02887183|363211359|FG000|Overall Study|Withdrawal by Subject|35|||
105330917|NCT00961350|363211360|FG000|Overall Study|Adverse Event|18|||
105330918|NCT00961350|363211361|FG001|Overall Study|Adverse Event|33|||
105330919|NCT00961350|363211360|FG000|Overall Study|Withdrawal by Subject|10|||
105330920|NCT00961350|363211361|FG001|Overall Study|Withdrawal by Subject|10|||
105330921|NCT00961350|363211360|FG000|Overall Study|Lost to Follow-up|3|||
105330922|NCT00961350|363211361|FG001|Overall Study|Lost to Follow-up|3|||
105330923|NCT00961350|363211360|FG000|Overall Study|Misc|16|||
105330924|NCT00961350|363211361|FG001|Overall Study|Misc|21|||
105330925|NCT02195869|363211365|FG000|Overall Study|cGVHD Progression|5|||
105330926|NCT02195869|363211365|FG000|Overall Study|Malignancy Progression/relapse|2|||
105330927|NCT02195869|363211365|FG000|Overall Study|Adverse Event|15|||
105330928|NCT02195869|363211365|FG000|Overall Study|Withdrawal by Subject|7|||
105330929|NCT02195869|363211365|FG000|Overall Study|Physician Decision|4|||
105330930|NCT02195869|363211365|FG000|Overall Study|Study Terminated by Sponsor|7|||
105330931|NCT02195869|363211365|FG000|Overall Study|Noncompliance with study drug|2|||
105330932|NCT05336227|363212753|FG000|Overall Study|Adverse Event|1|||
105330933|NCT05336227|363212754|FG001|Overall Study|Adverse Event|0|||
105330934|NCT05336227|363212753|FG000|Overall Study|Lost to Follow-up|2|||
105330935|NCT05336227|363212754|FG001|Overall Study|Lost to Follow-up|0|||
105330936|NCT05336227|363212753|FG000|Overall Study|Withdrawal by Subject|1|||
105330937|NCT05336227|363212754|FG001|Overall Study|Withdrawal by Subject|0|||
105330938|NCT03058705|363212755|FG000|Overall Study|Withdrawal by Subject|2|||
105330939|NCT03058705|363212755|FG000|Overall Study|Physician Decision|2|||
105330940|NCT01682226|363212756|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
105330941|NCT01682226|363212756|FG000|Overall Study|Participants did not receive treatment|2|||
105330942|NCT01682226|363212756|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
105330943|NCT02640950|363212759|FG000|Overall Study|Adverse Event|1|||
105330944|NCT02640950|363212759|FG000|Overall Study|Withdrawal by Subject|1|||
105330945|NCT00356603|363212760|FG000|Overall Study|Other|6|||
105330946|NCT00356603|363212761|FG001|Overall Study|Other|3|||
105330947|NCT00154284|363212762|FG000|Overall Study|Adverse Event|6|||
105330948|NCT00154284|363212763|FG001|Overall Study|Adverse Event|9|||
105330949|NCT00154284|363212762|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105330950|NCT00154284|363212763|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105330951|NCT00154284|363212762|FG000|Overall Study|Lack of Efficacy|1|||
105330952|NCT00154284|363212763|FG001|Overall Study|Lack of Efficacy|2|||
105330953|NCT00154284|363212762|FG000|Overall Study|Protocol Violation|0|||
105330954|NCT00154284|363212763|FG001|Overall Study|Protocol Violation|1|||
105330955|NCT00326716|363212764|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
105330956|NCT00326716|363212765|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
105330957|NCT00326716|363212766|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
105330958|NCT00326716|363212767|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
105330959|NCT05253573|363212769|FG000|Overall Study|Death|1|||
105330960|NCT05253573|363212770|FG001|Overall Study|Death|0|||
105330961|NCT00728468|363212771|FG000|Overall Study|Enrolled but not treated|1|||
105330962|NCT00728468|363212771|FG000|Overall Study|Death|1|||
105330963|NCT00728468|363212771|FG000|Overall Study|Protocol Violation|4|||
105330964|NCT00728468|363212771|FG000|Overall Study|Objective progression or relapse|9|||
105330965|NCT00728468|363212771|FG000|Overall Study|Study terminated by sponsor|1|||
105330966|NCT01568034|363212772|FG000|Overall Study|Withdrawal by Subject|1|||
105330967|NCT01568034|363212773|FG001|Overall Study|Withdrawal by Subject|0|||
105330968|NCT01568034|363212774|FG002|Overall Study|Withdrawal by Subject|0|||
105330969|NCT01568034|363212775|FG003|Overall Study|Withdrawal by Subject|0|||
105330970|NCT01262287|363212776|FG000|Overall Study|Lost to Follow-up|2|||
105330971|NCT01262287|363212777|FG001|Overall Study|Lost to Follow-up|1|||
105330972|NCT06098339|363212778|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
105330973|NCT06098339|363212779|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
105330974|NCT06098339|363212778|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
105330975|NCT06098339|363212779|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
105330976|NCT01209949|363212780|FG000|Overall Study|Lost to Follow-up|3|||
105330977|NCT01436370|363212792|FG000|Overall Study|Lost to Follow-up|0|||
105330978|NCT01436370|363212793|FG001|Overall Study|Lost to Follow-up|0|||
105330979|NCT01436370|363212794|FG002|Overall Study|Lost to Follow-up|0|||
105330980|NCT01436370|363212795|FG003|Overall Study|Lost to Follow-up|0|||
105330981|NCT01436370|363212796|FG004|Overall Study|Lost to Follow-up|1|||
105330982|NCT01436370|363212797|FG005|Overall Study|Lost to Follow-up|0|||
105330983|NCT01436370|363212798|FG006|Overall Study|Lost to Follow-up|0|||
105330984|NCT01436370|363212799|FG007|Overall Study|Lost to Follow-up|0|||
105330985|NCT02395848|363212800|FG000|Overall Study|Lost to Follow-up|2|||
105330986|NCT02276560|363212801|FG000|Overall Study|Adverse Event|1|||
105330987|NCT02276560|363212802|FG001|Overall Study|Adverse Event|0|||
105330988|NCT02276560|363212803|FG002|Overall Study|Adverse Event|0|||
105330989|NCT00300885|363212804|FG000|Treatment|Adverse Event|134|||
105330990|NCT00300885|363212805|FG001|Treatment|Adverse Event|82|||
105330991|NCT00300885|363212804|FG000|Treatment|Death|20|||
105330992|NCT00300885|363212805|FG001|Treatment|Death|7|||
105330993|NCT00300885|363212804|FG000|Treatment|Lack of Efficacy|1|||
105330994|NCT00300885|363212805|FG001|Treatment|Lack of Efficacy|1|||
105330995|NCT00300885|363212804|FG000|Treatment|Lost to Follow-up|3|||
105330996|NCT00300885|363212805|FG001|Treatment|Lost to Follow-up|2|||
105330997|NCT00300885|363212804|FG000|Treatment|Physician Decision|4|||
105330998|NCT00300885|363212805|FG001|Treatment|Physician Decision|5|||
105330999|NCT00300885|363212804|FG000|Treatment|Protocol Violation|11|||
105331000|NCT00300885|363212805|FG001|Treatment|Protocol Violation|11|||
105331001|NCT00300885|363212804|FG000|Treatment|Withdrawal by Subject|26|||
105331002|NCT00300885|363212805|FG001|Treatment|Withdrawal by Subject|23|||
105331003|NCT00300885|363212804|FG000|Treatment|Disease progression|171|||
105331004|NCT00300885|363212805|FG001|Treatment|Disease progression|238|||
105331005|NCT00300885|363212804|FG000|Treatment|Random code broken (subject died)|0|||
105331006|NCT00300885|363212805|FG001|Treatment|Random code broken (subject died)|1|||
105331007|NCT00300885|363212804|FG000|Treatment|Non-compliant with study medication|3|||
105331008|NCT00300885|363212805|FG001|Treatment|Non-compliant with study medication|4|||
105331009|NCT00300885|363212804|FG000|Follow-up|Death|141|||
105331010|NCT00300885|363212805|FG001|Follow-up|Death|163|||
105331011|NCT00300885|363212804|FG000|Follow-up|Lost to Follow-up|11|||
105331012|NCT00300885|363212805|FG001|Follow-up|Lost to Follow-up|7|||
105331013|NCT00300885|363212804|FG000|Follow-up|Withdrawal by Subject|26|||
105331014|NCT00300885|363212805|FG001|Follow-up|Withdrawal by Subject|25|||
105331015|NCT03168711|363212810|FG000|Overall Study|Adverse Event|2|||
105331016|NCT03168711|363212811|FG001|Overall Study|Adverse Event|0|||
105331017|NCT03168711|363212810|FG000|Overall Study|Withdrawal by Subject|0|||
105331018|NCT03168711|363212811|FG001|Overall Study|Withdrawal by Subject|1|||
105331019|NCT03168711|363212810|FG000|Overall Study|Death|0|||
105331020|NCT03168711|363212811|FG001|Overall Study|Death|1|||
105331021|NCT03656692|363212812|FG000|Overall Study|Worsening of disease activity|2|||
105331022|NCT03656692|363212812|FG000|Overall Study|Physician Decision|1|||
105331023|NCT01134107|363212813|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
105331024|NCT01134107|363212814|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
105331025|NCT01134107|363212813|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
105331026|NCT01134107|363212814|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
105331027|NCT01134107|363212813|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
105331028|NCT01134107|363212814|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
105331029|NCT01134107|363212813|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
105331030|NCT01134107|363212814|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
105331031|NCT01134107|363212813|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
105331032|NCT01134107|363212814|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
105331033|NCT01134107|363212813|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
105379693|NCT05324371|363395378|FG000|Overall Study|Death|1|||
105379694|NCT00927082|363395379|FG000|Overall Study|Lost to Follow-up|9|||
105379695|NCT00927082|363395380|FG001|Overall Study|Lost to Follow-up|8|||
105379696|NCT00927082|363395381|FG002|Overall Study|Lost to Follow-up|12|||
105379697|NCT00927082|363395382|FG003|Overall Study|Lost to Follow-up|16|||
105379698|NCT00927082|363395379|FG000|Overall Study|Withdrawal by Subject|3|||
105379699|NCT00927082|363395380|FG001|Overall Study|Withdrawal by Subject|2|||
105379700|NCT00927082|363395381|FG002|Overall Study|Withdrawal by Subject|7|||
105379701|NCT00927082|363395382|FG003|Overall Study|Withdrawal by Subject|2|||
105379702|NCT00927082|363395379|FG000|Overall Study|Death|0|||
105379703|NCT00927082|363395380|FG001|Overall Study|Death|0|||
105379704|NCT00927082|363395381|FG002|Overall Study|Death|1|||
105379705|NCT00927082|363395382|FG003|Overall Study|Death|0|||
105379706|NCT00927082|363395379|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
105379707|NCT00927082|363395380|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
105379708|NCT00927082|363395381|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
105379709|NCT00927082|363395382|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
105379710|NCT00812097|363395383|FG000|Overall Study|Death|3|||
105379711|NCT00812097|363395384|FG001|Overall Study|Death|10|||
105379712|NCT00812097|363395385|FG002|Overall Study|Death|3|||
105379713|NCT00812097|363395386|FG003|Overall Study|Death|3|||
105379714|NCT00812097|363395383|FG000|Overall Study|Withdrawal by Subject|14|||
105379715|NCT00812097|363395384|FG001|Overall Study|Withdrawal by Subject|12|||
105379716|NCT00812097|363395385|FG002|Overall Study|Withdrawal by Subject|8|||
105379717|NCT00812097|363395386|FG003|Overall Study|Withdrawal by Subject|2|||
105379718|NCT00812097|363395383|FG000|Overall Study|Lost to Follow-up|90|||
105379719|NCT00812097|363395384|FG001|Overall Study|Lost to Follow-up|14|||
105379720|NCT00812097|363395385|FG002|Overall Study|Lost to Follow-up|17|||
105379721|NCT00812097|363395386|FG003|Overall Study|Lost to Follow-up|5|||
105379722|NCT00812097|363395383|FG000|Overall Study|Explantation of study device(s)|27|||
105379723|NCT00812097|363395384|FG001|Overall Study|Explantation of study device(s)|29|||
105379724|NCT00812097|363395385|FG002|Overall Study|Explantation of study device(s)|14|||
105379725|NCT00812097|363395386|FG003|Overall Study|Explantation of study device(s)|20|||
105379726|NCT00812097|363395383|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
105379727|NCT00812097|363395384|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
105379728|NCT00812097|363395385|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
105379729|NCT00812097|363395386|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
105379730|NCT03983109|363395388|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
105379731|NCT03983109|363395389|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
105379732|NCT00317369|363395393|FG000|Overall Study|Adverse Event|2|||
105379733|NCT00317369|363395394|FG001|Overall Study|Adverse Event|1|||
105379734|NCT00317369|363395395|FG002|Overall Study|Adverse Event|0|||
105379735|NCT00317369|363395393|FG000|Overall Study|Lack of Efficacy|0|||
105379736|NCT00317369|363395394|FG001|Overall Study|Lack of Efficacy|1|||
105379737|NCT00317369|363395395|FG002|Overall Study|Lack of Efficacy|1|||
105379738|NCT00317369|363395393|FG000|Overall Study|Withdrawal by Subject|0|||
105379739|NCT00317369|363395394|FG001|Overall Study|Withdrawal by Subject|0|||
105379740|NCT00317369|363395395|FG002|Overall Study|Withdrawal by Subject|1|||
105379741|NCT01860404|363395396|FG000|Overall Study|Lost to Follow-up|3|||
105379742|NCT01860404|363395397|FG001|Overall Study|Lost to Follow-up|4|||
105379743|NCT01860404|363395398|FG002|Overall Study|Lost to Follow-up|1|||
105379744|NCT01860404|363395399|FG003|Overall Study|Lost to Follow-up|6|||
105379745|NCT01860404|363395400|FG004|Overall Study|Lost to Follow-up|4|||
105379746|NCT01860404|363395396|FG000|Overall Study|Withdrawal by Subject|0|||
105379747|NCT01860404|363395397|FG001|Overall Study|Withdrawal by Subject|0|||
105379748|NCT01860404|363395398|FG002|Overall Study|Withdrawal by Subject|4|||
105379749|NCT01860404|363395399|FG003|Overall Study|Withdrawal by Subject|0|||
105379750|NCT01860404|363395400|FG004|Overall Study|Withdrawal by Subject|0|||
105379751|NCT02068599|363395401|FG000|Overall Study|Adverse Event|4|||
105379752|NCT02068599|363395402|FG001|Overall Study|Adverse Event|1|||
105379753|NCT02068599|363395403|FG002|Overall Study|Adverse Event|1|||
105379754|NCT02068599|363395401|FG000|Overall Study|Withdrawal by Subject|2|||
105379755|NCT02068599|363395402|FG001|Overall Study|Withdrawal by Subject|7|||
105379756|NCT02068599|363395403|FG002|Overall Study|Withdrawal by Subject|5|||
105379757|NCT02068599|363395401|FG000|Overall Study|Protocol Violation|4|||
105379758|NCT02068599|363395402|FG001|Overall Study|Protocol Violation|2|||
105379759|NCT02068599|363395403|FG002|Overall Study|Protocol Violation|3|||
105379760|NCT02068599|363395401|FG000|Overall Study|Lost to Follow-up|1|||
105379761|NCT02068599|363395402|FG001|Overall Study|Lost to Follow-up|0|||
105379762|NCT02068599|363395403|FG002|Overall Study|Lost to Follow-up|0|||
105379763|NCT02068599|363395401|FG000|Overall Study|Lack of Efficacy|0|||
105580159|NCT03220737|364124214|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
105379764|NCT02068599|363395402|FG001|Overall Study|Lack of Efficacy|0|||
105379765|NCT02068599|363395403|FG002|Overall Study|Lack of Efficacy|3|||
105379766|NCT02068599|363395401|FG000|Overall Study|Noncompliance|0|||
105379767|NCT02068599|363395402|FG001|Overall Study|Noncompliance|0|||
105379768|NCT02068599|363395403|FG002|Overall Study|Noncompliance|1|||
105379769|NCT04822194|363395405|FG000|Overall Study|Withdrawal by Subject|5|||
105379770|NCT04822194|363395406|FG001|Overall Study|Withdrawal by Subject|4|||
105379771|NCT04822194|363395405|FG000|Overall Study|Technical issues with MR scanner|1|||
105379772|NCT04822194|363395406|FG001|Overall Study|Technical issues with MR scanner|0|||
105379773|NCT04822194|363395405|FG000|Overall Study|Lost to Follow-up|5|||
105379774|NCT04822194|363395406|FG001|Overall Study|Lost to Follow-up|7|||
105379775|NCT00118287|363395409|FG000|Overall Study|Intracranial haemorrhage|1|||
105379776|NCT00118287|363395409|FG000|Overall Study|Muscle pain|1|||
105379777|NCT03091439|363395414|FG000|Overall Study|Study Terminated by the Sponsor|1|||
105379778|NCT03091439|363395415|FG001|Overall Study|Study Terminated by the Sponsor|0|||
105379779|NCT02184156|363395416|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
105379780|NCT02184156|363395417|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
105379781|NCT02184156|363395416|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
105379782|NCT02184156|363395417|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
105379783|NCT00283959|363395423|FG000|Extension Period|Low Compliance|1|||
105379784|NCT05591755|363395424|FG000|Overall Study|Screen Failure|1|||
105379785|NCT05591755|363395425|FG001|Overall Study|Screen Failure|0|||
105379786|NCT05591755|363395426|FG002|Overall Study|Screen Failure|0|||
105379787|NCT05591755|363395427|FG003|Overall Study|Screen Failure|0|||
105379788|NCT05591755|363395424|FG000|Overall Study|Protocol Violation|0|||
105379789|NCT05591755|363395425|FG001|Overall Study|Protocol Violation|0|||
105379790|NCT05591755|363395426|FG002|Overall Study|Protocol Violation|2|||
105379791|NCT05591755|363395427|FG003|Overall Study|Protocol Violation|0|||
105379792|NCT05591755|363395424|FG000|Overall Study|Withdrawal by Subject|0|||
105379793|NCT05591755|363395425|FG001|Overall Study|Withdrawal by Subject|1|||
105379794|NCT05591755|363395426|FG002|Overall Study|Withdrawal by Subject|0|||
105379795|NCT05591755|363395427|FG003|Overall Study|Withdrawal by Subject|0|||
105379796|NCT01483651|363395432|FG000|Overall Study|Withdrawal by Subject|0|||
105379797|NCT01483651|363395433|FG001|Overall Study|Withdrawal by Subject|1|||
105379798|NCT01483651|363395434|FG002|Overall Study|Withdrawal by Subject|1|||
105379799|NCT01483651|363395435|FG003|Overall Study|Withdrawal by Subject|0|||
105379800|NCT01483651|363395436|FG004|Overall Study|Withdrawal by Subject|0|||
105379801|NCT01483651|363395437|FG005|Overall Study|Withdrawal by Subject|1|||
105379802|NCT01018953|363395442|FG000|Overall Study|Adverse Event|2|||
105379803|NCT01018953|363395442|FG000|Overall Study|Withdrawal by Subject|1|||
105379804|NCT01018953|363395442|FG000|Overall Study|Study termination by sponsor|5|||
105379805|NCT02665455|363395443|FG000|Overall Study|Withdrawal by Subject|6|||
105379806|NCT02665455|363395443|FG000|Overall Study|Lost to Follow-up|1|||
105379807|NCT02665455|363395443|FG000|Overall Study|Adverse Event|1|||
105379808|NCT02665455|363395443|FG000|Overall Study|Protocol Violation|1|||
105379809|NCT02916771|363395444|FG000|Overall Study|Withdrawal by Subject|9|||
105379810|NCT02916771|363395444|FG000|Overall Study|Physician Decision|1|||
105379811|NCT02916771|363395444|FG000|Overall Study|Began treatment for another active malignancy|1|||
105379812|NCT00724503|363395445|FG000|Overall Study|Lost to Follow-up|4|||
105379813|NCT00724503|363395446|FG001|Overall Study|Lost to Follow-up|8|||
105379814|NCT00724503|363395445|FG000|Overall Study|Withdrawal by Subject|11|||
105379815|NCT00724503|363395446|FG001|Overall Study|Withdrawal by Subject|23|||
105379816|NCT00724503|363395445|FG000|Overall Study|Death|190|||
105379817|NCT00724503|363395446|FG001|Overall Study|Death|182|||
105379818|NCT00724503|363395445|FG000|Overall Study|Adverse Event|1|||
105379819|NCT00724503|363395446|FG001|Overall Study|Adverse Event|0|||
105379820|NCT00724503|363395445|FG000|Overall Study|Not otherwise specified|4|||
105379821|NCT00724503|363395446|FG001|Overall Study|Not otherwise specified|7|||
105379822|NCT01186419|363395455|FG000|Overall Study|Withdrawal by Subject|5|||
105379823|NCT01186419|363395456|FG001|Overall Study|Withdrawal by Subject|3|||
105379824|NCT01186419|363395455|FG000|Overall Study|Adverse Event|1|||
105379825|NCT01186419|363395456|FG001|Overall Study|Adverse Event|2|||
105379826|NCT01186419|363395455|FG000|Overall Study|Physician Decision|0|||
105379827|NCT01186419|363395456|FG001|Overall Study|Physician Decision|3|||
105379828|NCT01186419|363395455|FG000|Overall Study|Other|1|||
105379829|NCT01186419|363395456|FG001|Overall Study|Other|1|||
105379830|NCT03932331|363395463|FG000|Overall Study|Death|0|||
105379831|NCT03932331|363395464|FG001|Overall Study|Death|7|||
105379832|NCT03932331|363395465|FG002|Overall Study|Death|2|||
105379833|NCT03932331|363395463|FG000|Overall Study|Withdrawal by Subject|0|||
105379834|NCT03932331|363395464|FG001|Overall Study|Withdrawal by Subject|3|||
105379835|NCT03932331|363395465|FG002|Overall Study|Withdrawal by Subject|0|||
105379836|NCT03932331|363395463|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
105379837|NCT03932331|363395464|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
105379838|NCT03932331|363395465|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
105379839|NCT03932331|363395463|FG000|Overall Study|Progressive disease|3|||
105379840|NCT03932331|363395464|FG001|Overall Study|Progressive disease|0|||
105379841|NCT03932331|363395465|FG002|Overall Study|Progressive disease|0|||
105379842|NCT03932331|363395463|FG000|Overall Study|Lung infection|1|||
105379843|NCT03932331|363395464|FG001|Overall Study|Lung infection|0|||
105379844|NCT03932331|363395465|FG002|Overall Study|Lung infection|0|||
105379845|NCT03932331|363395463|FG000|Overall Study|Other|0|||
105379846|NCT03932331|363395464|FG001|Overall Study|Other|0|||
105379847|NCT03932331|363395465|FG002|Overall Study|Other|58|||
105379848|NCT01407367|363395468|FG000|Overall Study|Death|24|||
105379849|NCT01407367|363395469|FG001|Overall Study|Death|32|||
105379850|NCT01407367|363395468|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
105379851|NCT01407367|363395469|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
105379852|NCT01407367|363395468|FG000|Overall Study|Withdrawal by Subject|4|||
105379853|NCT01407367|363395469|FG001|Overall Study|Withdrawal by Subject|15|||
105379854|NCT01407367|363395468|FG000|Overall Study|Lost to Follow-up|0|||
105379855|NCT01407367|363395469|FG001|Overall Study|Lost to Follow-up|2|||
105379856|NCT01452347|363395470|FG000|Overall Study|Adverse Event|2|||
105379857|NCT01452347|363395471|FG001|Overall Study|Adverse Event|1|||
105379858|NCT01452347|363395470|FG000|Overall Study|Non compliance protocol|2|||
105379859|NCT01452347|363395471|FG001|Overall Study|Non compliance protocol|0|||
105379860|NCT01452347|363395470|FG000|Overall Study|Lost to Follow-up|2|||
105379861|NCT01452347|363395471|FG001|Overall Study|Lost to Follow-up|0|||
105379862|NCT01452347|363395470|FG000|Overall Study|Withdrawal by Subject|3|||
105379863|NCT01452347|363395471|FG001|Overall Study|Withdrawal by Subject|3|||
105379864|NCT01452347|363395470|FG000|Overall Study|Not treated|6|||
105379865|NCT01452347|363395471|FG001|Overall Study|Not treated|3|||
105379866|NCT01452347|363395470|FG000|Overall Study|Other reason not defined above|2|||
105379867|NCT01452347|363395471|FG001|Overall Study|Other reason not defined above|0|||
105379868|NCT01671059|363395472|FG000|Overall Study|Adverse Event|4|||
105379869|NCT01671059|363395472|FG000|Overall Study|Lack of Efficacy|1|||
105379870|NCT01030900|363395476|FG000|Overall Study|Not treated due to congestive heart failure|1|||
105379871|NCT01030900|363395476|FG000|Overall Study|Not treated due to rapid disease|1|||
105379872|NCT01301092|363395479|FG000|Overall Study|Lost to Follow-up|0|||
105379873|NCT01301092|363395480|FG001|Overall Study|Lost to Follow-up|0|||
105379874|NCT01301092|363395481|FG002|Overall Study|Lost to Follow-up|1|||
105379875|NCT01033071|363395482|FG000|Overall Study|Adverse Event|28|||
105379876|NCT01033071|363395483|FG001|Overall Study|Adverse Event|51|||
105379877|NCT01033071|363395484|FG002|Overall Study|Adverse Event|26|||
105379878|NCT01033071|363395482|FG000|Overall Study|Protocol Violation|0|||
105379879|NCT01033071|363395483|FG001|Overall Study|Protocol Violation|2|||
105379880|NCT01033071|363395484|FG002|Overall Study|Protocol Violation|1|||
105379881|NCT01033071|363395482|FG000|Overall Study|Lost to Follow-up|4|||
105379882|NCT01033071|363395483|FG001|Overall Study|Lost to Follow-up|5|||
105379883|NCT01033071|363395484|FG002|Overall Study|Lost to Follow-up|5|||
105379884|NCT01033071|363395482|FG000|Overall Study|Withdrawal by Subject|17|||
105379885|NCT01033071|363395483|FG001|Overall Study|Withdrawal by Subject|14|||
105379886|NCT01033071|363395484|FG002|Overall Study|Withdrawal by Subject|11|||
105379887|NCT01033071|363395482|FG000|Overall Study|Lack of Efficacy|0|||
105379888|NCT01033071|363395483|FG001|Overall Study|Lack of Efficacy|1|||
105379889|NCT01033071|363395484|FG002|Overall Study|Lack of Efficacy|1|||
105379890|NCT01033071|363395482|FG000|Overall Study|Other|6|||
105379891|NCT01033071|363395483|FG001|Overall Study|Other|4|||
105379892|NCT01033071|363395484|FG002|Overall Study|Other|3|||
105379893|NCT04073407|363395485|FG000|Part 1|Withdrawal by Subject|1|||
105379894|NCT04073407|363395486|FG001|Part 1|Withdrawal by Subject|0|||
105379895|NCT04073407|363395485|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
105379896|NCT04073407|363395486|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
105379897|NCT04073407|363395485|FG000|Part 2|Withdrawal by Subject|0|||
105379898|NCT04073407|363395486|FG001|Part 2|Withdrawal by Subject|1|||
105379899|NCT02927145|363396935|FG000|Initial Recruitment|Withdrawal by Subject|0|||
105379900|NCT02927145|363396936|FG001|Initial Recruitment|Withdrawal by Subject|1|||
105379901|NCT02927145|363396937|FG002|Initial Recruitment|Withdrawal by Subject|1|||
105379902|NCT02927145|363396938|FG003|Initial Recruitment|Withdrawal by Subject|4|||
105379903|NCT02927145|363396939|FG004|Initial Recruitment|Withdrawal by Subject|1|||
105379904|NCT02927145|363396940|FG005|Initial Recruitment|Withdrawal by Subject|1|||
105379905|NCT02927145|363396941|FG006|Initial Recruitment|Withdrawal by Subject|0|||
105379906|NCT02927145|363396942|FG007|Initial Recruitment|Withdrawal by Subject|0|||
105379907|NCT02927145|363396943|FG008|Initial Recruitment|Withdrawal by Subject|2|||
105379908|NCT02927145|363396935|FG000|Initial Recruitment|Adverse Event|0|||
105379909|NCT02927145|363396936|FG001|Initial Recruitment|Adverse Event|0|||
105379910|NCT02927145|363396937|FG002|Initial Recruitment|Adverse Event|0|||
105379911|NCT02927145|363396938|FG003|Initial Recruitment|Adverse Event|0|||
105379912|NCT02927145|363396939|FG004|Initial Recruitment|Adverse Event|2|||
105379913|NCT02927145|363396940|FG005|Initial Recruitment|Adverse Event|0|||
105379914|NCT02927145|363396941|FG006|Initial Recruitment|Adverse Event|0|||
105379915|NCT02927145|363396942|FG007|Initial Recruitment|Adverse Event|0|||
105379916|NCT02927145|363396943|FG008|Initial Recruitment|Adverse Event|0|||
105379917|NCT02927145|363396935|FG000|Invitation for Additional Challenge|Pregnancy|0|||
105379918|NCT02927145|363396936|FG001|Invitation for Additional Challenge|Pregnancy|0|||
105379919|NCT02927145|363396937|FG002|Invitation for Additional Challenge|Pregnancy|0|||
105379920|NCT02927145|363396938|FG003|Invitation for Additional Challenge|Pregnancy|0|||
105379921|NCT02927145|363396939|FG004|Invitation for Additional Challenge|Pregnancy|0|||
105379922|NCT02927145|363396940|FG005|Invitation for Additional Challenge|Pregnancy|0|||
105379923|NCT02927145|363396941|FG006|Invitation for Additional Challenge|Pregnancy|1|||
105379924|NCT02927145|363396942|FG007|Invitation for Additional Challenge|Pregnancy|0|||
105379925|NCT02927145|363396943|FG008|Invitation for Additional Challenge|Pregnancy|0|||
105379926|NCT00992836|363396946|FG000|Overall Study|Lost to Follow-up|1|||
105379927|NCT00992836|363396946|FG000|Overall Study|Withdrawal by Subject|2|||
105379928|NCT00992836|363396946|FG000|Overall Study|Protocol Violation|2|||
105379929|NCT02323334|363396947|FG000|Period 3|Lost to Follow-up|0|||
105379930|NCT02323334|363396948|FG001|Period 3|Lost to Follow-up|0|||
105379931|NCT02323334|363396949|FG002|Period 3|Lost to Follow-up|1|||
105379932|NCT02323334|363396950|FG003|Period 3|Lost to Follow-up|0|||
105379933|NCT02323334|363396951|FG004|Period 3|Lost to Follow-up|0|||
105379934|NCT02323334|363396952|FG005|Period 3|Lost to Follow-up|0|||
105379935|NCT02323334|363396953|FG006|Period 3|Lost to Follow-up|0|||
105379936|NCT02323334|363396954|FG007|Period 3|Lost to Follow-up|0|||
105379937|NCT02323334|363396955|FG008|Period 3|Lost to Follow-up|0|||
105379938|NCT02323334|363396956|FG009|Period 3|Lost to Follow-up|0|||
105379939|NCT02323334|363396957|FG010|Period 3|Lost to Follow-up|0|||
105379940|NCT02323334|363396958|FG011|Period 3|Lost to Follow-up|0|||
105379941|NCT02323334|363396959|FG012|Period 3|Lost to Follow-up|0|||
105379942|NCT02323334|363396960|FG013|Period 3|Lost to Follow-up|0|||
105379943|NCT02323334|363396961|FG014|Period 3|Lost to Follow-up|0|||
105379944|NCT02323334|363396962|FG015|Period 3|Lost to Follow-up|0|||
105379945|NCT02323334|363396963|FG016|Period 3|Lost to Follow-up|0|||
105379946|NCT02323334|363396947|FG000|Period 3|Withdrawal by Subject|1|||
105379947|NCT02323334|363396948|FG001|Period 3|Withdrawal by Subject|0|||
105379948|NCT02323334|363396949|FG002|Period 3|Withdrawal by Subject|0|||
105379949|NCT02323334|363396950|FG003|Period 3|Withdrawal by Subject|0|||
105379950|NCT02323334|363396951|FG004|Period 3|Withdrawal by Subject|0|||
105379951|NCT02323334|363396952|FG005|Period 3|Withdrawal by Subject|0|||
105379952|NCT02323334|363396953|FG006|Period 3|Withdrawal by Subject|0|||
105379953|NCT02323334|363396954|FG007|Period 3|Withdrawal by Subject|0|||
105379954|NCT02323334|363396955|FG008|Period 3|Withdrawal by Subject|0|||
105379955|NCT02323334|363396956|FG009|Period 3|Withdrawal by Subject|0|||
105379956|NCT02323334|363396957|FG010|Period 3|Withdrawal by Subject|0|||
105379957|NCT02323334|363396958|FG011|Period 3|Withdrawal by Subject|0|||
105379958|NCT02323334|363396959|FG012|Period 3|Withdrawal by Subject|0|||
105379959|NCT02323334|363396960|FG013|Period 3|Withdrawal by Subject|0|||
105379960|NCT02323334|363396961|FG014|Period 3|Withdrawal by Subject|0|||
105379961|NCT02323334|363396962|FG015|Period 3|Withdrawal by Subject|0|||
105379962|NCT02323334|363396963|FG016|Period 3|Withdrawal by Subject|0|||
105379963|NCT02506036|363396965|FG000|First Intervention (4-6 Weeks)|Death|1|||
105379964|NCT02506036|363396966|FG001|First Intervention (4-6 Weeks)|Death|0|||
105379965|NCT02506036|363396965|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
105379966|NCT02506036|363396966|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
105379967|NCT02506036|363396965|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
105379968|NCT02506036|363396966|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
105379969|NCT02316613|363396967|FG000|Overall Study|Death|63|||
105379970|NCT02316613|363396967|FG000|Overall Study|Lost to Follow-up|9|||
105379971|NCT02316613|363396967|FG000|Overall Study|Lymphoma transformation|2|||
105379972|NCT02316613|363396967|FG000|Overall Study|Participant moved/changed medical team|11|||
105379973|NCT02316613|363396967|FG000|Overall Study|No data and duplicate cases|5|||
105379974|NCT02316613|363396967|FG000|Overall Study|Did not met selection criteria|14|||
105379975|NCT04621760|363396977|FG000|Overall Study|Lost to Follow-up|2|||
105379976|NCT04621760|363396978|FG001|Overall Study|Lost to Follow-up|4|||
105379977|NCT04621760|363396977|FG000|Overall Study|Withdrawal by Subject|1|||
105379978|NCT04621760|363396978|FG001|Overall Study|Withdrawal by Subject|0|||
105379979|NCT03677401|363396981|FG000|Overall Study|Adverse Event|4|||
105379980|NCT03677401|363396982|FG001|Overall Study|Adverse Event|14|||
105379981|NCT03677401|363396981|FG000|Overall Study|Lack of Efficacy|3|||
105379982|NCT03677401|363396982|FG001|Overall Study|Lack of Efficacy|1|||
105379983|NCT03677401|363396981|FG000|Overall Study|Withdrawal by Subject|2|||
105379984|NCT03677401|363396982|FG001|Overall Study|Withdrawal by Subject|2|||
105379985|NCT03677401|363396981|FG000|Overall Study|Sponsor decision|0|||
105379986|NCT03677401|363396982|FG001|Overall Study|Sponsor decision|1|||
105379987|NCT03677401|363396981|FG000|Overall Study|Reason Unspecified|1|||
105379988|NCT03677401|363396982|FG001|Overall Study|Reason Unspecified|0|||
105379989|NCT00923702|363396991|FG000|Overall Study|Ongoing enrollment|0|||
105379990|NCT00923702|363396992|FG001|Overall Study|Ongoing enrollment|0|||
105379991|NCT00923702|363396993|FG002|Overall Study|Ongoing enrollment|0|||
105379992|NCT00923702|363396994|FG003|Overall Study|Ongoing enrollment|0|||
105379993|NCT00923702|363396995|FG004|Overall Study|Ongoing enrollment|354|||
105379994|NCT00195429|363396997|FG000|Overall Study|Adverse Event|2|||
105379995|NCT00195429|363396998|FG001|Overall Study|Adverse Event|4|||
105379996|NCT00195429|363396997|FG000|Overall Study|Lack of Efficacy|2|||
105379997|NCT00195429|363396998|FG001|Overall Study|Lack of Efficacy|1|||
105379998|NCT00195429|363396997|FG000|Overall Study|Lost to Follow-up|1|||
105379999|NCT00195429|363396998|FG001|Overall Study|Lost to Follow-up|0|||
105380000|NCT00625378|363396999|FG000|Overall Study|Adverse Event|22|||
105380001|NCT00625378|363397000|FG001|Overall Study|Adverse Event|0|||
105380002|NCT00625378|363396999|FG000|Overall Study|Withdrawal by Subject|16|||
105380003|NCT00625378|363397000|FG001|Overall Study|Withdrawal by Subject|0|||
105380004|NCT00625378|363396999|FG000|Overall Study|Death|38|||
105380005|NCT00625378|363397000|FG001|Overall Study|Death|0|||
105380006|NCT00625378|363396999|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
105380007|NCT00625378|363397000|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
105380008|NCT00625378|363396999|FG000|Overall Study|Lost to Follow-up|17|||
105380009|NCT00625378|363397000|FG001|Overall Study|Lost to Follow-up|0|||
105380010|NCT00625378|363396999|FG000|Overall Study|Non-compliant with study medication|3|||
105380011|NCT00625378|363397000|FG001|Overall Study|Non-compliant with study medication|0|||
105380012|NCT00625378|363396999|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
105380013|NCT00625378|363397000|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
105380014|NCT00625378|363396999|FG000|Overall Study|Medical decision|1|||
105380015|NCT00625378|363397000|FG001|Overall Study|Medical decision|0|||
105380016|NCT00625378|363396999|FG000|Overall Study|Multiple toxicities|1|||
105380017|NCT00625378|363397000|FG001|Overall Study|Multiple toxicities|0|||
105380018|NCT00625378|363396999|FG000|Overall Study|New cancer|1|||
105380019|NCT00625378|363397000|FG001|Overall Study|New cancer|0|||
105380020|NCT00625378|363396999|FG000|Overall Study|PTA program|2|||
105380021|NCT00625378|363397000|FG001|Overall Study|PTA program|0|||
105380022|NCT00625378|363396999|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
105380023|NCT00625378|363397000|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
105380024|NCT00625378|363396999|FG000|Overall Study|Sponsor decision|1|||
105380025|NCT00625378|363397000|FG001|Overall Study|Sponsor decision|0|||
105380026|NCT00625378|363396999|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
105380027|NCT00625378|363397000|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
105380028|NCT00625378|363396999|FG000|Overall Study|Switch to commercial drug|6|||
105380029|NCT00625378|363397000|FG001|Overall Study|Switch to commercial drug|1|||
105380030|NCT00625378|363396999|FG000|Overall Study|Missing|2|||
105380031|NCT00625378|363397000|FG001|Overall Study|Missing|0|||
105380032|NCT00625378|363396999|FG000|Overall Study|End of treatment not available|2|||
105380033|NCT00625378|363397000|FG001|Overall Study|End of treatment not available|0|||
105380034|NCT00625378|363396999|FG000|Overall Study|Never treated|2|||
105380035|NCT00625378|363397000|FG001|Overall Study|Never treated|0|||
105380036|NCT02070991|363397001|FG000|Overall Study|Death|2|||
105380037|NCT02070991|363397002|FG001|Overall Study|Death|0|||
105380038|NCT02070991|363397001|FG000|Overall Study|Withdrawal by Subject|1|||
105380039|NCT02070991|363397002|FG001|Overall Study|Withdrawal by Subject|0|||
105380040|NCT03880565|363397003|FG000|Overall Study|Withdrawal by Subject|1|||
105380041|NCT03880565|363397004|FG001|Overall Study|Withdrawal by Subject|0|||
105380042|NCT04999020|363397005|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
105380043|NCT04999020|363397006|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
105380044|NCT04999020|363397007|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
105380045|NCT04999020|363397008|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
105380046|NCT04999020|363397005|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
105331034|NCT01134107|363212814|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
105331035|NCT01134107|363212813|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
105331036|NCT01134107|363212814|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
105331037|NCT02877004|363212820|FG000|Overall Study|Pregnancy|0|||
105331038|NCT02877004|363212821|FG001|Overall Study|Pregnancy|0|||
105331039|NCT02877004|363212822|FG002|Overall Study|Pregnancy|1|||
105331040|NCT03877068|363212823|FG000|Overall Study|Physician Decision|9|||
105331041|NCT03877068|363212824|FG001|Overall Study|Physician Decision|3|||
105331042|NCT02509507|363212825|FG000|Overall Study|Death|21|||
105331043|NCT02509507|363212826|FG001|Overall Study|Death|3|||
105331044|NCT02509507|363212827|FG002|Overall Study|Death|22|||
105331045|NCT02509507|363212828|FG003|Overall Study|Death|14|||
105331046|NCT02509507|363212829|FG004|Overall Study|Death|8|||
105331047|NCT02509507|363212830|FG005|Overall Study|Death|12|||
105331048|NCT02509507|363212831|FG006|Overall Study|Death|5|||
105331049|NCT02509507|363212832|FG007|Overall Study|Death|4|||
105380047|NCT04999020|363397006|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
105380048|NCT04999020|363397007|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
105380049|NCT04999020|363397008|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
105380050|NCT04999020|363397005|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
105380051|NCT04999020|363397006|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
105380052|NCT04999020|363397007|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
105380053|NCT04999020|363397008|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
105380054|NCT04999020|363397005|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105380055|NCT04999020|363397006|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105380056|NCT04999020|363397007|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
105380057|NCT04999020|363397008|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
105380058|NCT04999020|363397005|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
105380059|NCT04999020|363397006|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
105380060|NCT04999020|363397007|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
105380061|NCT04999020|363397008|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
105380062|NCT04999020|363397005|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
105380063|NCT04999020|363397006|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
105380064|NCT04999020|363397007|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
105380065|NCT04999020|363397008|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
105380066|NCT04999020|363397005|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
105380067|NCT04999020|363397006|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
105380068|NCT04999020|363397007|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
105380069|NCT04999020|363397008|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
105380070|NCT04999020|363397005|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
105380071|NCT04999020|363397006|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
105380072|NCT04999020|363397007|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
105380073|NCT04999020|363397008|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
105380074|NCT00367458|363397009|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
105380075|NCT00367458|363397010|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
105380076|NCT00997126|363397013|FG000|Overall Study|Physician Decision|7|||
105380077|NCT00997126|363397014|FG001|Overall Study|Physician Decision|11|||
105380078|NCT04925934|363397017|FG000|Overall Study|Adverse Event|1|||
105380079|NCT04925934|363397018|FG001|Overall Study|Adverse Event|0|||
105380080|NCT04925934|363397019|FG002|Overall Study|Adverse Event|0|||
105380081|NCT04925934|363397017|FG000|Overall Study|Lost to Follow-up|2|||
105380082|NCT04925934|363397018|FG001|Overall Study|Lost to Follow-up|0|||
105380083|NCT04925934|363397019|FG002|Overall Study|Lost to Follow-up|1|||
105380084|NCT04925934|363397017|FG000|Overall Study|Death|0|||
105380085|NCT04925934|363397018|FG001|Overall Study|Death|1|||
105380086|NCT04925934|363397019|FG002|Overall Study|Death|0|||
105380087|NCT04925934|363397017|FG000|Overall Study|Withdrawal by Subject|8|||
105380088|NCT04925934|363397018|FG001|Overall Study|Withdrawal by Subject|5|||
105380089|NCT04925934|363397019|FG002|Overall Study|Withdrawal by Subject|9|||
105380090|NCT04925934|363397017|FG000|Overall Study|Other|2|||
105380091|NCT04925934|363397018|FG001|Overall Study|Other|2|||
105380092|NCT04925934|363397019|FG002|Overall Study|Other|2|||
105380093|NCT04925934|363397017|FG000|Overall Study|Eastern European Conflict|7|||
105380094|NCT04925934|363397018|FG001|Overall Study|Eastern European Conflict|3|||
105380095|NCT04925934|363397019|FG002|Overall Study|Eastern European Conflict|2|||
105380096|NCT04433975|363397020|FG000|1-month Follow Up|Withdrawal by Subject|1|||
105380097|NCT04433975|363397021|FG001|1-month Follow Up|Withdrawal by Subject|1|||
105380098|NCT04433975|363397020|FG000|1-month Follow Up|Lost to Follow-up|21|||
105380099|NCT04433975|363397021|FG001|1-month Follow Up|Lost to Follow-up|25|||
105380100|NCT04433975|363397020|FG000|3-month Follow Up|Lost to Follow-up|20|||
105380101|NCT04433975|363397021|FG001|3-month Follow Up|Lost to Follow-up|24|||
105380102|NCT04433975|363397020|FG000|3-month Follow Up|Death|1|||
105380103|NCT04433975|363397021|FG001|3-month Follow Up|Death|0|||
105380104|NCT04433975|363397020|FG000|3-month Follow Up|Withdrawal by Subject|2|||
105380105|NCT04433975|363397021|FG001|3-month Follow Up|Withdrawal by Subject|0|||
105380106|NCT04433975|363397020|FG000|6-month Follow Up|Lost to Follow-up|23|||
105380107|NCT04433975|363397021|FG001|6-month Follow Up|Lost to Follow-up|28|||
105380108|NCT04433975|363397020|FG000|6-month Follow Up|Withdrawal by Subject|1|||
105380109|NCT04433975|363397021|FG001|6-month Follow Up|Withdrawal by Subject|1|||
105380110|NCT04433975|363397020|FG000|9-month Follow Up|Lost to Follow-up|27|||
105380111|NCT04433975|363397021|FG001|9-month Follow Up|Lost to Follow-up|36|||
105380112|NCT04433975|363397020|FG000|9-month Follow Up|Death|0|||
105380113|NCT04433975|363397021|FG001|9-month Follow Up|Death|1|||
105380114|NCT04433975|363397020|FG000|12-month Follow Up|Lost to Follow-up|27|||
105380115|NCT04433975|363397021|FG001|12-month Follow Up|Lost to Follow-up|31|||
105380116|NCT04606771|363397022|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
105380117|NCT04606771|363397023|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
105380118|NCT04606771|363397022|FG000|Overall Study|Death|5|||
105380119|NCT04606771|363397023|FG001|Overall Study|Death|6|||
105380120|NCT04606771|363397022|FG000|Overall Study|Wrong randomisation|0|||
105380121|NCT04606771|363397023|FG001|Overall Study|Wrong randomisation|1|||
105380122|NCT05221866|363397024|FG000|Overall Study|Withdrawal by Subject|5|||
105380123|NCT05221866|363397025|FG001|Overall Study|Withdrawal by Subject|7|||
105380124|NCT05221866|363397026|FG002|Overall Study|Withdrawal by Subject|6|||
105380125|NCT05221866|363397027|FG003|Overall Study|Withdrawal by Subject|4|||
105380126|NCT05221866|363397024|FG000|Overall Study|Physician Decision|3|||
105380127|NCT05221866|363397025|FG001|Overall Study|Physician Decision|2|||
105380128|NCT05221866|363397026|FG002|Overall Study|Physician Decision|1|||
105380129|NCT05221866|363397027|FG003|Overall Study|Physician Decision|4|||
105380130|NCT05221866|363397024|FG000|Overall Study|Lost to Follow-up|12|||
105380131|NCT05221866|363397025|FG001|Overall Study|Lost to Follow-up|17|||
105380132|NCT05221866|363397026|FG002|Overall Study|Lost to Follow-up|14|||
105380133|NCT05221866|363397027|FG003|Overall Study|Lost to Follow-up|14|||
105380134|NCT05221866|363397024|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
105380135|NCT05221866|363397025|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
105380136|NCT05221866|363397026|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
105380137|NCT05221866|363397027|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
105380138|NCT00896233|363397028|FG000|Overall Study|Claustrophobia during MRI|1|||
105380139|NCT03753542|363397029|FG000|Overall Study|Lost to Follow-up|9|||
105380140|NCT03753542|363397030|FG001|Overall Study|Lost to Follow-up|14|||
105380141|NCT05259033|363397033|FG000|Overall Study|Withdrawal by Subject|10|||
105380142|NCT05259033|363397034|FG001|Overall Study|Withdrawal by Subject|5|||
105380143|NCT05259033|363397033|FG000|Overall Study|Lost to Follow-up|1|||
105380144|NCT05259033|363397034|FG001|Overall Study|Lost to Follow-up|0|||
105380145|NCT05259033|363397033|FG000|Overall Study|Death|2|||
105380146|NCT05259033|363397034|FG001|Overall Study|Death|0|||
105380147|NCT05103332|363397035|FG000|Overall Study|Lost to Follow-up|0|||
105380148|NCT05103332|363397036|FG001|Overall Study|Lost to Follow-up|2|||
105380149|NCT05103332|363397037|FG002|Overall Study|Lost to Follow-up|1|||
105380150|NCT05103332|363397038|FG003|Overall Study|Lost to Follow-up|0|||
105380151|NCT05103332|363397039|FG004|Overall Study|Lost to Follow-up|0|||
105380152|NCT05103332|363397040|FG005|Overall Study|Lost to Follow-up|2|||
105380153|NCT05103332|363397035|FG000|Overall Study|Physician Decision|0|||
105380154|NCT05103332|363397036|FG001|Overall Study|Physician Decision|1|||
105380155|NCT05103332|363397037|FG002|Overall Study|Physician Decision|0|||
105380156|NCT05103332|363397038|FG003|Overall Study|Physician Decision|1|||
105380157|NCT05103332|363397039|FG004|Overall Study|Physician Decision|0|||
105380158|NCT05103332|363397040|FG005|Overall Study|Physician Decision|0|||
105380159|NCT05103332|363397035|FG000|Overall Study|Participant Stopped Participation in the Study|2|||
105380160|NCT05103332|363397036|FG001|Overall Study|Participant Stopped Participation in the Study|3|||
105380161|NCT05103332|363397037|FG002|Overall Study|Participant Stopped Participation in the Study|5|||
105380162|NCT05103332|363397038|FG003|Overall Study|Participant Stopped Participation in the Study|3|||
105380163|NCT05103332|363397039|FG004|Overall Study|Participant Stopped Participation in the Study|3|||
105380164|NCT05103332|363397040|FG005|Overall Study|Participant Stopped Participation in the Study|7|||
105380165|NCT05103332|363397035|FG000|Overall Study|Unspeccified|0|||
105380166|NCT05103332|363397036|FG001|Overall Study|Unspeccified|0|||
105380167|NCT05103332|363397037|FG002|Overall Study|Unspeccified|0|||
105331050|NCT02509507|363212833|FG008|Overall Study|Death|8|||
105331051|NCT02509507|363212825|FG000|Overall Study|Lost to Follow-up|0|||
105331052|NCT02509507|363212826|FG001|Overall Study|Lost to Follow-up|1|||
105331053|NCT02509507|363212827|FG002|Overall Study|Lost to Follow-up|0|||
105331054|NCT02509507|363212828|FG003|Overall Study|Lost to Follow-up|0|||
105331055|NCT02509507|363212829|FG004|Overall Study|Lost to Follow-up|0|||
105331056|NCT02509507|363212830|FG005|Overall Study|Lost to Follow-up|2|||
105331057|NCT02509507|363212831|FG006|Overall Study|Lost to Follow-up|0|||
105331058|NCT02509507|363212832|FG007|Overall Study|Lost to Follow-up|0|||
105331059|NCT02509507|363212833|FG008|Overall Study|Lost to Follow-up|0|||
105331060|NCT02509507|363212825|FG000|Overall Study|Withdrawal by Subject|2|||
105331061|NCT02509507|363212826|FG001|Overall Study|Withdrawal by Subject|0|||
105331062|NCT02509507|363212827|FG002|Overall Study|Withdrawal by Subject|1|||
105331063|NCT02509507|363212828|FG003|Overall Study|Withdrawal by Subject|4|||
105331064|NCT02509507|363212829|FG004|Overall Study|Withdrawal by Subject|1|||
105331065|NCT02509507|363212830|FG005|Overall Study|Withdrawal by Subject|3|||
105331066|NCT02509507|363212831|FG006|Overall Study|Withdrawal by Subject|4|||
105331067|NCT02509507|363212832|FG007|Overall Study|Withdrawal by Subject|0|||
105331068|NCT02509507|363212833|FG008|Overall Study|Withdrawal by Subject|1|||
105331069|NCT00461630|363212839|FG000|Overall Study|Death|798|||
105331070|NCT00461630|363212840|FG001|Overall Study|Death|732|||
105331071|NCT00461630|363212839|FG000|Overall Study|Lost to Follow-up|108|||
105331072|NCT00461630|363212840|FG001|Overall Study|Lost to Follow-up|95|||
105331073|NCT01346696|363212842|FG000|Overall Study|Death|1|||
105331074|NCT02510664|363212844|FG000|Overall Study|Transferred Care|9|||
105331075|NCT02510664|363212845|FG001|Overall Study|Transferred Care|9|||
105331076|NCT02510664|363212846|FG002|Overall Study|Transferred Care|0|||
105331077|NCT02510664|363212844|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
105331078|NCT02510664|363212845|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
105331079|NCT02510664|363212846|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
105331080|NCT02510664|363212844|FG000|Overall Study|Time Constraints|1|||
105331081|NCT02510664|363212845|FG001|Overall Study|Time Constraints|1|||
105331082|NCT02510664|363212846|FG002|Overall Study|Time Constraints|0|||
105331083|NCT00506415|363212857|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
105331084|NCT00506415|363212858|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
105331085|NCT00506415|363212859|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
105331086|NCT00506415|363212860|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
105331087|NCT00506415|363212857|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
105331088|NCT00506415|363212858|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
105331089|NCT00506415|363212859|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
105331090|NCT00506415|363212860|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
105331091|NCT00506415|363212857|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
105331092|NCT00506415|363212858|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
105331093|NCT00506415|363212859|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
105331094|NCT00506415|363212860|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
105331095|NCT00506415|363212857|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
105331096|NCT00506415|363212858|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
105331097|NCT00506415|363212859|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
105331098|NCT00506415|363212860|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
105331099|NCT00506415|363212857|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
105331100|NCT00506415|363212858|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
105331101|NCT00506415|363212859|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
105331102|NCT00506415|363212860|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
105331103|NCT00506415|363212857|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
105331104|NCT00506415|363212858|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
105331105|NCT00506415|363212859|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
105331106|NCT00506415|363212860|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
105331107|NCT00506415|363212857|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
105331108|NCT00506415|363212858|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
105331109|NCT00506415|363212859|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
105331110|NCT00506415|363212860|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
105331111|NCT00506415|363212857|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
105331112|NCT00506415|363212858|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
105331113|NCT00506415|363212859|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
105331114|NCT00506415|363212860|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
105331115|NCT00506415|363212857|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
105331116|NCT00506415|363212858|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
105380168|NCT05103332|363397038|FG003|Overall Study|Unspeccified|1|||
105380169|NCT05103332|363397039|FG004|Overall Study|Unspeccified|0|||
105380170|NCT05103332|363397040|FG005|Overall Study|Unspeccified|0|||
105380171|NCT05104567|363397041|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
105380172|NCT05104567|363397042|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
105380173|NCT05104567|363397043|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
105380174|NCT05104567|363397044|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
105380175|NCT05104567|363397045|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
105380176|NCT05104567|363397046|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
105380177|NCT05104567|363397047|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
105380178|NCT05104567|363397041|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
105380179|NCT05104567|363397042|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
105380180|NCT05104567|363397043|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
105380181|NCT05104567|363397044|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
105380182|NCT05104567|363397045|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
105380183|NCT05104567|363397046|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
105380184|NCT05104567|363397047|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
105380185|NCT05104567|363397041|FG000|Overall Study|Progressive disease|3|||
105380186|NCT05104567|363397042|FG001|Overall Study|Progressive disease|13|||
105380187|NCT05104567|363397043|FG002|Overall Study|Progressive disease|13|||
105380188|NCT05104567|363397044|FG003|Overall Study|Progressive disease|17|||
105380189|NCT05104567|363397045|FG004|Overall Study|Progressive disease|17|||
105380190|NCT05104567|363397046|FG005|Overall Study|Progressive disease|28|||
105380191|NCT05104567|363397047|FG006|Overall Study|Progressive disease|24|||
105380192|NCT05104567|363397041|FG000|Overall Study|Withdrawal by Subject|1|||
105380193|NCT05104567|363397042|FG001|Overall Study|Withdrawal by Subject|1|||
105380194|NCT05104567|363397043|FG002|Overall Study|Withdrawal by Subject|2|||
105380195|NCT05104567|363397044|FG003|Overall Study|Withdrawal by Subject|0|||
105380196|NCT05104567|363397045|FG004|Overall Study|Withdrawal by Subject|0|||
105380197|NCT05104567|363397046|FG005|Overall Study|Withdrawal by Subject|0|||
105380198|NCT05104567|363397047|FG006|Overall Study|Withdrawal by Subject|0|||
105380199|NCT05104567|363397041|FG000|Overall Study|Other|1|||
105380200|NCT05104567|363397042|FG001|Overall Study|Other|1|||
105380201|NCT05104567|363397043|FG002|Overall Study|Other|1|||
105380202|NCT05104567|363397044|FG003|Overall Study|Other|0|||
105380203|NCT05104567|363397045|FG004|Overall Study|Other|0|||
105380204|NCT05104567|363397046|FG005|Overall Study|Other|0|||
105380205|NCT05104567|363397047|FG006|Overall Study|Other|0|||
105380206|NCT04180696|363397048|FG000|Overall Study|Death|5|||
105380207|NCT04180696|363397049|FG001|Overall Study|Death|6|||
105380208|NCT04180696|363397048|FG000|Overall Study|Lost to Follow-up|1|||
105380209|NCT04180696|363397049|FG001|Overall Study|Lost to Follow-up|0|||
105380210|NCT04180696|363397048|FG000|Overall Study|Withdrawal by Subject|0|||
105380211|NCT04180696|363397049|FG001|Overall Study|Withdrawal by Subject|1|||
105380212|NCT05537571|363397050|FG000|Overall Study|Withdrawal by Subject|1|||
105380213|NCT05537571|363397051|FG001|Overall Study|Withdrawal by Subject|1|||
105380214|NCT05537571|363397052|FG002|Overall Study|Withdrawal by Subject|0|||
105380215|NCT05537571|363397053|FG003|Overall Study|Withdrawal by Subject|0|||
105380216|NCT05537571|363397054|FG004|Overall Study|Withdrawal by Subject|0|||
105380217|NCT05537571|363397050|FG000|Overall Study|Adverse Event|2|||
105380218|NCT05537571|363397051|FG001|Overall Study|Adverse Event|0|||
105380219|NCT05537571|363397052|FG002|Overall Study|Adverse Event|0|||
105380220|NCT05537571|363397053|FG003|Overall Study|Adverse Event|0|||
105380221|NCT05537571|363397054|FG004|Overall Study|Adverse Event|0|||
105380222|NCT05537571|363397050|FG000|Overall Study|Hepatitis A screening result|2|||
105380223|NCT05537571|363397051|FG001|Overall Study|Hepatitis A screening result|0|||
105380224|NCT05537571|363397052|FG002|Overall Study|Hepatitis A screening result|0|||
105380225|NCT05537571|363397053|FG003|Overall Study|Hepatitis A screening result|0|||
105380226|NCT05537571|363397054|FG004|Overall Study|Hepatitis A screening result|0|||
105380227|NCT05537571|363397050|FG000|Overall Study|Lost to Follow-up|0|||
105380228|NCT05537571|363397051|FG001|Overall Study|Lost to Follow-up|0|||
105380229|NCT05537571|363397052|FG002|Overall Study|Lost to Follow-up|1|||
105380230|NCT05537571|363397053|FG003|Overall Study|Lost to Follow-up|0|||
105380231|NCT05537571|363397054|FG004|Overall Study|Lost to Follow-up|1|||
105380232|NCT04739709|363397061|FG000|Overall Study|Physician Decision|1|||
105380233|NCT04739709|363397062|FG001|Overall Study|Physician Decision|0|||
105380234|NCT01980888|363397063|FG000|Overall Study|Study Terminated by Sponsor|116|||
105380235|NCT01980888|363397064|FG001|Overall Study|Study Terminated by Sponsor|122|||
105380236|NCT01980888|363397063|FG000|Overall Study|Withdrew Consent|17|||
105380237|NCT01980888|363397064|FG001|Overall Study|Withdrew Consent|6|||
105380238|NCT01980888|363397063|FG000|Overall Study|Investigator's Discretion|8|||
105380239|NCT01980888|363397064|FG001|Overall Study|Investigator's Discretion|3|||
105380240|NCT01980888|363397063|FG000|Overall Study|Non-Compliance with Study Drug|3|||
105380241|NCT01980888|363397064|FG001|Overall Study|Non-Compliance with Study Drug|2|||
105380242|NCT01560416|363397073|FG000|Randomized Phase|Crossover Participants|7|||
105380243|NCT01560416|363397074|FG001|Randomized Phase|Crossover Participants|0|||
105380244|NCT03334175|363397075|FG000|Overall Study|Lost to Follow-up|0|||
105380245|NCT03334175|363397076|FG001|Overall Study|Lost to Follow-up|1|||
105380246|NCT02638493|363397077|FG000|Overall Study|Inability to provide semen samples|2|||
105380247|NCT02638493|363397078|FG001|Overall Study|Inability to provide semen samples|0|||
105380248|NCT02638493|363397079|FG002|Overall Study|Inability to provide semen samples|0|||
105380249|NCT03298061|363398274|FG000|Overall Study|Adverse Event|3|||
105380250|NCT03298061|363398274|FG000|Overall Study|Lack of Efficacy|6|||
105380251|NCT03298061|363398274|FG000|Overall Study|Protocol Violation|1|||
105380252|NCT03298061|363398274|FG000|Overall Study|Physician Decision|7|||
105380253|NCT03298061|363398274|FG000|Overall Study|Withdrawal by Subject|10|||
105380254|NCT05276804|363398277|FG000|Overall Study|screen failure|23|||
105380255|NCT05276804|363398278|FG001|Overall Study|screen failure|0|||
105380256|NCT02827708|363398279|FG000|Overall Study|Lost to Follow-up|3|||
105380257|NCT02827708|363398280|FG001|Overall Study|Lost to Follow-up|1|||
105380258|NCT02827708|363398279|FG000|Overall Study|Withdrawal by Subject|1|||
105380259|NCT02827708|363398280|FG001|Overall Study|Withdrawal by Subject|2|||
105380260|NCT02827708|363398279|FG000|Overall Study|Death|1|||
105380261|NCT02827708|363398280|FG001|Overall Study|Death|2|||
105380262|NCT02383173|363398281|FG000|Overall Study|Palliative Care Team withdrew|0|||
105380263|NCT02383173|363398282|FG001|Overall Study|Palliative Care Team withdrew|2|||
105380264|NCT01348698|363398283|FG000|Overall Study|Does not meet lesion size criteria|1|||
105380265|NCT01348698|363398283|FG000|Overall Study|Death|3|||
105380266|NCT01348698|363398283|FG000|Overall Study|PI decision to close study|68|||
105380267|NCT01177410|363398284|FG000|Overall Study|Adverse Event|0|||
105380268|NCT01177410|363398285|FG001|Overall Study|Adverse Event|2|||
105380269|NCT01177410|363398286|FG002|Overall Study|Adverse Event|2|||
105380270|NCT01177410|363398284|FG000|Overall Study|Withdrawal by Subject|1|||
105380271|NCT01177410|363398285|FG001|Overall Study|Withdrawal by Subject|4|||
105380272|NCT01177410|363398286|FG002|Overall Study|Withdrawal by Subject|3|||
105380273|NCT01177410|363398284|FG000|Overall Study|Lost to Follow-up|0|||
105380274|NCT01177410|363398285|FG001|Overall Study|Lost to Follow-up|1|||
105380275|NCT01177410|363398286|FG002|Overall Study|Lost to Follow-up|0|||
105380276|NCT00421733|363398288|FG000|Overall Study|Adverse Event|4|||
105380277|NCT00421733|363398289|FG001|Overall Study|Adverse Event|9|||
105380278|NCT00421733|363398290|FG002|Overall Study|Adverse Event|2|||
105380279|NCT00421733|363398288|FG000|Overall Study|Lost to Follow-up|1|||
105380280|NCT00421733|363398289|FG001|Overall Study|Lost to Follow-up|2|||
105380281|NCT00421733|363398290|FG002|Overall Study|Lost to Follow-up|4|||
105380282|NCT00421733|363398288|FG000|Overall Study|Withdrawal by Subject|1|||
105380283|NCT00421733|363398289|FG001|Overall Study|Withdrawal by Subject|2|||
105380284|NCT00421733|363398290|FG002|Overall Study|Withdrawal by Subject|7|||
105380285|NCT00421733|363398288|FG000|Overall Study|Death|0|||
105380286|NCT00421733|363398289|FG001|Overall Study|Death|3|||
105380287|NCT00421733|363398290|FG002|Overall Study|Death|0|||
105380288|NCT00421733|363398288|FG000|Overall Study|Required dialysis|1|||
105380289|NCT00421733|363398289|FG001|Overall Study|Required dialysis|0|||
105380290|NCT00421733|363398290|FG002|Overall Study|Required dialysis|0|||
105380291|NCT00421733|363398288|FG000|Overall Study|Administrative|2|||
105380292|NCT00421733|363398289|FG001|Overall Study|Administrative|0|||
105380293|NCT00421733|363398290|FG002|Overall Study|Administrative|0|||
105380294|NCT00421733|363398288|FG000|Overall Study|Did not satisfy entry criteria|1|||
105380295|NCT00421733|363398289|FG001|Overall Study|Did not satisfy entry criteria|3|||
105380296|NCT00421733|363398290|FG002|Overall Study|Did not satisfy entry criteria|2|||
105380297|NCT00421733|363398288|FG000|Overall Study|Sponsor request|1|||
105380298|NCT00421733|363398289|FG001|Overall Study|Sponsor request|0|||
105380299|NCT00421733|363398290|FG002|Overall Study|Sponsor request|3|||
105380300|NCT00421733|363398288|FG000|Overall Study|Protocol deviation|4|||
105380301|NCT00421733|363398289|FG001|Overall Study|Protocol deviation|7|||
105380302|NCT00421733|363398290|FG002|Overall Study|Protocol deviation|2|||
105380303|NCT01913470|363398292|FG000|Overall Study|Lost to Follow-up|0|||
105380304|NCT01913470|363398293|FG001|Overall Study|Lost to Follow-up|1|||
105380305|NCT01913470|363398292|FG000|Overall Study|Physician Decision|0|||
105380306|NCT01913470|363398293|FG001|Overall Study|Physician Decision|1|||
105380307|NCT01913470|363398292|FG000|Overall Study|Withdrawal by Subject|0|||
105380308|NCT01913470|363398293|FG001|Overall Study|Withdrawal by Subject|1|||
105380309|NCT01160744|363398294|FG000|Overall Study|Withdrawal by Subject|11|||
105380310|NCT01160744|363398295|FG001|Overall Study|Withdrawal by Subject|5|||
105380311|NCT01160744|363398296|FG002|Overall Study|Withdrawal by Subject|6|||
105380312|NCT01160744|363398297|FG003|Overall Study|Withdrawal by Subject|4|||
105380313|NCT01160744|363398294|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
105380314|NCT01160744|363398295|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
105380315|NCT01160744|363398296|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
105380316|NCT01160744|363398297|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
105380317|NCT02384460|363398298|FG000|Overall Study|Protocol Violation|0|||
105380318|NCT02384460|363398299|FG001|Overall Study|Protocol Violation|1|||
105380319|NCT02384460|363398298|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
105380320|NCT02384460|363398299|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
105380321|NCT02384460|363398298|FG000|Overall Study|Adverse Event|5|||
105380322|NCT02384460|363398299|FG001|Overall Study|Adverse Event|2|||
105380323|NCT02384460|363398298|FG000|Overall Study|Withdrawal by Subject|0|||
105380324|NCT02384460|363398299|FG001|Overall Study|Withdrawal by Subject|3|||
105380325|NCT02384460|363398298|FG000|Overall Study|Elective medical treatment|1|||
105380326|NCT02384460|363398299|FG001|Overall Study|Elective medical treatment|0|||
105380327|NCT02384460|363398298|FG000|Overall Study|Non-compliance|1|||
105380328|NCT02384460|363398299|FG001|Overall Study|Non-compliance|0|||
105380329|NCT03446573|363398300|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
105380330|NCT03446573|363398301|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
105380331|NCT03446573|363398300|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
105380332|NCT03446573|363398301|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
105380333|NCT03446573|363398300|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
105380334|NCT03446573|363398301|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
105380335|NCT03446573|363398300|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
105380336|NCT03446573|363398301|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
105380337|NCT03446573|363398300|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
105380338|NCT03446573|363398301|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
105380339|NCT03446573|363398300|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
105380340|NCT03446573|363398301|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
105380341|NCT03446573|363398300|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
105380342|NCT03446573|363398301|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
105380343|NCT03446573|363398300|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
105380344|NCT03446573|363398301|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
105380345|NCT03446573|363398300|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
105380346|NCT03446573|363398301|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
105380347|NCT03446573|363398300|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
105380348|NCT03446573|363398301|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
105380349|NCT03446573|363398300|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
105380350|NCT03446573|363398301|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
105380351|NCT03446573|363398300|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
105380352|NCT03446573|363398301|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
105380353|NCT03446573|363398300|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
105380354|NCT03446573|363398301|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
105380355|NCT02143778|363398305|FG000|Overall Study|Withdrawal by Subject|2|||
105380356|NCT02143778|363398305|FG000|Overall Study|Device malfunction|1|||
105380357|NCT04676646|363398306|FG000|Open-label Run-in Phase|Adverse Event|3|||
105380358|NCT04676646|363398307|FG001|Open-label Run-in Phase|Adverse Event|0|||
105380359|NCT04676646|363398308|FG002|Open-label Run-in Phase|Adverse Event|0|||
105380360|NCT04676646|363398306|FG000|Open-label Run-in Phase|Death|3|||
105380361|NCT04676646|363398307|FG001|Open-label Run-in Phase|Death|0|||
105380362|NCT04676646|363398308|FG002|Open-label Run-in Phase|Death|0|||
105380363|NCT04676646|363398306|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
105380364|NCT04676646|363398307|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
105380365|NCT04676646|363398308|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
105380366|NCT04676646|363398306|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
105380367|NCT04676646|363398307|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
105380368|NCT04676646|363398308|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
105380369|NCT04676646|363398306|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
105380370|NCT04676646|363398307|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
105380371|NCT04676646|363398308|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
105380372|NCT04676646|363398306|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
105380373|NCT04676646|363398307|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
105380374|NCT04676646|363398308|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
105380375|NCT04676646|363398306|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
105380376|NCT04676646|363398307|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
105380377|NCT04676646|363398308|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
105380378|NCT04676646|363398306|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
105380379|NCT04676646|363398307|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
105380380|NCT04676646|363398308|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
105380381|NCT04676646|363398306|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
105380382|NCT04676646|363398307|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
105580160|NCT03220737|364124215|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
105580161|NCT01720797|364124216|FG000|Overall Study|Withdrawal by Subject|3|||
105580162|NCT01720797|364124217|FG001|Overall Study|Withdrawal by Subject|0|||
105580163|NCT00983619|364124220|FG000|Overall Study|Lost to Follow-up|0|||
105580164|NCT00983619|364124221|FG001|Overall Study|Lost to Follow-up|1|||
105580165|NCT00983619|364124222|FG002|Overall Study|Lost to Follow-up|0|||
105580166|NCT00983619|364124223|FG003|Overall Study|Lost to Follow-up|0|||
105580167|NCT00983619|364124224|FG004|Overall Study|Lost to Follow-up|0|||
105580168|NCT00983619|364124225|FG005|Overall Study|Lost to Follow-up|2|||
105580169|NCT00983619|364124226|FG006|Overall Study|Lost to Follow-up|0|||
105580170|NCT00983619|364124227|FG007|Overall Study|Lost to Follow-up|0|||
105580171|NCT00983619|364124228|FG008|Overall Study|Lost to Follow-up|0|||
105580172|NCT00983619|364124229|FG009|Overall Study|Lost to Follow-up|0|||
105580173|NCT00983619|364124230|FG010|Overall Study|Lost to Follow-up|0|||
105580174|NCT00983619|364124231|FG011|Overall Study|Lost to Follow-up|2|||
105580175|NCT00983619|364124220|FG000|Overall Study|Withdrawal by Subject|2|||
105580176|NCT00983619|364124221|FG001|Overall Study|Withdrawal by Subject|1|||
105580177|NCT00983619|364124222|FG002|Overall Study|Withdrawal by Subject|1|||
105580178|NCT00983619|364124223|FG003|Overall Study|Withdrawal by Subject|3|||
105580179|NCT00983619|364124224|FG004|Overall Study|Withdrawal by Subject|1|||
105580180|NCT00983619|364124225|FG005|Overall Study|Withdrawal by Subject|23|||
105580181|NCT00983619|364124226|FG006|Overall Study|Withdrawal by Subject|0|||
105580182|NCT00983619|364124227|FG007|Overall Study|Withdrawal by Subject|0|||
105580183|NCT00983619|364124228|FG008|Overall Study|Withdrawal by Subject|0|||
105580184|NCT00983619|364124229|FG009|Overall Study|Withdrawal by Subject|0|||
105580185|NCT00983619|364124230|FG010|Overall Study|Withdrawal by Subject|1|||
105580186|NCT00983619|364124231|FG011|Overall Study|Withdrawal by Subject|1|||
105580187|NCT00983619|364124220|FG000|Overall Study|Death|0|||
105580188|NCT00983619|364124221|FG001|Overall Study|Death|2|||
105580189|NCT00983619|364124222|FG002|Overall Study|Death|2|||
105580190|NCT00983619|364124223|FG003|Overall Study|Death|1|||
105380383|NCT04676646|363398308|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
105380384|NCT04676646|363398306|FG000|Randomised-withdrawal Phase|Death|0|||
105380385|NCT04676646|363398307|FG001|Randomised-withdrawal Phase|Death|1|||
105380386|NCT04676646|363398308|FG002|Randomised-withdrawal Phase|Death|2|||
105380387|NCT04676646|363398306|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
105380388|NCT04676646|363398307|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
105380389|NCT04676646|363398308|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
105380390|NCT04676646|363398306|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
105380391|NCT04676646|363398307|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
105380392|NCT04676646|363398308|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
105380393|NCT04676646|363398306|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
105380394|NCT04676646|363398307|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
105380395|NCT04676646|363398308|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
105380396|NCT04676646|363398306|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
105380397|NCT04676646|363398307|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
105380398|NCT04676646|363398308|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
105380399|NCT04676646|363398306|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
105380400|NCT04676646|363398307|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
105380401|NCT04676646|363398308|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
105380402|NCT04676646|363398306|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
105380403|NCT04676646|363398307|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
105380404|NCT04676646|363398308|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
105380405|NCT04676646|363398306|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
105380406|NCT04676646|363398307|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
105380407|NCT04676646|363398308|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
105380408|NCT02969018|363398309|FG000|Overall Study|Adverse Event|2|||
105380409|NCT02969018|363398310|FG001|Overall Study|Adverse Event|4|||
105380410|NCT02969018|363398311|FG002|Overall Study|Adverse Event|1|||
105380411|NCT02969018|363398312|FG003|Overall Study|Adverse Event|2|||
105380412|NCT02969018|363398313|FG004|Overall Study|Adverse Event|0|||
105380413|NCT02969018|363398314|FG005|Overall Study|Adverse Event|1|||
105380414|NCT02969018|363398315|FG006|Overall Study|Adverse Event|2|||
105380415|NCT02969018|363398316|FG007|Overall Study|Adverse Event|0|||
105380416|NCT02969018|363398309|FG000|Overall Study|Lack of Efficacy|0|||
105380417|NCT02969018|363398310|FG001|Overall Study|Lack of Efficacy|1|||
105380418|NCT02969018|363398311|FG002|Overall Study|Lack of Efficacy|0|||
105380419|NCT02969018|363398312|FG003|Overall Study|Lack of Efficacy|0|||
105380420|NCT02969018|363398313|FG004|Overall Study|Lack of Efficacy|1|||
105380421|NCT02969018|363398314|FG005|Overall Study|Lack of Efficacy|1|||
105380422|NCT02969018|363398315|FG006|Overall Study|Lack of Efficacy|1|||
105380423|NCT02969018|363398316|FG007|Overall Study|Lack of Efficacy|1|||
105380424|NCT02969018|363398309|FG000|Overall Study|Lost to Follow-up|1|||
105380425|NCT02969018|363398310|FG001|Overall Study|Lost to Follow-up|2|||
105380426|NCT02969018|363398311|FG002|Overall Study|Lost to Follow-up|2|||
105380427|NCT02969018|363398312|FG003|Overall Study|Lost to Follow-up|0|||
105380428|NCT02969018|363398313|FG004|Overall Study|Lost to Follow-up|1|||
105380429|NCT02969018|363398314|FG005|Overall Study|Lost to Follow-up|1|||
105380430|NCT02969018|363398315|FG006|Overall Study|Lost to Follow-up|0|||
105380431|NCT02969018|363398316|FG007|Overall Study|Lost to Follow-up|1|||
105380432|NCT02969018|363398309|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
105380433|NCT02969018|363398310|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
105380434|NCT02969018|363398311|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
105380435|NCT02969018|363398312|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
105380436|NCT02969018|363398313|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
105380437|NCT02969018|363398314|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
105380438|NCT02969018|363398315|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
105380439|NCT02969018|363398316|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
105380440|NCT02969018|363398309|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105380441|NCT02969018|363398310|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105380442|NCT02969018|363398311|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105380443|NCT02969018|363398312|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105380444|NCT02969018|363398313|FG004|Overall Study|Non-Compliance With Study Drug|0|||
105380445|NCT02969018|363398314|FG005|Overall Study|Non-Compliance With Study Drug|0|||
105380446|NCT02969018|363398315|FG006|Overall Study|Non-Compliance With Study Drug|0|||
105331117|NCT00506415|363212859|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
105331118|NCT00506415|363212860|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
105331119|NCT00506415|363212857|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
105331120|NCT00506415|363212858|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
105331121|NCT00506415|363212859|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
105331122|NCT00506415|363212860|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
105331123|NCT00506415|363212857|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
105331124|NCT00506415|363212858|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
105331125|NCT00506415|363212859|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
105331126|NCT00506415|363212860|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
105331127|NCT00506415|363212857|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
105331128|NCT00506415|363212858|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
105331129|NCT00506415|363212859|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
105331130|NCT00506415|363212860|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
105331131|NCT00506415|363212857|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
105331132|NCT00506415|363212858|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
105331133|NCT00506415|363212859|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
105331134|NCT00506415|363212860|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
105331135|NCT00506415|363212857|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
105331136|NCT00506415|363212858|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
105331137|NCT00506415|363212859|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
105331138|NCT00506415|363212860|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
105331139|NCT00506415|363212857|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
105331140|NCT00506415|363212858|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
105331141|NCT00506415|363212859|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
105331142|NCT00506415|363212860|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
105331143|NCT00506415|363212857|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
105331144|NCT00506415|363212858|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
105331145|NCT00506415|363212859|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
105331146|NCT00506415|363212860|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
105331147|NCT00506415|363212857|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
105331148|NCT00506415|363212858|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
105331149|NCT00506415|363212859|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
105331150|NCT00506415|363212860|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
105331151|NCT00506415|363212857|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
105331152|NCT00506415|363212858|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
105331153|NCT00506415|363212859|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
105331154|NCT00506415|363212860|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
105331155|NCT00506415|363212857|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
105331156|NCT00506415|363212858|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
105331157|NCT00506415|363212859|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
105331158|NCT00506415|363212860|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
105331159|NCT00506415|363212857|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
105331160|NCT00506415|363212858|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
105331161|NCT00506415|363212859|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
105331162|NCT00506415|363212860|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
105331163|NCT00506415|363212857|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
105331164|NCT00506415|363212858|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
105331165|NCT00506415|363212859|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
105331166|NCT00506415|363212860|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
105331167|NCT00506415|363212857|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
105331168|NCT00506415|363212858|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
105331169|NCT00506415|363212859|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
105331170|NCT00506415|363212860|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
105331171|NCT00506415|363212857|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
105331172|NCT00506415|363212858|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
105331173|NCT00506415|363212859|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
105331174|NCT00506415|363212860|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
105331175|NCT00506415|363212857|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
105331176|NCT00506415|363212858|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
105331177|NCT00506415|363212859|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
105331178|NCT00506415|363212860|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
105331179|NCT01703260|363212866|FG000|Overall Study|Adverse Event|1|||
105580191|NCT00983619|364124224|FG004|Overall Study|Death|2|||
105580192|NCT00983619|364124225|FG005|Overall Study|Death|30|||
105580193|NCT00983619|364124226|FG006|Overall Study|Death|1|||
105580194|NCT00983619|364124227|FG007|Overall Study|Death|0|||
105580195|NCT00983619|364124228|FG008|Overall Study|Death|1|||
105580196|NCT00983619|364124229|FG009|Overall Study|Death|2|||
105580197|NCT00983619|364124230|FG010|Overall Study|Death|9|||
105580198|NCT00983619|364124231|FG011|Overall Study|Death|8|||
105580199|NCT00983619|364124220|FG000|Overall Study|Other|1|||
105380447|NCT02969018|363398316|FG007|Overall Study|Non-Compliance With Study Drug|0|||
105380448|NCT02969018|363398309|FG000|Overall Study|Other|0|||
105380449|NCT02969018|363398310|FG001|Overall Study|Other|0|||
105380450|NCT02969018|363398311|FG002|Overall Study|Other|0|||
105380451|NCT02969018|363398312|FG003|Overall Study|Other|1|||
105380452|NCT02969018|363398313|FG004|Overall Study|Other|0|||
105380453|NCT02969018|363398314|FG005|Overall Study|Other|0|||
105380454|NCT02969018|363398315|FG006|Overall Study|Other|0|||
105380455|NCT02969018|363398316|FG007|Overall Study|Other|2|||
105380456|NCT02969018|363398309|FG000|Overall Study|Pregnancy|0|||
105380457|NCT02969018|363398310|FG001|Overall Study|Pregnancy|0|||
105380458|NCT02969018|363398311|FG002|Overall Study|Pregnancy|0|||
105380459|NCT02969018|363398312|FG003|Overall Study|Pregnancy|0|||
105380460|NCT02969018|363398313|FG004|Overall Study|Pregnancy|0|||
105380461|NCT02969018|363398314|FG005|Overall Study|Pregnancy|1|||
105380462|NCT02969018|363398315|FG006|Overall Study|Pregnancy|0|||
105380463|NCT02969018|363398316|FG007|Overall Study|Pregnancy|0|||
105380464|NCT02969018|363398309|FG000|Overall Study|Protocol Violation|0|||
105380465|NCT02969018|363398310|FG001|Overall Study|Protocol Violation|0|||
105380466|NCT02969018|363398311|FG002|Overall Study|Protocol Violation|1|||
105380467|NCT02969018|363398312|FG003|Overall Study|Protocol Violation|1|||
105380468|NCT02969018|363398313|FG004|Overall Study|Protocol Violation|0|||
105380469|NCT02969018|363398314|FG005|Overall Study|Protocol Violation|0|||
105380470|NCT02969018|363398315|FG006|Overall Study|Protocol Violation|0|||
105380471|NCT02969018|363398316|FG007|Overall Study|Protocol Violation|0|||
105380472|NCT02969018|363398309|FG000|Overall Study|Withdrawal by Subject|0|||
105380473|NCT02969018|363398310|FG001|Overall Study|Withdrawal by Subject|1|||
105380474|NCT02969018|363398311|FG002|Overall Study|Withdrawal by Subject|2|||
105380475|NCT02969018|363398312|FG003|Overall Study|Withdrawal by Subject|1|||
105380476|NCT02969018|363398313|FG004|Overall Study|Withdrawal by Subject|0|||
105380477|NCT02969018|363398314|FG005|Overall Study|Withdrawal by Subject|4|||
105380478|NCT02969018|363398315|FG006|Overall Study|Withdrawal by Subject|4|||
105380479|NCT02969018|363398316|FG007|Overall Study|Withdrawal by Subject|3|||
105380480|NCT02448043|363398317|FG000|Overall Study|Withdrawal by Subject|2|||
105380481|NCT02448043|363398318|FG001|Overall Study|Withdrawal by Subject|2|||
105380482|NCT02448043|363398317|FG000|Overall Study|Protocol Violation|1|||
105380483|NCT02448043|363398318|FG001|Overall Study|Protocol Violation|2|||
105380484|NCT00471107|363398322|FG000|Overall Study|Technical problems/data loss|3|||
105380485|NCT00471107|363398323|FG001|Overall Study|Technical problems/data loss|1|||
105380486|NCT00471107|363398324|FG002|Overall Study|Technical problems/data loss|3|||
105380487|NCT02942407|363398326|FG000|Overall Study|Lost to Follow-up|3|||
105380488|NCT02942407|363398327|FG001|Overall Study|Lost to Follow-up|2|||
105380489|NCT02942407|363398326|FG000|Overall Study|Withdrawal by Subject|7|||
105380490|NCT02942407|363398327|FG001|Overall Study|Withdrawal by Subject|9|||
105380491|NCT02942407|363398326|FG000|Overall Study|Death|16|||
105380492|NCT02942407|363398327|FG001|Overall Study|Death|13|||
105380493|NCT01769443|363398328|FG000|Overall Study|Study closure|1|||
105380494|NCT01769443|363398329|FG001|Overall Study|Study closure|0|||
105380495|NCT00933166|363398330|FG000|Overall Study|Lost to Follow-up|4|||
105380496|NCT00933166|363398330|FG000|Overall Study|Lack of Efficacy|9|||
105380497|NCT00933166|363398330|FG000|Overall Study|Unavailable|4|||
105380498|NCT00933166|363398330|FG000|Overall Study|Withdrawal by Subject|1|||
105331180|NCT01703260|363212867|FG001|Overall Study|Adverse Event|2|||
105331181|NCT01703260|363212868|FG002|Overall Study|Adverse Event|2|||
105331182|NCT01703260|363212866|FG000|Overall Study|Lost to Follow-up|1|||
105331183|NCT01703260|363212867|FG001|Overall Study|Lost to Follow-up|0|||
105331184|NCT01703260|363212868|FG002|Overall Study|Lost to Follow-up|0|||
105331185|NCT01703260|363212866|FG000|Overall Study|Withdrawal by Subject|0|||
105331186|NCT01703260|363212867|FG001|Overall Study|Withdrawal by Subject|0|||
105331187|NCT01703260|363212868|FG002|Overall Study|Withdrawal by Subject|1|||
105331188|NCT01703260|363212866|FG000|Overall Study|Study Termination|1|||
105331189|NCT01703260|363212867|FG001|Overall Study|Study Termination|2|||
105331190|NCT01703260|363212868|FG002|Overall Study|Study Termination|0|||
105331191|NCT01081769|363212873|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
105331192|NCT01081769|363212874|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
105331193|NCT01081769|363212873|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
105331194|NCT01081769|363212874|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
105331195|NCT01081769|363212873|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
105331196|NCT01081769|363212874|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
105580200|NCT00983619|364124221|FG001|Overall Study|Other|0|||
105580201|NCT00983619|364124222|FG002|Overall Study|Other|0|||
105580202|NCT00983619|364124223|FG003|Overall Study|Other|1|||
105331197|NCT01081769|363212873|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
105331198|NCT01081769|363212874|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
105331199|NCT01081769|363212873|FG000|CORE Intent-To-Treat|Adverse Event|14|||
105331200|NCT01081769|363212874|FG001|CORE Intent-To-Treat|Adverse Event|11|||
105331201|NCT01081769|363212873|FG000|CORE Intent-To-Treat|Death|1|||
105331202|NCT01081769|363212874|FG001|CORE Intent-To-Treat|Death|1|||
105331203|NCT01081769|363212873|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
105331204|NCT01081769|363212874|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
105331205|NCT01081769|363212873|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
105331206|NCT01081769|363212874|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
105331207|NCT01081769|363212873|FG000|CORE Intent-To-Treat|Pregnancy|1|||
105331208|NCT01081769|363212874|FG001|CORE Intent-To-Treat|Pregnancy|0|||
105331209|NCT01081769|363212873|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
105331210|NCT01081769|363212874|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
105331211|NCT01081769|363212873|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
105331212|NCT01081769|363212874|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
105331213|NCT01081769|363212873|FG000|CORE Intent-To-Treat|Other|0|||
105331214|NCT01081769|363212874|FG001|CORE Intent-To-Treat|Other|1|||
105331215|NCT01081769|363212873|FG000|CORE Intent-To-Treat|Ineligibility|3|||
105331216|NCT01081769|363212874|FG001|CORE Intent-To-Treat|Ineligibility|4|||
105331217|NCT01081769|363212873|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
105331218|NCT01081769|363212874|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
105331219|NCT01081769|363212873|FG000|CORE Intent-To-Treat|Patient Moved|2|||
105331220|NCT01081769|363212874|FG001|CORE Intent-To-Treat|Patient Moved|2|||
105331221|NCT00507455|363212875|FG000|Overall Study|Adverse Event|3|||
105331222|NCT00507455|363212876|FG001|Overall Study|Adverse Event|3|||
105331223|NCT00507455|363212877|FG002|Overall Study|Adverse Event|6|||
105331224|NCT00507455|363212875|FG000|Overall Study|Withdrawal by Subject|2|||
105331225|NCT00507455|363212876|FG001|Overall Study|Withdrawal by Subject|1|||
105331226|NCT00507455|363212877|FG002|Overall Study|Withdrawal by Subject|2|||
105331227|NCT00507455|363212875|FG000|Overall Study|Protocol Violation|4|||
105331228|NCT00507455|363212876|FG001|Overall Study|Protocol Violation|1|||
105331229|NCT00507455|363212877|FG002|Overall Study|Protocol Violation|1|||
105331230|NCT00507455|363212875|FG000|Overall Study|Lost to Follow-up|2|||
105331231|NCT00507455|363212876|FG001|Overall Study|Lost to Follow-up|0|||
105331232|NCT00507455|363212877|FG002|Overall Study|Lost to Follow-up|2|||
105331233|NCT00507455|363212875|FG000|Overall Study|Lack of Efficacy|0|||
105331234|NCT00507455|363212876|FG001|Overall Study|Lack of Efficacy|1|||
105331235|NCT00507455|363212877|FG002|Overall Study|Lack of Efficacy|0|||
105331236|NCT00507455|363212875|FG000|Overall Study|Other - miscellaneous reason|1|||
105331237|NCT00507455|363212876|FG001|Overall Study|Other - miscellaneous reason|0|||
105331238|NCT00507455|363212877|FG002|Overall Study|Other - miscellaneous reason|1|||
105331239|NCT02176655|363212878|FG000|Overall Study|Subjects did not treat|6|||
105331240|NCT00237458|363212887|FG000|Overall Study|Lack of Efficacy|1|||
105331241|NCT00237458|363212887|FG000|Overall Study|Adverse Event|1|||
105331242|NCT00237458|363212887|FG000|Overall Study|Withdrawal by Subject|1|||
105331243|NCT01578239|363212889|FG000|Treatment Period|Progressive Disease|19|||
105331244|NCT01578239|363212890|FG001|Treatment Period|Progressive Disease|64|||
105331245|NCT01578239|363212889|FG000|Treatment Period|Physician Decision|17|||
105331246|NCT01578239|363212890|FG001|Treatment Period|Physician Decision|17|||
105331247|NCT01578239|363212889|FG000|Treatment Period|Adverse Event|13|||
105331248|NCT01578239|363212890|FG001|Treatment Period|Adverse Event|10|||
105331249|NCT01578239|363212889|FG000|Treatment Period|Non-compliance|2|||
105331250|NCT01578239|363212890|FG001|Treatment Period|Non-compliance|0|||
105380499|NCT04996264|363398331|FG000|Overall Study|Lost to Follow-up|0|||
105380500|NCT04996264|363398332|FG001|Overall Study|Lost to Follow-up|1|||
105380501|NCT04996264|363398331|FG000|Overall Study|Withdrawal by Subject|4|||
105380502|NCT04996264|363398332|FG001|Overall Study|Withdrawal by Subject|3|||
105380503|NCT04996264|363398331|FG000|Overall Study|1 left AMA|0|||
105380504|NCT04996264|363398332|FG001|Overall Study|1 left AMA|1|||
105380505|NCT04996264|363398331|FG000|Overall Study|Subject changed hospitals|0|||
105380506|NCT04996264|363398332|FG001|Overall Study|Subject changed hospitals|1|||
105331251|NCT01578239|363212889|FG000|Treatment Period|Withdrawal by Subject|10|||
105331252|NCT01578239|363212890|FG001|Treatment Period|Withdrawal by Subject|9|||
105331253|NCT01578239|363212889|FG000|Treatment Period|Other|6|||
105331254|NCT01578239|363212890|FG001|Treatment Period|Other|1|||
105331255|NCT01578239|363212889|FG000|Long-term Follow-Up Period|Death|69|||
105380507|NCT04996264|363398331|FG000|Overall Study|unable to complete due to work|0|||
105380508|NCT04996264|363398332|FG001|Overall Study|unable to complete due to work|1|||
105380512|NCT04392635|363398338|FG000|Overall Study|Lost to Follow-up|0|||
105380513|NCT04392635|363398339|FG001|Overall Study|Lost to Follow-up|1|||
105380514|NCT02030418|363398340|FG000|Overall Study|Death|78|||
105380515|NCT02030418|363398340|FG000|Overall Study|Missed 12-Month Visit|9|||
105380516|NCT02030418|363398340|FG000|Overall Study|Withdrawn|57|||
105380517|NCT04477486|363398347|FG000|Overall Study|Death|2|||
105380518|NCT04477486|363398347|FG000|Overall Study|Ongoing at Time of Analysis|11|||
105380519|NCT04280562|363398348|FG000|Study|Adverse Event|2|||
105380520|NCT04280562|363398349|FG001|Study|Adverse Event|0|||
105380521|NCT04280562|363398348|FG000|Study|Lost to Follow-up|3|||
105380522|NCT04280562|363398349|FG001|Study|Lost to Follow-up|3|||
105380523|NCT04210375|363398354|FG000|Overall Study|Death|0|||
105380524|NCT04210375|363398355|FG001|Overall Study|Death|1|||
105380525|NCT04210375|363398356|FG002|Overall Study|Death|0|||
105380526|NCT04210375|363398357|FG003|Overall Study|Death|0|||
105380527|NCT05752487|363398358|FG000|Overall Study|Enrolled, not treated|9|||
105380528|NCT05752487|363398358|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
105380529|NCT05752487|363398358|FG000|Overall Study|Withdrawal by Subject|2|||
105380530|NCT02593864|363398360|FG000|Overall Study|Withdrawal by Subject|3|||
105380531|NCT02593864|363398360|FG000|Overall Study|Lost to Follow-up|3|||
105380532|NCT04124965|363398364|FG000|Overall Study|Adverse event, non-fatal|3|||
105380533|NCT04124965|363398365|FG001|Overall Study|Adverse event, non-fatal|1|||
105380534|NCT04124965|363398364|FG000|Overall Study|Withdrawal by Subject|1|||
105380535|NCT04124965|363398365|FG001|Overall Study|Withdrawal by Subject|1|||
105380536|NCT04124965|363398364|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
105380537|NCT04124965|363398365|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
105380538|NCT04124965|363398364|FG000|Overall Study|Pregnancy|1|||
105380539|NCT04124965|363398365|FG001|Overall Study|Pregnancy|0|||
105380540|NCT04124965|363398364|FG000|Overall Study|Sponsor and participant decision|0|||
105380541|NCT04124965|363398365|FG001|Overall Study|Sponsor and participant decision|1|||
105380542|NCT04124965|363398364|FG000|Overall Study|Personal surgery|0|||
105380543|NCT04124965|363398365|FG001|Overall Study|Personal surgery|1|||
105380544|NCT04124965|363398364|FG000|Overall Study|Physician Decision|0|||
105380545|NCT04124965|363398365|FG001|Overall Study|Physician Decision|1|||
105380546|NCT03003468|363398366|FG000|Overall Study|Withdrawal by Subject|0|||
105380547|NCT03003468|363398367|FG001|Overall Study|Withdrawal by Subject|0|||
105380548|NCT03003468|363398368|FG002|Overall Study|Withdrawal by Subject|1|||
105380549|NCT03003468|363398366|FG000|Overall Study|No measurable lesions|0|||
105380550|NCT03003468|363398367|FG001|Overall Study|No measurable lesions|0|||
105380551|NCT03003468|363398368|FG002|Overall Study|No measurable lesions|1|||
105380552|NCT00002874|363398369|FG000|Overall Study|Withdrawal by Subject|1|||
105380553|NCT00002874|363398370|FG001|Overall Study|Withdrawal by Subject|1|||
105380554|NCT00002874|363398369|FG000|Overall Study|Protocol Violation|44|||
105380555|NCT00002874|363398370|FG001|Overall Study|Protocol Violation|34|||
105380556|NCT00421993|363398373|FG000|Overall Study|Withdrawal by Subject|22|||
105380557|NCT00421993|363398374|FG001|Overall Study|Withdrawal by Subject|23|||
105380558|NCT00421993|363398375|FG002|Overall Study|Withdrawal by Subject|23|||
105380559|NCT00421993|363398376|FG003|Overall Study|Withdrawal by Subject|24|||
105380560|NCT00421993|363398373|FG000|Overall Study|Lost to Follow-up|18|||
105380561|NCT00421993|363398374|FG001|Overall Study|Lost to Follow-up|19|||
105380562|NCT00421993|363398375|FG002|Overall Study|Lost to Follow-up|22|||
105380563|NCT00421993|363398376|FG003|Overall Study|Lost to Follow-up|20|||
105380564|NCT00421993|363398373|FG000|Overall Study|Adverse Event|11|||
105380565|NCT00421993|363398374|FG001|Overall Study|Adverse Event|1|||
105380566|NCT00421993|363398375|FG002|Overall Study|Adverse Event|6|||
105380567|NCT00421993|363398376|FG003|Overall Study|Adverse Event|4|||
105380568|NCT00421993|363398373|FG000|Overall Study|Protocol Violation|2|||
105380569|NCT00421993|363398374|FG001|Overall Study|Protocol Violation|2|||
105380570|NCT00421993|363398375|FG002|Overall Study|Protocol Violation|0|||
105380571|NCT00421993|363398376|FG003|Overall Study|Protocol Violation|1|||
105380572|NCT00421993|363398373|FG000|Overall Study|Lack of Efficacy|0|||
105380573|NCT00421993|363398374|FG001|Overall Study|Lack of Efficacy|3|||
105380574|NCT00421993|363398375|FG002|Overall Study|Lack of Efficacy|0|||
105380575|NCT00421993|363398376|FG003|Overall Study|Lack of Efficacy|5|||
105380576|NCT00421993|363398373|FG000|Overall Study|Pregnancy|0|||
105380577|NCT00421993|363398374|FG001|Overall Study|Pregnancy|1|||
105380578|NCT00421993|363398375|FG002|Overall Study|Pregnancy|1|||
105380579|NCT00421993|363398376|FG003|Overall Study|Pregnancy|2|||
105380580|NCT00421993|363398373|FG000|Overall Study|Subject transportation issues|0|||
105380581|NCT00421993|363398374|FG001|Overall Study|Subject transportation issues|0|||
105380582|NCT00421993|363398375|FG002|Overall Study|Subject transportation issues|0|||
105380583|NCT00421993|363398376|FG003|Overall Study|Subject transportation issues|1|||
105380584|NCT02530242|363398377|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
105380585|NCT02530242|363398378|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
105380586|NCT03158311|363398379|FG000|Overall Study|Subject/Guardian Decision|10|||
105380587|NCT03158311|363398380|FG001|Overall Study|Subject/Guardian Decision|6|||
105380588|NCT03158311|363398381|FG002|Overall Study|Subject/Guardian Decision|11|||
105380589|NCT03158311|363398379|FG000|Overall Study|Adverse Event|5|||
105380590|NCT03158311|363398380|FG001|Overall Study|Adverse Event|3|||
105380591|NCT03158311|363398381|FG002|Overall Study|Adverse Event|3|||
105380592|NCT03158311|363398379|FG000|Overall Study|Techinical Problems|3|||
105380593|NCT03158311|363398380|FG001|Overall Study|Techinical Problems|1|||
105380594|NCT03158311|363398381|FG002|Overall Study|Techinical Problems|5|||
105380595|NCT03158311|363398379|FG000|Overall Study|Physician Decision|2|||
105380596|NCT03158311|363398380|FG001|Overall Study|Physician Decision|3|||
105380597|NCT03158311|363398381|FG002|Overall Study|Physician Decision|7|||
105380598|NCT03158311|363398379|FG000|Overall Study|Lost to Follow-up|1|||
105380599|NCT03158311|363398380|FG001|Overall Study|Lost to Follow-up|1|||
105380600|NCT03158311|363398381|FG002|Overall Study|Lost to Follow-up|1|||
105380601|NCT03158311|363398379|FG000|Overall Study|Sponsor decision|1|||
105380602|NCT03158311|363398380|FG001|Overall Study|Sponsor decision|0|||
105380603|NCT03158311|363398381|FG002|Overall Study|Sponsor decision|0|||
105380604|NCT03158311|363398379|FG000|Overall Study|Pregnancy|0|||
105380605|NCT03158311|363398380|FG001|Overall Study|Pregnancy|2|||
105380606|NCT03158311|363398381|FG002|Overall Study|Pregnancy|0|||
105380607|NCT03158311|363398379|FG000|Overall Study|Randomized in error|0|||
105380608|NCT03158311|363398380|FG001|Overall Study|Randomized in error|0|||
105380609|NCT03158311|363398381|FG002|Overall Study|Randomized in error|1|||
105380610|NCT05643794|363399864|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
105380611|NCT05643794|363399865|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
105380612|NCT05643794|363399866|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
105380613|NCT05643794|363399864|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
105380614|NCT05643794|363399865|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105380615|NCT05643794|363399866|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105380616|NCT05643794|363399864|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
105380617|NCT05643794|363399865|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
105380618|NCT05643794|363399866|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
105380619|NCT05643794|363399864|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
105380620|NCT05643794|363399865|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
105380621|NCT05643794|363399866|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
105380622|NCT05643794|363399864|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
105380623|NCT05643794|363399865|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
105380624|NCT05643794|363399866|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
105380625|NCT05643794|363399864|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
105380626|NCT05643794|363399865|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
105380627|NCT05643794|363399866|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
105380628|NCT01363076|363399871|FG000|Overall Study|Withdrawal by Subject|0|||
105380629|NCT01363076|363399872|FG001|Overall Study|Withdrawal by Subject|1|||
105380630|NCT04706403|363399873|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
105380631|NCT04706403|363399874|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
105380632|NCT04706403|363399875|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
105380633|NCT04706403|363399876|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
105380634|NCT04706403|363399877|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
105380635|NCT01653262|363399878|FG000|Overall Study|Lack of Efficacy|1|||
105380636|NCT01653262|363399878|FG000|Overall Study|SAE, non-fatal|1|||
105380637|NCT01653262|363399878|FG000|Overall Study|AE, non-serious non-fatal|1|||
105380638|NCT04633447|363399882|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
105380639|NCT04633447|363399883|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
105380640|NCT04633447|363399882|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
105380641|NCT04633447|363399883|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
105380642|NCT04633447|363399882|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
105380643|NCT04633447|363399883|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
105380644|NCT04633447|363399882|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
105380645|NCT04633447|363399883|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
105380646|NCT04633447|363399882|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
105380647|NCT04633447|363399883|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
105380648|NCT04633447|363399882|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
105380649|NCT04633447|363399883|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
105380650|NCT01807520|363399884|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
105380651|NCT01807520|363399885|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
105380652|NCT01807520|363399886|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
105380653|NCT01807520|363399887|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
105380654|NCT01807520|363399888|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
105380655|NCT01807520|363399889|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
105380656|NCT01807520|363399890|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
105380657|NCT01807520|363399884|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
105380658|NCT01807520|363399885|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
105380659|NCT01807520|363399886|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
105380660|NCT01807520|363399887|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
105380661|NCT01807520|363399888|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
105380662|NCT01807520|363399889|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
105380663|NCT01807520|363399890|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
105380664|NCT01807520|363399884|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
105380665|NCT01807520|363399885|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
105380666|NCT01807520|363399886|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
105380667|NCT01807520|363399887|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
105380668|NCT01807520|363399888|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
105380669|NCT01807520|363399889|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
105380670|NCT01807520|363399890|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
105380671|NCT01807520|363399884|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
105380672|NCT01807520|363399885|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
105380673|NCT01807520|363399886|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
105380674|NCT01807520|363399887|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
105380675|NCT01807520|363399888|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
105380676|NCT01807520|363399889|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
105380677|NCT01807520|363399890|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
105380678|NCT01807520|363399884|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
105380679|NCT01807520|363399885|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
105380680|NCT01807520|363399886|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
105380681|NCT01807520|363399887|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
105380682|NCT01807520|363399888|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
105380683|NCT01807520|363399889|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
105380684|NCT01807520|363399890|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
105380685|NCT01807520|363399884|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
105380686|NCT01807520|363399885|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
105380687|NCT01807520|363399886|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
105380688|NCT01807520|363399887|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
105380689|NCT01807520|363399888|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
105380690|NCT01807520|363399889|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
105380691|NCT01807520|363399890|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
105380692|NCT01807520|363399884|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
105380693|NCT01807520|363399885|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
105380694|NCT01807520|363399886|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
105380695|NCT01807520|363399887|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
105380696|NCT01807520|363399888|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
105380697|NCT01807520|363399889|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
105380698|NCT01807520|363399890|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
105380699|NCT01807520|363399884|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
105380700|NCT01807520|363399885|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
105380701|NCT01807520|363399886|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
105380702|NCT01807520|363399887|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
105380703|NCT01807520|363399888|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
105380704|NCT01807520|363399889|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
105331256|NCT01578239|363212890|FG001|Long-term Follow-Up Period|Death|64|||
105331257|NCT01578239|363212889|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
105331258|NCT01578239|363212890|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
105331259|NCT01578239|363212889|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
105331260|NCT01578239|363212890|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
105331261|NCT01578239|363212889|FG000|Long-term Follow-Up Period|Other|2|||
105331262|NCT01578239|363212890|FG001|Long-term Follow-Up Period|Other|2|||
105331263|NCT03379727|363212891|FG000|Overall Study|Lack of Efficacy|73|||
105331264|NCT03379727|363212891|FG000|Overall Study|Adverse Event|32|||
105331265|NCT03379727|363212891|FG000|Overall Study|Death|18|||
105331266|NCT03379727|363212891|FG000|Overall Study|Patient/guardian decision|17|||
105331267|NCT03379727|363212891|FG000|Overall Study|Physician Decision|104|||
105331268|NCT03379727|363212891|FG000|Overall Study|Protocol Violation|4|||
105331269|NCT03379727|363212891|FG000|Overall Study|Lost to Follow-up|1|||
105331270|NCT02547220|363212897|FG000|Overall Study|Withdrawal by Subject|1|||
105331271|NCT02547220|363212898|FG001|Overall Study|Withdrawal by Subject|0|||
105331272|NCT02547220|363212897|FG000|Overall Study|Study terminated by sponsor|18|||
105331273|NCT02547220|363212898|FG001|Overall Study|Study terminated by sponsor|20|||
105331274|NCT00550043|363212899|FG000|Overall Study|Adverse Event|0|||
105331275|NCT00550043|363212900|FG001|Overall Study|Adverse Event|0|||
105331276|NCT00550043|363212901|FG002|Overall Study|Adverse Event|0|||
105331277|NCT00550043|363212902|FG003|Overall Study|Adverse Event|1|||
105331278|NCT00550043|363212903|FG004|Overall Study|Adverse Event|1|||
105331279|NCT00550043|363212899|FG000|Overall Study|Subject Withdrew Consent|0|||
105331280|NCT00550043|363212900|FG001|Overall Study|Subject Withdrew Consent|2|||
105331281|NCT00550043|363212901|FG002|Overall Study|Subject Withdrew Consent|1|||
105331282|NCT00550043|363212902|FG003|Overall Study|Subject Withdrew Consent|0|||
105331283|NCT00550043|363212903|FG004|Overall Study|Subject Withdrew Consent|0|||
105331284|NCT00550043|363212899|FG000|Overall Study|Other Reasons- Unspecified|0|||
105331285|NCT00550043|363212900|FG001|Overall Study|Other Reasons- Unspecified|1|||
105331286|NCT00550043|363212901|FG002|Overall Study|Other Reasons- Unspecified|0|||
105331287|NCT00550043|363212902|FG003|Overall Study|Other Reasons- Unspecified|1|||
105331288|NCT00550043|363212903|FG004|Overall Study|Other Reasons- Unspecified|0|||
105331289|NCT01031680|363212904|FG000|Overall Study|Adverse Event|8|||
105331290|NCT01031680|363212905|FG001|Overall Study|Adverse Event|3|||
105331291|NCT01031680|363212904|FG000|Overall Study|Lost to Follow-up|2|||
105331292|NCT01031680|363212905|FG001|Overall Study|Lost to Follow-up|10|||
105331293|NCT01031680|363212904|FG000|Overall Study|Withdrawal by Subject|12|||
105380705|NCT01807520|363399890|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
105380706|NCT01807520|363399884|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
105380707|NCT01807520|363399885|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
105380708|NCT01807520|363399886|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
105380709|NCT01807520|363399887|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
105331294|NCT01031680|363212905|FG001|Overall Study|Withdrawal by Subject|16|||
105331295|NCT01031680|363212904|FG000|Overall Study|Death|2|||
105331296|NCT01031680|363212905|FG001|Overall Study|Death|1|||
105331297|NCT01031680|363212904|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
105331298|NCT01031680|363212905|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
105331299|NCT01031680|363212904|FG000|Overall Study|Poor/Non-compliance|5|||
105331300|NCT01031680|363212905|FG001|Overall Study|Poor/Non-compliance|6|||
105331301|NCT01031680|363212904|FG000|Overall Study|Safety|1|||
105331302|NCT01031680|363212905|FG001|Overall Study|Safety|0|||
105331303|NCT01031680|363212904|FG000|Overall Study|Incorrect Enrolment|1|||
105331304|NCT01031680|363212905|FG001|Overall Study|Incorrect Enrolment|2|||
105331305|NCT01031680|363212904|FG000|Overall Study|Administrative Reason by Sponsor|0|||
105331306|NCT01031680|363212905|FG001|Overall Study|Administrative Reason by Sponsor|1|||
105331307|NCT01031680|363212904|FG000|Overall Study|Various|0|||
105331308|NCT01031680|363212905|FG001|Overall Study|Various|2|||
105331309|NCT02654977|363212908|FG000|Overall Study|Death|1|||
105331310|NCT02654977|363212908|FG000|Overall Study|Lost to Follow-up|1|||
105331311|NCT02654977|363212908|FG000|Overall Study|Adverse Event|1|||
105331312|NCT02654977|363212908|FG000|Overall Study|Withdrawal by Subject|1|||
105331313|NCT02654977|363212908|FG000|Overall Study|Lack of Efficacy|3|||
105331314|NCT01921101|363212909|FG000|Overall Study|Death|16|||
105331315|NCT01921101|363212910|FG001|Overall Study|Death|6|||
105331316|NCT02134015|363212911|FG000|Overall Study|Protocol Violation|0|||
105331317|NCT02134015|363212912|FG001|Overall Study|Protocol Violation|1|||
105331318|NCT02134015|363212911|FG000|Overall Study|Death|2|||
105331319|NCT02134015|363212912|FG001|Overall Study|Death|1|||
105331320|NCT02134015|363212911|FG000|Overall Study|Reason not provided|1|||
105331321|NCT02134015|363212912|FG001|Overall Study|Reason not provided|2|||
105331322|NCT02134015|363212911|FG000|Overall Study|Clinical progression|14|||
105331323|NCT02134015|363212912|FG001|Overall Study|Clinical progression|7|||
105331324|NCT02134015|363212911|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
105331325|NCT02134015|363212912|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
105331326|NCT02134015|363212911|FG000|Overall Study|Study terminated by sponsor|2|||
105331327|NCT02134015|363212912|FG001|Overall Study|Study terminated by sponsor|3|||
105331328|NCT02134015|363212911|FG000|Overall Study|Adverse Event|9|||
105331329|NCT02134015|363212912|FG001|Overall Study|Adverse Event|10|||
105331330|NCT02134015|363212911|FG000|Overall Study|Withdrawal by Subject|3|||
105331331|NCT02134015|363212912|FG001|Overall Study|Withdrawal by Subject|7|||
105380710|NCT01807520|363399888|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
105380711|NCT01807520|363399889|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
105380712|NCT01807520|363399890|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
105380713|NCT01807520|363399884|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
105380714|NCT01807520|363399885|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
105380715|NCT01807520|363399886|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
105380716|NCT01807520|363399887|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
105380717|NCT01807520|363399888|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
105380718|NCT01807520|363399889|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
105380719|NCT01807520|363399890|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
105380720|NCT01807520|363399884|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
105380721|NCT01807520|363399885|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
105380722|NCT01807520|363399886|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
105380723|NCT01807520|363399887|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
105380724|NCT01807520|363399888|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
105380725|NCT01807520|363399889|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
105380726|NCT01807520|363399890|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
105380727|NCT01807520|363399884|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
105380728|NCT01807520|363399885|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
105380729|NCT01807520|363399886|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
105380730|NCT01807520|363399887|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
105380731|NCT01807520|363399888|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
105380732|NCT01807520|363399889|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
105380733|NCT01807520|363399890|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
105380734|NCT01807520|363399884|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
105380735|NCT01807520|363399885|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
105380736|NCT01807520|363399886|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
105380737|NCT01807520|363399887|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
105380738|NCT01807520|363399888|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
105380739|NCT01807520|363399889|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
105380740|NCT01807520|363399890|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
105380741|NCT01807520|363399884|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
105380742|NCT01807520|363399885|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
105380743|NCT01807520|363399886|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
105380744|NCT01807520|363399887|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
105380745|NCT01807520|363399888|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
105380746|NCT01807520|363399889|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
105380747|NCT01807520|363399890|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
105380748|NCT01807520|363399884|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
105380749|NCT01807520|363399885|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
105380750|NCT01807520|363399886|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
105380751|NCT01807520|363399887|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
105380752|NCT01807520|363399888|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
105380753|NCT01807520|363399889|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
105380754|NCT01807520|363399890|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
105380755|NCT01807520|363399884|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
105380756|NCT01807520|363399885|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
105380757|NCT01807520|363399886|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
105380758|NCT01807520|363399887|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
105380759|NCT01807520|363399888|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
105380760|NCT01807520|363399889|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
105380761|NCT01807520|363399890|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
105380762|NCT01807520|363399884|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
105380763|NCT01807520|363399885|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
105380764|NCT01807520|363399886|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
105380765|NCT01807520|363399887|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
105380766|NCT01807520|363399888|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
105380767|NCT01807520|363399889|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
105380768|NCT01807520|363399890|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
105380769|NCT02400736|363399891|FG000|Overall Study|Lost to Follow-up|6|||
105380770|NCT02400736|363399892|FG001|Overall Study|Lost to Follow-up|6|||
105380771|NCT02400736|363399891|FG000|Overall Study|Withdrawal by Subject|2|||
105380772|NCT02400736|363399892|FG001|Overall Study|Withdrawal by Subject|1|||
105380773|NCT02400736|363399891|FG000|Overall Study|Moved from the area|3|||
105380774|NCT02400736|363399892|FG001|Overall Study|Moved from the area|1|||
105380775|NCT03684057|363399893|FG000|Overall Study|Withdrawal by Subject|4|||
105380776|NCT03684057|363399894|FG001|Overall Study|Withdrawal by Subject|5|||
105580203|NCT00983619|364124224|FG004|Overall Study|Other|0|||
105380777|NCT01105130|363399895|FG000|Overall Study|Withdrawal by Subject|4|||
105380778|NCT01105130|363399896|FG001|Overall Study|Withdrawal by Subject|6|||
105380779|NCT01105130|363399897|FG002|Overall Study|Withdrawal by Subject|2|||
105380780|NCT01105130|363399895|FG000|Overall Study|Never Started|2|||
105380781|NCT01105130|363399896|FG001|Overall Study|Never Started|2|||
105380782|NCT01105130|363399897|FG002|Overall Study|Never Started|4|||
105380783|NCT01105130|363399895|FG000|Overall Study|Toxicity|1|||
105380784|NCT01105130|363399896|FG001|Overall Study|Toxicity|3|||
105380785|NCT01105130|363399897|FG002|Overall Study|Toxicity|2|||
105380786|NCT01105130|363399895|FG000|Overall Study|Multiple Reasons|3|||
105380787|NCT01105130|363399896|FG001|Overall Study|Multiple Reasons|0|||
105380788|NCT01105130|363399897|FG002|Overall Study|Multiple Reasons|2|||
105380789|NCT02582632|363399902|FG000|Overall Study|Other|1|||
105380790|NCT01002105|363399903|FG000|Overall Study|Lost to Follow-up|10|||
105380791|NCT01002105|363399904|FG001|Overall Study|Lost to Follow-up|16|||
105380792|NCT01002105|363399903|FG000|Overall Study|non compliance|5|||
105380793|NCT01002105|363399904|FG001|Overall Study|non compliance|3|||
105380794|NCT01002105|363399903|FG000|Overall Study|condition worsened|4|||
105380795|NCT01002105|363399904|FG001|Overall Study|condition worsened|2|||
105380796|NCT01617967|363399907|FG000|Overall Study|Protocol Violation|0|||
105380797|NCT01617967|363399908|FG001|Overall Study|Protocol Violation|0|||
105380798|NCT01617967|363399909|FG002|Overall Study|Protocol Violation|0|||
105380799|NCT01617967|363399910|FG003|Overall Study|Protocol Violation|1|||
105380800|NCT01617967|363399911|FG004|Overall Study|Protocol Violation|0|||
105380801|NCT01617967|363399912|FG005|Overall Study|Protocol Violation|0|||
105380802|NCT01617967|363399907|FG000|Overall Study|Withdrawal by Subject|0|||
105380803|NCT01617967|363399908|FG001|Overall Study|Withdrawal by Subject|0|||
105380804|NCT01617967|363399909|FG002|Overall Study|Withdrawal by Subject|0|||
105380805|NCT01617967|363399910|FG003|Overall Study|Withdrawal by Subject|0|||
105380806|NCT01617967|363399911|FG004|Overall Study|Withdrawal by Subject|0|||
105380807|NCT01617967|363399912|FG005|Overall Study|Withdrawal by Subject|1|||
105380808|NCT01617967|363399907|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
105380809|NCT01617967|363399908|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
105380810|NCT01617967|363399909|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
105380811|NCT01617967|363399910|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
105380812|NCT01617967|363399911|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
105380813|NCT01617967|363399912|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
105380814|NCT00552058|363399915|FG000|Overall Study|Adverse Event|8|||
105380815|NCT00552058|363399916|FG001|Overall Study|Adverse Event|7|||
105380816|NCT00552058|363399915|FG000|Overall Study|Lack of Efficacy|1|||
105380817|NCT00552058|363399916|FG001|Overall Study|Lack of Efficacy|5|||
105380818|NCT00552058|363399915|FG000|Overall Study|Lost to Follow-up|1|||
105380819|NCT00552058|363399916|FG001|Overall Study|Lost to Follow-up|0|||
105380820|NCT00552058|363399915|FG000|Overall Study|Withdrawal by Subject|4|||
105380821|NCT00552058|363399916|FG001|Overall Study|Withdrawal by Subject|4|||
105380822|NCT00552058|363399915|FG000|Overall Study|Other: Protocol Violation|0|||
105380823|NCT00552058|363399916|FG001|Overall Study|Other: Protocol Violation|1|||
105380824|NCT00552058|363399915|FG000|Overall Study|Other: Non Compliance|1|||
105380825|NCT00552058|363399916|FG001|Overall Study|Other: Non Compliance|2|||
105380826|NCT00552058|363399915|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
105380827|NCT00552058|363399916|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
105380828|NCT00552058|363399915|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
105380829|NCT00552058|363399916|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
105380830|NCT00552058|363399915|FG000|Overall Study|Other: Positive Stool Result|0|||
105380831|NCT00552058|363399916|FG001|Overall Study|Other: Positive Stool Result|1|||
105380832|NCT00552058|363399915|FG000|Overall Study|Other: Randomized in error|0|||
105380833|NCT00552058|363399916|FG001|Overall Study|Other: Randomized in error|1|||
105380834|NCT00552058|363399915|FG000|Overall Study|Other: Sponsors Decision|0|||
105380835|NCT00552058|363399916|FG001|Overall Study|Other: Sponsors Decision|1|||
105380836|NCT00552058|363399915|FG000|Overall Study|Other: Early Roll Over|1|||
105380837|NCT00552058|363399916|FG001|Overall Study|Other: Early Roll Over|0|||
105380838|NCT03418675|363399917|FG000|Overall Study|Lost to Follow-up|13|||
105380839|NCT03418675|363399918|FG001|Overall Study|Lost to Follow-up|10|||
105380840|NCT03418675|363399917|FG000|Overall Study|Adverse Event|2|||
105380841|NCT03418675|363399918|FG001|Overall Study|Adverse Event|0|||
105380842|NCT01137812|363399923|FG000|Overall Study|Adverse Event|21|||
105380843|NCT01137812|363399924|FG001|Overall Study|Adverse Event|14|||
105380844|NCT01137812|363399923|FG000|Overall Study|Lost to Follow-up|6|||
105380845|NCT01137812|363399924|FG001|Overall Study|Lost to Follow-up|8|||
105380846|NCT01137812|363399923|FG000|Overall Study|Physician Decision|25|||
105380847|NCT01137812|363399924|FG001|Overall Study|Physician Decision|17|||
105380848|NCT01137812|363399923|FG000|Overall Study|Protocol Violation|5|||
105380849|NCT01137812|363399924|FG001|Overall Study|Protocol Violation|4|||
105380850|NCT01137812|363399923|FG000|Overall Study|Withdrawal by Subject|5|||
105380851|NCT01137812|363399924|FG001|Overall Study|Withdrawal by Subject|13|||
105380852|NCT01137812|363399923|FG000|Overall Study|Death|2|||
105380853|NCT01137812|363399924|FG001|Overall Study|Death|0|||
105380854|NCT01137812|363399923|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
105380855|NCT01137812|363399924|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
105380856|NCT01137812|363399923|FG000|Overall Study|Other|19|||
105380857|NCT01137812|363399924|FG001|Overall Study|Other|27|||
105380858|NCT02573467|363399929|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
105380859|NCT02573467|363399930|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
105380860|NCT02573467|363399931|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
105380861|NCT02573467|363399932|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
105380862|NCT02573467|363399929|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
105380863|NCT02573467|363399930|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
105380864|NCT02573467|363399931|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
105380865|NCT02573467|363399932|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
105380866|NCT02573467|363399929|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
105380867|NCT02573467|363399930|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
105380868|NCT02573467|363399931|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
105380869|NCT02573467|363399932|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
105380870|NCT02573467|363399929|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
105380871|NCT02573467|363399930|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
105380872|NCT02573467|363399931|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
105380873|NCT02573467|363399932|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
105380874|NCT02573467|363399929|FG000|Post-treatment Follow up Epoch|Death|1|||
105380875|NCT02573467|363399930|FG001|Post-treatment Follow up Epoch|Death|1|||
105380876|NCT02573467|363399931|FG002|Post-treatment Follow up Epoch|Death|0|||
105380877|NCT02573467|363399932|FG003|Post-treatment Follow up Epoch|Death|1|||
105380878|NCT02573467|363399929|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
105380879|NCT02573467|363399930|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
105380880|NCT02573467|363399931|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
105380881|NCT02573467|363399932|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
105380882|NCT02573467|363399929|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
105380883|NCT02573467|363399930|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
105380884|NCT02573467|363399931|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
105380885|NCT02573467|363399932|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
105380886|NCT02056288|363399934|FG000|In-Hospital Data|Surgery cancelled|1|||
105380887|NCT02056288|363399935|FG001|In-Hospital Data|Surgery cancelled|0|||
105380888|NCT02056288|363399934|FG000|In-Hospital Data|Protocol Violation|3|||
105380889|NCT02056288|363399935|FG001|In-Hospital Data|Protocol Violation|0|||
105380890|NCT02056288|363399934|FG000|In-Hospital Data|Physician Decision|1|||
105380891|NCT02056288|363399935|FG001|In-Hospital Data|Physician Decision|0|||
105380892|NCT02056288|363399934|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
105380893|NCT02056288|363399935|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
105380894|NCT00500110|363399936|FG000|Overall Study|Withdrawal by Subject|3|||
105380895|NCT02441114|363399937|FG000|Washout2|Withdrawal by Subject|4|||
105380896|NCT02639559|363399939|FG000|Overall Study|Mobilization failure|0|||
105380897|NCT02639559|363399940|FG001|Overall Study|Mobilization failure|3|||
105380898|NCT02639559|363399939|FG000|Overall Study|Issues with vascular acess|1|||
105380899|NCT02639559|363399940|FG001|Overall Study|Issues with vascular acess|0|||
105380900|NCT02202616|363399945|FG000|Overall Study|Screen failed|24|||
105380901|NCT02202616|363399945|FG000|Overall Study|Adverse Event|32|||
105380902|NCT02202616|363399945|FG000|Overall Study|Protocol deviation|18|||
105380903|NCT02202616|363399945|FG000|Overall Study|Patient withdrew consent|12|||
105380904|NCT02202616|363399945|FG000|Overall Study|Lost to Follow-up|6|||
105380905|NCT02202616|363399945|FG000|Overall Study|Administrative problems|6|||
105380906|NCT02202616|363399945|FG000|Overall Study|Abnormal test procedure result|1|||
105380907|NCT02202616|363399945|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105380908|NCT04790201|363399948|FG000|Overall Study|Lost to Follow-up|0|||
105380909|NCT04790201|363399949|FG001|Overall Study|Lost to Follow-up|0|||
105380910|NCT04790201|363399950|FG002|Overall Study|Lost to Follow-up|2|||
105380911|NCT04790201|363399948|FG000|Overall Study|Death|0|||
105380912|NCT04790201|363399949|FG001|Overall Study|Death|1|||
105380913|NCT04790201|363399950|FG002|Overall Study|Death|0|||
105380914|NCT04790201|363399948|FG000|Overall Study|Protocol Violation|1|||
105380915|NCT04790201|363399949|FG001|Overall Study|Protocol Violation|0|||
105380916|NCT04790201|363399950|FG002|Overall Study|Protocol Violation|1|||
105380917|NCT03670628|363399951|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
105380918|NCT03670628|363399952|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
105380919|NCT03670628|363399951|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
105380920|NCT03670628|363399952|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
105380921|NCT04339972|363399956|FG000|Overall Study|Scheduling Issues|3|||
105380922|NCT04339972|363399957|FG001|Overall Study|Scheduling Issues|3|||
105380923|NCT04339972|363399956|FG000|Overall Study|dropout|1|||
105380924|NCT04339972|363399957|FG001|Overall Study|dropout|1|||
105380925|NCT04339972|363399956|FG000|Overall Study|Technical issues|1|||
105380926|NCT04339972|363399957|FG001|Overall Study|Technical issues|0|||
105380927|NCT04339972|363399956|FG000|Overall Study|Claustraphobia|0|||
105380928|NCT04339972|363399957|FG001|Overall Study|Claustraphobia|1|||
105380929|NCT03158688|363399958|FG000|Overall Study|Withdrawal by Subject|14|||
105380930|NCT03158688|363399959|FG001|Overall Study|Withdrawal by Subject|28|||
105380931|NCT03158688|363399958|FG000|Overall Study|Decision by sponsor|13|||
105380932|NCT03158688|363399959|FG001|Overall Study|Decision by sponsor|37|||
105380933|NCT03158688|363399958|FG000|Overall Study|Lost to Follow-up|4|||
105380934|NCT03158688|363399959|FG001|Overall Study|Lost to Follow-up|3|||
105380935|NCT03158688|363399958|FG000|Overall Study|Death|74|||
105380936|NCT03158688|363399959|FG001|Overall Study|Death|142|||
105380937|NCT06038643|363399961|FG000|Overall Study|Withdrawal by Subject|9|||
105380938|NCT06038643|363399962|FG001|Overall Study|Withdrawal by Subject|4|||
105380939|NCT06038643|363399961|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
105380940|NCT06038643|363399962|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
105380941|NCT02675452|363399963|FG000|Overall Study|Sponsor decision|0|||
105380942|NCT02675452|363399964|FG001|Overall Study|Sponsor decision|0|||
105380943|NCT02675452|363399965|FG002|Overall Study|Sponsor decision|0|||
105380944|NCT02675452|363399966|FG003|Overall Study|Sponsor decision|0|||
105380945|NCT02675452|363399967|FG004|Overall Study|Sponsor decision|0|||
105380946|NCT02675452|363399968|FG005|Overall Study|Sponsor decision|0|||
105380947|NCT02675452|363399969|FG006|Overall Study|Sponsor decision|0|||
105380948|NCT02675452|363399970|FG007|Overall Study|Sponsor decision|0|||
105380949|NCT02675452|363399971|FG008|Overall Study|Sponsor decision|0|||
105380950|NCT02675452|363399972|FG009|Overall Study|Sponsor decision|1|||
105380951|NCT02675452|363399973|FG010|Overall Study|Sponsor decision|0|||
105380952|NCT02675452|363399974|FG011|Overall Study|Sponsor decision|0|||
105380953|NCT02675452|363399975|FG012|Overall Study|Sponsor decision|0|||
105380954|NCT02675452|363399976|FG013|Overall Study|Sponsor decision|2|||
105380955|NCT02675452|363399977|FG014|Overall Study|Sponsor decision|1|||
105380956|NCT02675452|363399978|FG015|Overall Study|Sponsor decision|0|||
105380957|NCT02675452|363399979|FG016|Overall Study|Sponsor decision|1|||
105380958|NCT02675452|363399980|FG017|Overall Study|Sponsor decision|0|||
105380959|NCT02675452|363399981|FG018|Overall Study|Sponsor decision|0|||
105380960|NCT02675452|363399982|FG019|Overall Study|Sponsor decision|0|||
105380961|NCT02675452|363399983|FG020|Overall Study|Sponsor decision|0|||
105380962|NCT02675452|363399984|FG021|Overall Study|Sponsor decision|0|||
105380963|NCT02675452|363399985|FG022|Overall Study|Sponsor decision|0|||
105380964|NCT02675452|363399986|FG023|Overall Study|Sponsor decision|0|||
105380965|NCT02675452|363399987|FG024|Overall Study|Sponsor decision|0|||
105380966|NCT02675452|363399988|FG025|Overall Study|Sponsor decision|0|||
105380967|NCT02675452|363399989|FG026|Overall Study|Sponsor decision|2|||
105380968|NCT02675452|363399990|FG027|Overall Study|Sponsor decision|0|||
105380969|NCT02675452|363399991|FG028|Overall Study|Sponsor decision|0|||
105380970|NCT02675452|363399963|FG000|Overall Study|Withdrawal by Subject|0|||
105380971|NCT02675452|363399964|FG001|Overall Study|Withdrawal by Subject|0|||
105380972|NCT02675452|363399965|FG002|Overall Study|Withdrawal by Subject|0|||
105380973|NCT02675452|363399966|FG003|Overall Study|Withdrawal by Subject|0|||
105380974|NCT02675452|363399967|FG004|Overall Study|Withdrawal by Subject|0|||
105380975|NCT02675452|363399968|FG005|Overall Study|Withdrawal by Subject|0|||
105380976|NCT02675452|363399969|FG006|Overall Study|Withdrawal by Subject|0|||
105380977|NCT02675452|363399970|FG007|Overall Study|Withdrawal by Subject|0|||
105380978|NCT02675452|363399971|FG008|Overall Study|Withdrawal by Subject|0|||
105380979|NCT02675452|363399972|FG009|Overall Study|Withdrawal by Subject|1|||
105380980|NCT02675452|363399973|FG010|Overall Study|Withdrawal by Subject|0|||
105380981|NCT02675452|363399974|FG011|Overall Study|Withdrawal by Subject|1|||
105380982|NCT02675452|363399975|FG012|Overall Study|Withdrawal by Subject|0|||
105380983|NCT02675452|363399976|FG013|Overall Study|Withdrawal by Subject|1|||
105380984|NCT02675452|363399977|FG014|Overall Study|Withdrawal by Subject|1|||
105380985|NCT02675452|363399978|FG015|Overall Study|Withdrawal by Subject|0|||
105380986|NCT02675452|363399979|FG016|Overall Study|Withdrawal by Subject|2|||
105380987|NCT02675452|363399980|FG017|Overall Study|Withdrawal by Subject|0|||
105380988|NCT02675452|363399981|FG018|Overall Study|Withdrawal by Subject|0|||
105380989|NCT02675452|363399982|FG019|Overall Study|Withdrawal by Subject|0|||
105380990|NCT02675452|363399983|FG020|Overall Study|Withdrawal by Subject|0|||
105380991|NCT02675452|363399984|FG021|Overall Study|Withdrawal by Subject|0|||
105380992|NCT02675452|363399985|FG022|Overall Study|Withdrawal by Subject|3|||
105380993|NCT02675452|363399986|FG023|Overall Study|Withdrawal by Subject|0|||
105380994|NCT02675452|363399987|FG024|Overall Study|Withdrawal by Subject|1|||
105380995|NCT02675452|363399988|FG025|Overall Study|Withdrawal by Subject|0|||
105380996|NCT02675452|363399989|FG026|Overall Study|Withdrawal by Subject|1|||
105380997|NCT02675452|363399990|FG027|Overall Study|Withdrawal by Subject|3|||
105380998|NCT02675452|363399991|FG028|Overall Study|Withdrawal by Subject|4|||
105380999|NCT02675452|363399963|FG000|Overall Study|Death|0|||
105381000|NCT02675452|363399964|FG001|Overall Study|Death|0|||
105381001|NCT02675452|363399965|FG002|Overall Study|Death|1|||
105381002|NCT02675452|363399966|FG003|Overall Study|Death|0|||
105381003|NCT02675452|363399967|FG004|Overall Study|Death|0|||
105381004|NCT02675452|363399968|FG005|Overall Study|Death|1|||
105381005|NCT02675452|363399969|FG006|Overall Study|Death|0|||
105381006|NCT02675452|363399970|FG007|Overall Study|Death|0|||
105381007|NCT02675452|363399971|FG008|Overall Study|Death|1|||
105381008|NCT02675452|363399972|FG009|Overall Study|Death|0|||
105381009|NCT02675452|363399973|FG010|Overall Study|Death|0|||
105381010|NCT02675452|363399974|FG011|Overall Study|Death|0|||
105381011|NCT02675452|363399975|FG012|Overall Study|Death|1|||
105381012|NCT02675452|363399976|FG013|Overall Study|Death|0|||
105381013|NCT02675452|363399977|FG014|Overall Study|Death|0|||
105381014|NCT02675452|363399978|FG015|Overall Study|Death|2|||
105381015|NCT02675452|363399979|FG016|Overall Study|Death|0|||
105381016|NCT02675452|363399980|FG017|Overall Study|Death|0|||
105381017|NCT02675452|363399981|FG018|Overall Study|Death|4|||
105381018|NCT02675452|363399982|FG019|Overall Study|Death|3|||
105381019|NCT02675452|363399983|FG020|Overall Study|Death|3|||
105381020|NCT02675452|363399984|FG021|Overall Study|Death|3|||
105381021|NCT02675452|363399985|FG022|Overall Study|Death|7|||
105381022|NCT02675452|363399986|FG023|Overall Study|Death|5|||
105381023|NCT02675452|363399987|FG024|Overall Study|Death|3|||
105381024|NCT02675452|363399988|FG025|Overall Study|Death|4|||
105381025|NCT02675452|363399989|FG026|Overall Study|Death|7|||
105381026|NCT02675452|363399990|FG027|Overall Study|Death|6|||
105381027|NCT02675452|363399991|FG028|Overall Study|Death|9|||
105381028|NCT02675452|363399963|FG000|Overall Study|Lost to Follow-up|0|||
105381029|NCT02675452|363399964|FG001|Overall Study|Lost to Follow-up|1|||
105381030|NCT02675452|363399965|FG002|Overall Study|Lost to Follow-up|0|||
105381031|NCT02675452|363399966|FG003|Overall Study|Lost to Follow-up|0|||
105381032|NCT02675452|363399967|FG004|Overall Study|Lost to Follow-up|0|||
105381033|NCT02675452|363399968|FG005|Overall Study|Lost to Follow-up|0|||
105381034|NCT02675452|363399969|FG006|Overall Study|Lost to Follow-up|0|||
105381035|NCT02675452|363399970|FG007|Overall Study|Lost to Follow-up|0|||
105381036|NCT02675452|363399971|FG008|Overall Study|Lost to Follow-up|0|||
105381037|NCT02675452|363399972|FG009|Overall Study|Lost to Follow-up|0|||
105381038|NCT02675452|363399973|FG010|Overall Study|Lost to Follow-up|0|||
105381039|NCT02675452|363399974|FG011|Overall Study|Lost to Follow-up|0|||
105381040|NCT02675452|363399975|FG012|Overall Study|Lost to Follow-up|1|||
105381041|NCT02675452|363399976|FG013|Overall Study|Lost to Follow-up|0|||
105381042|NCT02675452|363399977|FG014|Overall Study|Lost to Follow-up|0|||
105381043|NCT02675452|363399978|FG015|Overall Study|Lost to Follow-up|0|||
105381044|NCT02675452|363399979|FG016|Overall Study|Lost to Follow-up|0|||
105381045|NCT02675452|363399980|FG017|Overall Study|Lost to Follow-up|0|||
105381046|NCT02675452|363399981|FG018|Overall Study|Lost to Follow-up|0|||
105381047|NCT02675452|363399982|FG019|Overall Study|Lost to Follow-up|0|||
105381048|NCT02675452|363399983|FG020|Overall Study|Lost to Follow-up|0|||
105381049|NCT02675452|363399984|FG021|Overall Study|Lost to Follow-up|0|||
105381050|NCT02675452|363399985|FG022|Overall Study|Lost to Follow-up|0|||
105381051|NCT02675452|363399986|FG023|Overall Study|Lost to Follow-up|0|||
105381052|NCT02675452|363399987|FG024|Overall Study|Lost to Follow-up|0|||
105381053|NCT02675452|363399988|FG025|Overall Study|Lost to Follow-up|0|||
105381054|NCT02675452|363399989|FG026|Overall Study|Lost to Follow-up|1|||
105381055|NCT02675452|363399990|FG027|Overall Study|Lost to Follow-up|0|||
105381056|NCT02675452|363399991|FG028|Overall Study|Lost to Follow-up|0|||
105381057|NCT02675452|363399963|FG000|Overall Study|Other|0|||
105381058|NCT02675452|363399964|FG001|Overall Study|Other|0|||
105381059|NCT02675452|363399965|FG002|Overall Study|Other|0|||
105381060|NCT02675452|363399966|FG003|Overall Study|Other|0|||
105381061|NCT02675452|363399967|FG004|Overall Study|Other|0|||
105381062|NCT02675452|363399968|FG005|Overall Study|Other|0|||
105381063|NCT02675452|363399969|FG006|Overall Study|Other|0|||
105381064|NCT02675452|363399970|FG007|Overall Study|Other|0|||
105381065|NCT02675452|363399971|FG008|Overall Study|Other|0|||
105381066|NCT02675452|363399972|FG009|Overall Study|Other|0|||
105381067|NCT02675452|363399973|FG010|Overall Study|Other|0|||
105381068|NCT02675452|363399974|FG011|Overall Study|Other|0|||
105381069|NCT02675452|363399975|FG012|Overall Study|Other|0|||
105381070|NCT02675452|363399976|FG013|Overall Study|Other|0|||
105381071|NCT02675452|363399977|FG014|Overall Study|Other|0|||
105381072|NCT02675452|363399978|FG015|Overall Study|Other|0|||
105381073|NCT02675452|363399979|FG016|Overall Study|Other|0|||
105381074|NCT02675452|363399980|FG017|Overall Study|Other|0|||
105381075|NCT02675452|363399981|FG018|Overall Study|Other|0|||
105381076|NCT02675452|363399982|FG019|Overall Study|Other|0|||
105381077|NCT02675452|363399983|FG020|Overall Study|Other|0|||
105381078|NCT02675452|363399984|FG021|Overall Study|Other|0|||
105381079|NCT02675452|363399985|FG022|Overall Study|Other|0|||
105381080|NCT02675452|363399986|FG023|Overall Study|Other|0|||
105381081|NCT02675452|363399987|FG024|Overall Study|Other|0|||
105381082|NCT02675452|363399988|FG025|Overall Study|Other|0|||
105381083|NCT02675452|363399989|FG026|Overall Study|Other|1|||
105381084|NCT02675452|363399990|FG027|Overall Study|Other|0|||
105381085|NCT02675452|363399991|FG028|Overall Study|Other|0|||
105381086|NCT01405911|363399994|FG000|Overall Study|Pre-treatment lab AE|0|||
105381087|NCT01405911|363399995|FG001|Overall Study|Pre-treatment lab AE|1|||
105381088|NCT01405911|363399996|FG002|Overall Study|Pre-treatment lab AE|0|||
105381089|NCT01405911|363399994|FG000|Overall Study|Lost to Follow-up|0|||
105381090|NCT01405911|363399995|FG001|Overall Study|Lost to Follow-up|1|||
105381091|NCT01405911|363399996|FG002|Overall Study|Lost to Follow-up|0|||
105381092|NCT01405911|363399994|FG000|Overall Study|Protocol Violation|1|||
105381093|NCT01405911|363399995|FG001|Overall Study|Protocol Violation|0|||
105381094|NCT01405911|363399996|FG002|Overall Study|Protocol Violation|0|||
105381095|NCT01405911|363399994|FG000|Overall Study|Withdrawal by Subject|3|||
105381096|NCT01405911|363399995|FG001|Overall Study|Withdrawal by Subject|1|||
105381097|NCT01405911|363399996|FG002|Overall Study|Withdrawal by Subject|1|||
105381098|NCT02114684|363399999|FG000|Overall Study|Death|6|||
105381099|NCT02114684|363400000|FG001|Overall Study|Death|4|||
105381100|NCT02114684|363399999|FG000|Overall Study|Lost to Follow-up|1|||
105381101|NCT02114684|363400000|FG001|Overall Study|Lost to Follow-up|2|||
105381102|NCT02114684|363399999|FG000|Overall Study|Withdrawal by Subject|1|||
105381103|NCT02114684|363400000|FG001|Overall Study|Withdrawal by Subject|2|||
105381104|NCT02114684|363399999|FG000|Overall Study|Relocation|3|||
105381105|NCT02114684|363400000|FG001|Overall Study|Relocation|1|||
105381106|NCT02114684|363399999|FG000|Overall Study|Rifampicin resistant on culture|0|||
105381107|NCT02114684|363400000|FG001|Overall Study|Rifampicin resistant on culture|1|||
105381108|NCT02114684|363399999|FG000|Overall Study|Patient Incarcerated|1|||
105381109|NCT02114684|363400000|FG001|Overall Study|Patient Incarcerated|0|||
105381110|NCT02015104|363400009|FG000|Overall Study|Withdrew consent after first dose drug|1|||
105381111|NCT02015104|363400010|FG001|Overall Study|Withdrew consent after first dose drug|0|||
105381112|NCT02015104|363400009|FG000|Overall Study|Withdrew consent prior to treatment|0|||
105381113|NCT02015104|363400010|FG001|Overall Study|Withdrew consent prior to treatment|1|||
105381114|NCT03834883|363400011|FG000|Second Treatment|Withdrawal by Subject|1|||
105381115|NCT03834883|363400012|FG001|Second Treatment|Withdrawal by Subject|0|||
105381116|NCT03834883|363400013|FG002|Second Treatment|Withdrawal by Subject|0|||
105381117|NCT03834883|363400014|FG003|Second Treatment|Withdrawal by Subject|0|||
105381118|NCT03834883|363400011|FG000|Second Treatment|COVID-19 pandemic|1|||
105381119|NCT03834883|363400012|FG001|Second Treatment|COVID-19 pandemic|0|||
105381120|NCT03834883|363400013|FG002|Second Treatment|COVID-19 pandemic|1|||
105381121|NCT03834883|363400014|FG003|Second Treatment|COVID-19 pandemic|1|||
105381122|NCT05762744|363400015|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
105381123|NCT05762744|363400016|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
105381124|NCT05762744|363400015|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
105381125|NCT05762744|363400016|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
105381126|NCT00441896|363400017|FG000|Overall Study|Withdrawal by Subject|0|||
105381127|NCT00441896|363400018|FG001|Overall Study|Withdrawal by Subject|0|||
105381128|NCT00441896|363400019|FG002|Overall Study|Withdrawal by Subject|0|||
105381129|NCT00441896|363400020|FG003|Overall Study|Withdrawal by Subject|1|||
105381130|NCT00441896|363400021|FG004|Overall Study|Withdrawal by Subject|0|||
105381131|NCT00441896|363400022|FG005|Overall Study|Withdrawal by Subject|0|||
105381132|NCT00441896|363400023|FG006|Overall Study|Withdrawal by Subject|0|||
105381133|NCT00441896|363400024|FG007|Overall Study|Withdrawal by Subject|0|||
105381134|NCT00441896|363400025|FG008|Overall Study|Withdrawal by Subject|0|||
105381135|NCT00441896|363400026|FG009|Overall Study|Withdrawal by Subject|0|||
105381136|NCT00441896|363400017|FG000|Overall Study|Other|0|||
105381137|NCT00441896|363400018|FG001|Overall Study|Other|0|||
105381138|NCT00441896|363400019|FG002|Overall Study|Other|0|||
105381139|NCT00441896|363400020|FG003|Overall Study|Other|0|||
105381140|NCT00441896|363400021|FG004|Overall Study|Other|1|||
105381141|NCT00441896|363400022|FG005|Overall Study|Other|0|||
105381142|NCT00441896|363400023|FG006|Overall Study|Other|0|||
105381143|NCT00441896|363400024|FG007|Overall Study|Other|0|||
105381144|NCT00441896|363400025|FG008|Overall Study|Other|0|||
105381145|NCT00441896|363400026|FG009|Overall Study|Other|0|||
105492349|NCT04697056|363815725|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
105381146|NCT02487199|363400027|FG000|Overall Study|Withdrew Consent|0|||
105381147|NCT02487199|363400028|FG001|Overall Study|Withdrew Consent|1|||
105381148|NCT00182637|363401550|FG000|Overall Study|Adverse Event|2|||
105381149|NCT00182637|363401550|FG000|Overall Study|Disease Progression|1|||
105381150|NCT04333498|363401551|FG000|Overall Study|Lost to Follow-up|1|||
105381151|NCT04333498|363401552|FG001|Overall Study|Lost to Follow-up|0|||
105381152|NCT04333498|363401551|FG000|Overall Study|Lost to Follow-up|0|||
105381153|NCT04333498|363401552|FG001|Overall Study|Lost to Follow-up|1|||
105381154|NCT01565694|363401553|FG000|Dose-Titration Period|Adverse Event|4|||
105381155|NCT01565694|363401553|FG000|Dose-Titration Period|Protocol Violation|10|||
105381156|NCT01565694|363401553|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
105381157|NCT05417113|363401555|FG000|Overall Study|Lost to Follow-up|2|||
105381158|NCT05417113|363401556|FG001|Overall Study|Lost to Follow-up|2|||
105381159|NCT01022580|363401557|FG000|Overall Study|Death|18|||
105381160|NCT01022580|363401558|FG001|Overall Study|Death|22|||
105381161|NCT00884949|363401559|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
105381162|NCT00884949|363401559|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
105381163|NCT01631188|363401560|FG000|Overall Study|Physician Decision|75|||
105381164|NCT00327171|363401563|FG000|Overall Study|Did not receive study medication|3|||
105381165|NCT00327171|363401564|FG001|Overall Study|Did not receive study medication|0|||
105381166|NCT00327171|363401563|FG000|Overall Study|Adverse Event|23|||
105381167|NCT00327171|363401564|FG001|Overall Study|Adverse Event|23|||
105381168|NCT00327171|363401563|FG000|Overall Study|Disease progression/lack of efficacy|68|||
105381169|NCT00327171|363401564|FG001|Overall Study|Disease progression/lack of efficacy|69|||
105381170|NCT00327171|363401563|FG000|Overall Study|Investigator/participant request|1|||
105381171|NCT00327171|363401564|FG001|Overall Study|Investigator/participant request|8|||
105381172|NCT00327171|363401563|FG000|Overall Study|Clinical progression|12|||
105381173|NCT00327171|363401564|FG001|Overall Study|Clinical progression|8|||
105381174|NCT00327171|363401563|FG000|Overall Study|Undisclosed history of ischemia|0|||
105381175|NCT00327171|363401564|FG001|Overall Study|Undisclosed history of ischemia|1|||
105381176|NCT00327171|363401563|FG000|Overall Study|Other|1|||
105381177|NCT00327171|363401564|FG001|Overall Study|Other|0|||
105381178|NCT01363440|363401565|FG000|Overall Study|Adverse Event|5|||
105381179|NCT01363440|363401566|FG001|Overall Study|Adverse Event|4|||
105381180|NCT01363440|363401567|FG002|Overall Study|Adverse Event|4|||
105381181|NCT01363440|363401565|FG000|Overall Study|Death|3|||
105381182|NCT01363440|363401566|FG001|Overall Study|Death|7|||
105381183|NCT01363440|363401567|FG002|Overall Study|Death|5|||
105381184|NCT01363440|363401565|FG000|Overall Study|Withdrawal by Subject|9|||
105381185|NCT01363440|363401566|FG001|Overall Study|Withdrawal by Subject|11|||
105381186|NCT01363440|363401567|FG002|Overall Study|Withdrawal by Subject|11|||
105381187|NCT01363440|363401565|FG000|Overall Study|Lost to Follow-up|2|||
105381188|NCT01363440|363401566|FG001|Overall Study|Lost to Follow-up|4|||
105381189|NCT01363440|363401567|FG002|Overall Study|Lost to Follow-up|5|||
105381190|NCT01363440|363401565|FG000|Overall Study|Other|4|||
105381191|NCT01363440|363401566|FG001|Overall Study|Other|5|||
105381192|NCT01363440|363401567|FG002|Overall Study|Other|2|||
105381193|NCT01166945|363401568|FG000|Randomized|diagnosed with Group A strep|4|||
105381194|NCT01166945|363401569|FG001|Randomized|diagnosed with Group A strep|4|||
105381195|NCT01166945|363401568|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
105381196|NCT01166945|363401569|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
105381197|NCT01166945|363401568|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
105381198|NCT01166945|363401569|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
105381199|NCT01166945|363401568|FG000|Day 30|Lost to Follow-up|4|||
105381200|NCT01166945|363401569|FG001|Day 30|Lost to Follow-up|3|||
105381201|NCT03422718|363401570|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
105381202|NCT03422718|363401571|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
105381203|NCT03422718|363401572|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
105381204|NCT03422718|363401573|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
105381205|NCT03422718|363401574|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
105381206|NCT03422718|363401575|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
105381207|NCT03422718|363401576|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
105381208|NCT03422718|363401577|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
105381209|NCT03422718|363401570|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
105381210|NCT03422718|363401571|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
105381211|NCT03422718|363401572|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
105381212|NCT03422718|363401573|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
105381213|NCT03422718|363401574|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
105381214|NCT03422718|363401575|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
105381215|NCT03422718|363401576|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
105381216|NCT03422718|363401577|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
105381217|NCT03422718|363401570|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
105381218|NCT03422718|363401571|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
105381219|NCT03422718|363401572|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
105580204|NCT00983619|364124225|FG005|Overall Study|Other|12|||
105381220|NCT03422718|363401573|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
105381221|NCT03422718|363401574|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
105381222|NCT03422718|363401575|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
105381223|NCT03422718|363401576|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
105381224|NCT03422718|363401577|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
105381225|NCT03422718|363401570|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
105381226|NCT03422718|363401571|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
105381227|NCT03422718|363401572|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
105381228|NCT03422718|363401573|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
105381229|NCT03422718|363401574|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
105381230|NCT03422718|363401575|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
105381231|NCT03422718|363401576|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
105381232|NCT03422718|363401577|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
105381233|NCT03422718|363401570|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
105381234|NCT03422718|363401571|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
105381235|NCT03422718|363401572|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
105381236|NCT03422718|363401573|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
105381237|NCT03422718|363401574|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
105381238|NCT03422718|363401575|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
105381239|NCT03422718|363401576|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
105381240|NCT03422718|363401577|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
105381241|NCT03422718|363401570|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
105381242|NCT03422718|363401571|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
105381243|NCT03422718|363401572|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
105381244|NCT03422718|363401573|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
105381245|NCT03422718|363401574|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
105381246|NCT03422718|363401575|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
105381247|NCT03422718|363401576|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
105381248|NCT03422718|363401577|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
105381249|NCT03309605|363401578|FG000|Overall Study|Adverse Event|0|||
105381250|NCT03309605|363401579|FG001|Overall Study|Adverse Event|0|||
105381251|NCT03309605|363401580|FG002|Overall Study|Adverse Event|0|||
105381252|NCT03309605|363401581|FG003|Overall Study|Adverse Event|1|||
105381253|NCT03309605|363401582|FG004|Overall Study|Adverse Event|0|||
105381254|NCT03309605|363401583|FG005|Overall Study|Adverse Event|0|||
105381255|NCT03309605|363401584|FG006|Overall Study|Adverse Event|2|||
105381256|NCT03309605|363401585|FG007|Overall Study|Adverse Event|1|||
105381257|NCT03309605|363401578|FG000|Overall Study|Withdrawal by Subject|0|||
105381258|NCT03309605|363401579|FG001|Overall Study|Withdrawal by Subject|0|||
105381259|NCT03309605|363401580|FG002|Overall Study|Withdrawal by Subject|0|||
105381260|NCT03309605|363401581|FG003|Overall Study|Withdrawal by Subject|0|||
105381261|NCT03309605|363401582|FG004|Overall Study|Withdrawal by Subject|1|||
105381262|NCT03309605|363401583|FG005|Overall Study|Withdrawal by Subject|0|||
105381263|NCT03309605|363401584|FG006|Overall Study|Withdrawal by Subject|1|||
105381264|NCT03309605|363401585|FG007|Overall Study|Withdrawal by Subject|1|||
105381265|NCT01625182|363401586|FG000|Overall Study|Administrative problems|1|||
105381266|NCT01625182|363401587|FG001|Overall Study|Administrative problems|0|||
105381267|NCT01625182|363401586|FG000|Overall Study|Protocol deviation|0|||
105381268|NCT01625182|363401587|FG001|Overall Study|Protocol deviation|2|||
105381269|NCT01625182|363401586|FG000|Overall Study|Adverse Event|2|||
105381270|NCT01625182|363401587|FG001|Overall Study|Adverse Event|0|||
105381271|NCT01625182|363401586|FG000|Overall Study|Withdrawal by Subject|5|||
105381272|NCT01625182|363401587|FG001|Overall Study|Withdrawal by Subject|1|||
105381273|NCT01625182|363401586|FG000|Overall Study|Lack of Efficacy|12|||
105381274|NCT01625182|363401587|FG001|Overall Study|Lack of Efficacy|8|||
105381275|NCT00447278|363401590|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
105381276|NCT00447278|363401591|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
105381277|NCT00447278|363401590|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
105381278|NCT00447278|363401591|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
105381279|NCT00447278|363401590|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
105381280|NCT00447278|363401591|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
105381281|NCT00447278|363401590|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
105381282|NCT00447278|363401591|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
105381283|NCT00447278|363401590|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
105381284|NCT00447278|363401591|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
105381285|NCT00447278|363401590|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
105381286|NCT00447278|363401591|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
105381287|NCT00447278|363401590|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
105381288|NCT00447278|363401591|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
105381289|NCT00447278|363401590|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
105381290|NCT00447278|363401591|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
105381291|NCT00447278|363401590|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
105381292|NCT00447278|363401591|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
105381293|NCT00447278|363401590|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
105381294|NCT00447278|363401591|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
105381295|NCT00447278|363401590|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
105381296|NCT00447278|363401591|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
105381297|NCT00447278|363401590|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
105381298|NCT00447278|363401591|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
105381299|NCT00447278|363401590|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
105381300|NCT00447278|363401591|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
105381301|NCT00447278|363401590|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
105381302|NCT00447278|363401591|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
105381303|NCT02595749|363401592|FG000|Overall Study|Withdrawal by Subject|12|||
105381304|NCT02595749|363401593|FG001|Overall Study|Withdrawal by Subject|7|||
105381305|NCT05427916|363401594|FG000|Overall Study|Adverse Event|3|||
105381306|NCT05427916|363401595|FG001|Overall Study|Adverse Event|0|||
105381307|NCT05427916|363401594|FG000|Overall Study|Lack of Efficacy|6|||
105381308|NCT05427916|363401595|FG001|Overall Study|Lack of Efficacy|0|||
105381309|NCT05427916|363401594|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
105381310|NCT05427916|363401595|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
105381311|NCT04076579|363401596|FG000|Overall Study|Adverse Event|2|||
105381312|NCT04076579|363401597|FG001|Overall Study|Adverse Event|0|||
105381313|NCT04076579|363401596|FG000|Overall Study|discontinued due to toxicity|1|||
105381314|NCT04076579|363401597|FG001|Overall Study|discontinued due to toxicity|0|||
105381315|NCT04076579|363401596|FG000|Overall Study|Physician Decision|1|||
105381316|NCT04076579|363401597|FG001|Overall Study|Physician Decision|0|||
105381317|NCT04076579|363401596|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
105381318|NCT04076579|363401597|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
105381319|NCT04076579|363401596|FG000|Overall Study|Noncompliance|0|||
105381320|NCT04076579|363401597|FG001|Overall Study|Noncompliance|1|||
105381321|NCT04076579|363401596|FG000|Overall Study|Withdrawal by Subject|0|||
105381322|NCT04076579|363401597|FG001|Overall Study|Withdrawal by Subject|2|||
105381323|NCT01875237|363401598|FG000|Overall Study|GVDH before DLI|1|||
105381324|NCT01875237|363401599|FG001|Overall Study|GVDH before DLI|0|||
105381325|NCT01875237|363401598|FG000|Overall Study|DLI cells could not be produced|1|||
105381326|NCT01875237|363401599|FG001|Overall Study|DLI cells could not be produced|0|||
105381327|NCT05558410|363401600|FG000|Overall Study|Adverse Event|1|||
105381328|NCT05558410|363401601|FG001|Overall Study|Adverse Event|2|||
105381329|NCT05558410|363401602|FG002|Overall Study|Adverse Event|0|||
105381330|NCT05558410|363401600|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
105381331|NCT05558410|363401601|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
105381332|NCT05558410|363401602|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
105381333|NCT05558410|363401600|FG000|Overall Study|Lost to Follow-up|10|||
105381334|NCT05558410|363401601|FG001|Overall Study|Lost to Follow-up|17|||
105381335|NCT05558410|363401602|FG002|Overall Study|Lost to Follow-up|19|||
105381336|NCT05558410|363401600|FG000|Overall Study|Death|1|||
105381337|NCT05558410|363401601|FG001|Overall Study|Death|0|||
105381338|NCT05558410|363401602|FG002|Overall Study|Death|0|||
105381339|NCT05558410|363401600|FG000|Overall Study|Other non-compliance|0|||
105381340|NCT05558410|363401601|FG001|Overall Study|Other non-compliance|1|||
105381341|NCT05558410|363401602|FG002|Overall Study|Other non-compliance|2|||
105381342|NCT05558410|363401600|FG000|Overall Study|Sponsor Decision|1|||
105381343|NCT05558410|363401601|FG001|Overall Study|Sponsor Decision|0|||
105381344|NCT05558410|363401602|FG002|Overall Study|Sponsor Decision|0|||
105381345|NCT05558410|363401600|FG000|Overall Study|Other|1|||
105381346|NCT05558410|363401601|FG001|Overall Study|Other|0|||
105381347|NCT05558410|363401602|FG002|Overall Study|Other|1|||
105381348|NCT02265744|363401603|FG000|Overall Study|Poor/Non-compliance|1|||
105381349|NCT02265744|363401604|FG001|Overall Study|Poor/Non-compliance|1|||
105381350|NCT02265744|363401605|FG002|Overall Study|Poor/Non-compliance|0|||
105381351|NCT02265744|363401606|FG003|Overall Study|Poor/Non-compliance|0|||
105381352|NCT02265744|363401607|FG004|Overall Study|Poor/Non-compliance|2|||
105381353|NCT02265744|363401603|FG000|Overall Study|Lost to Follow-up|0|||
105381354|NCT02265744|363401604|FG001|Overall Study|Lost to Follow-up|0|||
105381355|NCT02265744|363401605|FG002|Overall Study|Lost to Follow-up|0|||
105381356|NCT02265744|363401606|FG003|Overall Study|Lost to Follow-up|1|||
105381357|NCT02265744|363401607|FG004|Overall Study|Lost to Follow-up|0|||
105381358|NCT02265744|363401603|FG000|Overall Study|Death|0|||
105381359|NCT02265744|363401604|FG001|Overall Study|Death|0|||
105381360|NCT02265744|363401605|FG002|Overall Study|Death|0|||
105381361|NCT02265744|363401606|FG003|Overall Study|Death|2|||
105381362|NCT02265744|363401607|FG004|Overall Study|Death|0|||
105381363|NCT02265744|363401603|FG000|Overall Study|Withdrawal by Subject|2|||
105381364|NCT02265744|363401604|FG001|Overall Study|Withdrawal by Subject|0|||
105381365|NCT02265744|363401605|FG002|Overall Study|Withdrawal by Subject|0|||
105381366|NCT02265744|363401606|FG003|Overall Study|Withdrawal by Subject|2|||
105381367|NCT02265744|363401607|FG004|Overall Study|Withdrawal by Subject|0|||
105381368|NCT02265744|363401603|FG000|Overall Study|Participant request to discontinue|2|||
105381369|NCT02265744|363401604|FG001|Overall Study|Participant request to discontinue|2|||
105381370|NCT02265744|363401605|FG002|Overall Study|Participant request to discontinue|2|||
105381371|NCT02265744|363401606|FG003|Overall Study|Participant request to discontinue|0|||
105381372|NCT02265744|363401607|FG004|Overall Study|Participant request to discontinue|0|||
105381373|NCT02265744|363401603|FG000|Overall Study|Adverse Event|8|||
105381374|NCT02265744|363401604|FG001|Overall Study|Adverse Event|4|||
105381375|NCT02265744|363401605|FG002|Overall Study|Adverse Event|9|||
105381376|NCT02265744|363401606|FG003|Overall Study|Adverse Event|8|||
105381377|NCT02265744|363401607|FG004|Overall Study|Adverse Event|2|||
105381378|NCT02265744|363401603|FG000|Overall Study|Lack of Efficacy|2|||
105381379|NCT02265744|363401604|FG001|Overall Study|Lack of Efficacy|4|||
105381380|NCT02265744|363401605|FG002|Overall Study|Lack of Efficacy|3|||
105381381|NCT02265744|363401606|FG003|Overall Study|Lack of Efficacy|4|||
105381382|NCT02265744|363401607|FG004|Overall Study|Lack of Efficacy|5|||
105381383|NCT02265744|363401603|FG000|Overall Study|Reason not provided by Investigator|1|||
105381384|NCT02265744|363401604|FG001|Overall Study|Reason not provided by Investigator|0|||
105381385|NCT02265744|363401605|FG002|Overall Study|Reason not provided by Investigator|0|||
105381386|NCT02265744|363401606|FG003|Overall Study|Reason not provided by Investigator|2|||
105381387|NCT02265744|363401607|FG004|Overall Study|Reason not provided by Investigator|0|||
105381388|NCT02265744|363401603|FG000|Overall Study|Administrative reason by sponsor|3|||
105381389|NCT02265744|363401604|FG001|Overall Study|Administrative reason by sponsor|2|||
105381390|NCT02265744|363401605|FG002|Overall Study|Administrative reason by sponsor|2|||
105381391|NCT02265744|363401606|FG003|Overall Study|Administrative reason by sponsor|3|||
105381392|NCT02265744|363401607|FG004|Overall Study|Administrative reason by sponsor|3|||
105381393|NCT02265744|363401603|FG000|Overall Study|Subject no longer meets study criteria|0|||
105381394|NCT02265744|363401604|FG001|Overall Study|Subject no longer meets study criteria|0|||
105381395|NCT02265744|363401605|FG002|Overall Study|Subject no longer meets study criteria|0|||
105381396|NCT02265744|363401606|FG003|Overall Study|Subject no longer meets study criteria|0|||
105381397|NCT02265744|363401607|FG004|Overall Study|Subject no longer meets study criteria|1|||
105381398|NCT02265744|363401603|FG000|Overall Study|Pregnancy|1|||
105381399|NCT02265744|363401604|FG001|Overall Study|Pregnancy|2|||
105381400|NCT02265744|363401605|FG002|Overall Study|Pregnancy|1|||
105381401|NCT02265744|363401606|FG003|Overall Study|Pregnancy|1|||
105381402|NCT02265744|363401607|FG004|Overall Study|Pregnancy|0|||
105381403|NCT00685698|363401621|FG000|Overall Study|Withdrawal by Subject|1|||
105381404|NCT00685698|363401621|FG000|Overall Study|Protocol Violation|6|||
105381405|NCT00685698|363401621|FG000|Overall Study|Adverse Event|3|||
105381406|NCT00685698|363401621|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
105381407|NCT00685698|363401621|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
105381408|NCT00685698|363401621|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
105381409|NCT01149538|363401624|FG000|Overall Study|Lost to Follow-up|0|||
105381410|NCT01149538|363401625|FG001|Overall Study|Lost to Follow-up|1|||
105381411|NCT01149538|363401624|FG000|Overall Study|Withdrawal by Subject|5|||
105381412|NCT01149538|363401625|FG001|Overall Study|Withdrawal by Subject|3|||
105381413|NCT04465955|363401633|FG000|Overall Study|Withdrew consent|6|||
105381414|NCT04465955|363401634|FG001|Overall Study|Withdrew consent|10|||
105381415|NCT04465955|363401635|FG002|Overall Study|Withdrew consent|7|||
105381416|NCT04465955|363401633|FG000|Overall Study|Adverse Event|6|||
105381417|NCT04465955|363401634|FG001|Overall Study|Adverse Event|5|||
105381418|NCT04465955|363401635|FG002|Overall Study|Adverse Event|1|||
105381419|NCT04465955|363401633|FG000|Overall Study|Lost to Follow-up|2|||
105381420|NCT04465955|363401634|FG001|Overall Study|Lost to Follow-up|0|||
105381421|NCT04465955|363401635|FG002|Overall Study|Lost to Follow-up|3|||
105381422|NCT04465955|363401633|FG000|Overall Study|Other|1|||
105381423|NCT04465955|363401634|FG001|Overall Study|Other|1|||
105381424|NCT04465955|363401635|FG002|Overall Study|Other|3|||
105381425|NCT02497755|363401636|FG000|Overall Study|Protocol Violation|1|||
105381426|NCT02497755|363401637|FG001|Overall Study|Protocol Violation|0|||
105381427|NCT03501277|363401640|FG000|Intervention Period 1 (4 Days)|Other|0|||
105381428|NCT03501277|363401641|FG001|Intervention Period 1 (4 Days)|Other|0|||
105381429|NCT03501277|363401642|FG002|Intervention Period 1 (4 Days)|Other|1|||
105381430|NCT03501277|363401643|FG003|Intervention Period 1 (4 Days)|Other|0|||
105381431|NCT03501277|363401640|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
105381432|NCT03501277|363401641|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
105381433|NCT03501277|363401642|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
105381434|NCT03501277|363401643|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
105381435|NCT03501277|363401640|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
105381436|NCT03501277|363401641|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
105381437|NCT03501277|363401642|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
105381438|NCT03501277|363401643|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
105381439|NCT03501277|363401640|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
105381440|NCT03501277|363401641|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
105381441|NCT03501277|363401642|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
105381442|NCT03501277|363401643|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
105381443|NCT01131585|363401644|FG000|Overall Study|Adverse Event|0|||
105381444|NCT01131585|363401645|FG001|Overall Study|Adverse Event|2|||
105381445|NCT01131585|363401644|FG000|Overall Study|Abnormal laboratory value|1|||
105381446|NCT01131585|363401645|FG001|Overall Study|Abnormal laboratory value|0|||
105381447|NCT01131585|363401644|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105381448|NCT01131585|363401645|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105381449|NCT01131585|363401644|FG000|Overall Study|Protocol Violation|2|||
105381450|NCT01131585|363401645|FG001|Overall Study|Protocol Violation|1|||
105381451|NCT01131585|363401644|FG000|Overall Study|Withdrawal by Subject|3|||
105381452|NCT01131585|363401645|FG001|Overall Study|Withdrawal by Subject|3|||
105381453|NCT01131585|363401644|FG000|Overall Study|Lost to Follow-up|0|||
105381454|NCT01131585|363401645|FG001|Overall Study|Lost to Follow-up|1|||
105381455|NCT01131585|363401644|FG000|Overall Study|Administrative problems|1|||
105381456|NCT01131585|363401645|FG001|Overall Study|Administrative problems|1|||
105381457|NCT01131585|363401644|FG000|Overall Study|Study termination|78|||
105381458|NCT01131585|363401645|FG001|Overall Study|Study termination|32|||
105381459|NCT01968785|363401646|FG000|Overall Study|Withdrawal by Subject|1|||
105381460|NCT01968785|363401647|FG001|Overall Study|Withdrawal by Subject|0|||
105381461|NCT02939781|363401654|FG000|Overall Study|Protocol Violation|8|||
105381462|NCT02939781|363401654|FG000|Overall Study|Withdrawal by Subject|1|||
105381463|NCT01666314|363401655|FG000|Overall Study|Adverse Event|3|||
105381464|NCT01666314|363401656|FG001|Overall Study|Adverse Event|13|||
105381465|NCT01666314|363401657|FG002|Overall Study|Adverse Event|7|||
105381466|NCT01666314|363401658|FG003|Overall Study|Adverse Event|7|||
105381467|NCT01666314|363401655|FG000|Overall Study|Progressive Disease|11|||
105381468|NCT01666314|363401656|FG001|Overall Study|Progressive Disease|9|||
105381469|NCT01666314|363401657|FG002|Overall Study|Progressive Disease|19|||
105381470|NCT01666314|363401658|FG003|Overall Study|Progressive Disease|20|||
105381471|NCT01666314|363401655|FG000|Overall Study|Symptomatic Deterioration|1|||
105381472|NCT01666314|363401656|FG001|Overall Study|Symptomatic Deterioration|0|||
105381473|NCT01666314|363401657|FG002|Overall Study|Symptomatic Deterioration|2|||
105381474|NCT01666314|363401658|FG003|Overall Study|Symptomatic Deterioration|0|||
105381475|NCT01666314|363401655|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
105381476|NCT01666314|363401656|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
105381477|NCT01666314|363401657|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
105381478|NCT01666314|363401658|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
105381479|NCT01666314|363401655|FG000|Overall Study|Withdrawal by Subject|1|||
105381480|NCT01666314|363401656|FG001|Overall Study|Withdrawal by Subject|1|||
105381481|NCT01666314|363401657|FG002|Overall Study|Withdrawal by Subject|2|||
105381482|NCT01666314|363401658|FG003|Overall Study|Withdrawal by Subject|3|||
105381483|NCT01666314|363401655|FG000|Overall Study|Reason not Specified|10|||
105381484|NCT01666314|363401656|FG001|Overall Study|Reason not Specified|7|||
105381485|NCT01666314|363401657|FG002|Overall Study|Reason not Specified|5|||
105381486|NCT01666314|363401658|FG003|Overall Study|Reason not Specified|5|||
105381487|NCT00032487|363401659|FG000|Overall Study|Withdrawal by Subject|67|||
105381488|NCT00032487|363401660|FG001|Overall Study|Withdrawal by Subject|43|||
105381489|NCT00032487|363401659|FG000|Overall Study|Adverse Event|3|||
105381490|NCT00032487|363401660|FG001|Overall Study|Adverse Event|7|||
105381491|NCT00032487|363401659|FG000|Overall Study|Lost to Follow-up|57|||
105381492|NCT00032487|363401660|FG001|Overall Study|Lost to Follow-up|58|||
105381493|NCT00032487|363401659|FG000|Overall Study|Had other reason|12|||
105381494|NCT00032487|363401660|FG001|Overall Study|Had other reason|12|||
105381495|NCT01541254|363401661|FG000|Overall Study|Withdrawal by Subject|1|||
105381496|NCT01541254|363401661|FG000|Overall Study|excluded - metal allergy|1|||
105381497|NCT01541254|363401661|FG000|Overall Study|enrolled after study closed|1|||
105381498|NCT01541254|363401661|FG000|Overall Study|GI bleed prior to procedure|1|||
105381499|NCT01541254|363401661|FG000|Overall Study|stent not required|1|||
105381500|NCT01541254|363401661|FG000|Overall Study|alternate stent used|1|||
105381501|NCT06100250|363401662|FG000|Overall Study|Lost to Follow-up|5|||
105381502|NCT02021318|363401663|FG000|Overall Study|Adverse Event|2|||
105381503|NCT02021318|363401664|FG001|Overall Study|Adverse Event|1|||
105381504|NCT02021318|363401663|FG000|Overall Study|Death|33|||
105381505|NCT02021318|363401664|FG001|Overall Study|Death|34|||
105381506|NCT02021318|363401663|FG000|Overall Study|Lost to Follow-up|3|||
105381507|NCT02021318|363401664|FG001|Overall Study|Lost to Follow-up|3|||
105381508|NCT02021318|363401663|FG000|Overall Study|Progressive Disease|0|||
105381509|NCT02021318|363401664|FG001|Overall Study|Progressive Disease|1|||
105381510|NCT02021318|363401663|FG000|Overall Study|Withdrawal by Subject|30|||
105381511|NCT02021318|363401664|FG001|Overall Study|Withdrawal by Subject|18|||
105381512|NCT02021318|363401663|FG000|Overall Study|Physician Decision|3|||
105381513|NCT02021318|363401664|FG001|Overall Study|Physician Decision|3|||
105381514|NCT02021318|363401663|FG000|Overall Study|Miscellaneous|2|||
105381515|NCT02021318|363401664|FG001|Overall Study|Miscellaneous|3|||
105381516|NCT02569242|363401665|FG000|Overall Study|Death|1|||
105381517|NCT02569242|363401666|FG001|Overall Study|Death|0|||
105381518|NCT02569242|363401665|FG000|Overall Study|Withdrawal by Subject|0|||
105381519|NCT02569242|363401666|FG001|Overall Study|Withdrawal by Subject|1|||
105381520|NCT00689052|363401667|FG000|Overall Study|Adverse Event|4|||
105381521|NCT00689052|363401668|FG001|Overall Study|Adverse Event|6|||
105381522|NCT00689052|363401667|FG000|Overall Study|Protocol Violation|1|||
105381523|NCT00689052|363401668|FG001|Overall Study|Protocol Violation|0|||
105381524|NCT00689052|363401667|FG000|Overall Study|Lost to Follow-up|2|||
105381525|NCT00689052|363401668|FG001|Overall Study|Lost to Follow-up|0|||
105381526|NCT00689052|363401667|FG000|Overall Study|Withdrawal by Subject|2|||
105381527|NCT00689052|363401668|FG001|Overall Study|Withdrawal by Subject|0|||
105381528|NCT00689052|363401667|FG000|Overall Study|Early termination of the trial|22|||
105381529|NCT00689052|363401668|FG001|Overall Study|Early termination of the trial|24|||
105381530|NCT05661734|363401669|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
105381531|NCT05661734|363401669|FG000|Overall Study|Lost to Follow-up|13|||
105381532|NCT05661734|363401669|FG000|Overall Study|Enrolled but not dosed|2|||
105381533|NCT01727154|363401671|FG000|Overall Study|Death|17|||
105381534|NCT01727154|363401671|FG000|Overall Study|Withdrawal by Subject|14|||
105381535|NCT01727154|363401671|FG000|Overall Study|Subject Withdrew Consent|18|||
105381536|NCT01727154|363401671|FG000|Overall Study|Study Terminated|6|||
105381537|NCT01727154|363401671|FG000|Overall Study|No Discontinuation Documentation|4|||
105381538|NCT00004859|363401672|FG000|Overall Study|Lack of Efficacy|43|||
105381539|NCT00004859|363401673|FG001|Overall Study|Lack of Efficacy|113|||
105381540|NCT00004859|363401672|FG000|Overall Study|Adverse Event|31|||
105381541|NCT00004859|363401673|FG001|Overall Study|Adverse Event|93|||
105381542|NCT00004859|363401672|FG000|Overall Study|Death|5|||
105381543|NCT00004859|363401673|FG001|Overall Study|Death|5|||
105381544|NCT00004859|363401672|FG000|Overall Study|Withdrawal by Subject|7|||
105381545|NCT00004859|363401673|FG001|Overall Study|Withdrawal by Subject|33|||
105381546|NCT00004859|363401672|FG000|Overall Study|Protocol Violation|2|||
105381547|NCT00004859|363401673|FG001|Overall Study|Protocol Violation|2|||
105381548|NCT00004859|363401672|FG000|Overall Study|other disease|0|||
105381549|NCT00004859|363401673|FG001|Overall Study|other disease|3|||
105381550|NCT00004859|363401672|FG000|Overall Study|error|3|||
105381551|NCT00004859|363401673|FG001|Overall Study|error|1|||
105381552|NCT00004859|363401672|FG000|Overall Study|missing data|14|||
105381553|NCT00004859|363401673|FG001|Overall Study|missing data|11|||
105381554|NCT00004859|363401672|FG000|Overall Study|Other|13|||
105381555|NCT00004859|363401673|FG001|Overall Study|Other|21|||
105381556|NCT02724644|363403188|FG000|Overall Study|Adverse Event|7|||
105381557|NCT02724644|363403189|FG001|Overall Study|Adverse Event|1|||
105381558|NCT02724644|363403188|FG000|Overall Study|Lost to Follow-up|6|||
105381559|NCT02724644|363403189|FG001|Overall Study|Lost to Follow-up|2|||
105381560|NCT02724644|363403188|FG000|Overall Study|Withdrawal by Subject|7|||
105381561|NCT02724644|363403189|FG001|Overall Study|Withdrawal by Subject|1|||
105381562|NCT02724644|363403188|FG000|Overall Study|Administrative|1|||
105381563|NCT02724644|363403189|FG001|Overall Study|Administrative|0|||
105381564|NCT04766333|363403190|FG000|Overall Study|Lost to Follow-up|40|||
105381565|NCT04766333|363403191|FG001|Overall Study|Lost to Follow-up|826|||
105381566|NCT00266812|363403196|FG000|Overall Study|Disease Progression|9|||
105381567|NCT00266812|363403197|FG001|Overall Study|Disease Progression|3|||
105381568|NCT00266812|363403196|FG000|Overall Study|Death|5|||
105381569|NCT00266812|363403197|FG001|Overall Study|Death|4|||
105381570|NCT00266812|363403196|FG000|Overall Study|Adverse Event|3|||
105381571|NCT00266812|363403197|FG001|Overall Study|Adverse Event|1|||
105381572|NCT00266812|363403196|FG000|Overall Study|Protocol Violation|0|||
105381573|NCT00266812|363403197|FG001|Overall Study|Protocol Violation|1|||
105381574|NCT00266812|363403196|FG000|Overall Study|Withdrawal by Subject|0|||
105381575|NCT00266812|363403197|FG001|Overall Study|Withdrawal by Subject|2|||
105381576|NCT00266812|363403196|FG000|Overall Study|Discontinued before starting study drug|4|||
105381577|NCT00266812|363403197|FG001|Overall Study|Discontinued before starting study drug|0|||
105381578|NCT00530075|363403198|FG000|Overall Study|Adverse Event|1|||
105381579|NCT00530075|363403198|FG000|Overall Study|Death|1|||
105381580|NCT00530075|363403198|FG000|Overall Study|Lack of Efficacy|3|||
105381581|NCT00530075|363403198|FG000|Overall Study|Protocol Violation|1|||
105381582|NCT00530075|363403198|FG000|Overall Study|Withdrawal by Subject|1|||
105381583|NCT02636283|363403199|FG000|Overall Study|Adverse Event|2|||
105381584|NCT02636283|363403200|FG001|Overall Study|Adverse Event|0|||
105381585|NCT02636283|363403199|FG000|Overall Study|Trial Terminated Prematurely|0|||
105381586|NCT02636283|363403200|FG001|Overall Study|Trial Terminated Prematurely|3|||
105381587|NCT00145327|363403201|FG000|Overall Study|Withdrawal by Subject|77|||
105381588|NCT00145327|363403202|FG001|Overall Study|Withdrawal by Subject|72|||
105381589|NCT00145327|363403203|FG002|Overall Study|Withdrawal by Subject|164|||
105381590|NCT00145327|363403201|FG000|Overall Study|Death|26|||
105381591|NCT00145327|363403202|FG001|Overall Study|Death|18|||
105381592|NCT00145327|363403203|FG002|Overall Study|Death|30|||
105381593|NCT00145327|363403201|FG000|Overall Study|Adverse Event|14|||
105381594|NCT00145327|363403202|FG001|Overall Study|Adverse Event|11|||
105381595|NCT00145327|363403203|FG002|Overall Study|Adverse Event|22|||
105381596|NCT00145327|363403201|FG000|Overall Study|Lost to Follow-up|9|||
105381597|NCT00145327|363403202|FG001|Overall Study|Lost to Follow-up|14|||
105381598|NCT00145327|363403203|FG002|Overall Study|Lost to Follow-up|14|||
105381599|NCT00145327|363403201|FG000|Overall Study|Administrative problems|12|||
105381600|NCT00145327|363403202|FG001|Overall Study|Administrative problems|9|||
105381601|NCT00145327|363403203|FG002|Overall Study|Administrative problems|13|||
105381602|NCT00145327|363403201|FG000|Overall Study|Protocol Violation|2|||
105381603|NCT00145327|363403202|FG001|Overall Study|Protocol Violation|0|||
105381604|NCT00145327|363403203|FG002|Overall Study|Protocol Violation|2|||
105381605|NCT00145327|363403201|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105381606|NCT00145327|363403202|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105381607|NCT00145327|363403203|FG002|Overall Study|Abnormal laboratory value(s)|2|||
105381608|NCT00145327|363403201|FG000|Overall Study|Missing - not stated|1|||
105381609|NCT00145327|363403202|FG001|Overall Study|Missing - not stated|0|||
105381610|NCT00145327|363403203|FG002|Overall Study|Missing - not stated|1|||
105381611|NCT00986232|363403206|FG000|Overall Study|Adverse Event|1|||
105381612|NCT00986232|363403207|FG001|Overall Study|Adverse Event|2|||
105381613|NCT00986232|363403208|FG002|Overall Study|Adverse Event|3|||
105381614|NCT00986232|363403209|FG003|Overall Study|Adverse Event|0|||
105381615|NCT00986232|363403206|FG000|Overall Study|Lost to Follow-up|19|||
105381616|NCT00986232|363403207|FG001|Overall Study|Lost to Follow-up|12|||
105381617|NCT00986232|363403208|FG002|Overall Study|Lost to Follow-up|12|||
105381618|NCT00986232|363403209|FG003|Overall Study|Lost to Follow-up|7|||
105381619|NCT00986232|363403206|FG000|Overall Study|Protocol Violation|2|||
105381620|NCT00986232|363403207|FG001|Overall Study|Protocol Violation|3|||
105381621|NCT00986232|363403208|FG002|Overall Study|Protocol Violation|0|||
105381622|NCT00986232|363403209|FG003|Overall Study|Protocol Violation|1|||
105381623|NCT00986232|363403206|FG000|Overall Study|Withdrawal by Subject|13|||
105381624|NCT00986232|363403207|FG001|Overall Study|Withdrawal by Subject|16|||
105381625|NCT00986232|363403208|FG002|Overall Study|Withdrawal by Subject|12|||
105381626|NCT00986232|363403209|FG003|Overall Study|Withdrawal by Subject|3|||
105381627|NCT00986232|363403206|FG000|Overall Study|Missed one or more bleeds|13|||
105381628|NCT00986232|363403207|FG001|Overall Study|Missed one or more bleeds|10|||
105381629|NCT00986232|363403208|FG002|Overall Study|Missed one or more bleeds|6|||
105381630|NCT00986232|363403209|FG003|Overall Study|Missed one or more bleeds|7|||
105381631|NCT00986232|363403206|FG000|Overall Study|Incomplete safety follow-up|3|||
105381632|NCT00986232|363403207|FG001|Overall Study|Incomplete safety follow-up|7|||
105381633|NCT00986232|363403208|FG002|Overall Study|Incomplete safety follow-up|2|||
105381634|NCT00986232|363403209|FG003|Overall Study|Incomplete safety follow-up|2|||
105381635|NCT02930941|363403211|FG000|Overall Study|Lost to Follow-up|1|||
105381636|NCT02930941|363403212|FG001|Overall Study|Lost to Follow-up|2|||
105381637|NCT01967277|363403215|FG000|Overall Study|Lost to Follow-up|1|||
105381638|NCT01967277|363403216|FG001|Overall Study|Lost to Follow-up|2|||
105381639|NCT01967277|363403215|FG000|Overall Study|Unrelated illness|0|||
105381640|NCT01967277|363403216|FG001|Overall Study|Unrelated illness|1|||
105381641|NCT01243424|363403219|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
105381642|NCT01243424|363403220|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
105381643|NCT01243424|363403219|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
105381644|NCT01243424|363403220|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
105381645|NCT01243424|363403219|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
105381646|NCT01243424|363403220|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
105381647|NCT01243424|363403219|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
105381648|NCT01243424|363403220|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
105381649|NCT01243424|363403219|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
105381650|NCT01243424|363403220|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
105381651|NCT01243424|363403219|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
105381652|NCT01243424|363403220|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
105381653|NCT01243424|363403219|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
105381654|NCT01243424|363403220|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
105381655|NCT01243424|363403219|FG000|Discontinuation From Treatment|Not treated|5|||
105381656|NCT01243424|363403220|FG001|Discontinuation From Treatment|Not treated|4|||
105580205|NCT00983619|364124226|FG006|Overall Study|Other|2|||
105381657|NCT01243424|363403219|FG000|Discontinuation From Treatment|Adverse Event|457|||
105381658|NCT01243424|363403220|FG001|Discontinuation From Treatment|Adverse Event|523|||
105381659|NCT01243424|363403219|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
105381660|NCT01243424|363403220|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
105381661|NCT01243424|363403219|FG000|Discontinuation From Treatment|Protocol Violation|46|||
105381662|NCT01243424|363403220|FG001|Discontinuation From Treatment|Protocol Violation|47|||
105381663|NCT01243424|363403219|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
105381664|NCT01243424|363403220|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
105381665|NCT01243424|363403219|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
105381666|NCT01243424|363403220|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
105381667|NCT01243424|363403219|FG000|Discontinuation From Treatment|Other than listed above|230|||
105381668|NCT01243424|363403220|FG001|Discontinuation From Treatment|Other than listed above|211|||
105381669|NCT00397930|363403223|FG000|Overall Study|Personal reasons|14|||
105381670|NCT00397930|363403224|FG001|Overall Study|Personal reasons|8|||
105381671|NCT00397930|363403223|FG000|Overall Study|Other medical|9|||
105381672|NCT00397930|363403224|FG001|Overall Study|Other medical|4|||
105381673|NCT00397930|363403223|FG000|Overall Study|Unknown reasons|9|||
105381674|NCT00397930|363403224|FG001|Overall Study|Unknown reasons|14|||
105381675|NCT00397930|363403223|FG000|Overall Study|Noncompliant|3|||
105381676|NCT00397930|363403224|FG001|Overall Study|Noncompliant|2|||
105381677|NCT00397930|363403223|FG000|Overall Study|Too time-consuming|2|||
105381678|NCT00397930|363403224|FG001|Overall Study|Too time-consuming|9|||
105381679|NCT00397930|363403223|FG000|Overall Study|Started own yoga program|1|||
105381680|NCT00397930|363403224|FG001|Overall Study|Started own yoga program|1|||
105381681|NCT00397930|363403223|FG000|Overall Study|Did not want to be in control group|0|||
105381682|NCT00397930|363403224|FG001|Overall Study|Did not want to be in control group|1|||
105381683|NCT00397930|363403223|FG000|Overall Study|Withdrawal by Subject|0|||
105381684|NCT00397930|363403224|FG001|Overall Study|Withdrawal by Subject|8|||
105381685|NCT00397930|363403223|FG000|Overall Study|Missing data|0|||
105381686|NCT00397930|363403224|FG001|Overall Study|Missing data|4|||
105381687|NCT02400580|363403239|FG000|Overall Study|Withdrawal by Subject|1|||
105381688|NCT02400580|363403240|FG001|Overall Study|Withdrawal by Subject|1|||
105381689|NCT02400580|363403239|FG000|Overall Study|Adverse Event|1|||
105381690|NCT02400580|363403240|FG001|Overall Study|Adverse Event|0|||
105381691|NCT01060111|363403241|FG000|Overall Study|Adverse Event|9|||
105381692|NCT01060111|363403242|FG001|Overall Study|Adverse Event|5|||
105381693|NCT01060111|363403243|FG002|Overall Study|Adverse Event|18|||
105381694|NCT01060111|363403241|FG000|Overall Study|Lack of Efficacy|2|||
105381695|NCT01060111|363403242|FG001|Overall Study|Lack of Efficacy|1|||
105381696|NCT01060111|363403243|FG002|Overall Study|Lack of Efficacy|0|||
105381697|NCT01060111|363403241|FG000|Overall Study|Inappropriate participant|5|||
105381698|NCT01060111|363403242|FG001|Overall Study|Inappropriate participant|4|||
105381699|NCT01060111|363403243|FG002|Overall Study|Inappropriate participant|5|||
105381700|NCT01060111|363403241|FG000|Overall Study|Participants' evasion for hospital visit|0|||
105381701|NCT01060111|363403242|FG001|Overall Study|Participants' evasion for hospital visit|3|||
105381702|NCT01060111|363403243|FG002|Overall Study|Participants' evasion for hospital visit|2|||
105381703|NCT01060111|363403241|FG000|Overall Study|Participants' non-cooperation|8|||
105381704|NCT01060111|363403242|FG001|Overall Study|Participants' non-cooperation|6|||
105381705|NCT01060111|363403243|FG002|Overall Study|Participants' non-cooperation|6|||
105381706|NCT01060111|363403241|FG000|Overall Study|Adverse event and insufficient effect|0|||
105381707|NCT01060111|363403242|FG001|Overall Study|Adverse event and insufficient effect|1|||
105381708|NCT01060111|363403243|FG002|Overall Study|Adverse event and insufficient effect|0|||
105381709|NCT01060111|363403241|FG000|Overall Study|Participants' non-cooperation|1|||
105381710|NCT01060111|363403242|FG001|Overall Study|Participants' non-cooperation|0|||
105381711|NCT01060111|363403243|FG002|Overall Study|Participants' non-cooperation|0|||
105381712|NCT01060111|363403241|FG000|Overall Study|Other|2|||
105381713|NCT01060111|363403242|FG001|Overall Study|Other|3|||
105381714|NCT01060111|363403243|FG002|Overall Study|Other|4|||
105381715|NCT01336972|363403245|FG000|Overall Study|Adverse Event|1|||
105381716|NCT01336972|363403246|FG001|Overall Study|Adverse Event|1|||
105381717|NCT01336972|363403247|FG002|Overall Study|Adverse Event|0|||
105381718|NCT03954938|363403253|FG000|Overall Study|Withdrawal by Subject|2|||
105381719|NCT03954938|363403253|FG000|Overall Study|Adverse Event|1|||
105381720|NCT00617903|363403254|FG000|Overall Study|Withdrawal by Subject|2|||
105381721|NCT00617903|363403255|FG001|Overall Study|Withdrawal by Subject|3|||
105381722|NCT00617903|363403254|FG000|Overall Study|Lost to Follow-up|1|||
105381723|NCT00617903|363403255|FG001|Overall Study|Lost to Follow-up|1|||
105381724|NCT00617903|363403254|FG000|Overall Study|Lack of Efficacy|0|||
105381725|NCT00617903|363403255|FG001|Overall Study|Lack of Efficacy|1|||
105381726|NCT00617903|363403254|FG000|Overall Study|Adverse Event|0|||
105381727|NCT00617903|363403255|FG001|Overall Study|Adverse Event|1|||
105381728|NCT00617903|363403254|FG000|Overall Study|noncompliance|0|||
105381729|NCT00617903|363403255|FG001|Overall Study|noncompliance|1|||
105381730|NCT02217982|363403256|FG000|Overall Study|Trial discontinued|1|||
105381731|NCT02217982|363403257|FG001|Overall Study|Trial discontinued|0|||
105381732|NCT02217982|363403256|FG000|Overall Study|Adverse Event|0|||
105381733|NCT02217982|363403257|FG001|Overall Study|Adverse Event|1|||
105381734|NCT02421510|363403258|FG000|Overall Study|Other|4|||
105381735|NCT02421510|363403259|FG001|Overall Study|Other|2|||
105381736|NCT02421510|363403260|FG002|Overall Study|Other|3|||
105580206|NCT00983619|364124227|FG007|Overall Study|Other|2|||
105381737|NCT02421510|363403258|FG000|Overall Study|Protocol Violation|1|||
105381738|NCT02421510|363403259|FG001|Overall Study|Protocol Violation|2|||
105381739|NCT02421510|363403260|FG002|Overall Study|Protocol Violation|0|||
105381740|NCT02421510|363403258|FG000|Overall Study|Death|1|||
105381741|NCT02421510|363403259|FG001|Overall Study|Death|0|||
105381742|NCT02421510|363403260|FG002|Overall Study|Death|0|||
105381743|NCT02421510|363403258|FG000|Overall Study|Noncompliance with study drug|1|||
105381744|NCT02421510|363403259|FG001|Overall Study|Noncompliance with study drug|0|||
105381745|NCT02421510|363403260|FG002|Overall Study|Noncompliance with study drug|0|||
105580207|NCT00983619|364124228|FG008|Overall Study|Other|0|||
105381746|NCT02421510|363403258|FG000|Overall Study|Physician Decision|1|||
105381747|NCT02421510|363403259|FG001|Overall Study|Physician Decision|1|||
105381748|NCT02421510|363403260|FG002|Overall Study|Physician Decision|3|||
105381749|NCT02421510|363403258|FG000|Overall Study|Adverse Event|9|||
105381750|NCT02421510|363403259|FG001|Overall Study|Adverse Event|10|||
105381751|NCT02421510|363403260|FG002|Overall Study|Adverse Event|18|||
105381752|NCT02421510|363403258|FG000|Overall Study|Pregnancy|1|||
105381753|NCT02421510|363403259|FG001|Overall Study|Pregnancy|1|||
105381754|NCT02421510|363403260|FG002|Overall Study|Pregnancy|0|||
105381755|NCT02421510|363403258|FG000|Overall Study|Withdrawal by Subject|14|||
105381756|NCT02421510|363403259|FG001|Overall Study|Withdrawal by Subject|18|||
105381757|NCT02421510|363403260|FG002|Overall Study|Withdrawal by Subject|12|||
105381758|NCT02421510|363403258|FG000|Overall Study|Lost to Follow-up|1|||
105381759|NCT02421510|363403259|FG001|Overall Study|Lost to Follow-up|1|||
105381760|NCT02421510|363403260|FG002|Overall Study|Lost to Follow-up|0|||
105381761|NCT00827242|363403261|FG000|Overall Study|Withdrawal by Subject|2|||
105381762|NCT00827242|363403262|FG001|Overall Study|Withdrawal by Subject|4|||
105381763|NCT00827242|363403261|FG000|Overall Study|Protocol Violation|1|||
105381764|NCT00827242|363403262|FG001|Overall Study|Protocol Violation|3|||
105381765|NCT00827242|363403261|FG000|Overall Study|Lost to Follow-up|0|||
105381766|NCT00827242|363403262|FG001|Overall Study|Lost to Follow-up|3|||
105381767|NCT00827242|363403261|FG000|Overall Study|Adverse Event Excluding Death|2|||
105381768|NCT00827242|363403262|FG001|Overall Study|Adverse Event Excluding Death|1|||
105381769|NCT00827242|363403261|FG000|Overall Study|Entry Criteria Not Met|4|||
105381770|NCT00827242|363403262|FG001|Overall Study|Entry Criteria Not Met|1|||
105381771|NCT00827242|363403261|FG000|Overall Study|Physician Decision|2|||
105381772|NCT00827242|363403262|FG001|Overall Study|Physician Decision|0|||
105381773|NCT00827242|363403261|FG000|Overall Study|Death|1|||
105381774|NCT00827242|363403262|FG001|Overall Study|Death|0|||
105381775|NCT00827242|363403261|FG000|Overall Study|Lack of Efficacy|1|||
105381776|NCT00827242|363403262|FG001|Overall Study|Lack of Efficacy|0|||
105381777|NCT03123588|363403269|FG000|Overall Study|Study Terminated by Sponsor|2|||
105381778|NCT03123588|363403270|FG001|Overall Study|Study Terminated by Sponsor|5|||
105381779|NCT03123588|363403269|FG000|Overall Study|Withdrawal by Subject|1|||
105381780|NCT03123588|363403270|FG001|Overall Study|Withdrawal by Subject|0|||
105381781|NCT03123588|363403269|FG000|Overall Study|Adverse Event|1|||
105381782|NCT03123588|363403270|FG001|Overall Study|Adverse Event|0|||
105381783|NCT03123588|363403269|FG000|Overall Study|Physician Decision|2|||
105381784|NCT03123588|363403270|FG001|Overall Study|Physician Decision|1|||
105381785|NCT01755637|363403271|FG000|Period 1|Adverse Event|0|||
105381786|NCT01755637|363403272|FG001|Period 1|Adverse Event|1|||
105381787|NCT05987540|363403273|FG000|Overall Study|Withdrawal by Subject|2|||
105381788|NCT05987540|363403273|FG000|Overall Study|Death|1|||
105381789|NCT05987540|363403273|FG000|Overall Study|Study Termination|1|||
105381790|NCT05987540|363403273|FG000|Overall Study|Adverse Event|2|||
105381791|NCT03338023|363403274|FG000|Overall Study|Withdrawal by Subject|3|||
105381792|NCT03338023|363403275|FG001|Overall Study|Withdrawal by Subject|4|||
105381793|NCT03338023|363403274|FG000|Overall Study|Protocol Violation|3|||
105381794|NCT03338023|363403275|FG001|Overall Study|Protocol Violation|3|||
105381795|NCT03338023|363403274|FG000|Overall Study|Lost to Follow-up|2|||
105381796|NCT03338023|363403275|FG001|Overall Study|Lost to Follow-up|1|||
105381797|NCT03338023|363403274|FG000|Overall Study|Physician Decision|1|||
105381798|NCT03338023|363403275|FG001|Overall Study|Physician Decision|2|||
105381799|NCT05064800|363403276|FG000|Period 3|Withdrawal by Subject|0|||
105381800|NCT05064800|363403277|FG001|Period 3|Withdrawal by Subject|0|||
105381801|NCT05064800|363403278|FG002|Period 3|Withdrawal by Subject|0|||
105381802|NCT05064800|363403279|FG003|Period 3|Withdrawal by Subject|0|||
105381803|NCT05064800|363403280|FG004|Period 3|Withdrawal by Subject|1|||
105381804|NCT05064800|363403281|FG005|Period 3|Withdrawal by Subject|0|||
105381805|NCT01774370|363403282|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
105381806|NCT01774370|363403282|FG000|Overall Study|Administered prior to the contract date|4|||
105381807|NCT01774370|363403282|FG000|Overall Study|Subjects of contraindications|34|||
105381808|NCT01774370|363403282|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
105381809|NCT01774370|363403282|FG000|Overall Study|Follow-up failure|34|||
105381810|NCT00514917|363403283|FG000|Overall Study|Death|4|||
105381811|NCT00514917|363403284|FG001|Overall Study|Death|10|||
105381812|NCT00514917|363403283|FG000|Overall Study|Protocol Violation|1|||
105381813|NCT00514917|363403284|FG001|Overall Study|Protocol Violation|0|||
105381814|NCT00514917|363403283|FG000|Overall Study|Lost to Follow-up|4|||
105381815|NCT00514917|363403284|FG001|Overall Study|Lost to Follow-up|3|||
105381816|NCT00514917|363403283|FG000|Overall Study|Withdrawal by Subject|18|||
105381817|NCT00514917|363403284|FG001|Overall Study|Withdrawal by Subject|16|||
105381818|NCT00514917|363403283|FG000|Overall Study|Discontinued due to study closure|88|||
105381819|NCT00514917|363403284|FG001|Overall Study|Discontinued due to study closure|81|||
105381820|NCT00514917|363403283|FG000|Overall Study|Undefined|11|||
105381821|NCT00514917|363403284|FG001|Overall Study|Undefined|5|||
105381822|NCT02697422|363403285|FG000|Overall Study|Declined exit survey|9|||
105381823|NCT02697422|363403286|FG001|Overall Study|Declined exit survey|2|||
105381824|NCT02697422|363403285|FG000|Overall Study|Lost to Follow-up|13|||
105381825|NCT02697422|363403286|FG001|Overall Study|Lost to Follow-up|8|||
105381826|NCT02697422|363403285|FG000|Overall Study|Death|2|||
105381827|NCT02697422|363403286|FG001|Overall Study|Death|1|||
105381828|NCT02697422|363403285|FG000|Overall Study|Withdrawal by Subject|0|||
105381829|NCT02697422|363403286|FG001|Overall Study|Withdrawal by Subject|1|||
105381830|NCT02697422|363403285|FG000|Overall Study|Physician Decision|1|||
105381831|NCT02697422|363403286|FG001|Overall Study|Physician Decision|1|||
105381832|NCT02697422|363403285|FG000|Overall Study|Exit survey data lost|1|||
105381833|NCT02697422|363403286|FG001|Overall Study|Exit survey data lost|0|||
105381834|NCT01436500|363403287|FG000|Overall Study|Death|1|||
105381835|NCT01436500|363403288|FG001|Overall Study|Death|0|||
105381836|NCT01436500|363403289|FG002|Overall Study|Death|0|||
105381837|NCT01436500|363403290|FG003|Overall Study|Death|0|||
105381838|NCT01436500|363403291|FG004|Overall Study|Death|0|||
105381839|NCT01436500|363403287|FG000|Overall Study|Adverse Event|0|||
105381840|NCT01436500|363403288|FG001|Overall Study|Adverse Event|2|||
105381841|NCT01436500|363403289|FG002|Overall Study|Adverse Event|2|||
105381842|NCT01436500|363403290|FG003|Overall Study|Adverse Event|0|||
105381843|NCT01436500|363403291|FG004|Overall Study|Adverse Event|1|||
105381844|NCT01436500|363403287|FG000|Overall Study|Withdrawal by Subject|0|||
105381845|NCT01436500|363403288|FG001|Overall Study|Withdrawal by Subject|0|||
105381846|NCT01436500|363403289|FG002|Overall Study|Withdrawal by Subject|2|||
105381847|NCT01436500|363403290|FG003|Overall Study|Withdrawal by Subject|0|||
105381848|NCT01436500|363403291|FG004|Overall Study|Withdrawal by Subject|2|||
105381849|NCT01436500|363403287|FG000|Overall Study|Physician Decision|0|||
105381850|NCT01436500|363403288|FG001|Overall Study|Physician Decision|0|||
105381851|NCT01436500|363403289|FG002|Overall Study|Physician Decision|1|||
105381852|NCT01436500|363403290|FG003|Overall Study|Physician Decision|0|||
105381853|NCT01436500|363403291|FG004|Overall Study|Physician Decision|0|||
105381854|NCT01436500|363403287|FG000|Overall Study|liver transplant|1|||
105381855|NCT01436500|363403288|FG001|Overall Study|liver transplant|0|||
105381856|NCT01436500|363403289|FG002|Overall Study|liver transplant|0|||
105381857|NCT01436500|363403290|FG003|Overall Study|liver transplant|0|||
105381858|NCT01436500|363403291|FG004|Overall Study|liver transplant|0|||
105381859|NCT01436500|363403287|FG000|Overall Study|initiation of dialysis|0|||
105381860|NCT01436500|363403288|FG001|Overall Study|initiation of dialysis|0|||
105381861|NCT01436500|363403289|FG002|Overall Study|initiation of dialysis|0|||
105381862|NCT01436500|363403290|FG003|Overall Study|initiation of dialysis|0|||
105381863|NCT01436500|363403291|FG004|Overall Study|initiation of dialysis|1|||
105381864|NCT01436500|363403287|FG000|Overall Study|discontinued study drug|1|||
105381865|NCT01436500|363403288|FG001|Overall Study|discontinued study drug|0|||
105381866|NCT01436500|363403289|FG002|Overall Study|discontinued study drug|0|||
105381867|NCT01436500|363403290|FG003|Overall Study|discontinued study drug|0|||
105381868|NCT01436500|363403291|FG004|Overall Study|discontinued study drug|0|||
105381869|NCT01436500|363403287|FG000|Overall Study|Other|0|||
105381870|NCT01436500|363403288|FG001|Overall Study|Other|1|||
105381871|NCT01436500|363403289|FG002|Overall Study|Other|0|||
105381872|NCT01436500|363403290|FG003|Overall Study|Other|1|||
105381873|NCT01436500|363403291|FG004|Overall Study|Other|0|||
105381874|NCT00977561|363403292|FG000|Overall Study|Death|3|||
105381875|NCT00977561|363403293|FG001|Overall Study|Death|2|||
105381876|NCT00977561|363403292|FG000|Overall Study|Study terminated|0|||
105381877|NCT00977561|363403293|FG001|Overall Study|Study terminated|2|||
105381878|NCT00977561|363403292|FG000|Overall Study|Other|2|||
105381879|NCT00977561|363403293|FG001|Overall Study|Other|0|||
105381880|NCT04149353|363403296|FG000|Overall Study|Study terminated|1|||
105381881|NCT00825175|363403298|FG000|Overall Study|Withdrawal by Subject|0|||
105381882|NCT00825175|363403299|FG001|Overall Study|Withdrawal by Subject|5|||
105381883|NCT04595370|363403305|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
105381884|NCT04595370|363403306|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
105381885|NCT04595370|363403307|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
105381886|NCT04595370|363403308|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
105381887|NCT04595370|363403309|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
105381888|NCT04595370|363403310|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
105381889|NCT04595370|363403305|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
105381890|NCT04595370|363403306|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
105381891|NCT04595370|363403307|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
105381892|NCT04595370|363403308|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
105381893|NCT04595370|363403309|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
105381894|NCT04595370|363403310|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
105381895|NCT04595370|363403305|FG000|Overall Study|Adverse Event|0|||
105381896|NCT04595370|363403306|FG001|Overall Study|Adverse Event|4|||
105381897|NCT04595370|363403307|FG002|Overall Study|Adverse Event|3|||
105381898|NCT04595370|363403308|FG003|Overall Study|Adverse Event|1|||
105381899|NCT04595370|363403309|FG004|Overall Study|Adverse Event|1|||
105381900|NCT04595370|363403310|FG005|Overall Study|Adverse Event|1|||
105381901|NCT04595370|363403305|FG000|Overall Study|Withdrawal of Consent|1|||
105381902|NCT04595370|363403306|FG001|Overall Study|Withdrawal of Consent|1|||
105381903|NCT04595370|363403307|FG002|Overall Study|Withdrawal of Consent|1|||
105381904|NCT04595370|363403308|FG003|Overall Study|Withdrawal of Consent|0|||
105381905|NCT04595370|363403309|FG004|Overall Study|Withdrawal of Consent|0|||
105381906|NCT04595370|363403310|FG005|Overall Study|Withdrawal of Consent|0|||
105381907|NCT04595370|363403305|FG000|Overall Study|Death|0|||
105381908|NCT04595370|363403306|FG001|Overall Study|Death|1|||
105381909|NCT04595370|363403307|FG002|Overall Study|Death|0|||
105381910|NCT04595370|363403308|FG003|Overall Study|Death|0|||
105381911|NCT04595370|363403309|FG004|Overall Study|Death|1|||
105381912|NCT04595370|363403310|FG005|Overall Study|Death|0|||
105381913|NCT04595370|363403305|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105381914|NCT04595370|363403306|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105381915|NCT04595370|363403307|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
105381916|NCT04595370|363403308|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105580208|NCT00983619|364124229|FG009|Overall Study|Other|1|||
105381917|NCT04595370|363403309|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105381918|NCT04595370|363403310|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105381919|NCT04595370|363403305|FG000|Overall Study|Withdrawal by Subject|0|||
105381920|NCT04595370|363403306|FG001|Overall Study|Withdrawal by Subject|0|||
105381921|NCT04595370|363403307|FG002|Overall Study|Withdrawal by Subject|1|||
105381922|NCT04595370|363403308|FG003|Overall Study|Withdrawal by Subject|0|||
105381923|NCT04595370|363403309|FG004|Overall Study|Withdrawal by Subject|2|||
105381924|NCT04595370|363403310|FG005|Overall Study|Withdrawal by Subject|0|||
105381925|NCT04595370|363403305|FG000|Overall Study|Lost to Follow-up|0|||
105381926|NCT04595370|363403306|FG001|Overall Study|Lost to Follow-up|0|||
105381927|NCT04595370|363403307|FG002|Overall Study|Lost to Follow-up|0|||
105381928|NCT04595370|363403308|FG003|Overall Study|Lost to Follow-up|0|||
105381929|NCT04595370|363403309|FG004|Overall Study|Lost to Follow-up|1|||
105381930|NCT04595370|363403310|FG005|Overall Study|Lost to Follow-up|0|||
105381931|NCT04595370|363403305|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
105381932|NCT04595370|363403306|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
105381933|NCT04595370|363403307|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
105381934|NCT04595370|363403308|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
105381935|NCT04595370|363403309|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
105381936|NCT04595370|363403310|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
105381937|NCT05660538|363403312|FG000|Overall Study|Adverse Event|0|||
105381938|NCT05660538|363403313|FG001|Overall Study|Adverse Event|0|||
105381939|NCT05660538|363403314|FG002|Overall Study|Adverse Event|1|||
105381940|NCT05660538|363403315|FG003|Overall Study|Adverse Event|0|||
105381941|NCT05660538|363403312|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
105381942|NCT05660538|363403313|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
105381943|NCT05660538|363403314|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
105381944|NCT05660538|363403315|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
105381945|NCT05660538|363403312|FG000|Overall Study|Lost to Follow-up|0|||
105381946|NCT05660538|363403313|FG001|Overall Study|Lost to Follow-up|0|||
105381947|NCT05660538|363403314|FG002|Overall Study|Lost to Follow-up|1|||
105381948|NCT05660538|363403315|FG003|Overall Study|Lost to Follow-up|1|||
105381949|NCT05660538|363403312|FG000|Overall Study|Death|0|||
105492350|NCT04697056|363815726|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
105381950|NCT05660538|363403313|FG001|Overall Study|Death|0|||
105381951|NCT05660538|363403314|FG002|Overall Study|Death|1|||
105381952|NCT05660538|363403315|FG003|Overall Study|Death|0|||
105381953|NCT05660538|363403312|FG000|Overall Study|Physician Decision|0|||
105381954|NCT05660538|363403313|FG001|Overall Study|Physician Decision|0|||
105381955|NCT05660538|363403314|FG002|Overall Study|Physician Decision|0|||
105381956|NCT05660538|363403315|FG003|Overall Study|Physician Decision|1|||
105381957|NCT05660538|363403312|FG000|Overall Study|Sponsor Decision|1|||
105381958|NCT05660538|363403313|FG001|Overall Study|Sponsor Decision|0|||
105381959|NCT05660538|363403314|FG002|Overall Study|Sponsor Decision|0|||
105381960|NCT05660538|363403315|FG003|Overall Study|Sponsor Decision|0|||
105381961|NCT05660538|363403312|FG000|Overall Study|Other|1|||
105381962|NCT05660538|363403313|FG001|Overall Study|Other|0|||
105381963|NCT05660538|363403314|FG002|Overall Study|Other|0|||
105381964|NCT05660538|363403315|FG003|Overall Study|Other|1|||
105381965|NCT05660538|363403312|FG000|Overall Study|Randomized but did not receive study drug|1|||
105381966|NCT05660538|363403313|FG001|Overall Study|Randomized but did not receive study drug|0|||
105381967|NCT05660538|363403314|FG002|Overall Study|Randomized but did not receive study drug|0|||
105381968|NCT05660538|363403315|FG003|Overall Study|Randomized but did not receive study drug|1|||
105381969|NCT05660538|363403312|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
105381970|NCT05660538|363403313|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
105381971|NCT05660538|363403314|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
105381972|NCT05660538|363403315|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
105381973|NCT04625972|363403316|FG000|Overall Study|Death|3|||
105381974|NCT04625972|363403317|FG001|Overall Study|Death|2|||
105381975|NCT04625972|363403316|FG000|Overall Study|Lost to Follow-up|82|||
105381976|NCT04625972|363403317|FG001|Overall Study|Lost to Follow-up|38|||
105381977|NCT04625972|363403316|FG000|Overall Study|Physician Decision|2|||
105381978|NCT04625972|363403317|FG001|Overall Study|Physician Decision|0|||
105381979|NCT04625972|363403316|FG000|Overall Study|Protocol Violation|0|||
105381980|NCT04625972|363403317|FG001|Overall Study|Protocol Violation|1|||
105381981|NCT04625972|363403316|FG000|Overall Study|Withdrawal by Subject|37|||
105381982|NCT04625972|363403317|FG001|Overall Study|Withdrawal by Subject|24|||
105381983|NCT04625972|363403316|FG000|Overall Study|Not specified elsewhere|8|||
105381984|NCT04625972|363403317|FG001|Overall Study|Not specified elsewhere|6|||
105381985|NCT00165698|363403318|FG000|Overall Study|Adverse Event|2|||
105381986|NCT00165698|363403319|FG001|Overall Study|Adverse Event|10|||
105381987|NCT00165698|363403318|FG000|Overall Study|Lost to Follow-up|2|||
105381988|NCT00165698|363403319|FG001|Overall Study|Lost to Follow-up|2|||
105381989|NCT00165698|363403318|FG000|Overall Study|Withdrawal by Subject|2|||
105580209|NCT00983619|364124230|FG010|Overall Study|Other|1|||
105381990|NCT00165698|363403319|FG001|Overall Study|Withdrawal by Subject|1|||
105381991|NCT00165698|363403318|FG000|Overall Study|Protocol Violation|1|||
105381992|NCT00165698|363403319|FG001|Overall Study|Protocol Violation|0|||
105381993|NCT00165698|363403318|FG000|Overall Study|Not Taken/Lost the medicine|1|||
105381994|NCT00165698|363403319|FG001|Overall Study|Not Taken/Lost the medicine|2|||
105381995|NCT01107457|363403320|FG000|Part A|Adverse Event|1|||
105381996|NCT01107457|363403321|FG001|Part A|Adverse Event|2|||
105381997|NCT01107457|363403322|FG002|Part A|Adverse Event|1|||
105381998|NCT01107457|363403323|FG003|Part A|Adverse Event|0|||
105381999|NCT01107457|363403324|FG004|Part A|Adverse Event|0|||
105382000|NCT01107457|363403325|FG005|Part A|Adverse Event|0|||
105382001|NCT01107457|363403320|FG000|Part A|Withdrawal by Subject|3|||
105382002|NCT01107457|363403321|FG001|Part A|Withdrawal by Subject|3|||
105580210|NCT00983619|364124231|FG011|Overall Study|Other|0|||
105580211|NCT04011384|364124232|FG000|Overall Study|Withdrawal by Subject|2|||
105580212|NCT04011384|364124233|FG001|Overall Study|Withdrawal by Subject|0|||
105580213|NCT00688259|364124235|FG000|Overall Study|Lost to Follow-up|2|||
105580214|NCT00688259|364124236|FG001|Overall Study|Lost to Follow-up|4|||
105382003|NCT01107457|363403322|FG002|Part A|Withdrawal by Subject|0|||
105382004|NCT01107457|363403323|FG003|Part A|Withdrawal by Subject|3|||
105382005|NCT01107457|363403324|FG004|Part A|Withdrawal by Subject|1|||
105382006|NCT01107457|363403325|FG005|Part A|Withdrawal by Subject|0|||
105580215|NCT00688259|364124235|FG000|Overall Study|Physician Decision|1|||
105580216|NCT00688259|364124236|FG001|Overall Study|Physician Decision|0|||
105382007|NCT01107457|363403320|FG000|Part A|Lost to Follow-up|0|||
105382008|NCT01107457|363403321|FG001|Part A|Lost to Follow-up|1|||
105382009|NCT01107457|363403322|FG002|Part A|Lost to Follow-up|0|||
105382010|NCT01107457|363403323|FG003|Part A|Lost to Follow-up|0|||
105580217|NCT00688259|364124235|FG000|Overall Study|Withdrawal by Subject|2|||
105382011|NCT01107457|363403324|FG004|Part A|Lost to Follow-up|0|||
105382012|NCT01107457|363403325|FG005|Part A|Lost to Follow-up|0|||
105382013|NCT01107457|363403320|FG000|Part A|Lack of Efficacy|1|||
105382014|NCT01107457|363403321|FG001|Part A|Lack of Efficacy|0|||
105382015|NCT01107457|363403322|FG002|Part A|Lack of Efficacy|0|||
105382016|NCT01107457|363403323|FG003|Part A|Lack of Efficacy|0|||
105382017|NCT01107457|363403324|FG004|Part A|Lack of Efficacy|0|||
105382018|NCT01107457|363403325|FG005|Part A|Lack of Efficacy|0|||
105382019|NCT01107457|363403320|FG000|Part A|Protocol Violation|0|||
105382020|NCT01107457|363403321|FG001|Part A|Protocol Violation|1|||
105382021|NCT01107457|363403322|FG002|Part A|Protocol Violation|0|||
105382022|NCT01107457|363403323|FG003|Part A|Protocol Violation|0|||
105382023|NCT01107457|363403324|FG004|Part A|Protocol Violation|0|||
105382024|NCT01107457|363403325|FG005|Part A|Protocol Violation|0|||
105382025|NCT01107457|363403320|FG000|Part B and C|Adverse Event|0|||
105382026|NCT01107457|363403321|FG001|Part B and C|Adverse Event|0|||
105382027|NCT01107457|363403322|FG002|Part B and C|Adverse Event|0|||
105382028|NCT01107457|363403323|FG003|Part B and C|Adverse Event|0|||
105382029|NCT01107457|363403324|FG004|Part B and C|Adverse Event|0|||
105382030|NCT01107457|363403325|FG005|Part B and C|Adverse Event|12|||
105382031|NCT01107457|363403320|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
105382032|NCT01107457|363403321|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
105382033|NCT01107457|363403322|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
105382034|NCT01107457|363403323|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
105382035|NCT01107457|363403324|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
105382036|NCT01107457|363403325|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
105382037|NCT01107457|363403320|FG000|Part B and C|Physician Decision|0|||
105382038|NCT01107457|363403321|FG001|Part B and C|Physician Decision|0|||
105382039|NCT01107457|363403322|FG002|Part B and C|Physician Decision|0|||
105382040|NCT01107457|363403323|FG003|Part B and C|Physician Decision|0|||
105382041|NCT01107457|363403324|FG004|Part B and C|Physician Decision|0|||
105382042|NCT01107457|363403325|FG005|Part B and C|Physician Decision|3|||
105382043|NCT01107457|363403320|FG000|Part B and C|Lack of Efficacy|0|||
105382044|NCT01107457|363403321|FG001|Part B and C|Lack of Efficacy|0|||
105382045|NCT01107457|363403322|FG002|Part B and C|Lack of Efficacy|0|||
105382046|NCT01107457|363403323|FG003|Part B and C|Lack of Efficacy|0|||
105382047|NCT01107457|363403324|FG004|Part B and C|Lack of Efficacy|0|||
105382048|NCT01107457|363403325|FG005|Part B and C|Lack of Efficacy|7|||
105382049|NCT01107457|363403320|FG000|Part B and C|Lost to Follow-up|0|||
105382050|NCT01107457|363403321|FG001|Part B and C|Lost to Follow-up|0|||
105382051|NCT01107457|363403322|FG002|Part B and C|Lost to Follow-up|0|||
105382052|NCT01107457|363403323|FG003|Part B and C|Lost to Follow-up|0|||
105382053|NCT01107457|363403324|FG004|Part B and C|Lost to Follow-up|0|||
105382054|NCT01107457|363403325|FG005|Part B and C|Lost to Follow-up|10|||
105382055|NCT01107457|363403320|FG000|Part B and C|Protocol Violation|0|||
105382056|NCT01107457|363403321|FG001|Part B and C|Protocol Violation|0|||
105382057|NCT01107457|363403322|FG002|Part B and C|Protocol Violation|0|||
105382058|NCT01107457|363403323|FG003|Part B and C|Protocol Violation|0|||
105382059|NCT01107457|363403324|FG004|Part B and C|Protocol Violation|0|||
105382060|NCT01107457|363403325|FG005|Part B and C|Protocol Violation|1|||
105382061|NCT01107457|363403320|FG000|Part B and C|Sponsor Decision|0|||
105382062|NCT01107457|363403321|FG001|Part B and C|Sponsor Decision|0|||
105382063|NCT01107457|363403322|FG002|Part B and C|Sponsor Decision|0|||
105382064|NCT01107457|363403323|FG003|Part B and C|Sponsor Decision|0|||
105382065|NCT01107457|363403324|FG004|Part B and C|Sponsor Decision|0|||
105382066|NCT01107457|363403325|FG005|Part B and C|Sponsor Decision|66|||
105382067|NCT01107457|363403320|FG000|Part B and C|Withdrawal by Subject|0|||
105382068|NCT01107457|363403321|FG001|Part B and C|Withdrawal by Subject|0|||
105382069|NCT01107457|363403322|FG002|Part B and C|Withdrawal by Subject|0|||
105382070|NCT01107457|363403323|FG003|Part B and C|Withdrawal by Subject|0|||
105382071|NCT01107457|363403324|FG004|Part B and C|Withdrawal by Subject|0|||
105382072|NCT01107457|363403325|FG005|Part B and C|Withdrawal by Subject|16|||
105382073|NCT01107457|363403320|FG000|Part B and C|Clinical Relapse|0|||
105382074|NCT01107457|363403321|FG001|Part B and C|Clinical Relapse|0|||
105382075|NCT01107457|363403322|FG002|Part B and C|Clinical Relapse|0|||
105382076|NCT01107457|363403323|FG003|Part B and C|Clinical Relapse|0|||
105382077|NCT01107457|363403324|FG004|Part B and C|Clinical Relapse|0|||
105382078|NCT01107457|363403325|FG005|Part B and C|Clinical Relapse|4|||
105382079|NCT00105508|363403326|FG000|Overall Study|Prephase Dropout|1|||
105382080|NCT00105508|363403327|FG001|Overall Study|Prephase Dropout|0|||
105382081|NCT00105508|363403326|FG000|Overall Study|Adverse Event|16|||
105382082|NCT00105508|363403327|FG001|Overall Study|Adverse Event|19|||
105382083|NCT00105508|363403326|FG000|Overall Study|Insufficient Efficacy|1|||
105382084|NCT00105508|363403327|FG001|Overall Study|Insufficient Efficacy|0|||
105382085|NCT00105508|363403326|FG000|Overall Study|Withdrawal by Subject|10|||
105382086|NCT00105508|363403327|FG001|Overall Study|Withdrawal by Subject|6|||
105382087|NCT00105508|363403326|FG000|Overall Study|Lost to Follow-up|3|||
105382088|NCT00105508|363403327|FG001|Overall Study|Lost to Follow-up|0|||
105382089|NCT00105508|363403326|FG000|Overall Study|Protocol Violation|1|||
105382090|NCT00105508|363403327|FG001|Overall Study|Protocol Violation|2|||
105382091|NCT00105508|363403326|FG000|Overall Study|Other|8|||
105382092|NCT00105508|363403327|FG001|Overall Study|Other|9|||
105382093|NCT00086307|363403328|FG000|Overall Study|Lack of Efficacy|1|||
105382094|NCT00086307|363403329|FG001|Overall Study|Lack of Efficacy|1|||
105382095|NCT00086307|363403330|FG002|Overall Study|Lack of Efficacy|2|||
105382096|NCT00086307|363403328|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
105382097|NCT00086307|363403329|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
105382098|NCT00086307|363403330|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
105382099|NCT00086307|363403328|FG000|Overall Study|Nausea and headaches|0|||
105382100|NCT00086307|363403329|FG001|Overall Study|Nausea and headaches|0|||
105382101|NCT00086307|363403330|FG002|Overall Study|Nausea and headaches|1|||
105580218|NCT00688259|364124236|FG001|Overall Study|Withdrawal by Subject|0|||
105580219|NCT00688259|364124235|FG000|Overall Study|Declined Interview|2|||
105382102|NCT00086307|363403328|FG000|Overall Study|Constipation and sleepiness|0|||
105382103|NCT00086307|363403329|FG001|Overall Study|Constipation and sleepiness|0|||
105382104|NCT00086307|363403330|FG002|Overall Study|Constipation and sleepiness|1|||
105382105|NCT00086307|363403328|FG000|Overall Study|Suicidal ideation|0|||
105580220|NCT00688259|364124236|FG001|Overall Study|Declined Interview|3|||
105382106|NCT00086307|363403329|FG001|Overall Study|Suicidal ideation|0|||
105382107|NCT00086307|363403330|FG002|Overall Study|Suicidal ideation|1|||
105580221|NCT00688259|364124235|FG000|Overall Study|Hospitalized at Follow-up|0|||
105580222|NCT00688259|364124236|FG001|Overall Study|Hospitalized at Follow-up|1|||
105580223|NCT01310868|364124238|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
105580224|NCT04227340|364124239|FG000|Overall Study|Withdrawal by Subject|3|||
105580225|NCT02019602|364124244|FG000|Screening Period|Ineligibility|4|||
105382108|NCT00086307|363403328|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
105382109|NCT00086307|363403329|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
105382110|NCT00086307|363403330|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
105382111|NCT00086307|363403328|FG000|Overall Study|Withdrawal by Subject|0|||
105382112|NCT00086307|363403329|FG001|Overall Study|Withdrawal by Subject|0|||
105382113|NCT00086307|363403330|FG002|Overall Study|Withdrawal by Subject|2|||
105382114|NCT00003474|363403331|FG000|Overall Study|Not Evaluable|14|||
105382115|NCT01937117|363403336|FG000|Overall Study|Disease Progression|7|||
105382116|NCT01937117|363403336|FG000|Overall Study|Physician Decision|4|||
105382117|NCT01937117|363403336|FG000|Overall Study|Adverse Event|2|||
105382118|NCT03738215|363403337|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
105382119|NCT03738215|363403338|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
105382120|NCT03738215|363403339|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
105382121|NCT03738215|363403337|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
105382122|NCT03738215|363403338|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
105382123|NCT03738215|363403339|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
105382124|NCT03738215|363403337|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
105382125|NCT03738215|363403338|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
105382126|NCT03738215|363403339|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
105382127|NCT03738215|363403337|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
105382128|NCT03738215|363403338|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
105382129|NCT03738215|363403339|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
105382130|NCT03738215|363403337|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
105382131|NCT03738215|363403338|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
105382132|NCT03738215|363403339|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
105382133|NCT03738215|363403337|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
105382134|NCT03738215|363403338|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
105382135|NCT03738215|363403339|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
105382136|NCT03738215|363403337|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
105382137|NCT03738215|363403338|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
105382138|NCT03738215|363403339|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
105382139|NCT03738215|363403337|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
105382140|NCT03738215|363403338|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
105382141|NCT03738215|363403339|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
105382142|NCT03738215|363403337|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
105382143|NCT03738215|363403338|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
105382144|NCT03738215|363403339|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
105382145|NCT03738215|363403337|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
105382146|NCT03738215|363403338|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
105382147|NCT03738215|363403339|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
105382148|NCT00853047|363403340|FG000|Core Phase|Participant Request|0|||
105382149|NCT00853047|363403341|FG001|Core Phase|Participant Request|0|||
105580226|NCT02019602|364124245|FG001|Screening Period|Ineligibility|0|||
105382150|NCT00853047|363403342|FG002|Core Phase|Participant Request|0|||
105382151|NCT00853047|363403343|FG003|Core Phase|Participant Request|1|||
105382152|NCT00853047|363403344|FG004|Core Phase|Participant Request|0|||
105382153|NCT00853047|363403345|FG005|Core Phase|Participant Request|0|||
105382154|NCT00853047|363403340|FG000|Open-Label Extension Phase|Participant Request|0|||
105382155|NCT00853047|363403341|FG001|Open-Label Extension Phase|Participant Request|0|||
105382156|NCT00853047|363403342|FG002|Open-Label Extension Phase|Participant Request|0|||
105382157|NCT00853047|363403343|FG003|Open-Label Extension Phase|Participant Request|0|||
105382158|NCT00853047|363403344|FG004|Open-Label Extension Phase|Participant Request|0|||
105382159|NCT00853047|363403345|FG005|Open-Label Extension Phase|Participant Request|7|||
105382160|NCT00853047|363403340|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
105382161|NCT00853047|363403341|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
105382162|NCT00853047|363403342|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
105382163|NCT00853047|363403343|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
105382164|NCT00853047|363403344|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
105580227|NCT02019602|364124244|FG000|Screening Period|Adverse Event|1|||
105382165|NCT00853047|363403345|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
105382166|NCT00853047|363403340|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
105382167|NCT00853047|363403341|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
105382168|NCT00853047|363403342|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
105382169|NCT00853047|363403343|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
105382170|NCT00853047|363403344|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
105382171|NCT00853047|363403345|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
105382172|NCT00853047|363403340|FG000|Open-Label Extension Phase|Investigator Decision|0|||
105382173|NCT00853047|363403341|FG001|Open-Label Extension Phase|Investigator Decision|0|||
105382174|NCT00853047|363403342|FG002|Open-Label Extension Phase|Investigator Decision|0|||
105382175|NCT00853047|363403343|FG003|Open-Label Extension Phase|Investigator Decision|0|||
105382176|NCT00853047|363403344|FG004|Open-Label Extension Phase|Investigator Decision|0|||
105382177|NCT00853047|363403345|FG005|Open-Label Extension Phase|Investigator Decision|1|||
105382178|NCT00853047|363403340|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
105382179|NCT00853047|363403341|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
105382180|NCT00853047|363403342|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
105382181|NCT00853047|363403343|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
105382182|NCT00853047|363403344|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
105382183|NCT00853047|363403345|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
105382184|NCT03695094|363405745|FG000|Overall Study|Adverse Event|1|||
105382185|NCT03695094|363405746|FG001|Overall Study|Adverse Event|1|||
105382186|NCT03695094|363405745|FG000|Overall Study|Withdrawal by Subject|1|||
105382187|NCT03695094|363405746|FG001|Overall Study|Withdrawal by Subject|0|||
105382188|NCT03520569|363405751|FG000|Overall Study|Withdrawal by Subject|1|||
105382189|NCT00422461|363405754|FG000|Overall Study|Adverse Event|1|||
105382190|NCT00422461|363405755|FG001|Overall Study|Adverse Event|2|||
105382191|NCT00422461|363405756|FG002|Overall Study|Adverse Event|1|||
105382192|NCT00422461|363405757|FG003|Overall Study|Adverse Event|1|||
105382193|NCT00422461|363405754|FG000|Overall Study|Other|0|||
105382194|NCT00422461|363405755|FG001|Overall Study|Other|0|||
105382195|NCT00422461|363405756|FG002|Overall Study|Other|0|||
105382196|NCT00422461|363405757|FG003|Overall Study|Other|2|||
105382197|NCT00422461|363405754|FG000|Overall Study|Participants no longer willing to participate in study|1|||
105382198|NCT00422461|363405755|FG001|Overall Study|Participants no longer willing to participate in study|0|||
105382199|NCT00422461|363405756|FG002|Overall Study|Participants no longer willing to participate in study|0|||
105492351|NCT01925274|363815727|FG000|Overall Study|Death|1|||
105382200|NCT00422461|363405757|FG003|Overall Study|Participants no longer willing to participate in study|0|||
105382201|NCT00422461|363405754|FG000|Overall Study|Randomized but not treated|1|||
105382202|NCT00422461|363405755|FG001|Overall Study|Randomized but not treated|1|||
105382203|NCT00422461|363405756|FG002|Overall Study|Randomized but not treated|0|||
105382204|NCT00422461|363405757|FG003|Overall Study|Randomized but not treated|0|||
105382205|NCT01795937|363405760|FG000|Overall Study|Withdrawal by Subject|1|||
105382206|NCT01795937|363405761|FG001|Overall Study|Withdrawal by Subject|0|||
105382207|NCT01795937|363405762|FG002|Overall Study|Withdrawal by Subject|0|||
105382208|NCT01795937|363405760|FG000|Overall Study|Physician Decision|0|||
105382209|NCT01795937|363405761|FG001|Overall Study|Physician Decision|1|||
105382210|NCT01795937|363405762|FG002|Overall Study|Physician Decision|0|||
105382211|NCT01028053|363405763|FG000|Overall Study|Screen Failure|113|||
105492352|NCT01925274|363815728|FG001|Overall Study|Death|0|||
105580228|NCT02019602|364124245|FG001|Screening Period|Adverse Event|0|||
105382212|NCT01028053|363405763|FG000|Overall Study|Patient Request|11|||
105382213|NCT01028053|363405763|FG000|Overall Study|Protocol Violation|1|||
105382214|NCT01028053|363405763|FG000|Overall Study|Physician Decision|2|||
105382215|NCT01028053|363405763|FG000|Overall Study|Technical Problem|1|||
105382216|NCT01028053|363405763|FG000|Overall Study|Terminated by Sponsor|1|||
105382217|NCT01028053|363405763|FG000|Overall Study|Various reasons|4|||
105382218|NCT03315689|363405764|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
105382219|NCT03315689|363405765|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
105382220|NCT03315689|363405764|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
105382221|NCT03315689|363405765|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
105382222|NCT03315689|363405764|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
105382223|NCT03315689|363405765|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
105382224|NCT00864513|363405766|FG000|Overall Study|Withdrawal by Subject|3|||
105492353|NCT01925274|363815729|FG002|Overall Study|Death|0|||
105492354|NCT01925274|363815727|FG000|Overall Study|Lost to Follow-up|0|||
105382225|NCT00762788|363405767|FG000|Overall Study|Lost to Follow-up|26|||
105382226|NCT00762788|363405768|FG001|Overall Study|Lost to Follow-up|37|||
105382227|NCT00762788|363405769|FG002|Overall Study|Lost to Follow-up|21|||
105382228|NCT00762788|363405770|FG003|Overall Study|Lost to Follow-up|26|||
105382229|NCT00762788|363405771|FG004|Overall Study|Lost to Follow-up|13|||
105382230|NCT00762788|363405772|FG005|Overall Study|Lost to Follow-up|21|||
105382231|NCT03073109|363405773|FG000|Overall Study|Adverse Event|0|||
105382232|NCT03073109|363405774|FG001|Overall Study|Adverse Event|1|||
105382233|NCT03073109|363405773|FG000|Overall Study|Other|2|||
105382234|NCT03073109|363405774|FG001|Overall Study|Other|0|||
105382235|NCT03073109|363405773|FG000|Overall Study|Lost to Follow-up|8|||
105382236|NCT03073109|363405774|FG001|Overall Study|Lost to Follow-up|1|||
105382237|NCT00669331|363405775|FG000|Randomisation to First Dose|Adverse Event|1|||
105382238|NCT00669331|363405776|FG001|Randomisation to First Dose|Adverse Event|0|||
105492355|NCT01925274|363815728|FG001|Overall Study|Lost to Follow-up|1|||
105492356|NCT01925274|363815729|FG002|Overall Study|Lost to Follow-up|0|||
105492357|NCT01925274|363815727|FG000|Overall Study|Withdrawal by Subject|1|||
105382239|NCT00669331|363405775|FG000|Randomisation to First Dose|Protocol Violation|1|||
105492358|NCT01925274|363815728|FG001|Overall Study|Withdrawal by Subject|2|||
105492359|NCT01925274|363815729|FG002|Overall Study|Withdrawal by Subject|0|||
105382240|NCT00669331|363405776|FG001|Randomisation to First Dose|Protocol Violation|0|||
105382241|NCT00669331|363405775|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
105382242|NCT00669331|363405776|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
105382243|NCT00669331|363405775|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
105382244|NCT00669331|363405776|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
105382245|NCT00669331|363405775|FG000|Randomisation to First Dose|Death|1|||
105382246|NCT00669331|363405776|FG001|Randomisation to First Dose|Death|0|||
105382247|NCT00669331|363405775|FG000|Randomisation to First Dose|Sponsor decision|0|||
105382248|NCT00669331|363405776|FG001|Randomisation to First Dose|Sponsor decision|1|||
105382249|NCT00669331|363405775|FG000|Randomisation to First Dose|Randomised in error|3|||
105382250|NCT00669331|363405776|FG001|Randomisation to First Dose|Randomised in error|10|||
105382251|NCT00669331|363405775|FG000|Blinded Treatment Period|Adverse Event|16|||
105382252|NCT00669331|363405776|FG001|Blinded Treatment Period|Adverse Event|10|||
105382253|NCT00669331|363405775|FG000|Blinded Treatment Period|Protocol Violation|1|||
105382254|NCT00669331|363405776|FG001|Blinded Treatment Period|Protocol Violation|1|||
105382255|NCT00669331|363405775|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
105382256|NCT00669331|363405776|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
105382257|NCT00669331|363405775|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
105382258|NCT00669331|363405776|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
105382259|NCT00669331|363405775|FG000|Blinded Treatment Period|Death|0|||
105382260|NCT00669331|363405776|FG001|Blinded Treatment Period|Death|2|||
105382261|NCT00669331|363405775|FG000|Blinded Treatment Period|Physician Decision|3|||
105382262|NCT00669331|363405776|FG001|Blinded Treatment Period|Physician Decision|3|||
105382263|NCT00669331|363405775|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
105382264|NCT00669331|363405776|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
105382265|NCT00471354|363405779|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
105382266|NCT00471354|363405779|FG000|Overall Study|Adverse Event|13|||
105382267|NCT00471354|363405779|FG000|Overall Study|Protocol Violation|12|||
105382268|NCT00471354|363405779|FG000|Overall Study|Withdrawal by Subject|1|||
105382269|NCT00471354|363405779|FG000|Overall Study|Physician Decision|4|||
105382270|NCT00471354|363405779|FG000|Overall Study|Sponsor Decision|1|||
105382271|NCT00471354|363405779|FG000|Overall Study|Lost to Follow-up|3|||
105382272|NCT00471354|363405779|FG000|Overall Study|Lack of Efficacy|5|||
105382273|NCT00471354|363405779|FG000|Overall Study|Patient/Caregiver Decision|12|||
105382274|NCT03558672|363405780|FG000|Overall Study|Study Early Termination|10|||
105382275|NCT00983957|363405781|FG000|Overall Study|Adverse Event|1|||
105382276|NCT00983957|363405781|FG000|Overall Study|Personal Reasons|1|||
105382277|NCT01027416|363405786|FG000|Overall Study|Withdrawal by Subject|0|||
105382278|NCT01027416|363405787|FG001|Overall Study|Withdrawal by Subject|1|||
105382279|NCT01027416|363405786|FG000|Overall Study|Physician Decision|1|||
105382280|NCT01027416|363405787|FG001|Overall Study|Physician Decision|4|||
105382281|NCT00790933|363405788|FG000|Overall Study|Adverse Event|94|||
105382282|NCT00790933|363405789|FG001|Overall Study|Adverse Event|119|||
105382283|NCT00790933|363405790|FG002|Overall Study|Adverse Event|65|||
105382284|NCT00790933|363405791|FG003|Overall Study|Adverse Event|5|||
105382285|NCT00790933|363405792|FG004|Overall Study|Adverse Event|69|||
105382286|NCT00790933|363405788|FG000|Overall Study|Protocol Violation(s)|8|||
105382287|NCT00790933|363405789|FG001|Overall Study|Protocol Violation(s)|18|||
105382288|NCT00790933|363405790|FG002|Overall Study|Protocol Violation(s)|7|||
105382289|NCT00790933|363405791|FG003|Overall Study|Protocol Violation(s)|0|||
105382290|NCT00790933|363405792|FG004|Overall Study|Protocol Violation(s)|12|||
105382291|NCT00790933|363405788|FG000|Overall Study|Lack of Efficacy|192|||
105382292|NCT00790933|363405789|FG001|Overall Study|Lack of Efficacy|176|||
105382293|NCT00790933|363405790|FG002|Overall Study|Lack of Efficacy|130|||
105382294|NCT00790933|363405791|FG003|Overall Study|Lack of Efficacy|1|||
105382295|NCT00790933|363405792|FG004|Overall Study|Lack of Efficacy|121|||
105382296|NCT00790933|363405788|FG000|Overall Study|Study Terminated by Sponsor|0|||
105382297|NCT00790933|363405789|FG001|Overall Study|Study Terminated by Sponsor|0|||
105382298|NCT00790933|363405790|FG002|Overall Study|Study Terminated by Sponsor|1|||
105382299|NCT00790933|363405791|FG003|Overall Study|Study Terminated by Sponsor|0|||
105382300|NCT00790933|363405792|FG004|Overall Study|Study Terminated by Sponsor|0|||
105382301|NCT00790933|363405788|FG000|Overall Study|Withdrawal by Subject|123|||
105382302|NCT00790933|363405789|FG001|Overall Study|Withdrawal by Subject|120|||
105382303|NCT00790933|363405790|FG002|Overall Study|Withdrawal by Subject|52|||
105382304|NCT00790933|363405791|FG003|Overall Study|Withdrawal by Subject|6|||
105382305|NCT00790933|363405792|FG004|Overall Study|Withdrawal by Subject|50|||
105382306|NCT00790933|363405788|FG000|Overall Study|Lost to Follow-up|13|||
105382307|NCT00790933|363405789|FG001|Overall Study|Lost to Follow-up|31|||
105382308|NCT00790933|363405790|FG002|Overall Study|Lost to Follow-up|10|||
105382309|NCT00790933|363405791|FG003|Overall Study|Lost to Follow-up|1|||
105382310|NCT00790933|363405792|FG004|Overall Study|Lost to Follow-up|15|||
105382311|NCT00790933|363405788|FG000|Overall Study|Reason Not Specified|8|||
105382312|NCT00790933|363405789|FG001|Overall Study|Reason Not Specified|16|||
105382313|NCT00790933|363405790|FG002|Overall Study|Reason Not Specified|4|||
105382314|NCT00790933|363405791|FG003|Overall Study|Reason Not Specified|1|||
105382315|NCT00790933|363405792|FG004|Overall Study|Reason Not Specified|9|||
105382316|NCT00676052|363405793|FG000|Overall Study|Adverse Event|0|||
105382317|NCT00676052|363405794|FG001|Overall Study|Adverse Event|1|||
105382318|NCT00676052|363405795|FG002|Overall Study|Adverse Event|1|||
105382319|NCT00676052|363405796|FG003|Overall Study|Adverse Event|2|||
105382320|NCT00676052|363405797|FG004|Overall Study|Adverse Event|2|||
105382321|NCT00676052|363405798|FG005|Overall Study|Adverse Event|2|||
105382322|NCT00676052|363405793|FG000|Overall Study|Lack of Efficacy|2|||
105382323|NCT00676052|363405794|FG001|Overall Study|Lack of Efficacy|2|||
105382324|NCT00676052|363405795|FG002|Overall Study|Lack of Efficacy|1|||
105382325|NCT00676052|363405796|FG003|Overall Study|Lack of Efficacy|1|||
105382326|NCT00676052|363405797|FG004|Overall Study|Lack of Efficacy|2|||
105382327|NCT00676052|363405798|FG005|Overall Study|Lack of Efficacy|1|||
105382328|NCT00676052|363405793|FG000|Overall Study|Protocol Violation|5|||
105382329|NCT00676052|363405794|FG001|Overall Study|Protocol Violation|3|||
105382330|NCT00676052|363405795|FG002|Overall Study|Protocol Violation|2|||
105382331|NCT00676052|363405796|FG003|Overall Study|Protocol Violation|2|||
105382332|NCT00676052|363405797|FG004|Overall Study|Protocol Violation|1|||
105382333|NCT00676052|363405798|FG005|Overall Study|Protocol Violation|2|||
105382334|NCT00676052|363405793|FG000|Overall Study|Lost to Follow-up|0|||
105382335|NCT00676052|363405794|FG001|Overall Study|Lost to Follow-up|0|||
105382336|NCT00676052|363405795|FG002|Overall Study|Lost to Follow-up|0|||
105382337|NCT00676052|363405796|FG003|Overall Study|Lost to Follow-up|0|||
105382338|NCT00676052|363405797|FG004|Overall Study|Lost to Follow-up|1|||
105382339|NCT00676052|363405798|FG005|Overall Study|Lost to Follow-up|0|||
105382340|NCT00676052|363405793|FG000|Overall Study|Physician Decision|1|||
105382341|NCT00676052|363405794|FG001|Overall Study|Physician Decision|1|||
105382342|NCT00676052|363405795|FG002|Overall Study|Physician Decision|1|||
105382343|NCT00676052|363405796|FG003|Overall Study|Physician Decision|0|||
105382344|NCT00676052|363405797|FG004|Overall Study|Physician Decision|0|||
105382345|NCT00676052|363405798|FG005|Overall Study|Physician Decision|1|||
105382346|NCT00676052|363405793|FG000|Overall Study|Withdrawal by Subject|1|||
105382347|NCT00676052|363405794|FG001|Overall Study|Withdrawal by Subject|0|||
105382348|NCT00676052|363405795|FG002|Overall Study|Withdrawal by Subject|1|||
105382349|NCT00676052|363405796|FG003|Overall Study|Withdrawal by Subject|0|||
105382350|NCT00676052|363405797|FG004|Overall Study|Withdrawal by Subject|0|||
105382351|NCT00676052|363405798|FG005|Overall Study|Withdrawal by Subject|0|||
105382352|NCT01829165|363405807|FG000|Overall Study|Did not complete intervention|2|||
105382353|NCT01829165|363405808|FG001|Overall Study|Did not complete intervention|0|||
105382354|NCT00965094|363405816|FG000|Overall Study|Adverse Event|5|||
105382355|NCT00965094|363405817|FG001|Overall Study|Adverse Event|0|||
105382356|NCT00965094|363405816|FG000|Overall Study|Lost to Follow-up|0|||
105382357|NCT00965094|363405817|FG001|Overall Study|Lost to Follow-up|1|||
105382358|NCT01441414|363405818|FG000|Overall Study|Participant died|9|||
105382359|NCT01441414|363405818|FG000|Overall Study|Other reasons|3|||
105382360|NCT01441414|363405818|FG000|Overall Study|Study terminated by sponsor|2|||
105382361|NCT01441414|363405818|FG000|Overall Study|Subject refused further follow-up|1|||
105382362|NCT01814332|363405821|FG000|Overall Study|Adverse Event|8|||
105382363|NCT01814332|363405822|FG001|Overall Study|Adverse Event|3|||
105382364|NCT01814332|363405821|FG000|Overall Study|Withdrawal by Subject|3|||
105382365|NCT01814332|363405822|FG001|Overall Study|Withdrawal by Subject|8|||
105382366|NCT01814332|363405821|FG000|Overall Study|Protocol Violation|0|||
105382367|NCT01814332|363405822|FG001|Overall Study|Protocol Violation|4|||
105382368|NCT01814332|363405821|FG000|Overall Study|Lost to Follow-up|5|||
105382369|NCT01814332|363405822|FG001|Overall Study|Lost to Follow-up|1|||
105382370|NCT02061592|363405823|FG000|Period 1|Withdrawal by Subject|1|||
105382371|NCT02061592|363405824|FG001|Period 1|Withdrawal by Subject|0|||
105382372|NCT02061592|363405823|FG000|Period 1|Protocol Violation|1|||
105382373|NCT02061592|363405824|FG001|Period 1|Protocol Violation|0|||
105382374|NCT02061592|363405823|FG000|Period 2|Lost to Follow-up|0|||
105382375|NCT02061592|363405824|FG001|Period 2|Lost to Follow-up|1|||
105382376|NCT00888849|363405825|FG000|Overall Study|Death|4|||
105492360|NCT01925274|363815727|FG000|Overall Study|Study terminated by sponsor|4|||
105382377|NCT00888849|363405826|FG001|Overall Study|Death|7|||
105382378|NCT00888849|363405825|FG000|Overall Study|Lost to Follow-up|1|||
105382379|NCT00888849|363405826|FG001|Overall Study|Lost to Follow-up|2|||
105382380|NCT02583477|363405828|FG000|Overall Study|Adverse Event|0|||
105382381|NCT02583477|363405829|FG001|Overall Study|Adverse Event|2|||
105382382|NCT02583477|363405828|FG000|Overall Study|Death|1|||
105382383|NCT02583477|363405829|FG001|Overall Study|Death|16|||
105382384|NCT02583477|363405828|FG000|Overall Study|Study terminated|2|||
105382385|NCT02583477|363405829|FG001|Overall Study|Study terminated|2|||
105382386|NCT04243837|363405835|FG000|Overall Study|Adverse Event|2|||
105382387|NCT04243837|363405836|FG001|Overall Study|Adverse Event|1|||
105382388|NCT04243837|363405835|FG000|Overall Study|Withdrawal by Subject|4|||
105382389|NCT04243837|363405836|FG001|Overall Study|Withdrawal by Subject|2|||
105382390|NCT04243837|363405835|FG000|Overall Study|Covid-19 lock down|1|||
105382391|NCT04243837|363405836|FG001|Overall Study|Covid-19 lock down|0|||
105492361|NCT01925274|363815728|FG001|Overall Study|Study terminated by sponsor|0|||
105492362|NCT01925274|363815729|FG002|Overall Study|Study terminated by sponsor|0|||
105492363|NCT01925274|363815727|FG000|Overall Study|Protocol amendment|1|||
105492364|NCT01925274|363815728|FG001|Overall Study|Protocol amendment|3|||
105492365|NCT01925274|363815729|FG002|Overall Study|Protocol amendment|6|||
105492366|NCT04327674|363815730|FG000|Overall Study|Protocol Violation|19|||
105382392|NCT04243837|363405835|FG000|Overall Study|Study Terminated by Sponsor|11|||
105382393|NCT04243837|363405836|FG001|Overall Study|Study Terminated by Sponsor|12|||
105382394|NCT01873833|363405839|FG000|Overall Study|Withdrawal by Subject|1|||
105382395|NCT00356421|363405842|FG000|Overall Study|Lack of Efficacy|3|||
105382396|NCT00356421|363405843|FG001|Overall Study|Lack of Efficacy|0|||
105382397|NCT00356421|363405842|FG000|Overall Study|Withdrawal by Subject|9|||
105382398|NCT00356421|363405843|FG001|Overall Study|Withdrawal by Subject|2|||
105382399|NCT00356421|363405842|FG000|Overall Study|Related to study drug|15|||
105382400|NCT00356421|363405843|FG001|Overall Study|Related to study drug|12|||
105382401|NCT00356421|363405842|FG000|Overall Study|Not related to study drug|5|||
105382402|NCT00356421|363405843|FG001|Overall Study|Not related to study drug|3|||
105382403|NCT00501085|363405844|FG000|Overall Study|Lost to Follow-up|195|||
105382404|NCT00501085|363405844|FG000|Overall Study|Withdrawal by Subject|34|||
105382405|NCT00501085|363405844|FG000|Overall Study|Subject Decision|1|||
105382406|NCT00501085|363405844|FG000|Overall Study|Revision Surgery|7|||
105382407|NCT00501085|363405844|FG000|Overall Study|Explantation Surgery|26|||
105382408|NCT00501085|363405844|FG000|Overall Study|Adverse Event|4|||
105382409|NCT00501085|363405844|FG000|Overall Study|Non-Compliance|24|||
105580229|NCT01083160|364124246|FG000|Overall Study|Adverse Event|1|||
105580230|NCT00918749|364124247|FG000|Overall Study|Adverse Event|1|||
105580231|NCT00918749|364124248|FG001|Overall Study|Adverse Event|0|||
105580232|NCT00918749|364124249|FG002|Overall Study|Adverse Event|1|||
105580233|NCT00918749|364124247|FG000|Overall Study|Lost to Follow-up|0|||
105580234|NCT00918749|364124248|FG001|Overall Study|Lost to Follow-up|0|||
105580235|NCT00918749|364124249|FG002|Overall Study|Lost to Follow-up|1|||
105580236|NCT00918749|364124247|FG000|Overall Study|Withdrawal by Subject|5|||
105580237|NCT00918749|364124248|FG001|Overall Study|Withdrawal by Subject|3|||
105382410|NCT00501085|363405844|FG000|Overall Study|Study closed by sponsor|109|||
105382411|NCT00501085|363405844|FG000|Overall Study|Other loss to follow-up|32|||
105382412|NCT00887588|363405845|FG000|Core Period|Death|1|||
105382413|NCT00887588|363405846|FG001|Core Period|Death|1|||
105382414|NCT00887588|363405845|FG000|Core Period|Lost to Follow-up|3|||
105382415|NCT00887588|363405846|FG001|Core Period|Lost to Follow-up|1|||
105382416|NCT00887588|363405845|FG000|Core Period|Withdrawal by Subject|6|||
105382417|NCT00887588|363405846|FG001|Core Period|Withdrawal by Subject|8|||
105382418|NCT00887588|363405845|FG000|Core Period|Adverse Event|9|||
105382419|NCT00887588|363405846|FG001|Core Period|Adverse Event|11|||
105382420|NCT00887588|363405845|FG000|Extension Period|Adverse Event|4|||
105382421|NCT00887588|363405846|FG001|Extension Period|Adverse Event|4|||
105382422|NCT00887588|363405845|FG000|Extension Period|Death|0|||
105382423|NCT00887588|363405846|FG001|Extension Period|Death|1|||
105382424|NCT00887588|363405845|FG000|Extension Period|Protocol deviation|1|||
105382425|NCT00887588|363405846|FG001|Extension Period|Protocol deviation|0|||
105382426|NCT00887588|363405845|FG000|Extension Period|Lost to Follow-up|1|||
105382427|NCT00887588|363405846|FG001|Extension Period|Lost to Follow-up|0|||
105580238|NCT00918749|364124249|FG002|Overall Study|Withdrawal by Subject|5|||
105580239|NCT00918749|364124247|FG000|Overall Study|No Study Medication Taken|1|||
105382430|NCT04913675|363405849|FG000|Main Study (Up to Week 36)|Death|0|||
105382431|NCT04913675|363405850|FG001|Main Study (Up to Week 36)|Death|2|||
105382432|NCT04913675|363405851|FG002|Main Study (Up to Week 36)|Death|2|||
105382433|NCT04913675|363405852|FG003|Main Study (Up to Week 36)|Death|0|||
105382434|NCT04913675|363405849|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
105382435|NCT04913675|363405850|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
105382436|NCT04913675|363405851|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
105382437|NCT04913675|363405852|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
105382438|NCT04913675|363405849|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
105382439|NCT04913675|363405850|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
105382440|NCT04913675|363405851|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
105382441|NCT04913675|363405852|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
105382442|NCT04913675|363405849|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
105382443|NCT04913675|363405850|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
105382444|NCT04913675|363405851|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
105580240|NCT00918749|364124248|FG001|Overall Study|No Study Medication Taken|0|||
105580241|NCT00918749|364124249|FG002|Overall Study|No Study Medication Taken|0|||
105580242|NCT01712789|364124250|FG000|Overall Study|Lack of Efficacy|2|||
105580243|NCT01712789|364124250|FG000|Overall Study|Lost to Follow-up|1|||
105382445|NCT04913675|363405852|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
105382446|NCT04913675|363405849|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
105580244|NCT01712789|364124250|FG000|Overall Study|Progressive Disease|504|||
105382447|NCT04913675|363405850|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
105382448|NCT04913675|363405851|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
105382449|NCT04913675|363405852|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
105382450|NCT04518410|363405853|FG000|Overall Study|Lost to Follow-up|1|||
105382451|NCT04518410|363405854|FG001|Overall Study|Lost to Follow-up|1|||
105382452|NCT04518410|363405855|FG002|Overall Study|Lost to Follow-up|8|||
105382453|NCT04518410|363405856|FG003|Overall Study|Lost to Follow-up|5|||
105382454|NCT04518410|363405857|FG004|Overall Study|Lost to Follow-up|92|||
105382455|NCT04518410|363405858|FG005|Overall Study|Lost to Follow-up|25|||
105382456|NCT04518410|363405859|FG006|Overall Study|Lost to Follow-up|25|||
105382457|NCT04518410|363405860|FG007|Overall Study|Lost to Follow-up|3|||
105382458|NCT04518410|363405861|FG008|Overall Study|Lost to Follow-up|2|||
105382459|NCT04518410|363405862|FG009|Overall Study|Lost to Follow-up|13|||
105382460|NCT04518410|363405863|FG010|Overall Study|Lost to Follow-up|9|||
105382461|NCT04518410|363405864|FG011|Overall Study|Lost to Follow-up|13|||
105382462|NCT04518410|363405865|FG012|Overall Study|Lost to Follow-up|9|||
105382463|NCT04518410|363405866|FG013|Overall Study|Lost to Follow-up|13|||
105382464|NCT04518410|363405867|FG014|Overall Study|Lost to Follow-up|8|||
105382465|NCT04518410|363405868|FG015|Overall Study|Lost to Follow-up|10|||
105382466|NCT04518410|363405869|FG016|Overall Study|Lost to Follow-up|6|||
105382467|NCT04518410|363405870|FG017|Overall Study|Lost to Follow-up|13|||
105382468|NCT04518410|363405871|FG018|Overall Study|Lost to Follow-up|21|||
105382469|NCT04518410|363405872|FG019|Overall Study|Lost to Follow-up|6|||
105382470|NCT04518410|363405873|FG020|Overall Study|Lost to Follow-up|7|||
105382471|NCT04518410|363405874|FG021|Overall Study|Lost to Follow-up|21|||
105382472|NCT04518410|363405875|FG022|Overall Study|Lost to Follow-up|1|||
105382473|NCT04518410|363405876|FG023|Overall Study|Lost to Follow-up|7|||
105382474|NCT04518410|363405877|FG024|Overall Study|Lost to Follow-up|6|||
105382475|NCT04518410|363405853|FG000|Overall Study|Withdrawal by Subject|1|||
105382476|NCT04518410|363405854|FG001|Overall Study|Withdrawal by Subject|2|||
105382477|NCT04518410|363405855|FG002|Overall Study|Withdrawal by Subject|2|||
105382478|NCT04518410|363405856|FG003|Overall Study|Withdrawal by Subject|3|||
105382479|NCT04518410|363405857|FG004|Overall Study|Withdrawal by Subject|20|||
105382480|NCT04518410|363405858|FG005|Overall Study|Withdrawal by Subject|20|||
105382481|NCT04518410|363405859|FG006|Overall Study|Withdrawal by Subject|25|||
105382482|NCT04518410|363405860|FG007|Overall Study|Withdrawal by Subject|6|||
105382483|NCT04518410|363405861|FG008|Overall Study|Withdrawal by Subject|1|||
105382484|NCT04518410|363405862|FG009|Overall Study|Withdrawal by Subject|12|||
105382485|NCT04518410|363405863|FG010|Overall Study|Withdrawal by Subject|5|||
105382486|NCT04518410|363405864|FG011|Overall Study|Withdrawal by Subject|7|||
105382487|NCT04518410|363405865|FG012|Overall Study|Withdrawal by Subject|2|||
105382488|NCT04518410|363405866|FG013|Overall Study|Withdrawal by Subject|13|||
105382489|NCT04518410|363405867|FG014|Overall Study|Withdrawal by Subject|4|||
105382490|NCT04518410|363405868|FG015|Overall Study|Withdrawal by Subject|9|||
105382491|NCT04518410|363405869|FG016|Overall Study|Withdrawal by Subject|0|||
105382492|NCT04518410|363405870|FG017|Overall Study|Withdrawal by Subject|15|||
105382493|NCT04518410|363405871|FG018|Overall Study|Withdrawal by Subject|12|||
105382494|NCT04518410|363405872|FG019|Overall Study|Withdrawal by Subject|9|||
105382495|NCT04518410|363405873|FG020|Overall Study|Withdrawal by Subject|14|||
105382496|NCT04518410|363405874|FG021|Overall Study|Withdrawal by Subject|3|||
105382497|NCT04518410|363405875|FG022|Overall Study|Withdrawal by Subject|2|||
105382498|NCT04518410|363405876|FG023|Overall Study|Withdrawal by Subject|9|||
105382499|NCT04518410|363405877|FG024|Overall Study|Withdrawal by Subject|8|||
105382500|NCT04518410|363405853|FG000|Overall Study|Other|1|||
105382501|NCT04518410|363405854|FG001|Overall Study|Other|0|||
105382502|NCT04518410|363405855|FG002|Overall Study|Other|0|||
105382503|NCT04518410|363405856|FG003|Overall Study|Other|1|||
105382504|NCT04518410|363405857|FG004|Overall Study|Other|6|||
105382505|NCT04518410|363405858|FG005|Overall Study|Other|6|||
105382506|NCT04518410|363405859|FG006|Overall Study|Other|5|||
105382507|NCT04518410|363405860|FG007|Overall Study|Other|2|||
105382508|NCT04518410|363405861|FG008|Overall Study|Other|0|||
105382509|NCT04518410|363405862|FG009|Overall Study|Other|1|||
105382510|NCT04518410|363405863|FG010|Overall Study|Other|0|||
105382511|NCT04518410|363405864|FG011|Overall Study|Other|2|||
105382512|NCT04518410|363405865|FG012|Overall Study|Other|0|||
105382513|NCT04518410|363405866|FG013|Overall Study|Other|0|||
105382514|NCT04518410|363405867|FG014|Overall Study|Other|0|||
105382515|NCT04518410|363405868|FG015|Overall Study|Other|3|||
105382516|NCT04518410|363405869|FG016|Overall Study|Other|1|||
105382517|NCT04518410|363405870|FG017|Overall Study|Other|1|||
105382518|NCT04518410|363405871|FG018|Overall Study|Other|1|||
105382519|NCT04518410|363405872|FG019|Overall Study|Other|0|||
105382520|NCT04518410|363405873|FG020|Overall Study|Other|1|||
105382521|NCT04518410|363405874|FG021|Overall Study|Other|0|||
105382522|NCT04518410|363405875|FG022|Overall Study|Other|1|||
105382523|NCT04518410|363405876|FG023|Overall Study|Other|2|||
105382524|NCT04518410|363405877|FG024|Overall Study|Other|2|||
105382525|NCT04518410|363405853|FG000|Overall Study|Protocol Violation|0|||
105382526|NCT04518410|363405854|FG001|Overall Study|Protocol Violation|0|||
105382527|NCT04518410|363405855|FG002|Overall Study|Protocol Violation|0|||
105382528|NCT04518410|363405856|FG003|Overall Study|Protocol Violation|2|||
105382529|NCT04518410|363405857|FG004|Overall Study|Protocol Violation|17|||
105382530|NCT04518410|363405858|FG005|Overall Study|Protocol Violation|1|||
105492367|NCT03053271|363815735|FG000|Overall Study|Did not meet randomization criteria|3|||
105382531|NCT04518410|363405859|FG006|Overall Study|Protocol Violation|2|||
105382532|NCT04518410|363405860|FG007|Overall Study|Protocol Violation|1|||
105382533|NCT04518410|363405861|FG008|Overall Study|Protocol Violation|0|||
105382534|NCT04518410|363405862|FG009|Overall Study|Protocol Violation|0|||
105382535|NCT04518410|363405863|FG010|Overall Study|Protocol Violation|0|||
105382536|NCT04518410|363405864|FG011|Overall Study|Protocol Violation|0|||
105382537|NCT04518410|363405865|FG012|Overall Study|Protocol Violation|0|||
105382538|NCT04518410|363405866|FG013|Overall Study|Protocol Violation|0|||
105382539|NCT04518410|363405867|FG014|Overall Study|Protocol Violation|0|||
105382540|NCT04518410|363405868|FG015|Overall Study|Protocol Violation|0|||
105382541|NCT04518410|363405869|FG016|Overall Study|Protocol Violation|1|||
105382542|NCT04518410|363405870|FG017|Overall Study|Protocol Violation|1|||
105382543|NCT04518410|363405871|FG018|Overall Study|Protocol Violation|0|||
105382544|NCT04518410|363405872|FG019|Overall Study|Protocol Violation|0|||
105382545|NCT04518410|363405873|FG020|Overall Study|Protocol Violation|1|||
105382546|NCT04518410|363405874|FG021|Overall Study|Protocol Violation|2|||
105382547|NCT04518410|363405875|FG022|Overall Study|Protocol Violation|0|||
105382548|NCT04518410|363405876|FG023|Overall Study|Protocol Violation|3|||
105382549|NCT04518410|363405877|FG024|Overall Study|Protocol Violation|0|||
105382550|NCT04518410|363405853|FG000|Overall Study|Death|0|||
105382551|NCT04518410|363405854|FG001|Overall Study|Death|0|||
105382552|NCT04518410|363405855|FG002|Overall Study|Death|0|||
105382553|NCT04518410|363405856|FG003|Overall Study|Death|0|||
105382554|NCT04518410|363405857|FG004|Overall Study|Death|12|||
105382555|NCT04518410|363405858|FG005|Overall Study|Death|2|||
105382556|NCT04518410|363405859|FG006|Overall Study|Death|11|||
105382557|NCT04518410|363405860|FG007|Overall Study|Death|0|||
105382558|NCT04518410|363405861|FG008|Overall Study|Death|1|||
105382559|NCT04518410|363405862|FG009|Overall Study|Death|0|||
105382560|NCT04518410|363405863|FG010|Overall Study|Death|0|||
105382561|NCT04518410|363405864|FG011|Overall Study|Death|0|||
105382562|NCT04518410|363405865|FG012|Overall Study|Death|0|||
105382563|NCT04518410|363405866|FG013|Overall Study|Death|1|||
105382564|NCT04518410|363405867|FG014|Overall Study|Death|1|||
105382565|NCT04518410|363405868|FG015|Overall Study|Death|0|||
105382566|NCT04518410|363405869|FG016|Overall Study|Death|0|||
105382567|NCT04518410|363405870|FG017|Overall Study|Death|1|||
105382568|NCT04518410|363405871|FG018|Overall Study|Death|4|||
105382569|NCT04518410|363405872|FG019|Overall Study|Death|4|||
105382570|NCT04518410|363405873|FG020|Overall Study|Death|1|||
105382571|NCT04518410|363405874|FG021|Overall Study|Death|0|||
105382572|NCT04518410|363405875|FG022|Overall Study|Death|0|||
105382573|NCT04518410|363405876|FG023|Overall Study|Death|0|||
105382574|NCT04518410|363405877|FG024|Overall Study|Death|0|||
105382575|NCT04518410|363405853|FG000|Overall Study|Requirement to start alternative therapy|0|||
105382576|NCT04518410|363405854|FG001|Overall Study|Requirement to start alternative therapy|0|||
105382577|NCT04518410|363405855|FG002|Overall Study|Requirement to start alternative therapy|1|||
105382578|NCT04518410|363405856|FG003|Overall Study|Requirement to start alternative therapy|0|||
105382579|NCT04518410|363405857|FG004|Overall Study|Requirement to start alternative therapy|0|||
105382580|NCT04518410|363405858|FG005|Overall Study|Requirement to start alternative therapy|0|||
105382581|NCT04518410|363405859|FG006|Overall Study|Requirement to start alternative therapy|0|||
105382582|NCT04518410|363405860|FG007|Overall Study|Requirement to start alternative therapy|0|||
105382583|NCT04518410|363405861|FG008|Overall Study|Requirement to start alternative therapy|0|||
105382584|NCT04518410|363405862|FG009|Overall Study|Requirement to start alternative therapy|0|||
105382585|NCT04518410|363405863|FG010|Overall Study|Requirement to start alternative therapy|0|||
105382586|NCT04518410|363405864|FG011|Overall Study|Requirement to start alternative therapy|0|||
105382587|NCT04518410|363405865|FG012|Overall Study|Requirement to start alternative therapy|0|||
105382588|NCT04518410|363405866|FG013|Overall Study|Requirement to start alternative therapy|0|||
105382589|NCT04518410|363405867|FG014|Overall Study|Requirement to start alternative therapy|0|||
105382590|NCT04518410|363405868|FG015|Overall Study|Requirement to start alternative therapy|0|||
105382591|NCT04518410|363405869|FG016|Overall Study|Requirement to start alternative therapy|0|||
105382592|NCT04518410|363405870|FG017|Overall Study|Requirement to start alternative therapy|0|||
105382593|NCT04518410|363405871|FG018|Overall Study|Requirement to start alternative therapy|0|||
105382594|NCT04518410|363405872|FG019|Overall Study|Requirement to start alternative therapy|0|||
105382595|NCT04518410|363405873|FG020|Overall Study|Requirement to start alternative therapy|0|||
105382596|NCT04518410|363405874|FG021|Overall Study|Requirement to start alternative therapy|0|||
105382597|NCT04518410|363405875|FG022|Overall Study|Requirement to start alternative therapy|0|||
105580245|NCT01712789|364124250|FG000|Overall Study|Death|57|||
105580246|NCT01712789|364124250|FG000|Overall Study|Adverse Event|52|||
105580247|NCT01712789|364124250|FG000|Overall Study|Miscellaneous|31|||
105580248|NCT01712789|364124250|FG000|Overall Study|Withdrawal by Subject|21|||
105580249|NCT01712789|364124250|FG000|Overall Study|Transition to Commercial Treatment|8|||
105382598|NCT04518410|363405876|FG023|Overall Study|Requirement to start alternative therapy|0|||
105580250|NCT01712789|364124250|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
105580251|NCT00873093|364124251|FG000|Overall Study|Adverse Event|0|||
105382599|NCT04518410|363405877|FG024|Overall Study|Requirement to start alternative therapy|0|||
105382600|NCT04518410|363405853|FG000|Overall Study|Randomized but not treated|0|||
105382601|NCT04518410|363405854|FG001|Overall Study|Randomized but not treated|0|||
105382602|NCT04518410|363405855|FG002|Overall Study|Randomized but not treated|0|||
105382603|NCT04518410|363405856|FG003|Overall Study|Randomized but not treated|2|||
105382604|NCT04518410|363405857|FG004|Overall Study|Randomized but not treated|6|||
105382605|NCT04518410|363405858|FG005|Overall Study|Randomized but not treated|4|||
105382606|NCT04518410|363405859|FG006|Overall Study|Randomized but not treated|3|||
105382607|NCT04518410|363405860|FG007|Overall Study|Randomized but not treated|3|||
105382608|NCT04518410|363405861|FG008|Overall Study|Randomized but not treated|0|||
105382609|NCT04518410|363405862|FG009|Overall Study|Randomized but not treated|4|||
105382610|NCT04518410|363405863|FG010|Overall Study|Randomized but not treated|0|||
105382611|NCT04518410|363405864|FG011|Overall Study|Randomized but not treated|0|||
105382612|NCT04518410|363405865|FG012|Overall Study|Randomized but not treated|1|||
105382613|NCT04518410|363405866|FG013|Overall Study|Randomized but not treated|3|||
105382614|NCT04518410|363405867|FG014|Overall Study|Randomized but not treated|3|||
105382615|NCT04518410|363405868|FG015|Overall Study|Randomized but not treated|3|||
105382616|NCT04518410|363405869|FG016|Overall Study|Randomized but not treated|4|||
105382617|NCT04518410|363405870|FG017|Overall Study|Randomized but not treated|5|||
105382618|NCT04518410|363405871|FG018|Overall Study|Randomized but not treated|4|||
105382619|NCT04518410|363405872|FG019|Overall Study|Randomized but not treated|0|||
105382620|NCT04518410|363405873|FG020|Overall Study|Randomized but not treated|0|||
105382621|NCT04518410|363405874|FG021|Overall Study|Randomized but not treated|5|||
105382622|NCT04518410|363405875|FG022|Overall Study|Randomized but not treated|0|||
105382623|NCT04518410|363405876|FG023|Overall Study|Randomized but not treated|3|||
105382624|NCT04518410|363405877|FG024|Overall Study|Randomized but not treated|1|||
105382625|NCT04518410|363405853|FG000|Overall Study|Screen Fail but Randomized|0|||
105382626|NCT04518410|363405854|FG001|Overall Study|Screen Fail but Randomized|0|||
105382627|NCT04518410|363405855|FG002|Overall Study|Screen Fail but Randomized|0|||
105382628|NCT04518410|363405856|FG003|Overall Study|Screen Fail but Randomized|0|||
105382629|NCT04518410|363405857|FG004|Overall Study|Screen Fail but Randomized|2|||
105382630|NCT04518410|363405858|FG005|Overall Study|Screen Fail but Randomized|0|||
105382631|NCT04518410|363405859|FG006|Overall Study|Screen Fail but Randomized|0|||
105382632|NCT04518410|363405860|FG007|Overall Study|Screen Fail but Randomized|0|||
105580252|NCT00873093|364124252|FG001|Overall Study|Adverse Event|2|||
105580253|NCT00873093|364124253|FG002|Overall Study|Adverse Event|0|||
105382633|NCT04518410|363405861|FG008|Overall Study|Screen Fail but Randomized|0|||
105382634|NCT04518410|363405862|FG009|Overall Study|Screen Fail but Randomized|0|||
105382635|NCT04518410|363405863|FG010|Overall Study|Screen Fail but Randomized|0|||
105382636|NCT04518410|363405864|FG011|Overall Study|Screen Fail but Randomized|0|||
105382637|NCT04518410|363405865|FG012|Overall Study|Screen Fail but Randomized|0|||
105382638|NCT04518410|363405866|FG013|Overall Study|Screen Fail but Randomized|0|||
105382639|NCT04518410|363405867|FG014|Overall Study|Screen Fail but Randomized|0|||
105382640|NCT04518410|363405868|FG015|Overall Study|Screen Fail but Randomized|0|||
105382641|NCT04518410|363405869|FG016|Overall Study|Screen Fail but Randomized|0|||
105382642|NCT04518410|363405870|FG017|Overall Study|Screen Fail but Randomized|0|||
105382643|NCT04518410|363405871|FG018|Overall Study|Screen Fail but Randomized|0|||
105382644|NCT04518410|363405872|FG019|Overall Study|Screen Fail but Randomized|0|||
105382645|NCT04518410|363405873|FG020|Overall Study|Screen Fail but Randomized|0|||
105382646|NCT04518410|363405874|FG021|Overall Study|Screen Fail but Randomized|0|||
105382647|NCT04518410|363405875|FG022|Overall Study|Screen Fail but Randomized|0|||
105382648|NCT04518410|363405876|FG023|Overall Study|Screen Fail but Randomized|0|||
105382649|NCT04518410|363405877|FG024|Overall Study|Screen Fail but Randomized|0|||
105382650|NCT04518410|363405853|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
105382651|NCT04518410|363405854|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
105382652|NCT04518410|363405855|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
105382653|NCT04518410|363405856|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
105382654|NCT04518410|363405857|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
105382655|NCT04518410|363405858|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
105382656|NCT04518410|363405859|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
105382657|NCT04518410|363405860|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
105382658|NCT04518410|363405861|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
105382659|NCT04518410|363405862|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
105382660|NCT04518410|363405863|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
105382661|NCT04518410|363405864|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
105382662|NCT04518410|363405865|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
105382663|NCT04518410|363405866|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
105382664|NCT04518410|363405867|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
105382665|NCT04518410|363405868|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
105382666|NCT04518410|363405869|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
105382667|NCT04518410|363405870|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
105382668|NCT04518410|363405871|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
105382669|NCT04518410|363405872|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
105382670|NCT04518410|363405873|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
105382671|NCT04518410|363405874|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
105382672|NCT04518410|363405875|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
105382673|NCT04518410|363405876|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
105382674|NCT04518410|363405877|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
105382675|NCT04518410|363405853|FG000|Overall Study|Dual Enrolled Subject|0|||
105382676|NCT04518410|363405854|FG001|Overall Study|Dual Enrolled Subject|0|||
105382677|NCT04518410|363405855|FG002|Overall Study|Dual Enrolled Subject|0|||
105382678|NCT04518410|363405856|FG003|Overall Study|Dual Enrolled Subject|0|||
105382679|NCT04518410|363405857|FG004|Overall Study|Dual Enrolled Subject|0|||
105382680|NCT04518410|363405858|FG005|Overall Study|Dual Enrolled Subject|0|||
105382681|NCT04518410|363405859|FG006|Overall Study|Dual Enrolled Subject|0|||
105382682|NCT04518410|363405860|FG007|Overall Study|Dual Enrolled Subject|0|||
105382683|NCT04518410|363405861|FG008|Overall Study|Dual Enrolled Subject|0|||
105382684|NCT04518410|363405862|FG009|Overall Study|Dual Enrolled Subject|0|||
105382685|NCT04518410|363405863|FG010|Overall Study|Dual Enrolled Subject|0|||
105382686|NCT04518410|363405864|FG011|Overall Study|Dual Enrolled Subject|0|||
105382687|NCT04518410|363405865|FG012|Overall Study|Dual Enrolled Subject|0|||
105382688|NCT04518410|363405866|FG013|Overall Study|Dual Enrolled Subject|0|||
105382689|NCT04518410|363405867|FG014|Overall Study|Dual Enrolled Subject|0|||
105382690|NCT04518410|363405868|FG015|Overall Study|Dual Enrolled Subject|0|||
105382691|NCT04518410|363405869|FG016|Overall Study|Dual Enrolled Subject|0|||
105382692|NCT04518410|363405870|FG017|Overall Study|Dual Enrolled Subject|1|||
105382693|NCT04518410|363405871|FG018|Overall Study|Dual Enrolled Subject|0|||
105382694|NCT04518410|363405872|FG019|Overall Study|Dual Enrolled Subject|0|||
105382695|NCT04518410|363405873|FG020|Overall Study|Dual Enrolled Subject|0|||
105580254|NCT00873093|364124254|FG003|Overall Study|Adverse Event|0|||
105580255|NCT00873093|364124255|FG004|Overall Study|Adverse Event|0|||
105382696|NCT04518410|363405874|FG021|Overall Study|Dual Enrolled Subject|0|||
105382697|NCT04518410|363405875|FG022|Overall Study|Dual Enrolled Subject|0|||
105382698|NCT04518410|363405876|FG023|Overall Study|Dual Enrolled Subject|0|||
105382699|NCT04518410|363405877|FG024|Overall Study|Dual Enrolled Subject|0|||
105382700|NCT03651336|363405878|FG000|Overall Study|Withdrawal by Subject|4|||
105382701|NCT01125748|363405879|FG000|Overall Study|Adverse Event|0|||
105382702|NCT01125748|363405880|FG001|Overall Study|Adverse Event|2|||
105382703|NCT01125748|363405879|FG000|Overall Study|Lost to Follow-up|0|||
105382704|NCT01125748|363405880|FG001|Overall Study|Lost to Follow-up|1|||
105382705|NCT01125748|363405879|FG000|Overall Study|Physician Decision|8|||
105382706|NCT01125748|363405880|FG001|Overall Study|Physician Decision|7|||
105382707|NCT01125748|363405879|FG000|Overall Study|Patient Decision to Withdraw|2|||
105382708|NCT01125748|363405880|FG001|Overall Study|Patient Decision to Withdraw|4|||
105382709|NCT02547935|363405881|FG000|Overall Study|Other|0|||
105382710|NCT02547935|363405882|FG001|Overall Study|Other|1|||
105382711|NCT02547935|363405883|FG002|Overall Study|Other|0|||
105382712|NCT02547935|363405881|FG000|Overall Study|Withdrawal by Subject|2|||
105382713|NCT02547935|363405882|FG001|Overall Study|Withdrawal by Subject|3|||
105382714|NCT02547935|363405883|FG002|Overall Study|Withdrawal by Subject|4|||
105382715|NCT02547935|363405881|FG000|Overall Study|Screen Failure|2|||
105382716|NCT02547935|363405882|FG001|Overall Study|Screen Failure|0|||
105382717|NCT02547935|363405883|FG002|Overall Study|Screen Failure|0|||
105382718|NCT02547935|363405881|FG000|Overall Study|Physician Decision|0|||
105382719|NCT02547935|363405882|FG001|Overall Study|Physician Decision|1|||
105382720|NCT02547935|363405883|FG002|Overall Study|Physician Decision|0|||
105382721|NCT02547935|363405881|FG000|Overall Study|Lost to Follow-up|0|||
105382722|NCT02547935|363405882|FG001|Overall Study|Lost to Follow-up|2|||
105382723|NCT02547935|363405883|FG002|Overall Study|Lost to Follow-up|1|||
105382724|NCT02547935|363405881|FG000|Overall Study|Death|1|||
105382725|NCT02547935|363405882|FG001|Overall Study|Death|1|||
105382726|NCT02547935|363405883|FG002|Overall Study|Death|0|||
105382727|NCT00694122|363405884|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
105382728|NCT00694122|363405885|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
105382729|NCT00694122|363405884|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
105382730|NCT00694122|363405885|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
105382731|NCT00694122|363405884|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
105382732|NCT00694122|363405885|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
105382733|NCT00683384|363405886|FG000|Overall Study|Death|1|||
105382734|NCT00683384|363405886|FG000|Overall Study|Adverse Event|1|||
105382735|NCT00120874|363405890|FG000|Overall Study|Death|0|||
105382736|NCT00120874|363405891|FG001|Overall Study|Death|1|||
105382737|NCT01198548|363405902|FG000|Overall Study|Disease Progression|9|||
105382738|NCT01198548|363405902|FG000|Overall Study|Administrative Decision|1|||
105382739|NCT01800058|363405903|FG000|Overall Study|Lost to Follow-up|1|||
105382740|NCT00290238|363405904|FG000|Overall Study|Study terminated|27|||
105382741|NCT00290238|363405905|FG001|Overall Study|Study terminated|27|||
105382742|NCT00290238|363405904|FG000|Overall Study|Lost to Follow-up|0|||
105382743|NCT00290238|363405905|FG001|Overall Study|Lost to Follow-up|1|||
105382744|NCT00290238|363405904|FG000|Overall Study|Withdrawal by Subject|15|||
105382745|NCT00290238|363405905|FG001|Overall Study|Withdrawal by Subject|13|||
105382746|NCT01245062|363405907|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
105382747|NCT01245062|363405908|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
105382748|NCT01245062|363405909|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
105382749|NCT01245062|363405907|FG000|Randomization and Crossover Phase|Physician Decision|2|||
105382750|NCT01245062|363405908|FG001|Randomization and Crossover Phase|Physician Decision|4|||
105382751|NCT01245062|363405909|FG002|Randomization and Crossover Phase|Physician Decision|0|||
105382752|NCT01245062|363405907|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
105382753|NCT01245062|363405908|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
105382754|NCT01245062|363405909|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
105382755|NCT01245062|363405907|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
105382756|NCT01245062|363405908|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
105382757|NCT01245062|363405909|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
105382758|NCT01245062|363405907|FG000|Cross-over Phase|Lost to Follow-up|0|||
105382759|NCT01245062|363405908|FG001|Cross-over Phase|Lost to Follow-up|0|||
105382760|NCT01245062|363405909|FG002|Cross-over Phase|Lost to Follow-up|1|||
105382761|NCT01245062|363405907|FG000|Cross-over Phase|Physician Decision|0|||
105382762|NCT01245062|363405908|FG001|Cross-over Phase|Physician Decision|0|||
105382763|NCT01245062|363405909|FG002|Cross-over Phase|Physician Decision|1|||
105382764|NCT01245062|363405907|FG000|Cross-over Phase|Withdrew Consent|0|||
105382765|NCT01245062|363405908|FG001|Cross-over Phase|Withdrew Consent|0|||
105382766|NCT01245062|363405909|FG002|Cross-over Phase|Withdrew Consent|4|||
105382767|NCT01245062|363405907|FG000|Cross-over Phase|Study closed/ terminated|0|||
105382768|NCT01245062|363405908|FG001|Cross-over Phase|Study closed/ terminated|0|||
105382769|NCT01245062|363405909|FG002|Cross-over Phase|Study closed/ terminated|11|||
105382770|NCT06025695|363405910|FG000|Overall Study|Adverse Event|5|||
105382771|NCT06025695|363405911|FG001|Overall Study|Adverse Event|6|||
105382772|NCT06025695|363405910|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
105382773|NCT06025695|363405911|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
105382774|NCT06025695|363405910|FG000|Overall Study|Other|23|||
105382775|NCT06025695|363405911|FG001|Overall Study|Other|19|||
105382776|NCT06025695|363405910|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
105382777|NCT06025695|363405911|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
105382778|NCT05330429|363405912|FG000|Overall Study|Study Terminated by Sponsor|4|||
105382779|NCT05330429|363405913|FG001|Overall Study|Study Terminated by Sponsor|33|||
105382780|NCT05330429|363405914|FG002|Overall Study|Study Terminated by Sponsor|12|||
105382781|NCT05330429|363405912|FG000|Overall Study|Death|5|||
105382782|NCT05330429|363405913|FG001|Overall Study|Death|2|||
105382783|NCT05330429|363405914|FG002|Overall Study|Death|4|||
105382784|NCT05330429|363405912|FG000|Overall Study|Withdrew Consent|0|||
105382785|NCT05330429|363405913|FG001|Overall Study|Withdrew Consent|5|||
105382786|NCT05330429|363405914|FG002|Overall Study|Withdrew Consent|4|||
105382787|NCT05330429|363405912|FG000|Overall Study|Investigator's Discretion|0|||
105382788|NCT05330429|363405913|FG001|Overall Study|Investigator's Discretion|1|||
105382789|NCT05330429|363405914|FG002|Overall Study|Investigator's Discretion|3|||
105382790|NCT05330429|363405912|FG000|Overall Study|Subject Decision|1|||
105382791|NCT05330429|363405913|FG001|Overall Study|Subject Decision|2|||
105382792|NCT05330429|363405914|FG002|Overall Study|Subject Decision|0|||
105382793|NCT05330429|363405912|FG000|Overall Study|Lost to Follow-up|0|||
105382794|NCT05330429|363405913|FG001|Overall Study|Lost to Follow-up|1|||
105382795|NCT05330429|363405914|FG002|Overall Study|Lost to Follow-up|0|||
105382796|NCT03022630|363408189|FG000|Overall Study|Death|9|||
105382797|NCT03022630|363408190|FG001|Overall Study|Death|7|||
105382798|NCT03022630|363408189|FG000|Overall Study|Withdrawal by Subject|0|||
105382799|NCT03022630|363408190|FG001|Overall Study|Withdrawal by Subject|5|||
105382800|NCT01797185|363408196|FG000|Overall Study|Adverse Event|5|||
105382801|NCT01797185|363408197|FG001|Overall Study|Adverse Event|15|||
105382802|NCT01797185|363408198|FG002|Overall Study|Adverse Event|6|||
105382803|NCT01797185|363408196|FG000|Overall Study|Withdrawal by Subject|6|||
105382804|NCT01797185|363408197|FG001|Overall Study|Withdrawal by Subject|9|||
105382805|NCT01797185|363408198|FG002|Overall Study|Withdrawal by Subject|5|||
105382806|NCT01797185|363408196|FG000|Overall Study|Site terminated|8|||
105382807|NCT01797185|363408197|FG001|Overall Study|Site terminated|4|||
105382808|NCT01797185|363408198|FG002|Overall Study|Site terminated|0|||
105382809|NCT01797185|363408196|FG000|Overall Study|Lost to Follow-up|2|||
105382810|NCT01797185|363408197|FG001|Overall Study|Lost to Follow-up|6|||
105382811|NCT01797185|363408198|FG002|Overall Study|Lost to Follow-up|1|||
105382812|NCT01797185|363408196|FG000|Overall Study|Withdrawn per sponsor|5|||
105382813|NCT01797185|363408197|FG001|Overall Study|Withdrawn per sponsor|0|||
105382814|NCT01797185|363408198|FG002|Overall Study|Withdrawn per sponsor|0|||
105382815|NCT01797185|363408196|FG000|Overall Study|Physician Decision|1|||
105382816|NCT01797185|363408197|FG001|Overall Study|Physician Decision|3|||
105382817|NCT01797185|363408198|FG002|Overall Study|Physician Decision|0|||
105382818|NCT01797185|363408196|FG000|Overall Study|Protocol Violation|1|||
105382819|NCT01797185|363408197|FG001|Overall Study|Protocol Violation|1|||
105382820|NCT01797185|363408198|FG002|Overall Study|Protocol Violation|0|||
105382821|NCT01778985|363408199|FG000|Overall Study|Lost to Follow-up|1|||
105382822|NCT01778985|363408200|FG001|Overall Study|Lost to Follow-up|0|||
105382823|NCT01778985|363408199|FG000|Overall Study|Physician Decision|2|||
105382824|NCT01778985|363408200|FG001|Overall Study|Physician Decision|2|||
105382825|NCT01778985|363408199|FG000|Overall Study|Protocol Violation|4|||
105382826|NCT01778985|363408200|FG001|Overall Study|Protocol Violation|1|||
105382827|NCT00723944|363408201|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
105382828|NCT00723944|363408202|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
105382829|NCT00723944|363408201|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
105382830|NCT00723944|363408202|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
105382831|NCT00723944|363408201|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
105382832|NCT00723944|363408202|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
105382833|NCT00835978|363408206|FG000|Overall Study|Death|33|||
105382834|NCT00835978|363408207|FG001|Overall Study|Death|40|||
105382835|NCT00835978|363408208|FG002|Overall Study|Death|49|||
105382836|NCT00835978|363408209|FG003|Overall Study|Death|4|||
105382837|NCT00835978|363408206|FG000|Overall Study|Lost to Follow-up|3|||
105382838|NCT00835978|363408207|FG001|Overall Study|Lost to Follow-up|4|||
105580256|NCT00873093|364124251|FG000|Overall Study|Death|0|||
105382839|NCT00835978|363408208|FG002|Overall Study|Lost to Follow-up|2|||
105382840|NCT00835978|363408209|FG003|Overall Study|Lost to Follow-up|1|||
105382841|NCT00835978|363408206|FG000|Overall Study|Other|5|||
105382842|NCT00835978|363408207|FG001|Overall Study|Other|1|||
105382843|NCT00835978|363408208|FG002|Overall Study|Other|8|||
105382844|NCT00835978|363408209|FG003|Overall Study|Other|0|||
105382845|NCT00835978|363408206|FG000|Overall Study|Objective progression or relapse|2|||
105382846|NCT00835978|363408207|FG001|Overall Study|Objective progression or relapse|0|||
105382847|NCT00835978|363408208|FG002|Overall Study|Objective progression or relapse|1|||
105382848|NCT00835978|363408209|FG003|Overall Study|Objective progression or relapse|0|||
105382849|NCT00835978|363408206|FG000|Overall Study|Adverse Event|1|||
105382850|NCT00835978|363408207|FG001|Overall Study|Adverse Event|0|||
105382851|NCT00835978|363408208|FG002|Overall Study|Adverse Event|1|||
105382852|NCT00835978|363408209|FG003|Overall Study|Adverse Event|0|||
105382853|NCT00835978|363408206|FG000|Overall Study|Withdrawal by Subject|0|||
105382854|NCT00835978|363408207|FG001|Overall Study|Withdrawal by Subject|3|||
105382855|NCT00835978|363408208|FG002|Overall Study|Withdrawal by Subject|0|||
105382856|NCT00835978|363408209|FG003|Overall Study|Withdrawal by Subject|5|||
105382857|NCT00835978|363408206|FG000|Overall Study|Study terminated by sponsor|12|||
105382858|NCT00835978|363408207|FG001|Overall Study|Study terminated by sponsor|8|||
105382859|NCT00835978|363408208|FG002|Overall Study|Study terminated by sponsor|30|||
105382860|NCT00835978|363408209|FG003|Overall Study|Study terminated by sponsor|0|||
105382861|NCT04575324|363408212|FG000|Overall Study|Lost to Follow-up|29|||
105382862|NCT04575324|363408213|FG001|Overall Study|Lost to Follow-up|25|||
105382863|NCT04575324|363408212|FG000|Overall Study|Death|1|||
105382864|NCT04575324|363408213|FG001|Overall Study|Death|2|||
105382865|NCT04575324|363408212|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
105382866|NCT04575324|363408213|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
105382867|NCT00456612|363408216|FG000|Overall Study|Withdrawal by Subject|3|||
105382868|NCT01178411|363408219|FG000|Overall Study|Adverse Event|5|||
105382869|NCT01178411|363408219|FG000|Overall Study|Withdrawal by Subject|4|||
105382870|NCT01178411|363408219|FG000|Overall Study|Protocol Violation|1|||
105382871|NCT01178411|363408219|FG000|Overall Study|Progressive disease per RECIST|32|||
105382872|NCT01178411|363408219|FG000|Overall Study|Progressive disease per clinician|9|||
105382873|NCT01178411|363408219|FG000|Overall Study|Physician Decision|6|||
105382874|NCT01178411|363408219|FG000|Overall Study|Death|1|||
105382875|NCT01178411|363408219|FG000|Overall Study|No reason provided|1|||
105382876|NCT01178411|363408219|FG000|Overall Study|Drug manufacturing ended|1|||
105382877|NCT03197935|363408223|FG000|Overall Study|Death due to any cause|26|||
105382878|NCT03197935|363408224|FG001|Overall Study|Death due to any cause|15|||
105382879|NCT03197935|363408223|FG000|Overall Study|Lost to Follow-up|3|||
105382880|NCT03197935|363408224|FG001|Overall Study|Lost to Follow-up|5|||
105382881|NCT03197935|363408223|FG000|Overall Study|Physician Decision|2|||
105382882|NCT03197935|363408224|FG001|Overall Study|Physician Decision|1|||
105382883|NCT03197935|363408223|FG000|Overall Study|Withdrawal by Subject|16|||
105382884|NCT03197935|363408224|FG001|Overall Study|Withdrawal by Subject|8|||
105382885|NCT01471574|363408225|FG000|Treatment Period|Lack of Efficacy|12|||
105382886|NCT01471574|363408226|FG001|Treatment Period|Lack of Efficacy|4|||
105382887|NCT01471574|363408227|FG002|Treatment Period|Lack of Efficacy|14|||
105382888|NCT01471574|363408228|FG003|Treatment Period|Lack of Efficacy|1|||
105382889|NCT01471574|363408225|FG000|Treatment Period|Adverse Event|7|||
105382890|NCT01471574|363408226|FG001|Treatment Period|Adverse Event|3|||
105382891|NCT01471574|363408227|FG002|Treatment Period|Adverse Event|6|||
105382892|NCT01471574|363408228|FG003|Treatment Period|Adverse Event|1|||
105382893|NCT01471574|363408225|FG000|Treatment Period|Withdrawal by Subject|5|||
105382894|NCT01471574|363408226|FG001|Treatment Period|Withdrawal by Subject|1|||
105382895|NCT01471574|363408227|FG002|Treatment Period|Withdrawal by Subject|1|||
105382896|NCT01471574|363408228|FG003|Treatment Period|Withdrawal by Subject|0|||
105382897|NCT01471574|363408225|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
105382898|NCT01471574|363408226|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
105382899|NCT01471574|363408227|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
105382900|NCT01471574|363408228|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
105382901|NCT01471574|363408225|FG000|Treatment Period|Lost to Follow-up|1|||
105382902|NCT01471574|363408226|FG001|Treatment Period|Lost to Follow-up|2|||
105382903|NCT01471574|363408227|FG002|Treatment Period|Lost to Follow-up|2|||
105382904|NCT01471574|363408228|FG003|Treatment Period|Lost to Follow-up|0|||
105382905|NCT01471574|363408225|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
105382906|NCT01471574|363408226|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
105382907|NCT01471574|363408227|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
105382908|NCT01471574|363408228|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
105382909|NCT01471574|363408225|FG000|Treatment Period|Other|1|||
105382910|NCT01471574|363408226|FG001|Treatment Period|Other|0|||
105382911|NCT01471574|363408227|FG002|Treatment Period|Other|0|||
105382912|NCT01471574|363408228|FG003|Treatment Period|Other|0|||
105382913|NCT01471574|363408225|FG000|Follow-up Period|Withdrawal by Subject|3|||
105580257|NCT00873093|364124252|FG001|Overall Study|Death|3|||
105382914|NCT01471574|363408226|FG001|Follow-up Period|Withdrawal by Subject|0|||
105382915|NCT01471574|363408227|FG002|Follow-up Period|Withdrawal by Subject|3|||
105382916|NCT01471574|363408228|FG003|Follow-up Period|Withdrawal by Subject|1|||
105382917|NCT01471574|363408225|FG000|Follow-up Period|Lost to Follow-up|4|||
105382918|NCT01471574|363408226|FG001|Follow-up Period|Lost to Follow-up|1|||
105382919|NCT01471574|363408227|FG002|Follow-up Period|Lost to Follow-up|3|||
105382920|NCT01471574|363408228|FG003|Follow-up Period|Lost to Follow-up|2|||
105382921|NCT01471574|363408225|FG000|Follow-up Period|Death|0|||
105382922|NCT01471574|363408226|FG001|Follow-up Period|Death|0|||
105382923|NCT01471574|363408227|FG002|Follow-up Period|Death|1|||
105382924|NCT01471574|363408228|FG003|Follow-up Period|Death|0|||
105382925|NCT01471574|363408225|FG000|Follow-up Period|Follow-up no longer required|0|||
105382926|NCT01471574|363408226|FG001|Follow-up Period|Follow-up no longer required|1|||
105382927|NCT01471574|363408227|FG002|Follow-up Period|Follow-up no longer required|0|||
105382928|NCT01471574|363408228|FG003|Follow-up Period|Follow-up no longer required|0|||
105382929|NCT01783015|363408229|FG000|Blinded Treatment|Adverse Event|0|||
105382930|NCT01783015|363408230|FG001|Blinded Treatment|Adverse Event|1|||
105382931|NCT01783015|363408231|FG002|Blinded Treatment|Adverse Event|0|||
105382932|NCT01783015|363408229|FG000|Blinded Treatment|Protocol Violation|0|||
105382933|NCT01783015|363408230|FG001|Blinded Treatment|Protocol Violation|1|||
105382934|NCT01783015|363408231|FG002|Blinded Treatment|Protocol Violation|0|||
105382935|NCT01783015|363408229|FG000|Blinded Treatment|Withdrawal by Subject|0|||
105382936|NCT01783015|363408230|FG001|Blinded Treatment|Withdrawal by Subject|1|||
105382937|NCT01783015|363408231|FG002|Blinded Treatment|Withdrawal by Subject|0|||
105382938|NCT01783015|363408229|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
105382939|NCT01783015|363408230|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
105382940|NCT01783015|363408231|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
105382941|NCT01783015|363408229|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
105382942|NCT01783015|363408230|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
105382943|NCT01783015|363408231|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
105382944|NCT01562444|363408232|FG000|Overall Study|Did not meet entry criteria|2|||
105382945|NCT01562444|363408233|FG001|Overall Study|Did not meet entry criteria|0|||
105382946|NCT01562444|363408234|FG002|Overall Study|Did not meet entry criteria|3|||
105382947|NCT01562444|363408232|FG000|Overall Study|Did not comply with blood draw schedule|1|||
105382948|NCT01562444|363408233|FG001|Overall Study|Did not comply with blood draw schedule|0|||
105382949|NCT01562444|363408234|FG002|Overall Study|Did not comply with blood draw schedule|1|||
105382950|NCT01562444|363408232|FG000|Overall Study|Unavailable serological results|0|||
105382951|NCT01562444|363408233|FG001|Overall Study|Unavailable serological results|2|||
105382952|NCT01562444|363408234|FG002|Overall Study|Unavailable serological results|2|||
105382953|NCT01562444|363408232|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
105382954|NCT01562444|363408233|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
105382955|NCT01562444|363408234|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
105382956|NCT01562444|363408232|FG000|Overall Study|Protocol forbidden medication|1|||
105382957|NCT01562444|363408233|FG001|Overall Study|Protocol forbidden medication|0|||
105382958|NCT01562444|363408234|FG002|Overall Study|Protocol forbidden medication|0|||
105382959|NCT04602000|363408236|FG000|Overall Study|Withdrawal by Subject|3|||
105382960|NCT04602000|363408237|FG001|Overall Study|Withdrawal by Subject|6|||
105382961|NCT04602000|363408238|FG002|Overall Study|Withdrawal by Subject|3|||
105382962|NCT04602000|363408239|FG003|Overall Study|Withdrawal by Subject|27|||
105382963|NCT04602000|363408240|FG004|Overall Study|Withdrawal by Subject|39|||
105382964|NCT04602000|363408236|FG000|Overall Study|Physician Decision|1|||
105382965|NCT04602000|363408237|FG001|Overall Study|Physician Decision|0|||
105382966|NCT04602000|363408238|FG002|Overall Study|Physician Decision|0|||
105382967|NCT04602000|363408239|FG003|Overall Study|Physician Decision|2|||
105382968|NCT04602000|363408240|FG004|Overall Study|Physician Decision|2|||
105382969|NCT04602000|363408236|FG000|Overall Study|Death|0|||
105382970|NCT04602000|363408237|FG001|Overall Study|Death|1|||
105382971|NCT04602000|363408238|FG002|Overall Study|Death|0|||
105382972|NCT04602000|363408239|FG003|Overall Study|Death|1|||
105382973|NCT04602000|363408240|FG004|Overall Study|Death|2|||
105382974|NCT04602000|363408236|FG000|Overall Study|Lost to Follow-up|0|||
105382975|NCT04602000|363408237|FG001|Overall Study|Lost to Follow-up|0|||
105382976|NCT04602000|363408238|FG002|Overall Study|Lost to Follow-up|0|||
105382977|NCT04602000|363408239|FG003|Overall Study|Lost to Follow-up|3|||
105382978|NCT04602000|363408240|FG004|Overall Study|Lost to Follow-up|4|||
105382979|NCT04602000|363408236|FG000|Overall Study|Other|4|||
105382980|NCT04602000|363408237|FG001|Overall Study|Other|1|||
105382981|NCT04602000|363408238|FG002|Overall Study|Other|2|||
105382982|NCT04602000|363408239|FG003|Overall Study|Other|5|||
105382983|NCT04602000|363408240|FG004|Overall Study|Other|4|||
105382984|NCT04602000|363408236|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
105382985|NCT04602000|363408237|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
105382986|NCT04602000|363408238|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
105382987|NCT04602000|363408239|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
105382988|NCT04602000|363408240|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
105492368|NCT03053271|363815735|FG000|Overall Study|Withdrawal by Subject|1|||
105382989|NCT00585585|363408246|FG000|Overall Study|Adverse Event|1|||
105382990|NCT04233580|363408249|FG000|Overall Study|Adverse Event|3|||
105382991|NCT04233580|363408250|FG001|Overall Study|Adverse Event|3|||
105382992|NCT04233580|363408249|FG000|Overall Study|Withdrawal by Subject|2|||
105382993|NCT04233580|363408250|FG001|Overall Study|Withdrawal by Subject|1|||
105382994|NCT00378560|363408251|FG000|Overall Study|Adverse Event|1|||
105382995|NCT00378560|363408252|FG001|Overall Study|Adverse Event|0|||
105382996|NCT00378560|363408251|FG000|Overall Study|Lost to Follow-up|24|||
105382997|NCT00378560|363408252|FG001|Overall Study|Lost to Follow-up|29|||
105382998|NCT00378560|363408251|FG000|Overall Study|Protocol Violation|2|||
105382999|NCT00378560|363408252|FG001|Overall Study|Protocol Violation|0|||
105383000|NCT00378560|363408251|FG000|Overall Study|Withdrawal by Subject|17|||
105383001|NCT00378560|363408252|FG001|Overall Study|Withdrawal by Subject|21|||
105383002|NCT00378560|363408251|FG000|Overall Study|Moved|4|||
105383003|NCT00378560|363408252|FG001|Overall Study|Moved|3|||
105383004|NCT00378560|363408251|FG000|Overall Study|Pregnancy|7|||
105383005|NCT00378560|363408252|FG001|Overall Study|Pregnancy|5|||
105383006|NCT00378560|363408251|FG000|Overall Study|Laboratory test values abnormal|1|||
105383007|NCT00378560|363408252|FG001|Overall Study|Laboratory test values abnormal|0|||
105383008|NCT00976391|363408258|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
105383009|NCT00976391|363408259|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
105383010|NCT00976391|363408258|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
105383011|NCT00976391|363408259|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
105383012|NCT00976391|363408258|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
105383013|NCT00976391|363408259|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
105383014|NCT00976391|363408258|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
105383015|NCT00976391|363408259|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
105383016|NCT00976391|363408258|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
105383017|NCT00976391|363408259|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
105383018|NCT00976391|363408258|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
105383019|NCT00976391|363408259|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
105383020|NCT00976391|363408258|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
105383021|NCT00976391|363408259|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
105383022|NCT00976391|363408258|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
105383023|NCT00976391|363408259|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
105383024|NCT00976391|363408258|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
105383025|NCT00976391|363408259|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
105383026|NCT00976391|363408258|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
105383027|NCT00976391|363408259|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
105383028|NCT00976391|363408258|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
105383029|NCT00976391|363408259|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
105492369|NCT03114488|363815736|FG000|Time Period 2|Withdrawal by Subject|1|||
105383030|NCT00976391|363408258|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
105383031|NCT00976391|363408259|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
105383032|NCT00976391|363408258|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
105383033|NCT00976391|363408259|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
105383034|NCT00976391|363408258|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
105383035|NCT00976391|363408259|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
105383036|NCT01371565|363408260|FG000|Overall Study|Withdrawal by Subject|1|||
105383037|NCT01371565|363408260|FG000|Overall Study|Death|1|||
105383038|NCT01371565|363408260|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
105383039|NCT04270760|363408261|FG000|Overall Study|Withdrawal by Subject|0|||
105383040|NCT04270760|363408262|FG001|Overall Study|Withdrawal by Subject|1|||
105383041|NCT04270760|363408263|FG002|Overall Study|Withdrawal by Subject|3|||
105383042|NCT04270760|363408264|FG003|Overall Study|Withdrawal by Subject|0|||
105383043|NCT04270760|363408265|FG004|Overall Study|Withdrawal by Subject|0|||
105383044|NCT04270760|363408261|FG000|Overall Study|Lost to Follow-up|1|||
105383045|NCT04270760|363408262|FG001|Overall Study|Lost to Follow-up|2|||
105383046|NCT04270760|363408263|FG002|Overall Study|Lost to Follow-up|1|||
105383047|NCT04270760|363408264|FG003|Overall Study|Lost to Follow-up|0|||
105383048|NCT04270760|363408265|FG004|Overall Study|Lost to Follow-up|0|||
105383049|NCT04270760|363408261|FG000|Overall Study|Death|0|||
105383050|NCT04270760|363408262|FG001|Overall Study|Death|0|||
105383051|NCT04270760|363408263|FG002|Overall Study|Death|0|||
105383052|NCT04270760|363408264|FG003|Overall Study|Death|0|||
105383053|NCT04270760|363408265|FG004|Overall Study|Death|1|||
105383054|NCT02287025|363408269|FG000|Overall Study|Not treated|2|||
105383055|NCT02287025|363408270|FG001|Overall Study|Not treated|0|||
105383056|NCT02287025|363408269|FG000|Overall Study|Progression of disease|3|||
105383057|NCT02287025|363408270|FG001|Overall Study|Progression of disease|2|||
105383058|NCT02287025|363408269|FG000|Overall Study|Adverse Event|2|||
105383059|NCT02287025|363408270|FG001|Overall Study|Adverse Event|4|||
105383060|NCT02287025|363408269|FG000|Overall Study|Withdrawal by Subject|2|||
105383061|NCT02287025|363408270|FG001|Overall Study|Withdrawal by Subject|2|||
105383062|NCT02287025|363408269|FG000|Overall Study|Screening failed|1|||
105383063|NCT02287025|363408270|FG001|Overall Study|Screening failed|1|||
105383064|NCT00899847|363408271|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
105383065|NCT00756444|363408274|FG000|Overall Study|Adverse Event|1|||
105383066|NCT00756444|363408275|FG001|Overall Study|Adverse Event|1|||
105383067|NCT00756444|363408274|FG000|Overall Study|Withdrawal by Subject|6|||
105383068|NCT00756444|363408275|FG001|Overall Study|Withdrawal by Subject|8|||
105383069|NCT00756444|363408274|FG000|Overall Study|Lost to Follow-up|0|||
105383070|NCT00756444|363408275|FG001|Overall Study|Lost to Follow-up|1|||
105383071|NCT00756444|363408274|FG000|Overall Study|Death|5|||
105383072|NCT00756444|363408275|FG001|Overall Study|Death|4|||
105383073|NCT00756444|363408274|FG000|Overall Study|Disease Progression|2|||
105383074|NCT00756444|363408275|FG001|Overall Study|Disease Progression|7|||
105383075|NCT00756444|363408274|FG000|Overall Study|Ineligibility Determined|1|||
105383076|NCT00756444|363408275|FG001|Overall Study|Ineligibility Determined|0|||
105383077|NCT02346370|363408276|FG000|Overall Study|Not treated|1|||
105383078|NCT02346370|363408277|FG001|Overall Study|Not treated|0|||
105383079|NCT02346370|363408278|FG002|Overall Study|Not treated|0|||
105383080|NCT02346370|363408276|FG000|Overall Study|Withdrawal of consent|1|||
105383081|NCT02346370|363408277|FG001|Overall Study|Withdrawal of consent|0|||
105383082|NCT02346370|363408278|FG002|Overall Study|Withdrawal of consent|0|||
105383083|NCT02346370|363408276|FG000|Overall Study|Death|1|||
105383084|NCT02346370|363408277|FG001|Overall Study|Death|3|||
105383085|NCT02346370|363408278|FG002|Overall Study|Death|1|||
105383086|NCT02346370|363408276|FG000|Overall Study|Sponsor discontinued study|5|||
105383087|NCT02346370|363408277|FG001|Overall Study|Sponsor discontinued study|0|||
105383088|NCT02346370|363408278|FG002|Overall Study|Sponsor discontinued study|2|||
105383089|NCT02346370|363408276|FG000|Overall Study|Radiologic progression|0|||
105383090|NCT02346370|363408277|FG001|Overall Study|Radiologic progression|0|||
105383091|NCT02346370|363408278|FG002|Overall Study|Radiologic progression|1|||
105383092|NCT02346370|363408276|FG000|Overall Study|Physician Decision|0|||
105383093|NCT02346370|363408277|FG001|Overall Study|Physician Decision|1|||
105383094|NCT02346370|363408278|FG002|Overall Study|Physician Decision|0|||
105383095|NCT01279200|363408280|FG000|Overall Study|Withdrawal by Subject|1|||
105383096|NCT01279200|363408281|FG001|Overall Study|Withdrawal by Subject|3|||
105383097|NCT01279200|363408280|FG000|Overall Study|Patient withdrawal due to high cost|0|||
105383098|NCT01279200|363408281|FG001|Overall Study|Patient withdrawal due to high cost|1|||
105383099|NCT01279200|363408280|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
105383100|NCT01279200|363408281|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
105383101|NCT01279200|363408280|FG000|Overall Study|ultrasound screening failure|0|||
105383102|NCT01279200|363408281|FG001|Overall Study|ultrasound screening failure|1|||
105383103|NCT01279200|363408280|FG000|Overall Study|Lost to Follow-up|0|||
105383104|NCT01279200|363408281|FG001|Overall Study|Lost to Follow-up|1|||
105383105|NCT01279200|363408280|FG000|Overall Study|Adverse Event|1|||
105383106|NCT01279200|363408281|FG001|Overall Study|Adverse Event|0|||
105383107|NCT00455455|363408286|FG000|Washout|Withdrawal by Subject|0|||
105383108|NCT00455455|363408287|FG001|Washout|Withdrawal by Subject|1|||
105383109|NCT00455455|363408286|FG000|Washout|Withdrawal by Subject|1|||
105383110|NCT00455455|363408287|FG001|Washout|Withdrawal by Subject|0|||
105383111|NCT01370538|363408288|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
105383112|NCT01370538|363408289|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
105383113|NCT01370538|363408288|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105383114|NCT01370538|363408289|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
105383115|NCT01370538|363408288|FG000|Overall Study|Adverse Event|1|||
105383116|NCT01370538|363408289|FG001|Overall Study|Adverse Event|0|||
105383117|NCT01370538|363408288|FG000|Overall Study|Protocol Violation|8|||
105383118|NCT01370538|363408289|FG001|Overall Study|Protocol Violation|5|||
105383119|NCT01370538|363408288|FG000|Overall Study|Development of study specific withdrawal|1|||
105383120|NCT01370538|363408289|FG001|Overall Study|Development of study specific withdrawal|1|||
105383121|NCT01370538|363408288|FG000|Overall Study|Lost to follow up|6|||
105383122|NCT01370538|363408289|FG001|Overall Study|Lost to follow up|10|||
105383123|NCT01263028|363408292|FG000|Overall Study|Withdrawal by Subject|1|||
105383124|NCT01263028|363408292|FG000|Overall Study|Adverse Event|1|||
105383125|NCT01263028|363408292|FG000|Overall Study|Study terminated due to low enrollment.|4|||
105383126|NCT00309244|363408293|FG000|Overall Study|Adverse Event|29|||
105383127|NCT00309244|363408294|FG001|Overall Study|Adverse Event|12|||
105383128|NCT00309244|363408293|FG000|Overall Study|Lost to Follow-up|6|||
105383129|NCT00309244|363408294|FG001|Overall Study|Lost to Follow-up|22|||
105383130|NCT00309244|363408293|FG000|Overall Study|Physician Decision|5|||
105383131|NCT00309244|363408294|FG001|Overall Study|Physician Decision|8|||
105383132|NCT00309244|363408293|FG000|Overall Study|Protocol Violation|6|||
105383133|NCT00309244|363408294|FG001|Overall Study|Protocol Violation|3|||
105383134|NCT00309244|363408293|FG000|Overall Study|Withdrawal by Subject|50|||
105383135|NCT00309244|363408294|FG001|Overall Study|Withdrawal by Subject|32|||
105383136|NCT00309244|363408293|FG000|Overall Study|Various|7|||
105383137|NCT00309244|363408294|FG001|Overall Study|Various|7|||
105383138|NCT00309244|363408293|FG000|Overall Study|Randomized but not dosed|11|||
105383139|NCT00309244|363408294|FG001|Overall Study|Randomized but not dosed|12|||
105383140|NCT00309244|363408293|FG000|Overall Study|Death|4|||
105383141|NCT00309244|363408294|FG001|Overall Study|Death|1|||
105383142|NCT02762604|363408295|FG000|Overall Study|Lost to Follow-up|2|||
105383143|NCT02762604|363408296|FG001|Overall Study|Lost to Follow-up|7|||
105383144|NCT02762604|363408295|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
105383145|NCT02762604|363408296|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
105383146|NCT02958527|363408301|FG000|Overall Study|Not collected CRFs|12|||
105383147|NCT02366130|363408302|FG000|Overall Study|Withdrawal by Subject|3|||
105383148|NCT02366130|363408302|FG000|Overall Study|Ineligible|6|||
105383149|NCT02945046|363408303|FG000|Overall Study|Adverse Event|1|||
105383150|NCT02945046|363408304|FG001|Overall Study|Adverse Event|0|||
105383151|NCT02945046|363408305|FG002|Overall Study|Adverse Event|2|||
105383152|NCT02945046|363408303|FG000|Overall Study|Withdrawal by Subject|3|||
105383153|NCT02945046|363408304|FG001|Overall Study|Withdrawal by Subject|3|||
105383154|NCT02945046|363408305|FG002|Overall Study|Withdrawal by Subject|3|||
105383155|NCT02945046|363408303|FG000|Overall Study|Protocol Violation|2|||
105383156|NCT02945046|363408304|FG001|Overall Study|Protocol Violation|3|||
105383157|NCT02945046|363408305|FG002|Overall Study|Protocol Violation|2|||
105383158|NCT02945046|363408303|FG000|Overall Study|Lost to Follow-up|1|||
105383159|NCT02945046|363408304|FG001|Overall Study|Lost to Follow-up|1|||
105383160|NCT02945046|363408305|FG002|Overall Study|Lost to Follow-up|0|||
105383161|NCT02945046|363408303|FG000|Overall Study|Lack of Efficacy|1|||
105383162|NCT02945046|363408304|FG001|Overall Study|Lack of Efficacy|2|||
105383163|NCT02945046|363408305|FG002|Overall Study|Lack of Efficacy|1|||
105383164|NCT02945046|363408303|FG000|Overall Study|Other than specified|5|||
105383165|NCT02945046|363408304|FG001|Overall Study|Other than specified|4|||
105383166|NCT02945046|363408305|FG002|Overall Study|Other than specified|7|||
105383167|NCT00567112|363408306|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
105383168|NCT00567112|363408307|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
105383169|NCT00567112|363408308|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
105383170|NCT00567112|363408306|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
105383171|NCT00567112|363408307|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
105383172|NCT00567112|363408308|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
105383173|NCT00567112|363408306|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
105383174|NCT00567112|363408307|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
105492370|NCT03114488|363815737|FG001|Time Period 2|Withdrawal by Subject|3|||
105383175|NCT00567112|363408308|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
105383176|NCT00545948|363408311|FG000|Overall Study|Not Treated|1|||
105383177|NCT00545948|363408312|FG001|Overall Study|Not Treated|1|||
105383178|NCT00545948|363408313|FG002|Overall Study|Not Treated|7|||
105383179|NCT03467945|363408314|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105383180|NCT03467945|363408315|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105383181|NCT03467945|363408316|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105383182|NCT03467945|363408317|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105383183|NCT03467945|363408314|FG000|Treatment Period 3|Withdrawal by Subject|1|||
105383184|NCT03467945|363408315|FG001|Treatment Period 3|Withdrawal by Subject|0|||
105383185|NCT03467945|363408316|FG002|Treatment Period 3|Withdrawal by Subject|2|||
105383186|NCT03467945|363408317|FG003|Treatment Period 3|Withdrawal by Subject|1|||
105383187|NCT02187055|363408320|FG000|Overall Study|Lack of Efficacy|10|||
105383188|NCT02187055|363408321|FG001|Overall Study|Lack of Efficacy|3|||
105383189|NCT02187055|363408322|FG002|Overall Study|Lack of Efficacy|7|||
105383190|NCT02187055|363408320|FG000|Overall Study|Lost to Follow-up|2|||
105383191|NCT02187055|363408321|FG001|Overall Study|Lost to Follow-up|7|||
105383192|NCT02187055|363408322|FG002|Overall Study|Lost to Follow-up|3|||
105383193|NCT02187055|363408320|FG000|Overall Study|No longer meets eligibility criteria|0|||
105383194|NCT02187055|363408321|FG001|Overall Study|No longer meets eligibility criteria|2|||
105383195|NCT02187055|363408322|FG002|Overall Study|No longer meets eligibility criteria|0|||
105383196|NCT02187055|363408320|FG000|Overall Study|No longer willing to participate|6|||
105383197|NCT02187055|363408321|FG001|Overall Study|No longer willing to participate|8|||
105383198|NCT02187055|363408322|FG002|Overall Study|No longer willing to participate|10|||
105383199|NCT02187055|363408320|FG000|Overall Study|Other|5|||
105383200|NCT02187055|363408321|FG001|Overall Study|Other|6|||
105383201|NCT02187055|363408322|FG002|Overall Study|Other|3|||
105383202|NCT02187055|363408320|FG000|Overall Study|Protocol Violation|9|||
105383203|NCT02187055|363408321|FG001|Overall Study|Protocol Violation|9|||
105383204|NCT02187055|363408322|FG002|Overall Study|Protocol Violation|4|||
105383205|NCT02187055|363408320|FG000|Overall Study|Pregnancy|3|||
105383206|NCT02187055|363408321|FG001|Overall Study|Pregnancy|1|||
105383207|NCT02187055|363408322|FG002|Overall Study|Pregnancy|0|||
105383208|NCT02187055|363408320|FG000|Overall Study|Withdrawal by Subject|11|||
105383209|NCT02187055|363408321|FG001|Overall Study|Withdrawal by Subject|11|||
105383210|NCT02187055|363408322|FG002|Overall Study|Withdrawal by Subject|11|||
105383211|NCT02187055|363408320|FG000|Overall Study|Adverse Event|21|||
105383212|NCT02187055|363408321|FG001|Overall Study|Adverse Event|26|||
105383213|NCT02187055|363408322|FG002|Overall Study|Adverse Event|36|||
105383214|NCT02187055|363408320|FG000|Overall Study|Death|2|||
105383215|NCT02187055|363408321|FG001|Overall Study|Death|0|||
105383216|NCT02187055|363408322|FG002|Overall Study|Death|0|||
105383217|NCT03520387|363408325|FG000|Pre-Randomization|Withdrawal by Subject|1|||
105383218|NCT03520387|363408326|FG001|Pre-Randomization|Withdrawal by Subject|0|||
105383219|NCT03520387|363408327|FG002|Pre-Randomization|Withdrawal by Subject|0|||
105383220|NCT03520387|363408328|FG003|Pre-Randomization|Withdrawal by Subject|0|||
105383221|NCT03520387|363408329|FG004|Pre-Randomization|Withdrawal by Subject|0|||
105383222|NCT03520387|363408325|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
105383223|NCT03520387|363408326|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
105383224|NCT03520387|363408327|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
105383225|NCT03520387|363408328|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
105383226|NCT03520387|363408329|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
105383227|NCT03336866|363408330|FG000|Overall Study|Lost to Follow-up|2|||
105383228|NCT03336866|363408331|FG001|Overall Study|Lost to Follow-up|0|||
105383229|NCT03336866|363408332|FG002|Overall Study|Lost to Follow-up|3|||
105383230|NCT03336866|363408330|FG000|Overall Study|Withdrawal by Subject|1|||
105383231|NCT03336866|363408331|FG001|Overall Study|Withdrawal by Subject|1|||
105383232|NCT03336866|363408332|FG002|Overall Study|Withdrawal by Subject|0|||
105383233|NCT03336866|363408330|FG000|Overall Study|Noncompliance with clinic house rules|0|||
105383234|NCT03336866|363408331|FG001|Overall Study|Noncompliance with clinic house rules|0|||
105383235|NCT03336866|363408332|FG002|Overall Study|Noncompliance with clinic house rules|1|||
105383236|NCT00541775|363408333|FG000|Overall Study|Adverse Event|3|||
105383237|NCT00541775|363408334|FG001|Overall Study|Adverse Event|2|||
105383238|NCT00541775|363408335|FG002|Overall Study|Adverse Event|1|||
105383239|NCT00541775|363408333|FG000|Overall Study|Lack of Efficacy|0|||
105383240|NCT00541775|363408334|FG001|Overall Study|Lack of Efficacy|0|||
105383241|NCT00541775|363408335|FG002|Overall Study|Lack of Efficacy|3|||
105492371|NCT01225887|363815739|FG000|Overall Study|Ineligible:required test not done|2|||
105383242|NCT00541775|363408333|FG000|Overall Study|Lost to Follow-up|0|||
105383243|NCT00541775|363408334|FG001|Overall Study|Lost to Follow-up|0|||
105383244|NCT00541775|363408335|FG002|Overall Study|Lost to Follow-up|2|||
105383245|NCT00541775|363408333|FG000|Overall Study|Protocol Violation|1|||
105383246|NCT00541775|363408334|FG001|Overall Study|Protocol Violation|0|||
105383247|NCT00541775|363408335|FG002|Overall Study|Protocol Violation|0|||
105383248|NCT00541775|363408333|FG000|Overall Study|Withdrawal by Subject and Other|5|||
105383249|NCT00541775|363408334|FG001|Overall Study|Withdrawal by Subject and Other|0|||
105383250|NCT00541775|363408335|FG002|Overall Study|Withdrawal by Subject and Other|2|||
105383251|NCT01945242|363408336|FG000|Overall Study|Physician Decision|3|||
105383252|NCT01945242|363408337|FG001|Overall Study|Physician Decision|3|||
105383253|NCT02975700|363408338|FG000|Overall Study|Adverse Event|1|||
105383254|NCT02975700|363408338|FG000|Overall Study|Progressive disease|3|||
105383255|NCT02975700|363408338|FG000|Overall Study|Failed screening criteria|2|||
105383256|NCT05737745|363408340|FG000|Overall Study|Withdrawal by Subject|0|||
105383257|NCT05737745|363408341|FG001|Overall Study|Withdrawal by Subject|6|||
105383258|NCT05737745|363408342|FG002|Overall Study|Withdrawal by Subject|1|||
105580258|NCT00873093|364124253|FG002|Overall Study|Death|2|||
105580259|NCT00873093|364124254|FG003|Overall Study|Death|0|||
105580260|NCT00873093|364124255|FG004|Overall Study|Death|0|||
105580261|NCT00873093|364124251|FG000|Overall Study|Physician Decision|0|||
105580262|NCT00873093|364124252|FG001|Overall Study|Physician Decision|17|||
105580263|NCT00873093|364124253|FG002|Overall Study|Physician Decision|10|||
105580264|NCT00873093|364124254|FG003|Overall Study|Physician Decision|10|||
105580265|NCT00873093|364124255|FG004|Overall Study|Physician Decision|2|||
105580266|NCT00873093|364124251|FG000|Overall Study|Withdrawal by Subject|1|||
105383267|NCT01341990|363408345|FG000|Overall Study|Adverse Event|0|||
105383268|NCT01341990|363408346|FG001|Overall Study|Adverse Event|1|||
105383269|NCT01341990|363408345|FG000|Overall Study|Torn Study Lens|1|||
105383270|NCT01341990|363408346|FG001|Overall Study|Torn Study Lens|0|||
105383271|NCT01341990|363408345|FG000|Overall Study|Withdrawal by Subject|2|||
105383272|NCT01341990|363408346|FG001|Overall Study|Withdrawal by Subject|0|||
105383273|NCT01028391|363408347|FG000|Overall Study|Adverse Event|4|||
105383274|NCT01028391|363408348|FG001|Overall Study|Adverse Event|0|||
105383275|NCT01028391|363408347|FG000|Overall Study|Lack of Efficacy|0|||
105383276|NCT01028391|363408348|FG001|Overall Study|Lack of Efficacy|2|||
105383277|NCT01028391|363408347|FG000|Overall Study|Lost to Follow-up|3|||
105383278|NCT01028391|363408348|FG001|Overall Study|Lost to Follow-up|4|||
105383279|NCT01028391|363408347|FG000|Overall Study|Physician Decision|0|||
105383280|NCT01028391|363408348|FG001|Overall Study|Physician Decision|1|||
105383281|NCT01028391|363408347|FG000|Overall Study|Withdrawal by Subject|6|||
105383282|NCT01028391|363408348|FG001|Overall Study|Withdrawal by Subject|3|||
105383283|NCT01028391|363408347|FG000|Overall Study|Needed excluded medication|1|||
105383284|NCT01028391|363408348|FG001|Overall Study|Needed excluded medication|1|||
105383285|NCT04401293|363408349|FG000|Overall Study|Withdrawal by Subject|1|||
105383286|NCT04401293|363408350|FG001|Overall Study|Withdrawal by Subject|3|||
105383287|NCT03679884|363408351|FG000|Overall Study|Other|12|||
105383288|NCT03679884|363408352|FG001|Overall Study|Other|12|||
105383289|NCT03679884|363408353|FG002|Overall Study|Other|12|||
105383290|NCT03679884|363408354|FG003|Overall Study|Other|7|||
105383291|NCT03679884|363408355|FG004|Overall Study|Other|8|||
105383292|NCT03679884|363408351|FG000|Overall Study|Lack of Efficacy|15|||
105383293|NCT03679884|363408352|FG001|Overall Study|Lack of Efficacy|29|||
105383294|NCT03679884|363408353|FG002|Overall Study|Lack of Efficacy|13|||
105383295|NCT03679884|363408354|FG003|Overall Study|Lack of Efficacy|29|||
105383296|NCT03679884|363408355|FG004|Overall Study|Lack of Efficacy|10|||
105383297|NCT03679884|363408351|FG000|Overall Study|Death|1|||
105383298|NCT03679884|363408352|FG001|Overall Study|Death|0|||
105383299|NCT03679884|363408353|FG002|Overall Study|Death|0|||
105383300|NCT03679884|363408354|FG003|Overall Study|Death|0|||
105383301|NCT03679884|363408355|FG004|Overall Study|Death|0|||
105383302|NCT03679884|363408351|FG000|Overall Study|Adverse Event|2|||
105383303|NCT03679884|363408352|FG001|Overall Study|Adverse Event|10|||
105383304|NCT03679884|363408353|FG002|Overall Study|Adverse Event|9|||
105383305|NCT03679884|363408354|FG003|Overall Study|Adverse Event|6|||
105383306|NCT03679884|363408355|FG004|Overall Study|Adverse Event|6|||
105383307|NCT03679884|363408351|FG000|Overall Study|Withdrawal by Subject|12|||
105383308|NCT03679884|363408352|FG001|Overall Study|Withdrawal by Subject|23|||
105383309|NCT03679884|363408353|FG002|Overall Study|Withdrawal by Subject|8|||
105383310|NCT03679884|363408354|FG003|Overall Study|Withdrawal by Subject|8|||
105383311|NCT03679884|363408355|FG004|Overall Study|Withdrawal by Subject|9|||
105383312|NCT03679884|363408351|FG000|Overall Study|Lost to Follow-up|1|||
105383313|NCT03679884|363408352|FG001|Overall Study|Lost to Follow-up|4|||
105383314|NCT03679884|363408353|FG002|Overall Study|Lost to Follow-up|2|||
105383315|NCT03679884|363408354|FG003|Overall Study|Lost to Follow-up|0|||
105383316|NCT03679884|363408355|FG004|Overall Study|Lost to Follow-up|3|||
105383317|NCT01026038|363408356|FG000|Overall Study|Lost to Follow-up|1|||
105383318|NCT01026038|363408357|FG001|Overall Study|Lost to Follow-up|1|||
105383319|NCT01026038|363408358|FG002|Overall Study|Lost to Follow-up|0|||
105383320|NCT06868667|363408359|FG000|Overall Study|Death|0|||
105383321|NCT06868667|363408360|FG001|Overall Study|Death|4|||
105492372|NCT01225887|363815739|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
105492373|NCT01225887|363815739|FG000|Overall Study|Ineligible:inadequate pathology|2|||
105580267|NCT00873093|364124252|FG001|Overall Study|Withdrawal by Subject|4|||
105383322|NCT06868667|363408359|FG000|Overall Study|Lost to Follow-up|0|||
105383323|NCT06868667|363408360|FG001|Overall Study|Lost to Follow-up|1|||
105383324|NCT06868667|363408359|FG000|Overall Study|Withdrawal by Subject|1|||
105383325|NCT06868667|363408360|FG001|Overall Study|Withdrawal by Subject|0|||
105383326|NCT06868667|363408359|FG000|Overall Study|Ongoing|9|||
105383327|NCT06868667|363408360|FG001|Overall Study|Ongoing|9|||
105383328|NCT06097273|363408361|FG000|Overall Study|Death|2|||
105383329|NCT06097273|363408362|FG001|Overall Study|Death|1|||
105383330|NCT06097273|363408363|FG002|Overall Study|Death|2|||
105383331|NCT06097273|363408364|FG003|Overall Study|Death|2|||
105383332|NCT06097273|363408361|FG000|Overall Study|Lost to Follow-up|27|||
105383333|NCT06097273|363408362|FG001|Overall Study|Lost to Follow-up|18|||
105383334|NCT06097273|363408363|FG002|Overall Study|Lost to Follow-up|36|||
105383335|NCT06097273|363408364|FG003|Overall Study|Lost to Follow-up|31|||
105383336|NCT06097273|363408361|FG000|Overall Study|Physician Decision|0|||
105580268|NCT00873093|364124253|FG002|Overall Study|Withdrawal by Subject|4|||
105383337|NCT06097273|363408362|FG001|Overall Study|Physician Decision|1|||
105383338|NCT06097273|363408363|FG002|Overall Study|Physician Decision|0|||
105383339|NCT06097273|363408364|FG003|Overall Study|Physician Decision|3|||
105383340|NCT06097273|363408361|FG000|Overall Study|Protocol Violation|1|||
105492374|NCT02869438|363815740|FG000|Overall Study|Lost to Follow-up|1|||
105383341|NCT06097273|363408362|FG001|Overall Study|Protocol Violation|1|||
105383342|NCT06097273|363408363|FG002|Overall Study|Protocol Violation|2|||
105383343|NCT06097273|363408364|FG003|Overall Study|Protocol Violation|1|||
105383344|NCT06097273|363408361|FG000|Overall Study|Withdrawal by Subject|14|||
105383345|NCT06097273|363408362|FG001|Overall Study|Withdrawal by Subject|11|||
105383346|NCT06097273|363408363|FG002|Overall Study|Withdrawal by Subject|14|||
105383347|NCT06097273|363408364|FG003|Overall Study|Withdrawal by Subject|15|||
105383348|NCT06097273|363408361|FG000|Overall Study|Other Than Specified|7|||
105383349|NCT06097273|363408362|FG001|Overall Study|Other Than Specified|3|||
105383350|NCT06097273|363408363|FG002|Overall Study|Other Than Specified|11|||
105383351|NCT06097273|363408364|FG003|Overall Study|Other Than Specified|6|||
105383352|NCT03599713|363408365|FG000|Overall Study|Death|38|||
105383353|NCT03599713|363408366|FG001|Overall Study|Death|3|||
105383354|NCT03599713|363408365|FG000|Overall Study|Withdrawal by Subject|17|||
105383355|NCT03599713|363408366|FG001|Overall Study|Withdrawal by Subject|0|||
105383356|NCT03599713|363408365|FG000|Overall Study|Lost to Follow-up|4|||
105383357|NCT03599713|363408366|FG001|Overall Study|Lost to Follow-up|0|||
105383358|NCT03599713|363408365|FG000|Overall Study|Discontinued Due to End of Study|42|||
105383359|NCT03599713|363408366|FG001|Overall Study|Discontinued Due to End of Study|3|||
105383360|NCT03921541|363409669|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
105383361|NCT03921541|363409670|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
105383362|NCT03554473|363409671|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
105383363|NCT03554473|363409672|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
105383364|NCT03554473|363409673|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
105383365|NCT03554473|363409671|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
105383366|NCT03554473|363409672|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
105383367|NCT03554473|363409673|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
105383368|NCT03554473|363409671|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
105383369|NCT03554473|363409672|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
105383370|NCT03554473|363409673|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
105383371|NCT01245751|363409680|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
105383372|NCT01245751|363409681|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
105383373|NCT01245751|363409682|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
105383374|NCT01245751|363409683|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
105383375|NCT01245751|363409680|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
105383376|NCT01245751|363409681|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
105383377|NCT01245751|363409682|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
105383378|NCT01245751|363409683|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
105383379|NCT01245751|363409680|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
105383380|NCT01245751|363409681|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
105383381|NCT01245751|363409682|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
105383382|NCT01245751|363409683|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
105383383|NCT00509600|363409686|FG000|Overall Study|Adverse Event|1|||
105383384|NCT00245570|363409687|FG000|Washout Between Periods III and IV|Adverse Event|0|||
105383385|NCT00245570|363409688|FG001|Washout Between Periods III and IV|Adverse Event|1|||
105383386|NCT00245570|363409689|FG002|Washout Between Periods III and IV|Adverse Event|0|||
105383387|NCT00245570|363409690|FG003|Washout Between Periods III and IV|Adverse Event|0|||
105383388|NCT00245570|363409691|FG004|Washout Between Periods III and IV|Adverse Event|0|||
105383389|NCT00245570|363409692|FG005|Washout Between Periods III and IV|Adverse Event|0|||
105383390|NCT00103506|363409693|FG000|Overall Study|Study closed by sponsor|34|||
105383391|NCT00103506|363409694|FG001|Overall Study|Study closed by sponsor|37|||
105383392|NCT00103506|363409693|FG000|Overall Study|Death|257|||
105383393|NCT00103506|363409694|FG001|Overall Study|Death|253|||
105383394|NCT00103506|363409693|FG000|Overall Study|Lost to Follow-up|13|||
105383395|NCT00103506|363409694|FG001|Overall Study|Lost to Follow-up|13|||
105383396|NCT00103506|363409693|FG000|Overall Study|Withdrawal by Subject|18|||
105383397|NCT00103506|363409694|FG001|Overall Study|Withdrawal by Subject|21|||
105383398|NCT00574951|363409695|FG000|Overall Study|Ineligible - improper prior treatment|1|||
105383399|NCT00585169|363409696|FG000|Overall Study|Withdrawal by Subject|1|||
105383400|NCT01560988|363409714|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
105383401|NCT01560988|363409715|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
105383402|NCT01560988|363409714|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
105492375|NCT02869438|363815741|FG001|Overall Study|Lost to Follow-up|0|||
105492376|NCT02869438|363815740|FG000|Overall Study|Adverse Event|1|||
105492377|NCT02869438|363815741|FG001|Overall Study|Adverse Event|0|||
105383403|NCT01560988|363409715|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
105383404|NCT01560988|363409714|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
105383405|NCT01560988|363409715|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
105383406|NCT01346709|363409716|FG000|Overall Study|Protocol Violation|35|||
105383407|NCT01346709|363409716|FG000|Overall Study|Lost to Follow-up|31|||
105383408|NCT01346709|363409716|FG000|Overall Study|Missing data in candidate risk factor|285|||
105383409|NCT01433978|363409721|FG000|Core Study|Adverse Event, Non-Fatal|0|||
105383410|NCT01433978|363409722|FG001|Core Study|Adverse Event, Non-Fatal|1|||
105383411|NCT01433978|363409723|FG002|Core Study|Adverse Event, Non-Fatal|0|||
105383412|NCT01433978|363409721|FG000|Core Study|Lack of Efficacy|5|||
105383413|NCT01433978|363409722|FG001|Core Study|Lack of Efficacy|1|||
105383414|NCT01433978|363409723|FG002|Core Study|Lack of Efficacy|0|||
105383415|NCT01433978|363409721|FG000|Core Study|Study Terminated by Sponsor|6|||
105383416|NCT01433978|363409722|FG001|Core Study|Study Terminated by Sponsor|9|||
105383417|NCT01433978|363409723|FG002|Core Study|Study Terminated by Sponsor|0|||
105383418|NCT01433978|363409721|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
105383419|NCT01433978|363409722|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
105383420|NCT01433978|363409723|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
105383421|NCT01433978|363409721|FG000|Extension Phase|Lack of Efficacy|0|||
105383422|NCT01433978|363409722|FG001|Extension Phase|Lack of Efficacy|0|||
105383423|NCT01433978|363409723|FG002|Extension Phase|Lack of Efficacy|1|||
105383424|NCT01433978|363409721|FG000|Extension Phase|Study Terminated by Sponsor|0|||
105383425|NCT01433978|363409722|FG001|Extension Phase|Study Terminated by Sponsor|0|||
105383426|NCT01433978|363409723|FG002|Extension Phase|Study Terminated by Sponsor|4|||
105383427|NCT01773889|363409730|FG000|Overall Study|lack of funding|2|||
105580269|NCT00873093|364124254|FG003|Overall Study|Withdrawal by Subject|0|||
105580270|NCT00873093|364124255|FG004|Overall Study|Withdrawal by Subject|0|||
105580271|NCT00873093|364124251|FG000|Overall Study|Ineligible|0|||
105580272|NCT00873093|364124252|FG001|Overall Study|Ineligible|1|||
105580273|NCT00873093|364124253|FG002|Overall Study|Ineligible|0|||
105580274|NCT00873093|364124254|FG003|Overall Study|Ineligible|1|||
105580275|NCT00873093|364124255|FG004|Overall Study|Ineligible|0|||
105580276|NCT01708187|364124256|FG000|Overall Study|Lost to Follow-up|0|||
105580277|NCT01708187|364124257|FG001|Overall Study|Lost to Follow-up|1|||
105580278|NCT01994720|364124260|FG000|Overall Study|Withdrawal by Subject|46|||
105383428|NCT01502072|363409731|FG000|Overall Study|Withdrawal by Subject|1|||
105383429|NCT01502072|363409732|FG001|Overall Study|Withdrawal by Subject|0|||
105383430|NCT01502072|363409733|FG002|Overall Study|Withdrawal by Subject|0|||
105383431|NCT01502072|363409731|FG000|Overall Study|Death|0|||
105383432|NCT01502072|363409732|FG001|Overall Study|Death|1|||
105383433|NCT01502072|363409733|FG002|Overall Study|Death|0|||
105383434|NCT05156125|363409734|FG000|Overall Study|Lack of Efficacy|1|||
105383435|NCT05156125|363409735|FG001|Overall Study|Lack of Efficacy|1|||
105383436|NCT05156125|363409736|FG002|Overall Study|Lack of Efficacy|1|||
105383437|NCT05156125|363409734|FG000|Overall Study|Physician Decision|0|||
105383438|NCT05156125|363409735|FG001|Overall Study|Physician Decision|0|||
105383439|NCT05156125|363409736|FG002|Overall Study|Physician Decision|1|||
105383440|NCT05156125|363409734|FG000|Overall Study|Non-compliance|0|||
105383441|NCT05156125|363409735|FG001|Overall Study|Non-compliance|1|||
105383442|NCT05156125|363409736|FG002|Overall Study|Non-compliance|1|||
105383443|NCT05156125|363409734|FG000|Overall Study|Withdrawal by Subject|0|||
105383444|NCT05156125|363409735|FG001|Overall Study|Withdrawal by Subject|0|||
105383445|NCT05156125|363409736|FG002|Overall Study|Withdrawal by Subject|1|||
105383446|NCT05156125|363409734|FG000|Overall Study|Adverse Event|2|||
105383447|NCT05156125|363409735|FG001|Overall Study|Adverse Event|1|||
105383448|NCT05156125|363409736|FG002|Overall Study|Adverse Event|0|||
105383449|NCT02609633|363409737|FG000|Overall Study|Consent Withdrawn|0|||
105383450|NCT02609633|363409738|FG001|Overall Study|Consent Withdrawn|1|||
105383451|NCT02609633|363409737|FG000|Overall Study|Protocol Deviation|1|||
105383452|NCT02609633|363409738|FG001|Overall Study|Protocol Deviation|0|||
105383453|NCT02609633|363409737|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
105383454|NCT02609633|363409738|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
105383455|NCT02609633|363409737|FG000|Overall Study|Reason not Specified|2|||
105383456|NCT02609633|363409738|FG001|Overall Study|Reason not Specified|1|||
105383457|NCT00337194|363409739|FG000|Overall Study|Adverse Event|5|||
105383458|NCT00337194|363409740|FG001|Overall Study|Adverse Event|1|||
105383459|NCT00337194|363409739|FG000|Overall Study|Death|2|||
105383460|NCT00337194|363409740|FG001|Overall Study|Death|0|||
105383461|NCT00337194|363409739|FG000|Overall Study|Withdrawal by Subject|1|||
105383462|NCT00337194|363409740|FG001|Overall Study|Withdrawal by Subject|0|||
105383463|NCT00337194|363409739|FG000|Overall Study|Disease progression|1|||
105383464|NCT00337194|363409740|FG001|Overall Study|Disease progression|2|||
105383465|NCT00337194|363409739|FG000|Overall Study|Subsequent non-protocol therapy|3|||
105383466|NCT00337194|363409740|FG001|Overall Study|Subsequent non-protocol therapy|1|||
105383467|NCT02018887|363409743|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
105383468|NCT02018887|363409744|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105383469|NCT02018887|363409745|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105383470|NCT02018887|363409746|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105383471|NCT02018887|363409747|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105383472|NCT02018887|363409748|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105383473|NCT02018887|363409749|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105383474|NCT02018887|363409750|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105383475|NCT02018887|363409751|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105383476|NCT02018887|363409752|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105383477|NCT02018887|363409753|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105383478|NCT02018887|363409743|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105383479|NCT02018887|363409744|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105383480|NCT02018887|363409745|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105383481|NCT02018887|363409746|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105383482|NCT02018887|363409747|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
105383483|NCT02018887|363409748|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105383484|NCT02018887|363409749|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
105383485|NCT02018887|363409750|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
105492378|NCT02869438|363815740|FG000|Overall Study|Withdrawal by Subject|1|||
105492379|NCT02869438|363815741|FG001|Overall Study|Withdrawal by Subject|2|||
105492380|NCT01669928|363815742|FG000|First Intervention|Withdrawal by Subject|3|||
105492381|NCT01669928|363815743|FG001|First Intervention|Withdrawal by Subject|5|||
105383486|NCT02018887|363409751|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105383487|NCT02018887|363409752|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105383488|NCT02018887|363409753|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105383489|NCT02018887|363409743|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
105383490|NCT02018887|363409744|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
105383491|NCT02018887|363409745|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
105383492|NCT02018887|363409746|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
105383493|NCT02018887|363409747|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
105383494|NCT02018887|363409748|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
105383495|NCT02018887|363409749|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
105383496|NCT02018887|363409750|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
105383497|NCT02018887|363409751|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
105383498|NCT02018887|363409752|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
105383499|NCT02018887|363409753|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
105383500|NCT02018887|363409743|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
105383501|NCT02018887|363409744|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
105383502|NCT02018887|363409745|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
105383503|NCT02018887|363409746|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
105383504|NCT02018887|363409747|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
105383505|NCT02018887|363409748|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
105383506|NCT02018887|363409749|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
105383507|NCT02018887|363409750|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
105383508|NCT02018887|363409751|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
105383509|NCT02018887|363409752|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
105383510|NCT02018887|363409753|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
105383511|NCT00122187|363409759|FG000|Overall Study|Withdrew because of resource limitations|2|||
105383512|NCT00122187|363409760|FG001|Overall Study|Withdrew because of resource limitations|2|||
105383513|NCT00799864|363409761|FG000|Overall Study|Participant reached a virologic endpoint|9|||
105383514|NCT00799864|363409762|FG001|Overall Study|Participant reached a virologic endpoint|2|||
105383515|NCT00799864|363409763|FG002|Overall Study|Participant reached a virologic endpoint|2|||
105383516|NCT00799864|363409764|FG003|Overall Study|Participant reached a virologic endpoint|0|||
105383517|NCT00799864|363409765|FG004|Overall Study|Participant reached a virologic endpoint|0|||
105383518|NCT00799864|363409761|FG000|Overall Study|Other|2|||
105383519|NCT00799864|363409762|FG001|Overall Study|Other|1|||
105383520|NCT00799864|363409763|FG002|Overall Study|Other|0|||
105383521|NCT00799864|363409764|FG003|Overall Study|Other|0|||
105383522|NCT00799864|363409765|FG004|Overall Study|Other|0|||
105383523|NCT00564070|363409766|FG000|Overall Study|Lost to Follow-up|9|||
105383524|NCT00564070|363409767|FG001|Overall Study|Lost to Follow-up|7|||
105383525|NCT00564070|363409766|FG000|Overall Study|Worsening depression, referred to care|3|||
105383526|NCT00564070|363409767|FG001|Overall Study|Worsening depression, referred to care|0|||
105383527|NCT03528577|363409770|FG000|Sequence 1|Failed Spirometry|1|||
105383528|NCT03528577|363409770|FG000|Sequence 1|Restricted medication|1|||
105383529|NCT03528577|363409770|FG000|Sequence 2|Adverse Event|1|||
105383530|NCT03528577|363409770|FG000|Sequence 2|Withdrawal by Subject|1|||
105383531|NCT03528577|363409770|FG000|Sequence 2|Failed Spirometry|1|||
105383532|NCT03528577|363409770|FG000|Sequence 3|Failed Spirometry|1|||
105383533|NCT03528577|363409770|FG000|Sequence 4|Failed Spirometry|2|||
105383534|NCT03528577|363409770|FG000|Sequence 4|Adverse Event|1|||
105383535|NCT04098302|363409771|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
105383536|NCT04098302|363409772|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
105383537|NCT04098302|363409773|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
105383538|NCT04098302|363409774|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
105383539|NCT04098302|363409771|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
105383540|NCT04098302|363409772|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
105383541|NCT04098302|363409773|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
105383542|NCT04098302|363409774|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
105383543|NCT04098302|363409771|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
105383544|NCT04098302|363409772|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
105383545|NCT04098302|363409773|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
105383546|NCT04098302|363409774|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
105383547|NCT04098302|363409771|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
105383548|NCT04098302|363409772|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
105383549|NCT04098302|363409773|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
105383550|NCT04098302|363409774|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
105383551|NCT04098302|363409771|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
105383552|NCT04098302|363409772|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
105383553|NCT04098302|363409773|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
105383554|NCT04098302|363409774|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
105383555|NCT04098302|363409771|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
105383556|NCT04098302|363409772|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
105383557|NCT04098302|363409773|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
105383558|NCT04098302|363409774|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
105492382|NCT00057876|363815746|FG000|Overall Study|Adverse Event|8|||
105492383|NCT00057876|363815747|FG001|Overall Study|Adverse Event|8|||
105383559|NCT04098302|363409771|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
105383560|NCT04098302|363409772|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
105383561|NCT04098302|363409773|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
105383562|NCT04098302|363409774|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
105383563|NCT04098302|363409771|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
105383564|NCT04098302|363409772|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
105383565|NCT04098302|363409773|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
105383566|NCT04098302|363409774|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
105383567|NCT05061706|363409775|FG000|Overall Study|Adverse Event|29|||
105383568|NCT05061706|363409776|FG001|Overall Study|Adverse Event|1|||
105383569|NCT05061706|363409775|FG000|Overall Study|Lack of Efficacy|0|||
105383570|NCT05061706|363409776|FG001|Overall Study|Lack of Efficacy|1|||
105383571|NCT05061706|363409775|FG000|Overall Study|Lost to Follow-up|2|||
105383572|NCT05061706|363409776|FG001|Overall Study|Lost to Follow-up|2|||
105383573|NCT05061706|363409775|FG000|Overall Study|Protocol Violation|3|||
105383574|NCT05061706|363409776|FG001|Overall Study|Protocol Violation|1|||
105383575|NCT05061706|363409775|FG000|Overall Study|Withdrawal by Subject|3|||
105383576|NCT05061706|363409776|FG001|Overall Study|Withdrawal by Subject|9|||
105383577|NCT00724893|363409778|FG000|Overall Study|Adverse Event|76|||
105383578|NCT00724893|363409779|FG001|Overall Study|Adverse Event|142|||
105383579|NCT00724893|363409778|FG000|Overall Study|Withdrawal by Subject|0|||
105383580|NCT00724893|363409779|FG001|Overall Study|Withdrawal by Subject|1|||
105383581|NCT00724893|363409778|FG000|Overall Study|Lack of virologic response|94|||
105383582|NCT00724893|363409779|FG001|Overall Study|Lack of virologic response|202|||
105383583|NCT00724893|363409778|FG000|Overall Study|Reason not specified|193|||
105383584|NCT00724893|363409779|FG001|Overall Study|Reason not specified|7|||
105383585|NCT00724893|363409778|FG000|Overall Study|Patient choice|0|||
105383586|NCT00724893|363409779|FG001|Overall Study|Patient choice|26|||
105383587|NCT00724893|363409778|FG000|Overall Study|Geographic reasons|0|||
105383588|NCT00724893|363409779|FG001|Overall Study|Geographic reasons|11|||
105383589|NCT00724893|363409778|FG000|Overall Study|Incarceration|0|||
105383590|NCT00724893|363409779|FG001|Overall Study|Incarceration|9|||
105383591|NCT00724893|363409778|FG000|Overall Study|Substance abuse|0|||
105383592|NCT00724893|363409779|FG001|Overall Study|Substance abuse|3|||
105383593|NCT00724893|363409778|FG000|Overall Study|Financial reasons|0|||
105383594|NCT00724893|363409779|FG001|Overall Study|Financial reasons|2|||
105383595|NCT00724893|363409778|FG000|Overall Study|Assigned shorter treatment|0|||
105383596|NCT00724893|363409779|FG001|Overall Study|Assigned shorter treatment|2|||
105383597|NCT00724893|363409778|FG000|Overall Study|Lost to Follow-up|0|||
105383598|NCT00724893|363409779|FG001|Overall Study|Lost to Follow-up|52|||
105383599|NCT00724893|363409778|FG000|Overall Study|Unknown, missing data|1|||
105383600|NCT00724893|363409779|FG001|Overall Study|Unknown, missing data|1|||
105383601|NCT01290731|363409782|FG000|Overall Study|Withdrawal by Subject|1|||
105383602|NCT01399099|363409784|FG000|Overall Study|Lost to Follow-up|14|||
105383603|NCT01399099|363409784|FG000|Overall Study|Physician Decision|1|||
105383604|NCT01399099|363409784|FG000|Overall Study|Protocol Violation|1|||
105383605|NCT01399099|363409784|FG000|Overall Study|Skin Irritation|13|||
105383606|NCT01399099|363409784|FG000|Overall Study|Infection|1|||
105383607|NCT01399099|363409784|FG000|Overall Study|Miscellaneous|4|||
105383608|NCT01668537|363409786|FG000|Overall Study|Request to Discontinue Prematurely|1|||
105383609|NCT01668537|363409787|FG001|Overall Study|Request to Discontinue Prematurely|1|||
105383610|NCT01668537|363409786|FG000|Overall Study|Subject unwilling/unable to comply|5|||
105383611|NCT01668537|363409787|FG001|Overall Study|Subject unwilling/unable to comply|0|||
105383612|NCT01668537|363409786|FG000|Overall Study|Reason Precludes Participation|1|||
105383613|NCT01668537|363409787|FG001|Overall Study|Reason Precludes Participation|0|||
105383614|NCT01668537|363409786|FG000|Overall Study|Lost to Follow-up|13|||
105383615|NCT01668537|363409787|FG001|Overall Study|Lost to Follow-up|6|||
105383616|NCT01668537|363409786|FG000|Overall Study|Other|2|||
105383617|NCT01668537|363409787|FG001|Overall Study|Other|3|||
105383618|NCT00629239|363409789|FG000|Overall Study|Adverse Event|7|||
105383619|NCT00629239|363409790|FG001|Overall Study|Adverse Event|4|||
105383620|NCT00629239|363409789|FG000|Overall Study|Physician Decision|1|||
105383621|NCT00629239|363409790|FG001|Overall Study|Physician Decision|0|||
105383622|NCT01936974|363409792|FG000|Overall Study|Physician Decision|2|||
105383623|NCT01936974|363409793|FG001|Overall Study|Physician Decision|5|||
105383624|NCT01078545|363409796|FG000|Overall Study|Lost to Follow-up|13|||
105383625|NCT01078545|363409796|FG000|Overall Study|Physician Decision|6|||
105383626|NCT01078545|363409796|FG000|Overall Study|Withdrawal by Subject|3|||
105383627|NCT01078545|363409796|FG000|Overall Study|Death|3|||
105383628|NCT01078545|363409796|FG000|Overall Study|Participant moved to another physician|1|||
105383629|NCT02280499|363409802|FG000|Overall Study|Death|14|||
105383630|NCT02280499|363409802|FG000|Overall Study|Lost to Follow-up|42|||
105383631|NCT02280499|363409802|FG000|Overall Study|Adverse Event|5|||
105383632|NCT04000724|363409809|FG000|Overall Study|Withdrawal by Subject|5|||
105383633|NCT04000724|363409810|FG001|Overall Study|Withdrawal by Subject|3|||
105383634|NCT04000724|363409811|FG002|Overall Study|Withdrawal by Subject|4|||
105383635|NCT04000724|363409809|FG000|Overall Study|Lost to Follow-up|11|||
105580279|NCT01994720|364124261|FG001|Overall Study|Withdrawal by Subject|56|||
105383636|NCT04000724|363409810|FG001|Overall Study|Lost to Follow-up|7|||
105383637|NCT04000724|363409811|FG002|Overall Study|Lost to Follow-up|13|||
105383638|NCT03113136|363409812|FG000|Overall Study|Lost to Follow-up|22|||
105383639|NCT03113136|363409813|FG001|Overall Study|Lost to Follow-up|47|||
105383640|NCT03113136|363409814|FG002|Overall Study|Lost to Follow-up|54|||
105383641|NCT03113136|363409812|FG000|Overall Study|Withdrawal by Subject|4|||
105383642|NCT03113136|363409813|FG001|Overall Study|Withdrawal by Subject|13|||
105383643|NCT03113136|363409814|FG002|Overall Study|Withdrawal by Subject|14|||
105383644|NCT03113136|363409812|FG000|Overall Study|Ineligible|0|||
105383645|NCT03113136|363409813|FG001|Overall Study|Ineligible|2|||
105383646|NCT03113136|363409814|FG002|Overall Study|Ineligible|1|||
105383647|NCT03113136|363409812|FG000|Overall Study|Study Team Decision|1|||
105383648|NCT03113136|363409813|FG001|Overall Study|Study Team Decision|4|||
105383649|NCT03113136|363409814|FG002|Overall Study|Study Team Decision|0|||
105383650|NCT00250718|363409816|FG000|Overall Study|Death|1|||
105383651|NCT00250718|363409816|FG000|Overall Study|Adverse Event|1|||
105383652|NCT00250718|363409816|FG000|Overall Study|Withdrawal by Subject|1|||
105383653|NCT01751685|363409818|FG000|6-mo Followup|Missed study visit|1|||
105383654|NCT01751685|363409819|FG001|6-mo Followup|Missed study visit|0|||
105383655|NCT01751685|363409818|FG000|6-mo Followup|Withdrawal by Subject|2|||
105383656|NCT01751685|363409819|FG001|6-mo Followup|Withdrawal by Subject|2|||
105383657|NCT01751685|363409818|FG000|6-mo Followup|Lost to Follow-up|0|||
105383658|NCT01751685|363409819|FG001|6-mo Followup|Lost to Follow-up|1|||
105383659|NCT01751685|363409818|FG000|12-mo Followup|Lost to Follow-up|5|||
105383660|NCT01751685|363409819|FG001|12-mo Followup|Lost to Follow-up|0|||
105383661|NCT03601052|363409820|FG000|Overall Study|Lost to Follow-up|2|||
105383662|NCT00837330|363409821|FG000|Overall Study|Lost to Follow-up|1|||
105383663|NCT00837330|363409822|FG001|Overall Study|Lost to Follow-up|3|||
105383664|NCT01227395|363409823|FG000|Overall Study|Protocol Violation|0|||
105383665|NCT01227395|363409824|FG001|Overall Study|Protocol Violation|1|||
105383666|NCT03259308|363409829|FG000|Overall Study|Adverse Event|5|||
105383667|NCT03259308|363409830|FG001|Overall Study|Adverse Event|4|||
105383668|NCT03259308|363409831|FG002|Overall Study|Adverse Event|1|||
105383669|NCT03259308|363409829|FG000|Overall Study|Withdrawal by Subject|2|||
105383670|NCT03259308|363409830|FG001|Overall Study|Withdrawal by Subject|1|||
105383671|NCT03259308|363409831|FG002|Overall Study|Withdrawal by Subject|3|||
105383672|NCT03259308|363409829|FG000|Overall Study|Lost to Follow-up|0|||
105383673|NCT03259308|363409830|FG001|Overall Study|Lost to Follow-up|0|||
105383674|NCT03259308|363409831|FG002|Overall Study|Lost to Follow-up|1|||
105383675|NCT03259308|363409829|FG000|Overall Study|Pregnancy|0|||
105383676|NCT03259308|363409830|FG001|Overall Study|Pregnancy|0|||
105383677|NCT03259308|363409831|FG002|Overall Study|Pregnancy|1|||
105383678|NCT03259308|363409829|FG000|Overall Study|Protocol Deviation|0|||
105383679|NCT03259308|363409830|FG001|Overall Study|Protocol Deviation|3|||
105383680|NCT03259308|363409831|FG002|Overall Study|Protocol Deviation|0|||
105383681|NCT03259308|363409829|FG000|Overall Study|Lack of Efficacy|0|||
105383682|NCT03259308|363409830|FG001|Overall Study|Lack of Efficacy|0|||
105383683|NCT03259308|363409831|FG002|Overall Study|Lack of Efficacy|1|||
105383684|NCT00362609|363409832|FG000|Overall Study|Withdrawal by Subject|0|||
105383685|NCT00362609|363409833|FG001|Overall Study|Withdrawal by Subject|1|||
105383686|NCT00362609|363409832|FG000|Overall Study|Protocol Violation|0|||
105383687|NCT00362609|363409833|FG001|Overall Study|Protocol Violation|1|||
105383688|NCT02642679|363411623|FG000|Overall Study|Withdrawal by Subject|1|||
105383689|NCT02642679|363411623|FG000|Overall Study|Physician Decision|1|||
105580280|NCT00479674|364124262|FG000|Overall Study|Adverse Event|18|||
105580281|NCT00479674|364124262|FG000|Overall Study|Withdrawal by Subject|6|||
105383690|NCT02642679|363411623|FG000|Overall Study|Physician Decision|1|||
105383691|NCT01112267|363411624|FG000|Overall Study|Adverse Event|24|||
105383692|NCT01112267|363411625|FG001|Overall Study|Adverse Event|6|||
105383693|NCT01112267|363411624|FG000|Overall Study|Withdrawal by Subject|3|||
105383694|NCT01112267|363411625|FG001|Overall Study|Withdrawal by Subject|5|||
105383695|NCT01112267|363411624|FG000|Overall Study|Protocol Violation|5|||
105383696|NCT01112267|363411625|FG001|Overall Study|Protocol Violation|3|||
105383697|NCT01112267|363411624|FG000|Overall Study|Participants not compliant|1|||
105383698|NCT01112267|363411625|FG001|Overall Study|Participants not compliant|2|||
105383699|NCT01112267|363411624|FG000|Overall Study|Participants not receive any study drug|1|||
105383700|NCT01112267|363411625|FG001|Overall Study|Participants not receive any study drug|2|||
105383701|NCT03166631|363411627|FG000|Overall Study|Progressive disease|2|||
105383702|NCT03166631|363411628|FG001|Overall Study|Progressive disease|1|||
105383703|NCT03166631|363411629|FG002|Overall Study|Progressive disease|3|||
105383704|NCT03166631|363411630|FG003|Overall Study|Progressive disease|4|||
105383705|NCT03166631|363411631|FG004|Overall Study|Progressive disease|2|||
105383706|NCT03166631|363411632|FG005|Overall Study|Progressive disease|2|||
105383707|NCT03166631|363411633|FG006|Overall Study|Progressive disease|5|||
105383708|NCT03166631|363411634|FG007|Overall Study|Progressive disease|6|||
105383709|NCT03166631|363411635|FG008|Overall Study|Progressive disease|11|||
105383710|NCT03166631|363411636|FG009|Overall Study|Progressive disease|5|||
105383711|NCT03166631|363411637|FG010|Overall Study|Progressive disease|7|||
105383712|NCT03166631|363411627|FG000|Overall Study|Physician Decision|0|||
105383713|NCT03166631|363411628|FG001|Overall Study|Physician Decision|0|||
105383714|NCT03166631|363411629|FG002|Overall Study|Physician Decision|0|||
105383715|NCT03166631|363411630|FG003|Overall Study|Physician Decision|0|||
105383716|NCT03166631|363411631|FG004|Overall Study|Physician Decision|0|||
105383717|NCT03166631|363411632|FG005|Overall Study|Physician Decision|0|||
105383718|NCT03166631|363411633|FG006|Overall Study|Physician Decision|1|||
105383719|NCT03166631|363411634|FG007|Overall Study|Physician Decision|0|||
105383720|NCT03166631|363411635|FG008|Overall Study|Physician Decision|1|||
105383721|NCT03166631|363411636|FG009|Overall Study|Physician Decision|0|||
105383722|NCT03166631|363411637|FG010|Overall Study|Physician Decision|1|||
105383723|NCT03166631|363411627|FG000|Overall Study|Death|0|||
105383724|NCT03166631|363411628|FG001|Overall Study|Death|0|||
105383725|NCT03166631|363411629|FG002|Overall Study|Death|0|||
105383726|NCT03166631|363411630|FG003|Overall Study|Death|0|||
105383727|NCT03166631|363411631|FG004|Overall Study|Death|1|||
105383728|NCT03166631|363411632|FG005|Overall Study|Death|0|||
105383729|NCT03166631|363411633|FG006|Overall Study|Death|1|||
105383730|NCT03166631|363411634|FG007|Overall Study|Death|0|||
105383731|NCT03166631|363411635|FG008|Overall Study|Death|0|||
105383732|NCT03166631|363411636|FG009|Overall Study|Death|0|||
105383733|NCT03166631|363411637|FG010|Overall Study|Death|0|||
105383734|NCT03166631|363411627|FG000|Overall Study|Adverse Event|1|||
105383735|NCT03166631|363411628|FG001|Overall Study|Adverse Event|0|||
105383736|NCT03166631|363411629|FG002|Overall Study|Adverse Event|0|||
105383737|NCT03166631|363411630|FG003|Overall Study|Adverse Event|0|||
105383738|NCT03166631|363411631|FG004|Overall Study|Adverse Event|0|||
105383739|NCT03166631|363411632|FG005|Overall Study|Adverse Event|1|||
105383740|NCT03166631|363411633|FG006|Overall Study|Adverse Event|1|||
105383741|NCT03166631|363411634|FG007|Overall Study|Adverse Event|0|||
105383742|NCT03166631|363411635|FG008|Overall Study|Adverse Event|1|||
105383743|NCT03166631|363411636|FG009|Overall Study|Adverse Event|2|||
105383744|NCT03166631|363411637|FG010|Overall Study|Adverse Event|1|||
105383745|NCT03166631|363411627|FG000|Overall Study|Withdrawal by Subject|0|||
105383746|NCT03166631|363411628|FG001|Overall Study|Withdrawal by Subject|0|||
105383747|NCT03166631|363411629|FG002|Overall Study|Withdrawal by Subject|0|||
105383748|NCT03166631|363411630|FG003|Overall Study|Withdrawal by Subject|0|||
105383749|NCT03166631|363411631|FG004|Overall Study|Withdrawal by Subject|0|||
105580282|NCT00479674|364124262|FG000|Overall Study|Physician Decision|14|||
105383750|NCT03166631|363411632|FG005|Overall Study|Withdrawal by Subject|0|||
105383751|NCT03166631|363411633|FG006|Overall Study|Withdrawal by Subject|0|||
105383752|NCT03166631|363411634|FG007|Overall Study|Withdrawal by Subject|0|||
105383753|NCT03166631|363411635|FG008|Overall Study|Withdrawal by Subject|1|||
105383754|NCT03166631|363411636|FG009|Overall Study|Withdrawal by Subject|1|||
105383755|NCT03166631|363411637|FG010|Overall Study|Withdrawal by Subject|0|||
105383756|NCT00420407|363411638|FG000|Overall Study|Lost to Follow-up|0|||
105383757|NCT00420407|363411639|FG001|Overall Study|Lost to Follow-up|3|||
105383758|NCT00420407|363411638|FG000|Overall Study|Physician Decision|2|||
105383759|NCT00420407|363411639|FG001|Overall Study|Physician Decision|1|||
105383760|NCT00420407|363411638|FG000|Overall Study|subject identified as detainee|1|||
105383761|NCT00420407|363411639|FG001|Overall Study|subject identified as detainee|0|||
105383762|NCT00420407|363411638|FG000|Overall Study|subject identified as Jehovah's witness|1|||
105383763|NCT00420407|363411639|FG001|Overall Study|subject identified as Jehovah's witness|0|||
105383764|NCT00420407|363411638|FG000|Overall Study|Withdrawal by Subject|0|||
105383765|NCT00420407|363411639|FG001|Overall Study|Withdrawal by Subject|2|||
105383766|NCT03641924|363411642|FG000|Overall Study|Withdrawal by Subject|26|||
105383767|NCT03641924|363411642|FG000|Overall Study|Lost to Follow-up|16|||
105383768|NCT03641924|363411642|FG000|Overall Study|Protocol Violation|10|||
105383769|NCT00567580|363411643|FG000|Overall Study|Protocol Violation|28|||
105383770|NCT00567580|363411644|FG001|Overall Study|Protocol Violation|24|||
105383771|NCT00567580|363411645|FG002|Overall Study|Protocol Violation|24|||
105383772|NCT01500096|363411646|FG000|Overall Study|Lost to Follow-up|1|||
105383773|NCT01500096|363411647|FG001|Overall Study|Lost to Follow-up|0|||
105383774|NCT01500096|363411648|FG002|Overall Study|Lost to Follow-up|0|||
105383775|NCT01500096|363411649|FG003|Overall Study|Lost to Follow-up|2|||
105383776|NCT01567085|363411650|FG000|Overall Study|Death|6|||
105383777|NCT01567085|363411650|FG000|Overall Study|Adverse Event|6|||
105383778|NCT01567085|363411650|FG000|Overall Study|Lost to Follow-up|3|||
105383779|NCT01567085|363411650|FG000|Overall Study|Graft loss|2|||
105383780|NCT01567085|363411650|FG000|Overall Study|Renal transplantectomy|1|||
105383781|NCT01567085|363411650|FG000|Overall Study|Returned to chronic dialysis|1|||
105383782|NCT01567085|363411650|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
105383783|NCT04289298|363411651|FG000|Overall Study|Lost to Follow-up|5|||
105383784|NCT04289298|363411652|FG001|Overall Study|Lost to Follow-up|0|||
105383785|NCT04289298|363411651|FG000|Overall Study|Withdrawal by Subject|2|||
105383786|NCT04289298|363411652|FG001|Overall Study|Withdrawal by Subject|0|||
105383787|NCT01734928|363411653|FG000|Randomization|Physician Decision|0|||
105383788|NCT01734928|363411654|FG001|Randomization|Physician Decision|1|||
105383789|NCT01734928|363411653|FG000|Randomization|clinical progression|0|||
105383790|NCT01734928|363411654|FG001|Randomization|clinical progression|1|||
105383791|NCT01734928|363411653|FG000|Randomization|progressive disease|0|||
105383792|NCT01734928|363411654|FG001|Randomization|progressive disease|2|||
105383793|NCT01734928|363411653|FG000|Randomization|Withdrew informed consent|0|||
105383794|NCT01734928|363411654|FG001|Randomization|Withdrew informed consent|4|||
105383795|NCT01734928|363411653|FG000|Randomization|Death|1|||
105383796|NCT01734928|363411654|FG001|Randomization|Death|0|||
105383797|NCT01734928|363411653|FG000|Randomization|Randomization error|1|||
105383798|NCT01734928|363411654|FG001|Randomization|Randomization error|0|||
105383799|NCT01734928|363411653|FG000|Randomization|Lost to Follow-up|1|||
105383800|NCT01734928|363411654|FG001|Randomization|Lost to Follow-up|0|||
105383801|NCT01734928|363411653|FG000|Treatment Period|Lost to Follow-up|0|||
105383802|NCT01734928|363411654|FG001|Treatment Period|Lost to Follow-up|2|||
105383803|NCT01734928|363411653|FG000|Treatment Period|Progressive Disease|167|||
105383804|NCT01734928|363411654|FG001|Treatment Period|Progressive Disease|165|||
105383805|NCT01734928|363411653|FG000|Treatment Period|Adverse Event|39|||
105383806|NCT01734928|363411654|FG001|Treatment Period|Adverse Event|52|||
105383807|NCT01734928|363411653|FG000|Treatment Period|Withdrawal of Consent|25|||
105383808|NCT01734928|363411654|FG001|Treatment Period|Withdrawal of Consent|22|||
105383809|NCT01734928|363411653|FG000|Treatment Period|Death|20|||
105383810|NCT01734928|363411654|FG001|Treatment Period|Death|9|||
105383811|NCT01734928|363411653|FG000|Treatment Period|Other Reasons|27|||
105383812|NCT01734928|363411654|FG001|Treatment Period|Other Reasons|19|||
105383813|NCT01734928|363411653|FG000|Treatment Period|Pregnancy|0|||
105383814|NCT01734928|363411654|FG001|Treatment Period|Pregnancy|1|||
105383815|NCT00504231|363411655|FG000|Overall Study|Discrepant chart documentation re route|0|||
105383816|NCT00504231|363411656|FG001|Overall Study|Discrepant chart documentation re route|0|||
105383817|NCT00504231|363411657|FG002|Overall Study|Discrepant chart documentation re route|1|||
105383818|NCT00504231|363411658|FG003|Overall Study|Discrepant chart documentation re route|0|||
105383819|NCT00088881|363411660|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
105383820|NCT00088881|363411660|FG000|Step 1 - R-CHOP|Adverse Event|1|||
105383821|NCT00088881|363411660|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
105383822|NCT00088881|363411660|FG000|Step 1 - R-CHOP|Physician Decision|1|||
105383823|NCT00088881|363411660|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
105383824|NCT00088881|363411660|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
105383825|NCT00088881|363411660|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
105383826|NCT03600350|363411669|FG000|Overall Study|Death|1|||
105383827|NCT03600350|363411669|FG000|Overall Study|On Follow Up|18|||
105383828|NCT02370394|363411670|FG000|Overall Study|Lost to Follow-up|2|||
105383829|NCT02370394|363411671|FG001|Overall Study|Lost to Follow-up|1|||
105383830|NCT02370394|363411670|FG000|Overall Study|Withdrawal by Subject|0|||
105383831|NCT02370394|363411671|FG001|Overall Study|Withdrawal by Subject|1|||
105383832|NCT01108796|363411672|FG000|Overall Study|Adverse Event|0|||
105383833|NCT01108796|363411673|FG001|Overall Study|Adverse Event|1|||
105383834|NCT01108796|363411672|FG000|Overall Study|Lost to Follow-up|7|||
105383835|NCT01108796|363411673|FG001|Overall Study|Lost to Follow-up|6|||
105383836|NCT00454142|363411674|FG000|Overall Study|Withdrawal by Subject|1|||
105383837|NCT00758043|363411675|FG000|Overall Study|Adverse Event|1|||
105383838|NCT00758043|363411676|FG001|Overall Study|Adverse Event|20|||
105383839|NCT00758043|363411677|FG002|Overall Study|Adverse Event|12|||
105383840|NCT00758043|363411678|FG003|Overall Study|Adverse Event|62|||
105383841|NCT00758043|363411675|FG000|Overall Study|Lack of Efficacy|0|||
105580283|NCT00479674|364124262|FG000|Overall Study|none provided|3|||
105383842|NCT00758043|363411676|FG001|Overall Study|Lack of Efficacy|6|||
105383843|NCT00758043|363411677|FG002|Overall Study|Lack of Efficacy|18|||
105383844|NCT00758043|363411678|FG003|Overall Study|Lack of Efficacy|12|||
105383845|NCT00758043|363411675|FG000|Overall Study|Refused Further Treatment|0|||
105383846|NCT00758043|363411676|FG001|Overall Study|Refused Further Treatment|11|||
105383847|NCT00758043|363411677|FG002|Overall Study|Refused Further Treatment|5|||
105383848|NCT00758043|363411678|FG003|Overall Study|Refused Further Treatment|8|||
105383849|NCT00758043|363411675|FG000|Overall Study|Lost to Follow-up|0|||
105383850|NCT00758043|363411676|FG001|Overall Study|Lost to Follow-up|2|||
105383851|NCT00758043|363411677|FG002|Overall Study|Lost to Follow-up|2|||
105383852|NCT00758043|363411678|FG003|Overall Study|Lost to Follow-up|5|||
105383853|NCT00758043|363411675|FG000|Overall Study|Withdrawal by Subject|0|||
105383854|NCT00758043|363411676|FG001|Overall Study|Withdrawal by Subject|1|||
105383855|NCT00758043|363411677|FG002|Overall Study|Withdrawal by Subject|1|||
105383856|NCT00758043|363411678|FG003|Overall Study|Withdrawal by Subject|4|||
105383857|NCT00758043|363411675|FG000|Overall Study|Required Prohibited Medication|0|||
105383858|NCT00758043|363411676|FG001|Overall Study|Required Prohibited Medication|0|||
105383859|NCT00758043|363411677|FG002|Overall Study|Required Prohibited Medication|1|||
105383860|NCT00758043|363411678|FG003|Overall Study|Required Prohibited Medication|3|||
105383861|NCT00758043|363411675|FG000|Overall Study|Non-Compliant With study Drug|0|||
105383862|NCT00758043|363411676|FG001|Overall Study|Non-Compliant With study Drug|0|||
105383863|NCT00758043|363411677|FG002|Overall Study|Non-Compliant With study Drug|0|||
105383864|NCT00758043|363411678|FG003|Overall Study|Non-Compliant With study Drug|1|||
105383865|NCT00758043|363411675|FG000|Overall Study|Other Reasons|0|||
105383866|NCT00758043|363411676|FG001|Overall Study|Other Reasons|1|||
105383867|NCT00758043|363411677|FG002|Overall Study|Other Reasons|0|||
105383868|NCT00758043|363411678|FG003|Overall Study|Other Reasons|5|||
105383869|NCT01129284|363411683|FG000|Overall Study|Adverse Event|2|||
105383870|NCT01129284|363411684|FG001|Overall Study|Adverse Event|0|||
105383871|NCT01129284|363411685|FG002|Overall Study|Adverse Event|1|||
105383872|NCT00784927|363411686|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
105383873|NCT00784927|363411686|FG000|Overall Study|Protocol Violation|1|||
105383874|NCT00784927|363411686|FG000|Overall Study|Ineligible|1|||
105383875|NCT02082483|363411687|FG000|Overall Study|Lost to Follow-up|1|||
105383876|NCT02082483|363411688|FG001|Overall Study|Lost to Follow-up|1|||
105383877|NCT02082483|363411687|FG000|Overall Study|Withdrawal by Subject|2|||
105383878|NCT02082483|363411688|FG001|Overall Study|Withdrawal by Subject|1|||
105383879|NCT02082483|363411687|FG000|Overall Study|Physician Decision|1|||
105383880|NCT02082483|363411688|FG001|Overall Study|Physician Decision|1|||
105383881|NCT02082483|363411687|FG000|Overall Study|Death|2|||
105383882|NCT02082483|363411688|FG001|Overall Study|Death|3|||
105383883|NCT04027946|363411690|FG000|Overall Study|Screen failures|3|||
105383884|NCT03055195|363411692|FG000|Overall Study|Lack of Efficacy|1|||
105383885|NCT03055195|363411693|FG001|Overall Study|Lack of Efficacy|0|||
105383886|NCT03055195|363411692|FG000|Overall Study|Withdrawal by Subject|6|||
105383887|NCT03055195|363411693|FG001|Overall Study|Withdrawal by Subject|7|||
105383888|NCT03055195|363411692|FG000|Overall Study|Study Terminated by Sponsor|2|||
105383889|NCT03055195|363411693|FG001|Overall Study|Study Terminated by Sponsor|6|||
105383890|NCT03055195|363411692|FG000|Overall Study|Protocol Violation|2|||
105383891|NCT03055195|363411693|FG001|Overall Study|Protocol Violation|1|||
105383892|NCT03055195|363411692|FG000|Overall Study|Physician Decision|1|||
105383893|NCT03055195|363411693|FG001|Overall Study|Physician Decision|0|||
105383894|NCT02568423|363411694|FG000|Overall Study|Lost to Follow-up|0|||
105383895|NCT02568423|363411695|FG001|Overall Study|Lost to Follow-up|2|||
105383896|NCT02568423|363411696|FG002|Overall Study|Lost to Follow-up|0|||
105383897|NCT02568423|363411697|FG003|Overall Study|Lost to Follow-up|0|||
105383898|NCT02568423|363411698|FG004|Overall Study|Lost to Follow-up|0|||
105383899|NCT02568423|363411699|FG005|Overall Study|Lost to Follow-up|0|||
105383900|NCT02568423|363411700|FG006|Overall Study|Lost to Follow-up|0|||
105383901|NCT02568423|363411701|FG007|Overall Study|Lost to Follow-up|0|||
105383902|NCT02568423|363411694|FG000|Overall Study|Physician Decision|0|||
105580284|NCT03619174|364124263|FG000|Overall Study|Lost to Follow-up|3|||
105383903|NCT02568423|363411695|FG001|Overall Study|Physician Decision|0|||
105383904|NCT02568423|363411696|FG002|Overall Study|Physician Decision|0|||
105383905|NCT02568423|363411697|FG003|Overall Study|Physician Decision|0|||
105383906|NCT02568423|363411698|FG004|Overall Study|Physician Decision|0|||
105580285|NCT03619174|364124264|FG001|Overall Study|Lost to Follow-up|0|||
105580286|NCT03619174|364124263|FG000|Overall Study|Withdrawal by Subject|4|||
105580287|NCT03619174|364124264|FG001|Overall Study|Withdrawal by Subject|3|||
105383907|NCT02568423|363411699|FG005|Overall Study|Physician Decision|1|||
105383908|NCT02568423|363411700|FG006|Overall Study|Physician Decision|0|||
105383909|NCT02568423|363411701|FG007|Overall Study|Physician Decision|0|||
105383910|NCT02301429|363411704|FG000|Overall Study|not acceptable vascular anatomy|3|||
105383911|NCT03636269|363411705|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
105383912|NCT03636269|363411706|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
105383913|NCT03636269|363411707|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
105383914|NCT03636269|363411705|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
105383915|NCT03636269|363411706|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
105383916|NCT03636269|363411707|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
105580288|NCT03619174|364124263|FG000|Overall Study|Pregnancy|1|||
105580289|NCT03619174|364124264|FG001|Overall Study|Pregnancy|1|||
105383917|NCT03636269|363411705|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
105383918|NCT03636269|363411706|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
105383919|NCT03636269|363411707|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
105383920|NCT03636269|363411705|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
105383921|NCT03636269|363411706|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
105383922|NCT03636269|363411707|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
105383923|NCT03636269|363411705|FG000|Period 1: Double-blind Phase|Other|6|||
105383924|NCT03636269|363411706|FG001|Period 1: Double-blind Phase|Other|3|||
105383925|NCT03636269|363411707|FG002|Period 1: Double-blind Phase|Other|0|||
105383926|NCT03636269|363411705|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
105383927|NCT03636269|363411706|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
105383928|NCT03636269|363411707|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
105383929|NCT03636269|363411705|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
105383930|NCT03636269|363411706|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
105383931|NCT03636269|363411707|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
105383932|NCT03636269|363411705|FG000|Period 2: Open-label Phase|Adverse Event|0|||
105383933|NCT03636269|363411706|FG001|Period 2: Open-label Phase|Adverse Event|0|||
105383934|NCT03636269|363411707|FG002|Period 2: Open-label Phase|Adverse Event|21|||
105383935|NCT03636269|363411705|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
105383936|NCT03636269|363411706|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
105383937|NCT03636269|363411707|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
105383938|NCT03636269|363411705|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
105383939|NCT03636269|363411706|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
105383940|NCT03636269|363411707|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
105383941|NCT03636269|363411705|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
105383942|NCT03636269|363411706|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
105383943|NCT03636269|363411707|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
105383944|NCT03636269|363411705|FG000|Period 2: Open-label Phase|Administrative|0|||
105383945|NCT03636269|363411706|FG001|Period 2: Open-label Phase|Administrative|0|||
105383946|NCT03636269|363411707|FG002|Period 2: Open-label Phase|Administrative|36|||
105383947|NCT03636269|363411705|FG000|Period 2: Open-label Phase|Other|0|||
105383948|NCT03636269|363411706|FG001|Period 2: Open-label Phase|Other|0|||
105383949|NCT03636269|363411707|FG002|Period 2: Open-label Phase|Other|9|||
105383950|NCT03636269|363411705|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
105383951|NCT03636269|363411706|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
105383952|NCT03636269|363411707|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
105383953|NCT02852434|363411718|FG000|Overall Study|Withdrawal by Subject|0|||
105383954|NCT02852434|363411719|FG001|Overall Study|Withdrawal by Subject|1|||
105383955|NCT02852434|363411718|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
105383956|NCT02852434|363411719|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
105383957|NCT03188705|363411720|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
105383958|NCT03188705|363411720|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
105383959|NCT01174459|363411723|FG000|Overall Study|case report form (CRF) not collected|5|||
105383960|NCT01145222|363411724|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
105383961|NCT01145222|363411725|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
105383962|NCT01145222|363411726|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
105383963|NCT01145222|363411727|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
105383964|NCT01145222|363411724|FG000|Overall Study|Poor bowel preparation|0|||
105383965|NCT01145222|363411725|FG001|Overall Study|Poor bowel preparation|0|||
105383966|NCT01145222|363411726|FG002|Overall Study|Poor bowel preparation|0|||
105383967|NCT01145222|363411727|FG003|Overall Study|Poor bowel preparation|1|||
105383968|NCT00927186|363411728|FG000|12 Months Primary Study|Adverse Event|5|||
105383969|NCT00927186|363411729|FG001|12 Months Primary Study|Adverse Event|2|||
105383970|NCT00927186|363411728|FG000|12 Months Primary Study|Lost to Follow-up|1|||
105383971|NCT00927186|363411729|FG001|12 Months Primary Study|Lost to Follow-up|0|||
105383972|NCT00927186|363411728|FG000|12 Months Primary Study|Protocol Violation|0|||
105383973|NCT00927186|363411729|FG001|12 Months Primary Study|Protocol Violation|1|||
105383974|NCT00927186|363411728|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
105383975|NCT00927186|363411729|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
105383976|NCT01717859|363411734|FG000|Overall Study|Adverse Event|5|||
105383977|NCT01717859|363411734|FG000|Overall Study|Moved out of state|1|||
105383978|NCT01717859|363411734|FG000|Overall Study|Patient concerned about mental health|1|||
105383979|NCT01717859|363411734|FG000|Overall Study|Lost to Follow-up|1|||
105383980|NCT01717859|363411734|FG000|Overall Study|Withdrawal by Subject|2|||
105383981|NCT01623752|363411735|FG000|Phase 1 (78 Weeks)|No Data|249|||
105383982|NCT01623752|363411736|FG001|Phase 1 (78 Weeks)|No Data|66|||
105383983|NCT01623752|363411737|FG002|Phase 1 (78 Weeks)|No Data|2|||
105383984|NCT01623752|363411735|FG000|Phase 1 (78 Weeks)|Other|33|||
105383985|NCT01623752|363411736|FG001|Phase 1 (78 Weeks)|Other|20|||
105383986|NCT01623752|363411737|FG002|Phase 1 (78 Weeks)|Other|0|||
105383987|NCT01623752|363411735|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
105383988|NCT01623752|363411736|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
105383989|NCT01623752|363411737|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
105383990|NCT01623752|363411735|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
105383991|NCT01623752|363411736|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
105383992|NCT01623752|363411737|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
105383993|NCT01623752|363411735|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
105383994|NCT01623752|363411736|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
105383995|NCT01623752|363411737|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
105383996|NCT01623752|363411735|FG000|Phase 2 (78 Weeks)|Other|5|||
105383997|NCT01623752|363411736|FG001|Phase 2 (78 Weeks)|Other|1|||
105383998|NCT01623752|363411737|FG002|Phase 2 (78 Weeks)|Other|0|||
105383999|NCT01623752|363411735|FG000|Phase 2 (78 Weeks)|No Data|43|||
105384000|NCT01623752|363411736|FG001|Phase 2 (78 Weeks)|No Data|11|||
105384001|NCT01623752|363411737|FG002|Phase 2 (78 Weeks)|No Data|0|||
105384002|NCT01623752|363411735|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
105384003|NCT01623752|363411736|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
105384004|NCT01623752|363411737|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
105384005|NCT01111292|363411738|FG000|Treatment|Physician Decision|1|||
105384006|NCT01111292|363411739|FG001|Treatment|Physician Decision|1|||
105384007|NCT01750281|363411740|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
105384008|NCT01750281|363411741|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
105384009|NCT01750281|363411742|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
105384010|NCT01750281|363411740|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
105384011|NCT01750281|363411741|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
105384012|NCT01750281|363411742|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
105384013|NCT01750281|363411740|FG000|Overall Study|Did not receive treatment|0|||
105384014|NCT01750281|363411741|FG001|Overall Study|Did not receive treatment|1|||
105384015|NCT01750281|363411742|FG002|Overall Study|Did not receive treatment|0|||
105384016|NCT02959892|363411743|FG000|Overall Study|PET tracer synthesis failure|1|||
105384017|NCT02959892|363411744|FG001|Overall Study|PET tracer synthesis failure|0|||
105384018|NCT02959892|363411743|FG000|Overall Study|Study termination|0|||
105384019|NCT02959892|363411744|FG001|Overall Study|Study termination|1|||
105384020|NCT05529173|363411751|FG000|Overall Study|Physician Decision|3|||
105384021|NCT05529173|363411752|FG001|Overall Study|Physician Decision|6|||
105384022|NCT05529173|363411751|FG000|Overall Study|Sample shipment delay more than one day|4|||
105384023|NCT05529173|363411752|FG001|Overall Study|Sample shipment delay more than one day|0|||
105384024|NCT04865978|363411753|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
105384025|NCT04865978|363411754|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
105384026|NCT04882215|363411755|FG000|Overall Study|Withdrawal by Subject|5|||
105384027|NCT04882215|363411756|FG001|Overall Study|Withdrawal by Subject|0|||
105384028|NCT03835117|363411757|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
105384029|NCT03835117|363411758|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
105384030|NCT00609973|363411763|FG000|Overall Study|Adverse Event|2|||
105384031|NCT00609973|363411764|FG001|Overall Study|Adverse Event|1|||
105384032|NCT00609973|363411763|FG000|Overall Study|Protocol Violation|4|||
105384033|NCT00609973|363411764|FG001|Overall Study|Protocol Violation|3|||
105384034|NCT00609973|363411763|FG000|Overall Study|Lost to Follow-up|2|||
105384035|NCT00609973|363411764|FG001|Overall Study|Lost to Follow-up|1|||
105384036|NCT00609973|363411763|FG000|Overall Study|Withdrawal by Subject|0|||
105384037|NCT00609973|363411764|FG001|Overall Study|Withdrawal by Subject|1|||
105384038|NCT03892915|363411765|FG000|Overall Study|Lost to Follow-up|6|||
105384039|NCT03892915|363411766|FG001|Overall Study|Lost to Follow-up|12|||
105384040|NCT03892915|363411765|FG000|Overall Study|Death|0|||
105384041|NCT03892915|363411766|FG001|Overall Study|Death|2|||
105384042|NCT03892915|363411765|FG000|Overall Study|Withdrawal by Subject|1|||
105384043|NCT03892915|363411766|FG001|Overall Study|Withdrawal by Subject|1|||
105384044|NCT03892915|363411765|FG000|Overall Study|unsuccessful delivery|13|||
105384045|NCT03892915|363411766|FG001|Overall Study|unsuccessful delivery|18|||
105384046|NCT01851369|363411767|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105384047|NCT01851369|363411768|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105384048|NCT01851369|363411769|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105384049|NCT01851369|363411770|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105384050|NCT01851369|363411771|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105384051|NCT01851369|363411772|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
105384052|NCT01851369|363411773|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105384053|NCT01851369|363411774|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105384054|NCT01851369|363411775|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105384055|NCT01851369|363411776|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105384056|NCT01851369|363411777|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105384057|NCT01851369|363411778|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105384058|NCT01851369|363411779|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105384059|NCT00052715|363411780|FG000|Overall Study|wrong histology|1|||
105384060|NCT04584554|363411781|FG000|Overall Study|Withdrawal by Subject|2|||
105384061|NCT04584554|363411782|FG001|Overall Study|Withdrawal by Subject|2|||
105384062|NCT02807181|363411783|FG000|Overall Study|Death|28|||
105384063|NCT02807181|363411784|FG001|Overall Study|Death|24|||
105384064|NCT02807181|363411783|FG000|Overall Study|Withdrawal by Subject|1|||
105384065|NCT02807181|363411784|FG001|Overall Study|Withdrawal by Subject|1|||
105384066|NCT02807181|363411783|FG000|Overall Study|Lost to Follow-up|0|||
105384067|NCT02807181|363411784|FG001|Overall Study|Lost to Follow-up|2|||
105384068|NCT02807181|363411783|FG000|Overall Study|Subject decision|1|||
105384069|NCT02807181|363411784|FG001|Overall Study|Subject decision|0|||
105384070|NCT02807181|363411783|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
105384071|NCT02807181|363411784|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
105384072|NCT02807181|363411783|FG000|Overall Study|In Study|3|||
105580290|NCT03619174|364124263|FG000|Overall Study|Discomfort during treatment|1|||
105580291|NCT03619174|364124264|FG001|Overall Study|Discomfort during treatment|0|||
105384073|NCT02807181|363411784|FG001|Overall Study|In Study|3|||
105384074|NCT02807181|363411783|FG000|Overall Study|Post Progression|3|||
105384075|NCT02807181|363411784|FG001|Overall Study|Post Progression|2|||
105384076|NCT05436288|363411785|FG000|Overall Study|Lost to Follow-up|1|||
105580292|NCT01439711|364124266|FG000|Overall Study|Ineligible|13|||
105384077|NCT05436288|363411785|FG000|Overall Study|Adverse Event|1|||
105384078|NCT00286455|363411788|FG000|Overall Study|Hyperglycemia rescue|19|||
105384079|NCT00286455|363411789|FG001|Overall Study|Hyperglycemia rescue|13|||
105384080|NCT00286455|363411790|FG002|Overall Study|Hyperglycemia rescue|10|||
105384081|NCT00286455|363411788|FG000|Overall Study|Adverse Event|1|||
105384082|NCT00286455|363411789|FG001|Overall Study|Adverse Event|3|||
105384083|NCT00286455|363411790|FG002|Overall Study|Adverse Event|2|||
105384084|NCT00286455|363411788|FG000|Overall Study|Lost to Follow-up|0|||
105384085|NCT00286455|363411789|FG001|Overall Study|Lost to Follow-up|3|||
105384086|NCT00286455|363411790|FG002|Overall Study|Lost to Follow-up|3|||
105384087|NCT00286455|363411788|FG000|Overall Study|Physician Decision|3|||
105384088|NCT00286455|363411789|FG001|Overall Study|Physician Decision|0|||
105384089|NCT00286455|363411790|FG002|Overall Study|Physician Decision|2|||
105384090|NCT00286455|363411788|FG000|Overall Study|Protocol Violation|1|||
105384091|NCT00286455|363411789|FG001|Overall Study|Protocol Violation|1|||
105384092|NCT00286455|363411790|FG002|Overall Study|Protocol Violation|0|||
105384093|NCT00286455|363411788|FG000|Overall Study|Participant Non-compliance|1|||
105384094|NCT00286455|363411789|FG001|Overall Study|Participant Non-compliance|0|||
105384095|NCT00286455|363411790|FG002|Overall Study|Participant Non-compliance|0|||
105384096|NCT00286455|363411788|FG000|Overall Study|Withdrawal by Subject|0|||
105384097|NCT00286455|363411789|FG001|Overall Study|Withdrawal by Subject|8|||
105384098|NCT00286455|363411790|FG002|Overall Study|Withdrawal by Subject|7|||
105384099|NCT03055221|363413719|FG000|Overall Study|Adverse Event|2|||
105384100|NCT03055221|363413719|FG000|Overall Study|Withdrawal by Subject|4|||
105384101|NCT03055221|363413719|FG000|Overall Study|Death|6|||
105384102|NCT03055221|363413719|FG000|Overall Study|Physician Decision|1|||
105384103|NCT03055221|363413719|FG000|Overall Study|Study terminated by Sponsor|3|||
105384104|NCT03055221|363413719|FG000|Overall Study|Lost to Follow-up|4|||
105384105|NCT01960842|363413724|FG000|Overall Study|Adverse Event|1|||
105384106|NCT01960842|363413724|FG000|Overall Study|Withdrawal by Subject|2|||
105384107|NCT02391584|363413725|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
105384108|NCT02391584|363413726|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
105384109|NCT02391584|363413725|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
105384110|NCT02391584|363413726|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
105384111|NCT02391584|363413725|FG000|3 Month|Lost to Follow-up|1|||
105384112|NCT02391584|363413726|FG001|3 Month|Lost to Follow-up|0|||
105384113|NCT02391584|363413725|FG000|6 Month|Withdrawal by Subject|1|||
105384114|NCT02391584|363413726|FG001|6 Month|Withdrawal by Subject|0|||
105384115|NCT02391584|363413725|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
105384116|NCT02391584|363413726|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
105384117|NCT01716559|363413729|FG000|Overall Study|Adverse Event|11|||
105384118|NCT01716559|363413729|FG000|Overall Study|Death|21|||
105384119|NCT01716559|363413729|FG000|Overall Study|Withdrawal by Subject|4|||
105384120|NCT01716559|363413729|FG000|Overall Study|Other withdrawal reason|75|||
105384121|NCT01058005|363413733|FG000|Overall Study|Adverse Event|0|||
105384122|NCT01058005|363413734|FG001|Overall Study|Adverse Event|2|||
105384123|NCT01058005|363413735|FG002|Overall Study|Adverse Event|1|||
105384124|NCT01058005|363413733|FG000|Overall Study|Physician Decision|2|||
105384125|NCT01058005|363413734|FG001|Overall Study|Physician Decision|2|||
105384126|NCT01058005|363413735|FG002|Overall Study|Physician Decision|0|||
105384127|NCT01058005|363413733|FG000|Overall Study|Withdrawal by Subject|4|||
105384128|NCT01058005|363413734|FG001|Overall Study|Withdrawal by Subject|5|||
105384129|NCT01058005|363413735|FG002|Overall Study|Withdrawal by Subject|11|||
105384130|NCT01058005|363413733|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
105384131|NCT01058005|363413734|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
105384132|NCT01058005|363413735|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
105384133|NCT01058005|363413733|FG000|Overall Study|Reason Missing|5|||
105384134|NCT01058005|363413734|FG001|Overall Study|Reason Missing|3|||
105384135|NCT01058005|363413735|FG002|Overall Study|Reason Missing|1|||
105384136|NCT00604383|363413737|FG000|Overall Study|Withdrawal by Subject|33|||
105384137|NCT00604383|363413738|FG001|Overall Study|Withdrawal by Subject|31|||
105384138|NCT00604383|363413737|FG000|Overall Study|Lost to Follow-up|24|||
105384139|NCT00604383|363413738|FG001|Overall Study|Lost to Follow-up|19|||
105384140|NCT00604383|363413737|FG000|Overall Study|Death|14|||
105384141|NCT00604383|363413738|FG001|Overall Study|Death|22|||
105384142|NCT00604383|363413737|FG000|Overall Study|Adverse Event|16|||
105384143|NCT00604383|363413738|FG001|Overall Study|Adverse Event|9|||
105384144|NCT00604383|363413737|FG000|Overall Study|Physician Decision|0|||
105384145|NCT00604383|363413738|FG001|Overall Study|Physician Decision|3|||
105384146|NCT01698008|363413739|FG000|Overall Study|Withdrawal by Subject|1|||
105384147|NCT01698008|363413740|FG001|Overall Study|Withdrawal by Subject|2|||
105384148|NCT01011283|363413743|FG000|Overall Study|Adverse Event|4|||
105580293|NCT01439711|364124266|FG000|Overall Study|Cancel|3|||
105580294|NCT01439711|364124266|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
105384149|NCT01011283|363413744|FG001|Overall Study|Adverse Event|2|||
105384150|NCT01011283|363413743|FG000|Overall Study|Progressive Disease|0|||
105384151|NCT01011283|363413744|FG001|Overall Study|Progressive Disease|2|||
105384152|NCT01011283|363413743|FG000|Overall Study|Terminated by Sponsor|5|||
105384153|NCT01011283|363413744|FG001|Overall Study|Terminated by Sponsor|5|||
105384154|NCT01011283|363413743|FG000|Overall Study|Other|2|||
105384155|NCT01011283|363413744|FG001|Overall Study|Other|2|||
105384156|NCT03994120|363413746|FG000|Overall Study|Lost to Follow-up|3|||
105384157|NCT03994120|363413747|FG001|Overall Study|Lost to Follow-up|1|||
105384158|NCT04053452|363413748|FG000|Overall Study|Withdrawal by Subject|1|||
105384159|NCT04053452|363413749|FG001|Overall Study|Withdrawal by Subject|0|||
105384160|NCT04053452|363413748|FG000|Overall Study|Time restraint due to inpatient needs|1|||
105384161|NCT04053452|363413749|FG001|Overall Study|Time restraint due to inpatient needs|2|||
105384162|NCT00281580|363413756|FG000|Overall Study|Adverse Event|2|||
105384163|NCT00281580|363413757|FG001|Overall Study|Adverse Event|0|||
105384164|NCT00281580|363413758|FG002|Overall Study|Adverse Event|2|||
105384165|NCT00281580|363413759|FG003|Overall Study|Adverse Event|4|||
105384166|NCT00281580|363413760|FG004|Overall Study|Adverse Event|1|||
105384167|NCT00281580|363413761|FG005|Overall Study|Adverse Event|0|||
105384168|NCT00281580|363413762|FG006|Overall Study|Adverse Event|1|||
105384169|NCT00281580|363413763|FG007|Overall Study|Adverse Event|0|||
105384170|NCT00281580|363413764|FG008|Overall Study|Adverse Event|1|||
105384171|NCT00281580|363413765|FG009|Overall Study|Adverse Event|6|||
105384172|NCT00281580|363413766|FG010|Overall Study|Adverse Event|0|||
105384173|NCT00281580|363413767|FG011|Overall Study|Adverse Event|5|||
105384174|NCT00281580|363413768|FG012|Overall Study|Adverse Event|8|||
105384175|NCT00281580|363413769|FG013|Overall Study|Adverse Event|2|||
105384176|NCT00281580|363413770|FG014|Overall Study|Adverse Event|3|||
105384177|NCT00281580|363413771|FG015|Overall Study|Adverse Event|3|||
105384178|NCT00281580|363413756|FG000|Overall Study|Protocol Violation|0|||
105384179|NCT00281580|363413757|FG001|Overall Study|Protocol Violation|0|||
105384180|NCT00281580|363413758|FG002|Overall Study|Protocol Violation|1|||
105384181|NCT00281580|363413759|FG003|Overall Study|Protocol Violation|1|||
105384182|NCT00281580|363413760|FG004|Overall Study|Protocol Violation|0|||
105384183|NCT00281580|363413761|FG005|Overall Study|Protocol Violation|0|||
105384184|NCT00281580|363413762|FG006|Overall Study|Protocol Violation|1|||
105384185|NCT00281580|363413763|FG007|Overall Study|Protocol Violation|0|||
105384186|NCT00281580|363413764|FG008|Overall Study|Protocol Violation|2|||
105384187|NCT00281580|363413765|FG009|Overall Study|Protocol Violation|0|||
105384188|NCT00281580|363413766|FG010|Overall Study|Protocol Violation|1|||
105384189|NCT00281580|363413767|FG011|Overall Study|Protocol Violation|2|||
105384190|NCT00281580|363413768|FG012|Overall Study|Protocol Violation|0|||
105384191|NCT00281580|363413769|FG013|Overall Study|Protocol Violation|1|||
105384192|NCT00281580|363413770|FG014|Overall Study|Protocol Violation|1|||
105384193|NCT00281580|363413771|FG015|Overall Study|Protocol Violation|3|||
105384194|NCT00281580|363413756|FG000|Overall Study|Withdrawal by Subject|3|||
105384195|NCT00281580|363413757|FG001|Overall Study|Withdrawal by Subject|0|||
105384196|NCT00281580|363413758|FG002|Overall Study|Withdrawal by Subject|1|||
105384197|NCT00281580|363413759|FG003|Overall Study|Withdrawal by Subject|1|||
105384198|NCT00281580|363413760|FG004|Overall Study|Withdrawal by Subject|1|||
105384199|NCT00281580|363413761|FG005|Overall Study|Withdrawal by Subject|2|||
105384200|NCT00281580|363413762|FG006|Overall Study|Withdrawal by Subject|2|||
105384201|NCT00281580|363413763|FG007|Overall Study|Withdrawal by Subject|0|||
105384202|NCT00281580|363413764|FG008|Overall Study|Withdrawal by Subject|1|||
105384203|NCT00281580|363413765|FG009|Overall Study|Withdrawal by Subject|4|||
105384204|NCT00281580|363413766|FG010|Overall Study|Withdrawal by Subject|1|||
105384205|NCT00281580|363413767|FG011|Overall Study|Withdrawal by Subject|1|||
105384206|NCT00281580|363413768|FG012|Overall Study|Withdrawal by Subject|2|||
105384207|NCT00281580|363413769|FG013|Overall Study|Withdrawal by Subject|2|||
105384208|NCT00281580|363413770|FG014|Overall Study|Withdrawal by Subject|1|||
105384209|NCT00281580|363413771|FG015|Overall Study|Withdrawal by Subject|5|||
105384210|NCT00281580|363413756|FG000|Overall Study|Lack of Efficacy|2|||
105384211|NCT00281580|363413757|FG001|Overall Study|Lack of Efficacy|1|||
105384212|NCT00281580|363413758|FG002|Overall Study|Lack of Efficacy|1|||
105384213|NCT00281580|363413759|FG003|Overall Study|Lack of Efficacy|6|||
105384214|NCT00281580|363413760|FG004|Overall Study|Lack of Efficacy|2|||
105492384|NCT00057876|363815746|FG000|Overall Study|Death|2|||
105384215|NCT00281580|363413761|FG005|Overall Study|Lack of Efficacy|0|||
105384216|NCT00281580|363413762|FG006|Overall Study|Lack of Efficacy|0|||
105384217|NCT00281580|363413763|FG007|Overall Study|Lack of Efficacy|0|||
105384218|NCT00281580|363413764|FG008|Overall Study|Lack of Efficacy|0|||
105384219|NCT00281580|363413765|FG009|Overall Study|Lack of Efficacy|0|||
105384220|NCT00281580|363413766|FG010|Overall Study|Lack of Efficacy|0|||
105384221|NCT00281580|363413767|FG011|Overall Study|Lack of Efficacy|1|||
105384222|NCT00281580|363413768|FG012|Overall Study|Lack of Efficacy|0|||
105384223|NCT00281580|363413769|FG013|Overall Study|Lack of Efficacy|2|||
105384224|NCT00281580|363413770|FG014|Overall Study|Lack of Efficacy|1|||
105384225|NCT00281580|363413771|FG015|Overall Study|Lack of Efficacy|0|||
105384226|NCT00281580|363413756|FG000|Overall Study|Lost to Follow-up|0|||
105384227|NCT00281580|363413757|FG001|Overall Study|Lost to Follow-up|0|||
105384228|NCT00281580|363413758|FG002|Overall Study|Lost to Follow-up|0|||
105384229|NCT00281580|363413759|FG003|Overall Study|Lost to Follow-up|3|||
105384230|NCT00281580|363413760|FG004|Overall Study|Lost to Follow-up|0|||
105384231|NCT00281580|363413761|FG005|Overall Study|Lost to Follow-up|1|||
105384232|NCT00281580|363413762|FG006|Overall Study|Lost to Follow-up|0|||
105384233|NCT00281580|363413763|FG007|Overall Study|Lost to Follow-up|1|||
105384234|NCT00281580|363413764|FG008|Overall Study|Lost to Follow-up|2|||
105384235|NCT00281580|363413765|FG009|Overall Study|Lost to Follow-up|1|||
105384236|NCT00281580|363413766|FG010|Overall Study|Lost to Follow-up|1|||
105384237|NCT00281580|363413767|FG011|Overall Study|Lost to Follow-up|0|||
105384238|NCT00281580|363413768|FG012|Overall Study|Lost to Follow-up|1|||
105384239|NCT00281580|363413769|FG013|Overall Study|Lost to Follow-up|0|||
105384240|NCT00281580|363413770|FG014|Overall Study|Lost to Follow-up|0|||
105384241|NCT00281580|363413771|FG015|Overall Study|Lost to Follow-up|0|||
105384242|NCT00281580|363413756|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
105384243|NCT00281580|363413757|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
105384244|NCT00281580|363413758|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
105384245|NCT00281580|363413759|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
105384246|NCT00281580|363413760|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
105384247|NCT00281580|363413761|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
105384248|NCT00281580|363413762|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
105384249|NCT00281580|363413763|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
105384250|NCT00281580|363413764|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
105384251|NCT00281580|363413765|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
105384252|NCT00281580|363413766|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
105384253|NCT00281580|363413767|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
105384254|NCT00281580|363413768|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
105384255|NCT00281580|363413769|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
105384256|NCT00281580|363413770|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
105384257|NCT00281580|363413771|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
105384258|NCT05463705|363413772|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
105384259|NCT05463705|363413773|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
105384260|NCT05463705|363413774|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
105384261|NCT05463705|363413775|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
105384262|NCT05463705|363413776|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
105384263|NCT05463705|363413777|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
105384264|NCT00225758|363413778|FG000|Overall Study|Adverse Event|4|||
105384265|NCT00621322|363413779|FG000|Overall Study|Lost to Follow-up|0|||
105384266|NCT00621322|363413780|FG001|Overall Study|Lost to Follow-up|0|||
105384267|NCT00621322|363413781|FG002|Overall Study|Lost to Follow-up|0|||
105384268|NCT00621322|363413782|FG003|Overall Study|Lost to Follow-up|0|||
105384269|NCT00621322|363413783|FG004|Overall Study|Lost to Follow-up|1|||
105384270|NCT00621322|363413784|FG005|Overall Study|Lost to Follow-up|0|||
105384271|NCT00621322|363413779|FG000|Overall Study|Physician Decision|0|||
105384272|NCT00621322|363413780|FG001|Overall Study|Physician Decision|0|||
105384273|NCT00621322|363413781|FG002|Overall Study|Physician Decision|1|||
105384274|NCT00621322|363413782|FG003|Overall Study|Physician Decision|1|||
105384275|NCT00621322|363413783|FG004|Overall Study|Physician Decision|0|||
105384276|NCT00621322|363413784|FG005|Overall Study|Physician Decision|0|||
105384277|NCT00621322|363413779|FG000|Overall Study|Withdrawal by Subject|0|||
105384278|NCT00621322|363413780|FG001|Overall Study|Withdrawal by Subject|0|||
105384279|NCT00621322|363413781|FG002|Overall Study|Withdrawal by Subject|0|||
105384280|NCT00621322|363413782|FG003|Overall Study|Withdrawal by Subject|1|||
105384281|NCT00621322|363413783|FG004|Overall Study|Withdrawal by Subject|0|||
105384282|NCT00621322|363413784|FG005|Overall Study|Withdrawal by Subject|2|||
105384283|NCT00621322|363413779|FG000|Overall Study|Migrated/moved from study area|1|||
105384284|NCT00621322|363413780|FG001|Overall Study|Migrated/moved from study area|0|||
105384285|NCT00621322|363413781|FG002|Overall Study|Migrated/moved from study area|1|||
105384286|NCT00621322|363413782|FG003|Overall Study|Migrated/moved from study area|1|||
105384287|NCT00621322|363413783|FG004|Overall Study|Migrated/moved from study area|0|||
105384288|NCT00621322|363413784|FG005|Overall Study|Migrated/moved from study area|2|||
105384289|NCT03071965|363413785|FG000|Overall Study|Adverse Event|0|||
105384290|NCT03071965|363413786|FG001|Overall Study|Adverse Event|0|||
105384291|NCT03071965|363413787|FG002|Overall Study|Adverse Event|1|||
105384292|NCT03071965|363413788|FG003|Overall Study|Adverse Event|0|||
105384293|NCT03071965|363413785|FG000|Overall Study|Death|0|||
105384294|NCT03071965|363413786|FG001|Overall Study|Death|0|||
105384295|NCT03071965|363413787|FG002|Overall Study|Death|1|||
105384296|NCT03071965|363413788|FG003|Overall Study|Death|1|||
105384297|NCT03071965|363413785|FG000|Overall Study|COVID-19|0|||
105384298|NCT03071965|363413786|FG001|Overall Study|COVID-19|1|||
105384299|NCT03071965|363413787|FG002|Overall Study|COVID-19|0|||
105384300|NCT03071965|363413788|FG003|Overall Study|COVID-19|1|||
105492385|NCT00057876|363815747|FG001|Overall Study|Death|1|||
105492386|NCT00057876|363815746|FG000|Overall Study|Withdrawal by Subject|5|||
105384301|NCT03071965|363413785|FG000|Overall Study|Other Health Reason|0|||
105384302|NCT03071965|363413786|FG001|Overall Study|Other Health Reason|0|||
105384303|NCT03071965|363413787|FG002|Overall Study|Other Health Reason|0|||
105384304|NCT03071965|363413788|FG003|Overall Study|Other Health Reason|1|||
105384305|NCT04263532|363413789|FG000|Overall Study|Withdrawal by Subject|2|||
105384306|NCT04263532|363413790|FG001|Overall Study|Withdrawal by Subject|0|||
105384307|NCT04034056|363413794|FG000|Overall Study|Withdrawal by Subject|2|||
105384308|NCT04034056|363413794|FG000|Overall Study|Reason Not Specified|13|||
105384309|NCT04034056|363413794|FG000|Overall Study|Adverse Event|56|||
105384310|NCT03225989|363413795|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
105384311|NCT03225989|363413796|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
105492387|NCT00057876|363815747|FG001|Overall Study|Withdrawal by Subject|6|||
105492388|NCT00057876|363815746|FG000|Overall Study|Lack of Efficacy|10|||
105492389|NCT00057876|363815747|FG001|Overall Study|Lack of Efficacy|8|||
105492390|NCT00057876|363815746|FG000|Overall Study|Ineligible|1|||
105492391|NCT00057876|363815747|FG001|Overall Study|Ineligible|2|||
105492392|NCT00057876|363815746|FG000|Overall Study|other reason|2|||
105492393|NCT00057876|363815747|FG001|Overall Study|other reason|2|||
105492394|NCT00057876|363815746|FG000|Overall Study|other complicating disease|1|||
105492395|NCT00057876|363815747|FG001|Overall Study|other complicating disease|0|||
105492396|NCT01368432|363815750|FG000|Overall Study|Lost to Follow-up|0|||
105492397|NCT01368432|363815751|FG001|Overall Study|Lost to Follow-up|1|||
105492398|NCT01008150|363815755|FG000|Overall Study|did not receive study drug|1|||
105492399|NCT01008150|363815756|FG001|Overall Study|did not receive study drug|1|||
105492400|NCT01008150|363815757|FG002|Overall Study|did not receive study drug|1|||
105492401|NCT01008150|363815758|FG003|Overall Study|did not receive study drug|0|||
105492402|NCT00737438|363815762|FG000|Overall Study|Withdrawal by Subject|2|||
105492403|NCT00737438|363815762|FG000|Overall Study|Patient ineligible|1|||
105492404|NCT02791594|363815768|FG000|Overall Study|Physician Decision|2|||
105492405|NCT03845543|363815769|FG000|Overall Study|Death|25|||
105492406|NCT03845543|363815769|FG000|Overall Study|Withdrawal by Subject|2|||
105492407|NCT03845543|363815769|FG000|Overall Study|Lost to Follow-up|12|||
105492408|NCT03845543|363815769|FG000|Overall Study|Adverse Event|17|||
105492409|NCT00857415|363815770|FG000|Overall Study|Image acquisition failure|2|||
105492410|NCT00857415|363815771|FG001|Overall Study|Image acquisition failure|0|||
105492411|NCT00857415|363815770|FG000|Overall Study|Invalid image or not imaged|3|||
105492412|NCT00857415|363815771|FG001|Overall Study|Invalid image or not imaged|0|||
105492413|NCT00857415|363815770|FG000|Overall Study|Subject still living at end of study|110|||
105492414|NCT00857415|363815771|FG001|Overall Study|Subject still living at end of study|0|||
105492415|NCT00857415|363815770|FG000|Overall Study|Deceased with no autopsy|2|||
105492416|NCT00857415|363815771|FG001|Overall Study|Deceased with no autopsy|0|||
105492417|NCT01484132|363815776|FG000|Overall Study|Lost to Follow-up|8|||
105492418|NCT01484132|363815776|FG000|Overall Study|Difficulty with time commitment|2|||
105492419|NCT01484132|363815776|FG000|Overall Study|Ineligible|1|||
105492420|NCT01484132|363815776|FG000|Overall Study|No pre-treatment urine sample collected|1|||
105492421|NCT01484132|363815776|FG000|Overall Study|No post-treatment urine sample collected|10|||
105492422|NCT04209348|363815781|FG000|Overall Study|Lost to Follow-up|1|||
105492423|NCT04209348|363815782|FG001|Overall Study|Lost to Follow-up|0|||
105492424|NCT02035475|363815783|FG000|Overall Study|Withdrawal by Subject|4|||
105492425|NCT02035475|363815783|FG000|Overall Study|Physician Decision|1|||
105492426|NCT02035475|363815783|FG000|Overall Study|Equipment Error|1|||
105492427|NCT01231347|363815784|FG000|Overall Study|Full Consent withdrawn|19|||
105492428|NCT01231347|363815785|FG001|Overall Study|Full Consent withdrawn|19|||
105492429|NCT01231347|363815786|FG002|Overall Study|Full Consent withdrawn|11|||
105492430|NCT01231347|363815784|FG000|Overall Study|Lost to Follow-up|4|||
105492431|NCT01231347|363815785|FG001|Overall Study|Lost to Follow-up|2|||
105492432|NCT01231347|363815786|FG002|Overall Study|Lost to Follow-up|2|||
105492433|NCT01231347|363815784|FG000|Overall Study|Death|202|||
105492434|NCT01231347|363815785|FG001|Overall Study|Death|210|||
105492435|NCT01231347|363815786|FG002|Overall Study|Death|101|||
105492436|NCT01231347|363815784|FG000|Overall Study|other event|7|||
105492437|NCT01231347|363815785|FG001|Overall Study|other event|9|||
105492438|NCT01231347|363815786|FG002|Overall Study|other event|3|||
105492439|NCT01977937|363815787|FG000|Overall Study|Withdrawal by Subject|2|||
105492440|NCT01977937|363815788|FG001|Overall Study|Withdrawal by Subject|1|||
105492441|NCT01977937|363815787|FG000|Overall Study|Adverse Event|1|||
105492442|NCT01977937|363815788|FG001|Overall Study|Adverse Event|0|||
105492443|NCT01977937|363815787|FG000|Overall Study|Physician Decision|0|||
105492444|NCT01977937|363815788|FG001|Overall Study|Physician Decision|1|||
105492445|NCT00915356|363815789|FG000|Overall Study|Withdrawal by Subject|1|||
105492446|NCT00915356|363815790|FG001|Overall Study|Withdrawal by Subject|0|||
105492447|NCT00915356|363815791|FG002|Overall Study|Withdrawal by Subject|0|||
105492448|NCT00915356|363815792|FG003|Overall Study|Withdrawal by Subject|0|||
105492449|NCT00915356|363815793|FG004|Overall Study|Withdrawal by Subject|0|||
105492450|NCT00191646|363815797|FG000|Overall Study|Toxicity|26|||
105492451|NCT00191646|363815798|FG001|Overall Study|Toxicity|37|||
105384312|NCT03225989|363413797|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
105492452|NCT00191646|363815797|FG000|Overall Study|Disease Progression|5|||
105492453|NCT00191646|363815798|FG001|Overall Study|Disease Progression|6|||
105492454|NCT00191646|363815797|FG000|Overall Study|Physician Decision|20|||
105492455|NCT00191646|363815798|FG001|Overall Study|Physician Decision|11|||
105492456|NCT00191646|363815797|FG000|Overall Study|Withdrawal by Subject|58|||
105492457|NCT00191646|363815798|FG001|Overall Study|Withdrawal by Subject|39|||
105492458|NCT00191646|363815797|FG000|Overall Study|Protocol Violation|5|||
105492459|NCT00191646|363815798|FG001|Overall Study|Protocol Violation|7|||
105492460|NCT00191646|363815797|FG000|Overall Study|Death|6|||
105492461|NCT00191646|363815798|FG001|Overall Study|Death|8|||
105492462|NCT00191646|363815797|FG000|Overall Study|Other|33|||
105492463|NCT00191646|363815798|FG001|Overall Study|Other|34|||
105492464|NCT00191646|363815797|FG000|Overall Study|Missing Data|18|||
105492465|NCT00191646|363815798|FG001|Overall Study|Missing Data|11|||
105492466|NCT01822496|363815810|FG000|Overall Study|Protocol Violation|2|||
105492467|NCT01822496|363815811|FG001|Overall Study|Protocol Violation|2|||
105492468|NCT01822496|363815812|FG002|Overall Study|Protocol Violation|0|||
105492469|NCT01822496|363815813|FG003|Overall Study|Protocol Violation|1|||
105492470|NCT01822496|363815810|FG000|Overall Study|Withdrawal by Subject|0|||
105492471|NCT01822496|363815811|FG001|Overall Study|Withdrawal by Subject|0|||
105492472|NCT01822496|363815812|FG002|Overall Study|Withdrawal by Subject|0|||
105492473|NCT01822496|363815813|FG003|Overall Study|Withdrawal by Subject|3|||
105492474|NCT02766465|363815814|FG000|Overall Study|Withdrawal by Subject|0|||
105492475|NCT02766465|363815815|FG001|Overall Study|Withdrawal by Subject|10|||
105492476|NCT02711345|363815816|FG000|Overall Study|Adverse Event|0|||
105492477|NCT02711345|363815817|FG001|Overall Study|Adverse Event|0|||
105492478|NCT02711345|363815818|FG002|Overall Study|Adverse Event|0|||
105492479|NCT02711345|363815819|FG003|Overall Study|Adverse Event|1|||
105492480|NCT02711345|363815820|FG004|Overall Study|Adverse Event|1|||
105492481|NCT02711345|363815821|FG005|Overall Study|Adverse Event|2|||
105492482|NCT02711345|363815822|FG006|Overall Study|Adverse Event|1|||
105492483|NCT02711345|363815823|FG007|Overall Study|Adverse Event|0|||
105492484|NCT02711345|363815824|FG008|Overall Study|Adverse Event|0|||
105492485|NCT02711345|363815825|FG009|Overall Study|Adverse Event|2|||
105492486|NCT02711345|363815816|FG000|Overall Study|Physician Decision|0|||
105492487|NCT02711345|363815817|FG001|Overall Study|Physician Decision|0|||
105492488|NCT02711345|363815818|FG002|Overall Study|Physician Decision|1|||
105492489|NCT02711345|363815819|FG003|Overall Study|Physician Decision|0|||
105492490|NCT02711345|363815820|FG004|Overall Study|Physician Decision|0|||
105492491|NCT02711345|363815821|FG005|Overall Study|Physician Decision|0|||
105580295|NCT01439711|364124266|FG000|Overall Study|Adverse Event|5|||
105580296|NCT01439711|364124266|FG000|Overall Study|Withdrawal by Subject|3|||
105580297|NCT01439711|364124266|FG000|Overall Study|Progression During Active Tx|3|||
105580298|NCT01439711|364124266|FG000|Overall Study|Noncompliance|3|||
105580299|NCT01439711|364124266|FG000|Overall Study|No MRI|9|||
105580300|NCT01012973|364124267|FG000|Overall Study|Adverse Event|5|||
105580301|NCT01012973|364124268|FG001|Overall Study|Adverse Event|5|||
105580302|NCT01012973|364124267|FG000|Overall Study|Lack of Efficacy|0|||
105580303|NCT01012973|364124268|FG001|Overall Study|Lack of Efficacy|5|||
105580304|NCT01012973|364124267|FG000|Overall Study|Lost to Follow-up|1|||
105580305|NCT01012973|364124268|FG001|Overall Study|Lost to Follow-up|0|||
105580306|NCT01012973|364124267|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
105580307|NCT01012973|364124268|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
105580308|NCT01012973|364124267|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
105580309|NCT01012973|364124268|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
105580310|NCT01012973|364124267|FG000|Overall Study|Protocol Violation|5|||
105580311|NCT01012973|364124268|FG001|Overall Study|Protocol Violation|2|||
105580312|NCT01012973|364124267|FG000|Overall Study|Withdrawal by Subject|4|||
105580313|NCT01012973|364124268|FG001|Overall Study|Withdrawal by Subject|6|||
105580314|NCT02448719|364124269|FG000|Overall Study|Withdrawal by Subject|0|||
105580315|NCT02448719|364124270|FG001|Overall Study|Withdrawal by Subject|0|||
105580316|NCT02448719|364124271|FG002|Overall Study|Withdrawal by Subject|0|||
105580317|NCT02448719|364124272|FG003|Overall Study|Withdrawal by Subject|0|||
105580318|NCT02448719|364124273|FG004|Overall Study|Withdrawal by Subject|1|||
105580319|NCT02448719|364124274|FG005|Overall Study|Withdrawal by Subject|0|||
105580320|NCT02448719|364124275|FG006|Overall Study|Withdrawal by Subject|0|||
105580321|NCT02448719|364124276|FG007|Overall Study|Withdrawal by Subject|0|||
105580322|NCT02448719|364124277|FG008|Overall Study|Withdrawal by Subject|0|||
105580323|NCT02448719|364124278|FG009|Overall Study|Withdrawal by Subject|0|||
105580324|NCT02448719|364124279|FG010|Overall Study|Withdrawal by Subject|0|||
105580325|NCT00946647|364124283|FG000|Phase 1 Part|Adverse Event|2|||
105580326|NCT00946647|364124284|FG001|Phase 1 Part|Adverse Event|5|||
105580327|NCT00946647|364124285|FG002|Phase 1 Part|Adverse Event|3|||
105580328|NCT00946647|364124286|FG003|Phase 1 Part|Adverse Event|0|||
105580329|NCT00946647|364124287|FG004|Phase 1 Part|Adverse Event|0|||
105580330|NCT00946647|364124283|FG000|Phase 1 Part|Disease progression|3|||
105580331|NCT00946647|364124284|FG001|Phase 1 Part|Disease progression|6|||
105580332|NCT00946647|364124285|FG002|Phase 1 Part|Disease progression|1|||
105580333|NCT00946647|364124286|FG003|Phase 1 Part|Disease progression|0|||
105580334|NCT00946647|364124287|FG004|Phase 1 Part|Disease progression|0|||
105580335|NCT00946647|364124283|FG000|Phase 1 Part|Withdrawal by Subject|1|||
105580336|NCT00946647|364124284|FG001|Phase 1 Part|Withdrawal by Subject|4|||
105580337|NCT00946647|364124285|FG002|Phase 1 Part|Withdrawal by Subject|3|||
105580338|NCT00946647|364124286|FG003|Phase 1 Part|Withdrawal by Subject|0|||
105580339|NCT00946647|364124287|FG004|Phase 1 Part|Withdrawal by Subject|0|||
105580340|NCT00946647|364124283|FG000|Phase 1 Part|Abnormal values|0|||
105580341|NCT00946647|364124284|FG001|Phase 1 Part|Abnormal values|2|||
105580342|NCT00946647|364124285|FG002|Phase 1 Part|Abnormal values|0|||
105580343|NCT00946647|364124286|FG003|Phase 1 Part|Abnormal values|0|||
105580344|NCT00946647|364124287|FG004|Phase 1 Part|Abnormal values|0|||
105580345|NCT00946647|364124283|FG000|Phase 1 Part|Reason missing|0|||
105580346|NCT00946647|364124284|FG001|Phase 1 Part|Reason missing|1|||
105580347|NCT00946647|364124285|FG002|Phase 1 Part|Reason missing|0|||
105580348|NCT00946647|364124286|FG003|Phase 1 Part|Reason missing|0|||
105580349|NCT00946647|364124287|FG004|Phase 1 Part|Reason missing|0|||
105580350|NCT00946647|364124283|FG000|Phase ll Part|Untreated|0|||
105580351|NCT00946647|364124284|FG001|Phase ll Part|Untreated|0|||
105580352|NCT00946647|364124285|FG002|Phase ll Part|Untreated|0|||
105580353|NCT00946647|364124286|FG003|Phase ll Part|Untreated|0|||
105580354|NCT00946647|364124287|FG004|Phase ll Part|Untreated|2|||
105580355|NCT00946647|364124283|FG000|Phase ll Part|Adverse Event|0|||
105580356|NCT00946647|364124284|FG001|Phase ll Part|Adverse Event|0|||
105580357|NCT00946647|364124285|FG002|Phase ll Part|Adverse Event|0|||
105580358|NCT00946647|364124286|FG003|Phase ll Part|Adverse Event|10|||
105580359|NCT00946647|364124287|FG004|Phase ll Part|Adverse Event|6|||
105580360|NCT00946647|364124283|FG000|Phase ll Part|Withdrawal by Subject|0|||
105580361|NCT00946647|364124284|FG001|Phase ll Part|Withdrawal by Subject|0|||
105580362|NCT00946647|364124285|FG002|Phase ll Part|Withdrawal by Subject|0|||
105580363|NCT00946647|364124286|FG003|Phase ll Part|Withdrawal by Subject|8|||
105580364|NCT00946647|364124287|FG004|Phase ll Part|Withdrawal by Subject|6|||
105580365|NCT00946647|364124283|FG000|Phase ll Part|Administrative problems|0|||
105580366|NCT00946647|364124284|FG001|Phase ll Part|Administrative problems|0|||
105580367|NCT00946647|364124285|FG002|Phase ll Part|Administrative problems|0|||
105580368|NCT00946647|364124286|FG003|Phase ll Part|Administrative problems|3|||
105580369|NCT00946647|364124287|FG004|Phase ll Part|Administrative problems|8|||
105580370|NCT00946647|364124283|FG000|Phase ll Part|Death|0|||
105580371|NCT00946647|364124284|FG001|Phase ll Part|Death|0|||
105580372|NCT00946647|364124285|FG002|Phase ll Part|Death|0|||
105580373|NCT00946647|364124286|FG003|Phase ll Part|Death|7|||
105580374|NCT00946647|364124287|FG004|Phase ll Part|Death|4|||
105580375|NCT00946647|364124283|FG000|Phase ll Part|Disease progression|0|||
105580376|NCT00946647|364124284|FG001|Phase ll Part|Disease progression|0|||
105580377|NCT00946647|364124285|FG002|Phase ll Part|Disease progression|0|||
105580378|NCT00946647|364124286|FG003|Phase ll Part|Disease progression|6|||
105580379|NCT00946647|364124287|FG004|Phase ll Part|Disease progression|14|||
105580380|NCT00946647|364124283|FG000|Phase ll Part|Protocol Violation|0|||
105492492|NCT02711345|363815822|FG006|Overall Study|Physician Decision|0|||
105492493|NCT02711345|363815823|FG007|Overall Study|Physician Decision|0|||
105492494|NCT02711345|363815824|FG008|Overall Study|Physician Decision|1|||
105492495|NCT02711345|363815825|FG009|Overall Study|Physician Decision|0|||
105492496|NCT02711345|363815816|FG000|Overall Study|Progressive disease|1|||
105492497|NCT02711345|363815817|FG001|Overall Study|Progressive disease|3|||
105492498|NCT02711345|363815818|FG002|Overall Study|Progressive disease|5|||
105492499|NCT02711345|363815819|FG003|Overall Study|Progressive disease|3|||
105492500|NCT02711345|363815820|FG004|Overall Study|Progressive disease|7|||
105492501|NCT02711345|363815821|FG005|Overall Study|Progressive disease|2|||
105492502|NCT02711345|363815822|FG006|Overall Study|Progressive disease|8|||
105492503|NCT02711345|363815823|FG007|Overall Study|Progressive disease|4|||
105492504|NCT02711345|363815824|FG008|Overall Study|Progressive disease|5|||
105492505|NCT02711345|363815825|FG009|Overall Study|Progressive disease|6|||
105492506|NCT02711345|363815816|FG000|Overall Study|Subject/guardian decision|0|||
105492507|NCT02711345|363815817|FG001|Overall Study|Subject/guardian decision|0|||
105492508|NCT02711345|363815818|FG002|Overall Study|Subject/guardian decision|0|||
105492509|NCT02711345|363815819|FG003|Overall Study|Subject/guardian decision|0|||
105492510|NCT02711345|363815820|FG004|Overall Study|Subject/guardian decision|0|||
105492511|NCT02711345|363815821|FG005|Overall Study|Subject/guardian decision|2|||
105492512|NCT02711345|363815822|FG006|Overall Study|Subject/guardian decision|3|||
105492513|NCT02711345|363815823|FG007|Overall Study|Subject/guardian decision|1|||
105492514|NCT02711345|363815824|FG008|Overall Study|Subject/guardian decision|0|||
105492515|NCT02711345|363815825|FG009|Overall Study|Subject/guardian decision|4|||
105492516|NCT02711345|363815816|FG000|Overall Study|Death|1|||
105492517|NCT02711345|363815817|FG001|Overall Study|Death|0|||
105492518|NCT02711345|363815818|FG002|Overall Study|Death|0|||
105492519|NCT02711345|363815819|FG003|Overall Study|Death|0|||
105492520|NCT02711345|363815820|FG004|Overall Study|Death|0|||
105492521|NCT02711345|363815821|FG005|Overall Study|Death|0|||
105492522|NCT02711345|363815822|FG006|Overall Study|Death|0|||
105492523|NCT02711345|363815823|FG007|Overall Study|Death|1|||
105492524|NCT02711345|363815824|FG008|Overall Study|Death|0|||
105492525|NCT02711345|363815825|FG009|Overall Study|Death|0|||
105492526|NCT01011738|363815826|FG000|Overall Study|Death|12|||
105492527|NCT01011738|363815827|FG001|Overall Study|Death|3|||
105492528|NCT01011738|363815828|FG002|Overall Study|Death|0|||
105492529|NCT01011738|363815826|FG000|Overall Study|Unknown reasons|312|||
105492530|NCT01011738|363815827|FG001|Overall Study|Unknown reasons|291|||
105492531|NCT01011738|363815828|FG002|Overall Study|Unknown reasons|17|||
105492532|NCT02567552|363815829|FG000|Overall Study|Adverse Event|0|||
105492533|NCT02567552|363815830|FG001|Overall Study|Adverse Event|1|||
105492534|NCT05521906|363815833|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
105492535|NCT05521906|363815834|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
105492536|NCT03350620|363815835|FG000|Stage 2|Adverse Event|0|||
105492537|NCT03350620|363815836|FG001|Stage 2|Adverse Event|1|||
105492538|NCT03350620|363815837|FG002|Stage 2|Adverse Event|1|||
105492539|NCT03350620|363815835|FG000|Stage 2|Lack of Efficacy|0|||
105492540|NCT03350620|363815836|FG001|Stage 2|Lack of Efficacy|2|||
105492541|NCT03350620|363815837|FG002|Stage 2|Lack of Efficacy|0|||
105492542|NCT03350620|363815835|FG000|Stage 2|Lost to Follow-up|1|||
105492543|NCT03350620|363815836|FG001|Stage 2|Lost to Follow-up|2|||
105492544|NCT03350620|363815837|FG002|Stage 2|Lost to Follow-up|2|||
105492545|NCT03350620|363815835|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
105492546|NCT03350620|363815836|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
105492547|NCT03350620|363815837|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
105492548|NCT03507400|363815841|FG000|Overall Study|discontinued|5|||
105580381|NCT00946647|364124284|FG001|Phase ll Part|Protocol Violation|0|||
105580382|NCT00946647|364124285|FG002|Phase ll Part|Protocol Violation|0|||
105580383|NCT00946647|364124286|FG003|Phase ll Part|Protocol Violation|4|||
105580384|NCT00946647|364124287|FG004|Phase ll Part|Protocol Violation|2|||
105492549|NCT03507400|363815842|FG001|Overall Study|discontinued|1|||
105492550|NCT03507400|363815841|FG000|Overall Study|Lost to Follow-up|8|||
105492551|NCT03507400|363815842|FG001|Overall Study|Lost to Follow-up|6|||
105492552|NCT03507400|363815841|FG000|Overall Study|Protocol Violation|0|||
105492553|NCT03507400|363815842|FG001|Overall Study|Protocol Violation|1|||
105492554|NCT00560885|363815843|FG000|Overall Study|Death|7|||
105492555|NCT00560885|363815843|FG000|Overall Study|Withdrawal by Subject|1|||
105492556|NCT05419908|363815845|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
105580385|NCT00946647|364124283|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
105580386|NCT00946647|364124284|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
105580387|NCT00946647|364124285|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
105580388|NCT00946647|364124286|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
105580389|NCT00946647|364124287|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
105580390|NCT01368211|364124288|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
105580391|NCT01368211|364124289|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
105580392|NCT01960790|364124296|FG000|Overall Study|Survey forms could not be recovered|3|||
105580393|NCT01960790|364124296|FG000|Overall Study|Treat with Humira outside survey period|3|||
105580394|NCT01960790|364124296|FG000|Overall Study|Transferred to another hospital|4|||
105580395|NCT01960790|364124296|FG000|Overall Study|Unevaluable for safety|1|||
105580396|NCT01824472|364124302|FG000|Overall Study|Lost to Follow-up|0|||
105580397|NCT01824472|364124303|FG001|Overall Study|Lost to Follow-up|0|||
105580398|NCT01824472|364124304|FG002|Overall Study|Lost to Follow-up|1|||
105580399|NCT01824472|364124302|FG000|Overall Study|Withdrawal by Subject|1|||
105580400|NCT01824472|364124303|FG001|Overall Study|Withdrawal by Subject|5|||
105580401|NCT01824472|364124304|FG002|Overall Study|Withdrawal by Subject|3|||
105580402|NCT01824472|364124302|FG000|Overall Study|Ineligible post randomization&screening|0|||
105580403|NCT01824472|364124303|FG001|Overall Study|Ineligible post randomization&screening|2|||
105580404|NCT01824472|364124304|FG002|Overall Study|Ineligible post randomization&screening|0|||
105580405|NCT03387514|364124310|FG000|Overall Study|Withdrawal by Subject|2|||
105580406|NCT03387514|364124310|FG000|Overall Study|Physician Decision|1|||
105580407|NCT03387514|364124310|FG000|Overall Study|Lost to Follow-up|2|||
105580408|NCT00245011|364124315|FG000|Overall Study|Lack of Efficacy|1|||
105580409|NCT03317379|364124316|FG000|Overall Study|Lost to Follow-up|0|||
105580410|NCT03317379|364124317|FG001|Overall Study|Lost to Follow-up|3|||
105580411|NCT03317379|364124318|FG002|Overall Study|Lost to Follow-up|2|||
105580412|NCT00742885|364126415|FG000|Overall Study|Lost to Follow-up|1|||
105580413|NCT00742885|364126416|FG001|Overall Study|Lost to Follow-up|0|||
105580414|NCT01755689|364126417|FG000|Overall Study|Withdrawal by Subject|1|||
105580415|NCT01755689|364126418|FG001|Overall Study|Withdrawal by Subject|3|||
105580416|NCT01755689|364126419|FG002|Overall Study|Withdrawal by Subject|2|||
105580417|NCT01755689|364126420|FG003|Overall Study|Withdrawal by Subject|1|||
105580418|NCT01755689|364126421|FG004|Overall Study|Withdrawal by Subject|1|||
105580419|NCT01755689|364126417|FG000|Overall Study|Migrated/moved from study area|0|||
105580420|NCT01755689|364126418|FG001|Overall Study|Migrated/moved from study area|1|||
105580421|NCT01755689|364126419|FG002|Overall Study|Migrated/moved from study area|1|||
105580422|NCT01755689|364126420|FG003|Overall Study|Migrated/moved from study area|1|||
105580423|NCT01755689|364126421|FG004|Overall Study|Migrated/moved from study area|1|||
105580424|NCT01755689|364126417|FG000|Overall Study|Lost to Follow-up|1|||
105580425|NCT01755689|364126418|FG001|Overall Study|Lost to Follow-up|0|||
105580426|NCT01755689|364126419|FG002|Overall Study|Lost to Follow-up|1|||
105580427|NCT01755689|364126420|FG003|Overall Study|Lost to Follow-up|0|||
105580428|NCT01755689|364126421|FG004|Overall Study|Lost to Follow-up|2|||
105580429|NCT01755689|364126417|FG000|Overall Study|Pregnancy|1|||
105580430|NCT01755689|364126418|FG001|Overall Study|Pregnancy|1|||
105580431|NCT01755689|364126419|FG002|Overall Study|Pregnancy|2|||
105580432|NCT01755689|364126420|FG003|Overall Study|Pregnancy|4|||
105580433|NCT01755689|364126421|FG004|Overall Study|Pregnancy|2|||
105580434|NCT00329719|364126422|FG000|Overall Study|Lost to Follow-up|0|||
105580435|NCT00329719|364126423|FG001|Overall Study|Lost to Follow-up|0|||
105580436|NCT00329719|364126424|FG002|Overall Study|Lost to Follow-up|0|||
105580437|NCT00329719|364126425|FG003|Overall Study|Lost to Follow-up|1|||
105580438|NCT01681368|364126426|FG000|Overall Study|Refused further treatment|1|||
105580439|NCT01681368|364126426|FG000|Overall Study|Refused further follow up|1|||
105580440|NCT02692235|364126427|FG000|Overall Study|Withdrawal by Subject|2|||
105580441|NCT02692235|364126428|FG001|Overall Study|Withdrawal by Subject|1|||
105580442|NCT02692235|364126427|FG000|Overall Study|Adverse Event|1|||
105580443|NCT02692235|364126428|FG001|Overall Study|Adverse Event|2|||
105580444|NCT00830947|364126429|FG000|Overall Study|Lost to Follow-up|4|||
105580445|NCT00830947|364126430|FG001|Overall Study|Lost to Follow-up|4|||
105580446|NCT04212169|364126431|FG000|Overall Study|Adverse Event|0|||
105580447|NCT04212169|364126432|FG001|Overall Study|Adverse Event|0|||
105580448|NCT04212169|364126433|FG002|Overall Study|Adverse Event|0|||
105580449|NCT04212169|364126434|FG003|Overall Study|Adverse Event|2|||
105580450|NCT04212169|364126431|FG000|Overall Study|Lost to Follow-up|1|||
105580451|NCT04212169|364126432|FG001|Overall Study|Lost to Follow-up|0|||
105580452|NCT04212169|364126433|FG002|Overall Study|Lost to Follow-up|0|||
105580453|NCT04212169|364126434|FG003|Overall Study|Lost to Follow-up|2|||
105580454|NCT04212169|364126431|FG000|Overall Study|Withdrawal by Subject|10|||
105580455|NCT04212169|364126432|FG001|Overall Study|Withdrawal by Subject|2|||
105580456|NCT04212169|364126433|FG002|Overall Study|Withdrawal by Subject|5|||
105580457|NCT04212169|364126434|FG003|Overall Study|Withdrawal by Subject|7|||
105580458|NCT04212169|364126431|FG000|Overall Study|Other reason, unspecified|3|||
105580459|NCT04212169|364126432|FG001|Overall Study|Other reason, unspecified|1|||
105580460|NCT04212169|364126433|FG002|Overall Study|Other reason, unspecified|0|||
105580461|NCT04212169|364126434|FG003|Overall Study|Other reason, unspecified|2|||
105580462|NCT02176928|364126435|FG000|Overall Study|Lost to Follow-up|2|||
105580463|NCT02176928|364126436|FG001|Overall Study|Lost to Follow-up|4|||
105580464|NCT02018861|364126444|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
105580465|NCT02018861|364126445|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
105580466|NCT02018861|364126446|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
105580467|NCT02018861|364126447|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
105580468|NCT02018861|364126448|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
105580469|NCT02018861|364126449|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
105580470|NCT02018861|364126450|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
105580471|NCT02018861|364126451|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
105580472|NCT02018861|364126452|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
105580473|NCT02018861|364126453|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
105580474|NCT02018861|364126444|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
105580475|NCT02018861|364126445|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
105580476|NCT02018861|364126446|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
105580477|NCT02018861|364126447|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
105580478|NCT02018861|364126448|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
105580479|NCT02018861|364126449|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
105580480|NCT02018861|364126450|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
105580481|NCT02018861|364126451|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
105580482|NCT02018861|364126452|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
105580483|NCT02018861|364126453|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
105580484|NCT02018861|364126444|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
105580485|NCT02018861|364126445|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
105580486|NCT02018861|364126446|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
105580487|NCT02018861|364126447|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
105580488|NCT02018861|364126448|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
105580489|NCT02018861|364126449|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
105580490|NCT02018861|364126450|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
105580491|NCT02018861|364126451|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
105580492|NCT02018861|364126452|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
105580493|NCT02018861|364126453|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
105580494|NCT02018861|364126444|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
105580495|NCT02018861|364126445|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
105580496|NCT02018861|364126446|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
105580497|NCT02018861|364126447|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
105580498|NCT02018861|364126448|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
105580499|NCT02018861|364126449|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
105580500|NCT02018861|364126450|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
105580501|NCT02018861|364126451|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
105580502|NCT02018861|364126452|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
105580503|NCT02018861|364126453|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
105580504|NCT02018861|364126444|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
105580505|NCT02018861|364126445|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
105580506|NCT02018861|364126446|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
105580507|NCT02018861|364126447|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
105580508|NCT02018861|364126448|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
105580509|NCT02018861|364126449|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
105580510|NCT02018861|364126450|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
105580511|NCT02018861|364126451|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
105580512|NCT02018861|364126452|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
105580513|NCT02018861|364126453|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
105580514|NCT02018861|364126444|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
105580515|NCT02018861|364126445|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
105580516|NCT02018861|364126446|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
105580517|NCT02018861|364126447|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
105580518|NCT02018861|364126448|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
105580519|NCT02018861|364126449|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
105580520|NCT02018861|364126450|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
105580521|NCT02018861|364126451|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
105580522|NCT02018861|364126452|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
105580523|NCT02018861|364126453|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
105492557|NCT05419908|363815846|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
105492558|NCT05419908|363815845|FG000|Overall Study|Serious Adverse Event|0|||
105492559|NCT05419908|363815846|FG001|Overall Study|Serious Adverse Event|2|||
105492560|NCT05419908|363815845|FG000|Overall Study|Withdrawal by Subject|2|||
105492561|NCT05419908|363815846|FG001|Overall Study|Withdrawal by Subject|0|||
105492562|NCT05419908|363815845|FG000|Overall Study|Miscellaneous|1|||
105492563|NCT05419908|363815846|FG001|Overall Study|Miscellaneous|1|||
105492564|NCT01554397|363815849|FG000|Overall Study|Withdrawal by Subject|1|||
105492565|NCT01554397|363815850|FG001|Overall Study|Withdrawal by Subject|0|||
105492566|NCT01554397|363815849|FG000|Overall Study|Ineligible|7|||
105492567|NCT01554397|363815850|FG001|Overall Study|Ineligible|0|||
105492568|NCT02160782|363817087|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
105492569|NCT02160782|363817088|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
105492570|NCT02160782|363817089|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
105492571|NCT02160782|363817090|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
105492572|NCT02160782|363817091|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
105492573|NCT02160782|363817087|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
105492574|NCT02160782|363817088|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
105492575|NCT02160782|363817089|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
105492576|NCT02160782|363817090|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
105492577|NCT02160782|363817091|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
105492578|NCT02160782|363817087|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
105492579|NCT02160782|363817088|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
105492580|NCT02160782|363817089|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
105492581|NCT02160782|363817090|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
105492582|NCT02160782|363817091|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
105492583|NCT02160782|363817087|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
105492584|NCT02160782|363817088|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
105492585|NCT02160782|363817089|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
105492586|NCT02160782|363817090|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
105492587|NCT02160782|363817091|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
105492588|NCT02160782|363817087|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
105492589|NCT02160782|363817088|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
105492590|NCT02160782|363817089|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
105492591|NCT02160782|363817090|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
105492592|NCT02160782|363817091|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
105492593|NCT02160782|363817087|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
105492594|NCT02160782|363817088|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
105492595|NCT02160782|363817089|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
105492596|NCT02160782|363817090|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
105492597|NCT02160782|363817091|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
105492598|NCT02160782|363817087|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
105492599|NCT02160782|363817088|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
105492600|NCT02160782|363817089|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
105492601|NCT02160782|363817090|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
105492602|NCT02160782|363817091|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
105492603|NCT01397201|363817093|FG000|Overall Study|Not treated|0|||
105492604|NCT01397201|363817094|FG001|Overall Study|Not treated|0|||
105492605|NCT01397201|363817095|FG002|Overall Study|Not treated|1|||
105492606|NCT01397201|363817096|FG003|Overall Study|Not treated|0|||
105492607|NCT01397201|363817097|FG004|Overall Study|Not treated|0|||
105492608|NCT01397201|363817093|FG000|Overall Study|Not yet defined|3|||
105492609|NCT01397201|363817094|FG001|Overall Study|Not yet defined|6|||
105492610|NCT01397201|363817095|FG002|Overall Study|Not yet defined|5|||
105492611|NCT01397201|363817096|FG003|Overall Study|Not yet defined|5|||
105492612|NCT01397201|363817097|FG004|Overall Study|Not yet defined|4|||
105492613|NCT01397201|363817093|FG000|Overall Study|Adverse Event|2|||
105492614|NCT01397201|363817094|FG001|Overall Study|Adverse Event|0|||
105492615|NCT01397201|363817095|FG002|Overall Study|Adverse Event|0|||
105492616|NCT01397201|363817096|FG003|Overall Study|Adverse Event|0|||
105492617|NCT01397201|363817097|FG004|Overall Study|Adverse Event|0|||
105492618|NCT03437512|363817098|FG000|Randomized|Withdrawal by Subject|0|||
105492619|NCT03437512|363817099|FG001|Randomized|Withdrawal by Subject|2|||
105492620|NCT03437512|363817098|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
105492621|NCT03437512|363817099|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
105492622|NCT04493333|363817100|FG000|Overall Study|Withdrawal by Subject|1|||
105492623|NCT04493333|363817101|FG001|Overall Study|Withdrawal by Subject|1|||
105492624|NCT04493333|363817100|FG000|Overall Study|Ineligible|0|||
105492625|NCT04493333|363817101|FG001|Overall Study|Ineligible|1|||
105492626|NCT04493333|363817100|FG000|Overall Study|Noncompliance|2|||
105492627|NCT04493333|363817101|FG001|Overall Study|Noncompliance|1|||
105492628|NCT00674973|363817104|FG000|Overall Study|Insufficient Therapeutic Response|77|||
105492629|NCT00674973|363817105|FG001|Overall Study|Insufficient Therapeutic Response|72|||
105492630|NCT00674973|363817104|FG000|Overall Study|Refused Treatment|1|||
105492631|NCT00674973|363817105|FG001|Overall Study|Refused Treatment|5|||
105492632|NCT00674973|363817104|FG000|Overall Study|Failure to Return|1|||
105492633|NCT00674973|363817105|FG001|Overall Study|Failure to Return|0|||
105492634|NCT00674973|363817104|FG000|Overall Study|Adverse Event|2|||
105492635|NCT00674973|363817105|FG001|Overall Study|Adverse Event|9|||
105492636|NCT00674973|363817104|FG000|Overall Study|Death|19|||
105492637|NCT00674973|363817105|FG001|Overall Study|Death|15|||
105492638|NCT00674973|363817104|FG000|Overall Study|Protocol Violation|0|||
105492639|NCT00674973|363817105|FG001|Overall Study|Protocol Violation|1|||
105492640|NCT00451451|363817106|FG000|Overall Study|Adverse Event|11|||
105492641|NCT00451451|363817107|FG001|Overall Study|Adverse Event|21|||
105492642|NCT00451451|363817108|FG002|Overall Study|Adverse Event|26|||
105492643|NCT00451451|363817109|FG003|Overall Study|Adverse Event|10|||
105492644|NCT00451451|363817106|FG000|Overall Study|Lost to Follow-up|11|||
105492645|NCT00451451|363817107|FG001|Overall Study|Lost to Follow-up|9|||
105492646|NCT00451451|363817108|FG002|Overall Study|Lost to Follow-up|8|||
105492647|NCT00451451|363817109|FG003|Overall Study|Lost to Follow-up|11|||
105492648|NCT00451451|363817106|FG000|Overall Study|Consent Withdrawn|14|||
105492649|NCT00451451|363817107|FG001|Overall Study|Consent Withdrawn|9|||
105492650|NCT00451451|363817108|FG002|Overall Study|Consent Withdrawn|17|||
105492651|NCT00451451|363817109|FG003|Overall Study|Consent Withdrawn|17|||
105492652|NCT00451451|363817106|FG000|Overall Study|Investigator Decision|6|||
105492653|NCT00451451|363817107|FG001|Overall Study|Investigator Decision|2|||
105492654|NCT00451451|363817108|FG002|Overall Study|Investigator Decision|1|||
105492655|NCT00451451|363817109|FG003|Overall Study|Investigator Decision|2|||
105492656|NCT00451451|363817106|FG000|Overall Study|Subject Non-Compliance|8|||
105492657|NCT00451451|363817107|FG001|Overall Study|Subject Non-Compliance|4|||
105492658|NCT00451451|363817108|FG002|Overall Study|Subject Non-Compliance|3|||
105492659|NCT00451451|363817109|FG003|Overall Study|Subject Non-Compliance|3|||
105492660|NCT00451451|363817106|FG000|Overall Study|Death|1|||
105492661|NCT00451451|363817107|FG001|Overall Study|Death|0|||
105492662|NCT00451451|363817108|FG002|Overall Study|Death|0|||
105492663|NCT00451451|363817109|FG003|Overall Study|Death|1|||
105492664|NCT00451451|363817106|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
105492665|NCT00451451|363817107|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
105492666|NCT00451451|363817108|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
105492667|NCT00451451|363817109|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
105492668|NCT05036369|363817110|FG000|Overall Study|Run In non compliance|1|||
105492669|NCT05036369|363817111|FG001|Overall Study|Run In non compliance|2|||
105492670|NCT05036369|363817110|FG000|Overall Study|Change in eligibility criteria|0|||
105492671|NCT05036369|363817111|FG001|Overall Study|Change in eligibility criteria|1|||
105492672|NCT03332771|363817112|FG000|Overall Study|Adverse Event|6|||
105492673|NCT03332771|363817113|FG001|Overall Study|Adverse Event|4|||
105492674|NCT03332771|363817114|FG002|Overall Study|Adverse Event|1|||
105492675|NCT03332771|363817115|FG003|Overall Study|Adverse Event|3|||
105492676|NCT03332771|363817112|FG000|Overall Study|Poor Compliance to Protocol|0|||
105492677|NCT03332771|363817113|FG001|Overall Study|Poor Compliance to Protocol|1|||
105492678|NCT03332771|363817114|FG002|Overall Study|Poor Compliance to Protocol|0|||
105492679|NCT03332771|363817115|FG003|Overall Study|Poor Compliance to Protocol|1|||
105492680|NCT03332771|363817112|FG000|Overall Study|Lost to Follow-up|2|||
105492681|NCT03332771|363817113|FG001|Overall Study|Lost to Follow-up|2|||
105492682|NCT03332771|363817114|FG002|Overall Study|Lost to Follow-up|1|||
105492683|NCT03332771|363817115|FG003|Overall Study|Lost to Follow-up|2|||
105492684|NCT03332771|363817112|FG000|Overall Study|At the Participant's own request|20|||
105492685|NCT03332771|363817113|FG001|Overall Study|At the Participant's own request|26|||
105492686|NCT03332771|363817114|FG002|Overall Study|At the Participant's own request|14|||
105492687|NCT03332771|363817115|FG003|Overall Study|At the Participant's own request|23|||
105492688|NCT03332771|363817112|FG000|Overall Study|Reason Not Specified|6|||
105492689|NCT03332771|363817113|FG001|Overall Study|Reason Not Specified|18|||
105492690|NCT03332771|363817114|FG002|Overall Study|Reason Not Specified|16|||
105492691|NCT03332771|363817115|FG003|Overall Study|Reason Not Specified|19|||
105492692|NCT01920555|363817116|FG000|Overall Study|Physician Decision|1|||
105492693|NCT01920555|363817117|FG001|Overall Study|Physician Decision|2|||
105492694|NCT01920555|363817118|FG002|Overall Study|Physician Decision|1|||
105492695|NCT01920555|363817119|FG003|Overall Study|Physician Decision|2|||
105492696|NCT01920555|363817120|FG004|Overall Study|Physician Decision|0|||
105492697|NCT01920555|363817116|FG000|Overall Study|Lack of Efficacy|2|||
105492698|NCT01920555|363817117|FG001|Overall Study|Lack of Efficacy|0|||
105492699|NCT01920555|363817118|FG002|Overall Study|Lack of Efficacy|0|||
105492700|NCT01920555|363817119|FG003|Overall Study|Lack of Efficacy|0|||
105492701|NCT01920555|363817120|FG004|Overall Study|Lack of Efficacy|0|||
105492702|NCT01920555|363817116|FG000|Overall Study|Travel Difficulties|1|||
105492703|NCT01920555|363817117|FG001|Overall Study|Travel Difficulties|1|||
105492704|NCT01920555|363817118|FG002|Overall Study|Travel Difficulties|0|||
105492705|NCT01920555|363817119|FG003|Overall Study|Travel Difficulties|0|||
105492706|NCT01920555|363817120|FG004|Overall Study|Travel Difficulties|1|||
105492707|NCT01920555|363817116|FG000|Overall Study|Lost to Follow-up|0|||
105492708|NCT01920555|363817117|FG001|Overall Study|Lost to Follow-up|1|||
105492709|NCT01920555|363817118|FG002|Overall Study|Lost to Follow-up|0|||
105492710|NCT01920555|363817119|FG003|Overall Study|Lost to Follow-up|1|||
105492711|NCT01920555|363817120|FG004|Overall Study|Lost to Follow-up|0|||
105492712|NCT00697073|363817121|FG000|Overall Study|Withdrawal by Subject|2|||
105492713|NCT00697073|363817121|FG000|Overall Study|Pregnancy|1|||
105492714|NCT00697073|363817121|FG000|Overall Study|non compliance and other|6|||
105492715|NCT03061097|363817124|FG000|Overall Study|Withdrawal by Subject|0|||
105492716|NCT03061097|363817125|FG001|Overall Study|Withdrawal by Subject|3|||
105492717|NCT03228420|363817126|FG000|Overall Study|Lost to Follow-up|5|||
105492718|NCT03228420|363817127|FG001|Overall Study|Lost to Follow-up|3|||
105492719|NCT03228420|363817126|FG000|Overall Study|Withdrawal by Subject|10|||
105492720|NCT03228420|363817127|FG001|Overall Study|Withdrawal by Subject|0|||
105492721|NCT03228420|363817126|FG000|Overall Study|Adverse Event|5|||
105492722|NCT03228420|363817127|FG001|Overall Study|Adverse Event|2|||
105492723|NCT01298531|363817128|FG000|Overall Study|Lack of Efficacy|0|||
105492724|NCT01298531|363817129|FG001|Overall Study|Lack of Efficacy|1|||
105492725|NCT01298531|363817128|FG000|Overall Study|Lost to Follow-up|2|||
105492726|NCT01298531|363817129|FG001|Overall Study|Lost to Follow-up|0|||
105492727|NCT01298531|363817128|FG000|Overall Study|Protocol Violation|1|||
105492728|NCT01298531|363817129|FG001|Overall Study|Protocol Violation|1|||
105492729|NCT01298531|363817128|FG000|Overall Study|Adverse Event|4|||
105492730|NCT01298531|363817129|FG001|Overall Study|Adverse Event|3|||
105492731|NCT01298531|363817128|FG000|Overall Study|Does not meet entrance criteria|0|||
105492732|NCT01298531|363817129|FG001|Overall Study|Does not meet entrance criteria|1|||
105492733|NCT01298531|363817128|FG000|Overall Study|Other|2|||
105492734|NCT01298531|363817129|FG001|Overall Study|Other|1|||
105492735|NCT02213042|363817132|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
105492736|NCT02213042|363817133|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
105492737|NCT02213042|363817134|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
105492738|NCT02213042|363817132|FG000|Overall Study|Adverse Event|2|||
105492739|NCT02213042|363817133|FG001|Overall Study|Adverse Event|1|||
105492740|NCT02213042|363817134|FG002|Overall Study|Adverse Event|0|||
105492741|NCT02213042|363817132|FG000|Overall Study|Withdrawal by Subject|0|||
105492742|NCT02213042|363817133|FG001|Overall Study|Withdrawal by Subject|1|||
105492743|NCT02213042|363817134|FG002|Overall Study|Withdrawal by Subject|1|||
105492744|NCT02213042|363817132|FG000|Overall Study|Protocol Violation|1|||
105492745|NCT02213042|363817133|FG001|Overall Study|Protocol Violation|0|||
105492746|NCT02213042|363817134|FG002|Overall Study|Protocol Violation|0|||
105492747|NCT02213042|363817132|FG000|Overall Study|Investigator discretion|0|||
105492748|NCT02213042|363817133|FG001|Overall Study|Investigator discretion|0|||
105492749|NCT02213042|363817134|FG002|Overall Study|Investigator discretion|1|||
105492750|NCT02556203|363817135|FG000|Overall Study|Withdrawal by Subject|21|||
105492751|NCT02556203|363817136|FG001|Overall Study|Withdrawal by Subject|21|||
105492752|NCT02556203|363817135|FG000|Overall Study|Lost to Follow-up|5|||
105492753|NCT02556203|363817136|FG001|Overall Study|Lost to Follow-up|5|||
105492754|NCT02556203|363817135|FG000|Overall Study|Adverse Event|1|||
105492755|NCT02556203|363817136|FG001|Overall Study|Adverse Event|0|||
105492756|NCT00580970|363817140|FG000|Pre-treatment|Non-compliance|1|||
105492757|NCT00580970|363817140|FG000|Treatment (Lovastatin)|Non-compliance|6|||
105492758|NCT00580970|363817140|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
105492759|NCT00580970|363817140|FG000|Treatment (Lovastatin)|Physician Decision|4|||
105492760|NCT00580970|363817140|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
105492761|NCT00580970|363817140|FG000|Treatment (Lovastatin)|Death|1|||
105492762|NCT01086423|363817141|FG000|Overall Study|Protocol Violation|0|||
105384313|NCT03225989|363413795|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
105384314|NCT03225989|363413796|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
105384315|NCT03225989|363413797|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
105384316|NCT03225989|363413795|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
105384317|NCT03225989|363413796|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
105384318|NCT03225989|363413797|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
105384319|NCT03225989|363413795|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
105384320|NCT03225989|363413796|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
105384321|NCT03225989|363413797|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
105384322|NCT03225989|363413795|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
105492763|NCT01086423|363817142|FG001|Overall Study|Protocol Violation|0|||
105492764|NCT01086423|363817143|FG002|Overall Study|Protocol Violation|1|||
105492765|NCT01086423|363817141|FG000|Overall Study|Migrated/moved from study area|2|||
105492766|NCT01086423|363817142|FG001|Overall Study|Migrated/moved from study area|0|||
105384323|NCT03225989|363413796|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
105384324|NCT03225989|363413797|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
105384325|NCT03225989|363413795|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
105384326|NCT03225989|363413796|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
105384327|NCT03225989|363413797|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
105384328|NCT03225989|363413795|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
105384329|NCT03225989|363413796|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
105384330|NCT03225989|363413797|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
105384331|NCT03225989|363413795|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
105384332|NCT03225989|363413796|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
105384333|NCT03225989|363413797|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
105384334|NCT03225989|363413795|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
105384335|NCT03225989|363413796|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
105384336|NCT03225989|363413797|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
105384337|NCT03225989|363413795|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
105384338|NCT03225989|363413796|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
105384339|NCT03225989|363413797|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
105384340|NCT03225989|363413795|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
105384341|NCT03225989|363413796|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
105384342|NCT03225989|363413797|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
105384343|NCT03225989|363413795|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
105384344|NCT03225989|363413796|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
105492767|NCT01086423|363817143|FG002|Overall Study|Migrated/moved from study area|4|||
105492768|NCT01086423|363817141|FG000|Overall Study|Adverse event, fatal|1|||
105492769|NCT01086423|363817142|FG001|Overall Study|Adverse event, fatal|1|||
105492770|NCT01086423|363817143|FG002|Overall Study|Adverse event, fatal|0|||
105492771|NCT01086423|363817141|FG000|Overall Study|Adverse event, non-fatal|2|||
105492772|NCT01086423|363817142|FG001|Overall Study|Adverse event, non-fatal|1|||
105492773|NCT01086423|363817143|FG002|Overall Study|Adverse event, non-fatal|0|||
105492774|NCT01086423|363817141|FG000|Overall Study|Withdrawal by Subject|5|||
105492775|NCT01086423|363817142|FG001|Overall Study|Withdrawal by Subject|1|||
105492776|NCT01086423|363817143|FG002|Overall Study|Withdrawal by Subject|3|||
105492777|NCT01086423|363817141|FG000|Overall Study|Lost to Follow-up|0|||
105492778|NCT01086423|363817142|FG001|Overall Study|Lost to Follow-up|0|||
105492779|NCT01086423|363817143|FG002|Overall Study|Lost to Follow-up|1|||
105492780|NCT02456103|363817146|FG000|Overall Study|Study Closure|207|||
105492781|NCT02456103|363817146|FG000|Overall Study|Physician Decision|1|||
105492782|NCT02456103|363817146|FG000|Overall Study|Required prohibited medications|5|||
105492783|NCT02456103|363817146|FG000|Overall Study|Protocol Violation|1|||
105492784|NCT02456103|363817146|FG000|Overall Study|Adverse Event|5|||
105492785|NCT02456103|363817146|FG000|Overall Study|Abnormal Laboratory Value|2|||
105492786|NCT02456103|363817146|FG000|Overall Study|Lost to Follow-up|1|||
105492787|NCT02456103|363817146|FG000|Overall Study|Withdrawal by Subject|24|||
105492788|NCT00470847|363817154|FG000|Overall Study|Pt still receiving treatment|1|||
105492789|NCT00764491|363817159|FG000|Overall Study|Lost to Follow-up|35|||
105492790|NCT00764491|363817160|FG001|Overall Study|Lost to Follow-up|17|||
105492791|NCT01638819|363817162|FG000|Overall Study|Lost to Follow-up|1|||
105492792|NCT01638819|363817163|FG001|Overall Study|Lost to Follow-up|0|||
105492793|NCT03911154|363817164|FG000|Overall Study|Withdrawal by Subject|1|||
105492794|NCT02322021|363817165|FG000|Core Phase|Adverse Event|1|||
105492795|NCT02322021|363817166|FG001|Core Phase|Adverse Event|3|||
105492796|NCT02322021|363817167|FG002|Core Phase|Adverse Event|4|||
105492797|NCT02322021|363817168|FG003|Core Phase|Adverse Event|2|||
105492798|NCT02322021|363817169|FG004|Core Phase|Adverse Event|0|||
105492799|NCT02322021|363817165|FG000|Core Phase|Participant Choice|4|||
105492800|NCT02322021|363817166|FG001|Core Phase|Participant Choice|5|||
105492801|NCT02322021|363817167|FG002|Core Phase|Participant Choice|4|||
105492802|NCT02322021|363817168|FG003|Core Phase|Participant Choice|2|||
105492803|NCT02322021|363817169|FG004|Core Phase|Participant Choice|0|||
105492804|NCT02322021|363817165|FG000|Core Phase|Lost to Follow-up|0|||
105492805|NCT02322021|363817166|FG001|Core Phase|Lost to Follow-up|0|||
105492806|NCT02322021|363817167|FG002|Core Phase|Lost to Follow-up|0|||
105492807|NCT02322021|363817168|FG003|Core Phase|Lost to Follow-up|1|||
105492808|NCT02322021|363817169|FG004|Core Phase|Lost to Follow-up|0|||
105492809|NCT02322021|363817165|FG000|Core Phase|Other|0|||
105492810|NCT02322021|363817166|FG001|Core Phase|Other|0|||
105492811|NCT02322021|363817167|FG002|Core Phase|Other|1|||
105492812|NCT02322021|363817168|FG003|Core Phase|Other|0|||
105492813|NCT02322021|363817169|FG004|Core Phase|Other|0|||
105492814|NCT02322021|363817165|FG000|Extension Phase|Adverse Event|0|||
105492815|NCT02322021|363817166|FG001|Extension Phase|Adverse Event|0|||
105492816|NCT02322021|363817167|FG002|Extension Phase|Adverse Event|0|||
105492817|NCT02322021|363817168|FG003|Extension Phase|Adverse Event|0|||
105492818|NCT02322021|363817169|FG004|Extension Phase|Adverse Event|3|||
105492819|NCT02322021|363817165|FG000|Extension Phase|Participant Choice|0|||
105580524|NCT02018861|364126444|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
105580525|NCT02018861|364126445|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
105580526|NCT02018861|364126446|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
105580527|NCT02018861|364126447|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
105580528|NCT02018861|364126448|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
105580529|NCT02018861|364126449|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
105580530|NCT02018861|364126450|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
105580531|NCT02018861|364126451|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
105580532|NCT02018861|364126452|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
105580533|NCT02018861|364126453|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
105580534|NCT02018861|364126444|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
105580535|NCT02018861|364126445|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
105580536|NCT02018861|364126446|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
105580537|NCT02018861|364126447|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
105580538|NCT02018861|364126448|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
105384345|NCT03225989|363413797|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
105384346|NCT00601107|363413798|FG000|Overall Study|Adverse Event|0|||
105384347|NCT00601107|363413799|FG001|Overall Study|Adverse Event|1|||
105384348|NCT00601107|363413800|FG002|Overall Study|Adverse Event|3|||
105384349|NCT00601107|363413801|FG003|Overall Study|Adverse Event|0|||
105384350|NCT00601107|363413798|FG000|Overall Study|Withdrawal by Subject|5|||
105384351|NCT00601107|363413799|FG001|Overall Study|Withdrawal by Subject|4|||
105384352|NCT00601107|363413800|FG002|Overall Study|Withdrawal by Subject|7|||
105384353|NCT00601107|363413801|FG003|Overall Study|Withdrawal by Subject|4|||
105384354|NCT00601107|363413798|FG000|Overall Study|Lost to Follow-up|3|||
105384355|NCT00601107|363413799|FG001|Overall Study|Lost to Follow-up|3|||
105384356|NCT00601107|363413800|FG002|Overall Study|Lost to Follow-up|0|||
105384357|NCT00601107|363413801|FG003|Overall Study|Lost to Follow-up|3|||
105384358|NCT00601107|363413798|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
105384359|NCT00601107|363413799|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
105384360|NCT00601107|363413800|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
105384361|NCT00601107|363413801|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
105384362|NCT00601107|363413798|FG000|Overall Study|Worsening of Psoriasis|4|||
105384363|NCT00601107|363413799|FG001|Overall Study|Worsening of Psoriasis|1|||
105384364|NCT00601107|363413800|FG002|Overall Study|Worsening of Psoriasis|1|||
105384365|NCT00601107|363413801|FG003|Overall Study|Worsening of Psoriasis|4|||
105384366|NCT00601107|363413798|FG000|Overall Study|Undefined|1|||
105384367|NCT00601107|363413799|FG001|Overall Study|Undefined|0|||
105384368|NCT00601107|363413800|FG002|Overall Study|Undefined|1|||
105384369|NCT00601107|363413801|FG003|Overall Study|Undefined|0|||
105384370|NCT02181738|363413802|FG000|Overall Study|Participant Withdrew Consent|2|||
105384371|NCT02181738|363413803|FG001|Overall Study|Participant Withdrew Consent|1|||
105384372|NCT02181738|363413804|FG002|Overall Study|Participant Withdrew Consent|1|||
105384373|NCT02181738|363413805|FG003|Overall Study|Participant Withdrew Consent|1|||
105384374|NCT02181738|363413802|FG000|Overall Study|Lost to Follow-up|1|||
105384375|NCT02181738|363413803|FG001|Overall Study|Lost to Follow-up|2|||
105384376|NCT02181738|363413804|FG002|Overall Study|Lost to Follow-up|1|||
105384377|NCT02181738|363413805|FG003|Overall Study|Lost to Follow-up|1|||
105384378|NCT02181738|363413802|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
105384379|NCT02181738|363413803|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
105384380|NCT02181738|363413804|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
105384381|NCT02181738|363413805|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
105384382|NCT02181738|363413802|FG000|Overall Study|Poor/Non-Compliance|1|||
105384383|NCT02181738|363413803|FG001|Overall Study|Poor/Non-Compliance|0|||
105384384|NCT02181738|363413804|FG002|Overall Study|Poor/Non-Compliance|2|||
105384385|NCT02181738|363413805|FG003|Overall Study|Poor/Non-Compliance|1|||
105384386|NCT02181738|363413802|FG000|Overall Study|Disease Progression|28|||
105384387|NCT02181738|363413803|FG001|Overall Study|Disease Progression|35|||
105384388|NCT02181738|363413804|FG002|Overall Study|Disease Progression|40|||
105384389|NCT02181738|363413805|FG003|Overall Study|Disease Progression|0|||
105384390|NCT02181738|363413802|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
105384391|NCT02181738|363413803|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
105384392|NCT02181738|363413804|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
105384393|NCT02181738|363413805|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
105384394|NCT02181738|363413802|FG000|Overall Study|Study Drug Toxicity|6|||
105384395|NCT02181738|363413803|FG001|Overall Study|Study Drug Toxicity|11|||
105384396|NCT02181738|363413804|FG002|Overall Study|Study Drug Toxicity|8|||
105384397|NCT02181738|363413805|FG003|Overall Study|Study Drug Toxicity|1|||
105384398|NCT02181738|363413802|FG000|Overall Study|Other Reasons|14|||
105384399|NCT02181738|363413803|FG001|Overall Study|Other Reasons|16|||
105384400|NCT02181738|363413804|FG002|Overall Study|Other Reasons|28|||
105384401|NCT02181738|363413805|FG003|Overall Study|Other Reasons|0|||
105384402|NCT02181738|363413802|FG000|Overall Study|Maximum Clinical Benefit|3|||
105384403|NCT02181738|363413803|FG001|Overall Study|Maximum Clinical Benefit|0|||
105384404|NCT02181738|363413804|FG002|Overall Study|Maximum Clinical Benefit|1|||
105384405|NCT02181738|363413805|FG003|Overall Study|Maximum Clinical Benefit|0|||
105384406|NCT02181738|363413802|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
105384407|NCT02181738|363413803|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
105384408|NCT02181738|363413804|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
105384409|NCT02181738|363413805|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
105384410|NCT00191152|363413806|FG000|Initial Treatment|Adverse Event|43|||
105384411|NCT00191152|363413807|FG001|Initial Treatment|Adverse Event|67|||
105384412|NCT00191152|363413806|FG000|Initial Treatment|Physician Decision|40|||
105384413|NCT00191152|363413807|FG001|Initial Treatment|Physician Decision|31|||
105384414|NCT00191152|363413806|FG000|Initial Treatment|Withdrawal by Subject|40|||
105384415|NCT00191152|363413807|FG001|Initial Treatment|Withdrawal by Subject|28|||
105384416|NCT00191152|363413806|FG000|Initial Treatment|Lost to Follow-up|0|||
105384417|NCT00191152|363413807|FG001|Initial Treatment|Lost to Follow-up|6|||
105384418|NCT00191152|363413806|FG000|Initial Treatment|Other|18|||
105384419|NCT00191152|363413807|FG001|Initial Treatment|Other|21|||
105384420|NCT00191152|363413806|FG000|Crossover Treatment|Adverse Event|8|||
105384421|NCT00191152|363413807|FG001|Crossover Treatment|Adverse Event|8|||
105384422|NCT00191152|363413806|FG000|Crossover Treatment|Physician Decision|7|||
105384423|NCT00191152|363413807|FG001|Crossover Treatment|Physician Decision|7|||
105384424|NCT00191152|363413806|FG000|Crossover Treatment|Withdrawal by Subject|6|||
105384425|NCT00191152|363413807|FG001|Crossover Treatment|Withdrawal by Subject|9|||
105384426|NCT00191152|363413806|FG000|Crossover Treatment|Lost to Follow-up|2|||
105384427|NCT00191152|363413807|FG001|Crossover Treatment|Lost to Follow-up|1|||
105384428|NCT00191152|363413806|FG000|Crossover Treatment|Other|4|||
105384429|NCT00191152|363413807|FG001|Crossover Treatment|Other|3|||
105384430|NCT00114777|363413808|FG000|Randomization to Month 36|Death|10|||
105384431|NCT00114777|363413809|FG001|Randomization to Month 36|Death|4|||
105384432|NCT00114777|363413810|FG002|Randomization to Month 36|Death|3|||
105384433|NCT00114777|363413808|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
105384434|NCT00114777|363413809|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
105384435|NCT00114777|363413810|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
105384436|NCT00114777|363413808|FG000|Randomization to Month 36|Lack of Efficacy|19|||
105384437|NCT00114777|363413809|FG001|Randomization to Month 36|Lack of Efficacy|15|||
105384438|NCT00114777|363413810|FG002|Randomization to Month 36|Lack of Efficacy|17|||
105384439|NCT00114777|363413808|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
105384440|NCT00114777|363413809|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
105384441|NCT00114777|363413810|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
105384442|NCT00114777|363413808|FG000|Randomization to Month 36|Adverse Event|34|||
105384443|NCT00114777|363413809|FG001|Randomization to Month 36|Adverse Event|35|||
105384444|NCT00114777|363413810|FG002|Randomization to Month 36|Adverse Event|44|||
105384445|NCT00114777|363413808|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
105384446|NCT00114777|363413809|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
105384447|NCT00114777|363413810|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
105384448|NCT00114777|363413808|FG000|Randomization to Month 36|Other|9|||
105384449|NCT00114777|363413809|FG001|Randomization to Month 36|Other|3|||
105384450|NCT00114777|363413810|FG002|Randomization to Month 36|Other|12|||
105384451|NCT00114777|363413808|FG000|Long-Term Extension to Month 84|Death|8|||
105384452|NCT00114777|363413809|FG001|Long-Term Extension to Month 84|Death|13|||
105384453|NCT00114777|363413810|FG002|Long-Term Extension to Month 84|Death|7|||
105384454|NCT00114777|363413808|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
105384455|NCT00114777|363413809|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
105384456|NCT00114777|363413810|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
105384457|NCT00114777|363413808|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
105384458|NCT00114777|363413809|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
105384459|NCT00114777|363413810|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
105384460|NCT00114777|363413808|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
105384461|NCT00114777|363413809|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
105384462|NCT00114777|363413810|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
105384463|NCT00114777|363413808|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
105384464|NCT00114777|363413809|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
105384465|NCT00114777|363413810|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
105384466|NCT00114777|363413808|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
105384467|NCT00114777|363413809|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
105384468|NCT00114777|363413810|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
105384469|NCT00114777|363413808|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
105384470|NCT00114777|363413809|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
105384471|NCT00114777|363413810|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
105384472|NCT00114777|363413808|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
105384473|NCT00114777|363413809|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
105384474|NCT00114777|363413810|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
105384475|NCT00114777|363413808|FG000|Long-Term Extension to Month 84|Other|2|||
105384476|NCT00114777|363413809|FG001|Long-Term Extension to Month 84|Other|0|||
105384477|NCT00114777|363413810|FG002|Long-Term Extension to Month 84|Other|2|||
105384478|NCT01181128|363413811|FG000|Overall Study|Withdrawal by Subject|2|||
105384479|NCT01181128|363413812|FG001|Overall Study|Withdrawal by Subject|2|||
105384480|NCT01181128|363413813|FG002|Overall Study|Withdrawal by Subject|0|||
105384481|NCT01181128|363413811|FG000|Overall Study|Death|1|||
105384482|NCT01181128|363413812|FG001|Overall Study|Death|0|||
105384483|NCT01181128|363413813|FG002|Overall Study|Death|0|||
105384484|NCT01181128|363413811|FG000|Overall Study|Physician Decision|2|||
105384485|NCT01181128|363413812|FG001|Overall Study|Physician Decision|0|||
105384486|NCT01181128|363413813|FG002|Overall Study|Physician Decision|0|||
105384487|NCT01181128|363413811|FG000|Overall Study|Adverse Event|0|||
105384488|NCT01181128|363413812|FG001|Overall Study|Adverse Event|2|||
105384489|NCT01181128|363413813|FG002|Overall Study|Adverse Event|0|||
105384490|NCT01181128|363413811|FG000|Overall Study|Other|1|||
105384491|NCT01181128|363413812|FG001|Overall Study|Other|1|||
105384492|NCT01181128|363413813|FG002|Overall Study|Other|1|||
105384493|NCT03364686|363413814|FG000|Overall Study|Physician Decision|2|||
105384494|NCT02336503|363413817|FG000|Overall Study|Lost to Follow-up|0|||
105384495|NCT02336503|363413818|FG001|Overall Study|Lost to Follow-up|3|||
105384496|NCT02336503|363413819|FG002|Overall Study|Lost to Follow-up|0|||
105384497|NCT02336503|363413820|FG003|Overall Study|Lost to Follow-up|2|||
105384498|NCT02336503|363413817|FG000|Overall Study|Withdrawal by Subject|2|||
105384499|NCT02336503|363413818|FG001|Overall Study|Withdrawal by Subject|0|||
105384500|NCT02336503|363413819|FG002|Overall Study|Withdrawal by Subject|0|||
105384501|NCT02336503|363413820|FG003|Overall Study|Withdrawal by Subject|4|||
105384502|NCT02336503|363413817|FG000|Overall Study|Adverse Event|0|||
105384503|NCT02336503|363413818|FG001|Overall Study|Adverse Event|0|||
105384504|NCT02336503|363413819|FG002|Overall Study|Adverse Event|1|||
105384505|NCT02336503|363413820|FG003|Overall Study|Adverse Event|0|||
105384506|NCT01210443|363413832|FG000|Overall Study|Study terminated by sponsor|2|||
105384507|NCT01309100|363413834|FG000|Overall Study|Protocol Violation|1|||
105384508|NCT01309100|363413834|FG000|Overall Study|Positive Slit lamp finding|1|||
105384509|NCT03767894|363413835|FG000|Overall Study|Withdrawal by Subject|1|||
105384510|NCT01489358|363413836|FG000|Overall Study|Lost to Follow-up|0|||
105384511|NCT01489358|363413837|FG001|Overall Study|Lost to Follow-up|0|||
105384512|NCT01489358|363413838|FG002|Overall Study|Lost to Follow-up|2|||
105384513|NCT00472641|363413840|FG000|Overall Study|Lack of Efficacy|3|||
105384514|NCT00472641|363413840|FG000|Overall Study|Adverse Event|3|||
105384515|NCT00472641|363413840|FG000|Overall Study|Lost to Follow-up|1|||
105384516|NCT01827943|363413841|FG000|Overall Study|Protocol Violation|8|||
105384517|NCT01827943|363413841|FG000|Overall Study|Never treated because of an rapid progression|1|||
105384518|NCT04689009|363413842|FG000|Overall Study|Adverse Event|1|||
105384519|NCT04689009|363413843|FG001|Overall Study|Adverse Event|0|||
105384520|NCT04689009|363413842|FG000|Overall Study|Lost to Follow-up|1|||
105384521|NCT04689009|363413843|FG001|Overall Study|Lost to Follow-up|2|||
105384522|NCT04689009|363413842|FG000|Overall Study|Withdrawal by Subject|4|||
105384523|NCT04689009|363413843|FG001|Overall Study|Withdrawal by Subject|3|||
105384524|NCT04689009|363413842|FG000|Overall Study|Protocol Violation|1|||
105384525|NCT04689009|363413843|FG001|Overall Study|Protocol Violation|0|||
105384526|NCT05652140|363413854|FG000|Overall Study|Lost to Follow-up|7|||
105384527|NCT05652140|363413855|FG001|Overall Study|Lost to Follow-up|16|||
105384528|NCT05652140|363413856|FG002|Overall Study|Lost to Follow-up|22|||
105384529|NCT05652140|363413857|FG003|Overall Study|Lost to Follow-up|31|||
105384530|NCT02218268|363413858|FG000|24 Hour Washout|Physician Decision|11|||
105384531|NCT02218268|363413859|FG001|24 Hour Washout|Physician Decision|9|||
105384532|NCT00962650|363413863|FG000|Overall Study|Transgastric DP was not completed|2|||
105384533|NCT00694161|363413867|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
105384534|NCT00694161|363413867|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
105384535|NCT00694161|363413867|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
105384536|NCT03020888|363413872|FG000|Overall Study|Physician Decision|4|||
105384537|NCT03020888|363413872|FG000|Overall Study|Withdrawal by Subject|6|||
105492820|NCT02322021|363817166|FG001|Extension Phase|Participant Choice|0|||
105492821|NCT02322021|363817167|FG002|Extension Phase|Participant Choice|0|||
105492822|NCT02322021|363817168|FG003|Extension Phase|Participant Choice|0|||
105384538|NCT03020888|363413872|FG000|Overall Study|Insurance coverage|2|||
105384539|NCT03020888|363413872|FG000|Overall Study|Lost to Follow-up|1|||
105384540|NCT02205359|363413875|FG000|Overall Study|Death|293|||
105384541|NCT02205359|363413876|FG001|Overall Study|Death|327|||
105384542|NCT02205359|363413875|FG000|Overall Study|Lost to Follow-up|182|||
105384543|NCT02205359|363413876|FG001|Overall Study|Lost to Follow-up|162|||
105384544|NCT02205359|363413875|FG000|Overall Study|Physician Decision|51|||
105384545|NCT02205359|363413876|FG001|Overall Study|Physician Decision|53|||
105384546|NCT02205359|363413875|FG000|Overall Study|Withdrawal by Subject|167|||
105384547|NCT02205359|363413876|FG001|Overall Study|Withdrawal by Subject|169|||
105384548|NCT00300495|363413877|FG000|Overall Study|Protocol Violation|4|||
105384549|NCT00300495|363413878|FG001|Overall Study|Protocol Violation|1|||
105384550|NCT00682435|363413883|FG000|Overall Study|Insufficient data|5|||
105384551|NCT00682435|363413883|FG000|Overall Study|Erroneously enrolled twice|2|||
105384552|NCT01117350|363413884|FG000|Comparative Period|Not Treated|5|||
105384553|NCT01117350|363413885|FG001|Comparative Period|Not Treated|8|||
105384554|NCT01117350|363413884|FG000|Comparative Period|Adverse Event|6|||
105384555|NCT01117350|363413885|FG001|Comparative Period|Adverse Event|33|||
105384556|NCT01117350|363413884|FG000|Comparative Period|Lost to Follow-up|11|||
105384557|NCT01117350|363413885|FG001|Comparative Period|Lost to Follow-up|7|||
105384558|NCT01117350|363413884|FG000|Comparative Period|Withdrawal by Subject|9|||
105384559|NCT01117350|363413885|FG001|Comparative Period|Withdrawal by Subject|13|||
105384560|NCT01117350|363413884|FG000|Comparative Period|Protocol Violation|8|||
105384561|NCT01117350|363413885|FG001|Comparative Period|Protocol Violation|12|||
105384562|NCT01117350|363413884|FG000|Comparative Period|Lack of Efficacy|1|||
105384563|NCT01117350|363413885|FG001|Comparative Period|Lack of Efficacy|0|||
105384564|NCT01117350|363413884|FG000|Comparative Period|Physician Decision|0|||
105384565|NCT01117350|363413885|FG001|Comparative Period|Physician Decision|1|||
105384566|NCT01117350|363413884|FG000|Comparative Period|Move to another city/country|2|||
105384567|NCT01117350|363413885|FG001|Comparative Period|Move to another city/country|1|||
105384568|NCT01117350|363413884|FG000|Extension Period|Not included in extension, not treated|0|||
105384569|NCT01117350|363413885|FG001|Extension Period|Not included in extension, not treated|50|||
105384570|NCT01117350|363413884|FG000|Extension Period|Adverse Event|0|||
105384571|NCT01117350|363413885|FG001|Extension Period|Adverse Event|2|||
105384572|NCT01117350|363413884|FG000|Extension Period|Protocol Violation|0|||
105384573|NCT01117350|363413885|FG001|Extension Period|Protocol Violation|2|||
105384574|NCT01117350|363413884|FG000|Extension Period|Lost to Follow-up|0|||
105384575|NCT01117350|363413885|FG001|Extension Period|Lost to Follow-up|2|||
105384576|NCT01117350|363413884|FG000|Extension Period|Withdrawal by Subject|0|||
105384577|NCT01117350|363413885|FG001|Extension Period|Withdrawal by Subject|3|||
105384578|NCT01117350|363413884|FG000|Extension Period|Lack of Efficacy|0|||
105384579|NCT01117350|363413885|FG001|Extension Period|Lack of Efficacy|2|||
105384580|NCT01117350|363413884|FG000|Extension Period|Inclusion criteria not respected|0|||
105384581|NCT01117350|363413885|FG001|Extension Period|Inclusion criteria not respected|1|||
105384582|NCT01117350|363413884|FG000|Extension Period|Prohibited medication|0|||
105384583|NCT01117350|363413885|FG001|Extension Period|Prohibited medication|1|||
105384584|NCT01049828|363413893|FG000|Overall Study|Claustrophibia and Frustration|2|||
105384585|NCT03572218|363413894|FG000|Overall Study|Lost to Follow-up|3|||
105384586|NCT03572218|363413895|FG001|Overall Study|Lost to Follow-up|2|||
105384587|NCT03572218|363413894|FG000|Overall Study|No longer available for study visits|2|||
105384588|NCT03572218|363413895|FG001|Overall Study|No longer available for study visits|1|||
105384589|NCT03572218|363413894|FG000|Overall Study|No longer interested|1|||
105384590|NCT03572218|363413895|FG001|Overall Study|No longer interested|2|||
105384591|NCT05788328|363415177|FG000|Treatment Period 4 (5 Days)|Other|1|||
105384592|NCT05788328|363415177|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
105384593|NCT00960856|363415178|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
105384594|NCT00960856|363415179|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
105384595|NCT00960856|363415180|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
105384596|NCT00960856|363415181|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
105384597|NCT00960856|363415178|FG000|Washout Period of 7 Days|Adverse Event|0|||
105384598|NCT00960856|363415179|FG001|Washout Period of 7 Days|Adverse Event|0|||
105384599|NCT00960856|363415180|FG002|Washout Period of 7 Days|Adverse Event|1|||
105384600|NCT00960856|363415181|FG003|Washout Period of 7 Days|Adverse Event|0|||
105384601|NCT05938010|363415183|FG000|Overall Study|Lost to Follow-up|2|||
105384602|NCT03548415|363415184|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
105384603|NCT03548415|363415185|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
105384604|NCT03548415|363415186|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
105492823|NCT02322021|363817169|FG004|Extension Phase|Participant Choice|6|||
105492824|NCT02322021|363817165|FG000|Extension Phase|Other|0|||
105492825|NCT02322021|363817166|FG001|Extension Phase|Other|0|||
105492826|NCT02322021|363817167|FG002|Extension Phase|Other|0|||
105492827|NCT02322021|363817168|FG003|Extension Phase|Other|0|||
105492828|NCT02322021|363817169|FG004|Extension Phase|Other|3|||
105492829|NCT02322021|363817165|FG000|Extension Phase|Lost to Follow-up|0|||
105384605|NCT03548415|363415187|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
105384606|NCT03548415|363415188|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
105384607|NCT00985192|363415189|FG000|Overall Study|Withdrawal by Subject|1|||
105384608|NCT00985192|363415189|FG000|Overall Study|Disease Progression|1|||
105384609|NCT00985192|363415189|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
105384610|NCT01454063|363415190|FG000|Randomized|Adverse Event|1|||
105384611|NCT01454063|363415191|FG001|Randomized|Adverse Event|1|||
105384612|NCT01454063|363415190|FG000|Randomized|Protocol Violation|0|||
105384613|NCT01454063|363415191|FG001|Randomized|Protocol Violation|1|||
105384614|NCT03387046|363415194|FG000|Overall Study|Adverse Event|1|||
105384615|NCT03387046|363415195|FG001|Overall Study|Adverse Event|1|||
105384616|NCT01529112|363415196|FG000|Overall Study|Adverse Event|2|||
105384617|NCT01529112|363415197|FG001|Overall Study|Adverse Event|0|||
105492830|NCT02322021|363817166|FG001|Extension Phase|Lost to Follow-up|0|||
105384618|NCT01529112|363415196|FG000|Overall Study|Death|59|||
105384619|NCT01529112|363415197|FG001|Overall Study|Death|38|||
105384620|NCT01529112|363415196|FG000|Overall Study|Protocol Violation|1|||
105384621|NCT01529112|363415197|FG001|Overall Study|Protocol Violation|0|||
105384622|NCT01529112|363415196|FG000|Overall Study|Withdrawal by Subject|7|||
105384623|NCT01529112|363415197|FG001|Overall Study|Withdrawal by Subject|3|||
105384624|NCT02255279|363415198|FG000|Overall Study|Lost to Follow-up|2|||
105384625|NCT02255279|363415199|FG001|Overall Study|Lost to Follow-up|2|||
105384626|NCT02255279|363415198|FG000|Overall Study|Protocol Violation|0|||
105384627|NCT02255279|363415199|FG001|Overall Study|Protocol Violation|1|||
105384628|NCT02255279|363415198|FG000|Overall Study|Withdrawal by Subject|3|||
105384629|NCT02255279|363415199|FG001|Overall Study|Withdrawal by Subject|6|||
105384630|NCT03607695|363415203|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
105384631|NCT03607695|363415203|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
105384632|NCT02741193|363415204|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
105384633|NCT02741193|363415204|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
105384634|NCT00720083|363415208|FG000|Overall Study|Ineligible|1|||
105384635|NCT00720083|363415209|FG001|Overall Study|Ineligible|2|||
105384636|NCT00976898|363415210|FG000|Overall Study|Protocol Violation|1|||
105384637|NCT00976898|363415210|FG000|Overall Study|Adverse Event|1|||
105384638|NCT00976898|363415210|FG000|Overall Study|Physician Decision|1|||
105384639|NCT00976898|363415210|FG000|Overall Study|Liver Transplant|1|||
105384640|NCT00976898|363415210|FG000|Overall Study|Progressive Disease|1|||
105384641|NCT04389671|363415216|FG000|Overall Study|Death|7|||
105384642|NCT02453191|363415220|FG000|Overall Study|Withdrawal by Subject|1|||
105384643|NCT02965456|363415224|FG000|Overall Study|Lost to Follow-up|40|||
105384644|NCT02965456|363415225|FG001|Overall Study|Lost to Follow-up|18|||
105384645|NCT02965456|363415224|FG000|Overall Study|Subject Request|22|||
105384646|NCT02965456|363415225|FG001|Overall Study|Subject Request|13|||
105384647|NCT02965456|363415224|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
105384648|NCT02965456|363415225|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
105384649|NCT02965456|363415224|FG000|Overall Study|Adverse Event|3|||
105384650|NCT02965456|363415225|FG001|Overall Study|Adverse Event|0|||
105384651|NCT02965456|363415224|FG000|Overall Study|Noncompliance with Study Drug|1|||
105492831|NCT02322021|363817167|FG002|Extension Phase|Lost to Follow-up|0|||
105384652|NCT02965456|363415225|FG001|Overall Study|Noncompliance with Study Drug|1|||
105384653|NCT02965456|363415224|FG000|Overall Study|Worsening Condition|0|||
105384654|NCT02965456|363415225|FG001|Overall Study|Worsening Condition|2|||
105384655|NCT02965456|363415224|FG000|Overall Study|Lack of Efficacy|1|||
105384656|NCT02965456|363415225|FG001|Overall Study|Lack of Efficacy|0|||
105384657|NCT02965456|363415224|FG000|Overall Study|Physician Decision|0|||
105384658|NCT02965456|363415225|FG001|Overall Study|Physician Decision|1|||
105384659|NCT02965456|363415224|FG000|Overall Study|Pregnancy|1|||
105384660|NCT02965456|363415225|FG001|Overall Study|Pregnancy|0|||
105384661|NCT02965456|363415224|FG000|Overall Study|Protocol Violation|0|||
105384662|NCT02965456|363415225|FG001|Overall Study|Protocol Violation|1|||
105384663|NCT02965456|363415224|FG000|Overall Study|Participant ran out of study drug|0|||
105384664|NCT02965456|363415225|FG001|Overall Study|Participant ran out of study drug|1|||
105492832|NCT02322021|363817168|FG003|Extension Phase|Lost to Follow-up|0|||
105492833|NCT02322021|363817169|FG004|Extension Phase|Lost to Follow-up|1|||
105384665|NCT05507450|363415226|FG000|Overall Study|Death|0|||
105384666|NCT05507450|363415227|FG001|Overall Study|Death|0|||
105384667|NCT05507450|363415228|FG002|Overall Study|Death|1|||
105384668|NCT05507450|363415229|FG003|Overall Study|Death|0|||
105384669|NCT05507450|363415226|FG000|Overall Study|Lost to Follow-up|22|||
105384670|NCT05507450|363415227|FG001|Overall Study|Lost to Follow-up|20|||
105384671|NCT05507450|363415228|FG002|Overall Study|Lost to Follow-up|20|||
105384672|NCT05507450|363415229|FG003|Overall Study|Lost to Follow-up|7|||
105384673|NCT05507450|363415226|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105384674|NCT05507450|363415227|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
105384675|NCT05507450|363415228|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
105384676|NCT05507450|363415229|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105384677|NCT05507450|363415226|FG000|Overall Study|Withdrawal by Subject|4|||
105384678|NCT05507450|363415227|FG001|Overall Study|Withdrawal by Subject|11|||
105384679|NCT05507450|363415228|FG002|Overall Study|Withdrawal by Subject|7|||
105384680|NCT05507450|363415229|FG003|Overall Study|Withdrawal by Subject|3|||
105384681|NCT05507450|363415226|FG000|Overall Study|Participant left the country|0|||
105384682|NCT05507450|363415227|FG001|Overall Study|Participant left the country|0|||
105384683|NCT05507450|363415228|FG002|Overall Study|Participant left the country|1|||
105384684|NCT05507450|363415229|FG003|Overall Study|Participant left the country|0|||
105384685|NCT00407030|363415230|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
105384686|NCT00407030|363415231|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
105384687|NCT00407030|363415232|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
105384688|NCT00407030|363415230|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
105384689|NCT00407030|363415231|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
105384690|NCT00407030|363415232|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
105384691|NCT00407030|363415230|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
105384692|NCT00407030|363415231|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
105384693|NCT00407030|363415232|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
105384694|NCT00407030|363415230|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
105384695|NCT00407030|363415231|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
105384696|NCT00407030|363415232|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
105384697|NCT00407030|363415230|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
105384698|NCT00407030|363415231|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
105384699|NCT00407030|363415232|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
105384700|NCT00407030|363415230|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
105384701|NCT00407030|363415231|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
105384702|NCT00407030|363415232|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
105384703|NCT00407030|363415230|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
105384704|NCT00407030|363415231|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
105384705|NCT00407030|363415232|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
105384706|NCT00407030|363415230|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
105384707|NCT00407030|363415231|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
105384708|NCT00407030|363415232|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
105384709|NCT00407030|363415230|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
105384710|NCT00407030|363415231|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
105384711|NCT00407030|363415232|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
105384712|NCT00407030|363415230|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
105384713|NCT00407030|363415231|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
105384714|NCT00407030|363415232|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
105384715|NCT00407030|363415230|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
105384716|NCT00407030|363415231|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
105384717|NCT00407030|363415232|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
105384718|NCT00407030|363415230|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
105384719|NCT00407030|363415231|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
105384720|NCT00407030|363415232|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
105384721|NCT00407030|363415230|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
105384722|NCT00407030|363415231|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
105384723|NCT00407030|363415232|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
105384724|NCT00736476|363415234|FG000|Overall Study|Adverse Event|1|||
105384725|NCT00736476|363415235|FG001|Overall Study|Adverse Event|0|||
105384726|NCT03808909|363415236|FG000|Overall Study|Lost to Follow-up|3|||
105384727|NCT03808909|363415237|FG001|Overall Study|Lost to Follow-up|0|||
105384728|NCT03019588|363415238|FG000|Overall Study|Death|44|||
105384729|NCT03019588|363415239|FG001|Overall Study|Death|46|||
105384730|NCT03019588|363415238|FG000|Overall Study|Study terminated by Sponsor|3|||
105384731|NCT03019588|363415239|FG001|Overall Study|Study terminated by Sponsor|1|||
105384732|NCT02362412|363415240|FG000|Treatment Period III|Lost to Follow-up|0|||
105384733|NCT02362412|363415241|FG001|Treatment Period III|Lost to Follow-up|1|||
105384734|NCT03462563|363415244|FG000|Overall Study|Death|1|||
105384735|NCT03462563|363415245|FG001|Overall Study|Death|1|||
105384736|NCT03462563|363415244|FG000|Overall Study|Termination of study|2|||
105384737|NCT03462563|363415245|FG001|Overall Study|Termination of study|1|||
105384738|NCT03462563|363415244|FG000|Overall Study|Adverse Event|1|||
105384739|NCT03462563|363415245|FG001|Overall Study|Adverse Event|3|||
105384740|NCT03462563|363415244|FG000|Overall Study|Unspecified reason|10|||
105384741|NCT03462563|363415245|FG001|Overall Study|Unspecified reason|12|||
105384742|NCT03462563|363415244|FG000|Overall Study|Physician Decision|1|||
105384743|NCT03462563|363415245|FG001|Overall Study|Physician Decision|0|||
105384744|NCT01740427|363415246|FG000|Overall Study|Objective Progression or Relapse|286|||
105384745|NCT01740427|363415247|FG001|Overall Study|Objective Progression or Relapse|172|||
105384746|NCT01740427|363415246|FG000|Overall Study|Adverse Event|32|||
105384747|NCT01740427|363415247|FG001|Overall Study|Adverse Event|9|||
105384748|NCT01740427|363415246|FG000|Overall Study|Global Deterioration of Health Status|28|||
105384749|NCT01740427|363415247|FG001|Overall Study|Global Deterioration of Health Status|12|||
105384750|NCT01740427|363415246|FG000|Overall Study|Participant Refused Continued Treatment|27|||
105492834|NCT02322021|363817165|FG000|Extension Phase|Study terminated by sponsor|0|||
105384751|NCT01740427|363415247|FG001|Overall Study|Participant Refused Continued Treatment|15|||
105384752|NCT01740427|363415246|FG000|Overall Study|Unspecified reasons|52|||
105384753|NCT01740427|363415247|FG001|Overall Study|Unspecified reasons|8|||
105384754|NCT01740427|363415246|FG000|Overall Study|Death|10|||
105384755|NCT01740427|363415247|FG001|Overall Study|Death|3|||
105384756|NCT01740427|363415246|FG000|Overall Study|Protocol Violation|5|||
105384757|NCT01740427|363415247|FG001|Overall Study|Protocol Violation|3|||
105384758|NCT01740427|363415246|FG000|Overall Study|Lost to Follow-up|3|||
105384759|NCT01740427|363415247|FG001|Overall Study|Lost to Follow-up|0|||
105384760|NCT01740427|363415246|FG000|Overall Study|Site Terminated by Sponsor|1|||
105384761|NCT01740427|363415247|FG001|Overall Study|Site Terminated by Sponsor|0|||
105384762|NCT04796207|363415248|FG000|Overall Study|Lost to Follow-up|7|||
105384763|NCT04796207|363415249|FG001|Overall Study|Lost to Follow-up|2|||
105384764|NCT02405962|363415252|FG000|Overall Study|Lost to Follow-up|1|||
105384765|NCT02405962|363415253|FG001|Overall Study|Lost to Follow-up|4|||
105384766|NCT02405962|363415252|FG000|Overall Study|A participant has moved to another place|0|||
105384767|NCT02405962|363415253|FG001|Overall Study|A participant has moved to another place|1|||
105384768|NCT03339453|363415264|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
105384769|NCT03339453|363415265|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
105384770|NCT01348490|363415269|FG000|Overall Study|Death|1|||
105384771|NCT01348490|363415269|FG000|Overall Study|Adverse Event|3|||
105384772|NCT01348490|363415269|FG000|Overall Study|Consent withdrawn|7|||
105384773|NCT01348490|363415269|FG000|Overall Study|Disease progression|3|||
105384774|NCT01348490|363415269|FG000|Overall Study|Lost to Follow-up|1|||
105384775|NCT01348490|363415269|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
105384776|NCT01348490|363415269|FG000|Overall Study|Other Unspecified|8|||
105384777|NCT03632720|363415270|FG000|Overall Study|Adverse Event|2|||
105384778|NCT03632720|363415271|FG001|Overall Study|Adverse Event|0|||
105384779|NCT03632720|363415272|FG002|Overall Study|Adverse Event|0|||
105384780|NCT03632720|363415270|FG000|Overall Study|Lost to Follow-up|0|||
105384781|NCT03632720|363415271|FG001|Overall Study|Lost to Follow-up|1|||
105384782|NCT03632720|363415272|FG002|Overall Study|Lost to Follow-up|0|||
105384783|NCT03632720|363415270|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
105384784|NCT03632720|363415271|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
105384785|NCT03632720|363415272|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
105384786|NCT03632720|363415270|FG000|Overall Study|Screen failure|0|||
105384787|NCT03632720|363415271|FG001|Overall Study|Screen failure|1|||
105384788|NCT03632720|363415272|FG002|Overall Study|Screen failure|0|||
105384789|NCT00954538|363415279|FG000|Part III|Withdrawal by Subject|0|||
105384790|NCT00954538|363415280|FG001|Part III|Withdrawal by Subject|0|||
105384791|NCT00954538|363415281|FG002|Part III|Withdrawal by Subject|0|||
105384792|NCT00954538|363415282|FG003|Part III|Withdrawal by Subject|0|||
105384793|NCT00954538|363415283|FG004|Part III|Withdrawal by Subject|1|||
105384794|NCT00954538|363415284|FG005|Part III|Withdrawal by Subject|0|||
105384795|NCT00382070|363416627|FG000|Overall Study|No follow up data mapped to Other|17|||
105384796|NCT00382070|363416628|FG001|Overall Study|No follow up data mapped to Other|19|||
105384797|NCT00382070|363416627|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
105384798|NCT00382070|363416628|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
105384799|NCT00382070|363416627|FG000|Overall Study|No clinical assessment|9|||
105384800|NCT00382070|363416628|FG001|Overall Study|No clinical assessment|11|||
105384801|NCT03928704|363416630|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
105384802|NCT03928704|363416631|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
105384803|NCT03928704|363416632|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
105384804|NCT03928704|363416633|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
105384805|NCT03928704|363416634|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
105384806|NCT03928704|363416635|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
105384807|NCT03928704|363416630|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
105384808|NCT03928704|363416631|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
105384809|NCT03928704|363416632|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
105384810|NCT03928704|363416633|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
105384811|NCT03928704|363416634|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
105384812|NCT03928704|363416635|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
105384813|NCT03928704|363416630|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
105384814|NCT03928704|363416631|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
105384815|NCT03928704|363416632|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
105384816|NCT03928704|363416633|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
105384817|NCT03928704|363416634|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
105384818|NCT03928704|363416635|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
105384819|NCT03928704|363416630|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
105384820|NCT03928704|363416631|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
105384821|NCT03928704|363416632|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
105384822|NCT03928704|363416633|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
105384823|NCT03928704|363416634|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
105384824|NCT03928704|363416635|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
105384825|NCT03928704|363416630|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
105384826|NCT03928704|363416631|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
105384827|NCT03928704|363416632|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
105384828|NCT03928704|363416633|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
105384829|NCT03928704|363416634|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
105384830|NCT03928704|363416635|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
105384831|NCT03928704|363416630|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
105384832|NCT03928704|363416631|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
105384833|NCT03928704|363416632|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
105384834|NCT03928704|363416633|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
105384835|NCT03928704|363416634|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
105384836|NCT03928704|363416635|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
105384837|NCT03928704|363416630|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
105384838|NCT03928704|363416631|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
105384839|NCT03928704|363416632|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
105384840|NCT03928704|363416633|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
105384841|NCT03928704|363416634|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
105384842|NCT03928704|363416635|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
105384843|NCT03928704|363416630|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
105384844|NCT03928704|363416631|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
105384845|NCT03928704|363416632|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
105384846|NCT03928704|363416633|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
105384847|NCT03928704|363416634|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
105384848|NCT03928704|363416635|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
105384849|NCT03928704|363416630|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
105384850|NCT03928704|363416631|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
105384851|NCT03928704|363416632|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
105384852|NCT03928704|363416633|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
105384853|NCT03928704|363416634|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
105384854|NCT03928704|363416635|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
105384855|NCT03928704|363416630|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
105384856|NCT03928704|363416631|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
105384857|NCT03928704|363416632|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
105384858|NCT03928704|363416633|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
105384859|NCT03928704|363416634|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
105384860|NCT03928704|363416635|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
105384861|NCT00284934|363416636|FG000|Overall Study|Adverse Event|1|||
105384862|NCT00284934|363416637|FG001|Overall Study|Adverse Event|2|||
105384863|NCT00284934|363416636|FG000|Overall Study|Other reasons|3|||
105384864|NCT00284934|363416637|FG001|Overall Study|Other reasons|1|||
105384865|NCT00326495|363416644|FG000|Overall Study|Switched to alternative treatment|1|||
105384866|NCT00326495|363416644|FG000|Overall Study|Disease progression before treatment|1|||
105384867|NCT00326495|363416644|FG000|Overall Study|Refused further treatment|2|||
105384868|NCT00326495|363416644|FG000|Overall Study|Subject off study before assessment|1|||
105384869|NCT04359680|363416645|FG000|Overall Study|Withdrawal by Subject|29|||
105384870|NCT04359680|363416646|FG001|Overall Study|Withdrawal by Subject|24|||
105384871|NCT04359680|363416645|FG000|Overall Study|Adverse Event|6|||
105384872|NCT04359680|363416646|FG001|Overall Study|Adverse Event|2|||
105384873|NCT04359680|363416645|FG000|Overall Study|Lost to Follow-up|56|||
105384874|NCT04359680|363416646|FG001|Overall Study|Lost to Follow-up|59|||
105384875|NCT04359680|363416645|FG000|Overall Study|Protocol Violation|3|||
105384876|NCT04359680|363416646|FG001|Overall Study|Protocol Violation|5|||
105384877|NCT04359680|363416645|FG000|Overall Study|Physician Decision|1|||
105384878|NCT04359680|363416646|FG001|Overall Study|Physician Decision|1|||
105384879|NCT04359680|363416645|FG000|Overall Study|Sponsor Decision|0|||
105384880|NCT04359680|363416646|FG001|Overall Study|Sponsor Decision|1|||
105384881|NCT00520572|363416647|FG000|Overall Study|Adverse Event|9|||
105384882|NCT00520572|363416648|FG001|Overall Study|Adverse Event|3|||
105384883|NCT00520572|363416649|FG002|Overall Study|Adverse Event|6|||
105384884|NCT00520572|363416650|FG003|Overall Study|Adverse Event|9|||
105384885|NCT00520572|363416651|FG004|Overall Study|Adverse Event|7|||
105384886|NCT00520572|363416652|FG005|Overall Study|Adverse Event|2|||
105384887|NCT00520572|363416647|FG000|Overall Study|Withdrawal by Subject|0|||
105384888|NCT00520572|363416648|FG001|Overall Study|Withdrawal by Subject|9|||
105384889|NCT00520572|363416649|FG002|Overall Study|Withdrawal by Subject|5|||
105384890|NCT00520572|363416650|FG003|Overall Study|Withdrawal by Subject|2|||
105384891|NCT00520572|363416651|FG004|Overall Study|Withdrawal by Subject|2|||
105384892|NCT00520572|363416652|FG005|Overall Study|Withdrawal by Subject|0|||
105384893|NCT00520572|363416647|FG000|Overall Study|Protocol Violation|0|||
105384894|NCT00520572|363416648|FG001|Overall Study|Protocol Violation|0|||
105384895|NCT00520572|363416649|FG002|Overall Study|Protocol Violation|1|||
105384896|NCT00520572|363416650|FG003|Overall Study|Protocol Violation|0|||
105384897|NCT00520572|363416651|FG004|Overall Study|Protocol Violation|0|||
105384898|NCT00520572|363416652|FG005|Overall Study|Protocol Violation|0|||
105384899|NCT00520572|363416647|FG000|Overall Study|Lack of Efficacy|1|||
105384900|NCT00520572|363416648|FG001|Overall Study|Lack of Efficacy|1|||
105384901|NCT00520572|363416649|FG002|Overall Study|Lack of Efficacy|1|||
105384902|NCT00520572|363416650|FG003|Overall Study|Lack of Efficacy|2|||
105384903|NCT00520572|363416651|FG004|Overall Study|Lack of Efficacy|1|||
105384904|NCT00520572|363416652|FG005|Overall Study|Lack of Efficacy|0|||
105580539|NCT02018861|364126449|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
105384905|NCT00520572|363416647|FG000|Overall Study|Lost to Follow-up|0|||
105384906|NCT00520572|363416648|FG001|Overall Study|Lost to Follow-up|0|||
105384907|NCT00520572|363416649|FG002|Overall Study|Lost to Follow-up|0|||
105384908|NCT00520572|363416650|FG003|Overall Study|Lost to Follow-up|0|||
105384909|NCT00520572|363416651|FG004|Overall Study|Lost to Follow-up|1|||
105384910|NCT00520572|363416652|FG005|Overall Study|Lost to Follow-up|0|||
105384911|NCT00520572|363416647|FG000|Overall Study|Incorrect enrollment|1|||
105384912|NCT00520572|363416648|FG001|Overall Study|Incorrect enrollment|0|||
105384913|NCT00520572|363416649|FG002|Overall Study|Incorrect enrollment|1|||
105384914|NCT00520572|363416650|FG003|Overall Study|Incorrect enrollment|0|||
105384915|NCT00520572|363416651|FG004|Overall Study|Incorrect enrollment|1|||
105384916|NCT00520572|363416652|FG005|Overall Study|Incorrect enrollment|0|||
105384917|NCT00520572|363416647|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
105384918|NCT00520572|363416648|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
105384919|NCT00520572|363416649|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
105384920|NCT00520572|363416650|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
105384921|NCT00520572|363416651|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
105384922|NCT00520572|363416652|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
105384923|NCT00520572|363416647|FG000|Overall Study|Long break in taking Medication|0|||
105384924|NCT00520572|363416648|FG001|Overall Study|Long break in taking Medication|0|||
105384925|NCT00520572|363416649|FG002|Overall Study|Long break in taking Medication|0|||
105384926|NCT00520572|363416650|FG003|Overall Study|Long break in taking Medication|1|||
105384927|NCT00520572|363416651|FG004|Overall Study|Long break in taking Medication|0|||
105384928|NCT00520572|363416652|FG005|Overall Study|Long break in taking Medication|0|||
105384929|NCT00520572|363416647|FG000|Overall Study|Did not receive Treatment|1|||
105384930|NCT00520572|363416648|FG001|Overall Study|Did not receive Treatment|0|||
105384931|NCT00520572|363416649|FG002|Overall Study|Did not receive Treatment|1|||
105384932|NCT00520572|363416650|FG003|Overall Study|Did not receive Treatment|0|||
105384933|NCT00520572|363416651|FG004|Overall Study|Did not receive Treatment|0|||
105384934|NCT00520572|363416652|FG005|Overall Study|Did not receive Treatment|0|||
105384935|NCT03794544|363416656|FG000|Overall Study|Withdrawal by Subject|1|||
105384936|NCT03794544|363416657|FG001|Overall Study|Withdrawal by Subject|1|||
105384937|NCT03794544|363416658|FG002|Overall Study|Withdrawal by Subject|0|||
105384938|NCT03794544|363416659|FG003|Overall Study|Withdrawal by Subject|0|||
105384939|NCT03794544|363416656|FG000|Overall Study|Death|0|||
105384940|NCT03794544|363416657|FG001|Overall Study|Death|0|||
105384941|NCT03794544|363416658|FG002|Overall Study|Death|0|||
105384942|NCT03794544|363416659|FG003|Overall Study|Death|1|||
105384943|NCT03794544|363416656|FG000|Overall Study|Lost to Follow-up|0|||
105384944|NCT03794544|363416657|FG001|Overall Study|Lost to Follow-up|1|||
105384945|NCT03794544|363416658|FG002|Overall Study|Lost to Follow-up|1|||
105384946|NCT03794544|363416659|FG003|Overall Study|Lost to Follow-up|0|||
105384947|NCT03794544|363416656|FG000|Overall Study|Other|0|||
105384948|NCT03794544|363416657|FG001|Overall Study|Other|1|||
105384949|NCT03794544|363416658|FG002|Overall Study|Other|0|||
105384950|NCT03794544|363416659|FG003|Overall Study|Other|0|||
105384951|NCT00289978|363416662|FG000|Overall Study|Withdrawal by Subject|31|||
105384952|NCT00289978|363416663|FG001|Overall Study|Withdrawal by Subject|17|||
105384953|NCT00289978|363416664|FG002|Overall Study|Withdrawal by Subject|28|||
105384954|NCT00289978|363416662|FG000|Overall Study|Adverse Event|22|||
105384955|NCT00289978|363416663|FG001|Overall Study|Adverse Event|13|||
105384956|NCT00289978|363416664|FG002|Overall Study|Adverse Event|18|||
105384957|NCT00289978|363416662|FG000|Overall Study|Lack of Efficacy|13|||
105384958|NCT00289978|363416663|FG001|Overall Study|Lack of Efficacy|6|||
105384959|NCT00289978|363416664|FG002|Overall Study|Lack of Efficacy|25|||
105384960|NCT00289978|363416662|FG000|Overall Study|Abnormal laboratory value(s)|20|||
105384961|NCT00289978|363416663|FG001|Overall Study|Abnormal laboratory value(s)|9|||
105384962|NCT00289978|363416664|FG002|Overall Study|Abnormal laboratory value(s)|1|||
105384963|NCT00289978|363416662|FG000|Overall Study|Lost to Follow-up|3|||
105384964|NCT00289978|363416663|FG001|Overall Study|Lost to Follow-up|5|||
105384965|NCT00289978|363416664|FG002|Overall Study|Lost to Follow-up|7|||
105384966|NCT00289978|363416662|FG000|Overall Study|Protocol Violation|5|||
105384967|NCT00289978|363416663|FG001|Overall Study|Protocol Violation|5|||
105384968|NCT00289978|363416664|FG002|Overall Study|Protocol Violation|4|||
105384969|NCT00289978|363416662|FG000|Overall Study|Abnormal test procedure result(s)|2|||
105384970|NCT00289978|363416663|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105384971|NCT00289978|363416664|FG002|Overall Study|Abnormal test procedure result(s)|1|||
105580540|NCT02018861|364126450|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
105384972|NCT00289978|363416662|FG000|Overall Study|Death|1|||
105384973|NCT00289978|363416663|FG001|Overall Study|Death|0|||
105384974|NCT00289978|363416664|FG002|Overall Study|Death|2|||
105384975|NCT00363467|363416665|FG000|Overall Study|Physician Decision|1|||
105384976|NCT00120250|363416666|FG000|Overall Study|Lost to Follow-up|1|||
105384977|NCT00120250|363416667|FG001|Overall Study|Lost to Follow-up|1|||
105384978|NCT00120250|363416666|FG000|Overall Study|Protocol Violation|0|||
105384979|NCT00120250|363416667|FG001|Overall Study|Protocol Violation|1|||
105384980|NCT01524705|363416668|FG000|Overall Study|Adverse Event|2|||
105384981|NCT01524705|363416669|FG001|Overall Study|Adverse Event|0|||
105384982|NCT01524705|363416668|FG000|Overall Study|Death|1|||
105384983|NCT01524705|363416669|FG001|Overall Study|Death|0|||
105384984|NCT01524705|363416668|FG000|Overall Study|Lost to Follow-up|0|||
105384985|NCT01524705|363416669|FG001|Overall Study|Lost to Follow-up|1|||
105384986|NCT01524705|363416668|FG000|Overall Study|Withdrawal by Subject|0|||
105384987|NCT01524705|363416669|FG001|Overall Study|Withdrawal by Subject|1|||
105384988|NCT01524705|363416668|FG000|Overall Study|Pancreatic Cancer|0|||
105384989|NCT01524705|363416669|FG001|Overall Study|Pancreatic Cancer|1|||
105384990|NCT01755156|363416679|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
105384991|NCT01755156|363416680|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
105384992|NCT01755156|363416679|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
105384993|NCT01755156|363416680|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
105384994|NCT01755156|363416679|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
105384995|NCT01755156|363416680|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
105384996|NCT01755156|363416679|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
105384997|NCT01755156|363416680|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
105384998|NCT01755156|363416679|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
105384999|NCT01755156|363416680|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
105385000|NCT01755156|363416679|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
105385001|NCT01755156|363416680|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
105385002|NCT01755156|363416679|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
105385003|NCT01755156|363416680|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
105385004|NCT01755156|363416679|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
105385005|NCT01755156|363416680|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
105385006|NCT01755156|363416679|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
105385007|NCT01755156|363416680|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
105385008|NCT01755156|363416679|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
105385009|NCT01755156|363416680|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
105385010|NCT01755156|363416679|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
105385011|NCT01755156|363416680|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
105385012|NCT03142451|363416681|FG000|Overall Study|Adverse Event|5|||
105385013|NCT03142451|363416682|FG001|Overall Study|Adverse Event|2|||
105385014|NCT03142451|363416681|FG000|Overall Study|Lost to Follow-up|25|||
105385015|NCT03142451|363416682|FG001|Overall Study|Lost to Follow-up|8|||
105385016|NCT03142451|363416681|FG000|Overall Study|Participant request|24|||
105385017|NCT03142451|363416682|FG001|Overall Study|Participant request|12|||
105385018|NCT03142451|363416681|FG000|Overall Study|Protocol Violation|3|||
105385019|NCT03142451|363416682|FG001|Overall Study|Protocol Violation|1|||
105385020|NCT03142451|363416681|FG000|Overall Study|Other|1|||
105385021|NCT03142451|363416682|FG001|Overall Study|Other|1|||
105385022|NCT00090402|363416683|FG000|Overall Study|Death|1|||
105385023|NCT00090402|363416684|FG001|Overall Study|Death|1|||
105385024|NCT00090402|363416685|FG002|Overall Study|Death|0|||
105385025|NCT00090402|363416683|FG000|Overall Study|subject moved|0|||
105385026|NCT00090402|363416684|FG001|Overall Study|subject moved|1|||
105385027|NCT00090402|363416685|FG002|Overall Study|subject moved|0|||
105385028|NCT00090402|363416683|FG000|Overall Study|stopped taking study medication|1|||
105385029|NCT00090402|363416684|FG001|Overall Study|stopped taking study medication|0|||
105385030|NCT00090402|363416685|FG002|Overall Study|stopped taking study medication|1|||
105385031|NCT01530256|363416688|FG000|Overall Study|Death|2|||
105385032|NCT00710970|363416691|FG000|Overall Study|Never took drug|3|||
105385033|NCT01028560|363416692|FG000|Overall Study|Lack of Efficacy|3|||
105385034|NCT01028560|363416693|FG001|Overall Study|Lack of Efficacy|6|||
105385035|NCT01028560|363416692|FG000|Overall Study|Withdrawal by Subject|7|||
105385036|NCT01028560|363416693|FG001|Overall Study|Withdrawal by Subject|12|||
105385037|NCT01964560|363416696|FG000|Overall Study|Adverse Event|23|||
105385038|NCT01964560|363416696|FG000|Overall Study|Lack of Efficacy|46|||
105385039|NCT01964560|363416696|FG000|Overall Study|Protocol deviation|2|||
105385040|NCT01964560|363416696|FG000|Overall Study|Lost to Follow-up|4|||
105385041|NCT01964560|363416696|FG000|Overall Study|Withdrawal by Subject|64|||
105385042|NCT01964560|363416696|FG000|Overall Study|Surgery-hemispherotomy|1|||
105385043|NCT01964560|363416696|FG000|Overall Study|Surgery|1|||
105385044|NCT01964560|363416696|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
105385045|NCT01964560|363416696|FG000|Overall Study|Patient and Investigator choice|1|||
105385046|NCT01964560|363416696|FG000|Overall Study|Patient was prescribed CBD|1|||
105385047|NCT01964560|363416696|FG000|Overall Study|Participant moved to another country|1|||
105385048|NCT01093885|363416697|FG000|Overall Study|Adverse Event|4|||
105385049|NCT01093885|363416697|FG000|Overall Study|Lost to Follow-up|1|||
105385050|NCT00710554|363416698|FG000|Overall Study|Adverse Event|24|||
105385051|NCT00710554|363416699|FG001|Overall Study|Adverse Event|7|||
105385052|NCT00710554|363416698|FG000|Overall Study|Withdrawal by Subject|7|||
105385053|NCT00710554|363416699|FG001|Overall Study|Withdrawal by Subject|3|||
105385054|NCT00710554|363416698|FG000|Overall Study|Lost to Follow-up|7|||
105385055|NCT00710554|363416699|FG001|Overall Study|Lost to Follow-up|1|||
105385056|NCT00710554|363416698|FG000|Overall Study|Lack of Efficacy|11|||
105385057|NCT00710554|363416699|FG001|Overall Study|Lack of Efficacy|12|||
105385058|NCT00710554|363416698|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
105385059|NCT00710554|363416699|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
105385060|NCT01301001|363416700|FG000|First Intervention|Lost to Follow-up|4|||
105385061|NCT01301001|363416701|FG001|First Intervention|Lost to Follow-up|4|||
105385062|NCT01301001|363416700|FG000|First Intervention|Withdrawal by Subject|1|||
105385063|NCT01301001|363416701|FG001|First Intervention|Withdrawal by Subject|4|||
105385064|NCT01301001|363416700|FG000|First Intervention|Adverse Event|5|||
105385065|NCT01301001|363416701|FG001|First Intervention|Adverse Event|0|||
105385066|NCT01301001|363416700|FG000|First Intervention|Protocol Violation|0|||
105385067|NCT01301001|363416701|FG001|First Intervention|Protocol Violation|1|||
105385068|NCT01301001|363416700|FG000|Second Intervention|Adverse Event|2|||
105385069|NCT01301001|363416701|FG001|Second Intervention|Adverse Event|0|||
105385070|NCT01301001|363416700|FG000|Second Intervention|Withdrawal by Subject|2|||
105385071|NCT01301001|363416701|FG001|Second Intervention|Withdrawal by Subject|0|||
105385072|NCT00292370|363416702|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
105385073|NCT00292370|363416703|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
105385074|NCT00292370|363416704|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
105385075|NCT00292370|363416702|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
105385076|NCT00292370|363416703|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
105385077|NCT00292370|363416704|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
105385078|NCT00292370|363416702|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
105385079|NCT00292370|363416703|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
105385080|NCT00292370|363416704|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
105385081|NCT00292370|363416702|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
105385082|NCT00292370|363416703|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
105385083|NCT00292370|363416704|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
105385084|NCT00292370|363416702|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
105385085|NCT00292370|363416703|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
105385086|NCT00292370|363416704|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
105385087|NCT00292370|363416702|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
105385088|NCT00292370|363416703|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
105385089|NCT00292370|363416704|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
105385090|NCT02533674|363416705|FG000|Dose Level I|Progressive disease|1|||
105385091|NCT02533674|363416706|FG001|Dose Level I|Progressive disease|0|||
105385092|NCT02533674|363416707|FG002|Dose Level I|Progressive disease|0|||
105385093|NCT02533674|363416708|FG003|Dose Level I|Progressive disease|0|||
105385094|NCT02533674|363416709|FG004|Dose Level I|Progressive disease|0|||
105385095|NCT02533674|363416710|FG005|Dose Level I|Progressive disease|0|||
105385096|NCT02533674|363416711|FG006|Dose Level I|Progressive disease|0|||
105385097|NCT02533674|363416712|FG007|Dose Level I|Progressive disease|0|||
105385098|NCT02533674|363416705|FG000|Dose Level I|Withdrawal by Subject|1|||
105385099|NCT02533674|363416706|FG001|Dose Level I|Withdrawal by Subject|0|||
105385100|NCT02533674|363416707|FG002|Dose Level I|Withdrawal by Subject|0|||
105385101|NCT02533674|363416708|FG003|Dose Level I|Withdrawal by Subject|0|||
105385102|NCT02533674|363416709|FG004|Dose Level I|Withdrawal by Subject|0|||
105385103|NCT02533674|363416710|FG005|Dose Level I|Withdrawal by Subject|0|||
105385104|NCT02533674|363416711|FG006|Dose Level I|Withdrawal by Subject|0|||
105385105|NCT02533674|363416712|FG007|Dose Level I|Withdrawal by Subject|0|||
105385106|NCT02533674|363416705|FG000|Dose Level I|Physician Decision|1|||
105385107|NCT02533674|363416706|FG001|Dose Level I|Physician Decision|0|||
105385108|NCT02533674|363416707|FG002|Dose Level I|Physician Decision|0|||
105385109|NCT02533674|363416708|FG003|Dose Level I|Physician Decision|0|||
105385110|NCT02533674|363416709|FG004|Dose Level I|Physician Decision|0|||
105385111|NCT02533674|363416710|FG005|Dose Level I|Physician Decision|0|||
105385112|NCT02533674|363416711|FG006|Dose Level I|Physician Decision|0|||
105385113|NCT02533674|363416712|FG007|Dose Level I|Physician Decision|0|||
105385114|NCT02533674|363416705|FG000|Dose Level I|Death|1|||
105385115|NCT02533674|363416706|FG001|Dose Level I|Death|0|||
105385116|NCT02533674|363416707|FG002|Dose Level I|Death|0|||
105492835|NCT02322021|363817166|FG001|Extension Phase|Study terminated by sponsor|0|||
105492836|NCT02322021|363817167|FG002|Extension Phase|Study terminated by sponsor|0|||
105492837|NCT02322021|363817168|FG003|Extension Phase|Study terminated by sponsor|0|||
105492838|NCT02322021|363817169|FG004|Extension Phase|Study terminated by sponsor|28|||
105385117|NCT02533674|363416708|FG003|Dose Level I|Death|0|||
105385118|NCT02533674|363416709|FG004|Dose Level I|Death|0|||
105385119|NCT02533674|363416710|FG005|Dose Level I|Death|0|||
105385120|NCT02533674|363416711|FG006|Dose Level I|Death|0|||
105385121|NCT02533674|363416712|FG007|Dose Level I|Death|0|||
105385122|NCT02533674|363416705|FG000|Dose Level I|Never Treated|1|||
105385123|NCT02533674|363416706|FG001|Dose Level I|Never Treated|0|||
105385124|NCT02533674|363416707|FG002|Dose Level I|Never Treated|0|||
105385125|NCT02533674|363416708|FG003|Dose Level I|Never Treated|0|||
105385126|NCT02533674|363416709|FG004|Dose Level I|Never Treated|0|||
105385127|NCT02533674|363416710|FG005|Dose Level I|Never Treated|0|||
105385128|NCT02533674|363416711|FG006|Dose Level I|Never Treated|0|||
105385129|NCT02533674|363416712|FG007|Dose Level I|Never Treated|0|||
105385130|NCT02533674|363416705|FG000|Dose Level II|Progressive disease|0|||
105385131|NCT02533674|363416706|FG001|Dose Level II|Progressive disease|3|||
105385132|NCT02533674|363416707|FG002|Dose Level II|Progressive disease|0|||
105385133|NCT02533674|363416708|FG003|Dose Level II|Progressive disease|0|||
105385134|NCT02533674|363416709|FG004|Dose Level II|Progressive disease|0|||
105385135|NCT02533674|363416710|FG005|Dose Level II|Progressive disease|0|||
105385136|NCT02533674|363416711|FG006|Dose Level II|Progressive disease|0|||
105385137|NCT02533674|363416712|FG007|Dose Level II|Progressive disease|0|||
105385138|NCT02533674|363416705|FG000|Dose Level II|Withdrawal by Subject|0|||
105385139|NCT02533674|363416706|FG001|Dose Level II|Withdrawal by Subject|1|||
105385140|NCT02533674|363416707|FG002|Dose Level II|Withdrawal by Subject|0|||
105385141|NCT02533674|363416708|FG003|Dose Level II|Withdrawal by Subject|0|||
105385142|NCT02533674|363416709|FG004|Dose Level II|Withdrawal by Subject|0|||
105385143|NCT02533674|363416710|FG005|Dose Level II|Withdrawal by Subject|0|||
105385144|NCT02533674|363416711|FG006|Dose Level II|Withdrawal by Subject|0|||
105385145|NCT02533674|363416712|FG007|Dose Level II|Withdrawal by Subject|0|||
105385146|NCT02533674|363416705|FG000|Dose Level II|Treatment-related AE|0|||
105385147|NCT02533674|363416706|FG001|Dose Level II|Treatment-related AE|1|||
105385148|NCT02533674|363416707|FG002|Dose Level II|Treatment-related AE|0|||
105385149|NCT02533674|363416708|FG003|Dose Level II|Treatment-related AE|0|||
105385150|NCT02533674|363416709|FG004|Dose Level II|Treatment-related AE|0|||
105385151|NCT02533674|363416710|FG005|Dose Level II|Treatment-related AE|0|||
105385152|NCT02533674|363416711|FG006|Dose Level II|Treatment-related AE|0|||
105385153|NCT02533674|363416712|FG007|Dose Level II|Treatment-related AE|0|||
105385154|NCT02533674|363416705|FG000|Dose Level II|Physician Decision|0|||
105385155|NCT02533674|363416706|FG001|Dose Level II|Physician Decision|1|||
105385156|NCT02533674|363416707|FG002|Dose Level II|Physician Decision|0|||
105385157|NCT02533674|363416708|FG003|Dose Level II|Physician Decision|0|||
105385158|NCT02533674|363416709|FG004|Dose Level II|Physician Decision|0|||
105385159|NCT02533674|363416710|FG005|Dose Level II|Physician Decision|0|||
105385160|NCT02533674|363416711|FG006|Dose Level II|Physician Decision|0|||
105385161|NCT02533674|363416712|FG007|Dose Level II|Physician Decision|0|||
105385162|NCT02533674|363416705|FG000|Dose Level II|Non-treatment-related AE|0|||
105385163|NCT02533674|363416706|FG001|Dose Level II|Non-treatment-related AE|1|||
105385164|NCT02533674|363416707|FG002|Dose Level II|Non-treatment-related AE|0|||
105385165|NCT02533674|363416708|FG003|Dose Level II|Non-treatment-related AE|0|||
105385166|NCT02533674|363416709|FG004|Dose Level II|Non-treatment-related AE|0|||
105385167|NCT02533674|363416710|FG005|Dose Level II|Non-treatment-related AE|0|||
105385168|NCT02533674|363416711|FG006|Dose Level II|Non-treatment-related AE|0|||
105385169|NCT02533674|363416712|FG007|Dose Level II|Non-treatment-related AE|0|||
105385170|NCT02533674|363416705|FG000|Dose Level III|Progressive disease|0|||
105385171|NCT02533674|363416706|FG001|Dose Level III|Progressive disease|0|||
105385172|NCT02533674|363416707|FG002|Dose Level III|Progressive disease|2|||
105385173|NCT02533674|363416708|FG003|Dose Level III|Progressive disease|0|||
105385174|NCT02533674|363416709|FG004|Dose Level III|Progressive disease|0|||
105385175|NCT02533674|363416710|FG005|Dose Level III|Progressive disease|0|||
105385176|NCT02533674|363416711|FG006|Dose Level III|Progressive disease|0|||
105385177|NCT02533674|363416712|FG007|Dose Level III|Progressive disease|0|||
105385178|NCT02533674|363416705|FG000|Dose Level III|Withdrawal by Subject|0|||
105385179|NCT02533674|363416706|FG001|Dose Level III|Withdrawal by Subject|0|||
105385180|NCT02533674|363416707|FG002|Dose Level III|Withdrawal by Subject|1|||
105385181|NCT02533674|363416708|FG003|Dose Level III|Withdrawal by Subject|0|||
105385182|NCT02533674|363416709|FG004|Dose Level III|Withdrawal by Subject|0|||
105385183|NCT02533674|363416710|FG005|Dose Level III|Withdrawal by Subject|0|||
105385184|NCT02533674|363416711|FG006|Dose Level III|Withdrawal by Subject|0|||
105385185|NCT02533674|363416712|FG007|Dose Level III|Withdrawal by Subject|0|||
105385186|NCT02533674|363416705|FG000|Dose Level III|Treatment-related AE|0|||
105385187|NCT02533674|363416706|FG001|Dose Level III|Treatment-related AE|0|||
105385188|NCT02533674|363416707|FG002|Dose Level III|Treatment-related AE|1|||
105385189|NCT02533674|363416708|FG003|Dose Level III|Treatment-related AE|0|||
105385190|NCT02533674|363416709|FG004|Dose Level III|Treatment-related AE|0|||
105385191|NCT02533674|363416710|FG005|Dose Level III|Treatment-related AE|0|||
105385192|NCT02533674|363416711|FG006|Dose Level III|Treatment-related AE|0|||
105385193|NCT02533674|363416712|FG007|Dose Level III|Treatment-related AE|0|||
105385194|NCT02533674|363416705|FG000|Dose Level IV|Progressive disease|0|||
105385195|NCT02533674|363416706|FG001|Dose Level IV|Progressive disease|0|||
105385196|NCT02533674|363416707|FG002|Dose Level IV|Progressive disease|0|||
105385197|NCT02533674|363416708|FG003|Dose Level IV|Progressive disease|3|||
105385198|NCT02533674|363416709|FG004|Dose Level IV|Progressive disease|0|||
105385199|NCT02533674|363416710|FG005|Dose Level IV|Progressive disease|0|||
105385200|NCT02533674|363416711|FG006|Dose Level IV|Progressive disease|0|||
105385201|NCT02533674|363416712|FG007|Dose Level IV|Progressive disease|0|||
105385202|NCT02533674|363416705|FG000|Dose Level IV|Withdrawal by Subject|0|||
105385203|NCT02533674|363416706|FG001|Dose Level IV|Withdrawal by Subject|0|||
105385204|NCT02533674|363416707|FG002|Dose Level IV|Withdrawal by Subject|0|||
105385205|NCT02533674|363416708|FG003|Dose Level IV|Withdrawal by Subject|1|||
105385206|NCT02533674|363416709|FG004|Dose Level IV|Withdrawal by Subject|0|||
105385207|NCT02533674|363416710|FG005|Dose Level IV|Withdrawal by Subject|0|||
105385208|NCT02533674|363416711|FG006|Dose Level IV|Withdrawal by Subject|0|||
105385209|NCT02533674|363416712|FG007|Dose Level IV|Withdrawal by Subject|0|||
105385210|NCT02533674|363416705|FG000|Dose Level IV|Physician Decision|0|||
105385211|NCT02533674|363416706|FG001|Dose Level IV|Physician Decision|0|||
105385212|NCT02533674|363416707|FG002|Dose Level IV|Physician Decision|0|||
105385213|NCT02533674|363416708|FG003|Dose Level IV|Physician Decision|1|||
105385214|NCT02533674|363416709|FG004|Dose Level IV|Physician Decision|0|||
105385215|NCT02533674|363416710|FG005|Dose Level IV|Physician Decision|0|||
105385216|NCT02533674|363416711|FG006|Dose Level IV|Physician Decision|0|||
105385217|NCT02533674|363416712|FG007|Dose Level IV|Physician Decision|0|||
105385218|NCT02533674|363416705|FG000|Dose Level V|Progressive disease|0|||
105385219|NCT02533674|363416706|FG001|Dose Level V|Progressive disease|0|||
105385220|NCT02533674|363416707|FG002|Dose Level V|Progressive disease|0|||
105385221|NCT02533674|363416708|FG003|Dose Level V|Progressive disease|0|||
105385222|NCT02533674|363416709|FG004|Dose Level V|Progressive disease|3|||
105385223|NCT02533674|363416710|FG005|Dose Level V|Progressive disease|0|||
105385224|NCT02533674|363416711|FG006|Dose Level V|Progressive disease|0|||
105385225|NCT02533674|363416712|FG007|Dose Level V|Progressive disease|0|||
105385226|NCT02533674|363416705|FG000|Dose Level V|Withdrawal by Subject|0|||
105385227|NCT02533674|363416706|FG001|Dose Level V|Withdrawal by Subject|0|||
105385228|NCT02533674|363416707|FG002|Dose Level V|Withdrawal by Subject|0|||
105385229|NCT02533674|363416708|FG003|Dose Level V|Withdrawal by Subject|0|||
105385230|NCT02533674|363416709|FG004|Dose Level V|Withdrawal by Subject|1|||
105385231|NCT02533674|363416710|FG005|Dose Level V|Withdrawal by Subject|0|||
105385232|NCT02533674|363416711|FG006|Dose Level V|Withdrawal by Subject|0|||
105385233|NCT02533674|363416712|FG007|Dose Level V|Withdrawal by Subject|0|||
105385234|NCT02533674|363416705|FG000|Dose Level V|Physician Decision|0|||
105385235|NCT02533674|363416706|FG001|Dose Level V|Physician Decision|0|||
105385236|NCT02533674|363416707|FG002|Dose Level V|Physician Decision|0|||
105385237|NCT02533674|363416708|FG003|Dose Level V|Physician Decision|0|||
105385238|NCT02533674|363416709|FG004|Dose Level V|Physician Decision|1|||
105385239|NCT02533674|363416710|FG005|Dose Level V|Physician Decision|0|||
105385240|NCT02533674|363416711|FG006|Dose Level V|Physician Decision|0|||
105385241|NCT02533674|363416712|FG007|Dose Level V|Physician Decision|0|||
105385242|NCT02533674|363416705|FG000|Dose Level VI|Progressive disease|0|||
105385243|NCT02533674|363416706|FG001|Dose Level VI|Progressive disease|0|||
105385244|NCT02533674|363416707|FG002|Dose Level VI|Progressive disease|0|||
105385245|NCT02533674|363416708|FG003|Dose Level VI|Progressive disease|0|||
105385246|NCT02533674|363416709|FG004|Dose Level VI|Progressive disease|0|||
105385247|NCT02533674|363416710|FG005|Dose Level VI|Progressive disease|7|||
105385248|NCT02533674|363416711|FG006|Dose Level VI|Progressive disease|0|||
105385249|NCT02533674|363416712|FG007|Dose Level VI|Progressive disease|0|||
105385250|NCT02533674|363416705|FG000|Dose Level VI|Withdrawal by Subject|0|||
105385251|NCT02533674|363416706|FG001|Dose Level VI|Withdrawal by Subject|0|||
105385252|NCT02533674|363416707|FG002|Dose Level VI|Withdrawal by Subject|0|||
105385253|NCT02533674|363416708|FG003|Dose Level VI|Withdrawal by Subject|0|||
105385254|NCT02533674|363416709|FG004|Dose Level VI|Withdrawal by Subject|0|||
105385255|NCT02533674|363416710|FG005|Dose Level VI|Withdrawal by Subject|1|||
105385256|NCT02533674|363416711|FG006|Dose Level VI|Withdrawal by Subject|0|||
105385257|NCT02533674|363416712|FG007|Dose Level VI|Withdrawal by Subject|0|||
105385258|NCT02533674|363416705|FG000|Dose Level VI|Treatment-related AE|0|||
105385259|NCT02533674|363416706|FG001|Dose Level VI|Treatment-related AE|0|||
105385260|NCT02533674|363416707|FG002|Dose Level VI|Treatment-related AE|0|||
105385261|NCT02533674|363416708|FG003|Dose Level VI|Treatment-related AE|0|||
105385262|NCT02533674|363416709|FG004|Dose Level VI|Treatment-related AE|0|||
105385263|NCT02533674|363416710|FG005|Dose Level VI|Treatment-related AE|1|||
105385264|NCT02533674|363416711|FG006|Dose Level VI|Treatment-related AE|0|||
105385265|NCT02533674|363416712|FG007|Dose Level VI|Treatment-related AE|0|||
105492839|NCT00299182|363817170|FG000|Overall Study|Withdrawal by Subject|0|||
105492840|NCT00299182|363817171|FG001|Overall Study|Withdrawal by Subject|0|||
105492841|NCT00299182|363817172|FG002|Overall Study|Withdrawal by Subject|1|||
105492842|NCT00299182|363817173|FG003|Overall Study|Withdrawal by Subject|0|||
105492843|NCT00299182|363817174|FG004|Overall Study|Withdrawal by Subject|1|||
105492844|NCT00299182|363817175|FG005|Overall Study|Withdrawal by Subject|2|||
105385266|NCT02533674|363416705|FG000|Dose Level VII|Progressive disease|0|||
105385267|NCT02533674|363416706|FG001|Dose Level VII|Progressive disease|0|||
105385268|NCT02533674|363416707|FG002|Dose Level VII|Progressive disease|0|||
105385269|NCT02533674|363416708|FG003|Dose Level VII|Progressive disease|0|||
105385270|NCT02533674|363416709|FG004|Dose Level VII|Progressive disease|0|||
105385271|NCT02533674|363416710|FG005|Dose Level VII|Progressive disease|0|||
105385272|NCT02533674|363416711|FG006|Dose Level VII|Progressive disease|10|||
105385273|NCT02533674|363416712|FG007|Dose Level VII|Progressive disease|0|||
105385274|NCT02533674|363416705|FG000|Dose Level VII|Withdrawal by Subject|0|||
105385275|NCT02533674|363416706|FG001|Dose Level VII|Withdrawal by Subject|0|||
105385276|NCT02533674|363416707|FG002|Dose Level VII|Withdrawal by Subject|0|||
105385277|NCT02533674|363416708|FG003|Dose Level VII|Withdrawal by Subject|0|||
105580541|NCT02018861|364126451|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
105580542|NCT02018861|364126452|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
105385278|NCT02533674|363416709|FG004|Dose Level VII|Withdrawal by Subject|0|||
105385279|NCT02533674|363416710|FG005|Dose Level VII|Withdrawal by Subject|0|||
105385280|NCT02533674|363416711|FG006|Dose Level VII|Withdrawal by Subject|3|||
105385281|NCT02533674|363416712|FG007|Dose Level VII|Withdrawal by Subject|0|||
105385282|NCT02533674|363416705|FG000|Dose Level VII|Treatment-related AE|0|||
105385283|NCT02533674|363416706|FG001|Dose Level VII|Treatment-related AE|0|||
105385284|NCT02533674|363416707|FG002|Dose Level VII|Treatment-related AE|0|||
105385285|NCT02533674|363416708|FG003|Dose Level VII|Treatment-related AE|0|||
105385286|NCT02533674|363416709|FG004|Dose Level VII|Treatment-related AE|0|||
105385287|NCT02533674|363416710|FG005|Dose Level VII|Treatment-related AE|0|||
105385288|NCT02533674|363416711|FG006|Dose Level VII|Treatment-related AE|1|||
105385289|NCT02533674|363416712|FG007|Dose Level VII|Treatment-related AE|0|||
105385290|NCT02533674|363416705|FG000|Dose Level VII|Death|0|||
105385291|NCT02533674|363416706|FG001|Dose Level VII|Death|0|||
105385292|NCT02533674|363416707|FG002|Dose Level VII|Death|0|||
105385293|NCT02533674|363416708|FG003|Dose Level VII|Death|0|||
105385294|NCT02533674|363416709|FG004|Dose Level VII|Death|0|||
105385295|NCT02533674|363416710|FG005|Dose Level VII|Death|0|||
105385296|NCT02533674|363416711|FG006|Dose Level VII|Death|2|||
105385297|NCT02533674|363416712|FG007|Dose Level VII|Death|0|||
105385298|NCT02533674|363416705|FG000|Dose Level VIII|Progressive disease|0|||
105385299|NCT02533674|363416706|FG001|Dose Level VIII|Progressive disease|0|||
105385300|NCT02533674|363416707|FG002|Dose Level VIII|Progressive disease|0|||
105385301|NCT02533674|363416708|FG003|Dose Level VIII|Progressive disease|0|||
105385302|NCT02533674|363416709|FG004|Dose Level VIII|Progressive disease|0|||
105385303|NCT02533674|363416710|FG005|Dose Level VIII|Progressive disease|0|||
105385304|NCT02533674|363416711|FG006|Dose Level VIII|Progressive disease|0|||
105385305|NCT02533674|363416712|FG007|Dose Level VIII|Progressive disease|3|||
105385306|NCT02533674|363416705|FG000|Dose Level VIII|Withdrawal by Subject|0|||
105385307|NCT02533674|363416706|FG001|Dose Level VIII|Withdrawal by Subject|0|||
105385308|NCT02533674|363416707|FG002|Dose Level VIII|Withdrawal by Subject|0|||
105385309|NCT02533674|363416708|FG003|Dose Level VIII|Withdrawal by Subject|0|||
105385310|NCT02533674|363416709|FG004|Dose Level VIII|Withdrawal by Subject|0|||
105385311|NCT02533674|363416710|FG005|Dose Level VIII|Withdrawal by Subject|0|||
105385312|NCT02533674|363416711|FG006|Dose Level VIII|Withdrawal by Subject|0|||
105385313|NCT02533674|363416712|FG007|Dose Level VIII|Withdrawal by Subject|1|||
105385314|NCT02533674|363416705|FG000|Dose Level VIII|Treatment-related AE|0|||
105385315|NCT02533674|363416706|FG001|Dose Level VIII|Treatment-related AE|0|||
105385316|NCT02533674|363416707|FG002|Dose Level VIII|Treatment-related AE|0|||
105385317|NCT02533674|363416708|FG003|Dose Level VIII|Treatment-related AE|0|||
105385318|NCT02533674|363416709|FG004|Dose Level VIII|Treatment-related AE|0|||
105385319|NCT02533674|363416710|FG005|Dose Level VIII|Treatment-related AE|0|||
105385320|NCT02533674|363416711|FG006|Dose Level VIII|Treatment-related AE|0|||
105385321|NCT02533674|363416712|FG007|Dose Level VIII|Treatment-related AE|1|||
105385322|NCT02533674|363416705|FG000|Dose Level VIII|Never treated|0|||
105385323|NCT02533674|363416706|FG001|Dose Level VIII|Never treated|0|||
105385324|NCT02533674|363416707|FG002|Dose Level VIII|Never treated|0|||
105492845|NCT00299182|363817176|FG006|Overall Study|Withdrawal by Subject|0|||
105385325|NCT02533674|363416708|FG003|Dose Level VIII|Never treated|0|||
105385326|NCT02533674|363416709|FG004|Dose Level VIII|Never treated|0|||
105385327|NCT02533674|363416710|FG005|Dose Level VIII|Never treated|0|||
105385328|NCT02533674|363416711|FG006|Dose Level VIII|Never treated|0|||
105385329|NCT02533674|363416712|FG007|Dose Level VIII|Never treated|1|||
105385330|NCT04821245|363416717|FG000|Overall Study|Withdrawal by Subject|3|||
105385331|NCT04821245|363416717|FG000|Overall Study|Physician Decision|1|||
105385332|NCT04821245|363416717|FG000|Overall Study|Protocol Violation|5|||
105385333|NCT02565186|363416718|FG000|Overall Study|Adverse Event|113|||
105385334|NCT02565186|363416719|FG001|Overall Study|Adverse Event|148|||
105385335|NCT02565186|363416718|FG000|Overall Study|Lost to Follow-up|102|||
105385336|NCT02565186|363416719|FG001|Overall Study|Lost to Follow-up|93|||
105385337|NCT02565186|363416718|FG000|Overall Study|Non-Compliance|57|||
105385338|NCT02565186|363416719|FG001|Overall Study|Non-Compliance|55|||
105385339|NCT02565186|363416718|FG000|Overall Study|Withdrawal by Subject|229|||
105385340|NCT02565186|363416719|FG001|Overall Study|Withdrawal by Subject|214|||
105385341|NCT02565186|363416718|FG000|Overall Study|Physician Decision|18|||
105385342|NCT02565186|363416719|FG001|Overall Study|Physician Decision|16|||
105385343|NCT02565186|363416718|FG000|Overall Study|Sponsor Request|5|||
105385344|NCT02565186|363416719|FG001|Overall Study|Sponsor Request|9|||
105385345|NCT02565186|363416718|FG000|Overall Study|Missing|1|||
105385346|NCT02565186|363416719|FG001|Overall Study|Missing|0|||
105385347|NCT02565186|363416718|FG000|Overall Study|Did Not Receive Study Drug|55|||
105385348|NCT02565186|363416719|FG001|Overall Study|Did Not Receive Study Drug|86|||
105385349|NCT01791205|363416722|FG000|Phase II|Lack of Efficacy|6|||
105385350|NCT01791205|363416723|FG001|Phase II|Lack of Efficacy|0|||
105385351|NCT01791205|363416722|FG000|Phase II|Adverse Event|2|||
105385352|NCT01791205|363416723|FG001|Phase II|Adverse Event|0|||
105385353|NCT01791205|363416722|FG000|Phase II|Safety|1|||
105385354|NCT01791205|363416723|FG001|Phase II|Safety|0|||
105385355|NCT01791205|363416722|FG000|Phase II|Lost to Follow-up|1|||
105385356|NCT01791205|363416723|FG001|Phase II|Lost to Follow-up|0|||
105385357|NCT01791205|363416722|FG000|Phase II|Remission of disease|1|||
105385358|NCT01791205|363416723|FG001|Phase II|Remission of disease|0|||
105385359|NCT01791205|363416722|FG000|Phase II|Physician's decision|1|||
105385360|NCT01791205|363416723|FG001|Phase II|Physician's decision|0|||
105385361|NCT01429623|363416729|FG000|Overall Study|Death|1|||
105385362|NCT01429623|363416730|FG001|Overall Study|Death|0|||
105385363|NCT01429623|363416729|FG000|Overall Study|Adverse Event|7|||
105385364|NCT01429623|363416730|FG001|Overall Study|Adverse Event|14|||
105385365|NCT01429623|363416729|FG000|Overall Study|Withdrawal by Subject|19|||
105385366|NCT01429623|363416730|FG001|Overall Study|Withdrawal by Subject|13|||
105385367|NCT01429623|363416729|FG000|Overall Study|Physician Decision|2|||
105385368|NCT01429623|363416730|FG001|Overall Study|Physician Decision|3|||
105385369|NCT01429623|363416729|FG000|Overall Study|Protocol Violation|3|||
105385370|NCT01429623|363416730|FG001|Overall Study|Protocol Violation|2|||
105385371|NCT01429623|363416729|FG000|Overall Study|Assorted|1|||
105385372|NCT01429623|363416730|FG001|Overall Study|Assorted|2|||
105385373|NCT01429623|363416729|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
105385374|NCT01429623|363416730|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
105385375|NCT01429623|363416729|FG000|Overall Study|No post baseline data|4|||
105385376|NCT01429623|363416730|FG001|Overall Study|No post baseline data|4|||
105385377|NCT02619812|363416731|FG000|Overall Study|Withdrawal by Subject|0|||
105385378|NCT02619812|363416732|FG001|Overall Study|Withdrawal by Subject|0|||
105385379|NCT02619812|363416733|FG002|Overall Study|Withdrawal by Subject|1|||
105385380|NCT02619812|363416734|FG003|Overall Study|Withdrawal by Subject|2|||
105385381|NCT01096186|363416735|FG000|Overall Study|Adverse Event|16|||
105385382|NCT01096186|363416735|FG000|Overall Study|Death|4|||
105385383|NCT01096186|363416735|FG000|Overall Study|Lack of Efficacy|4|||
105385384|NCT01096186|363416735|FG000|Overall Study|Lost to Follow-up|2|||
105385385|NCT01096186|363416735|FG000|Overall Study|Withdrawal by Subject|22|||
105492846|NCT00299182|363817170|FG000|Overall Study|Chemotherapy Changed|0|||
105492847|NCT00299182|363817171|FG001|Overall Study|Chemotherapy Changed|0|||
105492848|NCT00299182|363817172|FG002|Overall Study|Chemotherapy Changed|1|||
105492849|NCT00299182|363817173|FG003|Overall Study|Chemotherapy Changed|0|||
105385386|NCT01096186|363416735|FG000|Overall Study|Physician Decision|1|||
105385387|NCT01096186|363416735|FG000|Overall Study|Noncompliance with study drug|1|||
105385388|NCT01421134|363416736|FG000|Overall Study|Adverse Event|3|||
105385389|NCT01421134|363416737|FG001|Overall Study|Adverse Event|5|||
105385390|NCT01421134|363416736|FG000|Overall Study|Lack of Efficacy|2|||
105385391|NCT01421134|363416737|FG001|Overall Study|Lack of Efficacy|4|||
105385392|NCT01421134|363416736|FG000|Overall Study|Protocol Violation|0|||
105385393|NCT01421134|363416737|FG001|Overall Study|Protocol Violation|3|||
105385394|NCT01421134|363416736|FG000|Overall Study|Withdrawal by Subject|1|||
105385395|NCT01421134|363416737|FG001|Overall Study|Withdrawal by Subject|1|||
105385396|NCT01421134|363416736|FG000|Overall Study|Administrative|0|||
105385397|NCT01421134|363416737|FG001|Overall Study|Administrative|1|||
105492850|NCT00299182|363817174|FG004|Overall Study|Chemotherapy Changed|1|||
105385398|NCT01421134|363416736|FG000|Overall Study|Lost to Follow-up|1|||
105385399|NCT01421134|363416737|FG001|Overall Study|Lost to Follow-up|1|||
105385400|NCT01061710|363416738|FG000|Overall Study|Protocol Violation|14|||
105385401|NCT01217047|363416740|FG000|Overall Study|Lost to Follow-up|0|||
105385402|NCT01217047|363416741|FG001|Overall Study|Lost to Follow-up|1|||
105385403|NCT01217047|363416742|FG002|Overall Study|Lost to Follow-up|0|||
105385404|NCT06399471|363416743|FG000|Overall Study|Withdrawal by Subject|1|||
105385405|NCT06083493|363416744|FG000|Overall Study|Technical issues with the interventional device|2|||
105385406|NCT06083493|363416745|FG001|Overall Study|Technical issues with the interventional device|2|||
105385407|NCT06083493|363416744|FG000|Overall Study|Performed incorrect visual task|1|||
105385408|NCT06083493|363416745|FG001|Overall Study|Performed incorrect visual task|0|||
105385409|NCT06083493|363416744|FG000|Overall Study|Insufficient baseline performance|0|||
105385410|NCT06083493|363416745|FG001|Overall Study|Insufficient baseline performance|1|||
105385411|NCT03671148|363416746|FG000|Overall Study|Adverse Event|3|||
105385412|NCT03671148|363416747|FG001|Overall Study|Adverse Event|2|||
105385413|NCT03671148|363416746|FG000|Overall Study|Withdrawal by Subject|8|||
105385414|NCT03671148|363416747|FG001|Overall Study|Withdrawal by Subject|2|||
105385415|NCT03671148|363416746|FG000|Overall Study|Lost to Follow-up|1|||
105385416|NCT03671148|363416747|FG001|Overall Study|Lost to Follow-up|2|||
105385417|NCT03671148|363416746|FG000|Overall Study|Lack of Efficacy|7|||
105385418|NCT03671148|363416747|FG001|Overall Study|Lack of Efficacy|2|||
105385419|NCT03671148|363416746|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
105385420|NCT03671148|363416747|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
105385421|NCT03671148|363416746|FG000|Overall Study|Other|1|||
105385422|NCT03671148|363416747|FG001|Overall Study|Other|0|||
105385423|NCT03671148|363416746|FG000|Overall Study|Incomplete Randomization Visit|1|||
105385424|NCT03671148|363416747|FG001|Overall Study|Incomplete Randomization Visit|0|||
105385425|NCT01362270|363416748|FG000|Overall Study|Withdrawal by Subject|1|||
105385426|NCT01362270|363416749|FG001|Overall Study|Withdrawal by Subject|0|||
105385427|NCT01362270|363416748|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
105385428|NCT01362270|363416749|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
105385429|NCT01362270|363416748|FG000|Overall Study|Met excl. criteria before 1st session|1|||
105385430|NCT01362270|363416749|FG001|Overall Study|Met excl. criteria before 1st session|1|||
105385431|NCT03518203|363416756|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
105385432|NCT03518203|363416756|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
105385433|NCT03182244|363416757|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
105385434|NCT03182244|363416758|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
105385435|NCT03182244|363416757|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
105385436|NCT03182244|363416758|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
105385437|NCT03182244|363416757|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
105385438|NCT03182244|363416758|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
105385439|NCT03182244|363416757|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
105385440|NCT03182244|363416758|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
105385441|NCT03182244|363416757|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
105385442|NCT03182244|363416758|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
105385443|NCT03182244|363416757|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
105385444|NCT03182244|363416758|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
105385445|NCT03182244|363416757|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
105385446|NCT03182244|363416758|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
105385447|NCT03182244|363416757|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
105385448|NCT03182244|363416758|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
105385449|NCT03182244|363416757|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
105385450|NCT03182244|363416758|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
105385451|NCT03182244|363416757|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
105385452|NCT03182244|363416758|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
105385453|NCT03182244|363416757|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
105385454|NCT03182244|363416758|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
105385455|NCT03182244|363416757|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
105385456|NCT03182244|363416758|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
105385457|NCT03182244|363416757|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
105385458|NCT03182244|363416758|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
105385459|NCT02829957|363416759|FG000|Overall Study|Lost to Follow-up|2|||
105385460|NCT02829957|363416760|FG001|Overall Study|Lost to Follow-up|1|||
105385461|NCT05259722|363416765|FG000|Overall Study|Adverse Event|2|||
105385462|NCT05259722|363416766|FG001|Overall Study|Adverse Event|24|||
105385463|NCT05259722|363416765|FG000|Overall Study|Lost to Follow-up|5|||
105385464|NCT05259722|363416766|FG001|Overall Study|Lost to Follow-up|1|||
105385465|NCT05259722|363416765|FG000|Overall Study|Lack of Efficacy|8|||
105385466|NCT05259722|363416766|FG001|Overall Study|Lack of Efficacy|26|||
105385467|NCT05259722|363416765|FG000|Overall Study|Withdrawal by Subject|15|||
105385468|NCT05259722|363416766|FG001|Overall Study|Withdrawal by Subject|33|||
105385469|NCT05259722|363416765|FG000|Overall Study|Various reasons|3|||
105385470|NCT05259722|363416766|FG001|Overall Study|Various reasons|9|||
105385471|NCT05259722|363416765|FG000|Overall Study|Not exposed to IMP|1|||
105385472|NCT05259722|363416766|FG001|Overall Study|Not exposed to IMP|12|||
105385473|NCT05259722|363416765|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
105385474|NCT05259722|363416766|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
105385475|NCT03069937|363416767|FG000|Overall Study|Second primary malignancy noted|1|||
105385476|NCT01472835|363416770|FG000|Overall Study|Lost to Follow-up|2|||
105385477|NCT01472835|363416771|FG001|Overall Study|Lost to Follow-up|0|||
105385478|NCT00450749|363416772|FG000|Overall Study|Withdrawal by Subject|0|||
105385479|NCT00450749|363416773|FG001|Overall Study|Withdrawal by Subject|0|||
105385480|NCT00450749|363416774|FG002|Overall Study|Withdrawal by Subject|2|||
105385481|NCT00450749|363416772|FG000|Overall Study|Noncompliant|0|||
105385482|NCT00450749|363416773|FG001|Overall Study|Noncompliant|1|||
105385483|NCT00450749|363416774|FG002|Overall Study|Noncompliant|0|||
105385484|NCT04941898|363418708|FG000|Overall Study|Protocol Violation|1|||
105385485|NCT00160615|363418709|FG000|Overall Study|Adverse Event|5|||
105385486|NCT00160615|363418710|FG001|Overall Study|Adverse Event|12|||
105385487|NCT00160615|363418709|FG000|Overall Study|Withdrawal by Subject|0|||
105385488|NCT00160615|363418710|FG001|Overall Study|Withdrawal by Subject|2|||
105385489|NCT00160615|363418709|FG000|Overall Study|Lack of Efficacy|11|||
105385490|NCT00160615|363418710|FG001|Overall Study|Lack of Efficacy|23|||
105385491|NCT00160615|363418709|FG000|Overall Study|Patient decision|1|||
105385492|NCT00160615|363418710|FG001|Overall Study|Patient decision|2|||
105385493|NCT00160615|363418709|FG000|Overall Study|Investigator decision|1|||
105385494|NCT00160615|363418710|FG001|Overall Study|Investigator decision|1|||
105385495|NCT00160615|363418709|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
105385496|NCT00160615|363418710|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
105385497|NCT00160615|363418709|FG000|Overall Study|Switch to surgical treatment|0|||
105385498|NCT00160615|363418710|FG001|Overall Study|Switch to surgical treatment|2|||
105385499|NCT00160615|363418709|FG000|Overall Study|Non-compliance was suspected|0|||
105385500|NCT00160615|363418710|FG001|Overall Study|Non-compliance was suspected|1|||
105385501|NCT00160615|363418709|FG000|Overall Study|Poor compliance|0|||
105385502|NCT00160615|363418710|FG001|Overall Study|Poor compliance|1|||
105385503|NCT04193176|363418714|FG000|Overall Study|Withdrawal by Subject|6|||
105385504|NCT04193176|363418715|FG001|Overall Study|Withdrawal by Subject|10|||
105385505|NCT02821000|363418717|FG000|Overall Study|Death|89|||
105385506|NCT02821000|363418717|FG000|Overall Study|Sponsor Decision|12|||
105385507|NCT02821000|363418717|FG000|Overall Study|Withdrawal by Subject|2|||
105385508|NCT02545127|363418718|FG000|Overall Study|Lost to Follow-up|1|||
105385509|NCT02545127|363418719|FG001|Overall Study|Lost to Follow-up|0|||
105385510|NCT00394472|363418720|FG000|Overall Study|Protocol Violation|1|||
105385511|NCT00394472|363418721|FG001|Overall Study|Protocol Violation|3|||
105385512|NCT00394472|363418720|FG000|Overall Study|incorrect enrolment|4|||
105385513|NCT00394472|363418721|FG001|Overall Study|incorrect enrolment|2|||
105385514|NCT00394472|363418720|FG000|Overall Study|Adverse Event|4|||
105385515|NCT00394472|363418721|FG001|Overall Study|Adverse Event|2|||
105385516|NCT00394472|363418720|FG000|Overall Study|Withdrawal by Subject|0|||
105385517|NCT00394472|363418721|FG001|Overall Study|Withdrawal by Subject|2|||
105385518|NCT00394472|363418720|FG000|Overall Study|Physician Decision|0|||
105385519|NCT00394472|363418721|FG001|Overall Study|Physician Decision|1|||
105385520|NCT00394472|363418720|FG000|Overall Study|Lost to Follow-up|0|||
105385521|NCT00394472|363418721|FG001|Overall Study|Lost to Follow-up|1|||
105385522|NCT00527748|363418724|FG000|Overall Study|Other|3|||
105385523|NCT02004275|363418726|FG000|Phase 1|Ineligible|0|||
105385524|NCT02004275|363418727|FG001|Phase 1|Ineligible|0|||
105385525|NCT02004275|363418728|FG002|Phase 1|Ineligible|0|||
105385526|NCT02004275|363418729|FG003|Phase 1|Ineligible|1|||
105385527|NCT02004275|363418730|FG004|Phase 1|Ineligible|1|||
105385528|NCT02004275|363418731|FG005|Phase 1|Ineligible|0|||
105385529|NCT02004275|363418726|FG000|Phase 1|Protocol Violation|0|||
105385530|NCT02004275|363418727|FG001|Phase 1|Protocol Violation|0|||
105385531|NCT02004275|363418728|FG002|Phase 1|Protocol Violation|0|||
105385532|NCT02004275|363418729|FG003|Phase 1|Protocol Violation|1|||
105385533|NCT02004275|363418730|FG004|Phase 1|Protocol Violation|0|||
105385534|NCT02004275|363418731|FG005|Phase 1|Protocol Violation|5|||
105385535|NCT02004275|363418726|FG000|Phase 2 Part 1|Ineligible|6|||
105385536|NCT02004275|363418727|FG001|Phase 2 Part 1|Ineligible|9|||
105385537|NCT02004275|363418728|FG002|Phase 2 Part 1|Ineligible|0|||
105385538|NCT02004275|363418729|FG003|Phase 2 Part 1|Ineligible|0|||
105385539|NCT02004275|363418730|FG004|Phase 2 Part 1|Ineligible|0|||
105385540|NCT02004275|363418731|FG005|Phase 2 Part 1|Ineligible|0|||
105385541|NCT02004275|363418726|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
105385542|NCT02004275|363418727|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
105385543|NCT02004275|363418728|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
105385544|NCT02004275|363418729|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
105385545|NCT02004275|363418730|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
105385546|NCT02004275|363418731|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
105385547|NCT04621786|363418732|FG000|Overall Study|Lost to Follow-up|9|||
105385548|NCT04621786|363418732|FG000|Overall Study|Protocol Violation|3|||
105385549|NCT00474968|363418742|FG000|Overall Study|Withdrawal by Subject|8|||
105385550|NCT00474968|363418743|FG001|Overall Study|Withdrawal by Subject|7|||
105385551|NCT00474968|363418742|FG000|Overall Study|Protocol Violation|9|||
105385552|NCT00474968|363418743|FG001|Overall Study|Protocol Violation|8|||
105385553|NCT00474968|363418742|FG000|Overall Study|Sample not collected|1|||
105385554|NCT00474968|363418743|FG001|Overall Study|Sample not collected|1|||
105385555|NCT01259024|363418744|FG000|Overall Study|Physician Decision|1|||
105385556|NCT03093870|363418750|FG000|Overall Study|Withdrawal by Subject|2|||
105385557|NCT03093870|363418751|FG001|Overall Study|Withdrawal by Subject|6|||
105385558|NCT03093870|363418752|FG002|Overall Study|Withdrawal by Subject|5|||
105385559|NCT03093870|363418750|FG000|Overall Study|Death|1|||
105385560|NCT03093870|363418751|FG001|Overall Study|Death|35|||
105385561|NCT03093870|363418752|FG002|Overall Study|Death|35|||
105385562|NCT03093870|363418750|FG000|Overall Study|Radiographic disease progression|10|||
105385563|NCT03093870|363418751|FG001|Overall Study|Radiographic disease progression|0|||
105385564|NCT03093870|363418752|FG002|Overall Study|Radiographic disease progression|0|||
105385565|NCT03093870|363418750|FG000|Overall Study|Clinical disease progression|1|||
105385566|NCT03093870|363418751|FG001|Overall Study|Clinical disease progression|0|||
105385567|NCT03093870|363418752|FG002|Overall Study|Clinical disease progression|0|||
105385568|NCT03093870|363418750|FG000|Overall Study|Physician Decision|2|||
105385569|NCT03093870|363418751|FG001|Overall Study|Physician Decision|0|||
105385570|NCT03093870|363418752|FG002|Overall Study|Physician Decision|0|||
105385571|NCT03093870|363418750|FG000|Overall Study|Adverse Event|7|||
105385572|NCT03093870|363418751|FG001|Overall Study|Adverse Event|0|||
105385573|NCT03093870|363418752|FG002|Overall Study|Adverse Event|0|||
105385574|NCT03093870|363418750|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
105385575|NCT03093870|363418751|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
105385576|NCT03093870|363418752|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
105385577|NCT03093870|363418750|FG000|Overall Study|Lost to Follow-up|0|||
105385578|NCT03093870|363418751|FG001|Overall Study|Lost to Follow-up|0|||
105385579|NCT03093870|363418752|FG002|Overall Study|Lost to Follow-up|1|||
105385580|NCT01520714|363418759|FG000|Overall Study|Protocol Violation|0|||
105385581|NCT01520714|363418760|FG001|Overall Study|Protocol Violation|3|||
105385582|NCT01520714|363418759|FG000|Overall Study|Adverse Event|0|||
105385583|NCT01520714|363418760|FG001|Overall Study|Adverse Event|2|||
105385584|NCT01520714|363418759|FG000|Overall Study|Lack of Efficacy|0|||
105385585|NCT01520714|363418760|FG001|Overall Study|Lack of Efficacy|1|||
105385586|NCT01691482|363418761|FG000|Treatment Period 2|Adverse Event|0|||
105385587|NCT01691482|363418762|FG001|Treatment Period 2|Adverse Event|1|||
105385588|NCT01691482|363418761|FG000|Treatment Period 2|Protocol Violation|1|||
105385589|NCT01691482|363418762|FG001|Treatment Period 2|Protocol Violation|1|||
105385590|NCT00183391|363418763|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
105385591|NCT00183391|363418764|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
105385592|NCT00183391|363418763|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
105385593|NCT00183391|363418764|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
105385594|NCT01543503|363418765|FG000|Overall Study|Lost to Follow-up|32|||
105385595|NCT01543503|363418766|FG001|Overall Study|Lost to Follow-up|36|||
105385596|NCT01543503|363418765|FG000|Overall Study|Adverse Event|9|||
105385597|NCT01543503|363418766|FG001|Overall Study|Adverse Event|13|||
105385598|NCT01543503|363418765|FG000|Overall Study|Lack of Efficacy|4|||
105385599|NCT01543503|363418766|FG001|Overall Study|Lack of Efficacy|16|||
105385600|NCT01543503|363418765|FG000|Overall Study|Participant withdrew informed consent|8|||
105385601|NCT01543503|363418766|FG001|Overall Study|Participant withdrew informed consent|10|||
105385602|NCT01543503|363418765|FG000|Overall Study|Change of jobs|0|||
105385603|NCT01543503|363418766|FG001|Overall Study|Change of jobs|1|||
105385604|NCT01543503|363418765|FG000|Overall Study|Intolerance to the biologic treatment|0|||
105385605|NCT01543503|363418766|FG001|Overall Study|Intolerance to the biologic treatment|1|||
105385606|NCT01543503|363418765|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
105385607|NCT01543503|363418766|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
105385608|NCT01543503|363418765|FG000|Overall Study|Participant did not complete last visit|0|||
105385609|NCT01543503|363418766|FG001|Overall Study|Participant did not complete last visit|2|||
105492851|NCT00299182|363817175|FG005|Overall Study|Chemotherapy Changed|0|||
105492852|NCT00299182|363817176|FG006|Overall Study|Chemotherapy Changed|1|||
105492853|NCT00299182|363817170|FG000|Overall Study|Adverse Event|0|||
105492854|NCT00299182|363817171|FG001|Overall Study|Adverse Event|0|||
105385610|NCT01543503|363418765|FG000|Overall Study|Refused to continue treatment|7|||
105385611|NCT01543503|363418766|FG001|Overall Study|Refused to continue treatment|0|||
105385612|NCT01543503|363418765|FG000|Overall Study|Incorrect medication received|1|||
105385613|NCT01543503|363418766|FG001|Overall Study|Incorrect medication received|0|||
105385614|NCT01543503|363418765|FG000|Overall Study|Participant moved to another city|2|||
105385615|NCT01543503|363418766|FG001|Overall Study|Participant moved to another city|0|||
105385616|NCT01543503|363418765|FG000|Overall Study|Participant will not return for visits|0|||
105385617|NCT01543503|363418766|FG001|Overall Study|Participant will not return for visits|2|||
105385618|NCT01543503|363418765|FG000|Overall Study|Participant transferred to another city|1|||
105385619|NCT01543503|363418766|FG001|Overall Study|Participant transferred to another city|0|||
105385620|NCT01543503|363418765|FG000|Overall Study|Participant moved to Scotland|1|||
105385621|NCT01543503|363418766|FG001|Overall Study|Participant moved to Scotland|0|||
105385622|NCT01543503|363418765|FG000|Overall Study|Participant decision to stop treatment|1|||
105385623|NCT01543503|363418766|FG001|Overall Study|Participant decision to stop treatment|0|||
105385624|NCT01543503|363418765|FG000|Overall Study|Investigator did not wish to participate|1|||
105385625|NCT01543503|363418766|FG001|Overall Study|Investigator did not wish to participate|1|||
105385626|NCT01543503|363418765|FG000|Overall Study|Participant recruited after closing date|0|||
105385627|NCT01543503|363418766|FG001|Overall Study|Participant recruited after closing date|1|||
105385628|NCT01543503|363418765|FG000|Overall Study|Site stopped participation|5|||
105385629|NCT01543503|363418766|FG001|Overall Study|Site stopped participation|1|||
105385630|NCT01543503|363418765|FG000|Overall Study|Participant did not attend a visit|1|||
105385631|NCT01543503|363418766|FG001|Overall Study|Participant did not attend a visit|0|||
105385632|NCT01543503|363418765|FG000|Overall Study|Moved to other rheumatologic site|0|||
105385633|NCT01543503|363418766|FG001|Overall Study|Moved to other rheumatologic site|1|||
105385634|NCT01543503|363418765|FG000|Overall Study|Participant consented to another study|0|||
105385635|NCT01543503|363418766|FG001|Overall Study|Participant consented to another study|2|||
105385636|NCT01543503|363418765|FG000|Overall Study|Participant went to United States|1|||
105385637|NCT01543503|363418766|FG001|Overall Study|Participant went to United States|0|||
105385638|NCT01543503|363418765|FG000|Overall Study|Screen failure|1|||
105385639|NCT01543503|363418766|FG001|Overall Study|Screen failure|0|||
105385640|NCT02460380|363418767|FG000|Overall Study|Withdrawal by Subject|10|||
105385641|NCT02460380|363418768|FG001|Overall Study|Withdrawal by Subject|5|||
105385642|NCT02134028|363418769|FG000|Overall Study|Lack of Efficacy|1|||
105385643|NCT02134028|363418770|FG001|Overall Study|Lack of Efficacy|0|||
105492855|NCT00299182|363817172|FG002|Overall Study|Adverse Event|0|||
105492856|NCT00299182|363817173|FG003|Overall Study|Adverse Event|0|||
105492857|NCT00299182|363817174|FG004|Overall Study|Adverse Event|0|||
105492858|NCT00299182|363817175|FG005|Overall Study|Adverse Event|1|||
105492859|NCT00299182|363817176|FG006|Overall Study|Adverse Event|0|||
105492860|NCT00299182|363817170|FG000|Overall Study|Not Eligible|0|||
105492861|NCT00299182|363817171|FG001|Overall Study|Not Eligible|0|||
105492862|NCT00299182|363817172|FG002|Overall Study|Not Eligible|0|||
105492863|NCT00299182|363817173|FG003|Overall Study|Not Eligible|0|||
105492864|NCT00299182|363817174|FG004|Overall Study|Not Eligible|1|||
105492865|NCT00299182|363817175|FG005|Overall Study|Not Eligible|0|||
105492866|NCT00299182|363817176|FG006|Overall Study|Not Eligible|0|||
105492867|NCT02001181|363817178|FG000|Overall Study|Adverse Event|0|||
105492868|NCT02001181|363817179|FG001|Overall Study|Adverse Event|2|||
105492869|NCT02001181|363817178|FG000|Overall Study|Lost to Follow-up|1|||
105492870|NCT02001181|363817179|FG001|Overall Study|Lost to Follow-up|0|||
105492871|NCT02001181|363817178|FG000|Overall Study|Withdrawal by Subject|0|||
105492872|NCT02001181|363817179|FG001|Overall Study|Withdrawal by Subject|1|||
105492873|NCT01090973|363817182|FG000|Overall Study|Disease progression|1|||
105492874|NCT02027376|363817184|FG000|Overall Study|Death|1|||
105492875|NCT02027376|363817185|FG001|Overall Study|Death|0|||
105492876|NCT02027376|363817186|FG002|Overall Study|Death|0|||
105492877|NCT03131453|363817187|FG000|Overall Study|Study terminated by Sponsor|424|||
105492878|NCT03131453|363817188|FG001|Overall Study|Study terminated by Sponsor|222|||
105492879|NCT03131453|363817189|FG002|Overall Study|Study terminated by Sponsor|438|||
105492880|NCT03131453|363817187|FG000|Overall Study|Withdrawal by Subject|18|||
105492881|NCT03131453|363817188|FG001|Overall Study|Withdrawal by Subject|7|||
105492882|NCT03131453|363817189|FG002|Overall Study|Withdrawal by Subject|13|||
105492883|NCT03131453|363817187|FG000|Overall Study|Adverse Event|10|||
105492884|NCT03131453|363817188|FG001|Overall Study|Adverse Event|3|||
105492885|NCT03131453|363817189|FG002|Overall Study|Adverse Event|3|||
105492886|NCT03131453|363817187|FG000|Overall Study|Lost to Follow-up|1|||
105492887|NCT03131453|363817188|FG001|Overall Study|Lost to Follow-up|0|||
105492888|NCT03131453|363817189|FG002|Overall Study|Lost to Follow-up|1|||
105492889|NCT03131453|363817187|FG000|Overall Study|Physician Decision|1|||
105492890|NCT03131453|363817188|FG001|Overall Study|Physician Decision|0|||
105492891|NCT03131453|363817189|FG002|Overall Study|Physician Decision|1|||
105492892|NCT03131453|363817187|FG000|Overall Study|Non-compliance with study treatment|1|||
105492893|NCT03131453|363817188|FG001|Overall Study|Non-compliance with study treatment|0|||
105492894|NCT03131453|363817189|FG002|Overall Study|Non-compliance with study treatment|0|||
105492895|NCT03131453|363817187|FG000|Overall Study|Technical problems|1|||
105492896|NCT03131453|363817188|FG001|Overall Study|Technical problems|0|||
105492897|NCT03131453|363817189|FG002|Overall Study|Technical problems|0|||
105492898|NCT03131453|363817187|FG000|Overall Study|Protocol deviation|0|||
105492899|NCT03131453|363817188|FG001|Overall Study|Protocol deviation|1|||
105492900|NCT03131453|363817189|FG002|Overall Study|Protocol deviation|0|||
105385644|NCT02134028|363418771|FG002|Overall Study|Lack of Efficacy|3|||
105385645|NCT02134028|363418772|FG003|Overall Study|Lack of Efficacy|2|||
105385646|NCT02134028|363418773|FG004|Overall Study|Lack of Efficacy|1|||
105385647|NCT02134028|363418774|FG005|Overall Study|Lack of Efficacy|2|||
105385648|NCT02134028|363418775|FG006|Overall Study|Lack of Efficacy|1|||
105385649|NCT02134028|363418776|FG007|Overall Study|Lack of Efficacy|0|||
105385650|NCT02134028|363418769|FG000|Overall Study|Poor compliance to protocol|1|||
105385651|NCT02134028|363418770|FG001|Overall Study|Poor compliance to protocol|1|||
105385652|NCT02134028|363418771|FG002|Overall Study|Poor compliance to protocol|3|||
105385653|NCT02134028|363418772|FG003|Overall Study|Poor compliance to protocol|7|||
105385654|NCT02134028|363418773|FG004|Overall Study|Poor compliance to protocol|1|||
105385655|NCT02134028|363418774|FG005|Overall Study|Poor compliance to protocol|1|||
105385656|NCT02134028|363418775|FG006|Overall Study|Poor compliance to protocol|0|||
105385657|NCT02134028|363418776|FG007|Overall Study|Poor compliance to protocol|0|||
105385658|NCT02134028|363418769|FG000|Overall Study|Other unspecified|4|||
105385659|NCT02134028|363418770|FG001|Overall Study|Other unspecified|22|||
105385660|NCT02134028|363418771|FG002|Overall Study|Other unspecified|33|||
105385661|NCT02134028|363418772|FG003|Overall Study|Other unspecified|64|||
105385662|NCT02134028|363418773|FG004|Overall Study|Other unspecified|8|||
105385663|NCT02134028|363418774|FG005|Overall Study|Other unspecified|6|||
105385664|NCT02134028|363418775|FG006|Overall Study|Other unspecified|2|||
105385665|NCT02134028|363418776|FG007|Overall Study|Other unspecified|1|||
105385666|NCT02134028|363418769|FG000|Overall Study|Adverse Event|3|||
105385667|NCT02134028|363418770|FG001|Overall Study|Adverse Event|19|||
105385668|NCT02134028|363418771|FG002|Overall Study|Adverse Event|13|||
105385669|NCT02134028|363418772|FG003|Overall Study|Adverse Event|32|||
105385670|NCT02134028|363418773|FG004|Overall Study|Adverse Event|4|||
105385671|NCT02134028|363418774|FG005|Overall Study|Adverse Event|5|||
105385672|NCT02134028|363418775|FG006|Overall Study|Adverse Event|1|||
105385673|NCT02134028|363418776|FG007|Overall Study|Adverse Event|2|||
105385674|NCT01478087|363418777|FG000|Overall Study|due to sponsor closing study|1|||
105385675|NCT03566550|363418779|FG000|Overall Study|Withdrawal by Subject|0|||
105385676|NCT03566550|363418780|FG001|Overall Study|Withdrawal by Subject|1|||
105385677|NCT04576949|363418781|FG000|Overall Study|Adverse Event|1|||
105385678|NCT04576949|363418782|FG001|Overall Study|Adverse Event|3|||
105385679|NCT04576949|363418783|FG002|Overall Study|Adverse Event|2|||
105385680|NCT04576949|363418781|FG000|Overall Study|Withdrawal by Subject|41|||
105385681|NCT04576949|363418782|FG001|Overall Study|Withdrawal by Subject|26|||
105385682|NCT04576949|363418783|FG002|Overall Study|Withdrawal by Subject|18|||
105385683|NCT04576949|363418781|FG000|Overall Study|Physician Decision|3|||
105385684|NCT04576949|363418782|FG001|Overall Study|Physician Decision|0|||
105385685|NCT04576949|363418783|FG002|Overall Study|Physician Decision|0|||
105385686|NCT04576949|363418781|FG000|Overall Study|Death|0|||
105385687|NCT04576949|363418782|FG001|Overall Study|Death|1|||
105385688|NCT04576949|363418783|FG002|Overall Study|Death|0|||
105385689|NCT04576949|363418781|FG000|Overall Study|Lost to Follow-up|29|||
105385690|NCT04576949|363418782|FG001|Overall Study|Lost to Follow-up|37|||
105385691|NCT04576949|363418783|FG002|Overall Study|Lost to Follow-up|24|||
105492901|NCT02520661|363817191|FG000|Overall Study|Lost to Follow-up|7|||
105492902|NCT02520661|363817192|FG001|Overall Study|Lost to Follow-up|3|||
105492903|NCT02520661|363817191|FG000|Overall Study|Admitted from ED|49|||
105492904|NCT02520661|363817192|FG001|Overall Study|Admitted from ED|48|||
105492905|NCT02520661|363817191|FG000|Overall Study|ED greater than 24 hours|29|||
105492906|NCT02520661|363817192|FG001|Overall Study|ED greater than 24 hours|38|||
105492907|NCT02520661|363817191|FG000|Overall Study|other ineligibility|14|||
105492908|NCT02520661|363817192|FG001|Overall Study|other ineligibility|22|||
105492909|NCT02520661|363817191|FG000|Overall Study|Withdrawal by Subject|7|||
105492910|NCT02520661|363817192|FG001|Overall Study|Withdrawal by Subject|16|||
105492911|NCT02919696|363817193|FG000|Overall Study|Adverse Event|1|||
105492912|NCT02919696|363817194|FG001|Overall Study|Adverse Event|2|||
105492913|NCT02919696|363817193|FG000|Overall Study|Withdrawal by Subject|2|||
105492914|NCT02919696|363817194|FG001|Overall Study|Withdrawal by Subject|1|||
105492915|NCT02919696|363817193|FG000|Overall Study|Sponsor Decision|1|||
105492916|NCT02919696|363817194|FG001|Overall Study|Sponsor Decision|1|||
105492917|NCT02919696|363817193|FG000|Overall Study|Never Treated|0|||
105492918|NCT02919696|363817194|FG001|Overall Study|Never Treated|1|||
105492919|NCT00945555|363817195|FG000|Overall Study|Referred to another hospital|5|||
105492920|NCT00945555|363817195|FG000|Overall Study|Worsening condition, intensive care unit|1|||
105492921|NCT00945555|363817195|FG000|Overall Study|Withdrawal by Subject|2|||
105492922|NCT00945555|363817195|FG000|Overall Study|Participant continued treatment at home|1|||
105385692|NCT04576949|363418781|FG000|Overall Study|Other, Not Specified|2|||
105385693|NCT04576949|363418782|FG001|Overall Study|Other, Not Specified|3|||
105385694|NCT04576949|363418783|FG002|Overall Study|Other, Not Specified|1|||
105385695|NCT04576949|363418781|FG000|Overall Study|Other|1|||
105385696|NCT04576949|363418782|FG001|Overall Study|Other|0|||
105385697|NCT04576949|363418783|FG002|Overall Study|Other|0|||
105385698|NCT00063999|363418784|FG000|Overall Study|Withdrawal by Subject|1|||
105385699|NCT00063999|363418785|FG001|Overall Study|Withdrawal by Subject|0|||
105385700|NCT00063999|363418784|FG000|Overall Study|Ineligible|44|||
105385701|NCT00063999|363418785|FG001|Overall Study|Ineligible|24|||
105385702|NCT01260311|363418786|FG000|Overall Study|Adverse Event|11|||
105385703|NCT01260311|363418786|FG000|Overall Study|Lack of Efficacy|4|||
105385704|NCT01260311|363418786|FG000|Overall Study|Lost to Follow-up|25|||
105385705|NCT01260311|363418786|FG000|Overall Study|Withdrawal by Subject|6|||
105385706|NCT01260311|363418786|FG000|Overall Study|Financial Constraints|77|||
105385707|NCT01260311|363418786|FG000|Overall Study|Gone to Province|2|||
105385708|NCT01260311|363418786|FG000|Overall Study|Medication Stopped|1|||
105385709|NCT01260311|363418786|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
105385710|NCT03511066|363418789|FG000|Overall Study|Withdrawal by Subject|1|||
105385711|NCT03511066|363418790|FG001|Overall Study|Withdrawal by Subject|2|||
105385712|NCT03511066|363418791|FG002|Overall Study|Withdrawal by Subject|3|||
105385713|NCT03511066|363418789|FG000|Overall Study|Lost to Follow-up|2|||
105385714|NCT03511066|363418790|FG001|Overall Study|Lost to Follow-up|3|||
105385715|NCT03511066|363418791|FG002|Overall Study|Lost to Follow-up|0|||
105385716|NCT01089543|363418793|FG000|Overall Study|Withdrawal by Subject|2|||
105385717|NCT01089543|363418794|FG001|Overall Study|Withdrawal by Subject|3|||
105385718|NCT01089543|363418795|FG002|Overall Study|Withdrawal by Subject|3|||
105385719|NCT01089543|363418796|FG003|Overall Study|Withdrawal by Subject|1|||
105385720|NCT01089543|363418793|FG000|Overall Study|Physician Decision|1|||
105385721|NCT01089543|363418794|FG001|Overall Study|Physician Decision|0|||
105385722|NCT01089543|363418795|FG002|Overall Study|Physician Decision|0|||
105385723|NCT01089543|363418796|FG003|Overall Study|Physician Decision|1|||
105385724|NCT01089543|363418793|FG000|Overall Study|Adverse Event|0|||
105385725|NCT01089543|363418794|FG001|Overall Study|Adverse Event|1|||
105385726|NCT01089543|363418795|FG002|Overall Study|Adverse Event|0|||
105385727|NCT01089543|363418796|FG003|Overall Study|Adverse Event|0|||
105385728|NCT04560309|363418797|FG000|Overall Study|Meet drop out criteria|1|||
105385729|NCT04560309|363418798|FG001|Overall Study|Meet drop out criteria|1|||
105385730|NCT05085405|363418799|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
105385731|NCT05085405|363418800|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
105385732|NCT05085405|363418801|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
105385733|NCT05085405|363418802|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
105385734|NCT05085405|363418803|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
105385735|NCT05085405|363418804|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
105385736|NCT05085405|363418799|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
105385737|NCT05085405|363418800|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
105385738|NCT05085405|363418801|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
105385739|NCT05085405|363418802|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
105385740|NCT05085405|363418803|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
105385741|NCT05085405|363418804|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
105385742|NCT04146909|363418805|FG000|Overall Study|Withdrawal by Subject|3|||
105385743|NCT04146909|363418805|FG000|Overall Study|Did not qualify after consented|1|||
105385744|NCT01663987|363418806|FG000|Overall Study|Adverse Event|7|||
105385745|NCT01663987|363418807|FG001|Overall Study|Adverse Event|2|||
105385746|NCT01663987|363418806|FG000|Overall Study|Lost to Follow-up|1|||
105385747|NCT01663987|363418807|FG001|Overall Study|Lost to Follow-up|1|||
105385748|NCT01663987|363418806|FG000|Overall Study|Withdrawal by Subject|2|||
105385749|NCT01663987|363418807|FG001|Overall Study|Withdrawal by Subject|3|||
105385750|NCT01663987|363418806|FG000|Overall Study|Other reason not defined above|3|||
105385751|NCT01663987|363418807|FG001|Overall Study|Other reason not defined above|0|||
105385752|NCT02006654|363418811|FG000|Overall Study|Withdrawal before treatment|4|||
105385753|NCT02006654|363418812|FG001|Overall Study|Withdrawal before treatment|2|||
105385754|NCT02006654|363418811|FG000|Overall Study|Adverse Event|16|||
105385755|NCT02006654|363418812|FG001|Overall Study|Adverse Event|17|||
105385756|NCT02006654|363418811|FG000|Overall Study|Death|1|||
105385757|NCT02006654|363418812|FG001|Overall Study|Death|0|||
105385758|NCT02006654|363418811|FG000|Overall Study|Withdrawal by Subject|14|||
105385759|NCT02006654|363418812|FG001|Overall Study|Withdrawal by Subject|12|||
105385760|NCT02006654|363418811|FG000|Overall Study|Protocol Violation|5|||
105385761|NCT02006654|363418812|FG001|Overall Study|Protocol Violation|8|||
105385762|NCT02006654|363418811|FG000|Overall Study|Lost to Follow-up|1|||
105385763|NCT02006654|363418812|FG001|Overall Study|Lost to Follow-up|0|||
105385764|NCT02006654|363418811|FG000|Overall Study|patient's will|2|||
105492923|NCT00945555|363817195|FG000|Overall Study|Death|18|||
105492924|NCT00945555|363817195|FG000|Overall Study|Other|1|||
105492925|NCT04399837|363817200|FG000|Overall Study|Other than listed|0|||
105492926|NCT04399837|363817201|FG001|Overall Study|Other than listed|2|||
105492927|NCT04399837|363817202|FG002|Overall Study|Other than listed|2|||
105492928|NCT04399837|363817203|FG003|Overall Study|Other than listed|3|||
105385765|NCT02006654|363418812|FG001|Overall Study|patient's will|1|||
105385766|NCT02006654|363418811|FG000|Overall Study|insufficient compliance|1|||
105385767|NCT02006654|363418812|FG001|Overall Study|insufficient compliance|0|||
105385768|NCT02006654|363418811|FG000|Overall Study|worsening cognitive condition|0|||
105385769|NCT02006654|363418812|FG001|Overall Study|worsening cognitive condition|1|||
105385770|NCT02006654|363418811|FG000|Overall Study|faecal incontinence|0|||
105385771|NCT02006654|363418812|FG001|Overall Study|faecal incontinence|1|||
105385772|NCT02006654|363418811|FG000|Overall Study|mood disorder|0|||
105385773|NCT02006654|363418812|FG001|Overall Study|mood disorder|1|||
105385774|NCT02006654|363418811|FG000|Overall Study|disallowed medication|1|||
105385775|NCT02006654|363418812|FG001|Overall Study|disallowed medication|0|||
105385776|NCT02006654|363418811|FG000|Overall Study|moving out of state|0|||
105385777|NCT02006654|363418812|FG001|Overall Study|moving out of state|1|||
105385778|NCT00478140|363418813|FG000|Overall Study|Clinical Disease Progression|1|||
105385779|NCT04193527|363418814|FG000|Overall Study|Other|1|||
105385780|NCT04193527|363418815|FG001|Overall Study|Other|1|||
105385781|NCT04193527|363418816|FG002|Overall Study|Other|0|||
105385782|NCT00560404|363418820|FG000|Overall Study|Adverse Event|2|||
105385783|NCT00560404|363418821|FG001|Overall Study|Adverse Event|3|||
105385784|NCT00560404|363418820|FG000|Overall Study|Death|3|||
105385785|NCT00560404|363418821|FG001|Overall Study|Death|3|||
105385786|NCT00560404|363418820|FG000|Overall Study|Protocol Violation|12|||
105385787|NCT00560404|363418821|FG001|Overall Study|Protocol Violation|7|||
105385788|NCT00560404|363418820|FG000|Overall Study|Administrative Reasons|1|||
105385789|NCT00560404|363418821|FG001|Overall Study|Administrative Reasons|1|||
105385790|NCT00560404|363418820|FG000|Overall Study|Withdrew Consent|4|||
105385791|NCT00560404|363418821|FG001|Overall Study|Withdrew Consent|0|||
105385792|NCT00560404|363418820|FG000|Overall Study|Failure to return|1|||
105385793|NCT00560404|363418821|FG001|Overall Study|Failure to return|2|||
105385794|NCT00560404|363418820|FG000|Overall Study|Other withdrawal reason|13|||
105385795|NCT00560404|363418821|FG001|Overall Study|Other withdrawal reason|5|||
105385796|NCT01871727|363418822|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
105385797|NCT01871727|363418823|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
105385798|NCT01871727|363418824|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
105385799|NCT01871727|363418825|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
105385800|NCT01871727|363418826|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
105385801|NCT01871727|363418822|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
105385802|NCT01871727|363418823|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
105385803|NCT01871727|363418824|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
105385804|NCT01871727|363418825|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
105385805|NCT01871727|363418826|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
105385806|NCT01871727|363418822|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
105385807|NCT01871727|363418823|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
105385808|NCT01871727|363418824|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
105385809|NCT01871727|363418825|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
105385810|NCT01871727|363418826|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
105385811|NCT01871727|363418822|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
105385812|NCT01871727|363418823|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
105385813|NCT01871727|363418824|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
105385814|NCT01871727|363418825|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
105385815|NCT01871727|363418826|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
105385816|NCT01871727|363418822|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
105385817|NCT01871727|363418823|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
105385818|NCT01871727|363418824|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
105385819|NCT01871727|363418825|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
105385820|NCT01871727|363418826|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
105385821|NCT01871727|363418822|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
105385822|NCT01871727|363418823|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
105385823|NCT01871727|363418824|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
105385824|NCT01871727|363418825|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
105385825|NCT01871727|363418826|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
105385826|NCT01871727|363418822|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
105385827|NCT01871727|363418823|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
105385828|NCT01871727|363418824|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
105385829|NCT01871727|363418825|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
105385830|NCT01871727|363418826|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
105385831|NCT01618708|363418827|FG000|Overall Study|Adverse Event|10|||
105385832|NCT01618708|363418828|FG001|Overall Study|Adverse Event|10|||
105385833|NCT01618708|363418827|FG000|Overall Study|Lost to Follow-up|3|||
105385834|NCT01618708|363418828|FG001|Overall Study|Lost to Follow-up|3|||
105385835|NCT01618708|363418827|FG000|Overall Study|Withdrawal by Subject|17|||
105385836|NCT01618708|363418828|FG001|Overall Study|Withdrawal by Subject|22|||
105385837|NCT01618708|363418827|FG000|Overall Study|Lack of Efficacy|8|||
105385838|NCT01618708|363418828|FG001|Overall Study|Lack of Efficacy|8|||
105385839|NCT01618708|363418827|FG000|Overall Study|Technical problems|2|||
105385840|NCT01618708|363418828|FG001|Overall Study|Technical problems|0|||
105385841|NCT01618708|363418827|FG000|Overall Study|Other than specified above|1|||
105385842|NCT01618708|363418828|FG001|Overall Study|Other than specified above|1|||
105385843|NCT01618708|363418827|FG000|Overall Study|Randomized but not treated|3|||
105385844|NCT01618708|363418828|FG001|Overall Study|Randomized but not treated|2|||
105385845|NCT01905267|363418829|FG000|Overall Study|Physician Decision|2|||
105385846|NCT01905267|363418830|FG001|Overall Study|Physician Decision|2|||
105385847|NCT03888482|363418831|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
105385848|NCT03888482|363418832|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
105385849|NCT03888482|363418831|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
105385850|NCT03888482|363418832|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
105385851|NCT03721107|363418833|FG000|Overall Study|Adverse Event|1|||
105385852|NCT03721107|363418834|FG001|Overall Study|Adverse Event|1|||
105385853|NCT03721107|363418835|FG002|Overall Study|Adverse Event|6|||
105385854|NCT03721107|363418836|FG003|Overall Study|Adverse Event|5|||
105385855|NCT03721107|363418833|FG000|Overall Study|Lost to Follow-up|2|||
105385856|NCT03721107|363418834|FG001|Overall Study|Lost to Follow-up|0|||
105385857|NCT03721107|363418835|FG002|Overall Study|Lost to Follow-up|3|||
105385858|NCT03721107|363418836|FG003|Overall Study|Lost to Follow-up|0|||
105385859|NCT03721107|363418833|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
105385860|NCT03721107|363418834|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
105385861|NCT03721107|363418835|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
105385862|NCT03721107|363418836|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
105385863|NCT03721107|363418833|FG000|Overall Study|Physician Decision|0|||
105385864|NCT03721107|363418834|FG001|Overall Study|Physician Decision|1|||
105385865|NCT03721107|363418835|FG002|Overall Study|Physician Decision|0|||
105385866|NCT03721107|363418836|FG003|Overall Study|Physician Decision|0|||
105385867|NCT03721107|363418833|FG000|Overall Study|Pregnancy|0|||
105385868|NCT03721107|363418834|FG001|Overall Study|Pregnancy|0|||
105385869|NCT03721107|363418835|FG002|Overall Study|Pregnancy|1|||
105385870|NCT03721107|363418836|FG003|Overall Study|Pregnancy|0|||
105385871|NCT03721107|363418833|FG000|Overall Study|Withdrawal by Subject|1|||
105385872|NCT03721107|363418834|FG001|Overall Study|Withdrawal by Subject|1|||
105385873|NCT03721107|363418835|FG002|Overall Study|Withdrawal by Subject|5|||
105385874|NCT03721107|363418836|FG003|Overall Study|Withdrawal by Subject|5|||
105385875|NCT03721107|363418833|FG000|Overall Study|Other|1|||
105385876|NCT03721107|363418834|FG001|Overall Study|Other|0|||
105385877|NCT03721107|363418835|FG002|Overall Study|Other|0|||
105385878|NCT03721107|363418836|FG003|Overall Study|Other|1|||
105385879|NCT03438656|363418837|FG000|Overall Study|Lost to Follow-up|2|||
105385880|NCT01189227|363418838|FG000|Overall Study|Study terminated due to low accrual|6|||
105385881|NCT01189227|363418839|FG001|Overall Study|Study terminated due to low accrual|3|||
105385882|NCT01487161|363418840|FG000|Overall Study|Adverse Event|1|||
105385883|NCT01487161|363418841|FG001|Overall Study|Adverse Event|0|||
105385884|NCT01487161|363418842|FG002|Overall Study|Adverse Event|0|||
105385885|NCT01487161|363418843|FG003|Overall Study|Adverse Event|0|||
105385886|NCT01487161|363418840|FG000|Overall Study|Withdrawal by Subject|1|||
105385887|NCT01487161|363418841|FG001|Overall Study|Withdrawal by Subject|1|||
105385888|NCT01487161|363418842|FG002|Overall Study|Withdrawal by Subject|1|||
105385889|NCT01487161|363418843|FG003|Overall Study|Withdrawal by Subject|2|||
105385890|NCT01487161|363418840|FG000|Overall Study|missing data|0|||
105385891|NCT01487161|363418841|FG001|Overall Study|missing data|1|||
105385892|NCT01487161|363418842|FG002|Overall Study|missing data|0|||
105385893|NCT01487161|363418843|FG003|Overall Study|missing data|0|||
105385894|NCT03335566|363418844|FG000|Overall Study|Adverse Event|0|||
105385895|NCT03335566|363418845|FG001|Overall Study|Adverse Event|1|||
105385896|NCT03335566|363418844|FG000|Overall Study|Lost to Follow-up|1|||
105385897|NCT03335566|363418845|FG001|Overall Study|Lost to Follow-up|0|||
105385898|NCT03335566|363418844|FG000|Overall Study|Technical Problems|1|||
105385899|NCT03335566|363418845|FG001|Overall Study|Technical Problems|0|||
105385900|NCT03335566|363418844|FG000|Overall Study|Protocol Violation|1|||
105385901|NCT03335566|363418845|FG001|Overall Study|Protocol Violation|0|||
105492929|NCT04399837|363817200|FG000|Overall Study|Withdrawal by Subject|1|||
105492930|NCT04399837|363817201|FG001|Overall Study|Withdrawal by Subject|2|||
105492931|NCT04399837|363817202|FG002|Overall Study|Withdrawal by Subject|1|||
105385902|NCT03335566|363418844|FG000|Overall Study|Other than specified above|1|||
105385903|NCT03335566|363418845|FG001|Overall Study|Other than specified above|2|||
105385904|NCT01084135|363418846|FG000|20 Week|Physician Decision|0|||
105385905|NCT01084135|363418847|FG001|20 Week|Physician Decision|1|||
105385906|NCT00663351|363418848|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
105385907|NCT00663351|363418849|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
105385908|NCT00663351|363418848|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
105385909|NCT00663351|363418849|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
105385910|NCT00663351|363418848|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
105385911|NCT00663351|363418849|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
105385912|NCT00663351|363418848|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
105385913|NCT00663351|363418849|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
105385914|NCT00663351|363418848|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
105385915|NCT00663351|363418849|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
105385916|NCT00663351|363418848|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
105385917|NCT00663351|363418849|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
105385918|NCT03211832|363418850|FG000|Overall Study|No longer with agency|32|||
105385919|NCT03211832|363418851|FG001|Overall Study|No longer with agency|49|||
105385920|NCT03211832|363418852|FG002|Overall Study|No longer with agency|30|||
105385921|NCT03211832|363418850|FG000|Overall Study|Declined survey|3|||
105385922|NCT03211832|363418851|FG001|Overall Study|Declined survey|3|||
105385923|NCT03211832|363418852|FG002|Overall Study|Declined survey|2|||
105385924|NCT03211832|363418850|FG000|Overall Study|Not available during data collection|1|||
105385925|NCT03211832|363418851|FG001|Overall Study|Not available during data collection|0|||
105385926|NCT03211832|363418852|FG002|Overall Study|Not available during data collection|2|||
105385927|NCT03721965|363418853|FG000|Overall Study|Death|1|||
105385928|NCT03721965|363418853|FG000|Overall Study|Study Terminated by Sponsor|1|||
105385929|NCT02057666|363418856|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
105385930|NCT02057666|363418857|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
105385931|NCT02057666|363418856|FG000|Double Blind Treatment Period|Poor tolerability|7|||
105385932|NCT02057666|363418857|FG001|Double Blind Treatment Period|Poor tolerability|2|||
105385933|NCT02057666|363418856|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
105385934|NCT02057666|363418857|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
105385935|NCT02057666|363418856|FG000|Double Blind Treatment Period|Physician Decision|1|||
105385936|NCT02057666|363418857|FG001|Double Blind Treatment Period|Physician Decision|0|||
105385937|NCT02057666|363418856|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
105385938|NCT02057666|363418857|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
105385939|NCT02057666|363418856|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
105385940|NCT02057666|363418857|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
105385941|NCT02057666|363418856|FG000|Double Blind Treatment Period|Sponsor's request|70|||
105385942|NCT02057666|363418857|FG001|Double Blind Treatment Period|Sponsor's request|34|||
105385943|NCT02057666|363418856|FG000|Open-Label Treatment Period|Poor tolerability|0|||
105385944|NCT02057666|363418857|FG001|Open-Label Treatment Period|Poor tolerability|1|||
105385945|NCT02057666|363418856|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
105385946|NCT02057666|363418857|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
105385947|NCT02057666|363418856|FG000|Open-Label Treatment Period|Sponsor's request|0|||
105385948|NCT02057666|363418857|FG001|Open-Label Treatment Period|Sponsor's request|4|||
105385949|NCT00498485|363418858|FG000|Overall Study|Adverse Event|1|||
105385950|NCT00498485|363418859|FG001|Overall Study|Adverse Event|5|||
105385951|NCT01108055|363418860|FG000|Overall Study|Ineligible|11|||
105385952|NCT01108055|363418860|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
105385953|NCT03478787|363418861|FG000|Overall Study|Adverse Event|5|||
105385954|NCT03478787|363418862|FG001|Overall Study|Adverse Event|1|||
105385955|NCT03478787|363418861|FG000|Overall Study|Protocol Violation|3|||
105385956|NCT03478787|363418862|FG001|Overall Study|Protocol Violation|0|||
105385957|NCT03478787|363418861|FG000|Overall Study|Lack of Efficacy|7|||
105385958|NCT03478787|363418862|FG001|Overall Study|Lack of Efficacy|1|||
105385959|NCT03478787|363418861|FG000|Overall Study|Lost to Follow-up|9|||
105385960|NCT03478787|363418862|FG001|Overall Study|Lost to Follow-up|5|||
105385961|NCT03478787|363418861|FG000|Overall Study|Withdrawal by Subject|2|||
105385962|NCT03478787|363418862|FG001|Overall Study|Withdrawal by Subject|6|||
105385963|NCT03478787|363418861|FG000|Overall Study|Other, Not Specified|3|||
105492932|NCT04399837|363817203|FG003|Overall Study|Withdrawal by Subject|1|||
105492933|NCT03805646|363817204|FG000|Overall Study|Death|40|||
105492934|NCT03805646|363817205|FG001|Overall Study|Death|49|||
105492935|NCT03805646|363817204|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
105492936|NCT03805646|363817205|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
105385964|NCT03478787|363418862|FG001|Overall Study|Other, Not Specified|0|||
105385965|NCT01712074|363418865|FG000|Placebo Run-in Period|Adverse Event|2|||
105385966|NCT01712074|363418866|FG001|Placebo Run-in Period|Adverse Event|0|||
105385967|NCT01712074|363418867|FG002|Placebo Run-in Period|Adverse Event|0|||
105385968|NCT01712074|363418865|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
105385969|NCT01712074|363418866|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
105385970|NCT01712074|363418867|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
105385971|NCT01712074|363418865|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
105385972|NCT01712074|363418866|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
105385973|NCT01712074|363418867|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
105385974|NCT01712074|363418865|FG000|Placebo Run-in Period|Other|1|||
105385975|NCT01712074|363418866|FG001|Placebo Run-in Period|Other|0|||
105385976|NCT01712074|363418867|FG002|Placebo Run-in Period|Other|0|||
105385977|NCT01712074|363418865|FG000|Placebo Run-in Period|No longer willing to participate|1|||
105385978|NCT01712074|363418866|FG001|Placebo Run-in Period|No longer willing to participate|0|||
105385979|NCT01712074|363418867|FG002|Placebo Run-in Period|No longer willing to participate|0|||
105385980|NCT01712074|363418865|FG000|Double Blind Period|Adverse Event|0|||
105385981|NCT01712074|363418866|FG001|Double Blind Period|Adverse Event|2|||
105385982|NCT01712074|363418867|FG002|Double Blind Period|Adverse Event|1|||
105385983|NCT01712074|363418865|FG000|Double Blind Period|No longer willing to participate|0|||
105385984|NCT01712074|363418866|FG001|Double Blind Period|No longer willing to participate|2|||
105385985|NCT01712074|363418867|FG002|Double Blind Period|No longer willing to participate|4|||
105385986|NCT01712074|363418865|FG000|Double Blind Period|Death|0|||
105385987|NCT01712074|363418866|FG001|Double Blind Period|Death|1|||
105385988|NCT01712074|363418867|FG002|Double Blind Period|Death|0|||
105385989|NCT01712074|363418865|FG000|Double Blind Period|Lost to Follow-up|0|||
105385990|NCT01712074|363418866|FG001|Double Blind Period|Lost to Follow-up|2|||
105385991|NCT01712074|363418867|FG002|Double Blind Period|Lost to Follow-up|1|||
105385992|NCT01712074|363418865|FG000|Double Blind Period|Other|0|||
105385993|NCT01712074|363418866|FG001|Double Blind Period|Other|4|||
105385994|NCT01712074|363418867|FG002|Double Blind Period|Other|1|||
105385995|NCT01712074|363418865|FG000|Double Blind Period|Protocol Violation|0|||
105385996|NCT01712074|363418866|FG001|Double Blind Period|Protocol Violation|0|||
105385997|NCT01712074|363418867|FG002|Double Blind Period|Protocol Violation|1|||
105385998|NCT01712074|363418865|FG000|Double Blind Period|No longer met eligibility criteria|0|||
105385999|NCT01712074|363418866|FG001|Double Blind Period|No longer met eligibility criteria|3|||
105386000|NCT01712074|363418867|FG002|Double Blind Period|No longer met eligibility criteria|0|||
105386001|NCT02268851|363418868|FG000|Overall Study|Death|0|||
105386002|NCT02268851|363418869|FG001|Overall Study|Death|0|||
105386003|NCT02268851|363418870|FG002|Overall Study|Death|0|||
105386004|NCT02268851|363418871|FG003|Overall Study|Death|1|||
105386005|NCT02268851|363418872|FG004|Overall Study|Death|2|||
105386006|NCT02268851|363418873|FG005|Overall Study|Death|1|||
105386007|NCT02268851|363418868|FG000|Overall Study|Adverse Event|0|||
105386008|NCT02268851|363418869|FG001|Overall Study|Adverse Event|0|||
105386009|NCT02268851|363418870|FG002|Overall Study|Adverse Event|0|||
105386010|NCT02268851|363418871|FG003|Overall Study|Adverse Event|0|||
105386011|NCT02268851|363418872|FG004|Overall Study|Adverse Event|2|||
105386012|NCT02268851|363418873|FG005|Overall Study|Adverse Event|2|||
105386013|NCT02268851|363418868|FG000|Overall Study|Withdrawal by Subject|0|||
105386014|NCT02268851|363418869|FG001|Overall Study|Withdrawal by Subject|0|||
105386015|NCT02268851|363418870|FG002|Overall Study|Withdrawal by Subject|0|||
105386016|NCT02268851|363418871|FG003|Overall Study|Withdrawal by Subject|2|||
105386017|NCT02268851|363418872|FG004|Overall Study|Withdrawal by Subject|0|||
105386018|NCT02268851|363418873|FG005|Overall Study|Withdrawal by Subject|1|||
105386019|NCT02268851|363418868|FG000|Overall Study|Progressive Disease|1|||
105386020|NCT02268851|363418869|FG001|Overall Study|Progressive Disease|3|||
105386021|NCT02268851|363418870|FG002|Overall Study|Progressive Disease|0|||
105386022|NCT02268851|363418871|FG003|Overall Study|Progressive Disease|0|||
105386023|NCT02268851|363418872|FG004|Overall Study|Progressive Disease|1|||
105386024|NCT02268851|363418873|FG005|Overall Study|Progressive Disease|4|||
105386025|NCT02268851|363418868|FG000|Overall Study|Physician Decision|0|||
105386026|NCT02268851|363418869|FG001|Overall Study|Physician Decision|0|||
105386027|NCT02268851|363418870|FG002|Overall Study|Physician Decision|1|||
105386028|NCT02268851|363418871|FG003|Overall Study|Physician Decision|0|||
105386029|NCT02268851|363418872|FG004|Overall Study|Physician Decision|0|||
105386030|NCT02268851|363418873|FG005|Overall Study|Physician Decision|1|||
105386031|NCT02268851|363418868|FG000|Overall Study|Patient Compliance|0|||
105386032|NCT02268851|363418869|FG001|Overall Study|Patient Compliance|0|||
105386033|NCT02268851|363418870|FG002|Overall Study|Patient Compliance|0|||
105386034|NCT02268851|363418871|FG003|Overall Study|Patient Compliance|0|||
105386035|NCT02268851|363418872|FG004|Overall Study|Patient Compliance|1|||
105386036|NCT02268851|363418873|FG005|Overall Study|Patient Compliance|1|||
105386037|NCT02268851|363418868|FG000|Overall Study|Co-Morbid Condition|0|||
105386038|NCT02268851|363418869|FG001|Overall Study|Co-Morbid Condition|0|||
105386039|NCT02268851|363418870|FG002|Overall Study|Co-Morbid Condition|0|||
105386040|NCT02268851|363418871|FG003|Overall Study|Co-Morbid Condition|0|||
105386041|NCT02268851|363418872|FG004|Overall Study|Co-Morbid Condition|1|||
105386042|NCT02268851|363418873|FG005|Overall Study|Co-Morbid Condition|1|||
105386043|NCT02413346|363418874|FG000|Overall Study|Adverse Event|6|||
105386044|NCT02413346|363418875|FG001|Overall Study|Adverse Event|6|||
105386045|NCT02413346|363418874|FG000|Overall Study|Withdrawal by Subject|30|||
105386046|NCT02413346|363418875|FG001|Overall Study|Withdrawal by Subject|40|||
105386047|NCT02413346|363418874|FG000|Overall Study|Lost to Follow-up|17|||
105386048|NCT02413346|363418875|FG001|Overall Study|Lost to Follow-up|21|||
105492937|NCT02445391|363817209|FG000|Overall Study|No active protocol treatment|3|||
105386049|NCT02413346|363418874|FG000|Overall Study|Protocol Violation|2|||
105386050|NCT02413346|363418875|FG001|Overall Study|Protocol Violation|0|||
105386051|NCT02413346|363418874|FG000|Overall Study|Other Miscellaneous Reasons|4|||
105386052|NCT02413346|363418875|FG001|Overall Study|Other Miscellaneous Reasons|3|||
105386053|NCT01905683|363418880|FG000|Overall Study|Protocol Violation|1|||
105386054|NCT01905683|363418880|FG000|Overall Study|Re-injection criteria not met; others|13|||
105386055|NCT01905683|363418880|FG000|Overall Study|Physician Decision|1|||
105386056|NCT01905683|363418880|FG000|Overall Study|Lack of Efficacy|8|||
105386057|NCT01905683|363418880|FG000|Overall Study|Withdrawal by Subject|20|||
105386058|NCT01905683|363418880|FG000|Overall Study|Adverse Event|4|||
105386059|NCT01905683|363418880|FG000|Overall Study|Lost to Follow-up|4|||
105386060|NCT01245049|363418881|FG000|Overall Study|Migrated/moved from study area|0|||
105386061|NCT01245049|363418882|FG001|Overall Study|Migrated/moved from study area|1|||
105386062|NCT01245049|363418881|FG000|Overall Study|Withdrawal by Subject|0|||
105386063|NCT01245049|363418882|FG001|Overall Study|Withdrawal by Subject|1|||
105386064|NCT01245049|363418881|FG000|Overall Study|Lost to Follow-up|1|||
105386065|NCT01245049|363418882|FG001|Overall Study|Lost to Follow-up|2|||
105386066|NCT02568254|363418884|FG000|Period 2|Adverse Event|0|||
105386067|NCT02568254|363418885|FG001|Period 2|Adverse Event|0|||
105386068|NCT02568254|363418886|FG002|Period 2|Adverse Event|1|||
105386069|NCT02568254|363418887|FG003|Period 2|Adverse Event|0|||
105386070|NCT02568254|363418888|FG004|Period 2|Adverse Event|0|||
105386071|NCT02568254|363418889|FG005|Period 2|Adverse Event|0|||
105386072|NCT02568254|363418884|FG000|Period 3|Unstatisfactory Lens fitting|0|||
105386073|NCT02568254|363418885|FG001|Period 3|Unstatisfactory Lens fitting|0|||
105386074|NCT02568254|363418886|FG002|Period 3|Unstatisfactory Lens fitting|0|||
105386075|NCT02568254|363418887|FG003|Period 3|Unstatisfactory Lens fitting|0|||
105386076|NCT02568254|363418888|FG004|Period 3|Unstatisfactory Lens fitting|1|||
105386077|NCT02568254|363418889|FG005|Period 3|Unstatisfactory Lens fitting|0|||
105386078|NCT04495478|363418890|FG000|Overall Study|Withdrawal by Subject|0|||
105386079|NCT04495478|363418891|FG001|Overall Study|Withdrawal by Subject|0|||
105386080|NCT04495478|363418892|FG002|Overall Study|Withdrawal by Subject|0|||
105386081|NCT04495478|363418893|FG003|Overall Study|Withdrawal by Subject|1|||
105386082|NCT04495478|363418894|FG004|Overall Study|Withdrawal by Subject|0|||
105386083|NCT04495478|363418895|FG005|Overall Study|Withdrawal by Subject|0|||
105386084|NCT04495478|363418896|FG006|Overall Study|Withdrawal by Subject|0|||
105386085|NCT04495478|363418890|FG000|Overall Study|Physician Decision|0|||
105386086|NCT04495478|363418891|FG001|Overall Study|Physician Decision|1|||
105386087|NCT04495478|363418892|FG002|Overall Study|Physician Decision|0|||
105386088|NCT04495478|363418893|FG003|Overall Study|Physician Decision|0|||
105386089|NCT04495478|363418894|FG004|Overall Study|Physician Decision|1|||
105386090|NCT04495478|363418895|FG005|Overall Study|Physician Decision|0|||
105386091|NCT04495478|363418896|FG006|Overall Study|Physician Decision|0|||
105386092|NCT00655746|363418897|FG000|Overall Study|Withdrawal by Subject|1|||
105386093|NCT01902303|363420835|FG000|Overall Study|Adverse Event|0|||
105386094|NCT01902303|363420836|FG001|Overall Study|Adverse Event|1|||
105386095|NCT01902303|363420835|FG000|Overall Study|Lost to Follow-up|0|||
105386096|NCT01902303|363420836|FG001|Overall Study|Lost to Follow-up|1|||
105386097|NCT01902303|363420835|FG000|Overall Study|Protocol Violation|2|||
105386098|NCT01902303|363420836|FG001|Overall Study|Protocol Violation|2|||
105386099|NCT01902303|363420835|FG000|Overall Study|subject lost investigational product|0|||
105386100|NCT01902303|363420836|FG001|Overall Study|subject lost investigational product|1|||
105386101|NCT01902303|363420835|FG000|Overall Study|Did not develop a cold sore|21|||
105386102|NCT01902303|363420836|FG001|Overall Study|Did not develop a cold sore|19|||
105386103|NCT01772693|363420837|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
105580543|NCT02018861|364126453|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
105580544|NCT02018861|364126444|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
105386104|NCT01772693|363420838|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
105386105|NCT01772693|363420837|FG000|Overall Study|Withdrawal by Subject|2|||
105386106|NCT01772693|363420838|FG001|Overall Study|Withdrawal by Subject|0|||
105386107|NCT01772693|363420837|FG000|Overall Study|Alternative Treatment|2|||
105386108|NCT01772693|363420838|FG001|Overall Study|Alternative Treatment|0|||
105386109|NCT00290758|363420839|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
105386110|NCT00290758|363420840|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
105386111|NCT00290758|363420839|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
105386112|NCT00290758|363420840|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
105386113|NCT00290758|363420839|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
105386114|NCT00290758|363420840|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
105386115|NCT00290758|363420839|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
105386116|NCT00290758|363420840|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
105386117|NCT00290758|363420839|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
105386118|NCT00290758|363420840|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
105386119|NCT00290758|363420839|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
105386120|NCT00290758|363420840|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
105386121|NCT00290758|363420839|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
105386122|NCT00290758|363420840|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
105386123|NCT00290758|363420839|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
105386124|NCT00290758|363420840|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
105386125|NCT03436420|363420841|FG000|Overall Study|Lack of Efficacy|3|||
105386126|NCT05587998|363420846|FG000|Overall Study|Withdrawal by Subject|1|||
105386127|NCT05587998|363420847|FG001|Overall Study|Withdrawal by Subject|1|||
105386128|NCT05587998|363420846|FG000|Overall Study|Not treated|3|||
105386129|NCT05587998|363420847|FG001|Overall Study|Not treated|1|||
105386130|NCT05587998|363420846|FG000|Overall Study|Non-compliance with study procedures|0|||
105386131|NCT05587998|363420847|FG001|Overall Study|Non-compliance with study procedures|1|||
105386132|NCT00986102|363420848|FG000|Overall Study|Lost to Follow-up|0|||
105386133|NCT00986102|363420849|FG001|Overall Study|Lost to Follow-up|1|||
105386134|NCT00986102|363420850|FG002|Overall Study|Lost to Follow-up|0|||
105386135|NCT00986102|363420851|FG003|Overall Study|Lost to Follow-up|1|||
105386136|NCT00986102|363420848|FG000|Overall Study|Withdrawal by Subject|1|||
105386137|NCT00986102|363420849|FG001|Overall Study|Withdrawal by Subject|1|||
105386138|NCT00986102|363420850|FG002|Overall Study|Withdrawal by Subject|0|||
105386139|NCT00986102|363420851|FG003|Overall Study|Withdrawal by Subject|0|||
105386140|NCT01530997|363420852|FG000|Overall Study|Physician Decision|1|||
105386141|NCT01530997|363420852|FG000|Overall Study|Withdrawal by Subject|1|||
105386142|NCT02318277|363420853|FG000|Overall Study|Physician Decision|0|||
105386143|NCT02318277|363420854|FG001|Overall Study|Physician Decision|0|||
105386144|NCT02318277|363420855|FG002|Overall Study|Physician Decision|0|||
105386145|NCT02318277|363420856|FG003|Overall Study|Physician Decision|0|||
105386146|NCT02318277|363420857|FG004|Overall Study|Physician Decision|0|||
105386147|NCT02318277|363420858|FG005|Overall Study|Physician Decision|0|||
105386148|NCT02318277|363420859|FG006|Overall Study|Physician Decision|0|||
105386149|NCT02318277|363420860|FG007|Overall Study|Physician Decision|1|||
105386150|NCT02318277|363420853|FG000|Overall Study|Other|0|||
105386151|NCT02318277|363420854|FG001|Overall Study|Other|0|||
105386152|NCT02318277|363420855|FG002|Overall Study|Other|0|||
105386153|NCT02318277|363420856|FG003|Overall Study|Other|0|||
105386154|NCT02318277|363420857|FG004|Overall Study|Other|0|||
105386155|NCT02318277|363420858|FG005|Overall Study|Other|0|||
105580545|NCT02018861|364126445|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
105386156|NCT02318277|363420859|FG006|Overall Study|Other|1|||
105386157|NCT02318277|363420860|FG007|Overall Study|Other|0|||
105386158|NCT02318277|363420853|FG000|Overall Study|Withdrawal by Subject|0|||
105386159|NCT02318277|363420854|FG001|Overall Study|Withdrawal by Subject|0|||
105580546|NCT02018861|364126446|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
105386160|NCT02318277|363420855|FG002|Overall Study|Withdrawal by Subject|1|||
105580547|NCT02018861|364126447|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
105386161|NCT02318277|363420856|FG003|Overall Study|Withdrawal by Subject|0|||
105386162|NCT02318277|363420857|FG004|Overall Study|Withdrawal by Subject|1|||
105386163|NCT02318277|363420858|FG005|Overall Study|Withdrawal by Subject|1|||
105386164|NCT02318277|363420859|FG006|Overall Study|Withdrawal by Subject|6|||
105386165|NCT02318277|363420860|FG007|Overall Study|Withdrawal by Subject|14|||
105386166|NCT02318277|363420853|FG000|Overall Study|Participant trial terminated by sponsor|0|||
105386167|NCT02318277|363420854|FG001|Overall Study|Participant trial terminated by sponsor|0|||
105386168|NCT02318277|363420855|FG002|Overall Study|Participant trial terminated by sponsor|1|||
105386169|NCT02318277|363420856|FG003|Overall Study|Participant trial terminated by sponsor|0|||
105386170|NCT02318277|363420857|FG004|Overall Study|Participant trial terminated by sponsor|1|||
105386171|NCT02318277|363420858|FG005|Overall Study|Participant trial terminated by sponsor|2|||
105386172|NCT02318277|363420859|FG006|Overall Study|Participant trial terminated by sponsor|5|||
105386173|NCT02318277|363420860|FG007|Overall Study|Participant trial terminated by sponsor|16|||
105386174|NCT02318277|363420853|FG000|Overall Study|Lost to Follow-up|1|||
105386175|NCT02318277|363420854|FG001|Overall Study|Lost to Follow-up|0|||
105386176|NCT02318277|363420855|FG002|Overall Study|Lost to Follow-up|1|||
105386177|NCT02318277|363420856|FG003|Overall Study|Lost to Follow-up|0|||
105386178|NCT02318277|363420857|FG004|Overall Study|Lost to Follow-up|0|||
105386179|NCT02318277|363420858|FG005|Overall Study|Lost to Follow-up|0|||
105386180|NCT02318277|363420859|FG006|Overall Study|Lost to Follow-up|3|||
105386181|NCT02318277|363420860|FG007|Overall Study|Lost to Follow-up|4|||
105386182|NCT02318277|363420853|FG000|Overall Study|Death|5|||
105386183|NCT02318277|363420854|FG001|Overall Study|Death|3|||
105386184|NCT02318277|363420855|FG002|Overall Study|Death|1|||
105386185|NCT02318277|363420856|FG003|Overall Study|Death|4|||
105386186|NCT02318277|363420857|FG004|Overall Study|Death|6|||
105386187|NCT02318277|363420858|FG005|Overall Study|Death|5|||
105386188|NCT02318277|363420859|FG006|Overall Study|Death|34|||
105386189|NCT02318277|363420860|FG007|Overall Study|Death|58|||
105386190|NCT02318277|363420853|FG000|Overall Study|Transitioned to Hospice|0|||
105386191|NCT02318277|363420854|FG001|Overall Study|Transitioned to Hospice|0|||
105386192|NCT02318277|363420855|FG002|Overall Study|Transitioned to Hospice|0|||
105386193|NCT02318277|363420856|FG003|Overall Study|Transitioned to Hospice|0|||
105386194|NCT02318277|363420857|FG004|Overall Study|Transitioned to Hospice|0|||
105386195|NCT02318277|363420858|FG005|Overall Study|Transitioned to Hospice|1|||
105386196|NCT02318277|363420859|FG006|Overall Study|Transitioned to Hospice|0|||
105386197|NCT02318277|363420860|FG007|Overall Study|Transitioned to Hospice|0|||
105386198|NCT00395512|363420861|FG000|Overall Study|Adverse Event|3|||
105386199|NCT00395512|363420862|FG001|Overall Study|Adverse Event|8|||
105386200|NCT00395512|363420863|FG002|Overall Study|Adverse Event|6|||
105386201|NCT00395512|363420864|FG003|Overall Study|Adverse Event|6|||
105386202|NCT00395512|363420861|FG000|Overall Study|Protocol Violation|2|||
105386203|NCT00395512|363420862|FG001|Overall Study|Protocol Violation|3|||
105386204|NCT00395512|363420863|FG002|Overall Study|Protocol Violation|6|||
105386205|NCT00395512|363420864|FG003|Overall Study|Protocol Violation|7|||
105386206|NCT00395512|363420861|FG000|Overall Study|Lost to Follow-up|2|||
105386207|NCT00395512|363420862|FG001|Overall Study|Lost to Follow-up|6|||
105386208|NCT00395512|363420863|FG002|Overall Study|Lost to Follow-up|5|||
105386209|NCT00395512|363420864|FG003|Overall Study|Lost to Follow-up|5|||
105386210|NCT00395512|363420861|FG000|Overall Study|Withdrawal by Subject|6|||
105386211|NCT00395512|363420862|FG001|Overall Study|Withdrawal by Subject|5|||
105386212|NCT00395512|363420863|FG002|Overall Study|Withdrawal by Subject|5|||
105386213|NCT00395512|363420864|FG003|Overall Study|Withdrawal by Subject|12|||
105386214|NCT00395512|363420861|FG000|Overall Study|Physician Decision|6|||
105386215|NCT00395512|363420862|FG001|Overall Study|Physician Decision|4|||
105386216|NCT00395512|363420863|FG002|Overall Study|Physician Decision|2|||
105386217|NCT00395512|363420864|FG003|Overall Study|Physician Decision|2|||
105386218|NCT00395512|363420861|FG000|Overall Study|Other|1|||
105386219|NCT00395512|363420862|FG001|Overall Study|Other|1|||
105386220|NCT00395512|363420863|FG002|Overall Study|Other|0|||
105386221|NCT00395512|363420864|FG003|Overall Study|Other|0|||
105386222|NCT00395512|363420861|FG000|Overall Study|Hyperglycemic Rescue|18|||
105386223|NCT00395512|363420862|FG001|Overall Study|Hyperglycemic Rescue|10|||
105386224|NCT00395512|363420863|FG002|Overall Study|Hyperglycemic Rescue|4|||
105386225|NCT00395512|363420864|FG003|Overall Study|Hyperglycemic Rescue|6|||
105386226|NCT01986751|363420870|FG000|Overall Study|improperly consented|10|||
105386227|NCT01986751|363420871|FG001|Overall Study|improperly consented|2|||
105386228|NCT00819832|363420874|FG000|Overall Study|Sponsor Termination of Study|3|||
105386229|NCT00819832|363420875|FG001|Overall Study|Sponsor Termination of Study|0|||
105386230|NCT00819832|363420876|FG002|Overall Study|Sponsor Termination of Study|0|||
105386231|NCT00819832|363420877|FG003|Overall Study|Sponsor Termination of Study|0|||
105386232|NCT00819832|363420878|FG004|Overall Study|Sponsor Termination of Study|0|||
105386233|NCT00819832|363420879|FG005|Overall Study|Sponsor Termination of Study|0|||
105386234|NCT01063881|363420885|FG000|Overall Study|Adverse Event|12|||
105386235|NCT01063881|363420886|FG001|Overall Study|Adverse Event|2|||
105386236|NCT01063881|363420887|FG002|Overall Study|Adverse Event|0|||
105386237|NCT01063881|363420885|FG000|Overall Study|Lost to Follow-up|13|||
105386238|NCT01063881|363420886|FG001|Overall Study|Lost to Follow-up|7|||
105386239|NCT01063881|363420887|FG002|Overall Study|Lost to Follow-up|1|||
105386240|NCT01063881|363420885|FG000|Overall Study|Withdrawal by Subject|25|||
105386241|NCT01063881|363420886|FG001|Overall Study|Withdrawal by Subject|1|||
105386242|NCT01063881|363420887|FG002|Overall Study|Withdrawal by Subject|0|||
105386243|NCT01063881|363420885|FG000|Overall Study|Reason for not completed not specified|5|||
105386244|NCT01063881|363420886|FG001|Overall Study|Reason for not completed not specified|1|||
105386245|NCT01063881|363420887|FG002|Overall Study|Reason for not completed not specified|0|||
105386246|NCT01452789|363420888|FG000|Overall Study|Withdrawal by Subject|3|||
105386247|NCT01452789|363420889|FG001|Overall Study|Withdrawal by Subject|2|||
105386248|NCT03722030|363420890|FG000|Overall Study|Withdrawal by Subject|1|||
105386249|NCT03722030|363420891|FG001|Overall Study|Withdrawal by Subject|0|||
105386250|NCT00676689|363420897|FG000|Overall Study|Screen Failure|2|||
105386251|NCT00676689|363420897|FG000|Overall Study|Death|2|||
105386252|NCT00676689|363420897|FG000|Overall Study|Lost to Follow-up|4|||
105386253|NCT00676689|363420897|FG000|Overall Study|Physician Decision|1|||
105386254|NCT00676689|363420897|FG000|Overall Study|Withdrawal by Subject|3|||
105386255|NCT00676689|363420897|FG000|Overall Study|Continuing FU|49|||
105386256|NCT02991859|363420904|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105386257|NCT02991859|363420905|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
105386258|NCT02991859|363420906|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105386259|NCT02991859|363420907|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105386260|NCT02991859|363420908|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
105386261|NCT02991859|363420909|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105386262|NCT02991859|363420910|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105386263|NCT02991859|363420911|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105386264|NCT02991859|363420912|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105386265|NCT02991859|363420913|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105492938|NCT02445391|363817210|FG001|Overall Study|No active protocol treatment|0|||
105492939|NCT02445391|363817211|FG002|Overall Study|No active protocol treatment|0|||
105386266|NCT02991859|363420914|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105386267|NCT02991859|363420915|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105386268|NCT02991859|363420916|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105386269|NCT02991859|363420917|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105386270|NCT02991859|363420918|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105386271|NCT02991859|363420919|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105386272|NCT02991859|363420920|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105386273|NCT02991859|363420904|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105386274|NCT02991859|363420905|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105386275|NCT02991859|363420906|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105386276|NCT02991859|363420907|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105386277|NCT02991859|363420908|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105386278|NCT02991859|363420909|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105386279|NCT02991859|363420910|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105386280|NCT02991859|363420911|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105386281|NCT02991859|363420912|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105386282|NCT02991859|363420913|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105386283|NCT02991859|363420914|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105386284|NCT02991859|363420915|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105386285|NCT02991859|363420916|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
105386286|NCT02991859|363420917|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
105386287|NCT02991859|363420918|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105386288|NCT02991859|363420919|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105386289|NCT02991859|363420920|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105386290|NCT02991859|363420904|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386291|NCT02991859|363420905|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386292|NCT02991859|363420906|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386293|NCT02991859|363420907|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386294|NCT02991859|363420908|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386295|NCT02991859|363420909|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
105386296|NCT02991859|363420910|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386297|NCT02991859|363420911|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386298|NCT02991859|363420912|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386299|NCT02991859|363420913|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386300|NCT02991859|363420914|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386301|NCT02991859|363420915|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386302|NCT02991859|363420916|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386303|NCT02991859|363420917|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386304|NCT02991859|363420918|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386305|NCT02991859|363420919|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386306|NCT02991859|363420920|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105386307|NCT02991859|363420904|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386308|NCT02991859|363420905|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386309|NCT02991859|363420906|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386310|NCT02991859|363420907|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386311|NCT02991859|363420908|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386312|NCT02991859|363420909|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386313|NCT02991859|363420910|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386314|NCT02991859|363420911|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386315|NCT02991859|363420912|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386316|NCT02991859|363420913|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
105386317|NCT02991859|363420914|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386318|NCT02991859|363420915|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386319|NCT02991859|363420916|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386320|NCT02991859|363420917|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386321|NCT02991859|363420918|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386322|NCT02991859|363420919|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386323|NCT02991859|363420920|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105386324|NCT02991859|363420904|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386325|NCT02991859|363420905|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386326|NCT02991859|363420906|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386327|NCT02991859|363420907|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386328|NCT02991859|363420908|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386329|NCT02991859|363420909|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386330|NCT02991859|363420910|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386331|NCT02991859|363420911|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386332|NCT02991859|363420912|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
105386333|NCT02991859|363420913|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386334|NCT02991859|363420914|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386335|NCT02991859|363420915|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386336|NCT02991859|363420916|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386337|NCT02991859|363420917|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386338|NCT02991859|363420918|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386339|NCT02991859|363420919|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386340|NCT02991859|363420920|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105386341|NCT03163264|363420927|FG000|Overall Study|Withdrawal by Subject|13|||
105386342|NCT03163264|363420928|FG001|Overall Study|Withdrawal by Subject|3|||
105386343|NCT03163264|363420929|FG002|Overall Study|Withdrawal by Subject|4|||
105386344|NCT03163264|363420930|FG003|Overall Study|Withdrawal by Subject|2|||
105386345|NCT03163264|363420927|FG000|Overall Study|Lost to Follow-up|17|||
105386346|NCT03163264|363420928|FG001|Overall Study|Lost to Follow-up|20|||
105386347|NCT03163264|363420929|FG002|Overall Study|Lost to Follow-up|0|||
105386348|NCT03163264|363420930|FG003|Overall Study|Lost to Follow-up|0|||
105386349|NCT03163264|363420927|FG000|Overall Study|Death|0|||
105386350|NCT03163264|363420928|FG001|Overall Study|Death|2|||
105386351|NCT03163264|363420929|FG002|Overall Study|Death|0|||
105386352|NCT03163264|363420930|FG003|Overall Study|Death|0|||
105386353|NCT04648241|363420931|FG000|Overall Study|Lost to Follow-up|1|||
105386354|NCT04648241|363420932|FG001|Overall Study|Lost to Follow-up|0|||
105386355|NCT04565756|363420940|FG000|Overall Study|Withdrawal by Subject|0|||
105386356|NCT04565756|363420941|FG001|Overall Study|Withdrawal by Subject|0|||
105386357|NCT04565756|363420942|FG002|Overall Study|Withdrawal by Subject|0|||
105386358|NCT04565756|363420943|FG003|Overall Study|Withdrawal by Subject|0|||
105386359|NCT04565756|363420944|FG004|Overall Study|Withdrawal by Subject|1|||
105386360|NCT04565756|363420945|FG005|Overall Study|Withdrawal by Subject|0|||
105386361|NCT04565756|363420940|FG000|Overall Study|Protocol Violation|0|||
105386362|NCT04565756|363420941|FG001|Overall Study|Protocol Violation|0|||
105386363|NCT04565756|363420942|FG002|Overall Study|Protocol Violation|0|||
105386364|NCT04565756|363420943|FG003|Overall Study|Protocol Violation|0|||
105386365|NCT04565756|363420944|FG004|Overall Study|Protocol Violation|0|||
105386366|NCT04565756|363420945|FG005|Overall Study|Protocol Violation|1|||
105386367|NCT01185366|363420946|FG000|First Line Therapy|Insurance Coverage Denied|1|||
105386368|NCT01185366|363420947|FG001|First Line Therapy|Insurance Coverage Denied|1|||
105386369|NCT01185366|363420946|FG000|First Line Therapy|Withdrawal by Subject|1|||
105386370|NCT01185366|363420947|FG001|First Line Therapy|Withdrawal by Subject|0|||
105386371|NCT01185366|363420946|FG000|First Line Therapy|Lack of Metastatic Site|1|||
105386372|NCT01185366|363420947|FG001|First Line Therapy|Lack of Metastatic Site|0|||
105386373|NCT01185366|363420946|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
105386374|NCT01185366|363420947|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
105386375|NCT01185366|363420946|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
105386376|NCT01185366|363420947|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
105386377|NCT01185366|363420946|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
105386378|NCT01185366|363420947|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
105386379|NCT01185366|363420946|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
105492940|NCT02445391|363817209|FG000|Overall Study|Adverse Event|0|||
105492941|NCT02445391|363817210|FG001|Overall Study|Adverse Event|21|||
105386380|NCT01185366|363420947|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
105386381|NCT00127933|363420950|FG000|Overall Study|Randomized but not dosed|1|||
105386382|NCT00127933|363420951|FG001|Overall Study|Randomized but not dosed|0|||
105386383|NCT01783938|363420952|FG000|Overall Study|Disease Progression|18|||
105386384|NCT01783938|363420953|FG001|Overall Study|Disease Progression|41|||
105386385|NCT01783938|363420952|FG000|Overall Study|Study Drug Toxicity|27|||
105386386|NCT01783938|363420953|FG001|Overall Study|Study Drug Toxicity|14|||
105386387|NCT01783938|363420952|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
105386388|NCT01783938|363420953|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
105386389|NCT01783938|363420952|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
105386390|NCT01783938|363420953|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
105386391|NCT01783938|363420952|FG000|Overall Study|Participant Withdrew Consent|2|||
105386392|NCT01783938|363420953|FG001|Overall Study|Participant Withdrew Consent|0|||
105386393|NCT01783938|363420952|FG000|Overall Study|Maximum Clinical Benefit|1|||
105386394|NCT01783938|363420953|FG001|Overall Study|Maximum Clinical Benefit|0|||
105386395|NCT01783938|363420952|FG000|Overall Study|Other Reasons|3|||
105386396|NCT01783938|363420953|FG001|Overall Study|Other Reasons|1|||
105386397|NCT00025233|363420954|FG000|Overall Study|Ineligible: wrong cell type|1|||
105386398|NCT00025233|363420954|FG000|Overall Study|Ineligible: wrong primary|1|||
105386399|NCT00025233|363420954|FG000|Overall Study|Ineligible: improper prior treatment|1|||
105386400|NCT00025233|363420954|FG000|Overall Study|Never treated|1|||
105386401|NCT03111732|363420955|FG000|Overall Study|Enrolled in different study|1|||
105386402|NCT03111732|363420955|FG000|Overall Study|Progressive disease|3|||
105386403|NCT03111732|363420955|FG000|Overall Study|Withdrawal by Subject|1|||
105386404|NCT00452400|363420956|FG000|Overall Study|Adverse Event|1|||
105386405|NCT00452400|363420957|FG001|Overall Study|Adverse Event|1|||
105386406|NCT00452400|363420958|FG002|Overall Study|Adverse Event|5|||
105386407|NCT00452400|363420959|FG003|Overall Study|Adverse Event|0|||
105386408|NCT00452400|363420960|FG004|Overall Study|Adverse Event|2|||
105386409|NCT00452400|363420956|FG000|Overall Study|Protocol Violation|0|||
105386410|NCT00452400|363420957|FG001|Overall Study|Protocol Violation|0|||
105386411|NCT00452400|363420958|FG002|Overall Study|Protocol Violation|1|||
105386412|NCT00452400|363420959|FG003|Overall Study|Protocol Violation|0|||
105386413|NCT00452400|363420960|FG004|Overall Study|Protocol Violation|0|||
105386414|NCT00452400|363420956|FG000|Overall Study|Lost to Follow-up|1|||
105386415|NCT00452400|363420957|FG001|Overall Study|Lost to Follow-up|0|||
105386416|NCT00452400|363420958|FG002|Overall Study|Lost to Follow-up|0|||
105386417|NCT00452400|363420959|FG003|Overall Study|Lost to Follow-up|0|||
105386418|NCT00452400|363420960|FG004|Overall Study|Lost to Follow-up|0|||
105386419|NCT00452400|363420956|FG000|Overall Study|Withdrawal by Subject|1|||
105386420|NCT00452400|363420957|FG001|Overall Study|Withdrawal by Subject|0|||
105386421|NCT00452400|363420958|FG002|Overall Study|Withdrawal by Subject|1|||
105386422|NCT00452400|363420959|FG003|Overall Study|Withdrawal by Subject|0|||
105386423|NCT00452400|363420960|FG004|Overall Study|Withdrawal by Subject|0|||
105386424|NCT00452400|363420956|FG000|Overall Study|Lack of Efficacy|2|||
105386425|NCT00452400|363420957|FG001|Overall Study|Lack of Efficacy|0|||
105386426|NCT00452400|363420958|FG002|Overall Study|Lack of Efficacy|0|||
105386427|NCT00452400|363420959|FG003|Overall Study|Lack of Efficacy|0|||
105386428|NCT00452400|363420960|FG004|Overall Study|Lack of Efficacy|0|||
105386429|NCT00452400|363420956|FG000|Overall Study|Other reasons not listed above|0|||
105386430|NCT00452400|363420957|FG001|Overall Study|Other reasons not listed above|0|||
105386431|NCT00452400|363420958|FG002|Overall Study|Other reasons not listed above|0|||
105386432|NCT00452400|363420959|FG003|Overall Study|Other reasons not listed above|1|||
105386433|NCT00452400|363420960|FG004|Overall Study|Other reasons not listed above|1|||
105386434|NCT00562861|363420961|FG000|Overall Study|Adverse Event|1|||
105386435|NCT00562861|363420962|FG001|Overall Study|Adverse Event|1|||
105386436|NCT00562861|363420961|FG000|Overall Study|Lack of Efficacy|5|||
105386437|NCT00562861|363420962|FG001|Overall Study|Lack of Efficacy|5|||
105386438|NCT00562861|363420961|FG000|Overall Study|noncompliance, moved|7|||
105386439|NCT00562861|363420962|FG001|Overall Study|noncompliance, moved|2|||
105386440|NCT00562861|363420961|FG000|Overall Study|Lost to Follow-up|7|||
105386441|NCT00562861|363420962|FG001|Overall Study|Lost to Follow-up|3|||
105386442|NCT01184118|363420963|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
105386443|NCT01184118|363420963|FG000|Overall Study|No physiologic confirmation of asthma|8|||
105386444|NCT01184118|363420963|FG000|Overall Study|FEV1 <60% predicted|2|||
105386445|NCT01184118|363420963|FG000|Overall Study|Exclusionary medical condition|2|||
105386446|NCT01184118|363420963|FG000|Overall Study|Withdrawal by Subject|5|||
105386447|NCT00553475|363420966|FG000|Overall Study|Adverse Event|7|||
105386448|NCT00553475|363420967|FG001|Overall Study|Adverse Event|17|||
105386449|NCT00553475|363420968|FG002|Overall Study|Adverse Event|13|||
105386450|NCT00553475|363420966|FG000|Overall Study|Lack of Efficacy|7|||
105386451|NCT00553475|363420967|FG001|Overall Study|Lack of Efficacy|1|||
105386452|NCT00553475|363420968|FG002|Overall Study|Lack of Efficacy|0|||
105386453|NCT00553475|363420966|FG000|Overall Study|Withdrawal by Subject|1|||
105386454|NCT00553475|363420967|FG001|Overall Study|Withdrawal by Subject|1|||
105386455|NCT00553475|363420968|FG002|Overall Study|Withdrawal by Subject|0|||
105386456|NCT00553475|363420966|FG000|Overall Study|Physician Decision|1|||
105386457|NCT00553475|363420967|FG001|Overall Study|Physician Decision|0|||
105386458|NCT00553475|363420968|FG002|Overall Study|Physician Decision|0|||
105386459|NCT00553475|363420966|FG000|Overall Study|Due to moving|0|||
105492942|NCT02445391|363817211|FG002|Overall Study|Adverse Event|12|||
105386460|NCT00553475|363420967|FG001|Overall Study|Due to moving|1|||
105386461|NCT00553475|363420968|FG002|Overall Study|Due to moving|0|||
105386462|NCT01694771|363420969|FG000|Overall Study|Adverse Event|18|||
105386463|NCT01694771|363420970|FG001|Overall Study|Adverse Event|16|||
105386464|NCT01694771|363420969|FG000|Overall Study|Lack of Efficacy|1|||
105386465|NCT01694771|363420970|FG001|Overall Study|Lack of Efficacy|0|||
105386466|NCT01694771|363420969|FG000|Overall Study|Non compliance protocol|7|||
105386467|NCT01694771|363420970|FG001|Overall Study|Non compliance protocol|6|||
105386468|NCT01694771|363420969|FG000|Overall Study|Lost to Follow-up|2|||
105386469|NCT01694771|363420970|FG001|Overall Study|Lost to Follow-up|3|||
105386470|NCT01694771|363420969|FG000|Overall Study|Consent withdrawn|7|||
105386471|NCT01694771|363420970|FG001|Overall Study|Consent withdrawn|9|||
105386472|NCT01694771|363420969|FG000|Overall Study|Other reasons|5|||
105386473|NCT01694771|363420970|FG001|Overall Study|Other reasons|6|||
105386474|NCT00800384|363420971|FG000|Overall Study|Withdrawal by Subject|24|||
105386475|NCT00800384|363420972|FG001|Overall Study|Withdrawal by Subject|17|||
105386476|NCT00800384|363420971|FG000|Overall Study|Lost to Follow-up|17|||
105386477|NCT00800384|363420972|FG001|Overall Study|Lost to Follow-up|26|||
105386478|NCT02186171|363420973|FG000|Overall Study|Withdrawal by Subject|1|||
105386479|NCT02186171|363420974|FG001|Overall Study|Withdrawal by Subject|9|||
105386480|NCT02186171|363420973|FG000|Overall Study|Lost to Follow-up|2|||
105386481|NCT02186171|363420974|FG001|Overall Study|Lost to Follow-up|2|||
105386482|NCT02186171|363420973|FG000|Overall Study|Death|1|||
105386483|NCT02186171|363420974|FG001|Overall Study|Death|2|||
105386484|NCT02186171|363420973|FG000|Overall Study|Protocol-specified Criteria|0|||
105386485|NCT02186171|363420974|FG001|Overall Study|Protocol-specified Criteria|2|||
105386486|NCT02946996|363420977|FG000|Overall Study|non-evaluable|3|||
105386487|NCT02946996|363420978|FG001|Overall Study|non-evaluable|6|||
105386488|NCT02946996|363420979|FG002|Overall Study|non-evaluable|5|||
105386489|NCT00992394|363420982|FG000|Overall Study|Lack of Efficacy|6|||
105386490|NCT00992394|363420983|FG001|Overall Study|Lack of Efficacy|3|||
105386491|NCT00992394|363420982|FG000|Overall Study|Adverse Event|4|||
105386492|NCT00992394|363420983|FG001|Overall Study|Adverse Event|5|||
105386493|NCT00992394|363420982|FG000|Overall Study|Withdrawal by Subject|8|||
105386494|NCT00992394|363420983|FG001|Overall Study|Withdrawal by Subject|2|||
105386495|NCT00992394|363420982|FG000|Overall Study|Physician Decision|1|||
105386496|NCT00992394|363420983|FG001|Overall Study|Physician Decision|0|||
105386497|NCT00992394|363420982|FG000|Overall Study|Protocol Violation|2|||
105386498|NCT00992394|363420983|FG001|Overall Study|Protocol Violation|4|||
105386499|NCT00992394|363420982|FG000|Overall Study|Lost to Follow-up|2|||
105386500|NCT00992394|363420983|FG001|Overall Study|Lost to Follow-up|0|||
105386501|NCT00992394|363420982|FG000|Overall Study|Other event|1|||
105386502|NCT00992394|363420983|FG001|Overall Study|Other event|0|||
105386503|NCT02151604|363420984|FG000|Overall Study|Lost to Follow-up|3|||
105386504|NCT02151604|363420984|FG000|Overall Study|Withdrawal by Subject|2|||
105386505|NCT02151604|363420984|FG000|Overall Study|Physician Decision|3|||
105386506|NCT02151604|363420984|FG000|Overall Study|Death|1|||
105386507|NCT00537082|363420985|FG000|Overall Study|Adverse Event|6|||
105386508|NCT00537082|363420986|FG001|Overall Study|Adverse Event|6|||
105386509|NCT00537082|363420987|FG002|Overall Study|Adverse Event|3|||
105386510|NCT00537082|363420985|FG000|Overall Study|Protocol Violation|0|||
105386511|NCT00537082|363420986|FG001|Overall Study|Protocol Violation|2|||
105386512|NCT00537082|363420987|FG002|Overall Study|Protocol Violation|1|||
105386513|NCT00537082|363420985|FG000|Overall Study|Lack of Efficacy|0|||
105386514|NCT00537082|363420986|FG001|Overall Study|Lack of Efficacy|0|||
105386515|NCT00537082|363420987|FG002|Overall Study|Lack of Efficacy|2|||
105386516|NCT00537082|363420985|FG000|Overall Study|Withdrawal by Subject|0|||
105386517|NCT00537082|363420986|FG001|Overall Study|Withdrawal by Subject|1|||
105386518|NCT00537082|363420987|FG002|Overall Study|Withdrawal by Subject|0|||
105386519|NCT00537082|363420985|FG000|Overall Study|Discontinued before initiating treatment|3|||
105386520|NCT00537082|363420986|FG001|Overall Study|Discontinued before initiating treatment|0|||
105386521|NCT00537082|363420987|FG002|Overall Study|Discontinued before initiating treatment|0|||
105492943|NCT02445391|363817209|FG000|Overall Study|Alternative therapy|0|||
105386522|NCT03882801|363422447|FG000|Period 1|Adverse Event|0|||
105386523|NCT03882801|363422448|FG001|Period 1|Adverse Event|1|||
105386524|NCT03882801|363422447|FG000|Period 1|Non-compliance with study drug|1|||
105492944|NCT02445391|363817210|FG001|Overall Study|Alternative therapy|0|||
105492945|NCT02445391|363817211|FG002|Overall Study|Alternative therapy|1|||
105386525|NCT03882801|363422448|FG001|Period 1|Non-compliance with study drug|1|||
105386526|NCT03882801|363422447|FG000|Period 1|Never treated with study drug|1|||
105386527|NCT03882801|363422448|FG001|Period 1|Never treated with study drug|0|||
105386528|NCT03882801|363422447|FG000|Washout Period|Physician Decision|0|||
105386529|NCT03882801|363422448|FG001|Washout Period|Physician Decision|1|||
105386530|NCT03882801|363422447|FG000|Period 2|Non-compliance with study drug|0|||
105386531|NCT03882801|363422448|FG001|Period 2|Non-compliance with study drug|1|||
105386532|NCT04971837|363422449|FG000|Overall Study|Long Term Illness|1|||
105386533|NCT04971837|363422449|FG000|Overall Study|BMI too low|9|||
105386534|NCT04971837|363422449|FG000|Overall Study|geographic location|1|||
105386535|NCT04971837|363422449|FG000|Overall Study|Discontinued scheduling conflict|1|||
105386536|NCT05206604|363422450|FG000|Overall Study|Non-compliance with study drug|0|||
105386537|NCT05206604|363422451|FG001|Overall Study|Non-compliance with study drug|0|||
105386538|NCT05206604|363422452|FG002|Overall Study|Non-compliance with study drug|0|||
105386539|NCT05206604|363422453|FG003|Overall Study|Non-compliance with study drug|0|||
105386540|NCT05206604|363422454|FG004|Overall Study|Non-compliance with study drug|0|||
105386541|NCT05206604|363422455|FG005|Overall Study|Non-compliance with study drug|1|||
105386542|NCT05206604|363422456|FG006|Overall Study|Non-compliance with study drug|0|||
105386543|NCT05206604|363422457|FG007|Overall Study|Non-compliance with study drug|0|||
105386544|NCT03735498|363422458|FG000|Overall Study|Withdrawal by Subject|3|||
105386545|NCT03735498|363422458|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
105386546|NCT03787212|363422460|FG000|Period 1|Study Termination|2|||
105386547|NCT03787212|363422461|FG001|Period 1|Study Termination|2|||
105386548|NCT02014103|363422462|FG000|Overall Study|Protocol Violation|7|||
105386549|NCT02014103|363422463|FG001|Overall Study|Protocol Violation|7|||
105386550|NCT02014103|363422462|FG000|Overall Study|Adverse Event|1|||
105386551|NCT02014103|363422463|FG001|Overall Study|Adverse Event|0|||
105386552|NCT02014103|363422462|FG000|Overall Study|Lost venous access|1|||
105386553|NCT02014103|363422463|FG001|Overall Study|Lost venous access|0|||
105386554|NCT02014103|363422462|FG000|Overall Study|Withdrawal by Subject|0|||
105386555|NCT02014103|363422463|FG001|Overall Study|Withdrawal by Subject|2|||
105386556|NCT00620035|363422466|FG000|Overall Study|Adverse Event|106|||
105386557|NCT00620035|363422466|FG000|Overall Study|Withdrawal of Informed Consent|1|||
105386558|NCT00620035|363422466|FG000|Overall Study|Other Reason|38|||
105386559|NCT01027754|363422468|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
105386560|NCT01027754|363422469|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
105386561|NCT01027754|363422468|FG000|Overall Study|Withdrawal by Subject|0|||
105386562|NCT01027754|363422469|FG001|Overall Study|Withdrawal by Subject|5|||
105386563|NCT01629563|363422470|FG000|Overall Study|Adverse Event|16|||
105386564|NCT01629563|363422471|FG001|Overall Study|Adverse Event|16|||
105386565|NCT01629563|363422470|FG000|Overall Study|Death|2|||
105386566|NCT01629563|363422471|FG001|Overall Study|Death|0|||
105386567|NCT01629563|363422470|FG000|Overall Study|Lack of Efficacy|2|||
105386568|NCT01629563|363422471|FG001|Overall Study|Lack of Efficacy|3|||
105386569|NCT01629563|363422470|FG000|Overall Study|Lost to Follow-up|1|||
105386570|NCT01629563|363422471|FG001|Overall Study|Lost to Follow-up|0|||
105386571|NCT01629563|363422470|FG000|Overall Study|Pregnancy|1|||
105386572|NCT01629563|363422471|FG001|Overall Study|Pregnancy|2|||
105386573|NCT01629563|363422470|FG000|Overall Study|Protocol Violation|0|||
105386574|NCT01629563|363422471|FG001|Overall Study|Protocol Violation|1|||
105386575|NCT01629563|363422470|FG000|Overall Study|Withdrawal by Subject|27|||
105386576|NCT01629563|363422471|FG001|Overall Study|Withdrawal by Subject|20|||
105386577|NCT01629563|363422470|FG000|Overall Study|surgery|0|||
105386578|NCT01629563|363422471|FG001|Overall Study|surgery|3|||
105386579|NCT01629563|363422470|FG000|Overall Study|Lack of return of menses|12|||
105386580|NCT01629563|363422471|FG001|Overall Study|Lack of return of menses|7|||
105386581|NCT01629563|363422470|FG000|Overall Study|Protocol Violation|0|||
105386582|NCT01629563|363422471|FG001|Overall Study|Protocol Violation|1|||
105386583|NCT01699685|363422476|FG000|Period 1|Adverse Event|1|||
105386584|NCT01699685|363422477|FG001|Period 1|Adverse Event|1|||
105386585|NCT01699685|363422476|FG000|Period 1|Medical or ethical, noncompliance|2|||
105386586|NCT01699685|363422477|FG001|Period 1|Medical or ethical, noncompliance|0|||
105386587|NCT01699685|363422476|FG000|Period 1|Other|0|||
105386588|NCT01699685|363422477|FG001|Period 1|Other|1|||
105386589|NCT01699685|363422476|FG000|Period 1|Patient request|0|||
105386590|NCT01699685|363422477|FG001|Period 1|Patient request|1|||
105386591|NCT01699685|363422476|FG000|Period 2|Lost to Follow-up|1|||
105386592|NCT01699685|363422477|FG001|Period 2|Lost to Follow-up|0|||
105386593|NCT02181621|363422478|FG000|Overall Study|Adverse Event|1|||
105386594|NCT02181621|363422479|FG001|Overall Study|Adverse Event|0|||
105386595|NCT02181621|363422478|FG000|Overall Study|Previously Enrolled|0|||
105386596|NCT02181621|363422479|FG001|Overall Study|Previously Enrolled|1|||
105386597|NCT02181621|363422478|FG000|Overall Study|Enrollment Hold|1|||
105386598|NCT02181621|363422479|FG001|Overall Study|Enrollment Hold|1|||
105386599|NCT02802865|363422480|FG000|Overall Study|Pregnancy|1|||
105386600|NCT02802865|363422481|FG001|Overall Study|Pregnancy|1|||
105386601|NCT02802865|363422480|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
105386602|NCT02802865|363422481|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
105386603|NCT03931785|363422482|FG000|Overall Study|Lost to Follow-up|4|||
105386604|NCT03931785|363422483|FG001|Overall Study|Lost to Follow-up|1|||
105386605|NCT03931785|363422484|FG002|Overall Study|Lost to Follow-up|4|||
105386606|NCT03931785|363422485|FG003|Overall Study|Lost to Follow-up|3|||
105386607|NCT03931785|363422482|FG000|Overall Study|Adverse Event|1|||
105386608|NCT03931785|363422483|FG001|Overall Study|Adverse Event|0|||
105580548|NCT02018861|364126448|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
105386609|NCT03931785|363422484|FG002|Overall Study|Adverse Event|3|||
105386610|NCT03931785|363422485|FG003|Overall Study|Adverse Event|4|||
105386611|NCT03931785|363422482|FG000|Overall Study|Protocol Violation|0|||
105386612|NCT03931785|363422483|FG001|Overall Study|Protocol Violation|1|||
105386613|NCT03931785|363422484|FG002|Overall Study|Protocol Violation|0|||
105386614|NCT03931785|363422485|FG003|Overall Study|Protocol Violation|0|||
105386615|NCT03931785|363422482|FG000|Overall Study|Noncompliance With Study drug|0|||
105386616|NCT03931785|363422483|FG001|Overall Study|Noncompliance With Study drug|1|||
105386617|NCT03931785|363422484|FG002|Overall Study|Noncompliance With Study drug|0|||
105386618|NCT03931785|363422485|FG003|Overall Study|Noncompliance With Study drug|0|||
105386619|NCT03931785|363422482|FG000|Overall Study|Other Not specified|0|||
105386620|NCT03931785|363422483|FG001|Overall Study|Other Not specified|2|||
105386621|NCT03931785|363422484|FG002|Overall Study|Other Not specified|2|||
105386622|NCT03931785|363422485|FG003|Overall Study|Other Not specified|2|||
105386623|NCT03931785|363422482|FG000|Overall Study|Withdrawal by Subject|0|||
105386624|NCT03931785|363422483|FG001|Overall Study|Withdrawal by Subject|2|||
105386625|NCT03931785|363422484|FG002|Overall Study|Withdrawal by Subject|4|||
105386626|NCT03931785|363422485|FG003|Overall Study|Withdrawal by Subject|1|||
105386627|NCT03931785|363422482|FG000|Overall Study|Pregnancy|0|||
105386628|NCT03931785|363422483|FG001|Overall Study|Pregnancy|0|||
105386629|NCT03931785|363422484|FG002|Overall Study|Pregnancy|0|||
105386630|NCT03931785|363422485|FG003|Overall Study|Pregnancy|1|||
105386631|NCT01803737|363422486|FG000|Overall Study|Lack of Time|1|||
105386632|NCT01803737|363422487|FG001|Overall Study|Lack of Time|0|||
105386633|NCT01803737|363422486|FG000|Overall Study|Medical Reason|0|||
105386634|NCT01803737|363422487|FG001|Overall Study|Medical Reason|1|||
105386635|NCT01803737|363422486|FG000|Overall Study|Lost to Follow-up|0|||
105386636|NCT01803737|363422487|FG001|Overall Study|Lost to Follow-up|2|||
105386637|NCT02596893|363422490|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
105386638|NCT02596893|363422491|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
105386639|NCT02596893|363422492|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
105386640|NCT02596893|363422493|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
105386641|NCT02596893|363422490|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
105386642|NCT02596893|363422491|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
105386643|NCT02596893|363422492|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
105386644|NCT02596893|363422493|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
105386645|NCT02596893|363422490|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
105386646|NCT02596893|363422491|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
105386647|NCT02596893|363422492|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
105386648|NCT02596893|363422493|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
105386649|NCT02596893|363422490|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
105386650|NCT02596893|363422491|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
105386651|NCT02596893|363422492|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
105386652|NCT02596893|363422493|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
105386653|NCT02596893|363422490|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
105386654|NCT02596893|363422491|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
105386655|NCT02596893|363422492|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
105386656|NCT02596893|363422493|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
105386657|NCT02596893|363422490|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
105386658|NCT02596893|363422491|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
105386659|NCT02596893|363422492|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
105386660|NCT02596893|363422493|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
105386661|NCT02596893|363422490|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
105386662|NCT02596893|363422491|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
105386663|NCT02596893|363422492|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
105386664|NCT02596893|363422493|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
105386665|NCT02596893|363422490|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
105386666|NCT02596893|363422491|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
105386667|NCT02596893|363422492|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
105386668|NCT02596893|363422493|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
105386669|NCT02596893|363422490|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
105386670|NCT02596893|363422491|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
105386671|NCT02596893|363422492|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
105386672|NCT02596893|363422493|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
105386673|NCT02596893|363422490|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
105386674|NCT02596893|363422491|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
105386675|NCT02596893|363422492|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
105386676|NCT02596893|363422493|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
105386677|NCT02596893|363422490|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
105386678|NCT02596893|363422491|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
105386679|NCT02596893|363422492|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
105386680|NCT02596893|363422493|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
105386681|NCT00004228|363422496|FG000|Overall Study|Adverse Event|0|||
105386682|NCT00004228|363422497|FG001|Overall Study|Adverse Event|1|||
105386683|NCT00004228|363422498|FG002|Overall Study|Adverse Event|0|||
105386684|NCT00004228|363422499|FG003|Overall Study|Adverse Event|0|||
105386685|NCT00004228|363422500|FG004|Overall Study|Adverse Event|1|||
105386686|NCT00004228|363422501|FG005|Overall Study|Adverse Event|0|||
105386687|NCT00004228|363422502|FG006|Overall Study|Adverse Event|0|||
105386688|NCT00004228|363422496|FG000|Overall Study|Death|0|||
105386689|NCT00004228|363422497|FG001|Overall Study|Death|1|||
105386690|NCT00004228|363422498|FG002|Overall Study|Death|2|||
105386691|NCT00004228|363422499|FG003|Overall Study|Death|0|||
105386692|NCT00004228|363422500|FG004|Overall Study|Death|1|||
105386693|NCT00004228|363422501|FG005|Overall Study|Death|0|||
105386694|NCT00004228|363422502|FG006|Overall Study|Death|0|||
105386695|NCT00004228|363422496|FG000|Overall Study|Lack of Efficacy|1|||
105386696|NCT00004228|363422497|FG001|Overall Study|Lack of Efficacy|6|||
105386697|NCT00004228|363422498|FG002|Overall Study|Lack of Efficacy|5|||
105386698|NCT00004228|363422499|FG003|Overall Study|Lack of Efficacy|3|||
105386699|NCT00004228|363422500|FG004|Overall Study|Lack of Efficacy|9|||
105386700|NCT00004228|363422501|FG005|Overall Study|Lack of Efficacy|8|||
105386701|NCT00004228|363422502|FG006|Overall Study|Lack of Efficacy|4|||
105386702|NCT00004228|363422496|FG000|Overall Study|Lost to Follow-up|0|||
105386703|NCT00004228|363422497|FG001|Overall Study|Lost to Follow-up|0|||
105386704|NCT00004228|363422498|FG002|Overall Study|Lost to Follow-up|1|||
105386705|NCT00004228|363422499|FG003|Overall Study|Lost to Follow-up|0|||
105386706|NCT00004228|363422500|FG004|Overall Study|Lost to Follow-up|0|||
105386707|NCT00004228|363422501|FG005|Overall Study|Lost to Follow-up|0|||
105386708|NCT00004228|363422502|FG006|Overall Study|Lost to Follow-up|0|||
105386709|NCT00004228|363422496|FG000|Overall Study|Physician Decision|1|||
105386710|NCT00004228|363422497|FG001|Overall Study|Physician Decision|0|||
105386711|NCT00004228|363422498|FG002|Overall Study|Physician Decision|3|||
105386712|NCT00004228|363422499|FG003|Overall Study|Physician Decision|2|||
105386713|NCT00004228|363422500|FG004|Overall Study|Physician Decision|1|||
105386714|NCT00004228|363422501|FG005|Overall Study|Physician Decision|1|||
105386715|NCT00004228|363422502|FG006|Overall Study|Physician Decision|1|||
105386716|NCT00004228|363422496|FG000|Overall Study|Protocol Violation|0|||
105386717|NCT00004228|363422497|FG001|Overall Study|Protocol Violation|5|||
105386718|NCT00004228|363422498|FG002|Overall Study|Protocol Violation|2|||
105386719|NCT00004228|363422499|FG003|Overall Study|Protocol Violation|1|||
105386720|NCT00004228|363422500|FG004|Overall Study|Protocol Violation|1|||
105386721|NCT00004228|363422501|FG005|Overall Study|Protocol Violation|2|||
105386722|NCT00004228|363422502|FG006|Overall Study|Protocol Violation|0|||
105386723|NCT00004228|363422496|FG000|Overall Study|Withdrawal by Subject|3|||
105386724|NCT00004228|363422497|FG001|Overall Study|Withdrawal by Subject|0|||
105386725|NCT00004228|363422498|FG002|Overall Study|Withdrawal by Subject|1|||
105386726|NCT00004228|363422499|FG003|Overall Study|Withdrawal by Subject|0|||
105386727|NCT00004228|363422500|FG004|Overall Study|Withdrawal by Subject|2|||
105386728|NCT00004228|363422501|FG005|Overall Study|Withdrawal by Subject|1|||
105386729|NCT00004228|363422502|FG006|Overall Study|Withdrawal by Subject|2|||
105386730|NCT00004228|363422496|FG000|Overall Study|Other|0|||
105386731|NCT00004228|363422497|FG001|Overall Study|Other|0|||
105386732|NCT00004228|363422498|FG002|Overall Study|Other|1|||
105386733|NCT00004228|363422499|FG003|Overall Study|Other|0|||
105386734|NCT00004228|363422500|FG004|Overall Study|Other|0|||
105386735|NCT00004228|363422501|FG005|Overall Study|Other|0|||
105386736|NCT00004228|363422502|FG006|Overall Study|Other|0|||
105386737|NCT00004228|363422496|FG000|Overall Study|ineligible|4|||
105386738|NCT00004228|363422497|FG001|Overall Study|ineligible|2|||
105386739|NCT00004228|363422498|FG002|Overall Study|ineligible|4|||
105386740|NCT00004228|363422499|FG003|Overall Study|ineligible|1|||
105386741|NCT00004228|363422500|FG004|Overall Study|ineligible|1|||
105386742|NCT00004228|363422501|FG005|Overall Study|ineligible|2|||
105386743|NCT00004228|363422502|FG006|Overall Study|ineligible|5|||
105386744|NCT01013870|363422503|FG000|Overall Study|Lost to Follow-up|1|||
105386745|NCT01013870|363422504|FG001|Overall Study|Lost to Follow-up|3|||
105386746|NCT02502383|363422505|FG000|Overall Study|Lost to Follow-up|130|||
105386747|NCT02502383|363422506|FG001|Overall Study|Lost to Follow-up|131|||
105386748|NCT02502383|363422505|FG000|Overall Study|Withdrawal by Subject|31|||
105386749|NCT02502383|363422506|FG001|Overall Study|Withdrawal by Subject|24|||
105386750|NCT00432991|363422507|FG000|Overall Study|Protocol Violation|7|||
105386751|NCT00432991|363422508|FG001|Overall Study|Protocol Violation|12|||
105386752|NCT01292473|363422513|FG000|Overall Study|Adverse Event|1|||
105386753|NCT01292473|363422514|FG001|Overall Study|Adverse Event|0|||
105386754|NCT01292473|363422515|FG002|Overall Study|Adverse Event|1|||
105386755|NCT01292473|363422516|FG003|Overall Study|Adverse Event|1|||
105386756|NCT01292473|363422513|FG000|Overall Study|Lost to Follow-up|1|||
105386757|NCT01292473|363422514|FG001|Overall Study|Lost to Follow-up|1|||
105386758|NCT01292473|363422515|FG002|Overall Study|Lost to Follow-up|2|||
105386759|NCT01292473|363422516|FG003|Overall Study|Lost to Follow-up|2|||
105386760|NCT01292473|363422513|FG000|Overall Study|Withdrawal by Subject|3|||
105386761|NCT01292473|363422514|FG001|Overall Study|Withdrawal by Subject|4|||
105386762|NCT01292473|363422515|FG002|Overall Study|Withdrawal by Subject|3|||
105386763|NCT01292473|363422516|FG003|Overall Study|Withdrawal by Subject|3|||
105386764|NCT01292473|363422513|FG000|Overall Study|Physician Decision|0|||
105386765|NCT01292473|363422514|FG001|Overall Study|Physician Decision|1|||
105386766|NCT01292473|363422515|FG002|Overall Study|Physician Decision|0|||
105386767|NCT01292473|363422516|FG003|Overall Study|Physician Decision|0|||
105386768|NCT01292473|363422513|FG000|Overall Study|Disease Progression|0|||
105386769|NCT01292473|363422514|FG001|Overall Study|Disease Progression|1|||
105386770|NCT01292473|363422515|FG002|Overall Study|Disease Progression|3|||
105386771|NCT01292473|363422516|FG003|Overall Study|Disease Progression|6|||
105386772|NCT00348374|363422517|FG000|Overall Study|Adverse Event|1|||
105386773|NCT00348374|363422518|FG001|Overall Study|Adverse Event|4|||
105386774|NCT00348374|363422517|FG000|Overall Study|Lost to Follow-up|1|||
105386775|NCT00348374|363422518|FG001|Overall Study|Lost to Follow-up|3|||
105386776|NCT00348374|363422517|FG000|Overall Study|Withdrawal by Subject|5|||
105386777|NCT00348374|363422518|FG001|Overall Study|Withdrawal by Subject|5|||
105386778|NCT00348374|363422517|FG000|Overall Study|Other|11|||
105386779|NCT00348374|363422518|FG001|Overall Study|Other|12|||
105386780|NCT00348374|363422517|FG000|Overall Study|ongoing at date of cutoff|1|||
105386781|NCT00348374|363422518|FG001|Overall Study|ongoing at date of cutoff|1|||
105386782|NCT00348374|363422517|FG000|Overall Study|randomized but did not receive treatment|0|||
105386783|NCT00348374|363422518|FG001|Overall Study|randomized but did not receive treatment|7|||
105386784|NCT02242903|363422532|FG000|Overall Study|Withdrawal by Subject|1|||
105386785|NCT02242903|363422533|FG001|Overall Study|Withdrawal by Subject|0|||
105386786|NCT02242903|363422534|FG002|Overall Study|Withdrawal by Subject|0|||
105386787|NCT02242903|363422535|FG003|Overall Study|Withdrawal by Subject|0|||
105386788|NCT02242903|363422536|FG004|Overall Study|Withdrawal by Subject|0|||
105386789|NCT02242903|363422537|FG005|Overall Study|Withdrawal by Subject|0|||
105386790|NCT02242903|363422538|FG006|Overall Study|Withdrawal by Subject|0|||
105386791|NCT01975285|363422541|FG000|Overall Study|Failed Block and follow up|2|||
105386792|NCT01975285|363422542|FG001|Overall Study|Failed Block and follow up|2|||
105386793|NCT04914000|363422543|FG000|Overall Study|Lost to Follow-up|8|||
105386794|NCT04914000|363422543|FG000|Overall Study|Withdrawal by Subject|1|||
105386795|NCT00981175|363422544|FG000|Primary Dose Vaccination|Adverse Event|1|||
105386796|NCT00981175|363422545|FG001|Primary Dose Vaccination|Adverse Event|0|||
105386797|NCT00981175|363422544|FG000|Primary Dose Vaccination|Protocol Violation|0|||
105386798|NCT00981175|363422545|FG001|Primary Dose Vaccination|Protocol Violation|1|||
105386799|NCT00981175|363422544|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
105386800|NCT00981175|363422545|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
105386801|NCT00981175|363422544|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
105386802|NCT00981175|363422545|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
105386803|NCT04189588|363422546|FG000|Overall Study|Death|0|||
105386804|NCT04189588|363422547|FG001|Overall Study|Death|1|||
105386805|NCT04189588|363422546|FG000|Overall Study|Lost to Follow-up|0|||
105386806|NCT04189588|363422547|FG001|Overall Study|Lost to Follow-up|1|||
105386807|NCT04641975|363422552|FG000|Overall Study|Protocol Violation|1|||
105386808|NCT04641975|363422553|FG001|Overall Study|Protocol Violation|2|||
105386809|NCT04641975|363422554|FG002|Overall Study|Protocol Violation|0|||
105386810|NCT04641975|363422555|FG003|Overall Study|Protocol Violation|0|||
105386811|NCT04641975|363422552|FG000|Overall Study|Adverse Event|0|||
105386812|NCT04641975|363422553|FG001|Overall Study|Adverse Event|0|||
105386813|NCT04641975|363422554|FG002|Overall Study|Adverse Event|1|||
105386814|NCT04641975|363422555|FG003|Overall Study|Adverse Event|1|||
105386815|NCT04641975|363422552|FG000|Overall Study|Withdrawal by Subject|1|||
105386816|NCT04641975|363422553|FG001|Overall Study|Withdrawal by Subject|0|||
105386817|NCT04641975|363422554|FG002|Overall Study|Withdrawal by Subject|0|||
105386818|NCT04641975|363422555|FG003|Overall Study|Withdrawal by Subject|0|||
105386819|NCT00066170|363422556|FG000|Overall Study|Adverse Event|2|||
105386820|NCT00066170|363422557|FG001|Overall Study|Adverse Event|4|||
105386821|NCT00066170|363422558|FG002|Overall Study|Adverse Event|1|||
105386822|NCT00066170|363422559|FG003|Overall Study|Adverse Event|7|||
105386823|NCT00066170|363422556|FG000|Overall Study|Serious Adverse Event|0|||
105386824|NCT00066170|363422557|FG001|Overall Study|Serious Adverse Event|0|||
105386825|NCT00066170|363422558|FG002|Overall Study|Serious Adverse Event|1|||
105386826|NCT00066170|363422559|FG003|Overall Study|Serious Adverse Event|1|||
105386827|NCT00066170|363422556|FG000|Overall Study|Lost to Follow-up|0|||
105386828|NCT00066170|363422557|FG001|Overall Study|Lost to Follow-up|1|||
105386829|NCT00066170|363422558|FG002|Overall Study|Lost to Follow-up|0|||
105386830|NCT00066170|363422559|FG003|Overall Study|Lost to Follow-up|0|||
105386831|NCT00066170|363422556|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
105386832|NCT00066170|363422557|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
105386833|NCT00066170|363422558|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
105386834|NCT00066170|363422559|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
105386835|NCT00066170|363422556|FG000|Overall Study|Protocol Violation|3|||
105386836|NCT00066170|363422557|FG001|Overall Study|Protocol Violation|0|||
105386837|NCT00066170|363422558|FG002|Overall Study|Protocol Violation|0|||
105386838|NCT00066170|363422559|FG003|Overall Study|Protocol Violation|0|||
105386839|NCT00066170|363422556|FG000|Overall Study|Other|1|||
105386840|NCT00066170|363422557|FG001|Overall Study|Other|5|||
105386841|NCT00066170|363422558|FG002|Overall Study|Other|2|||
105386842|NCT00066170|363422559|FG003|Overall Study|Other|0|||
105386843|NCT00366535|363422560|FG000|First Phase: 12 Weeks|Adverse Event|1|||
105386844|NCT00366535|363422561|FG001|First Phase: 12 Weeks|Adverse Event|3|||
105386845|NCT00366535|363422560|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
105386846|NCT00366535|363422561|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
105386847|NCT00366535|363422560|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
105386848|NCT00366535|363422561|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
105386849|NCT00366535|363422560|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
105386850|NCT00366535|363422561|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
105386851|NCT00563316|363422562|FG000|Overall Study|Adverse Event|2|||
105386852|NCT00563316|363422562|FG000|Overall Study|Physician Decision|1|||
105386853|NCT00563316|363422562|FG000|Overall Study|Lost to Follow-up|2|||
105386854|NCT00563316|363422562|FG000|Overall Study|Death|1|||
105386855|NCT00563316|363422562|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
105386856|NCT00563316|363422562|FG000|Overall Study|Other|1|||
105386857|NCT01065766|363422563|FG000|Overall Study|Assessed before the contracted date|1|||
105386858|NCT01065766|363422563|FG000|Overall Study|Contraindication to administration|6|||
105386859|NCT01065766|363422563|FG000|Overall Study|Violated dosage/administration|25|||
105386860|NCT01608308|363422565|FG000|Overall Study|pretreatment medical and billing reasons|0|||
105386861|NCT01608308|363422566|FG001|Overall Study|pretreatment medical and billing reasons|2|||
105386862|NCT01725308|363422568|FG000|Treatment Period I|Did Not Receive Drug|1|||
105386863|NCT01725308|363422569|FG001|Treatment Period I|Did Not Receive Drug|0|||
105386864|NCT01725308|363422570|FG002|Treatment Period I|Did Not Receive Drug|0|||
105386865|NCT01725308|363422568|FG000|Treatment Period I|Adverse Event|5|||
105386866|NCT01725308|363422569|FG001|Treatment Period I|Adverse Event|4|||
105386867|NCT01725308|363422570|FG002|Treatment Period I|Adverse Event|21|||
105386868|NCT01725308|363422568|FG000|Treatment Period I|Insufficient Response|7|||
105386869|NCT01725308|363422569|FG001|Treatment Period I|Insufficient Response|0|||
105386870|NCT01725308|363422570|FG002|Treatment Period I|Insufficient Response|5|||
105386871|NCT01725308|363422568|FG000|Treatment Period I|Worsening of the Target Disease|8|||
105386872|NCT01725308|363422569|FG001|Treatment Period I|Worsening of the Target Disease|0|||
105386873|NCT01725308|363422570|FG002|Treatment Period I|Worsening of the Target Disease|2|||
105386874|NCT01725308|363422568|FG000|Treatment Period I|Changes in the Episodes|3|||
105386875|NCT01725308|363422569|FG001|Treatment Period I|Changes in the Episodes|0|||
105386876|NCT01725308|363422570|FG002|Treatment Period I|Changes in the Episodes|2|||
105386877|NCT01725308|363422568|FG000|Treatment Period I|Withdrawal of Consent|12|||
105386878|NCT01725308|363422569|FG001|Treatment Period I|Withdrawal of Consent|7|||
105386879|NCT01725308|363422570|FG002|Treatment Period I|Withdrawal of Consent|5|||
105386880|NCT01725308|363422568|FG000|Treatment Period I|Lost to Follow-up|3|||
105386881|NCT01725308|363422569|FG001|Treatment Period I|Lost to Follow-up|2|||
105386882|NCT01725308|363422570|FG002|Treatment Period I|Lost to Follow-up|2|||
105386883|NCT01725308|363422568|FG000|Treatment Period I|Protocol Deviations|3|||
105386884|NCT01725308|363422569|FG001|Treatment Period I|Protocol Deviations|1|||
105386885|NCT01725308|363422570|FG002|Treatment Period I|Protocol Deviations|1|||
105386886|NCT01725308|363422568|FG000|Treatment Period I|Miscellaneous|2|||
105386887|NCT01725308|363422569|FG001|Treatment Period I|Miscellaneous|0|||
105386888|NCT01725308|363422570|FG002|Treatment Period I|Miscellaneous|3|||
105386889|NCT01725308|363422568|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
105386890|NCT01725308|363422569|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
105386891|NCT01725308|363422570|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
105386892|NCT01725308|363422568|FG000|Treatment Period II|Did Not Receive Drug|4|||
105386893|NCT01725308|363422569|FG001|Treatment Period II|Did Not Receive Drug|0|||
105386894|NCT01725308|363422570|FG002|Treatment Period II|Did Not Receive Drug|0|||
105386895|NCT01725308|363422568|FG000|Treatment Period II|Adverse Event|13|||
105386896|NCT01725308|363422569|FG001|Treatment Period II|Adverse Event|8|||
105386897|NCT01725308|363422570|FG002|Treatment Period II|Adverse Event|20|||
105386898|NCT01725308|363422568|FG000|Treatment Period II|Insufficient Response|2|||
105386899|NCT01725308|363422569|FG001|Treatment Period II|Insufficient Response|4|||
105386900|NCT01725308|363422570|FG002|Treatment Period II|Insufficient Response|6|||
105386901|NCT01725308|363422568|FG000|Treatment Period II|Worsening of the Target Disease|1|||
105386902|NCT01725308|363422569|FG001|Treatment Period II|Worsening of the Target Disease|4|||
105386903|NCT01725308|363422570|FG002|Treatment Period II|Worsening of the Target Disease|2|||
105386904|NCT01725308|363422568|FG000|Treatment Period II|Changes in the Episodes|1|||
105386905|NCT01725308|363422569|FG001|Treatment Period II|Changes in the Episodes|0|||
105386906|NCT01725308|363422570|FG002|Treatment Period II|Changes in the Episodes|5|||
105386907|NCT01725308|363422568|FG000|Treatment Period II|Withdrawal of Consent|28|||
105386908|NCT01725308|363422569|FG001|Treatment Period II|Withdrawal of Consent|2|||
105386909|NCT01725308|363422570|FG002|Treatment Period II|Withdrawal of Consent|16|||
105386910|NCT01725308|363422568|FG000|Treatment Period II|Lost to Follow-up|1|||
105386911|NCT01725308|363422569|FG001|Treatment Period II|Lost to Follow-up|5|||
105386912|NCT01725308|363422570|FG002|Treatment Period II|Lost to Follow-up|3|||
105386913|NCT01725308|363422568|FG000|Treatment Period II|Protocol Deviations|0|||
105386914|NCT01725308|363422569|FG001|Treatment Period II|Protocol Deviations|0|||
105386915|NCT01725308|363422570|FG002|Treatment Period II|Protocol Deviations|1|||
105386916|NCT01725308|363422568|FG000|Treatment Period II|Miscellaneous|5|||
105386917|NCT01725308|363422569|FG001|Treatment Period II|Miscellaneous|3|||
105386918|NCT01725308|363422570|FG002|Treatment Period II|Miscellaneous|7|||
105386919|NCT06048705|363422572|FG000|Overall Study|Physician Decision|1|||
105386920|NCT06048705|363422573|FG001|Overall Study|Physician Decision|0|||
105386921|NCT06048705|363422574|FG002|Overall Study|Physician Decision|0|||
105386922|NCT06048705|363422572|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
105386923|NCT06048705|363422573|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
105386924|NCT06048705|363422574|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
105386925|NCT06048705|363422572|FG000|Overall Study|Death prior to lymphodepletion|0|||
105386926|NCT06048705|363422573|FG001|Overall Study|Death prior to lymphodepletion|0|||
105386927|NCT06048705|363422574|FG002|Overall Study|Death prior to lymphodepletion|1|||
105386928|NCT01016015|363422575|FG000|Overall Study|Not Treated|3|||
105386929|NCT01016015|363422575|FG000|Overall Study|Withdrawal by Subject|1|||
105386930|NCT01016015|363422575|FG000|Overall Study|Adverse Event|15|||
105386931|NCT03072875|363422578|FG000|Overall Study|Lost to Follow-up|1|||
105386932|NCT02792257|363422582|FG000|Overall Study|Lost to Follow-up|3|||
105386933|NCT02792257|363422583|FG001|Overall Study|Lost to Follow-up|4|||
105386934|NCT02792257|363422582|FG000|Overall Study|Allergy|0|||
105386935|NCT02792257|363422583|FG001|Overall Study|Allergy|1|||
105386936|NCT02792257|363422582|FG000|Overall Study|Protocol Violation|2|||
105386937|NCT02792257|363422583|FG001|Overall Study|Protocol Violation|0|||
105386938|NCT02792257|363422582|FG000|Overall Study|Excessive Agitation|0|||
105386939|NCT02792257|363422583|FG001|Overall Study|Excessive Agitation|1|||
105386940|NCT02792257|363422582|FG000|Overall Study|Not Feeling Well|0|||
105386941|NCT02792257|363422583|FG001|Overall Study|Not Feeling Well|1|||
105386942|NCT00507507|363422584|FG000|Treatment Period|Lost to Follow-up|0|||
105386943|NCT00507507|363422585|FG001|Treatment Period|Lost to Follow-up|2|||
105386944|NCT00507507|363422584|FG000|Treatment Period|Physician Decision|4|||
105386945|NCT00507507|363422585|FG001|Treatment Period|Physician Decision|1|||
105386946|NCT00507507|363422584|FG000|Treatment Period|Protocol Violation|1|||
105386947|NCT00507507|363422585|FG001|Treatment Period|Protocol Violation|2|||
105386948|NCT00507507|363422584|FG000|Treatment Period|Adverse Event|1|||
105386949|NCT00507507|363422585|FG001|Treatment Period|Adverse Event|1|||
105386950|NCT00507507|363422584|FG000|Treatment Period|Withdrawal by Subject|46|||
105386951|NCT00507507|363422585|FG001|Treatment Period|Withdrawal by Subject|47|||
105386952|NCT00507507|363422584|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
105386953|NCT00507507|363422585|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
105386954|NCT00507507|363422584|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
105386955|NCT00507507|363422585|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
105386956|NCT00507507|363422584|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
105386957|NCT00507507|363422585|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
105386958|NCT03178942|363422591|FG000|Overall Study|Withdrawal by Subject|2|||
105386959|NCT03178942|363422592|FG001|Overall Study|Withdrawal by Subject|0|||
105386960|NCT03178942|363422591|FG000|Overall Study|Lost to Follow-up|1|||
105386961|NCT03178942|363422592|FG001|Overall Study|Lost to Follow-up|2|||
105386962|NCT01657942|363422593|FG000|Overall Study|Alternative Treatment|7|||
105386963|NCT01657942|363422593|FG000|Overall Study|Lost to Follow-up|1|||
105386964|NCT01557244|363424711|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
105386965|NCT01557244|363424712|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
105386966|NCT01557244|363424713|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
105386967|NCT01557244|363424714|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
105386968|NCT01557244|363424715|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
105386969|NCT01557244|363424716|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
105386970|NCT01557244|363424717|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
105386971|NCT01557244|363424711|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
105386972|NCT01557244|363424712|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
105386973|NCT01557244|363424713|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
105386974|NCT01557244|363424714|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
105386975|NCT01557244|363424715|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
105386976|NCT01557244|363424716|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
105386977|NCT01557244|363424717|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
105386978|NCT01557244|363424711|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
105386979|NCT01557244|363424712|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
105386980|NCT01557244|363424713|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
105386981|NCT01557244|363424714|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
105386982|NCT01557244|363424715|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
105386983|NCT01557244|363424716|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
105386984|NCT01557244|363424717|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
105386985|NCT01557244|363424711|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
105386986|NCT01557244|363424712|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
105492946|NCT02445391|363817209|FG000|Overall Study|Disease progression|0|||
105386987|NCT01557244|363424713|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
105386988|NCT01557244|363424714|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
105386989|NCT01557244|363424715|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
105386990|NCT01557244|363424716|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
105386991|NCT01557244|363424717|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
105386992|NCT01557244|363424711|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
105386993|NCT01557244|363424712|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
105386994|NCT01557244|363424713|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
105386995|NCT01557244|363424714|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
105386996|NCT01557244|363424715|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
105386997|NCT01557244|363424716|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
105386998|NCT01557244|363424717|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
105386999|NCT01557244|363424711|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
105387000|NCT01557244|363424712|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
105387001|NCT01557244|363424713|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
105387002|NCT01557244|363424714|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
105387003|NCT01557244|363424715|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
105387004|NCT01557244|363424716|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
105387005|NCT01557244|363424717|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
105387006|NCT01557244|363424711|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
105387007|NCT01557244|363424712|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
105387008|NCT01557244|363424713|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
105387009|NCT01557244|363424714|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
105387010|NCT01557244|363424715|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
105387011|NCT01557244|363424716|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
105387012|NCT01557244|363424717|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
105387013|NCT01557244|363424711|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
105387014|NCT01557244|363424712|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
105387015|NCT01557244|363424713|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
105387016|NCT01557244|363424714|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
105387017|NCT01557244|363424715|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
105387018|NCT01557244|363424716|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
105387019|NCT01557244|363424717|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
105387020|NCT01557244|363424711|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
105387021|NCT01557244|363424712|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
105387022|NCT01557244|363424713|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
105387023|NCT01557244|363424714|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
105387024|NCT01557244|363424715|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
105387025|NCT01557244|363424716|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
105387026|NCT01557244|363424717|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
105387027|NCT01557244|363424711|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
105387028|NCT01557244|363424712|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
105387029|NCT01557244|363424713|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
105387030|NCT01557244|363424714|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
105387031|NCT01557244|363424715|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
105387032|NCT01557244|363424716|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
105387033|NCT01557244|363424717|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
105387034|NCT01557244|363424711|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
105387035|NCT01557244|363424712|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
105387036|NCT01557244|363424713|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
105387037|NCT01557244|363424714|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
105387038|NCT01557244|363424715|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
105387039|NCT01557244|363424716|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
105387040|NCT01557244|363424717|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
105387041|NCT01557244|363424711|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
105387042|NCT01557244|363424712|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
105387043|NCT01557244|363424713|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
105387044|NCT01557244|363424714|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
105492947|NCT02445391|363817210|FG001|Overall Study|Disease progression|7|||
105492948|NCT02445391|363817211|FG002|Overall Study|Disease progression|22|||
105492949|NCT02445391|363817209|FG000|Overall Study|Complicating disease|0|||
105387045|NCT01557244|363424715|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
105387046|NCT01557244|363424716|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
105387047|NCT01557244|363424717|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
105387048|NCT00944645|363424718|FG000|Period 2|Adverse Event|1|||
105387049|NCT00944645|363424719|FG001|Period 2|Adverse Event|0|||
105387050|NCT00944645|363424718|FG000|Period 2|Lost to Follow-up|0|||
105387051|NCT00944645|363424719|FG001|Period 2|Lost to Follow-up|3|||
105387052|NCT00944645|363424718|FG000|Period 2|Withdrawal by Subject|7|||
105387053|NCT00944645|363424719|FG001|Period 2|Withdrawal by Subject|6|||
105387054|NCT03537729|363424720|FG000|Overall Study|Death|2|||
105387055|NCT03537729|363424721|FG001|Overall Study|Death|2|||
105387056|NCT03537729|363424722|FG002|Overall Study|Death|7|||
105387057|NCT03537729|363424720|FG000|Overall Study|Withdrawal by Subject|3|||
105387058|NCT03537729|363424721|FG001|Overall Study|Withdrawal by Subject|3|||
105387059|NCT03537729|363424722|FG002|Overall Study|Withdrawal by Subject|0|||
105387060|NCT03537729|363424720|FG000|Overall Study|Subject Moved|8|||
105387061|NCT03537729|363424721|FG001|Overall Study|Subject Moved|5|||
105387062|NCT03537729|363424722|FG002|Overall Study|Subject Moved|4|||
105387063|NCT03537729|363424720|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
105387064|NCT03537729|363424721|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
105387065|NCT03537729|363424722|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
105387066|NCT03537729|363424720|FG000|Overall Study|COVID-19 Site Restrictions|11|||
105387067|NCT03537729|363424721|FG001|Overall Study|COVID-19 Site Restrictions|15|||
105387068|NCT03537729|363424722|FG002|Overall Study|COVID-19 Site Restrictions|18|||
105387069|NCT03537729|363424720|FG000|Overall Study|Decline in Health|5|||
105387070|NCT03537729|363424721|FG001|Overall Study|Decline in Health|9|||
105387071|NCT03537729|363424722|FG002|Overall Study|Decline in Health|4|||
105387072|NCT03537729|363424720|FG000|Overall Study|Determined Ineligible|0|||
105387073|NCT03537729|363424721|FG001|Overall Study|Determined Ineligible|0|||
105387074|NCT03537729|363424722|FG002|Overall Study|Determined Ineligible|1|||
105387075|NCT02562040|363424724|FG000|Overall Study|Lost to Follow-up|20|||
105387076|NCT02562040|363424725|FG001|Overall Study|Lost to Follow-up|28|||
105387077|NCT02562040|363424724|FG000|Overall Study|Withdrawal by Subject|8|||
105387078|NCT02562040|363424725|FG001|Overall Study|Withdrawal by Subject|7|||
105387079|NCT02562040|363424724|FG000|Overall Study|Adverse Event|1|||
105387080|NCT02562040|363424725|FG001|Overall Study|Adverse Event|0|||
105387081|NCT00368849|363424726|FG000|Overall Study|Withdrawal by Subject|0|||
105387082|NCT00368849|363424727|FG001|Overall Study|Withdrawal by Subject|1|||
105387083|NCT00368849|363424726|FG000|Overall Study|Physician Decision|0|||
105387084|NCT00368849|363424727|FG001|Overall Study|Physician Decision|1|||
105387085|NCT02123511|363424733|FG000|Overall Study|Cancelled treatment|1|||
105387086|NCT02123511|363424734|FG001|Overall Study|Cancelled treatment|0|||
105387087|NCT02123511|363424733|FG000|Overall Study|Incomplete data|1|||
105387088|NCT02123511|363424734|FG001|Overall Study|Incomplete data|3|||
105387089|NCT02123511|363424733|FG000|Overall Study|Ineligible|0|||
105387090|NCT02123511|363424734|FG001|Overall Study|Ineligible|1|||
105387091|NCT02595437|363424735|FG000|Triferic Via IV|Withdrawal by Subject|1|||
105387092|NCT00458705|363424736|FG000|Overall Study|Adverse Event|4|||
105387093|NCT00458705|363424736|FG000|Overall Study|Not Treated|1|||
105387094|NCT02070380|363424744|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
105387095|NCT02070380|363424745|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
105387096|NCT02070380|363424746|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
105387097|NCT02070380|363424747|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
105387098|NCT02070380|363424744|FG000|Second Injection|Image sets missing or technically inadeq|0|||
105387099|NCT02070380|363424745|FG001|Second Injection|Image sets missing or technically inadeq|1|||
105387100|NCT02070380|363424746|FG002|Second Injection|Image sets missing or technically inadeq|0|||
105387101|NCT02070380|363424747|FG003|Second Injection|Image sets missing or technically inadeq|0|||
105492950|NCT02445391|363817210|FG001|Overall Study|Complicating disease|2|||
105492951|NCT02445391|363817211|FG002|Overall Study|Complicating disease|1|||
105492952|NCT02445391|363817209|FG000|Overall Study|Withdrawal by Subject|0|||
105387102|NCT02070380|363424744|FG000|Second Injection|Protocol Violation|0|||
105387103|NCT02070380|363424745|FG001|Second Injection|Protocol Violation|1|||
105387104|NCT02070380|363424746|FG002|Second Injection|Protocol Violation|1|||
105387105|NCT02070380|363424747|FG003|Second Injection|Protocol Violation|5|||
105387106|NCT01362530|363424758|FG000|Base Study (Cycle 1)|Adverse Event|2|||
105387107|NCT01362530|363424759|FG001|Base Study (Cycle 1)|Adverse Event|0|||
105387108|NCT01362530|363424758|FG000|Base Study (Cycle 1)|Physician Decision|0|||
105387109|NCT01362530|363424759|FG001|Base Study (Cycle 1)|Physician Decision|1|||
105387110|NCT01362530|363424758|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
105387111|NCT01362530|363424759|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
105387112|NCT01362530|363424758|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
105387113|NCT01362530|363424759|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
105387114|NCT01362530|363424758|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
105387115|NCT01362530|363424759|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
105387116|NCT01362530|363424758|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
105387117|NCT01362530|363424759|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
105387118|NCT01362530|363424758|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
105387119|NCT01362530|363424759|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
105387120|NCT01362530|363424758|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
105387121|NCT01362530|363424759|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
105387122|NCT01362530|363424758|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
105387123|NCT01362530|363424759|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
105387124|NCT01362530|363424758|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
105387125|NCT01362530|363424759|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
105387126|NCT01362530|363424758|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
105387127|NCT01362530|363424759|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
105387128|NCT01362530|363424758|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
105387129|NCT01362530|363424759|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
105387130|NCT01362530|363424758|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
105387131|NCT01362530|363424759|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
105387132|NCT01034657|363424760|FG000|Core Phase|Withdrawal by Subject|1|||
105387133|NCT01034657|363424761|FG001|Core Phase|Withdrawal by Subject|0|||
105387134|NCT01034657|363424762|FG002|Core Phase|Withdrawal by Subject|0|||
105387135|NCT01034657|363424760|FG000|Core Phase|Lack of Efficacy|2|||
105387136|NCT01034657|363424761|FG001|Core Phase|Lack of Efficacy|0|||
105387137|NCT01034657|363424762|FG002|Core Phase|Lack of Efficacy|0|||
105387138|NCT01034657|363424760|FG000|Core Phase|Abnormal laboratory value|1|||
105387139|NCT01034657|363424761|FG001|Core Phase|Abnormal laboratory value|0|||
105387140|NCT01034657|363424762|FG002|Core Phase|Abnormal laboratory value|0|||
105387141|NCT01034657|363424760|FG000|Core Phase|Adverse Event|8|||
105387142|NCT01034657|363424761|FG001|Core Phase|Adverse Event|0|||
105387143|NCT01034657|363424762|FG002|Core Phase|Adverse Event|0|||
105387144|NCT01034657|363424760|FG000|Core Phase|Protocol Violation|2|||
105387145|NCT01034657|363424761|FG001|Core Phase|Protocol Violation|0|||
105387146|NCT01034657|363424762|FG002|Core Phase|Protocol Violation|0|||
105387147|NCT01034657|363424760|FG000|Randomized Phase|Withdrawal by Subject|0|||
105387148|NCT01034657|363424761|FG001|Randomized Phase|Withdrawal by Subject|2|||
105387149|NCT01034657|363424762|FG002|Randomized Phase|Withdrawal by Subject|0|||
105387150|NCT01034657|363424760|FG000|Randomized Phase|Lack of Efficacy|5|||
105387151|NCT01034657|363424761|FG001|Randomized Phase|Lack of Efficacy|1|||
105387152|NCT01034657|363424762|FG002|Randomized Phase|Lack of Efficacy|0|||
105387153|NCT01034657|363424760|FG000|Randomized Phase|Abnormal laboratory value|0|||
105387154|NCT01034657|363424761|FG001|Randomized Phase|Abnormal laboratory value|1|||
105387155|NCT01034657|363424762|FG002|Randomized Phase|Abnormal laboratory value|0|||
105387156|NCT01034657|363424760|FG000|Randomized Phase|Adverse Event|0|||
105387157|NCT01034657|363424761|FG001|Randomized Phase|Adverse Event|2|||
105387158|NCT01034657|363424762|FG002|Randomized Phase|Adverse Event|1|||
105387159|NCT01133977|363424763|FG000|Overall Study|Adverse Event|0|||
105387160|NCT01133977|363424764|FG001|Overall Study|Adverse Event|0|||
105387161|NCT01133977|363424765|FG002|Overall Study|Adverse Event|1|||
105387162|NCT01133977|363424766|FG003|Overall Study|Adverse Event|0|||
105387163|NCT01133977|363424767|FG004|Overall Study|Adverse Event|0|||
105387164|NCT01133977|363424763|FG000|Overall Study|Death|1|||
105387165|NCT01133977|363424764|FG001|Overall Study|Death|1|||
105387166|NCT01133977|363424765|FG002|Overall Study|Death|1|||
105387167|NCT01133977|363424766|FG003|Overall Study|Death|7|||
105387168|NCT01133977|363424767|FG004|Overall Study|Death|3|||
105387169|NCT01133977|363424763|FG000|Overall Study|Started a New Line of Therapy|2|||
105387170|NCT01133977|363424764|FG001|Overall Study|Started a New Line of Therapy|6|||
105387171|NCT01133977|363424765|FG002|Overall Study|Started a New Line of Therapy|4|||
105387172|NCT01133977|363424766|FG003|Overall Study|Started a New Line of Therapy|25|||
105387173|NCT01133977|363424767|FG004|Overall Study|Started a New Line of Therapy|33|||
105387174|NCT01133977|363424763|FG000|Overall Study|Lost to Follow-up|0|||
105387175|NCT01133977|363424764|FG001|Overall Study|Lost to Follow-up|0|||
105387176|NCT01133977|363424765|FG002|Overall Study|Lost to Follow-up|0|||
105387177|NCT01133977|363424766|FG003|Overall Study|Lost to Follow-up|2|||
105387178|NCT01133977|363424767|FG004|Overall Study|Lost to Follow-up|1|||
105387179|NCT01133977|363424763|FG000|Overall Study|Withdrawal by Subject|0|||
105387180|NCT01133977|363424764|FG001|Overall Study|Withdrawal by Subject|0|||
105387181|NCT01133977|363424765|FG002|Overall Study|Withdrawal by Subject|0|||
105387182|NCT01133977|363424766|FG003|Overall Study|Withdrawal by Subject|5|||
105387183|NCT01133977|363424767|FG004|Overall Study|Withdrawal by Subject|1|||
105387184|NCT02773537|363424768|FG000|Overall Study|Lost to Follow-up|0|||
105387185|NCT02773537|363424769|FG001|Overall Study|Lost to Follow-up|1|||
105387186|NCT02773537|363424770|FG002|Overall Study|Lost to Follow-up|4|||
105387187|NCT00662038|363424771|FG000|Overall Study|Reason not specified|3|||
105387188|NCT00662038|363424771|FG000|Overall Study|Withdrawn consent|22|||
105387189|NCT00662038|363424771|FG000|Overall Study|Withdrawal by Subject|83|||
105387190|NCT00662038|363424771|FG000|Overall Study|Sponsor decision|1|||
105387191|NCT00662038|363424771|FG000|Overall Study|Physician Decision|19|||
105387192|NCT00662038|363424771|FG000|Overall Study|Lung transplantation|44|||
105387193|NCT00662038|363424771|FG000|Overall Study|Lost to Follow-up|1|||
105387194|NCT00662038|363424771|FG000|Overall Study|Death|95|||
105387195|NCT00662038|363424771|FG000|Overall Study|Adverse Event|358|||
105387196|NCT00662038|363424771|FG000|Overall Study|Continued treatment|5|||
105387197|NCT00397046|363424776|FG000|Overall Study|Disease Progression|3|||
105387198|NCT00397046|363424777|FG001|Overall Study|Disease Progression|3|||
105387199|NCT00397046|363424778|FG002|Overall Study|Disease Progression|10|||
105387200|NCT00397046|363424779|FG003|Overall Study|Disease Progression|5|||
105387201|NCT02105012|363424781|FG000|Overall Study|Withdrawal by Subject|11|||
105387202|NCT02105012|363424781|FG000|Overall Study|Protocol Specified Criteria|9|||
105387203|NCT02105012|363424781|FG000|Overall Study|Lost to Follow-up|4|||
105387204|NCT02105012|363424781|FG000|Overall Study|Protocol Violation|4|||
105387205|NCT02105012|363424781|FG000|Overall Study|Physician Decision|3|||
105387206|NCT02105012|363424781|FG000|Overall Study|Adverse Event|1|||
105387207|NCT02105012|363424781|FG000|Overall Study|Lack of Efficacy|1|||
105387208|NCT03774810|363424782|FG000|Phase 1|Lack of Efficacy|21|||
105387209|NCT03774810|363424783|FG001|Phase 1|Lack of Efficacy|0|||
105387210|NCT03774810|363424784|FG002|Phase 1|Lack of Efficacy|0|||
105387211|NCT03774810|363424785|FG003|Phase 1|Lack of Efficacy|0|||
105387212|NCT03774810|363424786|FG004|Phase 1|Lack of Efficacy|0|||
105387213|NCT03774810|363424782|FG000|Phase 1|Withdrawal by Subject|9|||
105387214|NCT03774810|363424783|FG001|Phase 1|Withdrawal by Subject|0|||
105387215|NCT03774810|363424784|FG002|Phase 1|Withdrawal by Subject|0|||
105387216|NCT03774810|363424785|FG003|Phase 1|Withdrawal by Subject|0|||
105387217|NCT03774810|363424786|FG004|Phase 1|Withdrawal by Subject|0|||
105387218|NCT03774810|363424782|FG000|Phase 1|Lost to Follow-up|2|||
105387219|NCT03774810|363424783|FG001|Phase 1|Lost to Follow-up|0|||
105387220|NCT03774810|363424784|FG002|Phase 1|Lost to Follow-up|0|||
105387221|NCT03774810|363424785|FG003|Phase 1|Lost to Follow-up|0|||
105387222|NCT03774810|363424786|FG004|Phase 1|Lost to Follow-up|0|||
105387223|NCT03774810|363424782|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
105387224|NCT03774810|363424783|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
105387225|NCT03774810|363424784|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
105387226|NCT03774810|363424785|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
105387227|NCT03774810|363424786|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
105387228|NCT03774810|363424782|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
105387229|NCT03774810|363424783|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
105387230|NCT03774810|363424784|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
105387231|NCT03774810|363424785|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
105387232|NCT03774810|363424786|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
105387233|NCT03774810|363424782|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
105387234|NCT03774810|363424783|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
105387235|NCT03774810|363424784|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
105387236|NCT03774810|363424785|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
105387237|NCT03774810|363424786|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
105387238|NCT03774810|363424782|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
105387239|NCT03774810|363424783|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
105387240|NCT03774810|363424784|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
105387241|NCT03774810|363424785|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
105387242|NCT03774810|363424786|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
105387243|NCT03774810|363424782|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
105387244|NCT03774810|363424783|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
105387245|NCT03774810|363424784|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
105387246|NCT03774810|363424785|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
105387247|NCT03774810|363424786|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
105387248|NCT03774810|363424782|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
105387249|NCT03774810|363424783|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
105387250|NCT03774810|363424784|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
105387251|NCT03774810|363424785|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
105387252|NCT03774810|363424786|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
105387253|NCT01896986|363424788|FG000|Overall Study|samples lost|14|||
105387254|NCT01896986|363424789|FG001|Overall Study|samples lost|23|||
105387255|NCT03302936|363424790|FG000|Overall Study|Protocol Violation|3|||
105387256|NCT03302936|363424791|FG001|Overall Study|Protocol Violation|4|||
105387257|NCT01379937|363424792|FG000|Overall Study|Protocol Violation|0|||
105387258|NCT01379937|363424793|FG001|Overall Study|Protocol Violation|0|||
105387259|NCT01379937|363424794|FG002|Overall Study|Protocol Violation|0|||
105387260|NCT01379937|363424795|FG003|Overall Study|Protocol Violation|1|||
105387261|NCT01379937|363424792|FG000|Overall Study|Consent withdrawal|0|||
105387262|NCT01379937|363424793|FG001|Overall Study|Consent withdrawal|1|||
105387263|NCT01379937|363424794|FG002|Overall Study|Consent withdrawal|0|||
105387264|NCT01379937|363424795|FG003|Overall Study|Consent withdrawal|0|||
105387265|NCT01379937|363424792|FG000|Overall Study|Lost to Follow-up|1|||
105387266|NCT01379937|363424793|FG001|Overall Study|Lost to Follow-up|2|||
105387267|NCT01379937|363424794|FG002|Overall Study|Lost to Follow-up|2|||
105387268|NCT01379937|363424795|FG003|Overall Study|Lost to Follow-up|0|||
105387269|NCT01122680|363424796|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
105387270|NCT01122680|363424797|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
105387271|NCT01122680|363424798|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
105387272|NCT01122680|363424799|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
105387273|NCT01122680|363424796|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
105387274|NCT01122680|363424797|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
105387275|NCT01122680|363424798|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
105387276|NCT01122680|363424799|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
105387277|NCT01122680|363424796|FG000|Period 1 (4 Weeks)|Other|1|||
105387278|NCT01122680|363424797|FG001|Period 1 (4 Weeks)|Other|1|||
105387279|NCT01122680|363424798|FG002|Period 1 (4 Weeks)|Other|0|||
105387280|NCT01122680|363424799|FG003|Period 1 (4 Weeks)|Other|0|||
105387281|NCT01122680|363424796|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
105387282|NCT01122680|363424797|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
105387283|NCT01122680|363424798|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
105387284|NCT01122680|363424799|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
105387285|NCT01122680|363424796|FG000|Period 2 (4 Weeks)|Other|1|||
105387286|NCT01122680|363424797|FG001|Period 2 (4 Weeks)|Other|0|||
105387287|NCT01122680|363424798|FG002|Period 2 (4 Weeks)|Other|0|||
105387288|NCT01122680|363424799|FG003|Period 2 (4 Weeks)|Other|0|||
105387289|NCT01122680|363424796|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
105387290|NCT01122680|363424797|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
105387291|NCT01122680|363424798|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
105387292|NCT01122680|363424799|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
105387293|NCT01122680|363424796|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
105387294|NCT01122680|363424797|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
105387295|NCT01122680|363424798|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
105387296|NCT01122680|363424799|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
105387297|NCT01550965|363424802|FG000|Overall Study|Adverse Event|26|||
105387298|NCT01550965|363424802|FG000|Overall Study|Withdrawal by Subject|10|||
105387299|NCT01550965|363424802|FG000|Overall Study|Lost to Follow-up|2|||
105387300|NCT01550965|363424802|FG000|Overall Study|Lack of Efficacy|59|||
105387301|NCT01550965|363424802|FG000|Overall Study|Other|13|||
105387302|NCT01657500|363424807|FG000|Overall Study|set impropperly matched|3|||
105387303|NCT01657500|363424808|FG001|Overall Study|set impropperly matched|3|||
105387304|NCT01657500|363424807|FG000|Overall Study|Lost to Follow-up|2|||
105387305|NCT01657500|363424808|FG001|Overall Study|Lost to Follow-up|2|||
105387306|NCT02067156|363424810|FG000|Overall Study|Lost to Follow-up|4|||
105387307|NCT03142334|363424811|FG000|Overall Study|Death|18|||
105387308|NCT03142334|363424812|FG001|Overall Study|Death|33|||
105387309|NCT03142334|363424811|FG000|Overall Study|Withdrawal by Subject|15|||
105387310|NCT03142334|363424812|FG001|Overall Study|Withdrawal by Subject|11|||
105387311|NCT03142334|363424811|FG000|Overall Study|Ongoing on trial follow up|463|||
105387312|NCT03142334|363424812|FG001|Overall Study|Ongoing on trial follow up|454|||
105387313|NCT01655069|363424813|FG000|Overall Study|Physician Decision|0|||
105387314|NCT01655069|363424814|FG001|Overall Study|Physician Decision|0|||
105387315|NCT01655069|363424815|FG002|Overall Study|Physician Decision|0|||
105387316|NCT01655069|363424816|FG003|Overall Study|Physician Decision|1|||
105387317|NCT01655069|363424813|FG000|Overall Study|Adverse Event|6|||
105387318|NCT01655069|363424814|FG001|Overall Study|Adverse Event|7|||
105387319|NCT01655069|363424815|FG002|Overall Study|Adverse Event|2|||
105387320|NCT01655069|363424816|FG003|Overall Study|Adverse Event|3|||
105387321|NCT01655069|363424813|FG000|Overall Study|Lack of Efficacy|0|||
105387322|NCT01655069|363424814|FG001|Overall Study|Lack of Efficacy|1|||
105387323|NCT01655069|363424815|FG002|Overall Study|Lack of Efficacy|0|||
105387324|NCT01655069|363424816|FG003|Overall Study|Lack of Efficacy|0|||
105387325|NCT01655069|363424813|FG000|Overall Study|No Treatment Needed|0|||
105387326|NCT01655069|363424814|FG001|Overall Study|No Treatment Needed|1|||
105387327|NCT01655069|363424815|FG002|Overall Study|No Treatment Needed|0|||
105387328|NCT01655069|363424816|FG003|Overall Study|No Treatment Needed|0|||
105387329|NCT01655069|363424813|FG000|Overall Study|Withdrawal by Subject|2|||
105387330|NCT01655069|363424814|FG001|Overall Study|Withdrawal by Subject|3|||
105387331|NCT01655069|363424815|FG002|Overall Study|Withdrawal by Subject|0|||
105387332|NCT01655069|363424816|FG003|Overall Study|Withdrawal by Subject|0|||
105387333|NCT03473301|363424818|FG000|Overall Study|Protocol Violation|4|||
105387334|NCT03473301|363424819|FG001|Overall Study|Protocol Violation|0|||
105387335|NCT03473301|363424820|FG002|Overall Study|Protocol Violation|0|||
105387336|NCT03473301|363424818|FG000|Overall Study|Withdrawal by Subject|0|||
105387337|NCT03473301|363424819|FG001|Overall Study|Withdrawal by Subject|1|||
105387338|NCT03473301|363424820|FG002|Overall Study|Withdrawal by Subject|0|||
105387339|NCT03473301|363424818|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
105387340|NCT03473301|363424819|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
105387341|NCT03473301|363424820|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
105387342|NCT05287685|363424821|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
105387343|NCT05287685|363424822|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
105387344|NCT05287685|363424821|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
105387345|NCT05287685|363424822|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
105387346|NCT04008069|363424823|FG000|Open-Label Period|Adverse Event|1|||
105387347|NCT04008069|363424824|FG001|Open-Label Period|Adverse Event|0|||
105387348|NCT04008069|363424825|FG002|Open-Label Period|Adverse Event|0|||
105387349|NCT04008069|363424823|FG000|Open-Label Period|Lack of Efficacy|4|||
105387350|NCT04008069|363424824|FG001|Open-Label Period|Lack of Efficacy|0|||
105387351|NCT04008069|363424825|FG002|Open-Label Period|Lack of Efficacy|0|||
105387352|NCT04008069|363424823|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
105387353|NCT04008069|363424824|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
105387354|NCT04008069|363424825|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
105387355|NCT04008069|363424823|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
105387356|NCT04008069|363424824|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
105387357|NCT04008069|363424825|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
105387358|NCT02739828|363424830|FG000|Overall Study|Adverse Event|1|||
105387359|NCT02739828|363424830|FG000|Overall Study|Lost to Follow-up|4|||
105387360|NCT02314247|363424831|FG000|Overall Study|Adverse Event|2|||
105387361|NCT02314247|363424832|FG001|Overall Study|Adverse Event|1|||
105387362|NCT02314247|363424833|FG002|Overall Study|Adverse Event|0|||
105387363|NCT02314247|363424831|FG000|Overall Study|Withdrawal by Subject|1|||
105387364|NCT02314247|363424832|FG001|Overall Study|Withdrawal by Subject|3|||
105387365|NCT02314247|363424833|FG002|Overall Study|Withdrawal by Subject|1|||
105387366|NCT02314247|363424831|FG000|Overall Study|Progression of Disease|6|||
105387367|NCT02314247|363424832|FG001|Overall Study|Progression of Disease|2|||
105387368|NCT02314247|363424833|FG002|Overall Study|Progression of Disease|0|||
105387369|NCT01953354|363424834|FG000|Overall Study|Withdrawal by Subject|0|||
105387370|NCT01953354|363424835|FG001|Overall Study|Withdrawal by Subject|1|||
105387371|NCT01953354|363424834|FG000|Overall Study|Decision of Sponsor|0|||
105387372|NCT01953354|363424835|FG001|Overall Study|Decision of Sponsor|1|||
105387373|NCT01953354|363424834|FG000|Overall Study|Disease Exacerbation|1|||
105387374|NCT01953354|363424835|FG001|Overall Study|Disease Exacerbation|0|||
105387375|NCT01392495|363424836|FG000|Overall Study|Death|3|||
105387376|NCT01392495|363424836|FG000|Overall Study|Administrative problems|8|||
105387377|NCT01392495|363424836|FG000|Overall Study|Withdrawal by Subject|2|||
105387378|NCT01392495|363424836|FG000|Overall Study|Adverse Event|3|||
105387379|NCT02571244|363424837|FG000|Overall Study|Lost to Follow-up|0|||
105387380|NCT02571244|363424838|FG001|Overall Study|Lost to Follow-up|1|||
105387381|NCT02571244|363424837|FG000|Overall Study|Unable to reach out post discharge|3|||
105387382|NCT02571244|363424838|FG001|Overall Study|Unable to reach out post discharge|0|||
105387383|NCT01570192|363424842|FG000|Overall Study|no qualifying organism|6|||
105387384|NCT01570192|363424843|FG001|Overall Study|no qualifying organism|12|||
105387385|NCT01570192|363424842|FG000|Overall Study|changed to palliative care|1|||
105387386|NCT01570192|363424843|FG001|Overall Study|changed to palliative care|0|||
105387387|NCT01570192|363424842|FG000|Overall Study|Physician Decision|0|||
105387388|NCT01570192|363424843|FG001|Overall Study|Physician Decision|1|||
105387389|NCT00806026|363424844|FG000|Overall Study|Death|0|||
105387390|NCT00806026|363424845|FG001|Overall Study|Death|0|||
105387391|NCT00806026|363424846|FG002|Overall Study|Death|0|||
105387392|NCT00806026|363424847|FG003|Overall Study|Death|1|||
105387393|NCT00806026|363424848|FG004|Overall Study|Death|0|||
105387394|NCT00806026|363424849|FG005|Overall Study|Death|0|||
105387395|NCT00806026|363424844|FG000|Overall Study|Did not meet entrance criteria|4|||
105387396|NCT00806026|363424845|FG001|Overall Study|Did not meet entrance criteria|1|||
105387397|NCT00806026|363424846|FG002|Overall Study|Did not meet entrance criteria|2|||
105387398|NCT00806026|363424847|FG003|Overall Study|Did not meet entrance criteria|1|||
105387399|NCT00806026|363424848|FG004|Overall Study|Did not meet entrance criteria|0|||
105387400|NCT00806026|363424849|FG005|Overall Study|Did not meet entrance criteria|0|||
105387401|NCT00806026|363424844|FG000|Overall Study|Lack of Efficacy|5|||
105387402|NCT00806026|363424845|FG001|Overall Study|Lack of Efficacy|18|||
105387403|NCT00806026|363424846|FG002|Overall Study|Lack of Efficacy|13|||
105387404|NCT00806026|363424847|FG003|Overall Study|Lack of Efficacy|4|||
105387405|NCT00806026|363424848|FG004|Overall Study|Lack of Efficacy|8|||
105387406|NCT00806026|363424849|FG005|Overall Study|Lack of Efficacy|7|||
105387407|NCT00806026|363424844|FG000|Overall Study|Lost to Follow-up|8|||
105387408|NCT00806026|363424845|FG001|Overall Study|Lost to Follow-up|15|||
105387409|NCT00806026|363424846|FG002|Overall Study|Lost to Follow-up|8|||
105387410|NCT00806026|363424847|FG003|Overall Study|Lost to Follow-up|2|||
105387411|NCT00806026|363424848|FG004|Overall Study|Lost to Follow-up|6|||
105387412|NCT00806026|363424849|FG005|Overall Study|Lost to Follow-up|6|||
105387413|NCT00806026|363424844|FG000|Overall Study|Withdrawal by Subject|14|||
105387414|NCT00806026|363424845|FG001|Overall Study|Withdrawal by Subject|17|||
105387415|NCT00806026|363424846|FG002|Overall Study|Withdrawal by Subject|9|||
105387416|NCT00806026|363424847|FG003|Overall Study|Withdrawal by Subject|2|||
105387417|NCT00806026|363424848|FG004|Overall Study|Withdrawal by Subject|5|||
105387418|NCT00806026|363424849|FG005|Overall Study|Withdrawal by Subject|3|||
105387419|NCT00806026|363424844|FG000|Overall Study|Other|3|||
105387420|NCT00806026|363424845|FG001|Overall Study|Other|6|||
105387421|NCT00806026|363424846|FG002|Overall Study|Other|8|||
105387422|NCT00806026|363424847|FG003|Overall Study|Other|2|||
105387423|NCT00806026|363424848|FG004|Overall Study|Other|0|||
105387424|NCT00806026|363424849|FG005|Overall Study|Other|4|||
105387425|NCT00806026|363424844|FG000|Overall Study|Protocol Violation|6|||
105387426|NCT00806026|363424845|FG001|Overall Study|Protocol Violation|9|||
105387427|NCT00806026|363424846|FG002|Overall Study|Protocol Violation|9|||
105387428|NCT00806026|363424847|FG003|Overall Study|Protocol Violation|0|||
105387429|NCT00806026|363424848|FG004|Overall Study|Protocol Violation|2|||
105387430|NCT00806026|363424849|FG005|Overall Study|Protocol Violation|3|||
105387431|NCT00806026|363424844|FG000|Overall Study|Adverse Event|52|||
105387432|NCT00806026|363424845|FG001|Overall Study|Adverse Event|35|||
105387433|NCT00806026|363424846|FG002|Overall Study|Adverse Event|44|||
105387434|NCT00806026|363424847|FG003|Overall Study|Adverse Event|17|||
105387435|NCT00806026|363424848|FG004|Overall Study|Adverse Event|9|||
105387436|NCT00806026|363424849|FG005|Overall Study|Adverse Event|9|||
105387437|NCT01646216|363424859|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
105387438|NCT01646216|363424860|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
105387439|NCT01646216|363424859|FG000|Overall Study|Did not complete training|0|||
105387440|NCT01646216|363424860|FG001|Overall Study|Did not complete training|2|||
105387441|NCT01646216|363424859|FG000|Overall Study|Investigator decision|1|||
105387442|NCT01646216|363424860|FG001|Overall Study|Investigator decision|1|||
105387443|NCT00098293|363424861|FG000|Double-blind (DB) Phase|Adverse Event|14|||
105387444|NCT00098293|363424862|FG001|Double-blind (DB) Phase|Adverse Event|27|||
105387445|NCT00098293|363424863|FG002|Double-blind (DB) Phase|Adverse Event|60|||
105387446|NCT00098293|363424864|FG003|Double-blind (DB) Phase|Adverse Event|0|||
105387447|NCT00098293|363424865|FG004|Double-blind (DB) Phase|Adverse Event|0|||
105387448|NCT00098293|363424861|FG000|Double-blind (DB) Phase|Pregnancy|0|||
105387449|NCT00098293|363424862|FG001|Double-blind (DB) Phase|Pregnancy|7|||
105387450|NCT00098293|363424863|FG002|Double-blind (DB) Phase|Pregnancy|9|||
105387451|NCT00098293|363424864|FG003|Double-blind (DB) Phase|Pregnancy|0|||
105387452|NCT00098293|363424865|FG004|Double-blind (DB) Phase|Pregnancy|0|||
105387453|NCT00098293|363424861|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
105387454|NCT00098293|363424862|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
105387455|NCT00098293|363424863|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
105387456|NCT00098293|363424864|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
105387457|NCT00098293|363424865|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
105387458|NCT00098293|363424861|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
105387459|NCT00098293|363424862|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
105387460|NCT00098293|363424863|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
105387461|NCT00098293|363424864|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
105387462|NCT00098293|363424865|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
105387463|NCT00098293|363424861|FG000|Double-blind (DB) Phase|Death|1|||
105387464|NCT00098293|363424862|FG001|Double-blind (DB) Phase|Death|2|||
105387465|NCT00098293|363424863|FG002|Double-blind (DB) Phase|Death|2|||
105387466|NCT00098293|363424864|FG003|Double-blind (DB) Phase|Death|0|||
105387467|NCT00098293|363424865|FG004|Double-blind (DB) Phase|Death|0|||
105387468|NCT00098293|363424861|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
105387469|NCT00098293|363424862|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
105387470|NCT00098293|363424863|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
105387471|NCT00098293|363424864|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
105387472|NCT00098293|363424865|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
105387473|NCT00098293|363424861|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
105387474|NCT00098293|363424862|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
105387475|NCT00098293|363424863|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
105387476|NCT00098293|363424864|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
105387477|NCT00098293|363424865|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
105387478|NCT00098293|363424861|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
105387479|NCT00098293|363424862|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
105387480|NCT00098293|363424863|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
105387481|NCT00098293|363424864|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
105387482|NCT00098293|363424865|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
105387483|NCT00098293|363424861|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
105387484|NCT00098293|363424862|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
105387485|NCT00098293|363424863|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
105387486|NCT00098293|363424864|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
105387487|NCT00098293|363424865|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
105387488|NCT00098293|363424861|FG000|Open-label (OL) Phase|Adverse Event|0|||
105387489|NCT00098293|363424862|FG001|Open-label (OL) Phase|Adverse Event|3|||
105387490|NCT00098293|363424863|FG002|Open-label (OL) Phase|Adverse Event|7|||
105387491|NCT00098293|363424864|FG003|Open-label (OL) Phase|Adverse Event|6|||
105387492|NCT00098293|363424865|FG004|Open-label (OL) Phase|Adverse Event|0|||
105387493|NCT00098293|363424861|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
105387494|NCT00098293|363424862|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
105387495|NCT00098293|363424863|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
105387496|NCT00098293|363424864|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
105387497|NCT00098293|363424865|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
105387498|NCT00098293|363424861|FG000|Open-label (OL) Phase|Pregnancy|0|||
105387499|NCT00098293|363424862|FG001|Open-label (OL) Phase|Pregnancy|1|||
105387500|NCT00098293|363424863|FG002|Open-label (OL) Phase|Pregnancy|0|||
105387501|NCT00098293|363424864|FG003|Open-label (OL) Phase|Pregnancy|3|||
105387502|NCT00098293|363424865|FG004|Open-label (OL) Phase|Pregnancy|0|||
105387503|NCT00098293|363424861|FG000|Open-label (OL) Phase|Protocol Violation|0|||
105387504|NCT00098293|363424862|FG001|Open-label (OL) Phase|Protocol Violation|6|||
105387505|NCT00098293|363424863|FG002|Open-label (OL) Phase|Protocol Violation|13|||
105387506|NCT00098293|363424864|FG003|Open-label (OL) Phase|Protocol Violation|16|||
105387507|NCT00098293|363424865|FG004|Open-label (OL) Phase|Protocol Violation|0|||
105387508|NCT00098293|363424861|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
105387509|NCT00098293|363424862|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
105387510|NCT00098293|363424863|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
105387511|NCT00098293|363424864|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
105387512|NCT00098293|363424865|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
105387513|NCT00098293|363424861|FG000|Open-label (OL) Phase|Death|0|||
105387514|NCT00098293|363424862|FG001|Open-label (OL) Phase|Death|2|||
105387515|NCT00098293|363424863|FG002|Open-label (OL) Phase|Death|3|||
105387516|NCT00098293|363424864|FG003|Open-label (OL) Phase|Death|0|||
105387517|NCT00098293|363424865|FG004|Open-label (OL) Phase|Death|0|||
105387518|NCT00098293|363424861|FG000|Supplemental Phase (SP)|Death|0|||
105387519|NCT00098293|363424862|FG001|Supplemental Phase (SP)|Death|0|||
105387520|NCT00098293|363424863|FG002|Supplemental Phase (SP)|Death|0|||
105387521|NCT00098293|363424864|FG003|Supplemental Phase (SP)|Death|0|||
105387522|NCT00098293|363424865|FG004|Supplemental Phase (SP)|Death|1|||
105387523|NCT00098293|363424861|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
105387524|NCT00098293|363424862|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
105387525|NCT00098293|363424863|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
105387526|NCT00098293|363424864|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
105387527|NCT00098293|363424865|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
105387528|NCT00098293|363424861|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
105387529|NCT00098293|363424862|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
105387530|NCT00098293|363424863|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
105387531|NCT00098293|363424864|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
105387532|NCT00098293|363424865|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
105387533|NCT00098293|363424861|FG000|Supplemental Phase (SP)|Other|0|||
105387534|NCT00098293|363424862|FG001|Supplemental Phase (SP)|Other|0|||
105387535|NCT00098293|363424863|FG002|Supplemental Phase (SP)|Other|0|||
105387536|NCT00098293|363424864|FG003|Supplemental Phase (SP)|Other|0|||
105387537|NCT00098293|363424865|FG004|Supplemental Phase (SP)|Other|22|||
105387538|NCT02294019|363424868|FG000|Overall Study|Adverse Event|2|||
105387539|NCT02294019|363424868|FG000|Overall Study|Protocol Violation|68|||
105387540|NCT02294019|363424868|FG000|Overall Study|Lost to Follow-up|31|||
105387541|NCT02294019|363424868|FG000|Overall Study|Other|1|||
105387542|NCT02294019|363424868|FG000|Overall Study|Withdrawal by Subject|1|||
105387543|NCT02554474|363424869|FG000|Overall Study|Protocol Violation|1|||
105387544|NCT02554474|363424870|FG001|Overall Study|Protocol Violation|1|||
105387545|NCT02554474|363424869|FG000|Overall Study|Health issue not related to the study|1|||
105387546|NCT02554474|363424870|FG001|Overall Study|Health issue not related to the study|0|||
105387547|NCT02554474|363424869|FG000|Overall Study|Withdrawal by Subject|1|||
105387548|NCT02554474|363424870|FG001|Overall Study|Withdrawal by Subject|1|||
105387549|NCT02774278|363424871|FG000|Overall Study|Lack of Efficacy|199|||
105387550|NCT02774278|363424871|FG000|Overall Study|Death|29|||
105387551|NCT02774278|363424871|FG000|Overall Study|Adverse event/intercurrent illness|16|||
105387552|NCT02774278|363424871|FG000|Overall Study|Refused treatment/did not cooperate|9|||
105387553|NCT02774278|363424871|FG000|Overall Study|Administrative reasons|6|||
105387554|NCT02774278|363424871|FG000|Overall Study|Withdrawal by Subject|3|||
105387555|NCT02774278|363424871|FG000|Overall Study|Protocol Violation|2|||
105387556|NCT01539525|363424872|FG000|Overall Study|Lost to Follow-up|19|||
105387557|NCT01539525|363424873|FG001|Overall Study|Lost to Follow-up|12|||
105387558|NCT01539525|363424874|FG002|Overall Study|Lost to Follow-up|11|||
105387559|NCT01539525|363424872|FG000|Overall Study|Withdrawal by Subject|0|||
105387560|NCT01539525|363424873|FG001|Overall Study|Withdrawal by Subject|3|||
105387561|NCT01539525|363424874|FG002|Overall Study|Withdrawal by Subject|2|||
105387562|NCT01539525|363424872|FG000|Overall Study|Protocol Violation|1|||
105387563|NCT01539525|363424873|FG001|Overall Study|Protocol Violation|1|||
105387564|NCT01539525|363424874|FG002|Overall Study|Protocol Violation|4|||
105387565|NCT02539394|363424875|FG000|Overall Study|Protocol Violation|1|||
105387566|NCT02539394|363424876|FG001|Overall Study|Protocol Violation|3|||
105387567|NCT02539394|363424875|FG000|Overall Study|Lost to Follow-up|1|||
105387568|NCT02539394|363424876|FG001|Overall Study|Lost to Follow-up|2|||
105387569|NCT02539394|363424875|FG000|Overall Study|Incomplete dataset|6|||
105387570|NCT02539394|363424876|FG001|Overall Study|Incomplete dataset|6|||
105387571|NCT03061214|363424895|FG000|Overall Study|Withdrawal by Subject|21|||
105387572|NCT03061214|363424896|FG001|Overall Study|Withdrawal by Subject|26|||
105387573|NCT03061214|363424897|FG002|Overall Study|Withdrawal by Subject|9|||
105387574|NCT03061214|363424895|FG000|Overall Study|Lost to Follow-up|3|||
105387575|NCT03061214|363424896|FG001|Overall Study|Lost to Follow-up|1|||
105387576|NCT03061214|363424897|FG002|Overall Study|Lost to Follow-up|1|||
105387577|NCT03061214|363424895|FG000|Overall Study|Death|1|||
105387578|NCT03061214|363424896|FG001|Overall Study|Death|1|||
105387579|NCT03061214|363424897|FG002|Overall Study|Death|0|||
105387580|NCT01316900|363424898|FG000|Overall Study|Adverse Event|10|||
105387581|NCT01316900|363424899|FG001|Overall Study|Adverse Event|10|||
105387582|NCT01316900|363424900|FG002|Overall Study|Adverse Event|15|||
105387583|NCT01316900|363424901|FG003|Overall Study|Adverse Event|9|||
105387584|NCT01316900|363424898|FG000|Overall Study|Lack of Efficacy|17|||
105387585|NCT01316900|363424899|FG001|Overall Study|Lack of Efficacy|9|||
105387586|NCT01316900|363424900|FG002|Overall Study|Lack of Efficacy|5|||
105387587|NCT01316900|363424901|FG003|Overall Study|Lack of Efficacy|7|||
105387588|NCT01316900|363424898|FG000|Overall Study|Protocol Violation|7|||
105387589|NCT01316900|363424899|FG001|Overall Study|Protocol Violation|1|||
105387590|NCT01316900|363424900|FG002|Overall Study|Protocol Violation|4|||
105387591|NCT01316900|363424901|FG003|Overall Study|Protocol Violation|0|||
105387592|NCT01316900|363424898|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
105387593|NCT01316900|363424899|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
105387594|NCT01316900|363424900|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
105387595|NCT01316900|363424901|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
105387596|NCT01316900|363424898|FG000|Overall Study|Lost to Follow-up|1|||
105387597|NCT01316900|363424899|FG001|Overall Study|Lost to Follow-up|0|||
105387598|NCT01316900|363424900|FG002|Overall Study|Lost to Follow-up|1|||
105387599|NCT01316900|363424901|FG003|Overall Study|Lost to Follow-up|1|||
105387600|NCT01316900|363424898|FG000|Overall Study|Withdrawal by Subject|7|||
105387601|NCT01316900|363424899|FG001|Overall Study|Withdrawal by Subject|8|||
105387602|NCT01316900|363424900|FG002|Overall Study|Withdrawal by Subject|6|||
105387603|NCT01316900|363424901|FG003|Overall Study|Withdrawal by Subject|9|||
105387604|NCT00236197|363424904|FG000|Overall Study|Withdrawal by Subject|3|||
105387605|NCT00236197|363424905|FG001|Overall Study|Withdrawal by Subject|2|||
105387606|NCT00236197|363424904|FG000|Overall Study|Lost to Follow-up|1|||
105387607|NCT00236197|363424905|FG001|Overall Study|Lost to Follow-up|5|||
105387608|NCT00236197|363424904|FG000|Overall Study|Protocol Violation|0|||
105387609|NCT00236197|363424905|FG001|Overall Study|Protocol Violation|3|||
105387610|NCT00236197|363424904|FG000|Overall Study|Medication non-compliance|1|||
105387611|NCT00236197|363424905|FG001|Overall Study|Medication non-compliance|2|||
105387612|NCT00236197|363424904|FG000|Overall Study|Other|0|||
105387613|NCT00236197|363424905|FG001|Overall Study|Other|2|||
105387614|NCT02916433|363424906|FG000|Overall Study|Withdrawal by Subject|1|||
105387615|NCT02916433|363424907|FG001|Overall Study|Withdrawal by Subject|0|||
105387616|NCT02916433|363424906|FG000|Overall Study|Physician Decision|1|||
105387617|NCT02916433|363424907|FG001|Overall Study|Physician Decision|0|||
105387618|NCT03760666|363424908|FG000|Overall Study|Adverse Event|2|||
105387619|NCT03760666|363424909|FG001|Overall Study|Adverse Event|4|||
105387620|NCT03760666|363424910|FG002|Overall Study|Adverse Event|1|||
105387621|NCT03760666|363424908|FG000|Overall Study|AML Disease Progression|3|||
105387622|NCT03760666|363424909|FG001|Overall Study|AML Disease Progression|3|||
105387623|NCT03760666|363424910|FG002|Overall Study|AML Disease Progression|0|||
105387624|NCT03760666|363424908|FG000|Overall Study|Physician Decision|0|||
105387625|NCT03760666|363424909|FG001|Overall Study|Physician Decision|3|||
105387626|NCT03760666|363424910|FG002|Overall Study|Physician Decision|0|||
105387627|NCT03760666|363424908|FG000|Overall Study|Withdrawal by Subject|0|||
105387628|NCT03760666|363424909|FG001|Overall Study|Withdrawal by Subject|1|||
105387629|NCT03760666|363424910|FG002|Overall Study|Withdrawal by Subject|0|||
105387630|NCT03289741|363424912|FG000|Overall Study|Adverse Event|1|||
105387631|NCT03289741|363424913|FG001|Overall Study|Adverse Event|1|||
105387632|NCT03289741|363424912|FG000|Overall Study|Physician Decision|2|||
105387633|NCT03289741|363424913|FG001|Overall Study|Physician Decision|2|||
105387634|NCT03289741|363424912|FG000|Overall Study|Withdrawal by Subject|1|||
105387635|NCT03289741|363424913|FG001|Overall Study|Withdrawal by Subject|0|||
105387636|NCT02931539|363424915|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
105387637|NCT02931539|363424916|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
105387638|NCT02931539|363424917|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
105387639|NCT02931539|363424915|FG000|Period 1: Treatment Phase|Adverse Event|5|||
105387640|NCT02931539|363424916|FG001|Period 1: Treatment Phase|Adverse Event|1|||
105387641|NCT02931539|363424917|FG002|Period 1: Treatment Phase|Adverse Event|0|||
105387642|NCT02931539|363424915|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
105387643|NCT02931539|363424916|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
105387644|NCT02931539|363424917|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
105387645|NCT02931539|363424915|FG000|Period 1: Treatment Phase|Death|8|||
105387646|NCT02931539|363424916|FG001|Period 1: Treatment Phase|Death|24|||
105387647|NCT02931539|363424917|FG002|Period 1: Treatment Phase|Death|0|||
105387648|NCT02931539|363424915|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
105387649|NCT02931539|363424916|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
105387650|NCT02931539|363424917|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
105387651|NCT02931539|363424915|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
105387652|NCT02931539|363424916|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
105387653|NCT02931539|363424917|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
105387654|NCT02931539|363424915|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
105387655|NCT02931539|363424916|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
105387656|NCT02931539|363424917|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
105387657|NCT02931539|363424915|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
105387658|NCT02931539|363424916|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
105387659|NCT02931539|363424917|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
105387660|NCT03681093|363426775|FG000|Overall Study|Subject decision|0|||
105387661|NCT03681093|363426776|FG001|Overall Study|Subject decision|2|||
105387662|NCT03681093|363426777|FG002|Overall Study|Subject decision|1|||
105387663|NCT02529488|363426778|FG000|Overall Study|Adverse Event|1|||
105387664|NCT02529488|363426778|FG000|Overall Study|Death|3|||
105387665|NCT02698787|363426779|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
105387666|NCT02698787|363426780|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
105387667|NCT01882829|363426785|FG000|Overall Study|Adverse Event|4|||
105387668|NCT01882829|363426785|FG000|Overall Study|Protocol Violation|1|||
105387669|NCT01882829|363426785|FG000|Overall Study|Withdrawal by Subject|1|||
105387670|NCT03312114|363426787|FG000|Overall Study|All the five enrolled dropped out of the|5|||
105387671|NCT02933151|363426788|FG000|Overall Study|Lost to Follow-up|19|||
105387672|NCT02933151|363426789|FG001|Overall Study|Lost to Follow-up|18|||
105387673|NCT02933151|363426788|FG000|Overall Study|Death|1732|||
105387674|NCT02933151|363426789|FG001|Overall Study|Death|1827|||
105387675|NCT02933151|363426788|FG000|Overall Study|Transplant|210|||
105387676|NCT02933151|363426789|FG001|Overall Study|Transplant|278|||
105387677|NCT02933151|363426788|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
105387678|NCT02933151|363426789|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
105387679|NCT02933151|363426788|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
105387680|NCT02933151|363426789|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
105387681|NCT02933151|363426788|FG000|Overall Study|Recovered Kidney Function|47|||
105387682|NCT02933151|363426789|FG001|Overall Study|Recovered Kidney Function|29|||
105387683|NCT01862029|363426790|FG000|Overall Study|Physician Decision|1|||
105387684|NCT04605588|363426791|FG000|Overall Study|Withdrawal by Subject|1|||
105387685|NCT04605588|363426792|FG001|Overall Study|Withdrawal by Subject|0|||
105387686|NCT01230814|363426793|FG000|Overall Study|Lost to Follow-up|11|||
105387687|NCT01230814|363426794|FG001|Overall Study|Lost to Follow-up|3|||
105387688|NCT01230814|363426793|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
105387689|NCT01230814|363426794|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
105387690|NCT00504556|363426795|FG000|Overall Study|Adverse Event|11|||
105387691|NCT00504556|363426796|FG001|Overall Study|Adverse Event|11|||
105387692|NCT00504556|363426797|FG002|Overall Study|Adverse Event|14|||
105387693|NCT00504556|363426798|FG003|Overall Study|Adverse Event|13|||
105387694|NCT00504556|363426799|FG004|Overall Study|Adverse Event|5|||
105387695|NCT00504556|363426795|FG000|Overall Study|Death|3|||
105387696|NCT00504556|363426796|FG001|Overall Study|Death|3|||
105387697|NCT00504556|363426797|FG002|Overall Study|Death|1|||
105387698|NCT00504556|363426798|FG003|Overall Study|Death|0|||
105387699|NCT00504556|363426799|FG004|Overall Study|Death|2|||
105387700|NCT00504556|363426795|FG000|Overall Study|Protocol Violation|1|||
105387701|NCT00504556|363426796|FG001|Overall Study|Protocol Violation|3|||
105387702|NCT00504556|363426797|FG002|Overall Study|Protocol Violation|2|||
105387703|NCT00504556|363426798|FG003|Overall Study|Protocol Violation|1|||
105387704|NCT00504556|363426799|FG004|Overall Study|Protocol Violation|2|||
105387705|NCT00504556|363426795|FG000|Overall Study|Lost to Follow-up|0|||
105387706|NCT00504556|363426796|FG001|Overall Study|Lost to Follow-up|0|||
105387707|NCT00504556|363426797|FG002|Overall Study|Lost to Follow-up|1|||
105387708|NCT00504556|363426798|FG003|Overall Study|Lost to Follow-up|1|||
105387709|NCT00504556|363426799|FG004|Overall Study|Lost to Follow-up|1|||
105387710|NCT00504556|363426795|FG000|Overall Study|Withdrawal by Subject|16|||
105387711|NCT00504556|363426796|FG001|Overall Study|Withdrawal by Subject|16|||
105387712|NCT00504556|363426797|FG002|Overall Study|Withdrawal by Subject|7|||
105387713|NCT00504556|363426798|FG003|Overall Study|Withdrawal by Subject|8|||
105387714|NCT00504556|363426799|FG004|Overall Study|Withdrawal by Subject|12|||
105387715|NCT00504556|363426795|FG000|Overall Study|administrative reasons|0|||
105387716|NCT00504556|363426796|FG001|Overall Study|administrative reasons|2|||
105387717|NCT00504556|363426797|FG002|Overall Study|administrative reasons|2|||
105387718|NCT00504556|363426798|FG003|Overall Study|administrative reasons|1|||
105387719|NCT00504556|363426799|FG004|Overall Study|administrative reasons|2|||
105387720|NCT00504556|363426795|FG000|Overall Study|did not meet entry criteria|2|||
105387721|NCT00504556|363426796|FG001|Overall Study|did not meet entry criteria|0|||
105387722|NCT00504556|363426797|FG002|Overall Study|did not meet entry criteria|1|||
105387723|NCT00504556|363426798|FG003|Overall Study|did not meet entry criteria|1|||
105387724|NCT00504556|363426799|FG004|Overall Study|did not meet entry criteria|0|||
105387725|NCT00504556|363426795|FG000|Overall Study|data monitor committee decision|0|||
105387726|NCT00504556|363426796|FG001|Overall Study|data monitor committee decision|0|||
105387727|NCT00504556|363426797|FG002|Overall Study|data monitor committee decision|0|||
105387728|NCT00504556|363426798|FG003|Overall Study|data monitor committee decision|100|||
105387729|NCT00504556|363426799|FG004|Overall Study|data monitor committee decision|0|||
105387730|NCT00504556|363426795|FG000|Overall Study|Other|2|||
105387731|NCT00504556|363426796|FG001|Overall Study|Other|2|||
105387732|NCT00504556|363426797|FG002|Overall Study|Other|2|||
105387733|NCT00504556|363426798|FG003|Overall Study|Other|3|||
105387734|NCT00504556|363426799|FG004|Overall Study|Other|0|||
105387735|NCT00504556|363426795|FG000|Overall Study|not in safety analysis set|0|||
105387736|NCT00504556|363426796|FG001|Overall Study|not in safety analysis set|1|||
105387737|NCT00504556|363426797|FG002|Overall Study|not in safety analysis set|1|||
105387738|NCT00504556|363426798|FG003|Overall Study|not in safety analysis set|0|||
105387739|NCT00504556|363426799|FG004|Overall Study|not in safety analysis set|1|||
105387740|NCT03280615|363426800|FG000|Overall Study|Lost to Follow-up|1|||
105387741|NCT03280615|363426801|FG001|Overall Study|Lost to Follow-up|2|||
105387742|NCT03280615|363426800|FG000|Overall Study|Adverse Event|1|||
105387743|NCT03280615|363426801|FG001|Overall Study|Adverse Event|1|||
105387744|NCT03280615|363426800|FG000|Overall Study|Withdrawal by Subject|2|||
105387745|NCT03280615|363426801|FG001|Overall Study|Withdrawal by Subject|2|||
105387746|NCT00107614|363426809|FG000|Overall Study|Physician Decision|10|||
105387747|NCT00107614|363426809|FG000|Overall Study|Death|2|||
105387748|NCT00185614|363426810|FG000|Inter-treatment Period|Physician Decision|1|||
105387749|NCT00185614|363426810|FG000|Inter-treatment Period|Relapse|2|||
105387750|NCT00185614|363426810|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
105387751|NCT01052428|363426811|FG000|Overall Study|Death|1|||
105387752|NCT01052428|363426812|FG001|Overall Study|Death|0|||
105387753|NCT01052428|363426811|FG000|Overall Study|Withdrawal by Subject|0|||
105387754|NCT01052428|363426812|FG001|Overall Study|Withdrawal by Subject|1|||
105387755|NCT02365064|363426813|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
105387756|NCT02365064|363426814|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
105387757|NCT02365064|363426813|FG000|Overall Study|Withdrawal by Subject|6|||
105387758|NCT02365064|363426814|FG001|Overall Study|Withdrawal by Subject|9|||
105387759|NCT02365064|363426813|FG000|Overall Study|Treatment intolerance|2|||
105387760|NCT02365064|363426814|FG001|Overall Study|Treatment intolerance|4|||
105387761|NCT00866775|363426818|FG000|Overall Study|Adverse Event|5|||
105387762|NCT00866775|363426819|FG001|Overall Study|Adverse Event|19|||
105387763|NCT00866775|363426818|FG000|Overall Study|Death|1|||
105387764|NCT00866775|363426819|FG001|Overall Study|Death|0|||
105387765|NCT00866775|363426818|FG000|Overall Study|Lost to Follow-up|0|||
105387766|NCT00866775|363426819|FG001|Overall Study|Lost to Follow-up|4|||
105387767|NCT00866775|363426818|FG000|Overall Study|Physician Decision|0|||
105387768|NCT00866775|363426819|FG001|Overall Study|Physician Decision|3|||
105387769|NCT00866775|363426818|FG000|Overall Study|Protocol Violation|3|||
105387770|NCT00866775|363426819|FG001|Overall Study|Protocol Violation|4|||
105387771|NCT00866775|363426818|FG000|Overall Study|Withdrawal by Subject|4|||
105387772|NCT00866775|363426819|FG001|Overall Study|Withdrawal by Subject|4|||
105387773|NCT00866775|363426818|FG000|Overall Study|met exit criteria|23|||
105387774|NCT00866775|363426819|FG001|Overall Study|met exit criteria|17|||
105387775|NCT00866775|363426818|FG000|Overall Study|discontinued due to communication error|0|||
105387776|NCT00866775|363426819|FG001|Overall Study|discontinued due to communication error|1|||
105387777|NCT00605657|363426820|FG000|Overall Study|Adverse Event|1|||
105387778|NCT00605657|363426820|FG000|Overall Study|Protocol Violation|1|||
105387779|NCT00493285|363426825|FG000|Overall Study|Lost to Follow-up|0|||
105387780|NCT00493285|363426826|FG001|Overall Study|Lost to Follow-up|0|||
105387781|NCT00493285|363426827|FG002|Overall Study|Lost to Follow-up|0|||
105387782|NCT00493285|363426828|FG003|Overall Study|Lost to Follow-up|0|||
105387783|NCT00493285|363426829|FG004|Overall Study|Lost to Follow-up|1|||
105387784|NCT00493285|363426830|FG005|Overall Study|Lost to Follow-up|0|||
105387785|NCT02094885|363426831|FG000|Overall Study|Death|1|||
105580549|NCT02018861|364126449|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
105387786|NCT02094885|363426832|FG001|Overall Study|Death|5|||
105387787|NCT02094885|363426831|FG000|Overall Study|Withdrawn due to age|1|||
105387788|NCT02094885|363426832|FG001|Overall Study|Withdrawn due to age|0|||
105387789|NCT03021005|363426833|FG000|Overall Study|Lost to Follow-up|39|||
105387790|NCT03021005|363426834|FG001|Overall Study|Lost to Follow-up|26|||
105387791|NCT00215553|363426842|FG000|Overall Study|Adverse Event|0|||
105387792|NCT00215553|363426843|FG001|Overall Study|Adverse Event|1|||
105387793|NCT00215553|363426844|FG002|Overall Study|Adverse Event|2|||
105387794|NCT00215553|363426845|FG003|Overall Study|Adverse Event|1|||
105387795|NCT00215553|363426846|FG004|Overall Study|Adverse Event|2|||
105387796|NCT00215553|363426847|FG005|Overall Study|Adverse Event|6|||
105387797|NCT00215553|363426848|FG006|Overall Study|Adverse Event|0|||
105387798|NCT01658735|363426849|FG000|Overall Study|Lack of Efficacy|1|||
105387799|NCT01658735|363426850|FG001|Overall Study|Lack of Efficacy|0|||
105387800|NCT01658735|363426851|FG002|Overall Study|Lack of Efficacy|1|||
105387801|NCT01658735|363426849|FG000|Overall Study|Lost to Follow-up|1|||
105387802|NCT01658735|363426850|FG001|Overall Study|Lost to Follow-up|1|||
105387803|NCT01658735|363426851|FG002|Overall Study|Lost to Follow-up|0|||
105387804|NCT01658735|363426849|FG000|Overall Study|Protocol Violation|0|||
105387805|NCT01658735|363426850|FG001|Overall Study|Protocol Violation|1|||
105387806|NCT01658735|363426851|FG002|Overall Study|Protocol Violation|0|||
105387807|NCT01658735|363426849|FG000|Overall Study|Withdrawal by Subject|3|||
105387808|NCT01658735|363426850|FG001|Overall Study|Withdrawal by Subject|5|||
105387809|NCT01658735|363426851|FG002|Overall Study|Withdrawal by Subject|3|||
105387810|NCT03156621|363426852|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
105387811|NCT03156621|363426853|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
105387812|NCT03156621|363426852|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
105387813|NCT03156621|363426853|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
105387814|NCT01104870|363426854|FG000|Overall Study|Adverse Event|1|||
105387815|NCT01104870|363426855|FG001|Overall Study|Adverse Event|1|||
105387816|NCT01104870|363426856|FG002|Overall Study|Adverse Event|0|||
105387817|NCT01104870|363426854|FG000|Overall Study|Death|0|||
105387818|NCT01104870|363426855|FG001|Overall Study|Death|0|||
105387819|NCT01104870|363426856|FG002|Overall Study|Death|1|||
105387820|NCT01104870|363426854|FG000|Overall Study|Withdrawal by Subject|0|||
105387821|NCT01104870|363426855|FG001|Overall Study|Withdrawal by Subject|0|||
105387822|NCT01104870|363426856|FG002|Overall Study|Withdrawal by Subject|1|||
105387823|NCT05122143|363426857|FG000|Overall Study|Adverse Event|1|||
105387824|NCT05122143|363426858|FG001|Overall Study|Adverse Event|0|||
105387825|NCT05122143|363426859|FG002|Overall Study|Adverse Event|0|||
105387826|NCT05122143|363426860|FG003|Overall Study|Adverse Event|0|||
105387827|NCT05122143|363426861|FG004|Overall Study|Adverse Event|1|||
105387828|NCT05122143|363426862|FG005|Overall Study|Adverse Event|0|||
105387829|NCT05122143|363426857|FG000|Overall Study|Protocol non-compliance|0|||
105387830|NCT05122143|363426858|FG001|Overall Study|Protocol non-compliance|0|||
105387831|NCT05122143|363426859|FG002|Overall Study|Protocol non-compliance|1|||
105387832|NCT05122143|363426860|FG003|Overall Study|Protocol non-compliance|0|||
105387833|NCT05122143|363426861|FG004|Overall Study|Protocol non-compliance|0|||
105387834|NCT05122143|363426862|FG005|Overall Study|Protocol non-compliance|0|||
105387835|NCT05122143|363426857|FG000|Overall Study|Covid contact|0|||
105387836|NCT05122143|363426858|FG001|Overall Study|Covid contact|0|||
105387837|NCT05122143|363426859|FG002|Overall Study|Covid contact|0|||
105387838|NCT05122143|363426860|FG003|Overall Study|Covid contact|0|||
105387839|NCT05122143|363426861|FG004|Overall Study|Covid contact|1|||
105387840|NCT05122143|363426862|FG005|Overall Study|Covid contact|0|||
105387841|NCT03016403|363426866|FG000|Baseline|Death|5|||
105387842|NCT03016403|363426867|FG001|Baseline|Death|8|||
105387843|NCT03016403|363426868|FG002|Baseline|Death|1|||
105387844|NCT03016403|363426869|FG003|Baseline|Death|0|||
105387845|NCT03016403|363426866|FG000|Baseline|Withdrawal by Subject|2|||
105387846|NCT03016403|363426867|FG001|Baseline|Withdrawal by Subject|8|||
105387847|NCT03016403|363426868|FG002|Baseline|Withdrawal by Subject|4|||
105387848|NCT03016403|363426869|FG003|Baseline|Withdrawal by Subject|10|||
105387849|NCT03016403|363426866|FG000|Baseline|Lost to Follow-up|9|||
105387850|NCT03016403|363426867|FG001|Baseline|Lost to Follow-up|11|||
105387851|NCT03016403|363426868|FG002|Baseline|Lost to Follow-up|6|||
105387852|NCT03016403|363426869|FG003|Baseline|Lost to Follow-up|24|||
105387853|NCT03016403|363426866|FG000|6-week Follow-up|Death|1|||
105387854|NCT03016403|363426867|FG001|6-week Follow-up|Death|4|||
105387855|NCT03016403|363426868|FG002|6-week Follow-up|Death|0|||
105387856|NCT03016403|363426869|FG003|6-week Follow-up|Death|0|||
105387857|NCT03016403|363426866|FG000|6-week Follow-up|Lost to Follow-up|2|||
105387858|NCT03016403|363426867|FG001|6-week Follow-up|Lost to Follow-up|7|||
105387859|NCT03016403|363426868|FG002|6-week Follow-up|Lost to Follow-up|4|||
105387860|NCT03016403|363426869|FG003|6-week Follow-up|Lost to Follow-up|8|||
105387861|NCT03016403|363426866|FG000|6-week Follow-up|Withdrawal by Subject|0|||
105387862|NCT03016403|363426867|FG001|6-week Follow-up|Withdrawal by Subject|2|||
105387863|NCT03016403|363426868|FG002|6-week Follow-up|Withdrawal by Subject|0|||
105387864|NCT03016403|363426869|FG003|6-week Follow-up|Withdrawal by Subject|1|||
105387865|NCT03016403|363426866|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
105387866|NCT03016403|363426867|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
105387867|NCT03016403|363426868|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
105387868|NCT03016403|363426869|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
105387869|NCT03016403|363426866|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
105387870|NCT03016403|363426867|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
105387871|NCT03016403|363426868|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
105387872|NCT03016403|363426869|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
105387873|NCT03016403|363426866|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
105387874|NCT03016403|363426867|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
105387875|NCT03016403|363426868|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
105387876|NCT03016403|363426869|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
105387877|NCT00079781|363426870|FG000|Pre-implant Period|Withdrawal by Subject|2|||
105387878|NCT00079781|363426871|FG001|Pre-implant Period|Withdrawal by Subject|0|||
105387879|NCT00079781|363426872|FG002|Pre-implant Period|Withdrawal by Subject|0|||
105387880|NCT00079781|363426870|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
105387881|NCT00079781|363426871|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
105387882|NCT00079781|363426872|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
105387883|NCT00079781|363426870|FG000|Follow-up Period|Withdrawal by Subject|3|||
105387884|NCT00079781|363426871|FG001|Follow-up Period|Withdrawal by Subject|0|||
105387885|NCT00079781|363426872|FG002|Follow-up Period|Withdrawal by Subject|1|||
105387886|NCT00079781|363426870|FG000|Follow-up Period|Lost to Follow-up|1|||
105387887|NCT00079781|363426871|FG001|Follow-up Period|Lost to Follow-up|0|||
105387888|NCT00079781|363426872|FG002|Follow-up Period|Lost to Follow-up|0|||
105387889|NCT00079781|363426870|FG000|Follow-up Period|Death|0|||
105387890|NCT00079781|363426871|FG001|Follow-up Period|Death|0|||
105387891|NCT00079781|363426872|FG002|Follow-up Period|Death|1|||
105387892|NCT00576407|363426873|FG000|Overall Study|Death|7|||
105387893|NCT00576407|363426873|FG000|Overall Study|Physician Decision|1|||
105387894|NCT03596983|363426876|FG000|Overall Study|Withdrawal by Subject|3|||
105387895|NCT01340170|363426879|FG000|Overall Study|Lost to Follow-up|2|||
105387896|NCT01340170|363426880|FG001|Overall Study|Lost to Follow-up|4|||
105387897|NCT01340170|363426881|FG002|Overall Study|Lost to Follow-up|0|||
105387898|NCT01340170|363426879|FG000|Overall Study|Implant failure|1|||
105387899|NCT01340170|363426880|FG001|Overall Study|Implant failure|3|||
105387900|NCT01340170|363426881|FG002|Overall Study|Implant failure|0|||
105387901|NCT00452530|363426882|FG000|Overall Study|Death|1|||
105387902|NCT00452530|363426883|FG001|Overall Study|Death|0|||
105387903|NCT00452530|363426882|FG000|Overall Study|Adverse Event|40|||
105387904|NCT00452530|363426883|FG001|Overall Study|Adverse Event|44|||
105387905|NCT00452530|363426882|FG000|Overall Study|Withdrawal by Subject|68|||
105387906|NCT00452530|363426883|FG001|Overall Study|Withdrawal by Subject|57|||
105387907|NCT00452530|363426882|FG000|Overall Study|Lost to Follow-up|1|||
105387908|NCT00452530|363426883|FG001|Overall Study|Lost to Follow-up|0|||
105387909|NCT00452530|363426882|FG000|Overall Study|Poor compliance/noncompliance|1|||
105387910|NCT00452530|363426883|FG001|Overall Study|Poor compliance/noncompliance|2|||
105387911|NCT00452530|363426882|FG000|Overall Study|No longer met study criteria|18|||
105387912|NCT00452530|363426883|FG001|Overall Study|No longer met study criteria|22|||
105387913|NCT00452530|363426882|FG000|Overall Study|Other|7|||
105387914|NCT00452530|363426883|FG001|Overall Study|Other|11|||
105387915|NCT00754559|363426884|FG000|Overall Study|Adverse Event|15|||
105387916|NCT00754559|363426884|FG000|Overall Study|Protocol Violation|11|||
105387917|NCT00754559|363426884|FG000|Overall Study|Lack of Efficacy|10|||
105387918|NCT00754559|363426884|FG000|Overall Study|Lost to Follow-up|2|||
105387919|NCT00754559|363426884|FG000|Overall Study|Administrative reason|1|||
105387920|NCT00754559|363426884|FG000|Overall Study|Other|5|||
105387921|NCT00754559|363426884|FG000|Overall Study|Withdrawal by Subject|3|||
105387922|NCT00345592|363426885|FG000|Overall Study|Death|14|||
105387923|NCT00345592|363426886|FG001|Overall Study|Death|16|||
105387924|NCT00345592|363426885|FG000|Overall Study|Withdrawal by Subject|11|||
105387925|NCT00345592|363426886|FG001|Overall Study|Withdrawal by Subject|8|||
105387926|NCT01248468|363426887|FG000|Overall Study|Administrative problem|1|||
105387927|NCT01248468|363426888|FG001|Overall Study|Administrative problem|0|||
105387928|NCT01248468|363426889|FG002|Overall Study|Administrative problem|0|||
105387929|NCT01248468|363426887|FG000|Overall Study|Lost to Follow-up|9|||
105387930|NCT01248468|363426888|FG001|Overall Study|Lost to Follow-up|12|||
105387931|NCT01248468|363426889|FG002|Overall Study|Lost to Follow-up|4|||
105387932|NCT01248468|363426887|FG000|Overall Study|Pregnancy|1|||
105387933|NCT01248468|363426888|FG001|Overall Study|Pregnancy|0|||
105387934|NCT01248468|363426889|FG002|Overall Study|Pregnancy|0|||
105387935|NCT01248468|363426887|FG000|Overall Study|Withdrawal by Subject|4|||
105387936|NCT01248468|363426888|FG001|Overall Study|Withdrawal by Subject|2|||
105387937|NCT01248468|363426889|FG002|Overall Study|Withdrawal by Subject|0|||
105387938|NCT02191397|363426890|FG000|Overall Study|Adverse Event|28|||
105387939|NCT02191397|363426891|FG001|Overall Study|Adverse Event|17|||
105387940|NCT02191397|363426890|FG000|Overall Study|Lack of Efficacy|10|||
105387941|NCT02191397|363426891|FG001|Overall Study|Lack of Efficacy|5|||
105387942|NCT02191397|363426890|FG000|Overall Study|Protocol Violation|0|||
105387943|NCT02191397|363426891|FG001|Overall Study|Protocol Violation|3|||
105387944|NCT02191397|363426890|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
105387945|NCT02191397|363426891|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
105387946|NCT02191397|363426890|FG000|Overall Study|Lost to Follow-up|10|||
105387947|NCT02191397|363426891|FG001|Overall Study|Lost to Follow-up|11|||
105387948|NCT02191397|363426890|FG000|Overall Study|Physician Decision|8|||
105387949|NCT02191397|363426891|FG001|Overall Study|Physician Decision|3|||
105387950|NCT02191397|363426890|FG000|Overall Study|Withdrawal by Subject|22|||
105387951|NCT02191397|363426891|FG001|Overall Study|Withdrawal by Subject|27|||
105387952|NCT02176525|363426893|FG000|Overall Study|Adverse Event|0|||
105387953|NCT02176525|363426894|FG001|Overall Study|Adverse Event|0|||
105387954|NCT02176525|363426895|FG002|Overall Study|Adverse Event|0|||
105387955|NCT02176525|363426896|FG003|Overall Study|Adverse Event|1|||
105387956|NCT02176525|363426897|FG004|Overall Study|Adverse Event|1|||
105387957|NCT02176525|363426898|FG005|Overall Study|Adverse Event|0|||
105387958|NCT02176525|363426899|FG006|Overall Study|Adverse Event|1|||
105387959|NCT02176525|363426900|FG007|Overall Study|Adverse Event|0|||
105387960|NCT02176525|363426893|FG000|Overall Study|not treated|1|||
105387961|NCT02176525|363426894|FG001|Overall Study|not treated|0|||
105387962|NCT02176525|363426895|FG002|Overall Study|not treated|0|||
105387963|NCT02176525|363426896|FG003|Overall Study|not treated|0|||
105387964|NCT02176525|363426897|FG004|Overall Study|not treated|0|||
105387965|NCT02176525|363426898|FG005|Overall Study|not treated|1|||
105387966|NCT02176525|363426899|FG006|Overall Study|not treated|0|||
105387967|NCT02176525|363426900|FG007|Overall Study|not treated|0|||
105387968|NCT02100644|363426901|FG000|LTG Escalation Phase|Adverse Event|9|||
105387969|NCT02100644|363426902|FG001|LTG Escalation Phase|Adverse Event|0|||
105387970|NCT02100644|363426903|FG002|LTG Escalation Phase|Adverse Event|0|||
105387971|NCT02100644|363426901|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
105387972|NCT02100644|363426902|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
105387973|NCT02100644|363426903|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
105387974|NCT02100644|363426901|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
105387975|NCT02100644|363426902|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
105387976|NCT02100644|363426903|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
105387977|NCT00468546|363426904|FG000|Week 24 Analysis|Lack of Efficacy|83|||
105387978|NCT00468546|363426905|FG001|Week 24 Analysis|Lack of Efficacy|37|||
105387979|NCT00468546|363426904|FG000|Week 24 Analysis|Refused treatment|5|||
105387980|NCT00468546|363426905|FG001|Week 24 Analysis|Refused treatment|5|||
105387981|NCT00468546|363426904|FG000|Week 24 Analysis|Adverse Event|1|||
105387982|NCT00468546|363426905|FG001|Week 24 Analysis|Adverse Event|8|||
105387983|NCT00468546|363426904|FG000|Week 24 Analysis|Failure to return|3|||
105387984|NCT00468546|363426905|FG001|Week 24 Analysis|Failure to return|4|||
105387985|NCT00468546|363426904|FG000|Week 24 Analysis|Rescue therapy|2|||
105387986|NCT00468546|363426905|FG001|Week 24 Analysis|Rescue therapy|0|||
105387987|NCT00468546|363426904|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
105387988|NCT00468546|363426905|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
105387989|NCT00468546|363426904|FG000|Week 24 Analysis|Due to clinical hold|1|||
105387990|NCT00468546|363426905|FG001|Week 24 Analysis|Due to clinical hold|0|||
105387991|NCT00468546|363426904|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
105387992|NCT00468546|363426905|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
105387993|NCT00468546|363426904|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
105387994|NCT00468546|363426905|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
105387995|NCT00468546|363426904|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
105387996|NCT00468546|363426905|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
105387997|NCT00468546|363426904|FG000|Week 24 to Week 104 Analysis|Death|1|||
105387998|NCT00468546|363426905|FG001|Week 24 to Week 104 Analysis|Death|0|||
105387999|NCT00468546|363426904|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
105388000|NCT00468546|363426905|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
105388001|NCT00468546|363426904|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
105388002|NCT00468546|363426905|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
105388003|NCT00468546|363426904|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
105388004|NCT00468546|363426905|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
105388005|NCT00468546|363426904|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
105388006|NCT00468546|363426905|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
105388007|NCT00468546|363426904|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
105388008|NCT00468546|363426905|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
105388009|NCT00468546|363426904|FG000|Week 24 to Week 104 Analysis|Other|17|||
105388010|NCT00468546|363426905|FG001|Week 24 to Week 104 Analysis|Other|14|||
105388011|NCT04629521|363426906|FG000|Overall Study|Death|1|||
105388012|NCT04629521|363426906|FG000|Overall Study|Lost to Follow-up|3|||
105388013|NCT04629521|363426906|FG000|Overall Study|Subject withdrew consent|3|||
105388014|NCT04629521|363426906|FG000|Overall Study|Enrolled in error|1|||
105388015|NCT03760068|363426907|FG000|Overall Study|Withdrawal by Subject|7|||
105388016|NCT03760068|363426908|FG001|Overall Study|Withdrawal by Subject|8|||
105388017|NCT03760068|363426907|FG000|Overall Study|Adverse Event|1|||
105388018|NCT03760068|363426908|FG001|Overall Study|Adverse Event|2|||
105388019|NCT03760068|363426907|FG000|Overall Study|Administrative Decision by Sponsor|0|||
105388020|NCT03760068|363426908|FG001|Overall Study|Administrative Decision by Sponsor|2|||
105388021|NCT03760068|363426907|FG000|Overall Study|Physician Decision|1|||
105388022|NCT03760068|363426908|FG001|Overall Study|Physician Decision|2|||
105388023|NCT03760068|363426907|FG000|Overall Study|Lost to Follow-up|4|||
105388024|NCT03760068|363426908|FG001|Overall Study|Lost to Follow-up|9|||
105388025|NCT03760068|363426907|FG000|Overall Study|Subject Moved Out of State|1|||
105388026|NCT03760068|363426908|FG001|Overall Study|Subject Moved Out of State|0|||
105388027|NCT01898091|363426909|FG000|Overall Study|Lost to Follow-up|1|||
105388028|NCT01898091|363426910|FG001|Overall Study|Lost to Follow-up|1|||
105388029|NCT01898091|363426909|FG000|Overall Study|Withdrawal by Subject|1|||
105388030|NCT01898091|363426910|FG001|Overall Study|Withdrawal by Subject|5|||
105388031|NCT02369159|363426911|FG000|Overall Study|Adverse Event|0|||
105388032|NCT02369159|363426912|FG001|Overall Study|Adverse Event|1|||
105388033|NCT02369159|363426911|FG000|Overall Study|Lost to Follow-up|1|||
105388034|NCT02369159|363426912|FG001|Overall Study|Lost to Follow-up|1|||
105388035|NCT02369159|363426911|FG000|Overall Study|Withdrawal by Subject|7|||
105388036|NCT02369159|363426912|FG001|Overall Study|Withdrawal by Subject|0|||
105388037|NCT00425854|363426915|FG000|Overall Study|Progressive Disease|19|||
105388038|NCT00425854|363426916|FG001|Overall Study|Progressive Disease|12|||
105388039|NCT00425854|363426915|FG000|Overall Study|Dose reduction toxicity AE|8|||
105388040|NCT00425854|363426916|FG001|Overall Study|Dose reduction toxicity AE|7|||
105388041|NCT00425854|363426915|FG000|Overall Study|Other Adverse Event|2|||
105388042|NCT00425854|363426916|FG001|Overall Study|Other Adverse Event|2|||
105388043|NCT03511209|363426921|FG000|Overall Study|Withdrawal by Subject|2|||
105388044|NCT03511209|363426922|FG001|Overall Study|Withdrawal by Subject|4|||
105388045|NCT03511209|363426921|FG000|Overall Study|Death|1|||
105388046|NCT03511209|363426922|FG001|Overall Study|Death|0|||
105388047|NCT03511209|363426921|FG000|Overall Study|Lost to Follow-up|0|||
105388048|NCT03511209|363426922|FG001|Overall Study|Lost to Follow-up|2|||
105388049|NCT03769116|363426925|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
105388050|NCT03769116|363426926|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
105388051|NCT03769116|363426925|FG000|Part 3 - Open Label|Physician Decision|1|||
105388052|NCT03769116|363426926|FG001|Part 3 - Open Label|Physician Decision|0|||
105388053|NCT03769116|363426925|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
105388054|NCT03769116|363426926|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
105388055|NCT01602666|363426927|FG000|Induction Chemotherapy|Death|2|||
105388056|NCT01602666|363426928|FG001|Induction Chemotherapy|Death|1|||
105388057|NCT01602666|363426927|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
105388058|NCT01602666|363426928|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
105388059|NCT01602666|363426927|FG000|Induction Chemotherapy|Physician Decision|12|||
105388060|NCT01602666|363426928|FG001|Induction Chemotherapy|Physician Decision|5|||
105388061|NCT01602666|363426927|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
105388062|NCT01602666|363426928|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
105388063|NCT01602666|363426927|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
105388064|NCT01602666|363426928|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
105388065|NCT01602666|363426927|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
105388066|NCT01602666|363426928|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
105388067|NCT01602666|363426927|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
105388068|NCT01602666|363426928|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
105388069|NCT01602666|363426927|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
105388070|NCT01602666|363426928|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
105388071|NCT01602666|363426927|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
105388072|NCT01602666|363426928|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
105388073|NCT01602666|363426927|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
105388074|NCT01602666|363426928|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
105388075|NCT01602666|363426927|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
105388076|NCT01602666|363426928|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
105388077|NCT02489045|363426929|FG000|Overall Study|unable to collect usable data|53|||
105388078|NCT02489045|363426929|FG000|Follow-up|Lost to Follow-up|10|||
105388079|NCT03769467|363426932|FG000|Overall Study|Adverse Event|1|||
105388080|NCT03769467|363426933|FG001|Overall Study|Adverse Event|1|||
105388081|NCT03769467|363426934|FG002|Overall Study|Adverse Event|0|||
105388082|NCT03769467|363426932|FG000|Overall Study|Death|3|||
105388083|NCT03769467|363426933|FG001|Overall Study|Death|3|||
105388084|NCT03769467|363426934|FG002|Overall Study|Death|0|||
105388085|NCT03769467|363426932|FG000|Overall Study|Study Terminated By Sponsor|2|||
105388086|NCT03769467|363426933|FG001|Overall Study|Study Terminated By Sponsor|1|||
105388087|NCT03769467|363426934|FG002|Overall Study|Study Terminated By Sponsor|0|||
105388088|NCT03769467|363426932|FG000|Overall Study|Withdrawal by Subject|0|||
105388089|NCT03769467|363426933|FG001|Overall Study|Withdrawal by Subject|1|||
105388090|NCT03769467|363426934|FG002|Overall Study|Withdrawal by Subject|0|||
105388091|NCT04754399|363426935|FG000|Overall Study|Adverse Event|5|||
105388092|NCT04754399|363426935|FG000|Overall Study|Withdrawal by Subject|6|||
105388093|NCT02614066|363426936|FG000|Overall Study|Death|6|||
105388094|NCT02614066|363426937|FG001|Overall Study|Death|14|||
105388095|NCT02614066|363426938|FG002|Overall Study|Death|11|||
105388096|NCT02614066|363426939|FG003|Overall Study|Death|29|||
105388097|NCT02614066|363426936|FG000|Overall Study|Full consent withdrawn|0|||
105388098|NCT02614066|363426937|FG001|Overall Study|Full consent withdrawn|1|||
105388099|NCT02614066|363426938|FG002|Overall Study|Full consent withdrawn|0|||
105388100|NCT02614066|363426939|FG003|Overall Study|Full consent withdrawn|8|||
105388101|NCT02614066|363426936|FG000|Overall Study|Lost to Follow-up|0|||
105388102|NCT02614066|363426937|FG001|Overall Study|Lost to Follow-up|2|||
105388103|NCT02614066|363426938|FG002|Overall Study|Lost to Follow-up|2|||
105388104|NCT02614066|363426939|FG003|Overall Study|Lost to Follow-up|2|||
105388105|NCT02614066|363426936|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
105388106|NCT02614066|363426937|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
105388107|NCT02614066|363426938|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
105388108|NCT02614066|363426939|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
105388109|NCT02614066|363426936|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
105388110|NCT02614066|363426937|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
105388111|NCT02614066|363426938|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
105388112|NCT02614066|363426939|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
105388113|NCT02614066|363426936|FG000|Overall Study|Reason not specified|0|||
105388114|NCT02614066|363426937|FG001|Overall Study|Reason not specified|2|||
105388115|NCT02614066|363426938|FG002|Overall Study|Reason not specified|1|||
105388116|NCT02614066|363426939|FG003|Overall Study|Reason not specified|1|||
105388117|NCT03624036|363426940|FG000|Overall Study|Death|2|||
105388118|NCT03624036|363426941|FG001|Overall Study|Death|3|||
105388119|NCT03624036|363426942|FG002|Overall Study|Death|0|||
105388120|NCT03624036|363426943|FG003|Overall Study|Death|1|||
105388121|NCT03624036|363426940|FG000|Overall Study|Withdrawal by Subject|1|||
105388122|NCT03624036|363426941|FG001|Overall Study|Withdrawal by Subject|0|||
105388123|NCT03624036|363426942|FG002|Overall Study|Withdrawal by Subject|1|||
105388124|NCT03624036|363426943|FG003|Overall Study|Withdrawal by Subject|0|||
105388125|NCT03624036|363426940|FG000|Overall Study|Enrolled but Never Treated|1|||
105388126|NCT03624036|363426941|FG001|Overall Study|Enrolled but Never Treated|0|||
105388127|NCT03624036|363426942|FG002|Overall Study|Enrolled but Never Treated|0|||
105388128|NCT03624036|363426943|FG003|Overall Study|Enrolled but Never Treated|0|||
105388129|NCT03624036|363426940|FG000|Overall Study|Reason not Specified|3|||
105388130|NCT03624036|363426941|FG001|Overall Study|Reason not Specified|0|||
105388131|NCT03624036|363426942|FG002|Overall Study|Reason not Specified|2|||
105388132|NCT03624036|363426943|FG003|Overall Study|Reason not Specified|2|||
105388133|NCT01943825|363426944|FG000|Overall Study|Lost to Follow-up|9|||
105388134|NCT01943825|363426945|FG001|Overall Study|Lost to Follow-up|3|||
105388135|NCT01943825|363426946|FG002|Overall Study|Lost to Follow-up|12|||
105388136|NCT01943825|363426947|FG003|Overall Study|Lost to Follow-up|8|||
105388137|NCT01943825|363426944|FG000|Overall Study|Withdrawal by Subject|1|||
105388138|NCT01943825|363426945|FG001|Overall Study|Withdrawal by Subject|0|||
105388139|NCT01943825|363426946|FG002|Overall Study|Withdrawal by Subject|3|||
105388140|NCT01943825|363426947|FG003|Overall Study|Withdrawal by Subject|2|||
105388141|NCT01943825|363426944|FG000|Overall Study|Other than specified above|0|||
105388142|NCT01943825|363426945|FG001|Overall Study|Other than specified above|1|||
105388143|NCT01943825|363426946|FG002|Overall Study|Other than specified above|0|||
105388144|NCT01943825|363426947|FG003|Overall Study|Other than specified above|1|||
105388145|NCT01684033|363426952|FG000|Period 1, First 30 Days|Adverse Event|1|||
105388146|NCT01684033|363426953|FG001|Period 1, First 30 Days|Adverse Event|1|||
105388147|NCT01684033|363426952|FG000|Period 1, First 30 Days|Noncompliance|1|||
105388148|NCT01684033|363426953|FG001|Period 1, First 30 Days|Noncompliance|0|||
105388149|NCT01684033|363426952|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
105388150|NCT01684033|363426953|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
105388151|NCT01684033|363426952|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
105388152|NCT01684033|363426953|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
105388153|NCT01684033|363426952|FG000|Period 2, Second 30 Days|Adverse Event|1|||
105388154|NCT01684033|363426953|FG001|Period 2, Second 30 Days|Adverse Event|0|||
105388155|NCT01569763|363428854|FG000|Overall Study|Lack of Efficacy|2|||
105388156|NCT01569763|363428855|FG001|Overall Study|Lack of Efficacy|7|||
105388157|NCT01569763|363428854|FG000|Overall Study|Adverse Event|1|||
105388158|NCT01569763|363428855|FG001|Overall Study|Adverse Event|0|||
105388159|NCT01197300|363428859|FG000|Overall Study|Lost to Follow-up|0|||
105388160|NCT01197300|363428860|FG001|Overall Study|Lost to Follow-up|1|||
105388161|NCT01197300|363428859|FG000|Overall Study|Protocol Violation|0|||
105388162|NCT01197300|363428860|FG001|Overall Study|Protocol Violation|1|||
105388163|NCT01213251|363428863|FG000|Overall Study|Death|2|||
105388164|NCT01213251|363428864|FG001|Overall Study|Death|1|||
105388165|NCT01213251|363428865|FG002|Overall Study|Death|2|||
105388166|NCT01213251|363428863|FG000|Overall Study|Exit|3|||
105388167|NCT01213251|363428864|FG001|Overall Study|Exit|2|||
105388168|NCT01213251|363428865|FG002|Overall Study|Exit|8|||
105388169|NCT01213251|363428863|FG000|Overall Study|Protocol Violation|1|||
105388170|NCT01213251|363428864|FG001|Overall Study|Protocol Violation|1|||
105388171|NCT01213251|363428865|FG002|Overall Study|Protocol Violation|0|||
105388172|NCT01213251|363428863|FG000|Overall Study|Missed 18-Month Follow-up|0|||
105388173|NCT01213251|363428864|FG001|Overall Study|Missed 18-Month Follow-up|0|||
105388174|NCT01213251|363428865|FG002|Overall Study|Missed 18-Month Follow-up|1|||
105388175|NCT03635996|363428873|FG000|Overall Study|Study terminated by Sponsor|94|||
105388176|NCT03635996|363428873|FG000|Overall Study|Withdrawal by Subject|20|||
105388177|NCT03635996|363428873|FG000|Overall Study|Ablation|26|||
105388178|NCT03635996|363428873|FG000|Overall Study|Adverse Event|7|||
105388179|NCT03635996|363428873|FG000|Overall Study|Physician Decision|3|||
105388180|NCT03635996|363428873|FG000|Overall Study|Prohibited medication|5|||
105388181|NCT03635996|363428873|FG000|Overall Study|Did not meet eligibility criteria|5|||
105388182|NCT03635996|363428873|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
105388183|NCT03635996|363428873|FG000|Overall Study|Protocol Violation|1|||
105388184|NCT03635996|363428873|FG000|Overall Study|Lost to Follow-up|1|||
105388185|NCT01654250|363428874|FG000|Overall Study|Lost to Follow-up|1|||
105388186|NCT01654250|363428875|FG001|Overall Study|Lost to Follow-up|0|||
105388187|NCT01748552|363428877|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
105388188|NCT01748552|363428878|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
105388189|NCT01748552|363428879|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
105388190|NCT01748552|363428880|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
105388191|NCT01748552|363428881|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
105388192|NCT01748552|363428882|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
105388193|NCT01748552|363428883|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
105388194|NCT01748552|363428884|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
105388195|NCT01748552|363428885|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
105388196|NCT01748552|363428886|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
105388197|NCT01748552|363428887|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
105388198|NCT01748552|363428888|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
105388199|NCT01748552|363428877|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105388200|NCT01748552|363428878|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105388201|NCT01748552|363428879|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105388202|NCT01748552|363428880|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105388203|NCT01748552|363428881|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105388204|NCT01748552|363428882|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105388205|NCT01748552|363428883|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
105388206|NCT01748552|363428884|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
105388207|NCT01748552|363428885|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
105388208|NCT01748552|363428886|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105388209|NCT01748552|363428887|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105388210|NCT01748552|363428888|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105388211|NCT02180672|363428892|FG000|Overall Study|Lost to Follow-up|5|||
105388212|NCT02180672|363428893|FG001|Overall Study|Lost to Follow-up|7|||
105388213|NCT03574389|363428894|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
105388214|NCT03574389|363428895|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
105388215|NCT03574389|363428896|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
105388216|NCT03574389|363428897|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
105388217|NCT03574389|363428898|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
105388218|NCT03574389|363428899|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
105388219|NCT03574389|363428900|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
105388220|NCT03574389|363428894|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
105388221|NCT03574389|363428895|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
105388222|NCT03574389|363428896|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
105580550|NCT02018861|364126450|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
105580551|NCT02018861|364126451|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
105388223|NCT03574389|363428897|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
105580552|NCT02018861|364126452|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
105388224|NCT03574389|363428898|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
105388225|NCT03574389|363428899|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
105388226|NCT03574389|363428900|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
105388227|NCT03574389|363428894|FG000|Vaccination Period|Other|6|||
105388228|NCT03574389|363428895|FG001|Vaccination Period|Other|0|||
105388229|NCT03574389|363428896|FG002|Vaccination Period|Other|0|||
105388230|NCT03574389|363428897|FG003|Vaccination Period|Other|0|||
105388231|NCT03574389|363428898|FG004|Vaccination Period|Other|0|||
105388232|NCT03574389|363428899|FG005|Vaccination Period|Other|0|||
105388233|NCT03574389|363428900|FG006|Vaccination Period|Other|0|||
105388234|NCT03574389|363428894|FG000|Vaccination Period|Adverse Event|0|||
105388235|NCT03574389|363428895|FG001|Vaccination Period|Adverse Event|1|||
105388236|NCT03574389|363428896|FG002|Vaccination Period|Adverse Event|0|||
105388237|NCT03574389|363428897|FG003|Vaccination Period|Adverse Event|0|||
105388238|NCT03574389|363428898|FG004|Vaccination Period|Adverse Event|0|||
105388239|NCT03574389|363428899|FG005|Vaccination Period|Adverse Event|0|||
105388240|NCT03574389|363428900|FG006|Vaccination Period|Adverse Event|0|||
105388241|NCT03574389|363428894|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
105388242|NCT03574389|363428895|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
105388243|NCT03574389|363428896|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
105388244|NCT03574389|363428897|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
105388245|NCT03574389|363428898|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
105388246|NCT03574389|363428899|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
105388247|NCT03574389|363428900|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
105388248|NCT00912509|363428901|FG000|Overall Study|Lost to Follow-up|1|||
105388249|NCT00912509|363428902|FG001|Overall Study|Lost to Follow-up|0|||
105388250|NCT00912509|363428901|FG000|Overall Study|Lack of Efficacy|4|||
105388251|NCT00912509|363428902|FG001|Overall Study|Lack of Efficacy|3|||
105388252|NCT00756314|363428909|FG000|Overall Study|Lost to Follow-up|2|||
105388253|NCT00756314|363428910|FG001|Overall Study|Lost to Follow-up|59|||
105388254|NCT03757715|363428916|FG000|Overall Study|Lost to Follow-up|4|||
105388255|NCT03757715|363428917|FG001|Overall Study|Lost to Follow-up|9|||
105388256|NCT03757715|363428916|FG000|Overall Study|Withdrawal by Subject|1|||
105388257|NCT03757715|363428917|FG001|Overall Study|Withdrawal by Subject|1|||
105388258|NCT04985682|363428919|FG000|Overall Study|Withdrawal by Subject|1|||
105388259|NCT00692237|363428922|FG000|Overall Study|Withdrawal by Subject|1|||
105388260|NCT00692237|363428923|FG001|Overall Study|Withdrawal by Subject|3|||
105388261|NCT00692237|363428922|FG000|Overall Study|Adverse Event|0|||
105388262|NCT00692237|363428923|FG001|Overall Study|Adverse Event|1|||
105388263|NCT04829214|363428927|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
105388264|NCT04829214|363428928|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
105388265|NCT04829214|363428927|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
105388266|NCT04829214|363428928|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
105388267|NCT04135352|363428929|FG000|Overall Study|Not treated-randomization error|0|||
105388268|NCT04135352|363428930|FG001|Overall Study|Not treated-randomization error|0|||
105388269|NCT04135352|363428931|FG002|Overall Study|Not treated-randomization error|1|||
105388270|NCT04135352|363428932|FG003|Overall Study|Not treated-randomization error|0|||
105388271|NCT04135352|363428933|FG004|Overall Study|Not treated-randomization error|0|||
105388272|NCT04135352|363428934|FG005|Overall Study|Not treated-randomization error|0|||
105388273|NCT04135352|363428935|FG006|Overall Study|Not treated-randomization error|0|||
105388274|NCT04135352|363428936|FG007|Overall Study|Not treated-randomization error|0|||
105388275|NCT04135352|363428929|FG000|Overall Study|Withdrawal by Subject|0|||
105388276|NCT04135352|363428930|FG001|Overall Study|Withdrawal by Subject|0|||
105388277|NCT04135352|363428931|FG002|Overall Study|Withdrawal by Subject|2|||
105388278|NCT04135352|363428932|FG003|Overall Study|Withdrawal by Subject|0|||
105388279|NCT04135352|363428933|FG004|Overall Study|Withdrawal by Subject|0|||
105388280|NCT04135352|363428934|FG005|Overall Study|Withdrawal by Subject|0|||
105388281|NCT04135352|363428935|FG006|Overall Study|Withdrawal by Subject|0|||
105388282|NCT04135352|363428936|FG007|Overall Study|Withdrawal by Subject|0|||
105388283|NCT04135352|363428929|FG000|Overall Study|Sponsor Decision|0|||
105388284|NCT04135352|363428930|FG001|Overall Study|Sponsor Decision|0|||
105388285|NCT04135352|363428931|FG002|Overall Study|Sponsor Decision|2|||
105388286|NCT04135352|363428932|FG003|Overall Study|Sponsor Decision|5|||
105388287|NCT04135352|363428933|FG004|Overall Study|Sponsor Decision|1|||
105388288|NCT04135352|363428934|FG005|Overall Study|Sponsor Decision|4|||
105388289|NCT04135352|363428935|FG006|Overall Study|Sponsor Decision|0|||
105388290|NCT04135352|363428936|FG007|Overall Study|Sponsor Decision|0|||
105388291|NCT04135352|363428929|FG000|Overall Study|Physician Decision|0|||
105388292|NCT04135352|363428930|FG001|Overall Study|Physician Decision|0|||
105388293|NCT04135352|363428931|FG002|Overall Study|Physician Decision|1|||
105388294|NCT04135352|363428932|FG003|Overall Study|Physician Decision|0|||
105388295|NCT04135352|363428933|FG004|Overall Study|Physician Decision|1|||
105388296|NCT04135352|363428934|FG005|Overall Study|Physician Decision|0|||
105388297|NCT04135352|363428935|FG006|Overall Study|Physician Decision|0|||
105388298|NCT04135352|363428936|FG007|Overall Study|Physician Decision|0|||
105388299|NCT04135352|363428929|FG000|Overall Study|Death|3|||
105388300|NCT04135352|363428930|FG001|Overall Study|Death|4|||
105388301|NCT04135352|363428931|FG002|Overall Study|Death|7|||
105388302|NCT04135352|363428932|FG003|Overall Study|Death|0|||
105388303|NCT04135352|363428933|FG004|Overall Study|Death|3|||
105388304|NCT04135352|363428934|FG005|Overall Study|Death|1|||
105388305|NCT04135352|363428935|FG006|Overall Study|Death|0|||
105388306|NCT04135352|363428936|FG007|Overall Study|Death|0|||
105388307|NCT03878602|363428937|FG000|Overall Study|cord blood donation|7|||
105388308|NCT03878602|363428938|FG001|Overall Study|cord blood donation|1|||
105388309|NCT03878602|363428937|FG000|Overall Study|incomplete data collection|2|||
105388310|NCT03878602|363428938|FG001|Overall Study|incomplete data collection|0|||
105388311|NCT01370642|363428940|FG000|Overall Study|Adverse Event|2|||
105388312|NCT01370642|363428941|FG001|Overall Study|Adverse Event|1|||
105388313|NCT01370642|363428942|FG002|Overall Study|Adverse Event|1|||
105388314|NCT01370642|363428940|FG000|Overall Study|Detectable HCV RNA|0|||
105388315|NCT01370642|363428941|FG001|Overall Study|Detectable HCV RNA|0|||
105388316|NCT01370642|363428942|FG002|Overall Study|Detectable HCV RNA|22|||
105388317|NCT01370642|363428940|FG000|Overall Study|Lost to Follow-up|0|||
105388318|NCT01370642|363428941|FG001|Overall Study|Lost to Follow-up|0|||
105388319|NCT01370642|363428942|FG002|Overall Study|Lost to Follow-up|1|||
105388320|NCT01370642|363428940|FG000|Overall Study|Physician Decision|4|||
105388321|NCT01370642|363428941|FG001|Overall Study|Physician Decision|1|||
105388322|NCT01370642|363428942|FG002|Overall Study|Physician Decision|2|||
105388323|NCT01370642|363428940|FG000|Overall Study|Withdrawal by Subject|2|||
105388324|NCT01370642|363428941|FG001|Overall Study|Withdrawal by Subject|4|||
105388325|NCT01370642|363428942|FG002|Overall Study|Withdrawal by Subject|3|||
105388326|NCT01796470|363428949|FG000|Overall Study|Adverse Event|4|||
105388327|NCT01796470|363428950|FG001|Overall Study|Adverse Event|2|||
105388328|NCT01796470|363428951|FG002|Overall Study|Adverse Event|2|||
105388329|NCT01796470|363428952|FG003|Overall Study|Adverse Event|1|||
105388330|NCT01796470|363428953|FG004|Overall Study|Adverse Event|3|||
105388331|NCT01796470|363428949|FG000|Overall Study|Death|2|||
105388332|NCT01796470|363428950|FG001|Overall Study|Death|0|||
105388333|NCT01796470|363428951|FG002|Overall Study|Death|0|||
105388334|NCT01796470|363428952|FG003|Overall Study|Death|0|||
105388335|NCT01796470|363428953|FG004|Overall Study|Death|1|||
105388336|NCT01796470|363428949|FG000|Overall Study|Initiated New Therapy|9|||
105388337|NCT01796470|363428950|FG001|Overall Study|Initiated New Therapy|0|||
105388338|NCT01796470|363428951|FG002|Overall Study|Initiated New Therapy|0|||
105388339|NCT01796470|363428952|FG003|Overall Study|Initiated New Therapy|0|||
105388340|NCT01796470|363428953|FG004|Overall Study|Initiated New Therapy|2|||
105388341|NCT01796470|363428949|FG000|Overall Study|Lost to Follow-up|0|||
105388342|NCT01796470|363428950|FG001|Overall Study|Lost to Follow-up|1|||
105388343|NCT01796470|363428951|FG002|Overall Study|Lost to Follow-up|0|||
105388344|NCT01796470|363428952|FG003|Overall Study|Lost to Follow-up|0|||
105388345|NCT01796470|363428953|FG004|Overall Study|Lost to Follow-up|0|||
105388346|NCT01796470|363428949|FG000|Overall Study|Physician Decision|5|||
105388347|NCT01796470|363428950|FG001|Overall Study|Physician Decision|4|||
105388348|NCT01796470|363428951|FG002|Overall Study|Physician Decision|1|||
105388349|NCT01796470|363428952|FG003|Overall Study|Physician Decision|0|||
105388350|NCT01796470|363428953|FG004|Overall Study|Physician Decision|1|||
105388351|NCT01796470|363428949|FG000|Overall Study|Progressive Disease|7|||
105388352|NCT01796470|363428950|FG001|Overall Study|Progressive Disease|7|||
105388353|NCT01796470|363428951|FG002|Overall Study|Progressive Disease|3|||
105388354|NCT01796470|363428952|FG003|Overall Study|Progressive Disease|2|||
105388355|NCT01796470|363428953|FG004|Overall Study|Progressive Disease|0|||
105388356|NCT01796470|363428949|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
105388357|NCT01796470|363428950|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
105388358|NCT01796470|363428951|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
105388359|NCT01796470|363428952|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
105388360|NCT01796470|363428953|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
105388361|NCT01796470|363428949|FG000|Overall Study|Withdrawal by Subject|7|||
105388362|NCT01796470|363428950|FG001|Overall Study|Withdrawal by Subject|0|||
105388363|NCT01796470|363428951|FG002|Overall Study|Withdrawal by Subject|0|||
105388364|NCT01796470|363428952|FG003|Overall Study|Withdrawal by Subject|0|||
105388365|NCT01796470|363428953|FG004|Overall Study|Withdrawal by Subject|1|||
105388366|NCT00147537|363428954|FG000|Phase 1b|Death|0|||
105388367|NCT00147537|363428955|FG001|Phase 1b|Death|1|||
105388368|NCT00147537|363428956|FG002|Phase 1b|Death|2|||
105388369|NCT00147537|363428957|FG003|Phase 1b|Death|1|||
105388370|NCT00147537|363428958|FG004|Phase 1b|Death|2|||
105388371|NCT00147537|363428959|FG005|Phase 1b|Death|2|||
105388372|NCT00147537|363428960|FG006|Phase 1b|Death|1|||
105388373|NCT00147537|363428961|FG007|Phase 1b|Death|3|||
105388374|NCT00147537|363428962|FG008|Phase 1b|Death|9|||
105388375|NCT00147537|363428963|FG009|Phase 1b|Death|0|||
105388376|NCT00147537|363428964|FG010|Phase 1b|Death|0|||
105388377|NCT00147537|363428954|FG000|Phase 1b|Lost to Follow-up|2|||
105388378|NCT00147537|363428955|FG001|Phase 1b|Lost to Follow-up|1|||
105388379|NCT00147537|363428956|FG002|Phase 1b|Lost to Follow-up|0|||
105388380|NCT00147537|363428957|FG003|Phase 1b|Lost to Follow-up|0|||
105388381|NCT00147537|363428958|FG004|Phase 1b|Lost to Follow-up|0|||
105388382|NCT00147537|363428959|FG005|Phase 1b|Lost to Follow-up|0|||
105388383|NCT00147537|363428960|FG006|Phase 1b|Lost to Follow-up|2|||
105388384|NCT00147537|363428961|FG007|Phase 1b|Lost to Follow-up|0|||
105388385|NCT00147537|363428962|FG008|Phase 1b|Lost to Follow-up|1|||
105388386|NCT00147537|363428963|FG009|Phase 1b|Lost to Follow-up|0|||
105388387|NCT00147537|363428964|FG010|Phase 1b|Lost to Follow-up|0|||
105388388|NCT00147537|363428954|FG000|Phase 1b|Other|0|||
105388389|NCT00147537|363428955|FG001|Phase 1b|Other|0|||
105388390|NCT00147537|363428956|FG002|Phase 1b|Other|2|||
105388391|NCT00147537|363428957|FG003|Phase 1b|Other|1|||
105388392|NCT00147537|363428958|FG004|Phase 1b|Other|1|||
105388393|NCT00147537|363428959|FG005|Phase 1b|Other|1|||
105388394|NCT00147537|363428960|FG006|Phase 1b|Other|14|||
105388395|NCT00147537|363428961|FG007|Phase 1b|Other|4|||
105388396|NCT00147537|363428962|FG008|Phase 1b|Other|4|||
105388397|NCT00147537|363428963|FG009|Phase 1b|Other|0|||
105388398|NCT00147537|363428964|FG010|Phase 1b|Other|0|||
105388399|NCT00147537|363428954|FG000|Phase 1b|Withdrawal by Subject|0|||
105388400|NCT00147537|363428955|FG001|Phase 1b|Withdrawal by Subject|0|||
105388401|NCT00147537|363428956|FG002|Phase 1b|Withdrawal by Subject|0|||
105388402|NCT00147537|363428957|FG003|Phase 1b|Withdrawal by Subject|0|||
105388403|NCT00147537|363428958|FG004|Phase 1b|Withdrawal by Subject|0|||
105388404|NCT00147537|363428959|FG005|Phase 1b|Withdrawal by Subject|0|||
105388405|NCT00147537|363428960|FG006|Phase 1b|Withdrawal by Subject|0|||
105388406|NCT00147537|363428961|FG007|Phase 1b|Withdrawal by Subject|0|||
105388407|NCT00147537|363428962|FG008|Phase 1b|Withdrawal by Subject|2|||
105388408|NCT00147537|363428963|FG009|Phase 1b|Withdrawal by Subject|0|||
105388409|NCT00147537|363428964|FG010|Phase 1b|Withdrawal by Subject|0|||
105388410|NCT00147537|363428954|FG000|Phase 1b|Randomized but not treated|0|||
105388411|NCT00147537|363428955|FG001|Phase 1b|Randomized but not treated|0|||
105388412|NCT00147537|363428956|FG002|Phase 1b|Randomized but not treated|0|||
105388413|NCT00147537|363428957|FG003|Phase 1b|Randomized but not treated|0|||
105388414|NCT00147537|363428958|FG004|Phase 1b|Randomized but not treated|0|||
105388415|NCT00147537|363428959|FG005|Phase 1b|Randomized but not treated|0|||
105388416|NCT00147537|363428960|FG006|Phase 1b|Randomized but not treated|1|||
105388417|NCT00147537|363428961|FG007|Phase 1b|Randomized but not treated|0|||
105388418|NCT00147537|363428962|FG008|Phase 1b|Randomized but not treated|1|||
105388419|NCT00147537|363428963|FG009|Phase 1b|Randomized but not treated|0|||
105388420|NCT00147537|363428964|FG010|Phase 1b|Randomized but not treated|0|||
105388421|NCT00147537|363428954|FG000|Phase 2|Death|0|||
105388422|NCT00147537|363428955|FG001|Phase 2|Death|0|||
105388423|NCT00147537|363428956|FG002|Phase 2|Death|0|||
105388424|NCT00147537|363428957|FG003|Phase 2|Death|0|||
105388425|NCT00147537|363428958|FG004|Phase 2|Death|0|||
105388426|NCT00147537|363428959|FG005|Phase 2|Death|0|||
105388427|NCT00147537|363428960|FG006|Phase 2|Death|0|||
105388428|NCT00147537|363428961|FG007|Phase 2|Death|0|||
105388429|NCT00147537|363428962|FG008|Phase 2|Death|0|||
105388430|NCT00147537|363428963|FG009|Phase 2|Death|85|||
105388431|NCT00147537|363428964|FG010|Phase 2|Death|31|||
105388432|NCT00147537|363428954|FG000|Phase 2|Lost to Follow-up|0|||
105388433|NCT00147537|363428955|FG001|Phase 2|Lost to Follow-up|0|||
105388434|NCT00147537|363428956|FG002|Phase 2|Lost to Follow-up|0|||
105388435|NCT00147537|363428957|FG003|Phase 2|Lost to Follow-up|0|||
105388436|NCT00147537|363428958|FG004|Phase 2|Lost to Follow-up|0|||
105388437|NCT00147537|363428959|FG005|Phase 2|Lost to Follow-up|0|||
105388438|NCT00147537|363428960|FG006|Phase 2|Lost to Follow-up|0|||
105388439|NCT00147537|363428961|FG007|Phase 2|Lost to Follow-up|0|||
105388440|NCT00147537|363428962|FG008|Phase 2|Lost to Follow-up|0|||
105388441|NCT00147537|363428963|FG009|Phase 2|Lost to Follow-up|12|||
105388442|NCT00147537|363428964|FG010|Phase 2|Lost to Follow-up|4|||
105388443|NCT00147537|363428954|FG000|Phase 2|Other|0|||
105388444|NCT00147537|363428955|FG001|Phase 2|Other|0|||
105388445|NCT00147537|363428956|FG002|Phase 2|Other|0|||
105388446|NCT00147537|363428957|FG003|Phase 2|Other|0|||
105388447|NCT00147537|363428958|FG004|Phase 2|Other|0|||
105388448|NCT00147537|363428959|FG005|Phase 2|Other|0|||
105388449|NCT00147537|363428960|FG006|Phase 2|Other|0|||
105388450|NCT00147537|363428961|FG007|Phase 2|Other|0|||
105388451|NCT00147537|363428962|FG008|Phase 2|Other|0|||
105388452|NCT00147537|363428963|FG009|Phase 2|Other|47|||
105388453|NCT00147537|363428964|FG010|Phase 2|Other|12|||
105388454|NCT00147537|363428954|FG000|Phase 2|Withdrawal by Subject|0|||
105388455|NCT00147537|363428955|FG001|Phase 2|Withdrawal by Subject|0|||
105388456|NCT00147537|363428956|FG002|Phase 2|Withdrawal by Subject|0|||
105388457|NCT00147537|363428957|FG003|Phase 2|Withdrawal by Subject|0|||
105388458|NCT00147537|363428958|FG004|Phase 2|Withdrawal by Subject|0|||
105388459|NCT00147537|363428959|FG005|Phase 2|Withdrawal by Subject|0|||
105388460|NCT00147537|363428960|FG006|Phase 2|Withdrawal by Subject|0|||
105388461|NCT00147537|363428961|FG007|Phase 2|Withdrawal by Subject|0|||
105388462|NCT00147537|363428962|FG008|Phase 2|Withdrawal by Subject|0|||
105388463|NCT00147537|363428963|FG009|Phase 2|Withdrawal by Subject|16|||
105388464|NCT00147537|363428964|FG010|Phase 2|Withdrawal by Subject|4|||
105388465|NCT00147537|363428954|FG000|Phase 2|Randomized but not treated|0|||
105388466|NCT00147537|363428955|FG001|Phase 2|Randomized but not treated|0|||
105388467|NCT00147537|363428956|FG002|Phase 2|Randomized but not treated|0|||
105388468|NCT00147537|363428957|FG003|Phase 2|Randomized but not treated|0|||
105388469|NCT00147537|363428958|FG004|Phase 2|Randomized but not treated|0|||
105388470|NCT00147537|363428959|FG005|Phase 2|Randomized but not treated|0|||
105388471|NCT00147537|363428960|FG006|Phase 2|Randomized but not treated|0|||
105388472|NCT00147537|363428961|FG007|Phase 2|Randomized but not treated|0|||
105388473|NCT00147537|363428962|FG008|Phase 2|Randomized but not treated|0|||
105388474|NCT00147537|363428963|FG009|Phase 2|Randomized but not treated|1|||
105388475|NCT00147537|363428964|FG010|Phase 2|Randomized but not treated|1|||
105388476|NCT01927861|363428965|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
105388477|NCT01927861|363428966|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
105388478|NCT01927861|363428965|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
105388479|NCT01927861|363428966|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
105388480|NCT00987935|363428967|FG000|Overall Study|Progressive disease|3|||
105388481|NCT00987935|363428968|FG001|Overall Study|Progressive disease|2|||
105388482|NCT00987935|363428969|FG002|Overall Study|Progressive disease|3|||
105388483|NCT00987935|363428970|FG003|Overall Study|Progressive disease|2|||
105388484|NCT00987935|363428971|FG004|Overall Study|Progressive disease|5|||
105388485|NCT00987935|363428972|FG005|Overall Study|Progressive disease|3|||
105388486|NCT00987935|363428973|FG006|Overall Study|Progressive disease|9|||
105388487|NCT00987935|363428974|FG007|Overall Study|Progressive disease|48|||
105388488|NCT00987935|363428975|FG008|Overall Study|Progressive disease|23|||
105388489|NCT00987935|363428967|FG000|Overall Study|Adverse Event|0|||
105388490|NCT00987935|363428968|FG001|Overall Study|Adverse Event|1|||
105388491|NCT00987935|363428969|FG002|Overall Study|Adverse Event|0|||
105388492|NCT00987935|363428970|FG003|Overall Study|Adverse Event|1|||
105388493|NCT00987935|363428971|FG004|Overall Study|Adverse Event|1|||
105388494|NCT00987935|363428972|FG005|Overall Study|Adverse Event|0|||
105388495|NCT00987935|363428973|FG006|Overall Study|Adverse Event|2|||
105388496|NCT00987935|363428974|FG007|Overall Study|Adverse Event|10|||
105388497|NCT00987935|363428975|FG008|Overall Study|Adverse Event|6|||
105388498|NCT00987935|363428967|FG000|Overall Study|Refused to continue taking trial med.|1|||
105388499|NCT00987935|363428968|FG001|Overall Study|Refused to continue taking trial med.|0|||
105388500|NCT00987935|363428969|FG002|Overall Study|Refused to continue taking trial med.|0|||
105388501|NCT00987935|363428970|FG003|Overall Study|Refused to continue taking trial med.|0|||
105388502|NCT00987935|363428971|FG004|Overall Study|Refused to continue taking trial med.|1|||
105388503|NCT00987935|363428972|FG005|Overall Study|Refused to continue taking trial med.|0|||
105388504|NCT00987935|363428973|FG006|Overall Study|Refused to continue taking trial med.|4|||
105388505|NCT00987935|363428974|FG007|Overall Study|Refused to continue taking trial med.|4|||
105388506|NCT00987935|363428975|FG008|Overall Study|Refused to continue taking trial med.|2|||
105388507|NCT00987935|363428967|FG000|Overall Study|Reason other than those specified above|0|||
105388508|NCT00987935|363428968|FG001|Overall Study|Reason other than those specified above|0|||
105388509|NCT00987935|363428969|FG002|Overall Study|Reason other than those specified above|0|||
105388510|NCT00987935|363428970|FG003|Overall Study|Reason other than those specified above|0|||
105388511|NCT00987935|363428971|FG004|Overall Study|Reason other than those specified above|0|||
105388512|NCT00987935|363428972|FG005|Overall Study|Reason other than those specified above|0|||
105388513|NCT00987935|363428973|FG006|Overall Study|Reason other than those specified above|0|||
105388514|NCT00987935|363428974|FG007|Overall Study|Reason other than those specified above|0|||
105388515|NCT00987935|363428975|FG008|Overall Study|Reason other than those specified above|1|||
105388516|NCT00728182|363428979|FG000|Overall Study|Adverse Event|1|||
105388517|NCT00728182|363428980|FG001|Overall Study|Adverse Event|0|||
105388518|NCT00728182|363428979|FG000|Overall Study|Lost to Follow-up|2|||
105388519|NCT00728182|363428980|FG001|Overall Study|Lost to Follow-up|0|||
105388520|NCT00728182|363428979|FG000|Overall Study|Death|0|||
105388521|NCT00728182|363428980|FG001|Overall Study|Death|2|||
105388522|NCT00728182|363428979|FG000|Overall Study|Protocol Noncompliance|0|||
105388523|NCT00728182|363428980|FG001|Overall Study|Protocol Noncompliance|1|||
105388524|NCT04223687|363428985|FG000|Overall Study|Missing primary outcome|1|||
105388525|NCT04223687|363428986|FG001|Overall Study|Missing primary outcome|0|||
105388526|NCT01630811|363428988|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
105388527|NCT01630811|363428989|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
105388528|NCT04128228|363428994|FG000|Overall Study|Withdrawal by Subject|3|||
105388529|NCT04128228|363428995|FG001|Overall Study|Withdrawal by Subject|3|||
105388530|NCT04128228|363428996|FG002|Overall Study|Withdrawal by Subject|0|||
105388531|NCT04128228|363428997|FG003|Overall Study|Withdrawal by Subject|0|||
105388532|NCT04128228|363428994|FG000|Overall Study|noncompliance|2|||
105388533|NCT04128228|363428995|FG001|Overall Study|noncompliance|2|||
105388534|NCT04128228|363428996|FG002|Overall Study|noncompliance|0|||
105388535|NCT04128228|363428997|FG003|Overall Study|noncompliance|0|||
105388536|NCT00231465|363429004|FG000|Overall Study|Completed only one cycle|1|||
105388537|NCT00231465|363429004|FG000|Overall Study|Did not have follow up CT scans|1|||
105388538|NCT00968968|363429005|FG000|Overall Study|Study closed/terminated|10|||
105388539|NCT00968968|363429006|FG001|Overall Study|Study closed/terminated|10|||
105388540|NCT00968968|363429005|FG000|Overall Study|Protocol defined stopping criteria|3|||
105388541|NCT00968968|363429006|FG001|Overall Study|Protocol defined stopping criteria|1|||
105388542|NCT00968968|363429005|FG000|Overall Study|Withdrawal by Subject|2|||
105388543|NCT00968968|363429006|FG001|Overall Study|Withdrawal by Subject|0|||
105388544|NCT00968968|363429005|FG000|Overall Study|Physician Decision|1|||
105388545|NCT00968968|363429006|FG001|Overall Study|Physician Decision|2|||
105388546|NCT00968968|363429005|FG000|Overall Study|Lost to Follow-up|0|||
105388547|NCT00968968|363429006|FG001|Overall Study|Lost to Follow-up|1|||
105388548|NCT00930176|363429021|FG000|Overall Study|Death|1|||
105388549|NCT00401830|363429022|FG000|Overall Study|Adverse Event|10|||
105388550|NCT00401830|363429023|FG001|Overall Study|Adverse Event|18|||
105388551|NCT00401830|363429022|FG000|Overall Study|Lack of Efficacy|11|||
105388552|NCT00401830|363429023|FG001|Overall Study|Lack of Efficacy|5|||
105388553|NCT00401830|363429022|FG000|Overall Study|Withdrawal by Subject|4|||
105388554|NCT00401830|363429023|FG001|Overall Study|Withdrawal by Subject|3|||
105388555|NCT00401830|363429022|FG000|Overall Study|Protocol Violation|3|||
105388556|NCT00401830|363429023|FG001|Overall Study|Protocol Violation|3|||
105388557|NCT00401830|363429022|FG000|Overall Study|Non-compliance with drug study|1|||
105388558|NCT00401830|363429023|FG001|Overall Study|Non-compliance with drug study|0|||
105388559|NCT00401830|363429022|FG000|Overall Study|Lost to Follow-up|1|||
105388560|NCT00401830|363429023|FG001|Overall Study|Lost to Follow-up|3|||
105388561|NCT00401830|363429022|FG000|Overall Study|Other: Personal / Family problems|1|||
105388562|NCT00401830|363429023|FG001|Overall Study|Other: Personal / Family problems|0|||
105388563|NCT01720602|363429024|FG000|Overall Study|Adverse Event|3|||
105388564|NCT01720602|363429024|FG000|Overall Study|Progressive disease on therapy|2|||
105388565|NCT00655356|363429027|FG000|Overall Study|Withdrawal by Subject|3|||
105388566|NCT00655356|363429028|FG001|Overall Study|Withdrawal by Subject|4|||
105388567|NCT00655356|363429027|FG000|Overall Study|Sponsor Request|10|||
105388568|NCT00655356|363429028|FG001|Overall Study|Sponsor Request|4|||
105388569|NCT00655356|363429027|FG000|Overall Study|Adverse Event|1|||
105388570|NCT00655356|363429028|FG001|Overall Study|Adverse Event|1|||
105388571|NCT00655356|363429027|FG000|Overall Study|Protocol Violation|2|||
105388572|NCT00655356|363429028|FG001|Overall Study|Protocol Violation|1|||
105388573|NCT00655356|363429027|FG000|Overall Study|Other Reason|1|||
105388574|NCT00655356|363429028|FG001|Overall Study|Other Reason|0|||
105388575|NCT00421408|363429029|FG000|Overall Study|Lost to Follow-up|30|||
105388576|NCT00421408|363429030|FG001|Overall Study|Lost to Follow-up|20|||
105388577|NCT00421408|363429029|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
105388578|NCT00421408|363429030|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
105388579|NCT04105725|363429031|FG000|Primary Intervention|Lost to Follow-up|0|||
105388580|NCT04105725|363429032|FG001|Primary Intervention|Lost to Follow-up|2|||
105388581|NCT04105725|363429031|FG000|Primary Intervention|Withdrawal by Subject|0|||
105388582|NCT04105725|363429032|FG001|Primary Intervention|Withdrawal by Subject|1|||
105388583|NCT00089583|363429033|FG000|Overall Study|Adverse Event|0|||
105388584|NCT00089583|363429034|FG001|Overall Study|Adverse Event|3|||
105388585|NCT00089583|363429033|FG000|Overall Study|Insufficient Viral Load Response|5|||
105388586|NCT00089583|363429034|FG001|Overall Study|Insufficient Viral Load Response|5|||
105388587|NCT00089583|363429033|FG000|Overall Study|Withdrawal by Subject|0|||
105388588|NCT00089583|363429034|FG001|Overall Study|Withdrawal by Subject|4|||
105388589|NCT00089583|363429033|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
105388590|NCT00089583|363429034|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
105388591|NCT00089583|363429033|FG000|Overall Study|Participant Refused Study Medication|0|||
105388592|NCT00089583|363429034|FG001|Overall Study|Participant Refused Study Medication|2|||
105388593|NCT00089583|363429033|FG000|Overall Study|Non-Compliance|0|||
105388594|NCT00089583|363429034|FG001|Overall Study|Non-Compliance|4|||
105388595|NCT00089583|363429033|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
105388596|NCT00089583|363429034|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
105388597|NCT00089583|363429033|FG000|Overall Study|Participant Management Criteria Met|0|||
105388598|NCT00089583|363429034|FG001|Overall Study|Participant Management Criteria Met|1|||
105388599|NCT00089583|363429033|FG000|Overall Study|Reason Not Provided|0|||
105388600|NCT00089583|363429034|FG001|Overall Study|Reason Not Provided|1|||
105388601|NCT00089583|363429033|FG000|Overall Study|Protocol Violation|0|||
105388602|NCT00089583|363429034|FG001|Overall Study|Protocol Violation|3|||
105388603|NCT00089583|363429033|FG000|Overall Study|Principal Investigator Decision|0|||
105388604|NCT00089583|363429034|FG001|Overall Study|Principal Investigator Decision|10|||
105388605|NCT00089583|363429033|FG000|Overall Study|Start of Disallowed Medication|0|||
105388606|NCT00089583|363429034|FG001|Overall Study|Start of Disallowed Medication|1|||
105388607|NCT00089583|363429033|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
105388608|NCT00089583|363429034|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
105388609|NCT00089583|363429033|FG000|Overall Study|Participant Incarcerated|0|||
105388610|NCT00089583|363429034|FG001|Overall Study|Participant Incarcerated|1|||
105388611|NCT01623154|363429035|FG000|Overall Study|Did not drink Pranactin Citric|4|||
105388612|NCT01412983|363429036|FG000|1st Period|Ineligible|0|||
105388613|NCT01412983|363429037|FG001|1st Period|Ineligible|1|||
105388614|NCT01412983|363429036|FG000|1st Period|Positive slit lamp finding|0|||
105388615|NCT01412983|363429037|FG001|1st Period|Positive slit lamp finding|1|||
105388616|NCT01412983|363429036|FG000|1st Period|Unacceptable lens movement|0|||
105388617|NCT01412983|363429037|FG001|1st Period|Unacceptable lens movement|1|||
105388618|NCT01412983|363429036|FG000|1st Period|Inability to maintain wear|0|||
105388619|NCT01412983|363429037|FG001|1st Period|Inability to maintain wear|1|||
105388620|NCT00890097|363429038|FG000|Overall Study|Adverse Event|21|||
105388621|NCT00890097|363429039|FG001|Overall Study|Adverse Event|32|||
105388622|NCT00890097|363429040|FG002|Overall Study|Adverse Event|28|||
105388623|NCT00890097|363429038|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
105388624|NCT00890097|363429039|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
105388625|NCT00890097|363429040|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
105388626|NCT00890097|363429038|FG000|Overall Study|Withdrew Consent|9|||
105388627|NCT00890097|363429039|FG001|Overall Study|Withdrew Consent|6|||
105388628|NCT00890097|363429040|FG002|Overall Study|Withdrew Consent|9|||
105388629|NCT00890097|363429038|FG000|Overall Study|Lost to Follow-up|5|||
105388630|NCT00890097|363429039|FG001|Overall Study|Lost to Follow-up|5|||
105388631|NCT00890097|363429040|FG002|Overall Study|Lost to Follow-up|5|||
105388632|NCT00890097|363429038|FG000|Overall Study|Noncompliance|0|||
105388633|NCT00890097|363429039|FG001|Overall Study|Noncompliance|4|||
105388634|NCT00890097|363429040|FG002|Overall Study|Noncompliance|4|||
105388635|NCT00890097|363429038|FG000|Overall Study|Sponsor Decision|7|||
105388636|NCT00890097|363429039|FG001|Overall Study|Sponsor Decision|11|||
105388637|NCT00890097|363429040|FG002|Overall Study|Sponsor Decision|7|||
105388638|NCT00890097|363429038|FG000|Overall Study|Did not attend final visit|2|||
105388639|NCT00890097|363429039|FG001|Overall Study|Did not attend final visit|3|||
105388640|NCT00890097|363429040|FG002|Overall Study|Did not attend final visit|0|||
105388641|NCT00890097|363429038|FG000|Overall Study|Subject Decision|3|||
105388642|NCT00890097|363429039|FG001|Overall Study|Subject Decision|2|||
105388643|NCT00890097|363429040|FG002|Overall Study|Subject Decision|6|||
105388644|NCT00890097|363429038|FG000|Overall Study|Randomization Error|2|||
105388645|NCT00890097|363429039|FG001|Overall Study|Randomization Error|0|||
105388646|NCT00890097|363429040|FG002|Overall Study|Randomization Error|0|||
105388647|NCT00890097|363429038|FG000|Overall Study|Failed inclusion criteria|3|||
105388648|NCT00890097|363429039|FG001|Overall Study|Failed inclusion criteria|4|||
105388649|NCT00890097|363429040|FG002|Overall Study|Failed inclusion criteria|0|||
105388650|NCT00890097|363429038|FG000|Overall Study|Transportation|0|||
105388651|NCT00890097|363429039|FG001|Overall Study|Transportation|2|||
105388652|NCT00890097|363429040|FG002|Overall Study|Transportation|0|||
105388653|NCT00890097|363429038|FG000|Overall Study|Subject Moved|0|||
105388654|NCT00890097|363429039|FG001|Overall Study|Subject Moved|4|||
105388655|NCT00890097|363429040|FG002|Overall Study|Subject Moved|0|||
105388656|NCT00890097|363429038|FG000|Overall Study|Protocol Deviation|1|||
105388657|NCT00890097|363429039|FG001|Overall Study|Protocol Deviation|1|||
105388658|NCT00890097|363429040|FG002|Overall Study|Protocol Deviation|1|||
105388659|NCT04349098|363429043|FG000|Overall Study|Death|16|||
105388660|NCT04349098|363429044|FG001|Overall Study|Death|8|||
105388661|NCT04349098|363429043|FG000|Overall Study|Lost to Follow-up|11|||
105388662|NCT04349098|363429044|FG001|Overall Study|Lost to Follow-up|8|||
105388663|NCT04349098|363429043|FG000|Overall Study|Withdrawal by Subject|8|||
105388664|NCT04349098|363429044|FG001|Overall Study|Withdrawal by Subject|5|||
105388665|NCT04349098|363429043|FG000|Overall Study|Other|3|||
105388666|NCT04349098|363429044|FG001|Overall Study|Other|5|||
105388667|NCT02536339|363429046|FG000|Overall Study|Death|20|||
105388668|NCT02536339|363429046|FG000|Overall Study|Withdrawal by Subject|3|||
105388669|NCT02536339|363429046|FG000|Overall Study|Lost to Follow-up|2|||
105388670|NCT02536339|363429046|FG000|Overall Study|Treatment discontinued|2|||
105388671|NCT02536339|363429046|FG000|Overall Study|Physician Decision|1|||
105388672|NCT03449147|363429047|FG000|52-week Treatment Period|Death|0|||
105388673|NCT03449147|363429048|FG001|52-week Treatment Period|Death|1|||
105388674|NCT03449147|363429049|FG002|52-week Treatment Period|Death|0|||
105388675|NCT03449147|363429047|FG000|52-week Treatment Period|Lost to Follow-up|6|||
105388676|NCT03449147|363429048|FG001|52-week Treatment Period|Lost to Follow-up|2|||
105388677|NCT03449147|363429049|FG002|52-week Treatment Period|Lost to Follow-up|5|||
105388678|NCT03449147|363429047|FG000|52-week Treatment Period|Other|0|||
105388679|NCT03449147|363429048|FG001|52-week Treatment Period|Other|1|||
105388680|NCT03449147|363429049|FG002|52-week Treatment Period|Other|2|||
105388681|NCT03449147|363429047|FG000|52-week Treatment Period|Physician Decision|1|||
105388682|NCT03449147|363429048|FG001|52-week Treatment Period|Physician Decision|0|||
105388683|NCT03449147|363429049|FG002|52-week Treatment Period|Physician Decision|3|||
105388684|NCT03449147|363429047|FG000|52-week Treatment Period|Screen Failure|1|||
105388685|NCT03449147|363429048|FG001|52-week Treatment Period|Screen Failure|2|||
105388686|NCT03449147|363429049|FG002|52-week Treatment Period|Screen Failure|0|||
105388687|NCT03449147|363429047|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
105388688|NCT03449147|363429048|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
105388689|NCT03449147|363429049|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
105388690|NCT03449147|363429047|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
105388691|NCT03449147|363429048|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
105388692|NCT03449147|363429049|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
105388693|NCT03449147|363429047|FG000|12-Week Off-Treatment Durability Period|Other|0|||
105388694|NCT03449147|363429048|FG001|12-Week Off-Treatment Durability Period|Other|1|||
105388695|NCT03449147|363429049|FG002|12-Week Off-Treatment Durability Period|Other|0|||
105388696|NCT02037984|363429050|FG000|Overall Study|Lack of Efficacy|0|||
105388697|NCT02037984|363429051|FG001|Overall Study|Lack of Efficacy|0|||
105388698|NCT02037984|363429052|FG002|Overall Study|Lack of Efficacy|3|||
105388699|NCT02037984|363429053|FG003|Overall Study|Lack of Efficacy|10|||
105388700|NCT02037984|363429054|FG004|Overall Study|Lack of Efficacy|2|||
105388701|NCT02037984|363429055|FG005|Overall Study|Lack of Efficacy|2|||
105388702|NCT02037984|363429056|FG006|Overall Study|Lack of Efficacy|4|||
105388703|NCT02037984|363429057|FG007|Overall Study|Lack of Efficacy|3|||
105388704|NCT02037984|363429050|FG000|Overall Study|Lost to Follow-up|1|||
105388705|NCT02037984|363429051|FG001|Overall Study|Lost to Follow-up|0|||
105388706|NCT02037984|363429052|FG002|Overall Study|Lost to Follow-up|3|||
105388707|NCT02037984|363429053|FG003|Overall Study|Lost to Follow-up|5|||
105388708|NCT02037984|363429054|FG004|Overall Study|Lost to Follow-up|2|||
105388709|NCT02037984|363429055|FG005|Overall Study|Lost to Follow-up|2|||
105388710|NCT02037984|363429056|FG006|Overall Study|Lost to Follow-up|2|||
105388711|NCT02037984|363429057|FG007|Overall Study|Lost to Follow-up|4|||
105388712|NCT02037984|363429050|FG000|Overall Study|Physician Decision|0|||
105388713|NCT02037984|363429051|FG001|Overall Study|Physician Decision|0|||
105388714|NCT02037984|363429052|FG002|Overall Study|Physician Decision|0|||
105388715|NCT02037984|363429053|FG003|Overall Study|Physician Decision|0|||
105388716|NCT02037984|363429054|FG004|Overall Study|Physician Decision|0|||
105388717|NCT02037984|363429055|FG005|Overall Study|Physician Decision|0|||
105388718|NCT02037984|363429056|FG006|Overall Study|Physician Decision|1|||
105388719|NCT02037984|363429057|FG007|Overall Study|Physician Decision|0|||
105388720|NCT02037984|363429050|FG000|Overall Study|Protocol Violation|0|||
105388721|NCT02037984|363429051|FG001|Overall Study|Protocol Violation|0|||
105388722|NCT02037984|363429052|FG002|Overall Study|Protocol Violation|0|||
105388723|NCT02037984|363429053|FG003|Overall Study|Protocol Violation|0|||
105388724|NCT02037984|363429054|FG004|Overall Study|Protocol Violation|0|||
105388725|NCT02037984|363429055|FG005|Overall Study|Protocol Violation|1|||
105388726|NCT02037984|363429056|FG006|Overall Study|Protocol Violation|2|||
105388727|NCT02037984|363429057|FG007|Overall Study|Protocol Violation|0|||
105388728|NCT02037984|363429050|FG000|Overall Study|Technical Problems|0|||
105388729|NCT02037984|363429051|FG001|Overall Study|Technical Problems|0|||
105388730|NCT02037984|363429052|FG002|Overall Study|Technical Problems|3|||
105388731|NCT02037984|363429053|FG003|Overall Study|Technical Problems|3|||
105388732|NCT02037984|363429054|FG004|Overall Study|Technical Problems|2|||
105388733|NCT02037984|363429055|FG005|Overall Study|Technical Problems|3|||
105388734|NCT02037984|363429056|FG006|Overall Study|Technical Problems|4|||
105388735|NCT02037984|363429057|FG007|Overall Study|Technical Problems|2|||
105388736|NCT02037984|363429050|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105388737|NCT02037984|363429051|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105388738|NCT02037984|363429052|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
105388739|NCT02037984|363429053|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
105388740|NCT02037984|363429054|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
105388741|NCT02037984|363429055|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
105388742|NCT02037984|363429056|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
105388743|NCT02037984|363429057|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
105388744|NCT02037984|363429050|FG000|Overall Study|Withdrawal by Subject|0|||
105388745|NCT02037984|363429051|FG001|Overall Study|Withdrawal by Subject|0|||
105388746|NCT02037984|363429052|FG002|Overall Study|Withdrawal by Subject|0|||
105388747|NCT02037984|363429053|FG003|Overall Study|Withdrawal by Subject|1|||
105388748|NCT02037984|363429054|FG004|Overall Study|Withdrawal by Subject|1|||
105388749|NCT02037984|363429055|FG005|Overall Study|Withdrawal by Subject|3|||
105388750|NCT02037984|363429056|FG006|Overall Study|Withdrawal by Subject|0|||
105388751|NCT02037984|363429057|FG007|Overall Study|Withdrawal by Subject|1|||
105388752|NCT01832038|363430432|FG000|Overall Study|Death|5|||
105388753|NCT01832038|363430432|FG000|Overall Study|Adverse Event|50|||
105388754|NCT01832038|363430432|FG000|Overall Study|Lack of Efficacy|81|||
105388755|NCT01832038|363430432|FG000|Overall Study|Protocol Violation|7|||
105388756|NCT01832038|363430432|FG000|Overall Study|Lost to Follow-up|10|||
105388757|NCT01832038|363430432|FG000|Overall Study|Withdrawal by Subject|49|||
105388758|NCT01832038|363430432|FG000|Overall Study|Visit non-compliance|2|||
105388759|NCT01832038|363430432|FG000|Overall Study|Subject refused to return visit|2|||
105388760|NCT01832038|363430432|FG000|Overall Study|Not convenient to come back to site|2|||
105388761|NCT01832038|363430432|FG000|Overall Study|Participant was asked to quit|5|||
105388762|NCT01832038|363430432|FG000|Overall Study|Back home|1|||
105388763|NCT01832038|363430432|FG000|Overall Study|Pregnancy|1|||
105388764|NCT01832038|363430432|FG000|Overall Study|Low compliance|3|||
105388765|NCT01832038|363430432|FG000|Overall Study|Prohibit procedure|2|||
105388766|NCT01832038|363430432|FG000|Overall Study|Not possible to visit the hospital|1|||
105388767|NCT01832038|363430432|FG000|Overall Study|Changes of implementation system|3|||
105388768|NCT01832038|363430432|FG000|Overall Study|Plan to pregnancy|7|||
105388769|NCT01832038|363430432|FG000|Overall Study|Bad mood and has suicidal thought|1|||
105388770|NCT01832038|363430432|FG000|Overall Study|Prohibited concomitant medication|1|||
105388771|NCT01832038|363430432|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
105388772|NCT01832038|363430432|FG000|Overall Study|Subject considered the efficacy was poor|1|||
105388773|NCT03211858|363430433|FG000|Overall Study|Adverse Event|8|||
105388774|NCT03211858|363430434|FG001|Overall Study|Adverse Event|6|||
105388775|NCT03211858|363430433|FG000|Overall Study|Lack of Efficacy|0|||
105388776|NCT03211858|363430434|FG001|Overall Study|Lack of Efficacy|4|||
105388777|NCT03211858|363430433|FG000|Overall Study|Poor compliance to protocol|6|||
105388778|NCT03211858|363430434|FG001|Overall Study|Poor compliance to protocol|2|||
105388779|NCT03211858|363430433|FG000|Overall Study|Non-serious Hypoglycemia|1|||
105388780|NCT03211858|363430434|FG001|Overall Study|Non-serious Hypoglycemia|0|||
105388781|NCT03211858|363430433|FG000|Overall Study|Other than specified above|22|||
105388782|NCT03211858|363430434|FG001|Overall Study|Other than specified above|21|||
105388783|NCT02410200|363430447|FG000|Overall Study|Adverse Event|2|||
105388784|NCT01428713|363430448|FG000|Overall Study|Non-compliance|2|||
105388785|NCT01428713|363430449|FG001|Overall Study|Non-compliance|2|||
105388786|NCT01428713|363430448|FG000|Overall Study|Withdrawal by Subject|1|||
105388787|NCT01428713|363430449|FG001|Overall Study|Withdrawal by Subject|1|||
105388788|NCT01428713|363430448|FG000|Overall Study|Adverse Event|0|||
105388789|NCT01428713|363430449|FG001|Overall Study|Adverse Event|2|||
105388790|NCT01897896|363430450|FG000|Overall Study|Death|1|||
105388791|NCT01897896|363430451|FG001|Overall Study|Death|0|||
105388792|NCT01897896|363430450|FG000|Overall Study|Adverse Event|11|||
105388793|NCT01897896|363430451|FG001|Overall Study|Adverse Event|1|||
105388794|NCT01897896|363430450|FG000|Overall Study|Lost to Follow-up|1|||
105388795|NCT01897896|363430451|FG001|Overall Study|Lost to Follow-up|0|||
105388796|NCT01897896|363430450|FG000|Overall Study|Non-compliance with study drug dosing|1|||
105388797|NCT01897896|363430451|FG001|Overall Study|Non-compliance with study drug dosing|1|||
105388798|NCT01897896|363430450|FG000|Overall Study|Withdrawal by Subject|7|||
105388799|NCT01897896|363430451|FG001|Overall Study|Withdrawal by Subject|1|||
105388800|NCT01897896|363430450|FG000|Overall Study|Require drug that interfere with study|1|||
105388801|NCT01897896|363430451|FG001|Overall Study|Require drug that interfere with study|4|||
105388802|NCT01897896|363430450|FG000|Overall Study|Protocol Violation|1|||
105388803|NCT01897896|363430451|FG001|Overall Study|Protocol Violation|1|||
105388804|NCT01897896|363430450|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
105388805|NCT01897896|363430451|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
105388806|NCT01897896|363430450|FG000|Overall Study|Caregiver can no longer participate|0|||
105388807|NCT01897896|363430451|FG001|Overall Study|Caregiver can no longer participate|2|||
105388808|NCT01897896|363430450|FG000|Overall Study|Other than specified|2|||
105388809|NCT01897896|363430451|FG001|Overall Study|Other than specified|1|||
105388810|NCT03160573|363430452|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
105388811|NCT03160573|363430453|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
105388812|NCT03160573|363430454|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
105388813|NCT03160573|363430455|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
105388814|NCT00903344|363430456|FG000|Overall Study|Pregnancy|2|||
105388815|NCT00903344|363430457|FG001|Overall Study|Pregnancy|3|||
105388816|NCT00903344|363430456|FG000|Overall Study|Lost to Follow-up|3|||
105388817|NCT00903344|363430457|FG001|Overall Study|Lost to Follow-up|0|||
105388818|NCT03048019|363430479|FG000|Overall Study|Adverse Event|1|||
105388819|NCT03048019|363430480|FG001|Overall Study|Adverse Event|0|||
105388820|NCT01730729|363430481|FG000|Overall Study|Adverse Event|1|||
105388821|NCT01730729|363430481|FG000|Overall Study|Death|1|||
105388822|NCT01730729|363430481|FG000|Overall Study|Progressive Disease|12|||
105388823|NCT00871000|363430482|FG000|Overall Study|Withdrawal by Subject|1|||
105388824|NCT00871000|363430483|FG001|Overall Study|Withdrawal by Subject|0|||
105388825|NCT00382863|363430484|FG000|Overall Study|Death|9|||
105388826|NCT00382863|363430485|FG001|Overall Study|Death|9|||
105388827|NCT00382863|363430484|FG000|Overall Study|Lost to Follow-up|1|||
105388828|NCT00382863|363430485|FG001|Overall Study|Lost to Follow-up|2|||
105388829|NCT00382863|363430484|FG000|Overall Study|Withdrawal by Subject|5|||
105388830|NCT00382863|363430485|FG001|Overall Study|Withdrawal by Subject|25|||
105388831|NCT02168439|363430486|FG000|Overall Study|Protocol Violation|0|||
105388832|NCT02168439|363430487|FG001|Overall Study|Protocol Violation|2|||
105388833|NCT03400787|363430488|FG000|Overall Study|Lost to Follow-up|1|||
105388834|NCT03400787|363430489|FG001|Overall Study|Lost to Follow-up|0|||
105388835|NCT03400787|363430488|FG000|Overall Study|Death|1|||
105388836|NCT03400787|363430489|FG001|Overall Study|Death|0|||
105388837|NCT03400787|363430488|FG000|Overall Study|Protocol Violation|0|||
105388838|NCT03400787|363430489|FG001|Overall Study|Protocol Violation|2|||
105388839|NCT03400787|363430488|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
105388840|NCT03400787|363430489|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
105388841|NCT04432298|363430490|FG000|Overall Study|Other than specified|1|||
105388842|NCT04432298|363430491|FG001|Overall Study|Other than specified|0|||
105388843|NCT04432298|363430490|FG000|Overall Study|Lost to Follow-up|0|||
105388844|NCT04432298|363430491|FG001|Overall Study|Lost to Follow-up|1|||
105388845|NCT04432298|363430490|FG000|Overall Study|Death|3|||
105388846|NCT04432298|363430491|FG001|Overall Study|Death|2|||
105388847|NCT04432298|363430490|FG000|Overall Study|Withdrawal by Subject|2|||
105388848|NCT04432298|363430491|FG001|Overall Study|Withdrawal by Subject|0|||
105388849|NCT02715856|363430492|FG000|Overall Study|Software Issues|12|||
105388850|NCT02715856|363430493|FG001|Overall Study|Software Issues|7|||
105388851|NCT02715856|363430492|FG000|Overall Study|Death|6|||
105388852|NCT02715856|363430493|FG001|Overall Study|Death|5|||
105388853|NCT02715856|363430492|FG000|Overall Study|Non- Compliant|0|||
105388854|NCT02715856|363430493|FG001|Overall Study|Non- Compliant|40|||
105388855|NCT01633112|363430494|FG000|Overall Study|Lack of Efficacy|1|||
105388856|NCT01633112|363430495|FG001|Overall Study|Lack of Efficacy|6|||
105388857|NCT01633112|363430496|FG002|Overall Study|Lack of Efficacy|13|||
105388858|NCT01633112|363430494|FG000|Overall Study|Abnormal laboratory value(s)|3|||
105388859|NCT01633112|363430495|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105388860|NCT01633112|363430496|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105388861|NCT01633112|363430494|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105388862|NCT01633112|363430495|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105388863|NCT01633112|363430496|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105388864|NCT01633112|363430494|FG000|Overall Study|Administrative problems|1|||
105388865|NCT01633112|363430495|FG001|Overall Study|Administrative problems|2|||
105388866|NCT01633112|363430496|FG002|Overall Study|Administrative problems|5|||
105388867|NCT01633112|363430494|FG000|Overall Study|Adverse Event|16|||
105388868|NCT01633112|363430495|FG001|Overall Study|Adverse Event|18|||
105388869|NCT01633112|363430496|FG002|Overall Study|Adverse Event|20|||
105388870|NCT01633112|363430494|FG000|Overall Study|Lost to Follow-up|7|||
105388871|NCT01633112|363430495|FG001|Overall Study|Lost to Follow-up|19|||
105388872|NCT01633112|363430496|FG002|Overall Study|Lost to Follow-up|6|||
105388873|NCT01633112|363430494|FG000|Overall Study|Protocol Violation|4|||
105388874|NCT01633112|363430495|FG001|Overall Study|Protocol Violation|0|||
105388875|NCT01633112|363430496|FG002|Overall Study|Protocol Violation|2|||
105388876|NCT01633112|363430494|FG000|Overall Study|Subject no longer requires study drug|0|||
105388877|NCT01633112|363430495|FG001|Overall Study|Subject no longer requires study drug|0|||
105388878|NCT01633112|363430496|FG002|Overall Study|Subject no longer requires study drug|1|||
105388879|NCT01633112|363430494|FG000|Overall Study|Withdrawal by Subject|20|||
105388880|NCT01633112|363430495|FG001|Overall Study|Withdrawal by Subject|12|||
105388881|NCT01633112|363430496|FG002|Overall Study|Withdrawal by Subject|41|||
105388882|NCT01633112|363430494|FG000|Overall Study|missing Study Completion CRF|1|||
105388883|NCT01633112|363430495|FG001|Overall Study|missing Study Completion CRF|1|||
105388884|NCT01633112|363430496|FG002|Overall Study|missing Study Completion CRF|4|||
105388885|NCT04535362|363430497|FG000|Overall Study|Lost to Follow-up|3|||
105388886|NCT04535362|363430498|FG001|Overall Study|Lost to Follow-up|1|||
105388887|NCT00889005|363430499|FG000|Overall Study|Lost to Follow-up|4|||
105388888|NCT00889005|363430500|FG001|Overall Study|Lost to Follow-up|2|||
105388889|NCT00889005|363430499|FG000|Overall Study|Withdrawal by Subject|4|||
105388890|NCT00889005|363430500|FG001|Overall Study|Withdrawal by Subject|0|||
105388891|NCT01347086|363430503|FG000|Overall Study|failed screening visit|0|||
105388892|NCT01347086|363430504|FG001|Overall Study|failed screening visit|0|||
105388893|NCT01347086|363430505|FG002|Overall Study|failed screening visit|1|||
105388894|NCT01347086|363430506|FG003|Overall Study|failed screening visit|0|||
105388895|NCT01347086|363430507|FG004|Overall Study|failed screening visit|0|||
105388896|NCT01347086|363430508|FG005|Overall Study|failed screening visit|0|||
105388897|NCT01347086|363430509|FG006|Overall Study|failed screening visit|1|||
105388898|NCT01347086|363430510|FG007|Overall Study|failed screening visit|1|||
105388899|NCT01347086|363430511|FG008|Overall Study|failed screening visit|0|||
105388900|NCT01347086|363430512|FG009|Overall Study|failed screening visit|1|||
105388901|NCT00395447|363430514|FG000|Overall Study|Death|37|||
105388902|NCT00395447|363430515|FG001|Overall Study|Death|32|||
105388903|NCT00395447|363430514|FG000|Overall Study|Lost to Follow-up|52|||
105388904|NCT00395447|363430515|FG001|Overall Study|Lost to Follow-up|43|||
105388905|NCT00395447|363430514|FG000|Overall Study|Withdrawal by Subject|24|||
105388906|NCT00395447|363430515|FG001|Overall Study|Withdrawal by Subject|19|||
105388907|NCT00395447|363430514|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
105388908|NCT00395447|363430515|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
105388909|NCT03766906|363430516|FG000|Overall Study|Withdrawal by Subject|6|||
105388910|NCT02624687|363430518|FG000|Overall Study|Withdrawal by Subject|1|||
105388911|NCT02624687|363430519|FG001|Overall Study|Withdrawal by Subject|1|||
105388912|NCT02624687|363430518|FG000|Overall Study|medical leave from work|0|||
105388913|NCT02624687|363430519|FG001|Overall Study|medical leave from work|1|||
105388914|NCT00276380|363430522|FG000|Overall Study|Adverse Event|5|||
105388915|NCT00276380|363430523|FG001|Overall Study|Adverse Event|3|||
105388916|NCT00276380|363430522|FG000|Overall Study|Lost to Follow-up|1|||
105388917|NCT00276380|363430523|FG001|Overall Study|Lost to Follow-up|1|||
105388918|NCT00276380|363430522|FG000|Overall Study|Withdrawal by Subject|3|||
105388919|NCT00276380|363430523|FG001|Overall Study|Withdrawal by Subject|6|||
105388920|NCT00276380|363430522|FG000|Overall Study|Death|5|||
105388921|NCT00276380|363430523|FG001|Overall Study|Death|3|||
105388922|NCT00276380|363430522|FG000|Overall Study|Abnormal aPPT Levels|0|||
105388923|NCT00276380|363430523|FG001|Overall Study|Abnormal aPPT Levels|1|||
105388924|NCT01689649|363430524|FG000|Overall Study|Lack of Efficacy|3|||
105388925|NCT01689649|363430524|FG000|Overall Study|Non-compliance|11|||
105388926|NCT01689649|363430524|FG000|Overall Study|Protocol Violation|3|||
105388927|NCT01689649|363430524|FG000|Overall Study|Lost to Follow-up|5|||
105388928|NCT05071027|363430527|FG000|Overall Study|Lost to Follow-up|1|||
105388929|NCT05071027|363430528|FG001|Overall Study|Lost to Follow-up|4|||
105388930|NCT04576481|363430529|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
105388931|NCT04576481|363430530|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
105388932|NCT04576481|363430531|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
105388933|NCT04576481|363430532|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
105388934|NCT00595075|363430534|FG000|Overall Study|Withdrawal by Subject|1|||
105388935|NCT00595075|363430535|FG001|Overall Study|Withdrawal by Subject|0|||
105388936|NCT00511199|363430536|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
105388937|NCT00511199|363430537|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
105388938|NCT00511199|363430536|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
105388939|NCT00511199|363430537|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
105388940|NCT00511199|363430536|FG000|Overall Study|Withdrawal of Informed Consent|19|||
105388941|NCT00511199|363430537|FG001|Overall Study|Withdrawal of Informed Consent|4|||
105388942|NCT00511199|363430536|FG000|Overall Study|Pregnancy|6|||
105388943|NCT00511199|363430537|FG001|Overall Study|Pregnancy|3|||
105388944|NCT00511199|363430536|FG000|Overall Study|Pregnancy Wish|16|||
105388945|NCT00511199|363430537|FG001|Overall Study|Pregnancy Wish|8|||
105388946|NCT00511199|363430536|FG000|Overall Study|Lost to Follow-up|40|||
105388947|NCT00511199|363430537|FG001|Overall Study|Lost to Follow-up|17|||
105388948|NCT00511199|363430536|FG000|Overall Study|Other Reason|78|||
105388949|NCT00511199|363430537|FG001|Overall Study|Other Reason|37|||
105388950|NCT01696214|363430538|FG000|Overall Study|Lost to Follow-up|1|||
105388951|NCT01696214|363430539|FG001|Overall Study|Lost to Follow-up|0|||
105388952|NCT01696214|363430540|FG002|Overall Study|Lost to Follow-up|0|||
105388953|NCT01696214|363430541|FG003|Overall Study|Lost to Follow-up|0|||
105388954|NCT01682720|363430543|FG000|Overall Study|Randomized but Not Treated|0|||
105388955|NCT01682720|363430544|FG001|Overall Study|Randomized but Not Treated|1|||
105388956|NCT01682720|363430545|FG002|Overall Study|Randomized but Not Treated|1|||
105388957|NCT01682720|363430546|FG003|Overall Study|Randomized but Not Treated|0|||
105388958|NCT01682720|363430543|FG000|Overall Study|Terminated by Sponsor|83|||
105388959|NCT01682720|363430544|FG001|Overall Study|Terminated by Sponsor|0|||
105388960|NCT01682720|363430545|FG002|Overall Study|Terminated by Sponsor|0|||
105388961|NCT01682720|363430546|FG003|Overall Study|Terminated by Sponsor|0|||
105388962|NCT01682720|363430543|FG000|Overall Study|Efficacy Failure|0|||
105388963|NCT01682720|363430544|FG001|Overall Study|Efficacy Failure|3|||
105388964|NCT01682720|363430545|FG002|Overall Study|Efficacy Failure|3|||
105388965|NCT01682720|363430546|FG003|Overall Study|Efficacy Failure|30|||
105388966|NCT01682720|363430543|FG000|Overall Study|Lost to Follow-up|1|||
105388967|NCT01682720|363430544|FG001|Overall Study|Lost to Follow-up|1|||
105388968|NCT01682720|363430545|FG002|Overall Study|Lost to Follow-up|0|||
105388969|NCT01682720|363430546|FG003|Overall Study|Lost to Follow-up|6|||
105388970|NCT01682720|363430543|FG000|Overall Study|Subject Withdrew Consent|0|||
105388971|NCT01682720|363430544|FG001|Overall Study|Subject Withdrew Consent|0|||
105388972|NCT01682720|363430545|FG002|Overall Study|Subject Withdrew Consent|2|||
105388973|NCT01682720|363430546|FG003|Overall Study|Subject Withdrew Consent|2|||
105388974|NCT01682720|363430543|FG000|Overall Study|Adverse Event|1|||
105388975|NCT01682720|363430544|FG001|Overall Study|Adverse Event|0|||
105388976|NCT01682720|363430545|FG002|Overall Study|Adverse Event|1|||
105388977|NCT01682720|363430546|FG003|Overall Study|Adverse Event|1|||
105388978|NCT02965976|363430547|FG000|Overall Study|Withdrawal by Subject|2|||
105388979|NCT02965976|363430548|FG001|Overall Study|Withdrawal by Subject|0|||
105388980|NCT04191616|363430549|FG000|Overall Study|Death|26|||
105388981|NCT04191616|363430549|FG000|Overall Study|Withdrawal by Subject|1|||
105388982|NCT04191616|363430549|FG000|Overall Study|Sponsor decision|2|||
105388983|NCT04191616|363430549|FG000|Overall Study|Continuing study|25|||
105388984|NCT02395627|363430550|FG000|Overall Study|Withdrawal by Subject|0|||
105388985|NCT02395627|363430551|FG001|Overall Study|Withdrawal by Subject|2|||
105388986|NCT02395627|363430552|FG002|Overall Study|Withdrawal by Subject|0|||
105388987|NCT02395627|363430550|FG000|Overall Study|Did not receive pembrolizumab|3|||
105388988|NCT02395627|363430551|FG001|Overall Study|Did not receive pembrolizumab|1|||
105388989|NCT02395627|363430552|FG002|Overall Study|Did not receive pembrolizumab|0|||
105388990|NCT03378635|363430564|FG000|Overall Study|Adverse Event|1|||
105388991|NCT03378635|363430565|FG001|Overall Study|Adverse Event|0|||
105388992|NCT03378635|363430566|FG002|Overall Study|Adverse Event|0|||
105388993|NCT03378635|363430564|FG000|Overall Study|Withdrawal by Subject|1|||
105388994|NCT03378635|363430565|FG001|Overall Study|Withdrawal by Subject|0|||
105388995|NCT03378635|363430566|FG002|Overall Study|Withdrawal by Subject|0|||
105388996|NCT01835431|363430567|FG000|Overall Study|Adverse Event|1|||
105388997|NCT01835431|363430568|FG001|Overall Study|Adverse Event|0|||
105388998|NCT01835431|363430567|FG000|Overall Study|other|0|||
105388999|NCT01835431|363430568|FG001|Overall Study|other|2|||
105389000|NCT01835431|363430567|FG000|Overall Study|Withdrawal by Subject|6|||
105389001|NCT01835431|363430568|FG001|Overall Study|Withdrawal by Subject|10|||
105389002|NCT01835431|363430567|FG000|Overall Study|Protocol Violation|1|||
105389003|NCT01835431|363430568|FG001|Overall Study|Protocol Violation|0|||
105389004|NCT04634331|363430571|FG000|Overall Study|Withdrawal by Subject|2|||
105389005|NCT04634331|363430572|FG001|Overall Study|Withdrawal by Subject|2|||
105389006|NCT02766478|363430574|FG000|Overall Study|Withdrawal by Subject|1|||
105389007|NCT02766478|363430575|FG001|Overall Study|Withdrawal by Subject|1|||
105389008|NCT05626686|363430576|FG000|Overall Study|Protocol Violation|3|||
105389009|NCT05626686|363430576|FG000|Overall Study|Withdrawal by Subject|3|||
105389010|NCT01691092|363430577|FG000|Overall Study|Lost to Follow-up|10|||
105389011|NCT01691092|363430577|FG000|Overall Study|Physician Decision|4|||
105389012|NCT01691092|363430577|FG000|Overall Study|Withdrawal by Subject|3|||
105389013|NCT01691092|363430577|FG000|Overall Study|non-compliance|3|||
105389014|NCT01691092|363430577|FG000|Overall Study|used for different study|2|||
105389015|NCT01691092|363430577|FG000|Overall Study|screen fail|19|||
105389016|NCT01793129|363432527|FG000|Overall Study|Lost to Follow-up|3|||
105389017|NCT01793129|363432528|FG001|Overall Study|Lost to Follow-up|7|||
105389018|NCT01793129|363432527|FG000|Overall Study|Withdrawal by Subject|0|||
105389019|NCT01793129|363432528|FG001|Overall Study|Withdrawal by Subject|2|||
105389020|NCT02469961|363432529|FG000|Overall Study|Physician Decision|4|||
105389021|NCT02469961|363432530|FG001|Overall Study|Physician Decision|1|||
105389022|NCT05130281|363432533|FG000|Overall Study|Withdrawal by Subject|0|||
105389023|NCT05130281|363432534|FG001|Overall Study|Withdrawal by Subject|0|||
105389024|NCT05130281|363432535|FG002|Overall Study|Withdrawal by Subject|1|||
105389025|NCT05058456|363432536|FG000|Overall Study|Death|1|||
105389026|NCT05058456|363432536|FG000|Overall Study|End of Study data not yet due for release|34|||
105389027|NCT03810365|363432537|FG000|Overall Study|Lost to Follow-up|2|||
105389028|NCT03810365|363432538|FG001|Overall Study|Lost to Follow-up|2|||
105389029|NCT03810365|363432537|FG000|Overall Study|Withdrawal by Subject|4|||
105389030|NCT03810365|363432538|FG001|Overall Study|Withdrawal by Subject|5|||
105389031|NCT01386645|363432539|FG000|Overall Study|Physician Decision|0|||
105389032|NCT01386645|363432540|FG001|Overall Study|Physician Decision|0|||
105389033|NCT01386645|363432541|FG002|Overall Study|Physician Decision|1|||
105389034|NCT01386645|363432539|FG000|Overall Study|Withdrawal by Subject|0|||
105389035|NCT01386645|363432540|FG001|Overall Study|Withdrawal by Subject|1|||
105389036|NCT01386645|363432541|FG002|Overall Study|Withdrawal by Subject|1|||
105389037|NCT00101400|363432542|FG000|Survival Follow-Up|Alive|7|||
105389038|NCT00862277|363432546|FG000|Overall Study|Protocol Violation|1|||
105389039|NCT00862277|363432547|FG001|Overall Study|Protocol Violation|2|||
105389040|NCT00862277|363432548|FG002|Overall Study|Protocol Violation|5|||
105389041|NCT02451007|363432554|FG000|Overall Study|Withdrawal by Subject|4|||
105389042|NCT02451007|363432554|FG000|Overall Study|Adverse Event|1|||
105389043|NCT02451007|363432554|FG000|Overall Study|Disease Progression|2|||
105389044|NCT01423084|363432558|FG000|Overall Study|Adverse Event|0|||
105389045|NCT01423084|363432559|FG001|Overall Study|Adverse Event|1|||
105389046|NCT01423084|363432558|FG000|Overall Study|Withdrawal by Subject|2|||
105389047|NCT01423084|363432559|FG001|Overall Study|Withdrawal by Subject|3|||
105389048|NCT01661595|363432560|FG000|Phase 1: Week 0-4|Adverse Event|1|||
105389049|NCT01661595|363432561|FG001|Phase 1: Week 0-4|Adverse Event|0|||
105389050|NCT01661595|363432562|FG002|Phase 1: Week 0-4|Adverse Event|0|||
105389051|NCT01661595|363432563|FG003|Phase 1: Week 0-4|Adverse Event|0|||
105389052|NCT01661595|363432560|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
105389053|NCT01661595|363432561|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
105389054|NCT01661595|363432562|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
105389055|NCT01661595|363432563|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
105389056|NCT02837952|363432564|FG000|Overall Study|Adverse Event|0|||
105389057|NCT02837952|363432565|FG001|Overall Study|Adverse Event|1|||
105389058|NCT02837952|363432564|FG000|Overall Study|Withdrawal by Subject|4|||
105389059|NCT02837952|363432565|FG001|Overall Study|Withdrawal by Subject|5|||
105389060|NCT02837952|363432564|FG000|Overall Study|Medication Error|1|||
105389061|NCT02837952|363432565|FG001|Overall Study|Medication Error|0|||
105389062|NCT01682603|363432566|FG000|Overall Study|Lost to Follow-up|3|||
105389063|NCT01840163|363432567|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
105389064|NCT01840163|363432568|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
105389065|NCT01840163|363432567|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
105389066|NCT01840163|363432568|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
105389067|NCT01840163|363432567|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
105389068|NCT01840163|363432568|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
105389069|NCT00993473|363432569|FG000|Overall Study|Adverse Event|0|||
105389070|NCT00993473|363432570|FG001|Overall Study|Adverse Event|2|||
105389071|NCT00993473|363432569|FG000|Overall Study|Protocol Violation|1|||
105389072|NCT00993473|363432570|FG001|Overall Study|Protocol Violation|2|||
105389073|NCT00993473|363432569|FG000|Overall Study|Lost to Follow-up|1|||
105389074|NCT00993473|363432570|FG001|Overall Study|Lost to Follow-up|0|||
105389075|NCT00993473|363432569|FG000|Overall Study|Withdrawal by Subject|1|||
105389076|NCT00993473|363432570|FG001|Overall Study|Withdrawal by Subject|5|||
105389077|NCT00993473|363432569|FG000|Overall Study|Technical problem with CGM device|0|||
105389078|NCT00993473|363432570|FG001|Overall Study|Technical problem with CGM device|1|||
105389079|NCT00993473|363432569|FG000|Overall Study|Family event|1|||
105389080|NCT00993473|363432570|FG001|Overall Study|Family event|0|||
105389081|NCT00128492|363432573|FG000|Overall Study|AE unrelated to study|2|||
105389082|NCT00128492|363432574|FG001|Overall Study|AE unrelated to study|9|||
105389083|NCT00128492|363432573|FG000|Overall Study|Study drug intolerance (AE)|2|||
105389084|NCT00128492|363432574|FG001|Overall Study|Study drug intolerance (AE)|8|||
105389085|NCT00128492|363432573|FG000|Overall Study|AE related to study|1|||
105389086|NCT00128492|363432574|FG001|Overall Study|AE related to study|4|||
105389087|NCT00128492|363432573|FG000|Overall Study|Death|1|||
105389088|NCT00128492|363432574|FG001|Overall Study|Death|0|||
105389089|NCT00128492|363432573|FG000|Overall Study|Lost to Follow-up|1|||
105389090|NCT00128492|363432574|FG001|Overall Study|Lost to Follow-up|5|||
105389091|NCT00128492|363432573|FG000|Overall Study|Noncompliance|0|||
105389092|NCT00128492|363432574|FG001|Overall Study|Noncompliance|5|||
105389093|NCT00128492|363432573|FG000|Overall Study|Personal or administrative|10|||
105389094|NCT00128492|363432574|FG001|Overall Study|Personal or administrative|22|||
105389095|NCT00128492|363432573|FG000|Overall Study|Withdrawal by Subject|3|||
105389096|NCT00128492|363432574|FG001|Overall Study|Withdrawal by Subject|5|||
105389097|NCT00128492|363432573|FG000|Overall Study|Pregnancy|0|||
105389098|NCT00128492|363432574|FG001|Overall Study|Pregnancy|1|||
105389099|NCT00159874|363432575|FG000|Overall Study|Adverse Event|2|||
105389100|NCT00159874|363432576|FG001|Overall Study|Adverse Event|2|||
105389101|NCT00159874|363432577|FG002|Overall Study|Adverse Event|5|||
105389102|NCT00159874|363432578|FG003|Overall Study|Adverse Event|1|||
105389103|NCT00159874|363432579|FG004|Overall Study|Adverse Event|1|||
105389104|NCT00159874|363432580|FG005|Overall Study|Adverse Event|2|||
105389105|NCT00159874|363432581|FG006|Overall Study|Adverse Event|0|||
105389106|NCT00159874|363432575|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
105389107|NCT00159874|363432576|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
105389108|NCT00159874|363432577|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
105389109|NCT00159874|363432578|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
105389110|NCT00159874|363432579|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
105389111|NCT00159874|363432580|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
105389112|NCT00159874|363432581|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
105389113|NCT00159874|363432575|FG000|Overall Study|Lack of Efficacy|2|||
105389114|NCT00159874|363432576|FG001|Overall Study|Lack of Efficacy|0|||
105389115|NCT00159874|363432577|FG002|Overall Study|Lack of Efficacy|1|||
105389116|NCT00159874|363432578|FG003|Overall Study|Lack of Efficacy|1|||
105389117|NCT00159874|363432579|FG004|Overall Study|Lack of Efficacy|0|||
105389118|NCT00159874|363432580|FG005|Overall Study|Lack of Efficacy|3|||
105389119|NCT00159874|363432581|FG006|Overall Study|Lack of Efficacy|0|||
105389120|NCT00159874|363432575|FG000|Overall Study|Lost to Follow-up|1|||
105389121|NCT00159874|363432576|FG001|Overall Study|Lost to Follow-up|0|||
105389122|NCT00159874|363432577|FG002|Overall Study|Lost to Follow-up|3|||
105389123|NCT00159874|363432578|FG003|Overall Study|Lost to Follow-up|0|||
105389124|NCT00159874|363432579|FG004|Overall Study|Lost to Follow-up|1|||
105389125|NCT00159874|363432580|FG005|Overall Study|Lost to Follow-up|2|||
105389126|NCT00159874|363432581|FG006|Overall Study|Lost to Follow-up|1|||
105389127|NCT00159874|363432575|FG000|Overall Study|Other|8|||
105389128|NCT00159874|363432576|FG001|Overall Study|Other|8|||
105389129|NCT00159874|363432577|FG002|Overall Study|Other|8|||
105389130|NCT00159874|363432578|FG003|Overall Study|Other|0|||
105389131|NCT00159874|363432579|FG004|Overall Study|Other|2|||
105389132|NCT00159874|363432580|FG005|Overall Study|Other|1|||
105389133|NCT00159874|363432581|FG006|Overall Study|Other|3|||
105389134|NCT00159874|363432575|FG000|Overall Study|Protocol Violation|0|||
105389135|NCT00159874|363432576|FG001|Overall Study|Protocol Violation|5|||
105389136|NCT00159874|363432577|FG002|Overall Study|Protocol Violation|2|||
105389137|NCT00159874|363432578|FG003|Overall Study|Protocol Violation|0|||
105389138|NCT00159874|363432579|FG004|Overall Study|Protocol Violation|0|||
105389139|NCT00159874|363432580|FG005|Overall Study|Protocol Violation|0|||
105389140|NCT00159874|363432581|FG006|Overall Study|Protocol Violation|0|||
105389141|NCT00159874|363432575|FG000|Overall Study|Death|3|||
105389142|NCT00159874|363432576|FG001|Overall Study|Death|8|||
105389143|NCT00159874|363432577|FG002|Overall Study|Death|15|||
105389144|NCT00159874|363432578|FG003|Overall Study|Death|0|||
105389145|NCT00159874|363432579|FG004|Overall Study|Death|1|||
105389146|NCT00159874|363432580|FG005|Overall Study|Death|2|||
105389147|NCT00159874|363432581|FG006|Overall Study|Death|0|||
105389148|NCT00159874|363432575|FG000|Overall Study|Withdrawal by Subject|2|||
105389149|NCT00159874|363432576|FG001|Overall Study|Withdrawal by Subject|6|||
105389150|NCT00159874|363432577|FG002|Overall Study|Withdrawal by Subject|8|||
105389151|NCT00159874|363432578|FG003|Overall Study|Withdrawal by Subject|4|||
105389152|NCT00159874|363432579|FG004|Overall Study|Withdrawal by Subject|3|||
105389153|NCT00159874|363432580|FG005|Overall Study|Withdrawal by Subject|2|||
105389154|NCT00159874|363432581|FG006|Overall Study|Withdrawal by Subject|1|||
105389155|NCT00159874|363432575|FG000|Overall Study|Pregnancy|1|||
105389156|NCT00159874|363432576|FG001|Overall Study|Pregnancy|1|||
105389157|NCT00159874|363432577|FG002|Overall Study|Pregnancy|0|||
105389158|NCT00159874|363432578|FG003|Overall Study|Pregnancy|0|||
105389159|NCT00159874|363432579|FG004|Overall Study|Pregnancy|0|||
105389160|NCT00159874|363432580|FG005|Overall Study|Pregnancy|0|||
105389161|NCT00159874|363432581|FG006|Overall Study|Pregnancy|0|||
105389162|NCT01475825|363432584|FG000|Overall Study|Adverse Event|41|||
105389163|NCT01475825|363432585|FG001|Overall Study|Adverse Event|15|||
105389164|NCT01475825|363432586|FG002|Overall Study|Adverse Event|27|||
105389165|NCT01475825|363432587|FG003|Overall Study|Adverse Event|11|||
105389166|NCT01475825|363432584|FG000|Overall Study|Death|1|||
105389167|NCT01475825|363432585|FG001|Overall Study|Death|0|||
105389168|NCT01475825|363432586|FG002|Overall Study|Death|1|||
105389169|NCT01475825|363432587|FG003|Overall Study|Death|0|||
105389170|NCT01475825|363432584|FG000|Overall Study|Lack of Efficacy|0|||
105389171|NCT01475825|363432585|FG001|Overall Study|Lack of Efficacy|0|||
105389172|NCT01475825|363432586|FG002|Overall Study|Lack of Efficacy|1|||
105389173|NCT01475825|363432587|FG003|Overall Study|Lack of Efficacy|0|||
105389174|NCT01475825|363432584|FG000|Overall Study|Lost to Follow-up|0|||
105389175|NCT01475825|363432585|FG001|Overall Study|Lost to Follow-up|0|||
105389176|NCT01475825|363432586|FG002|Overall Study|Lost to Follow-up|3|||
105389177|NCT01475825|363432587|FG003|Overall Study|Lost to Follow-up|1|||
105389178|NCT01475825|363432584|FG000|Overall Study|Non-compliance with Study Drug|1|||
105389179|NCT01475825|363432585|FG001|Overall Study|Non-compliance with Study Drug|2|||
105389180|NCT01475825|363432586|FG002|Overall Study|Non-compliance with Study Drug|4|||
105389181|NCT01475825|363432587|FG003|Overall Study|Non-compliance with Study Drug|0|||
105389182|NCT01475825|363432584|FG000|Overall Study|Other: Not available|0|||
105389183|NCT01475825|363432585|FG001|Overall Study|Other: Not available|0|||
105389184|NCT01475825|363432586|FG002|Overall Study|Other: Not available|2|||
105389185|NCT01475825|363432587|FG003|Overall Study|Other: Not available|0|||
105389186|NCT01475825|363432584|FG000|Overall Study|Protocol Violation|1|||
105389187|NCT01475825|363432585|FG001|Overall Study|Protocol Violation|0|||
105389188|NCT01475825|363432586|FG002|Overall Study|Protocol Violation|0|||
105389189|NCT01475825|363432587|FG003|Overall Study|Protocol Violation|0|||
105389190|NCT01475825|363432584|FG000|Overall Study|Physician Decision|0|||
105389191|NCT01475825|363432585|FG001|Overall Study|Physician Decision|1|||
105389192|NCT01475825|363432586|FG002|Overall Study|Physician Decision|0|||
105389193|NCT01475825|363432587|FG003|Overall Study|Physician Decision|0|||
105389194|NCT01475825|363432584|FG000|Overall Study|Withdrawal by Subject|8|||
105389195|NCT01475825|363432585|FG001|Overall Study|Withdrawal by Subject|3|||
105389196|NCT01475825|363432586|FG002|Overall Study|Withdrawal by Subject|11|||
105389197|NCT01475825|363432587|FG003|Overall Study|Withdrawal by Subject|7|||
105389198|NCT01475825|363432584|FG000|Overall Study|Did not enter OLC|15|||
105389199|NCT01475825|363432585|FG001|Overall Study|Did not enter OLC|11|||
105389200|NCT01475825|363432586|FG002|Overall Study|Did not enter OLC|15|||
105389201|NCT01475825|363432587|FG003|Overall Study|Did not enter OLC|11|||
105389202|NCT02244957|363432588|FG000|Overall Study|Lack of Efficacy|1|||
105389203|NCT02244957|363432589|FG001|Overall Study|Lack of Efficacy|0|||
105389204|NCT01546987|363432594|FG000|Overall Study|Protocol Violation|3|||
105389205|NCT01546987|363432595|FG001|Overall Study|Protocol Violation|4|||
105389206|NCT02771145|363432596|FG000|Overall Study|Adverse Event|3|||
105389207|NCT02771145|363432596|FG000|Overall Study|Lost to Follow-up|1|||
105389208|NCT02264821|363432597|FG000|Overall Study|Protocol Violation|1|||
105389209|NCT02264821|363432598|FG001|Overall Study|Protocol Violation|3|||
105389210|NCT02264821|363432599|FG002|Overall Study|Protocol Violation|6|||
105389211|NCT02662582|363432600|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
105389212|NCT02662582|363432601|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
105389213|NCT02662582|363432600|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
105389214|NCT02662582|363432601|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
105389215|NCT02662582|363432600|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
105389216|NCT02662582|363432601|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
105389217|NCT02662582|363432600|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
105389218|NCT02662582|363432601|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
105389219|NCT05463952|363432602|FG000|Treatment|Progressive disease|4|||
105389220|NCT05463952|363432602|FG000|Treatment|Ongoing|2|||
105389221|NCT05261490|363432603|FG000|Overall Study|Other|1|||
105389222|NCT05261490|363432604|FG001|Overall Study|Other|0|||
105389223|NCT05261490|363432605|FG002|Overall Study|Other|0|||
105389224|NCT05261490|363432603|FG000|Overall Study|Study Terminated by Sponsor|1|||
105389225|NCT05261490|363432604|FG001|Overall Study|Study Terminated by Sponsor|1|||
105389226|NCT05261490|363432605|FG002|Overall Study|Study Terminated by Sponsor|4|||
105389227|NCT05261490|363432603|FG000|Overall Study|Death|1|||
105389228|NCT05261490|363432604|FG001|Overall Study|Death|2|||
105389229|NCT05261490|363432605|FG002|Overall Study|Death|0|||
105389230|NCT01687595|363432617|FG000|Overall Study|Withdrawal by Subject|8|||
105389231|NCT01687595|363432618|FG001|Overall Study|Withdrawal by Subject|0|||
105389232|NCT01687595|363432617|FG000|Overall Study|Lost to Follow-up|3|||
105389233|NCT01687595|363432618|FG001|Overall Study|Lost to Follow-up|1|||
105389234|NCT01687595|363432617|FG000|Overall Study|Investigator's decision|1|||
105389235|NCT01687595|363432618|FG001|Overall Study|Investigator's decision|0|||
105389236|NCT01687595|363432617|FG000|Overall Study|Sponsor's decision|1|||
105389237|NCT01687595|363432618|FG001|Overall Study|Sponsor's decision|0|||
105389238|NCT01687595|363432617|FG000|Overall Study|Noncompliance|1|||
105389239|NCT01687595|363432618|FG001|Overall Study|Noncompliance|2|||
105389240|NCT01687595|363432617|FG000|Overall Study|Other than specified|56|||
105389241|NCT01687595|363432618|FG001|Overall Study|Other than specified|7|||
105389242|NCT02852005|363432625|FG000|Overall Study|Lost to Follow-up|0|||
105389243|NCT02852005|363432626|FG001|Overall Study|Lost to Follow-up|0|||
105389244|NCT02852005|363432627|FG002|Overall Study|Lost to Follow-up|0|||
105389245|NCT02852005|363432628|FG003|Overall Study|Lost to Follow-up|0|||
105389246|NCT02852005|363432629|FG004|Overall Study|Lost to Follow-up|1|||
105389247|NCT02852005|363432625|FG000|Overall Study|Withdrawal by Subject|1|||
105389248|NCT02852005|363432626|FG001|Overall Study|Withdrawal by Subject|0|||
105389249|NCT02852005|363432627|FG002|Overall Study|Withdrawal by Subject|0|||
105389250|NCT02852005|363432628|FG003|Overall Study|Withdrawal by Subject|0|||
105389251|NCT02852005|363432629|FG004|Overall Study|Withdrawal by Subject|0|||
105389252|NCT03777020|363432630|FG000|Overall Study|Withdrawal by Subject|4|||
105389253|NCT03777020|363432631|FG001|Overall Study|Withdrawal by Subject|4|||
105389254|NCT03777020|363432630|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
105389255|NCT03777020|363432631|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
105389256|NCT00489476|363432634|FG000|Overall Study|Lost to Follow-up|0|||
105389257|NCT00489476|363432635|FG001|Overall Study|Lost to Follow-up|1|||
105389258|NCT00489476|363432636|FG002|Overall Study|Lost to Follow-up|0|||
105389259|NCT00489476|363432637|FG003|Overall Study|Lost to Follow-up|0|||
105389260|NCT01272219|363432648|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
105389261|NCT01272219|363432649|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
105389262|NCT01272219|363432650|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
105389263|NCT01272219|363432651|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
105389264|NCT01272219|363432652|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
105389265|NCT01272219|363432653|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
105389266|NCT01272219|363432648|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
105389267|NCT01272219|363432649|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
105389268|NCT01272219|363432650|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
105389269|NCT01272219|363432651|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
105389270|NCT01272219|363432652|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
105389271|NCT01272219|363432653|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
105389272|NCT01272219|363432648|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
105389273|NCT01272219|363432649|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
105389274|NCT01272219|363432650|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
105389275|NCT01272219|363432651|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
105389276|NCT01272219|363432652|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
105389277|NCT01272219|363432653|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
105389278|NCT01272219|363432648|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
105389279|NCT01272219|363432649|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
105389280|NCT01272219|363432650|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
105389281|NCT01272219|363432651|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
105389282|NCT01272219|363432652|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
105389283|NCT01272219|363432653|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
105389284|NCT01272219|363432648|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
105389285|NCT01272219|363432649|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
105389286|NCT01272219|363432650|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
105389287|NCT01272219|363432651|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
105389288|NCT01272219|363432652|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
105389289|NCT01272219|363432653|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
105389290|NCT01272219|363432648|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
105389291|NCT01272219|363432649|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
105389292|NCT01272219|363432650|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
105389293|NCT01272219|363432651|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
105389294|NCT01272219|363432652|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
105389295|NCT01272219|363432653|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
105389296|NCT01272219|363432648|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
105389297|NCT01272219|363432649|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
105389298|NCT01272219|363432650|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
105389299|NCT01272219|363432651|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
105389300|NCT01272219|363432652|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
105389301|NCT01272219|363432653|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
105389302|NCT01272219|363432648|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
105389303|NCT01272219|363432649|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
105389304|NCT01272219|363432650|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
105389305|NCT01272219|363432651|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
105389306|NCT01272219|363432652|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
105389307|NCT01272219|363432653|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
105389308|NCT01272219|363432648|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
105389309|NCT01272219|363432649|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
105389310|NCT01272219|363432650|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
105389311|NCT01272219|363432651|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
105389312|NCT01272219|363432652|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
105389313|NCT01272219|363432653|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
105389314|NCT01272219|363432648|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
105389315|NCT01272219|363432649|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
105389316|NCT01272219|363432650|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
105389317|NCT01272219|363432651|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
105389318|NCT01272219|363432652|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
105389319|NCT01272219|363432653|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
105389320|NCT01272219|363432648|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
105389321|NCT01272219|363432649|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
105389322|NCT01272219|363432650|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
105389323|NCT01272219|363432651|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
105389324|NCT01272219|363432652|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
105389325|NCT01272219|363432653|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
105389326|NCT01272219|363432648|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
105389327|NCT01272219|363432649|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
105389328|NCT01272219|363432650|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
105389329|NCT01272219|363432651|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
105389330|NCT01272219|363432652|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
105389331|NCT01272219|363432653|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
105389332|NCT01272219|363432648|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
105389333|NCT01272219|363432649|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
105389334|NCT01272219|363432650|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
105389335|NCT01272219|363432651|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
105389336|NCT01272219|363432652|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
105389337|NCT01272219|363432653|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
105389338|NCT01272219|363432648|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
105389339|NCT01272219|363432649|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
105389340|NCT01272219|363432650|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
105389341|NCT01272219|363432651|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
105389342|NCT01272219|363432652|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
105389343|NCT01272219|363432653|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
105389344|NCT01272219|363432648|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
105389345|NCT01272219|363432649|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
105389346|NCT01272219|363432650|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
105389347|NCT01272219|363432651|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
105389348|NCT01272219|363432652|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
105389349|NCT01272219|363432653|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
105389350|NCT01272219|363432648|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
105389351|NCT01272219|363432649|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
105389352|NCT01272219|363432650|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
105389353|NCT01272219|363432651|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
105389354|NCT01272219|363432652|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
105389355|NCT01272219|363432653|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
105389356|NCT00215657|363432656|FG000|Overall Study|Adverse Event|5|||
105389357|NCT00215657|363432657|FG001|Overall Study|Adverse Event|1|||
105389358|NCT00215657|363432658|FG002|Overall Study|Adverse Event|3|||
105389359|NCT00215657|363432659|FG003|Overall Study|Adverse Event|0|||
105389360|NCT00215657|363432660|FG004|Overall Study|Adverse Event|3|||
105389361|NCT00215657|363432661|FG005|Overall Study|Adverse Event|1|||
105389362|NCT00215657|363432662|FG006|Overall Study|Adverse Event|0|||
105389363|NCT00215657|363432663|FG007|Overall Study|Adverse Event|3|||
105389364|NCT00215657|363432656|FG000|Overall Study|Withdrawal by Subject|6|||
105389365|NCT00215657|363432657|FG001|Overall Study|Withdrawal by Subject|3|||
105389366|NCT00215657|363432658|FG002|Overall Study|Withdrawal by Subject|3|||
105389367|NCT00215657|363432659|FG003|Overall Study|Withdrawal by Subject|1|||
105389368|NCT00215657|363432660|FG004|Overall Study|Withdrawal by Subject|6|||
105389369|NCT00215657|363432661|FG005|Overall Study|Withdrawal by Subject|1|||
105389370|NCT00215657|363432662|FG006|Overall Study|Withdrawal by Subject|10|||
105389371|NCT00215657|363432663|FG007|Overall Study|Withdrawal by Subject|3|||
105389372|NCT00215657|363432656|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
105389373|NCT00215657|363432657|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
105389374|NCT00215657|363432658|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
105389375|NCT00215657|363432659|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
105389376|NCT00215657|363432660|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
105389377|NCT00215657|363432661|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
105389378|NCT00215657|363432662|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
105389379|NCT00215657|363432663|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
105389380|NCT00215657|363432656|FG000|Overall Study|Insufficient testosterone response|5|||
105389381|NCT00215657|363432657|FG001|Overall Study|Insufficient testosterone response|4|||
105389382|NCT00215657|363432658|FG002|Overall Study|Insufficient testosterone response|1|||
105389383|NCT00215657|363432659|FG003|Overall Study|Insufficient testosterone response|12|||
105389384|NCT00215657|363432660|FG004|Overall Study|Insufficient testosterone response|8|||
105389385|NCT00215657|363432661|FG005|Overall Study|Insufficient testosterone response|12|||
105389386|NCT00215657|363432662|FG006|Overall Study|Insufficient testosterone response|4|||
105389387|NCT00215657|363432663|FG007|Overall Study|Insufficient testosterone response|7|||
105389388|NCT00215657|363432656|FG000|Overall Study|Other|3|||
105389389|NCT00215657|363432657|FG001|Overall Study|Other|1|||
105389390|NCT00215657|363432658|FG002|Overall Study|Other|2|||
105389391|NCT00215657|363432659|FG003|Overall Study|Other|3|||
105389392|NCT00215657|363432660|FG004|Overall Study|Other|5|||
105389393|NCT00215657|363432661|FG005|Overall Study|Other|4|||
105389394|NCT00215657|363432662|FG006|Overall Study|Other|6|||
105389395|NCT00215657|363432663|FG007|Overall Study|Other|1|||
105389396|NCT00420056|363432664|FG000|Overall Study|Objective progression or relapse|17|||
105389397|NCT04090749|363432665|FG000|Open Label Pilot|Lost to Follow-up|1|||
105389398|NCT04090749|363432666|FG001|Open Label Pilot|Lost to Follow-up|0|||
105389399|NCT04090749|363432667|FG002|Open Label Pilot|Lost to Follow-up|0|||
105389400|NCT04090749|363432665|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
105389401|NCT04090749|363432666|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
105389402|NCT04090749|363432667|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
105389403|NCT04090749|363432665|FG000|Pilot Trial|Lost to Follow-up|0|||
105389404|NCT04090749|363432666|FG001|Pilot Trial|Lost to Follow-up|1|||
105389405|NCT04090749|363432667|FG002|Pilot Trial|Lost to Follow-up|1|||
105389406|NCT03425188|363432669|FG000|Overall Study|Withdrawal by Subject|1|||
105389407|NCT01044459|363432670|FG000|Overall Study|Withdrawal by Subject|21|||
105389408|NCT01044459|363432671|FG001|Overall Study|Withdrawal by Subject|28|||
105389409|NCT01044459|363432670|FG000|Overall Study|Terminated by Sponsor|22|||
105389410|NCT01044459|363432671|FG001|Overall Study|Terminated by Sponsor|21|||
105389411|NCT01044459|363432670|FG000|Overall Study|Adverse Event|22|||
105389412|NCT01044459|363432671|FG001|Overall Study|Adverse Event|20|||
105389413|NCT01044459|363432670|FG000|Overall Study|Lack of Efficacy|23|||
105389414|NCT01044459|363432671|FG001|Overall Study|Lack of Efficacy|12|||
105389415|NCT01044459|363432670|FG000|Overall Study|Protocol Violation|11|||
105389416|NCT01044459|363432671|FG001|Overall Study|Protocol Violation|16|||
105389417|NCT01044459|363432670|FG000|Overall Study|Other Reason|7|||
105389418|NCT01044459|363432671|FG001|Overall Study|Other Reason|14|||
105389419|NCT01044459|363432670|FG000|Overall Study|COPD exacerbation|9|||
105389420|NCT01044459|363432671|FG001|Overall Study|COPD exacerbation|8|||
105389421|NCT01044459|363432670|FG000|Overall Study|Lost to Follow-up|18|||
105389422|NCT01044459|363432671|FG001|Overall Study|Lost to Follow-up|12|||
105389423|NCT01093573|363432672|FG000|Overall Study|Physician Decision|0|||
105389424|NCT01093573|363432673|FG001|Overall Study|Physician Decision|0|||
105389425|NCT01093573|363432674|FG002|Overall Study|Physician Decision|1|||
105389426|NCT01093573|363432672|FG000|Overall Study|Insurance Denied|0|||
105389427|NCT01093573|363432673|FG001|Overall Study|Insurance Denied|0|||
105389428|NCT01093573|363432674|FG002|Overall Study|Insurance Denied|1|||
105389429|NCT00289900|363432675|FG000|Overall Study|Adverse Event|28|||
105389430|NCT00289900|363432676|FG001|Overall Study|Adverse Event|40|||
105389431|NCT00289900|363432677|FG002|Overall Study|Adverse Event|13|||
105389432|NCT00289900|363432678|FG003|Overall Study|Adverse Event|19|||
105389433|NCT00289900|363432679|FG004|Overall Study|Adverse Event|20|||
105389434|NCT00289900|363432680|FG005|Overall Study|Adverse Event|33|||
105389435|NCT00289900|363432675|FG000|Overall Study|Lost to Follow-up|7|||
105389436|NCT00289900|363432676|FG001|Overall Study|Lost to Follow-up|7|||
105389437|NCT00289900|363432677|FG002|Overall Study|Lost to Follow-up|8|||
105389438|NCT00289900|363432678|FG003|Overall Study|Lost to Follow-up|8|||
105389439|NCT00289900|363432679|FG004|Overall Study|Lost to Follow-up|4|||
105389440|NCT00289900|363432680|FG005|Overall Study|Lost to Follow-up|8|||
105389441|NCT00289900|363432675|FG000|Overall Study|Participant had flushing|18|||
105389442|NCT00289900|363432676|FG001|Overall Study|Participant had flushing|42|||
105389443|NCT00289900|363432677|FG002|Overall Study|Participant had flushing|1|||
105389444|NCT00289900|363432678|FG003|Overall Study|Participant had flushing|2|||
105389445|NCT00289900|363432679|FG004|Overall Study|Participant had flushing|0|||
105389446|NCT00289900|363432680|FG005|Overall Study|Participant had flushing|4|||
105389447|NCT00289900|363432675|FG000|Overall Study|Other|0|||
105389448|NCT00289900|363432676|FG001|Overall Study|Other|0|||
105389449|NCT00289900|363432677|FG002|Overall Study|Other|0|||
105389450|NCT00289900|363432678|FG003|Overall Study|Other|5|||
105389451|NCT00289900|363432679|FG004|Overall Study|Other|1|||
105389452|NCT00289900|363432680|FG005|Overall Study|Other|0|||
105389453|NCT00289900|363432675|FG000|Overall Study|Participant moved|1|||
105389454|NCT00289900|363432676|FG001|Overall Study|Participant moved|0|||
105389455|NCT00289900|363432677|FG002|Overall Study|Participant moved|0|||
105389456|NCT00289900|363432678|FG003|Overall Study|Participant moved|1|||
105389457|NCT00289900|363432679|FG004|Overall Study|Participant moved|1|||
105389458|NCT00289900|363432680|FG005|Overall Study|Participant moved|1|||
105389459|NCT00289900|363432675|FG000|Overall Study|Withdrawal by Subject|10|||
105389460|NCT00289900|363432676|FG001|Overall Study|Withdrawal by Subject|21|||
105389461|NCT00289900|363432677|FG002|Overall Study|Withdrawal by Subject|8|||
105389462|NCT00289900|363432678|FG003|Overall Study|Withdrawal by Subject|18|||
105389463|NCT00289900|363432679|FG004|Overall Study|Withdrawal by Subject|12|||
105389464|NCT00289900|363432680|FG005|Overall Study|Withdrawal by Subject|11|||
105389465|NCT00289900|363432675|FG000|Overall Study|Protocol Violation|3|||
105389466|NCT00289900|363432676|FG001|Overall Study|Protocol Violation|9|||
105389467|NCT00289900|363432677|FG002|Overall Study|Protocol Violation|2|||
105389468|NCT00289900|363432678|FG003|Overall Study|Protocol Violation|6|||
105389469|NCT00289900|363432679|FG004|Overall Study|Protocol Violation|7|||
105389470|NCT00289900|363432680|FG005|Overall Study|Protocol Violation|4|||
105389471|NCT00289900|363432675|FG000|Overall Study|site terminated|1|||
105389472|NCT00289900|363432676|FG001|Overall Study|site terminated|0|||
105389473|NCT00289900|363432677|FG002|Overall Study|site terminated|1|||
105389474|NCT00289900|363432678|FG003|Overall Study|site terminated|0|||
105389475|NCT00289900|363432679|FG004|Overall Study|site terminated|0|||
105389476|NCT00289900|363432680|FG005|Overall Study|site terminated|0|||
105389477|NCT00289900|363432675|FG000|Overall Study|Not treated|0|||
105389478|NCT00289900|363432676|FG001|Overall Study|Not treated|1|||
105389479|NCT00289900|363432677|FG002|Overall Study|Not treated|0|||
105389480|NCT00289900|363432678|FG003|Overall Study|Not treated|0|||
105389481|NCT00289900|363432679|FG004|Overall Study|Not treated|0|||
105389482|NCT00289900|363432680|FG005|Overall Study|Not treated|0|||
105389483|NCT01152385|363432683|FG000|Overall Study|Withdrawal by Subject|3|||
105389484|NCT01152385|363432684|FG001|Overall Study|Withdrawal by Subject|1|||
105389485|NCT01152385|363432685|FG002|Overall Study|Withdrawal by Subject|1|||
105389486|NCT01152385|363432686|FG003|Overall Study|Withdrawal by Subject|1|||
105389487|NCT01152385|363432683|FG000|Overall Study|Protocol Violation|0|||
105389488|NCT01152385|363432684|FG001|Overall Study|Protocol Violation|0|||
105389489|NCT01152385|363432685|FG002|Overall Study|Protocol Violation|0|||
105389490|NCT01152385|363432686|FG003|Overall Study|Protocol Violation|1|||
105389491|NCT01152385|363432683|FG000|Overall Study|Adverse Event|1|||
105389492|NCT01152385|363432684|FG001|Overall Study|Adverse Event|1|||
105389493|NCT01152385|363432685|FG002|Overall Study|Adverse Event|0|||
105389494|NCT01152385|363432686|FG003|Overall Study|Adverse Event|0|||
105389495|NCT01152385|363432683|FG000|Overall Study|Study-specific withdrawal criteria|1|||
105389496|NCT01152385|363432684|FG001|Overall Study|Study-specific withdrawal criteria|1|||
105389497|NCT01152385|363432685|FG002|Overall Study|Study-specific withdrawal criteria|2|||
105389498|NCT01152385|363432686|FG003|Overall Study|Study-specific withdrawal criteria|0|||
105389499|NCT01152385|363432683|FG000|Overall Study|Other|4|||
105389500|NCT01152385|363432684|FG001|Overall Study|Other|3|||
105389501|NCT01152385|363432685|FG002|Overall Study|Other|2|||
105389502|NCT01152385|363432686|FG003|Overall Study|Other|3|||
105389503|NCT05486065|363432687|FG000|Overall Study|Withdrawal by Subject|1|||
105389504|NCT05486065|363432688|FG001|Overall Study|Withdrawal by Subject|5|||
105389505|NCT05486065|363432689|FG002|Overall Study|Withdrawal by Subject|4|||
105389506|NCT05486065|363432690|FG003|Overall Study|Withdrawal by Subject|3|||
105389507|NCT05486065|363432687|FG000|Overall Study|Lost to Follow-up|4|||
105389508|NCT05486065|363432688|FG001|Overall Study|Lost to Follow-up|2|||
105389509|NCT05486065|363432689|FG002|Overall Study|Lost to Follow-up|2|||
105389510|NCT05486065|363432690|FG003|Overall Study|Lost to Follow-up|2|||
105389511|NCT05486065|363432687|FG000|Overall Study|Physician Decision|0|||
105389512|NCT05486065|363432688|FG001|Overall Study|Physician Decision|1|||
105389513|NCT05486065|363432689|FG002|Overall Study|Physician Decision|1|||
105389514|NCT05486065|363432690|FG003|Overall Study|Physician Decision|0|||
105389515|NCT05486065|363432687|FG000|Overall Study|Failure to meet randomization criteria|0|||
105389516|NCT05486065|363432688|FG001|Overall Study|Failure to meet randomization criteria|0|||
105389517|NCT05486065|363432689|FG002|Overall Study|Failure to meet randomization criteria|0|||
105389518|NCT05486065|363432690|FG003|Overall Study|Failure to meet randomization criteria|1|||
105389519|NCT01064622|363432691|FG000|Randomized Phase II|Withdrawal by Subject|2|||
105389520|NCT01064622|363432692|FG001|Randomized Phase II|Withdrawal by Subject|2|||
105389521|NCT01064622|363432691|FG000|Randomized Phase II|Protocol Violation|0|||
105389522|NCT01064622|363432692|FG001|Randomized Phase II|Protocol Violation|1|||
105389523|NCT04398706|363432693|FG000|Overall Study|Adverse Event|0|||
105389524|NCT04398706|363432694|FG001|Overall Study|Adverse Event|0|||
105389525|NCT04398706|363432695|FG002|Overall Study|Adverse Event|0|||
105389526|NCT04398706|363432696|FG003|Overall Study|Adverse Event|0|||
105389527|NCT04398706|363432697|FG004|Overall Study|Adverse Event|0|||
105389528|NCT04398706|363432698|FG005|Overall Study|Adverse Event|1|||
105389529|NCT04398706|363432699|FG006|Overall Study|Adverse Event|1|||
105389530|NCT04398706|363432700|FG007|Overall Study|Adverse Event|0|||
105389531|NCT04398706|363432693|FG000|Overall Study|Lost to Follow-up|0|||
105389532|NCT04398706|363432694|FG001|Overall Study|Lost to Follow-up|1|||
105389533|NCT04398706|363432695|FG002|Overall Study|Lost to Follow-up|2|||
105389534|NCT04398706|363432696|FG003|Overall Study|Lost to Follow-up|1|||
105389535|NCT04398706|363432697|FG004|Overall Study|Lost to Follow-up|6|||
105389536|NCT04398706|363432698|FG005|Overall Study|Lost to Follow-up|3|||
105389537|NCT04398706|363432699|FG006|Overall Study|Lost to Follow-up|8|||
105389538|NCT04398706|363432700|FG007|Overall Study|Lost to Follow-up|2|||
105389539|NCT04398706|363432693|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105389540|NCT04398706|363432694|FG001|Overall Study|Withdrawal by parent/guardian|2|||
105389541|NCT04398706|363432695|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105389542|NCT04398706|363432696|FG003|Overall Study|Withdrawal by parent/guardian|2|||
105389543|NCT04398706|363432697|FG004|Overall Study|Withdrawal by parent/guardian|19|||
105389544|NCT04398706|363432698|FG005|Overall Study|Withdrawal by parent/guardian|23|||
105389545|NCT04398706|363432699|FG006|Overall Study|Withdrawal by parent/guardian|13|||
105389546|NCT04398706|363432700|FG007|Overall Study|Withdrawal by parent/guardian|11|||
105389547|NCT04398706|363432693|FG000|Overall Study|Protocol deviation|0|||
105389548|NCT04398706|363432694|FG001|Overall Study|Protocol deviation|1|||
105389549|NCT04398706|363432695|FG002|Overall Study|Protocol deviation|0|||
105389550|NCT04398706|363432696|FG003|Overall Study|Protocol deviation|0|||
105389551|NCT04398706|363432697|FG004|Overall Study|Protocol deviation|6|||
105389552|NCT04398706|363432698|FG005|Overall Study|Protocol deviation|4|||
105389553|NCT04398706|363432699|FG006|Overall Study|Protocol deviation|6|||
105389554|NCT04398706|363432700|FG007|Overall Study|Protocol deviation|3|||
105389555|NCT03927846|363432704|FG000|Overall Study|Lost to Follow-up|10|||
105389556|NCT03927846|363432705|FG001|Overall Study|Lost to Follow-up|11|||
105492953|NCT02445391|363817210|FG001|Overall Study|Withdrawal by Subject|4|||
105389557|NCT03878069|363432706|FG000|Overall Study|Death|0|||
105389558|NCT03878069|363432707|FG001|Overall Study|Death|1|||
105389559|NCT03878069|363432708|FG002|Overall Study|Death|0|||
105389560|NCT03941093|363432709|FG000|Overall Study|Protocol Violation|0|||
105389561|NCT03941093|363432710|FG001|Overall Study|Protocol Violation|1|||
105389562|NCT03941093|363432709|FG000|Overall Study|Withdrawal by Subject|9|||
105389563|NCT03941093|363432710|FG001|Overall Study|Withdrawal by Subject|6|||
105389564|NCT03493945|363433946|FG000|Phase I Dose Escalation|Ineligible|0|||
105389565|NCT03493945|363433947|FG001|Phase I Dose Escalation|Ineligible|0|||
105389566|NCT03493945|363433948|FG002|Phase I Dose Escalation|Ineligible|1|||
105389567|NCT03493945|363433949|FG003|Phase I Dose Escalation|Ineligible|0|||
105389568|NCT03493945|363433950|FG004|Phase I Dose Escalation|Ineligible|0|||
105389569|NCT03493945|363433951|FG005|Phase I Dose Escalation|Ineligible|0|||
105389570|NCT03493945|363433952|FG006|Phase I Dose Escalation|Ineligible|0|||
105389571|NCT03493945|363433946|FG000|Phase I Dose Escalation|New therapy|0|||
105389572|NCT03493945|363433947|FG001|Phase I Dose Escalation|New therapy|1|||
105389573|NCT03493945|363433948|FG002|Phase I Dose Escalation|New therapy|0|||
105389574|NCT03493945|363433949|FG003|Phase I Dose Escalation|New therapy|0|||
105389575|NCT03493945|363433950|FG004|Phase I Dose Escalation|New therapy|0|||
105389576|NCT03493945|363433951|FG005|Phase I Dose Escalation|New therapy|0|||
105389577|NCT03493945|363433952|FG006|Phase I Dose Escalation|New therapy|0|||
105389578|NCT03493945|363433946|FG000|Phase II Dose Expansion|Refused further treatment|0|||
105389579|NCT03493945|363433947|FG001|Phase II Dose Expansion|Refused further treatment|0|||
105389580|NCT03493945|363433948|FG002|Phase II Dose Expansion|Refused further treatment|0|||
105389581|NCT03493945|363433949|FG003|Phase II Dose Expansion|Refused further treatment|0|||
105389582|NCT03493945|363433950|FG004|Phase II Dose Expansion|Refused further treatment|1|||
105389583|NCT03493945|363433951|FG005|Phase II Dose Expansion|Refused further treatment|1|||
105389584|NCT03493945|363433952|FG006|Phase II Dose Expansion|Refused further treatment|0|||
105389585|NCT03493945|363433946|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
105389586|NCT03493945|363433947|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
105389587|NCT03493945|363433948|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
105389588|NCT03493945|363433949|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
105389589|NCT03493945|363433950|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
105389590|NCT03493945|363433951|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
105389591|NCT03493945|363433952|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
105389592|NCT01926509|363433953|FG000|Overall Study|vital sign met discontinuation criteria|1|||
105389593|NCT01926509|363433954|FG001|Overall Study|vital sign met discontinuation criteria|0|||
105389594|NCT01926509|363433955|FG002|Overall Study|vital sign met discontinuation criteria|0|||
105389595|NCT01926509|363433956|FG003|Overall Study|vital sign met discontinuation criteria|0|||
105389596|NCT04744831|363433957|FG000|Overall Study|Progressive Disease|31|||
105389597|NCT04744831|363433958|FG001|Overall Study|Progressive Disease|27|||
105389598|NCT04744831|363433959|FG002|Overall Study|Progressive Disease|25|||
105389599|NCT04744831|363433957|FG000|Overall Study|Adverse Event|3|||
105389600|NCT04744831|363433958|FG001|Overall Study|Adverse Event|3|||
105389601|NCT04744831|363433959|FG002|Overall Study|Adverse Event|3|||
105389602|NCT04744831|363433957|FG000|Overall Study|Clinical Progression|3|||
105389603|NCT04744831|363433958|FG001|Overall Study|Clinical Progression|2|||
105389604|NCT04744831|363433959|FG002|Overall Study|Clinical Progression|5|||
105389605|NCT04744831|363433957|FG000|Overall Study|Other|0|||
105389606|NCT04744831|363433958|FG001|Overall Study|Other|2|||
105389607|NCT04744831|363433959|FG002|Overall Study|Other|1|||
105389608|NCT04744831|363433957|FG000|Overall Study|Death|0|||
105389609|NCT04744831|363433958|FG001|Overall Study|Death|2|||
105389610|NCT04744831|363433959|FG002|Overall Study|Death|1|||
105389611|NCT03004183|363433960|FG000|Overall Study|Adverse Event|7|||
105389612|NCT03004183|363433960|FG000|Overall Study|Lost to Follow-up|1|||
105389613|NCT03004183|363433960|FG000|Overall Study|Physician Decision|40|||
105389614|NCT03004183|363433960|FG000|Overall Study|Withdrawal by Subject|1|||
105389615|NCT03004183|363433960|FG000|Overall Study|COVID-19|1|||
105389616|NCT01313676|363433961|FG000|Overall Study|Adverse Event|395|||
105389617|NCT01313676|363433962|FG001|Overall Study|Adverse Event|365|||
105389618|NCT01313676|363433963|FG002|Overall Study|Adverse Event|372|||
105389619|NCT01313676|363433964|FG003|Overall Study|Adverse Event|333|||
105389620|NCT01313676|363433961|FG000|Overall Study|Lack of Efficacy|98|||
105389621|NCT01313676|363433962|FG001|Overall Study|Lack of Efficacy|90|||
105389622|NCT01313676|363433963|FG002|Overall Study|Lack of Efficacy|65|||
105389623|NCT01313676|363433964|FG003|Overall Study|Lack of Efficacy|46|||
105389624|NCT01313676|363433961|FG000|Overall Study|Protocol Violation|37|||
105389625|NCT01313676|363433962|FG001|Overall Study|Protocol Violation|44|||
105389626|NCT01313676|363433963|FG002|Overall Study|Protocol Violation|46|||
105389627|NCT01313676|363433964|FG003|Overall Study|Protocol Violation|44|||
105389628|NCT01313676|363433961|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
105389629|NCT01313676|363433962|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
105389630|NCT01313676|363433963|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
105389631|NCT01313676|363433964|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
105389632|NCT01313676|363433961|FG000|Overall Study|Study Closed/terminated|7|||
105389633|NCT01313676|363433962|FG001|Overall Study|Study Closed/terminated|6|||
105389634|NCT01313676|363433963|FG002|Overall Study|Study Closed/terminated|9|||
105389635|NCT01313676|363433964|FG003|Overall Study|Study Closed/terminated|9|||
105389636|NCT01313676|363433961|FG000|Overall Study|Lost to Follow-up|0|||
105389637|NCT01313676|363433962|FG001|Overall Study|Lost to Follow-up|0|||
105389638|NCT01313676|363433963|FG002|Overall Study|Lost to Follow-up|1|||
105580553|NCT02018861|364126453|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
105389639|NCT01313676|363433964|FG003|Overall Study|Lost to Follow-up|0|||
105389640|NCT01313676|363433961|FG000|Overall Study|Physician Decision|53|||
105389641|NCT01313676|363433962|FG001|Overall Study|Physician Decision|64|||
105389642|NCT01313676|363433963|FG002|Overall Study|Physician Decision|62|||
105389643|NCT01313676|363433964|FG003|Overall Study|Physician Decision|48|||
105389644|NCT01313676|363433961|FG000|Overall Study|Decision by Participant or Proxy|643|||
105389645|NCT01313676|363433962|FG001|Overall Study|Decision by Participant or Proxy|527|||
105389646|NCT01313676|363433963|FG002|Overall Study|Decision by Participant or Proxy|515|||
105389647|NCT01313676|363433964|FG003|Overall Study|Decision by Participant or Proxy|492|||
105389648|NCT01313676|363433961|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
105389649|NCT01313676|363433962|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
105389650|NCT01313676|363433963|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
105389651|NCT01313676|363433964|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
105389652|NCT01313676|363433961|FG000|Overall Study|Investigator Site Closed|12|||
105580554|NCT02018861|364126444|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
105389653|NCT01313676|363433962|FG001|Overall Study|Investigator Site Closed|11|||
105389654|NCT01313676|363433963|FG002|Overall Study|Investigator Site Closed|15|||
105389655|NCT01313676|363433964|FG003|Overall Study|Investigator Site Closed|10|||
105389656|NCT01313676|363433961|FG000|Overall Study|Missing|1|||
105389657|NCT01313676|363433962|FG001|Overall Study|Missing|1|||
105389658|NCT01313676|363433963|FG002|Overall Study|Missing|1|||
105389659|NCT01313676|363433964|FG003|Overall Study|Missing|0|||
105389660|NCT05333965|363433968|FG000|First Intervention|Adverse Event|0|||
105389661|NCT05333965|363433969|FG001|First Intervention|Adverse Event|1|||
105389662|NCT05333965|363433968|FG000|First Intervention|Withdrawal by Subject|0|||
105389663|NCT05333965|363433969|FG001|First Intervention|Withdrawal by Subject|1|||
105389664|NCT01500135|363433972|FG000|Overall Study|Withdrawal of Consent|4|||
105389665|NCT01500135|363433973|FG001|Overall Study|Withdrawal of Consent|0|||
105389666|NCT01500135|363433972|FG000|Overall Study|Lost to Follow-up|6|||
105389667|NCT01500135|363433973|FG001|Overall Study|Lost to Follow-up|4|||
105389668|NCT01500135|363433972|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
105389669|NCT01500135|363433973|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
105389670|NCT01500135|363433972|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
105389671|NCT01500135|363433973|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
105389672|NCT01500135|363433972|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
105389673|NCT01500135|363433973|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
105389674|NCT01500135|363433972|FG000|Overall Study|Participant was a Safety Concern|1|||
105389675|NCT01500135|363433973|FG001|Overall Study|Participant was a Safety Concern|0|||
105389676|NCT01500135|363433972|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
105389677|NCT01500135|363433973|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
105389678|NCT02872142|363433981|FG000|Overall Study|Adverse Event|2|||
105389679|NCT02872142|363433981|FG000|Overall Study|Death|1|||
105389680|NCT02872142|363433981|FG000|Overall Study|Participant Decision|3|||
105389681|NCT00814983|363433985|FG000|Overall Study|Screen failure|1|||
105389682|NCT00814983|363433986|FG001|Overall Study|Screen failure|0|||
105389683|NCT00814983|363433985|FG000|Overall Study|Withdrawal by Subject|1|||
105389684|NCT00814983|363433986|FG001|Overall Study|Withdrawal by Subject|0|||
105389685|NCT00814983|363433985|FG000|Overall Study|Graft failure|1|||
105389686|NCT00814983|363433986|FG001|Overall Study|Graft failure|0|||
105389687|NCT04893811|363433995|FG000|Vaccination Phase|Death|1|||
105389688|NCT04893811|363433996|FG001|Vaccination Phase|Death|0|||
105389689|NCT04893811|363433995|FG000|Vaccination Phase|Lost to Follow-up|1|||
105389690|NCT04893811|363433996|FG001|Vaccination Phase|Lost to Follow-up|1|||
105389691|NCT04893811|363433995|FG000|Vaccination Phase|Protocol Violation|2|||
105389692|NCT04893811|363433996|FG001|Vaccination Phase|Protocol Violation|0|||
105389693|NCT04893811|363433995|FG000|Vaccination Phase|Withdrawal by Subject|2|||
105389694|NCT04893811|363433996|FG001|Vaccination Phase|Withdrawal by Subject|1|||
105389695|NCT04893811|363433995|FG000|Vaccination Phase|Other|0|||
105389696|NCT04893811|363433996|FG001|Vaccination Phase|Other|1|||
105389697|NCT04893811|363433995|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
105389698|NCT04893811|363433996|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
105389699|NCT04893811|363433995|FG000|Follow-up Phase|Lost to Follow-up|0|||
105389700|NCT04893811|363433996|FG001|Follow-up Phase|Lost to Follow-up|1|||
105389701|NCT01725282|363433997|FG000|Overall Study|Adverse Event|1|||
105389702|NCT01725282|363433998|FG001|Overall Study|Adverse Event|3|||
105389703|NCT01725282|363433999|FG002|Overall Study|Adverse Event|6|||
105389704|NCT01725282|363434000|FG003|Overall Study|Adverse Event|4|||
105389705|NCT01725282|363433997|FG000|Overall Study|Exacerbation of Target Disease|1|||
105389706|NCT01725282|363433998|FG001|Overall Study|Exacerbation of Target Disease|0|||
105389707|NCT01725282|363433999|FG002|Overall Study|Exacerbation of Target Disease|0|||
105389708|NCT01725282|363434000|FG003|Overall Study|Exacerbation of Target Disease|1|||
105389709|NCT01725282|363433997|FG000|Overall Study|Met Exclusion Criteria|0|||
105389710|NCT01725282|363433998|FG001|Overall Study|Met Exclusion Criteria|0|||
105389711|NCT01725282|363433999|FG002|Overall Study|Met Exclusion Criteria|1|||
105389712|NCT01725282|363434000|FG003|Overall Study|Met Exclusion Criteria|0|||
105389713|NCT01725282|363433997|FG000|Overall Study|Study Site Withdrawal|0|||
105389714|NCT01725282|363433998|FG001|Overall Study|Study Site Withdrawal|1|||
105389715|NCT01725282|363433999|FG002|Overall Study|Study Site Withdrawal|0|||
105389716|NCT01725282|363434000|FG003|Overall Study|Study Site Withdrawal|0|||
105389717|NCT01725282|363433997|FG000|Overall Study|Withdrawal by Subject|0|||
105389718|NCT01725282|363433998|FG001|Overall Study|Withdrawal by Subject|0|||
105389719|NCT01725282|363433999|FG002|Overall Study|Withdrawal by Subject|1|||
105389720|NCT01725282|363434000|FG003|Overall Study|Withdrawal by Subject|1|||
105389721|NCT01725282|363433997|FG000|Overall Study|Lack of Efficacy|0|||
105389722|NCT01725282|363433998|FG001|Overall Study|Lack of Efficacy|1|||
105389723|NCT01725282|363433999|FG002|Overall Study|Lack of Efficacy|0|||
105389724|NCT01725282|363434000|FG003|Overall Study|Lack of Efficacy|1|||
105389725|NCT04204902|363434001|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
105389726|NCT04204902|363434002|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
105389727|NCT00489359|363434003|FG000|Overall Study|Death|0|||
105389728|NCT00489359|363434004|FG001|Overall Study|Death|2|||
105389729|NCT00489359|363434003|FG000|Overall Study|Progressive Disease|5|||
105389730|NCT00489359|363434004|FG001|Overall Study|Progressive Disease|6|||
105389731|NCT00489359|363434003|FG000|Overall Study|Lost to Follow-up|1|||
105389732|NCT00489359|363434004|FG001|Overall Study|Lost to Follow-up|0|||
105389733|NCT00489359|363434003|FG000|Overall Study|Withdrawal by Subject|1|||
105389734|NCT00489359|363434004|FG001|Overall Study|Withdrawal by Subject|5|||
105389735|NCT00489359|363434003|FG000|Overall Study|Adverse Event|0|||
105389736|NCT00489359|363434004|FG001|Overall Study|Adverse Event|16|||
105389737|NCT03180138|363434005|FG000|Overall Study|Mobile-phone could not be verified|2|||
105389738|NCT03180138|363434006|FG001|Overall Study|Mobile-phone could not be verified|13|||
105389739|NCT03180138|363434007|FG002|Overall Study|Mobile-phone could not be verified|15|||
105389740|NCT03180138|363434005|FG000|Overall Study|No prior immunization records|17|||
105389741|NCT03180138|363434006|FG001|Overall Study|No prior immunization records|0|||
105389742|NCT03180138|363434007|FG002|Overall Study|No prior immunization records|6|||
105389743|NCT03180138|363434005|FG000|Overall Study|Found to be >24 mon after randomization|3|||
105389744|NCT03180138|363434006|FG001|Overall Study|Found to be >24 mon after randomization|0|||
105389745|NCT03180138|363434007|FG002|Overall Study|Found to be >24 mon after randomization|3|||
105389746|NCT04191733|363434011|FG000|Overall Study|Withdrawn due to study closure|13|||
105389747|NCT04191733|363434012|FG001|Overall Study|Withdrawn due to study closure|14|||
105389748|NCT04191733|363434011|FG000|Overall Study|Withdrawal by Subject|2|||
105389749|NCT04191733|363434012|FG001|Overall Study|Withdrawal by Subject|4|||
105389750|NCT04191733|363434011|FG000|Overall Study|Physician Decision|1|||
105389751|NCT04191733|363434012|FG001|Overall Study|Physician Decision|1|||
105389752|NCT04191733|363434011|FG000|Overall Study|Lost to Follow-up|5|||
105389753|NCT04191733|363434012|FG001|Overall Study|Lost to Follow-up|6|||
105389754|NCT04191733|363434011|FG000|Overall Study|Death|0|||
105389755|NCT04191733|363434012|FG001|Overall Study|Death|1|||
105389756|NCT01903733|363434015|FG000|Overall Study|Death|23|||
105389757|NCT01903733|363434016|FG001|Overall Study|Death|54|||
105389758|NCT01903733|363434017|FG002|Overall Study|Death|30|||
105389759|NCT01903733|363434018|FG003|Overall Study|Death|98|||
105389760|NCT01903733|363434015|FG000|Overall Study|Participant refused further follow-up|35|||
105389761|NCT01903733|363434016|FG001|Overall Study|Participant refused further follow-up|38|||
105389762|NCT01903733|363434017|FG002|Overall Study|Participant refused further follow-up|13|||
105389763|NCT01903733|363434018|FG003|Overall Study|Participant refused further follow-up|9|||
105389764|NCT01903733|363434015|FG000|Overall Study|Lost to Follow-up|18|||
105389765|NCT01903733|363434016|FG001|Overall Study|Lost to Follow-up|19|||
105389766|NCT01903733|363434017|FG002|Overall Study|Lost to Follow-up|6|||
105389767|NCT01903733|363434018|FG003|Overall Study|Lost to Follow-up|9|||
105389768|NCT01903733|363434015|FG000|Overall Study|Other|10|||
105389769|NCT01903733|363434016|FG001|Overall Study|Other|15|||
105389770|NCT01903733|363434017|FG002|Overall Study|Other|12|||
105389771|NCT01903733|363434018|FG003|Overall Study|Other|3|||
105389772|NCT01903733|363434015|FG000|Overall Study|Missing|2|||
105389773|NCT01903733|363434016|FG001|Overall Study|Missing|0|||
105389774|NCT01903733|363434017|FG002|Overall Study|Missing|0|||
105389775|NCT01903733|363434018|FG003|Overall Study|Missing|0|||
105389776|NCT01903733|363434015|FG000|Overall Study|Investigator request|18|||
105389777|NCT01903733|363434016|FG001|Overall Study|Investigator request|0|||
105389778|NCT01903733|363434017|FG002|Overall Study|Investigator request|0|||
105389779|NCT01903733|363434018|FG003|Overall Study|Investigator request|0|||
105389780|NCT01714063|363434019|FG000|Overall Study|Equipment malfunction|2|||
105389781|NCT00069953|363434020|FG000|Overall Study|Protocol Violation|2|||
105389782|NCT00979407|363434021|FG000|Overall Study|Withdrawal by Subject|3|||
105389783|NCT00979407|363434022|FG001|Overall Study|Withdrawal by Subject|4|||
105389784|NCT00979407|363434021|FG000|Overall Study|Lost to Follow-up|3|||
105389785|NCT00979407|363434022|FG001|Overall Study|Lost to Follow-up|3|||
105389786|NCT01166646|363434023|FG000|Overall Study|Protocol Violation|0|||
105389787|NCT01166646|363434024|FG001|Overall Study|Protocol Violation|1|||
105389788|NCT01166646|363434023|FG000|Overall Study|Adverse Event|1|||
105389789|NCT01166646|363434024|FG001|Overall Study|Adverse Event|0|||
105389790|NCT02420314|363434025|FG000|Overall Study|Withdrawal by Subject|1|||
105389791|NCT02420314|363434025|FG000|Overall Study|Protocol Violation|1|||
105389792|NCT01335685|363434033|FG000|Overall Study|Study Terminated by Sponsor|2|||
105389793|NCT01335685|363434034|FG001|Overall Study|Study Terminated by Sponsor|1|||
105389794|NCT01335685|363434035|FG002|Overall Study|Study Terminated by Sponsor|1|||
105389795|NCT01335685|363434036|FG003|Overall Study|Study Terminated by Sponsor|10|||
105389796|NCT01335685|363434037|FG004|Overall Study|Study Terminated by Sponsor|0|||
105389797|NCT01335685|363434038|FG005|Overall Study|Study Terminated by Sponsor|4|||
105389798|NCT01335685|363434039|FG006|Overall Study|Study Terminated by Sponsor|2|||
105389799|NCT01335685|363434040|FG007|Overall Study|Study Terminated by Sponsor|3|||
105389800|NCT01335685|363434033|FG000|Overall Study|Withdrawal by Subject|1|||
105389801|NCT01335685|363434034|FG001|Overall Study|Withdrawal by Subject|0|||
105389802|NCT01335685|363434035|FG002|Overall Study|Withdrawal by Subject|0|||
105389803|NCT01335685|363434036|FG003|Overall Study|Withdrawal by Subject|1|||
105389804|NCT01335685|363434037|FG004|Overall Study|Withdrawal by Subject|0|||
105389805|NCT01335685|363434038|FG005|Overall Study|Withdrawal by Subject|0|||
105389806|NCT01335685|363434039|FG006|Overall Study|Withdrawal by Subject|0|||
105389807|NCT01335685|363434040|FG007|Overall Study|Withdrawal by Subject|0|||
105389808|NCT01335685|363434033|FG000|Overall Study|Reason not Specified|0|||
105389809|NCT01335685|363434034|FG001|Overall Study|Reason not Specified|0|||
105389810|NCT01335685|363434035|FG002|Overall Study|Reason not Specified|1|||
105389811|NCT01335685|363434036|FG003|Overall Study|Reason not Specified|0|||
105389812|NCT01335685|363434037|FG004|Overall Study|Reason not Specified|0|||
105389813|NCT01335685|363434038|FG005|Overall Study|Reason not Specified|1|||
105389814|NCT01335685|363434039|FG006|Overall Study|Reason not Specified|0|||
105389815|NCT01335685|363434040|FG007|Overall Study|Reason not Specified|0|||
105389816|NCT01848457|363434043|FG000|Overall Study|Death|1|||
105389817|NCT01848457|363434044|FG001|Overall Study|Death|0|||
105389818|NCT01848457|363434045|FG002|Overall Study|Death|0|||
105389819|NCT01848457|363434046|FG003|Overall Study|Death|0|||
105389820|NCT04818086|363434049|FG000|Overall Study|Physician Decision|1|||
105389821|NCT04818086|363434050|FG001|Overall Study|Physician Decision|0|||
105389822|NCT04818086|363434049|FG000|Overall Study|Withdrawal by Subject|0|||
105389823|NCT04818086|363434050|FG001|Overall Study|Withdrawal by Subject|1|||
105389824|NCT04042311|363434054|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
105389825|NCT04042311|363434054|FG000|Overall Study|Unable to tolerate|4|||
105389826|NCT04042311|363434054|FG000|Overall Study|Concurrent illness|2|||
105389827|NCT04042311|363434054|FG000|Overall Study|Adverse Event|2|||
105389828|NCT04042311|363434054|FG000|Overall Study|No longer meeting inclusion criteria|2|||
105389829|NCT04042311|363434054|FG000|Overall Study|No reason given|1|||
105389830|NCT04042311|363434054|FG000|Overall Study|Withdrawal by Subject|4|||
105389831|NCT01390584|363434057|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
105389832|NCT01390584|363434058|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
105389833|NCT01390584|363434059|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
105389834|NCT01703221|363434060|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
105389835|NCT01703221|363434061|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
105389836|NCT01703221|363434062|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
105389837|NCT01703221|363434060|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
105389838|NCT01703221|363434061|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
105389839|NCT01703221|363434062|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
105389840|NCT01703221|363434060|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
105389841|NCT01703221|363434061|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105389842|NCT01703221|363434062|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105389843|NCT01703221|363434060|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
105389844|NCT01703221|363434061|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
105389845|NCT01703221|363434062|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
105389846|NCT01703221|363434060|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105389847|NCT01703221|363434061|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105389848|NCT01703221|363434062|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
105389849|NCT01703221|363434060|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
105389850|NCT01703221|363434061|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
105389851|NCT01703221|363434062|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
105389852|NCT01703221|363434060|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
105389853|NCT01703221|363434061|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
105389854|NCT01703221|363434062|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
105389855|NCT01703221|363434060|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
105389856|NCT01703221|363434061|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
105389857|NCT01703221|363434062|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
105389858|NCT02656173|363434063|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
105389859|NCT02656173|363434064|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
105389860|NCT02656173|363434063|FG000|Overall Study|Adverse Event|7|||
105389861|NCT02656173|363434064|FG001|Overall Study|Adverse Event|5|||
105389862|NCT02656173|363434063|FG000|Overall Study|Withdrawal by Subject|1|||
105389863|NCT02656173|363434064|FG001|Overall Study|Withdrawal by Subject|3|||
105389864|NCT02656173|363434063|FG000|Overall Study|Protocol Violation|0|||
105389865|NCT02656173|363434064|FG001|Overall Study|Protocol Violation|1|||
105389866|NCT02656173|363434063|FG000|Overall Study|Miscellaneous|2|||
105389867|NCT02656173|363434064|FG001|Overall Study|Miscellaneous|0|||
105389868|NCT00834587|363434065|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
105389869|NCT00834587|363434066|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
105389870|NCT00176254|363434067|FG000|Overall Study|Lost to Follow-up|1|||
105389871|NCT02613507|363434069|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
105389872|NCT02613507|363434070|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
105389873|NCT02613507|363434069|FG000|Pre-Treamtent|Participant withdrew consent|0|||
105389874|NCT02613507|363434070|FG001|Pre-Treamtent|Participant withdrew consent|4|||
105389875|NCT02613507|363434069|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
105389876|NCT02613507|363434070|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
105389877|NCT02613507|363434069|FG000|Treatment|Not reported|3|||
105389878|NCT02613507|363434070|FG001|Treatment|Not reported|0|||
105389879|NCT02613507|363434069|FG000|Treatment|Other reasons|8|||
105389880|NCT02613507|363434070|FG001|Treatment|Other reasons|0|||
105389881|NCT02613507|363434069|FG000|Treatment|Participant no longer meets criteria|3|||
105389882|NCT02613507|363434070|FG001|Treatment|Participant no longer meets criteria|0|||
105389883|NCT02613507|363434069|FG000|Treatment|Maximum clinical benefit|5|||
105389884|NCT02613507|363434070|FG001|Treatment|Maximum clinical benefit|10|||
105389885|NCT02613507|363434069|FG000|Treatment|Lost to Follow-up|1|||
105389886|NCT02613507|363434070|FG001|Treatment|Lost to Follow-up|0|||
105389887|NCT02613507|363434069|FG000|Treatment|Participant withdrew consent|0|||
105389888|NCT02613507|363434070|FG001|Treatment|Participant withdrew consent|2|||
105389889|NCT02613507|363434069|FG000|Treatment|Participant request to discontinue study treatment|13|||
105389890|NCT02613507|363434070|FG001|Treatment|Participant request to discontinue study treatment|17|||
105389891|NCT02613507|363434069|FG000|Treatment|Adverse event unrelated to study drug|20|||
105389892|NCT02613507|363434070|FG001|Treatment|Adverse event unrelated to study drug|3|||
105389893|NCT02613507|363434069|FG000|Treatment|Death|2|||
105389894|NCT02613507|363434070|FG001|Treatment|Death|0|||
105389895|NCT02613507|363434069|FG000|Treatment|Study drug toxicity|19|||
105389896|NCT02613507|363434070|FG001|Treatment|Study drug toxicity|14|||
105389897|NCT02613507|363434069|FG000|Treatment|Disease progression|263|||
105389898|NCT02613507|363434070|FG001|Treatment|Disease progression|110|||
105389899|NCT00974233|363434072|FG000|Induction Chemoimmunotherapy|Death|2|||
105389900|NCT00974233|363434072|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
105389901|NCT00974233|363434072|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
105389902|NCT00974233|363434072|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
105389903|NCT00974233|363434072|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
105389904|NCT00974233|363434072|FG000|Maintenance Lenalidomide|Adverse Event|8|||
105389905|NCT05401409|363435322|FG000|Overall Study|Lost to Follow-up|1|||
105389906|NCT05401409|363435323|FG001|Overall Study|Lost to Follow-up|0|||
105389907|NCT06844812|363435324|FG000|Overall Study|Lost to Follow-up|5|||
105389908|NCT06844812|363435324|FG000|Overall Study|stigmatization concerns|2|||
105389909|NCT06844812|363435324|FG000|Overall Study|medication refusal|2|||
105389910|NCT06844812|363435324|FG000|Overall Study|concerns about possible side effects|2|||
105389911|NCT06844812|363435324|FG000|Overall Study|wanting to seek another specialist opinion|2|||
105389912|NCT06844812|363435324|FG000|Overall Study|side effects (dizziness)|1|||
105389913|NCT02144337|363435325|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
105389914|NCT02144337|363435326|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
105389915|NCT02144337|363435325|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
105389916|NCT02144337|363435326|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
105389917|NCT02144337|363435325|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
105389918|NCT02144337|363435326|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
105389919|NCT02144337|363435325|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
105389920|NCT02144337|363435326|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
105389921|NCT02144337|363435325|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
105389922|NCT02144337|363435326|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
105389923|NCT02402907|363435329|FG000|Overall Study|Delivered vaginally|9|||
105389924|NCT02402907|363435330|FG001|Overall Study|Delivered vaginally|3|||
105389925|NCT02402907|363435329|FG000|Overall Study|Delivered outside of Sinai|1|||
105389926|NCT02402907|363435330|FG001|Overall Study|Delivered outside of Sinai|1|||
105389927|NCT02402907|363435329|FG000|Overall Study|Lost to follow up after C-Section|10|||
105389928|NCT02402907|363435330|FG001|Overall Study|Lost to follow up after C-Section|23|||
105389929|NCT00203242|363435333|FG000|Overall Study|Lost to Follow-up|1|||
105389930|NCT00449787|363435334|FG000|Overall Study|Lost to Follow-up|10|||
105389931|NCT00449787|363435335|FG001|Overall Study|Lost to Follow-up|8|||
105389932|NCT00449787|363435334|FG000|Overall Study|Did not require medication|95|||
105389933|NCT00449787|363435335|FG001|Overall Study|Did not require medication|92|||
105389934|NCT03701074|363435336|FG000|Overall Study|Physician Decision|1|||
105389935|NCT03701074|363435337|FG001|Overall Study|Physician Decision|0|||
105389936|NCT00661687|363435340|FG000|Overall Study|Study related symptoms and complaints|5|||
105389937|NCT00661687|363435340|FG000|Overall Study|Positive slit lamp findings|4|||
105389938|NCT00661687|363435340|FG000|Overall Study|Inability to maintain wearing schedule|3|||
105389939|NCT00661687|363435340|FG000|Overall Study|Physician Decision|1|||
105389940|NCT00661687|363435340|FG000|Overall Study|Adverse Event|2|||
105389941|NCT02462057|363435341|FG000|Overall Study|Left Vitality|32|||
105389942|NCT02462057|363435342|FG001|Overall Study|Left Vitality|27|||
105389943|NCT02462057|363435343|FG002|Overall Study|Left Vitality|23|||
105389944|NCT02462057|363435344|FG003|Overall Study|Left Vitality|35|||
105389945|NCT02462057|363435345|FG004|Overall Study|Left Vitality|33|||
105389946|NCT02462057|363435341|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
105389947|NCT02462057|363435342|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
105389948|NCT02462057|363435343|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
105389949|NCT02462057|363435344|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
105389950|NCT02462057|363435345|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
105389951|NCT02336555|363435350|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105389952|NCT02336555|363435351|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
105389953|NCT02336555|363435350|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
105389954|NCT02336555|363435351|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
105389955|NCT02336555|363435350|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
105389956|NCT02336555|363435351|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
105389957|NCT01959919|363435355|FG000|Overall Study|Did not meet the eligibility criteria|2|||
105389958|NCT01908699|363435356|FG000|Overall Study|Adverse Event|8|||
105389959|NCT01908699|363435357|FG001|Overall Study|Adverse Event|12|||
105389960|NCT01908699|363435356|FG000|Overall Study|Lack of Efficacy|2|||
105389961|NCT01908699|363435357|FG001|Overall Study|Lack of Efficacy|2|||
105389962|NCT01908699|363435356|FG000|Overall Study|Lost to Follow-up|2|||
105389963|NCT01908699|363435357|FG001|Overall Study|Lost to Follow-up|4|||
105389964|NCT01908699|363435356|FG000|Overall Study|Physician Decision|8|||
105389965|NCT01908699|363435357|FG001|Overall Study|Physician Decision|8|||
105389966|NCT01908699|363435356|FG000|Overall Study|Withdrawal by Subject|15|||
105389967|NCT01908699|363435357|FG001|Overall Study|Withdrawal by Subject|10|||
105389968|NCT01908699|363435356|FG000|Overall Study|Pregnancy|0|||
105389969|NCT01908699|363435357|FG001|Overall Study|Pregnancy|1|||
105389970|NCT01908699|363435356|FG000|Overall Study|Randomized in Error|1|||
105389971|NCT01908699|363435357|FG001|Overall Study|Randomized in Error|0|||
105389972|NCT01908699|363435356|FG000|Overall Study|Death|9|||
105389973|NCT01908699|363435357|FG001|Overall Study|Death|12|||
105389974|NCT01908699|363435356|FG000|Overall Study|Progressive Disease|30|||
105389975|NCT01908699|363435357|FG001|Overall Study|Progressive Disease|29|||
105389976|NCT03791060|363435358|FG000|Overall Study|Withdrawal by Subject|1|||
105389977|NCT05345405|363435359|FG000|Overall Study|Withdrawal by Subject|2|||
105389978|NCT05345405|363435360|FG001|Overall Study|Withdrawal by Subject|0|||
105389979|NCT05345405|363435361|FG002|Overall Study|Withdrawal by Subject|0|||
105389980|NCT05345405|363435359|FG000|Overall Study|Did not meet eligibility criteria|0|||
105389981|NCT05345405|363435360|FG001|Overall Study|Did not meet eligibility criteria|2|||
105389982|NCT05345405|363435361|FG002|Overall Study|Did not meet eligibility criteria|0|||
105389983|NCT05345405|363435359|FG000|Overall Study|Lost to Follow-up|0|||
105389984|NCT05345405|363435360|FG001|Overall Study|Lost to Follow-up|0|||
105389985|NCT05345405|363435361|FG002|Overall Study|Lost to Follow-up|1|||
105389986|NCT01592747|363435362|FG000|Overall Study|Loss of Therapeutic Response|107|||
105389987|NCT01592747|363435363|FG001|Overall Study|Loss of Therapeutic Response|108|||
105389988|NCT01592747|363435364|FG002|Overall Study|Loss of Therapeutic Response|100|||
105389989|NCT01592747|363435362|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
105389990|NCT01592747|363435363|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
105389991|NCT01592747|363435364|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
105389992|NCT01592747|363435362|FG000|Overall Study|Adverse Event|1|||
105389993|NCT01592747|363435363|FG001|Overall Study|Adverse Event|0|||
105389994|NCT01592747|363435364|FG002|Overall Study|Adverse Event|0|||
105389995|NCT01592747|363435362|FG000|Overall Study|Protocol Violation|4|||
105389996|NCT01592747|363435363|FG001|Overall Study|Protocol Violation|0|||
105389997|NCT01592747|363435364|FG002|Overall Study|Protocol Violation|4|||
105389998|NCT01592747|363435362|FG000|Overall Study|Lack of Efficacy|0|||
105389999|NCT01592747|363435363|FG001|Overall Study|Lack of Efficacy|1|||
105390000|NCT01592747|363435364|FG002|Overall Study|Lack of Efficacy|0|||
105390001|NCT01592747|363435362|FG000|Overall Study|Withdrawal by Subject|2|||
105390002|NCT01592747|363435363|FG001|Overall Study|Withdrawal by Subject|0|||
105390003|NCT01592747|363435364|FG002|Overall Study|Withdrawal by Subject|2|||
105390004|NCT01592747|363435362|FG000|Overall Study|Lost to Follow-up|1|||
105390005|NCT01592747|363435363|FG001|Overall Study|Lost to Follow-up|0|||
105390006|NCT01592747|363435364|FG002|Overall Study|Lost to Follow-up|1|||
105390007|NCT01592747|363435362|FG000|Overall Study|Other Reasons|1|||
105390008|NCT01592747|363435363|FG001|Overall Study|Other Reasons|1|||
105390009|NCT01592747|363435364|FG002|Overall Study|Other Reasons|0|||
105390010|NCT03111108|363435370|FG000|Overall Study|Death|0|||
105390011|NCT03111108|363435371|FG001|Overall Study|Death|1|||
105390012|NCT03111108|363435370|FG000|Overall Study|Withdrawal by Subject|1|||
105390013|NCT03111108|363435371|FG001|Overall Study|Withdrawal by Subject|0|||
105390014|NCT01514357|363435372|FG000|Overall Study|Screen failure|2|||
105390015|NCT01514357|363435373|FG001|Overall Study|Screen failure|0|||
105390016|NCT01514357|363435372|FG000|Overall Study|Withdrawal by Subject|2|||
105390017|NCT01514357|363435373|FG001|Overall Study|Withdrawal by Subject|0|||
105390018|NCT00552279|363435374|FG000|Overall Study|Adverse Event|0|||
105390019|NCT00552279|363435375|FG001|Overall Study|Adverse Event|1|||
105390020|NCT00552279|363435374|FG000|Overall Study|Withdrawal by Subject|12|||
105390021|NCT00552279|363435375|FG001|Overall Study|Withdrawal by Subject|1|||
105390022|NCT00552279|363435374|FG000|Overall Study|Lost to Follow-up|1|||
105390023|NCT00552279|363435375|FG001|Overall Study|Lost to Follow-up|0|||
105390024|NCT00552279|363435374|FG000|Overall Study|Other|1|||
105390025|NCT00552279|363435375|FG001|Overall Study|Other|1|||
105390026|NCT01651208|363435377|FG000|Overall Study|Lost to Follow-up|14|||
105390027|NCT01651208|363435378|FG001|Overall Study|Lost to Follow-up|16|||
105390028|NCT00836901|363435384|FG000|First Intervention|Withdrawal by Subject|1|||
105390029|NCT00836901|363435385|FG001|First Intervention|Withdrawal by Subject|0|||
105390030|NCT01437189|363435389|FG000|Overall Study|Adverse Event|3|||
105390031|NCT01437189|363435389|FG000|Overall Study|Lack of Efficacy|4|||
105390032|NCT01437189|363435389|FG000|Overall Study|Withdrawal by Subject|8|||
105390033|NCT01853280|363435390|FG000|Overall Study|Lack of Efficacy|2|||
105390034|NCT01853280|363435391|FG001|Overall Study|Lack of Efficacy|2|||
105390035|NCT01853280|363435390|FG000|Overall Study|Lost to Follow-up|0|||
105390036|NCT01853280|363435391|FG001|Overall Study|Lost to Follow-up|1|||
105390037|NCT01853280|363435390|FG000|Overall Study|Physician Decision|0|||
105390038|NCT01853280|363435391|FG001|Overall Study|Physician Decision|1|||
105390039|NCT01853280|363435390|FG000|Overall Study|Withdrawal by Subject|0|||
105390040|NCT01853280|363435391|FG001|Overall Study|Withdrawal by Subject|1|||
105390041|NCT01853280|363435390|FG000|Overall Study|Ineligible|0|||
105390042|NCT01853280|363435391|FG001|Overall Study|Ineligible|1|||
105390043|NCT00104884|363435392|FG000|Overall Study|Disease progression|4|||
105390044|NCT03032484|363435393|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
105390045|NCT03032484|363435394|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
105390046|NCT03032484|363435393|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
105390047|NCT03032484|363435394|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
105390048|NCT01229111|363435395|FG000|Overall Study|Death|1|||
105390049|NCT00835549|363435398|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
105390050|NCT00835549|363435399|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
105390051|NCT03268499|363435400|FG000|Overall Study|Withdrawal by Subject|2|||
105390052|NCT03268499|363435401|FG001|Overall Study|Withdrawal by Subject|1|||
105390053|NCT03760081|363435405|FG000|Overall Study|Miscellaneous|0|||
105390054|NCT03760081|363435406|FG001|Overall Study|Miscellaneous|1|||
105390055|NCT03760081|363435405|FG000|Overall Study|Progressive Disease|5|||
105390056|NCT03760081|363435406|FG001|Overall Study|Progressive Disease|10|||
105390057|NCT03760081|363435405|FG000|Overall Study|Death|1|||
105390058|NCT03760081|363435406|FG001|Overall Study|Death|1|||
105390059|NCT03533491|363435407|FG000|Overall Study|Lost to Follow-up|2|||
105390060|NCT01946880|363435409|FG000|Overall Study|Lost to Follow-up|1|||
105390061|NCT01946880|363435410|FG001|Overall Study|Lost to Follow-up|0|||
105390062|NCT01946880|363435409|FG000|Overall Study|Physician Decision|1|||
105390063|NCT01946880|363435410|FG001|Overall Study|Physician Decision|1|||
105390064|NCT01946880|363435409|FG000|Overall Study|Withdrawal by Subject|3|||
105390065|NCT01946880|363435410|FG001|Overall Study|Withdrawal by Subject|2|||
105390066|NCT01946880|363435409|FG000|Overall Study|Met Primary Endpoint|1|||
105390067|NCT01946880|363435410|FG001|Overall Study|Met Primary Endpoint|0|||
105390068|NCT01946880|363435409|FG000|Overall Study|Personal and Family Issues|1|||
105390069|NCT01946880|363435410|FG001|Overall Study|Personal and Family Issues|0|||
105390070|NCT05430919|363435412|FG000|Overall Study|Protocol Violation|0|||
105390071|NCT05430919|363435413|FG001|Overall Study|Protocol Violation|0|||
105390072|NCT05430919|363435414|FG002|Overall Study|Protocol Violation|1|||
105390073|NCT05430919|363435415|FG003|Overall Study|Protocol Violation|0|||
105390074|NCT05430919|363435412|FG000|Overall Study|Lost to Follow-up|0|||
105390075|NCT05430919|363435413|FG001|Overall Study|Lost to Follow-up|1|||
105390076|NCT05430919|363435414|FG002|Overall Study|Lost to Follow-up|0|||
105390077|NCT05430919|363435415|FG003|Overall Study|Lost to Follow-up|0|||
105390078|NCT05430919|363435412|FG000|Overall Study|Withdrawal by Subject|3|||
105390079|NCT05430919|363435413|FG001|Overall Study|Withdrawal by Subject|0|||
105390080|NCT05430919|363435414|FG002|Overall Study|Withdrawal by Subject|0|||
105390081|NCT05430919|363435415|FG003|Overall Study|Withdrawal by Subject|1|||
105390082|NCT02913326|363435420|FG000|Overall Study|Reason not listed|0|||
105390083|NCT02913326|363435421|FG001|Overall Study|Reason not listed|1|||
105390084|NCT02913326|363435420|FG000|Overall Study|Lost to Follow-up|0|||
105390085|NCT02913326|363435421|FG001|Overall Study|Lost to Follow-up|1|||
105390086|NCT02913326|363435420|FG000|Overall Study|Adverse Event|1|||
105390087|NCT02913326|363435421|FG001|Overall Study|Adverse Event|0|||
105390088|NCT00803049|363435422|FG000|Overall Study|Adverse Event|21|||
105390089|NCT00803049|363435423|FG001|Overall Study|Adverse Event|33|||
105390090|NCT00803049|363435424|FG002|Overall Study|Adverse Event|13|||
105390091|NCT00803049|363435425|FG003|Overall Study|Adverse Event|27|||
105390092|NCT00803049|363435422|FG000|Overall Study|Lack of Efficacy|10|||
105390093|NCT00803049|363435423|FG001|Overall Study|Lack of Efficacy|19|||
105390094|NCT00803049|363435424|FG002|Overall Study|Lack of Efficacy|6|||
105390095|NCT00803049|363435425|FG003|Overall Study|Lack of Efficacy|13|||
105390096|NCT00803049|363435422|FG000|Overall Study|Lost to Follow-up|0|||
105390097|NCT00803049|363435423|FG001|Overall Study|Lost to Follow-up|2|||
105390098|NCT00803049|363435424|FG002|Overall Study|Lost to Follow-up|0|||
105390099|NCT00803049|363435425|FG003|Overall Study|Lost to Follow-up|3|||
105390100|NCT00803049|363435422|FG000|Overall Study|Death|2|||
105390101|NCT00803049|363435423|FG001|Overall Study|Death|1|||
105390102|NCT00803049|363435424|FG002|Overall Study|Death|0|||
105390103|NCT00803049|363435425|FG003|Overall Study|Death|2|||
105390104|NCT00803049|363435422|FG000|Overall Study|Progressive Disease|6|||
105390105|NCT00803049|363435423|FG001|Overall Study|Progressive Disease|10|||
105390106|NCT00803049|363435424|FG002|Overall Study|Progressive Disease|6|||
105390107|NCT00803049|363435425|FG003|Overall Study|Progressive Disease|6|||
105390108|NCT00803049|363435422|FG000|Overall Study|Withdrawal by Subject|19|||
105390109|NCT00803049|363435423|FG001|Overall Study|Withdrawal by Subject|43|||
105390110|NCT00803049|363435424|FG002|Overall Study|Withdrawal by Subject|16|||
105580555|NCT02018861|364126445|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
105390111|NCT00803049|363435425|FG003|Overall Study|Withdrawal by Subject|44|||
105390112|NCT00803049|363435422|FG000|Overall Study|Protocol Violation|0|||
105390113|NCT00803049|363435423|FG001|Overall Study|Protocol Violation|1|||
105390114|NCT00803049|363435424|FG002|Overall Study|Protocol Violation|1|||
105390115|NCT00803049|363435425|FG003|Overall Study|Protocol Violation|0|||
105390116|NCT00803049|363435422|FG000|Overall Study|Randomized and Not Treated|0|||
105390117|NCT00803049|363435423|FG001|Overall Study|Randomized and Not Treated|0|||
105390118|NCT00803049|363435424|FG002|Overall Study|Randomized and Not Treated|0|||
105390119|NCT00803049|363435425|FG003|Overall Study|Randomized and Not Treated|2|||
105390120|NCT00803049|363435422|FG000|Overall Study|Other than Specified Above|3|||
105390121|NCT00803049|363435423|FG001|Overall Study|Other than Specified Above|9|||
105390122|NCT00803049|363435424|FG002|Overall Study|Other than Specified Above|2|||
105390123|NCT00803049|363435425|FG003|Overall Study|Other than Specified Above|5|||
105390124|NCT03688139|363435426|FG000|Overall Study|Lost to Follow-up|2|||
105390125|NCT03688139|363435427|FG001|Overall Study|Lost to Follow-up|0|||
105390126|NCT03688139|363435426|FG000|Overall Study|Physician Decision|0|||
105390127|NCT03688139|363435427|FG001|Overall Study|Physician Decision|1|||
105390128|NCT03688139|363435426|FG000|Overall Study|Withdrawal by Subject|2|||
105390129|NCT03688139|363435427|FG001|Overall Study|Withdrawal by Subject|3|||
105390130|NCT02184442|363435431|FG000|Overall Study|Death|61|||
105390131|NCT02184442|363435432|FG001|Overall Study|Death|65|||
105390132|NCT02184442|363435431|FG000|Overall Study|Withdrawal by Subject|3|||
105390133|NCT02184442|363435432|FG001|Overall Study|Withdrawal by Subject|11|||
105390134|NCT01852214|363435433|FG000|Period 1|Adverse Event|1|||
105390135|NCT01852214|363435434|FG001|Period 1|Adverse Event|2|||
105390136|NCT01852214|363435433|FG000|Period 1|Withdrawal by Subject|0|||
105390137|NCT01852214|363435434|FG001|Period 1|Withdrawal by Subject|1|||
105390138|NCT01852214|363435433|FG000|Washout Period|Withdrawal by Subject|0|||
105390139|NCT01852214|363435434|FG001|Washout Period|Withdrawal by Subject|1|||
105390140|NCT04091438|363435435|FG000|Treatment Period 1 (1 Day)|Other|1|||
105390141|NCT04091438|363435436|FG001|Treatment Period 1 (1 Day)|Other|0|||
105390142|NCT04091438|363435435|FG000|Washout Period (1 Day)|Protocol deviation|0|||
105390143|NCT04091438|363435436|FG001|Washout Period (1 Day)|Protocol deviation|1|||
105390144|NCT04091438|363435435|FG000|Washout Period (1 Day)|Other|0|||
105390145|NCT04091438|363435436|FG001|Washout Period (1 Day)|Other|1|||
105390146|NCT05520333|363436918|FG000|Overall Study|Lost to Follow-up|3|||
105390147|NCT05520333|363436919|FG001|Overall Study|Lost to Follow-up|6|||
105390148|NCT05069415|363436921|FG000|Overall Study|Withdrawal by Subject|2|||
105390149|NCT05069415|363436922|FG001|Overall Study|Withdrawal by Subject|0|||
105390150|NCT05069415|363436921|FG000|Overall Study|Adverse Event|2|||
105390151|NCT05069415|363436922|FG001|Overall Study|Adverse Event|0|||
105390152|NCT01697501|363436929|FG000|Overall Study|Protocol Violation|2|||
105390153|NCT03715829|363436931|FG000|Dose Ranging Period|Adverse Event|2|||
105390154|NCT03715829|363436932|FG001|Dose Ranging Period|Adverse Event|4|||
105390155|NCT03715829|363436933|FG002|Dose Ranging Period|Adverse Event|5|||
105390156|NCT03715829|363436934|FG003|Dose Ranging Period|Adverse Event|2|||
105390157|NCT03715829|363436935|FG004|Dose Ranging Period|Adverse Event|3|||
105390158|NCT03715829|363436936|FG005|Dose Ranging Period|Adverse Event|3|||
105390159|NCT03715829|363436937|FG006|Dose Ranging Period|Adverse Event|0|||
105390160|NCT03715829|363436938|FG007|Dose Ranging Period|Adverse Event|0|||
105390161|NCT03715829|363436939|FG008|Dose Ranging Period|Adverse Event|0|||
105390162|NCT03715829|363436940|FG009|Dose Ranging Period|Adverse Event|0|||
105390163|NCT03715829|363436941|FG010|Dose Ranging Period|Adverse Event|0|||
105390164|NCT03715829|363436931|FG000|Dose Ranging Period|Lack of Efficacy|0|||
105390165|NCT03715829|363436932|FG001|Dose Ranging Period|Lack of Efficacy|1|||
105390166|NCT03715829|363436933|FG002|Dose Ranging Period|Lack of Efficacy|0|||
105390167|NCT03715829|363436934|FG003|Dose Ranging Period|Lack of Efficacy|1|||
105390168|NCT03715829|363436935|FG004|Dose Ranging Period|Lack of Efficacy|0|||
105390169|NCT03715829|363436936|FG005|Dose Ranging Period|Lack of Efficacy|0|||
105390170|NCT03715829|363436937|FG006|Dose Ranging Period|Lack of Efficacy|0|||
105390171|NCT03715829|363436938|FG007|Dose Ranging Period|Lack of Efficacy|0|||
105390172|NCT03715829|363436939|FG008|Dose Ranging Period|Lack of Efficacy|0|||
105390173|NCT03715829|363436940|FG009|Dose Ranging Period|Lack of Efficacy|0|||
105390174|NCT03715829|363436941|FG010|Dose Ranging Period|Lack of Efficacy|0|||
105390175|NCT03715829|363436931|FG000|Dose Ranging Period|Lost to Follow-up|2|||
105390176|NCT03715829|363436932|FG001|Dose Ranging Period|Lost to Follow-up|0|||
105390177|NCT03715829|363436933|FG002|Dose Ranging Period|Lost to Follow-up|1|||
105390178|NCT03715829|363436934|FG003|Dose Ranging Period|Lost to Follow-up|1|||
105390179|NCT03715829|363436935|FG004|Dose Ranging Period|Lost to Follow-up|1|||
105390180|NCT03715829|363436936|FG005|Dose Ranging Period|Lost to Follow-up|2|||
105390181|NCT03715829|363436937|FG006|Dose Ranging Period|Lost to Follow-up|0|||
105390182|NCT03715829|363436938|FG007|Dose Ranging Period|Lost to Follow-up|0|||
105390183|NCT03715829|363436939|FG008|Dose Ranging Period|Lost to Follow-up|0|||
105390184|NCT03715829|363436940|FG009|Dose Ranging Period|Lost to Follow-up|0|||
105390185|NCT03715829|363436941|FG010|Dose Ranging Period|Lost to Follow-up|0|||
105390186|NCT03715829|363436931|FG000|Dose Ranging Period|Protocol Violation|0|||
105390187|NCT03715829|363436932|FG001|Dose Ranging Period|Protocol Violation|0|||
105390188|NCT03715829|363436933|FG002|Dose Ranging Period|Protocol Violation|0|||
105390189|NCT03715829|363436934|FG003|Dose Ranging Period|Protocol Violation|1|||
105390190|NCT03715829|363436935|FG004|Dose Ranging Period|Protocol Violation|0|||
105580556|NCT02018861|364126446|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
105390191|NCT03715829|363436936|FG005|Dose Ranging Period|Protocol Violation|0|||
105390192|NCT03715829|363436937|FG006|Dose Ranging Period|Protocol Violation|0|||
105390193|NCT03715829|363436938|FG007|Dose Ranging Period|Protocol Violation|0|||
105390194|NCT03715829|363436939|FG008|Dose Ranging Period|Protocol Violation|0|||
105390195|NCT03715829|363436940|FG009|Dose Ranging Period|Protocol Violation|0|||
105390196|NCT03715829|363436941|FG010|Dose Ranging Period|Protocol Violation|0|||
105390197|NCT03715829|363436931|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
105390198|NCT03715829|363436932|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
105390199|NCT03715829|363436933|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
105390200|NCT03715829|363436934|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
105390201|NCT03715829|363436935|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
105390202|NCT03715829|363436936|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
105390203|NCT03715829|363436937|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
105390204|NCT03715829|363436938|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
105390205|NCT03715829|363436939|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
105390206|NCT03715829|363436940|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
105390207|NCT03715829|363436941|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
105390208|NCT03715829|363436931|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105390209|NCT03715829|363436932|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105390210|NCT03715829|363436933|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
105390211|NCT03715829|363436934|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105390212|NCT03715829|363436935|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105390213|NCT03715829|363436936|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105390214|NCT03715829|363436937|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105390215|NCT03715829|363436938|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105390216|NCT03715829|363436939|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105390217|NCT03715829|363436940|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105390218|NCT03715829|363436941|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105390219|NCT03715829|363436931|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105390220|NCT03715829|363436932|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105390221|NCT03715829|363436933|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
105390222|NCT03715829|363436934|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105390223|NCT03715829|363436935|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
105390224|NCT03715829|363436936|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105390225|NCT03715829|363436937|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105390226|NCT03715829|363436938|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105390227|NCT03715829|363436939|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105390228|NCT03715829|363436940|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105390229|NCT03715829|363436941|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105390230|NCT03715829|363436931|FG000|Dose Ranging Period|Other|0|||
105390231|NCT03715829|363436932|FG001|Dose Ranging Period|Other|0|||
105390232|NCT03715829|363436933|FG002|Dose Ranging Period|Other|2|||
105390233|NCT03715829|363436934|FG003|Dose Ranging Period|Other|0|||
105390234|NCT03715829|363436935|FG004|Dose Ranging Period|Other|0|||
105390235|NCT03715829|363436936|FG005|Dose Ranging Period|Other|3|||
105390236|NCT03715829|363436937|FG006|Dose Ranging Period|Other|0|||
105390237|NCT03715829|363436938|FG007|Dose Ranging Period|Other|0|||
105390238|NCT03715829|363436939|FG008|Dose Ranging Period|Other|0|||
105390239|NCT03715829|363436940|FG009|Dose Ranging Period|Other|0|||
105390240|NCT03715829|363436941|FG010|Dose Ranging Period|Other|0|||
105390241|NCT03715829|363436931|FG000|Extension Period|Adverse Event|0|||
105390242|NCT03715829|363436932|FG001|Extension Period|Adverse Event|0|||
105390243|NCT03715829|363436933|FG002|Extension Period|Adverse Event|0|||
105390244|NCT03715829|363436934|FG003|Extension Period|Adverse Event|0|||
105390245|NCT03715829|363436935|FG004|Extension Period|Adverse Event|0|||
105390246|NCT03715829|363436936|FG005|Extension Period|Adverse Event|0|||
105390247|NCT03715829|363436937|FG006|Extension Period|Adverse Event|3|||
105390248|NCT03715829|363436938|FG007|Extension Period|Adverse Event|1|||
105390249|NCT03715829|363436939|FG008|Extension Period|Adverse Event|6|||
105390250|NCT03715829|363436940|FG009|Extension Period|Adverse Event|0|||
105390251|NCT03715829|363436941|FG010|Extension Period|Adverse Event|0|||
105390252|NCT03715829|363436931|FG000|Extension Period|Lack of Efficacy|0|||
105390253|NCT03715829|363436932|FG001|Extension Period|Lack of Efficacy|0|||
105390254|NCT03715829|363436933|FG002|Extension Period|Lack of Efficacy|0|||
105390255|NCT03715829|363436934|FG003|Extension Period|Lack of Efficacy|0|||
105390256|NCT03715829|363436935|FG004|Extension Period|Lack of Efficacy|0|||
105390257|NCT03715829|363436936|FG005|Extension Period|Lack of Efficacy|0|||
105390258|NCT03715829|363436937|FG006|Extension Period|Lack of Efficacy|1|||
105390259|NCT03715829|363436938|FG007|Extension Period|Lack of Efficacy|9|||
105390260|NCT03715829|363436939|FG008|Extension Period|Lack of Efficacy|2|||
105390261|NCT03715829|363436940|FG009|Extension Period|Lack of Efficacy|0|||
105390262|NCT03715829|363436941|FG010|Extension Period|Lack of Efficacy|0|||
105390263|NCT03715829|363436931|FG000|Extension Period|Lost to Follow-up|0|||
105390264|NCT03715829|363436932|FG001|Extension Period|Lost to Follow-up|0|||
105390265|NCT03715829|363436933|FG002|Extension Period|Lost to Follow-up|0|||
105390266|NCT03715829|363436934|FG003|Extension Period|Lost to Follow-up|0|||
105390267|NCT03715829|363436935|FG004|Extension Period|Lost to Follow-up|0|||
105390268|NCT03715829|363436936|FG005|Extension Period|Lost to Follow-up|0|||
105390269|NCT03715829|363436937|FG006|Extension Period|Lost to Follow-up|0|||
105390270|NCT03715829|363436938|FG007|Extension Period|Lost to Follow-up|0|||
105390271|NCT03715829|363436939|FG008|Extension Period|Lost to Follow-up|2|||
105390272|NCT03715829|363436940|FG009|Extension Period|Lost to Follow-up|0|||
105390273|NCT03715829|363436941|FG010|Extension Period|Lost to Follow-up|0|||
105390274|NCT03715829|363436931|FG000|Extension Period|Protocol Violation|0|||
105390275|NCT03715829|363436932|FG001|Extension Period|Protocol Violation|0|||
105390276|NCT03715829|363436933|FG002|Extension Period|Protocol Violation|0|||
105390277|NCT03715829|363436934|FG003|Extension Period|Protocol Violation|0|||
105390278|NCT03715829|363436935|FG004|Extension Period|Protocol Violation|0|||
105390279|NCT03715829|363436936|FG005|Extension Period|Protocol Violation|0|||
105390280|NCT03715829|363436937|FG006|Extension Period|Protocol Violation|0|||
105390281|NCT03715829|363436938|FG007|Extension Period|Protocol Violation|0|||
105390282|NCT03715829|363436939|FG008|Extension Period|Protocol Violation|1|||
105390283|NCT03715829|363436940|FG009|Extension Period|Protocol Violation|0|||
105390284|NCT03715829|363436941|FG010|Extension Period|Protocol Violation|0|||
105390285|NCT03715829|363436931|FG000|Extension Period|Withdrawal by Subject|0|||
105390286|NCT03715829|363436932|FG001|Extension Period|Withdrawal by Subject|0|||
105390287|NCT03715829|363436933|FG002|Extension Period|Withdrawal by Subject|0|||
105390288|NCT03715829|363436934|FG003|Extension Period|Withdrawal by Subject|0|||
105390289|NCT03715829|363436935|FG004|Extension Period|Withdrawal by Subject|0|||
105390290|NCT03715829|363436936|FG005|Extension Period|Withdrawal by Subject|0|||
105390291|NCT03715829|363436937|FG006|Extension Period|Withdrawal by Subject|3|||
105390292|NCT03715829|363436938|FG007|Extension Period|Withdrawal by Subject|3|||
105390293|NCT03715829|363436939|FG008|Extension Period|Withdrawal by Subject|12|||
105390294|NCT03715829|363436940|FG009|Extension Period|Withdrawal by Subject|3|||
105390295|NCT03715829|363436941|FG010|Extension Period|Withdrawal by Subject|0|||
105390296|NCT03715829|363436931|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
105390297|NCT03715829|363436932|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
105390298|NCT03715829|363436933|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
105390299|NCT03715829|363436934|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
105390300|NCT03715829|363436935|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
105390301|NCT03715829|363436936|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
105390302|NCT03715829|363436937|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
105390303|NCT03715829|363436938|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
105390304|NCT03715829|363436939|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
105390305|NCT03715829|363436940|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
105390306|NCT03715829|363436941|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
105390307|NCT03715829|363436931|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
105390308|NCT03715829|363436932|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
105390309|NCT03715829|363436933|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
105390310|NCT03715829|363436934|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
105390311|NCT03715829|363436935|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
105390312|NCT03715829|363436936|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
105390313|NCT03715829|363436937|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
105390314|NCT03715829|363436938|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
105390315|NCT03715829|363436939|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
105390316|NCT03715829|363436940|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
105390317|NCT03715829|363436941|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
105390318|NCT03715829|363436931|FG000|Extension Period|Other|0|||
105390319|NCT03715829|363436932|FG001|Extension Period|Other|0|||
105390320|NCT03715829|363436933|FG002|Extension Period|Other|0|||
105390321|NCT03715829|363436934|FG003|Extension Period|Other|0|||
105390322|NCT03715829|363436935|FG004|Extension Period|Other|0|||
105390323|NCT03715829|363436936|FG005|Extension Period|Other|0|||
105390324|NCT03715829|363436937|FG006|Extension Period|Other|1|||
105390325|NCT03715829|363436938|FG007|Extension Period|Other|2|||
105390326|NCT03715829|363436939|FG008|Extension Period|Other|4|||
105390327|NCT03715829|363436940|FG009|Extension Period|Other|0|||
105390328|NCT03715829|363436941|FG010|Extension Period|Other|0|||
105390329|NCT02655601|363436944|FG000|Overall Study|Adverse Event|0|||
105390330|NCT02655601|363436945|FG001|Overall Study|Adverse Event|0|||
105390331|NCT02655601|363436946|FG002|Overall Study|Adverse Event|0|||
105390332|NCT02655601|363436947|FG003|Overall Study|Adverse Event|1|||
105390333|NCT02655601|363436948|FG004|Overall Study|Adverse Event|1|||
105390334|NCT02655601|363436949|FG005|Overall Study|Adverse Event|0|||
105390335|NCT02655601|363436944|FG000|Overall Study|Physician Decision|0|||
105390336|NCT02655601|363436945|FG001|Overall Study|Physician Decision|0|||
105390337|NCT02655601|363436946|FG002|Overall Study|Physician Decision|0|||
105390338|NCT02655601|363436947|FG003|Overall Study|Physician Decision|0|||
105390339|NCT02655601|363436948|FG004|Overall Study|Physician Decision|1|||
105390340|NCT02655601|363436949|FG005|Overall Study|Physician Decision|1|||
105390341|NCT02655601|363436944|FG000|Overall Study|Withdrawal by Subject|0|||
105390342|NCT02655601|363436945|FG001|Overall Study|Withdrawal by Subject|0|||
105390343|NCT02655601|363436946|FG002|Overall Study|Withdrawal by Subject|0|||
105390344|NCT02655601|363436947|FG003|Overall Study|Withdrawal by Subject|0|||
105390345|NCT02655601|363436948|FG004|Overall Study|Withdrawal by Subject|4|||
105390346|NCT02655601|363436949|FG005|Overall Study|Withdrawal by Subject|8|||
105390347|NCT02655601|363436944|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
105390348|NCT02655601|363436945|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
105390349|NCT02655601|363436946|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
105390350|NCT02655601|363436947|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
105390351|NCT02655601|363436948|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
105390352|NCT02655601|363436949|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
105390353|NCT02633527|363436950|FG000|Overall Study|Failed to meet eligibility|0|||
105390354|NCT02633527|363436951|FG001|Overall Study|Failed to meet eligibility|1|||
105390355|NCT02633527|363436952|FG002|Overall Study|Failed to meet eligibility|1|||
105390356|NCT02633527|363436953|FG003|Overall Study|Failed to meet eligibility|0|||
105390357|NCT02633527|363436954|FG004|Overall Study|Failed to meet eligibility|1|||
105390358|NCT02633527|363436950|FG000|Overall Study|Adverse Event|0|||
105390359|NCT02633527|363436951|FG001|Overall Study|Adverse Event|4|||
105390360|NCT02633527|363436952|FG002|Overall Study|Adverse Event|3|||
105390361|NCT02633527|363436953|FG003|Overall Study|Adverse Event|1|||
105390362|NCT02633527|363436954|FG004|Overall Study|Adverse Event|5|||
105390363|NCT02633527|363436950|FG000|Overall Study|Lost to Follow-up|1|||
105390364|NCT02633527|363436951|FG001|Overall Study|Lost to Follow-up|2|||
105390365|NCT02633527|363436952|FG002|Overall Study|Lost to Follow-up|5|||
105390366|NCT02633527|363436953|FG003|Overall Study|Lost to Follow-up|5|||
105390367|NCT02633527|363436954|FG004|Overall Study|Lost to Follow-up|4|||
105390368|NCT02633527|363436950|FG000|Overall Study|Withdrawal by Subject|0|||
105390369|NCT02633527|363436951|FG001|Overall Study|Withdrawal by Subject|3|||
105390370|NCT02633527|363436952|FG002|Overall Study|Withdrawal by Subject|5|||
105390371|NCT02633527|363436953|FG003|Overall Study|Withdrawal by Subject|4|||
105390372|NCT02633527|363436954|FG004|Overall Study|Withdrawal by Subject|4|||
105390373|NCT02633527|363436950|FG000|Overall Study|Protocol Violation|0|||
105390374|NCT02633527|363436951|FG001|Overall Study|Protocol Violation|1|||
105390375|NCT02633527|363436952|FG002|Overall Study|Protocol Violation|1|||
105390376|NCT02633527|363436953|FG003|Overall Study|Protocol Violation|1|||
105390377|NCT02633527|363436954|FG004|Overall Study|Protocol Violation|1|||
105390378|NCT02633527|363436950|FG000|Overall Study|Physician Decision|0|||
105390379|NCT02633527|363436951|FG001|Overall Study|Physician Decision|0|||
105390380|NCT02633527|363436952|FG002|Overall Study|Physician Decision|0|||
105390381|NCT02633527|363436953|FG003|Overall Study|Physician Decision|0|||
105390382|NCT02633527|363436954|FG004|Overall Study|Physician Decision|1|||
105390383|NCT02633527|363436950|FG000|Overall Study|Administrative reason|1|||
105390384|NCT02633527|363436951|FG001|Overall Study|Administrative reason|0|||
105390385|NCT02633527|363436952|FG002|Overall Study|Administrative reason|0|||
105390386|NCT02633527|363436953|FG003|Overall Study|Administrative reason|1|||
105390387|NCT02633527|363436954|FG004|Overall Study|Administrative reason|0|||
105390388|NCT02633527|363436950|FG000|Overall Study|Multiple reasons|1|||
105390389|NCT02633527|363436951|FG001|Overall Study|Multiple reasons|0|||
105390390|NCT02633527|363436952|FG002|Overall Study|Multiple reasons|2|||
105390391|NCT02633527|363436953|FG003|Overall Study|Multiple reasons|2|||
105390392|NCT02633527|363436954|FG004|Overall Study|Multiple reasons|1|||
105390393|NCT01681849|363436965|FG000|Overall Study|Protocol Violation|2|||
105390394|NCT01681849|363436966|FG001|Overall Study|Protocol Violation|0|||
105390395|NCT01681849|363436967|FG002|Overall Study|Protocol Violation|0|||
105390396|NCT01681849|363436965|FG000|Overall Study|Withdrawal by Subject|3|||
105390397|NCT01681849|363436966|FG001|Overall Study|Withdrawal by Subject|5|||
105390398|NCT01681849|363436967|FG002|Overall Study|Withdrawal by Subject|33|||
105390399|NCT01681849|363436965|FG000|Overall Study|Lost to Follow-up|3|||
105390400|NCT01681849|363436966|FG001|Overall Study|Lost to Follow-up|2|||
105390401|NCT01681849|363436967|FG002|Overall Study|Lost to Follow-up|6|||
105390402|NCT04525183|363436970|FG000|Overall Study|Withdrawal by Subject|0|||
105390403|NCT04525183|363436971|FG001|Overall Study|Withdrawal by Subject|0|||
105390404|NCT04525183|363436972|FG002|Overall Study|Withdrawal by Subject|3|||
105390405|NCT04525183|363436970|FG000|Overall Study|Study non-compliance|0|||
105390406|NCT04525183|363436971|FG001|Overall Study|Study non-compliance|0|||
105390407|NCT04525183|363436972|FG002|Overall Study|Study non-compliance|1|||
105390408|NCT04525183|363436970|FG000|Overall Study|Recurrent disease before starting on study|0|||
105390409|NCT04525183|363436971|FG001|Overall Study|Recurrent disease before starting on study|0|||
105390410|NCT04525183|363436972|FG002|Overall Study|Recurrent disease before starting on study|1|||
105390411|NCT01922895|363436973|FG000|Overall Study|Death|0|||
105390412|NCT01922895|363436974|FG001|Overall Study|Death|1|||
105390413|NCT01922895|363436973|FG000|Overall Study|Withdrawal by Subject|1|||
105390414|NCT01922895|363436974|FG001|Overall Study|Withdrawal by Subject|2|||
105390415|NCT01922895|363436973|FG000|Overall Study|Lost to Follow-up|5|||
105390416|NCT01922895|363436974|FG001|Overall Study|Lost to Follow-up|11|||
105390417|NCT02251041|363436975|FG000|Overall Study|Did not receive intervention|15|||
105390418|NCT02251041|363436976|FG001|Overall Study|Did not receive intervention|4|||
105390419|NCT04918771|363436977|FG000|Overall Study|Withdrawal by Subject|4|||
105390420|NCT04918771|363436978|FG001|Overall Study|Withdrawal by Subject|5|||
105390421|NCT04918771|363436977|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
105390422|NCT04918771|363436978|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
105390423|NCT03460704|363436979|FG000|Overall Study|Withdrawal by Subject|11|||
105390424|NCT03460704|363436980|FG001|Overall Study|Withdrawal by Subject|14|||
105390425|NCT03460704|363436979|FG000|Overall Study|Study terminated by the Sponsor|29|||
105390426|NCT03460704|363436980|FG001|Overall Study|Study terminated by the Sponsor|19|||
105390427|NCT03460704|363436979|FG000|Overall Study|Adverse Event|10|||
105390428|NCT03460704|363436980|FG001|Overall Study|Adverse Event|5|||
105390429|NCT03460704|363436979|FG000|Overall Study|Death|3|||
105390430|NCT03460704|363436980|FG001|Overall Study|Death|2|||
105390431|NCT03460704|363436979|FG000|Overall Study|Non-Compliance with Study Drug|3|||
105390432|NCT03460704|363436980|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105390433|NCT03460704|363436979|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105390434|NCT03460704|363436980|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
105390435|NCT03460704|363436979|FG000|Overall Study|Other|2|||
105390436|NCT03460704|363436980|FG001|Overall Study|Other|1|||
105390437|NCT01514422|363436985|FG000|Overall Study|Lost to Follow-up|1|||
105390438|NCT02514746|363436986|FG000|Overall Study|Chronically Ill|1|||
105390439|NCT02514746|363436987|FG001|Overall Study|Chronically Ill|2|||
105390440|NCT02514746|363436986|FG000|Overall Study|Physician Decision|4|||
105390441|NCT02514746|363436987|FG001|Overall Study|Physician Decision|2|||
105390442|NCT02514746|363436986|FG000|Overall Study|Withdrawal by Subject|12|||
105390443|NCT02514746|363436987|FG001|Overall Study|Withdrawal by Subject|10|||
105390444|NCT02514746|363436986|FG000|Overall Study|Other|5|||
105390445|NCT02514746|363436987|FG001|Overall Study|Other|1|||
105390446|NCT04003142|363436993|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
105390447|NCT04003142|363436994|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
105390448|NCT04003142|363436995|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
105390449|NCT04003142|363436996|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
105390450|NCT04003142|363436997|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
105390451|NCT04003142|363436993|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
105390452|NCT04003142|363436994|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
105390453|NCT04003142|363436995|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
105390454|NCT04003142|363436996|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
105390455|NCT04003142|363436997|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
105390456|NCT04003142|363436993|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
105390457|NCT04003142|363436994|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
105390458|NCT04003142|363436995|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
105390459|NCT04003142|363436996|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
105390460|NCT04003142|363436997|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
105390461|NCT04003142|363436993|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
105390462|NCT04003142|363436994|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
105390463|NCT04003142|363436995|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
105390464|NCT04003142|363436996|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
105390465|NCT04003142|363436997|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
105390466|NCT04003142|363436993|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
105390467|NCT04003142|363436994|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
105390468|NCT04003142|363436995|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
105390469|NCT04003142|363436996|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
105390470|NCT04003142|363436997|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
105390471|NCT04003142|363436993|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
105390472|NCT04003142|363436994|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
105390473|NCT04003142|363436995|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
105390474|NCT04003142|363436996|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
105390475|NCT04003142|363436997|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
105390476|NCT04003142|363436993|FG000|Extension Period (40 Weeks)|Death|0|||
105390477|NCT04003142|363436994|FG001|Extension Period (40 Weeks)|Death|0|||
105390478|NCT04003142|363436995|FG002|Extension Period (40 Weeks)|Death|0|||
105390479|NCT04003142|363436996|FG003|Extension Period (40 Weeks)|Death|0|||
105390480|NCT04003142|363436997|FG004|Extension Period (40 Weeks)|Death|1|||
105390481|NCT04003142|363436993|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
105390482|NCT04003142|363436994|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
105390483|NCT04003142|363436995|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
105390484|NCT04003142|363436996|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
105390485|NCT04003142|363436997|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
105390486|NCT04003142|363436993|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
105390487|NCT04003142|363436994|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
105390488|NCT04003142|363436995|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
105390489|NCT04003142|363436996|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
105390490|NCT04003142|363436997|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
105390491|NCT04003142|363436993|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
105390492|NCT04003142|363436994|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
105390493|NCT04003142|363436995|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
105390494|NCT04003142|363436996|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
105390495|NCT04003142|363436997|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
105390496|NCT04003142|363436993|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
105390497|NCT04003142|363436994|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
105390498|NCT04003142|363436995|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
105390499|NCT04003142|363436996|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
105390500|NCT04003142|363436997|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
105390501|NCT03382873|363436998|FG000|Overall Study|Lost to Follow-up|9|||
105390502|NCT03382873|363436999|FG001|Overall Study|Lost to Follow-up|10|||
105390503|NCT03382873|363436998|FG000|Overall Study|Withdrawal by Subject|6|||
105390504|NCT03382873|363436999|FG001|Overall Study|Withdrawal by Subject|11|||
105390505|NCT03382873|363436998|FG000|Overall Study|Visit not completed due to pandemic|16|||
105390506|NCT03382873|363436999|FG001|Overall Study|Visit not completed due to pandemic|41|||
105390507|NCT03996395|363437000|FG000|Overall Study|Lost to Follow-up|4|||
105390508|NCT03996395|363437000|FG000|Overall Study|Withdrawal by Subject|1|||
105390509|NCT03996395|363437000|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
105390510|NCT02061085|363437001|FG000|Overall Study|Adverse Event|8|||
105390511|NCT03301415|363437007|FG000|Overall Study|Lost to Follow-up|2|||
105390512|NCT03301415|363437007|FG000|Overall Study|Unable to comply with visit schedule|2|||
105390513|NCT03247673|363437010|FG000|Overall Study|Withdrawal by Subject|1|||
105390514|NCT03247673|363437011|FG001|Overall Study|Withdrawal by Subject|0|||
105390515|NCT03247673|363437012|FG002|Overall Study|Withdrawal by Subject|3|||
105390516|NCT03247673|363437010|FG000|Overall Study|Lost to Follow-up|0|||
105390517|NCT03247673|363437011|FG001|Overall Study|Lost to Follow-up|0|||
105390518|NCT03247673|363437012|FG002|Overall Study|Lost to Follow-up|1|||
105390519|NCT01887600|363437013|FG000|Overall Study|Death|39|||
105390520|NCT01887600|363437014|FG001|Overall Study|Death|16|||
105390521|NCT01887600|363437013|FG000|Overall Study|Lack of Efficacy|3|||
105390522|NCT01887600|363437014|FG001|Overall Study|Lack of Efficacy|26|||
105390523|NCT01887600|363437013|FG000|Overall Study|Lost to Follow-up|5|||
105390524|NCT01887600|363437014|FG001|Overall Study|Lost to Follow-up|1|||
105390525|NCT01887600|363437013|FG000|Overall Study|Physician Decision|7|||
105390526|NCT01887600|363437014|FG001|Overall Study|Physician Decision|8|||
105390527|NCT01887600|363437013|FG000|Overall Study|Protocol Deviation|3|||
105390528|NCT01887600|363437014|FG001|Overall Study|Protocol Deviation|0|||
105390529|NCT01887600|363437013|FG000|Overall Study|Withdrawal by Subject|58|||
105390530|NCT01887600|363437014|FG001|Overall Study|Withdrawal by Subject|52|||
105390531|NCT01887600|363437013|FG000|Overall Study|Adverse Event|21|||
105390532|NCT01887600|363437014|FG001|Overall Study|Adverse Event|9|||
105580557|NCT02018861|364126447|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
105580558|NCT02018861|364126448|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
105390533|NCT01887600|363437013|FG000|Overall Study|Non-compliance with study drug|3|||
105390534|NCT01887600|363437014|FG001|Overall Study|Non-compliance with study drug|0|||
105390535|NCT01887600|363437013|FG000|Overall Study|Miscellaneous|6|||
105390536|NCT01887600|363437014|FG001|Overall Study|Miscellaneous|2|||
105390537|NCT01887600|363437013|FG000|Overall Study|Progressive Disease|1|||
105390538|NCT01887600|363437014|FG001|Overall Study|Progressive Disease|0|||
105390539|NCT05346640|363437017|FG000|Overall Study|Lack of Efficacy|2|||
105390540|NCT05346640|363437017|FG000|Overall Study|Lost to Follow-up|14|||
105390541|NCT05346640|363437017|FG000|Overall Study|Protocol Violation|4|||
105390542|NCT05346640|363437017|FG000|Overall Study|Withdrawal by Subject|2|||
105390543|NCT05346640|363437017|FG000|Overall Study|Physiological Complications|3|||
105390544|NCT05346640|363437017|FG000|Overall Study|Other Reason|3|||
105390545|NCT00480025|363437018|FG000|Overall Study|Protocol Violation|12|||
105390546|NCT00480025|363437019|FG001|Overall Study|Protocol Violation|7|||
105390547|NCT00480025|363437018|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
105390548|NCT00480025|363437019|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
105390549|NCT00480025|363437018|FG000|Overall Study|Disease Progression / Recurrence|449|||
105390550|NCT00480025|363437019|FG001|Overall Study|Disease Progression / Recurrence|224|||
105390551|NCT00480025|363437018|FG000|Overall Study|Adverse Event|44|||
105390552|NCT00480025|363437019|FG001|Overall Study|Adverse Event|12|||
105390553|NCT00480025|363437018|FG000|Overall Study|Other|70|||
105390554|NCT00480025|363437019|FG001|Overall Study|Other|29|||
105390555|NCT00480025|363437018|FG000|Overall Study|SAE including intercurrent illness|76|||
105390556|NCT00480025|363437019|FG001|Overall Study|SAE including intercurrent illness|42|||
105390557|NCT00787800|363437020|FG000|Overall Study|Withdrawal by Subject|3|||
105390558|NCT00787800|363437021|FG001|Overall Study|Withdrawal by Subject|5|||
105390559|NCT00787800|363437020|FG000|Overall Study|Death|0|||
105390560|NCT00787800|363437021|FG001|Overall Study|Death|2|||
105390561|NCT00461812|363437025|FG000|Overall Study|study terminated|10|||
105390562|NCT02496156|363437026|FG000|Overall Study|Lost to Follow-up|5|||
105390563|NCT02496156|363437027|FG001|Overall Study|Lost to Follow-up|0|||
105390564|NCT02496156|363437026|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
105390565|NCT02496156|363437027|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
105390566|NCT03193437|363437034|FG000|Overall Study|Adverse Event|4|||
105390567|NCT03193437|363437034|FG000|Overall Study|Withdrawal by Subject|2|||
105390568|NCT03193437|363437034|FG000|Overall Study|Disease Progression|2|||
105390569|NCT03810495|363437037|FG000|Overall Study|Lost to Follow-up|2|||
105390570|NCT03810495|363437037|FG000|Overall Study|Withdrawal by Subject|1|||
105390571|NCT03359395|363437044|FG000|First Intervention A / B|Withdrawal by Subject|1|||
105390572|NCT03359395|363437045|FG001|First Intervention A / B|Withdrawal by Subject|0|||
105390573|NCT03359395|363437044|FG000|First Intervention A / B|Lost to Follow-up|2|||
105390574|NCT03359395|363437045|FG001|First Intervention A / B|Lost to Follow-up|3|||
105390575|NCT03359395|363437044|FG000|Second Intervention B/A|Exclusion criteria|0|||
105390576|NCT03359395|363437045|FG001|Second Intervention B/A|Exclusion criteria|1|||
105390577|NCT03359395|363437044|FG000|Second Intervention B/A|Lost to Follow-up|3|||
105390578|NCT03359395|363437045|FG001|Second Intervention B/A|Lost to Follow-up|2|||
105390579|NCT03164356|363437048|FG000|Overall Study|Lost to Follow-up|1|||
105390580|NCT03164356|363437049|FG001|Overall Study|Lost to Follow-up|1|||
105390581|NCT03164356|363437050|FG002|Overall Study|Lost to Follow-up|2|||
105390582|NCT03164356|363437051|FG003|Overall Study|Lost to Follow-up|1|||
105390583|NCT03164356|363437048|FG000|Overall Study|Physician Decision|0|||
105390584|NCT03164356|363437049|FG001|Overall Study|Physician Decision|0|||
105390585|NCT03164356|363437050|FG002|Overall Study|Physician Decision|3|||
105390586|NCT03164356|363437051|FG003|Overall Study|Physician Decision|0|||
105390587|NCT03164356|363437048|FG000|Overall Study|Protocol Violation|2|||
105390588|NCT03164356|363437049|FG001|Overall Study|Protocol Violation|1|||
105390589|NCT03164356|363437050|FG002|Overall Study|Protocol Violation|0|||
105390590|NCT03164356|363437051|FG003|Overall Study|Protocol Violation|0|||
105390591|NCT03164356|363437048|FG000|Overall Study|Withdrawal by Subject|1|||
105390592|NCT03164356|363437049|FG001|Overall Study|Withdrawal by Subject|0|||
105390593|NCT03164356|363437050|FG002|Overall Study|Withdrawal by Subject|0|||
105390594|NCT03164356|363437051|FG003|Overall Study|Withdrawal by Subject|0|||
105390595|NCT03164356|363437048|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
105390596|NCT03164356|363437049|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
105390597|NCT03164356|363437050|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
105390598|NCT03164356|363437051|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
105390599|NCT03164356|363437048|FG000|Overall Study|Subject Incarcerated|0|||
105390600|NCT03164356|363437049|FG001|Overall Study|Subject Incarcerated|1|||
105390601|NCT03164356|363437050|FG002|Overall Study|Subject Incarcerated|0|||
105390602|NCT03164356|363437051|FG003|Overall Study|Subject Incarcerated|0|||
105390603|NCT03164356|363437048|FG000|Overall Study|Prosthetist unable to participate|0|||
105390604|NCT03164356|363437049|FG001|Overall Study|Prosthetist unable to participate|2|||
105390605|NCT03164356|363437050|FG002|Overall Study|Prosthetist unable to participate|1|||
105390606|NCT03164356|363437051|FG003|Overall Study|Prosthetist unable to participate|0|||
105390607|NCT05943990|363437053|FG000|Overall Study|Study Terminated by Sponsor|0|||
105390608|NCT05943990|363437054|FG001|Overall Study|Study Terminated by Sponsor|0|||
105390609|NCT05943990|363437055|FG002|Overall Study|Study Terminated by Sponsor|1|||
105390610|NCT02457546|363438510|FG000|Overall Study|Other reasons|4|||
105390611|NCT02457546|363438511|FG001|Overall Study|Other reasons|1|||
105390612|NCT02457546|363438510|FG000|Overall Study|Refused to complete study/procedures|1|||
105390613|NCT02457546|363438511|FG001|Overall Study|Refused to complete study/procedures|1|||
105390614|NCT02457546|363438510|FG000|Overall Study|Lost to Follow-up|4|||
105390615|NCT02457546|363438511|FG001|Overall Study|Lost to Follow-up|1|||
105390616|NCT02457546|363438510|FG000|Overall Study|Adverse Event|0|||
105390617|NCT02457546|363438511|FG001|Overall Study|Adverse Event|1|||
105390618|NCT00668642|363438516|FG000|First Off-cycle|Cancer progression|1|||
105390619|NCT00668642|363438517|FG001|First Off-cycle|Cancer progression|0|||
105390620|NCT00668642|363438516|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
105390621|NCT00668642|363438517|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
105390622|NCT02003898|363438518|FG000|Overall Study|Death|3|||
105390623|NCT02003898|363438518|FG000|Overall Study|Lost to Follow-up|12|||
105390624|NCT02003898|363438518|FG000|Overall Study|Withdrawal by Subject|52|||
105390625|NCT03412591|363438519|FG000|Overall Study|Withdrawal by Subject|1|||
105390626|NCT03412591|363438520|FG001|Overall Study|Withdrawal by Subject|8|||
105390627|NCT03412591|363438519|FG000|Overall Study|Adverse Event|0|||
105390628|NCT03412591|363438520|FG001|Overall Study|Adverse Event|1|||
105390629|NCT00770679|363438523|FG000|Overall Study|Lost to Follow-up|3|||
105390630|NCT00770679|363438523|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
105390631|NCT05166902|363438524|FG000|First Intervention|Lost to Follow-up|0|||
105390632|NCT05166902|363438525|FG001|First Intervention|Lost to Follow-up|1|||
105390633|NCT00414609|363438526|FG000|Core Study|Adverse Event|9|||
105390634|NCT00414609|363438527|FG001|Core Study|Adverse Event|11|||
105390635|NCT00414609|363438528|FG002|Core Study|Adverse Event|0|||
105390636|NCT00414609|363438526|FG000|Core Study|Abnormal laboratory values|0|||
105390637|NCT00414609|363438527|FG001|Core Study|Abnormal laboratory values|1|||
105390638|NCT00414609|363438528|FG002|Core Study|Abnormal laboratory values|0|||
105390639|NCT00414609|363438526|FG000|Core Study|Abnormal test procedure results|1|||
105390640|NCT00414609|363438527|FG001|Core Study|Abnormal test procedure results|1|||
105390641|NCT00414609|363438528|FG002|Core Study|Abnormal test procedure results|0|||
105390642|NCT00414609|363438526|FG000|Core Study|Protocol deviation|0|||
105390643|NCT00414609|363438527|FG001|Core Study|Protocol deviation|1|||
105390644|NCT00414609|363438528|FG002|Core Study|Protocol deviation|0|||
105390645|NCT00414609|363438526|FG000|Core Study|Patient withdrew consent|10|||
105390646|NCT00414609|363438527|FG001|Core Study|Patient withdrew consent|11|||
105390647|NCT00414609|363438528|FG002|Core Study|Patient withdrew consent|0|||
105390648|NCT00414609|363438526|FG000|Core Study|Lost to Follow-up|7|||
105390649|NCT00414609|363438527|FG001|Core Study|Lost to Follow-up|4|||
105390650|NCT00414609|363438528|FG002|Core Study|Lost to Follow-up|0|||
105390651|NCT00414609|363438526|FG000|Core Study|Administrative problems|0|||
105390652|NCT00414609|363438527|FG001|Core Study|Administrative problems|2|||
105390653|NCT00414609|363438528|FG002|Core Study|Administrative problems|0|||
105390654|NCT00414609|363438526|FG000|Core Study|Death|7|||
105390655|NCT00414609|363438527|FG001|Core Study|Death|14|||
105390656|NCT00414609|363438528|FG002|Core Study|Death|0|||
105390657|NCT00414609|363438526|FG000|Extension Study|Adverse Event|0|||
105390658|NCT00414609|363438527|FG001|Extension Study|Adverse Event|0|||
105390659|NCT00414609|363438528|FG002|Extension Study|Adverse Event|14|||
105390660|NCT00414609|363438526|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
105390661|NCT00414609|363438527|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
105390662|NCT00414609|363438528|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
105390663|NCT00414609|363438526|FG000|Extension Study|Withdrawal by Subject|0|||
105390664|NCT00414609|363438527|FG001|Extension Study|Withdrawal by Subject|0|||
105390665|NCT00414609|363438528|FG002|Extension Study|Withdrawal by Subject|13|||
105390666|NCT00414609|363438526|FG000|Extension Study|Lost to Follow-up|0|||
105390667|NCT00414609|363438527|FG001|Extension Study|Lost to Follow-up|0|||
105390668|NCT00414609|363438528|FG002|Extension Study|Lost to Follow-up|10|||
105390669|NCT00414609|363438526|FG000|Extension Study|Administrative problems|0|||
105390670|NCT00414609|363438527|FG001|Extension Study|Administrative problems|0|||
105390671|NCT00414609|363438528|FG002|Extension Study|Administrative problems|1|||
105390672|NCT00414609|363438526|FG000|Extension Study|Death|0|||
105390673|NCT00414609|363438527|FG001|Extension Study|Death|0|||
105390674|NCT00414609|363438528|FG002|Extension Study|Death|17|||
105390675|NCT00266032|363438529|FG000|Treatment|Adverse Event|42|||
105390676|NCT00266032|363438530|FG001|Treatment|Adverse Event|26|||
105390677|NCT00266032|363438531|FG002|Treatment|Adverse Event|10|||
105390678|NCT00266032|363438529|FG000|Treatment|Lost to Follow-up|19|||
105390679|NCT00266032|363438530|FG001|Treatment|Lost to Follow-up|4|||
105390680|NCT00266032|363438531|FG002|Treatment|Lost to Follow-up|2|||
105390681|NCT00266032|363438529|FG000|Treatment|Pregnancy|3|||
105390682|NCT00266032|363438530|FG001|Treatment|Pregnancy|2|||
105390683|NCT00266032|363438531|FG002|Treatment|Pregnancy|2|||
105390684|NCT00266032|363438529|FG000|Treatment|Protocol Violation|6|||
105390685|NCT00266032|363438530|FG001|Treatment|Protocol Violation|14|||
105390686|NCT00266032|363438531|FG002|Treatment|Protocol Violation|13|||
105390687|NCT00266032|363438529|FG000|Treatment|Withdrawal by Subject|28|||
105390688|NCT00266032|363438530|FG001|Treatment|Withdrawal by Subject|13|||
105580559|NCT02018861|364126449|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
105580560|NCT02018861|364126450|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
105580561|NCT02018861|364126451|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
105390689|NCT00266032|363438531|FG002|Treatment|Withdrawal by Subject|12|||
105390690|NCT00266032|363438529|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
105390691|NCT00266032|363438530|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
105390692|NCT00266032|363438531|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
105390693|NCT00266032|363438529|FG000|Open-label Safety Extension|Adverse Event|5|||
105390694|NCT00266032|363438530|FG001|Open-label Safety Extension|Adverse Event|0|||
105390695|NCT00266032|363438531|FG002|Open-label Safety Extension|Adverse Event|4|||
105390696|NCT00266032|363438529|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
105390697|NCT00266032|363438530|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
105390698|NCT00266032|363438531|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
105390699|NCT00266032|363438529|FG000|Open-label Safety Extension|Pregnancy|4|||
105390700|NCT00266032|363438530|FG001|Open-label Safety Extension|Pregnancy|1|||
105390701|NCT00266032|363438531|FG002|Open-label Safety Extension|Pregnancy|2|||
105390702|NCT00266032|363438529|FG000|Open-label Safety Extension|Protocol Violation|1|||
105390703|NCT00266032|363438530|FG001|Open-label Safety Extension|Protocol Violation|3|||
105390704|NCT00266032|363438531|FG002|Open-label Safety Extension|Protocol Violation|2|||
105390705|NCT00266032|363438529|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
105390706|NCT00266032|363438530|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
105390707|NCT00266032|363438531|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
105390708|NCT00266032|363438529|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
105390709|NCT00266032|363438530|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
105390710|NCT00266032|363438531|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
105390711|NCT02605967|363438532|FG000|Overall Study|subject / guardian decision|1|||
105390712|NCT02605967|363438533|FG001|Overall Study|subject / guardian decision|2|||
105390713|NCT02605967|363438532|FG000|Overall Study|Physician Decision|10|||
105390714|NCT02605967|363438533|FG001|Overall Study|Physician Decision|1|||
105390715|NCT02605967|363438532|FG000|Overall Study|Death|4|||
105390716|NCT02605967|363438533|FG001|Overall Study|Death|2|||
105390717|NCT02605967|363438532|FG000|Overall Study|Adverse Event|1|||
105390718|NCT02605967|363438533|FG001|Overall Study|Adverse Event|0|||
105390719|NCT02605967|363438532|FG000|Overall Study|progressive disease|66|||
105390720|NCT02605967|363438533|FG001|Overall Study|progressive disease|35|||
105390721|NCT01903720|363438534|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
105390722|NCT01903720|363438534|FG000|Overall Study|Adverse Event|1|||
105390723|NCT01903720|363438534|FG000|Overall Study|Rescinding of informed consent|2|||
105390724|NCT01903720|363438534|FG000|Overall Study|Lost to Follow-up|2|||
105390725|NCT01903720|363438534|FG000|Overall Study|Treatment with alternative drug|1|||
105390726|NCT03627468|363438535|FG000|Overall Study|Adverse Event|5|||
105390727|NCT03627468|363438536|FG001|Overall Study|Adverse Event|33|||
105390728|NCT03627468|363438535|FG000|Overall Study|Withdrawal by Subject|13|||
105390729|NCT03627468|363438536|FG001|Overall Study|Withdrawal by Subject|23|||
105390730|NCT03627468|363438535|FG000|Overall Study|Physician Decision|1|||
105390731|NCT03627468|363438536|FG001|Overall Study|Physician Decision|0|||
105390732|NCT03627468|363438535|FG000|Overall Study|Protocol Violation|0|||
105390733|NCT03627468|363438536|FG001|Overall Study|Protocol Violation|2|||
105390734|NCT03627468|363438535|FG000|Overall Study|Lost to Follow-up|10|||
105390735|NCT03627468|363438536|FG001|Overall Study|Lost to Follow-up|16|||
105390736|NCT03627468|363438535|FG000|Overall Study|Death|1|||
105390737|NCT03627468|363438536|FG001|Overall Study|Death|0|||
105390738|NCT03627468|363438535|FG000|Overall Study|Pregnancy|1|||
105390739|NCT03627468|363438536|FG001|Overall Study|Pregnancy|1|||
105390740|NCT03627468|363438535|FG000|Overall Study|Lack of Efficacy|0|||
105390741|NCT03627468|363438536|FG001|Overall Study|Lack of Efficacy|2|||
105390742|NCT03627468|363438535|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
105390743|NCT03627468|363438536|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
105390744|NCT00309946|363438537|FG000|Overall Study|Withdrawal by Subject|1|||
105390745|NCT02150863|363438540|FG000|Overall Study|Lost to Follow-up|0|||
105390746|NCT02150863|363438541|FG001|Overall Study|Lost to Follow-up|1|||
105390747|NCT02150863|363438542|FG002|Overall Study|Lost to Follow-up|0|||
105390748|NCT00830336|363438543|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
105390749|NCT00830336|363438544|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
105390750|NCT00619918|363438549|FG000|Overall Study|Withdrawal by Subject|4|||
105390751|NCT00619918|363438550|FG001|Overall Study|Withdrawal by Subject|3|||
105390752|NCT00619918|363438549|FG000|Overall Study|Physician Decision|2|||
105390753|NCT00619918|363438550|FG001|Overall Study|Physician Decision|4|||
105390754|NCT00619918|363438549|FG000|Overall Study|Transfer to outside facility|3|||
105390755|NCT00619918|363438550|FG001|Overall Study|Transfer to outside facility|3|||
105390756|NCT00619918|363438549|FG000|Overall Study|Left before receiving first dose|7|||
105390757|NCT00619918|363438550|FG001|Overall Study|Left before receiving first dose|6|||
105390758|NCT00619918|363438549|FG000|Overall Study|ICU admission|4|||
105390759|NCT00619918|363438550|FG001|Overall Study|ICU admission|6|||
105390760|NCT03411044|363438552|FG000|Overall Study|Death|30|||
105390761|NCT03411044|363438552|FG000|Overall Study|Withdrawal by Subject|48|||
105390762|NCT03411044|363438552|FG000|Overall Study|Lost to Follow-up|78|||
105390763|NCT03411044|363438552|FG000|Overall Study|Adverse Event|30|||
105390764|NCT03411044|363438552|FG000|Overall Study|Missing status|4|||
105390765|NCT00456365|363438557|FG000|Overall Study|Lost to Follow-up|1|||
105390766|NCT00456365|363438558|FG001|Overall Study|Lost to Follow-up|3|||
105390767|NCT00456365|363438557|FG000|Overall Study|Withdrawal by Subject|4|||
105390768|NCT00456365|363438558|FG001|Overall Study|Withdrawal by Subject|7|||
105390769|NCT00456365|363438557|FG000|Overall Study|Pregnancy|1|||
105390770|NCT00456365|363438558|FG001|Overall Study|Pregnancy|1|||
105390771|NCT00456365|363438557|FG000|Overall Study|oncologic diagnosis|1|||
105390772|NCT00456365|363438558|FG001|Overall Study|oncologic diagnosis|1|||
105390773|NCT05451329|363438559|FG000|Overall Study|Adverse Event|1|||
105390774|NCT05451329|363438560|FG001|Overall Study|Adverse Event|1|||
105390775|NCT05451329|363438561|FG002|Overall Study|Adverse Event|0|||
105390776|NCT05451329|363438559|FG000|Overall Study|Withdrawal by Subject|1|||
105390777|NCT05451329|363438560|FG001|Overall Study|Withdrawal by Subject|0|||
105390778|NCT05451329|363438561|FG002|Overall Study|Withdrawal by Subject|0|||
105390779|NCT05451329|363438559|FG000|Overall Study|Investigational Product Lot exchange|1|||
105390780|NCT05451329|363438560|FG001|Overall Study|Investigational Product Lot exchange|1|||
105390781|NCT05451329|363438561|FG002|Overall Study|Investigational Product Lot exchange|0|||
105390782|NCT02202577|363438562|FG000|Overall Study|Lost to Follow-up|6|||
105390783|NCT02202577|363438563|FG001|Overall Study|Lost to Follow-up|16|||
105390784|NCT02202577|363438562|FG000|Overall Study|Protocol Violation|7|||
105390785|NCT02202577|363438563|FG001|Overall Study|Protocol Violation|3|||
105390786|NCT01421459|363438566|FG000|Overall Study|Adverse Event|6|||
105390787|NCT01421459|363438567|FG001|Overall Study|Adverse Event|10|||
105390788|NCT01421459|363438566|FG000|Overall Study|Death|1|||
105390789|NCT01421459|363438567|FG001|Overall Study|Death|1|||
105390790|NCT01421459|363438566|FG000|Overall Study|Lack of Efficacy|1|||
105390791|NCT01421459|363438567|FG001|Overall Study|Lack of Efficacy|2|||
105390792|NCT01421459|363438566|FG000|Overall Study|Lost to Follow-up|8|||
105390793|NCT01421459|363438567|FG001|Overall Study|Lost to Follow-up|9|||
105390794|NCT01421459|363438566|FG000|Overall Study|Physician Decision|9|||
105390795|NCT01421459|363438567|FG001|Overall Study|Physician Decision|9|||
105390796|NCT01421459|363438566|FG000|Overall Study|Protocol Violation|8|||
105390797|NCT01421459|363438567|FG001|Overall Study|Protocol Violation|5|||
105390798|NCT01421459|363438566|FG000|Overall Study|Withdrawal by Subject|12|||
105390799|NCT01421459|363438567|FG001|Overall Study|Withdrawal by Subject|16|||
105390800|NCT01422382|363438568|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
105390801|NCT04003389|363438570|FG000|Overall Study|Adverse Event|27|||
105390802|NCT04003389|363438571|FG001|Overall Study|Adverse Event|34|||
105390803|NCT04003389|363438572|FG002|Overall Study|Adverse Event|28|||
105390804|NCT04003389|363438570|FG000|Overall Study|Lost to Follow-up|39|||
105390805|NCT04003389|363438571|FG001|Overall Study|Lost to Follow-up|30|||
105390806|NCT04003389|363438572|FG002|Overall Study|Lost to Follow-up|33|||
105390807|NCT04003389|363438570|FG000|Overall Study|Protocol Violation|1|||
105390808|NCT04003389|363438571|FG001|Overall Study|Protocol Violation|6|||
105390809|NCT04003389|363438572|FG002|Overall Study|Protocol Violation|5|||
105390810|NCT04003389|363438570|FG000|Overall Study|Withdrawal by Subject|119|||
105390811|NCT04003389|363438571|FG001|Overall Study|Withdrawal by Subject|79|||
105390812|NCT04003389|363438572|FG002|Overall Study|Withdrawal by Subject|85|||
105390813|NCT04003389|363438570|FG000|Overall Study|Miscellaneous|14|||
105390814|NCT04003389|363438571|FG001|Overall Study|Miscellaneous|11|||
105390815|NCT04003389|363438572|FG002|Overall Study|Miscellaneous|14|||
105390816|NCT04003389|363438570|FG000|Overall Study|Participant did not receive study drug|1|||
105390817|NCT04003389|363438571|FG001|Overall Study|Participant did not receive study drug|0|||
105390818|NCT04003389|363438572|FG002|Overall Study|Participant did not receive study drug|0|||
105390819|NCT04439903|363438575|FG000|Overall Study|Withdrawal by Subject|2|||
105390820|NCT04439903|363438575|FG000|Overall Study|Screen Failure|1|||
105390821|NCT02899754|363438576|FG000|Overall Study|Lost to Follow-up|7|||
105390822|NCT02899754|363438577|FG001|Overall Study|Lost to Follow-up|9|||
105390823|NCT04818229|363438580|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
105390824|NCT04818229|363438581|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
105390825|NCT04818229|363438582|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
105390826|NCT04818229|363438580|FG000|Overall Study|Adverse Event|3|||
105390827|NCT04818229|363438581|FG001|Overall Study|Adverse Event|1|||
105390828|NCT04818229|363438582|FG002|Overall Study|Adverse Event|1|||
105580562|NCT02018861|364126452|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
105580563|NCT02018861|364126453|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
105580564|NCT02018861|364126444|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
105390829|NCT04818229|363438580|FG000|Overall Study|Withdrawal by Subject|0|||
105390830|NCT04818229|363438581|FG001|Overall Study|Withdrawal by Subject|0|||
105390831|NCT04818229|363438582|FG002|Overall Study|Withdrawal by Subject|2|||
105390832|NCT04818229|363438580|FG000|Overall Study|Lost to Follow-up|0|||
105390833|NCT04818229|363438581|FG001|Overall Study|Lost to Follow-up|0|||
105390834|NCT04818229|363438582|FG002|Overall Study|Lost to Follow-up|1|||
105390835|NCT03186378|363438583|FG000|Overall Study|Lost to Follow-up|1|||
105390836|NCT03186378|363438584|FG001|Overall Study|Lost to Follow-up|0|||
105390837|NCT02181413|363438587|FG000|Overall Study|Withdrawal by Subject|45|||
105390838|NCT02181413|363438588|FG001|Overall Study|Withdrawal by Subject|61|||
105390839|NCT02181413|363438587|FG000|Overall Study|Reason Not Specified|2|||
105390840|NCT02181413|363438588|FG001|Overall Study|Reason Not Specified|5|||
105390841|NCT02181413|363438587|FG000|Overall Study|Lost to Follow-up|8|||
105390842|NCT02181413|363438588|FG001|Overall Study|Lost to Follow-up|7|||
105390843|NCT00050011|363438590|FG000|Overall Study|Adverse Event|41|||
105390844|NCT00050011|363438591|FG001|Overall Study|Adverse Event|46|||
105390845|NCT00050011|363438590|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105390846|NCT00050011|363438591|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105390847|NCT00050011|363438590|FG000|Overall Study|Abnormal test procedure results|0|||
105390848|NCT00050011|363438591|FG001|Overall Study|Abnormal test procedure results|1|||
105390849|NCT00050011|363438590|FG000|Overall Study|Lack of Efficacy|16|||
105390850|NCT00050011|363438591|FG001|Overall Study|Lack of Efficacy|21|||
105390851|NCT00050011|363438590|FG000|Overall Study|Participant condition no longer required|1|||
105390852|NCT00050011|363438591|FG001|Overall Study|Participant condition no longer required|0|||
105390853|NCT00050011|363438590|FG000|Overall Study|Protocol Violation|4|||
105390854|NCT00050011|363438591|FG001|Overall Study|Protocol Violation|10|||
105390855|NCT00050011|363438590|FG000|Overall Study|Withdrawal by Subject|34|||
105390856|NCT00050011|363438591|FG001|Overall Study|Withdrawal by Subject|26|||
105390857|NCT00050011|363438590|FG000|Overall Study|Lost to Follow-up|7|||
105390858|NCT00050011|363438591|FG001|Overall Study|Lost to Follow-up|9|||
105390859|NCT00050011|363438590|FG000|Overall Study|Administrative problems|10|||
105390860|NCT00050011|363438591|FG001|Overall Study|Administrative problems|6|||
105390861|NCT00050011|363438590|FG000|Overall Study|Death|7|||
105390862|NCT00050011|363438591|FG001|Overall Study|Death|4|||
105390863|NCT00050011|363438590|FG000|Overall Study|Unknown - Reason is missing|0|||
105390864|NCT00050011|363438591|FG001|Overall Study|Unknown - Reason is missing|2|||
105390865|NCT04903093|363438598|FG000|Overall Study|Withdrawal by Subject|0|||
105390866|NCT04903093|363438599|FG001|Overall Study|Withdrawal by Subject|0|||
105390867|NCT04903093|363438600|FG002|Overall Study|Withdrawal by Subject|0|||
105390868|NCT04903093|363438601|FG003|Overall Study|Withdrawal by Subject|1|||
105390869|NCT04903093|363438602|FG004|Overall Study|Withdrawal by Subject|0|||
105390870|NCT04903093|363438603|FG005|Overall Study|Withdrawal by Subject|0|||
105390871|NCT02544763|363438604|FG000|Overall Study|Adverse Event|8|||
105390872|NCT02544763|363438605|FG001|Overall Study|Adverse Event|8|||
105390873|NCT02544763|363438606|FG002|Overall Study|Adverse Event|0|||
105390874|NCT02544763|363438604|FG000|Overall Study|Withdrawn by parent/guardian|1|||
105390875|NCT02544763|363438605|FG001|Overall Study|Withdrawn by parent/guardian|1|||
105390876|NCT02544763|363438606|FG002|Overall Study|Withdrawn by parent/guardian|1|||
105390877|NCT02544763|363438604|FG000|Overall Study|Met withdrawal criteria|0|||
105390878|NCT02544763|363438605|FG001|Overall Study|Met withdrawal criteria|2|||
105390879|NCT02544763|363438606|FG002|Overall Study|Met withdrawal criteria|0|||
105390880|NCT02544763|363438604|FG000|Overall Study|Physician Decision|0|||
105390881|NCT02544763|363438605|FG001|Overall Study|Physician Decision|1|||
105390882|NCT02544763|363438606|FG002|Overall Study|Physician Decision|0|||
105390883|NCT02544763|363438604|FG000|Overall Study|Difficulties taking IMP|1|||
105390884|NCT02544763|363438605|FG001|Overall Study|Difficulties taking IMP|0|||
105390885|NCT02544763|363438606|FG002|Overall Study|Difficulties taking IMP|0|||
105390886|NCT02097225|363438607|FG000|Dose Level 4|Adverse Event|0|||
105390887|NCT02097225|363438608|FG001|Dose Level 4|Adverse Event|0|||
105390888|NCT02097225|363438609|FG002|Dose Level 4|Adverse Event|0|||
105390889|NCT02097225|363438610|FG003|Dose Level 4|Adverse Event|0|||
105390890|NCT02097225|363438611|FG004|Dose Level 4|Adverse Event|1|||
105390891|NCT01027351|363438613|FG000|Overall Study|Withdrawal by Subject|1|||
105390892|NCT01027351|363438614|FG001|Overall Study|Withdrawal by Subject|0|||
105390893|NCT01027351|363438615|FG002|Overall Study|Withdrawal by Subject|1|||
105390894|NCT01027351|363438616|FG003|Overall Study|Withdrawal by Subject|0|||
105390895|NCT01027351|363438617|FG004|Overall Study|Withdrawal by Subject|3|||
105390896|NCT01027351|363438618|FG005|Overall Study|Withdrawal by Subject|5|||
105390897|NCT01027351|363438613|FG000|Overall Study|Lost to Follow-up|1|||
105390898|NCT01027351|363438614|FG001|Overall Study|Lost to Follow-up|1|||
105390899|NCT01027351|363438615|FG002|Overall Study|Lost to Follow-up|0|||
105390900|NCT01027351|363438616|FG003|Overall Study|Lost to Follow-up|1|||
105390901|NCT01027351|363438617|FG004|Overall Study|Lost to Follow-up|6|||
105390902|NCT01027351|363438618|FG005|Overall Study|Lost to Follow-up|0|||
105390903|NCT01027351|363438613|FG000|Overall Study|Inappropriate enrollment|0|||
105390904|NCT01027351|363438614|FG001|Overall Study|Inappropriate enrollment|0|||
105390905|NCT01027351|363438615|FG002|Overall Study|Inappropriate enrollment|0|||
105390906|NCT01027351|363438616|FG003|Overall Study|Inappropriate enrollment|0|||
105390907|NCT01027351|363438617|FG004|Overall Study|Inappropriate enrollment|1|||
105390908|NCT01027351|363438618|FG005|Overall Study|Inappropriate enrollment|0|||
105390909|NCT01027351|363438613|FG000|Overall Study|Protocol Violation|1|||
105390910|NCT01027351|363438614|FG001|Overall Study|Protocol Violation|0|||
105390911|NCT01027351|363438615|FG002|Overall Study|Protocol Violation|0|||
105390912|NCT01027351|363438616|FG003|Overall Study|Protocol Violation|1|||
105390913|NCT01027351|363438617|FG004|Overall Study|Protocol Violation|1|||
105390914|NCT01027351|363438618|FG005|Overall Study|Protocol Violation|0|||
105390915|NCT02971137|363438619|FG000|Overall Study|Lost to Follow-up|44|||
105390916|NCT02971137|363438620|FG001|Overall Study|Lost to Follow-up|56|||
105390917|NCT00911157|363438621|FG000|Overall Study|Adverse Event|4|||
105390918|NCT00911157|363438622|FG001|Overall Study|Adverse Event|1|||
105390919|NCT00911157|363438621|FG000|Overall Study|Withdrawal by Subject|1|||
105390920|NCT00911157|363438622|FG001|Overall Study|Withdrawal by Subject|1|||
105390921|NCT00911157|363438621|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
105390922|NCT00911157|363438622|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
105390923|NCT00911157|363438621|FG000|Overall Study|Need to treat for lung cancer|1|||
105390924|NCT00911157|363438622|FG001|Overall Study|Need to treat for lung cancer|0|||
105390925|NCT04755231|363438623|FG000|Overall Study|Lost to Follow-up|5|||
105390926|NCT04755231|363438623|FG000|Overall Study|Withdrawal by Subject|5|||
105390927|NCT02691494|363438627|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
105390928|NCT02691494|363438628|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
105390929|NCT02691494|363438629|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
105390930|NCT02691494|363438627|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
105390931|NCT02691494|363438628|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
105390932|NCT02691494|363438629|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
105390933|NCT02691494|363438627|FG000|Post-Treatment Follow-Up Period|Other|2|||
105390934|NCT02691494|363438628|FG001|Post-Treatment Follow-Up Period|Other|1|||
105390935|NCT02691494|363438629|FG002|Post-Treatment Follow-Up Period|Other|1|||
105390936|NCT02691494|363438627|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
105390937|NCT02691494|363438628|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
105390938|NCT02691494|363438629|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
105390939|NCT02691494|363438627|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
105390940|NCT02691494|363438628|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
105390941|NCT02691494|363438629|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
105390942|NCT04309500|363438630|FG000|Overall Study|Lost to Follow-up|1|||
105390943|NCT04309500|363438631|FG001|Overall Study|Lost to Follow-up|0|||
105390944|NCT04309500|363438632|FG002|Overall Study|Lost to Follow-up|0|||
105390945|NCT04309500|363438633|FG003|Overall Study|Lost to Follow-up|0|||
105390946|NCT03726879|363438634|FG000|Overall Study|Death|11|||
105390947|NCT03726879|363438635|FG001|Overall Study|Death|13|||
105390948|NCT03726879|363438634|FG000|Overall Study|Physician Decision|0|||
105390949|NCT03726879|363438635|FG001|Overall Study|Physician Decision|2|||
105390950|NCT03726879|363438634|FG000|Overall Study|Protocol Violation|0|||
105390951|NCT03726879|363438635|FG001|Overall Study|Protocol Violation|1|||
105390952|NCT03726879|363438634|FG000|Overall Study|Withdrawal by Subject|5|||
105390953|NCT03726879|363438635|FG001|Overall Study|Withdrawal by Subject|6|||
105390954|NCT03726879|363438634|FG000|Overall Study|TSH result is unstable|0|||
105390955|NCT03726879|363438635|FG001|Overall Study|TSH result is unstable|1|||
105390956|NCT03726879|363438634|FG000|Overall Study|Disease relapse|1|||
105390957|NCT03726879|363438635|FG001|Overall Study|Disease relapse|0|||
105390958|NCT03726879|363438634|FG000|Overall Study|Lost to Follow-up|3|||
105390959|NCT03726879|363438635|FG001|Overall Study|Lost to Follow-up|0|||
105390960|NCT02113878|363440257|FG000|Overall Study|Adverse Event|1|||
105390961|NCT02113878|363440258|FG001|Overall Study|Adverse Event|0|||
105390962|NCT02113878|363440257|FG000|Overall Study|Withdrawal by Subject|1|||
105390963|NCT02113878|363440258|FG001|Overall Study|Withdrawal by Subject|0|||
105390964|NCT02113878|363440257|FG000|Overall Study|patient non-compliance|1|||
105390965|NCT02113878|363440258|FG001|Overall Study|patient non-compliance|0|||
105390966|NCT02730169|363440263|FG000|Overall Study|Protocol Violation|1|||
105390967|NCT02730169|363440264|FG001|Overall Study|Protocol Violation|0|||
105390968|NCT02730169|363440265|FG002|Overall Study|Protocol Violation|0|||
105390969|NCT02730169|363440266|FG003|Overall Study|Protocol Violation|1|||
105390970|NCT02730169|363440263|FG000|Overall Study|Adverse Event|2|||
105390971|NCT02730169|363440264|FG001|Overall Study|Adverse Event|3|||
105390972|NCT02730169|363440265|FG002|Overall Study|Adverse Event|3|||
105390973|NCT02730169|363440266|FG003|Overall Study|Adverse Event|0|||
105390974|NCT02730169|363440263|FG000|Overall Study|Adverse Event of Special Interest|0|||
105390975|NCT02730169|363440264|FG001|Overall Study|Adverse Event of Special Interest|1|||
105390976|NCT02730169|363440265|FG002|Overall Study|Adverse Event of Special Interest|2|||
105390977|NCT02730169|363440266|FG003|Overall Study|Adverse Event of Special Interest|0|||
105390978|NCT02730169|363440263|FG000|Overall Study|Withdrawal by Subject|6|||
105390979|NCT02730169|363440264|FG001|Overall Study|Withdrawal by Subject|11|||
105390980|NCT02730169|363440265|FG002|Overall Study|Withdrawal by Subject|6|||
105390981|NCT02730169|363440266|FG003|Overall Study|Withdrawal by Subject|8|||
105390982|NCT02730169|363440263|FG000|Overall Study|Lost to Follow-up|5|||
105390983|NCT02730169|363440264|FG001|Overall Study|Lost to Follow-up|6|||
105390984|NCT02730169|363440265|FG002|Overall Study|Lost to Follow-up|5|||
105390985|NCT02730169|363440266|FG003|Overall Study|Lost to Follow-up|6|||
105390986|NCT02730169|363440263|FG000|Overall Study|Other|0|||
105492954|NCT02445391|363817211|FG002|Overall Study|Withdrawal by Subject|9|||
105390987|NCT02730169|363440264|FG001|Overall Study|Other|0|||
105390988|NCT02730169|363440265|FG002|Overall Study|Other|1|||
105390989|NCT02730169|363440266|FG003|Overall Study|Other|1|||
105390990|NCT00581100|363440267|FG000|Overall Study|Death|1|||
105390991|NCT00581100|363440268|FG001|Overall Study|Death|0|||
105492955|NCT02445391|363817209|FG000|Overall Study|Financial issue|0|||
105492956|NCT02445391|363817210|FG001|Overall Study|Financial issue|0|||
105492957|NCT02445391|363817211|FG002|Overall Study|Financial issue|2|||
105492958|NCT02445391|363817209|FG000|Overall Study|Still on treatment|0|||
105492959|NCT02445391|363817210|FG001|Overall Study|Still on treatment|7|||
105492960|NCT02445391|363817211|FG002|Overall Study|Still on treatment|16|||
105492961|NCT02445391|363817209|FG000|Overall Study|Not start protocol therapy|0|||
105492962|NCT02445391|363817210|FG001|Overall Study|Not start protocol therapy|12|||
105492963|NCT02445391|363817211|FG002|Overall Study|Not start protocol therapy|9|||
105492964|NCT02887859|363817213|FG000|Overall Study|Ongoing|6|||
105492965|NCT02887859|363817213|FG000|Overall Study|Adverse Event|7|||
105492966|NCT02887859|363817213|FG000|Overall Study|Death|1|||
105492967|NCT02887859|363817213|FG000|Overall Study|Physician Decision|1|||
105492968|NCT03148275|363817217|FG000|Overall Study|Death|6|||
105492969|NCT03148275|363817217|FG000|Overall Study|Adverse Event|3|||
105492970|NCT03148275|363817217|FG000|Overall Study|Liver transplant|2|||
105492971|NCT03148275|363817217|FG000|Overall Study|Patient decision|5|||
105492972|NCT03148275|363817217|FG000|Overall Study|transition to commercial drug|1|||
105492973|NCT03148275|363817217|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
105492974|NCT01083485|363818723|FG000|Overall Study|Adverse Event|0|||
105492975|NCT01083485|363818724|FG001|Overall Study|Adverse Event|1|||
105492976|NCT01083485|363818723|FG000|Overall Study|Protocol Violation|1|||
105492977|NCT01083485|363818724|FG001|Overall Study|Protocol Violation|0|||
105492978|NCT01083485|363818723|FG000|Overall Study|Withdrawal by Subject|5|||
105492979|NCT01083485|363818724|FG001|Overall Study|Withdrawal by Subject|2|||
105492980|NCT01083485|363818723|FG000|Overall Study|Other|1|||
105492981|NCT01083485|363818724|FG001|Overall Study|Other|0|||
105492982|NCT00537238|363818725|FG000|Overall Study|Death|1|||
105492983|NCT00537238|363818726|FG001|Overall Study|Death|2|||
105492984|NCT00537238|363818725|FG000|Overall Study|Adverse Event|31|||
105492985|NCT00537238|363818726|FG001|Overall Study|Adverse Event|22|||
105492986|NCT00537238|363818725|FG000|Overall Study|Lack of Efficacy|20|||
105492987|NCT00537238|363818726|FG001|Overall Study|Lack of Efficacy|21|||
105492988|NCT00537238|363818725|FG000|Overall Study|Lost to Follow-up|12|||
105492989|NCT00537238|363818726|FG001|Overall Study|Lost to Follow-up|8|||
105492990|NCT00537238|363818725|FG000|Overall Study|Withdrawal by Subject|51|||
105492991|NCT00537238|363818726|FG001|Overall Study|Withdrawal by Subject|47|||
105492992|NCT00537238|363818725|FG000|Overall Study|Protocol Violation|15|||
105492993|NCT00537238|363818726|FG001|Overall Study|Protocol Violation|19|||
105492994|NCT00537238|363818725|FG000|Overall Study|Does not meet entrance criteria|0|||
105492995|NCT00537238|363818726|FG001|Overall Study|Does not meet entrance criteria|2|||
105492996|NCT00537238|363818725|FG000|Overall Study|Other|44|||
105492997|NCT00537238|363818726|FG001|Overall Study|Other|52|||
105492998|NCT03906461|363818727|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
105580565|NCT02018861|364126445|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
105580566|NCT02018861|364126446|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
105580567|NCT02018861|364126447|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
105580568|NCT02018861|364126448|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
105580569|NCT02018861|364126449|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
105580570|NCT02018861|364126450|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
105580571|NCT02018861|364126451|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
105580572|NCT02018861|364126452|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
105580573|NCT02018861|364126453|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
105390992|NCT00581100|363440267|FG000|Overall Study|Adverse Event|2|||
105390993|NCT00581100|363440268|FG001|Overall Study|Adverse Event|1|||
105390994|NCT00581100|363440267|FG000|Overall Study|Withdrawal by Subject|1|||
105390995|NCT00581100|363440268|FG001|Overall Study|Withdrawal by Subject|4|||
105390996|NCT00581100|363440267|FG000|Overall Study|Other|3|||
105390997|NCT00581100|363440268|FG001|Overall Study|Other|0|||
105390998|NCT04616196|363440279|FG000|Overall Study|Progressive Disease|3|||
105390999|NCT04616196|363440280|FG001|Overall Study|Progressive Disease|0|||
105391000|NCT04616196|363440281|FG002|Overall Study|Progressive Disease|4|||
105391001|NCT04616196|363440282|FG003|Overall Study|Progressive Disease|1|||
105391002|NCT04616196|363440279|FG000|Overall Study|Death|2|||
105391003|NCT04616196|363440280|FG001|Overall Study|Death|4|||
105391004|NCT04616196|363440281|FG002|Overall Study|Death|1|||
105391005|NCT04616196|363440282|FG003|Overall Study|Death|0|||
105391006|NCT04616196|363440279|FG000|Overall Study|Withdrawal by Subject|0|||
105391007|NCT04616196|363440280|FG001|Overall Study|Withdrawal by Subject|2|||
105391008|NCT04616196|363440281|FG002|Overall Study|Withdrawal by Subject|0|||
105391009|NCT04616196|363440282|FG003|Overall Study|Withdrawal by Subject|0|||
105391010|NCT04616196|363440279|FG000|Overall Study|Lost to Follow-up|1|||
105391011|NCT04616196|363440280|FG001|Overall Study|Lost to Follow-up|0|||
105391012|NCT04616196|363440281|FG002|Overall Study|Lost to Follow-up|0|||
105391013|NCT04616196|363440282|FG003|Overall Study|Lost to Follow-up|0|||
105391014|NCT04616196|363440279|FG000|Overall Study|Sponsor request|2|||
105391015|NCT04616196|363440280|FG001|Overall Study|Sponsor request|1|||
105391016|NCT04616196|363440281|FG002|Overall Study|Sponsor request|1|||
105391017|NCT04616196|363440282|FG003|Overall Study|Sponsor request|2|||
105391018|NCT02371889|363440283|FG000|Overall Study|Adverse medication effect|11|||
105391019|NCT02371889|363440284|FG001|Overall Study|Adverse medication effect|2|||
105391020|NCT02371889|363440283|FG000|Overall Study|Lost to Follow-up|6|||
105391021|NCT02371889|363440284|FG001|Overall Study|Lost to Follow-up|5|||
105391022|NCT02371889|363440283|FG000|Overall Study|Personal time constraints|2|||
105391023|NCT02371889|363440284|FG001|Overall Study|Personal time constraints|4|||
105391024|NCT02371889|363440283|FG000|Overall Study|Lack of Efficacy|0|||
105391025|NCT02371889|363440284|FG001|Overall Study|Lack of Efficacy|2|||
105391026|NCT02371889|363440283|FG000|Overall Study|Relapse|0|||
105391027|NCT02371889|363440284|FG001|Overall Study|Relapse|1|||
105391028|NCT00003907|363440292|FG000|Overall Study|Adverse Event|2|||
105391029|NCT00003907|363440293|FG001|Overall Study|Adverse Event|11|||
105391030|NCT00003907|363440292|FG000|Overall Study|Death|2|||
105391031|NCT00003907|363440293|FG001|Overall Study|Death|0|||
105391032|NCT00003907|363440292|FG000|Overall Study|Withdrawal by Subject|1|||
105391033|NCT00003907|363440293|FG001|Overall Study|Withdrawal by Subject|3|||
105391034|NCT00003907|363440292|FG000|Overall Study|Progressive disease|4|||
105391035|NCT00003907|363440293|FG001|Overall Study|Progressive disease|4|||
105391036|NCT00003907|363440292|FG000|Overall Study|Complicating disease|1|||
105391037|NCT00003907|363440293|FG001|Overall Study|Complicating disease|0|||
105391038|NCT00003907|363440292|FG000|Overall Study|Other|1|||
105391039|NCT00003907|363440293|FG001|Overall Study|Other|3|||
105391040|NCT00003907|363440292|FG000|Overall Study|ineligible or not treated|2|||
105391041|NCT00003907|363440293|FG001|Overall Study|ineligible or not treated|2|||
105391042|NCT01517178|363440294|FG000|Period 1|Adverse Event|1|||
105391043|NCT01517178|363440295|FG001|Period 1|Adverse Event|2|||
105391044|NCT01517178|363440294|FG000|Period 1|Lack of Efficacy|0|||
105391045|NCT01517178|363440295|FG001|Period 1|Lack of Efficacy|1|||
105391046|NCT01517178|363440294|FG000|Period 1|E.g. study termination|3|||
105391047|NCT01517178|363440295|FG001|Period 1|E.g. study termination|1|||
105391048|NCT01517178|363440294|FG000|Period 1|Withdrawal by Subject|0|||
105391049|NCT01517178|363440295|FG001|Period 1|Withdrawal by Subject|1|||
105391050|NCT01517178|363440294|FG000|Period 2|Adverse Event|1|||
105391051|NCT01517178|363440295|FG001|Period 2|Adverse Event|0|||
105391052|NCT01517178|363440294|FG000|Period 2|Withdrawal by Subject|3|||
105391053|NCT01517178|363440295|FG001|Period 2|Withdrawal by Subject|0|||
105391054|NCT01517178|363440294|FG000|Period 2|E.g. study termination|2|||
105391055|NCT01517178|363440295|FG001|Period 2|E.g. study termination|2|||
105391056|NCT01050218|363440296|FG000|Overall Study|Adverse Event|37|||
105391057|NCT01050218|363440296|FG000|Overall Study|Lack of Efficacy|8|||
105391058|NCT01050218|363440296|FG000|Overall Study|Protocol Violation|3|||
105391059|NCT01050218|363440296|FG000|Overall Study|Withdrawal by Subject|18|||
105391060|NCT01050218|363440296|FG000|Overall Study|Discontinued by sponsor|18|||
105391061|NCT01050218|363440296|FG000|Overall Study|Compliance|2|||
105391062|NCT01050218|363440296|FG000|Overall Study|Failed to return|7|||
105391063|NCT01050218|363440296|FG000|Overall Study|Serious Adverse Event|1|||
105391064|NCT01050218|363440296|FG000|Overall Study|Family emergency|1|||
105391065|NCT03439072|363440305|FG000|Overall Study|Withdrawal by Subject|2|||
105391066|NCT03439072|363440306|FG001|Overall Study|Withdrawal by Subject|3|||
105391067|NCT03439072|363440305|FG000|Overall Study|Physician Decision|0|||
105391068|NCT03439072|363440306|FG001|Overall Study|Physician Decision|1|||
105391069|NCT02272985|363440309|FG000|Overall Study|Withdrawal by Subject|1|||
105391070|NCT02272985|363440309|FG000|Overall Study|hip fracture|1|||
105391071|NCT02272985|363440309|FG000|Overall Study|kidney transplantation|1|||
105391072|NCT03707821|363440310|FG000|Overall Study|Protocol Violation|0|||
105391073|NCT03707821|363440311|FG001|Overall Study|Protocol Violation|1|||
105391074|NCT03707821|363440310|FG000|Overall Study|Unsatisfactory Visual Response|1|||
105391075|NCT03707821|363440311|FG001|Overall Study|Unsatisfactory Visual Response|0|||
105391076|NCT03707821|363440310|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
105391077|NCT03707821|363440311|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
105391078|NCT03523585|363440312|FG000|Overall Study|Progressive Disease|174|||
105391079|NCT03523585|363440313|FG001|Overall Study|Progressive Disease|64|||
105391080|NCT03523585|363440314|FG002|Overall Study|Progressive Disease|77|||
105391081|NCT03523585|363440312|FG000|Overall Study|Adverse Event|74|||
105391082|NCT03523585|363440313|FG001|Overall Study|Adverse Event|5|||
105391083|NCT03523585|363440314|FG002|Overall Study|Adverse Event|9|||
105391084|NCT03523585|363440312|FG000|Overall Study|Withdrawal by Subject|30|||
105391085|NCT03523585|363440313|FG001|Overall Study|Withdrawal by Subject|11|||
105391086|NCT03523585|363440314|FG002|Overall Study|Withdrawal by Subject|6|||
105391087|NCT03523585|363440312|FG000|Overall Study|Clinical Progression|23|||
105391088|NCT03523585|363440313|FG001|Overall Study|Clinical Progression|5|||
105391089|NCT03523585|363440314|FG002|Overall Study|Clinical Progression|10|||
105391090|NCT03523585|363440312|FG000|Overall Study|Death|4|||
105391091|NCT03523585|363440313|FG001|Overall Study|Death|0|||
105391092|NCT03523585|363440314|FG002|Overall Study|Death|1|||
105391093|NCT03523585|363440312|FG000|Overall Study|Physician Decision|2|||
105391094|NCT03523585|363440313|FG001|Overall Study|Physician Decision|1|||
105391095|NCT03523585|363440314|FG002|Overall Study|Physician Decision|0|||
105391096|NCT03523585|363440312|FG000|Overall Study|Lost to Follow-up|1|||
105391097|NCT03523585|363440313|FG001|Overall Study|Lost to Follow-up|0|||
105391098|NCT03523585|363440314|FG002|Overall Study|Lost to Follow-up|0|||
105391099|NCT03523585|363440312|FG000|Overall Study|Miscellaneous|1|||
105391100|NCT03523585|363440313|FG001|Overall Study|Miscellaneous|0|||
105391101|NCT03523585|363440314|FG002|Overall Study|Miscellaneous|0|||
105391102|NCT03523585|363440312|FG000|Overall Study|Protocol Deviation|1|||
105391103|NCT03523585|363440313|FG001|Overall Study|Protocol Deviation|0|||
105391104|NCT03523585|363440314|FG002|Overall Study|Protocol Deviation|1|||
105391105|NCT03523585|363440312|FG000|Overall Study|Randomized But Not Treated|2|||
105391106|NCT03523585|363440313|FG001|Overall Study|Randomized But Not Treated|4|||
105391107|NCT03523585|363440314|FG002|Overall Study|Randomized But Not Treated|3|||
105391108|NCT00160563|363440320|FG000|Overall Study|Adverse Event|1|||
105391109|NCT00160563|363440321|FG001|Overall Study|Adverse Event|1|||
105391110|NCT00160563|363440322|FG002|Overall Study|Adverse Event|1|||
105391111|NCT00160563|363440320|FG000|Overall Study|Lost to Follow-up|1|||
105391112|NCT00160563|363440321|FG001|Overall Study|Lost to Follow-up|1|||
105391113|NCT00160563|363440322|FG002|Overall Study|Lost to Follow-up|2|||
105391114|NCT00160563|363440320|FG000|Overall Study|Protocol Violation|0|||
105391115|NCT00160563|363440321|FG001|Overall Study|Protocol Violation|0|||
105391116|NCT00160563|363440322|FG002|Overall Study|Protocol Violation|3|||
105391117|NCT00160563|363440320|FG000|Overall Study|Withdrawal by Subject|1|||
105391118|NCT00160563|363440321|FG001|Overall Study|Withdrawal by Subject|2|||
105391119|NCT00160563|363440322|FG002|Overall Study|Withdrawal by Subject|3|||
105391120|NCT00160563|363440320|FG000|Overall Study|Other (listed in the study report)|48|||
105391121|NCT00160563|363440321|FG001|Overall Study|Other (listed in the study report)|40|||
105391122|NCT00160563|363440322|FG002|Overall Study|Other (listed in the study report)|81|||
105391123|NCT00160563|363440320|FG000|Overall Study|Missing reason|0|||
105391124|NCT00160563|363440321|FG001|Overall Study|Missing reason|1|||
105391125|NCT00160563|363440322|FG002|Overall Study|Missing reason|0|||
105391126|NCT04157738|363440323|FG000|Overall Study|Moved out of state|0|||
105391127|NCT04157738|363440324|FG001|Overall Study|Moved out of state|2|||
105391128|NCT04157738|363440323|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
105391129|NCT04157738|363440324|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
105391130|NCT00752219|363440325|FG000|Overall Study|Clinical failure|0|||
105391131|NCT00752219|363440326|FG001|Overall Study|Clinical failure|1|||
105391132|NCT00752219|363440325|FG000|Overall Study|Adverse Event|5|||
105391133|NCT00752219|363440326|FG001|Overall Study|Adverse Event|3|||
105391134|NCT00752219|363440325|FG000|Overall Study|Protocol deviation|1|||
105391135|NCT00752219|363440326|FG001|Overall Study|Protocol deviation|0|||
105391136|NCT00752219|363440325|FG000|Overall Study|Lost to Follow-up|1|||
105391137|NCT00752219|363440326|FG001|Overall Study|Lost to Follow-up|2|||
105391138|NCT00752219|363440325|FG000|Overall Study|Randomized but not treated|1|||
105391139|NCT00752219|363440326|FG001|Overall Study|Randomized but not treated|0|||
105391140|NCT00752219|363440325|FG000|Overall Study|Other|3|||
105391141|NCT00752219|363440326|FG001|Overall Study|Other|0|||
105391142|NCT04691115|363440327|FG000|Overall Study|Withdrawal by Subject|0|||
105391143|NCT04691115|363440328|FG001|Overall Study|Withdrawal by Subject|0|||
105391144|NCT04691115|363440329|FG002|Overall Study|Withdrawal by Subject|0|||
105391145|NCT04691115|363440330|FG003|Overall Study|Withdrawal by Subject|0|||
105391146|NCT04691115|363440331|FG004|Overall Study|Withdrawal by Subject|0|||
105391147|NCT04691115|363440332|FG005|Overall Study|Withdrawal by Subject|1|||
105391148|NCT04691115|363440333|FG006|Overall Study|Withdrawal by Subject|0|||
105492999|NCT03906461|363818727|FG000|Completed 12-month Follow-up|Missed Visit|6|||
105493000|NCT00426231|363818730|FG000|Overall Study|Withdrawal by Subject|9|||
105493001|NCT00426231|363818731|FG001|Overall Study|Withdrawal by Subject|12|||
105493002|NCT03911713|363818738|FG000|Overall Study|Lost to Follow-up|0|||
105493003|NCT03911713|363818739|FG001|Overall Study|Lost to Follow-up|2|||
105493004|NCT03911713|363818740|FG002|Overall Study|Lost to Follow-up|0|||
105493005|NCT03911713|363818741|FG003|Overall Study|Lost to Follow-up|0|||
105493006|NCT03911713|363818742|FG004|Overall Study|Lost to Follow-up|0|||
105493007|NCT03911713|363818738|FG000|Overall Study|Other|0|||
105493008|NCT03911713|363818739|FG001|Overall Study|Other|0|||
105493009|NCT03911713|363818740|FG002|Overall Study|Other|0|||
105493010|NCT03911713|363818741|FG003|Overall Study|Other|1|||
105493011|NCT03911713|363818742|FG004|Overall Study|Other|0|||
105493012|NCT03911713|363818738|FG000|Overall Study|Randomized, Never Dosed|1|||
105493013|NCT03911713|363818739|FG001|Overall Study|Randomized, Never Dosed|0|||
105493014|NCT03911713|363818740|FG002|Overall Study|Randomized, Never Dosed|0|||
105493015|NCT03911713|363818741|FG003|Overall Study|Randomized, Never Dosed|1|||
105493016|NCT03911713|363818742|FG004|Overall Study|Randomized, Never Dosed|0|||
105493017|NCT04447417|363818745|FG000|Overall Study|Withdrawal by Subject|1|||
105493018|NCT04447417|363818746|FG001|Overall Study|Withdrawal by Subject|0|||
105493019|NCT04447417|363818745|FG000|Overall Study|Failure to meet inclusion criteria|1|||
105493020|NCT04447417|363818746|FG001|Overall Study|Failure to meet inclusion criteria|0|||
105493021|NCT04447417|363818745|FG000|Overall Study|Lost to Follow-up|1|||
105493022|NCT04447417|363818746|FG001|Overall Study|Lost to Follow-up|0|||
105493023|NCT03265665|363818747|FG000|24-week Data Collection|Withdrawal by Subject|2|||
105493024|NCT03265665|363818748|FG001|24-week Data Collection|Withdrawal by Subject|2|||
105493025|NCT03265665|363818747|FG000|24-week Data Collection|Lost to Follow-up|4|||
105493026|NCT03265665|363818748|FG001|24-week Data Collection|Lost to Follow-up|5|||
105493027|NCT03265665|363818747|FG000|36-week Data Collection|Lost to Follow-up|6|||
105493028|NCT03265665|363818748|FG001|36-week Data Collection|Lost to Follow-up|8|||
105493029|NCT01614600|363818749|FG000|Overall Study|Unacceptable fit|1|||
105493030|NCT01614600|363818749|FG000|Overall Study|Discomfort|1|||
105493031|NCT01614600|363818749|FG000|Overall Study|Unable to remove lens at the end of day|1|||
105493032|NCT01614600|363818749|FG000|Overall Study|Protocol deviation|1|||
105493033|NCT02437513|363818750|FG000|Overall Study|Withdrawal by Subject|2|||
105493034|NCT02423109|363818753|FG000|Lens 1|Adverse Event|1|||
105493035|NCT02423109|363818754|FG001|Lens 1|Adverse Event|0|||
105493036|NCT03956056|363818755|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
105493037|NCT03956056|363818755|FG000|Overall Study|Lack of Efficacy|1|||
105391149|NCT04691115|363440334|FG007|Overall Study|Withdrawal by Subject|0|||
105391150|NCT04691115|363440335|FG008|Overall Study|Withdrawal by Subject|0|||
105391151|NCT04691115|363440336|FG009|Overall Study|Withdrawal by Subject|0|||
105391152|NCT04691115|363440337|FG010|Overall Study|Withdrawal by Subject|0|||
105391153|NCT04691115|363440338|FG011|Overall Study|Withdrawal by Subject|0|||
105391154|NCT04691115|363440339|FG012|Overall Study|Withdrawal by Subject|0|||
105391155|NCT04691115|363440340|FG013|Overall Study|Withdrawal by Subject|0|||
105391156|NCT00347269|363440341|FG000|Overall Study|Lost to Follow-up|74|||
105391157|NCT00347269|363440342|FG001|Overall Study|Lost to Follow-up|65|||
105391158|NCT00347269|363440341|FG000|Overall Study|Withdrawal by Subject|18|||
105391159|NCT00347269|363440342|FG001|Overall Study|Withdrawal by Subject|38|||
105391160|NCT00347269|363440341|FG000|Overall Study|Death|2|||
105391161|NCT00347269|363440342|FG001|Overall Study|Death|3|||
105391162|NCT03654326|363440343|FG000|Overall Study|Withdrawal by Subject|5|||
105391163|NCT03654326|363440344|FG001|Overall Study|Withdrawal by Subject|3|||
105391164|NCT03654326|363440343|FG000|Overall Study|Physician Decision|0|||
105391165|NCT03654326|363440344|FG001|Overall Study|Physician Decision|1|||
105391166|NCT03654326|363440343|FG000|Overall Study|Unable to adhere to study schedule|0|||
105391167|NCT03654326|363440344|FG001|Overall Study|Unable to adhere to study schedule|1|||
105391168|NCT03654326|363440343|FG000|Overall Study|Lost to Follow-up|1|||
105391169|NCT03654326|363440344|FG001|Overall Study|Lost to Follow-up|1|||
105391170|NCT04102514|363440345|FG000|Overall Study|Death|3|||
105391171|NCT04102514|363440346|FG001|Overall Study|Death|0|||
105391172|NCT04102514|363440347|FG002|Overall Study|Death|0|||
105391173|NCT04102514|363440348|FG003|Overall Study|Death|0|||
105391174|NCT04102514|363440345|FG000|Overall Study|Lost to Follow-up|0|||
105391175|NCT04102514|363440346|FG001|Overall Study|Lost to Follow-up|0|||
105391176|NCT04102514|363440347|FG002|Overall Study|Lost to Follow-up|3|||
105391177|NCT04102514|363440348|FG003|Overall Study|Lost to Follow-up|0|||
105391178|NCT04102514|363440345|FG000|Overall Study|Physician Decision|0|||
105391179|NCT04102514|363440346|FG001|Overall Study|Physician Decision|0|||
105391180|NCT04102514|363440347|FG002|Overall Study|Physician Decision|1|||
105391181|NCT04102514|363440348|FG003|Overall Study|Physician Decision|0|||
105391182|NCT04102514|363440345|FG000|Overall Study|Withdrawal by Subject|7|||
105391183|NCT04102514|363440346|FG001|Overall Study|Withdrawal by Subject|13|||
105391184|NCT04102514|363440347|FG002|Overall Study|Withdrawal by Subject|7|||
105391185|NCT04102514|363440348|FG003|Overall Study|Withdrawal by Subject|14|||
105391186|NCT04102514|363440345|FG000|Overall Study|Moved to longterm care facility|6|||
105391187|NCT04102514|363440346|FG001|Overall Study|Moved to longterm care facility|0|||
105391188|NCT04102514|363440347|FG002|Overall Study|Moved to longterm care facility|4|||
105391189|NCT04102514|363440348|FG003|Overall Study|Moved to longterm care facility|0|||
105391190|NCT00835042|363440349|FG000|First Intervention|Withdrawal by Subject|3|||
105391191|NCT00835042|363440350|FG001|First Intervention|Withdrawal by Subject|0|||
105391192|NCT00835042|363440349|FG000|First Intervention|Adverse Event|1|||
105391193|NCT00835042|363440350|FG001|First Intervention|Adverse Event|2|||
105391194|NCT00835042|363440349|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
105391195|NCT00835042|363440350|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
105391196|NCT04725188|363440364|FG000|Overall Study|Death|44|||
105391197|NCT04725188|363440365|FG001|Overall Study|Death|46|||
105391198|NCT04725188|363440366|FG002|Overall Study|Death|48|||
105391199|NCT04725188|363440364|FG000|Overall Study|Lost to Follow-up|0|||
105391200|NCT04725188|363440365|FG001|Overall Study|Lost to Follow-up|0|||
105391201|NCT04725188|363440366|FG002|Overall Study|Lost to Follow-up|1|||
105391202|NCT04725188|363440364|FG000|Overall Study|Withdrawal by Subject|2|||
105391203|NCT04725188|363440365|FG001|Overall Study|Withdrawal by Subject|2|||
105391204|NCT04725188|363440366|FG002|Overall Study|Withdrawal by Subject|1|||
105391205|NCT04725188|363440364|FG000|Overall Study|Participants ongoing in the study|41|||
105493038|NCT01193660|363818756|FG000|Overall Study|Withdrawal by Subject|2|||
105493039|NCT01193660|363818757|FG001|Overall Study|Withdrawal by Subject|3|||
105493040|NCT01193660|363818758|FG002|Overall Study|Withdrawal by Subject|1|||
105493041|NCT01193660|363818756|FG000|Overall Study|Death|1|||
105391206|NCT04725188|363440365|FG001|Overall Study|Participants ongoing in the study|35|||
105391207|NCT04725188|363440366|FG002|Overall Study|Participants ongoing in the study|35|||
105391208|NCT04064567|363440372|FG000|Overall Study|Lost to Follow-up|23|||
105391209|NCT04064567|363440373|FG001|Overall Study|Lost to Follow-up|22|||
105493042|NCT01193660|363818757|FG001|Overall Study|Death|0|||
105493043|NCT01193660|363818758|FG002|Overall Study|Death|0|||
105391210|NCT04064567|363440372|FG000|Overall Study|Withdrawal by Subject|0|||
105391211|NCT04064567|363440373|FG001|Overall Study|Withdrawal by Subject|1|||
105391212|NCT04064567|363440372|FG000|Overall Study|Reincarcerated|7|||
105391213|NCT04064567|363440373|FG001|Overall Study|Reincarcerated|10|||
105391214|NCT04064567|363440372|FG000|Overall Study|Moved out of U.S.|0|||
105391215|NCT04064567|363440373|FG001|Overall Study|Moved out of U.S.|1|||
105391216|NCT05524948|363440378|FG000|Overall Study|Withdrawal by Subject|1|||
105391217|NCT05524948|363440379|FG001|Overall Study|Withdrawal by Subject|0|||
105493044|NCT01193660|363818756|FG000|Overall Study|Physician Decision|1|||
105493045|NCT01193660|363818757|FG001|Overall Study|Physician Decision|0|||
105391218|NCT05524948|363440378|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
105391219|NCT05524948|363440379|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
105391220|NCT02034565|363440380|FG000|Overall Study|Adverse Event|1|||
105391221|NCT02034565|363440381|FG001|Overall Study|Adverse Event|0|||
105391222|NCT04806373|363440387|FG000|Overall Study|Withdrawal by Subject|1|||
105391223|NCT04806373|363440388|FG001|Overall Study|Withdrawal by Subject|1|||
105391224|NCT03973489|363440389|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
105391225|NCT03973489|363440390|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
105391226|NCT03973489|363440391|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
105391227|NCT03973489|363440392|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
105391228|NCT03973489|363440393|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
105391229|NCT03973489|363440394|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
105391230|NCT03973489|363440395|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
105391231|NCT03973489|363440396|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
105391232|NCT03973489|363440389|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
105391233|NCT03973489|363440390|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
105580574|NCT02018861|364126444|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
105580575|NCT02018861|364126445|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
105391234|NCT03973489|363440391|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
105391235|NCT03973489|363440392|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
105391236|NCT03973489|363440393|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
105391237|NCT03973489|363440394|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
105391238|NCT03973489|363440395|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
105391239|NCT03973489|363440396|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
105391240|NCT03973489|363440389|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
105391241|NCT03973489|363440390|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
105391242|NCT03973489|363440391|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
105391243|NCT03973489|363440392|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
105391244|NCT03973489|363440393|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
105391245|NCT03973489|363440394|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
105391246|NCT03973489|363440395|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
105391247|NCT03973489|363440396|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
105391248|NCT03973489|363440389|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
105391249|NCT03973489|363440390|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
105391250|NCT03973489|363440391|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
105391251|NCT03973489|363440392|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
105391252|NCT03973489|363440393|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
105391253|NCT03973489|363440394|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
105391254|NCT03973489|363440395|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
105391255|NCT03973489|363440396|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
105391256|NCT03973489|363440389|FG000|Second Intervention (1 Day)|Adverse Event|0|||
105391257|NCT03973489|363440390|FG001|Second Intervention (1 Day)|Adverse Event|0|||
105391258|NCT03973489|363440391|FG002|Second Intervention (1 Day)|Adverse Event|0|||
105391259|NCT03973489|363440392|FG003|Second Intervention (1 Day)|Adverse Event|1|||
105391260|NCT03973489|363440393|FG004|Second Intervention (1 Day)|Adverse Event|0|||
105391261|NCT03973489|363440394|FG005|Second Intervention (1 Day)|Adverse Event|0|||
105391262|NCT03973489|363440395|FG006|Second Intervention (1 Day)|Adverse Event|0|||
105391263|NCT03973489|363440396|FG007|Second Intervention (1 Day)|Adverse Event|0|||
105391264|NCT00392288|363440397|FG000|Overall Study|Adverse Event|17|||
105391265|NCT00392288|363440398|FG001|Overall Study|Adverse Event|7|||
105391266|NCT00392288|363440399|FG002|Overall Study|Adverse Event|8|||
105391267|NCT00392288|363440397|FG000|Overall Study|Lack of Efficacy|8|||
105391268|NCT00392288|363440398|FG001|Overall Study|Lack of Efficacy|5|||
105391269|NCT00392288|363440399|FG002|Overall Study|Lack of Efficacy|3|||
105391270|NCT00392288|363440397|FG000|Overall Study|Protocol Violation|1|||
105391271|NCT00392288|363440398|FG001|Overall Study|Protocol Violation|3|||
105391272|NCT00392288|363440399|FG002|Overall Study|Protocol Violation|1|||
105391273|NCT00392288|363440397|FG000|Overall Study|Lost to Follow-up|1|||
105391274|NCT00392288|363440398|FG001|Overall Study|Lost to Follow-up|1|||
105391275|NCT00392288|363440399|FG002|Overall Study|Lost to Follow-up|1|||
105391276|NCT00392288|363440397|FG000|Overall Study|Withdrawal by Subject|1|||
105391277|NCT00392288|363440398|FG001|Overall Study|Withdrawal by Subject|0|||
105391278|NCT00392288|363440399|FG002|Overall Study|Withdrawal by Subject|2|||
105391279|NCT00392288|363440397|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
105391280|NCT00392288|363440398|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
105391281|NCT00392288|363440399|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
105391282|NCT00392288|363440397|FG000|Overall Study|Other|3|||
105391283|NCT00392288|363440398|FG001|Overall Study|Other|4|||
105391284|NCT00392288|363440399|FG002|Overall Study|Other|1|||
105391285|NCT02757963|363440400|FG000|Overall Study|Adverse Event|3|||
105493046|NCT01193660|363818758|FG002|Overall Study|Physician Decision|1|||
105391286|NCT02757963|363440400|FG000|Overall Study|Reached Stopping Criteria|1054|||
105391287|NCT02757963|363440400|FG000|Overall Study|Lost to Follow-up|5|||
105391288|NCT02757963|363440400|FG000|Overall Study|Physician Decision|1|||
105391289|NCT02757963|363440400|FG000|Overall Study|Withdrawal by Subject|34|||
105391290|NCT02528305|363440405|FG000|Overall Study|Withdrawal by Subject|1|||
105391291|NCT02528305|363440405|FG000|Overall Study|Adverse Event|1|||
105391292|NCT02528305|363440405|FG000|Overall Study|Physician Decision|1|||
105391293|NCT01308788|363440414|FG000|2-year Treatment|medication change by treating physician|4|||
105391294|NCT01308788|363440415|FG001|2-year Treatment|medication change by treating physician|11|||
105391295|NCT02414841|363440417|FG000|Overall Study|Withdrawal by Subject|7|||
105391296|NCT02414841|363440418|FG001|Overall Study|Withdrawal by Subject|5|||
105391297|NCT02414841|363440417|FG000|Overall Study|Lost to Follow-up|13|||
105391298|NCT02414841|363440418|FG001|Overall Study|Lost to Follow-up|6|||
105391299|NCT02414841|363440417|FG000|Overall Study|Death|17|||
105391300|NCT02414841|363440418|FG001|Overall Study|Death|14|||
105391301|NCT02414841|363440417|FG000|Overall Study|Received a Kidney Transplant|13|||
105391302|NCT02414841|363440418|FG001|Overall Study|Received a Kidney Transplant|4|||
105391303|NCT02414841|363440417|FG000|Overall Study|Randomized But Not Treated|6|||
105391304|NCT02414841|363440418|FG001|Overall Study|Randomized But Not Treated|4|||
105391305|NCT00964678|363440425|FG000|Overall Study|Physician Decision|4|||
105391306|NCT00561821|363440426|FG000|Overall Study|Not treated|0|||
105391307|NCT00561821|363440427|FG001|Overall Study|Not treated|0|||
105391308|NCT00561821|363440428|FG002|Overall Study|Not treated|1|||
105391309|NCT00561821|363440429|FG003|Overall Study|Not treated|0|||
105391310|NCT00561821|363440426|FG000|Overall Study|Withdrawal by Subject|0|||
105391311|NCT00561821|363440427|FG001|Overall Study|Withdrawal by Subject|1|||
105391312|NCT00561821|363440428|FG002|Overall Study|Withdrawal by Subject|0|||
105391313|NCT00561821|363440429|FG003|Overall Study|Withdrawal by Subject|2|||
105391314|NCT00561821|363440426|FG000|Overall Study|Reasons not related to trial|2|||
105391315|NCT00561821|363440427|FG001|Overall Study|Reasons not related to trial|1|||
105391316|NCT00561821|363440428|FG002|Overall Study|Reasons not related to trial|0|||
105391317|NCT00561821|363440429|FG003|Overall Study|Reasons not related to trial|0|||
105391318|NCT00561821|363440426|FG000|Overall Study|Other (reason not specified)|1|||
105391319|NCT00561821|363440427|FG001|Overall Study|Other (reason not specified)|1|||
105391320|NCT00561821|363440428|FG002|Overall Study|Other (reason not specified)|0|||
105391321|NCT00561821|363440429|FG003|Overall Study|Other (reason not specified)|0|||
105391322|NCT00561821|363440426|FG000|Overall Study|Adverse Event|2|||
105391323|NCT00561821|363440427|FG001|Overall Study|Adverse Event|3|||
105493047|NCT03347188|363818759|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
105493048|NCT03347188|363818760|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
105493049|NCT03347188|363818759|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
105493050|NCT03347188|363818760|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
105493051|NCT03347188|363818759|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
105493052|NCT03347188|363818760|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
105493053|NCT03347188|363818759|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
105493054|NCT03347188|363818760|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
105493055|NCT03347188|363818759|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
105493056|NCT03347188|363818760|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
105493057|NCT03347188|363818759|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
105493058|NCT03347188|363818760|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
105493059|NCT03347188|363818759|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
105493060|NCT03347188|363818760|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
105493061|NCT03347188|363818759|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
105493062|NCT03347188|363818760|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
105493063|NCT01845818|363818761|FG000|Overall Study|Withdrawal by Subject|0|||
105493064|NCT01845818|363818762|FG001|Overall Study|Withdrawal by Subject|1|||
105493065|NCT01845818|363818761|FG000|Overall Study|Lost to Follow-up|7|||
105493066|NCT01845818|363818762|FG001|Overall Study|Lost to Follow-up|5|||
105493067|NCT01845818|363818761|FG000|Overall Study|Administrative Reasons|3|||
105493068|NCT01845818|363818762|FG001|Overall Study|Administrative Reasons|1|||
105493069|NCT01845818|363818761|FG000|Overall Study|Serious Adverse Event|1|||
105493070|NCT01845818|363818762|FG001|Overall Study|Serious Adverse Event|1|||
105493071|NCT01845818|363818761|FG000|Overall Study|Other|25|||
105493072|NCT01845818|363818762|FG001|Overall Study|Other|8|||
105493073|NCT01845818|363818761|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
105493074|NCT01845818|363818762|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
105493075|NCT01845818|363818761|FG000|Overall Study|No Follow-Up Data Available|4|||
105493076|NCT01845818|363818762|FG001|Overall Study|No Follow-Up Data Available|1|||
105493077|NCT03403374|363818763|FG000|Overall Study|Lost to Follow-up|1|||
105493078|NCT00195273|363818764|FG000|Overall Study|Adverse Event|9|||
105493079|NCT00195273|363818765|FG001|Overall Study|Adverse Event|9|||
105493080|NCT00195273|363818764|FG000|Overall Study|Protocol deviation|0|||
105391324|NCT00561821|363440428|FG002|Overall Study|Adverse Event|1|||
105391325|NCT00561821|363440429|FG003|Overall Study|Adverse Event|1|||
105391326|NCT00908141|363440434|FG000|Overall Study|Withdrawal by Subject|0|||
105391327|NCT00908141|363440435|FG001|Overall Study|Withdrawal by Subject|1|||
105439862|NCT05066165|363616624|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
105439863|NCT05066165|363616623|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
105439864|NCT05066165|363616624|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
105439865|NCT03109184|363616626|FG000|Overall Study|Lost to Follow-up|6|||
105439866|NCT03109184|363616627|FG001|Overall Study|Lost to Follow-up|6|||
105439867|NCT03109184|363616626|FG000|Overall Study|Withdrawal by Subject|1|||
105439868|NCT03109184|363616627|FG001|Overall Study|Withdrawal by Subject|1|||
105439869|NCT00649428|363616628|FG000|Overall Study|Adverse Event|2|||
105439870|NCT00649428|363616629|FG001|Overall Study|Adverse Event|2|||
105439871|NCT00649428|363616628|FG000|Overall Study|Withdrawal by Subject|6|||
105439872|NCT00649428|363616629|FG001|Overall Study|Withdrawal by Subject|6|||
105439873|NCT00649428|363616628|FG000|Overall Study|Lost to Follow-up|1|||
105439874|NCT00649428|363616629|FG001|Overall Study|Lost to Follow-up|3|||
105439875|NCT00649428|363616628|FG000|Overall Study|Insufficient manufacturing yield|5|||
105439876|NCT00649428|363616629|FG001|Overall Study|Insufficient manufacturing yield|1|||
105439877|NCT00649428|363616628|FG000|Overall Study|Protocol Violation|6|||
105439878|NCT00649428|363616629|FG001|Overall Study|Protocol Violation|2|||
105439879|NCT00649428|363616628|FG000|Overall Study|Physician Decision|0|||
105439880|NCT00649428|363616629|FG001|Overall Study|Physician Decision|1|||
105439881|NCT04566601|363616632|FG000|Overall Study|Other than listed|13|||
105439882|NCT04566601|363616633|FG001|Overall Study|Other than listed|4|||
105439883|NCT04566601|363616634|FG002|Overall Study|Other than listed|2|||
105439884|NCT04566601|363616635|FG003|Overall Study|Other than listed|1|||
105439885|NCT04566601|363616636|FG004|Overall Study|Other than listed|4|||
105439886|NCT04566601|363616632|FG000|Overall Study|Protocol deviation|3|||
105439887|NCT04566601|363616633|FG001|Overall Study|Protocol deviation|0|||
105439888|NCT04566601|363616634|FG002|Overall Study|Protocol deviation|1|||
105439889|NCT04566601|363616635|FG003|Overall Study|Protocol deviation|1|||
105439890|NCT04566601|363616636|FG004|Overall Study|Protocol deviation|1|||
105439891|NCT04566601|363616632|FG000|Overall Study|Technical problems|0|||
105439892|NCT04566601|363616633|FG001|Overall Study|Technical problems|0|||
105439893|NCT04566601|363616634|FG002|Overall Study|Technical problems|1|||
105439894|NCT04566601|363616635|FG003|Overall Study|Technical problems|0|||
105439895|NCT04566601|363616636|FG004|Overall Study|Technical problems|0|||
105439896|NCT04566601|363616632|FG000|Overall Study|No reason available|3|||
105439897|NCT04566601|363616633|FG001|Overall Study|No reason available|2|||
105439898|NCT04566601|363616634|FG002|Overall Study|No reason available|7|||
105439899|NCT04566601|363616635|FG003|Overall Study|No reason available|1|||
105439900|NCT04566601|363616636|FG004|Overall Study|No reason available|5|||
105439901|NCT04566601|363616632|FG000|Overall Study|Burden of study procedures|3|||
105439902|NCT04566601|363616633|FG001|Overall Study|Burden of study procedures|0|||
105439903|NCT04566601|363616634|FG002|Overall Study|Burden of study procedures|0|||
105439904|NCT04566601|363616635|FG003|Overall Study|Burden of study procedures|3|||
105439905|NCT04566601|363616636|FG004|Overall Study|Burden of study procedures|1|||
105439906|NCT04566601|363616632|FG000|Overall Study|Change of residence|2|||
105439907|NCT04566601|363616633|FG001|Overall Study|Change of residence|2|||
105439908|NCT04566601|363616634|FG002|Overall Study|Change of residence|0|||
105439909|NCT04566601|363616635|FG003|Overall Study|Change of residence|1|||
105439910|NCT04566601|363616636|FG004|Overall Study|Change of residence|2|||
105439911|NCT04566601|363616632|FG000|Overall Study|Perceived lack of efficacy|2|||
105439912|NCT04566601|363616633|FG001|Overall Study|Perceived lack of efficacy|0|||
105439913|NCT04566601|363616634|FG002|Overall Study|Perceived lack of efficacy|1|||
105439914|NCT04566601|363616635|FG003|Overall Study|Perceived lack of efficacy|1|||
105439915|NCT04566601|363616636|FG004|Overall Study|Perceived lack of efficacy|2|||
105439916|NCT04566601|363616632|FG000|Overall Study|Adverse Event|7|||
105439917|NCT04566601|363616633|FG001|Overall Study|Adverse Event|4|||
105439918|NCT04566601|363616634|FG002|Overall Study|Adverse Event|6|||
105439919|NCT04566601|363616635|FG003|Overall Study|Adverse Event|5|||
105439920|NCT04566601|363616636|FG004|Overall Study|Adverse Event|12|||
105439921|NCT01618695|363616638|FG000|Core Phase|Adverse Event|4|||
105439922|NCT01618695|363616639|FG001|Core Phase|Adverse Event|5|||
105439923|NCT01618695|363616640|FG002|Core Phase|Adverse Event|15|||
105439924|NCT01618695|363616641|FG003|Core Phase|Adverse Event|20|||
105439925|NCT01618695|363616638|FG000|Core Phase|Lost to Follow-up|0|||
105439926|NCT01618695|363616639|FG001|Core Phase|Lost to Follow-up|0|||
105439927|NCT01618695|363616640|FG002|Core Phase|Lost to Follow-up|1|||
105439928|NCT01618695|363616641|FG003|Core Phase|Lost to Follow-up|0|||
105439929|NCT01618695|363616638|FG000|Core Phase|Withdrawal by Subject|16|||
105439930|NCT01618695|363616639|FG001|Core Phase|Withdrawal by Subject|11|||
105439931|NCT01618695|363616640|FG002|Core Phase|Withdrawal by Subject|9|||
105439932|NCT01618695|363616641|FG003|Core Phase|Withdrawal by Subject|13|||
105439933|NCT01618695|363616638|FG000|Core Phase|Pregnancy|2|||
105439934|NCT01618695|363616639|FG001|Core Phase|Pregnancy|0|||
105439935|NCT01618695|363616640|FG002|Core Phase|Pregnancy|0|||
105439936|NCT01618695|363616641|FG003|Core Phase|Pregnancy|0|||
105439937|NCT01618695|363616638|FG000|Core Phase|Lack of Efficacy|1|||
105391328|NCT01251965|363442046|FG000|Overall Study|Participant/physician decision|1|||
105391329|NCT01251965|363442047|FG001|Overall Study|Participant/physician decision|2|||
105391330|NCT01251965|363442048|FG002|Overall Study|Participant/physician decision|0|||
105391331|NCT01251965|363442046|FG000|Overall Study|Death|0|||
105391332|NCT01251965|363442047|FG001|Overall Study|Death|0|||
105391333|NCT01251965|363442048|FG002|Overall Study|Death|11|||
105391334|NCT00530257|363442054|FG000|Overall Study|Lost to Follow-up|1|||
105391335|NCT00488293|363442055|FG000|Overall Study|Lost to Follow-up|28|||
105391336|NCT00488293|363442056|FG001|Overall Study|Lost to Follow-up|25|||
105391337|NCT00488293|363442055|FG000|Overall Study|Withdrawal by Subject|5|||
105391338|NCT00488293|363442056|FG001|Overall Study|Withdrawal by Subject|3|||
105391339|NCT00488293|363442055|FG000|Overall Study|Death|2|||
105391340|NCT00488293|363442056|FG001|Overall Study|Death|1|||
105391341|NCT00488293|363442055|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
105391342|NCT00488293|363442056|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
105391343|NCT02801578|363442060|FG000|Overall Study|Adverse Event|2|||
105391344|NCT00137449|363442061|FG000|Overall Study|Disease Progression|8|||
105391345|NCT00137449|363442062|FG001|Overall Study|Disease Progression|13|||
105391346|NCT00137449|363442061|FG000|Overall Study|Death|4|||
105391347|NCT00137449|363442062|FG001|Overall Study|Death|3|||
105391348|NCT00137449|363442061|FG000|Overall Study|Adverse Event|3|||
105391349|NCT00137449|363442062|FG001|Overall Study|Adverse Event|1|||
105391350|NCT00137449|363442061|FG000|Overall Study|Withdrawal by Subject|1|||
105391351|NCT00137449|363442062|FG001|Overall Study|Withdrawal by Subject|1|||
105391352|NCT02263547|363442064|FG000|Overall Study|Adverse Event|1|||
105391353|NCT02263547|363442064|FG000|Overall Study|Lost to Follow-up|2|||
105391354|NCT01998477|363442065|FG000|Overall Study|Lost to Follow-up|4|||
105391355|NCT01998477|363442066|FG001|Overall Study|Lost to Follow-up|5|||
105391356|NCT01998477|363442065|FG000|Overall Study|Withdrawal by Subject|6|||
105391357|NCT01998477|363442066|FG001|Overall Study|Withdrawal by Subject|0|||
105391358|NCT03524157|363442067|FG000|Overall Study|cytology not readable|0|||
105391359|NCT03524157|363442068|FG001|Overall Study|cytology not readable|0|||
105391360|NCT03524157|363442069|FG002|Overall Study|cytology not readable|1|||
105391361|NCT05418426|363442073|FG000|Overall Study|Adverse Event|0|||
105391362|NCT05418426|363442074|FG001|Overall Study|Adverse Event|1|||
105391363|NCT05418426|363442075|FG002|Overall Study|Adverse Event|0|||
105391364|NCT05418426|363442073|FG000|Overall Study|Withdrawal by Subject|0|||
105391365|NCT05418426|363442074|FG001|Overall Study|Withdrawal by Subject|1|||
105391366|NCT05418426|363442075|FG002|Overall Study|Withdrawal by Subject|0|||
105391367|NCT05418426|363442073|FG000|Overall Study|Protocol Violation|0|||
105391368|NCT05418426|363442074|FG001|Overall Study|Protocol Violation|0|||
105391369|NCT05418426|363442075|FG002|Overall Study|Protocol Violation|1|||
105391370|NCT04661839|363442076|FG000|Overall Study|Not Treated|0|||
105391371|NCT04661839|363442077|FG001|Overall Study|Not Treated|0|||
105391372|NCT04661839|363442078|FG002|Overall Study|Not Treated|1|||
105391373|NCT04661839|363442079|FG003|Overall Study|Not Treated|0|||
105391374|NCT04661839|363442076|FG000|Overall Study|Lost to Follow-up|1|||
105391375|NCT04661839|363442077|FG001|Overall Study|Lost to Follow-up|0|||
105391376|NCT04661839|363442078|FG002|Overall Study|Lost to Follow-up|0|||
105391377|NCT04661839|363442079|FG003|Overall Study|Lost to Follow-up|1|||
105391378|NCT03579719|363442083|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
105391379|NCT01443026|363442084|FG000|Overall Study|Physician Decision|1|||
105391380|NCT01443026|363442085|FG001|Overall Study|Physician Decision|0|||
105391381|NCT01443026|363442084|FG000|Overall Study|Death|0|||
105391382|NCT01443026|363442085|FG001|Overall Study|Death|1|||
105391383|NCT01443026|363442084|FG000|Overall Study|Withdrawal by Subject|0|||
105391384|NCT01443026|363442085|FG001|Overall Study|Withdrawal by Subject|3|||
105391385|NCT01443026|363442084|FG000|Overall Study|Lost to Follow-up|2|||
105391386|NCT01443026|363442085|FG001|Overall Study|Lost to Follow-up|1|||
105391387|NCT00829868|363442086|FG000|Washout|Physician Decision|1|||
105391388|NCT00829868|363442087|FG001|Washout|Physician Decision|0|||
105391389|NCT03253627|363442088|FG000|Overall Study|Lost to Follow-up|1|||
105391390|NCT03253627|363442089|FG001|Overall Study|Lost to Follow-up|2|||
105391391|NCT03253627|363442088|FG000|Overall Study|Withdrawal by Subject|0|||
105391392|NCT03253627|363442089|FG001|Overall Study|Withdrawal by Subject|2|||
105391393|NCT03253627|363442088|FG000|Overall Study|Inability to complete MRI|1|||
105391394|NCT03253627|363442089|FG001|Overall Study|Inability to complete MRI|0|||
105391395|NCT06091956|363442090|FG000|Overall Study|Withdrawal by Subject|1|||
105391396|NCT06091956|363442090|FG000|Overall Study|Complicating Disease|1|||
105391397|NCT04642079|363442091|FG000|Overall Study|Lost to Follow-up|2|||
105391398|NCT04642079|363442092|FG001|Overall Study|Lost to Follow-up|5|||
105391399|NCT04642079|363442093|FG002|Overall Study|Lost to Follow-up|2|||
105391400|NCT04642079|363442094|FG003|Overall Study|Lost to Follow-up|0|||
105391401|NCT04642079|363442091|FG000|Overall Study|Withdrawal by Subject|0|||
105391402|NCT04642079|363442092|FG001|Overall Study|Withdrawal by Subject|4|||
105391403|NCT04642079|363442093|FG002|Overall Study|Withdrawal by Subject|1|||
105391404|NCT04642079|363442094|FG003|Overall Study|Withdrawal by Subject|2|||
105391405|NCT04642079|363442091|FG000|Overall Study|Other|0|||
105391406|NCT04642079|363442092|FG001|Overall Study|Other|0|||
105391407|NCT04642079|363442093|FG002|Overall Study|Other|0|||
105391408|NCT04642079|363442094|FG003|Overall Study|Other|1|||
105391409|NCT04642079|363442091|FG000|Overall Study|No longer met eligibility criteria|1|||
105391410|NCT04642079|363442092|FG001|Overall Study|No longer met eligibility criteria|0|||
105391411|NCT04642079|363442093|FG002|Overall Study|No longer met eligibility criteria|1|||
105391412|NCT04642079|363442094|FG003|Overall Study|No longer met eligibility criteria|1|||
105391413|NCT02226653|363442097|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
105391414|NCT02226653|363442098|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
105391415|NCT02226653|363442097|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
105391416|NCT02226653|363442098|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
105391417|NCT04876391|363442100|FG000|Overall Study|Withdrawal by Subject|1|||
105391418|NCT04876391|363442101|FG001|Overall Study|Withdrawal by Subject|10|||
105391419|NCT04876391|363442100|FG000|Overall Study|Lost to Follow-up|2|||
105391420|NCT04876391|363442101|FG001|Overall Study|Lost to Follow-up|4|||
105391421|NCT04876391|363442100|FG000|Overall Study|Lack of Efficacy|0|||
105391422|NCT04876391|363442101|FG001|Overall Study|Lack of Efficacy|2|||
105391423|NCT04876391|363442100|FG000|Overall Study|Adverse Event|3|||
105391424|NCT04876391|363442101|FG001|Overall Study|Adverse Event|1|||
105391425|NCT04876391|363442100|FG000|Overall Study|Patient non-compliance|0|||
105391426|NCT04876391|363442101|FG001|Overall Study|Patient non-compliance|1|||
105391427|NCT04876391|363442100|FG000|Overall Study|Personal reasons|0|||
105391428|NCT04876391|363442101|FG001|Overall Study|Personal reasons|1|||
105391429|NCT04876391|363442100|FG000|Overall Study|Withdrawn as per protocol|2|||
105391430|NCT04876391|363442101|FG001|Overall Study|Withdrawn as per protocol|2|||
105391431|NCT00209131|363442102|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
105391432|NCT00209131|363442103|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
105391433|NCT02796651|363442104|FG000|Overall Study|Adverse Event|6|||
105391434|NCT02796651|363442104|FG000|Overall Study|Lost to Follow-up|1|||
105391435|NCT02796651|363442104|FG000|Overall Study|Withdrawal by Subject|4|||
105391436|NCT02796651|363442104|FG000|Overall Study|Protocol Violation|4|||
105391437|NCT02796651|363442104|FG000|Overall Study|Lack of Efficacy|1|||
105391438|NCT02796651|363442104|FG000|Overall Study|Other|10|||
105391439|NCT05142306|363442105|FG000|Overall Study|Withdrawal by Subject|0|||
105391440|NCT05142306|363442106|FG001|Overall Study|Withdrawal by Subject|0|||
105391441|NCT05142306|363442107|FG002|Overall Study|Withdrawal by Subject|1|||
105391442|NCT04079920|363442108|FG000|Overall Study|Adverse event, not related to study drug|2|||
105391443|NCT04079920|363442108|FG000|Overall Study|Adverse event related to study drug|10|||
105391444|NCT04079920|363442108|FG000|Overall Study|Death|2|||
105391445|NCT04079920|363442108|FG000|Overall Study|Lost to Follow-up|22|||
105391446|NCT04079920|363442108|FG000|Overall Study|Physician Decision|1|||
105391447|NCT04079920|363442108|FG000|Overall Study|Withdrawal by Subject|11|||
105391448|NCT00680914|363442111|FG000|Overall Study|Consent withdrawal|6|||
105391449|NCT00680914|363442112|FG001|Overall Study|Consent withdrawal|3|||
105391450|NCT00680914|363442111|FG000|Overall Study|Lost to Follow-up|4|||
105391451|NCT00680914|363442112|FG001|Overall Study|Lost to Follow-up|0|||
105391452|NCT00680914|363442111|FG000|Overall Study|serious adverse event (SAE)|0|||
105391453|NCT00680914|363442112|FG001|Overall Study|serious adverse event (SAE)|1|||
105391454|NCT02940223|363442113|FG000|Overall Study|Failed Requirement|2|||
105391455|NCT02940223|363442114|FG001|Overall Study|Failed Requirement|0|||
105391456|NCT01299961|363442115|FG000|Overall Study|Adverse Event|3|||
105391457|NCT01299961|363442115|FG000|Overall Study|Lack of Efficacy|2|||
105391458|NCT01299961|363442115|FG000|Overall Study|Lost to Follow-up|1|||
105391459|NCT02904096|363442116|FG000|Overall Study|Adverse Event|1|||
105391460|NCT02904096|363442117|FG001|Overall Study|Adverse Event|0|||
105391461|NCT02904096|363442116|FG000|Overall Study|Withdrawal by Subject|4|||
105391462|NCT02904096|363442117|FG001|Overall Study|Withdrawal by Subject|3|||
105391463|NCT02904096|363442116|FG000|Overall Study|Lost to Follow-up|10|||
105391464|NCT02904096|363442117|FG001|Overall Study|Lost to Follow-up|17|||
105391465|NCT02904096|363442116|FG000|Overall Study|Non-compliant|3|||
105391466|NCT02904096|363442117|FG001|Overall Study|Non-compliant|1|||
105391467|NCT02904096|363442116|FG000|Overall Study|Sponsor instructed|1|||
105391468|NCT02904096|363442117|FG001|Overall Study|Sponsor instructed|0|||
105391469|NCT01767857|363442118|FG000|Overall Study|Adverse Event|27|||
105391470|NCT01767857|363442119|FG001|Overall Study|Adverse Event|7|||
105391471|NCT01767857|363442118|FG000|Overall Study|Death|28|||
105391472|NCT01767857|363442119|FG001|Overall Study|Death|13|||
105391473|NCT01767857|363442118|FG000|Overall Study|Lack of Efficacy|299|||
105391474|NCT01767857|363442119|FG001|Overall Study|Lack of Efficacy|151|||
105391475|NCT01767857|363442118|FG000|Overall Study|Lost to Follow-up|1|||
105391476|NCT01767857|363442119|FG001|Overall Study|Lost to Follow-up|1|||
105391477|NCT01767857|363442118|FG000|Overall Study|Withdrawal by Subject|38|||
105391478|NCT01767857|363442119|FG001|Overall Study|Withdrawal by Subject|18|||
105391479|NCT01767857|363442118|FG000|Overall Study|Physician Decision|17|||
105391480|NCT01767857|363442119|FG001|Overall Study|Physician Decision|10|||
105391481|NCT01767857|363442118|FG000|Overall Study|Protocol Terminated|1|||
105391482|NCT01767857|363442119|FG001|Overall Study|Protocol Terminated|0|||
105391483|NCT01767857|363442118|FG000|Overall Study|Randomized But Never Treated|19|||
105391484|NCT01767857|363442119|FG001|Overall Study|Randomized But Never Treated|13|||
105391485|NCT01813357|363442122|FG000|Overall Study|Lost to Follow-up|5|||
105391486|NCT01813357|363442123|FG001|Overall Study|Lost to Follow-up|6|||
105391487|NCT02298946|363442124|FG000|Overall Study|Did not receive treatment|2|||
105391488|NCT02298946|363442125|FG001|Overall Study|Did not receive treatment|0|||
105391489|NCT02298946|363442124|FG000|Overall Study|Unevaluable|2|||
105391490|NCT02298946|363442125|FG001|Overall Study|Unevaluable|1|||
105391491|NCT02412436|363442127|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
105391492|NCT02412436|363442127|FG000|Overall Study|Lost to Follow-up|6|||
105391493|NCT02412436|363442127|FG000|Overall Study|Unable to get to clinic|3|||
105391494|NCT02412436|363442127|FG000|Overall Study|Death|1|||
105391495|NCT02412436|363442127|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
105391496|NCT04650893|363442128|FG000|Overall Study|Lost to Follow-up|11|||
105391497|NCT04650893|363442129|FG001|Overall Study|Lost to Follow-up|10|||
105391498|NCT04650893|363442130|FG002|Overall Study|Lost to Follow-up|11|||
105391499|NCT00913835|363442134|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
105391500|NCT00913835|363442135|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
105391501|NCT00913835|363442134|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
105391502|NCT00913835|363442135|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
105391503|NCT00913835|363442134|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
105391504|NCT00913835|363442135|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
105391505|NCT00913835|363442134|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
105391506|NCT00913835|363442135|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
105391507|NCT00913835|363442134|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
105391508|NCT00913835|363442135|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
105391509|NCT00773461|363442136|FG000|Overall Study|Adverse Event|1|||
105391510|NCT00773461|363442137|FG001|Overall Study|Adverse Event|3|||
105391511|NCT00773461|363442136|FG000|Overall Study|Withdrawal by Subject|4|||
105391512|NCT00773461|363442137|FG001|Overall Study|Withdrawal by Subject|1|||
105391513|NCT05487378|363442138|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
105391514|NCT05487378|363442139|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
105391515|NCT05487378|363442138|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
105391516|NCT05487378|363442139|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
105391517|NCT03249558|363442142|FG000|Overall Study|Lost to Follow-up|2|||
105391518|NCT03249558|363442143|FG001|Overall Study|Lost to Follow-up|1|||
105391519|NCT03249558|363442144|FG002|Overall Study|Lost to Follow-up|4|||
105391520|NCT03249558|363442142|FG000|Overall Study|Physician Decision|1|||
105391521|NCT03249558|363442143|FG001|Overall Study|Physician Decision|0|||
105391522|NCT03249558|363442144|FG002|Overall Study|Physician Decision|0|||
105391523|NCT03249558|363442142|FG000|Overall Study|Withdrawal by Subject|6|||
105391524|NCT03249558|363442143|FG001|Overall Study|Withdrawal by Subject|5|||
105391525|NCT03249558|363442144|FG002|Overall Study|Withdrawal by Subject|7|||
105391526|NCT03249558|363442142|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
105391527|NCT03249558|363442143|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
105391528|NCT03249558|363442144|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
105391529|NCT03249558|363442142|FG000|Overall Study|Protocol Violation|1|||
105391530|NCT03249558|363442143|FG001|Overall Study|Protocol Violation|1|||
105391531|NCT03249558|363442144|FG002|Overall Study|Protocol Violation|2|||
105391532|NCT02520154|363442145|FG000|Overall Study|Death|1|||
105391533|NCT02520154|363442145|FG000|Overall Study|Withdrawal by Subject|2|||
105391534|NCT02520154|363442145|FG000|Overall Study|Physician Decision|2|||
105391535|NCT03648372|363442146|FG000|Overall Study|Withdrawal by Subject|2|||
105391536|NCT03648372|363442147|FG001|Overall Study|Withdrawal by Subject|0|||
105391537|NCT03648372|363442148|FG002|Overall Study|Withdrawal by Subject|0|||
105391538|NCT03648372|363442149|FG003|Overall Study|Withdrawal by Subject|0|||
105391539|NCT03648372|363442150|FG004|Overall Study|Withdrawal by Subject|0|||
105391540|NCT03648372|363442151|FG005|Overall Study|Withdrawal by Subject|1|||
105391541|NCT03648372|363442152|FG006|Overall Study|Withdrawal by Subject|2|||
105391542|NCT03648372|363442153|FG007|Overall Study|Withdrawal by Subject|0|||
105391543|NCT03648372|363442154|FG008|Overall Study|Withdrawal by Subject|0|||
105493081|NCT00195273|363818765|FG001|Overall Study|Protocol deviation|1|||
105391544|NCT03648372|363442155|FG009|Overall Study|Withdrawal by Subject|0|||
105391545|NCT03648372|363442156|FG010|Overall Study|Withdrawal by Subject|2|||
105391546|NCT03648372|363442157|FG011|Overall Study|Withdrawal by Subject|0|||
105391547|NCT03648372|363442158|FG012|Overall Study|Withdrawal by Subject|2|||
105391548|NCT03648372|363442159|FG013|Overall Study|Withdrawal by Subject|0|||
105391549|NCT03648372|363442160|FG014|Overall Study|Withdrawal by Subject|0|||
105391550|NCT03648372|363442161|FG015|Overall Study|Withdrawal by Subject|0|||
105391551|NCT03648372|363442162|FG016|Overall Study|Withdrawal by Subject|1|||
105391552|NCT03648372|363442163|FG017|Overall Study|Withdrawal by Subject|0|||
105391553|NCT03648372|363442164|FG018|Overall Study|Withdrawal by Subject|0|||
105493082|NCT00195273|363818764|FG000|Overall Study|Lack of Efficacy|3|||
105493083|NCT00195273|363818765|FG001|Overall Study|Lack of Efficacy|1|||
105493084|NCT00195273|363818764|FG000|Overall Study|Procedural complications|9|||
105493085|NCT00195273|363818765|FG001|Overall Study|Procedural complications|3|||
105493086|NCT01680965|363818766|FG000|Overall Study|Death|0|||
105391554|NCT03648372|363442165|FG019|Overall Study|Withdrawal by Subject|0|||
105391555|NCT03648372|363442166|FG020|Overall Study|Withdrawal by Subject|0|||
105391556|NCT03648372|363442146|FG000|Overall Study|Progressive Disease|2|||
105391557|NCT03648372|363442147|FG001|Overall Study|Progressive Disease|3|||
105391558|NCT03648372|363442148|FG002|Overall Study|Progressive Disease|4|||
105391559|NCT03648372|363442149|FG003|Overall Study|Progressive Disease|3|||
105391560|NCT03648372|363442150|FG004|Overall Study|Progressive Disease|2|||
105391561|NCT03648372|363442151|FG005|Overall Study|Progressive Disease|2|||
105391562|NCT03648372|363442152|FG006|Overall Study|Progressive Disease|3|||
105391563|NCT03648372|363442153|FG007|Overall Study|Progressive Disease|3|||
105391564|NCT03648372|363442154|FG008|Overall Study|Progressive Disease|5|||
105391565|NCT03648372|363442155|FG009|Overall Study|Progressive Disease|5|||
105391566|NCT03648372|363442156|FG010|Overall Study|Progressive Disease|2|||
105391567|NCT03648372|363442157|FG011|Overall Study|Progressive Disease|3|||
105391568|NCT03648372|363442158|FG012|Overall Study|Progressive Disease|3|||
105391569|NCT03648372|363442159|FG013|Overall Study|Progressive Disease|3|||
105391570|NCT03648372|363442160|FG014|Overall Study|Progressive Disease|6|||
105391571|NCT03648372|363442161|FG015|Overall Study|Progressive Disease|0|||
105391572|NCT03648372|363442162|FG016|Overall Study|Progressive Disease|0|||
105391573|NCT03648372|363442163|FG017|Overall Study|Progressive Disease|0|||
105391574|NCT03648372|363442164|FG018|Overall Study|Progressive Disease|0|||
105391575|NCT03648372|363442165|FG019|Overall Study|Progressive Disease|0|||
105391576|NCT03648372|363442166|FG020|Overall Study|Progressive Disease|0|||
105391577|NCT03648372|363442146|FG000|Overall Study|Other|0|||
105391578|NCT03648372|363442147|FG001|Overall Study|Other|0|||
105391579|NCT03648372|363442148|FG002|Overall Study|Other|0|||
105391580|NCT03648372|363442149|FG003|Overall Study|Other|0|||
105391581|NCT03648372|363442150|FG004|Overall Study|Other|1|||
105391582|NCT03648372|363442151|FG005|Overall Study|Other|0|||
105391583|NCT03648372|363442152|FG006|Overall Study|Other|0|||
105391584|NCT03648372|363442153|FG007|Overall Study|Other|0|||
105391585|NCT03648372|363442154|FG008|Overall Study|Other|0|||
105391586|NCT03648372|363442155|FG009|Overall Study|Other|0|||
105391587|NCT03648372|363442156|FG010|Overall Study|Other|1|||
105391588|NCT03648372|363442157|FG011|Overall Study|Other|2|||
105391589|NCT03648372|363442158|FG012|Overall Study|Other|1|||
105391590|NCT03648372|363442159|FG013|Overall Study|Other|3|||
105391591|NCT03648372|363442160|FG014|Overall Study|Other|0|||
105391592|NCT03648372|363442161|FG015|Overall Study|Other|5|||
105391593|NCT03648372|363442162|FG016|Overall Study|Other|1|||
105391594|NCT03648372|363442163|FG017|Overall Study|Other|5|||
105391595|NCT03648372|363442164|FG018|Overall Study|Other|0|||
105391596|NCT03648372|363442165|FG019|Overall Study|Other|1|||
105391597|NCT03648372|363442166|FG020|Overall Study|Other|0|||
105391598|NCT03648372|363442146|FG000|Overall Study|Lost to Follow-up|0|||
105391599|NCT03648372|363442147|FG001|Overall Study|Lost to Follow-up|0|||
105391600|NCT03648372|363442148|FG002|Overall Study|Lost to Follow-up|0|||
105391601|NCT03648372|363442149|FG003|Overall Study|Lost to Follow-up|0|||
105391602|NCT03648372|363442150|FG004|Overall Study|Lost to Follow-up|0|||
105391603|NCT03648372|363442151|FG005|Overall Study|Lost to Follow-up|0|||
105391604|NCT03648372|363442152|FG006|Overall Study|Lost to Follow-up|0|||
105391605|NCT03648372|363442153|FG007|Overall Study|Lost to Follow-up|0|||
105391606|NCT03648372|363442154|FG008|Overall Study|Lost to Follow-up|0|||
105391607|NCT03648372|363442155|FG009|Overall Study|Lost to Follow-up|0|||
105391608|NCT03648372|363442156|FG010|Overall Study|Lost to Follow-up|0|||
105391609|NCT03648372|363442157|FG011|Overall Study|Lost to Follow-up|0|||
105391610|NCT03648372|363442158|FG012|Overall Study|Lost to Follow-up|0|||
105391611|NCT03648372|363442159|FG013|Overall Study|Lost to Follow-up|1|||
105391612|NCT03648372|363442160|FG014|Overall Study|Lost to Follow-up|0|||
105391613|NCT03648372|363442161|FG015|Overall Study|Lost to Follow-up|1|||
105391614|NCT03648372|363442162|FG016|Overall Study|Lost to Follow-up|0|||
105391615|NCT03648372|363442163|FG017|Overall Study|Lost to Follow-up|1|||
105391616|NCT03648372|363442164|FG018|Overall Study|Lost to Follow-up|0|||
105391617|NCT03648372|363442165|FG019|Overall Study|Lost to Follow-up|0|||
105391618|NCT03648372|363442166|FG020|Overall Study|Lost to Follow-up|0|||
105493087|NCT01680965|363818767|FG001|Overall Study|Death|0|||
105391619|NCT03648372|363442146|FG000|Overall Study|Start of a New Systemic Treatment|0|||
105391620|NCT03648372|363442147|FG001|Overall Study|Start of a New Systemic Treatment|0|||
105391621|NCT03648372|363442148|FG002|Overall Study|Start of a New Systemic Treatment|0|||
105391622|NCT03648372|363442149|FG003|Overall Study|Start of a New Systemic Treatment|0|||
105391623|NCT03648372|363442150|FG004|Overall Study|Start of a New Systemic Treatment|0|||
105391624|NCT03648372|363442151|FG005|Overall Study|Start of a New Systemic Treatment|0|||
105391625|NCT03648372|363442152|FG006|Overall Study|Start of a New Systemic Treatment|0|||
105391626|NCT03648372|363442153|FG007|Overall Study|Start of a New Systemic Treatment|2|||
105391627|NCT03648372|363442154|FG008|Overall Study|Start of a New Systemic Treatment|0|||
105391628|NCT03648372|363442155|FG009|Overall Study|Start of a New Systemic Treatment|0|||
105391629|NCT03648372|363442156|FG010|Overall Study|Start of a New Systemic Treatment|1|||
105391630|NCT03648372|363442157|FG011|Overall Study|Start of a New Systemic Treatment|0|||
105391631|NCT03648372|363442158|FG012|Overall Study|Start of a New Systemic Treatment|0|||
105391632|NCT03648372|363442159|FG013|Overall Study|Start of a New Systemic Treatment|0|||
105493088|NCT01680965|363818768|FG002|Overall Study|Death|0|||
105391633|NCT03648372|363442160|FG014|Overall Study|Start of a New Systemic Treatment|0|||
105391634|NCT03648372|363442161|FG015|Overall Study|Start of a New Systemic Treatment|0|||
105391635|NCT03648372|363442162|FG016|Overall Study|Start of a New Systemic Treatment|0|||
105391636|NCT03648372|363442163|FG017|Overall Study|Start of a New Systemic Treatment|0|||
105391637|NCT03648372|363442164|FG018|Overall Study|Start of a New Systemic Treatment|0|||
105391638|NCT03648372|363442165|FG019|Overall Study|Start of a New Systemic Treatment|0|||
105391639|NCT03648372|363442166|FG020|Overall Study|Start of a New Systemic Treatment|0|||
105391640|NCT04191135|363442167|FG000|Induction Treatment|Not Treated|2|||
105391641|NCT04191135|363442168|FG001|Induction Treatment|Not Treated|0|||
105391642|NCT04191135|363442169|FG002|Induction Treatment|Not Treated|0|||
105391643|NCT04191135|363442167|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
105391644|NCT04191135|363442168|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
105391645|NCT04191135|363442169|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
105391646|NCT04191135|363442167|FG000|Induction Treatment|Adverse Event|25|||
105391647|NCT04191135|363442168|FG001|Induction Treatment|Adverse Event|0|||
105391648|NCT04191135|363442169|FG002|Induction Treatment|Adverse Event|0|||
105391649|NCT04191135|363442167|FG000|Induction Treatment|Clinical Progression|8|||
105391650|NCT04191135|363442168|FG001|Induction Treatment|Clinical Progression|0|||
105391651|NCT04191135|363442169|FG002|Induction Treatment|Clinical Progression|0|||
105391652|NCT04191135|363442167|FG000|Induction Treatment|Excluded Medication|1|||
105391653|NCT04191135|363442168|FG001|Induction Treatment|Excluded Medication|0|||
105391654|NCT04191135|363442169|FG002|Induction Treatment|Excluded Medication|0|||
105391655|NCT04191135|363442167|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
105391656|NCT04191135|363442168|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
105391657|NCT04191135|363442169|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
105391658|NCT04191135|363442167|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
105391659|NCT04191135|363442168|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
105391660|NCT04191135|363442169|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
105391661|NCT04191135|363442167|FG000|Induction Treatment|Physician Decision|2|||
105391662|NCT04191135|363442168|FG001|Induction Treatment|Physician Decision|0|||
105391663|NCT04191135|363442169|FG002|Induction Treatment|Physician Decision|0|||
105391664|NCT04191135|363442167|FG000|Induction Treatment|Progressive Disease|135|||
105391665|NCT04191135|363442168|FG001|Induction Treatment|Progressive Disease|0|||
105391666|NCT04191135|363442169|FG002|Induction Treatment|Progressive Disease|0|||
105391667|NCT04191135|363442167|FG000|Induction Treatment|Protocol Violation|10|||
105391668|NCT04191135|363442168|FG001|Induction Treatment|Protocol Violation|0|||
105391669|NCT04191135|363442169|FG002|Induction Treatment|Protocol Violation|0|||
105391670|NCT04191135|363442167|FG000|Induction Treatment|Withdrawal by Subject|4|||
105391671|NCT04191135|363442168|FG001|Induction Treatment|Withdrawal by Subject|0|||
105391672|NCT04191135|363442169|FG002|Induction Treatment|Withdrawal by Subject|0|||
105391673|NCT04191135|363442167|FG000|Randomized Treatment|Death|0|||
105391674|NCT04191135|363442168|FG001|Randomized Treatment|Death|50|||
105391675|NCT04191135|363442169|FG002|Randomized Treatment|Death|54|||
105391676|NCT04191135|363442167|FG000|Randomized Treatment|Lost to Follow-up|0|||
105391677|NCT04191135|363442168|FG001|Randomized Treatment|Lost to Follow-up|0|||
105391678|NCT04191135|363442169|FG002|Randomized Treatment|Lost to Follow-up|1|||
105391679|NCT04191135|363442167|FG000|Randomized Treatment|Withdrawal by Subject|0|||
105391680|NCT04191135|363442168|FG001|Randomized Treatment|Withdrawal by Subject|2|||
105391681|NCT04191135|363442169|FG002|Randomized Treatment|Withdrawal by Subject|0|||
105391682|NCT04191135|363442167|FG000|Randomized Treatment|Ongoing in Trial|0|||
105391683|NCT04191135|363442168|FG001|Randomized Treatment|Ongoing in Trial|83|||
105391684|NCT04191135|363442169|FG002|Randomized Treatment|Ongoing in Trial|81|||
105391685|NCT03058952|363443355|FG000|Overall Study|Adverse Event|1|||
105391686|NCT03058952|363443356|FG001|Overall Study|Adverse Event|0|||
105391687|NCT03058952|363443355|FG000|Overall Study|Lost to Follow-up|15|||
105391688|NCT03058952|363443356|FG001|Overall Study|Lost to Follow-up|15|||
105391689|NCT03058952|363443355|FG000|Overall Study|Withdrawal by Subject|7|||
105391690|NCT03058952|363443356|FG001|Overall Study|Withdrawal by Subject|11|||
105391691|NCT02363283|363443357|FG000|Overall Study|Withdrawal by Subject|1|||
105391692|NCT02363283|363443357|FG000|Overall Study|Not eligible due to transaminitis|1|||
105391693|NCT02904265|363443359|FG000|Overall Study|Physician Decision|1|||
105391694|NCT02904265|363443360|FG001|Overall Study|Physician Decision|2|||
105391695|NCT02579759|363443363|FG000|Overall Study|Protocol Violation|2|||
105391696|NCT02579759|363443364|FG001|Overall Study|Protocol Violation|0|||
105391697|NCT02579759|363443365|FG002|Overall Study|Protocol Violation|0|||
105391698|NCT02579759|363443363|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
105391699|NCT02579759|363443364|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
105391700|NCT02579759|363443365|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
105391701|NCT02579759|363443363|FG000|Overall Study|BfArM hold|13|||
105391702|NCT02579759|363443364|FG001|Overall Study|BfArM hold|12|||
105391703|NCT02579759|363443365|FG002|Overall Study|BfArM hold|12|||
105391704|NCT02579759|363443363|FG000|Overall Study|Sponsor stopped Dose 2|0|||
105391705|NCT02579759|363443364|FG001|Overall Study|Sponsor stopped Dose 2|41|||
105391706|NCT02579759|363443365|FG002|Overall Study|Sponsor stopped Dose 2|0|||
105391707|NCT02579759|363443363|FG000|Overall Study|Non compliance|0|||
105391708|NCT02579759|363443364|FG001|Overall Study|Non compliance|1|||
105391709|NCT02579759|363443365|FG002|Overall Study|Non compliance|0|||
105391710|NCT02579759|363443363|FG000|Overall Study|Pregnancy|0|||
105391711|NCT02579759|363443364|FG001|Overall Study|Pregnancy|1|||
105391712|NCT02579759|363443365|FG002|Overall Study|Pregnancy|0|||
105391713|NCT02579759|363443363|FG000|Overall Study|Inclusion/exclusion criteria|0|||
105391714|NCT02579759|363443364|FG001|Overall Study|Inclusion/exclusion criteria|0|||
105493089|NCT01680965|363818769|FG003|Overall Study|Death|6|||
105493090|NCT00595465|363818770|FG000|Overall Study|Adverse Event|4|||
105391715|NCT02579759|363443365|FG002|Overall Study|Inclusion/exclusion criteria|1|||
105493091|NCT00595465|363818771|FG001|Overall Study|Adverse Event|3|||
105391716|NCT02579759|363443363|FG000|Overall Study|Adverse Event|4|||
105391717|NCT02579759|363443364|FG001|Overall Study|Adverse Event|3|||
105391718|NCT02579759|363443365|FG002|Overall Study|Adverse Event|1|||
105391719|NCT02579759|363443363|FG000|Overall Study|Withdrawal by Subject|3|||
105391720|NCT02579759|363443364|FG001|Overall Study|Withdrawal by Subject|3|||
105391721|NCT02579759|363443365|FG002|Overall Study|Withdrawal by Subject|5|||
105391722|NCT02579759|363443363|FG000|Overall Study|Lost to Follow-up|2|||
105391723|NCT02579759|363443364|FG001|Overall Study|Lost to Follow-up|2|||
105391724|NCT02579759|363443365|FG002|Overall Study|Lost to Follow-up|2|||
105391725|NCT01557569|363443367|FG000|Overall Study|Adverse Event|2|||
105391726|NCT01557569|363443368|FG001|Overall Study|Adverse Event|0|||
105391727|NCT01557569|363443367|FG000|Overall Study|high blood pressure|0|||
105391728|NCT01557569|363443368|FG001|Overall Study|high blood pressure|1|||
105391729|NCT01557569|363443367|FG000|Overall Study|Withdrawal by Subject|3|||
105391730|NCT01557569|363443368|FG001|Overall Study|Withdrawal by Subject|5|||
105391731|NCT01557569|363443367|FG000|Overall Study|noncompliance with rules of residential|0|||
105391732|NCT01557569|363443368|FG001|Overall Study|noncompliance with rules of residential|1|||
105391733|NCT01149460|363443369|FG000|Overall Study|Withdrawal by Subject|0|||
105391734|NCT01149460|363443370|FG001|Overall Study|Withdrawal by Subject|2|||
105391735|NCT01356940|363443371|FG000|First Intervention (28 Days)|Adverse Event|1|||
105391736|NCT01356940|363443372|FG001|First Intervention (28 Days)|Adverse Event|0|||
105391737|NCT01356940|363443371|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
105391738|NCT01356940|363443372|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
105391739|NCT01537432|363443373|FG000|Overall Study|Lost to Follow-up|3|||
105391740|NCT01537432|363443374|FG001|Overall Study|Lost to Follow-up|1|||
105391741|NCT01537432|363443373|FG000|Overall Study|Withdrawal by Subject|0|||
105391742|NCT01537432|363443374|FG001|Overall Study|Withdrawal by Subject|1|||
105391743|NCT01537432|363443373|FG000|Overall Study|Administrative problems|1|||
105391744|NCT01537432|363443374|FG001|Overall Study|Administrative problems|0|||
105391745|NCT01537432|363443373|FG000|Overall Study|Adverse Event|1|||
105391746|NCT01537432|363443374|FG001|Overall Study|Adverse Event|0|||
105391747|NCT01537432|363443373|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105391748|NCT01537432|363443374|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105391749|NCT03682367|363443377|FG000|Overall Study|Protocol Violation|2|||
105391750|NCT03682367|363443378|FG001|Overall Study|Protocol Violation|1|||
105391751|NCT03682367|363443377|FG000|Overall Study|Closed Study Early|0|||
105391752|NCT03682367|363443378|FG001|Overall Study|Closed Study Early|3|||
105391753|NCT01378195|363443380|FG000|Overall Study|Lost to Follow-up|29|||
105391754|NCT01378195|363443381|FG001|Overall Study|Lost to Follow-up|18|||
105391755|NCT01047540|363443385|FG000|Overall Study|Protocol Violation|1|||
105391756|NCT01047540|363443386|FG001|Overall Study|Protocol Violation|0|||
105391757|NCT01047540|363443387|FG002|Overall Study|Protocol Violation|0|||
105391758|NCT01047540|363443388|FG003|Overall Study|Protocol Violation|0|||
105391759|NCT01047540|363443389|FG004|Overall Study|Protocol Violation|0|||
105391760|NCT01047540|363443385|FG000|Overall Study|Lost to Follow-up|1|||
105391761|NCT01047540|363443386|FG001|Overall Study|Lost to Follow-up|0|||
105391762|NCT01047540|363443387|FG002|Overall Study|Lost to Follow-up|0|||
105391763|NCT01047540|363443388|FG003|Overall Study|Lost to Follow-up|0|||
105391764|NCT01047540|363443389|FG004|Overall Study|Lost to Follow-up|0|||
105391765|NCT01047540|363443385|FG000|Overall Study|Withdrawal by Subject|1|||
105391766|NCT01047540|363443386|FG001|Overall Study|Withdrawal by Subject|0|||
105391767|NCT01047540|363443387|FG002|Overall Study|Withdrawal by Subject|3|||
105391768|NCT01047540|363443388|FG003|Overall Study|Withdrawal by Subject|0|||
105391769|NCT01047540|363443389|FG004|Overall Study|Withdrawal by Subject|1|||
105391770|NCT01047540|363443385|FG000|Overall Study|Pregnancy|1|||
105391771|NCT01047540|363443386|FG001|Overall Study|Pregnancy|0|||
105391772|NCT01047540|363443387|FG002|Overall Study|Pregnancy|0|||
105391773|NCT01047540|363443388|FG003|Overall Study|Pregnancy|0|||
105391774|NCT01047540|363443389|FG004|Overall Study|Pregnancy|0|||
105391775|NCT01047540|363443385|FG000|Overall Study|Adverse Event|1|||
105391776|NCT01047540|363443386|FG001|Overall Study|Adverse Event|0|||
105391777|NCT01047540|363443387|FG002|Overall Study|Adverse Event|0|||
105391778|NCT01047540|363443388|FG003|Overall Study|Adverse Event|0|||
105391779|NCT01047540|363443389|FG004|Overall Study|Adverse Event|0|||
105493092|NCT00595465|363818772|FG002|Overall Study|Adverse Event|3|||
105391780|NCT01916226|363443390|FG000|Overall Study|Adverse Event|1|||
105391781|NCT01916226|363443391|FG001|Overall Study|Adverse Event|0|||
105391782|NCT01916226|363443392|FG002|Overall Study|Adverse Event|1|||
105391783|NCT01916226|363443393|FG003|Overall Study|Adverse Event|1|||
105391784|NCT01916226|363443390|FG000|Overall Study|Lack of Efficacy|0|||
105391785|NCT01916226|363443391|FG001|Overall Study|Lack of Efficacy|0|||
105391786|NCT01916226|363443392|FG002|Overall Study|Lack of Efficacy|2|||
105391787|NCT01916226|363443393|FG003|Overall Study|Lack of Efficacy|1|||
105391788|NCT01916226|363443390|FG000|Overall Study|Protocol Violation|0|||
105391789|NCT01916226|363443391|FG001|Overall Study|Protocol Violation|1|||
105391790|NCT01916226|363443392|FG002|Overall Study|Protocol Violation|0|||
105391791|NCT01916226|363443393|FG003|Overall Study|Protocol Violation|1|||
105493093|NCT00595465|363818770|FG000|Overall Study|Pregnancy|0|||
105391792|NCT01916226|363443390|FG000|Overall Study|Physician Decision|0|||
105391793|NCT01916226|363443391|FG001|Overall Study|Physician Decision|0|||
105391794|NCT01916226|363443392|FG002|Overall Study|Physician Decision|0|||
105391795|NCT01916226|363443393|FG003|Overall Study|Physician Decision|1|||
105391796|NCT03163667|363443398|FG000|Overall Study|Death|15|||
105391797|NCT03163667|363443399|FG001|Overall Study|Death|27|||
105391798|NCT03163667|363443398|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
105391799|NCT03163667|363443399|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
105391800|NCT02971163|363443405|FG000|Overall Study|Lost to Follow-up|4|||
105391801|NCT02971163|363443406|FG001|Overall Study|Lost to Follow-up|2|||
105493094|NCT00595465|363818771|FG001|Overall Study|Pregnancy|0|||
105493095|NCT00595465|363818772|FG002|Overall Study|Pregnancy|1|||
105493096|NCT00595465|363818770|FG000|Overall Study|Protocol Violation|2|||
105391802|NCT00855166|363443407|FG000|Overall Study|Adverse Event|0|||
105493097|NCT00595465|363818771|FG001|Overall Study|Protocol Violation|1|||
105493098|NCT00595465|363818772|FG002|Overall Study|Protocol Violation|0|||
105391803|NCT00855166|363443408|FG001|Overall Study|Adverse Event|2|||
105391804|NCT00855166|363443407|FG000|Overall Study|Death|0|||
105391805|NCT00855166|363443408|FG001|Overall Study|Death|1|||
105391806|NCT00855166|363443407|FG000|Overall Study|Withdrawal by Subject|1|||
105391807|NCT00855166|363443408|FG001|Overall Study|Withdrawal by Subject|4|||
105391808|NCT00855166|363443407|FG000|Overall Study|Poor/non-compliance|2|||
105391809|NCT00855166|363443408|FG001|Overall Study|Poor/non-compliance|0|||
105391810|NCT00855166|363443407|FG000|Overall Study|Administrative reasons by sponsor|1|||
105391811|NCT00855166|363443408|FG001|Overall Study|Administrative reasons by sponsor|0|||
105391812|NCT00855166|363443407|FG000|Overall Study|Subject no longer meets study criteria|1|||
105391813|NCT00855166|363443408|FG001|Overall Study|Subject no longer meets study criteria|1|||
105391814|NCT00539500|363443409|FG000|Overall Study|Disease Progression|1|||
105391815|NCT00539500|363443409|FG000|Overall Study|Lost to Follow-up|2|||
105391816|NCT04126174|363443412|FG000|Overall Study|Lost to Follow-up|3|||
105391817|NCT04126174|363443413|FG001|Overall Study|Lost to Follow-up|3|||
105391818|NCT03773562|363443414|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
105391819|NCT03773562|363443414|FG000|Overall Study|Lost to Follow-up|10|||
105391820|NCT03773562|363443414|FG000|Overall Study|Withdrawal by Subject|1|||
105391821|NCT03131479|363443415|FG000|Overall Study|Adverse Event|0|||
105391822|NCT03131479|363443416|FG001|Overall Study|Adverse Event|0|||
105391823|NCT03131479|363443417|FG002|Overall Study|Adverse Event|1|||
105391824|NCT03131479|363443418|FG003|Overall Study|Adverse Event|1|||
105391825|NCT03131479|363443419|FG004|Overall Study|Adverse Event|0|||
105391826|NCT03131479|363443415|FG000|Overall Study|Subject/Guardian Decision|0|||
105391827|NCT03131479|363443416|FG001|Overall Study|Subject/Guardian Decision|0|||
105391828|NCT03131479|363443417|FG002|Overall Study|Subject/Guardian Decision|0|||
105391829|NCT03131479|363443418|FG003|Overall Study|Subject/Guardian Decision|1|||
105391830|NCT03131479|363443419|FG004|Overall Study|Subject/Guardian Decision|0|||
105391831|NCT05305651|363443420|FG000|Overall Study|Death|1|||
105391832|NCT05305651|363443420|FG000|Overall Study|Withdrawal by Subject|4|||
105391833|NCT05305651|363443420|FG000|Overall Study|Lost to Follow-up|4|||
105391834|NCT01979185|363443421|FG000|Period 2|Other|0|||
105391835|NCT01979185|363443422|FG001|Period 2|Other|1|||
105391836|NCT02231580|363443423|FG000|Overall Study|Adverse Event|5|||
105391837|NCT02231580|363443424|FG001|Overall Study|Adverse Event|0|||
105391838|NCT04221438|363443425|FG000|Overall Study|Adverse Event|1|||
105391839|NCT04221438|363443425|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
105391840|NCT03620981|363443426|FG000|Overall Study|Adverse Event|14|||
105391841|NCT03620981|363443427|FG001|Overall Study|Adverse Event|38|||
105391842|NCT03620981|363443428|FG002|Overall Study|Adverse Event|25|||
105391843|NCT03620981|363443426|FG000|Overall Study|Lack of Efficacy|2|||
105391844|NCT03620981|363443427|FG001|Overall Study|Lack of Efficacy|1|||
105391845|NCT03620981|363443428|FG002|Overall Study|Lack of Efficacy|1|||
105391846|NCT03620981|363443426|FG000|Overall Study|Physician Decision|7|||
105391847|NCT03620981|363443427|FG001|Overall Study|Physician Decision|4|||
105391848|NCT03620981|363443428|FG002|Overall Study|Physician Decision|4|||
105391849|NCT03620981|363443426|FG000|Overall Study|Protocol Violation|1|||
105391850|NCT03620981|363443427|FG001|Overall Study|Protocol Violation|2|||
105391851|NCT03620981|363443428|FG002|Overall Study|Protocol Violation|1|||
105391852|NCT03620981|363443426|FG000|Overall Study|Withdrawal by Legal Representative|2|||
105391853|NCT03620981|363443427|FG001|Overall Study|Withdrawal by Legal Representative|1|||
105391854|NCT03620981|363443428|FG002|Overall Study|Withdrawal by Legal Representative|1|||
105391855|NCT03620981|363443426|FG000|Overall Study|Withdrawal by Care Giver|2|||
105391856|NCT03620981|363443427|FG001|Overall Study|Withdrawal by Care Giver|0|||
105391857|NCT03620981|363443428|FG002|Overall Study|Withdrawal by Care Giver|1|||
105391858|NCT03620981|363443426|FG000|Overall Study|Non-compliance with Study Drug|1|||
105391859|NCT03620981|363443427|FG001|Overall Study|Non-compliance with Study Drug|1|||
105391860|NCT03620981|363443428|FG002|Overall Study|Non-compliance with Study Drug|0|||
105391861|NCT04082364|363443430|FG000|Overall Study|Death|23|||
105391862|NCT04082364|363443431|FG001|Overall Study|Death|1|||
105391863|NCT04082364|363443432|FG002|Overall Study|Death|1|||
105391864|NCT04082364|363443433|FG003|Overall Study|Death|2|||
105391865|NCT04082364|363443434|FG004|Overall Study|Death|1|||
105391866|NCT04082364|363443430|FG000|Overall Study|Lost to Follow-up|1|||
105391867|NCT04082364|363443431|FG001|Overall Study|Lost to Follow-up|0|||
105391868|NCT04082364|363443432|FG002|Overall Study|Lost to Follow-up|0|||
105391869|NCT04082364|363443433|FG003|Overall Study|Lost to Follow-up|0|||
105391870|NCT04082364|363443434|FG004|Overall Study|Lost to Follow-up|1|||
105391871|NCT04082364|363443430|FG000|Overall Study|Physician Decision|1|||
105391872|NCT04082364|363443431|FG001|Overall Study|Physician Decision|1|||
105391873|NCT04082364|363443432|FG002|Overall Study|Physician Decision|0|||
105391874|NCT04082364|363443433|FG003|Overall Study|Physician Decision|2|||
105391875|NCT04082364|363443434|FG004|Overall Study|Physician Decision|1|||
105391876|NCT04082364|363443430|FG000|Overall Study|Withdrawal by Subject|1|||
105391877|NCT04082364|363443431|FG001|Overall Study|Withdrawal by Subject|1|||
105391878|NCT04082364|363443432|FG002|Overall Study|Withdrawal by Subject|0|||
105391879|NCT04082364|363443433|FG003|Overall Study|Withdrawal by Subject|0|||
105391880|NCT04082364|363443434|FG004|Overall Study|Withdrawal by Subject|1|||
105391881|NCT04082364|363443430|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
105391882|NCT04082364|363443431|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
105391883|NCT04082364|363443432|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
105391884|NCT04082364|363443433|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
105391885|NCT04082364|363443434|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
105391886|NCT04082364|363443430|FG000|Overall Study|Disease progression|0|||
105391887|NCT04082364|363443431|FG001|Overall Study|Disease progression|0|||
105391888|NCT04082364|363443432|FG002|Overall Study|Disease progression|0|||
105391889|NCT04082364|363443433|FG003|Overall Study|Disease progression|1|||
105391890|NCT04082364|363443434|FG004|Overall Study|Disease progression|0|||
105391891|NCT03934684|363443436|FG000|Overall Study|Participants continuing in study|11|||
105391892|NCT03934684|363443437|FG001|Overall Study|Participants continuing in study|4|||
105391893|NCT03934684|363443436|FG000|Overall Study|Discontinuation of carfilzomib|20|||
105391894|NCT03934684|363443437|FG001|Overall Study|Discontinuation of carfilzomib|30|||
105391895|NCT03934684|363443436|FG000|Overall Study|Death|2|||
105391896|NCT03934684|363443437|FG001|Overall Study|Death|2|||
105391897|NCT03934684|363443436|FG000|Overall Study|Lost to Follow-up|2|||
105391898|NCT03934684|363443437|FG001|Overall Study|Lost to Follow-up|5|||
105391899|NCT03934684|363443436|FG000|Overall Study|Withdrawal by Subject|7|||
105391900|NCT03934684|363443437|FG001|Overall Study|Withdrawal by Subject|8|||
105391901|NCT03633058|363443440|FG000|Overall Study|Adverse Event|0|||
105391902|NCT03633058|363443441|FG001|Overall Study|Adverse Event|0|||
105391903|NCT03633058|363443442|FG002|Overall Study|Adverse Event|1|||
105391904|NCT03633058|363443443|FG003|Overall Study|Adverse Event|0|||
105391905|NCT03034044|363443444|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
105391906|NCT04134936|363443445|FG000|Overall Study|Adverse Event|3|||
105391907|NCT04134936|363443446|FG001|Overall Study|Adverse Event|2|||
105391908|NCT04134936|363443445|FG000|Overall Study|Withdrawal by Subject|2|||
105391909|NCT04134936|363443446|FG001|Overall Study|Withdrawal by Subject|3|||
105391910|NCT04134936|363443445|FG000|Overall Study|Physician Decision|0|||
105391911|NCT04134936|363443446|FG001|Overall Study|Physician Decision|1|||
105391912|NCT04134936|363443445|FG000|Overall Study|Progressive disease, joined another trial|1|||
105391913|NCT04134936|363443446|FG001|Overall Study|Progressive disease, joined another trial|0|||
105391914|NCT04134936|363443445|FG000|Overall Study|Progressive disease|1|||
105391915|NCT04134936|363443446|FG001|Overall Study|Progressive disease|0|||
105493099|NCT00595465|363818770|FG000|Overall Study|Lost to Follow-up|0|||
105493100|NCT00595465|363818771|FG001|Overall Study|Lost to Follow-up|0|||
105493101|NCT00595465|363818772|FG002|Overall Study|Lost to Follow-up|2|||
105493102|NCT00595465|363818770|FG000|Overall Study|administrative reason|0|||
105493103|NCT00595465|363818771|FG001|Overall Study|administrative reason|0|||
105493104|NCT00595465|363818772|FG002|Overall Study|administrative reason|1|||
105493105|NCT02595970|363818773|FG000|Overall Study|Withdrawal by Subject|2|||
105493106|NCT02595970|363818773|FG000|Overall Study|Physician Decision|2|||
105493107|NCT02595970|363818773|FG000|Overall Study|Protocol Violation|4|||
105493108|NCT02595970|363818773|FG000|Overall Study|Adverse Event|5|||
105391916|NCT01450631|363443450|FG000|Overall Study|Lost to Follow-up|2|||
105391917|NCT01450631|363443451|FG001|Overall Study|Lost to Follow-up|4|||
105391918|NCT01450631|363443450|FG000|Overall Study|Withdrawal by Subject|1|||
105391919|NCT01450631|363443451|FG001|Overall Study|Withdrawal by Subject|0|||
105493109|NCT02595970|363818773|FG000|Overall Study|Lack of Efficacy|7|||
105493110|NCT01886716|363818776|FG000|Week 1|Lost to Follow-up|0|||
105493111|NCT01886716|363818777|FG001|Week 1|Lost to Follow-up|0|||
105391920|NCT01903863|363443453|FG000|Overall Study|Physician Decision|2|||
105391921|NCT01903863|363443454|FG001|Overall Study|Physician Decision|0|||
105391922|NCT00323622|363443455|FG000|Overall Study|Other|30|||
105391923|NCT00323622|363443456|FG001|Overall Study|Other|91|||
105391924|NCT00323622|363443457|FG002|Overall Study|Other|4|||
105391925|NCT00323622|363443458|FG003|Overall Study|Other|12|||
105391926|NCT00323622|363443459|FG004|Overall Study|Other|32|||
105391927|NCT00323622|363443460|FG005|Overall Study|Other|74|||
105391928|NCT00323622|363443461|FG006|Overall Study|Other|5|||
105391929|NCT00323622|363443462|FG007|Overall Study|Other|13|||
105391930|NCT00323622|363443455|FG000|Overall Study|Death|1|||
105391931|NCT00323622|363443456|FG001|Overall Study|Death|1|||
105391932|NCT00323622|363443457|FG002|Overall Study|Death|0|||
105391933|NCT00323622|363443458|FG003|Overall Study|Death|0|||
105391934|NCT00323622|363443459|FG004|Overall Study|Death|7|||
105391935|NCT00323622|363443460|FG005|Overall Study|Death|0|||
105391936|NCT00323622|363443461|FG006|Overall Study|Death|0|||
105391937|NCT00323622|363443462|FG007|Overall Study|Death|2|||
105391938|NCT00835354|363443467|FG000|First Intervention|Adverse Event|0|||
105391939|NCT00835354|363443468|FG001|First Intervention|Adverse Event|1|||
105391940|NCT05021224|363443471|FG000|Overall Study|Did not complete all survey items|4|||
105391941|NCT05021224|363443472|FG001|Overall Study|Did not complete all survey items|1|||
105391942|NCT05021224|363443473|FG002|Overall Study|Did not complete all survey items|0|||
105391943|NCT05021224|363443474|FG003|Overall Study|Did not complete all survey items|2|||
105391944|NCT04551053|363443475|FG000|Overall Study|Death|9|||
105391945|NCT04551053|363443476|FG001|Overall Study|Death|9|||
105391946|NCT04551053|363443475|FG000|Overall Study|Lost to Follow-up|0|||
105391947|NCT04551053|363443476|FG001|Overall Study|Lost to Follow-up|2|||
105391948|NCT04551053|363443475|FG000|Overall Study|Study Terminated by Sponsor|53|||
105391949|NCT04551053|363443476|FG001|Overall Study|Study Terminated by Sponsor|63|||
105391950|NCT04551053|363443475|FG000|Overall Study|Withdrawal by Subject|12|||
105391951|NCT04551053|363443476|FG001|Overall Study|Withdrawal by Subject|5|||
105391952|NCT04551053|363443475|FG000|Overall Study|Adverse Event|1|||
105391953|NCT04551053|363443476|FG001|Overall Study|Adverse Event|0|||
105391954|NCT04551053|363443475|FG000|Overall Study|Lack of Efficacy|2|||
105391955|NCT04551053|363443476|FG001|Overall Study|Lack of Efficacy|0|||
105391956|NCT04551053|363443475|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
105391957|NCT04551053|363443476|FG001|Overall Study|Transitioned to Rollover per Protocol|3|||
105391958|NCT04551053|363443475|FG000|Overall Study|Splenapendectomi|1|||
105391959|NCT04551053|363443476|FG001|Overall Study|Splenapendectomi|0|||
105391960|NCT04551053|363443475|FG000|Overall Study|Cytomegalovirus pneumonia|1|||
105391961|NCT04551053|363443476|FG001|Overall Study|Cytomegalovirus pneumonia|0|||
105391962|NCT04551053|363443475|FG000|Overall Study|Medical Decision|0|||
105391963|NCT04551053|363443476|FG001|Overall Study|Medical Decision|1|||
105391964|NCT04551053|363443475|FG000|Overall Study|Ongoing|6|||
105391965|NCT04551053|363443476|FG001|Overall Study|Ongoing|4|||
105391966|NCT03204812|363443477|FG000|Overall Study|Adverse Event|3|||
105391967|NCT04116489|363443478|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
105391968|NCT04116489|363443478|FG000|Overall Study|Withdrawal by Subject|1|||
105391969|NCT00637156|363443479|FG000|Overall Study|Withdrawal by Subject|0|||
105391970|NCT00637156|363443480|FG001|Overall Study|Withdrawal by Subject|7|||
105391971|NCT00637156|363443479|FG000|Overall Study|Death|0|||
105391972|NCT00637156|363443480|FG001|Overall Study|Death|1|||
105391973|NCT00637156|363443479|FG000|Overall Study|Lost to Follow-up|10|||
105391974|NCT00637156|363443480|FG001|Overall Study|Lost to Follow-up|16|||
105391975|NCT01385995|363443481|FG000|Period 1, 2 Months|Physician Decision|1|||
105391976|NCT01385995|363443482|FG001|Period 1, 2 Months|Physician Decision|0|||
105391977|NCT00112385|363443483|FG000|Overall Study|Lost to Follow-up|1|||
105391978|NCT00112385|363443484|FG001|Overall Study|Lost to Follow-up|0|||
105391979|NCT00112385|363443483|FG000|Overall Study|Withdrawal by Subject|0|||
105391980|NCT00112385|363443484|FG001|Overall Study|Withdrawal by Subject|1|||
105493112|NCT01886716|363818778|FG002|Week 1|Lost to Follow-up|2|||
105493113|NCT01886716|363818779|FG003|Week 1|Lost to Follow-up|2|||
105391981|NCT04129398|363444780|FG000|Overall Study|Physician Decision|2|||
105391982|NCT00590317|363444783|FG000|Overall Study|Lack of Efficacy|1|||
105391983|NCT00590317|363444784|FG001|Overall Study|Lack of Efficacy|5|||
105391984|NCT02439957|363444785|FG000|Overall Study|Study Terminated|3|||
105391985|NCT02439957|363444786|FG001|Overall Study|Study Terminated|3|||
105391986|NCT02014467|363444787|FG000|Overall Study|Adverse Event|4|||
105391987|NCT02014467|363444788|FG001|Overall Study|Adverse Event|0|||
105391988|NCT02014467|363444787|FG000|Overall Study|Protocol Violation|3|||
105391989|NCT02014467|363444788|FG001|Overall Study|Protocol Violation|0|||
105391990|NCT02014467|363444787|FG000|Overall Study|Physician Decision|2|||
105391991|NCT02014467|363444788|FG001|Overall Study|Physician Decision|3|||
105391992|NCT02014467|363444787|FG000|Overall Study|Withdrawal by Subject|16|||
105391993|NCT02014467|363444788|FG001|Overall Study|Withdrawal by Subject|4|||
105391994|NCT01052779|363444790|FG000|Overall Study|Adverse Event|1|||
105391995|NCT01052779|363444791|FG001|Overall Study|Adverse Event|4|||
105391996|NCT01052779|363444790|FG000|Overall Study|Withdrawal by Subject|1|||
105391997|NCT01052779|363444791|FG001|Overall Study|Withdrawal by Subject|2|||
105391998|NCT01052779|363444790|FG000|Overall Study|Other-Protocol Violation|1|||
105391999|NCT01052779|363444791|FG001|Overall Study|Other-Protocol Violation|1|||
105392000|NCT01052779|363444790|FG000|Overall Study|Other-Surgery|0|||
105392001|NCT01052779|363444791|FG001|Overall Study|Other-Surgery|2|||
105392002|NCT01052779|363444790|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
105392003|NCT01052779|363444791|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
105392004|NCT03802916|363444792|FG000|Overall Study|Adverse Event|0|||
105392005|NCT03802916|363444793|FG001|Overall Study|Adverse Event|1|||
105392006|NCT03802916|363444792|FG000|Overall Study|Withdrawal by Subject|0|||
105392007|NCT03802916|363444793|FG001|Overall Study|Withdrawal by Subject|1|||
105392008|NCT00779909|363444794|FG000|Overall Study|Lost to Follow-up|1|||
105392009|NCT00779909|363444795|FG001|Overall Study|Lost to Follow-up|0|||
105392010|NCT00779909|363444796|FG002|Overall Study|Lost to Follow-up|0|||
105392011|NCT00779909|363444797|FG003|Overall Study|Lost to Follow-up|1|||
105392012|NCT00779909|363444794|FG000|Overall Study|Withdrawal by Subject|0|||
105392013|NCT00779909|363444795|FG001|Overall Study|Withdrawal by Subject|1|||
105392014|NCT00779909|363444796|FG002|Overall Study|Withdrawal by Subject|0|||
105392015|NCT00779909|363444797|FG003|Overall Study|Withdrawal by Subject|0|||
105392016|NCT01817777|363444798|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
105392017|NCT01817777|363444799|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
105392018|NCT01817777|363444800|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
105392019|NCT01817777|363444798|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
105392020|NCT01817777|363444799|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
105392021|NCT01817777|363444800|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
105392022|NCT01817777|363444798|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
105392023|NCT01817777|363444799|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
105392024|NCT01817777|363444800|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
105392025|NCT01817777|363444798|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
105392026|NCT01817777|363444799|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
105392027|NCT01817777|363444800|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
105392028|NCT01817777|363444798|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
105392029|NCT01817777|363444799|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
105392030|NCT01817777|363444800|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
105392031|NCT00129974|363444801|FG000|Overall Study|Other|1|||
105392032|NCT03242434|363444802|FG000|Overall Study|Death|0|||
105392033|NCT03242434|363444803|FG001|Overall Study|Death|2|||
105392034|NCT03729609|363444804|FG000|Overall Study|Protocol Violation|1|||
105392035|NCT00867334|363444805|FG000|Overall Study|Withdrawal by Subject|0|||
105392036|NCT00867334|363444806|FG001|Overall Study|Withdrawal by Subject|1|||
105392037|NCT00867334|363444805|FG000|Overall Study|Withdrawal by Subject|1|||
105392038|NCT00867334|363444806|FG001|Overall Study|Withdrawal by Subject|0|||
105392039|NCT00867334|363444805|FG000|Overall Study|Withdrawal by Subject|1|||
105392040|NCT00867334|363444806|FG001|Overall Study|Withdrawal by Subject|0|||
105392041|NCT01148771|363444809|FG000|Washout Period|Withdrawal by Subject|0|||
105392042|NCT01148771|363444810|FG001|Washout Period|Withdrawal by Subject|1|||
105392043|NCT03787615|363444811|FG000|Overall Study|Withdrawal by Subject|2|||
105392044|NCT03787615|363444811|FG000|Overall Study|Lost to Follow-up|2|||
105392045|NCT03766399|363444816|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392046|NCT03766399|363444817|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392047|NCT03766399|363444818|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392048|NCT03766399|363444819|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392049|NCT03766399|363444820|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392050|NCT03766399|363444821|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392051|NCT03766399|363444822|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392052|NCT03766399|363444823|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392053|NCT03766399|363444824|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392054|NCT03766399|363444825|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392055|NCT03766399|363444826|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392056|NCT03766399|363444827|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392057|NCT03766399|363444828|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392058|NCT03766399|363444829|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
105392059|NCT03766399|363444830|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392060|NCT03766399|363444831|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392061|NCT03766399|363444832|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392062|NCT03766399|363444833|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105392063|NCT01674062|363444838|FG000|Overall Study|Insufficient Therapeutic Response|56|||
105392064|NCT01674062|363444839|FG001|Overall Study|Insufficient Therapeutic Response|26|||
105392065|NCT01674062|363444838|FG000|Overall Study|Other|8|||
105392066|NCT01674062|363444839|FG001|Overall Study|Other|1|||
105392067|NCT01674062|363444838|FG000|Overall Study|Adverse Event|1|||
105392068|NCT01674062|363444839|FG001|Overall Study|Adverse Event|1|||
105392069|NCT01674062|363444838|FG000|Overall Study|Death|0|||
105392070|NCT01674062|363444839|FG001|Overall Study|Death|1|||
105392071|NCT01674062|363444838|FG000|Overall Study|Programming Error|1|||
105392072|NCT01674062|363444839|FG001|Overall Study|Programming Error|0|||
105392073|NCT04620668|363444840|FG000|Overall Study|Withdrawal by Subject|2|||
105392074|NCT04620668|363444841|FG001|Overall Study|Withdrawal by Subject|0|||
105392075|NCT04620668|363444840|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
105392076|NCT04620668|363444841|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
105392077|NCT04620668|363444840|FG000|Overall Study|Removed before analysis: missing data|2|||
105392078|NCT04620668|363444841|FG001|Overall Study|Removed before analysis: missing data|0|||
105392079|NCT04620668|363444840|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
105392080|NCT04620668|363444841|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
105392081|NCT04620668|363444840|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
105392082|NCT04620668|363444841|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
105392083|NCT03685149|363444845|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
105392084|NCT03685149|363444846|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
105392085|NCT03685149|363444845|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
105392086|NCT03685149|363444846|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
105392087|NCT03685149|363444845|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
105392088|NCT03685149|363444846|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
105392089|NCT00581919|363444853|FG000|Overall Study|Adverse Event|8|||
105392090|NCT00581919|363444853|FG000|Overall Study|Death|1|||
105392091|NCT00581919|363444853|FG000|Overall Study|Disease Progression|10|||
105392092|NCT00581919|363444853|FG000|Overall Study|Physician Decision|1|||
105392093|NCT00581919|363444853|FG000|Overall Study|Other Complicating Disease|1|||
105392094|NCT00581919|363444853|FG000|Overall Study|Started Non-Protocol Therapy|2|||
105392095|NCT00581919|363444853|FG000|Overall Study|Withdrawal by Subject|1|||
105392096|NCT00113373|363444854|FG000|Overall Study|Ineligible: wrong primary|1|||
105392097|NCT00113373|363444854|FG000|Overall Study|Ineligible: second primary|1|||
105392098|NCT00113373|363444854|FG000|Overall Study|Never Treated|1|||
105392099|NCT02871219|363444868|FG000|Overall Study|Adverse Event|15|||
105392100|NCT02871219|363444868|FG000|Overall Study|Death|3|||
105392101|NCT02871219|363444868|FG000|Overall Study|Progression|3|||
105392102|NCT02871219|363444868|FG000|Overall Study|Infections|7|||
105392103|NCT02871219|363444868|FG000|Overall Study|Infusion Related|4|||
105392104|NCT03312543|363444869|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
105392105|NCT03312543|363444870|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
105392106|NCT03312543|363444869|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
105392107|NCT03312543|363444870|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
105392108|NCT03312543|363444869|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
105392109|NCT03312543|363444870|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
105392110|NCT03312543|363444869|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
105392111|NCT03312543|363444870|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
105392112|NCT03312543|363444869|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
105392113|NCT03312543|363444870|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
105392114|NCT03312543|363444869|FG000|Regression (Week 12 to Week 24)|Death|0|||
105392115|NCT03312543|363444870|FG001|Regression (Week 12 to Week 24)|Death|1|||
105392116|NCT02402647|363444871|FG000|Overall Study|Lost to Follow-up|13|||
105392117|NCT02402647|363444872|FG001|Overall Study|Lost to Follow-up|7|||
105392118|NCT02402647|363444871|FG000|Overall Study|Protocol Violation|1|||
105392119|NCT02402647|363444872|FG001|Overall Study|Protocol Violation|1|||
105392120|NCT02402647|363444871|FG000|Overall Study|scheduled and timed out|2|||
105392121|NCT02402647|363444872|FG001|Overall Study|scheduled and timed out|1|||
105392122|NCT02402647|363444871|FG000|Overall Study|medical illness|2|||
105392123|NCT02402647|363444872|FG001|Overall Study|medical illness|4|||
105392124|NCT02402647|363444871|FG000|Overall Study|Moved|2|||
105392125|NCT02402647|363444872|FG001|Overall Study|Moved|0|||
105392126|NCT02402647|363444871|FG000|Overall Study|loved one illness|1|||
105392127|NCT02402647|363444872|FG001|Overall Study|loved one illness|0|||
105392128|NCT02402647|363444871|FG000|Overall Study|deceased preexisting condition|2|||
105392129|NCT02402647|363444872|FG001|Overall Study|deceased preexisting condition|0|||
105392130|NCT02402647|363444871|FG000|Overall Study|Other|2|||
105392131|NCT02402647|363444872|FG001|Overall Study|Other|1|||
105392132|NCT04197583|363444873|FG000|Overall Study|Study Stent Replacement|34|||
105392133|NCT04197583|363444874|FG001|Overall Study|Study Stent Replacement|8|||
105392134|NCT04197583|363444873|FG000|Overall Study|Lost to Follow-up|14|||
105392135|NCT04197583|363444874|FG001|Overall Study|Lost to Follow-up|3|||
105392136|NCT04197583|363444873|FG000|Overall Study|Death|3|||
105392137|NCT04197583|363444874|FG001|Overall Study|Death|0|||
105392138|NCT04197583|363444873|FG000|Overall Study|Physician Decision|1|||
105392139|NCT04197583|363444874|FG001|Overall Study|Physician Decision|0|||
105392140|NCT04197583|363444873|FG000|Overall Study|Withdrawal by Subject|1|||
105392141|NCT04197583|363444874|FG001|Overall Study|Withdrawal by Subject|1|||
105392142|NCT04197583|363444873|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
105392143|NCT04197583|363444874|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
105392144|NCT04197583|363444873|FG000|Overall Study|Screen Failure|0|||
105392145|NCT04197583|363444874|FG001|Overall Study|Screen Failure|20|||
105392146|NCT05852470|363444875|FG000|Overall Study|Withdrawal by Subject|0|||
105392147|NCT05852470|363444876|FG001|Overall Study|Withdrawal by Subject|1|||
105392148|NCT02420717|363444881|FG000|Overall Study|Did not receive all study medication|2|||
105392149|NCT02420717|363444882|FG001|Overall Study|Did not receive all study medication|0|||
105392150|NCT02420717|363444883|FG002|Overall Study|Did not receive all study medication|0|||
105392151|NCT05375929|363444888|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
105392152|NCT05375929|363444889|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
105392153|NCT05375929|363444890|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
105392154|NCT05375929|363444891|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
105392155|NCT05375929|363444888|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
105392156|NCT05375929|363444889|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
105392157|NCT05375929|363444890|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
105392158|NCT05375929|363444891|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
105392159|NCT05375929|363444888|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
105392160|NCT05375929|363444889|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
105392161|NCT05375929|363444890|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
105392162|NCT05375929|363444891|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
105392163|NCT05375929|363444888|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
105392164|NCT05375929|363444889|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
105392165|NCT05375929|363444890|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
105392166|NCT05375929|363444891|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
105392167|NCT05375929|363444888|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
105392168|NCT05375929|363444889|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
105392169|NCT05375929|363444890|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
105392170|NCT05375929|363444891|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
105392171|NCT05375929|363444888|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
105392172|NCT05375929|363444889|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
105392173|NCT05375929|363444890|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
105392174|NCT05375929|363444891|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
105392175|NCT05375929|363444888|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
105392176|NCT05375929|363444889|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
105392177|NCT05375929|363444890|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
105392178|NCT05375929|363444891|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
105392179|NCT05375929|363444888|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
105392180|NCT05375929|363444889|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
105392181|NCT05375929|363444890|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
105392182|NCT05375929|363444891|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
105392183|NCT05375929|363444888|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
105392184|NCT05375929|363444889|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
105392185|NCT05375929|363444890|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
105392186|NCT05375929|363444891|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
105392187|NCT05375929|363444888|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
105392188|NCT05375929|363444889|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
105392189|NCT05375929|363444890|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
105392190|NCT05375929|363444891|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
105392191|NCT02496000|363444892|FG000|Overall Study|Withdrawal by Subject|1|||
105392192|NCT02496000|363444893|FG001|Overall Study|Withdrawal by Subject|2|||
105392193|NCT02496000|363444894|FG002|Overall Study|Withdrawal by Subject|0|||
105392194|NCT02496000|363444892|FG000|Overall Study|Lost to Follow-up|1|||
105392195|NCT02496000|363444893|FG001|Overall Study|Lost to Follow-up|0|||
105392196|NCT02496000|363444894|FG002|Overall Study|Lost to Follow-up|1|||
105392197|NCT02496000|363444892|FG000|Overall Study|Protocol Violation|0|||
105392198|NCT02496000|363444893|FG001|Overall Study|Protocol Violation|0|||
105392199|NCT02496000|363444894|FG002|Overall Study|Protocol Violation|1|||
105392200|NCT02496000|363444892|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
105392201|NCT02496000|363444893|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
105392202|NCT02496000|363444894|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
105392203|NCT02496000|363444892|FG000|Overall Study|undetermined|0|||
105392204|NCT02496000|363444893|FG001|Overall Study|undetermined|1|||
105392205|NCT02496000|363444894|FG002|Overall Study|undetermined|0|||
105392206|NCT01111552|363444895|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
105392207|NCT01111552|363444896|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105392208|NCT01111552|363444897|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105392209|NCT01111552|363444898|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105392210|NCT01111552|363444899|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105392211|NCT01111552|363444895|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
105392212|NCT01111552|363444896|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105392213|NCT01111552|363444897|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105392214|NCT01111552|363444898|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105392215|NCT01111552|363444899|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105392216|NCT01111552|363444895|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
105392217|NCT01111552|363444896|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105392218|NCT01111552|363444897|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105392219|NCT01111552|363444898|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105392220|NCT01111552|363444899|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105392221|NCT01111552|363444895|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
105392222|NCT01111552|363444896|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
105392223|NCT01111552|363444897|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
105392224|NCT01111552|363444898|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
105392225|NCT01111552|363444899|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
105392226|NCT01111552|363444895|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
105392227|NCT01111552|363444896|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
105392228|NCT01111552|363444897|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
105392229|NCT01111552|363444898|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
105392230|NCT01111552|363444899|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
105392231|NCT01111552|363444895|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
105392232|NCT01111552|363444896|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
105392233|NCT01111552|363444897|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
105392234|NCT01111552|363444898|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
105392235|NCT01111552|363444899|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
105392236|NCT01111552|363444895|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
105392237|NCT01111552|363444896|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
105392238|NCT01111552|363444897|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
105392239|NCT01111552|363444898|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
105392240|NCT01111552|363444899|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
105392241|NCT01111552|363444895|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
105392242|NCT01111552|363444896|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
105392243|NCT01111552|363444897|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
105392244|NCT01111552|363444898|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
105392245|NCT01111552|363444899|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
105392246|NCT01111552|363444895|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105392247|NCT01111552|363444896|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105392248|NCT01111552|363444897|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105392249|NCT01111552|363444898|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
105392250|NCT01111552|363444899|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105392251|NCT01111552|363444895|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
105392252|NCT01111552|363444896|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
105392253|NCT01111552|363444897|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
105392254|NCT01111552|363444898|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
105392255|NCT01111552|363444899|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
105392256|NCT01111552|363444895|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
105392257|NCT01111552|363444896|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
105392258|NCT01111552|363444897|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
105392259|NCT01111552|363444898|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
105392260|NCT01111552|363444899|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
105392261|NCT01111552|363444895|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
105392262|NCT01111552|363444896|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
105392263|NCT01111552|363444897|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
105392264|NCT01111552|363444898|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
105392265|NCT01111552|363444899|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
105392266|NCT01111552|363444895|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
105392267|NCT01111552|363444896|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
105392268|NCT01111552|363444897|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
105392269|NCT01111552|363444898|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
105392270|NCT01111552|363444899|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
105392271|NCT01111552|363444895|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105392272|NCT01111552|363444896|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105392273|NCT01111552|363444897|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
105392274|NCT01111552|363444898|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105392275|NCT01111552|363444899|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105392276|NCT02255656|363444900|FG000|Overall Study|Adverse Event|11|||
105392277|NCT02255656|363444900|FG000|Overall Study|Poor compliance to protocol|3|||
105392278|NCT02255656|363444900|FG000|Overall Study|Lost to Follow-up|30|||
105392279|NCT02255656|363444900|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
105392280|NCT02255656|363444900|FG000|Overall Study|Other|126|||
105392281|NCT03734536|363444901|FG000|Overall Study|Withdrew Consent|1|||
105392282|NCT03734536|363444902|FG001|Overall Study|Withdrew Consent|5|||
105392283|NCT03734536|363444901|FG000|Overall Study|Lost to Follow-up|10|||
105392284|NCT03734536|363444902|FG001|Overall Study|Lost to Follow-up|7|||
105392285|NCT01346592|363444905|FG000|Overall Study|Lost to Follow-up|62|||
105392286|NCT01346592|363444906|FG001|Overall Study|Lost to Follow-up|29|||
105392287|NCT01346592|363444907|FG002|Overall Study|Lost to Follow-up|29|||
105392288|NCT01346592|363444905|FG000|Overall Study|Protocol Violation|2|||
105392289|NCT01346592|363444906|FG001|Overall Study|Protocol Violation|1|||
105392290|NCT01346592|363444907|FG002|Overall Study|Protocol Violation|0|||
105392291|NCT01346592|363444905|FG000|Overall Study|Death|1|||
105392292|NCT01346592|363444906|FG001|Overall Study|Death|3|||
105392293|NCT01346592|363444907|FG002|Overall Study|Death|4|||
105392294|NCT01346592|363444905|FG000|Overall Study|Adverse Event|0|||
105392295|NCT01346592|363444906|FG001|Overall Study|Adverse Event|1|||
105392296|NCT01346592|363444907|FG002|Overall Study|Adverse Event|0|||
105392297|NCT01346592|363444905|FG000|Overall Study|Withdrawal by Subject|77|||
105392298|NCT01346592|363444906|FG001|Overall Study|Withdrawal by Subject|51|||
105392299|NCT01346592|363444907|FG002|Overall Study|Withdrawal by Subject|38|||
105392300|NCT01346592|363444905|FG000|Overall Study|Inappropriate enrollment|3|||
105392301|NCT01346592|363444906|FG001|Overall Study|Inappropriate enrollment|1|||
105392302|NCT01346592|363444907|FG002|Overall Study|Inappropriate enrollment|1|||
105392303|NCT01346592|363444905|FG000|Overall Study|Administrative reason|1|||
105392304|NCT01346592|363444906|FG001|Overall Study|Administrative reason|0|||
105392305|NCT01346592|363444907|FG002|Overall Study|Administrative reason|0|||
105392306|NCT01346592|363444905|FG000|Overall Study|Unable to Classify|7|||
105392307|NCT01346592|363444906|FG001|Overall Study|Unable to Classify|3|||
105392308|NCT01346592|363444907|FG002|Overall Study|Unable to Classify|6|||
105392309|NCT00322218|363444908|FG000|Overall Study|Death|3|||
105392310|NCT00322218|363444909|FG001|Overall Study|Death|6|||
105392311|NCT00835367|363444912|FG000|Washout|Adverse Event|2|||
105392312|NCT00835367|363444913|FG001|Washout|Adverse Event|0|||
105392313|NCT00835367|363444912|FG000|Washout|Withdrawal by Subject|1|||
105392314|NCT00835367|363444913|FG001|Washout|Withdrawal by Subject|0|||
105392315|NCT00835367|363444912|FG000|Second Intervention|Adverse Event|1|||
105392316|NCT00835367|363444913|FG001|Second Intervention|Adverse Event|1|||
105392317|NCT03345550|363445847|FG000|Overall Study|Withdrawal by Subject|1|||
105392318|NCT03345550|363445848|FG001|Overall Study|Withdrawal by Subject|0|||
105392319|NCT03345550|363445847|FG000|Overall Study|Lost to Follow-up|4|||
105392320|NCT03345550|363445848|FG001|Overall Study|Lost to Follow-up|5|||
105392321|NCT02489279|363445862|FG000|Overall Study|Lost to Follow-up|12|||
105392322|NCT02489279|363445863|FG001|Overall Study|Lost to Follow-up|10|||
105392323|NCT00480532|363445866|FG000|Overall Study|Withdrawal by Subject|2|||
105392324|NCT00480532|363445867|FG001|Overall Study|Withdrawal by Subject|4|||
105392325|NCT00480532|363445868|FG002|Overall Study|Withdrawal by Subject|3|||
105392326|NCT00480532|363445869|FG003|Overall Study|Withdrawal by Subject|1|||
105392327|NCT00480532|363445866|FG000|Overall Study|Protocol Violation|0|||
105392328|NCT00480532|363445867|FG001|Overall Study|Protocol Violation|0|||
105392329|NCT00480532|363445868|FG002|Overall Study|Protocol Violation|1|||
105392330|NCT00480532|363445869|FG003|Overall Study|Protocol Violation|0|||
105392331|NCT00557440|363445870|FG000|Treatment Period 1|Adverse Event|0|||
105392332|NCT00557440|363445871|FG001|Treatment Period 1|Adverse Event|0|||
105392333|NCT00557440|363445872|FG002|Treatment Period 1|Adverse Event|1|||
105392334|NCT00124657|363445873|FG000|Overall Study|Toxicity|0|||
105392335|NCT00124657|363445874|FG001|Overall Study|Toxicity|0|||
105392336|NCT00124657|363445875|FG002|Overall Study|Toxicity|1|||
105392337|NCT00124657|363445873|FG000|Overall Study|Non-compliance|1|||
105392338|NCT00124657|363445874|FG001|Overall Study|Non-compliance|0|||
105392339|NCT00124657|363445875|FG002|Overall Study|Non-compliance|4|||
105392340|NCT00124657|363445873|FG000|Overall Study|Progressive disease|14|||
105392341|NCT00124657|363445874|FG001|Overall Study|Progressive disease|5|||
105392342|NCT00124657|363445875|FG002|Overall Study|Progressive disease|27|||
105392343|NCT00124657|363445873|FG000|Overall Study|Intercurrent illness|1|||
105392344|NCT00124657|363445874|FG001|Overall Study|Intercurrent illness|0|||
105392345|NCT00124657|363445875|FG002|Overall Study|Intercurrent illness|0|||
105392346|NCT02367885|363445876|FG000|Overall Study|Lost to Follow-up|1|||
105392347|NCT02367885|363445877|FG001|Overall Study|Lost to Follow-up|0|||
105392348|NCT02367885|363445878|FG002|Overall Study|Lost to Follow-up|0|||
105392349|NCT02367885|363445876|FG000|Overall Study|Withdrawal by Subject|1|||
105392350|NCT02367885|363445877|FG001|Overall Study|Withdrawal by Subject|0|||
105392351|NCT02367885|363445878|FG002|Overall Study|Withdrawal by Subject|0|||
105392352|NCT03427619|363445879|FG000|Overall Study|Physician Decision|3|||
105392353|NCT03427619|363445879|FG000|Overall Study|Withdrawal by Subject|4|||
105392354|NCT03427619|363445879|FG000|Overall Study|Lost to Follow-up|5|||
105392355|NCT03427619|363445879|FG000|Overall Study|Administrative|4|||
105392356|NCT03427619|363445879|FG000|Overall Study|Other|2|||
105392357|NCT03427619|363445879|FG000|Overall Study|Unknown or Missing Completion Status|48|||
105392358|NCT03847519|363445880|FG000|Overall Study|Death|5|||
105392359|NCT03847519|363445881|FG001|Overall Study|Death|8|||
105392360|NCT03847519|363445882|FG002|Overall Study|Death|1|||
105392361|NCT03847519|363445880|FG000|Overall Study|Lost to Follow-up|1|||
105392362|NCT03847519|363445881|FG001|Overall Study|Lost to Follow-up|2|||
105392363|NCT03847519|363445882|FG002|Overall Study|Lost to Follow-up|0|||
105392364|NCT03847519|363445880|FG000|Overall Study|Study Terminated by Sponsor|0|||
105392365|NCT03847519|363445881|FG001|Overall Study|Study Terminated by Sponsor|3|||
105392366|NCT03847519|363445882|FG002|Overall Study|Study Terminated by Sponsor|2|||
105392367|NCT02743962|363445883|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
105392368|NCT02743962|363445884|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
105392369|NCT00425555|363445888|FG000|Overall Study|Withdrawal by Subject|11|||
105392370|NCT00425555|363445889|FG001|Overall Study|Withdrawal by Subject|8|||
105392371|NCT00425555|363445888|FG000|Overall Study|Lost to Follow-up|0|||
105392372|NCT00425555|363445889|FG001|Overall Study|Lost to Follow-up|1|||
105392373|NCT00425555|363445888|FG000|Overall Study|Administrative problems|3|||
105392374|NCT00425555|363445889|FG001|Overall Study|Administrative problems|0|||
105392375|NCT00425555|363445888|FG000|Overall Study|Death|1|||
105392376|NCT00425555|363445889|FG001|Overall Study|Death|2|||
105392377|NCT00425555|363445888|FG000|Overall Study|New cancer therapy|2|||
105392378|NCT00425555|363445889|FG001|Overall Study|New cancer therapy|1|||
105392379|NCT00425555|363445888|FG000|Overall Study|Disease progression|36|||
105392380|NCT00425555|363445889|FG001|Overall Study|Disease progression|33|||
105392381|NCT00425555|363445888|FG000|Overall Study|Adverse Event|25|||
105392382|NCT00425555|363445889|FG001|Overall Study|Adverse Event|15|||
105392383|NCT00425555|363445888|FG000|Overall Study|Protocol Violation|1|||
105392384|NCT00425555|363445889|FG001|Overall Study|Protocol Violation|0|||
105392385|NCT00841815|363445890|FG000|Washout|Withdrawal by Subject|0|||
105392386|NCT00841815|363445891|FG001|Washout|Withdrawal by Subject|1|||
105392387|NCT03900650|363445894|FG000|Overall Study|Withdrawal by Subject|1|||
105392388|NCT03900650|363445895|FG001|Overall Study|Withdrawal by Subject|1|||
105392389|NCT03900650|363445896|FG002|Overall Study|Withdrawal by Subject|0|||
105392390|NCT03900650|363445897|FG003|Overall Study|Withdrawal by Subject|0|||
105392391|NCT03900650|363445894|FG000|Overall Study|Withdrawn by staff|1|||
105392392|NCT03900650|363445895|FG001|Overall Study|Withdrawn by staff|0|||
105392393|NCT03900650|363445896|FG002|Overall Study|Withdrawn by staff|0|||
105392394|NCT03900650|363445897|FG003|Overall Study|Withdrawn by staff|0|||
105392395|NCT01969409|363445900|FG000|Overall Study|Death|2|||
105392396|NCT01969409|363445901|FG001|Overall Study|Death|2|||
105392397|NCT01969409|363445900|FG000|Overall Study|Transplant|1|||
105392398|NCT01969409|363445901|FG001|Overall Study|Transplant|1|||
105392399|NCT01969409|363445900|FG000|Overall Study|Withdrawal by Subject|0|||
105392400|NCT01969409|363445901|FG001|Overall Study|Withdrawal by Subject|1|||
105392401|NCT02799043|363445903|FG000|Overall Study|Adverse Event|0|||
105392402|NCT02799043|363445904|FG001|Overall Study|Adverse Event|1|||
105392403|NCT02799043|363445903|FG000|Overall Study|Death|1|||
105392404|NCT02799043|363445904|FG001|Overall Study|Death|1|||
105392405|NCT02799043|363445903|FG000|Overall Study|Lost to Follow-up|3|||
105392406|NCT02799043|363445904|FG001|Overall Study|Lost to Follow-up|6|||
105392407|NCT02799043|363445903|FG000|Overall Study|Withdrawal by Subject|4|||
105392408|NCT02799043|363445904|FG001|Overall Study|Withdrawal by Subject|4|||
105392409|NCT02799043|363445903|FG000|Overall Study|Moved to different country|0|||
105392410|NCT02799043|363445904|FG001|Overall Study|Moved to different country|1|||
105392411|NCT02799043|363445903|FG000|Overall Study|Trial Screen Failure|1|||
105392412|NCT02799043|363445904|FG001|Overall Study|Trial Screen Failure|0|||
105392413|NCT02799043|363445903|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
105392414|NCT02799043|363445904|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
105392415|NCT03829683|363445905|FG000|Overall Study|Lost to Follow-up|1|||
105392416|NCT03829683|363445906|FG001|Overall Study|Lost to Follow-up|0|||
105392417|NCT03829683|363445905|FG000|Overall Study|Physician Decision|3|||
105392418|NCT03829683|363445906|FG001|Overall Study|Physician Decision|1|||
105392419|NCT03829683|363445905|FG000|Overall Study|Withdrawal by Subject|0|||
105392420|NCT03829683|363445906|FG001|Overall Study|Withdrawal by Subject|1|||
105392421|NCT03829683|363445905|FG000|Overall Study|Discharge from hospital|1|||
105392422|NCT03829683|363445906|FG001|Overall Study|Discharge from hospital|0|||
105392423|NCT03078868|363445913|FG000|Overall Study|Physician Decision|3|||
105392424|NCT00635050|363445916|FG000|Overall Study|Withdrawal by Subject|1|||
105392425|NCT03038620|363445917|FG000|Overall Study|Lost to Follow-up|18|||
105580576|NCT02018861|364126446|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
105392426|NCT03038620|363445918|FG001|Overall Study|Lost to Follow-up|23|||
105392427|NCT03038620|363445917|FG000|Overall Study|Withdrawal by Subject|0|||
105392428|NCT03038620|363445918|FG001|Overall Study|Withdrawal by Subject|15|||
105392429|NCT03038620|363445917|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
105392430|NCT03038620|363445918|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
105392431|NCT01435356|363445920|FG000|Overall Study|Adverse Event|2|||
105392432|NCT01435356|363445921|FG001|Overall Study|Adverse Event|0|||
105392433|NCT01435356|363445920|FG000|Overall Study|Disease progression/recurrence|17|||
105392434|NCT01435356|363445921|FG001|Overall Study|Disease progression/recurrence|10|||
105392435|NCT01435356|363445920|FG000|Overall Study|Protocol Violation|0|||
105392436|NCT01435356|363445921|FG001|Overall Study|Protocol Violation|1|||
105392437|NCT01435356|363445920|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
105392438|NCT01435356|363445921|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
105392439|NCT01435356|363445920|FG000|Overall Study|Withdrawal by Subject|1|||
105392440|NCT01435356|363445921|FG001|Overall Study|Withdrawal by Subject|1|||
105392441|NCT01435356|363445920|FG000|Overall Study|Facial palsy|1|||
105392442|NCT01435356|363445921|FG001|Overall Study|Facial palsy|0|||
105392443|NCT01435356|363445920|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
105392444|NCT01435356|363445921|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
105392445|NCT01435356|363445920|FG000|Overall Study|Physician Decision|1|||
105392446|NCT01435356|363445921|FG001|Overall Study|Physician Decision|0|||
105392447|NCT01435356|363445920|FG000|Overall Study|Patient decision|3|||
105392448|NCT01435356|363445921|FG001|Overall Study|Patient decision|0|||
105392449|NCT01435356|363445920|FG000|Overall Study|Patient moved to another city|1|||
105392450|NCT01435356|363445921|FG001|Overall Study|Patient moved to another city|1|||
105392451|NCT05360784|363445922|FG000|Overall Study|Discontinued|25|||
105392452|NCT05360784|363445923|FG001|Overall Study|Discontinued|11|||
105392453|NCT04875533|363445927|FG000|Overall Study|Adverse Event|6|||
105392454|NCT04875533|363445928|FG001|Overall Study|Adverse Event|4|||
105392455|NCT04875533|363445927|FG000|Overall Study|Protocol Violation|4|||
105392456|NCT04875533|363445928|FG001|Overall Study|Protocol Violation|0|||
105392457|NCT04875533|363445927|FG000|Overall Study|Withdrawal by Subject|8|||
105392458|NCT04875533|363445928|FG001|Overall Study|Withdrawal by Subject|5|||
105392459|NCT04875533|363445927|FG000|Overall Study|No longer meets eligibility criteria|1|||
105392460|NCT04875533|363445928|FG001|Overall Study|No longer meets eligibility criteria|0|||
105392461|NCT04875533|363445927|FG000|Overall Study|Other|0|||
105392462|NCT04875533|363445928|FG001|Overall Study|Other|2|||
105392463|NCT05014919|363445929|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
105392464|NCT05014919|363445930|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
105392465|NCT05014919|363445931|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
105392466|NCT05014919|363445929|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
105392467|NCT05014919|363445930|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
105392468|NCT05014919|363445931|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
105392469|NCT05014919|363445929|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
105392470|NCT05014919|363445930|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
105392471|NCT05014919|363445931|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
105392472|NCT05014919|363445929|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
105392473|NCT05014919|363445930|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
105392474|NCT05014919|363445931|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
105392475|NCT05014919|363445929|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
105392476|NCT05014919|363445930|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
105392477|NCT05014919|363445931|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
105392478|NCT05014919|363445929|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
105392479|NCT05014919|363445930|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
105392480|NCT05014919|363445931|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
105392481|NCT05014919|363445929|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
105392482|NCT05014919|363445930|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
105392483|NCT05014919|363445931|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
105392484|NCT05014919|363445929|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
105392485|NCT05014919|363445930|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
105392486|NCT05014919|363445931|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
105392487|NCT02679274|363445932|FG000|Overall Study|Withdrawal by Subject|1|||
105392488|NCT02679274|363445933|FG001|Overall Study|Withdrawal by Subject|0|||
105392489|NCT04144517|363445935|FG000|Overall Study|Physician Decision|0|||
105392490|NCT04144517|363445936|FG001|Overall Study|Physician Decision|1|||
105392491|NCT04144517|363445935|FG000|Overall Study|Other|2|||
105392492|NCT04144517|363445936|FG001|Overall Study|Other|2|||
105392493|NCT04144517|363445935|FG000|Overall Study|Death|6|||
105392494|NCT04144517|363445936|FG001|Overall Study|Death|3|||
105392495|NCT03379870|363447507|FG000|Overall Study|Lost to Follow-up|1|||
105392496|NCT03379870|363447508|FG001|Overall Study|Lost to Follow-up|0|||
105392497|NCT03379870|363447507|FG000|Overall Study|Protocol Violation|1|||
105392498|NCT03379870|363447508|FG001|Overall Study|Protocol Violation|1|||
105392499|NCT03837509|363447509|FG000|Phase 1|Death|5|||
105392500|NCT03837509|363447510|FG001|Phase 1|Death|2|||
105392501|NCT03837509|363447511|FG002|Phase 1|Death|0|||
105392502|NCT03837509|363447512|FG003|Phase 1|Death|0|||
105392503|NCT03837509|363447513|FG004|Phase 1|Death|0|||
105392504|NCT03837509|363447509|FG000|Phase 2|Death|0|||
105392505|NCT03837509|363447510|FG001|Phase 2|Death|0|||
105392506|NCT03837509|363447511|FG002|Phase 2|Death|0|||
105392507|NCT03837509|363447512|FG003|Phase 2|Death|1|||
105392508|NCT03837509|363447513|FG004|Phase 2|Death|1|||
105392509|NCT04280783|363447514|FG000|Overall Study|Family issues unrelated to the study.|1|||
105392510|NCT04280783|363447515|FG001|Overall Study|Family issues unrelated to the study.|0|||
105392511|NCT04280783|363447514|FG000|Overall Study|Withdrawal by Subject|0|||
105392512|NCT04280783|363447515|FG001|Overall Study|Withdrawal by Subject|1|||
105392513|NCT04101331|363447516|FG000|Overall Study|Adverse Event|9|||
105392514|NCT04101331|363447516|FG000|Overall Study|Disease progression|82|||
105392515|NCT04101331|363447516|FG000|Overall Study|Withdrawal by Subject|1|||
105392516|NCT04101331|363447516|FG000|Overall Study|Investigator decision|6|||
105392517|NCT04101331|363447516|FG000|Overall Study|Death|6|||
105392518|NCT04101331|363447516|FG000|Overall Study|Allogenic transplant|1|||
105392519|NCT05543174|363447517|FG000|Overall Study|Ongoing|7|||
105392520|NCT03977155|363447518|FG000|Overall Study|Adverse Event|3|||
105392521|NCT03977155|363447519|FG001|Overall Study|Adverse Event|0|||
105392522|NCT03977155|363447520|FG002|Overall Study|Adverse Event|0|||
105392523|NCT03977155|363447518|FG000|Overall Study|Lost to Follow-up|0|||
105392524|NCT03977155|363447519|FG001|Overall Study|Lost to Follow-up|1|||
105392525|NCT03977155|363447520|FG002|Overall Study|Lost to Follow-up|0|||
105392526|NCT03977155|363447518|FG000|Overall Study|Withdrawal by Subject|1|||
105392527|NCT03977155|363447519|FG001|Overall Study|Withdrawal by Subject|1|||
105392528|NCT03977155|363447520|FG002|Overall Study|Withdrawal by Subject|2|||
105392529|NCT03977155|363447518|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
105392530|NCT03977155|363447519|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
105392531|NCT03977155|363447520|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
105392532|NCT01373281|363447521|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
105392533|NCT01373281|363447522|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
105392534|NCT01373281|363447521|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
105392535|NCT01373281|363447522|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
105392536|NCT01373281|363447521|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
105392537|NCT01373281|363447522|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
105392538|NCT01373281|363447521|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
105392539|NCT01373281|363447522|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
105392540|NCT01373281|363447521|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
105392541|NCT01373281|363447522|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
105392542|NCT01373281|363447521|FG000|Surveillance Expansion Period|Protocol Violation|9|||
105392543|NCT01373281|363447522|FG001|Surveillance Expansion Period|Protocol Violation|1|||
105392544|NCT01373281|363447521|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
105392545|NCT01373281|363447522|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
105392546|NCT01373281|363447521|FG000|Surveillance Expansion Period|Serious adverse event|3|||
105392547|NCT01373281|363447522|FG001|Surveillance Expansion Period|Serious adverse event|4|||
105392548|NCT04110145|363447523|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
105392549|NCT04110145|363447524|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
105392550|NCT04110145|363447525|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
105392551|NCT04110145|363447526|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
105392552|NCT04110145|363447527|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
105392553|NCT00980044|363447528|FG000|Overall Study|Withdrawal by Subject|5|||
105392554|NCT00980044|363447529|FG001|Overall Study|Withdrawal by Subject|7|||
105392555|NCT00980044|363447530|FG002|Overall Study|Withdrawal by Subject|3|||
105392556|NCT00980044|363447528|FG000|Overall Study|Protocol Violation|0|||
105392557|NCT00980044|363447529|FG001|Overall Study|Protocol Violation|0|||
105392558|NCT00980044|363447530|FG002|Overall Study|Protocol Violation|2|||
105392559|NCT02254291|363447531|FG000|Overall Study|Withdrawal by Subject|0|||
105392560|NCT02254291|363447532|FG001|Overall Study|Withdrawal by Subject|3|||
105392561|NCT02254291|363447533|FG002|Overall Study|Withdrawal by Subject|1|||
105392562|NCT02254291|363447531|FG000|Overall Study|Missing follow-up information|0|||
105392563|NCT02254291|363447532|FG001|Overall Study|Missing follow-up information|0|||
105392564|NCT02254291|363447533|FG002|Overall Study|Missing follow-up information|1|||
105392565|NCT00500331|363447535|FG000|Overall Study|Adverse Event|0|||
105392566|NCT00500331|363447536|FG001|Overall Study|Adverse Event|2|||
105392567|NCT00500331|363447537|FG002|Overall Study|Adverse Event|0|||
105392568|NCT00500331|363447538|FG003|Overall Study|Adverse Event|1|||
105392569|NCT00500331|363447539|FG004|Overall Study|Adverse Event|2|||
105392570|NCT00500331|363447540|FG005|Overall Study|Adverse Event|2|||
105392571|NCT00500331|363447541|FG006|Overall Study|Adverse Event|0|||
105392572|NCT00500331|363447535|FG000|Overall Study|Lost to Follow-up|1|||
105392573|NCT00500331|363447536|FG001|Overall Study|Lost to Follow-up|1|||
105392574|NCT00500331|363447537|FG002|Overall Study|Lost to Follow-up|1|||
105580577|NCT02018861|364126447|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
105392575|NCT00500331|363447538|FG003|Overall Study|Lost to Follow-up|2|||
105392576|NCT00500331|363447539|FG004|Overall Study|Lost to Follow-up|1|||
105392577|NCT00500331|363447540|FG005|Overall Study|Lost to Follow-up|0|||
105392578|NCT00500331|363447541|FG006|Overall Study|Lost to Follow-up|0|||
105392579|NCT00500331|363447535|FG000|Overall Study|Protocol Violation|3|||
105392580|NCT00500331|363447536|FG001|Overall Study|Protocol Violation|1|||
105392581|NCT00500331|363447537|FG002|Overall Study|Protocol Violation|1|||
105392582|NCT00500331|363447538|FG003|Overall Study|Protocol Violation|0|||
105392583|NCT00500331|363447539|FG004|Overall Study|Protocol Violation|1|||
105392584|NCT00500331|363447540|FG005|Overall Study|Protocol Violation|1|||
105392585|NCT00500331|363447541|FG006|Overall Study|Protocol Violation|1|||
105392586|NCT00500331|363447535|FG000|Overall Study|Withdrawal by Subject|4|||
105392587|NCT00500331|363447536|FG001|Overall Study|Withdrawal by Subject|0|||
105392588|NCT00500331|363447537|FG002|Overall Study|Withdrawal by Subject|1|||
105392589|NCT00500331|363447538|FG003|Overall Study|Withdrawal by Subject|5|||
105392590|NCT00500331|363447539|FG004|Overall Study|Withdrawal by Subject|0|||
105392591|NCT00500331|363447540|FG005|Overall Study|Withdrawal by Subject|1|||
105392592|NCT00500331|363447541|FG006|Overall Study|Withdrawal by Subject|1|||
105392593|NCT00500331|363447535|FG000|Overall Study|Lack of Efficacy|3|||
105392594|NCT00500331|363447536|FG001|Overall Study|Lack of Efficacy|1|||
105392595|NCT00500331|363447537|FG002|Overall Study|Lack of Efficacy|0|||
105392596|NCT00500331|363447538|FG003|Overall Study|Lack of Efficacy|0|||
105392597|NCT00500331|363447539|FG004|Overall Study|Lack of Efficacy|0|||
105392598|NCT00500331|363447540|FG005|Overall Study|Lack of Efficacy|0|||
105392599|NCT00500331|363447541|FG006|Overall Study|Lack of Efficacy|0|||
105392600|NCT00500331|363447535|FG000|Overall Study|Liver function test abnormality|0|||
105392601|NCT00500331|363447536|FG001|Overall Study|Liver function test abnormality|0|||
105392602|NCT00500331|363447537|FG002|Overall Study|Liver function test abnormality|1|||
105392603|NCT00500331|363447538|FG003|Overall Study|Liver function test abnormality|0|||
105392604|NCT00500331|363447539|FG004|Overall Study|Liver function test abnormality|0|||
105392605|NCT00500331|363447540|FG005|Overall Study|Liver function test abnormality|0|||
105392606|NCT00500331|363447541|FG006|Overall Study|Liver function test abnormality|0|||
105392607|NCT00500331|363447535|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
105392608|NCT00500331|363447536|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
105392609|NCT00500331|363447537|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
105392610|NCT00500331|363447538|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
105392611|NCT00500331|363447539|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
105392612|NCT00500331|363447540|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
105392613|NCT00500331|363447541|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
105392614|NCT00500331|363447535|FG000|Overall Study|Didn't return for continuation of study|1|||
105392615|NCT00500331|363447536|FG001|Overall Study|Didn't return for continuation of study|0|||
105392616|NCT00500331|363447537|FG002|Overall Study|Didn't return for continuation of study|0|||
105392617|NCT00500331|363447538|FG003|Overall Study|Didn't return for continuation of study|0|||
105392618|NCT00500331|363447539|FG004|Overall Study|Didn't return for continuation of study|0|||
105392619|NCT00500331|363447540|FG005|Overall Study|Didn't return for continuation of study|0|||
105392620|NCT00500331|363447541|FG006|Overall Study|Didn't return for continuation of study|0|||
105392621|NCT00500331|363447535|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
105392622|NCT00500331|363447536|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
105392623|NCT00500331|363447537|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
105392624|NCT00500331|363447538|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
105392625|NCT00500331|363447539|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
105392626|NCT00500331|363447540|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
105392627|NCT00500331|363447541|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
105392628|NCT00500331|363447535|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
105392629|NCT00500331|363447536|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
105392630|NCT00500331|363447537|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
105392631|NCT00500331|363447538|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
105392632|NCT00500331|363447539|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
105392633|NCT00500331|363447540|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
105392634|NCT00500331|363447541|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
105392635|NCT00500331|363447535|FG000|Overall Study|Participant was randomized by mistake|1|||
105392636|NCT00500331|363447536|FG001|Overall Study|Participant was randomized by mistake|0|||
105392637|NCT00500331|363447537|FG002|Overall Study|Participant was randomized by mistake|0|||
105392638|NCT00500331|363447538|FG003|Overall Study|Participant was randomized by mistake|0|||
105392639|NCT00500331|363447539|FG004|Overall Study|Participant was randomized by mistake|0|||
105392640|NCT00500331|363447540|FG005|Overall Study|Participant was randomized by mistake|0|||
105392641|NCT00500331|363447541|FG006|Overall Study|Participant was randomized by mistake|0|||
105392642|NCT00500331|363447535|FG000|Overall Study|Diabetologist nurse in the study|0|||
105392643|NCT00500331|363447536|FG001|Overall Study|Diabetologist nurse in the study|0|||
105392644|NCT00500331|363447537|FG002|Overall Study|Diabetologist nurse in the study|1|||
105392645|NCT00500331|363447538|FG003|Overall Study|Diabetologist nurse in the study|0|||
105392646|NCT00500331|363447539|FG004|Overall Study|Diabetologist nurse in the study|0|||
105392647|NCT00500331|363447540|FG005|Overall Study|Diabetologist nurse in the study|0|||
105392648|NCT00500331|363447541|FG006|Overall Study|Diabetologist nurse in the study|0|||
105392649|NCT00500331|363447535|FG000|Overall Study|State ban of biological samples export|0|||
105392650|NCT00500331|363447536|FG001|Overall Study|State ban of biological samples export|0|||
105392651|NCT00500331|363447537|FG002|Overall Study|State ban of biological samples export|0|||
105392652|NCT00500331|363447538|FG003|Overall Study|State ban of biological samples export|1|||
105392653|NCT00500331|363447539|FG004|Overall Study|State ban of biological samples export|0|||
105392654|NCT00500331|363447540|FG005|Overall Study|State ban of biological samples export|0|||
105392655|NCT00500331|363447541|FG006|Overall Study|State ban of biological samples export|0|||
105392656|NCT00500331|363447535|FG000|Overall Study|Protocol violated|0|||
105392657|NCT00500331|363447536|FG001|Overall Study|Protocol violated|0|||
105392658|NCT00500331|363447537|FG002|Overall Study|Protocol violated|0|||
105392659|NCT00500331|363447538|FG003|Overall Study|Protocol violated|1|||
105392660|NCT00500331|363447539|FG004|Overall Study|Protocol violated|0|||
105392661|NCT00500331|363447540|FG005|Overall Study|Protocol violated|0|||
105392662|NCT00500331|363447541|FG006|Overall Study|Protocol violated|0|||
105392663|NCT03436732|363447542|FG000|Overall Study|Not treated-enrolled in different study|1|||
105392664|NCT03436732|363447543|FG001|Overall Study|Not treated-enrolled in different study|0|||
105392665|NCT03436732|363447542|FG000|Overall Study|Off study after cycle 1|1|||
105392666|NCT03436732|363447543|FG001|Overall Study|Off study after cycle 1|0|||
105392667|NCT03436732|363447542|FG000|Overall Study|Adverse Event|2|||
105392668|NCT03436732|363447543|FG001|Overall Study|Adverse Event|0|||
105392669|NCT03436732|363447542|FG000|Overall Study|Death|0|||
105392670|NCT03436732|363447543|FG001|Overall Study|Death|1|||
105392671|NCT00939185|363447544|FG000|Overall Study|Adverse Event|3|||
105392672|NCT00939185|363447544|FG000|Overall Study|Lack of Efficacy|1|||
105392673|NCT00939185|363447544|FG000|Overall Study|Lost to Follow-up|6|||
105392674|NCT00939185|363447544|FG000|Overall Study|Other|3|||
105392675|NCT00939185|363447544|FG000|Overall Study|Withdrawal by Subject|2|||
105392676|NCT00939185|363447544|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
105392677|NCT00833703|363447545|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
105392678|NCT00833703|363447546|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
105392679|NCT05538728|363447547|FG000|Overall Study|Withdrawal by Subject|1|||
105392680|NCT05538728|363447548|FG001|Overall Study|Withdrawal by Subject|1|||
105392681|NCT03033784|363447549|FG000|Overall Study|Anxiety related to MRI scanner|0|||
105392682|NCT03033784|363447550|FG001|Overall Study|Anxiety related to MRI scanner|1|||
105392683|NCT03033784|363447551|FG002|Overall Study|Anxiety related to MRI scanner|0|||
105392684|NCT03033784|363447552|FG003|Overall Study|Anxiety related to MRI scanner|0|||
105392685|NCT03033784|363447553|FG004|Overall Study|Anxiety related to MRI scanner|0|||
105392686|NCT03033784|363447554|FG005|Overall Study|Anxiety related to MRI scanner|0|||
105392687|NCT03033784|363447555|FG006|Overall Study|Anxiety related to MRI scanner|0|||
105392688|NCT03033784|363447556|FG007|Overall Study|Anxiety related to MRI scanner|0|||
105392689|NCT03033784|363447557|FG008|Overall Study|Anxiety related to MRI scanner|0|||
105392690|NCT03033784|363447558|FG009|Overall Study|Anxiety related to MRI scanner|0|||
105392691|NCT03033784|363447559|FG010|Overall Study|Anxiety related to MRI scanner|0|||
105392692|NCT03033784|363447560|FG011|Overall Study|Anxiety related to MRI scanner|0|||
105392693|NCT03033784|363447561|FG012|Overall Study|Anxiety related to MRI scanner|0|||
105392694|NCT03033784|363447549|FG000|Overall Study|Withdrawal by Subject|0|||
105392695|NCT03033784|363447550|FG001|Overall Study|Withdrawal by Subject|0|||
105392696|NCT03033784|363447551|FG002|Overall Study|Withdrawal by Subject|0|||
105392697|NCT03033784|363447552|FG003|Overall Study|Withdrawal by Subject|0|||
105392698|NCT03033784|363447553|FG004|Overall Study|Withdrawal by Subject|0|||
105392699|NCT03033784|363447554|FG005|Overall Study|Withdrawal by Subject|0|||
105392700|NCT03033784|363447555|FG006|Overall Study|Withdrawal by Subject|0|||
105392701|NCT03033784|363447556|FG007|Overall Study|Withdrawal by Subject|0|||
105392702|NCT03033784|363447557|FG008|Overall Study|Withdrawal by Subject|0|||
105392703|NCT03033784|363447558|FG009|Overall Study|Withdrawal by Subject|0|||
105392704|NCT03033784|363447559|FG010|Overall Study|Withdrawal by Subject|0|||
105392705|NCT03033784|363447560|FG011|Overall Study|Withdrawal by Subject|0|||
105392706|NCT03033784|363447561|FG012|Overall Study|Withdrawal by Subject|2|||
105392707|NCT00267488|363447562|FG000|Overall Study|Sponsor Terminated Study|9|||
105392708|NCT00267488|363447562|FG000|Overall Study|Protocol Violation|1|||
105392709|NCT00267488|363447562|FG000|Overall Study|Other (Disease Progression)|1|||
105392710|NCT02093520|363447563|FG000|Overall Study|Not treated|6|||
105392711|NCT02093520|363447564|FG001|Overall Study|Not treated|22|||
105392712|NCT04992273|363447572|FG000|Overall Study|Lost to Follow-up|0|||
105392713|NCT04992273|363447573|FG001|Overall Study|Lost to Follow-up|1|||
105392714|NCT01344356|363447574|FG000|Overall Study|Physician Decision|0|||
105392715|NCT01344356|363447575|FG001|Overall Study|Physician Decision|3|||
105392716|NCT01344356|363447574|FG000|Overall Study|Lost to Follow-up|0|||
105392717|NCT01344356|363447575|FG001|Overall Study|Lost to Follow-up|6|||
105392718|NCT00505687|363447578|FG000|Overall Study|Important protocol violation|2|||
105392719|NCT00505687|363447578|FG000|Overall Study|Lack of Efficacy|15|||
105392720|NCT00505687|363447578|FG000|Overall Study|Adverse Event|48|||
105392721|NCT00505687|363447578|FG000|Overall Study|Subject withdrew consent|15|||
105392722|NCT00505687|363447578|FG000|Overall Study|Lost to Follow-up|1|||
105392723|NCT00505687|363447578|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
105392724|NCT00505687|363447578|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
105392725|NCT00505687|363447578|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
105392726|NCT00505687|363447578|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
105392727|NCT00505687|363447578|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
105392728|NCT00505687|363447578|FG000|Overall Study|Other: Disease Progression|1|||
105392729|NCT00505687|363447578|FG000|Overall Study|Other: As Per Sponsor|8|||
105392730|NCT00567502|363447579|FG000|Overall Study|Lost to Follow-up|91|||
105392731|NCT00567502|363447580|FG001|Overall Study|Lost to Follow-up|14|||
105392732|NCT00567502|363447581|FG002|Overall Study|Lost to Follow-up|351|||
105392733|NCT00567502|363447582|FG003|Overall Study|Lost to Follow-up|2|||
105392734|NCT00567502|363447579|FG000|Overall Study|Death|65|||
105392735|NCT00567502|363447580|FG001|Overall Study|Death|16|||
105392736|NCT00567502|363447581|FG002|Overall Study|Death|360|||
105392737|NCT00567502|363447582|FG003|Overall Study|Death|5|||
105392738|NCT00567502|363447579|FG000|Overall Study|Other|64|||
105392739|NCT00567502|363447580|FG001|Overall Study|Other|2|||
105392740|NCT00567502|363447581|FG002|Overall Study|Other|134|||
105392741|NCT00567502|363447582|FG003|Overall Study|Other|6|||
105392742|NCT00567502|363447579|FG000|Overall Study|Participant request|12|||
105392743|NCT00567502|363447580|FG001|Overall Study|Participant request|1|||
105392744|NCT00567502|363447581|FG002|Overall Study|Participant request|33|||
105392745|NCT00567502|363447582|FG003|Overall Study|Participant request|1|||
105392746|NCT00567502|363447579|FG000|Overall Study|Sponsor request|9|||
105392747|NCT00567502|363447580|FG001|Overall Study|Sponsor request|0|||
105392748|NCT00567502|363447581|FG002|Overall Study|Sponsor request|30|||
105392749|NCT00567502|363447582|FG003|Overall Study|Sponsor request|1|||
105392750|NCT00567502|363447579|FG000|Overall Study|Never Initiated Treatment|0|||
105392751|NCT00567502|363447580|FG001|Overall Study|Never Initiated Treatment|0|||
105392752|NCT00567502|363447581|FG002|Overall Study|Never Initiated Treatment|0|||
105392753|NCT00567502|363447582|FG003|Overall Study|Never Initiated Treatment|72|||
105392754|NCT00856557|363447583|FG000|Overall Study|No patients with contextual flags|12|||
105392755|NCT00856557|363447584|FG001|Overall Study|No patients with contextual flags|16|||
105392756|NCT03673176|363447585|FG000|Overall Study|Death prior to intervention|1|||
105392757|NCT03673176|363447585|FG000|Overall Study|Death following intervention|3|||
105392758|NCT03673176|363447585|FG000|Overall Study|Withdrawal by Subject|1|||
105392759|NCT00337168|363447586|FG000|Overall Study|Death|5|||
105392760|NCT00337168|363447586|FG000|Overall Study|Not protocol specified|2|||
105392761|NCT00337168|363447586|FG000|Overall Study|Did not start therapy|1|||
105392762|NCT03283241|363447587|FG000|Overall Study|Adverse Event|4|||
105392763|NCT03283241|363447588|FG001|Overall Study|Adverse Event|1|||
105392764|NCT03283241|363447587|FG000|Overall Study|Withdrawal by Subject|0|||
105392765|NCT03283241|363447588|FG001|Overall Study|Withdrawal by Subject|1|||
105392766|NCT03283241|363447587|FG000|Overall Study|Subject relocated to Finland|0|||
105392767|NCT03283241|363447588|FG001|Overall Study|Subject relocated to Finland|1|||
105392768|NCT00666263|363447591|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
105392769|NCT00666263|363447592|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
105392770|NCT00666263|363447591|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
105392771|NCT00666263|363447592|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
105392772|NCT00666263|363447591|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
105392773|NCT00666263|363447592|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
105392774|NCT00586157|363447598|FG000|First Intervention|Worsening behavior|1|||
105392775|NCT00586157|363447599|FG001|First Intervention|Worsening behavior|0|||
105392776|NCT00586157|363447598|FG000|Second Intervention|Withdrawal by Subject|1|||
105392777|NCT00586157|363447599|FG001|Second Intervention|Withdrawal by Subject|0|||
105392778|NCT00586157|363447598|FG000|Second Intervention|Worsening behavior|1|||
105392779|NCT00586157|363447599|FG001|Second Intervention|Worsening behavior|0|||
105392780|NCT00586157|363447598|FG000|Second Intervention|Adverse Event|0|||
105392781|NCT00586157|363447599|FG001|Second Intervention|Adverse Event|1|||
105392782|NCT04484857|363447600|FG000|Overall Study|Adverse Event|2|||
105392783|NCT04484857|363447600|FG000|Overall Study|Death|10|||
105392784|NCT04484857|363447600|FG000|Overall Study|Withdrawal by Subject|3|||
105392785|NCT04484857|363447600|FG000|Overall Study|Transferred/Relocation|5|||
105392786|NCT04484857|363447600|FG000|Overall Study|Kidney Transplant|7|||
105392787|NCT04484857|363447600|FG000|Overall Study|Other than specified|4|||
105392788|NCT04484857|363447600|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
105392789|NCT01225952|363447602|FG000|Overall Study|Lost to Follow-up|1|||
105392790|NCT01225952|363447603|FG001|Overall Study|Lost to Follow-up|0|||
105580578|NCT02018861|364126448|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
105580579|NCT02018861|364126449|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
105392791|NCT01225952|363447604|FG002|Overall Study|Lost to Follow-up|0|||
105392792|NCT01225952|363447602|FG000|Overall Study|Study Eye Explanted|0|||
105392793|NCT01225952|363447603|FG001|Overall Study|Study Eye Explanted|0|||
105392794|NCT01225952|363447604|FG002|Overall Study|Study Eye Explanted|1|||
105392795|NCT01225952|363447602|FG000|Overall Study|Withdrawal by Subject|4|||
105392796|NCT01225952|363447603|FG001|Overall Study|Withdrawal by Subject|4|||
105392797|NCT01225952|363447604|FG002|Overall Study|Withdrawal by Subject|5|||
105392798|NCT01225952|363447602|FG000|Overall Study|Surgical complications|1|||
105392799|NCT01225952|363447603|FG001|Overall Study|Surgical complications|0|||
105392800|NCT01225952|363447604|FG002|Overall Study|Surgical complications|0|||
105392801|NCT02378480|363447605|FG000|Overall Study|Physician Decision|1|||
105392802|NCT02378480|363447606|FG001|Overall Study|Physician Decision|1|||
105392803|NCT02378480|363447605|FG000|Overall Study|Death|1|||
105392804|NCT02378480|363447606|FG001|Overall Study|Death|2|||
105392805|NCT02378480|363447605|FG000|Overall Study|Randomized, but Not Treated|6|||
105392806|NCT02378480|363447606|FG001|Overall Study|Randomized, but Not Treated|4|||
105392807|NCT02378480|363447605|FG000|Overall Study|Adverse Event|0|||
105392808|NCT02378480|363447606|FG001|Overall Study|Adverse Event|1|||
105392809|NCT02378480|363447605|FG000|Overall Study|Missed EOT/PTE Visit|1|||
105392810|NCT02378480|363447606|FG001|Overall Study|Missed EOT/PTE Visit|2|||
105392811|NCT02378480|363447605|FG000|Overall Study|Withdrawal by Subject|9|||
105392812|NCT02378480|363447606|FG001|Overall Study|Withdrawal by Subject|4|||
105392813|NCT02378480|363447605|FG000|Overall Study|Lost to Follow-up|10|||
105392814|NCT02378480|363447606|FG001|Overall Study|Lost to Follow-up|18|||
105392815|NCT01217892|363447607|FG000|Overall Study|Adverse Event|1|||
105392816|NCT01217892|363447608|FG001|Overall Study|Adverse Event|1|||
105392817|NCT01217892|363447609|FG002|Overall Study|Adverse Event|1|||
105392818|NCT01217892|363447610|FG003|Overall Study|Adverse Event|0|||
105392819|NCT01217892|363447607|FG000|Overall Study|Withdrawal by Subject|0|||
105392820|NCT01217892|363447608|FG001|Overall Study|Withdrawal by Subject|2|||
105392821|NCT01217892|363447609|FG002|Overall Study|Withdrawal by Subject|1|||
105392822|NCT01217892|363447610|FG003|Overall Study|Withdrawal by Subject|0|||
105392823|NCT01217892|363447607|FG000|Overall Study|Lab value|1|||
105392824|NCT01217892|363447608|FG001|Overall Study|Lab value|0|||
105392825|NCT01217892|363447609|FG002|Overall Study|Lab value|1|||
105392826|NCT01217892|363447610|FG003|Overall Study|Lab value|0|||
105392827|NCT01217892|363447607|FG000|Overall Study|Subject no longer meets study criteria|5|||
105392828|NCT01217892|363447608|FG001|Overall Study|Subject no longer meets study criteria|2|||
105392829|NCT01217892|363447609|FG002|Overall Study|Subject no longer meets study criteria|4|||
105392830|NCT01217892|363447610|FG003|Overall Study|Subject no longer meets study criteria|8|||
105392831|NCT01217892|363447607|FG000|Overall Study|Incorrect enrollment|0|||
105392832|NCT01217892|363447608|FG001|Overall Study|Incorrect enrollment|1|||
105392833|NCT01217892|363447609|FG002|Overall Study|Incorrect enrollment|1|||
105392834|NCT01217892|363447610|FG003|Overall Study|Incorrect enrollment|0|||
105392835|NCT01217892|363447607|FG000|Overall Study|Poor/Non-Compliance|0|||
105392836|NCT01217892|363447608|FG001|Overall Study|Poor/Non-Compliance|0|||
105392837|NCT01217892|363447609|FG002|Overall Study|Poor/Non-Compliance|1|||
105392838|NCT01217892|363447610|FG003|Overall Study|Poor/Non-Compliance|0|||
105392839|NCT01285102|363447611|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
105392840|NCT02157610|363447612|FG000|Overall Study|Death|4|||
105392841|NCT02157610|363447613|FG001|Overall Study|Death|4|||
105392842|NCT02327169|363447626|FG000|Overall Study|Progressive Disease|1|||
105392843|NCT02327169|363447627|FG001|Overall Study|Progressive Disease|3|||
105392844|NCT02327169|363447628|FG002|Overall Study|Progressive Disease|4|||
105392845|NCT02327169|363447629|FG003|Overall Study|Progressive Disease|3|||
105392846|NCT02327169|363447630|FG004|Overall Study|Progressive Disease|4|||
105392847|NCT02327169|363447631|FG005|Overall Study|Progressive Disease|3|||
105392848|NCT02327169|363447632|FG006|Overall Study|Progressive Disease|3|||
105392849|NCT02327169|363447633|FG007|Overall Study|Progressive Disease|3|||
105392850|NCT02327169|363447634|FG008|Overall Study|Progressive Disease|4|||
105392851|NCT02327169|363447635|FG009|Overall Study|Progressive Disease|4|||
105392852|NCT02327169|363447636|FG010|Overall Study|Progressive Disease|4|||
105392853|NCT02327169|363447637|FG011|Overall Study|Progressive Disease|3|||
105392854|NCT02327169|363447638|FG012|Overall Study|Progressive Disease|1|||
105392855|NCT02327169|363447639|FG013|Overall Study|Progressive Disease|3|||
105392856|NCT02327169|363447640|FG014|Overall Study|Progressive Disease|3|||
105392857|NCT02327169|363447626|FG000|Overall Study|Adverse Event|2|||
105392858|NCT02327169|363447627|FG001|Overall Study|Adverse Event|0|||
105392859|NCT02327169|363447628|FG002|Overall Study|Adverse Event|1|||
105392860|NCT02327169|363447629|FG003|Overall Study|Adverse Event|0|||
105392861|NCT02327169|363447630|FG004|Overall Study|Adverse Event|1|||
105392862|NCT02327169|363447631|FG005|Overall Study|Adverse Event|0|||
105392863|NCT02327169|363447632|FG006|Overall Study|Adverse Event|0|||
105392864|NCT02327169|363447633|FG007|Overall Study|Adverse Event|0|||
105392865|NCT02327169|363447634|FG008|Overall Study|Adverse Event|0|||
105392866|NCT02327169|363447635|FG009|Overall Study|Adverse Event|2|||
105392867|NCT02327169|363447636|FG010|Overall Study|Adverse Event|0|||
105392868|NCT02327169|363447637|FG011|Overall Study|Adverse Event|3|||
105392869|NCT02327169|363447638|FG012|Overall Study|Adverse Event|0|||
105392870|NCT02327169|363447639|FG013|Overall Study|Adverse Event|2|||
105392871|NCT02327169|363447640|FG014|Overall Study|Adverse Event|1|||
105392872|NCT02327169|363447626|FG000|Overall Study|Symptomatic Deterioration|0|||
105392873|NCT02327169|363447627|FG001|Overall Study|Symptomatic Deterioration|0|||
105392874|NCT02327169|363447628|FG002|Overall Study|Symptomatic Deterioration|1|||
105392875|NCT02327169|363447629|FG003|Overall Study|Symptomatic Deterioration|0|||
105392876|NCT02327169|363447630|FG004|Overall Study|Symptomatic Deterioration|1|||
105392877|NCT02327169|363447631|FG005|Overall Study|Symptomatic Deterioration|1|||
105392878|NCT02327169|363447632|FG006|Overall Study|Symptomatic Deterioration|0|||
105392879|NCT02327169|363447633|FG007|Overall Study|Symptomatic Deterioration|0|||
105392880|NCT02327169|363447634|FG008|Overall Study|Symptomatic Deterioration|2|||
105392881|NCT02327169|363447635|FG009|Overall Study|Symptomatic Deterioration|1|||
105392882|NCT02327169|363447636|FG010|Overall Study|Symptomatic Deterioration|0|||
105392883|NCT02327169|363447637|FG011|Overall Study|Symptomatic Deterioration|0|||
105392884|NCT02327169|363447638|FG012|Overall Study|Symptomatic Deterioration|0|||
105392885|NCT02327169|363447639|FG013|Overall Study|Symptomatic Deterioration|2|||
105392886|NCT02327169|363447640|FG014|Overall Study|Symptomatic Deterioration|1|||
105392887|NCT02327169|363447626|FG000|Overall Study|Reason Not Specified|0|||
105392888|NCT02327169|363447627|FG001|Overall Study|Reason Not Specified|0|||
105392889|NCT02327169|363447628|FG002|Overall Study|Reason Not Specified|1|||
105392890|NCT02327169|363447629|FG003|Overall Study|Reason Not Specified|0|||
105392891|NCT02327169|363447630|FG004|Overall Study|Reason Not Specified|0|||
105392892|NCT02327169|363447631|FG005|Overall Study|Reason Not Specified|0|||
105392893|NCT02327169|363447632|FG006|Overall Study|Reason Not Specified|0|||
105392894|NCT02327169|363447633|FG007|Overall Study|Reason Not Specified|0|||
105392895|NCT02327169|363447634|FG008|Overall Study|Reason Not Specified|0|||
105392896|NCT02327169|363447635|FG009|Overall Study|Reason Not Specified|1|||
105392897|NCT02327169|363447636|FG010|Overall Study|Reason Not Specified|2|||
105392898|NCT02327169|363447637|FG011|Overall Study|Reason Not Specified|1|||
105392899|NCT02327169|363447638|FG012|Overall Study|Reason Not Specified|0|||
105392900|NCT02327169|363447639|FG013|Overall Study|Reason Not Specified|0|||
105392901|NCT02327169|363447640|FG014|Overall Study|Reason Not Specified|2|||
105392902|NCT02327169|363447626|FG000|Overall Study|Withdrawal by Subject|1|||
105392903|NCT02327169|363447627|FG001|Overall Study|Withdrawal by Subject|0|||
105392904|NCT02327169|363447628|FG002|Overall Study|Withdrawal by Subject|0|||
105392905|NCT02327169|363447629|FG003|Overall Study|Withdrawal by Subject|0|||
105392906|NCT02327169|363447630|FG004|Overall Study|Withdrawal by Subject|1|||
105392907|NCT02327169|363447631|FG005|Overall Study|Withdrawal by Subject|0|||
105392908|NCT02327169|363447632|FG006|Overall Study|Withdrawal by Subject|0|||
105392909|NCT02327169|363447633|FG007|Overall Study|Withdrawal by Subject|1|||
105392910|NCT02327169|363447634|FG008|Overall Study|Withdrawal by Subject|0|||
105392911|NCT02327169|363447635|FG009|Overall Study|Withdrawal by Subject|0|||
105392912|NCT02327169|363447636|FG010|Overall Study|Withdrawal by Subject|0|||
105392913|NCT02327169|363447637|FG011|Overall Study|Withdrawal by Subject|0|||
105392914|NCT02327169|363447638|FG012|Overall Study|Withdrawal by Subject|0|||
105392915|NCT02327169|363447639|FG013|Overall Study|Withdrawal by Subject|0|||
105392916|NCT02327169|363447640|FG014|Overall Study|Withdrawal by Subject|3|||
105392917|NCT02327169|363447626|FG000|Overall Study|Lost to Follow-up|0|||
105392918|NCT02327169|363447627|FG001|Overall Study|Lost to Follow-up|0|||
105392919|NCT02327169|363447628|FG002|Overall Study|Lost to Follow-up|0|||
105392920|NCT02327169|363447629|FG003|Overall Study|Lost to Follow-up|0|||
105392921|NCT02327169|363447630|FG004|Overall Study|Lost to Follow-up|1|||
105392922|NCT02327169|363447631|FG005|Overall Study|Lost to Follow-up|0|||
105392923|NCT02327169|363447632|FG006|Overall Study|Lost to Follow-up|0|||
105392924|NCT02327169|363447633|FG007|Overall Study|Lost to Follow-up|0|||
105392925|NCT02327169|363447634|FG008|Overall Study|Lost to Follow-up|0|||
105392926|NCT02327169|363447635|FG009|Overall Study|Lost to Follow-up|0|||
105392927|NCT02327169|363447636|FG010|Overall Study|Lost to Follow-up|0|||
105392928|NCT02327169|363447637|FG011|Overall Study|Lost to Follow-up|0|||
105493114|NCT01886716|363818776|FG000|Week 2|Lost to Follow-up|3|||
105493115|NCT01886716|363818777|FG001|Week 2|Lost to Follow-up|2|||
105493116|NCT01886716|363818778|FG002|Week 2|Lost to Follow-up|1|||
105392929|NCT02327169|363447638|FG012|Overall Study|Lost to Follow-up|0|||
105392930|NCT02327169|363447639|FG013|Overall Study|Lost to Follow-up|0|||
105392931|NCT02327169|363447640|FG014|Overall Study|Lost to Follow-up|0|||
105392932|NCT00478257|363447642|FG000|Overall Study|Withdrawal by Subject|8|||
105392933|NCT00478257|363447643|FG001|Overall Study|Withdrawal by Subject|3|||
105392934|NCT01055028|363447645|FG000|Screening|Screen Failure|1|||
105392935|NCT01055028|363447646|FG001|Screening|Screen Failure|1|||
105392936|NCT01055028|363447645|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
105392937|NCT01055028|363447646|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
105392938|NCT01055028|363447645|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
105392939|NCT01055028|363447646|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
105392940|NCT01055028|363447645|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
105392941|NCT01055028|363447646|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
105392942|NCT03931330|363447647|FG000|Overall Study|Physician Decision|1|||
105392943|NCT01381679|363447650|FG000|Overall Study|Adverse Event|3|||
105392944|NCT01381679|363447650|FG000|Overall Study|Lost to Follow-up|885|||
105392945|NCT02758626|363447651|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
105493117|NCT01886716|363818779|FG003|Week 2|Lost to Follow-up|3|||
105392946|NCT02758626|363447652|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
105392947|NCT02758626|363447651|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
105392948|NCT02758626|363447652|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
105392949|NCT02758626|363447651|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
105392950|NCT02758626|363447652|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
105392951|NCT02758626|363447651|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
105392952|NCT02758626|363447652|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
105392953|NCT02609503|363447653|FG000|Overall Study|Adverse Event|1|||
105392954|NCT02609503|363447653|FG000|Overall Study|Death|1|||
105392955|NCT02609503|363447653|FG000|Overall Study|Withdrawal by Subject|1|||
105392956|NCT02609503|363447653|FG000|Overall Study|Disease progression|1|||
105392957|NCT02096354|363447654|FG000|Overall Study|Physician Decision|4|||
105392958|NCT02096354|363447655|FG001|Overall Study|Physician Decision|5|||
105392959|NCT02096354|363447656|FG002|Overall Study|Physician Decision|0|||
105392960|NCT02096354|363447654|FG000|Overall Study|Withdrawal by Subject|3|||
105392961|NCT02096354|363447655|FG001|Overall Study|Withdrawal by Subject|1|||
105392962|NCT02096354|363447656|FG002|Overall Study|Withdrawal by Subject|0|||
105392963|NCT02096354|363447654|FG000|Overall Study|Adverse Event|7|||
105392964|NCT02096354|363447655|FG001|Overall Study|Adverse Event|4|||
105392965|NCT02096354|363447656|FG002|Overall Study|Adverse Event|0|||
105392966|NCT02096354|363447654|FG000|Overall Study|Ineligible|0|||
105392967|NCT02096354|363447655|FG001|Overall Study|Ineligible|0|||
105392968|NCT02096354|363447656|FG002|Overall Study|Ineligible|11|||
105392969|NCT02951819|363447657|FG000|Overall Study|Death|9|||
105392970|NCT02951819|363447658|FG001|Overall Study|Death|7|||
105392971|NCT02951819|363447657|FG000|Overall Study|Withdrawal by Subject|3|||
105392972|NCT02951819|363447658|FG001|Overall Study|Withdrawal by Subject|0|||
105392973|NCT02951819|363447657|FG000|Overall Study|Adverse Event|1|||
105392974|NCT02951819|363447658|FG001|Overall Study|Adverse Event|0|||
105392975|NCT02951819|363447657|FG000|Overall Study|Lack of Efficacy|4|||
105392976|NCT02951819|363447658|FG001|Overall Study|Lack of Efficacy|0|||
105392977|NCT02951819|363447657|FG000|Overall Study|Lost to Follow-up|1|||
105392978|NCT02951819|363447658|FG001|Overall Study|Lost to Follow-up|0|||
105392979|NCT02951819|363447657|FG000|Overall Study|Progressive Disease|1|||
105392980|NCT02951819|363447658|FG001|Overall Study|Progressive Disease|0|||
105392981|NCT02951819|363447657|FG000|Overall Study|Other|9|||
105392982|NCT02951819|363447658|FG001|Overall Study|Other|0|||
105392983|NCT03647137|363447660|FG000|Overall Study|Scan Limitation|2|||
105392984|NCT03647137|363447661|FG001|Overall Study|Scan Limitation|1|||
105392985|NCT03647137|363447662|FG002|Overall Study|Scan Limitation|1|||
105392986|NCT03647137|363447663|FG003|Overall Study|Scan Limitation|2|||
105392987|NCT04629196|363447664|FG000|Overall Study|Subject discontinued study drug|1|||
105392988|NCT04629196|363447665|FG001|Overall Study|Subject discontinued study drug|0|||
105392989|NCT04629196|363447664|FG000|Overall Study|Subject study drug dosing increased|1|||
105392990|NCT04629196|363447665|FG001|Overall Study|Subject study drug dosing increased|1|||
105392991|NCT04629196|363447664|FG000|Overall Study|Withdrawal by Subject|1|||
105392992|NCT04629196|363447665|FG001|Overall Study|Withdrawal by Subject|2|||
105392993|NCT05810597|363447666|FG000|Period 1|Adverse Event|2|||
105392994|NCT05810597|363447667|FG001|Period 1|Adverse Event|0|||
105392995|NCT05810597|363447666|FG000|Period 1|Physician Decision|1|||
105392996|NCT05810597|363447667|FG001|Period 1|Physician Decision|0|||
105392997|NCT03709472|363447670|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
105392998|NCT03709472|363447671|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
105392999|NCT03709472|363447670|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
105393000|NCT03709472|363447671|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
105393001|NCT00642759|363447672|FG000|Overall Study|Protocol Violation|1|||
105393002|NCT02657356|363448836|FG000|Overall Study|Death|1|||
105393003|NCT02657356|363448837|FG001|Overall Study|Death|0|||
105393004|NCT02657356|363448836|FG000|Overall Study|Withdrawal by Subject|5|||
105493118|NCT01886716|363818776|FG000|Week 3|Lost to Follow-up|1|||
105493119|NCT01886716|363818777|FG001|Week 3|Lost to Follow-up|1|||
105393005|NCT02657356|363448837|FG001|Overall Study|Withdrawal by Subject|6|||
105393006|NCT02657356|363448836|FG000|Overall Study|Terminated by Sponsor|8|||
105493120|NCT01886716|363818778|FG002|Week 3|Lost to Follow-up|0|||
105393007|NCT02657356|363448837|FG001|Overall Study|Terminated by Sponsor|5|||
105493121|NCT01886716|363818779|FG003|Week 3|Lost to Follow-up|1|||
105493122|NCT00736957|363818780|FG000|Overall Study|Adverse Event|43|||
105393008|NCT02657356|363448836|FG000|Overall Study|Rolled over to EAP study|6|||
105393009|NCT02657356|363448837|FG001|Overall Study|Rolled over to EAP study|4|||
105393010|NCT03443401|363448840|FG000|Overall Study|Lost to Follow-up|13|||
105393011|NCT03443401|363448840|FG000|Overall Study|Influential outlier|1|||
105393012|NCT00936936|363448841|FG000|Overall Study|Adverse Event|7|||
105393013|NCT00936936|363448842|FG001|Overall Study|Adverse Event|1|||
105393014|NCT00936936|363448841|FG000|Overall Study|Disease Progression|2|||
105393015|NCT00936936|363448842|FG001|Overall Study|Disease Progression|2|||
105393016|NCT00936936|363448841|FG000|Overall Study|Unrelated|3|||
105493123|NCT00736957|363818780|FG000|Overall Study|Withdrawal by Subject|49|||
105393017|NCT00936936|363448842|FG001|Overall Study|Unrelated|1|||
105393018|NCT01394185|363448843|FG000|Overall Study|Withdrawal by Subject|2|||
105393019|NCT01394185|363448844|FG001|Overall Study|Withdrawal by Subject|0|||
105393020|NCT01394185|363448845|FG002|Overall Study|Withdrawal by Subject|0|||
105393021|NCT01394185|363448846|FG003|Overall Study|Withdrawal by Subject|0|||
105393022|NCT01394185|363448847|FG004|Overall Study|Withdrawal by Subject|1|||
105393023|NCT01394185|363448848|FG005|Overall Study|Withdrawal by Subject|0|||
105393024|NCT01394185|363448843|FG000|Overall Study|Change in protocol|3|||
105393025|NCT01394185|363448844|FG001|Overall Study|Change in protocol|0|||
105393026|NCT01394185|363448845|FG002|Overall Study|Change in protocol|0|||
105393027|NCT01394185|363448846|FG003|Overall Study|Change in protocol|0|||
105393028|NCT01394185|363448847|FG004|Overall Study|Change in protocol|3|||
105393029|NCT01394185|363448848|FG005|Overall Study|Change in protocol|0|||
105393030|NCT01394185|363448843|FG000|Overall Study|Protocol Violation|1|||
105393031|NCT01394185|363448844|FG001|Overall Study|Protocol Violation|0|||
105393032|NCT01394185|363448845|FG002|Overall Study|Protocol Violation|0|||
105393033|NCT01394185|363448846|FG003|Overall Study|Protocol Violation|1|||
105393034|NCT01394185|363448847|FG004|Overall Study|Protocol Violation|0|||
105393035|NCT01394185|363448848|FG005|Overall Study|Protocol Violation|1|||
105393036|NCT02254460|363448853|FG000|Overall Study|Adverse Event|1|||
105393037|NCT02254460|363448854|FG001|Overall Study|Adverse Event|0|||
105393038|NCT00321932|363448855|FG000|Overall Study|Death|3|||
105393039|NCT00321932|363448856|FG001|Overall Study|Death|6|||
105393040|NCT00321932|363448855|FG000|Overall Study|Withdrawal by Subject|3|||
105393041|NCT00321932|363448856|FG001|Overall Study|Withdrawal by Subject|6|||
105393042|NCT00321932|363448855|FG000|Overall Study|Early relapse|2|||
105393043|NCT00321932|363448856|FG001|Overall Study|Early relapse|8|||
105393044|NCT00321932|363448855|FG000|Overall Study|Missing data|2|||
105393045|NCT00321932|363448856|FG001|Overall Study|Missing data|1|||
105393046|NCT01904279|363448858|FG000|Overall Study|Lack of Efficacy|2|||
105393047|NCT01904279|363448859|FG001|Overall Study|Lack of Efficacy|3|||
105393048|NCT01904279|363448858|FG000|Overall Study|Withdrawal by Subject|1|||
105393049|NCT01904279|363448859|FG001|Overall Study|Withdrawal by Subject|0|||
105393050|NCT01230060|363448866|FG000|Overall Study|Withdrawal by Subject|1|||
105393051|NCT05763381|363448867|FG000|Overall Study|Lost to Follow-up|2|||
105393052|NCT05763381|363448868|FG001|Overall Study|Lost to Follow-up|3|||
105393053|NCT05763381|363448867|FG000|Overall Study|Withdrawal by Subject|1|||
105393054|NCT05763381|363448868|FG001|Overall Study|Withdrawal by Subject|2|||
105393055|NCT02853136|363448871|FG000|Wash-out|Adverse Event|0|||
105393056|NCT02853136|363448872|FG001|Wash-out|Adverse Event|0|||
105393057|NCT02853136|363448873|FG002|Wash-out|Adverse Event|0|||
105393058|NCT02853136|363448874|FG003|Wash-out|Adverse Event|1|||
105393059|NCT00863304|363448875|FG000|Overall Study|Adverse Event|10|||
105393060|NCT00863304|363448876|FG001|Overall Study|Adverse Event|4|||
105393061|NCT00863304|363448877|FG002|Overall Study|Adverse Event|14|||
105393062|NCT00863304|363448878|FG003|Overall Study|Adverse Event|16|||
105393063|NCT00863304|363448875|FG000|Overall Study|Lost to Follow-up|1|||
105393064|NCT00863304|363448876|FG001|Overall Study|Lost to Follow-up|5|||
105393065|NCT00863304|363448877|FG002|Overall Study|Lost to Follow-up|4|||
105393066|NCT00863304|363448878|FG003|Overall Study|Lost to Follow-up|2|||
105393067|NCT00863304|363448875|FG000|Overall Study|Lack of Efficacy|57|||
105393068|NCT00863304|363448876|FG001|Overall Study|Lack of Efficacy|26|||
105393069|NCT00863304|363448877|FG002|Overall Study|Lack of Efficacy|30|||
105393070|NCT00863304|363448878|FG003|Overall Study|Lack of Efficacy|28|||
105393071|NCT00863304|363448875|FG000|Overall Study|Withdrawal by Subject|19|||
105393072|NCT00863304|363448876|FG001|Overall Study|Withdrawal by Subject|14|||
105393073|NCT00863304|363448877|FG002|Overall Study|Withdrawal by Subject|20|||
105393074|NCT00863304|363448878|FG003|Overall Study|Withdrawal by Subject|18|||
105393075|NCT00863304|363448875|FG000|Overall Study|Other|1|||
105393076|NCT00863304|363448876|FG001|Overall Study|Other|0|||
105393077|NCT00863304|363448877|FG002|Overall Study|Other|0|||
105393078|NCT00863304|363448878|FG003|Overall Study|Other|1|||
105393079|NCT00863304|363448875|FG000|Overall Study|Protocol Violation|2|||
105393080|NCT00863304|363448876|FG001|Overall Study|Protocol Violation|6|||
105393081|NCT00863304|363448877|FG002|Overall Study|Protocol Violation|2|||
105393082|NCT00863304|363448878|FG003|Overall Study|Protocol Violation|0|||
105393083|NCT00863304|363448875|FG000|Overall Study|Randomized, but not Treated|3|||
105393084|NCT00863304|363448876|FG001|Overall Study|Randomized, but not Treated|1|||
105393085|NCT00863304|363448877|FG002|Overall Study|Randomized, but not Treated|4|||
105393086|NCT00863304|363448878|FG003|Overall Study|Randomized, but not Treated|1|||
105393087|NCT00863304|363448875|FG000|Overall Study|Entered extension study|101|||
105393088|NCT00863304|363448876|FG001|Overall Study|Entered extension study|129|||
105393089|NCT00863304|363448877|FG002|Overall Study|Entered extension study|113|||
105393090|NCT00863304|363448878|FG003|Overall Study|Entered extension study|125|||
105393091|NCT06582732|363448881|FG000|Initial Study Period|Adverse Event|0|||
105393092|NCT06582732|363448882|FG001|Initial Study Period|Adverse Event|0|||
105393093|NCT06582732|363448883|FG002|Initial Study Period|Adverse Event|0|||
105393094|NCT06582732|363448884|FG003|Initial Study Period|Adverse Event|2|||
105393095|NCT06582732|363448885|FG004|Initial Study Period|Adverse Event|0|||
105393096|NCT06582732|363448886|FG005|Initial Study Period|Adverse Event|0|||
105393097|NCT06582732|363448887|FG006|Initial Study Period|Adverse Event|0|||
105393098|NCT06582732|363448881|FG000|Initial Study Period|Death|1|||
105393099|NCT06582732|363448882|FG001|Initial Study Period|Death|0|||
105393100|NCT06582732|363448883|FG002|Initial Study Period|Death|0|||
105393101|NCT06582732|363448884|FG003|Initial Study Period|Death|0|||
105393102|NCT06582732|363448885|FG004|Initial Study Period|Death|1|||
105393103|NCT06582732|363448886|FG005|Initial Study Period|Death|0|||
105393104|NCT06582732|363448887|FG006|Initial Study Period|Death|0|||
105393105|NCT06582732|363448881|FG000|Initial Study Period|Lost to Follow-up|0|||
105393106|NCT06582732|363448882|FG001|Initial Study Period|Lost to Follow-up|0|||
105393107|NCT06582732|363448883|FG002|Initial Study Period|Lost to Follow-up|2|||
105393108|NCT06582732|363448884|FG003|Initial Study Period|Lost to Follow-up|0|||
105393109|NCT06582732|363448885|FG004|Initial Study Period|Lost to Follow-up|0|||
105393110|NCT06582732|363448886|FG005|Initial Study Period|Lost to Follow-up|0|||
105393111|NCT06582732|363448887|FG006|Initial Study Period|Lost to Follow-up|0|||
105393112|NCT06582732|363448881|FG000|Initial Study Period|Withdrawal by Subject|0|||
105393113|NCT06582732|363448882|FG001|Initial Study Period|Withdrawal by Subject|1|||
105393114|NCT06582732|363448883|FG002|Initial Study Period|Withdrawal by Subject|0|||
105393115|NCT06582732|363448884|FG003|Initial Study Period|Withdrawal by Subject|1|||
105393116|NCT06582732|363448885|FG004|Initial Study Period|Withdrawal by Subject|3|||
105393117|NCT06582732|363448886|FG005|Initial Study Period|Withdrawal by Subject|1|||
105393118|NCT06582732|363448887|FG006|Initial Study Period|Withdrawal by Subject|2|||
105393119|NCT06582732|363448881|FG000|Initial Study Period|Moved Away|0|||
105393120|NCT06582732|363448882|FG001|Initial Study Period|Moved Away|0|||
105393121|NCT06582732|363448883|FG002|Initial Study Period|Moved Away|0|||
105393122|NCT06582732|363448884|FG003|Initial Study Period|Moved Away|0|||
105393123|NCT06582732|363448885|FG004|Initial Study Period|Moved Away|1|||
105393124|NCT06582732|363448886|FG005|Initial Study Period|Moved Away|0|||
105393125|NCT06582732|363448887|FG006|Initial Study Period|Moved Away|0|||
105393126|NCT04023487|363448890|FG000|Overall Study|Lost to Follow-up|5|||
105393127|NCT04023487|363448891|FG001|Overall Study|Lost to Follow-up|4|||
105393128|NCT04023487|363448890|FG000|Overall Study|Pregnancy|1|||
105393129|NCT04023487|363448891|FG001|Overall Study|Pregnancy|2|||
105393130|NCT04023487|363448890|FG000|Overall Study|Withdrawal by Subject|4|||
105393131|NCT04023487|363448891|FG001|Overall Study|Withdrawal by Subject|5|||
105393132|NCT04023487|363448890|FG000|Overall Study|Partially completed testing|8|||
105393133|NCT04023487|363448891|FG001|Overall Study|Partially completed testing|4|||
105393134|NCT02919618|363448892|FG000|Overall Study|Death|1|||
105393135|NCT02592863|363448893|FG000|Overall Study|Withdrawal by Subject|2|||
105393136|NCT02592863|363448894|FG001|Overall Study|Withdrawal by Subject|2|||
105393137|NCT02592863|363448893|FG000|Overall Study|Lost to Follow-up|1|||
105393138|NCT02592863|363448894|FG001|Overall Study|Lost to Follow-up|1|||
105493124|NCT00736957|363818780|FG000|Overall Study|violation of eligibility criteria|2|||
105393139|NCT02743221|363448895|FG000|Overall Study|Progressive disease|29|||
105393140|NCT02743221|363448896|FG001|Overall Study|Progressive disease|38|||
105393141|NCT02743221|363448895|FG000|Overall Study|Adverse Event|17|||
105393142|NCT02743221|363448896|FG001|Overall Study|Adverse Event|14|||
105393143|NCT02743221|363448895|FG000|Overall Study|non medical reason|8|||
105393144|NCT02743221|363448896|FG001|Overall Study|non medical reason|2|||
105393145|NCT02743221|363448895|FG000|Overall Study|Physician Decision|2|||
105393146|NCT02743221|363448896|FG001|Overall Study|Physician Decision|5|||
105393147|NCT02743221|363448895|FG000|Overall Study|Patient not eligible, not treated|0|||
105393148|NCT02743221|363448896|FG001|Overall Study|Patient not eligible, not treated|1|||
105393149|NCT04770285|363448898|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
105393150|NCT04770285|363448899|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
105393151|NCT04770285|363448898|FG000|Overall Study|Lack of Efficacy|0|||
105393152|NCT04770285|363448899|FG001|Overall Study|Lack of Efficacy|1|||
105393153|NCT04770285|363448898|FG000|Overall Study|Lost to Follow-up|11|||
105393154|NCT04770285|363448899|FG001|Overall Study|Lost to Follow-up|8|||
105393155|NCT04770285|363448898|FG000|Overall Study|Protocol Deviation|6|||
105393156|NCT04770285|363448899|FG001|Overall Study|Protocol Deviation|6|||
105393157|NCT04770285|363448898|FG000|Overall Study|Technical Problem|0|||
105393158|NCT04770285|363448899|FG001|Overall Study|Technical Problem|1|||
105393159|NCT04770285|363448898|FG000|Overall Study|Withdrawal by Subject|9|||
105393160|NCT04770285|363448899|FG001|Overall Study|Withdrawal by Subject|8|||
105393161|NCT04770285|363448898|FG000|Overall Study|Reason Not Specified|0|||
105393162|NCT04770285|363448899|FG001|Overall Study|Reason Not Specified|1|||
105393163|NCT03464461|363448900|FG000|Overall Study|exclusionary medication given ,|1|||
105393164|NCT03464461|363448901|FG001|Overall Study|exclusionary medication given ,|2|||
105393165|NCT03464461|363448902|FG002|Overall Study|exclusionary medication given ,|0|||
105393166|NCT03464461|363448900|FG000|Overall Study|Physician Decision|0|||
105393167|NCT03464461|363448901|FG001|Overall Study|Physician Decision|1|||
105393168|NCT03464461|363448902|FG002|Overall Study|Physician Decision|0|||
105393169|NCT01472185|363448906|FG000|Overall Study|Randomized but Not Treated|0|||
105393170|NCT01472185|363448907|FG001|Overall Study|Randomized but Not Treated|1|||
105393171|NCT01472185|363448906|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
105393172|NCT01472185|363448907|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
105393173|NCT01472185|363448906|FG000|Overall Study|Hyperglycemia|5|||
105393174|NCT01472185|363448907|FG001|Overall Study|Hyperglycemia|2|||
105393175|NCT01472185|363448906|FG000|Overall Study|Investigator's Discretion|3|||
105393176|NCT01472185|363448907|FG001|Overall Study|Investigator's Discretion|1|||
105393177|NCT01472185|363448906|FG000|Overall Study|Lost to Follow-up|4|||
105393178|NCT01472185|363448907|FG001|Overall Study|Lost to Follow-up|1|||
105393179|NCT01472185|363448906|FG000|Overall Study|Protocol Violation|5|||
105393180|NCT01472185|363448907|FG001|Overall Study|Protocol Violation|1|||
105393181|NCT01472185|363448906|FG000|Overall Study|Subject Noncompliance|8|||
105393182|NCT01472185|363448907|FG001|Overall Study|Subject Noncompliance|15|||
105393183|NCT01472185|363448906|FG000|Overall Study|Subject Withdrew Consent|6|||
105393184|NCT01472185|363448907|FG001|Overall Study|Subject Withdrew Consent|3|||
105393185|NCT02284893|363448910|FG000|26 Week (Short Term)|Adverse Event|1|||
105393186|NCT02284893|363448911|FG001|26 Week (Short Term)|Adverse Event|9|||
105393187|NCT02284893|363448910|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
105393188|NCT02284893|363448911|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
105393189|NCT02284893|363448910|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
105393190|NCT02284893|363448911|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
105393191|NCT02284893|363448910|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
105393192|NCT02284893|363448911|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
105393193|NCT02284893|363448910|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
105393194|NCT02284893|363448911|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
105393195|NCT02284893|363448910|FG000|26 Week (Short Term)|Other|1|||
105393196|NCT02284893|363448911|FG001|26 Week (Short Term)|Other|1|||
105393197|NCT02284893|363448910|FG000|52 Week (Long Term)|Adverse Event|3|||
105393198|NCT02284893|363448911|FG001|52 Week (Long Term)|Adverse Event|1|||
105393199|NCT02284893|363448910|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
105393200|NCT02284893|363448911|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
105393201|NCT02284893|363448910|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
105393202|NCT02284893|363448911|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
105393203|NCT02284893|363448910|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
105393204|NCT02284893|363448911|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
105580580|NCT02018861|364126450|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
105580581|NCT02018861|364126451|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
105393205|NCT02284893|363448910|FG000|52 Week (Long Term)|Non-Compliance|2|||
105393206|NCT02284893|363448911|FG001|52 Week (Long Term)|Non-Compliance|3|||
105393207|NCT00265122|363448914|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
105393208|NCT00265122|363448915|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
105393209|NCT00265122|363448916|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
105393210|NCT00265122|363448917|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
105393211|NCT00265122|363448918|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
105393212|NCT00265122|363448919|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
105393213|NCT00265122|363448914|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
105580582|NCT02018861|364126452|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
105393214|NCT00265122|363448915|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
105393215|NCT00265122|363448916|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
105439938|NCT01618695|363616639|FG001|Core Phase|Lack of Efficacy|2|||
105580583|NCT02018861|364126453|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
105393216|NCT00265122|363448917|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
105393217|NCT00265122|363448918|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
105393218|NCT00265122|363448919|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
105393219|NCT00265122|363448914|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
105393220|NCT00265122|363448915|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
105393221|NCT00265122|363448916|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
105393222|NCT00265122|363448917|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
105393223|NCT00265122|363448918|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
105393224|NCT00265122|363448919|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
105393225|NCT00265122|363448914|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
105393226|NCT00265122|363448915|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
105393227|NCT00265122|363448916|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
105393228|NCT00265122|363448917|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
105393229|NCT00265122|363448918|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
105393230|NCT00265122|363448919|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
105393231|NCT00265122|363448914|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
105393232|NCT00265122|363448915|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
105393233|NCT00265122|363448916|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
105393234|NCT00265122|363448917|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
105393235|NCT00265122|363448918|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
105393236|NCT00265122|363448919|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
105393237|NCT00265122|363448914|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
105393238|NCT00265122|363448915|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
105393239|NCT00265122|363448916|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
105393240|NCT00265122|363448917|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
105393241|NCT00265122|363448918|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
105393242|NCT00265122|363448919|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
105393243|NCT02657343|363448920|FG000|Overall Study|Death|0|||
105393244|NCT02657343|363448921|FG001|Overall Study|Death|2|||
105393245|NCT02657343|363448922|FG002|Overall Study|Death|0|||
105393246|NCT02657343|363448923|FG003|Overall Study|Death|0|||
105393247|NCT02657343|363448924|FG004|Overall Study|Death|0|||
105393248|NCT02657343|363448925|FG005|Overall Study|Death|0|||
105393249|NCT02657343|363448920|FG000|Overall Study|Patient went to hospice|1|||
105393250|NCT02657343|363448921|FG001|Overall Study|Patient went to hospice|0|||
105393251|NCT02657343|363448922|FG002|Overall Study|Patient went to hospice|0|||
105393252|NCT02657343|363448923|FG003|Overall Study|Patient went to hospice|0|||
105393253|NCT02657343|363448924|FG004|Overall Study|Patient went to hospice|0|||
105393254|NCT02657343|363448925|FG005|Overall Study|Patient went to hospice|0|||
105393255|NCT02657343|363448920|FG000|Overall Study|Withdrawal by Subject|0|||
105393256|NCT02657343|363448921|FG001|Overall Study|Withdrawal by Subject|0|||
105393257|NCT02657343|363448922|FG002|Overall Study|Withdrawal by Subject|0|||
105393258|NCT02657343|363448923|FG003|Overall Study|Withdrawal by Subject|0|||
105393259|NCT02657343|363448924|FG004|Overall Study|Withdrawal by Subject|1|||
105393260|NCT02657343|363448925|FG005|Overall Study|Withdrawal by Subject|0|||
105393261|NCT02011542|363448926|FG000|Overall Study|Physician Decision|1|||
105393262|NCT00663260|363448928|FG000|Overall Study|Lack of Efficacy|2|||
105393263|NCT00663260|363448929|FG001|Overall Study|Lack of Efficacy|0|||
105393264|NCT00663260|363448930|FG002|Overall Study|Lack of Efficacy|0|||
105393265|NCT00663260|363448928|FG000|Overall Study|Adverse Event|12|||
105393266|NCT00663260|363448929|FG001|Overall Study|Adverse Event|7|||
105393267|NCT00663260|363448930|FG002|Overall Study|Adverse Event|6|||
105393268|NCT00663260|363448928|FG000|Overall Study|Withdrawal by Subject|3|||
105393269|NCT00663260|363448929|FG001|Overall Study|Withdrawal by Subject|1|||
105393270|NCT00663260|363448930|FG002|Overall Study|Withdrawal by Subject|6|||
105393271|NCT00663260|363448928|FG000|Overall Study|Death|1|||
105393272|NCT00663260|363448929|FG001|Overall Study|Death|0|||
105393273|NCT00663260|363448930|FG002|Overall Study|Death|1|||
105393274|NCT00663260|363448928|FG000|Overall Study|Lost to Follow-up|0|||
105393275|NCT00663260|363448929|FG001|Overall Study|Lost to Follow-up|1|||
105393276|NCT00663260|363448930|FG002|Overall Study|Lost to Follow-up|0|||
105393277|NCT00663260|363448928|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
105393278|NCT00663260|363448929|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
105393279|NCT00663260|363448930|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
105393280|NCT00980798|363448938|FG000|Overall Study|Adverse Event|7|||
105393281|NCT00980798|363448939|FG001|Overall Study|Adverse Event|36|||
105393282|NCT00980798|363448938|FG000|Overall Study|Lack of Efficacy|16|||
105393283|NCT00980798|363448939|FG001|Overall Study|Lack of Efficacy|5|||
105393284|NCT00980798|363448938|FG000|Overall Study|Lost to Follow-up|0|||
105393285|NCT00980798|363448939|FG001|Overall Study|Lost to Follow-up|1|||
105393286|NCT00980798|363448938|FG000|Overall Study|Physician Decision|2|||
105393287|NCT00980798|363448939|FG001|Overall Study|Physician Decision|1|||
105393288|NCT00980798|363448938|FG000|Overall Study|Withdrawal by Subject|8|||
105393289|NCT00980798|363448939|FG001|Overall Study|Withdrawal by Subject|11|||
105393290|NCT00980798|363448938|FG000|Overall Study|Other|0|||
105393291|NCT00980798|363448939|FG001|Overall Study|Other|1|||
105393292|NCT01491919|363448940|FG000|Overall Study|Insufficient PK sampling|1|||
105393293|NCT01491919|363448941|FG001|Overall Study|Insufficient PK sampling|2|||
105393294|NCT01491919|363448942|FG002|Overall Study|Insufficient PK sampling|1|||
105393295|NCT00522379|363448943|FG000|Overall Study|Adverse Event|12|||
105393296|NCT00522379|363448944|FG001|Overall Study|Adverse Event|15|||
105393297|NCT00522379|363448945|FG002|Overall Study|Adverse Event|12|||
105393298|NCT00522379|363448946|FG003|Overall Study|Adverse Event|5|||
105393299|NCT00522379|363448947|FG004|Overall Study|Adverse Event|17|||
105393300|NCT00522379|363448943|FG000|Overall Study|Lack of Efficacy|3|||
105393301|NCT00522379|363448944|FG001|Overall Study|Lack of Efficacy|0|||
105393302|NCT00522379|363448945|FG002|Overall Study|Lack of Efficacy|2|||
105393303|NCT00522379|363448946|FG003|Overall Study|Lack of Efficacy|2|||
105393304|NCT00522379|363448947|FG004|Overall Study|Lack of Efficacy|7|||
105393305|NCT00522379|363448943|FG000|Overall Study|Withdrawal by Subject|2|||
105393306|NCT00522379|363448944|FG001|Overall Study|Withdrawal by Subject|3|||
105393307|NCT00522379|363448945|FG002|Overall Study|Withdrawal by Subject|1|||
105393308|NCT00522379|363448946|FG003|Overall Study|Withdrawal by Subject|2|||
105393309|NCT00522379|363448947|FG004|Overall Study|Withdrawal by Subject|0|||
105393310|NCT00522379|363448943|FG000|Overall Study|Protocol Violation|1|||
105393311|NCT00522379|363448944|FG001|Overall Study|Protocol Violation|1|||
105393312|NCT00522379|363448945|FG002|Overall Study|Protocol Violation|2|||
105393313|NCT00522379|363448946|FG003|Overall Study|Protocol Violation|0|||
105393314|NCT00522379|363448947|FG004|Overall Study|Protocol Violation|0|||
105393315|NCT00522379|363448943|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
105393316|NCT00522379|363448944|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
105393317|NCT00522379|363448945|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
105393318|NCT00522379|363448946|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
105393319|NCT00522379|363448947|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
105393320|NCT00522379|363448943|FG000|Overall Study|Lost to Follow-up|1|||
105393321|NCT00522379|363448944|FG001|Overall Study|Lost to Follow-up|0|||
105393322|NCT00522379|363448945|FG002|Overall Study|Lost to Follow-up|4|||
105393323|NCT00522379|363448946|FG003|Overall Study|Lost to Follow-up|2|||
105393324|NCT00522379|363448947|FG004|Overall Study|Lost to Follow-up|2|||
105393325|NCT00522379|363448943|FG000|Overall Study|Randomization error|0|||
105393326|NCT00522379|363448944|FG001|Overall Study|Randomization error|0|||
105393327|NCT00522379|363448945|FG002|Overall Study|Randomization error|0|||
105393328|NCT00522379|363448946|FG003|Overall Study|Randomization error|0|||
105393329|NCT00522379|363448947|FG004|Overall Study|Randomization error|1|||
105393330|NCT00522379|363448943|FG000|Overall Study|Dispensing error|1|||
105393331|NCT00522379|363448944|FG001|Overall Study|Dispensing error|0|||
105393332|NCT00522379|363448945|FG002|Overall Study|Dispensing error|0|||
105393333|NCT00522379|363448946|FG003|Overall Study|Dispensing error|1|||
105393334|NCT00522379|363448947|FG004|Overall Study|Dispensing error|0|||
105393335|NCT00522379|363448943|FG000|Overall Study|Subject Moved|1|||
105393336|NCT00522379|363448944|FG001|Overall Study|Subject Moved|1|||
105393337|NCT00522379|363448945|FG002|Overall Study|Subject Moved|0|||
105393338|NCT00522379|363448946|FG003|Overall Study|Subject Moved|0|||
105393339|NCT00522379|363448947|FG004|Overall Study|Subject Moved|0|||
105393340|NCT00522379|363448943|FG000|Overall Study|Sponsor Request|0|||
105393341|NCT00522379|363448944|FG001|Overall Study|Sponsor Request|1|||
105393342|NCT00522379|363448945|FG002|Overall Study|Sponsor Request|0|||
105393343|NCT00522379|363448946|FG003|Overall Study|Sponsor Request|0|||
105393344|NCT00522379|363448947|FG004|Overall Study|Sponsor Request|0|||
105393345|NCT00522379|363448943|FG000|Overall Study|Family Problem|0|||
105393346|NCT00522379|363448944|FG001|Overall Study|Family Problem|0|||
105393347|NCT00522379|363448945|FG002|Overall Study|Family Problem|1|||
105393348|NCT00522379|363448946|FG003|Overall Study|Family Problem|0|||
105393349|NCT00522379|363448947|FG004|Overall Study|Family Problem|0|||
105393350|NCT00522379|363448943|FG000|Overall Study|Site Closed|0|||
105393351|NCT00522379|363448944|FG001|Overall Study|Site Closed|0|||
105393352|NCT00522379|363448945|FG002|Overall Study|Site Closed|0|||
105393353|NCT00522379|363448946|FG003|Overall Study|Site Closed|1|||
105393354|NCT00522379|363448947|FG004|Overall Study|Site Closed|0|||
105393355|NCT00522379|363448943|FG000|Overall Study|Subject Withdrawal|0|||
105393356|NCT00522379|363448944|FG001|Overall Study|Subject Withdrawal|0|||
105393357|NCT00522379|363448945|FG002|Overall Study|Subject Withdrawal|0|||
105393358|NCT00522379|363448946|FG003|Overall Study|Subject Withdrawal|1|||
105393359|NCT00522379|363448947|FG004|Overall Study|Subject Withdrawal|0|||
105393360|NCT00967499|363448952|FG000|Overall Study|Adverse Event|0|||
105393361|NCT00967499|363448953|FG001|Overall Study|Adverse Event|1|||
105393362|NCT00967499|363448952|FG000|Overall Study|Protocol Violation|1|||
105393363|NCT00967499|363448953|FG001|Overall Study|Protocol Violation|0|||
105393364|NCT00967499|363448952|FG000|Overall Study|Sponsor Decision|1|||
105393365|NCT00967499|363448953|FG001|Overall Study|Sponsor Decision|0|||
105393366|NCT00967499|363448952|FG000|Overall Study|Randomized but not treated|63|||
105393367|NCT00967499|363448953|FG001|Overall Study|Randomized but not treated|59|||
105393368|NCT05252702|363448954|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
105393369|NCT05252702|363448954|FG000|Overall Study|Death|16|||
105393370|NCT05252702|363448954|FG000|Overall Study|System explant|5|||
105393371|NCT05252702|363448954|FG000|Overall Study|Lost to Follow-up|1|||
105393372|NCT05252702|363448954|FG000|Overall Study|Withdrawn by investigator|1|||
105393373|NCT05252702|363448954|FG000|Overall Study|Visit not due|306|||
105393374|NCT05252702|363448954|FG000|Overall Study|Visit within window but not completed|92|||
105393375|NCT05252702|363448954|FG000|Overall Study|Unsuccessful implant|1|||
105393376|NCT02607722|363448955|FG000|Overall Study|No data reliability|1|||
105393377|NCT02607722|363448955|FG000|Overall Study|no patient visit|18|||
105393378|NCT02607722|363448955|FG000|Overall Study|missing info in CRF|13|||
105393379|NCT02607722|363448955|FG000|Overall Study|Withdrawal by Subject|616|||
105393380|NCT02607722|363448955|FG000|Overall Study|Lost to Follow-up|312|||
105393381|NCT02607722|363448955|FG000|Overall Study|Improved|22|||
105393382|NCT02607722|363448955|FG000|Overall Study|Lack of Efficacy|316|||
105393383|NCT02607722|363448955|FG000|Overall Study|Adverse Event|2553|||
105393384|NCT02607722|363448955|FG000|Overall Study|Not treated|1|||
105393385|NCT02607722|363448955|FG000|Overall Study|No CRF collected|138|||
105393386|NCT02607722|363448955|FG000|Overall Study|without CRF|4225|||
105393387|NCT02607722|363448955|FG000|Overall Study|Physician Decision|367|||
105393388|NCT04562090|363448956|FG000|Overall Study|Withdrawal by Subject|3|||
105393389|NCT04562090|363448957|FG001|Overall Study|Withdrawal by Subject|4|||
105393390|NCT04562090|363448956|FG000|Overall Study|Protocol Violation|2|||
105393391|NCT04562090|363448957|FG001|Overall Study|Protocol Violation|0|||
105393392|NCT04562090|363448956|FG000|Overall Study|Lack of Efficacy|0|||
105393393|NCT04562090|363448957|FG001|Overall Study|Lack of Efficacy|1|||
105393394|NCT04562090|363448956|FG000|Overall Study|Adverse Event|1|||
105393395|NCT04562090|363448957|FG001|Overall Study|Adverse Event|4|||
105393396|NCT04562090|363448956|FG000|Overall Study|Miscellaneous|0|||
105393397|NCT04562090|363448957|FG001|Overall Study|Miscellaneous|3|||
105393398|NCT00133705|363450051|FG000|Overall Study|Withdrawal by Subject|2|||
105393399|NCT00133705|363450052|FG001|Overall Study|Withdrawal by Subject|3|||
105393400|NCT00959049|363450053|FG000|Overall Study|Adverse Event|1|||
105393401|NCT00959049|363450054|FG001|Overall Study|Adverse Event|0|||
105393402|NCT00959049|363450055|FG002|Overall Study|Adverse Event|0|||
105393403|NCT00959049|363450056|FG003|Overall Study|Adverse Event|0|||
105393404|NCT00959049|363450057|FG004|Overall Study|Adverse Event|0|||
105393405|NCT00959049|363450058|FG005|Overall Study|Adverse Event|0|||
105393406|NCT00959049|363450053|FG000|Overall Study|Lost to Follow-up|17|||
105393407|NCT00959049|363450054|FG001|Overall Study|Lost to Follow-up|5|||
105393408|NCT00959049|363450055|FG002|Overall Study|Lost to Follow-up|1|||
105393409|NCT00959049|363450056|FG003|Overall Study|Lost to Follow-up|10|||
105393410|NCT00959049|363450057|FG004|Overall Study|Lost to Follow-up|9|||
105393411|NCT00959049|363450058|FG005|Overall Study|Lost to Follow-up|1|||
105393412|NCT00959049|363450053|FG000|Overall Study|Contraindicated medication|0|||
105393413|NCT00959049|363450054|FG001|Overall Study|Contraindicated medication|0|||
105393414|NCT00959049|363450055|FG002|Overall Study|Contraindicated medication|0|||
105393415|NCT00959049|363450056|FG003|Overall Study|Contraindicated medication|1|||
105393416|NCT00959049|363450057|FG004|Overall Study|Contraindicated medication|0|||
105393417|NCT00959049|363450058|FG005|Overall Study|Contraindicated medication|0|||
105393418|NCT00959049|363450053|FG000|Overall Study|Withdrawal by Subject|0|||
105393419|NCT00959049|363450054|FG001|Overall Study|Withdrawal by Subject|2|||
105393420|NCT00959049|363450055|FG002|Overall Study|Withdrawal by Subject|0|||
105393421|NCT00959049|363450056|FG003|Overall Study|Withdrawal by Subject|0|||
105393422|NCT00959049|363450057|FG004|Overall Study|Withdrawal by Subject|0|||
105393423|NCT00959049|363450058|FG005|Overall Study|Withdrawal by Subject|0|||
105393424|NCT01892189|363450060|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
105393425|NCT01892189|363450061|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
105393426|NCT01892189|363450062|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
105393427|NCT01892189|363450063|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
105393428|NCT01892189|363450064|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
105393429|NCT01892189|363450065|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
105393430|NCT01892189|363450066|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
105393431|NCT01892189|363450067|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
105393432|NCT01892189|363450068|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
105393433|NCT01892189|363450060|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105393434|NCT01892189|363450061|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105393435|NCT01892189|363450062|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
105393436|NCT01892189|363450063|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
105393437|NCT01892189|363450064|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105393438|NCT01892189|363450065|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105393439|NCT01892189|363450066|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
105393440|NCT01892189|363450067|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105393441|NCT01892189|363450068|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
105393442|NCT01892189|363450060|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
105393443|NCT01892189|363450061|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
105393444|NCT01892189|363450062|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
105393445|NCT01892189|363450063|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
105393446|NCT01892189|363450064|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
105393447|NCT01892189|363450065|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
105393448|NCT01892189|363450066|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
105393449|NCT01892189|363450067|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
105393450|NCT01892189|363450068|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
105393451|NCT00095576|363450069|FG000|Overall Study|Adverse Event|5|||
105393452|NCT00095576|363450070|FG001|Overall Study|Adverse Event|3|||
105393453|NCT00095576|363450069|FG000|Overall Study|Lost to Follow-up|233|||
105393454|NCT00095576|363450070|FG001|Overall Study|Lost to Follow-up|229|||
105393455|NCT00095576|363450069|FG000|Overall Study|Protocol Violation|1|||
105393456|NCT00095576|363450070|FG001|Overall Study|Protocol Violation|0|||
105393457|NCT00095576|363450069|FG000|Overall Study|Withdrawal by Subject|34|||
105393458|NCT00095576|363450070|FG001|Overall Study|Withdrawal by Subject|47|||
105393459|NCT00095576|363450069|FG000|Overall Study|Option to switch to a rollover study|1097|||
105393460|NCT00095576|363450070|FG001|Overall Study|Option to switch to a rollover study|1099|||
105393461|NCT00095576|363450069|FG000|Overall Study|Site terminated|75|||
105393462|NCT00095576|363450070|FG001|Overall Study|Site terminated|67|||
105393463|NCT00095576|363450069|FG000|Overall Study|Subject moved|30|||
105393464|NCT00095576|363450070|FG001|Overall Study|Subject moved|36|||
105393465|NCT00443456|363450071|FG000|Overall Study|Adverse Event|16|||
105393466|NCT00443456|363450071|FG000|Overall Study|Move|1|||
105393467|NCT00443456|363450071|FG000|Overall Study|Withdrawal by Subject|1|||
105393468|NCT01309230|363450081|FG000|Overall Study|Withdrawal by Subject|0|||
105393469|NCT01309230|363450082|FG001|Overall Study|Withdrawal by Subject|2|||
105393470|NCT01309230|363450081|FG000|Overall Study|Observation arm closed|0|||
105393471|NCT01309230|363450082|FG001|Overall Study|Observation arm closed|2|||
105393472|NCT00427700|363450085|FG000|Overall Study|Lost to Follow-up|2|||
105393473|NCT00427700|363450086|FG001|Overall Study|Lost to Follow-up|5|||
105393474|NCT00427700|363450085|FG000|Overall Study|no induction of menses|1|||
105393475|NCT00427700|363450086|FG001|Overall Study|no induction of menses|4|||
105393476|NCT00427700|363450085|FG000|Overall Study|Pregnancy|0|||
105393477|NCT00427700|363450086|FG001|Overall Study|Pregnancy|2|||
105393478|NCT04581395|363450087|FG000|Overall Study|Protocol Violation|4|||
105393479|NCT04581395|363450088|FG001|Overall Study|Protocol Violation|3|||
105393480|NCT04581395|363450089|FG002|Overall Study|Protocol Violation|2|||
105393481|NCT04581395|363450087|FG000|Overall Study|Physician Decision|0|||
105393482|NCT04581395|363450088|FG001|Overall Study|Physician Decision|1|||
105393483|NCT04581395|363450089|FG002|Overall Study|Physician Decision|0|||
105393484|NCT00721110|363450090|FG000|Overall Study|Ultram use|1|||
105393485|NCT00721110|363450091|FG001|Overall Study|Ultram use|0|||
105393486|NCT00721110|363450092|FG002|Overall Study|Ultram use|0|||
105393487|NCT00721110|363450093|FG003|Overall Study|Ultram use|0|||
105393488|NCT00721110|363450090|FG000|Overall Study|vertical incision|0|||
105393489|NCT00721110|363450091|FG001|Overall Study|vertical incision|0|||
105393490|NCT00721110|363450092|FG002|Overall Study|vertical incision|1|||
105393491|NCT00721110|363450093|FG003|Overall Study|vertical incision|0|||
105393492|NCT01554904|363450094|FG000|Overall Study|Withdrawal by Subject|3|||
105393493|NCT01554904|363450094|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
105393494|NCT02038647|363450097|FG000|Overall Study|Progressive Disease|50|||
105393495|NCT02038647|363450098|FG001|Overall Study|Progressive Disease|59|||
105393496|NCT02038647|363450097|FG000|Overall Study|Adverse Event|18|||
105393497|NCT02038647|363450098|FG001|Overall Study|Adverse Event|10|||
105393498|NCT02038647|363450097|FG000|Overall Study|Symptomatic Deterioration|7|||
105393499|NCT02038647|363450098|FG001|Overall Study|Symptomatic Deterioration|7|||
105393500|NCT02038647|363450097|FG000|Overall Study|Withdrawal by Subject|5|||
105393501|NCT02038647|363450098|FG001|Overall Study|Withdrawal by Subject|2|||
105393502|NCT02038647|363450097|FG000|Overall Study|Not Reported|0|||
105393503|NCT02038647|363450098|FG001|Overall Study|Not Reported|1|||
105393504|NCT02038647|363450097|FG000|Overall Study|Ongoing at Datacut|9|||
105393505|NCT02038647|363450098|FG001|Overall Study|Ongoing at Datacut|10|||
105393506|NCT05805150|363450099|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
105393507|NCT05805150|363450100|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
105393508|NCT02757430|363450101|FG000|Overall Study|Physician Decision|6|||
105393509|NCT02757430|363450101|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
105393510|NCT02757430|363450101|FG000|Overall Study|No informed consent|1|||
105393511|NCT02757430|363450101|FG000|Overall Study|No procedure performed|2|||
105393512|NCT04724837|363450102|FG000|Overall Study|Other|4|||
105393513|NCT04724837|363450103|FG001|Overall Study|Other|16|||
105393514|NCT04724837|363450104|FG002|Overall Study|Other|0|||
105393515|NCT04724837|363450102|FG000|Overall Study|Withdrawal by Subject|2|||
105393516|NCT04724837|363450103|FG001|Overall Study|Withdrawal by Subject|9|||
105393517|NCT04724837|363450104|FG002|Overall Study|Withdrawal by Subject|9|||
105393518|NCT04724837|363450102|FG000|Overall Study|Adverse Event|2|||
105393519|NCT04724837|363450103|FG001|Overall Study|Adverse Event|7|||
105393520|NCT04724837|363450104|FG002|Overall Study|Adverse Event|4|||
105393521|NCT04724837|363450102|FG000|Overall Study|Lost to Follow-up|0|||
105393522|NCT04724837|363450103|FG001|Overall Study|Lost to Follow-up|1|||
105393523|NCT04724837|363450104|FG002|Overall Study|Lost to Follow-up|3|||
105393524|NCT04724837|363450102|FG000|Overall Study|Physician Decision|1|||
105393525|NCT04724837|363450103|FG001|Overall Study|Physician Decision|2|||
105393526|NCT04724837|363450104|FG002|Overall Study|Physician Decision|0|||
105393527|NCT04724837|363450102|FG000|Overall Study|Death|0|||
105393528|NCT04724837|363450103|FG001|Overall Study|Death|0|||
105393529|NCT04724837|363450104|FG002|Overall Study|Death|1|||
105393530|NCT04724837|363450102|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
105393531|NCT04724837|363450103|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
105393532|NCT04724837|363450104|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
105393533|NCT04724837|363450102|FG000|Overall Study|Study Terminated by Sponsor|0|||
105393534|NCT04724837|363450103|FG001|Overall Study|Study Terminated by Sponsor|1|||
105393535|NCT04724837|363450104|FG002|Overall Study|Study Terminated by Sponsor|0|||
105393536|NCT03238196|363450105|FG000|Overall Study|Adverse Event|3|||
105393537|NCT03238196|363450106|FG001|Overall Study|Adverse Event|0|||
105393538|NCT03238196|363450107|FG002|Overall Study|Adverse Event|2|||
105393539|NCT03238196|363450108|FG003|Overall Study|Adverse Event|2|||
105393540|NCT03238196|363450105|FG000|Overall Study|Withdrawal by Subject|4|||
105393541|NCT03238196|363450106|FG001|Overall Study|Withdrawal by Subject|1|||
105393542|NCT03238196|363450107|FG002|Overall Study|Withdrawal by Subject|1|||
105393543|NCT03238196|363450108|FG003|Overall Study|Withdrawal by Subject|0|||
105393544|NCT03238196|363450105|FG000|Overall Study|Disease progression|14|||
105393545|NCT03238196|363450106|FG001|Overall Study|Disease progression|2|||
105393546|NCT03238196|363450107|FG002|Overall Study|Disease progression|3|||
105393547|NCT03238196|363450108|FG003|Overall Study|Disease progression|2|||
105393548|NCT03238196|363450105|FG000|Overall Study|Still on treatment|1|||
105393549|NCT03238196|363450106|FG001|Overall Study|Still on treatment|0|||
105393550|NCT03238196|363450107|FG002|Overall Study|Still on treatment|0|||
105393551|NCT03238196|363450108|FG003|Overall Study|Still on treatment|0|||
105393552|NCT00847730|363450109|FG000|Overall Study|Multiple interruptions in therapy|8|||
105393553|NCT04938427|363450112|FG000|Overall Study|Adverse Event|5|||
105393554|NCT04938427|363450113|FG001|Overall Study|Adverse Event|19|||
105393555|NCT04938427|363450112|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
105393556|NCT04938427|363450113|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105393557|NCT04938427|363450112|FG000|Overall Study|Withdrawal by Subject|1|||
105393558|NCT04938427|363450113|FG001|Overall Study|Withdrawal by Subject|0|||
105393559|NCT04938427|363450112|FG000|Overall Study|Reason Not Specified|2|||
105393560|NCT04938427|363450113|FG001|Overall Study|Reason Not Specified|1|||
105393561|NCT02302222|363450118|FG000|Overall Study|Physician Decision|0|||
105393562|NCT02302222|363450119|FG001|Overall Study|Physician Decision|4|||
105393563|NCT02302222|363450118|FG000|Overall Study|Lost to Follow-up|1|||
105393564|NCT02302222|363450119|FG001|Overall Study|Lost to Follow-up|0|||
105393565|NCT02302222|363450118|FG000|Overall Study|Treatment discontinued before day 5|0|||
105393566|NCT02302222|363450119|FG001|Overall Study|Treatment discontinued before day 5|1|||
105393567|NCT02302222|363450118|FG000|Overall Study|Withdrawn prior to any treatment|0|||
105393568|NCT02302222|363450119|FG001|Overall Study|Withdrawn prior to any treatment|1|||
105393569|NCT03559556|363450122|FG000|Overall Study|Withdrawal by Subject|1|||
105393570|NCT03110562|363450123|FG000|Initial Treatment Period|Disease Progression|1|||
105393571|NCT03110562|363450124|FG001|Initial Treatment Period|Disease Progression|1|||
105393572|NCT03110562|363450125|FG002|Initial Treatment Period|Disease Progression|0|||
105393573|NCT03110562|363450126|FG003|Initial Treatment Period|Disease Progression|0|||
105393574|NCT03110562|363450123|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
105393575|NCT03110562|363450124|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
105393576|NCT03110562|363450125|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
105393577|NCT03110562|363450126|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
105393578|NCT03110562|363450123|FG000|Initial Treatment Period|Adverse Event|1|||
105393579|NCT03110562|363450124|FG001|Initial Treatment Period|Adverse Event|0|||
105393580|NCT03110562|363450125|FG002|Initial Treatment Period|Adverse Event|0|||
105393581|NCT03110562|363450126|FG003|Initial Treatment Period|Adverse Event|0|||
105393582|NCT03110562|363450123|FG000|Initial Treatment Period|Death|74|||
105393583|NCT03110562|363450124|FG001|Initial Treatment Period|Death|82|||
105393584|NCT03110562|363450125|FG002|Initial Treatment Period|Death|0|||
105393585|NCT03110562|363450126|FG003|Initial Treatment Period|Death|0|||
105393586|NCT03110562|363450123|FG000|Initial Treatment Period|Lost to Follow-up|13|||
105393587|NCT03110562|363450124|FG001|Initial Treatment Period|Lost to Follow-up|8|||
105393588|NCT03110562|363450125|FG002|Initial Treatment Period|Lost to Follow-up|0|||
105393589|NCT03110562|363450126|FG003|Initial Treatment Period|Lost to Follow-up|0|||
105393590|NCT03110562|363450123|FG000|Initial Treatment Period|Protocol Deviation|1|||
105393591|NCT03110562|363450124|FG001|Initial Treatment Period|Protocol Deviation|0|||
105393592|NCT03110562|363450125|FG002|Initial Treatment Period|Protocol Deviation|0|||
105393593|NCT03110562|363450126|FG003|Initial Treatment Period|Protocol Deviation|0|||
105393594|NCT03110562|363450123|FG000|Initial Treatment Period|Physician Decision|2|||
105393595|NCT03110562|363450124|FG001|Initial Treatment Period|Physician Decision|1|||
105393596|NCT03110562|363450125|FG002|Initial Treatment Period|Physician Decision|0|||
105393597|NCT03110562|363450126|FG003|Initial Treatment Period|Physician Decision|0|||
105393598|NCT03110562|363450123|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
105393599|NCT03110562|363450124|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
105393600|NCT03110562|363450125|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
105393601|NCT03110562|363450126|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
105393602|NCT03110562|363450123|FG000|Initial Treatment Period|Other|5|||
105393603|NCT03110562|363450124|FG001|Initial Treatment Period|Other|4|||
105393604|NCT03110562|363450125|FG002|Initial Treatment Period|Other|0|||
105393605|NCT03110562|363450126|FG003|Initial Treatment Period|Other|0|||
105393606|NCT03110562|363450123|FG000|Initial Treatment Period|Randomized but never treated|0|||
105393607|NCT03110562|363450124|FG001|Initial Treatment Period|Randomized but never treated|3|||
105393608|NCT03110562|363450125|FG002|Initial Treatment Period|Randomized but never treated|0|||
105393609|NCT03110562|363450126|FG003|Initial Treatment Period|Randomized but never treated|0|||
105393610|NCT03110562|363450123|FG000|Crossover Period|Disease Progression|0|||
105393611|NCT03110562|363450124|FG001|Crossover Period|Disease Progression|0|||
105393612|NCT03110562|363450125|FG002|Crossover Period|Disease Progression|1|||
105393613|NCT03110562|363450126|FG003|Crossover Period|Disease Progression|0|||
105393614|NCT03110562|363450123|FG000|Crossover Period|Withdrawal by Subject|0|||
105393615|NCT03110562|363450124|FG001|Crossover Period|Withdrawal by Subject|0|||
105393616|NCT03110562|363450125|FG002|Crossover Period|Withdrawal by Subject|8|||
105393617|NCT03110562|363450126|FG003|Crossover Period|Withdrawal by Subject|6|||
105393618|NCT03110562|363450123|FG000|Crossover Period|Death|0|||
105393619|NCT03110562|363450124|FG001|Crossover Period|Death|0|||
105393620|NCT03110562|363450125|FG002|Crossover Period|Death|37|||
105393621|NCT03110562|363450126|FG003|Crossover Period|Death|3|||
105393622|NCT03110562|363450123|FG000|Crossover Period|Lost to Follow-up|0|||
105393623|NCT03110562|363450124|FG001|Crossover Period|Lost to Follow-up|0|||
105393624|NCT03110562|363450125|FG002|Crossover Period|Lost to Follow-up|0|||
105393625|NCT03110562|363450126|FG003|Crossover Period|Lost to Follow-up|1|||
105393626|NCT03110562|363450123|FG000|Crossover Period|Other|0|||
105393627|NCT03110562|363450124|FG001|Crossover Period|Other|0|||
105393628|NCT03110562|363450125|FG002|Crossover Period|Other|1|||
105393629|NCT03110562|363450126|FG003|Crossover Period|Other|1|||
105393630|NCT03110562|363450123|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
105393631|NCT03110562|363450124|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
105393632|NCT03110562|363450125|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
105393633|NCT03110562|363450126|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
105393634|NCT01877278|363450129|FG000|Overall Study|Lost to Follow-up|3|||
105393635|NCT01877278|363450130|FG001|Overall Study|Lost to Follow-up|3|||
105393636|NCT04727151|363450131|FG000|Overall Study|Death|0|||
105580584|NCT02018861|364126444|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
105393637|NCT04727151|363450132|FG001|Overall Study|Death|0|||
105393638|NCT04727151|363450133|FG002|Overall Study|Death|0|||
105393639|NCT04727151|363450134|FG003|Overall Study|Death|0|||
105393640|NCT04727151|363450135|FG004|Overall Study|Death|3|||
105393641|NCT04727151|363450131|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
105439939|NCT01618695|363616640|FG002|Core Phase|Lack of Efficacy|1|||
105393642|NCT04727151|363450132|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
105393643|NCT04727151|363450133|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
105393644|NCT04727151|363450134|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
105393645|NCT04727151|363450135|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
105393646|NCT02769481|363450136|FG000|Overall Study|Protocol Violation|1|||
105393647|NCT02769481|363450137|FG001|Overall Study|Protocol Violation|0|||
105393648|NCT02769481|363450136|FG000|Overall Study|Adverse Event|3|||
105393649|NCT02769481|363450137|FG001|Overall Study|Adverse Event|6|||
105393650|NCT02769481|363450136|FG000|Overall Study|Entry Criteria Not Met|1|||
105393651|NCT02769481|363450137|FG001|Overall Study|Entry Criteria Not Met|2|||
105393652|NCT02769481|363450136|FG000|Overall Study|Withdrawal by Subject|14|||
105393653|NCT02769481|363450137|FG001|Overall Study|Withdrawal by Subject|16|||
105393654|NCT02769481|363450136|FG000|Overall Study|Lost to Follow-up|9|||
105393655|NCT02769481|363450137|FG001|Overall Study|Lost to Follow-up|9|||
105393656|NCT02769481|363450136|FG000|Overall Study|Physician Decision|0|||
105393657|NCT02769481|363450137|FG001|Overall Study|Physician Decision|1|||
105393658|NCT02769481|363450136|FG000|Overall Study|Terminated by Sponsor|1|||
105393659|NCT02769481|363450137|FG001|Overall Study|Terminated by Sponsor|0|||
105393660|NCT02769481|363450136|FG000|Overall Study|Death|0|||
105393661|NCT02769481|363450137|FG001|Overall Study|Death|1|||
105393662|NCT02769481|363450136|FG000|Overall Study|Undefined|4|||
105393663|NCT02769481|363450137|FG001|Overall Study|Undefined|1|||
105393664|NCT03510715|363450138|FG000|Overall Study|Adverse Event|1|||
105393665|NCT03510715|363450139|FG001|Overall Study|Adverse Event|0|||
105393666|NCT02495883|363450148|FG000|Overall Study|Excessive head motion|1|||
105393667|NCT02495883|363450149|FG001|Overall Study|Excessive head motion|0|||
105393668|NCT00618787|363450150|FG000|Overall Study|Adverse Event|0|||
105393669|NCT00618787|363450151|FG001|Overall Study|Adverse Event|1|||
105393670|NCT00618787|363450150|FG000|Overall Study|Withdrawal by Subject|2|||
105393671|NCT00618787|363450151|FG001|Overall Study|Withdrawal by Subject|1|||
105393672|NCT00618787|363450150|FG000|Overall Study|Lost to Follow-up|1|||
105393673|NCT00618787|363450151|FG001|Overall Study|Lost to Follow-up|0|||
105393674|NCT01107886|363450152|FG000|Overall Study|Lost to Follow-up|15|||
105393675|NCT01107886|363450153|FG001|Overall Study|Lost to Follow-up|13|||
105393676|NCT01107886|363450152|FG000|Overall Study|Withdrawal by Subject|180|||
105393677|NCT01107886|363450153|FG001|Overall Study|Withdrawal by Subject|196|||
105393678|NCT01107886|363450152|FG000|Overall Study|Administrative withdrawal of consent|7|||
105393679|NCT01107886|363450153|FG001|Overall Study|Administrative withdrawal of consent|5|||
105393680|NCT01649869|363450158|FG000|Overall Study|Family member illness|1|||
105393681|NCT01649869|363450159|FG001|Overall Study|Family member illness|0|||
105393682|NCT01649869|363450158|FG000|Overall Study|Required treatment outside protocol|1|||
105393683|NCT01649869|363450159|FG001|Overall Study|Required treatment outside protocol|0|||
105393684|NCT01649869|363450158|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
105393685|NCT01649869|363450159|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
105393686|NCT02776735|363450160|FG000|Overall Study|Adverse Event|0|||
105393687|NCT02776735|363450161|FG001|Overall Study|Adverse Event|0|||
105393688|NCT02776735|363450162|FG002|Overall Study|Adverse Event|0|||
105393689|NCT02776735|363450163|FG003|Overall Study|Adverse Event|1|||
105393690|NCT02776735|363450164|FG004|Overall Study|Adverse Event|0|||
105393691|NCT02776735|363450165|FG005|Overall Study|Adverse Event|1|||
105393692|NCT02776735|363450160|FG000|Overall Study|Lost to Follow-up|0|||
105393693|NCT02776735|363450161|FG001|Overall Study|Lost to Follow-up|0|||
105393694|NCT02776735|363450162|FG002|Overall Study|Lost to Follow-up|0|||
105393695|NCT02776735|363450163|FG003|Overall Study|Lost to Follow-up|1|||
105393696|NCT02776735|363450164|FG004|Overall Study|Lost to Follow-up|0|||
105393697|NCT02776735|363450165|FG005|Overall Study|Lost to Follow-up|0|||
105393698|NCT02776735|363450160|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105393699|NCT02776735|363450161|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105393700|NCT02776735|363450162|FG002|Overall Study|Withdrawal by parent/guardian|2|||
105393701|NCT02776735|363450163|FG003|Overall Study|Withdrawal by parent/guardian|2|||
105393702|NCT02776735|363450164|FG004|Overall Study|Withdrawal by parent/guardian|0|||
105393703|NCT02776735|363450165|FG005|Overall Study|Withdrawal by parent/guardian|0|||
105393704|NCT02776735|363450160|FG000|Overall Study|Withdrawal by Subject|1|||
105393705|NCT02776735|363450161|FG001|Overall Study|Withdrawal by Subject|0|||
105393706|NCT02776735|363450162|FG002|Overall Study|Withdrawal by Subject|0|||
105393707|NCT02776735|363450163|FG003|Overall Study|Withdrawal by Subject|0|||
105393708|NCT02776735|363450164|FG004|Overall Study|Withdrawal by Subject|0|||
105393709|NCT02776735|363450165|FG005|Overall Study|Withdrawal by Subject|1|||
105393710|NCT02776735|363450160|FG000|Overall Study|Other|0|||
105393711|NCT02776735|363450161|FG001|Overall Study|Other|0|||
105393712|NCT02776735|363450162|FG002|Overall Study|Other|3|||
105393713|NCT02776735|363450163|FG003|Overall Study|Other|0|||
105393714|NCT02776735|363450164|FG004|Overall Study|Other|0|||
105393715|NCT02776735|363450165|FG005|Overall Study|Other|0|||
105393716|NCT03556891|363450168|FG000|Overall Study|Adverse Event|4|||
105393717|NCT03556891|363450168|FG000|Overall Study|MRI Need|3|||
105393718|NCT03556891|363450168|FG000|Overall Study|Device Failure|1|||
105393719|NCT03556891|363450168|FG000|Overall Study|Death|1|||
105393720|NCT03556891|363450168|FG000|Overall Study|Lost to Follow-up|1|||
105393721|NCT03556891|363450168|FG000|Overall Study|Missing at random|1|||
105393722|NCT03556891|363450168|FG000|Overall Study|Missing due to COVID|1|||
105393723|NCT03556891|363450168|FG000|Overall Study|Protocol Violation|1|||
105393724|NCT05654181|363452088|FG000|Overall Study|Adverse Event|1|||
105393725|NCT05654181|363452089|FG001|Overall Study|Adverse Event|0|||
105393726|NCT05654181|363452090|FG002|Overall Study|Adverse Event|0|||
105393727|NCT05654181|363452091|FG003|Overall Study|Adverse Event|0|||
105393728|NCT05654181|363452092|FG004|Overall Study|Adverse Event|0|||
105393729|NCT05654181|363452093|FG005|Overall Study|Adverse Event|0|||
105393730|NCT05654181|363452094|FG006|Overall Study|Adverse Event|0|||
105393731|NCT05654181|363452095|FG007|Overall Study|Adverse Event|1|||
105393732|NCT05654181|363452096|FG008|Overall Study|Adverse Event|0|||
105393733|NCT05654181|363452097|FG009|Overall Study|Adverse Event|0|||
105393734|NCT05654181|363452088|FG000|Overall Study|Withdrawal by Subject|0|||
105393735|NCT05654181|363452089|FG001|Overall Study|Withdrawal by Subject|0|||
105393736|NCT05654181|363452090|FG002|Overall Study|Withdrawal by Subject|0|||
105393737|NCT05654181|363452091|FG003|Overall Study|Withdrawal by Subject|0|||
105393738|NCT05654181|363452092|FG004|Overall Study|Withdrawal by Subject|0|||
105393739|NCT05654181|363452093|FG005|Overall Study|Withdrawal by Subject|0|||
105393740|NCT05654181|363452094|FG006|Overall Study|Withdrawal by Subject|0|||
105393741|NCT05654181|363452095|FG007|Overall Study|Withdrawal by Subject|1|||
105393742|NCT05654181|363452096|FG008|Overall Study|Withdrawal by Subject|0|||
105393743|NCT05654181|363452097|FG009|Overall Study|Withdrawal by Subject|0|||
105393744|NCT05654181|363452088|FG000|Overall Study|Other|0|||
105393745|NCT05654181|363452089|FG001|Overall Study|Other|0|||
105393746|NCT05654181|363452090|FG002|Overall Study|Other|0|||
105393747|NCT05654181|363452091|FG003|Overall Study|Other|0|||
105393748|NCT05654181|363452092|FG004|Overall Study|Other|1|||
105393749|NCT05654181|363452093|FG005|Overall Study|Other|1|||
105393750|NCT05654181|363452094|FG006|Overall Study|Other|0|||
105393751|NCT05654181|363452095|FG007|Overall Study|Other|0|||
105393752|NCT05654181|363452096|FG008|Overall Study|Other|0|||
105393753|NCT05654181|363452097|FG009|Overall Study|Other|0|||
105393754|NCT03440385|363452104|FG000|Overall Study|Other Reason|4|||
105393755|NCT03440385|363452105|FG001|Overall Study|Other Reason|1|||
105393756|NCT03440385|363452104|FG000|Overall Study|Site Closed|1|||
105393757|NCT03440385|363452105|FG001|Overall Study|Site Closed|0|||
105393758|NCT03440385|363452104|FG000|Overall Study|Lost to Follow-up|2|||
105393759|NCT03440385|363452105|FG001|Overall Study|Lost to Follow-up|0|||
105393760|NCT03440385|363452104|FG000|Overall Study|Withdrawal by Subject|12|||
105393761|NCT03440385|363452105|FG001|Overall Study|Withdrawal by Subject|6|||
105393762|NCT03440385|363452104|FG000|Overall Study|Lack of Efficacy|9|||
105393763|NCT03440385|363452105|FG001|Overall Study|Lack of Efficacy|2|||
105393764|NCT03440385|363452104|FG000|Overall Study|Adverse Event|15|||
105393765|NCT03440385|363452105|FG001|Overall Study|Adverse Event|11|||
105393766|NCT02475681|363452106|FG000|Overall Study|Death|16|||
105393767|NCT02475681|363452107|FG001|Overall Study|Death|6|||
105393768|NCT02475681|363452108|FG002|Overall Study|Death|9|||
105393769|NCT02475681|363452106|FG000|Overall Study|Physician Decision|0|||
105393770|NCT02475681|363452107|FG001|Overall Study|Physician Decision|3|||
105393771|NCT02475681|363452108|FG002|Overall Study|Physician Decision|1|||
105393772|NCT02475681|363452106|FG000|Overall Study|Withdrawal by Subject|12|||
105393773|NCT02475681|363452107|FG001|Overall Study|Withdrawal by Subject|6|||
105393774|NCT02475681|363452108|FG002|Overall Study|Withdrawal by Subject|9|||
105393775|NCT02475681|363452106|FG000|Overall Study|Lost to Follow-up|2|||
105393776|NCT02475681|363452107|FG001|Overall Study|Lost to Follow-up|1|||
105393777|NCT02475681|363452108|FG002|Overall Study|Lost to Follow-up|3|||
105393778|NCT02475681|363452106|FG000|Overall Study|Ongoing in Study|0|||
105393779|NCT02475681|363452107|FG001|Overall Study|Ongoing in Study|163|||
105393780|NCT02475681|363452108|FG002|Overall Study|Ongoing in Study|157|||
105393781|NCT02475681|363452106|FG000|Overall Study|Reasons other than above listed|2|||
105393782|NCT02475681|363452107|FG001|Overall Study|Reasons other than above listed|0|||
105393783|NCT02475681|363452108|FG002|Overall Study|Reasons other than above listed|0|||
105393784|NCT00363298|363452112|FG000|First Study Week|Lack of Efficacy|6|||
105393785|NCT00363298|363452113|FG001|First Study Week|Lack of Efficacy|5|||
105393786|NCT00363298|363452112|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
105393787|NCT00363298|363452113|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
105393788|NCT03552029|363452115|FG000|Overall Study|Death|3|||
105393789|NCT03552029|363452116|FG001|Overall Study|Death|0|||
105393790|NCT03552029|363452115|FG000|Overall Study|Adverse Event|1|||
105393791|NCT03552029|363452116|FG001|Overall Study|Adverse Event|0|||
105393792|NCT03552029|363452115|FG000|Overall Study|Lack of Efficacy|0|||
105393793|NCT03552029|363452116|FG001|Overall Study|Lack of Efficacy|2|||
105393794|NCT03552029|363452115|FG000|Overall Study|Physician Decision|0|||
105393795|NCT03552029|363452116|FG001|Overall Study|Physician Decision|1|||
105393796|NCT03552029|363452115|FG000|Overall Study|Study terminated by Sponsor|0|||
105393797|NCT03552029|363452116|FG001|Overall Study|Study terminated by Sponsor|1|||
105393798|NCT03552029|363452115|FG000|Overall Study|Other|0|||
105393799|NCT03552029|363452116|FG001|Overall Study|Other|2|||
105393800|NCT02374255|363452122|FG000|Overall Study|Withdrawal by Subject|2|||
105393801|NCT02374255|363452123|FG001|Overall Study|Withdrawal by Subject|0|||
105393802|NCT02374255|363452124|FG002|Overall Study|Withdrawal by Subject|0|||
105393803|NCT02374255|363452125|FG003|Overall Study|Withdrawal by Subject|0|||
105393804|NCT03332056|363452126|FG000|Overall Study|Incomplete questionnaires|8|||
105393805|NCT03332056|363452127|FG001|Overall Study|Incomplete questionnaires|9|||
105393806|NCT03332056|363452126|FG000|Overall Study|Passed stone prior to surgery date|1|||
105393807|NCT03332056|363452127|FG001|Overall Study|Passed stone prior to surgery date|0|||
105393808|NCT03332056|363452126|FG000|Overall Study|Did not require a ureteral stent|0|||
105393809|NCT03332056|363452127|FG001|Overall Study|Did not require a ureteral stent|1|||
105393810|NCT00851084|363452128|FG000|Overall Study|Randomized but not treated|1|||
105393811|NCT00851084|363452129|FG001|Overall Study|Randomized but not treated|0|||
105393812|NCT00851084|363452128|FG000|Overall Study|Adverse Event|26|||
105393813|NCT00851084|363452129|FG001|Overall Study|Adverse Event|36|||
105393814|NCT00851084|363452128|FG000|Overall Study|Disease progression|52|||
105393815|NCT00851084|363452129|FG001|Overall Study|Disease progression|47|||
105393816|NCT00851084|363452128|FG000|Overall Study|Poor compliance to protocol|1|||
105393817|NCT00851084|363452129|FG001|Overall Study|Poor compliance to protocol|1|||
105393818|NCT00851084|363452128|FG000|Overall Study|Physician Decision|13|||
105393819|NCT00851084|363452129|FG001|Overall Study|Physician Decision|14|||
105393820|NCT00851084|363452128|FG000|Overall Study|Consent withdrawn|0|||
105393821|NCT00851084|363452129|FG001|Overall Study|Consent withdrawn|2|||
105393822|NCT00851084|363452128|FG000|Overall Study|Withdrawal by Subject|11|||
105393823|NCT00851084|363452129|FG001|Overall Study|Withdrawal by Subject|12|||
105393824|NCT00851084|363452128|FG000|Overall Study|Metastatic surgery|6|||
105393825|NCT00851084|363452129|FG001|Overall Study|Metastatic surgery|6|||
105393826|NCT00851084|363452128|FG000|Overall Study|Other|7|||
105393827|NCT00851084|363452129|FG001|Overall Study|Other|1|||
105393828|NCT00734032|363452130|FG000|Overall Study|Adverse Event|0|||
105393829|NCT00734032|363452131|FG001|Overall Study|Adverse Event|1|||
105393830|NCT00734032|363452132|FG002|Overall Study|Adverse Event|0|||
105393831|NCT00734032|363452133|FG003|Overall Study|Adverse Event|0|||
105393832|NCT03360344|363452134|FG000|Overall Study|Withdrawal by Subject|0|||
105393833|NCT03360344|363452135|FG001|Overall Study|Withdrawal by Subject|1|||
105393834|NCT03360344|363452136|FG002|Overall Study|Withdrawal by Subject|1|||
105393835|NCT02301897|363452137|FG000|Treatment Course 1|Non-Compliance|0|||
105393836|NCT02301897|363452138|FG001|Treatment Course 1|Non-Compliance|0|||
105393837|NCT02301897|363452139|FG002|Treatment Course 1|Non-Compliance|1|||
105393838|NCT02301897|363452137|FG000|Treatment Course 1|Adverse Event|1|||
105393839|NCT02301897|363452138|FG001|Treatment Course 1|Adverse Event|1|||
105393840|NCT02301897|363452139|FG002|Treatment Course 1|Adverse Event|0|||
105393841|NCT02301897|363452137|FG000|Treatment Course 1|Lost to Follow-up|1|||
105393842|NCT02301897|363452138|FG001|Treatment Course 1|Lost to Follow-up|2|||
105393843|NCT02301897|363452139|FG002|Treatment Course 1|Lost to Follow-up|1|||
105393844|NCT02301897|363452137|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
105393845|NCT02301897|363452138|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
105393846|NCT02301897|363452139|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
105393847|NCT02301897|363452137|FG000|Treatment Course 1|Withdrawal by Subject|0|||
105393848|NCT02301897|363452138|FG001|Treatment Course 1|Withdrawal by Subject|0|||
105393849|NCT02301897|363452139|FG002|Treatment Course 1|Withdrawal by Subject|2|||
105393850|NCT02301897|363452137|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
105393851|NCT02301897|363452138|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
105393852|NCT02301897|363452139|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
105393853|NCT02301897|363452137|FG000|Treatment Course 2|Lost to Follow-up|0|||
105393854|NCT02301897|363452138|FG001|Treatment Course 2|Lost to Follow-up|2|||
105393855|NCT02301897|363452139|FG002|Treatment Course 2|Lost to Follow-up|0|||
105393856|NCT02301897|363452137|FG000|Treatment Course 2|Pregnancy|0|||
105393857|NCT02301897|363452138|FG001|Treatment Course 2|Pregnancy|1|||
105393858|NCT02301897|363452139|FG002|Treatment Course 2|Pregnancy|1|||
105393859|NCT02301897|363452137|FG000|Treatment Course 2|Withdrawal by Subject|0|||
105393860|NCT02301897|363452138|FG001|Treatment Course 2|Withdrawal by Subject|2|||
105393861|NCT02301897|363452139|FG002|Treatment Course 2|Withdrawal by Subject|0|||
105393862|NCT02301897|363452137|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
105393863|NCT02301897|363452138|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
105393864|NCT02301897|363452139|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
105393865|NCT00278161|363452140|FG000|Overall Study|Death|11|||
105393866|NCT04507763|363452142|FG000|Overall Study|Participants did not meet entrance criteria|201|||
105393867|NCT01602484|363452143|FG000|Overall Study|Airway issues unrelated to study|0|||
105393868|NCT01602484|363452144|FG001|Overall Study|Airway issues unrelated to study|1|||
105393869|NCT00754572|363452148|FG000|Overall Study|Adverse Event|19|||
105393870|NCT00754572|363452148|FG000|Overall Study|Other|39|||
105393871|NCT00754572|363452148|FG000|Overall Study|Protocol Violation|3|||
105393872|NCT00754572|363452148|FG000|Overall Study|Withdrawal by Subject|3|||
105393873|NCT00754572|363452148|FG000|Overall Study|Lack of Efficacy|2|||
105393874|NCT00754572|363452148|FG000|Overall Study|Death|1|||
105393875|NCT00754572|363452148|FG000|Overall Study|Administrative Reason|3|||
105393876|NCT00754572|363452148|FG000|Overall Study|Lost to Follow-up|1|||
105393877|NCT04617860|363452149|FG000|Overall Study|Adverse Event|0|||
105393878|NCT04617860|363452150|FG001|Overall Study|Adverse Event|2|||
105393879|NCT04617860|363452151|FG002|Overall Study|Adverse Event|2|||
105393880|NCT04617860|363452149|FG000|Overall Study|Withdrawal by Subject|0|||
105393881|NCT04617860|363452150|FG001|Overall Study|Withdrawal by Subject|0|||
105393882|NCT04617860|363452151|FG002|Overall Study|Withdrawal by Subject|2|||
105393883|NCT04617860|363452149|FG000|Overall Study|Physician Decision|0|||
105393884|NCT04617860|363452150|FG001|Overall Study|Physician Decision|1|||
105393885|NCT04617860|363452151|FG002|Overall Study|Physician Decision|0|||
105393886|NCT04617860|363452149|FG000|Overall Study|Sponsor Decision|0|||
105393887|NCT04617860|363452150|FG001|Overall Study|Sponsor Decision|3|||
105393888|NCT04617860|363452151|FG002|Overall Study|Sponsor Decision|1|||
105393889|NCT04617860|363452149|FG000|Overall Study|Termination of Study by Sponsor|8|||
105393890|NCT04617860|363452150|FG001|Overall Study|Termination of Study by Sponsor|4|||
105393891|NCT04617860|363452151|FG002|Overall Study|Termination of Study by Sponsor|13|||
105393892|NCT00605189|363452152|FG000|Overall Study|Adverse Event|1|||
105393893|NCT00605189|363452153|FG001|Overall Study|Adverse Event|0|||
105393894|NCT00605189|363452154|FG002|Overall Study|Adverse Event|0|||
105393895|NCT00605189|363452152|FG000|Overall Study|Other|2|||
105393896|NCT00605189|363452153|FG001|Overall Study|Other|2|||
105393897|NCT00605189|363452154|FG002|Overall Study|Other|0|||
105393898|NCT02697448|363452155|FG000|Overall Study|Protocol Violation|2|||
105393899|NCT02697448|363452156|FG001|Overall Study|Protocol Violation|4|||
105393900|NCT02697448|363452155|FG000|Overall Study|Clinical concerns during ablation|1|||
105393901|NCT02697448|363452156|FG001|Overall Study|Clinical concerns during ablation|1|||
105393902|NCT02697448|363452155|FG000|Overall Study|No data collected|2|||
105393903|NCT02697448|363452156|FG001|Overall Study|No data collected|0|||
105393904|NCT02507934|363452157|FG000|Overall Study|Lost to Follow-up|2|||
105393905|NCT02507934|363452158|FG001|Overall Study|Lost to Follow-up|0|||
105393906|NCT02507934|363452157|FG000|Overall Study|Withdrawal by Subject|2|||
105393907|NCT02507934|363452158|FG001|Overall Study|Withdrawal by Subject|0|||
105393908|NCT02661815|363452161|FG000|Overall Study|Withdrawal by Subject|1|||
105393909|NCT02661815|363452162|FG001|Overall Study|Withdrawal by Subject|0|||
105393910|NCT02661815|363452163|FG002|Overall Study|Withdrawal by Subject|0|||
105393911|NCT02661815|363452164|FG003|Overall Study|Withdrawal by Subject|0|||
105393912|NCT02014376|363452165|FG000|Overall Study|Adverse Event|1|||
105393913|NCT02014376|363452166|FG001|Overall Study|Adverse Event|1|||
105393914|NCT02014376|363452167|FG002|Overall Study|Adverse Event|0|||
105393915|NCT02014376|363452165|FG000|Overall Study|Lost to Follow-up|2|||
105393916|NCT02014376|363452166|FG001|Overall Study|Lost to Follow-up|0|||
105393917|NCT02014376|363452167|FG002|Overall Study|Lost to Follow-up|0|||
105393918|NCT00815633|363452168|FG000|Overall Study|study terminated|1|||
105393919|NCT00654355|363452169|FG000|Overall Study|Lost to Follow-up|2|||
105393920|NCT00654355|363452170|FG001|Overall Study|Lost to Follow-up|2|||
105393921|NCT01051661|363452171|FG000|Overall Study|Adverse Event|1|||
105393922|NCT01051661|363452172|FG001|Overall Study|Adverse Event|1|||
105393923|NCT01051661|363452173|FG002|Overall Study|Adverse Event|1|||
105393924|NCT01051661|363452174|FG003|Overall Study|Adverse Event|1|||
105393925|NCT01051661|363452175|FG004|Overall Study|Adverse Event|0|||
105393926|NCT01051661|363452176|FG005|Overall Study|Adverse Event|0|||
105393927|NCT01051661|363452171|FG000|Overall Study|Lost to Follow-up|13|||
105393928|NCT01051661|363452172|FG001|Overall Study|Lost to Follow-up|22|||
105393929|NCT01051661|363452173|FG002|Overall Study|Lost to Follow-up|15|||
105393930|NCT01051661|363452174|FG003|Overall Study|Lost to Follow-up|17|||
105393931|NCT01051661|363452175|FG004|Overall Study|Lost to Follow-up|10|||
105393932|NCT01051661|363452176|FG005|Overall Study|Lost to Follow-up|24|||
105393933|NCT01051661|363452171|FG000|Overall Study|Migrated/moved from study area|1|||
105393934|NCT01051661|363452172|FG001|Overall Study|Migrated/moved from study area|6|||
105393935|NCT01051661|363452173|FG002|Overall Study|Migrated/moved from study area|6|||
105393936|NCT01051661|363452174|FG003|Overall Study|Migrated/moved from study area|8|||
105393937|NCT01051661|363452175|FG004|Overall Study|Migrated/moved from study area|7|||
105393938|NCT01051661|363452176|FG005|Overall Study|Migrated/moved from study area|3|||
105393939|NCT01051661|363452171|FG000|Overall Study|Refused blood sampling|0|||
105393940|NCT01051661|363452172|FG001|Overall Study|Refused blood sampling|0|||
105393941|NCT01051661|363452173|FG002|Overall Study|Refused blood sampling|0|||
105393942|NCT01051661|363452174|FG003|Overall Study|Refused blood sampling|0|||
105393943|NCT01051661|363452175|FG004|Overall Study|Refused blood sampling|0|||
105393944|NCT01051661|363452176|FG005|Overall Study|Refused blood sampling|1|||
105393945|NCT01051661|363452171|FG000|Overall Study|Data not reliable|1|||
105393946|NCT01051661|363452172|FG001|Overall Study|Data not reliable|0|||
105393947|NCT01051661|363452173|FG002|Overall Study|Data not reliable|0|||
105393948|NCT01051661|363452174|FG003|Overall Study|Data not reliable|0|||
105393949|NCT01051661|363452175|FG004|Overall Study|Data not reliable|0|||
105393950|NCT01051661|363452176|FG005|Overall Study|Data not reliable|1|||
105393951|NCT01051661|363452171|FG000|Overall Study|Unable to attend visit(s)|2|||
105393952|NCT01051661|363452172|FG001|Overall Study|Unable to attend visit(s)|4|||
105393953|NCT01051661|363452173|FG002|Overall Study|Unable to attend visit(s)|2|||
105393954|NCT01051661|363452174|FG003|Overall Study|Unable to attend visit(s)|1|||
105393955|NCT01051661|363452175|FG004|Overall Study|Unable to attend visit(s)|3|||
105393956|NCT01051661|363452176|FG005|Overall Study|Unable to attend visit(s)|2|||
105393957|NCT01051661|363452171|FG000|Overall Study|Consent not received from both parents|0|||
105393958|NCT01051661|363452172|FG001|Overall Study|Consent not received from both parents|0|||
105393959|NCT01051661|363452173|FG002|Overall Study|Consent not received from both parents|0|||
105393960|NCT01051661|363452174|FG003|Overall Study|Consent not received from both parents|0|||
105393961|NCT01051661|363452175|FG004|Overall Study|Consent not received from both parents|0|||
105393962|NCT01051661|363452176|FG005|Overall Study|Consent not received from both parents|1|||
105393963|NCT01051661|363452171|FG000|Overall Study|Failure to comply with protocol|0|||
105393964|NCT01051661|363452172|FG001|Overall Study|Failure to comply with protocol|0|||
105393965|NCT01051661|363452173|FG002|Overall Study|Failure to comply with protocol|2|||
105393966|NCT01051661|363452174|FG003|Overall Study|Failure to comply with protocol|0|||
105393967|NCT01051661|363452175|FG004|Overall Study|Failure to comply with protocol|0|||
105393968|NCT01051661|363452176|FG005|Overall Study|Failure to comply with protocol|0|||
105393969|NCT01051661|363452171|FG000|Overall Study|Subject lost legal representation|0|||
105393970|NCT01051661|363452172|FG001|Overall Study|Subject lost legal representation|0|||
105393971|NCT01051661|363452173|FG002|Overall Study|Subject lost legal representation|0|||
105393972|NCT01051661|363452174|FG003|Overall Study|Subject lost legal representation|0|||
105393973|NCT01051661|363452175|FG004|Overall Study|Subject lost legal representation|1|||
105393974|NCT01051661|363452176|FG005|Overall Study|Subject lost legal representation|0|||
105393975|NCT01051661|363452171|FG000|Overall Study|Protocol Violation|0|||
105393976|NCT01051661|363452172|FG001|Overall Study|Protocol Violation|0|||
105393977|NCT01051661|363452173|FG002|Overall Study|Protocol Violation|0|||
105393978|NCT01051661|363452174|FG003|Overall Study|Protocol Violation|1|||
105393979|NCT01051661|363452175|FG004|Overall Study|Protocol Violation|2|||
105393980|NCT01051661|363452176|FG005|Overall Study|Protocol Violation|1|||
105393981|NCT01051661|363452171|FG000|Overall Study|Withdrawal by Subject|16|||
105393982|NCT01051661|363452172|FG001|Overall Study|Withdrawal by Subject|30|||
105393983|NCT01051661|363452173|FG002|Overall Study|Withdrawal by Subject|13|||
105393984|NCT01051661|363452174|FG003|Overall Study|Withdrawal by Subject|28|||
105393985|NCT01051661|363452175|FG004|Overall Study|Withdrawal by Subject|12|||
105393986|NCT01051661|363452176|FG005|Overall Study|Withdrawal by Subject|34|||
105393987|NCT01983111|363452181|FG000|Overall Study|Withdrawal by Subject|8|||
105393988|NCT01983111|363452182|FG001|Overall Study|Withdrawal by Subject|6|||
105393989|NCT01983111|363452181|FG000|Overall Study|Adverse Event|4|||
105393990|NCT01983111|363452182|FG001|Overall Study|Adverse Event|0|||
105393991|NCT01983111|363452181|FG000|Overall Study|Protocol Violation|0|||
105393992|NCT01983111|363452182|FG001|Overall Study|Protocol Violation|1|||
105393993|NCT00855335|363452183|FG000|Overall Study|Lost to Follow-up|0|||
105393994|NCT00855335|363452184|FG001|Overall Study|Lost to Follow-up|0|||
105393995|NCT00855335|363452185|FG002|Overall Study|Lost to Follow-up|3|||
105393996|NCT00855335|363452186|FG003|Overall Study|Lost to Follow-up|1|||
105393997|NCT00855335|363452187|FG004|Overall Study|Lost to Follow-up|0|||
105393998|NCT00855335|363452183|FG000|Overall Study|Withdrawal by Subject|0|||
105393999|NCT00855335|363452184|FG001|Overall Study|Withdrawal by Subject|0|||
105394000|NCT00855335|363452185|FG002|Overall Study|Withdrawal by Subject|0|||
105394001|NCT00855335|363452186|FG003|Overall Study|Withdrawal by Subject|1|||
105394002|NCT00855335|363452187|FG004|Overall Study|Withdrawal by Subject|0|||
105394003|NCT00855335|363452183|FG000|Overall Study|Adverse Event|2|||
105394004|NCT00855335|363452184|FG001|Overall Study|Adverse Event|0|||
105394005|NCT00855335|363452185|FG002|Overall Study|Adverse Event|0|||
105394006|NCT00855335|363452186|FG003|Overall Study|Adverse Event|0|||
105394007|NCT00855335|363452187|FG004|Overall Study|Adverse Event|0|||
105394008|NCT00855335|363452183|FG000|Overall Study|Physician Decision|1|||
105394009|NCT00855335|363452184|FG001|Overall Study|Physician Decision|1|||
105394010|NCT00855335|363452185|FG002|Overall Study|Physician Decision|0|||
105394011|NCT00855335|363452186|FG003|Overall Study|Physician Decision|0|||
105394012|NCT00855335|363452187|FG004|Overall Study|Physician Decision|0|||
105394013|NCT00855335|363452183|FG000|Overall Study|Other|2|||
105394014|NCT00855335|363452184|FG001|Overall Study|Other|1|||
105394015|NCT00855335|363452185|FG002|Overall Study|Other|2|||
105394016|NCT00855335|363452186|FG003|Overall Study|Other|5|||
105394017|NCT00855335|363452187|FG004|Overall Study|Other|1|||
105394018|NCT03502200|363452188|FG000|Overall Study|Adverse Event|1|||
105394019|NCT03502200|363452189|FG001|Overall Study|Adverse Event|0|||
105394020|NCT03502200|363452188|FG000|Overall Study|Lost to Follow-up|36|||
105394021|NCT03502200|363452189|FG001|Overall Study|Lost to Follow-up|38|||
105394022|NCT03502200|363452188|FG000|Overall Study|Study Team Decision|1|||
105394023|NCT03502200|363452189|FG001|Overall Study|Study Team Decision|1|||
105394024|NCT03502200|363452188|FG000|Overall Study|Withdrawal by Subject|5|||
105394025|NCT03502200|363452189|FG001|Overall Study|Withdrawal by Subject|7|||
105394026|NCT03502200|363452188|FG000|Overall Study|Death|0|||
105394027|NCT03502200|363452189|FG001|Overall Study|Death|2|||
105580585|NCT02018861|364126445|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
105580586|NCT02018861|364126446|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
105394028|NCT00759395|363452192|FG000|Overall Study|Adverse Event|1|||
105394029|NCT00759395|363452193|FG001|Overall Study|Adverse Event|0|||
105394030|NCT00759395|363452192|FG000|Overall Study|Withdrawal by Subject|1|||
105394031|NCT00759395|363452193|FG001|Overall Study|Withdrawal by Subject|0|||
105394032|NCT00759395|363452192|FG000|Overall Study|Lack of Efficacy|0|||
105394033|NCT00759395|363452193|FG001|Overall Study|Lack of Efficacy|2|||
105394034|NCT02526290|363452196|FG000|Overall Study|Adverse Event|3|||
105394035|NCT02526290|363452196|FG000|Overall Study|Withdrawal by Subject|4|||
105394036|NCT02526290|363452196|FG000|Overall Study|Physician Decision|1|||
105394037|NCT00086515|363452197|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
105394038|NCT00086515|363452198|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
105394039|NCT00086515|363452197|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
105394040|NCT00086515|363452198|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
105394041|NCT00086515|363452197|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
105394042|NCT00086515|363452198|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
105394043|NCT00086515|363452197|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
105394044|NCT00086515|363452198|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
105394045|NCT00086515|363452197|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
105394046|NCT00086515|363452198|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
105394047|NCT00086515|363452197|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
105394048|NCT00086515|363452198|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
105394049|NCT00086515|363452197|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
105394050|NCT00086515|363452198|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
105394051|NCT00086515|363452197|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
105394052|NCT00086515|363452198|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
105394053|NCT00086515|363452197|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
105394054|NCT00086515|363452198|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
105394055|NCT00086515|363452197|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
105394056|NCT00086515|363452198|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
105394057|NCT00086515|363452197|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
105394058|NCT00086515|363452198|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
105394059|NCT00086515|363452197|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
105394060|NCT00086515|363452198|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
105394061|NCT00086515|363452197|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
105394062|NCT00086515|363452198|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
105394063|NCT00086515|363452197|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
105394064|NCT00086515|363452198|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
105394065|NCT00086515|363452197|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
105394066|NCT00086515|363452198|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
105394067|NCT00086515|363452197|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
105394068|NCT00086515|363452198|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
105394069|NCT00086515|363452197|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
105394070|NCT00086515|363452198|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
105394071|NCT00086515|363452197|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
105394072|NCT00086515|363452198|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
105394073|NCT00086515|363452197|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
105394074|NCT00086515|363452198|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
105394075|NCT00086515|363452197|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
105580587|NCT02018861|364126447|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
105580588|NCT02018861|364126448|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
105394076|NCT00086515|363452198|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
105394077|NCT00086515|363452197|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
105394078|NCT00086515|363452198|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
105394079|NCT00086515|363452197|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
105394080|NCT00086515|363452198|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
105394081|NCT00086515|363452197|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
105394082|NCT00086515|363452198|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
105394083|NCT00086515|363452197|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
105394084|NCT00086515|363452198|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
105394085|NCT00086515|363452197|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
105394086|NCT00086515|363452198|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
105394087|NCT00086515|363452197|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
105394088|NCT00086515|363452198|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
105394089|NCT00086515|363452197|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
105394090|NCT00086515|363452198|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
105394091|NCT00086515|363452197|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
105394092|NCT00086515|363452198|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
105394093|NCT00086515|363452197|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
105394094|NCT00086515|363452198|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
105394095|NCT00086515|363452197|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
105394096|NCT00086515|363452198|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
105394097|NCT00086515|363452197|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
105394098|NCT00086515|363452198|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
105394099|NCT02082977|363452199|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
105394100|NCT02082977|363452200|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
105394101|NCT02082977|363452201|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
105394102|NCT02082977|363452202|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
105394103|NCT02082977|363452203|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
105394104|NCT02082977|363452204|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
105394105|NCT02082977|363452205|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
105394106|NCT02082977|363452206|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
105394107|NCT02082977|363452207|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
105394108|NCT02082977|363452208|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
105394109|NCT02082977|363452199|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105394110|NCT02082977|363452200|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105394111|NCT02082977|363452201|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105394112|NCT02082977|363452202|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105394113|NCT02082977|363452203|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105394114|NCT02082977|363452204|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105394115|NCT02082977|363452205|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105394116|NCT02082977|363452206|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
105394117|NCT02082977|363452207|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105394118|NCT02082977|363452208|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105394119|NCT02082977|363452199|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105394120|NCT02082977|363452200|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105394121|NCT02082977|363452201|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105394122|NCT02082977|363452202|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105394123|NCT02082977|363452203|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105394124|NCT02082977|363452204|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
105394125|NCT02082977|363452205|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105394126|NCT02082977|363452206|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105394127|NCT02082977|363452207|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105394128|NCT02082977|363452208|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105394129|NCT02082977|363452199|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
105394130|NCT02082977|363452200|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
105394131|NCT02082977|363452201|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
105394132|NCT02082977|363452202|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
105394133|NCT02082977|363452203|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
105394134|NCT02082977|363452204|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
105394135|NCT02082977|363452205|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
105394136|NCT02082977|363452206|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
105394137|NCT02082977|363452207|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
105394138|NCT02082977|363452208|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
105394139|NCT02082977|363452199|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105394140|NCT02082977|363452200|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105493125|NCT00736957|363818780|FG000|Overall Study|did not attend hospital appointments|1|||
105493126|NCT00736957|363818780|FG000|Overall Study|not eligible for Treatment Period I|22|||
105493127|NCT00736957|363818780|FG000|Overall Study|Physician Decision|5|||
105493128|NCT02231918|363818781|FG000|Overall Study|Withdrawal by Subject|0|||
105394141|NCT02082977|363452201|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105394142|NCT02082977|363452202|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105394143|NCT02082977|363452203|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105394144|NCT02082977|363452204|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105394145|NCT02082977|363452205|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105394146|NCT02082977|363452206|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
105394147|NCT02082977|363452207|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105394148|NCT02082977|363452208|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105394149|NCT00105066|363452209|FG000|Overall Study|Adverse Event|2|||
105394150|NCT00105066|363452210|FG001|Overall Study|Adverse Event|5|||
105394151|NCT02106832|363452211|FG000|Overall Study|Adverse Event|1|||
105394152|NCT02106832|363452212|FG001|Overall Study|Adverse Event|2|||
105394153|NCT02106832|363452213|FG002|Overall Study|Adverse Event|3|||
105394154|NCT02106832|363452214|FG003|Overall Study|Adverse Event|0|||
105394155|NCT02106832|363452211|FG000|Overall Study|Death|4|||
105394156|NCT02106832|363452212|FG001|Overall Study|Death|4|||
105394157|NCT02106832|363452213|FG002|Overall Study|Death|1|||
105394158|NCT02106832|363452214|FG003|Overall Study|Death|4|||
105394159|NCT02106832|363452211|FG000|Overall Study|Deterioration of general conditions|0|||
105394160|NCT02106832|363452212|FG001|Overall Study|Deterioration of general conditions|0|||
105394161|NCT02106832|363452213|FG002|Overall Study|Deterioration of general conditions|1|||
105394162|NCT02106832|363452214|FG003|Overall Study|Deterioration of general conditions|0|||
105394163|NCT02106832|363452211|FG000|Overall Study|Lost to Follow-up|0|||
105394164|NCT02106832|363452212|FG001|Overall Study|Lost to Follow-up|1|||
105394165|NCT02106832|363452213|FG002|Overall Study|Lost to Follow-up|1|||
105394166|NCT02106832|363452214|FG003|Overall Study|Lost to Follow-up|3|||
105394167|NCT02106832|363452211|FG000|Overall Study|Physician Decision|1|||
105394168|NCT02106832|363452212|FG001|Overall Study|Physician Decision|0|||
105394169|NCT02106832|363452213|FG002|Overall Study|Physician Decision|0|||
105394170|NCT02106832|363452214|FG003|Overall Study|Physician Decision|0|||
105394171|NCT02106832|363452211|FG000|Overall Study|Protocol Violation|0|||
105394172|NCT02106832|363452212|FG001|Overall Study|Protocol Violation|0|||
105394173|NCT02106832|363452213|FG002|Overall Study|Protocol Violation|0|||
105394174|NCT02106832|363452214|FG003|Overall Study|Protocol Violation|1|||
105394175|NCT02106832|363452211|FG000|Overall Study|Withdrawal by Subject|17|||
105394176|NCT02106832|363452212|FG001|Overall Study|Withdrawal by Subject|17|||
105394177|NCT02106832|363452213|FG002|Overall Study|Withdrawal by Subject|10|||
105394178|NCT02106832|363452214|FG003|Overall Study|Withdrawal by Subject|7|||
105394179|NCT02106832|363452211|FG000|Overall Study|Technical problems|0|||
105394180|NCT02106832|363452212|FG001|Overall Study|Technical problems|1|||
105394181|NCT02106832|363452213|FG002|Overall Study|Technical problems|0|||
105394182|NCT02106832|363452214|FG003|Overall Study|Technical problems|0|||
105394183|NCT00437073|363452215|FG000|Overall Study|Sponsor Terminated Study|1|||
105394184|NCT00437073|363452216|FG001|Overall Study|Sponsor Terminated Study|0|||
105394185|NCT00437073|363452215|FG000|Overall Study|Physician Decision|0|||
105394186|NCT00437073|363452216|FG001|Overall Study|Physician Decision|1|||
105394187|NCT03485157|363452217|FG000|Double Blind Phase|Lost to Follow-up|4|||
105394188|NCT03485157|363452218|FG001|Double Blind Phase|Lost to Follow-up|4|||
105394189|NCT03485157|363452217|FG000|Double Blind Phase|Adverse Event|2|||
105394190|NCT03485157|363452218|FG001|Double Blind Phase|Adverse Event|1|||
105493129|NCT02231918|363818782|FG001|Overall Study|Withdrawal by Subject|1|||
105493130|NCT02231918|363818783|FG002|Overall Study|Withdrawal by Subject|0|||
105394191|NCT03485157|363452217|FG000|Double Blind Phase|Withdrawal by Subject|6|||
105394192|NCT03485157|363452218|FG001|Double Blind Phase|Withdrawal by Subject|9|||
105493131|NCT02231918|363818781|FG000|Overall Study|Adverse Event|0|||
105394193|NCT03485157|363452217|FG000|Double Blind Phase|Removal by PI|3|||
105394194|NCT03485157|363452218|FG001|Double Blind Phase|Removal by PI|7|||
105394195|NCT03485157|363452217|FG000|Open Label Phase|Lost to Follow-up|1|||
105394196|NCT03485157|363452218|FG001|Open Label Phase|Lost to Follow-up|2|||
105394197|NCT03485157|363452217|FG000|Open Label Phase|Adverse Event|0|||
105394198|NCT03485157|363452218|FG001|Open Label Phase|Adverse Event|1|||
105394199|NCT03485157|363452217|FG000|Open Label Phase|Withdrawal by Subject|1|||
105394200|NCT03485157|363452218|FG001|Open Label Phase|Withdrawal by Subject|2|||
105394201|NCT03485157|363452217|FG000|Open Label Phase|Removal by PI|2|||
105394202|NCT03485157|363452218|FG001|Open Label Phase|Removal by PI|0|||
105394203|NCT01506726|363452225|FG000|Overall Study|Adverse Event|1|||
105394204|NCT01506726|363452226|FG001|Overall Study|Adverse Event|2|||
105394205|NCT03773484|363452227|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
105394206|NCT04976855|363452232|FG000|Part I|Withdrawal by Subject|0|||
105394207|NCT04976855|363452233|FG001|Part I|Withdrawal by Subject|1|||
105394208|NCT04976855|363452234|FG002|Part I|Withdrawal by Subject|0|||
105394209|NCT04976855|363452235|FG003|Part I|Withdrawal by Subject|0|||
105394210|NCT04976855|363452236|FG004|Part I|Withdrawal by Subject|0|||
105394211|NCT04976855|363452237|FG005|Part I|Withdrawal by Subject|0|||
105394212|NCT04976855|363452238|FG006|Part I|Withdrawal by Subject|0|||
105394213|NCT04976855|363452232|FG000|Part II|Adverse Event|0|||
105394214|NCT04976855|363452233|FG001|Part II|Adverse Event|0|||
105394215|NCT04976855|363452234|FG002|Part II|Adverse Event|0|||
105394216|NCT04976855|363452235|FG003|Part II|Adverse Event|1|||
105394217|NCT04976855|363452236|FG004|Part II|Adverse Event|0|||
105394218|NCT04976855|363452237|FG005|Part II|Adverse Event|0|||
105394219|NCT04976855|363452238|FG006|Part II|Adverse Event|0|||
105394220|NCT04976855|363452232|FG000|Part II|Withdrawal by Subject|0|||
105394221|NCT04976855|363452233|FG001|Part II|Withdrawal by Subject|0|||
105394222|NCT04976855|363452234|FG002|Part II|Withdrawal by Subject|0|||
105394223|NCT04976855|363452235|FG003|Part II|Withdrawal by Subject|0|||
105394224|NCT04976855|363452236|FG004|Part II|Withdrawal by Subject|1|||
105394225|NCT04976855|363452237|FG005|Part II|Withdrawal by Subject|0|||
105394226|NCT04976855|363452238|FG006|Part II|Withdrawal by Subject|0|||
105394227|NCT04976855|363452232|FG000|Part II|Lost to Follow-up|0|||
105394228|NCT04976855|363452233|FG001|Part II|Lost to Follow-up|0|||
105394229|NCT04976855|363452234|FG002|Part II|Lost to Follow-up|0|||
105394230|NCT04976855|363452235|FG003|Part II|Lost to Follow-up|0|||
105394231|NCT04976855|363452236|FG004|Part II|Lost to Follow-up|0|||
105394232|NCT04976855|363452237|FG005|Part II|Lost to Follow-up|1|||
105394233|NCT04976855|363452238|FG006|Part II|Lost to Follow-up|0|||
105394234|NCT05185453|363452241|FG000|Overall Study|Lost to Follow-up|13|||
105394235|NCT05185453|363452242|FG001|Overall Study|Lost to Follow-up|3|||
105394236|NCT01972659|363452255|FG000|Overall Study|Protocol Violation|2|||
105394237|NCT01972659|363452256|FG001|Overall Study|Protocol Violation|2|||
105394238|NCT01972659|363452255|FG000|Overall Study|problems realted to acceleromyograph|2|||
105394239|NCT01972659|363452256|FG001|Overall Study|problems realted to acceleromyograph|1|||
105394240|NCT03274466|363452268|FG000|Overall Study|Withdrawal by Subject|7|||
105394241|NCT03274466|363452269|FG001|Overall Study|Withdrawal by Subject|3|||
105394242|NCT03274466|363452268|FG000|Overall Study|Protocol Specified Withdrawal|5|||
105394243|NCT03274466|363452269|FG001|Overall Study|Protocol Specified Withdrawal|11|||
105394244|NCT03274466|363452268|FG000|Overall Study|Lost to Follow-up|5|||
105394245|NCT03274466|363452269|FG001|Overall Study|Lost to Follow-up|7|||
105394246|NCT03274466|363452268|FG000|Overall Study|Subject Non-compliance|0|||
105394247|NCT03274466|363452269|FG001|Overall Study|Subject Non-compliance|1|||
105394248|NCT03274466|363452268|FG000|Overall Study|Adverse Event|3|||
105394249|NCT03274466|363452269|FG001|Overall Study|Adverse Event|3|||
105394250|NCT03274466|363452268|FG000|Overall Study|Physician Decision|0|||
105394251|NCT03274466|363452269|FG001|Overall Study|Physician Decision|1|||
105394252|NCT03274466|363452268|FG000|Overall Study|Protocol Violation|3|||
105394253|NCT03274466|363452269|FG001|Overall Study|Protocol Violation|3|||
105394254|NCT03514134|363454668|FG000|Overall Study|Lost to Follow-up|0|||
105394255|NCT03514134|363454669|FG001|Overall Study|Lost to Follow-up|1|||
105394256|NCT03502681|363454674|FG000|Overall Study|Adverse Event|1|||
105394257|NCT03502681|363454675|FG001|Overall Study|Adverse Event|1|||
105394258|NCT03502681|363454674|FG000|Overall Study|Disease Progression|2|||
105394259|NCT03502681|363454675|FG001|Overall Study|Disease Progression|1|||
105394260|NCT01444781|363454676|FG000|Overall Study|Lost to Follow-up|0|||
105394261|NCT01444781|363454677|FG001|Overall Study|Lost to Follow-up|3|||
105394262|NCT01444781|363454678|FG002|Overall Study|Lost to Follow-up|1|||
105394263|NCT01444781|363454676|FG000|Overall Study|Withdrawal by Subject|3|||
105394264|NCT01444781|363454677|FG001|Overall Study|Withdrawal by Subject|1|||
105394265|NCT01444781|363454678|FG002|Overall Study|Withdrawal by Subject|2|||
105394266|NCT06790303|363454689|FG000|Overall Study|Study Terminated by sponsor|4|||
105394267|NCT06790303|363454689|FG000|Overall Study|Death|4|||
105394268|NCT00836706|363454690|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
105394269|NCT00836706|363454691|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
105394270|NCT02989857|363454692|FG000|Randomization Phase|Not Treated|3|||
105394271|NCT02989857|363454693|FG001|Randomization Phase|Not Treated|2|||
105493132|NCT02231918|363818782|FG001|Overall Study|Adverse Event|0|||
105394272|NCT02989857|363454694|FG002|Randomization Phase|Not Treated|0|||
105394273|NCT04622592|363454695|FG000|Overall Study|Death|0|||
105394274|NCT04622592|363454696|FG001|Overall Study|Death|0|||
105394275|NCT04622592|363454697|FG002|Overall Study|Death|1|||
105394276|NCT04622592|363454698|FG003|Overall Study|Death|0|||
105394277|NCT04622592|363454699|FG004|Overall Study|Death|0|||
105394278|NCT04622592|363454700|FG005|Overall Study|Death|0|||
105394279|NCT04622592|363454701|FG006|Overall Study|Death|0|||
105394280|NCT04622592|363454702|FG007|Overall Study|Death|1|||
105394281|NCT04622592|363454695|FG000|Overall Study|Lost to Follow-up|0|||
105394282|NCT04622592|363454696|FG001|Overall Study|Lost to Follow-up|0|||
105394283|NCT04622592|363454697|FG002|Overall Study|Lost to Follow-up|0|||
105394284|NCT04622592|363454698|FG003|Overall Study|Lost to Follow-up|3|||
105394285|NCT04622592|363454699|FG004|Overall Study|Lost to Follow-up|1|||
105394286|NCT04622592|363454700|FG005|Overall Study|Lost to Follow-up|0|||
105394287|NCT04622592|363454701|FG006|Overall Study|Lost to Follow-up|2|||
105394288|NCT04622592|363454702|FG007|Overall Study|Lost to Follow-up|2|||
105394289|NCT04622592|363454695|FG000|Overall Study|Physician Decision|0|||
105394290|NCT04622592|363454696|FG001|Overall Study|Physician Decision|0|||
105394291|NCT04622592|363454697|FG002|Overall Study|Physician Decision|0|||
105394292|NCT04622592|363454698|FG003|Overall Study|Physician Decision|0|||
105394293|NCT04622592|363454699|FG004|Overall Study|Physician Decision|1|||
105394294|NCT04622592|363454700|FG005|Overall Study|Physician Decision|0|||
105394295|NCT04622592|363454701|FG006|Overall Study|Physician Decision|0|||
105394296|NCT04622592|363454702|FG007|Overall Study|Physician Decision|0|||
105394297|NCT04622592|363454695|FG000|Overall Study|Withdrawal by Subject|1|||
105394298|NCT04622592|363454696|FG001|Overall Study|Withdrawal by Subject|0|||
105394299|NCT04622592|363454697|FG002|Overall Study|Withdrawal by Subject|2|||
105394300|NCT04622592|363454698|FG003|Overall Study|Withdrawal by Subject|0|||
105394301|NCT04622592|363454699|FG004|Overall Study|Withdrawal by Subject|0|||
105394302|NCT04622592|363454700|FG005|Overall Study|Withdrawal by Subject|0|||
105394303|NCT04622592|363454701|FG006|Overall Study|Withdrawal by Subject|1|||
105394304|NCT04622592|363454702|FG007|Overall Study|Withdrawal by Subject|4|||
105394305|NCT04622592|363454695|FG000|Overall Study|Other than specified above|0|||
105394306|NCT04622592|363454696|FG001|Overall Study|Other than specified above|0|||
105394307|NCT04622592|363454697|FG002|Overall Study|Other than specified above|1|||
105394308|NCT04622592|363454698|FG003|Overall Study|Other than specified above|0|||
105394309|NCT04622592|363454699|FG004|Overall Study|Other than specified above|0|||
105394310|NCT04622592|363454700|FG005|Overall Study|Other than specified above|0|||
105394311|NCT04622592|363454701|FG006|Overall Study|Other than specified above|0|||
105394312|NCT04622592|363454702|FG007|Overall Study|Other than specified above|0|||
105394313|NCT04734210|363454703|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
105394314|NCT04734210|363454704|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
105394315|NCT04734210|363454705|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
105394316|NCT04734210|363454703|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
105394317|NCT04734210|363454704|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
105394318|NCT04734210|363454705|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
105394319|NCT04734210|363454703|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
105394320|NCT04734210|363454704|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
105394321|NCT04734210|363454705|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
105394322|NCT04734210|363454703|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
105394323|NCT04734210|363454704|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
105394324|NCT04734210|363454705|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
105394325|NCT01209767|363454709|FG000|Overall Study|Withdrawal by Subject|1|||
105394326|NCT01209767|363454709|FG000|Overall Study|Lost to Follow-up|3|||
105394327|NCT03580044|363454710|FG000|Overall Study|Death|2|||
105394328|NCT03580044|363454711|FG001|Overall Study|Death|1|||
105394329|NCT03580044|363454710|FG000|Overall Study|Withdrawal by Subject|1|||
105394330|NCT03580044|363454711|FG001|Overall Study|Withdrawal by Subject|1|||
105394331|NCT01822925|363454712|FG000|Overall Study|Adverse Event|1|||
105394332|NCT01822925|363454713|FG001|Overall Study|Adverse Event|1|||
105394333|NCT01822925|363454714|FG002|Overall Study|Adverse Event|1|||
105394334|NCT01822925|363454715|FG003|Overall Study|Adverse Event|1|||
105394335|NCT01822925|363454712|FG000|Overall Study|Lost to Follow-up|0|||
105394336|NCT01822925|363454713|FG001|Overall Study|Lost to Follow-up|1|||
105394337|NCT01822925|363454714|FG002|Overall Study|Lost to Follow-up|0|||
105394338|NCT01822925|363454715|FG003|Overall Study|Lost to Follow-up|0|||
105394339|NCT01822925|363454712|FG000|Overall Study|Protocol Violation|1|||
105394340|NCT01822925|363454713|FG001|Overall Study|Protocol Violation|0|||
105394341|NCT01822925|363454714|FG002|Overall Study|Protocol Violation|0|||
105394342|NCT01822925|363454715|FG003|Overall Study|Protocol Violation|1|||
105394343|NCT01822925|363454712|FG000|Overall Study|Withdrawal by Subject|2|||
105394344|NCT01822925|363454713|FG001|Overall Study|Withdrawal by Subject|0|||
105394345|NCT01822925|363454714|FG002|Overall Study|Withdrawal by Subject|2|||
105493133|NCT02231918|363818783|FG002|Overall Study|Adverse Event|1|||
105394346|NCT01822925|363454715|FG003|Overall Study|Withdrawal by Subject|2|||
105394347|NCT01822925|363454712|FG000|Overall Study|Taking prohibited medication|2|||
105394348|NCT01822925|363454713|FG001|Overall Study|Taking prohibited medication|0|||
105394349|NCT01822925|363454714|FG002|Overall Study|Taking prohibited medication|0|||
105394350|NCT01822925|363454715|FG003|Overall Study|Taking prohibited medication|1|||
105394351|NCT01935947|363454720|FG000|Overall Study|Adverse Event|0|||
105394352|NCT01935947|363454721|FG001|Overall Study|Adverse Event|2|||
105394353|NCT01935947|363454722|FG002|Overall Study|Adverse Event|0|||
105493134|NCT02395666|363818784|FG000|Overall Study|Physician Decision|3|||
105493135|NCT02395666|363818785|FG001|Overall Study|Physician Decision|0|||
105493136|NCT02395666|363818784|FG000|Overall Study|Lost to Follow-up|1|||
105493137|NCT02395666|363818785|FG001|Overall Study|Lost to Follow-up|0|||
105493138|NCT02395666|363818784|FG000|Overall Study|Withdrawal by Subject|2|||
105493139|NCT02395666|363818785|FG001|Overall Study|Withdrawal by Subject|1|||
105394354|NCT01935947|363454720|FG000|Overall Study|Diease Progression|2|||
105394355|NCT01935947|363454721|FG001|Overall Study|Diease Progression|2|||
105394356|NCT01935947|363454722|FG002|Overall Study|Diease Progression|2|||
105394357|NCT01935947|363454720|FG000|Overall Study|Death|1|||
105394358|NCT01935947|363454721|FG001|Overall Study|Death|0|||
105394359|NCT01935947|363454722|FG002|Overall Study|Death|0|||
105394360|NCT00573768|363454724|FG000|Overall Study|Adverse Event|1|||
105394361|NCT00573768|363454725|FG001|Overall Study|Adverse Event|1|||
105394362|NCT00573768|363454726|FG002|Overall Study|Adverse Event|2|||
105394363|NCT00573768|363454724|FG000|Overall Study|Protocol Violation|1|||
105394364|NCT00573768|363454725|FG001|Overall Study|Protocol Violation|0|||
105394365|NCT00573768|363454726|FG002|Overall Study|Protocol Violation|1|||
105394366|NCT00573768|363454724|FG000|Overall Study|Withdrawal by Subject|0|||
105394367|NCT00573768|363454725|FG001|Overall Study|Withdrawal by Subject|1|||
105394368|NCT00573768|363454726|FG002|Overall Study|Withdrawal by Subject|0|||
105394369|NCT00573768|363454724|FG000|Overall Study|Lost to Follow-up|0|||
105394370|NCT00573768|363454725|FG001|Overall Study|Lost to Follow-up|0|||
105394371|NCT00573768|363454726|FG002|Overall Study|Lost to Follow-up|1|||
105394372|NCT03243084|363454727|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
105394373|NCT03243084|363454728|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
105394374|NCT03322566|363454729|FG000|Overall Study|Death|34|||
105394375|NCT03322566|363454730|FG001|Overall Study|Death|35|||
105394376|NCT03322566|363454731|FG002|Overall Study|Death|23|||
105394377|NCT03322566|363454729|FG000|Overall Study|Physician Decision|6|||
105394378|NCT03322566|363454730|FG001|Overall Study|Physician Decision|7|||
105394379|NCT03322566|363454731|FG002|Overall Study|Physician Decision|2|||
105394380|NCT03322566|363454729|FG000|Overall Study|Withdrawal by Subject|4|||
105394381|NCT03322566|363454730|FG001|Overall Study|Withdrawal by Subject|3|||
105394382|NCT03322566|363454731|FG002|Overall Study|Withdrawal by Subject|6|||
105394383|NCT03322566|363454729|FG000|Overall Study|Lost to Follow-up|0|||
105394384|NCT03322566|363454730|FG001|Overall Study|Lost to Follow-up|0|||
105394385|NCT03322566|363454731|FG002|Overall Study|Lost to Follow-up|1|||
105394386|NCT03322566|363454729|FG000|Overall Study|Study terminated by sponsor|1|||
105394387|NCT03322566|363454730|FG001|Overall Study|Study terminated by sponsor|0|||
105394388|NCT03322566|363454731|FG002|Overall Study|Study terminated by sponsor|1|||
105394389|NCT02314923|363454734|FG000|Overall Study|Death|0|||
105394390|NCT02314923|363454735|FG001|Overall Study|Death|0|||
105394391|NCT02314923|363454736|FG002|Overall Study|Death|0|||
105394392|NCT02314923|363454737|FG003|Overall Study|Death|1|||
105394393|NCT02314923|363454738|FG004|Overall Study|Death|0|||
105394394|NCT02314923|363454739|FG005|Overall Study|Death|0|||
105394395|NCT02314923|363454740|FG006|Overall Study|Death|0|||
105394396|NCT02314923|363454741|FG007|Overall Study|Death|0|||
105394397|NCT02314923|363454742|FG008|Overall Study|Death|0|||
105394398|NCT02314923|363454743|FG009|Overall Study|Death|0|||
105394399|NCT02314923|363454734|FG000|Overall Study|Lost to Follow-up|2|||
105394400|NCT02314923|363454735|FG001|Overall Study|Lost to Follow-up|3|||
105394401|NCT02314923|363454736|FG002|Overall Study|Lost to Follow-up|1|||
105394402|NCT02314923|363454737|FG003|Overall Study|Lost to Follow-up|0|||
105394403|NCT02314923|363454738|FG004|Overall Study|Lost to Follow-up|0|||
105394404|NCT02314923|363454739|FG005|Overall Study|Lost to Follow-up|0|||
105394405|NCT02314923|363454740|FG006|Overall Study|Lost to Follow-up|3|||
105394406|NCT02314923|363454741|FG007|Overall Study|Lost to Follow-up|4|||
105394407|NCT02314923|363454742|FG008|Overall Study|Lost to Follow-up|2|||
105394408|NCT02314923|363454743|FG009|Overall Study|Lost to Follow-up|0|||
105394409|NCT02314923|363454734|FG000|Overall Study|Withdrawal by Subject|0|||
105394410|NCT02314923|363454735|FG001|Overall Study|Withdrawal by Subject|0|||
105394411|NCT02314923|363454736|FG002|Overall Study|Withdrawal by Subject|1|||
105493140|NCT01092507|363818786|FG000|Overall Study|Withdrawal by Subject|2|||
105493141|NCT01092507|363818787|FG001|Overall Study|Withdrawal by Subject|0|||
105493142|NCT02486302|363818789|FG000|Overall Study|Discontinued prematurely|410|||
105493143|NCT02486302|363818789|FG000|Overall Study|Documentation not completed|255|||
105394412|NCT02314923|363454737|FG003|Overall Study|Withdrawal by Subject|0|||
105394413|NCT02314923|363454738|FG004|Overall Study|Withdrawal by Subject|1|||
105394414|NCT02314923|363454739|FG005|Overall Study|Withdrawal by Subject|0|||
105394415|NCT02314923|363454740|FG006|Overall Study|Withdrawal by Subject|1|||
105394416|NCT02314923|363454741|FG007|Overall Study|Withdrawal by Subject|0|||
105394417|NCT02314923|363454742|FG008|Overall Study|Withdrawal by Subject|0|||
105394418|NCT02314923|363454743|FG009|Overall Study|Withdrawal by Subject|0|||
105394419|NCT02314923|363454734|FG000|Overall Study|Physician Decision|0|||
105394420|NCT02314923|363454735|FG001|Overall Study|Physician Decision|1|||
105394421|NCT02314923|363454736|FG002|Overall Study|Physician Decision|0|||
105394422|NCT02314923|363454737|FG003|Overall Study|Physician Decision|0|||
105394423|NCT02314923|363454738|FG004|Overall Study|Physician Decision|0|||
105394424|NCT02314923|363454739|FG005|Overall Study|Physician Decision|0|||
105394425|NCT02314923|363454740|FG006|Overall Study|Physician Decision|0|||
105394426|NCT02314923|363454741|FG007|Overall Study|Physician Decision|0|||
105394427|NCT02314923|363454742|FG008|Overall Study|Physician Decision|0|||
105394428|NCT02314923|363454743|FG009|Overall Study|Physician Decision|0|||
105394429|NCT02314923|363454734|FG000|Overall Study|Participant unavailable|0|||
105394430|NCT02314923|363454735|FG001|Overall Study|Participant unavailable|0|||
105394431|NCT02314923|363454736|FG002|Overall Study|Participant unavailable|0|||
105394432|NCT02314923|363454737|FG003|Overall Study|Participant unavailable|0|||
105394433|NCT02314923|363454738|FG004|Overall Study|Participant unavailable|0|||
105394434|NCT02314923|363454739|FG005|Overall Study|Participant unavailable|1|||
105394435|NCT02314923|363454740|FG006|Overall Study|Participant unavailable|0|||
105394436|NCT02314923|363454741|FG007|Overall Study|Participant unavailable|0|||
105394437|NCT02314923|363454742|FG008|Overall Study|Participant unavailable|0|||
105394438|NCT02314923|363454743|FG009|Overall Study|Participant unavailable|0|||
105394439|NCT02314923|363454734|FG000|Overall Study|Screen failure|0|||
105394440|NCT02314923|363454735|FG001|Overall Study|Screen failure|0|||
105394441|NCT02314923|363454736|FG002|Overall Study|Screen failure|0|||
105394442|NCT02314923|363454737|FG003|Overall Study|Screen failure|0|||
105394443|NCT02314923|363454738|FG004|Overall Study|Screen failure|0|||
105394444|NCT02314923|363454739|FG005|Overall Study|Screen failure|0|||
105394445|NCT02314923|363454740|FG006|Overall Study|Screen failure|1|||
105394446|NCT02314923|363454741|FG007|Overall Study|Screen failure|0|||
105394447|NCT02314923|363454742|FG008|Overall Study|Screen failure|0|||
105394448|NCT02314923|363454743|FG009|Overall Study|Screen failure|0|||
105394449|NCT02314923|363454734|FG000|Overall Study|Participant relocation|1|||
105394450|NCT02314923|363454735|FG001|Overall Study|Participant relocation|0|||
105394451|NCT02314923|363454736|FG002|Overall Study|Participant relocation|0|||
105394452|NCT02314923|363454737|FG003|Overall Study|Participant relocation|0|||
105394453|NCT02314923|363454738|FG004|Overall Study|Participant relocation|0|||
105394454|NCT02314923|363454739|FG005|Overall Study|Participant relocation|0|||
105394455|NCT02314923|363454740|FG006|Overall Study|Participant relocation|0|||
105394456|NCT02314923|363454741|FG007|Overall Study|Participant relocation|1|||
105394457|NCT02314923|363454742|FG008|Overall Study|Participant relocation|0|||
105394458|NCT02314923|363454743|FG009|Overall Study|Participant relocation|0|||
105394459|NCT00725985|363454744|FG000|ITP- Treatment Disposition|Adverse Event|20|||
105394460|NCT00725985|363454745|FG001|ITP- Treatment Disposition|Adverse Event|10|||
105394461|NCT00725985|363454746|FG002|ITP- Treatment Disposition|Adverse Event|5|||
105394462|NCT00725985|363454747|FG003|ITP- Treatment Disposition|Adverse Event|0|||
105394463|NCT00725985|363454748|FG004|ITP- Treatment Disposition|Adverse Event|0|||
105394464|NCT00725985|363454749|FG005|ITP- Treatment Disposition|Adverse Event|0|||
105394465|NCT00725985|363454750|FG006|ITP- Treatment Disposition|Adverse Event|0|||
105394466|NCT00725985|363454751|FG007|ITP- Treatment Disposition|Adverse Event|0|||
105394467|NCT00725985|363454752|FG008|ITP- Treatment Disposition|Adverse Event|0|||
105394468|NCT00725985|363454753|FG009|ITP- Treatment Disposition|Adverse Event|0|||
105394469|NCT00725985|363454754|FG010|ITP- Treatment Disposition|Adverse Event|0|||
105394470|NCT00725985|363454755|FG011|ITP- Treatment Disposition|Adverse Event|0|||
105394471|NCT00725985|363454744|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
105394472|NCT00725985|363454745|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
105394473|NCT00725985|363454746|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
105394474|NCT00725985|363454747|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
105394475|NCT00725985|363454748|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
105394476|NCT00725985|363454749|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
105394477|NCT00725985|363454750|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
105394478|NCT00725985|363454751|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
105394479|NCT00725985|363454752|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
105394480|NCT00725985|363454753|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
105394481|NCT00725985|363454754|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
105394482|NCT00725985|363454755|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
105394483|NCT00725985|363454744|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
105394484|NCT00725985|363454745|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
105394485|NCT00725985|363454746|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
105394486|NCT00725985|363454747|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
105394487|NCT00725985|363454748|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
105493144|NCT02486302|363818789|FG000|Overall Study|Excluded due to legal reasons|8|||
105493145|NCT02486302|363818789|FG000|Overall Study|Not treated|3|||
105493146|NCT01871142|363818790|FG000|Overall Study|Adverse Event|1|||
105394488|NCT00725985|363454749|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
105394489|NCT00725985|363454750|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
105394490|NCT00725985|363454751|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
105394491|NCT00725985|363454752|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
105394492|NCT00725985|363454753|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
105394493|NCT00725985|363454754|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
105394494|NCT00725985|363454755|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
105394495|NCT00725985|363454744|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
105394496|NCT00725985|363454745|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
105394497|NCT00725985|363454746|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
105394498|NCT00725985|363454747|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
105394499|NCT00725985|363454748|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
105394500|NCT00725985|363454749|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
105394501|NCT00725985|363454750|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
105394502|NCT00725985|363454751|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
105394503|NCT00725985|363454752|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
105394504|NCT00725985|363454753|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
105394505|NCT00725985|363454754|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
105394506|NCT00725985|363454755|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
105394507|NCT00725985|363454744|FG000|ITP- Treatment Disposition|Other|50|||
105394508|NCT00725985|363454745|FG001|ITP- Treatment Disposition|Other|38|||
105394509|NCT00725985|363454746|FG002|ITP- Treatment Disposition|Other|24|||
105394510|NCT00725985|363454747|FG003|ITP- Treatment Disposition|Other|0|||
105394511|NCT00725985|363454748|FG004|ITP- Treatment Disposition|Other|0|||
105394512|NCT00725985|363454749|FG005|ITP- Treatment Disposition|Other|0|||
105394513|NCT00725985|363454750|FG006|ITP- Treatment Disposition|Other|0|||
105394514|NCT00725985|363454751|FG007|ITP- Treatment Disposition|Other|0|||
105394515|NCT00725985|363454752|FG008|ITP- Treatment Disposition|Other|0|||
105394516|NCT00725985|363454753|FG009|ITP- Treatment Disposition|Other|0|||
105394517|NCT00725985|363454754|FG010|ITP- Treatment Disposition|Other|0|||
105394518|NCT00725985|363454755|FG011|ITP- Treatment Disposition|Other|0|||
105394519|NCT00725985|363454744|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105394520|NCT00725985|363454745|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105394521|NCT00725985|363454746|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105394522|NCT00725985|363454747|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
105394523|NCT00725985|363454748|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
105394524|NCT00725985|363454749|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
105394525|NCT00725985|363454750|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105394526|NCT00725985|363454751|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105394527|NCT00725985|363454752|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105394528|NCT00725985|363454753|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105394529|NCT00725985|363454754|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105394530|NCT00725985|363454755|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105394531|NCT00725985|363454744|FG000|OLMP (Up to 96 Weeks)|Death|0|||
105394532|NCT00725985|363454745|FG001|OLMP (Up to 96 Weeks)|Death|0|||
105394533|NCT00725985|363454746|FG002|OLMP (Up to 96 Weeks)|Death|0|||
105394534|NCT00725985|363454747|FG003|OLMP (Up to 96 Weeks)|Death|0|||
105394535|NCT00725985|363454748|FG004|OLMP (Up to 96 Weeks)|Death|1|||
105394536|NCT00725985|363454749|FG005|OLMP (Up to 96 Weeks)|Death|0|||
105394537|NCT00725985|363454750|FG006|OLMP (Up to 96 Weeks)|Death|0|||
105394538|NCT00725985|363454751|FG007|OLMP (Up to 96 Weeks)|Death|0|||
105394539|NCT00725985|363454752|FG008|OLMP (Up to 96 Weeks)|Death|0|||
105394540|NCT00725985|363454753|FG009|OLMP (Up to 96 Weeks)|Death|0|||
105394541|NCT00725985|363454754|FG010|OLMP (Up to 96 Weeks)|Death|0|||
105394542|NCT00725985|363454755|FG011|OLMP (Up to 96 Weeks)|Death|0|||
105394543|NCT00725985|363454744|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105394544|NCT00725985|363454745|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105394545|NCT00725985|363454746|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105394546|NCT00725985|363454747|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
105394547|NCT00725985|363454748|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105394548|NCT00725985|363454749|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105394549|NCT00725985|363454750|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105394550|NCT00725985|363454751|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105394551|NCT00725985|363454752|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105394552|NCT00725985|363454753|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105394553|NCT00725985|363454754|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105394554|NCT00725985|363454755|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105394555|NCT00725985|363454744|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
105394556|NCT00725985|363454745|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
105394557|NCT00725985|363454746|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
105394558|NCT00725985|363454747|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
105394559|NCT00725985|363454748|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
105394560|NCT00725985|363454749|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
105394561|NCT00725985|363454750|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
105394562|NCT00725985|363454751|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
105394563|NCT00725985|363454752|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
105394564|NCT00725985|363454753|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
105394565|NCT00725985|363454754|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
105394566|NCT00725985|363454755|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
105394567|NCT00725985|363454744|FG000|OLMP (Up to 96 Weeks)|Other|0|||
105394568|NCT00725985|363454745|FG001|OLMP (Up to 96 Weeks)|Other|0|||
105394569|NCT00725985|363454746|FG002|OLMP (Up to 96 Weeks)|Other|0|||
105394570|NCT00725985|363454747|FG003|OLMP (Up to 96 Weeks)|Other|15|||
105493147|NCT00085709|363818791|FG000|Overall Study|Adverse Event|8|||
105394571|NCT00725985|363454748|FG004|OLMP (Up to 96 Weeks)|Other|20|||
105394572|NCT00725985|363454749|FG005|OLMP (Up to 96 Weeks)|Other|44|||
105394573|NCT00725985|363454750|FG006|OLMP (Up to 96 Weeks)|Other|0|||
105394574|NCT00725985|363454751|FG007|OLMP (Up to 96 Weeks)|Other|0|||
105394575|NCT00725985|363454752|FG008|OLMP (Up to 96 Weeks)|Other|0|||
105394576|NCT00725985|363454753|FG009|OLMP (Up to 96 Weeks)|Other|0|||
105394577|NCT00725985|363454754|FG010|OLMP (Up to 96 Weeks)|Other|0|||
105394578|NCT00725985|363454755|FG011|OLMP (Up to 96 Weeks)|Other|0|||
105394579|NCT00725985|363454744|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105394580|NCT00725985|363454745|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105394581|NCT00725985|363454746|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105394582|NCT00725985|363454747|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105394583|NCT00725985|363454748|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105394584|NCT00725985|363454749|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105394585|NCT00725985|363454750|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105394586|NCT00725985|363454751|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
105394587|NCT00725985|363454752|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105394588|NCT00725985|363454753|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105394589|NCT00725985|363454754|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105394590|NCT00725985|363454755|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105394591|NCT00725985|363454744|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105394592|NCT00725985|363454745|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105394593|NCT00725985|363454746|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105394594|NCT00725985|363454747|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105394595|NCT00725985|363454748|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105394596|NCT00725985|363454749|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105394597|NCT00725985|363454750|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105394598|NCT00725985|363454751|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105394599|NCT00725985|363454752|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
105394600|NCT00725985|363454753|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105394601|NCT00725985|363454754|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105394602|NCT00725985|363454755|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105394603|NCT00725985|363454744|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105394604|NCT00725985|363454745|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105394605|NCT00725985|363454746|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105394606|NCT00725985|363454747|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105394607|NCT00725985|363454748|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105394608|NCT00725985|363454749|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105394609|NCT00725985|363454750|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
105394610|NCT00725985|363454751|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
105394611|NCT00725985|363454752|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
105394612|NCT00725985|363454753|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105394613|NCT00725985|363454754|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105394614|NCT00725985|363454755|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105394615|NCT00725985|363454744|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105394616|NCT00725985|363454745|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105394617|NCT00725985|363454746|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105394618|NCT00725985|363454747|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105394619|NCT00725985|363454748|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105394620|NCT00725985|363454749|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105394621|NCT00725985|363454750|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105394622|NCT00725985|363454751|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105394623|NCT00725985|363454752|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105394624|NCT00725985|363454753|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
105394625|NCT00725985|363454754|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
105394626|NCT00725985|363454755|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
105394627|NCT00833690|363454756|FG000|Overall Study|Withdrawal by Subject|1|||
105394628|NCT00833690|363454757|FG001|Overall Study|Withdrawal by Subject|0|||
105394629|NCT00833690|363454758|FG002|Overall Study|Withdrawal by Subject|0|||
105394630|NCT00833690|363454756|FG000|Overall Study|Discontinued study drug|3|||
105394631|NCT00833690|363454757|FG001|Overall Study|Discontinued study drug|2|||
105394632|NCT00833690|363454758|FG002|Overall Study|Discontinued study drug|0|||
105394633|NCT03898180|363454759|FG000|Overall Study|Death|178|||
105394634|NCT03898180|363454760|FG001|Overall Study|Death|173|||
105394635|NCT03898180|363454759|FG000|Overall Study|Physician Decision|1|||
105394636|NCT03898180|363454760|FG001|Overall Study|Physician Decision|0|||
105394637|NCT03898180|363454759|FG000|Overall Study|Sponsor Decision|3|||
105394638|NCT03898180|363454760|FG001|Overall Study|Sponsor Decision|0|||
105394639|NCT03898180|363454759|FG000|Overall Study|Lost to Follow-up|1|||
105394640|NCT03898180|363454760|FG001|Overall Study|Lost to Follow-up|0|||
105394641|NCT03898180|363454759|FG000|Overall Study|Withdrawal by Subject|5|||
105394642|NCT03898180|363454760|FG001|Overall Study|Withdrawal by Subject|4|||
105394643|NCT04924114|363454763|FG000|Overall Study|Withdrawal by Subject|0|||
105394644|NCT04924114|363454764|FG001|Overall Study|Withdrawal by Subject|2|||
105394645|NCT04924114|363454765|FG002|Overall Study|Withdrawal by Subject|2|||
105394646|NCT04924114|363454766|FG003|Overall Study|Withdrawal by Subject|0|||
105394647|NCT04924114|363454767|FG004|Overall Study|Withdrawal by Subject|1|||
105394648|NCT05473715|363454768|FG000|Overall Study|Trial terminate|2|||
105394649|NCT05473715|363454769|FG001|Overall Study|Trial terminate|1|||
105394650|NCT03528902|363454773|FG000|Overall Study|Adverse Event|1|||
105394651|NCT03528902|363454774|FG001|Overall Study|Adverse Event|0|||
105394652|NCT05030766|363454775|FG000|Phase 1 Participants|Lost to Follow-up|12|||
105394653|NCT05030766|363454776|FG001|Phase 1 Participants|Lost to Follow-up|22|||
105394654|NCT05030766|363454777|FG002|Phase 1 Participants|Lost to Follow-up|0|||
105394655|NCT05030766|363454778|FG003|Phase 1 Participants|Lost to Follow-up|0|||
105394656|NCT05030766|363454775|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
105394657|NCT05030766|363454776|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
105394658|NCT05030766|363454777|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
105394659|NCT05030766|363454778|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
105394660|NCT05030766|363454775|FG000|Phase 2 Participants|Lost to Follow-up|0|||
105394661|NCT05030766|363454776|FG001|Phase 2 Participants|Lost to Follow-up|0|||
105394662|NCT05030766|363454777|FG002|Phase 2 Participants|Lost to Follow-up|6|||
105394663|NCT05030766|363454778|FG003|Phase 2 Participants|Lost to Follow-up|2|||
105394664|NCT00645658|363454779|FG000|Overall Study|Withdrawal by Subject|1|||
105394665|NCT00645658|363454780|FG001|Overall Study|Withdrawal by Subject|0|||
105394666|NCT00645658|363454779|FG000|Overall Study|Did not complete all assesments|0|||
105394667|NCT00645658|363454780|FG001|Overall Study|Did not complete all assesments|2|||
105394668|NCT03331354|363454789|FG000|Overall Study|Withdrawal by Subject|1|||
105394669|NCT03331354|363454790|FG001|Overall Study|Withdrawal by Subject|3|||
105394670|NCT03331354|363454789|FG000|Overall Study|Lost to Follow-up|3|||
105394671|NCT03331354|363454790|FG001|Overall Study|Lost to Follow-up|3|||
105394672|NCT03331354|363454789|FG000|Overall Study|Found employment before initiated active intervention|0|||
105394673|NCT03331354|363454790|FG001|Overall Study|Found employment before initiated active intervention|4|||
105394674|NCT00928668|363454793|FG000|Overall Study|Adverse Event|1|||
105394675|NCT00928668|363454794|FG001|Overall Study|Adverse Event|0|||
105394676|NCT00928668|363454795|FG002|Overall Study|Adverse Event|0|||
105394677|NCT00928668|363454796|FG003|Overall Study|Adverse Event|0|||
105394678|NCT00928668|363454797|FG004|Overall Study|Adverse Event|0|||
105394679|NCT00928668|363454793|FG000|Overall Study|Protocol Violation|0|||
105394680|NCT00928668|363454794|FG001|Overall Study|Protocol Violation|0|||
105394681|NCT00928668|363454795|FG002|Overall Study|Protocol Violation|0|||
105394682|NCT00928668|363454796|FG003|Overall Study|Protocol Violation|0|||
105394683|NCT00928668|363454797|FG004|Overall Study|Protocol Violation|1|||
105394684|NCT00928668|363454793|FG000|Overall Study|Withdrawal by Subject|0|||
105394685|NCT00928668|363454794|FG001|Overall Study|Withdrawal by Subject|1|||
105394686|NCT00928668|363454795|FG002|Overall Study|Withdrawal by Subject|1|||
105394687|NCT00928668|363454796|FG003|Overall Study|Withdrawal by Subject|0|||
105394688|NCT00928668|363454797|FG004|Overall Study|Withdrawal by Subject|0|||
105394689|NCT00928668|363454793|FG000|Overall Study|Other reasons not listed above|0|||
105394690|NCT00928668|363454794|FG001|Overall Study|Other reasons not listed above|0|||
105394691|NCT00928668|363454795|FG002|Overall Study|Other reasons not listed above|0|||
105394692|NCT00928668|363454796|FG003|Overall Study|Other reasons not listed above|1|||
105394693|NCT00928668|363454797|FG004|Overall Study|Other reasons not listed above|0|||
105394694|NCT05837481|363454806|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
105394695|NCT05837481|363454807|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
105394696|NCT00982280|363454808|FG000|Observation Period|Not eligible to be dosed|19|||
105394697|NCT00982280|363454808|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
105394698|NCT00982280|363454808|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
105394699|NCT00982280|363454808|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
105394700|NCT00982280|363454808|FG000|Maintenance Period|Adverse Event|1|||
105394701|NCT05852340|363454811|FG000|Period 5|Not completing the meal|0|||
105394702|NCT05852340|363454812|FG001|Period 5|Not completing the meal|1|||
105394703|NCT05852340|363454813|FG002|Period 5|Not completing the meal|0|||
105394704|NCT05852340|363454814|FG003|Period 5|Not completing the meal|0|||
105394705|NCT05852340|363454811|FG000|Period 5|Adverse Event|0|||
105394706|NCT05852340|363454812|FG001|Period 5|Adverse Event|0|||
105394707|NCT05852340|363454813|FG002|Period 5|Adverse Event|0|||
105394708|NCT05852340|363454814|FG003|Period 5|Adverse Event|1|||
105394709|NCT01889251|363454817|FG000|Overall Study|Adverse Event|1|||
105394710|NCT01889251|363454818|FG001|Overall Study|Adverse Event|0|||
105394711|NCT00071032|363454820|FG000|Overall Study|Lost to Follow-up|1|||
105394712|NCT00071032|363454821|FG001|Overall Study|Lost to Follow-up|1|||
105493148|NCT00085709|363818792|FG001|Overall Study|Adverse Event|0|||
105394713|NCT00071032|363454820|FG000|Overall Study|Withdrawal by Subject|8|||
105493149|NCT00085709|363818791|FG000|Overall Study|Death|8|||
105394714|NCT00071032|363454821|FG001|Overall Study|Withdrawal by Subject|6|||
105394715|NCT00071032|363454820|FG000|Overall Study|Missing Primary Outcome|0|||
105394716|NCT00071032|363454821|FG001|Overall Study|Missing Primary Outcome|1|||
105394717|NCT03781570|363454824|FG000|Overall Study|Technical Issues (equipment failure)|31|||
105394718|NCT03781570|363454824|FG000|Overall Study|Withdrawal by Subject|7|||
105394719|NCT03781570|363454824|FG000|Overall Study|Physical Constraints|11|||
105394720|NCT01107496|363454825|FG000|Overall Study|Adverse Event|1|||
105394721|NCT01107496|363454826|FG001|Overall Study|Adverse Event|0|||
105394722|NCT01107496|363454825|FG000|Overall Study|Lack of Efficacy|1|||
105394723|NCT01107496|363454826|FG001|Overall Study|Lack of Efficacy|0|||
105394724|NCT01107496|363454825|FG000|Overall Study|Protocol Violation|0|||
105394725|NCT01107496|363454826|FG001|Overall Study|Protocol Violation|1|||
105394726|NCT01107496|363454825|FG000|Overall Study|Lost to Follow-up|0|||
105394727|NCT01107496|363454826|FG001|Overall Study|Lost to Follow-up|1|||
105394728|NCT02757768|363454832|FG000|Overall Study|Randomized Never Received Study Drug|3|||
105394729|NCT02757768|363454833|FG001|Overall Study|Randomized Never Received Study Drug|4|||
105394730|NCT02757768|363454832|FG000|Overall Study|Adverse Event|5|||
105394731|NCT02757768|363454833|FG001|Overall Study|Adverse Event|3|||
105394732|NCT02757768|363454832|FG000|Overall Study|Lack of Efficacy|2|||
105394733|NCT02757768|363454833|FG001|Overall Study|Lack of Efficacy|1|||
105394734|NCT02757768|363454832|FG000|Overall Study|Lost to Follow-up|1|||
105394735|NCT02757768|363454833|FG001|Overall Study|Lost to Follow-up|0|||
105394736|NCT02757768|363454832|FG000|Overall Study|Protocol Deviation|2|||
105394737|NCT02757768|363454833|FG001|Overall Study|Protocol Deviation|9|||
105394738|NCT02757768|363454832|FG000|Overall Study|Withdrawal by Subject|16|||
105394739|NCT02757768|363454833|FG001|Overall Study|Withdrawal by Subject|9|||
105394740|NCT02757768|363454832|FG000|Overall Study|Miscellaneous|4|||
105394741|NCT02757768|363454833|FG001|Overall Study|Miscellaneous|2|||
105394742|NCT03768336|363456409|FG000|Overall Study|Lost to Follow-up|3|||
105394743|NCT03768336|363456410|FG001|Overall Study|Lost to Follow-up|2|||
105394744|NCT03768336|363456409|FG000|Overall Study|Became Ineligible|2|||
105394745|NCT03768336|363456410|FG001|Overall Study|Became Ineligible|0|||
105394746|NCT03768336|363456409|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
105394747|NCT03768336|363456410|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
105394748|NCT03768336|363456409|FG000|Overall Study|Missed final survey (post-treatment|0|||
105394749|NCT03768336|363456410|FG001|Overall Study|Missed final survey (post-treatment|1|||
105394750|NCT04123704|363456412|FG000|Overall Study|Disease progression|2|||
105394751|NCT03014089|363456414|FG000|Overall Study|Withdrawal by Subject|0|||
105394752|NCT03014089|363456415|FG001|Overall Study|Withdrawal by Subject|1|||
105394753|NCT03014089|363456416|FG002|Overall Study|Withdrawal by Subject|1|||
105394754|NCT03014089|363456417|FG003|Overall Study|Withdrawal by Subject|1|||
105394755|NCT03014089|363456414|FG000|Overall Study|Lost to Follow-up|1|||
105394756|NCT03014089|363456415|FG001|Overall Study|Lost to Follow-up|0|||
105394757|NCT03014089|363456416|FG002|Overall Study|Lost to Follow-up|0|||
105394758|NCT03014089|363456417|FG003|Overall Study|Lost to Follow-up|0|||
105394759|NCT03014089|363456414|FG000|Overall Study|Adverse Event|1|||
105394760|NCT03014089|363456415|FG001|Overall Study|Adverse Event|0|||
105394761|NCT03014089|363456416|FG002|Overall Study|Adverse Event|1|||
105394762|NCT03014089|363456417|FG003|Overall Study|Adverse Event|0|||
105394763|NCT03468998|363456418|FG000|Overall Study|Withdrawal by Subject|1|||
105394764|NCT03468998|363456419|FG001|Overall Study|Withdrawal by Subject|1|||
105394765|NCT03468998|363456420|FG002|Overall Study|Withdrawal by Subject|0|||
105394766|NCT03468998|363456421|FG003|Overall Study|Withdrawal by Subject|4|||
105394767|NCT03468998|363456422|FG004|Overall Study|Withdrawal by Subject|1|||
105394768|NCT03468998|363456423|FG005|Overall Study|Withdrawal by Subject|0|||
105394769|NCT03257657|363456427|FG000|Overall Study|Lost to Follow-up|0|||
105394770|NCT03257657|363456428|FG001|Overall Study|Lost to Follow-up|3|||
105394771|NCT03257657|363456427|FG000|Overall Study|Withdrawn|0|||
105394772|NCT03257657|363456428|FG001|Overall Study|Withdrawn|1|||
105394773|NCT03257657|363456427|FG000|Overall Study|Noted not eligible right after enrolled|0|||
105394774|NCT03257657|363456428|FG001|Overall Study|Noted not eligible right after enrolled|1|||
105394775|NCT03122184|363456438|FG000|Overall Study|Lost to Follow-up|4|||
105394776|NCT03122184|363456439|FG001|Overall Study|Lost to Follow-up|6|||
105394777|NCT03122184|363456438|FG000|Overall Study|Withdrawal by Subject|3|||
105394778|NCT03122184|363456439|FG001|Overall Study|Withdrawal by Subject|0|||
105580589|NCT02018861|364126449|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
105394779|NCT03122184|363456438|FG000|Overall Study|Terminated due to cognitive problem|1|||
105394780|NCT03122184|363456439|FG001|Overall Study|Terminated due to cognitive problem|0|||
105394781|NCT03440411|363456446|FG000|Overall Study|Adverse Event|0|||
105394782|NCT03440411|363456447|FG001|Overall Study|Adverse Event|0|||
105394783|NCT03440411|363456448|FG002|Overall Study|Adverse Event|1|||
105394784|NCT03440411|363456449|FG003|Overall Study|Adverse Event|0|||
105394785|NCT03440411|363456446|FG000|Overall Study|PD|2|||
105394786|NCT03440411|363456447|FG001|Overall Study|PD|1|||
105394787|NCT03440411|363456448|FG002|Overall Study|PD|1|||
105394788|NCT03440411|363456449|FG003|Overall Study|PD|1|||
105394789|NCT03440411|363456446|FG000|Overall Study|Withdrawal by Subject|1|||
105394790|NCT03440411|363456447|FG001|Overall Study|Withdrawal by Subject|0|||
105394791|NCT03440411|363456448|FG002|Overall Study|Withdrawal by Subject|0|||
105394792|NCT03440411|363456449|FG003|Overall Study|Withdrawal by Subject|0|||
105394793|NCT03440411|363456446|FG000|Overall Study|Closed study by sponsor|0|||
105394794|NCT03440411|363456447|FG001|Overall Study|Closed study by sponsor|0|||
105394795|NCT03440411|363456448|FG002|Overall Study|Closed study by sponsor|0|||
105394796|NCT03440411|363456449|FG003|Overall Study|Closed study by sponsor|1|||
105394797|NCT00688740|363456450|FG000|Overall Study|Adverse Event|45|||
105394798|NCT00688740|363456451|FG001|Overall Study|Adverse Event|8|||
105394799|NCT00688740|363456450|FG000|Overall Study|Death|2|||
105394800|NCT00688740|363456451|FG001|Overall Study|Death|2|||
105394801|NCT00688740|363456450|FG000|Overall Study|Lost to Follow-up|0|||
105394802|NCT00688740|363456451|FG001|Overall Study|Lost to Follow-up|1|||
105394803|NCT00688740|363456450|FG000|Overall Study|Consent Withdrawn|17|||
105394804|NCT00688740|363456451|FG001|Overall Study|Consent Withdrawn|17|||
105394805|NCT00688740|363456450|FG000|Overall Study|Breast Cancer Relapse|1|||
105394806|NCT00688740|363456451|FG001|Overall Study|Breast Cancer Relapse|4|||
105394807|NCT00688740|363456450|FG000|Overall Study|Violation of Inclusion Criteria|1|||
105394808|NCT00688740|363456451|FG001|Overall Study|Violation of Inclusion Criteria|3|||
105394809|NCT00189423|363456452|FG000|Overall Study|Death|746|||
105394810|NCT00189423|363456453|FG001|Overall Study|Death|747|||
105394811|NCT00189423|363456452|FG000|Overall Study|Withdrawal by Subject|9|||
105394812|NCT00189423|363456453|FG001|Overall Study|Withdrawal by Subject|9|||
105394813|NCT00189423|363456452|FG000|Overall Study|Lost to Follow-up|10|||
105394814|NCT00189423|363456453|FG001|Overall Study|Lost to Follow-up|10|||
105394815|NCT00023595|363456457|FG000|5 Year Follow up|Lost to Follow-up|2|||
105394816|NCT00023595|363456458|FG001|5 Year Follow up|Lost to Follow-up|2|||
105394817|NCT00023595|363456459|FG002|5 Year Follow up|Lost to Follow-up|1|||
105394818|NCT00023595|363456460|FG003|5 Year Follow up|Lost to Follow-up|7|||
105394819|NCT00023595|363456461|FG004|5 Year Follow up|Lost to Follow-up|3|||
105394820|NCT00023595|363456457|FG000|10 Year Follow up|Lost to Follow-up|12|||
105394821|NCT00023595|363456458|FG001|10 Year Follow up|Lost to Follow-up|10|||
105394822|NCT00023595|363456459|FG002|10 Year Follow up|Lost to Follow-up|3|||
105394823|NCT00023595|363456460|FG003|10 Year Follow up|Lost to Follow-up|0|||
105394824|NCT00023595|363456461|FG004|10 Year Follow up|Lost to Follow-up|0|||
105394825|NCT05889468|363456463|FG000|Overall Study|Lost to Follow-up|9|||
105394826|NCT05889468|363456464|FG001|Overall Study|Lost to Follow-up|2|||
105394827|NCT05889468|363456463|FG000|Overall Study|Withdrawal by Subject|2|||
105394828|NCT05889468|363456464|FG001|Overall Study|Withdrawal by Subject|2|||
105394829|NCT02958865|363456465|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105394830|NCT02958865|363456466|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
105394831|NCT02958865|363456467|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105394832|NCT02958865|363456468|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
105394833|NCT02958865|363456469|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
105394834|NCT02958865|363456470|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
105394835|NCT02958865|363456471|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
105394836|NCT02958865|363456472|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105394837|NCT02958865|363456473|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105394838|NCT02958865|363456474|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105394839|NCT02958865|363456475|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105394840|NCT02958865|363456476|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105394841|NCT02958865|363456477|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105394842|NCT02958865|363456478|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105394843|NCT02958865|363456479|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105394844|NCT02958865|363456480|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105394845|NCT02958865|363456465|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
105394846|NCT02958865|363456466|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
105394847|NCT02958865|363456467|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
105394848|NCT02958865|363456468|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
105394849|NCT02958865|363456469|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
105394850|NCT02958865|363456470|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
105394851|NCT02958865|363456471|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
105394852|NCT02958865|363456472|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
105394853|NCT02958865|363456473|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
105394854|NCT02958865|363456474|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
105394855|NCT02958865|363456475|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
105394856|NCT02958865|363456476|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
105394857|NCT02958865|363456477|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
105394858|NCT02958865|363456478|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
105394859|NCT02958865|363456479|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
105394860|NCT02958865|363456480|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
105394861|NCT02958865|363456465|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
105493150|NCT00085709|363818792|FG001|Overall Study|Death|2|||
105394862|NCT02958865|363456466|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
105394863|NCT02958865|363456467|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105394864|NCT02958865|363456468|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105394865|NCT02958865|363456469|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105394866|NCT02958865|363456470|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105394867|NCT02958865|363456471|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105394868|NCT02958865|363456472|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105394869|NCT02958865|363456473|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105394870|NCT02958865|363456474|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105394871|NCT02958865|363456475|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105580590|NCT02018861|364126450|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
105394872|NCT02958865|363456476|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105394873|NCT02958865|363456477|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105394874|NCT02958865|363456478|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105394875|NCT02958865|363456479|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105394876|NCT02958865|363456480|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105394877|NCT02958865|363456465|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
105394878|NCT02958865|363456466|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105394879|NCT02958865|363456467|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
105394880|NCT02958865|363456468|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
105394881|NCT02958865|363456469|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
105394882|NCT02958865|363456470|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
105394883|NCT02958865|363456471|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
105394884|NCT02958865|363456472|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105394885|NCT02958865|363456473|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105394886|NCT02958865|363456474|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105394887|NCT02958865|363456475|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105394888|NCT02958865|363456476|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105394889|NCT02958865|363456477|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105394890|NCT02958865|363456478|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105394891|NCT02958865|363456479|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105394892|NCT02958865|363456480|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105394893|NCT02958865|363456465|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105394894|NCT02958865|363456466|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105394895|NCT02958865|363456467|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105394896|NCT02958865|363456468|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
105394897|NCT02958865|363456469|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105394898|NCT02958865|363456470|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105394899|NCT02958865|363456471|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
105394900|NCT02958865|363456472|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105394901|NCT02958865|363456473|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105394902|NCT02958865|363456474|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105394903|NCT02958865|363456475|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105394904|NCT02958865|363456476|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105394905|NCT02958865|363456477|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105394906|NCT02958865|363456478|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105394907|NCT02958865|363456479|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105394908|NCT02958865|363456480|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105394909|NCT02958865|363456465|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105394910|NCT02958865|363456466|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105394911|NCT02958865|363456467|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
105394912|NCT02958865|363456468|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105394913|NCT02958865|363456469|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105394914|NCT02958865|363456470|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105394915|NCT02958865|363456471|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105394916|NCT02958865|363456472|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105394917|NCT02958865|363456473|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105394918|NCT02958865|363456474|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105394919|NCT02958865|363456475|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105394920|NCT02958865|363456476|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105394921|NCT02958865|363456477|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105394922|NCT02958865|363456478|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105394923|NCT02958865|363456479|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105394924|NCT02958865|363456480|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105394925|NCT02958865|363456465|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
105394926|NCT02958865|363456466|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
105394927|NCT02958865|363456467|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
105394928|NCT02958865|363456468|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105394929|NCT02958865|363456469|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105394930|NCT02958865|363456470|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105394931|NCT02958865|363456471|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105580591|NCT02018861|364126451|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
105394932|NCT02958865|363456472|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105394933|NCT02958865|363456473|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105394934|NCT02958865|363456474|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105394935|NCT02958865|363456475|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105394936|NCT02958865|363456476|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105394937|NCT02958865|363456477|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105394938|NCT02958865|363456478|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105394939|NCT02958865|363456479|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105394940|NCT02958865|363456480|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105394941|NCT02958865|363456465|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
105394942|NCT02958865|363456466|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
105394943|NCT02958865|363456467|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
105394944|NCT02958865|363456468|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
105394945|NCT02958865|363456469|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
105394946|NCT02958865|363456470|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
105394947|NCT02958865|363456471|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
105394948|NCT02958865|363456472|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
105394949|NCT02958865|363456473|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
105394950|NCT02958865|363456474|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
105394951|NCT02958865|363456475|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
105394952|NCT02958865|363456476|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
105394953|NCT02958865|363456477|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
105394954|NCT02958865|363456478|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
105394955|NCT02958865|363456479|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
105394956|NCT02958865|363456480|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
105394957|NCT02958865|363456465|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105394958|NCT02958865|363456466|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105394959|NCT02958865|363456467|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105394960|NCT02958865|363456468|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105394961|NCT02958865|363456469|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
105394962|NCT02958865|363456470|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105394963|NCT02958865|363456471|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105394964|NCT02958865|363456472|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105394965|NCT02958865|363456473|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105394966|NCT02958865|363456474|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105394967|NCT02958865|363456475|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105394968|NCT02958865|363456476|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105394969|NCT02958865|363456477|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105394970|NCT02958865|363456478|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105394971|NCT02958865|363456479|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105394972|NCT02958865|363456480|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105394973|NCT02958865|363456465|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105394974|NCT02958865|363456466|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105394975|NCT02958865|363456467|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105394976|NCT02958865|363456468|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105394977|NCT02958865|363456469|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105394978|NCT02958865|363456470|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105394979|NCT02958865|363456471|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105394980|NCT02958865|363456472|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
105394981|NCT02958865|363456473|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
105394982|NCT02958865|363456474|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
105394983|NCT02958865|363456475|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105394984|NCT02958865|363456476|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
105394985|NCT02958865|363456477|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
105394986|NCT02958865|363456478|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
105394987|NCT02958865|363456479|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
105394988|NCT02958865|363456480|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
105394989|NCT02958865|363456465|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105394990|NCT02958865|363456466|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105394991|NCT02958865|363456467|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105394992|NCT02958865|363456468|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105394993|NCT02958865|363456469|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105394994|NCT02958865|363456470|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105394995|NCT02958865|363456471|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105394996|NCT02958865|363456472|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105493151|NCT00085709|363818791|FG000|Overall Study|Refusal unrelated to adverse events|1|||
105493152|NCT00085709|363818792|FG001|Overall Study|Refusal unrelated to adverse events|2|||
105394997|NCT02958865|363456473|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
105493153|NCT00085709|363818791|FG000|Overall Study|Progression|3|||
105394998|NCT02958865|363456474|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
105394999|NCT02958865|363456475|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105395000|NCT02958865|363456476|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
105395001|NCT02958865|363456477|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105395002|NCT02958865|363456478|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
105395003|NCT02958865|363456479|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105395004|NCT02958865|363456480|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
105395005|NCT02958865|363456465|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105395006|NCT02958865|363456466|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105395007|NCT02958865|363456467|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105395008|NCT02958865|363456468|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105395009|NCT02958865|363456469|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105395010|NCT02958865|363456470|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105395011|NCT02958865|363456471|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105395012|NCT02958865|363456472|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105395013|NCT02958865|363456473|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105395014|NCT02958865|363456474|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
105395015|NCT02958865|363456475|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105395016|NCT02958865|363456476|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105395017|NCT02958865|363456477|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105395018|NCT02958865|363456478|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105395019|NCT02958865|363456479|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105395020|NCT02958865|363456480|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
105395021|NCT02958865|363456465|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105395022|NCT02958865|363456466|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105395023|NCT02958865|363456467|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105395024|NCT02958865|363456468|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105395025|NCT02958865|363456469|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105395026|NCT02958865|363456470|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105395027|NCT02958865|363456471|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105395028|NCT02958865|363456472|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105395029|NCT02958865|363456473|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105395030|NCT02958865|363456474|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105395031|NCT02958865|363456475|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105395032|NCT02958865|363456476|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
105395033|NCT02958865|363456477|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
105395034|NCT02958865|363456478|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
105395035|NCT02958865|363456479|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
105395036|NCT02958865|363456480|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
105395037|NCT02958865|363456465|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
105395038|NCT02958865|363456466|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
105395039|NCT02958865|363456467|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
105395040|NCT02958865|363456468|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
105395041|NCT02958865|363456469|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
105395042|NCT02958865|363456470|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
105395043|NCT02958865|363456471|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
105395044|NCT02958865|363456472|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
105395045|NCT02958865|363456473|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
105395046|NCT02958865|363456474|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
105395047|NCT02958865|363456475|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
105395048|NCT02958865|363456476|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
105395049|NCT02958865|363456477|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
105395050|NCT02958865|363456478|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
105395051|NCT02958865|363456479|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
105395052|NCT02958865|363456480|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
105395053|NCT02958865|363456465|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105395054|NCT02958865|363456466|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105395055|NCT02958865|363456467|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105395056|NCT02958865|363456468|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105395057|NCT02958865|363456469|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105395058|NCT02958865|363456470|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105395059|NCT02958865|363456471|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105395060|NCT02958865|363456472|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105395061|NCT02958865|363456473|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105395062|NCT02958865|363456474|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105395063|NCT02958865|363456475|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105395064|NCT02958865|363456476|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105395065|NCT02958865|363456477|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105395066|NCT02958865|363456478|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
105395067|NCT02958865|363456479|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105395068|NCT02958865|363456480|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105395069|NCT02958865|363456465|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105395070|NCT02958865|363456466|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105395071|NCT02958865|363456467|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105395072|NCT02958865|363456468|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105395073|NCT02958865|363456469|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105395074|NCT02958865|363456470|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105395075|NCT02958865|363456471|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105395076|NCT02958865|363456472|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105395077|NCT02958865|363456473|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105395078|NCT02958865|363456474|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105395079|NCT02958865|363456475|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105395080|NCT02958865|363456476|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105395081|NCT02958865|363456477|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105395082|NCT02958865|363456478|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
105395083|NCT02958865|363456479|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105395084|NCT02958865|363456480|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105395085|NCT02958865|363456465|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105395086|NCT02958865|363456466|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105395087|NCT02958865|363456467|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105395088|NCT02958865|363456468|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105395089|NCT02958865|363456469|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105395090|NCT02958865|363456470|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105395091|NCT02958865|363456471|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105395092|NCT02958865|363456472|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105395093|NCT02958865|363456473|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105395094|NCT02958865|363456474|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
105395095|NCT02958865|363456475|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105395096|NCT02958865|363456476|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105395097|NCT02958865|363456477|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105395098|NCT02958865|363456478|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105395099|NCT02958865|363456479|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105395100|NCT02958865|363456480|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105395101|NCT01767987|363456483|FG000|Overall Study|Physician Decision|4|||
105395102|NCT01767987|363456484|FG001|Overall Study|Physician Decision|1|||
105395103|NCT01153516|363456485|FG000|Overall Study|Both subjects refused surgery|2|||
105395104|NCT01153516|363456486|FG001|Overall Study|Both subjects refused surgery|0|||
105395105|NCT02457065|363456496|FG000|Overall Study|Lost to Follow-up|9|||
105395106|NCT02457065|363456497|FG001|Overall Study|Lost to Follow-up|11|||
105395107|NCT01362790|363456498|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
105395108|NCT01362790|363456499|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
105395109|NCT01362790|363456500|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
105395110|NCT01362790|363456501|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
105395111|NCT01362790|363456502|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
105395112|NCT01362790|363456503|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
105395113|NCT01362790|363456504|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
105395114|NCT01362790|363456498|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
105395115|NCT01362790|363456499|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
105395116|NCT01362790|363456500|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
105395117|NCT01362790|363456501|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
105395118|NCT01362790|363456502|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
105395119|NCT01362790|363456503|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
105395120|NCT01362790|363456504|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
105395121|NCT01362790|363456498|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
105395122|NCT01362790|363456499|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
105395123|NCT01362790|363456500|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
105395124|NCT01362790|363456501|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
105395125|NCT01362790|363456502|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
105395126|NCT01362790|363456503|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
105395127|NCT01362790|363456504|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
105395128|NCT01362790|363456498|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
105395129|NCT01362790|363456499|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
105395130|NCT01362790|363456500|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
105395131|NCT01362790|363456501|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
105395132|NCT01362790|363456502|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
105395133|NCT01362790|363456503|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
105395134|NCT01362790|363456504|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
105395135|NCT01362790|363456498|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
105395136|NCT01362790|363456499|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
105395137|NCT01362790|363456500|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
105395138|NCT01362790|363456501|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
105395139|NCT01362790|363456502|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
105395140|NCT01362790|363456503|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
105395141|NCT01362790|363456504|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
105395142|NCT01362790|363456498|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
105395143|NCT01362790|363456499|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
105395144|NCT01362790|363456500|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
105395145|NCT01362790|363456501|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
105395146|NCT01362790|363456502|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
105395147|NCT01362790|363456503|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
105395148|NCT01362790|363456504|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
105395149|NCT01362790|363456498|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
105395150|NCT01362790|363456499|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
105395151|NCT01362790|363456500|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
105395152|NCT01362790|363456501|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
105395153|NCT01362790|363456502|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
105395154|NCT01362790|363456503|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
105395155|NCT01362790|363456504|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
105395156|NCT01362790|363456498|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
105395157|NCT01362790|363456499|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
105395158|NCT01362790|363456500|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
105395159|NCT01362790|363456501|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
105395160|NCT01362790|363456502|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
105395161|NCT01362790|363456503|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
105395162|NCT01362790|363456504|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
105395163|NCT01362790|363456498|FG000|Pilot Phase & Phase 2|Death on study|0|||
105395164|NCT01362790|363456499|FG001|Pilot Phase & Phase 2|Death on study|0|||
105395165|NCT01362790|363456500|FG002|Pilot Phase & Phase 2|Death on study|0|||
105395166|NCT01362790|363456501|FG003|Pilot Phase & Phase 2|Death on study|1|||
105395167|NCT01362790|363456502|FG004|Pilot Phase & Phase 2|Death on study|0|||
105395168|NCT01362790|363456503|FG005|Pilot Phase & Phase 2|Death on study|0|||
105395169|NCT01362790|363456504|FG006|Pilot Phase & Phase 2|Death on study|0|||
105395170|NCT01362790|363456498|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
105395171|NCT01362790|363456499|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
105395172|NCT01362790|363456500|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
105395173|NCT01362790|363456501|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
105395174|NCT01362790|363456502|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
105395175|NCT01362790|363456503|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
105395176|NCT01362790|363456504|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
105395177|NCT01362790|363456498|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
105395178|NCT01362790|363456499|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
105439940|NCT01618695|363616641|FG003|Core Phase|Lack of Efficacy|1|||
105439941|NCT01618695|363616638|FG000|Core Phase|Other than specified|1|||
105439942|NCT01618695|363616639|FG001|Core Phase|Other than specified|2|||
105439943|NCT01618695|363616640|FG002|Core Phase|Other than specified|2|||
105395179|NCT01362790|363456500|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
105395180|NCT01362790|363456501|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
105395181|NCT01362790|363456502|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
105395182|NCT01362790|363456503|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
105395183|NCT01362790|363456504|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
105395184|NCT01362790|363456498|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
105395185|NCT01362790|363456499|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
105395186|NCT01362790|363456500|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
105395187|NCT01362790|363456501|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
105395188|NCT01362790|363456502|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
105395189|NCT01362790|363456503|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
105395190|NCT01362790|363456504|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
105395191|NCT03038087|363456505|FG000|Overall Study|lost data|1|||
105395192|NCT00049543|363456514|FG000|Overall Study|still on treatment|2|||
105395193|NCT00049543|363456515|FG001|Overall Study|still on treatment|9|||
105395194|NCT00526799|363456551|FG000|Overall Study|Withdrawal by Subject|1|||
105395195|NCT00526799|363456552|FG001|Overall Study|Withdrawal by Subject|0|||
105395196|NCT00526799|363456551|FG000|Overall Study|Intercurrent Complicating Disease|0|||
105395197|NCT00526799|363456552|FG001|Overall Study|Intercurrent Complicating Disease|1|||
105395198|NCT05535972|363456553|FG000|Overall Study|Withdrawal by Subject|31|||
105395199|NCT05535972|363456553|FG000|Overall Study|Lost to Follow-up|5|||
105395200|NCT05535972|363456553|FG000|Overall Study|Adverse Event|6|||
105395201|NCT05535972|363456553|FG000|Overall Study|Protocol Deviation|2|||
105395202|NCT04507269|363456554|FG000|Overall Study|Withdrawal by Subject|1|||
105395203|NCT04507269|363456555|FG001|Overall Study|Withdrawal by Subject|1|||
105395204|NCT04507269|363456556|FG002|Overall Study|Withdrawal by Subject|0|||
105395205|NCT04507269|363456557|FG003|Overall Study|Withdrawal by Subject|0|||
105395206|NCT04507269|363456558|FG004|Overall Study|Withdrawal by Subject|0|||
105395207|NCT04507269|363456559|FG005|Overall Study|Withdrawal by Subject|0|||
105395208|NCT04507269|363456554|FG000|Overall Study|Lost to Follow-up|0|||
105395209|NCT04507269|363456555|FG001|Overall Study|Lost to Follow-up|0|||
105395210|NCT04507269|363456556|FG002|Overall Study|Lost to Follow-up|0|||
105395211|NCT04507269|363456557|FG003|Overall Study|Lost to Follow-up|0|||
105395212|NCT04507269|363456558|FG004|Overall Study|Lost to Follow-up|1|||
105395213|NCT04507269|363456559|FG005|Overall Study|Lost to Follow-up|0|||
105395214|NCT00432965|363456560|FG000|Overall Study|Lost to Follow-up|22|||
105395215|NCT00432965|363456561|FG001|Overall Study|Lost to Follow-up|19|||
105395216|NCT00432965|363456560|FG000|Overall Study|Withdrawal by Subject|13|||
105395217|NCT00432965|363456561|FG001|Overall Study|Withdrawal by Subject|13|||
105395218|NCT00432965|363456560|FG000|Overall Study|Physician Decision|14|||
105395219|NCT00432965|363456561|FG001|Overall Study|Physician Decision|13|||
105395220|NCT00432965|363456560|FG000|Overall Study|Lack of Efficacy|8|||
105395221|NCT00432965|363456561|FG001|Overall Study|Lack of Efficacy|13|||
105395222|NCT00432965|363456560|FG000|Overall Study|Non-compliance|7|||
105395223|NCT00432965|363456561|FG001|Overall Study|Non-compliance|0|||
105395224|NCT00432965|363456560|FG000|Overall Study|Adverse Event|22|||
105395225|NCT00432965|363456561|FG001|Overall Study|Adverse Event|19|||
105395226|NCT00432965|363456560|FG000|Overall Study|Death|3|||
105395227|NCT00432965|363456561|FG001|Overall Study|Death|4|||
105395228|NCT00432965|363456560|FG000|Overall Study|Exclusionary Methods|1|||
105395229|NCT00432965|363456561|FG001|Overall Study|Exclusionary Methods|2|||
105395230|NCT00432965|363456560|FG000|Overall Study|Incomplete Data|4|||
105395231|NCT00432965|363456561|FG001|Overall Study|Incomplete Data|3|||
105395232|NCT01344226|363456562|FG000|Overall Study|Protocol Violation|2|||
105395233|NCT01344226|363456562|FG000|Overall Study|Withdrawal by Subject|3|||
105395234|NCT01344226|363456562|FG000|Overall Study|Lack of Efficacy|3|||
105395235|NCT03636022|363456564|FG000|Overall Study|Withdrawal by Subject|1|||
105395236|NCT03636022|363456565|FG001|Overall Study|Withdrawal by Subject|3|||
105395237|NCT01969058|363456566|FG000|Overall Study|Withdrawal by Subject|2|||
105395238|NCT01969058|363456567|FG001|Overall Study|Withdrawal by Subject|0|||
105395239|NCT01969058|363456566|FG000|Overall Study|Adverse Event|1|||
105395240|NCT01969058|363456567|FG001|Overall Study|Adverse Event|0|||
105395241|NCT03012880|363456568|FG000|Overall Study|Withdrawal by Subject|1|||
105395242|NCT03012880|363456569|FG001|Overall Study|Withdrawal by Subject|0|||
105395243|NCT03012880|363456568|FG000|Overall Study|Ineligible|1|||
105395244|NCT03012880|363456569|FG001|Overall Study|Ineligible|0|||
105395245|NCT01587196|363456570|FG000|Overall Study|Lost to Follow-up|50|||
105395246|NCT01587196|363456570|FG000|Overall Study|Withdrawal by Subject|4|||
105395247|NCT01355627|363456571|FG000|Overall Study|Request By the Patient to Discontinue|5|||
105395248|NCT01355627|363456572|FG001|Overall Study|Request By the Patient to Discontinue|7|||
105395249|NCT01355627|363456571|FG000|Overall Study|Lost to Follow-up|8|||
105395250|NCT01355627|363456572|FG001|Overall Study|Lost to Follow-up|7|||
105395251|NCT01355627|363456571|FG000|Overall Study|Fatal Adverse Event|19|||
105395252|NCT01355627|363456572|FG001|Overall Study|Fatal Adverse Event|23|||
105395253|NCT01355627|363456571|FG000|Overall Study|Other|1|||
105395254|NCT01355627|363456572|FG001|Overall Study|Other|1|||
105395255|NCT02022202|363456573|FG000|Overall Study|Withdrawal by Subject|2|||
105395256|NCT02022202|363456573|FG000|Overall Study|Disease Progression|3|||
105395257|NCT02022202|363456573|FG000|Overall Study|Desire go to immediately to surgery|3|||
105395258|NCT02038036|363456578|FG000|Core Study|Adverse Event|7|||
105395259|NCT02038036|363456579|FG001|Core Study|Adverse Event|7|||
105395260|NCT02038036|363456578|FG000|Core Study|Death|1|||
105395261|NCT02038036|363456579|FG001|Core Study|Death|1|||
105395262|NCT02038036|363456578|FG000|Core Study|Disease progression|2|||
105395263|NCT02038036|363456579|FG001|Core Study|Disease progression|2|||
105395264|NCT02038036|363456578|FG000|Core Study|Lost to Follow-up|0|||
105395265|NCT02038036|363456579|FG001|Core Study|Lost to Follow-up|1|||
105395266|NCT02038036|363456578|FG000|Core Study|Physician Decision|2|||
105395267|NCT02038036|363456579|FG001|Core Study|Physician Decision|1|||
105395268|NCT02038036|363456578|FG000|Core Study|Subject/guardian decision|0|||
105395269|NCT02038036|363456579|FG001|Core Study|Subject/guardian decision|1|||
105395270|NCT02038036|363456578|FG000|Core Study|Withdrawal by Subject|3|||
105395271|NCT02038036|363456579|FG001|Core Study|Withdrawal by Subject|1|||
105395272|NCT02038036|363456578|FG000|Crossover Period|Withdrawal by Subject|0|||
105395273|NCT02038036|363456579|FG001|Crossover Period|Withdrawal by Subject|3|||
105395274|NCT02038036|363456578|FG000|Crossover Period|Adverse Event|0|||
105395275|NCT02038036|363456579|FG001|Crossover Period|Adverse Event|9|||
105395276|NCT02038036|363456578|FG000|Crossover Period|Death|0|||
105395277|NCT02038036|363456579|FG001|Crossover Period|Death|2|||
105395278|NCT02038036|363456578|FG000|Crossover Period|Disease progression|0|||
105395279|NCT02038036|363456579|FG001|Crossover Period|Disease progression|3|||
105395280|NCT02038036|363456578|FG000|Crossover Period|Lost to Follow-up|0|||
105395281|NCT02038036|363456579|FG001|Crossover Period|Lost to Follow-up|1|||
105395282|NCT02038036|363456578|FG000|Crossover Period|Physician Decision|0|||
105395283|NCT02038036|363456579|FG001|Crossover Period|Physician Decision|2|||
105395284|NCT05715827|363456584|FG000|Overall Study|Physician Decision|0|||
105395285|NCT05715827|363456585|FG001|Overall Study|Physician Decision|1|||
105395286|NCT05715827|363456584|FG000|Overall Study|console communication error|0|||
105395287|NCT05715827|363456585|FG001|Overall Study|console communication error|1|||
105395288|NCT03423979|363456586|FG000|Overall Study|Death|1|||
105395289|NCT03663582|363458008|FG000|Overall Study|Physician Decision|1|||
105395290|NCT02390076|363458009|FG000|Overall Study|Lost to Follow-up|2|||
105395291|NCT02390076|363458010|FG001|Overall Study|Lost to Follow-up|1|||
105395292|NCT02390076|363458011|FG002|Overall Study|Lost to Follow-up|4|||
105395293|NCT01905540|363458015|FG000|Period 3|Other|1|||
105395294|NCT01905540|363458016|FG001|Period 3|Other|0|||
105395295|NCT01905540|363458017|FG002|Period 3|Other|1|||
105395296|NCT01905540|363458018|FG003|Period 3|Other|1|||
105395297|NCT02546323|363458019|FG000|Overall Study|Withdrawal by Subject|36|||
105395298|NCT02546323|363458020|FG001|Overall Study|Withdrawal by Subject|33|||
105395299|NCT02546323|363458019|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
105395300|NCT02546323|363458020|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
105395301|NCT02546323|363458019|FG000|Overall Study|Adverse Event|17|||
105395302|NCT02546323|363458020|FG001|Overall Study|Adverse Event|11|||
105395303|NCT02546323|363458019|FG000|Overall Study|Patient Specific Reasons|1|||
105395304|NCT02546323|363458020|FG001|Overall Study|Patient Specific Reasons|2|||
105395305|NCT02546323|363458019|FG000|Overall Study|Lost to Follow-up|2|||
105395306|NCT02546323|363458020|FG001|Overall Study|Lost to Follow-up|3|||
105395307|NCT02546323|363458019|FG000|Overall Study|Non-compliance with Study Drug|2|||
105395308|NCT02546323|363458020|FG001|Overall Study|Non-compliance with Study Drug|2|||
105395309|NCT02546323|363458019|FG000|Overall Study|Met Withdrawal Criteria|2|||
105395310|NCT02546323|363458020|FG001|Overall Study|Met Withdrawal Criteria|14|||
105395311|NCT02090764|363458021|FG000|Overall Study|Adverse Event|1|||
105395312|NCT02090764|363458022|FG001|Overall Study|Adverse Event|3|||
105395313|NCT02090764|363458021|FG000|Overall Study|Lack of Efficacy|0|||
105395314|NCT02090764|363458022|FG001|Overall Study|Lack of Efficacy|13|||
105395315|NCT02090764|363458021|FG000|Overall Study|Withdrawal by Subject|2|||
105395316|NCT02090764|363458022|FG001|Overall Study|Withdrawal by Subject|1|||
105395317|NCT02090764|363458021|FG000|Overall Study|Intercurrent illness and other|1|||
105395318|NCT02090764|363458022|FG001|Overall Study|Intercurrent illness and other|1|||
105395319|NCT02090764|363458021|FG000|Overall Study|Lost to Follow-up|2|||
105395320|NCT02090764|363458022|FG001|Overall Study|Lost to Follow-up|2|||
105395321|NCT03412929|363458023|FG000|Overall Study|Protocol Violation|3|||
105395322|NCT01182350|363458024|FG000|Overall Study|Adverse Event|5|||
105395323|NCT01182350|363458025|FG001|Overall Study|Adverse Event|0|||
105395324|NCT01182350|363458026|FG002|Overall Study|Adverse Event|0|||
105395325|NCT01182350|363458027|FG003|Overall Study|Adverse Event|0|||
105395326|NCT01182350|363458028|FG004|Overall Study|Adverse Event|0|||
105395327|NCT01182350|363458024|FG000|Overall Study|Disease Progression|15|||
105395328|NCT01182350|363458025|FG001|Overall Study|Disease Progression|12|||
105395329|NCT01182350|363458026|FG002|Overall Study|Disease Progression|0|||
105493154|NCT00085709|363818792|FG001|Overall Study|Progression|4|||
105493155|NCT00085709|363818791|FG000|Overall Study|Not protocol specified|12|||
105493156|NCT00085709|363818792|FG001|Overall Study|Not protocol specified|22|||
105395330|NCT01182350|363458027|FG003|Overall Study|Disease Progression|1|||
105395331|NCT01182350|363458028|FG004|Overall Study|Disease Progression|0|||
105395332|NCT01182350|363458024|FG000|Overall Study|Death|0|||
105395333|NCT01182350|363458025|FG001|Overall Study|Death|1|||
105395334|NCT01182350|363458026|FG002|Overall Study|Death|1|||
105395335|NCT01182350|363458027|FG003|Overall Study|Death|0|||
105395336|NCT01182350|363458028|FG004|Overall Study|Death|0|||
105395337|NCT01182350|363458024|FG000|Overall Study|Withdrawal by Subject|3|||
105395338|NCT01182350|363458025|FG001|Overall Study|Withdrawal by Subject|1|||
105395339|NCT01182350|363458026|FG002|Overall Study|Withdrawal by Subject|0|||
105395340|NCT01182350|363458027|FG003|Overall Study|Withdrawal by Subject|1|||
105395341|NCT01182350|363458028|FG004|Overall Study|Withdrawal by Subject|0|||
105395342|NCT01182350|363458024|FG000|Overall Study|Alternative Therapy|2|||
105395343|NCT01182350|363458025|FG001|Overall Study|Alternative Therapy|0|||
105395344|NCT01182350|363458026|FG002|Overall Study|Alternative Therapy|1|||
105395345|NCT01182350|363458027|FG003|Overall Study|Alternative Therapy|0|||
105395346|NCT01182350|363458028|FG004|Overall Study|Alternative Therapy|0|||
105395347|NCT01182350|363458024|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
105395348|NCT01182350|363458025|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
105395349|NCT01182350|363458026|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
105395350|NCT01182350|363458027|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
105395351|NCT01182350|363458028|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
105395352|NCT01182350|363458024|FG000|Overall Study|Unevaluable for Biopsy|0|||
105395353|NCT01182350|363458025|FG001|Overall Study|Unevaluable for Biopsy|0|||
105395354|NCT01182350|363458026|FG002|Overall Study|Unevaluable for Biopsy|0|||
105395355|NCT01182350|363458027|FG003|Overall Study|Unevaluable for Biopsy|0|||
105395356|NCT01182350|363458028|FG004|Overall Study|Unevaluable for Biopsy|3|||
105395357|NCT03232567|363458029|FG000|Overall Study|Withdrawal by Subject|0|||
105395358|NCT03232567|363458030|FG001|Overall Study|Withdrawal by Subject|1|||
105395359|NCT03232567|363458031|FG002|Overall Study|Withdrawal by Subject|0|||
105395360|NCT03232567|363458032|FG003|Overall Study|Withdrawal by Subject|0|||
105395361|NCT01605097|363458033|FG000|Overall Study|Protocol Violation|1|||
105395362|NCT01728246|363458034|FG000|Overall Study|Participant needed rescue medication|1|||
105395363|NCT01728246|363458035|FG001|Overall Study|Participant needed rescue medication|5|||
105395364|NCT01728246|363458034|FG000|Overall Study|Protocol Violation|1|||
105395365|NCT01728246|363458035|FG001|Overall Study|Protocol Violation|0|||
105395366|NCT01728246|363458034|FG000|Overall Study|Withdrawal by Subject|2|||
105395367|NCT01728246|363458035|FG001|Overall Study|Withdrawal by Subject|3|||
105395368|NCT01728246|363458034|FG000|Overall Study|Lost to Follow-up|23|||
105395369|NCT01728246|363458035|FG001|Overall Study|Lost to Follow-up|22|||
105395370|NCT01728246|363458034|FG000|Overall Study|Lack of Efficacy|1|||
105395371|NCT01728246|363458035|FG001|Overall Study|Lack of Efficacy|1|||
105395372|NCT01728246|363458034|FG000|Overall Study|Adverse Event|8|||
105395373|NCT01728246|363458035|FG001|Overall Study|Adverse Event|5|||
105395374|NCT01038323|363458036|FG000|Overall Study|Withdrawal by Subject|3|||
105395375|NCT01038323|363458037|FG001|Overall Study|Withdrawal by Subject|2|||
105395376|NCT01038323|363458038|FG002|Overall Study|Withdrawal by Subject|4|||
105395377|NCT04380142|363458039|FG000|LD/CD Stabilization Period|Adverse Event|3|||
105395378|NCT04380142|363458040|FG001|LD/CD Stabilization Period|Adverse Event|0|||
105395379|NCT04380142|363458041|FG002|LD/CD Stabilization Period|Adverse Event|0|||
105395380|NCT04380142|363458039|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
105395381|NCT04380142|363458040|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
105395382|NCT04380142|363458041|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
105395383|NCT04380142|363458039|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
105395384|NCT04380142|363458040|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
105395385|NCT04380142|363458041|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
105395386|NCT04380142|363458039|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
105395387|NCT04380142|363458040|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
105395388|NCT04380142|363458041|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
105395389|NCT04380142|363458039|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
105395390|NCT04380142|363458040|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
105395391|NCT04380142|363458041|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
105395392|NCT04380142|363458039|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
105395393|NCT04380142|363458040|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
105395394|NCT04380142|363458041|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
105395395|NCT04380142|363458039|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105395396|NCT04380142|363458040|FG001|Double-Blind Treatment Period|Adverse Event|1|||
105395397|NCT04380142|363458041|FG002|Double-Blind Treatment Period|Adverse Event|14|||
105395398|NCT04380142|363458039|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
105395399|NCT04380142|363458040|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
105395400|NCT04380142|363458041|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
105395401|NCT04380142|363458039|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
105395402|NCT04380142|363458040|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
105395403|NCT04380142|363458041|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
105395404|NCT04380142|363458039|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
105395405|NCT04380142|363458040|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
105395406|NCT04380142|363458041|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
105395407|NCT04380142|363458039|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
105395408|NCT04380142|363458040|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
105395409|NCT04380142|363458041|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
105395410|NCT04380142|363458039|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
105493157|NCT00085709|363818791|FG000|Overall Study|Not eligible|19|||
105493158|NCT00085709|363818792|FG001|Overall Study|Not eligible|19|||
105395411|NCT04380142|363458040|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
105395412|NCT04380142|363458041|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
105395413|NCT00787150|363458047|FG000|Overall Study|Adverse Event|4|||
105395414|NCT00787150|363458048|FG001|Overall Study|Adverse Event|4|||
105395415|NCT00787150|363458049|FG002|Overall Study|Adverse Event|4|||
105395416|NCT00787150|363458047|FG000|Overall Study|Physician Decision|1|||
105395417|NCT00787150|363458048|FG001|Overall Study|Physician Decision|2|||
105395418|NCT00787150|363458049|FG002|Overall Study|Physician Decision|1|||
105395419|NCT00787150|363458047|FG000|Overall Study|Withdrawal by Subject|2|||
105395420|NCT00787150|363458048|FG001|Overall Study|Withdrawal by Subject|1|||
105395421|NCT00787150|363458049|FG002|Overall Study|Withdrawal by Subject|0|||
105395422|NCT00787150|363458047|FG000|Overall Study|Dosing incorrect study durg|2|||
105395423|NCT00787150|363458048|FG001|Overall Study|Dosing incorrect study durg|0|||
105395424|NCT00787150|363458049|FG002|Overall Study|Dosing incorrect study durg|0|||
105395425|NCT04347538|363458051|FG000|Overall Study|Lost to Follow-up|4|||
105395426|NCT04347538|363458052|FG001|Overall Study|Lost to Follow-up|5|||
105395427|NCT04347538|363458053|FG002|Overall Study|Lost to Follow-up|7|||
105395428|NCT02259231|363458054|FG000|Overall Study|Adverse Event|1|||
105395429|NCT02259231|363458055|FG001|Overall Study|Adverse Event|1|||
105395430|NCT02259231|363458056|FG002|Overall Study|Adverse Event|2|||
105395431|NCT02259231|363458057|FG003|Overall Study|Adverse Event|0|||
105395432|NCT02259231|363458058|FG004|Overall Study|Adverse Event|0|||
105395433|NCT02259231|363458059|FG005|Overall Study|Adverse Event|0|||
105395434|NCT02259231|363458060|FG006|Overall Study|Adverse Event|0|||
105395435|NCT02259231|363458054|FG000|Overall Study|Progressive Disease|4|||
105395436|NCT02259231|363458055|FG001|Overall Study|Progressive Disease|5|||
105395437|NCT02259231|363458056|FG002|Overall Study|Progressive Disease|4|||
105395438|NCT02259231|363458057|FG003|Overall Study|Progressive Disease|5|||
105395439|NCT02259231|363458058|FG004|Overall Study|Progressive Disease|4|||
105395440|NCT02259231|363458059|FG005|Overall Study|Progressive Disease|5|||
105395441|NCT02259231|363458060|FG006|Overall Study|Progressive Disease|4|||
105395442|NCT02259231|363458054|FG000|Overall Study|Sponsor termination of study|1|||
105395443|NCT02259231|363458055|FG001|Overall Study|Sponsor termination of study|0|||
105395444|NCT02259231|363458056|FG002|Overall Study|Sponsor termination of study|0|||
105395445|NCT02259231|363458057|FG003|Overall Study|Sponsor termination of study|1|||
105395446|NCT02259231|363458058|FG004|Overall Study|Sponsor termination of study|2|||
105395447|NCT02259231|363458059|FG005|Overall Study|Sponsor termination of study|1|||
105395448|NCT02259231|363458060|FG006|Overall Study|Sponsor termination of study|1|||
105395449|NCT06071104|363458073|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
105395450|NCT03518060|363458074|FG000|Overall Study|Death|1|||
105395451|NCT03518060|363458074|FG000|Overall Study|Poor adherence|1|||
105395452|NCT03518060|363458074|FG000|Overall Study|Withdrawal of informed consent|2|||
105395453|NCT03518060|363458074|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
105395454|NCT03518060|363458074|FG000|Overall Study|Physician Decision|7|||
105395455|NCT03518060|363458074|FG000|Overall Study|Adverse drug reactions|23|||
105395456|NCT03518060|363458074|FG000|Overall Study|Withdrawal by Subject|25|||
105395457|NCT03518060|363458074|FG000|Overall Study|Lost to Follow-up|13|||
105395458|NCT01722669|363458080|FG000|Overall Study|Withdrawal by Subject|0|||
105395459|NCT01722669|363458081|FG001|Overall Study|Withdrawal by Subject|0|||
105395460|NCT01722669|363458082|FG002|Overall Study|Withdrawal by Subject|0|||
105395461|NCT01722669|363458083|FG003|Overall Study|Withdrawal by Subject|0|||
105395462|NCT01722669|363458084|FG004|Overall Study|Withdrawal by Subject|0|||
105395463|NCT01722669|363458085|FG005|Overall Study|Withdrawal by Subject|2|||
105395464|NCT04756531|363458100|FG000|Overall Study|Adverse Event|0|||
105395465|NCT04756531|363458101|FG001|Overall Study|Adverse Event|0|||
105395466|NCT04756531|363458102|FG002|Overall Study|Adverse Event|0|||
105395467|NCT04756531|363458103|FG003|Overall Study|Adverse Event|0|||
105395468|NCT04756531|363458104|FG004|Overall Study|Adverse Event|1|||
105395469|NCT04756531|363458105|FG005|Overall Study|Adverse Event|0|||
105395470|NCT04756531|363458106|FG006|Overall Study|Adverse Event|0|||
105395471|NCT04756531|363458107|FG007|Overall Study|Adverse Event|0|||
105395472|NCT04756531|363458108|FG008|Overall Study|Adverse Event|0|||
105395473|NCT04756531|363458109|FG009|Overall Study|Adverse Event|0|||
105580592|NCT02018861|364126452|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
105395474|NCT04756531|363458110|FG010|Overall Study|Adverse Event|0|||
105395475|NCT04756531|363458111|FG011|Overall Study|Adverse Event|0|||
105395476|NCT04756531|363458112|FG012|Overall Study|Adverse Event|0|||
105395477|NCT04756531|363458113|FG013|Overall Study|Adverse Event|0|||
105395478|NCT04756531|363458114|FG014|Overall Study|Adverse Event|0|||
105395479|NCT04756531|363458115|FG015|Overall Study|Adverse Event|0|||
105395480|NCT04756531|363458116|FG016|Overall Study|Adverse Event|0|||
105580593|NCT02018861|364126453|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
105395481|NCT04756531|363458117|FG017|Overall Study|Adverse Event|0|||
105395482|NCT04756531|363458100|FG000|Overall Study|Withdrawal by Subject|0|||
105395483|NCT04756531|363458101|FG001|Overall Study|Withdrawal by Subject|0|||
105395484|NCT04756531|363458102|FG002|Overall Study|Withdrawal by Subject|0|||
105395485|NCT04756531|363458103|FG003|Overall Study|Withdrawal by Subject|0|||
105395486|NCT04756531|363458104|FG004|Overall Study|Withdrawal by Subject|0|||
105395487|NCT04756531|363458105|FG005|Overall Study|Withdrawal by Subject|0|||
105395488|NCT04756531|363458106|FG006|Overall Study|Withdrawal by Subject|1|||
105395489|NCT04756531|363458107|FG007|Overall Study|Withdrawal by Subject|0|||
105395490|NCT04756531|363458108|FG008|Overall Study|Withdrawal by Subject|0|||
105395491|NCT04756531|363458109|FG009|Overall Study|Withdrawal by Subject|0|||
105395492|NCT04756531|363458110|FG010|Overall Study|Withdrawal by Subject|0|||
105395493|NCT04756531|363458111|FG011|Overall Study|Withdrawal by Subject|0|||
105395494|NCT04756531|363458112|FG012|Overall Study|Withdrawal by Subject|0|||
105395495|NCT04756531|363458113|FG013|Overall Study|Withdrawal by Subject|0|||
105395496|NCT04756531|363458114|FG014|Overall Study|Withdrawal by Subject|0|||
105395497|NCT04756531|363458115|FG015|Overall Study|Withdrawal by Subject|0|||
105395498|NCT04756531|363458116|FG016|Overall Study|Withdrawal by Subject|0|||
105395499|NCT04756531|363458117|FG017|Overall Study|Withdrawal by Subject|0|||
105395500|NCT05318287|363458118|FG000|Overall Study|Lost to Follow-up|8|||
105395501|NCT03537508|363458121|FG000|Overall Study|Adverse Event|2|||
105395502|NCT03537508|363458122|FG001|Overall Study|Adverse Event|1|||
105395503|NCT03537508|363458121|FG000|Overall Study|Protocol Violation|65|||
105395504|NCT03537508|363458122|FG001|Overall Study|Protocol Violation|48|||
105395505|NCT03537508|363458121|FG000|Overall Study|Lost to Follow-up|86|||
105395506|NCT03537508|363458122|FG001|Overall Study|Lost to Follow-up|60|||
105395507|NCT03537508|363458121|FG000|Overall Study|Withdrawal by parent/guardian|263|||
105395508|NCT03537508|363458122|FG001|Overall Study|Withdrawal by parent/guardian|149|||
105395509|NCT04466891|363458127|FG000|Overall Study|Death|52|||
105395510|NCT04466891|363458128|FG001|Overall Study|Death|5|||
105395511|NCT04466891|363458127|FG000|Overall Study|Withdrawal by Subject|8|||
105395512|NCT04466891|363458128|FG001|Overall Study|Withdrawal by Subject|1|||
105395513|NCT02457793|363458140|FG000|Overall Study|Reason not specified|0|||
105395514|NCT02457793|363458141|FG001|Overall Study|Reason not specified|0|||
105395515|NCT02457793|363458142|FG002|Overall Study|Reason not specified|0|||
105395516|NCT02457793|363458143|FG003|Overall Study|Reason not specified|1|||
105395517|NCT02457793|363458144|FG004|Overall Study|Reason not specified|1|||
105395518|NCT02457793|363458145|FG005|Overall Study|Reason not specified|1|||
105395519|NCT02457793|363458140|FG000|Overall Study|Withdrawal by Subject|0|||
105395520|NCT02457793|363458141|FG001|Overall Study|Withdrawal by Subject|4|||
105395521|NCT02457793|363458142|FG002|Overall Study|Withdrawal by Subject|2|||
105395522|NCT02457793|363458143|FG003|Overall Study|Withdrawal by Subject|2|||
105395523|NCT02457793|363458144|FG004|Overall Study|Withdrawal by Subject|2|||
105395524|NCT02457793|363458145|FG005|Overall Study|Withdrawal by Subject|2|||
105395525|NCT02457793|363458140|FG000|Overall Study|Adverse Event|0|||
105395526|NCT02457793|363458141|FG001|Overall Study|Adverse Event|0|||
105395527|NCT02457793|363458142|FG002|Overall Study|Adverse Event|0|||
105395528|NCT02457793|363458143|FG003|Overall Study|Adverse Event|1|||
105395529|NCT02457793|363458144|FG004|Overall Study|Adverse Event|0|||
105395530|NCT02457793|363458145|FG005|Overall Study|Adverse Event|0|||
105395531|NCT02457793|363458140|FG000|Overall Study|Physician Decision|1|||
105395532|NCT02457793|363458141|FG001|Overall Study|Physician Decision|0|||
105395533|NCT02457793|363458142|FG002|Overall Study|Physician Decision|1|||
105395534|NCT02457793|363458143|FG003|Overall Study|Physician Decision|1|||
105395535|NCT02457793|363458144|FG004|Overall Study|Physician Decision|1|||
105395536|NCT02457793|363458145|FG005|Overall Study|Physician Decision|3|||
105395537|NCT03814044|363458146|FG000|Overall Study|Protocol deviation|1|||
105395538|NCT00835172|363458149|FG000|Washout|Protocol Violation|0|||
105395539|NCT00835172|363458150|FG001|Washout|Protocol Violation|1|||
105395540|NCT04890509|363458151|FG000|Overall Study|Death|4|||
105395541|NCT04890509|363458152|FG001|Overall Study|Death|4|||
105395542|NCT01992757|363459773|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
105395543|NCT00633126|363459774|FG000|Overall Study|Did not receive full dose|1|||
105395544|NCT01432444|363459780|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
105395545|NCT01432444|363459781|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
105395546|NCT01432444|363459782|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
105395547|NCT01432444|363459780|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
105395548|NCT01432444|363459781|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
105395549|NCT01432444|363459782|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
105395550|NCT01432444|363459780|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
105395551|NCT01432444|363459781|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
105395552|NCT01432444|363459782|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
105395553|NCT01432444|363459780|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
105395554|NCT01432444|363459781|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
105395555|NCT01432444|363459782|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
105395556|NCT01432444|363459780|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
105395557|NCT01432444|363459781|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
105395558|NCT01432444|363459782|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
105395559|NCT01432444|363459780|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
105395560|NCT01432444|363459781|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
105395561|NCT01432444|363459782|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
105395562|NCT01432444|363459780|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
105395563|NCT01432444|363459781|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
105395564|NCT01432444|363459782|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
105395565|NCT01432444|363459780|FG000|Treatment Phase|Lost to Follow-up|0|||
105395566|NCT01432444|363459781|FG001|Treatment Phase|Lost to Follow-up|33|||
105395567|NCT01432444|363459782|FG002|Treatment Phase|Lost to Follow-up|0|||
105395568|NCT01432444|363459780|FG000|Treatment Phase|Adverse Event|0|||
105395569|NCT01432444|363459781|FG001|Treatment Phase|Adverse Event|37|||
105395570|NCT01432444|363459782|FG002|Treatment Phase|Adverse Event|0|||
105395571|NCT01432444|363459780|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
105395572|NCT01432444|363459781|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
105395573|NCT01432444|363459782|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
105395574|NCT01432444|363459780|FG000|Treatment Phase|Physician Decision|0|||
105395575|NCT01432444|363459781|FG001|Treatment Phase|Physician Decision|5|||
105395576|NCT01432444|363459782|FG002|Treatment Phase|Physician Decision|0|||
105395577|NCT01432444|363459780|FG000|Treatment Phase|Withdrawal by Subject|0|||
105395578|NCT01432444|363459781|FG001|Treatment Phase|Withdrawal by Subject|41|||
105395579|NCT01432444|363459782|FG002|Treatment Phase|Withdrawal by Subject|0|||
105395580|NCT01432444|363459780|FG000|Treatment Phase|Protocol Deviation|0|||
105395581|NCT01432444|363459781|FG001|Treatment Phase|Protocol Deviation|3|||
105395582|NCT01432444|363459782|FG002|Treatment Phase|Protocol Deviation|0|||
105395583|NCT01432444|363459780|FG000|Treatment Phase|Lack of Efficacy|0|||
105395584|NCT01432444|363459781|FG001|Treatment Phase|Lack of Efficacy|10|||
105395585|NCT01432444|363459782|FG002|Treatment Phase|Lack of Efficacy|0|||
105395586|NCT01432444|363459780|FG000|Extension Phase|Lost to Follow-up|0|||
105395587|NCT01432444|363459781|FG001|Extension Phase|Lost to Follow-up|0|||
105395588|NCT01432444|363459782|FG002|Extension Phase|Lost to Follow-up|17|||
105395589|NCT01432444|363459780|FG000|Extension Phase|Adverse Event|0|||
105395590|NCT01432444|363459781|FG001|Extension Phase|Adverse Event|0|||
105395591|NCT01432444|363459782|FG002|Extension Phase|Adverse Event|10|||
105395592|NCT01432444|363459780|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
105395593|NCT01432444|363459781|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
105395594|NCT01432444|363459782|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
105395595|NCT01432444|363459780|FG000|Extension Phase|Met Withdrawal Criteria|0|||
105395596|NCT01432444|363459781|FG001|Extension Phase|Met Withdrawal Criteria|0|||
105395597|NCT01432444|363459782|FG002|Extension Phase|Met Withdrawal Criteria|144|||
105395598|NCT01432444|363459780|FG000|Extension Phase|Physician Decision|0|||
105395599|NCT01432444|363459781|FG001|Extension Phase|Physician Decision|0|||
105395600|NCT01432444|363459782|FG002|Extension Phase|Physician Decision|1|||
105395601|NCT01432444|363459780|FG000|Extension Phase|Withdrawal by Subject|0|||
105395602|NCT01432444|363459781|FG001|Extension Phase|Withdrawal by Subject|0|||
105395603|NCT01432444|363459782|FG002|Extension Phase|Withdrawal by Subject|13|||
105395604|NCT02538614|363459783|FG000|Overall Study|Progressive Disease|2|||
105395605|NCT00183248|363459784|FG000|Overall Study|Lost to Follow-up|0|||
105395606|NCT00183248|363459785|FG001|Overall Study|Lost to Follow-up|1|||
105395607|NCT00183248|363459784|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
105395608|NCT00183248|363459785|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
105395609|NCT03309202|363459786|FG000|Overall Study|Lost to Follow-up|1|||
105395610|NCT03309202|363459787|FG001|Overall Study|Lost to Follow-up|0|||
105395611|NCT03309202|363459788|FG002|Overall Study|Lost to Follow-up|0|||
105395612|NCT03309202|363459789|FG003|Overall Study|Lost to Follow-up|0|||
105395613|NCT05201807|363459790|FG000|Overall Study|Adverse Event|1|||
105395614|NCT05201807|363459790|FG000|Overall Study|COVID-19 Related|1|||
105395615|NCT00831389|363459793|FG000|Overall Study|Withdrawal by Subject|0|||
105395616|NCT00831389|363459794|FG001|Overall Study|Withdrawal by Subject|1|||
105395617|NCT01358734|363459801|FG000|Overall Study|Adverse Event|4|||
105395618|NCT01358734|363459802|FG001|Overall Study|Adverse Event|7|||
105395619|NCT01358734|363459803|FG002|Overall Study|Adverse Event|3|||
105395620|NCT01358734|363459801|FG000|Overall Study|Lack of Efficacy|0|||
105395621|NCT01358734|363459802|FG001|Overall Study|Lack of Efficacy|1|||
105395622|NCT01358734|363459803|FG002|Overall Study|Lack of Efficacy|3|||
105395623|NCT01358734|363459801|FG000|Overall Study|Withdrawal by Subject|1|||
105395624|NCT01358734|363459802|FG001|Overall Study|Withdrawal by Subject|6|||
105395625|NCT01358734|363459803|FG002|Overall Study|Withdrawal by Subject|3|||
105395626|NCT01358734|363459801|FG000|Overall Study|Death|3|||
105395627|NCT01358734|363459802|FG001|Overall Study|Death|7|||
105395628|NCT01358734|363459803|FG002|Overall Study|Death|2|||
105395629|NCT01358734|363459801|FG000|Overall Study|Progressive Disease|5|||
105395630|NCT01358734|363459802|FG001|Overall Study|Progressive Disease|13|||
105395631|NCT01358734|363459803|FG002|Overall Study|Progressive Disease|16|||
105395632|NCT01358734|363459801|FG000|Overall Study|Non-compliance with study drug|0|||
105439944|NCT01618695|363616641|FG003|Core Phase|Other than specified|2|||
105439945|NCT01618695|363616638|FG000|Core Phase|Not treated|1|||
105439946|NCT01618695|363616639|FG001|Core Phase|Not treated|0|||
105439947|NCT01618695|363616640|FG002|Core Phase|Not treated|2|||
105439948|NCT01618695|363616641|FG003|Core Phase|Not treated|0|||
105395633|NCT01358734|363459802|FG001|Overall Study|Non-compliance with study drug|0|||
105395634|NCT01358734|363459803|FG002|Overall Study|Non-compliance with study drug|1|||
105395635|NCT01358734|363459801|FG000|Overall Study|Other|2|||
105395636|NCT01358734|363459802|FG001|Overall Study|Other|5|||
105395637|NCT01358734|363459803|FG002|Overall Study|Other|4|||
105395638|NCT01358734|363459801|FG000|Overall Study|Protocol Violation|0|||
105395639|NCT01358734|363459802|FG001|Overall Study|Protocol Violation|0|||
105395640|NCT01358734|363459803|FG002|Overall Study|Protocol Violation|2|||
105395641|NCT03610048|363459804|FG000|Overall Study|Study terminated by sponsor|84|||
105395642|NCT03610048|363459804|FG000|Overall Study|Adverse Event|32|||
105395643|NCT03610048|363459804|FG000|Overall Study|Withdrawal by Subject|31|||
105395644|NCT03610048|363459804|FG000|Overall Study|Lost to Follow-up|8|||
105395645|NCT03610048|363459804|FG000|Overall Study|Other|4|||
105395646|NCT03610048|363459804|FG000|Overall Study|Physician Decision|1|||
105395647|NCT03610048|363459804|FG000|Overall Study|Pregnancy|1|||
105395648|NCT01198587|363459806|FG000|Overall Study|Lost to Follow-up|8|||
105395649|NCT01198587|363459807|FG001|Overall Study|Lost to Follow-up|0|||
105395650|NCT01198587|363459808|FG002|Overall Study|Lost to Follow-up|9|||
105395651|NCT01198587|363459809|FG003|Overall Study|Lost to Follow-up|0|||
105395652|NCT00320606|363459813|FG000|Overall Study|Adverse Event|1|||
105395653|NCT00320606|363459813|FG000|Overall Study|Protocol Violation|1|||
105395654|NCT00320606|363459813|FG000|Overall Study|Withdrawal by Subject|1|||
105395655|NCT03605693|363459816|FG000|Overall Study|Lost to Follow-up|4|||
105395656|NCT03605693|363459817|FG001|Overall Study|Lost to Follow-up|0|||
105395657|NCT03605693|363459816|FG000|Overall Study|Physician Decision|1|||
105395658|NCT03605693|363459817|FG001|Overall Study|Physician Decision|0|||
105395659|NCT03093415|363459818|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
105395660|NCT03093415|363459819|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
105395661|NCT03093415|363459820|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
105395662|NCT03093415|363459818|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
105395663|NCT03093415|363459819|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
105395664|NCT03093415|363459820|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
105395665|NCT03093415|363459818|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
105395666|NCT03093415|363459819|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
105395667|NCT03093415|363459820|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
105395668|NCT03093415|363459818|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
105395669|NCT03093415|363459819|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
105395670|NCT03093415|363459820|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
105395671|NCT03093415|363459818|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
105395672|NCT03093415|363459819|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
105395673|NCT03093415|363459820|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
105395674|NCT03093415|363459818|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
105395675|NCT03093415|363459819|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
105395676|NCT03093415|363459820|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
105395677|NCT03093415|363459818|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
105395678|NCT03093415|363459819|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
105395679|NCT03093415|363459820|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
105395680|NCT03093415|363459818|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
105395681|NCT03093415|363459819|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
105395682|NCT03093415|363459820|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
105395683|NCT03093415|363459818|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
105395684|NCT03093415|363459819|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
105395685|NCT03093415|363459820|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
105395686|NCT03093415|363459818|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
105395687|NCT03093415|363459819|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
105395688|NCT03093415|363459820|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
105395689|NCT03093415|363459818|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
105395690|NCT03093415|363459819|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
105395691|NCT03093415|363459820|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
105395692|NCT03895372|363459821|FG000|Investigational Treatment Period|Adverse Event|1|||
105395693|NCT03895372|363459822|FG001|Investigational Treatment Period|Adverse Event|0|||
105395694|NCT03895372|363459823|FG002|Investigational Treatment Period|Adverse Event|0|||
105395695|NCT03895372|363459824|FG003|Investigational Treatment Period|Adverse Event|0|||
105395696|NCT03895372|363459825|FG004|Investigational Treatment Period|Adverse Event|0|||
105395697|NCT03895372|363459826|FG005|Investigational Treatment Period|Adverse Event|0|||
105395698|NCT03895372|363459827|FG006|Investigational Treatment Period|Adverse Event|4|||
105395699|NCT03895372|363459828|FG007|Investigational Treatment Period|Adverse Event|3|||
105395700|NCT03895372|363459821|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
105395701|NCT03895372|363459822|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
105395702|NCT03895372|363459823|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
105395703|NCT03895372|363459824|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
105395704|NCT03895372|363459825|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
105395705|NCT03895372|363459826|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
105395706|NCT03895372|363459827|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
105395707|NCT03895372|363459828|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
105395708|NCT03895372|363459821|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
105395709|NCT03895372|363459822|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
105395710|NCT03895372|363459823|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
105395711|NCT03895372|363459824|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
105395712|NCT03895372|363459825|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
105395713|NCT03895372|363459826|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
105395714|NCT03895372|363459827|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
105395715|NCT03895372|363459828|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
105395716|NCT03895372|363459821|FG000|Investigational Treatment Period|Other|0|||
105395717|NCT03895372|363459822|FG001|Investigational Treatment Period|Other|0|||
105395718|NCT03895372|363459823|FG002|Investigational Treatment Period|Other|0|||
105395719|NCT03895372|363459824|FG003|Investigational Treatment Period|Other|0|||
105395720|NCT03895372|363459825|FG004|Investigational Treatment Period|Other|0|||
105395721|NCT03895372|363459826|FG005|Investigational Treatment Period|Other|1|||
105395722|NCT03895372|363459827|FG006|Investigational Treatment Period|Other|0|||
105395723|NCT03895372|363459828|FG007|Investigational Treatment Period|Other|2|||
105395724|NCT03895372|363459821|FG000|Investigational Treatment Period|Protocol Violation|0|||
105395725|NCT03895372|363459822|FG001|Investigational Treatment Period|Protocol Violation|0|||
105395726|NCT03895372|363459823|FG002|Investigational Treatment Period|Protocol Violation|0|||
105395727|NCT03895372|363459824|FG003|Investigational Treatment Period|Protocol Violation|1|||
105395728|NCT03895372|363459825|FG004|Investigational Treatment Period|Protocol Violation|0|||
105395729|NCT03895372|363459826|FG005|Investigational Treatment Period|Protocol Violation|0|||
105395730|NCT03895372|363459827|FG006|Investigational Treatment Period|Protocol Violation|0|||
105395731|NCT03895372|363459828|FG007|Investigational Treatment Period|Protocol Violation|0|||
105395732|NCT03895372|363459821|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
105395733|NCT03895372|363459822|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
105395734|NCT03895372|363459823|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
105395735|NCT03895372|363459824|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
105395736|NCT03895372|363459825|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
105395737|NCT03895372|363459826|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
105395738|NCT03895372|363459827|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
105395739|NCT03895372|363459828|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
105395740|NCT03895372|363459821|FG000|Extension Treatment Period|Adverse Event|0|||
105395741|NCT03895372|363459822|FG001|Extension Treatment Period|Adverse Event|1|||
105395742|NCT03895372|363459823|FG002|Extension Treatment Period|Adverse Event|0|||
105395743|NCT03895372|363459824|FG003|Extension Treatment Period|Adverse Event|1|||
105395744|NCT03895372|363459825|FG004|Extension Treatment Period|Adverse Event|0|||
105395745|NCT03895372|363459826|FG005|Extension Treatment Period|Adverse Event|0|||
105395746|NCT03895372|363459827|FG006|Extension Treatment Period|Adverse Event|3|||
105395747|NCT03895372|363459828|FG007|Extension Treatment Period|Adverse Event|3|||
105395748|NCT03895372|363459821|FG000|Extension Treatment Period|Other|1|||
105395749|NCT03895372|363459822|FG001|Extension Treatment Period|Other|3|||
105395750|NCT03895372|363459823|FG002|Extension Treatment Period|Other|0|||
105395751|NCT03895372|363459824|FG003|Extension Treatment Period|Other|0|||
105395752|NCT03895372|363459825|FG004|Extension Treatment Period|Other|1|||
105395753|NCT03895372|363459826|FG005|Extension Treatment Period|Other|0|||
105395754|NCT03895372|363459827|FG006|Extension Treatment Period|Other|0|||
105395755|NCT03895372|363459828|FG007|Extension Treatment Period|Other|2|||
105395756|NCT03895372|363459821|FG000|Extension Treatment Period|Pregnancy|0|||
105395757|NCT03895372|363459822|FG001|Extension Treatment Period|Pregnancy|0|||
105395758|NCT03895372|363459823|FG002|Extension Treatment Period|Pregnancy|0|||
105395759|NCT03895372|363459824|FG003|Extension Treatment Period|Pregnancy|0|||
105395760|NCT03895372|363459825|FG004|Extension Treatment Period|Pregnancy|1|||
105395761|NCT03895372|363459826|FG005|Extension Treatment Period|Pregnancy|0|||
105395762|NCT03895372|363459827|FG006|Extension Treatment Period|Pregnancy|0|||
105395763|NCT03895372|363459828|FG007|Extension Treatment Period|Pregnancy|0|||
105395764|NCT03895372|363459821|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
105395765|NCT03895372|363459822|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
105493159|NCT00085709|363818791|FG000|Overall Study|Withdrawal by Subject|2|||
105493160|NCT00085709|363818792|FG001|Overall Study|Withdrawal by Subject|1|||
105493161|NCT03793556|363818793|FG000|Overall Study|Withdrawal by Subject|12|||
105395766|NCT03895372|363459823|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
105395767|NCT03895372|363459824|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
105395768|NCT03895372|363459825|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
105395769|NCT03895372|363459826|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
105395770|NCT03895372|363459827|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
105395771|NCT03895372|363459828|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
105395772|NCT03559530|363459829|FG000|Overall Study|non-location of medical records|44|||
105395773|NCT03559530|363459830|FG001|Overall Study|non-location of medical records|0|||
105395774|NCT03559530|363459829|FG000|Overall Study|culture results not considered for treat|29|||
105395775|NCT03559530|363459830|FG001|Overall Study|culture results not considered for treat|0|||
105395776|NCT03559530|363459829|FG000|Overall Study|duplicate cases|8|||
105395777|NCT03559530|363459830|FG001|Overall Study|duplicate cases|0|||
105395778|NCT03559530|363459829|FG000|Overall Study|other species of Acinetobacte|7|||
105395779|NCT03559530|363459830|FG001|Overall Study|other species of Acinetobacte|0|||
105395780|NCT03559530|363459829|FG000|Overall Study|contamination / colonization|3|||
105395781|NCT03559530|363459830|FG001|Overall Study|contamination / colonization|0|||
105395782|NCT01646827|363459831|FG000|Overall Study|Lost to Follow-up|0|||
105395783|NCT01646827|363459832|FG001|Overall Study|Lost to Follow-up|3|||
105395784|NCT01646827|363459831|FG000|Overall Study|Physician Decision|1|||
105395785|NCT01646827|363459832|FG001|Overall Study|Physician Decision|2|||
105395786|NCT01646827|363459831|FG000|Overall Study|Withdrawal by Subject|1|||
105395787|NCT01646827|363459832|FG001|Overall Study|Withdrawal by Subject|0|||
105395788|NCT02303262|363459833|FG000|Overall Study|Withdrawal by Subject|2|||
105395789|NCT02706392|363459843|FG000|Overall Study|Death|1|||
105395790|NCT02706392|363459844|FG001|Overall Study|Death|0|||
105395791|NCT02706392|363459845|FG002|Overall Study|Death|2|||
105395792|NCT02706392|363459846|FG003|Overall Study|Death|2|||
105395793|NCT02706392|363459847|FG004|Overall Study|Death|5|||
105395794|NCT02706392|363459848|FG005|Overall Study|Death|2|||
105395795|NCT00619866|363459851|FG000|Weeks 1 - 12|Adverse Event|0|||
105395796|NCT00619866|363459852|FG001|Weeks 1 - 12|Adverse Event|1|||
105395797|NCT00619866|363459853|FG002|Weeks 1 - 12|Adverse Event|2|||
105395798|NCT00619866|363459854|FG003|Weeks 1 - 12|Adverse Event|0|||
105395799|NCT00619866|363459855|FG004|Weeks 1 - 12|Adverse Event|0|||
105395800|NCT00619866|363459851|FG000|Weeks 1 - 12|Non-compliance|0|||
105395801|NCT00619866|363459852|FG001|Weeks 1 - 12|Non-compliance|0|||
105395802|NCT00619866|363459853|FG002|Weeks 1 - 12|Non-compliance|1|||
105395803|NCT00619866|363459854|FG003|Weeks 1 - 12|Non-compliance|0|||
105395804|NCT00619866|363459855|FG004|Weeks 1 - 12|Non-compliance|0|||
105395805|NCT00619866|363459851|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
105395806|NCT00619866|363459852|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
105395807|NCT00619866|363459853|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
105395808|NCT00619866|363459854|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
105395809|NCT00619866|363459855|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
105395810|NCT00619866|363459851|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
105395811|NCT00619866|363459852|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
105395812|NCT00619866|363459853|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
105395813|NCT00619866|363459854|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
105395814|NCT00619866|363459855|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
105395815|NCT00619866|363459851|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
105395816|NCT00619866|363459852|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
105395817|NCT00619866|363459853|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
105395818|NCT00619866|363459854|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
105395819|NCT00619866|363459855|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
105395820|NCT00619866|363459851|FG000|Weeks 1 - 12|Sponsor Decision|0|||
105395821|NCT00619866|363459852|FG001|Weeks 1 - 12|Sponsor Decision|1|||
105395822|NCT00619866|363459853|FG002|Weeks 1 - 12|Sponsor Decision|0|||
105395823|NCT00619866|363459854|FG003|Weeks 1 - 12|Sponsor Decision|0|||
105395824|NCT00619866|363459855|FG004|Weeks 1 - 12|Sponsor Decision|0|||
105395825|NCT00619866|363459851|FG000|Weeks 13 - 24|Adverse Event|0|||
105395826|NCT00619866|363459852|FG001|Weeks 13 - 24|Adverse Event|0|||
105395827|NCT00619866|363459853|FG002|Weeks 13 - 24|Adverse Event|2|||
105395828|NCT00619866|363459854|FG003|Weeks 13 - 24|Adverse Event|1|||
105395829|NCT00619866|363459855|FG004|Weeks 13 - 24|Adverse Event|0|||
105395830|NCT00619866|363459851|FG000|Weeks 13 - 24|Protocol Deviation|0|||
105395831|NCT00619866|363459852|FG001|Weeks 13 - 24|Protocol Deviation|0|||
105395832|NCT00619866|363459853|FG002|Weeks 13 - 24|Protocol Deviation|0|||
105395833|NCT00619866|363459854|FG003|Weeks 13 - 24|Protocol Deviation|1|||
105395834|NCT00619866|363459855|FG004|Weeks 13 - 24|Protocol Deviation|0|||
105395835|NCT00619866|363459851|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
105395836|NCT00619866|363459852|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
105395837|NCT00619866|363459853|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
105395838|NCT00619866|363459854|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
105395839|NCT00619866|363459855|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
105395840|NCT00619866|363459851|FG000|Weeks 13 - 24|Non-compliance|0|||
105395841|NCT00619866|363459852|FG001|Weeks 13 - 24|Non-compliance|1|||
105395842|NCT00619866|363459853|FG002|Weeks 13 - 24|Non-compliance|1|||
105395843|NCT00619866|363459854|FG003|Weeks 13 - 24|Non-compliance|0|||
105395844|NCT00619866|363459855|FG004|Weeks 13 - 24|Non-compliance|0|||
105395845|NCT00619866|363459851|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
105395846|NCT00619866|363459852|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
105395847|NCT00619866|363459853|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
105395848|NCT00619866|363459854|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
105395849|NCT00619866|363459855|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
105395850|NCT04716894|363459858|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
105395851|NCT04716894|363459858|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
105395852|NCT05205616|363459859|FG000|Overall Study|Lost to Follow-up|4|||
105395853|NCT05205616|363459860|FG001|Overall Study|Lost to Follow-up|4|||
105395854|NCT01121757|363459861|FG000|First Drug|Death|1|||
105395855|NCT01121757|363459862|FG001|First Drug|Death|0|||
105395856|NCT01121757|363459861|FG000|First Drug|Disease Progression|0|||
105395857|NCT01121757|363459862|FG001|First Drug|Disease Progression|2|||
105395858|NCT01121757|363459861|FG000|Combination|Physician Decision|0|||
105395859|NCT01121757|363459862|FG001|Combination|Physician Decision|1|||
105395860|NCT01121757|363459861|FG000|Combination|Disease Progression|2|||
105395861|NCT01121757|363459862|FG001|Combination|Disease Progression|0|||
105395862|NCT04079738|363459863|FG000|Study Treatment|Death|1|||
105395863|NCT04079738|363459864|FG001|Study Treatment|Death|0|||
105395864|NCT04079738|363459865|FG002|Study Treatment|Death|0|||
105395865|NCT04079738|363459866|FG003|Study Treatment|Death|0|||
105395866|NCT04079738|363459863|FG000|Study Treatment|Adverse Event|2|||
105395867|NCT04079738|363459864|FG001|Study Treatment|Adverse Event|0|||
105395868|NCT04079738|363459865|FG002|Study Treatment|Adverse Event|0|||
105395869|NCT04079738|363459866|FG003|Study Treatment|Adverse Event|0|||
105395870|NCT04079738|363459863|FG000|Study Treatment|withdrawal before treatment|1|||
105395871|NCT04079738|363459864|FG001|Study Treatment|withdrawal before treatment|0|||
105395872|NCT04079738|363459865|FG002|Study Treatment|withdrawal before treatment|0|||
105395873|NCT04079738|363459866|FG003|Study Treatment|withdrawal before treatment|0|||
105395874|NCT04079738|363459863|FG000|Study Treatment|symptomatic deterioration|2|||
105395875|NCT04079738|363459864|FG001|Study Treatment|symptomatic deterioration|0|||
105395876|NCT04079738|363459865|FG002|Study Treatment|symptomatic deterioration|0|||
105395877|NCT04079738|363459866|FG003|Study Treatment|symptomatic deterioration|0|||
105395878|NCT04079738|363459863|FG000|Study Treatment|Disease Progression|1|||
105395879|NCT04079738|363459864|FG001|Study Treatment|Disease Progression|0|||
105395880|NCT04079738|363459865|FG002|Study Treatment|Disease Progression|0|||
105395881|NCT04079738|363459866|FG003|Study Treatment|Disease Progression|0|||
105395882|NCT04079738|363459863|FG000|Study Treatment|withdrawal after treatment|1|||
105395883|NCT04079738|363459864|FG001|Study Treatment|withdrawal after treatment|0|||
105395884|NCT04079738|363459865|FG002|Study Treatment|withdrawal after treatment|0|||
105395885|NCT04079738|363459866|FG003|Study Treatment|withdrawal after treatment|0|||
105395886|NCT04079738|363459863|FG000|Follow up|Withdrawal by Subject|3|||
105395887|NCT04079738|363459864|FG001|Follow up|Withdrawal by Subject|0|||
105395888|NCT04079738|363459865|FG002|Follow up|Withdrawal by Subject|0|||
105395889|NCT04079738|363459866|FG003|Follow up|Withdrawal by Subject|0|||
105395890|NCT04079738|363459863|FG000|Follow up|Death|5|||
105395891|NCT04079738|363459864|FG001|Follow up|Death|0|||
105395892|NCT04079738|363459865|FG002|Follow up|Death|0|||
105395893|NCT04079738|363459866|FG003|Follow up|Death|0|||
105395894|NCT01380080|363459870|FG000|Overall Study|Death|36|||
105395895|NCT01380080|363459871|FG001|Overall Study|Death|44|||
105395896|NCT01380080|363459870|FG000|Overall Study|Site is closing|28|||
105395897|NCT01380080|363459871|FG001|Overall Study|Site is closing|31|||
105395898|NCT01380080|363459870|FG000|Overall Study|Not able to get to clinic|7|||
105395899|NCT01380080|363459871|FG001|Overall Study|Not able to get to clinic|1|||
105395900|NCT01380080|363459870|FG000|Overall Study|Not willing to adhere to requirements|6|||
105395901|NCT01380080|363459871|FG001|Overall Study|Not willing to adhere to requirements|2|||
105395902|NCT01380080|363459870|FG000|Overall Study|Withdrawal by Subject|5|||
105395903|NCT01380080|363459871|FG001|Overall Study|Withdrawal by Subject|2|||
105395904|NCT01380080|363459870|FG000|Overall Study|Lost to Follow-up|3|||
105395905|NCT01380080|363459871|FG001|Overall Study|Lost to Follow-up|3|||
105395906|NCT02135133|363459872|FG000|Overall Study|Adverse Event|10|||
105395907|NCT02135133|363459872|FG000|Overall Study|regulatory mandate|5|||
105395908|NCT05081843|363459873|FG000|Overall Study|Lost to Follow-up|135|||
105395909|NCT05081843|363459874|FG001|Overall Study|Lost to Follow-up|145|||
105395910|NCT02303821|363459875|FG000|Overall Study|Withdrawal by Subject|0|||
105395911|NCT02303821|363459876|FG001|Overall Study|Withdrawal by Subject|0|||
105395912|NCT02303821|363459877|FG002|Overall Study|Withdrawal by Subject|0|||
105395913|NCT02303821|363459878|FG003|Overall Study|Withdrawal by Subject|0|||
105395914|NCT02303821|363459879|FG004|Overall Study|Withdrawal by Subject|0|||
105395915|NCT02303821|363459880|FG005|Overall Study|Withdrawal by Subject|0|||
105493162|NCT03793556|363818794|FG001|Overall Study|Withdrawal by Subject|1|||
105493163|NCT03793556|363818793|FG000|Overall Study|Lost to Follow-up|1|||
105493164|NCT03793556|363818794|FG001|Overall Study|Lost to Follow-up|1|||
105395916|NCT02303821|363459881|FG006|Overall Study|Withdrawal by Subject|0|||
105395917|NCT02303821|363459882|FG007|Overall Study|Withdrawal by Subject|2|||
105395918|NCT02303821|363459875|FG000|Overall Study|Death|0|||
105395919|NCT02303821|363459876|FG001|Overall Study|Death|2|||
105395920|NCT02303821|363459877|FG002|Overall Study|Death|0|||
105395921|NCT02303821|363459878|FG003|Overall Study|Death|0|||
105493165|NCT04416633|363818795|FG000|Overall Study|Death|1|||
105395922|NCT02303821|363459879|FG004|Overall Study|Death|0|||
105395923|NCT02303821|363459880|FG005|Overall Study|Death|3|||
105395924|NCT02303821|363459881|FG006|Overall Study|Death|41|||
105395925|NCT02303821|363459882|FG007|Overall Study|Death|29|||
105395926|NCT02303821|363459875|FG000|Overall Study|Lost to Follow-up|0|||
105395927|NCT02303821|363459876|FG001|Overall Study|Lost to Follow-up|0|||
105395928|NCT02303821|363459877|FG002|Overall Study|Lost to Follow-up|0|||
105395929|NCT02303821|363459878|FG003|Overall Study|Lost to Follow-up|0|||
105395930|NCT02303821|363459879|FG004|Overall Study|Lost to Follow-up|0|||
105395931|NCT02303821|363459880|FG005|Overall Study|Lost to Follow-up|0|||
105395932|NCT02303821|363459881|FG006|Overall Study|Lost to Follow-up|1|||
105395933|NCT02303821|363459882|FG007|Overall Study|Lost to Follow-up|0|||
105395934|NCT02303821|363459875|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
105395935|NCT02303821|363459876|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
105395936|NCT02303821|363459877|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
105395937|NCT02303821|363459878|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
105395938|NCT02303821|363459879|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
105395939|NCT02303821|363459880|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
105395940|NCT02303821|363459881|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
105395941|NCT02303821|363459882|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
105395942|NCT02303821|363459875|FG000|Overall Study|Decision by sponsor|0|||
105395943|NCT02303821|363459876|FG001|Overall Study|Decision by sponsor|0|||
105395944|NCT02303821|363459877|FG002|Overall Study|Decision by sponsor|0|||
105395945|NCT02303821|363459878|FG003|Overall Study|Decision by sponsor|0|||
105395946|NCT02303821|363459879|FG004|Overall Study|Decision by sponsor|0|||
105395947|NCT02303821|363459880|FG005|Overall Study|Decision by sponsor|1|||
105395948|NCT02303821|363459881|FG006|Overall Study|Decision by sponsor|0|||
105395949|NCT02303821|363459882|FG007|Overall Study|Decision by sponsor|0|||
105395950|NCT02303821|363459875|FG000|Overall Study|Protocol-specified criteria|0|||
105395951|NCT02303821|363459876|FG001|Overall Study|Protocol-specified criteria|1|||
105395952|NCT02303821|363459877|FG002|Overall Study|Protocol-specified criteria|0|||
105395953|NCT02303821|363459878|FG003|Overall Study|Protocol-specified criteria|0|||
105395954|NCT02303821|363459879|FG004|Overall Study|Protocol-specified criteria|0|||
105395955|NCT02303821|363459880|FG005|Overall Study|Protocol-specified criteria|1|||
105395956|NCT02303821|363459881|FG006|Overall Study|Protocol-specified criteria|0|||
105395957|NCT02303821|363459882|FG007|Overall Study|Protocol-specified criteria|0|||
105395958|NCT02711202|363459883|FG000|Overall Study|Adverse Event|3|||
105395959|NCT02711202|363459884|FG001|Overall Study|Adverse Event|0|||
105395960|NCT02711202|363459883|FG000|Overall Study|graft loss|1|||
105395961|NCT02711202|363459884|FG001|Overall Study|graft loss|0|||
105395962|NCT03211416|363459885|FG000|Overall Study|Adverse Event|7|||
105395963|NCT03211416|363459885|FG000|Overall Study|Lack of Efficacy|2|||
105395964|NCT03211416|363459885|FG000|Overall Study|Physician Decision|1|||
105395965|NCT03448393|363459896|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
105395966|NCT03448393|363459897|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
105395967|NCT03448393|363459898|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
105395968|NCT03448393|363459899|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
105395969|NCT03448393|363459900|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
105395970|NCT03448393|363459901|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
105395971|NCT03448393|363459902|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
105395972|NCT03448393|363459903|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
105395973|NCT03448393|363459904|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
105395974|NCT03448393|363459896|FG000|Dose Expansion|Not treated - screen failure|0|||
105395975|NCT03448393|363459897|FG001|Dose Expansion|Not treated - screen failure|0|||
105395976|NCT03448393|363459898|FG002|Dose Expansion|Not treated - screen failure|0|||
105395977|NCT03448393|363459899|FG003|Dose Expansion|Not treated - screen failure|0|||
105395978|NCT03448393|363459900|FG004|Dose Expansion|Not treated - screen failure|0|||
105395979|NCT03448393|363459901|FG005|Dose Expansion|Not treated - screen failure|0|||
105395980|NCT03448393|363459902|FG006|Dose Expansion|Not treated - screen failure|0|||
105395981|NCT03448393|363459903|FG007|Dose Expansion|Not treated - screen failure|0|||
105395982|NCT03448393|363459904|FG008|Dose Expansion|Not treated - screen failure|7|||
105395983|NCT04532749|363459907|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
105395984|NCT04532749|363459908|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
105395985|NCT04532749|363459907|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
105395986|NCT04532749|363459908|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
105395987|NCT04532749|363459907|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
105395988|NCT04532749|363459908|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
105395989|NCT04532749|363459907|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
105395990|NCT04532749|363459908|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
105395991|NCT04532749|363459907|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
105395992|NCT04532749|363459908|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
105395993|NCT04532749|363459907|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
105395994|NCT04532749|363459908|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
105395995|NCT04532749|363459907|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
105395996|NCT04532749|363459908|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
105395997|NCT04532749|363459907|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
105395998|NCT04532749|363459908|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
105395999|NCT04532749|363459907|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
105396000|NCT04532749|363459908|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
105396001|NCT04532749|363459907|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
105396002|NCT04532749|363459908|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
105396003|NCT02936323|363459909|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
105396004|NCT02936323|363459910|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
105396005|NCT02936323|363459911|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
105396006|NCT02936323|363459912|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
105396007|NCT02936323|363459913|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
105396008|NCT02936323|363459914|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
105396009|NCT02936323|363459915|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
105396010|NCT02936323|363459916|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
105396011|NCT02936323|363459917|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
105396012|NCT02936323|363459918|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
105396013|NCT02936323|363459909|FG000|Phase 1 Dose Escalation|Death|2|||
105396014|NCT02936323|363459910|FG001|Phase 1 Dose Escalation|Death|1|||
105396015|NCT02936323|363459911|FG002|Phase 1 Dose Escalation|Death|3|||
105396016|NCT02936323|363459912|FG003|Phase 1 Dose Escalation|Death|1|||
105396017|NCT02936323|363459913|FG004|Phase 1 Dose Escalation|Death|2|||
105396018|NCT02936323|363459914|FG005|Phase 1 Dose Escalation|Death|3|||
105396019|NCT02936323|363459915|FG006|Phase 1 Dose Escalation|Death|3|||
105396020|NCT02936323|363459916|FG007|Phase 1 Dose Escalation|Death|0|||
105396021|NCT02936323|363459917|FG008|Phase 1 Dose Escalation|Death|0|||
105396022|NCT02936323|363459918|FG009|Phase 1 Dose Escalation|Death|0|||
105396023|NCT02936323|363459909|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105396024|NCT02936323|363459910|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105396025|NCT02936323|363459911|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105396026|NCT02936323|363459912|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105396027|NCT02936323|363459913|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105396028|NCT02936323|363459914|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
105396029|NCT02936323|363459915|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105396030|NCT02936323|363459916|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105396031|NCT02936323|363459917|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105396032|NCT02936323|363459918|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105396033|NCT02936323|363459909|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
105396034|NCT02936323|363459910|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
105396035|NCT02936323|363459911|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
105396036|NCT02936323|363459912|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
105396037|NCT02936323|363459913|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
105396038|NCT02936323|363459914|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
105396039|NCT02936323|363459915|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
105396040|NCT02936323|363459916|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
105396041|NCT02936323|363459917|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
105396042|NCT02936323|363459918|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
105396043|NCT02936323|363459909|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
105396044|NCT02936323|363459910|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
105396045|NCT02936323|363459911|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
105396046|NCT02936323|363459912|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
105396047|NCT02936323|363459913|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
105396048|NCT02936323|363459914|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
105396049|NCT02936323|363459915|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
105396050|NCT02936323|363459916|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
105396051|NCT02936323|363459917|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
105396052|NCT02936323|363459918|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
105396053|NCT02936323|363459909|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105396054|NCT02936323|363459910|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105396055|NCT02936323|363459911|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105396056|NCT02936323|363459912|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105396057|NCT02936323|363459913|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105396058|NCT02936323|363459914|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105493166|NCT04416633|363818795|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
105396059|NCT02936323|363459915|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105396060|NCT02936323|363459916|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
105396061|NCT02936323|363459917|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
105396062|NCT02936323|363459918|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105396063|NCT02936323|363459909|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105396064|NCT02936323|363459910|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105396065|NCT02936323|363459911|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105396066|NCT02936323|363459912|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105396067|NCT02936323|363459913|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105396068|NCT02936323|363459914|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105396069|NCT02936323|363459915|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105396070|NCT02936323|363459916|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105396071|NCT02936323|363459917|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105396072|NCT02936323|363459918|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
105396073|NCT02936323|363459909|FG000|Phase 2a Dose Expansion|Death|0|||
105396074|NCT02936323|363459910|FG001|Phase 2a Dose Expansion|Death|0|||
105396075|NCT02936323|363459911|FG002|Phase 2a Dose Expansion|Death|0|||
105396076|NCT02936323|363459912|FG003|Phase 2a Dose Expansion|Death|0|||
105396077|NCT02936323|363459913|FG004|Phase 2a Dose Expansion|Death|0|||
105396078|NCT02936323|363459914|FG005|Phase 2a Dose Expansion|Death|0|||
105396079|NCT02936323|363459915|FG006|Phase 2a Dose Expansion|Death|0|||
105396080|NCT02936323|363459916|FG007|Phase 2a Dose Expansion|Death|4|||
105396081|NCT02936323|363459917|FG008|Phase 2a Dose Expansion|Death|8|||
105396082|NCT02936323|363459918|FG009|Phase 2a Dose Expansion|Death|10|||
105396083|NCT02781558|363459919|FG000|Overall Study|Lost to Follow-up|2|||
105396084|NCT02781558|363459920|FG001|Overall Study|Lost to Follow-up|2|||
105396085|NCT02781558|363459919|FG000|Overall Study|Adverse Event|1|||
105396086|NCT02781558|363459920|FG001|Overall Study|Adverse Event|0|||
105396087|NCT00545779|363459927|FG000|Overall Study|Violation of selection criteria at entry|8|||
105396088|NCT00545779|363459927|FG000|Overall Study|Other protocol violation|1|||
105396089|NCT00545779|363459927|FG000|Overall Study|Did not cooperate|7|||
105396090|NCT00545779|363459927|FG000|Overall Study|Withdrawal by Subject|20|||
105396091|NCT00545779|363459927|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
105396092|NCT00545779|363459927|FG000|Overall Study|Failure to return|3|||
105396093|NCT03612570|363459928|FG000|Overall Study|Lost to Follow-up|1|||
105396094|NCT03984188|363459936|FG000|Overall Study|Death|2|||
105396095|NCT03984188|363459937|FG001|Overall Study|Death|4|||
105396096|NCT03984188|363459936|FG000|Overall Study|Physician Decision|0|||
105396097|NCT03984188|363459937|FG001|Overall Study|Physician Decision|2|||
105396098|NCT03984188|363459936|FG000|Overall Study|Lost to Follow-up|3|||
105396099|NCT03984188|363459937|FG001|Overall Study|Lost to Follow-up|2|||
105396100|NCT03984188|363459936|FG000|Overall Study|Withdrawal by Subject|6|||
105396101|NCT03984188|363459937|FG001|Overall Study|Withdrawal by Subject|0|||
105396102|NCT00003645|363460932|FG000|Overall Study|Death|4|||
105396103|NCT00003645|363460933|FG001|Overall Study|Death|1|||
105396104|NCT00003645|363460932|FG000|Overall Study|Lost to Follow-up|7|||
105396105|NCT00003645|363460933|FG001|Overall Study|Lost to Follow-up|8|||
105396106|NCT00003645|363460932|FG000|Overall Study|Withdrawal by Subject|1|||
105396107|NCT00003645|363460933|FG001|Overall Study|Withdrawal by Subject|3|||
105396108|NCT04490278|363460936|FG000|Overall Study|Lost to Follow-up|6|||
105396109|NCT00565747|363460946|FG000|Overall Study|No embryo transfer|67|||
105396110|NCT00565747|363460947|FG001|Overall Study|No embryo transfer|73|||
105396111|NCT00415636|363460948|FG000|Overall Study|Symptomatic deterioration|1|||
105396112|NCT00415636|363460949|FG001|Overall Study|Symptomatic deterioration|0|||
105396113|NCT00415636|363460950|FG002|Overall Study|Symptomatic deterioration|1|||
105396114|NCT00415636|363460951|FG003|Overall Study|Symptomatic deterioration|2|||
105396115|NCT00415636|363460952|FG004|Overall Study|Symptomatic deterioration|0|||
105396116|NCT00415636|363460953|FG005|Overall Study|Symptomatic deterioration|1|||
105396117|NCT00415636|363460948|FG000|Overall Study|Adverse Event|0|||
105396118|NCT00415636|363460949|FG001|Overall Study|Adverse Event|0|||
105396119|NCT00415636|363460950|FG002|Overall Study|Adverse Event|0|||
105396120|NCT00415636|363460951|FG003|Overall Study|Adverse Event|1|||
105396121|NCT00415636|363460952|FG004|Overall Study|Adverse Event|1|||
105396122|NCT00415636|363460953|FG005|Overall Study|Adverse Event|0|||
105396123|NCT00415636|363460948|FG000|Overall Study|Withdrawal by Subject|0|||
105396124|NCT00415636|363460949|FG001|Overall Study|Withdrawal by Subject|0|||
105396125|NCT00415636|363460950|FG002|Overall Study|Withdrawal by Subject|0|||
105396126|NCT00415636|363460951|FG003|Overall Study|Withdrawal by Subject|0|||
105396127|NCT00415636|363460952|FG004|Overall Study|Withdrawal by Subject|1|||
105396128|NCT00415636|363460953|FG005|Overall Study|Withdrawal by Subject|0|||
105396129|NCT00415636|363460948|FG000|Overall Study|Disease progression|0|||
105396130|NCT00415636|363460949|FG001|Overall Study|Disease progression|0|||
105396131|NCT00415636|363460950|FG002|Overall Study|Disease progression|0|||
105396132|NCT00415636|363460951|FG003|Overall Study|Disease progression|3|||
105396133|NCT00415636|363460952|FG004|Overall Study|Disease progression|0|||
105396134|NCT00415636|363460953|FG005|Overall Study|Disease progression|1|||
105396135|NCT02138825|363460954|FG000|Main Study Treatment|Adverse Event|11|||
105396136|NCT02138825|363460955|FG001|Main Study Treatment|Adverse Event|3|||
105396137|NCT02138825|363460954|FG000|Main Study Treatment|Death|1|||
105396138|NCT02138825|363460955|FG001|Main Study Treatment|Death|2|||
105396139|NCT02138825|363460954|FG000|Main Study Treatment|Protocol Violation|2|||
105396140|NCT02138825|363460955|FG001|Main Study Treatment|Protocol Violation|2|||
105396141|NCT02138825|363460954|FG000|Main Study Treatment|Sponsor decision|12|||
105396142|NCT02138825|363460955|FG001|Main Study Treatment|Sponsor decision|18|||
105396143|NCT02138825|363460954|FG000|Main Study Treatment|Study terminated by sponsor|10|||
105396144|NCT02138825|363460955|FG001|Main Study Treatment|Study terminated by sponsor|9|||
105396145|NCT02138825|363460954|FG000|Main Study Treatment|Withdrawal by Subject|3|||
105396146|NCT02138825|363460955|FG001|Main Study Treatment|Withdrawal by Subject|1|||
105396147|NCT02138825|363460954|FG000|Main Study Treatment|Medical decision|1|||
105396148|NCT02138825|363460955|FG001|Main Study Treatment|Medical decision|0|||
105396149|NCT02138825|363460954|FG000|Long-term Extension|Study termination by sponsor|32|||
105396150|NCT02138825|363460955|FG001|Long-term Extension|Study termination by sponsor|38|||
105396151|NCT02138825|363460954|FG000|Safety Follow-up|Adverse Event|4|||
105396152|NCT02138825|363460955|FG001|Safety Follow-up|Adverse Event|3|||
105396153|NCT02138825|363460954|FG000|Safety Follow-up|Death|11|||
105396154|NCT02138825|363460955|FG001|Safety Follow-up|Death|5|||
105396155|NCT02138825|363460954|FG000|Safety Follow-up|Withdrawal by Subject|5|||
105396156|NCT02138825|363460955|FG001|Safety Follow-up|Withdrawal by Subject|3|||
105396157|NCT02138825|363460954|FG000|Safety Follow-up|clinic worsening|1|||
105396158|NCT02138825|363460955|FG001|Safety Follow-up|clinic worsening|0|||
105396159|NCT02138825|363460954|FG000|Safety Follow-up|withdrawal by PI|1|||
105396160|NCT02138825|363460955|FG001|Safety Follow-up|withdrawal by PI|0|||
105396161|NCT02138825|363460954|FG000|Safety Follow-up|logistical difficulties|0|||
105396162|NCT02138825|363460955|FG001|Safety Follow-up|logistical difficulties|1|||
105396163|NCT02138825|363460954|FG000|Safety Follow-up|progressive disease|0|||
105396164|NCT02138825|363460955|FG001|Safety Follow-up|progressive disease|2|||
105396165|NCT02138825|363460954|FG000|Safety Follow-up|too unwell to attend the visit|0|||
105396166|NCT02138825|363460955|FG001|Safety Follow-up|too unwell to attend the visit|1|||
105396167|NCT02138825|363460954|FG000|Safety Follow-up|treatment unblinded|0|||
105396168|NCT02138825|363460955|FG001|Safety Follow-up|treatment unblinded|1|||
105396169|NCT02138825|363460954|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
105396170|NCT02138825|363460955|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
105396171|NCT01517984|363460957|FG000|Overall Study|Lost to Follow-up|0|||
105396172|NCT01517984|363460958|FG001|Overall Study|Lost to Follow-up|1|||
105396173|NCT01517984|363460959|FG002|Overall Study|Lost to Follow-up|0|||
105396174|NCT01517984|363460960|FG003|Overall Study|Lost to Follow-up|0|||
105396175|NCT01517984|363460957|FG000|Overall Study|Withdrawal by Subject|1|||
105396176|NCT01517984|363460958|FG001|Overall Study|Withdrawal by Subject|8|||
105396177|NCT01517984|363460959|FG002|Overall Study|Withdrawal by Subject|4|||
105396178|NCT01517984|363460960|FG003|Overall Study|Withdrawal by Subject|1|||
105396179|NCT01517984|363460957|FG000|Overall Study|Screen Failure|4|||
105396180|NCT01517984|363460958|FG001|Overall Study|Screen Failure|0|||
105396181|NCT01517984|363460959|FG002|Overall Study|Screen Failure|0|||
105396182|NCT01517984|363460960|FG003|Overall Study|Screen Failure|0|||
105396183|NCT01517984|363460957|FG000|Overall Study|Ineligible for randomization|0|||
105396184|NCT01517984|363460958|FG001|Overall Study|Ineligible for randomization|14|||
105396185|NCT01517984|363460959|FG002|Overall Study|Ineligible for randomization|0|||
105396186|NCT01517984|363460960|FG003|Overall Study|Ineligible for randomization|0|||
105396187|NCT05067335|363460961|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
105396188|NCT05067335|363460962|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
105396189|NCT05067335|363460963|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
105396190|NCT05067335|363460964|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
105396191|NCT05067335|363460961|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
105396192|NCT05067335|363460962|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
105396193|NCT05067335|363460963|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
105396194|NCT05067335|363460964|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
105396195|NCT05067335|363460961|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
105396196|NCT05067335|363460962|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
105396197|NCT05067335|363460963|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
105580594|NCT01809210|364126454|FG000|Overall Study|Withdrawal by Subject|0|||
105396198|NCT05067335|363460964|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
105396199|NCT05067335|363460961|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
105396200|NCT05067335|363460962|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
105396201|NCT05067335|363460963|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
105396202|NCT05067335|363460964|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
105396203|NCT05067335|363460961|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
105396204|NCT05067335|363460962|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
105396205|NCT05067335|363460963|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
105396206|NCT05067335|363460964|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
105396207|NCT05067335|363460961|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
105396208|NCT05067335|363460962|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
105396209|NCT05067335|363460963|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
105396210|NCT05067335|363460964|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
105396211|NCT05067335|363460961|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
105396212|NCT05067335|363460962|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
105396213|NCT05067335|363460963|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
105396214|NCT05067335|363460964|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
105396215|NCT05067335|363460961|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
105396216|NCT05067335|363460962|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
105396217|NCT05067335|363460963|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
105396218|NCT05067335|363460964|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
105396219|NCT05067335|363460961|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
105396220|NCT05067335|363460962|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
105396221|NCT05067335|363460963|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
105396222|NCT05067335|363460964|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
105396223|NCT05067335|363460961|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
105396224|NCT05067335|363460962|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
105396225|NCT05067335|363460963|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
105396226|NCT05067335|363460964|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
105396227|NCT02164864|363460965|FG000|Overall Study|Trial disease worsening|7|||
105396228|NCT02164864|363460966|FG001|Overall Study|Trial disease worsening|5|||
105396229|NCT02164864|363460967|FG002|Overall Study|Trial disease worsening|1|||
105396230|NCT02164864|363460965|FG000|Overall Study|Other pre-existing disease worsening|6|||
105396231|NCT02164864|363460966|FG001|Overall Study|Other pre-existing disease worsening|4|||
105396232|NCT02164864|363460967|FG002|Overall Study|Other pre-existing disease worsening|9|||
105396233|NCT02164864|363460965|FG000|Overall Study|Other Adverse Event (AE)|52|||
105396234|NCT02164864|363460966|FG001|Overall Study|Other Adverse Event (AE)|32|||
105396235|NCT02164864|363460967|FG002|Overall Study|Other Adverse Event (AE)|49|||
105396236|NCT02164864|363460965|FG000|Overall Study|Protocol Violation|2|||
105396237|NCT02164864|363460966|FG001|Overall Study|Protocol Violation|4|||
105396238|NCT02164864|363460967|FG002|Overall Study|Protocol Violation|1|||
105396239|NCT02164864|363460965|FG000|Overall Study|Lost to Follow-up|4|||
105396240|NCT02164864|363460966|FG001|Overall Study|Lost to Follow-up|3|||
105396241|NCT02164864|363460967|FG002|Overall Study|Lost to Follow-up|2|||
105396242|NCT02164864|363460965|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
105396243|NCT02164864|363460966|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
105396244|NCT02164864|363460967|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
105396245|NCT02164864|363460965|FG000|Overall Study|Other than stated|3|||
105396246|NCT02164864|363460966|FG001|Overall Study|Other than stated|4|||
105396247|NCT02164864|363460967|FG002|Overall Study|Other than stated|14|||
105396248|NCT00652834|363460968|FG000|Overall Study|Withdrawal by Subject|3|||
105396249|NCT00652834|363460968|FG000|Overall Study|Lost to Follow-up|2|||
105396250|NCT02434081|363460969|FG000|Overall Study|Death (never started treatment)|2|||
105396251|NCT02434081|363460969|FG000|Overall Study|Death|2|||
105396252|NCT02434081|363460969|FG000|Overall Study|Progression|20|||
105396253|NCT02434081|363460969|FG000|Overall Study|Adverse Event|20|||
105396254|NCT02434081|363460969|FG000|Overall Study|Physician Decision|2|||
105396255|NCT02434081|363460969|FG000|Overall Study|Withdrawal by Subject|1|||
105396256|NCT02434081|363460969|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
105396257|NCT00419744|363460970|FG000|Overall Study|Adverse Event|39|||
105396258|NCT00419744|363460971|FG001|Overall Study|Adverse Event|40|||
105396259|NCT00419744|363460972|FG002|Overall Study|Adverse Event|50|||
105396260|NCT00419744|363460970|FG000|Overall Study|Withdrawal by Subject|45|||
105396261|NCT00419744|363460971|FG001|Overall Study|Withdrawal by Subject|49|||
105396262|NCT00419744|363460972|FG002|Overall Study|Withdrawal by Subject|52|||
105396263|NCT00419744|363460970|FG000|Overall Study|Lost to Follow-up|8|||
105396264|NCT00419744|363460971|FG001|Overall Study|Lost to Follow-up|10|||
105396265|NCT00419744|363460972|FG002|Overall Study|Lost to Follow-up|6|||
105396266|NCT00419744|363460970|FG000|Overall Study|Protocol Violation|4|||
105396267|NCT00419744|363460971|FG001|Overall Study|Protocol Violation|7|||
105396268|NCT00419744|363460972|FG002|Overall Study|Protocol Violation|8|||
105396269|NCT00419744|363460970|FG000|Overall Study|Randomized in error|9|||
105396270|NCT00419744|363460971|FG001|Overall Study|Randomized in error|6|||
105396271|NCT00419744|363460972|FG002|Overall Study|Randomized in error|7|||
105396272|NCT00419744|363460970|FG000|Overall Study|Moving out of state|2|||
105396273|NCT00419744|363460971|FG001|Overall Study|Moving out of state|0|||
105396274|NCT00419744|363460972|FG002|Overall Study|Moving out of state|1|||
105396275|NCT00419744|363460970|FG000|Overall Study|Physician Decision|10|||
105396276|NCT00419744|363460971|FG001|Overall Study|Physician Decision|5|||
105396277|NCT00419744|363460972|FG002|Overall Study|Physician Decision|6|||
105396278|NCT00419744|363460970|FG000|Overall Study|Spirometry mouthpiece issues|0|||
105396279|NCT00419744|363460971|FG001|Overall Study|Spirometry mouthpiece issues|1|||
105396280|NCT00419744|363460972|FG002|Overall Study|Spirometry mouthpiece issues|2|||
105396281|NCT00419744|363460970|FG000|Overall Study|Incorrect medication kit dispensed|0|||
105396282|NCT00419744|363460971|FG001|Overall Study|Incorrect medication kit dispensed|0|||
105396283|NCT00419744|363460972|FG002|Overall Study|Incorrect medication kit dispensed|1|||
105396284|NCT00553254|363460975|FG000|Overall Study|Death|3|||
105396285|NCT00553254|363460976|FG001|Overall Study|Death|6|||
105396286|NCT00553254|363460977|FG002|Overall Study|Death|25|||
105396287|NCT00553254|363460975|FG000|Overall Study|Lost to Follow-up|0|||
105396288|NCT00553254|363460976|FG001|Overall Study|Lost to Follow-up|0|||
105396289|NCT00553254|363460977|FG002|Overall Study|Lost to Follow-up|2|||
105396290|NCT00553254|363460975|FG000|Overall Study|Withdrawal by Subject|2|||
105396291|NCT00553254|363460976|FG001|Overall Study|Withdrawal by Subject|0|||
105396292|NCT00553254|363460977|FG002|Overall Study|Withdrawal by Subject|2|||
105396293|NCT00553254|363460975|FG000|Overall Study|Study terminated by Sponsor|0|||
105396294|NCT00553254|363460976|FG001|Overall Study|Study terminated by Sponsor|0|||
105396295|NCT00553254|363460977|FG002|Overall Study|Study terminated by Sponsor|1|||
105396296|NCT00553254|363460975|FG000|Overall Study|Other|1|||
105396297|NCT00553254|363460976|FG001|Overall Study|Other|0|||
105396298|NCT00553254|363460977|FG002|Overall Study|Other|13|||
105396299|NCT01493414|363460978|FG000|Overall Study|Adverse Event|405|||
105396300|NCT01493414|363460978|FG000|Overall Study|Disease progression|204|||
105396301|NCT01493414|363460978|FG000|Overall Study|Death|101|||
105396302|NCT01493414|363460978|FG000|Overall Study|Physician Decision|93|||
105396303|NCT01493414|363460978|FG000|Overall Study|Withdrawal by Subject|79|||
105396304|NCT01493414|363460978|FG000|Overall Study|Protocol deviation|27|||
105396305|NCT01493414|363460978|FG000|Overall Study|Administrative problems|25|||
105396306|NCT01493414|363460978|FG000|Overall Study|Lost to Follow-up|16|||
105396307|NCT05448950|363460980|FG000|Overall Study|Death|2|||
105396308|NCT05448950|363460980|FG000|Overall Study|Withdrawal by Subject|1|||
105396309|NCT05448950|363460980|FG000|Overall Study|AVG abandoned|4|||
105396310|NCT00879398|363460985|FG000|Overall Study|Visit Stop|399|||
105396311|NCT00879398|363460985|FG000|Overall Study|Lack of Efficacy|64|||
105396312|NCT00879398|363460985|FG000|Overall Study|Adverse Event|41|||
105396313|NCT00879398|363460985|FG000|Overall Study|Other Reasons|171|||
105396314|NCT04803214|363460990|FG000|Overall Study|Adverse Event|1|||
105396315|NCT04803214|363460991|FG001|Overall Study|Adverse Event|0|||
105396316|NCT04803214|363460990|FG000|Overall Study|Withdrawal by Subject|1|||
105396317|NCT04803214|363460991|FG001|Overall Study|Withdrawal by Subject|2|||
105396318|NCT04803214|363460990|FG000|Overall Study|Lost to Follow-up|2|||
105396319|NCT04803214|363460991|FG001|Overall Study|Lost to Follow-up|4|||
105396320|NCT04803214|363460990|FG000|Overall Study|Physician Decision|1|||
105396321|NCT04803214|363460991|FG001|Overall Study|Physician Decision|1|||
105396322|NCT04803214|363460990|FG000|Overall Study|Missed 12 month visit|0|||
105396323|NCT04803214|363460991|FG001|Overall Study|Missed 12 month visit|3|||
105396324|NCT03189719|363460996|FG000|Overall Study|Death|325|||
105396325|NCT03189719|363460997|FG001|Overall Study|Death|361|||
105396326|NCT03189719|363460996|FG000|Overall Study|Physician Decision|1|||
105396327|NCT03189719|363460997|FG001|Overall Study|Physician Decision|0|||
105396328|NCT03189719|363460996|FG000|Overall Study|Sponsor Decision|40|||
105396329|NCT03189719|363460997|FG001|Overall Study|Sponsor Decision|12|||
105396330|NCT03189719|363460996|FG000|Overall Study|Withdrawal by Subject|7|||
105396331|NCT03189719|363460997|FG001|Overall Study|Withdrawal by Subject|3|||
105396332|NCT00643279|363461008|FG000|Overall Study|Death|13|||
105396333|NCT00643279|363461009|FG001|Overall Study|Death|11|||
105396334|NCT00643279|363461008|FG000|Overall Study|Withdrawal by Subject|3|||
105396335|NCT00643279|363461009|FG001|Overall Study|Withdrawal by Subject|0|||
105396336|NCT00643279|363461008|FG000|Overall Study|Lost to Follow-up|0|||
105396337|NCT00643279|363461009|FG001|Overall Study|Lost to Follow-up|1|||
105580595|NCT01809210|364126455|FG001|Overall Study|Withdrawal by Subject|0|||
105396338|NCT00643279|363461008|FG000|Overall Study|Physician Decision|0|||
105396339|NCT00643279|363461009|FG001|Overall Study|Physician Decision|1|||
105396340|NCT00404248|363461011|FG000|Overall Study|pts declining status|0|||
105396341|NCT00404248|363461012|FG001|Overall Study|pts declining status|1|||
105396342|NCT00404248|363461013|FG002|Overall Study|pts declining status|0|||
105396343|NCT00404248|363461014|FG003|Overall Study|pts declining status|0|||
105396344|NCT00404248|363461015|FG004|Overall Study|pts declining status|0|||
105396345|NCT00404248|363461016|FG005|Overall Study|pts declining status|0|||
105396346|NCT00404248|363461017|FG006|Overall Study|pts declining status|0|||
105396347|NCT00404248|363461018|FG007|Overall Study|pts declining status|0|||
105396348|NCT00404248|363461019|FG008|Overall Study|pts declining status|0|||
105396349|NCT00789555|363461020|FG000|Overall Study|Protocol Amendment|78|||
105396350|NCT00789555|363461021|FG001|Overall Study|Protocol Amendment|76|||
105396351|NCT00789555|363461022|FG002|Overall Study|Protocol Amendment|80|||
105396352|NCT00789555|363461020|FG000|Overall Study|Adverse Event|17|||
105396353|NCT00789555|363461021|FG001|Overall Study|Adverse Event|7|||
105396354|NCT00789555|363461022|FG002|Overall Study|Adverse Event|10|||
105396355|NCT00789555|363461020|FG000|Overall Study|Lost to Follow-up|9|||
105396356|NCT00789555|363461021|FG001|Overall Study|Lost to Follow-up|10|||
105396357|NCT00789555|363461022|FG002|Overall Study|Lost to Follow-up|18|||
105396358|NCT00789555|363461020|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
105396359|NCT00789555|363461021|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
105396360|NCT00789555|363461022|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
105396361|NCT00789555|363461020|FG000|Overall Study|Treatment failure|11|||
105396362|NCT00789555|363461021|FG001|Overall Study|Treatment failure|8|||
105396363|NCT00789555|363461022|FG002|Overall Study|Treatment failure|12|||
105396364|NCT00789555|363461020|FG000|Overall Study|Protocol Violation|6|||
105396365|NCT00789555|363461021|FG001|Overall Study|Protocol Violation|9|||
105396366|NCT00789555|363461022|FG002|Overall Study|Protocol Violation|13|||
105396367|NCT01405196|363461025|FG000|Overall Study|Study Terminated by Sponsor|0|||
105396368|NCT01405196|363461026|FG001|Overall Study|Study Terminated by Sponsor|0|||
105396369|NCT01405196|363461027|FG002|Overall Study|Study Terminated by Sponsor|9|||
105396370|NCT01405196|363461028|FG003|Overall Study|Study Terminated by Sponsor|0|||
105396371|NCT01405196|363461025|FG000|Overall Study|Other|2|||
105396372|NCT01405196|363461026|FG001|Overall Study|Other|2|||
105396373|NCT01405196|363461027|FG002|Overall Study|Other|5|||
105396374|NCT01405196|363461028|FG003|Overall Study|Other|0|||
105396375|NCT01405196|363461025|FG000|Overall Study|Withdrawal by Subject|4|||
105396376|NCT01405196|363461026|FG001|Overall Study|Withdrawal by Subject|6|||
105396377|NCT01405196|363461027|FG002|Overall Study|Withdrawal by Subject|3|||
105396378|NCT01405196|363461028|FG003|Overall Study|Withdrawal by Subject|6|||
105396379|NCT01405196|363461025|FG000|Overall Study|Adverse Event|2|||
105396380|NCT01405196|363461026|FG001|Overall Study|Adverse Event|2|||
105396381|NCT01405196|363461027|FG002|Overall Study|Adverse Event|0|||
105396382|NCT01405196|363461028|FG003|Overall Study|Adverse Event|2|||
105396383|NCT01405196|363461025|FG000|Overall Study|Death|1|||
105396384|NCT01405196|363461026|FG001|Overall Study|Death|0|||
105396385|NCT01405196|363461027|FG002|Overall Study|Death|3|||
105396386|NCT01405196|363461028|FG003|Overall Study|Death|0|||
105396387|NCT01405196|363461025|FG000|Overall Study|Lost to Follow-up|2|||
105396388|NCT01405196|363461026|FG001|Overall Study|Lost to Follow-up|2|||
105396389|NCT01405196|363461027|FG002|Overall Study|Lost to Follow-up|3|||
105396390|NCT01405196|363461028|FG003|Overall Study|Lost to Follow-up|1|||
105396391|NCT00698841|363461029|FG000|Overall Study|Withdrawal by Subject|2|||
105396392|NCT00698841|363461029|FG000|Overall Study|Adverse Event|3|||
105396393|NCT00698841|363461029|FG000|Overall Study|Disease progression|7|||
105396394|NCT00698841|363461029|FG000|Overall Study|Failure to meet eligibility criteria|2|||
105396395|NCT00698841|363461029|FG000|Overall Study|Study drug toxicity|2|||
105396396|NCT00698841|363461029|FG000|Overall Study|Other|2|||
105396397|NCT05929326|363461034|FG000|Overall Study|unqualified sample|2|||
105396398|NCT05929326|363461035|FG001|Overall Study|unqualified sample|3|||
105396399|NCT05929326|363461036|FG002|Overall Study|unqualified sample|7|||
105396400|NCT01994876|363461037|FG000|Test Period 1|Withdrawal by Subject|0|||
105396401|NCT01994876|363461038|FG001|Test Period 1|Withdrawal by Subject|1|||
105396402|NCT01994876|363461037|FG000|Test Period 1|Adverse Event|0|||
105396403|NCT01994876|363461038|FG001|Test Period 1|Adverse Event|1|||
105396404|NCT01994876|363461037|FG000|Test Period 2|Adverse Event|1|||
105396405|NCT01994876|363461038|FG001|Test Period 2|Adverse Event|0|||
105396406|NCT01994876|363461037|FG000|Test Period 2|Protocol Violation|0|||
105396407|NCT01994876|363461038|FG001|Test Period 2|Protocol Violation|1|||
105396408|NCT03586973|363461039|FG000|Overall Study|Death|15|||
105396409|NCT03586973|363461040|FG001|Overall Study|Death|8|||
105396410|NCT03586973|363461039|FG000|Overall Study|Site Terminated by Sponsor|3|||
105396411|NCT03586973|363461040|FG001|Overall Study|Site Terminated by Sponsor|6|||
105396412|NCT03586973|363461039|FG000|Overall Study|Withdrawal by Subject|1|||
105396413|NCT03586973|363461040|FG001|Overall Study|Withdrawal by Subject|0|||
105396414|NCT03586973|363461039|FG000|Overall Study|Lost to Follow-up|1|||
105396415|NCT03586973|363461040|FG001|Overall Study|Lost to Follow-up|0|||
105580596|NCT01809210|364126456|FG002|Overall Study|Withdrawal by Subject|1|||
105396416|NCT02661672|363461041|FG000|Overall Study|Lost to Follow-up|1|||
105396417|NCT02661672|363461041|FG000|Overall Study|Death|4|||
105396418|NCT01397253|363462140|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
105396419|NCT01397253|363462141|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
105396420|NCT00442702|363462144|FG000|Titration Period|Adverse Event|2|||
105396421|NCT00442702|363462145|FG001|Titration Period|Adverse Event|0|||
105396422|NCT00442702|363462144|FG000|Titration Period|Death|3|||
105396423|NCT00442702|363462145|FG001|Titration Period|Death|2|||
105396424|NCT00442702|363462144|FG000|Titration Period|Insufficient Therapeutic Response|1|||
105396425|NCT00442702|363462145|FG001|Titration Period|Insufficient Therapeutic Response|0|||
105396426|NCT00442702|363462144|FG000|Titration Period|Refused Treatment|4|||
105580597|NCT01809210|364126457|FG003|Overall Study|Withdrawal by Subject|1|||
105396427|NCT00442702|363462145|FG001|Titration Period|Refused Treatment|1|||
105396428|NCT00442702|363462144|FG000|Titration Period|Failure to return|1|||
105396429|NCT00442702|363462145|FG001|Titration Period|Failure to return|0|||
105396430|NCT00442702|363462144|FG000|Titration Period|Hospitalized in another hospital|1|||
105396431|NCT00442702|363462145|FG001|Titration Period|Hospitalized in another hospital|0|||
105396432|NCT00442702|363462144|FG000|Evaluation Period|Adverse Event|1|||
105396433|NCT00442702|363462145|FG001|Evaluation Period|Adverse Event|0|||
105396434|NCT00442702|363462144|FG000|Evaluation Period|Death|1|||
105396435|NCT00442702|363462145|FG001|Evaluation Period|Death|1|||
105396436|NCT00442702|363462144|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
105396437|NCT00442702|363462145|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
105396438|NCT00442702|363462144|FG000|Evaluation Period|Refused treatment|1|||
105396439|NCT00442702|363462145|FG001|Evaluation Period|Refused treatment|1|||
105396440|NCT00442702|363462144|FG000|Evaluation Period|Renal transplant|0|||
105396441|NCT00442702|363462145|FG001|Evaluation Period|Renal transplant|1|||
105396442|NCT00442702|363462144|FG000|Evaluation Period|Failure to return|1|||
105396443|NCT00442702|363462145|FG001|Evaluation Period|Failure to return|0|||
105396444|NCT00442702|363462144|FG000|Evaluation Period|Site closure|0|||
105396445|NCT00442702|363462145|FG001|Evaluation Period|Site closure|1|||
105396446|NCT00730327|363462146|FG000|Overall Study|Lost to Follow-up|14|||
105396447|NCT00730327|363462147|FG001|Overall Study|Lost to Follow-up|16|||
105396448|NCT00730327|363462146|FG000|Overall Study|Adverse Event|8|||
105396449|NCT00730327|363462147|FG001|Overall Study|Adverse Event|1|||
105396450|NCT00730327|363462146|FG000|Overall Study|Withdrawal by Subject|3|||
105396451|NCT00730327|363462147|FG001|Overall Study|Withdrawal by Subject|13|||
105396452|NCT00730327|363462146|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
105396453|NCT00730327|363462147|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
105396454|NCT02552225|363462148|FG000|Overall Study|Withdrawal by Subject|1|||
105396455|NCT02552225|363462149|FG001|Overall Study|Withdrawal by Subject|0|||
105396456|NCT01168596|363462153|FG000|Overall Study|Withdrawal by Subject|3|||
105396457|NCT01168596|363462154|FG001|Overall Study|Withdrawal by Subject|1|||
105396458|NCT02297516|363462157|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
105396459|NCT02297516|363462158|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
105396460|NCT02297516|363462157|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
105396461|NCT02297516|363462158|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
105396462|NCT02297516|363462157|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
105396463|NCT02297516|363462158|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
105396464|NCT04507204|363462159|FG000|Overall Study|Adverse Event|8|||
105396465|NCT04507204|363462160|FG001|Overall Study|Adverse Event|13|||
105396466|NCT04507204|363462159|FG000|Overall Study|Death|0|||
105396467|NCT04507204|363462160|FG001|Overall Study|Death|1|||
105396468|NCT04507204|363462159|FG000|Overall Study|Lost to Follow-up|15|||
105396469|NCT04507204|363462160|FG001|Overall Study|Lost to Follow-up|14|||
105396470|NCT04507204|363462159|FG000|Overall Study|Poor Compliance with Protocol|2|||
105396471|NCT04507204|363462160|FG001|Overall Study|Poor Compliance with Protocol|4|||
105396472|NCT04507204|363462159|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
105396473|NCT04507204|363462160|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
105396474|NCT04507204|363462159|FG000|Overall Study|Withdrawal of Patient Consent|21|||
105396475|NCT04507204|363462160|FG001|Overall Study|Withdrawal of Patient Consent|13|||
105396476|NCT01664624|363462161|FG000|Overall Study|Adverse Event|0|||
105396477|NCT01664624|363462162|FG001|Overall Study|Adverse Event|1|||
105396478|NCT01664624|363462163|FG002|Overall Study|Adverse Event|0|||
105396479|NCT01664624|363462164|FG003|Overall Study|Adverse Event|0|||
105396480|NCT03983421|363462168|FG000|Overall Study|Lost to Follow-up|1|||
105396481|NCT03386773|363462169|FG000|Overall Study|Lost to Follow-up|24|||
105396482|NCT03386773|363462170|FG001|Overall Study|Lost to Follow-up|33|||
105396483|NCT03386773|363462169|FG000|Overall Study|Withdrawal by Subject|3|||
105396484|NCT03386773|363462170|FG001|Overall Study|Withdrawal by Subject|2|||
105396485|NCT04573972|363462175|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
105396486|NCT04573972|363462176|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
105396487|NCT02724839|363462177|FG000|Overall Study|Withdrawal by Subject|1|||
105396488|NCT02724839|363462178|FG001|Overall Study|Withdrawal by Subject|1|||
105396489|NCT02724839|363462179|FG002|Overall Study|Withdrawal by Subject|0|||
105396490|NCT02724839|363462177|FG000|Overall Study|Lost to Follow-up|0|||
105396491|NCT02724839|363462178|FG001|Overall Study|Lost to Follow-up|3|||
105396492|NCT02724839|363462179|FG002|Overall Study|Lost to Follow-up|2|||
105396493|NCT02724839|363462177|FG000|Overall Study|Physician Decision|0|||
105396494|NCT02724839|363462178|FG001|Overall Study|Physician Decision|0|||
105396495|NCT02724839|363462179|FG002|Overall Study|Physician Decision|3|||
105396496|NCT01155050|363462181|FG000|Overall Study|Lost to Follow-up|15|||
105580598|NCT01809210|364126458|FG004|Overall Study|Withdrawal by Subject|1|||
105396497|NCT01155050|363462182|FG001|Overall Study|Lost to Follow-up|20|||
105396498|NCT01155050|363462183|FG002|Overall Study|Lost to Follow-up|19|||
105396499|NCT01155050|363462184|FG003|Overall Study|Lost to Follow-up|22|||
105396500|NCT01645176|363462185|FG000|Overall Study|Lack of Efficacy|4|||
105396501|NCT01645176|363462185|FG000|Overall Study|did not complete final MRI|1|||
105396502|NCT05878067|363462186|FG000|Overall Study|Lost to Follow-up|2|||
105396503|NCT02234362|363462187|FG000|Overall Study|Not eligible after first screening visit|17|||
105396504|NCT02234362|363462187|FG000|Overall Study|Lost to Follow-up|6|||
105396505|NCT02234362|363462187|FG000|Overall Study|Withdrawal by Subject|3|||
105396506|NCT00560417|363462188|FG000|Overall Study|Adverse Event|3|||
105396507|NCT00560417|363462189|FG001|Overall Study|Adverse Event|2|||
105396508|NCT00560417|363462188|FG000|Overall Study|Entry Criteria Not Met|1|||
105396509|NCT00560417|363462189|FG001|Overall Study|Entry Criteria Not Met|0|||
105396510|NCT00560417|363462188|FG000|Overall Study|Lost to Follow-up|0|||
105396511|NCT00560417|363462189|FG001|Overall Study|Lost to Follow-up|1|||
105396512|NCT00560417|363462188|FG000|Overall Study|Physician Decision|2|||
105396513|NCT00560417|363462189|FG001|Overall Study|Physician Decision|6|||
105396514|NCT00560417|363462188|FG000|Overall Study|Protocol Violation|6|||
105396515|NCT00560417|363462189|FG001|Overall Study|Protocol Violation|5|||
105396516|NCT00560417|363462188|FG000|Overall Study|Sponsor Decision|2|||
105396517|NCT00560417|363462189|FG001|Overall Study|Sponsor Decision|0|||
105396518|NCT00560417|363462188|FG000|Overall Study|Withdrawal by Subject|3|||
105396519|NCT00560417|363462189|FG001|Overall Study|Withdrawal by Subject|3|||
105396520|NCT00904371|363462192|FG000|Overall Study|Adverse Event|2|||
105396521|NCT00904371|363462192|FG000|Overall Study|Lost to Follow-up|4|||
105396522|NCT00904371|363462192|FG000|Overall Study|Discontinued at target blood pressure|2|||
105396523|NCT00904371|363462192|FG000|Overall Study|Continued with Tritace|1|||
105396524|NCT00261833|363462193|FG000|Overall Study|Death|1|||
105396525|NCT00261833|363462194|FG001|Overall Study|Death|3|||
105396526|NCT00261833|363462193|FG000|Overall Study|Adverse Event|1|||
105396527|NCT00261833|363462194|FG001|Overall Study|Adverse Event|4|||
105396528|NCT00261833|363462193|FG000|Overall Study|Withdrawal by Subject|5|||
105396529|NCT00261833|363462194|FG001|Overall Study|Withdrawal by Subject|7|||
105396530|NCT00261833|363462193|FG000|Overall Study|Protocol Violation|0|||
105396531|NCT00261833|363462194|FG001|Overall Study|Protocol Violation|1|||
105396532|NCT00261833|363462193|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
105396533|NCT00261833|363462194|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
105396534|NCT00261833|363462193|FG000|Overall Study|Lung transplantation|1|||
105396535|NCT00261833|363462194|FG001|Overall Study|Lung transplantation|1|||
105396536|NCT00261833|363462193|FG000|Overall Study|Missing reason|1|||
105396537|NCT00261833|363462194|FG001|Overall Study|Missing reason|0|||
105396538|NCT00261833|363462193|FG000|Overall Study|Not interested in being participant|0|||
105396539|NCT00261833|363462194|FG001|Overall Study|Not interested in being participant|1|||
105396540|NCT00622726|363462195|FG000|March, 2008 to August, 2010|Death|5|||
105396541|NCT00622726|363462196|FG001|March, 2008 to August, 2010|Death|2|||
105396542|NCT00622726|363462195|FG000|August, 2010 to April, 2013|Death|1|||
105396543|NCT00622726|363462196|FG001|August, 2010 to April, 2013|Death|5|||
105396544|NCT04476784|363462197|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
105396545|NCT04476784|363462198|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
105396546|NCT00335829|363462199|FG000|Overall Study|Withdrawal by Subject|1|||
105396547|NCT00335829|363462199|FG000|Overall Study|Lost to Follow-up|1|||
105396548|NCT00335829|363462199|FG000|Overall Study|Adverse Event|1|||
105396549|NCT02735200|363462200|FG000|Overall Study|Lost to Follow-up|0|||
105396550|NCT02735200|363462201|FG001|Overall Study|Lost to Follow-up|5|||
105396551|NCT02735200|363462200|FG000|Overall Study|Withdrawal by Subject|8|||
105396552|NCT02735200|363462201|FG001|Overall Study|Withdrawal by Subject|0|||
105396553|NCT00673920|363462204|FG000|Baseline up to Week 48|Withdrew consent|1|||
105396554|NCT00673920|363462205|FG001|Baseline up to Week 48|Withdrew consent|0|||
105396555|NCT00673920|363462206|FG002|Baseline up to Week 48|Withdrew consent|2|||
105396556|NCT00673920|363462207|FG003|Baseline up to Week 48|Withdrew consent|0|||
105396557|NCT00673920|363462208|FG004|Baseline up to Week 48|Withdrew consent|0|||
105396558|NCT00673920|363462209|FG005|Baseline up to Week 48|Withdrew consent|0|||
105396559|NCT00673920|363462210|FG006|Baseline up to Week 48|Withdrew consent|0|||
105396560|NCT00673920|363462211|FG007|Baseline up to Week 48|Withdrew consent|0|||
105396561|NCT00673920|363462204|FG000|Baseline up to Week 48|Refused treatment|1|||
105396562|NCT00673920|363462205|FG001|Baseline up to Week 48|Refused treatment|0|||
105396563|NCT00673920|363462206|FG002|Baseline up to Week 48|Refused treatment|0|||
105396564|NCT00673920|363462207|FG003|Baseline up to Week 48|Refused treatment|0|||
105396565|NCT00673920|363462208|FG004|Baseline up to Week 48|Refused treatment|0|||
105396566|NCT00673920|363462209|FG005|Baseline up to Week 48|Refused treatment|0|||
105396567|NCT00673920|363462210|FG006|Baseline up to Week 48|Refused treatment|0|||
105396568|NCT00673920|363462211|FG007|Baseline up to Week 48|Refused treatment|0|||
105396569|NCT00673920|363462204|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
105396570|NCT00673920|363462205|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
105396571|NCT00673920|363462206|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
105396572|NCT00673920|363462207|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
105396573|NCT00673920|363462208|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
105396574|NCT00673920|363462209|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
105396575|NCT00673920|363462210|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
105396576|NCT00673920|363462211|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
105396577|NCT00673920|363462204|FG000|Baseline up to Week 48|Protocol Violation|0|||
105396578|NCT00673920|363462205|FG001|Baseline up to Week 48|Protocol Violation|0|||
105396579|NCT00673920|363462206|FG002|Baseline up to Week 48|Protocol Violation|1|||
105396580|NCT00673920|363462207|FG003|Baseline up to Week 48|Protocol Violation|0|||
105493167|NCT04416633|363818795|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
105493168|NCT04416633|363818795|FG000|Overall Study|Adverse Event|6|||
105493169|NCT04416633|363818795|FG000|Overall Study|Withdrawal by Subject|6|||
105493170|NCT04612790|363818796|FG000|DB Period (Up to 36 Weeks)|Death|1|||
105493171|NCT04612790|363818797|FG001|DB Period (Up to 36 Weeks)|Death|1|||
105493172|NCT04612790|363818798|FG002|DB Period (Up to 36 Weeks)|Death|0|||
105396581|NCT00673920|363462208|FG004|Baseline up to Week 48|Protocol Violation|0|||
105396582|NCT00673920|363462209|FG005|Baseline up to Week 48|Protocol Violation|0|||
105396583|NCT00673920|363462210|FG006|Baseline up to Week 48|Protocol Violation|0|||
105396584|NCT00673920|363462211|FG007|Baseline up to Week 48|Protocol Violation|0|||
105396585|NCT00673920|363462204|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
105396586|NCT00673920|363462205|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
105396587|NCT00673920|363462206|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
105396588|NCT00673920|363462207|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
105396589|NCT00673920|363462208|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
105396590|NCT00673920|363462209|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
105396591|NCT00673920|363462210|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
105396592|NCT00673920|363462211|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
105396593|NCT00673920|363462204|FG000|Baseline up to Week 48|Administrative/Other|0|||
105396594|NCT00673920|363462205|FG001|Baseline up to Week 48|Administrative/Other|1|||
105396595|NCT00673920|363462206|FG002|Baseline up to Week 48|Administrative/Other|2|||
105396596|NCT00673920|363462207|FG003|Baseline up to Week 48|Administrative/Other|0|||
105396597|NCT00673920|363462208|FG004|Baseline up to Week 48|Administrative/Other|0|||
105396598|NCT00673920|363462209|FG005|Baseline up to Week 48|Administrative/Other|0|||
105396599|NCT00673920|363462210|FG006|Baseline up to Week 48|Administrative/Other|0|||
105396600|NCT00673920|363462211|FG007|Baseline up to Week 48|Administrative/Other|0|||
105396601|NCT00673920|363462204|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
105396602|NCT00673920|363462205|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
105396603|NCT00673920|363462206|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
105396604|NCT00673920|363462207|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
105396605|NCT00673920|363462208|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
105396606|NCT00673920|363462209|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
105396607|NCT00673920|363462210|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
105396608|NCT00673920|363462211|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
105396609|NCT00673920|363462204|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
105396610|NCT00673920|363462205|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
105396611|NCT00673920|363462206|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
105396612|NCT00673920|363462207|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
105396613|NCT00673920|363462208|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
105396614|NCT00673920|363462209|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
105396615|NCT00673920|363462210|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
105396616|NCT00673920|363462211|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
105396617|NCT00673920|363462204|FG000|Week 24 to Week 48|Failure to return|0|||
105396618|NCT00673920|363462205|FG001|Week 24 to Week 48|Failure to return|0|||
105396619|NCT00673920|363462206|FG002|Week 24 to Week 48|Failure to return|0|||
105396620|NCT00673920|363462207|FG003|Week 24 to Week 48|Failure to return|0|||
105396621|NCT00673920|363462208|FG004|Week 24 to Week 48|Failure to return|0|||
105396622|NCT00673920|363462209|FG005|Week 24 to Week 48|Failure to return|1|||
105396623|NCT00673920|363462210|FG006|Week 24 to Week 48|Failure to return|0|||
105396624|NCT00673920|363462211|FG007|Week 24 to Week 48|Failure to return|0|||
105396625|NCT00673920|363462204|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
105396626|NCT00673920|363462205|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
105396627|NCT00673920|363462206|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
105493173|NCT04612790|363818799|FG003|DB Period (Up to 36 Weeks)|Death|0|||
105396628|NCT00673920|363462207|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
105396629|NCT00673920|363462208|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
105396630|NCT00673920|363462209|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
105396631|NCT00673920|363462210|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
105396632|NCT00673920|363462211|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
105396633|NCT00673920|363462204|FG000|Week 24 to Week 48|Death|0|||
105493174|NCT04612790|363818796|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
105493175|NCT04612790|363818797|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
105493176|NCT04612790|363818798|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
105396634|NCT00673920|363462205|FG001|Week 24 to Week 48|Death|0|||
105396635|NCT00673920|363462206|FG002|Week 24 to Week 48|Death|0|||
105396636|NCT00673920|363462207|FG003|Week 24 to Week 48|Death|0|||
105396637|NCT00673920|363462208|FG004|Week 24 to Week 48|Death|0|||
105493177|NCT04612790|363818799|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
105493178|NCT04612790|363818796|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
105396638|NCT00673920|363462209|FG005|Week 24 to Week 48|Death|1|||
105396639|NCT00673920|363462210|FG006|Week 24 to Week 48|Death|0|||
105396640|NCT00673920|363462211|FG007|Week 24 to Week 48|Death|0|||
105396641|NCT00673920|363462204|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
105396642|NCT00673920|363462205|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
105396643|NCT00673920|363462206|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
105396644|NCT00673920|363462207|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
105396645|NCT00673920|363462208|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
105396646|NCT00673920|363462209|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
105396647|NCT00673920|363462210|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
105396648|NCT00673920|363462211|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
105396649|NCT04856527|363462212|FG000|Overall Study|Unable to complete experimental task|2|||
105396650|NCT04856527|363462213|FG001|Overall Study|Unable to complete experimental task|0|||
105396651|NCT01816295|363462214|FG000|Double Blind Phase|Adverse Event|11|||
105396652|NCT01816295|363462215|FG001|Double Blind Phase|Adverse Event|8|||
105396653|NCT01816295|363462214|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
105396654|NCT01816295|363462215|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
105396655|NCT01816295|363462214|FG000|Double Blind Phase|Lost to Follow-up|3|||
105396656|NCT01816295|363462215|FG001|Double Blind Phase|Lost to Follow-up|5|||
105396657|NCT01816295|363462214|FG000|Double Blind Phase|Physician Decision|2|||
105396658|NCT01816295|363462215|FG001|Double Blind Phase|Physician Decision|2|||
105396659|NCT01816295|363462214|FG000|Double Blind Phase|Protocol Violation|17|||
105396660|NCT01816295|363462215|FG001|Double Blind Phase|Protocol Violation|11|||
105396661|NCT01816295|363462214|FG000|Double Blind Phase|Sponsor Decision|8|||
105396662|NCT01816295|363462215|FG001|Double Blind Phase|Sponsor Decision|8|||
105396663|NCT01816295|363462214|FG000|Double Blind Phase|Withdrawal by Subject|22|||
105396664|NCT01816295|363462215|FG001|Double Blind Phase|Withdrawal by Subject|20|||
105396665|NCT01816295|363462214|FG000|OLE Phase|Adverse Event|17|||
105396666|NCT01816295|363462215|FG001|OLE Phase|Adverse Event|15|||
105396667|NCT01816295|363462214|FG000|OLE Phase|Death|1|||
105396668|NCT01816295|363462215|FG001|OLE Phase|Death|0|||
105396669|NCT01816295|363462214|FG000|OLE Phase|Entry Criteria Not Met|3|||
105396670|NCT01816295|363462215|FG001|OLE Phase|Entry Criteria Not Met|5|||
105396671|NCT01816295|363462214|FG000|OLE Phase|Lost to Follow-up|5|||
105396672|NCT01816295|363462215|FG001|OLE Phase|Lost to Follow-up|5|||
105396673|NCT01816295|363462214|FG000|OLE Phase|Physician Decision|3|||
105396674|NCT01816295|363462215|FG001|OLE Phase|Physician Decision|1|||
105396675|NCT01816295|363462214|FG000|OLE Phase|Protocol Violation|4|||
105396676|NCT01816295|363462215|FG001|OLE Phase|Protocol Violation|4|||
105396677|NCT01816295|363462214|FG000|OLE Phase|Sponsor Decision|7|||
105396678|NCT01816295|363462215|FG001|OLE Phase|Sponsor Decision|9|||
105396679|NCT01816295|363462214|FG000|OLE Phase|Withdrawal by Subject|10|||
105396680|NCT01816295|363462215|FG001|OLE Phase|Withdrawal by Subject|10|||
105396681|NCT01816295|363462214|FG000|OLE Phase|Lack of Efficacy|3|||
105396682|NCT01816295|363462215|FG001|OLE Phase|Lack of Efficacy|7|||
105396683|NCT01968980|363462221|FG000|Overall Study|Death|0|||
105396684|NCT01968980|363462222|FG001|Overall Study|Death|1|||
105396685|NCT01968980|363462221|FG000|Overall Study|Adverse Event|1|||
105396686|NCT01968980|363462222|FG001|Overall Study|Adverse Event|3|||
105396687|NCT01968980|363462221|FG000|Overall Study|Does not meet entry criteria|1|||
105396688|NCT01968980|363462222|FG001|Overall Study|Does not meet entry criteria|3|||
105396689|NCT01968980|363462221|FG000|Overall Study|Withdrawal by Subject|13|||
105396690|NCT01968980|363462222|FG001|Overall Study|Withdrawal by Subject|5|||
105396691|NCT01968980|363462221|FG000|Overall Study|Other unspecified|1|||
105396692|NCT01968980|363462222|FG001|Overall Study|Other unspecified|2|||
105396693|NCT01242514|363462226|FG000|Overall Study|e.g., project closure|1042|||
105396694|NCT01242514|363462227|FG001|Overall Study|e.g., project closure|305|||
105396695|NCT01242514|363462228|FG002|Overall Study|e.g., project closure|171|||
105396696|NCT01242514|363462226|FG000|Overall Study|Subject decision|33|||
105396697|NCT01242514|363462227|FG001|Overall Study|Subject decision|8|||
105396698|NCT01242514|363462228|FG002|Overall Study|Subject decision|2|||
105396699|NCT01242514|363462226|FG000|Overall Study|Severe non-compliance to protocol|5|||
105396700|NCT01242514|363462227|FG001|Overall Study|Severe non-compliance to protocol|2|||
105396701|NCT01242514|363462228|FG002|Overall Study|Severe non-compliance to protocol|1|||
105396702|NCT01242514|363462226|FG000|Overall Study|Lack of therapeutic response|99|||
105396703|NCT01242514|363462227|FG001|Overall Study|Lack of therapeutic response|16|||
105396704|NCT01242514|363462228|FG002|Overall Study|Lack of therapeutic response|10|||
105396705|NCT01242514|363462226|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
105396706|NCT01242514|363462227|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
105396707|NCT01242514|363462228|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
105396708|NCT01242514|363462226|FG000|Overall Study|Lost to Follow-up|14|||
105396709|NCT01242514|363462227|FG001|Overall Study|Lost to Follow-up|5|||
105396710|NCT01242514|363462228|FG002|Overall Study|Lost to Follow-up|4|||
105396711|NCT01242514|363462226|FG000|Overall Study|Adverse Event|129|||
105396712|NCT01242514|363462227|FG001|Overall Study|Adverse Event|18|||
105396713|NCT01242514|363462228|FG002|Overall Study|Adverse Event|19|||
105396714|NCT00862940|363462230|FG000|Overall Study|Adverse Event|15|||
105396715|NCT00862940|363462231|FG001|Overall Study|Adverse Event|12|||
105396716|NCT00862940|363462230|FG000|Overall Study|Lack of Efficacy|1|||
105396717|NCT00862940|363462231|FG001|Overall Study|Lack of Efficacy|3|||
105396718|NCT00862940|363462230|FG000|Overall Study|Protocol Violation|2|||
105396719|NCT00862940|363462231|FG001|Overall Study|Protocol Violation|5|||
105396720|NCT00862940|363462230|FG000|Overall Study|Withdrawal by Subject|4|||
105396721|NCT00862940|363462231|FG001|Overall Study|Withdrawal by Subject|6|||
105396722|NCT00862940|363462230|FG000|Overall Study|Non-compliance|4|||
105396723|NCT00862940|363462231|FG001|Overall Study|Non-compliance|0|||
105396724|NCT00862940|363462230|FG000|Overall Study|Lost to Follow-up|0|||
105396725|NCT00862940|363462231|FG001|Overall Study|Lost to Follow-up|1|||
105396726|NCT00862940|363462230|FG000|Overall Study|Administrative or other reason(s)|4|||
105396727|NCT00862940|363462231|FG001|Overall Study|Administrative or other reason(s)|3|||
105396728|NCT04549454|363462247|FG000|T1 to T2|Lost to Follow-up|22|||
105396729|NCT04549454|363462248|FG001|T1 to T2|Lost to Follow-up|26|||
105396730|NCT04549454|363462247|FG000|T1 to T3|Lost to Follow-up|31|||
105396731|NCT04549454|363462248|FG001|T1 to T3|Lost to Follow-up|36|||
105396732|NCT00867035|363462249|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
105396733|NCT00867035|363462250|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
105396734|NCT00867035|363462249|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
105396735|NCT00867035|363462250|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
105396736|NCT00016354|363462251|FG000|Overall Study|Lack of Efficacy|0|||
105396737|NCT00016354|363462252|FG001|Overall Study|Lack of Efficacy|0|||
105396738|NCT00016354|363462253|FG002|Overall Study|Lack of Efficacy|0|||
105396739|NCT00016354|363462254|FG003|Overall Study|Lack of Efficacy|0|||
105396740|NCT00016354|363462255|FG004|Overall Study|Lack of Efficacy|0|||
105396741|NCT00016354|363462256|FG005|Overall Study|Lack of Efficacy|0|||
105396742|NCT00016354|363462257|FG006|Overall Study|Lack of Efficacy|0|||
105396743|NCT00016354|363462258|FG007|Overall Study|Lack of Efficacy|1|||
105396744|NCT02993263|363462259|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
105396745|NCT04704193|363462260|FG000|Overall Study|Withdrawal by Subject|1|||
105396746|NCT00829998|363462261|FG000|Washout|Adverse Event|0|||
105396747|NCT00829998|363462262|FG001|Washout|Adverse Event|1|||
105396748|NCT05270863|363462265|FG000|Visit 2 First Intervention|Randomization error|0|||
105396749|NCT05270863|363462266|FG001|Visit 2 First Intervention|Randomization error|0|||
105396750|NCT05270863|363462267|FG002|Visit 2 First Intervention|Randomization error|0|||
105396751|NCT05270863|363462268|FG003|Visit 2 First Intervention|Randomization error|1|||
105396752|NCT05270863|363462269|FG004|Visit 2 First Intervention|Randomization error|0|||
105396753|NCT05270863|363462270|FG005|Visit 2 First Intervention|Randomization error|0|||
105396754|NCT05270863|363462265|FG000|First Washout|Withdrawal by Subject|0|||
105396755|NCT05270863|363462266|FG001|First Washout|Withdrawal by Subject|0|||
105396756|NCT05270863|363462267|FG002|First Washout|Withdrawal by Subject|0|||
105396757|NCT05270863|363462268|FG003|First Washout|Withdrawal by Subject|0|||
105396758|NCT05270863|363462269|FG004|First Washout|Withdrawal by Subject|1|||
105396759|NCT05270863|363462270|FG005|First Washout|Withdrawal by Subject|1|||
105396760|NCT05270863|363462265|FG000|First Washout|Lost to Follow-up|0|||
105396761|NCT05270863|363462266|FG001|First Washout|Lost to Follow-up|0|||
105396762|NCT05270863|363462267|FG002|First Washout|Lost to Follow-up|0|||
105396763|NCT05270863|363462268|FG003|First Washout|Lost to Follow-up|0|||
105396764|NCT05270863|363462269|FG004|First Washout|Lost to Follow-up|0|||
105396765|NCT05270863|363462270|FG005|First Washout|Lost to Follow-up|1|||
105396766|NCT05270863|363462265|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
105396767|NCT05270863|363462266|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
105396768|NCT05270863|363462267|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
105396769|NCT05270863|363462268|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
105396770|NCT05270863|363462269|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
105396771|NCT05270863|363462270|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
105396772|NCT05270863|363462265|FG000|Second Washout|Withdrawal by Subject|1|||
105396773|NCT05270863|363462266|FG001|Second Washout|Withdrawal by Subject|1|||
105396774|NCT05270863|363462267|FG002|Second Washout|Withdrawal by Subject|0|||
105396775|NCT05270863|363462268|FG003|Second Washout|Withdrawal by Subject|0|||
105396776|NCT05270863|363462269|FG004|Second Washout|Withdrawal by Subject|0|||
105396777|NCT05270863|363462270|FG005|Second Washout|Withdrawal by Subject|0|||
105396778|NCT05270863|363462265|FG000|Second Washout|Lost to Follow-up|0|||
105396779|NCT05270863|363462266|FG001|Second Washout|Lost to Follow-up|0|||
105396780|NCT05270863|363462267|FG002|Second Washout|Lost to Follow-up|0|||
105396781|NCT05270863|363462268|FG003|Second Washout|Lost to Follow-up|1|||
105396782|NCT05270863|363462269|FG004|Second Washout|Lost to Follow-up|0|||
105396783|NCT05270863|363462270|FG005|Second Washout|Lost to Follow-up|0|||
105396784|NCT04712669|363462271|FG000|Double Blind Phase|Adverse Event|4|||
105396785|NCT04712669|363462272|FG001|Double Blind Phase|Adverse Event|4|||
105396786|NCT04712669|363462273|FG002|Double Blind Phase|Adverse Event|3|||
105396787|NCT04712669|363462274|FG003|Double Blind Phase|Adverse Event|0|||
105493179|NCT04612790|363818797|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
105493180|NCT04612790|363818798|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
105396788|NCT04712669|363462275|FG004|Double Blind Phase|Adverse Event|0|||
105396789|NCT04712669|363462276|FG005|Double Blind Phase|Adverse Event|0|||
105493181|NCT04612790|363818799|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
105396790|NCT04712669|363462277|FG006|Double Blind Phase|Adverse Event|0|||
105396791|NCT04712669|363462278|FG007|Double Blind Phase|Adverse Event|0|||
105396792|NCT04712669|363462271|FG000|Double Blind Phase|Physician Decision|1|||
105396793|NCT04712669|363462272|FG001|Double Blind Phase|Physician Decision|0|||
105396794|NCT04712669|363462273|FG002|Double Blind Phase|Physician Decision|0|||
105396795|NCT04712669|363462274|FG003|Double Blind Phase|Physician Decision|0|||
105396796|NCT04712669|363462275|FG004|Double Blind Phase|Physician Decision|0|||
105396797|NCT04712669|363462276|FG005|Double Blind Phase|Physician Decision|0|||
105396798|NCT04712669|363462277|FG006|Double Blind Phase|Physician Decision|0|||
105396799|NCT04712669|363462278|FG007|Double Blind Phase|Physician Decision|0|||
105396800|NCT04712669|363462271|FG000|Double Blind Phase|Withdrawal by Subject|3|||
105396801|NCT04712669|363462272|FG001|Double Blind Phase|Withdrawal by Subject|6|||
105396802|NCT04712669|363462273|FG002|Double Blind Phase|Withdrawal by Subject|0|||
105396803|NCT04712669|363462274|FG003|Double Blind Phase|Withdrawal by Subject|0|||
105396804|NCT04712669|363462275|FG004|Double Blind Phase|Withdrawal by Subject|0|||
105396805|NCT04712669|363462276|FG005|Double Blind Phase|Withdrawal by Subject|0|||
105396806|NCT04712669|363462277|FG006|Double Blind Phase|Withdrawal by Subject|0|||
105396807|NCT04712669|363462278|FG007|Double Blind Phase|Withdrawal by Subject|0|||
105396808|NCT04712669|363462271|FG000|Double Blind Phase|Termination by Sponsor|0|||
105396809|NCT04712669|363462272|FG001|Double Blind Phase|Termination by Sponsor|0|||
105396810|NCT04712669|363462273|FG002|Double Blind Phase|Termination by Sponsor|1|||
105396811|NCT04712669|363462274|FG003|Double Blind Phase|Termination by Sponsor|0|||
105396812|NCT04712669|363462275|FG004|Double Blind Phase|Termination by Sponsor|0|||
105396813|NCT04712669|363462276|FG005|Double Blind Phase|Termination by Sponsor|0|||
105396814|NCT04712669|363462277|FG006|Double Blind Phase|Termination by Sponsor|0|||
105396815|NCT04712669|363462278|FG007|Double Blind Phase|Termination by Sponsor|0|||
105396816|NCT04712669|363462271|FG000|Open Label Phase|Adverse Event|0|||
105396817|NCT04712669|363462272|FG001|Open Label Phase|Adverse Event|0|||
105396818|NCT04712669|363462273|FG002|Open Label Phase|Adverse Event|0|||
105396819|NCT04712669|363462274|FG003|Open Label Phase|Adverse Event|1|||
105396820|NCT04712669|363462275|FG004|Open Label Phase|Adverse Event|1|||
105396821|NCT04712669|363462276|FG005|Open Label Phase|Adverse Event|3|||
105396822|NCT04712669|363462277|FG006|Open Label Phase|Adverse Event|1|||
105396823|NCT04712669|363462278|FG007|Open Label Phase|Adverse Event|2|||
105396824|NCT04712669|363462271|FG000|Open Label Phase|Death|0|||
105396825|NCT04712669|363462272|FG001|Open Label Phase|Death|0|||
105396826|NCT04712669|363462273|FG002|Open Label Phase|Death|0|||
105396827|NCT04712669|363462274|FG003|Open Label Phase|Death|1|||
105396828|NCT04712669|363462275|FG004|Open Label Phase|Death|0|||
105396829|NCT04712669|363462276|FG005|Open Label Phase|Death|0|||
105396830|NCT04712669|363462277|FG006|Open Label Phase|Death|0|||
105396831|NCT04712669|363462278|FG007|Open Label Phase|Death|0|||
105396832|NCT04712669|363462271|FG000|Open Label Phase|Lack of Efficacy|0|||
105396833|NCT04712669|363462272|FG001|Open Label Phase|Lack of Efficacy|0|||
105396834|NCT04712669|363462273|FG002|Open Label Phase|Lack of Efficacy|0|||
105396835|NCT04712669|363462274|FG003|Open Label Phase|Lack of Efficacy|0|||
105396836|NCT04712669|363462275|FG004|Open Label Phase|Lack of Efficacy|1|||
105396837|NCT04712669|363462276|FG005|Open Label Phase|Lack of Efficacy|0|||
105396838|NCT04712669|363462277|FG006|Open Label Phase|Lack of Efficacy|0|||
105396839|NCT04712669|363462278|FG007|Open Label Phase|Lack of Efficacy|0|||
105396840|NCT04712669|363462271|FG000|Open Label Phase|Lost to Follow-up|0|||
105396841|NCT04712669|363462272|FG001|Open Label Phase|Lost to Follow-up|0|||
105396842|NCT04712669|363462273|FG002|Open Label Phase|Lost to Follow-up|0|||
105396843|NCT04712669|363462274|FG003|Open Label Phase|Lost to Follow-up|0|||
105396844|NCT04712669|363462275|FG004|Open Label Phase|Lost to Follow-up|0|||
105396845|NCT04712669|363462276|FG005|Open Label Phase|Lost to Follow-up|0|||
105396846|NCT04712669|363462277|FG006|Open Label Phase|Lost to Follow-up|1|||
105396847|NCT04712669|363462278|FG007|Open Label Phase|Lost to Follow-up|1|||
105396848|NCT04712669|363462271|FG000|Open Label Phase|Physician Decision|0|||
105396849|NCT04712669|363462272|FG001|Open Label Phase|Physician Decision|0|||
105396850|NCT04712669|363462273|FG002|Open Label Phase|Physician Decision|0|||
105396851|NCT04712669|363462274|FG003|Open Label Phase|Physician Decision|1|||
105396852|NCT04712669|363462275|FG004|Open Label Phase|Physician Decision|0|||
105396853|NCT04712669|363462276|FG005|Open Label Phase|Physician Decision|0|||
105396854|NCT04712669|363462277|FG006|Open Label Phase|Physician Decision|0|||
105396855|NCT04712669|363462278|FG007|Open Label Phase|Physician Decision|0|||
105396856|NCT04712669|363462271|FG000|Open Label Phase|Withdrawal by Subject|0|||
105396857|NCT04712669|363462272|FG001|Open Label Phase|Withdrawal by Subject|0|||
105396858|NCT04712669|363462273|FG002|Open Label Phase|Withdrawal by Subject|0|||
105396859|NCT04712669|363462274|FG003|Open Label Phase|Withdrawal by Subject|1|||
105396860|NCT04712669|363462275|FG004|Open Label Phase|Withdrawal by Subject|5|||
105396861|NCT04712669|363462276|FG005|Open Label Phase|Withdrawal by Subject|5|||
105396862|NCT04712669|363462277|FG006|Open Label Phase|Withdrawal by Subject|0|||
105396863|NCT04712669|363462278|FG007|Open Label Phase|Withdrawal by Subject|4|||
105396864|NCT04712669|363462271|FG000|Open Label Phase|Termination by Sponsor|0|||
105396865|NCT04712669|363462272|FG001|Open Label Phase|Termination by Sponsor|0|||
105396866|NCT04712669|363462273|FG002|Open Label Phase|Termination by Sponsor|0|||
105396867|NCT04712669|363462274|FG003|Open Label Phase|Termination by Sponsor|11|||
105396868|NCT04712669|363462275|FG004|Open Label Phase|Termination by Sponsor|9|||
105396869|NCT04712669|363462276|FG005|Open Label Phase|Termination by Sponsor|14|||
105396870|NCT04712669|363462277|FG006|Open Label Phase|Termination by Sponsor|0|||
105396871|NCT04712669|363462278|FG007|Open Label Phase|Termination by Sponsor|14|||
105396872|NCT04464473|363462279|FG000|Overall Study|New piercing could not be removed for scanning|0|||
105396873|NCT04464473|363462280|FG001|Overall Study|New piercing could not be removed for scanning|0|||
105396874|NCT04464473|363462281|FG002|Overall Study|New piercing could not be removed for scanning|0|||
105396875|NCT04464473|363462282|FG003|Overall Study|New piercing could not be removed for scanning|1|||
105396876|NCT04464473|363462283|FG004|Overall Study|New piercing could not be removed for scanning|0|||
105396877|NCT04464473|363462284|FG005|Overall Study|New piercing could not be removed for scanning|0|||
105396878|NCT04464473|363462279|FG000|Overall Study|Adverse Event|0|||
105396879|NCT04464473|363462280|FG001|Overall Study|Adverse Event|0|||
105396880|NCT04464473|363462281|FG002|Overall Study|Adverse Event|0|||
105396881|NCT04464473|363462282|FG003|Overall Study|Adverse Event|1|||
105396882|NCT04464473|363462283|FG004|Overall Study|Adverse Event|0|||
105396883|NCT04464473|363462284|FG005|Overall Study|Adverse Event|0|||
105396884|NCT04464473|363462279|FG000|Overall Study|Lost to Follow-up|0|||
105396885|NCT04464473|363462280|FG001|Overall Study|Lost to Follow-up|0|||
105396886|NCT04464473|363462281|FG002|Overall Study|Lost to Follow-up|0|||
105396887|NCT04464473|363462282|FG003|Overall Study|Lost to Follow-up|1|||
105396888|NCT04464473|363462283|FG004|Overall Study|Lost to Follow-up|0|||
105396889|NCT04464473|363462284|FG005|Overall Study|Lost to Follow-up|0|||
105396890|NCT03802396|363462285|FG000|Overall Study|Withdrawal by Subject|2|||
105396891|NCT03802396|363462286|FG001|Overall Study|Withdrawal by Subject|0|||
105396892|NCT03802396|363462285|FG000|Overall Study|Surgery Cancelled|1|||
105396893|NCT03802396|363462286|FG001|Overall Study|Surgery Cancelled|0|||
105396894|NCT00791648|363464147|FG000|Overall Study|Physician Decision|0|||
105396895|NCT00791648|363464148|FG001|Overall Study|Physician Decision|1|||
105396896|NCT00791648|363464147|FG000|Overall Study|Withdrawal by Subject|0|||
105396897|NCT00791648|363464148|FG001|Overall Study|Withdrawal by Subject|1|||
105396898|NCT00462826|363464149|FG000|Overall Study|Ineligible - second primary|1|||
105396899|NCT00462826|363464149|FG000|Overall Study|Ineligible - wrong cell type|1|||
105439949|NCT01618695|363616638|FG000|Extension Phase|Lack of Efficacy|17|||
105396900|NCT00462826|363464149|FG000|Overall Study|Ineligible - wrong primary|2|||
105396901|NCT00462826|363464149|FG000|Overall Study|Never treated|1|||
105396902|NCT04976777|363464150|FG000|Overall Study|COVID-19 Infection|1|||
105396903|NCT04976777|363464151|FG001|Overall Study|COVID-19 Infection|0|||
105396904|NCT01657370|363464152|FG000|Overall Study|Withdrawal by Subject|0|||
105396905|NCT01657370|363464153|FG001|Overall Study|Withdrawal by Subject|0|||
105396906|NCT01657370|363464154|FG002|Overall Study|Withdrawal by Subject|1|||
105396907|NCT01657370|363464155|FG003|Overall Study|Withdrawal by Subject|0|||
105396908|NCT01657370|363464156|FG004|Overall Study|Withdrawal by Subject|0|||
105396909|NCT01657370|363464157|FG005|Overall Study|Withdrawal by Subject|1|||
105396910|NCT01657370|363464152|FG000|Overall Study|Physician Decision|2|||
105396911|NCT01657370|363464153|FG001|Overall Study|Physician Decision|3|||
105396912|NCT01657370|363464154|FG002|Overall Study|Physician Decision|1|||
105396913|NCT01657370|363464155|FG003|Overall Study|Physician Decision|2|||
105396914|NCT01657370|363464156|FG004|Overall Study|Physician Decision|5|||
105396915|NCT01657370|363464157|FG005|Overall Study|Physician Decision|0|||
105396916|NCT01657370|363464152|FG000|Overall Study|Lack of Qualifying Event|1|||
105396917|NCT01657370|363464153|FG001|Overall Study|Lack of Qualifying Event|0|||
105396918|NCT01657370|363464154|FG002|Overall Study|Lack of Qualifying Event|3|||
105396919|NCT01657370|363464155|FG003|Overall Study|Lack of Qualifying Event|2|||
105396920|NCT01657370|363464156|FG004|Overall Study|Lack of Qualifying Event|1|||
105396921|NCT01657370|363464157|FG005|Overall Study|Lack of Qualifying Event|2|||
105396922|NCT01657370|363464152|FG000|Overall Study|Adverse Event|0|||
105396923|NCT01657370|363464153|FG001|Overall Study|Adverse Event|0|||
105396924|NCT01657370|363464154|FG002|Overall Study|Adverse Event|0|||
105396925|NCT01657370|363464155|FG003|Overall Study|Adverse Event|0|||
105396926|NCT01657370|363464156|FG004|Overall Study|Adverse Event|1|||
105396927|NCT01657370|363464157|FG005|Overall Study|Adverse Event|0|||
105396928|NCT01657370|363464152|FG000|Overall Study|Protocol Violation|1|||
105396929|NCT01657370|363464153|FG001|Overall Study|Protocol Violation|1|||
105396930|NCT01657370|363464154|FG002|Overall Study|Protocol Violation|1|||
105396931|NCT01657370|363464155|FG003|Overall Study|Protocol Violation|1|||
105396932|NCT01657370|363464156|FG004|Overall Study|Protocol Violation|0|||
105396933|NCT01657370|363464157|FG005|Overall Study|Protocol Violation|0|||
105396934|NCT01657370|363464152|FG000|Overall Study|Lost to Follow-up|2|||
105396935|NCT01657370|363464153|FG001|Overall Study|Lost to Follow-up|0|||
105396936|NCT01657370|363464154|FG002|Overall Study|Lost to Follow-up|1|||
105396937|NCT01657370|363464155|FG003|Overall Study|Lost to Follow-up|0|||
105396938|NCT01657370|363464156|FG004|Overall Study|Lost to Follow-up|0|||
105396939|NCT01657370|363464157|FG005|Overall Study|Lost to Follow-up|1|||
105396940|NCT04795531|363464158|FG000|Overall Study|Withdrawal by Subject|4|||
105396941|NCT04795531|363464159|FG001|Overall Study|Withdrawal by Subject|4|||
105396942|NCT04795531|363464158|FG000|Overall Study|Lost to Follow-up|0|||
105396943|NCT04795531|363464159|FG001|Overall Study|Lost to Follow-up|1|||
105396944|NCT04795531|363464158|FG000|Overall Study|Physician Decision|0|||
105396945|NCT04795531|363464159|FG001|Overall Study|Physician Decision|2|||
105396946|NCT04795531|363464158|FG000|Overall Study|Death|2|||
105396947|NCT04795531|363464159|FG001|Overall Study|Death|1|||
105396948|NCT04043286|363464160|FG000|Overall Study|Withdrawal by Subject|2|||
105396949|NCT04043286|363464161|FG001|Overall Study|Withdrawal by Subject|2|||
105396950|NCT01164007|363464168|FG000|Overall Study|Adverse Event|5|||
105396951|NCT01164007|363464168|FG000|Overall Study|Progression of Disease|30|||
105396952|NCT01164007|363464168|FG000|Overall Study|Protocol Violation|1|||
105396953|NCT01164007|363464168|FG000|Overall Study|Withdrawal by Subject|1|||
105396954|NCT01164007|363464168|FG000|Overall Study|Medical Decision|3|||
105396955|NCT02300233|363464169|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
105396956|NCT02300233|363464170|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
105396957|NCT02300233|363464171|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
105396958|NCT02300233|363464169|FG000|Overall Study|Withdrawal by Subject|1|||
105396959|NCT02300233|363464170|FG001|Overall Study|Withdrawal by Subject|0|||
105396960|NCT02300233|363464171|FG002|Overall Study|Withdrawal by Subject|3|||
105396961|NCT02300233|363464169|FG000|Overall Study|Investigator Judgement|0|||
105396962|NCT02300233|363464170|FG001|Overall Study|Investigator Judgement|0|||
105396963|NCT02300233|363464171|FG002|Overall Study|Investigator Judgement|1|||
105396964|NCT02300233|363464169|FG000|Overall Study|Reason Not Specified|0|||
105396965|NCT02300233|363464170|FG001|Overall Study|Reason Not Specified|0|||
105396966|NCT02300233|363464171|FG002|Overall Study|Reason Not Specified|5|||
105396967|NCT02519842|363464172|FG000|Base Study: Cycle 1|Screening Failure|1|||
105396968|NCT02519842|363464173|FG001|Base Study: Cycle 1|Screening Failure|1|||
105396969|NCT02519842|363464174|FG002|Base Study: Cycle 1|Screening Failure|0|||
105396970|NCT02519842|363464172|FG000|Base Study: Cycle 1|Adverse Event|1|||
105396971|NCT02519842|363464173|FG001|Base Study: Cycle 1|Adverse Event|0|||
105396972|NCT02519842|363464174|FG002|Base Study: Cycle 1|Adverse Event|0|||
105396973|NCT02519842|363464172|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
105396974|NCT02519842|363464173|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
105396975|NCT02519842|363464174|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
105396976|NCT02519842|363464172|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
105396977|NCT02519842|363464173|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
105396978|NCT02519842|363464174|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
105396979|NCT02519842|363464172|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
105396980|NCT02519842|363464173|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
105396981|NCT02519842|363464174|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
105396982|NCT02519842|363464172|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
105396983|NCT02519842|363464173|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
105396984|NCT02519842|363464174|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
105396985|NCT02519842|363464172|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
105396986|NCT02519842|363464173|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
105396987|NCT02519842|363464174|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
105396988|NCT02519842|363464172|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
105396989|NCT02519842|363464173|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
105396990|NCT02519842|363464174|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
105396991|NCT02519842|363464172|FG000|Optional Extension: Cycles 2-6|Death|0|||
105396992|NCT02519842|363464173|FG001|Optional Extension: Cycles 2-6|Death|0|||
105396993|NCT02519842|363464174|FG002|Optional Extension: Cycles 2-6|Death|1|||
105396994|NCT02519842|363464172|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
105396995|NCT02519842|363464173|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
105396996|NCT02519842|363464174|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
105396997|NCT02519842|363464172|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
105396998|NCT02519842|363464173|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
105396999|NCT02519842|363464174|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
105397000|NCT02519842|363464172|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
105397001|NCT02519842|363464173|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
105397002|NCT02519842|363464174|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
105397003|NCT02519842|363464172|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
105397004|NCT02519842|363464173|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
105397005|NCT02519842|363464174|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
105397006|NCT01561976|363464176|FG000|Period 1|Adverse Event|0|||
105397007|NCT01561976|363464177|FG001|Period 1|Adverse Event|0|||
105397008|NCT01561976|363464178|FG002|Period 1|Adverse Event|1|||
105397009|NCT01561976|363464179|FG003|Period 1|Adverse Event|0|||
105397010|NCT01561976|363464180|FG004|Period 1|Adverse Event|0|||
105397011|NCT01561976|363464181|FG005|Period 1|Adverse Event|0|||
105397012|NCT01561976|363464176|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
105397013|NCT01561976|363464177|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
105397014|NCT01561976|363464178|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
105397015|NCT01561976|363464179|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
105397016|NCT01561976|363464180|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
105397017|NCT01561976|363464181|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
105397018|NCT01561976|363464176|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105397019|NCT01561976|363464177|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105397020|NCT01561976|363464178|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105397021|NCT01561976|363464179|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105397022|NCT01561976|363464180|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105397023|NCT01561976|363464181|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
105397024|NCT01561976|363464176|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
105397025|NCT01561976|363464177|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
105397026|NCT01561976|363464178|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
105397027|NCT01561976|363464179|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
105397028|NCT01561976|363464180|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
105397029|NCT01561976|363464181|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
105397030|NCT05136170|363464182|FG000|Overall Study|Withdrawal by Subject|2|||
105397031|NCT05136170|363464183|FG001|Overall Study|Withdrawal by Subject|2|||
105397032|NCT05136170|363464182|FG000|Overall Study|Can no longer make office visits|1|||
105397033|NCT05136170|363464183|FG001|Overall Study|Can no longer make office visits|0|||
105397034|NCT02836249|363464184|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
105397035|NCT02836249|363464185|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
105397036|NCT02836249|363464186|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
105397037|NCT02836249|363464187|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
105397038|NCT02836249|363464184|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
105397039|NCT02836249|363464185|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
105397040|NCT02836249|363464186|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
105397041|NCT02836249|363464187|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
105493182|NCT04612790|363818796|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
105493183|NCT04612790|363818797|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
105493184|NCT04612790|363818798|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
105397042|NCT02836249|363464184|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
105397043|NCT02836249|363464185|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
105397044|NCT02836249|363464186|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
105397045|NCT02836249|363464187|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
105397046|NCT02836249|363464184|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105397047|NCT02836249|363464185|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
105397048|NCT02836249|363464186|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105397049|NCT02836249|363464187|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105397050|NCT02836249|363464184|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
105397051|NCT02836249|363464185|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
105397052|NCT02836249|363464186|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
105397053|NCT02836249|363464187|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
105397054|NCT02836249|363464184|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
105397055|NCT02836249|363464185|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
105397056|NCT02836249|363464186|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
105397057|NCT02836249|363464187|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
105397058|NCT02836249|363464184|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
105397059|NCT02836249|363464185|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
105397060|NCT02836249|363464186|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
105397061|NCT02836249|363464187|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
105397062|NCT02836249|363464184|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
105397063|NCT02836249|363464185|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
105397064|NCT02836249|363464186|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
105397065|NCT02836249|363464187|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
105397066|NCT02836249|363464184|FG000|Open-Label TAF Treatment Phase|Death|0|||
105397067|NCT02836249|363464185|FG001|Open-Label TAF Treatment Phase|Death|0|||
105397068|NCT02836249|363464186|FG002|Open-Label TAF Treatment Phase|Death|1|||
105397069|NCT02836249|363464187|FG003|Open-Label TAF Treatment Phase|Death|0|||
105397070|NCT02836249|363464184|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
105397071|NCT02836249|363464185|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
105397072|NCT02836249|363464186|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
105397073|NCT02836249|363464187|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
105397074|NCT02836249|363464184|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
105397075|NCT02836249|363464185|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
105397076|NCT02836249|363464186|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
105397077|NCT02836249|363464187|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
105397078|NCT02921256|363464201|FG000|Arm 1a v. Arm II|Adverse Event|6|||
105397079|NCT02921256|363464202|FG001|Arm 1a v. Arm II|Adverse Event|15|||
105397080|NCT02921256|363464203|FG002|Arm 1a v. Arm II|Adverse Event|0|||
105397081|NCT02921256|363464201|FG000|Arm 1a v. Arm II|Death|0|||
105397082|NCT02921256|363464202|FG001|Arm 1a v. Arm II|Death|2|||
105397083|NCT02921256|363464203|FG002|Arm 1a v. Arm II|Death|0|||
105397084|NCT02921256|363464201|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
105397085|NCT02921256|363464202|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
105397086|NCT02921256|363464203|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
105397087|NCT02921256|363464201|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
105397088|NCT02921256|363464202|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
105397089|NCT02921256|363464203|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
105397090|NCT02921256|363464201|FG000|Arm 1a v. Arm II|Physician Decision|1|||
105397091|NCT02921256|363464202|FG001|Arm 1a v. Arm II|Physician Decision|1|||
105397092|NCT02921256|363464203|FG002|Arm 1a v. Arm II|Physician Decision|0|||
105397093|NCT02921256|363464201|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
105397094|NCT02921256|363464202|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
105397095|NCT02921256|363464203|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
105397096|NCT02921256|363464201|FG000|Arm Ib v Arm III|Adverse Event|9|||
105397097|NCT02921256|363464202|FG001|Arm Ib v Arm III|Adverse Event|0|||
105397098|NCT02921256|363464203|FG002|Arm Ib v Arm III|Adverse Event|4|||
105397099|NCT02921256|363464201|FG000|Arm Ib v Arm III|Death|1|||
105397100|NCT02921256|363464202|FG001|Arm Ib v Arm III|Death|0|||
105397101|NCT02921256|363464203|FG002|Arm Ib v Arm III|Death|1|||
105397102|NCT02921256|363464201|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
105397103|NCT02921256|363464202|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
105397104|NCT02921256|363464203|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
105397105|NCT02921256|363464201|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
105397106|NCT02921256|363464202|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
105397107|NCT02921256|363464203|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
105397108|NCT02921256|363464201|FG000|Arm Ib v Arm III|Physician Decision|4|||
105397109|NCT02921256|363464202|FG001|Arm Ib v Arm III|Physician Decision|0|||
105580599|NCT01809210|364126459|FG005|Overall Study|Withdrawal by Subject|0|||
105580600|NCT01809210|364126460|FG006|Overall Study|Withdrawal by Subject|4|||
105397110|NCT02921256|363464203|FG002|Arm Ib v Arm III|Physician Decision|1|||
105397111|NCT02921256|363464201|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
105397112|NCT02921256|363464202|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
105397113|NCT02921256|363464203|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
105397114|NCT01448616|363464204|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
105397115|NCT01448616|363464205|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
105397116|NCT01448616|363464206|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
105397117|NCT01448616|363464207|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
105397118|NCT01448616|363464204|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
105397119|NCT01448616|363464205|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
105397120|NCT01448616|363464206|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
105397121|NCT01448616|363464207|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
105397122|NCT01448616|363464204|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
105397123|NCT01448616|363464205|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
105397124|NCT01448616|363464206|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
105397125|NCT01448616|363464207|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
105397126|NCT01448616|363464204|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
105397127|NCT01448616|363464205|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
105397128|NCT01448616|363464206|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
105397129|NCT01448616|363464207|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
105397130|NCT01448616|363464204|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
105397131|NCT01448616|363464205|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
105397132|NCT01448616|363464206|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
105397133|NCT01448616|363464207|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
105580601|NCT01809210|364126454|FG000|Overall Study|Death|1|||
105397134|NCT00760552|363464214|FG000|Overall Study|Death|2|||
105397135|NCT00760552|363464215|FG001|Overall Study|Death|0|||
105397136|NCT00760552|363464214|FG000|Overall Study|Lost to Follow-up|11|||
105397137|NCT00760552|363464215|FG001|Overall Study|Lost to Follow-up|10|||
105397138|NCT02943473|363464216|FG000|Overall Study|enrolled but not dosed|1|||
105397139|NCT02943473|363464216|FG000|Overall Study|screen failure|1|||
105397140|NCT02943473|363464216|FG000|Overall Study|Physician Decision|4|||
105397141|NCT01143402|363464217|FG000|Overall Study|Rapid clinical decline|1|||
105397142|NCT01143402|363464218|FG001|Overall Study|Rapid clinical decline|1|||
105397143|NCT01143402|363464219|FG002|Overall Study|Rapid clinical decline|0|||
105397144|NCT01143402|363464217|FG000|Overall Study|Not Treated|0|||
105397145|NCT01143402|363464218|FG001|Overall Study|Not Treated|0|||
105397146|NCT01143402|363464219|FG002|Overall Study|Not Treated|1|||
105397147|NCT00431964|363464220|FG000|Overall Study|Adverse Event|1|||
105397148|NCT00431964|363464221|FG001|Overall Study|Adverse Event|0|||
105397149|NCT00431964|363464220|FG000|Overall Study|Lost to Follow-up|1|||
105397150|NCT00431964|363464221|FG001|Overall Study|Lost to Follow-up|2|||
105397151|NCT00431964|363464220|FG000|Overall Study|Physician Decision|2|||
105397152|NCT00431964|363464221|FG001|Overall Study|Physician Decision|2|||
105493185|NCT04612790|363818799|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
105493186|NCT04612790|363818796|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
105493187|NCT04612790|363818797|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
105493188|NCT04612790|363818798|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
105493189|NCT04612790|363818799|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
105493190|NCT04612790|363818796|FG000|DB Period (Up to 36 Weeks)|Other|1|||
105397153|NCT00431964|363464220|FG000|Overall Study|Withdrawal by Subject|2|||
105397154|NCT00431964|363464221|FG001|Overall Study|Withdrawal by Subject|1|||
105397155|NCT00431964|363464220|FG000|Overall Study|Parental Consent Withdrawn|0|||
105397156|NCT00431964|363464221|FG001|Overall Study|Parental Consent Withdrawn|2|||
105397157|NCT00431964|363464220|FG000|Overall Study|Due to Unstable Health|0|||
105397158|NCT00431964|363464221|FG001|Overall Study|Due to Unstable Health|1|||
105397159|NCT04211363|363464222|FG000|Overall Study|Adverse Event|5|||
105397160|NCT04211363|363464223|FG001|Overall Study|Adverse Event|2|||
105397161|NCT04211363|363464222|FG000|Overall Study|Physician Decision|0|||
105397162|NCT04211363|363464223|FG001|Overall Study|Physician Decision|1|||
105397163|NCT04211363|363464222|FG000|Overall Study|Protocol Violation|1|||
105397164|NCT04211363|363464223|FG001|Overall Study|Protocol Violation|0|||
105397165|NCT04211363|363464222|FG000|Overall Study|Pregnancy|1|||
105397166|NCT04211363|363464223|FG001|Overall Study|Pregnancy|0|||
105397167|NCT04211363|363464222|FG000|Overall Study|Lost to Follow-up|12|||
105397168|NCT04211363|363464223|FG001|Overall Study|Lost to Follow-up|4|||
105397169|NCT04211363|363464222|FG000|Overall Study|Withdrawal by Subject|11|||
105397170|NCT04211363|363464223|FG001|Overall Study|Withdrawal by Subject|11|||
105397171|NCT04211363|363464222|FG000|Overall Study|Other|1|||
105397172|NCT04211363|363464223|FG001|Overall Study|Other|2|||
105397173|NCT03434834|363464224|FG000|Overall Study|unable to swallow OCT probe|16|||
105397174|NCT01736917|363464229|FG000|Overall Study|Adverse Event|1|||
105397175|NCT01736917|363464229|FG000|Overall Study|Protocol Violation|10|||
105397176|NCT01911260|363464230|FG000|Supplementation Period|transference or evasion of school|7|||
105397177|NCT01911260|363464231|FG001|Supplementation Period|transference or evasion of school|9|||
105397178|NCT01911260|363464232|FG002|Supplementation Period|transference or evasion of school|7|||
105397179|NCT01911260|363464233|FG003|Supplementation Period|transference or evasion of school|6|||
105397180|NCT01911260|363464230|FG000|Supplementation Period|Adverse Event|2|||
105397181|NCT01911260|363464231|FG001|Supplementation Period|Adverse Event|0|||
105397182|NCT01911260|363464232|FG002|Supplementation Period|Adverse Event|1|||
105397183|NCT01911260|363464233|FG003|Supplementation Period|Adverse Event|0|||
105397184|NCT01911260|363464230|FG000|Supplementation Period|refused to receive supplement|1|||
105397185|NCT01911260|363464231|FG001|Supplementation Period|refused to receive supplement|0|||
105397186|NCT01911260|363464232|FG002|Supplementation Period|refused to receive supplement|1|||
105397187|NCT01911260|363464233|FG003|Supplementation Period|refused to receive supplement|0|||
105397188|NCT01911260|363464230|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
105397189|NCT01911260|363464231|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
105397190|NCT01911260|363464232|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
105397191|NCT01911260|363464233|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
105397192|NCT01911260|363464230|FG000|Follow-up Period|transference or evasion of school|13|||
105397193|NCT01911260|363464231|FG001|Follow-up Period|transference or evasion of school|20|||
105397194|NCT01911260|363464232|FG002|Follow-up Period|transference or evasion of school|15|||
105397195|NCT01911260|363464233|FG003|Follow-up Period|transference or evasion of school|12|||
105397196|NCT01656161|363464241|FG000|Overall Study|Death|3|||
105397197|NCT01656161|363464241|FG000|Overall Study|Adverse Event|2|||
105397198|NCT01656161|363464241|FG000|Overall Study|Protocol Violation|1|||
105397199|NCT01656161|363464241|FG000|Overall Study|Withdrawal by Subject|1|||
105397200|NCT01696643|363464245|FG000|Overall Study|Adverse Event|15|||
105397201|NCT01696643|363464246|FG001|Overall Study|Adverse Event|7|||
105397202|NCT01696643|363464245|FG000|Overall Study|Death|1|||
105397203|NCT01696643|363464246|FG001|Overall Study|Death|2|||
105397204|NCT01696643|363464245|FG000|Overall Study|Lack of Efficacy|3|||
105397205|NCT01696643|363464246|FG001|Overall Study|Lack of Efficacy|0|||
105397206|NCT01696643|363464245|FG000|Overall Study|Lost to Follow-up|67|||
105397207|NCT01696643|363464246|FG001|Overall Study|Lost to Follow-up|67|||
105397208|NCT01696643|363464245|FG000|Overall Study|Physician Decision|3|||
105397209|NCT01696643|363464246|FG001|Overall Study|Physician Decision|2|||
105397210|NCT01696643|363464245|FG000|Overall Study|Pregnancy|0|||
105397211|NCT01696643|363464246|FG001|Overall Study|Pregnancy|1|||
105397212|NCT01696643|363464245|FG000|Overall Study|Protocol Violation|7|||
105397213|NCT01696643|363464246|FG001|Overall Study|Protocol Violation|7|||
105397214|NCT01696643|363464245|FG000|Overall Study|Study Terminated by Sponsor|286|||
105397215|NCT01696643|363464246|FG001|Overall Study|Study Terminated by Sponsor|294|||
105397216|NCT01696643|363464245|FG000|Overall Study|Withdrawal by Subject|142|||
105397217|NCT01696643|363464246|FG001|Overall Study|Withdrawal by Subject|149|||
105397218|NCT01696643|363464245|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
105397219|NCT01696643|363464246|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
105397220|NCT01696643|363464245|FG000|Overall Study|Site Error|2|||
105397221|NCT01696643|363464246|FG001|Overall Study|Site Error|1|||
105397222|NCT01696643|363464245|FG000|Overall Study|Participant Incarcerated|0|||
105397223|NCT01696643|363464246|FG001|Overall Study|Participant Incarcerated|1|||
105397224|NCT01696643|363464245|FG000|Overall Study|Medical Monitor Decision|0|||
105397225|NCT01696643|363464246|FG001|Overall Study|Medical Monitor Decision|2|||
105397226|NCT01696643|363464245|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
105397227|NCT01696643|363464246|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
105397228|NCT01215851|363464248|FG000|Treatment Period|Adverse Event|1|||
105397229|NCT01215851|363464249|FG001|Treatment Period|Adverse Event|1|||
105397230|NCT01215851|363464250|FG002|Treatment Period|Adverse Event|1|||
105397231|NCT01215851|363464251|FG003|Treatment Period|Adverse Event|3|||
105397232|NCT01215851|363464252|FG004|Treatment Period|Adverse Event|0|||
105397233|NCT01215851|363464253|FG005|Treatment Period|Adverse Event|1|||
105397234|NCT01215851|363464248|FG000|Follow up Period|Lost to Follow-up|0|||
105397235|NCT01215851|363464249|FG001|Follow up Period|Lost to Follow-up|0|||
105397236|NCT01215851|363464250|FG002|Follow up Period|Lost to Follow-up|0|||
105397237|NCT01215851|363464251|FG003|Follow up Period|Lost to Follow-up|0|||
105397238|NCT01215851|363464252|FG004|Follow up Period|Lost to Follow-up|0|||
105397239|NCT01215851|363464253|FG005|Follow up Period|Lost to Follow-up|1|||
105397240|NCT00485173|363464262|FG000|Overall Study|Death|4|||
105397241|NCT00485173|363464263|FG001|Overall Study|Death|3|||
105397242|NCT00485173|363464262|FG000|Overall Study|Lost to Follow-up|32|||
105397243|NCT00485173|363464263|FG001|Overall Study|Lost to Follow-up|61|||
105397244|NCT00746811|363464264|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
105397245|NCT00746811|363464265|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
105397246|NCT04881760|363464266|FG000|Overall Study|Adverse Event|0|||
105397247|NCT04881760|363464267|FG001|Overall Study|Adverse Event|1|||
105397248|NCT04881760|363464268|FG002|Overall Study|Adverse Event|1|||
105397249|NCT04881760|363464269|FG003|Overall Study|Adverse Event|0|||
105397250|NCT04881760|363464270|FG004|Overall Study|Adverse Event|1|||
105397251|NCT04881760|363464271|FG005|Overall Study|Adverse Event|1|||
105397252|NCT04881760|363464272|FG006|Overall Study|Adverse Event|2|||
105397253|NCT04881760|363464266|FG000|Overall Study|Death|0|||
105397254|NCT04881760|363464267|FG001|Overall Study|Death|0|||
105397255|NCT04881760|363464268|FG002|Overall Study|Death|0|||
105397256|NCT04881760|363464269|FG003|Overall Study|Death|1|||
105397257|NCT04881760|363464270|FG004|Overall Study|Death|0|||
105397258|NCT04881760|363464271|FG005|Overall Study|Death|0|||
105397259|NCT04881760|363464272|FG006|Overall Study|Death|0|||
105397260|NCT04881760|363464266|FG000|Overall Study|Lost to Follow-up|5|||
105397261|NCT04881760|363464267|FG001|Overall Study|Lost to Follow-up|7|||
105397262|NCT04881760|363464268|FG002|Overall Study|Lost to Follow-up|5|||
105397263|NCT04881760|363464269|FG003|Overall Study|Lost to Follow-up|1|||
105397264|NCT04881760|363464270|FG004|Overall Study|Lost to Follow-up|2|||
105397265|NCT04881760|363464271|FG005|Overall Study|Lost to Follow-up|4|||
105397266|NCT04881760|363464272|FG006|Overall Study|Lost to Follow-up|4|||
105397267|NCT04881760|363464266|FG000|Overall Study|Withdrawal by Subject|13|||
105397268|NCT04881760|363464267|FG001|Overall Study|Withdrawal by Subject|1|||
105397269|NCT04881760|363464268|FG002|Overall Study|Withdrawal by Subject|1|||
105397270|NCT04881760|363464269|FG003|Overall Study|Withdrawal by Subject|4|||
105397271|NCT04881760|363464270|FG004|Overall Study|Withdrawal by Subject|2|||
105397272|NCT04881760|363464271|FG005|Overall Study|Withdrawal by Subject|1|||
105397273|NCT04881760|363464272|FG006|Overall Study|Withdrawal by Subject|2|||
105397274|NCT04881760|363464266|FG000|Overall Study|Randomized but Never Treated|0|||
105397275|NCT04881760|363464267|FG001|Overall Study|Randomized but Never Treated|0|||
105397276|NCT04881760|363464268|FG002|Overall Study|Randomized but Never Treated|0|||
105397277|NCT04881760|363464269|FG003|Overall Study|Randomized but Never Treated|1|||
105397278|NCT04881760|363464270|FG004|Overall Study|Randomized but Never Treated|0|||
105397279|NCT04881760|363464271|FG005|Overall Study|Randomized but Never Treated|0|||
105397280|NCT04881760|363464272|FG006|Overall Study|Randomized but Never Treated|0|||
105397281|NCT04881760|363464266|FG000|Overall Study|Inadvertent Enrollment|2|||
105397282|NCT04881760|363464267|FG001|Overall Study|Inadvertent Enrollment|0|||
105397283|NCT04881760|363464268|FG002|Overall Study|Inadvertent Enrollment|0|||
105397284|NCT04881760|363464269|FG003|Overall Study|Inadvertent Enrollment|0|||
105397285|NCT04881760|363464270|FG004|Overall Study|Inadvertent Enrollment|0|||
105397286|NCT04881760|363464271|FG005|Overall Study|Inadvertent Enrollment|0|||
105397287|NCT04881760|363464272|FG006|Overall Study|Inadvertent Enrollment|0|||
105397288|NCT04881760|363464266|FG000|Overall Study|Site Closure|0|||
105397289|NCT04881760|363464267|FG001|Overall Study|Site Closure|0|||
105397290|NCT04881760|363464268|FG002|Overall Study|Site Closure|0|||
105397291|NCT04881760|363464269|FG003|Overall Study|Site Closure|1|||
105397292|NCT04881760|363464270|FG004|Overall Study|Site Closure|0|||
105397293|NCT04881760|363464271|FG005|Overall Study|Site Closure|0|||
105397294|NCT04881760|363464272|FG006|Overall Study|Site Closure|0|||
105397295|NCT01849276|363464273|FG000|Followed for Survival for 5 Years|Death|1|||
105397296|NCT01849276|363464273|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
105397297|NCT01538199|363464274|FG000|Overall Study|Lost to Follow-up|1|||
105397298|NCT01538199|363464275|FG001|Overall Study|Lost to Follow-up|2|||
105397299|NCT01538199|363464276|FG002|Overall Study|Lost to Follow-up|1|||
105397300|NCT01538199|363464277|FG003|Overall Study|Lost to Follow-up|0|||
105397301|NCT01538199|363464274|FG000|Overall Study|participant did not have time|1|||
105397302|NCT01538199|363464275|FG001|Overall Study|participant did not have time|0|||
105397303|NCT01538199|363464276|FG002|Overall Study|participant did not have time|0|||
105397304|NCT01538199|363464277|FG003|Overall Study|participant did not have time|2|||
105397305|NCT01538199|363464274|FG000|Overall Study|Lack of Efficacy|0|||
105397306|NCT01538199|363464275|FG001|Overall Study|Lack of Efficacy|1|||
105397307|NCT01538199|363464276|FG002|Overall Study|Lack of Efficacy|0|||
105397308|NCT01538199|363464277|FG003|Overall Study|Lack of Efficacy|0|||
105397309|NCT02081586|363464278|FG000|Overall Study|Lost to Follow-up|0|||
105397310|NCT02081586|363464279|FG001|Overall Study|Lost to Follow-up|1|||
105397311|NCT02081586|363464280|FG002|Overall Study|Lost to Follow-up|0|||
105397312|NCT02081586|363464281|FG003|Overall Study|Lost to Follow-up|1|||
105397313|NCT02081586|363464278|FG000|Overall Study|Head injury not related to study|0|||
105397314|NCT02081586|363464279|FG001|Overall Study|Head injury not related to study|0|||
105397315|NCT02081586|363464280|FG002|Overall Study|Head injury not related to study|1|||
105397316|NCT02081586|363464281|FG003|Overall Study|Head injury not related to study|0|||
105397317|NCT03770286|363464292|FG000|Overall Study|Lost to Follow-up|6|||
105397318|NCT03770286|363464293|FG001|Overall Study|Lost to Follow-up|4|||
105397319|NCT03770286|363464294|FG002|Overall Study|Lost to Follow-up|3|||
105397320|NCT03770286|363464292|FG000|Overall Study|Protocol Violation|1|||
105397321|NCT03770286|363464293|FG001|Overall Study|Protocol Violation|0|||
105397322|NCT03770286|363464294|FG002|Overall Study|Protocol Violation|2|||
105397323|NCT02297412|363464295|FG000|Overall Study|Canceled|1|||
105397324|NCT02297412|363464296|FG001|Overall Study|Canceled|1|||
105397325|NCT02031302|363464297|FG000|Overall Study|Death|115|||
105397326|NCT02031302|363464298|FG001|Overall Study|Death|0|||
105397327|NCT02031302|363464297|FG000|Overall Study|Not treated with study valve system|18|||
105397328|NCT02031302|363464298|FG001|Overall Study|Not treated with study valve system|0|||
105397329|NCT02031302|363464297|FG000|Overall Study|Missed Follow Up|27|||
105397330|NCT02031302|363464298|FG001|Overall Study|Missed Follow Up|0|||
105397331|NCT02031302|363464297|FG000|Overall Study|Lost to Follow-up|4|||
105397332|NCT02031302|363464298|FG001|Overall Study|Lost to Follow-up|0|||
105397333|NCT03950856|363464308|FG000|Overall Study|Death|1|||
105397334|NCT03950856|363464309|FG001|Overall Study|Death|2|||
105397335|NCT03950856|363464310|FG002|Overall Study|Death|0|||
105397336|NCT03950856|363464311|FG003|Overall Study|Death|0|||
105397337|NCT03950856|363464308|FG000|Overall Study|Lost to Follow-up|5|||
105397338|NCT03950856|363464309|FG001|Overall Study|Lost to Follow-up|6|||
105397339|NCT03950856|363464310|FG002|Overall Study|Lost to Follow-up|8|||
105397340|NCT03950856|363464311|FG003|Overall Study|Lost to Follow-up|2|||
105397341|NCT03950856|363464308|FG000|Overall Study|Protocol Violation|2|||
105397342|NCT03950856|363464309|FG001|Overall Study|Protocol Violation|0|||
105397343|NCT03950856|363464310|FG002|Overall Study|Protocol Violation|0|||
105397344|NCT03950856|363464311|FG003|Overall Study|Protocol Violation|1|||
105397345|NCT03950856|363464308|FG000|Overall Study|Withdrawal by Subject|4|||
105397346|NCT03950856|363464309|FG001|Overall Study|Withdrawal by Subject|1|||
105397347|NCT03950856|363464310|FG002|Overall Study|Withdrawal by Subject|3|||
105397348|NCT03950856|363464311|FG003|Overall Study|Withdrawal by Subject|1|||
105397349|NCT03950856|363464308|FG000|Overall Study|Unable to phone|7|||
105397350|NCT03950856|363464309|FG001|Overall Study|Unable to phone|6|||
105397351|NCT03950856|363464310|FG002|Overall Study|Unable to phone|7|||
105397352|NCT03950856|363464311|FG003|Overall Study|Unable to phone|2|||
105397353|NCT05899829|363464314|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
105397354|NCT05899829|363464315|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
105397355|NCT05899829|363464314|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
105397356|NCT05899829|363464315|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
105397357|NCT05788991|363464318|FG000|Overall Study|Not treated with study medication|1|||
105493191|NCT04612790|363818797|FG001|DB Period (Up to 36 Weeks)|Other|0|||
105493192|NCT04612790|363818798|FG002|DB Period (Up to 36 Weeks)|Other|0|||
105493193|NCT04612790|363818799|FG003|DB Period (Up to 36 Weeks)|Other|0|||
105397358|NCT05788991|363464319|FG001|Overall Study|Not treated with study medication|3|||
105397359|NCT05788991|363464318|FG000|Overall Study|Withdrawal by Subject|1|||
105397360|NCT05788991|363464319|FG001|Overall Study|Withdrawal by Subject|0|||
105397361|NCT05788991|363464318|FG000|Overall Study|Lack of Efficacy|0|||
105397362|NCT05788991|363464319|FG001|Overall Study|Lack of Efficacy|1|||
105397363|NCT05788991|363464318|FG000|Overall Study|Protocol Violation|1|||
105397364|NCT05788991|363464319|FG001|Overall Study|Protocol Violation|2|||
105397365|NCT03557502|363464320|FG000|Protocol 2|Withdrawal by Subject|1|||
105397366|NCT03557502|363464321|FG001|Protocol 2|Withdrawal by Subject|1|||
105397367|NCT03557502|363464320|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
105397368|NCT03557502|363464321|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
105397369|NCT02561962|363464326|FG000|Overall Study|Withdrawal by Subject|1|||
105397370|NCT02561962|363464327|FG001|Overall Study|Withdrawal by Subject|0|||
105397371|NCT02561962|363464328|FG002|Overall Study|Withdrawal by Subject|0|||
105397372|NCT02561962|363464329|FG003|Overall Study|Withdrawal by Subject|0|||
105397373|NCT02561962|363464330|FG004|Overall Study|Withdrawal by Subject|1|||
105397374|NCT02561962|363464331|FG005|Overall Study|Withdrawal by Subject|1|||
105397375|NCT02561962|363464332|FG006|Overall Study|Withdrawal by Subject|2|||
105397376|NCT02561962|363464333|FG007|Overall Study|Withdrawal by Subject|1|||
105397377|NCT02561962|363464334|FG008|Overall Study|Withdrawal by Subject|0|||
105397378|NCT02561962|363464326|FG000|Overall Study|Decision by sponsor|0|||
105397379|NCT02561962|363464327|FG001|Overall Study|Decision by sponsor|0|||
105397380|NCT02561962|363464328|FG002|Overall Study|Decision by sponsor|0|||
105397381|NCT02561962|363464329|FG003|Overall Study|Decision by sponsor|0|||
105397382|NCT02561962|363464330|FG004|Overall Study|Decision by sponsor|1|||
105397383|NCT02561962|363464331|FG005|Overall Study|Decision by sponsor|1|||
105397384|NCT02561962|363464332|FG006|Overall Study|Decision by sponsor|0|||
105397385|NCT02561962|363464333|FG007|Overall Study|Decision by sponsor|3|||
105397386|NCT02561962|363464334|FG008|Overall Study|Decision by sponsor|0|||
105397387|NCT02561962|363464326|FG000|Overall Study|Lost to Follow-up|0|||
105397388|NCT02561962|363464327|FG001|Overall Study|Lost to Follow-up|0|||
105397389|NCT02561962|363464328|FG002|Overall Study|Lost to Follow-up|0|||
105397390|NCT02561962|363464329|FG003|Overall Study|Lost to Follow-up|0|||
105397391|NCT02561962|363464330|FG004|Overall Study|Lost to Follow-up|0|||
105397392|NCT02561962|363464331|FG005|Overall Study|Lost to Follow-up|1|||
105397393|NCT02561962|363464332|FG006|Overall Study|Lost to Follow-up|0|||
105397394|NCT02561962|363464333|FG007|Overall Study|Lost to Follow-up|0|||
105397395|NCT02561962|363464334|FG008|Overall Study|Lost to Follow-up|0|||
105397396|NCT01346176|363464335|FG000|Recruited|Protocol Violation|1|||
105397397|NCT01346176|363464336|FG001|Recruited|Protocol Violation|0|||
105397398|NCT01346176|363464337|FG002|Recruited|Protocol Violation|0|||
105397399|NCT01346176|363464335|FG000|Completed Advance Directive|Death|3|||
105397400|NCT01346176|363464336|FG001|Completed Advance Directive|Death|2|||
105397401|NCT01346176|363464337|FG002|Completed Advance Directive|Death|2|||
105397402|NCT01346176|363464335|FG000|Completed Advance Directive|Became Ineligible|3|||
105397403|NCT01346176|363464336|FG001|Completed Advance Directive|Became Ineligible|0|||
105397404|NCT01346176|363464337|FG002|Completed Advance Directive|Became Ineligible|1|||
105397405|NCT01346176|363464335|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
105397406|NCT01346176|363464336|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
105397407|NCT01346176|363464337|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
105397408|NCT01346176|363464335|FG000|Completed Satisfaction Survey|Death|3|||
105397409|NCT01346176|363464336|FG001|Completed Satisfaction Survey|Death|0|||
105397410|NCT01346176|363464337|FG002|Completed Satisfaction Survey|Death|2|||
105397411|NCT01346176|363464335|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
105397412|NCT01346176|363464336|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
105397413|NCT01346176|363464337|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
105397414|NCT04237584|363464338|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
105397415|NCT04237584|363464339|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
105397416|NCT04237584|363464340|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
105397417|NCT04237584|363464341|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
105397418|NCT04237584|363464338|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
105397419|NCT04237584|363464339|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
105397420|NCT04237584|363464340|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
105397421|NCT04237584|363464341|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
105397422|NCT04237584|363464338|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
105397423|NCT04237584|363464339|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
105397424|NCT04237584|363464340|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
105397425|NCT04237584|363464341|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
105397426|NCT04237584|363464338|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
105397427|NCT04237584|363464339|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
105397428|NCT04237584|363464340|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
105493194|NCT04612790|363818796|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
105397429|NCT04237584|363464341|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
105397430|NCT04237584|363464338|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
105397431|NCT04237584|363464339|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
105493195|NCT04612790|363818797|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
105397432|NCT04237584|363464340|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
105397433|NCT04237584|363464341|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
105397434|NCT01400412|363464342|FG000|Overall Study|Lost to Follow-up|4|||
105397435|NCT01400412|363464343|FG001|Overall Study|Lost to Follow-up|7|||
105397436|NCT01400412|363464342|FG000|Overall Study|Withdrawal by Subject|3|||
105397437|NCT01400412|363464343|FG001|Overall Study|Withdrawal by Subject|4|||
105397438|NCT01400412|363464342|FG000|Overall Study|Unable to complete|3|||
105397439|NCT01400412|363464343|FG001|Overall Study|Unable to complete|3|||
105397440|NCT01400412|363464342|FG000|Overall Study|Never started study treatment|0|||
105397441|NCT01400412|363464343|FG001|Overall Study|Never started study treatment|3|||
105397442|NCT00529633|363466560|FG000|Overall Study|Withdrawal by Subject|1|||
105397443|NCT00529633|363466561|FG001|Overall Study|Withdrawal by Subject|1|||
105397444|NCT02471144|363466562|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
105397445|NCT02471144|363466563|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
105397446|NCT02471144|363466564|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
105397447|NCT02471144|363466565|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
105397448|NCT02471144|363466566|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
105397449|NCT02471144|363466567|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
105397450|NCT02471144|363466568|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
105397451|NCT02471144|363466569|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
105397452|NCT02471144|363466570|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
105397453|NCT02471144|363466571|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
105397454|NCT02471144|363466572|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
105397455|NCT02471144|363466562|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105397456|NCT02471144|363466563|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105397457|NCT02471144|363466564|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105397458|NCT02471144|363466565|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
105397459|NCT02471144|363466566|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105397460|NCT02471144|363466567|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105397461|NCT02471144|363466568|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105397462|NCT02471144|363466569|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105493196|NCT04612790|363818798|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
105397463|NCT02471144|363466570|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105397464|NCT02471144|363466571|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105397465|NCT02471144|363466572|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105397466|NCT02471144|363466562|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105397467|NCT02471144|363466563|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105397468|NCT02471144|363466564|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
105397469|NCT02471144|363466565|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105397470|NCT02471144|363466566|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105397471|NCT02471144|363466567|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105397472|NCT02471144|363466568|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105397473|NCT02471144|363466569|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105397474|NCT02471144|363466570|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105397475|NCT02471144|363466571|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105397476|NCT02471144|363466572|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105397477|NCT02471144|363466562|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
105397478|NCT02471144|363466563|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
105397479|NCT02471144|363466564|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105397480|NCT02471144|363466565|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105397481|NCT02471144|363466566|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105397482|NCT02471144|363466567|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105397483|NCT02471144|363466568|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105397484|NCT02471144|363466569|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105397485|NCT02471144|363466570|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105397486|NCT02471144|363466571|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105397487|NCT02471144|363466572|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105397488|NCT02471144|363466562|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105397489|NCT02471144|363466563|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105397490|NCT02471144|363466564|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105397491|NCT02471144|363466565|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105397492|NCT02471144|363466566|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
105397493|NCT02471144|363466567|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105397494|NCT02471144|363466568|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
105397495|NCT02471144|363466569|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105397496|NCT02471144|363466570|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
105397497|NCT02471144|363466571|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105397498|NCT02471144|363466572|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105397499|NCT02471144|363466562|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105397500|NCT02471144|363466563|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105397501|NCT02471144|363466564|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105397502|NCT02471144|363466565|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105397503|NCT02471144|363466566|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105397504|NCT02471144|363466567|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
105397505|NCT02471144|363466568|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105397506|NCT02471144|363466569|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105397507|NCT02471144|363466570|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
105397508|NCT02471144|363466571|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105397509|NCT02471144|363466572|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105397510|NCT02471144|363466562|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105397511|NCT02471144|363466563|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105397512|NCT02471144|363466564|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105397513|NCT02471144|363466565|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105397514|NCT02471144|363466566|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105397515|NCT02471144|363466567|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105397516|NCT02471144|363466568|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105397517|NCT02471144|363466569|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105397518|NCT02471144|363466570|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
105397519|NCT02471144|363466571|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105397520|NCT02471144|363466572|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105397521|NCT02471144|363466562|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105397522|NCT02471144|363466563|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105397523|NCT02471144|363466564|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105397524|NCT02471144|363466565|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105397525|NCT02471144|363466566|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105397526|NCT02471144|363466567|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105397527|NCT02471144|363466568|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105397528|NCT02471144|363466569|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
105397529|NCT02471144|363466570|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
105580602|NCT01809210|364126455|FG001|Overall Study|Death|1|||
105580603|NCT01809210|364126456|FG002|Overall Study|Death|2|||
105397530|NCT02471144|363466571|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105397531|NCT02471144|363466572|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105397532|NCT02471144|363466562|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105397533|NCT02471144|363466563|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105397534|NCT02471144|363466564|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105397535|NCT02471144|363466565|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105397536|NCT02471144|363466566|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105397537|NCT02471144|363466567|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105397538|NCT02471144|363466568|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105397539|NCT02471144|363466569|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105397540|NCT02471144|363466570|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105397541|NCT02471144|363466571|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
105397542|NCT02471144|363466572|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
105397543|NCT02471144|363466562|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105397544|NCT02471144|363466563|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105397545|NCT02471144|363466564|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105397546|NCT02471144|363466565|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105397547|NCT02471144|363466566|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105397548|NCT02471144|363466567|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105397549|NCT02471144|363466568|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105397550|NCT02471144|363466569|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105397551|NCT02471144|363466570|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105397552|NCT02471144|363466571|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
105397553|NCT02471144|363466572|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105397554|NCT02471144|363466562|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105397555|NCT02471144|363466563|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105397556|NCT02471144|363466564|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105397557|NCT02471144|363466565|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105397558|NCT02471144|363466566|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105397559|NCT02471144|363466567|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105397560|NCT02471144|363466568|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105397561|NCT02471144|363466569|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105397562|NCT02471144|363466570|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105397563|NCT02471144|363466571|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105397564|NCT02471144|363466572|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
105397565|NCT02471144|363466562|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105397566|NCT02471144|363466563|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105397567|NCT02471144|363466564|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105397568|NCT02471144|363466565|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105397569|NCT02471144|363466566|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105397570|NCT02471144|363466567|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105397571|NCT02471144|363466568|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105397572|NCT02471144|363466569|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105397573|NCT02471144|363466570|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105397574|NCT02471144|363466571|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
105397575|NCT02471144|363466572|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
105397576|NCT02471144|363466562|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105397577|NCT02471144|363466563|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105397578|NCT02471144|363466564|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105397579|NCT02471144|363466565|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105397580|NCT02471144|363466566|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105397581|NCT02471144|363466567|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105397582|NCT02471144|363466568|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105397583|NCT02471144|363466569|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105397584|NCT02471144|363466570|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105397585|NCT02471144|363466571|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
105397586|NCT02471144|363466572|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105397587|NCT02471144|363466562|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105397588|NCT02471144|363466563|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105397589|NCT02471144|363466564|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105397590|NCT02471144|363466565|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105397591|NCT02471144|363466566|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105397592|NCT02471144|363466567|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105439950|NCT01618695|363616639|FG001|Extension Phase|Lack of Efficacy|33|||
105439951|NCT01618695|363616640|FG002|Extension Phase|Lack of Efficacy|26|||
105439952|NCT01618695|363616641|FG003|Extension Phase|Lack of Efficacy|24|||
105397593|NCT02471144|363466568|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105397594|NCT02471144|363466569|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105397595|NCT02471144|363466570|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105397596|NCT02471144|363466571|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
105397597|NCT02471144|363466572|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
105397598|NCT02278003|363466573|FG000|Overall Study|Withdrawal by Subject|11|||
105397599|NCT02278003|363466574|FG001|Overall Study|Withdrawal by Subject|0|||
105397600|NCT02278003|363466573|FG000|Overall Study|Not Treated|1|||
105397601|NCT02278003|363466574|FG001|Overall Study|Not Treated|0|||
105397602|NCT02278003|363466573|FG000|Overall Study|Recognition task improperly completed|7|||
105397603|NCT02278003|363466574|FG001|Overall Study|Recognition task improperly completed|0|||
105397604|NCT00876447|363466577|FG000|Overall Study|Other miscellaneous reasons|3|||
105397605|NCT00876447|363466578|FG001|Overall Study|Other miscellaneous reasons|8|||
105397606|NCT00876447|363466577|FG000|Overall Study|Site closure|19|||
105397607|NCT00876447|363466578|FG001|Overall Study|Site closure|14|||
105397608|NCT00876447|363466577|FG000|Overall Study|Protocol Violation|9|||
105397609|NCT00876447|363466578|FG001|Overall Study|Protocol Violation|3|||
105397610|NCT00876447|363466577|FG000|Overall Study|Personal reasons|30|||
105397611|NCT00876447|363466578|FG001|Overall Study|Personal reasons|28|||
105397612|NCT00876447|363466577|FG000|Overall Study|Lost to Follow-up|6|||
105397613|NCT00876447|363466578|FG001|Overall Study|Lost to Follow-up|15|||
105397614|NCT00876447|363466577|FG000|Overall Study|Pregnancy|4|||
105397615|NCT00876447|363466578|FG001|Overall Study|Pregnancy|2|||
105397616|NCT00876447|363466577|FG000|Overall Study|Lack of Efficacy|5|||
105397617|NCT00876447|363466578|FG001|Overall Study|Lack of Efficacy|3|||
105397618|NCT00876447|363466577|FG000|Overall Study|Adverse Event|4|||
105397619|NCT00876447|363466578|FG001|Overall Study|Adverse Event|8|||
105397620|NCT03674281|363466579|FG000|Overall Study|screen failure|2|||
105397621|NCT03674281|363466580|FG001|Overall Study|screen failure|0|||
105397622|NCT03674281|363466581|FG002|Overall Study|screen failure|0|||
105397623|NCT03674281|363466579|FG000|Overall Study|Withdrawal by Subject|1|||
105397624|NCT03674281|363466580|FG001|Overall Study|Withdrawal by Subject|3|||
105397625|NCT03674281|363466581|FG002|Overall Study|Withdrawal by Subject|3|||
105397626|NCT00366457|363466582|FG000|Overall Study|never began study therapy|2|||
105397627|NCT01497197|363466583|FG000|Overall Study|Lost to Follow-up|1|||
105397628|NCT01497197|363466584|FG001|Overall Study|Lost to Follow-up|0|||
105397629|NCT01497197|363466583|FG000|Overall Study|Protocol Violation|0|||
105397630|NCT01497197|363466584|FG001|Overall Study|Protocol Violation|2|||
105397631|NCT01497197|363466583|FG000|Overall Study|Withdrawal by Subject|2|||
105397632|NCT01497197|363466584|FG001|Overall Study|Withdrawal by Subject|1|||
105397633|NCT01497197|363466583|FG000|Overall Study|Excessive/lack of response to treatment|1|||
105397634|NCT01497197|363466584|FG001|Overall Study|Excessive/lack of response to treatment|0|||
105397635|NCT01497197|363466583|FG000|Overall Study|Risk of OHSS|1|||
105397636|NCT01497197|363466584|FG001|Overall Study|Risk of OHSS|0|||
105397637|NCT01497197|363466583|FG000|Overall Study|No oocytes retrieved|3|||
105397638|NCT01497197|363466584|FG001|Overall Study|No oocytes retrieved|2|||
105397639|NCT01497197|363466583|FG000|Overall Study|No fertilisation|6|||
105397640|NCT01497197|363466584|FG001|Overall Study|No fertilisation|5|||
105397641|NCT01497197|363466583|FG000|Overall Study|Intention to freeze all embryos|0|||
105397642|NCT01497197|363466584|FG001|Overall Study|Intention to freeze all embryos|1|||
105397643|NCT01497197|363466583|FG000|Overall Study|All embryos discarded|0|||
105397644|NCT01497197|363466584|FG001|Overall Study|All embryos discarded|3|||
105397645|NCT01497197|363466583|FG000|Overall Study|Other|3|||
105397646|NCT01497197|363466584|FG001|Overall Study|Other|1|||
105397647|NCT01425814|363466586|FG000|Period 1|Stability criteria not fulfilled|0|||
105397648|NCT01425814|363466587|FG001|Period 1|Stability criteria not fulfilled|1|||
105397649|NCT01425814|363466588|FG002|Period 1|Stability criteria not fulfilled|0|||
105397650|NCT01425814|363466589|FG003|Period 1|Stability criteria not fulfilled|0|||
105397651|NCT01425814|363466590|FG004|Period 1|Stability criteria not fulfilled|0|||
105397652|NCT01425814|363466591|FG005|Period 1|Stability criteria not fulfilled|0|||
105397653|NCT01425814|363466586|FG000|Period 2|Stability criteria not fulfilled|0|||
105397654|NCT01425814|363466587|FG001|Period 2|Stability criteria not fulfilled|1|||
105397655|NCT01425814|363466588|FG002|Period 2|Stability criteria not fulfilled|0|||
105397656|NCT01425814|363466589|FG003|Period 2|Stability criteria not fulfilled|0|||
105397657|NCT01425814|363466590|FG004|Period 2|Stability criteria not fulfilled|0|||
105397658|NCT01425814|363466591|FG005|Period 2|Stability criteria not fulfilled|0|||
105397659|NCT01425814|363466586|FG000|Period 3|Adverse Event|0|||
105397660|NCT01425814|363466587|FG001|Period 3|Adverse Event|0|||
105397661|NCT01425814|363466588|FG002|Period 3|Adverse Event|0|||
105397662|NCT01425814|363466589|FG003|Period 3|Adverse Event|0|||
105397663|NCT01425814|363466590|FG004|Period 3|Adverse Event|0|||
105397664|NCT01425814|363466591|FG005|Period 3|Adverse Event|1|||
105397665|NCT01425814|363466586|FG000|Period 4|Adverse Event|1|||
105397666|NCT01425814|363466587|FG001|Period 4|Adverse Event|0|||
105397667|NCT01425814|363466588|FG002|Period 4|Adverse Event|1|||
105397668|NCT01425814|363466589|FG003|Period 4|Adverse Event|0|||
105397669|NCT01425814|363466590|FG004|Period 4|Adverse Event|0|||
105397670|NCT01425814|363466591|FG005|Period 4|Adverse Event|0|||
105397671|NCT01425814|363466586|FG000|Period 5|Stability criteria not fulfilled|0|||
105397672|NCT01425814|363466587|FG001|Period 5|Stability criteria not fulfilled|0|||
105397673|NCT01425814|363466588|FG002|Period 5|Stability criteria not fulfilled|1|||
105397674|NCT01425814|363466589|FG003|Period 5|Stability criteria not fulfilled|0|||
105397675|NCT01425814|363466590|FG004|Period 5|Stability criteria not fulfilled|0|||
105397676|NCT01425814|363466591|FG005|Period 5|Stability criteria not fulfilled|1|||
105397677|NCT03186638|363466592|FG000|Overall Study|Withdrawal by Subject|4|||
105397678|NCT03186638|363466593|FG001|Overall Study|Withdrawal by Subject|4|||
105397679|NCT03186638|363466592|FG000|Overall Study|Withdrawn due to medical problem|3|||
105397680|NCT03186638|363466593|FG001|Overall Study|Withdrawn due to medical problem|2|||
105397681|NCT03186638|363466592|FG000|Overall Study|Lost to Follow-up|1|||
105397682|NCT03186638|363466593|FG001|Overall Study|Lost to Follow-up|0|||
105397683|NCT03801525|363466597|FG000|Overall Study|Adverse Event|17|||
105397684|NCT03801525|363466598|FG001|Overall Study|Adverse Event|1|||
105397685|NCT03801525|363466599|FG002|Overall Study|Adverse Event|0|||
105397686|NCT03801525|363466597|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
105397687|NCT03801525|363466598|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
105397688|NCT03801525|363466599|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
105397689|NCT03801525|363466597|FG000|Overall Study|Death|29|||
105397690|NCT03801525|363466598|FG001|Overall Study|Death|1|||
105397691|NCT03801525|363466599|FG002|Overall Study|Death|4|||
105397692|NCT03801525|363466597|FG000|Overall Study|Disease Progression|6|||
105397693|NCT03801525|363466598|FG001|Overall Study|Disease Progression|0|||
105397694|NCT03801525|363466599|FG002|Overall Study|Disease Progression|1|||
105397695|NCT03801525|363466597|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
105580604|NCT01809210|364126457|FG003|Overall Study|Death|0|||
105580605|NCT01809210|364126458|FG004|Overall Study|Death|1|||
105580606|NCT01809210|364126459|FG005|Overall Study|Death|3|||
105580607|NCT01809210|364126460|FG006|Overall Study|Death|1|||
105580608|NCT01668147|364126461|FG000|Overall Study|Withdrawal by Subject|6|||
105397696|NCT03801525|363466598|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
105397697|NCT03801525|363466599|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
105397698|NCT03801525|363466597|FG000|Overall Study|Investigator Decision|18|||
105397699|NCT03801525|363466598|FG001|Overall Study|Investigator Decision|1|||
105397700|NCT03801525|363466599|FG002|Overall Study|Investigator Decision|0|||
105397701|NCT03801525|363466597|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
105397702|NCT03801525|363466598|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
105397703|NCT03801525|363466599|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
105397704|NCT03801525|363466597|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
105397705|NCT03801525|363466598|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
105397706|NCT03801525|363466599|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
105397707|NCT03801525|363466597|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
105397708|NCT03801525|363466598|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
105397709|NCT03801525|363466599|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
105397710|NCT03801525|363466597|FG000|Overall Study|Withdrawal of Subject Consent|38|||
105397711|NCT03801525|363466598|FG001|Overall Study|Withdrawal of Subject Consent|2|||
105397712|NCT03801525|363466599|FG002|Overall Study|Withdrawal of Subject Consent|1|||
105397713|NCT03801525|363466597|FG000|Overall Study|Reason not Specified|4|||
105397714|NCT03801525|363466598|FG001|Overall Study|Reason not Specified|0|||
105397715|NCT03801525|363466599|FG002|Overall Study|Reason not Specified|4|||
105397716|NCT01263119|363466602|FG000|Period 1|Protocol Violation|2|||
105397717|NCT01263119|363466602|FG000|Period 2|Adverse Event|2|||
105397718|NCT02684461|363466603|FG000|Overall Study|Adverse Event|1|||
105397719|NCT02684461|363466604|FG001|Overall Study|Adverse Event|0|||
105397720|NCT02684461|363466605|FG002|Overall Study|Adverse Event|0|||
105397721|NCT02684461|363466603|FG000|Overall Study|Lack of Efficacy|1|||
105397722|NCT02684461|363466604|FG001|Overall Study|Lack of Efficacy|2|||
105397723|NCT02684461|363466605|FG002|Overall Study|Lack of Efficacy|0|||
105397724|NCT01206517|363466610|FG000|Overall Study|Withdrawal by Subject|0|||
105397725|NCT01206517|363466611|FG001|Overall Study|Withdrawal by Subject|0|||
105397726|NCT01206517|363466612|FG002|Overall Study|Withdrawal by Subject|2|||
105397727|NCT01206517|363466613|FG003|Overall Study|Withdrawal by Subject|0|||
105397728|NCT01206517|363466614|FG004|Overall Study|Withdrawal by Subject|1|||
105397729|NCT01206517|363466615|FG005|Overall Study|Withdrawal by Subject|0|||
105580609|NCT01474512|364126465|FG000|Induction Period|Adverse Event|6|||
105580610|NCT01474512|364126466|FG001|Induction Period|Adverse Event|10|||
105580611|NCT01474512|364126467|FG002|Induction Period|Adverse Event|10|||
105580612|NCT01474512|364126468|FG003|Induction Period|Adverse Event|0|||
105397730|NCT01029535|363466616|FG000|Overall Study|Lost to Follow-up|24|||
105397731|NCT01029535|363466616|FG000|Overall Study|Protocol Violation|2|||
105397732|NCT01029535|363466616|FG000|Overall Study|Participant Withdrew Consent|2|||
105397733|NCT01029535|363466616|FG000|Overall Study|Adverse Event|1|||
105580613|NCT01474512|364126469|FG004|Induction Period|Adverse Event|0|||
105580614|NCT01474512|364126470|FG005|Induction Period|Adverse Event|0|||
105397734|NCT01029535|363466616|FG000|Overall Study|Use of Another Treatment|1|||
105397735|NCT01029535|363466616|FG000|Overall Study|Death|1|||
105397736|NCT04047446|363466617|FG000|Overall Study|Physician Decision|1|||
105397737|NCT04047446|363466618|FG001|Overall Study|Physician Decision|0|||
105397738|NCT02367456|363466619|FG000|Overall Study|Death|8|||
105397739|NCT02367456|363466620|FG001|Overall Study|Death|24|||
105397740|NCT02367456|363466621|FG002|Overall Study|Death|17|||
105397741|NCT02367456|363466619|FG000|Overall Study|Lost to Follow-up|1|||
105397742|NCT02367456|363466620|FG001|Overall Study|Lost to Follow-up|3|||
105397743|NCT02367456|363466621|FG002|Overall Study|Lost to Follow-up|1|||
105397744|NCT02367456|363466619|FG000|Overall Study|Other reason|3|||
105397745|NCT02367456|363466620|FG001|Overall Study|Other reason|3|||
105397746|NCT02367456|363466621|FG002|Overall Study|Other reason|9|||
105397747|NCT02367456|363466619|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
105397748|NCT02367456|363466620|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
105397749|NCT02367456|363466621|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
105397750|NCT00329420|363466622|FG000|Re-induction Phase|Lack of Efficacy|0|||
105397751|NCT00329420|363466623|FG001|Re-induction Phase|Lack of Efficacy|1|||
105397752|NCT00329420|363466624|FG002|Re-induction Phase|Lack of Efficacy|0|||
105397753|NCT00329420|363466622|FG000|Re-induction Phase|Withdrawal of Consent|0|||
105397754|NCT00329420|363466623|FG001|Re-induction Phase|Withdrawal of Consent|0|||
105397755|NCT00329420|363466624|FG002|Re-induction Phase|Withdrawal of Consent|1|||
105397756|NCT00329420|363466622|FG000|Re-induction Phase|Did not respond to re-induction|6|||
105397757|NCT00329420|363466623|FG001|Re-induction Phase|Did not respond to re-induction|5|||
105397758|NCT00329420|363466624|FG002|Re-induction Phase|Did not respond to re-induction|7|||
105397759|NCT00329420|363466622|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
105397760|NCT00329420|363466623|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
105397761|NCT00329420|363466624|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
105397762|NCT00329420|363466622|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
105397763|NCT00329420|363466623|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
105397764|NCT00329420|363466624|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
105397765|NCT00329420|363466622|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
105397766|NCT00329420|363466623|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
105397767|NCT00329420|363466624|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
105397768|NCT03639610|363466625|FG000|Overall Study|Adverse Event|7|||
105397769|NCT03639610|363466626|FG001|Overall Study|Adverse Event|1|||
105397770|NCT03639610|363466627|FG002|Overall Study|Adverse Event|0|||
105397771|NCT03639610|363466625|FG000|Overall Study|Physician Decision|3|||
105397772|NCT03639610|363466626|FG001|Overall Study|Physician Decision|1|||
105397773|NCT03639610|363466627|FG002|Overall Study|Physician Decision|0|||
105397774|NCT03639610|363466625|FG000|Overall Study|Disease progression|8|||
105397775|NCT03639610|363466626|FG001|Overall Study|Disease progression|5|||
105397776|NCT03639610|363466627|FG002|Overall Study|Disease progression|3|||
105397777|NCT03639610|363466625|FG000|Overall Study|Study terminated by sponsor|2|||
105397778|NCT03639610|363466626|FG001|Overall Study|Study terminated by sponsor|1|||
105397779|NCT03639610|363466627|FG002|Overall Study|Study terminated by sponsor|1|||
105397780|NCT03639610|363466625|FG000|Overall Study|Patient request to stop treatment|1|||
105397781|NCT03639610|363466626|FG001|Overall Study|Patient request to stop treatment|2|||
105397782|NCT03639610|363466627|FG002|Overall Study|Patient request to stop treatment|0|||
105397783|NCT01959529|363466630|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
105397784|NCT01959529|363466631|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
105397785|NCT01959529|363466630|FG000|Overall Study|Lost to Follow-up|4|||
105397786|NCT01959529|363466631|FG001|Overall Study|Lost to Follow-up|1|||
105397787|NCT01959529|363466630|FG000|Overall Study|Other|70|||
105397788|NCT01959529|363466631|FG001|Overall Study|Other|68|||
105397789|NCT01959529|363466630|FG000|Overall Study|Hypoglycaemia|1|||
105397790|NCT01959529|363466631|FG001|Overall Study|Hypoglycaemia|1|||
105397791|NCT01959529|363466630|FG000|Overall Study|Lack of glycaemic control|1|||
105397792|NCT01959529|363466631|FG001|Overall Study|Lack of glycaemic control|1|||
105397793|NCT00557193|363466632|FG000|Induction|Adverse Event|2|||
105397794|NCT00557193|363466633|FG001|Induction|Adverse Event|0|||
105397795|NCT00557193|363466634|FG002|Induction|Adverse Event|0|||
105397796|NCT00557193|363466635|FG003|Induction|Adverse Event|0|||
105493197|NCT04612790|363818799|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
105397797|NCT00557193|363466636|FG004|Induction|Adverse Event|0|||
105397798|NCT00557193|363466637|FG005|Induction|Adverse Event|0|||
105397799|NCT00557193|363466632|FG000|Induction|Death|6|||
105493198|NCT04612790|363818796|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
105397800|NCT00557193|363466633|FG001|Induction|Death|0|||
105397801|NCT00557193|363466634|FG002|Induction|Death|0|||
105397802|NCT00557193|363466635|FG003|Induction|Death|0|||
105397803|NCT00557193|363466636|FG004|Induction|Death|0|||
105397804|NCT00557193|363466637|FG005|Induction|Death|0|||
105397805|NCT00557193|363466632|FG000|Induction|Physician Decision|3|||
105397806|NCT00557193|363466633|FG001|Induction|Physician Decision|0|||
105397807|NCT00557193|363466634|FG002|Induction|Physician Decision|0|||
105397808|NCT00557193|363466635|FG003|Induction|Physician Decision|0|||
105397809|NCT00557193|363466636|FG004|Induction|Physician Decision|0|||
105397810|NCT00557193|363466637|FG005|Induction|Physician Decision|0|||
105397811|NCT00557193|363466632|FG000|Induction|Withdrawal by Subject|1|||
105397812|NCT00557193|363466633|FG001|Induction|Withdrawal by Subject|0|||
105397813|NCT00557193|363466634|FG002|Induction|Withdrawal by Subject|0|||
105397814|NCT00557193|363466635|FG003|Induction|Withdrawal by Subject|0|||
105397815|NCT00557193|363466636|FG004|Induction|Withdrawal by Subject|0|||
105397816|NCT00557193|363466637|FG005|Induction|Withdrawal by Subject|0|||
105397817|NCT00557193|363466632|FG000|Induction|Refusal of Further Protocol Therapy|2|||
105397818|NCT00557193|363466633|FG001|Induction|Refusal of Further Protocol Therapy|0|||
105397819|NCT00557193|363466634|FG002|Induction|Refusal of Further Protocol Therapy|0|||
105397820|NCT00557193|363466635|FG003|Induction|Refusal of Further Protocol Therapy|0|||
105397821|NCT00557193|363466636|FG004|Induction|Refusal of Further Protocol Therapy|0|||
105397822|NCT00557193|363466637|FG005|Induction|Refusal of Further Protocol Therapy|0|||
105397823|NCT00557193|363466632|FG000|Induction|Ineligible|8|||
105397824|NCT00557193|363466633|FG001|Induction|Ineligible|0|||
105397825|NCT00557193|363466634|FG002|Induction|Ineligible|0|||
105397826|NCT00557193|363466635|FG003|Induction|Ineligible|0|||
105397827|NCT00557193|363466636|FG004|Induction|Ineligible|0|||
105397828|NCT00557193|363466637|FG005|Induction|Ineligible|0|||
105397829|NCT00557193|363466632|FG000|Induction|Inevaluable for post Induction|2|||
105397830|NCT00557193|363466633|FG001|Induction|Inevaluable for post Induction|0|||
105397831|NCT00557193|363466634|FG002|Induction|Inevaluable for post Induction|0|||
105397832|NCT00557193|363466635|FG003|Induction|Inevaluable for post Induction|0|||
105397833|NCT00557193|363466636|FG004|Induction|Inevaluable for post Induction|0|||
105397834|NCT00557193|363466637|FG005|Induction|Inevaluable for post Induction|0|||
105397835|NCT00557193|363466632|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
105397836|NCT00557193|363466633|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
105397837|NCT00557193|363466634|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
105397838|NCT00557193|363466635|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
105397839|NCT00557193|363466636|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
105397840|NCT00557193|363466637|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
105397841|NCT00557193|363466632|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
105397842|NCT00557193|363466633|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
105397843|NCT00557193|363466634|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
105397844|NCT00557193|363466635|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
105397845|NCT00557193|363466636|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
105397846|NCT00557193|363466637|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
105397847|NCT00557193|363466632|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
105397848|NCT00557193|363466633|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
105397849|NCT00557193|363466634|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
105397850|NCT00557193|363466635|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
105397851|NCT00557193|363466636|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
105397852|NCT00557193|363466637|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
105397853|NCT00557193|363466632|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
105397854|NCT00557193|363466633|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
105397855|NCT00557193|363466634|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
105397856|NCT00557193|363466635|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
105397857|NCT00557193|363466636|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
105397858|NCT00557193|363466637|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
105397859|NCT00557193|363466632|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
105397860|NCT00557193|363466633|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
105397861|NCT00557193|363466634|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
105397862|NCT00557193|363466635|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
105397863|NCT00557193|363466636|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
105397864|NCT00557193|363466637|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
105397865|NCT00557193|363466632|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
105397866|NCT00557193|363466633|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
105397867|NCT00557193|363466634|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
105397868|NCT00557193|363466635|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
105397869|NCT00557193|363466636|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
105397870|NCT00557193|363466637|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
105397871|NCT00557193|363466632|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
105397872|NCT00557193|363466633|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
105397873|NCT00557193|363466634|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
105397874|NCT00557193|363466635|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
105397875|NCT00557193|363466636|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
105439953|NCT01618695|363616638|FG000|Extension Phase|Pregnancy|2|||
105439954|NCT01618695|363616639|FG001|Extension Phase|Pregnancy|0|||
105397876|NCT00557193|363466637|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
105397877|NCT00557193|363466632|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
105397878|NCT00557193|363466633|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
105397879|NCT00557193|363466634|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
105397880|NCT00557193|363466635|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
105397881|NCT00557193|363466636|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
105397882|NCT00557193|363466637|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
105397883|NCT00557193|363466632|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
105397884|NCT00557193|363466633|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
105397885|NCT00557193|363466634|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
105397886|NCT00557193|363466635|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
105397887|NCT00557193|363466636|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
105397888|NCT00557193|363466637|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
105397889|NCT03984825|363466638|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
105397890|NCT03984825|363466638|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
105397891|NCT03984825|363466638|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
105397892|NCT02569853|363466639|FG000|Overall Study|Adverse Event|2|||
105397893|NCT02569853|363466640|FG001|Overall Study|Adverse Event|0|||
105397894|NCT02569853|363466639|FG000|Overall Study|Withdrawal by Subject|3|||
105397895|NCT02569853|363466640|FG001|Overall Study|Withdrawal by Subject|2|||
105397896|NCT02569853|363466639|FG000|Overall Study|Lost to Follow-up|3|||
105397897|NCT02569853|363466640|FG001|Overall Study|Lost to Follow-up|3|||
105397898|NCT02569853|363466639|FG000|Overall Study|Protocol Violation|1|||
105397899|NCT02569853|363466640|FG001|Overall Study|Protocol Violation|1|||
105397900|NCT02569853|363466639|FG000|Overall Study|Did not experience migraine attack|10|||
105397901|NCT02569853|363466640|FG001|Overall Study|Did not experience migraine attack|7|||
105397902|NCT02569853|363466639|FG000|Overall Study|Physician Decision|1|||
105397903|NCT02569853|363466640|FG001|Overall Study|Physician Decision|1|||
105397904|NCT01948427|363466643|FG000|Overall Study|Serious Adverse Event|3|||
105397905|NCT01948427|363466644|FG001|Overall Study|Serious Adverse Event|0|||
105397906|NCT01948427|363466645|FG002|Overall Study|Serious Adverse Event|0|||
105397907|NCT01948427|363466646|FG003|Overall Study|Serious Adverse Event|0|||
105397908|NCT01948427|363466647|FG004|Overall Study|Serious Adverse Event|1|||
105397909|NCT01948427|363466643|FG000|Overall Study|Investigator Request|0|||
105397910|NCT01948427|363466644|FG001|Overall Study|Investigator Request|8|||
105397911|NCT01948427|363466645|FG002|Overall Study|Investigator Request|0|||
105397912|NCT01948427|363466646|FG003|Overall Study|Investigator Request|0|||
105397913|NCT01948427|363466647|FG004|Overall Study|Investigator Request|6|||
105397914|NCT01948427|363466643|FG000|Overall Study|Lost to Follow-up|1|||
105397915|NCT01948427|363466644|FG001|Overall Study|Lost to Follow-up|0|||
105397916|NCT01948427|363466645|FG002|Overall Study|Lost to Follow-up|0|||
105397917|NCT01948427|363466646|FG003|Overall Study|Lost to Follow-up|0|||
105397918|NCT01948427|363466647|FG004|Overall Study|Lost to Follow-up|4|||
105397919|NCT01948427|363466643|FG000|Overall Study|Withdrawal by Subject|2|||
105397920|NCT01948427|363466644|FG001|Overall Study|Withdrawal by Subject|0|||
105397921|NCT01948427|363466645|FG002|Overall Study|Withdrawal by Subject|0|||
105397922|NCT01948427|363466646|FG003|Overall Study|Withdrawal by Subject|0|||
105397923|NCT01948427|363466647|FG004|Overall Study|Withdrawal by Subject|1|||
105397924|NCT01948427|363466643|FG000|Overall Study|Other, Not Specified|1|||
105397925|NCT01948427|363466644|FG001|Overall Study|Other, Not Specified|9|||
105397926|NCT01948427|363466645|FG002|Overall Study|Other, Not Specified|0|||
105397927|NCT01948427|363466646|FG003|Overall Study|Other, Not Specified|0|||
105397928|NCT01948427|363466647|FG004|Overall Study|Other, Not Specified|2|||
105397929|NCT02095106|363466650|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
105397930|NCT02095106|363466651|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
105493199|NCT04612790|363818797|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
105397931|NCT01500317|363466656|FG000|Overall Study|Withdrawal by Subject|3|||
105397932|NCT01500317|363466657|FG001|Overall Study|Withdrawal by Subject|2|||
105397933|NCT01500317|363466658|FG002|Overall Study|Withdrawal by Subject|0|||
105397934|NCT00583219|363466659|FG000|Phase 2|Withdrawal by Subject|1|||
105397935|NCT01541371|363466660|FG000|Overall Study|Withdrawal by Subject|14|||
105397936|NCT01541371|363466660|FG000|Overall Study|Lost to Follow-up|21|||
105397937|NCT01541371|363466660|FG000|Overall Study|Adverse Event|15|||
105397938|NCT01541371|363466660|FG000|Overall Study|Lack of Efficacy|12|||
105397939|NCT01541371|363466660|FG000|Overall Study|Protocol Violation|6|||
105397940|NCT01541371|363466660|FG000|Overall Study|Study medication non-compliance|3|||
105397941|NCT01541371|363466660|FG000|Overall Study|Other|6|||
105397942|NCT02006927|363466663|FG000|Overall Study|Adverse Event|2|||
105493200|NCT04612790|363818798|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
105397943|NCT02006927|363466663|FG000|Overall Study|Withdrawal by Subject|1|||
105397944|NCT02493764|363466673|FG000|Overall Study|Adverse Event|2|||
105397945|NCT02493764|363466674|FG001|Overall Study|Adverse Event|2|||
105397946|NCT02493764|363466673|FG000|Overall Study|Death|44|||
105397947|NCT02493764|363466674|FG001|Overall Study|Death|58|||
105397948|NCT02493764|363466673|FG000|Overall Study|Lost to Follow-up|2|||
105397949|NCT02493764|363466674|FG001|Overall Study|Lost to Follow-up|1|||
105397950|NCT02493764|363466673|FG000|Overall Study|Protocol Violation|6|||
105397951|NCT02493764|363466674|FG001|Overall Study|Protocol Violation|7|||
105397952|NCT02493764|363466673|FG000|Overall Study|Physician Decision|1|||
105397953|NCT02493764|363466674|FG001|Overall Study|Physician Decision|1|||
105397954|NCT02493764|363466673|FG000|Overall Study|Participant moved|17|||
105397955|NCT02493764|363466674|FG001|Overall Study|Participant moved|5|||
105397956|NCT02493764|363466673|FG000|Overall Study|Withdrawal parent/guardian|0|||
105397957|NCT02493764|363466674|FG001|Overall Study|Withdrawal parent/guardian|1|||
105397958|NCT02493764|363466673|FG000|Overall Study|Withdrawal by Subject|11|||
105397959|NCT02493764|363466674|FG001|Overall Study|Withdrawal by Subject|7|||
105397960|NCT01307449|363466675|FG000|Overall Study|Adverse Event|1|||
105397961|NCT01307449|363466676|FG001|Overall Study|Adverse Event|0|||
105397962|NCT01307449|363466677|FG002|Overall Study|Adverse Event|0|||
105397963|NCT01307449|363466678|FG003|Overall Study|Adverse Event|0|||
105397964|NCT03218917|363466679|FG000|Overall Study|Adverse Event|3|||
105397965|NCT03218917|363466680|FG001|Overall Study|Adverse Event|3|||
105397966|NCT03218917|363466681|FG002|Overall Study|Adverse Event|2|||
105397967|NCT03218917|363466679|FG000|Overall Study|Subject withdrew consent|2|||
105397968|NCT03218917|363466680|FG001|Overall Study|Subject withdrew consent|4|||
105397969|NCT03218917|363466681|FG002|Overall Study|Subject withdrew consent|10|||
105397970|NCT03218917|363466679|FG000|Overall Study|Physician Decision|0|||
105397971|NCT03218917|363466680|FG001|Overall Study|Physician Decision|1|||
105397972|NCT03218917|363466681|FG002|Overall Study|Physician Decision|1|||
105397973|NCT03218917|363466679|FG000|Overall Study|Lost to Follow-up|1|||
105397974|NCT03218917|363466680|FG001|Overall Study|Lost to Follow-up|0|||
105397975|NCT03218917|363466681|FG002|Overall Study|Lost to Follow-up|0|||
105397976|NCT03218917|363466679|FG000|Overall Study|Reason Missing|0|||
105397977|NCT03218917|363466680|FG001|Overall Study|Reason Missing|2|||
105397978|NCT03218917|363466681|FG002|Overall Study|Reason Missing|0|||
105397979|NCT03218917|363466679|FG000|Overall Study|Death|0|||
105397980|NCT03218917|363466680|FG001|Overall Study|Death|1|||
105397981|NCT03218917|363466681|FG002|Overall Study|Death|0|||
105397982|NCT03218917|363466679|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105397983|NCT03218917|363466680|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105397984|NCT03218917|363466681|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105397985|NCT01463527|363466686|FG000|Overall Study|Protocol Violation|1|||
105397986|NCT01463527|363466687|FG001|Overall Study|Protocol Violation|1|||
105397987|NCT01463527|363466686|FG000|Overall Study|Crying >20% of sedation|5|||
105397988|NCT01463527|363466687|FG001|Overall Study|Crying >20% of sedation|6|||
105397989|NCT01977222|363466688|FG000|Overall Study|Withdrawal by Subject|1|||
105397990|NCT01088503|363466694|FG000|Overall Study|Withdrawal by Subject|118|||
105397991|NCT01088503|363466695|FG001|Overall Study|Withdrawal by Subject|327|||
105397992|NCT01088503|363466696|FG002|Overall Study|Withdrawal by Subject|10|||
105397993|NCT01088503|363466694|FG000|Overall Study|Death|64|||
105397994|NCT01088503|363466695|FG001|Overall Study|Death|358|||
105397995|NCT01088503|363466696|FG002|Overall Study|Death|7|||
105397996|NCT01076010|363466697|FG000|Overall Study|Death|15|||
105397997|NCT01076010|363466698|FG001|Overall Study|Death|1|||
105397998|NCT01076010|363466699|FG002|Overall Study|Death|0|||
105397999|NCT01076010|363466697|FG000|Overall Study|Adverse Event|7|||
105398000|NCT01076010|363466698|FG001|Overall Study|Adverse Event|2|||
105398001|NCT01076010|363466699|FG002|Overall Study|Adverse Event|0|||
105398002|NCT01076010|363466697|FG000|Overall Study|Progressive disease|90|||
105398003|NCT01076010|363466698|FG001|Overall Study|Progressive disease|30|||
105398004|NCT01076010|363466699|FG002|Overall Study|Progressive disease|1|||
105398005|NCT01076010|363466697|FG000|Overall Study|Lack of Efficacy|4|||
105398006|NCT01076010|363466698|FG001|Overall Study|Lack of Efficacy|0|||
105580615|NCT01474512|364126471|FG006|Induction Period|Adverse Event|0|||
105580616|NCT01474512|364126472|FG007|Induction Period|Adverse Event|0|||
105398007|NCT01076010|363466699|FG002|Overall Study|Lack of Efficacy|0|||
105398008|NCT01076010|363466697|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
105398009|NCT01076010|363466698|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
105398010|NCT01076010|363466699|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
105398011|NCT01076010|363466697|FG000|Overall Study|Significant Surgical Procedure|0|||
105398012|NCT01076010|363466698|FG001|Overall Study|Significant Surgical Procedure|1|||
105398013|NCT01076010|363466699|FG002|Overall Study|Significant Surgical Procedure|0|||
105398014|NCT01076010|363466697|FG000|Overall Study|Protocol Violation|0|||
105398015|NCT01076010|363466698|FG001|Overall Study|Protocol Violation|1|||
105398016|NCT01076010|363466699|FG002|Overall Study|Protocol Violation|0|||
105398017|NCT01076010|363466697|FG000|Overall Study|Noncompliance|1|||
105398018|NCT01076010|363466698|FG001|Overall Study|Noncompliance|1|||
105398019|NCT01076010|363466699|FG002|Overall Study|Noncompliance|0|||
105398020|NCT01076010|363466697|FG000|Overall Study|Withdrawal by Subject|3|||
105398021|NCT01076010|363466698|FG001|Overall Study|Withdrawal by Subject|0|||
105580617|NCT01474512|364126473|FG008|Induction Period|Adverse Event|0|||
105493201|NCT04612790|363818799|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
105493202|NCT04612790|363818796|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
105398022|NCT01076010|363466699|FG002|Overall Study|Withdrawal by Subject|1|||
105398023|NCT01076010|363466697|FG000|Overall Study|Other|5|||
105398024|NCT01076010|363466698|FG001|Overall Study|Other|2|||
105398025|NCT01076010|363466699|FG002|Overall Study|Other|0|||
105398026|NCT05134649|363466702|FG000|Overall Study|Lost to Follow-up|12|||
105398027|NCT05134649|363466702|FG000|Overall Study|Withdrawal by Subject|14|||
105398028|NCT05134649|363466702|FG000|Overall Study|Pregnancy|1|||
105398029|NCT05134649|363466702|FG000|Overall Study|Other, not specified|3|||
105398030|NCT02412670|363466705|FG000|Overall Study|Adverse Event|4|||
105398031|NCT02412670|363466706|FG001|Overall Study|Adverse Event|1|||
105398032|NCT02412670|363466705|FG000|Overall Study|Physician Decision|1|||
105398033|NCT02412670|363466706|FG001|Overall Study|Physician Decision|0|||
105398034|NCT02412670|363466705|FG000|Overall Study|Withdrawal by Subject|1|||
105398035|NCT02412670|363466706|FG001|Overall Study|Withdrawal by Subject|0|||
105493203|NCT04612790|363818797|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
105493204|NCT04612790|363818798|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
105398036|NCT02412670|363466705|FG000|Overall Study|Ineligible|1|||
105398037|NCT02412670|363466706|FG001|Overall Study|Ineligible|0|||
105398038|NCT00565409|363466707|FG000|Period 1 Open Label|Adverse Event|17|||
105398039|NCT00565409|363466708|FG001|Period 1 Open Label|Adverse Event|0|||
105398040|NCT00565409|363466709|FG002|Period 1 Open Label|Adverse Event|0|||
105398041|NCT00565409|363466710|FG003|Period 1 Open Label|Adverse Event|0|||
105398042|NCT00565409|363466707|FG000|Period 1 Open Label|Death|2|||
105398043|NCT00565409|363466708|FG001|Period 1 Open Label|Death|0|||
105398044|NCT00565409|363466709|FG002|Period 1 Open Label|Death|0|||
105398045|NCT00565409|363466710|FG003|Period 1 Open Label|Death|0|||
105398046|NCT00565409|363466707|FG000|Period 1 Open Label|Lost to Follow-up|1|||
105398047|NCT00565409|363466708|FG001|Period 1 Open Label|Lost to Follow-up|0|||
105398048|NCT00565409|363466709|FG002|Period 1 Open Label|Lost to Follow-up|0|||
105398049|NCT00565409|363466710|FG003|Period 1 Open Label|Lost to Follow-up|0|||
105398050|NCT00565409|363466707|FG000|Period 1 Open Label|Other|21|||
105398051|NCT00565409|363466708|FG001|Period 1 Open Label|Other|0|||
105398052|NCT00565409|363466709|FG002|Period 1 Open Label|Other|0|||
105398053|NCT00565409|363466710|FG003|Period 1 Open Label|Other|0|||
105398054|NCT00565409|363466707|FG000|Period 1 Open Label|Protocol Violation|14|||
105398055|NCT00565409|363466708|FG001|Period 1 Open Label|Protocol Violation|0|||
105398056|NCT00565409|363466709|FG002|Period 1 Open Label|Protocol Violation|0|||
105398057|NCT00565409|363466710|FG003|Period 1 Open Label|Protocol Violation|0|||
105398058|NCT00565409|363466707|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
105398059|NCT00565409|363466708|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
105398060|NCT00565409|363466709|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
105398061|NCT00565409|363466710|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
105398062|NCT00565409|363466707|FG000|Period 1 Open Label|no conclusion of participation record|1|||
105398063|NCT00565409|363466708|FG001|Period 1 Open Label|no conclusion of participation record|0|||
105398064|NCT00565409|363466709|FG002|Period 1 Open Label|no conclusion of participation record|0|||
105398065|NCT00565409|363466710|FG003|Period 1 Open Label|no conclusion of participation record|0|||
105398066|NCT00565409|363466707|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
105398067|NCT00565409|363466708|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
105398068|NCT00565409|363466709|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
105398069|NCT00565409|363466710|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
105398070|NCT00565409|363466707|FG000|Period 2 Double-Blind|Adverse Event|0|||
105398071|NCT00565409|363466708|FG001|Period 2 Double-Blind|Adverse Event|7|||
105398072|NCT00565409|363466709|FG002|Period 2 Double-Blind|Adverse Event|4|||
105398073|NCT00565409|363466710|FG003|Period 2 Double-Blind|Adverse Event|5|||
105398074|NCT00565409|363466707|FG000|Period 2 Double-Blind|Death|0|||
105398075|NCT00565409|363466708|FG001|Period 2 Double-Blind|Death|2|||
105398076|NCT00565409|363466709|FG002|Period 2 Double-Blind|Death|0|||
105398077|NCT00565409|363466710|FG003|Period 2 Double-Blind|Death|0|||
105398078|NCT00565409|363466707|FG000|Period 2 Double-Blind|Protocol Violation|0|||
105398079|NCT00565409|363466708|FG001|Period 2 Double-Blind|Protocol Violation|4|||
105398080|NCT00565409|363466709|FG002|Period 2 Double-Blind|Protocol Violation|6|||
105398081|NCT00565409|363466710|FG003|Period 2 Double-Blind|Protocol Violation|2|||
105398082|NCT00565409|363466707|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
105398083|NCT00565409|363466708|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
105398084|NCT00565409|363466709|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
105398085|NCT00565409|363466710|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
105398086|NCT00565409|363466707|FG000|Period 2 Double-Blind|Other|0|||
105398087|NCT00565409|363466708|FG001|Period 2 Double-Blind|Other|4|||
105398088|NCT00565409|363466709|FG002|Period 2 Double-Blind|Other|5|||
105398089|NCT00565409|363466710|FG003|Period 2 Double-Blind|Other|9|||
105398090|NCT00565409|363466707|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
105398091|NCT00565409|363466708|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
105398092|NCT00565409|363466709|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
105398093|NCT00565409|363466710|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
105398094|NCT00518180|363466713|FG000|Overall Study|Withdrawal by Subject|29|||
105398095|NCT00518180|363466714|FG001|Overall Study|Withdrawal by Subject|30|||
105398096|NCT00518180|363466715|FG002|Overall Study|Withdrawal by Subject|42|||
105398097|NCT00518180|363466713|FG000|Overall Study|Lost to Follow-up|30|||
105398098|NCT00518180|363466714|FG001|Overall Study|Lost to Follow-up|28|||
105398099|NCT00518180|363466715|FG002|Overall Study|Lost to Follow-up|34|||
105398100|NCT00518180|363466713|FG000|Overall Study|Administrative reason|0|||
105398101|NCT00518180|363466714|FG001|Overall Study|Administrative reason|2|||
105398102|NCT00518180|363466715|FG002|Overall Study|Administrative reason|2|||
105398103|NCT00518180|363466713|FG000|Overall Study|Protocol Violation|5|||
105398104|NCT00518180|363466714|FG001|Overall Study|Protocol Violation|7|||
105398105|NCT00518180|363466715|FG002|Overall Study|Protocol Violation|4|||
105398106|NCT00518180|363466713|FG000|Overall Study|Unable to classify|0|||
105398107|NCT00518180|363466714|FG001|Overall Study|Unable to classify|2|||
105398108|NCT00518180|363466715|FG002|Overall Study|Unable to classify|0|||
105398109|NCT00518180|363466713|FG000|Overall Study|Adverse Event|1|||
105398110|NCT00518180|363466714|FG001|Overall Study|Adverse Event|0|||
105398111|NCT00518180|363466715|FG002|Overall Study|Adverse Event|0|||
105398112|NCT01276106|363466718|FG000|Overall Study|Adverse Event|3|||
105398113|NCT01276106|363466719|FG001|Overall Study|Adverse Event|3|||
105398114|NCT01276106|363466720|FG002|Overall Study|Adverse Event|11|||
105398115|NCT01276106|363466721|FG003|Overall Study|Adverse Event|3|||
105398116|NCT01276106|363466718|FG000|Overall Study|Withdrawal by Subject|6|||
105398117|NCT01276106|363466719|FG001|Overall Study|Withdrawal by Subject|3|||
105398118|NCT01276106|363466720|FG002|Overall Study|Withdrawal by Subject|1|||
105398119|NCT01276106|363466721|FG003|Overall Study|Withdrawal by Subject|6|||
105398120|NCT01276106|363466718|FG000|Overall Study|Lack of Efficacy|0|||
105398121|NCT01276106|363466719|FG001|Overall Study|Lack of Efficacy|1|||
105398122|NCT01276106|363466720|FG002|Overall Study|Lack of Efficacy|0|||
105398123|NCT01276106|363466721|FG003|Overall Study|Lack of Efficacy|1|||
105398124|NCT01276106|363466718|FG000|Overall Study|Lost to Follow-up|2|||
105398125|NCT01276106|363466719|FG001|Overall Study|Lost to Follow-up|1|||
105398126|NCT01276106|363466720|FG002|Overall Study|Lost to Follow-up|1|||
105398127|NCT01276106|363466721|FG003|Overall Study|Lost to Follow-up|0|||
105398128|NCT01276106|363466718|FG000|Overall Study|Physician Decision|0|||
105398129|NCT01276106|363466719|FG001|Overall Study|Physician Decision|0|||
105398130|NCT01276106|363466720|FG002|Overall Study|Physician Decision|1|||
105398131|NCT01276106|363466721|FG003|Overall Study|Physician Decision|1|||
105398132|NCT01276106|363466718|FG000|Overall Study|Protocol Violation|1|||
105398133|NCT01276106|363466719|FG001|Overall Study|Protocol Violation|1|||
105398134|NCT01276106|363466720|FG002|Overall Study|Protocol Violation|0|||
105398135|NCT01276106|363466721|FG003|Overall Study|Protocol Violation|2|||
105398136|NCT01276106|363466718|FG000|Overall Study|Insufficient therapeutic effects|0|||
105398137|NCT01276106|363466719|FG001|Overall Study|Insufficient therapeutic effects|0|||
105398138|NCT01276106|363466720|FG002|Overall Study|Insufficient therapeutic effects|2|||
105398139|NCT01276106|363466721|FG003|Overall Study|Insufficient therapeutic effects|0|||
105398140|NCT00656370|363466727|FG000|Overall Study|Screen Failures|7|||
105398141|NCT00656370|363466727|FG000|Overall Study|Alternates|3|||
105398142|NCT03913130|363466729|FG000|Overall Study|Sponsor Decision|1|||
105398143|NCT01634152|363466730|FG000|Overall Study|Adverse Event|2|||
105398144|NCT01634152|363466731|FG001|Overall Study|Adverse Event|0|||
105398145|NCT01634152|363466732|FG002|Overall Study|Adverse Event|2|||
105398146|NCT01634152|363466730|FG000|Overall Study|Consent withdrawn not due to AE|1|||
105398147|NCT01634152|363466731|FG001|Overall Study|Consent withdrawn not due to AE|0|||
105398148|NCT01634152|363466732|FG002|Overall Study|Consent withdrawn not due to AE|1|||
105398149|NCT01634152|363466730|FG000|Overall Study|Not treated|0|||
105398150|NCT01634152|363466731|FG001|Overall Study|Not treated|1|||
105398151|NCT01634152|363466732|FG002|Overall Study|Not treated|0|||
105398152|NCT01634152|363466730|FG000|Overall Study|Other reason not defined above|1|||
105398153|NCT01634152|363466731|FG001|Overall Study|Other reason not defined above|0|||
105398154|NCT01634152|363466732|FG002|Overall Study|Other reason not defined above|1|||
105398155|NCT01542788|363466733|FG000|Overall Study|Randomized but Not Treated|2|||
105398156|NCT01542788|363466734|FG001|Overall Study|Randomized but Not Treated|0|||
105398157|NCT01542788|363466733|FG000|Overall Study|Lack of Efficacy|41|||
105398158|NCT01542788|363466734|FG001|Overall Study|Lack of Efficacy|71|||
105398159|NCT01542788|363466733|FG000|Overall Study|Lost to Follow-up|5|||
105398160|NCT01542788|363466734|FG001|Overall Study|Lost to Follow-up|0|||
105398161|NCT01542788|363466733|FG000|Overall Study|Death|3|||
105398162|NCT01542788|363466734|FG001|Overall Study|Death|0|||
105398163|NCT01542788|363466733|FG000|Overall Study|Protocol Violation|2|||
105398164|NCT01542788|363466734|FG001|Overall Study|Protocol Violation|0|||
105398165|NCT01542788|363466733|FG000|Overall Study|Physician Decision|1|||
105398166|NCT01542788|363466734|FG001|Overall Study|Physician Decision|0|||
105398167|NCT01542788|363466733|FG000|Overall Study|Withdrawal by Subject|1|||
105398168|NCT01542788|363466734|FG001|Overall Study|Withdrawal by Subject|0|||
105398169|NCT01323192|363468504|FG000|Overall Study|Adverse Event|6|||
105398170|NCT01323192|363468505|FG001|Overall Study|Adverse Event|1|||
105398171|NCT01323192|363468504|FG000|Overall Study|Withdrawal by Subject|3|||
105398172|NCT01323192|363468505|FG001|Overall Study|Withdrawal by Subject|1|||
105398173|NCT01323192|363468504|FG000|Overall Study|Noncompliance with study medication|0|||
105398174|NCT01323192|363468505|FG001|Overall Study|Noncompliance with study medication|3|||
105398175|NCT01323192|363468504|FG000|Overall Study|Nonmedical reasons|0|||
105398176|NCT01323192|363468505|FG001|Overall Study|Nonmedical reasons|1|||
105398177|NCT05246514|363468514|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
105398178|NCT05246514|363468514|FG000|Overall Study|Withdrawal by Subject|1|||
105398179|NCT05246514|363468514|FG000|Overall Study|Death|13|||
105398180|NCT00140140|363468518|FG000|Overall Study|Unacceptable toxicity|1|||
105398181|NCT00140140|363468519|FG001|Overall Study|Unacceptable toxicity|1|||
105398182|NCT00140140|363468520|FG002|Overall Study|Unacceptable toxicity|2|||
105398183|NCT00140140|363468518|FG000|Overall Study|Physician Decision|1|||
105398184|NCT00140140|363468519|FG001|Overall Study|Physician Decision|1|||
105398185|NCT00140140|363468520|FG002|Overall Study|Physician Decision|0|||
105398186|NCT02835690|363468521|FG000|Overall Study|Death|12|||
105398187|NCT02835690|363468522|FG001|Overall Study|Death|11|||
105398188|NCT02835690|363468523|FG002|Overall Study|Death|13|||
105398189|NCT02835690|363468521|FG000|Overall Study|Transferred to Extension Study|2|||
105398190|NCT02835690|363468522|FG001|Overall Study|Transferred to Extension Study|2|||
105398191|NCT02835690|363468523|FG002|Overall Study|Transferred to Extension Study|1|||
105398192|NCT02835690|363468521|FG000|Overall Study|Did Not Continue on Extension Study|0|||
105398193|NCT02835690|363468522|FG001|Overall Study|Did Not Continue on Extension Study|0|||
105398194|NCT02835690|363468523|FG002|Overall Study|Did Not Continue on Extension Study|1|||
105398195|NCT02835690|363468521|FG000|Overall Study|Not Treated|0|||
105398196|NCT02835690|363468522|FG001|Overall Study|Not Treated|2|||
105398197|NCT02835690|363468523|FG002|Overall Study|Not Treated|0|||
105398198|NCT02704208|363468527|FG000|Overall Study|Lost to Follow-up|42|||
105398199|NCT02704208|363468528|FG001|Overall Study|Lost to Follow-up|37|||
105398200|NCT03493958|363468530|FG000|Overall Study|Withdrawal by Subject|6|||
105398201|NCT03493958|363468530|FG000|Overall Study|Lost to Follow-up|7|||
105398202|NCT03493958|363468530|FG000|Overall Study|Did not complete all required study procedures|2|||
105398203|NCT04388826|363468531|FG000|Overall Study|Lost to Follow-up|3|||
105398204|NCT04388826|363468532|FG001|Overall Study|Lost to Follow-up|2|||
105398205|NCT04388826|363468531|FG000|Overall Study|Adverse Event|1|||
105398206|NCT04388826|363468532|FG001|Overall Study|Adverse Event|0|||
105398207|NCT02410772|363468535|FG000|Overall Study|Death|3|||
105398208|NCT02410772|363468536|FG001|Overall Study|Death|4|||
105398209|NCT02410772|363468537|FG002|Overall Study|Death|8|||
105398210|NCT02410772|363468535|FG000|Overall Study|Lost to Follow-up|31|||
105398211|NCT02410772|363468536|FG001|Overall Study|Lost to Follow-up|23|||
105398212|NCT02410772|363468537|FG002|Overall Study|Lost to Follow-up|22|||
105398213|NCT02410772|363468535|FG000|Overall Study|Pregnancy|8|||
105398214|NCT02410772|363468536|FG001|Overall Study|Pregnancy|4|||
105398215|NCT02410772|363468537|FG002|Overall Study|Pregnancy|5|||
105398216|NCT02410772|363468535|FG000|Overall Study|Protocol Violation|8|||
105398217|NCT02410772|363468536|FG001|Overall Study|Protocol Violation|8|||
105398218|NCT02410772|363468537|FG002|Overall Study|Protocol Violation|4|||
105398219|NCT02410772|363468535|FG000|Overall Study|Baseline Drug Resistance|49|||
105398220|NCT02410772|363468536|FG001|Overall Study|Baseline Drug Resistance|40|||
105398221|NCT02410772|363468537|FG002|Overall Study|Baseline Drug Resistance|51|||
105398222|NCT02410772|363468535|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
105398223|NCT02410772|363468536|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
105398224|NCT02410772|363468537|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
105398225|NCT02410772|363468535|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
105398226|NCT02410772|363468536|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
105398227|NCT02410772|363468537|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
105398228|NCT00949533|363468538|FG000|Overall Study|Lost to Follow-up|0|||
105398229|NCT00949533|363468539|FG001|Overall Study|Lost to Follow-up|1|||
105398230|NCT01170663|363468544|FG000|Overall Study|Lost to Follow-up|3|||
105398231|NCT01170663|363468545|FG001|Overall Study|Lost to Follow-up|9|||
105398232|NCT01170663|363468544|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
105398233|NCT01170663|363468545|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
105398234|NCT00744861|363468547|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
105398235|NCT00744861|363468548|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
105398236|NCT00744861|363468549|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
105398237|NCT00744861|363468550|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
105398238|NCT00744861|363468547|FG000|Feasibility Stage 1|Pregnancy|0|||
105398239|NCT00744861|363468548|FG001|Feasibility Stage 1|Pregnancy|1|||
105398240|NCT00744861|363468549|FG002|Feasibility Stage 1|Pregnancy|0|||
105398241|NCT00744861|363468550|FG003|Feasibility Stage 1|Pregnancy|0|||
105398242|NCT00744861|363468547|FG000|Pivotal Stage 2|Adverse Event|0|||
105398243|NCT00744861|363468548|FG001|Pivotal Stage 2|Adverse Event|0|||
105398244|NCT00744861|363468549|FG002|Pivotal Stage 2|Adverse Event|6|||
105398245|NCT00744861|363468550|FG003|Pivotal Stage 2|Adverse Event|11|||
105398246|NCT00744861|363468547|FG000|Pivotal Stage 2|Death|0|||
105398247|NCT00744861|363468548|FG001|Pivotal Stage 2|Death|0|||
105398248|NCT00744861|363468549|FG002|Pivotal Stage 2|Death|0|||
105398249|NCT00744861|363468550|FG003|Pivotal Stage 2|Death|1|||
105398250|NCT00744861|363468547|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
105398251|NCT00744861|363468548|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
105398252|NCT00744861|363468549|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
105398253|NCT00744861|363468550|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
105398254|NCT00744861|363468547|FG000|Pivotal Stage 2|Physician Decision|0|||
105398255|NCT00744861|363468548|FG001|Pivotal Stage 2|Physician Decision|0|||
105398256|NCT00744861|363468549|FG002|Pivotal Stage 2|Physician Decision|3|||
105398257|NCT00744861|363468550|FG003|Pivotal Stage 2|Physician Decision|1|||
105398258|NCT00744861|363468547|FG000|Pivotal Stage 2|Protocol Violation|0|||
105398259|NCT00744861|363468548|FG001|Pivotal Stage 2|Protocol Violation|0|||
105398260|NCT00744861|363468549|FG002|Pivotal Stage 2|Protocol Violation|0|||
105398261|NCT00744861|363468550|FG003|Pivotal Stage 2|Protocol Violation|1|||
105398262|NCT00744861|363468547|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
105398263|NCT00744861|363468548|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
105398264|NCT00744861|363468549|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
105398265|NCT00744861|363468550|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
105398266|NCT00744861|363468547|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
105398267|NCT00744861|363468548|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
105398268|NCT00744861|363468549|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
105398269|NCT00744861|363468550|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
105398270|NCT01531998|363468551|FG000|Overall Study|Withdrawal by Subject|3|||
105398271|NCT01156844|363468552|FG000|Overall Study|Adverse Event|0|||
105398272|NCT01156844|363468553|FG001|Overall Study|Adverse Event|0|||
105398273|NCT01156844|363468554|FG002|Overall Study|Adverse Event|1|||
105398274|NCT01156844|363468555|FG003|Overall Study|Adverse Event|1|||
105398275|NCT01156844|363468552|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105398276|NCT01156844|363468553|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105398277|NCT01156844|363468554|FG002|Overall Study|Abnormal test procedure result(s)|2|||
105398278|NCT01156844|363468555|FG003|Overall Study|Abnormal test procedure result(s)|2|||
105398279|NCT01156844|363468552|FG000|Overall Study|Withdrawal by Subject|0|||
105398280|NCT01156844|363468553|FG001|Overall Study|Withdrawal by Subject|0|||
105398281|NCT01156844|363468554|FG002|Overall Study|Withdrawal by Subject|2|||
105398282|NCT01156844|363468555|FG003|Overall Study|Withdrawal by Subject|2|||
105398283|NCT01156844|363468552|FG000|Overall Study|Lost to Follow-up|0|||
105398284|NCT01156844|363468553|FG001|Overall Study|Lost to Follow-up|0|||
105398285|NCT01156844|363468554|FG002|Overall Study|Lost to Follow-up|1|||
105398286|NCT01156844|363468555|FG003|Overall Study|Lost to Follow-up|0|||
105398287|NCT01156844|363468552|FG000|Overall Study|Administrative problems|0|||
105398288|NCT01156844|363468553|FG001|Overall Study|Administrative problems|1|||
105398289|NCT01156844|363468554|FG002|Overall Study|Administrative problems|0|||
105398290|NCT01156844|363468555|FG003|Overall Study|Administrative problems|1|||
105398291|NCT01156844|363468552|FG000|Overall Study|Protocol deviation|2|||
105398292|NCT01156844|363468553|FG001|Overall Study|Protocol deviation|0|||
105398293|NCT01156844|363468554|FG002|Overall Study|Protocol deviation|0|||
105398294|NCT01156844|363468555|FG003|Overall Study|Protocol deviation|0|||
105398295|NCT03440008|363468559|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
105398296|NCT03440008|363468560|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
105398297|NCT03440008|363468559|FG000|Overall Study|Withdrawal by Subject|1|||
105398298|NCT03440008|363468560|FG001|Overall Study|Withdrawal by Subject|0|||
105398299|NCT00382174|363468569|FG000|Overall Study|Lost to Follow-up|1|||
105398300|NCT00382174|363468570|FG001|Overall Study|Lost to Follow-up|4|||
105398301|NCT00382174|363468571|FG002|Overall Study|Lost to Follow-up|5|||
105398302|NCT00382174|363468569|FG000|Overall Study|Adverse Event|1|||
105398303|NCT00382174|363468570|FG001|Overall Study|Adverse Event|4|||
105398304|NCT00382174|363468571|FG002|Overall Study|Adverse Event|5|||
105398305|NCT00382174|363468569|FG000|Overall Study|Withdrawal by Subject|1|||
105398306|NCT00382174|363468570|FG001|Overall Study|Withdrawal by Subject|4|||
105398307|NCT00382174|363468571|FG002|Overall Study|Withdrawal by Subject|5|||
105398308|NCT00382174|363468569|FG000|Overall Study|Non compliance|1|||
105398309|NCT00382174|363468570|FG001|Overall Study|Non compliance|0|||
105398310|NCT00382174|363468571|FG002|Overall Study|Non compliance|1|||
105398311|NCT00382174|363468569|FG000|Overall Study|Physician Decision|0|||
105398312|NCT00382174|363468570|FG001|Overall Study|Physician Decision|2|||
105398313|NCT00382174|363468571|FG002|Overall Study|Physician Decision|2|||
105398314|NCT00382174|363468569|FG000|Overall Study|Failed to meet criteria|0|||
105398315|NCT00382174|363468570|FG001|Overall Study|Failed to meet criteria|1|||
105398316|NCT00382174|363468571|FG002|Overall Study|Failed to meet criteria|1|||
105398317|NCT00382174|363468569|FG000|Overall Study|Wounds merged|0|||
105398318|NCT00382174|363468570|FG001|Overall Study|Wounds merged|2|||
105398319|NCT00382174|363468571|FG002|Overall Study|Wounds merged|2|||
105398320|NCT03097289|363468572|FG000|Overall Study|Adverse Event|1|||
105398321|NCT03097289|363468572|FG000|Overall Study|Equipment failure|2|||
105398322|NCT03097289|363468572|FG000|Overall Study|Collected platelet product unusable|3|||
105398323|NCT00654732|363468573|FG000|Overall Study|Adverse Event|4|||
105398324|NCT00654732|363468574|FG001|Overall Study|Adverse Event|6|||
105398325|NCT04138056|363468575|FG000|Primary Study|Lost to Follow-up|3|||
105398326|NCT04138056|363468576|FG001|Primary Study|Lost to Follow-up|4|||
105398327|NCT04138056|363468577|FG002|Primary Study|Lost to Follow-up|1|||
105398328|NCT04138056|363468578|FG003|Primary Study|Lost to Follow-up|1|||
105398329|NCT04138056|363468579|FG004|Primary Study|Lost to Follow-up|4|||
105398330|NCT04138056|363468575|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
105398331|NCT04138056|363468576|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
105398332|NCT04138056|363468577|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
105398333|NCT04138056|363468578|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
105398334|NCT04138056|363468579|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
105398335|NCT04138056|363468575|FG000|Extension Study|Lost to Follow-up|1|||
105398336|NCT04138056|363468576|FG001|Extension Study|Lost to Follow-up|2|||
105398337|NCT04138056|363468577|FG002|Extension Study|Lost to Follow-up|1|||
105398338|NCT04138056|363468578|FG003|Extension Study|Lost to Follow-up|0|||
105398339|NCT04138056|363468579|FG004|Extension Study|Lost to Follow-up|1|||
105398340|NCT01734902|363468580|FG000|Overall Study|Other than listed|0|||
105398341|NCT01734902|363468581|FG001|Overall Study|Other than listed|2|||
105398342|NCT00060944|363468582|FG000|Overall Study|Adverse Event|12|||
105398343|NCT00060944|363468583|FG001|Overall Study|Adverse Event|10|||
105398344|NCT00060944|363468582|FG000|Overall Study|Death|2|||
105398345|NCT00060944|363468583|FG001|Overall Study|Death|3|||
105398346|NCT00060944|363468582|FG000|Overall Study|Withdrawal by Subject|18|||
105398347|NCT00060944|363468583|FG001|Overall Study|Withdrawal by Subject|5|||
105398348|NCT00060944|363468582|FG000|Overall Study|Disease Progression|93|||
105398349|NCT00060944|363468583|FG001|Overall Study|Disease Progression|94|||
105398350|NCT00060944|363468582|FG000|Overall Study|Lost to Follow-up|1|||
105398351|NCT00060944|363468583|FG001|Overall Study|Lost to Follow-up|0|||
105398352|NCT00060944|363468582|FG000|Overall Study|Subject Ineligible To Continue|2|||
105398353|NCT00060944|363468583|FG001|Overall Study|Subject Ineligible To Continue|1|||
105398354|NCT00060944|363468582|FG000|Overall Study|Treatment Switch|0|||
105398355|NCT00060944|363468583|FG001|Overall Study|Treatment Switch|13|||
105398356|NCT00060944|363468582|FG000|Overall Study|Other|2|||
105398357|NCT00060944|363468583|FG001|Overall Study|Other|4|||
105398358|NCT00060944|363468582|FG000|Overall Study|randomized but not treated|6|||
105398359|NCT00060944|363468583|FG001|Overall Study|randomized but not treated|4|||
105398360|NCT00776230|363468584|FG000|Overall Study|Lost to Follow-up|2|||
105398361|NCT00776230|363468585|FG001|Overall Study|Lost to Follow-up|1|||
105398362|NCT00776230|363468586|FG002|Overall Study|Lost to Follow-up|5|||
105398363|NCT00776230|363468584|FG000|Overall Study|Not vaccinated at Day 0|1|||
105398364|NCT00776230|363468585|FG001|Overall Study|Not vaccinated at Day 0|0|||
105398365|NCT00776230|363468586|FG002|Overall Study|Not vaccinated at Day 0|0|||
105398366|NCT00776230|363468584|FG000|Overall Study|Withdrawal by Subject|0|||
105398367|NCT00776230|363468585|FG001|Overall Study|Withdrawal by Subject|1|||
105398368|NCT00776230|363468586|FG002|Overall Study|Withdrawal by Subject|0|||
105398369|NCT00776230|363468584|FG000|Overall Study|Subject missed Visit 4|0|||
105398370|NCT00776230|363468585|FG001|Overall Study|Subject missed Visit 4|1|||
105398371|NCT00776230|363468586|FG002|Overall Study|Subject missed Visit 4|0|||
105398372|NCT03510273|363468587|FG000|Overall Study|Withdrawal by Subject|2|||
105398373|NCT03510273|363468587|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
105398374|NCT03510273|363468587|FG000|Overall Study|Moved away from study area|4|||
105398375|NCT01374425|363468590|FG000|Overall Study|Radiographic Disease Progression|86|||
105398376|NCT01374425|363468591|FG001|Overall Study|Radiographic Disease Progression|81|||
105398377|NCT01374425|363468590|FG000|Overall Study|Clinical Disease Progression|9|||
105398378|NCT01374425|363468591|FG001|Overall Study|Clinical Disease Progression|6|||
105398379|NCT01374425|363468590|FG000|Overall Study|Adverse Event|29|||
105398380|NCT01374425|363468591|FG001|Overall Study|Adverse Event|18|||
105398381|NCT01374425|363468590|FG000|Overall Study|Death (Progression of Disease)|1|||
105398382|NCT01374425|363468591|FG001|Overall Study|Death (Progression of Disease)|0|||
105398383|NCT01374425|363468590|FG000|Overall Study|Death (Adverse Event)|2|||
105398384|NCT01374425|363468591|FG001|Overall Study|Death (Adverse Event)|4|||
105398385|NCT01374425|363468590|FG000|Overall Study|Withdrawal by Subject|6|||
105398386|NCT01374425|363468591|FG001|Overall Study|Withdrawal by Subject|7|||
105398387|NCT01374425|363468590|FG000|Overall Study|Refused Treatment|10|||
105398388|NCT01374425|363468591|FG001|Overall Study|Refused Treatment|24|||
105398389|NCT01374425|363468590|FG000|Overall Study|Protocol Violation|2|||
105398390|NCT01374425|363468591|FG001|Overall Study|Protocol Violation|3|||
105398391|NCT01374425|363468590|FG000|Overall Study|Sponsor Decision|0|||
105398392|NCT01374425|363468591|FG001|Overall Study|Sponsor Decision|1|||
105398393|NCT01374425|363468590|FG000|Overall Study|Lost to Follow-up|2|||
105398394|NCT01374425|363468591|FG001|Overall Study|Lost to Follow-up|1|||
105398395|NCT01374425|363468590|FG000|Overall Study|Other|41|||
105398396|NCT01374425|363468591|FG001|Overall Study|Other|43|||
105398397|NCT00956293|363468592|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
105398398|NCT00956293|363468593|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
105398399|NCT00956293|363468594|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
105398400|NCT00956293|363468592|FG000|Main Period (Pre-randomization)|Death|0|||
105398401|NCT00956293|363468593|FG001|Main Period (Pre-randomization)|Death|0|||
105398402|NCT00956293|363468594|FG002|Main Period (Pre-randomization)|Death|1|||
105398403|NCT00956293|363468592|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
105398404|NCT00956293|363468593|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
105398405|NCT00956293|363468594|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
105398406|NCT00956293|363468592|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
105398407|NCT00956293|363468593|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
105398408|NCT00956293|363468594|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
105398409|NCT00956293|363468592|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
105398410|NCT00956293|363468593|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
105398411|NCT00956293|363468594|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
105398412|NCT00956293|363468592|FG000|Main Period (Pre-randomization)|Graft loss|0|||
105398413|NCT00956293|363468593|FG001|Main Period (Pre-randomization)|Graft loss|0|||
105398414|NCT00956293|363468594|FG002|Main Period (Pre-randomization)|Graft loss|7|||
105398415|NCT00956293|363468592|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
105398416|NCT00956293|363468593|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
105398417|NCT00956293|363468594|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
105398418|NCT00956293|363468592|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
105398419|NCT00956293|363468593|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
105398420|NCT00956293|363468594|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
105398421|NCT00956293|363468592|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
105398422|NCT00956293|363468593|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
105398423|NCT00956293|363468594|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
105398424|NCT00956293|363468592|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
105398425|NCT00956293|363468593|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
105398426|NCT00956293|363468594|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
105398427|NCT00956293|363468592|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
105398428|NCT00956293|363468593|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
105398429|NCT00956293|363468594|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
105398430|NCT00956293|363468592|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
105398431|NCT00956293|363468593|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
105398432|NCT00956293|363468594|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
105398433|NCT00956293|363468592|FG000|Main Period (Randomization)|Adverse Event|0|||
105398434|NCT00956293|363468593|FG001|Main Period (Randomization)|Adverse Event|15|||
105398435|NCT00956293|363468594|FG002|Main Period (Randomization)|Adverse Event|0|||
105398436|NCT00956293|363468592|FG000|Follow-up Period|Follow-up period was terminated.|20|||
105398437|NCT00956293|363468593|FG001|Follow-up Period|Follow-up period was terminated.|32|||
105398438|NCT00956293|363468594|FG002|Follow-up Period|Follow-up period was terminated.|0|||
105398439|NCT03383666|363468595|FG000|Overall Study|Withdrawal by Subject|2|||
105398440|NCT03383666|363468595|FG000|Overall Study|Lost to Follow-up|2|||
105398441|NCT03507127|363468598|FG000|Overall Study|Withdrawal by Subject|1|||
105398442|NCT03507127|363468599|FG001|Overall Study|Withdrawal by Subject|0|||
105398443|NCT03507127|363468598|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
105398444|NCT03507127|363468599|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
105398445|NCT03508050|363468600|FG000|Overall Study|Pleural adhesions|1|||
105398446|NCT03508050|363468601|FG001|Overall Study|Pleural adhesions|0|||
105398447|NCT03508050|363468600|FG000|Overall Study|Mucus plug|1|||
105398448|NCT03508050|363468601|FG001|Overall Study|Mucus plug|0|||
105398449|NCT03508050|363468600|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
105398450|NCT03508050|363468601|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
105398451|NCT03508050|363468600|FG000|Overall Study|Sustained desaturation|0|||
105398452|NCT03508050|363468601|FG001|Overall Study|Sustained desaturation|1|||
105398453|NCT03961308|363468602|FG000|Overall Study|Withdrawal by Subject|1|||
105398454|NCT03961308|363468603|FG001|Overall Study|Withdrawal by Subject|0|||
105398455|NCT03961308|363468602|FG000|Overall Study|Other|1|||
105398456|NCT03961308|363468603|FG001|Overall Study|Other|0|||
105398457|NCT03961308|363468602|FG000|Overall Study|Lost to Follow-up|0|||
105398458|NCT03961308|363468603|FG001|Overall Study|Lost to Follow-up|1|||
105398459|NCT03961308|363468602|FG000|Overall Study|Adverse Event|0|||
105398460|NCT03961308|363468603|FG001|Overall Study|Adverse Event|1|||
105398461|NCT01677988|363468604|FG000|Overall Study|Lack of Efficacy|2|||
105398462|NCT00659425|363468605|FG000|Overall Study|Disease progression|1|||
105398463|NCT00659425|363468606|FG001|Overall Study|Disease progression|0|||
105398464|NCT00659425|363468607|FG002|Overall Study|Disease progression|0|||
105398465|NCT00659425|363468608|FG003|Overall Study|Disease progression|1|||
105398466|NCT00659425|363468609|FG004|Overall Study|Disease progression|0|||
105398467|NCT00659425|363468610|FG005|Overall Study|Disease progression|2|||
105398468|NCT00659425|363468611|FG006|Overall Study|Disease progression|4|||
105398469|NCT00659425|363468612|FG007|Overall Study|Disease progression|3|||
105398470|NCT00659425|363468613|FG008|Overall Study|Disease progression|5|||
105398471|NCT00659425|363468614|FG009|Overall Study|Disease progression|3|||
105398472|NCT00659425|363468605|FG000|Overall Study|Death|0|||
105398473|NCT00659425|363468606|FG001|Overall Study|Death|0|||
105398474|NCT00659425|363468607|FG002|Overall Study|Death|0|||
105398475|NCT00659425|363468608|FG003|Overall Study|Death|1|||
105398476|NCT00659425|363468609|FG004|Overall Study|Death|0|||
105398477|NCT00659425|363468610|FG005|Overall Study|Death|0|||
105398478|NCT00659425|363468611|FG006|Overall Study|Death|1|||
105398479|NCT00659425|363468612|FG007|Overall Study|Death|0|||
105398480|NCT00659425|363468613|FG008|Overall Study|Death|0|||
105398481|NCT00659425|363468614|FG009|Overall Study|Death|0|||
105398482|NCT00659425|363468605|FG000|Overall Study|Adverse Event|0|||
105398483|NCT00659425|363468606|FG001|Overall Study|Adverse Event|0|||
105398484|NCT00659425|363468607|FG002|Overall Study|Adverse Event|0|||
105580618|NCT01474512|364126474|FG009|Induction Period|Adverse Event|0|||
105580619|NCT01474512|364126475|FG010|Induction Period|Adverse Event|0|||
105398485|NCT00659425|363468608|FG003|Overall Study|Adverse Event|0|||
105398486|NCT00659425|363468609|FG004|Overall Study|Adverse Event|0|||
105398487|NCT00659425|363468610|FG005|Overall Study|Adverse Event|1|||
105398488|NCT00659425|363468611|FG006|Overall Study|Adverse Event|0|||
105398489|NCT00659425|363468612|FG007|Overall Study|Adverse Event|3|||
105398490|NCT00659425|363468613|FG008|Overall Study|Adverse Event|1|||
105398491|NCT00659425|363468614|FG009|Overall Study|Adverse Event|4|||
105398492|NCT00659425|363468605|FG000|Overall Study|Investigator Discretion|0|||
105398493|NCT00659425|363468606|FG001|Overall Study|Investigator Discretion|0|||
105398494|NCT00659425|363468607|FG002|Overall Study|Investigator Discretion|0|||
105398495|NCT00659425|363468608|FG003|Overall Study|Investigator Discretion|0|||
105398496|NCT00659425|363468609|FG004|Overall Study|Investigator Discretion|0|||
105398497|NCT00659425|363468610|FG005|Overall Study|Investigator Discretion|1|||
105398498|NCT00659425|363468611|FG006|Overall Study|Investigator Discretion|0|||
105398499|NCT00659425|363468612|FG007|Overall Study|Investigator Discretion|3|||
105398500|NCT00659425|363468613|FG008|Overall Study|Investigator Discretion|0|||
105398501|NCT00659425|363468614|FG009|Overall Study|Investigator Discretion|0|||
105398502|NCT00659425|363468605|FG000|Overall Study|Other|0|||
105398503|NCT00659425|363468606|FG001|Overall Study|Other|1|||
105398504|NCT00659425|363468607|FG002|Overall Study|Other|1|||
105398505|NCT00659425|363468608|FG003|Overall Study|Other|2|||
105398506|NCT00659425|363468609|FG004|Overall Study|Other|4|||
105398507|NCT00659425|363468610|FG005|Overall Study|Other|0|||
105398508|NCT00659425|363468611|FG006|Overall Study|Other|3|||
105398509|NCT00659425|363468612|FG007|Overall Study|Other|2|||
105398510|NCT00659425|363468613|FG008|Overall Study|Other|0|||
105398511|NCT00659425|363468614|FG009|Overall Study|Other|6|||
105398512|NCT01174563|363468615|FG000|Overall Study|Progressive Disease|45|||
105398513|NCT01174563|363468615|FG000|Overall Study|Death|5|||
105398514|NCT01174563|363468615|FG000|Overall Study|Investigator's Discretion|5|||
105398515|NCT01174563|363468615|FG000|Overall Study|Participant Withdrew Consent|3|||
105398516|NCT01174563|363468615|FG000|Overall Study|Rash Adverse Event|1|||
105398517|NCT01174563|363468615|FG000|Overall Study|Sponsor's decision|1|||
105398518|NCT00279214|363468633|FG000|Overall Study|Physician Decision|3|||
105398519|NCT00279214|363468634|FG001|Overall Study|Physician Decision|2|||
105398520|NCT04046939|363468635|FG000|Primary Assessment Period|Adverse Event|1|||
105398521|NCT04046939|363468636|FG001|Primary Assessment Period|Adverse Event|0|||
105398522|NCT04046939|363468637|FG002|Primary Assessment Period|Adverse Event|0|||
105398523|NCT04046939|363468638|FG003|Primary Assessment Period|Adverse Event|0|||
105398524|NCT04046939|363468635|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
105398525|NCT04046939|363468636|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
105398526|NCT04046939|363468637|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
105398527|NCT04046939|363468638|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
105398528|NCT04046939|363468635|FG000|Primary Assessment Period|Physician Decision|0|||
105398529|NCT04046939|363468636|FG001|Primary Assessment Period|Physician Decision|0|||
105493205|NCT04612790|363818799|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
105398530|NCT04046939|363468637|FG002|Primary Assessment Period|Physician Decision|1|||
105493206|NCT04612790|363818796|FG000|OLE Period (Up to 1 Year)|Other|0|||
105398531|NCT04046939|363468638|FG003|Primary Assessment Period|Physician Decision|0|||
105398532|NCT04046939|363468635|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
105493207|NCT04612790|363818797|FG001|OLE Period (Up to 1 Year)|Other|0|||
105398533|NCT04046939|363468636|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
105398534|NCT04046939|363468637|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
105493208|NCT04612790|363818798|FG002|OLE Period (Up to 1 Year)|Other|0|||
105398535|NCT04046939|363468638|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
105398536|NCT01280968|363468639|FG000|Overall Study|Lost to Follow-up|8|||
105398537|NCT01280968|363468640|FG001|Overall Study|Lost to Follow-up|2|||
105398538|NCT01280968|363468639|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
105398539|NCT01280968|363468640|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
105398540|NCT01280968|363468639|FG000|Overall Study|Commuting Problems|2|||
105398541|NCT01280968|363468640|FG001|Overall Study|Commuting Problems|0|||
105398542|NCT01280968|363468639|FG000|Overall Study|Anxiety|2|||
105398543|NCT01280968|363468640|FG001|Overall Study|Anxiety|0|||
105398544|NCT01280968|363468639|FG000|Overall Study|Adverse Event|1|||
105398545|NCT01280968|363468640|FG001|Overall Study|Adverse Event|0|||
105398546|NCT01280968|363468639|FG000|Overall Study|Scheduling Conflicts|1|||
105398547|NCT01280968|363468640|FG001|Overall Study|Scheduling Conflicts|1|||
105398548|NCT01280968|363468639|FG000|Overall Study|Pre-existing Neurological Condition|1|||
105398549|NCT01280968|363468640|FG001|Overall Study|Pre-existing Neurological Condition|0|||
105398550|NCT01280968|363468639|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
105398551|NCT01280968|363468640|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
105398552|NCT01729039|363468641|FG000|Overall Study|disqualified|2|||
105398553|NCT01729039|363468642|FG001|Overall Study|disqualified|5|||
105398554|NCT01729039|363468641|FG000|Overall Study|Withdrawal by Subject|8|||
105398555|NCT01729039|363468642|FG001|Overall Study|Withdrawal by Subject|7|||
105398556|NCT01214837|363468643|FG000|Overall Study|Death|0|||
105398557|NCT01214837|363468644|FG001|Overall Study|Death|0|||
105398558|NCT01214837|363468645|FG002|Overall Study|Death|1|||
105398559|NCT01214837|363468643|FG000|Overall Study|Adverse Event|1|||
105398560|NCT01214837|363468644|FG001|Overall Study|Adverse Event|2|||
105398561|NCT01214837|363468645|FG002|Overall Study|Adverse Event|1|||
105398562|NCT01214837|363468643|FG000|Overall Study|Withdrawal by Subject|27|||
105398563|NCT01214837|363468644|FG001|Overall Study|Withdrawal by Subject|36|||
105398564|NCT01214837|363468645|FG002|Overall Study|Withdrawal by Subject|28|||
105398565|NCT01214837|363468643|FG000|Overall Study|Lost to Follow-up|20|||
105398566|NCT01214837|363468644|FG001|Overall Study|Lost to Follow-up|15|||
105398567|NCT01214837|363468645|FG002|Overall Study|Lost to Follow-up|21|||
105398568|NCT01214837|363468643|FG000|Overall Study|Inappropriate Enrolment|0|||
105398569|NCT01214837|363468644|FG001|Overall Study|Inappropriate Enrolment|1|||
105398570|NCT01214837|363468645|FG002|Overall Study|Inappropriate Enrolment|2|||
105398571|NCT01214837|363468643|FG000|Overall Study|Administrative Reason|2|||
105398572|NCT01214837|363468644|FG001|Overall Study|Administrative Reason|6|||
105398573|NCT01214837|363468645|FG002|Overall Study|Administrative Reason|4|||
105398574|NCT01214837|363468643|FG000|Overall Study|Protocol Violation|3|||
105398575|NCT01214837|363468644|FG001|Overall Study|Protocol Violation|1|||
105398576|NCT01214837|363468645|FG002|Overall Study|Protocol Violation|5|||
105398577|NCT01214837|363468643|FG000|Overall Study|Unable to Classify|1|||
105398578|NCT01214837|363468644|FG001|Overall Study|Unable to Classify|3|||
105398579|NCT01214837|363468645|FG002|Overall Study|Unable to Classify|0|||
105398580|NCT05489328|363470643|FG000|Overall Study|Lost to Follow-up|0|||
105398581|NCT05489328|363470644|FG001|Overall Study|Lost to Follow-up|0|||
105398582|NCT05489328|363470645|FG002|Overall Study|Lost to Follow-up|1|||
105398583|NCT05489328|363470646|FG003|Overall Study|Lost to Follow-up|0|||
105398584|NCT05489328|363470647|FG004|Overall Study|Lost to Follow-up|2|||
105398585|NCT05489328|363470648|FG005|Overall Study|Lost to Follow-up|0|||
105398586|NCT05489328|363470649|FG006|Overall Study|Lost to Follow-up|0|||
105398587|NCT05489328|363470650|FG007|Overall Study|Lost to Follow-up|1|||
105398588|NCT05489328|363470651|FG008|Overall Study|Lost to Follow-up|0|||
105398589|NCT05489328|363470643|FG000|Overall Study|Withdrawal by Subject|0|||
105398590|NCT05489328|363470644|FG001|Overall Study|Withdrawal by Subject|0|||
105398591|NCT05489328|363470645|FG002|Overall Study|Withdrawal by Subject|0|||
105398592|NCT05489328|363470646|FG003|Overall Study|Withdrawal by Subject|0|||
105398593|NCT05489328|363470647|FG004|Overall Study|Withdrawal by Subject|0|||
105398594|NCT05489328|363470648|FG005|Overall Study|Withdrawal by Subject|0|||
105398595|NCT05489328|363470649|FG006|Overall Study|Withdrawal by Subject|1|||
105398596|NCT05489328|363470650|FG007|Overall Study|Withdrawal by Subject|1|||
105398597|NCT05489328|363470651|FG008|Overall Study|Withdrawal by Subject|0|||
105398598|NCT05489328|363470643|FG000|Overall Study|Other|0|||
105398599|NCT05489328|363470644|FG001|Overall Study|Other|0|||
105398600|NCT05489328|363470645|FG002|Overall Study|Other|0|||
105398601|NCT05489328|363470646|FG003|Overall Study|Other|0|||
105398602|NCT05489328|363470647|FG004|Overall Study|Other|0|||
105398603|NCT05489328|363470648|FG005|Overall Study|Other|0|||
105398604|NCT05489328|363470649|FG006|Overall Study|Other|0|||
105398605|NCT05489328|363470650|FG007|Overall Study|Other|1|||
105398606|NCT05489328|363470651|FG008|Overall Study|Other|1|||
105398607|NCT01083602|363470652|FG000|Overall Study|Adverse Event|11|||
105398608|NCT01083602|363470652|FG000|Overall Study|New Cancer Therapy|2|||
105398609|NCT01083602|363470652|FG000|Overall Study|Death|1|||
105398610|NCT01083602|363470652|FG000|Overall Study|Withdrawal by Subject|5|||
105398611|NCT01083602|363470652|FG000|Overall Study|Lack of Efficacy|36|||
105398612|NCT01585025|363470654|FG000|Overall Study|Withdrawal by Subject|0|||
105398613|NCT01585025|363470655|FG001|Overall Study|Withdrawal by Subject|3|||
105398614|NCT01585025|363470656|FG002|Overall Study|Withdrawal by Subject|4|||
105398615|NCT03698279|363470657|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105398616|NCT03698279|363470658|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105398617|NCT03698279|363470659|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105398618|NCT03698279|363470660|FG003|Overall Study|Withdrawal by parent/guardian|1|||
105398619|NCT03698279|363470661|FG004|Overall Study|Withdrawal by parent/guardian|0|||
105398620|NCT03698279|363470662|FG005|Overall Study|Withdrawal by parent/guardian|0|||
105398621|NCT03698279|363470657|FG000|Overall Study|Protocol deviation|1|||
105398622|NCT03698279|363470658|FG001|Overall Study|Protocol deviation|0|||
105398623|NCT03698279|363470659|FG002|Overall Study|Protocol deviation|1|||
105398624|NCT03698279|363470660|FG003|Overall Study|Protocol deviation|0|||
105398625|NCT03698279|363470661|FG004|Overall Study|Protocol deviation|0|||
105398626|NCT03698279|363470662|FG005|Overall Study|Protocol deviation|0|||
105398627|NCT03698279|363470657|FG000|Overall Study|Withdrawal by Subject|0|||
105398628|NCT03698279|363470658|FG001|Overall Study|Withdrawal by Subject|0|||
105398629|NCT03698279|363470659|FG002|Overall Study|Withdrawal by Subject|1|||
105398630|NCT03698279|363470660|FG003|Overall Study|Withdrawal by Subject|0|||
105398631|NCT03698279|363470661|FG004|Overall Study|Withdrawal by Subject|0|||
105398632|NCT03698279|363470662|FG005|Overall Study|Withdrawal by Subject|0|||
105398633|NCT03698279|363470657|FG000|Overall Study|Lost to Follow-up|3|||
105398634|NCT03698279|363470658|FG001|Overall Study|Lost to Follow-up|1|||
105398635|NCT03698279|363470659|FG002|Overall Study|Lost to Follow-up|4|||
105398636|NCT03698279|363470660|FG003|Overall Study|Lost to Follow-up|5|||
105398637|NCT03698279|363470661|FG004|Overall Study|Lost to Follow-up|0|||
105398638|NCT03698279|363470662|FG005|Overall Study|Lost to Follow-up|0|||
105398639|NCT00402987|363470670|FG000|Overall Study|Lack of Efficacy|0|||
105398640|NCT00402987|363470671|FG001|Overall Study|Lack of Efficacy|0|||
105398641|NCT00402987|363470672|FG002|Overall Study|Lack of Efficacy|1|||
105398642|NCT00402987|363470673|FG003|Overall Study|Lack of Efficacy|0|||
105398643|NCT01668004|363470674|FG000|Overall Study|Adverse Event|7|||
105398644|NCT01668004|363470674|FG000|Overall Study|Withdrawal by Subject|2|||
105398645|NCT01668004|363470674|FG000|Overall Study|Lost to Follow-up|5|||
105398646|NCT01668004|363470674|FG000|Overall Study|Lack of Efficacy|9|||
105398647|NCT01668004|363470674|FG000|Overall Study|Non-compliance with treatment|2|||
105398648|NCT02448381|363470675|FG000|Overall Study|Adverse Event|2|||
105398649|NCT02448381|363470676|FG001|Overall Study|Adverse Event|0|||
105398650|NCT02448381|363470675|FG000|Overall Study|Lost to Follow-up|16|||
105398651|NCT02448381|363470676|FG001|Overall Study|Lost to Follow-up|9|||
105398652|NCT02448381|363470675|FG000|Overall Study|Physician Decision|1|||
105398653|NCT02448381|363470676|FG001|Overall Study|Physician Decision|1|||
105398654|NCT02448381|363470675|FG000|Overall Study|Pregnancy|1|||
105398655|NCT02448381|363470676|FG001|Overall Study|Pregnancy|0|||
105398656|NCT02448381|363470675|FG000|Overall Study|Withdrawal by Subject|13|||
105398657|NCT02448381|363470676|FG001|Overall Study|Withdrawal by Subject|9|||
105398658|NCT02448381|363470675|FG000|Overall Study|Noncompliance with Study Procedures|2|||
105398659|NCT02448381|363470676|FG001|Overall Study|Noncompliance with Study Procedures|0|||
105398660|NCT00399035|363470677|FG000|Overall Study|Death|289|||
105398661|NCT00399035|363470678|FG001|Overall Study|Death|141|||
105398662|NCT00399035|363470679|FG002|Overall Study|Death|234|||
105398663|NCT00399035|363470677|FG000|Overall Study|Lost to Follow-up|2|||
105398664|NCT00399035|363470678|FG001|Overall Study|Lost to Follow-up|1|||
105398665|NCT00399035|363470679|FG002|Overall Study|Lost to Follow-up|5|||
105493209|NCT04612790|363818799|FG003|OLE Period (Up to 1 Year)|Other|1|||
105493210|NCT01539642|363818805|FG000|Overall Study|Lack of Efficacy|20|||
105398666|NCT00399035|363470677|FG000|Overall Study|Withdrawal by Subject|19|||
105398667|NCT00399035|363470678|FG001|Overall Study|Withdrawal by Subject|15|||
105398668|NCT00399035|363470679|FG002|Overall Study|Withdrawal by Subject|12|||
105398669|NCT00399035|363470677|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
105398670|NCT00399035|363470678|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
105398671|NCT00399035|363470679|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
105398672|NCT00399035|363470677|FG000|Overall Study|Severe non-compliance with protocol|2|||
105398673|NCT00399035|363470678|FG001|Overall Study|Severe non-compliance with protocol|1|||
105398674|NCT00399035|363470679|FG002|Overall Study|Severe non-compliance with protocol|0|||
105398675|NCT00854360|363470690|FG000|Overall Study|Adverse Event|0|||
105493211|NCT01539642|363818806|FG001|Overall Study|Lack of Efficacy|18|||
105493212|NCT01539642|363818805|FG000|Overall Study|Patient ready for early discharge|8|||
105398676|NCT00854360|363470691|FG001|Overall Study|Adverse Event|1|||
105398677|NCT00854360|363470692|FG002|Overall Study|Adverse Event|2|||
105398678|NCT00854360|363470693|FG003|Overall Study|Adverse Event|6|||
105398679|NCT00854360|363470690|FG000|Overall Study|Withdrawal by Subject|0|||
105398680|NCT00854360|363470691|FG001|Overall Study|Withdrawal by Subject|0|||
105493213|NCT01539642|363818806|FG001|Overall Study|Patient ready for early discharge|7|||
105398681|NCT00854360|363470692|FG002|Overall Study|Withdrawal by Subject|0|||
105398682|NCT00854360|363470693|FG003|Overall Study|Withdrawal by Subject|1|||
105398683|NCT00854360|363470690|FG000|Overall Study|Pregnancy|0|||
105398684|NCT00854360|363470691|FG001|Overall Study|Pregnancy|1|||
105398685|NCT00854360|363470692|FG002|Overall Study|Pregnancy|0|||
105398686|NCT00854360|363470693|FG003|Overall Study|Pregnancy|0|||
105398687|NCT00854360|363470690|FG000|Overall Study|Lack of Efficacy|2|||
105398688|NCT00854360|363470691|FG001|Overall Study|Lack of Efficacy|1|||
105398689|NCT00854360|363470692|FG002|Overall Study|Lack of Efficacy|0|||
105398690|NCT00854360|363470693|FG003|Overall Study|Lack of Efficacy|0|||
105398691|NCT00854360|363470690|FG000|Overall Study|Other|0|||
105398692|NCT00854360|363470691|FG001|Overall Study|Other|0|||
105398693|NCT00854360|363470692|FG002|Overall Study|Other|0|||
105398694|NCT00854360|363470693|FG003|Overall Study|Other|3|||
105398695|NCT02949011|363470694|FG000|Overall Study|Adverse Event|6|||
105398696|NCT02949011|363470695|FG001|Overall Study|Adverse Event|7|||
105398697|NCT02949011|363470696|FG002|Overall Study|Adverse Event|3|||
105398698|NCT02949011|363470694|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
105398699|NCT02949011|363470695|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
105398700|NCT02949011|363470696|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
105398701|NCT02949011|363470694|FG000|Overall Study|Protocol Deviation|5|||
105398702|NCT02949011|363470695|FG001|Overall Study|Protocol Deviation|3|||
105398703|NCT02949011|363470696|FG002|Overall Study|Protocol Deviation|3|||
105398704|NCT02949011|363470694|FG000|Overall Study|Lack of Efficacy|0|||
105398705|NCT02949011|363470695|FG001|Overall Study|Lack of Efficacy|2|||
105398706|NCT02949011|363470696|FG002|Overall Study|Lack of Efficacy|0|||
105398707|NCT02949011|363470694|FG000|Overall Study|Withdrawal by Subject|13|||
105398708|NCT02949011|363470695|FG001|Overall Study|Withdrawal by Subject|13|||
105398709|NCT02949011|363470696|FG002|Overall Study|Withdrawal by Subject|21|||
105398710|NCT02949011|363470694|FG000|Overall Study|Lost to Follow-up|7|||
105398711|NCT02949011|363470695|FG001|Overall Study|Lost to Follow-up|5|||
105398712|NCT02949011|363470696|FG002|Overall Study|Lost to Follow-up|5|||
105398713|NCT02949011|363470694|FG000|Overall Study|Death|0|||
105398714|NCT02949011|363470695|FG001|Overall Study|Death|0|||
105398715|NCT02949011|363470696|FG002|Overall Study|Death|1|||
105398716|NCT02949011|363470694|FG000|Overall Study|Miscellaneous|2|||
105398717|NCT02949011|363470695|FG001|Overall Study|Miscellaneous|4|||
105398718|NCT02949011|363470696|FG002|Overall Study|Miscellaneous|6|||
105398719|NCT02037529|363470699|FG000|Overall Study|Withdrawal by Subject|1|||
105398720|NCT02037529|363470700|FG001|Overall Study|Withdrawal by Subject|3|||
105398721|NCT02037529|363470699|FG000|Overall Study|Adverse Event|0|||
105398722|NCT02037529|363470700|FG001|Overall Study|Adverse Event|1|||
105398723|NCT02441218|363470701|FG000|Overall Study|Death|503|||
105398724|NCT02441218|363470702|FG001|Overall Study|Death|553|||
105398725|NCT02441218|363470701|FG000|Overall Study|Withdrawal by Subject|73|||
105398726|NCT02441218|363470702|FG001|Overall Study|Withdrawal by Subject|58|||
105398727|NCT02441218|363470701|FG000|Overall Study|Lost to Follow-up|2|||
105398728|NCT02441218|363470702|FG001|Overall Study|Lost to Follow-up|1|||
105398729|NCT00718315|363470703|FG000|Overall Study|Adverse Event|1|||
105398730|NCT00718315|363470704|FG001|Overall Study|Adverse Event|2|||
105398731|NCT00718315|363470705|FG002|Overall Study|Adverse Event|3|||
105398732|NCT00718315|363470703|FG000|Overall Study|Death|6|||
105398733|NCT00718315|363470704|FG001|Overall Study|Death|6|||
105398734|NCT00718315|363470705|FG002|Overall Study|Death|5|||
105398735|NCT00718315|363470703|FG000|Overall Study|Lost to Follow-up|2|||
105398736|NCT00718315|363470704|FG001|Overall Study|Lost to Follow-up|3|||
105398737|NCT00718315|363470705|FG002|Overall Study|Lost to Follow-up|4|||
105398738|NCT00718315|363470703|FG000|Overall Study|Protocol Violation|5|||
105398739|NCT00718315|363470704|FG001|Overall Study|Protocol Violation|5|||
105398740|NCT00718315|363470705|FG002|Overall Study|Protocol Violation|3|||
105398741|NCT00718315|363470703|FG000|Overall Study|Erlotinib dose decreased|4|||
105398742|NCT00718315|363470704|FG001|Overall Study|Erlotinib dose decreased|3|||
105398743|NCT00718315|363470705|FG002|Overall Study|Erlotinib dose decreased|1|||
105398744|NCT00718315|363470703|FG000|Overall Study|Use of Minocyclin|1|||
105493214|NCT01539642|363818805|FG000|Overall Study|Adverse Event|6|||
105493215|NCT01539642|363818806|FG001|Overall Study|Adverse Event|4|||
105398745|NCT00718315|363470704|FG001|Overall Study|Use of Minocyclin|1|||
105398746|NCT00718315|363470705|FG002|Overall Study|Use of Minocyclin|1|||
105398747|NCT00718315|363470703|FG000|Overall Study|Disease progression|0|||
105398748|NCT00718315|363470704|FG001|Overall Study|Disease progression|1|||
105398749|NCT00718315|363470705|FG002|Overall Study|Disease progression|1|||
105398750|NCT00718315|363470703|FG000|Overall Study|Other|0|||
105398751|NCT00718315|363470704|FG001|Overall Study|Other|0|||
105398752|NCT00718315|363470705|FG002|Overall Study|Other|1|||
105398753|NCT00718315|363470703|FG000|Overall Study|Use of ATB and Corticoids|0|||
105398754|NCT00718315|363470704|FG001|Overall Study|Use of ATB and Corticoids|1|||
105398755|NCT00718315|363470705|FG002|Overall Study|Use of ATB and Corticoids|2|||
105398756|NCT00163189|363470706|FG000|Overall Study|Other|6|||
105398757|NCT00163189|363470706|FG000|Overall Study|Lost to Follow-up|1|||
105398758|NCT00163189|363470706|FG000|Overall Study|Protocol Violation|2|||
105398759|NCT00163189|363470706|FG000|Overall Study|Death|3|||
105398760|NCT00163189|363470706|FG000|Overall Study|Adverse Event|6|||
105398761|NCT00163189|363470706|FG000|Overall Study|Lack of Efficacy|7|||
105493216|NCT01539642|363818805|FG000|Overall Study|Withdrawal by Subject|2|||
105398762|NCT00163189|363470706|FG000|Overall Study|Study terminated by sponsor|11|||
105398763|NCT00163189|363470706|FG000|Overall Study|Withdrawal by Subject|11|||
105398764|NCT00163189|363470706|FG000|Overall Study|Did not meet continuation criterion|16|||
105398765|NCT02271880|363470708|FG000|Overall Study|Premature discontinuation of study|3|||
105398766|NCT02271880|363470709|FG001|Overall Study|Premature discontinuation of study|4|||
105398767|NCT00806585|363470710|FG000|Overall Study|Study terminated by Sponsor|0|||
105398768|NCT00806585|363470711|FG001|Overall Study|Study terminated by Sponsor|0|||
105398769|NCT00806585|363470712|FG002|Overall Study|Study terminated by Sponsor|1|||
105398770|NCT00806585|363470713|FG003|Overall Study|Study terminated by Sponsor|2|||
105398771|NCT00806585|363470714|FG004|Overall Study|Study terminated by Sponsor|0|||
105398772|NCT00806585|363470710|FG000|Overall Study|Protocol Violation|3|||
105398773|NCT00806585|363470711|FG001|Overall Study|Protocol Violation|1|||
105398774|NCT00806585|363470712|FG002|Overall Study|Protocol Violation|2|||
105398775|NCT00806585|363470713|FG003|Overall Study|Protocol Violation|0|||
105398776|NCT00806585|363470714|FG004|Overall Study|Protocol Violation|0|||
105398777|NCT00806585|363470710|FG000|Overall Study|Physician Decision|0|||
105398778|NCT00806585|363470711|FG001|Overall Study|Physician Decision|2|||
105398779|NCT00806585|363470712|FG002|Overall Study|Physician Decision|3|||
105398780|NCT00806585|363470713|FG003|Overall Study|Physician Decision|0|||
105398781|NCT00806585|363470714|FG004|Overall Study|Physician Decision|1|||
105398782|NCT00806585|363470710|FG000|Overall Study|Lost to Follow-up|2|||
105398783|NCT00806585|363470711|FG001|Overall Study|Lost to Follow-up|1|||
105398784|NCT00806585|363470712|FG002|Overall Study|Lost to Follow-up|2|||
105398785|NCT00806585|363470713|FG003|Overall Study|Lost to Follow-up|2|||
105398786|NCT00806585|363470714|FG004|Overall Study|Lost to Follow-up|5|||
105398787|NCT00806585|363470710|FG000|Overall Study|Lack of Efficacy|1|||
105398788|NCT00806585|363470711|FG001|Overall Study|Lack of Efficacy|0|||
105398789|NCT00806585|363470712|FG002|Overall Study|Lack of Efficacy|0|||
105398790|NCT00806585|363470713|FG003|Overall Study|Lack of Efficacy|0|||
105398791|NCT00806585|363470714|FG004|Overall Study|Lack of Efficacy|0|||
105398792|NCT00806585|363470710|FG000|Overall Study|Adverse Event|1|||
105398793|NCT00806585|363470711|FG001|Overall Study|Adverse Event|5|||
105398794|NCT00806585|363470712|FG002|Overall Study|Adverse Event|3|||
105398795|NCT00806585|363470713|FG003|Overall Study|Adverse Event|4|||
105398796|NCT00806585|363470714|FG004|Overall Study|Adverse Event|2|||
105398797|NCT00806585|363470710|FG000|Overall Study|Withdrawal by Subject|10|||
105398798|NCT00806585|363470711|FG001|Overall Study|Withdrawal by Subject|8|||
105398799|NCT00806585|363470712|FG002|Overall Study|Withdrawal by Subject|9|||
105398800|NCT00806585|363470713|FG003|Overall Study|Withdrawal by Subject|3|||
105398801|NCT00806585|363470714|FG004|Overall Study|Withdrawal by Subject|11|||
105398802|NCT00806585|363470710|FG000|Overall Study|Completion status unknown|15|||
105398803|NCT00806585|363470711|FG001|Overall Study|Completion status unknown|14|||
105398804|NCT00806585|363470712|FG002|Overall Study|Completion status unknown|12|||
105398805|NCT00806585|363470713|FG003|Overall Study|Completion status unknown|4|||
105398806|NCT00806585|363470714|FG004|Overall Study|Completion status unknown|12|||
105398807|NCT00474903|363470716|FG000|Overall Study|Protocol Violation|1|||
105398808|NCT00474903|363470717|FG001|Overall Study|Protocol Violation|5|||
105398809|NCT00474903|363470718|FG002|Overall Study|Protocol Violation|2|||
105398810|NCT00506142|363470719|FG000|Overall Study|Adverse Event|8|||
105398811|NCT00506142|363470720|FG001|Overall Study|Adverse Event|7|||
105398812|NCT00506142|363470719|FG000|Overall Study|Lack of Efficacy|21|||
105398813|NCT00506142|363470720|FG001|Overall Study|Lack of Efficacy|7|||
105398814|NCT00506142|363470719|FG000|Overall Study|Withdrawal by Subject|4|||
105398815|NCT00506142|363470720|FG001|Overall Study|Withdrawal by Subject|5|||
105398816|NCT00506142|363470719|FG000|Overall Study|Physician Decision|1|||
105398817|NCT00506142|363470720|FG001|Overall Study|Physician Decision|0|||
105398818|NCT00506142|363470719|FG000|Overall Study|New health condition|1|||
105398819|NCT00506142|363470720|FG001|Overall Study|New health condition|0|||
105398820|NCT00399529|363470721|FG000|Overall Study|Off Study Prior to Treatment|2|||
105398821|NCT01936831|363470722|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105398822|NCT01936831|363470723|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105398823|NCT01936831|363470724|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105398824|NCT01936831|363470725|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105398825|NCT01936831|363470726|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105398826|NCT01936831|363470727|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
105398827|NCT01936831|363470728|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105398828|NCT01936831|363470729|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105398829|NCT01936831|363470730|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105398830|NCT03435380|363470731|FG000|Overall Study|Death|1|||
105398831|NCT03435380|363470732|FG001|Overall Study|Death|2|||
105398832|NCT03435380|363470733|FG002|Overall Study|Death|1|||
105398833|NCT03435380|363470731|FG000|Overall Study|Lost to Follow-up|12|||
105398834|NCT03435380|363470732|FG001|Overall Study|Lost to Follow-up|8|||
105580620|NCT01474512|364126476|FG011|Induction Period|Adverse Event|0|||
105398835|NCT03435380|363470733|FG002|Overall Study|Lost to Follow-up|6|||
105398836|NCT03435380|363470731|FG000|Overall Study|Physician Decision|1|||
105398837|NCT03435380|363470732|FG001|Overall Study|Physician Decision|0|||
105398838|NCT03435380|363470733|FG002|Overall Study|Physician Decision|0|||
105398839|NCT03435380|363470731|FG000|Overall Study|Withdrawal by Subject|0|||
105398840|NCT03435380|363470732|FG001|Overall Study|Withdrawal by Subject|1|||
105398841|NCT03435380|363470733|FG002|Overall Study|Withdrawal by Subject|1|||
105398842|NCT03435380|363470731|FG000|Overall Study|Ineligible|0|||
105398843|NCT03435380|363470732|FG001|Overall Study|Ineligible|1|||
105398844|NCT03435380|363470733|FG002|Overall Study|Ineligible|1|||
105398845|NCT02133573|363470739|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
105398846|NCT02133573|363470740|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
105398847|NCT02133573|363470739|FG000|Overall Study|Child Deaths|3|||
105398848|NCT02133573|363470740|FG001|Overall Study|Child Deaths|5|||
105398849|NCT02133573|363470739|FG000|Overall Study|Child Declined Follow Ups|2|||
105398850|NCT02133573|363470740|FG001|Overall Study|Child Declined Follow Ups|1|||
105398851|NCT02133573|363470739|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
105398852|NCT02133573|363470740|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
105398853|NCT02746809|363470745|FG000|Enrollment|Inclusion Exclusion not met|9|||
105398854|NCT02746809|363470745|FG000|Enrollment|Withdrawal by Subject|1|||
105398855|NCT02746809|363470745|FG000|Enrollment|Expected Enrollment Met|2|||
105398856|NCT02746809|363470745|FG000|Procedure|Death|1|||
105398857|NCT02746809|363470745|FG000|1-Month|Death|5|||
105398858|NCT02746809|363470745|FG000|6-Month|Death|2|||
105398859|NCT02746809|363470745|FG000|6-Month|Withdrawal by Subject|1|||
105398860|NCT02746809|363470745|FG000|12-Month|Death|3|||
105398861|NCT02746809|363470745|FG000|12-Month|Withdrawal by Subject|2|||
105398862|NCT02746809|363470745|FG000|24-Month|Death|1|||
105398863|NCT02746809|363470745|FG000|24-Month|Withdrawal by Subject|1|||
105398864|NCT02746809|363470745|FG000|36-Month|Death|8|||
105398865|NCT02746809|363470745|FG000|36-Month|Withdrawal by Subject|1|||
105398866|NCT02746809|363470745|FG000|48-Month|Death|7|||
105398867|NCT02746809|363470745|FG000|48-Month|Withdrawal by Subject|1|||
105398868|NCT02746809|363470745|FG000|60-Month|Death|1|||
105398869|NCT02746809|363470745|FG000|60-Month|Lost to Follow-up|2|||
105398870|NCT02431325|363470748|FG000|Overall Study|Adverse Event|3|||
105398871|NCT02431325|363470749|FG001|Overall Study|Adverse Event|0|||
105398872|NCT02431325|363470748|FG000|Overall Study|Lost to Follow-up|0|||
105398873|NCT02431325|363470749|FG001|Overall Study|Lost to Follow-up|1|||
105398874|NCT02431325|363470748|FG000|Overall Study|Withdrawal by Subject|1|||
105398875|NCT02431325|363470749|FG001|Overall Study|Withdrawal by Subject|2|||
105398876|NCT02431325|363470748|FG000|Overall Study|Declined to take study medication|1|||
105398877|NCT02431325|363470749|FG001|Overall Study|Declined to take study medication|0|||
105398878|NCT02431325|363470748|FG000|Overall Study|Withdrew before starting study medication|1|||
105398879|NCT02431325|363470749|FG001|Overall Study|Withdrew before starting study medication|0|||
105398880|NCT02431325|363470748|FG000|Overall Study|Placebo shortage|2|||
105398881|NCT02431325|363470749|FG001|Overall Study|Placebo shortage|0|||
105398882|NCT01128569|363470750|FG000|Washout Period 1|Adverse Event|0|||
105398883|NCT01128569|363470751|FG001|Washout Period 1|Adverse Event|0|||
105398884|NCT01128569|363470752|FG002|Washout Period 1|Adverse Event|1|||
105398885|NCT01128569|363470753|FG003|Washout Period 1|Adverse Event|0|||
105398886|NCT01128569|363470754|FG004|Washout Period 1|Adverse Event|0|||
105398887|NCT01128569|363470755|FG005|Washout Period 1|Adverse Event|0|||
105398888|NCT01128569|363470750|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105398889|NCT01128569|363470751|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105398890|NCT01128569|363470752|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105398891|NCT01128569|363470753|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105398892|NCT01128569|363470754|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105398893|NCT01128569|363470755|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105398894|NCT00894387|363470756|FG000|Overall Study|Adverse Event|44|||
105398895|NCT00894387|363470757|FG001|Overall Study|Adverse Event|45|||
105398896|NCT00894387|363470756|FG000|Overall Study|Abnormal Laboratory values|2|||
105398897|NCT00894387|363470757|FG001|Overall Study|Abnormal Laboratory values|2|||
105398898|NCT00894387|363470756|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105398899|NCT00894387|363470757|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105398900|NCT00894387|363470756|FG000|Overall Study|Lost to Follow-up|3|||
105398901|NCT00894387|363470757|FG001|Overall Study|Lost to Follow-up|5|||
105398902|NCT00894387|363470756|FG000|Overall Study|Administrative problems|2|||
105398903|NCT00894387|363470757|FG001|Overall Study|Administrative problems|2|||
105398904|NCT00894387|363470756|FG000|Overall Study|Death|77|||
105398905|NCT00894387|363470757|FG001|Overall Study|Death|76|||
105398906|NCT00894387|363470756|FG000|Overall Study|Protocol Deviation|4|||
105398907|NCT00894387|363470757|FG001|Overall Study|Protocol Deviation|0|||
105398908|NCT00894387|363470756|FG000|Overall Study|Patient's request|25|||
105398909|NCT00894387|363470757|FG001|Overall Study|Patient's request|30|||
105398910|NCT00894387|363470756|FG000|Overall Study|Other (Missing)|5|||
105398911|NCT00894387|363470757|FG001|Overall Study|Other (Missing)|3|||
105398912|NCT00894387|363470756|FG000|Overall Study|Mis-randomized|13|||
105398913|NCT00894387|363470757|FG001|Overall Study|Mis-randomized|9|||
105398914|NCT00894387|363470756|FG000|Overall Study|GCP non-compliance|0|||
105398915|NCT00894387|363470757|FG001|Overall Study|GCP non-compliance|2|||
105398916|NCT02115321|363470758|FG000|Overall Study|Death|1|||
105398917|NCT02115321|363470759|FG001|Overall Study|Death|0|||
105398918|NCT04403919|363470766|FG000|Overall Study|Lost to Follow-up|0|||
105398919|NCT04403919|363470767|FG001|Overall Study|Lost to Follow-up|0|||
105398920|NCT04403919|363470768|FG002|Overall Study|Lost to Follow-up|0|||
105398921|NCT04403919|363470769|FG003|Overall Study|Lost to Follow-up|1|||
105398922|NCT01612676|363470770|FG000|Overall Study|Adverse Event|2|||
105398923|NCT01612676|363470771|FG001|Overall Study|Adverse Event|3|||
105398924|NCT01612676|363470772|FG002|Overall Study|Adverse Event|1|||
105398925|NCT01612676|363470773|FG003|Overall Study|Adverse Event|3|||
105398926|NCT01612676|363470770|FG000|Overall Study|Protocol Violation|0|||
105398927|NCT01612676|363470771|FG001|Overall Study|Protocol Violation|1|||
105398928|NCT01612676|363470772|FG002|Overall Study|Protocol Violation|0|||
105398929|NCT01612676|363470773|FG003|Overall Study|Protocol Violation|0|||
105398930|NCT00181844|363470783|FG000|Signed Consent|Withdrawal by Subject|5|||
105398931|NCT00181844|363470783|FG000|Signed Consent|Did not meet entrance criteria|7|||
105398932|NCT00181844|363470783|FG000|Exposed to Study Medication|Adverse Event|10|||
105398933|NCT00181844|363470783|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
105398934|NCT00181844|363470783|FG000|Exposed to Study Medication|Non-compliance|2|||
105398935|NCT00181844|363470783|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
105398936|NCT00181844|363470783|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
105398937|NCT01987557|363470794|FG000|Overall Study|Protocol Violation|1|||
105398938|NCT01987557|363470795|FG001|Overall Study|Protocol Violation|0|||
105398939|NCT01987557|363470796|FG002|Overall Study|Protocol Violation|1|||
105398940|NCT01987557|363470794|FG000|Overall Study|Withdrawal by Subject|2|||
105398941|NCT01987557|363470795|FG001|Overall Study|Withdrawal by Subject|1|||
105398942|NCT01987557|363470796|FG002|Overall Study|Withdrawal by Subject|2|||
105398943|NCT01987557|363470794|FG000|Overall Study|Adverse Event|0|||
105398944|NCT01987557|363470795|FG001|Overall Study|Adverse Event|2|||
105398945|NCT01987557|363470796|FG002|Overall Study|Adverse Event|0|||
105398946|NCT01567722|363470799|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
105398947|NCT01567722|363470800|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
105398948|NCT01567722|363470801|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
105398949|NCT01567722|363470799|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
105398950|NCT01567722|363470800|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
105398951|NCT01567722|363470801|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
105398952|NCT01567722|363470799|FG000|Overall Study|Protocol closure by the OCG|2|||
105398953|NCT01567722|363470800|FG001|Overall Study|Protocol closure by the OCG|0|||
105398954|NCT01567722|363470801|FG002|Overall Study|Protocol closure by the OCG|0|||
105398955|NCT01567722|363470799|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
105398956|NCT01567722|363470800|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
105398957|NCT01567722|363470801|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
105398958|NCT01832727|363470806|FG000|Overall Study|Adverse Event|4|||
105398959|NCT01832727|363470807|FG001|Overall Study|Adverse Event|6|||
105398960|NCT01832727|363470808|FG002|Overall Study|Adverse Event|1|||
105398961|NCT01832727|363470809|FG003|Overall Study|Adverse Event|0|||
105398962|NCT01832727|363470810|FG004|Overall Study|Adverse Event|1|||
105398963|NCT01832727|363470811|FG005|Overall Study|Adverse Event|1|||
105398964|NCT01832727|363470812|FG006|Overall Study|Adverse Event|2|||
105398965|NCT01832727|363470813|FG007|Overall Study|Adverse Event|1|||
105398966|NCT01832727|363470814|FG008|Overall Study|Adverse Event|9|||
105398967|NCT01832727|363470806|FG000|Overall Study|Disease progression|3|||
105398968|NCT01832727|363470807|FG001|Overall Study|Disease progression|0|||
105398969|NCT01832727|363470808|FG002|Overall Study|Disease progression|2|||
105398970|NCT01832727|363470809|FG003|Overall Study|Disease progression|1|||
105398971|NCT01832727|363470810|FG004|Overall Study|Disease progression|3|||
105398972|NCT01832727|363470811|FG005|Overall Study|Disease progression|3|||
105398973|NCT01832727|363470812|FG006|Overall Study|Disease progression|6|||
105398974|NCT01832727|363470813|FG007|Overall Study|Disease progression|2|||
105398975|NCT01832727|363470814|FG008|Overall Study|Disease progression|7|||
105398976|NCT01832727|363470806|FG000|Overall Study|Lost to Follow-up|0|||
105398977|NCT01832727|363470807|FG001|Overall Study|Lost to Follow-up|0|||
105398978|NCT01832727|363470808|FG002|Overall Study|Lost to Follow-up|0|||
105398979|NCT01832727|363470809|FG003|Overall Study|Lost to Follow-up|1|||
105398980|NCT01832727|363470810|FG004|Overall Study|Lost to Follow-up|0|||
105398981|NCT01832727|363470811|FG005|Overall Study|Lost to Follow-up|0|||
105398982|NCT01832727|363470812|FG006|Overall Study|Lost to Follow-up|0|||
105398983|NCT01832727|363470813|FG007|Overall Study|Lost to Follow-up|0|||
105398984|NCT01832727|363470814|FG008|Overall Study|Lost to Follow-up|0|||
105398985|NCT01832727|363470806|FG000|Overall Study|Physician Decision|1|||
105398986|NCT01832727|363470807|FG001|Overall Study|Physician Decision|0|||
105398987|NCT01832727|363470808|FG002|Overall Study|Physician Decision|0|||
105398988|NCT01832727|363470809|FG003|Overall Study|Physician Decision|1|||
105398989|NCT01832727|363470810|FG004|Overall Study|Physician Decision|0|||
105398990|NCT01832727|363470811|FG005|Overall Study|Physician Decision|1|||
105398991|NCT01832727|363470812|FG006|Overall Study|Physician Decision|0|||
105398992|NCT01832727|363470813|FG007|Overall Study|Physician Decision|0|||
105398993|NCT01832727|363470814|FG008|Overall Study|Physician Decision|0|||
105398994|NCT01832727|363470806|FG000|Overall Study|Withdrawal by Subject|1|||
105398995|NCT01832727|363470807|FG001|Overall Study|Withdrawal by Subject|1|||
105398996|NCT01832727|363470808|FG002|Overall Study|Withdrawal by Subject|0|||
105398997|NCT01832727|363470809|FG003|Overall Study|Withdrawal by Subject|1|||
105398998|NCT01832727|363470810|FG004|Overall Study|Withdrawal by Subject|0|||
105398999|NCT01832727|363470811|FG005|Overall Study|Withdrawal by Subject|1|||
105399000|NCT01832727|363470812|FG006|Overall Study|Withdrawal by Subject|0|||
105399001|NCT01832727|363470813|FG007|Overall Study|Withdrawal by Subject|2|||
105399002|NCT01832727|363470814|FG008|Overall Study|Withdrawal by Subject|1|||
105399003|NCT01832727|363470806|FG000|Overall Study|Study terminated by sponsor|0|||
105399004|NCT01832727|363470807|FG001|Overall Study|Study terminated by sponsor|0|||
105399005|NCT01832727|363470808|FG002|Overall Study|Study terminated by sponsor|0|||
105399006|NCT01832727|363470809|FG003|Overall Study|Study terminated by sponsor|0|||
105399007|NCT01832727|363470810|FG004|Overall Study|Study terminated by sponsor|0|||
105399008|NCT01832727|363470811|FG005|Overall Study|Study terminated by sponsor|0|||
105399009|NCT01832727|363470812|FG006|Overall Study|Study terminated by sponsor|0|||
105399010|NCT01832727|363470813|FG007|Overall Study|Study terminated by sponsor|1|||
105399011|NCT01832727|363470814|FG008|Overall Study|Study terminated by sponsor|1|||
105399012|NCT03323164|363470817|FG000|Overall Study|Poor quality imaging/scans|2|||
105399013|NCT03323164|363470818|FG001|Overall Study|Poor quality imaging/scans|2|||
105399014|NCT01823289|363470819|FG000|Overall Study|Lost to Follow-up|5|||
105399015|NCT01823289|363470819|FG000|Overall Study|Adverse Event|5|||
105399016|NCT01823289|363470819|FG000|Overall Study|Lack of Efficacy|1|||
105399017|NCT01823289|363470819|FG000|Overall Study|Physician Decision|9|||
105399018|NCT01823289|363470819|FG000|Overall Study|Administered contraindicated medicine|1|||
105399019|NCT01823289|363470819|FG000|Overall Study|Transaminase increased more than 3 times|1|||
105399020|NCT01823289|363470819|FG000|Overall Study|Drug affected efficacy and safety|1|||
105399021|NCT01823289|363470819|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
105399022|NCT01657305|363470824|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
105399023|NCT01657305|363470824|FG000|Overall Study|Withdrawal by Subject|4|||
105399024|NCT01657305|363470824|FG000|Overall Study|Adverse Event|1|||
105399025|NCT01657305|363470824|FG000|Overall Study|Lost to Follow-up|1|||
105399026|NCT01657305|363470824|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
105399027|NCT04103450|363470827|FG000|Overall Study|Adverse Event|4|||
105399028|NCT04103450|363470828|FG001|Overall Study|Adverse Event|2|||
105399029|NCT04103450|363470827|FG000|Overall Study|Lack of Efficacy|3|||
105399030|NCT04103450|363470828|FG001|Overall Study|Lack of Efficacy|0|||
105399031|NCT04103450|363470827|FG000|Overall Study|Withdrawal by Subject|5|||
105399032|NCT04103450|363470828|FG001|Overall Study|Withdrawal by Subject|3|||
105399033|NCT04103450|363470827|FG000|Overall Study|Lost to Follow-up|1|||
105399034|NCT04103450|363470828|FG001|Overall Study|Lost to Follow-up|2|||
105399035|NCT04103450|363470827|FG000|Overall Study|Physician Decision|1|||
105399036|NCT04103450|363470828|FG001|Overall Study|Physician Decision|2|||
105399037|NCT04103450|363470827|FG000|Overall Study|Protocol Violation|1|||
105399038|NCT04103450|363470828|FG001|Overall Study|Protocol Violation|0|||
105399039|NCT04103450|363470827|FG000|Overall Study|Other|1|||
105399040|NCT04103450|363470828|FG001|Overall Study|Other|1|||
105399041|NCT01959932|363470834|FG000|Overall Study|Withdrawal by Subject|1|||
105399042|NCT01959932|363470835|FG001|Overall Study|Withdrawal by Subject|0|||
105399043|NCT01959932|363470836|FG002|Overall Study|Withdrawal by Subject|0|||
105399044|NCT00397540|363470837|FG000|Overall Study|short follow-up duration < 12 months|1|||
105399045|NCT00397540|363470838|FG001|Overall Study|short follow-up duration < 12 months|0|||
105399046|NCT01133847|363470839|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
105399047|NCT01133847|363470840|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
105399048|NCT01133847|363470841|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
105399049|NCT01133847|363470839|FG000|Follow-Up Phase|Lost to Follow-up|1|||
105399050|NCT01133847|363470840|FG001|Follow-Up Phase|Lost to Follow-up|3|||
105399051|NCT01133847|363470841|FG002|Follow-Up Phase|Lost to Follow-up|7|||
105399052|NCT00542178|363470844|FG000|Overall Study|did not complete year 4 follow-up|75|||
105399053|NCT00542178|363470845|FG001|Overall Study|did not complete year 4 follow-up|80|||
105399054|NCT00542178|363470846|FG002|Overall Study|did not complete year 4 follow-up|74|||
105399055|NCT00542178|363470847|FG003|Overall Study|did not complete year 4 follow-up|62|||
105399056|NCT00542178|363470848|FG004|Overall Study|did not complete year 4 follow-up|64|||
105399057|NCT00542178|363470849|FG005|Overall Study|did not complete year 4 follow-up|89|||
105399058|NCT00542178|363470850|FG006|Overall Study|did not complete year 4 follow-up|87|||
105399059|NCT00542178|363470851|FG007|Overall Study|did not complete year 4 follow-up|85|||
105399060|NCT04696146|363472080|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
105399061|NCT04696146|363472081|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
105399062|NCT04696146|363472080|FG000|Overall Study|Off hours issue with product|1|||
105399063|NCT04696146|363472081|FG001|Overall Study|Off hours issue with product|0|||
105399064|NCT01334918|363472082|FG000|Overall Study|Did not receive study drug|6|||
105399065|NCT01334918|363472083|FG001|Overall Study|Did not receive study drug|0|||
105399066|NCT01334918|363472082|FG000|Overall Study|Adverse Event|2|||
105399067|NCT01334918|363472083|FG001|Overall Study|Adverse Event|0|||
105399068|NCT01334918|363472082|FG000|Overall Study|Withdrawal by Subject|0|||
105399069|NCT01334918|363472083|FG001|Overall Study|Withdrawal by Subject|1|||
105399070|NCT02239926|363472086|FG000|Overall Study|Withdrawal by Subject|0|||
105399071|NCT02239926|363472087|FG001|Overall Study|Withdrawal by Subject|1|||
105399072|NCT01702298|363472088|FG000|Overall Study|Withdrawal by Subject|1|||
105399073|NCT02131766|363472093|FG000|Overall Study|Withdrawal by Subject|4|||
105399074|NCT00454116|363472095|FG000|Overall Study|Adverse Event|5|||
105399075|NCT00454116|363472096|FG001|Overall Study|Adverse Event|11|||
105399076|NCT00454116|363472097|FG002|Overall Study|Adverse Event|9|||
105399077|NCT00454116|363472095|FG000|Overall Study|Condition under investigation worsened|17|||
105399078|NCT00454116|363472096|FG001|Overall Study|Condition under investigation worsened|13|||
105399079|NCT00454116|363472097|FG002|Overall Study|Condition under investigation worsened|18|||
105399080|NCT00454116|363472095|FG000|Overall Study|Withdrawal by Subject|3|||
105399081|NCT00454116|363472096|FG001|Overall Study|Withdrawal by Subject|3|||
105399082|NCT00454116|363472097|FG002|Overall Study|Withdrawal by Subject|1|||
105399083|NCT00454116|363472095|FG000|Overall Study|Other|2|||
105399084|NCT00454116|363472096|FG001|Overall Study|Other|2|||
105399085|NCT00454116|363472097|FG002|Overall Study|Other|0|||
105399086|NCT01917318|363472102|FG000|First Treatment|Withdrawal by Subject|0|||
105399087|NCT01917318|363472103|FG001|First Treatment|Withdrawal by Subject|1|||
105399088|NCT00487981|363472104|FG000|Overall Study|Hypothyroidism diagnosis|1|||
105399089|NCT02980107|363472109|FG000|Overall Study|Withdrawal by Subject|51|||
105399090|NCT02980107|363472110|FG001|Overall Study|Withdrawal by Subject|62|||
105399091|NCT03179761|363472111|FG000|Overall Study|Death|2|||
105399092|NCT03179761|363472112|FG001|Overall Study|Death|5|||
105399093|NCT03179761|363472111|FG000|Overall Study|Lost to Follow-up|2|||
105399094|NCT03179761|363472112|FG001|Overall Study|Lost to Follow-up|2|||
105399095|NCT03179761|363472111|FG000|Overall Study|Protocol Violation|1|||
105399096|NCT03179761|363472112|FG001|Overall Study|Protocol Violation|0|||
105399097|NCT03179761|363472111|FG000|Overall Study|Withdrawal by Subject|1|||
105399098|NCT03179761|363472112|FG001|Overall Study|Withdrawal by Subject|4|||
105399099|NCT03179761|363472111|FG000|Overall Study|Investigator Request|0|||
105399100|NCT03179761|363472112|FG001|Overall Study|Investigator Request|2|||
105399101|NCT04562116|363472113|FG000|Overall Study|Lost to Follow-up|1|||
105399102|NCT04562116|363472113|FG000|Overall Study|Withdrawal by Subject|3|||
105399103|NCT03498716|363472115|FG000|Overall Study|Withdrawal by Subject|88|||
105399104|NCT03498716|363472116|FG001|Overall Study|Withdrawal by Subject|73|||
105399105|NCT03498716|363472115|FG000|Overall Study|Study Terminated By Sponsor|933|||
105399106|NCT03498716|363472116|FG001|Overall Study|Study Terminated By Sponsor|927|||
105399107|NCT03498716|363472115|FG000|Overall Study|Lost to Follow-up|15|||
105399108|NCT03498716|363472116|FG001|Overall Study|Lost to Follow-up|26|||
105399109|NCT03498716|363472115|FG000|Overall Study|Disease Relapse|0|||
105399110|NCT03498716|363472116|FG001|Overall Study|Disease Relapse|1|||
105399111|NCT03498716|363472115|FG000|Overall Study|Death|58|||
105399112|NCT03498716|363472116|FG001|Overall Study|Death|72|||
105399113|NCT03498716|363472115|FG000|Overall Study|Physician Decision|4|||
105399114|NCT03498716|363472116|FG001|Overall Study|Physician Decision|2|||
105399115|NCT04064905|363472117|FG000|Overall Study|Lost to Follow-up|0|||
105399116|NCT04064905|363472118|FG001|Overall Study|Lost to Follow-up|3|||
105399117|NCT04064905|363472119|FG002|Overall Study|Lost to Follow-up|1|||
105399118|NCT04064905|363472120|FG003|Overall Study|Lost to Follow-up|4|||
105399119|NCT04064905|363472121|FG004|Overall Study|Lost to Follow-up|2|||
105399120|NCT01570387|363472125|FG000|Overall Study|Adverse Event|1|||
105399121|NCT01570387|363472126|FG001|Overall Study|Adverse Event|0|||
105399122|NCT01570387|363472127|FG002|Overall Study|Adverse Event|0|||
105399123|NCT01570387|363472128|FG003|Overall Study|Adverse Event|0|||
105399124|NCT01570387|363472125|FG000|Overall Study|Death|0|||
105399125|NCT01570387|363472126|FG001|Overall Study|Death|0|||
105399126|NCT01570387|363472127|FG002|Overall Study|Death|0|||
105399127|NCT01570387|363472128|FG003|Overall Study|Death|1|||
105399128|NCT01570387|363472125|FG000|Overall Study|Withdrawal by Subject|0|||
105399129|NCT01570387|363472126|FG001|Overall Study|Withdrawal by Subject|0|||
105399130|NCT01570387|363472127|FG002|Overall Study|Withdrawal by Subject|0|||
105399131|NCT01570387|363472128|FG003|Overall Study|Withdrawal by Subject|1|||
105399132|NCT01378117|363472130|FG000|Overall Study|withdrawal|2|||
105399133|NCT01378117|363472131|FG001|Overall Study|withdrawal|1|||
105399134|NCT01378117|363472132|FG002|Overall Study|withdrawal|2|||
105399135|NCT01378117|363472130|FG000|Overall Study|discharged before med given|2|||
105399136|NCT01378117|363472131|FG001|Overall Study|discharged before med given|0|||
105399137|NCT01378117|363472132|FG002|Overall Study|discharged before med given|1|||
105399138|NCT00967616|363472133|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
105399139|NCT00967616|363472134|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
105399140|NCT00967616|363472133|FG000|Overall Study|Death|0|||
105399141|NCT00967616|363472134|FG001|Overall Study|Death|3|||
105399142|NCT00967616|363472133|FG000|Overall Study|Withdrawal by Subject|8|||
105399143|NCT00967616|363472134|FG001|Overall Study|Withdrawal by Subject|4|||
105399144|NCT00967616|363472133|FG000|Overall Study|Progressive Disease|31|||
105399145|NCT00967616|363472134|FG001|Overall Study|Progressive Disease|18|||
105399146|NCT00967616|363472133|FG000|Overall Study|Other|8|||
105399147|NCT00967616|363472134|FG001|Overall Study|Other|8|||
105580621|NCT01474512|364126477|FG012|Induction Period|Adverse Event|0|||
105399148|NCT00967616|363472133|FG000|Overall Study|Protocol Violation|1|||
105399149|NCT00967616|363472134|FG001|Overall Study|Protocol Violation|0|||
105399150|NCT02536664|363472135|FG000|Overall Study|Inadequate completion of documentation|2|||
105399151|NCT02536664|363472136|FG001|Overall Study|Inadequate completion of documentation|4|||
105399152|NCT02536664|363472135|FG000|Overall Study|Progression|13|||
105399153|NCT02536664|363472136|FG001|Overall Study|Progression|18|||
105399154|NCT02536664|363472135|FG000|Overall Study|Death due to lymphoma|2|||
105399155|NCT02536664|363472136|FG001|Overall Study|Death due to lymphoma|1|||
105399156|NCT02536664|363472135|FG000|Overall Study|Death due to other reason|3|||
105399157|NCT02536664|363472136|FG001|Overall Study|Death due to other reason|2|||
105399158|NCT02536664|363472135|FG000|Overall Study|Intolerability|8|||
105399159|NCT02536664|363472136|FG001|Overall Study|Intolerability|6|||
105399160|NCT02536664|363472135|FG000|Overall Study|Withdrawal by Subject|8|||
105399161|NCT02536664|363472136|FG001|Overall Study|Withdrawal by Subject|5|||
105399162|NCT02536664|363472135|FG000|Overall Study|Other|18|||
105399163|NCT02536664|363472136|FG001|Overall Study|Other|24|||
105399164|NCT02536664|363472135|FG000|Overall Study|Missing|53|||
105399165|NCT02536664|363472136|FG001|Overall Study|Missing|20|||
105399166|NCT00271544|363472154|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
105399167|NCT00271544|363472154|FG000|Overall Study|Model 4196 lead not attempted|9|||
105399168|NCT00271544|363472154|FG000|Overall Study|Implant not attempted|4|||
105399169|NCT03358030|363472155|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
105399170|NCT03358030|363472156|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
105399171|NCT03358030|363472157|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
105399172|NCT03358030|363472158|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
105399173|NCT03358030|363472155|FG000|Overall Study|Ineligibility|0|||
105399174|NCT03358030|363472156|FG001|Overall Study|Ineligibility|0|||
105399175|NCT03358030|363472157|FG002|Overall Study|Ineligibility|0|||
105399176|NCT03358030|363472158|FG003|Overall Study|Ineligibility|2|||
105399177|NCT03358030|363472155|FG000|Overall Study|Voluntary Withdrawal|1|||
105399178|NCT03358030|363472156|FG001|Overall Study|Voluntary Withdrawal|1|||
105399179|NCT03358030|363472157|FG002|Overall Study|Voluntary Withdrawal|3|||
105399180|NCT03358030|363472158|FG003|Overall Study|Voluntary Withdrawal|1|||
105399181|NCT03358030|363472155|FG000|Overall Study|Other|0|||
105399182|NCT03358030|363472156|FG001|Overall Study|Other|0|||
105399183|NCT03358030|363472157|FG002|Overall Study|Other|1|||
105399184|NCT03358030|363472158|FG003|Overall Study|Other|0|||
105399185|NCT04540367|363472159|FG000|Overall Study|Withdrawal by Subject|0|||
105399186|NCT04540367|363472160|FG001|Overall Study|Withdrawal by Subject|0|||
105399187|NCT04540367|363472161|FG002|Overall Study|Withdrawal by Subject|0|||
105399188|NCT04540367|363472162|FG003|Overall Study|Withdrawal by Subject|2|||
105399189|NCT04540367|363472159|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
105399190|NCT04540367|363472160|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
105399191|NCT04540367|363472161|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
105399192|NCT04540367|363472162|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
105399193|NCT04540367|363472159|FG000|Overall Study|Adverse Event|0|||
105399194|NCT04540367|363472160|FG001|Overall Study|Adverse Event|0|||
105399195|NCT04540367|363472161|FG002|Overall Study|Adverse Event|1|||
105399196|NCT04540367|363472162|FG003|Overall Study|Adverse Event|1|||
105399197|NCT00829244|363472163|FG000|Overall Study|Adverse Event|1|||
105399198|NCT00829244|363472164|FG001|Overall Study|Adverse Event|3|||
105399199|NCT00829244|363472163|FG000|Overall Study|Protocol Violation|1|||
105399200|NCT00829244|363472164|FG001|Overall Study|Protocol Violation|0|||
105399201|NCT00829244|363472163|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
105399202|NCT00829244|363472164|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
105399203|NCT00829244|363472163|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
105399204|NCT00829244|363472164|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
105399205|NCT00829244|363472163|FG000|Overall Study|No fertilization|2|||
105399206|NCT00829244|363472164|FG001|Overall Study|No fertilization|2|||
105399207|NCT00829244|363472163|FG000|Overall Study|All embryos discarded|0|||
105399208|NCT00829244|363472164|FG001|Overall Study|All embryos discarded|3|||
105399209|NCT00829244|363472163|FG000|Overall Study|No embryo cleavage|0|||
105399210|NCT00829244|363472164|FG001|Overall Study|No embryo cleavage|2|||
105399211|NCT00907621|363472168|FG000|Overall Study|Lost to Follow-up|6|||
105399212|NCT00907621|363472169|FG001|Overall Study|Lost to Follow-up|3|||
105399213|NCT00907621|363472168|FG000|Overall Study|intercurrent febrile illness|1|||
105399214|NCT00907621|363472169|FG001|Overall Study|intercurrent febrile illness|1|||
105399215|NCT00902330|363472172|FG000|Overall Study|Too overwhelmed by treatment|2|||
105399216|NCT00902330|363472173|FG001|Overall Study|Too overwhelmed by treatment|5|||
105399217|NCT00902330|363472172|FG000|Overall Study|Adverse Event|1|||
105399218|NCT00902330|363472173|FG001|Overall Study|Adverse Event|0|||
105580622|NCT01474512|364126478|FG013|Induction Period|Adverse Event|0|||
105399219|NCT00902330|363472172|FG000|Overall Study|No post baseline data|1|||
105439955|NCT01618695|363616640|FG002|Extension Phase|Pregnancy|1|||
105399220|NCT00902330|363472173|FG001|Overall Study|No post baseline data|0|||
105399221|NCT03342560|363472174|FG000|Overall Study|Lost to Follow-up|2|||
105399222|NCT03213509|363472175|FG000|Overall Study|Did not consent for verbal autopsy|4|||
105399223|NCT03213509|363472176|FG001|Overall Study|Did not consent for verbal autopsy|5|||
105399224|NCT02604511|363472177|FG000|Overall Study|Adverse Event|3|||
105399225|NCT02604511|363472177|FG000|Overall Study|Disease Progression|4|||
105399226|NCT02604511|363472177|FG000|Overall Study|Withdrawal by Subject|3|||
105399227|NCT02604511|363472177|FG000|Overall Study|Participant ineligible|1|||
105399228|NCT02604511|363472177|FG000|Overall Study|Intercurrent illness|1|||
105399229|NCT04290624|363472178|FG000|Overall Study|Adverse Event|1|||
105399230|NCT04290624|363472179|FG001|Overall Study|Adverse Event|0|||
105399231|NCT01342094|363472185|FG000|Overall Study|Adverse Event|5|||
105399232|NCT01342094|363472186|FG001|Overall Study|Adverse Event|0|||
105399233|NCT01342094|363472185|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
105399234|NCT01342094|363472186|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
105399235|NCT01342094|363472185|FG000|Overall Study|Withdrawal by Subject|0|||
105399236|NCT01342094|363472186|FG001|Overall Study|Withdrawal by Subject|2|||
105399237|NCT02121509|363472189|FG000|Washout Period (35 Days)|Adverse Event|1|||
105399238|NCT02121509|363472190|FG001|Washout Period (35 Days)|Adverse Event|1|||
105399239|NCT02121509|363472191|FG002|Washout Period (35 Days)|Adverse Event|0|||
105399240|NCT02121509|363472192|FG003|Washout Period (35 Days)|Adverse Event|0|||
105399241|NCT02121509|363472189|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
105399242|NCT02121509|363472190|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
105399243|NCT02121509|363472191|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
105399244|NCT02121509|363472192|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
105399245|NCT02121509|363472189|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
105399246|NCT02121509|363472190|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
105399247|NCT02121509|363472191|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
105399248|NCT02121509|363472192|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
105399249|NCT03069716|363472195|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
105399250|NCT03069716|363472196|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
105399251|NCT03069716|363472197|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
105399252|NCT03069716|363472195|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
105399253|NCT03069716|363472196|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
105399254|NCT03069716|363472197|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
105399255|NCT03069716|363472195|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
105399256|NCT03069716|363472196|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
105399257|NCT03069716|363472197|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
105399258|NCT03069716|363472195|FG000|Randomized Treatment|Withdrawal by Subject|0|||
105399259|NCT03069716|363472196|FG001|Randomized Treatment|Withdrawal by Subject|2|||
105399260|NCT03069716|363472197|FG002|Randomized Treatment|Withdrawal by Subject|0|||
105399261|NCT03402841|363472203|FG000|Overall Study|Withdrawal by Subject|3|||
105399262|NCT03402841|363472203|FG000|Overall Study|Lost to Follow-up|2|||
105399263|NCT03402841|363472203|FG000|Overall Study|Death|146|||
105399264|NCT01085214|363472206|FG000|Overall Study|Alternate treatment required|1|||
105399265|NCT01150357|363472207|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
105399266|NCT01150357|363472208|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
105399267|NCT01150357|363472209|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
105399268|NCT01150357|363472207|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
105399269|NCT01150357|363472208|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
105399270|NCT01150357|363472209|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
105399271|NCT01150357|363472207|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
105399272|NCT01150357|363472208|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
105399273|NCT01150357|363472209|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
105399274|NCT01150357|363472207|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
105399275|NCT01150357|363472208|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
105399276|NCT01150357|363472209|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
105399277|NCT01150357|363472207|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
105399278|NCT01150357|363472208|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
105399279|NCT01150357|363472209|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
105399280|NCT01150357|363472207|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
105399281|NCT01150357|363472208|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
105399282|NCT01150357|363472209|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
105493217|NCT01539642|363818806|FG001|Overall Study|Withdrawal by Subject|2|||
105493218|NCT02063880|363818807|FG000|Overall Study|Death|21|||
105399283|NCT01150357|363472207|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
105493219|NCT02063880|363818808|FG001|Overall Study|Death|18|||
105493220|NCT02063880|363818807|FG000|Overall Study|Lost to Follow-up|7|||
105493221|NCT02063880|363818808|FG001|Overall Study|Lost to Follow-up|7|||
105493222|NCT02063880|363818807|FG000|Overall Study|Ineligible|0|||
105493223|NCT02063880|363818808|FG001|Overall Study|Ineligible|2|||
105493224|NCT02106910|363818809|FG000|Overall Study|Lost to Follow-up|1|||
105399284|NCT01150357|363472208|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
105399285|NCT01150357|363472209|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
105399286|NCT01576783|363474085|FG000|Overall Study|Change in Medical Care|1|||
105399287|NCT01576783|363474086|FG001|Overall Study|Change in Medical Care|0|||
105399288|NCT01576783|363474085|FG000|Overall Study|Lost to Follow-up|14|||
105399289|NCT01576783|363474086|FG001|Overall Study|Lost to Follow-up|16|||
105399290|NCT01576783|363474085|FG000|Overall Study|Withdrawal by Subject|5|||
105399291|NCT01576783|363474086|FG001|Overall Study|Withdrawal by Subject|1|||
105399292|NCT02114177|363474087|FG000|Overall Study|Lost to Follow-up|1|||
105399293|NCT02114177|363474088|FG001|Overall Study|Lost to Follow-up|2|||
105399294|NCT02114177|363474087|FG000|Overall Study|Withdrawal by Subject|6|||
105399295|NCT02114177|363474088|FG001|Overall Study|Withdrawal by Subject|1|||
105399296|NCT02114177|363474087|FG000|Overall Study|Other|2|||
105399297|NCT02114177|363474088|FG001|Overall Study|Other|1|||
105399298|NCT01819272|363474089|FG000|Overall Study|Adverse Event|1|||
105399299|NCT01819272|363474090|FG001|Overall Study|Adverse Event|0|||
105399300|NCT01819272|363474091|FG002|Overall Study|Adverse Event|0|||
105399301|NCT01819272|363474092|FG003|Overall Study|Adverse Event|2|||
105399302|NCT01819272|363474093|FG004|Overall Study|Adverse Event|0|||
105399303|NCT01819272|363474094|FG005|Overall Study|Adverse Event|0|||
105399304|NCT01819272|363474089|FG000|Overall Study|Lost to Follow-up|3|||
105399305|NCT01819272|363474090|FG001|Overall Study|Lost to Follow-up|0|||
105399306|NCT01819272|363474091|FG002|Overall Study|Lost to Follow-up|1|||
105399307|NCT01819272|363474092|FG003|Overall Study|Lost to Follow-up|0|||
105399308|NCT01819272|363474093|FG004|Overall Study|Lost to Follow-up|0|||
105399309|NCT01819272|363474094|FG005|Overall Study|Lost to Follow-up|3|||
105399310|NCT01819272|363474089|FG000|Overall Study|Protocol Violation|0|||
105399311|NCT01819272|363474090|FG001|Overall Study|Protocol Violation|0|||
105399312|NCT01819272|363474091|FG002|Overall Study|Protocol Violation|0|||
105399313|NCT01819272|363474092|FG003|Overall Study|Protocol Violation|1|||
105399314|NCT01819272|363474093|FG004|Overall Study|Protocol Violation|2|||
105399315|NCT01819272|363474094|FG005|Overall Study|Protocol Violation|3|||
105399316|NCT01819272|363474089|FG000|Overall Study|Physician Decision|0|||
105399317|NCT01819272|363474090|FG001|Overall Study|Physician Decision|1|||
105399318|NCT01819272|363474091|FG002|Overall Study|Physician Decision|0|||
105399319|NCT01819272|363474092|FG003|Overall Study|Physician Decision|0|||
105399320|NCT01819272|363474093|FG004|Overall Study|Physician Decision|0|||
105399321|NCT01819272|363474094|FG005|Overall Study|Physician Decision|0|||
105399322|NCT01819272|363474089|FG000|Overall Study|Withdrawal of Consent|0|||
105399323|NCT01819272|363474090|FG001|Overall Study|Withdrawal of Consent|1|||
105399324|NCT01819272|363474091|FG002|Overall Study|Withdrawal of Consent|2|||
105399325|NCT01819272|363474092|FG003|Overall Study|Withdrawal of Consent|1|||
105399326|NCT01819272|363474093|FG004|Overall Study|Withdrawal of Consent|0|||
105399327|NCT01819272|363474094|FG005|Overall Study|Withdrawal of Consent|1|||
105399328|NCT01819272|363474089|FG000|Overall Study|Loss of Glucose Control|2|||
105399329|NCT01819272|363474090|FG001|Overall Study|Loss of Glucose Control|1|||
105399330|NCT01819272|363474091|FG002|Overall Study|Loss of Glucose Control|0|||
105399331|NCT01819272|363474092|FG003|Overall Study|Loss of Glucose Control|1|||
105399332|NCT01819272|363474093|FG004|Overall Study|Loss of Glucose Control|2|||
105399333|NCT01819272|363474094|FG005|Overall Study|Loss of Glucose Control|0|||
105399334|NCT01897493|363474096|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
105399335|NCT01173679|363474099|FG000|Overall Study|Death|1|||
105399336|NCT01250054|363474100|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
105399337|NCT01250054|363474101|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
105399338|NCT01732536|363474104|FG000|Overall Study|Withdrawal by Subject|1|||
105399339|NCT01732536|363474105|FG001|Overall Study|Withdrawal by Subject|1|||
105399340|NCT00503984|363474106|FG000|Overall Study|Protocol Violation|0|||
105399341|NCT00503984|363474107|FG001|Overall Study|Protocol Violation|1|||
105399342|NCT00503984|363474108|FG002|Overall Study|Protocol Violation|0|||
105399343|NCT00503984|363474109|FG003|Overall Study|Protocol Violation|0|||
105399344|NCT00503984|363474110|FG004|Overall Study|Protocol Violation|0|||
105399345|NCT00503984|363474111|FG005|Overall Study|Protocol Violation|0|||
105399346|NCT00503984|363474106|FG000|Overall Study|Adverse Event|0|||
105399347|NCT00503984|363474107|FG001|Overall Study|Adverse Event|1|||
105399348|NCT00503984|363474108|FG002|Overall Study|Adverse Event|0|||
105399349|NCT00503984|363474109|FG003|Overall Study|Adverse Event|0|||
105399350|NCT00503984|363474110|FG004|Overall Study|Adverse Event|0|||
105399351|NCT00503984|363474111|FG005|Overall Study|Adverse Event|0|||
105399352|NCT00503984|363474106|FG000|Overall Study|Death|0|||
105399353|NCT00503984|363474107|FG001|Overall Study|Death|0|||
105399354|NCT00503984|363474108|FG002|Overall Study|Death|0|||
105399355|NCT00503984|363474109|FG003|Overall Study|Death|0|||
105399356|NCT00503984|363474110|FG004|Overall Study|Death|1|||
105399357|NCT00503984|363474111|FG005|Overall Study|Death|0|||
105399358|NCT00805389|363474112|FG000|Overall Study|Adverse Event|0|||
105399359|NCT00805389|363474113|FG001|Overall Study|Adverse Event|0|||
105399360|NCT00805389|363474114|FG002|Overall Study|Adverse Event|1|||
105399361|NCT00805389|363474115|FG003|Overall Study|Adverse Event|2|||
105399362|NCT00805389|363474116|FG004|Overall Study|Adverse Event|0|||
105399363|NCT00805389|363474112|FG000|Overall Study|Lost to Follow-up|4|||
105399364|NCT00805389|363474113|FG001|Overall Study|Lost to Follow-up|3|||
105399365|NCT00805389|363474114|FG002|Overall Study|Lost to Follow-up|6|||
105399366|NCT00805389|363474115|FG003|Overall Study|Lost to Follow-up|10|||
105399367|NCT00805389|363474116|FG004|Overall Study|Lost to Follow-up|9|||
105399368|NCT00805389|363474112|FG000|Overall Study|Protocol Violation|0|||
105399369|NCT00805389|363474113|FG001|Overall Study|Protocol Violation|0|||
105399370|NCT00805389|363474114|FG002|Overall Study|Protocol Violation|1|||
105399371|NCT00805389|363474115|FG003|Overall Study|Protocol Violation|0|||
105399372|NCT00805389|363474116|FG004|Overall Study|Protocol Violation|0|||
105399373|NCT00805389|363474112|FG000|Overall Study|Withdrawal by Subject|3|||
105399374|NCT00805389|363474113|FG001|Overall Study|Withdrawal by Subject|2|||
105399375|NCT00805389|363474114|FG002|Overall Study|Withdrawal by Subject|4|||
105399376|NCT00805389|363474115|FG003|Overall Study|Withdrawal by Subject|5|||
105399377|NCT00805389|363474116|FG004|Overall Study|Withdrawal by Subject|4|||
105399378|NCT01246960|363474117|FG000|Overall Study|Lost to Follow-up|3|||
105399379|NCT01246960|363474118|FG001|Overall Study|Lost to Follow-up|1|||
105399380|NCT01246960|363474117|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
105399381|NCT01246960|363474118|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
105399382|NCT02296476|363474121|FG000|Overall Study|Disease Progression|6|||
105399383|NCT02296476|363474122|FG001|Overall Study|Disease Progression|4|||
105399384|NCT02296476|363474123|FG002|Overall Study|Disease Progression|2|||
105399385|NCT00272792|363474125|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
105399386|NCT00272792|363474126|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
105399387|NCT00272792|363474125|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
105399388|NCT00272792|363474126|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
105399389|NCT00272792|363474125|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
105399390|NCT00272792|363474126|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
105399391|NCT00272792|363474125|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
105399392|NCT00272792|363474126|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
105399393|NCT01276704|363474131|FG000|Overall Study|Lost to Follow-up|2|||
105399394|NCT01276704|363474132|FG001|Overall Study|Lost to Follow-up|3|||
105399395|NCT01276704|363474131|FG000|Overall Study|Non-compliant|2|||
105399396|NCT01276704|363474132|FG001|Overall Study|Non-compliant|2|||
105399397|NCT01276704|363474131|FG000|Overall Study|Withdrawal by Subject|7|||
105399398|NCT01276704|363474132|FG001|Overall Study|Withdrawal by Subject|1|||
105399399|NCT01276704|363474131|FG000|Overall Study|Physician Decision|3|||
105399400|NCT01276704|363474132|FG001|Overall Study|Physician Decision|5|||
105399401|NCT03376516|363474133|FG000|Overall Study|Not treated|1|||
105399402|NCT03376516|363474133|FG000|Overall Study|Consent withdrawn|1|||
105399403|NCT01359956|363474134|FG000|Overall Study|Death|58|||
105399404|NCT01359956|363474135|FG001|Overall Study|Death|60|||
105399405|NCT01359956|363474136|FG002|Overall Study|Death|66|||
105399406|NCT01359956|363474137|FG003|Overall Study|Death|57|||
105399407|NCT01359956|363474134|FG000|Overall Study|Lost to Follow-up|3|||
105399408|NCT01359956|363474135|FG001|Overall Study|Lost to Follow-up|4|||
105399409|NCT01359956|363474136|FG002|Overall Study|Lost to Follow-up|1|||
105399410|NCT01359956|363474137|FG003|Overall Study|Lost to Follow-up|1|||
105399411|NCT00710593|363474138|FG000|Overall Study|Incarceration|1|||
105399412|NCT00710593|363474139|FG001|Overall Study|Incarceration|0|||
105399413|NCT00710593|363474138|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
105399414|NCT00710593|363474139|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
105399415|NCT00710593|363474138|FG000|Overall Study|Lost to Follow-up|3|||
105399416|NCT00710593|363474139|FG001|Overall Study|Lost to Follow-up|1|||
105399417|NCT00710593|363474138|FG000|Overall Study|Moved out of area|1|||
105399418|NCT00710593|363474139|FG001|Overall Study|Moved out of area|0|||
105399419|NCT00710593|363474138|FG000|Overall Study|Failure to adhere or complete study eval|1|||
105399420|NCT00710593|363474139|FG001|Overall Study|Failure to adhere or complete study eval|1|||
105399421|NCT00710593|363474138|FG000|Overall Study|Protocol Violation|1|||
105399422|NCT00710593|363474139|FG001|Overall Study|Protocol Violation|1|||
105399423|NCT00710593|363474138|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
105493225|NCT02106910|363818810|FG001|Overall Study|Lost to Follow-up|1|||
105493226|NCT01859143|363818813|FG000|Overall Study|Lost to Follow-up|2|||
105493227|NCT01859143|363818814|FG001|Overall Study|Lost to Follow-up|0|||
105493228|NCT01675427|363818815|FG000|Overall Study|Withdrawal by Subject|7|||
105493229|NCT01675427|363818815|FG000|Overall Study|Participant Refused Sample Collection|18|||
105493230|NCT01675427|363818815|FG000|Overall Study|Sample not Collected by Mistake|2|||
105493231|NCT01675427|363818815|FG000|Overall Study|Lost to Follow-up|5|||
105399424|NCT00710593|363474139|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
105399425|NCT01784029|363474140|FG000|Overall Study|Lost to Follow-up|19|||
105399426|NCT01784029|363474141|FG001|Overall Study|Lost to Follow-up|20|||
105399427|NCT01784029|363474142|FG002|Overall Study|Lost to Follow-up|22|||
105399428|NCT02829996|363474143|FG000|Overall Study|Withdrawal by Subject|1|||
105399429|NCT02829996|363474144|FG001|Overall Study|Withdrawal by Subject|0|||
105399430|NCT02829996|363474145|FG002|Overall Study|Withdrawal by Subject|0|||
105399431|NCT02829996|363474146|FG003|Overall Study|Withdrawal by Subject|0|||
105399432|NCT02829996|363474147|FG004|Overall Study|Withdrawal by Subject|0|||
105399433|NCT00582907|363474148|FG000|1st Course|Withdrawal by Subject|1|||
105399434|NCT00582907|363474149|FG001|1st Course|Withdrawal by Subject|0|||
105399435|NCT00582907|363474150|FG002|1st Course|Withdrawal by Subject|0|||
105399436|NCT00582907|363474151|FG003|1st Course|Withdrawal by Subject|0|||
105399437|NCT00582907|363474148|FG000|1st Course|Lost to Follow-up|0|||
105399438|NCT00582907|363474149|FG001|1st Course|Lost to Follow-up|0|||
105399439|NCT00582907|363474150|FG002|1st Course|Lost to Follow-up|0|||
105399440|NCT00582907|363474151|FG003|1st Course|Lost to Follow-up|1|||
105399441|NCT00582907|363474148|FG000|2nd Course|Lack of Efficacy|1|||
105399442|NCT00582907|363474149|FG001|2nd Course|Lack of Efficacy|0|||
105399443|NCT00582907|363474150|FG002|2nd Course|Lack of Efficacy|0|||
105399444|NCT00582907|363474151|FG003|2nd Course|Lack of Efficacy|0|||
105399445|NCT02332928|363474153|FG000|Overall Study|Withdrawal by Subject|0|||
105399446|NCT02332928|363474154|FG001|Overall Study|Withdrawal by Subject|2|||
105399447|NCT02332928|363474153|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
105399448|NCT02332928|363474154|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
105399449|NCT01441960|363474155|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
105399450|NCT01441960|363474156|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
105399451|NCT01441960|363474155|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
105399452|NCT01441960|363474156|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
105399453|NCT01441960|363474155|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
105399454|NCT01441960|363474156|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
105399455|NCT00370292|363474157|FG000|Overall Study|Disease Progression|4|||
105399456|NCT00370292|363474157|FG000|Overall Study|Adverse Event|7|||
105399457|NCT00370292|363474157|FG000|Overall Study|Physician Decision|2|||
105399458|NCT02986074|363474158|FG000|First Trial Period|Adverse Event|1|||
105399459|NCT02986074|363474159|FG001|First Trial Period|Adverse Event|0|||
105399460|NCT02986074|363474160|FG002|First Trial Period|Adverse Event|0|||
105399461|NCT02986074|363474161|FG003|First Trial Period|Adverse Event|0|||
105399462|NCT02986074|363474158|FG000|Follow up Period|system explant|0|||
105399463|NCT02986074|363474159|FG001|Follow up Period|system explant|0|||
105399464|NCT02986074|363474160|FG002|Follow up Period|system explant|1|||
105399465|NCT02986074|363474161|FG003|Follow up Period|system explant|2|||
105399466|NCT02986074|363474158|FG000|Follow up Period|Physician Decision|0|||
105580623|NCT01474512|364126479|FG014|Induction Period|Adverse Event|0|||
105580624|NCT01474512|364126480|FG015|Induction Period|Adverse Event|0|||
105580625|NCT01474512|364126481|FG016|Induction Period|Adverse Event|0|||
105399467|NCT02986074|363474159|FG001|Follow up Period|Physician Decision|0|||
105399468|NCT02986074|363474160|FG002|Follow up Period|Physician Decision|0|||
105399469|NCT02986074|363474161|FG003|Follow up Period|Physician Decision|1|||
105399470|NCT00069641|363474162|FG000|Overall Study|Death|1|||
105399471|NCT00069641|363474163|FG001|Overall Study|Death|0|||
105399472|NCT00069641|363474164|FG002|Overall Study|Death|1|||
105399473|NCT00688597|363474165|FG000|Overall Study|Adverse Event|2|||
105399474|NCT00688597|363474166|FG001|Overall Study|Adverse Event|0|||
105399475|NCT00688597|363474167|FG002|Overall Study|Adverse Event|0|||
105399476|NCT00688597|363474165|FG000|Overall Study|Physician Decision|1|||
105399477|NCT00688597|363474166|FG001|Overall Study|Physician Decision|0|||
105399478|NCT00688597|363474167|FG002|Overall Study|Physician Decision|0|||
105399479|NCT00598650|363474170|FG000|Overall Study|Withdrawal by Subject|3|||
105399480|NCT00598650|363474170|FG000|Overall Study|Adverse Event|18|||
105399481|NCT00598650|363474170|FG000|Overall Study|No treatment for 3 weeks|1|||
105399482|NCT00598650|363474170|FG000|Overall Study|Not eligible|1|||
105399483|NCT00598650|363474170|FG000|Overall Study|Prohibited Concomitant Medication|2|||
105399484|NCT00598650|363474170|FG000|Overall Study|Physician Decision|2|||
105399485|NCT00492557|363474171|FG000|Overall Study|Subject request|12|||
105399486|NCT00492557|363474172|FG001|Overall Study|Subject request|11|||
105399487|NCT00492557|363474171|FG000|Overall Study|Protocol Violation|7|||
105399488|NCT00492557|363474172|FG001|Overall Study|Protocol Violation|8|||
105399489|NCT00492557|363474171|FG000|Overall Study|Other|2|||
105399490|NCT00492557|363474172|FG001|Overall Study|Other|2|||
105399491|NCT00492557|363474171|FG000|Overall Study|Death|1|||
105399492|NCT00492557|363474172|FG001|Overall Study|Death|1|||
105399493|NCT00492557|363474171|FG000|Overall Study|Adverse Event|1|||
105399494|NCT00492557|363474172|FG001|Overall Study|Adverse Event|0|||
105399495|NCT00492557|363474171|FG000|Overall Study|Failed to return|1|||
105399496|NCT00492557|363474172|FG001|Overall Study|Failed to return|0|||
105399497|NCT00492557|363474171|FG000|Overall Study|Lost to Follow-up|0|||
105399498|NCT00492557|363474172|FG001|Overall Study|Lost to Follow-up|1|||
105399499|NCT04778592|363474173|FG000|Overall Study|Adverse Event|1|||
105399500|NCT04778592|363474174|FG001|Overall Study|Adverse Event|2|||
105399501|NCT04778592|363474173|FG000|Overall Study|Withdrawal by Subject|1|||
105399502|NCT04778592|363474174|FG001|Overall Study|Withdrawal by Subject|2|||
105399503|NCT02862574|363474179|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105439956|NCT01618695|363616641|FG003|Extension Phase|Pregnancy|1|||
105399504|NCT02862574|363474180|FG001|Double-Blind Treatment Period|Adverse Event|1|||
105399505|NCT02862574|363474181|FG002|Double-Blind Treatment Period|Adverse Event|0|||
105399506|NCT02862574|363474179|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
105399507|NCT02862574|363474180|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
105399508|NCT02862574|363474181|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
105399509|NCT02862574|363474179|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
105399510|NCT02862574|363474180|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
105399511|NCT02862574|363474181|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
105399512|NCT02660229|363474183|FG000|Overall Study|Adverse Event|2|||
105399513|NCT02660229|363474184|FG001|Overall Study|Adverse Event|0|||
105399514|NCT02660229|363474183|FG000|Overall Study|Withdrawal by Subject|0|||
105399515|NCT02660229|363474184|FG001|Overall Study|Withdrawal by Subject|1|||
105399516|NCT01049373|363474189|FG000|Overall Study|Protocol Violation|9|||
105399517|NCT01049373|363474190|FG001|Overall Study|Protocol Violation|9|||
105399518|NCT01049373|363474189|FG000|Overall Study|Withdrawal by Subject|8|||
105399519|NCT01049373|363474190|FG001|Overall Study|Withdrawal by Subject|5|||
105399520|NCT01049373|363474189|FG000|Overall Study|Adverse Event|3|||
105399521|NCT01049373|363474190|FG001|Overall Study|Adverse Event|3|||
105399522|NCT01049373|363474189|FG000|Overall Study|Lost to Follow-up|9|||
105399523|NCT01049373|363474190|FG001|Overall Study|Lost to Follow-up|4|||
105399524|NCT01049373|363474189|FG000|Overall Study|no evaluable study values|9|||
105399525|NCT01049373|363474190|FG001|Overall Study|no evaluable study values|21|||
105399526|NCT01049373|363474189|FG000|Overall Study|Other|1|||
105399527|NCT01049373|363474190|FG001|Overall Study|Other|1|||
105399528|NCT01049373|363474189|FG000|Overall Study|Non-cooperation|0|||
105399529|NCT01049373|363474190|FG001|Overall Study|Non-cooperation|1|||
105399530|NCT01693367|363474195|FG000|Overall Study|Withdrawal by Subject|1|||
105399531|NCT01693367|363474196|FG001|Overall Study|Withdrawal by Subject|1|||
105399532|NCT01693367|363474195|FG000|Overall Study|Physician Decision|0|||
105399533|NCT01693367|363474196|FG001|Overall Study|Physician Decision|1|||
105399534|NCT02136914|363474197|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
105399535|NCT02136914|363474198|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
105399536|NCT02136914|363474197|FG000|Overall Study|Withdrawal by Subject|3|||
105399537|NCT02136914|363474198|FG001|Overall Study|Withdrawal by Subject|10|||
105399538|NCT02136914|363474197|FG000|Overall Study|Subject Unwilling to Proceed|7|||
105399539|NCT02136914|363474198|FG001|Overall Study|Subject Unwilling to Proceed|2|||
105399540|NCT02136914|363474197|FG000|Overall Study|Lost to Follow-up|1|||
105399541|NCT02136914|363474198|FG001|Overall Study|Lost to Follow-up|1|||
105399542|NCT02136914|363474197|FG000|Overall Study|Did Not Receive Study Drug|2|||
105399543|NCT02136914|363474198|FG001|Overall Study|Did Not Receive Study Drug|0|||
105399544|NCT02136914|363474197|FG000|Overall Study|Lack of Efficacy|1|||
105399545|NCT02136914|363474198|FG001|Overall Study|Lack of Efficacy|0|||
105399546|NCT02136914|363474197|FG000|Overall Study|Death|0|||
105399547|NCT02136914|363474198|FG001|Overall Study|Death|1|||
105399548|NCT00328172|363474199|FG000|Overall Study|Adverse Event|3|||
105399549|NCT00328172|363474200|FG001|Overall Study|Adverse Event|2|||
105399550|NCT00328172|363474201|FG002|Overall Study|Adverse Event|1|||
105399551|NCT00328172|363474202|FG003|Overall Study|Adverse Event|2|||
105399552|NCT00328172|363474203|FG004|Overall Study|Adverse Event|1|||
105399553|NCT00328172|363474199|FG000|Overall Study|Protocol Violation|0|||
105399554|NCT00328172|363474200|FG001|Overall Study|Protocol Violation|1|||
105399555|NCT00328172|363474201|FG002|Overall Study|Protocol Violation|1|||
105399556|NCT00328172|363474202|FG003|Overall Study|Protocol Violation|0|||
105399557|NCT00328172|363474203|FG004|Overall Study|Protocol Violation|0|||
105399558|NCT00328172|363474199|FG000|Overall Study|Lost to Follow-up|1|||
105399559|NCT00328172|363474200|FG001|Overall Study|Lost to Follow-up|1|||
105399560|NCT00328172|363474201|FG002|Overall Study|Lost to Follow-up|2|||
105399561|NCT00328172|363474202|FG003|Overall Study|Lost to Follow-up|1|||
105399562|NCT00328172|363474203|FG004|Overall Study|Lost to Follow-up|1|||
105399563|NCT00328172|363474199|FG000|Overall Study|Withdrawal by Subject|1|||
105399564|NCT00328172|363474200|FG001|Overall Study|Withdrawal by Subject|1|||
105399565|NCT00328172|363474201|FG002|Overall Study|Withdrawal by Subject|1|||
105399566|NCT00328172|363474202|FG003|Overall Study|Withdrawal by Subject|6|||
105399567|NCT00328172|363474203|FG004|Overall Study|Withdrawal by Subject|0|||
105399568|NCT00328172|363474199|FG000|Overall Study|Lack of Efficacy|14|||
105399569|NCT00328172|363474200|FG001|Overall Study|Lack of Efficacy|9|||
105399570|NCT00328172|363474201|FG002|Overall Study|Lack of Efficacy|4|||
105399571|NCT00328172|363474202|FG003|Overall Study|Lack of Efficacy|4|||
105399572|NCT00328172|363474203|FG004|Overall Study|Lack of Efficacy|3|||
105399573|NCT00328172|363474199|FG000|Overall Study|Other reason (not specified)|3|||
105399574|NCT00328172|363474200|FG001|Overall Study|Other reason (not specified)|0|||
105399575|NCT00328172|363474201|FG002|Overall Study|Other reason (not specified)|1|||
105399576|NCT00328172|363474202|FG003|Overall Study|Other reason (not specified)|0|||
105399577|NCT00328172|363474203|FG004|Overall Study|Other reason (not specified)|0|||
105493232|NCT01675427|363818815|FG000|Overall Study|Other|2|||
105399578|NCT00077974|363474204|FG000|Overall Study|Adverse Event|22|||
105399579|NCT00077974|363474204|FG000|Overall Study|Protocol Violation|1|||
105399580|NCT00077974|363474204|FG000|Overall Study|Withdrawal by Subject|3|||
105399581|NCT00077974|363474204|FG000|Overall Study|Lack of Efficacy|76|||
105399582|NCT00077974|363474204|FG000|Overall Study|Decision of Sponsor|2|||
105399583|NCT00256126|363474205|FG000|Overall Study|Adverse Event|1|||
105399584|NCT00256126|363474206|FG001|Overall Study|Adverse Event|0|||
105399585|NCT00256126|363474205|FG000|Overall Study|Other|1|||
105399586|NCT00256126|363474206|FG001|Overall Study|Other|2|||
105399587|NCT01990742|363474218|FG000|Overall Study|Withdrawal by facility|407|||
105399588|NCT01990742|363474219|FG001|Overall Study|Withdrawal by facility|1083|||
105399589|NCT01990742|363474218|FG000|Overall Study|Facility closed|0|||
105399590|NCT01990742|363474219|FG001|Overall Study|Facility closed|270|||
105399591|NCT00976456|363474220|FG000|Overall Study|Adverse Event|17|||
105399592|NCT00976456|363474221|FG001|Overall Study|Adverse Event|22|||
105399593|NCT00976456|363474220|FG000|Overall Study|Death|7|||
105399594|NCT00976456|363474221|FG001|Overall Study|Death|9|||
105399595|NCT00976456|363474220|FG000|Overall Study|Lack of Efficacy|5|||
105399596|NCT00976456|363474221|FG001|Overall Study|Lack of Efficacy|2|||
105399597|NCT00976456|363474220|FG000|Overall Study|Withdrawal by Subject|3|||
105399598|NCT00976456|363474221|FG001|Overall Study|Withdrawal by Subject|1|||
105399599|NCT00976456|363474220|FG000|Overall Study|screening failure, unknown|11|||
105399600|NCT00976456|363474221|FG001|Overall Study|screening failure, unknown|4|||
105399601|NCT02257684|363474222|FG000|Overall Study|Adverse Event|2|||
105399602|NCT02257684|363474222|FG000|Overall Study|Lack of Efficacy|1|||
105399603|NCT02257684|363474222|FG000|Overall Study|Sponsor's Decision|1|||
105399604|NCT03139448|363474226|FG000|Overall Study|Lack of Efficacy|6|||
105399605|NCT03139448|363474227|FG001|Overall Study|Lack of Efficacy|7|||
105399606|NCT03139448|363474226|FG000|Overall Study|Location of procedure changed|2|||
105399607|NCT03139448|363474227|FG001|Overall Study|Location of procedure changed|8|||
105399608|NCT03139448|363474226|FG000|Overall Study|Withdrawal by Subject|3|||
105399609|NCT03139448|363474227|FG001|Overall Study|Withdrawal by Subject|6|||
105399610|NCT03139448|363474226|FG000|Overall Study|Screen fail|1|||
105399611|NCT03139448|363474227|FG001|Overall Study|Screen fail|3|||
105399612|NCT03139448|363474226|FG000|Overall Study|Physician Decision|0|||
105399613|NCT03139448|363474227|FG001|Overall Study|Physician Decision|2|||
105399614|NCT02170064|363474228|FG000|Overall Study|Withdrawal by Subject|5|||
105399615|NCT02170064|363474229|FG001|Overall Study|Withdrawal by Subject|1|||
105399616|NCT02170064|363474230|FG002|Overall Study|Withdrawal by Subject|1|||
105399617|NCT02170064|363474228|FG000|Overall Study|Physician Decision|1|||
105399618|NCT02170064|363474229|FG001|Overall Study|Physician Decision|1|||
105399619|NCT02170064|363474230|FG002|Overall Study|Physician Decision|0|||
105399620|NCT04436744|363474236|FG000|Overall Study|Adverse Event|1|||
105399621|NCT04436744|363474237|FG001|Overall Study|Adverse Event|1|||
105399622|NCT04436744|363474236|FG000|Overall Study|Death|1|||
105399623|NCT04436744|363474237|FG001|Overall Study|Death|0|||
105399624|NCT04436744|363474236|FG000|Overall Study|Lost to Follow-up|0|||
105399625|NCT04436744|363474237|FG001|Overall Study|Lost to Follow-up|2|||
105399626|NCT04436744|363474236|FG000|Overall Study|Physician Decision|0|||
105399627|NCT04436744|363474237|FG001|Overall Study|Physician Decision|1|||
105399628|NCT04436744|363474236|FG000|Overall Study|Progressive Disease|0|||
105399629|NCT04436744|363474237|FG001|Overall Study|Progressive Disease|4|||
105399630|NCT04436744|363474236|FG000|Overall Study|Protocol Deviation|1|||
105399631|NCT04436744|363474237|FG001|Overall Study|Protocol Deviation|1|||
105399632|NCT04436744|363474236|FG000|Overall Study|Withdrawal by Subject|1|||
105399633|NCT04436744|363474237|FG001|Overall Study|Withdrawal by Subject|2|||
105399634|NCT00940602|363474238|FG000|Overall Study|Administrative problems|1|||
105399635|NCT00940602|363474239|FG001|Overall Study|Administrative problems|1|||
105399636|NCT00940602|363474238|FG000|Overall Study|Patient/guardian decision|13|||
105399637|NCT00940602|363474239|FG001|Overall Study|Patient/guardian decision|28|||
105399638|NCT00940602|363474238|FG000|Overall Study|Physician Decision|8|||
105399639|NCT00940602|363474239|FG001|Overall Study|Physician Decision|5|||
105399640|NCT00940602|363474238|FG000|Overall Study|Pregnancy|1|||
105399641|NCT00940602|363474239|FG001|Overall Study|Pregnancy|0|||
105399642|NCT00940602|363474238|FG000|Overall Study|Protocol Deviation (untreated)|1|||
105399643|NCT00940602|363474239|FG001|Overall Study|Protocol Deviation (untreated)|0|||
105399644|NCT00940602|363474238|FG000|Overall Study|Disease progression|8|||
105399645|NCT00940602|363474239|FG001|Overall Study|Disease progression|2|||
105399646|NCT00940602|363474238|FG000|Overall Study|Death|38|||
105399647|NCT00940602|363474239|FG001|Overall Study|Death|19|||
105399648|NCT00940602|363474238|FG000|Overall Study|Lost to Follow-up|3|||
105399649|NCT00940602|363474239|FG001|Overall Study|Lost to Follow-up|1|||
105399650|NCT00940602|363474238|FG000|Overall Study|Patient withdrew consent|26|||
105399651|NCT00940602|363474239|FG001|Overall Study|Patient withdrew consent|13|||
105399652|NCT00940602|363474238|FG000|Overall Study|Adverse Event|7|||
105399653|NCT00940602|363474239|FG001|Overall Study|Adverse Event|2|||
105399654|NCT00940602|363474238|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
105399655|NCT00940602|363474239|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
105399656|NCT01880957|363474240|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
105399657|NCT01880957|363474241|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
105399658|NCT01880957|363474240|FG000|Overall Study|Lost to Follow-up|11|||
105399659|NCT01880957|363474241|FG001|Overall Study|Lost to Follow-up|0|||
105399660|NCT01880957|363474240|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
105399661|NCT01880957|363474241|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
105399662|NCT01854528|363474244|FG000|Overall Study|Adverse Event|0|||
105399663|NCT01854528|363474245|FG001|Overall Study|Adverse Event|4|||
105399664|NCT01854528|363474244|FG000|Overall Study|Withdrawal by Subject|0|||
105399665|NCT01854528|363474245|FG001|Overall Study|Withdrawal by Subject|2|||
105399666|NCT01854528|363474244|FG000|Overall Study|Virologic Failure|0|||
105399667|NCT01854528|363474245|FG001|Overall Study|Virologic Failure|9|||
105399668|NCT00570713|363474246|FG000|Overall Study|Adverse Event|16|||
105399669|NCT00570713|363474247|FG001|Overall Study|Adverse Event|9|||
105399670|NCT00570713|363474246|FG000|Overall Study|Death|7|||
105399671|NCT00570713|363474247|FG001|Overall Study|Death|7|||
105399672|NCT00570713|363474246|FG000|Overall Study|Lack of Efficacy|40|||
105399673|NCT00570713|363474247|FG001|Overall Study|Lack of Efficacy|49|||
105399674|NCT00570713|363474246|FG000|Overall Study|Physician Decision|2|||
105399675|NCT00570713|363474247|FG001|Overall Study|Physician Decision|2|||
105399676|NCT00570713|363474246|FG000|Overall Study|Withdrawal by Subject|3|||
105399677|NCT00570713|363474247|FG001|Overall Study|Withdrawal by Subject|3|||
105399678|NCT00570713|363474246|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
105399679|NCT00570713|363474247|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
105399680|NCT03958331|363474250|FG000|Overall Study|Withdrawal by Subject|3|||
105399681|NCT03958331|363474251|FG001|Overall Study|Withdrawal by Subject|1|||
105399682|NCT03958331|363474252|FG002|Overall Study|Withdrawal by Subject|5|||
105399683|NCT03958331|363474250|FG000|Overall Study|Weaned from medicine|2|||
105399684|NCT03958331|363474251|FG001|Overall Study|Weaned from medicine|0|||
105399685|NCT03958331|363474252|FG002|Overall Study|Weaned from medicine|0|||
105399686|NCT03958331|363474250|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
105399687|NCT03958331|363474251|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
105399688|NCT03958331|363474252|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
105399689|NCT00730886|363474253|FG000|Overall Study|Lost to Follow-up|1|||
105399690|NCT00730886|363474254|FG001|Overall Study|Lost to Follow-up|0|||
105399691|NCT00730886|363474253|FG000|Overall Study|Physician Decision|1|||
105399692|NCT00730886|363474254|FG001|Overall Study|Physician Decision|0|||
105399693|NCT01152437|363474257|FG000|Overall Study|Other Adverse Event|8|||
105399694|NCT01152437|363474258|FG001|Overall Study|Other Adverse Event|1|||
105399695|NCT01152437|363474259|FG002|Overall Study|Other Adverse Event|7|||
105399696|NCT01152437|363474257|FG000|Overall Study|Not treated|0|||
105399697|NCT01152437|363474258|FG001|Overall Study|Not treated|1|||
105399698|NCT01152437|363474259|FG002|Overall Study|Not treated|2|||
105399699|NCT01152437|363474257|FG000|Overall Study|Progressive disease|27|||
105399700|NCT01152437|363474258|FG001|Overall Study|Progressive disease|13|||
105399701|NCT01152437|363474259|FG002|Overall Study|Progressive disease|32|||
105399702|NCT01152437|363474257|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
105399703|NCT01152437|363474258|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
105399704|NCT01152437|363474259|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
105399705|NCT02317627|363474263|FG000|Overall Study|Withdrawal by Subject|0|||
105399706|NCT02317627|363474264|FG001|Overall Study|Withdrawal by Subject|1|||
105399707|NCT02317627|363474265|FG002|Overall Study|Withdrawal by Subject|1|||
105399708|NCT02317627|363474263|FG000|Overall Study|Lost to Follow-up|2|||
105399709|NCT02317627|363474264|FG001|Overall Study|Lost to Follow-up|0|||
105399710|NCT02317627|363474265|FG002|Overall Study|Lost to Follow-up|0|||
105399711|NCT02317627|363474263|FG000|Overall Study|Stopped by Investigator|0|||
105399712|NCT02317627|363474264|FG001|Overall Study|Stopped by Investigator|1|||
105399713|NCT02317627|363474265|FG002|Overall Study|Stopped by Investigator|0|||
105399714|NCT02317627|363474263|FG000|Overall Study|Adverse Event|0|||
105399715|NCT02317627|363474264|FG001|Overall Study|Adverse Event|2|||
105399716|NCT02317627|363474265|FG002|Overall Study|Adverse Event|3|||
105399717|NCT02317627|363474263|FG000|Overall Study|Non-compliance with study drug|0|||
105399718|NCT02317627|363474264|FG001|Overall Study|Non-compliance with study drug|1|||
105399719|NCT02317627|363474265|FG002|Overall Study|Non-compliance with study drug|0|||
105399720|NCT00952705|363475863|FG000|Overall Study|Lost to Follow-up|24|||
105399721|NCT00952705|363475864|FG001|Overall Study|Lost to Follow-up|8|||
105399722|NCT00952705|363475865|FG002|Overall Study|Lost to Follow-up|9|||
105399723|NCT00952705|363475863|FG000|Overall Study|Withdrawal by Subject|2|||
105399724|NCT00952705|363475864|FG001|Overall Study|Withdrawal by Subject|1|||
105399725|NCT00952705|363475865|FG002|Overall Study|Withdrawal by Subject|1|||
105399726|NCT00952705|363475863|FG000|Overall Study|Death|2|||
105399727|NCT00952705|363475864|FG001|Overall Study|Death|0|||
105399728|NCT00952705|363475865|FG002|Overall Study|Death|0|||
105399729|NCT00952705|363475863|FG000|Overall Study|Incarcerated post dose|5|||
105399730|NCT00952705|363475864|FG001|Overall Study|Incarcerated post dose|0|||
105399731|NCT00952705|363475865|FG002|Overall Study|Incarcerated post dose|0|||
105399732|NCT00952705|363475863|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
105399733|NCT00952705|363475864|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
105399734|NCT00952705|363475865|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
105399735|NCT02276040|363475867|FG000|Overall Study|Physician Decision|15|||
105399736|NCT03545672|363475875|FG000|Overall Study|Uncertain diagnosis|2|||
105399737|NCT03545672|363475876|FG001|Overall Study|Uncertain diagnosis|1|||
105399738|NCT03545672|363475875|FG000|Overall Study|Protocol Violation|2|||
105399739|NCT03545672|363475876|FG001|Overall Study|Protocol Violation|2|||
105399740|NCT01628913|363475877|FG000|Overall Study|Adverse Event|12|||
105399741|NCT01628913|363475878|FG001|Overall Study|Adverse Event|5|||
105399742|NCT01628913|363475877|FG000|Overall Study|Disease Progression|11|||
105399743|NCT01628913|363475878|FG001|Overall Study|Disease Progression|14|||
105399744|NCT01628913|363475877|FG000|Overall Study|Protocol Violation|1|||
105399745|NCT01628913|363475878|FG001|Overall Study|Protocol Violation|0|||
105399746|NCT01628913|363475877|FG000|Overall Study|Death|1|||
105399747|NCT01628913|363475878|FG001|Overall Study|Death|0|||
105399748|NCT01628913|363475877|FG000|Overall Study|study terminated by Sponsor|4|||
105399749|NCT01628913|363475878|FG001|Overall Study|study terminated by Sponsor|9|||
105399750|NCT01628913|363475877|FG000|Overall Study|Withdrawal by Subject|1|||
105399751|NCT01628913|363475878|FG001|Overall Study|Withdrawal by Subject|0|||
105399752|NCT01628913|363475877|FG000|Overall Study|Physician Decision|1|||
105399753|NCT01628913|363475878|FG001|Overall Study|Physician Decision|3|||
105399754|NCT02415556|363475882|FG000|Overall Study|Adverse Event|3|||
105399755|NCT02415556|363475883|FG001|Overall Study|Adverse Event|4|||
105399756|NCT02415556|363475884|FG002|Overall Study|Adverse Event|2|||
105399757|NCT02415556|363475885|FG003|Overall Study|Adverse Event|4|||
105399758|NCT02415556|363475882|FG000|Overall Study|Lost to Follow-up|4|||
105399759|NCT02415556|363475883|FG001|Overall Study|Lost to Follow-up|5|||
105399760|NCT02415556|363475884|FG002|Overall Study|Lost to Follow-up|4|||
105399761|NCT02415556|363475885|FG003|Overall Study|Lost to Follow-up|1|||
105399762|NCT02415556|363475882|FG000|Overall Study|Withdrawal by Subject|13|||
105399763|NCT02415556|363475883|FG001|Overall Study|Withdrawal by Subject|4|||
105399764|NCT02415556|363475884|FG002|Overall Study|Withdrawal by Subject|14|||
105399765|NCT02415556|363475885|FG003|Overall Study|Withdrawal by Subject|12|||
105399766|NCT02415556|363475882|FG000|Overall Study|Physician Decision|1|||
105399767|NCT02415556|363475883|FG001|Overall Study|Physician Decision|3|||
105399768|NCT02415556|363475884|FG002|Overall Study|Physician Decision|1|||
105399769|NCT02415556|363475885|FG003|Overall Study|Physician Decision|2|||
105399770|NCT02415556|363475882|FG000|Overall Study|Censored - study completion|4|||
105399771|NCT02415556|363475883|FG001|Overall Study|Censored - study completion|5|||
105399772|NCT02415556|363475884|FG002|Overall Study|Censored - study completion|1|||
105399773|NCT02415556|363475885|FG003|Overall Study|Censored - study completion|0|||
105399774|NCT02415556|363475882|FG000|Overall Study|Family-related issues|0|||
105399775|NCT02415556|363475883|FG001|Overall Study|Family-related issues|0|||
105399776|NCT02415556|363475884|FG002|Overall Study|Family-related issues|0|||
105399777|NCT02415556|363475885|FG003|Overall Study|Family-related issues|1|||
105399778|NCT00105534|363475886|FG000|Overall Study|Adverse Event|2|||
105399779|NCT00105534|363475887|FG001|Overall Study|Adverse Event|5|||
105399780|NCT00105534|363475886|FG000|Overall Study|Protocol Violation|1|||
105399781|NCT00105534|363475887|FG001|Overall Study|Protocol Violation|4|||
105399782|NCT00105534|363475886|FG000|Overall Study|Withdrawal by Subject|6|||
105399783|NCT00105534|363475887|FG001|Overall Study|Withdrawal by Subject|6|||
105399784|NCT00105534|363475886|FG000|Overall Study|Lost to Follow-up|5|||
105399785|NCT00105534|363475887|FG001|Overall Study|Lost to Follow-up|1|||
105399786|NCT00105534|363475886|FG000|Overall Study|Lack of Efficacy|7|||
105399787|NCT00105534|363475887|FG001|Overall Study|Lack of Efficacy|15|||
105399788|NCT00105534|363475886|FG000|Overall Study|Treatment unmasked|1|||
105399789|NCT00105534|363475887|FG001|Overall Study|Treatment unmasked|0|||
105399790|NCT00105534|363475886|FG000|Overall Study|Other Reason|0|||
105399791|NCT00105534|363475887|FG001|Overall Study|Other Reason|2|||
105399792|NCT01944020|363475888|FG000|Overall Study|Withdrawal by Subject|5|||
105399793|NCT01944020|363475889|FG001|Overall Study|Withdrawal by Subject|0|||
105399794|NCT03423602|363475894|FG000|Overall Study|Death|1|||
105399795|NCT03423602|363475894|FG000|Overall Study|Lost to Follow-up|6|||
105399796|NCT03423602|363475894|FG000|Overall Study|Protocol Violation|1|||
105399797|NCT03423602|363475894|FG000|Overall Study|Withdrawal by Subject|4|||
105399798|NCT00560508|363475895|FG000|12 Week Double-blind Period|Adverse Event|3|||
105399799|NCT00560508|363475896|FG001|12 Week Double-blind Period|Adverse Event|2|||
105399800|NCT00560508|363475895|FG000|12 Week Double-blind Period|Protocol Violation|1|||
105399801|NCT00560508|363475896|FG001|12 Week Double-blind Period|Protocol Violation|0|||
105399802|NCT00560508|363475895|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
105399803|NCT00560508|363475896|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
105399804|NCT00560508|363475895|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
105399805|NCT00560508|363475896|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
105399806|NCT00560508|363475895|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
105399807|NCT00560508|363475896|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
105399808|NCT00560508|363475895|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
105399809|NCT00560508|363475896|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
105399810|NCT00560508|363475895|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
105580626|NCT01474512|364126482|FG017|Induction Period|Adverse Event|0|||
105580627|NCT01474512|364126465|FG000|Induction Period|Lack of Efficacy|7|||
105580628|NCT01474512|364126466|FG001|Induction Period|Lack of Efficacy|1|||
105580629|NCT01474512|364126467|FG002|Induction Period|Lack of Efficacy|0|||
105580630|NCT01474512|364126468|FG003|Induction Period|Lack of Efficacy|0|||
105580631|NCT01474512|364126469|FG004|Induction Period|Lack of Efficacy|0|||
105580632|NCT01474512|364126470|FG005|Induction Period|Lack of Efficacy|0|||
105580633|NCT01474512|364126471|FG006|Induction Period|Lack of Efficacy|0|||
105580634|NCT01474512|364126472|FG007|Induction Period|Lack of Efficacy|0|||
105580635|NCT01474512|364126473|FG008|Induction Period|Lack of Efficacy|0|||
105580636|NCT01474512|364126474|FG009|Induction Period|Lack of Efficacy|0|||
105399811|NCT00560508|363475896|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
105399812|NCT01192126|363475897|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
105399813|NCT01192126|363475898|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
105399814|NCT01192126|363475897|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
105399815|NCT01192126|363475898|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
105399816|NCT03257358|363475899|FG000|Overall Study|Adverse Event|25|||
105399817|NCT03257358|363475900|FG001|Overall Study|Adverse Event|12|||
105399818|NCT03257358|363475899|FG000|Overall Study|Lack of Efficacy|1|||
105399819|NCT03257358|363475900|FG001|Overall Study|Lack of Efficacy|1|||
105399820|NCT03257358|363475899|FG000|Overall Study|Lost to Follow-up|12|||
105399821|NCT03257358|363475900|FG001|Overall Study|Lost to Follow-up|4|||
105399822|NCT03257358|363475899|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
105399823|NCT03257358|363475900|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
105399824|NCT03257358|363475899|FG000|Overall Study|Physician Decision|2|||
105399825|NCT03257358|363475900|FG001|Overall Study|Physician Decision|2|||
105399826|NCT03257358|363475899|FG000|Overall Study|Protocol Violation|5|||
105399827|NCT03257358|363475900|FG001|Overall Study|Protocol Violation|3|||
105399828|NCT03257358|363475899|FG000|Overall Study|Technical problems|4|||
105399829|NCT03257358|363475900|FG001|Overall Study|Technical problems|1|||
105399830|NCT03257358|363475899|FG000|Overall Study|Withdrawal by Subject|8|||
105399831|NCT03257358|363475900|FG001|Overall Study|Withdrawal by Subject|3|||
105399832|NCT03257358|363475899|FG000|Overall Study|Withdrawal of informed consent|9|||
105399833|NCT03257358|363475900|FG001|Overall Study|Withdrawal of informed consent|5|||
105399834|NCT03257358|363475899|FG000|Overall Study|New therapy for study indication|1|||
105399835|NCT03257358|363475900|FG001|Overall Study|New therapy for study indication|0|||
105399836|NCT03257358|363475899|FG000|Overall Study|No longer requires treatment|0|||
105399837|NCT03257358|363475900|FG001|Overall Study|No longer requires treatment|1|||
105399838|NCT00305877|363475901|FG000|Overall Study|Lack of Efficacy|6|||
105399839|NCT00305877|363475902|FG001|Overall Study|Lack of Efficacy|9|||
105399840|NCT00305877|363475901|FG000|Overall Study|Adverse Event|9|||
105399841|NCT00305877|363475902|FG001|Overall Study|Adverse Event|14|||
105399842|NCT00305877|363475901|FG000|Overall Study|Death|0|||
105399843|NCT00305877|363475902|FG001|Overall Study|Death|1|||
105399844|NCT00305877|363475901|FG000|Overall Study|Withdrawal by Subject|4|||
105399845|NCT00305877|363475902|FG001|Overall Study|Withdrawal by Subject|2|||
105493233|NCT02028871|363818821|FG000|Overall Study|Positive urine drug screen|1|||
105493234|NCT02028871|363818822|FG001|Overall Study|Positive urine drug screen|1|||
105493235|NCT02028871|363818821|FG000|Overall Study|Withdrawal by Subject|1|||
105493236|NCT02028871|363818822|FG001|Overall Study|Withdrawal by Subject|2|||
105493237|NCT02028871|363818821|FG000|Overall Study|IV placement difficulty|1|||
105493238|NCT02028871|363818822|FG001|Overall Study|IV placement difficulty|0|||
105493239|NCT02028871|363818821|FG000|Overall Study|Current Illness|1|||
105493240|NCT02028871|363818822|FG001|Overall Study|Current Illness|0|||
105493241|NCT02808650|363818823|FG000|Overall Study|Death|0|||
105493242|NCT02808650|363818824|FG001|Overall Study|Death|0|||
105493243|NCT02808650|363818825|FG002|Overall Study|Death|0|||
105493244|NCT02808650|363818826|FG003|Overall Study|Death|0|||
105493245|NCT02808650|363818827|FG004|Overall Study|Death|1|||
105493246|NCT02808650|363818823|FG000|Overall Study|Lack of Efficacy|5|||
105580637|NCT01474512|364126475|FG010|Induction Period|Lack of Efficacy|0|||
105580638|NCT01474512|364126476|FG011|Induction Period|Lack of Efficacy|0|||
105580639|NCT01474512|364126477|FG012|Induction Period|Lack of Efficacy|0|||
105580640|NCT01474512|364126478|FG013|Induction Period|Lack of Efficacy|0|||
105399846|NCT00305877|363475901|FG000|Overall Study|Physician Decision|1|||
105399847|NCT00305877|363475902|FG001|Overall Study|Physician Decision|1|||
105399848|NCT00305877|363475901|FG000|Overall Study|Never start treatment|2|||
105399849|NCT00305877|363475902|FG001|Overall Study|Never start treatment|5|||
105399850|NCT00305877|363475901|FG000|Overall Study|Ineligible|2|||
105580641|NCT01474512|364126479|FG014|Induction Period|Lack of Efficacy|0|||
105580642|NCT01474512|364126480|FG015|Induction Period|Lack of Efficacy|0|||
105399851|NCT00305877|363475902|FG001|Overall Study|Ineligible|1|||
105399852|NCT00305877|363475901|FG000|Overall Study|Transportation issue with daily RT|0|||
105399853|NCT00305877|363475902|FG001|Overall Study|Transportation issue with daily RT|1|||
105493247|NCT02808650|363818824|FG001|Overall Study|Lack of Efficacy|5|||
105580643|NCT01474512|364126481|FG016|Induction Period|Lack of Efficacy|0|||
105580644|NCT01474512|364126482|FG017|Induction Period|Lack of Efficacy|0|||
105580645|NCT01474512|364126465|FG000|Induction Period|Withdrawal by Subject|6|||
105399854|NCT01114737|363475903|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
105399855|NCT01114737|363475904|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
105399856|NCT01114737|363475903|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
105399857|NCT01114737|363475904|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
105399858|NCT01114737|363475903|FG000|Randomized Treatment Period|Pregnancy|1|||
105399859|NCT01114737|363475904|FG001|Randomized Treatment Period|Pregnancy|0|||
105399860|NCT01114737|363475903|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
105399861|NCT01114737|363475904|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
105399862|NCT01114737|363475903|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
105399863|NCT01114737|363475904|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
105399864|NCT01114737|363475903|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
105399865|NCT01114737|363475904|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
105399866|NCT00457392|363475905|FG000|Overall Study|Objective Progression or Relapse|229|||
105399867|NCT00457392|363475906|FG001|Overall Study|Objective Progression or Relapse|296|||
105399868|NCT00457392|363475905|FG000|Overall Study|Death|106|||
105399869|NCT00457392|363475906|FG001|Overall Study|Death|106|||
105399870|NCT00457392|363475905|FG000|Overall Study|Adverse Event|84|||
105399871|NCT00457392|363475906|FG001|Overall Study|Adverse Event|41|||
105399872|NCT00457392|363475905|FG000|Overall Study|Global Deterioration of Health Status|22|||
105399873|NCT00457392|363475906|FG001|Overall Study|Global Deterioration of Health Status|8|||
105399874|NCT00457392|363475905|FG000|Overall Study|Withdrawal by Subject|14|||
105399875|NCT00457392|363475906|FG001|Overall Study|Withdrawal by Subject|8|||
105399876|NCT00457392|363475905|FG000|Overall Study|Lost to Follow-up|6|||
105399877|NCT00457392|363475906|FG001|Overall Study|Lost to Follow-up|7|||
105399878|NCT00457392|363475905|FG000|Overall Study|Protocol Violation|4|||
105399879|NCT00457392|363475906|FG001|Overall Study|Protocol Violation|3|||
105399880|NCT00457392|363475905|FG000|Overall Study|Other|7|||
105399881|NCT00457392|363475906|FG001|Overall Study|Other|4|||
105399882|NCT00457392|363475905|FG000|Overall Study|Study Terminated by Sponsor|1|||
105399883|NCT00457392|363475906|FG001|Overall Study|Study Terminated by Sponsor|4|||
105399884|NCT00457392|363475905|FG000|Overall Study|Randomized, Not Treated|7|||
105399885|NCT00457392|363475906|FG001|Overall Study|Randomized, Not Treated|3|||
105399886|NCT03046446|363475907|FG000|Overall Study|Lack of Efficacy|7|||
105399887|NCT03046446|363475907|FG000|Overall Study|Adverse Event|6|||
105399888|NCT03046446|363475907|FG000|Overall Study|Lost to Follow-up|3|||
105399889|NCT03046446|363475907|FG000|Overall Study|Withdrawal by Subject|14|||
105399890|NCT03046446|363475907|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
105399891|NCT03046446|363475907|FG000|Overall Study|Disease Progression (see caveats)|25|||
105399892|NCT03046446|363475907|FG000|Overall Study|Non OA related knee surgery|1|||
105399893|NCT01493089|363475908|FG000|Overall Study|Protocol Violation|2|||
105399894|NCT01493089|363475909|FG001|Overall Study|Protocol Violation|2|||
105399895|NCT01493089|363475908|FG000|Overall Study|Withdrawal by Subject|1|||
105399896|NCT01493089|363475909|FG001|Overall Study|Withdrawal by Subject|0|||
105399897|NCT01493089|363475908|FG000|Overall Study|Physician Decision|0|||
105399898|NCT01493089|363475909|FG001|Overall Study|Physician Decision|1|||
105399899|NCT00329030|363475910|FG000|Overall Study|Withdrawal by Subject|1|||
105399900|NCT00329030|363475911|FG001|Overall Study|Withdrawal by Subject|3|||
105399901|NCT00329030|363475910|FG000|Overall Study|Progressive Disease|6|||
105399902|NCT00329030|363475911|FG001|Overall Study|Progressive Disease|2|||
105399903|NCT00329030|363475910|FG000|Overall Study|Ineligible Pathology|1|||
105399904|NCT00329030|363475911|FG001|Overall Study|Ineligible Pathology|1|||
105399905|NCT01870869|363475912|FG000|Overall Study|Implanted with nonstudy device|1|||
105399906|NCT01870869|363475913|FG001|Overall Study|Implanted with nonstudy device|3|||
105399907|NCT01870869|363475914|FG002|Overall Study|Implanted with nonstudy device|14|||
105399908|NCT01870869|363475915|FG003|Overall Study|Implanted with nonstudy device|4|||
105399909|NCT01870869|363475912|FG000|Overall Study|Death|0|||
105399910|NCT01870869|363475913|FG001|Overall Study|Death|0|||
105399911|NCT01870869|363475914|FG002|Overall Study|Death|7|||
105399912|NCT01870869|363475915|FG003|Overall Study|Death|1|||
105399913|NCT01870869|363475912|FG000|Overall Study|Subject choice|6|||
105399914|NCT01870869|363475913|FG001|Overall Study|Subject choice|2|||
105399915|NCT01870869|363475914|FG002|Overall Study|Subject choice|22|||
105493248|NCT02808650|363818825|FG002|Overall Study|Lack of Efficacy|6|||
105399916|NCT01870869|363475915|FG003|Overall Study|Subject choice|8|||
105399917|NCT01870869|363475912|FG000|Overall Study|Lost to Follow-up|10|||
105399918|NCT01870869|363475913|FG001|Overall Study|Lost to Follow-up|2|||
105399919|NCT01870869|363475914|FG002|Overall Study|Lost to Follow-up|25|||
105399920|NCT01870869|363475915|FG003|Overall Study|Lost to Follow-up|3|||
105399921|NCT01870869|363475912|FG000|Overall Study|Reason not Specified|1|||
105399922|NCT01870869|363475913|FG001|Overall Study|Reason not Specified|2|||
105399923|NCT01870869|363475914|FG002|Overall Study|Reason not Specified|20|||
105399924|NCT01870869|363475915|FG003|Overall Study|Reason not Specified|4|||
105399925|NCT01870869|363475912|FG000|Overall Study|Not evaluable|10|||
105399926|NCT01870869|363475913|FG001|Overall Study|Not evaluable|5|||
105399927|NCT01870869|363475914|FG002|Overall Study|Not evaluable|42|||
105399928|NCT01870869|363475915|FG003|Overall Study|Not evaluable|10|||
105493249|NCT02808650|363818826|FG003|Overall Study|Lack of Efficacy|5|||
105399929|NCT02286895|363475916|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
105399930|NCT02286895|363475917|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
105399931|NCT02286895|363475916|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
105399932|NCT02286895|363475917|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
105399933|NCT02286895|363475916|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
105399934|NCT02286895|363475917|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
105399935|NCT01073293|363475918|FG000|Overall Study|Lost to Follow-up|0|||
105399936|NCT01073293|363475919|FG001|Overall Study|Lost to Follow-up|1|||
105399937|NCT01073293|363475918|FG000|Overall Study|Withdrawal by Subject|5|||
105399938|NCT01073293|363475919|FG001|Overall Study|Withdrawal by Subject|10|||
105399939|NCT00305448|363475922|FG000|Overall Study|Protocol Violation|0|||
105399940|NCT00305448|363475923|FG001|Overall Study|Protocol Violation|1|||
105399941|NCT00305448|363475924|FG002|Overall Study|Protocol Violation|0|||
105399942|NCT00305448|363475922|FG000|Overall Study|Withdrawal by Subject|2|||
105399943|NCT00305448|363475923|FG001|Overall Study|Withdrawal by Subject|0|||
105399944|NCT00305448|363475924|FG002|Overall Study|Withdrawal by Subject|1|||
105399945|NCT00305448|363475922|FG000|Overall Study|Adverse Event|1|||
105399946|NCT00305448|363475923|FG001|Overall Study|Adverse Event|0|||
105399947|NCT00305448|363475924|FG002|Overall Study|Adverse Event|1|||
105399948|NCT00305448|363475922|FG000|Overall Study|Disease Progression|27|||
105399949|NCT00305448|363475923|FG001|Overall Study|Disease Progression|31|||
105399950|NCT00305448|363475924|FG002|Overall Study|Disease Progression|28|||
105399951|NCT00305448|363475922|FG000|Overall Study|Subjective Disease Progression|1|||
105399952|NCT00305448|363475923|FG001|Overall Study|Subjective Disease Progression|2|||
105399953|NCT00305448|363475924|FG002|Overall Study|Subjective Disease Progression|2|||
105399954|NCT00305448|363475922|FG000|Overall Study|Tumor Marker Elevation|0|||
105399955|NCT00305448|363475923|FG001|Overall Study|Tumor Marker Elevation|0|||
105399956|NCT00305448|363475924|FG002|Overall Study|Tumor Marker Elevation|1|||
105399957|NCT00002766|363475925|FG000|Overall Study|Withdrawal by Subject|0|||
105399958|NCT00002766|363475926|FG001|Overall Study|Withdrawal by Subject|1|||
105399959|NCT00002766|363475925|FG000|Overall Study|Patient Not Treated|1|||
105399960|NCT00002766|363475926|FG001|Overall Study|Patient Not Treated|2|||
105399961|NCT00002766|363475925|FG000|Overall Study|Adverse Event|1|||
105399962|NCT00002766|363475926|FG001|Overall Study|Adverse Event|1|||
105399963|NCT00002766|363475925|FG000|Overall Study|Protocol Violation|1|||
105399964|NCT00002766|363475926|FG001|Overall Study|Protocol Violation|0|||
105399965|NCT00698828|363475929|FG000|Overall Study|Adverse Event|3|||
105399966|NCT00698828|363475930|FG001|Overall Study|Adverse Event|4|||
105399967|NCT00698828|363475931|FG002|Overall Study|Adverse Event|4|||
105399968|NCT00698828|363475929|FG000|Overall Study|Death|0|||
105399969|NCT00698828|363475930|FG001|Overall Study|Death|0|||
105399970|NCT00698828|363475931|FG002|Overall Study|Death|1|||
105399971|NCT00698828|363475929|FG000|Overall Study|Exacerbation of COPD|1|||
105399972|NCT00698828|363475930|FG001|Overall Study|Exacerbation of COPD|3|||
105399973|NCT00698828|363475931|FG002|Overall Study|Exacerbation of COPD|0|||
105399974|NCT00698828|363475929|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
105399975|NCT00698828|363475930|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
105399976|NCT00698828|363475931|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
105399977|NCT00698828|363475929|FG000|Overall Study|Investigator/Sponsor decision|1|||
105399978|NCT00698828|363475930|FG001|Overall Study|Investigator/Sponsor decision|0|||
105399979|NCT00698828|363475931|FG002|Overall Study|Investigator/Sponsor decision|2|||
105493250|NCT02808650|363818827|FG004|Overall Study|Lack of Efficacy|4|||
105493251|NCT02808650|363818823|FG000|Overall Study|Physician Decision|1|||
105493252|NCT02808650|363818824|FG001|Overall Study|Physician Decision|1|||
105493253|NCT02808650|363818825|FG002|Overall Study|Physician Decision|0|||
105493254|NCT02808650|363818826|FG003|Overall Study|Physician Decision|0|||
105493255|NCT02808650|363818827|FG004|Overall Study|Physician Decision|0|||
105493256|NCT02808650|363818823|FG000|Overall Study|Withdrawal by Subject|0|||
105493257|NCT02808650|363818824|FG001|Overall Study|Withdrawal by Subject|0|||
105493258|NCT02808650|363818825|FG002|Overall Study|Withdrawal by Subject|0|||
105493259|NCT02808650|363818826|FG003|Overall Study|Withdrawal by Subject|1|||
105493260|NCT02808650|363818827|FG004|Overall Study|Withdrawal by Subject|1|||
105493261|NCT00532155|363818828|FG000|Overall Study|Adverse Event|66|||
105493262|NCT00532155|363818829|FG001|Overall Study|Adverse Event|123|||
105493263|NCT00532155|363818828|FG000|Overall Study|Lack of Efficacy|332|||
105399980|NCT00698828|363475929|FG000|Overall Study|Lost to Follow-up|1|||
105399981|NCT00698828|363475930|FG001|Overall Study|Lost to Follow-up|1|||
105399982|NCT00698828|363475931|FG002|Overall Study|Lost to Follow-up|0|||
105399983|NCT00698828|363475929|FG000|Overall Study|Withdrew consent|0|||
105399984|NCT00698828|363475930|FG001|Overall Study|Withdrew consent|7|||
105399985|NCT00698828|363475931|FG002|Overall Study|Withdrew consent|4|||
105399986|NCT00698828|363475929|FG000|Overall Study|Withdrew consent (not treated)|2|||
105493264|NCT00532155|363818829|FG001|Overall Study|Lack of Efficacy|255|||
105493265|NCT00532155|363818828|FG000|Overall Study|Protocol Violation|1|||
105493266|NCT00532155|363818829|FG001|Overall Study|Protocol Violation|3|||
105493267|NCT00532155|363818828|FG000|Overall Study|Lost to Follow-up|2|||
105493268|NCT00532155|363818829|FG001|Overall Study|Lost to Follow-up|0|||
105399987|NCT00698828|363475930|FG001|Overall Study|Withdrew consent (not treated)|0|||
105399988|NCT00698828|363475931|FG002|Overall Study|Withdrew consent (not treated)|0|||
105399989|NCT02013609|363475932|FG000|Overall Study|Withdrawal by Subject|9|||
105399990|NCT02013609|363475932|FG000|Overall Study|Lost to Follow-up|3|||
105399991|NCT02013609|363475932|FG000|Overall Study|Adverse Event|3|||
105399992|NCT02013609|363475932|FG000|Overall Study|Met Withdrawal Criteria|3|||
105399993|NCT01788943|363475933|FG000|Overall Study|Withdrawal by Subject|1|||
105399994|NCT01788943|363475934|FG001|Overall Study|Withdrawal by Subject|0|||
105399995|NCT00783432|363475935|FG000|Overall Study|Adverse Event|22|||
105399996|NCT00783432|363475936|FG001|Overall Study|Adverse Event|17|||
105399997|NCT00783432|363475935|FG000|Overall Study|Lack of Efficacy|20|||
105399998|NCT00783432|363475936|FG001|Overall Study|Lack of Efficacy|21|||
105399999|NCT00783432|363475935|FG000|Overall Study|Lost to Follow-up|11|||
105400000|NCT00783432|363475936|FG001|Overall Study|Lost to Follow-up|6|||
105400001|NCT00783432|363475935|FG000|Overall Study|Withdrawal by Subject|23|||
105400002|NCT00783432|363475936|FG001|Overall Study|Withdrawal by Subject|20|||
105400003|NCT00783432|363475935|FG000|Overall Study|subject moved|3|||
105400004|NCT00783432|363475936|FG001|Overall Study|subject moved|5|||
105400005|NCT00783432|363475935|FG000|Overall Study|Protocol Violation|6|||
105400006|NCT00783432|363475936|FG001|Overall Study|Protocol Violation|9|||
105400007|NCT01119287|363475937|FG000|Overall Study|Patient Decision, not related to AE|0|||
105400008|NCT01119287|363475938|FG001|Overall Study|Patient Decision, not related to AE|0|||
105400009|NCT01119287|363475939|FG002|Overall Study|Patient Decision, not related to AE|2|||
105400010|NCT01119287|363475940|FG003|Overall Study|Patient Decision, not related to AE|2|||
105400011|NCT01119287|363475941|FG004|Overall Study|Patient Decision, not related to AE|1|||
105400012|NCT01119287|363475942|FG005|Overall Study|Patient Decision, not related to AE|0|||
105400013|NCT00186628|363475945|FG000|Overall Study|Death|2|||
105400014|NCT00186628|363475945|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
105400015|NCT02927795|363475946|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
105400016|NCT02927795|363475946|FG000|Overall Study|Not Treated|4|||
105400017|NCT01130337|363475949|FG000|Overall Study|Withdrawal by Subject|3|||
105400018|NCT01130337|363475949|FG000|Overall Study|Principal investigator decision|1|||
105400019|NCT01130337|363475949|FG000|Overall Study|Death|1|||
105400020|NCT01130337|363475949|FG000|Overall Study|Disease progression|1|||
105400021|NCT01130337|363475949|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
105400022|NCT01130337|363475949|FG000|Overall Study|Surgical resection (R2)|1|||
105400023|NCT00945659|363475950|FG000|Overall Study|Lost to Follow-up|7|||
105400024|NCT00945659|363475951|FG001|Overall Study|Lost to Follow-up|20|||
105400025|NCT00945659|363475952|FG002|Overall Study|Lost to Follow-up|17|||
105400026|NCT04661033|363475953|FG000|Overall Study|Adverse Event|0|||
105400027|NCT04661033|363475954|FG001|Overall Study|Adverse Event|0|||
105400028|NCT04661033|363475955|FG002|Overall Study|Adverse Event|1|||
105493269|NCT00532155|363818828|FG000|Overall Study|Physician Decision|16|||
105493270|NCT00532155|363818829|FG001|Overall Study|Physician Decision|15|||
105493271|NCT00532155|363818828|FG000|Overall Study|Withdrawal by Subject|23|||
105493272|NCT00532155|363818829|FG001|Overall Study|Withdrawal by Subject|44|||
105493273|NCT00532155|363818828|FG000|Overall Study|Consent withdrawn|5|||
105493274|NCT00532155|363818829|FG001|Overall Study|Consent withdrawn|7|||
105400029|NCT04661033|363475956|FG003|Overall Study|Adverse Event|0|||
105400030|NCT04661033|363475953|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
105493275|NCT00532155|363818828|FG000|Overall Study|Moved|1|||
105493276|NCT00532155|363818829|FG001|Overall Study|Moved|0|||
105493277|NCT00532155|363818828|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
105493278|NCT00532155|363818829|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
105493279|NCT00532155|363818828|FG000|Overall Study|Occurence of a second cancer|0|||
105493280|NCT00532155|363818829|FG001|Overall Study|Occurence of a second cancer|1|||
105493281|NCT00532155|363818828|FG000|Overall Study|Occurence of a secondary cancer|0|||
105493282|NCT00532155|363818829|FG001|Overall Study|Occurence of a secondary cancer|1|||
105493283|NCT00532155|363818828|FG000|Overall Study|Promotor ended study|1|||
105493284|NCT00532155|363818829|FG001|Overall Study|Promotor ended study|0|||
105493285|NCT00532155|363818828|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
105493286|NCT00532155|363818829|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
105493287|NCT00532155|363818828|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
105493288|NCT00532155|363818829|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
105493289|NCT00532155|363818828|FG000|Overall Study|Study stopped|1|||
105493290|NCT00532155|363818829|FG001|Overall Study|Study stopped|0|||
105493291|NCT00532155|363818828|FG000|Overall Study|Study terminated by sponsor|1|||
105493292|NCT00532155|363818829|FG001|Overall Study|Study terminated by sponsor|0|||
105493293|NCT00532155|363818828|FG000|Overall Study|Study termination stop further treatment|4|||
105493294|NCT00532155|363818829|FG001|Overall Study|Study termination stop further treatment|0|||
105400031|NCT04661033|363475954|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
105400032|NCT04661033|363475955|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
105400033|NCT04661033|363475956|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
105400034|NCT04661033|363475953|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
105493295|NCT00532155|363818828|FG000|Overall Study|Did not receive study medication|2|||
105493296|NCT00532155|363818829|FG001|Overall Study|Did not receive study medication|6|||
105493297|NCT02047227|363818830|FG000|Overall Study|Adverse Event|2|||
105493298|NCT02047227|363818831|FG001|Overall Study|Adverse Event|4|||
105493299|NCT02047227|363818830|FG000|Overall Study|Lost to Follow-up|0|||
105493300|NCT02047227|363818831|FG001|Overall Study|Lost to Follow-up|3|||
105493301|NCT02047227|363818830|FG000|Overall Study|Protocol Violation|1|||
105400035|NCT04661033|363475954|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
105400036|NCT04661033|363475955|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
105400037|NCT04661033|363475956|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
105400038|NCT04661033|363475953|FG000|Overall Study|Early discontinuation as per PI|1|||
105400039|NCT04661033|363475954|FG001|Overall Study|Early discontinuation as per PI|0|||
105400040|NCT04661033|363475955|FG002|Overall Study|Early discontinuation as per PI|0|||
105400041|NCT04661033|363475956|FG003|Overall Study|Early discontinuation as per PI|0|||
105400042|NCT00448448|363475957|FG000|Overall Study|Withdrawal by Subject|13|||
105400043|NCT00448448|363475958|FG001|Overall Study|Withdrawal by Subject|2|||
105400044|NCT00448448|363475957|FG000|Overall Study|On protocol when study ended|83|||
105400045|NCT00448448|363475958|FG001|Overall Study|On protocol when study ended|36|||
105400046|NCT00448448|363475957|FG000|Overall Study|Lost to Follow-up|2|||
105400047|NCT00448448|363475958|FG001|Overall Study|Lost to Follow-up|1|||
105400048|NCT00448448|363475957|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
105400049|NCT00448448|363475958|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
105400050|NCT00448448|363475957|FG000|Overall Study|Signed consent lost|0|||
105400051|NCT00448448|363475958|FG001|Overall Study|Signed consent lost|1|||
105400052|NCT02284191|363475959|FG000|Overall Study|Withdrawal by Subject|1|||
105400053|NCT02284191|363475960|FG001|Overall Study|Withdrawal by Subject|3|||
105400054|NCT02284191|363475959|FG000|Overall Study|Lost to Follow-up|1|||
105400055|NCT02284191|363475960|FG001|Overall Study|Lost to Follow-up|0|||
105400056|NCT01876381|363475961|FG000|Overall Study|Lack of Efficacy|5|||
105400057|NCT01876381|363475961|FG000|Overall Study|Physician Decision|1|||
105400058|NCT01876381|363475961|FG000|Overall Study|Withdrawal by Subject|1|||
105400059|NCT00523978|363475964|FG000|Overall Study|Withdrawal by Subject|3|||
105400060|NCT00523978|363475965|FG001|Overall Study|Withdrawal by Subject|7|||
105400061|NCT00523978|363475964|FG000|Overall Study|Screen Failures|5|||
105400062|NCT00523978|363475965|FG001|Overall Study|Screen Failures|1|||
105400063|NCT00523978|363475964|FG000|Overall Study|Death|1|||
105400064|NCT00523978|363475965|FG001|Overall Study|Death|0|||
105400065|NCT00332696|363475966|FG000|Overall Study|Death|24|||
105400066|NCT00332696|363475967|FG001|Overall Study|Death|14|||
105400067|NCT00332696|363475966|FG000|Overall Study|Insufficient therapeutic effect|4|||
105400068|NCT00332696|363475967|FG001|Overall Study|Insufficient therapeutic effect|11|||
105400069|NCT00332696|363475966|FG000|Overall Study|Adverse Event|1|||
105400070|NCT00332696|363475967|FG001|Overall Study|Adverse Event|2|||
105400071|NCT00332696|363475966|FG000|Overall Study|Condition does not justify treatment|0|||
105400072|NCT00332696|363475967|FG001|Overall Study|Condition does not justify treatment|2|||
105400073|NCT00332696|363475966|FG000|Overall Study|Lost to Follow-up|0|||
105400074|NCT00332696|363475967|FG001|Overall Study|Lost to Follow-up|1|||
105400075|NCT00332696|363475966|FG000|Overall Study|Withdrawal by Subject|1|||
105400076|NCT00332696|363475967|FG001|Overall Study|Withdrawal by Subject|0|||
105400077|NCT02216526|363475968|FG000|Overall Study|Adverse Event|1|||
105400078|NCT02216526|363475969|FG001|Overall Study|Adverse Event|1|||
105400079|NCT02216526|363475970|FG002|Overall Study|Adverse Event|0|||
105400080|NCT02216526|363475968|FG000|Overall Study|Death|0|||
105400081|NCT02216526|363475969|FG001|Overall Study|Death|1|||
105400082|NCT02216526|363475970|FG002|Overall Study|Death|3|||
105400083|NCT02216526|363475968|FG000|Overall Study|Protocol Violation|2|||
105400084|NCT02216526|363475969|FG001|Overall Study|Protocol Violation|0|||
105400085|NCT02216526|363475970|FG002|Overall Study|Protocol Violation|2|||
105400086|NCT02216526|363475968|FG000|Overall Study|Hospitalization|2|||
105493302|NCT02047227|363818831|FG001|Overall Study|Protocol Violation|0|||
105400087|NCT02216526|363475969|FG001|Overall Study|Hospitalization|1|||
105400088|NCT02216526|363475970|FG002|Overall Study|Hospitalization|3|||
105400089|NCT01463033|363475971|FG000|Overall Study|Lost to Follow-up|4|||
105400090|NCT01463033|363475972|FG001|Overall Study|Lost to Follow-up|4|||
105400091|NCT01463033|363475971|FG000|Overall Study|Death|3|||
105400092|NCT01463033|363475972|FG001|Overall Study|Death|2|||
105400093|NCT02961244|363475973|FG000|Overall Study|Protocol Violation|0|||
105400094|NCT02961244|363475974|FG001|Overall Study|Protocol Violation|1|||
105400095|NCT02961244|363475973|FG000|Overall Study|Withdrawal by Subject|1|||
105400096|NCT02961244|363475974|FG001|Overall Study|Withdrawal by Subject|2|||
105400097|NCT02961244|363475973|FG000|Overall Study|Surgery plan change after study approval|0|||
105400098|NCT02961244|363475974|FG001|Overall Study|Surgery plan change after study approval|2|||
105580646|NCT01474512|364126466|FG001|Induction Period|Withdrawal by Subject|6|||
105400099|NCT02961244|363475973|FG000|Overall Study|Lost to Follow-up|0|||
105400100|NCT02961244|363475974|FG001|Overall Study|Lost to Follow-up|2|||
105400101|NCT02961244|363475973|FG000|Overall Study|İnadequate data|0|||
105400102|NCT02961244|363475974|FG001|Overall Study|İnadequate data|2|||
105400103|NCT02230189|363475976|FG000|Overall Study|Withdrawal by Subject|3|||
105400104|NCT02230189|363475977|FG001|Overall Study|Withdrawal by Subject|0|||
105400105|NCT02230189|363475978|FG002|Overall Study|Withdrawal by Subject|1|||
105400106|NCT02230189|363475976|FG000|Overall Study|Lost to Follow-up|1|||
105400107|NCT02230189|363475977|FG001|Overall Study|Lost to Follow-up|0|||
105400108|NCT02230189|363475978|FG002|Overall Study|Lost to Follow-up|0|||
105400109|NCT02230189|363475976|FG000|Overall Study|Physician Decision|1|||
105400110|NCT02230189|363475977|FG001|Overall Study|Physician Decision|0|||
105400111|NCT02230189|363475978|FG002|Overall Study|Physician Decision|0|||
105580647|NCT01474512|364126467|FG002|Induction Period|Withdrawal by Subject|5|||
105580648|NCT01474512|364126468|FG003|Induction Period|Withdrawal by Subject|0|||
105580649|NCT01474512|364126469|FG004|Induction Period|Withdrawal by Subject|0|||
105580650|NCT01474512|364126470|FG005|Induction Period|Withdrawal by Subject|0|||
105580651|NCT01474512|364126471|FG006|Induction Period|Withdrawal by Subject|0|||
105580652|NCT01474512|364126472|FG007|Induction Period|Withdrawal by Subject|0|||
105400112|NCT02271529|363475982|FG000|Overall Study|Withdrawal by Subject|1|||
105400113|NCT02761642|363475991|FG000|Overall Study|Did not Receive Study Treatment|3|||
105400114|NCT02761642|363475991|FG000|Overall Study|Adverse Event|13|||
105400115|NCT02761642|363475991|FG000|Overall Study|Withdrawal by Subject|2|||
105400116|NCT02761642|363475991|FG000|Overall Study|Non-compliant|7|||
105400117|NCT02761642|363475991|FG000|Overall Study|Death|3|||
105400118|NCT02761642|363475991|FG000|Overall Study|Lack of Efficacy|20|||
105400119|NCT02761642|363475991|FG000|Overall Study|Physician Decision|1|||
105400120|NCT02761642|363475991|FG000|Overall Study|Reason Unspecified|21|||
105400121|NCT03783780|363475992|FG000|Overall Study|Withdrawn prior to completion|1|||
105400122|NCT03768427|363475996|FG000|Overall Study|Death|0|||
105400123|NCT03768427|363475997|FG001|Overall Study|Death|0|||
105400124|NCT03768427|363475998|FG002|Overall Study|Death|1|||
105400125|NCT03768427|363475999|FG003|Overall Study|Death|0|||
105400126|NCT03768427|363475996|FG000|Overall Study|Lost to Follow-up|2|||
105400127|NCT03768427|363475997|FG001|Overall Study|Lost to Follow-up|0|||
105400128|NCT03768427|363475998|FG002|Overall Study|Lost to Follow-up|0|||
105400129|NCT03768427|363475999|FG003|Overall Study|Lost to Follow-up|0|||
105400130|NCT03768427|363475996|FG000|Overall Study|Physician Decision|3|||
105400131|NCT03768427|363475997|FG001|Overall Study|Physician Decision|2|||
105400132|NCT03768427|363475998|FG002|Overall Study|Physician Decision|4|||
105400133|NCT03768427|363475999|FG003|Overall Study|Physician Decision|4|||
105400134|NCT03768427|363475996|FG000|Overall Study|Withdrawal by Subject|7|||
105400135|NCT03768427|363475997|FG001|Overall Study|Withdrawal by Subject|2|||
105400136|NCT03768427|363475998|FG002|Overall Study|Withdrawal by Subject|6|||
105400137|NCT03768427|363475999|FG003|Overall Study|Withdrawal by Subject|7|||
105400138|NCT02505425|363476000|FG000|Overall Study|Lost to Follow-up|41|||
105400139|NCT02505425|363476001|FG001|Overall Study|Lost to Follow-up|61|||
105400140|NCT02505425|363476002|FG002|Overall Study|Lost to Follow-up|31|||
105400141|NCT02505425|363476003|FG003|Overall Study|Lost to Follow-up|19|||
105400142|NCT02505425|363476000|FG000|Overall Study|Withdrawal by Subject|39|||
105400143|NCT02505425|363476001|FG001|Overall Study|Withdrawal by Subject|9|||
105400144|NCT02505425|363476002|FG002|Overall Study|Withdrawal by Subject|19|||
105400145|NCT02505425|363476003|FG003|Overall Study|Withdrawal by Subject|7|||
105400146|NCT02505425|363476000|FG000|Overall Study|Death|8|||
105400147|NCT02505425|363476001|FG001|Overall Study|Death|12|||
105400148|NCT02505425|363476002|FG002|Overall Study|Death|0|||
105400149|NCT02505425|363476003|FG003|Overall Study|Death|0|||
105400150|NCT05076045|363476009|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
105400151|NCT05076045|363476010|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
105400152|NCT03391882|363476011|FG000|Study Overall|Adverse Event|3|||
105400153|NCT03391882|363476012|FG001|Study Overall|Adverse Event|6|||
105580653|NCT01474512|364126473|FG008|Induction Period|Withdrawal by Subject|0|||
105580654|NCT01474512|364126474|FG009|Induction Period|Withdrawal by Subject|0|||
105400154|NCT03391882|363476013|FG002|Study Overall|Adverse Event|1|||
105400155|NCT03391882|363476014|FG003|Study Overall|Adverse Event|1|||
105400156|NCT03391882|363476015|FG004|Study Overall|Adverse Event|3|||
105400157|NCT03391882|363476016|FG005|Study Overall|Adverse Event|1|||
105580655|NCT01474512|364126475|FG010|Induction Period|Withdrawal by Subject|0|||
105580656|NCT01474512|364126476|FG011|Induction Period|Withdrawal by Subject|0|||
105400158|NCT03391882|363476011|FG000|Study Overall|Lack of Efficacy|13|||
105400159|NCT03391882|363476012|FG001|Study Overall|Lack of Efficacy|9|||
105400160|NCT03391882|363476013|FG002|Study Overall|Lack of Efficacy|0|||
105400161|NCT03391882|363476014|FG003|Study Overall|Lack of Efficacy|0|||
105400162|NCT03391882|363476015|FG004|Study Overall|Lack of Efficacy|0|||
105400163|NCT03391882|363476016|FG005|Study Overall|Lack of Efficacy|0|||
105400164|NCT03391882|363476011|FG000|Study Overall|Withdrawal by Subject|3|||
105400165|NCT03391882|363476012|FG001|Study Overall|Withdrawal by Subject|3|||
105400166|NCT03391882|363476013|FG002|Study Overall|Withdrawal by Subject|2|||
105400167|NCT03391882|363476014|FG003|Study Overall|Withdrawal by Subject|2|||
105400168|NCT03391882|363476015|FG004|Study Overall|Withdrawal by Subject|1|||
105400169|NCT03391882|363476016|FG005|Study Overall|Withdrawal by Subject|3|||
105400170|NCT03391882|363476011|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
105400171|NCT03391882|363476012|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
105400172|NCT03391882|363476013|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
105400173|NCT03391882|363476014|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
105400174|NCT03391882|363476015|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
105400175|NCT03391882|363476016|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
105400176|NCT03391882|363476011|FG000|Study Overall|Protocol Violation|1|||
105400177|NCT03391882|363476012|FG001|Study Overall|Protocol Violation|0|||
105400178|NCT03391882|363476013|FG002|Study Overall|Protocol Violation|0|||
105400179|NCT03391882|363476014|FG003|Study Overall|Protocol Violation|0|||
105400180|NCT03391882|363476015|FG004|Study Overall|Protocol Violation|0|||
105400181|NCT03391882|363476016|FG005|Study Overall|Protocol Violation|0|||
105400182|NCT03391882|363476011|FG000|Part A - Titration Phase|Adverse Event|3|||
105400183|NCT03391882|363476012|FG001|Part A - Titration Phase|Adverse Event|6|||
105400184|NCT03391882|363476013|FG002|Part A - Titration Phase|Adverse Event|0|||
105400185|NCT03391882|363476014|FG003|Part A - Titration Phase|Adverse Event|0|||
105400186|NCT03391882|363476015|FG004|Part A - Titration Phase|Adverse Event|0|||
105400187|NCT03391882|363476016|FG005|Part A - Titration Phase|Adverse Event|0|||
105400188|NCT03391882|363476011|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
105400189|NCT03391882|363476012|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
105400190|NCT03391882|363476013|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
105400191|NCT03391882|363476014|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
105400192|NCT03391882|363476015|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
105400193|NCT03391882|363476016|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
105400194|NCT03391882|363476011|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
105400195|NCT03391882|363476012|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
105400196|NCT03391882|363476013|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
105400197|NCT03391882|363476014|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
105400198|NCT03391882|363476015|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
105400199|NCT03391882|363476016|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
105400200|NCT03391882|363476011|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
105400201|NCT03391882|363476012|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
105400202|NCT03391882|363476013|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
105400203|NCT03391882|363476014|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
105400204|NCT03391882|363476015|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
105400205|NCT03391882|363476016|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
105400206|NCT03391882|363476011|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
105400207|NCT03391882|363476012|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
105400208|NCT03391882|363476013|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
105400209|NCT03391882|363476014|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
105400210|NCT03391882|363476015|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
105400211|NCT03391882|363476016|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
105400212|NCT03391882|363476011|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
105400213|NCT03391882|363476012|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
105400214|NCT03391882|363476013|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
105400215|NCT03391882|363476014|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
105400216|NCT03391882|363476015|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
105400217|NCT03391882|363476016|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
105400218|NCT03391882|363476011|FG000|Part B - Treatment Phase|Adverse Event|0|||
105400219|NCT03391882|363476012|FG001|Part B - Treatment Phase|Adverse Event|0|||
105400220|NCT03391882|363476013|FG002|Part B - Treatment Phase|Adverse Event|1|||
105400221|NCT03391882|363476014|FG003|Part B - Treatment Phase|Adverse Event|1|||
105400222|NCT03391882|363476015|FG004|Part B - Treatment Phase|Adverse Event|3|||
105400223|NCT03391882|363476016|FG005|Part B - Treatment Phase|Adverse Event|1|||
105400224|NCT03391882|363476011|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
105400225|NCT03391882|363476012|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
105400226|NCT03391882|363476013|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
105400227|NCT03391882|363476014|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
105400228|NCT03391882|363476015|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
105400229|NCT03391882|363476016|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
105400230|NCT01581684|363477719|FG000|Overall Study|Other reason not defined|0|||
105400231|NCT01581684|363477720|FG001|Overall Study|Other reason not defined|0|||
105400232|NCT01581684|363477721|FG002|Overall Study|Other reason not defined|0|||
105400233|NCT01581684|363477722|FG003|Overall Study|Other reason not defined|0|||
105400234|NCT01581684|363477723|FG004|Overall Study|Other reason not defined|0|||
105400235|NCT01581684|363477724|FG005|Overall Study|Other reason not defined|0|||
105400236|NCT01581684|363477725|FG006|Overall Study|Other reason not defined|0|||
105400237|NCT01581684|363477726|FG007|Overall Study|Other reason not defined|0|||
105400238|NCT01581684|363477727|FG008|Overall Study|Other reason not defined|1|||
105400239|NCT01581684|363477728|FG009|Overall Study|Other reason not defined|0|||
105400240|NCT03728933|363477729|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
105400241|NCT03728933|363477730|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105400242|NCT03728933|363477731|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105400243|NCT03728933|363477729|FG000|Overall Study|Withdrawal by Subject|0|||
105400244|NCT03728933|363477730|FG001|Overall Study|Withdrawal by Subject|0|||
105400245|NCT03728933|363477731|FG002|Overall Study|Withdrawal by Subject|1|||
105400246|NCT03728933|363477729|FG000|Overall Study|Lost to Follow-up|0|||
105400247|NCT03728933|363477730|FG001|Overall Study|Lost to Follow-up|1|||
105400248|NCT03728933|363477731|FG002|Overall Study|Lost to Follow-up|0|||
105400249|NCT03728933|363477729|FG000|Overall Study|Adverse Event|1|||
105400250|NCT03728933|363477730|FG001|Overall Study|Adverse Event|0|||
105400251|NCT03728933|363477731|FG002|Overall Study|Adverse Event|0|||
105400252|NCT00639457|363477732|FG000|Overall Study|Withdrawal by Subject|2|||
105400253|NCT00639457|363477733|FG001|Overall Study|Withdrawal by Subject|3|||
105400254|NCT03235050|363477734|FG000|Overall Study|Adverse Event|0|||
105400255|NCT03235050|363477735|FG001|Overall Study|Adverse Event|0|||
105400256|NCT03235050|363477736|FG002|Overall Study|Adverse Event|1|||
105400257|NCT03235050|363477737|FG003|Overall Study|Adverse Event|4|||
105400258|NCT03235050|363477738|FG004|Overall Study|Adverse Event|1|||
105400259|NCT03235050|363477734|FG000|Overall Study|Death|0|||
105400260|NCT03235050|363477735|FG001|Overall Study|Death|0|||
105400261|NCT03235050|363477736|FG002|Overall Study|Death|0|||
105400262|NCT03235050|363477737|FG003|Overall Study|Death|2|||
105400263|NCT03235050|363477738|FG004|Overall Study|Death|1|||
105400264|NCT03235050|363477734|FG000|Overall Study|Lost to Follow-up|1|||
105400265|NCT03235050|363477735|FG001|Overall Study|Lost to Follow-up|2|||
105400266|NCT03235050|363477736|FG002|Overall Study|Lost to Follow-up|1|||
105400267|NCT03235050|363477737|FG003|Overall Study|Lost to Follow-up|2|||
105400268|NCT03235050|363477738|FG004|Overall Study|Lost to Follow-up|0|||
105400269|NCT03235050|363477734|FG000|Overall Study|Withdrawal by Subject|3|||
105400270|NCT03235050|363477735|FG001|Overall Study|Withdrawal by Subject|2|||
105400271|NCT03235050|363477736|FG002|Overall Study|Withdrawal by Subject|2|||
105400272|NCT03235050|363477737|FG003|Overall Study|Withdrawal by Subject|5|||
105400273|NCT03235050|363477738|FG004|Overall Study|Withdrawal by Subject|7|||
105400274|NCT03235050|363477734|FG000|Overall Study|Other reasons|0|||
105400275|NCT03235050|363477735|FG001|Overall Study|Other reasons|1|||
105400276|NCT03235050|363477736|FG002|Overall Study|Other reasons|0|||
105400277|NCT03235050|363477737|FG003|Overall Study|Other reasons|1|||
105400278|NCT03235050|363477738|FG004|Overall Study|Other reasons|2|||
105400279|NCT02921789|363477739|FG000|Overall Study|Adverse Event|0|||
105400280|NCT02921789|363477740|FG001|Overall Study|Adverse Event|1|||
105400281|NCT02921789|363477739|FG000|Overall Study|Lost to Follow-up|1|||
105400282|NCT02921789|363477740|FG001|Overall Study|Lost to Follow-up|0|||
105400283|NCT02921789|363477739|FG000|Overall Study|Protocol Deviation|2|||
105400284|NCT02921789|363477740|FG001|Overall Study|Protocol Deviation|0|||
105400285|NCT02921789|363477739|FG000|Overall Study|Withdrawal by Subject|2|||
105400286|NCT02921789|363477740|FG001|Overall Study|Withdrawal by Subject|1|||
105400287|NCT02921789|363477739|FG000|Overall Study|Miscellaneous|3|||
105400288|NCT02921789|363477740|FG001|Overall Study|Miscellaneous|2|||
105400289|NCT04099277|363477741|FG000|Overall Study|Physician Decision|1|||
105400290|NCT04099277|363477741|FG000|Overall Study|Withdrawal by Subject|1|||
105400291|NCT01621178|363477742|FG000|Overall Study|Adverse Event|5|||
105400292|NCT01621178|363477743|FG001|Overall Study|Adverse Event|2|||
105400293|NCT01621178|363477744|FG002|Overall Study|Adverse Event|8|||
105400294|NCT01621178|363477742|FG000|Overall Study|Death|6|||
105400295|NCT01621178|363477743|FG001|Overall Study|Death|7|||
105400296|NCT01621178|363477744|FG002|Overall Study|Death|2|||
105400297|NCT01621178|363477742|FG000|Overall Study|Lost to Follow-up|1|||
105400298|NCT01621178|363477743|FG001|Overall Study|Lost to Follow-up|2|||
105400299|NCT01621178|363477744|FG002|Overall Study|Lost to Follow-up|1|||
105400300|NCT01621178|363477742|FG000|Overall Study|Withdrawal by Subject|14|||
105400301|NCT01621178|363477743|FG001|Overall Study|Withdrawal by Subject|17|||
105400302|NCT01621178|363477744|FG002|Overall Study|Withdrawal by Subject|18|||
105400303|NCT01621178|363477742|FG000|Overall Study|Physician Decision|5|||
105400304|NCT01621178|363477743|FG001|Overall Study|Physician Decision|2|||
105400305|NCT01621178|363477744|FG002|Overall Study|Physician Decision|7|||
105400306|NCT02935192|363477745|FG000|Overall Study|Withdrawal by Subject|8|||
105400307|NCT02935192|363477746|FG001|Overall Study|Withdrawal by Subject|4|||
105400308|NCT02465931|363477747|FG000|Overall Study|Lost to Follow-up|9|||
105400309|NCT02465931|363477748|FG001|Overall Study|Lost to Follow-up|11|||
105400310|NCT02465931|363477747|FG000|Overall Study|Protocol Violation|1|||
105400311|NCT02465931|363477748|FG001|Overall Study|Protocol Violation|0|||
105400312|NCT02465931|363477747|FG000|Overall Study|Withdrawal by Subject|1|||
105400313|NCT02465931|363477748|FG001|Overall Study|Withdrawal by Subject|0|||
105400314|NCT02896257|363477749|FG000|Providers|Without eligible patients|21|||
105400315|NCT02896257|363477750|FG001|Providers|Without eligible patients|28|||
105400316|NCT02896257|363477749|FG000|Patients|PFT entry criteria not met|43|||
105400317|NCT02896257|363477750|FG001|Patients|PFT entry criteria not met|50|||
105400318|NCT02896257|363477749|FG000|Patients|No capacity to review|8|||
105400319|NCT02896257|363477750|FG001|Patients|No capacity to review|11|||
105400320|NCT02896257|363477749|FG000|Patients|Appointment rescheduled/cancelled|5|||
105400321|NCT02896257|363477750|FG001|Patients|Appointment rescheduled/cancelled|7|||
105400322|NCT02896257|363477749|FG000|Patients|PCP not assigned a clinic|4|||
105400323|NCT02896257|363477750|FG001|Patients|PCP not assigned a clinic|0|||
105400324|NCT02896257|363477749|FG000|Patients|No history of COPD|0|||
105400325|NCT02896257|363477750|FG001|Patients|No history of COPD|1|||
105400326|NCT02896257|363477749|FG000|Patients|Deceased between review and index date|0|||
105400327|NCT02896257|363477750|FG001|Patients|Deceased between review and index date|1|||
105400328|NCT02896257|363477749|FG000|Patients|No ICS Rx upon review|1|||
105400329|NCT02896257|363477750|FG001|Patients|No ICS Rx upon review|1|||
105400330|NCT02896257|363477749|FG000|Patients|Protocol Violation|2|||
105400331|NCT02896257|363477750|FG001|Patients|Protocol Violation|1|||
105400332|NCT02896257|363477749|FG000|Patients|Hospice care|0|||
105400333|NCT02896257|363477750|FG001|Patients|Hospice care|1|||
105400334|NCT03423121|363477756|FG000|Overall Study|Lost to Follow-up|2|||
105400335|NCT03423121|363477757|FG001|Overall Study|Lost to Follow-up|6|||
105400336|NCT03423121|363477756|FG000|Overall Study|Adverse Event|1|||
105400337|NCT03423121|363477757|FG001|Overall Study|Adverse Event|0|||
105400338|NCT01354223|363477758|FG000|Overall Study|Withdrawal by Subject|3|||
105400339|NCT01354223|363477759|FG001|Overall Study|Withdrawal by Subject|1|||
105400340|NCT04102007|363477763|FG000|Overall Study|Adverse Event|4|||
105400341|NCT04102007|363477763|FG000|Overall Study|Lost to Follow-up|3|||
105400342|NCT04102007|363477763|FG000|Overall Study|Withdrawal by Subject|12|||
105400343|NCT04102007|363477763|FG000|Overall Study|Eligibility Violation|5|||
105400344|NCT04102007|363477763|FG000|Overall Study|Lack of Efficacy|6|||
105400345|NCT04102007|363477763|FG000|Overall Study|Protocol Deviation|5|||
105400346|NCT04102007|363477763|FG000|Overall Study|Protocol Compliance|1|||
105400347|NCT04102007|363477763|FG000|Overall Study|Withdrew Treatment|2|||
105400348|NCT04102007|363477763|FG000|Overall Study|Pregnancy|1|||
105400349|NCT01126190|363477765|FG000|Double-Blind Phase|Death|0|||
105400350|NCT01126190|363477766|FG001|Double-Blind Phase|Death|1|||
105400351|NCT01126190|363477767|FG002|Double-Blind Phase|Death|0|||
105400352|NCT01126190|363477765|FG000|Double-Blind Phase|Adverse Event|1|||
105400353|NCT01126190|363477766|FG001|Double-Blind Phase|Adverse Event|2|||
105400354|NCT01126190|363477767|FG002|Double-Blind Phase|Adverse Event|0|||
105400355|NCT01126190|363477765|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
105400356|NCT01126190|363477766|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
105400357|NCT01126190|363477767|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
105400358|NCT01126190|363477765|FG000|Double-Blind Phase|Request of Investigator|1|||
105400359|NCT01126190|363477766|FG001|Double-Blind Phase|Request of Investigator|0|||
105400360|NCT01126190|363477767|FG002|Double-Blind Phase|Request of Investigator|0|||
105400361|NCT01126190|363477765|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
105400362|NCT01126190|363477766|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
105400363|NCT01126190|363477767|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
105400364|NCT01126190|363477765|FG000|Double-Blind Phase|Non-compliance|1|||
105400365|NCT01126190|363477766|FG001|Double-Blind Phase|Non-compliance|0|||
105400366|NCT01126190|363477767|FG002|Double-Blind Phase|Non-compliance|0|||
105400367|NCT01126190|363477765|FG000|Double-Blind Phase|Lost to Follow-up|1|||
105400368|NCT01126190|363477766|FG001|Double-Blind Phase|Lost to Follow-up|3|||
105400369|NCT01126190|363477767|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105400370|NCT01126190|363477765|FG000|Open-Label Phase|Death|0|||
105400371|NCT01126190|363477766|FG001|Open-Label Phase|Death|0|||
105400372|NCT01126190|363477767|FG002|Open-Label Phase|Death|1|||
105400373|NCT01126190|363477765|FG000|Open-Label Phase|Adverse Event|0|||
105400374|NCT01126190|363477766|FG001|Open-Label Phase|Adverse Event|0|||
105400375|NCT01126190|363477767|FG002|Open-Label Phase|Adverse Event|4|||
105400376|NCT01126190|363477765|FG000|Open-Label Phase|Withdrawal by Subject|0|||
105400377|NCT01126190|363477766|FG001|Open-Label Phase|Withdrawal by Subject|0|||
105400378|NCT01126190|363477767|FG002|Open-Label Phase|Withdrawal by Subject|6|||
105400379|NCT01135992|363477768|FG000|Overall Study|Adverse Event|1|||
105400380|NCT01135992|363477768|FG000|Overall Study|Lack of Efficacy|1|||
105400381|NCT01135992|363477768|FG000|Overall Study|Protocol Violation|2|||
105400382|NCT01135992|363477768|FG000|Overall Study|Withdrawal criteria|10|||
105400383|NCT01135992|363477768|FG000|Overall Study|Unclassified|7|||
105400384|NCT02973997|363477769|FG000|Overall Study|Withdrawal by Subject|4|||
105400385|NCT02973997|363477770|FG001|Overall Study|Withdrawal by Subject|0|||
105400386|NCT02973997|363477769|FG000|Overall Study|Adverse Event|4|||
105400387|NCT02973997|363477770|FG001|Overall Study|Adverse Event|1|||
105400388|NCT02973997|363477769|FG000|Overall Study|Disease Progression|11|||
105400389|NCT02973997|363477770|FG001|Overall Study|Disease Progression|20|||
105400390|NCT02973997|363477769|FG000|Overall Study|Alternative Therapy|3|||
105493303|NCT02047227|363818830|FG000|Overall Study|Spontaneous pregnancy|1|||
105400391|NCT02973997|363477770|FG001|Overall Study|Alternative Therapy|0|||
105400392|NCT02973997|363477769|FG000|Overall Study|Other complicating disease|0|||
105400393|NCT02973997|363477770|FG001|Overall Study|Other complicating disease|1|||
105400394|NCT02973997|363477769|FG000|Overall Study|Death|0|||
105400395|NCT02973997|363477770|FG001|Overall Study|Death|1|||
105400396|NCT00892008|363477771|FG000|Overall Study|Death|5|||
105400397|NCT00892008|363477771|FG000|Overall Study|Lack of Efficacy|3|||
105400398|NCT00892008|363477771|FG000|Overall Study|Lost to Follow-up|142|||
105400399|NCT00892008|363477771|FG000|Overall Study|Other|378|||
105400400|NCT00892008|363477771|FG000|Overall Study|Adverse Event|37|||
105400401|NCT02727322|363477772|FG000|Overall Study|Withdrawal by Subject|1|||
105400402|NCT02727322|363477773|FG001|Overall Study|Withdrawal by Subject|1|||
105400403|NCT02727322|363477772|FG000|Overall Study|Protocol Violation|1|||
105400404|NCT02727322|363477773|FG001|Overall Study|Protocol Violation|0|||
105400405|NCT01123148|363477780|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
105400406|NCT01123148|363477780|FG000|Overall Study|Didn't meet milestone criteria|1|||
105400407|NCT00355030|363477781|FG000|Study Period 1 Treatment|Adverse Event|1|||
105400408|NCT00355030|363477782|FG001|Study Period 1 Treatment|Adverse Event|1|||
105400409|NCT00355030|363477781|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
105400410|NCT00355030|363477782|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
105400411|NCT00355030|363477781|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
105400412|NCT00355030|363477782|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
105400413|NCT00355030|363477781|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
105400414|NCT00355030|363477782|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
105400415|NCT00355030|363477781|FG000|Study Period 1 Treatment|Physician Decision|0|||
105400416|NCT00355030|363477782|FG001|Study Period 1 Treatment|Physician Decision|1|||
105400417|NCT00355030|363477781|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
105400418|NCT00355030|363477782|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
105400419|NCT00355030|363477781|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
105400420|NCT00355030|363477782|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
105400421|NCT00355030|363477781|FG000|Study Period 1 Treatment|Other|2|||
105400422|NCT00355030|363477782|FG001|Study Period 1 Treatment|Other|6|||
105400423|NCT00355030|363477781|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
105400424|NCT00355030|363477782|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
105400425|NCT00355030|363477781|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
105400426|NCT00355030|363477782|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
105400427|NCT00925002|363477786|FG000|Overall Study|Other|1|||
105400428|NCT00925002|363477787|FG001|Overall Study|Other|4|||
105400429|NCT00925002|363477788|FG002|Overall Study|Other|0|||
105400430|NCT00925002|363477786|FG000|Overall Study|Death|1|||
105400431|NCT00925002|363477787|FG001|Overall Study|Death|1|||
105400432|NCT00925002|363477788|FG002|Overall Study|Death|5|||
105400433|NCT00925002|363477786|FG000|Overall Study|Adverse Event|3|||
105400434|NCT00925002|363477787|FG001|Overall Study|Adverse Event|1|||
105400435|NCT00925002|363477788|FG002|Overall Study|Adverse Event|2|||
105400436|NCT00925002|363477786|FG000|Overall Study|Participant withdrew consent|1|||
105400437|NCT00925002|363477787|FG001|Overall Study|Participant withdrew consent|3|||
105400438|NCT00925002|363477788|FG002|Overall Study|Participant withdrew consent|3|||
105400439|NCT02154061|363477789|FG000|Overall Study|Pregnancy|1|||
105400440|NCT02154061|363477790|FG001|Overall Study|Pregnancy|0|||
105400441|NCT02154061|363477789|FG000|Overall Study|enrolled but not vaccinated|1|||
105400442|NCT02154061|363477790|FG001|Overall Study|enrolled but not vaccinated|0|||
105400443|NCT02581891|363477795|FG000|Overall Study|Adverse Event|4|||
105400444|NCT02581891|363477796|FG001|Overall Study|Adverse Event|6|||
105400445|NCT02581891|363477795|FG000|Overall Study|Death|3|||
105400446|NCT02581891|363477796|FG001|Overall Study|Death|4|||
105400447|NCT02581891|363477795|FG000|Overall Study|Lost to Follow-up|1|||
105400448|NCT02581891|363477796|FG001|Overall Study|Lost to Follow-up|2|||
105400449|NCT02581891|363477795|FG000|Overall Study|Physician Decision|0|||
105400450|NCT02581891|363477796|FG001|Overall Study|Physician Decision|1|||
105400451|NCT02581891|363477795|FG000|Overall Study|Withdrawal by Subject|4|||
105400452|NCT02581891|363477796|FG001|Overall Study|Withdrawal by Subject|5|||
105400453|NCT02581891|363477795|FG000|Overall Study|Other Reasons|3|||
105400454|NCT02581891|363477796|FG001|Overall Study|Other Reasons|1|||
105400455|NCT02581891|363477795|FG000|Overall Study|Discontinued during followup|1|||
105400456|NCT02581891|363477796|FG001|Overall Study|Discontinued during followup|0|||
105400457|NCT05525910|363477797|FG000|Period 4|Per sponsor due to study timelines|0|||
105400458|NCT05525910|363477798|FG001|Period 4|Per sponsor due to study timelines|0|||
105493304|NCT02047227|363818831|FG001|Overall Study|Spontaneous pregnancy|0|||
105400459|NCT05525910|363477799|FG002|Period 4|Per sponsor due to study timelines|1|||
105400460|NCT05525910|363477800|FG003|Period 4|Per sponsor due to study timelines|1|||
105400461|NCT05525910|363477801|FG004|Period 4|Per sponsor due to study timelines|1|||
105400462|NCT00107276|363477802|FG000|Overall Study|Progression|46|||
105400463|NCT00107276|363477802|FG000|Overall Study|Adverse Event|6|||
105400464|NCT00107276|363477802|FG000|Overall Study|M.D. decision|2|||
105400465|NCT00107276|363477802|FG000|Overall Study|Patient refusal|1|||
105400466|NCT00107276|363477802|FG000|Overall Study|Death|1|||
105493305|NCT02047227|363818830|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
105400467|NCT00107276|363477802|FG000|Overall Study|Ineligible|16|||
105493306|NCT02047227|363818831|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
105400468|NCT04846231|363477803|FG000|Overall Study|Lost to Follow-up|1|||
105400469|NCT04846231|363477804|FG001|Overall Study|Lost to Follow-up|0|||
105400470|NCT04846231|363477805|FG002|Overall Study|Lost to Follow-up|0|||
105400471|NCT04846231|363477806|FG003|Overall Study|Lost to Follow-up|0|||
105400472|NCT04846231|363477807|FG004|Overall Study|Lost to Follow-up|0|||
105400473|NCT04846231|363477808|FG005|Overall Study|Lost to Follow-up|0|||
105400474|NCT04846231|363477809|FG006|Overall Study|Lost to Follow-up|0|||
105400475|NCT04846231|363477810|FG007|Overall Study|Lost to Follow-up|1|||
105400476|NCT04846231|363477803|FG000|Overall Study|Withdrawal by Subject|0|||
105400477|NCT04846231|363477804|FG001|Overall Study|Withdrawal by Subject|1|||
105400478|NCT04846231|363477805|FG002|Overall Study|Withdrawal by Subject|2|||
105400479|NCT04846231|363477806|FG003|Overall Study|Withdrawal by Subject|1|||
105400480|NCT04846231|363477807|FG004|Overall Study|Withdrawal by Subject|0|||
105400481|NCT04846231|363477808|FG005|Overall Study|Withdrawal by Subject|0|||
105400482|NCT04846231|363477809|FG006|Overall Study|Withdrawal by Subject|0|||
105400483|NCT04846231|363477810|FG007|Overall Study|Withdrawal by Subject|0|||
105400484|NCT04846231|363477803|FG000|Overall Study|Protocol Violation|0|||
105400485|NCT04846231|363477804|FG001|Overall Study|Protocol Violation|1|||
105400486|NCT04846231|363477805|FG002|Overall Study|Protocol Violation|0|||
105400487|NCT04846231|363477806|FG003|Overall Study|Protocol Violation|0|||
105400488|NCT04846231|363477807|FG004|Overall Study|Protocol Violation|0|||
105400489|NCT04846231|363477808|FG005|Overall Study|Protocol Violation|0|||
105400490|NCT04846231|363477809|FG006|Overall Study|Protocol Violation|0|||
105400491|NCT04846231|363477810|FG007|Overall Study|Protocol Violation|0|||
105400492|NCT04846231|363477803|FG000|Overall Study|Adverse Event|0|||
105400493|NCT04846231|363477804|FG001|Overall Study|Adverse Event|0|||
105400494|NCT04846231|363477805|FG002|Overall Study|Adverse Event|0|||
105400495|NCT04846231|363477806|FG003|Overall Study|Adverse Event|0|||
105400496|NCT04846231|363477807|FG004|Overall Study|Adverse Event|0|||
105400497|NCT04846231|363477808|FG005|Overall Study|Adverse Event|0|||
105400498|NCT04846231|363477809|FG006|Overall Study|Adverse Event|1|||
105400499|NCT04846231|363477810|FG007|Overall Study|Adverse Event|1|||
105400500|NCT02504372|363477811|FG000|Overall Study|Death|136|||
105400501|NCT02504372|363477812|FG001|Overall Study|Death|154|||
105400502|NCT02504372|363477811|FG000|Overall Study|Lost to Follow-up|0|||
105400503|NCT02504372|363477812|FG001|Overall Study|Lost to Follow-up|2|||
105400504|NCT02504372|363477811|FG000|Overall Study|Withdrawal of consent|25|||
105400505|NCT02504372|363477812|FG001|Overall Study|Withdrawal of consent|16|||
105400506|NCT02504372|363477811|FG000|Overall Study|Participants ongoing|429|||
105400507|NCT02504372|363477812|FG001|Overall Study|Participants ongoing|415|||
105400508|NCT01188967|363477813|FG000|Overall Study|Withdrawal by Subject|1|||
105400509|NCT01188967|363477814|FG001|Overall Study|Withdrawal by Subject|1|||
105400510|NCT01188967|363477813|FG000|Overall Study|Physician Decision|1|||
105400511|NCT01188967|363477814|FG001|Overall Study|Physician Decision|1|||
105400512|NCT01188967|363477813|FG000|Overall Study|Lost to Follow-up|3|||
105400513|NCT01188967|363477814|FG001|Overall Study|Lost to Follow-up|2|||
105400514|NCT00461708|363477815|FG000|Overall Study|Adverse Event|17|||
105400515|NCT00461708|363477816|FG001|Overall Study|Adverse Event|7|||
105400516|NCT00461708|363477815|FG000|Overall Study|Lack of Efficacy|68|||
105400517|NCT00461708|363477816|FG001|Overall Study|Lack of Efficacy|20|||
105400518|NCT00461708|363477815|FG000|Overall Study|Physician Decision|10|||
105400519|NCT00461708|363477816|FG001|Overall Study|Physician Decision|4|||
105400520|NCT00461708|363477815|FG000|Overall Study|Withdrawal by Subject|8|||
105400521|NCT00461708|363477816|FG001|Overall Study|Withdrawal by Subject|2|||
105400522|NCT00461708|363477815|FG000|Overall Study|Other|4|||
105400523|NCT00461708|363477816|FG001|Overall Study|Other|4|||
105400524|NCT00461708|363477815|FG000|Overall Study|Death|8|||
105400525|NCT00461708|363477816|FG001|Overall Study|Death|1|||
105400526|NCT02750514|363477817|FG000|Track 1|Disease progression|20|||
105400527|NCT02750514|363477818|FG001|Track 1|Disease progression|1|||
105400528|NCT02750514|363477819|FG002|Track 1|Disease progression|0|||
105400529|NCT02750514|363477820|FG003|Track 1|Disease progression|1|||
105400530|NCT02750514|363477821|FG004|Track 1|Disease progression|0|||
105400531|NCT02750514|363477817|FG000|Track 1|Adverse event unrelated to study drug|1|||
105400532|NCT02750514|363477818|FG001|Track 1|Adverse event unrelated to study drug|0|||
105400533|NCT02750514|363477819|FG002|Track 1|Adverse event unrelated to study drug|0|||
105400534|NCT02750514|363477820|FG003|Track 1|Adverse event unrelated to study drug|0|||
105493307|NCT02047227|363818830|FG000|Overall Study|No oocytes retrieved|21|||
105493308|NCT02047227|363818831|FG001|Overall Study|No oocytes retrieved|20|||
105400535|NCT02750514|363477821|FG004|Track 1|Adverse event unrelated to study drug|0|||
105400536|NCT02750514|363477817|FG000|Track 1|Study drug toxicity|4|||
105400537|NCT02750514|363477818|FG001|Track 1|Study drug toxicity|1|||
105400538|NCT02750514|363477819|FG002|Track 1|Study drug toxicity|0|||
105400539|NCT02750514|363477820|FG003|Track 1|Study drug toxicity|1|||
105400540|NCT02750514|363477821|FG004|Track 1|Study drug toxicity|0|||
105400541|NCT02750514|363477817|FG000|Track 1|Participant request to discontinue|1|||
105400542|NCT02750514|363477818|FG001|Track 1|Participant request to discontinue|0|||
105400543|NCT02750514|363477819|FG002|Track 1|Participant request to discontinue|0|||
105400544|NCT02750514|363477820|FG003|Track 1|Participant request to discontinue|0|||
105400545|NCT02750514|363477821|FG004|Track 1|Participant request to discontinue|0|||
105400546|NCT02750514|363477817|FG000|Track 1|Other reasons|1|||
105400547|NCT02750514|363477818|FG001|Track 1|Other reasons|0|||
105400548|NCT02750514|363477819|FG002|Track 1|Other reasons|0|||
105400549|NCT02750514|363477820|FG003|Track 1|Other reasons|0|||
105400550|NCT02750514|363477821|FG004|Track 1|Other reasons|0|||
105400551|NCT02750514|363477817|FG000|Track 2|Disease progression|4|||
105400552|NCT02750514|363477818|FG001|Track 2|Disease progression|5|||
105400553|NCT02750514|363477819|FG002|Track 2|Disease progression|2|||
105400554|NCT02750514|363477820|FG003|Track 2|Disease progression|5|||
105400555|NCT02750514|363477821|FG004|Track 2|Disease progression|0|||
105400556|NCT02750514|363477817|FG000|Track 2|Adverse event unrelated to study drug|1|||
105400557|NCT02750514|363477818|FG001|Track 2|Adverse event unrelated to study drug|0|||
105400558|NCT02750514|363477819|FG002|Track 2|Adverse event unrelated to study drug|0|||
105400559|NCT02750514|363477820|FG003|Track 2|Adverse event unrelated to study drug|0|||
105400560|NCT02750514|363477821|FG004|Track 2|Adverse event unrelated to study drug|0|||
105400561|NCT02750514|363477817|FG000|Track 2|Study drug toxicity|1|||
105400562|NCT02750514|363477818|FG001|Track 2|Study drug toxicity|2|||
105400563|NCT02750514|363477819|FG002|Track 2|Study drug toxicity|0|||
105400564|NCT02750514|363477820|FG003|Track 2|Study drug toxicity|2|||
105400565|NCT02750514|363477821|FG004|Track 2|Study drug toxicity|0|||
105400566|NCT02750514|363477817|FG000|Track 2|Participant withdrew consent|0|||
105400567|NCT02750514|363477818|FG001|Track 2|Participant withdrew consent|1|||
105400568|NCT02750514|363477819|FG002|Track 2|Participant withdrew consent|0|||
105400569|NCT02750514|363477820|FG003|Track 2|Participant withdrew consent|0|||
105400570|NCT02750514|363477821|FG004|Track 2|Participant withdrew consent|0|||
105400571|NCT02750514|363477817|FG000|Track 3|Disease progression|0|||
105400572|NCT02750514|363477818|FG001|Track 3|Disease progression|24|||
105400573|NCT02750514|363477819|FG002|Track 3|Disease progression|13|||
105400574|NCT02750514|363477820|FG003|Track 3|Disease progression|14|||
105400575|NCT02750514|363477821|FG004|Track 3|Disease progression|0|||
105400576|NCT02750514|363477817|FG000|Track 3|Adverse event unrelated to study drug|0|||
105400577|NCT02750514|363477818|FG001|Track 3|Adverse event unrelated to study drug|1|||
105400578|NCT02750514|363477819|FG002|Track 3|Adverse event unrelated to study drug|1|||
105400579|NCT02750514|363477820|FG003|Track 3|Adverse event unrelated to study drug|1|||
105400580|NCT02750514|363477821|FG004|Track 3|Adverse event unrelated to study drug|0|||
105400581|NCT02750514|363477817|FG000|Track 3|Study drug toxicity|0|||
105400582|NCT02750514|363477818|FG001|Track 3|Study drug toxicity|3|||
105400583|NCT02750514|363477819|FG002|Track 3|Study drug toxicity|0|||
105400584|NCT02750514|363477820|FG003|Track 3|Study drug toxicity|1|||
105400585|NCT02750514|363477821|FG004|Track 3|Study drug toxicity|0|||
105400586|NCT02750514|363477817|FG000|Track 3|Participant request to discontinue|0|||
105400587|NCT02750514|363477818|FG001|Track 3|Participant request to discontinue|2|||
105400588|NCT02750514|363477819|FG002|Track 3|Participant request to discontinue|0|||
105400589|NCT02750514|363477820|FG003|Track 3|Participant request to discontinue|0|||
105400590|NCT02750514|363477821|FG004|Track 3|Participant request to discontinue|0|||
105400591|NCT02750514|363477817|FG000|Track 3|Participant withdrew consent|0|||
105400592|NCT02750514|363477818|FG001|Track 3|Participant withdrew consent|3|||
105400593|NCT02750514|363477819|FG002|Track 3|Participant withdrew consent|1|||
105400594|NCT02750514|363477820|FG003|Track 3|Participant withdrew consent|0|||
105400595|NCT02750514|363477821|FG004|Track 3|Participant withdrew consent|0|||
105400596|NCT02750514|363477817|FG000|Track 3|Other reasons|0|||
105400597|NCT02750514|363477818|FG001|Track 3|Other reasons|3|||
105400598|NCT02750514|363477819|FG002|Track 3|Other reasons|0|||
105400599|NCT02750514|363477820|FG003|Track 3|Other reasons|0|||
105400600|NCT02750514|363477821|FG004|Track 3|Other reasons|0|||
105400601|NCT02750514|363477817|FG000|Track 4|Study drug toxicity|0|||
105400602|NCT02750514|363477818|FG001|Track 4|Study drug toxicity|6|||
105400603|NCT02750514|363477819|FG002|Track 4|Study drug toxicity|0|||
105400604|NCT02750514|363477820|FG003|Track 4|Study drug toxicity|5|||
105400605|NCT02750514|363477821|FG004|Track 4|Study drug toxicity|0|||
105400606|NCT02750514|363477817|FG000|Track 4|Participant request to discontinue|0|||
105400607|NCT02750514|363477818|FG001|Track 4|Participant request to discontinue|1|||
105400608|NCT02750514|363477819|FG002|Track 4|Participant request to discontinue|0|||
105400609|NCT02750514|363477820|FG003|Track 4|Participant request to discontinue|1|||
105400610|NCT02750514|363477821|FG004|Track 4|Participant request to discontinue|0|||
105400611|NCT02750514|363477817|FG000|Track 4|Participant withdrew consent|0|||
105493309|NCT02047227|363818830|FG000|Overall Study|No fertilization|61|||
105400612|NCT02750514|363477818|FG001|Track 4|Participant withdrew consent|1|||
105400613|NCT02750514|363477819|FG002|Track 4|Participant withdrew consent|0|||
105400614|NCT02750514|363477820|FG003|Track 4|Participant withdrew consent|0|||
105400615|NCT02750514|363477821|FG004|Track 4|Participant withdrew consent|0|||
105400616|NCT02750514|363477817|FG000|Track 4|Other reasons|0|||
105400617|NCT02750514|363477818|FG001|Track 4|Other reasons|5|||
105400618|NCT02750514|363477819|FG002|Track 4|Other reasons|0|||
105400619|NCT02750514|363477820|FG003|Track 4|Other reasons|3|||
105400620|NCT02750514|363477821|FG004|Track 4|Other reasons|0|||
105400621|NCT02750514|363477817|FG000|Track 4|Disease progression|0|||
105400622|NCT02750514|363477818|FG001|Track 4|Disease progression|33|||
105400623|NCT02750514|363477819|FG002|Track 4|Disease progression|0|||
105400624|NCT02750514|363477820|FG003|Track 4|Disease progression|32|||
105400625|NCT02750514|363477821|FG004|Track 4|Disease progression|0|||
105400626|NCT02750514|363477817|FG000|Track 4|Adverse event unrelated to study drug|0|||
105400627|NCT02750514|363477818|FG001|Track 4|Adverse event unrelated to study drug|5|||
105400628|NCT02750514|363477819|FG002|Track 4|Adverse event unrelated to study drug|0|||
105400629|NCT02750514|363477820|FG003|Track 4|Adverse event unrelated to study drug|0|||
105400630|NCT02750514|363477821|FG004|Track 4|Adverse event unrelated to study drug|0|||
105400631|NCT02750514|363477817|FG000|Track 4|Death|0|||
105400632|NCT02750514|363477818|FG001|Track 4|Death|0|||
105400633|NCT02750514|363477819|FG002|Track 4|Death|0|||
105400634|NCT02750514|363477820|FG003|Track 4|Death|1|||
105400635|NCT02750514|363477821|FG004|Track 4|Death|0|||
105400636|NCT02750514|363477817|FG000|Track 5|Disease progression|0|||
105400637|NCT02750514|363477818|FG001|Track 5|Disease progression|0|||
105400638|NCT02750514|363477819|FG002|Track 5|Disease progression|0|||
105400639|NCT02750514|363477820|FG003|Track 5|Disease progression|0|||
105400640|NCT02750514|363477821|FG004|Track 5|Disease progression|34|||
105400641|NCT02750514|363477817|FG000|Track 5|Adverse event unrelated to study drug|0|||
105400642|NCT02750514|363477818|FG001|Track 5|Adverse event unrelated to study drug|0|||
105400643|NCT02750514|363477819|FG002|Track 5|Adverse event unrelated to study drug|0|||
105400644|NCT02750514|363477820|FG003|Track 5|Adverse event unrelated to study drug|0|||
105400645|NCT02750514|363477821|FG004|Track 5|Adverse event unrelated to study drug|2|||
105400646|NCT02750514|363477817|FG000|Track 5|Study drug toxicity|0|||
105400647|NCT02750514|363477818|FG001|Track 5|Study drug toxicity|0|||
105400648|NCT02750514|363477819|FG002|Track 5|Study drug toxicity|0|||
105400649|NCT02750514|363477820|FG003|Track 5|Study drug toxicity|0|||
105400650|NCT02750514|363477821|FG004|Track 5|Study drug toxicity|2|||
105400651|NCT02750514|363477817|FG000|Track 5|Participant request to discontinue|0|||
105400652|NCT02750514|363477818|FG001|Track 5|Participant request to discontinue|0|||
105400653|NCT02750514|363477819|FG002|Track 5|Participant request to discontinue|0|||
105400654|NCT02750514|363477820|FG003|Track 5|Participant request to discontinue|0|||
105400655|NCT02750514|363477821|FG004|Track 5|Participant request to discontinue|3|||
105400656|NCT02750514|363477817|FG000|Track 5|Other reasons|0|||
105400657|NCT02750514|363477818|FG001|Track 5|Other reasons|0|||
105400658|NCT02750514|363477819|FG002|Track 5|Other reasons|0|||
105400659|NCT02750514|363477820|FG003|Track 5|Other reasons|0|||
105400660|NCT02750514|363477821|FG004|Track 5|Other reasons|2|||
105400661|NCT00696878|363477823|FG000|Overall Study|Adverse Event|8|||
105400662|NCT00696878|363477823|FG000|Overall Study|Withdrawal by Subject|87|||
105400663|NCT00696878|363477823|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
105400664|NCT00696878|363477823|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
105400665|NCT00696878|363477823|FG000|Overall Study|Trial stopped|32|||
105400666|NCT00696878|363477823|FG000|Overall Study|Other reason (not specified)|55|||
105400667|NCT02259114|363477825|FG000|Overall Study|Progressive Disease|14|||
105400668|NCT02259114|363477826|FG001|Overall Study|Progressive Disease|2|||
105400669|NCT02259114|363477827|FG002|Overall Study|Progressive Disease|10|||
105400670|NCT02259114|363477828|FG003|Overall Study|Progressive Disease|2|||
105400671|NCT02259114|363477829|FG004|Overall Study|Progressive Disease|5|||
105400672|NCT02259114|363477825|FG000|Overall Study|Adverse Event|2|||
105400673|NCT02259114|363477826|FG001|Overall Study|Adverse Event|1|||
105400674|NCT02259114|363477827|FG002|Overall Study|Adverse Event|0|||
105400675|NCT02259114|363477828|FG003|Overall Study|Adverse Event|0|||
105400676|NCT02259114|363477829|FG004|Overall Study|Adverse Event|1|||
105400677|NCT02259114|363477825|FG000|Overall Study|Death|3|||
105400678|NCT02259114|363477826|FG001|Overall Study|Death|0|||
105400679|NCT02259114|363477827|FG002|Overall Study|Death|1|||
105400680|NCT02259114|363477828|FG003|Overall Study|Death|0|||
105400681|NCT02259114|363477829|FG004|Overall Study|Death|0|||
105400682|NCT02259114|363477825|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
105400683|NCT02259114|363477826|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
105400684|NCT02259114|363477827|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
105400685|NCT02259114|363477828|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
105400686|NCT02259114|363477829|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
105400687|NCT02259114|363477825|FG000|Overall Study|Withdrawal by Subject|0|||
105400688|NCT02259114|363477826|FG001|Overall Study|Withdrawal by Subject|0|||
105400689|NCT02259114|363477827|FG002|Overall Study|Withdrawal by Subject|1|||
105400690|NCT02259114|363477828|FG003|Overall Study|Withdrawal by Subject|1|||
105400691|NCT02259114|363477829|FG004|Overall Study|Withdrawal by Subject|0|||
105400692|NCT02259114|363477825|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
105400693|NCT02259114|363477826|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
105400694|NCT02259114|363477827|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
105400695|NCT02259114|363477828|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
105400696|NCT02259114|363477829|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
105400697|NCT02259114|363477825|FG000|Overall Study|Not Treated|1|||
105400698|NCT02259114|363477826|FG001|Overall Study|Not Treated|0|||
105400699|NCT02259114|363477827|FG002|Overall Study|Not Treated|0|||
105400700|NCT02259114|363477828|FG003|Overall Study|Not Treated|0|||
105400701|NCT02259114|363477829|FG004|Overall Study|Not Treated|0|||
105400702|NCT03937479|363477830|FG000|Overall Study|Adverse Event|2|||
105400703|NCT03937479|363477831|FG001|Overall Study|Adverse Event|3|||
105400704|NCT03937479|363477832|FG002|Overall Study|Adverse Event|0|||
105400705|NCT03937479|363477833|FG003|Overall Study|Adverse Event|0|||
105400706|NCT03937479|363477834|FG004|Overall Study|Adverse Event|1|||
105400707|NCT03937479|363477830|FG000|Overall Study|Withdrawal by Subject|3|||
105400708|NCT03937479|363477831|FG001|Overall Study|Withdrawal by Subject|5|||
105400709|NCT03937479|363477832|FG002|Overall Study|Withdrawal by Subject|2|||
105400710|NCT03937479|363477833|FG003|Overall Study|Withdrawal by Subject|2|||
105400711|NCT03937479|363477834|FG004|Overall Study|Withdrawal by Subject|1|||
105400712|NCT03937479|363477830|FG000|Overall Study|Protocol Violation|5|||
105400713|NCT03937479|363477831|FG001|Overall Study|Protocol Violation|6|||
105400714|NCT03937479|363477832|FG002|Overall Study|Protocol Violation|4|||
105400715|NCT03937479|363477833|FG003|Overall Study|Protocol Violation|3|||
105400716|NCT03937479|363477834|FG004|Overall Study|Protocol Violation|2|||
105400717|NCT03937479|363477830|FG000|Overall Study|Lost to Follow-up|0|||
105400718|NCT03937479|363477831|FG001|Overall Study|Lost to Follow-up|1|||
105400719|NCT03937479|363477832|FG002|Overall Study|Lost to Follow-up|0|||
105400720|NCT03937479|363477833|FG003|Overall Study|Lost to Follow-up|1|||
105400721|NCT03937479|363477834|FG004|Overall Study|Lost to Follow-up|0|||
105400722|NCT03937479|363477830|FG000|Overall Study|Physician Decision|0|||
105400723|NCT03937479|363477831|FG001|Overall Study|Physician Decision|0|||
105400724|NCT03937479|363477832|FG002|Overall Study|Physician Decision|1|||
105400725|NCT03937479|363477833|FG003|Overall Study|Physician Decision|0|||
105400726|NCT03937479|363477834|FG004|Overall Study|Physician Decision|1|||
105400727|NCT03789292|363477840|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
105400728|NCT03789292|363477841|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
105400729|NCT03789292|363477842|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
105400730|NCT03789292|363477840|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
105400731|NCT03789292|363477841|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
105400732|NCT03789292|363477842|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
105400733|NCT03789292|363477840|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
105400734|NCT03789292|363477841|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
105400735|NCT03789292|363477842|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
105400736|NCT03789292|363477840|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
105400737|NCT03789292|363477841|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
105400738|NCT03789292|363477842|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
105400739|NCT03789292|363477840|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
105400740|NCT03789292|363477841|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
105400741|NCT03789292|363477842|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
105400742|NCT03789292|363477840|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
105400743|NCT03789292|363477841|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
105400744|NCT03789292|363477842|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
105400745|NCT03789292|363477840|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
105493310|NCT02047227|363818831|FG001|Overall Study|No fertilization|51|||
105493311|NCT02047227|363818830|FG000|Overall Study|Intention to freeze all embryos|1|||
105493312|NCT02047227|363818831|FG001|Overall Study|Intention to freeze all embryos|0|||
105493313|NCT02047227|363818830|FG000|Overall Study|All embryos discarded|12|||
105493314|NCT02047227|363818831|FG001|Overall Study|All embryos discarded|11|||
105493315|NCT02047227|363818830|FG000|Overall Study|Other|10|||
105493316|NCT02047227|363818831|FG001|Overall Study|Other|9|||
105493317|NCT00304239|363818837|FG000|Overall Study|Protocol Deviations/Violations|15|||
105493318|NCT00304239|363818838|FG001|Overall Study|Protocol Deviations/Violations|0|||
105493319|NCT00304239|363818837|FG000|Overall Study|Adverse Event|2|||
105493320|NCT00304239|363818838|FG001|Overall Study|Adverse Event|0|||
105493321|NCT02979197|363818839|FG000|Overall Study|Adverse Event|4|||
105493322|NCT02979197|363818840|FG001|Overall Study|Adverse Event|2|||
105493323|NCT02979197|363818841|FG002|Overall Study|Adverse Event|0|||
105493324|NCT02979197|363818839|FG000|Overall Study|Protocol Violation|0|||
105493325|NCT02979197|363818840|FG001|Overall Study|Protocol Violation|1|||
105493326|NCT02979197|363818841|FG002|Overall Study|Protocol Violation|0|||
105493327|NCT02979197|363818839|FG000|Overall Study|Subject unable to commit to study dates|0|||
105493328|NCT02979197|363818840|FG001|Overall Study|Subject unable to commit to study dates|1|||
105400746|NCT03789292|363477841|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
105400747|NCT03789292|363477842|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
105400748|NCT03789292|363477840|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
105400749|NCT03789292|363477841|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
105493329|NCT02979197|363818841|FG002|Overall Study|Subject unable to commit to study dates|0|||
105400750|NCT03789292|363477842|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
105400751|NCT03789292|363477840|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
105493330|NCT01898208|363818844|FG000|Overall Study|Positive blood culture|17|||
105400752|NCT03789292|363477841|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
105400753|NCT03789292|363477842|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
105400754|NCT03789292|363477840|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
105400755|NCT03789292|363477841|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
105400756|NCT03789292|363477842|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
105400757|NCT03789292|363477840|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
105400758|NCT03789292|363477841|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
105400759|NCT03789292|363477842|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
105400760|NCT03789292|363477840|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
105400761|NCT03789292|363477841|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
105400762|NCT03789292|363477842|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
105400763|NCT03789292|363477840|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
105400764|NCT03789292|363477841|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
105400765|NCT03789292|363477842|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
105400766|NCT00575666|363477843|FG000|Overall Study|Withdrawal by Subject|3|||
105400767|NCT00575666|363477844|FG001|Overall Study|Withdrawal by Subject|2|||
105400768|NCT00575666|363477843|FG000|Overall Study|Physician Decision|1|||
105400769|NCT00575666|363477844|FG001|Overall Study|Physician Decision|1|||
105400770|NCT01368614|363477845|FG000|Screening Period|Screen Failure|58|||
105400771|NCT01368614|363477846|FG001|Screening Period|Screen Failure|0|||
105400772|NCT01368614|363477847|FG002|Screening Period|Screen Failure|0|||
105400773|NCT01368614|363477848|FG003|Screening Period|Screen Failure|0|||
105400774|NCT01368614|363477845|FG000|Study Period|Withdrawal by Subject|0|||
105400775|NCT01368614|363477846|FG001|Study Period|Withdrawal by Subject|1|||
105400776|NCT01368614|363477847|FG002|Study Period|Withdrawal by Subject|1|||
105400777|NCT01368614|363477848|FG003|Study Period|Withdrawal by Subject|3|||
105400778|NCT01368614|363477845|FG000|Study Period|Lost to Follow-up|0|||
105400779|NCT01368614|363477846|FG001|Study Period|Lost to Follow-up|0|||
105400780|NCT01368614|363477847|FG002|Study Period|Lost to Follow-up|1|||
105400781|NCT01368614|363477848|FG003|Study Period|Lost to Follow-up|0|||
105400782|NCT02951780|363477849|FG000|Period 1|Adverse Event|0|||
105400783|NCT02951780|363477850|FG001|Period 1|Adverse Event|0|||
105400784|NCT02951780|363477851|FG002|Period 1|Adverse Event|0|||
105400785|NCT02951780|363477852|FG003|Period 1|Adverse Event|1|||
105400786|NCT02951780|363477853|FG004|Period 1|Adverse Event|0|||
105400787|NCT02951780|363477854|FG005|Period 1|Adverse Event|0|||
105400788|NCT02951780|363477855|FG006|Period 1|Adverse Event|0|||
105400789|NCT02951780|363477856|FG007|Period 1|Adverse Event|0|||
105400790|NCT02951780|363477857|FG008|Period 1|Adverse Event|0|||
105400791|NCT02951780|363477849|FG000|Period 1|Scheduling Conflicts|0|||
105400792|NCT02951780|363477850|FG001|Period 1|Scheduling Conflicts|0|||
105400793|NCT02951780|363477851|FG002|Period 1|Scheduling Conflicts|0|||
105400794|NCT02951780|363477852|FG003|Period 1|Scheduling Conflicts|0|||
105400795|NCT02951780|363477853|FG004|Period 1|Scheduling Conflicts|0|||
105400796|NCT02951780|363477854|FG005|Period 1|Scheduling Conflicts|0|||
105400797|NCT02951780|363477855|FG006|Period 1|Scheduling Conflicts|0|||
105400798|NCT02951780|363477856|FG007|Period 1|Scheduling Conflicts|1|||
105400799|NCT02951780|363477857|FG008|Period 1|Scheduling Conflicts|0|||
105400800|NCT02951780|363477849|FG000|Period 2|Scheduling Conflicts|0|||
105400801|NCT02951780|363477850|FG001|Period 2|Scheduling Conflicts|0|||
105400802|NCT02951780|363477851|FG002|Period 2|Scheduling Conflicts|0|||
105400803|NCT02951780|363477852|FG003|Period 2|Scheduling Conflicts|0|||
105400804|NCT02951780|363477853|FG004|Period 2|Scheduling Conflicts|0|||
105400805|NCT02951780|363477854|FG005|Period 2|Scheduling Conflicts|0|||
105400806|NCT02951780|363477855|FG006|Period 2|Scheduling Conflicts|0|||
105493331|NCT01898208|363818845|FG001|Overall Study|Positive blood culture|23|||
105493332|NCT01898208|363818846|FG002|Overall Study|Positive blood culture|15|||
105400807|NCT02951780|363477856|FG007|Period 2|Scheduling Conflicts|1|||
105400808|NCT02951780|363477857|FG008|Period 2|Scheduling Conflicts|0|||
105400809|NCT02359903|363477861|FG000|Overall Study|Adverse Event|0|||
105400810|NCT02359903|363477862|FG001|Overall Study|Adverse Event|2|||
105400811|NCT00546481|363477863|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
105400812|NCT00546481|363477864|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
105400813|NCT00546481|363477865|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
105400814|NCT00546481|363477863|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
105400815|NCT00546481|363477864|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
105400816|NCT00546481|363477865|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
105400817|NCT00546481|363477863|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
105400818|NCT00546481|363477864|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
105400819|NCT00546481|363477865|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
105400820|NCT00546481|363477863|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
105400821|NCT00546481|363477864|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
105400822|NCT00546481|363477865|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
105400823|NCT00546481|363477863|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
105400824|NCT00546481|363477864|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
105400825|NCT00546481|363477865|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
105400826|NCT00546481|363477863|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
105400827|NCT00546481|363477864|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
105400828|NCT00546481|363477865|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
105400829|NCT00546481|363477863|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
105400830|NCT00546481|363477864|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
105400831|NCT00546481|363477865|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
105400832|NCT00546481|363477863|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
105400833|NCT00546481|363477864|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
105400834|NCT00546481|363477865|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
105400835|NCT00546481|363477863|FG000|Maintenance Phase (CERA)|Other Reason|0|||
105400836|NCT00546481|363477864|FG001|Maintenance Phase (CERA)|Other Reason|0|||
105400837|NCT00546481|363477865|FG002|Maintenance Phase (CERA)|Other Reason|1|||
105400838|NCT02629861|363477870|FG000|Overall Study|Adverse Event|7|||
105400839|NCT02629861|363477871|FG001|Overall Study|Adverse Event|5|||
105400840|NCT02629861|363477872|FG002|Overall Study|Adverse Event|4|||
105400841|NCT02629861|363477870|FG000|Overall Study|Withdrawal by Subject|5|||
105400842|NCT02629861|363477871|FG001|Overall Study|Withdrawal by Subject|8|||
105400843|NCT02629861|363477872|FG002|Overall Study|Withdrawal by Subject|13|||
105400844|NCT02629861|363477870|FG000|Overall Study|Protocol Violation|2|||
105400845|NCT02629861|363477871|FG001|Overall Study|Protocol Violation|3|||
105400846|NCT02629861|363477872|FG002|Overall Study|Protocol Violation|7|||
105400847|NCT02629861|363477870|FG000|Overall Study|Lost to Follow-up|12|||
105400848|NCT02629861|363477871|FG001|Overall Study|Lost to Follow-up|9|||
105400849|NCT02629861|363477872|FG002|Overall Study|Lost to Follow-up|4|||
105400850|NCT02629861|363477870|FG000|Overall Study|Other|1|||
105400851|NCT02629861|363477871|FG001|Overall Study|Other|1|||
105400852|NCT02629861|363477872|FG002|Overall Study|Other|0|||
105400853|NCT02629861|363477870|FG000|Overall Study|Pregnancy|2|||
105400854|NCT02629861|363477871|FG001|Overall Study|Pregnancy|1|||
105400855|NCT02629861|363477872|FG002|Overall Study|Pregnancy|0|||
105400856|NCT00165789|363477873|FG000|Overall Study|Adverse Event|0|||
105400857|NCT00165789|363477874|FG001|Overall Study|Adverse Event|3|||
105400858|NCT00165789|363477875|FG002|Overall Study|Adverse Event|0|||
105400859|NCT00165789|363477876|FG003|Overall Study|Adverse Event|12|||
105400860|NCT00165789|363477873|FG000|Overall Study|Withdrawal by Subject|0|||
105400861|NCT00165789|363477874|FG001|Overall Study|Withdrawal by Subject|1|||
105400862|NCT00165789|363477875|FG002|Overall Study|Withdrawal by Subject|1|||
105400863|NCT00165789|363477876|FG003|Overall Study|Withdrawal by Subject|2|||
105400864|NCT01847443|363477881|FG000|Study Period 1|Withdrawal by Subject|0|||
105400865|NCT01847443|363477882|FG001|Study Period 1|Withdrawal by Subject|1|||
105400866|NCT01847443|363477883|FG002|Study Period 1|Withdrawal by Subject|0|||
105400867|NCT01847443|363477884|FG003|Study Period 1|Withdrawal by Subject|0|||
105400868|NCT01847443|363477881|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
105400869|NCT01847443|363477882|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
105400870|NCT01847443|363477883|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
105400871|NCT01847443|363477884|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
105400872|NCT01847443|363477881|FG000|Washout Period Before Study Period 2|Other reason|1|||
105400873|NCT01847443|363477882|FG001|Washout Period Before Study Period 2|Other reason|0|||
105400874|NCT01847443|363477883|FG002|Washout Period Before Study Period 2|Other reason|0|||
105400875|NCT01847443|363477884|FG003|Washout Period Before Study Period 2|Other reason|0|||
105400876|NCT01847443|363477881|FG000|Washout Period Before Study Period 3|Other reason|1|||
105400877|NCT01847443|363477882|FG001|Washout Period Before Study Period 3|Other reason|0|||
105493333|NCT01898208|363818844|FG000|Overall Study|Death/comfort care within 24 hours|10|||
105493334|NCT01898208|363818845|FG001|Overall Study|Death/comfort care within 24 hours|9|||
105493335|NCT01898208|363818846|FG002|Overall Study|Death/comfort care within 24 hours|8|||
105493336|NCT01898208|363818844|FG000|Overall Study|Negative Gram Stain|6|||
105400878|NCT01847443|363477883|FG002|Washout Period Before Study Period 3|Other reason|0|||
105400879|NCT01847443|363477884|FG003|Washout Period Before Study Period 3|Other reason|0|||
105400880|NCT01847443|363477881|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
105400881|NCT01847443|363477882|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
105400882|NCT01847443|363477883|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
105400883|NCT01847443|363477884|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
105400884|NCT01847443|363477881|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
105400885|NCT01847443|363477882|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
105400886|NCT01847443|363477883|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
105400887|NCT01847443|363477884|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
105400888|NCT02112656|363477888|FG000|Overall Study|Death|78|||
105400889|NCT02112656|363477889|FG001|Overall Study|Death|82|||
105493337|NCT01898208|363818845|FG001|Overall Study|Negative Gram Stain|9|||
105400890|NCT02112656|363477888|FG000|Overall Study|Withdrawal by Subject|9|||
105400891|NCT02112656|363477889|FG001|Overall Study|Withdrawal by Subject|11|||
105400892|NCT02112656|363477888|FG000|Overall Study|Lost to Follow-up|2|||
105400893|NCT02112656|363477889|FG001|Overall Study|Lost to Follow-up|4|||
105400894|NCT02112656|363477888|FG000|Overall Study|Noncompliance|1|||
105400895|NCT02112656|363477889|FG001|Overall Study|Noncompliance|2|||
105400896|NCT00027560|363477890|FG000|Overall Study|Withdrawal by Subject|1|||
105400897|NCT01978145|363479958|FG000|Treatment Period 1|Adverse Event|1|||
105400898|NCT01978145|363479959|FG001|Treatment Period 1|Adverse Event|9|||
105400899|NCT01978145|363479958|FG000|Treatment Period 1|Physician Decision|1|||
105400900|NCT01978145|363479959|FG001|Treatment Period 1|Physician Decision|0|||
105400901|NCT01978145|363479958|FG000|Treatment Period 1|Withdrawal by Subject|5|||
105400902|NCT01978145|363479959|FG001|Treatment Period 1|Withdrawal by Subject|4|||
105400903|NCT01978145|363479958|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
105400904|NCT01978145|363479959|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
105400905|NCT01978145|363479958|FG000|Washout Period 1|Adverse Event|0|||
105400906|NCT01978145|363479959|FG001|Washout Period 1|Adverse Event|1|||
105400907|NCT01978145|363479958|FG000|Washout Period 1|Withdrawal by Subject|1|||
105400908|NCT01978145|363479959|FG001|Washout Period 1|Withdrawal by Subject|1|||
105400909|NCT01978145|363479958|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
105400910|NCT01978145|363479959|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
105400911|NCT01978145|363479958|FG000|Treatment Period 2|Adverse Event|3|||
105400912|NCT01978145|363479959|FG001|Treatment Period 2|Adverse Event|3|||
105400913|NCT01978145|363479958|FG000|Treatment Period 2|Protocol Violation|0|||
105400914|NCT01978145|363479959|FG001|Treatment Period 2|Protocol Violation|1|||
105400915|NCT01978145|363479958|FG000|Treatment Period 2|Lost to Follow-up|1|||
105400916|NCT01978145|363479959|FG001|Treatment Period 2|Lost to Follow-up|1|||
105400917|NCT01978145|363479958|FG000|Treatment Period 2|Withdrawal by Subject|7|||
105400918|NCT01978145|363479959|FG001|Treatment Period 2|Withdrawal by Subject|4|||
105400919|NCT01978145|363479958|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
105400920|NCT01978145|363479959|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
105400921|NCT02777086|363479960|FG000|Overall Study|Lost to Follow-up|96|||
105400922|NCT02777086|363479961|FG001|Overall Study|Lost to Follow-up|99|||
105400923|NCT01770743|363479962|FG000|Overall Study|Adverse Event|1|||
105400924|NCT01770743|363479963|FG001|Overall Study|Adverse Event|0|||
105400925|NCT01770743|363479964|FG002|Overall Study|Adverse Event|0|||
105400926|NCT01770743|363479965|FG003|Overall Study|Adverse Event|0|||
105400927|NCT01770743|363479966|FG004|Overall Study|Adverse Event|0|||
105400928|NCT01770743|363479962|FG000|Overall Study|Withdrawal by Subject|0|||
105400929|NCT01770743|363479963|FG001|Overall Study|Withdrawal by Subject|0|||
105400930|NCT01770743|363479964|FG002|Overall Study|Withdrawal by Subject|1|||
105400931|NCT01770743|363479965|FG003|Overall Study|Withdrawal by Subject|1|||
105400932|NCT01770743|363479966|FG004|Overall Study|Withdrawal by Subject|1|||
105400933|NCT01770743|363479962|FG000|Overall Study|Lost to Follow-up|0|||
105400934|NCT01770743|363479963|FG001|Overall Study|Lost to Follow-up|2|||
105400935|NCT01770743|363479964|FG002|Overall Study|Lost to Follow-up|0|||
105400936|NCT01770743|363479965|FG003|Overall Study|Lost to Follow-up|0|||
105400937|NCT01770743|363479966|FG004|Overall Study|Lost to Follow-up|1|||
105400938|NCT01770743|363479962|FG000|Overall Study|Sponsor Terminated Subject|1|||
105400939|NCT01770743|363479963|FG001|Overall Study|Sponsor Terminated Subject|0|||
105400940|NCT01770743|363479964|FG002|Overall Study|Sponsor Terminated Subject|0|||
105400941|NCT01770743|363479965|FG003|Overall Study|Sponsor Terminated Subject|1|||
105400942|NCT01770743|363479966|FG004|Overall Study|Sponsor Terminated Subject|0|||
105400943|NCT01770743|363479962|FG000|Overall Study|Moving Out of State|0|||
105400944|NCT01770743|363479963|FG001|Overall Study|Moving Out of State|1|||
105400945|NCT01770743|363479964|FG002|Overall Study|Moving Out of State|0|||
105400946|NCT01770743|363479965|FG003|Overall Study|Moving Out of State|0|||
105400947|NCT01770743|363479966|FG004|Overall Study|Moving Out of State|0|||
105400948|NCT00755807|363479969|FG000|Acute Phase|Adverse Event|16|||
105400949|NCT00755807|363479970|FG001|Acute Phase|Adverse Event|5|||
105493338|NCT01898208|363818846|FG002|Overall Study|Negative Gram Stain|6|||
105493339|NCT01898208|363818844|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
105493340|NCT01898208|363818845|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
105493341|NCT01898208|363818846|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
105493342|NCT01898208|363818844|FG000|Overall Study|System/Technical Error|1|||
105493343|NCT01898208|363818845|FG001|Overall Study|System/Technical Error|2|||
105493344|NCT01898208|363818846|FG002|Overall Study|System/Technical Error|3|||
105400950|NCT00755807|363479969|FG000|Acute Phase|Protocol Violation|1|||
105400951|NCT00755807|363479970|FG001|Acute Phase|Protocol Violation|3|||
105400952|NCT00755807|363479969|FG000|Acute Phase|Withdrawal by Subject|1|||
105400953|NCT00755807|363479970|FG001|Acute Phase|Withdrawal by Subject|2|||
105400954|NCT00755807|363479969|FG000|Acute Phase|Lack of Efficacy|0|||
105400955|NCT00755807|363479970|FG001|Acute Phase|Lack of Efficacy|1|||
105400956|NCT00755807|363479969|FG000|Acute Phase|Physician Decision|0|||
105400957|NCT00755807|363479970|FG001|Acute Phase|Physician Decision|1|||
105400958|NCT00755807|363479969|FG000|Open-label Extension Phase|Adverse Event|7|||
105400959|NCT00755807|363479970|FG001|Open-label Extension Phase|Adverse Event|7|||
105400960|NCT00755807|363479969|FG000|Open-label Extension Phase|Protocol Violation|5|||
105400961|NCT00755807|363479970|FG001|Open-label Extension Phase|Protocol Violation|2|||
105400962|NCT00755807|363479969|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
105400963|NCT00755807|363479970|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
105400964|NCT00755807|363479969|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
105400965|NCT00755807|363479970|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
105400966|NCT00755807|363479969|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
105400967|NCT00755807|363479970|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
105400968|NCT00755807|363479969|FG000|Open-label Extension Phase|Sponsor Decision|0|||
105400969|NCT00755807|363479970|FG001|Open-label Extension Phase|Sponsor Decision|1|||
105400970|NCT01133665|363479971|FG000|Overall Study|Physician Decision|2|||
105400971|NCT02122380|363479972|FG000|First Intervention (30 Days)|Adverse Event|1|||
105400972|NCT02122380|363479973|FG001|First Intervention (30 Days)|Adverse Event|0|||
105400973|NCT02122380|363479972|FG000|First Intervention (30 Days)|Physician Decision|0|||
105400974|NCT02122380|363479973|FG001|First Intervention (30 Days)|Physician Decision|1|||
105400975|NCT02122380|363479972|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
105400976|NCT02122380|363479973|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
105400977|NCT02122380|363479972|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
105400978|NCT02122380|363479973|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
105400979|NCT02122380|363479972|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
105400980|NCT02122380|363479973|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
105400981|NCT00276419|363479974|FG000|First Intervention|Adverse Event|1|||
105400982|NCT00276419|363479975|FG001|First Intervention|Adverse Event|0|||
105400983|NCT00276419|363479974|FG000|First Intervention|Withdrawal by Subject|0|||
105400984|NCT00276419|363479975|FG001|First Intervention|Withdrawal by Subject|2|||
105400985|NCT01334554|363479976|FG000|Overall Study|Adverse Event|4|||
105400986|NCT01334554|363479977|FG001|Overall Study|Adverse Event|2|||
105400987|NCT02393859|363479978|FG000|Overall Study|Decision by Sponsor|2|||
105400988|NCT02393859|363479979|FG001|Overall Study|Decision by Sponsor|4|||
105400989|NCT02393859|363479978|FG000|Overall Study|Withdrawal by Subject|11|||
105400990|NCT02393859|363479979|FG001|Overall Study|Withdrawal by Subject|6|||
105400991|NCT02393859|363479978|FG000|Overall Study|Death|27|||
105400992|NCT02393859|363479979|FG001|Overall Study|Death|10|||
105400993|NCT02393859|363479978|FG000|Overall Study|Lost to Follow-up|1|||
105400994|NCT02393859|363479979|FG001|Overall Study|Lost to Follow-up|1|||
105400995|NCT00524121|363479980|FG000|Overall Study|Disease progression|6|||
105400996|NCT00524121|363479980|FG000|Overall Study|Adverse Event|4|||
105400997|NCT00524121|363479980|FG000|Overall Study|Patient refused|2|||
105400998|NCT00524121|363479980|FG000|Overall Study|Other|1|||
105400999|NCT00524121|363479980|FG000|Overall Study|Death|1|||
105401000|NCT00524121|363479980|FG000|Overall Study|Not treated (became ineligible)|4|||
105401001|NCT00524121|363479980|FG000|Overall Study|Not treated (changed mind)|1|||
105401002|NCT01446874|363479981|FG000|Overall Study|Not eligible|1|||
105401003|NCT01446874|363479982|FG001|Overall Study|Not eligible|0|||
105401004|NCT01446874|363479983|FG002|Overall Study|Not eligible|0|||
105401005|NCT01446874|363479981|FG000|Overall Study|No surgery/No qualifying surgery|1|||
105401006|NCT01446874|363479982|FG001|Overall Study|No surgery/No qualifying surgery|0|||
105401007|NCT01446874|363479983|FG002|Overall Study|No surgery/No qualifying surgery|12|||
105401008|NCT01446874|363479981|FG000|Overall Study|Non-compliance|0|||
105401009|NCT01446874|363479982|FG001|Overall Study|Non-compliance|4|||
105401010|NCT01446874|363479983|FG002|Overall Study|Non-compliance|0|||
105401011|NCT01446874|363479981|FG000|Overall Study|Antibiotics for pre-op infection|0|||
105401012|NCT01446874|363479982|FG001|Overall Study|Antibiotics for pre-op infection|0|||
105401013|NCT01446874|363479983|FG002|Overall Study|Antibiotics for pre-op infection|2|||
105401014|NCT01446874|363479981|FG000|Overall Study|Withdrawal by Subject|0|||
105401015|NCT01446874|363479982|FG001|Overall Study|Withdrawal by Subject|0|||
105401016|NCT01446874|363479983|FG002|Overall Study|Withdrawal by Subject|4|||
105401017|NCT02852967|363479986|FG000|Overall Study|Adverse Event|3|||
105401018|NCT02852967|363479987|FG001|Overall Study|Adverse Event|1|||
105401019|NCT02852967|363479988|FG002|Overall Study|Adverse Event|0|||
105401020|NCT02852967|363479989|FG003|Overall Study|Adverse Event|1|||
105401021|NCT02852967|363479990|FG004|Overall Study|Adverse Event|0|||
105401022|NCT02852967|363479986|FG000|Overall Study|Death|1|||
105401023|NCT02852967|363479987|FG001|Overall Study|Death|0|||
105580657|NCT01474512|364126477|FG012|Induction Period|Withdrawal by Subject|0|||
105580658|NCT01474512|364126478|FG013|Induction Period|Withdrawal by Subject|0|||
105401024|NCT02852967|363479988|FG002|Overall Study|Death|0|||
105401025|NCT02852967|363479989|FG003|Overall Study|Death|0|||
105401026|NCT02852967|363479990|FG004|Overall Study|Death|0|||
105401027|NCT02852967|363479986|FG000|Overall Study|Lost to Follow-up|1|||
105401028|NCT02852967|363479987|FG001|Overall Study|Lost to Follow-up|2|||
105401029|NCT02852967|363479988|FG002|Overall Study|Lost to Follow-up|3|||
105401030|NCT02852967|363479989|FG003|Overall Study|Lost to Follow-up|4|||
105401031|NCT02852967|363479990|FG004|Overall Study|Lost to Follow-up|4|||
105401032|NCT02852967|363479986|FG000|Overall Study|Withdrawal by Subject|6|||
105401033|NCT02852967|363479987|FG001|Overall Study|Withdrawal by Subject|12|||
105493345|NCT01898208|363818844|FG000|Overall Study|Lost to Follow-up|3|||
105493346|NCT01898208|363818845|FG001|Overall Study|Lost to Follow-up|1|||
105493347|NCT01898208|363818846|FG002|Overall Study|Lost to Follow-up|1|||
105493348|NCT05182125|363818847|FG000|Overall Study|Withdrawal by Subject|0|||
105493349|NCT05182125|363818848|FG001|Overall Study|Withdrawal by Subject|0|||
105493350|NCT05182125|363818849|FG002|Overall Study|Withdrawal by Subject|0|||
105493351|NCT05182125|363818850|FG003|Overall Study|Withdrawal by Subject|0|||
105493352|NCT05182125|363818851|FG004|Overall Study|Withdrawal by Subject|2|||
105493353|NCT05182125|363818852|FG005|Overall Study|Withdrawal by Subject|0|||
105401034|NCT02852967|363479988|FG002|Overall Study|Withdrawal by Subject|7|||
105401035|NCT02852967|363479989|FG003|Overall Study|Withdrawal by Subject|10|||
105401036|NCT02852967|363479990|FG004|Overall Study|Withdrawal by Subject|10|||
105401037|NCT02852967|363479986|FG000|Overall Study|SAE|0|||
105401038|NCT02852967|363479987|FG001|Overall Study|SAE|0|||
105401039|NCT02852967|363479988|FG002|Overall Study|SAE|0|||
105401040|NCT02852967|363479989|FG003|Overall Study|SAE|3|||
105401041|NCT02852967|363479990|FG004|Overall Study|SAE|0|||
105401042|NCT02852967|363479986|FG000|Overall Study|Elevated Liver Enzymes|2|||
105401043|NCT02852967|363479987|FG001|Overall Study|Elevated Liver Enzymes|0|||
105401044|NCT02852967|363479988|FG002|Overall Study|Elevated Liver Enzymes|0|||
105401045|NCT02852967|363479989|FG003|Overall Study|Elevated Liver Enzymes|2|||
105401046|NCT02852967|363479990|FG004|Overall Study|Elevated Liver Enzymes|2|||
105401047|NCT02852967|363479986|FG000|Overall Study|Physician Decision|0|||
105401048|NCT02852967|363479987|FG001|Overall Study|Physician Decision|0|||
105401049|NCT02852967|363479988|FG002|Overall Study|Physician Decision|0|||
105401050|NCT02852967|363479989|FG003|Overall Study|Physician Decision|1|||
105401051|NCT02852967|363479990|FG004|Overall Study|Physician Decision|0|||
105401052|NCT02852967|363479986|FG000|Overall Study|Lack of Efficacy|0|||
105401053|NCT02852967|363479987|FG001|Overall Study|Lack of Efficacy|1|||
105401054|NCT02852967|363479988|FG002|Overall Study|Lack of Efficacy|0|||
105401055|NCT02852967|363479989|FG003|Overall Study|Lack of Efficacy|0|||
105401056|NCT02852967|363479990|FG004|Overall Study|Lack of Efficacy|0|||
105401057|NCT02852967|363479986|FG000|Overall Study|Non-compliance|0|||
105401058|NCT02852967|363479987|FG001|Overall Study|Non-compliance|0|||
105401059|NCT02852967|363479988|FG002|Overall Study|Non-compliance|1|||
105401060|NCT02852967|363479989|FG003|Overall Study|Non-compliance|1|||
105401061|NCT02852967|363479990|FG004|Overall Study|Non-compliance|0|||
105401062|NCT02852967|363479986|FG000|Overall Study|Dispensing Drug Violation|0|||
105401063|NCT02852967|363479987|FG001|Overall Study|Dispensing Drug Violation|0|||
105401064|NCT02852967|363479988|FG002|Overall Study|Dispensing Drug Violation|1|||
105401065|NCT02852967|363479989|FG003|Overall Study|Dispensing Drug Violation|0|||
105401066|NCT02852967|363479990|FG004|Overall Study|Dispensing Drug Violation|0|||
105401067|NCT02852967|363479986|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
105401068|NCT02852967|363479987|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
105401069|NCT02852967|363479988|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
105401070|NCT02852967|363479989|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
105401071|NCT02852967|363479990|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
105401072|NCT00812955|363479991|FG000|Overall Study|Adverse Event|7|||
105401073|NCT00812955|363479992|FG001|Overall Study|Adverse Event|6|||
105401074|NCT00812955|363479993|FG002|Overall Study|Adverse Event|3|||
105401075|NCT00812955|363479994|FG003|Overall Study|Adverse Event|4|||
105401076|NCT00812955|363479991|FG000|Overall Study|Lost to Follow-up|2|||
105401077|NCT00812955|363479992|FG001|Overall Study|Lost to Follow-up|1|||
105401078|NCT00812955|363479993|FG002|Overall Study|Lost to Follow-up|1|||
105401079|NCT00812955|363479994|FG003|Overall Study|Lost to Follow-up|2|||
105401080|NCT00812955|363479991|FG000|Overall Study|Withdrawal by Subject|1|||
105401081|NCT00812955|363479992|FG001|Overall Study|Withdrawal by Subject|0|||
105401082|NCT00812955|363479993|FG002|Overall Study|Withdrawal by Subject|1|||
105401083|NCT00812955|363479994|FG003|Overall Study|Withdrawal by Subject|2|||
105401084|NCT00812955|363479991|FG000|Overall Study|randomized in error|0|||
105493354|NCT05182125|363818847|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
105493355|NCT05182125|363818848|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
105580659|NCT01474512|364126479|FG014|Induction Period|Withdrawal by Subject|0|||
105580660|NCT01474512|364126480|FG015|Induction Period|Withdrawal by Subject|0|||
105401085|NCT00812955|363479992|FG001|Overall Study|randomized in error|0|||
105401086|NCT00812955|363479993|FG002|Overall Study|randomized in error|1|||
105401087|NCT00812955|363479994|FG003|Overall Study|randomized in error|0|||
105401088|NCT03338400|363479995|FG000|Overall Study|Lost to Follow-up|1|||
105493356|NCT05182125|363818849|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
105580661|NCT01474512|364126481|FG016|Induction Period|Withdrawal by Subject|0|||
105401089|NCT03338400|363479996|FG001|Overall Study|Lost to Follow-up|2|||
105401090|NCT02639390|363479999|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
105401091|NCT02639390|363480000|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
105401092|NCT01331681|363480008|FG000|Overall Study|Adverse Event|10|||
105401093|NCT01331681|363480009|FG001|Overall Study|Adverse Event|13|||
105401094|NCT01331681|363480010|FG002|Overall Study|Adverse Event|10|||
105401095|NCT01331681|363480008|FG000|Overall Study|Death|6|||
105401096|NCT01331681|363480009|FG001|Overall Study|Death|6|||
105401097|NCT01331681|363480010|FG002|Overall Study|Death|2|||
105401098|NCT01331681|363480008|FG000|Overall Study|Lack of Efficacy|0|||
105401099|NCT01331681|363480009|FG001|Overall Study|Lack of Efficacy|1|||
105401100|NCT01331681|363480010|FG002|Overall Study|Lack of Efficacy|0|||
105401101|NCT01331681|363480008|FG000|Overall Study|Withdrawal by Subject|12|||
105401102|NCT01331681|363480009|FG001|Overall Study|Withdrawal by Subject|8|||
105401103|NCT01331681|363480010|FG002|Overall Study|Withdrawal by Subject|15|||
105401104|NCT01331681|363480008|FG000|Overall Study|Protocol Violation|1|||
105401105|NCT01331681|363480009|FG001|Overall Study|Protocol Violation|1|||
105401106|NCT01331681|363480010|FG002|Overall Study|Protocol Violation|0|||
105401107|NCT01331681|363480008|FG000|Overall Study|Lost to Follow-up|2|||
105401108|NCT01331681|363480009|FG001|Overall Study|Lost to Follow-up|4|||
105401109|NCT01331681|363480010|FG002|Overall Study|Lost to Follow-up|1|||
105401110|NCT01331681|363480008|FG000|Overall Study|Physician Decision|2|||
105401111|NCT01331681|363480009|FG001|Overall Study|Physician Decision|0|||
105401112|NCT01331681|363480010|FG002|Overall Study|Physician Decision|4|||
105401113|NCT01331681|363480008|FG000|Overall Study|Therapeutic procedure required|1|||
105401114|NCT01331681|363480009|FG001|Overall Study|Therapeutic procedure required|0|||
105401115|NCT01331681|363480010|FG002|Overall Study|Therapeutic procedure required|0|||
105401116|NCT01331681|363480008|FG000|Overall Study|Sponsor decision|1|||
105401117|NCT01331681|363480009|FG001|Overall Study|Sponsor decision|1|||
105401118|NCT01331681|363480010|FG002|Overall Study|Sponsor decision|0|||
105401119|NCT01331681|363480008|FG000|Overall Study|Switching to other therapy|0|||
105401120|NCT01331681|363480009|FG001|Overall Study|Switching to other therapy|0|||
105401121|NCT01331681|363480010|FG002|Overall Study|Switching to other therapy|1|||
105401122|NCT01331681|363480008|FG000|Overall Study|Not Received Study Treatment|0|||
105401123|NCT01331681|363480009|FG001|Overall Study|Not Received Study Treatment|0|||
105401124|NCT01331681|363480010|FG002|Overall Study|Not Received Study Treatment|2|||
105401125|NCT01534481|363480011|FG000|Overall Study|Lost to Follow-up|29|||
105401126|NCT01534481|363480012|FG001|Overall Study|Lost to Follow-up|24|||
105401127|NCT01534481|363480011|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
105401128|NCT01534481|363480012|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
105401129|NCT00616642|363480013|FG000|Overall Study|Withdrawal by Subject|0|||
105401130|NCT00616642|363480014|FG001|Overall Study|Withdrawal by Subject|1|||
105401131|NCT02394561|363480016|FG000|CORE Phase|Adverse Event|7|||
105401132|NCT02394561|363480017|FG001|CORE Phase|Adverse Event|9|||
105401133|NCT02394561|363480016|FG000|CORE Phase|Death|0|||
105401134|NCT02394561|363480017|FG001|CORE Phase|Death|1|||
105401135|NCT02394561|363480016|FG000|CORE Phase|Pregnancy|1|||
105401136|NCT02394561|363480017|FG001|CORE Phase|Pregnancy|0|||
105401137|NCT02394561|363480016|FG000|CORE Phase|Lost to Follow-up|1|||
105401138|NCT02394561|363480017|FG001|CORE Phase|Lost to Follow-up|0|||
105401139|NCT02394561|363480016|FG000|CORE Phase|Physician Decision|1|||
105401140|NCT02394561|363480017|FG001|CORE Phase|Physician Decision|1|||
105401141|NCT02394561|363480016|FG000|CORE Phase|Withdrawal by Subject|2|||
105401142|NCT02394561|363480017|FG001|CORE Phase|Withdrawal by Subject|2|||
105401143|NCT02394561|363480016|FG000|CORE Phase|Lack of Efficacy|1|||
105401144|NCT02394561|363480017|FG001|CORE Phase|Lack of Efficacy|6|||
105401145|NCT02394561|363480016|FG000|Extension Phase|Adverse Event|6|||
105401146|NCT02394561|363480017|FG001|Extension Phase|Adverse Event|1|||
105401147|NCT02394561|363480016|FG000|Extension Phase|Death|0|||
105401148|NCT02394561|363480017|FG001|Extension Phase|Death|1|||
105401149|NCT02394561|363480016|FG000|Extension Phase|Protocol Violation|1|||
105401150|NCT02394561|363480017|FG001|Extension Phase|Protocol Violation|0|||
105401151|NCT02394561|363480016|FG000|Extension Phase|Lost to Follow-up|1|||
105401152|NCT02394561|363480017|FG001|Extension Phase|Lost to Follow-up|0|||
105401153|NCT02394561|363480016|FG000|Extension Phase|Physician Decision|0|||
105401154|NCT02394561|363480017|FG001|Extension Phase|Physician Decision|2|||
105401155|NCT02394561|363480016|FG000|Extension Phase|Withdrawal by Subject|0|||
105401156|NCT02394561|363480017|FG001|Extension Phase|Withdrawal by Subject|5|||
105401157|NCT02394561|363480016|FG000|Extension Phase|Lack of Efficacy|3|||
105401158|NCT02394561|363480017|FG001|Extension Phase|Lack of Efficacy|3|||
105401159|NCT02553629|363480018|FG000|Overall Study|Logistic reasons|3|||
105401160|NCT02553629|363480019|FG001|Overall Study|Logistic reasons|6|||
105401161|NCT02803203|363480020|FG000|Overall Study|Adverse Event|4|||
105401162|NCT02803203|363480020|FG000|Overall Study|Death|4|||
105401163|NCT02803203|363480020|FG000|Overall Study|Progressive disease|29|||
105401164|NCT02803203|363480020|FG000|Overall Study|Withdrawal by Subject|8|||
105401165|NCT02803203|363480020|FG000|Overall Study|Complete resection of target disease|2|||
105401166|NCT02803203|363480020|FG000|Overall Study|Switched to commercial Osi|1|||
105401167|NCT02803203|363480020|FG000|Overall Study|Participant moved away|1|||
105401168|NCT01812057|363480021|FG000|Overall Study|Protocol Violation|1|||
105401169|NCT01812057|363480022|FG001|Overall Study|Protocol Violation|0|||
105401170|NCT01812057|363480021|FG000|Overall Study|Physician Decision|1|||
105493357|NCT05182125|363818850|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
105493358|NCT05182125|363818851|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
105493359|NCT05182125|363818852|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
105493360|NCT05182125|363818847|FG000|Overall Study|Death|0|||
105493361|NCT05182125|363818848|FG001|Overall Study|Death|0|||
105493362|NCT05182125|363818849|FG002|Overall Study|Death|0|||
105493363|NCT05182125|363818850|FG003|Overall Study|Death|0|||
105493364|NCT05182125|363818851|FG004|Overall Study|Death|1|||
105493365|NCT05182125|363818852|FG005|Overall Study|Death|0|||
105493366|NCT05182125|363818847|FG000|Overall Study|Health Contact Follow-up|5|||
105493367|NCT05182125|363818848|FG001|Overall Study|Health Contact Follow-up|5|||
105493368|NCT05182125|363818849|FG002|Overall Study|Health Contact Follow-up|2|||
105493369|NCT05182125|363818850|FG003|Overall Study|Health Contact Follow-up|9|||
105401171|NCT01812057|363480022|FG001|Overall Study|Physician Decision|0|||
105401172|NCT01882465|363480025|FG000|Period 1|Lens Discomfort|0|||
105401173|NCT01882465|363480026|FG001|Period 1|Lens Discomfort|0|||
105401174|NCT01882465|363480027|FG002|Period 1|Lens Discomfort|0|||
105401175|NCT01882465|363480028|FG003|Period 1|Lens Discomfort|1|||
105401176|NCT01882465|363480029|FG004|Period 1|Lens Discomfort|0|||
105401177|NCT01882465|363480030|FG005|Period 1|Lens Discomfort|0|||
105401178|NCT01882465|363480031|FG006|Period 1|Lens Discomfort|0|||
105401179|NCT01882465|363480025|FG000|Period 1|Withdrawal by Subject|0|||
105401180|NCT01882465|363480026|FG001|Period 1|Withdrawal by Subject|0|||
105401181|NCT01882465|363480027|FG002|Period 1|Withdrawal by Subject|0|||
105401182|NCT01882465|363480028|FG003|Period 1|Withdrawal by Subject|0|||
105401183|NCT01882465|363480029|FG004|Period 1|Withdrawal by Subject|0|||
105401184|NCT01882465|363480030|FG005|Period 1|Withdrawal by Subject|0|||
105401185|NCT01882465|363480031|FG006|Period 1|Withdrawal by Subject|1|||
105401186|NCT01882465|363480025|FG000|Period 2|Protocol Violation|0|||
105401187|NCT01882465|363480026|FG001|Period 2|Protocol Violation|0|||
105401188|NCT01882465|363480027|FG002|Period 2|Protocol Violation|0|||
105401189|NCT01882465|363480028|FG003|Period 2|Protocol Violation|0|||
105401190|NCT01882465|363480029|FG004|Period 2|Protocol Violation|1|||
105401191|NCT01882465|363480030|FG005|Period 2|Protocol Violation|0|||
105401192|NCT01882465|363480031|FG006|Period 2|Protocol Violation|0|||
105401193|NCT01464879|363480032|FG000|Overall Study|Physician Decision|1|||
105401194|NCT01464879|363480032|FG000|Overall Study|Non-compliance|1|||
105401195|NCT02712788|363480042|FG000|Overall Study|Physician Decision|1|||
105401196|NCT02712788|363480043|FG001|Overall Study|Physician Decision|0|||
105401197|NCT02712788|363480042|FG000|Overall Study|Protocol Violation|1|||
105401198|NCT02712788|363480043|FG001|Overall Study|Protocol Violation|0|||
105401199|NCT00127855|363480044|FG000|Primary Vaccination Course|Adverse Event|0|||
105401200|NCT00127855|363480045|FG001|Primary Vaccination Course|Adverse Event|0|||
105401201|NCT00127855|363480046|FG002|Primary Vaccination Course|Adverse Event|1|||
105401202|NCT00127855|363480047|FG003|Primary Vaccination Course|Adverse Event|0|||
105401203|NCT00127855|363480048|FG004|Primary Vaccination Course|Adverse Event|0|||
105401204|NCT00127855|363480044|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
105401205|NCT00127855|363480045|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
105401206|NCT00127855|363480046|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
105401207|NCT00127855|363480047|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
105493370|NCT05182125|363818851|FG004|Overall Study|Health Contact Follow-up|7|||
105493371|NCT05182125|363818852|FG005|Overall Study|Health Contact Follow-up|2|||
105401208|NCT00127855|363480048|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
105401209|NCT00127855|363480044|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
105401210|NCT00127855|363480045|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
105401211|NCT00127855|363480046|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
105401212|NCT00127855|363480047|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
105401213|NCT00127855|363480048|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
105401214|NCT00127855|363480044|FG000|Primary Vaccination Course|Other|0|||
105401215|NCT00127855|363480045|FG001|Primary Vaccination Course|Other|0|||
105401216|NCT00127855|363480046|FG002|Primary Vaccination Course|Other|0|||
105401217|NCT00127855|363480047|FG003|Primary Vaccination Course|Other|0|||
105401218|NCT00127855|363480048|FG004|Primary Vaccination Course|Other|1|||
105401219|NCT01193101|363480052|FG000|Overall Study|Adverse Event|0|||
105493372|NCT02435069|363818853|FG000|Dose Response - First Intervention|Adverse Event|0|||
105493373|NCT02435069|363818854|FG001|Dose Response - First Intervention|Adverse Event|1|||
105401220|NCT01193101|363480053|FG001|Overall Study|Adverse Event|1|||
105401221|NCT01193101|363480054|FG002|Overall Study|Adverse Event|1|||
105401222|NCT01193101|363480055|FG003|Overall Study|Adverse Event|3|||
105401223|NCT01193101|363480052|FG000|Overall Study|Lack of Efficacy|3|||
105401224|NCT01193101|363480053|FG001|Overall Study|Lack of Efficacy|1|||
105401225|NCT01193101|363480054|FG002|Overall Study|Lack of Efficacy|0|||
105401226|NCT01193101|363480055|FG003|Overall Study|Lack of Efficacy|8|||
105401227|NCT01193101|363480052|FG000|Overall Study|Withdrawal by Subject|2|||
105401228|NCT01193101|363480053|FG001|Overall Study|Withdrawal by Subject|4|||
105401229|NCT01193101|363480054|FG002|Overall Study|Withdrawal by Subject|1|||
105401230|NCT01193101|363480055|FG003|Overall Study|Withdrawal by Subject|1|||
105401231|NCT01193101|363480052|FG000|Overall Study|Administrative problems|0|||
105401232|NCT01193101|363480053|FG001|Overall Study|Administrative problems|0|||
105401233|NCT01193101|363480054|FG002|Overall Study|Administrative problems|1|||
105401234|NCT01193101|363480055|FG003|Overall Study|Administrative problems|0|||
105401235|NCT01193101|363480052|FG000|Overall Study|Abnormal test procedure results|0|||
105401236|NCT01193101|363480053|FG001|Overall Study|Abnormal test procedure results|1|||
105401237|NCT01193101|363480054|FG002|Overall Study|Abnormal test procedure results|0|||
105401238|NCT01193101|363480055|FG003|Overall Study|Abnormal test procedure results|0|||
105401239|NCT01082614|363480058|FG000|Overall Study|Adverse Event|1|||
105401240|NCT01082614|363480059|FG001|Overall Study|Adverse Event|4|||
105401241|NCT01082614|363480058|FG000|Overall Study|Equipment Malfunction|0|||
105401242|NCT01082614|363480059|FG001|Overall Study|Equipment Malfunction|1|||
105401243|NCT01082614|363480058|FG000|Overall Study|Physician Decision|2|||
105401244|NCT01082614|363480059|FG001|Overall Study|Physician Decision|0|||
105401245|NCT01240863|363480060|FG000|Open-label Titration Period|Adverse Event|47|||
105401246|NCT01240863|363480061|FG001|Open-label Titration Period|Adverse Event|0|||
105401247|NCT01240863|363480062|FG002|Open-label Titration Period|Adverse Event|0|||
105401248|NCT01240863|363480060|FG000|Open-label Titration Period|Lack of Efficacy|19|||
105401249|NCT01240863|363480061|FG001|Open-label Titration Period|Lack of Efficacy|0|||
105401250|NCT01240863|363480062|FG002|Open-label Titration Period|Lack of Efficacy|0|||
105401251|NCT01240863|363480060|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
105401252|NCT01240863|363480061|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
105401253|NCT01240863|363480062|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
105401254|NCT01240863|363480060|FG000|Open-label Titration Period|Protocol Violation|7|||
105401255|NCT01240863|363480061|FG001|Open-label Titration Period|Protocol Violation|0|||
105401256|NCT01240863|363480062|FG002|Open-label Titration Period|Protocol Violation|0|||
105401257|NCT01240863|363480060|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
105401258|NCT01240863|363480061|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
105401259|NCT01240863|363480062|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
105401260|NCT01240863|363480060|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
105401261|NCT01240863|363480061|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
105401262|NCT01240863|363480062|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
105401263|NCT01240863|363480060|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
105401264|NCT01240863|363480061|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
105401265|NCT01240863|363480062|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
105401266|NCT01240863|363480060|FG000|Open-label Titration Period|Other|7|||
105401267|NCT01240863|363480061|FG001|Open-label Titration Period|Other|0|||
105401268|NCT01240863|363480062|FG002|Open-label Titration Period|Other|0|||
105401269|NCT01240863|363480060|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
105401270|NCT01240863|363480061|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
105401271|NCT01240863|363480062|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
105401272|NCT01240863|363480060|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
105401273|NCT01240863|363480061|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
105401274|NCT01240863|363480062|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
105401275|NCT01240863|363480060|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
105401276|NCT01240863|363480061|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
105401277|NCT01240863|363480062|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
105401278|NCT01240863|363480060|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
105401279|NCT01240863|363480061|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
105401280|NCT01240863|363480062|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
105401281|NCT01240863|363480060|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
105401282|NCT01240863|363480061|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
105401283|NCT01240863|363480062|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
105401284|NCT01240863|363480060|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
105401285|NCT01240863|363480061|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
105401286|NCT01240863|363480062|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
105401287|NCT01240863|363480060|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
105401288|NCT01240863|363480061|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
105493374|NCT02435069|363818855|FG002|Dose Response - First Intervention|Adverse Event|1|||
105401289|NCT01240863|363480062|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
105401290|NCT01240863|363480060|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
105401291|NCT01240863|363480061|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
105401292|NCT01240863|363480062|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
105401293|NCT03894891|363480063|FG000|Overall Study|Withdrawal by Subject|1|||
105401294|NCT03894891|363480063|FG000|Overall Study|Completed protocol treatment per protocol|5|||
105401295|NCT00950651|363480067|FG000|Overall Study|Adverse Event|17|||
105401296|NCT00950651|363480068|FG001|Overall Study|Adverse Event|20|||
105401297|NCT00950651|363480067|FG000|Overall Study|Death|1|||
105401298|NCT00950651|363480068|FG001|Overall Study|Death|0|||
105401299|NCT00950651|363480067|FG000|Overall Study|Lack of Efficacy|2|||
105401300|NCT00950651|363480068|FG001|Overall Study|Lack of Efficacy|2|||
105401301|NCT00950651|363480067|FG000|Overall Study|Protocol Violation|3|||
105401302|NCT00950651|363480068|FG001|Overall Study|Protocol Violation|4|||
105401303|NCT00950651|363480067|FG000|Overall Study|Withdrawal by Subject|8|||
105401304|NCT00950651|363480068|FG001|Overall Study|Withdrawal by Subject|9|||
105401305|NCT02756403|363480069|FG000|Overall Study|Unable to swallow medication|0|||
105401306|NCT02756403|363480070|FG001|Overall Study|Unable to swallow medication|1|||
105401307|NCT02756403|363480071|FG002|Overall Study|Unable to swallow medication|1|||
105401308|NCT02756403|363480072|FG003|Overall Study|Unable to swallow medication|1|||
105401309|NCT02756403|363480069|FG000|Overall Study|Did not complete Procedure|0|||
105401310|NCT02756403|363480070|FG001|Overall Study|Did not complete Procedure|1|||
105401311|NCT02756403|363480071|FG002|Overall Study|Did not complete Procedure|0|||
105401312|NCT02756403|363480072|FG003|Overall Study|Did not complete Procedure|0|||
105401313|NCT02756403|363480069|FG000|Overall Study|Changed Mind About Procedure|0|||
105401314|NCT02756403|363480070|FG001|Overall Study|Changed Mind About Procedure|0|||
105401315|NCT02756403|363480071|FG002|Overall Study|Changed Mind About Procedure|1|||
105401316|NCT02756403|363480072|FG003|Overall Study|Changed Mind About Procedure|0|||
105401317|NCT02756403|363480069|FG000|Overall Study|Protocol Violation|0|||
105401318|NCT02756403|363480070|FG001|Overall Study|Protocol Violation|1|||
105401319|NCT02756403|363480071|FG002|Overall Study|Protocol Violation|0|||
105401320|NCT02756403|363480072|FG003|Overall Study|Protocol Violation|1|||
105401321|NCT01644643|363480073|FG000|Overall Study|Death|1|||
105401322|NCT01644643|363480074|FG001|Overall Study|Death|0|||
105401323|NCT01644643|363480075|FG002|Overall Study|Death|3|||
105401324|NCT01644643|363480076|FG003|Overall Study|Death|3|||
105401325|NCT01644643|363480073|FG000|Overall Study|Lost to Follow-up|0|||
105401326|NCT01644643|363480074|FG001|Overall Study|Lost to Follow-up|0|||
105401327|NCT01644643|363480075|FG002|Overall Study|Lost to Follow-up|0|||
105401328|NCT01644643|363480076|FG003|Overall Study|Lost to Follow-up|4|||
105401329|NCT01644643|363480073|FG000|Overall Study|Withdrawal by Subject|1|||
105401330|NCT01644643|363480074|FG001|Overall Study|Withdrawal by Subject|0|||
105401331|NCT01644643|363480075|FG002|Overall Study|Withdrawal by Subject|2|||
105401332|NCT01644643|363480076|FG003|Overall Study|Withdrawal by Subject|1|||
105401333|NCT01644643|363480073|FG000|Overall Study|Other Eligibility criteria|0|||
105401334|NCT01644643|363480074|FG001|Overall Study|Other Eligibility criteria|0|||
105401335|NCT01644643|363480075|FG002|Overall Study|Other Eligibility criteria|0|||
105401336|NCT01644643|363480076|FG003|Overall Study|Other Eligibility criteria|2|||
105401337|NCT03710889|363480077|FG000|Overall Study|Adverse Event|2|||
105401338|NCT03710889|363480077|FG000|Overall Study|Protocol Deviation|1|||
105401339|NCT00776789|363480080|FG000|Overall Study|Consent refusal|2|||
105401340|NCT00776789|363480081|FG001|Overall Study|Consent refusal|2|||
105401341|NCT00776789|363480080|FG000|Overall Study|Poor quality video|1|||
105401342|NCT00776789|363480081|FG001|Overall Study|Poor quality video|1|||
105401343|NCT02850978|363480085|FG000|Overall Study|Uncollectable CRF|27|||
105401344|NCT02850978|363480085|FG000|Overall Study|No visit since the first visit|35|||
105401345|NCT02850978|363480085|FG000|Overall Study|Adverse Event|81|||
105401346|NCT02850978|363480085|FG000|Overall Study|Lack of Efficacy|40|||
105401347|NCT02850978|363480085|FG000|Overall Study|Improvement in condition|34|||
105401348|NCT02850978|363480085|FG000|Overall Study|Lost to Follow-up|121|||
105401349|NCT02850978|363480085|FG000|Overall Study|Reason not listed|88|||
105401350|NCT00114127|363480088|FG000|Overall Study|Adverse Event|2|||
105493375|NCT02435069|363818856|FG003|Dose Response - First Intervention|Adverse Event|0|||
105493376|NCT02435069|363818857|FG004|Dose Response - First Intervention|Adverse Event|0|||
105493377|NCT02435069|363818853|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
105493378|NCT02435069|363818854|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
105401351|NCT00114127|363480089|FG001|Overall Study|Adverse Event|1|||
105401352|NCT00114127|363480088|FG000|Overall Study|Lost to Follow-up|1|||
105401353|NCT00114127|363480089|FG001|Overall Study|Lost to Follow-up|0|||
105493379|NCT02435069|363818855|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
105401354|NCT00114127|363480088|FG000|Overall Study|Withdrawal by Subject|1|||
105401355|NCT00114127|363480089|FG001|Overall Study|Withdrawal by Subject|3|||
105401356|NCT00881894|363480090|FG000|Overall Study|Consent withdrawn|0|||
105401357|NCT00881894|363480091|FG001|Overall Study|Consent withdrawn|1|||
105401358|NCT00881894|363480090|FG000|Overall Study|Other reasons for premature termination|1|||
105401359|NCT00881894|363480091|FG001|Overall Study|Other reasons for premature termination|2|||
105401360|NCT00421148|363480092|FG000|Overall Study|Lost to Follow-up|0|||
105401361|NCT00421148|363480093|FG001|Overall Study|Lost to Follow-up|0|||
105401362|NCT00421148|363480094|FG002|Overall Study|Lost to Follow-up|0|||
105401363|NCT00421148|363480095|FG003|Overall Study|Lost to Follow-up|0|||
105401364|NCT00421148|363480096|FG004|Overall Study|Lost to Follow-up|0|||
105401365|NCT00421148|363480097|FG005|Overall Study|Lost to Follow-up|0|||
105401366|NCT00421148|363480098|FG006|Overall Study|Lost to Follow-up|0|||
105401367|NCT00421148|363480099|FG007|Overall Study|Lost to Follow-up|0|||
105401368|NCT00421148|363480100|FG008|Overall Study|Lost to Follow-up|0|||
105401369|NCT00421148|363480101|FG009|Overall Study|Lost to Follow-up|0|||
105401370|NCT00421148|363480102|FG010|Overall Study|Lost to Follow-up|0|||
105401371|NCT00421148|363480103|FG011|Overall Study|Lost to Follow-up|0|||
105401372|NCT00421148|363480104|FG012|Overall Study|Lost to Follow-up|0|||
105401373|NCT00421148|363480105|FG013|Overall Study|Lost to Follow-up|0|||
105401374|NCT00421148|363480106|FG014|Overall Study|Lost to Follow-up|0|||
105401375|NCT00421148|363480107|FG015|Overall Study|Lost to Follow-up|0|||
105401376|NCT00421148|363480108|FG016|Overall Study|Lost to Follow-up|0|||
105401377|NCT00421148|363480109|FG017|Overall Study|Lost to Follow-up|1|||
105401378|NCT00421148|363480110|FG018|Overall Study|Lost to Follow-up|0|||
105401379|NCT00421148|363480111|FG019|Overall Study|Lost to Follow-up|0|||
105401380|NCT00421148|363480092|FG000|Overall Study|Withdrawal by Subject|0|||
105401381|NCT00421148|363480093|FG001|Overall Study|Withdrawal by Subject|0|||
105401382|NCT00421148|363480094|FG002|Overall Study|Withdrawal by Subject|0|||
105401383|NCT00421148|363480095|FG003|Overall Study|Withdrawal by Subject|0|||
105401384|NCT00421148|363480096|FG004|Overall Study|Withdrawal by Subject|0|||
105401385|NCT00421148|363480097|FG005|Overall Study|Withdrawal by Subject|0|||
105401386|NCT00421148|363480098|FG006|Overall Study|Withdrawal by Subject|0|||
105401387|NCT00421148|363480099|FG007|Overall Study|Withdrawal by Subject|0|||
105401388|NCT00421148|363480100|FG008|Overall Study|Withdrawal by Subject|0|||
105401389|NCT00421148|363480101|FG009|Overall Study|Withdrawal by Subject|0|||
105401390|NCT00421148|363480102|FG010|Overall Study|Withdrawal by Subject|0|||
105401391|NCT00421148|363480103|FG011|Overall Study|Withdrawal by Subject|0|||
105401392|NCT00421148|363480104|FG012|Overall Study|Withdrawal by Subject|0|||
105401393|NCT00421148|363480105|FG013|Overall Study|Withdrawal by Subject|0|||
105401394|NCT00421148|363480106|FG014|Overall Study|Withdrawal by Subject|0|||
105401395|NCT00421148|363480107|FG015|Overall Study|Withdrawal by Subject|0|||
105401396|NCT00421148|363480108|FG016|Overall Study|Withdrawal by Subject|0|||
105401397|NCT00421148|363480109|FG017|Overall Study|Withdrawal by Subject|1|||
105401398|NCT00421148|363480110|FG018|Overall Study|Withdrawal by Subject|0|||
105401399|NCT00421148|363480111|FG019|Overall Study|Withdrawal by Subject|0|||
105401400|NCT00421148|363480092|FG000|Overall Study|Protocol Violation|0|||
105401401|NCT00421148|363480093|FG001|Overall Study|Protocol Violation|0|||
105401402|NCT00421148|363480094|FG002|Overall Study|Protocol Violation|0|||
105401403|NCT00421148|363480095|FG003|Overall Study|Protocol Violation|0|||
105401404|NCT00421148|363480096|FG004|Overall Study|Protocol Violation|0|||
105401405|NCT00421148|363480097|FG005|Overall Study|Protocol Violation|1|||
105401406|NCT00421148|363480098|FG006|Overall Study|Protocol Violation|0|||
105401407|NCT00421148|363480099|FG007|Overall Study|Protocol Violation|0|||
105401408|NCT00421148|363480100|FG008|Overall Study|Protocol Violation|0|||
105401409|NCT00421148|363480101|FG009|Overall Study|Protocol Violation|0|||
105401410|NCT00421148|363480102|FG010|Overall Study|Protocol Violation|0|||
105401411|NCT00421148|363480103|FG011|Overall Study|Protocol Violation|0|||
105401412|NCT00421148|363480104|FG012|Overall Study|Protocol Violation|0|||
105401413|NCT00421148|363480105|FG013|Overall Study|Protocol Violation|0|||
105401414|NCT00421148|363480106|FG014|Overall Study|Protocol Violation|0|||
105401415|NCT00421148|363480107|FG015|Overall Study|Protocol Violation|0|||
105401416|NCT00421148|363480108|FG016|Overall Study|Protocol Violation|0|||
105401417|NCT00421148|363480109|FG017|Overall Study|Protocol Violation|0|||
105401418|NCT00421148|363480110|FG018|Overall Study|Protocol Violation|1|||
105401419|NCT00421148|363480111|FG019|Overall Study|Protocol Violation|0|||
105401420|NCT03289533|363480112|FG000|Overall Study|Death|12|||
105401421|NCT03289533|363480112|FG000|Overall Study|Terminated from study by sponsor|10|||
105401422|NCT01030822|363480113|FG000|Overall Study|Moved/migrated from study area|6|||
105401423|NCT01030822|363480114|FG001|Overall Study|Moved/migrated from study area|7|||
105580662|NCT01474512|364126482|FG017|Induction Period|Withdrawal by Subject|0|||
105401424|NCT01030822|363480115|FG002|Overall Study|Moved/migrated from study area|3|||
105401425|NCT01030822|363480113|FG000|Overall Study|Withdrawal by Subject|16|||
105401426|NCT01030822|363480114|FG001|Overall Study|Withdrawal by Subject|13|||
105580663|NCT01474512|364126465|FG000|Induction Period|Protocol Violation|3|||
105580664|NCT01474512|364126466|FG001|Induction Period|Protocol Violation|6|||
105401427|NCT01030822|363480115|FG002|Overall Study|Withdrawal by Subject|16|||
105580665|NCT01474512|364126467|FG002|Induction Period|Protocol Violation|0|||
105401428|NCT01030822|363480113|FG000|Overall Study|Lost to Follow-up|9|||
105401429|NCT01030822|363480114|FG001|Overall Study|Lost to Follow-up|4|||
105401430|NCT01030822|363480115|FG002|Overall Study|Lost to Follow-up|7|||
105401431|NCT00363311|363480116|FG000|Overall Study|Adverse Event|6|||
105401432|NCT00363311|363480117|FG001|Overall Study|Adverse Event|4|||
105401433|NCT00363311|363480116|FG000|Overall Study|Lost to Follow-up|3|||
105401434|NCT00363311|363480117|FG001|Overall Study|Lost to Follow-up|0|||
105401435|NCT00363311|363480116|FG000|Overall Study|Protocol Violation|1|||
105401436|NCT00363311|363480117|FG001|Overall Study|Protocol Violation|2|||
105401437|NCT00363311|363480116|FG000|Overall Study|Withdrawal by Subject|12|||
105401438|NCT00363311|363480117|FG001|Overall Study|Withdrawal by Subject|6|||
105401439|NCT00363311|363480116|FG000|Overall Study|Physician Decision|1|||
105401440|NCT00363311|363480117|FG001|Overall Study|Physician Decision|1|||
105401441|NCT00363311|363480116|FG000|Overall Study|Sponsor Terminated Study|2|||
105401442|NCT00363311|363480117|FG001|Overall Study|Sponsor Terminated Study|2|||
105401443|NCT00363311|363480116|FG000|Overall Study|Disease Progression|46|||
105401444|NCT00363311|363480117|FG001|Overall Study|Disease Progression|26|||
105401445|NCT00363311|363480116|FG000|Overall Study|Non-Compliance|1|||
105401446|NCT00363311|363480117|FG001|Overall Study|Non-Compliance|1|||
105401447|NCT00363311|363480116|FG000|Overall Study|Participant Refused Biopsy|1|||
105401448|NCT00363311|363480117|FG001|Overall Study|Participant Refused Biopsy|0|||
105401449|NCT00363311|363480116|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
105401450|NCT00363311|363480117|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
105401451|NCT00363311|363480116|FG000|Overall Study|Participant Opted for Treatment|1|||
105401452|NCT00363311|363480117|FG001|Overall Study|Participant Opted for Treatment|0|||
105401453|NCT00363311|363480116|FG000|Overall Study|Participant Moved to Another Country|1|||
105401454|NCT00363311|363480117|FG001|Overall Study|Participant Moved to Another Country|0|||
105401455|NCT00363311|363480116|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
105401456|NCT00363311|363480117|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
105401457|NCT00363311|363480116|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
105401458|NCT00363311|363480117|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
105401459|NCT00363311|363480116|FG000|Overall Study|Participant Moved to Louisiana|0|||
105401460|NCT00363311|363480117|FG001|Overall Study|Participant Moved to Louisiana|1|||
105401461|NCT04068922|363480120|FG000|Overall Study|Lost to Follow-up|5|||
105401462|NCT04068922|363480120|FG000|Overall Study|Withdrawal by Subject|7|||
105401463|NCT04068922|363480120|FG000|Overall Study|Adverse Event|1|||
105401464|NCT01508910|363480121|FG000|Treatment|Death|2|||
105401465|NCT01508910|363480122|FG001|Treatment|Death|3|||
105401466|NCT01508910|363480123|FG002|Treatment|Death|2|||
105401467|NCT01508910|363480124|FG003|Treatment|Death|0|||
105401468|NCT01508910|363480121|FG000|Treatment|Lost to Follow-up|0|||
105401469|NCT01508910|363480122|FG001|Treatment|Lost to Follow-up|0|||
105401470|NCT01508910|363480123|FG002|Treatment|Lost to Follow-up|2|||
105401471|NCT01508910|363480124|FG003|Treatment|Lost to Follow-up|1|||
105401472|NCT01508910|363480121|FG000|Treatment|Withdrawal by Subject|0|||
105401473|NCT01508910|363480122|FG001|Treatment|Withdrawal by Subject|1|||
105401474|NCT01508910|363480123|FG002|Treatment|Withdrawal by Subject|6|||
105401475|NCT01508910|363480124|FG003|Treatment|Withdrawal by Subject|1|||
105401476|NCT01508910|363480121|FG000|Treatment|Sponsor Decision|0|||
105401477|NCT01508910|363480122|FG001|Treatment|Sponsor Decision|0|||
105401478|NCT01508910|363480123|FG002|Treatment|Sponsor Decision|0|||
105401479|NCT01508910|363480124|FG003|Treatment|Sponsor Decision|1|||
105401480|NCT04016714|363480125|FG000|Overall Study|Death|1|||
105401481|NCT04016714|363480126|FG001|Overall Study|Death|0|||
105401482|NCT04016714|363480125|FG000|Overall Study|Lost to Follow-up|3|||
105401483|NCT04016714|363480126|FG001|Overall Study|Lost to Follow-up|1|||
105493380|NCT02435069|363818856|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
105493381|NCT02435069|363818857|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
105493382|NCT02349542|363818858|FG000|Overall Study|Withdrawal by Subject|5|||
105493383|NCT00932737|363818861|FG000|Overall Study|Not treated in second episode|1|||
105493384|NCT00932737|363818862|FG001|Overall Study|Not treated in second episode|0|||
105493385|NCT00932737|363818861|FG000|Overall Study|Adverse Event|0|||
105493386|NCT00932737|363818862|FG001|Overall Study|Adverse Event|1|||
105493387|NCT05156073|363818863|FG000|Overall Study|Patient canceled appointment with PCP|1|||
105493388|NCT05430022|363818864|FG000|Overall Study|Withdrawal by Subject|4|||
105493389|NCT05430022|363818865|FG001|Overall Study|Withdrawal by Subject|4|||
105493390|NCT02719327|363818866|FG000|Overall Study|Withdrawal by Subject|11|||
105493391|NCT02719327|363818867|FG001|Overall Study|Withdrawal by Subject|8|||
105493392|NCT03803683|363818872|FG000|Overall Study|Lost to Follow-up|41|||
105493393|NCT03803683|363818873|FG001|Overall Study|Lost to Follow-up|18|||
105493394|NCT03803683|363818874|FG002|Overall Study|Lost to Follow-up|12|||
105401484|NCT04016714|363480125|FG000|Overall Study|Physician Decision|3|||
105493395|NCT03803683|363818872|FG000|Overall Study|Withdrawal by Subject|9|||
105493396|NCT03803683|363818873|FG001|Overall Study|Withdrawal by Subject|1|||
105401485|NCT04016714|363480126|FG001|Overall Study|Physician Decision|3|||
105401486|NCT04016714|363480125|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
105401487|NCT04016714|363480126|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
105401488|NCT01816048|363480130|FG000|Overall Study|Adverse Event|1|||
105401489|NCT01816048|363480130|FG000|Overall Study|Death|1|||
105401490|NCT01816048|363480130|FG000|Overall Study|Withdrawal by Subject|1|||
105401491|NCT01816048|363480130|FG000|Overall Study|Disease Progression|3|||
105401492|NCT01171677|363480131|FG000|Overall Study|Withdrawal by Subject|0|||
105401493|NCT01171677|363480132|FG001|Overall Study|Withdrawal by Subject|3|||
105401494|NCT01171677|363480131|FG000|Overall Study|Adverse Event|1|||
105401495|NCT01171677|363480132|FG001|Overall Study|Adverse Event|0|||
105401496|NCT01171677|363480131|FG000|Overall Study|completed <70% IntenSati classes|5|||
105401497|NCT01171677|363480132|FG001|Overall Study|completed <70% IntenSati classes|0|||
105401498|NCT03571971|363480133|FG000|Overall Study|Lost to Follow-up|2|||
105401499|NCT03571971|363480134|FG001|Overall Study|Lost to Follow-up|2|||
105401500|NCT03571971|363480133|FG000|Overall Study|Protocol Violation|2|||
105401501|NCT03571971|363480134|FG001|Overall Study|Protocol Violation|3|||
105401502|NCT03571971|363480133|FG000|Overall Study|Withdrawal by Subject|2|||
105401503|NCT03571971|363480134|FG001|Overall Study|Withdrawal by Subject|0|||
105401504|NCT03571971|363480133|FG000|Overall Study|Incomplete primary outcome data|2|||
105401505|NCT03571971|363480134|FG001|Overall Study|Incomplete primary outcome data|0|||
105401506|NCT04021290|363480136|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
105401507|NCT04021290|363480137|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
105401508|NCT04021290|363480138|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
105401509|NCT04021290|363480136|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
105401510|NCT04021290|363480137|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
105401511|NCT04021290|363480138|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
105401512|NCT04021290|363480136|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
105401513|NCT04021290|363480137|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
105401514|NCT04021290|363480138|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
105401515|NCT04021290|363480136|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
105401516|NCT04021290|363480137|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
105401517|NCT04021290|363480138|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
105401518|NCT04021290|363480136|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
105401519|NCT04021290|363480137|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
105401520|NCT04021290|363480138|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
105401521|NCT04021290|363480136|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
105401522|NCT04021290|363480137|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
105401523|NCT04021290|363480138|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
105401524|NCT04021290|363480136|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
105401525|NCT04021290|363480137|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
105401526|NCT04021290|363480138|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
105401527|NCT04021290|363480136|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
105401528|NCT04021290|363480137|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
105401529|NCT04021290|363480138|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
105401530|NCT04021290|363480136|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
105401531|NCT04021290|363480137|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
105401532|NCT04021290|363480138|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
105401533|NCT04021290|363480136|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
105401534|NCT04021290|363480137|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
105401535|NCT04021290|363480138|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
105401536|NCT04021290|363480136|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
105401537|NCT04021290|363480137|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
105401538|NCT04021290|363480138|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
105401539|NCT04021290|363480136|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
105401540|NCT04021290|363480137|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
105401541|NCT04021290|363480138|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
105401542|NCT03092479|363480141|FG000|Overall Study|Lost to Follow-up|3|||
105401543|NCT03092479|363480142|FG001|Overall Study|Lost to Follow-up|2|||
105401544|NCT03092479|363480141|FG000|Overall Study|Withdrawal by Subject|4|||
105401545|NCT03092479|363480142|FG001|Overall Study|Withdrawal by Subject|0|||
105401546|NCT04422431|363480143|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
105401547|NCT04422431|363480143|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
105401548|NCT04422431|363480143|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
105401549|NCT04422431|363480143|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
105401550|NCT04422431|363480143|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
105401551|NCT04422431|363480143|FG000|Extension Period (48 Weeks)|Other than specified|2|||
105401552|NCT00543985|363480144|FG000|Overall Study|Withdrawal by Subject|4|||
105401553|NCT01074931|363480145|FG000|Overall Study|Economic reasons|1|||
105401554|NCT01074931|363480145|FG000|Overall Study|Death|5|||
105401555|NCT03132467|363480146|FG000|Overall Study|Adverse Event|2|||
105401556|NCT03132467|363480146|FG000|Overall Study|Withdrawal by Subject|2|||
105401557|NCT05223673|363480148|FG000|Overall Study|Protocol Violation|1|||
105401558|NCT05223673|363480148|FG000|Overall Study|Study termination|6|||
105401559|NCT00457626|363480149|FG000|Overall Study|Adverse Event|3|||
105401560|NCT00457626|363480149|FG000|Overall Study|Administrative Problems|2|||
105401561|NCT00457626|363480149|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
105401562|NCT03384875|363480150|FG000|Overall Study|Death|1|||
105401563|NCT03384875|363480151|FG001|Overall Study|Death|1|||
105401564|NCT03384875|363480152|FG002|Overall Study|Death|0|||
105401565|NCT03384875|363480150|FG000|Overall Study|Reason not provided|1|||
105401566|NCT03384875|363480151|FG001|Overall Study|Reason not provided|0|||
105401567|NCT03384875|363480152|FG002|Overall Study|Reason not provided|0|||
105401568|NCT01492426|363481566|FG000|Treatment|Death|0|||
105401569|NCT01492426|363481567|FG001|Treatment|Death|1|||
105401570|NCT01492426|363481566|FG000|Treatment|Other|1|||
105401571|NCT01492426|363481567|FG001|Treatment|Other|0|||
105401572|NCT01492426|363481566|FG000|Treatment|Adverse Event|25|||
105401573|NCT01492426|363481567|FG001|Treatment|Adverse Event|25|||
105401574|NCT01492426|363481566|FG000|Treatment|Lack of Efficacy|38|||
105401575|NCT01492426|363481567|FG001|Treatment|Lack of Efficacy|5|||
105401576|NCT01492426|363481566|FG000|Treatment|Participant withdrew consent|1|||
105401577|NCT01492426|363481567|FG001|Treatment|Participant withdrew consent|2|||
105401578|NCT01492426|363481566|FG000|Treatment|Poor compliance/noncompliance|1|||
105401579|NCT01492426|363481567|FG001|Treatment|Poor compliance/noncompliance|0|||
105401580|NCT01492426|363481566|FG000|Treatment|Subject requested discontinue study drug|7|||
105401581|NCT01492426|363481567|FG001|Treatment|Subject requested discontinue study drug|3|||
105401582|NCT01492426|363481566|FG000|Treatment|Lost to Follow-up|9|||
105401583|NCT01492426|363481567|FG001|Treatment|Lost to Follow-up|4|||
105401584|NCT01492426|363481566|FG000|Treatment|Participant does not meet study criteria|1|||
105401585|NCT01492426|363481567|FG001|Treatment|Participant does not meet study criteria|0|||
105401586|NCT01492426|363481566|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
105401587|NCT01492426|363481567|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
105401588|NCT01492426|363481566|FG000|Follow-Up|Death|1|||
105401589|NCT01492426|363481567|FG001|Follow-Up|Death|0|||
105401590|NCT01492426|363481566|FG000|Follow-Up|Other|4|||
105401591|NCT01492426|363481567|FG001|Follow-Up|Other|2|||
105401592|NCT01492426|363481566|FG000|Follow-Up|Participant Withdrew Consent|6|||
105401593|NCT01492426|363481567|FG001|Follow-Up|Participant Withdrew Consent|1|||
105401594|NCT01492426|363481566|FG000|Follow-Up|Lost to Follow-up|12|||
105401595|NCT01492426|363481567|FG001|Follow-Up|Lost to Follow-up|6|||
105401596|NCT00322049|363481568|FG000|Overall Study|Moved out of area|0|||
105401597|NCT00322049|363481569|FG001|Overall Study|Moved out of area|0|||
105401598|NCT00322049|363481570|FG002|Overall Study|Moved out of area|0|||
105401599|NCT00322049|363481571|FG003|Overall Study|Moved out of area|1|||
105401600|NCT00322049|363481568|FG000|Overall Study|Infected with Dengue during study|0|||
105401601|NCT00322049|363481569|FG001|Overall Study|Infected with Dengue during study|1|||
105401602|NCT00322049|363481570|FG002|Overall Study|Infected with Dengue during study|0|||
105401603|NCT00322049|363481571|FG003|Overall Study|Infected with Dengue during study|0|||
105401604|NCT03247829|363481578|FG000|Overall Study|Death|3|||
105401605|NCT03247829|363481579|FG001|Overall Study|Death|4|||
105401606|NCT03247829|363481578|FG000|Overall Study|Enter Hospice Care|1|||
105401607|NCT03247829|363481579|FG001|Overall Study|Enter Hospice Care|0|||
105401608|NCT03247829|363481578|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
105401609|NCT03247829|363481579|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
105401610|NCT03247829|363481578|FG000|Overall Study|LVAD Explant|1|||
105401611|NCT03247829|363481579|FG001|Overall Study|LVAD Explant|1|||
105401612|NCT03247829|363481578|FG000|Overall Study|Transplant|1|||
105401613|NCT03247829|363481579|FG001|Overall Study|Transplant|1|||
105401614|NCT01783444|363481580|FG000|Treatment Phase|Adverse Event|9|||
105401615|NCT01783444|363481581|FG001|Treatment Phase|Adverse Event|20|||
105401616|NCT01783444|363481582|FG002|Treatment Phase|Adverse Event|19|||
105401617|NCT01783444|363481580|FG000|Treatment Phase|Disease Progression|76|||
105401618|NCT01783444|363481581|FG001|Treatment Phase|Disease Progression|66|||
105401619|NCT01783444|363481582|FG002|Treatment Phase|Disease Progression|64|||
105401620|NCT01783444|363481580|FG000|Treatment Phase|Death|2|||
105401621|NCT01783444|363481581|FG001|Treatment Phase|Death|2|||
105401622|NCT01783444|363481582|FG002|Treatment Phase|Death|2|||
105401623|NCT01783444|363481580|FG000|Treatment Phase|Protocol Violation|1|||
105401624|NCT01783444|363481581|FG001|Treatment Phase|Protocol Violation|1|||
105401625|NCT01783444|363481582|FG002|Treatment Phase|Protocol Violation|2|||
105580666|NCT01474512|364126468|FG003|Induction Period|Protocol Violation|0|||
105401626|NCT01783444|363481580|FG000|Treatment Phase|Withdrawal by Subject|6|||
105401627|NCT01783444|363481581|FG001|Treatment Phase|Withdrawal by Subject|8|||
105401628|NCT01783444|363481582|FG002|Treatment Phase|Withdrawal by Subject|9|||
105401629|NCT01783444|363481580|FG000|Treatment Phase|Administrative problems|2|||
105401630|NCT01783444|363481581|FG001|Treatment Phase|Administrative problems|0|||
105401631|NCT01783444|363481582|FG002|Treatment Phase|Administrative problems|1|||
105580667|NCT01474512|364126469|FG004|Induction Period|Protocol Violation|0|||
105401632|NCT01783444|363481580|FG000|Treatment Phase|Physician Decision|8|||
105401633|NCT01783444|363481581|FG001|Treatment Phase|Physician Decision|6|||
105401634|NCT01783444|363481582|FG002|Treatment Phase|Physician Decision|5|||
105401635|NCT01783444|363481580|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
105401636|NCT01783444|363481581|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
105401637|NCT01783444|363481582|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
105401638|NCT01783444|363481580|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
105401639|NCT01783444|363481581|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
105401640|NCT01783444|363481582|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
105401641|NCT01783444|363481580|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
105401642|NCT01783444|363481581|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
105401643|NCT01783444|363481582|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
105401644|NCT01783444|363481580|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
105401645|NCT01783444|363481581|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
105401646|NCT01783444|363481582|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
105401647|NCT01783444|363481580|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
105493397|NCT03803683|363818874|FG002|Overall Study|Withdrawal by Subject|4|||
105493398|NCT00107783|363820649|FG000|Overall Study|Adverse Event|0|||
105493399|NCT00107783|363820650|FG001|Overall Study|Adverse Event|2|||
105493400|NCT00107783|363820649|FG000|Overall Study|Death|0|||
105493401|NCT00107783|363820650|FG001|Overall Study|Death|1|||
105493402|NCT00107783|363820649|FG000|Overall Study|Withdrawal by Subject|2|||
105493403|NCT00107783|363820650|FG001|Overall Study|Withdrawal by Subject|0|||
105493404|NCT00107783|363820649|FG000|Overall Study|Second hip replacement|1|||
105493405|NCT00107783|363820650|FG001|Overall Study|Second hip replacement|1|||
105493406|NCT04879225|363820651|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
105493407|NCT04879225|363820651|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
105493408|NCT02367131|363820654|FG000|Overall Study|Adverse Event|64|||
105493409|NCT02367131|363820654|FG000|Overall Study|No visit since the first visit|3|||
105493410|NCT02367131|363820654|FG000|Overall Study|Request by patient|53|||
105493411|NCT02367131|363820654|FG000|Overall Study|Improvement/remission|2|||
105493412|NCT02367131|363820654|FG000|Overall Study|No change/progressive disease|78|||
105493413|NCT02367131|363820654|FG000|Overall Study|Other than stated above|20|||
105493414|NCT02367131|363820654|FG000|Overall Study|Not treated|2|||
105493415|NCT02360995|363820658|FG000|Overall Study|Lost to Follow-up|2|||
105493416|NCT02360995|363820659|FG001|Overall Study|Lost to Follow-up|0|||
105493417|NCT02360995|363820660|FG002|Overall Study|Lost to Follow-up|2|||
105493418|NCT02360995|363820658|FG000|Overall Study|Withdrawal by Subject|0|||
105493419|NCT02360995|363820659|FG001|Overall Study|Withdrawal by Subject|1|||
105493420|NCT02360995|363820660|FG002|Overall Study|Withdrawal by Subject|0|||
105493421|NCT00810108|363820661|FG000|Overall Study|Withdrawal by Subject|1|||
105493422|NCT00810108|363820662|FG001|Overall Study|Withdrawal by Subject|0|||
105493423|NCT00137631|363820665|FG000|Overall Study|Lost to Follow-up|37|||
105493424|NCT00137631|363820666|FG001|Overall Study|Lost to Follow-up|41|||
105493425|NCT02611960|363820667|FG000|Overall Study|Adverse Event|7|||
105493426|NCT02611960|363820668|FG001|Overall Study|Adverse Event|8|||
105493427|NCT02611960|363820667|FG000|Overall Study|Death|98|||
105493428|NCT02611960|363820668|FG001|Overall Study|Death|92|||
105493429|NCT02611960|363820667|FG000|Overall Study|Withdrawal by Subject|1|||
105493430|NCT02611960|363820668|FG001|Overall Study|Withdrawal by Subject|5|||
105493431|NCT02611960|363820667|FG000|Overall Study|Sponsor Decision|11|||
105493432|NCT02611960|363820668|FG001|Overall Study|Sponsor Decision|11|||
105493433|NCT01409434|363820681|FG000|Overall Study|Protocol Violation|4|||
105493434|NCT02436304|363820684|FG000|Overall Study|Lost to Follow-up|0|||
105493435|NCT02436304|363820685|FG001|Overall Study|Lost to Follow-up|1|||
105493436|NCT02436304|363820686|FG002|Overall Study|Lost to Follow-up|0|||
105493437|NCT02436304|363820684|FG000|Overall Study|Withdrawal by Subject|0|||
105493438|NCT02436304|363820685|FG001|Overall Study|Withdrawal by Subject|1|||
105493439|NCT02436304|363820686|FG002|Overall Study|Withdrawal by Subject|0|||
105493440|NCT02436304|363820684|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
105493441|NCT02436304|363820685|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
105493442|NCT02436304|363820686|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
105493443|NCT01229371|363820687|FG000|Overall Study|Withdrawal by Subject|0|||
105493444|NCT01229371|363820688|FG001|Overall Study|Withdrawal by Subject|1|||
105493445|NCT01229371|363820689|FG002|Overall Study|Withdrawal by Subject|0|||
105493446|NCT01229371|363820690|FG003|Overall Study|Withdrawal by Subject|0|||
105401648|NCT01783444|363481581|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
105493447|NCT04073368|363820691|FG000|Overall Study|Adverse Event|2|||
105493448|NCT04073368|363820692|FG001|Overall Study|Adverse Event|0|||
105493449|NCT04073368|363820693|FG002|Overall Study|Adverse Event|1|||
105493450|NCT04073368|363820694|FG003|Overall Study|Adverse Event|1|||
105493451|NCT04073368|363820691|FG000|Overall Study|Withdrawal by Subject|2|||
105493452|NCT04073368|363820692|FG001|Overall Study|Withdrawal by Subject|2|||
105493453|NCT04073368|363820693|FG002|Overall Study|Withdrawal by Subject|1|||
105493454|NCT04073368|363820694|FG003|Overall Study|Withdrawal by Subject|1|||
105493455|NCT04073368|363820691|FG000|Overall Study|Lost to Follow-up|1|||
105493456|NCT04073368|363820692|FG001|Overall Study|Lost to Follow-up|1|||
105493457|NCT04073368|363820693|FG002|Overall Study|Lost to Follow-up|1|||
105493458|NCT04073368|363820694|FG003|Overall Study|Lost to Follow-up|0|||
105493459|NCT04073368|363820691|FG000|Overall Study|Protocol Violation|0|||
105493460|NCT04073368|363820692|FG001|Overall Study|Protocol Violation|1|||
105493461|NCT04073368|363820693|FG002|Overall Study|Protocol Violation|0|||
105493462|NCT04073368|363820694|FG003|Overall Study|Protocol Violation|0|||
105401649|NCT01783444|363481582|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
105401650|NCT01783444|363481580|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
105401651|NCT01783444|363481581|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
105401652|NCT01783444|363481582|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
105401653|NCT05111145|363481583|FG000|Overall Study|Commercial drug is available for participant|76|||
105401654|NCT05111145|363481583|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
105401655|NCT00441272|363481584|FG000|Overall Study|Study terminated prior to enrollment|25|||
105401656|NCT00441272|363481585|FG001|Overall Study|Study terminated prior to enrollment|25|||
105401657|NCT01856322|363481586|FG000|Overall Study|off study due to lack of accrual|0|||
105401658|NCT01856322|363481587|FG001|Overall Study|off study due to lack of accrual|0|||
105401659|NCT01856322|363481588|FG002|Overall Study|off study due to lack of accrual|3|||
105401660|NCT00427011|363481589|FG000|Overall Study|Adverse Event|10|||
105401661|NCT00427011|363481589|FG000|Overall Study|Withdrawal by Subject|1|||
105401662|NCT00427011|363481589|FG000|Overall Study|Lack of Efficacy|2|||
105401663|NCT00427011|363481589|FG000|Overall Study|Other|12|||
105401664|NCT00954447|363481591|FG000|Overall Study|Adverse Event|33|||
105401665|NCT00954447|363481592|FG001|Overall Study|Adverse Event|25|||
105401666|NCT00954447|363481591|FG000|Overall Study|Lack of Efficacy|17|||
105401667|NCT00954447|363481592|FG001|Overall Study|Lack of Efficacy|3|||
105401668|NCT00954447|363481591|FG000|Overall Study|Protocol Violation|5|||
105401669|NCT00954447|363481592|FG001|Overall Study|Protocol Violation|7|||
105401670|NCT00954447|363481591|FG000|Overall Study|Lost to Follow-up|8|||
105401671|NCT00954447|363481592|FG001|Overall Study|Lost to Follow-up|14|||
105401672|NCT00954447|363481591|FG000|Overall Study|Withdrawal by Subject|26|||
105401673|NCT00954447|363481592|FG001|Overall Study|Withdrawal by Subject|21|||
105401674|NCT00954447|363481591|FG000|Overall Study|Other|21|||
105401675|NCT00954447|363481592|FG001|Overall Study|Other|18|||
105401676|NCT04592341|363481593|FG000|Overall Study|Physician Decision|5|||
105401677|NCT04592341|363481593|FG000|Overall Study|Study Terminated by Sponsor|5|||
105401678|NCT04592341|363481593|FG000|Overall Study|Withdrawal by Subject|53|||
105401679|NCT04592341|363481593|FG000|Overall Study|Lost to Follow-up|3|||
105401680|NCT04592341|363481593|FG000|Overall Study|Death|1|||
105401681|NCT04592341|363481593|FG000|Overall Study|Adverse Event|5|||
105580668|NCT01474512|364126470|FG005|Induction Period|Protocol Violation|0|||
105580669|NCT01474512|364126471|FG006|Induction Period|Protocol Violation|0|||
105580670|NCT01474512|364126472|FG007|Induction Period|Protocol Violation|0|||
105580671|NCT01474512|364126473|FG008|Induction Period|Protocol Violation|0|||
105401682|NCT04592341|363481593|FG000|Overall Study|other|4|||
105401683|NCT03759600|363481594|FG000|Overall Study|Adverse Event|2|||
105401684|NCT03759600|363481594|FG000|Overall Study|Progressive Disease|15|||
105401685|NCT03759600|363481594|FG000|Overall Study|Site Terminated by Sponsor|3|||
105401686|NCT05173974|363481595|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
105401687|NCT05173974|363481596|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
105401688|NCT05173974|363481597|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
105401689|NCT05173974|363481598|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
105401690|NCT05173974|363481595|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
105401691|NCT05173974|363481596|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
105401692|NCT05173974|363481597|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
105401693|NCT05173974|363481598|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
105401694|NCT00948688|363481599|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
105401695|NCT00948688|363481600|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
105401696|NCT00948688|363481599|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
105401697|NCT00948688|363481600|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
105401698|NCT00948688|363481599|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
105401699|NCT00948688|363481600|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
105401700|NCT01977898|363481603|FG000|Overall Study|Non functioning catheter|1|||
105401701|NCT01977898|363481604|FG001|Overall Study|Non functioning catheter|1|||
105401702|NCT01466491|363481605|FG000|Overall Study|Protocol Violation|0|||
105401703|NCT01466491|363481606|FG001|Overall Study|Protocol Violation|3|||
105401704|NCT01466491|363481607|FG002|Overall Study|Protocol Violation|2|||
105401705|NCT01466491|363481608|FG003|Overall Study|Protocol Violation|0|||
105401706|NCT01466491|363481605|FG000|Overall Study|Missing Data|0|||
105401707|NCT01466491|363481606|FG001|Overall Study|Missing Data|0|||
105401708|NCT01466491|363481607|FG002|Overall Study|Missing Data|1|||
105401709|NCT01466491|363481608|FG003|Overall Study|Missing Data|0|||
105401710|NCT00339040|363481609|FG000|Stage I|Not able to attend clinic|1|||
105401711|NCT00339040|363481610|FG001|Stage I|Not able to attend clinic|0|||
105401712|NCT00339040|363481609|FG000|Stage I|Protocol Violation|1|||
105401713|NCT00339040|363481610|FG001|Stage I|Protocol Violation|1|||
105401714|NCT00339040|363481609|FG000|Stage II|Lost to Follow-up|3|||
105580672|NCT01474512|364126474|FG009|Induction Period|Protocol Violation|0|||
105401715|NCT00339040|363481610|FG001|Stage II|Lost to Follow-up|0|||
105401716|NCT00339040|363481609|FG000|Stage II|Withdrawal by Subject|1|||
105401717|NCT00339040|363481610|FG001|Stage II|Withdrawal by Subject|2|||
105401718|NCT00339040|363481609|FG000|Stage II|Protocol Violation|3|||
105401719|NCT00339040|363481610|FG001|Stage II|Protocol Violation|0|||
105401720|NCT00339040|363481609|FG000|Stage II|Not able to attend clinic|1|||
105401721|NCT00339040|363481610|FG001|Stage II|Not able to attend clinic|0|||
105401722|NCT00339040|363481609|FG000|Stage II|Site closing|2|||
105401723|NCT00339040|363481610|FG001|Stage II|Site closing|0|||
105401724|NCT03341637|363481611|FG000|Overall Study|Lost to Follow-up|1|||
105401725|NCT03341637|363481612|FG001|Overall Study|Lost to Follow-up|0|||
105401726|NCT03341637|363481611|FG000|Overall Study|Withdrawal by Subject|3|||
105401727|NCT03341637|363481612|FG001|Overall Study|Withdrawal by Subject|3|||
105401728|NCT03341637|363481611|FG000|Overall Study|Reason not Specified|1|||
105401729|NCT03341637|363481612|FG001|Overall Study|Reason not Specified|1|||
105401730|NCT01146613|363481613|FG000|Overall Study|Lost to Follow-up|3|||
105401731|NCT01146613|363481614|FG001|Overall Study|Lost to Follow-up|8|||
105401732|NCT01146613|363481613|FG000|Overall Study|Lack of Efficacy|0|||
105401733|NCT01146613|363481614|FG001|Overall Study|Lack of Efficacy|1|||
105401734|NCT01146613|363481613|FG000|Overall Study|Death|1|||
105401735|NCT01146613|363481614|FG001|Overall Study|Death|0|||
105401736|NCT01146613|363481613|FG000|Overall Study|Physician Decision|1|||
105401737|NCT01146613|363481614|FG001|Overall Study|Physician Decision|0|||
105401738|NCT01146613|363481613|FG000|Overall Study|Withdrawal by Subject|0|||
105401739|NCT01146613|363481614|FG001|Overall Study|Withdrawal by Subject|3|||
105401740|NCT01146613|363481613|FG000|Overall Study|schedule conflict|1|||
105401741|NCT01146613|363481614|FG001|Overall Study|schedule conflict|0|||
105401742|NCT01146613|363481613|FG000|Overall Study|Outpatient detox|1|||
105401743|NCT01146613|363481614|FG001|Overall Study|Outpatient detox|0|||
105401744|NCT00325143|363481615|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
105401745|NCT00325143|363481615|FG000|Overall Study|Migrated/moved from study area|1|||
105401746|NCT00325143|363481615|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
105401747|NCT00325143|363481615|FG000|Overall Study|Withdrawal by Subject|8|||
105401748|NCT03036852|363481616|FG000|Overall Study|Death|2|||
105401749|NCT03036852|363481616|FG000|Overall Study|Lack of Efficacy|2|||
105401750|NCT03036852|363481616|FG000|Overall Study|Adverse Event|1|||
105401751|NCT03036852|363481616|FG000|Overall Study|Lost to Follow-up|1|||
105401752|NCT00742625|363481617|FG000|Remission Induction|Progression|6|||
105401753|NCT00742625|363481617|FG000|Remission Induction|Failed induction|8|||
105401754|NCT00742625|363481617|FG000|Remission Induction|Adverse Event|3|||
105401755|NCT00742625|363481617|FG000|Remission Induction|Death|10|||
105401756|NCT00742625|363481617|FG000|Remission Induction|Refusal|5|||
105401757|NCT00742625|363481617|FG000|Remission Induction|Non protocol treatment|17|||
105401758|NCT00742625|363481617|FG000|Remission Induction|Other, not specified|5|||
105401759|NCT00742625|363481617|FG000|Consolidation|Progression|5|||
105401760|NCT00742625|363481617|FG000|Consolidation|Adverse Event|1|||
105401761|NCT00742625|363481617|FG000|Consolidation|Death|1|||
105401762|NCT00742625|363481617|FG000|Consolidation|Refused|1|||
105401763|NCT00742625|363481617|FG000|Consolidation|Non protocol therapy|13|||
105401764|NCT02897115|363481618|FG000|Overall Study|Early termination of study by sponsor|11|||
105401765|NCT02897115|363481619|FG001|Overall Study|Early termination of study by sponsor|8|||
105401766|NCT03848416|363481620|FG000|Overall Study|Withdrawal by Subject|1|||
105401767|NCT03848416|363481621|FG001|Overall Study|Withdrawal by Subject|0|||
105401768|NCT03848416|363481622|FG002|Overall Study|Withdrawal by Subject|0|||
105401769|NCT03848416|363481620|FG000|Overall Study|Death|0|||
105401770|NCT03848416|363481621|FG001|Overall Study|Death|0|||
105401771|NCT03848416|363481622|FG002|Overall Study|Death|1|||
105493463|NCT04073368|363820691|FG000|Overall Study|Subject noncompliance|7|||
105493464|NCT04073368|363820692|FG001|Overall Study|Subject noncompliance|4|||
105493465|NCT04073368|363820693|FG002|Overall Study|Subject noncompliance|0|||
105493466|NCT04073368|363820694|FG003|Overall Study|Subject noncompliance|0|||
105493467|NCT00761579|363820695|FG000|Overall Study|Adverse Event|10|||
105493468|NCT00761579|363820695|FG000|Overall Study|Death|2|||
105401772|NCT01908140|363481623|FG000|Overall Study|Other or Progressive Disease|5|||
105401773|NCT01908140|363481624|FG001|Overall Study|Other or Progressive Disease|12|||
105401774|NCT01908140|363481623|FG000|Overall Study|Lack of Efficacy|7|||
105401775|NCT01908140|363481624|FG001|Overall Study|Lack of Efficacy|5|||
105401776|NCT01908140|363481623|FG000|Overall Study|Withdrawal by Subject|23|||
105401777|NCT01908140|363481624|FG001|Overall Study|Withdrawal by Subject|24|||
105401778|NCT01908140|363481623|FG000|Overall Study|Lost to Follow-up|1|||
105401779|NCT01908140|363481624|FG001|Overall Study|Lost to Follow-up|6|||
105401780|NCT01908140|363481623|FG000|Overall Study|Protocol Violation|8|||
105401781|NCT01908140|363481624|FG001|Overall Study|Protocol Violation|9|||
105401782|NCT01908140|363481623|FG000|Overall Study|Adverse Event|22|||
105401783|NCT01908140|363481624|FG001|Overall Study|Adverse Event|23|||
105401784|NCT03273907|363481626|FG000|Overall Study|Death|1|||
105401785|NCT03273907|363481626|FG000|Overall Study|Lost to Follow-up|4|||
105401786|NCT03273907|363481626|FG000|Overall Study|Withdrawal by Subject|2|||
105401787|NCT03273907|363481626|FG000|Overall Study|COVID 19|2|||
105401788|NCT03886493|363481628|FG000|Overall Study|Adverse Event|1|||
105401789|NCT01023217|363481630|FG000|Overall Study|Withdrawal by Subject|1|||
105401790|NCT01023217|363481631|FG001|Overall Study|Withdrawal by Subject|0|||
105401791|NCT00589797|363481632|FG000|Overall Study|Death|1|||
105401792|NCT00589797|363481633|FG001|Overall Study|Death|0|||
105401793|NCT00589797|363481632|FG000|Overall Study|Lost to Follow-up|12|||
105401794|NCT00589797|363481633|FG001|Overall Study|Lost to Follow-up|9|||
105401795|NCT00589797|363481632|FG000|Overall Study|Physician Decision|8|||
105401796|NCT00589797|363481633|FG001|Overall Study|Physician Decision|3|||
105401797|NCT00589797|363481632|FG000|Overall Study|Withdrawal by Subject|6|||
105401798|NCT00589797|363481633|FG001|Overall Study|Withdrawal by Subject|5|||
105401799|NCT00589797|363481632|FG000|Overall Study|Non-Randomized Training Subjects|46|||
105401800|NCT00589797|363481633|FG001|Overall Study|Non-Randomized Training Subjects|6|||
105401801|NCT00658541|363481634|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
105401802|NCT00658541|363481635|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105401803|NCT00658541|363481634|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
105401804|NCT00658541|363481635|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105401805|NCT05518461|363481636|FG000|Overall Study|Lost to Follow-up|25|||
105401806|NCT03326063|363481639|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
105401807|NCT03326063|363481640|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
105401808|NCT00501644|363481641|FG000|Overall Study|Adverse Event|4|||
105401809|NCT00501644|363481641|FG000|Overall Study|Withdrawal by Subject|1|||
105401810|NCT04577781|363481642|FG000|Overall Study|Adverse Event|2|||
105401811|NCT04577781|363481643|FG001|Overall Study|Adverse Event|2|||
105401812|NCT04577781|363481642|FG000|Overall Study|Physician Decision|1|||
105401813|NCT04577781|363481643|FG001|Overall Study|Physician Decision|0|||
105401814|NCT02343302|363481644|FG000|Overall Study|Physician Decision|1|||
105401815|NCT02343302|363481645|FG001|Overall Study|Physician Decision|1|||
105401816|NCT00508482|363481646|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
105401817|NCT00508482|363481647|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
105401818|NCT00508482|363481648|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
105401819|NCT00508482|363481646|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
105401820|NCT00508482|363481647|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
105401821|NCT00508482|363481648|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
105401822|NCT00508482|363481646|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
105401823|NCT00508482|363481647|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
105401824|NCT00508482|363481648|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
105401825|NCT02289469|363481649|FG000|Overall Study|Unable to match a control|6|||
105401826|NCT02289469|363481650|FG001|Overall Study|Unable to match a control|0|||
105401827|NCT02834819|363481651|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
105401828|NCT02834819|363481652|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
105401829|NCT01904721|363481654|FG000|Overall Study|Other Reasons|0|||
105401830|NCT01904721|363481655|FG001|Overall Study|Other Reasons|0|||
105401831|NCT01904721|363481656|FG002|Overall Study|Other Reasons|1|||
105401832|NCT01904721|363481657|FG003|Overall Study|Other Reasons|1|||
105401833|NCT01904721|363481658|FG004|Overall Study|Other Reasons|2|||
105401834|NCT01904721|363481659|FG005|Overall Study|Other Reasons|2|||
105401835|NCT01904721|363481660|FG006|Overall Study|Other Reasons|2|||
105401836|NCT01904721|363481654|FG000|Overall Study|Personal Reasons|0|||
105401837|NCT01904721|363481655|FG001|Overall Study|Personal Reasons|0|||
105401838|NCT01904721|363481656|FG002|Overall Study|Personal Reasons|0|||
105401839|NCT01904721|363481657|FG003|Overall Study|Personal Reasons|0|||
105401840|NCT01904721|363481658|FG004|Overall Study|Personal Reasons|2|||
105401841|NCT01904721|363481659|FG005|Overall Study|Personal Reasons|3|||
105401842|NCT01904721|363481660|FG006|Overall Study|Personal Reasons|3|||
105401843|NCT01904721|363481654|FG000|Overall Study|Lost to Follow-up|0|||
105401844|NCT01904721|363481655|FG001|Overall Study|Lost to Follow-up|0|||
105401845|NCT01904721|363481656|FG002|Overall Study|Lost to Follow-up|0|||
105401846|NCT01904721|363481657|FG003|Overall Study|Lost to Follow-up|0|||
105401847|NCT01904721|363481658|FG004|Overall Study|Lost to Follow-up|1|||
105401848|NCT01904721|363481659|FG005|Overall Study|Lost to Follow-up|3|||
105401849|NCT01904721|363481660|FG006|Overall Study|Lost to Follow-up|1|||
105401850|NCT01904721|363481654|FG000|Overall Study|Lack of Efficacy|0|||
105401851|NCT01904721|363481655|FG001|Overall Study|Lack of Efficacy|0|||
105401852|NCT01904721|363481656|FG002|Overall Study|Lack of Efficacy|0|||
105401853|NCT01904721|363481657|FG003|Overall Study|Lack of Efficacy|0|||
105401854|NCT01904721|363481658|FG004|Overall Study|Lack of Efficacy|0|||
105401855|NCT01904721|363481659|FG005|Overall Study|Lack of Efficacy|0|||
105401856|NCT01904721|363481660|FG006|Overall Study|Lack of Efficacy|1|||
105401857|NCT01904721|363481654|FG000|Overall Study|Adverse Event|0|||
105401858|NCT01904721|363481655|FG001|Overall Study|Adverse Event|0|||
105401859|NCT01904721|363481656|FG002|Overall Study|Adverse Event|0|||
105401860|NCT01904721|363481657|FG003|Overall Study|Adverse Event|0|||
105401861|NCT01904721|363481658|FG004|Overall Study|Adverse Event|3|||
105401862|NCT01904721|363481659|FG005|Overall Study|Adverse Event|1|||
105401863|NCT01904721|363481660|FG006|Overall Study|Adverse Event|0|||
105401864|NCT01957865|363481661|FG000|Overall Study|Found HIV negative|0|||
105401865|NCT01957865|363481662|FG001|Overall Study|Found HIV negative|0|||
105401866|NCT01957865|363481663|FG002|Overall Study|Found HIV negative|1|||
105401867|NCT01957865|363481661|FG000|Overall Study|Lost to Follow-up|0|||
105401868|NCT01957865|363481662|FG001|Overall Study|Lost to Follow-up|2|||
105401869|NCT01957865|363481663|FG002|Overall Study|Lost to Follow-up|2|||
105401870|NCT01077063|363481664|FG000|Overall Study|Adverse Event|3|||
105401871|NCT01077063|363481665|FG001|Overall Study|Adverse Event|0|||
105401872|NCT01077063|363481664|FG000|Overall Study|Death|1|||
105401873|NCT01077063|363481665|FG001|Overall Study|Death|1|||
105401874|NCT01077063|363481664|FG000|Overall Study|Withdrawal by Subject|0|||
105401875|NCT01077063|363481665|FG001|Overall Study|Withdrawal by Subject|2|||
105401876|NCT02750930|363481666|FG000|Overall Study|Study closed/terminated|8|||
105401877|NCT00553631|363481667|FG000|Overall Study|Withdrawal by Subject|0|||
105401878|NCT00553631|363481668|FG001|Overall Study|Withdrawal by Subject|1|||
105401879|NCT00553631|363481667|FG000|Overall Study|Lost to Follow-up|1|||
105401880|NCT00553631|363481668|FG001|Overall Study|Lost to Follow-up|0|||
105401881|NCT00469833|363481671|FG000|Overall Study|No IV access|2|||
105401882|NCT01932788|363481674|FG000|Overall Study|Protocol Violation|18|||
105401883|NCT01932788|363481675|FG001|Overall Study|Protocol Violation|0|||
105401884|NCT01932788|363481674|FG000|Overall Study|Lost to Follow-up|18|||
105401885|NCT01932788|363481675|FG001|Overall Study|Lost to Follow-up|46|||
105401886|NCT01932788|363481674|FG000|Overall Study|Lack of Efficacy|2|||
105401887|NCT01932788|363481675|FG001|Overall Study|Lack of Efficacy|0|||
105401888|NCT01932788|363481674|FG000|Overall Study|Withdrawal by Subject|0|||
105401889|NCT01932788|363481675|FG001|Overall Study|Withdrawal by Subject|5|||
105401890|NCT01816984|363481683|FG000|Overall Study|declining health status|1|||
105401891|NCT02806414|363481684|FG000|Overall Study|Lost to Follow-up|2|||
105401892|NCT00636181|363481687|FG000|Overall Study|Withdrawal by Subject|8|||
105401893|NCT00636181|363481688|FG001|Overall Study|Withdrawal by Subject|6|||
105401894|NCT00636181|363481689|FG002|Overall Study|Withdrawal by Subject|10|||
105401895|NCT01928433|363481694|FG000|Overall Study|Adverse Event|5|||
105401896|NCT01928433|363481695|FG001|Overall Study|Adverse Event|2|||
105401897|NCT01928433|363481696|FG002|Overall Study|Adverse Event|5|||
105401898|NCT01928433|363481694|FG000|Overall Study|Protocol Violation|0|||
105401899|NCT01928433|363481695|FG001|Overall Study|Protocol Violation|0|||
105401900|NCT01928433|363481696|FG002|Overall Study|Protocol Violation|2|||
105401901|NCT01928433|363481694|FG000|Overall Study|Lack of Efficacy|5|||
105401902|NCT01928433|363481695|FG001|Overall Study|Lack of Efficacy|4|||
105401903|NCT01928433|363481696|FG002|Overall Study|Lack of Efficacy|4|||
105401904|NCT01928433|363481694|FG000|Overall Study|Withdrawal by Subject|0|||
105401905|NCT01928433|363481695|FG001|Overall Study|Withdrawal by Subject|4|||
105401906|NCT01928433|363481696|FG002|Overall Study|Withdrawal by Subject|0|||
105401907|NCT01928433|363481694|FG000|Overall Study|Negative screening urine culture|7|||
105401908|NCT01928433|363481695|FG001|Overall Study|Negative screening urine culture|6|||
105401909|NCT01928433|363481696|FG002|Overall Study|Negative screening urine culture|10|||
105401910|NCT01928433|363481694|FG000|Overall Study|Lost to Follow-up|0|||
105401911|NCT01928433|363481695|FG001|Overall Study|Lost to Follow-up|2|||
105401912|NCT01928433|363481696|FG002|Overall Study|Lost to Follow-up|3|||
105401913|NCT01928433|363481694|FG000|Overall Study|Other reasons|3|||
105401914|NCT01928433|363481695|FG001|Overall Study|Other reasons|3|||
105401915|NCT01928433|363481696|FG002|Overall Study|Other reasons|4|||
105401916|NCT02670473|363481697|FG000|Overall Study|Withdrawal by Subject|1|||
105401917|NCT01673126|363481698|FG000|Overall Study|change of diagnosis|4|||
105401918|NCT01673126|363481699|FG001|Overall Study|change of diagnosis|3|||
105401919|NCT00237042|363481700|FG000|Treatment|Became ineligible post-randomization|0|||
105401920|NCT00237042|363481701|FG001|Treatment|Became ineligible post-randomization|1|||
105401921|NCT00237042|363481702|FG002|Treatment|Became ineligible post-randomization|16|||
105401922|NCT00237042|363481700|FG000|Treatment|Moved out of state|1|||
105401923|NCT00237042|363481701|FG001|Treatment|Moved out of state|1|||
105401924|NCT00237042|363481702|FG002|Treatment|Moved out of state|1|||
105401925|NCT00237042|363481700|FG000|Treatment|Completed no treatment|5|||
105401926|NCT00237042|363481701|FG001|Treatment|Completed no treatment|5|||
105401927|NCT00237042|363481702|FG002|Treatment|Completed no treatment|21|||
105401928|NCT00237042|363481700|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
105401929|NCT00237042|363481701|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
105401930|NCT00237042|363481702|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
105401931|NCT00237042|363481700|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
105401932|NCT00237042|363481701|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
105580673|NCT01474512|364126475|FG010|Induction Period|Protocol Violation|0|||
105580674|NCT01474512|364126476|FG011|Induction Period|Protocol Violation|0|||
105580675|NCT01474512|364126477|FG012|Induction Period|Protocol Violation|0|||
105401933|NCT00237042|363481702|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
105401934|NCT01897532|363481707|FG000|Discontinuation From Treatment|Not Treated|7|||
105401935|NCT01897532|363481708|FG001|Discontinuation From Treatment|Not Treated|5|||
105580676|NCT01474512|364126478|FG013|Induction Period|Protocol Violation|0|||
105401936|NCT01897532|363481707|FG000|Discontinuation From Treatment|Other reason than specified|196|||
105401937|NCT01897532|363481708|FG001|Discontinuation From Treatment|Other reason than specified|176|||
105401938|NCT01897532|363481707|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
105401939|NCT01897532|363481708|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
105401940|NCT01897532|363481707|FG000|Discontinuation From Treatment|Non compliance|24|||
105401941|NCT01897532|363481708|FG001|Discontinuation From Treatment|Non compliance|15|||
105401942|NCT01897532|363481707|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
105401943|NCT01897532|363481708|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
105401944|NCT01897532|363481707|FG000|Discontinuation From Trial|Not Treated|7|||
105401945|NCT01897532|363481708|FG001|Discontinuation From Trial|Not Treated|5|||
105401946|NCT01897532|363481707|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
105401947|NCT01897532|363481708|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
105401948|NCT00953706|363481711|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
105401949|NCT00953706|363481712|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
105401950|NCT00953706|363481713|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
105401951|NCT00953706|363481714|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
105401952|NCT00953706|363481711|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
105401953|NCT00953706|363481712|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
105401954|NCT00953706|363481713|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
105401955|NCT00953706|363481714|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
105401956|NCT00953706|363481711|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
105401957|NCT00953706|363481712|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
105401958|NCT00953706|363481713|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
105401959|NCT00953706|363481714|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
105401960|NCT00953706|363481711|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
105401961|NCT00953706|363481712|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
105401962|NCT00953706|363481713|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
105401963|NCT00953706|363481714|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
105401964|NCT00953706|363481711|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
105401965|NCT00953706|363481712|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
105401966|NCT00953706|363481713|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
105401967|NCT00953706|363481714|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
105401968|NCT00953706|363481711|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
105401969|NCT00953706|363481712|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
105401970|NCT00953706|363481713|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
105401971|NCT00953706|363481714|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
105401972|NCT00953706|363481711|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
105401973|NCT00953706|363481712|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
105401974|NCT00953706|363481713|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
105401975|NCT00953706|363481714|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
105401976|NCT00953706|363481711|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
105401977|NCT00953706|363481712|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
105401978|NCT00953706|363481713|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
105401979|NCT00953706|363481714|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
105401980|NCT00953706|363481711|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
105401981|NCT00953706|363481712|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
105401982|NCT00953706|363481713|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
105401983|NCT00953706|363481714|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
105401984|NCT00953706|363481711|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
105401985|NCT00953706|363481712|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
105401986|NCT00953706|363481713|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
105401987|NCT00953706|363481714|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
105401988|NCT00953706|363481711|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
105401989|NCT00953706|363481712|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
105401990|NCT00953706|363481713|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
105401991|NCT00953706|363481714|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
105401992|NCT03761056|363481715|FG000|Overall Study|Death|8|||
105401993|NCT03761056|363481715|FG000|Overall Study|Enrolled but never treated|2|||
105401994|NCT03761056|363481715|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
105401995|NCT03761056|363481715|FG000|Overall Study|Investigator decision|1|||
105401996|NCT04749745|363481716|FG000|Overall Study|Withdrawal by Subject|1|||
105401997|NCT04749745|363481717|FG001|Overall Study|Withdrawal by Subject|0|||
105401998|NCT01365455|363481720|FG000|Induction Period|Adverse Event|5|||
105401999|NCT01365455|363481721|FG001|Induction Period|Adverse Event|3|||
105402000|NCT01365455|363481722|FG002|Induction Period|Adverse Event|4|||
105402001|NCT01365455|363481723|FG003|Induction Period|Adverse Event|0|||
105402002|NCT01365455|363481724|FG004|Induction Period|Adverse Event|0|||
105402003|NCT01365455|363481720|FG000|Induction Period|Lack of Efficacy|1|||
105402004|NCT01365455|363481721|FG001|Induction Period|Lack of Efficacy|1|||
105402005|NCT01365455|363481722|FG002|Induction Period|Lack of Efficacy|0|||
105402006|NCT01365455|363481723|FG003|Induction Period|Lack of Efficacy|0|||
105402007|NCT01365455|363481724|FG004|Induction Period|Lack of Efficacy|0|||
105402008|NCT01365455|363481720|FG000|Induction Period|Pregnancy|0|||
105402009|NCT01365455|363481721|FG001|Induction Period|Pregnancy|1|||
105402010|NCT01365455|363481722|FG002|Induction Period|Pregnancy|0|||
105402011|NCT01365455|363481723|FG003|Induction Period|Pregnancy|0|||
105402012|NCT01365455|363481724|FG004|Induction Period|Pregnancy|0|||
105402013|NCT01365455|363481720|FG000|Induction Period|Protocol deviation|0|||
105402014|NCT01365455|363481721|FG001|Induction Period|Protocol deviation|1|||
105402015|NCT01365455|363481722|FG002|Induction Period|Protocol deviation|1|||
105402016|NCT01365455|363481723|FG003|Induction Period|Protocol deviation|0|||
105402017|NCT01365455|363481724|FG004|Induction Period|Protocol deviation|0|||
105402018|NCT01365455|363481720|FG000|Induction Period|Subject/guardian decision|9|||
105402019|NCT01365455|363481721|FG001|Induction Period|Subject/guardian decision|1|||
105402020|NCT01365455|363481722|FG002|Induction Period|Subject/guardian decision|8|||
105402021|NCT01365455|363481723|FG003|Induction Period|Subject/guardian decision|0|||
105402022|NCT01365455|363481724|FG004|Induction Period|Subject/guardian decision|0|||
105402023|NCT01365455|363481720|FG000|Induction Period|Lost to Follow-up|0|||
105402024|NCT01365455|363481721|FG001|Induction Period|Lost to Follow-up|0|||
105402025|NCT01365455|363481722|FG002|Induction Period|Lost to Follow-up|3|||
105402026|NCT01365455|363481723|FG003|Induction Period|Lost to Follow-up|0|||
105402027|NCT01365455|363481724|FG004|Induction Period|Lost to Follow-up|0|||
105402028|NCT01365455|363481720|FG000|Maintenance Period|Adverse Event|12|||
105402029|NCT01365455|363481721|FG001|Maintenance Period|Adverse Event|5|||
105402030|NCT01365455|363481722|FG002|Maintenance Period|Adverse Event|1|||
105402031|NCT01365455|363481723|FG003|Maintenance Period|Adverse Event|2|||
105402032|NCT01365455|363481724|FG004|Maintenance Period|Adverse Event|4|||
105402033|NCT01365455|363481720|FG000|Maintenance Period|Lack of Efficacy|10|||
105402034|NCT01365455|363481721|FG001|Maintenance Period|Lack of Efficacy|2|||
105402035|NCT01365455|363481722|FG002|Maintenance Period|Lack of Efficacy|0|||
105402036|NCT01365455|363481723|FG003|Maintenance Period|Lack of Efficacy|2|||
105402037|NCT01365455|363481724|FG004|Maintenance Period|Lack of Efficacy|2|||
105402038|NCT01365455|363481720|FG000|Maintenance Period|Lost to Follow-up|2|||
105402039|NCT01365455|363481721|FG001|Maintenance Period|Lost to Follow-up|4|||
105402040|NCT01365455|363481722|FG002|Maintenance Period|Lost to Follow-up|0|||
105402041|NCT01365455|363481723|FG003|Maintenance Period|Lost to Follow-up|0|||
105402042|NCT01365455|363481724|FG004|Maintenance Period|Lost to Follow-up|3|||
105402043|NCT01365455|363481720|FG000|Maintenance Period|Non-compliance with study treatment|0|||
105402044|NCT01365455|363481721|FG001|Maintenance Period|Non-compliance with study treatment|0|||
105402045|NCT01365455|363481722|FG002|Maintenance Period|Non-compliance with study treatment|0|||
105402046|NCT01365455|363481723|FG003|Maintenance Period|Non-compliance with study treatment|1|||
105402047|NCT01365455|363481724|FG004|Maintenance Period|Non-compliance with study treatment|0|||
105402048|NCT01365455|363481720|FG000|Maintenance Period|Physician Decision|0|||
105402049|NCT01365455|363481721|FG001|Maintenance Period|Physician Decision|1|||
105402050|NCT01365455|363481722|FG002|Maintenance Period|Physician Decision|0|||
105402051|NCT01365455|363481723|FG003|Maintenance Period|Physician Decision|0|||
105402052|NCT01365455|363481724|FG004|Maintenance Period|Physician Decision|1|||
105402053|NCT01365455|363481720|FG000|Maintenance Period|Pregnancy|0|||
105402054|NCT01365455|363481721|FG001|Maintenance Period|Pregnancy|4|||
105402055|NCT01365455|363481722|FG002|Maintenance Period|Pregnancy|0|||
105402056|NCT01365455|363481723|FG003|Maintenance Period|Pregnancy|0|||
105402057|NCT01365455|363481724|FG004|Maintenance Period|Pregnancy|2|||
105402058|NCT01365455|363481720|FG000|Maintenance Period|Protocol deviation|1|||
105402059|NCT01365455|363481721|FG001|Maintenance Period|Protocol deviation|1|||
105402060|NCT01365455|363481722|FG002|Maintenance Period|Protocol deviation|0|||
105402061|NCT01365455|363481723|FG003|Maintenance Period|Protocol deviation|0|||
105402062|NCT01365455|363481724|FG004|Maintenance Period|Protocol deviation|0|||
105402063|NCT01365455|363481720|FG000|Maintenance Period|Subject/guardian decision|4|||
105402064|NCT01365455|363481721|FG001|Maintenance Period|Subject/guardian decision|6|||
105402065|NCT01365455|363481722|FG002|Maintenance Period|Subject/guardian decision|2|||
105402066|NCT01365455|363481723|FG003|Maintenance Period|Subject/guardian decision|4|||
105402067|NCT01365455|363481724|FG004|Maintenance Period|Subject/guardian decision|1|||
105402068|NCT03559270|363481725|FG000|Overall Study|Adverse Event|6|||
105402069|NCT03559270|363481726|FG001|Overall Study|Adverse Event|5|||
105402070|NCT03559270|363481727|FG002|Overall Study|Adverse Event|3|||
105402071|NCT03559270|363481728|FG003|Overall Study|Adverse Event|0|||
105402072|NCT03559270|363481725|FG000|Overall Study|Lack of Efficacy|34|||
105402073|NCT03559270|363481726|FG001|Overall Study|Lack of Efficacy|52|||
105402074|NCT03559270|363481727|FG002|Overall Study|Lack of Efficacy|37|||
105402075|NCT03559270|363481728|FG003|Overall Study|Lack of Efficacy|2|||
105402076|NCT03559270|363481725|FG000|Overall Study|Death|0|||
105402077|NCT03559270|363481726|FG001|Overall Study|Death|2|||
105402078|NCT03559270|363481727|FG002|Overall Study|Death|0|||
105402079|NCT03559270|363481728|FG003|Overall Study|Death|0|||
105402080|NCT03559270|363481725|FG000|Overall Study|Lost to Follow-up|16|||
105402081|NCT03559270|363481726|FG001|Overall Study|Lost to Follow-up|4|||
105580677|NCT01474512|364126479|FG014|Induction Period|Protocol Violation|0|||
105580678|NCT01474512|364126480|FG015|Induction Period|Protocol Violation|0|||
105580679|NCT01474512|364126481|FG016|Induction Period|Protocol Violation|0|||
105580680|NCT01474512|364126482|FG017|Induction Period|Protocol Violation|0|||
105580681|NCT01474512|364126465|FG000|Induction Period|Sponsor Decision|1|||
105580682|NCT01474512|364126466|FG001|Induction Period|Sponsor Decision|1|||
105402082|NCT03559270|363481727|FG002|Overall Study|Lost to Follow-up|12|||
105402083|NCT03559270|363481728|FG003|Overall Study|Lost to Follow-up|3|||
105402084|NCT03559270|363481725|FG000|Overall Study|Sponsor Decision|38|||
105402085|NCT03559270|363481726|FG001|Overall Study|Sponsor Decision|31|||
105402086|NCT03559270|363481727|FG002|Overall Study|Sponsor Decision|35|||
105402087|NCT03559270|363481728|FG003|Overall Study|Sponsor Decision|18|||
105402088|NCT03559270|363481725|FG000|Overall Study|Withdrawal by Subject|19|||
105402089|NCT03559270|363481726|FG001|Overall Study|Withdrawal by Subject|21|||
105402090|NCT03559270|363481727|FG002|Overall Study|Withdrawal by Subject|18|||
105402091|NCT03559270|363481728|FG003|Overall Study|Withdrawal by Subject|7|||
105402092|NCT03559270|363481725|FG000|Overall Study|Physician Decision|3|||
105402093|NCT03559270|363481726|FG001|Overall Study|Physician Decision|2|||
105402094|NCT03559270|363481727|FG002|Overall Study|Physician Decision|1|||
105402095|NCT03559270|363481728|FG003|Overall Study|Physician Decision|0|||
105402096|NCT03559270|363481725|FG000|Overall Study|Pregnancy|0|||
105493469|NCT00761579|363820695|FG000|Overall Study|Lack of Efficacy|21|||
105493470|NCT00761579|363820695|FG000|Overall Study|Lost to Follow-up|16|||
105493471|NCT00761579|363820695|FG000|Overall Study|Pregnancy|1|||
105493472|NCT00761579|363820695|FG000|Overall Study|Withdrawal by Subject|34|||
105493473|NCT00761579|363820695|FG000|Overall Study|Lack of compliance|2|||
105493474|NCT00761579|363820695|FG000|Overall Study|Protocol deviation|1|||
105493475|NCT00761579|363820695|FG000|Overall Study|Drug overdose|1|||
105493476|NCT00761579|363820695|FG000|Overall Study|Aggravation of depression|1|||
105493477|NCT00761579|363820695|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
105493478|NCT00761579|363820695|FG000|Overall Study|Lost survey form|1|||
105493479|NCT00761579|363820695|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
105493480|NCT03611010|363820696|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
105493481|NCT03611010|363820697|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
105493482|NCT03611010|363820698|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
105493483|NCT03611010|363820699|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
105493484|NCT00598702|363820700|FG000|Overall Study|Other|0|||
105493485|NCT00598702|363820701|FG001|Overall Study|Other|2|||
105493486|NCT00598702|363820702|FG002|Overall Study|Other|0|||
105493487|NCT00598702|363820703|FG003|Overall Study|Other|0|||
105493488|NCT00598702|363820704|FG004|Overall Study|Other|0|||
105493489|NCT00598702|363820705|FG005|Overall Study|Other|1|||
105493490|NCT00598702|363820706|FG006|Overall Study|Other|0|||
105493491|NCT00598702|363820707|FG007|Overall Study|Other|0|||
105493492|NCT00598702|363820700|FG000|Overall Study|Early discharge from hospital|0|||
105493493|NCT00598702|363820701|FG001|Overall Study|Early discharge from hospital|0|||
105493494|NCT00598702|363820702|FG002|Overall Study|Early discharge from hospital|2|||
105493495|NCT00598702|363820703|FG003|Overall Study|Early discharge from hospital|5|||
105493496|NCT00598702|363820704|FG004|Overall Study|Early discharge from hospital|0|||
105493497|NCT00598702|363820705|FG005|Overall Study|Early discharge from hospital|10|||
105493498|NCT00598702|363820706|FG006|Overall Study|Early discharge from hospital|1|||
105493499|NCT00598702|363820707|FG007|Overall Study|Early discharge from hospital|0|||
105493500|NCT00598702|363820700|FG000|Overall Study|Adverse Event|0|||
105493501|NCT00598702|363820701|FG001|Overall Study|Adverse Event|0|||
105493502|NCT00598702|363820702|FG002|Overall Study|Adverse Event|0|||
105493503|NCT00598702|363820703|FG003|Overall Study|Adverse Event|1|||
105493504|NCT00598702|363820704|FG004|Overall Study|Adverse Event|0|||
105493505|NCT00598702|363820705|FG005|Overall Study|Adverse Event|0|||
105493506|NCT00598702|363820706|FG006|Overall Study|Adverse Event|0|||
105493507|NCT00598702|363820707|FG007|Overall Study|Adverse Event|0|||
105493508|NCT00598702|363820700|FG000|Overall Study|Withdrawal by Subject|0|||
105493509|NCT00598702|363820701|FG001|Overall Study|Withdrawal by Subject|0|||
105493510|NCT00598702|363820702|FG002|Overall Study|Withdrawal by Subject|0|||
105580683|NCT01474512|364126467|FG002|Induction Period|Sponsor Decision|1|||
105580684|NCT01474512|364126468|FG003|Induction Period|Sponsor Decision|0|||
105580685|NCT01474512|364126469|FG004|Induction Period|Sponsor Decision|0|||
105580686|NCT01474512|364126470|FG005|Induction Period|Sponsor Decision|0|||
105493511|NCT00598702|363820703|FG003|Overall Study|Withdrawal by Subject|1|||
105493512|NCT00598702|363820704|FG004|Overall Study|Withdrawal by Subject|1|||
105493513|NCT00598702|363820705|FG005|Overall Study|Withdrawal by Subject|0|||
105493514|NCT00598702|363820706|FG006|Overall Study|Withdrawal by Subject|0|||
105402097|NCT03559270|363481726|FG001|Overall Study|Pregnancy|1|||
105493515|NCT00598702|363820707|FG007|Overall Study|Withdrawal by Subject|0|||
105493516|NCT00598702|363820700|FG000|Overall Study|Physician Decision|0|||
105493517|NCT00598702|363820701|FG001|Overall Study|Physician Decision|0|||
105580687|NCT01474512|364126471|FG006|Induction Period|Sponsor Decision|0|||
105402098|NCT03559270|363481727|FG002|Overall Study|Pregnancy|0|||
105402099|NCT03559270|363481728|FG003|Overall Study|Pregnancy|0|||
105493518|NCT00598702|363820702|FG002|Overall Study|Physician Decision|0|||
105493519|NCT00598702|363820703|FG003|Overall Study|Physician Decision|0|||
105493520|NCT00598702|363820704|FG004|Overall Study|Physician Decision|1|||
105493521|NCT00598702|363820705|FG005|Overall Study|Physician Decision|0|||
105493522|NCT00598702|363820706|FG006|Overall Study|Physician Decision|0|||
105493523|NCT00598702|363820707|FG007|Overall Study|Physician Decision|0|||
105402100|NCT03559270|363481725|FG000|Overall Study|Protocol Violation|1|||
105402101|NCT03559270|363481726|FG001|Overall Study|Protocol Violation|0|||
105402102|NCT03559270|363481727|FG002|Overall Study|Protocol Violation|2|||
105402103|NCT03559270|363481728|FG003|Overall Study|Protocol Violation|0|||
105402104|NCT03816176|363481730|FG000|Overall Study|Miscellaneous|5|||
105402105|NCT03816176|363481730|FG000|Overall Study|Lack of Efficacy|4|||
105402106|NCT03816176|363481730|FG000|Overall Study|Adverse Event|3|||
105402107|NCT05010070|363483183|FG000|Overall Study|Lost to Follow-up|1|||
105402108|NCT05010070|363483183|FG000|Overall Study|Withdrawal by Subject|1|||
105402109|NCT02336815|363483194|FG000|Overall Study|Disease Progression|45|||
105402110|NCT02336815|363483195|FG001|Overall Study|Disease Progression|70|||
105402111|NCT02336815|363483194|FG000|Overall Study|Adverse Event|18|||
105402112|NCT02336815|363483195|FG001|Overall Study|Adverse Event|39|||
105402113|NCT02336815|363483194|FG000|Overall Study|Physician Decision|11|||
105402114|NCT02336815|363483195|FG001|Overall Study|Physician Decision|4|||
105402115|NCT02336815|363483194|FG000|Overall Study|Withdrawal by Subject|3|||
105402116|NCT02336815|363483195|FG001|Overall Study|Withdrawal by Subject|2|||
105402117|NCT02336815|363483194|FG000|Overall Study|Lost to Follow-up|1|||
105402118|NCT02336815|363483195|FG001|Overall Study|Lost to Follow-up|3|||
105402119|NCT02336815|363483194|FG000|Overall Study|Other|1|||
105402120|NCT02336815|363483195|FG001|Overall Study|Other|5|||
105402121|NCT00692003|363483196|FG000|Overall Study|Sponsor Decision|5|||
105402122|NCT00692003|363483197|FG001|Overall Study|Sponsor Decision|1|||
105402123|NCT03289143|363483198|FG000|Overall Study|Caregiver Unavailability|1|||
105402124|NCT03289143|363483199|FG001|Overall Study|Caregiver Unavailability|1|||
105402125|NCT03289143|363483200|FG002|Overall Study|Caregiver Unavailability|0|||
105402126|NCT03289143|363483201|FG003|Overall Study|Caregiver Unavailability|0|||
105402127|NCT03289143|363483198|FG000|Overall Study|Research Department Closure|0|||
105402128|NCT03289143|363483199|FG001|Overall Study|Research Department Closure|0|||
105402129|NCT03289143|363483200|FG002|Overall Study|Research Department Closure|1|||
105402130|NCT03289143|363483201|FG003|Overall Study|Research Department Closure|0|||
105402131|NCT03289143|363483198|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
105402132|NCT03289143|363483199|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
105402133|NCT03289143|363483200|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
105402134|NCT03289143|363483201|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
105402135|NCT03289143|363483198|FG000|Overall Study|Medical Monitor Decision|1|||
105402136|NCT03289143|363483199|FG001|Overall Study|Medical Monitor Decision|0|||
105402137|NCT03289143|363483200|FG002|Overall Study|Medical Monitor Decision|0|||
105402138|NCT03289143|363483201|FG003|Overall Study|Medical Monitor Decision|0|||
105402139|NCT03289143|363483198|FG000|Overall Study|Participant Non-Compliance|0|||
105402140|NCT03289143|363483199|FG001|Overall Study|Participant Non-Compliance|0|||
105402141|NCT03289143|363483200|FG002|Overall Study|Participant Non-Compliance|1|||
105402142|NCT03289143|363483201|FG003|Overall Study|Participant Non-Compliance|0|||
105402143|NCT03289143|363483198|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
105402144|NCT03289143|363483199|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
105402145|NCT03289143|363483200|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
105402146|NCT03289143|363483201|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
105402147|NCT03289143|363483198|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
105402148|NCT03289143|363483199|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
105402149|NCT03289143|363483200|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
105493524|NCT00598702|363820700|FG000|Overall Study|Dose limiting toxicity|0|||
105493525|NCT00598702|363820701|FG001|Overall Study|Dose limiting toxicity|0|||
105493526|NCT00598702|363820702|FG002|Overall Study|Dose limiting toxicity|0|||
105493527|NCT00598702|363820703|FG003|Overall Study|Dose limiting toxicity|1|||
105493528|NCT00598702|363820704|FG004|Overall Study|Dose limiting toxicity|1|||
105402150|NCT03289143|363483201|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
105402151|NCT03289143|363483198|FG000|Overall Study|Caregiver Passed Away|1|||
105402152|NCT03289143|363483199|FG001|Overall Study|Caregiver Passed Away|0|||
105493529|NCT00598702|363820705|FG005|Overall Study|Dose limiting toxicity|1|||
105402153|NCT03289143|363483200|FG002|Overall Study|Caregiver Passed Away|0|||
105402154|NCT03289143|363483201|FG003|Overall Study|Caregiver Passed Away|0|||
105402155|NCT03289143|363483198|FG000|Overall Study|Physician Decision|0|||
105402156|NCT03289143|363483199|FG001|Overall Study|Physician Decision|2|||
105402157|NCT03289143|363483200|FG002|Overall Study|Physician Decision|2|||
105402158|NCT03289143|363483201|FG003|Overall Study|Physician Decision|2|||
105402159|NCT03289143|363483198|FG000|Overall Study|Protocol Deviation|2|||
105402160|NCT03289143|363483199|FG001|Overall Study|Protocol Deviation|1|||
105402161|NCT03289143|363483200|FG002|Overall Study|Protocol Deviation|3|||
105402162|NCT03289143|363483201|FG003|Overall Study|Protocol Deviation|1|||
105493530|NCT00598702|363820706|FG006|Overall Study|Dose limiting toxicity|0|||
105493531|NCT00598702|363820707|FG007|Overall Study|Dose limiting toxicity|0|||
105493532|NCT00567593|363820708|FG000|Overall Study|Adverse Event|1|||
105493533|NCT00567593|363820708|FG000|Overall Study|Physician Decision|1|||
105493534|NCT04087213|363820711|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
105493535|NCT04087213|363820711|FG000|In-Facility Introduction|Adverse Event|1|||
105493536|NCT04087213|363820711|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
105493537|NCT04087213|363820711|FG000|Assisted Evaluable Period|Personal reasons|3|||
105493538|NCT04087213|363820711|FG000|Transition Period B|Renal Transplantation|1|||
105493539|NCT00700570|363820719|FG000|Overall Study|Adverse Event|2|||
105493540|NCT00700570|363820720|FG001|Overall Study|Adverse Event|6|||
105493541|NCT00700570|363820719|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
105493542|NCT00700570|363820720|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
105493543|NCT00700570|363820719|FG000|Overall Study|Disease Progression|8|||
105493544|NCT00700570|363820720|FG001|Overall Study|Disease Progression|11|||
105493545|NCT00700570|363820719|FG000|Overall Study|Withdrawal by Subject|1|||
105493546|NCT00700570|363820720|FG001|Overall Study|Withdrawal by Subject|6|||
105493547|NCT01031381|363820723|FG000|Overall Study|Physician Decision|3|||
105493548|NCT01031381|363820723|FG000|Overall Study|Withdrawal by Subject|6|||
105493549|NCT00122109|363820725|FG000|Overall Study|Did not meet criteria|6|||
105493550|NCT00122109|363820726|FG001|Overall Study|Did not meet criteria|7|||
105493551|NCT02642029|363820727|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
105493552|NCT02642029|363820728|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
105493553|NCT02642029|363820729|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
105493554|NCT02642029|363820730|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
105493555|NCT02642029|363820731|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
105493556|NCT02642029|363820732|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
105493557|NCT02642029|363820727|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
105493558|NCT02642029|363820728|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
105493559|NCT02642029|363820729|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
105493560|NCT02642029|363820730|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
105493561|NCT02642029|363820731|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
105493562|NCT02642029|363820732|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
105493563|NCT02642029|363820727|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
105493564|NCT02642029|363820728|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
105493565|NCT02642029|363820729|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
105493566|NCT02642029|363820730|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
105493567|NCT02642029|363820731|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
105493568|NCT02642029|363820732|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
105493569|NCT02642029|363820727|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
105493570|NCT02642029|363820728|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
105493571|NCT02642029|363820729|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
105493572|NCT02642029|363820730|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
105493573|NCT02642029|363820731|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
105493574|NCT02642029|363820732|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
105493575|NCT02642029|363820727|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
105493576|NCT02642029|363820728|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
105402163|NCT03289143|363483198|FG000|Overall Study|Study Terminated By Sponsor|101|||
105402164|NCT03289143|363483199|FG001|Overall Study|Study Terminated By Sponsor|75|||
105402165|NCT03289143|363483200|FG002|Overall Study|Study Terminated By Sponsor|100|||
105402166|NCT03289143|363483201|FG003|Overall Study|Study Terminated By Sponsor|69|||
105402167|NCT03289143|363483198|FG000|Overall Study|Withdrawal by Subject|14|||
105402168|NCT03289143|363483199|FG001|Overall Study|Withdrawal by Subject|6|||
105402169|NCT03289143|363483200|FG002|Overall Study|Withdrawal by Subject|14|||
105402170|NCT03289143|363483201|FG003|Overall Study|Withdrawal by Subject|12|||
105402171|NCT03289143|363483198|FG000|Overall Study|Adverse Event|10|||
105402172|NCT03289143|363483199|FG001|Overall Study|Adverse Event|7|||
105402173|NCT03289143|363483200|FG002|Overall Study|Adverse Event|6|||
105402174|NCT03289143|363483201|FG003|Overall Study|Adverse Event|5|||
105402175|NCT03289143|363483198|FG000|Overall Study|Death|2|||
105402176|NCT03289143|363483199|FG001|Overall Study|Death|0|||
105402177|NCT03289143|363483200|FG002|Overall Study|Death|2|||
105402178|NCT03289143|363483201|FG003|Overall Study|Death|1|||
105493577|NCT02642029|363820729|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
105493578|NCT02642029|363820730|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
105493579|NCT02642029|363820731|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
105493580|NCT02642029|363820732|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
105402179|NCT03289143|363483198|FG000|Overall Study|Lost to Follow-up|2|||
105402180|NCT03289143|363483199|FG001|Overall Study|Lost to Follow-up|1|||
105402181|NCT03289143|363483200|FG002|Overall Study|Lost to Follow-up|1|||
105402182|NCT03289143|363483201|FG003|Overall Study|Lost to Follow-up|0|||
105402183|NCT03289143|363483198|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
105580688|NCT01474512|364126472|FG007|Induction Period|Sponsor Decision|0|||
105402184|NCT03289143|363483199|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
105402185|NCT03289143|363483200|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
105402186|NCT03289143|363483201|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
105402187|NCT03289143|363483198|FG000|Overall Study|Withdrawal by Caregiver|0|||
105402188|NCT03289143|363483199|FG001|Overall Study|Withdrawal by Caregiver|1|||
105402189|NCT03289143|363483200|FG002|Overall Study|Withdrawal by Caregiver|0|||
105402190|NCT03289143|363483201|FG003|Overall Study|Withdrawal by Caregiver|0|||
105402191|NCT03289143|363483198|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
105402192|NCT03289143|363483199|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
105402193|NCT03289143|363483200|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
105402194|NCT03289143|363483201|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
105402195|NCT03289143|363483198|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
105402196|NCT03289143|363483199|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
105402197|NCT03289143|363483200|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
105402198|NCT03289143|363483201|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
105402199|NCT00730756|363483202|FG000|Overall Study|Adverse Event|2|||
105402200|NCT00730756|363483203|FG001|Overall Study|Adverse Event|0|||
105402201|NCT00730756|363483202|FG000|Overall Study|Lack of Efficacy|1|||
105402202|NCT00730756|363483203|FG001|Overall Study|Lack of Efficacy|1|||
105402203|NCT00730756|363483202|FG000|Overall Study|Protocol Deviation|1|||
105402204|NCT00730756|363483203|FG001|Overall Study|Protocol Deviation|2|||
105402205|NCT00730756|363483202|FG000|Overall Study|Lost to Follow-up|0|||
105402206|NCT00730756|363483203|FG001|Overall Study|Lost to Follow-up|1|||
105402207|NCT00730756|363483202|FG000|Overall Study|Withdrew Consent|0|||
105402208|NCT00730756|363483203|FG001|Overall Study|Withdrew Consent|1|||
105402209|NCT01475721|363483209|FG000|Overall Study|Death|3|||
105402210|NCT01475721|363483210|FG001|Overall Study|Death|6|||
105402211|NCT01475721|363483209|FG000|Overall Study|Withdrawal by Subject|8|||
105402212|NCT01475721|363483210|FG001|Overall Study|Withdrawal by Subject|8|||
105402213|NCT00690794|363483213|FG000|Overall Study|Adverse Event|12|||
105402214|NCT00690794|363483214|FG001|Overall Study|Adverse Event|10|||
105402215|NCT00690794|363483213|FG000|Overall Study|Lost to Follow-up|1|||
105402216|NCT00690794|363483214|FG001|Overall Study|Lost to Follow-up|4|||
105402217|NCT00690794|363483213|FG000|Overall Study|Withdrawal by Subject|0|||
105402218|NCT00690794|363483214|FG001|Overall Study|Withdrawal by Subject|9|||
105402219|NCT00690794|363483213|FG000|Overall Study|Protocol Violation|6|||
105402220|NCT00690794|363483214|FG001|Overall Study|Protocol Violation|7|||
105402221|NCT00690794|363483213|FG000|Overall Study|Noncompliance|1|||
105402222|NCT00690794|363483214|FG001|Overall Study|Noncompliance|2|||
105402223|NCT00690794|363483213|FG000|Overall Study|Other not specified|1|||
105402224|NCT00690794|363483214|FG001|Overall Study|Other not specified|3|||
105402225|NCT01496287|363483215|FG000|Overall Study|Lost to Follow-up|1|||
105402226|NCT01496287|363483215|FG000|Overall Study|Incomplete anesthesia|5|||
105402227|NCT03012334|363483216|FG000|Period 1|Withdrawal by Subject|0|||
105402228|NCT03012334|363483217|FG001|Period 1|Withdrawal by Subject|0|||
105402229|NCT03012334|363483218|FG002|Period 1|Withdrawal by Subject|0|||
105402230|NCT03012334|363483219|FG003|Period 1|Withdrawal by Subject|0|||
105402231|NCT03012334|363483220|FG004|Period 1|Withdrawal by Subject|0|||
105402232|NCT03012334|363483221|FG005|Period 1|Withdrawal by Subject|0|||
105402233|NCT03012334|363483222|FG006|Period 1|Withdrawal by Subject|0|||
105402234|NCT03012334|363483223|FG007|Period 1|Withdrawal by Subject|0|||
105402235|NCT03012334|363483224|FG008|Period 1|Withdrawal by Subject|0|||
105402236|NCT03012334|363483225|FG009|Period 1|Withdrawal by Subject|1|||
105402237|NCT03012334|363483216|FG000|Period 2|Withdrawal by Subject|0|||
105402238|NCT03012334|363483217|FG001|Period 2|Withdrawal by Subject|1|||
105402239|NCT03012334|363483218|FG002|Period 2|Withdrawal by Subject|0|||
105402240|NCT03012334|363483219|FG003|Period 2|Withdrawal by Subject|0|||
105402241|NCT03012334|363483220|FG004|Period 2|Withdrawal by Subject|0|||
105402242|NCT03012334|363483221|FG005|Period 2|Withdrawal by Subject|0|||
105402243|NCT03012334|363483222|FG006|Period 2|Withdrawal by Subject|0|||
105402244|NCT03012334|363483223|FG007|Period 2|Withdrawal by Subject|0|||
105402245|NCT03012334|363483224|FG008|Period 2|Withdrawal by Subject|0|||
105402246|NCT03012334|363483225|FG009|Period 2|Withdrawal by Subject|0|||
105402247|NCT03012334|363483216|FG000|Period 2|Protocol Violation|0|||
105402248|NCT03012334|363483217|FG001|Period 2|Protocol Violation|0|||
105402249|NCT03012334|363483218|FG002|Period 2|Protocol Violation|1|||
105402250|NCT03012334|363483219|FG003|Period 2|Protocol Violation|0|||
105493581|NCT02642029|363820727|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
105402251|NCT03012334|363483220|FG004|Period 2|Protocol Violation|0|||
105402252|NCT03012334|363483221|FG005|Period 2|Protocol Violation|0|||
105402253|NCT03012334|363483222|FG006|Period 2|Protocol Violation|0|||
105402254|NCT03012334|363483223|FG007|Period 2|Protocol Violation|1|||
105402255|NCT03012334|363483224|FG008|Period 2|Protocol Violation|0|||
105580689|NCT01474512|364126473|FG008|Induction Period|Sponsor Decision|0|||
105402256|NCT03012334|363483225|FG009|Period 2|Protocol Violation|0|||
105402257|NCT03012334|363483216|FG000|Period 4|Non-Compliance|0|||
105402258|NCT03012334|363483217|FG001|Period 4|Non-Compliance|0|||
105402259|NCT03012334|363483218|FG002|Period 4|Non-Compliance|0|||
105402260|NCT03012334|363483219|FG003|Period 4|Non-Compliance|0|||
105402261|NCT03012334|363483220|FG004|Period 4|Non-Compliance|0|||
105402262|NCT03012334|363483221|FG005|Period 4|Non-Compliance|0|||
105402263|NCT03012334|363483222|FG006|Period 4|Non-Compliance|1|||
105402264|NCT03012334|363483223|FG007|Period 4|Non-Compliance|0|||
105402265|NCT03012334|363483224|FG008|Period 4|Non-Compliance|0|||
105402266|NCT03012334|363483225|FG009|Period 4|Non-Compliance|0|||
105402267|NCT03012334|363483216|FG000|Period 4|Adverse Event|0|||
105402268|NCT03012334|363483217|FG001|Period 4|Adverse Event|0|||
105402269|NCT03012334|363483218|FG002|Period 4|Adverse Event|0|||
105402270|NCT03012334|363483219|FG003|Period 4|Adverse Event|0|||
105402271|NCT03012334|363483220|FG004|Period 4|Adverse Event|0|||
105402272|NCT03012334|363483221|FG005|Period 4|Adverse Event|0|||
105402273|NCT03012334|363483222|FG006|Period 4|Adverse Event|0|||
105402274|NCT03012334|363483223|FG007|Period 4|Adverse Event|0|||
105402275|NCT03012334|363483224|FG008|Period 4|Adverse Event|1|||
105402276|NCT03012334|363483225|FG009|Period 4|Adverse Event|0|||
105402277|NCT01823107|363483226|FG000|Overall Study|Withdrawal by Subject|1|||
105402278|NCT01008618|363483227|FG000|Period 1 (Titration Period)|Physician Decision|2|||
105402279|NCT01008618|363483228|FG001|Period 1 (Titration Period)|Physician Decision|0|||
105402280|NCT01008618|363483229|FG002|Period 1 (Titration Period)|Physician Decision|0|||
105402281|NCT01008618|363483227|FG000|Period 1 (Titration Period)|Adverse Event|33|||
105402282|NCT01008618|363483228|FG001|Period 1 (Titration Period)|Adverse Event|0|||
105402283|NCT01008618|363483229|FG002|Period 1 (Titration Period)|Adverse Event|0|||
105402284|NCT01008618|363483227|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
105402285|NCT01008618|363483228|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
105402286|NCT01008618|363483229|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
105402287|NCT01008618|363483227|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
105402288|NCT01008618|363483228|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
105402289|NCT01008618|363483229|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
105402290|NCT01008618|363483227|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
105402291|NCT01008618|363483228|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
105402292|NCT01008618|363483229|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
105402293|NCT01008618|363483227|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
105402294|NCT01008618|363483228|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
105402295|NCT01008618|363483229|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
105402296|NCT01008618|363483227|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
105402297|NCT01008618|363483228|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
105402298|NCT01008618|363483229|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
105402299|NCT01008618|363483227|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
105402300|NCT01008618|363483228|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
105402301|NCT01008618|363483229|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
105402302|NCT01008618|363483227|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
105402303|NCT01008618|363483228|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
105402304|NCT01008618|363483229|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
105402305|NCT01008618|363483227|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
105402306|NCT01008618|363483228|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
105402307|NCT01008618|363483229|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
105402308|NCT01008618|363483227|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
105402309|NCT01008618|363483228|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
105402310|NCT01008618|363483229|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
105402311|NCT01008618|363483227|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
105402312|NCT01008618|363483228|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
105402313|NCT01008618|363483229|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
105402314|NCT01213082|363483232|FG000|Overall Study|Lost to Follow-up|6|||
105402315|NCT01213082|363483233|FG001|Overall Study|Lost to Follow-up|7|||
105402316|NCT01213082|363483234|FG002|Overall Study|Lost to Follow-up|4|||
105402317|NCT01213082|363483232|FG000|Overall Study|Physician Decision|0|||
105402318|NCT01213082|363483233|FG001|Overall Study|Physician Decision|0|||
105402319|NCT01213082|363483234|FG002|Overall Study|Physician Decision|1|||
105402320|NCT01627691|363483238|FG000|Overall Study|Death|11|||
105402321|NCT01627691|363483238|FG000|Overall Study|Lost to Follow-up|3|||
105402322|NCT01627691|363483238|FG000|Overall Study|Withdrawal by Subject|1|||
105402323|NCT01627691|363483238|FG000|Overall Study|Missed the visit|3|||
105402324|NCT00856323|363483239|FG000|Overall Study|Withdrawal by Subject|2|||
105402325|NCT02848092|363483240|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
105402326|NCT02848092|363483241|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
105402327|NCT02848092|363483240|FG000|1-month Post-training Follow-up|Adverse Event|2|||
105402328|NCT02848092|363483241|FG001|1-month Post-training Follow-up|Adverse Event|1|||
105402329|NCT02848092|363483240|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
105402330|NCT02848092|363483241|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
105402331|NCT02848092|363483240|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
105402332|NCT02848092|363483241|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
105402333|NCT02848092|363483240|FG000|1-month Post-training Follow-up|fatigue|0|||
105402334|NCT02848092|363483241|FG001|1-month Post-training Follow-up|fatigue|1|||
105402335|NCT02848092|363483240|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
105402336|NCT02848092|363483241|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
105402337|NCT02848092|363483240|FG000|6-month Post-training Follow-up|Adverse Event|1|||
105402338|NCT02848092|363483241|FG001|6-month Post-training Follow-up|Adverse Event|1|||
105402339|NCT02848092|363483240|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
105402340|NCT02848092|363483241|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
105402341|NCT02848092|363483240|FG000|6-month Post-training Follow-up|frustrated with task|1|||
105402342|NCT02848092|363483241|FG001|6-month Post-training Follow-up|frustrated with task|0|||
105402343|NCT02848092|363483240|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
105402344|NCT02848092|363483241|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
105402345|NCT02848092|363483240|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
105402346|NCT02848092|363483241|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
105402347|NCT01639469|363483245|FG000|Overall Study|Death|4|||
105402348|NCT01639469|363483246|FG001|Overall Study|Death|2|||
105402349|NCT01639469|363483245|FG000|Overall Study|Lost to Follow-up|1|||
105402350|NCT01639469|363483246|FG001|Overall Study|Lost to Follow-up|1|||
105402351|NCT01119443|363483247|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
105402352|NCT01119443|363483248|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
105402353|NCT04828707|363483251|FG000|Overall Study|Lost to Follow-up|3|||
105402354|NCT04828707|363483252|FG001|Overall Study|Lost to Follow-up|2|||
105402355|NCT04828707|363483251|FG000|Overall Study|Withdrawal by Subject|2|||
105402356|NCT04828707|363483252|FG001|Overall Study|Withdrawal by Subject|1|||
105402357|NCT01887717|363483253|FG000|Overall Study|Withdrawal by Subject|1|||
105402358|NCT01887717|363483254|FG001|Overall Study|Withdrawal by Subject|7|||
105402359|NCT01887717|363483253|FG000|Overall Study|Physician Decision|0|||
105402360|NCT01887717|363483254|FG001|Overall Study|Physician Decision|2|||
105402361|NCT01887717|363483253|FG000|Overall Study|Administrative reasons|5|||
105402362|NCT01887717|363483254|FG001|Overall Study|Administrative reasons|2|||
105402363|NCT00087698|363483256|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
105402364|NCT00087698|363483256|FG000|Overall Study|Death from Other Causes|3|||
105402365|NCT00087698|363483256|FG000|Overall Study|Adverse Event|4|||
105402366|NCT00087698|363483256|FG000|Overall Study|Withdrawal by Subject|4|||
105402367|NCT00087698|363483256|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
105402368|NCT00087698|363483256|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
105402369|NCT00087698|363483256|FG000|Overall Study|Clinical Relapse|1|||
105402370|NCT00087698|363483256|FG000|Overall Study|Death from Study Disease|2|||
105402371|NCT00087698|363483256|FG000|Overall Study|Death from Study Drug Toxicity|2|||
105402372|NCT00087698|363483256|FG000|Overall Study|Protocol Violation|1|||
105402373|NCT02765399|363483261|FG000|Overall Study|Nausea|1|||
105402374|NCT02765399|363483262|FG001|Overall Study|Nausea|0|||
105402375|NCT00657267|363483268|FG000|Overall Study|Progressive disease|45|||
105402376|NCT00657267|363483268|FG000|Overall Study|Adverse Event|9|||
105402377|NCT04067492|363483269|FG000|Overall Study|Lost to Follow-up|0|||
105402378|NCT04067492|363483270|FG001|Overall Study|Lost to Follow-up|0|||
105402379|NCT04067492|363483271|FG002|Overall Study|Lost to Follow-up|0|||
105402380|NCT04067492|363483272|FG003|Overall Study|Lost to Follow-up|0|||
105402381|NCT04067492|363483273|FG004|Overall Study|Lost to Follow-up|0|||
105402382|NCT04067492|363483274|FG005|Overall Study|Lost to Follow-up|1|||
105402383|NCT04067492|363483269|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
105402384|NCT04067492|363483270|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
105402385|NCT04067492|363483271|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
105402386|NCT04067492|363483272|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
105402387|NCT04067492|363483273|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
105402388|NCT04067492|363483274|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
105402389|NCT04067492|363483269|FG000|Overall Study|COVID-19 epidemiological situation|0|||
105402390|NCT04067492|363483270|FG001|Overall Study|COVID-19 epidemiological situation|0|||
105402391|NCT04067492|363483271|FG002|Overall Study|COVID-19 epidemiological situation|0|||
105402392|NCT04067492|363483272|FG003|Overall Study|COVID-19 epidemiological situation|1|||
105493582|NCT02642029|363820728|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
105580690|NCT01474512|364126474|FG009|Induction Period|Sponsor Decision|0|||
105402393|NCT04067492|363483273|FG004|Overall Study|COVID-19 epidemiological situation|0|||
105402394|NCT04067492|363483274|FG005|Overall Study|COVID-19 epidemiological situation|0|||
105402395|NCT02268383|363483282|FG000|Overall Study|Death|12|||
105402396|NCT02268383|363483282|FG000|Overall Study|Lost to Follow-up|2|||
105402397|NCT02268383|363483282|FG000|Overall Study|Withdrawal by Subject|9|||
105402398|NCT02268383|363483282|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
105402399|NCT02268383|363483282|FG000|Overall Study|Protocol deviation|3|||
105402400|NCT02268383|363483282|FG000|Overall Study|Sponsor decision|22|||
105402401|NCT02268383|363483282|FG000|Overall Study|Not reported|12|||
105402402|NCT00714948|363483283|FG000|Overall Study|Adverse Event|2|||
105402403|NCT01342926|363483288|FG000|Overall Study|Adverse Event|5|||
105402404|NCT01342926|363483289|FG001|Overall Study|Adverse Event|8|||
105402405|NCT01342926|363483290|FG002|Overall Study|Adverse Event|10|||
105402406|NCT01342926|363483291|FG003|Overall Study|Adverse Event|7|||
105402407|NCT01342926|363483288|FG000|Overall Study|Lost to Follow-up|0|||
105402408|NCT01342926|363483289|FG001|Overall Study|Lost to Follow-up|1|||
105402409|NCT01342926|363483290|FG002|Overall Study|Lost to Follow-up|1|||
105402410|NCT01342926|363483291|FG003|Overall Study|Lost to Follow-up|0|||
105402411|NCT01342926|363483288|FG000|Overall Study|Investigator Discretion|2|||
105402412|NCT01342926|363483289|FG001|Overall Study|Investigator Discretion|2|||
105402413|NCT01342926|363483290|FG002|Overall Study|Investigator Discretion|0|||
105402414|NCT01342926|363483291|FG003|Overall Study|Investigator Discretion|0|||
105402415|NCT01342926|363483288|FG000|Overall Study|Withdrawal by Subject|2|||
105402416|NCT01342926|363483289|FG001|Overall Study|Withdrawal by Subject|4|||
105402417|NCT01342926|363483290|FG002|Overall Study|Withdrawal by Subject|3|||
105402418|NCT01342926|363483291|FG003|Overall Study|Withdrawal by Subject|5|||
105402419|NCT04288089|363483292|FG000|Overall Study|Ongoing Treatment|2|||
105402420|NCT04288089|363483293|FG001|Overall Study|Ongoing Treatment|1|||
105402421|NCT04288089|363483294|FG002|Overall Study|Ongoing Treatment|1|||
105402422|NCT04288089|363483295|FG003|Overall Study|Ongoing Treatment|4|||
105402423|NCT02891226|363483296|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
105402424|NCT02891226|363483297|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
105402425|NCT02891226|363483298|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
105402426|NCT02891226|363483299|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105402427|NCT02891226|363483300|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105402428|NCT02891226|363483301|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105402429|NCT02891226|363483302|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105402430|NCT02891226|363483303|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105402431|NCT02891226|363483304|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105402432|NCT02891226|363483305|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105402433|NCT02891226|363483306|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105402434|NCT02891226|363483307|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105402435|NCT02891226|363483308|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105402436|NCT02891226|363483309|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105402437|NCT02891226|363483310|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105402438|NCT02891226|363483311|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105402439|NCT02891226|363483296|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
105402440|NCT02891226|363483297|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
105402441|NCT02891226|363483298|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105402442|NCT02891226|363483299|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105402443|NCT02891226|363483300|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105402444|NCT02891226|363483301|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105402445|NCT02891226|363483302|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105402446|NCT02891226|363483303|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105402447|NCT02891226|363483304|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105402448|NCT02891226|363483305|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105402449|NCT02891226|363483306|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105402450|NCT02891226|363483307|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105402451|NCT02891226|363483308|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105402452|NCT02891226|363483309|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105402453|NCT02891226|363483310|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105402454|NCT02891226|363483311|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105402455|NCT02891226|363483296|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105402456|NCT02891226|363483297|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105402457|NCT02891226|363483298|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105402458|NCT02891226|363483299|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
105402459|NCT02891226|363483300|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105402460|NCT02891226|363483301|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105402461|NCT02891226|363483302|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105402462|NCT02891226|363483303|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105402463|NCT02891226|363483304|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105402464|NCT02891226|363483305|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105402465|NCT02891226|363483306|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105402466|NCT02891226|363483307|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105402467|NCT02891226|363483308|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105402468|NCT02891226|363483309|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105402469|NCT02891226|363483310|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105402470|NCT02891226|363483311|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105402471|NCT02891226|363483296|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105402472|NCT02891226|363483297|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105402473|NCT02891226|363483298|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
105402474|NCT02891226|363483299|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105402475|NCT02891226|363483300|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105402476|NCT02891226|363483301|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105402477|NCT02891226|363483302|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105402478|NCT02891226|363483303|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105402479|NCT02891226|363483304|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105402480|NCT02891226|363483305|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105402481|NCT02891226|363483306|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105402482|NCT02891226|363483307|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105402483|NCT02891226|363483308|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105402484|NCT02891226|363483309|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105402485|NCT02891226|363483310|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105402486|NCT02891226|363483311|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105402487|NCT02891226|363483296|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105402488|NCT02891226|363483297|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105402489|NCT02891226|363483298|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105402490|NCT02891226|363483299|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
105402491|NCT02891226|363483300|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105402492|NCT02891226|363483301|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105402493|NCT02891226|363483302|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105402494|NCT02891226|363483303|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105402495|NCT02891226|363483304|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105402496|NCT02891226|363483305|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105402497|NCT02891226|363483306|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105402498|NCT02891226|363483307|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105402499|NCT02891226|363483308|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105402500|NCT02891226|363483309|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105402501|NCT02891226|363483310|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105402502|NCT02891226|363483311|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105402503|NCT02891226|363483296|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105402504|NCT02891226|363483297|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105402505|NCT02891226|363483298|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105402506|NCT02891226|363483299|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
105402507|NCT02891226|363483300|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105402508|NCT02891226|363483301|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105402509|NCT02891226|363483302|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105402510|NCT02891226|363483303|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105402511|NCT02891226|363483304|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105402512|NCT02891226|363483305|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105402513|NCT02891226|363483306|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105402514|NCT02891226|363483307|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105402515|NCT02891226|363483308|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105402516|NCT02891226|363483309|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105402517|NCT02891226|363483310|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105402518|NCT02891226|363483311|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105402519|NCT02891226|363483296|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105580691|NCT01474512|364126475|FG010|Induction Period|Sponsor Decision|0|||
105402520|NCT02891226|363483297|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105402521|NCT02891226|363483298|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105402522|NCT02891226|363483299|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105580692|NCT01474512|364126476|FG011|Induction Period|Sponsor Decision|0|||
105580693|NCT01474512|364126477|FG012|Induction Period|Sponsor Decision|0|||
105580694|NCT01474512|364126478|FG013|Induction Period|Sponsor Decision|0|||
105580695|NCT01474512|364126479|FG014|Induction Period|Sponsor Decision|0|||
105580696|NCT01474512|364126480|FG015|Induction Period|Sponsor Decision|0|||
105580697|NCT01474512|364126481|FG016|Induction Period|Sponsor Decision|0|||
105580698|NCT01474512|364126482|FG017|Induction Period|Sponsor Decision|0|||
105580699|NCT01474512|364126465|FG000|Induction Period|Lost to Follow-up|1|||
105580700|NCT01474512|364126466|FG001|Induction Period|Lost to Follow-up|0|||
105580701|NCT01474512|364126467|FG002|Induction Period|Lost to Follow-up|2|||
105580702|NCT01474512|364126468|FG003|Induction Period|Lost to Follow-up|0|||
105580703|NCT01474512|364126469|FG004|Induction Period|Lost to Follow-up|0|||
105580704|NCT01474512|364126470|FG005|Induction Period|Lost to Follow-up|0|||
105402523|NCT02891226|363483300|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105402524|NCT02891226|363483301|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105402525|NCT02891226|363483302|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
105402526|NCT02891226|363483303|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
105402527|NCT02891226|363483304|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
105402528|NCT02891226|363483305|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
105402529|NCT02891226|363483306|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105402530|NCT02891226|363483307|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105402531|NCT02891226|363483308|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105402532|NCT02891226|363483309|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105402533|NCT02891226|363483310|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105402534|NCT02891226|363483311|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105402535|NCT02891226|363483296|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105402536|NCT02891226|363483297|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105402537|NCT02891226|363483298|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105402538|NCT02891226|363483299|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105402539|NCT02891226|363483300|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105402540|NCT02891226|363483301|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
105402541|NCT02891226|363483302|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105580705|NCT01474512|364126471|FG006|Induction Period|Lost to Follow-up|0|||
105580706|NCT01474512|364126472|FG007|Induction Period|Lost to Follow-up|0|||
105580707|NCT01474512|364126473|FG008|Induction Period|Lost to Follow-up|0|||
105402542|NCT02891226|363483303|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105402543|NCT02891226|363483304|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105402544|NCT02891226|363483305|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
105402545|NCT02891226|363483306|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105402546|NCT02891226|363483307|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105402547|NCT02891226|363483308|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105402548|NCT02891226|363483309|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105402549|NCT02891226|363483310|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105402550|NCT02891226|363483311|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105402551|NCT02891226|363483296|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105402552|NCT02891226|363483297|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105402553|NCT02891226|363483298|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105402554|NCT02891226|363483299|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105402555|NCT02891226|363483300|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105402556|NCT02891226|363483301|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105402557|NCT02891226|363483302|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
105402558|NCT02891226|363483303|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
105402559|NCT02891226|363483304|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
105402560|NCT02891226|363483305|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
105402561|NCT02891226|363483306|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105402562|NCT02891226|363483307|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105402563|NCT02891226|363483308|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105402564|NCT02891226|363483309|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105402565|NCT02891226|363483310|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105402566|NCT02891226|363483311|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105402567|NCT02891226|363483296|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105402568|NCT02891226|363483297|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105402569|NCT02891226|363483298|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105402570|NCT02891226|363483299|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105402571|NCT02891226|363483300|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
105580708|NCT01474512|364126474|FG009|Induction Period|Lost to Follow-up|0|||
105580709|NCT01474512|364126475|FG010|Induction Period|Lost to Follow-up|0|||
105580710|NCT01474512|364126476|FG011|Induction Period|Lost to Follow-up|0|||
105580711|NCT01474512|364126477|FG012|Induction Period|Lost to Follow-up|0|||
105493583|NCT02642029|363820729|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
105493584|NCT02642029|363820730|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
105493585|NCT02642029|363820731|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
105493586|NCT02642029|363820732|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
105493587|NCT00267189|363820733|FG000|Overall Study|Patient withdrew consent|1|||
105493588|NCT00267189|363820734|FG001|Overall Study|Patient withdrew consent|1|||
105493589|NCT00267189|363820733|FG000|Overall Study|Death|1|||
105493590|NCT00267189|363820734|FG001|Overall Study|Death|0|||
105493591|NCT00267189|363820733|FG000|Overall Study|Missing|3|||
105493592|NCT00267189|363820734|FG001|Overall Study|Missing|0|||
105493593|NCT02477839|363820735|FG000|Overall Study|Adverse Event|0|||
105493594|NCT02477839|363820736|FG001|Overall Study|Adverse Event|1|||
105493595|NCT02477839|363820735|FG000|Overall Study|Protocol Violation|0|||
105493596|NCT02477839|363820736|FG001|Overall Study|Protocol Violation|2|||
105493597|NCT02477839|363820735|FG000|Overall Study|Withdrawal by Subject|3|||
105493598|NCT02477839|363820736|FG001|Overall Study|Withdrawal by Subject|3|||
105493599|NCT02477839|363820735|FG000|Overall Study|Participant had PGS during V6|0|||
105493600|NCT02477839|363820736|FG001|Overall Study|Participant had PGS during V6|1|||
105493601|NCT02477839|363820735|FG000|Overall Study|Parents decided to stop medication|0|||
105493602|NCT02477839|363820736|FG001|Overall Study|Parents decided to stop medication|1|||
105493603|NCT02477839|363820735|FG000|Overall Study|Lack of tolerability|0|||
105493604|NCT02477839|363820736|FG001|Overall Study|Lack of tolerability|1|||
105493605|NCT02477839|363820735|FG000|Overall Study|Exclusion criterion|0|||
105493606|NCT02477839|363820736|FG001|Overall Study|Exclusion criterion|1|||
105493607|NCT01439568|363820741|FG000|Overall Study|Lost to Follow-up|1|||
105493608|NCT01439568|363820742|FG001|Overall Study|Lost to Follow-up|0|||
105493609|NCT01439568|363820741|FG000|Overall Study|Withdrawal by Subject|2|||
105493610|NCT01439568|363820742|FG001|Overall Study|Withdrawal by Subject|2|||
105493611|NCT02517866|363820745|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
105493612|NCT02517866|363820746|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
105493613|NCT02517866|363820747|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
105493614|NCT02517866|363820745|FG000|Overall Study|Significant Protocol Deviation|4|||
105493615|NCT02517866|363820746|FG001|Overall Study|Significant Protocol Deviation|1|||
105493616|NCT02517866|363820747|FG002|Overall Study|Significant Protocol Deviation|0|||
105493617|NCT02517866|363820745|FG000|Overall Study|Lost to Follow-up|1|||
105493618|NCT02517866|363820746|FG001|Overall Study|Lost to Follow-up|0|||
105493619|NCT02517866|363820747|FG002|Overall Study|Lost to Follow-up|0|||
105493620|NCT02517866|363820745|FG000|Overall Study|Voluntary Withdrawal|2|||
105493621|NCT02517866|363820746|FG001|Overall Study|Voluntary Withdrawal|2|||
105493622|NCT02517866|363820747|FG002|Overall Study|Voluntary Withdrawal|0|||
105493623|NCT02517866|363820745|FG000|Overall Study|Investigator Decision|2|||
105493624|NCT02517866|363820746|FG001|Overall Study|Investigator Decision|1|||
105493625|NCT02517866|363820747|FG002|Overall Study|Investigator Decision|0|||
105580712|NCT01474512|364126478|FG013|Induction Period|Lost to Follow-up|0|||
105402572|NCT02891226|363483301|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105402573|NCT02891226|363483302|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105402574|NCT02891226|363483303|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105402575|NCT02891226|363483304|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105402576|NCT02891226|363483305|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105402577|NCT02891226|363483306|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105402578|NCT02891226|363483307|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105402579|NCT02891226|363483308|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105402580|NCT02891226|363483309|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105402581|NCT02891226|363483310|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105402582|NCT02891226|363483311|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105402583|NCT02891226|363483296|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105402584|NCT02891226|363483297|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105402585|NCT02891226|363483298|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105402586|NCT02891226|363483299|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105402587|NCT02891226|363483300|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105402588|NCT02891226|363483301|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105493626|NCT02517866|363820745|FG000|Overall Study|Reason not specified|2|||
105493627|NCT02517866|363820746|FG001|Overall Study|Reason not specified|0|||
105493628|NCT02517866|363820747|FG002|Overall Study|Reason not specified|0|||
105493629|NCT01147640|363820748|FG000|Overall Study|Adverse Event|2|||
105493630|NCT01147640|363820749|FG001|Overall Study|Adverse Event|0|||
105580713|NCT01474512|364126479|FG014|Induction Period|Lost to Follow-up|0|||
105580714|NCT01474512|364126480|FG015|Induction Period|Lost to Follow-up|0|||
105402589|NCT02891226|363483302|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
105493631|NCT01147640|363820748|FG000|Overall Study|Physician Decision|1|||
105493632|NCT01147640|363820749|FG001|Overall Study|Physician Decision|0|||
105493633|NCT01147640|363820748|FG000|Overall Study|Withdrawal by Subject|1|||
105493634|NCT01147640|363820749|FG001|Overall Study|Withdrawal by Subject|0|||
105493635|NCT01147640|363820748|FG000|Overall Study|Lost to Follow-up|0|||
105493636|NCT01147640|363820749|FG001|Overall Study|Lost to Follow-up|1|||
105493637|NCT01147640|363820748|FG000|Overall Study|Didn't meet eligibility criteria|1|||
105493638|NCT01147640|363820749|FG001|Overall Study|Didn't meet eligibility criteria|0|||
105493639|NCT03711266|363820751|FG000|Overall Study|Lost to Follow-up|10|||
105493640|NCT01954342|363820752|FG000|Overall Study|Missing data from 13-16week study visit|0|||
105493641|NCT01954342|363820753|FG001|Overall Study|Missing data from 13-16week study visit|0|||
105493642|NCT01954342|363820754|FG002|Overall Study|Missing data from 13-16week study visit|0|||
105493643|NCT01954342|363820755|FG003|Overall Study|Missing data from 13-16week study visit|1|||
105493644|NCT01954342|363820752|FG000|Overall Study|Miscarriage|0|||
105493645|NCT01954342|363820753|FG001|Overall Study|Miscarriage|0|||
105493646|NCT01954342|363820754|FG002|Overall Study|Miscarriage|0|||
105493647|NCT01954342|363820755|FG003|Overall Study|Miscarriage|3|||
105493648|NCT01954342|363820752|FG000|Overall Study|Lost to Follow-up|0|||
105493649|NCT01954342|363820753|FG001|Overall Study|Lost to Follow-up|0|||
105493650|NCT01954342|363820754|FG002|Overall Study|Lost to Follow-up|0|||
105493651|NCT01954342|363820755|FG003|Overall Study|Lost to Follow-up|5|||
105493652|NCT01954342|363820752|FG000|Overall Study|Preterm delivery|0|||
105493653|NCT01954342|363820753|FG001|Overall Study|Preterm delivery|0|||
105493654|NCT01954342|363820754|FG002|Overall Study|Preterm delivery|0|||
105493655|NCT01954342|363820755|FG003|Overall Study|Preterm delivery|3|||
105493656|NCT01954342|363820752|FG000|Overall Study|Pre-eclampsia|0|||
105493657|NCT01954342|363820753|FG001|Overall Study|Pre-eclampsia|0|||
105493658|NCT01954342|363820754|FG002|Overall Study|Pre-eclampsia|0|||
105493659|NCT01954342|363820755|FG003|Overall Study|Pre-eclampsia|4|||
105493660|NCT01954342|363820752|FG000|Overall Study|Unreliable Data|0|||
105493661|NCT01954342|363820753|FG001|Overall Study|Unreliable Data|0|||
105493662|NCT01954342|363820754|FG002|Overall Study|Unreliable Data|0|||
105493663|NCT01954342|363820755|FG003|Overall Study|Unreliable Data|2|||
105493664|NCT00629772|363820756|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
105493665|NCT00629772|363820757|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
105493666|NCT00629772|363820756|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
105493667|NCT00629772|363820757|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
105493668|NCT00853073|363820758|FG000|Overall Study|Withdrawal by Subject|3|||
105493669|NCT00853073|363820759|FG001|Overall Study|Withdrawal by Subject|2|||
105493670|NCT01938573|363820760|FG000|Overall Study|Lack of Efficacy|1|||
105493671|NCT01938573|363820761|FG001|Overall Study|Lack of Efficacy|0|||
105493672|NCT01938573|363820760|FG000|Overall Study|Operation at other hospital|1|||
105493673|NCT01938573|363820761|FG001|Overall Study|Operation at other hospital|0|||
105493674|NCT01756053|363820769|FG000|Period 1 (10 Days)|Protocol Violation|1|||
105493675|NCT01756053|363820770|FG001|Period 1 (10 Days)|Protocol Violation|1|||
105493676|NCT01756053|363820769|FG000|Period 2 (10 Days)|Protocol Violation|0|||
105493677|NCT01756053|363820770|FG001|Period 2 (10 Days)|Protocol Violation|2|||
105493678|NCT02038452|363820773|FG000|Overall Study|Withdrawal by Subject|7|||
105493679|NCT02038452|363820774|FG001|Overall Study|Withdrawal by Subject|9|||
105493680|NCT02038452|363820773|FG000|Overall Study|Lost to Follow-up|31|||
105493681|NCT02038452|363820774|FG001|Overall Study|Lost to Follow-up|28|||
105493682|NCT00237185|363820777|FG000|Core|Adverse Event|3|||
105493683|NCT00237185|363820778|FG001|Core|Adverse Event|4|||
105493684|NCT00237185|363820777|FG000|Core|Abnormal laboratory value|0|||
105493685|NCT00237185|363820778|FG001|Core|Abnormal laboratory value|4|||
105493686|NCT00237185|363820777|FG000|Core|Abnormal test procedure results|1|||
105493687|NCT00237185|363820778|FG001|Core|Abnormal test procedure results|0|||
105493688|NCT00237185|363820777|FG000|Core|Lack of Efficacy|30|||
105493689|NCT00237185|363820778|FG001|Core|Lack of Efficacy|23|||
105493690|NCT00237185|363820777|FG000|Core|Protocol Violation|1|||
105493691|NCT00237185|363820778|FG001|Core|Protocol Violation|1|||
105493692|NCT00237185|363820777|FG000|Core|Withdrawal by Subject|4|||
105493693|NCT00237185|363820778|FG001|Core|Withdrawal by Subject|4|||
105493694|NCT00237185|363820777|FG000|Core|Administrative problems|0|||
105493695|NCT00237185|363820778|FG001|Core|Administrative problems|1|||
105493696|NCT00237185|363820777|FG000|Core|Death|4|||
105493697|NCT00237185|363820778|FG001|Core|Death|0|||
105493698|NCT00237185|363820777|FG000|Core|Determined ineligible post randomization|1|||
105493699|NCT00237185|363820778|FG001|Core|Determined ineligible post randomization|0|||
105402590|NCT02891226|363483303|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105402591|NCT02891226|363483304|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105402592|NCT02891226|363483305|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105402593|NCT02891226|363483306|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105402594|NCT02891226|363483307|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105402595|NCT02891226|363483308|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105402596|NCT02891226|363483309|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105402597|NCT02891226|363483310|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105402598|NCT02891226|363483311|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105402599|NCT02891226|363483296|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105402600|NCT02891226|363483297|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105402601|NCT02891226|363483298|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105402602|NCT02891226|363483299|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105402603|NCT02891226|363483300|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105402604|NCT02891226|363483301|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105402605|NCT02891226|363483302|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105402606|NCT02891226|363483303|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
105402607|NCT02891226|363483304|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
105402608|NCT02891226|363483305|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
105402609|NCT02891226|363483306|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105402610|NCT02891226|363483307|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105402611|NCT02891226|363483308|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105402612|NCT02891226|363483309|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105402613|NCT02891226|363483310|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105402614|NCT02891226|363483311|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105402615|NCT02891226|363483296|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105402616|NCT02891226|363483297|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105402617|NCT02891226|363483298|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105402618|NCT02891226|363483299|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105402619|NCT02891226|363483300|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105402620|NCT02891226|363483301|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105402621|NCT02891226|363483302|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105402622|NCT02891226|363483303|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
105402623|NCT02891226|363483304|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105402624|NCT02891226|363483305|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105402625|NCT02891226|363483306|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105402626|NCT02891226|363483307|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105402627|NCT02891226|363483308|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105402628|NCT02891226|363483309|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105402629|NCT02891226|363483310|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105402630|NCT02891226|363483311|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105402631|NCT02891226|363483296|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105402632|NCT02891226|363483297|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105402633|NCT02891226|363483298|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105402634|NCT02891226|363483299|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105402635|NCT02891226|363483300|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105402636|NCT02891226|363483301|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105402637|NCT02891226|363483302|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105402638|NCT02891226|363483303|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105402639|NCT02891226|363483304|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
105402640|NCT02891226|363483305|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105402641|NCT02891226|363483306|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105402642|NCT02891226|363483307|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105402643|NCT02891226|363483308|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105402644|NCT02891226|363483309|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105402645|NCT02891226|363483310|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105402646|NCT02891226|363483311|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105402647|NCT02891226|363483296|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105402648|NCT02891226|363483297|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105493700|NCT00237185|363820777|FG000|Extension|Adverse Event|1|||
105402649|NCT02891226|363483298|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105402650|NCT02891226|363483299|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105402651|NCT02891226|363483300|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105402652|NCT02891226|363483301|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105402653|NCT02891226|363483302|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105402654|NCT02891226|363483303|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105402655|NCT02891226|363483304|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105402656|NCT02891226|363483305|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
105402657|NCT02891226|363483306|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105402658|NCT02891226|363483307|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105402659|NCT02891226|363483308|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105402660|NCT02891226|363483309|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105402661|NCT02891226|363483310|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105402662|NCT02891226|363483311|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105402663|NCT02891226|363483296|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105402664|NCT02891226|363483297|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105402665|NCT02891226|363483298|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105402666|NCT02891226|363483299|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105402667|NCT02891226|363483300|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105402668|NCT02891226|363483301|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105402669|NCT02891226|363483302|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105402670|NCT02891226|363483303|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105402671|NCT02891226|363483304|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105402672|NCT02891226|363483305|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
105402673|NCT02891226|363483306|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105402674|NCT02891226|363483307|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105402675|NCT02891226|363483308|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105402676|NCT02891226|363483309|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105402677|NCT02891226|363483310|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105402678|NCT02891226|363483311|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105402679|NCT02891226|363483296|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105402680|NCT02891226|363483297|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105402681|NCT02891226|363483298|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105402682|NCT02891226|363483299|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105402683|NCT02891226|363483300|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105402684|NCT02891226|363483301|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105402685|NCT02891226|363483302|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105402686|NCT02891226|363483303|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105402687|NCT02891226|363483304|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105402688|NCT02891226|363483305|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105402689|NCT02891226|363483306|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
105402690|NCT02891226|363483307|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105402691|NCT02891226|363483308|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105402692|NCT02891226|363483309|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105402693|NCT02891226|363483310|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105402694|NCT02891226|363483311|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105402695|NCT02891226|363483296|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105402696|NCT02891226|363483297|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105402697|NCT02891226|363483298|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105402698|NCT02891226|363483299|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105402699|NCT02891226|363483300|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105402700|NCT02891226|363483301|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105402701|NCT02891226|363483302|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105402702|NCT02891226|363483303|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105402703|NCT02891226|363483304|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105402704|NCT02891226|363483305|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105402705|NCT02891226|363483306|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
105402706|NCT02891226|363483307|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105402707|NCT02891226|363483308|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105402708|NCT02891226|363483309|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105402709|NCT02891226|363483310|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105402710|NCT02891226|363483311|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105402711|NCT02891226|363483296|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105402712|NCT02891226|363483297|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105493701|NCT00237185|363820778|FG001|Extension|Adverse Event|0|||
105493702|NCT00237185|363820777|FG000|Extension|Abnormal laboratory value|0|||
105493703|NCT00237185|363820778|FG001|Extension|Abnormal laboratory value|1|||
105493704|NCT00237185|363820777|FG000|Extension|Lack of Efficacy|9|||
105493705|NCT00237185|363820778|FG001|Extension|Lack of Efficacy|14|||
105493706|NCT00237185|363820777|FG000|Extension|Condition no longer required study drug|0|||
105493707|NCT00237185|363820778|FG001|Extension|Condition no longer required study drug|1|||
105493708|NCT00237185|363820777|FG000|Extension|Withdrawal by Subject|3|||
105493709|NCT00237185|363820778|FG001|Extension|Withdrawal by Subject|2|||
105493710|NCT00237185|363820777|FG000|Extension|Lost to Follow-up|1|||
105493711|NCT00237185|363820778|FG001|Extension|Lost to Follow-up|0|||
105493712|NCT00237185|363820777|FG000|Extension|Administrative problems|1|||
105493713|NCT00237185|363820778|FG001|Extension|Administrative problems|0|||
105493714|NCT00237185|363820777|FG000|Extension|Death|1|||
105493715|NCT00237185|363820778|FG001|Extension|Death|1|||
105493716|NCT03643159|363820791|FG000|Overall Study|Adverse Event|1|||
105493717|NCT03643159|363820791|FG000|Overall Study|Withdrawal by Subject|1|||
105493718|NCT01631812|363820792|FG000|Overall Study|Adverse Event|25|||
105493719|NCT01631812|363820792|FG000|Overall Study|Lack of Efficacy|5|||
105493720|NCT01631812|363820792|FG000|Overall Study|Withdrawal by Subject|4|||
105493721|NCT01631812|363820792|FG000|Overall Study|Physician Decision|3|||
105493722|NCT01033851|363820794|FG000|Overall Study|Withdrawal by Subject|3|||
105493723|NCT01033851|363820795|FG001|Overall Study|Withdrawal by Subject|7|||
105493724|NCT03945266|363820796|FG000|Overall Study|Withdrawal by Subject|1|||
105493725|NCT03945266|363820797|FG001|Overall Study|Withdrawal by Subject|0|||
105493726|NCT03945266|363820796|FG000|Overall Study|Miscarriage|0|||
105493727|NCT03945266|363820797|FG001|Overall Study|Miscarriage|2|||
105493728|NCT03945266|363820796|FG000|Overall Study|Lost to Follow-up|1|||
105493729|NCT03945266|363820797|FG001|Overall Study|Lost to Follow-up|0|||
105493730|NCT04996797|363820801|FG000|Overall Study|Adverse Event|0|||
105493731|NCT04996797|363820802|FG001|Overall Study|Adverse Event|2|||
105493732|NCT04996797|363820803|FG002|Overall Study|Adverse Event|0|||
105493733|NCT04996797|363820804|FG003|Overall Study|Adverse Event|1|||
105493734|NCT04996797|363820801|FG000|Overall Study|Lack of Efficacy|0|||
105493735|NCT04996797|363820802|FG001|Overall Study|Lack of Efficacy|2|||
105493736|NCT04996797|363820803|FG002|Overall Study|Lack of Efficacy|0|||
105493737|NCT04996797|363820804|FG003|Overall Study|Lack of Efficacy|0|||
105493738|NCT04996797|363820801|FG000|Overall Study|Prohibited Medication|0|||
105493739|NCT04996797|363820802|FG001|Overall Study|Prohibited Medication|1|||
105493740|NCT04996797|363820803|FG002|Overall Study|Prohibited Medication|0|||
105493741|NCT04996797|363820804|FG003|Overall Study|Prohibited Medication|0|||
105493742|NCT04996797|363820801|FG000|Overall Study|Ongoing|68|||
105493743|NCT04996797|363820802|FG001|Overall Study|Ongoing|60|||
105493744|NCT04996797|363820803|FG002|Overall Study|Ongoing|22|||
105493745|NCT04996797|363820804|FG003|Overall Study|Ongoing|20|||
105493746|NCT04996797|363820801|FG000|Overall Study|Withdrawal by Subject|0|||
105493747|NCT04996797|363820802|FG001|Overall Study|Withdrawal by Subject|2|||
105493748|NCT04996797|363820803|FG002|Overall Study|Withdrawal by Subject|0|||
105493749|NCT04996797|363820804|FG003|Overall Study|Withdrawal by Subject|0|||
105493750|NCT04176705|363820805|FG000|Overall Study|Withdrawal by Subject|4|||
105493751|NCT04176705|363820806|FG001|Overall Study|Withdrawal by Subject|4|||
105493752|NCT04176705|363820805|FG000|Overall Study|Death|1|||
105493753|NCT04176705|363820806|FG001|Overall Study|Death|1|||
105493754|NCT04176705|363820805|FG000|Overall Study|Lost to Follow-up|3|||
105493755|NCT04176705|363820806|FG001|Overall Study|Lost to Follow-up|3|||
105493756|NCT03360747|363820813|FG000|Overall Study|Voluntary Withdrawal|1|||
105493757|NCT02024555|363820814|FG000|Overall Study|Lost to Follow-up|1|||
105493758|NCT02024555|363820815|FG001|Overall Study|Lost to Follow-up|1|||
105493759|NCT02024555|363820814|FG000|Overall Study|Withdrawal by Subject|5|||
105493760|NCT02024555|363820815|FG001|Overall Study|Withdrawal by Subject|1|||
105493761|NCT03104374|363820816|FG000|Overall Study|Adverse Event|7|||
105493762|NCT03104374|363820817|FG001|Overall Study|Adverse Event|6|||
105493763|NCT03104374|363820818|FG002|Overall Study|Adverse Event|12|||
105493764|NCT03104374|363820819|FG003|Overall Study|Adverse Event|15|||
105493765|NCT03104374|363820816|FG000|Overall Study|Withdrawal by Subject|18|||
105493766|NCT03104374|363820817|FG001|Overall Study|Withdrawal by Subject|10|||
105493767|NCT03104374|363820818|FG002|Overall Study|Withdrawal by Subject|10|||
105493768|NCT03104374|363820819|FG003|Overall Study|Withdrawal by Subject|17|||
105493769|NCT03104374|363820816|FG000|Overall Study|Lost to Follow-up|4|||
105493770|NCT03104374|363820817|FG001|Overall Study|Lost to Follow-up|4|||
105493771|NCT03104374|363820818|FG002|Overall Study|Lost to Follow-up|6|||
105493772|NCT03104374|363820819|FG003|Overall Study|Lost to Follow-up|8|||
105493773|NCT03104374|363820816|FG000|Overall Study|Lack of Efficacy|6|||
105493774|NCT03104374|363820817|FG001|Overall Study|Lack of Efficacy|7|||
105493775|NCT03104374|363820818|FG002|Overall Study|Lack of Efficacy|12|||
105493776|NCT03104374|363820819|FG003|Overall Study|Lack of Efficacy|6|||
105493777|NCT03104374|363820816|FG000|Overall Study|Other|2|||
105493778|NCT03104374|363820817|FG001|Overall Study|Other|2|||
105493779|NCT03104374|363820818|FG002|Overall Study|Other|4|||
105493780|NCT03104374|363820819|FG003|Overall Study|Other|7|||
105493781|NCT04340193|363820821|FG000|Overall Study|Other reason|0|||
105493782|NCT04340193|363820822|FG001|Overall Study|Other reason|0|||
105493783|NCT04340193|363820823|FG002|Overall Study|Other reason|1|||
105493784|NCT04340193|363820821|FG000|Overall Study|Disease recurrence|0|||
105493785|NCT04340193|363820822|FG001|Overall Study|Disease recurrence|1|||
105402713|NCT02891226|363483298|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105402714|NCT02891226|363483299|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105402715|NCT02891226|363483300|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105402716|NCT02891226|363483301|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105402717|NCT02891226|363483302|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105402718|NCT02891226|363483303|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105402719|NCT02891226|363483304|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105402720|NCT02891226|363483305|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105402721|NCT02891226|363483306|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
105402722|NCT02891226|363483307|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105402723|NCT02891226|363483308|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105402724|NCT02891226|363483309|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105402725|NCT02891226|363483310|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105402726|NCT02891226|363483311|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105402727|NCT02891226|363483296|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105402728|NCT02891226|363483297|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105402729|NCT02891226|363483298|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105402730|NCT02891226|363483299|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105402731|NCT02891226|363483300|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105402732|NCT02891226|363483301|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105402733|NCT02891226|363483302|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105402734|NCT02891226|363483303|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105402735|NCT02891226|363483304|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105402736|NCT02891226|363483305|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105402737|NCT02891226|363483306|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
105402738|NCT02891226|363483307|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105402739|NCT02891226|363483308|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105402740|NCT02891226|363483309|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105402741|NCT02891226|363483310|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105402742|NCT02891226|363483311|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105402743|NCT02891226|363483296|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105402744|NCT02891226|363483297|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105402745|NCT02891226|363483298|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105402746|NCT02891226|363483299|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105402747|NCT02891226|363483300|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105402748|NCT02891226|363483301|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105402749|NCT02891226|363483302|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105402750|NCT02891226|363483303|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105402751|NCT02891226|363483304|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105402752|NCT02891226|363483305|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105402753|NCT02891226|363483306|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
105402754|NCT02891226|363483307|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105402755|NCT02891226|363483308|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105402756|NCT02891226|363483309|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105402757|NCT02891226|363483310|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105402758|NCT02891226|363483311|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105402759|NCT02891226|363483296|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105402760|NCT02891226|363483297|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105402761|NCT02891226|363483298|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105402762|NCT02891226|363483299|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105402763|NCT02891226|363483300|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105402764|NCT02891226|363483301|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105402765|NCT02891226|363483302|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105402766|NCT02891226|363483303|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105402767|NCT02891226|363483304|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105402768|NCT02891226|363483305|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105402769|NCT02891226|363483306|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
105402770|NCT02891226|363483307|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105402771|NCT02891226|363483308|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105402772|NCT02891226|363483309|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105402773|NCT02891226|363483310|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105493786|NCT04340193|363820823|FG002|Overall Study|Disease recurrence|0|||
105493787|NCT04340193|363820821|FG000|Overall Study|Study drug toxicity|1|||
105493788|NCT04340193|363820822|FG001|Overall Study|Study drug toxicity|0|||
105493789|NCT04340193|363820823|FG002|Overall Study|Study drug toxicity|0|||
105493790|NCT04340193|363820821|FG000|Overall Study|Disease progression|1|||
105493791|NCT04340193|363820822|FG001|Overall Study|Disease progression|2|||
105493792|NCT04340193|363820823|FG002|Overall Study|Disease progression|3|||
105493793|NCT04340193|363820821|FG000|Overall Study|Administrative reasons by sponsor|0|||
105493794|NCT04340193|363820822|FG001|Overall Study|Administrative reasons by sponsor|1|||
105493795|NCT04340193|363820823|FG002|Overall Study|Administrative reasons by sponsor|0|||
105493796|NCT04340193|363820821|FG000|Overall Study|Adverse Event|1|||
105493797|NCT04340193|363820822|FG001|Overall Study|Adverse Event|1|||
105493798|NCT04340193|363820823|FG002|Overall Study|Adverse Event|0|||
105493799|NCT03894046|363822611|FG000|Overall Study|Protocol Violation|1|||
105493800|NCT03894046|363822612|FG001|Overall Study|Protocol Violation|0|||
105493801|NCT03894046|363822613|FG002|Overall Study|Protocol Violation|0|||
105493802|NCT03894046|363822611|FG000|Overall Study|Adverse Event|0|||
105493803|NCT03894046|363822612|FG001|Overall Study|Adverse Event|1|||
105493804|NCT03894046|363822613|FG002|Overall Study|Adverse Event|0|||
105493805|NCT03894046|363822611|FG000|Overall Study|Withdrawal by Subject|2|||
105493806|NCT03894046|363822612|FG001|Overall Study|Withdrawal by Subject|3|||
105493807|NCT03894046|363822613|FG002|Overall Study|Withdrawal by Subject|1|||
105493808|NCT03894046|363822611|FG000|Overall Study|Death|15|||
105493809|NCT03894046|363822612|FG001|Overall Study|Death|21|||
105493810|NCT03894046|363822613|FG002|Overall Study|Death|4|||
105493811|NCT03894046|363822611|FG000|Overall Study|No growth of ABC|2|||
105493812|NCT03894046|363822612|FG001|Overall Study|No growth of ABC|1|||
105493813|NCT03894046|363822613|FG002|Overall Study|No growth of ABC|0|||
105493814|NCT03894046|363822611|FG000|Overall Study|Physician Decision|1|||
105493815|NCT03894046|363822612|FG001|Overall Study|Physician Decision|1|||
105493816|NCT03894046|363822613|FG002|Overall Study|Physician Decision|1|||
105493817|NCT03894046|363822611|FG000|Overall Study|Prohibited concomitant medication|1|||
105493818|NCT03894046|363822612|FG001|Overall Study|Prohibited concomitant medication|0|||
105493819|NCT03894046|363822613|FG002|Overall Study|Prohibited concomitant medication|0|||
105493820|NCT03894046|363822611|FG000|Overall Study|Transferred to other arm/group|1|||
105493821|NCT03894046|363822612|FG001|Overall Study|Transferred to other arm/group|1|||
105493822|NCT03894046|363822613|FG002|Overall Study|Transferred to other arm/group|0|||
105493823|NCT02572388|363822614|FG000|Overall Study|Withdrawal by Subject|1|||
105493824|NCT02572388|363822615|FG001|Overall Study|Withdrawal by Subject|1|||
105493825|NCT02572388|363822616|FG002|Overall Study|Withdrawal by Subject|2|||
105493826|NCT02572388|363822617|FG003|Overall Study|Withdrawal by Subject|2|||
105493827|NCT01973569|363822620|FG000|Overall Study|Adverse Event|9|||
105493828|NCT01973569|363822621|FG001|Overall Study|Adverse Event|2|||
105493829|NCT01973569|363822622|FG002|Overall Study|Adverse Event|4|||
105493830|NCT01973569|363822620|FG000|Overall Study|Protocol Violation|2|||
105493831|NCT01973569|363822621|FG001|Overall Study|Protocol Violation|1|||
105493832|NCT01973569|363822622|FG002|Overall Study|Protocol Violation|3|||
105493833|NCT01973569|363822620|FG000|Overall Study|Withdrawal by Subject|7|||
105402774|NCT02891226|363483311|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105402775|NCT02891226|363483296|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105402776|NCT02891226|363483297|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105402777|NCT02891226|363483298|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105402778|NCT02891226|363483299|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105402779|NCT02891226|363483300|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105402780|NCT02891226|363483301|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105402781|NCT02891226|363483302|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105402782|NCT02891226|363483303|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105402783|NCT02891226|363483304|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105402784|NCT02891226|363483305|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105402785|NCT02891226|363483306|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
105402786|NCT02891226|363483307|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105402787|NCT02891226|363483308|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105402788|NCT02891226|363483309|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105493834|NCT01973569|363822621|FG001|Overall Study|Withdrawal by Subject|5|||
105493835|NCT01973569|363822622|FG002|Overall Study|Withdrawal by Subject|2|||
105493836|NCT01973569|363822620|FG000|Overall Study|Invasive dental treatment|3|||
105493837|NCT01973569|363822621|FG001|Overall Study|Invasive dental treatment|5|||
105493838|NCT01973569|363822622|FG002|Overall Study|Invasive dental treatment|6|||
105493839|NCT01973569|363822620|FG000|Overall Study|Prohibited concomitant d|1|||
105493840|NCT01973569|363822621|FG001|Overall Study|Prohibited concomitant d|5|||
105580715|NCT01474512|364126481|FG016|Induction Period|Lost to Follow-up|0|||
105493841|NCT01973569|363822622|FG002|Overall Study|Prohibited concomitant d|0|||
105493842|NCT01973569|363822620|FG000|Overall Study|Disease progression|0|||
105493843|NCT01973569|363822621|FG001|Overall Study|Disease progression|3|||
105580716|NCT01474512|364126482|FG017|Induction Period|Lost to Follow-up|0|||
105493844|NCT01973569|363822622|FG002|Overall Study|Disease progression|0|||
105493845|NCT01973569|363822620|FG000|Overall Study|Other|1|||
105493846|NCT01973569|363822621|FG001|Overall Study|Other|1|||
105493847|NCT01973569|363822622|FG002|Overall Study|Other|0|||
105493848|NCT01973569|363822620|FG000|Overall Study|Did not receive study drug|6|||
105493849|NCT01973569|363822621|FG001|Overall Study|Did not receive study drug|3|||
105493850|NCT01973569|363822622|FG002|Overall Study|Did not receive study drug|3|||
105493851|NCT01051466|363822623|FG000|Overall Study|Adverse Event|1|||
105493852|NCT01051466|363822624|FG001|Overall Study|Adverse Event|0|||
105493853|NCT01051466|363822623|FG000|Overall Study|Lost to Follow-up|1|||
105493854|NCT01051466|363822624|FG001|Overall Study|Lost to Follow-up|1|||
105493855|NCT01051466|363822623|FG000|Overall Study|Withdrawal by Subject|5|||
105493856|NCT01051466|363822624|FG001|Overall Study|Withdrawal by Subject|1|||
105493857|NCT01051466|363822623|FG000|Overall Study|Entry Criteria Not Met|0|||
105493858|NCT01051466|363822624|FG001|Overall Study|Entry Criteria Not Met|3|||
105493859|NCT01051466|363822623|FG000|Overall Study|Physician Decision|1|||
105493860|NCT01051466|363822624|FG001|Overall Study|Physician Decision|0|||
105493861|NCT00331864|363822631|FG000|Overall Study|Adverse Event|30|||
105493862|NCT00331864|363822632|FG001|Overall Study|Adverse Event|1|||
105493863|NCT00331864|363822631|FG000|Overall Study|Lack of Efficacy|4|||
105580717|NCT01474512|364126465|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
105402789|NCT02891226|363483310|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105402790|NCT02891226|363483311|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105402791|NCT02891226|363483296|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105402792|NCT02891226|363483297|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105402793|NCT02891226|363483298|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105402794|NCT02891226|363483299|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105402795|NCT02891226|363483300|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105402796|NCT02891226|363483301|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105402797|NCT02891226|363483302|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105402798|NCT02891226|363483303|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105402799|NCT02891226|363483304|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105402800|NCT02891226|363483305|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105402801|NCT02891226|363483306|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
105402802|NCT02891226|363483307|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105402803|NCT02891226|363483308|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105402804|NCT02891226|363483309|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105402805|NCT02891226|363483310|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105402806|NCT02891226|363483311|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105402807|NCT02891226|363483296|FG000|Follow-up Period|Withdrawal by Subject|0|||
105402808|NCT02891226|363483297|FG001|Follow-up Period|Withdrawal by Subject|0|||
105402809|NCT02891226|363483298|FG002|Follow-up Period|Withdrawal by Subject|0|||
105402810|NCT02891226|363483299|FG003|Follow-up Period|Withdrawal by Subject|0|||
105402811|NCT02891226|363483300|FG004|Follow-up Period|Withdrawal by Subject|0|||
105402812|NCT02891226|363483301|FG005|Follow-up Period|Withdrawal by Subject|0|||
105402813|NCT02891226|363483302|FG006|Follow-up Period|Withdrawal by Subject|0|||
105402814|NCT02891226|363483303|FG007|Follow-up Period|Withdrawal by Subject|0|||
105402815|NCT02891226|363483304|FG008|Follow-up Period|Withdrawal by Subject|0|||
105402816|NCT02891226|363483305|FG009|Follow-up Period|Withdrawal by Subject|0|||
105402817|NCT02891226|363483306|FG010|Follow-up Period|Withdrawal by Subject|0|||
105402818|NCT02891226|363483307|FG011|Follow-up Period|Withdrawal by Subject|1|||
105402819|NCT02891226|363483308|FG012|Follow-up Period|Withdrawal by Subject|0|||
105402820|NCT02891226|363483309|FG013|Follow-up Period|Withdrawal by Subject|0|||
105402821|NCT02891226|363483310|FG014|Follow-up Period|Withdrawal by Subject|1|||
105580718|NCT01474512|364126466|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
105580719|NCT01474512|364126467|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
105580720|NCT01474512|364126468|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
105402822|NCT02891226|363483311|FG015|Follow-up Period|Withdrawal by Subject|1|||
105402823|NCT01445847|363483314|FG000|Overall Study|Protocol Violation|13|||
105402824|NCT01445847|363483315|FG001|Overall Study|Protocol Violation|14|||
105402825|NCT01445847|363483314|FG000|Overall Study|Missed Data|1|||
105402826|NCT01445847|363483315|FG001|Overall Study|Missed Data|0|||
105493864|NCT00331864|363822632|FG001|Overall Study|Lack of Efficacy|0|||
105493865|NCT00331864|363822631|FG000|Overall Study|Protocol Violation|3|||
105493866|NCT00331864|363822632|FG001|Overall Study|Protocol Violation|0|||
105493867|NCT00331864|363822631|FG000|Overall Study|Withdrawal by Subject|10|||
105493868|NCT00331864|363822632|FG001|Overall Study|Withdrawal by Subject|0|||
105402827|NCT01985022|363483316|FG000|Overall Study|Lost to Follow-up|0|||
105402828|NCT01985022|363483317|FG001|Overall Study|Lost to Follow-up|1|||
105402829|NCT01985022|363483316|FG000|Overall Study|Protocol Violation|0|||
105402830|NCT01985022|363483317|FG001|Overall Study|Protocol Violation|1|||
105402831|NCT01985022|363483316|FG000|Overall Study|Withdrawal by Subject|4|||
105402832|NCT01985022|363483317|FG001|Overall Study|Withdrawal by Subject|1|||
105402833|NCT02015039|363483318|FG000|Overall Study|Not eligible|0|||
105402834|NCT02015039|363483319|FG001|Overall Study|Not eligible|1|||
105402835|NCT04570384|363483320|FG000|Overall Study|Adverse Event|2|||
105402836|NCT04570384|363483321|FG001|Overall Study|Adverse Event|1|||
105402837|NCT04570384|363483320|FG000|Overall Study|Death|2|||
105402838|NCT04570384|363483321|FG001|Overall Study|Death|5|||
105402839|NCT04570384|363483320|FG000|Overall Study|Lost to Follow-up|1|||
105402840|NCT04570384|363483321|FG001|Overall Study|Lost to Follow-up|0|||
105402841|NCT04570384|363483320|FG000|Overall Study|Other|1|||
105402842|NCT04570384|363483321|FG001|Overall Study|Other|0|||
105402843|NCT04570384|363483320|FG000|Overall Study|Protocol Violation|0|||
105402844|NCT04570384|363483321|FG001|Overall Study|Protocol Violation|1|||
105402845|NCT04570384|363483320|FG000|Overall Study|Sponsor Decision|1|||
105402846|NCT04570384|363483321|FG001|Overall Study|Sponsor Decision|0|||
105402847|NCT04570384|363483320|FG000|Overall Study|Withdrawal by Subject|4|||
105402848|NCT04570384|363483321|FG001|Overall Study|Withdrawal by Subject|2|||
105402849|NCT01404234|363483324|FG000|Overall Study|Withdrawal by Subject|2|||
105402850|NCT00806260|363483325|FG000|Period 1 (1 Day)|Adverse Event|0|||
105402851|NCT00806260|363483326|FG001|Period 1 (1 Day)|Adverse Event|0|||
105402852|NCT00806260|363483327|FG002|Period 1 (1 Day)|Adverse Event|0|||
105402853|NCT00806260|363483328|FG003|Period 1 (1 Day)|Adverse Event|0|||
105402854|NCT00806260|363483329|FG004|Period 1 (1 Day)|Adverse Event|3|||
105402855|NCT00806260|363483330|FG005|Period 1 (1 Day)|Adverse Event|0|||
105402856|NCT00806260|363483325|FG000|Period 2|Adverse Event|0|||
105402857|NCT00806260|363483326|FG001|Period 2|Adverse Event|0|||
105402858|NCT00806260|363483327|FG002|Period 2|Adverse Event|0|||
105402859|NCT00806260|363483328|FG003|Period 2|Adverse Event|1|||
105402860|NCT00806260|363483329|FG004|Period 2|Adverse Event|0|||
105402861|NCT00806260|363483330|FG005|Period 2|Adverse Event|0|||
105402862|NCT00806260|363483325|FG000|Period 2|Protocol Violation|1|||
105402863|NCT00806260|363483326|FG001|Period 2|Protocol Violation|0|||
105402864|NCT00806260|363483327|FG002|Period 2|Protocol Violation|1|||
105402865|NCT00806260|363483328|FG003|Period 2|Protocol Violation|0|||
105402866|NCT00806260|363483329|FG004|Period 2|Protocol Violation|0|||
105402867|NCT00806260|363483330|FG005|Period 2|Protocol Violation|0|||
105402868|NCT00806260|363483325|FG000|Period 2|Need to take concomitant medication|1|||
105402869|NCT00806260|363483326|FG001|Period 2|Need to take concomitant medication|0|||
105402870|NCT00806260|363483327|FG002|Period 2|Need to take concomitant medication|0|||
105402871|NCT00806260|363483328|FG003|Period 2|Need to take concomitant medication|0|||
105402872|NCT00806260|363483329|FG004|Period 2|Need to take concomitant medication|0|||
105402873|NCT00806260|363483330|FG005|Period 2|Need to take concomitant medication|0|||
105402874|NCT00806260|363483325|FG000|Period 2|sponsor request|0|||
105402875|NCT00806260|363483326|FG001|Period 2|sponsor request|0|||
105402876|NCT00806260|363483327|FG002|Period 2|sponsor request|1|||
105402877|NCT00806260|363483328|FG003|Period 2|sponsor request|1|||
105402878|NCT00806260|363483329|FG004|Period 2|sponsor request|0|||
105402879|NCT00806260|363483330|FG005|Period 2|sponsor request|0|||
105402880|NCT00806260|363483325|FG000|Period 3|Protocol Violation|0|||
105402881|NCT00806260|363483326|FG001|Period 3|Protocol Violation|1|||
105402882|NCT00806260|363483327|FG002|Period 3|Protocol Violation|1|||
105402883|NCT00806260|363483328|FG003|Period 3|Protocol Violation|0|||
105402884|NCT00806260|363483329|FG004|Period 3|Protocol Violation|0|||
105402885|NCT00806260|363483330|FG005|Period 3|Protocol Violation|0|||
105402886|NCT00806260|363483325|FG000|Period 3|Pregnancy|1|||
105402887|NCT00806260|363483326|FG001|Period 3|Pregnancy|0|||
105402888|NCT00806260|363483327|FG002|Period 3|Pregnancy|0|||
105402889|NCT00806260|363483328|FG003|Period 3|Pregnancy|0|||
105402890|NCT00806260|363483329|FG004|Period 3|Pregnancy|0|||
105402891|NCT00806260|363483330|FG005|Period 3|Pregnancy|0|||
105402892|NCT03965403|363483333|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
105402893|NCT02026011|363485571|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
105402894|NCT02026011|363485572|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
105402895|NCT02026011|363485571|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
105402896|NCT02026011|363485572|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
105402897|NCT02026011|363485571|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
105402898|NCT02026011|363485572|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
105402899|NCT02026011|363485571|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
105402900|NCT02026011|363485572|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
105402901|NCT00529243|363485575|FG000|Overall Study|Adverse Event|1|||
105402902|NCT00529243|363485575|FG000|Overall Study|Death|1|||
105402903|NCT00529243|363485575|FG000|Overall Study|Relocated|1|||
105402904|NCT00937495|363485578|FG000|Overall Study|Protocol Violation|2|||
105402905|NCT00661830|363485579|FG000|Overall Study|Death|37|||
105402906|NCT00661830|363485580|FG001|Overall Study|Death|33|||
105402907|NCT00661830|363485579|FG000|Overall Study|Lost to Follow-up|1|||
105402908|NCT00661830|363485580|FG001|Overall Study|Lost to Follow-up|3|||
105402909|NCT00661830|363485579|FG000|Overall Study|Withdrawal by Subject|1|||
105402910|NCT00661830|363485580|FG001|Overall Study|Withdrawal by Subject|1|||
105402911|NCT00661830|363485579|FG000|Overall Study|Other reason|1|||
105402912|NCT00661830|363485580|FG001|Overall Study|Other reason|5|||
105402913|NCT01669902|363485581|FG000|Overall Study|Adverse Event|11|||
105402914|NCT01669902|363485581|FG000|Overall Study|Lack of Efficacy|10|||
105402915|NCT01669902|363485581|FG000|Overall Study|Other|8|||
105402916|NCT01535287|363485584|FG000|Overall Study|drug not prepared in time|5|||
105402917|NCT01535287|363485585|FG001|Overall Study|drug not prepared in time|6|||
105402918|NCT02332187|363485588|FG000|Overall Study|Withdrawal by Subject|2|||
105402919|NCT02332187|363485589|FG001|Overall Study|Withdrawal by Subject|2|||
105402920|NCT02332187|363485588|FG000|Overall Study|Adverse Event|0|||
105402921|NCT02332187|363485589|FG001|Overall Study|Adverse Event|1|||
105402922|NCT01840943|363485590|FG000|Overall Study|Withdrawal by Subject|5|||
105402923|NCT01840943|363485591|FG001|Overall Study|Withdrawal by Subject|6|||
105402924|NCT01840943|363485590|FG000|Overall Study|Physician Decision|4|||
105402925|NCT01840943|363485591|FG001|Overall Study|Physician Decision|2|||
105402926|NCT01840943|363485590|FG000|Overall Study|Lost to Follow-up|4|||
105402927|NCT01840943|363485591|FG001|Overall Study|Lost to Follow-up|4|||
105402928|NCT02580877|363485592|FG000|Overall Study|Withdrawal by Subject|1|||
105402929|NCT02580877|363485593|FG001|Overall Study|Withdrawal by Subject|3|||
105402930|NCT02580877|363485592|FG000|Overall Study|Adverse Event|0|||
105402931|NCT02580877|363485593|FG001|Overall Study|Adverse Event|1|||
105402932|NCT00980148|363485594|FG000|Overall Study|Discharged from facility|89|||
105402933|NCT00980148|363485595|FG001|Overall Study|Discharged from facility|96|||
105402934|NCT00980148|363485594|FG000|Overall Study|Received other antichlamydia treatment|20|||
105402935|NCT00980148|363485595|FG001|Overall Study|Received other antichlamydia treatment|14|||
105402936|NCT00980148|363485594|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
105402937|NCT00980148|363485595|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
105402938|NCT00980148|363485594|FG000|Overall Study|Various other reasons|8|||
105402939|NCT00980148|363485595|FG001|Overall Study|Various other reasons|9|||
105402940|NCT02903823|363485596|FG000|Overall Study|Physician Decision|5|||
105402941|NCT02903823|363485596|FG000|Overall Study|Could not advance catheter|1|||
105402942|NCT02903823|363485596|FG000|Overall Study|Catheter dislodgement|1|||
105402943|NCT01747915|363485597|FG000|Overall Study|Other|1|||
105402944|NCT01747915|363485598|FG001|Overall Study|Other|1|||
105402945|NCT01747915|363485599|FG002|Overall Study|Other|1|||
105402946|NCT01747915|363485597|FG000|Overall Study|Adverse Event|8|||
105402947|NCT01747915|363485598|FG001|Overall Study|Adverse Event|5|||
105402948|NCT01747915|363485599|FG002|Overall Study|Adverse Event|2|||
105402949|NCT01747915|363485597|FG000|Overall Study|Death|0|||
105402950|NCT01747915|363485598|FG001|Overall Study|Death|0|||
105402951|NCT01747915|363485599|FG002|Overall Study|Death|1|||
105402952|NCT01747915|363485597|FG000|Overall Study|Lack of Efficacy|0|||
105402953|NCT01747915|363485598|FG001|Overall Study|Lack of Efficacy|1|||
105402954|NCT01747915|363485599|FG002|Overall Study|Lack of Efficacy|0|||
105402955|NCT01747915|363485597|FG000|Overall Study|Lost to Follow-up|1|||
105402956|NCT01747915|363485598|FG001|Overall Study|Lost to Follow-up|0|||
105402957|NCT01747915|363485599|FG002|Overall Study|Lost to Follow-up|0|||
105402958|NCT01747915|363485597|FG000|Overall Study|Withdrawal by Subject|4|||
105402959|NCT01747915|363485598|FG001|Overall Study|Withdrawal by Subject|4|||
105402960|NCT01747915|363485599|FG002|Overall Study|Withdrawal by Subject|1|||
105402961|NCT01747915|363485597|FG000|Overall Study|Protocol Violation|1|||
105402962|NCT01747915|363485598|FG001|Overall Study|Protocol Violation|0|||
105402963|NCT01747915|363485599|FG002|Overall Study|Protocol Violation|0|||
105402964|NCT01747915|363485597|FG000|Overall Study|Pregnancy|0|||
105402965|NCT01747915|363485598|FG001|Overall Study|Pregnancy|0|||
105402966|NCT01747915|363485599|FG002|Overall Study|Pregnancy|1|||
105402967|NCT00938912|363485600|FG000|Overall Study|Withdrawal by Subject|28|||
105402968|NCT00938912|363485600|FG000|Overall Study|Lost to Follow-up|4|||
105402969|NCT00938912|363485600|FG000|Overall Study|Lack of Efficacy|43|||
105402970|NCT00938912|363485600|FG000|Overall Study|Adverse event, non-fatal|24|||
105402971|NCT00938912|363485600|FG000|Overall Study|Adverse event, fatal|1|||
105402972|NCT00938912|363485600|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
105402973|NCT00938912|363485600|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
105402974|NCT00938912|363485600|FG000|Overall Study|Participant needed prohibit medication|1|||
105402975|NCT00938912|363485600|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
105402976|NCT00938912|363485600|FG000|Overall Study|Did not meet Eligibility criteria|1|||
105402977|NCT00938912|363485600|FG000|Overall Study|Participant relocated not related to AE|1|||
105402978|NCT00938912|363485600|FG000|Overall Study|Participant moved to another city|1|||
105493869|NCT00331864|363822631|FG000|Overall Study|Lost to Follow-up|4|||
105493870|NCT00331864|363822632|FG001|Overall Study|Lost to Follow-up|3|||
105493871|NCT00331864|363822631|FG000|Overall Study|Administrative Problems|1|||
105493872|NCT00331864|363822632|FG001|Overall Study|Administrative Problems|0|||
105493873|NCT00331864|363822631|FG000|Overall Study|Death|6|||
105493874|NCT00331864|363822632|FG001|Overall Study|Death|0|||
105493875|NCT00293215|363822638|FG000|Overall Study|Progressive disease|3|||
105493876|NCT00293215|363822639|FG001|Overall Study|Progressive disease|1|||
105493877|NCT00293215|363822638|FG000|Overall Study|Adverse Event|2|||
105493878|NCT00293215|363822639|FG001|Overall Study|Adverse Event|2|||
105493879|NCT05061966|363822640|FG000|Overall Study|Lost to Follow-up|13|||
105493880|NCT05061966|363822641|FG001|Overall Study|Lost to Follow-up|13|||
105493881|NCT00785928|363822644|FG000|Treatment Phase|Adverse Event|1|||
105493882|NCT00785928|363822645|FG001|Treatment Phase|Adverse Event|1|||
105493883|NCT00785928|363822646|FG002|Treatment Phase|Adverse Event|2|||
105493884|NCT00785928|363822647|FG003|Treatment Phase|Adverse Event|0|||
105493885|NCT00785928|363822648|FG004|Treatment Phase|Adverse Event|0|||
105493886|NCT00785928|363822649|FG005|Treatment Phase|Adverse Event|0|||
105493887|NCT00785928|363822650|FG006|Treatment Phase|Adverse Event|2|||
105493888|NCT00785928|363822644|FG000|Treatment Phase|Inadequate Response|0|||
105493889|NCT00785928|363822645|FG001|Treatment Phase|Inadequate Response|1|||
105493890|NCT00785928|363822646|FG002|Treatment Phase|Inadequate Response|0|||
105493891|NCT00785928|363822647|FG003|Treatment Phase|Inadequate Response|0|||
105493892|NCT00785928|363822648|FG004|Treatment Phase|Inadequate Response|0|||
105493893|NCT00785928|363822649|FG005|Treatment Phase|Inadequate Response|0|||
105493894|NCT00785928|363822650|FG006|Treatment Phase|Inadequate Response|0|||
105493895|NCT00785928|363822644|FG000|Treatment Phase|Lack of Efficacy|0|||
105493896|NCT00785928|363822645|FG001|Treatment Phase|Lack of Efficacy|1|||
105493897|NCT00785928|363822646|FG002|Treatment Phase|Lack of Efficacy|1|||
105493898|NCT00785928|363822647|FG003|Treatment Phase|Lack of Efficacy|0|||
105493899|NCT00785928|363822648|FG004|Treatment Phase|Lack of Efficacy|0|||
105493900|NCT00785928|363822649|FG005|Treatment Phase|Lack of Efficacy|0|||
105493901|NCT00785928|363822650|FG006|Treatment Phase|Lack of Efficacy|0|||
105493902|NCT00785928|363822644|FG000|Treatment Phase|Physician Decision|0|||
105493903|NCT00785928|363822645|FG001|Treatment Phase|Physician Decision|0|||
105493904|NCT00785928|363822646|FG002|Treatment Phase|Physician Decision|0|||
105493905|NCT00785928|363822647|FG003|Treatment Phase|Physician Decision|0|||
105493906|NCT00785928|363822648|FG004|Treatment Phase|Physician Decision|1|||
105493907|NCT00785928|363822649|FG005|Treatment Phase|Physician Decision|0|||
105493908|NCT00785928|363822650|FG006|Treatment Phase|Physician Decision|0|||
105493909|NCT00785928|363822644|FG000|Treatment Phase|Sponsor Decision|1|||
105493910|NCT00785928|363822645|FG001|Treatment Phase|Sponsor Decision|0|||
105493911|NCT00785928|363822646|FG002|Treatment Phase|Sponsor Decision|0|||
105493912|NCT00785928|363822647|FG003|Treatment Phase|Sponsor Decision|0|||
105493913|NCT00785928|363822648|FG004|Treatment Phase|Sponsor Decision|0|||
105493914|NCT00785928|363822649|FG005|Treatment Phase|Sponsor Decision|0|||
105493915|NCT00785928|363822650|FG006|Treatment Phase|Sponsor Decision|1|||
105493916|NCT00785928|363822644|FG000|Treatment Phase|Withdrawal by Subject|1|||
105493917|NCT00785928|363822645|FG001|Treatment Phase|Withdrawal by Subject|2|||
105493918|NCT00785928|363822646|FG002|Treatment Phase|Withdrawal by Subject|0|||
105493919|NCT00785928|363822647|FG003|Treatment Phase|Withdrawal by Subject|0|||
105493920|NCT00785928|363822648|FG004|Treatment Phase|Withdrawal by Subject|1|||
105493921|NCT00785928|363822649|FG005|Treatment Phase|Withdrawal by Subject|0|||
105493922|NCT00785928|363822650|FG006|Treatment Phase|Withdrawal by Subject|0|||
105493923|NCT02600351|363822658|FG000|Overall Study|Lack of Efficacy|3|||
105493924|NCT02600351|363822659|FG001|Overall Study|Lack of Efficacy|0|||
105493925|NCT02600351|363822660|FG002|Overall Study|Lack of Efficacy|5|||
105493926|NCT02600351|363822661|FG003|Overall Study|Lack of Efficacy|2|||
105493927|NCT02600351|363822658|FG000|Overall Study|Lost to Follow-up|1|||
105493928|NCT02600351|363822659|FG001|Overall Study|Lost to Follow-up|0|||
105493929|NCT02600351|363822660|FG002|Overall Study|Lost to Follow-up|0|||
105493930|NCT02600351|363822661|FG003|Overall Study|Lost to Follow-up|0|||
105493931|NCT02600351|363822658|FG000|Overall Study|Randomized but Not Treated|1|||
105493932|NCT02600351|363822659|FG001|Overall Study|Randomized but Not Treated|0|||
105493933|NCT02600351|363822660|FG002|Overall Study|Randomized but Not Treated|1|||
105493934|NCT02600351|363822661|FG003|Overall Study|Randomized but Not Treated|3|||
105493935|NCT02413372|363822665|FG000|Treatment|Lost to Follow-up|0|||
105493936|NCT02413372|363822666|FG001|Treatment|Lost to Follow-up|2|||
105493937|NCT02413372|363822667|FG002|Treatment|Lost to Follow-up|1|||
105493938|NCT02413372|363822665|FG000|Treatment|Withdrawal by Subject|1|||
105493939|NCT02413372|363822666|FG001|Treatment|Withdrawal by Subject|0|||
105493940|NCT02413372|363822667|FG002|Treatment|Withdrawal by Subject|0|||
105493941|NCT02413372|363822665|FG000|Follow-up|Lost to Follow-up|1|||
105493942|NCT02413372|363822666|FG001|Follow-up|Lost to Follow-up|1|||
105493943|NCT02413372|363822667|FG002|Follow-up|Lost to Follow-up|0|||
105493944|NCT02413372|363822665|FG000|Follow-up|Subject Withdrew Consent|1|||
105493945|NCT02413372|363822666|FG001|Follow-up|Subject Withdrew Consent|0|||
105493946|NCT02413372|363822667|FG002|Follow-up|Subject Withdrew Consent|1|||
105493947|NCT02413372|363822665|FG000|Follow-up|Subject unable to return for visit|0|||
105402979|NCT00938912|363485600|FG000|Overall Study|Participant experienced break through seizures|1|||
105402980|NCT00938912|363485600|FG000|Overall Study|No longer wished to participate in the study|1|||
105402981|NCT00938912|363485600|FG000|Overall Study|Protocol Deviation|2|||
105402982|NCT00887159|363485608|FG000|Overall Study|Disease progression|6|||
105402983|NCT00887159|363485609|FG001|Overall Study|Disease progression|39|||
105402984|NCT00887159|363485610|FG002|Overall Study|Disease progression|33|||
105402985|NCT00887159|363485608|FG000|Overall Study|Adverse Event|3|||
105402986|NCT00887159|363485609|FG001|Overall Study|Adverse Event|4|||
105402987|NCT00887159|363485610|FG002|Overall Study|Adverse Event|17|||
105402988|NCT00887159|363485608|FG000|Overall Study|Death|2|||
105402989|NCT00887159|363485609|FG001|Overall Study|Death|2|||
105402990|NCT00887159|363485610|FG002|Overall Study|Death|0|||
105402991|NCT00887159|363485608|FG000|Overall Study|Withdrawal by Subject|4|||
105402992|NCT00887159|363485609|FG001|Overall Study|Withdrawal by Subject|4|||
105402993|NCT00887159|363485610|FG002|Overall Study|Withdrawal by Subject|2|||
105402994|NCT00887159|363485608|FG000|Overall Study|Alternative therapy|2|||
105402995|NCT00887159|363485609|FG001|Overall Study|Alternative therapy|0|||
105402996|NCT00887159|363485610|FG002|Overall Study|Alternative therapy|0|||
105402997|NCT00887159|363485608|FG000|Overall Study|Physician Decision|1|||
105402998|NCT00887159|363485609|FG001|Overall Study|Physician Decision|1|||
105402999|NCT00887159|363485610|FG002|Overall Study|Physician Decision|0|||
105403000|NCT00887159|363485608|FG000|Overall Study|Sympomatic deterioration|1|||
105403001|NCT00887159|363485609|FG001|Overall Study|Sympomatic deterioration|0|||
105403002|NCT00887159|363485610|FG002|Overall Study|Sympomatic deterioration|0|||
105403003|NCT00887159|363485608|FG000|Overall Study|Treatment delayed|1|||
105403004|NCT00887159|363485609|FG001|Overall Study|Treatment delayed|1|||
105403005|NCT00887159|363485610|FG002|Overall Study|Treatment delayed|0|||
105403006|NCT00887159|363485608|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
105403007|NCT00887159|363485609|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
105403008|NCT00887159|363485610|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
105403009|NCT00887159|363485608|FG000|Overall Study|Received more tx instead of observation|1|||
105403010|NCT00887159|363485609|FG001|Overall Study|Received more tx instead of observation|0|||
105403011|NCT00887159|363485610|FG002|Overall Study|Received more tx instead of observation|0|||
105403012|NCT00887159|363485608|FG000|Overall Study|Ineligible|5|||
105403013|NCT00887159|363485609|FG001|Overall Study|Ineligible|1|||
105403014|NCT00887159|363485610|FG002|Overall Study|Ineligible|0|||
105403015|NCT00887159|363485608|FG000|Overall Study|Never started assigned therapy|3|||
105403016|NCT00887159|363485609|FG001|Overall Study|Never started assigned therapy|3|||
105403017|NCT00887159|363485610|FG002|Overall Study|Never started assigned therapy|4|||
105403018|NCT00803738|363485611|FG000|Overall Study|Adverse Event|3|||
105403019|NCT00803738|363485612|FG001|Overall Study|Adverse Event|5|||
105403020|NCT00803738|363485611|FG000|Overall Study|Lost to Follow-up|4|||
105403021|NCT00803738|363485612|FG001|Overall Study|Lost to Follow-up|4|||
105403022|NCT00803738|363485611|FG000|Overall Study|Protocol Violation|18|||
105403023|NCT00803738|363485612|FG001|Overall Study|Protocol Violation|10|||
105403024|NCT00803738|363485611|FG000|Overall Study|Withdrawal by Subject|1|||
105403025|NCT00803738|363485612|FG001|Overall Study|Withdrawal by Subject|4|||
105403026|NCT00803738|363485611|FG000|Overall Study|Lack of Efficacy|10|||
105403027|NCT00803738|363485612|FG001|Overall Study|Lack of Efficacy|16|||
105403028|NCT00803738|363485611|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
105403029|NCT00803738|363485612|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
105403030|NCT00803738|363485611|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
105403031|NCT00803738|363485612|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
105403032|NCT02391311|363485613|FG000|Overall Study|Lost to Follow-up|2|||
105403033|NCT02391311|363485614|FG001|Overall Study|Lost to Follow-up|1|||
105403034|NCT02391311|363485613|FG000|Overall Study|deemed ineligible after baseline|1|||
105403035|NCT02391311|363485614|FG001|Overall Study|deemed ineligible after baseline|1|||
105403036|NCT02364037|363485615|FG000|Overall Study|Withdrawal by Subject|7|||
105403037|NCT02364037|363485616|FG001|Overall Study|Withdrawal by Subject|4|||
105403038|NCT02364037|363485615|FG000|Overall Study|Lost to Follow-up|37|||
105403039|NCT02364037|363485616|FG001|Overall Study|Lost to Follow-up|49|||
105403040|NCT01772550|363485619|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
105403041|NCT01772550|363485620|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
105403042|NCT01772550|363485621|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
105403043|NCT01772550|363485619|FG000|Overall Study|Adverse Event|0|||
105403044|NCT01772550|363485620|FG001|Overall Study|Adverse Event|0|||
105403045|NCT01772550|363485621|FG002|Overall Study|Adverse Event|1|||
105403046|NCT01815424|363485622|FG000|Week 0 to 16|Adverse Event|1|||
105403047|NCT01815424|363485623|FG001|Week 0 to 16|Adverse Event|3|||
105403048|NCT01815424|363485624|FG002|Week 0 to 16|Adverse Event|3|||
105403049|NCT01815424|363485625|FG003|Week 0 to 16|Adverse Event|0|||
105403050|NCT01815424|363485626|FG004|Week 0 to 16|Adverse Event|0|||
105403051|NCT01815424|363485622|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
105403052|NCT01815424|363485623|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
105403053|NCT01815424|363485624|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
105403054|NCT01815424|363485625|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
105493948|NCT02413372|363822666|FG001|Follow-up|Subject unable to return for visit|0|||
105493949|NCT02413372|363822667|FG002|Follow-up|Subject unable to return for visit|1|||
105493950|NCT04587271|363822669|FG000|Overall Study|Lost to Follow-up|2|||
105493951|NCT04587271|363822670|FG001|Overall Study|Lost to Follow-up|2|||
105493952|NCT04587271|363822671|FG002|Overall Study|Lost to Follow-up|0|||
105493953|NCT04587271|363822672|FG003|Overall Study|Lost to Follow-up|2|||
105493954|NCT04587271|363822673|FG004|Overall Study|Lost to Follow-up|2|||
105493955|NCT04587271|363822674|FG005|Overall Study|Lost to Follow-up|0|||
105493956|NCT04587271|363822669|FG000|Overall Study|Caregiver brought child to visits|0|||
105493957|NCT04587271|363822670|FG001|Overall Study|Caregiver brought child to visits|0|||
105493958|NCT04587271|363822671|FG002|Overall Study|Caregiver brought child to visits|0|||
105493959|NCT04587271|363822672|FG003|Overall Study|Caregiver brought child to visits|1|||
105403055|NCT01815424|363485626|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
105403056|NCT01815424|363485622|FG000|Week 0 to 16|Lost to Follow-up|0|||
105403057|NCT01815424|363485623|FG001|Week 0 to 16|Lost to Follow-up|1|||
105403058|NCT01815424|363485624|FG002|Week 0 to 16|Lost to Follow-up|0|||
105403059|NCT01815424|363485625|FG003|Week 0 to 16|Lost to Follow-up|0|||
105403060|NCT01815424|363485626|FG004|Week 0 to 16|Lost to Follow-up|0|||
105403061|NCT01815424|363485622|FG000|Week 0 to 16|Withdrawal by Subject|0|||
105403062|NCT01815424|363485623|FG001|Week 0 to 16|Withdrawal by Subject|0|||
105403063|NCT01815424|363485624|FG002|Week 0 to 16|Withdrawal by Subject|1|||
105403064|NCT01815424|363485625|FG003|Week 0 to 16|Withdrawal by Subject|0|||
105403065|NCT01815424|363485626|FG004|Week 0 to 16|Withdrawal by Subject|0|||
105403066|NCT01815424|363485622|FG000|Week 0 to 16|Other|1|||
105403067|NCT01815424|363485623|FG001|Week 0 to 16|Other|0|||
105403068|NCT01815424|363485624|FG002|Week 0 to 16|Other|3|||
105403069|NCT01815424|363485625|FG003|Week 0 to 16|Other|0|||
105403070|NCT01815424|363485626|FG004|Week 0 to 16|Other|0|||
105403071|NCT01815424|363485622|FG000|Week 0 to 16|Protocol Violation|1|||
105403072|NCT01815424|363485623|FG001|Week 0 to 16|Protocol Violation|0|||
105403073|NCT01815424|363485624|FG002|Week 0 to 16|Protocol Violation|0|||
105403074|NCT01815424|363485625|FG003|Week 0 to 16|Protocol Violation|0|||
105403075|NCT01815424|363485626|FG004|Week 0 to 16|Protocol Violation|0|||
105403076|NCT01815424|363485622|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
105403077|NCT01815424|363485623|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
105403078|NCT01815424|363485624|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
105403079|NCT01815424|363485625|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
105403080|NCT01815424|363485626|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
105403081|NCT01815424|363485622|FG000|Week 16 to 52|Other|0|||
105403082|NCT01815424|363485623|FG001|Week 16 to 52|Other|1|||
105403083|NCT01815424|363485624|FG002|Week 16 to 52|Other|0|||
105403084|NCT01815424|363485625|FG003|Week 16 to 52|Other|0|||
105403085|NCT01815424|363485626|FG004|Week 16 to 52|Other|0|||
105403086|NCT01815424|363485622|FG000|Week 16 to 52|Adverse Event|0|||
105403087|NCT01815424|363485623|FG001|Week 16 to 52|Adverse Event|0|||
105403088|NCT01815424|363485624|FG002|Week 16 to 52|Adverse Event|0|||
105403089|NCT01815424|363485625|FG003|Week 16 to 52|Adverse Event|0|||
105403090|NCT01815424|363485626|FG004|Week 16 to 52|Adverse Event|1|||
105403091|NCT01815424|363485622|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
105403092|NCT01815424|363485623|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
105403093|NCT01815424|363485624|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
105403094|NCT01815424|363485625|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
105403095|NCT01815424|363485626|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
105403096|NCT01815424|363485622|FG000|Week 16 to 52|Lost to Follow-up|0|||
105403097|NCT01815424|363485623|FG001|Week 16 to 52|Lost to Follow-up|2|||
105403098|NCT01815424|363485624|FG002|Week 16 to 52|Lost to Follow-up|0|||
105403099|NCT01815424|363485625|FG003|Week 16 to 52|Lost to Follow-up|2|||
105403100|NCT01815424|363485626|FG004|Week 16 to 52|Lost to Follow-up|1|||
105403101|NCT01815424|363485622|FG000|Week 16 to 52|Withdrawal by Subject|1|||
105403102|NCT01815424|363485623|FG001|Week 16 to 52|Withdrawal by Subject|2|||
105403103|NCT01815424|363485624|FG002|Week 16 to 52|Withdrawal by Subject|0|||
105403104|NCT01815424|363485625|FG003|Week 16 to 52|Withdrawal by Subject|0|||
105493960|NCT04587271|363822673|FG004|Overall Study|Caregiver brought child to visits|0|||
105493961|NCT04587271|363822674|FG005|Overall Study|Caregiver brought child to visits|0|||
105403105|NCT01815424|363485626|FG004|Week 16 to 52|Withdrawal by Subject|0|||
105403106|NCT01309204|363485627|FG000|Overall Study|Adverse Event|48|||
105403107|NCT01309204|363485628|FG001|Overall Study|Adverse Event|58|||
105403108|NCT01309204|363485627|FG000|Overall Study|Lost to Follow-up|2|||
105403109|NCT01309204|363485628|FG001|Overall Study|Lost to Follow-up|2|||
105403110|NCT01309204|363485627|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
105403111|NCT01309204|363485628|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
105403112|NCT01309204|363485627|FG000|Overall Study|Inadequate control of IOP|4|||
105403113|NCT01309204|363485628|FG001|Overall Study|Inadequate control of IOP|4|||
105403114|NCT01309204|363485627|FG000|Overall Study|Other|4|||
105403115|NCT01309204|363485628|FG001|Overall Study|Other|1|||
105403116|NCT03374358|363485631|FG000|Overall Study|Withdrawal by Subject|0|||
105403117|NCT03374358|363485632|FG001|Overall Study|Withdrawal by Subject|2|||
105403118|NCT03183063|363485633|FG000|Overall Study|Withdrawal by Subject|2|||
105403119|NCT03183063|363485634|FG001|Overall Study|Withdrawal by Subject|0|||
105403120|NCT03183063|363485635|FG002|Overall Study|Withdrawal by Subject|0|||
105403121|NCT03183063|363485633|FG000|Overall Study|Physician Decision|3|||
105403122|NCT03183063|363485634|FG001|Overall Study|Physician Decision|4|||
105403123|NCT03183063|363485635|FG002|Overall Study|Physician Decision|4|||
105403124|NCT01127633|363485636|FG000|Overall Study|Adverse Event|74|||
105403125|NCT01127633|363485637|FG001|Overall Study|Adverse Event|73|||
105403126|NCT01127633|363485636|FG000|Overall Study|Death|40|||
105403127|NCT01127633|363485637|FG001|Overall Study|Death|43|||
105403128|NCT01127633|363485636|FG000|Overall Study|Lost to Follow-up|4|||
105403129|NCT01127633|363485637|FG001|Overall Study|Lost to Follow-up|0|||
105403130|NCT01127633|363485636|FG000|Overall Study|Parent/Caregiver Decision|246|||
105403131|NCT01127633|363485637|FG001|Overall Study|Parent/Caregiver Decision|228|||
105403132|NCT01127633|363485636|FG000|Overall Study|Physician Decision|60|||
105403133|NCT01127633|363485637|FG001|Overall Study|Physician Decision|45|||
105403134|NCT01127633|363485636|FG000|Overall Study|Withdrawal by Subject|57|||
105403135|NCT01127633|363485637|FG001|Overall Study|Withdrawal by Subject|72|||
105403136|NCT01127633|363485636|FG000|Overall Study|Sponsor Decision|163|||
105403137|NCT01127633|363485637|FG001|Overall Study|Sponsor Decision|195|||
105403138|NCT01127633|363485636|FG000|Overall Study|Protocol Violation|8|||
105403139|NCT01127633|363485637|FG001|Overall Study|Protocol Violation|16|||
105403140|NCT01127633|363485636|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
105403141|NCT01127633|363485637|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
105403142|NCT01127633|363485636|FG000|Overall Study|Not treated|1|||
105403143|NCT01127633|363485637|FG001|Overall Study|Not treated|0|||
105403144|NCT00688467|363485638|FG000|Treatment Period 1|Adverse Event|2|||
105403145|NCT00688467|363485639|FG001|Treatment Period 1|Adverse Event|1|||
105403146|NCT00688467|363485638|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
105403147|NCT00688467|363485639|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
105403148|NCT00688467|363485638|FG000|Treatment Period 2|Protocol Violation|0|||
105403149|NCT00688467|363485639|FG001|Treatment Period 2|Protocol Violation|1|||
105403150|NCT00688467|363485638|FG000|Treatment Period 2|Adverse Event|0|||
105403151|NCT00688467|363485639|FG001|Treatment Period 2|Adverse Event|1|||
105403152|NCT02808897|363485640|FG000|Overall Study|Lost to Follow-up|9|||
105403153|NCT02808897|363485641|FG001|Overall Study|Lost to Follow-up|11|||
105403154|NCT00558636|363485644|FG000|Treatment|Adverse Event|9|||
105403155|NCT00558636|363485645|FG001|Treatment|Adverse Event|2|||
105403156|NCT00558636|363485644|FG000|Treatment|Withdrawal by Subject|2|||
105403157|NCT00558636|363485645|FG001|Treatment|Withdrawal by Subject|0|||
105403158|NCT00558636|363485644|FG000|Treatment|Premature termination of the study|35|||
105403159|NCT00558636|363485645|FG001|Treatment|Premature termination of the study|37|||
105403160|NCT00558636|363485644|FG000|Treatment|Disease progression|1|||
105403161|NCT00558636|363485645|FG001|Treatment|Disease progression|5|||
105403162|NCT00558636|363485644|FG000|Follow-up|Premature termination of the study|12|||
105403163|NCT00558636|363485645|FG001|Follow-up|Premature termination of the study|7|||
105403164|NCT03443687|363485646|FG000|Overall Study|Lost to Follow-up|3|||
105403165|NCT03443687|363485647|FG001|Overall Study|Lost to Follow-up|5|||
105403166|NCT03443687|363485646|FG000|Overall Study|Withdrawal by Subject|1|||
105403167|NCT03443687|363485647|FG001|Overall Study|Withdrawal by Subject|0|||
105403168|NCT03443687|363485646|FG000|Overall Study|Discontinued intervention|1|||
105403169|NCT03443687|363485647|FG001|Overall Study|Discontinued intervention|1|||
105403170|NCT04108273|363485648|FG000|Overall Study|COVID Pandemic|1|||
105403171|NCT04108273|363485649|FG001|Overall Study|COVID Pandemic|0|||
105403172|NCT02805790|363485650|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
105403173|NCT02805790|363485651|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
105403174|NCT04460183|363485654|FG000|Overall Study|Lost to Follow-up|3|||
105403175|NCT04460183|363485655|FG001|Overall Study|Lost to Follow-up|1|||
105403176|NCT04460183|363485654|FG000|Overall Study|Withdrawal by Subject|1|||
105403177|NCT04460183|363485655|FG001|Overall Study|Withdrawal by Subject|0|||
105403178|NCT02808429|363485656|FG000|Overall Study|Lost to Follow-up|1|||
105403179|NCT02808429|363485657|FG001|Overall Study|Lost to Follow-up|0|||
105403180|NCT02808429|363485658|FG002|Overall Study|Lost to Follow-up|0|||
105403181|NCT02808429|363485656|FG000|Overall Study|Protocol Violation|0|||
105403182|NCT02808429|363485657|FG001|Overall Study|Protocol Violation|1|||
105403183|NCT02808429|363485658|FG002|Overall Study|Protocol Violation|0|||
105403184|NCT02808429|363485656|FG000|Overall Study|Premature study termination by sponsor|2|||
105403185|NCT02808429|363485657|FG001|Overall Study|Premature study termination by sponsor|0|||
105403186|NCT02808429|363485658|FG002|Overall Study|Premature study termination by sponsor|1|||
105403187|NCT02808429|363485656|FG000|Overall Study|Relocation|0|||
105403188|NCT02808429|363485657|FG001|Overall Study|Relocation|0|||
105403189|NCT02808429|363485658|FG002|Overall Study|Relocation|1|||
105403190|NCT01436110|363485661|FG000|Overall Study|Lack of Efficacy|23|||
105403191|NCT01436110|363485662|FG001|Overall Study|Lack of Efficacy|14|||
105403192|NCT01436110|363485663|FG002|Overall Study|Lack of Efficacy|9|||
105403193|NCT01436110|363485661|FG000|Overall Study|Withdrawal by Subject|6|||
105403194|NCT01436110|363485662|FG001|Overall Study|Withdrawal by Subject|8|||
105403195|NCT01436110|363485663|FG002|Overall Study|Withdrawal by Subject|4|||
105493962|NCT02497612|363822676|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
105493963|NCT02497612|363822677|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
105493964|NCT02497612|363822678|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
105493965|NCT02497612|363822679|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
105493966|NCT02497612|363822676|FG000|Overall Study|Participant's request|2|||
105493967|NCT02497612|363822677|FG001|Overall Study|Participant's request|3|||
105493968|NCT02497612|363822678|FG002|Overall Study|Participant's request|4|||
105493969|NCT02497612|363822679|FG003|Overall Study|Participant's request|1|||
105493970|NCT02497612|363822676|FG000|Overall Study|Investigator's judgement|1|||
105493971|NCT02497612|363822677|FG001|Overall Study|Investigator's judgement|0|||
105493972|NCT02497612|363822678|FG002|Overall Study|Investigator's judgement|0|||
105493973|NCT02497612|363822679|FG003|Overall Study|Investigator's judgement|2|||
105493974|NCT02497612|363822676|FG000|Overall Study|Adverse Event|3|||
105493975|NCT02497612|363822677|FG001|Overall Study|Adverse Event|1|||
105493976|NCT02497612|363822678|FG002|Overall Study|Adverse Event|4|||
105493977|NCT02497612|363822679|FG003|Overall Study|Adverse Event|1|||
105493978|NCT02497612|363822676|FG000|Overall Study|Lost to Follow-up|1|||
105493979|NCT02497612|363822677|FG001|Overall Study|Lost to Follow-up|1|||
105493980|NCT02497612|363822678|FG002|Overall Study|Lost to Follow-up|0|||
105493981|NCT02497612|363822679|FG003|Overall Study|Lost to Follow-up|1|||
105493982|NCT02497612|363822676|FG000|Overall Study|Other unspecified|1|||
105493983|NCT02497612|363822677|FG001|Overall Study|Other unspecified|1|||
105493984|NCT02497612|363822678|FG002|Overall Study|Other unspecified|2|||
105493985|NCT02497612|363822679|FG003|Overall Study|Other unspecified|0|||
105493986|NCT02497612|363822676|FG000|Overall Study|Not eligible|1|||
105493987|NCT02497612|363822677|FG001|Overall Study|Not eligible|0|||
105493988|NCT02497612|363822678|FG002|Overall Study|Not eligible|0|||
105493989|NCT02497612|363822679|FG003|Overall Study|Not eligible|1|||
105493990|NCT00611533|363822680|FG000|First Intervention (6 Weeks)|Never started study|0|||
105493991|NCT00611533|363822681|FG001|First Intervention (6 Weeks)|Never started study|1|||
105493992|NCT00611533|363822680|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
105493993|NCT00611533|363822681|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
105493994|NCT00611533|363822680|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
105493995|NCT00611533|363822681|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
105493996|NCT03270644|363822688|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
105493997|NCT03270644|363822688|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
105493998|NCT01461980|363822689|FG000|Overall Study|Other|9|||
105493999|NCT01461980|363822690|FG001|Overall Study|Other|8|||
105494000|NCT01461980|363822691|FG002|Overall Study|Other|6|||
105494001|NCT01461980|363822689|FG000|Overall Study|Medication error|7|||
105494002|NCT01461980|363822690|FG001|Overall Study|Medication error|5|||
105494003|NCT01461980|363822691|FG002|Overall Study|Medication error|6|||
105494004|NCT01461980|363822689|FG000|Overall Study|Adverse Event|12|||
105494005|NCT01461980|363822690|FG001|Overall Study|Adverse Event|5|||
105494006|NCT01461980|363822691|FG002|Overall Study|Adverse Event|6|||
105494007|NCT01461980|363822689|FG000|Overall Study|Protocol Violation|12|||
105494008|NCT01461980|363822690|FG001|Overall Study|Protocol Violation|19|||
105494009|NCT01461980|363822691|FG002|Overall Study|Protocol Violation|16|||
105494010|NCT01461980|363822689|FG000|Overall Study|No longer meets eligibility criteria|18|||
105494011|NCT01461980|363822690|FG001|Overall Study|No longer meets eligibility criteria|9|||
105494012|NCT01461980|363822691|FG002|Overall Study|No longer meets eligibility criteria|19|||
105494013|NCT01461980|363822689|FG000|Overall Study|Lost to Follow-up|52|||
105494014|NCT01461980|363822690|FG001|Overall Study|Lost to Follow-up|53|||
105494015|NCT01461980|363822691|FG002|Overall Study|Lost to Follow-up|51|||
105494016|NCT01461980|363822689|FG000|Overall Study|No longer willing to participate|52|||
105494017|NCT01461980|363822690|FG001|Overall Study|No longer willing to participate|38|||
105494018|NCT01461980|363822691|FG002|Overall Study|No longer willing to participate|54|||
105494019|NCT01461980|363822689|FG000|Overall Study|Randomized but not vaccinated|4|||
105494020|NCT01461980|363822690|FG001|Overall Study|Randomized but not vaccinated|8|||
105494021|NCT01461980|363822691|FG002|Overall Study|Randomized but not vaccinated|7|||
105494022|NCT00191906|363822692|FG000|Study Period II|Adverse Event|0|||
105494023|NCT00191906|363822693|FG001|Study Period II|Adverse Event|1|||
105494024|NCT00191906|363822694|FG002|Study Period II|Adverse Event|0|||
105494025|NCT00191906|363822695|FG003|Study Period II|Adverse Event|0|||
105494026|NCT00191906|363822692|FG000|Study Period II|Withdrawal by Subject|0|||
105494027|NCT00191906|363822693|FG001|Study Period II|Withdrawal by Subject|3|||
105494028|NCT00191906|363822694|FG002|Study Period II|Withdrawal by Subject|0|||
105494029|NCT00191906|363822695|FG003|Study Period II|Withdrawal by Subject|0|||
105494030|NCT00191906|363822692|FG000|Study Period II|Parent/Caregiver Decision|0|||
105494031|NCT00191906|363822693|FG001|Study Period II|Parent/Caregiver Decision|1|||
105494032|NCT00191906|363822694|FG002|Study Period II|Parent/Caregiver Decision|0|||
105494033|NCT00191906|363822695|FG003|Study Period II|Parent/Caregiver Decision|0|||
105494034|NCT00191906|363822692|FG000|Study Period II|Entry Criteria Exclusion|0|||
105494035|NCT00191906|363822693|FG001|Study Period II|Entry Criteria Exclusion|0|||
105494036|NCT00191906|363822694|FG002|Study Period II|Entry Criteria Exclusion|1|||
105494037|NCT00191906|363822695|FG003|Study Period II|Entry Criteria Exclusion|0|||
105403196|NCT01436110|363485661|FG000|Overall Study|Adverse Event|2|||
105403197|NCT01436110|363485662|FG001|Overall Study|Adverse Event|1|||
105403198|NCT01436110|363485663|FG002|Overall Study|Adverse Event|2|||
105403199|NCT01436110|363485661|FG000|Overall Study|Physician Decision|3|||
105403200|NCT01436110|363485662|FG001|Overall Study|Physician Decision|1|||
105403201|NCT01436110|363485663|FG002|Overall Study|Physician Decision|1|||
105403202|NCT01436110|363485661|FG000|Overall Study|Lost to Follow-up|1|||
105403203|NCT01436110|363485662|FG001|Overall Study|Lost to Follow-up|1|||
105403204|NCT01436110|363485663|FG002|Overall Study|Lost to Follow-up|3|||
105403205|NCT01436110|363485661|FG000|Overall Study|Protocol Violation|3|||
105403206|NCT01436110|363485662|FG001|Overall Study|Protocol Violation|1|||
105403207|NCT01436110|363485663|FG002|Overall Study|Protocol Violation|1|||
105403208|NCT01436110|363485661|FG000|Overall Study|Did Not Receive Trial Medication|1|||
105403209|NCT01436110|363485662|FG001|Overall Study|Did Not Receive Trial Medication|0|||
105403210|NCT01436110|363485663|FG002|Overall Study|Did Not Receive Trial Medication|3|||
105403211|NCT03637491|363485664|FG000|Overall Study|Death|9|||
105403212|NCT03637491|363485665|FG001|Overall Study|Death|9|||
105403213|NCT03637491|363485666|FG002|Overall Study|Death|5|||
105403214|NCT03637491|363485667|FG003|Overall Study|Death|3|||
105403215|NCT03637491|363485664|FG000|Overall Study|Lost to Follow-up|0|||
105403216|NCT03637491|363485665|FG001|Overall Study|Lost to Follow-up|1|||
105403217|NCT03637491|363485666|FG002|Overall Study|Lost to Follow-up|0|||
105403218|NCT03637491|363485667|FG003|Overall Study|Lost to Follow-up|1|||
105403219|NCT03637491|363485664|FG000|Overall Study|Study Terminated By Sponsor|0|||
105403220|NCT03637491|363485665|FG001|Overall Study|Study Terminated By Sponsor|2|||
105403221|NCT03637491|363485666|FG002|Overall Study|Study Terminated By Sponsor|1|||
105403222|NCT03637491|363485667|FG003|Overall Study|Study Terminated By Sponsor|0|||
105403223|NCT03637491|363485664|FG000|Overall Study|Withdrawal by Subject|1|||
105403224|NCT03637491|363485665|FG001|Overall Study|Withdrawal by Subject|0|||
105403225|NCT03637491|363485666|FG002|Overall Study|Withdrawal by Subject|1|||
105403226|NCT03637491|363485667|FG003|Overall Study|Withdrawal by Subject|2|||
105403227|NCT00527618|363485668|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
105403228|NCT00527618|363485669|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
105403229|NCT00527618|363485668|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
105403230|NCT00527618|363485669|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
105403231|NCT00527618|363485668|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
105403232|NCT00527618|363485669|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
105403233|NCT00527618|363485668|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
105403234|NCT00527618|363485669|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
105403235|NCT00527618|363485668|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
105403236|NCT00527618|363485669|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
105403237|NCT00527618|363485668|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
105403238|NCT00527618|363485669|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
105403239|NCT04419467|363485672|FG000|Overall Study|Not treated with IP|0|||
105403240|NCT04419467|363485673|FG001|Overall Study|Not treated with IP|0|||
105403241|NCT04419467|363485674|FG002|Overall Study|Not treated with IP|2|||
105403242|NCT04419467|363485672|FG000|Overall Study|Adverse Event|0|||
105403243|NCT04419467|363485673|FG001|Overall Study|Adverse Event|2|||
105403244|NCT04419467|363485674|FG002|Overall Study|Adverse Event|0|||
105403245|NCT04419467|363485672|FG000|Overall Study|Death|1|||
105403246|NCT04419467|363485673|FG001|Overall Study|Death|0|||
105403247|NCT04419467|363485674|FG002|Overall Study|Death|0|||
105403248|NCT04419467|363485672|FG000|Overall Study|Lost to Follow-up|0|||
105403249|NCT04419467|363485673|FG001|Overall Study|Lost to Follow-up|1|||
105403250|NCT04419467|363485674|FG002|Overall Study|Lost to Follow-up|2|||
105403251|NCT04419467|363485672|FG000|Overall Study|Withdrawal by Subject|0|||
105403252|NCT04419467|363485673|FG001|Overall Study|Withdrawal by Subject|0|||
105403253|NCT04419467|363485674|FG002|Overall Study|Withdrawal by Subject|4|||
105403254|NCT04419467|363485672|FG000|Overall Study|Pandemic related|0|||
105403255|NCT04419467|363485673|FG001|Overall Study|Pandemic related|0|||
105403256|NCT04419467|363485674|FG002|Overall Study|Pandemic related|1|||
105403257|NCT04419467|363485672|FG000|Overall Study|Reason not known|1|||
105580721|NCT01474512|364126469|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
105403258|NCT04419467|363485673|FG001|Overall Study|Reason not known|0|||
105403259|NCT04419467|363485674|FG002|Overall Study|Reason not known|0|||
105403260|NCT03314935|363485686|FG000|Phase 1|Death|4|||
105403261|NCT03314935|363485687|FG001|Phase 1|Death|2|||
105403262|NCT03314935|363485688|FG002|Phase 1|Death|5|||
105403263|NCT03314935|363485689|FG003|Phase 1|Death|4|||
105403264|NCT03314935|363485690|FG004|Phase 1|Death|3|||
105403265|NCT03314935|363485691|FG005|Phase 1|Death|4|||
105403266|NCT03314935|363485692|FG006|Phase 1|Death|5|||
105403267|NCT03314935|363485693|FG007|Phase 1|Death|4|||
105403268|NCT03314935|363485694|FG008|Phase 1|Death|3|||
105403269|NCT03314935|363485695|FG009|Phase 1|Death|0|||
105403270|NCT03314935|363485696|FG010|Phase 1|Death|0|||
105403271|NCT03314935|363485697|FG011|Phase 1|Death|0|||
105403272|NCT03314935|363485698|FG012|Phase 1|Death|0|||
105403273|NCT03314935|363485699|FG013|Phase 1|Death|0|||
105403274|NCT03314935|363485700|FG014|Phase 1|Death|0|||
105403275|NCT03314935|363485686|FG000|Phase 1|Withdrawal by Subject|2|||
105403276|NCT03314935|363485687|FG001|Phase 1|Withdrawal by Subject|1|||
105403277|NCT03314935|363485688|FG002|Phase 1|Withdrawal by Subject|1|||
105403278|NCT03314935|363485689|FG003|Phase 1|Withdrawal by Subject|2|||
105403279|NCT03314935|363485690|FG004|Phase 1|Withdrawal by Subject|1|||
105403280|NCT03314935|363485691|FG005|Phase 1|Withdrawal by Subject|0|||
105403281|NCT03314935|363485692|FG006|Phase 1|Withdrawal by Subject|1|||
105403282|NCT03314935|363485693|FG007|Phase 1|Withdrawal by Subject|0|||
105403283|NCT03314935|363485694|FG008|Phase 1|Withdrawal by Subject|1|||
105403284|NCT03314935|363485695|FG009|Phase 1|Withdrawal by Subject|0|||
105403285|NCT03314935|363485696|FG010|Phase 1|Withdrawal by Subject|0|||
105403286|NCT03314935|363485697|FG011|Phase 1|Withdrawal by Subject|0|||
105403287|NCT03314935|363485698|FG012|Phase 1|Withdrawal by Subject|0|||
105403288|NCT03314935|363485699|FG013|Phase 1|Withdrawal by Subject|0|||
105403289|NCT03314935|363485700|FG014|Phase 1|Withdrawal by Subject|0|||
105403290|NCT03314935|363485686|FG000|Phase 1|Progressive Disease|2|||
105403291|NCT03314935|363485687|FG001|Phase 1|Progressive Disease|0|||
105403292|NCT03314935|363485688|FG002|Phase 1|Progressive Disease|0|||
105403293|NCT03314935|363485689|FG003|Phase 1|Progressive Disease|1|||
105403294|NCT03314935|363485690|FG004|Phase 1|Progressive Disease|0|||
105403295|NCT03314935|363485691|FG005|Phase 1|Progressive Disease|0|||
105403296|NCT03314935|363485692|FG006|Phase 1|Progressive Disease|0|||
105403297|NCT03314935|363485693|FG007|Phase 1|Progressive Disease|0|||
105403298|NCT03314935|363485694|FG008|Phase 1|Progressive Disease|0|||
105403299|NCT03314935|363485695|FG009|Phase 1|Progressive Disease|0|||
105403300|NCT03314935|363485696|FG010|Phase 1|Progressive Disease|0|||
105403301|NCT03314935|363485697|FG011|Phase 1|Progressive Disease|0|||
105403302|NCT03314935|363485698|FG012|Phase 1|Progressive Disease|0|||
105403303|NCT03314935|363485699|FG013|Phase 1|Progressive Disease|0|||
105403304|NCT03314935|363485700|FG014|Phase 1|Progressive Disease|0|||
105403305|NCT03314935|363485686|FG000|Phase 1|Study Terminated by Sponsor|0|||
105403306|NCT03314935|363485687|FG001|Phase 1|Study Terminated by Sponsor|1|||
105403307|NCT03314935|363485688|FG002|Phase 1|Study Terminated by Sponsor|0|||
105403308|NCT03314935|363485689|FG003|Phase 1|Study Terminated by Sponsor|0|||
105403309|NCT03314935|363485690|FG004|Phase 1|Study Terminated by Sponsor|0|||
105403310|NCT03314935|363485691|FG005|Phase 1|Study Terminated by Sponsor|0|||
105403311|NCT03314935|363485692|FG006|Phase 1|Study Terminated by Sponsor|0|||
105403312|NCT03314935|363485693|FG007|Phase 1|Study Terminated by Sponsor|0|||
105403313|NCT03314935|363485694|FG008|Phase 1|Study Terminated by Sponsor|1|||
105403314|NCT03314935|363485695|FG009|Phase 1|Study Terminated by Sponsor|0|||
105403315|NCT03314935|363485696|FG010|Phase 1|Study Terminated by Sponsor|0|||
105403316|NCT03314935|363485697|FG011|Phase 1|Study Terminated by Sponsor|0|||
105403317|NCT03314935|363485698|FG012|Phase 1|Study Terminated by Sponsor|0|||
105403318|NCT03314935|363485699|FG013|Phase 1|Study Terminated by Sponsor|0|||
105403319|NCT03314935|363485700|FG014|Phase 1|Study Terminated by Sponsor|0|||
105403320|NCT03314935|363485686|FG000|Phase 1|"Captured as Other in Database"|0|||
105403321|NCT03314935|363485687|FG001|Phase 1|"Captured as Other in Database"|2|||
105403322|NCT03314935|363485688|FG002|Phase 1|"Captured as Other in Database"|0|||
105403323|NCT03314935|363485689|FG003|Phase 1|"Captured as Other in Database"|0|||
105403324|NCT03314935|363485690|FG004|Phase 1|"Captured as Other in Database"|0|||
105403325|NCT03314935|363485691|FG005|Phase 1|"Captured as Other in Database"|0|||
105403326|NCT03314935|363485692|FG006|Phase 1|"Captured as Other in Database"|1|||
105403327|NCT03314935|363485693|FG007|Phase 1|"Captured as Other in Database"|1|||
105403328|NCT03314935|363485694|FG008|Phase 1|"Captured as Other in Database"|1|||
105403329|NCT03314935|363485695|FG009|Phase 1|"Captured as Other in Database"|0|||
105403330|NCT03314935|363485696|FG010|Phase 1|"Captured as Other in Database"|0|||
105403331|NCT03314935|363485697|FG011|Phase 1|"Captured as Other in Database"|0|||
105403332|NCT03314935|363485698|FG012|Phase 1|"Captured as Other in Database"|0|||
105403333|NCT03314935|363485699|FG013|Phase 1|"Captured as Other in Database"|0|||
105403334|NCT03314935|363485700|FG014|Phase 1|"Captured as Other in Database"|0|||
105403335|NCT03314935|363485686|FG000|Phase 1|Lost to Follow-up|0|||
105403336|NCT03314935|363485687|FG001|Phase 1|Lost to Follow-up|0|||
105403337|NCT03314935|363485688|FG002|Phase 1|Lost to Follow-up|0|||
105403338|NCT03314935|363485689|FG003|Phase 1|Lost to Follow-up|0|||
105403339|NCT03314935|363485690|FG004|Phase 1|Lost to Follow-up|0|||
105403340|NCT03314935|363485691|FG005|Phase 1|Lost to Follow-up|0|||
105403341|NCT03314935|363485692|FG006|Phase 1|Lost to Follow-up|0|||
105403342|NCT03314935|363485693|FG007|Phase 1|Lost to Follow-up|0|||
105403343|NCT03314935|363485694|FG008|Phase 1|Lost to Follow-up|1|||
105403344|NCT03314935|363485695|FG009|Phase 1|Lost to Follow-up|0|||
105403345|NCT03314935|363485696|FG010|Phase 1|Lost to Follow-up|0|||
105494038|NCT00191906|363822692|FG000|Study Period III|Adverse Event|1|||
105403346|NCT03314935|363485697|FG011|Phase 1|Lost to Follow-up|0|||
105403347|NCT03314935|363485698|FG012|Phase 1|Lost to Follow-up|0|||
105403348|NCT03314935|363485699|FG013|Phase 1|Lost to Follow-up|0|||
105494039|NCT00191906|363822693|FG001|Study Period III|Adverse Event|0|||
105403349|NCT03314935|363485700|FG014|Phase 1|Lost to Follow-up|0|||
105403350|NCT03314935|363485686|FG000|Phase 2|Death|0|||
105403351|NCT03314935|363485687|FG001|Phase 2|Death|0|||
105403352|NCT03314935|363485688|FG002|Phase 2|Death|0|||
105494040|NCT00191906|363822694|FG002|Study Period III|Adverse Event|0|||
105403353|NCT03314935|363485689|FG003|Phase 2|Death|0|||
105403354|NCT03314935|363485690|FG004|Phase 2|Death|0|||
105403355|NCT03314935|363485691|FG005|Phase 2|Death|0|||
105403356|NCT03314935|363485692|FG006|Phase 2|Death|0|||
105403357|NCT03314935|363485693|FG007|Phase 2|Death|0|||
105403358|NCT03314935|363485694|FG008|Phase 2|Death|0|||
105403359|NCT03314935|363485695|FG009|Phase 2|Death|5|||
105403360|NCT03314935|363485696|FG010|Phase 2|Death|20|||
105403361|NCT03314935|363485697|FG011|Phase 2|Death|6|||
105403362|NCT03314935|363485698|FG012|Phase 2|Death|7|||
105403363|NCT03314935|363485699|FG013|Phase 2|Death|6|||
105403364|NCT03314935|363485700|FG014|Phase 2|Death|17|||
105403365|NCT03314935|363485686|FG000|Phase 2|Withdrawal by Subject|0|||
105403366|NCT03314935|363485687|FG001|Phase 2|Withdrawal by Subject|0|||
105403367|NCT03314935|363485688|FG002|Phase 2|Withdrawal by Subject|0|||
105403368|NCT03314935|363485689|FG003|Phase 2|Withdrawal by Subject|0|||
105403369|NCT03314935|363485690|FG004|Phase 2|Withdrawal by Subject|0|||
105403370|NCT03314935|363485691|FG005|Phase 2|Withdrawal by Subject|0|||
105403371|NCT03314935|363485692|FG006|Phase 2|Withdrawal by Subject|0|||
105403372|NCT03314935|363485693|FG007|Phase 2|Withdrawal by Subject|0|||
105403373|NCT03314935|363485694|FG008|Phase 2|Withdrawal by Subject|0|||
105403374|NCT03314935|363485695|FG009|Phase 2|Withdrawal by Subject|1|||
105403375|NCT03314935|363485696|FG010|Phase 2|Withdrawal by Subject|4|||
105403376|NCT03314935|363485697|FG011|Phase 2|Withdrawal by Subject|0|||
105403377|NCT03314935|363485698|FG012|Phase 2|Withdrawal by Subject|1|||
105403378|NCT03314935|363485699|FG013|Phase 2|Withdrawal by Subject|0|||
105403379|NCT03314935|363485700|FG014|Phase 2|Withdrawal by Subject|1|||
105403380|NCT03314935|363485686|FG000|Phase 2|Progressive Disease|0|||
105403381|NCT03314935|363485687|FG001|Phase 2|Progressive Disease|0|||
105403382|NCT03314935|363485688|FG002|Phase 2|Progressive Disease|0|||
105403383|NCT03314935|363485689|FG003|Phase 2|Progressive Disease|0|||
105403384|NCT03314935|363485690|FG004|Phase 2|Progressive Disease|0|||
105403385|NCT03314935|363485691|FG005|Phase 2|Progressive Disease|0|||
105403386|NCT03314935|363485692|FG006|Phase 2|Progressive Disease|0|||
105403387|NCT03314935|363485693|FG007|Phase 2|Progressive Disease|0|||
105403388|NCT03314935|363485694|FG008|Phase 2|Progressive Disease|0|||
105403389|NCT03314935|363485695|FG009|Phase 2|Progressive Disease|1|||
105403390|NCT03314935|363485696|FG010|Phase 2|Progressive Disease|1|||
105403391|NCT03314935|363485697|FG011|Phase 2|Progressive Disease|1|||
105403392|NCT03314935|363485698|FG012|Phase 2|Progressive Disease|2|||
105403393|NCT03314935|363485699|FG013|Phase 2|Progressive Disease|0|||
105403394|NCT03314935|363485700|FG014|Phase 2|Progressive Disease|1|||
105403395|NCT03314935|363485686|FG000|Phase 2|Study Terminated by Sponsor|0|||
105403396|NCT03314935|363485687|FG001|Phase 2|Study Terminated by Sponsor|0|||
105403397|NCT03314935|363485688|FG002|Phase 2|Study Terminated by Sponsor|0|||
105403398|NCT03314935|363485689|FG003|Phase 2|Study Terminated by Sponsor|0|||
105403399|NCT03314935|363485690|FG004|Phase 2|Study Terminated by Sponsor|0|||
105403400|NCT03314935|363485691|FG005|Phase 2|Study Terminated by Sponsor|0|||
105403401|NCT03314935|363485692|FG006|Phase 2|Study Terminated by Sponsor|0|||
105403402|NCT03314935|363485693|FG007|Phase 2|Study Terminated by Sponsor|0|||
105403403|NCT03314935|363485694|FG008|Phase 2|Study Terminated by Sponsor|0|||
105403404|NCT03314935|363485695|FG009|Phase 2|Study Terminated by Sponsor|0|||
105403405|NCT03314935|363485696|FG010|Phase 2|Study Terminated by Sponsor|7|||
105403406|NCT03314935|363485697|FG011|Phase 2|Study Terminated by Sponsor|2|||
105403407|NCT03314935|363485698|FG012|Phase 2|Study Terminated by Sponsor|1|||
105403408|NCT03314935|363485699|FG013|Phase 2|Study Terminated by Sponsor|4|||
105403409|NCT03314935|363485700|FG014|Phase 2|Study Terminated by Sponsor|4|||
105494041|NCT00191906|363822695|FG003|Study Period III|Adverse Event|0|||
105494042|NCT00191906|363822692|FG000|Study Period III|Lost to Follow-up|0|||
105494043|NCT00191906|363822693|FG001|Study Period III|Lost to Follow-up|1|||
105403410|NCT03314935|363485686|FG000|Phase 2|Lost to Follow-up|0|||
105403411|NCT03314935|363485687|FG001|Phase 2|Lost to Follow-up|0|||
105403412|NCT03314935|363485688|FG002|Phase 2|Lost to Follow-up|0|||
105403413|NCT03314935|363485689|FG003|Phase 2|Lost to Follow-up|0|||
105403414|NCT03314935|363485690|FG004|Phase 2|Lost to Follow-up|0|||
105403415|NCT03314935|363485691|FG005|Phase 2|Lost to Follow-up|0|||
105403416|NCT03314935|363485692|FG006|Phase 2|Lost to Follow-up|0|||
105403417|NCT03314935|363485693|FG007|Phase 2|Lost to Follow-up|0|||
105403418|NCT03314935|363485694|FG008|Phase 2|Lost to Follow-up|0|||
105403419|NCT03314935|363485695|FG009|Phase 2|Lost to Follow-up|1|||
105403420|NCT03314935|363485696|FG010|Phase 2|Lost to Follow-up|0|||
105403421|NCT03314935|363485697|FG011|Phase 2|Lost to Follow-up|0|||
105403422|NCT03314935|363485698|FG012|Phase 2|Lost to Follow-up|0|||
105403423|NCT03314935|363485699|FG013|Phase 2|Lost to Follow-up|0|||
105403424|NCT03314935|363485700|FG014|Phase 2|Lost to Follow-up|1|||
105403425|NCT03314935|363485686|FG000|Phase 2|Physician Decision|0|||
105403426|NCT03314935|363485687|FG001|Phase 2|Physician Decision|0|||
105403427|NCT03314935|363485688|FG002|Phase 2|Physician Decision|0|||
105403428|NCT03314935|363485689|FG003|Phase 2|Physician Decision|0|||
105403429|NCT03314935|363485690|FG004|Phase 2|Physician Decision|0|||
105403430|NCT03314935|363485691|FG005|Phase 2|Physician Decision|0|||
105494044|NCT00191906|363822694|FG002|Study Period III|Lost to Follow-up|0|||
105403431|NCT03314935|363485692|FG006|Phase 2|Physician Decision|0|||
105403432|NCT03314935|363485693|FG007|Phase 2|Physician Decision|0|||
105403433|NCT03314935|363485694|FG008|Phase 2|Physician Decision|0|||
105403434|NCT03314935|363485695|FG009|Phase 2|Physician Decision|0|||
105403435|NCT03314935|363485696|FG010|Phase 2|Physician Decision|1|||
105403436|NCT03314935|363485697|FG011|Phase 2|Physician Decision|0|||
105403437|NCT03314935|363485698|FG012|Phase 2|Physician Decision|0|||
105403438|NCT03314935|363485699|FG013|Phase 2|Physician Decision|0|||
105403439|NCT03314935|363485700|FG014|Phase 2|Physician Decision|0|||
105403440|NCT00600067|363485701|FG000|Overall Study|Adverse Event|0|||
105403441|NCT00600067|363485702|FG001|Overall Study|Adverse Event|1|||
105403442|NCT00600067|363485701|FG000|Overall Study|Lost to Follow-up|2|||
105403443|NCT00600067|363485702|FG001|Overall Study|Lost to Follow-up|3|||
105403444|NCT00600067|363485701|FG000|Overall Study|protocol non-compliance|0|||
105403445|NCT00600067|363485702|FG001|Overall Study|protocol non-compliance|3|||
105403446|NCT00600067|363485701|FG000|Overall Study|Lack of Efficacy|1|||
105403447|NCT00600067|363485702|FG001|Overall Study|Lack of Efficacy|0|||
105403448|NCT00699413|363485705|FG000|Overall Study|Withdrawal by Subject|0|||
105403449|NCT00699413|363485706|FG001|Overall Study|Withdrawal by Subject|2|||
105403450|NCT00699413|363485705|FG000|Overall Study|Study terminated by sponsor|4|||
105403451|NCT00699413|363485706|FG001|Overall Study|Study terminated by sponsor|2|||
105403452|NCT00251693|363485707|FG000|Overall Study|Adverse Event|17|||
105403453|NCT00251693|363485708|FG001|Overall Study|Adverse Event|9|||
105403454|NCT00251693|363485709|FG002|Overall Study|Adverse Event|9|||
105403455|NCT00251693|363485707|FG000|Overall Study|Protocol Violation|2|||
105403456|NCT00251693|363485708|FG001|Overall Study|Protocol Violation|0|||
105403457|NCT00251693|363485709|FG002|Overall Study|Protocol Violation|2|||
105403458|NCT00251693|363485707|FG000|Overall Study|Lost to Follow-up|12|||
105403459|NCT00251693|363485708|FG001|Overall Study|Lost to Follow-up|7|||
105403460|NCT00251693|363485709|FG002|Overall Study|Lost to Follow-up|8|||
105403461|NCT00251693|363485707|FG000|Overall Study|Withdrawal by Subject|11|||
105403462|NCT00251693|363485708|FG001|Overall Study|Withdrawal by Subject|17|||
105403463|NCT00251693|363485709|FG002|Overall Study|Withdrawal by Subject|14|||
105403464|NCT00251693|363485707|FG000|Overall Study|Lack of Efficacy|0|||
105403465|NCT00251693|363485708|FG001|Overall Study|Lack of Efficacy|1|||
105403466|NCT00251693|363485709|FG002|Overall Study|Lack of Efficacy|0|||
105403467|NCT00251693|363485707|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
105403468|NCT00251693|363485708|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
105403469|NCT00251693|363485709|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
105403470|NCT00251693|363485707|FG000|Overall Study|Noncompliant|0|||
105403471|NCT00251693|363485708|FG001|Overall Study|Noncompliant|0|||
105403472|NCT00251693|363485709|FG002|Overall Study|Noncompliant|2|||
105403473|NCT00251693|363485707|FG000|Overall Study|Possible Barrett's esophagus|3|||
105403474|NCT00251693|363485708|FG001|Overall Study|Possible Barrett's esophagus|5|||
105403475|NCT00251693|363485709|FG002|Overall Study|Possible Barrett's esophagus|2|||
105403476|NCT00251693|363485707|FG000|Overall Study|Subject request/subject unavailable|1|||
105403477|NCT00251693|363485708|FG001|Overall Study|Subject request/subject unavailable|2|||
105403478|NCT00251693|363485709|FG002|Overall Study|Subject request/subject unavailable|0|||
105403479|NCT00251693|363485707|FG000|Overall Study|Abnormal laboratory findings|0|||
105403480|NCT00251693|363485708|FG001|Overall Study|Abnormal laboratory findings|0|||
105403481|NCT00251693|363485709|FG002|Overall Study|Abnormal laboratory findings|1|||
105403482|NCT00442416|363485710|FG000|Overall Study|Adverse Event|4|||
105403483|NCT00442416|363485711|FG001|Overall Study|Adverse Event|1|||
105403484|NCT00442416|363485710|FG000|Overall Study|Death|1|||
105403485|NCT00442416|363485711|FG001|Overall Study|Death|0|||
105403486|NCT00442416|363485710|FG000|Overall Study|Lack of Efficacy|2|||
105403487|NCT00442416|363485711|FG001|Overall Study|Lack of Efficacy|0|||
105403488|NCT00442416|363485710|FG000|Overall Study|Protocol Violation|2|||
105403489|NCT00442416|363485711|FG001|Overall Study|Protocol Violation|3|||
105403490|NCT00442416|363485710|FG000|Overall Study|Withdrew consent|1|||
105403491|NCT00442416|363485711|FG001|Overall Study|Withdrew consent|2|||
105403492|NCT00442416|363485710|FG000|Overall Study|Administrative/Other|27|||
105403493|NCT00442416|363485711|FG001|Overall Study|Administrative/Other|33|||
105403494|NCT01253369|363485713|FG000|Overall Study|Adverse Event|4|||
105403495|NCT01253369|363485713|FG000|Overall Study|Withdrawal by Subject|2|||
105403496|NCT01253369|363485713|FG000|Overall Study|Death|1|||
105403497|NCT01253369|363485713|FG000|Overall Study|Progressive disease|23|||
105403498|NCT01253369|363485713|FG000|Overall Study|Not Evaluable|3|||
105403499|NCT01055613|363485719|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
105403500|NCT01055613|363485720|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
105403501|NCT01055613|363485719|FG000|Overall Study|Unacceptable lens fit|1|||
105403502|NCT01055613|363485720|FG001|Overall Study|Unacceptable lens fit|0|||
105403503|NCT01055613|363485719|FG000|Overall Study|Discomfort|2|||
105403504|NCT01055613|363485720|FG001|Overall Study|Discomfort|1|||
105403505|NCT01055613|363485719|FG000|Overall Study|Lost to Follow-up|1|||
105403506|NCT01055613|363485720|FG001|Overall Study|Lost to Follow-up|1|||
105403507|NCT01055613|363485719|FG000|Overall Study|Protocol Violation|1|||
105403508|NCT01055613|363485720|FG001|Overall Study|Protocol Violation|1|||
105403509|NCT01055613|363485719|FG000|Overall Study|Subject Disinterest|1|||
105403510|NCT01055613|363485720|FG001|Overall Study|Subject Disinterest|1|||
105403511|NCT02103062|363485724|FG000|Overall Study|Adverse Event|1|||
105403512|NCT02103062|363485725|FG001|Overall Study|Adverse Event|2|||
105403513|NCT02103062|363485724|FG000|Overall Study|Progressive Disease|17|||
105403514|NCT02103062|363485725|FG001|Overall Study|Progressive Disease|20|||
105403515|NCT02103062|363485724|FG000|Overall Study|Death|0|||
105403516|NCT02103062|363485725|FG001|Overall Study|Death|1|||
105403517|NCT00120627|363485726|FG000|Overall Study|Withdrawal by Subject|5|||
105403518|NCT00120627|363485727|FG001|Overall Study|Withdrawal by Subject|5|||
105403519|NCT01595529|363485732|FG000|Overall Study|Adverse Event|2|||
105403520|NCT01595529|363485733|FG001|Overall Study|Adverse Event|0|||
105403521|NCT01595529|363485732|FG000|Overall Study|Subject Non-Compliant|2|||
105403522|NCT01595529|363485733|FG001|Overall Study|Subject Non-Compliant|0|||
105403523|NCT01595529|363485732|FG000|Overall Study|Lost to Follow-up|8|||
105403524|NCT01595529|363485733|FG001|Overall Study|Lost to Follow-up|14|||
105403525|NCT01595529|363485732|FG000|Overall Study|Protocol Violation|1|||
105403526|NCT01595529|363485733|FG001|Overall Study|Protocol Violation|2|||
105403527|NCT01595529|363485732|FG000|Overall Study|Physician Decision|1|||
105403528|NCT01595529|363485733|FG001|Overall Study|Physician Decision|0|||
105403529|NCT01595529|363485732|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
105403530|NCT01595529|363485733|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
105403531|NCT01595529|363485732|FG000|Overall Study|Administrative Decision|1|||
105403532|NCT01595529|363485733|FG001|Overall Study|Administrative Decision|0|||
105403533|NCT01595529|363485732|FG000|Overall Study|Entry Failure/Screening Failure|6|||
105403534|NCT01595529|363485733|FG001|Overall Study|Entry Failure/Screening Failure|1|||
105403535|NCT01822665|363485736|FG000|Overall Study|Adverse Event|3|||
105403536|NCT01822665|363485736|FG000|Overall Study|Other Reason|5|||
105403537|NCT00959907|363485738|FG000|Overall Study|Protocol Violation|0|||
105403538|NCT00959907|363485739|FG001|Overall Study|Protocol Violation|1|||
105403539|NCT00959907|363485738|FG000|Overall Study|Adverse Event|1|||
105403540|NCT00959907|363485739|FG001|Overall Study|Adverse Event|0|||
105403541|NCT00959907|363485738|FG000|Overall Study|Withdrawal by Subject|2|||
105403542|NCT00959907|363485739|FG001|Overall Study|Withdrawal by Subject|0|||
105403543|NCT04781816|363485740|FG000|Overall Study|Adverse Event|0|||
105403544|NCT04781816|363485741|FG001|Overall Study|Adverse Event|1|||
105403545|NCT04781816|363485740|FG000|Overall Study|Withdrawal by Subject|1|||
105403546|NCT04781816|363485741|FG001|Overall Study|Withdrawal by Subject|1|||
105403547|NCT04781816|363485740|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
105403548|NCT04781816|363485741|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
105403549|NCT01991483|363485742|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
105403550|NCT01991483|363485743|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
105403551|NCT01991483|363485744|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
105403552|NCT01991483|363485745|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
105403553|NCT01991483|363485742|FG000|Dose Level 600 mg|Physician Decision|0|||
105403554|NCT01991483|363485743|FG001|Dose Level 600 mg|Physician Decision|0|||
105403555|NCT01991483|363485744|FG002|Dose Level 600 mg|Physician Decision|1|||
105403556|NCT01991483|363485745|FG003|Dose Level 600 mg|Physician Decision|0|||
105403557|NCT01991483|363485742|FG000|Dose Level 1000 mg|Protocol Violation|0|||
105403558|NCT01991483|363485743|FG001|Dose Level 1000 mg|Protocol Violation|0|||
105403559|NCT01991483|363485744|FG002|Dose Level 1000 mg|Protocol Violation|0|||
105403560|NCT01991483|363485745|FG003|Dose Level 1000 mg|Protocol Violation|1|||
105403561|NCT02030821|363485746|FG000|Overall Study|Physician Decision|2|||
105403562|NCT02030821|363485747|FG001|Overall Study|Physician Decision|2|||
105403563|NCT02030821|363485748|FG002|Overall Study|Physician Decision|5|||
105403564|NCT02030821|363485749|FG003|Overall Study|Physician Decision|2|||
105403565|NCT03192137|363485750|FG000|Overall Study|Adverse Event|10|||
105403566|NCT03192137|363485751|FG001|Overall Study|Adverse Event|11|||
105403567|NCT03192137|363485750|FG000|Overall Study|Physician Decision|1|||
105403568|NCT03192137|363485751|FG001|Overall Study|Physician Decision|0|||
105403569|NCT03192137|363485750|FG000|Overall Study|Lack of Efficacy|20|||
105403570|NCT03192137|363485751|FG001|Overall Study|Lack of Efficacy|37|||
105403571|NCT03192137|363485750|FG000|Overall Study|Withdrawal by Subject|3|||
105403572|NCT03192137|363485751|FG001|Overall Study|Withdrawal by Subject|3|||
105403573|NCT03192137|363485750|FG000|Overall Study|Protocol Violation|4|||
105403574|NCT03192137|363485751|FG001|Overall Study|Protocol Violation|3|||
105403575|NCT03192137|363485750|FG000|Overall Study|Surgery Cancelled|4|||
105403576|NCT03192137|363485751|FG001|Overall Study|Surgery Cancelled|1|||
105403577|NCT03192137|363485750|FG000|Overall Study|Other - Various Administrative Reasons|8|||
105403578|NCT03192137|363485751|FG001|Overall Study|Other - Various Administrative Reasons|3|||
105403579|NCT02737501|363485754|FG000|Randomized Phase|Died|41|||
105403580|NCT02737501|363485755|FG001|Randomized Phase|Died|29|||
105403581|NCT02737501|363485756|FG002|Randomized Phase|Died|0|||
105403582|NCT02737501|363485754|FG000|Randomized Phase|Withdrawal by Subject|16|||
105403583|NCT02737501|363485755|FG001|Randomized Phase|Withdrawal by Subject|6|||
105403584|NCT02737501|363485756|FG002|Randomized Phase|Withdrawal by Subject|0|||
105494045|NCT00191906|363822695|FG003|Study Period III|Lost to Follow-up|0|||
105494046|NCT00191906|363822692|FG000|Study Period III|Parent/Caregiver Decision|1|||
105494047|NCT00191906|363822693|FG001|Study Period III|Parent/Caregiver Decision|0|||
105494048|NCT00191906|363822694|FG002|Study Period III|Parent/Caregiver Decision|0|||
105494049|NCT00191906|363822695|FG003|Study Period III|Parent/Caregiver Decision|0|||
105494050|NCT00191906|363822692|FG000|Study Period III|Lack of Efficacy|3|||
105494051|NCT00191906|363822693|FG001|Study Period III|Lack of Efficacy|3|||
105494052|NCT00191906|363822694|FG002|Study Period III|Lack of Efficacy|0|||
105494053|NCT00191906|363822695|FG003|Study Period III|Lack of Efficacy|0|||
105494054|NCT01050543|363822696|FG000|Overall Study|Withdrawal by Subject|0|||
105494055|NCT01050543|363822697|FG001|Overall Study|Withdrawal by Subject|2|||
105494056|NCT01050543|363822696|FG000|Overall Study|Protocol Violation|0|||
105494057|NCT01050543|363822697|FG001|Overall Study|Protocol Violation|1|||
105494058|NCT01050543|363822696|FG000|Overall Study|Administrative|4|||
105494059|NCT01050543|363822697|FG001|Overall Study|Administrative|1|||
105494060|NCT00570765|363822698|FG000|DB Phase|Withdrawal by Subject|1|||
105494061|NCT00570765|363822699|FG001|DB Phase|Withdrawal by Subject|0|||
105494062|NCT00570765|363822700|FG002|DB Phase|Withdrawal by Subject|0|||
105494063|NCT00570765|363822701|FG003|DB Phase|Withdrawal by Subject|0|||
105494064|NCT00570765|363822698|FG000|DB Phase|Protocol Violation|0|||
105494065|NCT00570765|363822699|FG001|DB Phase|Protocol Violation|1|||
105494066|NCT00570765|363822700|FG002|DB Phase|Protocol Violation|0|||
105494067|NCT00570765|363822701|FG003|DB Phase|Protocol Violation|0|||
105494068|NCT00570765|363822698|FG000|DB Phase|Adverse Event|3|||
105494069|NCT00570765|363822699|FG001|DB Phase|Adverse Event|6|||
105494070|NCT00570765|363822700|FG002|DB Phase|Adverse Event|0|||
105494071|NCT00570765|363822701|FG003|DB Phase|Adverse Event|0|||
105494072|NCT00570765|363822698|FG000|DB Phase|Did Not Receive Study Drug|0|||
105494073|NCT00570765|363822699|FG001|DB Phase|Did Not Receive Study Drug|0|||
105494074|NCT00570765|363822700|FG002|DB Phase|Did Not Receive Study Drug|1|||
105494075|NCT00570765|363822701|FG003|DB Phase|Did Not Receive Study Drug|0|||
105494076|NCT00570765|363822698|FG000|LTSE Phase|Withdrawal by Subject|0|||
105494077|NCT00570765|363822699|FG001|LTSE Phase|Withdrawal by Subject|0|||
105494078|NCT00570765|363822700|FG002|LTSE Phase|Withdrawal by Subject|0|||
105494079|NCT00570765|363822701|FG003|LTSE Phase|Withdrawal by Subject|1|||
105494080|NCT00570765|363822698|FG000|LTSE Phase|Adverse Event|0|||
105494081|NCT00570765|363822699|FG001|LTSE Phase|Adverse Event|0|||
105494082|NCT00570765|363822700|FG002|LTSE Phase|Adverse Event|0|||
105494083|NCT00570765|363822701|FG003|LTSE Phase|Adverse Event|7|||
105494084|NCT00570765|363822698|FG000|LTSE Phase|Physician Decision|0|||
105494085|NCT00570765|363822699|FG001|LTSE Phase|Physician Decision|0|||
105494086|NCT00570765|363822700|FG002|LTSE Phase|Physician Decision|0|||
105494087|NCT00570765|363822701|FG003|LTSE Phase|Physician Decision|4|||
105494088|NCT00437320|363822702|FG000|Overall Study|Participant request|2|||
105494089|NCT00437320|363822703|FG001|Overall Study|Participant request|1|||
105494090|NCT00437320|363822704|FG002|Overall Study|Participant request|4|||
105494091|NCT01332331|363822712|FG000|Overall Study|Lost to Follow-up|0|||
105494092|NCT01332331|363822713|FG001|Overall Study|Lost to Follow-up|1|||
105403585|NCT02737501|363485754|FG000|Randomized Phase|Lost to Follow-up|0|||
105403586|NCT02737501|363485755|FG001|Randomized Phase|Lost to Follow-up|1|||
105403587|NCT02737501|363485756|FG002|Randomized Phase|Lost to Follow-up|0|||
105403588|NCT02737501|363485754|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
105403589|NCT02737501|363485755|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
105403590|NCT02737501|363485756|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
105403591|NCT02737501|363485754|FG000|Randomized Phase|Reason not Specified|1|||
105403592|NCT02737501|363485755|FG001|Randomized Phase|Reason not Specified|1|||
105403593|NCT02737501|363485756|FG002|Randomized Phase|Reason not Specified|0|||
105403594|NCT02737501|363485754|FG000|Randomized Phase|Never Treated|1|||
105403595|NCT02737501|363485755|FG001|Randomized Phase|Never Treated|1|||
105403596|NCT02737501|363485756|FG002|Randomized Phase|Never Treated|0|||
105494093|NCT01332331|363822712|FG000|Overall Study|Adverse Event|1|||
105494094|NCT01332331|363822713|FG001|Overall Study|Adverse Event|1|||
105494095|NCT01332331|363822712|FG000|Overall Study|Physician Decision|1|||
105494096|NCT01332331|363822713|FG001|Overall Study|Physician Decision|0|||
105494097|NCT01123850|363822714|FG000|Overall Study|Slow enrollment|45|||
105494098|NCT00973674|363822722|FG000|Overall Study|Protocol Violation|2|||
105494099|NCT00973674|363822723|FG001|Overall Study|Protocol Violation|0|||
105403597|NCT02737501|363485754|FG000|Crossover Phase|Died|0|||
105403598|NCT02737501|363485755|FG001|Crossover Phase|Died|0|||
105403599|NCT02737501|363485756|FG002|Crossover Phase|Died|22|||
105494100|NCT01460368|363822724|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
105494101|NCT01460368|363822725|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
105494102|NCT01460368|363822726|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
105494103|NCT01460368|363822727|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
105494104|NCT01460368|363822728|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
105494105|NCT01460368|363822729|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
105494106|NCT01460368|363822730|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
105494107|NCT01460368|363822724|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
105494108|NCT01460368|363822725|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
105494109|NCT01460368|363822726|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
105494110|NCT01460368|363822727|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
105494111|NCT01460368|363822728|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
105494112|NCT01460368|363822729|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
105494113|NCT01460368|363822730|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
105494114|NCT01460368|363822724|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
105494115|NCT01460368|363822725|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
105494116|NCT01460368|363822726|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
105494117|NCT01460368|363822727|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
105494118|NCT01460368|363822728|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
105494119|NCT01460368|363822729|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
105494120|NCT01460368|363822730|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
105494121|NCT01460368|363822724|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
105494122|NCT01460368|363822725|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
105494123|NCT01460368|363822726|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
105494124|NCT01460368|363822727|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
105494125|NCT01460368|363822728|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
105494126|NCT01460368|363822729|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
105494127|NCT01460368|363822730|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
105494128|NCT01460368|363822724|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
105403600|NCT02737501|363485754|FG000|Crossover Phase|Withdrew Consent|0|||
105403601|NCT02737501|363485755|FG001|Crossover Phase|Withdrew Consent|0|||
105403602|NCT02737501|363485756|FG002|Crossover Phase|Withdrew Consent|9|||
105403603|NCT02737501|363485754|FG000|Crossover Phase|Physician Decision|0|||
105403604|NCT02737501|363485755|FG001|Crossover Phase|Physician Decision|0|||
105403605|NCT02737501|363485756|FG002|Crossover Phase|Physician Decision|1|||
105403606|NCT02737501|363485754|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
105403607|NCT02737501|363485755|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
105403608|NCT02737501|363485756|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
105403609|NCT00716274|363485757|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
105403610|NCT00716274|363485758|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
105403611|NCT00716274|363485759|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
105403612|NCT00716274|363485760|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
105403613|NCT00716274|363485761|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
105403614|NCT00716274|363485762|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
105403615|NCT00716274|363485757|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
105403616|NCT00716274|363485758|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
105403617|NCT00716274|363485759|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
105403618|NCT00716274|363485760|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
105403619|NCT00716274|363485761|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
105403620|NCT00716274|363485762|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
105403621|NCT00716274|363485757|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
105403622|NCT00716274|363485758|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
105403623|NCT00716274|363485759|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
105403624|NCT00716274|363485760|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
105403625|NCT00716274|363485761|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
105403626|NCT00716274|363485762|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
105403627|NCT00716274|363485757|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
105403628|NCT00716274|363485758|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
105403629|NCT00716274|363485759|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
105403630|NCT00716274|363485760|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
105494129|NCT01460368|363822725|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
105494130|NCT01460368|363822726|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
105494131|NCT01460368|363822727|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
105494132|NCT01460368|363822728|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
105494133|NCT01460368|363822729|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
105494134|NCT01460368|363822730|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
105494135|NCT00747461|363822737|FG000|Overall Study|study terminated by sponsor|5|||
105403631|NCT00716274|363485761|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
105403632|NCT00716274|363485762|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
105403633|NCT00716274|363485757|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
105494136|NCT01934972|363822738|FG000|Overall Study|Withdrawal by Subject|9|||
105494137|NCT01934972|363822739|FG001|Overall Study|Withdrawal by Subject|6|||
105494138|NCT02770170|363822741|FG000|Overall Study|Withdrawal by Subject|0|||
105494139|NCT02770170|363822742|FG001|Overall Study|Withdrawal by Subject|0|||
105494140|NCT02770170|363822743|FG002|Overall Study|Withdrawal by Subject|0|||
105494141|NCT02770170|363822744|FG003|Overall Study|Withdrawal by Subject|2|||
105494142|NCT02770170|363822741|FG000|Overall Study|due to pregnancy|1|||
105494143|NCT02770170|363822742|FG001|Overall Study|due to pregnancy|0|||
105494144|NCT02770170|363822743|FG002|Overall Study|due to pregnancy|0|||
105494145|NCT02770170|363822744|FG003|Overall Study|due to pregnancy|0|||
105494146|NCT02770170|363822741|FG000|Overall Study|Lack of Efficacy|2|||
105494147|NCT02770170|363822742|FG001|Overall Study|Lack of Efficacy|0|||
105494148|NCT02770170|363822743|FG002|Overall Study|Lack of Efficacy|0|||
105494149|NCT02770170|363822744|FG003|Overall Study|Lack of Efficacy|1|||
105494150|NCT02770170|363822741|FG000|Overall Study|Adverse Event|4|||
105494151|NCT02770170|363822742|FG001|Overall Study|Adverse Event|3|||
105494152|NCT02770170|363822743|FG002|Overall Study|Adverse Event|5|||
105494153|NCT02770170|363822744|FG003|Overall Study|Adverse Event|3|||
105494154|NCT02770170|363822741|FG000|Overall Study|due to disease worsening|0|||
105494155|NCT02770170|363822742|FG001|Overall Study|due to disease worsening|0|||
105494156|NCT02770170|363822743|FG002|Overall Study|due to disease worsening|0|||
105494157|NCT02770170|363822744|FG003|Overall Study|due to disease worsening|1|||
105494158|NCT01710046|363822745|FG000|Overall Study|Lost to Follow-up|1|||
105494159|NCT01710046|363822746|FG001|Overall Study|Lost to Follow-up|0|||
105494160|NCT00961649|363822747|FG000|Overall Study|Adverse Event|4|||
105494161|NCT00961649|363822748|FG001|Overall Study|Adverse Event|0|||
105494162|NCT00961649|363822749|FG002|Overall Study|Adverse Event|0|||
105494163|NCT00961649|363822750|FG003|Overall Study|Adverse Event|2|||
105494164|NCT00961649|363822747|FG000|Overall Study|Inadequate control of IOP|0|||
105494165|NCT00961649|363822748|FG001|Overall Study|Inadequate control of IOP|0|||
105494166|NCT00961649|363822749|FG002|Overall Study|Inadequate control of IOP|0|||
105494167|NCT00961649|363822750|FG003|Overall Study|Inadequate control of IOP|1|||
105494168|NCT00961649|363822747|FG000|Overall Study|Patient has travel plans during holidays|0|||
105494169|NCT00961649|363822748|FG001|Overall Study|Patient has travel plans during holidays|0|||
105494170|NCT00961649|363822749|FG002|Overall Study|Patient has travel plans during holidays|1|||
105494171|NCT00961649|363822750|FG003|Overall Study|Patient has travel plans during holidays|0|||
105494172|NCT00961649|363822747|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
105494173|NCT00961649|363822748|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
105494174|NCT00961649|363822749|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
105494175|NCT00961649|363822750|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
105494176|NCT00961649|363822747|FG000|Overall Study|Study terminated by sponsor|4|||
105494177|NCT00961649|363822748|FG001|Overall Study|Study terminated by sponsor|4|||
105494178|NCT00961649|363822749|FG002|Overall Study|Study terminated by sponsor|4|||
105494179|NCT00961649|363822750|FG003|Overall Study|Study terminated by sponsor|1|||
105494180|NCT02030938|363822753|FG000|Overall Study|Lost to Follow-up|4|||
105494181|NCT02030938|363822753|FG000|Overall Study|Withdrawal by Subject|1|||
105494182|NCT03954132|363822754|FG000|Overall Study|Adverse Event|2|||
105494183|NCT03954132|363822755|FG001|Overall Study|Adverse Event|0|||
105494184|NCT03954132|363822754|FG000|Overall Study|Patient's wish|5|||
105494185|NCT03954132|363822755|FG001|Overall Study|Patient's wish|0|||
105494186|NCT03954132|363822754|FG000|Overall Study|Lost to Follow-up|10|||
105494187|NCT03954132|363822755|FG001|Overall Study|Lost to Follow-up|0|||
105494188|NCT03954132|363822754|FG000|Overall Study|Screening failure|0|||
105494189|NCT03954132|363822755|FG001|Overall Study|Screening failure|1|||
105494190|NCT03954132|363822754|FG000|Overall Study|No registration after Visit 1|5|||
105494191|NCT03954132|363822755|FG001|Overall Study|No registration after Visit 1|2|||
105494192|NCT03954132|363822754|FG000|Overall Study|Other reason than listed|2|||
105494193|NCT03954132|363822755|FG001|Overall Study|Other reason than listed|2|||
105494194|NCT03954132|363822754|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
105494195|NCT03954132|363822755|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
105494196|NCT03954132|363822754|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
105494197|NCT03954132|363822755|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
105494198|NCT01346969|363822758|FG000|Overall Study|Withdrawal by Subject|0|||
105494199|NCT01346969|363822759|FG001|Overall Study|Withdrawal by Subject|0|||
105494200|NCT01346969|363822760|FG002|Overall Study|Withdrawal by Subject|1|||
105494201|NCT01346969|363822761|FG003|Overall Study|Withdrawal by Subject|0|||
105494202|NCT01346969|363822758|FG000|Overall Study|Lost to Follow-up|1|||
105494203|NCT01346969|363822759|FG001|Overall Study|Lost to Follow-up|0|||
105494204|NCT01346969|363822760|FG002|Overall Study|Lost to Follow-up|2|||
105494205|NCT01346969|363822761|FG003|Overall Study|Lost to Follow-up|0|||
105494206|NCT01346969|363822758|FG000|Overall Study|Physician Decision|0|||
105494207|NCT01346969|363822759|FG001|Overall Study|Physician Decision|0|||
105494208|NCT01346969|363822760|FG002|Overall Study|Physician Decision|0|||
105494209|NCT01346969|363822761|FG003|Overall Study|Physician Decision|1|||
105494210|NCT01346969|363822758|FG000|Overall Study|Randomized but not treated|1|||
105403634|NCT00716274|363485758|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
105403635|NCT00716274|363485759|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
105403636|NCT00716274|363485760|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
105403637|NCT00716274|363485761|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
105403638|NCT00716274|363485762|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
105403639|NCT00716274|363485757|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
105403640|NCT00716274|363485758|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
105403641|NCT00716274|363485759|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
105403642|NCT00716274|363485760|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
105403643|NCT00716274|363485761|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
105403644|NCT00716274|363485762|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
105403645|NCT00716274|363485757|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
105403646|NCT00716274|363485758|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
105403647|NCT00716274|363485759|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
105403648|NCT00716274|363485760|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
105403649|NCT00716274|363485761|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
105403650|NCT00716274|363485762|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
105403651|NCT00716274|363485757|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
105403652|NCT00716274|363485758|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
105403653|NCT00716274|363485759|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
105403654|NCT00716274|363485760|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
105403655|NCT00716274|363485761|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
105403656|NCT00716274|363485762|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
105403657|NCT00716274|363485757|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
105403658|NCT00716274|363485758|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
105403659|NCT00716274|363485759|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
105403660|NCT00716274|363485760|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
105403661|NCT00716274|363485761|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
105403662|NCT00716274|363485762|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
105403663|NCT00716274|363485757|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
105403664|NCT00716274|363485758|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
105403665|NCT00716274|363485759|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
105403666|NCT00716274|363485760|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
105403667|NCT00716274|363485761|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
105403668|NCT00716274|363485762|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
105403669|NCT04819113|363485763|FG000|Overall Study|Withdrawal by parent/guardian|3|||
105403670|NCT04819113|363485763|FG000|Overall Study|Lost to Follow-up|1|||
105403671|NCT04819113|363485763|FG000|Overall Study|Withdrawn before vaccination|2|||
105403672|NCT00444925|363485764|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
105403673|NCT00444925|363485765|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
105403674|NCT00444925|363485766|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
105403675|NCT00444925|363485764|FG000|Double-blind Treatment Period|Death|2|||
105403676|NCT00444925|363485765|FG001|Double-blind Treatment Period|Death|0|||
105403677|NCT00444925|363485766|FG002|Double-blind Treatment Period|Death|0|||
105403678|NCT00444925|363485764|FG000|Double-blind Treatment Period|Adverse Event|6|||
105403679|NCT00444925|363485765|FG001|Double-blind Treatment Period|Adverse Event|28|||
105403680|NCT00444925|363485766|FG002|Double-blind Treatment Period|Adverse Event|44|||
105403681|NCT00444925|363485764|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
105403682|NCT00444925|363485765|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
105403683|NCT00444925|363485766|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
105403684|NCT00444925|363485764|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
105403685|NCT00444925|363485765|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
105403686|NCT00444925|363485766|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
105403687|NCT00444925|363485764|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
105494211|NCT01346969|363822759|FG001|Overall Study|Randomized but not treated|0|||
105494212|NCT01346969|363822760|FG002|Overall Study|Randomized but not treated|0|||
105494213|NCT01346969|363822761|FG003|Overall Study|Randomized but not treated|0|||
105494214|NCT01558739|363822766|FG000|Overall Study|Adverse Event|7|||
105494215|NCT01558739|363822766|FG000|Overall Study|Withdrawal by Subject|2|||
105494216|NCT01558739|363822766|FG000|Overall Study|Death|3|||
105403688|NCT00444925|363485765|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
105403689|NCT00444925|363485766|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
105494217|NCT01558739|363822766|FG000|Overall Study|Disease Progression|4|||
105494218|NCT01558739|363822766|FG000|Overall Study|Protocol Violation|1|||
105403690|NCT00444925|363485764|FG000|Double-blind Treatment Period|Other|7|||
105403691|NCT00444925|363485765|FG001|Double-blind Treatment Period|Other|7|||
105494219|NCT01467583|363822769|FG000|Overall Study|Death|1|||
105494220|NCT01467583|363822770|FG001|Overall Study|Death|1|||
105494221|NCT01467583|363822771|FG002|Overall Study|Death|0|||
105403692|NCT00444925|363485766|FG002|Double-blind Treatment Period|Other|12|||
105494222|NCT01467583|363822769|FG000|Overall Study|Withdrawal by Subject|1|||
105403693|NCT00833027|363485767|FG000|Overall Study|Adverse Event|33|||
105403694|NCT00833027|363485767|FG000|Overall Study|Death|1|||
105403695|NCT00833027|363485767|FG000|Overall Study|Lack of Efficacy|12|||
105403696|NCT00833027|363485767|FG000|Overall Study|Lost to Follow-up|24|||
105403697|NCT00833027|363485767|FG000|Overall Study|Protocol Violation|115|||
105403698|NCT00833027|363485767|FG000|Overall Study|Withdrawal by Subject|16|||
105403699|NCT00833027|363485767|FG000|Overall Study|Missing|10|||
105403700|NCT00943761|363485771|FG000|Overall Study|Lost to Follow-up|2|||
105403701|NCT00943761|363485772|FG001|Overall Study|Lost to Follow-up|0|||
105403702|NCT00943761|363485771|FG000|Overall Study|Withdrawal by Subject|2|||
105403703|NCT00943761|363485772|FG001|Overall Study|Withdrawal by Subject|1|||
105403704|NCT03382912|363485773|FG000|Overall Study|Physician Decision|0|||
105403705|NCT03382912|363485774|FG001|Overall Study|Physician Decision|1|||
105403706|NCT03382912|363485773|FG000|Overall Study|Sponsor Decision|6|||
105403707|NCT03382912|363485774|FG001|Overall Study|Sponsor Decision|6|||
105403708|NCT03382912|363485773|FG000|Overall Study|Withdrawal by Subject|0|||
105403709|NCT03382912|363485774|FG001|Overall Study|Withdrawal by Subject|5|||
105403710|NCT00403130|363485777|FG000|2 Years From Start of Treatment|Not Eligible|3|||
105403711|NCT00403130|363485777|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
105403712|NCT00403130|363485777|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
105403713|NCT00403130|363485777|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
105403714|NCT01088906|363485780|FG000|Overall Study|Inclusion error|1|||
105403715|NCT01088906|363485780|FG000|Overall Study|Did not receive study treatment|3|||
105403716|NCT01088906|363485780|FG000|Overall Study|Missing data|1|||
105403717|NCT00269113|363487484|FG000|Overall Study|Adverse Event|14|||
105403718|NCT00269113|363487485|FG001|Overall Study|Adverse Event|7|||
105403719|NCT00269113|363487484|FG000|Overall Study|Lack of Efficacy|35|||
105403720|NCT00269113|363487485|FG001|Overall Study|Lack of Efficacy|18|||
105403721|NCT00269113|363487484|FG000|Overall Study|Early Improvement|2|||
105403722|NCT00269113|363487485|FG001|Overall Study|Early Improvement|0|||
105403723|NCT00269113|363487484|FG000|Overall Study|Withdrawal by Subject|0|||
105403724|NCT00269113|363487485|FG001|Overall Study|Withdrawal by Subject|2|||
105403725|NCT00269113|363487484|FG000|Overall Study|Death|6|||
105403726|NCT00269113|363487485|FG001|Overall Study|Death|2|||
105403727|NCT00269113|363487484|FG000|Overall Study|Lost to Follow-up|2|||
105403728|NCT00269113|363487485|FG001|Overall Study|Lost to Follow-up|1|||
105403729|NCT00269113|363487484|FG000|Overall Study|Protocol Violation|15|||
105403730|NCT00269113|363487485|FG001|Overall Study|Protocol Violation|5|||
105403731|NCT00269113|363487484|FG000|Overall Study|Other|0|||
105403732|NCT00269113|363487485|FG001|Overall Study|Other|2|||
105403733|NCT01979614|363487486|FG000|Overall Study|Adverse Event|1|||
105403734|NCT01979614|363487487|FG001|Overall Study|Adverse Event|1|||
105403735|NCT00488514|363487488|FG000|Overall Study|Adverse Event|41|||
105403736|NCT00488514|363487488|FG000|Overall Study|Lost to Follow-up|44|||
105403737|NCT00488514|363487488|FG000|Overall Study|Protocol Violation|32|||
105403738|NCT00488514|363487488|FG000|Overall Study|Withdrawal by Subject|106|||
105403739|NCT00488514|363487488|FG000|Overall Study|Lack of Efficacy|28|||
105403740|NCT00488514|363487488|FG000|Overall Study|Did not meet criteria for treatment|30|||
105403741|NCT00488514|363487488|FG000|Overall Study|Postive drug screen|1|||
105403742|NCT00488514|363487488|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
105403743|NCT00488514|363487488|FG000|Overall Study|Investigator decision|1|||
105403744|NCT00488514|363487488|FG000|Overall Study|Participant had too few migraines|5|||
105403745|NCT00488514|363487488|FG000|Overall Study|Increase in number of migraines|2|||
105403746|NCT00488514|363487488|FG000|Overall Study|Increased use of concomitant medication|1|||
105403747|NCT01248793|363487489|FG000|Overall Study|Lost to Follow-up|0|||
105403748|NCT01248793|363487490|FG001|Overall Study|Lost to Follow-up|1|||
105403749|NCT01248793|363487489|FG000|Overall Study|Adverse Event|1|||
105403750|NCT01248793|363487490|FG001|Overall Study|Adverse Event|1|||
105403751|NCT01248793|363487489|FG000|Overall Study|Protocol Violation|0|||
105403752|NCT01248793|363487490|FG001|Overall Study|Protocol Violation|1|||
105403753|NCT01248793|363487489|FG000|Overall Study|Withdrawal by Subject|3|||
105403754|NCT01248793|363487490|FG001|Overall Study|Withdrawal by Subject|3|||
105403755|NCT00517699|363487491|FG000|Overall Study|Withdrawal by Subject|1|||
105403756|NCT00517699|363487491|FG000|Overall Study|Lack of Efficacy|1|||
105403757|NCT00517699|363487491|FG000|Overall Study|Administrative error|1|||
105403758|NCT00517699|363487491|FG000|Overall Study|Study terminated by Sponsor|2|||
105403759|NCT01343888|363487496|FG000|Overall Study|Adverse Event|12|||
105403760|NCT01343888|363487497|FG001|Overall Study|Adverse Event|22|||
105403761|NCT01343888|363487498|FG002|Overall Study|Adverse Event|5|||
105403762|NCT01343888|363487496|FG000|Overall Study|Lack of Efficacy|9|||
105403763|NCT01343888|363487497|FG001|Overall Study|Lack of Efficacy|9|||
105403764|NCT01343888|363487498|FG002|Overall Study|Lack of Efficacy|13|||
105403765|NCT01343888|363487496|FG000|Overall Study|Lost to Follow-up|0|||
105403766|NCT01343888|363487497|FG001|Overall Study|Lost to Follow-up|2|||
105403767|NCT01343888|363487498|FG002|Overall Study|Lost to Follow-up|1|||
105403768|NCT01343888|363487496|FG000|Overall Study|Protocol Violation|0|||
105403769|NCT01343888|363487497|FG001|Overall Study|Protocol Violation|2|||
105403770|NCT01343888|363487498|FG002|Overall Study|Protocol Violation|0|||
105403771|NCT01343888|363487496|FG000|Overall Study|Withdrawal by Subject|4|||
105494223|NCT01467583|363822770|FG001|Overall Study|Withdrawal by Subject|0|||
105494224|NCT01467583|363822771|FG002|Overall Study|Withdrawal by Subject|0|||
105494225|NCT01467583|363822769|FG000|Overall Study|Protocol Violation|0|||
105494226|NCT01467583|363822770|FG001|Overall Study|Protocol Violation|0|||
105494227|NCT01467583|363822771|FG002|Overall Study|Protocol Violation|2|||
105494228|NCT02484690|363822775|FG000|Overall Study|Adverse Event|1|||
105494229|NCT02484690|363822776|FG001|Overall Study|Adverse Event|3|||
105494230|NCT02484690|363822777|FG002|Overall Study|Adverse Event|0|||
105494231|NCT02484690|363822778|FG003|Overall Study|Adverse Event|0|||
105494232|NCT02484690|363822779|FG004|Overall Study|Adverse Event|5|||
105494233|NCT02484690|363822775|FG000|Overall Study|Death|0|||
105494234|NCT02484690|363822776|FG001|Overall Study|Death|0|||
105494235|NCT02484690|363822777|FG002|Overall Study|Death|0|||
105494236|NCT02484690|363822778|FG003|Overall Study|Death|0|||
105494237|NCT02484690|363822779|FG004|Overall Study|Death|1|||
105494238|NCT02484690|363822775|FG000|Overall Study|Withdrawal by Subject|1|||
105494239|NCT02484690|363822776|FG001|Overall Study|Withdrawal by Subject|3|||
105494240|NCT02484690|363822777|FG002|Overall Study|Withdrawal by Subject|1|||
105494241|NCT02484690|363822778|FG003|Overall Study|Withdrawal by Subject|2|||
105494242|NCT02484690|363822779|FG004|Overall Study|Withdrawal by Subject|0|||
105494243|NCT02484690|363822775|FG000|Overall Study|Physician Decision|2|||
105494244|NCT02484690|363822776|FG001|Overall Study|Physician Decision|0|||
105494245|NCT02484690|363822777|FG002|Overall Study|Physician Decision|1|||
105494246|NCT02484690|363822778|FG003|Overall Study|Physician Decision|0|||
105494247|NCT02484690|363822779|FG004|Overall Study|Physician Decision|0|||
105494248|NCT02484690|363822775|FG000|Overall Study|Lost to Follow-up|0|||
105494249|NCT02484690|363822776|FG001|Overall Study|Lost to Follow-up|0|||
105494250|NCT02484690|363822777|FG002|Overall Study|Lost to Follow-up|1|||
105494251|NCT02484690|363822778|FG003|Overall Study|Lost to Follow-up|0|||
105494252|NCT02484690|363822779|FG004|Overall Study|Lost to Follow-up|0|||
105494253|NCT00589290|363822794|FG000|Overall Study|Withdrawal by Subject|1|||
105494254|NCT00976677|363822795|FG000|Overall Study|Adverse Event|1|||
105494255|NCT00976677|363822796|FG001|Overall Study|Adverse Event|0|||
105494256|NCT00976677|363822795|FG000|Overall Study|Withdrawal by Subject|0|||
105494257|NCT00976677|363822796|FG001|Overall Study|Withdrawal by Subject|2|||
105494258|NCT00976677|363822795|FG000|Overall Study|Disease progression|1|||
105494259|NCT00976677|363822796|FG001|Overall Study|Disease progression|1|||
105494260|NCT00976677|363822795|FG000|Overall Study|Trial unblinded|2|||
105494261|NCT00976677|363822796|FG001|Overall Study|Trial unblinded|2|||
105494262|NCT00976677|363822795|FG000|Overall Study|Unknown/Missing|1|||
105494263|NCT00976677|363822796|FG001|Overall Study|Unknown/Missing|0|||
105494264|NCT01555983|363822797|FG000|Overall Study|Withdrawal by Subject|1|||
105494265|NCT01555983|363822798|FG001|Overall Study|Withdrawal by Subject|0|||
105494266|NCT01555983|363822799|FG002|Overall Study|Withdrawal by Subject|0|||
105494267|NCT01555983|363822800|FG003|Overall Study|Withdrawal by Subject|0|||
105494268|NCT01555983|363822801|FG004|Overall Study|Withdrawal by Subject|1|||
105494269|NCT01555983|363822802|FG005|Overall Study|Withdrawal by Subject|1|||
105494270|NCT05246397|363824788|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
105494271|NCT00004635|363824793|FG000|Period One|refused|2|||
105494272|NCT00004635|363824794|FG001|Period One|refused|1|||
105494273|NCT00004635|363824793|FG000|Period One|Withdrawal by Subject|1|||
105494274|NCT00004635|363824794|FG001|Period One|Withdrawal by Subject|1|||
105494275|NCT00004635|363824793|FG000|Period One|Protocol Violation|1|||
105494276|NCT00004635|363824794|FG001|Period One|Protocol Violation|0|||
105494277|NCT00004635|363824793|FG000|Period One|PSA did not go <5 ng/mL|1|||
105494278|NCT00004635|363824794|FG001|Period One|PSA did not go <5 ng/mL|0|||
105494279|NCT00004635|363824793|FG000|Period One|second malignancy|1|||
105494280|NCT00004635|363824794|FG001|Period One|second malignancy|0|||
105494281|NCT00004635|363824793|FG000|Period One|progressed|0|||
105494282|NCT00004635|363824794|FG001|Period One|progressed|2|||
105494283|NCT00004635|363824793|FG000|Period One|health problem|0|||
105494284|NCT00004635|363824794|FG001|Period One|health problem|1|||
105494285|NCT00004635|363824793|FG000|Period One|discrepancy in data entry|0|||
105580722|NCT01474512|364126470|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
105580723|NCT01474512|364126471|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
105580724|NCT01474512|364126472|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
105580725|NCT01474512|364126473|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
105494286|NCT00004635|363824794|FG001|Period One|discrepancy in data entry|1|||
105494287|NCT00004635|363824793|FG000|Period Two|progression|2|||
105494288|NCT00004635|363824794|FG001|Period Two|progression|3|||
105494289|NCT00004635|363824793|FG000|Period Two|Adverse Event|1|||
105494290|NCT00004635|363824794|FG001|Period Two|Adverse Event|0|||
105494291|NCT00004635|363824793|FG000|Period Two|refused|0|||
105494292|NCT00004635|363824794|FG001|Period Two|refused|2|||
105494293|NCT00004635|363824793|FG000|Period Two|health problem|1|||
105494294|NCT00004635|363824794|FG001|Period Two|health problem|1|||
105494295|NCT00004635|363824793|FG000|Period Two|travel issues|0|||
105494296|NCT00004635|363824794|FG001|Period Two|travel issues|1|||
105494297|NCT00004635|363824793|FG000|Period Two|secondary malignancy|1|||
105494298|NCT00004635|363824794|FG001|Period Two|secondary malignancy|1|||
105580726|NCT01474512|364126474|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
105494299|NCT00004635|363824793|FG000|Period Two|Lost to Follow-up|1|||
105494300|NCT00004635|363824794|FG001|Period Two|Lost to Follow-up|0|||
105494301|NCT00004635|363824793|FG000|Period Two|discrepancy in data entry|0|||
105494302|NCT00004635|363824794|FG001|Period Two|discrepancy in data entry|1|||
105494303|NCT00723398|363824795|FG000|Overall Study|Withdrawal by Subject|2|||
105494304|NCT00723398|363824796|FG001|Overall Study|Withdrawal by Subject|6|||
105494305|NCT00723398|363824797|FG002|Overall Study|Withdrawal by Subject|4|||
105403772|NCT01343888|363487497|FG001|Overall Study|Withdrawal by Subject|4|||
105403773|NCT01343888|363487498|FG002|Overall Study|Withdrawal by Subject|2|||
105403774|NCT01343888|363487496|FG000|Overall Study|other than stated above|0|||
105403775|NCT01343888|363487497|FG001|Overall Study|other than stated above|0|||
105403776|NCT01343888|363487498|FG002|Overall Study|other than stated above|1|||
105403777|NCT02477527|363487502|FG000|Overall Study|Lost to Follow-up|2|||
105403778|NCT02477527|363487502|FG000|Overall Study|Withdrawal by Subject|1|||
105403779|NCT02477527|363487502|FG000|Overall Study|Screen Failure|3|||
105403780|NCT00800735|363487504|FG000|Overall Study|Administrative/Other|2|||
105403781|NCT00800735|363487504|FG000|Overall Study|Insufficient Therapeutic Response|2|||
105403782|NCT00800735|363487504|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
105403783|NCT00800735|363487504|FG000|Overall Study|Withdrew Consent|3|||
105403784|NCT04567524|363487505|FG000|Overall Study|Adverse Event|1|||
105403785|NCT04567524|363487506|FG001|Overall Study|Adverse Event|1|||
105403786|NCT04567524|363487507|FG002|Overall Study|Adverse Event|0|||
105403787|NCT04567524|363487508|FG003|Overall Study|Adverse Event|0|||
105403788|NCT04567524|363487505|FG000|Overall Study|Withdrawal by Subject|2|||
105403789|NCT04567524|363487506|FG001|Overall Study|Withdrawal by Subject|0|||
105403790|NCT04567524|363487507|FG002|Overall Study|Withdrawal by Subject|0|||
105403791|NCT04567524|363487508|FG003|Overall Study|Withdrawal by Subject|1|||
105403792|NCT03500211|363487514|FG000|Overall Study|Withdrawal by Subject|1|||
105403793|NCT03500211|363487515|FG001|Overall Study|Withdrawal by Subject|1|||
105403794|NCT01865487|363487517|FG000|Overall Study|Lost to Follow-up|0|||
105403795|NCT01865487|363487518|FG001|Overall Study|Lost to Follow-up|0|||
105403796|NCT01865487|363487519|FG002|Overall Study|Lost to Follow-up|0|||
105403797|NCT01865487|363487520|FG003|Overall Study|Lost to Follow-up|1|||
105403798|NCT01865487|363487521|FG004|Overall Study|Lost to Follow-up|0|||
105403799|NCT01865487|363487522|FG005|Overall Study|Lost to Follow-up|0|||
105403800|NCT01865487|363487523|FG006|Overall Study|Lost to Follow-up|1|||
105403801|NCT01865487|363487524|FG007|Overall Study|Lost to Follow-up|0|||
105403802|NCT01865487|363487525|FG008|Overall Study|Lost to Follow-up|0|||
105403803|NCT01865487|363487526|FG009|Overall Study|Lost to Follow-up|0|||
105403804|NCT01865487|363487517|FG000|Overall Study|Withdrawal by Subject|0|||
105403805|NCT01865487|363487518|FG001|Overall Study|Withdrawal by Subject|0|||
105403806|NCT01865487|363487519|FG002|Overall Study|Withdrawal by Subject|0|||
105403807|NCT01865487|363487520|FG003|Overall Study|Withdrawal by Subject|0|||
105403808|NCT01865487|363487521|FG004|Overall Study|Withdrawal by Subject|1|||
105403809|NCT01865487|363487522|FG005|Overall Study|Withdrawal by Subject|0|||
105403810|NCT01865487|363487523|FG006|Overall Study|Withdrawal by Subject|0|||
105403811|NCT01865487|363487524|FG007|Overall Study|Withdrawal by Subject|0|||
105403812|NCT01865487|363487525|FG008|Overall Study|Withdrawal by Subject|0|||
105403813|NCT01865487|363487526|FG009|Overall Study|Withdrawal by Subject|0|||
105403814|NCT00420381|363487531|FG000|Overall Study|Protocol Violation|1|||
105403815|NCT00856609|363487543|FG000|Overall Study|Adverse Event|1|||
105403816|NCT00856609|363487544|FG001|Overall Study|Adverse Event|0|||
105403817|NCT01428219|363487545|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
105403818|NCT02071771|363487546|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
105403819|NCT02071771|363487547|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
105403820|NCT02071771|363487546|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
105403821|NCT02071771|363487547|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
105403822|NCT02078752|363487548|FG000|Overall Study|Death|0|||
105403823|NCT02078752|363487549|FG001|Overall Study|Death|3|||
105403824|NCT02078752|363487550|FG002|Overall Study|Death|0|||
105403825|NCT02078752|363487551|FG003|Overall Study|Death|0|||
105403826|NCT02078752|363487552|FG004|Overall Study|Death|0|||
105403827|NCT02078752|363487553|FG005|Overall Study|Death|1|||
105403828|NCT02078752|363487554|FG006|Overall Study|Death|0|||
105403829|NCT02078752|363487555|FG007|Overall Study|Death|1|||
105403830|NCT02078752|363487556|FG008|Overall Study|Death|0|||
105403831|NCT02078752|363487557|FG009|Overall Study|Death|4|||
105403832|NCT02078752|363487548|FG000|Overall Study|Lost to Follow-up|1|||
105403833|NCT02078752|363487549|FG001|Overall Study|Lost to Follow-up|0|||
105403834|NCT02078752|363487550|FG002|Overall Study|Lost to Follow-up|0|||
105403835|NCT02078752|363487551|FG003|Overall Study|Lost to Follow-up|1|||
105494306|NCT00723398|363824798|FG003|Overall Study|Withdrawal by Subject|4|||
105494307|NCT00723398|363824799|FG004|Overall Study|Withdrawal by Subject|4|||
105403836|NCT02078752|363487552|FG004|Overall Study|Lost to Follow-up|0|||
105403837|NCT02078752|363487553|FG005|Overall Study|Lost to Follow-up|0|||
105403838|NCT02078752|363487554|FG006|Overall Study|Lost to Follow-up|0|||
105403839|NCT02078752|363487555|FG007|Overall Study|Lost to Follow-up|0|||
105403840|NCT02078752|363487556|FG008|Overall Study|Lost to Follow-up|0|||
105403841|NCT02078752|363487557|FG009|Overall Study|Lost to Follow-up|0|||
105403842|NCT02078752|363487548|FG000|Overall Study|Withdrawal by Subject|1|||
105403843|NCT02078752|363487549|FG001|Overall Study|Withdrawal by Subject|1|||
105403844|NCT02078752|363487550|FG002|Overall Study|Withdrawal by Subject|1|||
105403845|NCT02078752|363487551|FG003|Overall Study|Withdrawal by Subject|1|||
105403846|NCT02078752|363487552|FG004|Overall Study|Withdrawal by Subject|0|||
105403847|NCT02078752|363487553|FG005|Overall Study|Withdrawal by Subject|3|||
105403848|NCT02078752|363487554|FG006|Overall Study|Withdrawal by Subject|2|||
105403849|NCT02078752|363487555|FG007|Overall Study|Withdrawal by Subject|1|||
105403850|NCT02078752|363487556|FG008|Overall Study|Withdrawal by Subject|0|||
105403851|NCT02078752|363487557|FG009|Overall Study|Withdrawal by Subject|1|||
105403852|NCT02078752|363487548|FG000|Overall Study|Other|0|||
105403853|NCT02078752|363487549|FG001|Overall Study|Other|3|||
105403854|NCT02078752|363487550|FG002|Overall Study|Other|0|||
105403855|NCT02078752|363487551|FG003|Overall Study|Other|0|||
105403856|NCT02078752|363487552|FG004|Overall Study|Other|1|||
105403857|NCT02078752|363487553|FG005|Overall Study|Other|0|||
105403858|NCT02078752|363487554|FG006|Overall Study|Other|0|||
105403859|NCT02078752|363487555|FG007|Overall Study|Other|1|||
105403860|NCT02078752|363487556|FG008|Overall Study|Other|0|||
105403861|NCT02078752|363487557|FG009|Overall Study|Other|0|||
105403862|NCT02078752|363487548|FG000|Overall Study|Study terminated by sponsor|0|||
105403863|NCT02078752|363487549|FG001|Overall Study|Study terminated by sponsor|0|||
105403864|NCT02078752|363487550|FG002|Overall Study|Study terminated by sponsor|0|||
105403865|NCT02078752|363487551|FG003|Overall Study|Study terminated by sponsor|0|||
105403866|NCT02078752|363487552|FG004|Overall Study|Study terminated by sponsor|0|||
105403867|NCT02078752|363487553|FG005|Overall Study|Study terminated by sponsor|0|||
105403868|NCT02078752|363487554|FG006|Overall Study|Study terminated by sponsor|0|||
105403869|NCT02078752|363487555|FG007|Overall Study|Study terminated by sponsor|0|||
105403870|NCT02078752|363487556|FG008|Overall Study|Study terminated by sponsor|0|||
105403871|NCT02078752|363487557|FG009|Overall Study|Study terminated by sponsor|5|||
105403872|NCT02479880|363487561|FG000|Overall Study|Study Terminated by Sponsor|13|||
105403873|NCT02479880|363487562|FG001|Overall Study|Study Terminated by Sponsor|12|||
105403874|NCT02479880|363487561|FG000|Overall Study|Pregnancy|0|||
105403875|NCT02479880|363487562|FG001|Overall Study|Pregnancy|1|||
105403876|NCT00110214|363487582|FG000|Overall Study|Never started treatment|21|||
105403877|NCT00110214|363487583|FG001|Overall Study|Never started treatment|20|||
105403878|NCT00110214|363487582|FG000|Overall Study|Disease progression or death|260|||
105403879|NCT00110214|363487583|FG001|Overall Study|Disease progression or death|151|||
105403880|NCT00110214|363487582|FG000|Overall Study|Adverse Event|115|||
105403881|NCT00110214|363487583|FG001|Overall Study|Adverse Event|192|||
105403882|NCT00110214|363487582|FG000|Overall Study|Refused further treatment|52|||
105403883|NCT00110214|363487583|FG001|Overall Study|Refused further treatment|65|||
105403884|NCT00110214|363487582|FG000|Overall Study|Other (not specified)|61|||
105403885|NCT00110214|363487583|FG001|Overall Study|Other (not specified)|75|||
105403886|NCT01847092|363487585|FG000|Overall Study|Adverse Event|12|||
105403887|NCT01847092|363487586|FG001|Overall Study|Adverse Event|3|||
105403888|NCT01847092|363487585|FG000|Overall Study|Withdrawal by Subject|5|||
105403889|NCT01847092|363487586|FG001|Overall Study|Withdrawal by Subject|5|||
105403890|NCT01847092|363487585|FG000|Overall Study|Protocol Specified|8|||
105403891|NCT01847092|363487586|FG001|Overall Study|Protocol Specified|0|||
105403892|NCT01847092|363487585|FG000|Overall Study|Physician Decision|1|||
105403893|NCT01847092|363487586|FG001|Overall Study|Physician Decision|1|||
105403894|NCT01847092|363487585|FG000|Overall Study|Protocol Violation|0|||
105403895|NCT01847092|363487586|FG001|Overall Study|Protocol Violation|2|||
105403896|NCT00775268|363487588|FG000|Baseline|Drug not synthesize dose|1|||
105403897|NCT00775268|363487589|FG001|Baseline|Drug not synthesize dose|0|||
105403898|NCT00775268|363487588|FG000|Baseline|Not treated-ineligible per CT|0|||
105403899|NCT00775268|363487589|FG001|Baseline|Not treated-ineligible per CT|1|||
105403900|NCT00775268|363487588|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
105403901|NCT00775268|363487589|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
105403902|NCT00775268|363487588|FG000|After Completion|Participant missed scan appointment|1|||
105403903|NCT00775268|363487589|FG001|After Completion|Participant missed scan appointment|0|||
105403904|NCT03604497|363487590|FG000|Overall Study|Protocol Violation|52|||
105403905|NCT00811954|363487591|FG000|Overall Study|Death|10|||
105403906|NCT00811954|363487592|FG001|Overall Study|Death|6|||
105403907|NCT00811954|363487593|FG002|Overall Study|Death|13|||
105403908|NCT00811954|363487591|FG000|Overall Study|Lost to Follow-up|29|||
105403909|NCT00811954|363487592|FG001|Overall Study|Lost to Follow-up|23|||
105403910|NCT00811954|363487593|FG002|Overall Study|Lost to Follow-up|34|||
105403911|NCT00811954|363487591|FG000|Overall Study|Not able to get to clinic|28|||
105403912|NCT00811954|363487592|FG001|Overall Study|Not able to get to clinic|35|||
105403913|NCT00811954|363487593|FG002|Overall Study|Not able to get to clinic|30|||
105403914|NCT00811954|363487591|FG000|Overall Study|Not willing to adhere to requirements|12|||
105403915|NCT00811954|363487592|FG001|Overall Study|Not willing to adhere to requirements|2|||
105403916|NCT00811954|363487593|FG002|Overall Study|Not willing to adhere to requirements|16|||
105403917|NCT00811954|363487591|FG000|Overall Study|Withdraw consent prior study completion|4|||
105403918|NCT00811954|363487592|FG001|Overall Study|Withdraw consent prior study completion|6|||
105403919|NCT00811954|363487593|FG002|Overall Study|Withdraw consent prior study completion|5|||
105403920|NCT00811954|363487591|FG000|Overall Study|Site Closure|4|||
105403921|NCT00811954|363487592|FG001|Overall Study|Site Closure|0|||
105403922|NCT00811954|363487593|FG002|Overall Study|Site Closure|1|||
105403923|NCT00811954|363487591|FG000|Overall Study|Severe Debilitation|2|||
105403924|NCT00811954|363487592|FG001|Overall Study|Severe Debilitation|0|||
105403925|NCT00811954|363487593|FG002|Overall Study|Severe Debilitation|1|||
105403926|NCT00811954|363487591|FG000|Overall Study|Complete Protocol: No follow-up|0|||
105403927|NCT00811954|363487592|FG001|Overall Study|Complete Protocol: No follow-up|0|||
105403928|NCT00811954|363487593|FG002|Overall Study|Complete Protocol: No follow-up|1|||
105403929|NCT00825994|363487594|FG000|Overall Study|Withdrawal by Subject|2|||
105403930|NCT00825994|363487594|FG000|Overall Study|Lost to Follow-up|1|||
105403931|NCT00825994|363487594|FG000|Overall Study|Protocol Violation|1|||
105403932|NCT00825994|363487594|FG000|Overall Study|Placebo Responder at V2|1|||
105403933|NCT00800982|363487598|FG000|Overall Study|Lost to Follow-up|1|||
105403934|NCT00800982|363487599|FG001|Overall Study|Lost to Follow-up|2|||
105403935|NCT00800982|363487598|FG000|Overall Study|Withdrawal by Subject|0|||
105403936|NCT00800982|363487599|FG001|Overall Study|Withdrawal by Subject|1|||
105403937|NCT00800982|363487598|FG000|Overall Study|Patient moved out of state|1|||
105403938|NCT00800982|363487599|FG001|Overall Study|Patient moved out of state|0|||
105403939|NCT03465722|363487600|FG000|Overall Study|Withdrawal by Subject|21|||
105403940|NCT03465722|363487601|FG001|Overall Study|Withdrawal by Subject|14|||
105403941|NCT03465722|363487600|FG000|Overall Study|Death|89|||
105403942|NCT03465722|363487601|FG001|Overall Study|Death|87|||
105403943|NCT03465722|363487600|FG000|Overall Study|Lost to Follow-up|5|||
105403944|NCT03465722|363487601|FG001|Overall Study|Lost to Follow-up|3|||
105403945|NCT03465722|363487600|FG000|Overall Study|Administrative/Other|33|||
105403946|NCT03465722|363487601|FG001|Overall Study|Administrative/Other|32|||
105403947|NCT03465722|363487600|FG000|Overall Study|Not treated|1|||
105403948|NCT03465722|363487601|FG001|Overall Study|Not treated|2|||
105403949|NCT03465722|363487600|FG000|Overall Study|Sponsor decision|91|||
105403950|NCT03465722|363487601|FG001|Overall Study|Sponsor decision|98|||
105403951|NCT02240121|363487604|FG000|Overall Study|Protocol Violation|1|||
105403952|NCT02240121|363487605|FG001|Overall Study|Protocol Violation|2|||
105403953|NCT02240121|363487604|FG000|Overall Study|Physician Decision|0|||
105403954|NCT02240121|363487605|FG001|Overall Study|Physician Decision|1|||
105403955|NCT02240121|363487604|FG000|Overall Study|Change in protocol interpretation|1|||
105403956|NCT02240121|363487605|FG001|Overall Study|Change in protocol interpretation|0|||
105403957|NCT02240121|363487604|FG000|Overall Study|Lack of Efficacy|2|||
105403958|NCT02240121|363487605|FG001|Overall Study|Lack of Efficacy|3|||
105403959|NCT02240121|363487604|FG000|Overall Study|Site closed|1|||
105403960|NCT02240121|363487605|FG001|Overall Study|Site closed|1|||
105403961|NCT02240121|363487604|FG000|Overall Study|Pregnancy|1|||
105403962|NCT02240121|363487605|FG001|Overall Study|Pregnancy|0|||
105403963|NCT02240121|363487604|FG000|Overall Study|Adverse Event|2|||
105403964|NCT02240121|363487605|FG001|Overall Study|Adverse Event|4|||
105403965|NCT02240121|363487604|FG000|Overall Study|Withdrawal by Subject|6|||
105403966|NCT02240121|363487605|FG001|Overall Study|Withdrawal by Subject|2|||
105403967|NCT02240121|363487604|FG000|Overall Study|Lost to Follow-up|3|||
105403968|NCT02240121|363487605|FG001|Overall Study|Lost to Follow-up|4|||
105403969|NCT02240121|363487604|FG000|Overall Study|Other than specified|1|||
105403970|NCT02240121|363487605|FG001|Overall Study|Other than specified|3|||
105403971|NCT00648037|363487608|FG000|Overall Study|Not Treated|1|||
105403972|NCT00648037|363487608|FG000|Overall Study|Withdrawal by Subject|1|||
105403973|NCT00648037|363487608|FG000|Overall Study|Adverse Event|11|||
105403974|NCT00648037|363487608|FG000|Overall Study|Relapse|2|||
105403975|NCT00648037|363487608|FG000|Overall Study|Other|1|||
105403976|NCT01925768|363487609|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
105403977|NCT01925768|363487610|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105403978|NCT01925768|363487609|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
105403979|NCT01925768|363487610|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
105403980|NCT01925768|363487609|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
105403981|NCT01925768|363487610|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
105403982|NCT01925768|363487609|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
105403983|NCT01925768|363487610|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
105403984|NCT01925768|363487609|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
105403985|NCT01925768|363487610|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
105403986|NCT01925768|363487609|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
105403987|NCT01925768|363487610|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
105403988|NCT01925768|363487609|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
105403989|NCT01925768|363487610|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
105494308|NCT00723398|363824795|FG000|Overall Study|Protocol Violation|2|||
105494309|NCT00723398|363824796|FG001|Overall Study|Protocol Violation|1|||
105494310|NCT00723398|363824797|FG002|Overall Study|Protocol Violation|5|||
105494311|NCT00723398|363824798|FG003|Overall Study|Protocol Violation|0|||
105494312|NCT00723398|363824799|FG004|Overall Study|Protocol Violation|0|||
105494313|NCT00723398|363824795|FG000|Overall Study|Physician Decision|2|||
105494314|NCT00723398|363824796|FG001|Overall Study|Physician Decision|2|||
105494315|NCT00723398|363824797|FG002|Overall Study|Physician Decision|5|||
105494316|NCT00723398|363824798|FG003|Overall Study|Physician Decision|0|||
105494317|NCT00723398|363824799|FG004|Overall Study|Physician Decision|1|||
105494318|NCT00723398|363824795|FG000|Overall Study|Adverse Event|0|||
105494319|NCT00723398|363824796|FG001|Overall Study|Adverse Event|5|||
105494320|NCT00723398|363824797|FG002|Overall Study|Adverse Event|3|||
105494321|NCT00723398|363824798|FG003|Overall Study|Adverse Event|1|||
105494322|NCT00723398|363824799|FG004|Overall Study|Adverse Event|4|||
105494323|NCT00723398|363824795|FG000|Overall Study|Lost to Follow-up|0|||
105494324|NCT00723398|363824796|FG001|Overall Study|Lost to Follow-up|1|||
105494325|NCT00723398|363824797|FG002|Overall Study|Lost to Follow-up|0|||
105494326|NCT00723398|363824798|FG003|Overall Study|Lost to Follow-up|0|||
105494327|NCT00723398|363824799|FG004|Overall Study|Lost to Follow-up|0|||
105494328|NCT00333801|363824800|FG000|Overall Study|Moved to another state|5|||
105494329|NCT00333801|363824801|FG001|Overall Study|Moved to another state|3|||
105494330|NCT00333801|363824800|FG000|Overall Study|Lost to Follow-up|2|||
105494331|NCT00333801|363824801|FG001|Overall Study|Lost to Follow-up|0|||
105494332|NCT00333801|363824800|FG000|Overall Study|Incarcerated|1|||
105494333|NCT00333801|363824801|FG001|Overall Study|Incarcerated|2|||
105494334|NCT00333801|363824800|FG000|Overall Study|Withdrawal by Subject|0|||
105494335|NCT00333801|363824801|FG001|Overall Study|Withdrawal by Subject|1|||
105494336|NCT03633617|363824802|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
105494337|NCT03633617|363824803|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
105494338|NCT03633617|363824804|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
105494339|NCT03633617|363824805|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
105494340|NCT03633617|363824806|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
105494341|NCT03633617|363824807|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
105494342|NCT03633617|363824808|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
105494343|NCT03633617|363824809|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
105494344|NCT03633617|363824810|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
105494345|NCT03633617|363824811|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
105494346|NCT03633617|363824812|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
105494347|NCT03633617|363824802|FG000|Part A|Unconfirmed early termination visit|1|||
105494348|NCT03633617|363824803|FG001|Part A|Unconfirmed early termination visit|0|||
105494349|NCT03633617|363824804|FG002|Part A|Unconfirmed early termination visit|0|||
105494350|NCT03633617|363824805|FG003|Part A|Unconfirmed early termination visit|0|||
105494351|NCT03633617|363824806|FG004|Part A|Unconfirmed early termination visit|0|||
105494352|NCT03633617|363824807|FG005|Part A|Unconfirmed early termination visit|0|||
105494353|NCT03633617|363824808|FG006|Part A|Unconfirmed early termination visit|0|||
105494354|NCT03633617|363824809|FG007|Part A|Unconfirmed early termination visit|0|||
105494355|NCT03633617|363824810|FG008|Part A|Unconfirmed early termination visit|0|||
105494356|NCT03633617|363824811|FG009|Part A|Unconfirmed early termination visit|0|||
105494357|NCT03633617|363824812|FG010|Part A|Unconfirmed early termination visit|0|||
105494358|NCT03633617|363824802|FG000|Part A|Adverse Event|0|||
105494359|NCT03633617|363824803|FG001|Part A|Adverse Event|1|||
105494360|NCT03633617|363824804|FG002|Part A|Adverse Event|0|||
105494361|NCT03633617|363824805|FG003|Part A|Adverse Event|0|||
105494362|NCT03633617|363824806|FG004|Part A|Adverse Event|0|||
105494363|NCT03633617|363824807|FG005|Part A|Adverse Event|0|||
105494364|NCT03633617|363824808|FG006|Part A|Adverse Event|0|||
105494365|NCT03633617|363824809|FG007|Part A|Adverse Event|0|||
105494366|NCT03633617|363824810|FG008|Part A|Adverse Event|0|||
105494367|NCT03633617|363824811|FG009|Part A|Adverse Event|0|||
105494368|NCT03633617|363824812|FG010|Part A|Adverse Event|0|||
105494369|NCT03633617|363824802|FG000|Part A|Pregnancy|1|||
105494370|NCT03633617|363824803|FG001|Part A|Pregnancy|0|||
105494371|NCT03633617|363824804|FG002|Part A|Pregnancy|0|||
105494372|NCT03633617|363824805|FG003|Part A|Pregnancy|0|||
105494373|NCT03633617|363824806|FG004|Part A|Pregnancy|0|||
105494374|NCT03633617|363824807|FG005|Part A|Pregnancy|0|||
105494375|NCT03633617|363824808|FG006|Part A|Pregnancy|0|||
105494376|NCT03633617|363824809|FG007|Part A|Pregnancy|0|||
105494377|NCT03633617|363824810|FG008|Part A|Pregnancy|0|||
105494378|NCT03633617|363824811|FG009|Part A|Pregnancy|0|||
105494379|NCT03633617|363824812|FG010|Part A|Pregnancy|0|||
105494380|NCT03633617|363824802|FG000|Part A|Withdrawal by Subject|0|||
105494381|NCT03633617|363824803|FG001|Part A|Withdrawal by Subject|1|||
105494382|NCT03633617|363824804|FG002|Part A|Withdrawal by Subject|0|||
105494383|NCT03633617|363824805|FG003|Part A|Withdrawal by Subject|0|||
105494384|NCT03633617|363824806|FG004|Part A|Withdrawal by Subject|0|||
105494385|NCT03633617|363824807|FG005|Part A|Withdrawal by Subject|0|||
105494386|NCT03633617|363824808|FG006|Part A|Withdrawal by Subject|0|||
105494387|NCT03633617|363824809|FG007|Part A|Withdrawal by Subject|0|||
105494388|NCT03633617|363824810|FG008|Part A|Withdrawal by Subject|0|||
105494389|NCT03633617|363824811|FG009|Part A|Withdrawal by Subject|0|||
105403990|NCT01925768|363487609|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
105403991|NCT01925768|363487610|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
105403992|NCT01925768|363487609|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
105403993|NCT01925768|363487610|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
105403994|NCT01925768|363487609|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
105403995|NCT01925768|363487610|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
105403996|NCT01925768|363487609|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
105403997|NCT01925768|363487610|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
105403998|NCT02967679|363487614|FG000|Overall Study|Adverse Event|1|||
105403999|NCT04339413|363487615|FG000|Overall Study|Reason Not Specified|2|||
105404000|NCT04339413|363487616|FG001|Overall Study|Reason Not Specified|7|||
105404001|NCT04339413|363487615|FG000|Overall Study|Study Terminated by Sponsor|30|||
105404002|NCT04339413|363487616|FG001|Overall Study|Study Terminated by Sponsor|33|||
105404003|NCT04339413|363487615|FG000|Overall Study|Progressive Disease|9|||
105404004|NCT04339413|363487616|FG001|Overall Study|Progressive Disease|6|||
105404005|NCT04339413|363487615|FG000|Overall Study|Withdrawal by Subject|9|||
105404006|NCT04339413|363487616|FG001|Overall Study|Withdrawal by Subject|10|||
105404007|NCT04339413|363487615|FG000|Overall Study|Physician Decision|3|||
105404008|NCT04339413|363487616|FG001|Overall Study|Physician Decision|1|||
105404009|NCT04339413|363487615|FG000|Overall Study|Death|2|||
105404010|NCT04339413|363487616|FG001|Overall Study|Death|0|||
105404011|NCT04339413|363487615|FG000|Overall Study|Adverse Event|3|||
105404012|NCT04339413|363487616|FG001|Overall Study|Adverse Event|0|||
105404013|NCT03188263|363487620|FG000|Overall Study|Withdrawal by Subject|3|||
105404014|NCT03188263|363487621|FG001|Overall Study|Withdrawal by Subject|0|||
105404015|NCT03188263|363487620|FG000|Overall Study|Physician Decision|1|||
105404016|NCT03188263|363487621|FG001|Overall Study|Physician Decision|0|||
105404017|NCT00539240|363487622|FG000|Overall Study|Withdrawal by Subject|0|||
105404018|NCT00539240|363487623|FG001|Overall Study|Withdrawal by Subject|2|||
105404019|NCT00539240|363487624|FG002|Overall Study|Withdrawal by Subject|0|||
105404020|NCT00539240|363487622|FG000|Overall Study|Protocol Violation|1|||
105404021|NCT00539240|363487623|FG001|Overall Study|Protocol Violation|1|||
105404022|NCT00539240|363487624|FG002|Overall Study|Protocol Violation|4|||
105404023|NCT00539240|363487622|FG000|Overall Study|Lost to Follow-up|2|||
105404024|NCT00539240|363487623|FG001|Overall Study|Lost to Follow-up|3|||
105404025|NCT00539240|363487624|FG002|Overall Study|Lost to Follow-up|1|||
105404026|NCT00539240|363487622|FG000|Overall Study|Adverse Event|3|||
105404027|NCT00539240|363487623|FG001|Overall Study|Adverse Event|1|||
105404028|NCT00539240|363487624|FG002|Overall Study|Adverse Event|10|||
105404029|NCT01284959|363487625|FG000|Overall Study|Withdrawal by Subject|1|||
105404030|NCT01284959|363487626|FG001|Overall Study|Withdrawal by Subject|0|||
105404031|NCT01284959|363487627|FG002|Overall Study|Withdrawal by Subject|0|||
105404032|NCT01284959|363487625|FG000|Overall Study|Adverse Event|0|||
105404033|NCT01284959|363487626|FG001|Overall Study|Adverse Event|0|||
105404034|NCT01284959|363487627|FG002|Overall Study|Adverse Event|1|||
105404035|NCT00326599|363487632|FG000|Overall Study|Withdrawal by Subject|1|||
105404036|NCT00326599|363487633|FG001|Overall Study|Withdrawal by Subject|0|||
105404037|NCT00326599|363487634|FG002|Overall Study|Withdrawal by Subject|5|||
105404038|NCT00326599|363487635|FG003|Overall Study|Withdrawal by Subject|2|||
105404039|NCT00326599|363487632|FG000|Overall Study|Adverse Event|1|||
105404040|NCT00326599|363487633|FG001|Overall Study|Adverse Event|0|||
105404041|NCT00326599|363487634|FG002|Overall Study|Adverse Event|32|||
105404042|NCT00326599|363487635|FG003|Overall Study|Adverse Event|3|||
105404043|NCT00326599|363487632|FG000|Overall Study|Disease Progression|3|||
105404044|NCT00326599|363487633|FG001|Overall Study|Disease Progression|1|||
105404045|NCT00326599|363487634|FG002|Overall Study|Disease Progression|13|||
105404046|NCT00326599|363487635|FG003|Overall Study|Disease Progression|11|||
105404047|NCT00326599|363487632|FG000|Overall Study|Alternate Treatment|1|||
105494390|NCT03633617|363824812|FG010|Part A|Withdrawal by Subject|0|||
105494391|NCT03633617|363824802|FG000|Part B|Adverse Event|0|||
105494392|NCT03633617|363824803|FG001|Part B|Adverse Event|0|||
105494393|NCT03633617|363824804|FG002|Part B|Adverse Event|2|||
105494394|NCT03633617|363824805|FG003|Part B|Adverse Event|2|||
105494395|NCT03633617|363824806|FG004|Part B|Adverse Event|1|||
105404048|NCT00326599|363487633|FG001|Overall Study|Alternate Treatment|0|||
105404049|NCT00326599|363487634|FG002|Overall Study|Alternate Treatment|0|||
105404050|NCT00326599|363487635|FG003|Overall Study|Alternate Treatment|0|||
105404051|NCT00326599|363487632|FG000|Overall Study|Death|0|||
105404052|NCT00326599|363487633|FG001|Overall Study|Death|0|||
105404053|NCT00326599|363487634|FG002|Overall Study|Death|1|||
105404054|NCT00326599|363487635|FG003|Overall Study|Death|2|||
105404055|NCT00326599|363487632|FG000|Overall Study|Other Unspecified Reason|0|||
105404056|NCT00326599|363487633|FG001|Overall Study|Other Unspecified Reason|0|||
105404057|NCT00326599|363487634|FG002|Overall Study|Other Unspecified Reason|2|||
105580727|NCT01474512|364126475|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
105580728|NCT01474512|364126476|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
105580729|NCT01474512|364126477|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
105580730|NCT01474512|364126478|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
105580731|NCT01474512|364126479|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
105580732|NCT01474512|364126480|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
105580733|NCT01474512|364126481|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
105580734|NCT01474512|364126482|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
105580735|NCT01474512|364126465|FG000|Maintenance Period|Adverse Event|0|||
105580736|NCT01474512|364126466|FG001|Maintenance Period|Adverse Event|0|||
105580737|NCT01474512|364126467|FG002|Maintenance Period|Adverse Event|0|||
105580738|NCT01474512|364126468|FG003|Maintenance Period|Adverse Event|4|||
105580739|NCT01474512|364126469|FG004|Maintenance Period|Adverse Event|2|||
105580740|NCT01474512|364126470|FG005|Maintenance Period|Adverse Event|7|||
105580741|NCT01474512|364126471|FG006|Maintenance Period|Adverse Event|0|||
105580742|NCT01474512|364126472|FG007|Maintenance Period|Adverse Event|19|||
105580743|NCT01474512|364126473|FG008|Maintenance Period|Adverse Event|1|||
105580744|NCT01474512|364126474|FG009|Maintenance Period|Adverse Event|3|||
105580745|NCT01474512|364126475|FG010|Maintenance Period|Adverse Event|0|||
105580746|NCT01474512|364126476|FG011|Maintenance Period|Adverse Event|0|||
105580747|NCT01474512|364126477|FG012|Maintenance Period|Adverse Event|0|||
105580748|NCT01474512|364126478|FG013|Maintenance Period|Adverse Event|0|||
105580749|NCT01474512|364126479|FG014|Maintenance Period|Adverse Event|0|||
105580750|NCT01474512|364126480|FG015|Maintenance Period|Adverse Event|0|||
105580751|NCT01474512|364126481|FG016|Maintenance Period|Adverse Event|0|||
105580752|NCT01474512|364126482|FG017|Maintenance Period|Adverse Event|0|||
105580753|NCT01474512|364126465|FG000|Maintenance Period|Withdrawal by Subject|0|||
105580754|NCT01474512|364126466|FG001|Maintenance Period|Withdrawal by Subject|0|||
105580755|NCT01474512|364126467|FG002|Maintenance Period|Withdrawal by Subject|0|||
105580756|NCT01474512|364126468|FG003|Maintenance Period|Withdrawal by Subject|6|||
105580757|NCT01474512|364126469|FG004|Maintenance Period|Withdrawal by Subject|2|||
105580758|NCT01474512|364126470|FG005|Maintenance Period|Withdrawal by Subject|3|||
105580759|NCT01474512|364126471|FG006|Maintenance Period|Withdrawal by Subject|1|||
105580760|NCT01474512|364126472|FG007|Maintenance Period|Withdrawal by Subject|6|||
105580761|NCT01474512|364126473|FG008|Maintenance Period|Withdrawal by Subject|3|||
105580762|NCT01474512|364126474|FG009|Maintenance Period|Withdrawal by Subject|1|||
105580763|NCT01474512|364126475|FG010|Maintenance Period|Withdrawal by Subject|0|||
105580764|NCT01474512|364126476|FG011|Maintenance Period|Withdrawal by Subject|0|||
105580765|NCT01474512|364126477|FG012|Maintenance Period|Withdrawal by Subject|0|||
105580766|NCT01474512|364126478|FG013|Maintenance Period|Withdrawal by Subject|0|||
105580767|NCT01474512|364126479|FG014|Maintenance Period|Withdrawal by Subject|0|||
105580768|NCT01474512|364126480|FG015|Maintenance Period|Withdrawal by Subject|0|||
105580769|NCT01474512|364126481|FG016|Maintenance Period|Withdrawal by Subject|0|||
105580770|NCT01474512|364126482|FG017|Maintenance Period|Withdrawal by Subject|0|||
105580771|NCT01474512|364126465|FG000|Maintenance Period|Lost to Follow-up|0|||
105580772|NCT01474512|364126466|FG001|Maintenance Period|Lost to Follow-up|0|||
105580773|NCT01474512|364126467|FG002|Maintenance Period|Lost to Follow-up|0|||
105580774|NCT01474512|364126468|FG003|Maintenance Period|Lost to Follow-up|3|||
105580775|NCT01474512|364126469|FG004|Maintenance Period|Lost to Follow-up|3|||
105580776|NCT01474512|364126470|FG005|Maintenance Period|Lost to Follow-up|0|||
105580777|NCT01474512|364126471|FG006|Maintenance Period|Lost to Follow-up|0|||
105580778|NCT01474512|364126472|FG007|Maintenance Period|Lost to Follow-up|2|||
105580779|NCT01474512|364126473|FG008|Maintenance Period|Lost to Follow-up|1|||
105580780|NCT01474512|364126474|FG009|Maintenance Period|Lost to Follow-up|1|||
105404058|NCT00326599|363487635|FG003|Overall Study|Other Unspecified Reason|1|||
105404059|NCT01182298|363487636|FG000|Overall Study|Lack of Efficacy|4|||
105404060|NCT01182298|363487636|FG000|Overall Study|Withdrawal by Subject|2|||
105404061|NCT01261975|363487640|FG000|Overall Study|Surgical complication|1|||
105404062|NCT02735421|363489019|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
105404063|NCT02735421|363489019|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
105404064|NCT02735421|363489019|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
105404065|NCT02735421|363489019|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
105404066|NCT02735421|363489019|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
105404067|NCT02735421|363489019|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
105404068|NCT02735421|363489019|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
105404069|NCT00652743|363489020|FG000|Months 12-18|Lost to Follow-up|1|||
105404070|NCT00652743|363489021|FG001|Months 12-18|Lost to Follow-up|2|||
105580781|NCT01474512|364126475|FG010|Maintenance Period|Lost to Follow-up|0|||
105580782|NCT01474512|364126476|FG011|Maintenance Period|Lost to Follow-up|0|||
105404071|NCT00652743|363489022|FG002|Months 12-18|Lost to Follow-up|7|||
105404072|NCT00652743|363489020|FG000|Months 24-30|Other|5|||
105404073|NCT00652743|363489021|FG001|Months 24-30|Other|1|||
105404074|NCT00652743|363489022|FG002|Months 24-30|Other|11|||
105404075|NCT00652743|363489020|FG000|Months 36-42|Serious Adverse Events|0|||
105580783|NCT01474512|364126477|FG012|Maintenance Period|Lost to Follow-up|0|||
105580784|NCT01474512|364126478|FG013|Maintenance Period|Lost to Follow-up|0|||
105580785|NCT01474512|364126479|FG014|Maintenance Period|Lost to Follow-up|0|||
105580786|NCT01474512|364126480|FG015|Maintenance Period|Lost to Follow-up|0|||
105580787|NCT01474512|364126481|FG016|Maintenance Period|Lost to Follow-up|0|||
105580788|NCT01474512|364126482|FG017|Maintenance Period|Lost to Follow-up|0|||
105580789|NCT01474512|364126465|FG000|Maintenance Period|Death|0|||
105580790|NCT01474512|364126466|FG001|Maintenance Period|Death|0|||
105580791|NCT01474512|364126467|FG002|Maintenance Period|Death|0|||
105580792|NCT01474512|364126468|FG003|Maintenance Period|Death|0|||
105580793|NCT01474512|364126469|FG004|Maintenance Period|Death|0|||
105580794|NCT01474512|364126470|FG005|Maintenance Period|Death|2|||
105580795|NCT01474512|364126471|FG006|Maintenance Period|Death|0|||
105580796|NCT01474512|364126472|FG007|Maintenance Period|Death|0|||
105404076|NCT00652743|363489021|FG001|Months 36-42|Serious Adverse Events|1|||
105404077|NCT00652743|363489022|FG002|Months 36-42|Serious Adverse Events|1|||
105404078|NCT00652743|363489020|FG000|Months 36-42|Withdrawal by Subject|1|||
105404079|NCT00652743|363489021|FG001|Months 36-42|Withdrawal by Subject|1|||
105404080|NCT00652743|363489022|FG002|Months 36-42|Withdrawal by Subject|0|||
105404081|NCT00652743|363489020|FG000|Months 36-42|Lost to Follow-up|0|||
105404082|NCT00652743|363489021|FG001|Months 36-42|Lost to Follow-up|1|||
105404083|NCT00652743|363489022|FG002|Months 36-42|Lost to Follow-up|0|||
105404084|NCT00652743|363489020|FG000|Months 36-42|Migrated/moved from study area|1|||
105404085|NCT00652743|363489021|FG001|Months 36-42|Migrated/moved from study area|0|||
105404086|NCT00652743|363489022|FG002|Months 36-42|Migrated/moved from study area|0|||
105404087|NCT00652743|363489020|FG000|Months 36-42|Other|4|||
105404088|NCT00652743|363489021|FG001|Months 36-42|Other|2|||
105404089|NCT00652743|363489022|FG002|Months 36-42|Other|8|||
105404090|NCT00456755|363489026|FG000|Overall Study|Lost to Follow-up|2|||
105404091|NCT00456755|363489027|FG001|Overall Study|Lost to Follow-up|1|||
105404092|NCT06164691|363489028|FG000|Overall Study|Withdrawal by Subject|2|||
105404093|NCT06164691|363489029|FG001|Overall Study|Withdrawal by Subject|0|||
105404094|NCT06164691|363489030|FG002|Overall Study|Withdrawal by Subject|0|||
105404095|NCT00387088|363489031|FG000|Overall Study|Adverse Event|143|||
105404096|NCT00387088|363489032|FG001|Overall Study|Adverse Event|156|||
105404097|NCT00387088|363489031|FG000|Overall Study|Protocol Violation|47|||
105404098|NCT00387088|363489032|FG001|Overall Study|Protocol Violation|35|||
105404099|NCT00387088|363489031|FG000|Overall Study|Withdrawal by Subject|20|||
105404100|NCT00387088|363489032|FG001|Overall Study|Withdrawal by Subject|35|||
105404101|NCT00387088|363489031|FG000|Overall Study|Lack of Efficacy|28|||
105404102|NCT00387088|363489032|FG001|Overall Study|Lack of Efficacy|67|||
105404103|NCT00387088|363489031|FG000|Overall Study|Lost to Follow-up|22|||
105404104|NCT00387088|363489032|FG001|Overall Study|Lost to Follow-up|28|||
105404105|NCT00387088|363489031|FG000|Overall Study|Other|58|||
105404106|NCT00387088|363489032|FG001|Overall Study|Other|52|||
105404107|NCT01306643|363489033|FG000|Overall Study|Adverse Event|5|||
105494396|NCT03633617|363824807|FG005|Part B|Adverse Event|0|||
105494397|NCT03633617|363824808|FG006|Part B|Adverse Event|0|||
105494398|NCT03633617|363824809|FG007|Part B|Adverse Event|0|||
105494399|NCT03633617|363824810|FG008|Part B|Adverse Event|0|||
105494400|NCT03633617|363824811|FG009|Part B|Adverse Event|0|||
105494401|NCT03633617|363824812|FG010|Part B|Adverse Event|0|||
105494402|NCT03633617|363824802|FG000|Part B|Withdrawal by Subject|0|||
105494403|NCT03633617|363824803|FG001|Part B|Withdrawal by Subject|0|||
105494404|NCT03633617|363824804|FG002|Part B|Withdrawal by Subject|1|||
105494405|NCT03633617|363824805|FG003|Part B|Withdrawal by Subject|0|||
105494406|NCT03633617|363824806|FG004|Part B|Withdrawal by Subject|2|||
105494407|NCT03633617|363824807|FG005|Part B|Withdrawal by Subject|0|||
105494408|NCT03633617|363824808|FG006|Part B|Withdrawal by Subject|0|||
105494409|NCT03633617|363824809|FG007|Part B|Withdrawal by Subject|0|||
105494410|NCT03633617|363824810|FG008|Part B|Withdrawal by Subject|0|||
105494411|NCT03633617|363824811|FG009|Part B|Withdrawal by Subject|0|||
105494412|NCT03633617|363824812|FG010|Part B|Withdrawal by Subject|0|||
105494413|NCT03633617|363824802|FG000|Part B|Lost to Follow-up|0|||
105494414|NCT03633617|363824803|FG001|Part B|Lost to Follow-up|0|||
105494415|NCT03633617|363824804|FG002|Part B|Lost to Follow-up|0|||
105494416|NCT03633617|363824805|FG003|Part B|Lost to Follow-up|0|||
105494417|NCT03633617|363824806|FG004|Part B|Lost to Follow-up|1|||
105494418|NCT03633617|363824807|FG005|Part B|Lost to Follow-up|0|||
105494419|NCT03633617|363824808|FG006|Part B|Lost to Follow-up|0|||
105494420|NCT03633617|363824809|FG007|Part B|Lost to Follow-up|0|||
105404108|NCT01306643|363489033|FG000|Overall Study|Disease Progression|7|||
105404109|NCT01306643|363489033|FG000|Overall Study|Other: Change in Eligibility Status|1|||
105404110|NCT02329743|363489034|FG000|Overall Study|Adverse Event|1|||
105494421|NCT03633617|363824810|FG008|Part B|Lost to Follow-up|0|||
105494422|NCT03633617|363824811|FG009|Part B|Lost to Follow-up|0|||
105494423|NCT03633617|363824812|FG010|Part B|Lost to Follow-up|0|||
105494424|NCT03633617|363824802|FG000|Part B|Physician Decision|0|||
105494425|NCT03633617|363824803|FG001|Part B|Physician Decision|0|||
105494426|NCT03633617|363824804|FG002|Part B|Physician Decision|0|||
105494427|NCT03633617|363824805|FG003|Part B|Physician Decision|0|||
105494428|NCT03633617|363824806|FG004|Part B|Physician Decision|1|||
105580797|NCT01474512|364126473|FG008|Maintenance Period|Death|0|||
105580798|NCT01474512|364126474|FG009|Maintenance Period|Death|0|||
105404111|NCT02329743|363489035|FG001|Overall Study|Adverse Event|1|||
105404112|NCT02329743|363489036|FG002|Overall Study|Adverse Event|3|||
105404113|NCT02329743|363489034|FG000|Overall Study|Lost to Follow-up|1|||
105404114|NCT02329743|363489035|FG001|Overall Study|Lost to Follow-up|0|||
105404115|NCT02329743|363489036|FG002|Overall Study|Lost to Follow-up|1|||
105404116|NCT02329743|363489034|FG000|Overall Study|Withdrawal by Subject|4|||
105404117|NCT02329743|363489035|FG001|Overall Study|Withdrawal by Subject|4|||
105404118|NCT02329743|363489036|FG002|Overall Study|Withdrawal by Subject|1|||
105404119|NCT02329743|363489034|FG000|Overall Study|Other|0|||
105404120|NCT02329743|363489035|FG001|Overall Study|Other|2|||
105404121|NCT02329743|363489036|FG002|Overall Study|Other|3|||
105404122|NCT01147393|363489041|FG000|Dose Level 1|Dose limiting Toxicity|2|||
105404123|NCT01147393|363489041|FG000|Dose Level -1|Dose Limited Toxicity|1|||
105404124|NCT01016067|363489044|FG000|Overall Study|Lost to Follow-up|1|||
105404125|NCT01016067|363489045|FG001|Overall Study|Lost to Follow-up|2|||
105404126|NCT01016067|363489044|FG000|Overall Study|Physician Decision|1|||
105404127|NCT01016067|363489045|FG001|Overall Study|Physician Decision|1|||
105404128|NCT01016067|363489044|FG000|Overall Study|Withdrew due to Relocation|0|||
105404129|NCT01016067|363489045|FG001|Overall Study|Withdrew due to Relocation|1|||
105404130|NCT04294459|363489046|FG000|Overall Study|Adverse Event|0|||
105404131|NCT04294459|363489047|FG001|Overall Study|Adverse Event|1|||
105404132|NCT01694433|363489052|FG000|Overall Study|Adverse Event|7|||
105404133|NCT01694433|363489053|FG001|Overall Study|Adverse Event|0|||
105404134|NCT01694433|363489052|FG000|Overall Study|Physician Decision|1|||
105404135|NCT01694433|363489053|FG001|Overall Study|Physician Decision|0|||
105404136|NCT01694433|363489052|FG000|Overall Study|Withdrawal by Subject|3|||
105404137|NCT01694433|363489053|FG001|Overall Study|Withdrawal by Subject|4|||
105404138|NCT00374595|363489054|FG000|Overall Study|Death|23|||
105404139|NCT00374595|363489054|FG000|Overall Study|Withdrawal by Subject|39|||
105404140|NCT00374595|363489054|FG000|Overall Study|Lost to Follow-up|3|||
105404141|NCT00374595|363489054|FG000|Overall Study|too much time commitment|1|||
105404142|NCT00374595|363489054|FG000|Overall Study|transfer care to other clinical site|1|||
105404143|NCT00374595|363489054|FG000|Overall Study|relocation|3|||
105404144|NCT03745768|363489055|FG000|Overall Study|discontinued study|2|||
105404145|NCT03745768|363489056|FG001|Overall Study|discontinued study|0|||
105404146|NCT01106157|363489060|FG000|Overall Study|Withdrawal by Subject|1|||
105404147|NCT01106157|363489061|FG001|Overall Study|Withdrawal by Subject|0|||
105404148|NCT02141672|363489062|FG000|Overall Study|Adverse Event|0|||
105404149|NCT02141672|363489063|FG001|Overall Study|Adverse Event|1|||
105404150|NCT02141672|363489064|FG002|Overall Study|Adverse Event|0|||
105404151|NCT02141672|363489062|FG000|Overall Study|Death|10|||
105404152|NCT02141672|363489063|FG001|Overall Study|Death|2|||
105404153|NCT02141672|363489064|FG002|Overall Study|Death|1|||
105404154|NCT02141672|363489062|FG000|Overall Study|Lack of Efficacy|0|||
105404155|NCT02141672|363489063|FG001|Overall Study|Lack of Efficacy|0|||
105404156|NCT02141672|363489064|FG002|Overall Study|Lack of Efficacy|2|||
105404157|NCT02141672|363489062|FG000|Overall Study|Lost to Follow-up|1|||
105404158|NCT02141672|363489063|FG001|Overall Study|Lost to Follow-up|1|||
105404159|NCT02141672|363489064|FG002|Overall Study|Lost to Follow-up|3|||
105404160|NCT02141672|363489062|FG000|Overall Study|Physician Decision|1|||
105404161|NCT02141672|363489063|FG001|Overall Study|Physician Decision|2|||
105404162|NCT02141672|363489064|FG002|Overall Study|Physician Decision|5|||
105404163|NCT02141672|363489062|FG000|Overall Study|Protocol Violation|0|||
105404164|NCT02141672|363489063|FG001|Overall Study|Protocol Violation|0|||
105404165|NCT02141672|363489064|FG002|Overall Study|Protocol Violation|1|||
105404166|NCT02141672|363489062|FG000|Overall Study|Withdrawal by Subject|3|||
105404167|NCT02141672|363489063|FG001|Overall Study|Withdrawal by Subject|2|||
105404168|NCT02141672|363489064|FG002|Overall Study|Withdrawal by Subject|5|||
105404169|NCT02141672|363489062|FG000|Overall Study|refused to follow-up|1|||
105404170|NCT02141672|363489063|FG001|Overall Study|refused to follow-up|0|||
105404171|NCT02141672|363489064|FG002|Overall Study|refused to follow-up|1|||
105404172|NCT01194245|363489065|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
105404173|NCT01194245|363489066|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
105404174|NCT01194245|363489067|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
105404175|NCT01194245|363489068|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
105404176|NCT01194245|363489069|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
105404177|NCT01194245|363489065|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
105404178|NCT01194245|363489066|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
105404179|NCT01194245|363489067|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
105404180|NCT01194245|363489068|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
105580799|NCT01474512|364126475|FG010|Maintenance Period|Death|0|||
105404181|NCT01194245|363489069|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
105404182|NCT01194245|363489065|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
105404183|NCT01194245|363489066|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
105404184|NCT01194245|363489067|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
105580800|NCT01474512|364126476|FG011|Maintenance Period|Death|0|||
105404185|NCT01194245|363489068|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
105404186|NCT01194245|363489069|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
105404187|NCT01194245|363489065|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
105404188|NCT01194245|363489066|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
105404189|NCT01194245|363489067|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
105404190|NCT01194245|363489068|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
105404191|NCT01194245|363489069|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
105404192|NCT01194245|363489065|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105404193|NCT01194245|363489066|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105404194|NCT01194245|363489067|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105404195|NCT01194245|363489068|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105404196|NCT01194245|363489069|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
105404197|NCT01194245|363489065|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105404198|NCT01194245|363489066|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105404199|NCT01194245|363489067|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
105404200|NCT01194245|363489068|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
105404201|NCT01194245|363489069|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
105404202|NCT02651116|363489071|FG000|Overall Study|Adverse Event|0|||
105404203|NCT02651116|363489072|FG001|Overall Study|Adverse Event|1|||
105404204|NCT02651116|363489071|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
105404205|NCT02651116|363489072|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
105404206|NCT02457247|363489073|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
105404207|NCT02457247|363489074|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
105404208|NCT02457247|363489075|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
105404209|NCT02457247|363489076|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
105404210|NCT02457247|363489073|FG000|Period 1|Significant Protocol Deviation|1|||
105404211|NCT02457247|363489074|FG001|Period 1|Significant Protocol Deviation|1|||
105404212|NCT02457247|363489075|FG002|Period 1|Significant Protocol Deviation|0|||
105404213|NCT02457247|363489076|FG003|Period 1|Significant Protocol Deviation|0|||
105404214|NCT02457247|363489073|FG000|Period 1|Voluntary Withdrawal|1|||
105404215|NCT02457247|363489074|FG001|Period 1|Voluntary Withdrawal|0|||
105404216|NCT02457247|363489075|FG002|Period 1|Voluntary Withdrawal|0|||
105404217|NCT02457247|363489076|FG003|Period 1|Voluntary Withdrawal|0|||
105404218|NCT02457247|363489073|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
105404219|NCT02457247|363489074|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
105404220|NCT02457247|363489075|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
105404221|NCT02457247|363489076|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
105404222|NCT02457247|363489073|FG000|Period 2|Significant Protocol Deviation|1|||
105404223|NCT02457247|363489074|FG001|Period 2|Significant Protocol Deviation|0|||
105404224|NCT02457247|363489075|FG002|Period 2|Significant Protocol Deviation|0|||
105404225|NCT02457247|363489076|FG003|Period 2|Significant Protocol Deviation|0|||
105404226|NCT02457247|363489073|FG000|Period 2|Lost to Follow-up|0|||
105404227|NCT02457247|363489074|FG001|Period 2|Lost to Follow-up|1|||
105404228|NCT02457247|363489075|FG002|Period 2|Lost to Follow-up|0|||
105404229|NCT02457247|363489076|FG003|Period 2|Lost to Follow-up|0|||
105404230|NCT02457247|363489073|FG000|Period 2|Voluntary Withdrawal|1|||
105404231|NCT02457247|363489074|FG001|Period 2|Voluntary Withdrawal|1|||
105404232|NCT02457247|363489075|FG002|Period 2|Voluntary Withdrawal|0|||
105404233|NCT02457247|363489076|FG003|Period 2|Voluntary Withdrawal|0|||
105404234|NCT01847755|363489086|FG000|Overall Study|Adverse Event|2|||
105404235|NCT01847755|363489086|FG000|Overall Study|Withdrawal by Subject|2|||
105404236|NCT01847755|363489086|FG000|Overall Study|Physician Decision|1|||
105404237|NCT00846846|363489087|FG000|Overall Study|Death|56|||
105404238|NCT00846846|363489087|FG000|Overall Study|Withdrawal by Subject|19|||
105404239|NCT02779777|363489088|FG000|Overall Study|Disease Progression|1|||
105404240|NCT02779777|363489089|FG001|Overall Study|Disease Progression|0|||
105404241|NCT02779777|363489090|FG002|Overall Study|Disease Progression|0|||
105404242|NCT02779777|363489088|FG000|Overall Study|Adverse Event|3|||
105404243|NCT02779777|363489089|FG001|Overall Study|Adverse Event|1|||
105404244|NCT02779777|363489090|FG002|Overall Study|Adverse Event|0|||
105404245|NCT02779777|363489088|FG000|Overall Study|Physician Decision|9|||
105404246|NCT02779777|363489089|FG001|Overall Study|Physician Decision|0|||
105404247|NCT02779777|363489090|FG002|Overall Study|Physician Decision|1|||
105404248|NCT02779777|363489088|FG000|Overall Study|Withdrawal by Subject|1|||
105404249|NCT02779777|363489089|FG001|Overall Study|Withdrawal by Subject|0|||
105404250|NCT02779777|363489090|FG002|Overall Study|Withdrawal by Subject|0|||
105404251|NCT04179305|363489095|FG000|Overall Study|Death|1|||
105580801|NCT01474512|364126477|FG012|Maintenance Period|Death|0|||
105404252|NCT04179305|363489096|FG001|Overall Study|Death|1|||
105404253|NCT04179305|363489097|FG002|Overall Study|Death|0|||
105404254|NCT04179305|363489098|FG003|Overall Study|Death|0|||
105404255|NCT04179305|363489095|FG000|Overall Study|Lost to Follow-up|1|||
105404256|NCT04179305|363489096|FG001|Overall Study|Lost to Follow-up|1|||
105404257|NCT04179305|363489097|FG002|Overall Study|Lost to Follow-up|0|||
105580802|NCT01474512|364126478|FG013|Maintenance Period|Death|0|||
105404258|NCT04179305|363489098|FG003|Overall Study|Lost to Follow-up|0|||
105404259|NCT04179305|363489095|FG000|Overall Study|Withdrawal by Subject|0|||
105404260|NCT04179305|363489096|FG001|Overall Study|Withdrawal by Subject|1|||
105404261|NCT04179305|363489097|FG002|Overall Study|Withdrawal by Subject|0|||
105404262|NCT04179305|363489098|FG003|Overall Study|Withdrawal by Subject|0|||
105404263|NCT04179305|363489095|FG000|Overall Study|Did not have scan|1|||
105404264|NCT04179305|363489096|FG001|Overall Study|Did not have scan|0|||
105404265|NCT04179305|363489097|FG002|Overall Study|Did not have scan|0|||
105404266|NCT04179305|363489098|FG003|Overall Study|Did not have scan|0|||
105404267|NCT04179305|363489095|FG000|Overall Study|In hospice care|3|||
105404268|NCT04179305|363489096|FG001|Overall Study|In hospice care|0|||
105404269|NCT04179305|363489097|FG002|Overall Study|In hospice care|0|||
105404270|NCT04179305|363489098|FG003|Overall Study|In hospice care|0|||
105404271|NCT00401843|363489099|FG000|Overall Study|Achieved Complete Response|1|||
105404272|NCT00401843|363489100|FG001|Overall Study|Achieved Complete Response|5|||
105404273|NCT00401843|363489101|FG002|Overall Study|Achieved Complete Response|11|||
105404274|NCT00401843|363489099|FG000|Overall Study|Adverse Event|7|||
105404275|NCT00401843|363489100|FG001|Overall Study|Adverse Event|26|||
105404276|NCT00401843|363489101|FG002|Overall Study|Adverse Event|27|||
105404277|NCT00401843|363489099|FG000|Overall Study|Death|0|||
105404278|NCT00401843|363489100|FG001|Overall Study|Death|8|||
105404279|NCT00401843|363489101|FG002|Overall Study|Death|10|||
105404280|NCT00401843|363489099|FG000|Overall Study|Disease progression|10|||
105404281|NCT00401843|363489100|FG001|Overall Study|Disease progression|60|||
105404282|NCT00401843|363489101|FG002|Overall Study|Disease progression|49|||
105404283|NCT00401843|363489099|FG000|Overall Study|End of Study|1|||
105404284|NCT00401843|363489100|FG001|Overall Study|End of Study|1|||
105404285|NCT00401843|363489101|FG002|Overall Study|End of Study|2|||
105404286|NCT00401843|363489099|FG000|Overall Study|Lost to Follow-up|0|||
105404287|NCT00401843|363489100|FG001|Overall Study|Lost to Follow-up|0|||
105404288|NCT00401843|363489101|FG002|Overall Study|Lost to Follow-up|2|||
105404289|NCT00401843|363489099|FG000|Overall Study|Other Unspecified|0|||
105404290|NCT00401843|363489100|FG001|Overall Study|Other Unspecified|3|||
105404291|NCT00401843|363489101|FG002|Overall Study|Other Unspecified|5|||
105404292|NCT00401843|363489099|FG000|Overall Study|Physician Decision|0|||
105404293|NCT00401843|363489100|FG001|Overall Study|Physician Decision|16|||
105404294|NCT00401843|363489101|FG002|Overall Study|Physician Decision|10|||
105404295|NCT00401843|363489099|FG000|Overall Study|Protocol Violation|0|||
105404296|NCT00401843|363489100|FG001|Overall Study|Protocol Violation|0|||
105404297|NCT00401843|363489101|FG002|Overall Study|Protocol Violation|1|||
105404298|NCT00401843|363489099|FG000|Overall Study|Withdrawal by Subject|1|||
105404299|NCT00401843|363489100|FG001|Overall Study|Withdrawal by Subject|5|||
105404300|NCT00401843|363489101|FG002|Overall Study|Withdrawal by Subject|5|||
105404301|NCT00401843|363489099|FG000|Overall Study|Withdrawal of consent to study agent|1|||
105404302|NCT00401843|363489100|FG001|Overall Study|Withdrawal of consent to study agent|15|||
105404303|NCT00401843|363489101|FG002|Overall Study|Withdrawal of consent to study agent|17|||
105404304|NCT00401843|363489099|FG000|Overall Study|Randomized but not Treated|0|||
105404305|NCT00401843|363489100|FG001|Overall Study|Randomized but not Treated|2|||
105404306|NCT00401843|363489101|FG002|Overall Study|Randomized but not Treated|3|||
105404307|NCT00401843|363489099|FG000|Overall Study|Received incorrect treatment|0|||
105404308|NCT00401843|363489100|FG001|Overall Study|Received incorrect treatment|3|||
105404309|NCT00401843|363489101|FG002|Overall Study|Received incorrect treatment|0|||
105404310|NCT00003869|363489102|FG000|Overall Study|Adverse Event|14|||
105404311|NCT00003869|363489103|FG001|Overall Study|Adverse Event|3|||
105404312|NCT00003869|363489102|FG000|Overall Study|Withdrawal by Subject|21|||
105404313|NCT00003869|363489103|FG001|Overall Study|Withdrawal by Subject|3|||
105404314|NCT00003869|363489102|FG000|Overall Study|Death|1|||
105404315|NCT00003869|363489103|FG001|Overall Study|Death|2|||
105404316|NCT00003869|363489102|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
105404317|NCT00003869|363489103|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
105404318|NCT01964378|363489104|FG000|Overall Study|Disc. due to death before first dosing|0|||
105404319|NCT01964378|363489105|FG001|Overall Study|Disc. due to death before first dosing|1|||
105404320|NCT01964378|363489104|FG000|Overall Study|Disc. due to AE before first dosing|1|||
105404321|NCT01964378|363489105|FG001|Overall Study|Disc. due to AE before first dosing|0|||
105404322|NCT01964378|363489104|FG000|Overall Study|Death|3|||
105404323|NCT01964378|363489105|FG001|Overall Study|Death|2|||
105404324|NCT01964378|363489104|FG000|Overall Study|Adverse Event|12|||
105580803|NCT01474512|364126479|FG014|Maintenance Period|Death|0|||
105580804|NCT01474512|364126480|FG015|Maintenance Period|Death|0|||
105404325|NCT01964378|363489105|FG001|Overall Study|Adverse Event|5|||
105404326|NCT01964378|363489104|FG000|Overall Study|Lack of Efficacy|0|||
105404327|NCT01964378|363489105|FG001|Overall Study|Lack of Efficacy|1|||
105404328|NCT01964378|363489104|FG000|Overall Study|Protocol Violation|0|||
105404329|NCT01964378|363489105|FG001|Overall Study|Protocol Violation|1|||
105580805|NCT01474512|364126481|FG016|Maintenance Period|Death|0|||
105404330|NCT01964378|363489104|FG000|Overall Study|Lost to Follow-up|0|||
105404331|NCT01964378|363489105|FG001|Overall Study|Lost to Follow-up|1|||
105404332|NCT01964378|363489104|FG000|Overall Study|Withdrawal by Subject|7|||
105494429|NCT03633617|363824807|FG005|Part B|Physician Decision|0|||
105494430|NCT03633617|363824808|FG006|Part B|Physician Decision|0|||
105494431|NCT03633617|363824809|FG007|Part B|Physician Decision|0|||
105494432|NCT03633617|363824810|FG008|Part B|Physician Decision|0|||
105494433|NCT03633617|363824811|FG009|Part B|Physician Decision|0|||
105494434|NCT03633617|363824812|FG010|Part B|Physician Decision|0|||
105494435|NCT03633617|363824802|FG000|Part B|COVID-19 Restrictions|0|||
105494436|NCT03633617|363824803|FG001|Part B|COVID-19 Restrictions|0|||
105494437|NCT03633617|363824804|FG002|Part B|COVID-19 Restrictions|1|||
105494438|NCT03633617|363824805|FG003|Part B|COVID-19 Restrictions|0|||
105494439|NCT03633617|363824806|FG004|Part B|COVID-19 Restrictions|0|||
105494440|NCT03633617|363824807|FG005|Part B|COVID-19 Restrictions|0|||
105494441|NCT03633617|363824808|FG006|Part B|COVID-19 Restrictions|0|||
105494442|NCT03633617|363824809|FG007|Part B|COVID-19 Restrictions|0|||
105494443|NCT03633617|363824810|FG008|Part B|COVID-19 Restrictions|0|||
105494444|NCT03633617|363824811|FG009|Part B|COVID-19 Restrictions|0|||
105494445|NCT03633617|363824812|FG010|Part B|COVID-19 Restrictions|0|||
105494446|NCT03633617|363824802|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
105494447|NCT03633617|363824803|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
105494448|NCT03633617|363824804|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
105494449|NCT03633617|363824805|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
105494450|NCT03633617|363824806|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
105494451|NCT03633617|363824807|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
105494452|NCT03633617|363824808|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
105494453|NCT03633617|363824809|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
105494454|NCT03633617|363824810|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
105494455|NCT03633617|363824811|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
105494456|NCT03633617|363824812|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
105494457|NCT03633617|363824802|FG000|Part C (& Follow-up)|Adverse Event|0|||
105494458|NCT03633617|363824803|FG001|Part C (& Follow-up)|Adverse Event|0|||
105494459|NCT03633617|363824804|FG002|Part C (& Follow-up)|Adverse Event|0|||
105494460|NCT03633617|363824805|FG003|Part C (& Follow-up)|Adverse Event|0|||
105494461|NCT03633617|363824806|FG004|Part C (& Follow-up)|Adverse Event|0|||
105494462|NCT03633617|363824807|FG005|Part C (& Follow-up)|Adverse Event|1|||
105494463|NCT03633617|363824808|FG006|Part C (& Follow-up)|Adverse Event|0|||
105494464|NCT03633617|363824809|FG007|Part C (& Follow-up)|Adverse Event|1|||
105494465|NCT03633617|363824810|FG008|Part C (& Follow-up)|Adverse Event|0|||
105494466|NCT03633617|363824811|FG009|Part C (& Follow-up)|Adverse Event|0|||
105494467|NCT03633617|363824812|FG010|Part C (& Follow-up)|Adverse Event|0|||
105494468|NCT03633617|363824802|FG000|Part C (& Follow-up)|Pregnancy|0|||
105494469|NCT03633617|363824803|FG001|Part C (& Follow-up)|Pregnancy|0|||
105494470|NCT03633617|363824804|FG002|Part C (& Follow-up)|Pregnancy|0|||
105494471|NCT03633617|363824805|FG003|Part C (& Follow-up)|Pregnancy|0|||
105494472|NCT03633617|363824806|FG004|Part C (& Follow-up)|Pregnancy|0|||
105494473|NCT03633617|363824807|FG005|Part C (& Follow-up)|Pregnancy|0|||
105494474|NCT03633617|363824808|FG006|Part C (& Follow-up)|Pregnancy|0|||
105494475|NCT03633617|363824809|FG007|Part C (& Follow-up)|Pregnancy|0|||
105494476|NCT03633617|363824810|FG008|Part C (& Follow-up)|Pregnancy|0|||
105494477|NCT03633617|363824811|FG009|Part C (& Follow-up)|Pregnancy|1|||
105494478|NCT03633617|363824812|FG010|Part C (& Follow-up)|Pregnancy|0|||
105494479|NCT03633617|363824802|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
105494480|NCT03633617|363824803|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
105494481|NCT03633617|363824804|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
105494482|NCT03633617|363824805|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
105494483|NCT03633617|363824806|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
105494484|NCT03633617|363824807|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
105494485|NCT03633617|363824808|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
105580806|NCT01474512|364126482|FG017|Maintenance Period|Death|0|||
105580807|NCT01474512|364126465|FG000|Maintenance Period|Physician Decision|0|||
105580808|NCT01474512|364126466|FG001|Maintenance Period|Physician Decision|0|||
105580809|NCT01474512|364126467|FG002|Maintenance Period|Physician Decision|0|||
105494486|NCT03633617|363824809|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
105494487|NCT03633617|363824810|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
105494488|NCT03633617|363824811|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
105494489|NCT03633617|363824812|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
105580810|NCT01474512|364126468|FG003|Maintenance Period|Physician Decision|0|||
105494490|NCT03633617|363824802|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
105494491|NCT03633617|363824803|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
105494492|NCT03633617|363824804|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
105494493|NCT03633617|363824805|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
105494494|NCT03633617|363824806|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
105494495|NCT03633617|363824807|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
105580811|NCT01474512|364126469|FG004|Maintenance Period|Physician Decision|0|||
105580812|NCT01474512|364126470|FG005|Maintenance Period|Physician Decision|1|||
105404333|NCT01964378|363489105|FG001|Overall Study|Withdrawal by Subject|5|||
105404334|NCT01964378|363489104|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
105404335|NCT01964378|363489105|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
105404336|NCT01964378|363489104|FG000|Overall Study|Other|1|||
105404337|NCT01964378|363489105|FG001|Overall Study|Other|2|||
105404338|NCT03364231|363489106|FG000|Overall Study|Adverse Event|1|||
105404339|NCT03364231|363489107|FG001|Overall Study|Adverse Event|4|||
105404340|NCT03364231|363489106|FG000|Overall Study|Death|1|||
105404341|NCT03364231|363489107|FG001|Overall Study|Death|0|||
105404342|NCT03364231|363489106|FG000|Overall Study|Investigator Decision|2|||
105404343|NCT03364231|363489107|FG001|Overall Study|Investigator Decision|2|||
105404344|NCT03364231|363489106|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
105404345|NCT03364231|363489107|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
105404346|NCT03364231|363489106|FG000|Overall Study|Withdrawal of Subject Consent|1|||
105404347|NCT03364231|363489107|FG001|Overall Study|Withdrawal of Subject Consent|0|||
105404348|NCT03364231|363489106|FG000|Overall Study|Reason Not Specified|1|||
105404349|NCT03364231|363489107|FG001|Overall Study|Reason Not Specified|0|||
105404350|NCT03364231|363489106|FG000|Overall Study|Disease Progression|0|||
105404351|NCT03364231|363489107|FG001|Overall Study|Disease Progression|6|||
105404352|NCT03328832|363489109|FG000|Overall Study|Lost to Follow-up|0|||
105404353|NCT03328832|363489110|FG001|Overall Study|Lost to Follow-up|1|||
105404354|NCT00786422|363489113|FG000|Rivaroxaban Treatment|Death|2|||
105404355|NCT00786422|363489113|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
105404356|NCT00786422|363489113|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
105404357|NCT00786422|363489113|FG000|Rivaroxaban Treatment|Physician Decision|1|||
105404358|NCT00786422|363489113|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
105404359|NCT00786422|363489113|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
105404360|NCT00786422|363489113|FG000|Rivaroxaban Treatment|Adverse Event|2|||
105404361|NCT00786422|363489113|FG000|Follow-up Period|Death|1|||
105404362|NCT00786422|363489113|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
105404363|NCT05588440|363489116|FG000|Overall Study|Sponsor Decision|2|||
105404364|NCT05588440|363489117|FG001|Overall Study|Sponsor Decision|0|||
105404365|NCT05588440|363489118|FG002|Overall Study|Sponsor Decision|1|||
105404366|NCT05588440|363489116|FG000|Overall Study|Death|1|||
105404367|NCT05588440|363489117|FG001|Overall Study|Death|1|||
105404368|NCT05588440|363489118|FG002|Overall Study|Death|1|||
105404369|NCT05588440|363489116|FG000|Overall Study|Screen Fail|0|||
105404370|NCT05588440|363489117|FG001|Overall Study|Screen Fail|1|||
105404371|NCT05588440|363489118|FG002|Overall Study|Screen Fail|1|||
105404372|NCT05588440|363489116|FG000|Overall Study|Withdrawal by Subject|0|||
105404373|NCT05588440|363489117|FG001|Overall Study|Withdrawal by Subject|0|||
105404374|NCT05588440|363489118|FG002|Overall Study|Withdrawal by Subject|1|||
105404375|NCT05653700|363489123|FG000|Overall Study|Non Responders|9|||
105404376|NCT05653700|363489124|FG001|Overall Study|Non Responders|0|||
105404377|NCT01900665|363489131|FG000|Placebo Controlled Period|Death|9|||
105404378|NCT01900665|363489132|FG001|Placebo Controlled Period|Death|16|||
105404379|NCT01900665|363489131|FG000|Placebo Controlled Period|Adverse Event|48|||
105404380|NCT01900665|363489132|FG001|Placebo Controlled Period|Adverse Event|39|||
105404381|NCT01900665|363489131|FG000|Placebo Controlled Period|Protocol Violation|1|||
105404382|NCT01900665|363489132|FG001|Placebo Controlled Period|Protocol Violation|7|||
105404383|NCT01900665|363489131|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
105404384|NCT01900665|363489132|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
105404385|NCT01900665|363489131|FG000|Placebo Controlled Period|Physician Decision|11|||
105404386|NCT01900665|363489132|FG001|Placebo Controlled Period|Physician Decision|7|||
105404387|NCT01900665|363489131|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
105404388|NCT01900665|363489132|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
105404389|NCT01900665|363489131|FG000|Placebo Controlled Period|Caregiver Decision|33|||
105404390|NCT01900665|363489132|FG001|Placebo Controlled Period|Caregiver Decision|41|||
105404391|NCT01900665|363489131|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
105404392|NCT01900665|363489132|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
105404393|NCT01900665|363489131|FG000|Open Label Period|Adverse Event|16|||
105404394|NCT01900665|363489132|FG001|Open Label Period|Adverse Event|20|||
105404395|NCT01900665|363489131|FG000|Open Label Period|Death|5|||
105404396|NCT01900665|363489132|FG001|Open Label Period|Death|6|||
105404397|NCT01900665|363489131|FG000|Open Label Period|Lost to Follow-up|1|||
105404398|NCT01900665|363489132|FG001|Open Label Period|Lost to Follow-up|1|||
105404399|NCT01900665|363489131|FG000|Open Label Period|Parent/Caregiver Decision|33|||
105404400|NCT01900665|363489132|FG001|Open Label Period|Parent/Caregiver Decision|34|||
105404401|NCT01900665|363489131|FG000|Open Label Period|Physician Decision|4|||
105404402|NCT01900665|363489132|FG001|Open Label Period|Physician Decision|4|||
105404403|NCT01900665|363489131|FG000|Open Label Period|Protocol Violation|0|||
105404404|NCT01900665|363489132|FG001|Open Label Period|Protocol Violation|1|||
105494496|NCT03633617|363824808|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
105494497|NCT03633617|363824809|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
105494498|NCT03633617|363824810|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
105494499|NCT03633617|363824811|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
105494500|NCT03633617|363824812|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
105404405|NCT01900665|363489131|FG000|Open Label Period|Sponsor Decision|802|||
105404406|NCT01900665|363489132|FG001|Open Label Period|Sponsor Decision|765|||
105404407|NCT01900665|363489131|FG000|Open Label Period|Withdrawal by Subject|20|||
105404408|NCT01900665|363489132|FG001|Open Label Period|Withdrawal by Subject|28|||
105404409|NCT04749914|363489133|FG000|Period 1|Adverse Event|1|||
105404410|NCT04749914|363489134|FG001|Period 1|Adverse Event|0|||
105404411|NCT04749914|363489135|FG002|Period 1|Adverse Event|0|||
105404412|NCT04749914|363489136|FG003|Period 1|Adverse Event|0|||
105404413|NCT04749914|363489133|FG000|Period 1|Withdrawal by Subject|1|||
105404414|NCT04749914|363489134|FG001|Period 1|Withdrawal by Subject|0|||
105404415|NCT04749914|363489135|FG002|Period 1|Withdrawal by Subject|1|||
105404416|NCT04749914|363489136|FG003|Period 1|Withdrawal by Subject|0|||
105404417|NCT01913327|363489139|FG000|Overall Study|Withdrawal by Subject|0|||
105404418|NCT01913327|363489140|FG001|Overall Study|Withdrawal by Subject|1|||
105404419|NCT03654274|363489142|FG000|Overall Study|Adverse Event|19|||
105404420|NCT03654274|363489143|FG001|Overall Study|Adverse Event|23|||
105404421|NCT03654274|363489144|FG002|Overall Study|Adverse Event|24|||
105404422|NCT03654274|363489142|FG000|Overall Study|Protocol Deviation|0|||
105404423|NCT03654274|363489143|FG001|Overall Study|Protocol Deviation|2|||
105404424|NCT03654274|363489144|FG002|Overall Study|Protocol Deviation|0|||
105404425|NCT03654274|363489142|FG000|Overall Study|Lost to Follow-up|8|||
105404426|NCT03654274|363489143|FG001|Overall Study|Lost to Follow-up|6|||
105404427|NCT03654274|363489144|FG002|Overall Study|Lost to Follow-up|5|||
105404428|NCT03654274|363489142|FG000|Overall Study|Withdrawal by Subject|46|||
105404429|NCT03654274|363489143|FG001|Overall Study|Withdrawal by Subject|25|||
105404430|NCT03654274|363489144|FG002|Overall Study|Withdrawal by Subject|33|||
105404431|NCT03654274|363489142|FG000|Overall Study|Lack of Efficacy|4|||
105404432|NCT03654274|363489143|FG001|Overall Study|Lack of Efficacy|5|||
105404433|NCT03654274|363489144|FG002|Overall Study|Lack of Efficacy|7|||
105404434|NCT03654274|363489142|FG000|Overall Study|Pregnancy|2|||
105404435|NCT03654274|363489143|FG001|Overall Study|Pregnancy|2|||
105404436|NCT03654274|363489144|FG002|Overall Study|Pregnancy|1|||
105404437|NCT03654274|363489142|FG000|Overall Study|Other|27|||
105404438|NCT03654274|363489143|FG001|Overall Study|Other|29|||
105404439|NCT03654274|363489144|FG002|Overall Study|Other|32|||
105404440|NCT03654274|363489142|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
105404441|NCT03654274|363489143|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
105404442|NCT03654274|363489144|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
105404443|NCT00038948|363489148|FG000|Overall Study|Adverse Event|131|||
105404444|NCT00038948|363489149|FG001|Overall Study|Adverse Event|43|||
105404445|NCT00038948|363489148|FG000|Overall Study|Lost to Follow-up|4|||
105404446|NCT00038948|363489149|FG001|Overall Study|Lost to Follow-up|4|||
105404447|NCT00038948|363489148|FG000|Overall Study|Nonmedical event|5|||
105404448|NCT00038948|363489149|FG001|Overall Study|Nonmedical event|7|||
105404449|NCT00038948|363489148|FG000|Overall Study|Withdrawal by Subject|23|||
105404450|NCT00038948|363489149|FG001|Overall Study|Withdrawal by Subject|10|||
105404451|NCT00038948|363489148|FG000|Overall Study|Protocol Violation|3|||
105404452|NCT00038948|363489149|FG001|Overall Study|Protocol Violation|7|||
105404453|NCT00038948|363489148|FG000|Overall Study|Lack of Efficacy|3|||
105404454|NCT00038948|363489149|FG001|Overall Study|Lack of Efficacy|6|||
105404455|NCT03549338|363490585|FG000|Overall Study|Progressive Disease|1|||
105404456|NCT03549338|363490586|FG001|Overall Study|Progressive Disease|0|||
105404457|NCT03549338|363490587|FG002|Overall Study|Progressive Disease|0|||
105404458|NCT03549338|363490585|FG000|Overall Study|Clinical Progression|0|||
105404459|NCT03549338|363490586|FG001|Overall Study|Clinical Progression|1|||
105404460|NCT03549338|363490587|FG002|Overall Study|Clinical Progression|0|||
105404461|NCT00939107|363490588|FG000|Overall Study|Lost to Follow-up|14|||
105404462|NCT00939107|363490589|FG001|Overall Study|Lost to Follow-up|12|||
105404463|NCT01047007|363490592|FG000|Overall Study|Adverse Event|0|||
105404464|NCT01047007|363490593|FG001|Overall Study|Adverse Event|2|||
105404465|NCT01047007|363490594|FG002|Overall Study|Adverse Event|1|||
105494501|NCT03633617|363824802|FG000|Part C (& Follow-up)|Physician Decision|0|||
105404466|NCT01047007|363490595|FG003|Overall Study|Adverse Event|0|||
105404467|NCT01047007|363490592|FG000|Overall Study|Progressive Disease|2|||
105404468|NCT01047007|363490593|FG001|Overall Study|Progressive Disease|4|||
105404469|NCT01047007|363490594|FG002|Overall Study|Progressive Disease|1|||
105404470|NCT01047007|363490595|FG003|Overall Study|Progressive Disease|0|||
105404471|NCT04776161|363490596|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
105494502|NCT03633617|363824803|FG001|Part C (& Follow-up)|Physician Decision|0|||
105404472|NCT04776161|363490597|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
105404473|NCT04776161|363490598|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
105404474|NCT04776161|363490596|FG000|Overall Study|Withdrawal by Subject|1|||
105404475|NCT04776161|363490597|FG001|Overall Study|Withdrawal by Subject|0|||
105404476|NCT04776161|363490598|FG002|Overall Study|Withdrawal by Subject|1|||
105404477|NCT04776161|363490596|FG000|Overall Study|Adverse Event|0|||
105404478|NCT04776161|363490597|FG001|Overall Study|Adverse Event|1|||
105404479|NCT04776161|363490598|FG002|Overall Study|Adverse Event|1|||
105404480|NCT04551898|363490601|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
105404481|NCT04551898|363490602|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
105404482|NCT04551898|363490603|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
105404483|NCT04551898|363490604|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
105404484|NCT04551898|363490601|FG000|Overall Study|Withdrawal by Subject|5|||
105404485|NCT04551898|363490602|FG001|Overall Study|Withdrawal by Subject|1|||
105404486|NCT04551898|363490603|FG002|Overall Study|Withdrawal by Subject|2|||
105404487|NCT04551898|363490604|FG003|Overall Study|Withdrawal by Subject|2|||
105404488|NCT04551898|363490601|FG000|Overall Study|Lost to Follow-up|2|||
105404489|NCT04551898|363490602|FG001|Overall Study|Lost to Follow-up|1|||
105404490|NCT04551898|363490603|FG002|Overall Study|Lost to Follow-up|2|||
105404491|NCT04551898|363490604|FG003|Overall Study|Lost to Follow-up|2|||
105404492|NCT04551898|363490601|FG000|Overall Study|Death|1|||
105404493|NCT04551898|363490602|FG001|Overall Study|Death|0|||
105404494|NCT04551898|363490603|FG002|Overall Study|Death|0|||
105404495|NCT04551898|363490604|FG003|Overall Study|Death|0|||
105404496|NCT04551898|363490601|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
105404497|NCT04551898|363490602|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
105404498|NCT04551898|363490603|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
105404499|NCT04551898|363490604|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
105404500|NCT03846427|363490605|FG000|Overall Study|Death|13|||
105404501|NCT03846427|363490605|FG000|Overall Study|Withdrawal by Subject|3|||
105404502|NCT03846427|363490605|FG000|Overall Study|Physician Decision|1|||
105404503|NCT00628446|363490606|FG000|Overall Study|Lost to Follow-up|3|||
105404504|NCT00628446|363490606|FG000|Overall Study|Withdrawal by Subject|1|||
105404505|NCT00628446|363490606|FG000|Overall Study|Protocol Violation|3|||
105404506|NCT01898286|363490607|FG000|Overall Study|Withdrawal by Subject|1|||
105404507|NCT01898286|363490607|FG000|Overall Study|Protocol Violation|1|||
105404508|NCT01898286|363490607|FG000|Overall Study|Lost to Follow-up|1|||
105404509|NCT01976299|363490612|FG000|Overall Study|Withdrawal by Subject|3|||
105404510|NCT01976299|363490613|FG001|Overall Study|Withdrawal by Subject|1|||
105404511|NCT01976299|363490612|FG000|Overall Study|Death|4|||
105404512|NCT01976299|363490613|FG001|Overall Study|Death|2|||
105404513|NCT01976299|363490612|FG000|Overall Study|Lost to Follow-up|7|||
105404514|NCT01976299|363490613|FG001|Overall Study|Lost to Follow-up|1|||
105404515|NCT01976299|363490612|FG000|Overall Study|See clarification above in comments|9|||
105404516|NCT01976299|363490613|FG001|Overall Study|See clarification above in comments|2|||
105404517|NCT03692403|363490614|FG000|Overall Study|Withdrawal by Subject|1|||
105404518|NCT03692403|363490615|FG001|Overall Study|Withdrawal by Subject|0|||
105404519|NCT03692403|363490616|FG002|Overall Study|Withdrawal by Subject|1|||
105404520|NCT03692403|363490617|FG003|Overall Study|Withdrawal by Subject|0|||
105404521|NCT03692403|363490614|FG000|Overall Study|Adverse Event|0|||
105404522|NCT03692403|363490615|FG001|Overall Study|Adverse Event|0|||
105404523|NCT03692403|363490616|FG002|Overall Study|Adverse Event|0|||
105404524|NCT03692403|363490617|FG003|Overall Study|Adverse Event|1|||
105404525|NCT03692403|363490614|FG000|Overall Study|Pregnancy|0|||
105404526|NCT03692403|363490615|FG001|Overall Study|Pregnancy|1|||
105404527|NCT03692403|363490616|FG002|Overall Study|Pregnancy|0|||
105404528|NCT03692403|363490617|FG003|Overall Study|Pregnancy|0|||
105404529|NCT03692403|363490614|FG000|Overall Study|Other|0|||
105404530|NCT03692403|363490615|FG001|Overall Study|Other|0|||
105404531|NCT03692403|363490616|FG002|Overall Study|Other|1|||
105404532|NCT03692403|363490617|FG003|Overall Study|Other|0|||
105404533|NCT02197572|363490622|FG000|Overall Study|Progressive Disease|28|||
105404534|NCT02197572|363490622|FG000|Overall Study|Withdrawal by Subject|9|||
105404535|NCT02197572|363490622|FG000|Overall Study|Adverse Event|3|||
105404536|NCT02197572|363490622|FG000|Overall Study|Reason Not Specified|4|||
105404537|NCT00355368|363490623|FG000|Overall Study|Protocol Violation|8|||
105404538|NCT00355368|363490624|FG001|Overall Study|Protocol Violation|7|||
105404539|NCT00355368|363490623|FG000|Overall Study|cardiac arrest prior to intubation|2|||
105404540|NCT00355368|363490624|FG001|Overall Study|cardiac arrest prior to intubation|2|||
105404541|NCT00592631|363490626|FG000|Overall Study|Lost to Follow-up|0|||
105404542|NCT00592631|363490627|FG001|Overall Study|Lost to Follow-up|2|||
105404543|NCT01244035|363490628|FG000|Part 1: Period 1|Adverse Event|0|||
105404544|NCT01244035|363490629|FG001|Part 1: Period 1|Adverse Event|0|||
105404545|NCT01244035|363490630|FG002|Part 1: Period 1|Adverse Event|0|||
105404546|NCT01244035|363490631|FG003|Part 1: Period 1|Adverse Event|0|||
105404547|NCT01244035|363490632|FG004|Part 1: Period 1|Adverse Event|0|||
105494503|NCT03633617|363824804|FG002|Part C (& Follow-up)|Physician Decision|0|||
105494504|NCT03633617|363824805|FG003|Part C (& Follow-up)|Physician Decision|0|||
105494505|NCT03633617|363824806|FG004|Part C (& Follow-up)|Physician Decision|0|||
105494506|NCT03633617|363824807|FG005|Part C (& Follow-up)|Physician Decision|0|||
105494507|NCT03633617|363824808|FG006|Part C (& Follow-up)|Physician Decision|0|||
105494508|NCT03633617|363824809|FG007|Part C (& Follow-up)|Physician Decision|1|||
105494509|NCT03633617|363824810|FG008|Part C (& Follow-up)|Physician Decision|0|||
105494510|NCT03633617|363824811|FG009|Part C (& Follow-up)|Physician Decision|0|||
105494511|NCT03633617|363824812|FG010|Part C (& Follow-up)|Physician Decision|1|||
105494512|NCT03633617|363824802|FG000|Part C (& Follow-up)|COVID-19 related|0|||
105494513|NCT03633617|363824803|FG001|Part C (& Follow-up)|COVID-19 related|0|||
105494514|NCT03633617|363824804|FG002|Part C (& Follow-up)|COVID-19 related|0|||
105494515|NCT03633617|363824805|FG003|Part C (& Follow-up)|COVID-19 related|0|||
105494516|NCT03633617|363824806|FG004|Part C (& Follow-up)|COVID-19 related|0|||
105494517|NCT03633617|363824807|FG005|Part C (& Follow-up)|COVID-19 related|1|||
105494518|NCT03633617|363824808|FG006|Part C (& Follow-up)|COVID-19 related|0|||
105494519|NCT03633617|363824809|FG007|Part C (& Follow-up)|COVID-19 related|0|||
105494520|NCT03633617|363824810|FG008|Part C (& Follow-up)|COVID-19 related|0|||
105494521|NCT03633617|363824811|FG009|Part C (& Follow-up)|COVID-19 related|0|||
105494522|NCT03633617|363824812|FG010|Part C (& Follow-up)|COVID-19 related|0|||
105494523|NCT03633617|363824802|FG000|Part C (& Follow-up)|Protocol Violation|0|||
105494524|NCT03633617|363824803|FG001|Part C (& Follow-up)|Protocol Violation|0|||
105494525|NCT03633617|363824804|FG002|Part C (& Follow-up)|Protocol Violation|0|||
105494526|NCT03633617|363824805|FG003|Part C (& Follow-up)|Protocol Violation|0|||
105494527|NCT03633617|363824806|FG004|Part C (& Follow-up)|Protocol Violation|0|||
105494528|NCT03633617|363824807|FG005|Part C (& Follow-up)|Protocol Violation|0|||
105494529|NCT03633617|363824808|FG006|Part C (& Follow-up)|Protocol Violation|0|||
105494530|NCT03633617|363824809|FG007|Part C (& Follow-up)|Protocol Violation|0|||
105494531|NCT03633617|363824810|FG008|Part C (& Follow-up)|Protocol Violation|0|||
105494532|NCT03633617|363824811|FG009|Part C (& Follow-up)|Protocol Violation|3|||
105494533|NCT03633617|363824812|FG010|Part C (& Follow-up)|Protocol Violation|1|||
105494534|NCT03633617|363824802|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
105494535|NCT03633617|363824803|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
105494536|NCT03633617|363824804|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
105494537|NCT03633617|363824805|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
105494538|NCT03633617|363824806|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
105494539|NCT03633617|363824807|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
105494540|NCT03633617|363824808|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
105494541|NCT03633617|363824809|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
105494542|NCT03633617|363824810|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
105494543|NCT03633617|363824811|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
105494544|NCT03633617|363824812|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
105494545|NCT00809354|363824813|FG000|Overall Study|Adverse Event|32|||
105494546|NCT00809354|363824814|FG001|Overall Study|Adverse Event|45|||
105494547|NCT00809354|363824815|FG002|Overall Study|Adverse Event|37|||
105494548|NCT00809354|363824816|FG003|Overall Study|Adverse Event|53|||
105494549|NCT00809354|363824817|FG004|Overall Study|Adverse Event|26|||
105494550|NCT00809354|363824818|FG005|Overall Study|Adverse Event|33|||
105494551|NCT00809354|363824819|FG006|Overall Study|Adverse Event|44|||
105494552|NCT00809354|363824820|FG007|Overall Study|Adverse Event|40|||
105494553|NCT00809354|363824821|FG008|Overall Study|Adverse Event|46|||
105494554|NCT00809354|363824822|FG009|Overall Study|Adverse Event|26|||
105494555|NCT00809354|363824813|FG000|Overall Study|Lack of Efficacy|23|||
105494556|NCT00809354|363824814|FG001|Overall Study|Lack of Efficacy|23|||
105494557|NCT00809354|363824815|FG002|Overall Study|Lack of Efficacy|22|||
105580813|NCT01474512|364126471|FG006|Maintenance Period|Physician Decision|0|||
105580814|NCT01474512|364126472|FG007|Maintenance Period|Physician Decision|2|||
105580815|NCT01474512|364126473|FG008|Maintenance Period|Physician Decision|0|||
105580816|NCT01474512|364126474|FG009|Maintenance Period|Physician Decision|0|||
105580817|NCT01474512|364126475|FG010|Maintenance Period|Physician Decision|0|||
105580818|NCT01474512|364126476|FG011|Maintenance Period|Physician Decision|0|||
105494558|NCT00809354|363824816|FG003|Overall Study|Lack of Efficacy|15|||
105580819|NCT01474512|364126477|FG012|Maintenance Period|Physician Decision|0|||
105494559|NCT00809354|363824817|FG004|Overall Study|Lack of Efficacy|40|||
105494560|NCT00809354|363824818|FG005|Overall Study|Lack of Efficacy|19|||
105494561|NCT00809354|363824819|FG006|Overall Study|Lack of Efficacy|21|||
105580820|NCT01474512|364126478|FG013|Maintenance Period|Physician Decision|0|||
105580821|NCT01474512|364126479|FG014|Maintenance Period|Physician Decision|0|||
105580822|NCT01474512|364126480|FG015|Maintenance Period|Physician Decision|0|||
105580823|NCT01474512|364126481|FG016|Maintenance Period|Physician Decision|0|||
105580824|NCT01474512|364126482|FG017|Maintenance Period|Physician Decision|0|||
105494562|NCT00809354|363824820|FG007|Overall Study|Lack of Efficacy|15|||
105494563|NCT00809354|363824821|FG008|Overall Study|Lack of Efficacy|18|||
105494564|NCT00809354|363824822|FG009|Overall Study|Lack of Efficacy|38|||
105494565|NCT00809354|363824813|FG000|Overall Study|Lost to Follow-up|10|||
105494566|NCT00809354|363824814|FG001|Overall Study|Lost to Follow-up|11|||
105494567|NCT00809354|363824815|FG002|Overall Study|Lost to Follow-up|8|||
105404548|NCT01244035|363490633|FG005|Part 1: Period 1|Adverse Event|1|||
105404549|NCT01244035|363490628|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
105404550|NCT01244035|363490629|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
105404551|NCT01244035|363490630|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
105404552|NCT01244035|363490631|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
105404553|NCT01244035|363490632|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
105404554|NCT01244035|363490633|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
105404555|NCT01244035|363490628|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
105404556|NCT01244035|363490629|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
105404557|NCT01244035|363490630|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
105404558|NCT01244035|363490631|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
105404559|NCT01244035|363490632|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
105404560|NCT01244035|363490633|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
105404561|NCT01244035|363490628|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
105404562|NCT01244035|363490629|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
105404563|NCT01244035|363490630|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
105404564|NCT01244035|363490631|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
105404565|NCT01244035|363490632|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
105404566|NCT01244035|363490633|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
105404567|NCT01244035|363490628|FG000|Part 1: Period 3|Adverse Event|0|||
105404568|NCT01244035|363490629|FG001|Part 1: Period 3|Adverse Event|0|||
105404569|NCT01244035|363490630|FG002|Part 1: Period 3|Adverse Event|0|||
105404570|NCT01244035|363490631|FG003|Part 1: Period 3|Adverse Event|0|||
105404571|NCT01244035|363490632|FG004|Part 1: Period 3|Adverse Event|0|||
105404572|NCT01244035|363490633|FG005|Part 1: Period 3|Adverse Event|1|||
105404573|NCT01244035|363490628|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
105404574|NCT01244035|363490629|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
105404575|NCT01244035|363490630|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
105404576|NCT01244035|363490631|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
105404577|NCT01244035|363490632|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
105404578|NCT01244035|363490633|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
105404579|NCT01244035|363490628|FG000|Part 1: Period 3|Protocol Deviation|0|||
105404580|NCT01244035|363490629|FG001|Part 1: Period 3|Protocol Deviation|1|||
105404581|NCT01244035|363490630|FG002|Part 1: Period 3|Protocol Deviation|0|||
105404582|NCT01244035|363490631|FG003|Part 1: Period 3|Protocol Deviation|0|||
105404583|NCT01244035|363490632|FG004|Part 1: Period 3|Protocol Deviation|0|||
105404584|NCT01244035|363490633|FG005|Part 1: Period 3|Protocol Deviation|0|||
105494568|NCT00809354|363824816|FG003|Overall Study|Lost to Follow-up|13|||
105494569|NCT00809354|363824817|FG004|Overall Study|Lost to Follow-up|6|||
105494570|NCT00809354|363824818|FG005|Overall Study|Lost to Follow-up|2|||
105494571|NCT00809354|363824819|FG006|Overall Study|Lost to Follow-up|0|||
105494572|NCT00809354|363824820|FG007|Overall Study|Lost to Follow-up|5|||
105494573|NCT00809354|363824821|FG008|Overall Study|Lost to Follow-up|4|||
105494574|NCT00809354|363824822|FG009|Overall Study|Lost to Follow-up|0|||
105494575|NCT00809354|363824813|FG000|Overall Study|Protocol Violation|7|||
105494576|NCT00809354|363824814|FG001|Overall Study|Protocol Violation|14|||
105494577|NCT00809354|363824815|FG002|Overall Study|Protocol Violation|14|||
105494578|NCT00809354|363824816|FG003|Overall Study|Protocol Violation|12|||
105494579|NCT00809354|363824817|FG004|Overall Study|Protocol Violation|14|||
105494580|NCT00809354|363824818|FG005|Overall Study|Protocol Violation|6|||
105494581|NCT00809354|363824819|FG006|Overall Study|Protocol Violation|4|||
105494582|NCT00809354|363824820|FG007|Overall Study|Protocol Violation|6|||
105494583|NCT00809354|363824821|FG008|Overall Study|Protocol Violation|9|||
105494584|NCT00809354|363824822|FG009|Overall Study|Protocol Violation|3|||
105580825|NCT01474512|364126465|FG000|Maintenance Period|Clinical Relapse|0|||
105580826|NCT01474512|364126466|FG001|Maintenance Period|Clinical Relapse|0|||
105580827|NCT01474512|364126467|FG002|Maintenance Period|Clinical Relapse|0|||
105494585|NCT00809354|363824813|FG000|Overall Study|Withdrawal by Subject|32|||
105494586|NCT00809354|363824814|FG001|Overall Study|Withdrawal by Subject|27|||
105494587|NCT00809354|363824815|FG002|Overall Study|Withdrawal by Subject|31|||
105494588|NCT00809354|363824816|FG003|Overall Study|Withdrawal by Subject|33|||
105580828|NCT01474512|364126468|FG003|Maintenance Period|Clinical Relapse|1|||
105580829|NCT01474512|364126469|FG004|Maintenance Period|Clinical Relapse|0|||
105580830|NCT01474512|364126470|FG005|Maintenance Period|Clinical Relapse|0|||
105580831|NCT01474512|364126471|FG006|Maintenance Period|Clinical Relapse|0|||
105580832|NCT01474512|364126472|FG007|Maintenance Period|Clinical Relapse|0|||
105404585|NCT02383862|363490635|FG000|3 Month Follow up|Lost to Follow-up|23|||
105404586|NCT02383862|363490636|FG001|3 Month Follow up|Lost to Follow-up|21|||
105404587|NCT01696773|363490637|FG000|Days 15-27, Washout|Adverse Event|1|||
105404588|NCT01696773|363490638|FG001|Days 15-27, Washout|Adverse Event|0|||
105404589|NCT01833494|363490639|FG000|Overall Study|Adverse Event|24|||
105494589|NCT00809354|363824817|FG004|Overall Study|Withdrawal by Subject|34|||
105494590|NCT00809354|363824818|FG005|Overall Study|Withdrawal by Subject|29|||
105494591|NCT00809354|363824819|FG006|Overall Study|Withdrawal by Subject|27|||
105494592|NCT00809354|363824820|FG007|Overall Study|Withdrawal by Subject|19|||
105494593|NCT00809354|363824821|FG008|Overall Study|Withdrawal by Subject|18|||
105404590|NCT01833494|363490639|FG000|Overall Study|Physician Decision|6|||
105404591|NCT01833494|363490639|FG000|Overall Study|Withdrawal by Subject|6|||
105404592|NCT01833494|363490639|FG000|Overall Study|Decrease in serum phosphorus|4|||
105404593|NCT01833494|363490639|FG000|Overall Study|Decrease in serum calcium|4|||
105404594|NCT01833494|363490639|FG000|Overall Study|Increase in serum ferritin|1|||
105404595|NCT00443118|363490643|FG000|Overall Study|unknown primary outcome|3|||
105404596|NCT00443118|363490644|FG001|Overall Study|unknown primary outcome|1|||
105404597|NCT00443118|363490645|FG002|Overall Study|unknown primary outcome|0|||
105404598|NCT00443118|363490643|FG000|Overall Study|Withdrawal by Subject|1|||
105404599|NCT00443118|363490644|FG001|Overall Study|Withdrawal by Subject|0|||
105404600|NCT00443118|363490645|FG002|Overall Study|Withdrawal by Subject|0|||
105404601|NCT00347932|363490646|FG000|Overall Study|Adverse Event|4|||
105404602|NCT00347932|363490647|FG001|Overall Study|Adverse Event|5|||
105404603|NCT00347932|363490646|FG000|Overall Study|Lack of Efficacy|3|||
105404604|NCT00347932|363490647|FG001|Overall Study|Lack of Efficacy|14|||
105404605|NCT00347932|363490646|FG000|Overall Study|Lost to Follow-up|10|||
105404606|NCT00347932|363490647|FG001|Overall Study|Lost to Follow-up|9|||
105404607|NCT00347932|363490646|FG000|Overall Study|Withdrawal by Subject|10|||
105404608|NCT00347932|363490647|FG001|Overall Study|Withdrawal by Subject|16|||
105404609|NCT00347932|363490646|FG000|Overall Study|Did not meet inclusion criteria|4|||
105404610|NCT00347932|363490647|FG001|Overall Study|Did not meet inclusion criteria|8|||
105404611|NCT00244621|363490652|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
105404612|NCT00244621|363490653|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
105404613|NCT00244621|363490654|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
105404614|NCT00244621|363490652|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
105404615|NCT00244621|363490653|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
105404616|NCT00244621|363490654|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105404617|NCT00244621|363490652|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
105404618|NCT00244621|363490653|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
105404619|NCT00244621|363490654|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
105404620|NCT00244621|363490652|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
105404621|NCT00244621|363490653|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
105404622|NCT00244621|363490654|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
105404623|NCT00244621|363490652|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
105404624|NCT00244621|363490653|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
105404625|NCT00244621|363490654|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
105404626|NCT00244621|363490652|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
105404627|NCT00244621|363490653|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
105404628|NCT00244621|363490654|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
105494594|NCT00809354|363824822|FG009|Overall Study|Withdrawal by Subject|20|||
105494595|NCT00809354|363824813|FG000|Overall Study|Other|10|||
105494596|NCT00809354|363824814|FG001|Overall Study|Other|2|||
105494597|NCT00809354|363824815|FG002|Overall Study|Other|7|||
105494598|NCT00809354|363824816|FG003|Overall Study|Other|10|||
105494599|NCT00809354|363824817|FG004|Overall Study|Other|5|||
105494600|NCT00809354|363824818|FG005|Overall Study|Other|3|||
105494601|NCT00809354|363824819|FG006|Overall Study|Other|2|||
105494602|NCT00809354|363824820|FG007|Overall Study|Other|3|||
105494603|NCT00809354|363824821|FG008|Overall Study|Other|4|||
105494604|NCT00809354|363824822|FG009|Overall Study|Other|3|||
105494605|NCT00809354|363824813|FG000|Overall Study|Study terminated by sponsor|138|||
105494606|NCT00809354|363824814|FG001|Overall Study|Study terminated by sponsor|134|||
105494607|NCT00809354|363824815|FG002|Overall Study|Study terminated by sponsor|129|||
105494608|NCT00809354|363824816|FG003|Overall Study|Study terminated by sponsor|120|||
105494609|NCT00809354|363824817|FG004|Overall Study|Study terminated by sponsor|126|||
105494610|NCT00809354|363824818|FG005|Overall Study|Study terminated by sponsor|133|||
105494611|NCT00809354|363824819|FG006|Overall Study|Study terminated by sponsor|124|||
105494612|NCT00809354|363824820|FG007|Overall Study|Study terminated by sponsor|148|||
105494613|NCT00809354|363824821|FG008|Overall Study|Study terminated by sponsor|127|||
105494614|NCT00809354|363824822|FG009|Overall Study|Study terminated by sponsor|135|||
105494615|NCT00809354|363824813|FG000|Overall Study|Withdrawn due to pregnancy|0|||
105494616|NCT00809354|363824814|FG001|Overall Study|Withdrawn due to pregnancy|1|||
105494617|NCT00809354|363824815|FG002|Overall Study|Withdrawn due to pregnancy|0|||
105404629|NCT00244621|363490652|FG000|Open-label Treatment Period|Adverse Event|0|||
105404630|NCT00244621|363490653|FG001|Open-label Treatment Period|Adverse Event|0|||
105404631|NCT00244621|363490654|FG002|Open-label Treatment Period|Adverse Event|1|||
105404632|NCT00244621|363490652|FG000|Open-label Treatment Period|Moved abroad|0|||
105404633|NCT00244621|363490653|FG001|Open-label Treatment Period|Moved abroad|0|||
105404634|NCT00244621|363490654|FG002|Open-label Treatment Period|Moved abroad|1|||
105404635|NCT00532844|363490657|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
105494618|NCT00809354|363824816|FG003|Overall Study|Withdrawn due to pregnancy|0|||
105494619|NCT00809354|363824817|FG004|Overall Study|Withdrawn due to pregnancy|0|||
105494620|NCT00809354|363824818|FG005|Overall Study|Withdrawn due to pregnancy|0|||
105494621|NCT00809354|363824819|FG006|Overall Study|Withdrawn due to pregnancy|0|||
105494622|NCT00809354|363824820|FG007|Overall Study|Withdrawn due to pregnancy|0|||
105404636|NCT00532844|363490658|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
105404637|NCT00532844|363490657|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
105404638|NCT00532844|363490658|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
105404639|NCT00532844|363490657|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
105404640|NCT00532844|363490658|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
105404641|NCT00532844|363490657|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
105404642|NCT00532844|363490658|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
105404643|NCT00532844|363490657|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
105404644|NCT00532844|363490658|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
105404645|NCT00811720|363490659|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
105404646|NCT00811720|363490660|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
105404647|NCT00811720|363490659|FG000|All Treated Patients|Adverse Event|20|||
105404648|NCT00811720|363490660|FG001|All Treated Patients|Adverse Event|62|||
105404649|NCT00811720|363490659|FG000|All Treated Patients|Lack of Efficacy|22|||
105404650|NCT00811720|363490660|FG001|All Treated Patients|Lack of Efficacy|18|||
105404651|NCT00811720|363490659|FG000|All Treated Patients|Non-compliance|0|||
105404652|NCT00811720|363490660|FG001|All Treated Patients|Non-compliance|14|||
105404653|NCT00811720|363490659|FG000|All Treated Patients|Protocol Violation|9|||
105404654|NCT00811720|363490660|FG001|All Treated Patients|Protocol Violation|16|||
105404655|NCT00811720|363490659|FG000|All Treated Patients|Withdrawal by Subject|28|||
105404656|NCT00811720|363490660|FG001|All Treated Patients|Withdrawal by Subject|34|||
105404657|NCT00811720|363490659|FG000|All Treated Patients|Lost to Follow-up|10|||
105404658|NCT00811720|363490660|FG001|All Treated Patients|Lost to Follow-up|16|||
105404659|NCT00811720|363490659|FG000|All Treated Patients|Other Reason|7|||
105404660|NCT00811720|363490660|FG001|All Treated Patients|Other Reason|4|||
105404661|NCT04389866|363490661|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
105404662|NCT04389866|363490662|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
105404663|NCT00928187|363490665|FG000|Overall Study|Death|1|||
105404664|NCT00928187|363490666|FG001|Overall Study|Death|2|||
105404665|NCT00928187|363490667|FG002|Overall Study|Death|3|||
105404666|NCT00928187|363490665|FG000|Overall Study|Lost to Follow-up|1|||
105404667|NCT00928187|363490666|FG001|Overall Study|Lost to Follow-up|2|||
105404668|NCT00928187|363490667|FG002|Overall Study|Lost to Follow-up|1|||
105404669|NCT00928187|363490665|FG000|Overall Study|Withdrawal by Subject|0|||
105404670|NCT00928187|363490666|FG001|Overall Study|Withdrawal by Subject|1|||
105404671|NCT00928187|363490667|FG002|Overall Study|Withdrawal by Subject|1|||
105404672|NCT00928187|363490665|FG000|Overall Study|Protocol Violation|0|||
105404673|NCT00928187|363490666|FG001|Overall Study|Protocol Violation|1|||
105404674|NCT00928187|363490667|FG002|Overall Study|Protocol Violation|0|||
105404675|NCT01490918|363490668|FG000|Overall Study|Lost to Follow-up|2|||
105404676|NCT01490918|363490669|FG001|Overall Study|Lost to Follow-up|1|||
105404677|NCT01490918|363490670|FG002|Overall Study|Lost to Follow-up|0|||
105404678|NCT01490918|363490668|FG000|Overall Study|Withdrawal by Subject|7|||
105404679|NCT01490918|363490669|FG001|Overall Study|Withdrawal by Subject|8|||
105404680|NCT01490918|363490670|FG002|Overall Study|Withdrawal by Subject|3|||
105404681|NCT01490918|363490668|FG000|Overall Study|Adverse Event|0|||
105404682|NCT01490918|363490669|FG001|Overall Study|Adverse Event|0|||
105404683|NCT01490918|363490670|FG002|Overall Study|Adverse Event|1|||
105404684|NCT01490918|363490668|FG000|Overall Study|other cause|4|||
105404685|NCT01490918|363490669|FG001|Overall Study|other cause|5|||
105404686|NCT01490918|363490670|FG002|Overall Study|other cause|8|||
105404687|NCT04940130|363490674|FG000|Overall Study|Travel|1|||
105404688|NCT04940130|363490675|FG001|Overall Study|Travel|0|||
105404689|NCT04940130|363490676|FG002|Overall Study|Travel|2|||
105404690|NCT04940130|363490674|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
105404691|NCT04940130|363490675|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
105404692|NCT04940130|363490676|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
105404693|NCT04940130|363490674|FG000|Overall Study|Adverse Event|0|||
105404694|NCT04940130|363490675|FG001|Overall Study|Adverse Event|0|||
105404695|NCT04940130|363490676|FG002|Overall Study|Adverse Event|2|||
105404696|NCT04940130|363490674|FG000|Overall Study|Disease progression/treatment failure|0|||
105404697|NCT04940130|363490675|FG001|Overall Study|Disease progression/treatment failure|0|||
105404698|NCT04940130|363490676|FG002|Overall Study|Disease progression/treatment failure|1|||
105404699|NCT04940130|363490674|FG000|Overall Study|Participant refusal|0|||
105404700|NCT04940130|363490675|FG001|Overall Study|Participant refusal|0|||
105404701|NCT04940130|363490676|FG002|Overall Study|Participant refusal|1|||
105404702|NCT00503425|363490684|FG000|Overall Study|Participant files lost|6|||
105404703|NCT00503425|363490684|FG000|Overall Study|Adverse Event|5|||
105404704|NCT00503425|363490684|FG000|Overall Study|Lack of Efficacy|25|||
105404705|NCT00503425|363490684|FG000|Overall Study|Withdrawal by Subject|8|||
105404706|NCT00503425|363490684|FG000|Overall Study|Lost to Follow-up|3|||
105404707|NCT00503425|363490684|FG000|Overall Study|Death|3|||
105404708|NCT00503425|363490684|FG000|Overall Study|Missing Data/Unknown|4|||
105404709|NCT03386435|363490685|FG000|Overall Study|Protocol Violation|5|||
105404710|NCT03386435|363490686|FG001|Overall Study|Protocol Violation|7|||
105404711|NCT00437268|363490689|FG000|Overall Study|Adverse Event|1|||
105404712|NCT00437268|363490690|FG001|Overall Study|Adverse Event|1|||
105404713|NCT00437268|363490689|FG000|Overall Study|Withdrawal by Subject|2|||
105404714|NCT00437268|363490690|FG001|Overall Study|Withdrawal by Subject|2|||
105404715|NCT00437268|363490689|FG000|Overall Study|Progressive disease|9|||
105404716|NCT00437268|363490690|FG001|Overall Study|Progressive disease|9|||
105404717|NCT00437268|363490689|FG000|Overall Study|Physician Decision|1|||
105404718|NCT00437268|363490690|FG001|Overall Study|Physician Decision|0|||
105404719|NCT00437268|363490689|FG000|Overall Study|Death|0|||
105404720|NCT00437268|363490690|FG001|Overall Study|Death|1|||
105404721|NCT03484429|363490693|FG000|Overall Study|Withdrawal by Subject|1|||
105404722|NCT03484429|363490694|FG001|Overall Study|Withdrawal by Subject|0|||
105404723|NCT03484429|363490693|FG000|Overall Study|Adverse Event|2|||
105404724|NCT03484429|363490694|FG001|Overall Study|Adverse Event|0|||
105404725|NCT03666988|363490695|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
105404726|NCT03666988|363490696|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
105404727|NCT03666988|363490697|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
105404728|NCT03666988|363490698|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
105404729|NCT03666988|363490699|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
105404730|NCT03666988|363490700|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
105404731|NCT03666988|363490695|FG000|Part 1 (Up to 28 Months)|Other|0|||
105404732|NCT03666988|363490696|FG001|Part 1 (Up to 28 Months)|Other|1|||
105404733|NCT03666988|363490697|FG002|Part 1 (Up to 28 Months)|Other|1|||
105404734|NCT03666988|363490698|FG003|Part 1 (Up to 28 Months)|Other|0|||
105404735|NCT03666988|363490699|FG004|Part 1 (Up to 28 Months)|Other|0|||
105404736|NCT03666988|363490700|FG005|Part 1 (Up to 28 Months)|Other|0|||
105404737|NCT03666988|363490695|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
105404738|NCT03666988|363490696|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
105404739|NCT03666988|363490697|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
105404740|NCT03666988|363490698|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
105404741|NCT03666988|363490699|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
105404742|NCT03666988|363490700|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
105404743|NCT03666988|363490695|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
105404744|NCT03666988|363490696|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
105404745|NCT03666988|363490697|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
105404746|NCT03666988|363490698|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
105404747|NCT03666988|363490699|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
105404748|NCT03666988|363490700|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
105404749|NCT03666988|363490695|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
105404750|NCT03666988|363490696|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
105404751|NCT03666988|363490697|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
105404752|NCT03666988|363490698|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
105404753|NCT03666988|363490699|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
105404754|NCT03666988|363490700|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
105494623|NCT00809354|363824821|FG008|Overall Study|Withdrawn due to pregnancy|0|||
105404755|NCT00444106|363490703|FG000|Overall Study|Lost to Follow-up|2|||
105404756|NCT00444106|363490704|FG001|Overall Study|Lost to Follow-up|1|||
105404757|NCT00444106|363490705|FG002|Overall Study|Lost to Follow-up|0|||
105404758|NCT00444106|363490703|FG000|Overall Study|Abnormal Test Procedure Results|0|||
105404759|NCT00444106|363490704|FG001|Overall Study|Abnormal Test Procedure Results|0|||
105404760|NCT00444106|363490705|FG002|Overall Study|Abnormal Test Procedure Results|1|||
105404761|NCT04409834|363490712|FG000|Overall Study|Death|55|||
105404762|NCT04409834|363490713|FG001|Overall Study|Death|62|||
105404763|NCT05414175|363490714|FG000|Overall Study|Withdrawal by Subject|1|||
105404764|NCT05414175|363490714|FG000|Overall Study|Other Reasons|1|||
105404765|NCT02137070|363490715|FG000|Overall Study|Adverse Event|12|||
105404766|NCT02137070|363490716|FG001|Overall Study|Adverse Event|3|||
105404767|NCT02137070|363490715|FG000|Overall Study|Death|2|||
105404768|NCT02137070|363490716|FG001|Overall Study|Death|0|||
105404769|NCT02137070|363490715|FG000|Overall Study|Lost to Follow-up|24|||
105404770|NCT02137070|363490716|FG001|Overall Study|Lost to Follow-up|9|||
105404771|NCT02137070|363490715|FG000|Overall Study|Physician Decision|0|||
105404772|NCT02137070|363490716|FG001|Overall Study|Physician Decision|1|||
105404773|NCT02137070|363490715|FG000|Overall Study|Protocol Violation|18|||
105404774|NCT02137070|363490716|FG001|Overall Study|Protocol Violation|4|||
105404775|NCT02137070|363490715|FG000|Overall Study|Withdrawal by Subject|18|||
105404776|NCT02137070|363490716|FG001|Overall Study|Withdrawal by Subject|1|||
105404777|NCT01349673|363492416|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
105404778|NCT01349673|363492416|FG000|Overall Study|No Longer Qualified For Study|1|||
105404779|NCT01349673|363492416|FG000|Overall Study|Site Closure|10|||
105404780|NCT01349673|363492416|FG000|Overall Study|Withdrawal by Subject|21|||
105404781|NCT01349673|363492416|FG000|Overall Study|Lost to Follow-up|6|||
105404782|NCT01349673|363492416|FG000|Overall Study|Adverse Event|17|||
105404783|NCT01349673|363492416|FG000|Overall Study|Study Terminated By Sponsor|50|||
105404784|NCT01349673|363492416|FG000|Overall Study|Lack of Efficacy|8|||
105404785|NCT03688919|363492419|FG000|Overall Study|Lost to Follow-up|2|||
105404786|NCT03688919|363492420|FG001|Overall Study|Lost to Follow-up|1|||
105404787|NCT03688919|363492419|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
105404788|NCT03688919|363492420|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
105404789|NCT03389308|363492427|FG000|Overall Study|Withdrawal by Subject|5|||
105404790|NCT03389308|363492427|FG000|Overall Study|Lost to Follow-up|3|||
105404791|NCT03389308|363492427|FG000|Overall Study|Adverse Event|2|||
105404792|NCT03389308|363492427|FG000|Overall Study|Sponsor Request|2|||
105404793|NCT04232943|363492430|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
105404794|NCT04232943|363492431|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
105404795|NCT04232943|363492432|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
105404796|NCT04232943|363492430|FG000|Overall Study|Withdrawal by Subject|1|||
105404797|NCT04232943|363492431|FG001|Overall Study|Withdrawal by Subject|1|||
105404798|NCT04232943|363492432|FG002|Overall Study|Withdrawal by Subject|0|||
105404799|NCT03462758|363492433|FG000|Overall Study|Chose no or other method of contraception|20|||
105404800|NCT03462758|363492434|FG001|Overall Study|Chose no or other method of contraception|23|||
105404801|NCT03462758|363492433|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
105404802|NCT03462758|363492434|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
105404803|NCT03462758|363492433|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
105404804|NCT03462758|363492434|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
105404805|NCT03462758|363492433|FG000|Overall Study|Medical contraindication|2|||
105404806|NCT03462758|363492434|FG001|Overall Study|Medical contraindication|2|||
105404807|NCT03462758|363492433|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
105404808|NCT03462758|363492434|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
105494624|NCT00809354|363824822|FG009|Overall Study|Withdrawn due to pregnancy|0|||
105494625|NCT00809354|363824813|FG000|Overall Study|Randomized but not Treated|3|||
105494626|NCT00809354|363824814|FG001|Overall Study|Randomized but not Treated|1|||
105494627|NCT00809354|363824815|FG002|Overall Study|Randomized but not Treated|6|||
105494628|NCT00809354|363824816|FG003|Overall Study|Randomized but not Treated|0|||
105494629|NCT00809354|363824817|FG004|Overall Study|Randomized but not Treated|5|||
105494630|NCT00809354|363824818|FG005|Overall Study|Randomized but not Treated|0|||
105494631|NCT00809354|363824819|FG006|Overall Study|Randomized but not Treated|1|||
105494632|NCT00809354|363824820|FG007|Overall Study|Randomized but not Treated|1|||
105494633|NCT00809354|363824821|FG008|Overall Study|Randomized but not Treated|2|||
105494634|NCT00809354|363824822|FG009|Overall Study|Randomized but not Treated|1|||
105494635|NCT00809354|363824813|FG000|Overall Study|Death|0|||
105494636|NCT00809354|363824814|FG001|Overall Study|Death|0|||
105494637|NCT00809354|363824815|FG002|Overall Study|Death|0|||
105494638|NCT00809354|363824816|FG003|Overall Study|Death|0|||
105404809|NCT02820844|363492435|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
105404810|NCT02820844|363492436|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
105404811|NCT02820844|363492437|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
105404812|NCT02820844|363492438|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
105404813|NCT02820844|363492439|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
105404814|NCT02820844|363492440|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
105404815|NCT02820844|363492435|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
105404816|NCT02820844|363492436|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
105404817|NCT02820844|363492437|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
105494639|NCT00809354|363824817|FG004|Overall Study|Death|0|||
105494640|NCT00809354|363824818|FG005|Overall Study|Death|0|||
105494641|NCT00809354|363824819|FG006|Overall Study|Death|0|||
105494642|NCT00809354|363824820|FG007|Overall Study|Death|1|||
105494643|NCT00809354|363824821|FG008|Overall Study|Death|0|||
105404818|NCT02820844|363492438|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
105404819|NCT02820844|363492439|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
105404820|NCT02820844|363492440|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
105404821|NCT02820844|363492435|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
105404822|NCT02820844|363492436|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
105404823|NCT02820844|363492437|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
105404824|NCT02820844|363492438|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
105404825|NCT02820844|363492439|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
105404826|NCT02820844|363492440|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
105404827|NCT02820844|363492435|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
105404828|NCT02820844|363492436|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
105404829|NCT02820844|363492437|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
105404830|NCT02820844|363492438|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
105404831|NCT02820844|363492439|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
105404832|NCT02820844|363492440|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
105404833|NCT02820844|363492435|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
105404834|NCT02820844|363492436|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
105404835|NCT02820844|363492437|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
105404836|NCT02820844|363492438|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
105404837|NCT02820844|363492439|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
105404838|NCT02820844|363492440|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
105404839|NCT02820844|363492435|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
105404840|NCT02820844|363492436|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
105404841|NCT02820844|363492437|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
105404842|NCT02820844|363492438|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
105404843|NCT02820844|363492439|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
105404844|NCT02820844|363492440|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
105404845|NCT02820844|363492435|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
105404846|NCT02820844|363492436|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
105404847|NCT02820844|363492437|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
105404848|NCT02820844|363492438|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
105404849|NCT02820844|363492439|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
105404850|NCT02820844|363492440|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
105404851|NCT02820844|363492435|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105404852|NCT02820844|363492436|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105404853|NCT02820844|363492437|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
105404854|NCT02820844|363492438|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
105404855|NCT02820844|363492439|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105404856|NCT02820844|363492440|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105404857|NCT02820844|363492435|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
105404858|NCT02820844|363492436|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
105404859|NCT02820844|363492437|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
105404860|NCT02820844|363492438|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
105404861|NCT02820844|363492439|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
105404862|NCT02820844|363492440|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
105404863|NCT02820844|363492435|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105404864|NCT02820844|363492436|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105404865|NCT02820844|363492437|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105404866|NCT02820844|363492438|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105404867|NCT02820844|363492439|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105404868|NCT02820844|363492440|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
105404869|NCT00573391|363492445|FG000|Overall Study|study stopped|2|||
105404870|NCT00573391|363492446|FG001|Overall Study|study stopped|2|||
105404871|NCT00573391|363492445|FG000|Overall Study|Death|1|||
105404872|NCT00573391|363492446|FG001|Overall Study|Death|0|||
105404873|NCT00413660|363492449|FG000|Up To Week 12|Adverse Event|1|||
105404874|NCT00413660|363492450|FG001|Up To Week 12|Adverse Event|3|||
105404875|NCT00413660|363492451|FG002|Up To Week 12|Adverse Event|1|||
105404876|NCT00413660|363492452|FG003|Up To Week 12|Adverse Event|4|||
105404877|NCT00413660|363492453|FG004|Up To Week 12|Adverse Event|6|||
105404878|NCT00413660|363492454|FG005|Up To Week 12|Adverse Event|4|||
105404879|NCT00413660|363492455|FG006|Up To Week 12|Adverse Event|1|||
105404880|NCT00413660|363492456|FG007|Up To Week 12|Adverse Event|0|||
105404881|NCT00413660|363492457|FG008|Up To Week 12|Adverse Event|0|||
105404882|NCT00413660|363492458|FG009|Up To Week 12|Adverse Event|0|||
105404883|NCT00413660|363492459|FG010|Up To Week 12|Adverse Event|0|||
105404884|NCT00413660|363492449|FG000|Up To Week 12|Lack of Efficacy|2|||
105494644|NCT00809354|363824822|FG009|Overall Study|Death|0|||
105494645|NCT03257371|363824825|FG000|Overall Study|Lost to Follow-up|1|||
105494646|NCT01649804|363824831|FG000|Overall Study|Administrative/Other|8|||
105494647|NCT00591344|363824832|FG000|Overall Study|Transportation issues|1|||
105494648|NCT00591344|363824833|FG001|Overall Study|Transportation issues|0|||
105494649|NCT00591344|363824832|FG000|Overall Study|Moved out of state|1|||
105494650|NCT00591344|363824833|FG001|Overall Study|Moved out of state|0|||
105494651|NCT00591344|363824832|FG000|Overall Study|Medical complications|1|||
105494652|NCT00591344|363824833|FG001|Overall Study|Medical complications|3|||
105494653|NCT00591344|363824832|FG000|Overall Study|Underwent DBS|2|||
105494654|NCT00591344|363824833|FG001|Overall Study|Underwent DBS|2|||
105494655|NCT00591344|363824832|FG000|Overall Study|Death|0|||
105494656|NCT00591344|363824833|FG001|Overall Study|Death|1|||
105494657|NCT00591344|363824832|FG000|Overall Study|Lost to Follow-up|0|||
105494658|NCT00591344|363824833|FG001|Overall Study|Lost to Follow-up|1|||
105494659|NCT00591344|363824832|FG000|Overall Study|Did not want to come off medication|0|||
105494660|NCT00591344|363824833|FG001|Overall Study|Did not want to come off medication|1|||
105494661|NCT00369707|363824834|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
105494662|NCT00369707|363824834|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
105494663|NCT00369707|363824834|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
105494664|NCT00369707|363824834|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
105494665|NCT00369707|363824834|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
105494666|NCT00369707|363824834|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
105494667|NCT00369707|363824834|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
105494668|NCT00369707|363824834|FG000|Follow up for 2 Years After Treatment|Death|1|||
105494669|NCT00369707|363824834|FG000|Follow up for 2 Years After Treatment|Other|2|||
105494670|NCT02046733|363824837|FG000|Overall Study|never initiated 'treatment visits'|6|||
105494671|NCT02046733|363824838|FG001|Overall Study|never initiated 'treatment visits'|0|||
105494672|NCT03605212|363824840|FG000|Treatment Period|Adverse Event|1|||
105494673|NCT03605212|363824841|FG001|Treatment Period|Adverse Event|0|||
105494674|NCT03605212|363824842|FG002|Treatment Period|Adverse Event|0|||
105494675|NCT03605212|363824843|FG003|Treatment Period|Adverse Event|0|||
105494676|NCT03605212|363824844|FG004|Treatment Period|Adverse Event|0|||
105494677|NCT03605212|363824840|FG000|Treatment Period|Physician Decision|0|||
105494678|NCT03605212|363824841|FG001|Treatment Period|Physician Decision|0|||
105580833|NCT01474512|364126473|FG008|Maintenance Period|Clinical Relapse|0|||
105580834|NCT01474512|364126474|FG009|Maintenance Period|Clinical Relapse|0|||
105580835|NCT01474512|364126475|FG010|Maintenance Period|Clinical Relapse|0|||
105404885|NCT00413660|363492450|FG001|Up To Week 12|Lack of Efficacy|0|||
105404886|NCT00413660|363492451|FG002|Up To Week 12|Lack of Efficacy|0|||
105404887|NCT00413660|363492452|FG003|Up To Week 12|Lack of Efficacy|0|||
105404888|NCT00413660|363492453|FG004|Up To Week 12|Lack of Efficacy|0|||
105404889|NCT00413660|363492454|FG005|Up To Week 12|Lack of Efficacy|0|||
105404890|NCT00413660|363492455|FG006|Up To Week 12|Lack of Efficacy|5|||
105404891|NCT00413660|363492456|FG007|Up To Week 12|Lack of Efficacy|0|||
105404892|NCT00413660|363492457|FG008|Up To Week 12|Lack of Efficacy|0|||
105404893|NCT00413660|363492458|FG009|Up To Week 12|Lack of Efficacy|0|||
105404894|NCT00413660|363492459|FG010|Up To Week 12|Lack of Efficacy|0|||
105404895|NCT00413660|363492449|FG000|Up To Week 12|Lost to Follow-up|0|||
105404896|NCT00413660|363492450|FG001|Up To Week 12|Lost to Follow-up|1|||
105404897|NCT00413660|363492451|FG002|Up To Week 12|Lost to Follow-up|0|||
105404898|NCT00413660|363492452|FG003|Up To Week 12|Lost to Follow-up|0|||
105404899|NCT00413660|363492453|FG004|Up To Week 12|Lost to Follow-up|1|||
105404900|NCT00413660|363492454|FG005|Up To Week 12|Lost to Follow-up|0|||
105404901|NCT00413660|363492455|FG006|Up To Week 12|Lost to Follow-up|0|||
105404902|NCT00413660|363492456|FG007|Up To Week 12|Lost to Follow-up|0|||
105404903|NCT00413660|363492457|FG008|Up To Week 12|Lost to Follow-up|0|||
105404904|NCT00413660|363492458|FG009|Up To Week 12|Lost to Follow-up|0|||
105404905|NCT00413660|363492459|FG010|Up To Week 12|Lost to Follow-up|0|||
105404906|NCT00413660|363492449|FG000|Up To Week 12|Withdrawal by Subject|0|||
105580836|NCT01474512|364126476|FG011|Maintenance Period|Clinical Relapse|0|||
105404907|NCT00413660|363492450|FG001|Up To Week 12|Withdrawal by Subject|2|||
105404908|NCT00413660|363492451|FG002|Up To Week 12|Withdrawal by Subject|0|||
105404909|NCT00413660|363492452|FG003|Up To Week 12|Withdrawal by Subject|2|||
105404910|NCT00413660|363492453|FG004|Up To Week 12|Withdrawal by Subject|0|||
105404911|NCT00413660|363492454|FG005|Up To Week 12|Withdrawal by Subject|2|||
105494679|NCT03605212|363824842|FG002|Treatment Period|Physician Decision|0|||
105494680|NCT03605212|363824843|FG003|Treatment Period|Physician Decision|0|||
105494681|NCT03605212|363824844|FG004|Treatment Period|Physician Decision|1|||
105404912|NCT00413660|363492455|FG006|Up To Week 12|Withdrawal by Subject|2|||
105494682|NCT02083081|363824845|FG000|Overall Study|Lost to Follow-up|31|||
105494683|NCT02083081|363824846|FG001|Overall Study|Lost to Follow-up|9|||
105494684|NCT04041375|363824847|FG000|Intervention Phase|Withdrawal by Subject|2|||
105494685|NCT04041375|363824848|FG001|Intervention Phase|Withdrawal by Subject|2|||
105404913|NCT00413660|363492456|FG007|Up To Week 12|Withdrawal by Subject|0|||
105404914|NCT00413660|363492457|FG008|Up To Week 12|Withdrawal by Subject|0|||
105580837|NCT01474512|364126477|FG012|Maintenance Period|Clinical Relapse|0|||
105404915|NCT00413660|363492458|FG009|Up To Week 12|Withdrawal by Subject|0|||
105404916|NCT00413660|363492459|FG010|Up To Week 12|Withdrawal by Subject|0|||
105404917|NCT00413660|363492449|FG000|Up To Week 12|Randomized, Not Treated|1|||
105404918|NCT00413660|363492450|FG001|Up To Week 12|Randomized, Not Treated|0|||
105404919|NCT00413660|363492451|FG002|Up To Week 12|Randomized, Not Treated|0|||
105404920|NCT00413660|363492452|FG003|Up To Week 12|Randomized, Not Treated|1|||
105404921|NCT00413660|363492453|FG004|Up To Week 12|Randomized, Not Treated|0|||
105404922|NCT00413660|363492454|FG005|Up To Week 12|Randomized, Not Treated|0|||
105404923|NCT00413660|363492455|FG006|Up To Week 12|Randomized, Not Treated|0|||
105404924|NCT00413660|363492456|FG007|Up To Week 12|Randomized, Not Treated|0|||
105404925|NCT00413660|363492457|FG008|Up To Week 12|Randomized, Not Treated|0|||
105404926|NCT00413660|363492458|FG009|Up To Week 12|Randomized, Not Treated|0|||
105404927|NCT00413660|363492459|FG010|Up To Week 12|Randomized, Not Treated|0|||
105404928|NCT00413660|363492449|FG000|Up To Week 12|Other|3|||
105404929|NCT00413660|363492450|FG001|Up To Week 12|Other|1|||
105404930|NCT00413660|363492451|FG002|Up To Week 12|Other|6|||
105404931|NCT00413660|363492452|FG003|Up To Week 12|Other|1|||
105404932|NCT00413660|363492453|FG004|Up To Week 12|Other|2|||
105404933|NCT00413660|363492454|FG005|Up To Week 12|Other|4|||
105404934|NCT00413660|363492455|FG006|Up To Week 12|Other|3|||
105404935|NCT00413660|363492456|FG007|Up To Week 12|Other|0|||
105404936|NCT00413660|363492457|FG008|Up To Week 12|Other|0|||
105404937|NCT00413660|363492458|FG009|Up To Week 12|Other|0|||
105404938|NCT00413660|363492459|FG010|Up To Week 12|Other|0|||
105404939|NCT00413660|363492449|FG000|Post Week 12|Adverse Event|2|||
105404940|NCT00413660|363492450|FG001|Post Week 12|Adverse Event|0|||
105404941|NCT00413660|363492451|FG002|Post Week 12|Adverse Event|2|||
105404942|NCT00413660|363492452|FG003|Post Week 12|Adverse Event|1|||
105404943|NCT00413660|363492453|FG004|Post Week 12|Adverse Event|4|||
105404944|NCT00413660|363492454|FG005|Post Week 12|Adverse Event|2|||
105404945|NCT00413660|363492455|FG006|Post Week 12|Adverse Event|2|||
105404946|NCT00413660|363492456|FG007|Post Week 12|Adverse Event|0|||
105404947|NCT00413660|363492457|FG008|Post Week 12|Adverse Event|0|||
105404948|NCT00413660|363492458|FG009|Post Week 12|Adverse Event|0|||
105404949|NCT00413660|363492459|FG010|Post Week 12|Adverse Event|0|||
105404950|NCT00413660|363492449|FG000|Post Week 12|Lack of Efficacy|0|||
105404951|NCT00413660|363492450|FG001|Post Week 12|Lack of Efficacy|0|||
105404952|NCT00413660|363492451|FG002|Post Week 12|Lack of Efficacy|1|||
105404953|NCT00413660|363492452|FG003|Post Week 12|Lack of Efficacy|0|||
105404954|NCT00413660|363492453|FG004|Post Week 12|Lack of Efficacy|0|||
105404955|NCT00413660|363492454|FG005|Post Week 12|Lack of Efficacy|0|||
105404956|NCT00413660|363492455|FG006|Post Week 12|Lack of Efficacy|0|||
105404957|NCT00413660|363492456|FG007|Post Week 12|Lack of Efficacy|0|||
105404958|NCT00413660|363492457|FG008|Post Week 12|Lack of Efficacy|0|||
105404959|NCT00413660|363492458|FG009|Post Week 12|Lack of Efficacy|1|||
105404960|NCT00413660|363492459|FG010|Post Week 12|Lack of Efficacy|0|||
105404961|NCT00413660|363492449|FG000|Post Week 12|Lost to Follow-up|0|||
105404962|NCT00413660|363492450|FG001|Post Week 12|Lost to Follow-up|1|||
105404963|NCT00413660|363492451|FG002|Post Week 12|Lost to Follow-up|1|||
105404964|NCT00413660|363492452|FG003|Post Week 12|Lost to Follow-up|0|||
105404965|NCT00413660|363492453|FG004|Post Week 12|Lost to Follow-up|0|||
105404966|NCT00413660|363492454|FG005|Post Week 12|Lost to Follow-up|0|||
105404967|NCT00413660|363492455|FG006|Post Week 12|Lost to Follow-up|0|||
105404968|NCT00413660|363492456|FG007|Post Week 12|Lost to Follow-up|0|||
105580838|NCT01474512|364126478|FG013|Maintenance Period|Clinical Relapse|0|||
105580839|NCT01474512|364126479|FG014|Maintenance Period|Clinical Relapse|0|||
105580840|NCT01474512|364126480|FG015|Maintenance Period|Clinical Relapse|0|||
105580841|NCT01474512|364126481|FG016|Maintenance Period|Clinical Relapse|0|||
105580842|NCT01474512|364126482|FG017|Maintenance Period|Clinical Relapse|0|||
105580843|NCT01474512|364126465|FG000|Maintenance Period|Lack of Efficacy|0|||
105580844|NCT01474512|364126466|FG001|Maintenance Period|Lack of Efficacy|0|||
105580845|NCT01474512|364126467|FG002|Maintenance Period|Lack of Efficacy|0|||
105580846|NCT01474512|364126468|FG003|Maintenance Period|Lack of Efficacy|1|||
105580847|NCT01474512|364126469|FG004|Maintenance Period|Lack of Efficacy|0|||
105404969|NCT00413660|363492457|FG008|Post Week 12|Lost to Follow-up|0|||
105404970|NCT00413660|363492458|FG009|Post Week 12|Lost to Follow-up|0|||
105404971|NCT00413660|363492459|FG010|Post Week 12|Lost to Follow-up|0|||
105404972|NCT00413660|363492449|FG000|Post Week 12|Withdrawal by Subject|0|||
105404973|NCT00413660|363492450|FG001|Post Week 12|Withdrawal by Subject|1|||
105404974|NCT00413660|363492451|FG002|Post Week 12|Withdrawal by Subject|1|||
105404975|NCT00413660|363492452|FG003|Post Week 12|Withdrawal by Subject|0|||
105404976|NCT00413660|363492453|FG004|Post Week 12|Withdrawal by Subject|1|||
105404977|NCT00413660|363492454|FG005|Post Week 12|Withdrawal by Subject|0|||
105404978|NCT00413660|363492455|FG006|Post Week 12|Withdrawal by Subject|0|||
105404979|NCT00413660|363492456|FG007|Post Week 12|Withdrawal by Subject|0|||
105404980|NCT00413660|363492457|FG008|Post Week 12|Withdrawal by Subject|0|||
105404981|NCT00413660|363492458|FG009|Post Week 12|Withdrawal by Subject|0|||
105404982|NCT00413660|363492459|FG010|Post Week 12|Withdrawal by Subject|1|||
105404983|NCT00413660|363492449|FG000|Post Week 12|Other|1|||
105404984|NCT00413660|363492450|FG001|Post Week 12|Other|2|||
105404985|NCT00413660|363492451|FG002|Post Week 12|Other|3|||
105404986|NCT00413660|363492452|FG003|Post Week 12|Other|0|||
105404987|NCT00413660|363492453|FG004|Post Week 12|Other|1|||
105404988|NCT00413660|363492454|FG005|Post Week 12|Other|1|||
105404989|NCT00413660|363492455|FG006|Post Week 12|Other|1|||
105404990|NCT00413660|363492456|FG007|Post Week 12|Other|0|||
105404991|NCT00413660|363492457|FG008|Post Week 12|Other|0|||
105404992|NCT00413660|363492458|FG009|Post Week 12|Other|0|||
105404993|NCT00413660|363492459|FG010|Post Week 12|Other|0|||
105404994|NCT01791517|363492467|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
105404995|NCT01791517|363492468|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
105404996|NCT01791517|363492469|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
105404997|NCT01791517|363492470|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
105404998|NCT01791517|363492471|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
105404999|NCT01791517|363492472|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
105405000|NCT01791517|363492473|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
105405001|NCT01791517|363492474|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
105405002|NCT01791517|363492475|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
105405003|NCT01791517|363492476|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
105405004|NCT01791517|363492477|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
105405005|NCT01791517|363492478|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
105405006|NCT01791517|363492467|FG000|Phase I: Period 1|Adverse Event|0|||
105405007|NCT01791517|363492468|FG001|Phase I: Period 1|Adverse Event|0|||
105405008|NCT01791517|363492469|FG002|Phase I: Period 1|Adverse Event|1|||
105405009|NCT01791517|363492470|FG003|Phase I: Period 1|Adverse Event|1|||
105405010|NCT01791517|363492471|FG004|Phase I: Period 1|Adverse Event|0|||
105405011|NCT01791517|363492472|FG005|Phase I: Period 1|Adverse Event|0|||
105405012|NCT01791517|363492473|FG006|Phase I: Period 1|Adverse Event|0|||
105405013|NCT01791517|363492474|FG007|Phase I: Period 1|Adverse Event|0|||
105405014|NCT01791517|363492475|FG008|Phase I: Period 1|Adverse Event|0|||
105405015|NCT01791517|363492476|FG009|Phase I: Period 1|Adverse Event|0|||
105405016|NCT01791517|363492477|FG010|Phase I: Period 1|Adverse Event|0|||
105405017|NCT01791517|363492478|FG011|Phase I: Period 1|Adverse Event|0|||
105405018|NCT01791517|363492467|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
105405019|NCT01791517|363492468|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105405020|NCT01791517|363492469|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105405021|NCT01791517|363492470|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105580848|NCT01474512|364126470|FG005|Maintenance Period|Lack of Efficacy|0|||
105405022|NCT01791517|363492471|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105405023|NCT01791517|363492472|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105405024|NCT01791517|363492473|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105405025|NCT01791517|363492474|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105405026|NCT01791517|363492475|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105405027|NCT01791517|363492476|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105405028|NCT01791517|363492477|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105580849|NCT01474512|364126471|FG006|Maintenance Period|Lack of Efficacy|0|||
105405029|NCT01791517|363492478|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105405030|NCT01791517|363492467|FG000|Phase I: Period 1|Protocol Violation|0|||
105405031|NCT01791517|363492468|FG001|Phase I: Period 1|Protocol Violation|1|||
105405032|NCT01791517|363492469|FG002|Phase I: Period 1|Protocol Violation|0|||
105405033|NCT01791517|363492470|FG003|Phase I: Period 1|Protocol Violation|0|||
105405034|NCT01791517|363492471|FG004|Phase I: Period 1|Protocol Violation|0|||
105405035|NCT01791517|363492472|FG005|Phase I: Period 1|Protocol Violation|0|||
105405036|NCT01791517|363492473|FG006|Phase I: Period 1|Protocol Violation|0|||
105405037|NCT01791517|363492474|FG007|Phase I: Period 1|Protocol Violation|0|||
105405038|NCT01791517|363492475|FG008|Phase I: Period 1|Protocol Violation|0|||
105405039|NCT01791517|363492476|FG009|Phase I: Period 1|Protocol Violation|0|||
105405040|NCT01791517|363492477|FG010|Phase I: Period 1|Protocol Violation|0|||
105405041|NCT01791517|363492478|FG011|Phase I: Period 1|Protocol Violation|0|||
105405042|NCT01791517|363492467|FG000|Phase I: Period 1|Lost to Follow-up|0|||
105405043|NCT01791517|363492468|FG001|Phase I: Period 1|Lost to Follow-up|0|||
105405044|NCT01791517|363492469|FG002|Phase I: Period 1|Lost to Follow-up|0|||
105405045|NCT01791517|363492470|FG003|Phase I: Period 1|Lost to Follow-up|1|||
105405046|NCT01791517|363492471|FG004|Phase I: Period 1|Lost to Follow-up|0|||
105405047|NCT01791517|363492472|FG005|Phase I: Period 1|Lost to Follow-up|0|||
105405048|NCT01791517|363492473|FG006|Phase I: Period 1|Lost to Follow-up|1|||
105405049|NCT01791517|363492474|FG007|Phase I: Period 1|Lost to Follow-up|0|||
105405050|NCT01791517|363492475|FG008|Phase I: Period 1|Lost to Follow-up|1|||
105405051|NCT01791517|363492476|FG009|Phase I: Period 1|Lost to Follow-up|1|||
105405052|NCT01791517|363492477|FG010|Phase I: Period 1|Lost to Follow-up|0|||
105405053|NCT01791517|363492478|FG011|Phase I: Period 1|Lost to Follow-up|0|||
105405054|NCT01791517|363492467|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
105405055|NCT01791517|363492468|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
105405056|NCT01791517|363492469|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
105494686|NCT04041375|363824847|FG000|Follow-up Phase|Death|2|||
105494687|NCT04041375|363824848|FG001|Follow-up Phase|Death|0|||
105494688|NCT04041375|363824847|FG000|Follow-up Phase|Lost to Follow-up|2|||
105494689|NCT04041375|363824848|FG001|Follow-up Phase|Lost to Follow-up|1|||
105494690|NCT04041375|363824847|FG000|Follow-up Phase|Too ill|3|||
105494691|NCT04041375|363824848|FG001|Follow-up Phase|Too ill|0|||
105494692|NCT01230710|363824851|FG000|Overall Study|Disease Progression|41|||
105494693|NCT01230710|363824851|FG000|Overall Study|Lost to Follow-up|3|||
105405057|NCT01791517|363492470|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
105405058|NCT01791517|363492471|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
105494694|NCT01230710|363824851|FG000|Overall Study|Death|4|||
105494695|NCT01230710|363824851|FG000|Overall Study|Withdrawal of Consent|1|||
105494696|NCT01104155|363824852|FG000|Overall Study|Adverse Event|15|||
105405059|NCT01791517|363492472|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
105405060|NCT01791517|363492473|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
105405061|NCT01791517|363492474|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
105405062|NCT01791517|363492475|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
105405063|NCT01791517|363492476|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
105405064|NCT01791517|363492477|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
105405065|NCT01791517|363492478|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
105405066|NCT01791517|363492467|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
105405067|NCT01791517|363492468|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105405068|NCT01791517|363492469|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105405069|NCT01791517|363492470|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105405070|NCT01791517|363492471|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105405071|NCT01791517|363492472|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105405072|NCT01791517|363492473|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105405073|NCT01791517|363492474|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105405074|NCT01791517|363492475|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105405075|NCT01791517|363492476|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105405076|NCT01791517|363492477|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105405077|NCT01791517|363492478|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105405078|NCT01791517|363492467|FG000|Phase I: Period 2|Protocol Violation|0|||
105405079|NCT01791517|363492468|FG001|Phase I: Period 2|Protocol Violation|0|||
105405080|NCT01791517|363492469|FG002|Phase I: Period 2|Protocol Violation|0|||
105405081|NCT01791517|363492470|FG003|Phase I: Period 2|Protocol Violation|1|||
105405082|NCT01791517|363492471|FG004|Phase I: Period 2|Protocol Violation|0|||
105405083|NCT01791517|363492472|FG005|Phase I: Period 2|Protocol Violation|0|||
105405084|NCT01791517|363492473|FG006|Phase I: Period 2|Protocol Violation|0|||
105405085|NCT01791517|363492474|FG007|Phase I: Period 2|Protocol Violation|0|||
105405086|NCT01791517|363492475|FG008|Phase I: Period 2|Protocol Violation|0|||
105405087|NCT01791517|363492476|FG009|Phase I: Period 2|Protocol Violation|0|||
105405088|NCT01791517|363492477|FG010|Phase I: Period 2|Protocol Violation|0|||
105405089|NCT01791517|363492478|FG011|Phase I: Period 2|Protocol Violation|0|||
105405090|NCT01791517|363492467|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
105405091|NCT01791517|363492468|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
105405092|NCT01791517|363492469|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
105405093|NCT01791517|363492470|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
105405094|NCT01791517|363492471|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
105405095|NCT01791517|363492472|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
105405096|NCT01791517|363492473|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
105405097|NCT01791517|363492474|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
105405098|NCT01791517|363492475|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
105405099|NCT01791517|363492476|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
105405100|NCT01791517|363492477|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
105405101|NCT01791517|363492478|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
105405102|NCT01791517|363492467|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105405103|NCT01791517|363492468|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105405104|NCT01791517|363492469|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105405105|NCT01791517|363492470|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105405106|NCT01791517|363492471|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105405107|NCT01791517|363492472|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105405108|NCT01791517|363492473|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105405109|NCT01791517|363492474|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105405110|NCT01791517|363492475|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105405111|NCT01791517|363492476|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105405112|NCT01791517|363492477|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
105405113|NCT01791517|363492478|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105405114|NCT01791517|363492467|FG000|Phase I: Period 2|Lens Discomfort|0|||
105405115|NCT01791517|363492468|FG001|Phase I: Period 2|Lens Discomfort|0|||
105405116|NCT01791517|363492469|FG002|Phase I: Period 2|Lens Discomfort|0|||
105405117|NCT01791517|363492470|FG003|Phase I: Period 2|Lens Discomfort|0|||
105405118|NCT01791517|363492471|FG004|Phase I: Period 2|Lens Discomfort|0|||
105405119|NCT01791517|363492472|FG005|Phase I: Period 2|Lens Discomfort|1|||
105494697|NCT01104155|363824853|FG001|Overall Study|Adverse Event|8|||
105494698|NCT01104155|363824852|FG000|Overall Study|Participant choice|6|||
105494699|NCT01104155|363824853|FG001|Overall Study|Participant choice|5|||
105494700|NCT01104155|363824852|FG000|Overall Study|Withdrawal of consent|1|||
105494701|NCT01104155|363824853|FG001|Overall Study|Withdrawal of consent|1|||
105405120|NCT01791517|363492473|FG006|Phase I: Period 2|Lens Discomfort|0|||
105405121|NCT01791517|363492474|FG007|Phase I: Period 2|Lens Discomfort|0|||
105405122|NCT01791517|363492475|FG008|Phase I: Period 2|Lens Discomfort|0|||
105405123|NCT01791517|363492476|FG009|Phase I: Period 2|Lens Discomfort|0|||
105405124|NCT01791517|363492477|FG010|Phase I: Period 2|Lens Discomfort|0|||
105494702|NCT01104155|363824852|FG000|Overall Study|Other|3|||
105405125|NCT01791517|363492478|FG011|Phase I: Period 2|Lens Discomfort|0|||
105405126|NCT01791517|363492467|FG000|Phase I: Period 2|Lost to Follow-up|0|||
105405127|NCT01791517|363492468|FG001|Phase I: Period 2|Lost to Follow-up|3|||
105405128|NCT01791517|363492469|FG002|Phase I: Period 2|Lost to Follow-up|2|||
105405129|NCT01791517|363492470|FG003|Phase I: Period 2|Lost to Follow-up|0|||
105405130|NCT01791517|363492471|FG004|Phase I: Period 2|Lost to Follow-up|0|||
105405131|NCT01791517|363492472|FG005|Phase I: Period 2|Lost to Follow-up|0|||
105405132|NCT01791517|363492473|FG006|Phase I: Period 2|Lost to Follow-up|0|||
105405133|NCT01791517|363492474|FG007|Phase I: Period 2|Lost to Follow-up|0|||
105405134|NCT01791517|363492475|FG008|Phase I: Period 2|Lost to Follow-up|0|||
105405135|NCT01791517|363492476|FG009|Phase I: Period 2|Lost to Follow-up|0|||
105405136|NCT01791517|363492477|FG010|Phase I: Period 2|Lost to Follow-up|0|||
105405137|NCT01791517|363492478|FG011|Phase I: Period 2|Lost to Follow-up|0|||
105405138|NCT01791517|363492467|FG000|Phase I: Period 3|Lens Discomfort|0|||
105405139|NCT01791517|363492468|FG001|Phase I: Period 3|Lens Discomfort|0|||
105405140|NCT01791517|363492469|FG002|Phase I: Period 3|Lens Discomfort|0|||
105405141|NCT01791517|363492470|FG003|Phase I: Period 3|Lens Discomfort|0|||
105405142|NCT01791517|363492471|FG004|Phase I: Period 3|Lens Discomfort|0|||
105405143|NCT01791517|363492472|FG005|Phase I: Period 3|Lens Discomfort|0|||
105405144|NCT01791517|363492473|FG006|Phase I: Period 3|Lens Discomfort|0|||
105405145|NCT01791517|363492474|FG007|Phase I: Period 3|Lens Discomfort|0|||
105405146|NCT01791517|363492475|FG008|Phase I: Period 3|Lens Discomfort|0|||
105405147|NCT01791517|363492476|FG009|Phase I: Period 3|Lens Discomfort|0|||
105405148|NCT01791517|363492477|FG010|Phase I: Period 3|Lens Discomfort|0|||
105405149|NCT01791517|363492478|FG011|Phase I: Period 3|Lens Discomfort|1|||
105405150|NCT01791517|363492467|FG000|Phase I: Period 3|Lost to Follow-up|0|||
105405151|NCT01791517|363492468|FG001|Phase I: Period 3|Lost to Follow-up|1|||
105405152|NCT01791517|363492469|FG002|Phase I: Period 3|Lost to Follow-up|0|||
105405153|NCT01791517|363492470|FG003|Phase I: Period 3|Lost to Follow-up|0|||
105405154|NCT01791517|363492471|FG004|Phase I: Period 3|Lost to Follow-up|1|||
105405155|NCT01791517|363492472|FG005|Phase I: Period 3|Lost to Follow-up|0|||
105405156|NCT01791517|363492473|FG006|Phase I: Period 3|Lost to Follow-up|0|||
105405157|NCT01791517|363492474|FG007|Phase I: Period 3|Lost to Follow-up|0|||
105405158|NCT01791517|363492475|FG008|Phase I: Period 3|Lost to Follow-up|0|||
105405159|NCT01791517|363492476|FG009|Phase I: Period 3|Lost to Follow-up|0|||
105405160|NCT01791517|363492477|FG010|Phase I: Period 3|Lost to Follow-up|0|||
105405161|NCT01791517|363492478|FG011|Phase I: Period 3|Lost to Follow-up|0|||
105405162|NCT01791517|363492467|FG000|Phase I: Period 3|Adverse Event|0|||
105405163|NCT01791517|363492468|FG001|Phase I: Period 3|Adverse Event|0|||
105405164|NCT01791517|363492469|FG002|Phase I: Period 3|Adverse Event|0|||
105405165|NCT01791517|363492470|FG003|Phase I: Period 3|Adverse Event|1|||
105405166|NCT01791517|363492471|FG004|Phase I: Period 3|Adverse Event|0|||
105405167|NCT01791517|363492472|FG005|Phase I: Period 3|Adverse Event|0|||
105405168|NCT01791517|363492473|FG006|Phase I: Period 3|Adverse Event|0|||
105405169|NCT01791517|363492474|FG007|Phase I: Period 3|Adverse Event|0|||
105405170|NCT01791517|363492475|FG008|Phase I: Period 3|Adverse Event|0|||
105405171|NCT01791517|363492476|FG009|Phase I: Period 3|Adverse Event|0|||
105405172|NCT01791517|363492477|FG010|Phase I: Period 3|Adverse Event|0|||
105405173|NCT01791517|363492478|FG011|Phase I: Period 3|Adverse Event|0|||
105405174|NCT01791517|363492467|FG000|Phase II|Lost to Follow-up|1|||
105405175|NCT01791517|363492468|FG001|Phase II|Lost to Follow-up|0|||
105405176|NCT01791517|363492469|FG002|Phase II|Lost to Follow-up|1|||
105405177|NCT01791517|363492470|FG003|Phase II|Lost to Follow-up|0|||
105405178|NCT01791517|363492471|FG004|Phase II|Lost to Follow-up|1|||
105405179|NCT01791517|363492472|FG005|Phase II|Lost to Follow-up|2|||
105405180|NCT01791517|363492473|FG006|Phase II|Lost to Follow-up|0|||
105405181|NCT01791517|363492474|FG007|Phase II|Lost to Follow-up|1|||
105405182|NCT01791517|363492475|FG008|Phase II|Lost to Follow-up|1|||
105405183|NCT01791517|363492476|FG009|Phase II|Lost to Follow-up|1|||
105405184|NCT01791517|363492477|FG010|Phase II|Lost to Follow-up|0|||
105405185|NCT01791517|363492478|FG011|Phase II|Lost to Follow-up|0|||
105405186|NCT01791517|363492467|FG000|Phase II|Withdrawal by Subject|1|||
105405187|NCT01791517|363492468|FG001|Phase II|Withdrawal by Subject|0|||
105405188|NCT01791517|363492469|FG002|Phase II|Withdrawal by Subject|0|||
105405189|NCT01791517|363492470|FG003|Phase II|Withdrawal by Subject|0|||
105405190|NCT01791517|363492471|FG004|Phase II|Withdrawal by Subject|0|||
105405191|NCT01791517|363492472|FG005|Phase II|Withdrawal by Subject|2|||
105405192|NCT01791517|363492473|FG006|Phase II|Withdrawal by Subject|0|||
105405193|NCT01791517|363492474|FG007|Phase II|Withdrawal by Subject|1|||
105405194|NCT01791517|363492475|FG008|Phase II|Withdrawal by Subject|0|||
105405195|NCT01791517|363492476|FG009|Phase II|Withdrawal by Subject|0|||
105405196|NCT01791517|363492477|FG010|Phase II|Withdrawal by Subject|1|||
105405197|NCT01791517|363492478|FG011|Phase II|Withdrawal by Subject|0|||
105405198|NCT01791517|363492467|FG000|Phase II|Lack of Efficacy|0|||
105405199|NCT01791517|363492468|FG001|Phase II|Lack of Efficacy|0|||
105405200|NCT01791517|363492469|FG002|Phase II|Lack of Efficacy|0|||
105405201|NCT01791517|363492470|FG003|Phase II|Lack of Efficacy|0|||
105405202|NCT01791517|363492471|FG004|Phase II|Lack of Efficacy|1|||
105405203|NCT01791517|363492472|FG005|Phase II|Lack of Efficacy|0|||
105405204|NCT01791517|363492473|FG006|Phase II|Lack of Efficacy|0|||
105405205|NCT01791517|363492474|FG007|Phase II|Lack of Efficacy|0|||
105405206|NCT01791517|363492475|FG008|Phase II|Lack of Efficacy|0|||
105405207|NCT01791517|363492476|FG009|Phase II|Lack of Efficacy|0|||
105405208|NCT01791517|363492477|FG010|Phase II|Lack of Efficacy|0|||
105405209|NCT01791517|363492478|FG011|Phase II|Lack of Efficacy|0|||
105405210|NCT01791517|363492467|FG000|Phase II|Adverse Event|0|||
105405211|NCT01791517|363492468|FG001|Phase II|Adverse Event|0|||
105405212|NCT01791517|363492469|FG002|Phase II|Adverse Event|0|||
105405213|NCT01791517|363492470|FG003|Phase II|Adverse Event|0|||
105405214|NCT01791517|363492471|FG004|Phase II|Adverse Event|0|||
105405215|NCT01791517|363492472|FG005|Phase II|Adverse Event|0|||
105405216|NCT01791517|363492473|FG006|Phase II|Adverse Event|2|||
105405217|NCT01791517|363492474|FG007|Phase II|Adverse Event|1|||
105405218|NCT01791517|363492475|FG008|Phase II|Adverse Event|0|||
105405219|NCT01791517|363492476|FG009|Phase II|Adverse Event|1|||
105405220|NCT01791517|363492477|FG010|Phase II|Adverse Event|0|||
105405221|NCT01791517|363492478|FG011|Phase II|Adverse Event|0|||
105405222|NCT01791517|363492467|FG000|Phase II|Lens Handling Difficulties|0|||
105405223|NCT01791517|363492468|FG001|Phase II|Lens Handling Difficulties|0|||
105405224|NCT01791517|363492469|FG002|Phase II|Lens Handling Difficulties|0|||
105405225|NCT01791517|363492470|FG003|Phase II|Lens Handling Difficulties|0|||
105405226|NCT01791517|363492471|FG004|Phase II|Lens Handling Difficulties|0|||
105405227|NCT01791517|363492472|FG005|Phase II|Lens Handling Difficulties|0|||
105405228|NCT01791517|363492473|FG006|Phase II|Lens Handling Difficulties|0|||
105405229|NCT01791517|363492474|FG007|Phase II|Lens Handling Difficulties|0|||
105405230|NCT01791517|363492475|FG008|Phase II|Lens Handling Difficulties|1|||
105405231|NCT01791517|363492476|FG009|Phase II|Lens Handling Difficulties|0|||
105405232|NCT01791517|363492477|FG010|Phase II|Lens Handling Difficulties|0|||
105405233|NCT01791517|363492478|FG011|Phase II|Lens Handling Difficulties|0|||
105405234|NCT01791517|363492467|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
105405235|NCT01791517|363492468|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
105405236|NCT01791517|363492469|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
105405237|NCT01791517|363492470|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
105405238|NCT01791517|363492471|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
105405239|NCT01791517|363492472|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
105405240|NCT01791517|363492473|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
105405241|NCT01791517|363492474|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
105405242|NCT01791517|363492475|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
105405243|NCT01791517|363492476|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
105405244|NCT01791517|363492477|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
105405245|NCT01791517|363492478|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
105405246|NCT01791517|363492467|FG000|Phase II|Pre-Existing Ocular Issue|0|||
105405247|NCT01791517|363492468|FG001|Phase II|Pre-Existing Ocular Issue|0|||
105405248|NCT01791517|363492469|FG002|Phase II|Pre-Existing Ocular Issue|0|||
105405249|NCT01791517|363492470|FG003|Phase II|Pre-Existing Ocular Issue|0|||
105405250|NCT01791517|363492471|FG004|Phase II|Pre-Existing Ocular Issue|0|||
105405251|NCT01791517|363492472|FG005|Phase II|Pre-Existing Ocular Issue|0|||
105405252|NCT01791517|363492473|FG006|Phase II|Pre-Existing Ocular Issue|0|||
105405253|NCT01791517|363492474|FG007|Phase II|Pre-Existing Ocular Issue|0|||
105405254|NCT01791517|363492475|FG008|Phase II|Pre-Existing Ocular Issue|0|||
105405255|NCT01791517|363492476|FG009|Phase II|Pre-Existing Ocular Issue|0|||
105405256|NCT01791517|363492477|FG010|Phase II|Pre-Existing Ocular Issue|0|||
105405257|NCT01791517|363492478|FG011|Phase II|Pre-Existing Ocular Issue|1|||
105405258|NCT01673646|363492482|FG000|Overall Study|Adverse Event|2|||
105405259|NCT01673646|363492483|FG001|Overall Study|Adverse Event|1|||
105405260|NCT01673646|363492484|FG002|Overall Study|Adverse Event|1|||
105405261|NCT01673646|363492482|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105405262|NCT01673646|363492483|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105405263|NCT01673646|363492484|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105405264|NCT01673646|363492482|FG000|Overall Study|Condition no longer requires study drug|0|||
105405265|NCT01673646|363492483|FG001|Overall Study|Condition no longer requires study drug|1|||
105405266|NCT01673646|363492484|FG002|Overall Study|Condition no longer requires study drug|0|||
105405267|NCT01673646|363492482|FG000|Overall Study|Withdrawal by Subject|0|||
105405268|NCT01673646|363492483|FG001|Overall Study|Withdrawal by Subject|2|||
105405269|NCT01673646|363492484|FG002|Overall Study|Withdrawal by Subject|2|||
105405270|NCT01673646|363492482|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
105405271|NCT01673646|363492483|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
105405272|NCT01673646|363492484|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
105405273|NCT01881009|363492485|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
105405274|NCT01881009|363492486|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
105405275|NCT04011735|363492487|FG000|Overall Study|Withdrawal by Subject|1|||
105405276|NCT04011735|363492488|FG001|Overall Study|Withdrawal by Subject|0|||
105405277|NCT04011735|363492489|FG002|Overall Study|Withdrawal by Subject|1|||
105405278|NCT04011735|363492487|FG000|Overall Study|Met exclusion criteria after study entry|0|||
105405279|NCT04011735|363492488|FG001|Overall Study|Met exclusion criteria after study entry|1|||
105405280|NCT04011735|363492489|FG002|Overall Study|Met exclusion criteria after study entry|0|||
105405281|NCT01000506|363492490|FG000|Overall Study|Adverse Event|6|||
105405282|NCT01000506|363492491|FG001|Overall Study|Adverse Event|5|||
105405283|NCT01000506|363492492|FG002|Overall Study|Adverse Event|8|||
105405284|NCT01000506|363492493|FG003|Overall Study|Adverse Event|9|||
105405285|NCT01000506|363492490|FG000|Overall Study|Lack of Efficacy|8|||
105405286|NCT01000506|363492491|FG001|Overall Study|Lack of Efficacy|6|||
105405287|NCT01000506|363492492|FG002|Overall Study|Lack of Efficacy|4|||
105405288|NCT01000506|363492493|FG003|Overall Study|Lack of Efficacy|4|||
105405289|NCT01000506|363492490|FG000|Overall Study|Protocol Violation|1|||
105405290|NCT01000506|363492491|FG001|Overall Study|Protocol Violation|1|||
105405291|NCT01000506|363492492|FG002|Overall Study|Protocol Violation|0|||
105405292|NCT01000506|363492493|FG003|Overall Study|Protocol Violation|0|||
105405293|NCT01000506|363492490|FG000|Overall Study|Lost to Follow-up|1|||
105405294|NCT01000506|363492491|FG001|Overall Study|Lost to Follow-up|1|||
105405295|NCT01000506|363492492|FG002|Overall Study|Lost to Follow-up|4|||
105405296|NCT01000506|363492493|FG003|Overall Study|Lost to Follow-up|0|||
105405297|NCT01000506|363492490|FG000|Overall Study|Physician Decision|1|||
105405298|NCT01000506|363492491|FG001|Overall Study|Physician Decision|3|||
105405299|NCT01000506|363492492|FG002|Overall Study|Physician Decision|3|||
105405300|NCT01000506|363492493|FG003|Overall Study|Physician Decision|3|||
105405301|NCT01000506|363492490|FG000|Overall Study|Withdrawal by Subject|11|||
105405302|NCT01000506|363492491|FG001|Overall Study|Withdrawal by Subject|8|||
105405303|NCT01000506|363492492|FG002|Overall Study|Withdrawal by Subject|2|||
105405304|NCT01000506|363492493|FG003|Overall Study|Withdrawal by Subject|7|||
105405305|NCT03064074|363492494|FG000|Overall Study|Physician Decision|0|||
105405306|NCT03064074|363492495|FG001|Overall Study|Physician Decision|0|||
105405307|NCT03064074|363492496|FG002|Overall Study|Physician Decision|0|||
105405308|NCT03064074|363492497|FG003|Overall Study|Physician Decision|1|||
105405309|NCT01722994|363492499|FG000|Overall Study|Missing data|25|||
105405310|NCT01722994|363492500|FG001|Overall Study|Missing data|17|||
105405311|NCT01063348|363492504|FG000|Overall Study|Lost to Follow-up|3|||
105405312|NCT01063348|363492505|FG001|Overall Study|Lost to Follow-up|10|||
105405313|NCT02688192|363492506|FG000|Overall Study|Lost to Follow-up|11|||
105405314|NCT02688192|363492507|FG001|Overall Study|Lost to Follow-up|5|||
105405315|NCT02688192|363492506|FG000|Overall Study|Physician Decision|1|||
105405316|NCT02688192|363492507|FG001|Overall Study|Physician Decision|0|||
105405317|NCT01118780|363492508|FG000|Overall Study|Adverse Event|15|||
105405318|NCT01118780|363492509|FG001|Overall Study|Adverse Event|15|||
105405319|NCT01118780|363492508|FG000|Overall Study|Death|1|||
105405320|NCT01118780|363492509|FG001|Overall Study|Death|0|||
105405321|NCT01118780|363492508|FG000|Overall Study|Lack of Efficacy|2|||
105405322|NCT01118780|363492509|FG001|Overall Study|Lack of Efficacy|6|||
105405323|NCT01118780|363492508|FG000|Overall Study|Physician Decision|2|||
105405324|NCT01118780|363492509|FG001|Overall Study|Physician Decision|0|||
105405325|NCT01118780|363492508|FG000|Overall Study|Protocol Violation|3|||
105405326|NCT01118780|363492509|FG001|Overall Study|Protocol Violation|6|||
105405327|NCT01118780|363492508|FG000|Overall Study|Withdrawal by Subject|13|||
105405328|NCT01118780|363492509|FG001|Overall Study|Withdrawal by Subject|8|||
105405329|NCT00269087|363492514|FG000|Overall Study|Adverse Event|20|||
105405330|NCT00269087|363492514|FG000|Overall Study|Withdrawal by Subject|1|||
105405331|NCT00269087|363492514|FG000|Overall Study|Exacerbation of COPD|13|||
105405332|NCT03962855|363492520|FG000|Overall Study|Death|0|||
105405333|NCT03962855|363492521|FG001|Overall Study|Death|1|||
105405334|NCT03962855|363492520|FG000|Overall Study|Lost to Follow-up|0|||
105405335|NCT03962855|363492521|FG001|Overall Study|Lost to Follow-up|1|||
105405336|NCT03962855|363492520|FG000|Overall Study|Adverse Event|0|||
105405337|NCT03962855|363492521|FG001|Overall Study|Adverse Event|1|||
105405338|NCT03962855|363492520|FG000|Overall Study|Physician Decision|0|||
105405339|NCT03962855|363492521|FG001|Overall Study|Physician Decision|2|||
105405340|NCT05384834|363492522|FG000|Overall Study|Lost to Follow-up|43|||
105405341|NCT05384834|363492522|FG000|Overall Study|Withdrawal by Subject|5|||
105405342|NCT01071954|363492523|FG000|Overall Study|Noncompliance|4|||
105405343|NCT01071954|363492523|FG000|Overall Study|Adverse Event|1|||
105405344|NCT01071954|363492523|FG000|Overall Study|Withdrawal by Subject|11|||
105405345|NCT01071954|363492523|FG000|Overall Study|Requirement for Alternative Therapy|5|||
105405346|NCT01071954|363492523|FG000|Overall Study|Administrative Decision|5|||
105405347|NCT01071954|363492523|FG000|Overall Study|Protocol Specified Criteria|1|||
105405348|NCT01061385|363492524|FG000|Overall Study|Lost to Follow-up|1|||
105405349|NCT01061385|363492525|FG001|Overall Study|Lost to Follow-up|0|||
105405350|NCT01061385|363492524|FG000|Overall Study|subject decision not related to AE|0|||
105405351|NCT01061385|363492525|FG001|Overall Study|subject decision not related to AE|1|||
105405352|NCT01492088|363492526|FG000|Overall Study|Withdrawal by Patient|0|||
105405353|NCT01492088|363492527|FG001|Overall Study|Withdrawal by Patient|2|||
105405354|NCT01492088|363492528|FG002|Overall Study|Withdrawal by Patient|0|||
105405355|NCT01492088|363492526|FG000|Overall Study|Death|1|||
105405356|NCT01492088|363492527|FG001|Overall Study|Death|6|||
105405357|NCT01492088|363492528|FG002|Overall Study|Death|2|||
105405358|NCT01492088|363492526|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
105405359|NCT01492088|363492527|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
105494703|NCT01104155|363824853|FG001|Overall Study|Other|4|||
105494704|NCT05394350|363824854|FG000|Overall Study|Death|2|||
105494705|NCT05394350|363824855|FG001|Overall Study|Death|2|||
105494706|NCT05394350|363824856|FG002|Overall Study|Death|4|||
105494707|NCT05394350|363824857|FG003|Overall Study|Death|0|||
105494708|NCT05394350|363824858|FG004|Overall Study|Death|1|||
105494709|NCT05394350|363824859|FG005|Overall Study|Death|0|||
105494710|NCT05394350|363824854|FG000|Overall Study|Study terminated by sponsor|1|||
105494711|NCT05394350|363824855|FG001|Overall Study|Study terminated by sponsor|1|||
105494712|NCT05394350|363824856|FG002|Overall Study|Study terminated by sponsor|7|||
105494713|NCT05394350|363824857|FG003|Overall Study|Study terminated by sponsor|3|||
105494714|NCT05394350|363824858|FG004|Overall Study|Study terminated by sponsor|2|||
105494715|NCT05394350|363824859|FG005|Overall Study|Study terminated by sponsor|4|||
105494716|NCT03800173|363824862|FG000|Overall Study|Lost to Follow-up|0|||
105494717|NCT03800173|363824863|FG001|Overall Study|Lost to Follow-up|0|||
105494718|NCT03800173|363824864|FG002|Overall Study|Lost to Follow-up|0|||
105580850|NCT01474512|364126472|FG007|Maintenance Period|Lack of Efficacy|11|||
105405360|NCT01492088|363492528|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
105405361|NCT01492088|363492526|FG000|Overall Study|Alive at Last Follow-up|0|||
105405362|NCT01492088|363492527|FG001|Overall Study|Alive at Last Follow-up|6|||
105405363|NCT01492088|363492528|FG002|Overall Study|Alive at Last Follow-up|11|||
105405364|NCT00533429|363492529|FG000|Overall Study|Adverse Event|3|||
105405365|NCT00533429|363492530|FG001|Overall Study|Adverse Event|1|||
105405366|NCT00533429|363492529|FG000|Overall Study|Death|1|||
105405367|NCT00533429|363492530|FG001|Overall Study|Death|0|||
105405368|NCT00533429|363492529|FG000|Overall Study|Withdrawal by Subject|2|||
105405369|NCT00533429|363492530|FG001|Overall Study|Withdrawal by Subject|0|||
105405370|NCT00533429|363492529|FG000|Overall Study|Progressive Disease|12|||
105405371|NCT00533429|363492530|FG001|Overall Study|Progressive Disease|13|||
105405372|NCT00533429|363492529|FG000|Overall Study|Symptomatic deterioration|1|||
105405373|NCT00533429|363492530|FG001|Overall Study|Symptomatic deterioration|2|||
105405374|NCT01881789|363492531|FG000|Overall Study|Withdrawal by Subject|0|||
105405375|NCT01881789|363492532|FG001|Overall Study|Withdrawal by Subject|2|||
105405376|NCT01881789|363492533|FG002|Overall Study|Withdrawal by Subject|1|||
105405377|NCT01881789|363492534|FG003|Overall Study|Withdrawal by Subject|0|||
105405378|NCT01881789|363492535|FG004|Overall Study|Withdrawal by Subject|1|||
105405379|NCT01881789|363492536|FG005|Overall Study|Withdrawal by Subject|1|||
105405380|NCT01881789|363492531|FG000|Overall Study|Study Terminated by Sponsor|0|||
105405381|NCT01881789|363492532|FG001|Overall Study|Study Terminated by Sponsor|0|||
105405382|NCT01881789|363492533|FG002|Overall Study|Study Terminated by Sponsor|0|||
105405383|NCT01881789|363492534|FG003|Overall Study|Study Terminated by Sponsor|0|||
105405384|NCT01881789|363492535|FG004|Overall Study|Study Terminated by Sponsor|0|||
105405385|NCT01881789|363492536|FG005|Overall Study|Study Terminated by Sponsor|1|||
105494719|NCT03800173|363824865|FG003|Overall Study|Lost to Follow-up|0|||
105405386|NCT01881789|363492531|FG000|Overall Study|Other|3|||
105405387|NCT01881789|363492532|FG001|Overall Study|Other|5|||
105405388|NCT01881789|363492533|FG002|Overall Study|Other|2|||
105405389|NCT01881789|363492534|FG003|Overall Study|Other|3|||
105405390|NCT01881789|363492535|FG004|Overall Study|Other|1|||
105494720|NCT03800173|363824866|FG004|Overall Study|Lost to Follow-up|1|||
105494721|NCT00936611|363824867|FG000|Overall Study|Progressive Disease|3|||
105405391|NCT01881789|363492536|FG005|Overall Study|Other|1|||
105405392|NCT02379052|363492544|FG000|Overall Study|Protocol Violation|0|||
105405393|NCT02379052|363492545|FG001|Overall Study|Protocol Violation|1|||
105405394|NCT02379052|363492544|FG000|Overall Study|Adverse Event|0|||
105405395|NCT02379052|363492545|FG001|Overall Study|Adverse Event|1|||
105405396|NCT02379052|363492544|FG000|Overall Study|Physician Decision|1|||
105405397|NCT02379052|363492545|FG001|Overall Study|Physician Decision|1|||
105405398|NCT02379052|363492544|FG000|Overall Study|Withdrawal by Subject|2|||
105405399|NCT02379052|363492545|FG001|Overall Study|Withdrawal by Subject|0|||
105405400|NCT02379052|363492544|FG000|Overall Study|Lost to Follow-up|2|||
105405401|NCT02379052|363492545|FG001|Overall Study|Lost to Follow-up|1|||
105405402|NCT02379052|363492544|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
105405403|NCT02379052|363492545|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
105405404|NCT02379052|363492544|FG000|Overall Study|Subject was Incarcerated|0|||
105405405|NCT02379052|363492545|FG001|Overall Study|Subject was Incarcerated|1|||
105405406|NCT02347085|363492548|FG000|Overall Study|Adverse Event|2|||
105405407|NCT02347085|363492548|FG000|Overall Study|Lack of Efficacy|1|||
105405408|NCT02347085|363492548|FG000|Overall Study|Withdrawal by Subject|4|||
105405409|NCT02347085|363492548|FG000|Overall Study|Lost to Follow-up|1|||
105405410|NCT02347085|363492548|FG000|Overall Study|Protocol Criteria|2|||
105405411|NCT02185534|363492557|FG000|First Period|Withdrawal by Subject|0|||
105405412|NCT02185534|363492558|FG001|First Period|Withdrawal by Subject|0|||
105405413|NCT02185534|363492559|FG002|First Period|Withdrawal by Subject|0|||
105405414|NCT02185534|363492560|FG003|First Period|Withdrawal by Subject|1|||
105405415|NCT02185534|363492561|FG004|First Period|Withdrawal by Subject|0|||
105405416|NCT02185534|363492562|FG005|First Period|Withdrawal by Subject|0|||
105405417|NCT02185534|363492557|FG000|First Washout Period|Withdrawal by Subject|1|||
105405418|NCT02185534|363492558|FG001|First Washout Period|Withdrawal by Subject|0|||
105405419|NCT02185534|363492559|FG002|First Washout Period|Withdrawal by Subject|0|||
105405420|NCT02185534|363492560|FG003|First Washout Period|Withdrawal by Subject|0|||
105405421|NCT02185534|363492561|FG004|First Washout Period|Withdrawal by Subject|1|||
105405422|NCT02185534|363492562|FG005|First Washout Period|Withdrawal by Subject|0|||
105405423|NCT02185534|363492557|FG000|First Washout Period|Protocol Violation|0|||
105405424|NCT02185534|363492558|FG001|First Washout Period|Protocol Violation|0|||
105405425|NCT02185534|363492559|FG002|First Washout Period|Protocol Violation|0|||
105405426|NCT02185534|363492560|FG003|First Washout Period|Protocol Violation|0|||
105405427|NCT02185534|363492561|FG004|First Washout Period|Protocol Violation|0|||
105405428|NCT02185534|363492562|FG005|First Washout Period|Protocol Violation|1|||
105405429|NCT01824290|363492563|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
105405430|NCT01824290|363492564|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
105405431|NCT01824290|363492565|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
105405432|NCT01824290|363492566|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
105405433|NCT01824290|363492563|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
105405434|NCT01824290|363492564|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
105405435|NCT01824290|363492565|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
105405436|NCT01824290|363492566|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
105405437|NCT01824290|363492563|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
105405438|NCT01824290|363492564|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
105405439|NCT01824290|363492565|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
105405440|NCT01824290|363492566|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
105405441|NCT01824290|363492563|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
105405442|NCT01824290|363492564|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
105405443|NCT01824290|363492565|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
105405444|NCT01824290|363492566|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
105405445|NCT01824290|363492563|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
105405446|NCT01824290|363492564|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
105405447|NCT01824290|363492565|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
105405448|NCT01824290|363492566|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
105405449|NCT01824290|363492563|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
105405450|NCT01824290|363492564|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
105405451|NCT01824290|363492565|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
105405452|NCT01824290|363492566|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
105405453|NCT03542266|363492573|FG000|Treatment Phase|Withdrawal by Subject|1|||
105405454|NCT03542266|363492573|FG000|Treatment Phase|Adverse Event|1|||
105405455|NCT03542266|363492573|FG000|Treatment Phase|PD|1|||
105405456|NCT00972023|363493621|FG000|Overall Study|Withdrawal by Subject|1|||
105405457|NCT00288015|363493622|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
105405458|NCT00288015|363493622|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
105405459|NCT00288015|363493622|FG000|First Response Assessment|Withdrawal by Subject|1|||
105405460|NCT00288015|363493622|FG000|First Response Assessment|Death|1|||
105405461|NCT00288015|363493622|FG000|First Response Assessment|Physician Decision|2|||
105405462|NCT00288015|363493622|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
105405463|NCT00288015|363493622|FG000|Follow up for Survival x 2 Years|Death|13|||
105405464|NCT00288015|363493622|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
105405465|NCT00288015|363493622|FG000|Follow up for Survival x 2 Years|Other|9|||
105405466|NCT00443703|363493623|FG000|Overall Study|Never Treated|3|||
105405467|NCT00443703|363493624|FG001|Overall Study|Never Treated|1|||
105405468|NCT00443703|363493623|FG000|Overall Study|Adverse Event|7|||
105405469|NCT00443703|363493624|FG001|Overall Study|Adverse Event|3|||
105405470|NCT00443703|363493623|FG000|Overall Study|Lack of Efficacy|3|||
105405471|NCT00443703|363493624|FG001|Overall Study|Lack of Efficacy|1|||
105405472|NCT00443703|363493623|FG000|Overall Study|Lost to Follow-up|0|||
105405473|NCT00443703|363493624|FG001|Overall Study|Lost to Follow-up|4|||
105405474|NCT00443703|363493623|FG000|Overall Study|Physician Decision|4|||
105405475|NCT00443703|363493624|FG001|Overall Study|Physician Decision|2|||
105405476|NCT00443703|363493623|FG000|Overall Study|Protocol Violation|1|||
105405477|NCT00443703|363493624|FG001|Overall Study|Protocol Violation|1|||
105405478|NCT00443703|363493623|FG000|Overall Study|Withdrawal by Subject|9|||
105405479|NCT00443703|363493624|FG001|Overall Study|Withdrawal by Subject|6|||
105405480|NCT00443703|363493623|FG000|Overall Study|Progressive Disease|1|||
105405481|NCT00443703|363493624|FG001|Overall Study|Progressive Disease|0|||
105405482|NCT01650831|363493629|FG000|Overall Study|Screen failure|1|||
105405483|NCT01462929|363493630|FG000|Overall Study|Adverse Event|3|||
105405484|NCT01462929|363493631|FG001|Overall Study|Adverse Event|3|||
105405485|NCT01462929|363493632|FG002|Overall Study|Adverse Event|4|||
105405486|NCT01462929|363493630|FG000|Overall Study|Withdrawal by Subject|2|||
105405487|NCT01462929|363493631|FG001|Overall Study|Withdrawal by Subject|1|||
105405488|NCT01462929|363493632|FG002|Overall Study|Withdrawal by Subject|0|||
105405489|NCT01462929|363493630|FG000|Overall Study|Lack of Efficacy|0|||
105405490|NCT01462929|363493631|FG001|Overall Study|Lack of Efficacy|0|||
105405491|NCT01462929|363493632|FG002|Overall Study|Lack of Efficacy|1|||
105405492|NCT01897727|363493633|FG000|Overall Study|Exclusion: central sleep apnea|0|||
105405493|NCT01897727|363493634|FG001|Overall Study|Exclusion: central sleep apnea|1|||
105405494|NCT04512001|363493635|FG000|Week 0 to Week 24|Adverse Event|14|||
105405495|NCT04512001|363493636|FG001|Week 0 to Week 24|Adverse Event|10|||
105405496|NCT04512001|363493637|FG002|Week 0 to Week 24|Adverse Event|0|||
105405497|NCT04512001|363493638|FG003|Week 0 to Week 24|Adverse Event|0|||
105405498|NCT04512001|363493639|FG004|Week 0 to Week 24|Adverse Event|0|||
105405499|NCT04512001|363493635|FG000|Week 0 to Week 24|Death|0|||
105405500|NCT04512001|363493636|FG001|Week 0 to Week 24|Death|2|||
105405501|NCT04512001|363493637|FG002|Week 0 to Week 24|Death|0|||
105405502|NCT04512001|363493638|FG003|Week 0 to Week 24|Death|0|||
105405503|NCT04512001|363493639|FG004|Week 0 to Week 24|Death|0|||
105405504|NCT04512001|363493635|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
105405505|NCT04512001|363493636|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
105405506|NCT04512001|363493637|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
105405507|NCT04512001|363493638|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
105405508|NCT04512001|363493639|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
105405509|NCT04512001|363493635|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
105405510|NCT04512001|363493636|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
105405511|NCT04512001|363493637|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
105405512|NCT04512001|363493638|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
105405513|NCT04512001|363493639|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
105405514|NCT04512001|363493635|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
105405515|NCT04512001|363493636|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
105405516|NCT04512001|363493637|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
105405517|NCT04512001|363493638|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
105405518|NCT04512001|363493639|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
105405519|NCT04512001|363493635|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
105405520|NCT04512001|363493636|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
105405521|NCT04512001|363493637|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
105405522|NCT04512001|363493638|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
105405523|NCT04512001|363493639|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
105405524|NCT04512001|363493635|FG000|Week 24 to Week 63|Adverse Event|0|||
105405525|NCT04512001|363493636|FG001|Week 24 to Week 63|Adverse Event|0|||
105405526|NCT04512001|363493637|FG002|Week 24 to Week 63|Adverse Event|13|||
105405527|NCT04512001|363493638|FG003|Week 24 to Week 63|Adverse Event|8|||
105405528|NCT04512001|363493639|FG004|Week 24 to Week 63|Adverse Event|6|||
105405529|NCT04512001|363493635|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
105405530|NCT04512001|363493636|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
105405531|NCT04512001|363493637|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
105405532|NCT04512001|363493638|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
105405533|NCT04512001|363493639|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
105405534|NCT04512001|363493635|FG000|Week 24 to Week 63|Death|0|||
105405535|NCT04512001|363493636|FG001|Week 24 to Week 63|Death|0|||
105405536|NCT04512001|363493637|FG002|Week 24 to Week 63|Death|0|||
105405537|NCT04512001|363493638|FG003|Week 24 to Week 63|Death|1|||
105405538|NCT04512001|363493639|FG004|Week 24 to Week 63|Death|1|||
105405539|NCT04512001|363493635|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
105405540|NCT04512001|363493636|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
105405541|NCT04512001|363493637|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
105405542|NCT04512001|363493638|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
105405543|NCT04512001|363493639|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
105405544|NCT04512001|363493635|FG000|Week 24 to Week 63|Miscellaneous|0|||
105405545|NCT04512001|363493636|FG001|Week 24 to Week 63|Miscellaneous|0|||
105405546|NCT04512001|363493637|FG002|Week 24 to Week 63|Miscellaneous|3|||
105405547|NCT04512001|363493638|FG003|Week 24 to Week 63|Miscellaneous|2|||
105405548|NCT04512001|363493639|FG004|Week 24 to Week 63|Miscellaneous|1|||
105405549|NCT00506779|363493640|FG000|Overall Study|Withdrawal by Subject|1|||
105405550|NCT00506779|363493641|FG001|Overall Study|Withdrawal by Subject|0|||
105405551|NCT00506779|363493642|FG002|Overall Study|Withdrawal by Subject|1|||
105405552|NCT00506779|363493643|FG003|Overall Study|Withdrawal by Subject|0|||
105405553|NCT00506779|363493640|FG000|Overall Study|Adverse Event|0|||
105405554|NCT00506779|363493641|FG001|Overall Study|Adverse Event|1|||
105405555|NCT00506779|363493642|FG002|Overall Study|Adverse Event|1|||
105405556|NCT00506779|363493643|FG003|Overall Study|Adverse Event|1|||
105405557|NCT04703192|363493644|FG000|Overall Study|Withdrawal by Subject|2|||
105405558|NCT04703192|363493645|FG001|Overall Study|Withdrawal by Subject|0|||
105405559|NCT04703192|363493644|FG000|Overall Study|Death|3|||
105405560|NCT04703192|363493645|FG001|Overall Study|Death|1|||
105405561|NCT04703192|363493644|FG000|Overall Study|Adverse Event|13|||
105405562|NCT04703192|363493645|FG001|Overall Study|Adverse Event|2|||
105405563|NCT04703192|363493644|FG000|Overall Study|Progressive or Relapsed Disease|46|||
105405564|NCT04703192|363493645|FG001|Overall Study|Progressive or Relapsed Disease|7|||
105405565|NCT04703192|363493644|FG000|Overall Study|Clinical Progression|19|||
105405566|NCT04703192|363493645|FG001|Overall Study|Clinical Progression|8|||
105405567|NCT04703192|363493644|FG000|Overall Study|Lost to Follow-up|1|||
105405568|NCT04703192|363493645|FG001|Overall Study|Lost to Follow-up|0|||
105405569|NCT04703192|363493644|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
105405570|NCT04703192|363493645|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
105405571|NCT04703192|363493644|FG000|Overall Study|Other|5|||
105405572|NCT04703192|363493645|FG001|Overall Study|Other|1|||
105405573|NCT04263766|363493646|FG000|Overall Study|Withdrawal by Subject|6|||
105405574|NCT04263766|363493647|FG001|Overall Study|Withdrawal by Subject|4|||
105405575|NCT04263766|363493646|FG000|Overall Study|Lack of Efficacy|1|||
105405576|NCT04263766|363493647|FG001|Overall Study|Lack of Efficacy|3|||
105405577|NCT02639247|363493648|FG000|Overall Study|Lost to Follow-up|2|||
105405578|NCT02639247|363493649|FG001|Overall Study|Lost to Follow-up|1|||
105405579|NCT02639247|363493648|FG000|Overall Study|Death|2|||
105405580|NCT02639247|363493649|FG001|Overall Study|Death|0|||
105405581|NCT02639247|363493648|FG000|Overall Study|Withdrew Consent|0|||
105405582|NCT02639247|363493649|FG001|Overall Study|Withdrew Consent|1|||
105405583|NCT02639247|363493648|FG000|Overall Study|Protocol Violation|1|||
105405584|NCT02639247|363493649|FG001|Overall Study|Protocol Violation|0|||
105405585|NCT02553928|363493651|FG000|Overall Study|Adverse Event|2|||
105405586|NCT02553928|363493652|FG001|Overall Study|Adverse Event|1|||
105405587|NCT02553928|363493651|FG000|Overall Study|Lost to Follow-up|0|||
105405588|NCT02553928|363493652|FG001|Overall Study|Lost to Follow-up|1|||
105405589|NCT02553928|363493651|FG000|Overall Study|Administrative reason(s)|0|||
105405590|NCT02553928|363493652|FG001|Overall Study|Administrative reason(s)|1|||
105405591|NCT00075764|363493653|FG000|Overall Study|Adverse Event|5|||
105405592|NCT00075764|363493654|FG001|Overall Study|Adverse Event|12|||
105405593|NCT00075764|363493653|FG000|Overall Study|Death|4|||
105405594|NCT00075764|363493654|FG001|Overall Study|Death|8|||
105405595|NCT00075764|363493653|FG000|Overall Study|Withdrawal by Subject|28|||
105405596|NCT00075764|363493654|FG001|Overall Study|Withdrawal by Subject|18|||
105405597|NCT00075764|363493653|FG000|Overall Study|Progression|269|||
105405598|NCT00075764|363493654|FG001|Overall Study|Progression|274|||
105405599|NCT00075764|363493653|FG000|Overall Study|Still on treatment|8|||
105405600|NCT00075764|363493654|FG001|Overall Study|Still on treatment|15|||
105405601|NCT00075764|363493653|FG000|Overall Study|Delinquent|4|||
105405602|NCT00075764|363493654|FG001|Overall Study|Delinquent|2|||
105405603|NCT00075764|363493653|FG000|Overall Study|Not protocol specified|27|||
105405604|NCT00075764|363493654|FG001|Overall Study|Not protocol specified|19|||
105405605|NCT00075764|363493653|FG000|Overall Study|Under review|0|||
105405606|NCT00075764|363493654|FG001|Overall Study|Under review|1|||
105405607|NCT00590967|363493655|FG000|Overall Study|Withdrawal by Subject|1|||
105405608|NCT00590967|363493656|FG001|Overall Study|Withdrawal by Subject|1|||
105405609|NCT00590967|363493655|FG000|Overall Study|Ineligible|1|||
105494722|NCT00936611|363824867|FG000|Overall Study|New Systemic Therapy|22|||
105405610|NCT00590967|363493656|FG001|Overall Study|Ineligible|0|||
105405611|NCT00590967|363493655|FG000|Overall Study|Poor performance status|0|||
105405612|NCT00590967|363493656|FG001|Overall Study|Poor performance status|1|||
105405613|NCT00590967|363493655|FG000|Overall Study|Non-compliant|0|||
105405614|NCT00590967|363493656|FG001|Overall Study|Non-compliant|2|||
105405615|NCT00590967|363493655|FG000|Overall Study|Did not sign consent form|0|||
105405616|NCT00590967|363493656|FG001|Overall Study|Did not sign consent form|1|||
105405617|NCT00590967|363493655|FG000|Overall Study|Did not receive chemo per protocol|1|||
105405618|NCT00590967|363493656|FG001|Overall Study|Did not receive chemo per protocol|0|||
105405619|NCT03824392|363493657|FG000|Overall Study|Adverse Event|1|||
105405620|NCT03824392|363493658|FG001|Overall Study|Adverse Event|0|||
105405621|NCT03824392|363493659|FG002|Overall Study|Adverse Event|0|||
105405622|NCT03824392|363493660|FG003|Overall Study|Adverse Event|0|||
105405623|NCT03824392|363493657|FG000|Overall Study|Investigator Decision|0|||
105405624|NCT03824392|363493658|FG001|Overall Study|Investigator Decision|1|||
105405625|NCT03824392|363493659|FG002|Overall Study|Investigator Decision|0|||
105405626|NCT03824392|363493660|FG003|Overall Study|Investigator Decision|0|||
105405627|NCT03824392|363493657|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
105405628|NCT03824392|363493658|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
105405629|NCT03824392|363493659|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
105405630|NCT03824392|363493660|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
105405631|NCT01282866|363493661|FG000|Overall Study|Adverse Event|1|||
105405632|NCT00920556|363493663|FG000|Overall Study|Adverse Event|16|||
105405633|NCT00920556|363493663|FG000|Overall Study|Physician Decision|7|||
105405634|NCT00920556|363493663|FG000|Overall Study|Withdrawal by Subject|1|||
105405635|NCT01299389|363493664|FG000|Double-blind|Adverse Event|45|||
105405636|NCT01299389|363493665|FG001|Double-blind|Adverse Event|27|||
105405637|NCT01299389|363493666|FG002|Double-blind|Adverse Event|0|||
105405638|NCT01299389|363493667|FG003|Double-blind|Adverse Event|0|||
105405639|NCT01299389|363493664|FG000|Double-blind|Lack of Efficacy|45|||
105405640|NCT01299389|363493665|FG001|Double-blind|Lack of Efficacy|21|||
105405641|NCT01299389|363493666|FG002|Double-blind|Lack of Efficacy|0|||
105405642|NCT01299389|363493667|FG003|Double-blind|Lack of Efficacy|0|||
105405643|NCT01299389|363493664|FG000|Double-blind|Lost to Follow-up|2|||
105405644|NCT01299389|363493665|FG001|Double-blind|Lost to Follow-up|1|||
105405645|NCT01299389|363493666|FG002|Double-blind|Lost to Follow-up|0|||
105405646|NCT01299389|363493667|FG003|Double-blind|Lost to Follow-up|0|||
105405647|NCT01299389|363493664|FG000|Double-blind|Withdrawal by Subject|16|||
105405648|NCT01299389|363493665|FG001|Double-blind|Withdrawal by Subject|13|||
105405649|NCT01299389|363493666|FG002|Double-blind|Withdrawal by Subject|0|||
105405650|NCT01299389|363493667|FG003|Double-blind|Withdrawal by Subject|0|||
105405651|NCT01299389|363493664|FG000|Double-blind|Other|1|||
105405652|NCT01299389|363493665|FG001|Double-blind|Other|1|||
105405653|NCT01299389|363493666|FG002|Double-blind|Other|0|||
105405654|NCT01299389|363493667|FG003|Double-blind|Other|0|||
105405655|NCT01299389|363493664|FG000|Double-blind|"fail to meet study population criteria"|0|||
105405656|NCT01299389|363493665|FG001|Double-blind|"fail to meet study population criteria"|1|||
105405657|NCT01299389|363493666|FG002|Double-blind|"fail to meet study population criteria"|0|||
105405658|NCT01299389|363493667|FG003|Double-blind|"fail to meet study population criteria"|0|||
105405659|NCT01299389|363493664|FG000|Post-observational|Other|0|||
105405660|NCT01299389|363493665|FG001|Post-observational|Other|0|||
105405661|NCT01299389|363493666|FG002|Post-observational|Other|12|||
105405662|NCT01299389|363493667|FG003|Post-observational|Other|6|||
105405663|NCT03072043|363493672|FG000|Overall Study|Death|0|||
105405664|NCT03072043|363493673|FG001|Overall Study|Death|0|||
105405665|NCT03072043|363493674|FG002|Overall Study|Death|3|||
105405666|NCT03072043|363493672|FG000|Overall Study|Adverse Event|0|||
105405667|NCT03072043|363493673|FG001|Overall Study|Adverse Event|0|||
105405668|NCT03072043|363493674|FG002|Overall Study|Adverse Event|2|||
105405669|NCT03072043|363493672|FG000|Overall Study|Withdrawal by Subject|0|||
105405670|NCT03072043|363493673|FG001|Overall Study|Withdrawal by Subject|0|||
105405671|NCT03072043|363493674|FG002|Overall Study|Withdrawal by Subject|4|||
105405672|NCT00886769|363493682|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
105405673|NCT00886769|363493683|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
105405674|NCT01070979|363493685|FG000|Overall Study|Adverse Event|2|||
105405675|NCT01070979|363493686|FG001|Overall Study|Adverse Event|3|||
105405676|NCT01070979|363493687|FG002|Overall Study|Adverse Event|3|||
105405677|NCT01070979|363493685|FG000|Overall Study|Lost to Follow-up|2|||
105405678|NCT01070979|363493686|FG001|Overall Study|Lost to Follow-up|1|||
105405679|NCT01070979|363493687|FG002|Overall Study|Lost to Follow-up|1|||
105405680|NCT01070979|363493685|FG000|Overall Study|Protocol Violation|0|||
105405681|NCT01070979|363493686|FG001|Overall Study|Protocol Violation|2|||
105405682|NCT01070979|363493687|FG002|Overall Study|Protocol Violation|6|||
105405683|NCT01070979|363493685|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
105405684|NCT01070979|363493686|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
105405685|NCT01070979|363493687|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
105405686|NCT01070979|363493685|FG000|Overall Study|Withdrawal by Subject|3|||
105405687|NCT01070979|363493686|FG001|Overall Study|Withdrawal by Subject|1|||
105405688|NCT01070979|363493687|FG002|Overall Study|Withdrawal by Subject|1|||
105405689|NCT01070979|363493685|FG000|Overall Study|No study drug taken|0|||
105405690|NCT01070979|363493686|FG001|Overall Study|No study drug taken|1|||
105405691|NCT01070979|363493687|FG002|Overall Study|No study drug taken|0|||
105405692|NCT00142792|363493691|FG000|Overall Study|Death|0|||
105405693|NCT00142792|363493692|FG001|Overall Study|Death|0|||
105405694|NCT00142792|363493693|FG002|Overall Study|Death|1|||
105405695|NCT00142792|363493691|FG000|Overall Study|Withdrawal by Subject|3|||
105405696|NCT00142792|363493692|FG001|Overall Study|Withdrawal by Subject|2|||
105405697|NCT00142792|363493693|FG002|Overall Study|Withdrawal by Subject|3|||
105405698|NCT00142792|363493691|FG000|Overall Study|Lost to Follow-up|8|||
105405699|NCT00142792|363493692|FG001|Overall Study|Lost to Follow-up|11|||
105405700|NCT00142792|363493693|FG002|Overall Study|Lost to Follow-up|7|||
105405701|NCT00142792|363493691|FG000|Overall Study|No category|1|||
105405702|NCT00142792|363493692|FG001|Overall Study|No category|2|||
105405703|NCT00142792|363493693|FG002|Overall Study|No category|1|||
105580851|NCT01474512|364126473|FG008|Maintenance Period|Lack of Efficacy|11|||
105405704|NCT02382991|363493696|FG000|Overall Study|Adverse Event|1|||
105405705|NCT02382991|363493697|FG001|Overall Study|Adverse Event|2|||
105405706|NCT02382991|363493696|FG000|Overall Study|Lost to Follow-up|1|||
105405707|NCT02382991|363493697|FG001|Overall Study|Lost to Follow-up|0|||
105405708|NCT02382991|363493696|FG000|Overall Study|Withdrawal by Subject|0|||
105405709|NCT02382991|363493697|FG001|Overall Study|Withdrawal by Subject|1|||
105405710|NCT02708680|363493698|FG000|Overall Study|Withdrawal by Subject|4|||
105405711|NCT02708680|363493699|FG001|Overall Study|Withdrawal by Subject|12|||
105405712|NCT02708680|363493700|FG002|Overall Study|Withdrawal by Subject|12|||
105405713|NCT02708680|363493698|FG000|Overall Study|Death|4|||
105405714|NCT02708680|363493699|FG001|Overall Study|Death|19|||
105405715|NCT02708680|363493700|FG002|Overall Study|Death|21|||
105405716|NCT02708680|363493698|FG000|Overall Study|Lost to Follow-up|0|||
105405717|NCT02708680|363493699|FG001|Overall Study|Lost to Follow-up|3|||
105405718|NCT02708680|363493700|FG002|Overall Study|Lost to Follow-up|3|||
105405719|NCT02708680|363493698|FG000|Overall Study|Study Terminated By Sponsor|0|||
105405720|NCT02708680|363493699|FG001|Overall Study|Study Terminated By Sponsor|5|||
105405721|NCT02708680|363493700|FG002|Overall Study|Study Terminated By Sponsor|4|||
105405722|NCT02708680|363493698|FG000|Overall Study|Other than Specified|0|||
105405723|NCT02708680|363493699|FG001|Overall Study|Other than Specified|0|||
105405724|NCT02708680|363493700|FG002|Overall Study|Other than Specified|1|||
105405725|NCT02708680|363493698|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
105405726|NCT02708680|363493699|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
105405727|NCT02708680|363493700|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
105405728|NCT04162470|363493701|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
105405729|NCT02131662|363493702|FG000|Overall Study|Protocol Violation|1|||
105405730|NCT02131662|363493703|FG001|Overall Study|Protocol Violation|0|||
105405731|NCT02131662|363493704|FG002|Overall Study|Protocol Violation|0|||
105405732|NCT02131662|363493705|FG003|Overall Study|Protocol Violation|0|||
105405733|NCT02131662|363493706|FG004|Overall Study|Protocol Violation|0|||
105405734|NCT02131662|363493702|FG000|Overall Study|Other|2|||
105405735|NCT02131662|363493703|FG001|Overall Study|Other|4|||
105405736|NCT02131662|363493704|FG002|Overall Study|Other|3|||
105405737|NCT02131662|363493705|FG003|Overall Study|Other|3|||
105405738|NCT02131662|363493706|FG004|Overall Study|Other|4|||
105405739|NCT02131662|363493702|FG000|Overall Study|Adverse Event|0|||
105405740|NCT02131662|363493703|FG001|Overall Study|Adverse Event|1|||
105580852|NCT01474512|364126474|FG009|Maintenance Period|Lack of Efficacy|12|||
105580853|NCT01474512|364126475|FG010|Maintenance Period|Lack of Efficacy|0|||
105580854|NCT01474512|364126476|FG011|Maintenance Period|Lack of Efficacy|0|||
105580855|NCT01474512|364126477|FG012|Maintenance Period|Lack of Efficacy|0|||
105580856|NCT01474512|364126478|FG013|Maintenance Period|Lack of Efficacy|0|||
105580857|NCT01474512|364126479|FG014|Maintenance Period|Lack of Efficacy|0|||
105580858|NCT01474512|364126480|FG015|Maintenance Period|Lack of Efficacy|0|||
105580859|NCT01474512|364126481|FG016|Maintenance Period|Lack of Efficacy|0|||
105405741|NCT02131662|363493704|FG002|Overall Study|Adverse Event|1|||
105405742|NCT02131662|363493705|FG003|Overall Study|Adverse Event|1|||
105405743|NCT02131662|363493706|FG004|Overall Study|Adverse Event|3|||
105405744|NCT02131662|363493702|FG000|Overall Study|Pregnancy|0|||
105405745|NCT02131662|363493703|FG001|Overall Study|Pregnancy|1|||
105405746|NCT02131662|363493704|FG002|Overall Study|Pregnancy|0|||
105405747|NCT02131662|363493705|FG003|Overall Study|Pregnancy|1|||
105580860|NCT01474512|364126482|FG017|Maintenance Period|Lack of Efficacy|0|||
105580861|NCT01474512|364126465|FG000|Maintenance Period|Protocol Violation|0|||
105580862|NCT01474512|364126466|FG001|Maintenance Period|Protocol Violation|0|||
105405748|NCT02131662|363493706|FG004|Overall Study|Pregnancy|0|||
105405749|NCT02131662|363493702|FG000|Overall Study|Wish for pregnancy|0|||
105405750|NCT02131662|363493703|FG001|Overall Study|Wish for pregnancy|0|||
105405751|NCT02131662|363493704|FG002|Overall Study|Wish for pregnancy|0|||
105405752|NCT02131662|363493705|FG003|Overall Study|Wish for pregnancy|0|||
105405753|NCT02131662|363493706|FG004|Overall Study|Wish for pregnancy|1|||
105580863|NCT01474512|364126467|FG002|Maintenance Period|Protocol Violation|0|||
105580864|NCT01474512|364126468|FG003|Maintenance Period|Protocol Violation|1|||
105405754|NCT02131662|363493702|FG000|Overall Study|Lack of Efficacy|1|||
105405755|NCT02131662|363493703|FG001|Overall Study|Lack of Efficacy|0|||
105405756|NCT02131662|363493704|FG002|Overall Study|Lack of Efficacy|0|||
105405757|NCT02131662|363493705|FG003|Overall Study|Lack of Efficacy|0|||
105405758|NCT02131662|363493706|FG004|Overall Study|Lack of Efficacy|1|||
105405759|NCT02131662|363493702|FG000|Overall Study|Withdrawal by Subject|1|||
105405760|NCT02131662|363493703|FG001|Overall Study|Withdrawal by Subject|5|||
105405761|NCT02131662|363493704|FG002|Overall Study|Withdrawal by Subject|1|||
105405762|NCT02131662|363493705|FG003|Overall Study|Withdrawal by Subject|5|||
105405763|NCT02131662|363493706|FG004|Overall Study|Withdrawal by Subject|6|||
105405764|NCT02131662|363493702|FG000|Overall Study|Lost to Follow-up|1|||
105405765|NCT02131662|363493703|FG001|Overall Study|Lost to Follow-up|3|||
105405766|NCT02131662|363493704|FG002|Overall Study|Lost to Follow-up|0|||
105405767|NCT02131662|363493705|FG003|Overall Study|Lost to Follow-up|9|||
105405768|NCT02131662|363493706|FG004|Overall Study|Lost to Follow-up|0|||
105405769|NCT02131662|363493702|FG000|Overall Study|Not treated|2|||
105405770|NCT02131662|363493703|FG001|Overall Study|Not treated|0|||
105405771|NCT02131662|363493704|FG002|Overall Study|Not treated|2|||
105405772|NCT02131662|363493705|FG003|Overall Study|Not treated|2|||
105405773|NCT02131662|363493706|FG004|Overall Study|Not treated|3|||
105405774|NCT03554018|363493707|FG000|Overall Study|Lost to Follow-up|3|||
105405775|NCT03554018|363493708|FG001|Overall Study|Lost to Follow-up|7|||
105405776|NCT03929913|363493709|FG000|Overall Study|Death|4|||
105405777|NCT03929913|363493709|FG000|Overall Study|Lost to Follow-up|1|||
105405778|NCT03929913|363493709|FG000|Overall Study|Failed Procedure|2|||
105405779|NCT01154452|363493710|FG000|Phase Ib|Not Treated|1|||
105405780|NCT01154452|363493711|FG001|Phase Ib|Not Treated|0|||
105405781|NCT01154452|363493712|FG002|Phase Ib|Not Treated|0|||
105405782|NCT01154452|363493713|FG003|Phase Ib|Not Treated|0|||
105405783|NCT01154452|363493710|FG000|Phase Ib|Adverse Event|2|||
105405784|NCT01154452|363493711|FG001|Phase Ib|Adverse Event|1|||
105405785|NCT01154452|363493712|FG002|Phase Ib|Adverse Event|0|||
105405786|NCT01154452|363493713|FG003|Phase Ib|Adverse Event|0|||
105405787|NCT01154452|363493710|FG000|Phase II|Withdrawal by Subject|0|||
105405788|NCT01154452|363493711|FG001|Phase II|Withdrawal by Subject|0|||
105405789|NCT01154452|363493712|FG002|Phase II|Withdrawal by Subject|1|||
105405790|NCT01154452|363493713|FG003|Phase II|Withdrawal by Subject|2|||
105405791|NCT01154452|363493710|FG000|Phase II|Adverse Event|0|||
105405792|NCT01154452|363493711|FG001|Phase II|Adverse Event|0|||
105405793|NCT01154452|363493712|FG002|Phase II|Adverse Event|4|||
105405794|NCT01154452|363493713|FG003|Phase II|Adverse Event|4|||
105405795|NCT01544348|363493714|FG000|Overall Study|Lost to Follow-up|1|||
105405796|NCT01544348|363493715|FG001|Overall Study|Lost to Follow-up|0|||
105405797|NCT01544348|363493716|FG002|Overall Study|Lost to Follow-up|0|||
105405798|NCT01544348|363493717|FG003|Overall Study|Lost to Follow-up|0|||
105405799|NCT01544348|363493718|FG004|Overall Study|Lost to Follow-up|0|||
105405800|NCT01544348|363493719|FG005|Overall Study|Lost to Follow-up|0|||
105405801|NCT01544348|363493720|FG006|Overall Study|Lost to Follow-up|1|||
105405802|NCT01544348|363493721|FG007|Overall Study|Lost to Follow-up|0|||
105405803|NCT01544348|363493714|FG000|Overall Study|Withdrawal by Subject|1|||
105405804|NCT01544348|363493715|FG001|Overall Study|Withdrawal by Subject|0|||
105405805|NCT01544348|363493716|FG002|Overall Study|Withdrawal by Subject|0|||
105405806|NCT01544348|363493717|FG003|Overall Study|Withdrawal by Subject|0|||
105405807|NCT01544348|363493718|FG004|Overall Study|Withdrawal by Subject|1|||
105405808|NCT01544348|363493719|FG005|Overall Study|Withdrawal by Subject|2|||
105405809|NCT01544348|363493720|FG006|Overall Study|Withdrawal by Subject|1|||
105405810|NCT01544348|363493721|FG007|Overall Study|Withdrawal by Subject|0|||
105405811|NCT01544348|363493714|FG000|Overall Study|Physician Decision|0|||
105405812|NCT01544348|363493715|FG001|Overall Study|Physician Decision|0|||
105405813|NCT01544348|363493716|FG002|Overall Study|Physician Decision|0|||
105405814|NCT01544348|363493717|FG003|Overall Study|Physician Decision|0|||
105405815|NCT01544348|363493718|FG004|Overall Study|Physician Decision|0|||
105405816|NCT01544348|363493719|FG005|Overall Study|Physician Decision|1|||
105405817|NCT01544348|363493720|FG006|Overall Study|Physician Decision|0|||
105405818|NCT01544348|363493721|FG007|Overall Study|Physician Decision|0|||
105405819|NCT00145626|363493722|FG000|Overall Study|Did not have NK infusions|2|||
105405820|NCT00145626|363493722|FG000|Overall Study|Turned 2 years old before treatment|1|||
105405821|NCT00145626|363493722|FG000|Overall Study|Death|1|||
105405822|NCT00145626|363493722|FG000|Overall Study|Withdrawal by Subject|1|||
105405823|NCT02573948|363493723|FG000|Longitudinal Cohort|Death|9|||
105405824|NCT02573948|363493723|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
105405825|NCT02573948|363493723|FG000|Longitudinal Cohort|Incarcerated|25|||
105405826|NCT00707993|363493724|FG000|Overall Study|Adverse Event|16|||
105405827|NCT00707993|363493725|FG001|Overall Study|Adverse Event|20|||
105405828|NCT00707993|363493724|FG000|Overall Study|Protocol Violation|4|||
105405829|NCT00707993|363493725|FG001|Overall Study|Protocol Violation|7|||
105405830|NCT00707993|363493724|FG000|Overall Study|Lost to Follow-up|0|||
105405831|NCT00707993|363493725|FG001|Overall Study|Lost to Follow-up|4|||
105405832|NCT00707993|363493724|FG000|Overall Study|Withdrawal by Subject|12|||
105405833|NCT00707993|363493725|FG001|Overall Study|Withdrawal by Subject|16|||
105405834|NCT00707993|363493724|FG000|Overall Study|Hyperglycemic Rescue|55|||
105405835|NCT00707993|363493725|FG001|Overall Study|Hyperglycemic Rescue|47|||
105405836|NCT00707993|363493724|FG000|Overall Study|Other|2|||
105405837|NCT00707993|363493725|FG001|Overall Study|Other|0|||
105405838|NCT03381287|363493731|FG000|Overall Study|Withdrawal by Subject|0|||
105405839|NCT03381287|363493732|FG001|Overall Study|Withdrawal by Subject|1|||
105405840|NCT03381287|363493733|FG002|Overall Study|Withdrawal by Subject|0|||
105405841|NCT03381287|363493734|FG003|Overall Study|Withdrawal by Subject|0|||
105405842|NCT03381287|363493731|FG000|Overall Study|Adverse Event|0|||
105405843|NCT03381287|363493732|FG001|Overall Study|Adverse Event|0|||
105405844|NCT03381287|363493733|FG002|Overall Study|Adverse Event|0|||
105405845|NCT03381287|363493734|FG003|Overall Study|Adverse Event|1|||
105405846|NCT03381287|363493731|FG000|Overall Study|Physician Decision|0|||
105405847|NCT03381287|363493732|FG001|Overall Study|Physician Decision|0|||
105405848|NCT03381287|363493733|FG002|Overall Study|Physician Decision|0|||
105405849|NCT03381287|363493734|FG003|Overall Study|Physician Decision|1|||
105405850|NCT03960684|363493735|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
105405851|NCT02685826|363493736|FG000|Overall Study|Adverse Event|2|||
105405852|NCT02685826|363493737|FG001|Overall Study|Adverse Event|0|||
105405853|NCT02685826|363493738|FG002|Overall Study|Adverse Event|1|||
105405854|NCT02685826|363493736|FG000|Overall Study|Progressive Disease|2|||
105405855|NCT02685826|363493737|FG001|Overall Study|Progressive Disease|1|||
105405856|NCT02685826|363493738|FG002|Overall Study|Progressive Disease|0|||
105405857|NCT02685826|363493736|FG000|Overall Study|Withdrawal by Subject|2|||
105405858|NCT02685826|363493737|FG001|Overall Study|Withdrawal by Subject|0|||
105405859|NCT02685826|363493738|FG002|Overall Study|Withdrawal by Subject|0|||
105405860|NCT02685826|363493736|FG000|Overall Study|Full Clinical Hold by FDA|19|||
105405861|NCT02685826|363493737|FG001|Overall Study|Full Clinical Hold by FDA|9|||
105405862|NCT02685826|363493738|FG002|Overall Study|Full Clinical Hold by FDA|20|||
105405863|NCT03154476|363493739|FG000|Overall Study|Lost to Follow-up|4|||
105405864|NCT03154476|363493740|FG001|Overall Study|Lost to Follow-up|4|||
105405865|NCT00200967|363493741|FG000|First Treatment Period|Withdrawal by Subject|5|||
105405866|NCT00200967|363493742|FG001|First Treatment Period|Withdrawal by Subject|1|||
105405867|NCT00200967|363493741|FG000|First Treatment Period|Pregnancy|1|||
105405868|NCT00200967|363493742|FG001|First Treatment Period|Pregnancy|0|||
105405869|NCT00200967|363493741|FG000|Wash-out Period|Lost to Follow-up|0|||
105405870|NCT00200967|363493742|FG001|Wash-out Period|Lost to Follow-up|1|||
105405871|NCT00200967|363493741|FG000|Second Treatment Period|Withdrawal by Subject|1|||
105405872|NCT00200967|363493742|FG001|Second Treatment Period|Withdrawal by Subject|2|||
105405873|NCT00200967|363493741|FG000|Run-out Period|Lost to Follow-up|1|||
105405874|NCT00200967|363493742|FG001|Run-out Period|Lost to Follow-up|0|||
105405875|NCT01444430|363493743|FG000|Overall Study|Withdrawal by Subject|53|||
105405876|NCT01444430|363493744|FG001|Overall Study|Withdrawal by Subject|72|||
105405877|NCT01444430|363493743|FG000|Overall Study|Death|6|||
105405878|NCT01444430|363493744|FG001|Overall Study|Death|8|||
105405879|NCT01444430|363493743|FG000|Overall Study|Lost to Follow-up|2|||
105405880|NCT01444430|363493744|FG001|Overall Study|Lost to Follow-up|0|||
105405881|NCT01444430|363493743|FG000|Overall Study|CRF termination module not completed.|0|||
105405882|NCT01444430|363493744|FG001|Overall Study|CRF termination module not completed.|1|||
105405883|NCT04472650|363495353|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
105405884|NCT04472650|363495354|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
105405885|NCT00552071|363495357|FG000|Overall Study|Adverse Event|1|||
105405886|NCT00552071|363495358|FG001|Overall Study|Adverse Event|0|||
105405887|NCT00552071|363495357|FG000|Overall Study|Lack of Efficacy|1|||
105405888|NCT00552071|363495358|FG001|Overall Study|Lack of Efficacy|0|||
105405889|NCT00552071|363495357|FG000|Overall Study|Physician Decision|1|||
105405890|NCT00552071|363495358|FG001|Overall Study|Physician Decision|0|||
105405891|NCT00552071|363495357|FG000|Overall Study|Pregnancy|1|||
105405892|NCT00552071|363495358|FG001|Overall Study|Pregnancy|0|||
105405893|NCT00552071|363495357|FG000|Overall Study|Death|0|||
105405894|NCT00552071|363495358|FG001|Overall Study|Death|1|||
105405895|NCT00552071|363495357|FG000|Overall Study|Withdrawal by Subject|0|||
105405896|NCT00552071|363495358|FG001|Overall Study|Withdrawal by Subject|1|||
105405897|NCT02549989|363495359|FG000|Overall Study|Adverse Event|4|||
105405898|NCT02549989|363495359|FG000|Overall Study|Death|1|||
105405899|NCT02549989|363495359|FG000|Overall Study|Lack of Efficacy|19|||
105405900|NCT02549989|363495359|FG000|Overall Study|Withdrawal by Subject|3|||
105405901|NCT02628444|363495360|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
105405902|NCT02628444|363495361|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105405903|NCT02628444|363495362|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105405904|NCT02628444|363495363|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105405905|NCT02628444|363495364|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105405906|NCT02628444|363495365|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105405907|NCT02628444|363495366|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105405908|NCT02628444|363495367|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105405909|NCT02628444|363495368|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105405910|NCT02628444|363495360|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
105405911|NCT02628444|363495361|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
105405912|NCT02628444|363495362|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
105405913|NCT02628444|363495363|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
105405914|NCT02628444|363495364|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
105405915|NCT02628444|363495365|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
105405916|NCT02628444|363495366|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
105405917|NCT02628444|363495367|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
105405918|NCT02628444|363495368|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
105405919|NCT02628444|363495360|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
105405920|NCT02628444|363495361|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
105405921|NCT02628444|363495362|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
105405922|NCT02628444|363495363|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
105405923|NCT02628444|363495364|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
105405924|NCT02628444|363495365|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
105405925|NCT02628444|363495366|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
105405926|NCT02628444|363495367|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
105405927|NCT02628444|363495368|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
105405928|NCT02628444|363495360|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
105405929|NCT02628444|363495361|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
105405930|NCT02628444|363495362|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
105405931|NCT02628444|363495363|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
105405932|NCT02628444|363495364|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
105405933|NCT02628444|363495365|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
105405934|NCT02628444|363495366|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
105405935|NCT02628444|363495367|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
105405936|NCT02628444|363495368|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
105405937|NCT02628444|363495360|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
105405938|NCT02628444|363495361|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
105405939|NCT02628444|363495362|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
105405940|NCT02628444|363495363|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
105405941|NCT02628444|363495364|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
105405942|NCT02628444|363495365|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
105405943|NCT02628444|363495366|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
105405944|NCT02628444|363495367|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
105405945|NCT02628444|363495368|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
105405946|NCT02628444|363495360|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105405947|NCT02628444|363495361|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105405948|NCT02628444|363495362|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105405949|NCT02628444|363495363|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
105405950|NCT02628444|363495364|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105405951|NCT02628444|363495365|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105405952|NCT02628444|363495366|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105405953|NCT02628444|363495367|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105405954|NCT02628444|363495368|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105405955|NCT02628444|363495360|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
105405956|NCT02628444|363495361|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
105405957|NCT02628444|363495362|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
105405958|NCT02628444|363495363|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
105405959|NCT02628444|363495364|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
105405960|NCT02628444|363495365|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
105405961|NCT02628444|363495366|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
105405962|NCT02628444|363495367|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
105405963|NCT02628444|363495368|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
105494723|NCT00936611|363824867|FG000|Overall Study|Lost to Follow-up|1|||
105494724|NCT00936611|363824867|FG000|Overall Study|Withdrawal by Subject|2|||
105494725|NCT00936611|363824867|FG000|Overall Study|Still on Follow-up|1|||
105494726|NCT00936611|363824867|FG000|Overall Study|Still on Active Therapy|7|||
105494727|NCT00936611|363824867|FG000|Overall Study|Ineligible for Study Drug|3|||
105405964|NCT02628444|363495360|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
105405965|NCT02628444|363495361|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
105405966|NCT02628444|363495362|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
105405967|NCT02628444|363495363|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
105405968|NCT02628444|363495364|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
105405969|NCT02628444|363495365|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
105405970|NCT02628444|363495366|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
105405971|NCT02628444|363495367|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
105405972|NCT02628444|363495368|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
105405973|NCT02628444|363495360|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
105405974|NCT02628444|363495361|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
105405975|NCT02628444|363495362|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
105405976|NCT02628444|363495363|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
105405977|NCT02628444|363495364|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
105405978|NCT02628444|363495365|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
105405979|NCT02628444|363495366|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
105405980|NCT02628444|363495367|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
105405981|NCT02628444|363495368|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
105405982|NCT02628444|363495360|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
105405983|NCT02628444|363495361|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
105405984|NCT02628444|363495362|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
105405985|NCT02628444|363495363|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
105405986|NCT02628444|363495364|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
105405987|NCT02628444|363495365|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
105405988|NCT02628444|363495366|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
105405989|NCT02628444|363495367|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
105405990|NCT02628444|363495368|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
105405991|NCT01333722|363495369|FG000|Overall Study|Lack of Efficacy|0|||
105405992|NCT01333722|363495370|FG001|Overall Study|Lack of Efficacy|2|||
105405993|NCT01333722|363495369|FG000|Overall Study|Withdrawal by Subject|0|||
105405994|NCT01333722|363495370|FG001|Overall Study|Withdrawal by Subject|1|||
105405995|NCT00532129|363495371|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
105405996|NCT00532129|363495371|FG000|Treatment Period|Physician Decision|15|||
105405997|NCT00532129|363495371|FG000|Treatment Period|Disease progression|3|||
105405998|NCT00532129|363495371|FG000|Treatment Period|Protocol Violation|1|||
105405999|NCT00532129|363495371|FG000|Treatment Period|Other|5|||
105406000|NCT00532129|363495371|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
105406001|NCT00532129|363495371|FG000|Follow-up Period|Disease progression|57|||
105406002|NCT00532129|363495371|FG000|Follow-up Period|Lost to Follow-up|1|||
105406003|NCT00532129|363495371|FG000|Follow-up Period|Other|6|||
105406004|NCT03432494|363495374|FG000|Overall Study|Death|1|||
105406005|NCT03432494|363495374|FG000|Overall Study|Noncompliance|1|||
105406006|NCT00833469|363495375|FG000|Overall Study|Withdrawal by Subject|1|||
105406007|NCT00833469|363495375|FG000|Overall Study|Lost to Follow-up|1|||
105406008|NCT03801928|363495376|FG000|Overall Study|Adverse Event|1|||
105406009|NCT03801928|363495377|FG001|Overall Study|Adverse Event|0|||
105406010|NCT03801928|363495378|FG002|Overall Study|Adverse Event|1|||
105406011|NCT03801928|363495379|FG003|Overall Study|Adverse Event|2|||
105406012|NCT03801928|363495380|FG004|Overall Study|Adverse Event|0|||
105406013|NCT03801928|363495381|FG005|Overall Study|Adverse Event|2|||
105406014|NCT03801928|363495376|FG000|Overall Study|Lack of Efficacy|0|||
105406015|NCT03801928|363495377|FG001|Overall Study|Lack of Efficacy|0|||
105406016|NCT03801928|363495378|FG002|Overall Study|Lack of Efficacy|1|||
105406017|NCT03801928|363495379|FG003|Overall Study|Lack of Efficacy|0|||
105406018|NCT03801928|363495380|FG004|Overall Study|Lack of Efficacy|0|||
105406019|NCT03801928|363495381|FG005|Overall Study|Lack of Efficacy|0|||
105406020|NCT03801928|363495376|FG000|Overall Study|Lost to Follow-up|5|||
105406021|NCT03801928|363495377|FG001|Overall Study|Lost to Follow-up|1|||
105406022|NCT03801928|363495378|FG002|Overall Study|Lost to Follow-up|1|||
105406023|NCT03801928|363495379|FG003|Overall Study|Lost to Follow-up|4|||
105406024|NCT03801928|363495380|FG004|Overall Study|Lost to Follow-up|4|||
105406025|NCT03801928|363495381|FG005|Overall Study|Lost to Follow-up|2|||
105406026|NCT03801928|363495376|FG000|Overall Study|Withdrawal by Subject|0|||
105406027|NCT03801928|363495377|FG001|Overall Study|Withdrawal by Subject|0|||
105406028|NCT03801928|363495378|FG002|Overall Study|Withdrawal by Subject|2|||
105406029|NCT03801928|363495379|FG003|Overall Study|Withdrawal by Subject|1|||
105406030|NCT03801928|363495380|FG004|Overall Study|Withdrawal by Subject|0|||
105406031|NCT03801928|363495381|FG005|Overall Study|Withdrawal by Subject|0|||
105406032|NCT03801928|363495376|FG000|Overall Study|Other|0|||
105406033|NCT03801928|363495377|FG001|Overall Study|Other|2|||
105406034|NCT03801928|363495378|FG002|Overall Study|Other|0|||
105406035|NCT03801928|363495379|FG003|Overall Study|Other|1|||
105406036|NCT03801928|363495380|FG004|Overall Study|Other|0|||
105406037|NCT03801928|363495381|FG005|Overall Study|Other|1|||
105406038|NCT01665911|363495382|FG000|Overall Study|Protocol Violation|4|||
105406039|NCT01665911|363495382|FG000|Overall Study|Withdrawal by Subject|1|||
105406040|NCT01665911|363495382|FG000|Overall Study|Adverse Event|1|||
105406041|NCT02370368|363495385|FG000|Overall Study|Adverse Event|1|||
105406042|NCT02370368|363495386|FG001|Overall Study|Adverse Event|2|||
105406043|NCT02370368|363495385|FG000|Overall Study|Withdrawal by Subject|5|||
105406044|NCT02370368|363495386|FG001|Overall Study|Withdrawal by Subject|4|||
105406045|NCT02776683|363495387|FG000|Pre-switch Period|Protocol Violation|1|||
105406046|NCT02776683|363495388|FG001|Pre-switch Period|Protocol Violation|0|||
105406047|NCT02776683|363495387|FG000|Pre-switch Period|Adverse Event|21|||
105406048|NCT02776683|363495388|FG001|Pre-switch Period|Adverse Event|0|||
105406049|NCT02776683|363495387|FG000|Pre-switch Period|Withdrawal by Subject|9|||
105406050|NCT02776683|363495388|FG001|Pre-switch Period|Withdrawal by Subject|0|||
105406051|NCT02776683|363495387|FG000|Pre-switch Period|Physician Decision|7|||
105406052|NCT02776683|363495388|FG001|Pre-switch Period|Physician Decision|0|||
105406053|NCT02776683|363495387|FG000|Pre-switch Period|Progressive disease|39|||
105406054|NCT02776683|363495388|FG001|Pre-switch Period|Progressive disease|0|||
105406055|NCT02776683|363495387|FG000|Pre-switch Period|Other than listed|3|||
105406056|NCT02776683|363495388|FG001|Pre-switch Period|Other than listed|0|||
105406057|NCT02776683|363495387|FG000|Post-switch Period|Adverse Event|0|||
105406058|NCT02776683|363495388|FG001|Post-switch Period|Adverse Event|3|||
105406059|NCT02776683|363495387|FG000|Post-switch Period|Withdrawal by Subject|0|||
105406060|NCT02776683|363495388|FG001|Post-switch Period|Withdrawal by Subject|2|||
105406061|NCT02776683|363495387|FG000|Post-switch Period|Physician Decision|0|||
105406062|NCT02776683|363495388|FG001|Post-switch Period|Physician Decision|3|||
105406063|NCT02776683|363495387|FG000|Post-switch Period|Progressive disease|0|||
105406064|NCT02776683|363495388|FG001|Post-switch Period|Progressive disease|20|||
105406065|NCT02776683|363495387|FG000|Post-switch Period|Other than listed|0|||
105406066|NCT02776683|363495388|FG001|Post-switch Period|Other than listed|15|||
105406067|NCT03198767|363495389|FG000|Overall Study|Protocol Violation|0|||
105406068|NCT03198767|363495390|FG001|Overall Study|Protocol Violation|0|||
105406069|NCT03198767|363495391|FG002|Overall Study|Protocol Violation|0|||
105406070|NCT03198767|363495392|FG003|Overall Study|Protocol Violation|6|||
105406071|NCT03198767|363495393|FG004|Overall Study|Protocol Violation|0|||
105406072|NCT03198767|363495394|FG005|Overall Study|Protocol Violation|0|||
105406073|NCT03198767|363495395|FG006|Overall Study|Protocol Violation|0|||
105406074|NCT02266147|363495397|FG000|PART 1: Dose Escalation|Physician Decision|0|||
105406075|NCT02266147|363495398|FG001|PART 1: Dose Escalation|Physician Decision|0|||
105406076|NCT02266147|363495399|FG002|PART 1: Dose Escalation|Physician Decision|1|||
105406077|NCT02266147|363495400|FG003|PART 1: Dose Escalation|Physician Decision|0|||
105406078|NCT02266147|363495397|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
105406079|NCT02266147|363495398|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
105406080|NCT02266147|363495399|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
105406081|NCT02266147|363495400|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
105406082|NCT02266147|363495397|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
105406083|NCT02266147|363495398|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
105406084|NCT02266147|363495399|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
105406085|NCT02266147|363495400|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
105406086|NCT02266147|363495397|FG000|PART 1: Dose Escalation|Other|1|||
105406087|NCT02266147|363495398|FG001|PART 1: Dose Escalation|Other|1|||
105406088|NCT02266147|363495399|FG002|PART 1: Dose Escalation|Other|0|||
105406089|NCT02266147|363495400|FG003|PART 1: Dose Escalation|Other|0|||
105406090|NCT02266147|363495397|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
105406091|NCT02266147|363495398|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
105406092|NCT02266147|363495399|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
105406093|NCT02266147|363495400|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
105406094|NCT02266147|363495397|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
105406095|NCT02266147|363495398|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
105406096|NCT02266147|363495399|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
105406097|NCT02266147|363495400|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
105406098|NCT03896477|363495401|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
105406099|NCT03896477|363495402|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
105406100|NCT03896477|363495403|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
105406101|NCT03896477|363495401|FG000|Overall Study|Parent Requested Withdrawal|8|||
105406102|NCT03896477|363495402|FG001|Overall Study|Parent Requested Withdrawal|12|||
105406103|NCT03896477|363495403|FG002|Overall Study|Parent Requested Withdrawal|9|||
105406104|NCT03896477|363495401|FG000|Overall Study|Adverse Event|0|||
105406105|NCT03896477|363495402|FG001|Overall Study|Adverse Event|0|||
105406106|NCT03896477|363495403|FG002|Overall Study|Adverse Event|1|||
105406107|NCT03896477|363495401|FG000|Overall Study|Death|1|||
105406108|NCT03896477|363495402|FG001|Overall Study|Death|0|||
105406109|NCT03896477|363495403|FG002|Overall Study|Death|0|||
105406110|NCT03896477|363495401|FG000|Overall Study|Other|5|||
105406111|NCT03896477|363495402|FG001|Overall Study|Other|6|||
105406112|NCT03896477|363495403|FG002|Overall Study|Other|7|||
105406113|NCT03896477|363495401|FG000|Overall Study|Lost to Follow-up|2|||
105406114|NCT03896477|363495402|FG001|Overall Study|Lost to Follow-up|1|||
105406115|NCT03896477|363495403|FG002|Overall Study|Lost to Follow-up|1|||
105406116|NCT00400517|363495404|FG000|Overall Study|Withdrawal by Subject|1|||
105406117|NCT00400517|363495404|FG000|Overall Study|Physician Decision|1|||
105406118|NCT00041470|363495405|FG000|Overall Study|Loss of Funding|38|||
105406119|NCT01871545|363495406|FG000|Overall Study|Death|2|||
105406120|NCT01871545|363495407|FG001|Overall Study|Death|0|||
105406121|NCT01871545|363495406|FG000|Overall Study|Lack of Efficacy|11|||
105406122|NCT01871545|363495407|FG001|Overall Study|Lack of Efficacy|2|||
105406123|NCT01871545|363495406|FG000|Overall Study|Physician Decision|4|||
105406124|NCT01871545|363495407|FG001|Overall Study|Physician Decision|0|||
105406125|NCT01871545|363495406|FG000|Overall Study|Withdrawal by Subject|0|||
105406126|NCT01871545|363495407|FG001|Overall Study|Withdrawal by Subject|1|||
105406127|NCT00739310|363495408|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
105406128|NCT00739310|363495408|FG000|Overall Study|Withdrawal by Subject|1|||
105406129|NCT00739310|363495408|FG000|Overall Study|Lost to Follow-up|2|||
105406130|NCT00988052|363495411|FG000|Overall Study|Missing|1|||
105406131|NCT00988052|363495412|FG001|Overall Study|Missing|0|||
105406132|NCT00988052|363495411|FG000|Overall Study|Teva requested subject withdrawal|3|||
105406133|NCT00988052|363495412|FG001|Overall Study|Teva requested subject withdrawal|1|||
105406134|NCT00988052|363495411|FG000|Overall Study|Death|1|||
105406135|NCT00988052|363495412|FG001|Overall Study|Death|3|||
105406136|NCT00988052|363495411|FG000|Overall Study|Protocol Violation|6|||
105406137|NCT00988052|363495412|FG001|Overall Study|Protocol Violation|5|||
105406138|NCT00988052|363495411|FG000|Overall Study|Pregnancy|6|||
105406139|NCT00988052|363495412|FG001|Overall Study|Pregnancy|6|||
105406140|NCT00988052|363495411|FG000|Overall Study|Lack of Efficacy|8|||
105406141|NCT00988052|363495412|FG001|Overall Study|Lack of Efficacy|7|||
105406142|NCT00988052|363495411|FG000|Overall Study|Lost to Follow-up|6|||
105406143|NCT00988052|363495412|FG001|Overall Study|Lost to Follow-up|11|||
105406144|NCT00988052|363495411|FG000|Overall Study|Physician Decision|27|||
105406145|NCT00988052|363495412|FG001|Overall Study|Physician Decision|28|||
105406146|NCT00988052|363495411|FG000|Overall Study|Adverse Event|35|||
105406147|NCT00988052|363495412|FG001|Overall Study|Adverse Event|28|||
105406148|NCT00988052|363495411|FG000|Overall Study|Withdrawal by Subject|90|||
105406149|NCT00988052|363495412|FG001|Overall Study|Withdrawal by Subject|91|||
105406150|NCT00988052|363495411|FG000|Overall Study|Study terminated by sponsor|240|||
105406151|NCT00988052|363495412|FG001|Overall Study|Study terminated by sponsor|236|||
105406152|NCT02954887|363495413|FG000|Overall Study|Withdrawal by Subject|3|||
105406153|NCT02954887|363495413|FG000|Overall Study|Lack of Efficacy|3|||
105406154|NCT02954887|363495413|FG000|Overall Study|Other|1|||
105406155|NCT01459666|363495415|FG000|Overall Study|PI left institution|5|||
105406156|NCT01459666|363495416|FG001|Overall Study|PI left institution|4|||
105406157|NCT01152788|363495418|FG000|Overall Study|Withdrawal by Subject|0|||
105406158|NCT01152788|363495419|FG001|Overall Study|Withdrawal by Subject|3|||
105406159|NCT01152788|363495418|FG000|Overall Study|No treatment|0|||
105406160|NCT01152788|363495419|FG001|Overall Study|No treatment|1|||
105406161|NCT02655887|363495421|FG000|Overall Study|Lost to Follow-up|3|||
105406162|NCT02655887|363495421|FG000|Overall Study|Death|4|||
105406163|NCT02655887|363495421|FG000|Overall Study|Withdrawal by Subject|3|||
105406164|NCT02655887|363495421|FG000|Overall Study|Missed 12-month follow-up visit|4|||
105406165|NCT04245709|363495422|FG000|Overall Study|Adverse Event|13|||
105406166|NCT04245709|363495422|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
105406167|NCT01434654|363495423|FG000|Overall Study|Withdrawal by Subject|1|||
105406168|NCT01434654|363495424|FG001|Overall Study|Withdrawal by Subject|0|||
105406169|NCT01434654|363495423|FG000|Overall Study|Lost to Follow-up|1|||
105406170|NCT01434654|363495424|FG001|Overall Study|Lost to Follow-up|0|||
105406171|NCT00889707|363495425|FG000|Overall Study|Adverse Event|1|||
105406172|NCT00889707|363495426|FG001|Overall Study|Adverse Event|0|||
105406173|NCT00889707|363495425|FG000|Overall Study|Withdrawal by Subject|4|||
105406174|NCT00889707|363495426|FG001|Overall Study|Withdrawal by Subject|3|||
105406175|NCT00889707|363495425|FG000|Overall Study|Lost to Follow-up|0|||
105406176|NCT00889707|363495426|FG001|Overall Study|Lost to Follow-up|2|||
105406177|NCT00889707|363495425|FG000|Overall Study|Lack of Efficacy|2|||
105406178|NCT00889707|363495426|FG001|Overall Study|Lack of Efficacy|5|||
105406179|NCT02948582|363495427|FG000|Washout Period 1|Adverse Event|0|||
105406180|NCT02948582|363495428|FG001|Washout Period 1|Adverse Event|2|||
105406181|NCT02948582|363495429|FG002|Washout Period 1|Adverse Event|0|||
105406182|NCT02948582|363495430|FG003|Washout Period 1|Adverse Event|0|||
105406183|NCT02948582|363495431|FG004|Washout Period 1|Adverse Event|0|||
105406184|NCT02948582|363495432|FG005|Washout Period 1|Adverse Event|0|||
105406185|NCT02948582|363495427|FG000|Washout Period 1|Protocol Violation|0|||
105406186|NCT02948582|363495428|FG001|Washout Period 1|Protocol Violation|0|||
105406187|NCT02948582|363495429|FG002|Washout Period 1|Protocol Violation|0|||
105580865|NCT01474512|364126469|FG004|Maintenance Period|Protocol Violation|0|||
105580866|NCT01474512|364126470|FG005|Maintenance Period|Protocol Violation|0|||
105580867|NCT01474512|364126471|FG006|Maintenance Period|Protocol Violation|0|||
105580868|NCT01474512|364126472|FG007|Maintenance Period|Protocol Violation|1|||
105580869|NCT01474512|364126473|FG008|Maintenance Period|Protocol Violation|0|||
105580870|NCT01474512|364126474|FG009|Maintenance Period|Protocol Violation|1|||
105580871|NCT01474512|364126475|FG010|Maintenance Period|Protocol Violation|0|||
105580872|NCT01474512|364126476|FG011|Maintenance Period|Protocol Violation|0|||
105580873|NCT01474512|364126477|FG012|Maintenance Period|Protocol Violation|0|||
105580874|NCT01474512|364126478|FG013|Maintenance Period|Protocol Violation|0|||
105580875|NCT01474512|364126479|FG014|Maintenance Period|Protocol Violation|0|||
105580876|NCT01474512|364126480|FG015|Maintenance Period|Protocol Violation|0|||
105580877|NCT01474512|364126481|FG016|Maintenance Period|Protocol Violation|0|||
105580878|NCT01474512|364126482|FG017|Maintenance Period|Protocol Violation|0|||
105580879|NCT01474512|364126465|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
105580880|NCT01474512|364126466|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
105580881|NCT01474512|364126467|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
105580882|NCT01474512|364126468|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
105580883|NCT01474512|364126469|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
105580884|NCT01474512|364126470|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
105580885|NCT01474512|364126471|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
105580886|NCT01474512|364126472|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
105580887|NCT01474512|364126473|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
105580888|NCT01474512|364126474|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
105580889|NCT01474512|364126475|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
105580890|NCT01474512|364126476|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
105580891|NCT01474512|364126477|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
105580892|NCT01474512|364126478|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
105580893|NCT01474512|364126479|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
105580894|NCT01474512|364126480|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
105580895|NCT01474512|364126481|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
105580896|NCT01474512|364126482|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
105580897|NCT01474512|364126465|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
105580898|NCT01474512|364126466|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
105580899|NCT01474512|364126467|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
105580900|NCT01474512|364126468|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
105406188|NCT02948582|363495430|FG003|Washout Period 1|Protocol Violation|0|||
105406189|NCT02948582|363495431|FG004|Washout Period 1|Protocol Violation|0|||
105406190|NCT02948582|363495432|FG005|Washout Period 1|Protocol Violation|1|||
105406191|NCT02948582|363495427|FG000|Washout Period 2|Adverse Event|0|||
105406192|NCT02948582|363495428|FG001|Washout Period 2|Adverse Event|1|||
105406193|NCT02948582|363495429|FG002|Washout Period 2|Adverse Event|0|||
105406194|NCT02948582|363495430|FG003|Washout Period 2|Adverse Event|0|||
105406195|NCT02948582|363495431|FG004|Washout Period 2|Adverse Event|0|||
105406196|NCT02948582|363495432|FG005|Washout Period 2|Adverse Event|0|||
105406197|NCT02948582|363495427|FG000|Washout Period 2|personal reasons|0|||
105406198|NCT02948582|363495428|FG001|Washout Period 2|personal reasons|0|||
105406199|NCT02948582|363495429|FG002|Washout Period 2|personal reasons|0|||
105406200|NCT02948582|363495430|FG003|Washout Period 2|personal reasons|1|||
105406201|NCT02948582|363495431|FG004|Washout Period 2|personal reasons|0|||
105406202|NCT02948582|363495432|FG005|Washout Period 2|personal reasons|0|||
105406203|NCT02948582|363495427|FG000|Washout Period 4|Adverse Event|1|||
105406204|NCT02948582|363495428|FG001|Washout Period 4|Adverse Event|0|||
105406205|NCT02948582|363495429|FG002|Washout Period 4|Adverse Event|1|||
105406206|NCT02948582|363495430|FG003|Washout Period 4|Adverse Event|0|||
105406207|NCT02948582|363495431|FG004|Washout Period 4|Adverse Event|0|||
105406208|NCT02948582|363495432|FG005|Washout Period 4|Adverse Event|0|||
105406209|NCT01151020|363495436|FG000|Overall Study|Death|25|||
105406210|NCT01151020|363495436|FG000|Overall Study|Conversion to open repair|1|||
105406211|NCT01151020|363495436|FG000|Overall Study|Lost to Follow-up|4|||
105406212|NCT01151020|363495436|FG000|Overall Study|Withdrawal by Subject|22|||
105406213|NCT01151020|363495436|FG000|Overall Study|Patients did not receive the device|2|||
105406214|NCT02041299|363495437|FG000|Overall Study|Adverse Event|9|||
105406215|NCT02041299|363495438|FG001|Overall Study|Adverse Event|3|||
105406216|NCT02041299|363495437|FG000|Overall Study|Lost to Follow-up|4|||
105406217|NCT02041299|363495438|FG001|Overall Study|Lost to Follow-up|1|||
105406218|NCT02041299|363495437|FG000|Overall Study|Physician Decision|1|||
105580901|NCT01474512|364126469|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
105580902|NCT01474512|364126470|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
105580903|NCT01474512|364126471|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
105406219|NCT02041299|363495438|FG001|Overall Study|Physician Decision|1|||
105406220|NCT02041299|363495437|FG000|Overall Study|Withdrawal by Subject|13|||
105406221|NCT02041299|363495438|FG001|Overall Study|Withdrawal by Subject|7|||
105406222|NCT02041299|363495437|FG000|Overall Study|Protocol Violation|11|||
105406223|NCT02041299|363495438|FG001|Overall Study|Protocol Violation|4|||
105406224|NCT02041299|363495437|FG000|Overall Study|Termination of the study|7|||
105406225|NCT02041299|363495438|FG001|Overall Study|Termination of the study|3|||
105406226|NCT02041299|363495437|FG000|Overall Study|Required bone marrow transplant|0|||
105406227|NCT02041299|363495438|FG001|Overall Study|Required bone marrow transplant|1|||
105406228|NCT02041299|363495437|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
105406229|NCT02041299|363495438|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
105406230|NCT02389465|363495439|FG000|Overall Study|Lost to Follow-up|1|||
105406231|NCT02389465|363495440|FG001|Overall Study|Lost to Follow-up|3|||
105406232|NCT02389465|363495441|FG002|Overall Study|Lost to Follow-up|3|||
105406233|NCT02389465|363495442|FG003|Overall Study|Lost to Follow-up|0|||
105406234|NCT02389465|363495439|FG000|Overall Study|Physician Decision|0|||
105406235|NCT02389465|363495440|FG001|Overall Study|Physician Decision|0|||
105406236|NCT02389465|363495441|FG002|Overall Study|Physician Decision|0|||
105406237|NCT02389465|363495442|FG003|Overall Study|Physician Decision|1|||
105406238|NCT02389465|363495439|FG000|Overall Study|Withdrawal by Subject|0|||
105406239|NCT02389465|363495440|FG001|Overall Study|Withdrawal by Subject|1|||
105406240|NCT02389465|363495441|FG002|Overall Study|Withdrawal by Subject|2|||
105406241|NCT02389465|363495442|FG003|Overall Study|Withdrawal by Subject|2|||
105406242|NCT01635998|363495443|FG000|Overall Study|Death|1|||
105406243|NCT01635998|363495444|FG001|Overall Study|Death|1|||
105406244|NCT01635998|363495443|FG000|Overall Study|Lost to Follow-up|2|||
105406245|NCT01635998|363495444|FG001|Overall Study|Lost to Follow-up|1|||
105406246|NCT01635998|363495443|FG000|Overall Study|Withdrawal by Subject|1|||
105406247|NCT01635998|363495444|FG001|Overall Study|Withdrawal by Subject|5|||
105406248|NCT01637584|363495451|FG000|Overall Study|Withdrawal by Subject|1|||
105406249|NCT01637584|363495452|FG001|Overall Study|Withdrawal by Subject|3|||
105406250|NCT02534883|363495457|FG000|Overall Study|Early Termination|8|||
105406251|NCT02534883|363495458|FG001|Overall Study|Early Termination|3|||
105406252|NCT00414076|363495461|FG000|Overall Study|Progression|1|||
105406253|NCT00414076|363495462|FG001|Overall Study|Progression|2|||
105406254|NCT00414076|363495461|FG000|Overall Study|Withdrawal by Subject|1|||
105406255|NCT00414076|363495462|FG001|Overall Study|Withdrawal by Subject|3|||
105406256|NCT00414076|363495461|FG000|Overall Study|Adverse Event|1|||
105406257|NCT00414076|363495462|FG001|Overall Study|Adverse Event|0|||
105406258|NCT00049257|363495463|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
105406259|NCT00049257|363495463|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
105406260|NCT00049257|363495463|FG000|Carboplatin, Paclitaxel|Death|2|||
105406261|NCT00049257|363495463|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
105406262|NCT00132301|363495464|FG000|Overall Study|Death|7|||
105406263|NCT00132301|363495465|FG001|Overall Study|Death|6|||
105406264|NCT00132301|363495464|FG000|Overall Study|Withdrawal by Subject|5|||
105406265|NCT00132301|363495465|FG001|Overall Study|Withdrawal by Subject|2|||
105406266|NCT00132301|363495464|FG000|Overall Study|Physician Decision|1|||
105406267|NCT00132301|363495465|FG001|Overall Study|Physician Decision|1|||
105406268|NCT00132301|363495464|FG000|Overall Study|Lost to Follow-up|5|||
105406269|NCT00132301|363495465|FG001|Overall Study|Lost to Follow-up|3|||
105406270|NCT00132301|363495464|FG000|Overall Study|Other|1|||
105406271|NCT00132301|363495465|FG001|Overall Study|Other|1|||
105406272|NCT00132301|363495464|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
105406273|NCT00132301|363495465|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
105406274|NCT04872569|363495470|FG000|Overall Study|Withdrawal by Subject|2|||
105406275|NCT01890265|363495475|FG000|Overall Study|Other (Unspecified reason)|0|||
105406276|NCT01890265|363495476|FG001|Overall Study|Other (Unspecified reason)|1|||
105406277|NCT01890265|363495477|FG002|Overall Study|Other (Unspecified reason)|0|||
105406278|NCT01890265|363495478|FG003|Overall Study|Other (Unspecified reason)|0|||
105406279|NCT01890265|363495479|FG004|Overall Study|Other (Unspecified reason)|0|||
105406280|NCT01890265|363495480|FG005|Overall Study|Other (Unspecified reason)|0|||
105406281|NCT01890265|363495475|FG000|Overall Study|Progressive disease|6|||
105406282|NCT01890265|363495476|FG001|Overall Study|Progressive disease|6|||
105406283|NCT01890265|363495477|FG002|Overall Study|Progressive disease|0|||
105406284|NCT01890265|363495478|FG003|Overall Study|Progressive disease|0|||
105406285|NCT01890265|363495479|FG004|Overall Study|Progressive disease|0|||
105406286|NCT01890265|363495480|FG005|Overall Study|Progressive disease|0|||
105406287|NCT01890265|363495475|FG000|Overall Study|Adverse Event|2|||
105406288|NCT01890265|363495476|FG001|Overall Study|Adverse Event|1|||
105406289|NCT01890265|363495477|FG002|Overall Study|Adverse Event|0|||
105406290|NCT01890265|363495478|FG003|Overall Study|Adverse Event|0|||
105406291|NCT01890265|363495479|FG004|Overall Study|Adverse Event|0|||
105406292|NCT01890265|363495480|FG005|Overall Study|Adverse Event|0|||
105406293|NCT01890265|363495475|FG000|Overall Study|Death|2|||
105406294|NCT01890265|363495476|FG001|Overall Study|Death|3|||
105406295|NCT01890265|363495477|FG002|Overall Study|Death|1|||
105406296|NCT01890265|363495478|FG003|Overall Study|Death|0|||
105406297|NCT01890265|363495479|FG004|Overall Study|Death|0|||
105406298|NCT01890265|363495480|FG005|Overall Study|Death|0|||
105406299|NCT01890265|363495475|FG000|Overall Study|Withdrawal by Subject|0|||
105406300|NCT01890265|363495476|FG001|Overall Study|Withdrawal by Subject|2|||
105406301|NCT01890265|363495477|FG002|Overall Study|Withdrawal by Subject|3|||
105406302|NCT01890265|363495478|FG003|Overall Study|Withdrawal by Subject|0|||
105406303|NCT01890265|363495479|FG004|Overall Study|Withdrawal by Subject|2|||
105406304|NCT01890265|363495480|FG005|Overall Study|Withdrawal by Subject|0|||
105406305|NCT01445613|363495481|FG000|30-day Follow-up|Withdrawal by Subject|6|||
105406306|NCT01445613|363495481|FG000|30-day Follow-up|Physician Decision|3|||
105406307|NCT01445613|363495481|FG000|30-day Follow-up|Missed visit|23|||
105406308|NCT01445613|363495481|FG000|30-day Follow-up|Death|3|||
105406309|NCT01445613|363495481|FG000|1-year Follow-up|Withdrawal by Subject|12|||
105406310|NCT01445613|363495481|FG000|1-year Follow-up|Missed visit|29|||
105406311|NCT01445613|363495481|FG000|1-year Follow-up|Lost to Follow-up|2|||
105406312|NCT01445613|363495481|FG000|1-year Follow-up|Death|30|||
105406313|NCT01445613|363495481|FG000|1-year Follow-up|Physician Decision|2|||
105406314|NCT01445613|363495481|FG000|1-year Follow-up|Received a non-study stent|2|||
105406315|NCT01402869|363495490|FG000|Overall Study|Required Tooth Extraction|0|||
105494728|NCT02507973|363824868|FG000|Overall Study|Adverse Event|1|||
105494729|NCT01565642|363824869|FG000|Overall Study|Withdrawal by Subject|2|||
105494730|NCT01565642|363824870|FG001|Overall Study|Withdrawal by Subject|1|||
105494731|NCT02955797|363824871|FG000|Overall Study|Protocol Violation|1|||
105494732|NCT02955797|363824872|FG001|Overall Study|Protocol Violation|0|||
105494733|NCT02955797|363824873|FG002|Overall Study|Protocol Violation|0|||
105494734|NCT02955797|363824874|FG003|Overall Study|Protocol Violation|1|||
105494735|NCT02955797|363824871|FG000|Overall Study|Withdrawal by Subject|2|||
105494736|NCT02955797|363824872|FG001|Overall Study|Withdrawal by Subject|2|||
105494737|NCT02955797|363824873|FG002|Overall Study|Withdrawal by Subject|0|||
105494738|NCT02955797|363824874|FG003|Overall Study|Withdrawal by Subject|1|||
105494739|NCT02955797|363824871|FG000|Overall Study|Lost to Follow-up|0|||
105494740|NCT02955797|363824872|FG001|Overall Study|Lost to Follow-up|1|||
105494741|NCT02955797|363824873|FG002|Overall Study|Lost to Follow-up|0|||
105494742|NCT02955797|363824874|FG003|Overall Study|Lost to Follow-up|0|||
105494743|NCT04043728|363824875|FG000|Overall Study|Lost to Follow-up|1|||
105494744|NCT04043728|363824876|FG001|Overall Study|Lost to Follow-up|2|||
105580904|NCT01474512|364126472|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
105580905|NCT01474512|364126473|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
105580906|NCT01474512|364126474|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
105406316|NCT01402869|363495491|FG001|Overall Study|Required Tooth Extraction|0|||
105406317|NCT01402869|363495492|FG002|Overall Study|Required Tooth Extraction|1|||
105406318|NCT01740687|363495496|FG000|Overall Study|Lost to Follow-up|11|||
105406319|NCT01740687|363495496|FG000|Overall Study|Withdrawal by Subject|2|||
105406320|NCT01740687|363495496|FG000|Overall Study|other reason|22|||
105406321|NCT01740687|363495496|FG000|Overall Study|treatment not received|2|||
105406322|NCT00100802|363495497|FG000|Overall Study|Adverse Event|9|||
105406323|NCT00100802|363495497|FG000|Overall Study|Death|1|||
105406324|NCT00100802|363495497|FG000|Overall Study|Lack of Efficacy|47|||
105406325|NCT00100802|363495497|FG000|Overall Study|Physician Decision|5|||
105406326|NCT00100802|363495497|FG000|Overall Study|Protocol Violation|1|||
105406327|NCT00100802|363495497|FG000|Overall Study|Withdrawal by Subject|5|||
105406328|NCT00100802|363495497|FG000|Overall Study|Ineligible|12|||
105406329|NCT02712996|363495498|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
105406330|NCT02712996|363495499|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
105406331|NCT00810277|363496963|FG000|Overall Study|Adverse Event|1|||
105406332|NCT00678288|363496970|FG000|Overall Study|Adverse Event|0|||
105406333|NCT00678288|363496971|FG001|Overall Study|Adverse Event|2|||
105406334|NCT00678288|363496970|FG000|Overall Study|Withdrawal by Subject|1|||
105406335|NCT00678288|363496971|FG001|Overall Study|Withdrawal by Subject|1|||
105406336|NCT00678288|363496970|FG000|Overall Study|Study terminated by the sponsor|2|||
105406337|NCT00678288|363496971|FG001|Overall Study|Study terminated by the sponsor|0|||
105406338|NCT00678288|363496970|FG000|Overall Study|Not compliant with study medication|0|||
105406339|NCT00678288|363496971|FG001|Overall Study|Not compliant with study medication|1|||
105406340|NCT00678288|363496970|FG000|Overall Study|Switch to commercial drug|0|||
105406341|NCT00678288|363496971|FG001|Overall Study|Switch to commercial drug|1|||
105406342|NCT00678288|363496970|FG000|Overall Study|Reason not reported|1|||
105406343|NCT00678288|363496971|FG001|Overall Study|Reason not reported|0|||
105406344|NCT00678288|363496970|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
105406345|NCT00678288|363496971|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
105406346|NCT00784368|363496972|FG000|Overall Study|Physician Decision|0|||
105406347|NCT00784368|363496973|FG001|Overall Study|Physician Decision|0|||
105406348|NCT00784368|363496974|FG002|Overall Study|Physician Decision|6|||
105494745|NCT04043728|363824877|FG002|Overall Study|Lost to Follow-up|0|||
105494746|NCT02436681|363824880|FG000|Overall Study|Lost to Follow-up|10|||
105494747|NCT02436681|363824880|FG000|Overall Study|Withdrawal by Subject|2|||
105494748|NCT02436681|363824880|FG000|Overall Study|Death|2|||
105494749|NCT01163266|363824881|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
105580907|NCT01474512|364126475|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
105406349|NCT00784368|363496972|FG000|Overall Study|Lack of Efficacy|2|||
105406350|NCT00784368|363496973|FG001|Overall Study|Lack of Efficacy|0|||
105406351|NCT00784368|363496974|FG002|Overall Study|Lack of Efficacy|1|||
105406352|NCT00784368|363496972|FG000|Overall Study|Adverse Event|6|||
105406353|NCT00784368|363496973|FG001|Overall Study|Adverse Event|9|||
105406354|NCT00784368|363496974|FG002|Overall Study|Adverse Event|2|||
105406355|NCT00784368|363496972|FG000|Overall Study|Diagnosis of fever|0|||
105406356|NCT00784368|363496973|FG001|Overall Study|Diagnosis of fever|0|||
105406357|NCT00784368|363496974|FG002|Overall Study|Diagnosis of fever|1|||
105406358|NCT00784368|363496972|FG000|Overall Study|Worsening of complications|0|||
105406359|NCT00784368|363496973|FG001|Overall Study|Worsening of complications|0|||
105406360|NCT00784368|363496974|FG002|Overall Study|Worsening of complications|1|||
105406361|NCT00784368|363496972|FG000|Overall Study|Worsening of symptoms|0|||
105406362|NCT00784368|363496973|FG001|Overall Study|Worsening of symptoms|1|||
105406363|NCT00784368|363496974|FG002|Overall Study|Worsening of symptoms|0|||
105406364|NCT00784368|363496972|FG000|Overall Study|Withdrawal of informed consent|0|||
105406365|NCT00784368|363496973|FG001|Overall Study|Withdrawal of informed consent|1|||
105406366|NCT00784368|363496974|FG002|Overall Study|Withdrawal of informed consent|0|||
105406367|NCT02079909|363496975|FG000|Overall Study|Adverse Event|23|||
105406368|NCT02079909|363496976|FG001|Overall Study|Adverse Event|23|||
105406369|NCT02079909|363496977|FG002|Overall Study|Adverse Event|7|||
105406370|NCT02079909|363496975|FG000|Overall Study|Withdrawal by Subject|9|||
105406371|NCT02079909|363496976|FG001|Overall Study|Withdrawal by Subject|17|||
105406372|NCT02079909|363496977|FG002|Overall Study|Withdrawal by Subject|4|||
105406373|NCT02079909|363496975|FG000|Overall Study|Lost to Follow-up|2|||
105406374|NCT02079909|363496976|FG001|Overall Study|Lost to Follow-up|3|||
105406375|NCT02079909|363496977|FG002|Overall Study|Lost to Follow-up|1|||
105406376|NCT02079909|363496975|FG000|Overall Study|Death|2|||
105406377|NCT02079909|363496976|FG001|Overall Study|Death|2|||
105406378|NCT02079909|363496977|FG002|Overall Study|Death|0|||
105406379|NCT02079909|363496975|FG000|Overall Study|Lack of Efficacy|0|||
105406380|NCT02079909|363496976|FG001|Overall Study|Lack of Efficacy|0|||
105406381|NCT02079909|363496977|FG002|Overall Study|Lack of Efficacy|1|||
105406382|NCT02079909|363496975|FG000|Overall Study|Protocol Violation|0|||
105406383|NCT02079909|363496976|FG001|Overall Study|Protocol Violation|1|||
105406384|NCT02079909|363496977|FG002|Overall Study|Protocol Violation|1|||
105406385|NCT02079909|363496975|FG000|Overall Study|Physician Decision|0|||
105406386|NCT02079909|363496976|FG001|Overall Study|Physician Decision|1|||
105406387|NCT02079909|363496977|FG002|Overall Study|Physician Decision|1|||
105406388|NCT02079909|363496975|FG000|Overall Study|Relocation etc.|2|||
105406389|NCT02079909|363496976|FG001|Overall Study|Relocation etc.|2|||
105406390|NCT02079909|363496977|FG002|Overall Study|Relocation etc.|3|||
105406391|NCT00720356|363496980|FG000|Registration to Study|Determined to have methylated MGMT|67|||
105406392|NCT00720356|363496980|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
105406393|NCT00720356|363496980|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
105406394|NCT00720356|363496980|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
105406395|NCT00720356|363496980|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
105406396|NCT00720356|363496980|FG000|Follow up Until Death|Withdrawal by Subject|1|||
105406397|NCT00720356|363496980|FG000|Follow up Until Death|Alive at last data collection|4|||
105406398|NCT02237001|363496981|FG000|Overall Study|Lost to Follow-up|2|||
105406399|NCT02237001|363496981|FG000|Overall Study|Withdrawal by Subject|1|||
105406400|NCT02237001|363496981|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
105406401|NCT02237001|363496981|FG000|Overall Study|Re-operation|4|||
105406402|NCT02237001|363496981|FG000|Overall Study|Incarceration|1|||
105406403|NCT00342628|363496985|FG000|Overall Study|Withdrawal by Subject|19|||
105406404|NCT00342628|363496986|FG001|Overall Study|Withdrawal by Subject|19|||
105406405|NCT00342628|363496987|FG002|Overall Study|Withdrawal by Subject|18|||
105406406|NCT00342628|363496985|FG000|Overall Study|Death|1|||
105406407|NCT00342628|363496986|FG001|Overall Study|Death|1|||
105406408|NCT00342628|363496987|FG002|Overall Study|Death|0|||
105406409|NCT00342628|363496985|FG000|Overall Study|moved residence|0|||
105406410|NCT00342628|363496986|FG001|Overall Study|moved residence|1|||
105406411|NCT00342628|363496987|FG002|Overall Study|moved residence|1|||
105406412|NCT03427814|363496988|FG000|Overall Study|Withdrawal by Subject|4|||
105406413|NCT03427814|363496989|FG001|Overall Study|Withdrawal by Subject|4|||
105406414|NCT03427814|363496988|FG000|Overall Study|Lost to Follow-up|0|||
105406415|NCT03427814|363496989|FG001|Overall Study|Lost to Follow-up|2|||
105406416|NCT03427814|363496988|FG000|Overall Study|Death|42|||
105406417|NCT03427814|363496989|FG001|Overall Study|Death|31|||
105406418|NCT03427814|363496988|FG000|Overall Study|Sponsor's Decision|1|||
105494750|NCT01163266|363824882|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
105494751|NCT01163266|363824883|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
105406419|NCT03427814|363496989|FG001|Overall Study|Sponsor's Decision|0|||
105406420|NCT03427814|363496988|FG000|Overall Study|Investigator's Decision|1|||
105406421|NCT03427814|363496989|FG001|Overall Study|Investigator's Decision|2|||
105406422|NCT03427814|363496988|FG000|Overall Study|Disease progression|1|||
105406423|NCT03427814|363496989|FG001|Overall Study|Disease progression|0|||
105406424|NCT03427814|363496988|FG000|Overall Study|Treatment Completed|0|||
105406425|NCT03427814|363496989|FG001|Overall Study|Treatment Completed|1|||
105406426|NCT03427814|363496988|FG000|Overall Study|Sponsor's Decision to End study|21|||
105406427|NCT03427814|363496989|FG001|Overall Study|Sponsor's Decision to End study|25|||
105406428|NCT03427814|363496988|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
105406429|NCT03427814|363496989|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
105406430|NCT01693250|363496990|FG000|Overall Study|Lost to Follow-up|2|||
105406431|NCT01693250|363496991|FG001|Overall Study|Lost to Follow-up|2|||
105406432|NCT01396187|363496994|FG000|Overall Study|Adverse Event|0|||
105406433|NCT01396187|363496995|FG001|Overall Study|Adverse Event|1|||
105406434|NCT01396187|363496996|FG002|Overall Study|Adverse Event|0|||
105406435|NCT01396187|363496997|FG003|Overall Study|Adverse Event|0|||
105406436|NCT01396187|363496998|FG004|Overall Study|Adverse Event|0|||
105406437|NCT01396187|363496994|FG000|Overall Study|Withdrawal by Subject|0|||
105406438|NCT01396187|363496995|FG001|Overall Study|Withdrawal by Subject|1|||
105406439|NCT01396187|363496996|FG002|Overall Study|Withdrawal by Subject|1|||
105406440|NCT01396187|363496997|FG003|Overall Study|Withdrawal by Subject|0|||
105406441|NCT01396187|363496998|FG004|Overall Study|Withdrawal by Subject|0|||
105406442|NCT01396187|363496994|FG000|Overall Study|Other|1|||
105406443|NCT01396187|363496995|FG001|Overall Study|Other|1|||
105406444|NCT01396187|363496996|FG002|Overall Study|Other|0|||
105406445|NCT01396187|363496997|FG003|Overall Study|Other|0|||
105406446|NCT01396187|363496998|FG004|Overall Study|Other|1|||
105406447|NCT00756275|363496999|FG000|Overall Study|Lost to Follow-up|25|||
105406448|NCT00756275|363497000|FG001|Overall Study|Lost to Follow-up|21|||
105406449|NCT00756275|363496999|FG000|Overall Study|Withdrawal by Subject|4|||
105406450|NCT00756275|363497000|FG001|Overall Study|Withdrawal by Subject|7|||
105406451|NCT00551031|363497001|FG000|Overall Study|Adverse Event|0|||
105406452|NCT00551031|363497002|FG001|Overall Study|Adverse Event|1|||
105406453|NCT00551031|363497003|FG002|Overall Study|Adverse Event|0|||
105406454|NCT00551031|363497004|FG003|Overall Study|Adverse Event|0|||
105406455|NCT00551031|363497005|FG004|Overall Study|Adverse Event|0|||
105406456|NCT00551031|363497001|FG000|Overall Study|Protocol Violation|1|||
105406457|NCT00551031|363497002|FG001|Overall Study|Protocol Violation|1|||
105406458|NCT00551031|363497003|FG002|Overall Study|Protocol Violation|0|||
105406459|NCT00551031|363497004|FG003|Overall Study|Protocol Violation|0|||
105406460|NCT00551031|363497005|FG004|Overall Study|Protocol Violation|0|||
105406461|NCT00551031|363497001|FG000|Overall Study|Lost to Follow-up|0|||
105406462|NCT00551031|363497002|FG001|Overall Study|Lost to Follow-up|1|||
105406463|NCT00551031|363497003|FG002|Overall Study|Lost to Follow-up|0|||
105406464|NCT00551031|363497004|FG003|Overall Study|Lost to Follow-up|1|||
105406465|NCT00551031|363497005|FG004|Overall Study|Lost to Follow-up|1|||
105406466|NCT00551031|363497001|FG000|Overall Study|Withdrawal by Subject|0|||
105406467|NCT00551031|363497002|FG001|Overall Study|Withdrawal by Subject|4|||
105406468|NCT00551031|363497003|FG002|Overall Study|Withdrawal by Subject|1|||
105406469|NCT00551031|363497004|FG003|Overall Study|Withdrawal by Subject|2|||
105406470|NCT00551031|363497005|FG004|Overall Study|Withdrawal by Subject|0|||
105406471|NCT00551031|363497001|FG000|Overall Study|Serious Adverse Event|0|||
105406472|NCT00551031|363497002|FG001|Overall Study|Serious Adverse Event|2|||
105406473|NCT00551031|363497003|FG002|Overall Study|Serious Adverse Event|1|||
105406474|NCT00551031|363497004|FG003|Overall Study|Serious Adverse Event|0|||
105406475|NCT00551031|363497005|FG004|Overall Study|Serious Adverse Event|0|||
105406476|NCT00551031|363497001|FG000|Overall Study|Did not receive vaccine|1|||
105406477|NCT00551031|363497002|FG001|Overall Study|Did not receive vaccine|2|||
105406478|NCT00551031|363497003|FG002|Overall Study|Did not receive vaccine|0|||
105406479|NCT00551031|363497004|FG003|Overall Study|Did not receive vaccine|0|||
105406480|NCT00551031|363497005|FG004|Overall Study|Did not receive vaccine|0|||
105406481|NCT00682929|363497009|FG000|Overall Study|Adverse Event|4|||
105406482|NCT00682929|363497010|FG001|Overall Study|Adverse Event|1|||
105406483|NCT00682929|363497011|FG002|Overall Study|Adverse Event|1|||
105406484|NCT00682929|363497009|FG000|Overall Study|Withdrawal by Subject|1|||
105406485|NCT00682929|363497010|FG001|Overall Study|Withdrawal by Subject|2|||
105406486|NCT00682929|363497011|FG002|Overall Study|Withdrawal by Subject|1|||
105406487|NCT00682929|363497009|FG000|Overall Study|dosing compliance < 80%|0|||
105406488|NCT00682929|363497010|FG001|Overall Study|dosing compliance < 80%|2|||
105406489|NCT00682929|363497011|FG002|Overall Study|dosing compliance < 80%|0|||
105406490|NCT00682929|363497009|FG000|Overall Study|lag in DEA renewal|1|||
105406491|NCT00682929|363497010|FG001|Overall Study|lag in DEA renewal|0|||
105406492|NCT00682929|363497011|FG002|Overall Study|lag in DEA renewal|0|||
105406493|NCT01048242|363497014|FG000|Overall Study|See study flow chart|4|||
105406494|NCT01048242|363497015|FG001|Overall Study|See study flow chart|2|||
105406495|NCT04072835|363497016|FG000|Overall Study|Overall trial ended|603|||
105406496|NCT04072835|363497016|FG000|Overall Study|Ablation|97|||
105406497|NCT04072835|363497016|FG000|Overall Study|Withdrawal of consent|66|||
105406498|NCT04072835|363497016|FG000|Overall Study|Physician Decision|50|||
105406499|NCT04072835|363497016|FG000|Overall Study|Lost to Follow-up|39|||
105406500|NCT04072835|363497016|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
105406501|NCT04072835|363497016|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
105406502|NCT04072835|363497016|FG000|Overall Study|Adverse Event|25|||
105406503|NCT04072835|363497016|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
105406504|NCT04072835|363497016|FG000|Overall Study|Death|11|||
105406505|NCT04072835|363497016|FG000|Overall Study|Participant felt the drug did not work|8|||
105406506|NCT04072835|363497016|FG000|Overall Study|Participant tolerability|5|||
105406507|NCT04072835|363497016|FG000|Overall Study|Missing|5|||
105406508|NCT04072835|363497016|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
105406509|NCT04072835|363497016|FG000|Overall Study|Pregnancy|3|||
105406510|NCT01336712|363497017|FG000|Overall Study|Death|2|||
105406511|NCT01336712|363497017|FG000|Overall Study|Lack of Efficacy|1|||
105406512|NCT00078806|363497020|FG000|Part 1A|Adverse Event|2|||
105406513|NCT00078806|363497021|FG001|Part 1A|Adverse Event|0|||
105406514|NCT00078806|363497022|FG002|Part 1A|Adverse Event|0|||
105406515|NCT00078806|363497023|FG003|Part 1A|Adverse Event|0|||
105406516|NCT00078806|363497020|FG000|Part 1A|Lack of Efficacy|7|||
105406517|NCT00078806|363497021|FG001|Part 1A|Lack of Efficacy|0|||
105406518|NCT00078806|363497022|FG002|Part 1A|Lack of Efficacy|0|||
105406519|NCT00078806|363497023|FG003|Part 1A|Lack of Efficacy|0|||
105406520|NCT00078806|363497020|FG000|Part 1A|Other|1|||
105406521|NCT00078806|363497021|FG001|Part 1A|Other|0|||
105406522|NCT00078806|363497022|FG002|Part 1A|Other|0|||
105406523|NCT00078806|363497023|FG003|Part 1A|Other|0|||
105406524|NCT00078806|363497020|FG000|Part 1B|Adverse Event|1|||
105406525|NCT00078806|363497021|FG001|Part 1B|Adverse Event|0|||
105406526|NCT00078806|363497022|FG002|Part 1B|Adverse Event|0|||
105406527|NCT00078806|363497023|FG003|Part 1B|Adverse Event|0|||
105406528|NCT00078806|363497020|FG000|Part 1B|Lack of Efficacy|7|||
105406529|NCT00078806|363497021|FG001|Part 1B|Lack of Efficacy|0|||
105406530|NCT00078806|363497022|FG002|Part 1B|Lack of Efficacy|0|||
105406531|NCT00078806|363497023|FG003|Part 1B|Lack of Efficacy|0|||
105406532|NCT00078806|363497020|FG000|Part 2|Adverse Event|0|||
105406533|NCT00078806|363497021|FG001|Part 2|Adverse Event|1|||
105406534|NCT00078806|363497022|FG002|Part 2|Adverse Event|0|||
105406535|NCT00078806|363497023|FG003|Part 2|Adverse Event|0|||
105406536|NCT01273038|363497024|FG000|Second Intervention (14 Days)|Adverse Event|0|||
105406537|NCT01273038|363497025|FG001|Second Intervention (14 Days)|Adverse Event|1|||
105406538|NCT01273038|363497024|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
105406539|NCT01273038|363497025|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
105406540|NCT01465386|363497026|FG000|Overall Study|Lack of Efficacy|3|||
105406541|NCT01465386|363497026|FG000|Overall Study|Adverse Event|1|||
105406542|NCT00570323|363497028|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
105406543|NCT00570323|363497029|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
105406544|NCT00570323|363497028|FG000|Started Treatment After Randomization|Protocol Violation|1|||
105406545|NCT00570323|363497029|FG001|Started Treatment After Randomization|Protocol Violation|0|||
105406546|NCT00570323|363497028|FG000|Started Treatment After Randomization|Physician Decision|1|||
105406547|NCT00570323|363497029|FG001|Started Treatment After Randomization|Physician Decision|0|||
105406548|NCT00570323|363497028|FG000|Complete Study After Start|Lost to Follow-up|0|||
105406549|NCT00570323|363497029|FG001|Complete Study After Start|Lost to Follow-up|1|||
105406550|NCT00570323|363497028|FG000|Complete Study After Start|Withdrawal by Subject|2|||
105406551|NCT00570323|363497029|FG001|Complete Study After Start|Withdrawal by Subject|0|||
105406552|NCT00570323|363497028|FG000|Complete Study After Start|Physician Decision|1|||
105406553|NCT00570323|363497029|FG001|Complete Study After Start|Physician Decision|0|||
105406554|NCT01891396|363497030|FG000|Overall Study|Withdrawal by Subject|4|||
105406555|NCT01891396|363497031|FG001|Overall Study|Withdrawal by Subject|4|||
105406556|NCT01891396|363497032|FG002|Overall Study|Withdrawal by Subject|3|||
105406557|NCT01891396|363497030|FG000|Overall Study|Lost to Follow-up|0|||
105406558|NCT01891396|363497031|FG001|Overall Study|Lost to Follow-up|1|||
105406559|NCT01891396|363497032|FG002|Overall Study|Lost to Follow-up|0|||
105406560|NCT00540592|363497033|FG000|Overall Study|Adverse Event|0|||
105406561|NCT00540592|363497034|FG001|Overall Study|Adverse Event|1|||
105406562|NCT00540592|363497035|FG002|Overall Study|Adverse Event|0|||
105406563|NCT00540592|363497036|FG003|Overall Study|Adverse Event|0|||
105406564|NCT00540592|363497037|FG004|Overall Study|Adverse Event|1|||
105406565|NCT00540592|363497038|FG005|Overall Study|Adverse Event|0|||
105406566|NCT00540592|363497039|FG006|Overall Study|Adverse Event|0|||
105406567|NCT00540592|363497040|FG007|Overall Study|Adverse Event|1|||
105406568|NCT00540592|363497041|FG008|Overall Study|Adverse Event|1|||
105406569|NCT00540592|363497042|FG009|Overall Study|Adverse Event|2|||
105406570|NCT00540592|363497033|FG000|Overall Study|Lost to Follow-up|2|||
105406571|NCT00540592|363497034|FG001|Overall Study|Lost to Follow-up|0|||
105406572|NCT00540592|363497035|FG002|Overall Study|Lost to Follow-up|0|||
105406573|NCT00540592|363497036|FG003|Overall Study|Lost to Follow-up|0|||
105406574|NCT00540592|363497037|FG004|Overall Study|Lost to Follow-up|0|||
105406575|NCT00540592|363497038|FG005|Overall Study|Lost to Follow-up|0|||
105406576|NCT00540592|363497039|FG006|Overall Study|Lost to Follow-up|0|||
105406577|NCT00540592|363497040|FG007|Overall Study|Lost to Follow-up|0|||
105406578|NCT00540592|363497041|FG008|Overall Study|Lost to Follow-up|0|||
105406579|NCT00540592|363497042|FG009|Overall Study|Lost to Follow-up|0|||
105406580|NCT00540592|363497033|FG000|Overall Study|Withdrawal by Subject|0|||
105406581|NCT00540592|363497034|FG001|Overall Study|Withdrawal by Subject|0|||
105406582|NCT00540592|363497035|FG002|Overall Study|Withdrawal by Subject|1|||
105406583|NCT00540592|363497036|FG003|Overall Study|Withdrawal by Subject|1|||
105406584|NCT00540592|363497037|FG004|Overall Study|Withdrawal by Subject|0|||
105406585|NCT00540592|363497038|FG005|Overall Study|Withdrawal by Subject|0|||
105406586|NCT00540592|363497039|FG006|Overall Study|Withdrawal by Subject|0|||
105406587|NCT00540592|363497040|FG007|Overall Study|Withdrawal by Subject|0|||
105406588|NCT00540592|363497041|FG008|Overall Study|Withdrawal by Subject|0|||
105406589|NCT00540592|363497042|FG009|Overall Study|Withdrawal by Subject|0|||
105406590|NCT01456130|363497043|FG000|Overall Study|Adverse Event|4|||
105406591|NCT01456130|363497043|FG000|Overall Study|Voluntary Withdrawal|1|||
105406592|NCT01456130|363497043|FG000|Overall Study|Lack of Efficacy|4|||
105406593|NCT01456130|363497043|FG000|Overall Study|Other|1|||
105406594|NCT03369665|363497044|FG000|Overall Study|Adverse Event|3|||
105406595|NCT03369665|363497044|FG000|Overall Study|Lost to Follow-up|7|||
105406596|NCT03369665|363497044|FG000|Overall Study|Withdrawal by Subject|15|||
105406597|NCT03369665|363497044|FG000|Overall Study|Progression Disease|2|||
105406598|NCT03369665|363497044|FG000|Overall Study|Not classified|3|||
105406599|NCT00131352|363497045|FG000|Initial Treatment Period|Adverse Event|1|||
105406600|NCT00131352|363497046|FG001|Initial Treatment Period|Adverse Event|3|||
105406601|NCT00131352|363497045|FG000|Initial Treatment Period|Non-compliant|1|||
105406602|NCT00131352|363497046|FG001|Initial Treatment Period|Non-compliant|2|||
105406603|NCT00131352|363497045|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
105406604|NCT00131352|363497046|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
105406605|NCT00131352|363497045|FG000|Initial Treatment Period|Lack of Efficacy|6|||
105406606|NCT00131352|363497046|FG001|Initial Treatment Period|Lack of Efficacy|4|||
105406607|NCT00131352|363497045|FG000|Initial Treatment Period|Other|0|||
105406608|NCT00131352|363497046|FG001|Initial Treatment Period|Other|2|||
105406609|NCT00131352|363497045|FG000|Repeat Treatment Period|Adverse Event|1|||
105406610|NCT00131352|363497046|FG001|Repeat Treatment Period|Adverse Event|0|||
105406611|NCT00131352|363497045|FG000|Repeat Treatment Period|Other|1|||
105406612|NCT00131352|363497046|FG001|Repeat Treatment Period|Other|0|||
105406613|NCT01664247|363497047|FG000|Overall Study|Adverse Event|5|||
105406614|NCT01664247|363497048|FG001|Overall Study|Adverse Event|3|||
105406615|NCT01664247|363497047|FG000|Overall Study|Protocol Violation|3|||
105406616|NCT01664247|363497048|FG001|Overall Study|Protocol Violation|5|||
105406617|NCT01664247|363497047|FG000|Overall Study|Withdrawal Criteria|1|||
105406618|NCT01664247|363497048|FG001|Overall Study|Withdrawal Criteria|4|||
105406619|NCT01664247|363497047|FG000|Overall Study|Unclassified|5|||
105406620|NCT01664247|363497048|FG001|Overall Study|Unclassified|29|||
105406621|NCT03230318|363497052|FG000|Overall Study|Radiographic disease progression|72|||
105406622|NCT03230318|363497053|FG001|Overall Study|Radiographic disease progression|19|||
105406623|NCT03230318|363497052|FG000|Overall Study|Clinical progression|17|||
105406624|NCT03230318|363497053|FG001|Overall Study|Clinical progression|7|||
105406625|NCT03230318|363497052|FG000|Overall Study|Adverse Event|5|||
105406626|NCT03230318|363497053|FG001|Overall Study|Adverse Event|3|||
105406627|NCT03230318|363497052|FG000|Overall Study|Physician Decision|2|||
105406628|NCT03230318|363497053|FG001|Overall Study|Physician Decision|3|||
105406629|NCT03230318|363497052|FG000|Overall Study|Death|3|||
105406630|NCT03230318|363497053|FG001|Overall Study|Death|2|||
105406631|NCT03230318|363497052|FG000|Overall Study|Lost to Follow-up|1|||
105406632|NCT03230318|363497053|FG001|Overall Study|Lost to Follow-up|0|||
105406633|NCT03230318|363497052|FG000|Overall Study|Withdrawal by Subject|1|||
105406634|NCT03230318|363497053|FG001|Overall Study|Withdrawal by Subject|3|||
105406635|NCT03230318|363497052|FG000|Overall Study|Other|3|||
105406636|NCT03230318|363497053|FG001|Overall Study|Other|7|||
105406637|NCT03782064|363497058|FG000|Overall Study|Lack of Efficacy|2|||
105406638|NCT03782064|363497058|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
105406639|NCT01541865|363497059|FG000|Overall Study|Lost to Follow-up|11|||
105406640|NCT01541865|363497059|FG000|Overall Study|Withdrawal by Subject|9|||
105406641|NCT01541865|363497059|FG000|Overall Study|Adverse Event|1|||
105406642|NCT01541865|363497059|FG000|Overall Study|Protocol Violation|1|||
105406643|NCT03810014|363497060|FG000|Overall Study|Pregnancy|2|||
105406644|NCT03810014|363497061|FG001|Overall Study|Pregnancy|2|||
105406645|NCT03810014|363497062|FG002|Overall Study|Pregnancy|0|||
105406646|NCT03810014|363497063|FG003|Overall Study|Pregnancy|2|||
105406647|NCT00003631|363497066|FG000|Overall Study|Patient not treated|1|||
105406648|NCT00003631|363497067|FG001|Overall Study|Patient not treated|0|||
105406649|NCT00003631|363497068|FG002|Overall Study|Patient not treated|1|||
105406650|NCT00003631|363497066|FG000|Overall Study|Protocol Violation|1|||
105406651|NCT00003631|363497067|FG001|Overall Study|Protocol Violation|0|||
105406652|NCT00003631|363497068|FG002|Overall Study|Protocol Violation|0|||
105406653|NCT00003631|363497066|FG000|Overall Study|Adverse Event|1|||
105406654|NCT00003631|363497067|FG001|Overall Study|Adverse Event|1|||
105406655|NCT00003631|363497068|FG002|Overall Study|Adverse Event|5|||
105406656|NCT00003631|363497066|FG000|Overall Study|Death|0|||
105406657|NCT00003631|363497067|FG001|Overall Study|Death|0|||
105406658|NCT00003631|363497068|FG002|Overall Study|Death|1|||
105406659|NCT00003631|363497066|FG000|Overall Study|Evaluable for toxicity only|0|||
105406660|NCT00003631|363497067|FG001|Overall Study|Evaluable for toxicity only|0|||
105406661|NCT00003631|363497068|FG002|Overall Study|Evaluable for toxicity only|2|||
105406662|NCT00049322|363497069|FG000|Overall Study|disease burden|0|||
105406663|NCT00049322|363497070|FG001|Overall Study|disease burden|3|||
105406664|NCT00049322|363497069|FG000|Overall Study|Adverse Event|1|||
105406665|NCT00049322|363497070|FG001|Overall Study|Adverse Event|0|||
105406666|NCT00049322|363497069|FG000|Overall Study|refused angio|0|||
105406667|NCT00049322|363497070|FG001|Overall Study|refused angio|3|||
105406668|NCT04571060|363497076|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
105406669|NCT04571060|363497077|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
105406670|NCT04571060|363497076|FG000|Overall Study|Never treated migraine|47|||
105406671|NCT04571060|363497077|FG001|Overall Study|Never treated migraine|36|||
105406672|NCT04571060|363497076|FG000|Overall Study|Protocol Violation|4|||
105406673|NCT04571060|363497077|FG001|Overall Study|Protocol Violation|2|||
105406674|NCT04571060|363497076|FG000|Overall Study|Withdrawal by Subject|6|||
105406675|NCT04571060|363497077|FG001|Overall Study|Withdrawal by Subject|2|||
105406676|NCT04571060|363497076|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
105406677|NCT04571060|363497077|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
105406678|NCT02625220|363497078|FG000|Overall Study|Adverse Event|2|||
105406679|NCT02625220|363497078|FG000|Overall Study|Lost to Follow-up|2|||
105406680|NCT02625220|363497078|FG000|Overall Study|Protocol Violation|1|||
105406681|NCT02625220|363497078|FG000|Overall Study|Study discontinued at site|2|||
105406682|NCT02375373|363497081|FG000|Overall Study|Withdrawal by Subject|11|||
105406683|NCT01603043|363497082|FG000|Overall Study|Study Futility|7|||
105406684|NCT01603043|363497083|FG001|Overall Study|Study Futility|3|||
105406685|NCT01392573|363497084|FG000|Overall Study|Adverse Event|1|||
105406686|NCT01392573|363497085|FG001|Overall Study|Adverse Event|3|||
105406687|NCT01392573|363497084|FG000|Overall Study|Lack of Efficacy|1|||
105406688|NCT01392573|363497085|FG001|Overall Study|Lack of Efficacy|2|||
105406689|NCT01392573|363497084|FG000|Overall Study|Protocol Violation|0|||
105406690|NCT01392573|363497085|FG001|Overall Study|Protocol Violation|2|||
105406691|NCT01392573|363497084|FG000|Overall Study|Withdrawal Criteria|13|||
105406692|NCT01392573|363497085|FG001|Overall Study|Withdrawal Criteria|15|||
105406693|NCT01392573|363497084|FG000|Overall Study|Site closure|8|||
105406694|NCT01392573|363497085|FG001|Overall Study|Site closure|7|||
105406695|NCT01392573|363497084|FG000|Overall Study|Unclassified|9|||
105406696|NCT01392573|363497085|FG001|Overall Study|Unclassified|6|||
105406697|NCT00436436|363497086|FG000|Overall Study|Progression|4|||
105406698|NCT00436436|363497086|FG000|Overall Study|Adverse Event|2|||
105406699|NCT00436436|363497086|FG000|Overall Study|Death|6|||
105406700|NCT03941483|363497088|FG000|Overall Study|Miscellaneous|2|||
105406701|NCT03941483|363497089|FG001|Overall Study|Miscellaneous|3|||
105406702|NCT03941483|363497090|FG002|Overall Study|Miscellaneous|0|||
105406703|NCT03941483|363497088|FG000|Overall Study|Study Terminated by Sponsor|1|||
105406704|NCT03941483|363497089|FG001|Overall Study|Study Terminated by Sponsor|0|||
105406705|NCT03941483|363497090|FG002|Overall Study|Study Terminated by Sponsor|0|||
105406706|NCT03941483|363497088|FG000|Overall Study|Withdrawal by Subject|1|||
105406707|NCT03941483|363497089|FG001|Overall Study|Withdrawal by Subject|4|||
105406708|NCT03941483|363497090|FG002|Overall Study|Withdrawal by Subject|1|||
105406709|NCT03941483|363497088|FG000|Overall Study|Lost to Follow-up|2|||
105406710|NCT03941483|363497089|FG001|Overall Study|Lost to Follow-up|1|||
105406711|NCT03941483|363497090|FG002|Overall Study|Lost to Follow-up|8|||
105406712|NCT03941483|363497088|FG000|Overall Study|Death|3|||
105406713|NCT03941483|363497089|FG001|Overall Study|Death|2|||
105406714|NCT03941483|363497090|FG002|Overall Study|Death|6|||
105406715|NCT00670930|363497091|FG000|Overall Study|Adminstrative Problem|0|||
105406716|NCT00670930|363497092|FG001|Overall Study|Adminstrative Problem|1|||
105406717|NCT00670930|363497091|FG000|Overall Study|Lost to Follow-up|1|||
105406718|NCT00670930|363497092|FG001|Overall Study|Lost to Follow-up|0|||
105406719|NCT04790279|363498621|FG000|Overall Study|Did not meet medication start criteria|27|||
105406720|NCT04790279|363498622|FG001|Overall Study|Did not meet medication start criteria|15|||
105406721|NCT04790279|363498621|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
105406722|NCT04790279|363498622|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
105406723|NCT04790279|363498621|FG000|Overall Study|Protocol Violation|8|||
105406724|NCT04790279|363498622|FG001|Overall Study|Protocol Violation|3|||
105406725|NCT04790279|363498621|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
105406726|NCT04790279|363498622|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
105406727|NCT02257242|363498623|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
105406728|NCT02257242|363498624|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105406729|NCT02257242|363498625|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105406730|NCT02257242|363498626|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105406731|NCT02257242|363498627|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105406732|NCT02257242|363498628|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105406733|NCT02257242|363498629|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105406734|NCT02257242|363498630|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105406735|NCT02257242|363498631|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105406736|NCT04240886|363498635|FG000|Treatment Phase|Death|4|||
105406737|NCT04240886|363498635|FG000|Treatment Phase|Discontinuation by Subject|1|||
105406738|NCT04240886|363498635|FG000|Treatment Phase|Adverse Event|5|||
105406739|NCT04240886|363498635|FG000|Follow-up Phase|Withdrawal by Subject|1|||
105406740|NCT04240886|363498635|FG000|Follow-up Phase|Discontinuation by Subject|1|||
105406741|NCT04240886|363498635|FG000|Follow-up Phase|Death|2|||
105406742|NCT00399568|363498636|FG000|Overall Study|Adverse Event|1|||
105406743|NCT00399568|363498637|FG001|Overall Study|Adverse Event|2|||
105406744|NCT00399568|363498636|FG000|Overall Study|Withdrawal by Subject|7|||
105406745|NCT00399568|363498637|FG001|Overall Study|Withdrawal by Subject|3|||
105406746|NCT00399568|363498636|FG000|Overall Study|Protocol non-compliance|2|||
105406747|NCT00399568|363498637|FG001|Overall Study|Protocol non-compliance|2|||
105406748|NCT00399568|363498636|FG000|Overall Study|Lost to Follow-up|2|||
105406749|NCT00399568|363498637|FG001|Overall Study|Lost to Follow-up|2|||
105406750|NCT00566982|363498638|FG000|Overall Study|Adverse Event|6|||
105406751|NCT00566982|363498639|FG001|Overall Study|Adverse Event|48|||
105406752|NCT00566982|363498638|FG000|Overall Study|Withdrawal by Subject|1|||
105406753|NCT00566982|363498639|FG001|Overall Study|Withdrawal by Subject|14|||
105406754|NCT00566982|363498638|FG000|Overall Study|Protocol Violation|1|||
105406755|NCT00566982|363498639|FG001|Overall Study|Protocol Violation|4|||
105406756|NCT00566982|363498638|FG000|Overall Study|Lost to Follow-up|0|||
105406757|NCT00566982|363498639|FG001|Overall Study|Lost to Follow-up|1|||
105406758|NCT00566982|363498638|FG000|Overall Study|Other-family problems & doctor's request|0|||
105406759|NCT00566982|363498639|FG001|Overall Study|Other-family problems & doctor's request|2|||
105406760|NCT00841776|363498643|FG000|Overall Study|Lack of Efficacy|0|||
105406761|NCT00841776|363498644|FG001|Overall Study|Lack of Efficacy|1|||
105406762|NCT00841776|363498643|FG000|Overall Study|Lost to Follow-up|2|||
105406763|NCT00841776|363498644|FG001|Overall Study|Lost to Follow-up|1|||
105406764|NCT00841776|363498643|FG000|Overall Study|Withdrawal by Subject|0|||
105406765|NCT00841776|363498644|FG001|Overall Study|Withdrawal by Subject|1|||
105406766|NCT01279044|363498647|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
105406767|NCT01279044|363498648|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
105406768|NCT01279044|363498649|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
105406769|NCT01279044|363498647|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
105406770|NCT01279044|363498648|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
105406771|NCT01279044|363498649|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
105406772|NCT01279044|363498647|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
105406773|NCT01279044|363498648|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
105406774|NCT01279044|363498649|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
105406775|NCT00473889|363498650|FG000|Overall Study|Did not receive study medication|1|||
105406776|NCT00473889|363498651|FG001|Overall Study|Did not receive study medication|4|||
105406777|NCT00473889|363498650|FG000|Overall Study|Adverse Event|30|||
105406778|NCT00473889|363498651|FG001|Overall Study|Adverse Event|17|||
105406779|NCT00473889|363498650|FG000|Overall Study|Protocol Violation|4|||
105406780|NCT00473889|363498651|FG001|Overall Study|Protocol Violation|2|||
105406781|NCT00473889|363498650|FG000|Overall Study|Lack of Efficacy|28|||
105406782|NCT00473889|363498651|FG001|Overall Study|Lack of Efficacy|29|||
105406783|NCT00473889|363498650|FG000|Overall Study|Lost to Follow-up|2|||
105406784|NCT00473889|363498651|FG001|Overall Study|Lost to Follow-up|1|||
105406785|NCT00473889|363498650|FG000|Overall Study|Physician Decision|10|||
105406786|NCT00473889|363498651|FG001|Overall Study|Physician Decision|5|||
105406787|NCT00473889|363498650|FG000|Overall Study|Trial Terminated|3|||
105406788|NCT00473889|363498651|FG001|Overall Study|Trial Terminated|6|||
105406789|NCT00473889|363498650|FG000|Overall Study|Withdrawal by Subject|5|||
105406790|NCT00473889|363498651|FG001|Overall Study|Withdrawal by Subject|0|||
105406791|NCT03783962|363498652|FG000|Overall Study|Lost to Follow-up|3|||
105406792|NCT03783962|363498653|FG001|Overall Study|Lost to Follow-up|6|||
105406793|NCT03783962|363498652|FG000|Overall Study|Protocol Violation|0|||
105406794|NCT03783962|363498653|FG001|Overall Study|Protocol Violation|1|||
105406795|NCT00856635|363498654|FG000|Overall Study|Lost to Follow-up|2|||
105406796|NCT00856635|363498655|FG001|Overall Study|Lost to Follow-up|5|||
105406797|NCT00856635|363498654|FG000|Overall Study|Pregnancy|1|||
105406798|NCT00856635|363498655|FG001|Overall Study|Pregnancy|0|||
105406799|NCT00856635|363498654|FG000|Overall Study|Withdrawal by Subject|3|||
105406800|NCT00856635|363498655|FG001|Overall Study|Withdrawal by Subject|1|||
105406801|NCT00856635|363498654|FG000|Overall Study|Serious Adverse Event|1|||
105406802|NCT00856635|363498655|FG001|Overall Study|Serious Adverse Event|0|||
105406803|NCT00856635|363498654|FG000|Overall Study|Other|1|||
105406804|NCT00856635|363498655|FG001|Overall Study|Other|0|||
105406805|NCT00856635|363498654|FG000|Overall Study|Discontinued at Randomization|2|||
105580908|NCT01474512|364126476|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
105580909|NCT01474512|364126477|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
105580910|NCT01474512|364126478|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
105580911|NCT01474512|364126479|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
105580912|NCT01474512|364126480|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
105580913|NCT01474512|364126481|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
105580914|NCT01474512|364126482|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
105580915|NCT01474512|364126465|FG000|Long-Term Extension Period|Adverse Event|0|||
105580916|NCT01474512|364126466|FG001|Long-Term Extension Period|Adverse Event|0|||
105580917|NCT01474512|364126467|FG002|Long-Term Extension Period|Adverse Event|0|||
105580918|NCT01474512|364126468|FG003|Long-Term Extension Period|Adverse Event|0|||
105580919|NCT01474512|364126469|FG004|Long-Term Extension Period|Adverse Event|0|||
105580920|NCT01474512|364126470|FG005|Long-Term Extension Period|Adverse Event|0|||
105580921|NCT01474512|364126471|FG006|Long-Term Extension Period|Adverse Event|0|||
105580922|NCT01474512|364126472|FG007|Long-Term Extension Period|Adverse Event|0|||
105580923|NCT01474512|364126473|FG008|Long-Term Extension Period|Adverse Event|0|||
105580924|NCT01474512|364126474|FG009|Long-Term Extension Period|Adverse Event|0|||
105580925|NCT01474512|364126475|FG010|Long-Term Extension Period|Adverse Event|0|||
105580926|NCT01474512|364126476|FG011|Long-Term Extension Period|Adverse Event|1|||
105580927|NCT01474512|364126477|FG012|Long-Term Extension Period|Adverse Event|57|||
105406806|NCT00856635|363498655|FG001|Overall Study|Discontinued at Randomization|2|||
105406807|NCT03592771|363498658|FG000|Overall Study|Adverse Event|2|||
105406808|NCT03592771|363498659|FG001|Overall Study|Adverse Event|0|||
105406809|NCT03592771|363498660|FG002|Overall Study|Adverse Event|1|||
105406810|NCT03592771|363498658|FG000|Overall Study|Death|0|||
105406811|NCT03592771|363498659|FG001|Overall Study|Death|1|||
105406812|NCT03592771|363498660|FG002|Overall Study|Death|1|||
105406813|NCT03592771|363498658|FG000|Overall Study|Lost to Follow-up|5|||
105406814|NCT03592771|363498659|FG001|Overall Study|Lost to Follow-up|11|||
105406815|NCT03592771|363498660|FG002|Overall Study|Lost to Follow-up|15|||
105406816|NCT03592771|363498658|FG000|Overall Study|Withdrawal by Subject|0|||
105406817|NCT03592771|363498659|FG001|Overall Study|Withdrawal by Subject|2|||
105406818|NCT03592771|363498660|FG002|Overall Study|Withdrawal by Subject|0|||
105406819|NCT01724216|363498661|FG000|Overall Study|Scan was not completed|1|||
105406820|NCT01014767|363498662|FG000|Overall Study|PI left institution, data unavailable|12|||
105406821|NCT01014767|363498663|FG001|Overall Study|PI left institution, data unavailable|1|||
105406822|NCT01014767|363498664|FG002|Overall Study|PI left institution, data unavailable|4|||
105406823|NCT01014767|363498665|FG003|Overall Study|PI left institution, data unavailable|1|||
105406824|NCT00635349|363498667|FG000|Overall Study|Other|8|||
105406825|NCT00635349|363498668|FG001|Overall Study|Other|6|||
105406826|NCT00635349|363498667|FG000|Overall Study|Protocol Violation|18|||
105406827|NCT00635349|363498668|FG001|Overall Study|Protocol Violation|22|||
105406828|NCT00635349|363498667|FG000|Overall Study|Withdrawal by Subject|3|||
105406829|NCT00635349|363498668|FG001|Overall Study|Withdrawal by Subject|8|||
105406830|NCT00635349|363498667|FG000|Overall Study|Lost to Follow-up|4|||
105406831|NCT00635349|363498668|FG001|Overall Study|Lost to Follow-up|3|||
105406832|NCT00635349|363498667|FG000|Overall Study|Adverse Event|11|||
105406833|NCT00635349|363498668|FG001|Overall Study|Adverse Event|9|||
105406834|NCT04860869|363498673|FG000|Overall Study|Withdrawal by Subject|1|||
105406835|NCT04860869|363498674|FG001|Overall Study|Withdrawal by Subject|0|||
105406836|NCT03951766|363498675|FG000|Treatment Phase|Lost to Follow-up|1|||
105406837|NCT03951766|363498675|FG000|Follow-up Phase|Lost to Follow-up|10|||
105406838|NCT04834726|363498678|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
105406839|NCT04834726|363498679|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
105406840|NCT04834726|363498680|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
105406841|NCT04834726|363498681|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
105406842|NCT04834726|363498682|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
105406843|NCT04834726|363498683|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
105406844|NCT04834726|363498684|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
105406845|NCT04834726|363498685|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
105406846|NCT04834726|363498686|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
105406847|NCT03606486|363498689|FG000|Overall Study|Unable to collect sample|5|||
105406848|NCT02446769|363498690|FG000|Screening Period|Screen Failure|11|||
105406849|NCT02446769|363498691|FG001|Screening Period|Screen Failure|0|||
105580928|NCT01474512|364126478|FG013|Long-Term Extension Period|Adverse Event|58|||
105580929|NCT01474512|364126479|FG014|Long-Term Extension Period|Adverse Event|0|||
105406850|NCT02446769|363498692|FG002|Screening Period|Screen Failure|0|||
105406851|NCT02446769|363498690|FG000|Study Period|Randomized in Error|0|||
105406852|NCT02446769|363498691|FG001|Study Period|Randomized in Error|2|||
105406853|NCT02446769|363498692|FG002|Study Period|Randomized in Error|0|||
105580930|NCT01474512|364126480|FG015|Long-Term Extension Period|Adverse Event|0|||
105580931|NCT01474512|364126481|FG016|Long-Term Extension Period|Adverse Event|0|||
105580932|NCT01474512|364126482|FG017|Long-Term Extension Period|Adverse Event|0|||
105406854|NCT00703963|363498697|FG000|Overall Study|Withdrawal by Subject|7|||
105406855|NCT00703963|363498698|FG001|Overall Study|Withdrawal by Subject|13|||
105406856|NCT00703963|363498697|FG000|Overall Study|Physician Decision|0|||
105406857|NCT00703963|363498698|FG001|Overall Study|Physician Decision|1|||
105406858|NCT01340664|363498707|FG000|Overall Study|Adverse Event|0|||
105406859|NCT01340664|363498708|FG001|Overall Study|Adverse Event|1|||
105406860|NCT01340664|363498709|FG002|Overall Study|Adverse Event|7|||
105406861|NCT01340664|363498707|FG000|Overall Study|Lost to Follow-up|2|||
105406862|NCT01340664|363498708|FG001|Overall Study|Lost to Follow-up|0|||
105406863|NCT01340664|363498709|FG002|Overall Study|Lost to Follow-up|2|||
105406864|NCT01340664|363498707|FG000|Overall Study|Withdrawal by Subject|2|||
105406865|NCT01340664|363498708|FG001|Overall Study|Withdrawal by Subject|4|||
105406866|NCT01340664|363498709|FG002|Overall Study|Withdrawal by Subject|0|||
105406867|NCT01340664|363498707|FG000|Overall Study|Glycemic withdrawal criteria|2|||
105406868|NCT01340664|363498708|FG001|Overall Study|Glycemic withdrawal criteria|0|||
105406869|NCT01340664|363498709|FG002|Overall Study|Glycemic withdrawal criteria|0|||
105406870|NCT01340664|363498707|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
105406871|NCT01340664|363498708|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
105406872|NCT01340664|363498709|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
105406873|NCT01340664|363498707|FG000|Overall Study|Other|1|||
105406874|NCT01340664|363498708|FG001|Overall Study|Other|2|||
105406875|NCT01340664|363498709|FG002|Overall Study|Other|2|||
105406876|NCT01277822|363498712|FG000|Overall Study|Adverse Event|2|||
105406877|NCT01277822|363498713|FG001|Overall Study|Adverse Event|1|||
105406878|NCT01277822|363498712|FG000|Overall Study|Withdrawal by Subject|6|||
105406879|NCT01277822|363498713|FG001|Overall Study|Withdrawal by Subject|7|||
105406880|NCT01277822|363498712|FG000|Overall Study|Physician Decision|1|||
105406881|NCT01277822|363498713|FG001|Overall Study|Physician Decision|1|||
105406882|NCT01277822|363498712|FG000|Overall Study|Protocol Violation|1|||
105406883|NCT01277822|363498713|FG001|Overall Study|Protocol Violation|0|||
105406884|NCT01277822|363498712|FG000|Overall Study|Lost to Follow-up|2|||
105406885|NCT01277822|363498713|FG001|Overall Study|Lost to Follow-up|1|||
105406886|NCT01277822|363498712|FG000|Overall Study|Contraindicated medication used|2|||
105406887|NCT01277822|363498713|FG001|Overall Study|Contraindicated medication used|1|||
105406888|NCT01277822|363498712|FG000|Overall Study|Participant moved|1|||
105406889|NCT01277822|363498713|FG001|Overall Study|Participant moved|0|||
105406890|NCT00997984|363498714|FG000|Overall Study|Adverse Event|1|||
105406891|NCT00997984|363498715|FG001|Overall Study|Adverse Event|8|||
105406892|NCT00997984|363498716|FG002|Overall Study|Adverse Event|8|||
105406893|NCT00997984|363498714|FG000|Overall Study|Protocol Violation|1|||
105406894|NCT00997984|363498715|FG001|Overall Study|Protocol Violation|3|||
105406895|NCT00997984|363498716|FG002|Overall Study|Protocol Violation|0|||
105406896|NCT00997984|363498714|FG000|Overall Study|Withdrawal by Subject|6|||
105406897|NCT00997984|363498715|FG001|Overall Study|Withdrawal by Subject|9|||
105406898|NCT00997984|363498716|FG002|Overall Study|Withdrawal by Subject|5|||
105406899|NCT00997984|363498714|FG000|Overall Study|Lost to Follow-up|8|||
105406900|NCT00997984|363498715|FG001|Overall Study|Lost to Follow-up|5|||
105406901|NCT00997984|363498716|FG002|Overall Study|Lost to Follow-up|4|||
105406902|NCT00997984|363498714|FG000|Overall Study|Lack of Efficacy|20|||
105406903|NCT00997984|363498715|FG001|Overall Study|Lack of Efficacy|6|||
105406904|NCT00997984|363498716|FG002|Overall Study|Lack of Efficacy|3|||
105406905|NCT00997984|363498714|FG000|Overall Study|Met exclusion criteria|1|||
105406906|NCT00997984|363498715|FG001|Overall Study|Met exclusion criteria|0|||
105406907|NCT00997984|363498716|FG002|Overall Study|Met exclusion criteria|0|||
105406908|NCT00997984|363498714|FG000|Overall Study|non-compliance|0|||
105406909|NCT00997984|363498715|FG001|Overall Study|non-compliance|2|||
105406910|NCT00997984|363498716|FG002|Overall Study|non-compliance|3|||
105406911|NCT00997984|363498714|FG000|Overall Study|Wrong medication dispensed|0|||
105406912|NCT00997984|363498715|FG001|Overall Study|Wrong medication dispensed|1|||
105406913|NCT00997984|363498716|FG002|Overall Study|Wrong medication dispensed|0|||
105406914|NCT00997984|363498714|FG000|Overall Study|Suicidal ideation|0|||
105406915|NCT00997984|363498715|FG001|Overall Study|Suicidal ideation|0|||
105406916|NCT00997984|363498716|FG002|Overall Study|Suicidal ideation|1|||
105406917|NCT00997984|363498714|FG000|Overall Study|Work schedule|0|||
105494752|NCT01163266|363824881|FG000|Overall Study|Lack of Efficacy|1|||
105494753|NCT01163266|363824882|FG001|Overall Study|Lack of Efficacy|3|||
105494754|NCT01163266|363824883|FG002|Overall Study|Lack of Efficacy|1|||
105494755|NCT01163266|363824881|FG000|Overall Study|Noncompliance with Study Drug|0|||
105494756|NCT01163266|363824882|FG001|Overall Study|Noncompliance with Study Drug|2|||
105494757|NCT01163266|363824883|FG002|Overall Study|Noncompliance with Study Drug|0|||
105494758|NCT01163266|363824881|FG000|Overall Study|Protocol Deviations|2|||
105580933|NCT01474512|364126465|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
105406918|NCT00997984|363498715|FG001|Overall Study|Work schedule|0|||
105406919|NCT00997984|363498716|FG002|Overall Study|Work schedule|2|||
105406920|NCT01220401|363498717|FG000|Overall Study|Withdrawal by Subject|2|||
105494759|NCT01163266|363824882|FG001|Overall Study|Protocol Deviations|2|||
105406921|NCT01220401|363498717|FG000|Overall Study|Protocol Violation|1|||
105494760|NCT01163266|363824883|FG002|Overall Study|Protocol Deviations|5|||
105494761|NCT01163266|363824881|FG000|Overall Study|Withdrawal of Consent|5|||
105494762|NCT01163266|363824882|FG001|Overall Study|Withdrawal of Consent|7|||
105494763|NCT01163266|363824883|FG002|Overall Study|Withdrawal of Consent|3|||
105406922|NCT01853462|363498718|FG000|Overall Study|Withdrawal by Subject|1|||
105406923|NCT01853462|363498719|FG001|Overall Study|Withdrawal by Subject|1|||
105406924|NCT01119066|363498720|FG000|Overall Study|Withdrawal by Subject|4|||
105406925|NCT01119066|363498721|FG001|Overall Study|Withdrawal by Subject|6|||
105406926|NCT01119066|363498722|FG002|Overall Study|Withdrawal by Subject|0|||
105406927|NCT01119066|363498723|FG003|Overall Study|Withdrawal by Subject|0|||
105406928|NCT01119066|363498720|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
105406929|NCT01119066|363498721|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
105406930|NCT01119066|363498722|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
105406931|NCT01119066|363498723|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
105406932|NCT01119066|363498720|FG000|Overall Study|Relapse identified before transplant|1|||
105406933|NCT01119066|363498721|FG001|Overall Study|Relapse identified before transplant|0|||
105406934|NCT01119066|363498722|FG002|Overall Study|Relapse identified before transplant|0|||
105406935|NCT01119066|363498723|FG003|Overall Study|Relapse identified before transplant|0|||
105406936|NCT01119066|363498720|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
105406937|NCT01119066|363498721|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
105406938|NCT01119066|363498722|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
105406939|NCT01119066|363498723|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
105406940|NCT01119066|363498720|FG000|Overall Study|Relapse identified before transplant|0|||
105494764|NCT01163266|363824881|FG000|Overall Study|Lost to Follow-up|7|||
105494765|NCT01163266|363824882|FG001|Overall Study|Lost to Follow-up|7|||
105494766|NCT01163266|363824883|FG002|Overall Study|Lost to Follow-up|10|||
105494767|NCT01163266|363824881|FG000|Overall Study|Other|1|||
105494768|NCT01163266|363824882|FG001|Overall Study|Other|1|||
105494769|NCT01163266|363824883|FG002|Overall Study|Other|2|||
105494770|NCT02586064|363824884|FG000|Overall Study|Other Obligations|6|||
105494771|NCT02586064|363824885|FG001|Overall Study|Other Obligations|6|||
105494772|NCT02586064|363824884|FG000|Overall Study|Other|3|||
105494773|NCT02586064|363824885|FG001|Overall Study|Other|7|||
105494774|NCT02586064|363824884|FG000|Overall Study|Never Started|3|||
105494775|NCT02586064|363824885|FG001|Overall Study|Never Started|3|||
105494776|NCT02586064|363824884|FG000|Overall Study|Lost Interest|1|||
105494777|NCT02586064|363824885|FG001|Overall Study|Lost Interest|4|||
105494778|NCT02586064|363824884|FG000|Overall Study|Miscellaneous Life Issues|0|||
105494779|NCT02586064|363824885|FG001|Overall Study|Miscellaneous Life Issues|5|||
105494780|NCT02586064|363824884|FG000|Overall Study|Infrequent Attendance|2|||
105494781|NCT02586064|363824885|FG001|Overall Study|Infrequent Attendance|1|||
105494782|NCT02586064|363824884|FG000|Overall Study|Timed Out|2|||
105494783|NCT02586064|363824885|FG001|Overall Study|Timed Out|0|||
105494784|NCT02586064|363824884|FG000|Overall Study|AUD relapse|0|||
105494785|NCT02586064|363824885|FG001|Overall Study|AUD relapse|2|||
105494786|NCT02586064|363824884|FG000|Overall Study|Legal Issue|1|||
105494787|NCT02586064|363824885|FG001|Overall Study|Legal Issue|0|||
105494788|NCT04308304|363824886|FG000|Overall Study|Withdrawal by Subject|4|||
105494789|NCT04308304|363824887|FG001|Overall Study|Withdrawal by Subject|0|||
105494790|NCT04308304|363824886|FG000|Overall Study|Protocol Violation|1|||
105494791|NCT04308304|363824887|FG001|Overall Study|Protocol Violation|0|||
105494792|NCT04128371|363824890|FG000|Overall Study|Lack of Efficacy|1|||
105494793|NCT02906332|363824897|FG000|Overall Study|Withdrawal by Subject|1|||
105494794|NCT02949700|363824898|FG000|Phase I|Withdrawal by Subject|1|||
105494795|NCT02949700|363824899|FG001|Phase I|Withdrawal by Subject|1|||
105494796|NCT02949700|363824900|FG002|Phase I|Withdrawal by Subject|0|||
105494797|NCT02949700|363824901|FG003|Phase I|Withdrawal by Subject|0|||
105494798|NCT02949700|363824898|FG000|Phase I|Protocol Violation|1|||
105494799|NCT02949700|363824899|FG001|Phase I|Protocol Violation|0|||
105494800|NCT02949700|363824900|FG002|Phase I|Protocol Violation|0|||
105494801|NCT02949700|363824901|FG003|Phase I|Protocol Violation|0|||
105494802|NCT02949700|363824898|FG000|Phase II|Withdrawal by Subject|0|||
105494803|NCT02949700|363824899|FG001|Phase II|Withdrawal by Subject|0|||
105494804|NCT02949700|363824900|FG002|Phase II|Withdrawal by Subject|0|||
105494805|NCT02949700|363824901|FG003|Phase II|Withdrawal by Subject|2|||
105494806|NCT02949700|363824898|FG000|Phase II|Protocol Violation|0|||
105494807|NCT02949700|363824899|FG001|Phase II|Protocol Violation|0|||
105494808|NCT02949700|363824900|FG002|Phase II|Protocol Violation|1|||
105494809|NCT02949700|363824901|FG003|Phase II|Protocol Violation|3|||
105494810|NCT01686828|363824905|FG000|Overall Study|Physician Decision|1|||
105494811|NCT01686828|363824906|FG001|Overall Study|Physician Decision|0|||
105494812|NCT01686828|363824907|FG002|Overall Study|Physician Decision|0|||
105494813|NCT01686828|363824908|FG003|Overall Study|Physician Decision|0|||
105494814|NCT01686828|363824905|FG000|Overall Study|New Job|0|||
105494815|NCT01686828|363824906|FG001|Overall Study|New Job|1|||
105494816|NCT01686828|363824907|FG002|Overall Study|New Job|0|||
105494817|NCT01686828|363824908|FG003|Overall Study|New Job|0|||
105494818|NCT01686828|363824905|FG000|Overall Study|Weight Loss|0|||
105494819|NCT01686828|363824906|FG001|Overall Study|Weight Loss|0|||
105494820|NCT01686828|363824907|FG002|Overall Study|Weight Loss|1|||
105494821|NCT01686828|363824908|FG003|Overall Study|Weight Loss|0|||
105494822|NCT03698331|363824913|FG000|Overall Study|Adverse Event|2|||
105494823|NCT03698331|363824914|FG001|Overall Study|Adverse Event|3|||
105494824|NCT03698331|363824913|FG000|Overall Study|Withdrawal by Subject|1|||
105494825|NCT03698331|363824914|FG001|Overall Study|Withdrawal by Subject|1|||
105494826|NCT03698331|363824913|FG000|Overall Study|Lost to Follow-up|0|||
105494827|NCT03698331|363824914|FG001|Overall Study|Lost to Follow-up|2|||
105494828|NCT03698331|363824913|FG000|Overall Study|Non-compliance with study drug|1|||
105494829|NCT03698331|363824914|FG001|Overall Study|Non-compliance with study drug|0|||
105494830|NCT01193842|363824915|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
105406941|NCT01119066|363498721|FG001|Overall Study|Relapse identified before transplant|4|||
105406942|NCT01119066|363498722|FG002|Overall Study|Relapse identified before transplant|0|||
105406943|NCT01119066|363498723|FG003|Overall Study|Relapse identified before transplant|0|||
105406944|NCT00295646|363498724|FG000|Overall Study|Protocol Violation|18|||
105406945|NCT00295646|363498725|FG001|Overall Study|Protocol Violation|20|||
105406946|NCT00295646|363498726|FG002|Overall Study|Protocol Violation|20|||
105406947|NCT00295646|363498727|FG003|Overall Study|Protocol Violation|18|||
105406948|NCT00295646|363498724|FG000|Overall Study|Withdrawal by Subject|8|||
105406949|NCT00295646|363498725|FG001|Overall Study|Withdrawal by Subject|9|||
105406950|NCT00295646|363498726|FG002|Overall Study|Withdrawal by Subject|11|||
105406951|NCT00295646|363498727|FG003|Overall Study|Withdrawal by Subject|14|||
105406952|NCT00295646|363498724|FG000|Overall Study|Lost to Follow-up|0|||
105406953|NCT00295646|363498725|FG001|Overall Study|Lost to Follow-up|5|||
105406954|NCT00295646|363498726|FG002|Overall Study|Lost to Follow-up|1|||
105406955|NCT00295646|363498727|FG003|Overall Study|Lost to Follow-up|5|||
105406956|NCT00295646|363498724|FG000|Overall Study|Death|9|||
105406957|NCT00295646|363498725|FG001|Overall Study|Death|7|||
105406958|NCT00295646|363498726|FG002|Overall Study|Death|18|||
105406959|NCT00295646|363498727|FG003|Overall Study|Death|8|||
105406960|NCT02441101|363498728|FG000|Overall Study|Withdrawal by Subject|1|||
105406961|NCT02441101|363498729|FG001|Overall Study|Withdrawal by Subject|0|||
105406962|NCT02441101|363498728|FG000|Overall Study|Lost to Follow-up|1|||
105406963|NCT02441101|363498729|FG001|Overall Study|Lost to Follow-up|0|||
105406964|NCT02441101|363498728|FG000|Overall Study|PI relocated and study terminated|1|||
105406965|NCT02441101|363498729|FG001|Overall Study|PI relocated and study terminated|0|||
105406966|NCT02528942|363498732|FG000|Overall Study|Did not meet imaging criteria|9|||
105406967|NCT02528942|363498732|FG000|Overall Study|Lost to Follow-up|25|||
105406968|NCT02148263|363498733|FG000|Overall Study|Withdrawal by Subject|3|||
105406969|NCT02148263|363498734|FG001|Overall Study|Withdrawal by Subject|2|||
105406970|NCT02709720|363498736|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
105406971|NCT02709720|363498736|FG000|Overall Study|Protocol Violation|1|||
105406972|NCT02709720|363498736|FG000|Overall Study|Not take study medication|1|||
105406973|NCT01451749|363498739|FG000|Overall Study|Protocol Violation|14|||
105406974|NCT01451749|363498740|FG001|Overall Study|Protocol Violation|7|||
105406975|NCT01451749|363498739|FG000|Overall Study|Lost to Follow-up|15|||
105406976|NCT01451749|363498740|FG001|Overall Study|Lost to Follow-up|5|||
105406977|NCT01451749|363498739|FG000|Overall Study|Meet the exclusion criteria,and|1|||
105406978|NCT01451749|363498740|FG001|Overall Study|Meet the exclusion criteria,and|1|||
105406979|NCT01451749|363498739|FG000|Overall Study|Adverse Event|2|||
105406980|NCT01451749|363498740|FG001|Overall Study|Adverse Event|0|||
105406981|NCT01451749|363498739|FG000|Overall Study|Withdrawal by Subject|0|||
105406982|NCT01451749|363498740|FG001|Overall Study|Withdrawal by Subject|1|||
105580934|NCT01474512|364126466|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
105580935|NCT01474512|364126467|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
105580936|NCT01474512|364126468|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
105406983|NCT01265992|363498741|FG000|Overall Study|Lost to Follow-up|1|||
105406984|NCT01265992|363498741|FG000|Overall Study|Withdrawal by Subject|1|||
105406985|NCT01265992|363498741|FG000|Overall Study|Adverse Event|1|||
105406986|NCT01265992|363498741|FG000|Overall Study|Administrative reasons|2|||
105406987|NCT01265992|363498741|FG000|Overall Study|Stopped treatment|3|||
105406988|NCT01265992|363498741|FG000|Overall Study|Did not receive treatment|1|||
105406989|NCT01198574|363498770|FG000|Overall Study|Resigned from schools|4|||
105406990|NCT01198574|363498771|FG001|Overall Study|Resigned from schools|1|||
105406991|NCT01198574|363498772|FG002|Overall Study|Resigned from schools|1|||
105494831|NCT01193842|363824916|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
105580937|NCT01474512|364126469|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
105406992|NCT01198574|363498773|FG003|Overall Study|Resigned from schools|4|||
105406993|NCT01837680|363498774|FG000|Overall Study|Lost to Follow-up|2|||
105494832|NCT01193842|363824917|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
105494833|NCT01193842|363824918|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
105406994|NCT01837680|363498775|FG001|Overall Study|Lost to Follow-up|2|||
105406995|NCT01837680|363498774|FG000|Overall Study|lack of insurance|0|||
105406996|NCT01837680|363498775|FG001|Overall Study|lack of insurance|2|||
105406997|NCT01837680|363498774|FG000|Overall Study|allergic reaction|6|||
105406998|NCT01837680|363498775|FG001|Overall Study|allergic reaction|0|||
105406999|NCT01837680|363498774|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
105407000|NCT01837680|363498775|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
105407001|NCT03533660|363498776|FG000|Overall Study|Withdrawal by Subject|2|||
105407002|NCT03533660|363498777|FG001|Overall Study|Withdrawal by Subject|2|||
105407003|NCT03533660|363498776|FG000|Overall Study|Death|2|||
105407004|NCT03533660|363498777|FG001|Overall Study|Death|4|||
105407005|NCT03533660|363498776|FG000|Overall Study|Adverse Event|0|||
105407006|NCT03533660|363498777|FG001|Overall Study|Adverse Event|2|||
105407007|NCT05005273|363498778|FG000|Overall Study|Study Terminated|1|||
105407008|NCT05005273|363498779|FG001|Overall Study|Study Terminated|0|||
105407009|NCT02701764|363498780|FG000|Overall Study|Lost to Follow-up|0|||
105407010|NCT02701764|363498781|FG001|Overall Study|Lost to Follow-up|1|||
105407011|NCT00996658|363498785|FG000|Overall Study|Adverse Event|2|||
105407012|NCT00996658|363498786|FG001|Overall Study|Adverse Event|5|||
105407013|NCT00996658|363498785|FG000|Overall Study|Protocol Violation|0|||
105407014|NCT00996658|363498786|FG001|Overall Study|Protocol Violation|1|||
105407015|NCT00996658|363498785|FG000|Overall Study|Lost to Follow-up|2|||
105407016|NCT00996658|363498786|FG001|Overall Study|Lost to Follow-up|5|||
105407017|NCT00996658|363498785|FG000|Overall Study|Non-compliance issues|3|||
105407018|NCT00996658|363498786|FG001|Overall Study|Non-compliance issues|3|||
105407019|NCT00996658|363498785|FG000|Overall Study|Other|9|||
105407020|NCT00996658|363498786|FG001|Overall Study|Other|7|||
105407021|NCT02524145|363498787|FG000|Overall Study|Withdrawal by Subject|2|||
105407022|NCT02524145|363498788|FG001|Overall Study|Withdrawal by Subject|2|||
105407023|NCT02524145|363498789|FG002|Overall Study|Withdrawal by Subject|3|||
105407024|NCT03145064|363500042|FG000|Overall Study|Death|24|||
105407025|NCT03145064|363500042|FG000|Overall Study|Lost to Follow-up|3|||
105407026|NCT03145064|363500042|FG000|Overall Study|Withdrawal by Subject|6|||
105407027|NCT03145064|363500042|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
105407028|NCT03145064|363500042|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
105407029|NCT04245449|363500053|FG000|Overall Study|COVID shutdown|7|||
105407030|NCT01408277|363500057|FG000|Overall Study|Adverse Event|3|||
105407031|NCT01408277|363500058|FG001|Overall Study|Adverse Event|4|||
105407032|NCT01408277|363500057|FG000|Overall Study|Lost to Follow-up|1|||
105407033|NCT01408277|363500058|FG001|Overall Study|Lost to Follow-up|0|||
105407034|NCT01408277|363500057|FG000|Overall Study|Withdrawal by Subject|2|||
105407035|NCT01408277|363500058|FG001|Overall Study|Withdrawal by Subject|0|||
105407036|NCT01408277|363500057|FG000|Overall Study|Protocol Violation|2|||
105407037|NCT01408277|363500058|FG001|Overall Study|Protocol Violation|0|||
105407038|NCT01582009|363500059|FG000|Overall Study|Withdrawal by Subject|1|||
105407039|NCT01582009|363500059|FG000|Overall Study|Physician Decision|1|||
105407040|NCT02840253|363500061|FG000|Overall Study|Unsuccessful block|4|||
105407041|NCT01947283|363500062|FG000|Overall Study|Death|1|||
105407042|NCT01947283|363500063|FG001|Overall Study|Death|1|||
105407043|NCT01947283|363500064|FG002|Overall Study|Death|1|||
105407044|NCT01947283|363500065|FG003|Overall Study|Death|0|||
105407045|NCT01947283|363500066|FG004|Overall Study|Death|0|||
105407046|NCT01947283|363500067|FG005|Overall Study|Death|0|||
105407047|NCT01947283|363500068|FG006|Overall Study|Death|0|||
105407048|NCT01947283|363500062|FG000|Overall Study|Lost to Follow-up|4|||
105407049|NCT01947283|363500063|FG001|Overall Study|Lost to Follow-up|6|||
105407050|NCT01947283|363500064|FG002|Overall Study|Lost to Follow-up|5|||
105407051|NCT01947283|363500065|FG003|Overall Study|Lost to Follow-up|5|||
105407052|NCT01947283|363500066|FG004|Overall Study|Lost to Follow-up|0|||
105494834|NCT01193842|363824919|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
105494835|NCT01193842|363824915|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
105494836|NCT01193842|363824916|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
105494837|NCT01193842|363824917|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
105494838|NCT01193842|363824918|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
105494839|NCT01193842|363824919|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
105494840|NCT01193842|363824915|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
105580938|NCT01474512|364126470|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
105407053|NCT01947283|363500067|FG005|Overall Study|Lost to Follow-up|2|||
105407054|NCT01947283|363500068|FG006|Overall Study|Lost to Follow-up|5|||
105407055|NCT01947283|363500062|FG000|Overall Study|Withdrawal by Subject|10|||
105407056|NCT01947283|363500063|FG001|Overall Study|Withdrawal by Subject|8|||
105407057|NCT01947283|363500064|FG002|Overall Study|Withdrawal by Subject|4|||
105407058|NCT01947283|363500065|FG003|Overall Study|Withdrawal by Subject|1|||
105407059|NCT01947283|363500066|FG004|Overall Study|Withdrawal by Subject|0|||
105407060|NCT01947283|363500067|FG005|Overall Study|Withdrawal by Subject|0|||
105407061|NCT01947283|363500068|FG006|Overall Study|Withdrawal by Subject|2|||
105494841|NCT01193842|363824916|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
105494842|NCT01193842|363824917|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
105407062|NCT01947283|363500062|FG000|Overall Study|No Clinical Recording|12|||
105407063|NCT01947283|363500063|FG001|Overall Study|No Clinical Recording|6|||
105407064|NCT01947283|363500064|FG002|Overall Study|No Clinical Recording|8|||
105407065|NCT01947283|363500065|FG003|Overall Study|No Clinical Recording|10|||
105407066|NCT01947283|363500066|FG004|Overall Study|No Clinical Recording|0|||
105407067|NCT01947283|363500067|FG005|Overall Study|No Clinical Recording|0|||
105407068|NCT01947283|363500068|FG006|Overall Study|No Clinical Recording|0|||
105407069|NCT01947283|363500062|FG000|Overall Study|Non-coding Clinical Recording language|0|||
105407070|NCT01947283|363500063|FG001|Overall Study|Non-coding Clinical Recording language|0|||
105407071|NCT01947283|363500064|FG002|Overall Study|Non-coding Clinical Recording language|0|||
105407072|NCT01947283|363500065|FG003|Overall Study|Non-coding Clinical Recording language|1|||
105407073|NCT01947283|363500066|FG004|Overall Study|Non-coding Clinical Recording language|0|||
105407074|NCT01947283|363500067|FG005|Overall Study|Non-coding Clinical Recording language|0|||
105407075|NCT01947283|363500068|FG006|Overall Study|Non-coding Clinical Recording language|0|||
105407076|NCT01947283|363500062|FG000|Overall Study|Missing Follow-up Assessment|2|||
105407077|NCT01947283|363500063|FG001|Overall Study|Missing Follow-up Assessment|2|||
105407078|NCT01947283|363500064|FG002|Overall Study|Missing Follow-up Assessment|3|||
105407079|NCT01947283|363500065|FG003|Overall Study|Missing Follow-up Assessment|0|||
105407080|NCT01947283|363500066|FG004|Overall Study|Missing Follow-up Assessment|0|||
105407081|NCT01947283|363500067|FG005|Overall Study|Missing Follow-up Assessment|2|||
105407082|NCT01947283|363500068|FG006|Overall Study|Missing Follow-up Assessment|0|||
105407083|NCT01947283|363500062|FG000|Overall Study|No patients were enrolled in study|0|||
105407084|NCT01947283|363500063|FG001|Overall Study|No patients were enrolled in study|0|||
105407085|NCT01947283|363500064|FG002|Overall Study|No patients were enrolled in study|0|||
105407086|NCT01947283|363500065|FG003|Overall Study|No patients were enrolled in study|0|||
105407087|NCT01947283|363500066|FG004|Overall Study|No patients were enrolled in study|0|||
105407088|NCT01947283|363500067|FG005|Overall Study|No patients were enrolled in study|3|||
105407089|NCT01947283|363500068|FG006|Overall Study|No patients were enrolled in study|1|||
105407090|NCT00564733|363500069|FG000|Overall Study|Withdrawal by Subject|4|||
105407091|NCT00564733|363500069|FG000|Overall Study|Ineligible|5|||
105407092|NCT02010593|363500074|FG000|Overall Study|Lost to Follow-up|1|||
105407093|NCT02010593|363500075|FG001|Overall Study|Lost to Follow-up|0|||
105407094|NCT02010593|363500074|FG000|Overall Study|Physician Decision|1|||
105407095|NCT02010593|363500075|FG001|Overall Study|Physician Decision|0|||
105407096|NCT02010593|363500074|FG000|Overall Study|Unable to adhere to visit schedule|0|||
105407097|NCT02010593|363500075|FG001|Overall Study|Unable to adhere to visit schedule|2|||
105407098|NCT01135459|363500076|FG000|Overall Study|Adverse Event|8|||
105407099|NCT01135459|363500077|FG001|Overall Study|Adverse Event|10|||
105407100|NCT01135459|363500076|FG000|Overall Study|Lack of Efficacy|3|||
105407101|NCT01135459|363500077|FG001|Overall Study|Lack of Efficacy|1|||
105407102|NCT01135459|363500076|FG000|Overall Study|Withdrawal by Subject|2|||
105407103|NCT01135459|363500077|FG001|Overall Study|Withdrawal by Subject|3|||
105407104|NCT01135459|363500076|FG000|Overall Study|Protocol Violation|5|||
105407105|NCT01135459|363500077|FG001|Overall Study|Protocol Violation|3|||
105407106|NCT01135459|363500076|FG000|Overall Study|Lost to Follow-up|2|||
105407107|NCT01135459|363500077|FG001|Overall Study|Lost to Follow-up|1|||
105407108|NCT01135459|363500076|FG000|Overall Study|Non-compliance to study procedures|0|||
105407109|NCT01135459|363500077|FG001|Overall Study|Non-compliance to study procedures|1|||
105407110|NCT01135459|363500076|FG000|Overall Study|Other than specified|1|||
105407111|NCT01135459|363500077|FG001|Overall Study|Other than specified|1|||
105407112|NCT01803880|363500078|FG000|Overall Study|Adverse Event|1|||
105407113|NCT01803880|363500079|FG001|Overall Study|Adverse Event|0|||
105407114|NCT01803880|363500080|FG002|Overall Study|Adverse Event|0|||
105407115|NCT01803880|363500078|FG000|Overall Study|Withdrawal by Subject|1|||
105407116|NCT01803880|363500079|FG001|Overall Study|Withdrawal by Subject|1|||
105407117|NCT01803880|363500080|FG002|Overall Study|Withdrawal by Subject|4|||
105407118|NCT01803880|363500078|FG000|Overall Study|Physician Decision|0|||
105407119|NCT01803880|363500079|FG001|Overall Study|Physician Decision|0|||
105407120|NCT01803880|363500080|FG002|Overall Study|Physician Decision|1|||
105407121|NCT01803880|363500078|FG000|Overall Study|Unable to return for follow-up visits|0|||
105407122|NCT01803880|363500079|FG001|Overall Study|Unable to return for follow-up visits|1|||
105407123|NCT01803880|363500080|FG002|Overall Study|Unable to return for follow-up visits|2|||
105407124|NCT01803880|363500078|FG000|Overall Study|Lost to Follow-up|1|||
105407125|NCT01803880|363500079|FG001|Overall Study|Lost to Follow-up|2|||
105407126|NCT01803880|363500080|FG002|Overall Study|Lost to Follow-up|3|||
105407127|NCT01803880|363500078|FG000|Overall Study|Protocol Violation|1|||
105407128|NCT01803880|363500079|FG001|Overall Study|Protocol Violation|0|||
105407129|NCT01803880|363500080|FG002|Overall Study|Protocol Violation|0|||
105407130|NCT01803880|363500078|FG000|Overall Study|Early study termination|0|||
105407131|NCT01803880|363500079|FG001|Overall Study|Early study termination|6|||
105407132|NCT01803880|363500080|FG002|Overall Study|Early study termination|5|||
105407133|NCT01803880|363500078|FG000|Overall Study|Incomplete data entry by sites|2|||
105407134|NCT01803880|363500079|FG001|Overall Study|Incomplete data entry by sites|0|||
105407135|NCT01803880|363500080|FG002|Overall Study|Incomplete data entry by sites|0|||
105407136|NCT01766037|363500081|FG000|Overall Study|Adverse Event|1|||
105407137|NCT01766037|363500082|FG001|Overall Study|Adverse Event|0|||
105407138|NCT01766037|363500081|FG000|Overall Study|Lack of Efficacy|1|||
105407139|NCT01766037|363500082|FG001|Overall Study|Lack of Efficacy|0|||
105407140|NCT01766037|363500081|FG000|Overall Study|Lost to Follow-up|0|||
105407141|NCT01766037|363500082|FG001|Overall Study|Lost to Follow-up|10|||
105407142|NCT01766037|363500081|FG000|Overall Study|Physician Decision|0|||
105407143|NCT01766037|363500082|FG001|Overall Study|Physician Decision|1|||
105407144|NCT01766037|363500081|FG000|Overall Study|Withdrawal by Subject|18|||
105407145|NCT01766037|363500082|FG001|Overall Study|Withdrawal by Subject|16|||
105407146|NCT01766037|363500081|FG000|Overall Study|Moved from area|5|||
105407147|NCT01766037|363500082|FG001|Overall Study|Moved from area|0|||
105407148|NCT01766037|363500081|FG000|Overall Study|medical - unrelated|1|||
105407149|NCT01766037|363500082|FG001|Overall Study|medical - unrelated|2|||
105407150|NCT01766037|363500081|FG000|Overall Study|nausea / discomfort|3|||
105407151|NCT01766037|363500082|FG001|Overall Study|nausea / discomfort|0|||
105407152|NCT01194219|363500083|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
105407153|NCT01194219|363500084|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
105407154|NCT01194219|363500085|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105407155|NCT01194219|363500086|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105407156|NCT01194219|363500087|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105407157|NCT01194219|363500088|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105407158|NCT01194219|363500089|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105407159|NCT01194219|363500090|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105407160|NCT01194219|363500091|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105407161|NCT01194219|363500092|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105407162|NCT01194219|363500083|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
105407163|NCT01194219|363500084|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
105407164|NCT01194219|363500085|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105407165|NCT01194219|363500086|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105407166|NCT01194219|363500087|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105407167|NCT01194219|363500088|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105407168|NCT01194219|363500089|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105407169|NCT01194219|363500090|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105407170|NCT01194219|363500091|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105407171|NCT01194219|363500092|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105407172|NCT01194219|363500083|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
105407173|NCT01194219|363500084|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105407174|NCT01194219|363500085|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105407175|NCT01194219|363500086|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105407176|NCT01194219|363500087|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105407177|NCT01194219|363500088|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105407178|NCT01194219|363500089|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105407179|NCT01194219|363500090|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105407180|NCT01194219|363500091|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105407181|NCT01194219|363500092|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105407182|NCT01194219|363500083|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
105407183|NCT01194219|363500084|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
105407184|NCT01194219|363500085|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105407185|NCT01194219|363500086|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105407186|NCT01194219|363500087|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105407187|NCT01194219|363500088|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105407188|NCT01194219|363500089|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105407189|NCT01194219|363500090|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105407190|NCT01194219|363500091|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105407191|NCT01194219|363500092|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105407192|NCT01194219|363500083|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105494843|NCT01193842|363824918|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
105494844|NCT01193842|363824919|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
105494845|NCT01193842|363824915|FG000|Phase II: Randomized Groups|Death|0|||
105407193|NCT01194219|363500084|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
105494846|NCT01193842|363824916|FG001|Phase II: Randomized Groups|Death|0|||
105494847|NCT01193842|363824917|FG002|Phase II: Randomized Groups|Death|0|||
105407194|NCT01194219|363500085|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105407195|NCT01194219|363500086|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105407196|NCT01194219|363500087|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105407197|NCT01194219|363500088|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105407198|NCT01194219|363500089|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105407199|NCT01194219|363500090|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105407200|NCT01194219|363500091|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105407201|NCT01194219|363500092|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105407202|NCT01194219|363500083|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
105407203|NCT01194219|363500084|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
105407204|NCT01194219|363500085|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
105407205|NCT01194219|363500086|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
105407206|NCT01194219|363500087|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
105407207|NCT01194219|363500088|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
105407208|NCT01194219|363500089|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
105407209|NCT01194219|363500090|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
105407210|NCT01194219|363500091|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
105407211|NCT01194219|363500092|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
105407212|NCT01194219|363500083|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
105407213|NCT01194219|363500084|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
105407214|NCT01194219|363500085|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105407215|NCT01194219|363500086|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105407216|NCT01194219|363500087|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105407217|NCT01194219|363500088|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105407218|NCT01194219|363500089|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105407219|NCT01194219|363500090|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105407220|NCT01194219|363500091|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105407221|NCT01194219|363500092|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105407222|NCT01194219|363500083|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
105407223|NCT01194219|363500084|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
105407224|NCT01194219|363500085|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105407225|NCT01194219|363500086|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105407226|NCT01194219|363500087|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105407227|NCT01194219|363500088|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105407228|NCT01194219|363500089|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105407229|NCT01194219|363500090|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105407230|NCT01194219|363500091|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105407231|NCT01194219|363500092|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105407232|NCT01194219|363500083|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
105407233|NCT01194219|363500084|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
105407234|NCT01194219|363500085|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
105407235|NCT01194219|363500086|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
105407236|NCT01194219|363500087|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
105407237|NCT01194219|363500088|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
105407238|NCT01194219|363500089|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
105407239|NCT01194219|363500090|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
105407240|NCT01194219|363500091|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
105407241|NCT01194219|363500092|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
105407242|NCT01194219|363500083|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
105407243|NCT01194219|363500084|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
105407244|NCT01194219|363500085|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
105407245|NCT01194219|363500086|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
105407246|NCT01194219|363500087|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
105407247|NCT01194219|363500088|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
105407248|NCT01194219|363500089|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
105407249|NCT01194219|363500090|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
105407250|NCT01194219|363500091|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
105407251|NCT01194219|363500092|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
105407252|NCT01194219|363500083|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
105407253|NCT01194219|363500084|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
105494848|NCT01193842|363824918|FG003|Phase II: Randomized Groups|Death|1|||
105494849|NCT01193842|363824919|FG004|Phase II: Randomized Groups|Death|1|||
105494850|NCT01193842|363824915|FG000|Phase II: Randomized Groups|Adverse Event|0|||
105494851|NCT01193842|363824916|FG001|Phase II: Randomized Groups|Adverse Event|0|||
105407254|NCT01194219|363500085|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
105407255|NCT01194219|363500086|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
105407256|NCT01194219|363500087|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
105407257|NCT01194219|363500088|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
105494852|NCT01193842|363824917|FG002|Phase II: Randomized Groups|Adverse Event|0|||
105494853|NCT01193842|363824918|FG003|Phase II: Randomized Groups|Adverse Event|5|||
105494854|NCT01193842|363824919|FG004|Phase II: Randomized Groups|Adverse Event|3|||
105494855|NCT01193842|363824915|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
105407258|NCT01194219|363500089|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
105407259|NCT01194219|363500090|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
105407260|NCT01194219|363500091|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
105407261|NCT01194219|363500092|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
105407262|NCT01194219|363500083|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105407263|NCT01194219|363500084|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105407264|NCT01194219|363500085|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
105407265|NCT01194219|363500086|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
105407266|NCT01194219|363500087|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105407267|NCT01194219|363500088|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105407268|NCT01194219|363500089|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105407269|NCT01194219|363500090|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105407270|NCT01194219|363500091|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105407271|NCT01194219|363500092|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105407272|NCT01194219|363500083|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105407273|NCT01194219|363500084|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105407274|NCT01194219|363500085|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
105407275|NCT01194219|363500086|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105407276|NCT01194219|363500087|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105407277|NCT01194219|363500088|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105407278|NCT01194219|363500089|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105407279|NCT01194219|363500090|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105407280|NCT01194219|363500091|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105407281|NCT01194219|363500092|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105407282|NCT01194219|363500083|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105407283|NCT01194219|363500084|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105407284|NCT01194219|363500085|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105407285|NCT01194219|363500086|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
105407286|NCT01194219|363500087|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105407287|NCT01194219|363500088|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105407288|NCT01194219|363500089|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105407289|NCT01194219|363500090|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105407290|NCT01194219|363500091|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105407291|NCT01194219|363500092|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105407292|NCT01194219|363500083|FG000|Maintenance Phase Weeks16-32|Other|0|||
105407293|NCT01194219|363500084|FG001|Maintenance Phase Weeks16-32|Other|0|||
105407294|NCT01194219|363500085|FG002|Maintenance Phase Weeks16-32|Other|2|||
105407295|NCT01194219|363500086|FG003|Maintenance Phase Weeks16-32|Other|1|||
105407296|NCT01194219|363500087|FG004|Maintenance Phase Weeks16-32|Other|0|||
105407297|NCT01194219|363500088|FG005|Maintenance Phase Weeks16-32|Other|0|||
105407298|NCT01194219|363500089|FG006|Maintenance Phase Weeks16-32|Other|0|||
105407299|NCT01194219|363500090|FG007|Maintenance Phase Weeks16-32|Other|0|||
105407300|NCT01194219|363500091|FG008|Maintenance Phase Weeks16-32|Other|0|||
105407301|NCT01194219|363500092|FG009|Maintenance Phase Weeks16-32|Other|0|||
105407302|NCT01194219|363500083|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
105407303|NCT01194219|363500084|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
105407304|NCT01194219|363500085|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
105407305|NCT01194219|363500086|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
105407306|NCT01194219|363500087|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
105407307|NCT01194219|363500088|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
105407308|NCT01194219|363500089|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
105407309|NCT01194219|363500090|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
105407310|NCT01194219|363500091|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
105407311|NCT01194219|363500092|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
105407312|NCT01194219|363500083|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
105407313|NCT01194219|363500084|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
105407314|NCT01194219|363500085|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
105407315|NCT01194219|363500086|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
105407316|NCT01194219|363500087|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
105407317|NCT01194219|363500088|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
105407318|NCT01194219|363500089|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
105407319|NCT01194219|363500090|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
105407320|NCT01194219|363500091|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
105407321|NCT01194219|363500092|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
105407322|NCT01194219|363500083|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105407323|NCT01194219|363500084|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105407324|NCT01194219|363500085|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105407325|NCT01194219|363500086|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105407326|NCT01194219|363500087|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
105407327|NCT01194219|363500088|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105407328|NCT01194219|363500089|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
105407329|NCT01194219|363500090|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105407330|NCT01194219|363500091|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105407331|NCT01194219|363500092|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105407332|NCT01194219|363500083|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
105407333|NCT01194219|363500084|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
105407334|NCT01194219|363500085|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
105407335|NCT01194219|363500086|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
105407336|NCT01194219|363500087|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
105407337|NCT01194219|363500088|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
105407338|NCT01194219|363500089|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
105407339|NCT01194219|363500090|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
105407340|NCT01194219|363500091|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
105407341|NCT01194219|363500092|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
105407342|NCT01194219|363500083|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
105407343|NCT01194219|363500084|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
105407344|NCT01194219|363500085|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
105407345|NCT01194219|363500086|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
105407346|NCT01194219|363500087|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
105407347|NCT01194219|363500088|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
105407348|NCT01194219|363500089|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
105407349|NCT01194219|363500090|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
105407350|NCT01194219|363500091|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
105407351|NCT01194219|363500092|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
105407352|NCT01194219|363500083|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105407353|NCT01194219|363500084|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105407354|NCT01194219|363500085|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105407355|NCT01194219|363500086|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105407356|NCT01194219|363500087|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105407357|NCT01194219|363500088|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105407358|NCT01194219|363500089|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105407359|NCT01194219|363500090|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
105407360|NCT01194219|363500091|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105407361|NCT01194219|363500092|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105407362|NCT01194219|363500083|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105407363|NCT01194219|363500084|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105407364|NCT01194219|363500085|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105407365|NCT01194219|363500086|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105407366|NCT01194219|363500087|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105407367|NCT01194219|363500088|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105407368|NCT01194219|363500089|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
105407369|NCT01194219|363500090|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105407370|NCT01194219|363500091|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105407371|NCT01194219|363500092|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105407372|NCT01194219|363500083|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105407373|NCT01194219|363500084|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105407374|NCT01194219|363500085|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105494856|NCT01193842|363824916|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
105494857|NCT01193842|363824917|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
105494858|NCT01193842|363824918|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
105494859|NCT01193842|363824919|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
105494860|NCT01193842|363824915|FG000|Phase II: Randomized Groups|Ineligible|0|||
105494861|NCT01193842|363824916|FG001|Phase II: Randomized Groups|Ineligible|0|||
105494862|NCT01193842|363824917|FG002|Phase II: Randomized Groups|Ineligible|0|||
105494863|NCT01193842|363824918|FG003|Phase II: Randomized Groups|Ineligible|0|||
105494864|NCT01193842|363824919|FG004|Phase II: Randomized Groups|Ineligible|1|||
105494865|NCT01193842|363824915|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
105494866|NCT01193842|363824916|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
105494867|NCT01193842|363824917|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
105407375|NCT01194219|363500086|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105407376|NCT01194219|363500087|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105407377|NCT01194219|363500088|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105407378|NCT01194219|363500089|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105407379|NCT01194219|363500090|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105407380|NCT01194219|363500091|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
105407381|NCT01194219|363500092|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
105407382|NCT01194219|363500083|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105407383|NCT01194219|363500084|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105407384|NCT01194219|363500085|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105407385|NCT01194219|363500086|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105407386|NCT01194219|363500087|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105407387|NCT01194219|363500088|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105407388|NCT01194219|363500089|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105407389|NCT01194219|363500090|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105407390|NCT01194219|363500091|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
105407391|NCT01194219|363500092|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
105407392|NCT01194219|363500083|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105407393|NCT01194219|363500084|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105407394|NCT01194219|363500085|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105407395|NCT01194219|363500086|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105407396|NCT01194219|363500087|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105407397|NCT01194219|363500088|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105407398|NCT01194219|363500089|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105407399|NCT01194219|363500090|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105407400|NCT01194219|363500091|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
105407401|NCT01194219|363500092|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
105407402|NCT01194219|363500083|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105407403|NCT01194219|363500084|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105407404|NCT01194219|363500085|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105407405|NCT01194219|363500086|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105407406|NCT01194219|363500087|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105407407|NCT01194219|363500088|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105407408|NCT01194219|363500089|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105407409|NCT01194219|363500090|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105407410|NCT01194219|363500091|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
105407411|NCT01194219|363500092|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
105407412|NCT01194219|363500083|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
105407413|NCT01194219|363500084|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
105407414|NCT01194219|363500085|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
105407415|NCT01194219|363500086|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
105407416|NCT01194219|363500087|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
105407417|NCT01194219|363500088|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
105407418|NCT01194219|363500089|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
105407419|NCT01194219|363500090|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
105407420|NCT01194219|363500091|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
105407421|NCT01194219|363500092|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
105407422|NCT01194219|363500083|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105407423|NCT01194219|363500084|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105407424|NCT01194219|363500085|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105407425|NCT01194219|363500086|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105407426|NCT01194219|363500087|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105407427|NCT01194219|363500088|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105407428|NCT01194219|363500089|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105407429|NCT01194219|363500090|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105407430|NCT01194219|363500091|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
105407431|NCT01194219|363500092|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
105407432|NCT01194219|363500083|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105407433|NCT01194219|363500084|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105407434|NCT01194219|363500085|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105407435|NCT01194219|363500086|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105407436|NCT01194219|363500087|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105407437|NCT01194219|363500088|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105407438|NCT01194219|363500089|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105407439|NCT01194219|363500090|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105407440|NCT01194219|363500091|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
105494868|NCT01193842|363824918|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
105494869|NCT01193842|363824919|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
105407441|NCT01194219|363500092|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105407442|NCT01194219|363500083|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
105407443|NCT01194219|363500084|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
105407444|NCT01194219|363500085|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
105407445|NCT01194219|363500086|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
105407446|NCT01194219|363500087|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
105407447|NCT01194219|363500088|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
105407448|NCT01194219|363500089|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
105407449|NCT01194219|363500090|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
105407450|NCT01194219|363500091|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
105407451|NCT01194219|363500092|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
105407452|NCT00292045|363500093|FG000|Core Study (Through Week 13)|Adverse Event|1|||
105407453|NCT00292045|363500093|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
105407454|NCT04474197|363500094|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
105407455|NCT04474197|363500095|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
105407456|NCT04474197|363500096|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
105407457|NCT04474197|363500097|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
105407458|NCT02236572|363500098|FG000|Overall Study|Withdrawal by Subject|1|||
105407459|NCT02236572|363500098|FG000|Overall Study|Protocol Violation|1|||
105407460|NCT02236572|363500098|FG000|Overall Study|Lost to Follow-up|1|||
105407461|NCT01057693|363500099|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
105407462|NCT01057693|363500100|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
105407463|NCT01057693|363500101|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
105407464|NCT01057693|363500099|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
105407465|NCT01057693|363500100|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
105407466|NCT01057693|363500101|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
105407467|NCT01057693|363500099|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
105407468|NCT01057693|363500100|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
105407469|NCT01057693|363500101|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
105407470|NCT01057693|363500099|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
105407471|NCT01057693|363500100|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
105407472|NCT01057693|363500101|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
105407473|NCT01057693|363500099|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
105407474|NCT01057693|363500100|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
105407475|NCT01057693|363500101|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
105407476|NCT01057693|363500099|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
105407477|NCT01057693|363500100|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
105407478|NCT01057693|363500101|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
105407479|NCT01057693|363500099|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
105407480|NCT01057693|363500100|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
105407481|NCT01057693|363500101|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
105407482|NCT01057693|363500099|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
105407483|NCT01057693|363500100|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
105407484|NCT01057693|363500101|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
105407485|NCT01057693|363500099|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
105407486|NCT01057693|363500100|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
105407487|NCT01057693|363500101|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
105407488|NCT01057693|363500099|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
105407489|NCT01057693|363500100|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
105407490|NCT01057693|363500101|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
105407491|NCT01057693|363500099|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
105407492|NCT01057693|363500100|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
105407493|NCT01057693|363500101|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
105407494|NCT01057693|363500099|FG000|Between Single-Blind and Double-Blind|Other|6|||
105407495|NCT01057693|363500100|FG001|Between Single-Blind and Double-Blind|Other|0|||
105407496|NCT01057693|363500101|FG002|Between Single-Blind and Double-Blind|Other|0|||
105407497|NCT01057693|363500099|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
105407498|NCT01057693|363500100|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
105407499|NCT01057693|363500101|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
105407500|NCT01057693|363500099|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
105407501|NCT01057693|363500100|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
105407502|NCT01057693|363500101|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
105407503|NCT01057693|363500099|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
105407504|NCT01057693|363500100|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
105494870|NCT02130024|363824920|FG000|Overall Study|Adverse Event|10|||
105494871|NCT02130024|363824921|FG001|Overall Study|Adverse Event|11|||
105494872|NCT02130024|363824920|FG000|Overall Study|Death|2|||
105494873|NCT02130024|363824921|FG001|Overall Study|Death|2|||
105407505|NCT01057693|363500101|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
105407506|NCT01057693|363500099|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
105407507|NCT01057693|363500100|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
105407508|NCT01057693|363500101|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
105407509|NCT01057693|363500099|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
105407510|NCT01057693|363500100|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
105407511|NCT01057693|363500101|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
105407512|NCT01057693|363500099|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
105407513|NCT01057693|363500100|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
105407514|NCT01057693|363500101|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
105407515|NCT01057693|363500099|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
105407516|NCT01057693|363500100|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
105407517|NCT01057693|363500101|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
105407518|NCT02413996|363500102|FG000|Overall Study|not comfortable with the intervention|9|||
105407519|NCT02413996|363500103|FG001|Overall Study|not comfortable with the intervention|2|||
105407520|NCT02443337|363500105|FG000|Overall Study|Adverse Event|0|||
105407521|NCT02443337|363500106|FG001|Overall Study|Adverse Event|1|||
105407522|NCT02443337|363500105|FG000|Overall Study|Clinical Progressive Disease|3|||
105407523|NCT02443337|363500106|FG001|Overall Study|Clinical Progressive Disease|0|||
105407524|NCT02443337|363500105|FG000|Overall Study|Withdrawal by Subject|2|||
105407525|NCT02443337|363500106|FG001|Overall Study|Withdrawal by Subject|1|||
105407526|NCT00709319|363500107|FG000|Overall Study|Death|4|||
105407527|NCT00709319|363500107|FG000|Overall Study|Withdrawal by Subject|2|||
105407528|NCT00579553|363500108|FG000|Overall Study|Lost to Follow-up|16|||
105407529|NCT00579553|363500109|FG001|Overall Study|Lost to Follow-up|13|||
105407530|NCT01318135|363500110|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
105407531|NCT01318135|363500111|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105407532|NCT01318135|363500112|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105407533|NCT01318135|363500113|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105407534|NCT01318135|363500114|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105407535|NCT01318135|363500115|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105407536|NCT01318135|363500116|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105407537|NCT01318135|363500117|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105494874|NCT02130024|363824920|FG000|Overall Study|Lost to Follow-up|1|||
105494875|NCT02130024|363824921|FG001|Overall Study|Lost to Follow-up|1|||
105494876|NCT02130024|363824920|FG000|Overall Study|Physician Decision|1|||
105494877|NCT02130024|363824921|FG001|Overall Study|Physician Decision|3|||
105494878|NCT02130024|363824920|FG000|Overall Study|Protocol Deviation|4|||
105494879|NCT02130024|363824921|FG001|Overall Study|Protocol Deviation|0|||
105494880|NCT02130024|363824920|FG000|Overall Study|Site Administration Problems|1|||
105494881|NCT02130024|363824921|FG001|Overall Study|Site Administration Problems|0|||
105494882|NCT02130024|363824920|FG000|Overall Study|Subject Withdrew Consent|6|||
105494883|NCT02130024|363824921|FG001|Overall Study|Subject Withdrew Consent|14|||
105494884|NCT05274165|363824922|FG000|Overall Study|Withdrawal by Subject|3|||
105494885|NCT05274165|363824923|FG001|Overall Study|Withdrawal by Subject|3|||
105494886|NCT01759511|363824924|FG000|Overall Study|Adverse Event|4|||
105494887|NCT01759511|363824924|FG000|Overall Study|Death|2|||
105407538|NCT01318135|363500110|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
105407539|NCT01318135|363500111|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
105407540|NCT01318135|363500112|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
105407541|NCT01318135|363500113|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
105494888|NCT01759511|363824924|FG000|Overall Study|Lack of Efficacy|2|||
105494889|NCT01759511|363824924|FG000|Overall Study|Physician Decision|1|||
105494890|NCT01759511|363824924|FG000|Overall Study|Progressive Disease|5|||
105494891|NCT01759511|363824924|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
105407542|NCT01318135|363500114|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
105407543|NCT01318135|363500115|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
105407544|NCT01318135|363500116|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
105407545|NCT01318135|363500117|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
105407546|NCT01318135|363500110|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
105407547|NCT01318135|363500111|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
105407548|NCT01318135|363500112|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
105407549|NCT01318135|363500113|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
105407550|NCT01318135|363500114|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
105407551|NCT01318135|363500115|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
105407552|NCT01318135|363500116|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
105407553|NCT01318135|363500117|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
105407554|NCT01318135|363500110|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
105407555|NCT01318135|363500111|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
105407556|NCT01318135|363500112|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
105407557|NCT01318135|363500113|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
105407558|NCT01318135|363500114|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
105407559|NCT01318135|363500115|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
105407560|NCT01318135|363500116|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
105407561|NCT01318135|363500117|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
105407562|NCT01318135|363500110|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105407563|NCT01318135|363500111|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105407564|NCT01318135|363500112|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105407565|NCT01318135|363500113|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105407566|NCT01318135|363500114|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105407567|NCT01318135|363500115|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
105580939|NCT01474512|364126471|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
105580940|NCT01474512|364126472|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
105580941|NCT01474512|364126473|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
105580942|NCT01474512|364126474|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
105580943|NCT01474512|364126475|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
105580944|NCT01474512|364126476|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
105580945|NCT01474512|364126477|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
105580946|NCT01474512|364126478|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
105580947|NCT01474512|364126479|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
105580948|NCT01474512|364126480|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
105580949|NCT01474512|364126481|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
105580950|NCT01474512|364126482|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
105580951|NCT01474512|364126465|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
105580952|NCT01474512|364126466|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
105580953|NCT01474512|364126467|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
105580954|NCT01474512|364126468|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
105580955|NCT01474512|364126469|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
105580956|NCT01474512|364126470|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
105580957|NCT01474512|364126471|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
105580958|NCT01474512|364126472|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
105580959|NCT01474512|364126473|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
105580960|NCT01474512|364126474|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
105580961|NCT01474512|364126475|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
105580962|NCT01474512|364126476|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
105580963|NCT01474512|364126477|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
105580964|NCT01474512|364126478|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
105580965|NCT01474512|364126479|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
105580966|NCT01474512|364126480|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
105580967|NCT01474512|364126481|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
105580968|NCT01474512|364126482|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
105580969|NCT01474512|364126465|FG000|Long-Term Extension Period|Physician Decision|0|||
105580970|NCT01474512|364126466|FG001|Long-Term Extension Period|Physician Decision|0|||
105580971|NCT01474512|364126467|FG002|Long-Term Extension Period|Physician Decision|0|||
105580972|NCT01474512|364126468|FG003|Long-Term Extension Period|Physician Decision|0|||
105580973|NCT01474512|364126469|FG004|Long-Term Extension Period|Physician Decision|0|||
105580974|NCT01474512|364126470|FG005|Long-Term Extension Period|Physician Decision|0|||
105580975|NCT01474512|364126471|FG006|Long-Term Extension Period|Physician Decision|0|||
105580976|NCT01474512|364126472|FG007|Long-Term Extension Period|Physician Decision|0|||
105580977|NCT01474512|364126473|FG008|Long-Term Extension Period|Physician Decision|0|||
105580978|NCT01474512|364126474|FG009|Long-Term Extension Period|Physician Decision|0|||
105580979|NCT01474512|364126475|FG010|Long-Term Extension Period|Physician Decision|0|||
105580980|NCT01474512|364126476|FG011|Long-Term Extension Period|Physician Decision|0|||
105407568|NCT01318135|363500116|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
105407569|NCT01318135|363500117|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105407570|NCT01318135|363500110|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
105407571|NCT01318135|363500111|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
105407572|NCT01318135|363500112|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
105407573|NCT01318135|363500113|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
105407574|NCT01318135|363500114|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
105407575|NCT01318135|363500115|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
105407576|NCT01318135|363500116|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
105407577|NCT01318135|363500117|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
105407578|NCT01318135|363500110|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
105407579|NCT01318135|363500111|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
105407580|NCT01318135|363500112|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
105407581|NCT01318135|363500113|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
105407582|NCT01318135|363500114|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
105407583|NCT01318135|363500115|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
105407584|NCT01318135|363500116|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
105407585|NCT01318135|363500117|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
105407586|NCT01672879|363500118|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
105407587|NCT01672879|363500119|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
105407588|NCT01672879|363500120|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
105407589|NCT01672879|363500118|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
105407590|NCT01672879|363500119|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
105407591|NCT01672879|363500120|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
105407592|NCT01672879|363500118|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
105407593|NCT01672879|363500119|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
105407594|NCT01672879|363500120|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
105407595|NCT01672879|363500118|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
105407596|NCT01672879|363500119|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
105407597|NCT01672879|363500120|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
105407598|NCT01672879|363500118|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
105407599|NCT01672879|363500119|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
105407600|NCT01672879|363500120|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
105407601|NCT01672879|363500118|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
105407602|NCT01672879|363500119|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
105407603|NCT01672879|363500120|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
105407604|NCT01672879|363500118|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
105407605|NCT01672879|363500119|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
105407606|NCT01672879|363500120|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
105407607|NCT01672879|363500118|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
105407608|NCT01672879|363500119|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
105407609|NCT01672879|363500120|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
105407610|NCT01672879|363500118|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
105407611|NCT01672879|363500119|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
105407612|NCT01672879|363500120|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
105407613|NCT01672879|363500118|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
105407614|NCT01672879|363500119|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
105407615|NCT01672879|363500120|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
105407616|NCT01672879|363500118|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
105407617|NCT01672879|363500119|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
105407618|NCT01672879|363500120|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
105407619|NCT01672879|363500118|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
105407620|NCT01672879|363500119|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
105407621|NCT01672879|363500120|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
105407622|NCT01672879|363500118|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
105407623|NCT01672879|363500119|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
105407624|NCT01672879|363500120|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
105407625|NCT03748706|363500122|FG000|Overall Study|Lost to Follow-up|1|||
105407626|NCT01775553|363500123|FG000|Overall Study|Adverse Event|1|||
105407627|NCT01775553|363500123|FG000|Overall Study|Disease Progression|12|||
105407628|NCT00803361|363500126|FG000|Overall Study|Adverse Event|13|||
105407629|NCT00803361|363500127|FG001|Overall Study|Adverse Event|3|||
105407630|NCT00803361|363500126|FG000|Overall Study|Lack of Efficacy|4|||
105494892|NCT01759511|363824924|FG000|Overall Study|Study Terminated by Sponsor|13|||
105494893|NCT01759511|363824924|FG000|Overall Study|Withdrawal by Subject|3|||
105494894|NCT04916769|363824925|FG000|Period 1|Physician Decision|0|||
105494895|NCT04916769|363824926|FG001|Period 1|Physician Decision|0|||
105407631|NCT00803361|363500127|FG001|Overall Study|Lack of Efficacy|13|||
105407632|NCT00803361|363500126|FG000|Overall Study|Lost to Follow-up|1|||
105407633|NCT00803361|363500127|FG001|Overall Study|Lost to Follow-up|2|||
105407634|NCT00803361|363500126|FG000|Overall Study|Physician Decision|1|||
105407635|NCT00803361|363500127|FG001|Overall Study|Physician Decision|0|||
105407636|NCT00803361|363500126|FG000|Overall Study|Protocol Violation|2|||
105407637|NCT00803361|363500127|FG001|Overall Study|Protocol Violation|4|||
105407638|NCT00803361|363500126|FG000|Overall Study|Withdrawal by Subject|5|||
105407639|NCT00803361|363500127|FG001|Overall Study|Withdrawal by Subject|6|||
105407640|NCT00402324|363500130|FG000|Overall Study|Lost to Follow-up|11|||
105407641|NCT00402324|363500131|FG001|Overall Study|Lost to Follow-up|11|||
105407642|NCT00402324|363500130|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
105407643|NCT00402324|363500131|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
105407644|NCT00402324|363500130|FG000|Overall Study|Protocol Violation|8|||
105407645|NCT00402324|363500131|FG001|Overall Study|Protocol Violation|7|||
105407646|NCT00402324|363500130|FG000|Overall Study|Withdrawal by Subject|5|||
105407647|NCT00402324|363500131|FG001|Overall Study|Withdrawal by Subject|2|||
105407648|NCT00402324|363500130|FG000|Overall Study|Physician Decision|2|||
105407649|NCT00402324|363500131|FG001|Overall Study|Physician Decision|4|||
105407650|NCT00402324|363500130|FG000|Overall Study|Sponsor Decision|4|||
105407651|NCT00402324|363500131|FG001|Overall Study|Sponsor Decision|5|||
105407652|NCT00402324|363500130|FG000|Overall Study|Lack of Efficacy|1|||
105407653|NCT00402324|363500131|FG001|Overall Study|Lack of Efficacy|4|||
105407654|NCT00402324|363500130|FG000|Overall Study|Adverse Event|6|||
105407655|NCT00402324|363500131|FG001|Overall Study|Adverse Event|4|||
105407656|NCT00402324|363500130|FG000|Overall Study|Death|1|||
105407657|NCT00402324|363500131|FG001|Overall Study|Death|0|||
105407658|NCT02997865|363500134|FG000|Overall Study|Death|2|||
105407659|NCT02997865|363500135|FG001|Overall Study|Death|1|||
105407660|NCT02997865|363500134|FG000|Overall Study|Lost to Follow-up|6|||
105407661|NCT02997865|363500135|FG001|Overall Study|Lost to Follow-up|3|||
105407662|NCT02997865|363500134|FG000|Overall Study|Withdrawal by Subject|5|||
105407663|NCT02997865|363500135|FG001|Overall Study|Withdrawal by Subject|0|||
105407664|NCT01926444|363500136|FG000|Overall Study|Colonoscopy not performed|0|||
105407665|NCT01926444|363500137|FG001|Overall Study|Colonoscopy not performed|0|||
105580981|NCT01474512|364126477|FG012|Long-Term Extension Period|Physician Decision|21|||
105580982|NCT01474512|364126478|FG013|Long-Term Extension Period|Physician Decision|21|||
105580983|NCT01474512|364126479|FG014|Long-Term Extension Period|Physician Decision|0|||
105580984|NCT01474512|364126480|FG015|Long-Term Extension Period|Physician Decision|0|||
105580985|NCT01474512|364126481|FG016|Long-Term Extension Period|Physician Decision|0|||
105580986|NCT01474512|364126482|FG017|Long-Term Extension Period|Physician Decision|0|||
105580987|NCT01474512|364126465|FG000|Long-Term Extension Period|Clinical Relapse|0|||
105580988|NCT01474512|364126466|FG001|Long-Term Extension Period|Clinical Relapse|0|||
105580989|NCT01474512|364126467|FG002|Long-Term Extension Period|Clinical Relapse|0|||
105580990|NCT01474512|364126468|FG003|Long-Term Extension Period|Clinical Relapse|0|||
105580991|NCT01474512|364126469|FG004|Long-Term Extension Period|Clinical Relapse|0|||
105580992|NCT01474512|364126470|FG005|Long-Term Extension Period|Clinical Relapse|0|||
105580993|NCT01474512|364126471|FG006|Long-Term Extension Period|Clinical Relapse|0|||
105580994|NCT01474512|364126472|FG007|Long-Term Extension Period|Clinical Relapse|0|||
105580995|NCT01474512|364126473|FG008|Long-Term Extension Period|Clinical Relapse|0|||
105580996|NCT01474512|364126474|FG009|Long-Term Extension Period|Clinical Relapse|0|||
105580997|NCT01474512|364126475|FG010|Long-Term Extension Period|Clinical Relapse|0|||
105580998|NCT01474512|364126476|FG011|Long-Term Extension Period|Clinical Relapse|0|||
105580999|NCT01474512|364126477|FG012|Long-Term Extension Period|Clinical Relapse|9|||
105581000|NCT01474512|364126478|FG013|Long-Term Extension Period|Clinical Relapse|9|||
105581001|NCT01474512|364126479|FG014|Long-Term Extension Period|Clinical Relapse|0|||
105581002|NCT01474512|364126480|FG015|Long-Term Extension Period|Clinical Relapse|0|||
105581003|NCT01474512|364126481|FG016|Long-Term Extension Period|Clinical Relapse|0|||
105581004|NCT01474512|364126482|FG017|Long-Term Extension Period|Clinical Relapse|0|||
105581005|NCT01474512|364126465|FG000|Long-Term Extension Period|Death|0|||
105581006|NCT01474512|364126466|FG001|Long-Term Extension Period|Death|0|||
105581007|NCT01474512|364126467|FG002|Long-Term Extension Period|Death|0|||
105581008|NCT01474512|364126468|FG003|Long-Term Extension Period|Death|0|||
105581009|NCT01474512|364126469|FG004|Long-Term Extension Period|Death|0|||
105407666|NCT01926444|363500138|FG002|Overall Study|Colonoscopy not performed|4|||
105581010|NCT01474512|364126470|FG005|Long-Term Extension Period|Death|0|||
105581011|NCT01474512|364126471|FG006|Long-Term Extension Period|Death|0|||
105581012|NCT01474512|364126472|FG007|Long-Term Extension Period|Death|0|||
105581013|NCT01474512|364126473|FG008|Long-Term Extension Period|Death|0|||
105581014|NCT01474512|364126474|FG009|Long-Term Extension Period|Death|0|||
105581015|NCT01474512|364126475|FG010|Long-Term Extension Period|Death|0|||
105407667|NCT01926444|363500139|FG003|Overall Study|Colonoscopy not performed|2|||
105407668|NCT00955474|363500140|FG000|Overall Study|Physician Decision|7|||
105407669|NCT00955474|363500141|FG001|Overall Study|Physician Decision|5|||
105407670|NCT01945996|363500142|FG000|Overall Study|Lost to Follow-up|3|||
105407671|NCT01945996|363500143|FG001|Overall Study|Lost to Follow-up|5|||
105407672|NCT00625586|363500144|FG000|Overall Study|Adverse Event|1|||
105407673|NCT00625586|363500144|FG000|Overall Study|Progressive disease|1|||
105407674|NCT02366923|363500145|FG000|Overall Study|Withdrawal by Subject|1|||
105407675|NCT02366923|363500145|FG000|Overall Study|Positive Slit Lamp Findings|2|||
105407676|NCT02366923|363500145|FG000|Overall Study|High Astigmatism|3|||
105407677|NCT03083665|363500147|FG000|Double-Blind Period|Adverse Event|5|||
105407678|NCT03083665|363500148|FG001|Double-Blind Period|Adverse Event|4|||
105407679|NCT03083665|363500149|FG002|Double-Blind Period|Adverse Event|5|||
105407680|NCT03083665|363500150|FG003|Double-Blind Period|Adverse Event|0|||
105407681|NCT03083665|363500151|FG004|Double-Blind Period|Adverse Event|0|||
105407682|NCT03083665|363500152|FG005|Double-Blind Period|Adverse Event|0|||
105407683|NCT03083665|363500147|FG000|Double-Blind Period|Lack of Efficacy|0|||
105407684|NCT03083665|363500148|FG001|Double-Blind Period|Lack of Efficacy|0|||
105407685|NCT03083665|363500149|FG002|Double-Blind Period|Lack of Efficacy|1|||
105407686|NCT03083665|363500150|FG003|Double-Blind Period|Lack of Efficacy|0|||
105407687|NCT03083665|363500151|FG004|Double-Blind Period|Lack of Efficacy|0|||
105407688|NCT03083665|363500152|FG005|Double-Blind Period|Lack of Efficacy|0|||
105407689|NCT03083665|363500147|FG000|Double-Blind Period|Protocol Violation|1|||
105407690|NCT03083665|363500148|FG001|Double-Blind Period|Protocol Violation|0|||
105407691|NCT03083665|363500149|FG002|Double-Blind Period|Protocol Violation|1|||
105407692|NCT03083665|363500150|FG003|Double-Blind Period|Protocol Violation|0|||
105407693|NCT03083665|363500151|FG004|Double-Blind Period|Protocol Violation|0|||
105407694|NCT03083665|363500152|FG005|Double-Blind Period|Protocol Violation|0|||
105407695|NCT03083665|363500147|FG000|Double-Blind Period|Lost to Follow-up|1|||
105407696|NCT03083665|363500148|FG001|Double-Blind Period|Lost to Follow-up|0|||
105407697|NCT03083665|363500149|FG002|Double-Blind Period|Lost to Follow-up|1|||
105407698|NCT03083665|363500150|FG003|Double-Blind Period|Lost to Follow-up|0|||
105407699|NCT03083665|363500151|FG004|Double-Blind Period|Lost to Follow-up|0|||
105407700|NCT03083665|363500152|FG005|Double-Blind Period|Lost to Follow-up|0|||
105407701|NCT03083665|363500147|FG000|Double-Blind Period|Withdrawal by Subject|3|||
105407702|NCT03083665|363500148|FG001|Double-Blind Period|Withdrawal by Subject|0|||
105407703|NCT03083665|363500149|FG002|Double-Blind Period|Withdrawal by Subject|0|||
105407704|NCT03083665|363500150|FG003|Double-Blind Period|Withdrawal by Subject|0|||
105407705|NCT03083665|363500151|FG004|Double-Blind Period|Withdrawal by Subject|0|||
105407706|NCT03083665|363500152|FG005|Double-Blind Period|Withdrawal by Subject|0|||
105494896|NCT04916769|363824927|FG002|Period 1|Physician Decision|0|||
105407707|NCT03083665|363500147|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
105407708|NCT03083665|363500148|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
105494897|NCT04916769|363824928|FG003|Period 1|Physician Decision|0|||
105494898|NCT04916769|363824929|FG004|Period 1|Physician Decision|0|||
105494899|NCT04916769|363824930|FG005|Period 1|Physician Decision|1|||
105494900|NCT04916769|363824925|FG000|Period 2|Physician Decision|0|||
105494901|NCT04916769|363824926|FG001|Period 2|Physician Decision|1|||
105494902|NCT04916769|363824927|FG002|Period 2|Physician Decision|0|||
105494903|NCT04916769|363824928|FG003|Period 2|Physician Decision|0|||
105494904|NCT04916769|363824929|FG004|Period 2|Physician Decision|0|||
105494905|NCT04916769|363824930|FG005|Period 2|Physician Decision|0|||
105494906|NCT05736224|363824931|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
105494907|NCT04526509|363824932|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
105581016|NCT01474512|364126476|FG011|Long-Term Extension Period|Death|0|||
105407709|NCT03083665|363500149|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
105407710|NCT03083665|363500150|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
105407711|NCT03083665|363500151|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
105407712|NCT03083665|363500152|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
105407713|NCT03083665|363500147|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
105407714|NCT03083665|363500148|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
105407715|NCT03083665|363500149|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
105407716|NCT03083665|363500150|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
105407717|NCT03083665|363500151|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
105407718|NCT03083665|363500152|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
105407719|NCT03083665|363500147|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
105407720|NCT03083665|363500148|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
105407721|NCT03083665|363500149|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
105407722|NCT03083665|363500150|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
105407723|NCT03083665|363500151|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
105407724|NCT03083665|363500152|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
105407725|NCT03083665|363500147|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
105407726|NCT03083665|363500148|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
105407727|NCT03083665|363500149|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
105407728|NCT03083665|363500150|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
105407729|NCT03083665|363500151|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
105407730|NCT03083665|363500152|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
105407731|NCT03083665|363500147|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
105407732|NCT03083665|363500148|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
105407733|NCT03083665|363500149|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
105407734|NCT03083665|363500150|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
105407735|NCT03083665|363500151|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
105407736|NCT03083665|363500152|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
105407737|NCT03083665|363500147|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
105407738|NCT03083665|363500148|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
105407739|NCT03083665|363500149|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
105407740|NCT03083665|363500150|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
105407741|NCT03083665|363500151|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
105407742|NCT03083665|363500152|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
105407743|NCT03083665|363500147|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
105407744|NCT03083665|363500148|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
105407745|NCT03083665|363500149|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
105407746|NCT03083665|363500150|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
105407747|NCT03083665|363500151|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
105407748|NCT03083665|363500152|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
105407749|NCT03083665|363500147|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
105407750|NCT03083665|363500148|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
105407751|NCT03083665|363500149|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
105407752|NCT03083665|363500150|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
105407753|NCT03083665|363500151|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
105407754|NCT03083665|363500152|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
105407755|NCT03083665|363500147|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
105407756|NCT03083665|363500148|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
105407757|NCT03083665|363500149|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
105407758|NCT03083665|363500150|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
105407759|NCT03083665|363500151|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
105407760|NCT03083665|363500152|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
105407761|NCT02484443|363500155|FG000|Overall Study|Lack of Efficacy|28|||
105407762|NCT02484443|363500155|FG000|Overall Study|Physician Decision|2|||
105581017|NCT01474512|364126477|FG012|Long-Term Extension Period|Death|9|||
105407763|NCT02484443|363500155|FG000|Overall Study|Ineligible|2|||
105407764|NCT01467466|363500156|FG000|Overall Study|Withdrawal by Subject|15|||
105407765|NCT01467466|363500157|FG001|Overall Study|Withdrawal by Subject|18|||
105407766|NCT01467466|363500158|FG002|Overall Study|Withdrawal by Subject|13|||
105407767|NCT01467466|363500159|FG003|Overall Study|Withdrawal by Subject|11|||
105407768|NCT01467466|363500156|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
105407769|NCT01467466|363500157|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
105407770|NCT01467466|363500158|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
105407771|NCT01467466|363500159|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
105407772|NCT01467466|363500156|FG000|Overall Study|Procedure Cancelled|46|||
105407773|NCT01467466|363500157|FG001|Overall Study|Procedure Cancelled|45|||
105407774|NCT01467466|363500158|FG002|Overall Study|Procedure Cancelled|25|||
105407775|NCT01467466|363500159|FG003|Overall Study|Procedure Cancelled|29|||
105407776|NCT01467466|363500156|FG000|Overall Study|No Endpoint Blood Draw|38|||
105407777|NCT01467466|363500157|FG001|Overall Study|No Endpoint Blood Draw|32|||
105407778|NCT01467466|363500158|FG002|Overall Study|No Endpoint Blood Draw|51|||
105407779|NCT01467466|363500159|FG003|Overall Study|No Endpoint Blood Draw|43|||
105407780|NCT02012218|363500164|FG000|Overall Study|Withdrawal by Subject|1|||
105407781|NCT02012218|363500165|FG001|Overall Study|Withdrawal by Subject|0|||
105407782|NCT02012218|363500166|FG002|Overall Study|Withdrawal by Subject|1|||
105407783|NCT02012218|363500167|FG003|Overall Study|Withdrawal by Subject|1|||
105407784|NCT02012218|363500168|FG004|Overall Study|Withdrawal by Subject|1|||
105407785|NCT02012218|363500164|FG000|Overall Study|Adverse Event|1|||
105407786|NCT02012218|363500165|FG001|Overall Study|Adverse Event|0|||
105407787|NCT02012218|363500166|FG002|Overall Study|Adverse Event|0|||
105407788|NCT02012218|363500167|FG003|Overall Study|Adverse Event|1|||
105407789|NCT02012218|363500168|FG004|Overall Study|Adverse Event|0|||
105407790|NCT02012218|363500164|FG000|Overall Study|Lost to Follow-up|0|||
105407791|NCT02012218|363500165|FG001|Overall Study|Lost to Follow-up|1|||
105407792|NCT02012218|363500166|FG002|Overall Study|Lost to Follow-up|1|||
105407793|NCT02012218|363500167|FG003|Overall Study|Lost to Follow-up|0|||
105407794|NCT02012218|363500168|FG004|Overall Study|Lost to Follow-up|0|||
105407795|NCT02012218|363500164|FG000|Overall Study|Protocol Specified|1|||
105407796|NCT02012218|363500165|FG001|Overall Study|Protocol Specified|0|||
105407797|NCT02012218|363500166|FG002|Overall Study|Protocol Specified|0|||
105407798|NCT02012218|363500167|FG003|Overall Study|Protocol Specified|0|||
105407799|NCT02012218|363500168|FG004|Overall Study|Protocol Specified|0|||
105407800|NCT02012218|363500164|FG000|Overall Study|Protocol Deviation|1|||
105407801|NCT02012218|363500165|FG001|Overall Study|Protocol Deviation|0|||
105407802|NCT02012218|363500166|FG002|Overall Study|Protocol Deviation|0|||
105407803|NCT02012218|363500167|FG003|Overall Study|Protocol Deviation|0|||
105407804|NCT02012218|363500168|FG004|Overall Study|Protocol Deviation|0|||
105407805|NCT01232127|363500169|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
105407806|NCT01232127|363500170|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
105407807|NCT01232127|363500171|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
105407808|NCT03008070|363500172|FG000|Overall Study|Adverse Event|3|||
105407809|NCT03008070|363500173|FG001|Overall Study|Adverse Event|3|||
105407810|NCT03008070|363500174|FG002|Overall Study|Adverse Event|3|||
105407811|NCT03008070|363500172|FG000|Overall Study|Lost to Follow-up|1|||
105407812|NCT03008070|363500173|FG001|Overall Study|Lost to Follow-up|1|||
105407813|NCT03008070|363500174|FG002|Overall Study|Lost to Follow-up|0|||
105407814|NCT03008070|363500172|FG000|Overall Study|Non compliance|0|||
105407815|NCT03008070|363500173|FG001|Overall Study|Non compliance|1|||
105407816|NCT03008070|363500174|FG002|Overall Study|Non compliance|1|||
105407817|NCT03008070|363500172|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
105407818|NCT03008070|363500173|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
105407819|NCT03008070|363500174|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
105407820|NCT03008070|363500172|FG000|Overall Study|Withdrawal by Subject|2|||
105407821|NCT03008070|363500173|FG001|Overall Study|Withdrawal by Subject|0|||
105407822|NCT03008070|363500174|FG002|Overall Study|Withdrawal by Subject|1|||
105407823|NCT03008070|363500172|FG000|Overall Study|Use of prohibited drug|0|||
105407824|NCT03008070|363500173|FG001|Overall Study|Use of prohibited drug|0|||
105407825|NCT03008070|363500174|FG002|Overall Study|Use of prohibited drug|2|||
105407826|NCT00104728|363500177|FG000|Overall Study|screen failures|19|||
105407827|NCT01963767|363500178|FG000|Overall Study|Withdrawal by Subject|4|||
105407828|NCT01963767|363500179|FG001|Overall Study|Withdrawal by Subject|2|||
105407829|NCT01963767|363500178|FG000|Overall Study|Adverse Event|2|||
105407830|NCT01963767|363500179|FG001|Overall Study|Adverse Event|0|||
105407831|NCT03640325|363501737|FG000|Overall Study|Withdrawal by Subject|4|||
105407832|NCT03640325|363501738|FG001|Overall Study|Withdrawal by Subject|1|||
105407833|NCT03640325|363501739|FG002|Overall Study|Withdrawal by Subject|0|||
105407834|NCT03640325|363501737|FG000|Overall Study|Lost to Follow-up|4|||
105407835|NCT03640325|363501738|FG001|Overall Study|Lost to Follow-up|5|||
105407836|NCT03640325|363501739|FG002|Overall Study|Lost to Follow-up|21|||
105407837|NCT03640325|363501737|FG000|Overall Study|Death|5|||
105581018|NCT01474512|364126478|FG013|Long-Term Extension Period|Death|9|||
105407838|NCT03640325|363501738|FG001|Overall Study|Death|5|||
105407839|NCT03640325|363501739|FG002|Overall Study|Death|0|||
105407840|NCT01566149|363501742|FG000|Overall Study|Adverse Event|0|||
105407841|NCT01566149|363501743|FG001|Overall Study|Adverse Event|1|||
105407842|NCT01566149|363501742|FG000|Overall Study|Non-compliance with study medication|2|||
105407843|NCT01566149|363501743|FG001|Overall Study|Non-compliance with study medication|0|||
105407844|NCT01566149|363501742|FG000|Overall Study|Protocol Violation|0|||
105407845|NCT01566149|363501743|FG001|Overall Study|Protocol Violation|1|||
105407846|NCT01566149|363501742|FG000|Overall Study|Withdrawal by Subject|1|||
105407847|NCT01566149|363501743|FG001|Overall Study|Withdrawal by Subject|0|||
105407848|NCT03276728|363501744|FG000|Overall Study|Lost to Follow-up|0|||
105407849|NCT03276728|363501745|FG001|Overall Study|Lost to Follow-up|0|||
105407850|NCT03276728|363501746|FG002|Overall Study|Lost to Follow-up|2|||
105407851|NCT03276728|363501747|FG003|Overall Study|Lost to Follow-up|2|||
105407852|NCT03276728|363501748|FG004|Overall Study|Lost to Follow-up|0|||
105407853|NCT03276728|363501749|FG005|Overall Study|Lost to Follow-up|0|||
105407854|NCT03276728|363501750|FG006|Overall Study|Lost to Follow-up|0|||
105407855|NCT03276728|363501751|FG007|Overall Study|Lost to Follow-up|0|||
105407856|NCT03276728|363501744|FG000|Overall Study|Withdrawal by Subject|0|||
105407857|NCT03276728|363501745|FG001|Overall Study|Withdrawal by Subject|0|||
105407858|NCT03276728|363501746|FG002|Overall Study|Withdrawal by Subject|0|||
105407859|NCT03276728|363501747|FG003|Overall Study|Withdrawal by Subject|3|||
105407860|NCT03276728|363501748|FG004|Overall Study|Withdrawal by Subject|0|||
105407861|NCT03276728|363501749|FG005|Overall Study|Withdrawal by Subject|0|||
105407862|NCT03276728|363501750|FG006|Overall Study|Withdrawal by Subject|0|||
105407863|NCT03276728|363501751|FG007|Overall Study|Withdrawal by Subject|0|||
105407864|NCT03276728|363501744|FG000|Overall Study|Decision by sponsor|0|||
105407865|NCT03276728|363501745|FG001|Overall Study|Decision by sponsor|0|||
105407866|NCT03276728|363501746|FG002|Overall Study|Decision by sponsor|0|||
105407867|NCT03276728|363501747|FG003|Overall Study|Decision by sponsor|0|||
105407868|NCT03276728|363501748|FG004|Overall Study|Decision by sponsor|1|||
105407869|NCT03276728|363501749|FG005|Overall Study|Decision by sponsor|0|||
105407870|NCT03276728|363501750|FG006|Overall Study|Decision by sponsor|2|||
105407871|NCT03276728|363501751|FG007|Overall Study|Decision by sponsor|1|||
105407872|NCT02982772|363501754|FG000|Intervention|Lost to Follow-up|19|||
105407873|NCT02982772|363501755|FG001|Intervention|Lost to Follow-up|13|||
105407874|NCT02982772|363501754|FG000|1M Follow-Up|Lost to Follow-up|21|||
105407875|NCT02982772|363501755|FG001|1M Follow-Up|Lost to Follow-up|18|||
105407876|NCT02982772|363501754|FG000|3M Follow-Up|Lost to Follow-up|17|||
105407877|NCT02982772|363501755|FG001|3M Follow-Up|Lost to Follow-up|11|||
105407878|NCT02982772|363501754|FG000|6M Follow-Up|Lost to Follow-up|11|||
105407879|NCT02982772|363501755|FG001|6M Follow-Up|Lost to Follow-up|9|||
105407880|NCT02982772|363501754|FG000|12M Follow-Up|Lost to Follow-up|11|||
105407881|NCT02982772|363501755|FG001|12M Follow-Up|Lost to Follow-up|5|||
105407882|NCT01713582|363501758|FG000|Overall Study|Disease progression|3|||
105407883|NCT01713582|363501759|FG001|Overall Study|Disease progression|3|||
105407884|NCT01713582|363501760|FG002|Overall Study|Disease progression|3|||
105407885|NCT01713582|363501761|FG003|Overall Study|Disease progression|2|||
105407886|NCT01713582|363501762|FG004|Overall Study|Disease progression|3|||
105407887|NCT01713582|363501763|FG005|Overall Study|Disease progression|3|||
105407888|NCT01713582|363501764|FG006|Overall Study|Disease progression|3|||
105407889|NCT01713582|363501765|FG007|Overall Study|Disease progression|3|||
105407890|NCT01713582|363501766|FG008|Overall Study|Disease progression|3|||
105494908|NCT04526509|363824933|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
105494909|NCT04526509|363824934|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
105494910|NCT04526509|363824935|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
105494911|NCT04526509|363824936|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
105407891|NCT01713582|363501767|FG009|Overall Study|Disease progression|11|||
105407892|NCT01713582|363501768|FG010|Overall Study|Disease progression|10|||
105407893|NCT01713582|363501769|FG011|Overall Study|Disease progression|5|||
105407894|NCT01713582|363501770|FG012|Overall Study|Disease progression|3|||
105407895|NCT01713582|363501771|FG013|Overall Study|Disease progression|3|||
105407896|NCT01713582|363501772|FG014|Overall Study|Disease progression|6|||
105407897|NCT01713582|363501773|FG015|Overall Study|Disease progression|6|||
105407898|NCT01713582|363501774|FG016|Overall Study|Disease progression|5|||
105407899|NCT01713582|363501775|FG017|Overall Study|Disease progression|2|||
105407900|NCT01713582|363501776|FG018|Overall Study|Disease progression|3|||
105407901|NCT01713582|363501777|FG019|Overall Study|Disease progression|5|||
105407902|NCT01713582|363501778|FG020|Overall Study|Disease progression|15|||
105407903|NCT01713582|363501758|FG000|Overall Study|Death|0|||
105407904|NCT01713582|363501759|FG001|Overall Study|Death|0|||
105407905|NCT01713582|363501760|FG002|Overall Study|Death|0|||
105494912|NCT04526509|363824937|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
105494913|NCT04526509|363824938|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
105581019|NCT01474512|364126479|FG014|Long-Term Extension Period|Death|0|||
105581020|NCT01474512|364126480|FG015|Long-Term Extension Period|Death|0|||
105581021|NCT01474512|364126481|FG016|Long-Term Extension Period|Death|0|||
105581022|NCT01474512|364126482|FG017|Long-Term Extension Period|Death|0|||
105407906|NCT01713582|363501761|FG003|Overall Study|Death|1|||
105407907|NCT01713582|363501762|FG004|Overall Study|Death|1|||
105407908|NCT01713582|363501763|FG005|Overall Study|Death|3|||
105407909|NCT01713582|363501764|FG006|Overall Study|Death|3|||
105581023|NCT01474512|364126465|FG000|Long-Term Extension Period|Sponsor Decision|0|||
105581024|NCT01474512|364126466|FG001|Long-Term Extension Period|Sponsor Decision|0|||
105581025|NCT01474512|364126467|FG002|Long-Term Extension Period|Sponsor Decision|0|||
105581026|NCT01474512|364126468|FG003|Long-Term Extension Period|Sponsor Decision|0|||
105581027|NCT01474512|364126469|FG004|Long-Term Extension Period|Sponsor Decision|0|||
105581028|NCT01474512|364126470|FG005|Long-Term Extension Period|Sponsor Decision|0|||
105581029|NCT01474512|364126471|FG006|Long-Term Extension Period|Sponsor Decision|0|||
105581030|NCT01474512|364126472|FG007|Long-Term Extension Period|Sponsor Decision|0|||
105581031|NCT01474512|364126473|FG008|Long-Term Extension Period|Sponsor Decision|0|||
105581032|NCT01474512|364126474|FG009|Long-Term Extension Period|Sponsor Decision|0|||
105581033|NCT01474512|364126475|FG010|Long-Term Extension Period|Sponsor Decision|0|||
105581034|NCT01474512|364126476|FG011|Long-Term Extension Period|Sponsor Decision|0|||
105581035|NCT01474512|364126477|FG012|Long-Term Extension Period|Sponsor Decision|6|||
105581036|NCT01474512|364126478|FG013|Long-Term Extension Period|Sponsor Decision|6|||
105581037|NCT01474512|364126479|FG014|Long-Term Extension Period|Sponsor Decision|0|||
105581038|NCT01474512|364126480|FG015|Long-Term Extension Period|Sponsor Decision|0|||
105581039|NCT01474512|364126481|FG016|Long-Term Extension Period|Sponsor Decision|0|||
105581040|NCT01474512|364126482|FG017|Long-Term Extension Period|Sponsor Decision|0|||
105581041|NCT01474512|364126465|FG000|Long-Term Extension Period|Protocol Violation|0|||
105581042|NCT01474512|364126466|FG001|Long-Term Extension Period|Protocol Violation|0|||
105581043|NCT01474512|364126467|FG002|Long-Term Extension Period|Protocol Violation|0|||
105581044|NCT01474512|364126468|FG003|Long-Term Extension Period|Protocol Violation|0|||
105581045|NCT01474512|364126469|FG004|Long-Term Extension Period|Protocol Violation|0|||
105581046|NCT01474512|364126470|FG005|Long-Term Extension Period|Protocol Violation|0|||
105581047|NCT01474512|364126471|FG006|Long-Term Extension Period|Protocol Violation|0|||
105581048|NCT01474512|364126472|FG007|Long-Term Extension Period|Protocol Violation|0|||
105581049|NCT01474512|364126473|FG008|Long-Term Extension Period|Protocol Violation|0|||
105581050|NCT01474512|364126474|FG009|Long-Term Extension Period|Protocol Violation|0|||
105581051|NCT01474512|364126475|FG010|Long-Term Extension Period|Protocol Violation|0|||
105581052|NCT01474512|364126476|FG011|Long-Term Extension Period|Protocol Violation|0|||
105581053|NCT01474512|364126477|FG012|Long-Term Extension Period|Protocol Violation|5|||
105581054|NCT01474512|364126478|FG013|Long-Term Extension Period|Protocol Violation|5|||
105581055|NCT01474512|364126479|FG014|Long-Term Extension Period|Protocol Violation|0|||
105581056|NCT01474512|364126480|FG015|Long-Term Extension Period|Protocol Violation|0|||
105581057|NCT01474512|364126481|FG016|Long-Term Extension Period|Protocol Violation|0|||
105581058|NCT01474512|364126482|FG017|Long-Term Extension Period|Protocol Violation|0|||
105581059|NCT01474512|364126465|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581060|NCT01474512|364126466|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581061|NCT01474512|364126467|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581062|NCT01474512|364126468|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581063|NCT01474512|364126469|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581064|NCT01474512|364126470|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581065|NCT01474512|364126471|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581066|NCT01474512|364126472|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581067|NCT01474512|364126473|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581068|NCT01474512|364126474|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581069|NCT01474512|364126475|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581070|NCT01474512|364126476|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581071|NCT01474512|364126477|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
105581072|NCT01474512|364126478|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
105581073|NCT01474512|364126479|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581074|NCT01474512|364126480|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581075|NCT01474512|364126481|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581076|NCT01474512|364126482|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
105581077|NCT01474512|364126465|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105581078|NCT01474512|364126466|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105581079|NCT01474512|364126467|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105581080|NCT01474512|364126468|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105581081|NCT01474512|364126469|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105581082|NCT01474512|364126470|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105581083|NCT01474512|364126471|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105581084|NCT01474512|364126472|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105581085|NCT01474512|364126473|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105581086|NCT01474512|364126474|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105581087|NCT01474512|364126475|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105581088|NCT01474512|364126476|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
105581089|NCT01474512|364126477|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105581090|NCT01474512|364126478|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105407910|NCT01713582|363501765|FG007|Overall Study|Death|2|||
105407911|NCT01713582|363501766|FG008|Overall Study|Death|3|||
105407912|NCT01713582|363501767|FG009|Overall Study|Death|4|||
105407913|NCT01713582|363501768|FG010|Overall Study|Death|3|||
105407914|NCT01713582|363501769|FG011|Overall Study|Death|0|||
105407915|NCT01713582|363501770|FG012|Overall Study|Death|0|||
105407916|NCT01713582|363501771|FG013|Overall Study|Death|0|||
105407917|NCT01713582|363501772|FG014|Overall Study|Death|0|||
105407918|NCT01713582|363501773|FG015|Overall Study|Death|0|||
105407919|NCT01713582|363501774|FG016|Overall Study|Death|0|||
105407920|NCT01713582|363501775|FG017|Overall Study|Death|0|||
105407921|NCT01713582|363501776|FG018|Overall Study|Death|0|||
105407922|NCT01713582|363501777|FG019|Overall Study|Death|0|||
105407923|NCT01713582|363501778|FG020|Overall Study|Death|0|||
105407924|NCT01713582|363501758|FG000|Overall Study|Adverse event-related|0|||
105407925|NCT01713582|363501759|FG001|Overall Study|Adverse event-related|0|||
105407926|NCT01713582|363501760|FG002|Overall Study|Adverse event-related|0|||
105407927|NCT01713582|363501761|FG003|Overall Study|Adverse event-related|0|||
105407928|NCT01713582|363501762|FG004|Overall Study|Adverse event-related|0|||
105407929|NCT01713582|363501763|FG005|Overall Study|Adverse event-related|0|||
105407930|NCT01713582|363501764|FG006|Overall Study|Adverse event-related|0|||
105407931|NCT01713582|363501765|FG007|Overall Study|Adverse event-related|0|||
105407932|NCT01713582|363501766|FG008|Overall Study|Adverse event-related|0|||
105407933|NCT01713582|363501767|FG009|Overall Study|Adverse event-related|1|||
105407934|NCT01713582|363501768|FG010|Overall Study|Adverse event-related|1|||
105407935|NCT01713582|363501769|FG011|Overall Study|Adverse event-related|0|||
105407936|NCT01713582|363501770|FG012|Overall Study|Adverse event-related|0|||
105407937|NCT01713582|363501771|FG013|Overall Study|Adverse event-related|0|||
105407938|NCT01713582|363501772|FG014|Overall Study|Adverse event-related|0|||
105407939|NCT01713582|363501773|FG015|Overall Study|Adverse event-related|0|||
105407940|NCT01713582|363501774|FG016|Overall Study|Adverse event-related|0|||
105407941|NCT01713582|363501775|FG017|Overall Study|Adverse event-related|0|||
105407942|NCT01713582|363501776|FG018|Overall Study|Adverse event-related|1|||
105407943|NCT01713582|363501777|FG019|Overall Study|Adverse event-related|0|||
105407944|NCT01713582|363501778|FG020|Overall Study|Adverse event-related|0|||
105407945|NCT01713582|363501758|FG000|Overall Study|Adverse event-unrelated|0|||
105407946|NCT01713582|363501759|FG001|Overall Study|Adverse event-unrelated|0|||
105407947|NCT01713582|363501760|FG002|Overall Study|Adverse event-unrelated|0|||
105407948|NCT01713582|363501761|FG003|Overall Study|Adverse event-unrelated|0|||
105407949|NCT01713582|363501762|FG004|Overall Study|Adverse event-unrelated|0|||
105407950|NCT01713582|363501763|FG005|Overall Study|Adverse event-unrelated|1|||
105407951|NCT01713582|363501764|FG006|Overall Study|Adverse event-unrelated|1|||
105407952|NCT01713582|363501765|FG007|Overall Study|Adverse event-unrelated|1|||
105407953|NCT01713582|363501766|FG008|Overall Study|Adverse event-unrelated|0|||
105407954|NCT01713582|363501767|FG009|Overall Study|Adverse event-unrelated|0|||
105407955|NCT01713582|363501768|FG010|Overall Study|Adverse event-unrelated|0|||
105407956|NCT01713582|363501769|FG011|Overall Study|Adverse event-unrelated|0|||
105407957|NCT01713582|363501770|FG012|Overall Study|Adverse event-unrelated|0|||
105407958|NCT01713582|363501771|FG013|Overall Study|Adverse event-unrelated|1|||
105407959|NCT01713582|363501772|FG014|Overall Study|Adverse event-unrelated|1|||
105407960|NCT01713582|363501773|FG015|Overall Study|Adverse event-unrelated|0|||
105407961|NCT01713582|363501774|FG016|Overall Study|Adverse event-unrelated|0|||
105407962|NCT01713582|363501775|FG017|Overall Study|Adverse event-unrelated|0|||
105407963|NCT01713582|363501776|FG018|Overall Study|Adverse event-unrelated|0|||
105407964|NCT01713582|363501777|FG019|Overall Study|Adverse event-unrelated|0|||
105407965|NCT01713582|363501778|FG020|Overall Study|Adverse event-unrelated|0|||
105407966|NCT01713582|363501758|FG000|Overall Study|Withdrawal of consent|0|||
105407967|NCT01713582|363501759|FG001|Overall Study|Withdrawal of consent|0|||
105407968|NCT01713582|363501760|FG002|Overall Study|Withdrawal of consent|1|||
105407969|NCT01713582|363501761|FG003|Overall Study|Withdrawal of consent|0|||
105407970|NCT01713582|363501762|FG004|Overall Study|Withdrawal of consent|0|||
105407971|NCT01713582|363501763|FG005|Overall Study|Withdrawal of consent|1|||
105407972|NCT01713582|363501764|FG006|Overall Study|Withdrawal of consent|0|||
105407973|NCT01713582|363501765|FG007|Overall Study|Withdrawal of consent|0|||
105407974|NCT01713582|363501766|FG008|Overall Study|Withdrawal of consent|0|||
105407975|NCT01713582|363501767|FG009|Overall Study|Withdrawal of consent|1|||
105407976|NCT01713582|363501768|FG010|Overall Study|Withdrawal of consent|0|||
105407977|NCT01713582|363501769|FG011|Overall Study|Withdrawal of consent|0|||
105407978|NCT01713582|363501770|FG012|Overall Study|Withdrawal of consent|0|||
105407979|NCT01713582|363501771|FG013|Overall Study|Withdrawal of consent|0|||
105407980|NCT01713582|363501772|FG014|Overall Study|Withdrawal of consent|0|||
105494914|NCT04526509|363824932|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
105494915|NCT04526509|363824933|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
105581091|NCT01474512|364126479|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105407981|NCT01713582|363501773|FG015|Overall Study|Withdrawal of consent|0|||
105407982|NCT01713582|363501774|FG016|Overall Study|Withdrawal of consent|0|||
105407983|NCT01713582|363501775|FG017|Overall Study|Withdrawal of consent|0|||
105407984|NCT01713582|363501776|FG018|Overall Study|Withdrawal of consent|1|||
105407985|NCT01713582|363501777|FG019|Overall Study|Withdrawal of consent|0|||
105407986|NCT01713582|363501778|FG020|Overall Study|Withdrawal of consent|0|||
105407987|NCT01713582|363501758|FG000|Overall Study|Lack of Efficacy|0|||
105407988|NCT01713582|363501759|FG001|Overall Study|Lack of Efficacy|0|||
105407989|NCT01713582|363501760|FG002|Overall Study|Lack of Efficacy|0|||
105407990|NCT01713582|363501761|FG003|Overall Study|Lack of Efficacy|0|||
105407991|NCT01713582|363501762|FG004|Overall Study|Lack of Efficacy|0|||
105407992|NCT01713582|363501763|FG005|Overall Study|Lack of Efficacy|0|||
105407993|NCT01713582|363501764|FG006|Overall Study|Lack of Efficacy|0|||
105407994|NCT01713582|363501765|FG007|Overall Study|Lack of Efficacy|0|||
105407995|NCT01713582|363501766|FG008|Overall Study|Lack of Efficacy|0|||
105407996|NCT01713582|363501767|FG009|Overall Study|Lack of Efficacy|1|||
105407997|NCT01713582|363501768|FG010|Overall Study|Lack of Efficacy|2|||
105407998|NCT01713582|363501769|FG011|Overall Study|Lack of Efficacy|0|||
105407999|NCT01713582|363501770|FG012|Overall Study|Lack of Efficacy|0|||
105408000|NCT01713582|363501771|FG013|Overall Study|Lack of Efficacy|0|||
105408001|NCT01713582|363501772|FG014|Overall Study|Lack of Efficacy|0|||
105408002|NCT01713582|363501773|FG015|Overall Study|Lack of Efficacy|0|||
105494916|NCT04526509|363824934|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
105494917|NCT04526509|363824935|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
105494918|NCT04526509|363824936|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
105494919|NCT04526509|363824937|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
105494920|NCT04526509|363824938|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
105494921|NCT04526509|363824932|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
105494922|NCT04526509|363824933|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
105494923|NCT04526509|363824934|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
105494924|NCT04526509|363824935|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
105494925|NCT04526509|363824936|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
105494926|NCT04526509|363824937|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
105494927|NCT04526509|363824938|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
105494928|NCT04526509|363824932|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
105494929|NCT04526509|363824933|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
105494930|NCT04526509|363824934|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
105494931|NCT04526509|363824935|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
105494932|NCT04526509|363824936|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
105494933|NCT04526509|363824937|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
105494934|NCT04526509|363824938|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
105494935|NCT04526509|363824932|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
105494936|NCT04526509|363824933|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
105494937|NCT04526509|363824934|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
105494938|NCT04526509|363824935|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
105494939|NCT04526509|363824936|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
105494940|NCT04526509|363824937|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
105494941|NCT04526509|363824938|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
105494942|NCT04526509|363824932|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
105494943|NCT04526509|363824933|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
105494944|NCT04526509|363824934|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
105494945|NCT04526509|363824935|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
105494946|NCT04526509|363824936|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
105408003|NCT01713582|363501774|FG016|Overall Study|Lack of Efficacy|0|||
105408004|NCT01713582|363501775|FG017|Overall Study|Lack of Efficacy|0|||
105408005|NCT01713582|363501776|FG018|Overall Study|Lack of Efficacy|0|||
105408006|NCT01713582|363501777|FG019|Overall Study|Lack of Efficacy|0|||
105408007|NCT01713582|363501778|FG020|Overall Study|Lack of Efficacy|0|||
105408008|NCT01713582|363501758|FG000|Overall Study|Withdrawal by Subject|0|||
105408009|NCT01713582|363501759|FG001|Overall Study|Withdrawal by Subject|0|||
105408010|NCT01713582|363501760|FG002|Overall Study|Withdrawal by Subject|0|||
105408011|NCT01713582|363501761|FG003|Overall Study|Withdrawal by Subject|0|||
105408012|NCT01713582|363501762|FG004|Overall Study|Withdrawal by Subject|0|||
105408013|NCT01713582|363501763|FG005|Overall Study|Withdrawal by Subject|0|||
105408014|NCT01713582|363501764|FG006|Overall Study|Withdrawal by Subject|0|||
105408015|NCT01713582|363501765|FG007|Overall Study|Withdrawal by Subject|0|||
105408016|NCT01713582|363501766|FG008|Overall Study|Withdrawal by Subject|0|||
105408017|NCT01713582|363501767|FG009|Overall Study|Withdrawal by Subject|0|||
105408018|NCT01713582|363501768|FG010|Overall Study|Withdrawal by Subject|0|||
105408019|NCT01713582|363501769|FG011|Overall Study|Withdrawal by Subject|0|||
105408020|NCT01713582|363501770|FG012|Overall Study|Withdrawal by Subject|0|||
105408021|NCT01713582|363501771|FG013|Overall Study|Withdrawal by Subject|0|||
105408022|NCT01713582|363501772|FG014|Overall Study|Withdrawal by Subject|0|||
105408023|NCT01713582|363501773|FG015|Overall Study|Withdrawal by Subject|0|||
105408024|NCT01713582|363501774|FG016|Overall Study|Withdrawal by Subject|0|||
105408025|NCT01713582|363501775|FG017|Overall Study|Withdrawal by Subject|1|||
105408026|NCT01713582|363501776|FG018|Overall Study|Withdrawal by Subject|0|||
105408027|NCT01713582|363501777|FG019|Overall Study|Withdrawal by Subject|0|||
105408028|NCT01713582|363501778|FG020|Overall Study|Withdrawal by Subject|0|||
105408029|NCT01713582|363501758|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
105408030|NCT01713582|363501759|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
105408031|NCT01713582|363501760|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
105408032|NCT01713582|363501761|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
105408033|NCT01713582|363501762|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
105408034|NCT01713582|363501763|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
105408035|NCT01713582|363501764|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
105408036|NCT01713582|363501765|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
105408037|NCT01713582|363501766|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
105408038|NCT01713582|363501767|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
105408039|NCT01713582|363501768|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
105408040|NCT01713582|363501769|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
105408041|NCT01713582|363501770|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
105408042|NCT01713582|363501771|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
105408043|NCT01713582|363501772|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
105408044|NCT01713582|363501773|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
105408045|NCT01713582|363501774|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
105408046|NCT01713582|363501775|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
105408047|NCT01713582|363501776|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
105408048|NCT01713582|363501777|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
105408049|NCT01713582|363501778|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
105408050|NCT01713582|363501758|FG000|Overall Study|Disease progression and adverse event|0|||
105408051|NCT01713582|363501759|FG001|Overall Study|Disease progression and adverse event|0|||
105408052|NCT01713582|363501760|FG002|Overall Study|Disease progression and adverse event|0|||
105408053|NCT01713582|363501761|FG003|Overall Study|Disease progression and adverse event|0|||
105408054|NCT01713582|363501762|FG004|Overall Study|Disease progression and adverse event|0|||
105408055|NCT01713582|363501763|FG005|Overall Study|Disease progression and adverse event|0|||
105408056|NCT01713582|363501764|FG006|Overall Study|Disease progression and adverse event|0|||
105408057|NCT01713582|363501765|FG007|Overall Study|Disease progression and adverse event|0|||
105408058|NCT01713582|363501766|FG008|Overall Study|Disease progression and adverse event|0|||
105408059|NCT01713582|363501767|FG009|Overall Study|Disease progression and adverse event|0|||
105408060|NCT01713582|363501768|FG010|Overall Study|Disease progression and adverse event|0|||
105408061|NCT01713582|363501769|FG011|Overall Study|Disease progression and adverse event|0|||
105408062|NCT01713582|363501770|FG012|Overall Study|Disease progression and adverse event|0|||
105408063|NCT01713582|363501771|FG013|Overall Study|Disease progression and adverse event|0|||
105408064|NCT01713582|363501772|FG014|Overall Study|Disease progression and adverse event|0|||
105408065|NCT01713582|363501773|FG015|Overall Study|Disease progression and adverse event|0|||
105408066|NCT01713582|363501774|FG016|Overall Study|Disease progression and adverse event|1|||
105408067|NCT01713582|363501775|FG017|Overall Study|Disease progression and adverse event|0|||
105408068|NCT01713582|363501776|FG018|Overall Study|Disease progression and adverse event|0|||
105408069|NCT01713582|363501777|FG019|Overall Study|Disease progression and adverse event|0|||
105408070|NCT01713582|363501778|FG020|Overall Study|Disease progression and adverse event|0|||
105408071|NCT04971967|363501779|FG000|Overall Study|Lost to Follow-up|6|||
105408072|NCT04971967|363501780|FG001|Overall Study|Lost to Follow-up|7|||
105408073|NCT02297815|363501790|FG000|Overall Study|Lost to Follow-up|236|||
105408074|NCT02297815|363501791|FG001|Overall Study|Lost to Follow-up|140|||
105408075|NCT00662831|363501795|FG000|Overall Study|Death|4|||
105408076|NCT00662831|363501796|FG001|Overall Study|Death|1|||
105408077|NCT00662831|363501795|FG000|Overall Study|Lack of Efficacy|6|||
105408078|NCT00662831|363501796|FG001|Overall Study|Lack of Efficacy|6|||
105581092|NCT01474512|364126480|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105581093|NCT01474512|364126481|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105581094|NCT01474512|364126482|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105581095|NCT01474512|364126465|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
105581096|NCT01474512|364126466|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
105581097|NCT01474512|364126467|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
105581098|NCT01474512|364126468|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
105581099|NCT01474512|364126469|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
105581100|NCT01474512|364126470|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
105581101|NCT01474512|364126471|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
105581102|NCT01474512|364126472|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
105581103|NCT01474512|364126473|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
105581104|NCT01474512|364126474|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
105581105|NCT01474512|364126475|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
105581106|NCT01474512|364126476|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
105581107|NCT01474512|364126477|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
105581108|NCT01474512|364126478|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
105581109|NCT01474512|364126479|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
105581110|NCT01474512|364126480|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
105581111|NCT01474512|364126481|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
105581112|NCT01474512|364126482|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
105581113|NCT01474512|364126465|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105581114|NCT01474512|364126466|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105581115|NCT01474512|364126467|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105581116|NCT01474512|364126468|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105581117|NCT01474512|364126469|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105581118|NCT01474512|364126470|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105581119|NCT01474512|364126471|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105581120|NCT01474512|364126472|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105581121|NCT01474512|364126473|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105581122|NCT01474512|364126474|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105581123|NCT01474512|364126475|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105581124|NCT01474512|364126476|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105581125|NCT01474512|364126477|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105581126|NCT01474512|364126478|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105581127|NCT01474512|364126479|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
105581128|NCT01474512|364126480|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
105581129|NCT01474512|364126481|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
105581130|NCT01474512|364126482|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
105581131|NCT01474512|364126465|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
105581132|NCT01474512|364126466|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
105581133|NCT01474512|364126467|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
105581134|NCT01474512|364126468|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
105581135|NCT01474512|364126469|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
105581136|NCT01474512|364126470|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
105581137|NCT01474512|364126471|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
105581138|NCT01474512|364126472|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
105581139|NCT01474512|364126473|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
105581140|NCT01474512|364126474|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
105581141|NCT01474512|364126475|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
105581142|NCT01474512|364126476|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
105581143|NCT01474512|364126477|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
105581144|NCT01474512|364126478|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
105581145|NCT01474512|364126479|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
105581146|NCT01474512|364126480|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
105581147|NCT01474512|364126481|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
105581148|NCT01474512|364126482|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
105581149|NCT01474512|364126465|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105581150|NCT01474512|364126466|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105581151|NCT01474512|364126467|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105581152|NCT01474512|364126468|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105581153|NCT01474512|364126469|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105581154|NCT01474512|364126470|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105581155|NCT01474512|364126471|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105581156|NCT01474512|364126472|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105581157|NCT01474512|364126473|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105581158|NCT01474512|364126474|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105581159|NCT01474512|364126475|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105581160|NCT01474512|364126476|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105581161|NCT01474512|364126477|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105581162|NCT01474512|364126478|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105581163|NCT01474512|364126479|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105408079|NCT00662831|363501795|FG000|Overall Study|Lost to Follow-up|1|||
105408080|NCT00662831|363501796|FG001|Overall Study|Lost to Follow-up|0|||
105408081|NCT00662831|363501795|FG000|Overall Study|Withdrawal by Subject|2|||
105408082|NCT00662831|363501796|FG001|Overall Study|Withdrawal by Subject|1|||
105408083|NCT00662831|363501795|FG000|Overall Study|Other|62|||
105408084|NCT00662831|363501796|FG001|Overall Study|Other|31|||
105408085|NCT00662831|363501795|FG000|Overall Study|Protocol Violation|8|||
105408086|NCT00662831|363501796|FG001|Overall Study|Protocol Violation|4|||
105408087|NCT00662831|363501795|FG000|Overall Study|Adverse Event|23|||
105408088|NCT00662831|363501796|FG001|Overall Study|Adverse Event|16|||
105408089|NCT02964273|363501797|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
105408090|NCT02964273|363501798|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
105408091|NCT02964273|363501799|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
105408092|NCT02964273|363501800|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
105408093|NCT02964273|363501797|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
105408094|NCT02964273|363501798|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
105408095|NCT02964273|363501799|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
105408096|NCT02964273|363501800|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
105408097|NCT02964273|363501797|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
105408098|NCT02964273|363501798|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
105408099|NCT02964273|363501799|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
105408100|NCT02964273|363501800|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
105408101|NCT02964273|363501797|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
105408102|NCT02964273|363501798|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
105408103|NCT02964273|363501799|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
105408104|NCT02964273|363501800|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
105408105|NCT02964273|363501797|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
105408106|NCT02964273|363501798|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
105408107|NCT02964273|363501799|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
105408108|NCT02964273|363501800|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
105408109|NCT02964273|363501797|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
105408110|NCT02964273|363501798|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
105408111|NCT02964273|363501799|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
105408112|NCT02964273|363501800|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
105408113|NCT03333928|363501802|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
105408114|NCT03333928|363501803|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
105408115|NCT03333928|363501804|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
105408116|NCT03333928|363501802|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
105408117|NCT03333928|363501803|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
105408118|NCT03333928|363501804|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
105408119|NCT03333928|363501802|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
105408120|NCT03333928|363501803|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
105408121|NCT03333928|363501804|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
105408122|NCT03333928|363501802|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
105408123|NCT03333928|363501803|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
105408124|NCT03333928|363501804|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
105408125|NCT03333928|363501802|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
105408126|NCT03333928|363501803|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
105408127|NCT03333928|363501804|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
105408128|NCT03333928|363501802|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
105408129|NCT03333928|363501803|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
105408130|NCT03333928|363501804|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
105408131|NCT03333928|363501802|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
105408132|NCT03333928|363501803|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
105408133|NCT03333928|363501804|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
105408134|NCT03333928|363501802|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
105408135|NCT03333928|363501803|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
105408136|NCT03333928|363501804|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
105408137|NCT01453036|363501805|FG000|Overall Study|Lost to Follow-up|26|||
105408138|NCT01453036|363501806|FG001|Overall Study|Lost to Follow-up|115|||
105408139|NCT01453036|363501807|FG002|Overall Study|Lost to Follow-up|31|||
105408140|NCT00559104|363501808|FG000|Overall Study|Lack of Efficacy|9|||
105408141|NCT00559104|363501809|FG001|Overall Study|Lack of Efficacy|0|||
105408142|NCT04723355|363501810|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
105408143|NCT04723355|363501810|FG000|Overall Study|Errors in the informed consent form|2|||
105581164|NCT01474512|364126480|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
105408144|NCT03073525|363501812|FG000|Overall Study|Withdrawal by Subject|0|||
105408145|NCT03073525|363501813|FG001|Overall Study|Withdrawal by Subject|0|||
105408146|NCT03073525|363501814|FG002|Overall Study|Withdrawal by Subject|3|||
105408147|NCT03458325|363501815|FG000|Overall Study|Withdrawal by Subject|1|||
105408148|NCT00735553|363501823|FG000|Overall Study|Study prematurely terminated|77|||
105408149|NCT00175916|363501824|FG000|Overall Study|Death|19|||
105408150|NCT00175916|363501824|FG000|Overall Study|Adverse Event|81|||
105408151|NCT00175916|363501824|FG000|Overall Study|Lack of Efficacy|354|||
105408152|NCT00175916|363501824|FG000|Overall Study|Lost to Follow-up|17|||
105408153|NCT00175916|363501824|FG000|Overall Study|Subject Choice|98|||
105408154|NCT00175916|363501824|FG000|Overall Study|Lack of compliance|8|||
105408155|NCT00175916|363501824|FG000|Overall Study|Patient cannot record seizures|1|||
105408156|NCT00175916|363501824|FG000|Overall Study|Sponsor decision|17|||
105408157|NCT00175916|363501824|FG000|Overall Study|Vigabatrin intake|1|||
105408158|NCT00175916|363501824|FG000|Overall Study|Suicidal behaviour|1|||
105408159|NCT00175916|363501824|FG000|Overall Study|Withdrawal by Subject|1|||
105408160|NCT00175916|363501824|FG000|Overall Study|Seizure - free|4|||
105408161|NCT00175916|363501824|FG000|Overall Study|Administrative reason|1|||
105408162|NCT00175916|363501824|FG000|Overall Study|Pregnancy|1|||
105408163|NCT00175916|363501824|FG000|Overall Study|Patient's request|2|||
105408164|NCT00175916|363501824|FG000|Overall Study|Treating physiciant's choice|1|||
105408165|NCT00175916|363501824|FG000|Overall Study|Moved overseas|1|||
105408166|NCT00175916|363501824|FG000|Overall Study|Loss of job and economic burden|1|||
105408167|NCT00175916|363501824|FG000|Overall Study|Site was closed|9|||
105408168|NCT00175916|363501824|FG000|Overall Study|Patient went to prison|1|||
105408169|NCT00310375|363501825|FG000|Primary Reporting Phase|Adverse Event|28|||
105408170|NCT00310375|363501826|FG001|Primary Reporting Phase|Adverse Event|22|||
105408171|NCT00310375|363501827|FG002|Primary Reporting Phase|Adverse Event|0|||
105408172|NCT00310375|363501825|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
105408173|NCT00310375|363501826|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
105408174|NCT00310375|363501827|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
105408175|NCT00310375|363501825|FG000|Primary Reporting Phase|Pregnancy|2|||
105408176|NCT00310375|363501826|FG001|Primary Reporting Phase|Pregnancy|2|||
105408177|NCT00310375|363501827|FG002|Primary Reporting Phase|Pregnancy|0|||
105408178|NCT00310375|363501825|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
105408179|NCT00310375|363501826|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
105408180|NCT00310375|363501827|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
105408181|NCT00310375|363501825|FG000|Primary Reporting Phase|Protocol Violation|8|||
105408182|NCT00310375|363501826|FG001|Primary Reporting Phase|Protocol Violation|5|||
105408183|NCT00310375|363501827|FG002|Primary Reporting Phase|Protocol Violation|0|||
105408184|NCT00310375|363501825|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
105408185|NCT00310375|363501826|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
105408186|NCT00310375|363501827|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
105408187|NCT00310375|363501825|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
105408188|NCT00310375|363501826|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
105408189|NCT00310375|363501827|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
105408190|NCT00310375|363501825|FG000|Primary Reporting Phase|Physician Decision|5|||
105408191|NCT00310375|363501826|FG001|Primary Reporting Phase|Physician Decision|3|||
105408192|NCT00310375|363501827|FG002|Primary Reporting Phase|Physician Decision|0|||
105408193|NCT00310375|363501825|FG000|Primary Reporting Phase|Request of the sponsor|2|||
105408194|NCT00310375|363501826|FG001|Primary Reporting Phase|Request of the sponsor|2|||
105408195|NCT00310375|363501827|FG002|Primary Reporting Phase|Request of the sponsor|0|||
105408196|NCT00310375|363501825|FG000|Primary Reporting Phase|Failed to return|1|||
105408197|NCT00310375|363501826|FG001|Primary Reporting Phase|Failed to return|3|||
105408198|NCT00310375|363501827|FG002|Primary Reporting Phase|Failed to return|0|||
105408199|NCT00310375|363501825|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
105408200|NCT00310375|363501826|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
105408201|NCT00310375|363501827|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
105408202|NCT00310375|363501825|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
105408203|NCT00310375|363501826|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
105408204|NCT00310375|363501827|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
105408205|NCT00310375|363501825|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
105408206|NCT00310375|363501826|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
105408207|NCT00310375|363501827|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
105408208|NCT00310375|363501825|FG000|Primary Reporting Phase|Site closure|3|||
105408209|NCT00310375|363501826|FG001|Primary Reporting Phase|Site closure|0|||
105408210|NCT00310375|363501827|FG002|Primary Reporting Phase|Site closure|0|||
105408211|NCT00310375|363501825|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
105408212|NCT00310375|363501826|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
105408213|NCT00310375|363501827|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
105408214|NCT00310375|363501825|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
105581165|NCT01474512|364126481|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
105581166|NCT01474512|364126482|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
105581167|NCT01474512|364126465|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
105581168|NCT01474512|364126466|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
105581169|NCT01474512|364126467|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
105581170|NCT01474512|364126468|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
105581171|NCT01474512|364126469|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
105581172|NCT01474512|364126470|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
105581173|NCT01474512|364126471|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
105581174|NCT01474512|364126472|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
105494947|NCT04526509|363824937|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
105494948|NCT04526509|363824938|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
105494949|NCT04526509|363824932|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
105494950|NCT04526509|363824933|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
105494951|NCT04526509|363824934|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
105494952|NCT04526509|363824935|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
105494953|NCT04526509|363824936|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
105494954|NCT04526509|363824937|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
105494955|NCT04526509|363824938|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
105494956|NCT04526509|363824932|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
105494957|NCT04526509|363824933|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
105494958|NCT04526509|363824934|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
105494959|NCT04526509|363824935|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
105494960|NCT04526509|363824936|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
105494961|NCT04526509|363824937|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
105494962|NCT04526509|363824938|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
105494963|NCT04526509|363824932|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
105494964|NCT04526509|363824933|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
105494965|NCT04526509|363824934|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
105494966|NCT04526509|363824935|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
105494967|NCT04526509|363824936|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
105494968|NCT04526509|363824937|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
105494969|NCT04526509|363824938|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
105494970|NCT04526509|363824932|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
105494971|NCT04526509|363824933|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
105581175|NCT01474512|364126473|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
105581176|NCT01474512|364126474|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
105581177|NCT01474512|364126475|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
105408215|NCT00310375|363501826|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
105408216|NCT00310375|363501827|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
105408217|NCT00310375|363501825|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
105408218|NCT00310375|363501826|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
105408219|NCT00310375|363501827|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
105408220|NCT00310375|363501825|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
105408221|NCT00310375|363501826|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
105408222|NCT00310375|363501827|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
105408223|NCT01973231|363501829|FG000|Overall Study|Protocol Violation|1|||
105408224|NCT01973231|363501830|FG001|Overall Study|Protocol Violation|1|||
105408225|NCT01973231|363501829|FG000|Overall Study|Lost to Follow-up|1|||
105408226|NCT01973231|363501830|FG001|Overall Study|Lost to Follow-up|1|||
105408227|NCT01973231|363501829|FG000|Overall Study|unclassified|2|||
105408228|NCT01973231|363501830|FG001|Overall Study|unclassified|1|||
105408229|NCT01973231|363501829|FG000|Overall Study|Withdrawal by Subject|7|||
105408230|NCT01973231|363501830|FG001|Overall Study|Withdrawal by Subject|9|||
105408231|NCT02831855|363501833|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
105408232|NCT02831855|363501834|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
105408233|NCT02831855|363501835|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
105408234|NCT02831855|363501833|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
105408235|NCT02831855|363501834|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
105408236|NCT02831855|363501835|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
105408237|NCT02831855|363501833|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
105408238|NCT02831855|363501834|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
105408239|NCT02831855|363501835|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
105408240|NCT02831855|363501833|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
105408241|NCT02831855|363501834|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
105408242|NCT02831855|363501835|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
105408243|NCT02831855|363501833|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
105408244|NCT02831855|363501834|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
105408245|NCT02831855|363501835|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
105408246|NCT02831855|363501833|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
105408247|NCT02831855|363501834|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
105408248|NCT02831855|363501835|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
105408249|NCT02831855|363501833|FG000|Open Label Phase (24 Weeks)|Other|4|||
105408250|NCT02831855|363501834|FG001|Open Label Phase (24 Weeks)|Other|0|||
105408251|NCT02831855|363501835|FG002|Open Label Phase (24 Weeks)|Other|0|||
105408252|NCT02831855|363501833|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
105408253|NCT02831855|363501834|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
105408254|NCT02831855|363501835|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
105408255|NCT02831855|363501833|FG000|Double Blind Phase (24 Weeks)|Death|0|||
105408256|NCT02831855|363501834|FG001|Double Blind Phase (24 Weeks)|Death|0|||
105408257|NCT02831855|363501835|FG002|Double Blind Phase (24 Weeks)|Death|2|||
105408258|NCT02831855|363501833|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
105408259|NCT02831855|363501834|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
105408260|NCT02831855|363501835|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
105408261|NCT02831855|363501833|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
105408262|NCT02831855|363501834|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
105408263|NCT02831855|363501835|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
105408264|NCT02831855|363501833|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
105494972|NCT04526509|363824934|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
105494973|NCT04526509|363824935|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
105494974|NCT04526509|363824936|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
105494975|NCT04526509|363824937|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
105494976|NCT04526509|363824938|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
105494977|NCT04526509|363824932|FG000|Enrolled|Study Terminated by Sponsor|0|||
105494978|NCT04526509|363824933|FG001|Enrolled|Study Terminated by Sponsor|0|||
105494979|NCT04526509|363824934|FG002|Enrolled|Study Terminated by Sponsor|0|||
105494980|NCT04526509|363824935|FG003|Enrolled|Study Terminated by Sponsor|0|||
105494981|NCT04526509|363824936|FG004|Enrolled|Study Terminated by Sponsor|0|||
105494982|NCT04526509|363824937|FG005|Enrolled|Study Terminated by Sponsor|0|||
105494983|NCT04526509|363824938|FG006|Enrolled|Study Terminated by Sponsor|1|||
105494984|NCT04526509|363824932|FG000|Enrolled|Death prior to lymphodepletion|0|||
105494985|NCT04526509|363824933|FG001|Enrolled|Death prior to lymphodepletion|0|||
105494986|NCT04526509|363824934|FG002|Enrolled|Death prior to lymphodepletion|0|||
105494987|NCT04526509|363824935|FG003|Enrolled|Death prior to lymphodepletion|1|||
105408265|NCT02831855|363501834|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
105408266|NCT02831855|363501835|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
105408267|NCT02831855|363501833|FG000|Double Blind Phase (24 Weeks)|Other|0|||
105408268|NCT02831855|363501834|FG001|Double Blind Phase (24 Weeks)|Other|2|||
105408269|NCT02831855|363501835|FG002|Double Blind Phase (24 Weeks)|Other|5|||
105408270|NCT02831855|363501833|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
105408271|NCT02831855|363501834|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
105408272|NCT02831855|363501835|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
105408273|NCT02831855|363501833|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
105494988|NCT04526509|363824936|FG004|Enrolled|Death prior to lymphodepletion|0|||
105408274|NCT02831855|363501834|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
105494989|NCT04526509|363824937|FG005|Enrolled|Death prior to lymphodepletion|0|||
105494990|NCT04526509|363824938|FG006|Enrolled|Death prior to lymphodepletion|0|||
105494991|NCT04526509|363824932|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
105494992|NCT04526509|363824933|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
105494993|NCT04526509|363824934|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
105494994|NCT04526509|363824935|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
105494995|NCT04526509|363824936|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
105494996|NCT04526509|363824937|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
105494997|NCT04526509|363824938|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
105494998|NCT04526509|363824932|FG000|Enrolled|Physician Decision|0|||
105494999|NCT04526509|363824933|FG001|Enrolled|Physician Decision|1|||
105495000|NCT04526509|363824934|FG002|Enrolled|Physician Decision|0|||
105495001|NCT04526509|363824935|FG003|Enrolled|Physician Decision|0|||
105495002|NCT04526509|363824936|FG004|Enrolled|Physician Decision|0|||
105495003|NCT04526509|363824937|FG005|Enrolled|Physician Decision|0|||
105495004|NCT04526509|363824938|FG006|Enrolled|Physician Decision|0|||
105495005|NCT02612129|363824939|FG000|Single Dose Treatment Period|Screening Failure|1|||
105495006|NCT02612129|363824940|FG001|Single Dose Treatment Period|Screening Failure|0|||
105495007|NCT02612129|363824941|FG002|Single Dose Treatment Period|Screening Failure|0|||
105495008|NCT02612129|363824939|FG000|Continuous Treatment Period|Early Escape|0|||
105495009|NCT02612129|363824940|FG001|Continuous Treatment Period|Early Escape|2|||
105495010|NCT02612129|363824941|FG002|Continuous Treatment Period|Early Escape|0|||
105495011|NCT02612129|363824939|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
105495012|NCT02612129|363824940|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
105408275|NCT02831855|363501835|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
105408276|NCT02831855|363501833|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
105408277|NCT02831855|363501834|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
105408278|NCT02831855|363501835|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
105408279|NCT02298868|363501836|FG000|Overall Study|Adverse Event|1|||
105408280|NCT02298868|363501836|FG000|Overall Study|Death|1|||
105408281|NCT02298868|363501836|FG000|Overall Study|Patient underwent transplant|1|||
105408282|NCT01485796|363501837|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
105408283|NCT01485796|363501837|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
105408284|NCT01485796|363501837|FG000|Period 2: Epoch 2|Adverse Event|3|||
105408285|NCT01485796|363501837|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
105408286|NCT01485796|363501837|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
105408287|NCT01485796|363501837|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
105408288|NCT01485796|363501837|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
105408289|NCT01485796|363501837|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
105408290|NCT04830215|363501838|FG000|Overall Study|Adverse Event|6|||
105408291|NCT04830215|363501838|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
105408292|NCT04830215|363501838|FG000|Overall Study|Withdrawal by Subject|3|||
105408293|NCT04830215|363501838|FG000|Overall Study|Protocol Deviation|1|||
105408294|NCT01206140|363501840|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
105408295|NCT01206140|363501841|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
105408296|NCT01773967|363501842|FG000|Overall Study|Lost to Follow-up|15|||
105408297|NCT01773967|363501843|FG001|Overall Study|Lost to Follow-up|13|||
105408298|NCT00211172|363501846|FG000|Overall Study|Died or lost health plan eligibility|39|||
105408299|NCT00211172|363501847|FG001|Overall Study|Died or lost health plan eligibility|32|||
105408300|NCT01643408|363501852|FG000|Overall Study|Adverse Event|12|||
105408301|NCT01643408|363501852|FG000|Overall Study|Other|2|||
105408302|NCT04677543|363501853|FG000|Overall Study|Withdrawal by Subject|4|||
105408303|NCT04677543|363501854|FG001|Overall Study|Withdrawal by Subject|1|||
105408304|NCT04677543|363501853|FG000|Overall Study|Physician Decision|0|||
105408305|NCT04677543|363501854|FG001|Overall Study|Physician Decision|1|||
105408306|NCT04677543|363501853|FG000|Overall Study|Adverse Event|0|||
105408307|NCT04677543|363501854|FG001|Overall Study|Adverse Event|1|||
105408308|NCT03902392|363501855|FG000|Overall Study|Lost to Follow-up|7|||
105408309|NCT03902392|363501856|FG001|Overall Study|Lost to Follow-up|7|||
105408310|NCT02969915|363501857|FG000|Overall Study|Death|104|||
105408311|NCT02969915|363501858|FG001|Overall Study|Death|125|||
105408312|NCT02969915|363501857|FG000|Overall Study|Lost to Follow-up|108|||
105408313|NCT02969915|363501858|FG001|Overall Study|Lost to Follow-up|112|||
105408314|NCT02969915|363501857|FG000|Overall Study|Censored due to COVID-19|481|||
105408315|NCT02969915|363501858|FG001|Overall Study|Censored due to COVID-19|471|||
105408316|NCT02503085|363501859|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
105408317|NCT02503085|363501860|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
105408318|NCT02503085|363501861|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
105408319|NCT02503085|363501862|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
105408320|NCT02131311|363501866|FG000|Overall Study|Adverse Event|2|||
105408321|NCT02131311|363501866|FG000|Overall Study|Protocol Violation|1|||
105408322|NCT02131311|363501866|FG000|Overall Study|Lost to Follow-up|1|||
105408323|NCT02063984|363501869|FG000|Overall Study|Lost to Follow-up|6|||
105408324|NCT02063984|363501870|FG001|Overall Study|Lost to Follow-up|5|||
105408325|NCT04466384|363501874|FG000|First Phase|Protocol Violation|1|||
105408326|NCT04466384|363501875|FG001|First Phase|Protocol Violation|0|||
105408327|NCT04466384|363501874|FG000|First Phase|Missing data|1|||
105408328|NCT04466384|363501875|FG001|First Phase|Missing data|0|||
105408329|NCT04466384|363501874|FG000|Cross Over Phase|Physician Decision|1|||
105408330|NCT04466384|363501875|FG001|Cross Over Phase|Physician Decision|0|||
105408331|NCT04466384|363501874|FG000|Cross Over Phase|Withdrawal by Subject|0|||
105408332|NCT04466384|363501875|FG001|Cross Over Phase|Withdrawal by Subject|1|||
105408333|NCT03599518|363501878|FG000|Overall Study|Clinical progression|0|||
105408334|NCT03599518|363501879|FG001|Overall Study|Clinical progression|0|||
105408335|NCT03599518|363501880|FG002|Overall Study|Clinical progression|0|||
105408336|NCT03599518|363501881|FG003|Overall Study|Clinical progression|0|||
105408337|NCT03599518|363501882|FG004|Overall Study|Clinical progression|1|||
105408338|NCT03599518|363501878|FG000|Overall Study|Adverse Event|0|||
105408339|NCT03599518|363501879|FG001|Overall Study|Adverse Event|0|||
105408340|NCT03599518|363501880|FG002|Overall Study|Adverse Event|0|||
105408341|NCT03599518|363501881|FG003|Overall Study|Adverse Event|0|||
105408342|NCT03599518|363501882|FG004|Overall Study|Adverse Event|1|||
105408343|NCT03599518|363501878|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
105408344|NCT03599518|363501879|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
105408345|NCT03599518|363501880|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
105408346|NCT03599518|363501881|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
105408347|NCT03599518|363501882|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
105495013|NCT02612129|363824941|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
105495014|NCT02612129|363824939|FG000|Continuous Treatment Period|Safety Reasons|0|||
105408348|NCT03599518|363501878|FG000|Overall Study|Participant withdrawal from study treatment|0|||
105408349|NCT03599518|363501879|FG001|Overall Study|Participant withdrawal from study treatment|0|||
105408350|NCT03599518|363501880|FG002|Overall Study|Participant withdrawal from study treatment|1|||
105408351|NCT03599518|363501881|FG003|Overall Study|Participant withdrawal from study treatment|0|||
105408352|NCT03599518|363501882|FG004|Overall Study|Participant withdrawal from study treatment|0|||
105408353|NCT01016132|363501886|FG000|Overall Study|Discomfort|1|||
105408354|NCT00326001|363501887|FG000|Overall Study|Adverse Event|4|||
105408355|NCT00326001|363501888|FG001|Overall Study|Adverse Event|5|||
105408356|NCT00326001|363501887|FG000|Overall Study|Physician Decision|3|||
105408357|NCT00326001|363501888|FG001|Overall Study|Physician Decision|3|||
105408358|NCT02931838|363501889|FG000|Overall Study|Reason not provided by investigator|1|||
105408359|NCT02931838|363501890|FG001|Overall Study|Reason not provided by investigator|0|||
105408360|NCT02931838|363501891|FG002|Overall Study|Reason not provided by investigator|1|||
105408361|NCT02931838|363501892|FG003|Overall Study|Reason not provided by investigator|0|||
105408362|NCT02931838|363501893|FG004|Overall Study|Reason not provided by investigator|0|||
105408363|NCT02931838|363501894|FG005|Overall Study|Reason not provided by investigator|0|||
105408364|NCT02931838|363501889|FG000|Overall Study|Poor/non-compliance|0|||
105408365|NCT02931838|363501890|FG001|Overall Study|Poor/non-compliance|0|||
105408366|NCT02931838|363501891|FG002|Overall Study|Poor/non-compliance|1|||
105408367|NCT02931838|363501892|FG003|Overall Study|Poor/non-compliance|0|||
105408368|NCT02931838|363501893|FG004|Overall Study|Poor/non-compliance|0|||
105408369|NCT02931838|363501894|FG005|Overall Study|Poor/non-compliance|0|||
105408370|NCT02931838|363501889|FG000|Overall Study|Lack of Efficacy|5|||
105408371|NCT02931838|363501890|FG001|Overall Study|Lack of Efficacy|4|||
105408372|NCT02931838|363501891|FG002|Overall Study|Lack of Efficacy|0|||
105408373|NCT02931838|363501892|FG003|Overall Study|Lack of Efficacy|0|||
105408374|NCT02931838|363501893|FG004|Overall Study|Lack of Efficacy|0|||
105408375|NCT02931838|363501894|FG005|Overall Study|Lack of Efficacy|1|||
105408376|NCT02931838|363501889|FG000|Overall Study|Lost to Follow-up|1|||
105408377|NCT02931838|363501890|FG001|Overall Study|Lost to Follow-up|0|||
105408378|NCT02931838|363501891|FG002|Overall Study|Lost to Follow-up|1|||
105408379|NCT02931838|363501892|FG003|Overall Study|Lost to Follow-up|1|||
105408380|NCT02931838|363501893|FG004|Overall Study|Lost to Follow-up|2|||
105408381|NCT02931838|363501894|FG005|Overall Study|Lost to Follow-up|0|||
105408382|NCT02931838|363501889|FG000|Overall Study|Subject request to discontinue treatment|4|||
105408383|NCT02931838|363501890|FG001|Overall Study|Subject request to discontinue treatment|3|||
105408384|NCT02931838|363501891|FG002|Overall Study|Subject request to discontinue treatment|3|||
105408385|NCT02931838|363501892|FG003|Overall Study|Subject request to discontinue treatment|0|||
105408386|NCT02931838|363501893|FG004|Overall Study|Subject request to discontinue treatment|1|||
105408387|NCT02931838|363501894|FG005|Overall Study|Subject request to discontinue treatment|0|||
105408388|NCT02931838|363501889|FG000|Overall Study|Withdrawal by Subject|1|||
105408389|NCT02931838|363501890|FG001|Overall Study|Withdrawal by Subject|2|||
105408390|NCT02931838|363501891|FG002|Overall Study|Withdrawal by Subject|0|||
105408391|NCT02931838|363501892|FG003|Overall Study|Withdrawal by Subject|1|||
105408392|NCT02931838|363501893|FG004|Overall Study|Withdrawal by Subject|0|||
105408393|NCT02931838|363501894|FG005|Overall Study|Withdrawal by Subject|0|||
105408394|NCT02931838|363501889|FG000|Overall Study|Adverse Event|2|||
105408395|NCT02931838|363501890|FG001|Overall Study|Adverse Event|1|||
105408396|NCT02931838|363501891|FG002|Overall Study|Adverse Event|2|||
105408397|NCT02931838|363501892|FG003|Overall Study|Adverse Event|1|||
105408398|NCT02931838|363501893|FG004|Overall Study|Adverse Event|3|||
105408399|NCT02931838|363501894|FG005|Overall Study|Adverse Event|1|||
105408400|NCT02151786|363501895|FG000|Overall Study|Unavailability of Case Report Form|26|||
105408401|NCT02151786|363501895|FG000|Overall Study|Outside the Contract Period|1|||
105408402|NCT02151786|363501895|FG000|Overall Study|Randomized, not Treated|1|||
105408403|NCT02151786|363501895|FG000|Overall Study|Unavailability of Information|8|||
105408404|NCT02949024|363501896|FG000|Overall Study|Withdrawal by Subject|0|||
105408405|NCT02949024|363501897|FG001|Overall Study|Withdrawal by Subject|1|||
105408406|NCT01082081|363501900|FG000|Overall Study|Lost to Follow-up|0|||
105408407|NCT01082081|363501901|FG001|Overall Study|Lost to Follow-up|0|||
105408408|NCT01082081|363501902|FG002|Overall Study|Lost to Follow-up|1|||
105408409|NCT01082081|363501900|FG000|Overall Study|Withdrawal by Subject|0|||
105408410|NCT01082081|363501901|FG001|Overall Study|Withdrawal by Subject|0|||
105408411|NCT01082081|363501902|FG002|Overall Study|Withdrawal by Subject|1|||
105408412|NCT01082081|363501900|FG000|Overall Study|Other Reason|0|||
105408413|NCT01082081|363501901|FG001|Overall Study|Other Reason|1|||
105408414|NCT01082081|363501902|FG002|Overall Study|Other Reason|0|||
105408415|NCT01042158|363501907|FG000|Overall Study|Physician Decision|1|||
105408416|NCT01575808|363501909|FG000|Overall Study|Death|2|||
105408417|NCT01575808|363501910|FG001|Overall Study|Death|0|||
105408418|NCT01575808|363501909|FG000|Overall Study|Withdrawal by Subject|1|||
105408419|NCT01575808|363501910|FG001|Overall Study|Withdrawal by Subject|0|||
105408420|NCT03159468|363501911|FG000|Overall Study|Withdrawal by Subject|0|||
105408421|NCT03159468|363501912|FG001|Overall Study|Withdrawal by Subject|0|||
105408422|NCT03159468|363501913|FG002|Overall Study|Withdrawal by Subject|3|||
105408423|NCT03159468|363501914|FG003|Overall Study|Withdrawal by Subject|0|||
105408424|NCT03159468|363501915|FG004|Overall Study|Withdrawal by Subject|0|||
105408425|NCT03159468|363501916|FG005|Overall Study|Withdrawal by Subject|0|||
105408426|NCT00375674|363501919|FG000|Overall Study|Other|26|||
105408427|NCT00375674|363501920|FG001|Overall Study|Other|18|||
105408428|NCT00375674|363501919|FG000|Overall Study|Death|67|||
105408429|NCT00375674|363501920|FG001|Overall Study|Death|76|||
105408430|NCT00375674|363501919|FG000|Overall Study|Participants refused further follow-up|31|||
105408431|NCT00375674|363501920|FG001|Overall Study|Participants refused further follow-up|30|||
105408432|NCT00375674|363501919|FG000|Overall Study|Lost to Follow-up|17|||
105408433|NCT00375674|363501920|FG001|Overall Study|Lost to Follow-up|15|||
105408434|NCT00375674|363501919|FG000|Overall Study|Enrolled but not treated|3|||
105408435|NCT00375674|363501920|FG001|Overall Study|Enrolled but not treated|2|||
105408436|NCT00912782|363501921|FG000|Overall Study|Death|2|||
105408437|NCT00912782|363501922|FG001|Overall Study|Death|1|||
105408438|NCT00912782|363501921|FG000|Overall Study|Lost to Follow-up|0|||
105408439|NCT00912782|363501922|FG001|Overall Study|Lost to Follow-up|1|||
105408440|NCT00912782|363501921|FG000|Overall Study|Did not receive vascular access type|1|||
105408441|NCT00912782|363501922|FG001|Overall Study|Did not receive vascular access type|2|||
105408442|NCT00912782|363501921|FG000|Overall Study|Relocated before study completion|0|||
105408443|NCT00912782|363501922|FG001|Overall Study|Relocated before study completion|1|||
105408444|NCT00600106|363503723|FG000|Overall Study|Withdrawal by Subject|1|||
105408445|NCT00600106|363503724|FG001|Overall Study|Withdrawal by Subject|1|||
105408446|NCT00620373|363503726|FG000|Overall Study|Unverified cancer status|33|||
105408447|NCT01061723|363503727|FG000|Overall Study|Adverse Event|0|||
105408448|NCT01061723|363503728|FG001|Overall Study|Adverse Event|2|||
105408449|NCT01061723|363503729|FG002|Overall Study|Adverse Event|5|||
105408450|NCT01061723|363503730|FG003|Overall Study|Adverse Event|5|||
105408451|NCT01061723|363503731|FG004|Overall Study|Adverse Event|2|||
105408452|NCT01061723|363503732|FG005|Overall Study|Adverse Event|6|||
105408453|NCT01061723|363503727|FG000|Overall Study|Lack of Efficacy|2|||
105408454|NCT01061723|363503728|FG001|Overall Study|Lack of Efficacy|3|||
105408455|NCT01061723|363503729|FG002|Overall Study|Lack of Efficacy|4|||
105408456|NCT01061723|363503730|FG003|Overall Study|Lack of Efficacy|2|||
105408457|NCT01061723|363503731|FG004|Overall Study|Lack of Efficacy|1|||
105408458|NCT01061723|363503732|FG005|Overall Study|Lack of Efficacy|1|||
105408459|NCT01061723|363503727|FG000|Overall Study|Randomized but not treated|0|||
105408460|NCT01061723|363503728|FG001|Overall Study|Randomized but not treated|0|||
105408461|NCT01061723|363503729|FG002|Overall Study|Randomized but not treated|0|||
105408462|NCT01061723|363503730|FG003|Overall Study|Randomized but not treated|0|||
105408463|NCT01061723|363503731|FG004|Overall Study|Randomized but not treated|0|||
105408464|NCT01061723|363503732|FG005|Overall Study|Randomized but not treated|1|||
105408465|NCT01061723|363503727|FG000|Overall Study|Other than specified above|2|||
105408466|NCT01061723|363503728|FG001|Overall Study|Other than specified above|1|||
105408467|NCT01061723|363503729|FG002|Overall Study|Other than specified above|1|||
105408468|NCT01061723|363503730|FG003|Overall Study|Other than specified above|1|||
105408469|NCT01061723|363503731|FG004|Overall Study|Other than specified above|0|||
105408470|NCT01061723|363503732|FG005|Overall Study|Other than specified above|1|||
105408471|NCT00293813|363503733|FG000|Overall Study|Physician Decision|0|||
105408472|NCT00293813|363503734|FG001|Overall Study|Physician Decision|1|||
105408473|NCT00293813|363503735|FG002|Overall Study|Physician Decision|0|||
105408474|NCT00293813|363503733|FG000|Overall Study|Adverse Event|3|||
105408475|NCT00293813|363503734|FG001|Overall Study|Adverse Event|1|||
105408476|NCT00293813|363503735|FG002|Overall Study|Adverse Event|1|||
105408477|NCT00293813|363503733|FG000|Overall Study|Withdrawal by Subject|7|||
105408478|NCT00293813|363503734|FG001|Overall Study|Withdrawal by Subject|4|||
105408479|NCT00293813|363503735|FG002|Overall Study|Withdrawal by Subject|4|||
105408480|NCT00293813|363503733|FG000|Overall Study|Lost to Follow-up|3|||
105408481|NCT00293813|363503734|FG001|Overall Study|Lost to Follow-up|2|||
105408482|NCT00293813|363503735|FG002|Overall Study|Lost to Follow-up|3|||
105408483|NCT00293813|363503733|FG000|Overall Study|Noncompliance|0|||
105408484|NCT00293813|363503734|FG001|Overall Study|Noncompliance|1|||
105408485|NCT00293813|363503735|FG002|Overall Study|Noncompliance|0|||
105408486|NCT03308968|363503738|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
105408487|NCT03308968|363503739|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
105408488|NCT03308968|363503740|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
105408489|NCT03308968|363503738|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
105408490|NCT03308968|363503739|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
105408491|NCT03308968|363503740|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
105408492|NCT03308968|363503738|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
105408493|NCT03308968|363503739|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
105408494|NCT03308968|363503740|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
105581178|NCT01474512|364126476|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
105581179|NCT01474512|364126477|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
105581180|NCT01474512|364126478|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
105581181|NCT01474512|364126479|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
105581182|NCT01474512|364126480|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
105581183|NCT01474512|364126481|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
105581184|NCT01474512|364126482|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
105581185|NCT01474512|364126465|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
105581186|NCT01474512|364126466|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
105581187|NCT01474512|364126467|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
105581188|NCT01474512|364126468|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
105408495|NCT03308968|363503738|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
105581189|NCT01474512|364126469|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
105581190|NCT01474512|364126470|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
105581191|NCT01474512|364126471|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
105581192|NCT01474512|364126472|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
105581193|NCT01474512|364126473|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
105581194|NCT01474512|364126474|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
105581195|NCT01474512|364126475|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
105581196|NCT01474512|364126476|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
105581197|NCT01474512|364126477|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
105581198|NCT01474512|364126478|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
105581199|NCT01474512|364126479|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
105581200|NCT01474512|364126480|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
105581201|NCT01474512|364126481|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
105581202|NCT01474512|364126482|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
105581203|NCT01474512|364126465|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
105581204|NCT01474512|364126466|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
105581205|NCT01474512|364126467|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
105408496|NCT03308968|363503739|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
105408497|NCT03308968|363503740|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
105408498|NCT03308968|363503738|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
105408499|NCT03308968|363503739|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
105408500|NCT03308968|363503740|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
105408501|NCT03308968|363503738|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
105408502|NCT03308968|363503739|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
105408503|NCT03308968|363503740|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
105408504|NCT03308968|363503738|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
105408505|NCT03308968|363503739|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
105408506|NCT03308968|363503740|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
105408507|NCT03308968|363503738|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
105408508|NCT03308968|363503739|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
105408509|NCT03308968|363503740|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
105408510|NCT03308968|363503738|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
105408511|NCT03308968|363503739|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
105408512|NCT03308968|363503740|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
105408513|NCT03308968|363503738|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
105408514|NCT03308968|363503739|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
105408515|NCT03308968|363503740|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
105408516|NCT03308968|363503738|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
105408517|NCT03308968|363503739|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
105408518|NCT03308968|363503740|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
105408519|NCT03308968|363503738|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
105408520|NCT03308968|363503739|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
105408521|NCT03308968|363503740|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
105408522|NCT03308968|363503738|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
105408523|NCT03308968|363503739|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
105408524|NCT03308968|363503740|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
105408525|NCT03308968|363503738|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
105408526|NCT03308968|363503739|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
105408527|NCT03308968|363503740|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
105408528|NCT02140970|363503741|FG000|Overall Study|Lost to Follow-up|1|||
105408529|NCT02140970|363503742|FG001|Overall Study|Lost to Follow-up|2|||
105408530|NCT02140970|363503741|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
105581206|NCT01474512|364126468|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
105581207|NCT01474512|364126469|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
105581208|NCT01474512|364126470|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
105581209|NCT01474512|364126471|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
105581210|NCT01474512|364126472|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
105408531|NCT02140970|363503742|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
105408532|NCT02140970|363503741|FG000|Overall Study|Did not meet inclusion criteria|0|||
105408533|NCT02140970|363503742|FG001|Overall Study|Did not meet inclusion criteria|1|||
105408534|NCT03650413|363503743|FG000|Overall Study|Adverse Event|1|||
105408535|NCT03650413|363503743|FG000|Overall Study|Lack of Efficacy|17|||
105408536|NCT03650413|363503743|FG000|Overall Study|Other|9|||
105408537|NCT03650413|363503743|FG000|Overall Study|Physician Decision|2|||
105408538|NCT03650413|363503743|FG000|Overall Study|Study Terminated By Sponsor|16|||
105408539|NCT03650413|363503743|FG000|Overall Study|Withdrawal by Subject|16|||
105408540|NCT01484496|363503749|FG000|Period 1|Protocol Violation|3|||
105408541|NCT01484496|363503750|FG001|Period 1|Protocol Violation|4|||
105408542|NCT01484496|363503751|FG002|Period 1|Protocol Violation|0|||
105408543|NCT01484496|363503752|FG003|Period 1|Protocol Violation|0|||
105408544|NCT01484496|363503749|FG000|Period 1|Physician Decision|5|||
105408545|NCT01484496|363503750|FG001|Period 1|Physician Decision|1|||
105408546|NCT01484496|363503751|FG002|Period 1|Physician Decision|0|||
105408547|NCT01484496|363503752|FG003|Period 1|Physician Decision|0|||
105408548|NCT01484496|363503749|FG000|Period 1|Lack of Efficacy|10|||
105408549|NCT01484496|363503750|FG001|Period 1|Lack of Efficacy|15|||
105408550|NCT01484496|363503751|FG002|Period 1|Lack of Efficacy|0|||
105408551|NCT01484496|363503752|FG003|Period 1|Lack of Efficacy|0|||
105408552|NCT01484496|363503749|FG000|Period 1|Adverse Event|25|||
105408553|NCT01484496|363503750|FG001|Period 1|Adverse Event|40|||
105408554|NCT01484496|363503751|FG002|Period 1|Adverse Event|0|||
105408555|NCT01484496|363503752|FG003|Period 1|Adverse Event|0|||
105408556|NCT01484496|363503749|FG000|Period 1|Withdrawal by Subject|15|||
105408557|NCT01484496|363503750|FG001|Period 1|Withdrawal by Subject|12|||
105408558|NCT01484496|363503751|FG002|Period 1|Withdrawal by Subject|0|||
105408559|NCT01484496|363503752|FG003|Period 1|Withdrawal by Subject|0|||
105408560|NCT01484496|363503749|FG000|Period 1|Lost to Follow-up|2|||
105408561|NCT01484496|363503750|FG001|Period 1|Lost to Follow-up|6|||
105408562|NCT01484496|363503751|FG002|Period 1|Lost to Follow-up|0|||
105408563|NCT01484496|363503752|FG003|Period 1|Lost to Follow-up|0|||
105408564|NCT01484496|363503749|FG000|Period 1|Positive Pregnancy|1|||
105408565|NCT01484496|363503750|FG001|Period 1|Positive Pregnancy|6|||
105408566|NCT01484496|363503751|FG002|Period 1|Positive Pregnancy|0|||
105408567|NCT01484496|363503752|FG003|Period 1|Positive Pregnancy|0|||
105408568|NCT01484496|363503749|FG000|Period 1|Treatment Failure|3|||
105408569|NCT01484496|363503750|FG001|Period 1|Treatment Failure|6|||
105408570|NCT01484496|363503751|FG002|Period 1|Treatment Failure|0|||
105408571|NCT01484496|363503752|FG003|Period 1|Treatment Failure|0|||
105408572|NCT01484496|363503749|FG000|Period 1|Lack of Compliance|2|||
105408573|NCT01484496|363503750|FG001|Period 1|Lack of Compliance|1|||
105408574|NCT01484496|363503751|FG002|Period 1|Lack of Compliance|0|||
105408575|NCT01484496|363503752|FG003|Period 1|Lack of Compliance|0|||
105408576|NCT01484496|363503749|FG000|Period 1|Unable to Visit Site|0|||
105408577|NCT01484496|363503750|FG001|Period 1|Unable to Visit Site|2|||
105408578|NCT01484496|363503751|FG002|Period 1|Unable to Visit Site|0|||
105408579|NCT01484496|363503752|FG003|Period 1|Unable to Visit Site|0|||
105408580|NCT01484496|363503749|FG000|Period 2|Lack of Efficacy|0|||
105408581|NCT01484496|363503750|FG001|Period 2|Lack of Efficacy|0|||
105408582|NCT01484496|363503751|FG002|Period 2|Lack of Efficacy|1|||
105408583|NCT01484496|363503752|FG003|Period 2|Lack of Efficacy|3|||
105408584|NCT01484496|363503749|FG000|Period 2|Adverse Event|0|||
105408585|NCT01484496|363503750|FG001|Period 2|Adverse Event|0|||
105408586|NCT01484496|363503751|FG002|Period 2|Adverse Event|5|||
105408587|NCT01484496|363503752|FG003|Period 2|Adverse Event|13|||
105408588|NCT01484496|363503749|FG000|Period 2|Other|0|||
105408589|NCT01484496|363503750|FG001|Period 2|Other|0|||
105408590|NCT01484496|363503751|FG002|Period 2|Other|9|||
105408591|NCT01484496|363503752|FG003|Period 2|Other|6|||
105408592|NCT02168101|363503755|FG000|Overall Study|Death|2|||
105408593|NCT02168101|363503756|FG001|Overall Study|Death|2|||
105408594|NCT02168101|363503757|FG002|Overall Study|Death|1|||
105408595|NCT00770562|363503762|FG000|Overall Study|Did not take treatment|1|||
105408596|NCT00770562|363503763|FG001|Overall Study|Did not take treatment|1|||
105408597|NCT00881530|363503787|FG000|Overall Study|Adverse Event|5|||
105408598|NCT00881530|363503788|FG001|Overall Study|Adverse Event|1|||
105408599|NCT00881530|363503789|FG002|Overall Study|Adverse Event|1|||
105408600|NCT00881530|363503790|FG003|Overall Study|Adverse Event|4|||
105408601|NCT00881530|363503791|FG004|Overall Study|Adverse Event|10|||
105408602|NCT00881530|363503792|FG005|Overall Study|Adverse Event|2|||
105408603|NCT00881530|363503787|FG000|Overall Study|Lack of Efficacy|1|||
105408604|NCT00881530|363503788|FG001|Overall Study|Lack of Efficacy|0|||
105408605|NCT00881530|363503789|FG002|Overall Study|Lack of Efficacy|0|||
105408606|NCT00881530|363503790|FG003|Overall Study|Lack of Efficacy|0|||
105408607|NCT00881530|363503791|FG004|Overall Study|Lack of Efficacy|1|||
105408608|NCT00881530|363503792|FG005|Overall Study|Lack of Efficacy|1|||
105408609|NCT00881530|363503787|FG000|Overall Study|Not compliant with the protocol|0|||
105408610|NCT00881530|363503788|FG001|Overall Study|Not compliant with the protocol|0|||
105408611|NCT00881530|363503789|FG002|Overall Study|Not compliant with the protocol|0|||
105408612|NCT00881530|363503790|FG003|Overall Study|Not compliant with the protocol|0|||
105408613|NCT00881530|363503791|FG004|Overall Study|Not compliant with the protocol|2|||
105408614|NCT00881530|363503792|FG005|Overall Study|Not compliant with the protocol|0|||
105408615|NCT00881530|363503787|FG000|Overall Study|Lost to Follow-up|0|||
105408616|NCT00881530|363503788|FG001|Overall Study|Lost to Follow-up|1|||
105408617|NCT00881530|363503789|FG002|Overall Study|Lost to Follow-up|1|||
105408618|NCT00881530|363503790|FG003|Overall Study|Lost to Follow-up|3|||
105408619|NCT00881530|363503791|FG004|Overall Study|Lost to Follow-up|1|||
105408620|NCT00881530|363503792|FG005|Overall Study|Lost to Follow-up|0|||
105408621|NCT00881530|363503787|FG000|Overall Study|Refused to continue medication|7|||
105408622|NCT00881530|363503788|FG001|Overall Study|Refused to continue medication|2|||
105408623|NCT00881530|363503789|FG002|Overall Study|Refused to continue medication|1|||
105408624|NCT00881530|363503790|FG003|Overall Study|Refused to continue medication|2|||
105408625|NCT00881530|363503791|FG004|Overall Study|Refused to continue medication|0|||
105408626|NCT00881530|363503792|FG005|Overall Study|Refused to continue medication|0|||
105408627|NCT00881530|363503787|FG000|Overall Study|Other reason not defined above|1|||
105408628|NCT00881530|363503788|FG001|Overall Study|Other reason not defined above|1|||
105408629|NCT00881530|363503789|FG002|Overall Study|Other reason not defined above|2|||
105408630|NCT00881530|363503790|FG003|Overall Study|Other reason not defined above|0|||
105408631|NCT00881530|363503791|FG004|Overall Study|Other reason not defined above|0|||
105408632|NCT00881530|363503792|FG005|Overall Study|Other reason not defined above|2|||
105408633|NCT01509846|363503793|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
105408634|NCT01509846|363503794|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
105408635|NCT01509846|363503795|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
105408636|NCT01509846|363503796|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
105408637|NCT01509846|363503797|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
105408638|NCT01509846|363503793|FG000|Received Vaccination 2|Illness|0|||
105408639|NCT01509846|363503794|FG001|Received Vaccination 2|Illness|0|||
105408640|NCT01509846|363503795|FG002|Received Vaccination 2|Illness|0|||
105408641|NCT01509846|363503796|FG003|Received Vaccination 2|Illness|0|||
105408642|NCT01509846|363503797|FG004|Received Vaccination 2|Illness|1|||
105408643|NCT01509846|363503793|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
105408644|NCT01509846|363503794|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
105408645|NCT01509846|363503795|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
105408646|NCT01509846|363503796|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
105408647|NCT01509846|363503797|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
105495015|NCT02612129|363824940|FG001|Continuous Treatment Period|Safety Reasons|3|||
105495016|NCT02612129|363824941|FG002|Continuous Treatment Period|Safety Reasons|0|||
105495017|NCT02612129|363824939|FG000|Continuous Treatment Period|Death|0|||
105495018|NCT02612129|363824940|FG001|Continuous Treatment Period|Death|1|||
105495019|NCT02612129|363824941|FG002|Continuous Treatment Period|Death|0|||
105495020|NCT02612129|363824939|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
105495021|NCT02612129|363824940|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
105495022|NCT02612129|363824941|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
105495023|NCT01067976|363824942|FG000|Overall Study|Study drug never administered|20|||
105495024|NCT01067976|363824942|FG000|Overall Study|Study prematurely discontinued|2|||
105495025|NCT04449861|363824943|FG000|Overall Study|Withdrawal by Subject|4|||
105495026|NCT04449861|363824943|FG000|Overall Study|Lost to Follow-up|5|||
105495027|NCT04449861|363824943|FG000|Overall Study|Death|112|||
105495028|NCT05268055|363824944|FG000|Overall Study|Lost to Follow-up|68|||
105495029|NCT05268055|363824945|FG001|Overall Study|Lost to Follow-up|68|||
105495030|NCT05268055|363824944|FG000|Overall Study|Withdrawal by Subject|12|||
105495031|NCT05268055|363824945|FG001|Overall Study|Withdrawal by Subject|8|||
105495032|NCT06238362|363824946|FG000|Overall Study|Insufficient total sleep time|1|||
105495033|NCT06238362|363824947|FG001|Overall Study|Insufficient total sleep time|0|||
105495034|NCT06238362|363824946|FG000|Overall Study|Inadequate signal quality|1|||
105495035|NCT06238362|363824947|FG001|Overall Study|Inadequate signal quality|0|||
105495036|NCT05136690|363824948|FG000|Period 1|Withdrawal by Subject|0|||
105495037|NCT05136690|363824949|FG001|Period 1|Withdrawal by Subject|1|||
105495038|NCT05136690|363824948|FG000|Period 2|Lost to Follow-up|0|||
105495039|NCT05136690|363824949|FG001|Period 2|Lost to Follow-up|3|||
105495040|NCT05136690|363824948|FG000|Period 2|Withdrawal by Subject|0|||
105495041|NCT05136690|363824949|FG001|Period 2|Withdrawal by Subject|1|||
105495042|NCT00891462|363826240|FG000|Overall Study|Withdrawal by Subject|9|||
105495043|NCT00891462|363826241|FG001|Overall Study|Withdrawal by Subject|6|||
105495044|NCT00891462|363826242|FG002|Overall Study|Withdrawal by Subject|7|||
105495045|NCT00891462|363826240|FG000|Overall Study|Adverse Event|7|||
105495046|NCT00891462|363826241|FG001|Overall Study|Adverse Event|8|||
105495047|NCT00891462|363826242|FG002|Overall Study|Adverse Event|7|||
105495048|NCT00891462|363826240|FG000|Overall Study|Lack of Efficacy|10|||
105495049|NCT00891462|363826241|FG001|Overall Study|Lack of Efficacy|5|||
105495050|NCT00891462|363826242|FG002|Overall Study|Lack of Efficacy|1|||
105495051|NCT00891462|363826240|FG000|Overall Study|COPD exacerbation|7|||
105495052|NCT00891462|363826241|FG001|Overall Study|COPD exacerbation|4|||
105495053|NCT00891462|363826242|FG002|Overall Study|COPD exacerbation|1|||
105408648|NCT01509846|363503793|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
105581211|NCT01474512|364126473|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
105581212|NCT01474512|364126474|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
105581213|NCT01474512|364126475|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
105581214|NCT01474512|364126476|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
105581215|NCT01474512|364126477|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
105581216|NCT01474512|364126478|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
105581217|NCT01474512|364126479|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
105581218|NCT01474512|364126480|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
105581219|NCT01474512|364126481|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
105581220|NCT01474512|364126482|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
105581221|NCT01474512|364126465|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581222|NCT01474512|364126466|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581223|NCT01474512|364126467|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581224|NCT01474512|364126468|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581225|NCT01474512|364126469|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581226|NCT01474512|364126470|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581227|NCT01474512|364126471|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581228|NCT01474512|364126472|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581229|NCT01474512|364126473|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581230|NCT01474512|364126474|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581231|NCT01474512|364126475|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581232|NCT01474512|364126476|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581233|NCT01474512|364126477|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581234|NCT01474512|364126478|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581235|NCT01474512|364126479|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
105581236|NCT01474512|364126480|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581237|NCT01474512|364126481|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
105581238|NCT01474512|364126482|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
105581239|NCT01474512|364126465|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105581240|NCT01474512|364126466|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105581241|NCT01474512|364126467|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105581242|NCT01474512|364126468|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105581243|NCT01474512|364126469|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105581244|NCT01474512|364126470|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105581245|NCT01474512|364126471|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105408649|NCT01509846|363503794|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
105408650|NCT01509846|363503795|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
105408651|NCT01509846|363503796|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
105408652|NCT01509846|363503797|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
105408653|NCT01509846|363503793|FG000|Received Vaccination 3|Pregnancy|0|||
105408654|NCT01509846|363503794|FG001|Received Vaccination 3|Pregnancy|0|||
105408655|NCT01509846|363503795|FG002|Received Vaccination 3|Pregnancy|0|||
105408656|NCT01509846|363503796|FG003|Received Vaccination 3|Pregnancy|1|||
105408657|NCT01509846|363503797|FG004|Received Vaccination 3|Pregnancy|0|||
105408658|NCT01509846|363503793|FG000|Received Vaccination 3|Lost to Follow-up|0|||
105408659|NCT01509846|363503794|FG001|Received Vaccination 3|Lost to Follow-up|0|||
105408660|NCT01509846|363503795|FG002|Received Vaccination 3|Lost to Follow-up|1|||
105408661|NCT01509846|363503796|FG003|Received Vaccination 3|Lost to Follow-up|0|||
105408662|NCT01509846|363503797|FG004|Received Vaccination 3|Lost to Follow-up|0|||
105408663|NCT04396795|363503799|FG000|Month 1|Lost to Follow-up|2|||
105408664|NCT04396795|363503800|FG001|Month 1|Lost to Follow-up|3|||
105408665|NCT04396795|363503799|FG000|Month 3|Lost to Follow-up|1|||
105408666|NCT04396795|363503800|FG001|Month 3|Lost to Follow-up|3|||
105408667|NCT04396795|363503799|FG000|Month 6|Lost to Follow-up|3|||
105408668|NCT04396795|363503800|FG001|Month 6|Lost to Follow-up|3|||
105581246|NCT01474512|364126472|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105581247|NCT01474512|364126473|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105581248|NCT01474512|364126474|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105581249|NCT01474512|364126475|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105581250|NCT01474512|364126476|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105581251|NCT01474512|364126477|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105581252|NCT01474512|364126478|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105581253|NCT01474512|364126479|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
105581254|NCT01474512|364126480|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105408669|NCT03799952|363503801|FG000|Overall Study|Program was too easy, discontinued|1|||
105408670|NCT03799952|363503802|FG001|Overall Study|Program was too easy, discontinued|0|||
105408671|NCT03799952|363503801|FG000|Overall Study|Lost to Follow-up|0|||
105581255|NCT01474512|364126481|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
105581256|NCT01474512|364126482|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
105408672|NCT03799952|363503802|FG001|Overall Study|Lost to Follow-up|2|||
105408673|NCT01393899|363503803|FG000|Overall Study|Study terminated by sponsor|1|||
105581257|NCT01474512|364126465|FG000|Post-Treatment Follow-Up|Death|0|||
105581258|NCT01474512|364126466|FG001|Post-Treatment Follow-Up|Death|0|||
105581259|NCT01474512|364126467|FG002|Post-Treatment Follow-Up|Death|0|||
105581260|NCT01474512|364126468|FG003|Post-Treatment Follow-Up|Death|0|||
105581261|NCT01474512|364126469|FG004|Post-Treatment Follow-Up|Death|0|||
105581262|NCT01474512|364126470|FG005|Post-Treatment Follow-Up|Death|0|||
105581263|NCT01474512|364126471|FG006|Post-Treatment Follow-Up|Death|0|||
105581264|NCT01474512|364126472|FG007|Post-Treatment Follow-Up|Death|0|||
105581265|NCT01474512|364126473|FG008|Post-Treatment Follow-Up|Death|0|||
105581266|NCT01474512|364126474|FG009|Post-Treatment Follow-Up|Death|0|||
105581267|NCT01474512|364126475|FG010|Post-Treatment Follow-Up|Death|0|||
105581268|NCT01474512|364126476|FG011|Post-Treatment Follow-Up|Death|0|||
105581269|NCT01474512|364126477|FG012|Post-Treatment Follow-Up|Death|0|||
105581270|NCT01474512|364126478|FG013|Post-Treatment Follow-Up|Death|0|||
105581271|NCT01474512|364126479|FG014|Post-Treatment Follow-Up|Death|0|||
105581272|NCT01474512|364126480|FG015|Post-Treatment Follow-Up|Death|0|||
105581273|NCT01474512|364126481|FG016|Post-Treatment Follow-Up|Death|1|||
105581274|NCT01474512|364126482|FG017|Post-Treatment Follow-Up|Death|0|||
105581275|NCT01154036|364126485|FG000|Phase I|Physician Decision|0|||
105581276|NCT01154036|364126486|FG001|Phase I|Physician Decision|1|||
105581277|NCT01154036|364126487|FG002|Phase I|Physician Decision|0|||
105408674|NCT01393899|363503804|FG001|Overall Study|Study terminated by sponsor|0|||
105408675|NCT01393899|363503805|FG002|Overall Study|Study terminated by sponsor|1|||
105581278|NCT01154036|364126488|FG003|Phase I|Physician Decision|0|||
105581279|NCT01154036|364126489|FG004|Phase I|Physician Decision|0|||
105408676|NCT01393899|363503803|FG000|Overall Study|Other|1|||
105408677|NCT01393899|363503804|FG001|Overall Study|Other|0|||
105408678|NCT01393899|363503805|FG002|Overall Study|Other|0|||
105408679|NCT01393899|363503803|FG000|Overall Study|Withdrawal by Subject|2|||
105581280|NCT01154036|364126490|FG005|Phase I|Physician Decision|0|||
105581281|NCT01154036|364126491|FG006|Phase I|Physician Decision|0|||
105581282|NCT01154036|364126492|FG007|Phase I|Physician Decision|0|||
105581283|NCT01154036|364126485|FG000|Phase I|Lost to Follow-up|0|||
105581284|NCT01154036|364126486|FG001|Phase I|Lost to Follow-up|3|||
105581285|NCT01154036|364126487|FG002|Phase I|Lost to Follow-up|6|||
105581286|NCT01154036|364126488|FG003|Phase I|Lost to Follow-up|0|||
105581287|NCT01154036|364126489|FG004|Phase I|Lost to Follow-up|0|||
105581288|NCT01154036|364126490|FG005|Phase I|Lost to Follow-up|0|||
105581289|NCT01154036|364126491|FG006|Phase I|Lost to Follow-up|0|||
105581290|NCT01154036|364126492|FG007|Phase I|Lost to Follow-up|0|||
105581291|NCT01154036|364126485|FG000|Phase I|Protocol Violation|0|||
105581292|NCT01154036|364126486|FG001|Phase I|Protocol Violation|3|||
105581293|NCT01154036|364126487|FG002|Phase I|Protocol Violation|9|||
105581294|NCT01154036|364126488|FG003|Phase I|Protocol Violation|0|||
105581295|NCT01154036|364126489|FG004|Phase I|Protocol Violation|0|||
105581296|NCT01154036|364126490|FG005|Phase I|Protocol Violation|0|||
105581297|NCT01154036|364126491|FG006|Phase I|Protocol Violation|0|||
105581298|NCT01154036|364126492|FG007|Phase I|Protocol Violation|0|||
105581299|NCT01154036|364126485|FG000|Phase I|Withdrawal by Subject|2|||
105581300|NCT01154036|364126486|FG001|Phase I|Withdrawal by Subject|10|||
105581301|NCT01154036|364126487|FG002|Phase I|Withdrawal by Subject|29|||
105581302|NCT01154036|364126488|FG003|Phase I|Withdrawal by Subject|0|||
105581303|NCT01154036|364126489|FG004|Phase I|Withdrawal by Subject|0|||
105581304|NCT01154036|364126490|FG005|Phase I|Withdrawal by Subject|0|||
105408680|NCT01393899|363503804|FG001|Overall Study|Withdrawal by Subject|2|||
105408681|NCT01393899|363503805|FG002|Overall Study|Withdrawal by Subject|1|||
105581305|NCT01154036|364126491|FG006|Phase I|Withdrawal by Subject|0|||
105581306|NCT01154036|364126492|FG007|Phase I|Withdrawal by Subject|0|||
105581307|NCT01154036|364126485|FG000|Phase I|Adverse Event|1|||
105581308|NCT01154036|364126486|FG001|Phase I|Adverse Event|11|||
105581309|NCT01154036|364126487|FG002|Phase I|Adverse Event|12|||
105581310|NCT01154036|364126488|FG003|Phase I|Adverse Event|0|||
105408682|NCT01393899|363503803|FG000|Overall Study|Lost to Follow-up|0|||
105408683|NCT01393899|363503804|FG001|Overall Study|Lost to Follow-up|0|||
105408684|NCT01393899|363503805|FG002|Overall Study|Lost to Follow-up|1|||
105408685|NCT01393899|363503803|FG000|Overall Study|Does not meet entrance criteria|1|||
105408686|NCT01393899|363503804|FG001|Overall Study|Does not meet entrance criteria|0|||
105581311|NCT01154036|364126489|FG004|Phase I|Adverse Event|0|||
105581312|NCT01154036|364126490|FG005|Phase I|Adverse Event|0|||
105581313|NCT01154036|364126491|FG006|Phase I|Adverse Event|0|||
105581314|NCT01154036|364126492|FG007|Phase I|Adverse Event|0|||
105581315|NCT01154036|364126485|FG000|Phase II|Adverse Event|0|||
105581316|NCT01154036|364126486|FG001|Phase II|Adverse Event|0|||
105581317|NCT01154036|364126487|FG002|Phase II|Adverse Event|0|||
105581318|NCT01154036|364126488|FG003|Phase II|Adverse Event|0|||
105581319|NCT01154036|364126489|FG004|Phase II|Adverse Event|1|||
105581320|NCT01154036|364126490|FG005|Phase II|Adverse Event|1|||
105581321|NCT01154036|364126491|FG006|Phase II|Adverse Event|1|||
105581322|NCT01154036|364126492|FG007|Phase II|Adverse Event|1|||
105581323|NCT01154036|364126485|FG000|Phase II|Physician Decision|0|||
105581324|NCT01154036|364126486|FG001|Phase II|Physician Decision|0|||
105581325|NCT01154036|364126487|FG002|Phase II|Physician Decision|0|||
105581326|NCT01154036|364126488|FG003|Phase II|Physician Decision|0|||
105408687|NCT01393899|363503805|FG002|Overall Study|Does not meet entrance criteria|1|||
105408688|NCT01393899|363503803|FG000|Overall Study|Lack of Efficacy|26|||
105408689|NCT01393899|363503804|FG001|Overall Study|Lack of Efficacy|21|||
105408690|NCT01393899|363503805|FG002|Overall Study|Lack of Efficacy|16|||
105408691|NCT01393899|363503803|FG000|Overall Study|Adverse Event|1|||
105408692|NCT01393899|363503804|FG001|Overall Study|Adverse Event|5|||
105408693|NCT01393899|363503805|FG002|Overall Study|Adverse Event|3|||
105408694|NCT02595866|363503812|FG000|Overall Study|Adverse Event|2|||
105581327|NCT01154036|364126489|FG004|Phase II|Physician Decision|0|||
105581328|NCT01154036|364126490|FG005|Phase II|Physician Decision|0|||
105581329|NCT01154036|364126491|FG006|Phase II|Physician Decision|1|||
105581330|NCT01154036|364126492|FG007|Phase II|Physician Decision|0|||
105581331|NCT01154036|364126485|FG000|Phase II|Lost to Follow-up|0|||
105581332|NCT01154036|364126486|FG001|Phase II|Lost to Follow-up|0|||
105581333|NCT01154036|364126487|FG002|Phase II|Lost to Follow-up|0|||
105581334|NCT01154036|364126488|FG003|Phase II|Lost to Follow-up|1|||
105581335|NCT01154036|364126489|FG004|Phase II|Lost to Follow-up|2|||
105581336|NCT01154036|364126490|FG005|Phase II|Lost to Follow-up|0|||
105581337|NCT01154036|364126491|FG006|Phase II|Lost to Follow-up|2|||
105581338|NCT01154036|364126492|FG007|Phase II|Lost to Follow-up|1|||
105581339|NCT01154036|364126485|FG000|Phase II|Protocol Violation|0|||
105581340|NCT01154036|364126486|FG001|Phase II|Protocol Violation|0|||
105581341|NCT01154036|364126487|FG002|Phase II|Protocol Violation|0|||
105581342|NCT01154036|364126488|FG003|Phase II|Protocol Violation|0|||
105581343|NCT01154036|364126489|FG004|Phase II|Protocol Violation|1|||
105581344|NCT01154036|364126490|FG005|Phase II|Protocol Violation|2|||
105581345|NCT01154036|364126491|FG006|Phase II|Protocol Violation|0|||
105581346|NCT01154036|364126492|FG007|Phase II|Protocol Violation|0|||
105581347|NCT01154036|364126485|FG000|Phase II|Withdrawal by Subject|0|||
105581348|NCT01154036|364126486|FG001|Phase II|Withdrawal by Subject|0|||
105581349|NCT01154036|364126487|FG002|Phase II|Withdrawal by Subject|0|||
105581350|NCT01154036|364126488|FG003|Phase II|Withdrawal by Subject|0|||
105581351|NCT01154036|364126489|FG004|Phase II|Withdrawal by Subject|4|||
105581352|NCT01154036|364126490|FG005|Phase II|Withdrawal by Subject|2|||
105581353|NCT01154036|364126491|FG006|Phase II|Withdrawal by Subject|5|||
105581354|NCT01154036|364126492|FG007|Phase II|Withdrawal by Subject|4|||
105581355|NCT02206152|364126495|FG000|Pre-Randomization|Withdrawal by Subject|2|||
105581356|NCT00322374|364126501|FG000|Starting Dose|Physician Decision|2|||
105581357|NCT00322374|364126502|FG001|Starting Dose|Physician Decision|0|||
105581358|NCT00322374|364126503|FG002|Starting Dose|Physician Decision|0|||
105581359|NCT00322374|364126504|FG003|Starting Dose|Physician Decision|0|||
105581360|NCT00322374|364126501|FG000|Starting Dose|Study Drug Toxicity|4|||
105581361|NCT00322374|364126502|FG001|Starting Dose|Study Drug Toxicity|0|||
105581362|NCT00322374|364126503|FG002|Starting Dose|Study Drug Toxicity|0|||
105581363|NCT00322374|364126504|FG003|Starting Dose|Study Drug Toxicity|0|||
105581364|NCT00322374|364126501|FG000|First Escalation|Documented Disease Progression|0|||
105581365|NCT00322374|364126502|FG001|First Escalation|Documented Disease Progression|6|||
105581366|NCT00322374|364126503|FG002|First Escalation|Documented Disease Progression|0|||
105581367|NCT00322374|364126504|FG003|First Escalation|Documented Disease Progression|0|||
105581368|NCT00322374|364126501|FG000|First Escalation|Physician Decision|0|||
105581369|NCT00322374|364126502|FG001|First Escalation|Physician Decision|12|||
105581370|NCT00322374|364126503|FG002|First Escalation|Physician Decision|0|||
105581371|NCT00322374|364126504|FG003|First Escalation|Physician Decision|0|||
105581372|NCT00322374|364126501|FG000|First Escalation|Study Drug Toxicity|0|||
105581373|NCT00322374|364126502|FG001|First Escalation|Study Drug Toxicity|11|||
105581374|NCT00322374|364126503|FG002|First Escalation|Study Drug Toxicity|0|||
105581375|NCT00322374|364126504|FG003|First Escalation|Study Drug Toxicity|0|||
105581376|NCT00322374|364126501|FG000|First Escalation|Participant Request|0|||
105581377|NCT00322374|364126502|FG001|First Escalation|Participant Request|1|||
105581378|NCT00322374|364126503|FG002|First Escalation|Participant Request|0|||
105408695|NCT02595866|363503813|FG001|Overall Study|Adverse Event|5|||
105408696|NCT02595866|363503812|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
105408697|NCT02595866|363503813|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
105408698|NCT02595866|363503812|FG000|Overall Study|Death|0|||
105408699|NCT02595866|363503813|FG001|Overall Study|Death|1|||
105408700|NCT02595866|363503812|FG000|Overall Study|Incarceration|1|||
105408701|NCT02595866|363503813|FG001|Overall Study|Incarceration|0|||
105408702|NCT02595866|363503812|FG000|Overall Study|Lack of Efficacy|17|||
105408703|NCT02595866|363503813|FG001|Overall Study|Lack of Efficacy|7|||
105408704|NCT02595866|363503812|FG000|Overall Study|Physician Decision|4|||
105408705|NCT02595866|363503813|FG001|Overall Study|Physician Decision|3|||
105408706|NCT02595866|363503812|FG000|Overall Study|Switched to Alternative Treatment|1|||
105408707|NCT02595866|363503813|FG001|Overall Study|Switched to Alternative Treatment|0|||
105408708|NCT02595866|363503812|FG000|Overall Study|Study Terminated|0|||
105408709|NCT02595866|363503813|FG001|Overall Study|Study Terminated|4|||
105408710|NCT02595866|363503812|FG000|Overall Study|Withdrawal by Subject|6|||
105581379|NCT00322374|364126504|FG003|First Escalation|Participant Request|0|||
105581380|NCT00322374|364126501|FG000|Second Escalation|Physician Decision|0|||
105581381|NCT00322374|364126502|FG001|Second Escalation|Physician Decision|0|||
105581382|NCT00322374|364126503|FG002|Second Escalation|Physician Decision|5|||
105581383|NCT00322374|364126504|FG003|Second Escalation|Physician Decision|0|||
105581384|NCT00322374|364126501|FG000|Second Escalation|Study Drug Toxicity|0|||
105581385|NCT00322374|364126502|FG001|Second Escalation|Study Drug Toxicity|0|||
105581386|NCT00322374|364126503|FG002|Second Escalation|Study Drug Toxicity|1|||
105581387|NCT00322374|364126504|FG003|Second Escalation|Study Drug Toxicity|0|||
105581388|NCT00683449|364126505|FG000|Overall Study|Lost to Follow-up|0|||
105581389|NCT00683449|364126506|FG001|Overall Study|Lost to Follow-up|1|||
105408711|NCT02595866|363503813|FG001|Overall Study|Withdrawal by Subject|1|||
105408712|NCT00778336|363503814|FG000|Index Procedure-Discharge|Death|6|||
105408713|NCT00778336|363503815|FG001|Index Procedure-Discharge|Death|3|||
105408714|NCT00778336|363503816|FG002|Index Procedure-Discharge|Death|2|||
105408715|NCT00778336|363503817|FG003|Index Procedure-Discharge|Death|0|||
105408716|NCT00778336|363503814|FG000|3 Month Follow Up|Lost to Follow-up|15|||
105408717|NCT00778336|363503815|FG001|3 Month Follow Up|Lost to Follow-up|20|||
105408718|NCT00778336|363503816|FG002|3 Month Follow Up|Lost to Follow-up|3|||
105408719|NCT00778336|363503817|FG003|3 Month Follow Up|Lost to Follow-up|0|||
105408720|NCT00778336|363503814|FG000|3 Month Follow Up|Death|8|||
105408721|NCT00778336|363503815|FG001|3 Month Follow Up|Death|3|||
105408722|NCT00778336|363503816|FG002|3 Month Follow Up|Death|2|||
105408723|NCT00778336|363503817|FG003|3 Month Follow Up|Death|0|||
105408724|NCT02623205|363503818|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
105408725|NCT02623205|363503819|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
105408726|NCT03035864|363503820|FG000|Treatment Period|Adverse Event|1|||
105408727|NCT03035864|363503821|FG001|Treatment Period|Adverse Event|0|||
105408728|NCT03035864|363503820|FG000|Treatment Period|Other|3|||
105408729|NCT03035864|363503821|FG001|Treatment Period|Other|1|||
105408730|NCT03035864|363503820|FG000|Follow-up Period|Adverse Event|1|||
105408731|NCT03035864|363503821|FG001|Follow-up Period|Adverse Event|0|||
105408732|NCT03035864|363503820|FG000|Follow-up Period|Lost to Follow-up|6|||
105408733|NCT03035864|363503821|FG001|Follow-up Period|Lost to Follow-up|2|||
105408734|NCT03035864|363503820|FG000|Follow-up Period|Physician Decision|1|||
105408735|NCT03035864|363503821|FG001|Follow-up Period|Physician Decision|0|||
105408736|NCT03035864|363503820|FG000|Follow-up Period|Other|3|||
105408737|NCT03035864|363503821|FG001|Follow-up Period|Other|2|||
105408738|NCT02342288|363503822|FG000|Overall Study|no protocol anesthesiologist available|3|||
105408739|NCT02342288|363503823|FG001|Overall Study|no protocol anesthesiologist available|2|||
105408740|NCT02342288|363503822|FG000|Overall Study|anesthesia leak in system|1|||
105408741|NCT02342288|363503823|FG001|Overall Study|anesthesia leak in system|0|||
105408742|NCT02342288|363503822|FG000|Overall Study|Withdrawal by Subject|1|||
105408743|NCT02342288|363503823|FG001|Overall Study|Withdrawal by Subject|0|||
105408744|NCT02342288|363503822|FG000|Overall Study|coordinator contaminated with blood|0|||
105408745|NCT02342288|363503823|FG001|Overall Study|coordinator contaminated with blood|1|||
105408746|NCT02342288|363503822|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
105408747|NCT02342288|363503823|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
105408748|NCT02342288|363503822|FG000|Overall Study|coordinator not available|0|||
105408749|NCT02342288|363503823|FG001|Overall Study|coordinator not available|2|||
105408750|NCT02720523|363503826|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
105408751|NCT02720523|363503827|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
105408752|NCT02720523|363503828|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
105408753|NCT02720523|363503829|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
105408754|NCT02720523|363503830|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
105408755|NCT02720523|363503831|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
105408756|NCT02720523|363503832|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
105408757|NCT02720523|363503826|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
105408758|NCT02720523|363503827|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105408759|NCT02720523|363503828|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105408760|NCT02720523|363503829|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105408761|NCT02720523|363503830|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105408762|NCT02720523|363503831|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105408763|NCT02720523|363503832|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105408764|NCT02720523|363503826|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
105408765|NCT02720523|363503827|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
105408766|NCT02720523|363503828|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
105408767|NCT02720523|363503829|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
105408768|NCT02720523|363503830|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
105408769|NCT02720523|363503831|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
105408770|NCT02720523|363503832|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
105408771|NCT02720523|363503826|FG000|Period 1: Placebo-controlled Period|Other|0|||
105408772|NCT02720523|363503827|FG001|Period 1: Placebo-controlled Period|Other|0|||
105408773|NCT02720523|363503828|FG002|Period 1: Placebo-controlled Period|Other|1|||
105408774|NCT02720523|363503829|FG003|Period 1: Placebo-controlled Period|Other|1|||
105408775|NCT02720523|363503830|FG004|Period 1: Placebo-controlled Period|Other|0|||
105408776|NCT02720523|363503831|FG005|Period 1: Placebo-controlled Period|Other|0|||
105408777|NCT02720523|363503832|FG006|Period 1: Placebo-controlled Period|Other|0|||
105408778|NCT02720523|363503826|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
105408779|NCT02720523|363503827|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
105408780|NCT02720523|363503828|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
105408781|NCT02720523|363503829|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
105495054|NCT00891462|363826240|FG000|Overall Study|Other Reason|2|||
105408782|NCT02720523|363503830|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
105408783|NCT02720523|363503831|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
105408784|NCT02720523|363503832|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
105408785|NCT02720523|363503826|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
105408786|NCT02720523|363503827|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
105408787|NCT02720523|363503828|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
105408788|NCT02720523|363503829|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
105408789|NCT02720523|363503830|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
105408790|NCT02720523|363503831|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
105408791|NCT02720523|363503832|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
105408792|NCT02720523|363503826|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
105408793|NCT02720523|363503827|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
105408794|NCT02720523|363503828|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
105408795|NCT02720523|363503829|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
105408796|NCT02720523|363503830|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
105408797|NCT02720523|363503831|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
105408798|NCT02720523|363503832|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
105408799|NCT02720523|363503826|FG000|Period 2: Long-term Extension Period|Other|0|||
105408800|NCT02720523|363503827|FG001|Period 2: Long-term Extension Period|Other|0|||
105408801|NCT02720523|363503828|FG002|Period 2: Long-term Extension Period|Other|0|||
105408802|NCT02720523|363503829|FG003|Period 2: Long-term Extension Period|Other|0|||
105408803|NCT02720523|363503830|FG004|Period 2: Long-term Extension Period|Other|2|||
105408804|NCT02720523|363503831|FG005|Period 2: Long-term Extension Period|Other|0|||
105408805|NCT02720523|363503832|FG006|Period 2: Long-term Extension Period|Other|3|||
105408806|NCT03089047|363503839|FG000|Overall Study|Lost to Follow-up|1|||
105408807|NCT03089047|363503840|FG001|Overall Study|Lost to Follow-up|0|||
105408808|NCT02517398|363503855|FG000|Overall Study|Death|2|||
105408809|NCT02517398|363503856|FG001|Overall Study|Death|3|||
105408810|NCT02517398|363503857|FG002|Overall Study|Death|4|||
105408811|NCT02517398|363503858|FG003|Overall Study|Death|2|||
105408812|NCT02517398|363503859|FG004|Overall Study|Death|3|||
105408813|NCT02517398|363503860|FG005|Overall Study|Death|8|||
105408814|NCT02517398|363503861|FG006|Overall Study|Death|3|||
105408815|NCT02517398|363503862|FG007|Overall Study|Death|2|||
105408816|NCT02517398|363503863|FG008|Overall Study|Death|6|||
105408817|NCT02517398|363503864|FG009|Overall Study|Death|24|||
105408818|NCT02517398|363503865|FG010|Overall Study|Death|53|||
105408819|NCT02517398|363503866|FG011|Overall Study|Death|25|||
105408820|NCT02517398|363503867|FG012|Overall Study|Death|73|||
105408821|NCT02517398|363503868|FG013|Overall Study|Death|29|||
105408822|NCT02517398|363503869|FG014|Overall Study|Death|26|||
105408823|NCT02517398|363503870|FG015|Overall Study|Death|23|||
105408824|NCT02517398|363503871|FG016|Overall Study|Death|26|||
105408825|NCT02517398|363503872|FG017|Overall Study|Death|25|||
105408826|NCT02517398|363503873|FG018|Overall Study|Death|22|||
105408827|NCT02517398|363503874|FG019|Overall Study|Death|7|||
105408828|NCT02517398|363503875|FG020|Overall Study|Death|26|||
105408829|NCT02517398|363503876|FG021|Overall Study|Death|30|||
105408830|NCT02517398|363503877|FG022|Overall Study|Death|20|||
105408831|NCT02517398|363503855|FG000|Overall Study|Other|0|||
105408832|NCT02517398|363503856|FG001|Overall Study|Other|0|||
105408833|NCT02517398|363503857|FG002|Overall Study|Other|0|||
105408834|NCT02517398|363503858|FG003|Overall Study|Other|1|||
105408835|NCT02517398|363503859|FG004|Overall Study|Other|0|||
105408836|NCT02517398|363503860|FG005|Overall Study|Other|0|||
105408837|NCT02517398|363503861|FG006|Overall Study|Other|0|||
105408838|NCT02517398|363503862|FG007|Overall Study|Other|0|||
105408839|NCT02517398|363503863|FG008|Overall Study|Other|0|||
105408840|NCT02517398|363503864|FG009|Overall Study|Other|1|||
105408841|NCT02517398|363503865|FG010|Overall Study|Other|0|||
105408842|NCT02517398|363503866|FG011|Overall Study|Other|0|||
105408843|NCT02517398|363503867|FG012|Overall Study|Other|0|||
105408844|NCT02517398|363503868|FG013|Overall Study|Other|1|||
105408845|NCT02517398|363503869|FG014|Overall Study|Other|0|||
105408846|NCT02517398|363503870|FG015|Overall Study|Other|1|||
105408847|NCT02517398|363503871|FG016|Overall Study|Other|1|||
105408848|NCT02517398|363503872|FG017|Overall Study|Other|0|||
105408849|NCT02517398|363503873|FG018|Overall Study|Other|0|||
105408850|NCT02517398|363503874|FG019|Overall Study|Other|1|||
105408851|NCT02517398|363503875|FG020|Overall Study|Other|0|||
105408852|NCT02517398|363503876|FG021|Overall Study|Other|0|||
105408853|NCT02517398|363503877|FG022|Overall Study|Other|0|||
105408854|NCT02517398|363503855|FG000|Overall Study|Lost to Follow-up|0|||
105408855|NCT02517398|363503856|FG001|Overall Study|Lost to Follow-up|0|||
105408856|NCT02517398|363503857|FG002|Overall Study|Lost to Follow-up|0|||
105408857|NCT02517398|363503858|FG003|Overall Study|Lost to Follow-up|0|||
105408858|NCT02517398|363503859|FG004|Overall Study|Lost to Follow-up|0|||
105408859|NCT02517398|363503860|FG005|Overall Study|Lost to Follow-up|0|||
105408860|NCT02517398|363503861|FG006|Overall Study|Lost to Follow-up|0|||
105408861|NCT02517398|363503862|FG007|Overall Study|Lost to Follow-up|0|||
105408862|NCT02517398|363503863|FG008|Overall Study|Lost to Follow-up|0|||
105408863|NCT02517398|363503864|FG009|Overall Study|Lost to Follow-up|1|||
105408864|NCT02517398|363503865|FG010|Overall Study|Lost to Follow-up|0|||
105408865|NCT02517398|363503866|FG011|Overall Study|Lost to Follow-up|2|||
105408866|NCT02517398|363503867|FG012|Overall Study|Lost to Follow-up|2|||
105408867|NCT02517398|363503868|FG013|Overall Study|Lost to Follow-up|0|||
105408868|NCT02517398|363503869|FG014|Overall Study|Lost to Follow-up|1|||
105408869|NCT02517398|363503870|FG015|Overall Study|Lost to Follow-up|1|||
105408870|NCT02517398|363503871|FG016|Overall Study|Lost to Follow-up|0|||
105408871|NCT02517398|363503872|FG017|Overall Study|Lost to Follow-up|3|||
105408872|NCT02517398|363503873|FG018|Overall Study|Lost to Follow-up|1|||
105408873|NCT02517398|363503874|FG019|Overall Study|Lost to Follow-up|0|||
105408874|NCT02517398|363503875|FG020|Overall Study|Lost to Follow-up|1|||
105408875|NCT02517398|363503876|FG021|Overall Study|Lost to Follow-up|0|||
105408876|NCT02517398|363503877|FG022|Overall Study|Lost to Follow-up|2|||
105408877|NCT02517398|363503855|FG000|Overall Study|Withdrew Consent|0|||
105408878|NCT02517398|363503856|FG001|Overall Study|Withdrew Consent|0|||
105408879|NCT02517398|363503857|FG002|Overall Study|Withdrew Consent|0|||
105408880|NCT02517398|363503858|FG003|Overall Study|Withdrew Consent|0|||
105408881|NCT02517398|363503859|FG004|Overall Study|Withdrew Consent|0|||
105408882|NCT02517398|363503860|FG005|Overall Study|Withdrew Consent|0|||
105408883|NCT02517398|363503861|FG006|Overall Study|Withdrew Consent|1|||
105408884|NCT02517398|363503862|FG007|Overall Study|Withdrew Consent|0|||
105408885|NCT02517398|363503863|FG008|Overall Study|Withdrew Consent|0|||
105408886|NCT02517398|363503864|FG009|Overall Study|Withdrew Consent|2|||
105408887|NCT02517398|363503865|FG010|Overall Study|Withdrew Consent|7|||
105408888|NCT02517398|363503866|FG011|Overall Study|Withdrew Consent|1|||
105408889|NCT02517398|363503867|FG012|Overall Study|Withdrew Consent|5|||
105408890|NCT02517398|363503868|FG013|Overall Study|Withdrew Consent|4|||
105408891|NCT02517398|363503869|FG014|Overall Study|Withdrew Consent|2|||
105408892|NCT02517398|363503870|FG015|Overall Study|Withdrew Consent|5|||
105408893|NCT02517398|363503871|FG016|Overall Study|Withdrew Consent|4|||
105408894|NCT02517398|363503872|FG017|Overall Study|Withdrew Consent|2|||
105408895|NCT02517398|363503873|FG018|Overall Study|Withdrew Consent|3|||
105408896|NCT02517398|363503874|FG019|Overall Study|Withdrew Consent|2|||
105408897|NCT02517398|363503875|FG020|Overall Study|Withdrew Consent|9|||
105408898|NCT02517398|363503876|FG021|Overall Study|Withdrew Consent|3|||
105408899|NCT02517398|363503877|FG022|Overall Study|Withdrew Consent|1|||
105408900|NCT00429182|363503878|FG000|Overall Study|Not evaluable, Disease Progression|2|||
105408901|NCT00429182|363503878|FG000|Overall Study|Not eligible|5|||
105408902|NCT00809926|363503879|FG000|Overall Study|Adverse Event|18|||
105408903|NCT00809926|363503880|FG001|Overall Study|Adverse Event|10|||
105408904|NCT00809926|363503879|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
105408905|NCT00809926|363503880|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105408906|NCT00809926|363503879|FG000|Overall Study|Patient withdrew consent|8|||
105495055|NCT00891462|363826241|FG001|Overall Study|Other Reason|5|||
105408907|NCT00809926|363503880|FG001|Overall Study|Patient withdrew consent|6|||
105408908|NCT00809926|363503879|FG000|Overall Study|Lost to Follow-up|2|||
105408909|NCT00809926|363503880|FG001|Overall Study|Lost to Follow-up|1|||
105408910|NCT00809926|363503879|FG000|Overall Study|Administrative Problems|0|||
105408911|NCT00809926|363503880|FG001|Overall Study|Administrative Problems|1|||
105408912|NCT00809926|363503879|FG000|Overall Study|Protocol deviation|0|||
105408913|NCT00809926|363503880|FG001|Overall Study|Protocol deviation|2|||
105408914|NCT00130039|363503881|FG000|Overall Study|Withdrawal by Subject|15|||
105408915|NCT00130039|363503882|FG001|Overall Study|Withdrawal by Subject|11|||
105408916|NCT00130039|363503881|FG000|Overall Study|Lost to Follow-up|3|||
105408917|NCT00130039|363503882|FG001|Overall Study|Lost to Follow-up|1|||
105408918|NCT00130039|363503881|FG000|Overall Study|Adverse Event|4|||
105408919|NCT00130039|363503882|FG001|Overall Study|Adverse Event|2|||
105408920|NCT00130039|363503881|FG000|Overall Study|Physician Decision|3|||
105408921|NCT00130039|363503882|FG001|Overall Study|Physician Decision|0|||
105408922|NCT00130039|363503881|FG000|Overall Study|clinical events without follow up MRI|5|||
105408923|NCT00130039|363503882|FG001|Overall Study|clinical events without follow up MRI|4|||
105408924|NCT00642707|363503887|FG000|Overall Study|Adverse Event|0|||
105408925|NCT00642707|363503888|FG001|Overall Study|Adverse Event|0|||
105408926|NCT00642707|363503889|FG002|Overall Study|Adverse Event|0|||
105408927|NCT00642707|363503890|FG003|Overall Study|Adverse Event|2|||
105408928|NCT00642707|363503887|FG000|Overall Study|Withdrawal by Subject|1|||
105408929|NCT00642707|363503888|FG001|Overall Study|Withdrawal by Subject|0|||
105408930|NCT00642707|363503889|FG002|Overall Study|Withdrawal by Subject|0|||
105408931|NCT00642707|363503890|FG003|Overall Study|Withdrawal by Subject|0|||
105408932|NCT02311881|363503902|FG000|Overall Study|Did not meet the study criteria|2|||
105408933|NCT02311881|363503903|FG001|Overall Study|Did not meet the study criteria|2|||
105408934|NCT02311881|363503904|FG002|Overall Study|Did not meet the study criteria|0|||
105408935|NCT02311881|363503902|FG000|Overall Study|Adverse Event|7|||
105408936|NCT02311881|363503903|FG001|Overall Study|Adverse Event|15|||
105408937|NCT02311881|363503904|FG002|Overall Study|Adverse Event|8|||
105408938|NCT02311881|363503902|FG000|Overall Study|Lost to Follow-up|3|||
105408939|NCT02311881|363503903|FG001|Overall Study|Lost to Follow-up|3|||
105408940|NCT02311881|363503904|FG002|Overall Study|Lost to Follow-up|2|||
105408941|NCT02311881|363503902|FG000|Overall Study|Protocol Violation|1|||
105408942|NCT02311881|363503903|FG001|Overall Study|Protocol Violation|2|||
105408943|NCT02311881|363503904|FG002|Overall Study|Protocol Violation|3|||
105408944|NCT02311881|363503902|FG000|Overall Study|Withdrawal of consent|14|||
105408945|NCT02311881|363503903|FG001|Overall Study|Withdrawal of consent|16|||
105408946|NCT02311881|363503904|FG002|Overall Study|Withdrawal of consent|17|||
105408947|NCT02311881|363503902|FG000|Overall Study|Other|0|||
105408948|NCT02311881|363503903|FG001|Overall Study|Other|0|||
105408949|NCT02311881|363503904|FG002|Overall Study|Other|1|||
105408950|NCT02311881|363503902|FG000|Overall Study|Lack of Efficacy|1|||
105408951|NCT02311881|363503903|FG001|Overall Study|Lack of Efficacy|2|||
105408952|NCT02311881|363503904|FG002|Overall Study|Lack of Efficacy|0|||
105408953|NCT02311881|363503902|FG000|Overall Study|Subject has border line pregnancy test|1|||
105408954|NCT02311881|363503903|FG001|Overall Study|Subject has border line pregnancy test|0|||
105408955|NCT02311881|363503904|FG002|Overall Study|Subject has border line pregnancy test|0|||
105408956|NCT02311881|363503902|FG000|Overall Study|Withdrawal by Subject|3|||
105408957|NCT02311881|363503903|FG001|Overall Study|Withdrawal by Subject|1|||
105408958|NCT02311881|363503904|FG002|Overall Study|Withdrawal by Subject|4|||
105408959|NCT02311881|363503902|FG000|Overall Study|Sponsor Decision|1|||
105408960|NCT02311881|363503903|FG001|Overall Study|Sponsor Decision|1|||
105408961|NCT02311881|363503904|FG002|Overall Study|Sponsor Decision|1|||
105408962|NCT02311881|363503902|FG000|Overall Study|Protocol Deviation|1|||
105408963|NCT02311881|363503903|FG001|Overall Study|Protocol Deviation|0|||
105408964|NCT02311881|363503904|FG002|Overall Study|Protocol Deviation|0|||
105408965|NCT02311881|363503902|FG000|Overall Study|Non-Compliance|1|||
105408966|NCT02311881|363503903|FG001|Overall Study|Non-Compliance|0|||
105408967|NCT02311881|363503904|FG002|Overall Study|Non-Compliance|2|||
105408968|NCT02311881|363503902|FG000|Overall Study|Physician Decision|0|||
105408969|NCT02311881|363503903|FG001|Overall Study|Physician Decision|0|||
105408970|NCT02311881|363503904|FG002|Overall Study|Physician Decision|1|||
105408971|NCT02311881|363503902|FG000|Overall Study|Medical Monitor Discretion|0|||
105408972|NCT02311881|363503903|FG001|Overall Study|Medical Monitor Discretion|0|||
105408973|NCT02311881|363503904|FG002|Overall Study|Medical Monitor Discretion|1|||
105408974|NCT02311881|363503902|FG000|Overall Study|Participant taking another medication|0|||
105408975|NCT02311881|363503903|FG001|Overall Study|Participant taking another medication|0|||
105408976|NCT02311881|363503904|FG002|Overall Study|Participant taking another medication|1|||
105408977|NCT02311881|363503902|FG000|Overall Study|Serious Adverse Event|0|||
105408978|NCT02311881|363503903|FG001|Overall Study|Serious Adverse Event|1|||
105408979|NCT02311881|363503904|FG002|Overall Study|Serious Adverse Event|0|||
105408980|NCT01102491|363503907|FG000|Overall Study|Protocol Violation|11|||
105408981|NCT01102491|363503908|FG001|Overall Study|Protocol Violation|12|||
105408982|NCT00790582|363503915|FG000|Overall Study|Death|14|||
105408983|NCT00790582|363503916|FG001|Overall Study|Death|32|||
105408984|NCT00790582|363503915|FG000|Overall Study|Physician Decision|7|||
105408985|NCT00790582|363503916|FG001|Overall Study|Physician Decision|1|||
105408986|NCT00790582|363503915|FG000|Overall Study|Lost to Follow-up|3|||
105408987|NCT00790582|363503916|FG001|Overall Study|Lost to Follow-up|3|||
105408988|NCT00790582|363503915|FG000|Overall Study|Withdrawal by Subject|7|||
105408989|NCT00790582|363503916|FG001|Overall Study|Withdrawal by Subject|51|||
105408990|NCT00556439|363503918|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
105408991|NCT00556439|363503919|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
105408992|NCT00556439|363503920|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
105408993|NCT00556439|363503921|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
105408994|NCT00556439|363503918|FG000|Study Entry to Week 12|Physician Decision|1|||
105408995|NCT00556439|363503919|FG001|Study Entry to Week 12|Physician Decision|0|||
105408996|NCT00556439|363503920|FG002|Study Entry to Week 12|Physician Decision|0|||
105408997|NCT00556439|363503921|FG003|Study Entry to Week 12|Physician Decision|0|||
105408998|NCT00556439|363503918|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
105408999|NCT00556439|363503919|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
105409000|NCT00556439|363503920|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
105409001|NCT00556439|363503921|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
105409002|NCT00556439|363503918|FG000|Study Entry to Week 12|Recurrent infection|1|||
105409003|NCT00556439|363503919|FG001|Study Entry to Week 12|Recurrent infection|0|||
105409004|NCT00556439|363503920|FG002|Study Entry to Week 12|Recurrent infection|0|||
105409005|NCT00556439|363503921|FG003|Study Entry to Week 12|Recurrent infection|0|||
105409006|NCT00556439|363503918|FG000|Study Entry to Week 12|Malignancy|0|||
105409007|NCT00556439|363503919|FG001|Study Entry to Week 12|Malignancy|0|||
105409008|NCT00556439|363503920|FG002|Study Entry to Week 12|Malignancy|1|||
105409009|NCT00556439|363503921|FG003|Study Entry to Week 12|Malignancy|0|||
105409010|NCT00556439|363503918|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
105409011|NCT00556439|363503919|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
105409012|NCT00556439|363503920|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
105409013|NCT00556439|363503921|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
105409014|NCT00556439|363503918|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
105409015|NCT00556439|363503919|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
105409016|NCT00556439|363503920|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
105409017|NCT00556439|363503921|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
105409018|NCT00556439|363503918|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
105409019|NCT00556439|363503919|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
105409020|NCT00556439|363503920|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
105409021|NCT00556439|363503921|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
105409022|NCT00556439|363503918|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
105409023|NCT00556439|363503919|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
105409024|NCT00556439|363503920|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
105409025|NCT00556439|363503921|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
105409026|NCT00325130|363503922|FG000|Overall Study|Lost to Follow-up|6|||
105409027|NCT00325130|363503923|FG001|Overall Study|Lost to Follow-up|14|||
105409028|NCT00325130|363503922|FG000|Overall Study|Withdrawal by Subject|12|||
105409029|NCT00325130|363503923|FG001|Overall Study|Withdrawal by Subject|14|||
105409030|NCT00325130|363503922|FG000|Overall Study|Protocol Deviation|0|||
105409031|NCT00325130|363503923|FG001|Overall Study|Protocol Deviation|1|||
105409032|NCT00325130|363503922|FG000|Overall Study|Moved|0|||
105409033|NCT00325130|363503923|FG001|Overall Study|Moved|1|||
105409034|NCT00325130|363503922|FG000|Overall Study|Patient Discontinued for Other|1|||
105409035|NCT00325130|363503923|FG001|Overall Study|Patient Discontinued for Other|0|||
105409036|NCT01027650|363503925|FG000|Overall Study|Personal Reasons|0|||
105409037|NCT01027650|363503926|FG001|Overall Study|Personal Reasons|0|||
105409038|NCT01027650|363503927|FG002|Overall Study|Personal Reasons|0|||
105409039|NCT01027650|363503928|FG003|Overall Study|Personal Reasons|0|||
105409040|NCT01027650|363503929|FG004|Overall Study|Personal Reasons|2|||
105409041|NCT01027650|363503930|FG005|Overall Study|Personal Reasons|1|||
105409042|NCT01027650|363503931|FG006|Overall Study|Personal Reasons|0|||
105409043|NCT01027650|363503932|FG007|Overall Study|Personal Reasons|0|||
105409044|NCT01027650|363503925|FG000|Overall Study|Lost to Follow-up|0|||
105409045|NCT01027650|363503926|FG001|Overall Study|Lost to Follow-up|0|||
105409046|NCT01027650|363503927|FG002|Overall Study|Lost to Follow-up|0|||
105409047|NCT01027650|363503928|FG003|Overall Study|Lost to Follow-up|0|||
105409048|NCT01027650|363503929|FG004|Overall Study|Lost to Follow-up|0|||
105409049|NCT01027650|363503930|FG005|Overall Study|Lost to Follow-up|0|||
105409050|NCT01027650|363503931|FG006|Overall Study|Lost to Follow-up|1|||
105409051|NCT01027650|363503932|FG007|Overall Study|Lost to Follow-up|0|||
105409052|NCT01027650|363503925|FG000|Overall Study|Lack of Efficacy|0|||
105409053|NCT01027650|363503926|FG001|Overall Study|Lack of Efficacy|0|||
105409054|NCT01027650|363503927|FG002|Overall Study|Lack of Efficacy|0|||
105409055|NCT01027650|363503928|FG003|Overall Study|Lack of Efficacy|0|||
105409056|NCT01027650|363503929|FG004|Overall Study|Lack of Efficacy|0|||
105409057|NCT01027650|363503930|FG005|Overall Study|Lack of Efficacy|1|||
105409058|NCT01027650|363503931|FG006|Overall Study|Lack of Efficacy|0|||
105409059|NCT01027650|363503932|FG007|Overall Study|Lack of Efficacy|0|||
105409060|NCT03110029|363503933|FG000|Overall Study|Withdrawal by Subject|1|||
105409061|NCT03110029|363503934|FG001|Overall Study|Withdrawal by Subject|1|||
105409062|NCT02175277|363503935|FG000|Overall Study|Protocol-specified Criteria|1|||
105409063|NCT00460655|363505094|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
105409064|NCT00460655|363505095|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105409065|NCT00460655|363505096|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105409066|NCT00460655|363505097|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105409067|NCT00460655|363505094|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
105409068|NCT00460655|363505095|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105409069|NCT00460655|363505096|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105409070|NCT00460655|363505097|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105409071|NCT00460655|363505094|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
105409072|NCT00460655|363505095|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
105409073|NCT00460655|363505096|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
105409074|NCT00460655|363505097|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
105409075|NCT00460655|363505094|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
105409076|NCT00460655|363505095|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
105409077|NCT00460655|363505096|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
105409078|NCT00460655|363505097|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
105409079|NCT00460655|363505094|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105409080|NCT00460655|363505095|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105409081|NCT00460655|363505096|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
105409082|NCT00460655|363505097|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
105409083|NCT00460655|363505094|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
105409084|NCT00460655|363505095|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
105409085|NCT00460655|363505096|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
105409086|NCT00460655|363505097|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
105409087|NCT02705105|363505098|FG000|Treatment|Objective Disease Progression|1|||
105409088|NCT02705105|363505099|FG001|Treatment|Objective Disease Progression|50|||
105409089|NCT02705105|363505098|FG000|Treatment|Withdrawal by Subject|3|||
105409090|NCT02705105|363505099|FG001|Treatment|Withdrawal by Subject|5|||
105409091|NCT02705105|363505098|FG000|Treatment|Adverse Event|0|||
105409092|NCT02705105|363505099|FG001|Treatment|Adverse Event|17|||
105409093|NCT02705105|363505098|FG000|Treatment|Clinical Disease Progression|0|||
105409094|NCT02705105|363505099|FG001|Treatment|Clinical Disease Progression|32|||
105495056|NCT00891462|363826242|FG002|Overall Study|Other Reason|3|||
105409095|NCT02705105|363505098|FG000|Treatment|Physician Decision|0|||
105409096|NCT02705105|363505099|FG001|Treatment|Physician Decision|3|||
105409097|NCT02705105|363505098|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
105409098|NCT02705105|363505099|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
105409099|NCT02705105|363505098|FG000|Follow-Up|Death|3|||
105409100|NCT02705105|363505099|FG001|Follow-Up|Death|68|||
105409101|NCT02705105|363505098|FG000|Follow-Up|Withdrawal by Subject|1|||
105409102|NCT02705105|363505099|FG001|Follow-Up|Withdrawal by Subject|14|||
105409103|NCT02705105|363505098|FG000|Follow-Up|Study Terminated|0|||
105409104|NCT02705105|363505099|FG001|Follow-Up|Study Terminated|26|||
105409105|NCT02705105|363505098|FG000|Follow-Up|Discontinued per Amendment 3|0|||
105409106|NCT02705105|363505099|FG001|Follow-Up|Discontinued per Amendment 3|2|||
105409107|NCT00375427|363505100|FG000|Overall Study|Adverse Event|21|||
105409108|NCT00375427|363505101|FG001|Overall Study|Adverse Event|27|||
105409109|NCT00375427|363505100|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105409110|NCT00375427|363505101|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105409111|NCT00375427|363505100|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105409112|NCT00375427|363505101|FG001|Overall Study|Abnormal laboratory value(s)|2|||
105409113|NCT00375427|363505100|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105409114|NCT00375427|363505101|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
105495057|NCT00891462|363826240|FG000|Overall Study|Protocol Violation|2|||
105409115|NCT00375427|363505100|FG000|Overall Study|Patient no longer requires study drug|3|||
105409116|NCT00375427|363505101|FG001|Overall Study|Patient no longer requires study drug|7|||
105495058|NCT00891462|363826241|FG001|Overall Study|Protocol Violation|1|||
105409117|NCT00375427|363505100|FG000|Overall Study|Protocol Violation|10|||
105409118|NCT00375427|363505101|FG001|Overall Study|Protocol Violation|8|||
105495059|NCT00891462|363826242|FG002|Overall Study|Protocol Violation|3|||
105495060|NCT00891462|363826240|FG000|Overall Study|Inclusion/exclusion criteria|0|||
105409119|NCT00375427|363505100|FG000|Overall Study|Withdrawal by Subject|9|||
105409120|NCT00375427|363505101|FG001|Overall Study|Withdrawal by Subject|13|||
105409121|NCT00375427|363505100|FG000|Overall Study|Lost to Follow-up|1|||
105409122|NCT00375427|363505101|FG001|Overall Study|Lost to Follow-up|1|||
105409123|NCT00375427|363505100|FG000|Overall Study|Administrative reasons|0|||
105409124|NCT00375427|363505101|FG001|Overall Study|Administrative reasons|1|||
105409125|NCT00375427|363505100|FG000|Overall Study|Death|11|||
105409126|NCT00375427|363505101|FG001|Overall Study|Death|10|||
105409127|NCT02817594|363505107|FG000|Overall Study|Withdrawal by Subject|1|||
105409128|NCT02817594|363505107|FG000|Overall Study|Other|1|||
105409129|NCT02817594|363505107|FG000|Overall Study|Did Not Receive Treatment|1|||
105409130|NCT02229825|363505111|FG000|Overall Study|Personal Reasons|0|||
105409131|NCT02229825|363505112|FG001|Overall Study|Personal Reasons|1|||
105409132|NCT02229825|363505111|FG000|Overall Study|Refused continuing medication|7|||
105409133|NCT02229825|363505112|FG001|Overall Study|Refused continuing medication|6|||
105409134|NCT02229825|363505111|FG000|Overall Study|Lost to Follow-up|1|||
105409135|NCT02229825|363505112|FG001|Overall Study|Lost to Follow-up|2|||
105409136|NCT02229825|363505111|FG000|Overall Study|Protocol Violation|1|||
105409137|NCT02229825|363505112|FG001|Overall Study|Protocol Violation|1|||
105409138|NCT02229825|363505111|FG000|Overall Study|Lack of Efficacy|4|||
105409139|NCT02229825|363505112|FG001|Overall Study|Lack of Efficacy|10|||
105409140|NCT02229825|363505111|FG000|Overall Study|Adverse Event|11|||
105409141|NCT02229825|363505112|FG001|Overall Study|Adverse Event|9|||
105409142|NCT02229825|363505111|FG000|Overall Study|Not treated|0|||
105409143|NCT02229825|363505112|FG001|Overall Study|Not treated|1|||
105409144|NCT00040742|363505117|FG000|Overall Study|Death|0|||
105409145|NCT00040742|363505118|FG001|Overall Study|Death|0|||
105409146|NCT00040742|363505119|FG002|Overall Study|Death|1|||
105409147|NCT00040742|363505120|FG003|Overall Study|Death|0|||
105409148|NCT00040742|363505117|FG000|Overall Study|Adverse Event|15|||
105409149|NCT00040742|363505118|FG001|Overall Study|Adverse Event|16|||
105409150|NCT00040742|363505119|FG002|Overall Study|Adverse Event|21|||
105409151|NCT00040742|363505120|FG003|Overall Study|Adverse Event|9|||
105409152|NCT00040742|363505117|FG000|Overall Study|Withdrawal by Subject|7|||
105409153|NCT00040742|363505118|FG001|Overall Study|Withdrawal by Subject|15|||
105409154|NCT00040742|363505119|FG002|Overall Study|Withdrawal by Subject|10|||
105409155|NCT00040742|363505120|FG003|Overall Study|Withdrawal by Subject|13|||
105409156|NCT00040742|363505117|FG000|Overall Study|Chemotoxicity|4|||
105409157|NCT00040742|363505118|FG001|Overall Study|Chemotoxicity|3|||
105409158|NCT00040742|363505119|FG002|Overall Study|Chemotoxicity|5|||
105409159|NCT00040742|363505120|FG003|Overall Study|Chemotoxicity|2|||
105409160|NCT00040742|363505117|FG000|Overall Study|Incomplete Forms|6|||
105409161|NCT00040742|363505118|FG001|Overall Study|Incomplete Forms|10|||
105409162|NCT00040742|363505119|FG002|Overall Study|Incomplete Forms|4|||
105409163|NCT00040742|363505120|FG003|Overall Study|Incomplete Forms|5|||
105409164|NCT00040742|363505117|FG000|Overall Study|Other medical|7|||
105409165|NCT00040742|363505118|FG001|Overall Study|Other medical|5|||
105409166|NCT00040742|363505119|FG002|Overall Study|Other medical|5|||
105409167|NCT00040742|363505120|FG003|Overall Study|Other medical|5|||
105409168|NCT03726658|363505123|FG000|Overall Study|Lost to Follow-up|0|||
105409169|NCT03726658|363505124|FG001|Overall Study|Lost to Follow-up|0|||
105409170|NCT03726658|363505125|FG002|Overall Study|Lost to Follow-up|2|||
105409171|NCT03726658|363505126|FG003|Overall Study|Lost to Follow-up|0|||
105409172|NCT03726658|363505127|FG004|Overall Study|Lost to Follow-up|0|||
105409173|NCT03726658|363505128|FG005|Overall Study|Lost to Follow-up|1|||
105409174|NCT03726658|363505129|FG006|Overall Study|Lost to Follow-up|1|||
105409175|NCT03726658|363505123|FG000|Overall Study|Withdrawal by Subject|1|||
105409176|NCT03726658|363505124|FG001|Overall Study|Withdrawal by Subject|0|||
105409177|NCT03726658|363505125|FG002|Overall Study|Withdrawal by Subject|0|||
105409178|NCT03726658|363505126|FG003|Overall Study|Withdrawal by Subject|0|||
105409179|NCT03726658|363505127|FG004|Overall Study|Withdrawal by Subject|6|||
105409180|NCT03726658|363505128|FG005|Overall Study|Withdrawal by Subject|4|||
105409181|NCT03726658|363505129|FG006|Overall Study|Withdrawal by Subject|2|||
105409182|NCT03726658|363505123|FG000|Overall Study|Pregnancy|0|||
105409183|NCT03726658|363505124|FG001|Overall Study|Pregnancy|0|||
105409184|NCT03726658|363505125|FG002|Overall Study|Pregnancy|0|||
105409185|NCT03726658|363505126|FG003|Overall Study|Pregnancy|0|||
105409186|NCT03726658|363505127|FG004|Overall Study|Pregnancy|0|||
105409187|NCT03726658|363505128|FG005|Overall Study|Pregnancy|0|||
105409188|NCT03726658|363505129|FG006|Overall Study|Pregnancy|1|||
105409189|NCT03726658|363505123|FG000|Overall Study|Not Reported|0|||
105409190|NCT03726658|363505124|FG001|Overall Study|Not Reported|0|||
105409191|NCT03726658|363505125|FG002|Overall Study|Not Reported|0|||
105409192|NCT03726658|363505126|FG003|Overall Study|Not Reported|0|||
105409193|NCT03726658|363505127|FG004|Overall Study|Not Reported|0|||
105409194|NCT03726658|363505128|FG005|Overall Study|Not Reported|0|||
105409195|NCT03726658|363505129|FG006|Overall Study|Not Reported|1|||
105409196|NCT00090779|363505130|FG000|Step 1|Withdrawal by Subject|4|||
105409197|NCT00090779|363505131|FG001|Step 1|Withdrawal by Subject|2|||
105409198|NCT00090779|363505130|FG000|Step 1|Lost to Follow-up|3|||
105409199|NCT00090779|363505131|FG001|Step 1|Lost to Follow-up|2|||
105409200|NCT00090779|363505130|FG000|Step 1|Death|0|||
105409201|NCT00090779|363505131|FG001|Step 1|Death|2|||
105409202|NCT00090779|363505130|FG000|Step 1|Physician Decision|1|||
105409203|NCT00090779|363505131|FG001|Step 1|Physician Decision|0|||
105409204|NCT00090779|363505130|FG000|Step 1|Pregnancy|1|||
105409205|NCT00090779|363505131|FG001|Step 1|Pregnancy|0|||
105409206|NCT00090779|363505130|FG000|Step 1|Non-compliance to study requirements|0|||
105409207|NCT00090779|363505131|FG001|Step 1|Non-compliance to study requirements|1|||
105409208|NCT00090779|363505130|FG000|Step 1|Subject relocated|2|||
105409209|NCT00090779|363505131|FG001|Step 1|Subject relocated|8|||
105409210|NCT00090779|363505130|FG000|Step 2|Off study per study closure|6|||
105409211|NCT00090779|363505131|FG001|Step 2|Off study per study closure|16|||
105409212|NCT00090779|363505130|FG000|Step 2|Subject relocated|0|||
105409213|NCT00090779|363505131|FG001|Step 2|Subject relocated|1|||
105409214|NCT00090779|363505130|FG000|Step 2|Non-compliance to study requirements|0|||
105409215|NCT00090779|363505131|FG001|Step 2|Non-compliance to study requirements|1|||
105409216|NCT00090779|363505130|FG000|Step 3|Initiation of ART and off extended study|3|||
105409217|NCT00090779|363505131|FG001|Step 3|Initiation of ART and off extended study|2|||
105409218|NCT00090779|363505130|FG000|Step 3|Off extended study due to study closure|4|||
105409219|NCT00090779|363505131|FG001|Step 3|Off extended study due to study closure|3|||
105495061|NCT00891462|363826241|FG001|Overall Study|Inclusion/exclusion criteria|2|||
105495062|NCT00891462|363826242|FG002|Overall Study|Inclusion/exclusion criteria|2|||
105495063|NCT00891462|363826240|FG000|Overall Study|Lost to Follow-up|0|||
105495064|NCT00891462|363826241|FG001|Overall Study|Lost to Follow-up|2|||
105495065|NCT00891462|363826242|FG002|Overall Study|Lost to Follow-up|0|||
105495066|NCT00100178|363826256|FG000|Overall Study|Lost to Follow-up|0|||
105495067|NCT00100178|363826257|FG001|Overall Study|Lost to Follow-up|6|||
105409220|NCT01523743|363505132|FG000|Period 1|Adverse Event|1|||
105409221|NCT01523743|363505133|FG001|Period 1|Adverse Event|0|||
105409222|NCT01523743|363505132|FG000|Period 1|Withdrawal by Subject|6|||
105409223|NCT01523743|363505133|FG001|Period 1|Withdrawal by Subject|2|||
105409224|NCT01523743|363505132|FG000|Period 1|Lost to Follow-up|1|||
105409225|NCT01523743|363505133|FG001|Period 1|Lost to Follow-up|0|||
105409226|NCT01523743|363505132|FG000|Period 1|Lack of Efficacy|1|||
105409227|NCT01523743|363505133|FG001|Period 1|Lack of Efficacy|0|||
105409228|NCT01523743|363505132|FG000|Period 1|Felt unable to empty bladder|1|||
105409229|NCT01523743|363505133|FG001|Period 1|Felt unable to empty bladder|0|||
105409230|NCT01523743|363505132|FG000|Period 2|Withdrawal by Subject|0|||
105409231|NCT01523743|363505133|FG001|Period 2|Withdrawal by Subject|2|||
105409232|NCT01523743|363505132|FG000|Period 2|Adverse Event|1|||
105409233|NCT01523743|363505133|FG001|Period 2|Adverse Event|0|||
105409234|NCT00363142|363505134|FG000|Overall Study|Adverse Event|2|||
105495068|NCT00100178|363826258|FG002|Overall Study|Lost to Follow-up|5|||
105495069|NCT00100178|363826256|FG000|Overall Study|Adverse Event|2|||
105495070|NCT00100178|363826257|FG001|Overall Study|Adverse Event|2|||
105495071|NCT00100178|363826258|FG002|Overall Study|Adverse Event|1|||
105495072|NCT00100178|363826256|FG000|Overall Study|Withdrawal by Subject|1|||
105495073|NCT00100178|363826257|FG001|Overall Study|Withdrawal by Subject|1|||
105495074|NCT00100178|363826258|FG002|Overall Study|Withdrawal by Subject|1|||
105409235|NCT00363142|363505135|FG001|Overall Study|Adverse Event|0|||
105409236|NCT00363142|363505134|FG000|Overall Study|Lack of Efficacy|0|||
105409237|NCT00363142|363505135|FG001|Overall Study|Lack of Efficacy|1|||
105409238|NCT00363142|363505134|FG000|Overall Study|Lost to Follow-up|1|||
105409239|NCT00363142|363505135|FG001|Overall Study|Lost to Follow-up|0|||
105409240|NCT00363142|363505134|FG000|Overall Study|Non-compliance|1|||
105409241|NCT00363142|363505135|FG001|Overall Study|Non-compliance|1|||
105409242|NCT00363142|363505134|FG000|Overall Study|Withdrawal by Subject|3|||
105495075|NCT00100178|363826256|FG000|Overall Study|Physician Decision|6|||
105495076|NCT00100178|363826257|FG001|Overall Study|Physician Decision|1|||
105495077|NCT00100178|363826258|FG002|Overall Study|Physician Decision|3|||
105495078|NCT02607930|363826259|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
105495079|NCT02607930|363826260|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
105495080|NCT02607930|363826261|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
105495081|NCT02607930|363826262|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
105495082|NCT02607930|363826259|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
105495083|NCT02607930|363826260|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
105495084|NCT02607930|363826261|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
105495085|NCT02607930|363826262|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
105495086|NCT02607930|363826259|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
105495087|NCT02607930|363826260|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
105495088|NCT02607930|363826261|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
105495089|NCT02607930|363826262|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
105495090|NCT02607930|363826259|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
105495091|NCT02607930|363826260|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
105495092|NCT02607930|363826261|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
105495093|NCT02607930|363826262|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
105495094|NCT02607930|363826259|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
105409243|NCT00363142|363505135|FG001|Overall Study|Withdrawal by Subject|1|||
105409244|NCT00645840|363505139|FG000|Overall Study|Protocol Violation|3|||
105409245|NCT02923531|363505140|FG000|Overall Study|Adverse Event|4|||
105409246|NCT02923531|363505140|FG000|Overall Study|Clinical Deterioration|1|||
105409247|NCT02923531|363505140|FG000|Overall Study|Disease Progression|3|||
105409248|NCT02923531|363505140|FG000|Overall Study|Study Termination|1|||
105409249|NCT01823198|363505144|FG000|Overall Study|Physician Decision|0|||
105409250|NCT01823198|363505145|FG001|Overall Study|Physician Decision|1|||
105495095|NCT02607930|363826260|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
105495096|NCT02607930|363826261|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
105495097|NCT02607930|363826262|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
105495098|NCT02607930|363826259|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
105495099|NCT02607930|363826260|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
105409251|NCT01823198|363505146|FG002|Overall Study|Physician Decision|0|||
105409252|NCT01823198|363505147|FG003|Overall Study|Physician Decision|0|||
105495100|NCT02607930|363826261|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
105495101|NCT02607930|363826262|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
105495102|NCT02607930|363826259|FG000|Double-Blinded Treatment Phase|Death|2|||
105495103|NCT02607930|363826260|FG001|Double-Blinded Treatment Phase|Death|1|||
105495104|NCT02607930|363826261|FG002|Double-Blinded Treatment Phase|Death|0|||
105495105|NCT02607930|363826262|FG003|Double-Blinded Treatment Phase|Death|0|||
105495106|NCT02607930|363826259|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
105495107|NCT02607930|363826260|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
105495108|NCT02607930|363826261|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
105495109|NCT02607930|363826262|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
105495110|NCT02607930|363826259|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
105495111|NCT02607930|363826260|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
105495112|NCT02607930|363826261|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
105495113|NCT02607930|363826262|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
105495114|NCT02607930|363826259|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
105495115|NCT02607930|363826260|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
105495116|NCT02607930|363826261|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
105495117|NCT02607930|363826262|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
105495118|NCT02607930|363826259|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
105495119|NCT02607930|363826260|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
105495120|NCT02607930|363826261|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
105495121|NCT02607930|363826262|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
105409253|NCT01823198|363505148|FG004|Overall Study|Physician Decision|0|||
105409254|NCT01823198|363505149|FG005|Overall Study|Physician Decision|3|||
105581390|NCT00683449|364126507|FG002|Overall Study|Lost to Follow-up|0|||
105581391|NCT00683449|364126508|FG003|Overall Study|Lost to Follow-up|0|||
105581392|NCT00683449|364126509|FG004|Overall Study|Lost to Follow-up|0|||
105581393|NCT02117544|364126510|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
105581394|NCT02117544|364126511|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
105581395|NCT01991197|364126512|FG000|Overall Study|Lost to Follow-up|1|||
105581396|NCT01991197|364126513|FG001|Overall Study|Lost to Follow-up|1|||
105581397|NCT01991197|364126512|FG000|Overall Study|Physician Decision|0|||
105581398|NCT01991197|364126513|FG001|Overall Study|Physician Decision|2|||
105581399|NCT01991197|364126512|FG000|Overall Study|Withdrawal by Subject|2|||
105581400|NCT01991197|364126513|FG001|Overall Study|Withdrawal by Subject|0|||
105581401|NCT01010217|364126514|FG000|Overall Study|Lost to Follow-up|4|||
105581402|NCT01010217|364126515|FG001|Overall Study|Lost to Follow-up|5|||
105581403|NCT01010217|364126516|FG002|Overall Study|Lost to Follow-up|1|||
105581404|NCT01010217|364126517|FG003|Overall Study|Lost to Follow-up|0|||
105409255|NCT01823198|363505150|FG006|Overall Study|Physician Decision|3|||
105409256|NCT03943290|363505153|FG000|Overall Study|Sponsor Terminated Study|6|||
105409257|NCT03943290|363505154|FG001|Overall Study|Sponsor Terminated Study|1|||
105409258|NCT03943290|363505155|FG002|Overall Study|Sponsor Terminated Study|11|||
105409259|NCT03943290|363505156|FG003|Overall Study|Sponsor Terminated Study|6|||
105409260|NCT03943290|363505157|FG004|Overall Study|Sponsor Terminated Study|7|||
105409261|NCT03943290|363505158|FG005|Overall Study|Sponsor Terminated Study|6|||
105409262|NCT03943290|363505159|FG006|Overall Study|Sponsor Terminated Study|6|||
105409263|NCT03943290|363505160|FG007|Overall Study|Sponsor Terminated Study|7|||
105409264|NCT03943290|363505161|FG008|Overall Study|Sponsor Terminated Study|8|||
105409265|NCT03943290|363505153|FG000|Overall Study|Lost to Follow-up|1|||
105409266|NCT03943290|363505154|FG001|Overall Study|Lost to Follow-up|0|||
105409267|NCT03943290|363505155|FG002|Overall Study|Lost to Follow-up|1|||
105409268|NCT03943290|363505156|FG003|Overall Study|Lost to Follow-up|0|||
105409269|NCT03943290|363505157|FG004|Overall Study|Lost to Follow-up|0|||
105409270|NCT03943290|363505158|FG005|Overall Study|Lost to Follow-up|0|||
105409271|NCT03943290|363505159|FG006|Overall Study|Lost to Follow-up|0|||
105409272|NCT03943290|363505160|FG007|Overall Study|Lost to Follow-up|1|||
105409273|NCT03943290|363505161|FG008|Overall Study|Lost to Follow-up|0|||
105409274|NCT03943290|363505153|FG000|Overall Study|Withdrawal by Subject|0|||
105409275|NCT03943290|363505154|FG001|Overall Study|Withdrawal by Subject|0|||
105409276|NCT03943290|363505155|FG002|Overall Study|Withdrawal by Subject|1|||
105409277|NCT03943290|363505156|FG003|Overall Study|Withdrawal by Subject|0|||
105409278|NCT03943290|363505157|FG004|Overall Study|Withdrawal by Subject|0|||
105409279|NCT03943290|363505158|FG005|Overall Study|Withdrawal by Subject|0|||
105409280|NCT03943290|363505159|FG006|Overall Study|Withdrawal by Subject|0|||
105409281|NCT03943290|363505160|FG007|Overall Study|Withdrawal by Subject|0|||
105409282|NCT03943290|363505161|FG008|Overall Study|Withdrawal by Subject|0|||
105409283|NCT01737762|363505163|FG000|Overall Study|Adverse Event|2|||
105409284|NCT01737762|363505164|FG001|Overall Study|Adverse Event|2|||
105409285|NCT01737762|363505163|FG000|Overall Study|Lost to Follow-up|1|||
105409286|NCT01737762|363505164|FG001|Overall Study|Lost to Follow-up|0|||
105409287|NCT01737762|363505163|FG000|Overall Study|Withdrawal by Subject|2|||
105409288|NCT01737762|363505164|FG001|Overall Study|Withdrawal by Subject|2|||
105409289|NCT01737762|363505163|FG000|Overall Study|Progressive disease|1|||
105409290|NCT01737762|363505164|FG001|Overall Study|Progressive disease|2|||
105409291|NCT01737762|363505163|FG000|Overall Study|Physician Decision|1|||
105409292|NCT01737762|363505164|FG001|Overall Study|Physician Decision|1|||
105409293|NCT01737762|363505163|FG000|Overall Study|Moved from area|2|||
105409294|NCT01737762|363505164|FG001|Overall Study|Moved from area|1|||
105409295|NCT01737762|363505163|FG000|Overall Study|Trial termination|11|||
105409296|NCT01737762|363505164|FG001|Overall Study|Trial termination|9|||
105409297|NCT01162473|363505165|FG000|Overall Study|Adverse Event|2|||
105409298|NCT01162473|363505166|FG001|Overall Study|Adverse Event|1|||
105409299|NCT01162473|363505165|FG000|Overall Study|Withdrawal by Subject|0|||
105409300|NCT01162473|363505166|FG001|Overall Study|Withdrawal by Subject|4|||
105409301|NCT01001767|363505167|FG000|Overall Study|no baseline study performed|1|||
105409302|NCT01001767|363505168|FG001|Overall Study|no baseline study performed|0|||
105409303|NCT01001767|363505167|FG000|Overall Study|Protocol Violation|1|||
105409304|NCT01001767|363505168|FG001|Overall Study|Protocol Violation|0|||
105409305|NCT01001767|363505167|FG000|Overall Study|Lost to Follow-up|1|||
105409306|NCT01001767|363505168|FG001|Overall Study|Lost to Follow-up|0|||
105409307|NCT01001767|363505167|FG000|Overall Study|Physician Decision|1|||
105409308|NCT01001767|363505168|FG001|Overall Study|Physician Decision|0|||
105409309|NCT04721158|363505169|FG000|Overall Study|Lost to Follow-up|4|||
105409310|NCT04721158|363505169|FG000|Overall Study|Device did not connect|1|||
105581405|NCT01010217|364126518|FG004|Overall Study|Lost to Follow-up|0|||
105581406|NCT01010217|364126514|FG000|Overall Study|Withdrawal by Subject|1|||
105581407|NCT01010217|364126515|FG001|Overall Study|Withdrawal by Subject|0|||
105581408|NCT01010217|364126516|FG002|Overall Study|Withdrawal by Subject|0|||
105581409|NCT01010217|364126517|FG003|Overall Study|Withdrawal by Subject|0|||
105409311|NCT02520388|363505170|FG000|Overall Study|Physician Decision|1|||
105581410|NCT01010217|364126518|FG004|Overall Study|Withdrawal by Subject|0|||
105409312|NCT02520388|363505171|FG001|Overall Study|Physician Decision|0|||
105409313|NCT02520388|363505170|FG000|Overall Study|Subject or parent/guardian request|0|||
105409314|NCT02520388|363505171|FG001|Overall Study|Subject or parent/guardian request|6|||
105409315|NCT02520388|363505170|FG000|Overall Study|Adverse Event|1|||
105409316|NCT02520388|363505171|FG001|Overall Study|Adverse Event|4|||
105409317|NCT02520388|363505170|FG000|Overall Study|Lost to Follow-up|3|||
105409318|NCT02520388|363505171|FG001|Overall Study|Lost to Follow-up|2|||
105409319|NCT02520388|363505170|FG000|Overall Study|Other (reason not defined)|4|||
105409320|NCT02520388|363505171|FG001|Overall Study|Other (reason not defined)|4|||
105409321|NCT01437111|363505173|FG000|Overall Study|Adverse Event|2|||
105409322|NCT01437111|363505173|FG000|Overall Study|Withdrawal by Subject|4|||
105409323|NCT01437111|363505173|FG000|Overall Study|Not reported|5|||
105409324|NCT01437111|363505173|FG000|Overall Study|Physician Decision|1|||
105409325|NCT01437111|363505173|FG000|Overall Study|Lost to Follow-up|5|||
105409326|NCT01437111|363505173|FG000|Overall Study|Protocol Violation|1|||
105409327|NCT04188834|363505176|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
105409328|NCT00553436|363505177|FG000|Overall Study|Conversion to another procedure|1|||
105409329|NCT00577707|363505178|FG000|Overall Study|Withdrawal by Subject|3|||
105409330|NCT03299244|363505179|FG000|Overall Study|Withdrawal by Subject|34|||
105409331|NCT03299244|363505180|FG001|Overall Study|Withdrawal by Subject|29|||
105409332|NCT03299244|363505179|FG000|Overall Study|Decision by Sponsor|4|||
105409333|NCT03299244|363505180|FG001|Overall Study|Decision by Sponsor|5|||
105409334|NCT03299244|363505179|FG000|Overall Study|Death|9|||
105409335|NCT03299244|363505180|FG001|Overall Study|Death|4|||
105409336|NCT00465972|363505184|FG000|Overall Study|Withdrawal by Subject|2|||
105409337|NCT00465972|363505185|FG001|Overall Study|Withdrawal by Subject|1|||
105409338|NCT00819156|363505194|FG000|Overall Study|Adverse Event|1|||
105409339|NCT00819156|363505195|FG001|Overall Study|Adverse Event|4|||
105409340|NCT00819156|363505196|FG002|Overall Study|Adverse Event|2|||
105409341|NCT00819156|363505197|FG003|Overall Study|Adverse Event|1|||
105409342|NCT00819156|363505198|FG004|Overall Study|Adverse Event|2|||
105409343|NCT00819156|363505199|FG005|Overall Study|Adverse Event|3|||
105409344|NCT00819156|363505194|FG000|Overall Study|Withdrawal by Subject|0|||
105409345|NCT00819156|363505195|FG001|Overall Study|Withdrawal by Subject|3|||
105409346|NCT00819156|363505196|FG002|Overall Study|Withdrawal by Subject|2|||
105409347|NCT00819156|363505197|FG003|Overall Study|Withdrawal by Subject|0|||
105409348|NCT00819156|363505198|FG004|Overall Study|Withdrawal by Subject|1|||
105409349|NCT00819156|363505199|FG005|Overall Study|Withdrawal by Subject|0|||
105409350|NCT00819156|363505194|FG000|Overall Study|Protocol Violation|1|||
105409351|NCT00819156|363505195|FG001|Overall Study|Protocol Violation|0|||
105409352|NCT00819156|363505196|FG002|Overall Study|Protocol Violation|1|||
105409353|NCT00819156|363505197|FG003|Overall Study|Protocol Violation|0|||
105409354|NCT00819156|363505198|FG004|Overall Study|Protocol Violation|0|||
105409355|NCT00819156|363505199|FG005|Overall Study|Protocol Violation|1|||
105409356|NCT00819156|363505194|FG000|Overall Study|Lost to Follow-up|0|||
105409357|NCT00819156|363505195|FG001|Overall Study|Lost to Follow-up|1|||
105409358|NCT00819156|363505196|FG002|Overall Study|Lost to Follow-up|0|||
105409359|NCT00819156|363505197|FG003|Overall Study|Lost to Follow-up|0|||
105409360|NCT00819156|363505198|FG004|Overall Study|Lost to Follow-up|0|||
105409361|NCT00819156|363505199|FG005|Overall Study|Lost to Follow-up|2|||
105409362|NCT00819156|363505194|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
105409363|NCT00819156|363505195|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
105409364|NCT00819156|363505196|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
105409365|NCT00819156|363505197|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
105409366|NCT00819156|363505198|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
105409367|NCT00819156|363505199|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
105409368|NCT00819156|363505194|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
105409369|NCT00819156|363505195|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
105409370|NCT00819156|363505196|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
105495122|NCT02607930|363826259|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
105495123|NCT02607930|363826260|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
105495124|NCT02607930|363826261|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
105495125|NCT02607930|363826262|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
105495126|NCT02607930|363826259|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
105495127|NCT02607930|363826260|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
105495128|NCT02607930|363826261|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
105495129|NCT02607930|363826262|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
105495130|NCT02607930|363826259|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
105581411|NCT01010217|364126514|FG000|Overall Study|Physician Decision|0|||
105409371|NCT00819156|363505197|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
105409372|NCT00819156|363505198|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
105409373|NCT00819156|363505199|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
105409374|NCT00819156|363505194|FG000|Overall Study|Prostate-specific antigen progression|0|||
105409375|NCT00819156|363505195|FG001|Overall Study|Prostate-specific antigen progression|0|||
105409376|NCT00819156|363505196|FG002|Overall Study|Prostate-specific antigen progression|0|||
105581412|NCT01010217|364126515|FG001|Overall Study|Physician Decision|0|||
105581413|NCT01010217|364126516|FG002|Overall Study|Physician Decision|0|||
105581414|NCT01010217|364126517|FG003|Overall Study|Physician Decision|6|||
105581415|NCT01010217|364126518|FG004|Overall Study|Physician Decision|3|||
105581416|NCT03389893|364126519|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
105581417|NCT03389893|364126520|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
105581418|NCT03389893|364126521|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
105581419|NCT03389893|364126522|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
105581420|NCT03389893|364126519|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
105581421|NCT03389893|364126520|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
105581422|NCT03389893|364126521|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
105581423|NCT03389893|364126522|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
105581424|NCT03389893|364126519|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
105581425|NCT03389893|364126520|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
105581426|NCT03389893|364126521|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
105581427|NCT03389893|364126522|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
105581428|NCT03389893|364126519|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
105581429|NCT03389893|364126520|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
105581430|NCT03389893|364126521|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
105581431|NCT03389893|364126522|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
105581432|NCT00388362|364126539|FG000|Enrolled|Ineligible|1|||
105581433|NCT00388362|364126539|FG000|Enrolled|Adverse Event|9|||
105581434|NCT00388362|364126539|FG000|Enrolled|Death|1|||
105581435|NCT00388362|364126539|FG000|Enrolled|Loss insurance|1|||
105581436|NCT00388362|364126539|FG000|Enrolled|Withdrawal by Subject|1|||
105581437|NCT00388362|364126539|FG000|Remained on Study Median of 514 Days|Death|2|||
105581438|NCT03259373|364126544|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
105581439|NCT03259373|364126545|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
105581440|NCT03259373|364126544|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
105581441|NCT03259373|364126545|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
105581442|NCT03259373|364126544|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
105581443|NCT03259373|364126545|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
105581444|NCT03259373|364126544|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
105581445|NCT03259373|364126545|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
105581446|NCT03259373|364126544|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
105581447|NCT03259373|364126545|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
105581448|NCT03259373|364126544|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
105581449|NCT03259373|364126545|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
105581450|NCT01923428|364126552|FG000|Overall Study|Adverse Event|8|||
105581451|NCT01923428|364126553|FG001|Overall Study|Adverse Event|6|||
105409377|NCT00819156|363505197|FG003|Overall Study|Prostate-specific antigen progression|0|||
105409378|NCT00819156|363505198|FG004|Overall Study|Prostate-specific antigen progression|1|||
105409379|NCT00819156|363505199|FG005|Overall Study|Prostate-specific antigen progression|0|||
105409380|NCT00984594|363505200|FG000|Overall Study|Lost to Follow-up|1|||
105409381|NCT00984594|363505201|FG001|Overall Study|Lost to Follow-up|0|||
105409382|NCT00984594|363505200|FG000|Overall Study|Withdrawal by Subject|0|||
105409383|NCT00984594|363505201|FG001|Overall Study|Withdrawal by Subject|1|||
105409384|NCT00803595|363505202|FG000|Overall Study|Adverse Event|3|||
105409385|NCT00803595|363505203|FG001|Overall Study|Adverse Event|4|||
105409386|NCT00803595|363505204|FG002|Overall Study|Adverse Event|1|||
105581452|NCT01923428|364126554|FG002|Overall Study|Adverse Event|3|||
105581453|NCT01923428|364126555|FG003|Overall Study|Adverse Event|3|||
105409387|NCT00803595|363505202|FG000|Overall Study|Protocol Violation|7|||
105409388|NCT00803595|363505203|FG001|Overall Study|Protocol Violation|2|||
105409389|NCT00803595|363505204|FG002|Overall Study|Protocol Violation|12|||
105409390|NCT00803595|363505202|FG000|Overall Study|Withdrawal by Subject|5|||
105409391|NCT00803595|363505203|FG001|Overall Study|Withdrawal by Subject|2|||
105409392|NCT00803595|363505204|FG002|Overall Study|Withdrawal by Subject|3|||
105409393|NCT03135431|363505206|FG000|Overall Study|Study Surgeon not available|2|||
105409394|NCT03135431|363505207|FG001|Overall Study|Study Surgeon not available|0|||
105409395|NCT02100423|363505209|FG000|Overall Study|Death|1|||
105409396|NCT02100423|363505209|FG000|Overall Study|Withdrawal by Subject|3|||
105409397|NCT02100423|363505209|FG000|Overall Study|Adverse Event|1|||
105409398|NCT02100423|363505209|FG000|Overall Study|Physician Decision|1|||
105409399|NCT02454530|363505210|FG000|Overall Study|Other|8|||
105409400|NCT02454530|363505211|FG001|Overall Study|Other|13|||
105409401|NCT02454530|363505210|FG000|Overall Study|Missing information|56|||
105409402|NCT02454530|363505211|FG001|Overall Study|Missing information|69|||
105409403|NCT02454530|363505210|FG000|Overall Study|Death|2|||
105409404|NCT02454530|363505211|FG001|Overall Study|Death|41|||
105409405|NCT02454530|363505210|FG000|Overall Study|Lost to Follow-up|4|||
105409406|NCT02454530|363505211|FG001|Overall Study|Lost to Follow-up|4|||
105409407|NCT02195700|363505212|FG000|Overall Study|Protocol Violation|0|||
105409408|NCT02195700|363505213|FG001|Overall Study|Protocol Violation|2|||
105409409|NCT02195700|363505212|FG000|Overall Study|Noncompliance|1|||
105409410|NCT02195700|363505213|FG001|Overall Study|Noncompliance|0|||
105409411|NCT02195700|363505212|FG000|Overall Study|Adverse Event|1|||
105409412|NCT02195700|363505213|FG001|Overall Study|Adverse Event|2|||
105409413|NCT02195700|363505212|FG000|Overall Study|Withdrawal by Subject|3|||
105409414|NCT02195700|363505213|FG001|Overall Study|Withdrawal by Subject|2|||
105409415|NCT02195700|363505212|FG000|Overall Study|Lost to Follow-up|1|||
105409416|NCT02195700|363505213|FG001|Overall Study|Lost to Follow-up|1|||
105409417|NCT03265145|363505214|FG000|Overall Study|Protocol Violation|2|||
105409418|NCT03265145|363505215|FG001|Overall Study|Protocol Violation|0|||
105409419|NCT03265145|363505214|FG000|Overall Study|Adverse Event|1|||
105409420|NCT03265145|363505215|FG001|Overall Study|Adverse Event|0|||
105409421|NCT03265145|363505214|FG000|Overall Study|Withdrawal by Subject|23|||
105409422|NCT03265145|363505215|FG001|Overall Study|Withdrawal by Subject|19|||
105409423|NCT03265145|363505214|FG000|Overall Study|Death|12|||
105409424|NCT03265145|363505215|FG001|Overall Study|Death|12|||
105409425|NCT03265145|363505214|FG000|Overall Study|Lost to Follow-up|13|||
105409426|NCT03265145|363505215|FG001|Overall Study|Lost to Follow-up|9|||
105409427|NCT03265145|363505214|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
105409428|NCT03265145|363505215|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
105409429|NCT03265145|363505214|FG000|Overall Study|Switched back to previous medication|1|||
105409430|NCT03265145|363505215|FG001|Overall Study|Switched back to previous medication|0|||
105409431|NCT03265145|363505214|FG000|Overall Study|Did not want to take medication|1|||
105409432|NCT03265145|363505215|FG001|Overall Study|Did not want to take medication|0|||
105409433|NCT03265145|363505214|FG000|Overall Study|Subject could not afford medication|0|||
105409434|NCT03265145|363505215|FG001|Overall Study|Subject could not afford medication|1|||
105409435|NCT03265145|363505214|FG000|Overall Study|Site closed|2|||
105409436|NCT03265145|363505215|FG001|Overall Study|Site closed|3|||
105409437|NCT03265145|363505214|FG000|Overall Study|Incorrectly randomized|16|||
105409438|NCT03265145|363505215|FG001|Overall Study|Incorrectly randomized|6|||
105409439|NCT03265145|363505214|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
105409440|NCT03265145|363505215|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
105409441|NCT03265145|363505214|FG000|Overall Study|Physician Decision|0|||
105409442|NCT03265145|363505215|FG001|Overall Study|Physician Decision|3|||
105409443|NCT03265145|363505214|FG000|Overall Study|Subject transferred to another facility|0|||
105409444|NCT03265145|363505215|FG001|Overall Study|Subject transferred to another facility|1|||
105409445|NCT00837161|363505216|FG000|Overall Study|refused hysterectomy|2|||
105409446|NCT01127607|363506615|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
105409447|NCT01127607|363506616|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
105409448|NCT01127607|363506615|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
105409449|NCT01127607|363506616|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
105409450|NCT03941873|363506623|FG000|Overall Study|Death|0|||
105409451|NCT03941873|363506624|FG001|Overall Study|Death|12|||
105409452|NCT03941873|363506625|FG002|Overall Study|Death|2|||
105409453|NCT03941873|363506626|FG003|Overall Study|Death|53|||
105409454|NCT03941873|363506623|FG000|Overall Study|Withdrawal by Subject|1|||
105409455|NCT03941873|363506624|FG001|Overall Study|Withdrawal by Subject|1|||
105409456|NCT03941873|363506625|FG002|Overall Study|Withdrawal by Subject|0|||
105409457|NCT03941873|363506626|FG003|Overall Study|Withdrawal by Subject|5|||
105409458|NCT03941873|363506623|FG000|Overall Study|Lost to Follow-up|1|||
105409459|NCT03941873|363506624|FG001|Overall Study|Lost to Follow-up|2|||
105409460|NCT03941873|363506625|FG002|Overall Study|Lost to Follow-up|0|||
105409461|NCT03941873|363506626|FG003|Overall Study|Lost to Follow-up|0|||
105409462|NCT03941873|363506623|FG000|Overall Study|Sponsor Decision|0|||
105409463|NCT03941873|363506624|FG001|Overall Study|Sponsor Decision|6|||
105409464|NCT03941873|363506625|FG002|Overall Study|Sponsor Decision|0|||
105409465|NCT03941873|363506626|FG003|Overall Study|Sponsor Decision|15|||
105409466|NCT01234480|363506629|FG000|Overall Study|Pregnancy|88|||
105409467|NCT01234480|363506629|FG000|Overall Study|>36/Normal History|50|||
105409468|NCT01234480|363506629|FG000|Overall Study|Age|3|||
105409469|NCT01234480|363506629|FG000|Overall Study|HPV Vaccine History|28|||
105409470|NCT01234480|363506629|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
105409471|NCT01234480|363506629|FG000|Overall Study|Hysterectomy|2|||
105409472|NCT01234480|363506629|FG000|Overall Study|Hysterectomy post enrollment|1|||
105409473|NCT01234480|363506629|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
105409474|NCT01234480|363506629|FG000|Overall Study|Informed Consent Form Violation|30|||
105409475|NCT01234480|363506629|FG000|Overall Study|Incorrect Visit|3|||
105409476|NCT01234480|363506629|FG000|Overall Study|No Florida Lab License|20|||
105409477|NCT01234480|363506629|FG000|Overall Study|Out of Window|42|||
105409478|NCT01234480|363506629|FG000|Overall Study|Sample Processing/Storage|92|||
105409479|NCT01234480|363506629|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
105409480|NCT01234480|363506629|FG000|Overall Study|Site/Subject non-compliance|44|||
105409481|NCT01234480|363506629|FG000|Overall Study|Missing Sample|9|||
105409482|NCT03370419|363506630|FG000|Overall Study|Lost to Follow-up|16|||
105409483|NCT02522429|363506631|FG000|Overall Study|Lost to Follow-up|8|||
105409484|NCT02522429|363506631|FG000|Overall Study|Adverse Event|2|||
105409485|NCT02522429|363506631|FG000|Overall Study|Death|1|||
105409486|NCT02522429|363506631|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
105409487|NCT02263326|363506635|FG000|Overall Study|Lost to Follow-up|1|||
105409488|NCT02263326|363506636|FG001|Overall Study|Lost to Follow-up|1|||
105409489|NCT01734785|363506637|FG000|Open-Label Period|Adverse Event|0|||
105409490|NCT01734785|363506638|FG001|Open-Label Period|Adverse Event|0|||
105409491|NCT01734785|363506639|FG002|Open-Label Period|Adverse Event|0|||
105409492|NCT01734785|363506640|FG003|Open-Label Period|Adverse Event|9|||
105409493|NCT01734785|363506637|FG000|Open-Label Period|Lack of Efficacy|0|||
105409494|NCT01734785|363506638|FG001|Open-Label Period|Lack of Efficacy|0|||
105409495|NCT01734785|363506639|FG002|Open-Label Period|Lack of Efficacy|0|||
105409496|NCT01734785|363506640|FG003|Open-Label Period|Lack of Efficacy|1|||
105409497|NCT01734785|363506637|FG000|Open-Label Period|Protocol Violation|0|||
105409498|NCT01734785|363506638|FG001|Open-Label Period|Protocol Violation|0|||
105409499|NCT01734785|363506639|FG002|Open-Label Period|Protocol Violation|0|||
105409500|NCT01734785|363506640|FG003|Open-Label Period|Protocol Violation|13|||
105409501|NCT01734785|363506637|FG000|Open-Label Period|Lost to Follow-up|0|||
105409502|NCT01734785|363506638|FG001|Open-Label Period|Lost to Follow-up|0|||
105409503|NCT01734785|363506639|FG002|Open-Label Period|Lost to Follow-up|0|||
105409504|NCT01734785|363506640|FG003|Open-Label Period|Lost to Follow-up|14|||
105409505|NCT01734785|363506637|FG000|Open-Label Period|Withdrawal by Subject|0|||
105409506|NCT01734785|363506638|FG001|Open-Label Period|Withdrawal by Subject|0|||
105409507|NCT01734785|363506639|FG002|Open-Label Period|Withdrawal by Subject|0|||
105409508|NCT01734785|363506640|FG003|Open-Label Period|Withdrawal by Subject|12|||
105409509|NCT01734785|363506637|FG000|Open-Label Period|Other Reasons|0|||
105409510|NCT01734785|363506638|FG001|Open-Label Period|Other Reasons|0|||
105409511|NCT01734785|363506639|FG002|Open-Label Period|Other Reasons|0|||
105409512|NCT01734785|363506640|FG003|Open-Label Period|Other Reasons|224|||
105409513|NCT01734785|363506637|FG000|Double-Blind Period|Adverse Event|0|||
105409514|NCT01734785|363506638|FG001|Double-Blind Period|Adverse Event|3|||
105409515|NCT01734785|363506639|FG002|Double-Blind Period|Adverse Event|2|||
105409516|NCT01734785|363506640|FG003|Double-Blind Period|Adverse Event|0|||
105409517|NCT01734785|363506637|FG000|Double-Blind Period|Lack of Efficacy|0|||
105409518|NCT01734785|363506638|FG001|Double-Blind Period|Lack of Efficacy|1|||
105409519|NCT01734785|363506639|FG002|Double-Blind Period|Lack of Efficacy|0|||
105409520|NCT01734785|363506640|FG003|Double-Blind Period|Lack of Efficacy|0|||
105409521|NCT01734785|363506637|FG000|Double-Blind Period|Protocol Violation|0|||
105409522|NCT01734785|363506638|FG001|Double-Blind Period|Protocol Violation|1|||
105409523|NCT01734785|363506639|FG002|Double-Blind Period|Protocol Violation|1|||
105409524|NCT01734785|363506640|FG003|Double-Blind Period|Protocol Violation|0|||
105409525|NCT01734785|363506637|FG000|Double-Blind Period|Lost to Follow-up|2|||
105409526|NCT01734785|363506638|FG001|Double-Blind Period|Lost to Follow-up|4|||
105409527|NCT01734785|363506639|FG002|Double-Blind Period|Lost to Follow-up|2|||
105409528|NCT01734785|363506640|FG003|Double-Blind Period|Lost to Follow-up|0|||
105409529|NCT01734785|363506637|FG000|Double-Blind Period|Withdrawal by Subject|2|||
105409530|NCT01734785|363506638|FG001|Double-Blind Period|Withdrawal by Subject|0|||
105409531|NCT01734785|363506639|FG002|Double-Blind Period|Withdrawal by Subject|0|||
105409532|NCT01734785|363506640|FG003|Double-Blind Period|Withdrawal by Subject|0|||
105409533|NCT01734785|363506637|FG000|Double-Blind Period|Not treated|1|||
105409534|NCT01734785|363506638|FG001|Double-Blind Period|Not treated|0|||
105409535|NCT01734785|363506639|FG002|Double-Blind Period|Not treated|0|||
105409536|NCT01734785|363506640|FG003|Double-Blind Period|Not treated|0|||
105409537|NCT02397915|363506641|FG000|Period 1|Protocol Violation|0|||
105409538|NCT02397915|363506642|FG001|Period 1|Protocol Violation|1|||
105409539|NCT02397915|363506643|FG002|Period 1|Protocol Violation|0|||
105409540|NCT02397915|363506644|FG003|Period 1|Protocol Violation|0|||
105409541|NCT02397915|363506641|FG000|Period 1|Physician Decision|1|||
105409542|NCT02397915|363506642|FG001|Period 1|Physician Decision|0|||
105409543|NCT02397915|363506643|FG002|Period 1|Physician Decision|0|||
105409544|NCT02397915|363506644|FG003|Period 1|Physician Decision|0|||
105409545|NCT01645735|363506649|FG000|Overall Study|Physician Decision|2|||
105409546|NCT01645735|363506650|FG001|Overall Study|Physician Decision|0|||
105409547|NCT01645735|363506649|FG000|Overall Study|Withdrawal by Subject|1|||
105409548|NCT01645735|363506650|FG001|Overall Study|Withdrawal by Subject|0|||
105409549|NCT01645735|363506649|FG000|Overall Study|Protocol Violation|1|||
105409550|NCT01645735|363506650|FG001|Overall Study|Protocol Violation|0|||
105409551|NCT01645735|363506649|FG000|Overall Study|Adverse Event|0|||
105409552|NCT01645735|363506650|FG001|Overall Study|Adverse Event|1|||
105409553|NCT01995526|363506651|FG000|Overall Study|Physician Decision|1|||
105409554|NCT00383331|363506652|FG000|Overall Study|Protocol Violation|0|||
105409555|NCT00383331|363506653|FG001|Overall Study|Protocol Violation|1|||
105409556|NCT03226249|363506659|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
105409557|NCT03226249|363506659|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
105409558|NCT03226249|363506659|FG000|Survival Follow-up|Patients still in follow-up.|30|||
105409559|NCT00606411|363506660|FG000|Overall Study|Adverse Event|1|||
105409560|NCT00606411|363506661|FG001|Overall Study|Adverse Event|2|||
105409561|NCT00606411|363506660|FG000|Overall Study|Lack of Adherence|1|||
105409562|NCT00606411|363506661|FG001|Overall Study|Lack of Adherence|1|||
105409563|NCT00606411|363506660|FG000|Overall Study|Lack of Efficacy|1|||
105409564|NCT00606411|363506661|FG001|Overall Study|Lack of Efficacy|1|||
105409565|NCT00606411|363506660|FG000|Overall Study|Withdrawal by Subject|2|||
105409566|NCT00606411|363506661|FG001|Overall Study|Withdrawal by Subject|0|||
105409567|NCT00606411|363506660|FG000|Overall Study|Lost to Follow-up|1|||
105409568|NCT00606411|363506661|FG001|Overall Study|Lost to Follow-up|2|||
105409569|NCT00606411|363506660|FG000|Overall Study|Move out of state|0|||
105409570|NCT00606411|363506661|FG001|Overall Study|Move out of state|1|||
105409571|NCT01390298|363506663|FG000|Overall Study|Death|1|||
105409572|NCT01390298|363506663|FG000|Overall Study|long term ICU admission|1|||
105409573|NCT01390298|363506663|FG000|Overall Study|Withdrawal by Subject|14|||
105409574|NCT01390298|363506663|FG000|Overall Study|Lost to Follow-up|7|||
105409575|NCT01390298|363506663|FG000|Overall Study|Surgery cancelled|1|||
105409576|NCT01524224|363506666|FG000|Overall Study|Progressive Disease|1|||
105409577|NCT01524224|363506667|FG001|Overall Study|Progressive Disease|0|||
105409578|NCT01524224|363506668|FG002|Overall Study|Progressive Disease|2|||
105409579|NCT01524224|363506669|FG003|Overall Study|Progressive Disease|1|||
105409580|NCT01524224|363506670|FG004|Overall Study|Progressive Disease|2|||
105409581|NCT01524224|363506671|FG005|Overall Study|Progressive Disease|1|||
105409582|NCT01524224|363506672|FG006|Overall Study|Progressive Disease|1|||
105409583|NCT01524224|363506673|FG007|Overall Study|Progressive Disease|5|||
105409584|NCT01524224|363506666|FG000|Overall Study|Withdrawal by Subject|2|||
105409585|NCT01524224|363506667|FG001|Overall Study|Withdrawal by Subject|0|||
105409586|NCT01524224|363506668|FG002|Overall Study|Withdrawal by Subject|0|||
105409587|NCT01524224|363506669|FG003|Overall Study|Withdrawal by Subject|0|||
105409588|NCT01524224|363506670|FG004|Overall Study|Withdrawal by Subject|0|||
105409589|NCT01524224|363506671|FG005|Overall Study|Withdrawal by Subject|0|||
105409590|NCT01524224|363506672|FG006|Overall Study|Withdrawal by Subject|2|||
105409591|NCT01524224|363506673|FG007|Overall Study|Withdrawal by Subject|0|||
105409592|NCT01524224|363506666|FG000|Overall Study|Adverse Event|0|||
105409593|NCT01524224|363506667|FG001|Overall Study|Adverse Event|1|||
105409594|NCT01524224|363506668|FG002|Overall Study|Adverse Event|0|||
105409595|NCT01524224|363506669|FG003|Overall Study|Adverse Event|0|||
105409596|NCT01524224|363506670|FG004|Overall Study|Adverse Event|0|||
105409597|NCT01524224|363506671|FG005|Overall Study|Adverse Event|1|||
105409598|NCT01524224|363506672|FG006|Overall Study|Adverse Event|0|||
105409599|NCT01524224|363506673|FG007|Overall Study|Adverse Event|0|||
105409600|NCT01524224|363506666|FG000|Overall Study|Physician Decision|0|||
105409601|NCT01524224|363506667|FG001|Overall Study|Physician Decision|0|||
105409602|NCT01524224|363506668|FG002|Overall Study|Physician Decision|0|||
105409603|NCT01524224|363506669|FG003|Overall Study|Physician Decision|1|||
105409604|NCT01524224|363506670|FG004|Overall Study|Physician Decision|1|||
105409605|NCT01524224|363506671|FG005|Overall Study|Physician Decision|0|||
105409606|NCT01524224|363506672|FG006|Overall Study|Physician Decision|0|||
105409607|NCT01524224|363506673|FG007|Overall Study|Physician Decision|1|||
105409608|NCT01524224|363506666|FG000|Overall Study|Sponsor Decision|0|||
105409609|NCT01524224|363506667|FG001|Overall Study|Sponsor Decision|0|||
105409610|NCT01524224|363506668|FG002|Overall Study|Sponsor Decision|0|||
105409611|NCT01524224|363506669|FG003|Overall Study|Sponsor Decision|0|||
105409612|NCT01524224|363506670|FG004|Overall Study|Sponsor Decision|1|||
105409613|NCT01524224|363506671|FG005|Overall Study|Sponsor Decision|0|||
105409614|NCT01524224|363506672|FG006|Overall Study|Sponsor Decision|0|||
105409615|NCT01524224|363506673|FG007|Overall Study|Sponsor Decision|0|||
105409616|NCT02819297|363506676|FG000|Overall Study|Withdrawal by Subject|25|||
105409617|NCT02819297|363506677|FG001|Overall Study|Withdrawal by Subject|13|||
105409618|NCT02819297|363506676|FG000|Overall Study|Lost to Follow-up|12|||
105409619|NCT02819297|363506677|FG001|Overall Study|Lost to Follow-up|14|||
105409620|NCT02819297|363506676|FG000|Overall Study|Adverse Event|12|||
105409621|NCT02819297|363506677|FG001|Overall Study|Adverse Event|10|||
105409622|NCT02819297|363506676|FG000|Overall Study|Physician Decision|5|||
105409623|NCT02819297|363506677|FG001|Overall Study|Physician Decision|5|||
105409624|NCT02819297|363506676|FG000|Overall Study|Lack of Efficacy|5|||
105409625|NCT02819297|363506677|FG001|Overall Study|Lack of Efficacy|8|||
105409626|NCT02819297|363506676|FG000|Overall Study|Protocol Violation|1|||
105409627|NCT02819297|363506677|FG001|Overall Study|Protocol Violation|2|||
105409628|NCT03994211|363506678|FG000|Core Phase|Adverse Event|0|||
105409629|NCT03994211|363506679|FG001|Core Phase|Adverse Event|1|||
105409630|NCT03994211|363506680|FG002|Core Phase|Adverse Event|0|||
105409631|NCT03994211|363506678|FG000|Extension Phase|Adverse Event|0|||
105409632|NCT03994211|363506679|FG001|Extension Phase|Adverse Event|0|||
105409633|NCT03994211|363506680|FG002|Extension Phase|Adverse Event|1|||
105409634|NCT03994211|363506678|FG000|Extension Phase|Physician Decision|0|||
105409635|NCT03994211|363506679|FG001|Extension Phase|Physician Decision|0|||
105409636|NCT03994211|363506680|FG002|Extension Phase|Physician Decision|1|||
105409637|NCT03994211|363506678|FG000|Extension Phase|Progressive Disease|0|||
105409638|NCT03994211|363506679|FG001|Extension Phase|Progressive Disease|0|||
105409639|NCT03994211|363506680|FG002|Extension Phase|Progressive Disease|20|||
105409640|NCT03994211|363506678|FG000|Extension Phase|Withdrawal by Subject|0|||
105409641|NCT03994211|363506679|FG001|Extension Phase|Withdrawal by Subject|0|||
105409642|NCT03994211|363506680|FG002|Extension Phase|Withdrawal by Subject|2|||
105409643|NCT02201329|363506681|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
105409644|NCT02201329|363506681|FG000|Overall Study|Withdrawal by Subject|2|||
105409645|NCT01140867|363506682|FG000|Overall Study|Adverse Event|22|||
105409646|NCT01140867|363506682|FG000|Overall Study|Lack of Efficacy|3|||
105409647|NCT01140867|363506682|FG000|Overall Study|Lost to Follow-up|2|||
105409648|NCT01140867|363506682|FG000|Overall Study|Withdrawal by Subject|1|||
105409649|NCT01140867|363506682|FG000|Overall Study|Protocol Violation|1|||
105409650|NCT01140867|363506682|FG000|Overall Study|Uncooperative patient|2|||
105409651|NCT01140867|363506682|FG000|Overall Study|Medication Noncompliance|2|||
105409652|NCT00783835|363506683|FG000|Overall Study|Adverse Event|3|||
105409653|NCT00783835|363506683|FG000|Overall Study|Medical Criteria|1|||
105409654|NCT00783835|363506683|FG000|Overall Study|Withdrawal by Subject|2|||
105409655|NCT00783835|363506683|FG000|Overall Study|Lost to Follow-up|1|||
105409656|NCT00783835|363506683|FG000|Overall Study|Participant not Adherent|3|||
105409657|NCT00690430|363506687|FG000|Core Phase|Abnormal Laboratory value|0|||
105409658|NCT00690430|363506688|FG001|Core Phase|Abnormal Laboratory value|1|||
105409659|NCT00690430|363506689|FG002|Core Phase|Abnormal Laboratory value|0|||
105409660|NCT00690430|363506687|FG000|Core Phase|Adverse Event|5|||
105409661|NCT00690430|363506688|FG001|Core Phase|Adverse Event|1|||
105409662|NCT00690430|363506689|FG002|Core Phase|Adverse Event|0|||
105409663|NCT00690430|363506687|FG000|Core Phase|Death|0|||
105409664|NCT00690430|363506688|FG001|Core Phase|Death|2|||
105409665|NCT00690430|363506689|FG002|Core Phase|Death|0|||
105409666|NCT00690430|363506687|FG000|Core Phase|Protocol Violation|1|||
105409667|NCT00690430|363506688|FG001|Core Phase|Protocol Violation|0|||
105409668|NCT00690430|363506689|FG002|Core Phase|Protocol Violation|0|||
105409669|NCT00690430|363506687|FG000|Core Phase|Withdrawal by Subject|3|||
105409670|NCT00690430|363506688|FG001|Core Phase|Withdrawal by Subject|3|||
105409671|NCT00690430|363506689|FG002|Core Phase|Withdrawal by Subject|0|||
105409672|NCT00690430|363506687|FG000|Core Phase|Subject no longer requires study drug|1|||
105409673|NCT00690430|363506688|FG001|Core Phase|Subject no longer requires study drug|0|||
105409674|NCT00690430|363506689|FG002|Core Phase|Subject no longer requires study drug|0|||
105409675|NCT00690430|363506687|FG000|Core Phase|Lack of Efficacy|8|||
105409676|NCT00690430|363506688|FG001|Core Phase|Lack of Efficacy|10|||
105409677|NCT00690430|363506689|FG002|Core Phase|Lack of Efficacy|0|||
105409678|NCT00690430|363506687|FG000|Core Phase|Administrative Problems|0|||
105409679|NCT00690430|363506688|FG001|Core Phase|Administrative Problems|1|||
105409680|NCT00690430|363506689|FG002|Core Phase|Administrative Problems|0|||
105409681|NCT00690430|363506687|FG000|Core Phase|Early Termination|0|||
105409682|NCT00690430|363506688|FG001|Core Phase|Early Termination|5|||
105409683|NCT00690430|363506689|FG002|Core Phase|Early Termination|0|||
105409684|NCT00690430|363506687|FG000|Extension Phase|Lack of Efficacy|3|||
105409685|NCT00690430|363506688|FG001|Extension Phase|Lack of Efficacy|1|||
105409686|NCT00690430|363506689|FG002|Extension Phase|Lack of Efficacy|4|||
105409687|NCT00690430|363506687|FG000|Extension Phase|Abnormal Lab Values|1|||
105581454|NCT01923428|364126552|FG000|Overall Study|Withdrawal by Subject|5|||
105581455|NCT01923428|364126553|FG001|Overall Study|Withdrawal by Subject|3|||
105581456|NCT01923428|364126554|FG002|Overall Study|Withdrawal by Subject|0|||
105581457|NCT01923428|364126555|FG003|Overall Study|Withdrawal by Subject|4|||
105581458|NCT01923428|364126552|FG000|Overall Study|Lost to Follow-up|2|||
105581459|NCT01923428|364126553|FG001|Overall Study|Lost to Follow-up|1|||
105581460|NCT01923428|364126554|FG002|Overall Study|Lost to Follow-up|5|||
105581461|NCT01923428|364126555|FG003|Overall Study|Lost to Follow-up|0|||
105581462|NCT01923428|364126552|FG000|Overall Study|Protocol Violation|3|||
105581463|NCT01923428|364126553|FG001|Overall Study|Protocol Violation|0|||
105581464|NCT01923428|364126554|FG002|Overall Study|Protocol Violation|2|||
105581465|NCT01923428|364126555|FG003|Overall Study|Protocol Violation|1|||
105581466|NCT01923428|364126552|FG000|Overall Study|Non Compliance to treatment|1|||
105581467|NCT01923428|364126553|FG001|Overall Study|Non Compliance to treatment|2|||
105581468|NCT01923428|364126554|FG002|Overall Study|Non Compliance to treatment|0|||
105581469|NCT01923428|364126555|FG003|Overall Study|Non Compliance to treatment|1|||
105581470|NCT01923428|364126552|FG000|Overall Study|Lack of Efficacy|0|||
105581471|NCT01923428|364126553|FG001|Overall Study|Lack of Efficacy|0|||
105581472|NCT01923428|364126554|FG002|Overall Study|Lack of Efficacy|1|||
105581473|NCT01923428|364126555|FG003|Overall Study|Lack of Efficacy|1|||
105581474|NCT01563978|364126559|FG000|Overall Study|Physician Decision|1|||
105581475|NCT01563978|364126560|FG001|Overall Study|Physician Decision|0|||
105581476|NCT01563978|364126559|FG000|Overall Study|Lost to Follow-up|1|||
105581477|NCT01563978|364126560|FG001|Overall Study|Lost to Follow-up|0|||
105581478|NCT01563978|364126559|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
105581479|NCT01563978|364126560|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
105581480|NCT01563978|364126559|FG000|Overall Study|Adverse Event|1|||
105581481|NCT01563978|364126560|FG001|Overall Study|Adverse Event|2|||
105581482|NCT05593211|364126561|FG000|Overall Study|Withdrawal by Subject|1|||
105581483|NCT03077620|364126565|FG000|Overall Study|Unable to place lumbar catheter|1|||
105581484|NCT03077620|364126566|FG001|Overall Study|Unable to place lumbar catheter|0|||
105581485|NCT03077620|364126567|FG002|Overall Study|Unable to place lumbar catheter|1|||
105581486|NCT03077620|364126568|FG003|Overall Study|Unable to place lumbar catheter|0|||
105581487|NCT03077620|364126565|FG000|Overall Study|Withdrawal by Subject|0|||
105581488|NCT03077620|364126566|FG001|Overall Study|Withdrawal by Subject|1|||
105581489|NCT03077620|364126567|FG002|Overall Study|Withdrawal by Subject|0|||
105581490|NCT03077620|364126568|FG003|Overall Study|Withdrawal by Subject|0|||
105581491|NCT03077620|364126565|FG000|Overall Study|Physician Decision|0|||
105581492|NCT03077620|364126566|FG001|Overall Study|Physician Decision|0|||
105581493|NCT03077620|364126567|FG002|Overall Study|Physician Decision|1|||
105409688|NCT00690430|363506688|FG001|Extension Phase|Abnormal Lab Values|0|||
105409689|NCT00690430|363506689|FG002|Extension Phase|Abnormal Lab Values|0|||
105409690|NCT00690430|363506687|FG000|Extension Phase|Abnormal test procedure results|1|||
105409691|NCT00690430|363506688|FG001|Extension Phase|Abnormal test procedure results|0|||
105409692|NCT00690430|363506689|FG002|Extension Phase|Abnormal test procedure results|0|||
105409693|NCT00690430|363506687|FG000|Extension Phase|Administrative Problems|0|||
105409694|NCT00690430|363506688|FG001|Extension Phase|Administrative Problems|1|||
105409695|NCT00690430|363506689|FG002|Extension Phase|Administrative Problems|1|||
105409696|NCT00690430|363506687|FG000|Extension Phase|Adverse Event|2|||
105409697|NCT00690430|363506688|FG001|Extension Phase|Adverse Event|1|||
105409698|NCT00690430|363506689|FG002|Extension Phase|Adverse Event|2|||
105409699|NCT00690430|363506687|FG000|Extension Phase|Death|1|||
105409700|NCT00690430|363506688|FG001|Extension Phase|Death|1|||
105409701|NCT00690430|363506689|FG002|Extension Phase|Death|1|||
105409702|NCT00690430|363506687|FG000|Extension Phase|Withdrawal by Subject|0|||
105409703|NCT00690430|363506688|FG001|Extension Phase|Withdrawal by Subject|0|||
105409704|NCT00690430|363506689|FG002|Extension Phase|Withdrawal by Subject|2|||
105409705|NCT00690430|363506687|FG000|Extension Phase|Early Termination|10|||
105409706|NCT00690430|363506688|FG001|Extension Phase|Early Termination|1|||
105409707|NCT00690430|363506689|FG002|Extension Phase|Early Termination|3|||
105409708|NCT00763256|363506691|FG000|Overall Study|Didn't return for appointments|7|||
105409709|NCT00763256|363506692|FG001|Overall Study|Didn't return for appointments|10|||
105409710|NCT02544750|363506693|FG000|Overall Study|Physician Decision|3|||
105409711|NCT02544750|363506694|FG001|Overall Study|Physician Decision|1|||
105409712|NCT02544750|363506693|FG000|Overall Study|Other reasons|69|||
105409713|NCT02544750|363506694|FG001|Overall Study|Other reasons|39|||
105581494|NCT03077620|364126568|FG003|Overall Study|Physician Decision|0|||
105581495|NCT03225846|364126569|FG000|Overall Study|Adverse Event|0|||
105581496|NCT03225846|364126570|FG001|Overall Study|Adverse Event|0|||
105581497|NCT03225846|364126571|FG002|Overall Study|Adverse Event|0|||
105581498|NCT03225846|364126572|FG003|Overall Study|Adverse Event|0|||
105409714|NCT02544750|363506693|FG000|Overall Study|Met withdrawal criteria|2|||
105409715|NCT02544750|363506694|FG001|Overall Study|Met withdrawal criteria|2|||
105581499|NCT03225846|364126573|FG004|Overall Study|Adverse Event|0|||
105581500|NCT03225846|364126574|FG005|Overall Study|Adverse Event|0|||
105581501|NCT03225846|364126575|FG006|Overall Study|Adverse Event|6|||
105581502|NCT03225846|364126569|FG000|Overall Study|Withdrawal by Subject|0|||
105581503|NCT03225846|364126570|FG001|Overall Study|Withdrawal by Subject|1|||
105409716|NCT02544750|363506693|FG000|Overall Study|Transition To Commercial Product|1|||
105409717|NCT02544750|363506694|FG001|Overall Study|Transition To Commercial Product|0|||
105409718|NCT02544750|363506693|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
105409719|NCT02544750|363506694|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
105409720|NCT02544750|363506693|FG000|Overall Study|Adverse Event|8|||
105409721|NCT02544750|363506694|FG001|Overall Study|Adverse Event|10|||
105409722|NCT02544750|363506693|FG000|Overall Study|Withdrawal by Subject|10|||
105409723|NCT02544750|363506694|FG001|Overall Study|Withdrawal by Subject|4|||
105409724|NCT02544750|363506693|FG000|Overall Study|Lost to Follow-up|1|||
105409725|NCT02544750|363506694|FG001|Overall Study|Lost to Follow-up|0|||
105409726|NCT02125838|363506695|FG000|Overall Study|Lost to Follow-up|4|||
105409727|NCT02125838|363506696|FG001|Overall Study|Lost to Follow-up|4|||
105409728|NCT00244725|363506702|FG000|Overall Study|Lost to Follow-up|3|||
105409729|NCT00244725|363506703|FG001|Overall Study|Lost to Follow-up|4|||
105409730|NCT00244725|363506704|FG002|Overall Study|Lost to Follow-up|9|||
105409731|NCT00244725|363506705|FG003|Overall Study|Lost to Follow-up|2|||
105409732|NCT00244725|363506702|FG000|Overall Study|Withdrawal by Subject|9|||
105409733|NCT00244725|363506703|FG001|Overall Study|Withdrawal by Subject|7|||
105409734|NCT00244725|363506704|FG002|Overall Study|Withdrawal by Subject|7|||
105409735|NCT00244725|363506705|FG003|Overall Study|Withdrawal by Subject|8|||
105409736|NCT00244725|363506702|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
105409737|NCT00244725|363506703|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
105409738|NCT00244725|363506704|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
105409739|NCT00244725|363506705|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
105409740|NCT00244725|363506702|FG000|Overall Study|Physician Decision|3|||
105409741|NCT00244725|363506703|FG001|Overall Study|Physician Decision|0|||
105409742|NCT00244725|363506704|FG002|Overall Study|Physician Decision|1|||
105409743|NCT00244725|363506705|FG003|Overall Study|Physician Decision|2|||
105409744|NCT00244725|363506702|FG000|Overall Study|Adverse Events|3|||
105409745|NCT00244725|363506703|FG001|Overall Study|Adverse Events|1|||
105409746|NCT00244725|363506704|FG002|Overall Study|Adverse Events|4|||
105409747|NCT00244725|363506705|FG003|Overall Study|Adverse Events|4|||
105409748|NCT00244725|363506702|FG000|Overall Study|Withdrwal by participant|1|||
105409749|NCT00244725|363506703|FG001|Overall Study|Withdrwal by participant|0|||
105409750|NCT00244725|363506704|FG002|Overall Study|Withdrwal by participant|0|||
105409751|NCT00244725|363506705|FG003|Overall Study|Withdrwal by participant|1|||
105409752|NCT00244725|363506702|FG000|Overall Study|Liver function test abnormality|2|||
105409753|NCT00244725|363506703|FG001|Overall Study|Liver function test abnormality|0|||
105409754|NCT00244725|363506704|FG002|Overall Study|Liver function test abnormality|0|||
105409755|NCT00244725|363506705|FG003|Overall Study|Liver function test abnormality|1|||
105409756|NCT00244725|363506702|FG000|Overall Study|Sponsor withdrew the participant|1|||
105409757|NCT00244725|363506703|FG001|Overall Study|Sponsor withdrew the participant|0|||
105409758|NCT00244725|363506704|FG002|Overall Study|Sponsor withdrew the participant|0|||
105409759|NCT00244725|363506705|FG003|Overall Study|Sponsor withdrew the participant|1|||
105409760|NCT00244725|363506702|FG000|Overall Study|Mediciation Error|0|||
105409761|NCT00244725|363506703|FG001|Overall Study|Mediciation Error|1|||
105409762|NCT00244725|363506704|FG002|Overall Study|Mediciation Error|0|||
105409763|NCT00244725|363506705|FG003|Overall Study|Mediciation Error|0|||
105409764|NCT00244725|363506702|FG000|Overall Study|Rehab Refused to allow participantion|0|||
105409765|NCT00244725|363506703|FG001|Overall Study|Rehab Refused to allow participantion|1|||
105409766|NCT00244725|363506704|FG002|Overall Study|Rehab Refused to allow participantion|0|||
105409767|NCT00244725|363506705|FG003|Overall Study|Rehab Refused to allow participantion|0|||
105409768|NCT00244725|363506702|FG000|Overall Study|Headache|0|||
105409769|NCT00244725|363506703|FG001|Overall Study|Headache|1|||
105409770|NCT00244725|363506704|FG002|Overall Study|Headache|0|||
105409771|NCT00244725|363506705|FG003|Overall Study|Headache|0|||
105409772|NCT00244725|363506702|FG000|Overall Study|Received prohibited medication|0|||
105409773|NCT00244725|363506703|FG001|Overall Study|Received prohibited medication|1|||
105409774|NCT00244725|363506704|FG002|Overall Study|Received prohibited medication|0|||
105495131|NCT02607930|363826260|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
105495132|NCT02607930|363826261|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
105581504|NCT03225846|364126571|FG002|Overall Study|Withdrawal by Subject|0|||
105409775|NCT00244725|363506705|FG003|Overall Study|Received prohibited medication|1|||
105495133|NCT02607930|363826262|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
105495134|NCT02607930|363826259|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
105495135|NCT02607930|363826260|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
105495136|NCT02607930|363826261|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
105495137|NCT02607930|363826262|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
105495138|NCT02607930|363826259|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
105495139|NCT02607930|363826260|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
105495140|NCT02607930|363826261|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
105409776|NCT00244725|363506702|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
105495141|NCT02607930|363826262|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
105409777|NCT00244725|363506703|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
105409778|NCT00244725|363506704|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
105409779|NCT00244725|363506705|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
105409780|NCT00244725|363506702|FG000|Overall Study|Administrative reason|0|||
105409781|NCT00244725|363506703|FG001|Overall Study|Administrative reason|0|||
105409782|NCT00244725|363506704|FG002|Overall Study|Administrative reason|1|||
105409783|NCT00244725|363506705|FG003|Overall Study|Administrative reason|0|||
105409784|NCT00244725|363506702|FG000|Overall Study|Vomit|0|||
105409785|NCT00244725|363506703|FG001|Overall Study|Vomit|0|||
105409786|NCT00244725|363506704|FG002|Overall Study|Vomit|1|||
105409787|NCT00244725|363506705|FG003|Overall Study|Vomit|0|||
105409788|NCT00244725|363506702|FG000|Overall Study|Failed to follow-up|0|||
105409789|NCT00244725|363506703|FG001|Overall Study|Failed to follow-up|0|||
105409790|NCT00244725|363506704|FG002|Overall Study|Failed to follow-up|1|||
105409791|NCT00244725|363506705|FG003|Overall Study|Failed to follow-up|1|||
105409792|NCT03472495|363506706|FG000|Overall Study|Treatment no longer indicated|1|||
105409793|NCT03472495|363506707|FG001|Overall Study|Treatment no longer indicated|2|||
105409794|NCT03472495|363506706|FG000|Overall Study|Physician Decision|0|||
105409795|NCT03472495|363506707|FG001|Overall Study|Physician Decision|2|||
105409796|NCT01144416|363506708|FG000|Intervention Period|Adverse Event|5|||
105409797|NCT01144416|363506709|FG001|Intervention Period|Adverse Event|6|||
105409798|NCT01144416|363506708|FG000|Intervention Period|Insufficient ovarian response|11|||
105409799|NCT01144416|363506709|FG001|Intervention Period|Insufficient ovarian response|17|||
105409800|NCT01144416|363506708|FG000|Intervention Period|Risk of OHSS|0|||
105409801|NCT01144416|363506709|FG001|Intervention Period|Risk of OHSS|1|||
105409802|NCT01144416|363506708|FG000|Intervention Period|Too high ovarian response|4|||
105409803|NCT01144416|363506709|FG001|Intervention Period|Too high ovarian response|2|||
105409804|NCT01144416|363506708|FG000|Intervention Period|No/too few/bad oocytes|7|||
105409805|NCT01144416|363506709|FG001|Intervention Period|No/too few/bad oocytes|5|||
105409806|NCT01144416|363506708|FG000|Intervention Period|No or abnormal fertilization|25|||
105409807|NCT01144416|363506709|FG001|Intervention Period|No or abnormal fertilization|10|||
105409808|NCT01144416|363506708|FG000|Intervention Period|No/too few/bad quality embryos|3|||
105409809|NCT01144416|363506709|FG001|Intervention Period|No/too few/bad quality embryos|3|||
105409810|NCT01144416|363506708|FG000|Intervention Period|Other|7|||
105409811|NCT01144416|363506709|FG001|Intervention Period|Other|5|||
105409812|NCT00124072|363506710|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
105409813|NCT00124072|363506711|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
105409814|NCT00124072|363506712|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
105409815|NCT00124072|363506713|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
105409816|NCT00124072|363506710|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
105409817|NCT00124072|363506711|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
105409818|NCT00124072|363506712|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
105409819|NCT00124072|363506713|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
105409820|NCT00124072|363506710|FG000|Overall Study|Death|499|||
105409821|NCT00124072|363506711|FG001|Overall Study|Death|484|||
105409822|NCT00124072|363506712|FG002|Overall Study|Death|471|||
105409823|NCT00124072|363506713|FG003|Overall Study|Death|480|||
105409824|NCT00995436|363506714|FG000|Overall Study|Withdrawal by Subject|2|||
105409825|NCT00995436|363506715|FG001|Overall Study|Withdrawal by Subject|5|||
105409826|NCT00995436|363506716|FG002|Overall Study|Withdrawal by Subject|0|||
105409827|NCT01107392|363506718|FG000|Overall Study|Adverse Event|2|||
105409828|NCT01107392|363506719|FG001|Overall Study|Adverse Event|0|||
105409829|NCT01107392|363506718|FG000|Overall Study|Personal Reasons|2|||
105409830|NCT01107392|363506719|FG001|Overall Study|Personal Reasons|3|||
105409831|NCT01107392|363506718|FG000|Overall Study|Administrative decision|1|||
105409832|NCT01107392|363506719|FG001|Overall Study|Administrative decision|0|||
105409833|NCT02038946|363506720|FG000|Overall Study|Death|5|||
105409834|NCT02038946|363506720|FG000|Overall Study|Withdrawal by Subject|3|||
105409835|NCT02038946|363506720|FG000|Overall Study|Lost to Follow-up|2|||
105409836|NCT02038946|363506720|FG000|Overall Study|Other reasons|2|||
105409837|NCT03519997|363506721|FG000|Overall Study|Adverse Event|4|||
105409838|NCT03519997|363506721|FG000|Overall Study|Withdrawal by Subject|2|||
105409839|NCT03519997|363506721|FG000|Overall Study|Protocol Violation|1|||
105409840|NCT03162796|363506724|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
105409841|NCT03162796|363506725|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
105409842|NCT03162796|363506726|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
105409843|NCT03162796|363506724|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
105409844|NCT03162796|363506725|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
105409845|NCT03162796|363506726|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
105409846|NCT03162796|363506724|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
105409847|NCT03162796|363506725|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
105409848|NCT03162796|363506726|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
105409849|NCT03162796|363506724|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
105409850|NCT03162796|363506725|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
105409851|NCT03162796|363506726|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
105409852|NCT03162796|363506724|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
105409853|NCT03162796|363506725|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
105409854|NCT03162796|363506726|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
105409855|NCT03162796|363506724|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
105409856|NCT03162796|363506725|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
105409857|NCT03162796|363506726|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
105409858|NCT03162796|363506724|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
105409859|NCT03162796|363506725|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
105409860|NCT03162796|363506726|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
105409861|NCT03162796|363506724|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
105409862|NCT03162796|363506725|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
105409863|NCT03162796|363506726|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
105409864|NCT03162796|363506724|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
105409865|NCT03162796|363506725|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
105409866|NCT03162796|363506726|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
105409867|NCT03162796|363506724|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
105409868|NCT03162796|363506725|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
105409869|NCT03162796|363506726|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
105409870|NCT03162796|363506724|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
105409871|NCT03162796|363506725|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
105409872|NCT03162796|363506726|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
105409873|NCT02473471|363506727|FG000|Overall Study|poor oral hygiene|2|||
105409874|NCT02473471|363506727|FG000|Overall Study|Lost to Follow-up|1|||
105409875|NCT01916824|363506732|FG000|Overall Study|Lost to Follow-up|3|||
105409876|NCT01916824|363506733|FG001|Overall Study|Lost to Follow-up|6|||
105409877|NCT01916824|363506732|FG000|Overall Study|Physician Decision|2|||
105409878|NCT01916824|363506733|FG001|Overall Study|Physician Decision|0|||
105409879|NCT01916824|363506732|FG000|Overall Study|Withdrawal by Subject|2|||
105409880|NCT01916824|363506733|FG001|Overall Study|Withdrawal by Subject|3|||
105409881|NCT00771927|363506734|FG000|Overall Study|Adverse Event|100|||
105409882|NCT00771927|363506735|FG001|Overall Study|Adverse Event|105|||
105409883|NCT00771927|363506734|FG000|Overall Study|Lack of Efficacy|70|||
105409884|NCT00771927|363506735|FG001|Overall Study|Lack of Efficacy|42|||
105409885|NCT00771927|363506734|FG000|Overall Study|Lost to Follow-up|46|||
105409886|NCT00771927|363506735|FG001|Overall Study|Lost to Follow-up|46|||
105409887|NCT00771927|363506734|FG000|Overall Study|Withdrawal by Subject|16|||
105409888|NCT00771927|363506735|FG001|Overall Study|Withdrawal by Subject|17|||
105409889|NCT00771927|363506734|FG000|Overall Study|Other reason|23|||
105409890|NCT00771927|363506735|FG001|Overall Study|Other reason|27|||
105409891|NCT00316706|363508638|FG000|Overall Study|Lost to Follow-up|38|||
105409892|NCT00316706|363508639|FG001|Overall Study|Lost to Follow-up|48|||
105409893|NCT00283803|363508640|FG000|Overall Study|Physician Decision|9|||
105409894|NCT00283803|363508640|FG000|Overall Study|Withdrawal by Subject|4|||
105409895|NCT03493451|363508641|FG000|Overall Study|Death|11|||
105409896|NCT03493451|363508642|FG001|Overall Study|Death|26|||
105409897|NCT03493451|363508643|FG002|Overall Study|Death|3|||
105409898|NCT03493451|363508641|FG000|Overall Study|Lost to Follow-up|1|||
105409899|NCT03493451|363508642|FG001|Overall Study|Lost to Follow-up|4|||
105409900|NCT03493451|363508643|FG002|Overall Study|Lost to Follow-up|1|||
105409901|NCT03493451|363508641|FG000|Overall Study|Withdrawal by Subject|1|||
105409902|NCT03493451|363508642|FG001|Overall Study|Withdrawal by Subject|1|||
105409903|NCT03493451|363508643|FG002|Overall Study|Withdrawal by Subject|2|||
105409904|NCT03493451|363508641|FG000|Overall Study|Progressive Disease|1|||
105409905|NCT03493451|363508642|FG001|Overall Study|Progressive Disease|0|||
105409906|NCT03493451|363508643|FG002|Overall Study|Progressive Disease|0|||
105409907|NCT03493451|363508641|FG000|Overall Study|Transferred to long term extension study|8|||
105409908|NCT03493451|363508642|FG001|Overall Study|Transferred to long term extension study|13|||
105409909|NCT03493451|363508643|FG002|Overall Study|Transferred to long term extension study|5|||
105409910|NCT01133756|363508645|FG000|Overall Study|Adverse Event|1|||
105409911|NCT01133756|363508646|FG001|Overall Study|Adverse Event|2|||
105409912|NCT01133756|363508647|FG002|Overall Study|Adverse Event|1|||
105409913|NCT01133756|363508645|FG000|Overall Study|Investigator Decision|1|||
105409914|NCT01133756|363508646|FG001|Overall Study|Investigator Decision|0|||
105409915|NCT01133756|363508647|FG002|Overall Study|Investigator Decision|0|||
105409916|NCT01133756|363508645|FG000|Overall Study|Withdrawal by Subject|0|||
105409917|NCT01133756|363508646|FG001|Overall Study|Withdrawal by Subject|1|||
105409918|NCT01133756|363508647|FG002|Overall Study|Withdrawal by Subject|0|||
105409919|NCT01133756|363508645|FG000|Overall Study|Progression of Disease|0|||
105409920|NCT01133756|363508646|FG001|Overall Study|Progression of Disease|0|||
105409921|NCT01133756|363508647|FG002|Overall Study|Progression of Disease|1|||
105409922|NCT01238991|363508651|FG000|Overall Study|Adverse Event|1|||
105409923|NCT01238991|363508652|FG001|Overall Study|Adverse Event|0|||
105409924|NCT01238991|363508653|FG002|Overall Study|Adverse Event|3|||
105409925|NCT01238991|363508654|FG003|Overall Study|Adverse Event|1|||
105409926|NCT01238991|363508655|FG004|Overall Study|Adverse Event|1|||
105409927|NCT01238991|363508656|FG005|Overall Study|Adverse Event|0|||
105409928|NCT01238991|363508657|FG006|Overall Study|Adverse Event|1|||
105409929|NCT01238991|363508658|FG007|Overall Study|Adverse Event|1|||
105409930|NCT01238991|363508659|FG008|Overall Study|Adverse Event|0|||
105409931|NCT01238991|363508660|FG009|Overall Study|Adverse Event|0|||
105409932|NCT01238991|363508651|FG000|Overall Study|Death|0|||
105409933|NCT01238991|363508652|FG001|Overall Study|Death|0|||
105409934|NCT01238991|363508653|FG002|Overall Study|Death|0|||
105409935|NCT01238991|363508654|FG003|Overall Study|Death|1|||
105409936|NCT01238991|363508655|FG004|Overall Study|Death|0|||
105409937|NCT01238991|363508656|FG005|Overall Study|Death|0|||
105409938|NCT01238991|363508657|FG006|Overall Study|Death|0|||
105409939|NCT01238991|363508658|FG007|Overall Study|Death|0|||
105409940|NCT01238991|363508659|FG008|Overall Study|Death|0|||
105409941|NCT01238991|363508660|FG009|Overall Study|Death|0|||
105409942|NCT01238991|363508651|FG000|Overall Study|Lack of Efficacy|0|||
105409943|NCT01238991|363508652|FG001|Overall Study|Lack of Efficacy|0|||
105409944|NCT01238991|363508653|FG002|Overall Study|Lack of Efficacy|1|||
105409945|NCT01238991|363508654|FG003|Overall Study|Lack of Efficacy|0|||
105409946|NCT01238991|363508655|FG004|Overall Study|Lack of Efficacy|0|||
105409947|NCT01238991|363508656|FG005|Overall Study|Lack of Efficacy|0|||
105409948|NCT01238991|363508657|FG006|Overall Study|Lack of Efficacy|0|||
105409949|NCT01238991|363508658|FG007|Overall Study|Lack of Efficacy|0|||
105409950|NCT01238991|363508659|FG008|Overall Study|Lack of Efficacy|1|||
105409951|NCT01238991|363508660|FG009|Overall Study|Lack of Efficacy|0|||
105409952|NCT01238991|363508651|FG000|Overall Study|Withdrawal by Subject|0|||
105409953|NCT01238991|363508652|FG001|Overall Study|Withdrawal by Subject|0|||
105409954|NCT01238991|363508653|FG002|Overall Study|Withdrawal by Subject|1|||
105409955|NCT01238991|363508654|FG003|Overall Study|Withdrawal by Subject|0|||
105409956|NCT01238991|363508655|FG004|Overall Study|Withdrawal by Subject|0|||
105409957|NCT01238991|363508656|FG005|Overall Study|Withdrawal by Subject|0|||
105409958|NCT01238991|363508657|FG006|Overall Study|Withdrawal by Subject|0|||
105409959|NCT01238991|363508658|FG007|Overall Study|Withdrawal by Subject|0|||
105409960|NCT01238991|363508659|FG008|Overall Study|Withdrawal by Subject|0|||
105409961|NCT01238991|363508660|FG009|Overall Study|Withdrawal by Subject|0|||
105409962|NCT01238991|363508651|FG000|Overall Study|Study Terminated by Sponsor|0|||
105409963|NCT01238991|363508652|FG001|Overall Study|Study Terminated by Sponsor|0|||
105409964|NCT01238991|363508653|FG002|Overall Study|Study Terminated by Sponsor|0|||
105409965|NCT01238991|363508654|FG003|Overall Study|Study Terminated by Sponsor|0|||
105409966|NCT01238991|363508655|FG004|Overall Study|Study Terminated by Sponsor|1|||
105409967|NCT01238991|363508656|FG005|Overall Study|Study Terminated by Sponsor|0|||
105409968|NCT01238991|363508657|FG006|Overall Study|Study Terminated by Sponsor|7|||
105409969|NCT01238991|363508658|FG007|Overall Study|Study Terminated by Sponsor|4|||
105409970|NCT01238991|363508659|FG008|Overall Study|Study Terminated by Sponsor|2|||
105409971|NCT01238991|363508660|FG009|Overall Study|Study Terminated by Sponsor|2|||
105409972|NCT01238991|363508651|FG000|Overall Study|Caregiver's request|0|||
105409973|NCT01238991|363508652|FG001|Overall Study|Caregiver's request|0|||
105409974|NCT01238991|363508653|FG002|Overall Study|Caregiver's request|0|||
105409975|NCT01238991|363508654|FG003|Overall Study|Caregiver's request|0|||
105409976|NCT01238991|363508655|FG004|Overall Study|Caregiver's request|0|||
105409977|NCT01238991|363508656|FG005|Overall Study|Caregiver's request|0|||
105409978|NCT01238991|363508657|FG006|Overall Study|Caregiver's request|0|||
105409979|NCT01238991|363508658|FG007|Overall Study|Caregiver's request|0|||
105409980|NCT01238991|363508659|FG008|Overall Study|Caregiver's request|1|||
105409981|NCT01238991|363508660|FG009|Overall Study|Caregiver's request|0|||
105409982|NCT01238991|363508651|FG000|Overall Study|Admission to a nursing home|1|||
105409983|NCT01238991|363508652|FG001|Overall Study|Admission to a nursing home|0|||
105409984|NCT01238991|363508653|FG002|Overall Study|Admission to a nursing home|1|||
105409985|NCT01238991|363508654|FG003|Overall Study|Admission to a nursing home|0|||
105409986|NCT01238991|363508655|FG004|Overall Study|Admission to a nursing home|0|||
105409987|NCT01238991|363508656|FG005|Overall Study|Admission to a nursing home|0|||
105409988|NCT01238991|363508657|FG006|Overall Study|Admission to a nursing home|0|||
105409989|NCT01238991|363508658|FG007|Overall Study|Admission to a nursing home|0|||
105409990|NCT01238991|363508659|FG008|Overall Study|Admission to a nursing home|0|||
105409991|NCT01238991|363508660|FG009|Overall Study|Admission to a nursing home|0|||
105409992|NCT00294671|363508668|FG000|Overall Study|Lack of Efficacy|11|||
105409993|NCT00294671|363508669|FG001|Overall Study|Lack of Efficacy|23|||
105409994|NCT00294671|363508668|FG000|Overall Study|Liver transplant|7|||
105409995|NCT00294671|363508669|FG001|Overall Study|Liver transplant|9|||
105409996|NCT00294671|363508668|FG000|Overall Study|Drug related adverse event (AE)|4|||
105409997|NCT00294671|363508669|FG001|Overall Study|Drug related adverse event (AE)|2|||
105409998|NCT00294671|363508668|FG000|Overall Study|Non-drug related AE|3|||
105409999|NCT00294671|363508669|FG001|Overall Study|Non-drug related AE|2|||
105410000|NCT00294671|363508668|FG000|Overall Study|Lost to Follow-up|1|||
105410001|NCT00294671|363508669|FG001|Overall Study|Lost to Follow-up|3|||
105410002|NCT00294671|363508668|FG000|Overall Study|Non-compliance|1|||
105410003|NCT00294671|363508669|FG001|Overall Study|Non-compliance|0|||
105410004|NCT00294671|363508668|FG000|Overall Study|Death|0|||
105410005|NCT00294671|363508669|FG001|Overall Study|Death|1|||
105410006|NCT00500357|363508673|FG000|Overall Study|Death|1|||
105410007|NCT00301262|363508674|FG000|Double Blind Phase (DB)|Adverse Event|1|||
105410008|NCT00301262|363508675|FG001|Double Blind Phase (DB)|Adverse Event|0|||
105410009|NCT00301262|363508674|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
105410010|NCT00301262|363508675|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
105410011|NCT00301262|363508674|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
105410012|NCT00301262|363508675|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
105410013|NCT00301262|363508674|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
105410014|NCT00301262|363508675|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
105410015|NCT00301262|363508674|FG000|Double Blind Phase (DB)|Other|1|||
105410016|NCT00301262|363508675|FG001|Double Blind Phase (DB)|Other|4|||
105410017|NCT00301262|363508674|FG000|Open Label Phase (OL)|Adverse Event|1|||
105410018|NCT00301262|363508675|FG001|Open Label Phase (OL)|Adverse Event|0|||
105410019|NCT00301262|363508674|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
105410020|NCT00301262|363508675|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
105410021|NCT00301262|363508674|FG000|Open Label Phase (OL)|Other|2|||
105410022|NCT00301262|363508675|FG001|Open Label Phase (OL)|Other|0|||
105410023|NCT01893411|363508676|FG000|Overall Study|Protocol Violation|1|||
105410024|NCT01893411|363508677|FG001|Overall Study|Protocol Violation|0|||
105410025|NCT01893411|363508678|FG002|Overall Study|Protocol Violation|0|||
105410026|NCT01893411|363508676|FG000|Overall Study|Physician Decision|1|||
105410027|NCT01893411|363508677|FG001|Overall Study|Physician Decision|1|||
105410028|NCT01893411|363508678|FG002|Overall Study|Physician Decision|2|||
105410029|NCT01893411|363508676|FG000|Overall Study|Lack of Efficacy|2|||
105410030|NCT01893411|363508677|FG001|Overall Study|Lack of Efficacy|1|||
105410031|NCT01893411|363508678|FG002|Overall Study|Lack of Efficacy|0|||
105410032|NCT01893411|363508676|FG000|Overall Study|Other|3|||
105410033|NCT01893411|363508677|FG001|Overall Study|Other|1|||
105410034|NCT01893411|363508678|FG002|Overall Study|Other|3|||
105410035|NCT01893411|363508676|FG000|Overall Study|Adverse Event|1|||
105410036|NCT01893411|363508677|FG001|Overall Study|Adverse Event|0|||
105410037|NCT01893411|363508678|FG002|Overall Study|Adverse Event|0|||
105410038|NCT01893411|363508676|FG000|Overall Study|Withdrawal by Subject|7|||
105410039|NCT01893411|363508677|FG001|Overall Study|Withdrawal by Subject|4|||
105410040|NCT01893411|363508678|FG002|Overall Study|Withdrawal by Subject|3|||
105410041|NCT01893411|363508676|FG000|Overall Study|Lost to Follow-up|2|||
105410042|NCT01893411|363508677|FG001|Overall Study|Lost to Follow-up|0|||
105410043|NCT01893411|363508678|FG002|Overall Study|Lost to Follow-up|1|||
105410044|NCT02013778|363508679|FG000|Overall Study|Death|4|||
105410045|NCT02013778|363508679|FG000|Overall Study|Withdrawal by Subject|1|||
105410046|NCT02013778|363508679|FG000|Overall Study|Physician Decision|1|||
105410047|NCT02013778|363508679|FG000|Overall Study|Adverse Event|1|||
105410048|NCT02719691|363508680|FG000|Overall Study|Physician Decision|0|||
105410049|NCT02719691|363508681|FG001|Overall Study|Physician Decision|0|||
105410050|NCT02719691|363508682|FG002|Overall Study|Physician Decision|1|||
105410051|NCT02719691|363508683|FG003|Overall Study|Physician Decision|0|||
105410052|NCT02719691|363508684|FG004|Overall Study|Physician Decision|0|||
105410053|NCT02719691|363508685|FG005|Overall Study|Physician Decision|0|||
105410054|NCT02719691|363508686|FG006|Overall Study|Physician Decision|0|||
105410055|NCT02719691|363508680|FG000|Overall Study|Withdrawal by Subject|0|||
105410056|NCT02719691|363508681|FG001|Overall Study|Withdrawal by Subject|0|||
105410057|NCT02719691|363508682|FG002|Overall Study|Withdrawal by Subject|0|||
105410058|NCT02719691|363508683|FG003|Overall Study|Withdrawal by Subject|0|||
105410059|NCT02719691|363508684|FG004|Overall Study|Withdrawal by Subject|0|||
105410060|NCT02719691|363508685|FG005|Overall Study|Withdrawal by Subject|1|||
105410061|NCT02719691|363508686|FG006|Overall Study|Withdrawal by Subject|0|||
105410062|NCT00861757|363508687|FG000|Overall Study|Adverse Event|1|||
105410063|NCT00861757|363508688|FG001|Overall Study|Adverse Event|5|||
105410064|NCT00861757|363508689|FG002|Overall Study|Adverse Event|7|||
105410065|NCT00861757|363508690|FG003|Overall Study|Adverse Event|2|||
105410066|NCT00861757|363508687|FG000|Overall Study|Entry Criteria Not Met|1|||
105410067|NCT00861757|363508688|FG001|Overall Study|Entry Criteria Not Met|2|||
105410068|NCT00861757|363508689|FG002|Overall Study|Entry Criteria Not Met|1|||
105410069|NCT00861757|363508690|FG003|Overall Study|Entry Criteria Not Met|1|||
105410070|NCT00861757|363508687|FG000|Overall Study|Lack of Efficacy|3|||
105410071|NCT00861757|363508688|FG001|Overall Study|Lack of Efficacy|1|||
105410072|NCT00861757|363508689|FG002|Overall Study|Lack of Efficacy|0|||
105410073|NCT00861757|363508690|FG003|Overall Study|Lack of Efficacy|1|||
105410074|NCT00861757|363508687|FG000|Overall Study|Lost to Follow-up|1|||
105410075|NCT00861757|363508688|FG001|Overall Study|Lost to Follow-up|0|||
105410076|NCT00861757|363508689|FG002|Overall Study|Lost to Follow-up|1|||
105410077|NCT00861757|363508690|FG003|Overall Study|Lost to Follow-up|1|||
105495142|NCT03198078|363826263|FG000|Overall Study|Adverse Event|0|||
105495143|NCT03198078|363826264|FG001|Overall Study|Adverse Event|1|||
105410078|NCT00861757|363508687|FG000|Overall Study|Physician Decision|0|||
105410079|NCT00861757|363508688|FG001|Overall Study|Physician Decision|0|||
105410080|NCT00861757|363508689|FG002|Overall Study|Physician Decision|0|||
105410081|NCT00861757|363508690|FG003|Overall Study|Physician Decision|1|||
105410082|NCT00861757|363508687|FG000|Overall Study|Protocol Violation|2|||
105410083|NCT00861757|363508688|FG001|Overall Study|Protocol Violation|2|||
105410084|NCT00861757|363508689|FG002|Overall Study|Protocol Violation|4|||
105410085|NCT00861757|363508690|FG003|Overall Study|Protocol Violation|1|||
105410086|NCT00861757|363508687|FG000|Overall Study|Withdrawal by Subject|1|||
105410087|NCT00861757|363508688|FG001|Overall Study|Withdrawal by Subject|5|||
105410088|NCT00861757|363508689|FG002|Overall Study|Withdrawal by Subject|5|||
105410089|NCT00861757|363508690|FG003|Overall Study|Withdrawal by Subject|2|||
105410090|NCT02482298|363508691|FG000|Overall Study|Withdrawal by Subject|2|||
105410091|NCT02482298|363508692|FG001|Overall Study|Withdrawal by Subject|1|||
105410092|NCT02482298|363508693|FG002|Overall Study|Withdrawal by Subject|2|||
105410093|NCT02482298|363508691|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
105410094|NCT02482298|363508692|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
105410095|NCT02482298|363508693|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
105410096|NCT02482298|363508691|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
105410097|NCT02482298|363508692|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
105410098|NCT02482298|363508693|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
105410099|NCT02482298|363508691|FG000|Overall Study|Lost to Follow-up|0|||
105410100|NCT02482298|363508692|FG001|Overall Study|Lost to Follow-up|1|||
105410101|NCT02482298|363508693|FG002|Overall Study|Lost to Follow-up|0|||
105410102|NCT02141633|363508694|FG000|Overall Study|Physician Decision|1|||
105410103|NCT02141633|363508695|FG001|Overall Study|Physician Decision|0|||
105410104|NCT03332173|363508696|FG000|Overall Study|Death|7|||
105410105|NCT03332173|363508696|FG000|Overall Study|Withdrawal by Subject|6|||
105410106|NCT03332173|363508696|FG000|Overall Study|Lost to Follow-up|2|||
105410107|NCT03332173|363508696|FG000|Overall Study|Transferred to long-term extension study|29|||
105410108|NCT00700622|363508697|FG000|Overall Study|Adverse Event|4|||
105410109|NCT00700622|363508698|FG001|Overall Study|Adverse Event|0|||
105410110|NCT00700622|363508697|FG000|Overall Study|Lost to Follow-up|0|||
105410111|NCT00700622|363508698|FG001|Overall Study|Lost to Follow-up|1|||
105410112|NCT00700622|363508697|FG000|Overall Study|Physician Decision|2|||
105410113|NCT00700622|363508698|FG001|Overall Study|Physician Decision|1|||
105410114|NCT00700622|363508697|FG000|Overall Study|Protocol Violation|0|||
105410115|NCT00700622|363508698|FG001|Overall Study|Protocol Violation|1|||
105410116|NCT00700622|363508697|FG000|Overall Study|Withdrawal by Subject|4|||
105410117|NCT00700622|363508698|FG001|Overall Study|Withdrawal by Subject|1|||
105410118|NCT00700622|363508697|FG000|Overall Study|Other|3|||
105410119|NCT00700622|363508698|FG001|Overall Study|Other|1|||
105410120|NCT05507567|363508699|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
105410121|NCT05507567|363508700|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
105410122|NCT05507567|363508701|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
105410123|NCT05507567|363508699|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
105410124|NCT05507567|363508700|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
105410125|NCT05507567|363508701|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
105410126|NCT05507567|363508699|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
105410127|NCT05507567|363508700|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
105410128|NCT05507567|363508701|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
105410129|NCT05507567|363508699|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
105410130|NCT05507567|363508700|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
105410131|NCT05507567|363508701|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
105410132|NCT02096952|363508704|FG000|Overall Study|Adverse Event|1|||
105410133|NCT00372619|363508705|FG000|Overall Study|Ineligible|0|||
105410134|NCT00372619|363508706|FG001|Overall Study|Ineligible|0|||
105410135|NCT00372619|363508707|FG002|Overall Study|Ineligible|0|||
105410136|NCT00372619|363508708|FG003|Overall Study|Ineligible|0|||
105410137|NCT00372619|363508709|FG004|Overall Study|Ineligible|0|||
105410138|NCT00372619|363508710|FG005|Overall Study|Ineligible|2|||
105410139|NCT00372619|363508711|FG006|Overall Study|Ineligible|0|||
105410140|NCT00372619|363508705|FG000|Overall Study|Inevaluable|0|||
105410141|NCT00372619|363508706|FG001|Overall Study|Inevaluable|0|||
105410142|NCT00372619|363508707|FG002|Overall Study|Inevaluable|0|||
105410143|NCT00372619|363508708|FG003|Overall Study|Inevaluable|0|||
105410144|NCT00372619|363508709|FG004|Overall Study|Inevaluable|0|||
105410145|NCT00372619|363508710|FG005|Overall Study|Inevaluable|1|||
105410146|NCT00372619|363508711|FG006|Overall Study|Inevaluable|0|||
105410147|NCT01092780|363508718|FG000|Washout Period 1|Adverse Event|0|||
105410148|NCT01092780|363508719|FG001|Washout Period 1|Adverse Event|1|||
105410149|NCT01092780|363508720|FG002|Washout Period 1|Adverse Event|0|||
105410150|NCT01092780|363508721|FG003|Washout Period 1|Adverse Event|0|||
105410151|NCT01092780|363508718|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
105410152|NCT01092780|363508719|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
105410153|NCT01092780|363508720|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
105410154|NCT01092780|363508721|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
105410155|NCT01092780|363508718|FG000|Washout Period 2|Adverse Event|0|||
105410156|NCT01092780|363508719|FG001|Washout Period 2|Adverse Event|1|||
105410157|NCT01092780|363508720|FG002|Washout Period 2|Adverse Event|1|||
105410158|NCT01092780|363508721|FG003|Washout Period 2|Adverse Event|0|||
105410159|NCT00615719|363508723|FG000|Overall Study|Physician Decision|5|||
105410160|NCT04550832|363508724|FG000|Overall Study|Adverse Event|0|||
105410161|NCT04550832|363508725|FG001|Overall Study|Adverse Event|0|||
105410162|NCT04550832|363508726|FG002|Overall Study|Adverse Event|2|||
105410163|NCT04550832|363508727|FG003|Overall Study|Adverse Event|0|||
105410164|NCT04550832|363508728|FG004|Overall Study|Adverse Event|1|||
105410165|NCT02569476|363508729|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
105410166|NCT02569476|363508729|FG000|Overall Study|Death|33|||
105410167|NCT02569476|363508729|FG000|Overall Study|Withdrawal by Subject|9|||
105410168|NCT02569476|363508729|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
105410169|NCT02569476|363508729|FG000|Overall Study|Palliative care|1|||
105410170|NCT02569476|363508729|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
105410171|NCT02569476|363508729|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
105410172|NCT04482439|363508734|FG000|Overall Study|Lost to Follow-up|1|||
105410173|NCT04482439|363508734|FG000|Overall Study|Unrelated illness|1|||
105410174|NCT02318368|363508735|FG000|Overall Study|Withdrawal by Subject|2|||
105410175|NCT02318368|363508736|FG001|Overall Study|Withdrawal by Subject|0|||
105410176|NCT02318368|363508735|FG000|Overall Study|Study terminated by the sponsor|5|||
105410177|NCT02318368|363508736|FG001|Overall Study|Study terminated by the sponsor|2|||
105410178|NCT02318368|363508735|FG000|Overall Study|Death|0|||
105410179|NCT02318368|363508736|FG001|Overall Study|Death|1|||
105410180|NCT01901614|363508737|FG000|Overall Study|Adverse Event|0|||
105410181|NCT01901614|363508738|FG001|Overall Study|Adverse Event|1|||
105410182|NCT01901614|363508737|FG000|Overall Study|Lost to Follow-up|1|||
105410183|NCT01901614|363508738|FG001|Overall Study|Lost to Follow-up|0|||
105410184|NCT01901614|363508737|FG000|Overall Study|Screen Fail|1|||
105410185|NCT01901614|363508738|FG001|Overall Study|Screen Fail|0|||
105410186|NCT01534351|363508739|FG000|Overall Study|Study Terminated Early|1|||
105410187|NCT01534351|363508740|FG001|Overall Study|Study Terminated Early|0|||
105410188|NCT01534351|363508741|FG002|Overall Study|Study Terminated Early|0|||
105410189|NCT02243371|363508744|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
105410190|NCT02243371|363508745|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
105410191|NCT02243371|363508744|FG000|Overall Study|Death (unrelated)|2|||
105410192|NCT02243371|363508745|FG001|Overall Study|Death (unrelated)|4|||
105410193|NCT02243371|363508744|FG000|Overall Study|Adverse Event (unrelated)|0|||
105410194|NCT02243371|363508745|FG001|Overall Study|Adverse Event (unrelated)|1|||
105410195|NCT02243371|363508744|FG000|Overall Study|Lack of Clinical Benefit|0|||
105410196|NCT02243371|363508745|FG001|Overall Study|Lack of Clinical Benefit|1|||
105410197|NCT02243371|363508744|FG000|Overall Study|Withdrawal by Subject|0|||
105410198|NCT02243371|363508745|FG001|Overall Study|Withdrawal by Subject|2|||
105410199|NCT01369199|363508746|FG000|Overall Study|Withdrawal by Subject|1|||
105410200|NCT01369199|363508746|FG000|Overall Study|Lost to Follow-up|2|||
105410201|NCT03012828|363508749|FG000|Overall Study|Lost to Follow-up|1|||
105410202|NCT03012828|363508750|FG001|Overall Study|Lost to Follow-up|0|||
105410203|NCT03012828|363508751|FG002|Overall Study|Lost to Follow-up|1|||
105410204|NCT03012828|363508752|FG003|Overall Study|Lost to Follow-up|0|||
105410205|NCT03012828|363508753|FG004|Overall Study|Lost to Follow-up|1|||
105410206|NCT03012828|363508754|FG005|Overall Study|Lost to Follow-up|0|||
105410207|NCT03012828|363508749|FG000|Overall Study|Withdrawal by Subject|0|||
105410208|NCT03012828|363508750|FG001|Overall Study|Withdrawal by Subject|0|||
105410209|NCT03012828|363508751|FG002|Overall Study|Withdrawal by Subject|1|||
105410210|NCT03012828|363508752|FG003|Overall Study|Withdrawal by Subject|0|||
105410211|NCT03012828|363508753|FG004|Overall Study|Withdrawal by Subject|0|||
105410212|NCT03012828|363508754|FG005|Overall Study|Withdrawal by Subject|1|||
105410213|NCT03012828|363508749|FG000|Overall Study|Non-compliance with protocol|0|||
105410214|NCT03012828|363508750|FG001|Overall Study|Non-compliance with protocol|0|||
105410215|NCT03012828|363508751|FG002|Overall Study|Non-compliance with protocol|0|||
105410216|NCT03012828|363508752|FG003|Overall Study|Non-compliance with protocol|0|||
105410217|NCT03012828|363508753|FG004|Overall Study|Non-compliance with protocol|1|||
105410218|NCT03012828|363508754|FG005|Overall Study|Non-compliance with protocol|0|||
105410219|NCT03012828|363508749|FG000|Overall Study|Delay to last visit would delay DBL|0|||
105410220|NCT03012828|363508750|FG001|Overall Study|Delay to last visit would delay DBL|0|||
105410221|NCT03012828|363508751|FG002|Overall Study|Delay to last visit would delay DBL|0|||
105410222|NCT03012828|363508752|FG003|Overall Study|Delay to last visit would delay DBL|0|||
105410223|NCT03012828|363508753|FG004|Overall Study|Delay to last visit would delay DBL|0|||
105410224|NCT03012828|363508754|FG005|Overall Study|Delay to last visit would delay DBL|1|||
105410225|NCT03900728|363508755|FG000|Overall Study|No text responses|0|||
105410226|NCT03900728|363508756|FG001|Overall Study|No text responses|0|||
105410227|NCT03900728|363508757|FG002|Overall Study|No text responses|4|||
105410228|NCT02565147|363508760|FG000|Overall Study|Withdrawal by Subject|5|||
105410229|NCT02565147|363508761|FG001|Overall Study|Withdrawal by Subject|1|||
105410230|NCT02565147|363508760|FG000|Overall Study|Lost to Follow-up|0|||
105410231|NCT02565147|363508761|FG001|Overall Study|Lost to Follow-up|1|||
105410232|NCT02565147|363508760|FG000|Overall Study|Death|1|||
105410233|NCT02565147|363508761|FG001|Overall Study|Death|1|||
105410234|NCT03082677|363508766|FG000|Overall Study|Not Treated|2|||
105410235|NCT03835481|363508767|FG000|Double-blind Period|Other not stated below|0|||
105410236|NCT03835481|363508768|FG001|Double-blind Period|Other not stated below|0|||
105410237|NCT03835481|363508769|FG002|Double-blind Period|Other not stated below|0|||
105495144|NCT03198078|363826265|FG002|Overall Study|Adverse Event|2|||
105495145|NCT03198078|363826263|FG000|Overall Study|Lack of Efficacy|0|||
105495146|NCT03198078|363826264|FG001|Overall Study|Lack of Efficacy|0|||
105495147|NCT03198078|363826265|FG002|Overall Study|Lack of Efficacy|3|||
105495148|NCT03198078|363826263|FG000|Overall Study|Lost to Follow-up|1|||
105495149|NCT03198078|363826264|FG001|Overall Study|Lost to Follow-up|0|||
105581505|NCT03225846|364126572|FG003|Overall Study|Withdrawal by Subject|0|||
105410238|NCT03835481|363508770|FG003|Double-blind Period|Other not stated below|1|||
105410239|NCT03835481|363508771|FG004|Double-blind Period|Other not stated below|1|||
105410240|NCT03835481|363508767|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
105410241|NCT03835481|363508768|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
105410242|NCT03835481|363508769|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
105410243|NCT03835481|363508770|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
105410244|NCT03835481|363508771|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
105410245|NCT03835481|363508767|FG000|Double-blind Period|Withdrawal by Subject|0|||
105410246|NCT03835481|363508768|FG001|Double-blind Period|Withdrawal by Subject|0|||
105410247|NCT03835481|363508769|FG002|Double-blind Period|Withdrawal by Subject|1|||
105410248|NCT03835481|363508770|FG003|Double-blind Period|Withdrawal by Subject|0|||
105410249|NCT03835481|363508771|FG004|Double-blind Period|Withdrawal by Subject|5|||
105410250|NCT03835481|363508767|FG000|Double-blind Period|Lost to Follow-up|0|||
105410251|NCT03835481|363508768|FG001|Double-blind Period|Lost to Follow-up|0|||
105410252|NCT03835481|363508769|FG002|Double-blind Period|Lost to Follow-up|0|||
105410253|NCT03835481|363508770|FG003|Double-blind Period|Lost to Follow-up|1|||
105410254|NCT03835481|363508771|FG004|Double-blind Period|Lost to Follow-up|0|||
105410255|NCT03835481|363508767|FG000|Double-blind Period|Protocol Violation|0|||
105410256|NCT03835481|363508768|FG001|Double-blind Period|Protocol Violation|2|||
105410257|NCT03835481|363508769|FG002|Double-blind Period|Protocol Violation|0|||
105410258|NCT03835481|363508770|FG003|Double-blind Period|Protocol Violation|1|||
105410259|NCT03835481|363508771|FG004|Double-blind Period|Protocol Violation|0|||
105410260|NCT03835481|363508767|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
105410261|NCT03835481|363508768|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
105410262|NCT03835481|363508769|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
105410263|NCT03835481|363508770|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
105410264|NCT03835481|363508771|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
105410265|NCT03835481|363508767|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
105410266|NCT03835481|363508768|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
105410267|NCT03835481|363508769|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
105410268|NCT03835481|363508770|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
105410269|NCT03835481|363508771|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
105410270|NCT03835481|363508767|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
105410271|NCT03835481|363508768|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
105410272|NCT03835481|363508769|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
105410273|NCT03835481|363508770|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
105410274|NCT03835481|363508771|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
105410275|NCT03835481|363508767|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
105410276|NCT03835481|363508768|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
105410277|NCT03835481|363508769|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
105410278|NCT03835481|363508770|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
105410279|NCT03835481|363508771|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
105410280|NCT03835481|363508767|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
105410281|NCT03835481|363508768|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
105410282|NCT03835481|363508769|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
105410283|NCT03835481|363508770|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
105410284|NCT03835481|363508771|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
105410285|NCT03835481|363508767|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
105410286|NCT03835481|363508768|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
105410287|NCT03835481|363508769|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
105410288|NCT03835481|363508770|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
105410289|NCT03835481|363508771|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
105410290|NCT00255723|363508773|FG000|Overall Study|Adverse Event|1|||
105410291|NCT00255723|363508774|FG001|Overall Study|Adverse Event|1|||
105410292|NCT00255723|363508773|FG000|Overall Study|Death|0|||
105410293|NCT00255723|363508774|FG001|Overall Study|Death|1|||
105410294|NCT00255723|363508773|FG000|Overall Study|Response Data Not Available|1|||
105410295|NCT00255723|363508774|FG001|Overall Study|Response Data Not Available|0|||
105410296|NCT03711370|363508776|FG000|Overall Study|Lost to Follow-up|16|||
105410297|NCT03711370|363508777|FG001|Overall Study|Lost to Follow-up|10|||
105410298|NCT03711370|363508776|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
105410299|NCT03711370|363508777|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
105410300|NCT00407602|363508778|FG000|Overall Study|Death - unrelated to device|1|||
105410301|NCT00407602|363508778|FG000|Overall Study|Device explanted|5|||
105410302|NCT00407602|363508778|FG000|Overall Study|Withdrawal by Subject|1|||
105410303|NCT00976716|363508779|FG000|Overall Study|Adverse Event|1|||
105410304|NCT03028129|363508780|FG000|Overall Study|Adverse Event|13|||
105581506|NCT03225846|364126573|FG004|Overall Study|Withdrawal by Subject|0|||
105410305|NCT03028129|363508781|FG001|Overall Study|Adverse Event|2|||
105410306|NCT03028129|363508780|FG000|Overall Study|Lost to Follow-up|50|||
105410307|NCT03028129|363508781|FG001|Overall Study|Lost to Follow-up|38|||
105410308|NCT03028129|363508780|FG000|Overall Study|Physician Decision|0|||
105410309|NCT03028129|363508781|FG001|Overall Study|Physician Decision|1|||
105410310|NCT03028129|363508780|FG000|Overall Study|Protocol Violation|1|||
105410311|NCT03028129|363508781|FG001|Overall Study|Protocol Violation|1|||
105410312|NCT03028129|363508780|FG000|Overall Study|Withdrawal by Subject|62|||
105410313|NCT03028129|363508781|FG001|Overall Study|Withdrawal by Subject|45|||
105410314|NCT01169701|363508786|FG000|Overall Study|Lost to Follow-up|1|||
105410315|NCT01169701|363508787|FG001|Overall Study|Lost to Follow-up|1|||
105410316|NCT01169701|363508786|FG000|Overall Study|Withdrawal by Subject|1|||
105410317|NCT01169701|363508787|FG001|Overall Study|Withdrawal by Subject|3|||
105410318|NCT01169701|363508786|FG000|Overall Study|Adverse Event|1|||
105410319|NCT01169701|363508787|FG001|Overall Study|Adverse Event|2|||
105410320|NCT01169701|363508786|FG000|Overall Study|Exclusion criteria|2|||
105410321|NCT01169701|363508787|FG001|Overall Study|Exclusion criteria|0|||
105410322|NCT01169701|363508786|FG000|Overall Study|Death|0|||
105410323|NCT01169701|363508787|FG001|Overall Study|Death|1|||
105410324|NCT01169701|363508786|FG000|Overall Study|Administrative problems|0|||
105410325|NCT01169701|363508787|FG001|Overall Study|Administrative problems|1|||
105410326|NCT01169701|363508786|FG000|Overall Study|Serious adverse event|0|||
105410327|NCT01169701|363508787|FG001|Overall Study|Serious adverse event|1|||
105410328|NCT01169701|363508786|FG000|Overall Study|Sponsor decision|0|||
105410329|NCT01169701|363508787|FG001|Overall Study|Sponsor decision|1|||
105410330|NCT03583359|363508788|FG000|Overall Study|Withdrawal by Subject|15|||
105410331|NCT03583359|363508789|FG001|Overall Study|Withdrawal by Subject|6|||
105410332|NCT03583359|363508788|FG000|Overall Study|Lost to Follow-up|12|||
105410333|NCT03583359|363508789|FG001|Overall Study|Lost to Follow-up|3|||
105410334|NCT03583359|363508788|FG000|Overall Study|Adverse Event|0|||
105410335|NCT03583359|363508789|FG001|Overall Study|Adverse Event|1|||
105410336|NCT03583359|363508788|FG000|Overall Study|Protocol Violation|0|||
105410337|NCT03583359|363508789|FG001|Overall Study|Protocol Violation|1|||
105410338|NCT03583359|363508788|FG000|Overall Study|Other|2|||
105410339|NCT03583359|363508789|FG001|Overall Study|Other|1|||
105410340|NCT00375505|363508795|FG000|Overall Study|Adverse Event|1|||
105410341|NCT00375505|363508796|FG001|Overall Study|Adverse Event|2|||
105410342|NCT03497039|363508798|FG000|Overall Study|Withdrawal by Subject|1|||
105410343|NCT03497039|363508799|FG001|Overall Study|Withdrawal by Subject|0|||
105410344|NCT03497039|363508798|FG000|Overall Study|Protocol Violation|0|||
105410345|NCT03497039|363508799|FG001|Overall Study|Protocol Violation|1|||
105410346|NCT02567799|363508800|FG000|Concurrent Chemoradiotherapy|Death|1|||
105410347|NCT02567799|363508801|FG001|Concurrent Chemoradiotherapy|Death|0|||
105410348|NCT02567799|363508802|FG002|Concurrent Chemoradiotherapy|Death|0|||
105410349|NCT02567799|363508800|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
105410350|NCT02567799|363508801|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
105410351|NCT02567799|363508802|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
105410352|NCT02567799|363508800|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
105410353|NCT02567799|363508801|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
105410354|NCT02567799|363508802|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
105410355|NCT02567799|363508800|FG000|Follow-up|Death|1|||
105410356|NCT02567799|363508801|FG001|Follow-up|Death|0|||
105410357|NCT02567799|363508802|FG002|Follow-up|Death|1|||
105410358|NCT02567799|363508800|FG000|Follow-up|Progressive Disease|1|||
105410359|NCT02567799|363508801|FG001|Follow-up|Progressive Disease|1|||
105410360|NCT02567799|363508802|FG002|Follow-up|Progressive Disease|3|||
105410361|NCT03292640|363508805|FG000|Overall Study|Withdrawal by Subject|17|||
105410362|NCT03292640|363508806|FG001|Overall Study|Withdrawal by Subject|16|||
105410363|NCT03292640|363508805|FG000|Overall Study|Adverse Event|20|||
105410364|NCT03292640|363508806|FG001|Overall Study|Adverse Event|2|||
105410365|NCT03292640|363508805|FG000|Overall Study|Lost to Follow-up|24|||
105410366|NCT03292640|363508806|FG001|Overall Study|Lost to Follow-up|24|||
105410367|NCT00972517|363508808|FG000|Overall Study|Adverse Event|0|||
105410368|NCT00972517|363508809|FG001|Overall Study|Adverse Event|0|||
105410369|NCT00972517|363508810|FG002|Overall Study|Adverse Event|0|||
105410370|NCT00972517|363508811|FG003|Overall Study|Adverse Event|1|||
105495150|NCT03198078|363826265|FG002|Overall Study|Lost to Follow-up|0|||
105495151|NCT03198078|363826263|FG000|Overall Study|Pregnancy|0|||
105410371|NCT00972517|363508812|FG004|Overall Study|Adverse Event|0|||
105410372|NCT00972517|363508813|FG005|Overall Study|Adverse Event|0|||
105410373|NCT00972517|363508808|FG000|Overall Study|Withdrawal by Subject|0|||
105410374|NCT00972517|363508809|FG001|Overall Study|Withdrawal by Subject|1|||
105410375|NCT00972517|363508810|FG002|Overall Study|Withdrawal by Subject|0|||
105410376|NCT00972517|363508811|FG003|Overall Study|Withdrawal by Subject|2|||
105495152|NCT03198078|363826264|FG001|Overall Study|Pregnancy|1|||
105495153|NCT03198078|363826265|FG002|Overall Study|Pregnancy|0|||
105410377|NCT00972517|363508812|FG004|Overall Study|Withdrawal by Subject|1|||
105410378|NCT00972517|363508813|FG005|Overall Study|Withdrawal by Subject|0|||
105410379|NCT00851890|363508816|FG000|Overall Study|Lost to Follow-up|0|||
105410380|NCT00851890|363508817|FG001|Overall Study|Lost to Follow-up|1|||
105410381|NCT00851890|363508818|FG002|Overall Study|Lost to Follow-up|0|||
105410382|NCT00851890|363508819|FG003|Overall Study|Lost to Follow-up|1|||
105410383|NCT02015481|363508821|FG000|Overall Study|Death|1|||
105410384|NCT03419897|363510462|FG000|Overall Study|Death|180|||
105410385|NCT03419897|363510462|FG000|Overall Study|Lost to Follow-up|1|||
105410386|NCT03419897|363510462|FG000|Overall Study|Withdrawal by Subject|6|||
105410387|NCT03419897|363510462|FG000|Overall Study|Sponsor Decision|61|||
105410388|NCT03419897|363510462|FG000|Overall Study|Physician Decision|1|||
105410389|NCT01905943|363510463|FG000|Overall Study|Withdrawal of consent|90|||
105410390|NCT01905943|363510463|FG000|Overall Study|Lost to Follow-up|16|||
105410391|NCT01905943|363510463|FG000|Overall Study|Investigator discretion|7|||
105410392|NCT01905943|363510463|FG000|Overall Study|Death|186|||
105410393|NCT01905943|363510463|FG000|Overall Study|Adverse Event|3|||
105410394|NCT01905943|363510463|FG000|Overall Study|Other|12|||
105410395|NCT02222688|363510464|FG000|Overall Study|Withdrawal by Subject|0|||
105410396|NCT02222688|363510465|FG001|Overall Study|Withdrawal by Subject|0|||
105410397|NCT02222688|363510466|FG002|Overall Study|Withdrawal by Subject|0|||
105410398|NCT02222688|363510467|FG003|Overall Study|Withdrawal by Subject|2|||
105410399|NCT02222688|363510468|FG004|Overall Study|Withdrawal by Subject|1|||
105410400|NCT02222688|363510469|FG005|Overall Study|Withdrawal by Subject|0|||
105410401|NCT02222688|363510470|FG006|Overall Study|Withdrawal by Subject|1|||
105410402|NCT02222688|363510464|FG000|Overall Study|Disease progression|1|||
105410403|NCT02222688|363510465|FG001|Overall Study|Disease progression|0|||
105410404|NCT02222688|363510466|FG002|Overall Study|Disease progression|0|||
105410405|NCT02222688|363510467|FG003|Overall Study|Disease progression|0|||
105410406|NCT02222688|363510468|FG004|Overall Study|Disease progression|0|||
105410407|NCT02222688|363510469|FG005|Overall Study|Disease progression|0|||
105410408|NCT02222688|363510470|FG006|Overall Study|Disease progression|0|||
105410409|NCT00958360|363510475|FG000|Overall Study|Withdrawal by Subject|3|||
105410410|NCT00958360|363510476|FG001|Overall Study|Withdrawal by Subject|1|||
105410411|NCT00958360|363510475|FG000|Overall Study|Death|6|||
105410412|NCT00958360|363510476|FG001|Overall Study|Death|7|||
105410413|NCT00958360|363510475|FG000|Overall Study|Physician Decision|2|||
105410414|NCT00958360|363510476|FG001|Overall Study|Physician Decision|1|||
105410415|NCT00958360|363510475|FG000|Overall Study|Lost to Follow-up|0|||
105410416|NCT00958360|363510476|FG001|Overall Study|Lost to Follow-up|1|||
105410417|NCT03015363|363510477|FG000|Overall Study|Physician Decision|14|||
105410418|NCT03015363|363510477|FG000|Overall Study|Withdrawal by Subject|3|||
105410419|NCT03107052|363510478|FG000|Overall Study|Adverse Event|6|||
105410420|NCT03107052|363510479|FG001|Overall Study|Adverse Event|1|||
105410421|NCT03107052|363510480|FG002|Overall Study|Adverse Event|2|||
105410422|NCT03107052|363510478|FG000|Overall Study|Withdrawal by Subject|9|||
105410423|NCT03107052|363510479|FG001|Overall Study|Withdrawal by Subject|5|||
105410424|NCT03107052|363510480|FG002|Overall Study|Withdrawal by Subject|8|||
105410425|NCT03107052|363510478|FG000|Overall Study|Protocol Violation|6|||
105410426|NCT03107052|363510479|FG001|Overall Study|Protocol Violation|0|||
105410427|NCT03107052|363510480|FG002|Overall Study|Protocol Violation|3|||
105410428|NCT03107052|363510478|FG000|Overall Study|Lost to Follow-up|4|||
105410429|NCT03107052|363510479|FG001|Overall Study|Lost to Follow-up|0|||
105410430|NCT03107052|363510480|FG002|Overall Study|Lost to Follow-up|1|||
105410431|NCT03107052|363510478|FG000|Overall Study|Lack of Efficacy|23|||
105410432|NCT03107052|363510479|FG001|Overall Study|Lack of Efficacy|7|||
105410433|NCT03107052|363510480|FG002|Overall Study|Lack of Efficacy|4|||
105410434|NCT03107052|363510478|FG000|Overall Study|Other than specified|4|||
105410435|NCT03107052|363510479|FG001|Overall Study|Other than specified|2|||
105410436|NCT03107052|363510480|FG002|Overall Study|Other than specified|0|||
105410437|NCT03107052|363510478|FG000|Overall Study|Study terminated due to futility|67|||
105410438|NCT03107052|363510479|FG001|Overall Study|Study terminated due to futility|31|||
105410439|NCT03107052|363510480|FG002|Overall Study|Study terminated due to futility|23|||
105410440|NCT00368745|363510481|FG000|Double-blind Treatment Period|Adverse Event|6|||
105410441|NCT00368745|363510482|FG001|Double-blind Treatment Period|Adverse Event|6|||
105410442|NCT00368745|363510481|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
105410443|NCT00368745|363510482|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
105410444|NCT00368745|363510481|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
105410445|NCT00368745|363510482|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
105410446|NCT00368745|363510481|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
105410447|NCT00368745|363510482|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
105410448|NCT00368745|363510481|FG000|Double-blind Treatment Period|Other|7|||
105410449|NCT00368745|363510482|FG001|Double-blind Treatment Period|Other|6|||
105410450|NCT00854724|363510483|FG000|First Intervention|Withdrawal by Subject|1|||
105410451|NCT00854724|363510484|FG001|First Intervention|Withdrawal by Subject|1|||
105410452|NCT00854724|363510483|FG000|Washout|Protocol Violation|1|||
105410453|NCT00854724|363510484|FG001|Washout|Protocol Violation|0|||
105410454|NCT00854724|363510483|FG000|Washout|Withdrawal by Subject|0|||
105410455|NCT00854724|363510484|FG001|Washout|Withdrawal by Subject|1|||
105410456|NCT00854724|363510483|FG000|Second Intervention|Protocol Violation|1|||
105410457|NCT00854724|363510484|FG001|Second Intervention|Protocol Violation|0|||
105410458|NCT00854724|363510483|FG000|Second Intervention|Physician Decision|0|||
105410459|NCT00854724|363510484|FG001|Second Intervention|Physician Decision|1|||
105410460|NCT00336284|363510487|FG000|Overall Study|Death|52|||
105410461|NCT00336284|363510488|FG001|Overall Study|Death|26|||
105410462|NCT00336284|363510487|FG000|Overall Study|Lost to Follow-up|82|||
105410463|NCT00336284|363510488|FG001|Overall Study|Lost to Follow-up|61|||
105410464|NCT00336284|363510487|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
105410465|NCT00336284|363510488|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
105410466|NCT05002985|363510491|FG000|Overall Study|Withdrawal by Subject|1|||
105410467|NCT00603941|363510495|FG000|Overall Study|Disease progression|6|||
105410468|NCT00603941|363510496|FG001|Overall Study|Disease progression|7|||
105410469|NCT00603941|363510497|FG002|Overall Study|Disease progression|1|||
105410470|NCT00603941|363510495|FG000|Overall Study|Adverse Event|1|||
105410471|NCT00603941|363510496|FG001|Overall Study|Adverse Event|0|||
105410472|NCT00603941|363510497|FG002|Overall Study|Adverse Event|1|||
105410473|NCT00603941|363510495|FG000|Overall Study|Physician Decision|0|||
105410474|NCT00603941|363510496|FG001|Overall Study|Physician Decision|1|||
105410475|NCT00603941|363510497|FG002|Overall Study|Physician Decision|0|||
105410476|NCT00603941|363510495|FG000|Overall Study|Withdrawal by Subject|0|||
105410477|NCT00603941|363510496|FG001|Overall Study|Withdrawal by Subject|2|||
105410478|NCT00603941|363510497|FG002|Overall Study|Withdrawal by Subject|0|||
105410479|NCT03654040|363510498|FG000|Overall Study|Death|1|||
105410480|NCT03654040|363510499|FG001|Overall Study|Death|0|||
105410481|NCT03654040|363510498|FG000|Overall Study|Withdrawal by Subject|1|||
105410482|NCT03654040|363510499|FG001|Overall Study|Withdrawal by Subject|0|||
105410483|NCT03654040|363510498|FG000|Overall Study|Study terminated by sponsor|8|||
105410484|NCT03654040|363510499|FG001|Overall Study|Study terminated by sponsor|2|||
105410485|NCT03654040|363510498|FG000|Overall Study|Failure to initiate study therapy|2|||
105410486|NCT03654040|363510499|FG001|Overall Study|Failure to initiate study therapy|0|||
105410487|NCT03654040|363510498|FG000|Overall Study|Transplanted at another center|2|||
105410488|NCT03654040|363510499|FG001|Overall Study|Transplanted at another center|0|||
105410489|NCT03654040|363510498|FG000|Overall Study|Failure to meet eligibility criteria|14|||
105410490|NCT03654040|363510499|FG001|Overall Study|Failure to meet eligibility criteria|2|||
105410491|NCT03654040|363510498|FG000|Overall Study|No longer transplant candidate|1|||
105410492|NCT03654040|363510499|FG001|Overall Study|No longer transplant candidate|0|||
105410493|NCT03654040|363510498|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
105410494|NCT03654040|363510499|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
105410495|NCT03654040|363510498|FG000|Overall Study|Recipient ineligible|0|||
105410496|NCT03654040|363510499|FG001|Overall Study|Recipient ineligible|2|||
105410497|NCT03654040|363510498|FG000|Overall Study|Received deceased liver|0|||
105410498|NCT03654040|363510499|FG001|Overall Study|Received deceased liver|1|||
105410499|NCT00910910|363510502|FG000|Overall Study|Adverse Event|63|||
105410500|NCT00910910|363510503|FG001|Overall Study|Adverse Event|35|||
105410501|NCT00910910|363510502|FG000|Overall Study|PD without histologic change|27|||
105410502|NCT00910910|363510503|FG001|Overall Study|PD without histologic change|23|||
105410503|NCT00910910|363510502|FG000|Overall Study|PD with histologic change|0|||
105410504|NCT00910910|363510503|FG001|Overall Study|PD with histologic change|2|||
105410505|NCT00910910|363510502|FG000|Overall Study|Withdrawal by Subject|7|||
105410506|NCT00910910|363510503|FG001|Overall Study|Withdrawal by Subject|5|||
105410507|NCT00910910|363510502|FG000|Overall Study|Lost to Follow-up|2|||
105410508|NCT00910910|363510503|FG001|Overall Study|Lost to Follow-up|2|||
105410509|NCT00910910|363510502|FG000|Overall Study|Death|9|||
105410510|NCT00910910|363510503|FG001|Overall Study|Death|3|||
105410511|NCT00910910|363510502|FG000|Overall Study|Protocol Violation|2|||
105410512|NCT00910910|363510503|FG001|Overall Study|Protocol Violation|2|||
105410513|NCT00910910|363510502|FG000|Overall Study|Completed 13 cycles of treatment|0|||
105410514|NCT00910910|363510503|FG001|Overall Study|Completed 13 cycles of treatment|118|||
105410515|NCT00910910|363510502|FG000|Overall Study|Other|114|||
105410516|NCT00910910|363510503|FG001|Overall Study|Other|32|||
105410517|NCT00910910|363510502|FG000|Overall Study|Untreated before cycle 1|1|||
105410518|NCT00910910|363510503|FG001|Overall Study|Untreated before cycle 1|2|||
105410519|NCT00624468|363510508|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
105410520|NCT00624468|363510509|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
105410521|NCT00624468|363510510|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
105410522|NCT00624468|363510511|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
105410523|NCT00624468|363510508|FG000|Double-blind Period|Withdrew Prematurely|1|||
105410524|NCT00624468|363510509|FG001|Double-blind Period|Withdrew Prematurely|1|||
105410525|NCT00624468|363510510|FG002|Double-blind Period|Withdrew Prematurely|0|||
105410526|NCT00624468|363510511|FG003|Double-blind Period|Withdrew Prematurely|0|||
105410527|NCT00624468|363510508|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
105410528|NCT00624468|363510509|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
105410529|NCT00624468|363510510|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
105410530|NCT00624468|363510511|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
105410531|NCT00624468|363510508|FG000|Safety Follow-up (SFU) Period|Other|0|||
105410532|NCT00624468|363510509|FG001|Safety Follow-up (SFU) Period|Other|0|||
105410533|NCT00624468|363510510|FG002|Safety Follow-up (SFU) Period|Other|1|||
105410534|NCT00624468|363510511|FG003|Safety Follow-up (SFU) Period|Other|1|||
105410535|NCT00066222|363510513|FG000|Overall Study|No protocol treatment received|1|||
105410536|NCT00405392|363510514|FG000|Overall Study|Adverse Event|15|||
105410537|NCT00405392|363510515|FG001|Overall Study|Adverse Event|14|||
105410538|NCT00405392|363510514|FG000|Overall Study|Did not meet Eligibility criteria|7|||
105410539|NCT00405392|363510515|FG001|Overall Study|Did not meet Eligibility criteria|2|||
105410540|NCT00405392|363510514|FG000|Overall Study|Withdrawal by Subject|4|||
105410541|NCT00405392|363510515|FG001|Overall Study|Withdrawal by Subject|3|||
105410542|NCT00405392|363510514|FG000|Overall Study|Lost to Follow-up|1|||
105410543|NCT00405392|363510515|FG001|Overall Study|Lost to Follow-up|2|||
105410544|NCT00405392|363510514|FG000|Overall Study|Data missing|2|||
105410545|NCT00405392|363510515|FG001|Overall Study|Data missing|0|||
105410546|NCT00405392|363510514|FG000|Overall Study|Non-compliance|0|||
105410547|NCT00405392|363510515|FG001|Overall Study|Non-compliance|1|||
105410548|NCT00405392|363510514|FG000|Overall Study|Other|1|||
105410549|NCT00405392|363510515|FG001|Overall Study|Other|5|||
105410550|NCT02684617|363510516|FG000|Overall Study|Adverse Event|1|||
105410551|NCT02684617|363510517|FG001|Overall Study|Adverse Event|0|||
105410552|NCT02684617|363510518|FG002|Overall Study|Adverse Event|1|||
105410553|NCT02684617|363510516|FG000|Overall Study|Death|8|||
105410554|NCT02684617|363510517|FG001|Overall Study|Death|16|||
105410555|NCT02684617|363510518|FG002|Overall Study|Death|28|||
105410556|NCT02684617|363510516|FG000|Overall Study|Withdrawal by Subject|2|||
105410557|NCT02684617|363510517|FG001|Overall Study|Withdrawal by Subject|0|||
105410558|NCT02684617|363510518|FG002|Overall Study|Withdrawal by Subject|4|||
105410559|NCT02684617|363510516|FG000|Overall Study|Screen Failure|1|||
105410560|NCT02684617|363510517|FG001|Overall Study|Screen Failure|0|||
105410561|NCT02684617|363510518|FG002|Overall Study|Screen Failure|2|||
105410562|NCT02684617|363510516|FG000|Overall Study|Study Terminated by Sponsor|6|||
105410563|NCT02684617|363510517|FG001|Overall Study|Study Terminated by Sponsor|1|||
105410564|NCT02684617|363510518|FG002|Overall Study|Study Terminated by Sponsor|5|||
105410565|NCT00412958|363510519|FG000|Overall Study|Withdrawal by Subject|3|||
105410566|NCT00412958|363510520|FG001|Overall Study|Withdrawal by Subject|0|||
105410567|NCT00412958|363510521|FG002|Overall Study|Withdrawal by Subject|0|||
105410568|NCT00412958|363510522|FG003|Overall Study|Withdrawal by Subject|1|||
105410569|NCT00412958|363510519|FG000|Overall Study|Adverse Event|0|||
105410570|NCT00412958|363510520|FG001|Overall Study|Adverse Event|1|||
105410571|NCT00412958|363510521|FG002|Overall Study|Adverse Event|0|||
105410572|NCT00412958|363510522|FG003|Overall Study|Adverse Event|0|||
105410573|NCT00412958|363510519|FG000|Overall Study|Lost to Follow-up|0|||
105410574|NCT00412958|363510520|FG001|Overall Study|Lost to Follow-up|1|||
105410575|NCT00412958|363510521|FG002|Overall Study|Lost to Follow-up|0|||
105410576|NCT00412958|363510522|FG003|Overall Study|Lost to Follow-up|0|||
105410577|NCT00412958|363510519|FG000|Overall Study|Death|0|||
105410578|NCT00412958|363510520|FG001|Overall Study|Death|1|||
105410579|NCT00412958|363510521|FG002|Overall Study|Death|0|||
105410580|NCT00412958|363510522|FG003|Overall Study|Death|0|||
105410581|NCT00412958|363510519|FG000|Overall Study|Transport issue|0|||
105410582|NCT00412958|363510520|FG001|Overall Study|Transport issue|1|||
105410583|NCT00412958|363510521|FG002|Overall Study|Transport issue|0|||
105410584|NCT00412958|363510522|FG003|Overall Study|Transport issue|0|||
105410585|NCT01703091|363510533|FG000|Overall Study|Adverse Event|5|||
105410586|NCT01703091|363510534|FG001|Overall Study|Adverse Event|3|||
105410587|NCT01703091|363510533|FG000|Overall Study|Physician Decision|2|||
105410588|NCT01703091|363510534|FG001|Overall Study|Physician Decision|1|||
105410589|NCT01703091|363510533|FG000|Overall Study|Withdrawal by Subject|1|||
105410590|NCT01703091|363510534|FG001|Overall Study|Withdrawal by Subject|0|||
105410591|NCT01703091|363510533|FG000|Overall Study|Sponsor Decision|1|||
105410592|NCT01703091|363510534|FG001|Overall Study|Sponsor Decision|0|||
105410593|NCT00022763|363510538|FG000|Overall Study|Adverse Event|1|||
105410594|NCT00022763|363510539|FG001|Overall Study|Adverse Event|2|||
105410595|NCT00022763|363510538|FG000|Overall Study|Injection Site Reactions|0|||
105410596|NCT00022763|363510539|FG001|Overall Study|Injection Site Reactions|2|||
105410597|NCT00022763|363510538|FG000|Overall Study|Death|0|||
105410598|NCT00022763|363510539|FG001|Overall Study|Death|1|||
105410599|NCT00022763|363510538|FG000|Overall Study|Lost to Follow-up|0|||
105410600|NCT00022763|363510539|FG001|Overall Study|Lost to Follow-up|3|||
105410601|NCT00022763|363510538|FG000|Overall Study|Withdrawal by Subject|4|||
105410602|NCT00022763|363510539|FG001|Overall Study|Withdrawal by Subject|7|||
105410603|NCT00022763|363510538|FG000|Overall Study|Insufficient Therapy|1|||
105581507|NCT03225846|364126574|FG005|Overall Study|Withdrawal by Subject|0|||
105410604|NCT00022763|363510539|FG001|Overall Study|Insufficient Therapy|0|||
105410605|NCT00022763|363510538|FG000|Overall Study|Admin|3|||
105410606|NCT00022763|363510539|FG001|Overall Study|Admin|2|||
105410607|NCT01670279|363510542|FG000|Overall Study|Adverse Event|0|||
105410608|NCT01670279|363510543|FG001|Overall Study|Adverse Event|1|||
105410609|NCT01670279|363510544|FG002|Overall Study|Adverse Event|0|||
105410610|NCT01670279|363510545|FG003|Overall Study|Adverse Event|0|||
105410611|NCT01670279|363510542|FG000|Overall Study|Physician Decision|0|||
105410612|NCT01670279|363510543|FG001|Overall Study|Physician Decision|1|||
105410613|NCT01670279|363510544|FG002|Overall Study|Physician Decision|0|||
105410614|NCT01670279|363510545|FG003|Overall Study|Physician Decision|0|||
105410615|NCT01670279|363510542|FG000|Overall Study|Participant met withdrawal criteria|0|||
105410616|NCT01670279|363510543|FG001|Overall Study|Participant met withdrawal criteria|0|||
105410617|NCT01670279|363510544|FG002|Overall Study|Participant met withdrawal criteria|0|||
105410618|NCT01670279|363510545|FG003|Overall Study|Participant met withdrawal criteria|1|||
105410619|NCT02702609|363510546|FG000|Overall Study|Lost to Follow-up|8|||
105410620|NCT02702609|363510547|FG001|Overall Study|Lost to Follow-up|4|||
105410621|NCT02702609|363510546|FG000|Overall Study|Physician Decision|1|||
105410622|NCT02702609|363510547|FG001|Overall Study|Physician Decision|0|||
105410623|NCT02674464|363510548|FG000|Overall Study|Death|10|||
105410624|NCT02674464|363510549|FG001|Overall Study|Death|21|||
105410625|NCT02674464|363510548|FG000|Overall Study|Withdrawal by Subject|24|||
105410626|NCT02674464|363510549|FG001|Overall Study|Withdrawal by Subject|44|||
105410627|NCT02674464|363510548|FG000|Overall Study|Lost to Follow-up|97|||
105410628|NCT02674464|363510549|FG001|Overall Study|Lost to Follow-up|92|||
105410629|NCT02674464|363510548|FG000|Overall Study|Outside survey window|6|||
105410630|NCT02674464|363510549|FG001|Overall Study|Outside survey window|3|||
105410631|NCT01071252|363510550|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
105410632|NCT01071252|363510551|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
105410633|NCT01071252|363510552|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
105410634|NCT01071252|363510553|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
105410635|NCT01071252|363510554|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
105410636|NCT01071252|363510550|FG000|Overall Study|Withdrawal by Subject|8|||
105410637|NCT01071252|363510551|FG001|Overall Study|Withdrawal by Subject|2|||
105410638|NCT01071252|363510552|FG002|Overall Study|Withdrawal by Subject|1|||
105410639|NCT01071252|363510553|FG003|Overall Study|Withdrawal by Subject|2|||
105410640|NCT01071252|363510554|FG004|Overall Study|Withdrawal by Subject|3|||
105410641|NCT01071252|363510550|FG000|Overall Study|administrative problems|1|||
105410642|NCT01071252|363510551|FG001|Overall Study|administrative problems|1|||
105410643|NCT01071252|363510552|FG002|Overall Study|administrative problems|0|||
105410644|NCT01071252|363510553|FG003|Overall Study|administrative problems|2|||
105410645|NCT01071252|363510554|FG004|Overall Study|administrative problems|1|||
105410646|NCT01071252|363510550|FG000|Overall Study|Lost to Follow-up|1|||
105410647|NCT01071252|363510551|FG001|Overall Study|Lost to Follow-up|0|||
105410648|NCT01071252|363510552|FG002|Overall Study|Lost to Follow-up|1|||
105410649|NCT01071252|363510553|FG003|Overall Study|Lost to Follow-up|2|||
105410650|NCT01071252|363510554|FG004|Overall Study|Lost to Follow-up|0|||
105410651|NCT01071252|363510550|FG000|Overall Study|Adverse Event|1|||
105410652|NCT01071252|363510551|FG001|Overall Study|Adverse Event|1|||
105410653|NCT01071252|363510552|FG002|Overall Study|Adverse Event|0|||
105410654|NCT01071252|363510553|FG003|Overall Study|Adverse Event|1|||
105410655|NCT01071252|363510554|FG004|Overall Study|Adverse Event|0|||
105410656|NCT01071252|363510550|FG000|Overall Study|Death|0|||
105410657|NCT01071252|363510551|FG001|Overall Study|Death|0|||
105410658|NCT01071252|363510552|FG002|Overall Study|Death|0|||
105410659|NCT01071252|363510553|FG003|Overall Study|Death|0|||
105410660|NCT01071252|363510554|FG004|Overall Study|Death|1|||
105410661|NCT01066104|363510555|FG000|Overall Study|Adverse Event|1|||
105410662|NCT01066104|363510556|FG001|Overall Study|Adverse Event|1|||
105410663|NCT01066104|363510555|FG000|Overall Study|Protocol Violation|1|||
105410664|NCT01066104|363510556|FG001|Overall Study|Protocol Violation|0|||
105410665|NCT03928418|363510557|FG000|Overall Study|Lost to Follow-up|5|||
105410666|NCT03928418|363510558|FG001|Overall Study|Lost to Follow-up|3|||
105410667|NCT03928418|363510559|FG002|Overall Study|Lost to Follow-up|5|||
105410668|NCT03928418|363510557|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
105410669|NCT03928418|363510558|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
105581508|NCT03225846|364126575|FG006|Overall Study|Withdrawal by Subject|0|||
105410670|NCT03928418|363510559|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
105410671|NCT00271856|363510565|FG000|Overall Study|Withdrawal by Subject|1|||
105410672|NCT00271856|363510566|FG001|Overall Study|Withdrawal by Subject|7|||
105410673|NCT00271856|363510565|FG000|Overall Study|Lost to Follow-up|10|||
105410674|NCT00271856|363510566|FG001|Overall Study|Lost to Follow-up|11|||
105581509|NCT03225846|364126569|FG000|Overall Study|Death|0|||
105410675|NCT02091362|363510567|FG000|Period 1|Protocol Violation|1|||
105581510|NCT03225846|364126570|FG001|Overall Study|Death|1|||
105410676|NCT02091362|363510568|FG001|Period 1|Protocol Violation|0|||
105410677|NCT02091362|363510567|FG000|Period 1|Withdrawal by Subject|2|||
105410678|NCT02091362|363510568|FG001|Period 1|Withdrawal by Subject|3|||
105410679|NCT02091362|363510567|FG000|Period 1|Lost to Follow-up|0|||
105410680|NCT02091362|363510568|FG001|Period 1|Lost to Follow-up|1|||
105410681|NCT02091362|363510567|FG000|Period 1|Adverse Event|2|||
105410682|NCT02091362|363510568|FG001|Period 1|Adverse Event|0|||
105410683|NCT02091362|363510567|FG000|Wash-out|Lost to Follow-up|1|||
105410684|NCT02091362|363510568|FG001|Wash-out|Lost to Follow-up|1|||
105410685|NCT02091362|363510567|FG000|Wash-out|Withdrawal by Subject|0|||
105410686|NCT02091362|363510568|FG001|Wash-out|Withdrawal by Subject|2|||
105410687|NCT02091362|363510567|FG000|Period 2|Adverse Event|1|||
105410688|NCT02091362|363510568|FG001|Period 2|Adverse Event|0|||
105410689|NCT02091362|363510567|FG000|Period 2|Lost to Follow-up|0|||
105410690|NCT02091362|363510568|FG001|Period 2|Lost to Follow-up|1|||
105410691|NCT02091362|363510567|FG000|Period 2|Withdrawal by Subject|1|||
105410692|NCT02091362|363510568|FG001|Period 2|Withdrawal by Subject|1|||
105410693|NCT00470262|363510569|FG000|Overall Study|Withdrawal by Subject|2|||
105410694|NCT00470262|363510570|FG001|Overall Study|Withdrawal by Subject|0|||
105410695|NCT00787839|363510571|FG000|Overall Study|Failure to have the OGTT was most common|404|||
105410696|NCT02122146|363510576|FG000|Part 1: Dose Escalation|Death|0|||
105410697|NCT02122146|363510577|FG001|Part 1: Dose Escalation|Death|1|||
105410698|NCT02122146|363510578|FG002|Part 1: Dose Escalation|Death|1|||
105410699|NCT02122146|363510579|FG003|Part 1: Dose Escalation|Death|0|||
105410700|NCT02122146|363510580|FG004|Part 1: Dose Escalation|Death|0|||
105410701|NCT02122146|363510581|FG005|Part 1: Dose Escalation|Death|0|||
105410702|NCT02122146|363510582|FG006|Part 1: Dose Escalation|Death|0|||
105410703|NCT02122146|363510583|FG007|Part 1: Dose Escalation|Death|0|||
105410704|NCT02122146|363510576|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
105410705|NCT02122146|363510577|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
105410706|NCT02122146|363510578|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
105410707|NCT02122146|363510579|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
105410708|NCT02122146|363510580|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
105410709|NCT02122146|363510581|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
105410710|NCT02122146|363510582|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
105410711|NCT02122146|363510583|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
105410712|NCT02122146|363510576|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105410713|NCT02122146|363510577|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105410714|NCT02122146|363510578|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105410715|NCT02122146|363510579|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
105410716|NCT02122146|363510580|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105410717|NCT02122146|363510581|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105410718|NCT02122146|363510582|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105410719|NCT02122146|363510583|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105410720|NCT02122146|363510576|FG000|Part 1: Dose Escalation|Other|1|||
105410721|NCT02122146|363510577|FG001|Part 1: Dose Escalation|Other|0|||
105410722|NCT02122146|363510578|FG002|Part 1: Dose Escalation|Other|0|||
105410723|NCT02122146|363510579|FG003|Part 1: Dose Escalation|Other|0|||
105410724|NCT02122146|363510580|FG004|Part 1: Dose Escalation|Other|0|||
105410725|NCT02122146|363510581|FG005|Part 1: Dose Escalation|Other|1|||
105410726|NCT02122146|363510582|FG006|Part 1: Dose Escalation|Other|1|||
105410727|NCT02122146|363510583|FG007|Part 1: Dose Escalation|Other|2|||
105410728|NCT02036580|363510584|FG000|Overall Study|Withdrawal by Subject|0|||
105410729|NCT02036580|363510585|FG001|Overall Study|Withdrawal by Subject|1|||
105410730|NCT02036580|363510586|FG002|Overall Study|Withdrawal by Subject|0|||
105410731|NCT02036580|363510584|FG000|Overall Study|Adverse Event|1|||
105410732|NCT02036580|363510585|FG001|Overall Study|Adverse Event|0|||
105410733|NCT02036580|363510586|FG002|Overall Study|Adverse Event|0|||
105410734|NCT02998671|363510587|FG000|Period 1|Study Terminated By Sponsor|2|||
105410735|NCT02998671|363510588|FG001|Period 1|Study Terminated By Sponsor|1|||
105410736|NCT02998671|363510589|FG002|Period 1|Study Terminated By Sponsor|0|||
105410737|NCT02998671|363510590|FG003|Period 1|Study Terminated By Sponsor|0|||
105410738|NCT02998671|363510591|FG004|Period 1|Study Terminated By Sponsor|1|||
105410739|NCT02998671|363510587|FG000|Period 1|Withdrawal by Subject|1|||
105410740|NCT02998671|363510588|FG001|Period 1|Withdrawal by Subject|2|||
105410741|NCT02998671|363510589|FG002|Period 1|Withdrawal by Subject|0|||
105410742|NCT02998671|363510590|FG003|Period 1|Withdrawal by Subject|0|||
105410743|NCT02998671|363510591|FG004|Period 1|Withdrawal by Subject|2|||
105410744|NCT02998671|363510587|FG000|Period 1|Pregnancy|1|||
105410745|NCT02998671|363510588|FG001|Period 1|Pregnancy|0|||
105410746|NCT02998671|363510589|FG002|Period 1|Pregnancy|0|||
105410747|NCT02998671|363510590|FG003|Period 1|Pregnancy|0|||
105410748|NCT02998671|363510591|FG004|Period 1|Pregnancy|0|||
105410749|NCT02998671|363510587|FG000|Period 1|Adverse Event|0|||
105410750|NCT02998671|363510588|FG001|Period 1|Adverse Event|0|||
105410751|NCT02998671|363510589|FG002|Period 1|Adverse Event|0|||
105410752|NCT02998671|363510590|FG003|Period 1|Adverse Event|0|||
105410753|NCT02998671|363510591|FG004|Period 1|Adverse Event|1|||
105410754|NCT02998671|363510587|FG000|Period 2|Adverse Event|0|||
105410755|NCT02998671|363510588|FG001|Period 2|Adverse Event|1|||
105410756|NCT02998671|363510589|FG002|Period 2|Adverse Event|0|||
105410757|NCT02998671|363510590|FG003|Period 2|Adverse Event|0|||
105410758|NCT02998671|363510591|FG004|Period 2|Adverse Event|0|||
105410759|NCT02998671|363510587|FG000|Period 2|Study Terminated By Sponsor|3|||
105495154|NCT03198078|363826263|FG000|Overall Study|Withdrawal by Subject|1|||
105495155|NCT03198078|363826264|FG001|Overall Study|Withdrawal by Subject|0|||
105495156|NCT03198078|363826265|FG002|Overall Study|Withdrawal by Subject|2|||
105410760|NCT02998671|363510588|FG001|Period 2|Study Terminated By Sponsor|5|||
105410761|NCT02998671|363510589|FG002|Period 2|Study Terminated By Sponsor|1|||
105495157|NCT03198078|363826263|FG000|Overall Study|Withdrawal by Caregiver|1|||
105495158|NCT03198078|363826264|FG001|Overall Study|Withdrawal by Caregiver|3|||
105495159|NCT03198078|363826265|FG002|Overall Study|Withdrawal by Caregiver|5|||
105495160|NCT01578330|363826266|FG000|Overall Study|Adverse Event|2|||
105410762|NCT02998671|363510590|FG003|Period 2|Study Terminated By Sponsor|3|||
105410763|NCT02998671|363510591|FG004|Period 2|Study Terminated By Sponsor|0|||
105495161|NCT01578330|363826266|FG000|Overall Study|Protocol Violation|5|||
105495162|NCT01134731|363826267|FG000|Overall Study|Adverse Event|3|||
105495163|NCT01134731|363826268|FG001|Overall Study|Adverse Event|2|||
105495164|NCT01134731|363826269|FG002|Overall Study|Adverse Event|1|||
105495165|NCT01134731|363826267|FG000|Overall Study|Physician Decision|2|||
105410764|NCT02998671|363510587|FG000|Period 2|Withdrawal by Subject|0|||
105410765|NCT02998671|363510588|FG001|Period 2|Withdrawal by Subject|1|||
105410766|NCT02998671|363510589|FG002|Period 2|Withdrawal by Subject|0|||
105410767|NCT02998671|363510590|FG003|Period 2|Withdrawal by Subject|0|||
105410768|NCT02998671|363510591|FG004|Period 2|Withdrawal by Subject|0|||
105410769|NCT02998671|363510587|FG000|Period 2|Lost to Follow-up|0|||
105410770|NCT02998671|363510588|FG001|Period 2|Lost to Follow-up|0|||
105410771|NCT02998671|363510589|FG002|Period 2|Lost to Follow-up|0|||
105410772|NCT02998671|363510590|FG003|Period 2|Lost to Follow-up|1|||
105410773|NCT02998671|363510591|FG004|Period 2|Lost to Follow-up|0|||
105410774|NCT02676895|363510592|FG000|Overall Study|Administrative reason|1|||
105410775|NCT02676895|363510593|FG001|Overall Study|Administrative reason|0|||
105410776|NCT02676895|363510594|FG002|Overall Study|Administrative reason|0|||
105410777|NCT02676895|363510592|FG000|Overall Study|Protocol Violation|1|||
105410778|NCT02676895|363510593|FG001|Overall Study|Protocol Violation|0|||
105410779|NCT02676895|363510594|FG002|Overall Study|Protocol Violation|0|||
105410780|NCT02676895|363510592|FG000|Overall Study|Adverse Event|0|||
105410781|NCT02676895|363510593|FG001|Overall Study|Adverse Event|3|||
105410782|NCT02676895|363510594|FG002|Overall Study|Adverse Event|1|||
105410783|NCT02676895|363510592|FG000|Overall Study|Lost to Follow-up|0|||
105410784|NCT02676895|363510593|FG001|Overall Study|Lost to Follow-up|0|||
105410785|NCT02676895|363510594|FG002|Overall Study|Lost to Follow-up|1|||
105410786|NCT02676895|363510592|FG000|Overall Study|Withdrawal by Subject|0|||
105410787|NCT02676895|363510593|FG001|Overall Study|Withdrawal by Subject|0|||
105410788|NCT02676895|363510594|FG002|Overall Study|Withdrawal by Subject|1|||
105410789|NCT04222699|363510601|FG000|Overall Study|Lost to Follow-up|2|||
105410790|NCT01221753|363510606|FG000|Overall Study|Adverse Event|1|||
105410791|NCT00431444|363510608|FG000|Overall Study|Protocol Violation|1|||
105410792|NCT00431444|363510609|FG001|Overall Study|Protocol Violation|4|||
105410793|NCT00431444|363510608|FG000|Overall Study|Adverse Event|2|||
105410794|NCT00431444|363510609|FG001|Overall Study|Adverse Event|1|||
105410795|NCT00431444|363510608|FG000|Overall Study|Withdrawal by Subject|1|||
105410796|NCT00431444|363510609|FG001|Overall Study|Withdrawal by Subject|1|||
105410797|NCT00431444|363510608|FG000|Overall Study|Lost to Follow-up|1|||
105410798|NCT00431444|363510609|FG001|Overall Study|Lost to Follow-up|0|||
105410799|NCT00431444|363510608|FG000|Overall Study|Administrative Problems|0|||
105410800|NCT00431444|363510609|FG001|Overall Study|Administrative Problems|1|||
105410801|NCT01262560|363510610|FG000|Overall Study|Protocol Violation|0|||
105410802|NCT01262560|363510611|FG001|Overall Study|Protocol Violation|1|||
105410803|NCT01262560|363510612|FG002|Overall Study|Protocol Violation|2|||
105410804|NCT04238481|363510613|FG000|Overall Study|Miscellaneous|0|||
105410805|NCT04238481|363510614|FG001|Overall Study|Miscellaneous|1|||
105410806|NCT04238481|363510615|FG002|Overall Study|Miscellaneous|0|||
105410807|NCT04238481|363510616|FG003|Overall Study|Miscellaneous|0|||
105410808|NCT00005947|363510617|FG000|Overall Study|Death|54|||
105410809|NCT00005947|363510618|FG001|Overall Study|Death|40|||
105410810|NCT00005947|363510617|FG000|Overall Study|Patient Refused to Continue|2|||
105410811|NCT00005947|363510618|FG001|Overall Study|Patient Refused to Continue|1|||
105410812|NCT00005947|363510617|FG000|Overall Study|Site Closure|1|||
105410813|NCT00005947|363510618|FG001|Overall Study|Site Closure|0|||
105410814|NCT02470585|363510619|FG000|Overall Study|Death|224|||
105410815|NCT02470585|363510620|FG001|Overall Study|Death|227|||
105410816|NCT02470585|363510621|FG002|Overall Study|Death|199|||
105410817|NCT02470585|363510619|FG000|Overall Study|Withdrew consent|21|||
105410818|NCT02470585|363510620|FG001|Overall Study|Withdrew consent|22|||
105410819|NCT02470585|363510621|FG002|Overall Study|Withdrew consent|31|||
105410820|NCT02470585|363510619|FG000|Overall Study|Lost to Follow-up|8|||
105410821|NCT02470585|363510620|FG001|Overall Study|Lost to Follow-up|15|||
105410822|NCT02470585|363510621|FG002|Overall Study|Lost to Follow-up|13|||
105410823|NCT02470585|363510619|FG000|Overall Study|Sponsor discontinued study|117|||
105410824|NCT02470585|363510620|FG001|Overall Study|Sponsor discontinued study|110|||
105410825|NCT02470585|363510621|FG002|Overall Study|Sponsor discontinued study|122|||
105410826|NCT02470585|363510619|FG000|Overall Study|Other, not specified|5|||
105410827|NCT02470585|363510620|FG001|Overall Study|Other, not specified|7|||
105410828|NCT02470585|363510621|FG002|Overall Study|Other, not specified|14|||
105410829|NCT02470585|363510619|FG000|Overall Study|Missing due to site non-compliance|0|||
105410830|NCT02470585|363510620|FG001|Overall Study|Missing due to site non-compliance|2|||
105581511|NCT03225846|364126571|FG002|Overall Study|Death|0|||
105410831|NCT02470585|363510621|FG002|Overall Study|Missing due to site non-compliance|3|||
105410832|NCT05111002|363510622|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
105410833|NCT05111002|363510623|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
105410834|NCT05111002|363510622|FG000|Secondary Outcome|Lost to Follow-up|1|||
105410835|NCT05111002|363510623|FG001|Secondary Outcome|Lost to Follow-up|0|||
105410836|NCT03306433|363510624|FG000|Overall Study|Lost to Follow-up|3|||
105410837|NCT03306433|363510624|FG000|Overall Study|Patient did not have teeth extracted|1|||
105410838|NCT03306433|363510624|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
105410839|NCT03122145|363510625|FG000|Overall Study|Concurrent respiratory disease|3|||
105410840|NCT03122145|363510626|FG001|Overall Study|Concurrent respiratory disease|0|||
105410841|NCT00334737|363510629|FG000|Hospital Phase|Death|1|||
105410842|NCT00334737|363510630|FG001|Hospital Phase|Death|2|||
105410843|NCT00334737|363510631|FG002|Hospital Phase|Death|3|||
105410844|NCT00334737|363510629|FG000|Hospital Phase|Withdrawal by Subject|0|||
105410845|NCT00334737|363510630|FG001|Hospital Phase|Withdrawal by Subject|0|||
105410846|NCT00334737|363510631|FG002|Hospital Phase|Withdrawal by Subject|1|||
105410847|NCT00334737|363510629|FG000|Hospital Phase|Did not receive study drug|1|||
105410848|NCT00334737|363510630|FG001|Hospital Phase|Did not receive study drug|0|||
105581512|NCT03225846|364126572|FG003|Overall Study|Death|0|||
105581513|NCT03225846|364126573|FG004|Overall Study|Death|0|||
105581514|NCT03225846|364126574|FG005|Overall Study|Death|0|||
105581515|NCT03225846|364126575|FG006|Overall Study|Death|0|||
105581516|NCT03225846|364126569|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
105581517|NCT03225846|364126570|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
105581518|NCT03225846|364126571|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
105581519|NCT03225846|364126572|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
105581520|NCT03225846|364126573|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
105581521|NCT03225846|364126574|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
105581522|NCT03225846|364126575|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
105581523|NCT03225846|364126569|FG000|Overall Study|Patient decision|0|||
105581524|NCT03225846|364126570|FG001|Overall Study|Patient decision|0|||
105581525|NCT03225846|364126571|FG002|Overall Study|Patient decision|0|||
105581526|NCT03225846|364126572|FG003|Overall Study|Patient decision|0|||
105581527|NCT03225846|364126573|FG004|Overall Study|Patient decision|0|||
105581528|NCT03225846|364126574|FG005|Overall Study|Patient decision|0|||
105581529|NCT03225846|364126575|FG006|Overall Study|Patient decision|1|||
105581530|NCT00996580|364126576|FG000|Overall Study|Adverse Event|466|||
105581531|NCT00996580|364126576|FG000|Overall Study|Lost to Follow-up|480|||
105581532|NCT00996580|364126576|FG000|Overall Study|Noncompliance with the protocol|137|||
105581533|NCT00996580|364126576|FG000|Overall Study|Physician Decision|5|||
105581534|NCT00996580|364126576|FG000|Overall Study|Pregnancy|68|||
105581535|NCT00996580|364126576|FG000|Overall Study|Protocol Violation|16|||
105581536|NCT00996580|364126576|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
105581537|NCT00996580|364126576|FG000|Overall Study|Withdrawal by Subject|217|||
105581538|NCT00996580|364126576|FG000|Overall Study|Other|29|||
105581539|NCT05708846|364126579|FG000|Overall Study|Death|5|||
105581540|NCT05708846|364126579|FG000|Overall Study|Withdrawal by Subject|20|||
105581541|NCT02036515|364126580|FG000|Overall Study|Adverse Event|1|||
105581542|NCT02036515|364126581|FG001|Overall Study|Adverse Event|1|||
105581543|NCT02036515|364126582|FG002|Overall Study|Adverse Event|2|||
105581544|NCT02036515|364126580|FG000|Overall Study|Lost to Follow-up|0|||
105581545|NCT02036515|364126581|FG001|Overall Study|Lost to Follow-up|2|||
105581546|NCT02036515|364126582|FG002|Overall Study|Lost to Follow-up|0|||
105581547|NCT02036515|364126580|FG000|Overall Study|Non-compliance with study drug|0|||
105581548|NCT02036515|364126581|FG001|Overall Study|Non-compliance with study drug|0|||
105581549|NCT02036515|364126582|FG002|Overall Study|Non-compliance with study drug|2|||
105581550|NCT02036515|364126580|FG000|Overall Study|Screen failure|0|||
105581551|NCT02036515|364126581|FG001|Overall Study|Screen failure|2|||
105581552|NCT02036515|364126582|FG002|Overall Study|Screen failure|0|||
105581553|NCT02036515|364126580|FG000|Overall Study|Withdrawal by Subject|4|||
105581554|NCT02036515|364126581|FG001|Overall Study|Withdrawal by Subject|7|||
105581555|NCT02036515|364126582|FG002|Overall Study|Withdrawal by Subject|9|||
105581556|NCT02036515|364126580|FG000|Overall Study|Hyperglycemia|0|||
105581557|NCT02036515|364126581|FG001|Overall Study|Hyperglycemia|0|||
105581558|NCT02036515|364126582|FG002|Overall Study|Hyperglycemia|1|||
105581559|NCT00238420|364126583|FG000|Overall Study|Protocol Violation|1|||
105581560|NCT00238420|364126584|FG001|Overall Study|Protocol Violation|1|||
105581561|NCT03428815|364126587|FG000|Overall Study|Lost to Follow-up|2|||
105581562|NCT03428815|364126588|FG001|Overall Study|Lost to Follow-up|2|||
105581563|NCT03428815|364126587|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
105410849|NCT00334737|363510631|FG002|Hospital Phase|Did not receive study drug|0|||
105581564|NCT03428815|364126588|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
105581565|NCT03428815|364126587|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
105410850|NCT00334737|363510629|FG000|Follow up Phase|Lost to Follow-up|5|||
105410851|NCT00334737|363510630|FG001|Follow up Phase|Lost to Follow-up|3|||
105581566|NCT03428815|364126588|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
105581567|NCT04140890|364126589|FG000|Overall Study|Withdrawal by Subject|0|||
105581568|NCT04140890|364126590|FG001|Overall Study|Withdrawal by Subject|1|||
105581569|NCT01700348|364126591|FG000|Overall Study|Withdrawal by Subject|22|||
105581570|NCT01700348|364126591|FG000|Overall Study|Lost to Follow-up|1|||
105581571|NCT00209274|364126594|FG000|Overall Study|Missed visit|3|||
105581572|NCT00209274|364126595|FG001|Overall Study|Missed visit|2|||
105581573|NCT00209274|364126594|FG000|Overall Study|Death|32|||
105581574|NCT00209274|364126595|FG001|Overall Study|Death|15|||
105581575|NCT00209274|364126594|FG000|Overall Study|Withdrawal by Subject|30|||
105581576|NCT00209274|364126595|FG001|Overall Study|Withdrawal by Subject|15|||
105581577|NCT00209274|364126594|FG000|Overall Study|Randomized not treated (RNT)|6|||
105581578|NCT00209274|364126595|FG001|Overall Study|Randomized not treated (RNT)|15|||
105410852|NCT00334737|363510631|FG002|Follow up Phase|Lost to Follow-up|6|||
105581579|NCT04445155|364126596|FG000|Overall Study|Lost to Follow-up|11|||
105581580|NCT04445155|364126597|FG001|Overall Study|Lost to Follow-up|2|||
105581581|NCT04445155|364126598|FG002|Overall Study|Lost to Follow-up|3|||
105581582|NCT04445155|364126599|FG003|Overall Study|Lost to Follow-up|0|||
105581583|NCT04445155|364126596|FG000|Overall Study|Withdrawal by Subject|8|||
105581584|NCT04445155|364126597|FG001|Overall Study|Withdrawal by Subject|0|||
105581585|NCT04445155|364126598|FG002|Overall Study|Withdrawal by Subject|0|||
105581586|NCT04445155|364126599|FG003|Overall Study|Withdrawal by Subject|0|||
105581587|NCT04445155|364126596|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
105581588|NCT04445155|364126597|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
105581589|NCT04445155|364126598|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
105581590|NCT04445155|364126599|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
105581591|NCT04445155|364126596|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
105581592|NCT04445155|364126597|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
105581593|NCT04445155|364126598|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
105581594|NCT04445155|364126599|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
105581595|NCT02462083|364127823|FG000|Overall Study|Sponsor request|39|||
105581596|NCT02462083|364127823|FG000|Overall Study|Withdrawal by Subject|87|||
105581597|NCT02462083|364127823|FG000|Overall Study|Lost to Follow-up|41|||
105581598|NCT02462083|364127823|FG000|Overall Study|Lack of Efficacy|151|||
105581599|NCT02462083|364127823|FG000|Overall Study|Pregnancy|1|||
105581600|NCT02462083|364127823|FG000|Overall Study|Protocol Violation|6|||
105581601|NCT02462083|364127823|FG000|Overall Study|Adverse Event|33|||
105581602|NCT02462083|364127823|FG000|Overall Study|Worsening condition|16|||
105581603|NCT02462083|364127823|FG000|Overall Study|Other than specified|45|||
105581604|NCT02711995|364127824|FG000|Washout (90 Days)|Conflicting medication|1|||
105581605|NCT00590980|364127825|FG000|Overall Study|Did not meet all inclusion criteria|10|||
105581606|NCT02819479|364127826|FG000|Overall Study|Adverse Event|2|||
105581607|NCT00504348|364127827|FG000|Overall Study|Adverse Event|3|||
105581608|NCT00504348|364127827|FG000|Overall Study|Lack of Efficacy|4|||
105581609|NCT00504348|364127827|FG000|Overall Study|Physician Decision|1|||
105581610|NCT00224133|364127828|FG000|Overall Study|Adverse Event|93|||
105581611|NCT00224133|364127828|FG000|Overall Study|Protocol Violation|6|||
105581612|NCT00224133|364127828|FG000|Overall Study|Withdrawal by Subject|33|||
105581613|NCT00224133|364127828|FG000|Overall Study|Lack of Efficacy|58|||
105581614|NCT00224133|364127828|FG000|Overall Study|Lost to Follow-up|21|||
105581615|NCT00224133|364127828|FG000|Overall Study|Physician Decision|1|||
105581616|NCT00224133|364127828|FG000|Overall Study|Other|14|||
105581617|NCT05406791|364127831|FG000|Overall Study|Lost to Follow-up|13|||
105410853|NCT00948857|363512282|FG000|Overall Study|Lost to Follow-up|1|||
105581618|NCT05406791|364127832|FG001|Overall Study|Lost to Follow-up|10|||
105581619|NCT01625338|364127836|FG000|Overall Study|Enrolled but not Treated|0|||
105581620|NCT01625338|364127837|FG001|Overall Study|Enrolled but not Treated|0|||
105581621|NCT01625338|364127838|FG002|Overall Study|Enrolled but not Treated|1|||
105581622|NCT01625338|364127836|FG000|Overall Study|Efficacy Failure|27|||
105581623|NCT01625338|364127837|FG001|Overall Study|Efficacy Failure|39|||
105581624|NCT01625338|364127838|FG002|Overall Study|Efficacy Failure|31|||
105581625|NCT01625338|364127836|FG000|Overall Study|Lost to Follow-up|3|||
105581626|NCT01625338|364127837|FG001|Overall Study|Lost to Follow-up|3|||
105581627|NCT01625338|364127838|FG002|Overall Study|Lost to Follow-up|2|||
105581628|NCT01625338|364127836|FG000|Overall Study|Investigator Decision|0|||
105581629|NCT01625338|364127837|FG001|Overall Study|Investigator Decision|2|||
105581630|NCT01625338|364127838|FG002|Overall Study|Investigator Decision|1|||
105581631|NCT01625338|364127836|FG000|Overall Study|Subject Withdrew Consent|1|||
105581632|NCT01625338|364127837|FG001|Overall Study|Subject Withdrew Consent|0|||
105410854|NCT00948857|363512283|FG001|Overall Study|Lost to Follow-up|0|||
105581633|NCT01625338|364127838|FG002|Overall Study|Subject Withdrew Consent|2|||
105581634|NCT01625338|364127836|FG000|Overall Study|Adverse Event|1|||
105581635|NCT01625338|364127837|FG001|Overall Study|Adverse Event|0|||
105581636|NCT01625338|364127838|FG002|Overall Study|Adverse Event|1|||
105581637|NCT01625338|364127836|FG000|Overall Study|Study Discontinued by Sponsor|0|||
105581638|NCT01625338|364127837|FG001|Overall Study|Study Discontinued by Sponsor|0|||
105581639|NCT01625338|364127838|FG002|Overall Study|Study Discontinued by Sponsor|1|||
105410855|NCT02974140|363512287|FG000|Overall Study|Adverse Event|2|||
105581640|NCT04006366|364127844|FG000|Overall Study|Withdrawal by Subject|1|||
105581641|NCT03019458|364127845|FG000|Overall Study|Death|0|||
105581642|NCT03019458|364127846|FG001|Overall Study|Death|1|||
105581643|NCT04466618|364127849|FG000|Overall Study|Withdrawal by Subject|0|||
105581644|NCT04466618|364127850|FG001|Overall Study|Withdrawal by Subject|1|||
105581645|NCT02491892|364127851|FG000|Overall Study|Adverse Event|1|||
105581646|NCT02491892|364127852|FG001|Overall Study|Adverse Event|1|||
105581647|NCT02491892|364127851|FG000|Overall Study|Death|1|||
105581648|NCT02491892|364127852|FG001|Overall Study|Death|1|||
105581649|NCT02491892|364127851|FG000|Overall Study|Lack of Efficacy|37|||
105581650|NCT02491892|364127852|FG001|Overall Study|Lack of Efficacy|36|||
105581651|NCT02491892|364127851|FG000|Overall Study|Refused Treatment|1|||
105581652|NCT02491892|364127852|FG001|Overall Study|Refused Treatment|0|||
105581653|NCT02491892|364127851|FG000|Overall Study|Lost to Follow-up|1|||
105581654|NCT02491892|364127852|FG001|Overall Study|Lost to Follow-up|0|||
105581655|NCT00661258|364127853|FG000|Overall Study|Death|1|||
105581656|NCT00661258|364127854|FG001|Overall Study|Death|0|||
105581657|NCT00661258|364127853|FG000|Overall Study|caught by police and in detox center|2|||
105581658|NCT00661258|364127854|FG001|Overall Study|caught by police and in detox center|1|||
105581659|NCT03890120|364127855|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
105581660|NCT03890120|364127856|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
105581661|NCT03890120|364127857|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
105581662|NCT03890120|364127858|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
105581663|NCT03890120|364127855|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
105581664|NCT03890120|364127856|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
105581665|NCT03890120|364127857|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
105581666|NCT03890120|364127858|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
105581667|NCT03890120|364127855|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
105581668|NCT03890120|364127856|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
105581669|NCT03890120|364127857|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
105581670|NCT03890120|364127858|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
105581671|NCT03890120|364127855|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
105581672|NCT03890120|364127856|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
105581673|NCT03890120|364127857|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
105581674|NCT03890120|364127858|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
105581675|NCT03890120|364127855|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
105581676|NCT03890120|364127856|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
105581677|NCT03890120|364127857|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
105581678|NCT03890120|364127858|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
105581679|NCT03890120|364127855|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
105581680|NCT03890120|364127856|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
105581681|NCT03890120|364127857|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
105581682|NCT03890120|364127858|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
105581683|NCT03890120|364127855|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
105581684|NCT03890120|364127856|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
105581685|NCT03890120|364127857|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
105581686|NCT03890120|364127858|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
105581687|NCT03890120|364127855|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
105581688|NCT03890120|364127856|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
105581689|NCT03890120|364127857|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
105581690|NCT03890120|364127858|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
105581691|NCT03890120|364127855|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
105581692|NCT03890120|364127856|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
105581693|NCT03890120|364127857|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
105581694|NCT03890120|364127858|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
105581695|NCT03890120|364127855|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
105581696|NCT03890120|364127856|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
105581697|NCT03890120|364127857|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
105581698|NCT03890120|364127858|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
105581699|NCT03890120|364127855|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
105581700|NCT03890120|364127856|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
105581701|NCT03890120|364127857|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
105581702|NCT03890120|364127858|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
105581703|NCT03890120|364127855|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
105581704|NCT03890120|364127856|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
105581705|NCT03890120|364127857|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
105581706|NCT03890120|364127858|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
105410856|NCT02974140|363512287|FG000|Overall Study|Lost to Follow-up|1|||
105410857|NCT02974140|363512287|FG000|Overall Study|Study Terminated by Sponsor|36|||
105410858|NCT00617084|363512288|FG000|Overall Study|Withdrawal by Subject|5|||
105410859|NCT00617084|363512289|FG001|Overall Study|Withdrawal by Subject|7|||
105410860|NCT00617084|363512288|FG000|Overall Study|Missed 12 Months visit|16|||
105410861|NCT00617084|363512289|FG001|Overall Study|Missed 12 Months visit|19|||
105410862|NCT02574078|363512290|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105410863|NCT02574078|363512291|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105410864|NCT02574078|363512292|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105410865|NCT02574078|363512293|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105410866|NCT02574078|363512294|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105410867|NCT02574078|363512295|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
105410868|NCT02574078|363512296|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
105410869|NCT02574078|363512297|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105495166|NCT01134731|363826268|FG001|Overall Study|Physician Decision|2|||
105495167|NCT01134731|363826269|FG002|Overall Study|Physician Decision|2|||
105495168|NCT01134731|363826267|FG000|Overall Study|Lack of Efficacy|0|||
105495169|NCT01134731|363826268|FG001|Overall Study|Lack of Efficacy|0|||
105495170|NCT01134731|363826269|FG002|Overall Study|Lack of Efficacy|1|||
105495171|NCT01134731|363826267|FG000|Overall Study|Withdrawal by Subject|3|||
105495172|NCT01134731|363826268|FG001|Overall Study|Withdrawal by Subject|3|||
105495173|NCT01134731|363826269|FG002|Overall Study|Withdrawal by Subject|1|||
105495174|NCT01134731|363826267|FG000|Overall Study|Lost to Follow-up|5|||
105495175|NCT01134731|363826268|FG001|Overall Study|Lost to Follow-up|4|||
105495176|NCT01134731|363826269|FG002|Overall Study|Lost to Follow-up|3|||
105495177|NCT00676338|363826270|FG000|Overall Study|Adverse Event|6|||
105495178|NCT00676338|363826271|FG001|Overall Study|Adverse Event|6|||
105495179|NCT00676338|363826272|FG002|Overall Study|Adverse Event|5|||
105495180|NCT00676338|363826273|FG003|Overall Study|Adverse Event|1|||
105495181|NCT00676338|363826270|FG000|Overall Study|Lost to Follow-up|4|||
105495182|NCT00676338|363826271|FG001|Overall Study|Lost to Follow-up|1|||
105410870|NCT02574078|363512298|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
105410871|NCT02574078|363512299|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105410872|NCT02574078|363512300|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105410873|NCT02574078|363512301|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105410874|NCT02574078|363512302|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105410875|NCT02574078|363512290|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
105410876|NCT02574078|363512291|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
105410877|NCT02574078|363512292|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
105410878|NCT02574078|363512293|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
105410879|NCT02574078|363512294|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
105410880|NCT02574078|363512295|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
105410881|NCT02574078|363512296|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
105410882|NCT02574078|363512297|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
105410883|NCT02574078|363512298|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
105410884|NCT02574078|363512299|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
105410885|NCT02574078|363512300|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
105410886|NCT02574078|363512301|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
105410887|NCT02574078|363512302|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
105410888|NCT02574078|363512290|FG000|Pre-Treatment Period|Other reasons|0|||
105495183|NCT00676338|363826272|FG002|Overall Study|Lost to Follow-up|3|||
105495184|NCT00676338|363826273|FG003|Overall Study|Lost to Follow-up|4|||
105495185|NCT00676338|363826270|FG000|Overall Study|Physician Decision|3|||
105495186|NCT00676338|363826271|FG001|Overall Study|Physician Decision|3|||
105495187|NCT00676338|363826272|FG002|Overall Study|Physician Decision|2|||
105495188|NCT00676338|363826273|FG003|Overall Study|Physician Decision|3|||
105495189|NCT00676338|363826270|FG000|Overall Study|Protocol Violation|5|||
105495190|NCT00676338|363826271|FG001|Overall Study|Protocol Violation|9|||
105495191|NCT00676338|363826272|FG002|Overall Study|Protocol Violation|2|||
105495192|NCT00676338|363826273|FG003|Overall Study|Protocol Violation|5|||
105495193|NCT00676338|363826270|FG000|Overall Study|Withdrawal by Subject|17|||
105495194|NCT00676338|363826271|FG001|Overall Study|Withdrawal by Subject|9|||
105495195|NCT00676338|363826272|FG002|Overall Study|Withdrawal by Subject|12|||
105495196|NCT00676338|363826273|FG003|Overall Study|Withdrawal by Subject|6|||
105495197|NCT00676338|363826270|FG000|Overall Study|Entry Criteria Not Met|0|||
105495198|NCT00676338|363826271|FG001|Overall Study|Entry Criteria Not Met|2|||
105495199|NCT00676338|363826272|FG002|Overall Study|Entry Criteria Not Met|1|||
105495200|NCT00676338|363826273|FG003|Overall Study|Entry Criteria Not Met|1|||
105495201|NCT00676338|363826270|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
105495202|NCT00676338|363826271|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
105495203|NCT00676338|363826272|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
105495204|NCT00676338|363826273|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
105495205|NCT00412542|363826274|FG000|Overall Study|Withdrawal by Subject|0|||
105495206|NCT00412542|363826275|FG001|Overall Study|Withdrawal by Subject|2|||
105495207|NCT00412542|363826274|FG000|Overall Study|Not Eligible|0|||
105495208|NCT00412542|363826275|FG001|Overall Study|Not Eligible|1|||
105495209|NCT03387683|363826276|FG000|Overall Study|In receipt of disallowed medication|1|||
105495210|NCT03387683|363826277|FG001|Overall Study|In receipt of disallowed medication|0|||
105495211|NCT03387683|363826276|FG000|Overall Study|Did not receive treatment|1|||
105495212|NCT03387683|363826277|FG001|Overall Study|Did not receive treatment|0|||
105495213|NCT01495975|363826278|FG000|Overall Study|Lost to Follow-up|1|||
105495214|NCT01495975|363826279|FG001|Overall Study|Lost to Follow-up|0|||
105495215|NCT04810481|363826285|FG000|Overall Study|Disqualified data sets|10|||
105495216|NCT04810481|363826286|FG001|Overall Study|Disqualified data sets|28|||
105495217|NCT00285818|363826287|FG000|Overall Study|Withdrawal by Subject|3|||
105581707|NCT03890120|364127855|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
105495218|NCT00285818|363826288|FG001|Overall Study|Withdrawal by Subject|2|||
105495219|NCT00285818|363826287|FG000|Overall Study|Lost to Follow-up|1|||
105495220|NCT00285818|363826288|FG001|Overall Study|Lost to Follow-up|0|||
105495221|NCT00199875|363826292|FG000|Overall Study|Withdrawal by Subject|0|||
105495222|NCT00199875|363826293|FG001|Overall Study|Withdrawal by Subject|0|||
105495223|NCT00199875|363826294|FG002|Overall Study|Withdrawal by Subject|0|||
105495224|NCT00199875|363826295|FG003|Overall Study|Withdrawal by Subject|0|||
105495225|NCT00199875|363826296|FG004|Overall Study|Withdrawal by Subject|1|||
105495226|NCT01024231|363826297|FG000|Overall Study|Other Reasons|1|||
105495227|NCT01024231|363826298|FG001|Overall Study|Other Reasons|2|||
105495228|NCT01024231|363826299|FG002|Overall Study|Other Reasons|0|||
105495229|NCT01024231|363826300|FG003|Overall Study|Other Reasons|0|||
105495230|NCT01024231|363826301|FG004|Overall Study|Other Reasons|2|||
105495231|NCT01024231|363826302|FG005|Overall Study|Other Reasons|0|||
105495232|NCT01024231|363826303|FG006|Overall Study|Other Reasons|1|||
105495233|NCT01024231|363826297|FG000|Overall Study|Maximum Clinical Benefit|1|||
105495234|NCT01024231|363826298|FG001|Overall Study|Maximum Clinical Benefit|2|||
105495235|NCT01024231|363826299|FG002|Overall Study|Maximum Clinical Benefit|0|||
105495236|NCT01024231|363826300|FG003|Overall Study|Maximum Clinical Benefit|1|||
105495237|NCT01024231|363826301|FG004|Overall Study|Maximum Clinical Benefit|1|||
105495238|NCT01024231|363826302|FG005|Overall Study|Maximum Clinical Benefit|0|||
105495239|NCT01024231|363826303|FG006|Overall Study|Maximum Clinical Benefit|0|||
105495240|NCT01024231|363826297|FG000|Overall Study|Disease Progression|3|||
105495241|NCT01024231|363826298|FG001|Overall Study|Disease Progression|1|||
105495242|NCT01024231|363826299|FG002|Overall Study|Disease Progression|3|||
105495243|NCT01024231|363826300|FG003|Overall Study|Disease Progression|0|||
105495244|NCT01024231|363826301|FG004|Overall Study|Disease Progression|4|||
105495245|NCT01024231|363826302|FG005|Overall Study|Disease Progression|11|||
105495246|NCT01024231|363826303|FG006|Overall Study|Disease Progression|6|||
105495247|NCT01024231|363826297|FG000|Overall Study|AE unrelated to Study Drug|0|||
105495248|NCT01024231|363826298|FG001|Overall Study|AE unrelated to Study Drug|1|||
105495249|NCT01024231|363826299|FG002|Overall Study|AE unrelated to Study Drug|0|||
105495250|NCT01024231|363826300|FG003|Overall Study|AE unrelated to Study Drug|0|||
105495251|NCT01024231|363826301|FG004|Overall Study|AE unrelated to Study Drug|0|||
105495252|NCT01024231|363826302|FG005|Overall Study|AE unrelated to Study Drug|0|||
105495253|NCT01024231|363826303|FG006|Overall Study|AE unrelated to Study Drug|0|||
105495254|NCT01024231|363826297|FG000|Overall Study|No longer meets criteria|0|||
105495255|NCT01024231|363826298|FG001|Overall Study|No longer meets criteria|0|||
105581708|NCT03890120|364127856|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
105581709|NCT03890120|364127857|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
105581710|NCT03890120|364127858|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
105581711|NCT04496167|364127859|FG000|Overall Study|Adverse Event|6|||
105581712|NCT04496167|364127860|FG001|Overall Study|Adverse Event|2|||
105581713|NCT04496167|364127859|FG000|Overall Study|Withdrawal by Subject|7|||
105581714|NCT04496167|364127860|FG001|Overall Study|Withdrawal by Subject|6|||
105581715|NCT04496167|364127859|FG000|Overall Study|Lost to Follow-up|3|||
105581716|NCT04496167|364127860|FG001|Overall Study|Lost to Follow-up|5|||
105581717|NCT04496167|364127859|FG000|Overall Study|Not Treated|1|||
105581718|NCT04496167|364127860|FG001|Overall Study|Not Treated|2|||
105581719|NCT04496167|364127859|FG000|Overall Study|Other Than Specified|1|||
105581720|NCT04496167|364127860|FG001|Overall Study|Other Than Specified|1|||
105495256|NCT01024231|363826299|FG002|Overall Study|No longer meets criteria|0|||
105495257|NCT01024231|363826300|FG003|Overall Study|No longer meets criteria|0|||
105495258|NCT01024231|363826301|FG004|Overall Study|No longer meets criteria|1|||
105495259|NCT01024231|363826302|FG005|Overall Study|No longer meets criteria|0|||
105581721|NCT00146640|364127861|FG000|Overall Study|Adverse Event|12|||
105581722|NCT00146640|364127862|FG001|Overall Study|Adverse Event|10|||
105581723|NCT00146640|364127861|FG000|Overall Study|Medical Reasons|3|||
105581724|NCT00146640|364127862|FG001|Overall Study|Medical Reasons|0|||
105581725|NCT00146640|364127861|FG000|Overall Study|Non-Medical Reasons|8|||
105581726|NCT00146640|364127862|FG001|Overall Study|Non-Medical Reasons|4|||
105581727|NCT04242875|364127864|FG000|Overall Study|Adverse Event|2|||
105581728|NCT00231894|364127865|FG000|Overall Study|Withdrawal by Subject|1|||
105581729|NCT00231894|364127866|FG001|Overall Study|Withdrawal by Subject|1|||
105581730|NCT01473420|364127867|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
105581731|NCT01473420|364127868|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
105581732|NCT01473420|364127867|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
105581733|NCT01473420|364127868|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
105581734|NCT01473420|364127867|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
105581735|NCT01473420|364127868|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
105581736|NCT01473420|364127867|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
105581737|NCT01473420|364127868|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
105581738|NCT01473420|364127867|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
105581739|NCT01473420|364127868|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
105581740|NCT01473420|364127867|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
105581741|NCT01473420|364127868|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
105581742|NCT01473420|364127867|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
105581743|NCT01473420|364127868|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
105581744|NCT01473420|364127867|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
105581745|NCT01473420|364127868|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
105581746|NCT01473420|364127867|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
105581747|NCT01473420|364127868|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
105581748|NCT01473420|364127867|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
105581749|NCT01473420|364127868|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
105581750|NCT01473420|364127867|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
105581751|NCT01473420|364127868|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
105581752|NCT01473420|364127867|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
105581753|NCT01473420|364127868|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
105581754|NCT01473420|364127867|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
105581755|NCT01473420|364127868|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
105581756|NCT03246672|364127870|FG000|Overall Study|Lost to Follow-up|2|||
105581757|NCT02806336|364127871|FG000|Overall Study|Physician Decision|1|||
105581758|NCT02806336|364127872|FG001|Overall Study|Physician Decision|0|||
105581759|NCT02806336|364127871|FG000|Overall Study|Withdrawal by Subject|2|||
105581760|NCT02806336|364127872|FG001|Overall Study|Withdrawal by Subject|4|||
105581761|NCT02806336|364127871|FG000|Overall Study|COVID-19 research shut down|3|||
105581762|NCT02806336|364127872|FG001|Overall Study|COVID-19 research shut down|4|||
105581763|NCT02806336|364127871|FG000|Overall Study|Lack of Efficacy|0|||
105581764|NCT02806336|364127872|FG001|Overall Study|Lack of Efficacy|1|||
105581765|NCT01670500|364127877|FG000|Overall Study|Withdrawal by Subject|1|||
105581766|NCT01670500|364127878|FG001|Overall Study|Withdrawal by Subject|0|||
105581767|NCT03714022|364127879|FG000|Overall Study|Adverse Event|1|||
105581768|NCT03714022|364127880|FG001|Overall Study|Adverse Event|0|||
105581769|NCT03714022|364127879|FG000|Overall Study|Consent withdrawal|0|||
105581770|NCT03714022|364127880|FG001|Overall Study|Consent withdrawal|1|||
105581771|NCT03714022|364127879|FG000|Overall Study|Lost to Follow-up|3|||
105581772|NCT03714022|364127880|FG001|Overall Study|Lost to Follow-up|2|||
105581773|NCT02148718|364127881|FG000|Overall Study|Protocol Violation|26|||
105581774|NCT02148718|364127881|FG000|Overall Study|Discontinued Study Prematurely|5|||
105581775|NCT04793464|364127882|FG000|Overall Study|Lost to Follow-up|458|||
105581776|NCT04793464|364127883|FG001|Overall Study|Lost to Follow-up|168|||
105581777|NCT04793464|364127884|FG002|Overall Study|Lost to Follow-up|5|||
105581778|NCT04793464|364127882|FG000|Overall Study|Withdrawal by Subject|43|||
105581779|NCT04793464|364127883|FG001|Overall Study|Withdrawal by Subject|15|||
105581780|NCT04793464|364127884|FG002|Overall Study|Withdrawal by Subject|0|||
105581781|NCT00003509|364127885|FG000|Overall Study|Not evaluable|5|||
105581782|NCT03873246|364127886|FG000|Overall Study|Adverse Event|1|||
105581783|NCT03873246|364127887|FG001|Overall Study|Adverse Event|3|||
105581784|NCT03873246|364127888|FG002|Overall Study|Adverse Event|3|||
105581785|NCT03873246|364127886|FG000|Overall Study|Lost to Follow-up|4|||
105581786|NCT03873246|364127887|FG001|Overall Study|Lost to Follow-up|4|||
105581787|NCT03873246|364127888|FG002|Overall Study|Lost to Follow-up|5|||
105581788|NCT03873246|364127886|FG000|Overall Study|Protocol Violation|0|||
105581789|NCT03873246|364127887|FG001|Overall Study|Protocol Violation|1|||
105581790|NCT03873246|364127888|FG002|Overall Study|Protocol Violation|0|||
105581791|NCT03873246|364127886|FG000|Overall Study|Withdrawal by Subject|0|||
105581792|NCT03873246|364127887|FG001|Overall Study|Withdrawal by Subject|4|||
105581793|NCT03873246|364127888|FG002|Overall Study|Withdrawal by Subject|1|||
105581794|NCT03285711|364127889|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
105581795|NCT03285711|364127890|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
105581796|NCT03285711|364127891|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
105581797|NCT03285711|364127892|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
105581798|NCT03285711|364127889|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
105581799|NCT03285711|364127890|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
105581800|NCT03285711|364127891|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
105410889|NCT02574078|363512291|FG001|Pre-Treatment Period|Other reasons|0|||
105410890|NCT02574078|363512292|FG002|Pre-Treatment Period|Other reasons|0|||
105410891|NCT02574078|363512293|FG003|Pre-Treatment Period|Other reasons|0|||
105410892|NCT02574078|363512294|FG004|Pre-Treatment Period|Other reasons|0|||
105410893|NCT02574078|363512295|FG005|Pre-Treatment Period|Other reasons|0|||
105410894|NCT02574078|363512296|FG006|Pre-Treatment Period|Other reasons|2|||
105410895|NCT02574078|363512297|FG007|Pre-Treatment Period|Other reasons|0|||
105410896|NCT02574078|363512298|FG008|Pre-Treatment Period|Other reasons|0|||
105410897|NCT02574078|363512299|FG009|Pre-Treatment Period|Other reasons|0|||
105410898|NCT02574078|363512300|FG010|Pre-Treatment Period|Other reasons|2|||
105410899|NCT02574078|363512301|FG011|Pre-Treatment Period|Other reasons|0|||
105410900|NCT02574078|363512302|FG012|Pre-Treatment Period|Other reasons|0|||
105410901|NCT02574078|363512290|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
105410902|NCT02574078|363512291|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
105410903|NCT02574078|363512292|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
105410904|NCT02574078|363512293|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
105410905|NCT02574078|363512294|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
105410906|NCT02574078|363512295|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
105410907|NCT02574078|363512296|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
105410908|NCT02574078|363512297|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
105410909|NCT02574078|363512298|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
105410910|NCT02574078|363512299|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
105410911|NCT02574078|363512300|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
105410912|NCT02574078|363512301|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
105410913|NCT02574078|363512302|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
105410914|NCT02574078|363512290|FG000|Treatment Period|Disease progression|6|||
105410915|NCT02574078|363512291|FG001|Treatment Period|Disease progression|4|||
105410916|NCT02574078|363512292|FG002|Treatment Period|Disease progression|7|||
105410917|NCT02574078|363512293|FG003|Treatment Period|Disease progression|18|||
105410918|NCT02574078|363512294|FG004|Treatment Period|Disease progression|16|||
105410919|NCT02574078|363512295|FG005|Treatment Period|Disease progression|26|||
105410920|NCT02574078|363512296|FG006|Treatment Period|Disease progression|5|||
105410921|NCT02574078|363512297|FG007|Treatment Period|Disease progression|9|||
105410922|NCT02574078|363512298|FG008|Treatment Period|Disease progression|8|||
105410923|NCT02574078|363512299|FG009|Treatment Period|Disease progression|5|||
105410924|NCT02574078|363512300|FG010|Treatment Period|Disease progression|20|||
105410925|NCT02574078|363512301|FG011|Treatment Period|Disease progression|29|||
105410926|NCT02574078|363512302|FG012|Treatment Period|Disease progression|2|||
105410927|NCT02574078|363512290|FG000|Treatment Period|Study drug toxicity|1|||
105581801|NCT03285711|364127892|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
105410928|NCT02574078|363512291|FG001|Treatment Period|Study drug toxicity|1|||
105410929|NCT02574078|363512292|FG002|Treatment Period|Study drug toxicity|0|||
105410930|NCT02574078|363512293|FG003|Treatment Period|Study drug toxicity|5|||
105410931|NCT02574078|363512294|FG004|Treatment Period|Study drug toxicity|3|||
105410932|NCT02574078|363512295|FG005|Treatment Period|Study drug toxicity|1|||
105410933|NCT02574078|363512296|FG006|Treatment Period|Study drug toxicity|2|||
105410934|NCT02574078|363512297|FG007|Treatment Period|Study drug toxicity|0|||
105410935|NCT02574078|363512298|FG008|Treatment Period|Study drug toxicity|2|||
105410936|NCT02574078|363512299|FG009|Treatment Period|Study drug toxicity|1|||
105410937|NCT02574078|363512300|FG010|Treatment Period|Study drug toxicity|16|||
105410938|NCT02574078|363512301|FG011|Treatment Period|Study drug toxicity|2|||
105410939|NCT02574078|363512302|FG012|Treatment Period|Study drug toxicity|4|||
105410940|NCT02574078|363512290|FG000|Treatment Period|Death|2|||
105410941|NCT02574078|363512291|FG001|Treatment Period|Death|0|||
105410942|NCT02574078|363512292|FG002|Treatment Period|Death|0|||
105410943|NCT02574078|363512293|FG003|Treatment Period|Death|0|||
105410944|NCT02574078|363512294|FG004|Treatment Period|Death|1|||
105410945|NCT02574078|363512295|FG005|Treatment Period|Death|1|||
105410946|NCT02574078|363512296|FG006|Treatment Period|Death|1|||
105410947|NCT02574078|363512297|FG007|Treatment Period|Death|1|||
105410948|NCT02574078|363512298|FG008|Treatment Period|Death|7|||
105410949|NCT02574078|363512299|FG009|Treatment Period|Death|1|||
105410950|NCT02574078|363512300|FG010|Treatment Period|Death|0|||
105410951|NCT02574078|363512301|FG011|Treatment Period|Death|2|||
105410952|NCT02574078|363512302|FG012|Treatment Period|Death|1|||
105410953|NCT02574078|363512290|FG000|Treatment Period|Adverse event unrelated to drug|0|||
105410954|NCT02574078|363512291|FG001|Treatment Period|Adverse event unrelated to drug|0|||
105410955|NCT02574078|363512292|FG002|Treatment Period|Adverse event unrelated to drug|1|||
105410956|NCT02574078|363512293|FG003|Treatment Period|Adverse event unrelated to drug|0|||
105410957|NCT02574078|363512294|FG004|Treatment Period|Adverse event unrelated to drug|2|||
105410958|NCT02574078|363512295|FG005|Treatment Period|Adverse event unrelated to drug|3|||
105410959|NCT02574078|363512296|FG006|Treatment Period|Adverse event unrelated to drug|0|||
105410960|NCT02574078|363512297|FG007|Treatment Period|Adverse event unrelated to drug|0|||
105410961|NCT02574078|363512298|FG008|Treatment Period|Adverse event unrelated to drug|1|||
105410962|NCT02574078|363512299|FG009|Treatment Period|Adverse event unrelated to drug|2|||
105410963|NCT02574078|363512300|FG010|Treatment Period|Adverse event unrelated to drug|4|||
105410964|NCT02574078|363512301|FG011|Treatment Period|Adverse event unrelated to drug|1|||
105410965|NCT02574078|363512302|FG012|Treatment Period|Adverse event unrelated to drug|0|||
105410966|NCT02574078|363512290|FG000|Treatment Period|Administrative reason by Sponsor|0|||
105410967|NCT02574078|363512291|FG001|Treatment Period|Administrative reason by Sponsor|1|||
105410968|NCT02574078|363512292|FG002|Treatment Period|Administrative reason by Sponsor|0|||
105410969|NCT02574078|363512293|FG003|Treatment Period|Administrative reason by Sponsor|0|||
105410970|NCT02574078|363512294|FG004|Treatment Period|Administrative reason by Sponsor|0|||
105410971|NCT02574078|363512295|FG005|Treatment Period|Administrative reason by Sponsor|0|||
105410972|NCT02574078|363512296|FG006|Treatment Period|Administrative reason by Sponsor|1|||
105410973|NCT02574078|363512297|FG007|Treatment Period|Administrative reason by Sponsor|0|||
105410974|NCT02574078|363512298|FG008|Treatment Period|Administrative reason by Sponsor|0|||
105410975|NCT02574078|363512299|FG009|Treatment Period|Administrative reason by Sponsor|0|||
105410976|NCT02574078|363512300|FG010|Treatment Period|Administrative reason by Sponsor|0|||
105410977|NCT02574078|363512301|FG011|Treatment Period|Administrative reason by Sponsor|0|||
105410978|NCT02574078|363512302|FG012|Treatment Period|Administrative reason by Sponsor|3|||
105410979|NCT02574078|363512290|FG000|Treatment Period|Other reasons|1|||
105410980|NCT02574078|363512291|FG001|Treatment Period|Other reasons|0|||
105410981|NCT02574078|363512292|FG002|Treatment Period|Other reasons|1|||
105410982|NCT02574078|363512293|FG003|Treatment Period|Other reasons|3|||
105410983|NCT02574078|363512294|FG004|Treatment Period|Other reasons|3|||
105410984|NCT02574078|363512295|FG005|Treatment Period|Other reasons|1|||
105410985|NCT02574078|363512296|FG006|Treatment Period|Other reasons|2|||
105410986|NCT02574078|363512297|FG007|Treatment Period|Other reasons|1|||
105495260|NCT01024231|363826303|FG006|Overall Study|No longer meets criteria|1|||
105495261|NCT01024231|363826297|FG000|Overall Study|Study Drug Toxicity|1|||
105495262|NCT01024231|363826298|FG001|Overall Study|Study Drug Toxicity|6|||
105495263|NCT01024231|363826299|FG002|Overall Study|Study Drug Toxicity|6|||
105495264|NCT01024231|363826300|FG003|Overall Study|Study Drug Toxicity|4|||
105495265|NCT01024231|363826301|FG004|Overall Study|Study Drug Toxicity|2|||
105410987|NCT02574078|363512298|FG008|Treatment Period|Other reasons|3|||
105495266|NCT01024231|363826302|FG005|Overall Study|Study Drug Toxicity|0|||
105495267|NCT01024231|363826303|FG006|Overall Study|Study Drug Toxicity|7|||
105410988|NCT02574078|363512299|FG009|Treatment Period|Other reasons|1|||
105410989|NCT02574078|363512300|FG010|Treatment Period|Other reasons|1|||
105410990|NCT02574078|363512301|FG011|Treatment Period|Other reasons|3|||
105410991|NCT02574078|363512302|FG012|Treatment Period|Other reasons|1|||
105410992|NCT02574078|363512290|FG000|Treatment Period|Participant request to stop drug|0|||
105495268|NCT01024231|363826297|FG000|Overall Study|Death|6|||
105495269|NCT01024231|363826298|FG001|Overall Study|Death|2|||
105581802|NCT03285711|364127889|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
105410993|NCT02574078|363512291|FG001|Treatment Period|Participant request to stop drug|0|||
105410994|NCT02574078|363512292|FG002|Treatment Period|Participant request to stop drug|0|||
105410995|NCT02574078|363512293|FG003|Treatment Period|Participant request to stop drug|2|||
105410996|NCT02574078|363512294|FG004|Treatment Period|Participant request to stop drug|4|||
105495270|NCT01024231|363826299|FG002|Overall Study|Death|1|||
105495271|NCT01024231|363826300|FG003|Overall Study|Death|0|||
105410997|NCT02574078|363512295|FG005|Treatment Period|Participant request to stop drug|0|||
105410998|NCT02574078|363512296|FG006|Treatment Period|Participant request to stop drug|1|||
105410999|NCT02574078|363512297|FG007|Treatment Period|Participant request to stop drug|0|||
105411000|NCT02574078|363512298|FG008|Treatment Period|Participant request to stop drug|3|||
105411001|NCT02574078|363512299|FG009|Treatment Period|Participant request to stop drug|2|||
105411002|NCT02574078|363512300|FG010|Treatment Period|Participant request to stop drug|2|||
105411003|NCT02574078|363512301|FG011|Treatment Period|Participant request to stop drug|4|||
105411004|NCT02574078|363512302|FG012|Treatment Period|Participant request to stop drug|1|||
105411005|NCT02574078|363512290|FG000|Treatment Period|Participant withdrew consent|0|||
105411006|NCT02574078|363512291|FG001|Treatment Period|Participant withdrew consent|0|||
105411007|NCT02574078|363512292|FG002|Treatment Period|Participant withdrew consent|0|||
105411008|NCT02574078|363512293|FG003|Treatment Period|Participant withdrew consent|0|||
105411009|NCT02574078|363512294|FG004|Treatment Period|Participant withdrew consent|1|||
105411010|NCT02574078|363512295|FG005|Treatment Period|Participant withdrew consent|1|||
105411011|NCT02574078|363512296|FG006|Treatment Period|Participant withdrew consent|0|||
105495272|NCT01024231|363826301|FG004|Overall Study|Death|4|||
105411012|NCT02574078|363512297|FG007|Treatment Period|Participant withdrew consent|1|||
105411013|NCT02574078|363512298|FG008|Treatment Period|Participant withdrew consent|0|||
105411014|NCT02574078|363512299|FG009|Treatment Period|Participant withdrew consent|2|||
105411015|NCT02574078|363512300|FG010|Treatment Period|Participant withdrew consent|1|||
105411016|NCT02574078|363512301|FG011|Treatment Period|Participant withdrew consent|4|||
105411017|NCT02574078|363512302|FG012|Treatment Period|Participant withdrew consent|1|||
105411018|NCT02574078|363512290|FG000|Treatment Period|Participant no longer meets criteria|0|||
105411019|NCT02574078|363512291|FG001|Treatment Period|Participant no longer meets criteria|0|||
105411020|NCT02574078|363512292|FG002|Treatment Period|Participant no longer meets criteria|0|||
105495273|NCT01024231|363826302|FG005|Overall Study|Death|3|||
105495274|NCT01024231|363826303|FG006|Overall Study|Death|5|||
105495275|NCT01024231|363826297|FG000|Overall Study|Lost to Follow-up|0|||
105495276|NCT01024231|363826298|FG001|Overall Study|Lost to Follow-up|0|||
105495277|NCT01024231|363826299|FG002|Overall Study|Lost to Follow-up|0|||
105495278|NCT01024231|363826300|FG003|Overall Study|Lost to Follow-up|0|||
105495279|NCT01024231|363826301|FG004|Overall Study|Lost to Follow-up|0|||
105411021|NCT02574078|363512293|FG003|Treatment Period|Participant no longer meets criteria|0|||
105411022|NCT02574078|363512294|FG004|Treatment Period|Participant no longer meets criteria|1|||
105411023|NCT02574078|363512295|FG005|Treatment Period|Participant no longer meets criteria|0|||
105411024|NCT02574078|363512296|FG006|Treatment Period|Participant no longer meets criteria|0|||
105411025|NCT02574078|363512297|FG007|Treatment Period|Participant no longer meets criteria|0|||
105411026|NCT02574078|363512298|FG008|Treatment Period|Participant no longer meets criteria|0|||
105411027|NCT02574078|363512299|FG009|Treatment Period|Participant no longer meets criteria|1|||
105411028|NCT02574078|363512300|FG010|Treatment Period|Participant no longer meets criteria|1|||
105411029|NCT02574078|363512301|FG011|Treatment Period|Participant no longer meets criteria|1|||
105411030|NCT02574078|363512302|FG012|Treatment Period|Participant no longer meets criteria|0|||
105411031|NCT02574078|363512290|FG000|Treatment Period|Lost to Follow-up|0|||
105411032|NCT02574078|363512291|FG001|Treatment Period|Lost to Follow-up|0|||
105411033|NCT02574078|363512292|FG002|Treatment Period|Lost to Follow-up|0|||
105411034|NCT02574078|363512293|FG003|Treatment Period|Lost to Follow-up|0|||
105411035|NCT02574078|363512294|FG004|Treatment Period|Lost to Follow-up|0|||
105411036|NCT02574078|363512295|FG005|Treatment Period|Lost to Follow-up|0|||
105411037|NCT02574078|363512296|FG006|Treatment Period|Lost to Follow-up|0|||
105495280|NCT01024231|363826302|FG005|Overall Study|Lost to Follow-up|0|||
105495281|NCT01024231|363826303|FG006|Overall Study|Lost to Follow-up|1|||
105495282|NCT01024231|363826297|FG000|Overall Study|Withdrew Consent|0|||
105495283|NCT01024231|363826298|FG001|Overall Study|Withdrew Consent|1|||
105495284|NCT01024231|363826299|FG002|Overall Study|Withdrew Consent|0|||
105495285|NCT01024231|363826300|FG003|Overall Study|Withdrew Consent|0|||
105495286|NCT01024231|363826301|FG004|Overall Study|Withdrew Consent|0|||
105581803|NCT03285711|364127890|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
105411038|NCT02574078|363512297|FG007|Treatment Period|Lost to Follow-up|0|||
105411039|NCT02574078|363512298|FG008|Treatment Period|Lost to Follow-up|0|||
105411040|NCT02574078|363512299|FG009|Treatment Period|Lost to Follow-up|1|||
105411041|NCT02574078|363512300|FG010|Treatment Period|Lost to Follow-up|0|||
105495287|NCT01024231|363826302|FG005|Overall Study|Withdrew Consent|0|||
105495288|NCT01024231|363826303|FG006|Overall Study|Withdrew Consent|0|||
105411042|NCT02574078|363512301|FG011|Treatment Period|Lost to Follow-up|1|||
105411043|NCT02574078|363512302|FG012|Treatment Period|Lost to Follow-up|0|||
105411044|NCT02574078|363512290|FG000|Treatment Period|Maximum clinical benefit|0|||
105411045|NCT02574078|363512291|FG001|Treatment Period|Maximum clinical benefit|0|||
105411046|NCT02574078|363512292|FG002|Treatment Period|Maximum clinical benefit|0|||
105411047|NCT02574078|363512293|FG003|Treatment Period|Maximum clinical benefit|0|||
105411048|NCT02574078|363512294|FG004|Treatment Period|Maximum clinical benefit|0|||
105411049|NCT02574078|363512295|FG005|Treatment Period|Maximum clinical benefit|0|||
105411050|NCT02574078|363512296|FG006|Treatment Period|Maximum clinical benefit|0|||
105411051|NCT02574078|363512297|FG007|Treatment Period|Maximum clinical benefit|0|||
105411052|NCT02574078|363512298|FG008|Treatment Period|Maximum clinical benefit|0|||
105411053|NCT02574078|363512299|FG009|Treatment Period|Maximum clinical benefit|1|||
105411054|NCT02574078|363512300|FG010|Treatment Period|Maximum clinical benefit|0|||
105411055|NCT02574078|363512301|FG011|Treatment Period|Maximum clinical benefit|0|||
105411056|NCT02574078|363512302|FG012|Treatment Period|Maximum clinical benefit|0|||
105411057|NCT03292874|363512313|FG000|Overall Study|Due to pandemic|5|||
105411058|NCT00161616|363512314|FG000|Overall Study|Withdrawal by Subject|6|||
105411059|NCT00161616|363512315|FG001|Overall Study|Withdrawal by Subject|5|||
105411060|NCT00161616|363512314|FG000|Overall Study|Physician Decision|1|||
105411061|NCT00161616|363512315|FG001|Overall Study|Physician Decision|0|||
105411062|NCT00161616|363512314|FG000|Overall Study|Death|1|||
105411063|NCT00161616|363512315|FG001|Overall Study|Death|1|||
105411064|NCT00161616|363512314|FG000|Overall Study|Lost to Follow-up|17|||
105411065|NCT00161616|363512315|FG001|Overall Study|Lost to Follow-up|13|||
105411066|NCT00161616|363512314|FG000|Overall Study|Protocol deviation|1|||
105411067|NCT00161616|363512315|FG001|Overall Study|Protocol deviation|0|||
105411068|NCT00933608|363512316|FG000|Overall Study|Adverse Event|4|||
105411069|NCT00933608|363512317|FG001|Overall Study|Adverse Event|2|||
105411070|NCT00933608|363512316|FG000|Overall Study|Physician Decision|1|||
105411071|NCT00933608|363512317|FG001|Overall Study|Physician Decision|0|||
105411072|NCT01961297|363512329|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
105411073|NCT01961297|363512330|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
105411074|NCT01521923|363512331|FG000|Overall Study|AE, serious fatal|1|||
105411075|NCT01521923|363512332|FG001|Overall Study|AE, serious fatal|0|||
105411076|NCT01521923|363512333|FG002|Overall Study|AE, serious fatal|0|||
105411077|NCT01521923|363512334|FG003|Overall Study|AE, serious fatal|0|||
105411078|NCT01521923|363512331|FG000|Overall Study|SAE, non-fatal|0|||
105411079|NCT01521923|363512332|FG001|Overall Study|SAE, non-fatal|2|||
105411080|NCT01521923|363512333|FG002|Overall Study|SAE, non-fatal|2|||
105411081|NCT01521923|363512334|FG003|Overall Study|SAE, non-fatal|0|||
105411082|NCT01521923|363512331|FG000|Overall Study|AE, non-serious, non-fatal|1|||
105411083|NCT01521923|363512332|FG001|Overall Study|AE, non-serious, non-fatal|3|||
105411084|NCT01521923|363512333|FG002|Overall Study|AE, non-serious, non-fatal|6|||
105411085|NCT01521923|363512334|FG003|Overall Study|AE, non-serious, non-fatal|2|||
105411086|NCT01521923|363512331|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
105411087|NCT01521923|363512332|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
105411088|NCT01521923|363512333|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
105411089|NCT01521923|363512334|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
105411090|NCT01521923|363512331|FG000|Overall Study|Lack of Efficacy|1|||
105411091|NCT01521923|363512332|FG001|Overall Study|Lack of Efficacy|1|||
105411092|NCT01521923|363512333|FG002|Overall Study|Lack of Efficacy|0|||
105411093|NCT01521923|363512334|FG003|Overall Study|Lack of Efficacy|0|||
105411094|NCT01521923|363512331|FG000|Overall Study|Protocol Violation|0|||
105411095|NCT01521923|363512332|FG001|Overall Study|Protocol Violation|0|||
105411096|NCT01521923|363512333|FG002|Overall Study|Protocol Violation|1|||
105411097|NCT01521923|363512334|FG003|Overall Study|Protocol Violation|0|||
105411098|NCT01521923|363512331|FG000|Overall Study|Lost to Follow-up|1|||
105411099|NCT01521923|363512332|FG001|Overall Study|Lost to Follow-up|0|||
105411100|NCT01521923|363512333|FG002|Overall Study|Lost to Follow-up|2|||
105581804|NCT03285711|364127891|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
105581805|NCT03285711|364127892|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
105411101|NCT01521923|363512334|FG003|Overall Study|Lost to Follow-up|1|||
105411102|NCT01521923|363512331|FG000|Overall Study|Withdrawal by Subject|1|||
105411103|NCT01521923|363512332|FG001|Overall Study|Withdrawal by Subject|1|||
105411104|NCT01521923|363512333|FG002|Overall Study|Withdrawal by Subject|1|||
105411105|NCT01521923|363512334|FG003|Overall Study|Withdrawal by Subject|2|||
105411106|NCT01521923|363512331|FG000|Overall Study|Other|2|||
105411107|NCT01521923|363512332|FG001|Overall Study|Other|1|||
105411108|NCT01521923|363512333|FG002|Overall Study|Other|3|||
105411109|NCT01521923|363512334|FG003|Overall Study|Other|6|||
105411110|NCT01521923|363512331|FG000|Overall Study|AE, captured in Period 1|0|||
105411111|NCT01521923|363512332|FG001|Overall Study|AE, captured in Period 1|1|||
105411112|NCT01521923|363512333|FG002|Overall Study|AE, captured in Period 1|0|||
105411113|NCT01521923|363512334|FG003|Overall Study|AE, captured in Period 1|1|||
105411114|NCT00391053|363512339|FG000|Overall Study|Serious Adverse Events|1|||
105411115|NCT00391053|363512340|FG001|Overall Study|Serious Adverse Events|0|||
105411116|NCT00391053|363512341|FG002|Overall Study|Serious Adverse Events|1|||
105495289|NCT01024231|363826297|FG000|Overall Study|Continuing on Treatment|0|||
105495290|NCT01024231|363826298|FG001|Overall Study|Continuing on Treatment|0|||
105495291|NCT01024231|363826299|FG002|Overall Study|Continuing on Treatment|0|||
105495292|NCT01024231|363826300|FG003|Overall Study|Continuing on Treatment|0|||
105495293|NCT01024231|363826301|FG004|Overall Study|Continuing on Treatment|3|||
105495294|NCT01024231|363826302|FG005|Overall Study|Continuing on Treatment|2|||
105495295|NCT01024231|363826303|FG006|Overall Study|Continuing on Treatment|0|||
105495296|NCT01013350|363826304|FG000|Overall Study|Lost to Follow-up|15|||
105495297|NCT01013350|363826305|FG001|Overall Study|Lost to Follow-up|95|||
105495298|NCT01013350|363826304|FG000|Overall Study|Adverse Event|0|||
105495299|NCT01013350|363826305|FG001|Overall Study|Adverse Event|1|||
105495300|NCT01013350|363826304|FG000|Overall Study|Physician Decision|4|||
105495301|NCT01013350|363826305|FG001|Overall Study|Physician Decision|20|||
105495302|NCT01013350|363826304|FG000|Overall Study|Withdrawal by Subject|15|||
105495303|NCT01013350|363826305|FG001|Overall Study|Withdrawal by Subject|38|||
105495304|NCT01013350|363826304|FG000|Overall Study|Death|3|||
105495305|NCT01013350|363826305|FG001|Overall Study|Death|5|||
105495306|NCT01013350|363826304|FG000|Overall Study|Participant entered interventional study|0|||
105495307|NCT01013350|363826305|FG001|Overall Study|Participant entered interventional study|8|||
105495308|NCT01013350|363826304|FG000|Overall Study|Other|1|||
105495309|NCT01013350|363826305|FG001|Overall Study|Other|25|||
105495310|NCT02019277|363826306|FG000|Overall Study|Withdrawal by Subject|3|||
105495311|NCT02019277|363826306|FG000|Overall Study|Death|7|||
105495312|NCT02019277|363826306|FG000|Overall Study|Did no Cooperate|1|||
105495313|NCT02019277|363826306|FG000|Overall Study|Adverse Event|1|||
105495314|NCT02633501|363826308|FG000|Overall Study|Adverse Event|0|||
105495315|NCT02633501|363826309|FG001|Overall Study|Adverse Event|0|||
105495316|NCT02633501|363826310|FG002|Overall Study|Adverse Event|1|||
105495317|NCT02633501|363826311|FG003|Overall Study|Adverse Event|0|||
105495318|NCT02633501|363826312|FG004|Overall Study|Adverse Event|1|||
105495319|NCT02633501|363826313|FG005|Overall Study|Adverse Event|1|||
105495320|NCT02633501|363826308|FG000|Overall Study|Withdrawal by Subject|2|||
105495321|NCT02633501|363826309|FG001|Overall Study|Withdrawal by Subject|1|||
105495322|NCT02633501|363826310|FG002|Overall Study|Withdrawal by Subject|2|||
105495323|NCT02633501|363826311|FG003|Overall Study|Withdrawal by Subject|2|||
105495324|NCT02633501|363826312|FG004|Overall Study|Withdrawal by Subject|1|||
105411117|NCT00391053|363512342|FG003|Overall Study|Serious Adverse Events|4|||
105411118|NCT00391053|363512339|FG000|Overall Study|Protocol Violation|2|||
105411119|NCT00391053|363512340|FG001|Overall Study|Protocol Violation|0|||
105411120|NCT00391053|363512341|FG002|Overall Study|Protocol Violation|0|||
105411121|NCT00391053|363512342|FG003|Overall Study|Protocol Violation|0|||
105411122|NCT00391053|363512339|FG000|Overall Study|Lost to Follow-up|1|||
105411123|NCT00391053|363512340|FG001|Overall Study|Lost to Follow-up|0|||
105411124|NCT00391053|363512341|FG002|Overall Study|Lost to Follow-up|0|||
105411125|NCT00391053|363512342|FG003|Overall Study|Lost to Follow-up|5|||
105411126|NCT00391053|363512339|FG000|Overall Study|Withdrawal by Subject|5|||
105411127|NCT00391053|363512340|FG001|Overall Study|Withdrawal by Subject|1|||
105411128|NCT00391053|363512341|FG002|Overall Study|Withdrawal by Subject|1|||
105411129|NCT00391053|363512342|FG003|Overall Study|Withdrawal by Subject|1|||
105411130|NCT00430989|363512343|FG000|Overall Study|Lost to Follow-up|2|||
105411131|NCT00430989|363512344|FG001|Overall Study|Lost to Follow-up|3|||
105411132|NCT00430989|363512343|FG000|Overall Study|Withdrawal by Subject|15|||
105411133|NCT00430989|363512344|FG001|Overall Study|Withdrawal by Subject|14|||
105411134|NCT00430989|363512343|FG000|Overall Study|Protocol Violation|30|||
105411135|NCT00430989|363512344|FG001|Overall Study|Protocol Violation|37|||
105411136|NCT00430989|363512343|FG000|Overall Study|Not eligible|13|||
105411137|NCT00430989|363512344|FG001|Overall Study|Not eligible|6|||
105411138|NCT03782259|363512345|FG000|Overall Study|Lost to Follow-up|1|||
105411139|NCT03782259|363512346|FG001|Overall Study|Lost to Follow-up|1|||
105411140|NCT03782259|363512345|FG000|Overall Study|Moved out of state|0|||
105411141|NCT03782259|363512346|FG001|Overall Study|Moved out of state|2|||
105411142|NCT03782259|363512345|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
105411143|NCT03782259|363512346|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
105411144|NCT03782259|363512345|FG000|Overall Study|Subject discontinued intervention|1|||
105411145|NCT03782259|363512346|FG001|Overall Study|Subject discontinued intervention|0|||
105411146|NCT00590122|363512347|FG000|Overall Study|swallowed oral dissolving dose|1|||
105411147|NCT00590122|363512348|FG001|Overall Study|swallowed oral dissolving dose|0|||
105411148|NCT01642901|363512349|FG000|12-month Follow-up|Withdrawal by Subject|1|||
105411149|NCT01642901|363512350|FG001|12-month Follow-up|Withdrawal by Subject|0|||
105411150|NCT05069597|363512351|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
105411151|NCT05069597|363512352|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
105411152|NCT01709110|363512353|FG000|Overall Study|Adverse Event|56|||
105411153|NCT01709110|363512354|FG001|Overall Study|Adverse Event|48|||
105495325|NCT02633501|363826313|FG005|Overall Study|Withdrawal by Subject|3|||
105495326|NCT02633501|363826308|FG000|Overall Study|Various other reasons|0|||
105495327|NCT02633501|363826309|FG001|Overall Study|Various other reasons|2|||
105411154|NCT01709110|363512353|FG000|Overall Study|Death|14|||
105411155|NCT01709110|363512354|FG001|Overall Study|Death|6|||
105411156|NCT01709110|363512353|FG000|Overall Study|Lost to Follow-up|7|||
105411157|NCT01709110|363512354|FG001|Overall Study|Lost to Follow-up|5|||
105411158|NCT01709110|363512353|FG000|Overall Study|Protocol Violation|4|||
105411159|NCT01709110|363512354|FG001|Overall Study|Protocol Violation|6|||
105411160|NCT01709110|363512353|FG000|Overall Study|Withdrawal by Subject|96|||
105411161|NCT01709110|363512354|FG001|Overall Study|Withdrawal by Subject|89|||
105411162|NCT01709110|363512353|FG000|Overall Study|Physician Decision|4|||
105411163|NCT01709110|363512354|FG001|Overall Study|Physician Decision|10|||
105411164|NCT01709110|363512353|FG000|Overall Study|Sponsor Decision|2|||
105411165|NCT01709110|363512354|FG001|Overall Study|Sponsor Decision|2|||
105411166|NCT01709110|363512353|FG000|Overall Study|Lack of Efficacy|1|||
105411167|NCT01709110|363512354|FG001|Overall Study|Lack of Efficacy|1|||
105411168|NCT01709110|363512353|FG000|Overall Study|Caregiver Decision|1|||
105411169|NCT01709110|363512354|FG001|Overall Study|Caregiver Decision|1|||
105411170|NCT02120781|363512355|FG000|Overall Study|Physician Decision|2|||
105411171|NCT02120781|363512356|FG001|Overall Study|Physician Decision|0|||
105411172|NCT02120781|363512355|FG000|Overall Study|Completion not documented|2|||
105411173|NCT02120781|363512356|FG001|Overall Study|Completion not documented|1|||
105411174|NCT00485758|363512357|FG000|Overall Study|Adverse Event|102|||
105411175|NCT00485758|363512358|FG001|Overall Study|Adverse Event|31|||
105411176|NCT00485758|363512357|FG000|Overall Study|Death|0|||
105411177|NCT00485758|363512358|FG001|Overall Study|Death|1|||
105411178|NCT00485758|363512357|FG000|Overall Study|Lost to Follow-up|5|||
105411179|NCT00485758|363512358|FG001|Overall Study|Lost to Follow-up|1|||
105411180|NCT00485758|363512357|FG000|Overall Study|Physician Decision|3|||
105411181|NCT00485758|363512358|FG001|Overall Study|Physician Decision|3|||
105411182|NCT00485758|363512357|FG000|Overall Study|Protocol Violation|11|||
105411183|NCT00485758|363512358|FG001|Overall Study|Protocol Violation|2|||
105411184|NCT00485758|363512357|FG000|Overall Study|Withdrawal by Subject|32|||
105411185|NCT00485758|363512358|FG001|Overall Study|Withdrawal by Subject|27|||
105411186|NCT00485758|363512357|FG000|Overall Study|Study Terminated by Sponsor|3|||
105411187|NCT00485758|363512358|FG001|Overall Study|Study Terminated by Sponsor|0|||
105411188|NCT04556591|363512359|FG000|Overall Study|Lost to Follow-up|1|||
105411189|NCT04556591|363512360|FG001|Overall Study|Lost to Follow-up|0|||
105411190|NCT04556591|363512359|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
105411191|NCT04556591|363512360|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
105411192|NCT03462641|363512367|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
105411193|NCT03462641|363512368|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
105411194|NCT03462641|363512367|FG000|Visit 2|Withdrawal by Subject|0|||
105411195|NCT03462641|363512368|FG001|Visit 2|Withdrawal by Subject|1|||
105411196|NCT02526212|363512369|FG000|Overall Study|Incarceration|1|||
105411197|NCT02526212|363512370|FG001|Overall Study|Incarceration|0|||
105411198|NCT02526212|363512369|FG000|Overall Study|Lost to Follow-up|1|||
105411199|NCT02526212|363512370|FG001|Overall Study|Lost to Follow-up|0|||
105411200|NCT02526212|363512369|FG000|Overall Study|Death|0|||
105411201|NCT02526212|363512370|FG001|Overall Study|Death|1|||
105411202|NCT00070109|363512371|FG000|Overall Study|Death|1|||
105411203|NCT00070109|363512372|FG001|Overall Study|Death|1|||
105411204|NCT00070109|363512373|FG002|Overall Study|Death|0|||
105411205|NCT00070109|363512374|FG003|Overall Study|Death|0|||
105411206|NCT00070109|363512375|FG004|Overall Study|Death|1|||
105411207|NCT00070109|363512371|FG000|Overall Study|Lack of Efficacy|6|||
105411208|NCT00070109|363512372|FG001|Overall Study|Lack of Efficacy|4|||
105411209|NCT00070109|363512373|FG002|Overall Study|Lack of Efficacy|5|||
105411210|NCT00070109|363512374|FG003|Overall Study|Lack of Efficacy|15|||
105411211|NCT00070109|363512375|FG004|Overall Study|Lack of Efficacy|5|||
105411212|NCT00070109|363512371|FG000|Overall Study|Physician Decision|1|||
105411213|NCT00070109|363512372|FG001|Overall Study|Physician Decision|0|||
105411214|NCT00070109|363512373|FG002|Overall Study|Physician Decision|0|||
105411215|NCT00070109|363512374|FG003|Overall Study|Physician Decision|0|||
105411216|NCT00070109|363512375|FG004|Overall Study|Physician Decision|0|||
105411217|NCT00070109|363512371|FG000|Overall Study|Withdrawal by Subject|0|||
105411218|NCT00070109|363512372|FG001|Overall Study|Withdrawal by Subject|1|||
105411219|NCT00070109|363512373|FG002|Overall Study|Withdrawal by Subject|1|||
105411220|NCT00070109|363512374|FG003|Overall Study|Withdrawal by Subject|0|||
105411221|NCT00070109|363512375|FG004|Overall Study|Withdrawal by Subject|0|||
105411222|NCT00070109|363512371|FG000|Overall Study|Adverse Event|0|||
105411223|NCT00070109|363512372|FG001|Overall Study|Adverse Event|0|||
105411224|NCT00070109|363512373|FG002|Overall Study|Adverse Event|2|||
105411225|NCT00070109|363512374|FG003|Overall Study|Adverse Event|4|||
105411226|NCT00070109|363512375|FG004|Overall Study|Adverse Event|2|||
105411227|NCT00070109|363512371|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
105411228|NCT00070109|363512372|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
105411229|NCT00070109|363512373|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
105411230|NCT00070109|363512374|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
105411231|NCT00070109|363512375|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
105411232|NCT01262638|363512380|FG000|Overall Study|Adverse Event|3|||
105411233|NCT01262638|363512381|FG001|Overall Study|Adverse Event|4|||
105411234|NCT01262638|363512382|FG002|Overall Study|Adverse Event|3|||
105411235|NCT01262638|363512383|FG003|Overall Study|Adverse Event|4|||
105411236|NCT01262638|363512380|FG000|Overall Study|Protocol Violation|1|||
105411237|NCT01262638|363512381|FG001|Overall Study|Protocol Violation|0|||
105411238|NCT01262638|363512382|FG002|Overall Study|Protocol Violation|0|||
105411239|NCT01262638|363512383|FG003|Overall Study|Protocol Violation|1|||
105411240|NCT01262638|363512380|FG000|Overall Study|Withdrawal by Subject|2|||
105411241|NCT01262638|363512381|FG001|Overall Study|Withdrawal by Subject|1|||
105411242|NCT01262638|363512382|FG002|Overall Study|Withdrawal by Subject|0|||
105411243|NCT01262638|363512383|FG003|Overall Study|Withdrawal by Subject|1|||
105411244|NCT01262638|363512380|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
105411245|NCT01262638|363512381|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
105411246|NCT01262638|363512382|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
105411247|NCT01262638|363512383|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
105411248|NCT01262638|363512380|FG000|Overall Study|Lost to Follow-up|1|||
105411249|NCT01262638|363512381|FG001|Overall Study|Lost to Follow-up|1|||
105411250|NCT01262638|363512382|FG002|Overall Study|Lost to Follow-up|1|||
105411251|NCT01262638|363512383|FG003|Overall Study|Lost to Follow-up|1|||
105411252|NCT01262638|363512380|FG000|Overall Study|Participant Went Out of Town|0|||
105411253|NCT01262638|363512381|FG001|Overall Study|Participant Went Out of Town|0|||
105411254|NCT01262638|363512382|FG002|Overall Study|Participant Went Out of Town|1|||
105411255|NCT01262638|363512383|FG003|Overall Study|Participant Went Out of Town|0|||
105411256|NCT00335738|363512386|FG000|Overall Study|Physician Decision|6|||
105411257|NCT00335738|363512387|FG001|Overall Study|Physician Decision|0|||
105411258|NCT00335738|363512386|FG000|Overall Study|Withdrawal by Subject|2|||
105411259|NCT00335738|363512387|FG001|Overall Study|Withdrawal by Subject|0|||
105411260|NCT00335738|363512386|FG000|Overall Study|Ineligible|3|||
105411261|NCT00335738|363512387|FG001|Overall Study|Ineligible|4|||
105411262|NCT03248167|363512390|FG000|Overall Study|Withdrawal by Subject|2|||
105411263|NCT03248167|363512391|FG001|Overall Study|Withdrawal by Subject|2|||
105411264|NCT03248167|363512390|FG000|Overall Study|Physician Decision|0|||
105411265|NCT03248167|363512391|FG001|Overall Study|Physician Decision|1|||
105411266|NCT03248167|363512390|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
105411267|NCT03248167|363512391|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
105411268|NCT03248167|363512390|FG000|Overall Study|Lost to Follow-up|1|||
105411269|NCT03248167|363512391|FG001|Overall Study|Lost to Follow-up|0|||
105411270|NCT00506454|363512392|FG000|Overall Study|Withdrawal by Subject|1|||
105411271|NCT00506454|363512393|FG001|Overall Study|Withdrawal by Subject|1|||
105411272|NCT01558596|363512396|FG000|Overall Study|Withdrawal by Subject|1|||
105411273|NCT01558596|363512397|FG001|Overall Study|Withdrawal by Subject|0|||
105411274|NCT01558596|363512396|FG000|Overall Study|surgery elsewhere or cancelled|1|||
105411275|NCT01558596|363512397|FG001|Overall Study|surgery elsewhere or cancelled|1|||
105411276|NCT01558596|363512396|FG000|Overall Study|Protocol Violation|1|||
105411277|NCT01558596|363512397|FG001|Overall Study|Protocol Violation|0|||
105411278|NCT00902850|363512399|FG000|Overall Study|Physician Decision|2|||
105411279|NCT00902850|363512400|FG001|Overall Study|Physician Decision|2|||
105411280|NCT00260832|363512401|FG000|Overall Study|Adverse Event|26|||
105411281|NCT00260832|363512402|FG001|Overall Study|Adverse Event|19|||
105411282|NCT00260832|363512401|FG000|Overall Study|Progression|116|||
105411283|NCT00260832|363512402|FG001|Overall Study|Progression|96|||
105411284|NCT00260832|363512401|FG000|Overall Study|Withdrawal by Subject|15|||
105411285|NCT00260832|363512402|FG001|Overall Study|Withdrawal by Subject|17|||
105411286|NCT00260832|363512401|FG000|Overall Study|Physician Decision|15|||
105411287|NCT00260832|363512402|FG001|Overall Study|Physician Decision|9|||
105411288|NCT00260832|363512401|FG000|Overall Study|Death|43|||
105411289|NCT00260832|363512402|FG001|Overall Study|Death|62|||
105411290|NCT00260832|363512401|FG000|Overall Study|Other|10|||
105411291|NCT00260832|363512402|FG001|Overall Study|Other|7|||
105411292|NCT00260832|363512401|FG000|Overall Study|Protocol Violation|3|||
105411293|NCT00260832|363512402|FG001|Overall Study|Protocol Violation|1|||
105411294|NCT03098433|363512403|FG000|Overall Study|Withdrawal by Subject|10|||
105411295|NCT03640507|363512409|FG000|Overall Study|Withdrawal by Subject|0|||
105411296|NCT03640507|363512410|FG001|Overall Study|Withdrawal by Subject|0|||
105411297|NCT03640507|363512411|FG002|Overall Study|Withdrawal by Subject|1|||
105411298|NCT02725476|363512413|FG000|Overall Study|Physician Decision|2|||
105411299|NCT02725476|363512414|FG001|Overall Study|Physician Decision|0|||
105411300|NCT02725476|363512413|FG000|Overall Study|Adverse Event|1|||
105411301|NCT02725476|363512414|FG001|Overall Study|Adverse Event|1|||
105411302|NCT00191945|363512415|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
105411303|NCT00191945|363512416|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
105411304|NCT00191945|363512415|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
105411305|NCT00191945|363512416|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
105411306|NCT00191945|363512415|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
105411307|NCT00191945|363512416|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
105411308|NCT00191945|363512415|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
105411309|NCT00191945|363512416|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
105411310|NCT03604172|363512421|FG000|Overall Study|Lost to Follow-up|1|||
105411311|NCT03604172|363512422|FG001|Overall Study|Lost to Follow-up|2|||
105411312|NCT00289289|363512423|FG000|Overall Study|Withdrawal by Subject|5|||
105411313|NCT00289289|363512424|FG001|Overall Study|Withdrawal by Subject|3|||
105411314|NCT00289289|363512425|FG002|Overall Study|Withdrawal by Subject|15|||
105411315|NCT00289289|363512423|FG000|Overall Study|Lost to Follow-up|1|||
105411316|NCT00289289|363512424|FG001|Overall Study|Lost to Follow-up|0|||
105411317|NCT00289289|363512425|FG002|Overall Study|Lost to Follow-up|1|||
105411318|NCT00289289|363512423|FG000|Overall Study|Death|4|||
105411319|NCT00289289|363512424|FG001|Overall Study|Death|2|||
105411320|NCT00289289|363512425|FG002|Overall Study|Death|5|||
105411321|NCT00289289|363512423|FG000|Overall Study|No implant attempted|0|||
105411322|NCT00289289|363512424|FG001|Overall Study|No implant attempted|0|||
105411323|NCT00289289|363512425|FG002|Overall Study|No implant attempted|1|||
105411324|NCT00289289|363512423|FG000|Overall Study|Physician Decision|1|||
105411325|NCT00289289|363512424|FG001|Overall Study|Physician Decision|0|||
105411326|NCT00289289|363512425|FG002|Overall Study|Physician Decision|6|||
105411327|NCT00289289|363512423|FG000|Overall Study|Non-study device implanted|2|||
105411328|NCT00289289|363512424|FG001|Overall Study|Non-study device implanted|1|||
105411329|NCT00289289|363512425|FG002|Overall Study|Non-study device implanted|3|||
105411330|NCT00289289|363512423|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
105411331|NCT00289289|363512424|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
105411332|NCT00289289|363512425|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
105411333|NCT00289289|363512423|FG000|Overall Study|Other Exit Reason|6|||
105411334|NCT00289289|363512424|FG001|Overall Study|Other Exit Reason|4|||
105411335|NCT00289289|363512425|FG002|Overall Study|Other Exit Reason|12|||
105411336|NCT01270880|363512428|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
105411337|NCT00923351|363512431|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
105411338|NCT00923351|363512432|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
105411339|NCT00923351|363512433|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
105411340|NCT03213938|363512440|FG000|Overall Study|Lost to Follow-up|4|||
105411341|NCT03213938|363512441|FG001|Overall Study|Lost to Follow-up|3|||
105411342|NCT03213938|363512440|FG000|Overall Study|Lack of Efficacy|1|||
105411343|NCT03213938|363512441|FG001|Overall Study|Lack of Efficacy|0|||
105411344|NCT03213938|363512440|FG000|Overall Study|Decline to participate|5|||
105411345|NCT03213938|363512441|FG001|Overall Study|Decline to participate|4|||
105411346|NCT03213938|363512440|FG000|Overall Study|Without reason|4|||
105411347|NCT03213938|363512441|FG001|Overall Study|Without reason|5|||
105411348|NCT01814046|363512445|FG000|Drug Administration|Death due to complications of RSV|1|||
105411349|NCT01814046|363512446|FG001|Drug Administration|Death due to complications of RSV|0|||
105411350|NCT01814046|363512447|FG002|Drug Administration|Death due to complications of RSV|0|||
105411351|NCT00564902|363512448|FG000|Overall Study|Withdrawal by Subject|0|||
105411352|NCT00564902|363512449|FG001|Overall Study|Withdrawal by Subject|3|||
105411353|NCT00564902|363512450|FG002|Overall Study|Withdrawal by Subject|4|||
105411354|NCT00564902|363512448|FG000|Overall Study|Death|1|||
105411355|NCT00564902|363512449|FG001|Overall Study|Death|1|||
105411356|NCT00564902|363512450|FG002|Overall Study|Death|0|||
105411357|NCT02952313|363512453|FG000|Primary Endpoint|Lost to Follow-up|4|||
105411358|NCT02952313|363512453|FG000|Primary Endpoint|Withdrawal by Subject|1|||
105411359|NCT02952313|363512453|FG000|Primary Endpoint|Lack of Efficacy|1|||
105411360|NCT02952313|363512453|FG000|Primary Endpoint|Missed visit|1|||
105411361|NCT02952313|363512453|FG000|Long-term Follow-up|Lost to Follow-up|12|||
105411362|NCT02952313|363512453|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
105411363|NCT02952313|363512453|FG000|Long-term Follow-up|Lack of Efficacy|6|||
105411364|NCT02952313|363512453|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
105411365|NCT02952313|363512453|FG000|Long-term Follow-up|Physician Decision|1|||
105411366|NCT02952313|363512453|FG000|Long-term Follow-up|Death|1|||
105411367|NCT02798315|363512454|FG000|Overall Study|Failure to return|1|||
105411368|NCT02146131|363512455|FG000|Overall Study|Physician Decision|61|||
105411369|NCT02146131|363512456|FG001|Overall Study|Physician Decision|56|||
105411370|NCT01059864|363512463|FG000|Open-Label Run-In Phase|Adverse Event|7|||
105581806|NCT03285711|364127889|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
105411371|NCT01059864|363512464|FG001|Open-Label Run-In Phase|Adverse Event|0|||
105411372|NCT01059864|363512465|FG002|Open-Label Run-In Phase|Adverse Event|0|||
105411373|NCT01059864|363512463|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
105411374|NCT01059864|363512464|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
105411375|NCT01059864|363512465|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
105411376|NCT01059864|363512463|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
105411377|NCT01059864|363512464|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
105411378|NCT01059864|363512465|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
105411379|NCT01059864|363512463|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
105411380|NCT01059864|363512464|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
105581807|NCT03285711|364127890|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
105581808|NCT03285711|364127891|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
105581809|NCT03285711|364127892|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
105581810|NCT03658811|364127893|FG000|Overall Study|Lost to Follow-up|3|||
105581811|NCT02169219|364127898|FG000|Overall Study|Lack of Efficacy|6|||
105411381|NCT01059864|363512465|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
105411382|NCT01059864|363512463|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
105411383|NCT01059864|363512464|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
105411384|NCT01059864|363512465|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
105411385|NCT01059864|363512463|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
105411386|NCT01059864|363512464|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
105411387|NCT01059864|363512465|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
105411388|NCT00451958|363512466|FG000|CS21A (NCT00451958)|Adverse Event|21|||
105411389|NCT00451958|363512467|FG001|CS21A (NCT00451958)|Adverse Event|34|||
105411390|NCT00451958|363512468|FG002|CS21A (NCT00451958)|Adverse Event|14|||
105411391|NCT00451958|363512469|FG003|CS21A (NCT00451958)|Adverse Event|17|||
105411392|NCT00451958|363512470|FG004|CS21A (NCT00451958)|Adverse Event|0|||
105411393|NCT00451958|363512466|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
105411394|NCT00451958|363512467|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
105411395|NCT00451958|363512468|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
105411396|NCT00451958|363512469|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
105411397|NCT00451958|363512470|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
105411398|NCT00451958|363512466|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
105411399|NCT00451958|363512467|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
105411400|NCT00451958|363512468|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
105411401|NCT00451958|363512469|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
105411402|NCT00451958|363512470|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
105411403|NCT00451958|363512466|FG000|CS21A (NCT00451958)|Physician Decision|2|||
105411404|NCT00451958|363512467|FG001|CS21A (NCT00451958)|Physician Decision|4|||
105411405|NCT00451958|363512468|FG002|CS21A (NCT00451958)|Physician Decision|4|||
105411406|NCT00451958|363512469|FG003|CS21A (NCT00451958)|Physician Decision|4|||
105411407|NCT00451958|363512470|FG004|CS21A (NCT00451958)|Physician Decision|0|||
105411408|NCT00451958|363512466|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
105411409|NCT00451958|363512467|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
105411410|NCT00451958|363512468|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
105411411|NCT00451958|363512469|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
105411412|NCT00451958|363512470|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
105411413|NCT00451958|363512466|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
105411414|NCT00451958|363512467|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
105411415|NCT00451958|363512468|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
105411416|NCT00451958|363512469|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
105411417|NCT00451958|363512470|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
105411418|NCT03281629|363512472|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
105411419|NCT03281629|363512473|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
105411420|NCT03281629|363512472|FG000|Overall Study|Death|0|||
105411421|NCT03281629|363512473|FG001|Overall Study|Death|1|||
105411422|NCT03281629|363512472|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
105411423|NCT03281629|363512473|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
105411424|NCT03430843|363514535|FG000|Overall Study|Death|233|||
105411425|NCT03430843|363514536|FG001|Overall Study|Death|233|||
105411426|NCT03430843|363514535|FG000|Overall Study|Sponsor Decision|17|||
105411427|NCT03430843|363514536|FG001|Overall Study|Sponsor Decision|6|||
105411428|NCT03430843|363514535|FG000|Overall Study|Withdrawal by Subject|5|||
105411429|NCT03430843|363514536|FG001|Overall Study|Withdrawal by Subject|14|||
105411430|NCT03430843|363514535|FG000|Overall Study|Lost to Follow-up|1|||
105411431|NCT03430843|363514536|FG001|Overall Study|Lost to Follow-up|3|||
105411432|NCT01188551|363514539|FG000|Overall Study|Pharmacy issues|1|||
105411433|NCT01188551|363514540|FG001|Overall Study|Pharmacy issues|0|||
105411434|NCT01188551|363514541|FG002|Overall Study|Pharmacy issues|0|||
105411435|NCT01188551|363514542|FG003|Overall Study|Pharmacy issues|0|||
105411436|NCT04908384|363514545|FG000|Overall Study|Lost to Follow-up|4|||
105411437|NCT04908384|363514546|FG001|Overall Study|Lost to Follow-up|4|||
105411438|NCT04908384|363514547|FG002|Overall Study|Lost to Follow-up|0|||
105411439|NCT04908384|363514548|FG003|Overall Study|Lost to Follow-up|0|||
105411440|NCT01208324|363514549|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
105411441|NCT01208324|363514550|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
105411442|NCT01208324|363514551|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
105411443|NCT01208324|363514552|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
105411444|NCT01701362|363514553|FG000|Overall Study|Adverse events not related to study drug|1|||
105411445|NCT01701362|363514554|FG001|Overall Study|Adverse events not related to study drug|6|||
105411446|NCT01701362|363514553|FG000|Overall Study|Adverse events related to study drug|12|||
105411447|NCT01701362|363514554|FG001|Overall Study|Adverse events related to study drug|10|||
105411448|NCT01701362|363514553|FG000|Overall Study|Protocol Violation|5|||
105411449|NCT01701362|363514554|FG001|Overall Study|Protocol Violation|3|||
105411450|NCT01701362|363514553|FG000|Overall Study|No longer willing to participate|8|||
105411451|NCT01701362|363514554|FG001|Overall Study|No longer willing to participate|14|||
105411452|NCT01701362|363514553|FG000|Overall Study|Lost to Follow-up|6|||
105411453|NCT01701362|363514554|FG001|Overall Study|Lost to Follow-up|9|||
105411454|NCT01701362|363514553|FG000|Overall Study|Insufficient clinical response|6|||
105411455|NCT01701362|363514554|FG001|Overall Study|Insufficient clinical response|6|||
105411456|NCT01701362|363514553|FG000|Overall Study|Death|0|||
105411457|NCT01701362|363514554|FG001|Overall Study|Death|1|||
105411458|NCT01701362|363514553|FG000|Overall Study|Randomized but not treated|1|||
105411459|NCT01701362|363514554|FG001|Overall Study|Randomized but not treated|2|||
105411460|NCT01701362|363514553|FG000|Overall Study|Reasons other than those mentioned above|3|||
105411461|NCT01701362|363514554|FG001|Overall Study|Reasons other than those mentioned above|5|||
105411462|NCT00711594|363514555|FG000|Overall Study|Progressive disease|2|||
105411463|NCT00711594|363514556|FG001|Overall Study|Progressive disease|2|||
105411464|NCT00711594|363514557|FG002|Overall Study|Progressive disease|6|||
105411465|NCT00711594|363514558|FG003|Overall Study|Progressive disease|44|||
105411466|NCT00711594|363514555|FG000|Overall Study|Other Adverse Event|1|||
105411467|NCT00711594|363514556|FG001|Overall Study|Other Adverse Event|0|||
105411468|NCT00711594|363514557|FG002|Overall Study|Other Adverse Event|0|||
105411469|NCT00711594|363514558|FG003|Overall Study|Other Adverse Event|16|||
105411470|NCT00711594|363514555|FG000|Overall Study|Withdrawal by Subject|0|||
105411471|NCT00711594|363514556|FG001|Overall Study|Withdrawal by Subject|1|||
105411472|NCT00711594|363514557|FG002|Overall Study|Withdrawal by Subject|0|||
105411473|NCT00711594|363514558|FG003|Overall Study|Withdrawal by Subject|2|||
105411474|NCT04551963|363514570|FG000|Overall Study|Physician Decision|1|||
105411475|NCT04551963|363514571|FG001|Overall Study|Physician Decision|1|||
105411476|NCT04551963|363514570|FG000|Overall Study|Death|1|||
105411477|NCT04551963|363514571|FG001|Overall Study|Death|0|||
105411478|NCT00984165|363514572|FG000|Overall Study|Death on study|2|||
105411479|NCT00984165|363514573|FG001|Overall Study|Death on study|0|||
105411480|NCT00984165|363514574|FG002|Overall Study|Death on study|0|||
105411481|NCT00984165|363514575|FG003|Overall Study|Death on study|0|||
105411482|NCT00984165|363514572|FG000|Overall Study|Disease progression on study|5|||
105411483|NCT00984165|363514573|FG001|Overall Study|Disease progression on study|1|||
105411484|NCT00984165|363514574|FG002|Overall Study|Disease progression on study|0|||
105411485|NCT00984165|363514575|FG003|Overall Study|Disease progression on study|0|||
105411486|NCT00984165|363514572|FG000|Overall Study|Death of recipient|0|||
105411487|NCT00984165|363514573|FG001|Overall Study|Death of recipient|0|||
105411488|NCT00984165|363514574|FG002|Overall Study|Death of recipient|0|||
105411489|NCT00984165|363514575|FG003|Overall Study|Death of recipient|1|||
105411490|NCT00984165|363514572|FG000|Overall Study|New protocol|0|||
105411491|NCT00984165|363514573|FG001|Overall Study|New protocol|0|||
105411492|NCT00984165|363514574|FG002|Overall Study|New protocol|0|||
105411493|NCT00984165|363514575|FG003|Overall Study|New protocol|1|||
105411494|NCT00984165|363514572|FG000|Overall Study|P+/donor pair removed from protocol|0|||
105411495|NCT00984165|363514573|FG001|Overall Study|P+/donor pair removed from protocol|0|||
105411496|NCT00984165|363514574|FG002|Overall Study|P+/donor pair removed from protocol|0|||
105411497|NCT00984165|363514575|FG003|Overall Study|P+/donor pair removed from protocol|1|||
105411498|NCT00984165|363514572|FG000|Overall Study|removed with a pair recipient|0|||
105411499|NCT00984165|363514573|FG001|Overall Study|removed with a pair recipient|0|||
105411500|NCT00984165|363514574|FG002|Overall Study|removed with a pair recipient|0|||
105411501|NCT00984165|363514575|FG003|Overall Study|removed with a pair recipient|1|||
105411502|NCT03367403|363514582|FG000|Overall Study|Adverse Event|20|||
105411503|NCT03367403|363514583|FG001|Overall Study|Adverse Event|6|||
105411504|NCT03367403|363514584|FG002|Overall Study|Adverse Event|2|||
105411505|NCT03367403|363514582|FG000|Overall Study|Withdrawal by Subject|12|||
105411506|NCT03367403|363514583|FG001|Overall Study|Withdrawal by Subject|13|||
105411507|NCT03367403|363514584|FG002|Overall Study|Withdrawal by Subject|1|||
105411508|NCT03367403|363514582|FG000|Overall Study|Death|1|||
105411509|NCT03367403|363514583|FG001|Overall Study|Death|2|||
105411510|NCT03367403|363514584|FG002|Overall Study|Death|0|||
105411511|NCT03367403|363514582|FG000|Overall Study|Physician Decision|0|||
105411512|NCT03367403|363514583|FG001|Overall Study|Physician Decision|1|||
105411513|NCT03367403|363514584|FG002|Overall Study|Physician Decision|0|||
105411514|NCT03367403|363514582|FG000|Overall Study|Protocol Violation|1|||
105411515|NCT03367403|363514583|FG001|Overall Study|Protocol Violation|1|||
105411516|NCT03367403|363514584|FG002|Overall Study|Protocol Violation|0|||
105411517|NCT03367403|363514582|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
105411518|NCT03367403|363514583|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
105411519|NCT03367403|363514584|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
105411520|NCT03367403|363514582|FG000|Overall Study|COVID-19|3|||
105411521|NCT03367403|363514583|FG001|Overall Study|COVID-19|6|||
105411522|NCT03367403|363514584|FG002|Overall Study|COVID-19|0|||
105411523|NCT03367403|363514582|FG000|Overall Study|Abuse of Alcohol Intake|0|||
105411524|NCT03367403|363514583|FG001|Overall Study|Abuse of Alcohol Intake|1|||
105411525|NCT03367403|363514584|FG002|Overall Study|Abuse of Alcohol Intake|0|||
105411526|NCT03367403|363514582|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
105411527|NCT03367403|363514583|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
105411528|NCT03367403|363514584|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
105411529|NCT01977729|363514585|FG000|Overall Study|Study terminated|1|||
105411530|NCT00194077|363514586|FG000|Overall Study|Lack of Efficacy|22|||
105411531|NCT00194077|363514587|FG001|Overall Study|Lack of Efficacy|29|||
105411532|NCT00194077|363514586|FG000|Overall Study|Study nonadherence|1|||
105411533|NCT00194077|363514587|FG001|Overall Study|Study nonadherence|0|||
105411534|NCT00194077|363514586|FG000|Overall Study|Withdrawal by Subject|1|||
105411535|NCT00194077|363514587|FG001|Overall Study|Withdrawal by Subject|1|||
105411536|NCT05332392|363514590|FG000|Overall Study|Did not meet inclusion criteria|25|||
105411537|NCT05332392|363514590|FG000|Overall Study|Principal Investigator's decision|17|||
105411538|NCT05332392|363514590|FG000|Overall Study|Adverse Event|1|||
105411539|NCT05332392|363514590|FG000|Overall Study|Subject's decision|1|||
105411540|NCT03850093|363514594|FG000|Overall Study|Withdrawal by Subject|1|||
105411541|NCT03850093|363514595|FG001|Overall Study|Withdrawal by Subject|0|||
105411542|NCT03850093|363514596|FG002|Overall Study|Withdrawal by Subject|2|||
105411543|NCT02836717|363514599|FG000|Test Phase|Lack of Efficacy|14|||
105411544|NCT02836717|363514600|FG001|Test Phase|Lack of Efficacy|8|||
105411545|NCT02836717|363514601|FG002|Test Phase|Lack of Efficacy|0|||
105411546|NCT02836717|363514599|FG000|Study Phase|Adverse Event|2|||
105411547|NCT02836717|363514600|FG001|Study Phase|Adverse Event|0|||
105411548|NCT02836717|363514601|FG002|Study Phase|Adverse Event|0|||
105411549|NCT02836717|363514599|FG000|Study Phase|Lack of Efficacy|8|||
105411550|NCT02836717|363514600|FG001|Study Phase|Lack of Efficacy|6|||
105411551|NCT02836717|363514601|FG002|Study Phase|Lack of Efficacy|1|||
105411552|NCT02836717|363514599|FG000|Study Phase|Withdrawal by Subject|1|||
105411553|NCT02836717|363514600|FG001|Study Phase|Withdrawal by Subject|0|||
105411554|NCT02836717|363514601|FG002|Study Phase|Withdrawal by Subject|0|||
105411555|NCT02836717|363514599|FG000|Study Phase|Death|1|||
105411556|NCT02836717|363514600|FG001|Study Phase|Death|0|||
105411557|NCT02836717|363514601|FG002|Study Phase|Death|0|||
105411558|NCT02836717|363514599|FG000|Study Phase|abdominal surgeries|2|||
105411559|NCT02836717|363514600|FG001|Study Phase|abdominal surgeries|1|||
105411560|NCT02836717|363514601|FG002|Study Phase|abdominal surgeries|0|||
105411561|NCT00224120|363514602|FG000|Overall Study|Adverse Event|10|||
105411562|NCT00224120|363514603|FG001|Overall Study|Adverse Event|4|||
105411563|NCT00224120|363514602|FG000|Overall Study|Protocol Violation|1|||
105411564|NCT00224120|363514603|FG001|Overall Study|Protocol Violation|0|||
105411565|NCT00224120|363514602|FG000|Overall Study|Withdrawal by Subject|5|||
105411566|NCT00224120|363514603|FG001|Overall Study|Withdrawal by Subject|10|||
105411567|NCT00224120|363514602|FG000|Overall Study|Lack of Efficacy|0|||
105411568|NCT00224120|363514603|FG001|Overall Study|Lack of Efficacy|2|||
105411569|NCT00224120|363514602|FG000|Overall Study|Lost to Follow-up|2|||
105411570|NCT00224120|363514603|FG001|Overall Study|Lost to Follow-up|3|||
105411571|NCT00224120|363514602|FG000|Overall Study|Other|4|||
105411572|NCT00224120|363514603|FG001|Overall Study|Other|5|||
105411573|NCT04560816|363514604|FG000|Overall Study|Withdrawal by Subject|1|||
105411574|NCT04560816|363514605|FG001|Overall Study|Withdrawal by Subject|1|||
105411575|NCT04560816|363514606|FG002|Overall Study|Withdrawal by Subject|1|||
105411576|NCT04560816|363514607|FG003|Overall Study|Withdrawal by Subject|0|||
105411577|NCT04560816|363514608|FG004|Overall Study|Withdrawal by Subject|3|||
105411578|NCT04560816|363514609|FG005|Overall Study|Withdrawal by Subject|0|||
105411579|NCT04560816|363514604|FG000|Overall Study|Lost to Follow-up|1|||
105411580|NCT04560816|363514605|FG001|Overall Study|Lost to Follow-up|0|||
105411581|NCT04560816|363514606|FG002|Overall Study|Lost to Follow-up|0|||
105411582|NCT04560816|363514607|FG003|Overall Study|Lost to Follow-up|0|||
105411583|NCT04560816|363514608|FG004|Overall Study|Lost to Follow-up|0|||
105411584|NCT04560816|363514609|FG005|Overall Study|Lost to Follow-up|0|||
105411585|NCT04560816|363514604|FG000|Overall Study|Protocol Violation|1|||
105411586|NCT04560816|363514605|FG001|Overall Study|Protocol Violation|0|||
105411587|NCT04560816|363514606|FG002|Overall Study|Protocol Violation|0|||
105411588|NCT04560816|363514607|FG003|Overall Study|Protocol Violation|0|||
105411589|NCT04560816|363514608|FG004|Overall Study|Protocol Violation|0|||
105411590|NCT04560816|363514609|FG005|Overall Study|Protocol Violation|0|||
105411591|NCT01532921|363514610|FG000|Overall Study|Death|3|||
105411592|NCT01532921|363514610|FG000|Overall Study|Withdrawal by Subject|2|||
105411593|NCT01532921|363514610|FG000|Overall Study|Lost to Follow-up|3|||
105411594|NCT01532921|363514610|FG000|Overall Study|Physician Decision|7|||
105411595|NCT01532921|363514610|FG000|Overall Study|Device was explanted during procedure|1|||
105411596|NCT05059301|363514617|FG000|Overall Study|Adverse Event|0|||
105411597|NCT05059301|363514618|FG001|Overall Study|Adverse Event|2|||
105411598|NCT05059301|363514619|FG002|Overall Study|Adverse Event|2|||
105411599|NCT05059301|363514617|FG000|Overall Study|Lost to Follow-up|2|||
105411600|NCT05059301|363514618|FG001|Overall Study|Lost to Follow-up|3|||
105411601|NCT05059301|363514619|FG002|Overall Study|Lost to Follow-up|3|||
105411602|NCT02151903|363514620|FG000|Overall Study|Withdrawal by Subject|1|||
105411603|NCT02151903|363514621|FG001|Overall Study|Withdrawal by Subject|0|||
105411604|NCT02151903|363514620|FG000|Overall Study|Progressive disease|2|||
105411605|NCT02151903|363514621|FG001|Overall Study|Progressive disease|1|||
105411606|NCT00935493|363514624|FG000|Overall Study|Lost to Follow-up|1|||
105411607|NCT00935493|363514625|FG001|Overall Study|Lost to Follow-up|1|||
105411608|NCT00935493|363514626|FG002|Overall Study|Lost to Follow-up|1|||
105411609|NCT00935493|363514624|FG000|Overall Study|Treatment Discontinued|0|||
105411610|NCT00935493|363514625|FG001|Overall Study|Treatment Discontinued|1|||
105411611|NCT00935493|363514626|FG002|Overall Study|Treatment Discontinued|0|||
105411612|NCT01555073|363514629|FG000|Overall Study|Lost to Follow-up|1|||
105581812|NCT02507219|364127902|FG000|Overall Study|Physician Decision|1|||
105411613|NCT01555073|363514630|FG001|Overall Study|Lost to Follow-up|2|||
105411614|NCT01555073|363514631|FG002|Overall Study|Lost to Follow-up|0|||
105411615|NCT01555073|363514632|FG003|Overall Study|Lost to Follow-up|5|||
105411616|NCT01500252|363514633|FG000|Overall Study|Death|4|||
105411617|NCT01500252|363514634|FG001|Overall Study|Death|2|||
105411618|NCT01500252|363514633|FG000|Overall Study|Lost to Follow-up|5|||
105411619|NCT01500252|363514634|FG001|Overall Study|Lost to Follow-up|4|||
105411620|NCT02027311|363514635|FG000|Overall Study|Protocol Violation|3|||
105411621|NCT02027311|363514636|FG001|Overall Study|Protocol Violation|2|||
105411622|NCT04599803|363514639|FG000|Overall Study|Withdrawal by Subject|5|||
105411623|NCT04599803|363514639|FG000|Overall Study|Lost to Follow-up|26|||
105581813|NCT02507219|364127903|FG001|Overall Study|Physician Decision|0|||
105411624|NCT02584452|363514644|FG000|Overall Study|Physician Decision|1|||
105411625|NCT02584452|363514645|FG001|Overall Study|Physician Decision|1|||
105411626|NCT02584452|363514644|FG000|Overall Study|Lost to Follow-up|1|||
105411627|NCT02584452|363514645|FG001|Overall Study|Lost to Follow-up|1|||
105411628|NCT01479764|363514646|FG000|Randomized|Adverse Event|1|||
105411629|NCT01479764|363514647|FG001|Randomized|Adverse Event|1|||
105411630|NCT01479764|363514646|FG000|Randomized|Withdrawal by Subject|1|||
105411631|NCT01479764|363514647|FG001|Randomized|Withdrawal by Subject|0|||
105411632|NCT01479764|363514646|FG000|Treated|Lost to Follow-up|0|||
105411633|NCT01479764|363514647|FG001|Treated|Lost to Follow-up|2|||
105411634|NCT01667133|363514648|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
105411635|NCT01667133|363514649|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
105411636|NCT01667133|363514650|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
105411637|NCT01667133|363514651|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
105411638|NCT01667133|363514652|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
105411639|NCT01667133|363514653|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
105411640|NCT01667133|363514654|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
105411641|NCT01667133|363514655|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
105411642|NCT01667133|363514656|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
105411643|NCT01667133|363514657|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
105411644|NCT01667133|363514658|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
105411645|NCT01667133|363514659|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
105495328|NCT02633501|363826310|FG002|Overall Study|Various other reasons|4|||
105495329|NCT02633501|363826311|FG003|Overall Study|Various other reasons|1|||
105495330|NCT02633501|363826312|FG004|Overall Study|Various other reasons|7|||
105495331|NCT02633501|363826313|FG005|Overall Study|Various other reasons|11|||
105411646|NCT01667133|363514648|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105411647|NCT01667133|363514649|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105411648|NCT01667133|363514650|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
105411649|NCT01667133|363514651|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105411650|NCT01667133|363514652|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105411651|NCT01667133|363514653|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105411652|NCT01667133|363514654|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105411653|NCT01667133|363514655|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105411654|NCT01667133|363514656|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105411655|NCT01667133|363514657|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105411656|NCT01667133|363514658|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105411657|NCT01667133|363514659|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105411658|NCT01667133|363514648|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
105411659|NCT01667133|363514649|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
105411660|NCT01667133|363514650|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
105411661|NCT01667133|363514651|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
105411662|NCT01667133|363514652|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
105411663|NCT01667133|363514653|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
105411664|NCT01667133|363514654|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
105411665|NCT01667133|363514655|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
105411666|NCT01667133|363514656|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
105411667|NCT01667133|363514657|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
105411668|NCT01667133|363514658|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
105411669|NCT01667133|363514659|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
105411670|NCT01667133|363514648|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105411671|NCT01667133|363514649|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105411672|NCT01667133|363514650|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105411673|NCT01667133|363514651|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
105411674|NCT01667133|363514652|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105411675|NCT01667133|363514653|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105411676|NCT01667133|363514654|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105411677|NCT01667133|363514655|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105411678|NCT01667133|363514656|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105411679|NCT01667133|363514657|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105411680|NCT01667133|363514658|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105411681|NCT01667133|363514659|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105411682|NCT01667133|363514648|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
105411683|NCT01667133|363514649|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
105411684|NCT01667133|363514650|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
105411685|NCT01667133|363514651|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
105411686|NCT01667133|363514652|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
105495332|NCT02633501|363826308|FG000|Overall Study|Lost to Follow-up|0|||
105411687|NCT01667133|363514653|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
105411688|NCT01667133|363514654|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
105411689|NCT01667133|363514655|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
105495333|NCT02633501|363826309|FG001|Overall Study|Lost to Follow-up|0|||
105411690|NCT01667133|363514656|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
105411691|NCT01667133|363514657|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
105495334|NCT02633501|363826310|FG002|Overall Study|Lost to Follow-up|0|||
105411692|NCT01667133|363514658|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
105411693|NCT01667133|363514659|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
105411694|NCT01667133|363514648|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105411695|NCT01667133|363514649|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105411696|NCT01667133|363514650|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105411697|NCT01667133|363514651|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105411698|NCT01667133|363514652|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105411699|NCT01667133|363514653|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105411700|NCT01667133|363514654|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105411701|NCT01667133|363514655|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105411702|NCT01667133|363514656|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105411703|NCT01667133|363514657|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
105411704|NCT01667133|363514658|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105411705|NCT01667133|363514659|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105411706|NCT01667133|363514648|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
105411707|NCT01667133|363514649|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
105411708|NCT01667133|363514650|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
105411709|NCT01667133|363514651|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
105411710|NCT01667133|363514652|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
105411711|NCT01667133|363514653|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
105411712|NCT01667133|363514654|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
105411713|NCT01667133|363514655|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
105411714|NCT01667133|363514656|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
105411715|NCT01667133|363514657|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
105411716|NCT01667133|363514658|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
105411717|NCT01667133|363514659|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
105411718|NCT01667133|363514648|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105411719|NCT01667133|363514649|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105411720|NCT01667133|363514650|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105411721|NCT01667133|363514651|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105411722|NCT01667133|363514652|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105411723|NCT01667133|363514653|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105411724|NCT01667133|363514654|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105411725|NCT01667133|363514655|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105411726|NCT01667133|363514656|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105411727|NCT01667133|363514657|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
105411728|NCT01667133|363514658|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105411729|NCT01667133|363514659|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105411730|NCT01667133|363514648|FG000|Phase 2: Dose-expansion|Death|0|||
105411731|NCT01667133|363514649|FG001|Phase 2: Dose-expansion|Death|0|||
105411732|NCT01667133|363514650|FG002|Phase 2: Dose-expansion|Death|0|||
105411733|NCT01667133|363514651|FG003|Phase 2: Dose-expansion|Death|0|||
105411734|NCT01667133|363514652|FG004|Phase 2: Dose-expansion|Death|0|||
105411735|NCT01667133|363514653|FG005|Phase 2: Dose-expansion|Death|0|||
105411736|NCT01667133|363514654|FG006|Phase 2: Dose-expansion|Death|0|||
105411737|NCT01667133|363514655|FG007|Phase 2: Dose-expansion|Death|0|||
105411738|NCT01667133|363514656|FG008|Phase 2: Dose-expansion|Death|0|||
105411739|NCT01667133|363514657|FG009|Phase 2: Dose-expansion|Death|1|||
105411740|NCT01667133|363514658|FG010|Phase 2: Dose-expansion|Death|0|||
105411741|NCT01667133|363514659|FG011|Phase 2: Dose-expansion|Death|0|||
105411742|NCT01667133|363514648|FG000|Phase 2: Dose-expansion|Other|0|||
105495335|NCT02633501|363826311|FG003|Overall Study|Lost to Follow-up|1|||
105411743|NCT01667133|363514649|FG001|Phase 2: Dose-expansion|Other|0|||
105411744|NCT01667133|363514650|FG002|Phase 2: Dose-expansion|Other|0|||
105411745|NCT01667133|363514651|FG003|Phase 2: Dose-expansion|Other|0|||
105411746|NCT01667133|363514652|FG004|Phase 2: Dose-expansion|Other|0|||
105495336|NCT02633501|363826312|FG004|Overall Study|Lost to Follow-up|2|||
105495337|NCT02633501|363826313|FG005|Overall Study|Lost to Follow-up|0|||
105495338|NCT00395733|363826314|FG000|Period 2|Withdrawal by Subject|1|||
105495339|NCT00395733|363826315|FG001|Period 2|Withdrawal by Subject|2|||
105495340|NCT00395733|363826314|FG000|Period 2|Protocol Violation|0|||
105495341|NCT00395733|363826315|FG001|Period 2|Protocol Violation|1|||
105495342|NCT00395733|363826314|FG000|Period 2|Adverse Event|0|||
105495343|NCT00395733|363826315|FG001|Period 2|Adverse Event|2|||
105495344|NCT00395733|363826314|FG000|Period 2|Technical problems|1|||
105495345|NCT00395733|363826315|FG001|Period 2|Technical problems|0|||
105495346|NCT02787551|363826318|FG000|Core Period: 26 Weeks|Adverse Event|10|||
105495347|NCT02787551|363826319|FG001|Core Period: 26 Weeks|Adverse Event|0|||
105495348|NCT02787551|363826318|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
105495349|NCT02787551|363826319|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
105495350|NCT02787551|363826318|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
105495351|NCT02787551|363826319|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
105495352|NCT02787551|363826318|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
105495353|NCT02787551|363826319|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
105495354|NCT02787551|363826318|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
105495355|NCT02787551|363826319|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
105495356|NCT02787551|363826318|FG000|Core Period: 26 Weeks|Other than specified|3|||
105495357|NCT02787551|363826319|FG001|Core Period: 26 Weeks|Other than specified|1|||
105495358|NCT02787551|363826318|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
105495359|NCT02787551|363826319|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
105495360|NCT02787551|363826318|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
105495361|NCT02787551|363826319|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
105495362|NCT02787551|363826318|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
105495363|NCT02787551|363826319|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
105495364|NCT03799211|363826320|FG000|Overall Study|Lost to Follow-up|2|||
105495365|NCT03799211|363826321|FG001|Overall Study|Lost to Follow-up|13|||
105495366|NCT03799211|363826320|FG000|Overall Study|Withdrawal by Subject|2|||
105495367|NCT03799211|363826321|FG001|Overall Study|Withdrawal by Subject|0|||
105495368|NCT01672736|363826322|FG000|Overall Study|Available drug expired on 31 May 16|3|||
105495369|NCT01336569|363826323|FG000|Overall Study|Lost to Follow-up|4|||
105495370|NCT00464269|363826324|FG000|Overall Study|Lack of Efficacy|1|||
105495371|NCT00464269|363826325|FG001|Overall Study|Lack of Efficacy|0|||
105495372|NCT00464269|363826326|FG002|Overall Study|Lack of Efficacy|0|||
105495373|NCT00464269|363826327|FG003|Overall Study|Lack of Efficacy|0|||
105495374|NCT00464269|363826324|FG000|Overall Study|Lost to Follow-up|0|||
105495375|NCT00464269|363826325|FG001|Overall Study|Lost to Follow-up|4|||
105495376|NCT00464269|363826326|FG002|Overall Study|Lost to Follow-up|0|||
105495377|NCT00464269|363826327|FG003|Overall Study|Lost to Follow-up|1|||
105495378|NCT00464269|363826324|FG000|Overall Study|Withdrawal by Subject|0|||
105495379|NCT00464269|363826325|FG001|Overall Study|Withdrawal by Subject|2|||
105495380|NCT00464269|363826326|FG002|Overall Study|Withdrawal by Subject|1|||
105495381|NCT00464269|363826327|FG003|Overall Study|Withdrawal by Subject|1|||
105495382|NCT00464269|363826324|FG000|Overall Study|Other reason|3|||
105495383|NCT00464269|363826325|FG001|Overall Study|Other reason|3|||
105495384|NCT00464269|363826326|FG002|Overall Study|Other reason|1|||
105495385|NCT00464269|363826327|FG003|Overall Study|Other reason|1|||
105495386|NCT00464269|363826324|FG000|Overall Study|AE, serious fatal|0|||
105495387|NCT00464269|363826325|FG001|Overall Study|AE, serious fatal|0|||
105495388|NCT00464269|363826326|FG002|Overall Study|AE, serious fatal|1|||
105495389|NCT00464269|363826327|FG003|Overall Study|AE, serious fatal|1|||
105495390|NCT00464269|363826324|FG000|Overall Study|SAE, non-fatal|0|||
105495391|NCT00464269|363826325|FG001|Overall Study|SAE, non-fatal|0|||
105495392|NCT00464269|363826326|FG002|Overall Study|SAE, non-fatal|0|||
105495393|NCT00464269|363826327|FG003|Overall Study|SAE, non-fatal|1|||
105495394|NCT00464269|363826324|FG000|Overall Study|AE, non-serious non-fatal|2|||
105495395|NCT00464269|363826325|FG001|Overall Study|AE, non-serious non-fatal|8|||
105495396|NCT00464269|363826326|FG002|Overall Study|AE, non-serious non-fatal|3|||
105495397|NCT00464269|363826327|FG003|Overall Study|AE, non-serious non-fatal|4|||
105495398|NCT00464269|363826324|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
105495399|NCT00464269|363826325|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
105495400|NCT00464269|363826326|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
105495401|NCT00464269|363826327|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
105495402|NCT02149875|363826328|FG000|Overall Study|Lost to Follow-up|3|||
105495403|NCT02149875|363826329|FG001|Overall Study|Lost to Follow-up|4|||
105495404|NCT02149875|363826330|FG002|Overall Study|Lost to Follow-up|5|||
105495405|NCT02149875|363826328|FG000|Overall Study|Withdrawal by Subject|3|||
105495406|NCT02149875|363826329|FG001|Overall Study|Withdrawal by Subject|2|||
105495407|NCT02149875|363826330|FG002|Overall Study|Withdrawal by Subject|2|||
105495408|NCT02149875|363826328|FG000|Overall Study|Physician Decision|1|||
105495409|NCT02149875|363826329|FG001|Overall Study|Physician Decision|2|||
105495410|NCT02149875|363826330|FG002|Overall Study|Physician Decision|2|||
105495411|NCT01032174|363826331|FG000|Overall Study|Adverse Event|0|||
105495412|NCT01032174|363826332|FG001|Overall Study|Adverse Event|1|||
105495413|NCT03452228|363826333|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
105495414|NCT03452228|363826334|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
105495415|NCT03452228|363826335|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
105495416|NCT03452228|363826333|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
105495417|NCT03452228|363826334|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
105495418|NCT03452228|363826335|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
105495419|NCT03452228|363826333|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
105495420|NCT03452228|363826334|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
105495421|NCT03452228|363826335|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
105495422|NCT03452228|363826333|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
105495423|NCT03452228|363826334|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
105495424|NCT03452228|363826335|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
105495425|NCT02713204|363826338|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
105495426|NCT02713204|363826339|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
105495427|NCT02713204|363826340|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
105495428|NCT02713204|363826341|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
105495429|NCT02713204|363826342|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
105495430|NCT02713204|363826343|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
105495431|NCT02713204|363826344|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
105495432|NCT02713204|363826345|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
105495433|NCT02713204|363826338|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105495434|NCT02713204|363826339|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105495435|NCT02713204|363826340|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
105495436|NCT02713204|363826341|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105495437|NCT02713204|363826342|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105495438|NCT02713204|363826343|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105495439|NCT02713204|363826344|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105495440|NCT02713204|363826345|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105495441|NCT02713204|363826338|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105495442|NCT02713204|363826339|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
105495443|NCT02713204|363826340|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105495444|NCT02713204|363826341|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105495445|NCT02713204|363826342|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105495446|NCT02713204|363826343|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105495447|NCT02713204|363826344|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105495448|NCT02713204|363826345|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105495449|NCT02713204|363826338|FG000|From Week 12 up to Week 36|Adverse Event|1|||
105495450|NCT02713204|363826339|FG001|From Week 12 up to Week 36|Adverse Event|0|||
105495451|NCT02713204|363826340|FG002|From Week 12 up to Week 36|Adverse Event|0|||
105495452|NCT02713204|363826341|FG003|From Week 12 up to Week 36|Adverse Event|1|||
105495453|NCT02713204|363826342|FG004|From Week 12 up to Week 36|Adverse Event|1|||
105495454|NCT02713204|363826343|FG005|From Week 12 up to Week 36|Adverse Event|0|||
105495455|NCT02713204|363826344|FG006|From Week 12 up to Week 36|Adverse Event|2|||
105495456|NCT02713204|363826345|FG007|From Week 12 up to Week 36|Adverse Event|1|||
105495457|NCT02713204|363826338|FG000|From Week 12 up to Week 36|Death|0|||
105495458|NCT02713204|363826339|FG001|From Week 12 up to Week 36|Death|0|||
105495459|NCT02713204|363826340|FG002|From Week 12 up to Week 36|Death|0|||
105495460|NCT02713204|363826341|FG003|From Week 12 up to Week 36|Death|1|||
105495461|NCT02713204|363826342|FG004|From Week 12 up to Week 36|Death|0|||
105495462|NCT02713204|363826343|FG005|From Week 12 up to Week 36|Death|1|||
105495463|NCT02713204|363826344|FG006|From Week 12 up to Week 36|Death|0|||
105495464|NCT02713204|363826345|FG007|From Week 12 up to Week 36|Death|3|||
105495465|NCT02713204|363826338|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
105495466|NCT02713204|363826339|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
105495467|NCT02713204|363826340|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
105495468|NCT02713204|363826341|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
105495469|NCT02713204|363826342|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
105495470|NCT02713204|363826343|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
105495471|NCT02713204|363826344|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
105495472|NCT02713204|363826345|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
105581814|NCT02507219|364127904|FG002|Overall Study|Physician Decision|0|||
105495473|NCT02713204|363826338|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
105495474|NCT02713204|363826339|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
105495475|NCT02713204|363826340|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
105495476|NCT02713204|363826341|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
105495477|NCT02713204|363826342|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
105495478|NCT02713204|363826343|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
105495479|NCT02713204|363826344|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
105495480|NCT02713204|363826345|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
105495481|NCT04251273|363826348|FG000|Overall Study|Lost to Follow-up|331|||
105495482|NCT04251273|363826349|FG001|Overall Study|Lost to Follow-up|290|||
105495483|NCT02081183|363826350|FG000|Overall Study|Lost to Follow-up|0|||
105495484|NCT02081183|363826351|FG001|Overall Study|Lost to Follow-up|1|||
105495485|NCT02081183|363826350|FG000|Overall Study|Protocol Violation|1|||
105495486|NCT02081183|363826351|FG001|Overall Study|Protocol Violation|0|||
105495487|NCT02081183|363826350|FG000|Overall Study|Other|3|||
105495488|NCT02081183|363826351|FG001|Overall Study|Other|3|||
105495489|NCT01528033|363826356|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
105495490|NCT01528033|363826357|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
105411747|NCT01667133|363514653|FG005|Phase 2: Dose-expansion|Other|0|||
105411748|NCT01667133|363514654|FG006|Phase 2: Dose-expansion|Other|0|||
105411749|NCT01667133|363514655|FG007|Phase 2: Dose-expansion|Other|0|||
105411750|NCT01667133|363514656|FG008|Phase 2: Dose-expansion|Other|0|||
105411751|NCT01667133|363514657|FG009|Phase 2: Dose-expansion|Other|0|||
105411752|NCT01667133|363514658|FG010|Phase 2: Dose-expansion|Other|0|||
105411753|NCT01667133|363514659|FG011|Phase 2: Dose-expansion|Other|1|||
105411754|NCT00182078|363514665|FG000|Overall Study|Withdrawal by Subject|1|||
105411755|NCT00182078|363514666|FG001|Overall Study|Withdrawal by Subject|0|||
105411756|NCT00395486|363514667|FG000|Overall Study|Adverse Event|1|||
105411757|NCT00395486|363514668|FG001|Overall Study|Adverse Event|2|||
105411758|NCT00395486|363514667|FG000|Overall Study|Withdrawal by Subject|5|||
105411759|NCT00395486|363514668|FG001|Overall Study|Withdrawal by Subject|2|||
105411760|NCT00395486|363514667|FG000|Overall Study|Lost to Follow-up|0|||
105411761|NCT00395486|363514668|FG001|Overall Study|Lost to Follow-up|1|||
105411762|NCT01030952|363514669|FG000|Overall Study|Protocol Violation|0|||
105411763|NCT01030952|363514670|FG001|Overall Study|Protocol Violation|1|||
105411764|NCT01030952|363514669|FG000|Overall Study|Informed consent withdrawal|1|||
105411765|NCT01030952|363514670|FG001|Overall Study|Informed consent withdrawal|0|||
105411766|NCT01030952|363514669|FG000|Overall Study|Lost to Follow-up|0|||
105495491|NCT01528033|363826356|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
105495492|NCT01528033|363826357|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
105411767|NCT01030952|363514670|FG001|Overall Study|Lost to Follow-up|1|||
105411768|NCT01030952|363514669|FG000|Overall Study|Unexplained|1|||
105411769|NCT01030952|363514670|FG001|Overall Study|Unexplained|1|||
105411770|NCT01814397|363514672|FG000|Overall Study|Adverse Event|7|||
105411771|NCT01814397|363514672|FG000|Overall Study|Withdrawal by Subject|7|||
105411772|NCT02455336|363514673|FG000|Overall Study|Withdrawal by Subject|0|||
105411773|NCT02455336|363514674|FG001|Overall Study|Withdrawal by Subject|2|||
105411774|NCT02455336|363514673|FG000|Overall Study|Adverse Event|3|||
105411775|NCT02455336|363514674|FG001|Overall Study|Adverse Event|0|||
105411776|NCT02455336|363514673|FG000|Overall Study|Non-responder to treatment|2|||
105411777|NCT02455336|363514674|FG001|Overall Study|Non-responder to treatment|0|||
105411778|NCT00391430|363514675|FG000|Overall Study|Withdrawal by Subject|3|||
105411779|NCT00391430|363514676|FG001|Overall Study|Withdrawal by Subject|0|||
105411780|NCT00391430|363514677|FG002|Overall Study|Withdrawal by Subject|12|||
105411781|NCT02467192|363514680|FG000|Overall Study|Death|1|||
105411782|NCT02467192|363514680|FG000|Overall Study|revealed to have pneumonia before|2|||
105411783|NCT00958347|363514681|FG000|Overall Study|Death|43|||
105411784|NCT00958347|363514681|FG000|Overall Study|Withdrawal by Subject|23|||
105411785|NCT00958347|363514681|FG000|Overall Study|Lost to Follow-up|15|||
105411786|NCT00958347|363514681|FG000|Overall Study|revision/removal|10|||
105495493|NCT01528033|363826356|FG000|Primary Endpoint Assessment ITT|Death|2|||
105495494|NCT01528033|363826357|FG001|Primary Endpoint Assessment ITT|Death|2|||
105495495|NCT01528033|363826356|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
105495496|NCT01528033|363826357|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
105495497|NCT01528033|363826356|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
105495498|NCT01528033|363826357|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
105495499|NCT01528033|363826356|FG000|Follow Up|No data available|46|||
105495500|NCT01528033|363826357|FG001|Follow Up|No data available|44|||
105495501|NCT00543543|363826358|FG000|Base Study|Adverse Event|1|||
105495502|NCT00543543|363826359|FG001|Base Study|Adverse Event|11|||
105495503|NCT00543543|363826360|FG002|Base Study|Adverse Event|0|||
105495504|NCT00543543|363826361|FG003|Base Study|Adverse Event|5|||
105495505|NCT00543543|363826358|FG000|Base Study|Lost to Follow-up|12|||
105495506|NCT00543543|363826359|FG001|Base Study|Lost to Follow-up|749|||
105411787|NCT00958347|363514681|FG000|Overall Study|study termination|135|||
105411788|NCT04532294|363514684|FG000|Overall Study|Withdrawal by Subject|0|||
105411789|NCT04532294|363514685|FG001|Overall Study|Withdrawal by Subject|0|||
105411790|NCT04532294|363514686|FG002|Overall Study|Withdrawal by Subject|1|||
105411791|NCT04532294|363514684|FG000|Overall Study|Participants Not Dosed|0|||
105411792|NCT04532294|363514685|FG001|Overall Study|Participants Not Dosed|0|||
105411793|NCT04532294|363514686|FG002|Overall Study|Participants Not Dosed|2|||
105411794|NCT03146663|363514687|FG000|Overall Study|Did not receive study treatment|1|||
105411795|NCT03146663|363514688|FG001|Overall Study|Did not receive study treatment|1|||
105411796|NCT00673231|363514689|FG000|Overall Study|Withdrawal by Subject|14|||
105411797|NCT00673231|363514690|FG001|Overall Study|Withdrawal by Subject|10|||
105411798|NCT00673231|363514691|FG002|Overall Study|Withdrawal by Subject|8|||
105411799|NCT00673231|363514692|FG003|Overall Study|Withdrawal by Subject|6|||
105411800|NCT00673231|363514689|FG000|Overall Study|Adverse Event|6|||
105411801|NCT00673231|363514690|FG001|Overall Study|Adverse Event|5|||
105411802|NCT00673231|363514691|FG002|Overall Study|Adverse Event|9|||
105411803|NCT00673231|363514692|FG003|Overall Study|Adverse Event|6|||
105411804|NCT00673231|363514689|FG000|Overall Study|Lost to Follow-up|1|||
105411805|NCT00673231|363514690|FG001|Overall Study|Lost to Follow-up|2|||
105411806|NCT00673231|363514691|FG002|Overall Study|Lost to Follow-up|1|||
105411807|NCT00673231|363514692|FG003|Overall Study|Lost to Follow-up|2|||
105411808|NCT00673231|363514689|FG000|Overall Study|Death|0|||
105411809|NCT00673231|363514690|FG001|Overall Study|Death|0|||
105411810|NCT00673231|363514691|FG002|Overall Study|Death|1|||
105411811|NCT00673231|363514692|FG003|Overall Study|Death|0|||
105411812|NCT00673231|363514689|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
105411813|NCT00673231|363514690|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
105411814|NCT00673231|363514691|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
105411815|NCT00673231|363514692|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
105411816|NCT01831466|363514693|FG000|Overall Study|Protocol Violation|1|||
105411817|NCT01831466|363514694|FG001|Overall Study|Protocol Violation|1|||
105411818|NCT01831466|363514695|FG002|Overall Study|Protocol Violation|2|||
105411819|NCT01831466|363514696|FG003|Overall Study|Protocol Violation|0|||
105411820|NCT01831466|363514697|FG004|Overall Study|Protocol Violation|0|||
105411821|NCT01831466|363514698|FG005|Overall Study|Protocol Violation|1|||
105411822|NCT01831466|363514699|FG006|Overall Study|Protocol Violation|0|||
105411823|NCT01831466|363514700|FG007|Overall Study|Protocol Violation|0|||
105411824|NCT01831466|363514701|FG008|Overall Study|Protocol Violation|0|||
105411825|NCT01831466|363514702|FG009|Overall Study|Protocol Violation|0|||
105411826|NCT01831466|363514703|FG010|Overall Study|Protocol Violation|0|||
105411827|NCT01831466|363514704|FG011|Overall Study|Protocol Violation|0|||
105411828|NCT01831466|363514693|FG000|Overall Study|Other|2|||
105411829|NCT01831466|363514694|FG001|Overall Study|Other|3|||
105411830|NCT01831466|363514695|FG002|Overall Study|Other|2|||
105411831|NCT01831466|363514696|FG003|Overall Study|Other|2|||
105411832|NCT01831466|363514697|FG004|Overall Study|Other|2|||
105411833|NCT01831466|363514698|FG005|Overall Study|Other|1|||
105411834|NCT01831466|363514699|FG006|Overall Study|Other|0|||
105411835|NCT01831466|363514700|FG007|Overall Study|Other|0|||
105411836|NCT01831466|363514701|FG008|Overall Study|Other|0|||
105411837|NCT01831466|363514702|FG009|Overall Study|Other|0|||
105411838|NCT01831466|363514703|FG010|Overall Study|Other|0|||
105411839|NCT01831466|363514704|FG011|Overall Study|Other|0|||
105411840|NCT01831466|363514693|FG000|Overall Study|Non-compliance with study treatment|2|||
105411841|NCT01831466|363514694|FG001|Overall Study|Non-compliance with study treatment|1|||
105411842|NCT01831466|363514695|FG002|Overall Study|Non-compliance with study treatment|1|||
105411843|NCT01831466|363514696|FG003|Overall Study|Non-compliance with study treatment|0|||
105411844|NCT01831466|363514697|FG004|Overall Study|Non-compliance with study treatment|0|||
105411845|NCT01831466|363514698|FG005|Overall Study|Non-compliance with study treatment|1|||
105411846|NCT01831466|363514699|FG006|Overall Study|Non-compliance with study treatment|0|||
105411847|NCT01831466|363514700|FG007|Overall Study|Non-compliance with study treatment|0|||
105411848|NCT01831466|363514701|FG008|Overall Study|Non-compliance with study treatment|0|||
105411849|NCT01831466|363514702|FG009|Overall Study|Non-compliance with study treatment|0|||
105411850|NCT01831466|363514703|FG010|Overall Study|Non-compliance with study treatment|0|||
105411851|NCT01831466|363514704|FG011|Overall Study|Non-compliance with study treatment|0|||
105411852|NCT01831466|363514693|FG000|Overall Study|Death|0|||
105411853|NCT01831466|363514694|FG001|Overall Study|Death|1|||
105495507|NCT00543543|363826360|FG002|Base Study|Lost to Follow-up|9|||
105495508|NCT00543543|363826361|FG003|Base Study|Lost to Follow-up|701|||
105495509|NCT00543543|363826358|FG000|Base Study|Physician Decision|0|||
105495510|NCT00543543|363826359|FG001|Base Study|Physician Decision|4|||
105495511|NCT00543543|363826360|FG002|Base Study|Physician Decision|0|||
105495512|NCT00543543|363826361|FG003|Base Study|Physician Decision|7|||
105411854|NCT01831466|363514695|FG002|Overall Study|Death|0|||
105411855|NCT01831466|363514696|FG003|Overall Study|Death|0|||
105411856|NCT01831466|363514697|FG004|Overall Study|Death|0|||
105411857|NCT01831466|363514698|FG005|Overall Study|Death|0|||
105411858|NCT01831466|363514699|FG006|Overall Study|Death|0|||
105411859|NCT01831466|363514700|FG007|Overall Study|Death|0|||
105411860|NCT01831466|363514701|FG008|Overall Study|Death|0|||
105411861|NCT01831466|363514702|FG009|Overall Study|Death|0|||
105411862|NCT01831466|363514703|FG010|Overall Study|Death|0|||
105411863|NCT01831466|363514704|FG011|Overall Study|Death|0|||
105411864|NCT01831466|363514693|FG000|Overall Study|Withdrawal by Subject|6|||
105411865|NCT01831466|363514694|FG001|Overall Study|Withdrawal by Subject|3|||
105411866|NCT01831466|363514695|FG002|Overall Study|Withdrawal by Subject|3|||
105411867|NCT01831466|363514696|FG003|Overall Study|Withdrawal by Subject|3|||
105411868|NCT01831466|363514697|FG004|Overall Study|Withdrawal by Subject|3|||
105411869|NCT01831466|363514698|FG005|Overall Study|Withdrawal by Subject|5|||
105411870|NCT01831466|363514699|FG006|Overall Study|Withdrawal by Subject|0|||
105411871|NCT01831466|363514700|FG007|Overall Study|Withdrawal by Subject|0|||
105411872|NCT01831466|363514701|FG008|Overall Study|Withdrawal by Subject|0|||
105411873|NCT01831466|363514702|FG009|Overall Study|Withdrawal by Subject|1|||
105411874|NCT01831466|363514703|FG010|Overall Study|Withdrawal by Subject|0|||
105411875|NCT01831466|363514704|FG011|Overall Study|Withdrawal by Subject|1|||
105411876|NCT01831466|363514693|FG000|Overall Study|Lost to Follow-up|0|||
105411877|NCT01831466|363514694|FG001|Overall Study|Lost to Follow-up|1|||
105411878|NCT01831466|363514695|FG002|Overall Study|Lost to Follow-up|4|||
105411879|NCT01831466|363514696|FG003|Overall Study|Lost to Follow-up|2|||
105411880|NCT01831466|363514697|FG004|Overall Study|Lost to Follow-up|0|||
105411881|NCT01831466|363514698|FG005|Overall Study|Lost to Follow-up|3|||
105411882|NCT01831466|363514699|FG006|Overall Study|Lost to Follow-up|0|||
105581815|NCT02507219|364127905|FG003|Overall Study|Physician Decision|0|||
105411883|NCT01831466|363514700|FG007|Overall Study|Lost to Follow-up|0|||
105411884|NCT01831466|363514701|FG008|Overall Study|Lost to Follow-up|0|||
105411885|NCT01831466|363514702|FG009|Overall Study|Lost to Follow-up|1|||
105411886|NCT01831466|363514703|FG010|Overall Study|Lost to Follow-up|0|||
105411887|NCT01831466|363514704|FG011|Overall Study|Lost to Follow-up|1|||
105411888|NCT01831466|363514693|FG000|Overall Study|Lack of Efficacy|5|||
105411889|NCT01831466|363514694|FG001|Overall Study|Lack of Efficacy|8|||
105411890|NCT01831466|363514695|FG002|Overall Study|Lack of Efficacy|7|||
105411891|NCT01831466|363514696|FG003|Overall Study|Lack of Efficacy|6|||
105411892|NCT01831466|363514697|FG004|Overall Study|Lack of Efficacy|9|||
105411893|NCT01831466|363514698|FG005|Overall Study|Lack of Efficacy|8|||
105411894|NCT01831466|363514699|FG006|Overall Study|Lack of Efficacy|1|||
105411895|NCT01831466|363514700|FG007|Overall Study|Lack of Efficacy|1|||
105411896|NCT01831466|363514701|FG008|Overall Study|Lack of Efficacy|2|||
105411897|NCT01831466|363514702|FG009|Overall Study|Lack of Efficacy|2|||
105411898|NCT01831466|363514703|FG010|Overall Study|Lack of Efficacy|2|||
105411899|NCT01831466|363514704|FG011|Overall Study|Lack of Efficacy|0|||
105411900|NCT01831466|363514693|FG000|Overall Study|Adverse Event|0|||
105411901|NCT01831466|363514694|FG001|Overall Study|Adverse Event|0|||
105411902|NCT01831466|363514695|FG002|Overall Study|Adverse Event|4|||
105411903|NCT01831466|363514696|FG003|Overall Study|Adverse Event|6|||
105411904|NCT01831466|363514697|FG004|Overall Study|Adverse Event|3|||
105411905|NCT01831466|363514698|FG005|Overall Study|Adverse Event|7|||
105411906|NCT01831466|363514699|FG006|Overall Study|Adverse Event|0|||
105411907|NCT01831466|363514700|FG007|Overall Study|Adverse Event|1|||
105411908|NCT01831466|363514701|FG008|Overall Study|Adverse Event|1|||
105411909|NCT01831466|363514702|FG009|Overall Study|Adverse Event|1|||
105411910|NCT01831466|363514703|FG010|Overall Study|Adverse Event|0|||
105411911|NCT01831466|363514704|FG011|Overall Study|Adverse Event|2|||
105411912|NCT02218697|363514705|FG000|Overall Study|Adverse Event|0|||
105411913|NCT02218697|363514706|FG001|Overall Study|Adverse Event|2|||
105411914|NCT02218697|363514705|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
105411915|NCT02218697|363514706|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
105411916|NCT02218697|363514705|FG000|Overall Study|Withdrawal by Subject|2|||
105411917|NCT02218697|363514706|FG001|Overall Study|Withdrawal by Subject|3|||
105411918|NCT01170273|363514711|FG000|Overall Study|Lost to Follow-up|6|||
105411919|NCT01170273|363514712|FG001|Overall Study|Lost to Follow-up|8|||
105411920|NCT01170273|363514711|FG000|Overall Study|Protocol Violation|1|||
105411921|NCT01170273|363514712|FG001|Overall Study|Protocol Violation|0|||
105411922|NCT01170273|363514711|FG000|Overall Study|Death|1|||
105411923|NCT01170273|363514712|FG001|Overall Study|Death|0|||
105411924|NCT01170273|363514711|FG000|Overall Study|Adverse Event|0|||
105411925|NCT01170273|363514712|FG001|Overall Study|Adverse Event|1|||
105411926|NCT02220855|363516627|FG000|Overall Study|Adverse Event|8|||
105581816|NCT02507219|364127906|FG004|Overall Study|Physician Decision|0|||
105581817|NCT02507219|364127907|FG005|Overall Study|Physician Decision|0|||
105581818|NCT02507219|364127902|FG000|Overall Study|Withdrawal by Subject|0|||
105581819|NCT02507219|364127903|FG001|Overall Study|Withdrawal by Subject|0|||
105411927|NCT02220855|363516627|FG000|Overall Study|Disease Progression|5|||
105411928|NCT02220855|363516627|FG000|Overall Study|Withdrawal by Subject|1|||
105411929|NCT03280303|363516628|FG000|Overall Study|Death|505|||
105411930|NCT03280303|363516628|FG000|Overall Study|Study terminated by sponsor|383|||
105411931|NCT03280303|363516628|FG000|Overall Study|Other|148|||
105411932|NCT03280303|363516628|FG000|Overall Study|No longer willing to participate in study|101|||
105411933|NCT03280303|363516628|FG000|Overall Study|Lost to follow up|39|||
105411934|NCT03280303|363516628|FG000|Overall Study|Adverse Event|20|||
105411935|NCT00064259|363516629|FG000|Overall Study|Adverse Event|1|||
105411936|NCT00064259|363516630|FG001|Overall Study|Adverse Event|0|||
105411937|NCT00064259|363516631|FG002|Overall Study|Adverse Event|0|||
105411938|NCT00064259|363516632|FG003|Overall Study|Adverse Event|1|||
105411939|NCT01132651|363516634|FG000|Overall Study|Lost to Follow-up|1|||
105411940|NCT01132651|363516635|FG001|Overall Study|Lost to Follow-up|1|||
105411941|NCT02482428|363516641|FG000|Overall Study|Lost to Follow-up|4|||
105411942|NCT02482428|363516642|FG001|Overall Study|Lost to Follow-up|9|||
105411943|NCT02482428|363516643|FG002|Overall Study|Lost to Follow-up|1|||
105411944|NCT02482428|363516644|FG003|Overall Study|Lost to Follow-up|2|||
105411945|NCT02482428|363516645|FG004|Overall Study|Lost to Follow-up|4|||
105411946|NCT02482428|363516641|FG000|Overall Study|Physician Decision|0|||
105411947|NCT02482428|363516642|FG001|Overall Study|Physician Decision|0|||
105411948|NCT02482428|363516643|FG002|Overall Study|Physician Decision|0|||
105411949|NCT02482428|363516644|FG003|Overall Study|Physician Decision|0|||
105411950|NCT02482428|363516645|FG004|Overall Study|Physician Decision|1|||
105411951|NCT02482428|363516641|FG000|Overall Study|protocol deviation|1|||
105411952|NCT02482428|363516642|FG001|Overall Study|protocol deviation|1|||
105411953|NCT02482428|363516643|FG002|Overall Study|protocol deviation|0|||
105411954|NCT02482428|363516644|FG003|Overall Study|protocol deviation|0|||
105411955|NCT02482428|363516645|FG004|Overall Study|protocol deviation|0|||
105411956|NCT02482428|363516641|FG000|Overall Study|subject/guardian decision|4|||
105411957|NCT02482428|363516642|FG001|Overall Study|subject/guardian decision|2|||
105411958|NCT02482428|363516643|FG002|Overall Study|subject/guardian decision|0|||
105411959|NCT02482428|363516644|FG003|Overall Study|subject/guardian decision|0|||
105411960|NCT02482428|363516645|FG004|Overall Study|subject/guardian decision|2|||
105411961|NCT05935878|363516649|FG000|Overall Study|Death|1|||
105411962|NCT05935878|363516650|FG001|Overall Study|Death|2|||
105411963|NCT05935878|363516649|FG000|Overall Study|Withdrawal by Subject|5|||
105411964|NCT05935878|363516650|FG001|Overall Study|Withdrawal by Subject|5|||
105411965|NCT05935878|363516649|FG000|Overall Study|Revision of implant|1|||
105411966|NCT05935878|363516650|FG001|Overall Study|Revision of implant|1|||
105411967|NCT05935878|363516649|FG000|Overall Study|Mobile bearing dislocation|0|||
105411968|NCT05935878|363516650|FG001|Overall Study|Mobile bearing dislocation|1|||
105411969|NCT05924165|363516651|FG000|Overall Study|Physician Decision|2|||
105411970|NCT05924165|363516652|FG001|Overall Study|Physician Decision|3|||
105411971|NCT03037476|363516653|FG000|Overall Study|Lost to Follow-up|63|||
105411972|NCT03037476|363516654|FG001|Overall Study|Lost to Follow-up|46|||
105411973|NCT03053440|363516655|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
105411974|NCT03053440|363516656|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
105411975|NCT03053440|363516655|FG000|Overall Study|Death|18|||
105411976|NCT03053440|363516656|FG001|Overall Study|Death|14|||
105411977|NCT03053440|363516655|FG000|Overall Study|Withdrawal by Subject|9|||
105411978|NCT03053440|363516656|FG001|Overall Study|Withdrawal by Subject|8|||
105411979|NCT03053440|363516655|FG000|Overall Study|Lost to Follow-up|1|||
105411980|NCT03053440|363516656|FG001|Overall Study|Lost to Follow-up|0|||
105411981|NCT03053440|363516655|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
105411982|NCT03053440|363516656|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
105411983|NCT03053440|363516655|FG000|Overall Study|Physician Decision|2|||
105411984|NCT03053440|363516656|FG001|Overall Study|Physician Decision|1|||
105411985|NCT03053440|363516655|FG000|Overall Study|Participant Randomized but died before dosing|1|||
105411986|NCT03053440|363516656|FG001|Overall Study|Participant Randomized but died before dosing|0|||
105411987|NCT02943070|363516659|FG000|Overall Study|Physician Decision|1|||
105411988|NCT02943070|363516659|FG000|Overall Study|Adverse Event|2|||
105411989|NCT02943070|363516659|FG000|Overall Study|Death|2|||
105411990|NCT02943070|363516659|FG000|Overall Study|Withdrawal by Subject|3|||
105411991|NCT02943070|363516659|FG000|Overall Study|Lost to Follow-up|4|||
105411992|NCT02943070|363516659|FG000|Overall Study|Retreatment or TURP|13|||
105411993|NCT02943070|363516659|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
105411994|NCT00570778|363516660|FG000|Overall Study|Protocol deviation|2|||
105411995|NCT00570778|363516661|FG001|Overall Study|Protocol deviation|1|||
105411996|NCT00570778|363516662|FG002|Overall Study|Protocol deviation|2|||
105411997|NCT00570778|363516663|FG003|Overall Study|Protocol deviation|2|||
105411998|NCT00570778|363516660|FG000|Overall Study|Adverse Event|0|||
105411999|NCT00570778|363516661|FG001|Overall Study|Adverse Event|1|||
105412000|NCT00570778|363516662|FG002|Overall Study|Adverse Event|4|||
105412001|NCT00570778|363516663|FG003|Overall Study|Adverse Event|1|||
105412002|NCT00570778|363516660|FG000|Overall Study|Subject withdrew consent|0|||
105412003|NCT00570778|363516661|FG001|Overall Study|Subject withdrew consent|1|||
105495513|NCT00543543|363826358|FG000|Base Study|Protocol Violation|0|||
105495514|NCT00543543|363826359|FG001|Base Study|Protocol Violation|6|||
105495515|NCT00543543|363826360|FG002|Base Study|Protocol Violation|0|||
105495516|NCT00543543|363826361|FG003|Base Study|Protocol Violation|6|||
105495517|NCT00543543|363826358|FG000|Base Study|Withdrawal by Subject|7|||
105495518|NCT00543543|363826359|FG001|Base Study|Withdrawal by Subject|482|||
105495519|NCT00543543|363826360|FG002|Base Study|Withdrawal by Subject|5|||
105495520|NCT00543543|363826361|FG003|Base Study|Withdrawal by Subject|503|||
105412004|NCT00570778|363516662|FG002|Overall Study|Subject withdrew consent|0|||
105412005|NCT00570778|363516663|FG003|Overall Study|Subject withdrew consent|1|||
105412006|NCT00570778|363516660|FG000|Overall Study|Abnormal test procedure|1|||
105412007|NCT00570778|363516661|FG001|Overall Study|Abnormal test procedure|0|||
105412008|NCT00570778|363516662|FG002|Overall Study|Abnormal test procedure|0|||
105412009|NCT00570778|363516663|FG003|Overall Study|Abnormal test procedure|0|||
105412010|NCT00570778|363516660|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105412011|NCT00570778|363516661|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105412012|NCT00570778|363516662|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105412013|NCT00570778|363516663|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
105412014|NCT00570778|363516660|FG000|Overall Study|Lost to Follow-up|0|||
105412015|NCT00570778|363516661|FG001|Overall Study|Lost to Follow-up|0|||
105412016|NCT00570778|363516662|FG002|Overall Study|Lost to Follow-up|1|||
105412017|NCT00570778|363516663|FG003|Overall Study|Lost to Follow-up|0|||
105412018|NCT00570778|363516660|FG000|Overall Study|Subject no longer requires study drug|0|||
105412019|NCT00570778|363516661|FG001|Overall Study|Subject no longer requires study drug|1|||
105412020|NCT00570778|363516662|FG002|Overall Study|Subject no longer requires study drug|0|||
105412021|NCT00570778|363516663|FG003|Overall Study|Subject no longer requires study drug|0|||
105412022|NCT04123093|363516666|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
105412023|NCT04123093|363516667|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
105412024|NCT04123093|363516666|FG000|Phase 2|Physician Decision|0|||
105412025|NCT04123093|363516667|FG001|Phase 2|Physician Decision|1|||
105412026|NCT04123093|363516666|FG000|Phase 2|Withdrawal by Subject|0|||
105412027|NCT04123093|363516667|FG001|Phase 2|Withdrawal by Subject|1|||
105412028|NCT00654745|363516668|FG000|Overall Study|Adverse Event|12|||
105412029|NCT00654745|363516668|FG000|Overall Study|Lost to Follow-up|7|||
105412030|NCT00654745|363516668|FG000|Overall Study|Protocol Violation|11|||
105412031|NCT00654745|363516668|FG000|Overall Study|Withdrawal by Subject|10|||
105412032|NCT00654745|363516668|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
105412033|NCT03379259|363516669|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
105412034|NCT03379259|363516670|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
105412035|NCT03379259|363516671|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
105412036|NCT03379259|363516672|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
105412037|NCT03379259|363516673|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
105412038|NCT03379259|363516674|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
105412039|NCT03379259|363516669|FG000|Overall Study|Death|0|||
105412040|NCT03379259|363516670|FG001|Overall Study|Death|1|||
105412041|NCT03379259|363516671|FG002|Overall Study|Death|2|||
105412042|NCT03379259|363516672|FG003|Overall Study|Death|1|||
105412043|NCT03379259|363516673|FG004|Overall Study|Death|4|||
105412044|NCT03379259|363516674|FG005|Overall Study|Death|2|||
105412045|NCT03379259|363516669|FG000|Overall Study|Withdrawal by Subject|0|||
105412046|NCT03379259|363516670|FG001|Overall Study|Withdrawal by Subject|0|||
105412047|NCT03379259|363516671|FG002|Overall Study|Withdrawal by Subject|1|||
105412048|NCT03379259|363516672|FG003|Overall Study|Withdrawal by Subject|0|||
105412049|NCT03379259|363516673|FG004|Overall Study|Withdrawal by Subject|2|||
105412050|NCT03379259|363516674|FG005|Overall Study|Withdrawal by Subject|0|||
105412051|NCT03379259|363516669|FG000|Overall Study|Study terminated by sponsor|0|||
105412052|NCT03379259|363516670|FG001|Overall Study|Study terminated by sponsor|0|||
105412053|NCT03379259|363516671|FG002|Overall Study|Study terminated by sponsor|0|||
105412054|NCT03379259|363516672|FG003|Overall Study|Study terminated by sponsor|1|||
105412055|NCT03379259|363516673|FG004|Overall Study|Study terminated by sponsor|1|||
105412056|NCT03379259|363516674|FG005|Overall Study|Study terminated by sponsor|4|||
105412057|NCT03379259|363516669|FG000|Overall Study|Disease progression|0|||
105412058|NCT03379259|363516670|FG001|Overall Study|Disease progression|0|||
105495521|NCT00543543|363826358|FG000|Extension Study|Adverse Event|0|||
105495522|NCT00543543|363826359|FG001|Extension Study|Adverse Event|0|||
105495523|NCT00543543|363826360|FG002|Extension Study|Adverse Event|0|||
105412059|NCT03379259|363516671|FG002|Overall Study|Disease progression|0|||
105412060|NCT03379259|363516672|FG003|Overall Study|Disease progression|1|||
105412061|NCT03379259|363516673|FG004|Overall Study|Disease progression|0|||
105412062|NCT03379259|363516674|FG005|Overall Study|Disease progression|1|||
105412063|NCT03379259|363516669|FG000|Overall Study|Lost to Follow-up|0|||
105412064|NCT03379259|363516670|FG001|Overall Study|Lost to Follow-up|0|||
105412065|NCT03379259|363516671|FG002|Overall Study|Lost to Follow-up|0|||
105412066|NCT03379259|363516672|FG003|Overall Study|Lost to Follow-up|0|||
105412067|NCT03379259|363516673|FG004|Overall Study|Lost to Follow-up|1|||
105412068|NCT03379259|363516674|FG005|Overall Study|Lost to Follow-up|0|||
105495524|NCT00543543|363826361|FG003|Extension Study|Adverse Event|5|||
105495525|NCT00543543|363826358|FG000|Extension Study|Lost to Follow-up|0|||
105495526|NCT00543543|363826359|FG001|Extension Study|Lost to Follow-up|0|||
105495527|NCT00543543|363826360|FG002|Extension Study|Lost to Follow-up|0|||
105495528|NCT00543543|363826361|FG003|Extension Study|Lost to Follow-up|77|||
105495529|NCT00543543|363826358|FG000|Extension Study|Physician Decision|0|||
105495530|NCT00543543|363826359|FG001|Extension Study|Physician Decision|0|||
105495531|NCT00543543|363826360|FG002|Extension Study|Physician Decision|0|||
105495532|NCT00543543|363826361|FG003|Extension Study|Physician Decision|7|||
105495533|NCT00543543|363826358|FG000|Extension Study|Pregnancy|0|||
105495534|NCT00543543|363826359|FG001|Extension Study|Pregnancy|0|||
105495535|NCT00543543|363826360|FG002|Extension Study|Pregnancy|0|||
105495536|NCT00543543|363826361|FG003|Extension Study|Pregnancy|6|||
105495537|NCT00543543|363826358|FG000|Extension Study|Protocol Violation|0|||
105495538|NCT00543543|363826359|FG001|Extension Study|Protocol Violation|0|||
105495539|NCT00543543|363826360|FG002|Extension Study|Protocol Violation|0|||
105495540|NCT00543543|363826361|FG003|Extension Study|Protocol Violation|11|||
105495541|NCT00543543|363826358|FG000|Extension Study|Withdrawal by Subject|0|||
105495542|NCT00543543|363826359|FG001|Extension Study|Withdrawal by Subject|0|||
105495543|NCT00543543|363826360|FG002|Extension Study|Withdrawal by Subject|0|||
105495544|NCT00543543|363826361|FG003|Extension Study|Withdrawal by Subject|120|||
105495545|NCT04815031|363826363|FG000|Overall Study|No adverse event information (missing information)|33|||
105495546|NCT04502979|363826364|FG000|Overall Study|Lost to Follow-up|1|||
105495547|NCT04502979|363826365|FG001|Overall Study|Lost to Follow-up|3|||
105495548|NCT04502979|363826364|FG000|Overall Study|Withdrawal by Subject|2|||
105495549|NCT04502979|363826365|FG001|Overall Study|Withdrawal by Subject|1|||
105495550|NCT03331250|363826366|FG000|Overall Study|Withdrawal by Subject|1|||
105495551|NCT00761631|363826367|FG000|Overall Study|Parent/legal guardian request|8|||
105495552|NCT00761631|363826368|FG001|Overall Study|Parent/legal guardian request|3|||
105495553|NCT00761631|363826369|FG002|Overall Study|Parent/legal guardian request|8|||
105495554|NCT00761631|363826370|FG003|Overall Study|Parent/legal guardian request|0|||
105495555|NCT00761631|363826371|FG004|Overall Study|Parent/legal guardian request|5|||
105495556|NCT00761631|363826372|FG005|Overall Study|Parent/legal guardian request|0|||
105495557|NCT00761631|363826367|FG000|Overall Study|Lost to Follow-up|2|||
105495558|NCT00761631|363826368|FG001|Overall Study|Lost to Follow-up|4|||
105495559|NCT00761631|363826369|FG002|Overall Study|Lost to Follow-up|7|||
105495560|NCT00761631|363826370|FG003|Overall Study|Lost to Follow-up|1|||
105495561|NCT00761631|363826371|FG004|Overall Study|Lost to Follow-up|6|||
105495562|NCT00761631|363826372|FG005|Overall Study|Lost to Follow-up|1|||
105495563|NCT00761631|363826367|FG000|Overall Study|Protocol Violation|2|||
105495564|NCT00761631|363826368|FG001|Overall Study|Protocol Violation|0|||
105495565|NCT00761631|363826369|FG002|Overall Study|Protocol Violation|0|||
105495566|NCT00761631|363826370|FG003|Overall Study|Protocol Violation|1|||
105495567|NCT00761631|363826371|FG004|Overall Study|Protocol Violation|5|||
105495568|NCT00761631|363826372|FG005|Overall Study|Protocol Violation|1|||
105495569|NCT00761631|363826367|FG000|Overall Study|Randomized, not treated|1|||
105495570|NCT00761631|363826368|FG001|Overall Study|Randomized, not treated|0|||
105495571|NCT00761631|363826369|FG002|Overall Study|Randomized, not treated|0|||
105495572|NCT00761631|363826370|FG003|Overall Study|Randomized, not treated|0|||
105495573|NCT00761631|363826371|FG004|Overall Study|Randomized, not treated|0|||
105495574|NCT00761631|363826372|FG005|Overall Study|Randomized, not treated|0|||
105495575|NCT00761631|363826367|FG000|Overall Study|Failed to return|1|||
105495576|NCT00761631|363826368|FG001|Overall Study|Failed to return|0|||
105495577|NCT00761631|363826369|FG002|Overall Study|Failed to return|1|||
105495578|NCT00761631|363826370|FG003|Overall Study|Failed to return|1|||
105495579|NCT00761631|363826371|FG004|Overall Study|Failed to return|5|||
105495580|NCT00761631|363826372|FG005|Overall Study|Failed to return|2|||
105495581|NCT00761631|363826367|FG000|Overall Study|Physician Decision|1|||
105495582|NCT00761631|363826368|FG001|Overall Study|Physician Decision|0|||
105495583|NCT00761631|363826369|FG002|Overall Study|Physician Decision|0|||
105495584|NCT00761631|363826370|FG003|Overall Study|Physician Decision|0|||
105495585|NCT00761631|363826371|FG004|Overall Study|Physician Decision|0|||
105495586|NCT00761631|363826372|FG005|Overall Study|Physician Decision|0|||
105495587|NCT00761631|363826367|FG000|Overall Study|Other|0|||
105495588|NCT00761631|363826368|FG001|Overall Study|Other|0|||
105495589|NCT00761631|363826369|FG002|Overall Study|Other|0|||
105495590|NCT00761631|363826370|FG003|Overall Study|Other|0|||
105495591|NCT00761631|363826371|FG004|Overall Study|Other|1|||
105495592|NCT00761631|363826372|FG005|Overall Study|Other|1|||
105495593|NCT00289016|363826373|FG000|Overall Study|Disease Progression|29|||
105495594|NCT00289016|363826373|FG000|Overall Study|Death|2|||
105495595|NCT00289016|363826373|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
105495596|NCT00289016|363826373|FG000|Overall Study|Withdrawal by Subject|2|||
105495597|NCT00289016|363826373|FG000|Overall Study|Adverse Event|1|||
105495598|NCT00289016|363826373|FG000|Overall Study|Other|1|||
105495599|NCT03553927|363826374|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
105495600|NCT03553927|363826375|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
105495601|NCT03553927|363826374|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
105495602|NCT03553927|363826375|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
105412069|NCT03379259|363516669|FG000|Overall Study|Deteriorating condition|0|||
105412070|NCT03379259|363516670|FG001|Overall Study|Deteriorating condition|0|||
105412071|NCT03379259|363516671|FG002|Overall Study|Deteriorating condition|0|||
105412072|NCT03379259|363516672|FG003|Overall Study|Deteriorating condition|0|||
105412073|NCT03379259|363516673|FG004|Overall Study|Deteriorating condition|1|||
105412074|NCT03379259|363516674|FG005|Overall Study|Deteriorating condition|0|||
105412075|NCT00748618|363516675|FG000|Overall Study|Adverse Event|1|||
105412076|NCT00748618|363516676|FG001|Overall Study|Adverse Event|0|||
105412077|NCT00135330|363516681|FG000|Overall Study|Adverse Event|2|||
105412078|NCT00135330|363516682|FG001|Overall Study|Adverse Event|5|||
105412079|NCT00135330|363516683|FG002|Overall Study|Adverse Event|1|||
105412080|NCT00135330|363516681|FG000|Overall Study|Lost to Follow-up|0|||
105412081|NCT00135330|363516682|FG001|Overall Study|Lost to Follow-up|2|||
105412082|NCT00135330|363516683|FG002|Overall Study|Lost to Follow-up|3|||
105412083|NCT00135330|363516681|FG000|Overall Study|Physician Decision|1|||
105412084|NCT00135330|363516682|FG001|Overall Study|Physician Decision|1|||
105412085|NCT00135330|363516683|FG002|Overall Study|Physician Decision|0|||
105412086|NCT00135330|363516681|FG000|Overall Study|Protocol Violation|4|||
105412087|NCT00135330|363516682|FG001|Overall Study|Protocol Violation|3|||
105412088|NCT00135330|363516683|FG002|Overall Study|Protocol Violation|3|||
105412089|NCT00135330|363516681|FG000|Overall Study|Patient Decision|5|||
105412090|NCT00135330|363516682|FG001|Overall Study|Patient Decision|1|||
105412091|NCT00135330|363516683|FG002|Overall Study|Patient Decision|4|||
105412092|NCT00135330|363516681|FG000|Overall Study|Sponsor Decision|0|||
105412093|NCT00135330|363516682|FG001|Overall Study|Sponsor Decision|1|||
105412094|NCT00135330|363516683|FG002|Overall Study|Sponsor Decision|0|||
105412095|NCT01268046|363516684|FG000|Overall Study|Withdrawal by Subject|1|||
105412096|NCT01268046|363516685|FG001|Overall Study|Withdrawal by Subject|0|||
105412097|NCT01268046|363516686|FG002|Overall Study|Withdrawal by Subject|0|||
105412098|NCT01268046|363516687|FG003|Overall Study|Withdrawal by Subject|1|||
105412099|NCT01268046|363516684|FG000|Overall Study|Lost to Follow-up|0|||
105412100|NCT01268046|363516685|FG001|Overall Study|Lost to Follow-up|0|||
105412101|NCT01268046|363516686|FG002|Overall Study|Lost to Follow-up|1|||
105412102|NCT01268046|363516687|FG003|Overall Study|Lost to Follow-up|0|||
105412103|NCT00104416|363516689|FG000|Double-Blind Phase|Adverse Event|2|||
105412104|NCT00104416|363516690|FG001|Double-Blind Phase|Adverse Event|1|||
105412105|NCT00104416|363516691|FG002|Double-Blind Phase|Adverse Event|0|||
105412106|NCT00104416|363516692|FG003|Double-Blind Phase|Adverse Event|0|||
105412107|NCT00104416|363516693|FG004|Double-Blind Phase|Adverse Event|0|||
105412108|NCT00104416|363516689|FG000|Double-Blind Phase|Lost to Follow-up|0|||
105412109|NCT00104416|363516690|FG001|Double-Blind Phase|Lost to Follow-up|1|||
105412110|NCT00104416|363516691|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105412111|NCT00104416|363516692|FG003|Double-Blind Phase|Lost to Follow-up|0|||
105412112|NCT00104416|363516693|FG004|Double-Blind Phase|Lost to Follow-up|0|||
105412113|NCT00104416|363516689|FG000|Double-Blind Phase|Protocol Violation|0|||
105412114|NCT00104416|363516690|FG001|Double-Blind Phase|Protocol Violation|1|||
105412115|NCT00104416|363516691|FG002|Double-Blind Phase|Protocol Violation|0|||
105412116|NCT00104416|363516692|FG003|Double-Blind Phase|Protocol Violation|0|||
105412117|NCT00104416|363516693|FG004|Double-Blind Phase|Protocol Violation|0|||
105412118|NCT00104416|363516689|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
105412119|NCT00104416|363516690|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
105412120|NCT00104416|363516691|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
105412121|NCT00104416|363516692|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
105412122|NCT00104416|363516693|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
105412123|NCT00104416|363516689|FG000|Double-Blind Phase|Pregnancy|1|||
105412124|NCT00104416|363516690|FG001|Double-Blind Phase|Pregnancy|0|||
105412125|NCT00104416|363516691|FG002|Double-Blind Phase|Pregnancy|0|||
105412126|NCT00104416|363516692|FG003|Double-Blind Phase|Pregnancy|0|||
105412127|NCT00104416|363516693|FG004|Double-Blind Phase|Pregnancy|0|||
105412128|NCT00104416|363516689|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
105495603|NCT02423772|363826376|FG000|Overall Study|Lost to Follow-up|3|||
105495604|NCT02423772|363826377|FG001|Overall Study|Lost to Follow-up|3|||
105412129|NCT00104416|363516690|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
105412130|NCT00104416|363516691|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
105412131|NCT00104416|363516692|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
105412132|NCT00104416|363516693|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
105412133|NCT00104416|363516689|FG000|Continuation Phase|Adverse Event|0|||
105412134|NCT00104416|363516690|FG001|Continuation Phase|Adverse Event|0|||
105412135|NCT00104416|363516691|FG002|Continuation Phase|Adverse Event|2|||
105412136|NCT00104416|363516692|FG003|Continuation Phase|Adverse Event|0|||
105412137|NCT00104416|363516693|FG004|Continuation Phase|Adverse Event|2|||
105412138|NCT00104416|363516689|FG000|Continuation Phase|Lost to Follow-up|0|||
105412139|NCT00104416|363516690|FG001|Continuation Phase|Lost to Follow-up|0|||
105412140|NCT00104416|363516691|FG002|Continuation Phase|Lost to Follow-up|1|||
105412141|NCT00104416|363516692|FG003|Continuation Phase|Lost to Follow-up|0|||
105412142|NCT00104416|363516693|FG004|Continuation Phase|Lost to Follow-up|1|||
105412143|NCT00104416|363516689|FG000|Continuation Phase|Withdrawal by Subject|0|||
105412144|NCT00104416|363516690|FG001|Continuation Phase|Withdrawal by Subject|0|||
105495605|NCT02423772|363826376|FG000|Overall Study|Did not begin intervention|2|||
105495606|NCT02423772|363826377|FG001|Overall Study|Did not begin intervention|5|||
105495607|NCT01066000|363826384|FG000|Overall Study|Protocol Violation|4|||
105495608|NCT01066000|363826384|FG000|Overall Study|Death|3|||
105495609|NCT01066000|363826384|FG000|Overall Study|Withdrawal by Subject|1|||
105495610|NCT01066000|363826384|FG000|Overall Study|Adverse Event|1|||
105412145|NCT00104416|363516691|FG002|Continuation Phase|Withdrawal by Subject|2|||
105412146|NCT00104416|363516692|FG003|Continuation Phase|Withdrawal by Subject|1|||
105412147|NCT00104416|363516693|FG004|Continuation Phase|Withdrawal by Subject|1|||
105412148|NCT00104416|363516689|FG000|Continuation Phase|Pregnancy|0|||
105412149|NCT00104416|363516690|FG001|Continuation Phase|Pregnancy|0|||
105412150|NCT00104416|363516691|FG002|Continuation Phase|Pregnancy|1|||
105412151|NCT00104416|363516692|FG003|Continuation Phase|Pregnancy|1|||
105412152|NCT00104416|363516693|FG004|Continuation Phase|Pregnancy|0|||
105412153|NCT00104416|363516689|FG000|Continuation Phase|Non-compliance|0|||
105412154|NCT00104416|363516690|FG001|Continuation Phase|Non-compliance|0|||
105412155|NCT00104416|363516691|FG002|Continuation Phase|Non-compliance|0|||
105412156|NCT00104416|363516692|FG003|Continuation Phase|Non-compliance|0|||
105412157|NCT00104416|363516693|FG004|Continuation Phase|Non-compliance|1|||
105412158|NCT00588237|363516699|FG000|Overall Study|Evaluable for toxicity only|3|||
105412159|NCT00588237|363516699|FG000|Overall Study|Patien not treated|1|||
105412160|NCT01147250|363516700|FG000|Overall Study|Lost to Follow-up|14|||
105412161|NCT01147250|363516701|FG001|Overall Study|Lost to Follow-up|11|||
105412162|NCT01147250|363516700|FG000|Overall Study|Withdrawal by Subject|83|||
105412163|NCT01147250|363516701|FG001|Overall Study|Withdrawal by Subject|88|||
105412164|NCT01147250|363516700|FG000|Overall Study|Site termination by sponsor|13|||
105412165|NCT01147250|363516701|FG001|Overall Study|Site termination by sponsor|5|||
105412166|NCT01147250|363516700|FG000|Overall Study|Other than specified|0|||
105412167|NCT01147250|363516701|FG001|Overall Study|Other than specified|1|||
105412168|NCT01035463|363516704|FG000|Overall Study|Adverse Event|0|||
105412169|NCT01035463|363516705|FG001|Overall Study|Adverse Event|0|||
105412170|NCT01035463|363516706|FG002|Overall Study|Adverse Event|4|||
105412171|NCT01035463|363516707|FG003|Overall Study|Adverse Event|1|||
105412172|NCT01035463|363516708|FG004|Overall Study|Adverse Event|5|||
105412173|NCT01035463|363516709|FG005|Overall Study|Adverse Event|7|||
105412174|NCT01035463|363516704|FG000|Overall Study|Withdrawal by Subject|0|||
105412175|NCT01035463|363516705|FG001|Overall Study|Withdrawal by Subject|2|||
105412176|NCT01035463|363516706|FG002|Overall Study|Withdrawal by Subject|1|||
105412177|NCT01035463|363516707|FG003|Overall Study|Withdrawal by Subject|0|||
105412178|NCT01035463|363516708|FG004|Overall Study|Withdrawal by Subject|1|||
105412179|NCT01035463|363516709|FG005|Overall Study|Withdrawal by Subject|4|||
105412180|NCT01035463|363516704|FG000|Overall Study|Disease progression|0|||
105412181|NCT01035463|363516705|FG001|Overall Study|Disease progression|0|||
105412182|NCT01035463|363516706|FG002|Overall Study|Disease progression|0|||
105412183|NCT01035463|363516707|FG003|Overall Study|Disease progression|0|||
105412184|NCT01035463|363516708|FG004|Overall Study|Disease progression|0|||
105412185|NCT01035463|363516709|FG005|Overall Study|Disease progression|3|||
105412186|NCT01035463|363516704|FG000|Overall Study|Other Malignancy|0|||
105412187|NCT01035463|363516705|FG001|Overall Study|Other Malignancy|0|||
105412188|NCT01035463|363516706|FG002|Overall Study|Other Malignancy|0|||
105412189|NCT01035463|363516707|FG003|Overall Study|Other Malignancy|0|||
105412190|NCT01035463|363516708|FG004|Overall Study|Other Malignancy|0|||
105412191|NCT01035463|363516709|FG005|Overall Study|Other Malignancy|2|||
105412192|NCT01035463|363516704|FG000|Overall Study|Other|0|||
105412193|NCT01035463|363516705|FG001|Overall Study|Other|0|||
105412194|NCT01035463|363516706|FG002|Overall Study|Other|0|||
105412195|NCT01035463|363516707|FG003|Overall Study|Other|1|||
105412196|NCT01035463|363516708|FG004|Overall Study|Other|0|||
105412197|NCT01035463|363516709|FG005|Overall Study|Other|2|||
105412198|NCT02858440|363516712|FG000|Overall Study|Lost to Follow-up|3|||
105412199|NCT02858440|363516712|FG000|Overall Study|Protocol Violation|2|||
105412200|NCT02858440|363516712|FG000|Overall Study|Consent withdrawal|3|||
105495611|NCT01386008|363826385|FG000|Overall Study|exited w/o incident /study discontinued|17|||
105495612|NCT01386008|363826385|FG000|Overall Study|Adverse Event|3|||
105495613|NCT00257608|363827873|FG000|Chemotherapy Phase|Adverse Event|138|||
105412201|NCT02858440|363516712|FG000|Overall Study|Migrated/moved from study area|4|||
105412202|NCT03629223|363516713|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
105412203|NCT03629223|363516714|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
105412204|NCT03629223|363516715|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
105412205|NCT03629223|363516716|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
105412206|NCT03629223|363516717|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
105412207|NCT03629223|363516718|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
105412208|NCT03629223|363516713|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
105412209|NCT03629223|363516714|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
105412210|NCT03629223|363516715|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
105412211|NCT03629223|363516716|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
105412212|NCT03629223|363516717|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
105412213|NCT03629223|363516718|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
105495614|NCT00257608|363827874|FG001|Chemotherapy Phase|Adverse Event|0|||
105495615|NCT00257608|363827875|FG002|Chemotherapy Phase|Adverse Event|0|||
105495616|NCT00257608|363827873|FG000|Chemotherapy Phase|Disease progression|139|||
105495617|NCT00257608|363827874|FG001|Chemotherapy Phase|Disease progression|0|||
105495618|NCT00257608|363827875|FG002|Chemotherapy Phase|Disease progression|0|||
105495619|NCT00257608|363827873|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
105495620|NCT00257608|363827874|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
105495621|NCT00257608|363827875|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
105495622|NCT00257608|363827873|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
105495623|NCT00257608|363827874|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
105495624|NCT00257608|363827875|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
105495625|NCT00257608|363827873|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
105495626|NCT00257608|363827874|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
105495627|NCT00257608|363827875|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
105495628|NCT00257608|363827873|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
105495629|NCT00257608|363827874|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
105495630|NCT00257608|363827875|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
105495631|NCT00257608|363827873|FG000|Chemotherapy Phase|Physician Decision|28|||
105495632|NCT00257608|363827874|FG001|Chemotherapy Phase|Physician Decision|0|||
105495633|NCT00257608|363827875|FG002|Chemotherapy Phase|Physician Decision|0|||
105495634|NCT00257608|363827873|FG000|Post Chemotherapy Phase|Adverse Event|0|||
105495635|NCT00257608|363827874|FG001|Post Chemotherapy Phase|Adverse Event|34|||
105495636|NCT00257608|363827875|FG002|Post Chemotherapy Phase|Adverse Event|38|||
105495637|NCT00257608|363827873|FG000|Post Chemotherapy Phase|Disease progression|0|||
105495638|NCT00257608|363827874|FG001|Post Chemotherapy Phase|Disease progression|204|||
105495639|NCT00257608|363827875|FG002|Post Chemotherapy Phase|Disease progression|168|||
105495640|NCT00257608|363827873|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
105495641|NCT00257608|363827874|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
105495642|NCT00257608|363827875|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
105495643|NCT00257608|363827873|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
105495644|NCT00257608|363827874|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
105495645|NCT00257608|363827875|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
105495646|NCT00257608|363827873|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
105495647|NCT00257608|363827874|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
105495648|NCT00257608|363827875|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
105495649|NCT00257608|363827873|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
105495650|NCT00257608|363827874|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
105495651|NCT00257608|363827875|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
105495652|NCT00257608|363827873|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
105495653|NCT00257608|363827874|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
105495654|NCT00257608|363827875|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
105495655|NCT00257608|363827873|FG000|Post Chemotherapy Phase|Physician Decision|0|||
105495656|NCT00257608|363827874|FG001|Post Chemotherapy Phase|Physician Decision|8|||
105495657|NCT00257608|363827875|FG002|Post Chemotherapy Phase|Physician Decision|11|||
105495658|NCT00257608|363827873|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
105495659|NCT00257608|363827874|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
105495660|NCT00257608|363827875|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
105495661|NCT00257608|363827873|FG000|Post Chemotherapy Phase|Not treated|0|||
105495662|NCT00257608|363827874|FG001|Post Chemotherapy Phase|Not treated|4|||
105495663|NCT00257608|363827875|FG002|Post Chemotherapy Phase|Not treated|7|||
105495664|NCT01846104|363827877|FG000|Overall Study|Withdrawal by Subject|1|||
105495665|NCT02349061|363827879|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
105495666|NCT02349061|363827880|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
105495667|NCT02349061|363827881|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
105495668|NCT02349061|363827879|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
105495669|NCT02349061|363827880|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
105495670|NCT02349061|363827881|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
105495671|NCT02349061|363827879|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
105495672|NCT02349061|363827880|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
105495673|NCT02349061|363827881|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
105495674|NCT02349061|363827879|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
105495675|NCT02349061|363827880|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
105495676|NCT02349061|363827881|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
105495677|NCT02349061|363827879|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
105495678|NCT02349061|363827880|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
105412214|NCT03629223|363516713|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
105412215|NCT03629223|363516714|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
105412216|NCT03629223|363516715|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
105412217|NCT03629223|363516716|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
105412218|NCT03629223|363516717|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
105412219|NCT03629223|363516718|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
105412220|NCT03629223|363516713|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
105412221|NCT03629223|363516714|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
105412222|NCT03629223|363516715|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
105412223|NCT03629223|363516716|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
105412224|NCT03629223|363516717|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
105412225|NCT03629223|363516718|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
105412226|NCT03629223|363516713|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
105412227|NCT03629223|363516714|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
105412228|NCT03629223|363516715|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
105412229|NCT03629223|363516716|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
105412230|NCT03629223|363516717|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
105412231|NCT03629223|363516718|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
105412232|NCT04153981|363516719|FG000|Overall Study|Death|1|||
105412233|NCT04153981|363516719|FG000|Overall Study|Withdrawal by Subject|24|||
105412234|NCT04153981|363516719|FG000|Overall Study|Lost to Follow-up|1|||
105412235|NCT04153981|363516719|FG000|Overall Study|Physician Decision|1|||
105412236|NCT04153981|363516719|FG000|Overall Study|Due to Unavailable Glucometer|1|||
105412237|NCT04153981|363516719|FG000|Overall Study|Covid 19|52|||
105412238|NCT04153981|363516719|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
105412239|NCT04153981|363516719|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
105412240|NCT01355679|363516720|FG000|Overall Study|benign tumor types found at biopsy|2|||
105412241|NCT03490292|363516721|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
105412242|NCT03490292|363516722|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
105412243|NCT03490292|363516721|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
105412244|NCT03490292|363516722|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
105412245|NCT03490292|363516721|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
105412246|NCT03490292|363516722|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
105412247|NCT03490292|363516721|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
105412248|NCT03490292|363516722|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
105412249|NCT03490292|363516721|FG000|1 Year Follow Up Post Last Dose|Death|1|||
105412250|NCT03490292|363516722|FG001|1 Year Follow Up Post Last Dose|Death|1|||
105412251|NCT00904670|363516723|FG000|Open Label Phase|Withdrawal by Subject|2|||
105412252|NCT00904670|363516724|FG001|Open Label Phase|Withdrawal by Subject|0|||
105412253|NCT00904670|363516723|FG000|Open Label Phase|Adverse Event|2|||
105412254|NCT00904670|363516724|FG001|Open Label Phase|Adverse Event|0|||
105412255|NCT00904670|363516723|FG000|Open Label Phase|Lack of Efficacy|1|||
105412256|NCT00904670|363516724|FG001|Open Label Phase|Lack of Efficacy|0|||
105412257|NCT00904670|363516723|FG000|Open Label Phase|Lost to Follow-up|1|||
105412258|NCT00904670|363516724|FG001|Open Label Phase|Lost to Follow-up|0|||
105412259|NCT03768089|363516725|FG000|Part A|Lost to Follow-up|0|||
105412260|NCT03768089|363516726|FG001|Part A|Lost to Follow-up|0|||
105412261|NCT03768089|363516727|FG002|Part A|Lost to Follow-up|0|||
105412262|NCT03768089|363516728|FG003|Part A|Lost to Follow-up|0|||
105412263|NCT03768089|363516729|FG004|Part A|Lost to Follow-up|1|||
105412264|NCT03768089|363516730|FG005|Part A|Lost to Follow-up|0|||
105412265|NCT03768089|363516731|FG006|Part A|Lost to Follow-up|0|||
105412266|NCT03768089|363516732|FG007|Part A|Lost to Follow-up|0|||
105412267|NCT03768089|363516733|FG008|Part A|Lost to Follow-up|0|||
105412268|NCT03768089|363516734|FG009|Part A|Lost to Follow-up|0|||
105412269|NCT03768089|363516735|FG010|Part A|Lost to Follow-up|0|||
105412270|NCT03768089|363516736|FG011|Part A|Lost to Follow-up|0|||
105412271|NCT03768089|363516737|FG012|Part A|Lost to Follow-up|0|||
105412272|NCT03768089|363516738|FG013|Part A|Lost to Follow-up|0|||
105412273|NCT03768089|363516739|FG014|Part A|Lost to Follow-up|0|||
105412274|NCT03768089|363516740|FG015|Part A|Lost to Follow-up|0|||
105412275|NCT03768089|363516741|FG016|Part A|Lost to Follow-up|0|||
105412276|NCT03768089|363516742|FG017|Part A|Lost to Follow-up|0|||
105412277|NCT03768089|363516725|FG000|Part C|Randomized, Never Dosed|0|||
105412278|NCT03768089|363516726|FG001|Part C|Randomized, Never Dosed|0|||
105412279|NCT03768089|363516727|FG002|Part C|Randomized, Never Dosed|0|||
105412280|NCT03768089|363516728|FG003|Part C|Randomized, Never Dosed|0|||
105412281|NCT03768089|363516729|FG004|Part C|Randomized, Never Dosed|0|||
105412282|NCT03768089|363516730|FG005|Part C|Randomized, Never Dosed|0|||
105412283|NCT03768089|363516731|FG006|Part C|Randomized, Never Dosed|0|||
105412284|NCT03768089|363516732|FG007|Part C|Randomized, Never Dosed|0|||
105412285|NCT03768089|363516733|FG008|Part C|Randomized, Never Dosed|0|||
105412286|NCT03768089|363516734|FG009|Part C|Randomized, Never Dosed|0|||
105412287|NCT03768089|363516735|FG010|Part C|Randomized, Never Dosed|0|||
105495679|NCT02349061|363827881|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
105495680|NCT02349061|363827879|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
105495681|NCT02349061|363827880|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
105495682|NCT02349061|363827881|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
105495683|NCT02349061|363827879|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
105495684|NCT02349061|363827880|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
105495685|NCT02349061|363827881|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
105581820|NCT02507219|364127904|FG002|Overall Study|Withdrawal by Subject|0|||
105581821|NCT02507219|364127905|FG003|Overall Study|Withdrawal by Subject|0|||
105581822|NCT02507219|364127906|FG004|Overall Study|Withdrawal by Subject|1|||
105581823|NCT02507219|364127907|FG005|Overall Study|Withdrawal by Subject|0|||
105581824|NCT02886936|364127908|FG000|Overall Study|Lost to Follow-up|4|||
105581825|NCT02886936|364127909|FG001|Overall Study|Lost to Follow-up|3|||
105581826|NCT02886936|364127910|FG002|Overall Study|Lost to Follow-up|0|||
105581827|NCT04562779|364127911|FG000|Overall Study|Lost to Follow-up|7|||
105581828|NCT04562779|364127912|FG001|Overall Study|Lost to Follow-up|5|||
105581829|NCT04562779|364127913|FG002|Overall Study|Lost to Follow-up|10|||
105581830|NCT04562779|364127911|FG000|Overall Study|Protocol Violation|2|||
105581831|NCT04562779|364127912|FG001|Overall Study|Protocol Violation|2|||
105581832|NCT04562779|364127913|FG002|Overall Study|Protocol Violation|0|||
105581833|NCT00333138|364127914|FG000|Core Study (6 Months)|Adverse Event|4|||
105581834|NCT00333138|364127915|FG001|Core Study (6 Months)|Adverse Event|5|||
105581835|NCT00333138|364127916|FG002|Core Study (6 Months)|Adverse Event|8|||
105581836|NCT00333138|364127914|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
105581837|NCT00333138|364127915|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
105581838|NCT00333138|364127916|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
105581839|NCT00333138|364127914|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
105581840|NCT00333138|364127915|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
105581841|NCT00333138|364127916|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
105581842|NCT00333138|364127914|FG000|Core Study (6 Months)|Protocol Violation|1|||
105581843|NCT00333138|364127915|FG001|Core Study (6 Months)|Protocol Violation|0|||
105581844|NCT00333138|364127916|FG002|Core Study (6 Months)|Protocol Violation|1|||
105581845|NCT00333138|364127914|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
105581846|NCT00333138|364127915|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
105581847|NCT00333138|364127916|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
105581848|NCT00333138|364127914|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
105581849|NCT00333138|364127915|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
105581850|NCT00333138|364127916|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
105581851|NCT00333138|364127914|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
105581852|NCT00333138|364127915|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
105581853|NCT00333138|364127916|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
105581854|NCT00333138|364127914|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
105581855|NCT00333138|364127915|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
105581856|NCT00333138|364127916|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
105581857|NCT00333138|364127914|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
105581858|NCT00333138|364127915|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
105581859|NCT00333138|364127916|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
105581860|NCT00333138|364127914|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
105581861|NCT00333138|364127915|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
105581862|NCT00333138|364127916|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
105581863|NCT00333138|364127914|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
105581864|NCT00333138|364127915|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
105581865|NCT00333138|364127916|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
105581866|NCT00333138|364127914|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
105581867|NCT00333138|364127915|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
105581868|NCT00333138|364127916|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
105581869|NCT00333138|364127914|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
105495686|NCT02349061|363827879|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
105495687|NCT02349061|363827880|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
105581870|NCT00333138|364127915|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
105581871|NCT00333138|364127916|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
105581872|NCT00333138|364127914|FG000|Extension Study (Month6 to End of Study)|Death|0|||
105581873|NCT00333138|364127915|FG001|Extension Study (Month6 to End of Study)|Death|1|||
105412288|NCT03768089|363516736|FG011|Part C|Randomized, Never Dosed|0|||
105412289|NCT03768089|363516737|FG012|Part C|Randomized, Never Dosed|0|||
105412290|NCT03768089|363516738|FG013|Part C|Randomized, Never Dosed|0|||
105412291|NCT03768089|363516739|FG014|Part C|Randomized, Never Dosed|1|||
105412292|NCT03768089|363516740|FG015|Part C|Randomized, Never Dosed|0|||
105412293|NCT03768089|363516741|FG016|Part C|Randomized, Never Dosed|0|||
105412294|NCT03768089|363516742|FG017|Part C|Randomized, Never Dosed|0|||
105412295|NCT00286091|363516753|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
105412296|NCT00286091|363516754|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
105412297|NCT00286091|363516753|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
105412298|NCT00286091|363516754|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
105412299|NCT00286091|363516753|FG000|Double-blind Treatment Phase|Death|58|||
105412300|NCT00286091|363516754|FG001|Double-blind Treatment Phase|Death|65|||
105412301|NCT00286091|363516753|FG000|Double-blind Treatment Phase|Adverse Event|28|||
105412302|NCT00286091|363516754|FG001|Double-blind Treatment Phase|Adverse Event|40|||
105412303|NCT00286091|363516753|FG000|Double-blind Treatment Phase|Disease Progression|22|||
105412304|NCT00286091|363516754|FG001|Double-blind Treatment Phase|Disease Progression|35|||
105412305|NCT00286091|363516753|FG000|Double-blind Treatment Phase|Other|25|||
105412306|NCT00286091|363516754|FG001|Double-blind Treatment Phase|Other|33|||
105412307|NCT00286091|363516753|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
105412308|NCT00286091|363516754|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
105412309|NCT00286091|363516753|FG000|Double-blind Treatment Phase|Noncompliance|8|||
105412310|NCT00286091|363516754|FG001|Double-blind Treatment Phase|Noncompliance|8|||
105412311|NCT00286091|363516753|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
105412312|NCT00286091|363516754|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
105412313|NCT00286091|363516753|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
105412314|NCT00286091|363516754|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
105412315|NCT00286091|363516753|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
105412316|NCT00286091|363516754|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
105412317|NCT00286091|363516753|FG000|Open-label Treatment Phase|Physician Decision|24|||
105412318|NCT00286091|363516754|FG001|Open-label Treatment Phase|Physician Decision|21|||
105412319|NCT00286091|363516753|FG000|Open-label Treatment Phase|Adverse Event|5|||
105412320|NCT00286091|363516754|FG001|Open-label Treatment Phase|Adverse Event|16|||
105412321|NCT00286091|363516753|FG000|Open-label Treatment Phase|Other|11|||
105412322|NCT00286091|363516754|FG001|Open-label Treatment Phase|Other|11|||
105412323|NCT00286091|363516753|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
105412324|NCT00286091|363516754|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
105412325|NCT00286091|363516753|FG000|Open-label Treatment Phase|Death|10|||
105412326|NCT00286091|363516754|FG001|Open-label Treatment Phase|Death|7|||
105412327|NCT00286091|363516753|FG000|Open-label Treatment Phase|Disease Progression|9|||
105412328|NCT00286091|363516754|FG001|Open-label Treatment Phase|Disease Progression|3|||
105412329|NCT00286091|363516753|FG000|Open-label Treatment Phase|Noncompliance|3|||
105412330|NCT00286091|363516754|FG001|Open-label Treatment Phase|Noncompliance|1|||
105412331|NCT00286091|363516753|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
105412332|NCT00286091|363516754|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
105412333|NCT00286091|363516753|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
105412334|NCT00286091|363516754|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
105412335|NCT00286091|363516753|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
105412336|NCT00286091|363516754|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
105412337|NCT03423238|363516755|FG000|Overall Study|Lost to Follow-up|1|||
105412338|NCT03423238|363516756|FG001|Overall Study|Lost to Follow-up|0|||
105412339|NCT03423238|363516755|FG000|Overall Study|Withdrawal by Subject|1|||
105412340|NCT03423238|363516756|FG001|Overall Study|Withdrawal by Subject|0|||
105412341|NCT00851552|363516757|FG000|Overall Study|Death|2|||
105412342|NCT00851552|363516757|FG000|Overall Study|Adverse Event|1|||
105412343|NCT00851552|363516757|FG000|Overall Study|Disease Progression|4|||
105412344|NCT02689206|363516758|FG000|Overall Study|Adverse Event|0|||
105412345|NCT02689206|363516759|FG001|Overall Study|Adverse Event|0|||
105412346|NCT02689206|363516760|FG002|Overall Study|Adverse Event|1|||
105412347|NCT02689206|363516761|FG003|Overall Study|Adverse Event|0|||
105412348|NCT02689206|363516762|FG004|Overall Study|Adverse Event|2|||
105412349|NCT02689206|363516758|FG000|Overall Study|Protocol Violation|1|||
105412350|NCT02689206|363516759|FG001|Overall Study|Protocol Violation|0|||
105412351|NCT02689206|363516760|FG002|Overall Study|Protocol Violation|0|||
105412352|NCT02689206|363516761|FG003|Overall Study|Protocol Violation|1|||
105412353|NCT02689206|363516762|FG004|Overall Study|Protocol Violation|2|||
105412354|NCT02689206|363516758|FG000|Overall Study|Other: Reached stopping criteria|0|||
105412355|NCT02689206|363516759|FG001|Overall Study|Other: Reached stopping criteria|1|||
105412356|NCT02689206|363516760|FG002|Overall Study|Other: Reached stopping criteria|2|||
105412357|NCT02689206|363516761|FG003|Overall Study|Other: Reached stopping criteria|3|||
105412358|NCT02689206|363516762|FG004|Overall Study|Other: Reached stopping criteria|4|||
105412359|NCT02689206|363516758|FG000|Overall Study|Physician Decision|1|||
105412360|NCT02689206|363516759|FG001|Overall Study|Physician Decision|0|||
105412361|NCT02689206|363516760|FG002|Overall Study|Physician Decision|0|||
105412362|NCT02689206|363516761|FG003|Overall Study|Physician Decision|0|||
105412363|NCT02689206|363516762|FG004|Overall Study|Physician Decision|0|||
105412364|NCT02689206|363516758|FG000|Overall Study|Withdrawal by Subject|1|||
105412365|NCT02689206|363516759|FG001|Overall Study|Withdrawal by Subject|0|||
105412366|NCT02689206|363516760|FG002|Overall Study|Withdrawal by Subject|1|||
105412367|NCT02689206|363516761|FG003|Overall Study|Withdrawal by Subject|0|||
105412368|NCT02689206|363516762|FG004|Overall Study|Withdrawal by Subject|0|||
105412369|NCT01606176|363516763|FG000|Overall Study|Adverse Event|2|||
105412370|NCT01606176|363516764|FG001|Overall Study|Adverse Event|3|||
105412371|NCT01606176|363516763|FG000|Overall Study|Disease progression|1|||
105412372|NCT01606176|363516764|FG001|Overall Study|Disease progression|0|||
105412373|NCT01606176|363516763|FG000|Overall Study|Withdrawal by Subject|1|||
105412374|NCT01606176|363516764|FG001|Overall Study|Withdrawal by Subject|0|||
105412375|NCT01076205|363516765|FG000|Overall Study|Adverse Drug Reaction|299|||
105412376|NCT01076205|363516765|FG000|Overall Study|Lack of Effectiveness|1423|||
105412377|NCT01076205|363516765|FG000|Overall Study|Other Reason|1075|||
105412378|NCT01076205|363516765|FG000|Overall Study|Unknown Reason|71|||
105412379|NCT01076205|363516765|FG000|Overall Study|Lost to Follow-up|3151|||
105412380|NCT01832493|363516766|FG000|Overall Study|Physician Decision|2|||
105412381|NCT01832493|363516766|FG000|Overall Study|Protocol Violation|4|||
105412382|NCT01832493|363516766|FG000|Overall Study|Unable to place LV lead|2|||
105412383|NCT02993822|363516767|FG000|Overall Study|Lack of Efficacy|1|||
105412384|NCT02993822|363516768|FG001|Overall Study|Lack of Efficacy|1|||
105412385|NCT02993822|363516769|FG002|Overall Study|Lack of Efficacy|0|||
105412386|NCT02993822|363516770|FG003|Overall Study|Lack of Efficacy|0|||
105412387|NCT02993822|363516767|FG000|Overall Study|Protocol Violation|1|||
105412388|NCT02993822|363516768|FG001|Overall Study|Protocol Violation|0|||
105412389|NCT02993822|363516769|FG002|Overall Study|Protocol Violation|0|||
105412390|NCT02993822|363516770|FG003|Overall Study|Protocol Violation|0|||
105412391|NCT02993822|363516767|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
105412392|NCT02993822|363516768|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
105412393|NCT02993822|363516769|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
105412394|NCT02993822|363516770|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
105412395|NCT02993822|363516767|FG000|Overall Study|Adverse Event|3|||
105412396|NCT02993822|363516768|FG001|Overall Study|Adverse Event|1|||
105412397|NCT02993822|363516769|FG002|Overall Study|Adverse Event|7|||
105412398|NCT02993822|363516770|FG003|Overall Study|Adverse Event|0|||
105412399|NCT02993822|363516767|FG000|Overall Study|Withdrawal by Subject|4|||
105412400|NCT02993822|363516768|FG001|Overall Study|Withdrawal by Subject|2|||
105412401|NCT02993822|363516769|FG002|Overall Study|Withdrawal by Subject|2|||
105412402|NCT02993822|363516770|FG003|Overall Study|Withdrawal by Subject|3|||
105412403|NCT02993822|363516767|FG000|Overall Study|Lost to Follow-up|1|||
105412404|NCT02993822|363516768|FG001|Overall Study|Lost to Follow-up|0|||
105412405|NCT02993822|363516769|FG002|Overall Study|Lost to Follow-up|1|||
105412406|NCT02993822|363516770|FG003|Overall Study|Lost to Follow-up|0|||
105581874|NCT00333138|364127916|FG002|Extension Study (Month6 to End of Study)|Death|0|||
105412408|NCT02241733|363516777|FG000|Overall Study|Lost to Follow-up|9|||
105412409|NCT02241733|363516778|FG001|Overall Study|Lost to Follow-up|4|||
105412410|NCT02241733|363516777|FG000|Overall Study|Physician Decision|6|||
105412411|NCT02241733|363516778|FG001|Overall Study|Physician Decision|2|||
105412412|NCT02241733|363516777|FG000|Overall Study|Withdrawal by Subject|0|||
105412413|NCT02241733|363516778|FG001|Overall Study|Withdrawal by Subject|2|||
105412414|NCT02241733|363516777|FG000|Overall Study|Death|0|||
105412415|NCT02241733|363516778|FG001|Overall Study|Death|2|||
105412416|NCT02485639|363516787|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
105412417|NCT02485639|363516787|FG000|Overall Study|Early termination|4|||
105412418|NCT02485639|363516787|FG000|Overall Study|Withdrawal by Subject|4|||
105412419|NCT04621240|363516788|FG000|Overall Study|Withdrawal by Subject|36|||
105412420|NCT01659996|363516789|FG000|Overall Study|Protocol Violation|3|||
105412421|NCT01659996|363516790|FG001|Overall Study|Protocol Violation|3|||
105412422|NCT01659996|363516791|FG002|Overall Study|Protocol Violation|3|||
105412423|NCT01659996|363516789|FG000|Overall Study|Lost to Follow-up|1|||
105412424|NCT01659996|363516790|FG001|Overall Study|Lost to Follow-up|3|||
105412425|NCT01659996|363516791|FG002|Overall Study|Lost to Follow-up|2|||
105412426|NCT01659996|363516789|FG000|Overall Study|Adverse Event|0|||
105412427|NCT01659996|363516790|FG001|Overall Study|Adverse Event|0|||
105412428|NCT01659996|363516791|FG002|Overall Study|Adverse Event|1|||
105412429|NCT01659996|363516789|FG000|Overall Study|Withdrawal by Subject|4|||
105412430|NCT01659996|363516790|FG001|Overall Study|Withdrawal by Subject|1|||
105412431|NCT01659996|363516791|FG002|Overall Study|Withdrawal by Subject|5|||
105412432|NCT02709577|363516792|FG000|Overall Study|non-accommodating anatomy|0|||
105412433|NCT02709577|363516793|FG001|Overall Study|non-accommodating anatomy|1|||
105412434|NCT02709577|363516794|FG002|Overall Study|non-accommodating anatomy|0|||
105412435|NCT02709577|363516795|FG003|Overall Study|non-accommodating anatomy|0|||
105412436|NCT02709577|363516792|FG000|Overall Study|procedural complication|0|||
105412437|NCT02709577|363516793|FG001|Overall Study|procedural complication|1|||
105412438|NCT02709577|363516794|FG002|Overall Study|procedural complication|0|||
105412439|NCT02709577|363516795|FG003|Overall Study|procedural complication|0|||
105412440|NCT02709577|363516792|FG000|Overall Study|Withdrawal by Subject|2|||
105412441|NCT02709577|363516793|FG001|Overall Study|Withdrawal by Subject|3|||
105412442|NCT02709577|363516794|FG002|Overall Study|Withdrawal by Subject|2|||
105412443|NCT02709577|363516795|FG003|Overall Study|Withdrawal by Subject|0|||
105412444|NCT05959447|363518465|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
105581875|NCT02320721|364127918|FG000|Overall Study|Adverse Event|6|||
105581876|NCT02320721|364127919|FG001|Overall Study|Adverse Event|6|||
105581877|NCT02320721|364127918|FG000|Overall Study|Lack of Efficacy|2|||
105581878|NCT02320721|364127919|FG001|Overall Study|Lack of Efficacy|0|||
105581879|NCT02320721|364127918|FG000|Overall Study|Poor compliance to protocol|3|||
105581880|NCT02320721|364127919|FG001|Overall Study|Poor compliance to protocol|7|||
105581881|NCT02320721|364127918|FG000|Overall Study|Randomized but not treated|0|||
105581882|NCT02320721|364127919|FG001|Overall Study|Randomized but not treated|1|||
105581883|NCT02320721|364127918|FG000|Overall Study|Hypoglycemia|1|||
105581884|NCT02320721|364127919|FG001|Overall Study|Hypoglycemia|0|||
105581885|NCT02320721|364127918|FG000|Overall Study|Other than specified above|15|||
105581886|NCT02320721|364127919|FG001|Overall Study|Other than specified above|20|||
105581887|NCT04630756|364127924|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
105581888|NCT04630756|364127925|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
105581889|NCT04630756|364127926|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
105581890|NCT04131907|364127927|FG000|Overall Study|Adverse Event|2|||
105581891|NCT04131907|364127928|FG001|Overall Study|Adverse Event|0|||
105581892|NCT04131907|364127929|FG002|Overall Study|Adverse Event|0|||
105581893|NCT04131907|364127927|FG000|Overall Study|Physician Decision|4|||
105581894|NCT04131907|364127928|FG001|Overall Study|Physician Decision|22|||
105581895|NCT04131907|364127929|FG002|Overall Study|Physician Decision|0|||
105581896|NCT04131907|364127927|FG000|Overall Study|Withdrawal by Subject|2|||
105581897|NCT04131907|364127928|FG001|Overall Study|Withdrawal by Subject|0|||
105581898|NCT04131907|364127929|FG002|Overall Study|Withdrawal by Subject|1|||
105581899|NCT04131907|364127927|FG000|Overall Study|Treatment failure|2|||
105581900|NCT04131907|364127928|FG001|Overall Study|Treatment failure|0|||
105581901|NCT04131907|364127929|FG002|Overall Study|Treatment failure|1|||
105581902|NCT00847301|364127930|FG000|Overall Study|Adverse Event|35|||
105581903|NCT00847301|364127930|FG000|Overall Study|Switch to other anticoagulants|16|||
105581904|NCT00847301|364127930|FG000|Overall Study|Lost to Follow-up|1|||
105581905|NCT00847301|364127930|FG000|Overall Study|No prescription after hospital discharge|1|||
105581906|NCT00847301|364127930|FG000|Overall Study|Other reason not defined above|1|||
105581907|NCT04248465|364127931|FG000|Randomized-Controlled Period|Death|12|||
105581908|NCT04248465|364127932|FG001|Randomized-Controlled Period|Death|5|||
105581909|NCT04248465|364127931|FG000|Randomized-Controlled Period|Adverse Event|2|||
105581910|NCT04248465|364127932|FG001|Randomized-Controlled Period|Adverse Event|0|||
105581911|NCT04248465|364127931|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
105581912|NCT04248465|364127932|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
105581913|NCT04248465|364127931|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
105581914|NCT04248465|364127932|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
105581915|NCT04248465|364127931|FG000|Randomized-Controlled Period|Physician Decision|1|||
105581916|NCT04248465|364127932|FG001|Randomized-Controlled Period|Physician Decision|1|||
105581917|NCT04248465|364127931|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
105581918|NCT04248465|364127932|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
105581919|NCT04248465|364127931|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
105581920|NCT04248465|364127932|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
105581921|NCT04248465|364127931|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
105581922|NCT04248465|364127932|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
105581923|NCT01342887|364127933|FG000|Overall Study|Death|2|||
105581924|NCT01544582|364127934|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
105581925|NCT01544582|364127935|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
105581926|NCT01544582|364127936|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
105581927|NCT01544582|364127937|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
105581928|NCT01544582|364127934|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
105581929|NCT01544582|364127935|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
105581930|NCT01544582|364127936|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
105581931|NCT01544582|364127937|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
105581932|NCT01544582|364127934|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
105581933|NCT01544582|364127935|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
105581934|NCT01544582|364127936|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
105581935|NCT01544582|364127937|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
105581936|NCT01544582|364127934|FG000|Analysis Population|Physician Decision|0|||
105581937|NCT01544582|364127935|FG001|Analysis Population|Physician Decision|13|||
105412445|NCT05959447|363518466|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
105581938|NCT01544582|364127936|FG002|Analysis Population|Physician Decision|10|||
105581939|NCT01544582|364127937|FG003|Analysis Population|Physician Decision|9|||
105581940|NCT01544582|364127934|FG000|Analysis Population|Safety Reason|0|||
105581941|NCT01544582|364127935|FG001|Analysis Population|Safety Reason|33|||
105581942|NCT01544582|364127936|FG002|Analysis Population|Safety Reason|31|||
105581943|NCT01544582|364127937|FG003|Analysis Population|Safety Reason|8|||
105581944|NCT01544582|364127934|FG000|Analysis Population|Effectiveness Reason|0|||
105495688|NCT02349061|363827881|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
105495689|NCT02349061|363827879|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
105495690|NCT02349061|363827880|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
105495691|NCT02349061|363827881|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
105495692|NCT02349061|363827879|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
105495693|NCT02349061|363827880|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
105495694|NCT02349061|363827881|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
105495695|NCT02349061|363827879|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
105495696|NCT02349061|363827880|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
105495697|NCT02349061|363827881|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
105495698|NCT02349061|363827879|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
105495699|NCT02349061|363827880|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
105495700|NCT02349061|363827881|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
105495701|NCT02349061|363827879|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
105495702|NCT02349061|363827880|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
105495703|NCT02349061|363827881|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
105495704|NCT00401531|363827887|FG000|Overall Study|Adverse Event|2|||
105495705|NCT00401531|363827888|FG001|Overall Study|Adverse Event|0|||
105495706|NCT00401531|363827887|FG000|Overall Study|Protocol Violation|3|||
105495707|NCT00401531|363827888|FG001|Overall Study|Protocol Violation|7|||
105495708|NCT00401531|363827887|FG000|Overall Study|Lost to Follow-up|1|||
105495709|NCT00401531|363827888|FG001|Overall Study|Lost to Follow-up|1|||
105495710|NCT00401531|363827887|FG000|Overall Study|Withdrawal by Subject|3|||
105495711|NCT00401531|363827888|FG001|Overall Study|Withdrawal by Subject|2|||
105495712|NCT00282412|363827889|FG000|Overall Study|Death|2|||
105495713|NCT01858376|363827892|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
105495714|NCT02203071|363827893|FG000|Overall Study|Lost to Follow-up|3|||
105495715|NCT02203071|363827894|FG001|Overall Study|Lost to Follow-up|1|||
105495716|NCT03589469|363827897|FG000|Overall Study|Withdrawal by Subject|8|||
105495717|NCT03589469|363827897|FG000|Overall Study|Physician Decision|20|||
105495718|NCT03589469|363827897|FG000|Overall Study|Death|97|||
105495719|NCT03589469|363827897|FG000|Overall Study|Lost to Follow-up|8|||
105495720|NCT03589469|363827897|FG000|Overall Study|Miscellaneous|1|||
105495721|NCT02202837|363827898|FG000|Overall Study|Enbrel treatment discontinued|36|||
105495722|NCT02202837|363827899|FG001|Overall Study|Enbrel treatment discontinued|4|||
105495723|NCT02202837|363827898|FG000|Overall Study|Other|10|||
105495724|NCT02202837|363827899|FG001|Overall Study|Other|0|||
105495725|NCT02202837|363827898|FG000|Overall Study|Lost to Follow-up|7|||
105495726|NCT02202837|363827899|FG001|Overall Study|Lost to Follow-up|1|||
105495727|NCT01364649|363827909|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
105495728|NCT01364649|363827910|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
105495729|NCT01364649|363827909|FG000|Overall Study|Lack of Efficacy|6|||
105495730|NCT01364649|363827910|FG001|Overall Study|Lack of Efficacy|0|||
105495731|NCT01364649|363827909|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
105495732|NCT01364649|363827910|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
105495733|NCT01364649|363827909|FG000|Overall Study|Protocol Deviations|4|||
105495734|NCT01364649|363827910|FG001|Overall Study|Protocol Deviations|8|||
105495735|NCT01364649|363827909|FG000|Overall Study|Withdrawal of Consent|9|||
105495736|NCT01364649|363827910|FG001|Overall Study|Withdrawal of Consent|7|||
105495737|NCT01364649|363827909|FG000|Overall Study|Lost to Follow-up|12|||
105495738|NCT01364649|363827910|FG001|Overall Study|Lost to Follow-up|13|||
105495739|NCT01364649|363827909|FG000|Overall Study|Other|4|||
105495740|NCT01364649|363827910|FG001|Overall Study|Other|1|||
105495741|NCT02468232|363827911|FG000|Core Part of Study|Adverse Event|0|||
105495742|NCT02468232|363827912|FG001|Core Part of Study|Adverse Event|1|||
105495743|NCT02468232|363827913|FG002|Core Part of Study|Adverse Event|0|||
105495744|NCT02468232|363827914|FG003|Core Part of Study|Adverse Event|0|||
105495745|NCT02468232|363827911|FG000|Core Part of Study|Death|20|||
105495746|NCT02468232|363827912|FG001|Core Part of Study|Death|17|||
105495747|NCT02468232|363827913|FG002|Core Part of Study|Death|0|||
105495748|NCT02468232|363827914|FG003|Core Part of Study|Death|0|||
105495749|NCT02468232|363827911|FG000|Core Part of Study|Technical Problems|1|||
105495750|NCT02468232|363827912|FG001|Core Part of Study|Technical Problems|1|||
105495751|NCT02468232|363827913|FG002|Core Part of Study|Technical Problems|0|||
105495752|NCT02468232|363827914|FG003|Core Part of Study|Technical Problems|0|||
105495753|NCT02468232|363827911|FG000|OLE Part of Study|Adverse Event|0|||
105495754|NCT02468232|363827912|FG001|OLE Part of Study|Adverse Event|0|||
105495755|NCT02468232|363827913|FG002|OLE Part of Study|Adverse Event|4|||
105495756|NCT02468232|363827914|FG003|OLE Part of Study|Adverse Event|5|||
105495757|NCT02468232|363827911|FG000|OLE Part of Study|Death|0|||
105495758|NCT02468232|363827912|FG001|OLE Part of Study|Death|0|||
105495759|NCT02468232|363827913|FG002|OLE Part of Study|Death|4|||
105495760|NCT02468232|363827914|FG003|OLE Part of Study|Death|2|||
105495761|NCT02468232|363827911|FG000|OLE Part of Study|Physician Decision|0|||
105581945|NCT01544582|364127935|FG001|Analysis Population|Effectiveness Reason|48|||
105495762|NCT02468232|363827912|FG001|OLE Part of Study|Physician Decision|0|||
105412446|NCT05959447|363518465|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
105412447|NCT05959447|363518466|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
105412448|NCT05959447|363518465|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
105412449|NCT05959447|363518466|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
105412450|NCT05959447|363518465|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
105412451|NCT05959447|363518466|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
105412452|NCT04308239|363518467|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
105412453|NCT04308239|363518468|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
105412454|NCT04308239|363518467|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
105412455|NCT04308239|363518468|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
105412456|NCT04308239|363518467|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
105412457|NCT04308239|363518468|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
105412458|NCT04308239|363518467|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
105412459|NCT04308239|363518468|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
105412460|NCT01436656|363518469|FG000|Dose Escalation|Death|1|||
105412461|NCT01436656|363518470|FG001|Dose Escalation|Death|3|||
105412462|NCT01436656|363518471|FG002|Dose Escalation|Death|1|||
105412463|NCT01436656|363518472|FG003|Dose Escalation|Death|0|||
105412464|NCT01436656|363518473|FG004|Dose Escalation|Death|2|||
105412465|NCT01436656|363518474|FG005|Dose Escalation|Death|1|||
105412466|NCT01436656|363518475|FG006|Dose Escalation|Death|1|||
105412467|NCT01436656|363518476|FG007|Dose Escalation|Death|1|||
105412468|NCT01436656|363518477|FG008|Dose Escalation|Death|1|||
105412469|NCT01436656|363518478|FG009|Dose Escalation|Death|0|||
105412470|NCT01436656|363518479|FG010|Dose Escalation|Death|0|||
105412471|NCT01436656|363518480|FG011|Dose Escalation|Death|0|||
105412472|NCT01436656|363518481|FG012|Dose Escalation|Death|0|||
105412473|NCT01436656|363518482|FG013|Dose Escalation|Death|0|||
105412474|NCT01436656|363518483|FG014|Dose Escalation|Death|0|||
105412475|NCT01436656|363518484|FG015|Dose Escalation|Death|0|||
105412476|NCT01436656|363518485|FG016|Dose Escalation|Death|0|||
105412477|NCT01436656|363518486|FG017|Dose Escalation|Death|0|||
105412478|NCT01436656|363518469|FG000|Dose Escalation|Protocol Violation|0|||
105412479|NCT01436656|363518470|FG001|Dose Escalation|Protocol Violation|0|||
105412480|NCT01436656|363518471|FG002|Dose Escalation|Protocol Violation|0|||
105412481|NCT01436656|363518472|FG003|Dose Escalation|Protocol Violation|0|||
105412482|NCT01436656|363518473|FG004|Dose Escalation|Protocol Violation|0|||
105412483|NCT01436656|363518474|FG005|Dose Escalation|Protocol Violation|1|||
105412484|NCT01436656|363518475|FG006|Dose Escalation|Protocol Violation|0|||
105412485|NCT01436656|363518476|FG007|Dose Escalation|Protocol Violation|0|||
105412486|NCT01436656|363518477|FG008|Dose Escalation|Protocol Violation|0|||
105412487|NCT01436656|363518478|FG009|Dose Escalation|Protocol Violation|0|||
105412488|NCT01436656|363518479|FG010|Dose Escalation|Protocol Violation|0|||
105412489|NCT01436656|363518480|FG011|Dose Escalation|Protocol Violation|0|||
105412490|NCT01436656|363518481|FG012|Dose Escalation|Protocol Violation|0|||
105412491|NCT01436656|363518482|FG013|Dose Escalation|Protocol Violation|0|||
105412492|NCT01436656|363518483|FG014|Dose Escalation|Protocol Violation|0|||
105412493|NCT01436656|363518484|FG015|Dose Escalation|Protocol Violation|0|||
105412494|NCT01436656|363518485|FG016|Dose Escalation|Protocol Violation|0|||
105412495|NCT01436656|363518486|FG017|Dose Escalation|Protocol Violation|0|||
105412496|NCT01436656|363518469|FG000|Dose Escalation|Withdrawal by Subject|0|||
105412497|NCT01436656|363518470|FG001|Dose Escalation|Withdrawal by Subject|0|||
105412498|NCT01436656|363518471|FG002|Dose Escalation|Withdrawal by Subject|0|||
105412499|NCT01436656|363518472|FG003|Dose Escalation|Withdrawal by Subject|0|||
105412500|NCT01436656|363518473|FG004|Dose Escalation|Withdrawal by Subject|1|||
105412501|NCT01436656|363518474|FG005|Dose Escalation|Withdrawal by Subject|0|||
105412502|NCT01436656|363518475|FG006|Dose Escalation|Withdrawal by Subject|0|||
105412503|NCT01436656|363518476|FG007|Dose Escalation|Withdrawal by Subject|2|||
105412504|NCT01436656|363518477|FG008|Dose Escalation|Withdrawal by Subject|0|||
105412505|NCT01436656|363518478|FG009|Dose Escalation|Withdrawal by Subject|1|||
105495763|NCT02468232|363827913|FG002|OLE Part of Study|Physician Decision|4|||
105495764|NCT02468232|363827914|FG003|OLE Part of Study|Physician Decision|0|||
105495765|NCT02468232|363827911|FG000|OLE Part of Study|Subject/Guardian decision|0|||
105495766|NCT02468232|363827912|FG001|OLE Part of Study|Subject/Guardian decision|0|||
105495767|NCT02468232|363827913|FG002|OLE Part of Study|Subject/Guardian decision|2|||
105495768|NCT02468232|363827914|FG003|OLE Part of Study|Subject/Guardian decision|5|||
105495769|NCT02764333|363827917|FG000|Overall Study|Ineligible|1|||
105495770|NCT00902668|363827920|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
105495771|NCT02024529|363827923|FG000|Overall Study|Withdrawal by Subject|11|||
105495772|NCT02024529|363827924|FG001|Overall Study|Withdrawal by Subject|21|||
105495773|NCT02024529|363827923|FG000|Overall Study|Lost to Follow-up|2|||
105495774|NCT02024529|363827924|FG001|Overall Study|Lost to Follow-up|4|||
105495775|NCT00354614|363827925|FG000|Overall Study|Lack of Efficacy|28|||
105495776|NCT01676727|363827926|FG000|Overall Study|Death|18|||
105495777|NCT01676727|363827926|FG000|Overall Study|Withdrawal by Subject|6|||
105495778|NCT01676727|363827926|FG000|Overall Study|Screening failure|5|||
105495779|NCT01676727|363827926|FG000|Overall Study|Not willing to attend 1-year visit|2|||
105495780|NCT01676727|363827926|FG000|Overall Study|Valve explanted|1|||
105495781|NCT02122458|363827929|FG000|Overall Study|Withdrawal by Subject|0|||
105495782|NCT02122458|363827930|FG001|Overall Study|Withdrawal by Subject|0|||
105495783|NCT02122458|363827931|FG002|Overall Study|Withdrawal by Subject|0|||
105495784|NCT02122458|363827932|FG003|Overall Study|Withdrawal by Subject|4|||
105495785|NCT02122458|363827933|FG004|Overall Study|Withdrawal by Subject|4|||
105495786|NCT02122458|363827934|FG005|Overall Study|Withdrawal by Subject|4|||
105495787|NCT02122458|363827935|FG006|Overall Study|Withdrawal by Subject|0|||
105495788|NCT02122458|363827929|FG000|Overall Study|Lost to Follow-up|1|||
105495789|NCT02122458|363827930|FG001|Overall Study|Lost to Follow-up|3|||
105495790|NCT02122458|363827931|FG002|Overall Study|Lost to Follow-up|0|||
105495791|NCT02122458|363827932|FG003|Overall Study|Lost to Follow-up|7|||
105495792|NCT02122458|363827933|FG004|Overall Study|Lost to Follow-up|5|||
105495793|NCT02122458|363827934|FG005|Overall Study|Lost to Follow-up|15|||
105495794|NCT02122458|363827935|FG006|Overall Study|Lost to Follow-up|1|||
105495795|NCT02122458|363827929|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
105495796|NCT02122458|363827930|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
105495797|NCT02122458|363827931|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
105495798|NCT02122458|363827932|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
105495799|NCT02122458|363827933|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
105495800|NCT02122458|363827934|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
105495801|NCT02122458|363827935|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
105495802|NCT02122458|363827929|FG000|Overall Study|Adverse Event|1|||
105495803|NCT02122458|363827930|FG001|Overall Study|Adverse Event|0|||
105495804|NCT02122458|363827931|FG002|Overall Study|Adverse Event|0|||
105495805|NCT02122458|363827932|FG003|Overall Study|Adverse Event|0|||
105495806|NCT02122458|363827933|FG004|Overall Study|Adverse Event|0|||
105495807|NCT02122458|363827934|FG005|Overall Study|Adverse Event|0|||
105495808|NCT02122458|363827935|FG006|Overall Study|Adverse Event|0|||
105495809|NCT02122458|363827929|FG000|Overall Study|Experimental Error|0|||
105495810|NCT02122458|363827930|FG001|Overall Study|Experimental Error|0|||
105495811|NCT02122458|363827931|FG002|Overall Study|Experimental Error|0|||
105495812|NCT02122458|363827932|FG003|Overall Study|Experimental Error|0|||
105495813|NCT02122458|363827933|FG004|Overall Study|Experimental Error|3|||
105495814|NCT02122458|363827934|FG005|Overall Study|Experimental Error|0|||
105495815|NCT02122458|363827935|FG006|Overall Study|Experimental Error|0|||
105495816|NCT02122458|363827929|FG000|Overall Study|Deployed or Moved|0|||
105495817|NCT02122458|363827930|FG001|Overall Study|Deployed or Moved|0|||
105495818|NCT02122458|363827931|FG002|Overall Study|Deployed or Moved|0|||
105495819|NCT02122458|363827932|FG003|Overall Study|Deployed or Moved|0|||
105495820|NCT02122458|363827933|FG004|Overall Study|Deployed or Moved|1|||
105495821|NCT02122458|363827934|FG005|Overall Study|Deployed or Moved|0|||
105495822|NCT02122458|363827935|FG006|Overall Study|Deployed or Moved|0|||
105495823|NCT02122458|363827929|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
105495824|NCT02122458|363827930|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
105495825|NCT02122458|363827931|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
105495826|NCT02122458|363827932|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
105495827|NCT02122458|363827933|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
105495828|NCT02122458|363827934|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
105495829|NCT02122458|363827935|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
105495830|NCT02122458|363827929|FG000|Overall Study|Noncompliance|0|||
105495831|NCT02122458|363827930|FG001|Overall Study|Noncompliance|1|||
105495832|NCT02122458|363827931|FG002|Overall Study|Noncompliance|0|||
105495833|NCT02122458|363827932|FG003|Overall Study|Noncompliance|0|||
105495834|NCT02122458|363827933|FG004|Overall Study|Noncompliance|0|||
105495835|NCT02122458|363827934|FG005|Overall Study|Noncompliance|0|||
105495836|NCT02122458|363827935|FG006|Overall Study|Noncompliance|0|||
105495837|NCT03161093|363827938|FG000|Overall Study|Protocol Violation|11|||
105495838|NCT03161093|363827939|FG001|Overall Study|Protocol Violation|14|||
105495839|NCT03161093|363827940|FG002|Overall Study|Protocol Violation|6|||
105495840|NCT03161093|363827941|FG003|Overall Study|Protocol Violation|13|||
105495841|NCT03161093|363827942|FG004|Overall Study|Protocol Violation|1|||
105495842|NCT03161093|363827943|FG005|Overall Study|Protocol Violation|0|||
105495843|NCT03161093|363827938|FG000|Overall Study|Adverse Event|5|||
105495844|NCT03161093|363827939|FG001|Overall Study|Adverse Event|21|||
105495845|NCT03161093|363827940|FG002|Overall Study|Adverse Event|16|||
105495846|NCT03161093|363827941|FG003|Overall Study|Adverse Event|35|||
105495847|NCT03161093|363827942|FG004|Overall Study|Adverse Event|2|||
105495848|NCT03161093|363827943|FG005|Overall Study|Adverse Event|1|||
105495849|NCT03161093|363827938|FG000|Overall Study|Lack of Efficacy|9|||
105495850|NCT03161093|363827939|FG001|Overall Study|Lack of Efficacy|13|||
105495851|NCT03161093|363827940|FG002|Overall Study|Lack of Efficacy|9|||
105495852|NCT03161093|363827941|FG003|Overall Study|Lack of Efficacy|24|||
105495853|NCT03161093|363827942|FG004|Overall Study|Lack of Efficacy|4|||
105495854|NCT03161093|363827943|FG005|Overall Study|Lack of Efficacy|1|||
105495855|NCT03161093|363827938|FG000|Overall Study|Physician Decision|0|||
105495856|NCT03161093|363827939|FG001|Overall Study|Physician Decision|1|||
105495857|NCT03161093|363827940|FG002|Overall Study|Physician Decision|0|||
105495858|NCT03161093|363827941|FG003|Overall Study|Physician Decision|2|||
105581946|NCT01544582|364127936|FG002|Analysis Population|Effectiveness Reason|29|||
105581947|NCT01544582|364127937|FG003|Analysis Population|Effectiveness Reason|12|||
105412506|NCT01436656|363518479|FG010|Dose Escalation|Withdrawal by Subject|1|||
105412507|NCT01436656|363518480|FG011|Dose Escalation|Withdrawal by Subject|0|||
105412508|NCT01436656|363518481|FG012|Dose Escalation|Withdrawal by Subject|0|||
105412509|NCT01436656|363518482|FG013|Dose Escalation|Withdrawal by Subject|0|||
105412510|NCT01436656|363518483|FG014|Dose Escalation|Withdrawal by Subject|0|||
105412511|NCT01436656|363518484|FG015|Dose Escalation|Withdrawal by Subject|0|||
105412512|NCT01436656|363518485|FG016|Dose Escalation|Withdrawal by Subject|0|||
105412513|NCT01436656|363518486|FG017|Dose Escalation|Withdrawal by Subject|0|||
105412514|NCT01436656|363518469|FG000|Dose Escalation|Administrative problems|0|||
105412515|NCT01436656|363518470|FG001|Dose Escalation|Administrative problems|1|||
105412516|NCT01436656|363518471|FG002|Dose Escalation|Administrative problems|0|||
105412517|NCT01436656|363518472|FG003|Dose Escalation|Administrative problems|0|||
105412518|NCT01436656|363518473|FG004|Dose Escalation|Administrative problems|0|||
105412519|NCT01436656|363518474|FG005|Dose Escalation|Administrative problems|0|||
105412520|NCT01436656|363518475|FG006|Dose Escalation|Administrative problems|0|||
105412521|NCT01436656|363518476|FG007|Dose Escalation|Administrative problems|0|||
105412522|NCT01436656|363518477|FG008|Dose Escalation|Administrative problems|0|||
105412523|NCT01436656|363518478|FG009|Dose Escalation|Administrative problems|0|||
105412524|NCT01436656|363518479|FG010|Dose Escalation|Administrative problems|0|||
105412525|NCT01436656|363518480|FG011|Dose Escalation|Administrative problems|0|||
105412526|NCT01436656|363518481|FG012|Dose Escalation|Administrative problems|0|||
105412527|NCT01436656|363518482|FG013|Dose Escalation|Administrative problems|0|||
105412528|NCT01436656|363518483|FG014|Dose Escalation|Administrative problems|0|||
105412529|NCT01436656|363518484|FG015|Dose Escalation|Administrative problems|0|||
105412530|NCT01436656|363518485|FG016|Dose Escalation|Administrative problems|0|||
105412531|NCT01436656|363518486|FG017|Dose Escalation|Administrative problems|0|||
105412532|NCT01436656|363518469|FG000|Dose Escalation|Lost to Follow-up|1|||
105412533|NCT01436656|363518470|FG001|Dose Escalation|Lost to Follow-up|0|||
105412534|NCT01436656|363518471|FG002|Dose Escalation|Lost to Follow-up|0|||
105412535|NCT01436656|363518472|FG003|Dose Escalation|Lost to Follow-up|0|||
105412536|NCT01436656|363518473|FG004|Dose Escalation|Lost to Follow-up|1|||
105412537|NCT01436656|363518474|FG005|Dose Escalation|Lost to Follow-up|0|||
105412538|NCT01436656|363518475|FG006|Dose Escalation|Lost to Follow-up|0|||
105412539|NCT01436656|363518476|FG007|Dose Escalation|Lost to Follow-up|0|||
105412540|NCT01436656|363518477|FG008|Dose Escalation|Lost to Follow-up|0|||
105412541|NCT01436656|363518478|FG009|Dose Escalation|Lost to Follow-up|0|||
105412542|NCT01436656|363518479|FG010|Dose Escalation|Lost to Follow-up|0|||
105412543|NCT01436656|363518480|FG011|Dose Escalation|Lost to Follow-up|0|||
105412544|NCT01436656|363518481|FG012|Dose Escalation|Lost to Follow-up|0|||
105412545|NCT01436656|363518482|FG013|Dose Escalation|Lost to Follow-up|0|||
105412546|NCT01436656|363518483|FG014|Dose Escalation|Lost to Follow-up|0|||
105412547|NCT01436656|363518484|FG015|Dose Escalation|Lost to Follow-up|0|||
105412548|NCT01436656|363518485|FG016|Dose Escalation|Lost to Follow-up|0|||
105412549|NCT01436656|363518486|FG017|Dose Escalation|Lost to Follow-up|0|||
105412550|NCT01436656|363518469|FG000|Dose Escalation|New anti-cancer therapy|1|||
105412551|NCT01436656|363518470|FG001|Dose Escalation|New anti-cancer therapy|0|||
105412552|NCT01436656|363518471|FG002|Dose Escalation|New anti-cancer therapy|0|||
105412553|NCT01436656|363518472|FG003|Dose Escalation|New anti-cancer therapy|0|||
105412554|NCT01436656|363518473|FG004|Dose Escalation|New anti-cancer therapy|0|||
105412555|NCT01436656|363518474|FG005|Dose Escalation|New anti-cancer therapy|0|||
105412556|NCT01436656|363518475|FG006|Dose Escalation|New anti-cancer therapy|0|||
105495859|NCT03161093|363827942|FG004|Overall Study|Physician Decision|17|||
105495860|NCT03161093|363827943|FG005|Overall Study|Physician Decision|15|||
105581948|NCT01544582|364127934|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
105495861|NCT03161093|363827938|FG000|Overall Study|Withdrawal by Subject|24|||
105412557|NCT01436656|363518476|FG007|Dose Escalation|New anti-cancer therapy|0|||
105412558|NCT01436656|363518477|FG008|Dose Escalation|New anti-cancer therapy|1|||
105412559|NCT01436656|363518478|FG009|Dose Escalation|New anti-cancer therapy|1|||
105412560|NCT01436656|363518479|FG010|Dose Escalation|New anti-cancer therapy|0|||
105495862|NCT03161093|363827939|FG001|Overall Study|Withdrawal by Subject|73|||
105495863|NCT03161093|363827940|FG002|Overall Study|Withdrawal by Subject|44|||
105495864|NCT03161093|363827941|FG003|Overall Study|Withdrawal by Subject|97|||
105495865|NCT03161093|363827942|FG004|Overall Study|Withdrawal by Subject|11|||
105495866|NCT03161093|363827943|FG005|Overall Study|Withdrawal by Subject|10|||
105495867|NCT03161093|363827938|FG000|Overall Study|Lost to Follow-up|3|||
105495868|NCT03161093|363827939|FG001|Overall Study|Lost to Follow-up|12|||
105495869|NCT03161093|363827940|FG002|Overall Study|Lost to Follow-up|4|||
105495870|NCT03161093|363827941|FG003|Overall Study|Lost to Follow-up|7|||
105495871|NCT03161093|363827942|FG004|Overall Study|Lost to Follow-up|8|||
105495872|NCT03161093|363827943|FG005|Overall Study|Lost to Follow-up|13|||
105495873|NCT03161093|363827938|FG000|Overall Study|Death|3|||
105495874|NCT03161093|363827939|FG001|Overall Study|Death|9|||
105495875|NCT03161093|363827940|FG002|Overall Study|Death|7|||
105495876|NCT03161093|363827941|FG003|Overall Study|Death|9|||
105495877|NCT03161093|363827942|FG004|Overall Study|Death|0|||
105495878|NCT03161093|363827943|FG005|Overall Study|Death|0|||
105581949|NCT01544582|364127935|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
105581950|NCT01544582|364127936|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
105581951|NCT01544582|364127937|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
105581952|NCT01544582|364127934|FG000|Analysis Population|Lost to Follow-up|0|||
105581953|NCT01544582|364127935|FG001|Analysis Population|Lost to Follow-up|6|||
105581954|NCT01544582|364127936|FG002|Analysis Population|Lost to Follow-up|6|||
105581955|NCT01544582|364127937|FG003|Analysis Population|Lost to Follow-up|5|||
105412561|NCT01436656|363518480|FG011|Dose Escalation|New anti-cancer therapy|0|||
105412562|NCT01436656|363518481|FG012|Dose Escalation|New anti-cancer therapy|0|||
105412563|NCT01436656|363518482|FG013|Dose Escalation|New anti-cancer therapy|0|||
105412564|NCT01436656|363518483|FG014|Dose Escalation|New anti-cancer therapy|0|||
105412565|NCT01436656|363518484|FG015|Dose Escalation|New anti-cancer therapy|0|||
105412566|NCT01436656|363518485|FG016|Dose Escalation|New anti-cancer therapy|0|||
105412567|NCT01436656|363518486|FG017|Dose Escalation|New anti-cancer therapy|0|||
105412568|NCT01436656|363518469|FG000|Dose Expansion|Adverse Event|0|||
105412569|NCT01436656|363518470|FG001|Dose Expansion|Adverse Event|0|||
105412570|NCT01436656|363518471|FG002|Dose Expansion|Adverse Event|0|||
105412571|NCT01436656|363518472|FG003|Dose Expansion|Adverse Event|0|||
105412572|NCT01436656|363518473|FG004|Dose Expansion|Adverse Event|0|||
105495879|NCT03161093|363827938|FG000|Overall Study|Unknown - Not reported|0|||
105495880|NCT03161093|363827939|FG001|Overall Study|Unknown - Not reported|1|||
105495881|NCT03161093|363827940|FG002|Overall Study|Unknown - Not reported|0|||
105495882|NCT03161093|363827941|FG003|Overall Study|Unknown - Not reported|0|||
105495883|NCT03161093|363827942|FG004|Overall Study|Unknown - Not reported|0|||
105495884|NCT03161093|363827943|FG005|Overall Study|Unknown - Not reported|1|||
105495885|NCT03643575|363827950|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
105495886|NCT03643575|363827951|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
105495887|NCT03643575|363827952|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
105495888|NCT03643575|363827953|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
105495889|NCT03643575|363827954|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
105495890|NCT03643575|363827955|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
105495891|NCT03643575|363827950|FG000|Washout: 7 Days|Adverse Event|1|||
105495892|NCT03643575|363827951|FG001|Washout: 7 Days|Adverse Event|0|||
105495893|NCT03643575|363827952|FG002|Washout: 7 Days|Adverse Event|0|||
105495894|NCT03643575|363827953|FG003|Washout: 7 Days|Adverse Event|0|||
105495895|NCT03643575|363827954|FG004|Washout: 7 Days|Adverse Event|0|||
105495896|NCT03643575|363827955|FG005|Washout: 7 Days|Adverse Event|0|||
105495897|NCT03643575|363827950|FG000|Washout: 7 Days|Non compliance check in|0|||
105495898|NCT03643575|363827951|FG001|Washout: 7 Days|Non compliance check in|1|||
105495899|NCT03643575|363827952|FG002|Washout: 7 Days|Non compliance check in|0|||
105495900|NCT03643575|363827953|FG003|Washout: 7 Days|Non compliance check in|0|||
105495901|NCT03643575|363827954|FG004|Washout: 7 Days|Non compliance check in|0|||
105495902|NCT03643575|363827955|FG005|Washout: 7 Days|Non compliance check in|0|||
105495903|NCT01309165|363827956|FG000|Overall Study|Lost to Follow-up|4|||
105495904|NCT01309165|363827957|FG001|Overall Study|Lost to Follow-up|3|||
105495905|NCT01309165|363827956|FG000|Overall Study|Return to work|1|||
105495906|NCT01309165|363827957|FG001|Overall Study|Return to work|2|||
105495907|NCT01309165|363827956|FG000|Overall Study|Left country|0|||
105495908|NCT01309165|363827957|FG001|Overall Study|Left country|1|||
105495909|NCT01309165|363827956|FG000|Overall Study|No transportation|0|||
105495910|NCT01309165|363827957|FG001|Overall Study|No transportation|1|||
105495911|NCT01309165|363827956|FG000|Overall Study|Admitted to hospital for second stroke|1|||
105495912|NCT01309165|363827957|FG001|Overall Study|Admitted to hospital for second stroke|0|||
105495913|NCT01497275|363827959|FG000|Overall Study|Death|1|||
105495914|NCT01497275|363827959|FG000|Overall Study|Adverse Event|1|||
105495915|NCT01950169|363827960|FG000|Overall Study|Withdrawal by Subject|2|||
105495916|NCT01950169|363827961|FG001|Overall Study|Withdrawal by Subject|8|||
105495917|NCT01950169|363827962|FG002|Overall Study|Withdrawal by Subject|1|||
105495918|NCT01950169|363827960|FG000|Overall Study|Death|1|||
105495919|NCT01950169|363827961|FG001|Overall Study|Death|0|||
105495920|NCT01950169|363827962|FG002|Overall Study|Death|0|||
105495921|NCT01739309|363827966|FG000|Overall Study|Adverse Event|1|||
105495922|NCT01739309|363827966|FG000|Overall Study|Withdrawal by Subject|1|||
105495923|NCT00986830|363827967|FG000|Overall Study|Death|1|||
105495924|NCT00986830|363827967|FG000|Overall Study|Lost to Follow-up|1|||
105495925|NCT00986830|363827967|FG000|Overall Study|Lack of Efficacy|1|||
105495926|NCT00986830|363827967|FG000|Overall Study|Unable to access sinus with device|5|||
105495927|NCT00808483|363827970|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
105495928|NCT00808483|363827971|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
105495929|NCT00808483|363827970|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
105495930|NCT00808483|363827971|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
105495931|NCT00808483|363827970|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
105495932|NCT00808483|363827971|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
105495933|NCT00850070|363827972|FG000|Overall Study|Lack of Efficacy|1|||
105495934|NCT00850070|363827973|FG001|Overall Study|Lack of Efficacy|1|||
105495935|NCT00850070|363827972|FG000|Overall Study|Adverse Event|2|||
105495936|NCT00850070|363827973|FG001|Overall Study|Adverse Event|0|||
105495937|NCT01254292|363827976|FG000|Comparative Phase|Adverse Event|25|||
105495938|NCT01254292|363827977|FG001|Comparative Phase|Adverse Event|25|||
105495939|NCT01254292|363827976|FG000|Comparative Phase|Lost to Follow-up|3|||
105495940|NCT01254292|363827977|FG001|Comparative Phase|Lost to Follow-up|21|||
105495941|NCT01254292|363827976|FG000|Comparative Phase|Pregnancy|2|||
105495942|NCT01254292|363827977|FG001|Comparative Phase|Pregnancy|6|||
105495943|NCT01254292|363827976|FG000|Comparative Phase|Withdrawal by Subject|20|||
105495944|NCT01254292|363827977|FG001|Comparative Phase|Withdrawal by Subject|21|||
105495945|NCT01254292|363827976|FG000|Comparative Phase|Protocol Violation|1|||
105495946|NCT01254292|363827977|FG001|Comparative Phase|Protocol Violation|2|||
105495947|NCT01254292|363827976|FG000|Comparative Phase|Wish for pregnancy|4|||
105495948|NCT01254292|363827977|FG001|Comparative Phase|Wish for pregnancy|6|||
105495949|NCT01254292|363827976|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
105495950|NCT01254292|363827977|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
105495951|NCT01254292|363827976|FG000|LCS12 Extension Phase|Adverse Event|9|||
105495952|NCT01254292|363827977|FG001|LCS12 Extension Phase|Adverse Event|0|||
105495953|NCT01254292|363827976|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
105495954|NCT01254292|363827977|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
105495955|NCT01254292|363827976|FG000|LCS12 Extension Phase|Other unknown|4|||
105495956|NCT01254292|363827977|FG001|LCS12 Extension Phase|Other unknown|0|||
105495957|NCT01254292|363827976|FG000|LCS12 Extension Phase|Pregnancy|2|||
105495958|NCT01254292|363827977|FG001|LCS12 Extension Phase|Pregnancy|0|||
105495959|NCT01254292|363827976|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
105495960|NCT01254292|363827977|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
105495961|NCT02963935|363827985|FG000|Overall Study|Adverse Event|12|||
105495962|NCT02963935|363827986|FG001|Overall Study|Adverse Event|6|||
105495963|NCT02963935|363827985|FG000|Overall Study|Protocol Violation|2|||
105495964|NCT02963935|363827986|FG001|Overall Study|Protocol Violation|1|||
105495965|NCT02963935|363827985|FG000|Overall Study|Lack of Efficacy|0|||
105495966|NCT02963935|363827986|FG001|Overall Study|Lack of Efficacy|2|||
105495967|NCT02963935|363827985|FG000|Overall Study|Lost to Follow-up|1|||
105495968|NCT02963935|363827986|FG001|Overall Study|Lost to Follow-up|6|||
105495969|NCT02963935|363827985|FG000|Overall Study|Unclassified|13|||
105495970|NCT02963935|363827986|FG001|Overall Study|Unclassified|22|||
105495971|NCT02128932|363827987|FG000|Overall Study|Withdrawal by Subject|11|||
105495972|NCT02128932|363827988|FG001|Overall Study|Withdrawal by Subject|7|||
105495973|NCT02128932|363827989|FG002|Overall Study|Withdrawal by Subject|8|||
105495974|NCT02128932|363827987|FG000|Overall Study|Death|2|||
105495975|NCT02128932|363827988|FG001|Overall Study|Death|0|||
105495976|NCT02128932|363827989|FG002|Overall Study|Death|2|||
105495977|NCT02128932|363827987|FG000|Overall Study|Lost to Follow-up|2|||
105495978|NCT02128932|363827988|FG001|Overall Study|Lost to Follow-up|1|||
105495979|NCT02128932|363827989|FG002|Overall Study|Lost to Follow-up|1|||
105495980|NCT02128932|363827987|FG000|Overall Study|No reason for withdrawal|12|||
105495981|NCT02128932|363827988|FG001|Overall Study|No reason for withdrawal|11|||
105495982|NCT02128932|363827989|FG002|Overall Study|No reason for withdrawal|7|||
105495983|NCT01361568|363827990|FG000|Overall Study|Adverse Event|0|||
105495984|NCT01361568|363827991|FG001|Overall Study|Adverse Event|0|||
105495985|NCT01361568|363827992|FG002|Overall Study|Adverse Event|0|||
105495986|NCT01361568|363827993|FG003|Overall Study|Adverse Event|0|||
105495987|NCT01361568|363827994|FG004|Overall Study|Adverse Event|1|||
105495988|NCT01361568|363827995|FG005|Overall Study|Adverse Event|0|||
105495989|NCT01361568|363827990|FG000|Overall Study|Physician Decision|0|||
105495990|NCT01361568|363827991|FG001|Overall Study|Physician Decision|0|||
105495991|NCT01361568|363827992|FG002|Overall Study|Physician Decision|0|||
105495992|NCT01361568|363827993|FG003|Overall Study|Physician Decision|0|||
105495993|NCT01361568|363827994|FG004|Overall Study|Physician Decision|0|||
105495994|NCT01361568|363827995|FG005|Overall Study|Physician Decision|1|||
105495995|NCT01361568|363827990|FG000|Overall Study|Withdrawal by Subject|2|||
105495996|NCT01361568|363827991|FG001|Overall Study|Withdrawal by Subject|1|||
105495997|NCT01361568|363827992|FG002|Overall Study|Withdrawal by Subject|0|||
105495998|NCT01361568|363827993|FG003|Overall Study|Withdrawal by Subject|0|||
105495999|NCT01361568|363827994|FG004|Overall Study|Withdrawal by Subject|0|||
105496000|NCT01361568|363827995|FG005|Overall Study|Withdrawal by Subject|1|||
105496001|NCT00657358|363828000|FG000|Overall Study|Lack of Efficacy|6|||
105496002|NCT01254630|363828001|FG000|Overall Study|Adverse Event|36|||
105412573|NCT01436656|363518474|FG005|Dose Expansion|Adverse Event|0|||
105412574|NCT01436656|363518475|FG006|Dose Expansion|Adverse Event|0|||
105412575|NCT01436656|363518476|FG007|Dose Expansion|Adverse Event|0|||
105412576|NCT01436656|363518477|FG008|Dose Expansion|Adverse Event|0|||
105412577|NCT01436656|363518478|FG009|Dose Expansion|Adverse Event|0|||
105412578|NCT01436656|363518479|FG010|Dose Expansion|Adverse Event|0|||
105412579|NCT01436656|363518480|FG011|Dose Expansion|Adverse Event|1|||
105412580|NCT01436656|363518481|FG012|Dose Expansion|Adverse Event|0|||
105412581|NCT01436656|363518482|FG013|Dose Expansion|Adverse Event|0|||
105412582|NCT01436656|363518483|FG014|Dose Expansion|Adverse Event|0|||
105412583|NCT01436656|363518484|FG015|Dose Expansion|Adverse Event|0|||
105412584|NCT01436656|363518485|FG016|Dose Expansion|Adverse Event|0|||
105412585|NCT01436656|363518486|FG017|Dose Expansion|Adverse Event|0|||
105412586|NCT01436656|363518469|FG000|Dose Expansion|Withdrawal by Subject|0|||
105412587|NCT01436656|363518470|FG001|Dose Expansion|Withdrawal by Subject|0|||
105412588|NCT01436656|363518471|FG002|Dose Expansion|Withdrawal by Subject|0|||
105412589|NCT01436656|363518472|FG003|Dose Expansion|Withdrawal by Subject|0|||
105412590|NCT01436656|363518473|FG004|Dose Expansion|Withdrawal by Subject|0|||
105412591|NCT01436656|363518474|FG005|Dose Expansion|Withdrawal by Subject|0|||
105412592|NCT01436656|363518475|FG006|Dose Expansion|Withdrawal by Subject|0|||
105496003|NCT01254630|363828002|FG001|Overall Study|Adverse Event|15|||
105496004|NCT01254630|363828003|FG002|Overall Study|Adverse Event|40|||
105496005|NCT01254630|363828004|FG003|Overall Study|Adverse Event|8|||
105412593|NCT01436656|363518476|FG007|Dose Expansion|Withdrawal by Subject|0|||
105412594|NCT01436656|363518477|FG008|Dose Expansion|Withdrawal by Subject|0|||
105496006|NCT01254630|363828001|FG000|Overall Study|Death|461|||
105496007|NCT01254630|363828002|FG001|Overall Study|Death|151|||
105496008|NCT01254630|363828003|FG002|Overall Study|Death|478|||
105496009|NCT01254630|363828004|FG003|Overall Study|Death|139|||
105496010|NCT01254630|363828001|FG000|Overall Study|Lost to Follow-up|80|||
105496011|NCT01254630|363828002|FG001|Overall Study|Lost to Follow-up|26|||
105496012|NCT01254630|363828003|FG002|Overall Study|Lost to Follow-up|89|||
105496013|NCT01254630|363828004|FG003|Overall Study|Lost to Follow-up|32|||
105496014|NCT01254630|363828001|FG000|Overall Study|Physician Decision|24|||
105496015|NCT01254630|363828002|FG001|Overall Study|Physician Decision|8|||
105496016|NCT01254630|363828003|FG002|Overall Study|Physician Decision|16|||
105496017|NCT01254630|363828004|FG003|Overall Study|Physician Decision|7|||
105496018|NCT01254630|363828001|FG000|Overall Study|Withdrawal by Subject|201|||
105496019|NCT01254630|363828002|FG001|Overall Study|Withdrawal by Subject|94|||
105496020|NCT01254630|363828003|FG002|Overall Study|Withdrawal by Subject|188|||
105496021|NCT01254630|363828004|FG003|Overall Study|Withdrawal by Subject|89|||
105496022|NCT01254630|363828001|FG000|Overall Study|Study terminated by sponsor|0|||
105496023|NCT01254630|363828002|FG001|Overall Study|Study terminated by sponsor|994|||
105496024|NCT01254630|363828003|FG002|Overall Study|Study terminated by sponsor|0|||
105412595|NCT01436656|363518478|FG009|Dose Expansion|Withdrawal by Subject|0|||
105412596|NCT01436656|363518479|FG010|Dose Expansion|Withdrawal by Subject|0|||
105412597|NCT01436656|363518480|FG011|Dose Expansion|Withdrawal by Subject|1|||
105412598|NCT01436656|363518481|FG012|Dose Expansion|Withdrawal by Subject|3|||
105496025|NCT01254630|363828004|FG003|Overall Study|Study terminated by sponsor|1010|||
105496026|NCT01254630|363828001|FG000|Overall Study|Status not recorded|0|||
105496027|NCT01254630|363828002|FG001|Overall Study|Status not recorded|0|||
105496028|NCT01254630|363828003|FG002|Overall Study|Status not recorded|1|||
105496029|NCT01254630|363828004|FG003|Overall Study|Status not recorded|0|||
105496030|NCT00423722|363829774|FG000|Overall Study|Death|4|||
105496031|NCT00423722|363829775|FG001|Overall Study|Death|4|||
105496032|NCT00423722|363829774|FG000|Overall Study|Declined to participate|2|||
105496033|NCT00423722|363829775|FG001|Overall Study|Declined to participate|3|||
105496034|NCT00423722|363829774|FG000|Overall Study|Unable to complete questionnaires|4|||
105496035|NCT00423722|363829775|FG001|Overall Study|Unable to complete questionnaires|4|||
105496036|NCT00423722|363829774|FG000|Overall Study|Withdrawal by Subject|4|||
105496037|NCT00423722|363829775|FG001|Overall Study|Withdrawal by Subject|2|||
105496038|NCT00518687|363829778|FG000|Overall Study|Adverse Event|201|||
105496039|NCT00518687|363829779|FG001|Overall Study|Adverse Event|177|||
105496040|NCT00518687|363829778|FG000|Overall Study|Lost to Follow-up|144|||
105496041|NCT00518687|363829779|FG001|Overall Study|Lost to Follow-up|155|||
105496042|NCT00518687|363829778|FG000|Overall Study|Physician Decision|42|||
105496043|NCT00518687|363829779|FG001|Overall Study|Physician Decision|48|||
105496044|NCT00518687|363829778|FG000|Overall Study|Progressive disease|2|||
105496045|NCT00518687|363829779|FG001|Overall Study|Progressive disease|2|||
105496046|NCT00518687|363829778|FG000|Overall Study|Protocol Violation|8|||
105496047|NCT00518687|363829779|FG001|Overall Study|Protocol Violation|10|||
105496048|NCT00518687|363829778|FG000|Overall Study|Study terminated by sponsor|930|||
105496049|NCT00518687|363829779|FG001|Overall Study|Study terminated by sponsor|918|||
105496050|NCT00518687|363829778|FG000|Overall Study|Withdrawal by Subject|110|||
105496051|NCT00518687|363829779|FG001|Overall Study|Withdrawal by Subject|110|||
105496052|NCT00851630|363829780|FG000|Overall Study|Death|2|||
105496053|NCT00851630|363829781|FG001|Overall Study|Death|1|||
105496054|NCT00851630|363829780|FG000|Overall Study|Clinical failure|0|||
105496055|NCT00851630|363829781|FG001|Overall Study|Clinical failure|1|||
105496056|NCT00398411|363829782|FG000|Overall Study|Death|0|||
105496057|NCT00398411|363829783|FG001|Overall Study|Death|1|||
105496058|NCT01397162|363829784|FG000|Overall Study|Adverse Event|4|||
105496059|NCT01397162|363829785|FG001|Overall Study|Adverse Event|0|||
105496060|NCT01397162|363829786|FG002|Overall Study|Adverse Event|0|||
105496061|NCT01397162|363829787|FG003|Overall Study|Adverse Event|0|||
105496062|NCT01397162|363829788|FG004|Overall Study|Adverse Event|0|||
105496063|NCT01397162|363829784|FG000|Overall Study|Not yet defined|3|||
105412599|NCT01436656|363518482|FG013|Dose Expansion|Withdrawal by Subject|1|||
105412600|NCT01436656|363518483|FG014|Dose Expansion|Withdrawal by Subject|2|||
105412601|NCT01436656|363518484|FG015|Dose Expansion|Withdrawal by Subject|0|||
105412602|NCT01436656|363518485|FG016|Dose Expansion|Withdrawal by Subject|1|||
105412603|NCT01436656|363518486|FG017|Dose Expansion|Withdrawal by Subject|1|||
105412604|NCT01436656|363518469|FG000|Dose Expansion|Death|0|||
105412605|NCT01436656|363518470|FG001|Dose Expansion|Death|0|||
105412606|NCT01436656|363518471|FG002|Dose Expansion|Death|0|||
105412607|NCT01436656|363518472|FG003|Dose Expansion|Death|0|||
105412608|NCT01436656|363518473|FG004|Dose Expansion|Death|0|||
105412609|NCT01436656|363518474|FG005|Dose Expansion|Death|0|||
105412610|NCT01436656|363518475|FG006|Dose Expansion|Death|0|||
105412611|NCT01436656|363518476|FG007|Dose Expansion|Death|0|||
105412612|NCT01436656|363518477|FG008|Dose Expansion|Death|0|||
105412613|NCT01436656|363518478|FG009|Dose Expansion|Death|0|||
105412614|NCT01436656|363518479|FG010|Dose Expansion|Death|0|||
105412615|NCT01436656|363518480|FG011|Dose Expansion|Death|0|||
105412616|NCT01436656|363518481|FG012|Dose Expansion|Death|1|||
105412617|NCT01436656|363518482|FG013|Dose Expansion|Death|0|||
105412618|NCT01436656|363518483|FG014|Dose Expansion|Death|3|||
105412619|NCT01436656|363518484|FG015|Dose Expansion|Death|0|||
105412620|NCT01436656|363518485|FG016|Dose Expansion|Death|3|||
105412621|NCT01436656|363518486|FG017|Dose Expansion|Death|3|||
105412622|NCT01436656|363518469|FG000|Dose Expansion|Lost to Follow-up|0|||
105412623|NCT01436656|363518470|FG001|Dose Expansion|Lost to Follow-up|0|||
105412624|NCT01436656|363518471|FG002|Dose Expansion|Lost to Follow-up|0|||
105412625|NCT01436656|363518472|FG003|Dose Expansion|Lost to Follow-up|0|||
105412626|NCT01436656|363518473|FG004|Dose Expansion|Lost to Follow-up|0|||
105412627|NCT01436656|363518474|FG005|Dose Expansion|Lost to Follow-up|0|||
105412628|NCT01436656|363518475|FG006|Dose Expansion|Lost to Follow-up|0|||
105412629|NCT01436656|363518476|FG007|Dose Expansion|Lost to Follow-up|0|||
105412630|NCT01436656|363518477|FG008|Dose Expansion|Lost to Follow-up|0|||
105412631|NCT01436656|363518478|FG009|Dose Expansion|Lost to Follow-up|0|||
105412632|NCT01436656|363518479|FG010|Dose Expansion|Lost to Follow-up|0|||
105412633|NCT01436656|363518480|FG011|Dose Expansion|Lost to Follow-up|0|||
105412634|NCT01436656|363518481|FG012|Dose Expansion|Lost to Follow-up|0|||
105412635|NCT01436656|363518482|FG013|Dose Expansion|Lost to Follow-up|0|||
105412636|NCT01436656|363518483|FG014|Dose Expansion|Lost to Follow-up|0|||
105412637|NCT01436656|363518484|FG015|Dose Expansion|Lost to Follow-up|0|||
105496064|NCT01397162|363829785|FG001|Overall Study|Not yet defined|4|||
105496065|NCT01397162|363829786|FG002|Overall Study|Not yet defined|3|||
105412638|NCT01436656|363518485|FG016|Dose Expansion|Lost to Follow-up|0|||
105412639|NCT01436656|363518486|FG017|Dose Expansion|Lost to Follow-up|3|||
105412640|NCT01436656|363518469|FG000|Dose Expansion|Disease progression|0|||
105496066|NCT01397162|363829787|FG003|Overall Study|Not yet defined|5|||
105496067|NCT01397162|363829788|FG004|Overall Study|Not yet defined|3|||
105496068|NCT02339285|363829789|FG000|Overall Study|Withdrawal by Subject|0|||
105496069|NCT02339285|363829790|FG001|Overall Study|Withdrawal by Subject|1|||
105581956|NCT01544582|364127934|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
105412641|NCT01436656|363518470|FG001|Dose Expansion|Disease progression|0|||
105412642|NCT01436656|363518471|FG002|Dose Expansion|Disease progression|0|||
105412643|NCT01436656|363518472|FG003|Dose Expansion|Disease progression|0|||
105412644|NCT01436656|363518473|FG004|Dose Expansion|Disease progression|0|||
105412645|NCT01436656|363518474|FG005|Dose Expansion|Disease progression|0|||
105412646|NCT01436656|363518475|FG006|Dose Expansion|Disease progression|0|||
105412647|NCT01436656|363518476|FG007|Dose Expansion|Disease progression|0|||
105412648|NCT01436656|363518477|FG008|Dose Expansion|Disease progression|0|||
105412649|NCT01436656|363518478|FG009|Dose Expansion|Disease progression|0|||
105412650|NCT01436656|363518479|FG010|Dose Expansion|Disease progression|0|||
105412651|NCT01436656|363518480|FG011|Dose Expansion|Disease progression|3|||
105412652|NCT01436656|363518481|FG012|Dose Expansion|Disease progression|1|||
105412653|NCT01436656|363518482|FG013|Dose Expansion|Disease progression|0|||
105412654|NCT01436656|363518483|FG014|Dose Expansion|Disease progression|1|||
105412655|NCT01436656|363518484|FG015|Dose Expansion|Disease progression|0|||
105412656|NCT01436656|363518485|FG016|Dose Expansion|Disease progression|0|||
105412657|NCT01436656|363518486|FG017|Dose Expansion|Disease progression|1|||
105412658|NCT01436656|363518469|FG000|Dose Expansion|New cancer therapy|0|||
105412659|NCT01436656|363518470|FG001|Dose Expansion|New cancer therapy|0|||
105412660|NCT01436656|363518471|FG002|Dose Expansion|New cancer therapy|0|||
105412661|NCT01436656|363518472|FG003|Dose Expansion|New cancer therapy|0|||
105412662|NCT01436656|363518473|FG004|Dose Expansion|New cancer therapy|0|||
105412663|NCT01436656|363518474|FG005|Dose Expansion|New cancer therapy|0|||
105412664|NCT01436656|363518475|FG006|Dose Expansion|New cancer therapy|0|||
105412665|NCT01436656|363518476|FG007|Dose Expansion|New cancer therapy|0|||
105412666|NCT01436656|363518477|FG008|Dose Expansion|New cancer therapy|0|||
105412667|NCT01436656|363518478|FG009|Dose Expansion|New cancer therapy|0|||
105412668|NCT01436656|363518479|FG010|Dose Expansion|New cancer therapy|0|||
105412669|NCT01436656|363518480|FG011|Dose Expansion|New cancer therapy|1|||
105412670|NCT01436656|363518481|FG012|Dose Expansion|New cancer therapy|1|||
105412671|NCT01436656|363518482|FG013|Dose Expansion|New cancer therapy|0|||
105412672|NCT01436656|363518483|FG014|Dose Expansion|New cancer therapy|2|||
105412673|NCT01436656|363518484|FG015|Dose Expansion|New cancer therapy|0|||
105412674|NCT01436656|363518485|FG016|Dose Expansion|New cancer therapy|0|||
105412675|NCT01436656|363518486|FG017|Dose Expansion|New cancer therapy|0|||
105412676|NCT00576628|363518488|FG000|Overall Study|Adverse Event|11|||
105412677|NCT00576628|363518488|FG000|Overall Study|Death|2|||
105412678|NCT00576628|363518488|FG000|Overall Study|Failure to return|1|||
105412679|NCT00576628|363518488|FG000|Overall Study|Refused Treatment|8|||
105412680|NCT00576628|363518488|FG000|Overall Study|Pregnancy|1|||
105412681|NCT00576628|363518488|FG000|Overall Study|RBC transfusion|1|||
105412682|NCT00576628|363518488|FG000|Overall Study|Progression of Kidney Disease|1|||
105412683|NCT00576628|363518488|FG000|Overall Study|Progression of Renal Failure|1|||
105412684|NCT00576628|363518488|FG000|Overall Study|The patient move into other town|1|||
105412685|NCT00576628|363518488|FG000|Overall Study|Transplantation|1|||
105412686|NCT00576628|363518488|FG000|Overall Study|Dialysis|15|||
105412687|NCT00466947|363518490|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
105412688|NCT00466947|363518491|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
105412689|NCT00466947|363518490|FG000|Study End Analysis Period|Adverse Event|35|||
105412690|NCT00466947|363518491|FG001|Study End Analysis Period|Adverse Event|43|||
105412691|NCT00466947|363518490|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
105412692|NCT00466947|363518491|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
105412693|NCT00466947|363518490|FG000|Study End Analysis Period|Physician Decision|29|||
105412694|NCT00466947|363518491|FG001|Study End Analysis Period|Physician Decision|29|||
105412695|NCT00466947|363518490|FG000|Study End Analysis Period|Protocol Violation|9|||
105412696|NCT00466947|363518491|FG001|Study End Analysis Period|Protocol Violation|17|||
105412697|NCT00466947|363518490|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
105412698|NCT00466947|363518491|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
105412699|NCT00466947|363518490|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
105496070|NCT02339285|363829791|FG002|Overall Study|Withdrawal by Subject|1|||
105496071|NCT02339285|363829789|FG000|Overall Study|Lost to Follow-up|1|||
105496072|NCT02339285|363829790|FG001|Overall Study|Lost to Follow-up|1|||
105496073|NCT02339285|363829791|FG002|Overall Study|Lost to Follow-up|1|||
105496074|NCT02339285|363829789|FG000|Overall Study|Protocol Deviation|0|||
105496075|NCT02339285|363829790|FG001|Overall Study|Protocol Deviation|1|||
105496076|NCT02339285|363829791|FG002|Overall Study|Protocol Deviation|0|||
105496077|NCT00108433|363829792|FG000|Overall Study|Lack of Efficacy|1|||
105496078|NCT00108433|363829793|FG001|Overall Study|Lack of Efficacy|2|||
105412700|NCT00466947|363518491|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
105496079|NCT00108433|363829792|FG000|Overall Study|Death|3|||
105496080|NCT00108433|363829793|FG001|Overall Study|Death|0|||
105412701|NCT00466947|363518490|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
105496081|NCT00108433|363829792|FG000|Overall Study|Adverse Event|3|||
105496082|NCT00108433|363829793|FG001|Overall Study|Adverse Event|1|||
105496083|NCT00108433|363829792|FG000|Overall Study|Other|14|||
105496084|NCT00108433|363829793|FG001|Overall Study|Other|14|||
105412702|NCT00466947|363518491|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
105412703|NCT00466947|363518490|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
105412704|NCT00466947|363518491|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
105412705|NCT02253433|363518492|FG000|Overall Study|Unable to Contact|9|||
105412706|NCT02253433|363518493|FG001|Overall Study|Unable to Contact|16|||
105412707|NCT02253433|363518492|FG000|Overall Study|Death|1|||
105412708|NCT02253433|363518493|FG001|Overall Study|Death|1|||
105412709|NCT02253433|363518492|FG000|Overall Study|No Longer Interested|3|||
105412710|NCT02253433|363518493|FG001|Overall Study|No Longer Interested|15|||
105412711|NCT02253433|363518492|FG000|Overall Study|Out of Study Area|2|||
105412712|NCT02253433|363518493|FG001|Overall Study|Out of Study Area|7|||
105412713|NCT02253433|363518492|FG000|Overall Study|Uncomfortable with home visitors|0|||
105412714|NCT02253433|363518493|FG001|Overall Study|Uncomfortable with home visitors|3|||
105412715|NCT02253433|363518492|FG000|Overall Study|Unstable Housing/Homeless|0|||
105412716|NCT02253433|363518493|FG001|Overall Study|Unstable Housing/Homeless|7|||
105412717|NCT02253433|363518492|FG000|Overall Study|Too Busy|0|||
105412718|NCT02253433|363518493|FG001|Overall Study|Too Busy|4|||
105412719|NCT02253433|363518492|FG000|Overall Study|Medical or Other Concerns|1|||
105412720|NCT02253433|363518493|FG001|Overall Study|Medical or Other Concerns|2|||
105412721|NCT00759876|363518496|FG000|Overall Study|Sponsor terminated study early|36|||
105412722|NCT02314156|363518497|FG000|Overall Study|Adverse Event|1|||
105412723|NCT02314156|363518498|FG001|Overall Study|Adverse Event|0|||
105412724|NCT02314156|363518497|FG000|Overall Study|Withdrawal by Subject|1|||
105412725|NCT02314156|363518498|FG001|Overall Study|Withdrawal by Subject|0|||
105412726|NCT01309997|363518499|FG000|Overall Study|Adverse Event|1|||
105412727|NCT01309997|363518500|FG001|Overall Study|Adverse Event|0|||
105412728|NCT01309997|363518499|FG000|Overall Study|Death|1|||
105412729|NCT01309997|363518500|FG001|Overall Study|Death|3|||
105412730|NCT01309997|363518499|FG000|Overall Study|Lack of Efficacy|2|||
105412731|NCT01309997|363518500|FG001|Overall Study|Lack of Efficacy|2|||
105412732|NCT01309997|363518499|FG000|Overall Study|Withdrawal by Subject|1|||
105412733|NCT01309997|363518500|FG001|Overall Study|Withdrawal by Subject|1|||
105412734|NCT00282087|363518501|FG000|Overall Study|Death|1|||
105412735|NCT02277691|363518502|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
105412736|NCT02277691|363518502|FG000|Overall Study|Voluntary Withdrawal|7|||
105412737|NCT02277691|363518502|FG000|Overall Study|Lack of Efficacy|5|||
105412738|NCT02277691|363518502|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
105412739|NCT03818607|363518506|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
105412740|NCT03818607|363518507|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
105412741|NCT03818607|363518506|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
105412742|NCT03818607|363518507|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
105412743|NCT03818607|363518506|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
105412744|NCT03818607|363518507|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
105412745|NCT01804049|363518508|FG000|Overall Study|Adverse Event|2|||
105412746|NCT01804049|363518509|FG001|Overall Study|Adverse Event|10|||
105412747|NCT01804049|363518508|FG000|Overall Study|Lost to Follow-up|2|||
105412748|NCT01804049|363518509|FG001|Overall Study|Lost to Follow-up|1|||
105412749|NCT01804049|363518508|FG000|Overall Study|Decreased interest/personal|4|||
105412750|NCT01804049|363518509|FG001|Overall Study|Decreased interest/personal|5|||
105412751|NCT01804049|363518508|FG000|Overall Study|Other health concerns|2|||
105412752|NCT01804049|363518509|FG001|Overall Study|Other health concerns|7|||
105412753|NCT01804049|363518508|FG000|Overall Study|Moved out of area|0|||
105412754|NCT01804049|363518509|FG001|Overall Study|Moved out of area|7|||
105412755|NCT01804049|363518508|FG000|Overall Study|other MD recommended|1|||
105412756|NCT01804049|363518509|FG001|Overall Study|other MD recommended|1|||
105412757|NCT01804049|363518508|FG000|Overall Study|Enrollment in dual studies|0|||
105412758|NCT01804049|363518509|FG001|Overall Study|Enrollment in dual studies|1|||
105412759|NCT03520920|363518512|FG000|Overall Study|Death|13|||
105412760|NCT03520920|363518513|FG001|Overall Study|Death|1|||
105412761|NCT03520920|363518514|FG002|Overall Study|Death|0|||
105412762|NCT03520920|363518512|FG000|Overall Study|Withdrawal by Subject|2|||
105412763|NCT03520920|363518513|FG001|Overall Study|Withdrawal by Subject|1|||
105412764|NCT03520920|363518514|FG002|Overall Study|Withdrawal by Subject|0|||
105412765|NCT03520920|363518512|FG000|Overall Study|Study Terminated by the Sponsor|5|||
105412766|NCT03520920|363518513|FG001|Overall Study|Study Terminated by the Sponsor|14|||
105412767|NCT03520920|363518514|FG002|Overall Study|Study Terminated by the Sponsor|5|||
105412768|NCT03248531|363518515|FG000|Overall Study|Adverse Event|0|||
105412769|NCT03248531|363518516|FG001|Overall Study|Adverse Event|0|||
105412770|NCT03248531|363518517|FG002|Overall Study|Adverse Event|1|||
105412771|NCT03248531|363518515|FG000|Overall Study|Lost to Follow-up|1|||
105412772|NCT03248531|363518516|FG001|Overall Study|Lost to Follow-up|0|||
105412773|NCT03248531|363518517|FG002|Overall Study|Lost to Follow-up|5|||
105412774|NCT03248531|363518515|FG000|Overall Study|Withdrawal by Subject|3|||
105412775|NCT03248531|363518516|FG001|Overall Study|Withdrawal by Subject|3|||
105412776|NCT03248531|363518517|FG002|Overall Study|Withdrawal by Subject|2|||
105412777|NCT03248531|363518515|FG000|Overall Study|Sponsor Request|0|||
105412778|NCT03248531|363518516|FG001|Overall Study|Sponsor Request|2|||
105412779|NCT03248531|363518517|FG002|Overall Study|Sponsor Request|0|||
105412780|NCT04075513|363518518|FG000|Overall Study|Withdrawal by Subject|2|||
105412781|NCT04075513|363518519|FG001|Overall Study|Withdrawal by Subject|2|||
105412782|NCT04075513|363518518|FG000|Overall Study|Lack of Efficacy|1|||
105412783|NCT04075513|363518519|FG001|Overall Study|Lack of Efficacy|0|||
105412784|NCT04075513|363518518|FG000|Overall Study|Lost to Follow-up|4|||
105412785|NCT04075513|363518519|FG001|Overall Study|Lost to Follow-up|2|||
105412786|NCT04075513|363518518|FG000|Overall Study|Switch to insulin pump|1|||
105412787|NCT04075513|363518519|FG001|Overall Study|Switch to insulin pump|0|||
105412788|NCT04660552|363518527|FG000|Overall Study|Withdrawal by Subject|3|||
105412789|NCT04660552|363518528|FG001|Overall Study|Withdrawal by Subject|1|||
105412790|NCT02936869|363518534|FG000|Overall Study|Lost to Follow-up|1|||
105412791|NCT02936869|363518535|FG001|Overall Study|Lost to Follow-up|3|||
105412792|NCT02936869|363518534|FG000|Overall Study|Death|0|||
105412793|NCT02936869|363518535|FG001|Overall Study|Death|1|||
105412794|NCT02936869|363518534|FG000|Overall Study|Legal Case|0|||
105412795|NCT02936869|363518535|FG001|Overall Study|Legal Case|1|||
105412796|NCT02936869|363518534|FG000|Overall Study|Protocol Violation|1|||
105412797|NCT02936869|363518535|FG001|Overall Study|Protocol Violation|0|||
105412798|NCT04154293|363518536|FG000|Overall Study|Withdrawal by Subject|2|||
105412799|NCT04154293|363518537|FG001|Overall Study|Withdrawal by Subject|3|||
105412800|NCT04154293|363518538|FG002|Overall Study|Withdrawal by Subject|1|||
105412801|NCT04154293|363518536|FG000|Overall Study|Physician Decision|0|||
105412802|NCT04154293|363518537|FG001|Overall Study|Physician Decision|0|||
105496085|NCT02186873|363829794|FG000|Overall Study|Adverse Event|1|||
105496086|NCT02186873|363829795|FG001|Overall Study|Adverse Event|3|||
105496087|NCT02186873|363829794|FG000|Overall Study|Lack of Efficacy|0|||
105496088|NCT02186873|363829795|FG001|Overall Study|Lack of Efficacy|1|||
105496089|NCT02186873|363829794|FG000|Overall Study|Lost to Follow-up|1|||
105496090|NCT02186873|363829795|FG001|Overall Study|Lost to Follow-up|2|||
105496091|NCT02186873|363829794|FG000|Overall Study|Withdrawal by Subject|7|||
105496092|NCT02186873|363829795|FG001|Overall Study|Withdrawal by Subject|2|||
105496093|NCT01824342|363829800|FG000|Overall Study|Withdrawal by Subject|0|||
105496094|NCT01824342|363829801|FG001|Overall Study|Withdrawal by Subject|3|||
105496095|NCT01824342|363829800|FG000|Overall Study|Adverse Event|1|||
105496096|NCT01824342|363829801|FG001|Overall Study|Adverse Event|1|||
105496097|NCT01824342|363829800|FG000|Overall Study|Disease Progression|1|||
105496098|NCT01824342|363829801|FG001|Overall Study|Disease Progression|1|||
105496099|NCT01824342|363829800|FG000|Overall Study|Physician Decision|5|||
105496100|NCT01824342|363829801|FG001|Overall Study|Physician Decision|0|||
105496101|NCT01824342|363829800|FG000|Overall Study|Death|2|||
105496102|NCT01824342|363829801|FG001|Overall Study|Death|0|||
105496103|NCT04195906|363829802|FG000|Part 1|Adverse Event|3|||
105496104|NCT04195906|363829803|FG001|Part 1|Adverse Event|7|||
105496105|NCT04195906|363829802|FG000|Part 1|Withdrawal by Subject|0|||
105496106|NCT04195906|363829803|FG001|Part 1|Withdrawal by Subject|1|||
105496107|NCT04195906|363829802|FG000|Part 2|Adverse Event|1|||
105496108|NCT04195906|363829803|FG001|Part 2|Adverse Event|1|||
105496109|NCT04195906|363829802|FG000|Part 2|Withdrawal by Subject|0|||
105496110|NCT04195906|363829803|FG001|Part 2|Withdrawal by Subject|3|||
105496111|NCT04195906|363829802|FG000|Part 2|Other|1|||
105496112|NCT04195906|363829803|FG001|Part 2|Other|3|||
105496113|NCT02281773|363829806|FG000|Overall Study|Adverse Event|6|||
105496114|NCT02281773|363829807|FG001|Overall Study|Adverse Event|1|||
105496115|NCT02281773|363829808|FG002|Overall Study|Adverse Event|4|||
105496116|NCT02281773|363829809|FG003|Overall Study|Adverse Event|8|||
105496117|NCT02281773|363829810|FG004|Overall Study|Adverse Event|9|||
105496118|NCT02281773|363829806|FG000|Overall Study|Protocol Violation|1|||
105496119|NCT02281773|363829807|FG001|Overall Study|Protocol Violation|0|||
105496120|NCT02281773|363829808|FG002|Overall Study|Protocol Violation|0|||
105496121|NCT02281773|363829809|FG003|Overall Study|Protocol Violation|2|||
105496122|NCT02281773|363829810|FG004|Overall Study|Protocol Violation|2|||
105496123|NCT02281773|363829806|FG000|Overall Study|Lost to Follow-up|2|||
105496124|NCT02281773|363829807|FG001|Overall Study|Lost to Follow-up|2|||
105496125|NCT02281773|363829808|FG002|Overall Study|Lost to Follow-up|6|||
105496126|NCT02281773|363829809|FG003|Overall Study|Lost to Follow-up|2|||
105496127|NCT02281773|363829810|FG004|Overall Study|Lost to Follow-up|10|||
105412803|NCT04154293|363518538|FG002|Overall Study|Physician Decision|1|||
105412804|NCT00861692|363518539|FG000|Overall Study|Death|6|||
105412805|NCT02907216|363518540|FG000|Overall Study|No benefit to be obtained by continuing|0|||
105496128|NCT02281773|363829806|FG000|Overall Study|Withdrawal by Subject|2|||
105412806|NCT02907216|363518541|FG001|Overall Study|No benefit to be obtained by continuing|1|||
105412807|NCT02907216|363518540|FG000|Overall Study|Withdrawal by Subject|1|||
105496129|NCT02281773|363829807|FG001|Overall Study|Withdrawal by Subject|8|||
105496130|NCT02281773|363829808|FG002|Overall Study|Withdrawal by Subject|6|||
105496131|NCT02281773|363829809|FG003|Overall Study|Withdrawal by Subject|6|||
105412808|NCT02907216|363518541|FG001|Overall Study|Withdrawal by Subject|0|||
105412809|NCT04776720|363518545|FG000|Overall Study|COVID Related|4|||
105412810|NCT04776720|363518546|FG001|Overall Study|COVID Related|2|||
105412811|NCT04776720|363518545|FG000|Overall Study|Adverse Event|2|||
105412812|NCT04776720|363518546|FG001|Overall Study|Adverse Event|0|||
105412813|NCT04776720|363518545|FG000|Overall Study|Serious Adverse Event|0|||
105412814|NCT04776720|363518546|FG001|Overall Study|Serious Adverse Event|1|||
105412815|NCT04776720|363518545|FG000|Overall Study|Too Busy|3|||
105412816|NCT04776720|363518546|FG001|Overall Study|Too Busy|1|||
105412817|NCT04776720|363518545|FG000|Overall Study|Lost to Follow-up|1|||
105412818|NCT04776720|363518546|FG001|Overall Study|Lost to Follow-up|2|||
105412819|NCT04776720|363518545|FG000|Overall Study|Family|2|||
105412820|NCT04776720|363518546|FG001|Overall Study|Family|2|||
105412821|NCT04776720|363518545|FG000|Overall Study|No remote technology access|0|||
105412822|NCT04776720|363518546|FG001|Overall Study|No remote technology access|1|||
105412823|NCT04776720|363518545|FG000|Overall Study|Withdrawal by Subject|1|||
105412824|NCT04776720|363518546|FG001|Overall Study|Withdrawal by Subject|0|||
105412825|NCT04776720|363518545|FG000|Overall Study|Cannot tolerate intervention|1|||
105412826|NCT04776720|363518546|FG001|Overall Study|Cannot tolerate intervention|0|||
105412827|NCT04776720|363518545|FG000|Overall Study|Incomplete outcome data|6|||
105412828|NCT04776720|363518546|FG001|Overall Study|Incomplete outcome data|1|||
105412829|NCT00792740|363518549|FG000|Overall Study|Disease Worsening|3|||
105412830|NCT00792740|363518550|FG001|Overall Study|Disease Worsening|2|||
105412831|NCT00792740|363518549|FG000|Overall Study|Personal Reason|1|||
105412832|NCT00792740|363518550|FG001|Overall Study|Personal Reason|0|||
105412833|NCT00792740|363518549|FG000|Overall Study|Adverse Event|1|||
105412834|NCT00792740|363518550|FG001|Overall Study|Adverse Event|3|||
105412835|NCT00792740|363518549|FG000|Overall Study|Patient's withdrawal of consent|0|||
105412836|NCT00792740|363518550|FG001|Overall Study|Patient's withdrawal of consent|1|||
105412837|NCT00792740|363518549|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
105412838|NCT00792740|363518550|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
105412839|NCT00792740|363518549|FG000|Overall Study|Other reasons|0|||
105412840|NCT00792740|363518550|FG001|Overall Study|Other reasons|1|||
105412841|NCT00703846|363518551|FG000|Overall Study|Adverse Event|8|||
105412842|NCT00703846|363518551|FG000|Overall Study|Lost to Follow-up|55|||
105412843|NCT00703846|363518551|FG000|Overall Study|Lack of Efficacy|15|||
105412844|NCT00703846|363518551|FG000|Overall Study|Noncompliance with Study Treatment|2|||
105412845|NCT00703846|363518551|FG000|Overall Study|Withdrawal by Subject|40|||
105412846|NCT00703846|363518551|FG000|Overall Study|Death|1|||
105412847|NCT00703846|363518551|FG000|Overall Study|Other|14|||
105412848|NCT00703846|363518551|FG000|Overall Study|Did Not Receive Study Drug|2|||
105412849|NCT02016716|363518554|FG000|Overall Study|Withdrawal by Subject|5|||
105412850|NCT02016716|363518555|FG001|Overall Study|Withdrawal by Subject|5|||
105412851|NCT02016716|363518556|FG002|Overall Study|Withdrawal by Subject|5|||
105412852|NCT02016716|363518554|FG000|Overall Study|Protocol-specified Criteria|0|||
105412853|NCT02016716|363518555|FG001|Overall Study|Protocol-specified Criteria|1|||
105496132|NCT02281773|363829810|FG004|Overall Study|Withdrawal by Subject|8|||
105496133|NCT02281773|363829806|FG000|Overall Study|Other Reason|0|||
105496134|NCT02281773|363829807|FG001|Overall Study|Other Reason|4|||
105496135|NCT02281773|363829808|FG002|Overall Study|Other Reason|2|||
105412854|NCT02016716|363518556|FG002|Overall Study|Protocol-specified Criteria|0|||
105412855|NCT02016716|363518554|FG000|Overall Study|Lost to Follow-up|1|||
105412856|NCT02016716|363518555|FG001|Overall Study|Lost to Follow-up|2|||
105412857|NCT02016716|363518556|FG002|Overall Study|Lost to Follow-up|1|||
105412858|NCT00079391|363518557|FG000|Overall Study|Withdrawal by Subject|1|||
105412859|NCT02248649|363518558|FG000|Overall Study|Death|7|||
105496136|NCT02281773|363829809|FG003|Overall Study|Other Reason|3|||
105496137|NCT02281773|363829810|FG004|Overall Study|Other Reason|1|||
105496138|NCT00385762|363829817|FG000|Overall Study|Adverse Event|1|||
105496139|NCT00385762|363829817|FG000|Overall Study|Lost to Follow-up|1|||
105496140|NCT00313300|363829818|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
105496141|NCT00313300|363829819|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
105496142|NCT00313300|363829820|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
105496143|NCT00313300|363829821|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
105496144|NCT00313300|363829822|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
105496145|NCT00313300|363829818|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
105496146|NCT00313300|363829819|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
105496147|NCT00313300|363829820|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
105496148|NCT00313300|363829821|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
105496149|NCT00313300|363829822|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
105496150|NCT00313300|363829818|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
105496151|NCT00313300|363829819|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
105496152|NCT00313300|363829820|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
105496153|NCT00313300|363829821|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
105496154|NCT00313300|363829822|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
105496155|NCT00313300|363829818|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
105496156|NCT00313300|363829819|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
105496157|NCT00313300|363829820|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
105496158|NCT00313300|363829821|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
105412860|NCT02248649|363518559|FG001|Overall Study|Death|11|||
105412861|NCT02248649|363518558|FG000|Overall Study|Lost to Follow-up|14|||
105412862|NCT02248649|363518559|FG001|Overall Study|Lost to Follow-up|10|||
105412863|NCT01597908|363518560|FG000|Randomized Phase|Death|217|||
105412864|NCT01597908|363518561|FG001|Randomized Phase|Death|238|||
105412865|NCT01597908|363518562|FG002|Randomized Phase|Death|0|||
105412866|NCT01597908|363518560|FG000|Randomized Phase|Sponsor Decision|93|||
105412867|NCT01597908|363518561|FG001|Randomized Phase|Sponsor Decision|39|||
105412868|NCT01597908|363518562|FG002|Randomized Phase|Sponsor Decision|0|||
105412869|NCT01597908|363518560|FG000|Randomized Phase|Lost to Follow-up|9|||
105412870|NCT01597908|363518561|FG001|Randomized Phase|Lost to Follow-up|16|||
105412871|NCT01597908|363518562|FG002|Randomized Phase|Lost to Follow-up|0|||
105412872|NCT01597908|363518560|FG000|Randomized Phase|Physician Decision|6|||
105412873|NCT01597908|363518561|FG001|Randomized Phase|Physician Decision|3|||
105412874|NCT01597908|363518562|FG002|Randomized Phase|Physician Decision|0|||
105412875|NCT01597908|363518560|FG000|Randomized Phase|Withdrawal by Subject|26|||
105412876|NCT01597908|363518561|FG001|Randomized Phase|Withdrawal by Subject|22|||
105412877|NCT01597908|363518562|FG002|Randomized Phase|Withdrawal by Subject|0|||
105412878|NCT01597908|363518560|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
105412879|NCT01597908|363518561|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
105412880|NCT01597908|363518562|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
105412881|NCT01597908|363518560|FG000|Crossover Phase|Death|0|||
105412882|NCT01597908|363518561|FG001|Crossover Phase|Death|0|||
105412883|NCT01597908|363518562|FG002|Crossover Phase|Death|11|||
105412884|NCT01597908|363518560|FG000|Crossover Phase|Withdrawal by Subject|0|||
105412885|NCT01597908|363518561|FG001|Crossover Phase|Withdrawal by Subject|0|||
105412886|NCT01597908|363518562|FG002|Crossover Phase|Withdrawal by Subject|3|||
105412887|NCT01597908|363518560|FG000|Crossover Phase|Sponsor Decision|0|||
105412888|NCT01597908|363518561|FG001|Crossover Phase|Sponsor Decision|0|||
105412889|NCT01597908|363518562|FG002|Crossover Phase|Sponsor Decision|20|||
105412890|NCT00281099|363518565|FG000|Overall Study|Death|46|||
105412891|NCT00281099|363518566|FG001|Overall Study|Death|57|||
105412892|NCT00281099|363518565|FG000|Overall Study|Lost to Follow-up|10|||
105412893|NCT00281099|363518566|FG001|Overall Study|Lost to Follow-up|19|||
105412894|NCT00281099|363518565|FG000|Overall Study|Withdrawal by Subject|65|||
105412895|NCT00281099|363518566|FG001|Overall Study|Withdrawal by Subject|70|||
105412896|NCT00281099|363518565|FG000|Overall Study|Physician Decision|79|||
105412897|NCT00281099|363518566|FG001|Overall Study|Physician Decision|72|||
105412898|NCT00281099|363518565|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
105496159|NCT00313300|363829822|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
105496160|NCT00313300|363829818|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
105412899|NCT00281099|363518566|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
105412900|NCT02628600|363518569|FG000|Overall Study|Death|2|||
105412901|NCT02628600|363518570|FG001|Overall Study|Death|1|||
105412902|NCT02628600|363518569|FG000|Overall Study|Adverse Event|3|||
105496161|NCT00313300|363829819|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
105412903|NCT02628600|363518570|FG001|Overall Study|Adverse Event|20|||
105412904|NCT02628600|363518569|FG000|Overall Study|Protocol Violation|0|||
105412905|NCT02628600|363518570|FG001|Overall Study|Protocol Violation|1|||
105412906|NCT02628600|363518569|FG000|Overall Study|Lack of Efficacy|2|||
105412907|NCT02628600|363518570|FG001|Overall Study|Lack of Efficacy|0|||
105412908|NCT02628600|363518569|FG000|Overall Study|Withdrawal by Subject|13|||
105412909|NCT02628600|363518570|FG001|Overall Study|Withdrawal by Subject|8|||
105412910|NCT02628600|363518569|FG000|Overall Study|Lost to Follow-up|1|||
105412911|NCT02628600|363518570|FG001|Overall Study|Lost to Follow-up|0|||
105412912|NCT02628600|363518569|FG000|Overall Study|Physician Decision|2|||
105412913|NCT02628600|363518570|FG001|Overall Study|Physician Decision|2|||
105412914|NCT02628600|363518569|FG000|Overall Study|Other not specified|1|||
105412915|NCT02628600|363518570|FG001|Overall Study|Other not specified|0|||
105412916|NCT03206918|363518577|FG000|Overall Study|Death|11|||
105412917|NCT03206918|363518577|FG000|Overall Study|Withdrawal by Subject|5|||
105412918|NCT03206918|363518577|FG000|Overall Study|Study terminated by sponsor|12|||
105412919|NCT03206918|363518577|FG000|Overall Study|Lost to Follow-up|3|||
105412920|NCT03206918|363518577|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
105412921|NCT01673854|363518583|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
105412922|NCT01673854|363518583|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
105412923|NCT01673854|363518583|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
105412924|NCT01673854|363518583|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
105412925|NCT01673854|363518583|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
105412926|NCT01673854|363518583|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
105412927|NCT01673854|363518583|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
105412928|NCT01673854|363518583|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
105412929|NCT01673854|363518583|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
105412930|NCT01673854|363518583|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
105412931|NCT01673854|363518583|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
105412932|NCT01673854|363518583|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
105496162|NCT00313300|363829820|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
105496163|NCT00313300|363829821|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
105496164|NCT00313300|363829822|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
105496165|NCT00313300|363829818|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
105496166|NCT00313300|363829819|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
105496167|NCT00313300|363829820|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
105496168|NCT00313300|363829821|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
105496169|NCT00313300|363829822|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
105496170|NCT00313300|363829818|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
105496171|NCT00313300|363829819|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
105496172|NCT00313300|363829820|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
105496173|NCT00313300|363829821|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
105496174|NCT00313300|363829822|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
105496175|NCT00313300|363829818|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
105496176|NCT00313300|363829819|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
105496177|NCT00313300|363829820|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
105496178|NCT00313300|363829821|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
105496179|NCT00313300|363829822|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
105496180|NCT00313300|363829818|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
105496181|NCT00313300|363829819|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
105496182|NCT00313300|363829820|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
105496183|NCT00313300|363829821|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
105496184|NCT00313300|363829822|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
105496185|NCT00313300|363829818|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
105496186|NCT00313300|363829819|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
105496187|NCT00313300|363829820|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
105496188|NCT00313300|363829821|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
105496189|NCT00313300|363829822|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
105496190|NCT00313300|363829818|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
105496191|NCT00313300|363829819|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
105496192|NCT00313300|363829820|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
105496193|NCT00313300|363829821|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
105496194|NCT00313300|363829822|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
105496195|NCT00313300|363829818|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
105496196|NCT00313300|363829819|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
105496197|NCT00313300|363829820|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
105496198|NCT00313300|363829821|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
105496199|NCT00313300|363829822|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
105496200|NCT00313300|363829818|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
105496201|NCT00313300|363829819|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
105496202|NCT00313300|363829820|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
105496203|NCT00313300|363829821|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
105496204|NCT00313300|363829822|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
105496205|NCT00313300|363829818|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
105496206|NCT00313300|363829819|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
105496207|NCT00313300|363829820|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
105496208|NCT00313300|363829821|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
105496209|NCT00313300|363829822|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
105496210|NCT00313300|363829818|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
105496211|NCT00313300|363829819|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
105496212|NCT00313300|363829820|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
105496213|NCT00313300|363829821|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
105496214|NCT00313300|363829822|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
105496215|NCT00313300|363829818|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
105496216|NCT00313300|363829819|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
105496217|NCT00313300|363829820|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
105496218|NCT00313300|363829821|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
105496219|NCT00313300|363829822|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
105496220|NCT00313300|363829818|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
105496221|NCT00313300|363829819|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
105496222|NCT00313300|363829820|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
105496223|NCT00313300|363829821|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
105496224|NCT00313300|363829822|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
105496225|NCT00313300|363829818|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
105581957|NCT01544582|364127935|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
105581958|NCT01544582|364127936|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
105496226|NCT00313300|363829819|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
105412933|NCT00583752|363518584|FG000|Overall Study|Lost to Follow-up|5|||
105412934|NCT00583752|363518585|FG001|Overall Study|Lost to Follow-up|5|||
105412935|NCT02316353|363518586|FG000|Overall Study|Pregnancy|1|||
105412936|NCT02316353|363518587|FG001|Overall Study|Pregnancy|3|||
105412937|NCT02316353|363518586|FG000|Overall Study|Adverse Event|1|||
105412938|NCT02316353|363518587|FG001|Overall Study|Adverse Event|3|||
105412939|NCT02316353|363518586|FG000|Overall Study|Withdrawal by Subject|6|||
105496227|NCT00313300|363829820|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
105496228|NCT00313300|363829821|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
105496229|NCT00313300|363829822|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
105496230|NCT00313300|363829818|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
105496231|NCT00313300|363829819|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
105496232|NCT00313300|363829820|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
105496233|NCT00313300|363829821|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
105496234|NCT00313300|363829822|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
105496235|NCT00313300|363829818|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
105496236|NCT00313300|363829819|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
105496237|NCT00313300|363829820|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
105496238|NCT00313300|363829821|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
105496239|NCT00313300|363829822|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
105496240|NCT00313300|363829818|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
105496241|NCT00313300|363829819|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
105496242|NCT00313300|363829820|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
105496243|NCT00313300|363829821|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
105496244|NCT00313300|363829822|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
105496245|NCT00428792|363829823|FG000|Overall Study|Lack of Efficacy|1|||
105496246|NCT00428792|363829824|FG001|Overall Study|Lack of Efficacy|3|||
105496247|NCT00428792|363829823|FG000|Overall Study|Lost to Follow-up|0|||
105496248|NCT00428792|363829824|FG001|Overall Study|Lost to Follow-up|1|||
105496249|NCT01500031|363829825|FG000|Overall Study|Death|1|||
105496250|NCT01500031|363829825|FG000|Overall Study|Withdrawal by Subject|4|||
105496251|NCT00091442|363829826|FG000|Overall Study|Progressive Disease|220|||
105496252|NCT00091442|363829827|FG001|Overall Study|Progressive Disease|189|||
105496253|NCT00091442|363829826|FG000|Overall Study|Physician Decision|61|||
105412940|NCT02316353|363518587|FG001|Overall Study|Withdrawal by Subject|2|||
105412941|NCT02644096|363518591|FG000|Overall Study|Withdrawal by Subject|28|||
105412942|NCT02644096|363518592|FG001|Overall Study|Withdrawal by Subject|25|||
105412943|NCT02147197|363518593|FG000|Overall Study|Adverse Event|1|||
105412944|NCT02147197|363518594|FG001|Overall Study|Adverse Event|0|||
105412945|NCT02147197|363518595|FG002|Overall Study|Adverse Event|0|||
105496254|NCT00091442|363829827|FG001|Overall Study|Physician Decision|58|||
105496255|NCT00091442|363829826|FG000|Overall Study|Withdrawal by Subject|38|||
105496256|NCT00091442|363829827|FG001|Overall Study|Withdrawal by Subject|46|||
105412946|NCT02147197|363518593|FG000|Overall Study|Withdrawal of Consent|4|||
105412947|NCT02147197|363518594|FG001|Overall Study|Withdrawal of Consent|3|||
105581959|NCT01544582|364127937|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
105581960|NCT01544582|364127934|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
105581961|NCT01544582|364127935|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
105581962|NCT01544582|364127936|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
105581963|NCT01544582|364127937|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
105581964|NCT01544582|364127934|FG000|Analysis Population|Intolerance|0|||
105581965|NCT01544582|364127935|FG001|Analysis Population|Intolerance|1|||
105581966|NCT01544582|364127936|FG002|Analysis Population|Intolerance|0|||
105581967|NCT01544582|364127937|FG003|Analysis Population|Intolerance|0|||
105581968|NCT01544582|364127934|FG000|Analysis Population|Liver Transplantation|0|||
105581969|NCT01544582|364127935|FG001|Analysis Population|Liver Transplantation|0|||
105496257|NCT00091442|363829826|FG000|Overall Study|Adverse Event|29|||
105496258|NCT00091442|363829827|FG001|Overall Study|Adverse Event|48|||
105496259|NCT00091442|363829826|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
105496260|NCT00091442|363829827|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
105496261|NCT00091442|363829826|FG000|Overall Study|Death|9|||
105496262|NCT00091442|363829827|FG001|Overall Study|Death|7|||
105496263|NCT00091442|363829826|FG000|Overall Study|Lost to Follow-up|1|||
105496264|NCT00091442|363829827|FG001|Overall Study|Lost to Follow-up|3|||
105496265|NCT00091442|363829826|FG000|Overall Study|Other|2|||
105496266|NCT00091442|363829827|FG001|Overall Study|Other|6|||
105496267|NCT00131508|363829830|FG000|Overall Study|Disease progression|0|||
105496268|NCT00131508|363829831|FG001|Overall Study|Disease progression|2|||
105496269|NCT00131508|363829830|FG000|Overall Study|Non-Compliance|2|||
105496270|NCT00131508|363829831|FG001|Overall Study|Non-Compliance|4|||
105496271|NCT00131508|363829830|FG000|Overall Study|Withdrawal by Subject|1|||
105496272|NCT00131508|363829831|FG001|Overall Study|Withdrawal by Subject|2|||
105496273|NCT03080454|363829832|FG000|Baseline|Adverse Event|2|||
105496274|NCT03080454|363829832|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
105496275|NCT03080454|363829832|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
105496276|NCT00694707|363829833|FG000|Overall Study|Did Not Receive Treatment|0|||
105496277|NCT00694707|363829834|FG001|Overall Study|Did Not Receive Treatment|0|||
105496278|NCT00694707|363829835|FG002|Overall Study|Did Not Receive Treatment|1|||
105496279|NCT00694707|363829836|FG003|Overall Study|Did Not Receive Treatment|1|||
105496280|NCT00694707|363829837|FG004|Overall Study|Did Not Receive Treatment|1|||
105496281|NCT00694707|363829833|FG000|Overall Study|Adverse Event|22|||
105496282|NCT00694707|363829834|FG001|Overall Study|Adverse Event|14|||
105496283|NCT00694707|363829835|FG002|Overall Study|Adverse Event|8|||
105496284|NCT00694707|363829836|FG003|Overall Study|Adverse Event|12|||
105496285|NCT00694707|363829837|FG004|Overall Study|Adverse Event|13|||
105496286|NCT00694707|363829833|FG000|Overall Study|Insufficient Therapeutic Response|33|||
105496287|NCT00694707|363829834|FG001|Overall Study|Insufficient Therapeutic Response|18|||
105496288|NCT00694707|363829835|FG002|Overall Study|Insufficient Therapeutic Response|17|||
105496289|NCT00694707|363829836|FG003|Overall Study|Insufficient Therapeutic Response|15|||
105496290|NCT00694707|363829837|FG004|Overall Study|Insufficient Therapeutic Response|10|||
105496291|NCT00694707|363829833|FG000|Overall Study|Protocol Violation|1|||
105496292|NCT00694707|363829834|FG001|Overall Study|Protocol Violation|2|||
105496293|NCT00694707|363829835|FG002|Overall Study|Protocol Violation|1|||
105496294|NCT00694707|363829836|FG003|Overall Study|Protocol Violation|3|||
105496295|NCT00694707|363829837|FG004|Overall Study|Protocol Violation|1|||
105496296|NCT00694707|363829833|FG000|Overall Study|Withdrawal of Consent|14|||
105496297|NCT00694707|363829834|FG001|Overall Study|Withdrawal of Consent|18|||
105496298|NCT00694707|363829835|FG002|Overall Study|Withdrawal of Consent|22|||
105496299|NCT00694707|363829836|FG003|Overall Study|Withdrawal of Consent|16|||
105496300|NCT00694707|363829837|FG004|Overall Study|Withdrawal of Consent|15|||
105496301|NCT00694707|363829833|FG000|Overall Study|Lost to Follow-up|0|||
105496302|NCT00694707|363829834|FG001|Overall Study|Lost to Follow-up|1|||
105581970|NCT01544582|364127936|FG002|Analysis Population|Liver Transplantation|1|||
105581971|NCT01544582|364127937|FG003|Analysis Population|Liver Transplantation|0|||
105581972|NCT01544582|364127934|FG000|Analysis Population|No Social Insurance|0|||
105581973|NCT01544582|364127935|FG001|Analysis Population|No Social Insurance|0|||
105581974|NCT01544582|364127936|FG002|Analysis Population|No Social Insurance|1|||
105581975|NCT01544582|364127937|FG003|Analysis Population|No Social Insurance|0|||
105496303|NCT00694707|363829835|FG002|Overall Study|Lost to Follow-up|2|||
105496304|NCT00694707|363829836|FG003|Overall Study|Lost to Follow-up|0|||
105496305|NCT00694707|363829837|FG004|Overall Study|Lost to Follow-up|0|||
105496306|NCT00694707|363829833|FG000|Overall Study|Jeopardizing Parole Status|1|||
105496307|NCT00694707|363829834|FG001|Overall Study|Jeopardizing Parole Status|0|||
105496308|NCT00694707|363829835|FG002|Overall Study|Jeopardizing Parole Status|0|||
105496309|NCT00694707|363829836|FG003|Overall Study|Jeopardizing Parole Status|0|||
105581976|NCT01544582|364127934|FG000|Analysis Population|Poor Adherence|0|||
105581977|NCT01544582|364127935|FG001|Analysis Population|Poor Adherence|0|||
105496310|NCT00694707|363829837|FG004|Overall Study|Jeopardizing Parole Status|0|||
105496311|NCT00694707|363829833|FG000|Overall Study|Death in the Family|1|||
105496312|NCT00694707|363829834|FG001|Overall Study|Death in the Family|0|||
105496313|NCT00694707|363829835|FG002|Overall Study|Death in the Family|0|||
105496314|NCT00694707|363829836|FG003|Overall Study|Death in the Family|0|||
105496315|NCT00694707|363829837|FG004|Overall Study|Death in the Family|0|||
105496316|NCT00694707|363829833|FG000|Overall Study|Arrest by Police|0|||
105496317|NCT00694707|363829834|FG001|Overall Study|Arrest by Police|1|||
105496318|NCT00694707|363829835|FG002|Overall Study|Arrest by Police|0|||
105496319|NCT00694707|363829836|FG003|Overall Study|Arrest by Police|0|||
105496320|NCT00694707|363829837|FG004|Overall Study|Arrest by Police|0|||
105496321|NCT00694707|363829833|FG000|Overall Study|Administrative Reasons|0|||
105496322|NCT00694707|363829834|FG001|Overall Study|Administrative Reasons|1|||
105496323|NCT00694707|363829835|FG002|Overall Study|Administrative Reasons|0|||
105496324|NCT00694707|363829836|FG003|Overall Study|Administrative Reasons|2|||
105496325|NCT00694707|363829837|FG004|Overall Study|Administrative Reasons|0|||
105496326|NCT00694707|363829833|FG000|Overall Study|Notification of Past Head Injury|0|||
105496327|NCT00694707|363829834|FG001|Overall Study|Notification of Past Head Injury|0|||
105496328|NCT00694707|363829835|FG002|Overall Study|Notification of Past Head Injury|0|||
105496329|NCT00694707|363829836|FG003|Overall Study|Notification of Past Head Injury|1|||
105496330|NCT00694707|363829837|FG004|Overall Study|Notification of Past Head Injury|0|||
105496331|NCT04674644|363829851|FG000|Overall Study|with missing data|37|||
105496332|NCT03277690|363829852|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
105496333|NCT03277690|363829853|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
105496334|NCT03277690|363829852|FG000|Dose Titration and Maintenance|Physician Decision|1|||
105496335|NCT03277690|363829853|FG001|Dose Titration and Maintenance|Physician Decision|0|||
105496336|NCT03277690|363829852|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
105496337|NCT03277690|363829853|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
105496338|NCT03277690|363829852|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
105496339|NCT03277690|363829853|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
105496340|NCT03277690|363829852|FG000|Dose Titration and Maintenance|Adverse Event|15|||
105496341|NCT03277690|363829853|FG001|Dose Titration and Maintenance|Adverse Event|0|||
105496342|NCT03277690|363829852|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
105496343|NCT03277690|363829853|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
105496344|NCT03277690|363829852|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
105496345|NCT03277690|363829853|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
105496346|NCT01691898|363829854|FG000|Overall Study|Death|34|||
105496347|NCT01691898|363829855|FG001|Overall Study|Death|32|||
105496348|NCT01691898|363829856|FG002|Overall Study|Death|6|||
105496349|NCT01691898|363829857|FG003|Overall Study|Death|3|||
105496350|NCT01691898|363829858|FG004|Overall Study|Death|8|||
105496351|NCT01691898|363829859|FG005|Overall Study|Death|31|||
105496352|NCT01691898|363829854|FG000|Overall Study|Adverse Event|0|||
105496353|NCT01691898|363829855|FG001|Overall Study|Adverse Event|1|||
105496354|NCT01691898|363829856|FG002|Overall Study|Adverse Event|0|||
105496355|NCT01691898|363829857|FG003|Overall Study|Adverse Event|1|||
105496356|NCT01691898|363829858|FG004|Overall Study|Adverse Event|1|||
105496357|NCT01691898|363829859|FG005|Overall Study|Adverse Event|0|||
105496358|NCT01691898|363829854|FG000|Overall Study|Progression of Disease|1|||
105496359|NCT01691898|363829855|FG001|Overall Study|Progression of Disease|2|||
105496360|NCT01691898|363829856|FG002|Overall Study|Progression of Disease|1|||
105496361|NCT01691898|363829857|FG003|Overall Study|Progression of Disease|0|||
105496362|NCT01691898|363829858|FG004|Overall Study|Progression of Disease|0|||
105496363|NCT01691898|363829859|FG005|Overall Study|Progression of Disease|1|||
105496364|NCT01691898|363829854|FG000|Overall Study|Lost to Follow-up|3|||
105496365|NCT01691898|363829855|FG001|Overall Study|Lost to Follow-up|1|||
105496366|NCT01691898|363829856|FG002|Overall Study|Lost to Follow-up|0|||
105496367|NCT01691898|363829857|FG003|Overall Study|Lost to Follow-up|0|||
105496368|NCT01691898|363829858|FG004|Overall Study|Lost to Follow-up|1|||
105496369|NCT01691898|363829859|FG005|Overall Study|Lost to Follow-up|0|||
105496370|NCT01691898|363829854|FG000|Overall Study|Withdrawal by Subject|9|||
105496371|NCT01691898|363829855|FG001|Overall Study|Withdrawal by Subject|8|||
105496372|NCT01691898|363829856|FG002|Overall Study|Withdrawal by Subject|2|||
105496373|NCT01691898|363829857|FG003|Overall Study|Withdrawal by Subject|1|||
105496374|NCT01691898|363829858|FG004|Overall Study|Withdrawal by Subject|3|||
105496375|NCT01691898|363829859|FG005|Overall Study|Withdrawal by Subject|3|||
105496376|NCT01691898|363829854|FG000|Overall Study|Non-Compliance|0|||
105496377|NCT01691898|363829855|FG001|Overall Study|Non-Compliance|0|||
105496378|NCT01691898|363829856|FG002|Overall Study|Non-Compliance|0|||
105496379|NCT01691898|363829857|FG003|Overall Study|Non-Compliance|0|||
105496380|NCT01691898|363829858|FG004|Overall Study|Non-Compliance|1|||
105496381|NCT01691898|363829859|FG005|Overall Study|Non-Compliance|0|||
105496382|NCT01986140|363829860|FG000|Overall Study|Withdrawal by Subject|31|||
105496383|NCT01986140|363829861|FG001|Overall Study|Withdrawal by Subject|25|||
105496384|NCT01986140|363829860|FG000|Overall Study|alternative treatment|1|||
105496385|NCT01986140|363829861|FG001|Overall Study|alternative treatment|1|||
105496386|NCT01986140|363829860|FG000|Overall Study|found not eligible|3|||
105496387|NCT01986140|363829861|FG001|Overall Study|found not eligible|0|||
105496388|NCT01986140|363829860|FG000|Overall Study|Adverse Event|0|||
105496389|NCT01986140|363829861|FG001|Overall Study|Adverse Event|1|||
105496390|NCT01986140|363829860|FG000|Overall Study|progression disease|0|||
105496391|NCT01986140|363829861|FG001|Overall Study|progression disease|1|||
105496392|NCT04738734|363829862|FG000|Overall Study|Withdrawal by Subject|2|||
105496393|NCT04738734|363829863|FG001|Overall Study|Withdrawal by Subject|4|||
105496394|NCT04738734|363829862|FG000|Overall Study|Lost to Follow-up|5|||
105496395|NCT04738734|363829863|FG001|Overall Study|Lost to Follow-up|2|||
105496396|NCT04738734|363829862|FG000|Overall Study|Physician Decision|0|||
105496397|NCT04738734|363829863|FG001|Overall Study|Physician Decision|1|||
105496398|NCT04738734|363829862|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
105496399|NCT04738734|363829863|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
105496400|NCT02939079|363829864|FG000|Overall Study|Adverse Event|2|||
105496401|NCT02939079|363829865|FG001|Overall Study|Adverse Event|1|||
105496402|NCT02939079|363829864|FG000|Overall Study|Lost to Follow-up|0|||
105496403|NCT02939079|363829865|FG001|Overall Study|Lost to Follow-up|2|||
105496404|NCT02939079|363829864|FG000|Overall Study|Protocol Violation|1|||
105496405|NCT02939079|363829865|FG001|Overall Study|Protocol Violation|0|||
105496406|NCT02939079|363829864|FG000|Overall Study|Withdrawal by Subject|0|||
105496407|NCT02939079|363829865|FG001|Overall Study|Withdrawal by Subject|1|||
105496408|NCT02939079|363829864|FG000|Overall Study|relapse during the study|1|||
105496409|NCT02939079|363829865|FG001|Overall Study|relapse during the study|1|||
105496410|NCT04093414|363829866|FG000|3 Month Follow up|Physician Decision|0|||
105496411|NCT04093414|363829867|FG001|3 Month Follow up|Physician Decision|1|||
105496412|NCT04093414|363829866|FG000|6month Follow up|Physician Decision|1|||
105496413|NCT04093414|363829867|FG001|6month Follow up|Physician Decision|3|||
105496414|NCT02337738|363829869|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
105496415|NCT02337738|363829870|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
105496416|NCT02337738|363829871|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
105496417|NCT02337738|363829869|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
105496418|NCT02337738|363829870|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
105496419|NCT02337738|363829871|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
105496420|NCT02337738|363829869|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
105496421|NCT02337738|363829870|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
105496422|NCT02337738|363829871|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
105496423|NCT02337738|363829869|FG000|Overall Study|Voluntary Withdrawal|10|||
105496424|NCT02337738|363829870|FG001|Overall Study|Voluntary Withdrawal|5|||
105412948|NCT02147197|363518595|FG002|Overall Study|Withdrawal of Consent|2|||
105412949|NCT02147197|363518593|FG000|Overall Study|Lost to Follow-up|2|||
105412950|NCT02147197|363518594|FG001|Overall Study|Lost to Follow-up|3|||
105412951|NCT02147197|363518595|FG002|Overall Study|Lost to Follow-up|1|||
105412952|NCT02147197|363518593|FG000|Overall Study|Protocol Violation|1|||
105412953|NCT02147197|363518594|FG001|Overall Study|Protocol Violation|0|||
105412954|NCT02147197|363518595|FG002|Overall Study|Protocol Violation|3|||
105412955|NCT02147197|363518593|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105412956|NCT02147197|363518594|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105412957|NCT02147197|363518595|FG002|Overall Study|Other Miscellaneous Reasons|3|||
105412958|NCT00830375|363518596|FG000|Overall Study|Lost to Follow-up|1|||
105412959|NCT01700959|363518597|FG000|Overall Study|Adverse Event|0|||
105412960|NCT01700959|363518598|FG001|Overall Study|Adverse Event|1|||
105412961|NCT01700959|363518599|FG002|Overall Study|Adverse Event|1|||
105412962|NCT01700959|363518600|FG003|Overall Study|Adverse Event|2|||
105496425|NCT02337738|363829871|FG002|Overall Study|Voluntary Withdrawal|2|||
105496426|NCT02337738|363829869|FG000|Overall Study|Lack of Efficacy|2|||
105496427|NCT02337738|363829870|FG001|Overall Study|Lack of Efficacy|4|||
105496428|NCT02337738|363829871|FG002|Overall Study|Lack of Efficacy|0|||
105496429|NCT02337738|363829869|FG000|Overall Study|Investigator's Judgment|1|||
105496430|NCT02337738|363829870|FG001|Overall Study|Investigator's Judgment|1|||
105496431|NCT02337738|363829871|FG002|Overall Study|Investigator's Judgment|3|||
105496432|NCT05055128|363829872|FG000|Overall Study|Adverse Event|0|||
105496433|NCT05055128|363829873|FG001|Overall Study|Adverse Event|0|||
105496434|NCT05055128|363829874|FG002|Overall Study|Adverse Event|0|||
105496435|NCT05055128|363829875|FG003|Overall Study|Adverse Event|1|||
105496436|NCT05055128|363829876|FG004|Overall Study|Adverse Event|1|||
105412963|NCT01700959|363518601|FG004|Overall Study|Adverse Event|0|||
105412964|NCT01700959|363518602|FG005|Overall Study|Adverse Event|2|||
105496437|NCT05055128|363829872|FG000|Overall Study|Protocol Violation|0|||
105412965|NCT01700959|363518597|FG000|Overall Study|Withdrawal by Subject|15|||
105412966|NCT01700959|363518598|FG001|Overall Study|Withdrawal by Subject|9|||
105412967|NCT01700959|363518599|FG002|Overall Study|Withdrawal by Subject|12|||
105412968|NCT01700959|363518600|FG003|Overall Study|Withdrawal by Subject|11|||
105412969|NCT01700959|363518601|FG004|Overall Study|Withdrawal by Subject|8|||
105412970|NCT01700959|363518602|FG005|Overall Study|Withdrawal by Subject|12|||
105412971|NCT01700959|363518597|FG000|Overall Study|Ineligible|2|||
105412972|NCT01700959|363518598|FG001|Overall Study|Ineligible|1|||
105412973|NCT01700959|363518599|FG002|Overall Study|Ineligible|2|||
105412974|NCT01700959|363518600|FG003|Overall Study|Ineligible|0|||
105412975|NCT01700959|363518601|FG004|Overall Study|Ineligible|0|||
105412976|NCT01700959|363518602|FG005|Overall Study|Ineligible|1|||
105412977|NCT01700959|363518597|FG000|Overall Study|Noncompliant|9|||
105412978|NCT01700959|363518598|FG001|Overall Study|Noncompliant|9|||
105412979|NCT01700959|363518599|FG002|Overall Study|Noncompliant|17|||
105412980|NCT01700959|363518600|FG003|Overall Study|Noncompliant|18|||
105412981|NCT01700959|363518601|FG004|Overall Study|Noncompliant|15|||
105412982|NCT01700959|363518602|FG005|Overall Study|Noncompliant|9|||
105412983|NCT01700959|363518597|FG000|Overall Study|Side effects|1|||
105412984|NCT01700959|363518598|FG001|Overall Study|Side effects|4|||
105412985|NCT01700959|363518599|FG002|Overall Study|Side effects|8|||
105412986|NCT01700959|363518600|FG003|Overall Study|Side effects|4|||
105412987|NCT01700959|363518601|FG004|Overall Study|Side effects|4|||
105412988|NCT01700959|363518602|FG005|Overall Study|Side effects|1|||
105412989|NCT02403817|363520338|FG000|Overall Study|Withdrawal by Subject|5|||
105412990|NCT02403817|363520339|FG001|Overall Study|Withdrawal by Subject|0|||
105412991|NCT01498692|363520340|FG000|Overall Study|Death|4|||
105412992|NCT01498692|363520340|FG000|Overall Study|Withdrawal by Subject|1|||
105412993|NCT01498692|363520340|FG000|Overall Study|Missed 12-month visit|3|||
105412994|NCT03050450|363520341|FG000|Overall Study|Physician Decision|1|||
105412995|NCT03050450|363520342|FG001|Overall Study|Physician Decision|0|||
105412996|NCT03050450|363520343|FG002|Overall Study|Physician Decision|0|||
105412997|NCT03050450|363520344|FG003|Overall Study|Physician Decision|0|||
105412998|NCT03050450|363520345|FG004|Overall Study|Physician Decision|0|||
105412999|NCT02707965|363520347|FG000|Overall Study|Withdrawal by Subject|0|||
105413000|NCT02707965|363520348|FG001|Overall Study|Withdrawal by Subject|0|||
105413001|NCT02707965|363520349|FG002|Overall Study|Withdrawal by Subject|1|||
105413002|NCT02707965|363520350|FG003|Overall Study|Withdrawal by Subject|0|||
105413003|NCT02707965|363520351|FG004|Overall Study|Withdrawal by Subject|0|||
105413004|NCT02707965|363520352|FG005|Overall Study|Withdrawal by Subject|0|||
105413005|NCT02707965|363520353|FG006|Overall Study|Withdrawal by Subject|0|||
105413006|NCT02707965|363520354|FG007|Overall Study|Withdrawal by Subject|2|||
105413007|NCT02707965|363520355|FG008|Overall Study|Withdrawal by Subject|0|||
105413008|NCT02707965|363520356|FG009|Overall Study|Withdrawal by Subject|0|||
105413009|NCT02707965|363520357|FG010|Overall Study|Withdrawal by Subject|0|||
105413010|NCT02707965|363520358|FG011|Overall Study|Withdrawal by Subject|0|||
105413011|NCT02707965|363520359|FG012|Overall Study|Withdrawal by Subject|0|||
105413012|NCT02707965|363520360|FG013|Overall Study|Withdrawal by Subject|0|||
105413013|NCT02707965|363520361|FG014|Overall Study|Withdrawal by Subject|0|||
105413014|NCT02707965|363520362|FG015|Overall Study|Withdrawal by Subject|0|||
105413015|NCT02707965|363520347|FG000|Overall Study|PI decisions|0|||
105413016|NCT02707965|363520348|FG001|Overall Study|PI decisions|0|||
105413017|NCT02707965|363520349|FG002|Overall Study|PI decisions|0|||
105413018|NCT02707965|363520350|FG003|Overall Study|PI decisions|0|||
105413019|NCT02707965|363520351|FG004|Overall Study|PI decisions|0|||
105413020|NCT02707965|363520352|FG005|Overall Study|PI decisions|0|||
105413021|NCT02707965|363520353|FG006|Overall Study|PI decisions|0|||
105413022|NCT02707965|363520354|FG007|Overall Study|PI decisions|0|||
105413023|NCT02707965|363520355|FG008|Overall Study|PI decisions|0|||
105413024|NCT02707965|363520356|FG009|Overall Study|PI decisions|0|||
105413025|NCT02707965|363520357|FG010|Overall Study|PI decisions|0|||
105413026|NCT02707965|363520358|FG011|Overall Study|PI decisions|0|||
105413027|NCT02707965|363520359|FG012|Overall Study|PI decisions|0|||
105413028|NCT02707965|363520360|FG013|Overall Study|PI decisions|0|||
105496438|NCT05055128|363829873|FG001|Overall Study|Protocol Violation|0|||
105496439|NCT05055128|363829874|FG002|Overall Study|Protocol Violation|0|||
105496440|NCT05055128|363829875|FG003|Overall Study|Protocol Violation|1|||
105496441|NCT05055128|363829876|FG004|Overall Study|Protocol Violation|0|||
105496442|NCT05055128|363829872|FG000|Overall Study|Withdrawal by Subject|5|||
105496443|NCT05055128|363829873|FG001|Overall Study|Withdrawal by Subject|2|||
105496444|NCT05055128|363829874|FG002|Overall Study|Withdrawal by Subject|2|||
105496445|NCT05055128|363829875|FG003|Overall Study|Withdrawal by Subject|4|||
105496446|NCT05055128|363829876|FG004|Overall Study|Withdrawal by Subject|2|||
105496447|NCT05055128|363829872|FG000|Overall Study|Randomized By Mistake|0|||
105496448|NCT05055128|363829873|FG001|Overall Study|Randomized By Mistake|1|||
105496449|NCT05055128|363829874|FG002|Overall Study|Randomized By Mistake|0|||
105496450|NCT05055128|363829875|FG003|Overall Study|Randomized By Mistake|0|||
105496451|NCT05055128|363829876|FG004|Overall Study|Randomized By Mistake|0|||
105496452|NCT05055128|363829872|FG000|Overall Study|Other|1|||
105496453|NCT05055128|363829873|FG001|Overall Study|Other|0|||
105496454|NCT05055128|363829874|FG002|Overall Study|Other|0|||
105496455|NCT05055128|363829875|FG003|Overall Study|Other|0|||
105496456|NCT05055128|363829876|FG004|Overall Study|Other|0|||
105496457|NCT02639546|363829877|FG000|Overall Study|Death|2|||
105496458|NCT02639546|363829878|FG001|Overall Study|Death|2|||
105496459|NCT02639546|363829879|FG002|Overall Study|Death|1|||
105496460|NCT02639546|363829880|FG003|Overall Study|Death|2|||
105496461|NCT02639546|363829881|FG004|Overall Study|Death|2|||
105496462|NCT02639546|363829882|FG005|Overall Study|Death|2|||
105496463|NCT02639546|363829883|FG006|Overall Study|Death|0|||
105496464|NCT02639546|363829884|FG007|Overall Study|Death|0|||
105496465|NCT02639546|363829877|FG000|Overall Study|Lost to Follow-up|0|||
105496466|NCT02639546|363829878|FG001|Overall Study|Lost to Follow-up|0|||
105496467|NCT02639546|363829879|FG002|Overall Study|Lost to Follow-up|1|||
105496468|NCT02639546|363829880|FG003|Overall Study|Lost to Follow-up|0|||
105496469|NCT02639546|363829881|FG004|Overall Study|Lost to Follow-up|1|||
105496470|NCT02639546|363829882|FG005|Overall Study|Lost to Follow-up|1|||
105496471|NCT02639546|363829883|FG006|Overall Study|Lost to Follow-up|0|||
105496472|NCT02639546|363829884|FG007|Overall Study|Lost to Follow-up|1|||
105496473|NCT02639546|363829877|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
105496474|NCT02639546|363829878|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
105496475|NCT02639546|363829879|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
105496476|NCT02639546|363829880|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
105496477|NCT02639546|363829881|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
105496478|NCT02639546|363829882|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
105496479|NCT02639546|363829883|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
105496480|NCT02639546|363829884|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
105496481|NCT02639546|363829877|FG000|Overall Study|Study Terminated By Sponsor|0|||
105496482|NCT02639546|363829878|FG001|Overall Study|Study Terminated By Sponsor|2|||
105496483|NCT02639546|363829879|FG002|Overall Study|Study Terminated By Sponsor|3|||
105496484|NCT02639546|363829880|FG003|Overall Study|Study Terminated By Sponsor|4|||
105496485|NCT02639546|363829881|FG004|Overall Study|Study Terminated By Sponsor|4|||
105496486|NCT02639546|363829882|FG005|Overall Study|Study Terminated By Sponsor|3|||
105496487|NCT02639546|363829883|FG006|Overall Study|Study Terminated By Sponsor|3|||
105496488|NCT02639546|363829884|FG007|Overall Study|Study Terminated By Sponsor|9|||
105496489|NCT02639546|363829877|FG000|Overall Study|Withdrawal by Subject|2|||
105496490|NCT02639546|363829878|FG001|Overall Study|Withdrawal by Subject|2|||
105496491|NCT02639546|363829879|FG002|Overall Study|Withdrawal by Subject|1|||
105496492|NCT02639546|363829880|FG003|Overall Study|Withdrawal by Subject|0|||
105496493|NCT02639546|363829881|FG004|Overall Study|Withdrawal by Subject|0|||
105496494|NCT02639546|363829882|FG005|Overall Study|Withdrawal by Subject|1|||
105496495|NCT02639546|363829883|FG006|Overall Study|Withdrawal by Subject|2|||
105496496|NCT02639546|363829884|FG007|Overall Study|Withdrawal by Subject|1|||
105496497|NCT01385371|363829885|FG000|Overall Study|Adverse Event|54|||
105496498|NCT01385371|363829886|FG001|Overall Study|Adverse Event|19|||
105496499|NCT01385371|363829885|FG000|Overall Study|Lost to Follow-up|16|||
105496500|NCT01385371|363829886|FG001|Overall Study|Lost to Follow-up|16|||
105496501|NCT01385371|363829885|FG000|Overall Study|Withdrawal by Subject|52|||
105496502|NCT01385371|363829886|FG001|Overall Study|Withdrawal by Subject|39|||
105496503|NCT01385371|363829885|FG000|Overall Study|Protocol Violation|25|||
105496504|NCT01385371|363829886|FG001|Overall Study|Protocol Violation|21|||
105496505|NCT01385371|363829885|FG000|Overall Study|Administrative|2|||
105496506|NCT01385371|363829886|FG001|Overall Study|Administrative|2|||
105496507|NCT00702689|363829887|FG000|Overall Study|Withdrawal by Subject|4|||
105496508|NCT00702689|363829887|FG000|Overall Study|Recurrent malignancy|1|||
105496509|NCT00702689|363829887|FG000|Overall Study|Adverse Event|1|||
105496510|NCT00669396|363829888|FG000|Overall Study|Lost to Follow-up|10|||
105496511|NCT00669396|363829889|FG001|Overall Study|Lost to Follow-up|12|||
105496512|NCT02155881|363829890|FG000|Overall Study|Withdrawal by Subject|0|||
105496513|NCT02155881|363829891|FG001|Overall Study|Withdrawal by Subject|2|||
105496514|NCT02155881|363829890|FG000|Overall Study|Inappropriately randomized|2|||
105496515|NCT02155881|363829891|FG001|Overall Study|Inappropriately randomized|2|||
105496516|NCT03780543|363829893|FG000|Overall Study|Adverse Event|1|||
105496517|NCT03780543|363829894|FG001|Overall Study|Adverse Event|0|||
105496518|NCT03780543|363829895|FG002|Overall Study|Adverse Event|2|||
105496519|NCT03780543|363829893|FG000|Overall Study|Lost to Follow-up|2|||
105496520|NCT03780543|363829894|FG001|Overall Study|Lost to Follow-up|0|||
105496521|NCT03780543|363829895|FG002|Overall Study|Lost to Follow-up|1|||
105496522|NCT03780543|363829893|FG000|Overall Study|Study terminated by Sponsor|8|||
105496523|NCT03780543|363829894|FG001|Overall Study|Study terminated by Sponsor|7|||
105496524|NCT03780543|363829895|FG002|Overall Study|Study terminated by Sponsor|13|||
105496525|NCT03780543|363829893|FG000|Overall Study|Withdrawal by Subject|1|||
105496526|NCT03780543|363829894|FG001|Overall Study|Withdrawal by Subject|8|||
105496527|NCT03780543|363829895|FG002|Overall Study|Withdrawal by Subject|1|||
105496528|NCT03780543|363829893|FG000|Overall Study|Noncompliance with study drug|1|||
105496529|NCT03780543|363829894|FG001|Overall Study|Noncompliance with study drug|0|||
105496530|NCT03780543|363829895|FG002|Overall Study|Noncompliance with study drug|0|||
105496531|NCT03841448|363829897|FG000|Double-blind Treatment (DBT) Period|Death|1|||
105496532|NCT03841448|363829898|FG001|Double-blind Treatment (DBT) Period|Death|1|||
105496533|NCT03841448|363829899|FG002|Double-blind Treatment (DBT) Period|Death|0|||
105496534|NCT03841448|363829900|FG003|Double-blind Treatment (DBT) Period|Death|0|||
105496535|NCT03841448|363829897|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
105496536|NCT03841448|363829898|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
105496537|NCT03841448|363829899|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
105496538|NCT03841448|363829900|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
105496539|NCT03841448|363829897|FG000|Open-Label Extension (OLE) Period|Death|0|||
105496540|NCT03841448|363829898|FG001|Open-Label Extension (OLE) Period|Death|0|||
105496541|NCT03841448|363829899|FG002|Open-Label Extension (OLE) Period|Death|0|||
105496542|NCT03841448|363829900|FG003|Open-Label Extension (OLE) Period|Death|1|||
105496543|NCT03841448|363829897|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
105496544|NCT03841448|363829898|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
105496545|NCT03841448|363829899|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
105496546|NCT03841448|363829900|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
105496547|NCT03841448|363829897|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
105496548|NCT03841448|363829898|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
105496549|NCT03841448|363829899|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
105496550|NCT03841448|363829900|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
105496551|NCT03841448|363829897|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
105496552|NCT03841448|363829898|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
105496553|NCT03841448|363829899|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
105496554|NCT03841448|363829900|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
105496555|NCT02840721|363829901|FG000|Treatment Period|Adverse Event|1|||
105496556|NCT02840721|363829901|FG000|Follow-Up|Lack of Efficacy|1|||
105496557|NCT02840721|363829901|FG000|Follow-Up|Withdrawal by Subject|4|||
105496558|NCT02840721|363829901|FG000|Follow-Up|Withdrawal of Consent|2|||
105496559|NCT01967173|363829902|FG000|Overall Study|Lost to Follow-up|5|||
105496560|NCT01967173|363829903|FG001|Overall Study|Lost to Follow-up|3|||
105496561|NCT01967173|363829904|FG002|Overall Study|Lost to Follow-up|2|||
105496562|NCT01967173|363829905|FG003|Overall Study|Lost to Follow-up|4|||
105496563|NCT01967173|363829906|FG004|Overall Study|Lost to Follow-up|8|||
105496564|NCT01967173|363829907|FG005|Overall Study|Lost to Follow-up|12|||
105496565|NCT01967173|363829908|FG006|Overall Study|Lost to Follow-up|6|||
105496566|NCT01967173|363829909|FG007|Overall Study|Lost to Follow-up|8|||
105496567|NCT01967173|363829902|FG000|Overall Study|Physician Decision|2|||
105496568|NCT01967173|363829903|FG001|Overall Study|Physician Decision|0|||
105496569|NCT01967173|363829904|FG002|Overall Study|Physician Decision|2|||
105496570|NCT01967173|363829905|FG003|Overall Study|Physician Decision|1|||
105496571|NCT01967173|363829906|FG004|Overall Study|Physician Decision|1|||
105496572|NCT01967173|363829907|FG005|Overall Study|Physician Decision|1|||
105496573|NCT01967173|363829908|FG006|Overall Study|Physician Decision|1|||
105496574|NCT01967173|363829909|FG007|Overall Study|Physician Decision|0|||
105496575|NCT01967173|363829902|FG000|Overall Study|Lack of Efficacy|2|||
105496576|NCT01967173|363829903|FG001|Overall Study|Lack of Efficacy|0|||
105496577|NCT01967173|363829904|FG002|Overall Study|Lack of Efficacy|2|||
105496578|NCT01967173|363829905|FG003|Overall Study|Lack of Efficacy|2|||
105496579|NCT01967173|363829906|FG004|Overall Study|Lack of Efficacy|0|||
105496580|NCT01967173|363829907|FG005|Overall Study|Lack of Efficacy|1|||
105496581|NCT01967173|363829908|FG006|Overall Study|Lack of Efficacy|0|||
105496582|NCT01967173|363829909|FG007|Overall Study|Lack of Efficacy|2|||
105496583|NCT01967173|363829902|FG000|Overall Study|Pregnancy|0|||
105496584|NCT01967173|363829903|FG001|Overall Study|Pregnancy|0|||
105496585|NCT01967173|363829904|FG002|Overall Study|Pregnancy|0|||
105496586|NCT01967173|363829905|FG003|Overall Study|Pregnancy|0|||
105496587|NCT01967173|363829906|FG004|Overall Study|Pregnancy|0|||
105496588|NCT01967173|363829907|FG005|Overall Study|Pregnancy|0|||
105496589|NCT01967173|363829908|FG006|Overall Study|Pregnancy|1|||
105496590|NCT01967173|363829909|FG007|Overall Study|Pregnancy|1|||
105496591|NCT01967173|363829902|FG000|Overall Study|Adverse Event|0|||
105496592|NCT01967173|363829903|FG001|Overall Study|Adverse Event|0|||
105496593|NCT01967173|363829904|FG002|Overall Study|Adverse Event|0|||
105496594|NCT01967173|363829905|FG003|Overall Study|Adverse Event|0|||
105496595|NCT01967173|363829906|FG004|Overall Study|Adverse Event|0|||
105496596|NCT01967173|363829907|FG005|Overall Study|Adverse Event|0|||
105496597|NCT01967173|363829908|FG006|Overall Study|Adverse Event|0|||
105496598|NCT01967173|363829909|FG007|Overall Study|Adverse Event|1|||
105496599|NCT01967173|363829902|FG000|Overall Study|Withdrawal by Subject|15|||
105496600|NCT01967173|363829903|FG001|Overall Study|Withdrawal by Subject|14|||
105496601|NCT01967173|363829904|FG002|Overall Study|Withdrawal by Subject|10|||
105496602|NCT01967173|363829905|FG003|Overall Study|Withdrawal by Subject|7|||
105496603|NCT01967173|363829906|FG004|Overall Study|Withdrawal by Subject|8|||
105496604|NCT01967173|363829907|FG005|Overall Study|Withdrawal by Subject|9|||
105496605|NCT01967173|363829908|FG006|Overall Study|Withdrawal by Subject|10|||
105496606|NCT01967173|363829909|FG007|Overall Study|Withdrawal by Subject|12|||
105496607|NCT04122534|363829917|FG000|Overall Study|Lost to Follow-up|4|||
105496608|NCT00810355|363829922|FG000|Overall Study|Lost to Follow-up|13|||
105496609|NCT00810355|363829923|FG001|Overall Study|Lost to Follow-up|17|||
105496610|NCT00810355|363829924|FG002|Overall Study|Lost to Follow-up|11|||
105496611|NCT00810355|363829922|FG000|Overall Study|Withdrawal by Subject|1|||
105581978|NCT01544582|364127936|FG002|Analysis Population|Poor Adherence|1|||
105581979|NCT01544582|364127937|FG003|Analysis Population|Poor Adherence|0|||
105581980|NCT01544582|364127934|FG000|Analysis Population|Poor Participant Compliance|0|||
105581981|NCT01544582|364127935|FG001|Analysis Population|Poor Participant Compliance|1|||
105581982|NCT01544582|364127936|FG002|Analysis Population|Poor Participant Compliance|0|||
105413029|NCT02707965|363520361|FG014|Overall Study|PI decisions|2|||
105413030|NCT02707965|363520362|FG015|Overall Study|PI decisions|0|||
105413031|NCT02707965|363520347|FG000|Overall Study|Protocol deviation|1|||
105413032|NCT02707965|363520348|FG001|Overall Study|Protocol deviation|1|||
105413033|NCT02707965|363520349|FG002|Overall Study|Protocol deviation|0|||
105413034|NCT02707965|363520350|FG003|Overall Study|Protocol deviation|0|||
105413035|NCT02707965|363520351|FG004|Overall Study|Protocol deviation|0|||
105413036|NCT02707965|363520352|FG005|Overall Study|Protocol deviation|0|||
105413037|NCT02707965|363520353|FG006|Overall Study|Protocol deviation|0|||
105413038|NCT02707965|363520354|FG007|Overall Study|Protocol deviation|1|||
105413039|NCT02707965|363520355|FG008|Overall Study|Protocol deviation|0|||
105413040|NCT02707965|363520356|FG009|Overall Study|Protocol deviation|0|||
105413041|NCT02707965|363520357|FG010|Overall Study|Protocol deviation|0|||
105413042|NCT02707965|363520358|FG011|Overall Study|Protocol deviation|0|||
105413043|NCT02707965|363520359|FG012|Overall Study|Protocol deviation|0|||
105413044|NCT02707965|363520360|FG013|Overall Study|Protocol deviation|0|||
105413045|NCT02707965|363520361|FG014|Overall Study|Protocol deviation|0|||
105413046|NCT02707965|363520362|FG015|Overall Study|Protocol deviation|0|||
105413047|NCT00249808|363520363|FG000|Overall Study|Other|27|||
105413048|NCT00249808|363520363|FG000|Overall Study|Protocol Violation|3|||
105413049|NCT00249808|363520363|FG000|Overall Study|Lost to Follow-up|8|||
105413050|NCT00249808|363520363|FG000|Overall Study|Adverse Event|81|||
105413051|NCT00249808|363520363|FG000|Overall Study|Lack of Efficacy|52|||
105413052|NCT00249808|363520363|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
105413053|NCT01576146|363520364|FG000|Extension Period 1|Adverse Event|2|||
105413054|NCT01576146|363520364|FG000|Extension Period 1|Death|2|||
105413055|NCT01576146|363520364|FG000|Extension Period 1|Physician Decision|2|||
105413056|NCT01576146|363520364|FG000|Extension Period 1|Withdrawal by Subject|1|||
105413057|NCT01576146|363520364|FG000|Extension Period 1|Lost to Follow-up|1|||
105413058|NCT01576146|363520364|FG000|Extension Period 1|Parathyroidectomy|1|||
105413059|NCT01576146|363520364|FG000|Extension Period 1|Renal Transplant|1|||
105413060|NCT01576146|363520364|FG000|Extension Period 2|Sponsor Decision|13|||
105413061|NCT01576146|363520364|FG000|Extension Period 2|Death|1|||
105413062|NCT01576146|363520364|FG000|Extension Period 2|Adverse Event|1|||
105413063|NCT01576146|363520364|FG000|Extension Period 2|Renal Transplant|1|||
105413064|NCT01576146|363520364|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
105413065|NCT02516982|363520365|FG000|Overall Study|Called in to antenatal appointment|32|||
105413066|NCT02516982|363520366|FG001|Overall Study|Called in to antenatal appointment|35|||
105413067|NCT02516982|363520367|FG002|Overall Study|Called in to antenatal appointment|0|||
105413068|NCT02516982|363520368|FG003|Overall Study|Called in to antenatal appointment|0|||
105413069|NCT02516982|363520365|FG000|Overall Study|Withdrawal by Subject|0|||
105413070|NCT02516982|363520366|FG001|Overall Study|Withdrawal by Subject|0|||
105413071|NCT02516982|363520367|FG002|Overall Study|Withdrawal by Subject|1|||
105413072|NCT02516982|363520368|FG003|Overall Study|Withdrawal by Subject|2|||
105496612|NCT00810355|363829923|FG001|Overall Study|Withdrawal by Subject|0|||
105496613|NCT00810355|363829924|FG002|Overall Study|Withdrawal by Subject|0|||
105581983|NCT01544582|364127937|FG003|Analysis Population|Poor Participant Compliance|0|||
105413073|NCT02516982|363520365|FG000|Overall Study|Protocol Violation|0|||
105413074|NCT02516982|363520366|FG001|Overall Study|Protocol Violation|0|||
105496614|NCT00397215|363829929|FG000|Month 0 (Day 0)|Adverse Event|0|||
105496615|NCT00397215|363829930|FG001|Month 0 (Day 0)|Adverse Event|1|||
105496616|NCT00397215|363829931|FG002|Month 0 (Day 0)|Adverse Event|0|||
105413075|NCT02516982|363520367|FG002|Overall Study|Protocol Violation|1|||
105413076|NCT02516982|363520368|FG003|Overall Study|Protocol Violation|1|||
105413077|NCT02516982|363520365|FG000|Overall Study|Did not install the app|0|||
105413078|NCT02516982|363520366|FG001|Overall Study|Did not install the app|0|||
105413079|NCT02516982|363520367|FG002|Overall Study|Did not install the app|46|||
105413080|NCT02516982|363520368|FG003|Overall Study|Did not install the app|47|||
105413081|NCT00443872|363520369|FG000|Overall Study|Protocol Violation|7|||
105413082|NCT00443872|363520369|FG000|Overall Study|Lost to Follow-up|2|||
105413083|NCT00443872|363520369|FG000|Overall Study|Adverse Event|8|||
105413084|NCT02789345|363520370|FG000|Overall Study|Adverse Event|0|||
105413085|NCT02789345|363520371|FG001|Overall Study|Adverse Event|0|||
105413086|NCT02789345|363520372|FG002|Overall Study|Adverse Event|1|||
105413087|NCT02789345|363520370|FG000|Overall Study|Death|0|||
105413088|NCT02789345|363520371|FG001|Overall Study|Death|0|||
105413089|NCT02789345|363520372|FG002|Overall Study|Death|1|||
105413090|NCT02789345|363520370|FG000|Overall Study|Physician Decision|2|||
105413091|NCT02789345|363520371|FG001|Overall Study|Physician Decision|0|||
105413092|NCT02789345|363520372|FG002|Overall Study|Physician Decision|1|||
105413093|NCT02789345|363520370|FG000|Overall Study|Progressive Disease|1|||
105413094|NCT02789345|363520371|FG001|Overall Study|Progressive Disease|3|||
105413095|NCT02789345|363520372|FG002|Overall Study|Progressive Disease|14|||
105413096|NCT03470194|363520374|FG000|Overall Study|Lost to Follow-up|11|||
105413097|NCT03470194|363520375|FG001|Overall Study|Lost to Follow-up|17|||
105413098|NCT01822899|363520376|FG000|Overall Study|Adverse Event|6|||
105413099|NCT01822899|363520377|FG001|Overall Study|Adverse Event|5|||
105413100|NCT01822899|363520376|FG000|Overall Study|Lack of Efficacy|6|||
105413101|NCT01822899|363520377|FG001|Overall Study|Lack of Efficacy|3|||
105413102|NCT01822899|363520376|FG000|Overall Study|Protocol Violation|6|||
105413103|NCT01822899|363520377|FG001|Overall Study|Protocol Violation|3|||
105413104|NCT01822899|363520376|FG000|Overall Study|Lost to Follow-up|1|||
105413105|NCT01822899|363520377|FG001|Overall Study|Lost to Follow-up|0|||
105413106|NCT01822899|363520376|FG000|Overall Study|Withdrawal by Subject|5|||
105413107|NCT01822899|363520377|FG001|Overall Study|Withdrawal by Subject|7|||
105413108|NCT01164891|363520382|FG000|Overall Study|Disease Progression|5|||
105413109|NCT01164891|363520382|FG000|Overall Study|Adverse Event|1|||
105413110|NCT03985943|363520383|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
105413111|NCT03985943|363520384|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
105413112|NCT03985943|363520385|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
105413113|NCT03985943|363520386|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
105413114|NCT03985943|363520387|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
105413115|NCT03985943|363520388|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
105413116|NCT03985943|363520383|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
105413117|NCT03985943|363520384|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
105413118|NCT03985943|363520385|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105413119|NCT03985943|363520386|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105413120|NCT03985943|363520387|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105413121|NCT03985943|363520388|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105413122|NCT03985943|363520383|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
105413123|NCT03985943|363520384|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
105413124|NCT03985943|363520385|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105413125|NCT03985943|363520386|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105413126|NCT03985943|363520387|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105413127|NCT03985943|363520388|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105413128|NCT03985943|363520383|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
105413129|NCT03985943|363520384|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
105413130|NCT03985943|363520385|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
105413131|NCT03985943|363520386|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
105413132|NCT03985943|363520387|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
105413133|NCT03985943|363520388|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
105413134|NCT03985943|363520383|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105413135|NCT03985943|363520384|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
105413136|NCT03985943|363520385|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105413137|NCT03985943|363520386|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105413138|NCT03985943|363520387|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105413139|NCT03985943|363520388|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105413140|NCT03985943|363520383|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
105413141|NCT03985943|363520384|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
105413142|NCT03985943|363520385|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
105413143|NCT03985943|363520386|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
105413144|NCT03985943|363520387|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
105413145|NCT03985943|363520388|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
105413146|NCT03985943|363520383|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
105413147|NCT03985943|363520384|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
105413148|NCT03985943|363520385|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
105413149|NCT03985943|363520386|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
105413150|NCT03985943|363520387|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
105413151|NCT03985943|363520388|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
105413152|NCT03985943|363520383|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
105413153|NCT03985943|363520384|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
105413154|NCT03985943|363520385|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
105413155|NCT03985943|363520386|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
105413156|NCT03985943|363520387|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
105413157|NCT03985943|363520388|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
105413158|NCT03985943|363520383|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
105413159|NCT03985943|363520384|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
105413160|NCT03985943|363520385|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
105413161|NCT03985943|363520386|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
105413162|NCT03985943|363520387|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
105413163|NCT03985943|363520388|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
105413164|NCT03985943|363520383|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
105413165|NCT03985943|363520384|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
105413166|NCT03985943|363520385|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
105413167|NCT03985943|363520386|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
105413168|NCT03985943|363520387|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
105413169|NCT03985943|363520388|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
105413170|NCT03985943|363520383|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
105413171|NCT03985943|363520384|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
105413172|NCT03985943|363520385|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
105413173|NCT03985943|363520386|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
105413174|NCT03985943|363520387|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
105413175|NCT03985943|363520388|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
105413176|NCT03985943|363520383|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105413177|NCT03985943|363520384|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105413178|NCT03985943|363520385|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105413179|NCT03985943|363520386|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
105413180|NCT03985943|363520387|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
105413181|NCT03985943|363520388|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
105413182|NCT03985943|363520383|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
105413183|NCT03985943|363520384|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
105413184|NCT03985943|363520385|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
105413185|NCT03985943|363520386|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
105413186|NCT03985943|363520387|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
105413187|NCT03985943|363520388|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
105413188|NCT03985943|363520383|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
105413189|NCT03985943|363520384|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
105413190|NCT03985943|363520385|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
105413191|NCT03985943|363520386|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
105413192|NCT03985943|363520387|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
105413193|NCT03985943|363520388|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
105413194|NCT03985943|363520383|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
105413195|NCT03985943|363520384|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
105413196|NCT03985943|363520385|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
105413197|NCT03985943|363520386|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
105413198|NCT03985943|363520387|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
105413199|NCT03985943|363520388|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
105413200|NCT00441142|363520389|FG000|Overall Study|Adverse Event|2|||
105413201|NCT00441142|363520390|FG001|Overall Study|Adverse Event|3|||
105413202|NCT00441142|363520391|FG002|Overall Study|Adverse Event|3|||
105413203|NCT00441142|363520392|FG003|Overall Study|Adverse Event|22|||
105413204|NCT00441142|363520389|FG000|Overall Study|Lack of Efficacy|3|||
105413205|NCT00441142|363520390|FG001|Overall Study|Lack of Efficacy|3|||
105413206|NCT00441142|363520391|FG002|Overall Study|Lack of Efficacy|17|||
105413207|NCT00441142|363520392|FG003|Overall Study|Lack of Efficacy|32|||
105413208|NCT00441142|363520389|FG000|Overall Study|Withdrawal by Subject|0|||
105413209|NCT00441142|363520390|FG001|Overall Study|Withdrawal by Subject|0|||
105413210|NCT00441142|363520391|FG002|Overall Study|Withdrawal by Subject|2|||
105413211|NCT00441142|363520392|FG003|Overall Study|Withdrawal by Subject|10|||
105413212|NCT00441142|363520389|FG000|Overall Study|Patient still receiving active study tx|1|||
105413213|NCT00441142|363520390|FG001|Overall Study|Patient still receiving active study tx|0|||
105413214|NCT00441142|363520391|FG002|Overall Study|Patient still receiving active study tx|0|||
105413215|NCT00441142|363520392|FG003|Overall Study|Patient still receiving active study tx|2|||
105413216|NCT00441142|363520389|FG000|Overall Study|Physician Decision|0|||
105413217|NCT00441142|363520390|FG001|Overall Study|Physician Decision|1|||
105413218|NCT00441142|363520391|FG002|Overall Study|Physician Decision|0|||
105413219|NCT00441142|363520392|FG003|Overall Study|Physician Decision|1|||
105413220|NCT00441142|363520389|FG000|Overall Study|Death|0|||
105413221|NCT00441142|363520390|FG001|Overall Study|Death|0|||
105413222|NCT00441142|363520391|FG002|Overall Study|Death|0|||
105413223|NCT00441142|363520392|FG003|Overall Study|Death|1|||
105413224|NCT00338286|363520393|FG000|Overall Study|Withdrawal by Subject|50|||
105413225|NCT00338286|363520394|FG001|Overall Study|Withdrawal by Subject|54|||
105413226|NCT00338286|363520393|FG000|Overall Study|Lost to Follow-up|80|||
105413227|NCT00338286|363520394|FG001|Overall Study|Lost to Follow-up|66|||
105413228|NCT00338286|363520393|FG000|Overall Study|Other|103|||
105413229|NCT00338286|363520394|FG001|Overall Study|Other|93|||
105413230|NCT04952597|363520395|FG000|Overall Study|Death|12|||
105413231|NCT04952597|363520396|FG001|Overall Study|Death|13|||
105413232|NCT04952597|363520397|FG002|Overall Study|Death|14|||
105413233|NCT04952597|363520395|FG000|Overall Study|Withdrawal by Subject|1|||
105413234|NCT04952597|363520396|FG001|Overall Study|Withdrawal by Subject|0|||
105413235|NCT04952597|363520397|FG002|Overall Study|Withdrawal by Subject|3|||
105413236|NCT04952597|363520395|FG000|Overall Study|Lost to Follow-up|0|||
105413237|NCT04952597|363520396|FG001|Overall Study|Lost to Follow-up|1|||
105413238|NCT04952597|363520397|FG002|Overall Study|Lost to Follow-up|1|||
105413239|NCT00716482|363520401|FG000|Overall Study|Lost to Follow-up|6|||
105413240|NCT00716482|363520401|FG000|Overall Study|Inadequate acquisition or analysis|50|||
105413241|NCT00716482|363520401|FG000|Overall Study|no pathology obtained|10|||
105413242|NCT00716482|363520401|FG000|Overall Study|technical/machine error|28|||
105413243|NCT00716482|363520401|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
105413244|NCT02141399|363520402|FG000|Overall Study|Adverse Event|158|||
105413245|NCT02141399|363520402|FG000|Overall Study|Lack of Efficacy|62|||
105413246|NCT02141399|363520402|FG000|Overall Study|Lost to Follow-up|151|||
105413247|NCT02141399|363520402|FG000|Overall Study|Non-compliance with study drug|18|||
105496617|NCT00397215|363829932|FG003|Month 0 (Day 0)|Adverse Event|0|||
105496618|NCT00397215|363829929|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
105496619|NCT00397215|363829930|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
105496620|NCT00397215|363829931|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
105496621|NCT00397215|363829932|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
105496622|NCT00397215|363829929|FG000|Month 0 (Day 0)|Other|4|||
105496623|NCT00397215|363829930|FG001|Month 0 (Day 0)|Other|1|||
105496624|NCT00397215|363829931|FG002|Month 0 (Day 0)|Other|3|||
105496625|NCT00397215|363829932|FG003|Month 0 (Day 0)|Other|3|||
105496626|NCT00397215|363829929|FG000|Month 6 (Day 180)|Adverse Event|0|||
105496627|NCT00397215|363829930|FG001|Month 6 (Day 180)|Adverse Event|3|||
105496628|NCT00397215|363829931|FG002|Month 6 (Day 180)|Adverse Event|2|||
105496629|NCT00397215|363829932|FG003|Month 6 (Day 180)|Adverse Event|0|||
105496630|NCT00397215|363829929|FG000|Month 6 (Day 180)|Other|2|||
105496631|NCT00397215|363829930|FG001|Month 6 (Day 180)|Other|0|||
105496632|NCT00397215|363829931|FG002|Month 6 (Day 180)|Other|3|||
105496633|NCT00397215|363829932|FG003|Month 6 (Day 180)|Other|0|||
105496634|NCT00423514|363829933|FG000|Overall Study|Ineligible|1|||
105496635|NCT00423514|363829934|FG001|Overall Study|Ineligible|0|||
105496636|NCT03685123|363829935|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
105413248|NCT02141399|363520402|FG000|Overall Study|Other|45|||
105413249|NCT02141399|363520402|FG000|Overall Study|Physician Decision|17|||
105413250|NCT02141399|363520402|FG000|Overall Study|Pregnancy|3|||
105413251|NCT02141399|363520402|FG000|Overall Study|Protocol Violation|38|||
105413252|NCT02141399|363520402|FG000|Overall Study|Withdrawal by Subject|238|||
105413253|NCT02141399|363520402|FG000|Overall Study|Failure to meet eligibility criteria|14|||
105413254|NCT02550288|363520405|FG000|Overall Study|Adverse Event|0|||
105413255|NCT02550288|363520406|FG001|Overall Study|Adverse Event|1|||
105413256|NCT02550288|363520407|FG002|Overall Study|Adverse Event|0|||
105413257|NCT02550288|363520408|FG003|Overall Study|Adverse Event|0|||
105413258|NCT02550288|363520409|FG004|Overall Study|Adverse Event|0|||
105413259|NCT02550288|363520405|FG000|Overall Study|Physician Decision|0|||
105413260|NCT02550288|363520406|FG001|Overall Study|Physician Decision|0|||
105413261|NCT02550288|363520407|FG002|Overall Study|Physician Decision|0|||
105413262|NCT02550288|363520408|FG003|Overall Study|Physician Decision|1|||
105413263|NCT02550288|363520409|FG004|Overall Study|Physician Decision|0|||
105413264|NCT02550288|363520405|FG000|Overall Study|Protocol Violation|2|||
105413265|NCT02550288|363520406|FG001|Overall Study|Protocol Violation|2|||
105413266|NCT02550288|363520407|FG002|Overall Study|Protocol Violation|1|||
105413267|NCT02550288|363520408|FG003|Overall Study|Protocol Violation|0|||
105413268|NCT02550288|363520409|FG004|Overall Study|Protocol Violation|3|||
105413269|NCT02550288|363520405|FG000|Overall Study|Participant moved|0|||
105413270|NCT02550288|363520406|FG001|Overall Study|Participant moved|0|||
105413271|NCT02550288|363520407|FG002|Overall Study|Participant moved|0|||
105413272|NCT02550288|363520408|FG003|Overall Study|Participant moved|1|||
105413273|NCT02550288|363520409|FG004|Overall Study|Participant moved|0|||
105413274|NCT02550288|363520405|FG000|Overall Study|Withdrawal by Subject|0|||
105413275|NCT02550288|363520406|FG001|Overall Study|Withdrawal by Subject|0|||
105413276|NCT02550288|363520407|FG002|Overall Study|Withdrawal by Subject|0|||
105413277|NCT02550288|363520408|FG003|Overall Study|Withdrawal by Subject|1|||
105413278|NCT02550288|363520409|FG004|Overall Study|Withdrawal by Subject|0|||
105413279|NCT03517371|363520413|FG000|Overall Study|Adverse Event|8|||
105413280|NCT03517371|363520414|FG001|Overall Study|Adverse Event|9|||
105413281|NCT03517371|363520413|FG000|Overall Study|Lost to Follow-up|1|||
105413282|NCT03517371|363520414|FG001|Overall Study|Lost to Follow-up|2|||
105413283|NCT03517371|363520413|FG000|Overall Study|Withdrawal by Subject|4|||
105413284|NCT03517371|363520414|FG001|Overall Study|Withdrawal by Subject|4|||
105413285|NCT03517371|363520413|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
105413286|NCT03517371|363520414|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
105413287|NCT03517371|363520413|FG000|Overall Study|COVID restrictions|2|||
105413288|NCT03517371|363520414|FG001|Overall Study|COVID restrictions|0|||
105413289|NCT03517371|363520413|FG000|Overall Study|Receiving DBS Surgery|0|||
105413290|NCT03517371|363520414|FG001|Overall Study|Receiving DBS Surgery|1|||
105413291|NCT05420961|363520415|FG000|Overall Study|Withdrawal by Subject|2|||
105413292|NCT05420961|363520416|FG001|Overall Study|Withdrawal by Subject|1|||
105413293|NCT05420961|363520417|FG002|Overall Study|Withdrawal by Subject|1|||
105413294|NCT05420961|363520418|FG003|Overall Study|Withdrawal by Subject|0|||
105413295|NCT05420961|363520419|FG004|Overall Study|Withdrawal by Subject|0|||
105413296|NCT05420961|363520415|FG000|Overall Study|Lost to Follow-up|0|||
105413297|NCT05420961|363520416|FG001|Overall Study|Lost to Follow-up|0|||
105413298|NCT05420961|363520417|FG002|Overall Study|Lost to Follow-up|1|||
105413299|NCT05420961|363520418|FG003|Overall Study|Lost to Follow-up|0|||
105413300|NCT05420961|363520419|FG004|Overall Study|Lost to Follow-up|0|||
105413301|NCT05420961|363520415|FG000|Overall Study|Randomized by mistake without study treatment|0|||
105496637|NCT03685123|363829936|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
105496638|NCT03685123|363829937|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
105496639|NCT03685123|363829935|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
105496640|NCT03685123|363829936|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
105496641|NCT03685123|363829937|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
105496642|NCT03685123|363829935|FG000|Weight Loss Phase|Lost to Follow-up|1|||
105496643|NCT03685123|363829936|FG001|Weight Loss Phase|Lost to Follow-up|0|||
105496644|NCT03685123|363829937|FG002|Weight Loss Phase|Lost to Follow-up|0|||
105496645|NCT03685123|363829935|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
105496646|NCT03685123|363829936|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
105496647|NCT03685123|363829937|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
105496648|NCT03685123|363829935|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
105496649|NCT03685123|363829936|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
105413302|NCT05420961|363520416|FG001|Overall Study|Randomized by mistake without study treatment|0|||
105413303|NCT05420961|363520417|FG002|Overall Study|Randomized by mistake without study treatment|1|||
105413304|NCT05420961|363520418|FG003|Overall Study|Randomized by mistake without study treatment|0|||
105413305|NCT05420961|363520419|FG004|Overall Study|Randomized by mistake without study treatment|1|||
105413306|NCT04283656|363520420|FG000|Overall Study|Adverse Event|1|||
105413307|NCT04283656|363520421|FG001|Overall Study|Adverse Event|0|||
105413308|NCT04283656|363520420|FG000|Overall Study|Lost to Follow-up|0|||
105413309|NCT04283656|363520421|FG001|Overall Study|Lost to Follow-up|1|||
105413310|NCT01345929|363520422|FG000|Overall Study|Withdrawal by Subject|9|||
105413311|NCT01345929|363520423|FG001|Overall Study|Withdrawal by Subject|8|||
105413312|NCT01345929|363520422|FG000|Overall Study|Lost to Follow-up|9|||
105413313|NCT01345929|363520423|FG001|Overall Study|Lost to Follow-up|9|||
105413314|NCT01345929|363520422|FG000|Overall Study|Adverse Event|0|||
105413315|NCT01345929|363520423|FG001|Overall Study|Adverse Event|1|||
105413316|NCT01345929|363520422|FG000|Overall Study|Didn't meet eligibility criteria|2|||
105413317|NCT01345929|363520423|FG001|Overall Study|Didn't meet eligibility criteria|0|||
105413318|NCT01345929|363520422|FG000|Overall Study|40,000 CFU/ML|1|||
105413319|NCT01345929|363520423|FG001|Overall Study|40,000 CFU/ML|0|||
105413320|NCT01345929|363520422|FG000|Overall Study|Patient withdrawal|0|||
105413321|NCT01345929|363520423|FG001|Overall Study|Patient withdrawal|1|||
105413322|NCT01864148|363520424|FG000|Overall Study|Other|2|||
105413323|NCT01864148|363520425|FG001|Overall Study|Other|1|||
105413324|NCT01864148|363520426|FG002|Overall Study|Other|1|||
105413325|NCT01864148|363520427|FG003|Overall Study|Other|3|||
105413326|NCT01864148|363520428|FG004|Overall Study|Other|1|||
105413327|NCT01864148|363520424|FG000|Overall Study|Death|0|||
105413328|NCT01864148|363520425|FG001|Overall Study|Death|0|||
105413329|NCT01864148|363520426|FG002|Overall Study|Death|0|||
105413330|NCT01864148|363520427|FG003|Overall Study|Death|1|||
105413331|NCT01864148|363520428|FG004|Overall Study|Death|0|||
105413332|NCT01864148|363520424|FG000|Overall Study|Investigator Decision|5|||
105413333|NCT01864148|363520425|FG001|Overall Study|Investigator Decision|0|||
105413334|NCT01864148|363520426|FG002|Overall Study|Investigator Decision|0|||
105413335|NCT01864148|363520427|FG003|Overall Study|Investigator Decision|4|||
105413336|NCT01864148|363520428|FG004|Overall Study|Investigator Decision|6|||
105413337|NCT01864148|363520424|FG000|Overall Study|Withdrawal by Subject|9|||
105413338|NCT01864148|363520425|FG001|Overall Study|Withdrawal by Subject|2|||
105413339|NCT01864148|363520426|FG002|Overall Study|Withdrawal by Subject|6|||
105413340|NCT01864148|363520427|FG003|Overall Study|Withdrawal by Subject|8|||
105413341|NCT01864148|363520428|FG004|Overall Study|Withdrawal by Subject|8|||
105413342|NCT01864148|363520424|FG000|Overall Study|Lost to Follow-up|0|||
105413343|NCT01864148|363520425|FG001|Overall Study|Lost to Follow-up|0|||
105413344|NCT01864148|363520426|FG002|Overall Study|Lost to Follow-up|0|||
105413345|NCT01864148|363520427|FG003|Overall Study|Lost to Follow-up|2|||
105413346|NCT01864148|363520428|FG004|Overall Study|Lost to Follow-up|1|||
105413347|NCT01864148|363520424|FG000|Overall Study|Adverse Event|4|||
105413348|NCT01864148|363520425|FG001|Overall Study|Adverse Event|2|||
105413349|NCT01864148|363520426|FG002|Overall Study|Adverse Event|4|||
105413350|NCT01864148|363520427|FG003|Overall Study|Adverse Event|7|||
105413351|NCT01864148|363520428|FG004|Overall Study|Adverse Event|7|||
105413352|NCT01864148|363520424|FG000|Overall Study|Not Dosed|0|||
105413353|NCT01864148|363520425|FG001|Overall Study|Not Dosed|0|||
105413354|NCT01864148|363520426|FG002|Overall Study|Not Dosed|0|||
105413355|NCT01864148|363520427|FG003|Overall Study|Not Dosed|1|||
105413356|NCT01864148|363520428|FG004|Overall Study|Not Dosed|0|||
105413357|NCT00964002|363520430|FG000|Overall Study|Protocol Violation|8|||
105413358|NCT02466425|363520431|FG000|Overall Study|Adverse Event|3|||
105413359|NCT02466425|363520432|FG001|Overall Study|Adverse Event|11|||
105413360|NCT02466425|363520431|FG000|Overall Study|Lack of Efficacy|4|||
105413361|NCT02466425|363520432|FG001|Overall Study|Lack of Efficacy|1|||
105413362|NCT02466425|363520431|FG000|Overall Study|Lost to Follow-up|3|||
105413363|NCT02466425|363520432|FG001|Overall Study|Lost to Follow-up|0|||
105413364|NCT02466425|363520431|FG000|Overall Study|Protocol Violation|1|||
105413365|NCT02466425|363520432|FG001|Overall Study|Protocol Violation|0|||
105413366|NCT02466425|363520431|FG000|Overall Study|Withdrawal by Subject|0|||
105413367|NCT02466425|363520432|FG001|Overall Study|Withdrawal by Subject|1|||
105413368|NCT02466425|363520431|FG000|Overall Study|Other|1|||
105413369|NCT02466425|363520432|FG001|Overall Study|Other|3|||
105413370|NCT02466425|363520431|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
105413371|NCT02466425|363520432|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105413372|NCT01721486|363520437|FG000|Overall Study|Protocol Violation|1|||
105413373|NCT01721486|363520438|FG001|Overall Study|Protocol Violation|0|||
105413374|NCT01721486|363520437|FG000|Overall Study|Physician Decision|0|||
105413375|NCT01721486|363520438|FG001|Overall Study|Physician Decision|1|||
105413376|NCT04004221|363520445|FG000|Overall Study|Death|89|||
105413377|NCT04004221|363520445|FG000|Overall Study|Withdrawal by Subject|5|||
105413378|NCT04004221|363520445|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
105413379|NCT04004221|363520445|FG000|Overall Study|Sponsor Decision|9|||
105413380|NCT04004221|363520445|FG000|Overall Study|Participant refused to enter LTE|1|||
105413381|NCT05141175|363520446|FG000|Overall Study|Withdrawal by Subject|1|||
105413382|NCT01901289|363520448|FG000|Overall Study|Death|32|||
105496650|NCT03685123|363829937|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
105496651|NCT03685123|363829935|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
105496652|NCT03685123|363829936|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
105496653|NCT03685123|363829937|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
105496654|NCT02959983|363829938|FG000|Overall Study|Protocol Violation|0|||
105496655|NCT02959983|363829939|FG001|Overall Study|Protocol Violation|1|||
105496656|NCT02959983|363829938|FG000|Overall Study|Lack of Efficacy|0|||
105496657|NCT02959983|363829939|FG001|Overall Study|Lack of Efficacy|1|||
105496658|NCT02959983|363829938|FG000|Overall Study|Lost to Follow-up|12|||
105496659|NCT02959983|363829939|FG001|Overall Study|Lost to Follow-up|9|||
105496660|NCT02959983|363829938|FG000|Overall Study|Other|1|||
105496661|NCT02959983|363829939|FG001|Overall Study|Other|1|||
105496662|NCT02959983|363829938|FG000|Overall Study|Physician Decision|1|||
105496663|NCT02959983|363829939|FG001|Overall Study|Physician Decision|0|||
105496664|NCT02959983|363829938|FG000|Overall Study|Adverse Event|5|||
105496665|NCT02959983|363829939|FG001|Overall Study|Adverse Event|1|||
105496666|NCT02959983|363829938|FG000|Overall Study|Withdrawal by Subject|7|||
105496667|NCT02959983|363829939|FG001|Overall Study|Withdrawal by Subject|12|||
105496668|NCT00484094|363829940|FG000|Overall Study|Discontinued|39|||
105496669|NCT00484094|363829940|FG000|Overall Study|Other|3|||
105496670|NCT00165984|363829944|FG000|Overall Study|Death|15|||
105496671|NCT01414608|363829945|FG000|Overall Study|Ineligible|5|||
105496672|NCT01414608|363829946|FG001|Overall Study|Ineligible|2|||
105496673|NCT04478266|363829947|FG000|Overall Study|Adverse Event|20|||
105496674|NCT04478266|363829948|FG001|Overall Study|Adverse Event|21|||
105496675|NCT04478266|363829947|FG000|Overall Study|Progressive disease|146|||
105496676|NCT04478266|363829948|FG001|Overall Study|Progressive disease|168|||
105496677|NCT04478266|363829947|FG000|Overall Study|Poor compliance to protocol|1|||
105496678|NCT04478266|363829948|FG001|Overall Study|Poor compliance to protocol|0|||
105496679|NCT04478266|363829947|FG000|Overall Study|Withdrawal by Subject|19|||
105496680|NCT04478266|363829948|FG001|Overall Study|Withdrawal by Subject|16|||
105496681|NCT04478266|363829947|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
105496682|NCT04478266|363829948|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
105496683|NCT04478266|363829947|FG000|Overall Study|Study terminated by sponsor|33|||
105496684|NCT04478266|363829948|FG001|Overall Study|Study terminated by sponsor|35|||
105496685|NCT04478266|363829947|FG000|Overall Study|Other: unspecified|5|||
105496686|NCT04478266|363829948|FG001|Overall Study|Other: unspecified|7|||
105496687|NCT04478266|363829947|FG000|Overall Study|Randomized but not treated|1|||
105496688|NCT04478266|363829948|FG001|Overall Study|Randomized but not treated|1|||
105496689|NCT03001882|363829949|FG000|Overall Study|Death|1|||
105496690|NCT03001882|363829950|FG001|Overall Study|Death|0|||
105496691|NCT03001882|363829951|FG002|Overall Study|Death|0|||
105496692|NCT03001882|363829952|FG003|Overall Study|Death|3|||
105496693|NCT03001882|363829949|FG000|Overall Study|Participant withdrew consent|0|||
105496694|NCT03001882|363829950|FG001|Overall Study|Participant withdrew consent|1|||
105496695|NCT03001882|363829951|FG002|Overall Study|Participant withdrew consent|0|||
105496696|NCT03001882|363829952|FG003|Overall Study|Participant withdrew consent|5|||
105496697|NCT03001882|363829949|FG000|Overall Study|Other reasons|1|||
105496698|NCT03001882|363829950|FG001|Overall Study|Other reasons|2|||
105496699|NCT03001882|363829951|FG002|Overall Study|Other reasons|0|||
105496700|NCT03001882|363829952|FG003|Overall Study|Other reasons|5|||
105496701|NCT03001882|363829949|FG000|Overall Study|Administrative reason by sponsor|0|||
105496702|NCT03001882|363829950|FG001|Overall Study|Administrative reason by sponsor|0|||
105496703|NCT03001882|363829951|FG002|Overall Study|Administrative reason by sponsor|0|||
105496704|NCT03001882|363829952|FG003|Overall Study|Administrative reason by sponsor|1|||
105496705|NCT03001882|363829949|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
105496706|NCT03001882|363829950|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
105496707|NCT03001882|363829951|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
105496708|NCT03001882|363829952|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
105496709|NCT03001882|363829949|FG000|Overall Study|Not reported|0|||
105496710|NCT03001882|363829950|FG001|Overall Study|Not reported|0|||
105496711|NCT03001882|363829951|FG002|Overall Study|Not reported|0|||
105581984|NCT01544582|364127934|FG000|Analysis Population|Programmed Surgery|0|||
105581985|NCT01544582|364127935|FG001|Analysis Population|Programmed Surgery|1|||
105581986|NCT01544582|364127936|FG002|Analysis Population|Programmed Surgery|0|||
105496712|NCT03001882|363829952|FG003|Overall Study|Not reported|6|||
105496713|NCT03001882|363829949|FG000|Overall Study|Maximum clinical benefit|2|||
105496714|NCT03001882|363829950|FG001|Overall Study|Maximum clinical benefit|3|||
105496715|NCT03001882|363829951|FG002|Overall Study|Maximum clinical benefit|0|||
105496716|NCT03001882|363829952|FG003|Overall Study|Maximum clinical benefit|10|||
105496717|NCT03001882|363829949|FG000|Overall Study|AE unrelated to study drug|3|||
105496718|NCT03001882|363829950|FG001|Overall Study|AE unrelated to study drug|3|||
105496719|NCT03001882|363829951|FG002|Overall Study|AE unrelated to study drug|0|||
105496720|NCT03001882|363829952|FG003|Overall Study|AE unrelated to study drug|11|||
105496721|NCT03001882|363829949|FG000|Overall Study|Study Drug Toxicity|8|||
105581987|NCT01544582|364127937|FG003|Analysis Population|Programmed Surgery|0|||
105496722|NCT03001882|363829950|FG001|Overall Study|Study Drug Toxicity|5|||
105496723|NCT03001882|363829951|FG002|Overall Study|Study Drug Toxicity|0|||
105496724|NCT03001882|363829952|FG003|Overall Study|Study Drug Toxicity|37|||
105496725|NCT03001882|363829949|FG000|Overall Study|Disease progression|16|||
105496726|NCT03001882|363829950|FG001|Overall Study|Disease progression|14|||
105496727|NCT03001882|363829951|FG002|Overall Study|Disease progression|1|||
105496728|NCT03001882|363829952|FG003|Overall Study|Disease progression|90|||
105496729|NCT01897714|363831916|FG000|Phase I (Dose Escalation)|Disease progression|3|||
105496730|NCT01897714|363831917|FG001|Phase I (Dose Escalation)|Disease progression|5|||
105496731|NCT01897714|363831918|FG002|Phase I (Dose Escalation)|Disease progression|1|||
105413383|NCT01901289|363520448|FG000|Overall Study|Lost to Follow-up|16|||
105413384|NCT01901289|363520448|FG000|Overall Study|Withdrawal by Subject|35|||
105413385|NCT01901289|363520448|FG000|Overall Study|Other type of endpoint met|2|||
105413386|NCT00992056|363520449|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
105413387|NCT00992056|363520450|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
105413388|NCT00992056|363520449|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
105413389|NCT00992056|363520450|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
105413390|NCT00177294|363520453|FG000|Overall Study|Withdrawal by Subject|7|||
105413391|NCT00177294|363520454|FG001|Overall Study|Withdrawal by Subject|5|||
105413392|NCT03745638|363520460|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
105413393|NCT03745638|363520461|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
105413394|NCT03745638|363520462|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
105413395|NCT03745638|363520463|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105413396|NCT03745638|363520464|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105413397|NCT03745638|363520465|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105413398|NCT03745638|363520466|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105413399|NCT03745638|363520460|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
105413400|NCT03745638|363520461|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105413401|NCT03745638|363520462|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105413402|NCT03745638|363520463|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105413403|NCT03745638|363520464|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105413404|NCT03745638|363520465|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105413405|NCT03745638|363520466|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105413406|NCT03745638|363520460|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
105413407|NCT03745638|363520461|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
105413408|NCT03745638|363520462|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
105413409|NCT03745638|363520463|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105413410|NCT03745638|363520464|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105413411|NCT03745638|363520465|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105413412|NCT03745638|363520466|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105496732|NCT01897714|363831919|FG003|Phase I (Dose Escalation)|Disease progression|3|||
105496733|NCT01897714|363831920|FG004|Phase I (Dose Escalation)|Disease progression|0|||
105496734|NCT01897714|363831921|FG005|Phase I (Dose Escalation)|Disease progression|0|||
105496735|NCT01897714|363831916|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
105413413|NCT03745638|363520460|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
105581988|NCT01544582|364127934|FG000|Analysis Population|Participant in Jail|0|||
105581989|NCT01544582|364127935|FG001|Analysis Population|Participant in Jail|0|||
105581990|NCT01544582|364127936|FG002|Analysis Population|Participant in Jail|1|||
105581991|NCT01544582|364127937|FG003|Analysis Population|Participant in Jail|0|||
105581992|NCT01778062|364127938|FG000|Overall Study|Adverse Event|1|||
105581993|NCT01778062|364127939|FG001|Overall Study|Adverse Event|3|||
105581994|NCT01778062|364127938|FG000|Overall Study|Consent Withdrawal|1|||
105581995|NCT01778062|364127939|FG001|Overall Study|Consent Withdrawal|5|||
105581996|NCT01778062|364127938|FG000|Overall Study|major protocol deviation|4|||
105581997|NCT01778062|364127939|FG001|Overall Study|major protocol deviation|3|||
105581998|NCT03958630|364127940|FG000|Overall Study|Withdrawal by Subject|0|||
105413414|NCT03745638|363520461|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
105413415|NCT03745638|363520462|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105413416|NCT03745638|363520463|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105413417|NCT03745638|363520464|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105413418|NCT03745638|363520465|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105413419|NCT03745638|363520466|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105413420|NCT03745638|363520460|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
105413421|NCT03745638|363520461|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
105413422|NCT03745638|363520462|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
105413423|NCT03745638|363520463|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
105413424|NCT03745638|363520464|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
105413425|NCT03745638|363520465|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
105413426|NCT03745638|363520466|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
105413427|NCT03745638|363520460|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105413428|NCT03745638|363520461|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
105413429|NCT03745638|363520462|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105413430|NCT03745638|363520463|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105413431|NCT03745638|363520464|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105413432|NCT03745638|363520465|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105413433|NCT03745638|363520466|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105413434|NCT03745638|363520460|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
105413435|NCT03745638|363520461|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
105413436|NCT03745638|363520462|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
105413437|NCT03745638|363520463|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105413438|NCT03745638|363520464|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105413439|NCT03745638|363520465|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105413440|NCT03745638|363520466|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105413441|NCT03745638|363520460|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
105413442|NCT03745638|363520461|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
105413443|NCT03745638|363520462|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
105413444|NCT03745638|363520463|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
105413445|NCT03745638|363520464|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
105413446|NCT03745638|363520465|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
105413447|NCT03745638|363520466|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
105413448|NCT03745638|363520460|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105413449|NCT03745638|363520461|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105413450|NCT03745638|363520462|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105413451|NCT03745638|363520463|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105413452|NCT03745638|363520464|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105413453|NCT03745638|363520465|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
105413454|NCT03745638|363520466|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
105413455|NCT03745638|363520460|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105413456|NCT03745638|363520461|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105413457|NCT03745638|363520462|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105413458|NCT03745638|363520463|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
105413459|NCT03745638|363520464|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105413460|NCT03745638|363520465|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
105413461|NCT03745638|363520466|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
105413462|NCT03745638|363520460|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
105413463|NCT03745638|363520461|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
105413464|NCT03745638|363520462|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
105581999|NCT03958630|364127941|FG001|Overall Study|Withdrawal by Subject|0|||
105582000|NCT03958630|364127942|FG002|Overall Study|Withdrawal by Subject|1|||
105582001|NCT03958630|364127940|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
105582002|NCT03958630|364127941|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
105582003|NCT03958630|364127942|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
105582004|NCT00394095|364129936|FG000|Screening|Withdrawal by Subject|1|||
105582005|NCT00394095|364129937|FG001|Screening|Withdrawal by Subject|0|||
105582006|NCT00394095|364129936|FG000|Randomized|Withdrawal by Subject|5|||
105582007|NCT00394095|364129937|FG001|Randomized|Withdrawal by Subject|1|||
105582008|NCT00394095|364129936|FG000|Randomized|Adverse Event|1|||
105582009|NCT00394095|364129937|FG001|Randomized|Adverse Event|1|||
105582010|NCT00394095|364129936|FG000|Randomized|Overdose|1|||
105582011|NCT00394095|364129937|FG001|Randomized|Overdose|0|||
105582012|NCT00394095|364129936|FG000|Randomized|Lost to Follow-up|1|||
105582013|NCT00394095|364129937|FG001|Randomized|Lost to Follow-up|2|||
105582014|NCT02169830|364129938|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
105582015|NCT02169830|364129939|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
105582016|NCT02169830|364129940|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
105582017|NCT02169830|364129938|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
105582018|NCT02169830|364129939|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
105582019|NCT02169830|364129940|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
105582020|NCT02169830|364129938|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
105582021|NCT02169830|364129939|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
105582022|NCT02169830|364129940|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
105582023|NCT02169830|364129938|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
105582024|NCT02169830|364129939|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
105582025|NCT02169830|364129940|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
105582026|NCT02169830|364129938|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
105582027|NCT02169830|364129939|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
105582028|NCT02169830|364129940|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
105582029|NCT00777803|364129941|FG000|Overall Study|Lost to Follow-up|12|||
105582030|NCT00777803|364129942|FG001|Overall Study|Lost to Follow-up|5|||
105582031|NCT00777803|364129941|FG000|Overall Study|Adverse Event|1|||
105582032|NCT00777803|364129942|FG001|Overall Study|Adverse Event|0|||
105582033|NCT00777803|364129941|FG000|Overall Study|Non-compliance|2|||
105582034|NCT00777803|364129942|FG001|Overall Study|Non-compliance|2|||
105582035|NCT04129580|364129946|FG000|Overall Study|Lost to Follow-up|14|||
105582036|NCT04129580|364129947|FG001|Overall Study|Lost to Follow-up|25|||
105582037|NCT00802841|364129948|FG000|Overall Study|Administrative problems|1|||
105582038|NCT00802841|364129949|FG001|Overall Study|Administrative problems|0|||
105582039|NCT00802841|364129948|FG000|Overall Study|Lost to Follow-up|2|||
105582040|NCT00802841|364129949|FG001|Overall Study|Lost to Follow-up|1|||
105582041|NCT00802841|364129948|FG000|Overall Study|Death|1|||
105582042|NCT00802841|364129949|FG001|Overall Study|Death|2|||
105582043|NCT00802841|364129948|FG000|Overall Study|Adverse Event|8|||
105582044|NCT00802841|364129949|FG001|Overall Study|Adverse Event|2|||
105582045|NCT00802841|364129948|FG000|Overall Study|Disease progression|7|||
105582046|NCT00802841|364129949|FG001|Overall Study|Disease progression|3|||
105582047|NCT00802841|364129948|FG000|Overall Study|Withdrawal by Subject|9|||
105582048|NCT00802841|364129949|FG001|Overall Study|Withdrawal by Subject|5|||
105582049|NCT00802841|364129948|FG000|Overall Study|Protocol deviation|2|||
105582050|NCT00802841|364129949|FG001|Overall Study|Protocol deviation|6|||
105582051|NCT00802841|364129948|FG000|Overall Study|Treatment duration completed|66|||
105582052|NCT00802841|364129949|FG001|Overall Study|Treatment duration completed|76|||
105582053|NCT03615482|364129952|FG000|Overall Study|Death|1|||
105582054|NCT03615482|364129953|FG001|Overall Study|Death|0|||
105582055|NCT03615482|364129952|FG000|Overall Study|Lost to Follow-up|7|||
105582056|NCT03615482|364129953|FG001|Overall Study|Lost to Follow-up|7|||
105582057|NCT03615482|364129952|FG000|Overall Study|Physician Decision|2|||
105582058|NCT03615482|364129953|FG001|Overall Study|Physician Decision|3|||
105582059|NCT03615482|364129952|FG000|Overall Study|Withdrawal by Subject|7|||
105582060|NCT03615482|364129953|FG001|Overall Study|Withdrawal by Subject|7|||
105582061|NCT00322868|364129954|FG000|Overall Study|disease progression|1|||
105582062|NCT02955277|364129957|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
105582063|NCT02955277|364129958|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
105582064|NCT02955277|364129957|FG000|Post to Follow-up|Lost to Follow-up|8|||
105582065|NCT02955277|364129958|FG001|Post to Follow-up|Lost to Follow-up|11|||
105582066|NCT00107380|364129961|FG000|Overall Study|Adverse Event|7|||
105582067|NCT00107380|364129961|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
105582068|NCT00107380|364129961|FG000|Overall Study|Progression/relapse|4|||
105582069|NCT00107380|364129961|FG000|Overall Study|Death|3|||
105582070|NCT00107380|364129961|FG000|Overall Study|Other - not protocol specified|7|||
105582071|NCT00107380|364129961|FG000|Overall Study|Ineligible|2|||
105582072|NCT01642186|364129969|FG000|Overall Study|Death|0|||
105582073|NCT01642186|364129970|FG001|Overall Study|Death|2|||
105582074|NCT01642186|364129971|FG002|Overall Study|Death|2|||
105582075|NCT01642186|364129969|FG000|Overall Study|Lost to Follow-up|0|||
105582076|NCT01642186|364129970|FG001|Overall Study|Lost to Follow-up|0|||
105582077|NCT01642186|364129971|FG002|Overall Study|Lost to Follow-up|1|||
105582078|NCT02718417|364129972|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
105582079|NCT02718417|364129973|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
105582080|NCT02718417|364129974|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
105582081|NCT02718417|364129972|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
105582082|NCT02718417|364129973|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
105582083|NCT02718417|364129974|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
105582084|NCT02718417|364129972|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
105582085|NCT02718417|364129973|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
105582086|NCT02718417|364129974|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
105582087|NCT02718417|364129972|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
105582088|NCT02718417|364129973|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
105582089|NCT02718417|364129974|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
105582090|NCT02718417|364129972|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
105582091|NCT02718417|364129973|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
105582092|NCT02718417|364129974|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
105582093|NCT02718417|364129972|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
105582094|NCT02718417|364129973|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
105582095|NCT02718417|364129974|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
105582096|NCT02718417|364129972|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
105582097|NCT02718417|364129973|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
105582098|NCT02718417|364129974|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
105582099|NCT02718417|364129972|FG000|Chemotherapy Phase (CP)|Other|2|||
105582100|NCT02718417|364129973|FG001|Chemotherapy Phase (CP)|Other|0|||
105582101|NCT02718417|364129974|FG002|Chemotherapy Phase (CP)|Other|1|||
105582102|NCT02718417|364129972|FG000|Maintenance Phase (MP)|Adverse Event|21|||
105582103|NCT02718417|364129973|FG001|Maintenance Phase (MP)|Adverse Event|26|||
105582104|NCT02718417|364129974|FG002|Maintenance Phase (MP)|Adverse Event|0|||
105582105|NCT02718417|364129972|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
105582106|NCT02718417|364129973|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
105582107|NCT02718417|364129974|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
105582108|NCT02718417|364129972|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
105582109|NCT02718417|364129973|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
105582110|NCT02718417|364129974|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
105582111|NCT02718417|364129972|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
105582112|NCT02718417|364129973|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
105582113|NCT02718417|364129974|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
105582114|NCT02718417|364129972|FG000|Maintenance Phase (MP)|Physician's decision|6|||
105582115|NCT02718417|364129973|FG001|Maintenance Phase (MP)|Physician's decision|7|||
105582116|NCT02718417|364129974|FG002|Maintenance Phase (MP)|Physician's decision|0|||
105582117|NCT02718417|364129972|FG000|Maintenance Phase (MP)|Progressive disease|100|||
105582118|NCT02718417|364129973|FG001|Maintenance Phase (MP)|Progressive disease|88|||
105582119|NCT02718417|364129974|FG002|Maintenance Phase (MP)|Progressive disease|0|||
105582120|NCT02718417|364129972|FG000|Maintenance Phase (MP)|Other|2|||
105582121|NCT02718417|364129973|FG001|Maintenance Phase (MP)|Other|1|||
105582122|NCT02718417|364129974|FG002|Maintenance Phase (MP)|Other|0|||
105582123|NCT02718417|364129972|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
105582124|NCT02718417|364129973|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
105582125|NCT02718417|364129974|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
105582126|NCT02718417|364129972|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
105582127|NCT02718417|364129973|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
105582128|NCT02718417|364129974|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
105582129|NCT02718417|364129972|FG000|Observation Phase (OP)|Adverse Event|0|||
105582130|NCT02718417|364129973|FG001|Observation Phase (OP)|Adverse Event|0|||
105582131|NCT02718417|364129974|FG002|Observation Phase (OP)|Adverse Event|1|||
105582132|NCT02718417|364129972|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
105582133|NCT02718417|364129973|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
105582134|NCT02718417|364129974|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
105582135|NCT02718417|364129972|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
105582136|NCT02718417|364129973|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
105582137|NCT02718417|364129974|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
105582138|NCT02718417|364129972|FG000|Observation Phase (OP)|Physician Decision|0|||
105582139|NCT02718417|364129973|FG001|Observation Phase (OP)|Physician Decision|0|||
105582140|NCT02718417|364129974|FG002|Observation Phase (OP)|Physician Decision|9|||
105582141|NCT02718417|364129972|FG000|Observation Phase (OP)|Progressive disease|0|||
105582142|NCT02718417|364129973|FG001|Observation Phase (OP)|Progressive disease|0|||
105582143|NCT02718417|364129974|FG002|Observation Phase (OP)|Progressive disease|92|||
105582144|NCT02718417|364129972|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
105582145|NCT02718417|364129973|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
105413465|NCT03745638|363520463|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
105413466|NCT03745638|363520464|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
105413467|NCT03745638|363520465|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
105413468|NCT03745638|363520466|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
105413469|NCT03745638|363520460|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105413470|NCT03745638|363520461|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105413471|NCT03745638|363520462|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105413472|NCT03745638|363520463|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105413473|NCT03745638|363520464|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
105413474|NCT03745638|363520465|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
105413475|NCT03745638|363520466|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105413476|NCT03745638|363520460|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105413477|NCT03745638|363520461|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105413478|NCT03745638|363520462|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105413479|NCT03745638|363520463|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105413480|NCT03745638|363520464|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105413481|NCT03745638|363520465|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
105413482|NCT03745638|363520466|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105413483|NCT03745638|363520460|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
105413484|NCT03745638|363520461|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
105413485|NCT03745638|363520462|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
105413486|NCT03745638|363520463|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
105413487|NCT03745638|363520464|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
105413488|NCT03745638|363520465|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
105413489|NCT03745638|363520466|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
105413490|NCT03745638|363520460|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
105413491|NCT03745638|363520461|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
105413492|NCT03745638|363520462|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
105413493|NCT03745638|363520463|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
105413494|NCT03745638|363520464|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
105413495|NCT03745638|363520465|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
105413496|NCT03745638|363520466|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
105413497|NCT04470050|363520469|FG000|Double-blind Treatment Phase|Adverse Event|0|||
105413498|NCT04470050|363520470|FG001|Double-blind Treatment Phase|Adverse Event|0|||
105413499|NCT04470050|363520471|FG002|Double-blind Treatment Phase|Adverse Event|0|||
105413500|NCT04470050|363520472|FG003|Double-blind Treatment Phase|Adverse Event|1|||
105413501|NCT04470050|363520473|FG004|Double-blind Treatment Phase|Adverse Event|0|||
105413502|NCT04470050|363520474|FG005|Double-blind Treatment Phase|Adverse Event|0|||
105413503|NCT04470050|363520475|FG006|Double-blind Treatment Phase|Adverse Event|0|||
105413504|NCT04470050|363520469|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
105413505|NCT04470050|363520470|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
105413506|NCT04470050|363520471|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
105413507|NCT04470050|363520472|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
105413508|NCT04470050|363520473|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
105413509|NCT04470050|363520474|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
105413510|NCT04470050|363520475|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
105413511|NCT04470050|363520469|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
105413512|NCT04470050|363520470|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
105413513|NCT04470050|363520471|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
105413514|NCT04470050|363520472|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
105413515|NCT04470050|363520473|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
105413516|NCT04470050|363520474|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
105413517|NCT04470050|363520475|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
105413518|NCT01813058|363520476|FG000|Overall Study|Withdrawal by Subject|5|||
105413519|NCT01813058|363520477|FG001|Overall Study|Withdrawal by Subject|4|||
105413520|NCT01104545|363520479|FG000|Overall Study|Adverse Event|0|||
105413521|NCT01104545|363520480|FG001|Overall Study|Adverse Event|1|||
105413522|NCT01104545|363520481|FG002|Overall Study|Adverse Event|2|||
105413523|NCT03585764|363520484|FG000|Overall Study|Death|3|||
105413524|NCT03585764|363520485|FG001|Overall Study|Death|2|||
105413525|NCT03585764|363520486|FG002|Overall Study|Death|3|||
105413526|NCT03585764|363520487|FG003|Overall Study|Death|0|||
105582146|NCT02718417|364129974|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
105582147|NCT02718417|364129972|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
105582148|NCT02718417|364129973|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
105582149|NCT02718417|364129974|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
105496736|NCT01897714|363831917|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
105496737|NCT01897714|363831918|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
105496738|NCT01897714|363831919|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
105496739|NCT01897714|363831920|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
105496740|NCT01897714|363831921|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
105496741|NCT01897714|363831916|FG000|Phase I (Dose Escalation)|Other|0|||
105496742|NCT01897714|363831917|FG001|Phase I (Dose Escalation)|Other|1|||
105496743|NCT01897714|363831918|FG002|Phase I (Dose Escalation)|Other|0|||
105496744|NCT01897714|363831919|FG003|Phase I (Dose Escalation)|Other|0|||
105496745|NCT01897714|363831920|FG004|Phase I (Dose Escalation)|Other|0|||
105496746|NCT01897714|363831921|FG005|Phase I (Dose Escalation)|Other|0|||
105496747|NCT01897714|363831916|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
105496748|NCT01897714|363831917|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
105496749|NCT01897714|363831918|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
105496750|NCT01897714|363831919|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
105496751|NCT01897714|363831920|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
105496752|NCT01897714|363831921|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
105496753|NCT01897714|363831916|FG000|Phase II (MTD)|Lost to Follow-up|0|||
105496754|NCT01897714|363831917|FG001|Phase II (MTD)|Lost to Follow-up|0|||
105496755|NCT01897714|363831918|FG002|Phase II (MTD)|Lost to Follow-up|0|||
105496756|NCT01897714|363831919|FG003|Phase II (MTD)|Lost to Follow-up|0|||
105496757|NCT01897714|363831920|FG004|Phase II (MTD)|Lost to Follow-up|1|||
105496758|NCT01897714|363831921|FG005|Phase II (MTD)|Lost to Follow-up|0|||
105496759|NCT01897714|363831916|FG000|Phase II (MTD)|Death|0|||
105496760|NCT01897714|363831917|FG001|Phase II (MTD)|Death|0|||
105496761|NCT01897714|363831918|FG002|Phase II (MTD)|Death|0|||
105496762|NCT01897714|363831919|FG003|Phase II (MTD)|Death|0|||
105496763|NCT01897714|363831920|FG004|Phase II (MTD)|Death|25|||
105496764|NCT01897714|363831921|FG005|Phase II (MTD)|Death|10|||
105496765|NCT01897714|363831916|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
105496766|NCT01897714|363831917|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
105496767|NCT01897714|363831918|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
105496768|NCT01897714|363831919|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
105496769|NCT01897714|363831920|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
105496770|NCT01897714|363831921|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
105496771|NCT01897714|363831916|FG000|Phase II (MTD)|Other|0|||
105496772|NCT01897714|363831917|FG001|Phase II (MTD)|Other|0|||
105496773|NCT01897714|363831918|FG002|Phase II (MTD)|Other|0|||
105496774|NCT01897714|363831919|FG003|Phase II (MTD)|Other|0|||
105496775|NCT01897714|363831920|FG004|Phase II (MTD)|Other|3|||
105496776|NCT01897714|363831921|FG005|Phase II (MTD)|Other|0|||
105496777|NCT00392015|363831923|FG000|Overall Study|Lost to Follow-up|2|||
105496778|NCT00392015|363831924|FG001|Overall Study|Lost to Follow-up|0|||
105496779|NCT00392015|363831925|FG002|Overall Study|Lost to Follow-up|2|||
105496780|NCT00392015|363831926|FG003|Overall Study|Lost to Follow-up|1|||
105496781|NCT00392015|363831927|FG004|Overall Study|Lost to Follow-up|1|||
105413527|NCT03585764|363520484|FG000|Overall Study|Lost to Follow-up|0|||
105413528|NCT03585764|363520485|FG001|Overall Study|Lost to Follow-up|1|||
105413529|NCT03585764|363520486|FG002|Overall Study|Lost to Follow-up|0|||
105413530|NCT03585764|363520487|FG003|Overall Study|Lost to Follow-up|0|||
105413531|NCT03585764|363520484|FG000|Overall Study|Physician Decision|0|||
105413532|NCT03585764|363520485|FG001|Overall Study|Physician Decision|0|||
105413533|NCT03585764|363520486|FG002|Overall Study|Physician Decision|2|||
105413534|NCT03585764|363520487|FG003|Overall Study|Physician Decision|0|||
105413535|NCT01536561|363520489|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
105413536|NCT01536561|363520489|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
105413537|NCT01536561|363520489|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
105413538|NCT01536561|363520489|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
105413539|NCT01536561|363520489|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
105413540|NCT01536561|363520489|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
105496782|NCT00392015|363831928|FG005|Overall Study|Lost to Follow-up|0|||
105496783|NCT00392015|363831923|FG000|Overall Study|Withdrawal by Subject|0|||
105496784|NCT00392015|363831924|FG001|Overall Study|Withdrawal by Subject|0|||
105496785|NCT00392015|363831925|FG002|Overall Study|Withdrawal by Subject|2|||
105496786|NCT00392015|363831926|FG003|Overall Study|Withdrawal by Subject|0|||
105496787|NCT00392015|363831927|FG004|Overall Study|Withdrawal by Subject|0|||
105496788|NCT00392015|363831928|FG005|Overall Study|Withdrawal by Subject|0|||
105496789|NCT00392015|363831923|FG000|Overall Study|Adverse Event|0|||
105413541|NCT01732510|363520490|FG000|Overall Study|Adverse Event|0|||
105413542|NCT01732510|363520491|FG001|Overall Study|Adverse Event|1|||
105413543|NCT01732510|363520492|FG002|Overall Study|Adverse Event|1|||
105413544|NCT01732510|363520493|FG003|Overall Study|Adverse Event|0|||
105413545|NCT01732510|363520494|FG004|Overall Study|Adverse Event|0|||
105413546|NCT01732510|363520495|FG005|Overall Study|Adverse Event|0|||
105496790|NCT00392015|363831924|FG001|Overall Study|Adverse Event|0|||
105496791|NCT00392015|363831925|FG002|Overall Study|Adverse Event|0|||
105496792|NCT00392015|363831926|FG003|Overall Study|Adverse Event|0|||
105496793|NCT00392015|363831927|FG004|Overall Study|Adverse Event|1|||
105496794|NCT00392015|363831928|FG005|Overall Study|Adverse Event|0|||
105496795|NCT00392015|363831923|FG000|Overall Study|Previous trial recipient|0|||
105413547|NCT01732510|363520496|FG006|Overall Study|Adverse Event|1|||
105413548|NCT01732510|363520490|FG000|Overall Study|Protocol Violation|0|||
105413549|NCT01732510|363520491|FG001|Overall Study|Protocol Violation|0|||
105413550|NCT01732510|363520492|FG002|Overall Study|Protocol Violation|0|||
105413551|NCT01732510|363520493|FG003|Overall Study|Protocol Violation|1|||
105413552|NCT01732510|363520494|FG004|Overall Study|Protocol Violation|0|||
105413553|NCT01732510|363520495|FG005|Overall Study|Protocol Violation|0|||
105413554|NCT01732510|363520496|FG006|Overall Study|Protocol Violation|0|||
105413555|NCT01732510|363520490|FG000|Overall Study|Withdrawal by Subject|1|||
105413556|NCT01732510|363520491|FG001|Overall Study|Withdrawal by Subject|3|||
105413557|NCT01732510|363520492|FG002|Overall Study|Withdrawal by Subject|2|||
105413558|NCT01732510|363520493|FG003|Overall Study|Withdrawal by Subject|1|||
105413559|NCT01732510|363520494|FG004|Overall Study|Withdrawal by Subject|5|||
105413560|NCT01732510|363520495|FG005|Overall Study|Withdrawal by Subject|0|||
105413561|NCT01732510|363520496|FG006|Overall Study|Withdrawal by Subject|1|||
105413562|NCT01732510|363520490|FG000|Overall Study|Lost to Follow-up|0|||
105413563|NCT01732510|363520491|FG001|Overall Study|Lost to Follow-up|0|||
105413564|NCT01732510|363520492|FG002|Overall Study|Lost to Follow-up|1|||
105413565|NCT01732510|363520493|FG003|Overall Study|Lost to Follow-up|1|||
105413566|NCT01732510|363520494|FG004|Overall Study|Lost to Follow-up|0|||
105413567|NCT01732510|363520495|FG005|Overall Study|Lost to Follow-up|1|||
105413568|NCT01732510|363520496|FG006|Overall Study|Lost to Follow-up|0|||
105413569|NCT01732510|363520490|FG000|Overall Study|Physician Decision|0|||
105413570|NCT01732510|363520491|FG001|Overall Study|Physician Decision|1|||
105413571|NCT01732510|363520492|FG002|Overall Study|Physician Decision|0|||
105413572|NCT01732510|363520493|FG003|Overall Study|Physician Decision|0|||
105413573|NCT01732510|363520494|FG004|Overall Study|Physician Decision|0|||
105413574|NCT01732510|363520495|FG005|Overall Study|Physician Decision|0|||
105413575|NCT01732510|363520496|FG006|Overall Study|Physician Decision|0|||
105413576|NCT01732510|363520490|FG000|Overall Study|Pregnancy|0|||
105413577|NCT01732510|363520491|FG001|Overall Study|Pregnancy|0|||
105413578|NCT01732510|363520492|FG002|Overall Study|Pregnancy|0|||
105413579|NCT01732510|363520493|FG003|Overall Study|Pregnancy|1|||
105413580|NCT01732510|363520494|FG004|Overall Study|Pregnancy|0|||
105413581|NCT01732510|363520495|FG005|Overall Study|Pregnancy|0|||
105413582|NCT01732510|363520496|FG006|Overall Study|Pregnancy|0|||
105413583|NCT01732510|363520490|FG000|Overall Study|Study Terminated By Sponsor|0|||
105413584|NCT01732510|363520491|FG001|Overall Study|Study Terminated By Sponsor|0|||
105413585|NCT01732510|363520492|FG002|Overall Study|Study Terminated By Sponsor|0|||
105413586|NCT01732510|363520493|FG003|Overall Study|Study Terminated By Sponsor|1|||
105413587|NCT01732510|363520494|FG004|Overall Study|Study Terminated By Sponsor|0|||
105413588|NCT01732510|363520495|FG005|Overall Study|Study Terminated By Sponsor|12|||
105413589|NCT01732510|363520496|FG006|Overall Study|Study Terminated By Sponsor|6|||
105413590|NCT00313144|363520497|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
105413591|NCT00313144|363520497|FG000|Overall Study|Death|7|||
105413592|NCT00313144|363520497|FG000|Overall Study|Lost to Follow-up|5|||
105413593|NCT00313144|363520497|FG000|Overall Study|Withdrawal by Subject|4|||
105413594|NCT00313144|363520497|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
105413595|NCT00313144|363520497|FG000|Overall Study|Physician Decision|4|||
105413596|NCT00313144|363520497|FG000|Overall Study|Adverse event - transient|5|||
105413597|NCT00313144|363520497|FG000|Overall Study|Liver transplant|1|||
105413598|NCT00313144|363520497|FG000|Overall Study|Insurance (homecare provider) change|1|||
105413599|NCT00313144|363520497|FG000|Overall Study|Change to different product|1|||
105413600|NCT00313144|363520497|FG000|Overall Study|Due to termination of the study|66|||
105413601|NCT01208961|363520498|FG000|High-Fat Period III|Protocol Violation|1|||
105413602|NCT01208961|363520499|FG001|High-Fat Period III|Protocol Violation|0|||
105496796|NCT00392015|363831924|FG001|Overall Study|Previous trial recipient|0|||
105496797|NCT00392015|363831925|FG002|Overall Study|Previous trial recipient|0|||
105496798|NCT00392015|363831926|FG003|Overall Study|Previous trial recipient|0|||
105496799|NCT00392015|363831927|FG004|Overall Study|Previous trial recipient|1|||
105413603|NCT01939977|363520500|FG000|Overall Study|Adverse Event|4|||
105413604|NCT01939977|363520501|FG001|Overall Study|Adverse Event|3|||
105413605|NCT01939977|363520500|FG000|Overall Study|Lack of Efficacy|3|||
105413606|NCT01939977|363520501|FG001|Overall Study|Lack of Efficacy|0|||
105413607|NCT01939977|363520500|FG000|Overall Study|Physician Decision|1|||
105413608|NCT01939977|363520501|FG001|Overall Study|Physician Decision|1|||
105413609|NCT01939977|363520500|FG000|Overall Study|Withdrawal by Subject|0|||
105413610|NCT01939977|363520501|FG001|Overall Study|Withdrawal by Subject|2|||
105413611|NCT01939977|363520500|FG000|Overall Study|Did not meet inclusion criteria|1|||
105413612|NCT01939977|363520501|FG001|Overall Study|Did not meet inclusion criteria|0|||
105413613|NCT01939977|363520500|FG000|Overall Study|Did not receive study medication|0|||
105413614|NCT01939977|363520501|FG001|Overall Study|Did not receive study medication|1|||
105413615|NCT01932372|363520504|FG000|Overall Study|Not meeting eligibility criteria|33|||
105413616|NCT01932372|363520505|FG001|Overall Study|Not meeting eligibility criteria|179|||
105496800|NCT00392015|363831928|FG005|Overall Study|Previous trial recipient|0|||
105496801|NCT02598960|363831929|FG000|Treatment Period|Disease Progression|4|||
105496802|NCT02598960|363831930|FG001|Treatment Period|Disease Progression|4|||
105496803|NCT02598960|363831931|FG002|Treatment Period|Disease Progression|4|||
105496804|NCT02598960|363831932|FG003|Treatment Period|Disease Progression|6|||
105496805|NCT02598960|363831933|FG004|Treatment Period|Disease Progression|8|||
105496806|NCT02598960|363831934|FG005|Treatment Period|Disease Progression|2|||
105496807|NCT02598960|363831935|FG006|Treatment Period|Disease Progression|2|||
105496808|NCT02598960|363831936|FG007|Treatment Period|Disease Progression|3|||
105496809|NCT02598960|363831937|FG008|Treatment Period|Disease Progression|7|||
105496810|NCT02598960|363831938|FG009|Treatment Period|Disease Progression|9|||
105496811|NCT02598960|363831939|FG010|Treatment Period|Disease Progression|7|||
105496812|NCT02598960|363831940|FG011|Treatment Period|Disease Progression|143|||
105496813|NCT02598960|363831941|FG012|Treatment Period|Disease Progression|23|||
105496814|NCT02598960|363831929|FG000|Treatment Period|Study drug toxicity|0|||
105496815|NCT02598960|363831930|FG001|Treatment Period|Study drug toxicity|0|||
105496816|NCT02598960|363831931|FG002|Treatment Period|Study drug toxicity|0|||
105496817|NCT02598960|363831932|FG003|Treatment Period|Study drug toxicity|0|||
105496818|NCT02598960|363831933|FG004|Treatment Period|Study drug toxicity|0|||
105496819|NCT02598960|363831934|FG005|Treatment Period|Study drug toxicity|0|||
105496820|NCT02598960|363831935|FG006|Treatment Period|Study drug toxicity|0|||
105496821|NCT02598960|363831936|FG007|Treatment Period|Study drug toxicity|0|||
105496822|NCT02598960|363831937|FG008|Treatment Period|Study drug toxicity|0|||
105496823|NCT02598960|363831938|FG009|Treatment Period|Study drug toxicity|1|||
105496824|NCT02598960|363831939|FG010|Treatment Period|Study drug toxicity|0|||
105496825|NCT02598960|363831940|FG011|Treatment Period|Study drug toxicity|3|||
105496826|NCT02598960|363831941|FG012|Treatment Period|Study drug toxicity|0|||
105496827|NCT02598960|363831929|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
105496828|NCT02598960|363831930|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
105496829|NCT02598960|363831931|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
105496830|NCT02598960|363831932|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
105496831|NCT02598960|363831933|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
105496832|NCT02598960|363831934|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
105496833|NCT02598960|363831935|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
105496834|NCT02598960|363831936|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
105496835|NCT02598960|363831937|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
105496836|NCT02598960|363831938|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
105496837|NCT02598960|363831939|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
105496838|NCT02598960|363831940|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
105496839|NCT02598960|363831941|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
105496840|NCT02598960|363831929|FG000|Treatment Period|participant request to discontinue|0|||
105496841|NCT02598960|363831930|FG001|Treatment Period|participant request to discontinue|1|||
105496842|NCT02598960|363831931|FG002|Treatment Period|participant request to discontinue|0|||
105496843|NCT02598960|363831932|FG003|Treatment Period|participant request to discontinue|0|||
105496844|NCT02598960|363831933|FG004|Treatment Period|participant request to discontinue|1|||
105496845|NCT02598960|363831934|FG005|Treatment Period|participant request to discontinue|0|||
105496846|NCT02598960|363831935|FG006|Treatment Period|participant request to discontinue|0|||
105496847|NCT02598960|363831936|FG007|Treatment Period|participant request to discontinue|0|||
105496848|NCT02598960|363831937|FG008|Treatment Period|participant request to discontinue|0|||
105496849|NCT02598960|363831938|FG009|Treatment Period|participant request to discontinue|0|||
105496850|NCT02598960|363831939|FG010|Treatment Period|participant request to discontinue|1|||
105496851|NCT02598960|363831940|FG011|Treatment Period|participant request to discontinue|4|||
105496852|NCT02598960|363831941|FG012|Treatment Period|participant request to discontinue|0|||
105496853|NCT02598960|363831929|FG000|Treatment Period|participant withdrew consent|0|||
105496854|NCT02598960|363831930|FG001|Treatment Period|participant withdrew consent|0|||
105496855|NCT02598960|363831931|FG002|Treatment Period|participant withdrew consent|0|||
105496856|NCT02598960|363831932|FG003|Treatment Period|participant withdrew consent|0|||
105496857|NCT02598960|363831933|FG004|Treatment Period|participant withdrew consent|0|||
105496858|NCT02598960|363831934|FG005|Treatment Period|participant withdrew consent|0|||
105496859|NCT02598960|363831935|FG006|Treatment Period|participant withdrew consent|0|||
105496860|NCT02598960|363831936|FG007|Treatment Period|participant withdrew consent|0|||
105496861|NCT02598960|363831937|FG008|Treatment Period|participant withdrew consent|0|||
105496862|NCT02598960|363831938|FG009|Treatment Period|participant withdrew consent|0|||
105582150|NCT02718417|364129972|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
105496863|NCT02598960|363831939|FG010|Treatment Period|participant withdrew consent|0|||
105496864|NCT02598960|363831940|FG011|Treatment Period|participant withdrew consent|3|||
105496865|NCT02598960|363831941|FG012|Treatment Period|participant withdrew consent|0|||
105496866|NCT02598960|363831929|FG000|Treatment Period|No longer meets study criteria|0|||
105496867|NCT02598960|363831930|FG001|Treatment Period|No longer meets study criteria|0|||
105496868|NCT02598960|363831931|FG002|Treatment Period|No longer meets study criteria|0|||
105413617|NCT02095873|363520508|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
105413618|NCT02095873|363520509|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
105413619|NCT02095873|363520508|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
105413620|NCT02095873|363520509|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
105413621|NCT02095873|363520508|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
105413622|NCT02095873|363520509|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
105413623|NCT03989349|363520513|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
105413624|NCT03989349|363520514|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105413625|NCT03989349|363520515|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105413626|NCT03989349|363520516|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105413627|NCT03989349|363520517|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105496869|NCT02598960|363831932|FG003|Treatment Period|No longer meets study criteria|0|||
105413628|NCT03989349|363520518|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105413629|NCT03989349|363520513|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
105413630|NCT03989349|363520514|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
105413631|NCT03989349|363520515|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105413632|NCT03989349|363520516|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105413633|NCT03989349|363520517|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105413634|NCT03989349|363520518|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105413635|NCT03989349|363520513|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
105413636|NCT03989349|363520514|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
105413637|NCT03989349|363520515|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
105413638|NCT03989349|363520516|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
105413639|NCT03989349|363520517|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
105413640|NCT03989349|363520518|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
105413641|NCT03989349|363520513|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
105413642|NCT03989349|363520514|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
105413643|NCT03989349|363520515|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105413644|NCT03989349|363520516|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105413645|NCT03989349|363520517|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105413646|NCT03989349|363520518|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105413647|NCT03989349|363520513|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
105413648|NCT03989349|363520514|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
105413649|NCT03989349|363520515|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
105413650|NCT03989349|363520516|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
105413651|NCT03989349|363520517|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
105413652|NCT03989349|363520518|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
105413653|NCT03989349|363520513|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
105413654|NCT03989349|363520514|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
105413655|NCT03989349|363520515|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
105413656|NCT03989349|363520516|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
105413657|NCT03989349|363520517|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
105413658|NCT03989349|363520518|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
105413659|NCT03989349|363520513|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
105413660|NCT03989349|363520514|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
105413661|NCT03989349|363520515|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
105413662|NCT03989349|363520516|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
105413663|NCT03989349|363520517|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
105413664|NCT03989349|363520518|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
105413665|NCT03989349|363520513|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
105413666|NCT03989349|363520514|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
105413667|NCT03989349|363520515|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
105413668|NCT03989349|363520516|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
105413669|NCT03989349|363520517|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
105413670|NCT03989349|363520518|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
105413671|NCT03989349|363520513|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
105413672|NCT03989349|363520514|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
105413673|NCT03989349|363520515|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
105413674|NCT03989349|363520516|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
105413675|NCT03989349|363520517|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
105413676|NCT03989349|363520518|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
105413677|NCT03989349|363520513|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
105413678|NCT03989349|363520514|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
105413679|NCT03989349|363520515|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
105413680|NCT03989349|363520516|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
105413681|NCT03989349|363520517|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
105413682|NCT03989349|363520518|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
105413683|NCT03989349|363520513|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105413684|NCT03989349|363520514|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105413685|NCT03989349|363520515|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
105413686|NCT03989349|363520516|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105413687|NCT03989349|363520517|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
105413688|NCT03989349|363520518|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105496870|NCT02598960|363831933|FG004|Treatment Period|No longer meets study criteria|0|||
105496871|NCT02598960|363831934|FG005|Treatment Period|No longer meets study criteria|0|||
105496872|NCT02598960|363831935|FG006|Treatment Period|No longer meets study criteria|0|||
105496873|NCT02598960|363831936|FG007|Treatment Period|No longer meets study criteria|0|||
105496874|NCT02598960|363831937|FG008|Treatment Period|No longer meets study criteria|0|||
105496875|NCT02598960|363831938|FG009|Treatment Period|No longer meets study criteria|0|||
105496876|NCT02598960|363831939|FG010|Treatment Period|No longer meets study criteria|0|||
105496877|NCT02598960|363831940|FG011|Treatment Period|No longer meets study criteria|1|||
105496878|NCT02598960|363831941|FG012|Treatment Period|No longer meets study criteria|0|||
105496879|NCT02598960|363831929|FG000|Treatment Period|Other Reasons|0|||
105496880|NCT02598960|363831930|FG001|Treatment Period|Other Reasons|0|||
105496881|NCT02598960|363831931|FG002|Treatment Period|Other Reasons|0|||
105496882|NCT02598960|363831932|FG003|Treatment Period|Other Reasons|0|||
105496883|NCT02598960|363831933|FG004|Treatment Period|Other Reasons|0|||
105496884|NCT02598960|363831934|FG005|Treatment Period|Other Reasons|0|||
105496885|NCT02598960|363831935|FG006|Treatment Period|Other Reasons|0|||
105496886|NCT02598960|363831936|FG007|Treatment Period|Other Reasons|0|||
105496887|NCT02598960|363831937|FG008|Treatment Period|Other Reasons|0|||
105496888|NCT02598960|363831938|FG009|Treatment Period|Other Reasons|0|||
105496889|NCT02598960|363831939|FG010|Treatment Period|Other Reasons|0|||
105496890|NCT02598960|363831940|FG011|Treatment Period|Other Reasons|0|||
105496891|NCT02598960|363831941|FG012|Treatment Period|Other Reasons|1|||
105496892|NCT02598960|363831929|FG000|Participants Entering Follow Up Period|Death|1|||
105496893|NCT02598960|363831930|FG001|Participants Entering Follow Up Period|Death|0|||
105496894|NCT02598960|363831931|FG002|Participants Entering Follow Up Period|Death|0|||
105496895|NCT02598960|363831932|FG003|Participants Entering Follow Up Period|Death|0|||
105496896|NCT02598960|363831933|FG004|Participants Entering Follow Up Period|Death|0|||
105496897|NCT02598960|363831934|FG005|Participants Entering Follow Up Period|Death|0|||
105496898|NCT02598960|363831935|FG006|Participants Entering Follow Up Period|Death|0|||
105496899|NCT02598960|363831936|FG007|Participants Entering Follow Up Period|Death|0|||
105496900|NCT02598960|363831937|FG008|Participants Entering Follow Up Period|Death|0|||
105496901|NCT02598960|363831938|FG009|Participants Entering Follow Up Period|Death|1|||
105496902|NCT02598960|363831939|FG010|Participants Entering Follow Up Period|Death|0|||
105496903|NCT02598960|363831940|FG011|Participants Entering Follow Up Period|Death|11|||
105496904|NCT02598960|363831941|FG012|Participants Entering Follow Up Period|Death|2|||
105496905|NCT02598960|363831929|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
105496906|NCT02598960|363831930|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
105496907|NCT02598960|363831931|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
105496908|NCT02598960|363831932|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
105496909|NCT02598960|363831933|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
105496910|NCT02598960|363831934|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
105496911|NCT02598960|363831935|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
105496912|NCT02598960|363831936|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
105496913|NCT02598960|363831937|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
105496914|NCT02598960|363831938|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
105413689|NCT03989349|363520513|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
105413690|NCT03989349|363520514|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
105413691|NCT03989349|363520515|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
105413692|NCT03989349|363520516|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
105413693|NCT03989349|363520517|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
105413694|NCT03989349|363520518|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
105413695|NCT03989349|363520513|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
105413696|NCT03989349|363520514|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
105413697|NCT03989349|363520515|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
105496915|NCT02598960|363831939|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
105496916|NCT02598960|363831940|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
105496917|NCT02598960|363831941|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
105496918|NCT02598960|363831929|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
105496919|NCT02598960|363831930|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
105496920|NCT02598960|363831931|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
105496921|NCT02598960|363831932|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
105496922|NCT02598960|363831933|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
105496923|NCT02598960|363831934|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
105496924|NCT02598960|363831935|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
105496925|NCT02598960|363831936|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
105496926|NCT02598960|363831937|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
105496927|NCT02598960|363831938|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
105582151|NCT02718417|364129973|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
105582152|NCT02718417|364129974|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
105582153|NCT02718417|364129972|FG000|Observation Phase (OP)|Other|0|||
105582154|NCT02718417|364129973|FG001|Observation Phase (OP)|Other|0|||
105582155|NCT02718417|364129974|FG002|Observation Phase (OP)|Other|7|||
105582156|NCT02718417|364129972|FG000|Follow-up Phase|Adverse Event|3|||
105582157|NCT02718417|364129973|FG001|Follow-up Phase|Adverse Event|1|||
105582158|NCT02718417|364129974|FG002|Follow-up Phase|Adverse Event|1|||
105582159|NCT02718417|364129972|FG000|Follow-up Phase|Other|4|||
105582160|NCT02718417|364129973|FG001|Follow-up Phase|Other|6|||
105582161|NCT02718417|364129974|FG002|Follow-up Phase|Other|4|||
105582162|NCT02718417|364129972|FG000|Follow-up Phase|Withdrawal by Subject|19|||
105582163|NCT02718417|364129973|FG001|Follow-up Phase|Withdrawal by Subject|17|||
105582164|NCT02718417|364129974|FG002|Follow-up Phase|Withdrawal by Subject|5|||
105582165|NCT02718417|364129972|FG000|Follow-up Phase|Study terminated by sponsor|100|||
105582166|NCT02718417|364129973|FG001|Follow-up Phase|Study terminated by sponsor|138|||
105582167|NCT02718417|364129974|FG002|Follow-up Phase|Study terminated by sponsor|6|||
105582168|NCT02718417|364129972|FG000|Follow-up Phase|Lost to Follow-up|2|||
105582169|NCT02718417|364129973|FG001|Follow-up Phase|Lost to Follow-up|3|||
105582170|NCT02718417|364129974|FG002|Follow-up Phase|Lost to Follow-up|0|||
105582171|NCT02718417|364129972|FG000|Follow-up Phase|Death leading to discontinuation|7|||
105582172|NCT02718417|364129973|FG001|Follow-up Phase|Death leading to discontinuation|7|||
105582173|NCT02718417|364129974|FG002|Follow-up Phase|Death leading to discontinuation|3|||
105582174|NCT02718417|364129972|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
105582175|NCT02718417|364129973|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
105413698|NCT03989349|363520516|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
105413699|NCT03989349|363520517|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
105413700|NCT03989349|363520518|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
105413701|NCT03989349|363520513|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
105413702|NCT03989349|363520514|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
105413703|NCT03989349|363520515|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
105413704|NCT03989349|363520516|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
105413705|NCT03989349|363520517|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
105413706|NCT03989349|363520518|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
105413707|NCT05823974|363522553|FG000|Overall Study|Lost to Follow-up|0|||
105413708|NCT05823974|363522554|FG001|Overall Study|Lost to Follow-up|3|||
105413709|NCT05823974|363522555|FG002|Overall Study|Lost to Follow-up|1|||
105413710|NCT05823974|363522556|FG003|Overall Study|Lost to Follow-up|0|||
105413711|NCT05823974|363522557|FG004|Overall Study|Lost to Follow-up|1|||
105413712|NCT05823974|363522558|FG005|Overall Study|Lost to Follow-up|0|||
105413713|NCT05823974|363522559|FG006|Overall Study|Lost to Follow-up|1|||
105413714|NCT05823974|363522560|FG007|Overall Study|Lost to Follow-up|0|||
105413715|NCT05823974|363522561|FG008|Overall Study|Lost to Follow-up|0|||
105413716|NCT05823974|363522562|FG009|Overall Study|Lost to Follow-up|1|||
105413717|NCT05823974|363522563|FG010|Overall Study|Lost to Follow-up|1|||
105413718|NCT05823974|363522564|FG011|Overall Study|Lost to Follow-up|0|||
105413719|NCT05823974|363522565|FG012|Overall Study|Lost to Follow-up|1|||
105413720|NCT05823974|363522566|FG013|Overall Study|Lost to Follow-up|2|||
105413721|NCT05823974|363522567|FG014|Overall Study|Lost to Follow-up|1|||
105413722|NCT05823974|363522568|FG015|Overall Study|Lost to Follow-up|1|||
105413723|NCT05823974|363522569|FG016|Overall Study|Lost to Follow-up|1|||
105413724|NCT05823974|363522570|FG017|Overall Study|Lost to Follow-up|0|||
105413725|NCT05823974|363522571|FG018|Overall Study|Lost to Follow-up|0|||
105413726|NCT05823974|363522572|FG019|Overall Study|Lost to Follow-up|2|||
105413727|NCT05823974|363522573|FG020|Overall Study|Lost to Follow-up|0|||
105413728|NCT05823974|363522553|FG000|Overall Study|Physician Decision|0|||
105413729|NCT05823974|363522554|FG001|Overall Study|Physician Decision|0|||
105413730|NCT05823974|363522555|FG002|Overall Study|Physician Decision|0|||
105413731|NCT05823974|363522556|FG003|Overall Study|Physician Decision|0|||
105413732|NCT05823974|363522557|FG004|Overall Study|Physician Decision|0|||
105582176|NCT02718417|364129974|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
105582177|NCT02718417|364129972|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
105582178|NCT02718417|364129973|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
105582179|NCT02718417|364129974|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
105582180|NCT02718417|364129972|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
105496928|NCT02598960|363831939|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
105496929|NCT02598960|363831940|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
105496930|NCT02598960|363831941|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
105496931|NCT02598960|363831929|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
105496932|NCT02598960|363831930|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
105496933|NCT02598960|363831931|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
105496934|NCT02598960|363831932|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
105496935|NCT02598960|363831933|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
105496936|NCT02598960|363831934|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
105496937|NCT02598960|363831935|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
105496938|NCT02598960|363831936|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
105496939|NCT02598960|363831937|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
105496940|NCT02598960|363831938|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
105496941|NCT02598960|363831939|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
105496942|NCT02598960|363831940|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
105496943|NCT02598960|363831941|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
105496944|NCT02598960|363831929|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
105496945|NCT02598960|363831930|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
105496946|NCT02598960|363831931|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
105496947|NCT02598960|363831932|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
105496948|NCT02598960|363831933|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
105496949|NCT02598960|363831934|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
105496950|NCT02598960|363831935|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
105496951|NCT02598960|363831936|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
105496952|NCT02598960|363831937|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
105496953|NCT02598960|363831938|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
105496954|NCT02598960|363831939|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
105496955|NCT02598960|363831940|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
105496956|NCT02598960|363831941|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
105496957|NCT01507298|363831947|FG000|Overall Study|Protocol Violation|0|||
105496958|NCT01507298|363831948|FG001|Overall Study|Protocol Violation|6|||
105496959|NCT00734474|363831949|FG000|Overall Study|Entry Criteria Not Met|0|||
105496960|NCT00734474|363831950|FG001|Overall Study|Entry Criteria Not Met|0|||
105496961|NCT00734474|363831951|FG002|Overall Study|Entry Criteria Not Met|5|||
105496962|NCT00734474|363831952|FG003|Overall Study|Entry Criteria Not Met|0|||
105496963|NCT00734474|363831953|FG004|Overall Study|Entry Criteria Not Met|3|||
105496964|NCT00734474|363831954|FG005|Overall Study|Entry Criteria Not Met|1|||
105496965|NCT00734474|363831955|FG006|Overall Study|Entry Criteria Not Met|0|||
105496966|NCT00734474|363831956|FG007|Overall Study|Entry Criteria Not Met|1|||
105496967|NCT00734474|363831957|FG008|Overall Study|Entry Criteria Not Met|1|||
105496968|NCT00734474|363831949|FG000|Overall Study|Lost to Follow-up|1|||
105496969|NCT00734474|363831950|FG001|Overall Study|Lost to Follow-up|0|||
105496970|NCT00734474|363831951|FG002|Overall Study|Lost to Follow-up|13|||
105496971|NCT00734474|363831952|FG003|Overall Study|Lost to Follow-up|0|||
105496972|NCT00734474|363831953|FG004|Overall Study|Lost to Follow-up|11|||
105496973|NCT00734474|363831954|FG005|Overall Study|Lost to Follow-up|1|||
105413733|NCT05823974|363522558|FG005|Overall Study|Physician Decision|0|||
105413734|NCT05823974|363522559|FG006|Overall Study|Physician Decision|0|||
105413735|NCT05823974|363522560|FG007|Overall Study|Physician Decision|0|||
105413736|NCT05823974|363522561|FG008|Overall Study|Physician Decision|0|||
105413737|NCT05823974|363522562|FG009|Overall Study|Physician Decision|0|||
105413738|NCT05823974|363522563|FG010|Overall Study|Physician Decision|0|||
105413739|NCT05823974|363522564|FG011|Overall Study|Physician Decision|0|||
105413740|NCT05823974|363522565|FG012|Overall Study|Physician Decision|0|||
105496974|NCT00734474|363831955|FG006|Overall Study|Lost to Follow-up|0|||
105496975|NCT00734474|363831956|FG007|Overall Study|Lost to Follow-up|9|||
105496976|NCT00734474|363831957|FG008|Overall Study|Lost to Follow-up|4|||
105496977|NCT00734474|363831949|FG000|Overall Study|Withdrawal by Subject|2|||
105496978|NCT00734474|363831950|FG001|Overall Study|Withdrawal by Subject|1|||
105496979|NCT00734474|363831951|FG002|Overall Study|Withdrawal by Subject|18|||
105496980|NCT00734474|363831952|FG003|Overall Study|Withdrawal by Subject|0|||
105413741|NCT05823974|363522566|FG013|Overall Study|Physician Decision|0|||
105413742|NCT05823974|363522567|FG014|Overall Study|Physician Decision|0|||
105413743|NCT05823974|363522568|FG015|Overall Study|Physician Decision|1|||
105413744|NCT05823974|363522569|FG016|Overall Study|Physician Decision|0|||
105496981|NCT00734474|363831953|FG004|Overall Study|Withdrawal by Subject|24|||
105496982|NCT00734474|363831954|FG005|Overall Study|Withdrawal by Subject|2|||
105496983|NCT00734474|363831955|FG006|Overall Study|Withdrawal by Subject|0|||
105496984|NCT00734474|363831956|FG007|Overall Study|Withdrawal by Subject|36|||
105413745|NCT05823974|363522570|FG017|Overall Study|Physician Decision|1|||
105413746|NCT05823974|363522571|FG018|Overall Study|Physician Decision|1|||
105413747|NCT05823974|363522572|FG019|Overall Study|Physician Decision|0|||
105413748|NCT05823974|363522573|FG020|Overall Study|Physician Decision|0|||
105413749|NCT05823974|363522553|FG000|Overall Study|Withdrawal by Subject|1|||
105413750|NCT05823974|363522554|FG001|Overall Study|Withdrawal by Subject|1|||
105413751|NCT05823974|363522555|FG002|Overall Study|Withdrawal by Subject|2|||
105413752|NCT05823974|363522556|FG003|Overall Study|Withdrawal by Subject|0|||
105413753|NCT05823974|363522557|FG004|Overall Study|Withdrawal by Subject|2|||
105413754|NCT05823974|363522558|FG005|Overall Study|Withdrawal by Subject|3|||
105413755|NCT05823974|363522559|FG006|Overall Study|Withdrawal by Subject|1|||
105413756|NCT05823974|363522560|FG007|Overall Study|Withdrawal by Subject|1|||
105413757|NCT05823974|363522561|FG008|Overall Study|Withdrawal by Subject|2|||
105413758|NCT05823974|363522562|FG009|Overall Study|Withdrawal by Subject|1|||
105413759|NCT05823974|363522563|FG010|Overall Study|Withdrawal by Subject|1|||
105413760|NCT05823974|363522564|FG011|Overall Study|Withdrawal by Subject|0|||
105413761|NCT05823974|363522565|FG012|Overall Study|Withdrawal by Subject|0|||
105413762|NCT05823974|363522566|FG013|Overall Study|Withdrawal by Subject|1|||
105413763|NCT05823974|363522567|FG014|Overall Study|Withdrawal by Subject|1|||
105413764|NCT05823974|363522568|FG015|Overall Study|Withdrawal by Subject|3|||
105413765|NCT05823974|363522569|FG016|Overall Study|Withdrawal by Subject|0|||
105413766|NCT05823974|363522570|FG017|Overall Study|Withdrawal by Subject|2|||
105413767|NCT05823974|363522571|FG018|Overall Study|Withdrawal by Subject|2|||
105413768|NCT05823974|363522572|FG019|Overall Study|Withdrawal by Subject|0|||
105413769|NCT05823974|363522573|FG020|Overall Study|Withdrawal by Subject|1|||
105413770|NCT05823974|363522553|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413771|NCT05823974|363522554|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413772|NCT05823974|363522555|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105413773|NCT05823974|363522556|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105496985|NCT00734474|363831957|FG008|Overall Study|Withdrawal by Subject|21|||
105496986|NCT00734474|363831949|FG000|Overall Study|Physician Decision|0|||
105496987|NCT00734474|363831950|FG001|Overall Study|Physician Decision|0|||
105496988|NCT00734474|363831951|FG002|Overall Study|Physician Decision|4|||
105413774|NCT05823974|363522557|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413775|NCT05823974|363522558|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413776|NCT05823974|363522559|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413777|NCT05823974|363522560|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105496989|NCT00734474|363831952|FG003|Overall Study|Physician Decision|1|||
105413778|NCT05823974|363522561|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413779|NCT05823974|363522562|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413780|NCT05823974|363522563|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413781|NCT05823974|363522564|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413782|NCT05823974|363522565|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413783|NCT05823974|363522566|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413784|NCT05823974|363522567|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105413785|NCT05823974|363522568|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413786|NCT05823974|363522569|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413787|NCT05823974|363522570|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413788|NCT05823974|363522571|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413789|NCT05823974|363522572|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413790|NCT05823974|363522573|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105413791|NCT05823974|363522553|FG000|Overall Study|Other|0|||
105413792|NCT05823974|363522554|FG001|Overall Study|Other|1|||
105413793|NCT05823974|363522555|FG002|Overall Study|Other|1|||
105413794|NCT05823974|363522556|FG003|Overall Study|Other|1|||
105413795|NCT05823974|363522557|FG004|Overall Study|Other|0|||
105413796|NCT05823974|363522558|FG005|Overall Study|Other|1|||
105413797|NCT05823974|363522559|FG006|Overall Study|Other|1|||
105413798|NCT05823974|363522560|FG007|Overall Study|Other|1|||
105413799|NCT05823974|363522561|FG008|Overall Study|Other|1|||
105413800|NCT05823974|363522562|FG009|Overall Study|Other|0|||
105413801|NCT05823974|363522563|FG010|Overall Study|Other|0|||
105413802|NCT05823974|363522564|FG011|Overall Study|Other|0|||
105413803|NCT05823974|363522565|FG012|Overall Study|Other|2|||
105413804|NCT05823974|363522566|FG013|Overall Study|Other|1|||
105413805|NCT05823974|363522567|FG014|Overall Study|Other|0|||
105413806|NCT05823974|363522568|FG015|Overall Study|Other|1|||
105413807|NCT05823974|363522569|FG016|Overall Study|Other|0|||
105413808|NCT05823974|363522570|FG017|Overall Study|Other|0|||
105413809|NCT05823974|363522571|FG018|Overall Study|Other|0|||
105413810|NCT05823974|363522572|FG019|Overall Study|Other|0|||
105413811|NCT05823974|363522573|FG020|Overall Study|Other|0|||
105413812|NCT03744910|363522574|FG000|Overall Study|Withdrew Consent|1|||
105413813|NCT03744910|363522575|FG001|Overall Study|Withdrew Consent|8|||
105413814|NCT03744910|363522574|FG000|Overall Study|Physician Decision|5|||
105413815|NCT03744910|363522575|FG001|Overall Study|Physician Decision|4|||
105413816|NCT03744910|363522574|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
105413817|NCT03744910|363522575|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
105413818|NCT03744910|363522574|FG000|Overall Study|Lost to Follow-up|0|||
105496990|NCT00734474|363831953|FG004|Overall Study|Physician Decision|11|||
105496991|NCT00734474|363831954|FG005|Overall Study|Physician Decision|0|||
105496992|NCT00734474|363831955|FG006|Overall Study|Physician Decision|0|||
105413819|NCT03744910|363522575|FG001|Overall Study|Lost to Follow-up|1|||
105413820|NCT03744910|363522574|FG000|Overall Study|Other-unspecified|4|||
105413821|NCT03744910|363522575|FG001|Overall Study|Other-unspecified|1|||
105413822|NCT02255435|363522576|FG000|Overall Study|Patient's Limited Time Availability|0|||
105413823|NCT02255435|363522577|FG001|Overall Study|Patient's Limited Time Availability|0|||
105413824|NCT02255435|363522578|FG002|Overall Study|Patient's Limited Time Availability|0|||
105413825|NCT02255435|363522579|FG003|Overall Study|Patient's Limited Time Availability|0|||
105413826|NCT02255435|363522580|FG004|Overall Study|Patient's Limited Time Availability|0|||
105413827|NCT02255435|363522581|FG005|Overall Study|Patient's Limited Time Availability|0|||
105413828|NCT02255435|363522582|FG006|Overall Study|Patient's Limited Time Availability|0|||
105413829|NCT02255435|363522583|FG007|Overall Study|Patient's Limited Time Availability|1|||
105413830|NCT02255435|363522584|FG008|Overall Study|Patient's Limited Time Availability|0|||
105413831|NCT02255435|363522585|FG009|Overall Study|Patient's Limited Time Availability|0|||
105413832|NCT02255435|363522576|FG000|Overall Study|Withdrawal by Subject|0|||
105413833|NCT02255435|363522577|FG001|Overall Study|Withdrawal by Subject|0|||
105413834|NCT02255435|363522578|FG002|Overall Study|Withdrawal by Subject|0|||
105413835|NCT02255435|363522579|FG003|Overall Study|Withdrawal by Subject|0|||
105413836|NCT02255435|363522580|FG004|Overall Study|Withdrawal by Subject|0|||
105413837|NCT02255435|363522581|FG005|Overall Study|Withdrawal by Subject|0|||
105413838|NCT02255435|363522582|FG006|Overall Study|Withdrawal by Subject|0|||
105413839|NCT02255435|363522583|FG007|Overall Study|Withdrawal by Subject|0|||
105413840|NCT02255435|363522584|FG008|Overall Study|Withdrawal by Subject|1|||
105413841|NCT02255435|363522585|FG009|Overall Study|Withdrawal by Subject|4|||
105413842|NCT02255435|363522576|FG000|Overall Study|Administrative reasons|0|||
105413843|NCT02255435|363522577|FG001|Overall Study|Administrative reasons|0|||
105413844|NCT02255435|363522578|FG002|Overall Study|Administrative reasons|0|||
105413845|NCT02255435|363522579|FG003|Overall Study|Administrative reasons|0|||
105413846|NCT02255435|363522580|FG004|Overall Study|Administrative reasons|0|||
105413847|NCT02255435|363522581|FG005|Overall Study|Administrative reasons|0|||
105413848|NCT02255435|363522582|FG006|Overall Study|Administrative reasons|0|||
105413849|NCT02255435|363522583|FG007|Overall Study|Administrative reasons|0|||
105413850|NCT02255435|363522584|FG008|Overall Study|Administrative reasons|0|||
105413851|NCT02255435|363522585|FG009|Overall Study|Administrative reasons|2|||
105413852|NCT05828095|363522586|FG000|Overall Study|Lost to Follow-up|1|||
105413853|NCT05828095|363522587|FG001|Overall Study|Lost to Follow-up|0|||
105413854|NCT05828095|363522586|FG000|Overall Study|Reactogenicity symptom|0|||
105413855|NCT05828095|363522587|FG001|Overall Study|Reactogenicity symptom|1|||
105413856|NCT05360966|363522588|FG000|Overall Study|Adverse Event|5|||
105413857|NCT05360966|363522589|FG001|Overall Study|Adverse Event|5|||
105413858|NCT05360966|363522588|FG000|Overall Study|Withdrawal of Consent|5|||
105413859|NCT05360966|363522589|FG001|Overall Study|Withdrawal of Consent|3|||
105413860|NCT05360966|363522588|FG000|Overall Study|Noncompliance|2|||
105413861|NCT05360966|363522589|FG001|Overall Study|Noncompliance|1|||
105413862|NCT05360966|363522588|FG000|Overall Study|Lost to Follow-up|2|||
105413863|NCT05360966|363522589|FG001|Overall Study|Lost to Follow-up|3|||
105413864|NCT05360966|363522588|FG000|Overall Study|Protocol Deviation|2|||
105413865|NCT05360966|363522589|FG001|Overall Study|Protocol Deviation|1|||
105413866|NCT05360966|363522588|FG000|Overall Study|As specified in the Clinical Study Report|1|||
105413867|NCT05360966|363522589|FG001|Overall Study|As specified in the Clinical Study Report|3|||
105413868|NCT05396014|363522590|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
105413869|NCT05396014|363522591|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413870|NCT05396014|363522592|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413871|NCT05396014|363522593|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413872|NCT05396014|363522594|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413873|NCT05396014|363522595|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413874|NCT05396014|363522596|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413875|NCT05396014|363522597|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413876|NCT05396014|363522598|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413877|NCT05396014|363522599|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413878|NCT05396014|363522600|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413879|NCT05396014|363522601|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413880|NCT05396014|363522602|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105496993|NCT00734474|363831956|FG007|Overall Study|Physician Decision|9|||
105496994|NCT00734474|363831957|FG008|Overall Study|Physician Decision|9|||
105496995|NCT00734474|363831949|FG000|Overall Study|Adverse Event|4|||
105496996|NCT00734474|363831950|FG001|Overall Study|Adverse Event|4|||
105496997|NCT00734474|363831951|FG002|Overall Study|Adverse Event|63|||
105496998|NCT00734474|363831952|FG003|Overall Study|Adverse Event|1|||
105496999|NCT00734474|363831953|FG004|Overall Study|Adverse Event|64|||
105497000|NCT00734474|363831954|FG005|Overall Study|Adverse Event|0|||
105497001|NCT00734474|363831955|FG006|Overall Study|Adverse Event|1|||
105497002|NCT00734474|363831956|FG007|Overall Study|Adverse Event|65|||
105497003|NCT00734474|363831957|FG008|Overall Study|Adverse Event|39|||
105497004|NCT00734474|363831949|FG000|Overall Study|Protocol Violation|0|||
105497005|NCT00734474|363831950|FG001|Overall Study|Protocol Violation|0|||
105497006|NCT00734474|363831951|FG002|Overall Study|Protocol Violation|4|||
105497007|NCT00734474|363831952|FG003|Overall Study|Protocol Violation|0|||
105497008|NCT00734474|363831953|FG004|Overall Study|Protocol Violation|3|||
105497009|NCT00734474|363831954|FG005|Overall Study|Protocol Violation|0|||
105497010|NCT00734474|363831955|FG006|Overall Study|Protocol Violation|0|||
105497011|NCT00734474|363831956|FG007|Overall Study|Protocol Violation|3|||
105497012|NCT00734474|363831957|FG008|Overall Study|Protocol Violation|1|||
105497013|NCT00734474|363831949|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
105497014|NCT00734474|363831950|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
105497015|NCT00734474|363831951|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
105582181|NCT02718417|364129973|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
105582182|NCT02718417|364129974|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
105582183|NCT02718417|364129972|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
105582184|NCT02718417|364129973|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
105582185|NCT02718417|364129974|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
105582186|NCT02718417|364129972|FG000|Long-term Follow-up Phase|Other|0|||
105582187|NCT02718417|364129973|FG001|Long-term Follow-up Phase|Other|2|||
105582188|NCT02718417|364129974|FG002|Long-term Follow-up Phase|Other|0|||
105582189|NCT01890967|364129975|FG000|Overall Study|Adverse Event|3|||
105582190|NCT01890967|364129976|FG001|Overall Study|Adverse Event|3|||
105582191|NCT01890967|364129977|FG002|Overall Study|Adverse Event|3|||
105582192|NCT01890967|364129978|FG003|Overall Study|Adverse Event|2|||
105582193|NCT01890967|364129979|FG004|Overall Study|Adverse Event|1|||
105582194|NCT01890967|364129980|FG005|Overall Study|Adverse Event|7|||
105582195|NCT01890967|364129975|FG000|Overall Study|Death|1|||
105582196|NCT01890967|364129976|FG001|Overall Study|Death|0|||
105582197|NCT01890967|364129977|FG002|Overall Study|Death|0|||
105582198|NCT01890967|364129978|FG003|Overall Study|Death|0|||
105582199|NCT01890967|364129979|FG004|Overall Study|Death|0|||
105582200|NCT01890967|364129980|FG005|Overall Study|Death|0|||
105582201|NCT01890967|364129975|FG000|Overall Study|Lost to Follow-up|1|||
105413881|NCT05396014|363522603|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
105413882|NCT05396014|363522604|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413883|NCT05396014|363522605|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413884|NCT05396014|363522606|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413885|NCT05396014|363522607|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413886|NCT05396014|363522608|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413887|NCT05396014|363522609|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413888|NCT05396014|363522610|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413889|NCT05396014|363522611|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413890|NCT05396014|363522612|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413891|NCT05396014|363522613|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413892|NCT05396014|363522614|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413893|NCT05396014|363522615|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413894|NCT05396014|363522616|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
105413895|NCT05396014|363522617|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413896|NCT05396014|363522618|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413897|NCT05396014|363522619|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413898|NCT05396014|363522620|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413899|NCT05396014|363522621|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413900|NCT05396014|363522622|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413901|NCT05396014|363522623|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413902|NCT05396014|363522624|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413903|NCT05396014|363522625|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413904|NCT05396014|363522626|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413905|NCT05396014|363522627|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413906|NCT05396014|363522628|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413907|NCT05396014|363522629|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
105413908|NCT05396014|363522630|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413909|NCT05396014|363522631|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413910|NCT05396014|363522632|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105413911|NCT05396014|363522590|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
105413912|NCT05396014|363522591|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413913|NCT05396014|363522592|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413914|NCT05396014|363522593|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413915|NCT05396014|363522594|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105582202|NCT01890967|364129976|FG001|Overall Study|Lost to Follow-up|1|||
105582203|NCT01890967|364129977|FG002|Overall Study|Lost to Follow-up|1|||
105582204|NCT01890967|364129978|FG003|Overall Study|Lost to Follow-up|1|||
105582205|NCT01890967|364129979|FG004|Overall Study|Lost to Follow-up|0|||
105497016|NCT00734474|363831952|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
105497017|NCT00734474|363831953|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
105497018|NCT00734474|363831954|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
105497019|NCT00734474|363831955|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
105497020|NCT00734474|363831956|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
105497021|NCT00734474|363831957|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
105497022|NCT00734474|363831949|FG000|Overall Study|Sponsor Decision|0|||
105497023|NCT00734474|363831950|FG001|Overall Study|Sponsor Decision|0|||
105497024|NCT00734474|363831951|FG002|Overall Study|Sponsor Decision|0|||
105497025|NCT00734474|363831952|FG003|Overall Study|Sponsor Decision|0|||
105497026|NCT00734474|363831953|FG004|Overall Study|Sponsor Decision|2|||
105497027|NCT00734474|363831954|FG005|Overall Study|Sponsor Decision|0|||
105497028|NCT00734474|363831955|FG006|Overall Study|Sponsor Decision|0|||
105497029|NCT00734474|363831956|FG007|Overall Study|Sponsor Decision|0|||
105497030|NCT00734474|363831957|FG008|Overall Study|Sponsor Decision|0|||
105497031|NCT00734474|363831949|FG000|Overall Study|Death|0|||
105497032|NCT00734474|363831950|FG001|Overall Study|Death|0|||
105497033|NCT00734474|363831951|FG002|Overall Study|Death|1|||
105497034|NCT00734474|363831952|FG003|Overall Study|Death|0|||
105497035|NCT00734474|363831953|FG004|Overall Study|Death|0|||
105497036|NCT00734474|363831954|FG005|Overall Study|Death|0|||
105497037|NCT00734474|363831955|FG006|Overall Study|Death|0|||
105497038|NCT00734474|363831956|FG007|Overall Study|Death|2|||
105497039|NCT00734474|363831957|FG008|Overall Study|Death|1|||
105497040|NCT00734474|363831949|FG000|Overall Study|Lack of Efficacy|0|||
105497041|NCT00734474|363831950|FG001|Overall Study|Lack of Efficacy|0|||
105497042|NCT00734474|363831951|FG002|Overall Study|Lack of Efficacy|4|||
105497043|NCT00734474|363831952|FG003|Overall Study|Lack of Efficacy|0|||
105497044|NCT00734474|363831953|FG004|Overall Study|Lack of Efficacy|0|||
105497045|NCT00734474|363831954|FG005|Overall Study|Lack of Efficacy|0|||
105497046|NCT00734474|363831955|FG006|Overall Study|Lack of Efficacy|0|||
105497047|NCT00734474|363831956|FG007|Overall Study|Lack of Efficacy|4|||
105497048|NCT00734474|363831957|FG008|Overall Study|Lack of Efficacy|6|||
105497049|NCT04622306|363831958|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
105497050|NCT04622306|363831959|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
105497051|NCT04622306|363831960|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
105497052|NCT04622306|363831961|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
105497053|NCT04622306|363831962|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
105497054|NCT04622306|363831963|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
105497055|NCT04622306|363831958|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
105497056|NCT04622306|363831959|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
105497057|NCT04622306|363831960|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
105497058|NCT04622306|363831961|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
105497059|NCT04622306|363831962|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
105497060|NCT04622306|363831963|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
105497061|NCT00617851|363831964|FG000|Overall Study|Death|0|||
105497062|NCT00617851|363831965|FG001|Overall Study|Death|0|||
105497063|NCT00617851|363831966|FG002|Overall Study|Death|0|||
105497064|NCT00617851|363831967|FG003|Overall Study|Death|1|||
105497065|NCT00617851|363831964|FG000|Overall Study|Withdrawal by Subject|14|||
105497066|NCT00617851|363831965|FG001|Overall Study|Withdrawal by Subject|7|||
105497067|NCT00617851|363831966|FG002|Overall Study|Withdrawal by Subject|12|||
105497068|NCT00617851|363831967|FG003|Overall Study|Withdrawal by Subject|4|||
105497069|NCT00617851|363831964|FG000|Overall Study|Lost to Follow-up|27|||
105497070|NCT00617851|363831965|FG001|Overall Study|Lost to Follow-up|29|||
105497071|NCT00617851|363831966|FG002|Overall Study|Lost to Follow-up|31|||
105497072|NCT00617851|363831967|FG003|Overall Study|Lost to Follow-up|19|||
105497073|NCT00617851|363831964|FG000|Overall Study|Inappropriate Enrollment|5|||
105497074|NCT00617851|363831965|FG001|Overall Study|Inappropriate Enrollment|4|||
105497075|NCT00617851|363831966|FG002|Overall Study|Inappropriate Enrollment|1|||
105497076|NCT00617851|363831967|FG003|Overall Study|Inappropriate Enrollment|1|||
105497077|NCT00617851|363831964|FG000|Overall Study|Unable to classify|1|||
105497078|NCT00617851|363831965|FG001|Overall Study|Unable to classify|0|||
105497079|NCT00617851|363831966|FG002|Overall Study|Unable to classify|1|||
105497080|NCT00617851|363831967|FG003|Overall Study|Unable to classify|0|||
105497081|NCT01200524|363831968|FG000|Overall Study|Withdrawal by Subject|1|||
105497082|NCT01200524|363831969|FG001|Overall Study|Withdrawal by Subject|1|||
105497083|NCT01200524|363831970|FG002|Overall Study|Withdrawal by Subject|3|||
105497084|NCT01200524|363831968|FG000|Overall Study|Adverse Event|1|||
105497085|NCT01200524|363831969|FG001|Overall Study|Adverse Event|0|||
105497086|NCT01200524|363831970|FG002|Overall Study|Adverse Event|0|||
105497087|NCT01200524|363831968|FG000|Overall Study|Non availability of study nurse|0|||
105497088|NCT01200524|363831969|FG001|Overall Study|Non availability of study nurse|0|||
105497089|NCT01200524|363831970|FG002|Overall Study|Non availability of study nurse|1|||
105497090|NCT00615108|363831973|FG000|Overall Study|Adverse Event|122|||
105497091|NCT00615108|363831973|FG000|Overall Study|Other|370|||
105582206|NCT01890967|364129980|FG005|Overall Study|Lost to Follow-up|1|||
105582207|NCT01890967|364129975|FG000|Overall Study|Protocol Violation|0|||
105413916|NCT05396014|363522595|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413917|NCT05396014|363522596|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413918|NCT05396014|363522597|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413919|NCT05396014|363522598|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413920|NCT05396014|363522599|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413921|NCT05396014|363522600|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413922|NCT05396014|363522601|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413923|NCT05396014|363522602|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413924|NCT05396014|363522603|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
105413925|NCT05396014|363522604|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413926|NCT05396014|363522605|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413927|NCT05396014|363522606|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413928|NCT05396014|363522607|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413929|NCT05396014|363522608|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413930|NCT05396014|363522609|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413931|NCT05396014|363522610|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413932|NCT05396014|363522611|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413933|NCT05396014|363522612|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413934|NCT05396014|363522613|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413935|NCT05396014|363522614|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413936|NCT05396014|363522615|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413937|NCT05396014|363522616|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
105413938|NCT05396014|363522617|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413939|NCT05396014|363522618|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413940|NCT05396014|363522619|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413941|NCT05396014|363522620|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413942|NCT05396014|363522621|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413943|NCT05396014|363522622|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413944|NCT05396014|363522623|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413945|NCT05396014|363522624|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413946|NCT05396014|363522625|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413947|NCT05396014|363522626|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413948|NCT05396014|363522627|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413949|NCT05396014|363522628|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413950|NCT05396014|363522629|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
105413951|NCT05396014|363522630|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413952|NCT05396014|363522631|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413953|NCT05396014|363522632|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105413954|NCT05396014|363522590|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
105582208|NCT01890967|364129976|FG001|Overall Study|Protocol Violation|3|||
105582209|NCT01890967|364129977|FG002|Overall Study|Protocol Violation|3|||
105582210|NCT01890967|364129978|FG003|Overall Study|Protocol Violation|2|||
105582211|NCT01890967|364129979|FG004|Overall Study|Protocol Violation|4|||
105582212|NCT01890967|364129980|FG005|Overall Study|Protocol Violation|1|||
105582213|NCT01890967|364129975|FG000|Overall Study|Sponsor Decision|2|||
105582214|NCT01890967|364129976|FG001|Overall Study|Sponsor Decision|0|||
105582215|NCT01890967|364129977|FG002|Overall Study|Sponsor Decision|1|||
105582216|NCT01890967|364129978|FG003|Overall Study|Sponsor Decision|3|||
105582217|NCT01890967|364129979|FG004|Overall Study|Sponsor Decision|2|||
105582218|NCT01890967|364129980|FG005|Overall Study|Sponsor Decision|3|||
105582219|NCT01890967|364129975|FG000|Overall Study|Withdrawal by Subject|3|||
105413955|NCT05396014|363522591|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413956|NCT05396014|363522592|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413957|NCT05396014|363522593|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413958|NCT05396014|363522594|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413959|NCT05396014|363522595|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413960|NCT05396014|363522596|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413961|NCT05396014|363522597|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413962|NCT05396014|363522598|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413963|NCT05396014|363522599|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413964|NCT05396014|363522600|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413965|NCT05396014|363522601|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413966|NCT05396014|363522602|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413967|NCT05396014|363522603|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
105413968|NCT05396014|363522604|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413969|NCT05396014|363522605|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105582220|NCT01890967|364129976|FG001|Overall Study|Withdrawal by Subject|4|||
105413970|NCT05396014|363522606|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413971|NCT05396014|363522607|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413972|NCT05396014|363522608|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413973|NCT05396014|363522609|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413974|NCT05396014|363522610|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413975|NCT05396014|363522611|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413976|NCT05396014|363522612|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413977|NCT05396014|363522613|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413978|NCT05396014|363522614|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413979|NCT05396014|363522615|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413980|NCT05396014|363522616|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
105413981|NCT05396014|363522617|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413982|NCT05396014|363522618|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413983|NCT05396014|363522619|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413984|NCT05396014|363522620|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413985|NCT05396014|363522621|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413986|NCT05396014|363522622|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413987|NCT05396014|363522623|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413988|NCT05396014|363522624|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413989|NCT05396014|363522625|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413990|NCT05396014|363522626|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413991|NCT05396014|363522627|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413992|NCT05396014|363522628|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413993|NCT05396014|363522629|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
105413994|NCT05396014|363522630|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413995|NCT05396014|363522631|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413996|NCT05396014|363522632|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105413997|NCT05396014|363522590|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105413998|NCT05396014|363522591|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105413999|NCT05396014|363522592|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414000|NCT05396014|363522593|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414001|NCT05396014|363522594|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414002|NCT05396014|363522595|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414003|NCT05396014|363522596|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414004|NCT05396014|363522597|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414005|NCT05396014|363522598|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414006|NCT05396014|363522599|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414007|NCT05396014|363522600|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414008|NCT05396014|363522601|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414009|NCT05396014|363522602|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414010|NCT05396014|363522603|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414011|NCT05396014|363522604|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414012|NCT05396014|363522605|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414013|NCT05396014|363522606|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414014|NCT05396014|363522607|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414015|NCT05396014|363522608|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414016|NCT05396014|363522609|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414017|NCT05396014|363522610|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414018|NCT05396014|363522611|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105497092|NCT00615108|363831973|FG000|Overall Study|Lost to Follow-up|15|||
105497093|NCT01914757|363831974|FG000|Overall Study|Severe non-compliance to protocol|3|||
105497094|NCT01914757|363831975|FG001|Overall Study|Severe non-compliance to protocol|1|||
105497095|NCT01914757|363831976|FG002|Overall Study|Severe non-compliance to protocol|2|||
105497096|NCT01914757|363831974|FG000|Overall Study|Lost to Follow-up|5|||
105497097|NCT01914757|363831975|FG001|Overall Study|Lost to Follow-up|8|||
105497098|NCT01914757|363831976|FG002|Overall Study|Lost to Follow-up|6|||
105497099|NCT01914757|363831974|FG000|Overall Study|Withdrawal by Subject|15|||
105497100|NCT01914757|363831975|FG001|Overall Study|Withdrawal by Subject|27|||
105497101|NCT01914757|363831976|FG002|Overall Study|Withdrawal by Subject|19|||
105497102|NCT01914757|363831974|FG000|Overall Study|Death|2|||
105497103|NCT01914757|363831975|FG001|Overall Study|Death|2|||
105497104|NCT01914757|363831976|FG002|Overall Study|Death|1|||
105497105|NCT01914757|363831974|FG000|Overall Study|Adverse Event|4|||
105497106|NCT01914757|363831975|FG001|Overall Study|Adverse Event|3|||
105497107|NCT01914757|363831976|FG002|Overall Study|Adverse Event|4|||
105497108|NCT01914757|363831974|FG000|Overall Study|Study specific withdrawal criteria|0|||
105497109|NCT01914757|363831975|FG001|Overall Study|Study specific withdrawal criteria|1|||
105497110|NCT01914757|363831976|FG002|Overall Study|Study specific withdrawal criteria|0|||
105497111|NCT01914757|363831974|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
105497112|NCT01914757|363831975|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105414019|NCT05396014|363522612|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414020|NCT05396014|363522613|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414021|NCT05396014|363522614|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414022|NCT05396014|363522615|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414023|NCT05396014|363522616|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
105414024|NCT05396014|363522617|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414025|NCT05396014|363522618|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414026|NCT05396014|363522619|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414027|NCT05396014|363522620|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414028|NCT05396014|363522621|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414029|NCT05396014|363522622|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414030|NCT05396014|363522623|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414031|NCT05396014|363522624|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414032|NCT05396014|363522625|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414033|NCT05396014|363522626|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414034|NCT05396014|363522627|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414035|NCT05396014|363522628|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414036|NCT05396014|363522629|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
105414037|NCT05396014|363522630|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414038|NCT05396014|363522631|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414039|NCT05396014|363522632|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105414040|NCT05396014|363522590|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414041|NCT05396014|363522591|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414042|NCT05396014|363522592|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414043|NCT05396014|363522593|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414044|NCT05396014|363522594|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414045|NCT05396014|363522595|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414046|NCT05396014|363522596|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414047|NCT05396014|363522597|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414048|NCT05396014|363522598|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414049|NCT05396014|363522599|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414050|NCT05396014|363522600|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414051|NCT05396014|363522601|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414052|NCT05396014|363522602|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414053|NCT05396014|363522603|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414054|NCT05396014|363522604|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414055|NCT05396014|363522605|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414056|NCT05396014|363522606|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414057|NCT05396014|363522607|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414058|NCT05396014|363522608|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414059|NCT05396014|363522609|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414060|NCT05396014|363522610|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414061|NCT05396014|363522611|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414062|NCT05396014|363522612|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414063|NCT05396014|363522613|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414064|NCT05396014|363522614|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414065|NCT05396014|363522615|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414066|NCT05396014|363522616|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
105414067|NCT05396014|363522617|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414068|NCT05396014|363522618|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414069|NCT05396014|363522619|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414070|NCT05396014|363522620|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414071|NCT05396014|363522621|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414072|NCT05396014|363522622|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414073|NCT05396014|363522623|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414074|NCT05396014|363522624|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414075|NCT05396014|363522625|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414076|NCT05396014|363522626|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414077|NCT05396014|363522627|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414078|NCT05396014|363522628|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414079|NCT05396014|363522629|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414080|NCT05396014|363522630|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414081|NCT05396014|363522631|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105414082|NCT05396014|363522632|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105497113|NCT01914757|363831976|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
105497114|NCT01914757|363831974|FG000|Overall Study|Other reasons|5|||
105582221|NCT01890967|364129977|FG002|Overall Study|Withdrawal by Subject|2|||
105582222|NCT01890967|364129978|FG003|Overall Study|Withdrawal by Subject|3|||
105582223|NCT01890967|364129979|FG004|Overall Study|Withdrawal by Subject|3|||
105582224|NCT01890967|364129980|FG005|Overall Study|Withdrawal by Subject|1|||
105582225|NCT01646320|364129985|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
105582226|NCT01646320|364129986|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
105582227|NCT01646320|364129985|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
105582228|NCT01646320|364129986|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
105582229|NCT01646320|364129985|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
105582230|NCT01646320|364129986|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
105582231|NCT01646320|364129985|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
105582232|NCT01646320|364129986|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
105582233|NCT01646320|364129985|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
105582234|NCT01646320|364129986|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
105582235|NCT01646320|364129985|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
105582236|NCT01646320|364129986|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
105582237|NCT01646320|364129985|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
105582238|NCT01646320|364129986|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
105582239|NCT01646320|364129985|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
105582240|NCT01646320|364129986|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
105582241|NCT01646320|364129985|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
105582242|NCT01646320|364129986|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
105582243|NCT01646320|364129985|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
105582244|NCT01646320|364129986|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
105582245|NCT01646320|364129985|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
105582246|NCT01646320|364129986|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
105582247|NCT01489020|364129987|FG000|Overall Study|Withdrawal by Subject|1|||
105582248|NCT01489020|364129988|FG001|Overall Study|Withdrawal by Subject|0|||
105582249|NCT01489020|364129989|FG002|Overall Study|Withdrawal by Subject|0|||
105582250|NCT01489020|364129990|FG003|Overall Study|Withdrawal by Subject|0|||
105582251|NCT01489020|364129991|FG004|Overall Study|Withdrawal by Subject|0|||
105582252|NCT01489020|364129992|FG005|Overall Study|Withdrawal by Subject|0|||
105582253|NCT01489020|364129987|FG000|Overall Study|Adverse Event|0|||
105582254|NCT01489020|364129988|FG001|Overall Study|Adverse Event|0|||
105582255|NCT01489020|364129989|FG002|Overall Study|Adverse Event|3|||
105582256|NCT01489020|364129990|FG003|Overall Study|Adverse Event|0|||
105582257|NCT01489020|364129991|FG004|Overall Study|Adverse Event|3|||
105582258|NCT01489020|364129992|FG005|Overall Study|Adverse Event|0|||
105582259|NCT01489020|364129987|FG000|Overall Study|Concomitant disease|0|||
105582260|NCT01489020|364129988|FG001|Overall Study|Concomitant disease|0|||
105582261|NCT01489020|364129989|FG002|Overall Study|Concomitant disease|0|||
105582262|NCT01489020|364129990|FG003|Overall Study|Concomitant disease|0|||
105582263|NCT01489020|364129991|FG004|Overall Study|Concomitant disease|3|||
105582264|NCT01489020|364129992|FG005|Overall Study|Concomitant disease|0|||
105582265|NCT02561455|364129993|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
105582266|NCT02561455|364129994|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
105582267|NCT02561455|364129995|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
105582268|NCT02561455|364129996|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
105582269|NCT02561455|364129993|FG000|Overall Study|Withdrawal by Subject|1|||
105582270|NCT02561455|364129994|FG001|Overall Study|Withdrawal by Subject|0|||
105582271|NCT02561455|364129995|FG002|Overall Study|Withdrawal by Subject|1|||
105582272|NCT02561455|364129996|FG003|Overall Study|Withdrawal by Subject|0|||
105582273|NCT02561455|364129993|FG000|Overall Study|Disease Progression|0|||
105582274|NCT02561455|364129994|FG001|Overall Study|Disease Progression|1|||
105582275|NCT02561455|364129995|FG002|Overall Study|Disease Progression|0|||
105582276|NCT02561455|364129996|FG003|Overall Study|Disease Progression|0|||
105582277|NCT02451930|364129997|FG000|Overall Study|Death|0|||
105582278|NCT02451930|364129998|FG001|Overall Study|Death|15|||
105582279|NCT02451930|364129997|FG000|Overall Study|Lost to Follow-up|0|||
105582280|NCT02451930|364129998|FG001|Overall Study|Lost to Follow-up|3|||
105582281|NCT02451930|364129997|FG000|Overall Study|Sponsor Decision|2|||
105582282|NCT02451930|364129998|FG001|Overall Study|Sponsor Decision|10|||
105582283|NCT02451930|364129997|FG000|Overall Study|Withdrawal by Subject|0|||
105582284|NCT02451930|364129998|FG001|Overall Study|Withdrawal by Subject|1|||
105414083|NCT05396014|363522590|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105582285|NCT02451930|364129997|FG000|Overall Study|Other|0|||
105582286|NCT02451930|364129998|FG001|Overall Study|Other|1|||
105414084|NCT05396014|363522591|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414085|NCT05396014|363522592|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414086|NCT05396014|363522593|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105582287|NCT01254305|364129999|FG000|Overall Study|Adverse Event|6|||
105582288|NCT01254305|364130000|FG001|Overall Study|Adverse Event|3|||
105497115|NCT01914757|363831975|FG001|Overall Study|Other reasons|9|||
105497116|NCT01914757|363831976|FG002|Overall Study|Other reasons|4|||
105497117|NCT05021081|363831977|FG000|Phase 2|Subject enrolled in error|1|||
105497118|NCT05021081|363831978|FG001|Phase 2|Subject enrolled in error|1|||
105497119|NCT05021081|363831979|FG002|Phase 2|Subject enrolled in error|0|||
105497120|NCT00369122|363831980|FG000|Overall Study|Ineligible|10|||
105497121|NCT00369122|363831980|FG000|Overall Study|No protocol treatment|1|||
105497122|NCT04171765|363831985|FG000|Overall Study|Adverse Event|2|||
105497123|NCT04171765|363831986|FG001|Overall Study|Adverse Event|0|||
105497124|NCT04171765|363831987|FG002|Overall Study|Adverse Event|1|||
105497125|NCT04171765|363831988|FG003|Overall Study|Adverse Event|0|||
105497126|NCT04171765|363831985|FG000|Overall Study|Lost to Follow-up|0|||
105497127|NCT04171765|363831986|FG001|Overall Study|Lost to Follow-up|2|||
105497128|NCT04171765|363831987|FG002|Overall Study|Lost to Follow-up|2|||
105497129|NCT04171765|363831988|FG003|Overall Study|Lost to Follow-up|2|||
105497130|NCT04171765|363831985|FG000|Overall Study|Week 58 visit missed|0|||
105497131|NCT04171765|363831986|FG001|Overall Study|Week 58 visit missed|0|||
105497132|NCT04171765|363831987|FG002|Overall Study|Week 58 visit missed|1|||
105497133|NCT04171765|363831988|FG003|Overall Study|Week 58 visit missed|0|||
105497134|NCT04171765|363831985|FG000|Overall Study|Study terminated by sponsor|2|||
105497135|NCT04171765|363831986|FG001|Overall Study|Study terminated by sponsor|0|||
105497136|NCT04171765|363831987|FG002|Overall Study|Study terminated by sponsor|0|||
105497137|NCT04171765|363831988|FG003|Overall Study|Study terminated by sponsor|0|||
105497138|NCT04171765|363831985|FG000|Overall Study|Withdrawal by Subject|1|||
105497139|NCT04171765|363831986|FG001|Overall Study|Withdrawal by Subject|0|||
105497140|NCT04171765|363831987|FG002|Overall Study|Withdrawal by Subject|0|||
105497141|NCT04171765|363831988|FG003|Overall Study|Withdrawal by Subject|3|||
105497142|NCT01426438|363831989|FG000|Overall Study|Lost to Follow-up|1|||
105497143|NCT01426438|363831990|FG001|Overall Study|Lost to Follow-up|3|||
105497144|NCT01426438|363831989|FG000|Overall Study|Off study Treatment|9|||
105497145|NCT01426438|363831990|FG001|Overall Study|Off study Treatment|3|||
105497146|NCT01426438|363831989|FG000|Overall Study|Poor scan quality|3|||
105497147|NCT01426438|363831990|FG001|Overall Study|Poor scan quality|2|||
105497148|NCT01426438|363831989|FG000|Overall Study|Missed Scan|2|||
105497149|NCT01426438|363831990|FG001|Overall Study|Missed Scan|2|||
105497150|NCT00697788|363831991|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
105497151|NCT00697788|363831992|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
105497152|NCT00697788|363831993|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
105497153|NCT00697788|363831994|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
105497154|NCT00697788|363831995|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
105497155|NCT00697788|363831996|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
105497156|NCT00697788|363831997|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
105497157|NCT00697788|363831998|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
105497158|NCT00697788|363831991|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
105497159|NCT00697788|363831992|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
105497160|NCT00697788|363831993|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
105497161|NCT00697788|363831994|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
105497162|NCT00697788|363831995|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
105497163|NCT00697788|363831996|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
105497164|NCT00697788|363831997|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
105497165|NCT00697788|363831998|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
105497166|NCT02833350|363831999|FG000|Overall Study|Adverse Event|0|||
105497167|NCT02833350|363832000|FG001|Overall Study|Adverse Event|3|||
105497168|NCT02833350|363832001|FG002|Overall Study|Adverse Event|4|||
105497169|NCT02833350|363832002|FG003|Overall Study|Adverse Event|4|||
105497170|NCT02833350|363832003|FG004|Overall Study|Adverse Event|1|||
105497171|NCT02833350|363832004|FG005|Overall Study|Adverse Event|0|||
105497172|NCT02833350|363832005|FG006|Overall Study|Adverse Event|1|||
105497173|NCT02833350|363831999|FG000|Overall Study|Death|0|||
105497174|NCT02833350|363832000|FG001|Overall Study|Death|0|||
105497175|NCT02833350|363832001|FG002|Overall Study|Death|1|||
105497176|NCT02833350|363832002|FG003|Overall Study|Death|0|||
105497177|NCT02833350|363832003|FG004|Overall Study|Death|0|||
105497178|NCT02833350|363832004|FG005|Overall Study|Death|0|||
105497179|NCT02833350|363832005|FG006|Overall Study|Death|0|||
105497180|NCT02833350|363831999|FG000|Overall Study|Lack of Efficacy|0|||
105497181|NCT02833350|363832000|FG001|Overall Study|Lack of Efficacy|2|||
105497182|NCT02833350|363832001|FG002|Overall Study|Lack of Efficacy|1|||
105497183|NCT02833350|363832002|FG003|Overall Study|Lack of Efficacy|4|||
105497184|NCT02833350|363832003|FG004|Overall Study|Lack of Efficacy|0|||
105497185|NCT02833350|363832004|FG005|Overall Study|Lack of Efficacy|1|||
105497186|NCT02833350|363832005|FG006|Overall Study|Lack of Efficacy|1|||
105497187|NCT02833350|363831999|FG000|Overall Study|Lost to Follow-up|0|||
105497188|NCT02833350|363832000|FG001|Overall Study|Lost to Follow-up|1|||
105497189|NCT02833350|363832001|FG002|Overall Study|Lost to Follow-up|0|||
105497190|NCT02833350|363832002|FG003|Overall Study|Lost to Follow-up|0|||
105497191|NCT02833350|363832003|FG004|Overall Study|Lost to Follow-up|0|||
105497192|NCT02833350|363832004|FG005|Overall Study|Lost to Follow-up|0|||
105497193|NCT02833350|363832005|FG006|Overall Study|Lost to Follow-up|1|||
105497194|NCT02833350|363831999|FG000|Overall Study|Withdrawal by Subject|3|||
105497195|NCT02833350|363832000|FG001|Overall Study|Withdrawal by Subject|3|||
105497196|NCT02833350|363832001|FG002|Overall Study|Withdrawal by Subject|2|||
105497197|NCT02833350|363832002|FG003|Overall Study|Withdrawal by Subject|0|||
105497198|NCT02833350|363832003|FG004|Overall Study|Withdrawal by Subject|2|||
105497199|NCT02833350|363832004|FG005|Overall Study|Withdrawal by Subject|0|||
105497200|NCT02833350|363832005|FG006|Overall Study|Withdrawal by Subject|2|||
105497201|NCT01788046|363832006|FG000|Overall Study|Withdrawal by Subject|12|||
105497202|NCT01788046|363832007|FG001|Overall Study|Withdrawal by Subject|12|||
105497203|NCT01788046|363832006|FG000|Overall Study|Lost to Follow-up|12|||
105497204|NCT01788046|363832007|FG001|Overall Study|Lost to Follow-up|19|||
105497205|NCT01788046|363832006|FG000|Overall Study|Death|7|||
105497206|NCT01788046|363832007|FG001|Overall Study|Death|5|||
105497207|NCT01788046|363832006|FG000|Overall Study|Protocol Specified Criteria|25|||
105497208|NCT01788046|363832007|FG001|Overall Study|Protocol Specified Criteria|1|||
105497209|NCT02124161|363832012|FG000|Overall Study|Other unspecified|0|||
105497210|NCT02124161|363832013|FG001|Overall Study|Other unspecified|1|||
105497211|NCT02124161|363832012|FG000|Overall Study|Death|1|||
105497212|NCT02124161|363832013|FG001|Overall Study|Death|0|||
105497213|NCT02124161|363832012|FG000|Overall Study|Protocol Violation|2|||
105497214|NCT02124161|363832013|FG001|Overall Study|Protocol Violation|1|||
105497215|NCT02124161|363832012|FG000|Overall Study|Withdrawal by Subject|1|||
105497216|NCT02124161|363832013|FG001|Overall Study|Withdrawal by Subject|2|||
105497217|NCT02124161|363832012|FG000|Overall Study|Adverse Event|2|||
105497218|NCT02124161|363832013|FG001|Overall Study|Adverse Event|0|||
105497219|NCT02124161|363832012|FG000|Overall Study|Does not meet entrance criteria|2|||
105497220|NCT02124161|363832013|FG001|Overall Study|Does not meet entrance criteria|3|||
105497221|NCT02124161|363832012|FG000|Overall Study|No longer meets eligibility criteria|5|||
105497222|NCT02124161|363832013|FG001|Overall Study|No longer meets eligibility criteria|4|||
105497223|NCT02124161|363832012|FG000|Overall Study|Lost to Follow-up|3|||
105497224|NCT02124161|363832013|FG001|Overall Study|Lost to Follow-up|4|||
105497225|NCT01856907|363832014|FG000|Overall Study|Pregnancy|0|||
105497226|NCT01856907|363832015|FG001|Overall Study|Pregnancy|1|||
105497227|NCT01856907|363832016|FG002|Overall Study|Pregnancy|0|||
105497228|NCT01856907|363832014|FG000|Overall Study|Pregnancy|0|||
105497229|NCT01856907|363832015|FG001|Overall Study|Pregnancy|1|||
105497230|NCT01856907|363832016|FG002|Overall Study|Pregnancy|0|||
105497231|NCT01856907|363832014|FG000|Overall Study|Withdrawal by Subject|0|||
105497232|NCT01856907|363832015|FG001|Overall Study|Withdrawal by Subject|1|||
105497233|NCT01856907|363832016|FG002|Overall Study|Withdrawal by Subject|0|||
105497234|NCT01797731|363832017|FG000|Overall Study|Didn't have proper radiographs required|3|||
105497235|NCT01797731|363832018|FG001|Overall Study|Didn't have proper radiographs required|3|||
105497236|NCT01604408|363832019|FG000|Treatment Period 1|Protocol Violation|0|||
105497237|NCT01604408|363832020|FG001|Treatment Period 1|Protocol Violation|1|||
105497238|NCT01604408|363832019|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105497239|NCT01604408|363832020|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105497240|NCT01604408|363832019|FG000|Treatment Period 2|Protocol Violation|1|||
105497241|NCT01604408|363832020|FG001|Treatment Period 2|Protocol Violation|0|||
105497242|NCT01604408|363832019|FG000|Treatment Period 2|Adverse Event|0|||
105497243|NCT01604408|363832020|FG001|Treatment Period 2|Adverse Event|1|||
105497244|NCT01604408|363832019|FG000|Treatment Period 3|Protocol Violation|1|||
105497245|NCT01604408|363832020|FG001|Treatment Period 3|Protocol Violation|1|||
105497246|NCT01604408|363832019|FG000|Treatment Period 3|Adverse Event|0|||
105497247|NCT01604408|363832020|FG001|Treatment Period 3|Adverse Event|3|||
105497248|NCT01604408|363832019|FG000|Treatment Period 3|Withdrawal by Subject|3|||
105497249|NCT01604408|363832020|FG001|Treatment Period 3|Withdrawal by Subject|1|||
105497250|NCT01604408|363832019|FG000|Treatment Period 3|Sponsor Decision|1|||
105497251|NCT01604408|363832020|FG001|Treatment Period 3|Sponsor Decision|0|||
105497252|NCT01604408|363832019|FG000|Treatment Period 4|Death|1|||
105497253|NCT01604408|363832020|FG001|Treatment Period 4|Death|0|||
105497254|NCT01604408|363832019|FG000|Treatment Period 4|Withdrawal by Subject|2|||
105497255|NCT01604408|363832020|FG001|Treatment Period 4|Withdrawal by Subject|1|||
105497256|NCT01604408|363832019|FG000|Treatment Period 4|Adverse Event|0|||
105497257|NCT01604408|363832020|FG001|Treatment Period 4|Adverse Event|1|||
105497258|NCT01604408|363832019|FG000|Treatment Period 5|Adverse Event|4|||
105497259|NCT01604408|363832020|FG001|Treatment Period 5|Adverse Event|0|||
105497260|NCT01604408|363832019|FG000|Treatment Period 6|Lost to Follow-up|0|||
105497261|NCT01604408|363832020|FG001|Treatment Period 6|Lost to Follow-up|1|||
105497262|NCT01604408|363832019|FG000|Treatment Period 6|Adverse Event|2|||
105497263|NCT01604408|363832020|FG001|Treatment Period 6|Adverse Event|0|||
105497264|NCT01604408|363832019|FG000|Treatment Period 6|Sponsor decision|0|||
105497265|NCT01604408|363832020|FG001|Treatment Period 6|Sponsor decision|1|||
105497266|NCT01604408|363832019|FG000|Observation Period|Adverse Event|1|||
105497267|NCT01604408|363832020|FG001|Observation Period|Adverse Event|1|||
105414087|NCT05396014|363522594|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414088|NCT05396014|363522595|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414089|NCT05396014|363522596|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414090|NCT05396014|363522597|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414091|NCT05396014|363522598|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414092|NCT05396014|363522599|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414093|NCT05396014|363522600|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414094|NCT05396014|363522601|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414095|NCT05396014|363522602|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414096|NCT05396014|363522603|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
105414097|NCT05396014|363522604|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414098|NCT05396014|363522605|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414099|NCT05396014|363522606|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414100|NCT05396014|363522607|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414101|NCT05396014|363522608|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414102|NCT05396014|363522609|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414103|NCT05396014|363522610|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414104|NCT05396014|363522611|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414105|NCT05396014|363522612|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414106|NCT05396014|363522613|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414107|NCT05396014|363522614|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414108|NCT05396014|363522615|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414109|NCT05396014|363522616|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414110|NCT05396014|363522617|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414111|NCT05396014|363522618|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414112|NCT05396014|363522619|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414113|NCT05396014|363522620|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414114|NCT05396014|363522621|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414115|NCT05396014|363522622|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414116|NCT05396014|363522623|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414117|NCT05396014|363522624|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414118|NCT05396014|363522625|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414119|NCT05396014|363522626|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414120|NCT05396014|363522627|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414121|NCT05396014|363522628|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414122|NCT05396014|363522629|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414123|NCT05396014|363522630|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105582289|NCT01254305|364130001|FG002|Overall Study|Adverse Event|2|||
105414124|NCT05396014|363522631|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414125|NCT05396014|363522632|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105414126|NCT05396014|363522590|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
105414127|NCT05396014|363522591|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414128|NCT05396014|363522592|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414129|NCT05396014|363522593|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414130|NCT05396014|363522594|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414131|NCT05396014|363522595|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414132|NCT05396014|363522596|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414133|NCT05396014|363522597|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414134|NCT05396014|363522598|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414135|NCT05396014|363522599|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414136|NCT05396014|363522600|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414137|NCT05396014|363522601|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414138|NCT05396014|363522602|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414139|NCT05396014|363522603|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
105414140|NCT05396014|363522604|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414141|NCT05396014|363522605|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414142|NCT05396014|363522606|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414143|NCT05396014|363522607|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414144|NCT05396014|363522608|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414145|NCT05396014|363522609|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414146|NCT05396014|363522610|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414147|NCT05396014|363522611|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414148|NCT05396014|363522612|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105582290|NCT01254305|364129999|FG000|Overall Study|Lack of Efficacy|1|||
105414149|NCT05396014|363522613|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414150|NCT05396014|363522614|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414151|NCT05396014|363522615|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414152|NCT05396014|363522616|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414153|NCT05396014|363522617|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414154|NCT05396014|363522618|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414155|NCT05396014|363522619|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414156|NCT05396014|363522620|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414157|NCT05396014|363522621|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414158|NCT05396014|363522622|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414159|NCT05396014|363522623|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414160|NCT05396014|363522624|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414161|NCT05396014|363522625|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414162|NCT05396014|363522626|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414163|NCT05396014|363522627|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414164|NCT05396014|363522628|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414165|NCT05396014|363522629|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
105414166|NCT05396014|363522630|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414167|NCT05396014|363522631|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414168|NCT05396014|363522632|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105414169|NCT05396014|363522590|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
105414170|NCT05396014|363522591|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414171|NCT05396014|363522592|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414172|NCT05396014|363522593|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414173|NCT05396014|363522594|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414174|NCT05396014|363522595|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414175|NCT05396014|363522596|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414176|NCT05396014|363522597|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414177|NCT05396014|363522598|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414178|NCT05396014|363522599|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414179|NCT05396014|363522600|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414180|NCT05396014|363522601|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414181|NCT05396014|363522602|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414182|NCT05396014|363522603|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414183|NCT05396014|363522604|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414184|NCT05396014|363522605|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414185|NCT05396014|363522606|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414186|NCT05396014|363522607|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414187|NCT05396014|363522608|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414188|NCT05396014|363522609|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414189|NCT05396014|363522610|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414190|NCT05396014|363522611|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414191|NCT05396014|363522612|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414192|NCT05396014|363522613|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414193|NCT05396014|363522614|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414194|NCT05396014|363522615|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414195|NCT05396014|363522616|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
105414196|NCT05396014|363522617|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414197|NCT05396014|363522618|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105582291|NCT01254305|364130000|FG001|Overall Study|Lack of Efficacy|0|||
105414198|NCT05396014|363522619|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414199|NCT05396014|363522620|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414200|NCT05396014|363522621|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414201|NCT05396014|363522622|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414202|NCT05396014|363522623|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414203|NCT05396014|363522624|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414204|NCT05396014|363522625|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414205|NCT05396014|363522626|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414206|NCT05396014|363522627|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414207|NCT05396014|363522628|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414208|NCT05396014|363522629|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414209|NCT05396014|363522630|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414210|NCT05396014|363522631|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105414211|NCT05396014|363522632|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105497268|NCT01604408|363832019|FG000|Observation Period|Withdrawal by Subject|0|||
105497269|NCT01604408|363832020|FG001|Observation Period|Withdrawal by Subject|2|||
105497270|NCT00917501|363832022|FG000|Overall Study|Lost to Follow-up|4|||
105497271|NCT00917501|363832023|FG001|Overall Study|Lost to Follow-up|1|||
105497272|NCT00917501|363832022|FG000|Overall Study|Withdrawal by Subject|3|||
105497273|NCT00917501|363832023|FG001|Overall Study|Withdrawal by Subject|1|||
105497274|NCT00917501|363832022|FG000|Overall Study|Lack of Efficacy|1|||
105497275|NCT00917501|363832023|FG001|Overall Study|Lack of Efficacy|2|||
105414212|NCT05396014|363522590|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105497276|NCT00917501|363832022|FG000|Overall Study|trouble swollowing capsules|0|||
105497277|NCT00917501|363832023|FG001|Overall Study|trouble swollowing capsules|1|||
105497278|NCT03342963|363832024|FG000|Overall Study|Adverse Event|1|||
105497279|NCT03342963|363832025|FG001|Overall Study|Adverse Event|2|||
105497280|NCT03342963|363832026|FG002|Overall Study|Adverse Event|0|||
105497281|NCT03342963|363832027|FG003|Overall Study|Adverse Event|0|||
105414213|NCT05396014|363522591|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414214|NCT05396014|363522592|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414215|NCT05396014|363522593|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414216|NCT05396014|363522594|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414217|NCT05396014|363522595|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414218|NCT05396014|363522596|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414219|NCT05396014|363522597|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414220|NCT05396014|363522598|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414221|NCT05396014|363522599|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414222|NCT05396014|363522600|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414223|NCT05396014|363522601|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414224|NCT05396014|363522602|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414225|NCT05396014|363522603|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
105414226|NCT05396014|363522604|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414227|NCT05396014|363522605|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414228|NCT05396014|363522606|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414229|NCT05396014|363522607|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414230|NCT05396014|363522608|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414231|NCT05396014|363522609|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414232|NCT05396014|363522610|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414233|NCT05396014|363522611|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414234|NCT05396014|363522612|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414235|NCT05396014|363522613|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414236|NCT05396014|363522614|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414237|NCT05396014|363522615|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414238|NCT05396014|363522616|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414239|NCT05396014|363522617|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414240|NCT05396014|363522618|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414241|NCT05396014|363522619|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414242|NCT05396014|363522620|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414243|NCT05396014|363522621|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414244|NCT05396014|363522622|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414245|NCT05396014|363522623|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414246|NCT05396014|363522624|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414247|NCT05396014|363522625|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414248|NCT05396014|363522626|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414249|NCT05396014|363522627|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414250|NCT05396014|363522628|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414251|NCT05396014|363522629|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414252|NCT05396014|363522630|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414253|NCT05396014|363522631|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414254|NCT05396014|363522632|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105414255|NCT05396014|363522590|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414256|NCT05396014|363522591|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414257|NCT05396014|363522592|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414258|NCT05396014|363522593|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
105414259|NCT05396014|363522594|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414260|NCT05396014|363522595|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105414261|NCT05396014|363522596|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105414262|NCT05396014|363522597|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414263|NCT05396014|363522598|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
105414264|NCT05396014|363522599|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105414265|NCT05396014|363522600|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414266|NCT05396014|363522601|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414267|NCT05396014|363522602|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414268|NCT05396014|363522603|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414269|NCT05396014|363522604|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414270|NCT05396014|363522605|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105414271|NCT05396014|363522606|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105582292|NCT01254305|364130001|FG002|Overall Study|Lack of Efficacy|1|||
105582293|NCT01254305|364129999|FG000|Overall Study|Protocol Violation|1|||
105582294|NCT01254305|364130000|FG001|Overall Study|Protocol Violation|7|||
105582295|NCT01254305|364130001|FG002|Overall Study|Protocol Violation|3|||
105582296|NCT01254305|364129999|FG000|Overall Study|Withdrawal by Subject|4|||
105582297|NCT01254305|364130000|FG001|Overall Study|Withdrawal by Subject|2|||
105582298|NCT01254305|364130001|FG002|Overall Study|Withdrawal by Subject|4|||
105582299|NCT01254305|364129999|FG000|Overall Study|Lost to Follow-up|10|||
105582300|NCT01254305|364130000|FG001|Overall Study|Lost to Follow-up|6|||
105582301|NCT01254305|364130001|FG002|Overall Study|Lost to Follow-up|5|||
105582302|NCT01254305|364129999|FG000|Overall Study|Other Reasons|0|||
105582303|NCT01254305|364130000|FG001|Overall Study|Other Reasons|0|||
105582304|NCT01254305|364130001|FG002|Overall Study|Other Reasons|2|||
105582305|NCT00031447|364130005|FG000|Overall Study|Lost to Follow-up|0|||
105582306|NCT00031447|364130006|FG001|Overall Study|Lost to Follow-up|1|||
105582307|NCT00031447|364130005|FG000|Overall Study|Non-compliant|1|||
105582308|NCT00031447|364130006|FG001|Overall Study|Non-compliant|1|||
105582309|NCT00031447|364130005|FG000|Overall Study|Re-activation of Disease|2|||
105582310|NCT00031447|364130006|FG001|Overall Study|Re-activation of Disease|1|||
105582311|NCT00031447|364130005|FG000|Overall Study|Disruption of blinded study drug supply|7|||
105582312|NCT00031447|364130006|FG001|Overall Study|Disruption of blinded study drug supply|4|||
105582313|NCT00997243|364130007|FG000|Overall Study|Early termination of study by sponsor|7|||
105582314|NCT02800928|364130010|FG000|Overall Study|Withdrawal by Subject|1|||
105582315|NCT02800928|364130011|FG001|Overall Study|Withdrawal by Subject|1|||
105582316|NCT02800928|364130010|FG000|Overall Study|Protocol Violation|1|||
105582317|NCT02800928|364130011|FG001|Overall Study|Protocol Violation|1|||
105582318|NCT00884286|364130016|FG000|Overall Study|Progressive disease|21|||
105582319|NCT00884286|364130017|FG001|Overall Study|Progressive disease|28|||
105582320|NCT00884286|364130016|FG000|Overall Study|Toxicity|4|||
105582321|NCT00884286|364130017|FG001|Overall Study|Toxicity|1|||
105582322|NCT00884286|364130016|FG000|Overall Study|Death|2|||
105582323|NCT00884286|364130017|FG001|Overall Study|Death|2|||
105582324|NCT00884286|364130016|FG000|Overall Study|Physician Decision|1|||
105582325|NCT00884286|364130017|FG001|Overall Study|Physician Decision|0|||
105582326|NCT00884286|364130016|FG000|Overall Study|Septic shock|1|||
105582327|NCT00884286|364130017|FG001|Overall Study|Septic shock|0|||
105582328|NCT00884286|364130016|FG000|Overall Study|Thrombus in right auricle|1|||
105582329|NCT00884286|364130017|FG001|Overall Study|Thrombus in right auricle|0|||
105582330|NCT00884286|364130016|FG000|Overall Study|Not treated|2|||
105582331|NCT00884286|364130017|FG001|Overall Study|Not treated|1|||
105582332|NCT00884286|364130016|FG000|Overall Study|Comprised lung carcinoma|0|||
105582333|NCT00884286|364130017|FG001|Overall Study|Comprised lung carcinoma|1|||
105582334|NCT03523871|364130020|FG000|Overall Study|Death|1|||
105582335|NCT01113463|364130024|FG000|Overall Study|Physician Decision|5|||
105582336|NCT00136916|364130025|FG000|Overall Study|Never received study treatment|3|||
105582337|NCT00136916|364130026|FG001|Overall Study|Never received study treatment|5|||
105582338|NCT00136916|364130025|FG000|Overall Study|Death|1|||
105582339|NCT00136916|364130026|FG001|Overall Study|Death|3|||
105582340|NCT00136916|364130025|FG000|Overall Study|Adverse Event|27|||
105582341|NCT00136916|364130026|FG001|Overall Study|Adverse Event|8|||
105582342|NCT00136916|364130025|FG000|Overall Study|Laboratory abnormality|0|||
105582343|NCT00136916|364130026|FG001|Overall Study|Laboratory abnormality|1|||
105582344|NCT00136916|364130025|FG000|Overall Study|Lack of Efficacy|13|||
105582345|NCT00136916|364130026|FG001|Overall Study|Lack of Efficacy|3|||
105582346|NCT00136916|364130025|FG000|Overall Study|Lost to Follow-up|12|||
105582347|NCT00136916|364130026|FG001|Overall Study|Lost to Follow-up|14|||
105582348|NCT00136916|364130025|FG000|Overall Study|Withdrawal by Subject|44|||
105582349|NCT00136916|364130026|FG001|Overall Study|Withdrawal by Subject|46|||
105582350|NCT00136916|364130025|FG000|Overall Study|Other|22|||
105582351|NCT00136916|364130026|FG001|Overall Study|Other|24|||
105582352|NCT00136916|364130025|FG000|Overall Study|Discontinued in follow up period|3|||
105582353|NCT00136916|364130026|FG001|Overall Study|Discontinued in follow up period|0|||
105582354|NCT02059161|364130029|FG000|Overall Study|Pregnancy|0|||
105582355|NCT02059161|364130030|FG001|Overall Study|Pregnancy|2|||
105582356|NCT02059161|364130029|FG000|Overall Study|Adverse Event|2|||
105582357|NCT02059161|364130030|FG001|Overall Study|Adverse Event|6|||
105582358|NCT02059161|364130029|FG000|Overall Study|Lost to Follow-up|20|||
105582359|NCT02059161|364130030|FG001|Overall Study|Lost to Follow-up|12|||
105582360|NCT02059161|364130029|FG000|Overall Study|Physician Decision|4|||
105582361|NCT02059161|364130030|FG001|Overall Study|Physician Decision|4|||
105582362|NCT02059161|364130029|FG000|Overall Study|Protocol Violation|1|||
105582363|NCT02059161|364130030|FG001|Overall Study|Protocol Violation|1|||
105582364|NCT02059161|364130029|FG000|Overall Study|Withdrawal by Subject|16|||
105582365|NCT02059161|364130030|FG001|Overall Study|Withdrawal by Subject|13|||
105582366|NCT02059161|364130029|FG000|Overall Study|Randomized in error, no study drug|0|||
105582367|NCT02059161|364130030|FG001|Overall Study|Randomized in error, no study drug|1|||
105582368|NCT02059161|364130029|FG000|Overall Study|Non-compliance with study drug|6|||
105582369|NCT02059161|364130030|FG001|Overall Study|Non-compliance with study drug|2|||
105582370|NCT03293485|364130031|FG000|Overall Study|Death|1|||
105414272|NCT05396014|363522607|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414273|NCT05396014|363522608|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414274|NCT05396014|363522609|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414275|NCT05396014|363522610|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414276|NCT05396014|363522611|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414277|NCT05396014|363522612|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105414278|NCT05396014|363522613|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105414279|NCT05396014|363522614|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105414280|NCT05396014|363522615|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
105414281|NCT05396014|363522616|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414282|NCT05396014|363522617|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414283|NCT05396014|363522618|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414284|NCT05396014|363522619|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414285|NCT05396014|363522620|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105414286|NCT05396014|363522621|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105414287|NCT05396014|363522622|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414288|NCT05396014|363522623|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414289|NCT05396014|363522624|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105414290|NCT05396014|363522625|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414291|NCT05396014|363522626|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414292|NCT05396014|363522627|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414293|NCT05396014|363522628|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414294|NCT05396014|363522629|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105414295|NCT05396014|363522630|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
105414296|NCT05396014|363522631|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
105414297|NCT05396014|363522632|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105414298|NCT05396014|363522590|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414299|NCT05396014|363522591|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414300|NCT05396014|363522592|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414301|NCT05396014|363522593|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414302|NCT05396014|363522594|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414303|NCT05396014|363522595|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414304|NCT05396014|363522596|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105414305|NCT05396014|363522597|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414306|NCT05396014|363522598|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
105414307|NCT05396014|363522599|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414308|NCT05396014|363522600|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414309|NCT05396014|363522601|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414310|NCT05396014|363522602|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414311|NCT05396014|363522603|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105414312|NCT05396014|363522604|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414313|NCT05396014|363522605|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414314|NCT05396014|363522606|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105414315|NCT05396014|363522607|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105414316|NCT05396014|363522608|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105414317|NCT05396014|363522609|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414318|NCT05396014|363522610|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414319|NCT05396014|363522611|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105414320|NCT05396014|363522612|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
105414321|NCT05396014|363522613|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414322|NCT05396014|363522614|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105414323|NCT05396014|363522615|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105414324|NCT05396014|363522616|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105582371|NCT03293485|364130031|FG000|Overall Study|Screen Failure|2|||
105414325|NCT05396014|363522617|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105414326|NCT05396014|363522618|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414327|NCT05396014|363522619|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414328|NCT05396014|363522620|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414329|NCT05396014|363522621|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105414330|NCT05396014|363522622|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105414331|NCT05396014|363522623|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414332|NCT05396014|363522624|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105414333|NCT05396014|363522625|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
105414334|NCT05396014|363522626|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414335|NCT05396014|363522627|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414336|NCT05396014|363522628|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414337|NCT05396014|363522629|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105414338|NCT05396014|363522630|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105414339|NCT05396014|363522631|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
105414340|NCT05396014|363522632|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105414341|NCT05396014|363522590|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414342|NCT05396014|363522591|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414343|NCT05396014|363522592|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414344|NCT05396014|363522593|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414345|NCT05396014|363522594|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414346|NCT05396014|363522595|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105497282|NCT03342963|363832024|FG000|Overall Study|Withdrawal by Subject|1|||
105497283|NCT03342963|363832025|FG001|Overall Study|Withdrawal by Subject|0|||
105497284|NCT03342963|363832026|FG002|Overall Study|Withdrawal by Subject|0|||
105497285|NCT03342963|363832027|FG003|Overall Study|Withdrawal by Subject|0|||
105497286|NCT00722423|363832030|FG000|Overall Study|Protocol Violation|0|||
105497287|NCT00722423|363832031|FG001|Overall Study|Protocol Violation|1|||
105497288|NCT05447897|363832032|FG000|Overall Study|Did not participate in survey|2|||
105497289|NCT04553679|363832033|FG000|Overall Study|Withdrawal by Subject|2|||
105497290|NCT04553679|363832034|FG001|Overall Study|Withdrawal by Subject|0|||
105497291|NCT04553679|363832033|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
105497292|NCT04553679|363832034|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
105497293|NCT01453725|363832035|FG000|Overall Study|Adverse Event|3|||
105497294|NCT01453725|363832036|FG001|Overall Study|Adverse Event|3|||
105497295|NCT01453725|363832035|FG000|Overall Study|Lost to Follow-up|4|||
105497296|NCT01453725|363832036|FG001|Overall Study|Lost to Follow-up|0|||
105497297|NCT01453725|363832035|FG000|Overall Study|Non-compliance With Protocol|1|||
105497298|NCT01453725|363832036|FG001|Overall Study|Non-compliance With Protocol|2|||
105497299|NCT01453725|363832035|FG000|Overall Study|Protocol Violation|1|||
105497300|NCT01453725|363832036|FG001|Overall Study|Protocol Violation|0|||
105497301|NCT01453725|363832035|FG000|Overall Study|Withdrawal by Subject|2|||
105497302|NCT01453725|363832036|FG001|Overall Study|Withdrawal by Subject|3|||
105414347|NCT05396014|363522596|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414348|NCT05396014|363522597|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414349|NCT05396014|363522598|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414350|NCT05396014|363522599|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414351|NCT05396014|363522600|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414352|NCT05396014|363522601|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414353|NCT05396014|363522602|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414354|NCT05396014|363522603|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
105414355|NCT05396014|363522604|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414356|NCT05396014|363522605|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414357|NCT05396014|363522606|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414358|NCT05396014|363522607|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414359|NCT05396014|363522608|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414360|NCT05396014|363522609|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414361|NCT05396014|363522610|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414362|NCT05396014|363522611|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414363|NCT05396014|363522612|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414364|NCT05396014|363522613|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414365|NCT05396014|363522614|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414366|NCT05396014|363522615|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414367|NCT05396014|363522616|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
105414368|NCT05396014|363522617|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105497303|NCT01453725|363832035|FG000|Overall Study|Pregnancy Wish|0|||
105497304|NCT01453725|363832036|FG001|Overall Study|Pregnancy Wish|2|||
105497305|NCT01453725|363832035|FG000|Overall Study|Pregnancy|1|||
105497306|NCT01453725|363832036|FG001|Overall Study|Pregnancy|0|||
105497307|NCT01453725|363832035|FG000|Overall Study|Physician Decision|1|||
105414369|NCT05396014|363522618|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414370|NCT05396014|363522619|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414371|NCT05396014|363522620|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414372|NCT05396014|363522621|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414373|NCT05396014|363522622|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414374|NCT05396014|363522623|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414375|NCT05396014|363522624|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
105414376|NCT05396014|363522625|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414377|NCT05396014|363522626|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414378|NCT05396014|363522627|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414379|NCT05396014|363522628|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414380|NCT05396014|363522629|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414381|NCT05396014|363522630|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414382|NCT05396014|363522631|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105414383|NCT05396014|363522632|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
105414384|NCT05396014|363522590|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414385|NCT05396014|363522591|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414386|NCT05396014|363522592|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414387|NCT05396014|363522593|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414388|NCT05396014|363522594|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414389|NCT05396014|363522595|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414390|NCT05396014|363522596|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414391|NCT05396014|363522597|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414392|NCT05396014|363522598|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414393|NCT05396014|363522599|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414394|NCT05396014|363522600|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414395|NCT05396014|363522601|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414396|NCT05396014|363522602|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414397|NCT05396014|363522603|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414398|NCT05396014|363522604|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414399|NCT05396014|363522605|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414400|NCT05396014|363522606|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414401|NCT05396014|363522607|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414402|NCT05396014|363522608|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414403|NCT05396014|363522609|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414404|NCT05396014|363522610|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414405|NCT05396014|363522611|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414406|NCT05396014|363522612|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414407|NCT05396014|363522613|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414408|NCT05396014|363522614|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414409|NCT05396014|363522615|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414410|NCT05396014|363522616|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
105414411|NCT05396014|363522617|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414412|NCT05396014|363522618|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414413|NCT05396014|363522619|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414414|NCT05396014|363522620|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414415|NCT05396014|363522621|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414416|NCT05396014|363522622|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414417|NCT05396014|363522623|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414418|NCT05396014|363522624|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414419|NCT05396014|363522625|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414420|NCT05396014|363522626|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414421|NCT05396014|363522627|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414422|NCT05396014|363522628|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414423|NCT05396014|363522629|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414424|NCT05396014|363522630|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414425|NCT05396014|363522631|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414426|NCT05396014|363522632|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105414427|NCT04683029|363522635|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
105414428|NCT04683029|363522636|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
105414429|NCT04683029|363522637|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
105497308|NCT01453725|363832036|FG001|Overall Study|Physician Decision|1|||
105497309|NCT04289623|363832037|FG000|Wave 1 Emails|Email was not delivered|268|||
105497310|NCT04289623|363832038|FG001|Wave 1 Emails|Email was not delivered|257|||
105497311|NCT04289623|363832039|FG002|Wave 1 Emails|Email was not delivered|0|||
105497312|NCT04289623|363832040|FG003|Wave 1 Emails|Email was not delivered|0|||
105497313|NCT04289623|363832041|FG004|Wave 1 Emails|Email was not delivered|0|||
105497314|NCT04289623|363832042|FG005|Wave 1 Emails|Email was not delivered|0|||
105497315|NCT00875979|363832043|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
105497316|NCT00875979|363832044|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
105497317|NCT00875979|363832043|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
105497318|NCT00875979|363832044|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
105497319|NCT00875979|363832043|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
105497320|NCT00875979|363832044|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
105414430|NCT04683029|363522638|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
105414431|NCT04683029|363522635|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
105414432|NCT04683029|363522636|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
105414433|NCT04683029|363522637|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
105414434|NCT04683029|363522638|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
105414435|NCT04683029|363522635|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
105414436|NCT04683029|363522636|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
105414437|NCT04683029|363522637|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
105414438|NCT04683029|363522638|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
105414439|NCT04299308|363522639|FG000|Overall Study|Withdrawal by Subject|1|||
105414440|NCT04299308|363522640|FG001|Overall Study|Withdrawal by Subject|0|||
105414441|NCT04299308|363522639|FG000|Overall Study|issue with PET image (1)|1|||
105414442|NCT04299308|363522640|FG001|Overall Study|issue with PET image (1)|0|||
105414443|NCT01696968|363522643|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
105414444|NCT01696968|363522644|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
105414445|NCT01696968|363522643|FG000|Overall Study|Died Before Randomization|3|||
105414446|NCT01696968|363522644|FG001|Overall Study|Died Before Randomization|8|||
105414447|NCT01696968|363522643|FG000|Overall Study|Died Before ASU (Control)|278|||
105414448|NCT01696968|363522644|FG001|Overall Study|Died Before ASU (Control)|0|||
105414449|NCT01696968|363522643|FG000|Overall Study|Refused ASU (Control)|920|||
105414450|NCT01696968|363522644|FG001|Overall Study|Refused ASU (Control)|0|||
105414451|NCT01696968|363522643|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
105414452|NCT01696968|363522644|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
105414453|NCT04075292|363522647|FG000|Overall Study|Withdrawal by Subject|1|||
105414454|NCT04075292|363522648|FG001|Overall Study|Withdrawal by Subject|9|||
105414455|NCT04075292|363522647|FG000|Overall Study|Death|2|||
105414456|NCT04075292|363522648|FG001|Overall Study|Death|5|||
105414457|NCT04075292|363522647|FG000|Overall Study|Remained on study at time of DCO|74|||
105414458|NCT04075292|363522648|FG001|Overall Study|Remained on study at time of DCO|64|||
105414459|NCT01314118|363522649|FG000|Overall Study|Adverse Event|9|||
105414460|NCT01314118|363522649|FG000|Overall Study|Progressive disease|27|||
105414461|NCT01314118|363522649|FG000|Overall Study|Physician Decision|11|||
105414462|NCT01314118|363522649|FG000|Overall Study|Death|4|||
105414463|NCT01314118|363522649|FG000|Overall Study|Protocol Violation|5|||
105414464|NCT01314118|363522649|FG000|Overall Study|Withdrawal by Subject|11|||
105414465|NCT01314118|363522649|FG000|Overall Study|Other|2|||
105414466|NCT01314118|363522649|FG000|Overall Study|Ongoing|62|||
105414467|NCT03814746|363522652|FG000|Overall Study|Participant decision|9|||
105414468|NCT03814746|363522653|FG001|Overall Study|Participant decision|6|||
105414469|NCT03814746|363522654|FG002|Overall Study|Participant decision|15|||
105414470|NCT03814746|363522652|FG000|Overall Study|Physician Decision|2|||
105414471|NCT03814746|363522653|FG001|Overall Study|Physician Decision|2|||
105414472|NCT03814746|363522654|FG002|Overall Study|Physician Decision|4|||
105414473|NCT03814746|363522652|FG000|Overall Study|Death|2|||
105414474|NCT03814746|363522653|FG001|Overall Study|Death|2|||
105414475|NCT03814746|363522654|FG002|Overall Study|Death|2|||
105414476|NCT03814746|363522652|FG000|Overall Study|Adverse Event|2|||
105414477|NCT03814746|363522653|FG001|Overall Study|Adverse Event|2|||
105414478|NCT03814746|363522654|FG002|Overall Study|Adverse Event|1|||
105414479|NCT03814746|363522652|FG000|Overall Study|Lost to Follow-up|2|||
105414480|NCT03814746|363522653|FG001|Overall Study|Lost to Follow-up|1|||
105414481|NCT03814746|363522654|FG002|Overall Study|Lost to Follow-up|2|||
105414482|NCT03814746|363522652|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105414483|NCT03814746|363522653|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105414484|NCT03814746|363522654|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
105414485|NCT03814746|363522652|FG000|Overall Study|Pregnancy|0|||
105414486|NCT03814746|363522653|FG001|Overall Study|Pregnancy|1|||
105414487|NCT03814746|363522654|FG002|Overall Study|Pregnancy|1|||
105414488|NCT03814746|363522652|FG000|Overall Study|Protocol Violation|1|||
105414489|NCT03814746|363522653|FG001|Overall Study|Protocol Violation|0|||
105414490|NCT03814746|363522654|FG002|Overall Study|Protocol Violation|0|||
105414491|NCT01696994|363522655|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
105414492|NCT01696994|363522656|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
105582372|NCT03293485|364130031|FG000|Overall Study|Withdrawal by Subject|2|||
105582373|NCT03486899|364130032|FG000|Overall Study|Lost to Follow-up|4|||
105582374|NCT03486899|364130033|FG001|Overall Study|Lost to Follow-up|1|||
105582375|NCT03486899|364130034|FG002|Overall Study|Lost to Follow-up|4|||
105582376|NCT03486899|364130035|FG003|Overall Study|Lost to Follow-up|3|||
105582377|NCT03486899|364130032|FG000|Overall Study|Death|1|||
105582378|NCT03486899|364130033|FG001|Overall Study|Death|0|||
105582379|NCT03486899|364130034|FG002|Overall Study|Death|0|||
105582380|NCT03486899|364130035|FG003|Overall Study|Death|1|||
105582381|NCT03486899|364130032|FG000|Overall Study|Adverse Event|0|||
105582382|NCT03486899|364130033|FG001|Overall Study|Adverse Event|2|||
105414493|NCT01696994|363522655|FG000|Overall Study|Died Before Randomization|1|||
105414494|NCT01696994|363522656|FG001|Overall Study|Died Before Randomization|2|||
105414495|NCT01696994|363522655|FG000|Overall Study|Died Before ASU (Control)|73|||
105414496|NCT01696994|363522656|FG001|Overall Study|Died Before ASU (Control)|0|||
105414497|NCT01696994|363522655|FG000|Overall Study|No Ovaries at Baseline|4807|||
105414498|NCT01696994|363522656|FG001|Overall Study|No Ovaries at Baseline|4851|||
105414499|NCT01696994|363522655|FG000|Overall Study|Refused ASU (Control)|311|||
105414500|NCT01696994|363522656|FG001|Overall Study|Refused ASU (Control)|0|||
105414501|NCT01696994|363522655|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
105414502|NCT01696994|363522656|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
105414503|NCT03458910|363522657|FG000|Overall Study|Withdrawal by Subject|7|||
105414504|NCT03458910|363522658|FG001|Overall Study|Withdrawal by Subject|8|||
105414505|NCT03458910|363522659|FG002|Overall Study|Withdrawal by Subject|6|||
105414506|NCT03458910|363522660|FG003|Overall Study|Withdrawal by Subject|4|||
105414507|NCT03458910|363522657|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
105414508|NCT03458910|363522658|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
105414509|NCT03458910|363522659|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
105414510|NCT03458910|363522660|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
105414511|NCT06004895|363522661|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
105414512|NCT06004895|363522661|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
105414513|NCT00878254|363522662|FG000|Overall Study|Physician Decision|1|||
105414514|NCT00878254|363522662|FG000|Overall Study|Death|1|||
105414515|NCT00878254|363522662|FG000|Overall Study|Withdrawal by Subject|1|||
105414516|NCT02854436|363522663|FG000|Overall Study|Adverse Event|1|||
105414517|NCT02854436|363522663|FG000|Overall Study|Death|208|||
105414518|NCT02854436|363522663|FG000|Overall Study|Lost to Follow-up|5|||
105414519|NCT02854436|363522663|FG000|Overall Study|Withdrawal by Subject|24|||
105414520|NCT02854436|363522663|FG000|Overall Study|Other|45|||
105414521|NCT02854436|363522663|FG000|Overall Study|Physician Decision|6|||
105414522|NCT04995419|363522664|FG000|Overall Study|Withdrawal by Subject|3|||
105414523|NCT04995419|363522664|FG000|Overall Study|Progressive Disease|19|||
105414524|NCT04995419|363522664|FG000|Overall Study|Adverse Event|2|||
105414525|NCT04995419|363522664|FG000|Overall Study|Ongoing|16|||
105414526|NCT03636893|363522666|FG000|Overall Study|Death|0|||
105414527|NCT03636893|363522667|FG001|Overall Study|Death|1|||
105414528|NCT03636893|363522666|FG000|Overall Study|Protocol Violation|0|||
105414529|NCT03636893|363522667|FG001|Overall Study|Protocol Violation|3|||
105414530|NCT03636893|363522666|FG000|Overall Study|Withdrawal by Subject|1|||
105414531|NCT03636893|363522667|FG001|Overall Study|Withdrawal by Subject|2|||
105414532|NCT03636893|363522666|FG000|Overall Study|Refusal to surgery|4|||
105414533|NCT03636893|363522667|FG001|Overall Study|Refusal to surgery|3|||
105414534|NCT03636893|363522666|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
105414535|NCT03636893|363522667|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
105414536|NCT03636893|363522666|FG000|Overall Study|Adverse Event|1|||
105414537|NCT03636893|363522667|FG001|Overall Study|Adverse Event|1|||
105414538|NCT02846389|363522668|FG000|Overall Study|Withdrawal by Subject|1|||
105414539|NCT02846389|363522669|FG001|Overall Study|Withdrawal by Subject|1|||
105414540|NCT04908865|363522672|FG000|Overall Study|Adverse Event|2|||
105414541|NCT04908865|363522672|FG000|Overall Study|Lack of Efficacy|5|||
105414542|NCT04908865|363522672|FG000|Overall Study|Lost to Follow-up|1|||
105414543|NCT02763566|363522673|FG000|Overall Study|Lost to Follow-up|1|||
105414544|NCT02763566|363522674|FG001|Overall Study|Lost to Follow-up|4|||
105414545|NCT02763566|363522675|FG002|Overall Study|Lost to Follow-up|0|||
105414546|NCT02763566|363522676|FG003|Overall Study|Lost to Follow-up|1|||
105582383|NCT03486899|364130034|FG002|Overall Study|Adverse Event|0|||
105582384|NCT03486899|364130035|FG003|Overall Study|Adverse Event|2|||
105582385|NCT03486899|364130032|FG000|Overall Study|Withdrawal by Subject|3|||
105582386|NCT03486899|364130033|FG001|Overall Study|Withdrawal by Subject|7|||
105582387|NCT03486899|364130034|FG002|Overall Study|Withdrawal by Subject|4|||
105414547|NCT02763566|363522673|FG000|Overall Study|On study treatment at study conclusion|114|||
105414548|NCT02763566|363522674|FG001|Overall Study|On study treatment at study conclusion|34|||
105414549|NCT02763566|363522675|FG002|Overall Study|On study treatment at study conclusion|54|||
105414550|NCT02763566|363522676|FG003|Overall Study|On study treatment at study conclusion|13|||
105414551|NCT02763566|363522673|FG000|Overall Study|Withdrawal by Subject|3|||
105414552|NCT02763566|363522674|FG001|Overall Study|Withdrawal by Subject|1|||
105497321|NCT00875979|363832043|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
105497322|NCT00875979|363832044|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
105497323|NCT00875979|363832043|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
105497324|NCT00875979|363832044|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
105497325|NCT00875979|363832043|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
105497326|NCT00875979|363832044|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
105497327|NCT00875979|363832043|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
105497328|NCT00875979|363832044|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
105497329|NCT00875979|363832043|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
105497330|NCT00875979|363832044|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
105497331|NCT00875979|363832043|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
105497332|NCT00875979|363832044|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
105497333|NCT01772160|363832045|FG000|Overall Study|Death|3|||
105497334|NCT01772160|363832045|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
105497335|NCT01772160|363832045|FG000|Overall Study|Consent withdrawal|3|||
105497336|NCT01772160|363832045|FG000|Overall Study|Migrated / moved from the study area|4|||
105497337|NCT01772160|363832045|FG000|Overall Study|Lost to Follow-up|30|||
105497338|NCT01772160|363832045|FG000|Overall Study|Other|5|||
105497339|NCT00747812|363832048|FG000|Overall Study|Research Site Staff Relocation|5|||
105497340|NCT00747812|363832049|FG001|Overall Study|Research Site Staff Relocation|3|||
105497341|NCT01069627|363832050|FG000|Overall Study|Disease progression|7|||
105497342|NCT01069627|363832050|FG000|Overall Study|Adverse Event|12|||
105497343|NCT01069627|363832050|FG000|Overall Study|Protocol Violation|1|||
105497344|NCT00406354|363832051|FG000|All Randomized Patients|Protocol Violation|0|||
105497345|NCT00406354|363832052|FG001|All Randomized Patients|Protocol Violation|0|||
105497346|NCT00406354|363832053|FG002|All Randomized Patients|Protocol Violation|1|||
105497347|NCT00406354|363832051|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
105497348|NCT00406354|363832052|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
105497349|NCT00406354|363832053|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
105497350|NCT00406354|363832051|FG000|All Randomized and Treated Patients|Adverse Event|6|||
105497351|NCT00406354|363832052|FG001|All Randomized and Treated Patients|Adverse Event|2|||
105497352|NCT00406354|363832053|FG002|All Randomized and Treated Patients|Adverse Event|1|||
105497353|NCT00406354|363832051|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
105497354|NCT00406354|363832052|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
105497355|NCT00406354|363832053|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
105497356|NCT00406354|363832051|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
105497357|NCT00406354|363832052|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
105497358|NCT00406354|363832053|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
105497359|NCT00406354|363832051|FG000|All Randomized and Treated Patients|Physician Decision|0|||
105497360|NCT00406354|363832052|FG001|All Randomized and Treated Patients|Physician Decision|0|||
105497361|NCT00406354|363832053|FG002|All Randomized and Treated Patients|Physician Decision|1|||
105497362|NCT01281137|363832056|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
105497363|NCT01281137|363832057|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
105497364|NCT01281137|363832056|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
105497365|NCT01281137|363832057|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
105497366|NCT01281137|363832056|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
105497367|NCT01281137|363832057|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
105497368|NCT01281137|363832056|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
105497369|NCT01281137|363832057|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
105497370|NCT01281137|363832056|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
105497371|NCT01281137|363832057|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
105497372|NCT04402060|363832058|FG000|Overall Study|Death|1|||
105497373|NCT04402060|363832059|FG001|Overall Study|Death|12|||
105497374|NCT04402060|363832060|FG002|Overall Study|Death|7|||
105497375|NCT04402060|363832058|FG000|Overall Study|Adverse Event|0|||
105497376|NCT04402060|363832059|FG001|Overall Study|Adverse Event|0|||
105497377|NCT04402060|363832060|FG002|Overall Study|Adverse Event|1|||
105497378|NCT04402060|363832058|FG000|Overall Study|Withdrawal by Subject|0|||
105497379|NCT04402060|363832059|FG001|Overall Study|Withdrawal by Subject|1|||
105497380|NCT04402060|363832060|FG002|Overall Study|Withdrawal by Subject|2|||
105497381|NCT04402060|363832058|FG000|Overall Study|Sponsor Request|0|||
105497382|NCT04402060|363832059|FG001|Overall Study|Sponsor Request|2|||
105497383|NCT04402060|363832060|FG002|Overall Study|Sponsor Request|0|||
105582388|NCT03486899|364130035|FG003|Overall Study|Withdrawal by Subject|3|||
105582389|NCT03486899|364130032|FG000|Overall Study|Other Reasons|0|||
105582390|NCT03486899|364130033|FG001|Overall Study|Other Reasons|1|||
105582391|NCT03486899|364130034|FG002|Overall Study|Other Reasons|0|||
105582392|NCT03486899|364130035|FG003|Overall Study|Other Reasons|1|||
105582393|NCT01723826|364130038|FG000|Overall Study|Adverse Event|4|||
105582394|NCT01723826|364130039|FG001|Overall Study|Adverse Event|1|||
105582395|NCT01723826|364130040|FG002|Overall Study|Adverse Event|4|||
105582396|NCT01723826|364130041|FG003|Overall Study|Adverse Event|5|||
105582397|NCT01723826|364130038|FG000|Overall Study|Death according to AE eCRF|2|||
105582398|NCT01723826|364130039|FG001|Overall Study|Death according to AE eCRF|3|||
105582399|NCT01723826|364130040|FG002|Overall Study|Death according to AE eCRF|3|||
105582400|NCT01723826|364130041|FG003|Overall Study|Death according to AE eCRF|7|||
105582401|NCT01723826|364130038|FG000|Overall Study|Lost to Follow-up|1|||
105582402|NCT01723826|364130039|FG001|Overall Study|Lost to Follow-up|3|||
105582403|NCT01723826|364130040|FG002|Overall Study|Lost to Follow-up|1|||
105582404|NCT01723826|364130041|FG003|Overall Study|Lost to Follow-up|1|||
105582405|NCT01723826|364130038|FG000|Overall Study|Non-compliance|0|||
105582406|NCT01723826|364130039|FG001|Overall Study|Non-compliance|1|||
105582407|NCT01723826|364130040|FG002|Overall Study|Non-compliance|3|||
105582408|NCT01723826|364130041|FG003|Overall Study|Non-compliance|3|||
105582409|NCT01723826|364130038|FG000|Overall Study|Non-compliance With Study Drug|0|||
105497384|NCT04402060|363832058|FG000|Overall Study|Physician Decision|0|||
105497385|NCT04402060|363832059|FG001|Overall Study|Physician Decision|0|||
105497386|NCT04402060|363832060|FG002|Overall Study|Physician Decision|1|||
105497387|NCT04402060|363832058|FG000|Overall Study|Other|0|||
105497388|NCT04402060|363832059|FG001|Overall Study|Other|1|||
105497389|NCT04402060|363832060|FG002|Overall Study|Other|0|||
105497390|NCT00331422|363832068|FG000|Overall Study|Did not receive entire study regimen|5|||
105497391|NCT02805972|363832069|FG000|Washout Period|Lost to Follow-up|3|||
105497392|NCT02805972|363832070|FG001|Washout Period|Lost to Follow-up|0|||
105497393|NCT00467857|363832074|FG000|Overall Study|Adverse Event|1|||
105497394|NCT00467857|363832075|FG001|Overall Study|Adverse Event|0|||
105497395|NCT00467857|363832074|FG000|Overall Study|Withdrew consent|2|||
105497396|NCT00467857|363832075|FG001|Overall Study|Withdrew consent|0|||
105497397|NCT00467857|363832074|FG000|Overall Study|Death|0|||
105497398|NCT00467857|363832075|FG001|Overall Study|Death|1|||
105497399|NCT00467857|363832074|FG000|Overall Study|Discharged from court service|0|||
105497400|NCT00467857|363832075|FG001|Overall Study|Discharged from court service|1|||
105497401|NCT00467857|363832074|FG000|Overall Study|Emergency care required|0|||
105497402|NCT00467857|363832075|FG001|Overall Study|Emergency care required|1|||
105497403|NCT00467857|363832074|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
105497404|NCT00467857|363832075|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
105497405|NCT00467857|363832074|FG000|Overall Study|Discontinuation reason missing|0|||
105497406|NCT00467857|363832075|FG001|Overall Study|Discontinuation reason missing|3|||
105497407|NCT03386474|363832078|FG000|Overall Study|Death|1|||
105497408|NCT03386474|363832079|FG001|Overall Study|Death|0|||
105497409|NCT03386474|363832078|FG000|Overall Study|Adverse Event|0|||
105497410|NCT03386474|363832079|FG001|Overall Study|Adverse Event|1|||
105497411|NCT02282358|363832080|FG000|Overall Study|Nonevaluable|1|||
105497412|NCT00910273|363832081|FG000|Overall Study|Lack of Efficacy|6|||
105497413|NCT00910273|363832082|FG001|Overall Study|Lack of Efficacy|9|||
105497414|NCT00910273|363832081|FG000|Overall Study|Adverse Event|1|||
105497415|NCT00910273|363832082|FG001|Overall Study|Adverse Event|1|||
105497416|NCT00910273|363832081|FG000|Overall Study|Withdrawal by Subject|1|||
105497417|NCT00910273|363832082|FG001|Overall Study|Withdrawal by Subject|0|||
105497418|NCT00910273|363832081|FG000|Overall Study|Discontinuation of study by sponsor|8|||
105497419|NCT00910273|363832082|FG001|Overall Study|Discontinuation of study by sponsor|2|||
105497420|NCT00910273|363832081|FG000|Overall Study|Protocol Violation|1|||
105497421|NCT00910273|363832082|FG001|Overall Study|Protocol Violation|0|||
105497422|NCT00910273|363832081|FG000|Overall Study|Lost to Follow-up|1|||
105497423|NCT00910273|363832082|FG001|Overall Study|Lost to Follow-up|1|||
105497424|NCT04357782|363832083|FG000|Overall Study|Discharged from hospital|1|||
105497425|NCT04357782|363832084|FG001|Overall Study|Discharged from hospital|0|||
105497426|NCT04357782|363832083|FG000|Overall Study|Death|0|||
105497427|NCT04357782|363832084|FG001|Overall Study|Death|2|||
105497428|NCT00621959|363832085|FG000|Overall Study|Adverse Event|4|||
105497429|NCT00621959|363832086|FG001|Overall Study|Adverse Event|2|||
105497430|NCT00621959|363832085|FG000|Overall Study|Lack of Efficacy|1|||
105497431|NCT00621959|363832086|FG001|Overall Study|Lack of Efficacy|1|||
105497432|NCT00621959|363832085|FG000|Overall Study|Lost to Follow-up|0|||
105497433|NCT00621959|363832086|FG001|Overall Study|Lost to Follow-up|2|||
105497434|NCT00621959|363832085|FG000|Overall Study|Withdrawal by Subject|1|||
105497435|NCT00621959|363832086|FG001|Overall Study|Withdrawal by Subject|1|||
105497436|NCT00621959|363832085|FG000|Overall Study|Other|1|||
105497437|NCT00621959|363832086|FG001|Overall Study|Other|3|||
105497438|NCT02764697|363832089|FG000|Overall Study|Lack of Efficacy|3|||
105497439|NCT01736124|363832090|FG000|Post-intervention Assessment|Death|2|||
105582410|NCT01723826|364130039|FG001|Overall Study|Non-compliance With Study Drug|1|||
105582411|NCT01723826|364130040|FG002|Overall Study|Non-compliance With Study Drug|0|||
105414553|NCT02763566|363522675|FG002|Overall Study|Withdrawal by Subject|0|||
105414554|NCT02763566|363522676|FG003|Overall Study|Withdrawal by Subject|0|||
105414555|NCT03631199|363522677|FG000|Overall Study|Progressive disease|9|||
105414556|NCT03631199|363522678|FG001|Overall Study|Progressive disease|5|||
105414557|NCT03631199|363522679|FG002|Overall Study|Progressive disease|5|||
105414558|NCT03631199|363522680|FG003|Overall Study|Progressive disease|149|||
105414559|NCT03631199|363522681|FG004|Overall Study|Progressive disease|148|||
105414560|NCT03631199|363522677|FG000|Overall Study|Physician Decision|0|||
105414561|NCT03631199|363522678|FG001|Overall Study|Physician Decision|2|||
105414562|NCT03631199|363522679|FG002|Overall Study|Physician Decision|3|||
105414563|NCT03631199|363522680|FG003|Overall Study|Physician Decision|19|||
105414564|NCT03631199|363522681|FG004|Overall Study|Physician Decision|13|||
105414565|NCT03631199|363522677|FG000|Overall Study|Adverse Event|1|||
105414566|NCT03631199|363522678|FG001|Overall Study|Adverse Event|1|||
105414567|NCT03631199|363522679|FG002|Overall Study|Adverse Event|0|||
105414568|NCT03631199|363522680|FG003|Overall Study|Adverse Event|28|||
105414569|NCT03631199|363522681|FG004|Overall Study|Adverse Event|29|||
105414570|NCT03631199|363522677|FG000|Overall Study|Death|0|||
105414571|NCT03631199|363522678|FG001|Overall Study|Death|1|||
105414572|NCT03631199|363522679|FG002|Overall Study|Death|0|||
105414573|NCT03631199|363522680|FG003|Overall Study|Death|35|||
105414574|NCT03631199|363522681|FG004|Overall Study|Death|48|||
105414575|NCT03631199|363522677|FG000|Overall Study|Subject decision|0|||
105414576|NCT03631199|363522678|FG001|Overall Study|Subject decision|1|||
105414577|NCT03631199|363522679|FG002|Overall Study|Subject decision|0|||
105414578|NCT03631199|363522680|FG003|Overall Study|Subject decision|12|||
105414579|NCT03631199|363522681|FG004|Overall Study|Subject decision|12|||
105414580|NCT03631199|363522677|FG000|Overall Study|No treated|0|||
105414581|NCT03631199|363522678|FG001|Overall Study|No treated|0|||
105414582|NCT03631199|363522679|FG002|Overall Study|No treated|0|||
105414583|NCT03631199|363522680|FG003|Overall Study|No treated|0|||
105414584|NCT03631199|363522681|FG004|Overall Study|No treated|1|||
105414585|NCT03631199|363522677|FG000|Overall Study|Treatment ongoing|0|||
105414586|NCT03631199|363522678|FG001|Overall Study|Treatment ongoing|1|||
105414587|NCT03631199|363522679|FG002|Overall Study|Treatment ongoing|1|||
105414588|NCT03631199|363522680|FG003|Overall Study|Treatment ongoing|76|||
105414589|NCT03631199|363522681|FG004|Overall Study|Treatment ongoing|71|||
105414590|NCT03631199|363522677|FG000|Overall Study|Guardian decision|0|||
105414591|NCT03631199|363522678|FG001|Overall Study|Guardian decision|0|||
105414592|NCT03631199|363522679|FG002|Overall Study|Guardian decision|0|||
105414593|NCT03631199|363522680|FG003|Overall Study|Guardian decision|1|||
105497440|NCT01736124|363832091|FG001|Post-intervention Assessment|Death|2|||
105497441|NCT01736124|363832090|FG000|Post-intervention Assessment|lost computer access|1|||
105497442|NCT01736124|363832091|FG001|Post-intervention Assessment|lost computer access|1|||
105497443|NCT01736124|363832090|FG000|Post-intervention Assessment|Moved away|3|||
105497444|NCT01736124|363832091|FG001|Post-intervention Assessment|Moved away|1|||
105497445|NCT01736124|363832090|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
105497446|NCT01736124|363832091|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
105497447|NCT01736124|363832090|FG000|Post-intervention Assessment|Illness|3|||
105497448|NCT01736124|363832091|FG001|Post-intervention Assessment|Illness|2|||
105497449|NCT01736124|363832090|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
105497450|NCT01736124|363832091|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
105497451|NCT01736124|363832090|FG000|Post-intervention Assessment|Temporarily away|3|||
105497452|NCT01736124|363832091|FG001|Post-intervention Assessment|Temporarily away|1|||
105497453|NCT01736124|363832090|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
105497454|NCT01736124|363832091|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
105497455|NCT01736124|363832090|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
105497456|NCT01736124|363832091|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
105497457|NCT01736124|363832090|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
105497458|NCT01736124|363832091|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
105497459|NCT01736124|363832090|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
105497460|NCT01736124|363832091|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
105414594|NCT03631199|363522681|FG004|Overall Study|Guardian decision|1|||
105414595|NCT00002540|363522682|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
105414596|NCT00002540|363522683|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
105414597|NCT00002540|363522682|FG000|Overall Study|Died Before Randomization|2|||
105414598|NCT00002540|363522683|FG001|Overall Study|Died Before Randomization|6|||
105414599|NCT00002540|363522682|FG000|Overall Study|Died Before ASU (Control)|202|||
105414600|NCT00002540|363522683|FG001|Overall Study|Died Before ASU (Control)|0|||
105414601|NCT00002540|363522682|FG000|Overall Study|Refused ASU (Control)|597|||
105414602|NCT00002540|363522683|FG001|Overall Study|Refused ASU (Control)|0|||
105414603|NCT00002540|363522682|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
105414604|NCT00002540|363522683|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
105414605|NCT05312697|363522685|FG000|Overall Study|Sponsor Terminated Trial|2|||
105414606|NCT00582712|363522688|FG000|Overall Study|Adverse Event|1|||
105414607|NCT00582712|363522688|FG000|Overall Study|Lack of Efficacy|1|||
105414608|NCT00582712|363522688|FG000|Overall Study|Withdrawal by Subject|1|||
105414609|NCT00582712|363522688|FG000|Overall Study|Complicating disease requiring treatment|1|||
105414610|NCT01970241|363522689|FG000|Overall Study|Withdrawal by Subject|2|||
105414611|NCT01970241|363522690|FG001|Overall Study|Withdrawal by Subject|0|||
105414612|NCT01970241|363522689|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
105414613|NCT01970241|363522690|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
105414614|NCT04951622|363522696|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
105414615|NCT04951622|363522697|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
105414616|NCT04951622|363522698|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
105414617|NCT04951622|363522699|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
105414618|NCT04951622|363522700|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
105414619|NCT04951622|363522696|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
105414620|NCT04951622|363522697|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
105414621|NCT04951622|363522698|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
105414622|NCT04951622|363522699|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
105414623|NCT04951622|363522700|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
105414624|NCT04951622|363522696|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
105414625|NCT04951622|363522697|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
105414626|NCT04951622|363522698|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
105414627|NCT04951622|363522699|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
105497461|NCT01736124|363832090|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
105497462|NCT01736124|363832091|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
105497463|NCT01736124|363832090|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
105497464|NCT01736124|363832091|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
105497465|NCT01736124|363832090|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
105497466|NCT01736124|363832091|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
105497467|NCT01736124|363832090|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
105497468|NCT01736124|363832091|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
105497469|NCT01736124|363832090|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
105497470|NCT01736124|363832091|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
105497471|NCT04223973|363832092|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
105497472|NCT04223973|363832093|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
105497473|NCT04223973|363832092|FG000|Overall Study|Adverse Event|4|||
105497474|NCT04223973|363832093|FG001|Overall Study|Adverse Event|0|||
105497475|NCT04223973|363832092|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
105497476|NCT04223973|363832093|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
105497477|NCT04223973|363832092|FG000|Overall Study|Physician Decision|1|||
105497478|NCT04223973|363832093|FG001|Overall Study|Physician Decision|1|||
105497479|NCT04223973|363832092|FG000|Overall Study|Withdrawal by Subject|0|||
105497480|NCT04223973|363832093|FG001|Overall Study|Withdrawal by Subject|1|||
105497481|NCT03672643|363832095|FG000|Overall Study|Adverse Event|3|||
105497482|NCT03672643|363832095|FG000|Overall Study|Death|2|||
105497483|NCT03672643|363832095|FG000|Overall Study|Withdrawal by Subject|1|||
105497484|NCT03672643|363832095|FG000|Overall Study|Progressive disease|11|||
105497485|NCT03672643|363832095|FG000|Overall Study|Global deterioration of health status|1|||
105497486|NCT03672643|363832095|FG000|Overall Study|Refused further treatment|7|||
105497487|NCT03672643|363832095|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
105497488|NCT02557295|363832096|FG000|Overall Study|Withdrawal by Subject|9|||
105497489|NCT02557295|363832097|FG001|Overall Study|Withdrawal by Subject|2|||
105497490|NCT02557295|363832098|FG002|Overall Study|Withdrawal by Subject|4|||
105497491|NCT02557295|363832099|FG003|Overall Study|Withdrawal by Subject|0|||
105497492|NCT02557295|363832100|FG004|Overall Study|Withdrawal by Subject|0|||
105497493|NCT02557295|363832101|FG005|Overall Study|Withdrawal by Subject|0|||
105497494|NCT02557295|363832102|FG006|Overall Study|Withdrawal by Subject|15|||
105497495|NCT02557295|363832103|FG007|Overall Study|Withdrawal by Subject|1|||
105497496|NCT02557295|363832104|FG008|Overall Study|Withdrawal by Subject|3|||
105497497|NCT02557295|363832096|FG000|Overall Study|Disease Progression|0|||
105497498|NCT02557295|363832097|FG001|Overall Study|Disease Progression|0|||
105497499|NCT02557295|363832098|FG002|Overall Study|Disease Progression|0|||
105497500|NCT02557295|363832099|FG003|Overall Study|Disease Progression|0|||
105497501|NCT02557295|363832100|FG004|Overall Study|Disease Progression|0|||
105497502|NCT02557295|363832101|FG005|Overall Study|Disease Progression|0|||
105497503|NCT02557295|363832102|FG006|Overall Study|Disease Progression|1|||
105497504|NCT02557295|363832103|FG007|Overall Study|Disease Progression|0|||
105497505|NCT02557295|363832104|FG008|Overall Study|Disease Progression|0|||
105497506|NCT02557295|363832096|FG000|Overall Study|Lack of Efficacy|24|||
105497507|NCT02557295|363832097|FG001|Overall Study|Lack of Efficacy|1|||
105497508|NCT02557295|363832098|FG002|Overall Study|Lack of Efficacy|3|||
105497509|NCT02557295|363832099|FG003|Overall Study|Lack of Efficacy|0|||
105497510|NCT02557295|363832100|FG004|Overall Study|Lack of Efficacy|0|||
105497511|NCT02557295|363832101|FG005|Overall Study|Lack of Efficacy|0|||
105497512|NCT02557295|363832102|FG006|Overall Study|Lack of Efficacy|12|||
105497513|NCT02557295|363832103|FG007|Overall Study|Lack of Efficacy|1|||
105497514|NCT02557295|363832104|FG008|Overall Study|Lack of Efficacy|0|||
105497515|NCT02557295|363832096|FG000|Overall Study|Adverse Event|16|||
105497516|NCT02557295|363832097|FG001|Overall Study|Adverse Event|2|||
105497517|NCT02557295|363832098|FG002|Overall Study|Adverse Event|3|||
105497518|NCT02557295|363832099|FG003|Overall Study|Adverse Event|0|||
105497519|NCT02557295|363832100|FG004|Overall Study|Adverse Event|0|||
105497520|NCT02557295|363832101|FG005|Overall Study|Adverse Event|0|||
105497521|NCT02557295|363832102|FG006|Overall Study|Adverse Event|2|||
105497522|NCT02557295|363832103|FG007|Overall Study|Adverse Event|1|||
105497523|NCT02557295|363832104|FG008|Overall Study|Adverse Event|1|||
105497524|NCT02557295|363832096|FG000|Overall Study|Lost to Follow-up|4|||
105497525|NCT02557295|363832097|FG001|Overall Study|Lost to Follow-up|0|||
105497526|NCT02557295|363832098|FG002|Overall Study|Lost to Follow-up|0|||
105497527|NCT02557295|363832099|FG003|Overall Study|Lost to Follow-up|0|||
105497528|NCT02557295|363832100|FG004|Overall Study|Lost to Follow-up|0|||
105497529|NCT02557295|363832101|FG005|Overall Study|Lost to Follow-up|0|||
105497530|NCT02557295|363832102|FG006|Overall Study|Lost to Follow-up|9|||
105497531|NCT02557295|363832103|FG007|Overall Study|Lost to Follow-up|0|||
105497532|NCT02557295|363832104|FG008|Overall Study|Lost to Follow-up|0|||
105497533|NCT02557295|363832096|FG000|Overall Study|Study Close|54|||
105497534|NCT02557295|363832097|FG001|Overall Study|Study Close|3|||
105497535|NCT02557295|363832098|FG002|Overall Study|Study Close|5|||
105497536|NCT02557295|363832099|FG003|Overall Study|Study Close|3|||
105414628|NCT04951622|363522700|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
105414629|NCT04951622|363522696|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
105414630|NCT04951622|363522697|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
105414631|NCT04951622|363522698|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
105414632|NCT04951622|363522699|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
105414633|NCT04951622|363522700|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
105414634|NCT04951622|363522696|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
105414635|NCT04951622|363522697|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
105414636|NCT04951622|363522698|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
105414637|NCT04951622|363522699|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
105414638|NCT04951622|363522700|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
105414639|NCT04951622|363522696|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
105414640|NCT04951622|363522697|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
105414641|NCT04951622|363522698|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
105414642|NCT04951622|363522699|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
105414643|NCT04951622|363522700|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
105414644|NCT04951622|363522696|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
105414645|NCT04951622|363522697|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
105414646|NCT04951622|363522698|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
105414647|NCT04951622|363522699|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
105414648|NCT04951622|363522700|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
105414649|NCT04951622|363522696|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
105414650|NCT04951622|363522697|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
105414651|NCT04951622|363522698|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
105414652|NCT04951622|363522699|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
105414653|NCT04951622|363522700|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
105414654|NCT04951622|363522696|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
105414655|NCT04951622|363522697|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
105414656|NCT04951622|363522698|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
105414657|NCT04951622|363522699|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
105414658|NCT04951622|363522700|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
105414659|NCT04951622|363522696|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
105414660|NCT04951622|363522697|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
105414661|NCT04951622|363522698|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
105414662|NCT04951622|363522699|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
105414663|NCT04951622|363522700|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
105414664|NCT04951622|363522696|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
105414665|NCT04951622|363522697|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
105414666|NCT04951622|363522698|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
105414667|NCT04951622|363522699|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
105414668|NCT04951622|363522700|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
105414669|NCT04951622|363522696|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
105414670|NCT04951622|363522697|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
105414671|NCT04951622|363522698|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
105414672|NCT04951622|363522699|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
105414673|NCT04951622|363522700|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
105414674|NCT04951622|363522696|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
105414675|NCT04951622|363522697|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
105414676|NCT04951622|363522698|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
105414677|NCT04951622|363522699|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
105414678|NCT04951622|363522700|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
105414679|NCT04951622|363522696|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
105414680|NCT04951622|363522697|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
105414681|NCT04951622|363522698|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
105414682|NCT04951622|363522699|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
105414683|NCT04951622|363522700|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
105414684|NCT04951622|363522696|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
105497537|NCT02557295|363832100|FG004|Overall Study|Study Close|0|||
105497538|NCT02557295|363832101|FG005|Overall Study|Study Close|0|||
105497539|NCT02557295|363832102|FG006|Overall Study|Study Close|37|||
105497540|NCT02557295|363832103|FG007|Overall Study|Study Close|3|||
105497541|NCT02557295|363832104|FG008|Overall Study|Study Close|19|||
105497542|NCT02557295|363832096|FG000|Overall Study|except for study close|4|||
105497543|NCT02557295|363832097|FG001|Overall Study|except for study close|0|||
105497544|NCT02557295|363832098|FG002|Overall Study|except for study close|0|||
105497545|NCT02557295|363832099|FG003|Overall Study|except for study close|0|||
105582412|NCT01723826|364130041|FG003|Overall Study|Non-compliance With Study Drug|0|||
105414685|NCT04951622|363522697|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
105414686|NCT04951622|363522698|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
105414687|NCT04951622|363522699|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
105414688|NCT04951622|363522700|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
105414689|NCT04951622|363522696|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
105414690|NCT04951622|363522697|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
105414691|NCT04951622|363522698|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
105414692|NCT04951622|363522699|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
105414693|NCT04951622|363522700|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
105414694|NCT04951622|363522696|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
105414695|NCT04951622|363522697|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
105414696|NCT04951622|363522698|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
105414697|NCT04951622|363522699|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
105414698|NCT04951622|363522700|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
105414699|NCT04951622|363522696|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
105414700|NCT04951622|363522697|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
105414701|NCT04951622|363522698|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
105414702|NCT04951622|363522699|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
105414703|NCT04951622|363522700|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
105414704|NCT04951622|363522696|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
105414705|NCT04951622|363522697|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
105414706|NCT04951622|363522698|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
105414707|NCT04951622|363522699|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
105414708|NCT04951622|363522700|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
105414709|NCT04951622|363522696|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
105414710|NCT04951622|363522697|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
105414711|NCT04951622|363522698|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
105414712|NCT04951622|363522699|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
105414713|NCT04951622|363522700|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
105414714|NCT02443116|363522701|FG000|Part 1|Adverse Event|2|||
105414715|NCT02443116|363522702|FG001|Part 1|Adverse Event|3|||
105414716|NCT02443116|363522703|FG002|Part 1|Adverse Event|0|||
105414717|NCT02443116|363522704|FG003|Part 1|Adverse Event|0|||
105414718|NCT02443116|363522705|FG004|Part 1|Adverse Event|0|||
105414719|NCT02443116|363522706|FG005|Part 1|Adverse Event|0|||
105414720|NCT02443116|363522707|FG006|Part 1|Adverse Event|0|||
105414721|NCT02443116|363522708|FG007|Part 1|Adverse Event|0|||
105414722|NCT02443116|363522709|FG008|Part 1|Adverse Event|0|||
105414723|NCT02443116|363522701|FG000|Part 1|Withdrew informed consent|0|||
105414724|NCT02443116|363522702|FG001|Part 1|Withdrew informed consent|1|||
105414725|NCT02443116|363522703|FG002|Part 1|Withdrew informed consent|0|||
105414726|NCT02443116|363522704|FG003|Part 1|Withdrew informed consent|0|||
105414727|NCT02443116|363522705|FG004|Part 1|Withdrew informed consent|0|||
105414728|NCT02443116|363522706|FG005|Part 1|Withdrew informed consent|0|||
105414729|NCT02443116|363522707|FG006|Part 1|Withdrew informed consent|0|||
105414730|NCT02443116|363522708|FG007|Part 1|Withdrew informed consent|0|||
105414731|NCT02443116|363522709|FG008|Part 1|Withdrew informed consent|0|||
105414732|NCT02443116|363522701|FG000|Part 1|Lost to Follow-up|0|||
105414733|NCT02443116|363522702|FG001|Part 1|Lost to Follow-up|0|||
105414734|NCT02443116|363522703|FG002|Part 1|Lost to Follow-up|2|||
105414735|NCT02443116|363522704|FG003|Part 1|Lost to Follow-up|0|||
105414736|NCT02443116|363522705|FG004|Part 1|Lost to Follow-up|0|||
105414737|NCT02443116|363522706|FG005|Part 1|Lost to Follow-up|0|||
105414738|NCT02443116|363522707|FG006|Part 1|Lost to Follow-up|0|||
105497546|NCT02557295|363832100|FG004|Overall Study|except for study close|0|||
105497547|NCT02557295|363832101|FG005|Overall Study|except for study close|0|||
105497548|NCT02557295|363832102|FG006|Overall Study|except for study close|5|||
105497549|NCT02557295|363832103|FG007|Overall Study|except for study close|1|||
105497550|NCT02557295|363832104|FG008|Overall Study|except for study close|0|||
105497551|NCT00566111|363832105|FG000|Overall Study|Adverse Event|0|||
105497552|NCT00566111|363832106|FG001|Overall Study|Adverse Event|2|||
105497553|NCT02171065|363834146|FG000|Overall Study|Withdrawal by Subject|1|||
105497554|NCT02171065|363834147|FG001|Overall Study|Withdrawal by Subject|0|||
105497555|NCT02171065|363834148|FG002|Overall Study|Withdrawal by Subject|0|||
105497556|NCT02171065|363834146|FG000|Overall Study|Lost to Follow-up|0|||
105497557|NCT02171065|363834147|FG001|Overall Study|Lost to Follow-up|0|||
105497558|NCT02171065|363834148|FG002|Overall Study|Lost to Follow-up|1|||
105497559|NCT00531934|363834149|FG000|Overall Study|Adverse Event|4|||
105497560|NCT00531934|363834150|FG001|Overall Study|Adverse Event|8|||
105414739|NCT02443116|363522708|FG007|Part 1|Lost to Follow-up|0|||
105414740|NCT02443116|363522709|FG008|Part 1|Lost to Follow-up|0|||
105414741|NCT02443116|363522701|FG000|Part 1|Participant moved out of state|0|||
105414742|NCT02443116|363522702|FG001|Part 1|Participant moved out of state|0|||
105414743|NCT02443116|363522703|FG002|Part 1|Participant moved out of state|1|||
105414744|NCT02443116|363522704|FG003|Part 1|Participant moved out of state|0|||
105414745|NCT02443116|363522705|FG004|Part 1|Participant moved out of state|0|||
105414746|NCT02443116|363522706|FG005|Part 1|Participant moved out of state|0|||
105414747|NCT02443116|363522707|FG006|Part 1|Participant moved out of state|0|||
105414748|NCT02443116|363522708|FG007|Part 1|Participant moved out of state|0|||
105414749|NCT02443116|363522709|FG008|Part 1|Participant moved out of state|0|||
105414750|NCT02443116|363522701|FG000|Part 1|Participant enrolled in another clinical trial|0|||
105414751|NCT02443116|363522702|FG001|Part 1|Participant enrolled in another clinical trial|0|||
105414752|NCT02443116|363522703|FG002|Part 1|Participant enrolled in another clinical trial|1|||
105414753|NCT02443116|363522704|FG003|Part 1|Participant enrolled in another clinical trial|0|||
105414754|NCT02443116|363522705|FG004|Part 1|Participant enrolled in another clinical trial|0|||
105414755|NCT02443116|363522706|FG005|Part 1|Participant enrolled in another clinical trial|0|||
105414756|NCT02443116|363522707|FG006|Part 1|Participant enrolled in another clinical trial|0|||
105414757|NCT02443116|363522708|FG007|Part 1|Participant enrolled in another clinical trial|0|||
105414758|NCT02443116|363522709|FG008|Part 1|Participant enrolled in another clinical trial|0|||
105414759|NCT02443116|363522701|FG000|Part 2|Adverse Event|0|||
105414760|NCT02443116|363522702|FG001|Part 2|Adverse Event|0|||
105414761|NCT02443116|363522703|FG002|Part 2|Adverse Event|0|||
105414762|NCT02443116|363522704|FG003|Part 2|Adverse Event|0|||
105414763|NCT02443116|363522705|FG004|Part 2|Adverse Event|1|||
105414764|NCT02443116|363522706|FG005|Part 2|Adverse Event|1|||
105414765|NCT02443116|363522707|FG006|Part 2|Adverse Event|2|||
105414766|NCT02443116|363522708|FG007|Part 2|Adverse Event|0|||
105414767|NCT02443116|363522709|FG008|Part 2|Adverse Event|0|||
105414768|NCT02443116|363522701|FG000|Part 2|Withdrew informed consent|0|||
105414769|NCT02443116|363522702|FG001|Part 2|Withdrew informed consent|0|||
105414770|NCT02443116|363522703|FG002|Part 2|Withdrew informed consent|0|||
105414771|NCT02443116|363522704|FG003|Part 2|Withdrew informed consent|0|||
105414772|NCT02443116|363522705|FG004|Part 2|Withdrew informed consent|0|||
105414773|NCT02443116|363522706|FG005|Part 2|Withdrew informed consent|1|||
105414774|NCT02443116|363522707|FG006|Part 2|Withdrew informed consent|1|||
105414775|NCT02443116|363522708|FG007|Part 2|Withdrew informed consent|0|||
105414776|NCT02443116|363522709|FG008|Part 2|Withdrew informed consent|0|||
105414777|NCT02443116|363522701|FG000|Part 2|Inability to comply with protocol|0|||
105414778|NCT02443116|363522702|FG001|Part 2|Inability to comply with protocol|0|||
105414779|NCT02443116|363522703|FG002|Part 2|Inability to comply with protocol|0|||
105414780|NCT02443116|363522704|FG003|Part 2|Inability to comply with protocol|1|||
105414781|NCT02443116|363522705|FG004|Part 2|Inability to comply with protocol|0|||
105414782|NCT02443116|363522706|FG005|Part 2|Inability to comply with protocol|0|||
105414783|NCT02443116|363522707|FG006|Part 2|Inability to comply with protocol|0|||
105582413|NCT01723826|364130038|FG000|Overall Study|Other Reason|8|||
105582414|NCT01723826|364130039|FG001|Overall Study|Other Reason|6|||
105582415|NCT01723826|364130040|FG002|Overall Study|Other Reason|12|||
105582416|NCT01723826|364130041|FG003|Overall Study|Other Reason|14|||
105582417|NCT01723826|364130038|FG000|Overall Study|Physician Decision|1|||
105582418|NCT01723826|364130039|FG001|Overall Study|Physician Decision|3|||
105582419|NCT01723826|364130040|FG002|Overall Study|Physician Decision|4|||
105582420|NCT01723826|364130041|FG003|Overall Study|Physician Decision|11|||
105582421|NCT01723826|364130038|FG000|Overall Study|Protocol Violation|1|||
105582422|NCT01723826|364130039|FG001|Overall Study|Protocol Violation|1|||
105582423|NCT01723826|364130040|FG002|Overall Study|Protocol Violation|3|||
105582424|NCT01723826|364130041|FG003|Overall Study|Protocol Violation|1|||
105582425|NCT01723826|364130038|FG000|Overall Study|Withdrawal by Subject|10|||
105582426|NCT01723826|364130039|FG001|Overall Study|Withdrawal by Subject|17|||
105582427|NCT01723826|364130040|FG002|Overall Study|Withdrawal by Subject|27|||
105582428|NCT01723826|364130041|FG003|Overall Study|Withdrawal by Subject|48|||
105582429|NCT02408549|364130042|FG000|Overall Study|Adverse Event|15|||
105582430|NCT02408549|364130042|FG000|Overall Study|Death|4|||
105582431|NCT02408549|364130042|FG000|Overall Study|Lack of Efficacy|17|||
105582432|NCT02408549|364130042|FG000|Overall Study|Protocol Violation|4|||
105582433|NCT02408549|364130042|FG000|Overall Study|Lost to Follow-up|6|||
105582434|NCT02408549|364130042|FG000|Overall Study|Consent withdrawn|30|||
105582435|NCT02408549|364130042|FG000|Overall Study|Neurology research program closing at site|1|||
105582436|NCT02408549|364130042|FG000|Overall Study|Site closure|1|||
105582437|NCT02408549|364130042|FG000|Overall Study|Pregnancy|1|||
105582438|NCT02408549|364130042|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
105582439|NCT02408549|364130042|FG000|Overall Study|Subject moved to another place, far from site|1|||
105582440|NCT02408549|364130042|FG000|Overall Study|Study terminated at site|1|||
105582441|NCT01782326|364130043|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
105582442|NCT01782326|364130044|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
105582443|NCT01782326|364130043|FG000|Planned Treatment Epoch|Death|29|||
105582444|NCT01782326|364130044|FG001|Planned Treatment Epoch|Death|30|||
105582445|NCT01782326|364130043|FG000|Planned Treatment Epoch|Physician Decision|18|||
105582446|NCT01782326|364130044|FG001|Planned Treatment Epoch|Physician Decision|16|||
105582447|NCT01782326|364130043|FG000|Planned Treatment Epoch|Protocol deviation|2|||
105582448|NCT01782326|364130044|FG001|Planned Treatment Epoch|Protocol deviation|3|||
105582449|NCT01782326|364130043|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
105582450|NCT01782326|364130044|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
105582451|NCT01782326|364130043|FG000|Planned Treatment Epoch|Technical problems|0|||
105582452|NCT01782326|364130044|FG001|Planned Treatment Epoch|Technical problems|4|||
105582453|NCT01782326|364130043|FG000|Double-blind Treatment|Adverse Event|129|||
105582454|NCT01782326|364130044|FG001|Double-blind Treatment|Adverse Event|145|||
105582455|NCT01782326|364130043|FG000|Double-blind Treatment|Subject/guardian decision|111|||
105582456|NCT01782326|364130044|FG001|Double-blind Treatment|Subject/guardian decision|125|||
105582457|NCT01782326|364130043|FG000|Double-blind Treatment|Lack of Efficacy|17|||
105582458|NCT01782326|364130044|FG001|Double-blind Treatment|Lack of Efficacy|22|||
105582459|NCT01782326|364130043|FG000|Double-blind Treatment|Physician Decision|13|||
105582460|NCT01782326|364130044|FG001|Double-blind Treatment|Physician Decision|16|||
105582461|NCT01782326|364130043|FG000|Double-blind Treatment|Protocol deviation|8|||
105582462|NCT01782326|364130044|FG001|Double-blind Treatment|Protocol deviation|7|||
105582463|NCT01782326|364130043|FG000|Double-blind Treatment|Technical problems|0|||
105582464|NCT01782326|364130044|FG001|Double-blind Treatment|Technical problems|5|||
105582465|NCT05968482|364130045|FG000|First Crossover Period|Withdrawal by Subject|0|||
105582466|NCT05968482|364130046|FG001|First Crossover Period|Withdrawal by Subject|0|||
105582467|NCT05968482|364130047|FG002|First Crossover Period|Withdrawal by Subject|1|||
105582468|NCT05968482|364130048|FG003|First Crossover Period|Withdrawal by Subject|0|||
105582469|NCT05968482|364130049|FG004|First Crossover Period|Withdrawal by Subject|0|||
105582470|NCT05968482|364130050|FG005|First Crossover Period|Withdrawal by Subject|0|||
105582471|NCT05968482|364130045|FG000|First Crossover Period|Adverse Event|0|||
105582472|NCT05968482|364130046|FG001|First Crossover Period|Adverse Event|0|||
105582473|NCT05968482|364130047|FG002|First Crossover Period|Adverse Event|0|||
105582474|NCT05968482|364130048|FG003|First Crossover Period|Adverse Event|0|||
105582475|NCT05968482|364130049|FG004|First Crossover Period|Adverse Event|0|||
105582476|NCT05968482|364130050|FG005|First Crossover Period|Adverse Event|1|||
105582477|NCT05968482|364130045|FG000|Second Crossover Period|Withdrawal by Subject|0|||
105582478|NCT05968482|364130046|FG001|Second Crossover Period|Withdrawal by Subject|0|||
105582479|NCT05968482|364130047|FG002|Second Crossover Period|Withdrawal by Subject|0|||
105582480|NCT05968482|364130048|FG003|Second Crossover Period|Withdrawal by Subject|0|||
105582481|NCT05968482|364130049|FG004|Second Crossover Period|Withdrawal by Subject|1|||
105582482|NCT05968482|364130050|FG005|Second Crossover Period|Withdrawal by Subject|0|||
105582483|NCT05968482|364130045|FG000|Third Crossover Period|Adverse Event|0|||
105582484|NCT05968482|364130046|FG001|Third Crossover Period|Adverse Event|0|||
105582485|NCT05968482|364130047|FG002|Third Crossover Period|Adverse Event|0|||
105582486|NCT05968482|364130048|FG003|Third Crossover Period|Adverse Event|0|||
105582487|NCT05968482|364130049|FG004|Third Crossover Period|Adverse Event|1|||
105414784|NCT02443116|363522708|FG007|Part 2|Inability to comply with protocol|0|||
105414785|NCT02443116|363522709|FG008|Part 2|Inability to comply with protocol|0|||
105414786|NCT02443116|363522701|FG000|Part 2|Lost to Follow-up|0|||
105414787|NCT02443116|363522702|FG001|Part 2|Lost to Follow-up|0|||
105414788|NCT02443116|363522703|FG002|Part 2|Lost to Follow-up|0|||
105414789|NCT02443116|363522704|FG003|Part 2|Lost to Follow-up|1|||
105414790|NCT02443116|363522705|FG004|Part 2|Lost to Follow-up|0|||
105414791|NCT02443116|363522706|FG005|Part 2|Lost to Follow-up|0|||
105414792|NCT02443116|363522707|FG006|Part 2|Lost to Follow-up|0|||
105414793|NCT02443116|363522708|FG007|Part 2|Lost to Follow-up|0|||
105414794|NCT02443116|363522709|FG008|Part 2|Lost to Follow-up|0|||
105414795|NCT02443116|363522701|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105414796|NCT02443116|363522702|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105414797|NCT02443116|363522703|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105414798|NCT02443116|363522704|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105414799|NCT02443116|363522705|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105414800|NCT02443116|363522706|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
105414801|NCT02443116|363522707|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105414802|NCT02443116|363522708|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105414803|NCT02443116|363522709|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105414804|NCT02443116|363522701|FG000|Part 3|Adverse Event|0|||
105414805|NCT02443116|363522702|FG001|Part 3|Adverse Event|0|||
105414806|NCT02443116|363522703|FG002|Part 3|Adverse Event|0|||
105414807|NCT02443116|363522704|FG003|Part 3|Adverse Event|0|||
105414808|NCT02443116|363522705|FG004|Part 3|Adverse Event|0|||
105414809|NCT02443116|363522706|FG005|Part 3|Adverse Event|0|||
105414810|NCT02443116|363522707|FG006|Part 3|Adverse Event|0|||
105414811|NCT02443116|363522708|FG007|Part 3|Adverse Event|0|||
105414812|NCT02443116|363522709|FG008|Part 3|Adverse Event|1|||
105414813|NCT02443116|363522701|FG000|Part 3|Withdrew informed consent|0|||
105414814|NCT02443116|363522702|FG001|Part 3|Withdrew informed consent|0|||
105414815|NCT02443116|363522703|FG002|Part 3|Withdrew informed consent|0|||
105414816|NCT02443116|363522704|FG003|Part 3|Withdrew informed consent|0|||
105414817|NCT02443116|363522705|FG004|Part 3|Withdrew informed consent|0|||
105414818|NCT02443116|363522706|FG005|Part 3|Withdrew informed consent|0|||
105414819|NCT02443116|363522707|FG006|Part 3|Withdrew informed consent|0|||
105414820|NCT02443116|363522708|FG007|Part 3|Withdrew informed consent|3|||
105414821|NCT02443116|363522709|FG008|Part 3|Withdrew informed consent|2|||
105414822|NCT02443116|363522701|FG000|Part 3|Lost to Follow-up|0|||
105414823|NCT02443116|363522702|FG001|Part 3|Lost to Follow-up|0|||
105414824|NCT02443116|363522703|FG002|Part 3|Lost to Follow-up|0|||
105414825|NCT02443116|363522704|FG003|Part 3|Lost to Follow-up|0|||
105414826|NCT02443116|363522705|FG004|Part 3|Lost to Follow-up|0|||
105414827|NCT02443116|363522706|FG005|Part 3|Lost to Follow-up|0|||
105414828|NCT02443116|363522707|FG006|Part 3|Lost to Follow-up|0|||
105414829|NCT02443116|363522708|FG007|Part 3|Lost to Follow-up|1|||
105414830|NCT02443116|363522709|FG008|Part 3|Lost to Follow-up|2|||
105414831|NCT04552288|363522710|FG000|Overall Study|Death|3|||
105414832|NCT04552288|363522710|FG000|Overall Study|Lost to Follow-up|6|||
105414833|NCT04552288|363522710|FG000|Overall Study|Physician Decision|3|||
105414834|NCT04552288|363522710|FG000|Overall Study|Protocol Violation|9|||
105414835|NCT04552288|363522710|FG000|Overall Study|Withdrawal by Subject|6|||
105414836|NCT04552288|363522710|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
105414837|NCT03497676|363522711|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
105414838|NCT03497676|363522712|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
105414839|NCT03497676|363522713|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
105414840|NCT03497676|363522714|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
105414841|NCT03497676|363522711|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
105414842|NCT03497676|363522712|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
105414843|NCT03497676|363522713|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
105414844|NCT03497676|363522714|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
105414845|NCT03497676|363522711|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
105414846|NCT03497676|363522712|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
105414847|NCT03497676|363522713|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
105414848|NCT03497676|363522714|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
105414849|NCT03497676|363522711|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
105414850|NCT03497676|363522712|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
105414851|NCT03497676|363522713|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
105414852|NCT03497676|363522714|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
105414853|NCT03497676|363522711|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
105414854|NCT03497676|363522712|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
105582488|NCT05968482|364130050|FG005|Third Crossover Period|Adverse Event|0|||
105582489|NCT05968482|364130045|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
105582490|NCT05968482|364130046|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
105582491|NCT05968482|364130047|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
105582492|NCT05968482|364130048|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
105582493|NCT05968482|364130049|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
105582494|NCT05968482|364130050|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
105582495|NCT02559817|364130051|FG000|Treatment Period|Adverse Event|1|||
105582496|NCT02559817|364130052|FG001|Treatment Period|Adverse Event|0|||
105582497|NCT02559817|364130053|FG002|Treatment Period|Adverse Event|1|||
105582498|NCT02559817|364130054|FG003|Treatment Period|Adverse Event|0|||
105582499|NCT02559817|364130055|FG004|Treatment Period|Adverse Event|0|||
105582500|NCT02559817|364130051|FG000|Treatment Period|Lack of Efficacy|0|||
105582501|NCT02559817|364130052|FG001|Treatment Period|Lack of Efficacy|1|||
105582502|NCT02559817|364130053|FG002|Treatment Period|Lack of Efficacy|0|||
105582503|NCT02559817|364130054|FG003|Treatment Period|Lack of Efficacy|0|||
105582504|NCT02559817|364130055|FG004|Treatment Period|Lack of Efficacy|0|||
105582505|NCT02559817|364130051|FG000|Treatment Period|Lost to Follow-up|0|||
105582506|NCT02559817|364130052|FG001|Treatment Period|Lost to Follow-up|1|||
105582507|NCT02559817|364130053|FG002|Treatment Period|Lost to Follow-up|0|||
105582508|NCT02559817|364130054|FG003|Treatment Period|Lost to Follow-up|1|||
105582509|NCT02559817|364130055|FG004|Treatment Period|Lost to Follow-up|0|||
105582510|NCT02559817|364130051|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
105582511|NCT02559817|364130052|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
105582512|NCT02559817|364130053|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
105582513|NCT02559817|364130054|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
105582514|NCT02559817|364130055|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
105582515|NCT02559817|364130051|FG000|Treatment Period|Protocol Violation|0|||
105582516|NCT02559817|364130052|FG001|Treatment Period|Protocol Violation|0|||
105582517|NCT02559817|364130053|FG002|Treatment Period|Protocol Violation|0|||
105582518|NCT02559817|364130054|FG003|Treatment Period|Protocol Violation|1|||
105582519|NCT02559817|364130055|FG004|Treatment Period|Protocol Violation|0|||
105582520|NCT04172987|364130058|FG000|Lead In Period|Adverse Event|1|||
105582521|NCT04172987|364130058|FG000|Lead In Period|Protocol Violation|1|||
105582522|NCT04172987|364130058|FG000|Period 1|Physician Decision|1|||
105582523|NCT04172987|364130058|FG000|Period 2|Adverse Event|5|||
105582524|NCT04172987|364130058|FG000|Period 2|Dosing Termination by Sponsor|4|||
105582525|NCT00738530|364130062|FG000|Overall Study|Death|220|||
105582526|NCT00738530|364130063|FG001|Overall Study|Death|224|||
105414855|NCT03497676|363522713|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
105414856|NCT03497676|363522714|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
105414857|NCT03497676|363522711|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
105414858|NCT03497676|363522712|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
105497561|NCT00531934|363834149|FG000|Overall Study|Progression|52|||
105497562|NCT00531934|363834150|FG001|Overall Study|Progression|42|||
105497563|NCT00531934|363834149|FG000|Overall Study|Death|7|||
105497564|NCT00531934|363834150|FG001|Overall Study|Death|10|||
105497565|NCT00531934|363834149|FG000|Overall Study|Withdrawal by Subject|1|||
105497566|NCT00531934|363834150|FG001|Overall Study|Withdrawal by Subject|1|||
105497567|NCT00531934|363834149|FG000|Overall Study|Other|2|||
105497568|NCT00531934|363834150|FG001|Overall Study|Other|2|||
105497569|NCT02925923|363834151|FG000|Overall Study|blood samples hemolyzed|0|||
105497570|NCT02925923|363834152|FG001|Overall Study|blood samples hemolyzed|2|||
105497571|NCT04806503|363834154|FG000|Overall Study|Lost to Follow-up|0|||
105497572|NCT04806503|363834155|FG001|Overall Study|Lost to Follow-up|0|||
105497573|NCT04806503|363834156|FG002|Overall Study|Lost to Follow-up|1|||
105497574|NCT04806503|363834157|FG003|Overall Study|Lost to Follow-up|0|||
105497575|NCT04806503|363834158|FG004|Overall Study|Lost to Follow-up|0|||
105497576|NCT04806503|363834154|FG000|Overall Study|Withdrawal by Subject|1|||
105497577|NCT04806503|363834155|FG001|Overall Study|Withdrawal by Subject|0|||
105497578|NCT04806503|363834156|FG002|Overall Study|Withdrawal by Subject|1|||
105497579|NCT04806503|363834157|FG003|Overall Study|Withdrawal by Subject|1|||
105497580|NCT04806503|363834158|FG004|Overall Study|Withdrawal by Subject|1|||
105497581|NCT04806503|363834154|FG000|Overall Study|Adverse Event|1|||
105497582|NCT04806503|363834155|FG001|Overall Study|Adverse Event|1|||
105497583|NCT04806503|363834156|FG002|Overall Study|Adverse Event|0|||
105497584|NCT04806503|363834157|FG003|Overall Study|Adverse Event|1|||
105497585|NCT04806503|363834158|FG004|Overall Study|Adverse Event|0|||
105497586|NCT02008318|363834163|FG000|Overall Study|Adverse Event|4|||
105497587|NCT02008318|363834164|FG001|Overall Study|Adverse Event|0|||
105497588|NCT02008318|363834163|FG000|Overall Study|Physician Decision|2|||
105497589|NCT02008318|363834164|FG001|Overall Study|Physician Decision|0|||
105497590|NCT02008318|363834163|FG000|Overall Study|Progressive Disease|2|||
105497591|NCT02008318|363834164|FG001|Overall Study|Progressive Disease|0|||
105497592|NCT02008318|363834163|FG000|Overall Study|Protocol Violation|1|||
105582527|NCT00738530|364130062|FG000|Overall Study|Lost to Follow-up|8|||
105582528|NCT00738530|364130063|FG001|Overall Study|Lost to Follow-up|6|||
105582529|NCT00738530|364130062|FG000|Overall Study|Withdrawal by Subject|6|||
105582530|NCT00738530|364130063|FG001|Overall Study|Withdrawal by Subject|8|||
105582531|NCT02839681|364130064|FG000|Overall Study|Death|2|||
105582532|NCT01653847|364130065|FG000|Overall Study|Withdrawal by Subject|1|||
105582533|NCT01653847|364130066|FG001|Overall Study|Withdrawal by Subject|0|||
105582534|NCT03100838|364130067|FG000|Overall Study|Adverse Event|1|||
105582535|NCT03100838|364130068|FG001|Overall Study|Adverse Event|0|||
105582536|NCT03100838|364130069|FG002|Overall Study|Adverse Event|0|||
105582537|NCT03100838|364130070|FG003|Overall Study|Adverse Event|0|||
105582538|NCT03100838|364130067|FG000|Overall Study|Physician Decision|1|||
105582539|NCT03100838|364130068|FG001|Overall Study|Physician Decision|1|||
105582540|NCT03100838|364130069|FG002|Overall Study|Physician Decision|1|||
105582541|NCT03100838|364130070|FG003|Overall Study|Physician Decision|1|||
105582542|NCT03100838|364130067|FG000|Overall Study|Pregnancy|0|||
105582543|NCT03100838|364130068|FG001|Overall Study|Pregnancy|1|||
105582544|NCT03100838|364130069|FG002|Overall Study|Pregnancy|0|||
105582545|NCT03100838|364130070|FG003|Overall Study|Pregnancy|0|||
105582546|NCT03100838|364130067|FG000|Overall Study|Lost to Follow-up|0|||
105582547|NCT03100838|364130068|FG001|Overall Study|Lost to Follow-up|0|||
105582548|NCT03100838|364130069|FG002|Overall Study|Lost to Follow-up|1|||
105582549|NCT03100838|364130070|FG003|Overall Study|Lost to Follow-up|0|||
105582550|NCT04707391|364130071|FG000|Overall Study|Adverse Event|5|||
105582551|NCT04707391|364130072|FG001|Overall Study|Adverse Event|8|||
105582552|NCT04707391|364130071|FG000|Overall Study|Lost to Follow-up|44|||
105582553|NCT04707391|364130072|FG001|Overall Study|Lost to Follow-up|31|||
105582554|NCT04707391|364130071|FG000|Overall Study|Protocol Violation|1|||
105582555|NCT04707391|364130072|FG001|Overall Study|Protocol Violation|5|||
105414859|NCT03497676|363522713|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
105414860|NCT03497676|363522714|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
105414861|NCT03497676|363522711|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
105414862|NCT03497676|363522712|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
105414863|NCT03497676|363522713|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
105414864|NCT03497676|363522714|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
105414865|NCT03497676|363522711|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
105414866|NCT03497676|363522712|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
105414867|NCT03497676|363522713|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
105414868|NCT03497676|363522714|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
105414869|NCT01917929|363522715|FG000|Overall Study|Death|8|||
105414870|NCT01917929|363522715|FG000|Overall Study|Lost to Follow-up|19|||
105414871|NCT01917929|363522715|FG000|Overall Study|Withdrawal by Subject|33|||
105414872|NCT01917929|363522715|FG000|Overall Study|Adverse Event|6|||
105414873|NCT01917929|363522715|FG000|Overall Study|Investigative Site Terminated|35|||
105414874|NCT01917929|363522715|FG000|Overall Study|Censored because study device not implanted|6|||
105414875|NCT01917929|363522715|FG000|Overall Study|Censored because surgery not performed|3|||
105414876|NCT01917929|363522715|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
105414877|NCT01917929|363522715|FG000|Overall Study|Sponsor terminated study|175|||
105414878|NCT05285644|363522716|FG000|Overall Study|Adverse Event|3|||
105414879|NCT05285644|363522717|FG001|Overall Study|Adverse Event|3|||
105414880|NCT05285644|363522716|FG000|Overall Study|Withdrawal of Consent|2|||
105414881|NCT05285644|363522717|FG001|Overall Study|Withdrawal of Consent|5|||
105414882|NCT05285644|363522716|FG000|Overall Study|Noncompliance|0|||
105414883|NCT05285644|363522717|FG001|Overall Study|Noncompliance|4|||
105414884|NCT05285644|363522716|FG000|Overall Study|Lost to Follow-up|4|||
105414885|NCT05285644|363522717|FG001|Overall Study|Lost to Follow-up|6|||
105414886|NCT05285644|363522716|FG000|Overall Study|Disallowed Concurrent Medication|1|||
105414887|NCT05285644|363522717|FG001|Overall Study|Disallowed Concurrent Medication|1|||
105414888|NCT05285644|363522716|FG000|Overall Study|Investigator Decision|2|||
105414889|NCT05285644|363522717|FG001|Overall Study|Investigator Decision|0|||
105414890|NCT05285644|363522716|FG000|Overall Study|Protocol Deviation|1|||
105414891|NCT05285644|363522717|FG001|Overall Study|Protocol Deviation|0|||
105414892|NCT05285644|363522716|FG000|Overall Study|As specified in the Clinical Study Report|7|||
105414893|NCT05285644|363522717|FG001|Overall Study|As specified in the Clinical Study Report|3|||
105414894|NCT04295759|363522718|FG000|Overall Study|Lack of Efficacy|9|||
105414895|NCT04295759|363522718|FG000|Overall Study|Death|1|||
105582556|NCT04707391|364130071|FG000|Overall Study|Withdrawal by Subject|27|||
105582557|NCT04707391|364130072|FG001|Overall Study|Withdrawal by Subject|25|||
105582558|NCT04707391|364130071|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
105582559|NCT04707391|364130072|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
105582560|NCT04707391|364130071|FG000|Overall Study|Other|0|||
105582561|NCT04707391|364130072|FG001|Overall Study|Other|2|||
105414896|NCT04295759|363522718|FG000|Overall Study|Withdrawal by Subject|2|||
105582562|NCT00801242|364130073|FG000|Overall Study|Adverse Event|10|||
105582563|NCT00801242|364130073|FG000|Overall Study|Withdrawal by Subject|13|||
105582564|NCT00801242|364130073|FG000|Overall Study|Protocol Violation|5|||
105582565|NCT00801242|364130073|FG000|Overall Study|Physician Decision|3|||
105414897|NCT04295759|363522718|FG000|Overall Study|Deemed ineligible|1|||
105414898|NCT01696981|363522719|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
105414899|NCT01696981|363522720|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
105414900|NCT01696981|363522719|FG000|Overall Study|Died Before Randomization|3|||
105414901|NCT01696981|363522720|FG001|Overall Study|Died Before Randomization|8|||
105414902|NCT01696981|363522719|FG000|Overall Study|Died Before ASU (Control)|278|||
105414903|NCT01696981|363522720|FG001|Overall Study|Died Before ASU (Control)|0|||
105414904|NCT01696981|363522719|FG000|Overall Study|Refused ASU (Control)|920|||
105414905|NCT01696981|363522720|FG001|Overall Study|Refused ASU (Control)|0|||
105414906|NCT01696981|363522719|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
105414907|NCT01696981|363522720|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
105414908|NCT04113018|363522723|FG000|Overall Study|Death|2|||
105414909|NCT04113018|363522723|FG000|Overall Study|Lost to Follow-up|1|||
105414910|NCT04113018|363522723|FG000|Overall Study|Still On Study (on study treatment)|24|||
105414911|NCT04113018|363522723|FG000|Overall Study|Still On Study (in follow up)|12|||
105414912|NCT04576455|363522724|FG000|Overall Study|Ongoing in the Study|48|||
105414913|NCT04576455|363522725|FG001|Overall Study|Ongoing in the Study|58|||
105414914|NCT04576455|363522724|FG000|Overall Study|Death|83|||
105414915|NCT04576455|363522725|FG001|Overall Study|Death|77|||
105414916|NCT04576455|363522724|FG000|Overall Study|Lost to Follow-up|4|||
105414917|NCT04576455|363522725|FG001|Overall Study|Lost to Follow-up|5|||
105414918|NCT04576455|363522724|FG000|Overall Study|Withdrawal by Subject|16|||
105414919|NCT04576455|363522725|FG001|Overall Study|Withdrawal by Subject|12|||
105414920|NCT04380753|363522726|FG000|Overall Study|Participants continuing study|4|||
105414921|NCT04380753|363522726|FG000|Overall Study|Death|2|||
105414922|NCT03823287|363522727|FG000|Overall Study|Withdrawal by Subject|25|||
105414923|NCT03823287|363522728|FG001|Overall Study|Withdrawal by Subject|17|||
105414924|NCT03823287|363522727|FG000|Overall Study|Death|13|||
105414925|NCT03823287|363522728|FG001|Overall Study|Death|7|||
105414926|NCT03823287|363522727|FG000|Overall Study|Lost to Follow-up|7|||
105414927|NCT03823287|363522728|FG001|Overall Study|Lost to Follow-up|8|||
105414928|NCT03823287|363522727|FG000|Overall Study|Adverse Event|6|||
105414929|NCT03823287|363522728|FG001|Overall Study|Adverse Event|8|||
105414930|NCT03823287|363522727|FG000|Overall Study|Physician Decision|5|||
105414931|NCT03823287|363522728|FG001|Overall Study|Physician Decision|2|||
105414932|NCT03823287|363522727|FG000|Overall Study|Lack of Efficacy|2|||
105414933|NCT03823287|363522728|FG001|Overall Study|Lack of Efficacy|0|||
105414934|NCT03823287|363522727|FG000|Overall Study|Other|2|||
105414935|NCT03823287|363522728|FG001|Overall Study|Other|4|||
105414936|NCT01221623|363522729|FG000|Overall Study|Withdrawal by Subject|19|||
105414937|NCT01221623|363522730|FG001|Overall Study|Withdrawal by Subject|8|||
105414938|NCT01221623|363522729|FG000|Overall Study|Lost to Follow-up|7|||
105414939|NCT01221623|363522730|FG001|Overall Study|Lost to Follow-up|1|||
105414940|NCT01221623|363522729|FG000|Overall Study|Adverse Event|6|||
105414941|NCT01221623|363522730|FG001|Overall Study|Adverse Event|3|||
105414942|NCT01221623|363522729|FG000|Overall Study|Death|1|||
105414943|NCT01221623|363522730|FG001|Overall Study|Death|0|||
105414944|NCT01221623|363522729|FG000|Overall Study|Other|5|||
105414945|NCT01221623|363522730|FG001|Overall Study|Other|2|||
105414946|NCT06899737|363522731|FG000|Overall Study|Lost to Follow-up|19|||
105414947|NCT06899737|363522732|FG001|Overall Study|Lost to Follow-up|7|||
105414948|NCT02744612|363524280|FG000|Overall Study|Withdrawal by Subject|0|||
105414949|NCT02744612|363524281|FG001|Overall Study|Withdrawal by Subject|2|||
105414950|NCT02954406|363524284|FG000|Overall Study|Adverse Event|0|||
105414951|NCT02954406|363524285|FG001|Overall Study|Adverse Event|1|||
105414952|NCT02954406|363524286|FG002|Overall Study|Adverse Event|0|||
105414953|NCT02954406|363524287|FG003|Overall Study|Adverse Event|0|||
105414954|NCT02954406|363524288|FG004|Overall Study|Adverse Event|1|||
105414955|NCT02954406|363524289|FG005|Overall Study|Adverse Event|0|||
105414956|NCT02954406|363524290|FG006|Overall Study|Adverse Event|0|||
105414957|NCT02954406|363524291|FG007|Overall Study|Adverse Event|0|||
105414958|NCT02954406|363524292|FG008|Overall Study|Adverse Event|1|||
105414959|NCT02954406|363524293|FG009|Overall Study|Adverse Event|1|||
105414960|NCT02954406|363524294|FG010|Overall Study|Adverse Event|0|||
105414961|NCT02954406|363524284|FG000|Overall Study|Progressive Disease|3|||
105414962|NCT02954406|363524285|FG001|Overall Study|Progressive Disease|4|||
105414963|NCT02954406|363524286|FG002|Overall Study|Progressive Disease|3|||
105414964|NCT02954406|363524287|FG003|Overall Study|Progressive Disease|4|||
105414965|NCT02954406|363524288|FG004|Overall Study|Progressive Disease|3|||
105414966|NCT02954406|363524289|FG005|Overall Study|Progressive Disease|3|||
105414967|NCT02954406|363524290|FG006|Overall Study|Progressive Disease|2|||
105414968|NCT02954406|363524291|FG007|Overall Study|Progressive Disease|2|||
105414969|NCT02954406|363524292|FG008|Overall Study|Progressive Disease|1|||
105414970|NCT02954406|363524293|FG009|Overall Study|Progressive Disease|1|||
105414971|NCT02954406|363524294|FG010|Overall Study|Progressive Disease|0|||
105414972|NCT02954406|363524284|FG000|Overall Study|Symptomatic Deterioration|0|||
105414973|NCT02954406|363524285|FG001|Overall Study|Symptomatic Deterioration|1|||
105414974|NCT02954406|363524286|FG002|Overall Study|Symptomatic Deterioration|0|||
105414975|NCT02954406|363524287|FG003|Overall Study|Symptomatic Deterioration|0|||
105414976|NCT02954406|363524288|FG004|Overall Study|Symptomatic Deterioration|0|||
105414977|NCT02954406|363524289|FG005|Overall Study|Symptomatic Deterioration|0|||
105414978|NCT02954406|363524290|FG006|Overall Study|Symptomatic Deterioration|0|||
105414979|NCT02954406|363524291|FG007|Overall Study|Symptomatic Deterioration|0|||
105414980|NCT02954406|363524292|FG008|Overall Study|Symptomatic Deterioration|0|||
105414981|NCT02954406|363524293|FG009|Overall Study|Symptomatic Deterioration|0|||
105414982|NCT02954406|363524294|FG010|Overall Study|Symptomatic Deterioration|0|||
105414983|NCT02954406|363524284|FG000|Overall Study|Death|0|||
105414984|NCT02954406|363524285|FG001|Overall Study|Death|0|||
105414985|NCT02954406|363524286|FG002|Overall Study|Death|0|||
105414986|NCT02954406|363524287|FG003|Overall Study|Death|0|||
105414987|NCT02954406|363524288|FG004|Overall Study|Death|1|||
105414988|NCT02954406|363524289|FG005|Overall Study|Death|0|||
105414989|NCT02954406|363524290|FG006|Overall Study|Death|0|||
105414990|NCT02954406|363524291|FG007|Overall Study|Death|0|||
105414991|NCT02954406|363524292|FG008|Overall Study|Death|1|||
105414992|NCT02954406|363524293|FG009|Overall Study|Death|1|||
105414993|NCT02954406|363524294|FG010|Overall Study|Death|0|||
105414994|NCT02954406|363524284|FG000|Overall Study|Reason Not Specified|0|||
105414995|NCT02954406|363524285|FG001|Overall Study|Reason Not Specified|0|||
105414996|NCT02954406|363524286|FG002|Overall Study|Reason Not Specified|3|||
105414997|NCT02954406|363524287|FG003|Overall Study|Reason Not Specified|2|||
105414998|NCT02954406|363524288|FG004|Overall Study|Reason Not Specified|2|||
105414999|NCT02954406|363524289|FG005|Overall Study|Reason Not Specified|0|||
105415000|NCT02954406|363524290|FG006|Overall Study|Reason Not Specified|1|||
105415001|NCT02954406|363524291|FG007|Overall Study|Reason Not Specified|0|||
105415002|NCT02954406|363524292|FG008|Overall Study|Reason Not Specified|1|||
105415003|NCT02954406|363524293|FG009|Overall Study|Reason Not Specified|0|||
105415004|NCT02954406|363524294|FG010|Overall Study|Reason Not Specified|0|||
105415005|NCT03522246|363524295|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
105415006|NCT03522246|363524296|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
105415007|NCT03522246|363524297|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
105415008|NCT03522246|363524298|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
105497593|NCT02008318|363834164|FG001|Overall Study|Protocol Violation|1|||
105497594|NCT02008318|363834163|FG000|Overall Study|Withdrawal by Subject|3|||
105497595|NCT02008318|363834164|FG001|Overall Study|Withdrawal by Subject|0|||
105497596|NCT00371826|363834165|FG000|Core Phase (12 Months)|Adverse Event|15|||
105497597|NCT00371826|363834166|FG001|Core Phase (12 Months)|Adverse Event|4|||
105497598|NCT00371826|363834167|FG002|Core Phase (12 Months)|Adverse Event|9|||
105497599|NCT00371826|363834165|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
105497600|NCT00371826|363834166|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
105497601|NCT00371826|363834167|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
105497602|NCT00371826|363834165|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
105497603|NCT00371826|363834166|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
105497604|NCT00371826|363834167|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
105497605|NCT00371826|363834165|FG000|Core Phase (12 Months)|Protocol Violation|1|||
105497606|NCT00371826|363834166|FG001|Core Phase (12 Months)|Protocol Violation|0|||
105497607|NCT00371826|363834167|FG002|Core Phase (12 Months)|Protocol Violation|1|||
105497608|NCT00371826|363834165|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
105497609|NCT00371826|363834166|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
105497610|NCT00371826|363834167|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
105497611|NCT00371826|363834165|FG000|Core Phase (12 Months)|Administrative problems|1|||
105497612|NCT00371826|363834166|FG001|Core Phase (12 Months)|Administrative problems|0|||
105497613|NCT00371826|363834167|FG002|Core Phase (12 Months)|Administrative problems|8|||
105497614|NCT00371826|363834165|FG000|Core Phase (12 Months)|Graft Loss|0|||
105497615|NCT00371826|363834166|FG001|Core Phase (12 Months)|Graft Loss|1|||
105497616|NCT00371826|363834167|FG002|Core Phase (12 Months)|Graft Loss|0|||
105497617|NCT00371826|363834165|FG000|Extension Phase (24 Months)|Adverse Event|4|||
105497618|NCT00371826|363834166|FG001|Extension Phase (24 Months)|Adverse Event|5|||
105497619|NCT00371826|363834167|FG002|Extension Phase (24 Months)|Adverse Event|0|||
105497620|NCT00371826|363834165|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
105497621|NCT00371826|363834166|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
105497622|NCT00371826|363834167|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
105497623|NCT00371826|363834165|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
105415009|NCT03522246|363524299|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
105415010|NCT00814580|363524300|FG000|Overall Study|Adverse Event|6|||
105415011|NCT00814580|363524301|FG001|Overall Study|Adverse Event|15|||
105415012|NCT00814580|363524300|FG000|Overall Study|Lack of Efficacy|18|||
105415013|NCT00814580|363524301|FG001|Overall Study|Lack of Efficacy|25|||
105415014|NCT00814580|363524300|FG000|Overall Study|Protocol Violation|2|||
105415015|NCT00814580|363524301|FG001|Overall Study|Protocol Violation|0|||
105415016|NCT00814580|363524300|FG000|Overall Study|Withdrawal by Subject|2|||
105582566|NCT00801242|364130073|FG000|Overall Study|Lost to Follow-up|1|||
105415017|NCT00814580|363524301|FG001|Overall Study|Withdrawal by Subject|2|||
105415018|NCT00814580|363524300|FG000|Overall Study|Other|1|||
105415019|NCT00814580|363524301|FG001|Overall Study|Other|3|||
105415020|NCT00814580|363524300|FG000|Overall Study|Did Not Take Drug|2|||
105415021|NCT00814580|363524301|FG001|Overall Study|Did Not Take Drug|2|||
105415022|NCT02582814|363524302|FG000|Overall Study|Study-specific withdrawal criteria|1|||
105415023|NCT02582814|363524303|FG001|Overall Study|Study-specific withdrawal criteria|0|||
105415024|NCT02582814|363524302|FG000|Overall Study|Withdrawal by Subject|4|||
105415025|NCT02582814|363524303|FG001|Overall Study|Withdrawal by Subject|3|||
105415026|NCT02582814|363524302|FG000|Overall Study|Adverse Event|4|||
105415027|NCT02582814|363524303|FG001|Overall Study|Adverse Event|4|||
105415028|NCT02150057|363524304|FG000|Overall Study|Lost to Follow-up|6|||
105415029|NCT02150057|363524305|FG001|Overall Study|Lost to Follow-up|4|||
105415030|NCT01558115|363524306|FG000|Overall Study|Withdrawal by Subject|3|||
105415031|NCT01558115|363524306|FG000|Overall Study|Study closed due to poor enrollment|4|||
105415032|NCT00316225|363524309|FG000|Overall Study|Adverse Event|2|||
105415033|NCT00316225|363524309|FG000|Overall Study|Physician Decision|3|||
105415034|NCT00316225|363524309|FG000|Overall Study|Progressive Disease|15|||
105415035|NCT00316225|363524309|FG000|Overall Study|Withdrawal by Subject|3|||
105415036|NCT00316225|363524309|FG000|Overall Study|Death|2|||
105415037|NCT02226562|363524310|FG000|Overall Study|Lost to Follow-up|0|||
105415038|NCT02226562|363524311|FG001|Overall Study|Lost to Follow-up|1|||
105415039|NCT00758069|363524313|FG000|Overall Study|Lack of Efficacy|0|||
105415040|NCT00758069|363524314|FG001|Overall Study|Lack of Efficacy|0|||
105415041|NCT00758069|363524315|FG002|Overall Study|Lack of Efficacy|1|||
105415042|NCT00758069|363524313|FG000|Overall Study|Incorrect Study Drug|1|||
105415043|NCT00758069|363524314|FG001|Overall Study|Incorrect Study Drug|0|||
105415044|NCT00758069|363524315|FG002|Overall Study|Incorrect Study Drug|0|||
105415045|NCT02752633|363524316|FG000|Overall Study|Withdrawal by Subject|1|||
105415046|NCT00853242|363524319|FG000|Overall Study|Adverse Event|0|||
105415047|NCT00853242|363524320|FG001|Overall Study|Adverse Event|1|||
105415048|NCT00853242|363524321|FG002|Overall Study|Adverse Event|1|||
105415049|NCT00853242|363524322|FG003|Overall Study|Adverse Event|0|||
105415050|NCT00853242|363524323|FG004|Overall Study|Adverse Event|3|||
105415051|NCT00853242|363524324|FG005|Overall Study|Adverse Event|1|||
105415052|NCT00853242|363524325|FG006|Overall Study|Adverse Event|1|||
105415053|NCT00853242|363524319|FG000|Overall Study|Noncompliant|0|||
105415054|NCT00853242|363524320|FG001|Overall Study|Noncompliant|0|||
105415055|NCT00853242|363524321|FG002|Overall Study|Noncompliant|0|||
105415056|NCT00853242|363524322|FG003|Overall Study|Noncompliant|0|||
105415057|NCT00853242|363524323|FG004|Overall Study|Noncompliant|1|||
105415058|NCT00853242|363524324|FG005|Overall Study|Noncompliant|0|||
105415059|NCT00853242|363524325|FG006|Overall Study|Noncompliant|0|||
105415060|NCT00853242|363524319|FG000|Overall Study|Withdrawal by Subject|1|||
105415061|NCT00853242|363524320|FG001|Overall Study|Withdrawal by Subject|2|||
105415062|NCT00853242|363524321|FG002|Overall Study|Withdrawal by Subject|0|||
105415063|NCT00853242|363524322|FG003|Overall Study|Withdrawal by Subject|4|||
105415064|NCT00853242|363524323|FG004|Overall Study|Withdrawal by Subject|0|||
105415065|NCT00853242|363524324|FG005|Overall Study|Withdrawal by Subject|0|||
105415066|NCT00853242|363524325|FG006|Overall Study|Withdrawal by Subject|2|||
105415067|NCT00853242|363524319|FG000|Overall Study|Other|2|||
105415068|NCT00853242|363524320|FG001|Overall Study|Other|0|||
105415069|NCT00853242|363524321|FG002|Overall Study|Other|2|||
105415070|NCT00853242|363524322|FG003|Overall Study|Other|0|||
105415071|NCT00853242|363524323|FG004|Overall Study|Other|0|||
105415072|NCT00853242|363524324|FG005|Overall Study|Other|1|||
105415073|NCT00853242|363524325|FG006|Overall Study|Other|2|||
105497624|NCT00371826|363834166|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
105497625|NCT00371826|363834167|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
105415074|NCT01296711|363524326|FG000|Overall Study|Adverse Event|3|||
105415075|NCT01296711|363524327|FG001|Overall Study|Adverse Event|1|||
105415076|NCT01296711|363524328|FG002|Overall Study|Adverse Event|4|||
105415077|NCT01296711|363524329|FG003|Overall Study|Adverse Event|3|||
105415078|NCT01296711|363524330|FG004|Overall Study|Adverse Event|1|||
105415079|NCT01296711|363524331|FG005|Overall Study|Adverse Event|6|||
105415080|NCT01296711|363524332|FG006|Overall Study|Adverse Event|11|||
105415081|NCT01296711|363524333|FG007|Overall Study|Adverse Event|3|||
105415082|NCT01296711|363524326|FG000|Overall Study|Lack of Efficacy|1|||
105415083|NCT01296711|363524327|FG001|Overall Study|Lack of Efficacy|4|||
105415084|NCT01296711|363524328|FG002|Overall Study|Lack of Efficacy|1|||
105415085|NCT01296711|363524329|FG003|Overall Study|Lack of Efficacy|1|||
105415086|NCT01296711|363524330|FG004|Overall Study|Lack of Efficacy|1|||
105415087|NCT01296711|363524331|FG005|Overall Study|Lack of Efficacy|0|||
105415088|NCT01296711|363524332|FG006|Overall Study|Lack of Efficacy|2|||
105415089|NCT01296711|363524333|FG007|Overall Study|Lack of Efficacy|3|||
105415090|NCT01296711|363524326|FG000|Overall Study|Lost to Follow-up|0|||
105415091|NCT01296711|363524327|FG001|Overall Study|Lost to Follow-up|0|||
105415092|NCT01296711|363524328|FG002|Overall Study|Lost to Follow-up|1|||
105415093|NCT01296711|363524329|FG003|Overall Study|Lost to Follow-up|1|||
105497626|NCT00371826|363834165|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
105497627|NCT00371826|363834166|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
105497628|NCT00371826|363834167|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
105497629|NCT00371826|363834165|FG000|Extension Phase (24 Months)|Administrative problems|0|||
105497630|NCT00371826|363834166|FG001|Extension Phase (24 Months)|Administrative problems|0|||
105497631|NCT00371826|363834167|FG002|Extension Phase (24 Months)|Administrative problems|2|||
105497632|NCT02104752|363834170|FG000|Overall Study|Withdrawal by Subject|1|||
105497633|NCT02104752|363834171|FG001|Overall Study|Withdrawal by Subject|0|||
105497634|NCT02104752|363834170|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
105497635|NCT02104752|363834171|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
105497636|NCT00573183|363834172|FG000|Overall Study|Lost to Follow-up|52|||
105497637|NCT00573183|363834173|FG001|Overall Study|Lost to Follow-up|50|||
105497638|NCT00573183|363834172|FG000|Overall Study|Withdrawal by Subject|8|||
105497639|NCT00573183|363834173|FG001|Overall Study|Withdrawal by Subject|2|||
105497640|NCT00573183|363834172|FG000|Overall Study|Death|0|||
105497641|NCT00573183|363834173|FG001|Overall Study|Death|1|||
105497642|NCT00573183|363834172|FG000|Overall Study|Adverse Event|2|||
105497643|NCT00573183|363834173|FG001|Overall Study|Adverse Event|0|||
105497644|NCT00573183|363834172|FG000|Overall Study|Incarceration|5|||
105497645|NCT00573183|363834173|FG001|Overall Study|Incarceration|8|||
105497646|NCT00573183|363834172|FG000|Overall Study|Other|5|||
105497647|NCT00573183|363834173|FG001|Overall Study|Other|2|||
105497648|NCT00850343|363834174|FG000|Overall Study|Withdrawal by Subject|11|||
105497649|NCT00850343|363834175|FG001|Overall Study|Withdrawal by Subject|0|||
105497650|NCT00850343|363834176|FG002|Overall Study|Withdrawal by Subject|3|||
105497651|NCT00850343|363834177|FG003|Overall Study|Withdrawal by Subject|2|||
105497652|NCT00850343|363834174|FG000|Overall Study|Adverse Event|15|||
105497653|NCT00850343|363834175|FG001|Overall Study|Adverse Event|2|||
105497654|NCT00850343|363834176|FG002|Overall Study|Adverse Event|6|||
105497655|NCT00850343|363834177|FG003|Overall Study|Adverse Event|6|||
105497656|NCT00850343|363834174|FG000|Overall Study|Pregnancy|0|||
105497657|NCT00850343|363834175|FG001|Overall Study|Pregnancy|0|||
105497658|NCT00850343|363834176|FG002|Overall Study|Pregnancy|0|||
105497659|NCT00850343|363834177|FG003|Overall Study|Pregnancy|1|||
105497660|NCT00850343|363834174|FG000|Overall Study|Lack of Efficacy|17|||
105497661|NCT00850343|363834175|FG001|Overall Study|Lack of Efficacy|0|||
105497662|NCT00850343|363834176|FG002|Overall Study|Lack of Efficacy|3|||
105497663|NCT00850343|363834177|FG003|Overall Study|Lack of Efficacy|2|||
105497664|NCT00850343|363834174|FG000|Overall Study|Non-compliance with Study Procedures|1|||
105497665|NCT00850343|363834175|FG001|Overall Study|Non-compliance with Study Procedures|0|||
105497666|NCT00850343|363834176|FG002|Overall Study|Non-compliance with Study Procedures|1|||
105497667|NCT00850343|363834177|FG003|Overall Study|Non-compliance with Study Procedures|1|||
105497668|NCT00850343|363834174|FG000|Overall Study|Physician Decision|2|||
105497669|NCT00850343|363834175|FG001|Overall Study|Physician Decision|1|||
105497670|NCT00850343|363834176|FG002|Overall Study|Physician Decision|1|||
105497671|NCT00850343|363834177|FG003|Overall Study|Physician Decision|1|||
105497672|NCT02570074|363834178|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
105497673|NCT02570074|363834179|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
105497674|NCT00246753|363834181|FG000|Overall Study|Withdrawal by Subject|2|||
105497675|NCT00246753|363834181|FG000|Overall Study|Physician Decision|2|||
105497676|NCT00246753|363834181|FG000|Overall Study|Adverse Event|2|||
105497677|NCT00246753|363834181|FG000|Overall Study|Unacceptable toxicity|2|||
105497678|NCT02478632|363834184|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
105497679|NCT02478632|363834185|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
105497680|NCT02478632|363834184|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
105497681|NCT02478632|363834185|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
105497682|NCT02478632|363834184|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
105497683|NCT02478632|363834185|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
105497684|NCT00864721|363834189|FG000|Overall Study|Patient request|11|||
105497685|NCT00864721|363834189|FG000|Overall Study|Hospitalized|1|||
105497686|NCT00864721|363834189|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
105497687|NCT00864721|363834189|FG000|Overall Study|Adverse Event|21|||
105497688|NCT02651467|363834190|FG000|Overall Study|Withdrawal by Subject|0|||
105497689|NCT02651467|363834191|FG001|Overall Study|Withdrawal by Subject|0|||
105497690|NCT02651467|363834192|FG002|Overall Study|Withdrawal by Subject|2|||
105497691|NCT02651467|363834190|FG000|Overall Study|Other (Not specified)|1|||
105497692|NCT02651467|363834191|FG001|Overall Study|Other (Not specified)|0|||
105497693|NCT02651467|363834192|FG002|Overall Study|Other (Not specified)|2|||
105497694|NCT01890746|363834195|FG000|Overall Study|Death|39|||
105497695|NCT01890746|363834196|FG001|Overall Study|Death|30|||
105497696|NCT01890746|363834195|FG000|Overall Study|Adverse Event|1|||
105497697|NCT01890746|363834196|FG001|Overall Study|Adverse Event|0|||
105497698|NCT01890746|363834195|FG000|Overall Study|Lost to Follow-up|4|||
105497699|NCT01890746|363834196|FG001|Overall Study|Lost to Follow-up|1|||
105497700|NCT01890746|363834195|FG000|Overall Study|Physician Decision|3|||
105582567|NCT00801242|364130073|FG000|Overall Study|Miscellaneous reasons|20|||
105582568|NCT01347645|364130076|FG000|Overall Study|Death|1|||
105582569|NCT01347645|364130077|FG001|Overall Study|Death|5|||
105582570|NCT01347645|364130078|FG002|Overall Study|Death|2|||
105582571|NCT01347645|364130079|FG003|Overall Study|Death|7|||
105582572|NCT01347645|364130080|FG004|Overall Study|Death|7|||
105582573|NCT01347645|364130076|FG000|Overall Study|Lost to Follow-up|1|||
105582574|NCT01347645|364130077|FG001|Overall Study|Lost to Follow-up|1|||
105582575|NCT01347645|364130078|FG002|Overall Study|Lost to Follow-up|0|||
105582576|NCT01347645|364130079|FG003|Overall Study|Lost to Follow-up|1|||
105582577|NCT01347645|364130080|FG004|Overall Study|Lost to Follow-up|1|||
105582578|NCT01347645|364130076|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
105582579|NCT01347645|364130077|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
105582580|NCT01347645|364130078|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
105582581|NCT01347645|364130079|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
105582582|NCT01347645|364130080|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
105582583|NCT01347645|364130076|FG000|Overall Study|Other|1|||
105582584|NCT01347645|364130077|FG001|Overall Study|Other|0|||
105582585|NCT01347645|364130078|FG002|Overall Study|Other|0|||
105582586|NCT01347645|364130079|FG003|Overall Study|Other|0|||
105582587|NCT01347645|364130080|FG004|Overall Study|Other|1|||
105582588|NCT01347645|364130076|FG000|Overall Study|Withdrawal by Subject|0|||
105582589|NCT01347645|364130077|FG001|Overall Study|Withdrawal by Subject|0|||
105582590|NCT01347645|364130078|FG002|Overall Study|Withdrawal by Subject|0|||
105582591|NCT01347645|364130079|FG003|Overall Study|Withdrawal by Subject|3|||
105582592|NCT01347645|364130080|FG004|Overall Study|Withdrawal by Subject|3|||
105582593|NCT01347645|364130076|FG000|Overall Study|Physician Decision|0|||
105582594|NCT01347645|364130077|FG001|Overall Study|Physician Decision|0|||
105582595|NCT01347645|364130078|FG002|Overall Study|Physician Decision|0|||
105582596|NCT01347645|364130079|FG003|Overall Study|Physician Decision|0|||
105582597|NCT01347645|364130080|FG004|Overall Study|Physician Decision|1|||
105582598|NCT01347645|364130076|FG000|Overall Study|Adverse Event|0|||
105582599|NCT01347645|364130077|FG001|Overall Study|Adverse Event|0|||
105582600|NCT01347645|364130078|FG002|Overall Study|Adverse Event|0|||
105582601|NCT01347645|364130079|FG003|Overall Study|Adverse Event|1|||
105582602|NCT01347645|364130080|FG004|Overall Study|Adverse Event|1|||
105582603|NCT00994279|364130081|FG000|Overall Study|Withdrawal by Subject|2|||
105582604|NCT00994279|364130082|FG001|Overall Study|Withdrawal by Subject|2|||
105582605|NCT00994279|364130081|FG000|Overall Study|Toxicity|1|||
105582606|NCT00994279|364130082|FG001|Overall Study|Toxicity|0|||
105582607|NCT00994279|364130081|FG000|Overall Study|Multiple reasons|1|||
105582608|NCT00994279|364130082|FG001|Overall Study|Multiple reasons|3|||
105582609|NCT01192295|364130083|FG000|Overall Study|Adverse Event|3|||
105582610|NCT01192295|364130084|FG001|Overall Study|Adverse Event|7|||
105582611|NCT01192295|364130083|FG000|Overall Study|Withdrawal by Subject|3|||
105582612|NCT01192295|364130084|FG001|Overall Study|Withdrawal by Subject|4|||
105582613|NCT01192295|364130083|FG000|Overall Study|Lost to Follow-up|0|||
105582614|NCT01192295|364130084|FG001|Overall Study|Lost to Follow-up|1|||
105582615|NCT01192295|364130083|FG000|Overall Study|Lack of Efficacy|0|||
105582616|NCT01192295|364130084|FG001|Overall Study|Lack of Efficacy|5|||
105582617|NCT01192295|364130083|FG000|Overall Study|Administrative|4|||
105582618|NCT01192295|364130084|FG001|Overall Study|Administrative|6|||
105582619|NCT03785340|364130085|FG000|Overall Study|Lost to Follow-up|2|||
105582620|NCT03785340|364130086|FG001|Overall Study|Lost to Follow-up|0|||
105582621|NCT03785340|364130085|FG000|Overall Study|Adverse Event|1|||
105582622|NCT03785340|364130086|FG001|Overall Study|Adverse Event|0|||
105582623|NCT03008122|364130090|FG000|Overall Study|Physician Decision|3|||
105582624|NCT03008122|364130091|FG001|Overall Study|Physician Decision|2|||
105582625|NCT03008122|364130092|FG002|Overall Study|Physician Decision|0|||
105582626|NCT03008122|364130090|FG000|Overall Study|Withdrawal by Subject|1|||
105582627|NCT03008122|364130091|FG001|Overall Study|Withdrawal by Subject|3|||
105582628|NCT03008122|364130092|FG002|Overall Study|Withdrawal by Subject|0|||
105415094|NCT01296711|363524330|FG004|Overall Study|Lost to Follow-up|2|||
105415095|NCT01296711|363524331|FG005|Overall Study|Lost to Follow-up|0|||
105582629|NCT03008122|364130090|FG000|Overall Study|Lost to Follow-up|4|||
105582630|NCT03008122|364130091|FG001|Overall Study|Lost to Follow-up|8|||
105582631|NCT03008122|364130092|FG002|Overall Study|Lost to Follow-up|3|||
105582632|NCT03008122|364130090|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
105582633|NCT03008122|364130091|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
105415096|NCT01296711|363524332|FG006|Overall Study|Lost to Follow-up|4|||
105582634|NCT03008122|364130092|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
105582635|NCT03008122|364130090|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
105415097|NCT01296711|363524333|FG007|Overall Study|Lost to Follow-up|2|||
105415098|NCT01296711|363524326|FG000|Overall Study|Protocol Violation|0|||
105415099|NCT01296711|363524327|FG001|Overall Study|Protocol Violation|0|||
105415100|NCT01296711|363524328|FG002|Overall Study|Protocol Violation|0|||
105415101|NCT01296711|363524329|FG003|Overall Study|Protocol Violation|1|||
105415102|NCT01296711|363524330|FG004|Overall Study|Protocol Violation|1|||
105415103|NCT01296711|363524331|FG005|Overall Study|Protocol Violation|0|||
105415104|NCT01296711|363524332|FG006|Overall Study|Protocol Violation|0|||
105415105|NCT01296711|363524333|FG007|Overall Study|Protocol Violation|0|||
105415106|NCT01296711|363524326|FG000|Overall Study|Withdrawal by Subject|4|||
105415107|NCT01296711|363524327|FG001|Overall Study|Withdrawal by Subject|2|||
105415108|NCT01296711|363524328|FG002|Overall Study|Withdrawal by Subject|2|||
105415109|NCT01296711|363524329|FG003|Overall Study|Withdrawal by Subject|1|||
105415110|NCT01296711|363524330|FG004|Overall Study|Withdrawal by Subject|1|||
105415111|NCT01296711|363524331|FG005|Overall Study|Withdrawal by Subject|1|||
105415112|NCT01296711|363524332|FG006|Overall Study|Withdrawal by Subject|2|||
105415113|NCT01296711|363524333|FG007|Overall Study|Withdrawal by Subject|1|||
105415114|NCT01296711|363524326|FG000|Overall Study|Study termination|8|||
105415115|NCT01296711|363524327|FG001|Overall Study|Study termination|1|||
105415116|NCT01296711|363524328|FG002|Overall Study|Study termination|5|||
105415117|NCT01296711|363524329|FG003|Overall Study|Study termination|4|||
105415118|NCT01296711|363524330|FG004|Overall Study|Study termination|4|||
105415119|NCT01296711|363524331|FG005|Overall Study|Study termination|4|||
105415120|NCT01296711|363524332|FG006|Overall Study|Study termination|8|||
105415121|NCT01296711|363524333|FG007|Overall Study|Study termination|10|||
105415122|NCT01296711|363524326|FG000|Overall Study|Continued elevated liver enzymes|0|||
105415123|NCT01296711|363524327|FG001|Overall Study|Continued elevated liver enzymes|0|||
105415124|NCT01296711|363524328|FG002|Overall Study|Continued elevated liver enzymes|0|||
105415125|NCT01296711|363524329|FG003|Overall Study|Continued elevated liver enzymes|1|||
105415126|NCT01296711|363524330|FG004|Overall Study|Continued elevated liver enzymes|0|||
105415127|NCT01296711|363524331|FG005|Overall Study|Continued elevated liver enzymes|0|||
105415128|NCT01296711|363524332|FG006|Overall Study|Continued elevated liver enzymes|0|||
105415129|NCT01296711|363524333|FG007|Overall Study|Continued elevated liver enzymes|0|||
105415130|NCT01296711|363524326|FG000|Overall Study|Methotrexate discontinued|0|||
105415131|NCT01296711|363524327|FG001|Overall Study|Methotrexate discontinued|0|||
105415132|NCT01296711|363524328|FG002|Overall Study|Methotrexate discontinued|0|||
105415133|NCT01296711|363524329|FG003|Overall Study|Methotrexate discontinued|1|||
105415134|NCT01296711|363524330|FG004|Overall Study|Methotrexate discontinued|0|||
105415135|NCT01296711|363524331|FG005|Overall Study|Methotrexate discontinued|0|||
105415136|NCT01296711|363524332|FG006|Overall Study|Methotrexate discontinued|0|||
105415137|NCT01296711|363524333|FG007|Overall Study|Methotrexate discontinued|0|||
105415138|NCT01296711|363524326|FG000|Overall Study|Investigator discretion|0|||
105415139|NCT01296711|363524327|FG001|Overall Study|Investigator discretion|0|||
105415140|NCT01296711|363524328|FG002|Overall Study|Investigator discretion|0|||
105415141|NCT01296711|363524329|FG003|Overall Study|Investigator discretion|0|||
105415142|NCT01296711|363524330|FG004|Overall Study|Investigator discretion|0|||
105415143|NCT01296711|363524331|FG005|Overall Study|Investigator discretion|0|||
105415144|NCT01296711|363524332|FG006|Overall Study|Investigator discretion|1|||
105415145|NCT01296711|363524333|FG007|Overall Study|Investigator discretion|0|||
105415146|NCT01296711|363524326|FG000|Overall Study|Other|0|||
105415147|NCT01296711|363524327|FG001|Overall Study|Other|0|||
105415148|NCT01296711|363524328|FG002|Overall Study|Other|0|||
105415149|NCT01296711|363524329|FG003|Overall Study|Other|0|||
105415150|NCT01296711|363524330|FG004|Overall Study|Other|0|||
105415151|NCT01296711|363524331|FG005|Overall Study|Other|0|||
105415152|NCT01296711|363524332|FG006|Overall Study|Other|1|||
105415153|NCT01296711|363524333|FG007|Overall Study|Other|0|||
105415154|NCT01296711|363524326|FG000|Overall Study|Required restricted steroid injections|0|||
105415155|NCT01296711|363524327|FG001|Overall Study|Required restricted steroid injections|0|||
105415156|NCT01296711|363524328|FG002|Overall Study|Required restricted steroid injections|0|||
105415157|NCT01296711|363524329|FG003|Overall Study|Required restricted steroid injections|0|||
105415158|NCT01296711|363524330|FG004|Overall Study|Required restricted steroid injections|0|||
105415159|NCT01296711|363524331|FG005|Overall Study|Required restricted steroid injections|0|||
105415160|NCT01296711|363524332|FG006|Overall Study|Required restricted steroid injections|1|||
105415161|NCT01296711|363524333|FG007|Overall Study|Required restricted steroid injections|0|||
105415162|NCT01296711|363524326|FG000|Overall Study|Ongoing missed appointments|0|||
105415163|NCT01296711|363524327|FG001|Overall Study|Ongoing missed appointments|0|||
105415164|NCT01296711|363524328|FG002|Overall Study|Ongoing missed appointments|0|||
105415165|NCT01296711|363524329|FG003|Overall Study|Ongoing missed appointments|0|||
105415166|NCT01296711|363524330|FG004|Overall Study|Ongoing missed appointments|0|||
105415167|NCT01296711|363524331|FG005|Overall Study|Ongoing missed appointments|0|||
105415168|NCT01296711|363524332|FG006|Overall Study|Ongoing missed appointments|1|||
105415169|NCT01296711|363524333|FG007|Overall Study|Ongoing missed appointments|0|||
105415170|NCT01296711|363524326|FG000|Overall Study|Failure to comply with visits|0|||
105415171|NCT01296711|363524327|FG001|Overall Study|Failure to comply with visits|0|||
105497701|NCT01890746|363834196|FG001|Overall Study|Physician Decision|2|||
105497702|NCT01890746|363834195|FG000|Overall Study|Withdrawal by Subject|5|||
105497703|NCT01890746|363834196|FG001|Overall Study|Withdrawal by Subject|8|||
105497704|NCT00631696|363834197|FG000|Overall Study|Entered, not randomized to treatment|1|||
105497705|NCT00631696|363834198|FG001|Overall Study|Entered, not randomized to treatment|1|||
105497706|NCT00631696|363834197|FG000|Overall Study|Discontinued after database release date|1|||
105497707|NCT00631696|363834198|FG001|Overall Study|Discontinued after database release date|0|||
105497708|NCT00631696|363834197|FG000|Overall Study|Follow up after database release date|1|||
105497709|NCT00631696|363834198|FG001|Overall Study|Follow up after database release date|0|||
105497710|NCT00631696|363834197|FG000|Overall Study|Lost to Follow-up|7|||
105497711|NCT00631696|363834198|FG001|Overall Study|Lost to Follow-up|10|||
105497712|NCT00631696|363834197|FG000|Overall Study|Withdrawal by Subject|2|||
105497713|NCT00631696|363834198|FG001|Overall Study|Withdrawal by Subject|9|||
105497714|NCT00631696|363834197|FG000|Overall Study|Other|8|||
105497715|NCT00631696|363834198|FG001|Overall Study|Other|8|||
105497716|NCT00631696|363834197|FG000|Overall Study|Protocol Violation|9|||
105497717|NCT00631696|363834198|FG001|Overall Study|Protocol Violation|9|||
105497718|NCT00631696|363834197|FG000|Overall Study|Study terminated by sponsor|3|||
105497719|NCT00631696|363834198|FG001|Overall Study|Study terminated by sponsor|3|||
105497720|NCT00631696|363834197|FG000|Overall Study|Adverse Event|5|||
105497721|NCT00631696|363834198|FG001|Overall Study|Adverse Event|0|||
105497722|NCT05095454|363834200|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
105497723|NCT05095454|363834201|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
105497724|NCT01708161|363834211|FG000|Overall Study|Adverse Event|1|||
105497725|NCT01708161|363834212|FG001|Overall Study|Adverse Event|3|||
105497726|NCT01708161|363834213|FG002|Overall Study|Adverse Event|4|||
105497727|NCT01708161|363834214|FG003|Overall Study|Adverse Event|2|||
105497728|NCT01708161|363834215|FG004|Overall Study|Adverse Event|3|||
105497729|NCT01708161|363834216|FG005|Overall Study|Adverse Event|0|||
105497730|NCT01708161|363834211|FG000|Overall Study|Death|0|||
105497731|NCT01708161|363834212|FG001|Overall Study|Death|0|||
105497732|NCT01708161|363834213|FG002|Overall Study|Death|0|||
105497733|NCT01708161|363834214|FG003|Overall Study|Death|1|||
105497734|NCT01708161|363834215|FG004|Overall Study|Death|0|||
105497735|NCT01708161|363834216|FG005|Overall Study|Death|1|||
105497736|NCT01708161|363834211|FG000|Overall Study|Withdrawal by Subject|0|||
105497737|NCT01708161|363834212|FG001|Overall Study|Withdrawal by Subject|1|||
105497738|NCT01708161|363834213|FG002|Overall Study|Withdrawal by Subject|1|||
105497739|NCT01708161|363834214|FG003|Overall Study|Withdrawal by Subject|0|||
105497740|NCT01708161|363834215|FG004|Overall Study|Withdrawal by Subject|0|||
105497741|NCT01708161|363834216|FG005|Overall Study|Withdrawal by Subject|0|||
105497742|NCT01708161|363834211|FG000|Overall Study|Administrative problems|0|||
105497743|NCT01708161|363834212|FG001|Overall Study|Administrative problems|1|||
105497744|NCT01708161|363834213|FG002|Overall Study|Administrative problems|0|||
105497745|NCT01708161|363834214|FG003|Overall Study|Administrative problems|0|||
105497746|NCT01708161|363834215|FG004|Overall Study|Administrative problems|0|||
105497747|NCT01708161|363834216|FG005|Overall Study|Administrative problems|0|||
105497748|NCT01708161|363834211|FG000|Overall Study|Disease progression|3|||
105497749|NCT01708161|363834212|FG001|Overall Study|Disease progression|5|||
105497750|NCT01708161|363834213|FG002|Overall Study|Disease progression|5|||
105497751|NCT01708161|363834214|FG003|Overall Study|Disease progression|13|||
105497752|NCT01708161|363834215|FG004|Overall Study|Disease progression|3|||
105497753|NCT01708161|363834216|FG005|Overall Study|Disease progression|0|||
105497754|NCT01268150|363834217|FG000|Treatment Phase|Progression of disease|18|||
105497755|NCT01268150|363834217|FG000|Treatment Phase|Adverse Event|3|||
105497756|NCT01268150|363834217|FG000|Treatment Phase|Withdrawal by Subject|3|||
105497757|NCT01268150|363834217|FG000|Treatment Phase|Other|4|||
105497758|NCT01268150|363834217|FG000|Extension Phase|Adverse Event|3|||
105497759|NCT01268150|363834217|FG000|Extension Phase|Disease progression|18|||
105497760|NCT01268150|363834217|FG000|Extension Phase|Other|6|||
105497761|NCT02435147|363834221|FG000|Overall Study|non-evaluable DXA scan|11|||
105497762|NCT00471146|363834222|FG000|Overall Study|Adverse Event|32|||
105497763|NCT00471146|363834223|FG001|Overall Study|Adverse Event|33|||
105497764|NCT00471146|363834222|FG000|Overall Study|Withdrawal by Subject|14|||
105497765|NCT00471146|363834223|FG001|Overall Study|Withdrawal by Subject|11|||
105497766|NCT00471146|363834222|FG000|Overall Study|Death|11|||
105497767|NCT00471146|363834223|FG001|Overall Study|Death|12|||
105497768|NCT00471146|363834222|FG000|Overall Study|Lost to Follow-up|4|||
105497769|NCT00471146|363834223|FG001|Overall Study|Lost to Follow-up|2|||
105497770|NCT00471146|363834222|FG000|Overall Study|Protocol Violation|2|||
105497771|NCT00471146|363834223|FG001|Overall Study|Protocol Violation|2|||
105497772|NCT00471146|363834222|FG000|Overall Study|Objective progression or relapse|84|||
105497773|NCT00471146|363834223|FG001|Overall Study|Objective progression or relapse|87|||
105497774|NCT00471146|363834222|FG000|Overall Study|Global deterioration of health status|12|||
105497775|NCT00471146|363834223|FG001|Overall Study|Global deterioration of health status|14|||
105497776|NCT00471146|363834222|FG000|Overall Study|Randomized but not treated|9|||
105497777|NCT00471146|363834223|FG001|Overall Study|Randomized but not treated|8|||
105415172|NCT01296711|363524328|FG002|Overall Study|Failure to comply with visits|0|||
105415173|NCT01296711|363524329|FG003|Overall Study|Failure to comply with visits|0|||
105415174|NCT01296711|363524330|FG004|Overall Study|Failure to comply with visits|0|||
105415175|NCT01296711|363524331|FG005|Overall Study|Failure to comply with visits|0|||
105415176|NCT01296711|363524332|FG006|Overall Study|Failure to comply with visits|0|||
105415177|NCT01296711|363524333|FG007|Overall Study|Failure to comply with visits|1|||
105415178|NCT01296711|363524326|FG000|Overall Study|Patient decision due to transport|0|||
105415179|NCT01296711|363524327|FG001|Overall Study|Patient decision due to transport|0|||
105415180|NCT01296711|363524328|FG002|Overall Study|Patient decision due to transport|0|||
105415181|NCT01296711|363524329|FG003|Overall Study|Patient decision due to transport|0|||
105415182|NCT01296711|363524330|FG004|Overall Study|Patient decision due to transport|0|||
105415183|NCT01296711|363524331|FG005|Overall Study|Patient decision due to transport|0|||
105415184|NCT01296711|363524332|FG006|Overall Study|Patient decision due to transport|0|||
105415185|NCT01296711|363524333|FG007|Overall Study|Patient decision due to transport|1|||
105415186|NCT03249909|363524334|FG000|Overall Study|Withdrawal by Subject|3|||
105415187|NCT03249909|363524335|FG001|Overall Study|Withdrawal by Subject|0|||
105415188|NCT03249909|363524336|FG002|Overall Study|Withdrawal by Subject|0|||
105415189|NCT03249909|363524334|FG000|Overall Study|Adverse Event|3|||
105415190|NCT03249909|363524335|FG001|Overall Study|Adverse Event|0|||
105415191|NCT03249909|363524336|FG002|Overall Study|Adverse Event|0|||
105415192|NCT03249909|363524334|FG000|Overall Study|Lost to Follow-up|0|||
105415193|NCT03249909|363524335|FG001|Overall Study|Lost to Follow-up|1|||
105415194|NCT03249909|363524336|FG002|Overall Study|Lost to Follow-up|0|||
105415195|NCT01854775|363524339|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
105415196|NCT01854775|363524340|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
105415197|NCT01854775|363524341|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
105415198|NCT01854775|363524339|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
105415199|NCT01854775|363524340|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
105415200|NCT01854775|363524341|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
105415201|NCT01854775|363524339|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
105415202|NCT01854775|363524340|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
105415203|NCT01854775|363524341|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
105415204|NCT01854775|363524339|FG000|Extension Phase|Pregnancy|3|||
105415205|NCT01854775|363524340|FG001|Extension Phase|Pregnancy|0|||
105415206|NCT01854775|363524341|FG002|Extension Phase|Pregnancy|0|||
105415207|NCT01854775|363524339|FG000|Extension Phase|Investigator's Discretion|1|||
105415208|NCT01854775|363524340|FG001|Extension Phase|Investigator's Discretion|0|||
105415209|NCT01854775|363524341|FG002|Extension Phase|Investigator's Discretion|0|||
105415210|NCT01854775|363524339|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
105415211|NCT01854775|363524340|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
105415212|NCT01854775|363524341|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
105415213|NCT01854775|363524339|FG000|Extension Phase|Lost to Follow-up|2|||
105415214|NCT01854775|363524340|FG001|Extension Phase|Lost to Follow-up|0|||
105415215|NCT01854775|363524341|FG002|Extension Phase|Lost to Follow-up|0|||
105415216|NCT01854775|363524339|FG000|Extension Phase|Still on Study|32|||
105415217|NCT01854775|363524340|FG001|Extension Phase|Still on Study|47|||
105415218|NCT01854775|363524341|FG002|Extension Phase|Still on Study|18|||
105415219|NCT05596734|363524342|FG000|Substudy A|Withdrawal by Subject|1|||
105415220|NCT05596734|363524343|FG001|Substudy A|Withdrawal by Subject|0|||
105415221|NCT05596734|363524344|FG002|Substudy A|Withdrawal by Subject|0|||
105415222|NCT05596734|363524345|FG003|Substudy A|Withdrawal by Subject|0|||
105415223|NCT05596734|363524346|FG004|Substudy A|Withdrawal by Subject|0|||
105415224|NCT05596734|363524347|FG005|Substudy A|Withdrawal by Subject|0|||
105415225|NCT05596734|363524348|FG006|Substudy A|Withdrawal by Subject|1|||
105415226|NCT05596734|363524349|FG007|Substudy A|Withdrawal by Subject|0|||
105415227|NCT05596734|363524350|FG008|Substudy A|Withdrawal by Subject|0|||
105497778|NCT00471146|363834222|FG000|Overall Study|Other|4|||
105497779|NCT00471146|363834223|FG001|Overall Study|Other|5|||
105497780|NCT02853344|363834228|FG000|Overall Study|Lost to Follow-up|1|||
105497781|NCT02853344|363834229|FG001|Overall Study|Lost to Follow-up|1|||
105497782|NCT02853344|363834228|FG000|Overall Study|Withdrawal by Subject|2|||
105497783|NCT02853344|363834229|FG001|Overall Study|Withdrawal by Subject|4|||
105497784|NCT02853344|363834228|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
105497785|NCT02853344|363834229|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
105497786|NCT02853344|363834228|FG000|Overall Study|Death|70|||
105497787|NCT02853344|363834229|FG001|Overall Study|Death|112|||
105497788|NCT02913612|363834230|FG000|Overall Study|Lost to Follow-up|6|||
105497789|NCT02913612|363834231|FG001|Overall Study|Lost to Follow-up|5|||
105497790|NCT02913612|363834232|FG002|Overall Study|Lost to Follow-up|2|||
105497791|NCT02913612|363834233|FG003|Overall Study|Lost to Follow-up|0|||
105497792|NCT02913612|363834230|FG000|Overall Study|Physician Decision|1|||
105497793|NCT02913612|363834231|FG001|Overall Study|Physician Decision|4|||
105497794|NCT02913612|363834232|FG002|Overall Study|Physician Decision|1|||
105497795|NCT02913612|363834233|FG003|Overall Study|Physician Decision|0|||
105497796|NCT02913612|363834230|FG000|Overall Study|Withdrawal by Subject|2|||
105582636|NCT03008122|364130091|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
105582637|NCT03008122|364130092|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
105582638|NCT03008122|364130090|FG000|Overall Study|Death|0|||
105582639|NCT03008122|364130091|FG001|Overall Study|Death|0|||
105582640|NCT03008122|364130092|FG002|Overall Study|Death|1|||
105582641|NCT04159896|364130093|FG000|Overall Study|Lack of Efficacy|7|||
105582642|NCT04159896|364130093|FG000|Overall Study|Withdrawal by Subject|1|||
105582643|NCT04159896|364130093|FG000|Overall Study|Adverse Event|1|||
105582644|NCT04159896|364130093|FG000|Overall Study|A transient ischaemic attack|1|||
105582645|NCT03473756|364130094|FG000|Overall Study|Withdrawal by Subject|1|||
105582646|NCT03473756|364130095|FG001|Overall Study|Withdrawal by Subject|4|||
105582647|NCT03473756|364130094|FG000|Overall Study|Adverse Event|6|||
105415228|NCT05596734|363524351|FG009|Substudy A|Withdrawal by Subject|0|||
105415229|NCT05596734|363524352|FG010|Substudy A|Withdrawal by Subject|0|||
105582648|NCT03473756|364130095|FG001|Overall Study|Adverse Event|7|||
105582649|NCT03473756|364130094|FG000|Overall Study|Lack of Efficacy|3|||
105582650|NCT03473756|364130095|FG001|Overall Study|Lack of Efficacy|10|||
105582651|NCT03473756|364130094|FG000|Overall Study|Physician Decision|0|||
105582652|NCT03473756|364130095|FG001|Overall Study|Physician Decision|2|||
105582653|NCT03473756|364130094|FG000|Overall Study|End of study treatment|0|||
105582654|NCT03473756|364130095|FG001|Overall Study|End of study treatment|2|||
105582655|NCT03473756|364130094|FG000|Overall Study|Lost to Follow-up|0|||
105582656|NCT03473756|364130095|FG001|Overall Study|Lost to Follow-up|1|||
105582657|NCT01449721|364130096|FG000|Overall Study|Physician Decision|0|||
105582658|NCT01449721|364130097|FG001|Overall Study|Physician Decision|1|||
105582659|NCT01449721|364130096|FG000|Overall Study|Physician Decision|0|||
105582660|NCT01449721|364130097|FG001|Overall Study|Physician Decision|1|||
105582661|NCT00885495|364130098|FG000|Overall Study|Adverse Event|1|||
105582662|NCT00885495|364130099|FG001|Overall Study|Adverse Event|2|||
105582663|NCT00885495|364130098|FG000|Overall Study|Protocol Violation|0|||
105582664|NCT00885495|364130099|FG001|Overall Study|Protocol Violation|1|||
105582665|NCT00885495|364130098|FG000|Overall Study|Withdrawal by Subject|1|||
105582666|NCT00885495|364130099|FG001|Overall Study|Withdrawal by Subject|0|||
105582667|NCT01400893|364130100|FG000|Overall Study|Death|27|||
105582668|NCT01400893|364130101|FG001|Overall Study|Death|21|||
105582669|NCT01400893|364130100|FG000|Overall Study|Lost to Follow-up|0|||
105582670|NCT01400893|364130101|FG001|Overall Study|Lost to Follow-up|6|||
105582671|NCT01513967|364130102|FG000|Overall Study|Pregnancy|0|||
105582672|NCT01513967|364130103|FG001|Overall Study|Pregnancy|0|||
105582673|NCT01513967|364130104|FG002|Overall Study|Pregnancy|0|||
105582674|NCT01513967|364130105|FG003|Overall Study|Pregnancy|0|||
105582675|NCT01513967|364130106|FG004|Overall Study|Pregnancy|0|||
105582676|NCT01513967|364130107|FG005|Overall Study|Pregnancy|0|||
105582677|NCT01513967|364130108|FG006|Overall Study|Pregnancy|1|||
105582678|NCT01513967|364130109|FG007|Overall Study|Pregnancy|0|||
105582679|NCT01513967|364130102|FG000|Overall Study|missed a study visit|0|||
105582680|NCT01513967|364130103|FG001|Overall Study|missed a study visit|0|||
105582681|NCT01513967|364130104|FG002|Overall Study|missed a study visit|0|||
105582682|NCT01513967|364130105|FG003|Overall Study|missed a study visit|0|||
105582683|NCT01513967|364130106|FG004|Overall Study|missed a study visit|0|||
105582684|NCT01513967|364130107|FG005|Overall Study|missed a study visit|0|||
105582685|NCT01513967|364130108|FG006|Overall Study|missed a study visit|1|||
105582686|NCT01513967|364130109|FG007|Overall Study|missed a study visit|0|||
105582687|NCT01513967|364130102|FG000|Overall Study|excluded due to positive drug screen|0|||
105582688|NCT01513967|364130103|FG001|Overall Study|excluded due to positive drug screen|0|||
105582689|NCT01513967|364130104|FG002|Overall Study|excluded due to positive drug screen|0|||
105582690|NCT01513967|364130105|FG003|Overall Study|excluded due to positive drug screen|0|||
105582691|NCT01513967|364130106|FG004|Overall Study|excluded due to positive drug screen|0|||
105582692|NCT01513967|364130107|FG005|Overall Study|excluded due to positive drug screen|0|||
105415230|NCT05596734|363524353|FG011|Substudy A|Withdrawal by Subject|0|||
105415231|NCT05596734|363524354|FG012|Substudy A|Withdrawal by Subject|0|||
105582693|NCT01513967|364130108|FG006|Overall Study|excluded due to positive drug screen|0|||
105582694|NCT01513967|364130109|FG007|Overall Study|excluded due to positive drug screen|2|||
105582695|NCT01513967|364130102|FG000|Overall Study|Physician Decision|0|||
105582696|NCT01513967|364130103|FG001|Overall Study|Physician Decision|0|||
105582697|NCT01513967|364130104|FG002|Overall Study|Physician Decision|0|||
105582698|NCT01513967|364130105|FG003|Overall Study|Physician Decision|0|||
105582699|NCT01513967|364130106|FG004|Overall Study|Physician Decision|0|||
105582700|NCT01513967|364130107|FG005|Overall Study|Physician Decision|1|||
105582701|NCT01513967|364130108|FG006|Overall Study|Physician Decision|0|||
105582702|NCT01513967|364130109|FG007|Overall Study|Physician Decision|0|||
105582703|NCT02322775|364130110|FG000|Overall Study|Adverse Event|1|||
105582704|NCT02322775|364130111|FG001|Overall Study|Adverse Event|0|||
105582705|NCT02322775|364130110|FG000|Overall Study|Lost to Follow-up|0|||
105582706|NCT02322775|364130111|FG001|Overall Study|Lost to Follow-up|1|||
105415232|NCT05596734|363524355|FG013|Substudy A|Withdrawal by Subject|0|||
105582707|NCT02322775|364130110|FG000|Overall Study|Protocol Violation|1|||
105582708|NCT02322775|364130111|FG001|Overall Study|Protocol Violation|0|||
105582709|NCT02322775|364130110|FG000|Overall Study|Withdrawal by Subject|3|||
105582710|NCT02322775|364130111|FG001|Overall Study|Withdrawal by Subject|4|||
105582711|NCT02322775|364130110|FG000|Overall Study|Not willing to perform all FU visits|0|||
105582712|NCT02322775|364130111|FG001|Overall Study|Not willing to perform all FU visits|1|||
105582713|NCT02711826|364130112|FG000|Overall Study|Physician Decision|0|||
105582714|NCT02711826|364130113|FG001|Overall Study|Physician Decision|0|||
105582715|NCT02711826|364130114|FG002|Overall Study|Physician Decision|0|||
105582716|NCT02711826|364130115|FG003|Overall Study|Physician Decision|1|||
105582717|NCT02711826|364130116|FG004|Overall Study|Physician Decision|0|||
105582718|NCT02711826|364130112|FG000|Overall Study|Withdrawal by Subject|0|||
105582719|NCT02711826|364130113|FG001|Overall Study|Withdrawal by Subject|1|||
105582720|NCT02711826|364130114|FG002|Overall Study|Withdrawal by Subject|0|||
105582721|NCT02711826|364130115|FG003|Overall Study|Withdrawal by Subject|4|||
105582722|NCT02711826|364130116|FG004|Overall Study|Withdrawal by Subject|0|||
105582723|NCT02711826|364130112|FG000|Overall Study|Failure to manufacture cellular product|0|||
105582724|NCT02711826|364130113|FG001|Overall Study|Failure to manufacture cellular product|0|||
105582725|NCT02711826|364130114|FG002|Overall Study|Failure to manufacture cellular product|5|||
105582726|NCT02711826|364130115|FG003|Overall Study|Failure to manufacture cellular product|0|||
105582727|NCT02711826|364130116|FG004|Overall Study|Failure to manufacture cellular product|0|||
105582728|NCT02711826|364130112|FG000|Overall Study|Infusion canceled for active infection|0|||
105582729|NCT02711826|364130113|FG001|Overall Study|Infusion canceled for active infection|1|||
105582730|NCT02711826|364130114|FG002|Overall Study|Infusion canceled for active infection|0|||
105582731|NCT02711826|364130115|FG003|Overall Study|Infusion canceled for active infection|0|||
105582732|NCT02711826|364130116|FG004|Overall Study|Infusion canceled for active infection|0|||
105582733|NCT02711826|364130112|FG000|Overall Study|Screen failures|0|||
105582734|NCT02711826|364130113|FG001|Overall Study|Screen failures|0|||
105582735|NCT02711826|364130114|FG002|Overall Study|Screen failures|0|||
105582736|NCT02711826|364130115|FG003|Overall Study|Screen failures|4|||
105582737|NCT02711826|364130116|FG004|Overall Study|Screen failures|0|||
105582738|NCT02906202|364130117|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
105582739|NCT00729690|364130120|FG000|Overall Study|IT Catheter Malfunction|0|||
105582740|NCT00729690|364130121|FG001|Overall Study|IT Catheter Malfunction|2|||
105582741|NCT00729690|364130122|FG002|Overall Study|IT Catheter Malfunction|2|||
105582742|NCT00442286|364130123|FG000|Overall Study|Death|2|||
105582743|NCT00442286|364130124|FG001|Overall Study|Death|2|||
105582744|NCT00442286|364130123|FG000|Overall Study|Lost to Follow-up|1|||
105582745|NCT00442286|364130124|FG001|Overall Study|Lost to Follow-up|0|||
105582746|NCT00442286|364130123|FG000|Overall Study|Withdrawal by Subject|2|||
105582747|NCT00442286|364130124|FG001|Overall Study|Withdrawal by Subject|0|||
105582748|NCT00442286|364130123|FG000|Overall Study|System explanted|1|||
105582749|NCT00442286|364130124|FG001|Overall Study|System explanted|0|||
105582750|NCT00442286|364130123|FG000|Overall Study|Patient Injury|1|||
105582751|NCT00442286|364130124|FG001|Overall Study|Patient Injury|0|||
105582752|NCT01388543|364130125|FG000|Day 14|Adverse Event|1|||
105582753|NCT01388543|364130126|FG001|Day 14|Adverse Event|4|||
105626668|NCT04167553|364298146|FG006|Overall Study|Withdrawal by Subject|0|||
105626669|NCT04167553|364298140|FG000|Overall Study|Physician Decision|0|||
105626670|NCT04167553|364298141|FG001|Overall Study|Physician Decision|0|||
105626671|NCT04167553|364298142|FG002|Overall Study|Physician Decision|0|||
105626672|NCT04167553|364298143|FG003|Overall Study|Physician Decision|0|||
105626673|NCT04167553|364298144|FG004|Overall Study|Physician Decision|2|||
105626674|NCT04167553|364298145|FG005|Overall Study|Physician Decision|2|||
105626675|NCT04167553|364298146|FG006|Overall Study|Physician Decision|0|||
105626676|NCT04167553|364298140|FG000|Overall Study|Lost to Follow-up|0|||
105626677|NCT04167553|364298141|FG001|Overall Study|Lost to Follow-up|0|||
105626678|NCT04167553|364298142|FG002|Overall Study|Lost to Follow-up|2|||
105626679|NCT04167553|364298143|FG003|Overall Study|Lost to Follow-up|0|||
105626680|NCT04167553|364298144|FG004|Overall Study|Lost to Follow-up|0|||
105626681|NCT04167553|364298145|FG005|Overall Study|Lost to Follow-up|0|||
105626682|NCT04167553|364298146|FG006|Overall Study|Lost to Follow-up|0|||
105626683|NCT03174275|364298150|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
105626684|NCT03174275|364298150|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
105626685|NCT03174275|364298150|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
105626686|NCT03174275|364298150|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
105626687|NCT03174275|364298150|FG000|Adjuvant Chemotherapy|Progression|1|||
105626688|NCT03174275|364298150|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
105626689|NCT03174275|364298150|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
105626690|NCT03174275|364298150|FG000|Adjuvant Durvalumab|Progression|1|||
105626691|NCT03174275|364298150|FG000|Adjuvant Durvalumab|Adverse Event|3|||
105415233|NCT05596734|363524356|FG014|Substudy A|Withdrawal by Subject|0|||
105626692|NCT03174275|364298150|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
105626693|NCT03174275|364298150|FG000|Adjuvant Radiotherapy|Progression|1|||
105626694|NCT03174275|364298150|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
105415234|NCT05596734|363524357|FG015|Substudy A|Withdrawal by Subject|0|||
105415235|NCT05596734|363524358|FG016|Substudy A|Withdrawal by Subject|0|||
105415236|NCT05596734|363524359|FG017|Substudy A|Withdrawal by Subject|0|||
105415237|NCT05596734|363524360|FG018|Substudy A|Withdrawal by Subject|0|||
105415238|NCT05596734|363524361|FG019|Substudy A|Withdrawal by Subject|0|||
105415239|NCT05596734|363524362|FG020|Substudy A|Withdrawal by Subject|0|||
105415240|NCT05596734|363524363|FG021|Substudy A|Withdrawal by Subject|0|||
105415241|NCT05596734|363524364|FG022|Substudy A|Withdrawal by Subject|0|||
105415242|NCT05596734|363524365|FG023|Substudy A|Withdrawal by Subject|0|||
105415243|NCT05596734|363524342|FG000|Substudy A|Lost to Follow-up|1|||
105415244|NCT05596734|363524343|FG001|Substudy A|Lost to Follow-up|0|||
105415245|NCT05596734|363524344|FG002|Substudy A|Lost to Follow-up|1|||
105415246|NCT05596734|363524345|FG003|Substudy A|Lost to Follow-up|0|||
105415247|NCT05596734|363524346|FG004|Substudy A|Lost to Follow-up|0|||
105415248|NCT05596734|363524347|FG005|Substudy A|Lost to Follow-up|0|||
105415249|NCT05596734|363524348|FG006|Substudy A|Lost to Follow-up|0|||
105415250|NCT05596734|363524349|FG007|Substudy A|Lost to Follow-up|0|||
105415251|NCT05596734|363524350|FG008|Substudy A|Lost to Follow-up|0|||
105415252|NCT05596734|363524351|FG009|Substudy A|Lost to Follow-up|0|||
105415253|NCT05596734|363524352|FG010|Substudy A|Lost to Follow-up|0|||
105415254|NCT05596734|363524353|FG011|Substudy A|Lost to Follow-up|0|||
105415255|NCT05596734|363524354|FG012|Substudy A|Lost to Follow-up|0|||
105415256|NCT05596734|363524355|FG013|Substudy A|Lost to Follow-up|0|||
105415257|NCT05596734|363524356|FG014|Substudy A|Lost to Follow-up|0|||
105415258|NCT05596734|363524357|FG015|Substudy A|Lost to Follow-up|0|||
105415259|NCT05596734|363524358|FG016|Substudy A|Lost to Follow-up|0|||
105415260|NCT05596734|363524359|FG017|Substudy A|Lost to Follow-up|0|||
105415261|NCT05596734|363524360|FG018|Substudy A|Lost to Follow-up|0|||
105415262|NCT05596734|363524361|FG019|Substudy A|Lost to Follow-up|0|||
105415263|NCT05596734|363524362|FG020|Substudy A|Lost to Follow-up|0|||
105415264|NCT05596734|363524363|FG021|Substudy A|Lost to Follow-up|0|||
105497797|NCT02913612|363834231|FG001|Overall Study|Withdrawal by Subject|4|||
105497798|NCT02913612|363834232|FG002|Overall Study|Withdrawal by Subject|0|||
105497799|NCT02913612|363834233|FG003|Overall Study|Withdrawal by Subject|0|||
105497800|NCT02913612|363834230|FG000|Overall Study|Hemangioma resolved|1|||
105497801|NCT02913612|363834231|FG001|Overall Study|Hemangioma resolved|0|||
105497802|NCT02913612|363834232|FG002|Overall Study|Hemangioma resolved|0|||
105497803|NCT02913612|363834233|FG003|Overall Study|Hemangioma resolved|0|||
105497804|NCT02913612|363834230|FG000|Overall Study|Local IRB decision|1|||
105497805|NCT02913612|363834231|FG001|Overall Study|Local IRB decision|0|||
105497806|NCT02913612|363834232|FG002|Overall Study|Local IRB decision|0|||
105497807|NCT02913612|363834233|FG003|Overall Study|Local IRB decision|0|||
105497808|NCT02913612|363834230|FG000|Overall Study|Study drug non-compliance|1|||
105497809|NCT02913612|363834231|FG001|Overall Study|Study drug non-compliance|1|||
105497810|NCT02913612|363834232|FG002|Overall Study|Study drug non-compliance|0|||
105497811|NCT02913612|363834233|FG003|Overall Study|Study drug non-compliance|0|||
105497812|NCT02913612|363834230|FG000|Overall Study|Insurance issues|0|||
105497813|NCT02913612|363834231|FG001|Overall Study|Insurance issues|1|||
105497814|NCT02913612|363834232|FG002|Overall Study|Insurance issues|0|||
105497815|NCT02913612|363834233|FG003|Overall Study|Insurance issues|0|||
105497816|NCT02913612|363834230|FG000|Overall Study|Needed to treat second hemangioma|0|||
105497817|NCT02913612|363834231|FG001|Overall Study|Needed to treat second hemangioma|1|||
105497818|NCT02913612|363834232|FG002|Overall Study|Needed to treat second hemangioma|0|||
105497819|NCT02913612|363834233|FG003|Overall Study|Needed to treat second hemangioma|0|||
105497820|NCT02913612|363834230|FG000|Overall Study|Study completion criteria not met|0|||
105497821|NCT02913612|363834231|FG001|Overall Study|Study completion criteria not met|1|||
105497822|NCT02913612|363834232|FG002|Overall Study|Study completion criteria not met|0|||
105497823|NCT02913612|363834233|FG003|Overall Study|Study completion criteria not met|0|||
105497824|NCT02913612|363834230|FG000|Overall Study|Ineligible|0|||
105497825|NCT02913612|363834231|FG001|Overall Study|Ineligible|1|||
105415265|NCT05596734|363524364|FG022|Substudy A|Lost to Follow-up|0|||
105415266|NCT05596734|363524365|FG023|Substudy A|Lost to Follow-up|0|||
105415267|NCT05596734|363524342|FG000|Substudy B|Withdrawal by Subject|0|||
105415268|NCT05596734|363524343|FG001|Substudy B|Withdrawal by Subject|0|||
105415269|NCT05596734|363524344|FG002|Substudy B|Withdrawal by Subject|0|||
105415270|NCT05596734|363524345|FG003|Substudy B|Withdrawal by Subject|0|||
105415271|NCT05596734|363524346|FG004|Substudy B|Withdrawal by Subject|0|||
105415272|NCT05596734|363524347|FG005|Substudy B|Withdrawal by Subject|0|||
105415273|NCT05596734|363524348|FG006|Substudy B|Withdrawal by Subject|0|||
105415274|NCT05596734|363524349|FG007|Substudy B|Withdrawal by Subject|0|||
105415275|NCT05596734|363524350|FG008|Substudy B|Withdrawal by Subject|0|||
105415276|NCT05596734|363524351|FG009|Substudy B|Withdrawal by Subject|0|||
105497826|NCT02913612|363834232|FG002|Overall Study|Ineligible|0|||
105497827|NCT02913612|363834233|FG003|Overall Study|Ineligible|0|||
105497828|NCT00071396|363834234|FG000|Overall Study|Withdrawal by Subject|1|||
105497829|NCT00071396|363834234|FG000|Overall Study|Physician Decision|2|||
105497830|NCT00839852|363834235|FG000|Overall Study|Adverse Event|10|||
105497831|NCT00839852|363834235|FG000|Overall Study|Insufficient Therapeutic Response|3|||
105497832|NCT00839852|363834235|FG000|Overall Study|Protocol Violation|9|||
105415277|NCT05596734|363524352|FG010|Substudy B|Withdrawal by Subject|0|||
105415278|NCT05596734|363524353|FG011|Substudy B|Withdrawal by Subject|0|||
105415279|NCT05596734|363524354|FG012|Substudy B|Withdrawal by Subject|1|||
105415280|NCT05596734|363524355|FG013|Substudy B|Withdrawal by Subject|0|||
105415281|NCT05596734|363524356|FG014|Substudy B|Withdrawal by Subject|1|||
105415282|NCT05596734|363524357|FG015|Substudy B|Withdrawal by Subject|2|||
105415283|NCT05596734|363524358|FG016|Substudy B|Withdrawal by Subject|2|||
105415284|NCT05596734|363524359|FG017|Substudy B|Withdrawal by Subject|1|||
105415285|NCT05596734|363524360|FG018|Substudy B|Withdrawal by Subject|2|||
105415286|NCT05596734|363524361|FG019|Substudy B|Withdrawal by Subject|0|||
105415287|NCT05596734|363524362|FG020|Substudy B|Withdrawal by Subject|0|||
105415288|NCT05596734|363524363|FG021|Substudy B|Withdrawal by Subject|0|||
105415289|NCT05596734|363524364|FG022|Substudy B|Withdrawal by Subject|0|||
105415290|NCT05596734|363524365|FG023|Substudy B|Withdrawal by Subject|1|||
105415291|NCT05596734|363524342|FG000|Substudy B|Physician Decision|0|||
105415292|NCT05596734|363524343|FG001|Substudy B|Physician Decision|0|||
105415293|NCT05596734|363524344|FG002|Substudy B|Physician Decision|0|||
105415294|NCT05596734|363524345|FG003|Substudy B|Physician Decision|0|||
105415295|NCT05596734|363524346|FG004|Substudy B|Physician Decision|0|||
105415296|NCT05596734|363524347|FG005|Substudy B|Physician Decision|0|||
105415297|NCT05596734|363524348|FG006|Substudy B|Physician Decision|0|||
105415298|NCT05596734|363524349|FG007|Substudy B|Physician Decision|0|||
105415299|NCT05596734|363524350|FG008|Substudy B|Physician Decision|0|||
105415300|NCT05596734|363524351|FG009|Substudy B|Physician Decision|0|||
105415301|NCT05596734|363524352|FG010|Substudy B|Physician Decision|0|||
105415302|NCT05596734|363524353|FG011|Substudy B|Physician Decision|0|||
105415303|NCT05596734|363524354|FG012|Substudy B|Physician Decision|0|||
105415304|NCT05596734|363524355|FG013|Substudy B|Physician Decision|0|||
105415305|NCT05596734|363524356|FG014|Substudy B|Physician Decision|0|||
105415306|NCT05596734|363524357|FG015|Substudy B|Physician Decision|1|||
105415307|NCT05596734|363524358|FG016|Substudy B|Physician Decision|0|||
105415308|NCT05596734|363524359|FG017|Substudy B|Physician Decision|0|||
105415309|NCT05596734|363524360|FG018|Substudy B|Physician Decision|0|||
105415310|NCT05596734|363524361|FG019|Substudy B|Physician Decision|0|||
105415311|NCT05596734|363524362|FG020|Substudy B|Physician Decision|0|||
105415312|NCT05596734|363524363|FG021|Substudy B|Physician Decision|0|||
105415313|NCT05596734|363524364|FG022|Substudy B|Physician Decision|0|||
105415314|NCT05596734|363524365|FG023|Substudy B|Physician Decision|0|||
105415315|NCT05596734|363524342|FG000|Substudy B|Lost to Follow-up|0|||
105415316|NCT05596734|363524343|FG001|Substudy B|Lost to Follow-up|0|||
105415317|NCT05596734|363524344|FG002|Substudy B|Lost to Follow-up|0|||
105415318|NCT05596734|363524345|FG003|Substudy B|Lost to Follow-up|0|||
105415319|NCT05596734|363524346|FG004|Substudy B|Lost to Follow-up|0|||
105415320|NCT05596734|363524347|FG005|Substudy B|Lost to Follow-up|0|||
105415321|NCT05596734|363524348|FG006|Substudy B|Lost to Follow-up|0|||
105415322|NCT05596734|363524349|FG007|Substudy B|Lost to Follow-up|0|||
105415323|NCT05596734|363524350|FG008|Substudy B|Lost to Follow-up|0|||
105415324|NCT05596734|363524351|FG009|Substudy B|Lost to Follow-up|0|||
105415325|NCT05596734|363524352|FG010|Substudy B|Lost to Follow-up|0|||
105415326|NCT05596734|363524353|FG011|Substudy B|Lost to Follow-up|0|||
105415327|NCT05596734|363524354|FG012|Substudy B|Lost to Follow-up|1|||
105415328|NCT05596734|363524355|FG013|Substudy B|Lost to Follow-up|0|||
105415329|NCT05596734|363524356|FG014|Substudy B|Lost to Follow-up|1|||
105415330|NCT05596734|363524357|FG015|Substudy B|Lost to Follow-up|1|||
105415331|NCT05596734|363524358|FG016|Substudy B|Lost to Follow-up|0|||
105415332|NCT05596734|363524359|FG017|Substudy B|Lost to Follow-up|0|||
105415333|NCT05596734|363524360|FG018|Substudy B|Lost to Follow-up|0|||
105415334|NCT05596734|363524361|FG019|Substudy B|Lost to Follow-up|0|||
105415335|NCT05596734|363524362|FG020|Substudy B|Lost to Follow-up|0|||
105415336|NCT05596734|363524363|FG021|Substudy B|Lost to Follow-up|0|||
105415337|NCT05596734|363524364|FG022|Substudy B|Lost to Follow-up|0|||
105415338|NCT05596734|363524365|FG023|Substudy B|Lost to Follow-up|0|||
105415339|NCT02059499|363524366|FG000|Upto Week 20|Lost to Follow-up|2|||
105415340|NCT02059499|363524367|FG001|Upto Week 20|Lost to Follow-up|6|||
105415341|NCT02059499|363524368|FG002|Upto Week 20|Lost to Follow-up|0|||
105415342|NCT02059499|363524366|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
105415343|NCT02059499|363524367|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
105415344|NCT02059499|363524368|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
105415345|NCT02059499|363524366|FG000|Upto Week 20|Withdrawal by Subject|1|||
105415346|NCT02059499|363524367|FG001|Upto Week 20|Withdrawal by Subject|1|||
105415347|NCT02059499|363524368|FG002|Upto Week 20|Withdrawal by Subject|0|||
105415348|NCT02059499|363524366|FG000|Upto Week 20|No treatment per protocol criteria|0|||
105415349|NCT02059499|363524367|FG001|Upto Week 20|No treatment per protocol criteria|0|||
105582754|NCT00163215|364131661|FG000|Overall Study|Lack of Efficacy|3|||
105415350|NCT02059499|363524368|FG002|Upto Week 20|No treatment per protocol criteria|5|||
105415351|NCT02059499|363524366|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
105415352|NCT02059499|363524367|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
105582755|NCT00163215|364131661|FG000|Overall Study|Withdrawal by Subject|5|||
105582756|NCT00163215|364131661|FG000|Overall Study|Other|7|||
105582757|NCT01268059|364131666|FG000|Overall Study|Lost to Follow-up|0|||
105582758|NCT01268059|364131667|FG001|Overall Study|Lost to Follow-up|1|||
105582759|NCT01268059|364131668|FG002|Overall Study|Lost to Follow-up|0|||
105582760|NCT01268059|364131669|FG003|Overall Study|Lost to Follow-up|0|||
105582761|NCT01268059|364131666|FG000|Overall Study|Withdrawal by Subject|7|||
105582762|NCT01268059|364131667|FG001|Overall Study|Withdrawal by Subject|4|||
105582763|NCT01268059|364131668|FG002|Overall Study|Withdrawal by Subject|0|||
105582764|NCT01268059|364131669|FG003|Overall Study|Withdrawal by Subject|0|||
105582765|NCT01268059|364131666|FG000|Overall Study|Death|20|||
105582766|NCT01268059|364131667|FG001|Overall Study|Death|30|||
105582767|NCT01268059|364131668|FG002|Overall Study|Death|3|||
105582768|NCT01268059|364131669|FG003|Overall Study|Death|5|||
105582769|NCT01268059|364131666|FG000|Overall Study|Progression of disease|1|||
105582770|NCT01268059|364131667|FG001|Overall Study|Progression of disease|0|||
105582771|NCT01268059|364131668|FG002|Overall Study|Progression of disease|0|||
105582772|NCT01268059|364131669|FG003|Overall Study|Progression of disease|0|||
105582773|NCT01155726|364131676|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
105582774|NCT01155726|364131677|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
105582775|NCT01155726|364131678|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
105582776|NCT01155726|364131679|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
105582777|NCT02424344|364131680|FG000|Overall Study|Lack of Efficacy|0|||
105582778|NCT02424344|364131681|FG001|Overall Study|Lack of Efficacy|1|||
105582779|NCT02424344|364131680|FG000|Overall Study|Withdrawal by Subject|2|||
105582780|NCT02424344|364131681|FG001|Overall Study|Withdrawal by Subject|1|||
105582781|NCT02424344|364131680|FG000|Overall Study|Lost to Follow-up|1|||
105582782|NCT02424344|364131681|FG001|Overall Study|Lost to Follow-up|0|||
105582783|NCT02424344|364131680|FG000|Overall Study|Adverse Event|4|||
105582784|NCT02424344|364131681|FG001|Overall Study|Adverse Event|8|||
105582785|NCT05257837|364131685|FG000|Overall Study|Excluded (did not find the guns)|4|||
105582786|NCT05257837|364131686|FG001|Overall Study|Excluded (did not find the guns)|2|||
105582787|NCT05257837|364131687|FG002|Overall Study|Excluded (did not find the guns)|4|||
105582788|NCT05257837|364131688|FG003|Overall Study|Excluded (did not find the guns)|0|||
105582789|NCT04822298|364131689|FG000|Overall Study|Death|3|||
105582790|NCT01781611|364131690|FG000|Overall Study|Adverse Event|4|||
105582791|NCT01781611|364131691|FG001|Overall Study|Adverse Event|0|||
105582792|NCT01333943|364131692|FG000|Overall Study|Known neuropathy|1|||
105582793|NCT01333943|364131693|FG001|Overall Study|Known neuropathy|0|||
105582794|NCT03639675|364131694|FG000|Overall Study|Withdrawal by Subject|1|||
105582795|NCT00262743|364131697|FG000|Overall Study|Adverse Event|0|||
105582796|NCT00262743|364131698|FG001|Overall Study|Adverse Event|9|||
105582797|NCT00262743|364131697|FG000|Overall Study|Disease progression|0|||
105582798|NCT00262743|364131698|FG001|Overall Study|Disease progression|3|||
105582799|NCT02373813|364131701|FG000|Run-In Period|Other, Not Specified|5|||
105582800|NCT02373813|364131702|FG001|Run-In Period|Other, Not Specified|0|||
105582801|NCT02373813|364131703|FG002|Run-In Period|Other, Not Specified|0|||
105582802|NCT02373813|364131704|FG003|Run-In Period|Other, Not Specified|0|||
105582803|NCT02373813|364131701|FG000|Run-In Period|Withdrawal by Subject|16|||
105582804|NCT02373813|364131702|FG001|Run-In Period|Withdrawal by Subject|0|||
105582805|NCT02373813|364131703|FG002|Run-In Period|Withdrawal by Subject|0|||
105415353|NCT02059499|363524368|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
105415354|NCT02059499|363524366|FG000|Post-week 20|Lost to Follow-up|0|||
105415355|NCT02059499|363524367|FG001|Post-week 20|Lost to Follow-up|2|||
105415356|NCT02059499|363524368|FG002|Post-week 20|Lost to Follow-up|0|||
105415357|NCT02059499|363524366|FG000|Post-week 20|Withdrawal by Subject|0|||
105415358|NCT02059499|363524367|FG001|Post-week 20|Withdrawal by Subject|1|||
105415359|NCT02059499|363524368|FG002|Post-week 20|Withdrawal by Subject|0|||
105415360|NCT02059499|363524366|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
105415361|NCT02059499|363524367|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
105415362|NCT02059499|363524368|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
105415363|NCT01892722|363524369|FG000|Overall Study|Protocol deviation|0|||
105415364|NCT01892722|363524370|FG001|Overall Study|Protocol deviation|1|||
105415365|NCT01892722|363524369|FG000|Overall Study|Administrative problems|0|||
105415366|NCT01892722|363524370|FG001|Overall Study|Administrative problems|1|||
105415367|NCT01892722|363524369|FG000|Overall Study|Patient/guardian decision|0|||
105415368|NCT01892722|363524370|FG001|Overall Study|Patient/guardian decision|2|||
105582806|NCT02373813|364131704|FG003|Run-In Period|Withdrawal by Subject|0|||
105582807|NCT02373813|364131701|FG000|Run-In Period|Decision by Sponsor|11|||
105582808|NCT02373813|364131702|FG001|Run-In Period|Decision by Sponsor|0|||
105582809|NCT02373813|364131703|FG002|Run-In Period|Decision by Sponsor|0|||
105415369|NCT01892722|363524369|FG000|Overall Study|Physician Decision|1|||
105582810|NCT02373813|364131704|FG003|Run-In Period|Decision by Sponsor|0|||
105582811|NCT02373813|364131701|FG000|Run-In Period|Protocol Violation|75|||
105582812|NCT02373813|364131702|FG001|Run-In Period|Protocol Violation|0|||
105582813|NCT02373813|364131703|FG002|Run-In Period|Protocol Violation|0|||
105582814|NCT02373813|364131704|FG003|Run-In Period|Protocol Violation|0|||
105582815|NCT02373813|364131701|FG000|Run-In Period|Lost to Follow-up|2|||
105415370|NCT01892722|363524370|FG001|Overall Study|Physician Decision|2|||
105415371|NCT01892722|363524369|FG000|Overall Study|Adverse Event|3|||
105415372|NCT01892722|363524370|FG001|Overall Study|Adverse Event|2|||
105415373|NCT01892722|363524369|FG000|Overall Study|Lack of Efficacy|0|||
105415374|NCT01892722|363524370|FG001|Overall Study|Lack of Efficacy|7|||
105415375|NCT01892722|363524369|FG000|Overall Study|Withdrawal by Subject|3|||
105415376|NCT01892722|363524370|FG001|Overall Study|Withdrawal by Subject|5|||
105415377|NCT05356910|363524371|FG000|Overall Study|Lost to Follow-up|10|||
105415378|NCT05356910|363524372|FG001|Overall Study|Lost to Follow-up|19|||
105415379|NCT05356910|363524373|FG002|Overall Study|Lost to Follow-up|0|||
105415380|NCT05356910|363524374|FG003|Overall Study|Lost to Follow-up|0|||
105415381|NCT05356910|363524371|FG000|Overall Study|Withdrawal by Subject|4|||
105415382|NCT05356910|363524372|FG001|Overall Study|Withdrawal by Subject|2|||
105415383|NCT05356910|363524373|FG002|Overall Study|Withdrawal by Subject|0|||
105415384|NCT05356910|363524374|FG003|Overall Study|Withdrawal by Subject|0|||
105415385|NCT03451851|363524378|FG000|PCP: Week 0 -16|Adverse Event|1|||
105415386|NCT03451851|363524379|FG001|PCP: Week 0 -16|Adverse Event|0|||
105415387|NCT03451851|363524380|FG002|PCP: Week 0 -16|Adverse Event|0|||
105415388|NCT03451851|363524381|FG003|PCP: Week 0 -16|Adverse Event|0|||
105415389|NCT03451851|363524382|FG004|PCP: Week 0 -16|Adverse Event|0|||
105415390|NCT03451851|363524383|FG005|PCP: Week 0 -16|Adverse Event|0|||
105415391|NCT03451851|363524384|FG006|PCP: Week 0 -16|Adverse Event|1|||
105415392|NCT03451851|363524385|FG007|PCP: Week 0 -16|Adverse Event|0|||
105415393|NCT03451851|363524378|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
105415394|NCT03451851|363524379|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
105415395|NCT03451851|363524380|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
105415396|NCT03451851|363524381|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
105415397|NCT03451851|363524382|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
105415398|NCT03451851|363524383|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
105415399|NCT03451851|363524384|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
105415400|NCT03451851|363524385|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
105415401|NCT03451851|363524378|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
105415402|NCT03451851|363524379|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
105415403|NCT03451851|363524380|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
105415404|NCT03451851|363524381|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
105415405|NCT03451851|363524382|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
105415406|NCT03451851|363524383|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
105415407|NCT03451851|363524384|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
105415408|NCT03451851|363524385|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
105415409|NCT03451851|363524378|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
105415410|NCT03451851|363524379|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
105415411|NCT03451851|363524380|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
105415412|NCT03451851|363524381|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
105415413|NCT03451851|363524382|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
105415414|NCT03451851|363524383|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
105415415|NCT03451851|363524384|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
105415416|NCT03451851|363524385|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
105415417|NCT03451851|363524378|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
105415418|NCT03451851|363524379|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
105415419|NCT03451851|363524380|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
105415420|NCT03451851|363524381|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
105415421|NCT03451851|363524382|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
105415422|NCT03451851|363524383|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
105415423|NCT03451851|363524384|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
105415424|NCT03451851|363524385|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
105415425|NCT03451851|363524378|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
105415426|NCT03451851|363524379|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
105415427|NCT03451851|363524380|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
105415428|NCT03451851|363524381|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
105415429|NCT03451851|363524382|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
105415430|NCT03451851|363524383|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
105497833|NCT00839852|363834235|FG000|Overall Study|Withdrawal of Consent|16|||
105415431|NCT03451851|363524384|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
105415432|NCT03451851|363524385|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
105415433|NCT02712983|363527467|FG000|Treatment Phase|Adverse Event|3|||
105415434|NCT02712983|363527468|FG001|Treatment Phase|Adverse Event|1|||
105497834|NCT00839852|363834235|FG000|Overall Study|Lost to Follow-up|7|||
105497835|NCT00839852|363834235|FG000|Overall Study|Lack of Compliance While in Jail|1|||
105497836|NCT00839852|363834235|FG000|Overall Study|Pregnancy|1|||
105497837|NCT03082261|363834236|FG000|Overall Study|Death|4|||
105497838|NCT03082261|363834236|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
105497839|NCT03082261|363834236|FG000|Overall Study|Insurance denial|1|||
105497840|NCT03082261|363834236|FG000|Overall Study|Peripheral lead added|1|||
105497841|NCT03082261|363834236|FG000|Overall Study|Withdrawal by Subject|40|||
105497842|NCT03082261|363834236|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
105497843|NCT03082261|363834236|FG000|Overall Study|Subject implanted with device other than study device|1|||
105497844|NCT03082261|363834236|FG000|Overall Study|Lost to Follow-up|14|||
105497845|NCT03082261|363834236|FG000|Overall Study|Subject moved to a different state|1|||
105497846|NCT03082261|363834236|FG000|Overall Study|Subject non-compliance|2|||
105497847|NCT03082261|363834236|FG000|Overall Study|Subject participation terminated by investigator|9|||
105497848|NCT03082261|363834236|FG000|Overall Study|Subject participation terminated by sponsor|4|||
105497849|NCT03082261|363834236|FG000|Overall Study|System explant|19|||
105497850|NCT03082261|363834236|FG000|Overall Study|Unable to place lead(s)|2|||
105497851|NCT03082261|363834236|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
105497852|NCT04545554|363834237|FG000|Overall Study|Withdrawal by Subject|0|||
105497853|NCT04545554|363834238|FG001|Overall Study|Withdrawal by Subject|0|||
105497854|NCT04545554|363834239|FG002|Overall Study|Withdrawal by Subject|0|||
105497855|NCT04545554|363834240|FG003|Overall Study|Withdrawal by Subject|1|||
105497856|NCT04545554|363834241|FG004|Overall Study|Withdrawal by Subject|0|||
105497857|NCT04545554|363834242|FG005|Overall Study|Withdrawal by Subject|0|||
105497858|NCT02478372|363834247|FG000|Overall Study|Protocol Violation|12|||
105497859|NCT02478372|363834248|FG001|Overall Study|Protocol Violation|8|||
105497860|NCT02478372|363834247|FG000|Overall Study|Lost to Follow-up|1|||
105497861|NCT02478372|363834248|FG001|Overall Study|Lost to Follow-up|4|||
105497862|NCT02478372|363834247|FG000|Overall Study|Death|0|||
105497863|NCT02478372|363834248|FG001|Overall Study|Death|2|||
105497864|NCT00116428|363834249|FG000|Overall Study|Withdrawal by Subject|2|||
105497865|NCT00116428|363834250|FG001|Overall Study|Withdrawal by Subject|5|||
105497866|NCT00116428|363834249|FG000|Overall Study|Did not meet inclusion criteria|1|||
105497867|NCT00116428|363834250|FG001|Overall Study|Did not meet inclusion criteria|0|||
105497868|NCT00386607|363834252|FG000|Core|Adverse Event|40|||
105497869|NCT00386607|363834253|FG001|Core|Adverse Event|0|||
105497870|NCT00386607|363834252|FG000|Core|Abnormal laboratory value(s)|3|||
105497871|NCT00386607|363834253|FG001|Core|Abnormal laboratory value(s)|0|||
105497872|NCT00386607|363834252|FG000|Core|Unsatisfactory therapeutic effect|23|||
105497873|NCT00386607|363834253|FG001|Core|Unsatisfactory therapeutic effect|0|||
105497874|NCT00386607|363834252|FG000|Core|Condition no longer requires study drug|4|||
105497875|NCT00386607|363834253|FG001|Core|Condition no longer requires study drug|0|||
105497876|NCT00386607|363834252|FG000|Core|Patient withdrew consent|15|||
105497877|NCT00386607|363834253|FG001|Core|Patient withdrew consent|0|||
105497878|NCT00386607|363834252|FG000|Core|Lost to Follow-up|23|||
105497879|NCT00386607|363834253|FG001|Core|Lost to Follow-up|0|||
105497880|NCT00386607|363834252|FG000|Core|Administrative problems|1|||
105497881|NCT00386607|363834253|FG001|Core|Administrative problems|0|||
105497882|NCT00386607|363834252|FG000|Core|Protocol Deviation|6|||
105497883|NCT00386607|363834253|FG001|Core|Protocol Deviation|0|||
105497884|NCT00386607|363834252|FG000|Extension|Adverse Event|0|||
105497885|NCT00386607|363834253|FG001|Extension|Adverse Event|6|||
105497886|NCT00386607|363834252|FG000|Extension|Abnormal laboratory value(s)|0|||
105497887|NCT00386607|363834253|FG001|Extension|Abnormal laboratory value(s)|1|||
105497888|NCT00386607|363834252|FG000|Extension|Administrative problems|0|||
105497889|NCT00386607|363834253|FG001|Extension|Administrative problems|1|||
105497890|NCT00386607|363834252|FG000|Extension|Lost to Follow-up|0|||
105497891|NCT00386607|363834253|FG001|Extension|Lost to Follow-up|3|||
105497892|NCT00386607|363834252|FG000|Extension|Patient withdrew consent|0|||
105497893|NCT00386607|363834253|FG001|Extension|Patient withdrew consent|5|||
105497894|NCT00386607|363834252|FG000|Extension|Unsatisfactory therapeutic effect|0|||
105497895|NCT00386607|363834253|FG001|Extension|Unsatisfactory therapeutic effect|1|||
105497896|NCT01262573|363834254|FG000|Overall Study|Withdrawal by Subject|0|||
105497897|NCT01262573|363834255|FG001|Overall Study|Withdrawal by Subject|1|||
105497898|NCT01986907|363834258|FG000|Overall Study|Adverse Event|11|||
105497899|NCT01986907|363834258|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
105497900|NCT01986907|363834258|FG000|Overall Study|Protocol Violation|4|||
105497901|NCT01986907|363834258|FG000|Overall Study|Withdrawal by Subject|76|||
105497902|NCT01986907|363834258|FG000|Overall Study|Lost to Follow-up|38|||
105497903|NCT01986907|363834258|FG000|Overall Study|Death|9|||
105497904|NCT00810693|363834261|FG000|Treatment Period|Adverse Event|8|||
105497905|NCT00810693|363834262|FG001|Treatment Period|Adverse Event|1|||
105497906|NCT00810693|363834263|FG002|Treatment Period|Adverse Event|7|||
105497907|NCT00810693|363834261|FG000|Treatment Period|Death|0|||
105497908|NCT00810693|363834262|FG001|Treatment Period|Death|1|||
105497909|NCT00810693|363834263|FG002|Treatment Period|Death|2|||
105497910|NCT00810693|363834261|FG000|Treatment Period|Lack of Efficacy|0|||
105582816|NCT02373813|364131702|FG001|Run-In Period|Lost to Follow-up|0|||
105582817|NCT02373813|364131703|FG002|Run-In Period|Lost to Follow-up|0|||
105582818|NCT02373813|364131704|FG003|Run-In Period|Lost to Follow-up|0|||
105582819|NCT02373813|364131701|FG000|Run-In Period|Adverse Event|3|||
105582820|NCT02373813|364131702|FG001|Run-In Period|Adverse Event|0|||
105582821|NCT02373813|364131703|FG002|Run-In Period|Adverse Event|0|||
105582822|NCT02373813|364131704|FG003|Run-In Period|Adverse Event|0|||
105582823|NCT02373813|364131701|FG000|Run-In Period|Noncompliance|1|||
105582824|NCT02373813|364131702|FG001|Run-In Period|Noncompliance|0|||
105582825|NCT02373813|364131703|FG002|Run-In Period|Noncompliance|0|||
105582826|NCT02373813|364131704|FG003|Run-In Period|Noncompliance|0|||
105582827|NCT02373813|364131701|FG000|Run-In Period|Ineligibility Determined|3|||
105582828|NCT02373813|364131702|FG001|Run-In Period|Ineligibility Determined|0|||
105582829|NCT02373813|364131703|FG002|Run-In Period|Ineligibility Determined|0|||
105582830|NCT02373813|364131704|FG003|Run-In Period|Ineligibility Determined|0|||
105582831|NCT02373813|364131701|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
105582832|NCT02373813|364131702|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
105582833|NCT02373813|364131703|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
105582834|NCT02373813|364131704|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
105582835|NCT02373813|364131701|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
105582836|NCT02373813|364131702|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
105582837|NCT02373813|364131703|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
105582838|NCT02373813|364131704|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
105582839|NCT02373813|364131701|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105582840|NCT02373813|364131702|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
105582841|NCT02373813|364131703|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
105582842|NCT02373813|364131704|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
105582843|NCT02373813|364131701|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105582844|NCT02373813|364131702|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
105582845|NCT02373813|364131703|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
105582846|NCT02373813|364131704|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
105582847|NCT00826280|364131705|FG000|Overall Study|Randomized but drug not received|1|||
105582848|NCT00826280|364131706|FG001|Overall Study|Randomized but drug not received|0|||
105582849|NCT00826280|364131707|FG002|Overall Study|Randomized but drug not received|1|||
105582850|NCT00826280|364131705|FG000|Overall Study|Adverse Event|1|||
105582851|NCT00826280|364131706|FG001|Overall Study|Adverse Event|3|||
105582852|NCT00826280|364131707|FG002|Overall Study|Adverse Event|0|||
105582853|NCT00826280|364131705|FG000|Overall Study|Lost to Follow-up|0|||
105582854|NCT00826280|364131706|FG001|Overall Study|Lost to Follow-up|1|||
105582855|NCT00826280|364131707|FG002|Overall Study|Lost to Follow-up|0|||
105582856|NCT00826280|364131705|FG000|Overall Study|Sponsor discontinued subject or study|1|||
105582857|NCT00826280|364131706|FG001|Overall Study|Sponsor discontinued subject or study|0|||
105582858|NCT00826280|364131707|FG002|Overall Study|Sponsor discontinued subject or study|0|||
105582859|NCT00826280|364131705|FG000|Overall Study|Reversible ischemic defect not present|43|||
105582860|NCT00826280|364131706|FG001|Overall Study|Reversible ischemic defect not present|40|||
105582861|NCT00826280|364131707|FG002|Overall Study|Reversible ischemic defect not present|44|||
105582862|NCT00826280|364131705|FG000|Overall Study|Interpretation Failure|1|||
105582863|NCT00826280|364131706|FG001|Overall Study|Interpretation Failure|0|||
105582864|NCT00826280|364131707|FG002|Overall Study|Interpretation Failure|0|||
105582865|NCT00826280|364131705|FG000|Overall Study|Machine Failure|1|||
105582866|NCT00826280|364131706|FG001|Overall Study|Machine Failure|1|||
105582867|NCT00826280|364131707|FG002|Overall Study|Machine Failure|0|||
105582868|NCT00826280|364131705|FG000|Overall Study|One or more non-interpretable scan|0|||
105582869|NCT00826280|364131706|FG001|Overall Study|One or more non-interpretable scan|1|||
105582870|NCT00826280|364131707|FG002|Overall Study|One or more non-interpretable scan|1|||
105582871|NCT01440049|364131712|FG000|Overall Study|Adverse Event|5|||
105582872|NCT02268552|364131714|FG000|Part 1|Death|1|||
105582873|NCT02268552|364131715|FG001|Part 1|Death|1|||
105582874|NCT02268552|364131716|FG002|Part 1|Death|1|||
105582875|NCT02268552|364131717|FG003|Part 1|Death|2|||
105582876|NCT02268552|364131718|FG004|Part 1|Death|0|||
105582877|NCT02268552|364131719|FG005|Part 1|Death|0|||
105582878|NCT02268552|364131720|FG006|Part 1|Death|0|||
105582879|NCT02268552|364131714|FG000|Part 1|Subject/guardian decision|0|||
105582880|NCT02268552|364131715|FG001|Part 1|Subject/guardian decision|0|||
105582881|NCT02268552|364131716|FG002|Part 1|Subject/guardian decision|0|||
105582882|NCT02268552|364131717|FG003|Part 1|Subject/guardian decision|1|||
105582883|NCT02268552|364131718|FG004|Part 1|Subject/guardian decision|0|||
105582884|NCT02268552|364131719|FG005|Part 1|Subject/guardian decision|0|||
105582885|NCT02268552|364131720|FG006|Part 1|Subject/guardian decision|0|||
105582886|NCT02268552|364131714|FG000|Part 2|Death|0|||
105582887|NCT02268552|364131715|FG001|Part 2|Death|0|||
105582888|NCT02268552|364131716|FG002|Part 2|Death|0|||
105582889|NCT02268552|364131717|FG003|Part 2|Death|0|||
105582890|NCT02268552|364131718|FG004|Part 2|Death|0|||
105582891|NCT02268552|364131719|FG005|Part 2|Death|0|||
105582892|NCT02268552|364131720|FG006|Part 2|Death|2|||
105415435|NCT02712983|363527469|FG002|Treatment Phase|Adverse Event|1|||
105415436|NCT02712983|363527470|FG003|Treatment Phase|Adverse Event|4|||
105415437|NCT02712983|363527471|FG004|Treatment Phase|Adverse Event|3|||
105415438|NCT02712983|363527472|FG005|Treatment Phase|Adverse Event|0|||
105415439|NCT02712983|363527473|FG006|Treatment Phase|Adverse Event|6|||
105415440|NCT02712983|363527474|FG007|Treatment Phase|Adverse Event|6|||
105415441|NCT02712983|363527475|FG008|Treatment Phase|Adverse Event|1|||
105415442|NCT02712983|363527467|FG000|Treatment Phase|Protocol Deviation|0|||
105415443|NCT02712983|363527468|FG001|Treatment Phase|Protocol Deviation|0|||
105415444|NCT02712983|363527469|FG002|Treatment Phase|Protocol Deviation|0|||
105415445|NCT02712983|363527470|FG003|Treatment Phase|Protocol Deviation|2|||
105415446|NCT02712983|363527471|FG004|Treatment Phase|Protocol Deviation|0|||
105497911|NCT00810693|363834262|FG001|Treatment Period|Lack of Efficacy|0|||
105497912|NCT00810693|363834263|FG002|Treatment Period|Lack of Efficacy|1|||
105497913|NCT00810693|363834261|FG000|Treatment Period|Lost to Follow-up|1|||
105497914|NCT00810693|363834262|FG001|Treatment Period|Lost to Follow-up|0|||
105497915|NCT00810693|363834263|FG002|Treatment Period|Lost to Follow-up|0|||
105497916|NCT00810693|363834261|FG000|Treatment Period|Non-compliance|1|||
105497917|NCT00810693|363834262|FG001|Treatment Period|Non-compliance|0|||
105497918|NCT00810693|363834263|FG002|Treatment Period|Non-compliance|0|||
105497919|NCT00810693|363834261|FG000|Treatment Period|Protocol Violation|1|||
105497920|NCT00810693|363834262|FG001|Treatment Period|Protocol Violation|2|||
105497921|NCT00810693|363834263|FG002|Treatment Period|Protocol Violation|2|||
105497922|NCT00810693|363834261|FG000|Treatment Period|Withdrawal by Subject|6|||
105497923|NCT00810693|363834262|FG001|Treatment Period|Withdrawal by Subject|2|||
105497924|NCT00810693|363834263|FG002|Treatment Period|Withdrawal by Subject|3|||
105497925|NCT00810693|363834261|FG000|Treatment Period|Not treated|0|||
105497926|NCT00810693|363834262|FG001|Treatment Period|Not treated|1|||
105497927|NCT00810693|363834263|FG002|Treatment Period|Not treated|1|||
105497928|NCT00810693|363834261|FG000|Follow-up Period (FUP)|Adverse Event|3|||
105497929|NCT00810693|363834262|FG001|Follow-up Period (FUP)|Adverse Event|1|||
105497930|NCT00810693|363834263|FG002|Follow-up Period (FUP)|Adverse Event|1|||
105497931|NCT00810693|363834261|FG000|Follow-up Period (FUP)|Death|2|||
105497932|NCT00810693|363834262|FG001|Follow-up Period (FUP)|Death|0|||
105497933|NCT00810693|363834263|FG002|Follow-up Period (FUP)|Death|1|||
105497934|NCT00810693|363834261|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
105497935|NCT00810693|363834262|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
105497936|NCT00810693|363834263|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
105497937|NCT00810693|363834261|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
105497938|NCT00810693|363834262|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
105497939|NCT00810693|363834263|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
105497940|NCT00810693|363834261|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
105497941|NCT00810693|363834262|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
105497942|NCT00810693|363834263|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
105497943|NCT01297920|363834264|FG000|Overall Study|Adverse Event|42|||
105497944|NCT01297920|363834265|FG001|Overall Study|Adverse Event|10|||
105497945|NCT01297920|363834266|FG002|Overall Study|Adverse Event|38|||
105497946|NCT01297920|363834264|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
105497947|NCT01297920|363834265|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
105497948|NCT01297920|363834266|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
105497949|NCT01297920|363834264|FG000|Overall Study|Noncompliance|1|||
105497950|NCT01297920|363834265|FG001|Overall Study|Noncompliance|0|||
105497951|NCT01297920|363834266|FG002|Overall Study|Noncompliance|0|||
105497952|NCT01297920|363834264|FG000|Overall Study|Protocol Violation|1|||
105497953|NCT01297920|363834265|FG001|Overall Study|Protocol Violation|3|||
105497954|NCT01297920|363834266|FG002|Overall Study|Protocol Violation|0|||
105497955|NCT01297920|363834264|FG000|Overall Study|Inadequate Control of IOP|7|||
105497956|NCT01297920|363834265|FG001|Overall Study|Inadequate Control of IOP|9|||
105497957|NCT01297920|363834266|FG002|Overall Study|Inadequate Control of IOP|17|||
105582893|NCT02268552|364131714|FG000|Part 2|Subject/guardian decision|0|||
105415447|NCT02712983|363527472|FG005|Treatment Phase|Protocol Deviation|0|||
105415448|NCT02712983|363527473|FG006|Treatment Phase|Protocol Deviation|1|||
105497958|NCT01297920|363834264|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
105497959|NCT01297920|363834265|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
105497960|NCT01297920|363834266|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
105497961|NCT00516074|363834279|FG000|Overall Study|Adverse Event|0|||
105497962|NCT00516074|363834280|FG001|Overall Study|Adverse Event|1|||
105497963|NCT00516074|363834279|FG000|Overall Study|Subject Decision|4|||
105497964|NCT00516074|363834280|FG001|Overall Study|Subject Decision|2|||
105497965|NCT00516074|363834279|FG000|Overall Study|Loss of Glucose Control|2|||
105497966|NCT00516074|363834280|FG001|Overall Study|Loss of Glucose Control|0|||
105497967|NCT02215096|363834281|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
105497968|NCT02215096|363834282|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
105497969|NCT02215096|363834283|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
105497970|NCT02215096|363834284|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
105582894|NCT02268552|364131715|FG001|Part 2|Subject/guardian decision|0|||
105582895|NCT02268552|364131716|FG002|Part 2|Subject/guardian decision|0|||
105582896|NCT02268552|364131717|FG003|Part 2|Subject/guardian decision|0|||
105582897|NCT02268552|364131718|FG004|Part 2|Subject/guardian decision|0|||
105582898|NCT02268552|364131719|FG005|Part 2|Subject/guardian decision|0|||
105582899|NCT02268552|364131720|FG006|Part 2|Subject/guardian decision|1|||
105582900|NCT02268552|364131714|FG000|Part 3 Extension|Death|0|||
105582901|NCT02268552|364131715|FG001|Part 3 Extension|Death|1|||
105582902|NCT02268552|364131716|FG002|Part 3 Extension|Death|1|||
105582903|NCT02268552|364131717|FG003|Part 3 Extension|Death|1|||
105582904|NCT02268552|364131718|FG004|Part 3 Extension|Death|1|||
105582905|NCT02268552|364131719|FG005|Part 3 Extension|Death|1|||
105582906|NCT02268552|364131720|FG006|Part 3 Extension|Death|0|||
105582907|NCT02268552|364131714|FG000|Part 3 Extension|Early termination of trial|1|||
105582908|NCT02268552|364131715|FG001|Part 3 Extension|Early termination of trial|0|||
105582909|NCT02268552|364131716|FG002|Part 3 Extension|Early termination of trial|0|||
105582910|NCT02268552|364131717|FG003|Part 3 Extension|Early termination of trial|0|||
105582911|NCT02268552|364131718|FG004|Part 3 Extension|Early termination of trial|2|||
105582912|NCT02268552|364131719|FG005|Part 3 Extension|Early termination of trial|9|||
105582913|NCT02268552|364131720|FG006|Part 3 Extension|Early termination of trial|11|||
105582914|NCT02268552|364131714|FG000|Part 3 Extension|Subject/guardian decision|0|||
105582915|NCT02268552|364131715|FG001|Part 3 Extension|Subject/guardian decision|0|||
105582916|NCT02268552|364131716|FG002|Part 3 Extension|Subject/guardian decision|0|||
105582917|NCT02268552|364131717|FG003|Part 3 Extension|Subject/guardian decision|0|||
105582918|NCT02268552|364131718|FG004|Part 3 Extension|Subject/guardian decision|0|||
105582919|NCT02268552|364131719|FG005|Part 3 Extension|Subject/guardian decision|0|||
105582920|NCT02268552|364131720|FG006|Part 3 Extension|Subject/guardian decision|1|||
105582921|NCT02703532|364131721|FG000|Overall Study|Withdrawal by Subject|0|||
105582922|NCT02703532|364131722|FG001|Overall Study|Withdrawal by Subject|1|||
105582923|NCT02703532|364131723|FG002|Overall Study|Withdrawal by Subject|0|||
105582924|NCT02703532|364131724|FG003|Overall Study|Withdrawal by Subject|1|||
105582925|NCT02703532|364131721|FG000|Overall Study|Lost to Follow-up|2|||
105582926|NCT02703532|364131722|FG001|Overall Study|Lost to Follow-up|0|||
105582927|NCT02703532|364131723|FG002|Overall Study|Lost to Follow-up|2|||
105582928|NCT02703532|364131724|FG003|Overall Study|Lost to Follow-up|0|||
105582929|NCT01636362|364131725|FG000|Overall Study|Physician Decision|6|||
105582930|NCT01636362|364131725|FG000|Overall Study|Subject healed, not returning|1|||
105582931|NCT01636362|364131725|FG000|Overall Study|Withdrawal by Subject|1|||
105582932|NCT02264574|364131726|FG000|Overall Study|Death|21|||
105582933|NCT02264574|364131727|FG001|Overall Study|Death|21|||
105582934|NCT02264574|364131726|FG000|Overall Study|Withdrawal by Subject|8|||
105582935|NCT02264574|364131727|FG001|Overall Study|Withdrawal by Subject|6|||
105582936|NCT02264574|364131726|FG000|Overall Study|Other, Not Specified|0|||
105582937|NCT02264574|364131727|FG001|Overall Study|Other, Not Specified|3|||
105582938|NCT03415022|364131728|FG000|Overall Study|Withdrawal by Subject|1|||
105582939|NCT03415022|364131729|FG001|Overall Study|Withdrawal by Subject|2|||
105582940|NCT03415022|364131728|FG000|Overall Study|COVID-19 Suspension|2|||
105582941|NCT03415022|364131729|FG001|Overall Study|COVID-19 Suspension|3|||
105582942|NCT03415022|364131728|FG000|Overall Study|Lost to Follow-up|2|||
105582943|NCT03415022|364131729|FG001|Overall Study|Lost to Follow-up|0|||
105582944|NCT01094171|364131735|FG000|Overall Study|Lost to Follow-up|2|||
105582945|NCT01094171|364131735|FG000|Overall Study|Informed consent withdrawal|4|||
105582946|NCT01094171|364131735|FG000|Overall Study|Migration from the study area|3|||
105582947|NCT01094171|364131735|FG000|Overall Study|Other|1|||
105582948|NCT01686932|364131736|FG000|Period 1|Adverse Event|1|||
105582949|NCT01686932|364131737|FG001|Period 1|Adverse Event|1|||
105582950|NCT02118714|364131738|FG000|Overall Study|Lost to Follow-up|2|||
105582951|NCT02118714|364131738|FG000|Overall Study|Protocol Violation|1|||
105582952|NCT01628874|364131739|FG000|Overall Study|Physician Decision|1|||
105582953|NCT01628874|364131740|FG001|Overall Study|Physician Decision|1|||
105582954|NCT01628874|364131739|FG000|Overall Study|Age >4 months|4|||
105582955|NCT01628874|364131740|FG001|Overall Study|Age >4 months|2|||
105582956|NCT03023332|364131743|FG000|Overall Study|Withdrawal by Subject|10|||
105582957|NCT03023332|364131744|FG001|Overall Study|Withdrawal by Subject|5|||
105582958|NCT03023332|364131745|FG002|Overall Study|Withdrawal by Subject|4|||
105582959|NCT03023332|364131746|FG003|Overall Study|Withdrawal by Subject|7|||
105582960|NCT03023332|364131743|FG000|Overall Study|Lost to Follow-up|13|||
105582961|NCT03023332|364131744|FG001|Overall Study|Lost to Follow-up|16|||
105582962|NCT03023332|364131745|FG002|Overall Study|Lost to Follow-up|8|||
105582963|NCT03023332|364131746|FG003|Overall Study|Lost to Follow-up|13|||
105582964|NCT03023332|364131743|FG000|Overall Study|Death|1|||
105582965|NCT03023332|364131744|FG001|Overall Study|Death|0|||
105582966|NCT03023332|364131745|FG002|Overall Study|Death|0|||
105582967|NCT03023332|364131746|FG003|Overall Study|Death|0|||
105582968|NCT02013687|364131747|FG000|Overall Study|Lost to Follow-up|0|||
105582969|NCT02013687|364131748|FG001|Overall Study|Lost to Follow-up|0|||
105582970|NCT02013687|364131749|FG002|Overall Study|Lost to Follow-up|1|||
105582971|NCT02013687|364131750|FG003|Overall Study|Lost to Follow-up|0|||
105582972|NCT02013687|364131747|FG000|Overall Study|Protocol Violation|0|||
105582973|NCT02013687|364131748|FG001|Overall Study|Protocol Violation|0|||
105582974|NCT02013687|364131749|FG002|Overall Study|Protocol Violation|0|||
105582975|NCT02013687|364131750|FG003|Overall Study|Protocol Violation|1|||
105582976|NCT02013687|364131747|FG000|Overall Study|Withdrawal by Subject|0|||
105582977|NCT02013687|364131748|FG001|Overall Study|Withdrawal by Subject|0|||
105582978|NCT02013687|364131749|FG002|Overall Study|Withdrawal by Subject|0|||
105582979|NCT02013687|364131750|FG003|Overall Study|Withdrawal by Subject|1|||
105582980|NCT02013687|364131747|FG000|Overall Study|Missed visits due to patient travel|0|||
105582981|NCT02013687|364131748|FG001|Overall Study|Missed visits due to patient travel|0|||
105582982|NCT02013687|364131749|FG002|Overall Study|Missed visits due to patient travel|1|||
105582983|NCT02013687|364131750|FG003|Overall Study|Missed visits due to patient travel|0|||
105582984|NCT01657032|364131751|FG000|Overall Study|Lost to Follow-up|0|||
105582985|NCT01657032|364131752|FG001|Overall Study|Lost to Follow-up|7|||
105582986|NCT01603121|364131753|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
105582987|NCT01603121|364131754|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
105582988|NCT00577720|364131755|FG000|Overall Study|Adverse Event|2|||
105582989|NCT00577720|364131756|FG001|Overall Study|Adverse Event|1|||
105582990|NCT00577720|364131757|FG002|Overall Study|Adverse Event|0|||
105582991|NCT00577720|364131758|FG003|Overall Study|Adverse Event|4|||
105582992|NCT00577720|364131755|FG000|Overall Study|Lost to Follow-up|0|||
105582993|NCT00577720|364131756|FG001|Overall Study|Lost to Follow-up|0|||
105582994|NCT00577720|364131757|FG002|Overall Study|Lost to Follow-up|1|||
105582995|NCT00577720|364131758|FG003|Overall Study|Lost to Follow-up|0|||
105582996|NCT00577720|364131755|FG000|Overall Study|Protocol Violation|0|||
105582997|NCT00577720|364131756|FG001|Overall Study|Protocol Violation|0|||
105582998|NCT00577720|364131757|FG002|Overall Study|Protocol Violation|0|||
105582999|NCT00577720|364131758|FG003|Overall Study|Protocol Violation|1|||
105583000|NCT00577720|364131755|FG000|Overall Study|Withdrawal by Subject|2|||
105583001|NCT00577720|364131756|FG001|Overall Study|Withdrawal by Subject|0|||
105583002|NCT00577720|364131757|FG002|Overall Study|Withdrawal by Subject|0|||
105583003|NCT00577720|364131758|FG003|Overall Study|Withdrawal by Subject|2|||
105583004|NCT02687919|364131759|FG000|Overall Study|Withdrawal by Subject|6|||
105583005|NCT02687919|364131760|FG001|Overall Study|Withdrawal by Subject|6|||
105583006|NCT02687919|364131759|FG000|Overall Study|Protocol Violation|2|||
105583007|NCT02687919|364131760|FG001|Overall Study|Protocol Violation|0|||
105583008|NCT01628510|364131761|FG000|Overall Study|Withdrawal by Subject|0|||
105583009|NCT01628510|364131762|FG001|Overall Study|Withdrawal by Subject|4|||
105583010|NCT01628510|364131761|FG000|Overall Study|Death|3|||
105583011|NCT01628510|364131762|FG001|Overall Study|Death|1|||
105583012|NCT04179461|364131763|FG000|Overall Study|Lost to Follow-up|4|||
105583013|NCT00772928|364131764|FG000|Overall Study|Lost to Follow-up|9|||
105583014|NCT00772928|364131765|FG001|Overall Study|Lost to Follow-up|6|||
105583015|NCT00772928|364131764|FG000|Overall Study|Protocol Violation|10|||
105583016|NCT00772928|364131765|FG001|Overall Study|Protocol Violation|12|||
105583017|NCT00772928|364131764|FG000|Overall Study|Withdrawal by Subject|25|||
105583018|NCT00772928|364131765|FG001|Overall Study|Withdrawal by Subject|22|||
105583019|NCT00772928|364131764|FG000|Overall Study|Did not receive vaccine|0|||
105583020|NCT00772928|364131765|FG001|Overall Study|Did not receive vaccine|1|||
105583021|NCT00162942|364131767|FG000|Overall Study|Adverse Event|10|||
105583022|NCT00162942|364131768|FG001|Overall Study|Adverse Event|6|||
105583023|NCT00162942|364131767|FG000|Overall Study|Death|1|||
105583024|NCT00162942|364131768|FG001|Overall Study|Death|0|||
105583025|NCT00162942|364131767|FG000|Overall Study|Withdrawal by Subject|3|||
105583026|NCT00162942|364131768|FG001|Overall Study|Withdrawal by Subject|6|||
105583027|NCT00162942|364131767|FG000|Overall Study|Physician Decision|1|||
105583028|NCT00162942|364131768|FG001|Overall Study|Physician Decision|0|||
105583029|NCT00162942|364131767|FG000|Overall Study|Enter Open-Label Study|76|||
105583030|NCT00162942|364131768|FG001|Overall Study|Enter Open-Label Study|35|||
105583031|NCT00162942|364131767|FG000|Overall Study|Alternate Therapy|6|||
105583032|NCT00162942|364131768|FG001|Overall Study|Alternate Therapy|2|||
105583033|NCT00162942|364131767|FG000|Overall Study|Lack of Efficacy|1|||
105583034|NCT00162942|364131768|FG001|Overall Study|Lack of Efficacy|0|||
105583035|NCT00162942|364131767|FG000|Overall Study|Flare During Active Treatment|7|||
105583036|NCT00162942|364131768|FG001|Overall Study|Flare During Active Treatment|3|||
105583037|NCT00162942|364131767|FG000|Overall Study|2 or more consecutive treatments missed|1|||
105583038|NCT00162942|364131768|FG001|Overall Study|2 or more consecutive treatments missed|0|||
105583039|NCT01253200|364131769|FG000|Overall Study|Death|1|||
105583040|NCT01253200|364131770|FG001|Overall Study|Death|0|||
105583041|NCT01253200|364131771|FG002|Overall Study|Death|0|||
105583042|NCT01253200|364131772|FG003|Overall Study|Death|0|||
105583043|NCT01253200|364131773|FG004|Overall Study|Death|0|||
105583044|NCT01253200|364131769|FG000|Overall Study|Lost to Follow-up|1|||
105583045|NCT01253200|364131770|FG001|Overall Study|Lost to Follow-up|1|||
105583046|NCT01253200|364131771|FG002|Overall Study|Lost to Follow-up|0|||
105583047|NCT01253200|364131772|FG003|Overall Study|Lost to Follow-up|0|||
105583048|NCT01253200|364131773|FG004|Overall Study|Lost to Follow-up|0|||
105415449|NCT02712983|363527474|FG007|Treatment Phase|Protocol Deviation|0|||
105415450|NCT02712983|363527475|FG008|Treatment Phase|Protocol Deviation|0|||
105415451|NCT02712983|363527467|FG000|Treatment Phase|Technical Problems|0|||
105415452|NCT02712983|363527468|FG001|Treatment Phase|Technical Problems|0|||
105415453|NCT02712983|363527469|FG002|Treatment Phase|Technical Problems|0|||
105415454|NCT02712983|363527470|FG003|Treatment Phase|Technical Problems|0|||
105415455|NCT02712983|363527471|FG004|Treatment Phase|Technical Problems|0|||
105415456|NCT02712983|363527472|FG005|Treatment Phase|Technical Problems|0|||
105415457|NCT02712983|363527473|FG006|Treatment Phase|Technical Problems|1|||
105415458|NCT02712983|363527474|FG007|Treatment Phase|Technical Problems|0|||
105415459|NCT02712983|363527475|FG008|Treatment Phase|Technical Problems|0|||
105415460|NCT02712983|363527467|FG000|Treatment Phase|Physician Decision|0|||
105415461|NCT02712983|363527468|FG001|Treatment Phase|Physician Decision|0|||
105415462|NCT02712983|363527469|FG002|Treatment Phase|Physician Decision|0|||
105415463|NCT02712983|363527470|FG003|Treatment Phase|Physician Decision|0|||
105415464|NCT02712983|363527471|FG004|Treatment Phase|Physician Decision|0|||
105415465|NCT02712983|363527472|FG005|Treatment Phase|Physician Decision|0|||
105415466|NCT02712983|363527473|FG006|Treatment Phase|Physician Decision|0|||
105415467|NCT02712983|363527474|FG007|Treatment Phase|Physician Decision|1|||
105415468|NCT02712983|363527475|FG008|Treatment Phase|Physician Decision|1|||
105415469|NCT02712983|363527467|FG000|Treatment Phase|Subject Decision|2|||
105415470|NCT02712983|363527468|FG001|Treatment Phase|Subject Decision|0|||
105415471|NCT02712983|363527469|FG002|Treatment Phase|Subject Decision|0|||
105415472|NCT02712983|363527470|FG003|Treatment Phase|Subject Decision|2|||
105415473|NCT02712983|363527471|FG004|Treatment Phase|Subject Decision|1|||
105415474|NCT02712983|363527472|FG005|Treatment Phase|Subject Decision|0|||
105415475|NCT02712983|363527473|FG006|Treatment Phase|Subject Decision|1|||
105415476|NCT02712983|363527474|FG007|Treatment Phase|Subject Decision|2|||
105415477|NCT02712983|363527475|FG008|Treatment Phase|Subject Decision|0|||
105415478|NCT02712983|363527467|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105415479|NCT02712983|363527468|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
105415480|NCT02712983|363527469|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105415481|NCT02712983|363527470|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105415482|NCT02712983|363527471|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105415483|NCT02712983|363527472|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105415484|NCT02712983|363527473|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
105415485|NCT02712983|363527474|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
105415486|NCT02712983|363527475|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105415487|NCT02712983|363527467|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105415488|NCT02712983|363527468|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105415489|NCT02712983|363527469|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105415490|NCT02712983|363527470|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
105415491|NCT02712983|363527471|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105415492|NCT02712983|363527472|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105415493|NCT02712983|363527473|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105415494|NCT02712983|363527474|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105415495|NCT02712983|363527475|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105415496|NCT02712983|363527467|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
105415497|NCT02712983|363527468|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
105415498|NCT02712983|363527469|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
105415499|NCT02712983|363527470|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
105415500|NCT02712983|363527471|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
105415501|NCT02712983|363527472|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
105415502|NCT02712983|363527473|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
105415503|NCT02712983|363527474|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
105415504|NCT02712983|363527475|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
105415505|NCT01271010|363527476|FG000|Overall Study|Reason not specified|11|||
105415506|NCT01271010|363527476|FG000|Overall Study|Start of new CLL therapy|1|||
105415507|NCT01271010|363527476|FG000|Overall Study|Protocol Violation|1|||
105415508|NCT01271010|363527476|FG000|Overall Study|Death|2|||
105415509|NCT01271010|363527476|FG000|Overall Study|Progression and relapse of disease|1|||
105415510|NCT01271010|363527476|FG000|Overall Study|Withdrawal by Subject|18|||
105415511|NCT01271010|363527476|FG000|Overall Study|Disease progression|27|||
105583049|NCT01253200|364131769|FG000|Overall Study|Withdrawal by Subject|2|||
105626695|NCT04186819|364298168|FG000|Overall Study|Adverse Event|1|||
105415512|NCT03062280|363527477|FG000|Overall Study|Adverse Event|1|||
105415513|NCT03062280|363527477|FG000|Overall Study|Death|1|||
105415514|NCT03062280|363527477|FG000|Overall Study|Fertility Treatment|2|||
105415515|NCT03062280|363527477|FG000|Overall Study|Physician Decision|2|||
105415516|NCT03062280|363527477|FG000|Overall Study|Pregnancy|5|||
105415517|NCT03062280|363527477|FG000|Overall Study|Withdrawal by Subject|11|||
105415518|NCT05258890|363527478|FG000|Overall Study|Patient withdrawal|6|||
105415519|NCT05258890|363527479|FG001|Overall Study|Patient withdrawal|7|||
105415520|NCT05258890|363527478|FG000|Overall Study|Patient lost to follow-up|10|||
105415521|NCT05258890|363527479|FG001|Overall Study|Patient lost to follow-up|3|||
105415522|NCT05258890|363527478|FG000|Overall Study|Social network member withdrawal|1|||
105415523|NCT05258890|363527479|FG001|Overall Study|Social network member withdrawal|0|||
105415524|NCT05258890|363527478|FG000|Overall Study|Social network member lost to follow-up|5|||
105415525|NCT05258890|363527479|FG001|Overall Study|Social network member lost to follow-up|0|||
105415526|NCT03530995|363527486|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
105415527|NCT03530995|363527487|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
105415528|NCT03530995|363527486|FG000|Part 1 Period 3|Protocol Violation|1|||
105415529|NCT03530995|363527487|FG001|Part 1 Period 3|Protocol Violation|0|||
105415530|NCT03530995|363527486|FG000|Part 1 Period 4|Physician Decision|1|||
105415531|NCT03530995|363527487|FG001|Part 1 Period 4|Physician Decision|0|||
105415532|NCT03530995|363527486|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
105415533|NCT03530995|363527487|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
105415534|NCT00218634|363527491|FG000|Overall Study|Lost to Follow-up|8|||
105415535|NCT00218634|363527492|FG001|Overall Study|Lost to Follow-up|15|||
105415536|NCT00623233|363527495|FG000|Overall Study|Adverse Event|10|||
105415537|NCT00623233|363527495|FG000|Overall Study|Physician Decision|10|||
105415538|NCT00623233|363527495|FG000|Overall Study|Lost to Follow-up|1|||
105415539|NCT00623233|363527495|FG000|Overall Study|Withdrawal by Subject|3|||
105415540|NCT05791565|363527499|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
105415541|NCT05791565|363527500|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
105415542|NCT04729972|363527503|FG000|Overall Study|Adverse Event|1|||
105415543|NCT00880269|363527504|FG000|Overall Study|Protocol Violation|1|||
105415544|NCT00880269|363527505|FG001|Overall Study|Protocol Violation|0|||
105415545|NCT00880269|363527504|FG000|Overall Study|Disease Progression|13|||
105415546|NCT00880269|363527505|FG001|Overall Study|Disease Progression|11|||
105415547|NCT00880269|363527504|FG000|Overall Study|New Cancer Therapy|1|||
105415548|NCT00880269|363527505|FG001|Overall Study|New Cancer Therapy|0|||
105415549|NCT00880269|363527504|FG000|Overall Study|Death|4|||
105415550|NCT00880269|363527505|FG001|Overall Study|Death|2|||
105415551|NCT00880269|363527504|FG000|Overall Study|Lost to Follow-up|0|||
105415552|NCT00880269|363527505|FG001|Overall Study|Lost to Follow-up|1|||
105415553|NCT00880269|363527504|FG000|Overall Study|Withdrawal by Subject|3|||
105415554|NCT00880269|363527505|FG001|Overall Study|Withdrawal by Subject|4|||
105415555|NCT00880269|363527504|FG000|Overall Study|Adverse Event|10|||
105415556|NCT00880269|363527505|FG001|Overall Study|Adverse Event|9|||
105415557|NCT01951586|363527512|FG000|Overall Study|Death|61|||
105415558|NCT01951586|363527513|FG001|Overall Study|Death|120|||
105415559|NCT01951586|363527512|FG000|Overall Study|Withdrawal by Subject|8|||
105415560|NCT01951586|363527513|FG001|Overall Study|Withdrawal by Subject|17|||
105415561|NCT01951586|363527512|FG000|Overall Study|Lost to Follow-up|0|||
105415562|NCT01951586|363527513|FG001|Overall Study|Lost to Follow-up|1|||
105415563|NCT01951586|363527512|FG000|Overall Study|Sponsor Decision|9|||
105415564|NCT01951586|363527513|FG001|Overall Study|Sponsor Decision|10|||
105415565|NCT01667224|363527517|FG000|Overall Study|Withdrawal by Subject|3|||
105415566|NCT01667224|363527518|FG001|Overall Study|Withdrawal by Subject|1|||
105415567|NCT01667224|363527517|FG000|Overall Study|Protocol Violation|1|||
105415568|NCT01667224|363527518|FG001|Overall Study|Protocol Violation|1|||
105415569|NCT01811485|363527522|FG000|Overall Study|Adverse Event|1|||
105415570|NCT01811485|363527523|FG001|Overall Study|Adverse Event|3|||
105415571|NCT01811485|363527524|FG002|Overall Study|Adverse Event|2|||
105415572|NCT01811485|363527522|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105415573|NCT01811485|363527523|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105415574|NCT01811485|363527524|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
105415575|NCT01811485|363527522|FG000|Overall Study|Administrative problems|1|||
105415576|NCT01811485|363527523|FG001|Overall Study|Administrative problems|0|||
105415577|NCT01811485|363527524|FG002|Overall Study|Administrative problems|0|||
105415578|NCT01811485|363527522|FG000|Overall Study|Protocol Deviation|0|||
105415579|NCT01811485|363527523|FG001|Overall Study|Protocol Deviation|1|||
105415580|NCT01811485|363527524|FG002|Overall Study|Protocol Deviation|0|||
105415581|NCT03645421|363527525|FG000|Overall Study|Adverse Event|0|||
105497971|NCT02215096|363834285|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
105415582|NCT03645421|363527526|FG001|Overall Study|Adverse Event|0|||
105415583|NCT03645421|363527527|FG002|Overall Study|Adverse Event|4|||
105415584|NCT03645421|363527528|FG003|Overall Study|Adverse Event|1|||
105415585|NCT03645421|363527525|FG000|Overall Study|Withdrawal by patient|0|||
105415586|NCT03645421|363527526|FG001|Overall Study|Withdrawal by patient|0|||
105415587|NCT03645421|363527527|FG002|Overall Study|Withdrawal by patient|0|||
105415588|NCT03645421|363527528|FG003|Overall Study|Withdrawal by patient|3|||
105415589|NCT03645421|363527525|FG000|Overall Study|Study specific withdrawal criteria|0|||
105415590|NCT03645421|363527526|FG001|Overall Study|Study specific withdrawal criteria|0|||
105415591|NCT03645421|363527527|FG002|Overall Study|Study specific withdrawal criteria|1|||
105415592|NCT03645421|363527528|FG003|Overall Study|Study specific withdrawal criteria|0|||
105415593|NCT03654404|363527529|FG000|Overall Study|Death|1|||
105415594|NCT03654404|363527529|FG000|Overall Study|Lost to Follow-up|2|||
105415595|NCT03654404|363527529|FG000|Overall Study|Withdrawal by Subject|5|||
105415596|NCT03215758|363527539|FG000|Overall Study|Technical Problems|1|||
105415597|NCT03215758|363527540|FG001|Overall Study|Technical Problems|0|||
105415598|NCT03215758|363527539|FG000|Overall Study|Protocol deviation|0|||
105415599|NCT03215758|363527540|FG001|Overall Study|Protocol deviation|1|||
105415600|NCT03215758|363527539|FG000|Overall Study|Physician Decision|0|||
105415601|NCT03215758|363527540|FG001|Overall Study|Physician Decision|1|||
105415602|NCT03215758|363527539|FG000|Overall Study|Death|0|||
105415603|NCT03215758|363527540|FG001|Overall Study|Death|1|||
105415604|NCT03215758|363527539|FG000|Overall Study|Adverse Event|1|||
105415605|NCT03215758|363527540|FG001|Overall Study|Adverse Event|2|||
105415606|NCT03215758|363527539|FG000|Overall Study|Subject/Guardian Decision|3|||
105415607|NCT03215758|363527540|FG001|Overall Study|Subject/Guardian Decision|3|||
105415608|NCT02003638|363527541|FG000|Overall Study|Withdrawal by Subject|1|||
105415609|NCT02003638|363527542|FG001|Overall Study|Withdrawal by Subject|0|||
105415610|NCT04115748|363527543|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
105415611|NCT04115748|363527544|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
105415612|NCT04115748|363527545|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
105415613|NCT04115748|363527546|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
105415614|NCT04115748|363527547|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
105415615|NCT04115748|363527548|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
105415616|NCT04115748|363527549|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
105415617|NCT04115748|363527550|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
105415618|NCT04115748|363527551|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
105415619|NCT04115748|363527552|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
105415620|NCT04115748|363527543|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105415621|NCT04115748|363527544|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105415622|NCT04115748|363527545|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105415623|NCT04115748|363527546|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
105415624|NCT04115748|363527547|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105415625|NCT04115748|363527548|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105415626|NCT04115748|363527549|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105415627|NCT04115748|363527550|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105415628|NCT04115748|363527551|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105415629|NCT04115748|363527552|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105497972|NCT02215096|363834281|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
105415630|NCT04115748|363527543|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
105415631|NCT04115748|363527544|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
105415632|NCT04115748|363527545|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
105415633|NCT04115748|363527546|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
105415634|NCT04115748|363527547|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
105497973|NCT02215096|363834282|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
105583050|NCT01253200|364131770|FG001|Overall Study|Withdrawal by Subject|0|||
105583051|NCT01253200|364131771|FG002|Overall Study|Withdrawal by Subject|0|||
105583052|NCT01253200|364131772|FG003|Overall Study|Withdrawal by Subject|0|||
105583053|NCT01253200|364131773|FG004|Overall Study|Withdrawal by Subject|0|||
105583054|NCT01253200|364131769|FG000|Overall Study|Protocol Violation|1|||
105583055|NCT01253200|364131770|FG001|Overall Study|Protocol Violation|4|||
105583056|NCT01253200|364131771|FG002|Overall Study|Protocol Violation|0|||
105583057|NCT01253200|364131772|FG003|Overall Study|Protocol Violation|0|||
105583058|NCT01253200|364131773|FG004|Overall Study|Protocol Violation|5|||
105583059|NCT01253200|364131769|FG000|Overall Study|intents|10|||
105583060|NCT01253200|364131770|FG001|Overall Study|intents|10|||
105583061|NCT01253200|364131771|FG002|Overall Study|intents|1|||
105583062|NCT01253200|364131772|FG003|Overall Study|intents|3|||
105583063|NCT01253200|364131773|FG004|Overall Study|intents|0|||
105583064|NCT01253200|364131769|FG000|Overall Study|Attempts|6|||
105583065|NCT01253200|364131770|FG001|Overall Study|Attempts|4|||
105583066|NCT01253200|364131771|FG002|Overall Study|Attempts|1|||
105583067|NCT01253200|364131772|FG003|Overall Study|Attempts|2|||
105583068|NCT01253200|364131773|FG004|Overall Study|Attempts|0|||
105583069|NCT01700530|364131777|FG000|Overall Study|Withdrawal by Subject|0|||
105583070|NCT01700530|364131778|FG001|Overall Study|Withdrawal by Subject|3|||
105583071|NCT01700530|364131779|FG002|Overall Study|Withdrawal by Subject|1|||
105583072|NCT04833855|364131780|FG000|Overall Study|Decision by sponsor|0|||
105583073|NCT04833855|364131781|FG001|Overall Study|Decision by sponsor|1|||
105583074|NCT04833855|364131782|FG002|Overall Study|Decision by sponsor|0|||
105583075|NCT04833855|364131783|FG003|Overall Study|Decision by sponsor|0|||
105583076|NCT04833855|364131780|FG000|Overall Study|Withdrawal by Subject|4|||
105583077|NCT04833855|364131781|FG001|Overall Study|Withdrawal by Subject|1|||
105583078|NCT04833855|364131782|FG002|Overall Study|Withdrawal by Subject|3|||
105583079|NCT04833855|364131783|FG003|Overall Study|Withdrawal by Subject|1|||
105583080|NCT04833855|364131780|FG000|Overall Study|Lost to Follow-up|1|||
105583081|NCT04833855|364131781|FG001|Overall Study|Lost to Follow-up|0|||
105583082|NCT04833855|364131782|FG002|Overall Study|Lost to Follow-up|2|||
105583083|NCT04833855|364131783|FG003|Overall Study|Lost to Follow-up|2|||
105583084|NCT04833855|364131780|FG000|Overall Study|Protocol specified criteria|0|||
105583085|NCT04833855|364131781|FG001|Overall Study|Protocol specified criteria|0|||
105583086|NCT04833855|364131782|FG002|Overall Study|Protocol specified criteria|2|||
105583087|NCT04833855|364131783|FG003|Overall Study|Protocol specified criteria|1|||
105583088|NCT02234310|364131793|FG000|Overall Study|Physician Decision|1|||
105583089|NCT02234310|364131793|FG000|Overall Study|Adverse Event|1|||
105583090|NCT02234310|364131793|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
105583091|NCT02234310|364131793|FG000|Overall Study|Withdrawal by Subject|2|||
105583092|NCT02192359|364131795|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
105583093|NCT02192359|364131796|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
105583094|NCT02192359|364131797|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
105583095|NCT02192359|364131798|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
105583096|NCT02192359|364131795|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
105583097|NCT02192359|364131796|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
105583098|NCT02192359|364131797|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
105583099|NCT02192359|364131798|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
105583100|NCT02192359|364131795|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
105583101|NCT02192359|364131796|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
105583102|NCT02192359|364131797|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
105583103|NCT02192359|364131798|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
105583104|NCT04951479|364131799|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
105583105|NCT05174065|364131811|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
105583106|NCT05174065|364131812|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
105583107|NCT05174065|364131813|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
105583108|NCT05174065|364131811|FG000|Placebo-controlled Period|Other|0|||
105583109|NCT05174065|364131812|FG001|Placebo-controlled Period|Other|1|||
105583110|NCT05174065|364131813|FG002|Placebo-controlled Period|Other|0|||
105583111|NCT05174065|364131811|FG000|Placebo-controlled Period|Adverse Event|1|||
105583112|NCT05174065|364131812|FG001|Placebo-controlled Period|Adverse Event|1|||
105583113|NCT05174065|364131813|FG002|Placebo-controlled Period|Adverse Event|0|||
105583114|NCT05174065|364131811|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
105583115|NCT05174065|364131812|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
105583116|NCT05174065|364131813|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
105583117|NCT05174065|364131811|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
105583118|NCT05174065|364131812|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
105583119|NCT05174065|364131813|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
105583120|NCT05174065|364131811|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
105583121|NCT05174065|364131812|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
105583122|NCT05174065|364131813|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
105583123|NCT00924560|364131814|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
105583124|NCT00924560|364131815|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
105583125|NCT00924560|364131816|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
105583126|NCT00924560|364131814|FG000|Overall Study|Non Compliance with the Protocol|20|||
105583127|NCT00924560|364131815|FG001|Overall Study|Non Compliance with the Protocol|15|||
105583128|NCT00924560|364131816|FG002|Overall Study|Non Compliance with the Protocol|4|||
105583129|NCT00924560|364131814|FG000|Overall Study|Physician Decision|2|||
105583130|NCT00924560|364131815|FG001|Overall Study|Physician Decision|3|||
105583131|NCT00924560|364131816|FG002|Overall Study|Physician Decision|4|||
105583132|NCT00924560|364131814|FG000|Overall Study|Withdrawal by Subject|50|||
105583133|NCT00924560|364131815|FG001|Overall Study|Withdrawal by Subject|44|||
105415635|NCT04115748|363527548|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
105415636|NCT04115748|363527549|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
105415637|NCT04115748|363527550|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
105415638|NCT04115748|363527551|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
105415639|NCT04115748|363527552|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
105415640|NCT04115748|363527543|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105415641|NCT04115748|363527544|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105415642|NCT04115748|363527545|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105415643|NCT04115748|363527546|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105415644|NCT04115748|363527547|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105415645|NCT04115748|363527548|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105415646|NCT04115748|363527549|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105415647|NCT04115748|363527550|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105415648|NCT04115748|363527551|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
105415649|NCT04115748|363527552|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105415650|NCT01200407|363527553|FG000|Overall Study|Lost to Follow-up|56|||
105415651|NCT01200407|363527553|FG000|Overall Study|Adverse Event|3|||
105415652|NCT01200407|363527553|FG000|Overall Study|Withdrawal by Subject|4|||
105415653|NCT01200407|363527553|FG000|Overall Study|Other|19|||
105415654|NCT00473668|363527554|FG000|Overall Study|Withdrawal by Subject|0|||
105415655|NCT00473668|363527555|FG001|Overall Study|Withdrawal by Subject|2|||
105415656|NCT00473668|363527556|FG002|Overall Study|Withdrawal by Subject|0|||
105415657|NCT00473668|363527554|FG000|Overall Study|Migrated/moved from study area|3|||
105415658|NCT00473668|363527555|FG001|Overall Study|Migrated/moved from study area|2|||
105415659|NCT00473668|363527556|FG002|Overall Study|Migrated/moved from study area|0|||
105415660|NCT00473668|363527554|FG000|Overall Study|Lost to Follow-up|0|||
105415661|NCT00473668|363527555|FG001|Overall Study|Lost to Follow-up|4|||
105415662|NCT00473668|363527556|FG002|Overall Study|Lost to Follow-up|6|||
105415663|NCT00473668|363527554|FG000|Overall Study|Other|2|||
105415664|NCT00473668|363527555|FG001|Overall Study|Other|3|||
105415665|NCT00473668|363527556|FG002|Overall Study|Other|4|||
105415666|NCT00334815|363527557|FG000|Overall Study|Adverse Event|3|||
105415667|NCT00334815|363527558|FG001|Overall Study|Adverse Event|2|||
105415668|NCT00334815|363527557|FG000|Overall Study|Death|0|||
105415669|NCT00334815|363527558|FG001|Overall Study|Death|2|||
105415670|NCT00334815|363527557|FG000|Overall Study|Progression|1|||
105415671|NCT00334815|363527558|FG001|Overall Study|Progression|0|||
105415672|NCT00334815|363527557|FG000|Overall Study|ineligible|1|||
105415673|NCT00334815|363527558|FG001|Overall Study|ineligible|1|||
105415674|NCT00334815|363527557|FG000|Overall Study|patient refused treatment|0|||
105415675|NCT00334815|363527558|FG001|Overall Study|patient refused treatment|1|||
105415676|NCT00334815|363527557|FG000|Overall Study|Physician Decision|2|||
105415677|NCT00334815|363527558|FG001|Overall Study|Physician Decision|4|||
105415678|NCT00438360|363527561|FG000|Overall Study|Adverse Event|6|||
105415679|NCT00438360|363527562|FG001|Overall Study|Adverse Event|1|||
105415680|NCT00438360|363527561|FG000|Overall Study|Lack of Efficacy|42|||
105415681|NCT00438360|363527562|FG001|Overall Study|Lack of Efficacy|27|||
105415682|NCT00438360|363527561|FG000|Overall Study|Other|24|||
105415683|NCT00438360|363527562|FG001|Overall Study|Other|15|||
105415684|NCT02957747|363527563|FG000|Overall Study|Withdrawal by Subject|0|||
105415685|NCT02957747|363527564|FG001|Overall Study|Withdrawal by Subject|3|||
105415686|NCT02957747|363527563|FG000|Overall Study|Lost to Follow-up|10|||
105415687|NCT02957747|363527564|FG001|Overall Study|Lost to Follow-up|5|||
105415688|NCT03497975|363527565|FG000|Overall Study|Withdrew Consent|34|||
105415689|NCT03497975|363527566|FG001|Overall Study|Withdrew Consent|35|||
105415690|NCT03497975|363527565|FG000|Overall Study|Lost to Follow-up|7|||
105415691|NCT03497975|363527566|FG001|Overall Study|Lost to Follow-up|7|||
105415692|NCT03497975|363527565|FG000|Overall Study|Physician Decision|4|||
105415693|NCT03497975|363527566|FG001|Overall Study|Physician Decision|5|||
105415694|NCT03497975|363527565|FG000|Overall Study|Discontinued|42|||
105415695|NCT03497975|363527566|FG001|Overall Study|Discontinued|39|||
105583134|NCT00924560|364131816|FG002|Overall Study|Withdrawal by Subject|18|||
105497974|NCT02215096|363834283|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
105497975|NCT02215096|363834284|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
105497976|NCT02215096|363834285|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
105497977|NCT02215096|363834281|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
105497978|NCT02215096|363834282|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
105497979|NCT02215096|363834283|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
105497980|NCT02215096|363834284|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
105497981|NCT02215096|363834285|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
105497982|NCT02215096|363834281|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
105497983|NCT02215096|363834282|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
105415696|NCT03497975|363527565|FG000|Overall Study|Reason Not Specified|15|||
105415697|NCT03497975|363527566|FG001|Overall Study|Reason Not Specified|14|||
105415698|NCT05286658|363527568|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
105415699|NCT05286658|363527568|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
105415700|NCT00610857|363527572|FG000|Overall Study|Not evaluable for response|2|||
105415701|NCT00842153|363527573|FG000|Overall Study|Adverse Event|0|||
105415702|NCT00842153|363527574|FG001|Overall Study|Adverse Event|1|||
105415703|NCT00842153|363527573|FG000|Overall Study|Lost to Follow-up|1|||
105415704|NCT00842153|363527574|FG001|Overall Study|Lost to Follow-up|2|||
105415705|NCT00054327|363527578|FG000|Overall Study|Engraftment failure|1|||
105415706|NCT00054327|363527579|FG001|Overall Study|Engraftment failure|0|||
105415707|NCT00054327|363527580|FG002|Overall Study|Engraftment failure|0|||
105415708|NCT00054327|363527581|FG003|Overall Study|Engraftment failure|0|||
105415709|NCT00054327|363527582|FG004|Overall Study|Engraftment failure|0|||
105415710|NCT00054327|363527583|FG005|Overall Study|Engraftment failure|0|||
105415711|NCT00613327|363527587|FG000|Overall Study|Adverse Event|38|||
105415712|NCT00613327|363527587|FG000|Overall Study|Lost to Follow-up|8|||
105415713|NCT00613327|363527587|FG000|Overall Study|Withdrawal by Subject|6|||
105415714|NCT00613327|363527587|FG000|Overall Study|Protocol Violation|2|||
105415715|NCT00613327|363527587|FG000|Overall Study|Other|47|||
105415716|NCT00700882|363527588|FG000|Overall Study|Never received treatment|6|||
105415717|NCT00700882|363527588|FG000|Overall Study|Ineligible|2|||
105415718|NCT00700882|363527588|FG000|Overall Study|No KIT mutation|51|||
105415719|NCT00361231|363527594|FG000|Overall Study|Physician Decision|3|||
105415720|NCT00361231|363527594|FG000|Overall Study|Symptomatic deterioration|5|||
105415721|NCT00361231|363527594|FG000|Overall Study|Radiographic disease progression|16|||
105415722|NCT00361231|363527594|FG000|Overall Study|Withdrawal by Subject|4|||
105415723|NCT00361231|363527594|FG000|Overall Study|Adverse Event|6|||
105415724|NCT04731298|363527607|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
105415725|NCT04731298|363527608|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
105415726|NCT03718884|363527618|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
105415727|NCT03718884|363527619|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
105415728|NCT03718884|363527618|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
105415729|NCT03718884|363527619|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
105415730|NCT03594747|363527627|FG000|Overall Study|Death|78|||
105415731|NCT03594747|363527628|FG001|Overall Study|Death|86|||
105415732|NCT03594747|363527629|FG002|Overall Study|Death|87|||
105415733|NCT03594747|363527627|FG000|Overall Study|Withdrawal by Subject|5|||
105415734|NCT03594747|363527628|FG001|Overall Study|Withdrawal by Subject|2|||
105415735|NCT03594747|363527629|FG002|Overall Study|Withdrawal by Subject|11|||
105415736|NCT03594747|363527627|FG000|Overall Study|Lost to Follow-up|4|||
105415737|NCT03594747|363527628|FG001|Overall Study|Lost to Follow-up|1|||
105415738|NCT03594747|363527629|FG002|Overall Study|Lost to Follow-up|1|||
105415739|NCT03594747|363527627|FG000|Overall Study|Physician Decision|0|||
105415740|NCT03594747|363527628|FG001|Overall Study|Physician Decision|1|||
105415741|NCT03594747|363527629|FG002|Overall Study|Physician Decision|0|||
105415742|NCT03594747|363527627|FG000|Overall Study|Sponsor decision|23|||
105415743|NCT03594747|363527628|FG001|Overall Study|Sponsor decision|17|||
105415744|NCT03594747|363527629|FG002|Overall Study|Sponsor decision|16|||
105415745|NCT03594747|363527627|FG000|Overall Study|Did not meet inclusion criteria|0|||
105415746|NCT03594747|363527628|FG001|Overall Study|Did not meet inclusion criteria|0|||
105415747|NCT03594747|363527629|FG002|Overall Study|Did not meet inclusion criteria|1|||
105415748|NCT03594747|363527627|FG000|Overall Study|Transfer to long term extension study|10|||
105415749|NCT03594747|363527628|FG001|Overall Study|Transfer to long term extension study|12|||
105415750|NCT03594747|363527629|FG002|Overall Study|Transfer to long term extension study|5|||
105415751|NCT04382586|363527630|FG000|Overall Study|Death|3|||
105415752|NCT04382586|363527631|FG001|Overall Study|Death|4|||
105415753|NCT04382586|363527630|FG000|Overall Study|Lost to Follow-up|11|||
105415754|NCT04382586|363527631|FG001|Overall Study|Lost to Follow-up|8|||
105415755|NCT04382586|363527630|FG000|Overall Study|Withdrawal by Subject|3|||
105415756|NCT04382586|363527631|FG001|Overall Study|Withdrawal by Subject|1|||
105415757|NCT04382586|363527630|FG000|Overall Study|Physician Decision|0|||
105415758|NCT04382586|363527631|FG001|Overall Study|Physician Decision|3|||
105415759|NCT03335150|363527633|FG000|Overall Study|Withdrawal by Subject|10|||
105583135|NCT00924560|364131814|FG000|Overall Study|Adverse Event|39|||
105583136|NCT00924560|364131815|FG001|Overall Study|Adverse Event|33|||
105583137|NCT00924560|364131816|FG002|Overall Study|Adverse Event|0|||
105415760|NCT03335150|363527634|FG001|Overall Study|Withdrawal by Subject|4|||
105415761|NCT03335150|363527633|FG000|Overall Study|Adverse Event|0|||
105415762|NCT03335150|363527634|FG001|Overall Study|Adverse Event|1|||
105583138|NCT00924560|364131814|FG000|Overall Study|Pregnancy|5|||
105583139|NCT00924560|364131815|FG001|Overall Study|Pregnancy|7|||
105583140|NCT00924560|364131816|FG002|Overall Study|Pregnancy|1|||
105583141|NCT00924560|364131814|FG000|Overall Study|Lost to Follow-up|78|||
105583142|NCT00924560|364131815|FG001|Overall Study|Lost to Follow-up|94|||
105583143|NCT00924560|364131816|FG002|Overall Study|Lost to Follow-up|45|||
105583144|NCT00924560|364131814|FG000|Overall Study|Miscellaneous Reasons|13|||
105583145|NCT00924560|364131815|FG001|Overall Study|Miscellaneous Reasons|10|||
105415763|NCT00349349|363527635|FG000|Overall Study|Adverse Event|5|||
105415764|NCT00349349|363527636|FG001|Overall Study|Adverse Event|6|||
105415765|NCT00349349|363527637|FG002|Overall Study|Adverse Event|2|||
105415766|NCT00349349|363527635|FG000|Overall Study|Withdrawal by Subject|5|||
105415767|NCT00349349|363527636|FG001|Overall Study|Withdrawal by Subject|2|||
105415768|NCT00349349|363527637|FG002|Overall Study|Withdrawal by Subject|1|||
105415769|NCT00349349|363527635|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
105415770|NCT00349349|363527636|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
105415771|NCT00349349|363527637|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
105415772|NCT00349349|363527635|FG000|Overall Study|Death|13|||
105415773|NCT00349349|363527636|FG001|Overall Study|Death|10|||
105415774|NCT00349349|363527637|FG002|Overall Study|Death|1|||
105415775|NCT00349349|363527635|FG000|Overall Study|Other Treatment Selected|2|||
105415776|NCT00349349|363527636|FG001|Overall Study|Other Treatment Selected|0|||
105415777|NCT00349349|363527637|FG002|Overall Study|Other Treatment Selected|0|||
105415778|NCT00349349|363527635|FG000|Overall Study|Participant Reduced General Condition|0|||
105415779|NCT00349349|363527636|FG001|Overall Study|Participant Reduced General Condition|1|||
105415780|NCT00349349|363527637|FG002|Overall Study|Participant Reduced General Condition|0|||
105415781|NCT00349349|363527635|FG000|Overall Study|Physician Decision|1|||
105415782|NCT00349349|363527636|FG001|Overall Study|Physician Decision|2|||
105415783|NCT00349349|363527637|FG002|Overall Study|Physician Decision|1|||
105415784|NCT00349349|363527635|FG000|Overall Study|No Response|0|||
105415785|NCT00349349|363527636|FG001|Overall Study|No Response|3|||
105415786|NCT00349349|363527637|FG002|Overall Study|No Response|0|||
105415787|NCT00349349|363527635|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
105415788|NCT00349349|363527636|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
105415789|NCT00349349|363527637|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
105415790|NCT02097719|363527639|FG000|Overall Study|Subject Withdrew Consent|1|||
105415791|NCT02097719|363527640|FG001|Overall Study|Subject Withdrew Consent|0|||
105415792|NCT02097719|363527639|FG000|Overall Study|Lost to Follow-up|0|||
105415793|NCT02097719|363527640|FG001|Overall Study|Lost to Follow-up|1|||
105415794|NCT02097719|363527639|FG000|Overall Study|Adverse Event|2|||
105415795|NCT02097719|363527640|FG001|Overall Study|Adverse Event|0|||
105415796|NCT03028415|363527641|FG000|Overall Study|Lost to Follow-up|6|||
105415797|NCT03028415|363527642|FG001|Overall Study|Lost to Follow-up|3|||
105415798|NCT03028415|363527641|FG000|Overall Study|Withdrawal by Subject|1|||
105415799|NCT03028415|363527642|FG001|Overall Study|Withdrawal by Subject|0|||
105415800|NCT03028415|363527641|FG000|Overall Study|Discontinued due to COVID-19|1|||
105415801|NCT03028415|363527642|FG001|Overall Study|Discontinued due to COVID-19|0|||
105415802|NCT01946529|363527648|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
105415803|NCT01946529|363527649|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
105415804|NCT01946529|363527650|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
105415805|NCT01946529|363527648|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
105415806|NCT01946529|363527649|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
105415807|NCT01946529|363527650|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
105415808|NCT00980538|363527651|FG000|Overall Study|Lost to Follow-up|20|||
105415809|NCT00980538|363527651|FG000|Overall Study|Sponsor's Decision|4|||
105415810|NCT00980538|363527651|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
105415811|NCT00980538|363527651|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
105415812|NCT00980538|363527651|FG000|Overall Study|Switch to Commercially Available Medication|25|||
105415813|NCT00980538|363527651|FG000|Overall Study|Participant Non-Compliant|9|||
105415814|NCT00980538|363527651|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
105415815|NCT00980538|363527651|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
105415816|NCT00980538|363527651|FG000|Overall Study|Other|60|||
105415817|NCT00980538|363527651|FG000|Overall Study|Other|1|||
105415818|NCT03802630|363527652|FG000|Overall Study|Study terminated by sponsor|130|||
105583146|NCT00924560|364131816|FG002|Overall Study|Miscellaneous Reasons|10|||
105583147|NCT03673098|364133783|FG000|Overall Study|Lost to Follow-up|2|||
105583148|NCT03673098|364133784|FG001|Overall Study|Lost to Follow-up|3|||
105583149|NCT03673098|364133783|FG000|Overall Study|Withdrawal by Subject|6|||
105583150|NCT03673098|364133784|FG001|Overall Study|Withdrawal by Subject|1|||
105583151|NCT03673098|364133783|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
105583152|NCT03673098|364133784|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
105583153|NCT03850444|364133785|FG000|Overall Study|Adverse Event|16|||
105583154|NCT03850444|364133786|FG001|Overall Study|Adverse Event|10|||
105583155|NCT03850444|364133785|FG000|Overall Study|Death|87|||
105583156|NCT03850444|364133786|FG001|Overall Study|Death|107|||
105583157|NCT03850444|364133785|FG000|Overall Study|Lost to Follow-up|1|||
105583158|NCT03850444|364133786|FG001|Overall Study|Lost to Follow-up|1|||
105583159|NCT03850444|364133785|FG000|Overall Study|Withdrawal by Subject|1|||
105583160|NCT03850444|364133786|FG001|Overall Study|Withdrawal by Subject|5|||
105583161|NCT03850444|364133785|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
105583162|NCT03850444|364133786|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
105583163|NCT01118962|364133788|FG000|Overall Study|Adverse Event|2|||
105583164|NCT01118962|364133788|FG000|Overall Study|Lack of Efficacy|1|||
105583165|NCT01118962|364133788|FG000|Overall Study|Protocol Violation|1|||
105583166|NCT01118962|364133788|FG000|Overall Study|Withdrawal by Subject|4|||
105583167|NCT01118962|364133788|FG000|Overall Study|Pregnancy|1|||
105583168|NCT01118962|364133788|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
105583169|NCT00795132|364133789|FG000|Overall Study|Death|1|||
105583170|NCT00795132|364133789|FG000|Overall Study|Relapse|2|||
105583171|NCT00765362|364133792|FG000|Overall Study|Death|9|||
105583172|NCT00765362|364133792|FG000|Overall Study|Adverse Event|2|||
105583173|NCT00765362|364133792|FG000|Overall Study|Protocol Violation|18|||
105583174|NCT00765362|364133792|FG000|Overall Study|Withdrawal by Subject|13|||
105583175|NCT00765362|364133792|FG000|Overall Study|Lost to Follow-up|95|||
105583176|NCT03930186|364133793|FG000|Weeks 0 to 16|Adverse Event|6|||
105583177|NCT03930186|364133793|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
105583178|NCT03930186|364133793|FG000|Weeks 16 to 32|Adverse Event|1|||
105583179|NCT03930186|364133793|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
105583180|NCT00557505|364133795|FG000|Overall Study|Death|0|||
105583181|NCT00557505|364133796|FG001|Overall Study|Death|0|||
105583182|NCT00557505|364133797|FG002|Overall Study|Death|0|||
105583183|NCT00557505|364133798|FG003|Overall Study|Death|0|||
105583184|NCT00557505|364133799|FG004|Overall Study|Death|0|||
105583185|NCT00557505|364133800|FG005|Overall Study|Death|0|||
105583186|NCT00557505|364133801|FG006|Overall Study|Death|0|||
105583187|NCT00557505|364133802|FG007|Overall Study|Death|0|||
105583188|NCT00557505|364133803|FG008|Overall Study|Death|1|||
105583189|NCT00557505|364133795|FG000|Overall Study|Adverse Event|0|||
105583190|NCT00557505|364133796|FG001|Overall Study|Adverse Event|0|||
105583191|NCT00557505|364133797|FG002|Overall Study|Adverse Event|1|||
105583192|NCT00557505|364133798|FG003|Overall Study|Adverse Event|0|||
105583193|NCT00557505|364133799|FG004|Overall Study|Adverse Event|0|||
105583194|NCT00557505|364133800|FG005|Overall Study|Adverse Event|0|||
105583195|NCT00557505|364133801|FG006|Overall Study|Adverse Event|1|||
105583196|NCT00557505|364133802|FG007|Overall Study|Adverse Event|0|||
105583197|NCT00557505|364133803|FG008|Overall Study|Adverse Event|0|||
105583198|NCT00557505|364133795|FG000|Overall Study|Global deterioration of health|1|||
105583199|NCT00557505|364133796|FG001|Overall Study|Global deterioration of health|0|||
105583200|NCT00557505|364133797|FG002|Overall Study|Global deterioration of health|0|||
105583201|NCT00557505|364133798|FG003|Overall Study|Global deterioration of health|0|||
105583202|NCT00557505|364133799|FG004|Overall Study|Global deterioration of health|0|||
105583203|NCT00557505|364133800|FG005|Overall Study|Global deterioration of health|0|||
105583204|NCT00557505|364133801|FG006|Overall Study|Global deterioration of health|0|||
105583205|NCT00557505|364133802|FG007|Overall Study|Global deterioration of health|0|||
105583206|NCT00557505|364133803|FG008|Overall Study|Global deterioration of health|0|||
105583207|NCT00557505|364133795|FG000|Overall Study|Objective progression or relapse|2|||
105583208|NCT00557505|364133796|FG001|Overall Study|Objective progression or relapse|3|||
105583209|NCT00557505|364133797|FG002|Overall Study|Objective progression or relapse|3|||
105583210|NCT00557505|364133798|FG003|Overall Study|Objective progression or relapse|2|||
105583211|NCT00557505|364133799|FG004|Overall Study|Objective progression or relapse|2|||
105583212|NCT00557505|364133800|FG005|Overall Study|Objective progression or relapse|3|||
105583213|NCT00557505|364133801|FG006|Overall Study|Objective progression or relapse|2|||
105583214|NCT00557505|364133802|FG007|Overall Study|Objective progression or relapse|5|||
105583215|NCT00557505|364133803|FG008|Overall Study|Objective progression or relapse|15|||
105583216|NCT00557505|364133795|FG000|Overall Study|Withdrawal by Subject|0|||
105583217|NCT00557505|364133796|FG001|Overall Study|Withdrawal by Subject|0|||
105583218|NCT00557505|364133797|FG002|Overall Study|Withdrawal by Subject|0|||
105583219|NCT00557505|364133798|FG003|Overall Study|Withdrawal by Subject|1|||
105583220|NCT00557505|364133799|FG004|Overall Study|Withdrawal by Subject|0|||
105583221|NCT00557505|364133800|FG005|Overall Study|Withdrawal by Subject|0|||
105583222|NCT00557505|364133801|FG006|Overall Study|Withdrawal by Subject|0|||
105583223|NCT00557505|364133802|FG007|Overall Study|Withdrawal by Subject|0|||
105415819|NCT03802630|363527653|FG001|Overall Study|Study terminated by sponsor|134|||
105415820|NCT03802630|363527652|FG000|Overall Study|Subject decision|16|||
105415821|NCT03802630|363527653|FG001|Overall Study|Subject decision|9|||
105415822|NCT03802630|363527652|FG000|Overall Study|Adverse Event|3|||
105415823|NCT03802630|363527653|FG001|Overall Study|Adverse Event|1|||
105415824|NCT03802630|363527652|FG000|Overall Study|Lost to Follow-up|2|||
105415825|NCT03802630|363527653|FG001|Overall Study|Lost to Follow-up|2|||
105415826|NCT03802630|363527652|FG000|Overall Study|Physician Decision|2|||
105415827|NCT03802630|363527653|FG001|Overall Study|Physician Decision|0|||
105415828|NCT03802630|363527652|FG000|Overall Study|Death|0|||
105415829|NCT03802630|363527653|FG001|Overall Study|Death|2|||
105497984|NCT02215096|363834283|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
105497985|NCT02215096|363834284|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
105497986|NCT02215096|363834285|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
105497987|NCT01903031|363834286|FG000|Overall Study|Not Able to Attend Clinic|1|||
105497988|NCT01903031|363834287|FG001|Overall Study|Not Able to Attend Clinic|1|||
105497989|NCT01903031|363834288|FG002|Overall Study|Not Able to Attend Clinic|0|||
105497990|NCT01903031|363834286|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
105497991|NCT01903031|363834287|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
105497992|NCT01903031|363834288|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
105497993|NCT01903031|363834286|FG000|Overall Study|Adverse Event|0|||
105497994|NCT01903031|363834287|FG001|Overall Study|Adverse Event|1|||
105497995|NCT01903031|363834288|FG002|Overall Study|Adverse Event|0|||
105497996|NCT01903031|363834286|FG000|Overall Study|Withdrawal by Subject|0|||
105497997|NCT01903031|363834287|FG001|Overall Study|Withdrawal by Subject|1|||
105497998|NCT01903031|363834288|FG002|Overall Study|Withdrawal by Subject|1|||
105497999|NCT01903031|363834286|FG000|Overall Study|Protocol Violation|0|||
105498000|NCT01903031|363834287|FG001|Overall Study|Protocol Violation|0|||
105498001|NCT01903031|363834288|FG002|Overall Study|Protocol Violation|2|||
105498002|NCT01903031|363834286|FG000|Overall Study|Lost to Follow-up|0|||
105498003|NCT01903031|363834287|FG001|Overall Study|Lost to Follow-up|0|||
105498004|NCT01903031|363834288|FG002|Overall Study|Lost to Follow-up|1|||
105498005|NCT01903031|363834286|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
105498006|NCT01903031|363834287|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
105498007|NCT01903031|363834288|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
105498008|NCT03896165|363834289|FG000|Overall Study|Withdrawal by Subject|2|||
105498009|NCT01811225|363834290|FG000|Treatment Period 1|Adverse Event|2|||
105498010|NCT01811225|363834291|FG001|Treatment Period 1|Adverse Event|3|||
105498011|NCT01811225|363834290|FG000|Treatment Period 1|Lost to Follow-up|12|||
105498012|NCT01811225|363834291|FG001|Treatment Period 1|Lost to Follow-up|8|||
105498013|NCT01811225|363834290|FG000|Treatment Period 1|transporation|1|||
105498014|NCT01811225|363834291|FG001|Treatment Period 1|transporation|0|||
105498015|NCT01811225|363834290|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
105498016|NCT01811225|363834291|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
105498017|NCT01811225|363834290|FG000|Treatment Period 2|Lost to Follow-up|1|||
105498018|NCT01811225|363834291|FG001|Treatment Period 2|Lost to Follow-up|2|||
105498019|NCT01811225|363834290|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
105498020|NCT01811225|363834291|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
105498021|NCT03181893|363834292|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
105498022|NCT03181893|363834293|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
105498023|NCT03181893|363834294|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
105498024|NCT03181893|363834295|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
105498025|NCT03181893|363834296|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
105498026|NCT03181893|363834297|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
105498027|NCT03181893|363834298|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
105415830|NCT01108731|363527654|FG000|Overall Study|Withdrawal by Subject|1|||
105415831|NCT01108731|363527655|FG001|Overall Study|Withdrawal by Subject|1|||
105415832|NCT01108731|363527654|FG000|Overall Study|Adverse Event|3|||
105415833|NCT01108731|363527655|FG001|Overall Study|Adverse Event|3|||
105415834|NCT01063062|363527656|FG000|Overall Study|Patient withdrew consent|0|||
105498028|NCT03181893|363834299|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
105498029|NCT03181893|363834300|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
105498030|NCT03181893|363834301|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
105498031|NCT03181893|363834302|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
105498032|NCT03181893|363834292|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
105498033|NCT03181893|363834293|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
105498034|NCT03181893|363834294|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
105498035|NCT03181893|363834295|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
105498036|NCT03181893|363834296|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
105498037|NCT03181893|363834297|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
105498038|NCT03181893|363834298|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
105498039|NCT03181893|363834299|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
105498040|NCT03181893|363834300|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
105583224|NCT00557505|364133803|FG008|Overall Study|Withdrawal by Subject|1|||
105583225|NCT01244763|364133806|FG000|Overall Study|Adverse Event|1|||
105583226|NCT01244763|364133807|FG001|Overall Study|Adverse Event|0|||
105583227|NCT01244763|364133808|FG002|Overall Study|Adverse Event|0|||
105583228|NCT01244763|364133809|FG003|Overall Study|Adverse Event|0|||
105583229|NCT01244763|364133810|FG004|Overall Study|Adverse Event|0|||
105583230|NCT01244763|364133811|FG005|Overall Study|Adverse Event|1|||
105583231|NCT01244763|364133806|FG000|Overall Study|Death|1|||
105583232|NCT01244763|364133807|FG001|Overall Study|Death|0|||
105583233|NCT01244763|364133808|FG002|Overall Study|Death|1|||
105583234|NCT01244763|364133809|FG003|Overall Study|Death|0|||
105583235|NCT01244763|364133810|FG004|Overall Study|Death|2|||
105583236|NCT01244763|364133811|FG005|Overall Study|Death|0|||
105583237|NCT01244763|364133806|FG000|Overall Study|Physician Decision|0|||
105583238|NCT01244763|364133807|FG001|Overall Study|Physician Decision|0|||
105583239|NCT01244763|364133808|FG002|Overall Study|Physician Decision|1|||
105583240|NCT01244763|364133809|FG003|Overall Study|Physician Decision|0|||
105583241|NCT01244763|364133810|FG004|Overall Study|Physician Decision|0|||
105583242|NCT01244763|364133811|FG005|Overall Study|Physician Decision|0|||
105583243|NCT01244763|364133806|FG000|Overall Study|Withdrawal by Subject|1|||
105583244|NCT01244763|364133807|FG001|Overall Study|Withdrawal by Subject|2|||
105583245|NCT01244763|364133808|FG002|Overall Study|Withdrawal by Subject|0|||
105583246|NCT01244763|364133809|FG003|Overall Study|Withdrawal by Subject|1|||
105583247|NCT01244763|364133810|FG004|Overall Study|Withdrawal by Subject|1|||
105583248|NCT01244763|364133811|FG005|Overall Study|Withdrawal by Subject|2|||
105583249|NCT01244763|364133806|FG000|Overall Study|Lost to Follow-up|0|||
105583250|NCT01244763|364133807|FG001|Overall Study|Lost to Follow-up|1|||
105583251|NCT01244763|364133808|FG002|Overall Study|Lost to Follow-up|0|||
105583252|NCT01244763|364133809|FG003|Overall Study|Lost to Follow-up|0|||
105583253|NCT01244763|364133810|FG004|Overall Study|Lost to Follow-up|0|||
105583254|NCT01244763|364133811|FG005|Overall Study|Lost to Follow-up|0|||
105583255|NCT01244763|364133806|FG000|Overall Study|Enrolled into the Extension Study|0|||
105583256|NCT01244763|364133807|FG001|Overall Study|Enrolled into the Extension Study|0|||
105583257|NCT01244763|364133808|FG002|Overall Study|Enrolled into the Extension Study|0|||
105583258|NCT01244763|364133809|FG003|Overall Study|Enrolled into the Extension Study|0|||
105583259|NCT01244763|364133810|FG004|Overall Study|Enrolled into the Extension Study|0|||
105583260|NCT01244763|364133811|FG005|Overall Study|Enrolled into the Extension Study|1|||
105583261|NCT03330119|364133816|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
105583262|NCT03330119|364133817|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
105583263|NCT00664521|364133826|FG000|Overall Study|Adverse Event|4|||
105583264|NCT00664521|364133827|FG001|Overall Study|Adverse Event|1|||
105583265|NCT00664521|364133826|FG000|Overall Study|Lost to Follow-up|1|||
105583266|NCT00664521|364133827|FG001|Overall Study|Lost to Follow-up|0|||
105583267|NCT00664521|364133826|FG000|Overall Study|Other|1|||
105583268|NCT00664521|364133827|FG001|Overall Study|Other|0|||
105583269|NCT02459964|364133828|FG000|Overall Study|Withdrawal by Subject|0|||
105583270|NCT02459964|364133829|FG001|Overall Study|Withdrawal by Subject|0|||
105583271|NCT02459964|364133830|FG002|Overall Study|Withdrawal by Subject|1|||
105583272|NCT02459964|364133828|FG000|Overall Study|Abnormal EKG changes|0|||
105583273|NCT02459964|364133829|FG001|Overall Study|Abnormal EKG changes|0|||
105583274|NCT02459964|364133830|FG002|Overall Study|Abnormal EKG changes|1|||
105583275|NCT00367237|364133831|FG000|Overall Study|Adverse Event|7|||
105583276|NCT00367237|364133832|FG001|Overall Study|Adverse Event|2|||
105583277|NCT00367237|364133831|FG000|Overall Study|Lost to Follow-up|1|||
105583278|NCT00367237|364133832|FG001|Overall Study|Lost to Follow-up|0|||
105583279|NCT00367237|364133831|FG000|Overall Study|Withdrawal by Subject|0|||
105583280|NCT00367237|364133832|FG001|Overall Study|Withdrawal by Subject|4|||
105583281|NCT00367237|364133831|FG000|Overall Study|Protocol Violation|2|||
105583282|NCT00367237|364133832|FG001|Overall Study|Protocol Violation|5|||
105583283|NCT02886728|364133834|FG000|Overall Study|Withdrew Consent|31|||
105583284|NCT02886728|364133835|FG001|Overall Study|Withdrew Consent|13|||
105583285|NCT02886728|364133836|FG002|Overall Study|Withdrew Consent|11|||
105583286|NCT02886728|364133837|FG003|Overall Study|Withdrew Consent|47|||
105583287|NCT02886728|364133834|FG000|Overall Study|Lost to Follow-up|12|||
105583288|NCT02886728|364133835|FG001|Overall Study|Lost to Follow-up|6|||
105583289|NCT02886728|364133836|FG002|Overall Study|Lost to Follow-up|13|||
105583290|NCT02886728|364133837|FG003|Overall Study|Lost to Follow-up|12|||
105583291|NCT02886728|364133834|FG000|Overall Study|Adverse Event|13|||
105583292|NCT02886728|364133835|FG001|Overall Study|Adverse Event|5|||
105583293|NCT02886728|364133836|FG002|Overall Study|Adverse Event|5|||
105583294|NCT02886728|364133837|FG003|Overall Study|Adverse Event|11|||
105583295|NCT02886728|364133834|FG000|Overall Study|Investigator's Discretion|11|||
105583296|NCT02886728|364133835|FG001|Overall Study|Investigator's Discretion|7|||
105583297|NCT02886728|364133836|FG002|Overall Study|Investigator's Discretion|5|||
105583298|NCT02886728|364133837|FG003|Overall Study|Investigator's Discretion|11|||
105583299|NCT02886728|364133834|FG000|Overall Study|Death|3|||
105583300|NCT02886728|364133835|FG001|Overall Study|Death|1|||
105583301|NCT02886728|364133836|FG002|Overall Study|Death|0|||
105415835|NCT01063062|363527657|FG001|Overall Study|Patient withdrew consent|1|||
105415836|NCT01063062|363527656|FG000|Overall Study|Adverse Event|2|||
105498041|NCT03181893|363834301|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
105498042|NCT03181893|363834302|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
105498043|NCT03181893|363834292|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
105498044|NCT03181893|363834293|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
105498045|NCT03181893|363834294|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
105498046|NCT03181893|363834295|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
105498047|NCT03181893|363834296|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
105498048|NCT03181893|363834297|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
105498049|NCT03181893|363834298|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
105498050|NCT03181893|363834299|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
105498051|NCT03181893|363834300|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
105498052|NCT03181893|363834301|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
105498053|NCT03181893|363834302|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
105498054|NCT03181893|363834292|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
105498055|NCT03181893|363834293|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
105498056|NCT03181893|363834294|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
105498057|NCT03181893|363834295|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
105498058|NCT03181893|363834296|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
105498059|NCT03181893|363834297|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
105498060|NCT03181893|363834298|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
105498061|NCT03181893|363834299|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
105498062|NCT03181893|363834300|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
105498063|NCT03181893|363834301|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
105498064|NCT03181893|363834302|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
105498065|NCT03181893|363834292|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
105498066|NCT03181893|363834293|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
105498067|NCT03181893|363834294|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
105498068|NCT03181893|363834295|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
105498069|NCT03181893|363834296|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
105498070|NCT03181893|363834297|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
105498071|NCT03181893|363834298|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
105498072|NCT03181893|363834299|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
105498073|NCT03181893|363834300|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
105498074|NCT03181893|363834301|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
105498075|NCT03181893|363834302|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
105498076|NCT02158975|363834303|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
105498077|NCT03000569|363834304|FG000|Overall Study|Withdrawal by Subject|1|||
105498078|NCT03000569|363834305|FG001|Overall Study|Withdrawal by Subject|0|||
105498079|NCT02298023|363834308|FG000|Overall Study|Withdrawal by Subject|1|||
105498080|NCT02298023|363834309|FG001|Overall Study|Withdrawal by Subject|0|||
105498081|NCT02298023|363834310|FG002|Overall Study|Withdrawal by Subject|0|||
105415837|NCT01063062|363527657|FG001|Overall Study|Adverse Event|4|||
105415838|NCT01063062|363527656|FG000|Overall Study|Protocol Violation|5|||
105415839|NCT01063062|363527657|FG001|Overall Study|Protocol Violation|4|||
105415840|NCT01063062|363527656|FG000|Overall Study|Investigator's request|1|||
105415841|NCT01063062|363527657|FG001|Overall Study|Investigator's request|0|||
105415842|NCT01063062|363527656|FG000|Overall Study|Lost to Follow-up|0|||
105415843|NCT01063062|363527657|FG001|Overall Study|Lost to Follow-up|2|||
105415844|NCT01063062|363527656|FG000|Overall Study|Miscellaneous reason|0|||
105415845|NCT01063062|363527657|FG001|Overall Study|Miscellaneous reason|1|||
105415846|NCT04601532|363527658|FG000|Overall Study|Lost to Follow-up|1|||
105415847|NCT04601532|363527659|FG001|Overall Study|Lost to Follow-up|2|||
105415848|NCT04601532|363527658|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
105415849|NCT04601532|363527659|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
105415850|NCT02597452|363527660|FG000|Overall Study|testing incomplete|30|||
105498082|NCT00968864|363834311|FG000|Overall Study|Protocol exception/ not evaluable|1|||
105498083|NCT02020577|363834313|FG000|Overall Study|Progressive disease|3|||
105415851|NCT01352221|363527661|FG000|Double-blind Phase|Adverse Event|6|||
105415852|NCT01352221|363527662|FG001|Double-blind Phase|Adverse Event|4|||
105498084|NCT02020577|363834314|FG001|Overall Study|Progressive disease|38|||
105498085|NCT02020577|363834313|FG000|Overall Study|Other AE or clinical progression|0|||
105498086|NCT02020577|363834314|FG001|Overall Study|Other AE or clinical progression|15|||
105498087|NCT02020577|363834313|FG000|Overall Study|Withdrawal by Subject|0|||
105498088|NCT02020577|363834314|FG001|Overall Study|Withdrawal by Subject|1|||
105498089|NCT02020577|363834313|FG000|Overall Study|Other than stated above|0|||
105498090|NCT02020577|363834314|FG001|Overall Study|Other than stated above|1|||
105498091|NCT01758523|363834315|FG000|Overall Study|Adverse Event|2|||
105498092|NCT01758523|363834316|FG001|Overall Study|Adverse Event|1|||
105415853|NCT01352221|363527663|FG002|Double-blind Phase|Adverse Event|0|||
105415854|NCT01352221|363527664|FG003|Double-blind Phase|Adverse Event|0|||
105415855|NCT01352221|363527661|FG000|Double-blind Phase|Withdrawal by Subject|3|||
105415856|NCT01352221|363527662|FG001|Double-blind Phase|Withdrawal by Subject|5|||
105415857|NCT01352221|363527663|FG002|Double-blind Phase|Withdrawal by Subject|0|||
105415858|NCT01352221|363527664|FG003|Double-blind Phase|Withdrawal by Subject|0|||
105415859|NCT01352221|363527661|FG000|Double-blind Phase|Lost to Follow-up|0|||
105415860|NCT01352221|363527662|FG001|Double-blind Phase|Lost to Follow-up|1|||
105415861|NCT01352221|363527663|FG002|Double-blind Phase|Lost to Follow-up|0|||
105415862|NCT01352221|363527664|FG003|Double-blind Phase|Lost to Follow-up|0|||
105415863|NCT01352221|363527661|FG000|Double-blind Phase|Protocol Violation|0|||
105415864|NCT01352221|363527662|FG001|Double-blind Phase|Protocol Violation|1|||
105415865|NCT01352221|363527663|FG002|Double-blind Phase|Protocol Violation|0|||
105415866|NCT01352221|363527664|FG003|Double-blind Phase|Protocol Violation|0|||
105415867|NCT01352221|363527661|FG000|Open-label Phase|Physician Decision|0|||
105415868|NCT01352221|363527662|FG001|Open-label Phase|Physician Decision|0|||
105415869|NCT01352221|363527663|FG002|Open-label Phase|Physician Decision|2|||
105415870|NCT01352221|363527664|FG003|Open-label Phase|Physician Decision|1|||
105415871|NCT01352221|363527661|FG000|Open-label Phase|Pregnancy|0|||
105415872|NCT01352221|363527662|FG001|Open-label Phase|Pregnancy|0|||
105415873|NCT01352221|363527663|FG002|Open-label Phase|Pregnancy|1|||
105415874|NCT01352221|363527664|FG003|Open-label Phase|Pregnancy|0|||
105415875|NCT01352221|363527661|FG000|Open-label Phase|Adverse Event|0|||
105415876|NCT01352221|363527662|FG001|Open-label Phase|Adverse Event|0|||
105415877|NCT01352221|363527663|FG002|Open-label Phase|Adverse Event|8|||
105415878|NCT01352221|363527664|FG003|Open-label Phase|Adverse Event|4|||
105415879|NCT01352221|363527661|FG000|Open-label Phase|Withdrawal by Subject|0|||
105415880|NCT01352221|363527662|FG001|Open-label Phase|Withdrawal by Subject|0|||
105415881|NCT01352221|363527663|FG002|Open-label Phase|Withdrawal by Subject|1|||
105415882|NCT01352221|363527664|FG003|Open-label Phase|Withdrawal by Subject|6|||
105415883|NCT01352221|363527661|FG000|Open-label Phase|Worsening of IBD|0|||
105415884|NCT01352221|363527662|FG001|Open-label Phase|Worsening of IBD|0|||
105415885|NCT01352221|363527663|FG002|Open-label Phase|Worsening of IBD|1|||
105415886|NCT01352221|363527664|FG003|Open-label Phase|Worsening of IBD|0|||
105415887|NCT02566785|363527665|FG000|Overall Study|Lost to Follow-up|0|||
105415888|NCT02566785|363527666|FG001|Overall Study|Lost to Follow-up|2|||
105415889|NCT02566785|363527665|FG000|Overall Study|Worsening condition|1|||
105415890|NCT02566785|363527666|FG001|Overall Study|Worsening condition|1|||
105415891|NCT03108521|363527667|FG000|Overall Study|Lost to Follow-up|3|||
105415892|NCT03108521|363527668|FG001|Overall Study|Lost to Follow-up|0|||
105415893|NCT03108521|363527667|FG000|Overall Study|Lack of Efficacy|2|||
105415894|NCT03108521|363527668|FG001|Overall Study|Lack of Efficacy|0|||
105415895|NCT03108521|363527667|FG000|Overall Study|Physician Decision|4|||
105583302|NCT02886728|364133837|FG003|Overall Study|Death|0|||
105583303|NCT02886728|364133834|FG000|Overall Study|Protocol Violation|0|||
105415896|NCT03108521|363527668|FG001|Overall Study|Physician Decision|0|||
105415897|NCT03108521|363527667|FG000|Overall Study|Adverse Event|3|||
105415898|NCT03108521|363527668|FG001|Overall Study|Adverse Event|0|||
105415899|NCT00875485|363529325|FG000|Challenge Dose Epoch|Pregnancy|1|||
105415900|NCT00875485|363529326|FG001|Challenge Dose Epoch|Pregnancy|0|||
105415901|NCT01945216|363529327|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
105415902|NCT01945216|363529327|FG000|Overall Study|Protocol Violation|42|||
105415903|NCT01945216|363529327|FG000|Overall Study|CRF not assured by investigators|5|||
105415904|NCT02920528|363529337|FG000|Overall Study|Incomplete Data|1|||
105415905|NCT02920528|363529338|FG001|Overall Study|Incomplete Data|1|||
105415906|NCT02920528|363529339|FG002|Overall Study|Incomplete Data|1|||
105415907|NCT02920528|363529337|FG000|Overall Study|Adverse Event|0|||
105415908|NCT02920528|363529338|FG001|Overall Study|Adverse Event|0|||
105415909|NCT02920528|363529339|FG002|Overall Study|Adverse Event|3|||
105415910|NCT02920528|363529337|FG000|Overall Study|Did not meet inclusion criteria|2|||
105415911|NCT02920528|363529338|FG001|Overall Study|Did not meet inclusion criteria|0|||
105415912|NCT02920528|363529339|FG002|Overall Study|Did not meet inclusion criteria|1|||
105415913|NCT00809835|363529340|FG000|Overall Study|Lost to Follow-up|7|||
105415914|NCT00809835|363529341|FG001|Overall Study|Lost to Follow-up|6|||
105415915|NCT00809835|363529342|FG002|Overall Study|Lost to Follow-up|10|||
105415916|NCT00809835|363529343|FG003|Overall Study|Lost to Follow-up|2|||
105415917|NCT00809835|363529340|FG000|Overall Study|Withdrawal by Subject|1|||
105415918|NCT00809835|363529341|FG001|Overall Study|Withdrawal by Subject|1|||
105415919|NCT00809835|363529342|FG002|Overall Study|Withdrawal by Subject|1|||
105415920|NCT00809835|363529343|FG003|Overall Study|Withdrawal by Subject|0|||
105415921|NCT02547038|363529344|FG000|Overall Study|Lost to Follow-up|3|||
105415922|NCT02547038|363529345|FG001|Overall Study|Lost to Follow-up|2|||
105415923|NCT00516893|363529346|FG000|Overall Study|Lost to Follow-up|4|||
105415924|NCT00516893|363529346|FG000|Overall Study|Adverse Event|3|||
105415925|NCT00516893|363529346|FG000|Overall Study|Withdrawal by Subject|2|||
105415926|NCT00516893|363529346|FG000|Overall Study|Noncompliance|2|||
105415927|NCT00516893|363529346|FG000|Overall Study|Death|1|||
105583304|NCT02886728|364133835|FG001|Overall Study|Protocol Violation|0|||
105583305|NCT02886728|364133836|FG002|Overall Study|Protocol Violation|0|||
105583306|NCT02886728|364133837|FG003|Overall Study|Protocol Violation|4|||
105583307|NCT02886728|364133834|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105583308|NCT02886728|364133835|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105583309|NCT02886728|364133836|FG002|Overall Study|Non-Compliance with Study Drug|1|||
105583310|NCT02886728|364133837|FG003|Overall Study|Non-Compliance with Study Drug|0|||
105583311|NCT02886728|364133834|FG000|Overall Study|Pregnancy|0|||
105583312|NCT02886728|364133835|FG001|Overall Study|Pregnancy|0|||
105583313|NCT02886728|364133836|FG002|Overall Study|Pregnancy|1|||
105583314|NCT02886728|364133837|FG003|Overall Study|Pregnancy|0|||
105583315|NCT02886728|364133834|FG000|Overall Study|Randomized but Not Dosed|1|||
105583316|NCT02886728|364133835|FG001|Overall Study|Randomized but Not Dosed|0|||
105583317|NCT02886728|364133836|FG002|Overall Study|Randomized but Not Dosed|0|||
105583318|NCT02886728|364133837|FG003|Overall Study|Randomized but Not Dosed|2|||
105583319|NCT04004208|364133844|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105583320|NCT04004208|364133845|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105583321|NCT04004208|364133844|FG000|Overall Study|Death|3|||
105583322|NCT04004208|364133845|FG001|Overall Study|Death|0|||
105583323|NCT04004208|364133844|FG000|Overall Study|COVID-19 pandemic|1|||
105583324|NCT04004208|364133845|FG001|Overall Study|COVID-19 pandemic|0|||
105583325|NCT04004208|364133844|FG000|Overall Study|Physician Decision|1|||
105583326|NCT04004208|364133845|FG001|Overall Study|Physician Decision|0|||
105583327|NCT04004208|364133844|FG000|Overall Study|Adverse Event|1|||
105583328|NCT04004208|364133845|FG001|Overall Study|Adverse Event|1|||
105583329|NCT01458249|364133847|FG000|Overall Study|Not treated|1|||
105583330|NCT01458249|364133847|FG000|Overall Study|Adverse Event|4|||
105583331|NCT01458249|364133847|FG000|Overall Study|Other|2|||
105583332|NCT01458249|364133847|FG000|Overall Study|Ongoing|1|||
105583333|NCT04990440|364133848|FG000|Overall Study|Sponsor's Decision|0|||
105583334|NCT04990440|364133849|FG001|Overall Study|Sponsor's Decision|0|||
105583335|NCT04990440|364133850|FG002|Overall Study|Sponsor's Decision|1|||
105583336|NCT03712098|364133851|FG000|Overall Study|Lost to Follow-up|3|||
105583337|NCT03712098|364133852|FG001|Overall Study|Lost to Follow-up|7|||
105583338|NCT03712098|364133851|FG000|Overall Study|Withdrawal by Subject|9|||
105583339|NCT03712098|364133852|FG001|Overall Study|Withdrawal by Subject|4|||
105583340|NCT03712098|364133851|FG000|Overall Study|Protocol Violation|2|||
105583341|NCT03712098|364133852|FG001|Overall Study|Protocol Violation|1|||
105583342|NCT02724020|364133859|FG000|Overall Study|Death|16|||
105583343|NCT02724020|364133860|FG001|Overall Study|Death|18|||
105583344|NCT02724020|364133861|FG002|Overall Study|Death|19|||
105583345|NCT02724020|364133859|FG000|Overall Study|Lost to Follow-up|0|||
105583346|NCT02724020|364133860|FG001|Overall Study|Lost to Follow-up|3|||
105583347|NCT02724020|364133861|FG002|Overall Study|Lost to Follow-up|0|||
105583348|NCT02724020|364133859|FG000|Overall Study|Site Terminated by Sponsor|15|||
105583349|NCT02724020|364133860|FG001|Overall Study|Site Terminated by Sponsor|8|||
105583350|NCT02724020|364133861|FG002|Overall Study|Site Terminated by Sponsor|8|||
105583351|NCT02724020|364133859|FG000|Overall Study|Withdrawal by Subject|1|||
105583352|NCT02724020|364133860|FG001|Overall Study|Withdrawal by Subject|3|||
105583353|NCT02724020|364133861|FG002|Overall Study|Withdrawal by Subject|5|||
105583354|NCT00425503|364133862|FG000|Overall Study|Adverse Event|2|||
105583355|NCT00425503|364133862|FG000|Overall Study|Protocol Violation|1|||
105583356|NCT00594932|364133863|FG000|First 3 Months|Withdrawal by Subject|1|||
105583357|NCT00594932|364133864|FG001|First 3 Months|Withdrawal by Subject|3|||
105583358|NCT00594932|364133863|FG000|Final 3 Months|Withdrawal by Subject|4|||
105583359|NCT00594932|364133864|FG001|Final 3 Months|Withdrawal by Subject|3|||
105583360|NCT01052662|364133869|FG000|Overall Study|Lost to Follow-up|15|||
105583361|NCT01052662|364133870|FG001|Overall Study|Lost to Follow-up|13|||
105583362|NCT01052662|364133871|FG002|Overall Study|Lost to Follow-up|18|||
105583363|NCT01052662|364133869|FG000|Overall Study|Withdrawal by Subject|3|||
105583364|NCT01052662|364133870|FG001|Overall Study|Withdrawal by Subject|2|||
105583365|NCT01052662|364133871|FG002|Overall Study|Withdrawal by Subject|1|||
105583366|NCT01052662|364133869|FG000|Overall Study|Pharmacy issue|1|||
105583367|NCT01052662|364133870|FG001|Overall Study|Pharmacy issue|3|||
105583368|NCT01052662|364133871|FG002|Overall Study|Pharmacy issue|3|||
105583369|NCT01052662|364133869|FG000|Overall Study|Adverse Event|1|||
105583370|NCT01052662|364133870|FG001|Overall Study|Adverse Event|1|||
105583371|NCT01052662|364133871|FG002|Overall Study|Adverse Event|0|||
105583372|NCT01052662|364133869|FG000|Overall Study|Legal Problem|2|||
105583373|NCT01052662|364133870|FG001|Overall Study|Legal Problem|0|||
105583374|NCT01052662|364133871|FG002|Overall Study|Legal Problem|0|||
105583375|NCT01052662|364133869|FG000|Overall Study|Administrative|0|||
105583376|NCT01052662|364133870|FG001|Overall Study|Administrative|3|||
105583377|NCT01052662|364133871|FG002|Overall Study|Administrative|0|||
105583378|NCT02015663|364133872|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
105583379|NCT02015663|364133873|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
105583380|NCT02015663|364133872|FG000|Overall Study|Withdrawal by Subject|1|||
105583381|NCT02015663|364133873|FG001|Overall Study|Withdrawal by Subject|0|||
105583382|NCT02015663|364133872|FG000|Overall Study|Protocol Violation|0|||
105583383|NCT02015663|364133873|FG001|Overall Study|Protocol Violation|1|||
105583384|NCT02015663|364133872|FG000|Overall Study|Adverse Event|3|||
105583385|NCT02015663|364133873|FG001|Overall Study|Adverse Event|0|||
105583386|NCT02015663|364133872|FG000|Overall Study|Administrative problems|10|||
105583387|NCT02015663|364133873|FG001|Overall Study|Administrative problems|11|||
105583388|NCT02015195|364133879|FG000|Overall Study|Adverse Event|0|||
105583389|NCT02015195|364133880|FG001|Overall Study|Adverse Event|0|||
105583390|NCT02015195|364133881|FG002|Overall Study|Adverse Event|0|||
105583391|NCT02015195|364133882|FG003|Overall Study|Adverse Event|1|||
105583392|NCT02015195|364133883|FG004|Overall Study|Adverse Event|0|||
105583393|NCT02015195|364133884|FG005|Overall Study|Adverse Event|0|||
105583394|NCT02015195|364133885|FG006|Overall Study|Adverse Event|0|||
105498093|NCT01758523|363834315|FG000|Overall Study|Lack of Efficacy|4|||
105498094|NCT01758523|363834316|FG001|Overall Study|Lack of Efficacy|2|||
105498095|NCT01758523|363834315|FG000|Overall Study|Lost to Follow-up|3|||
105498096|NCT01758523|363834316|FG001|Overall Study|Lost to Follow-up|4|||
105498097|NCT01758523|363834315|FG000|Overall Study|Withdrawal by Subject|12|||
105498098|NCT01758523|363834316|FG001|Overall Study|Withdrawal by Subject|7|||
105498099|NCT00590135|363834317|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
105498100|NCT02663908|363834318|FG000|Overall Study|Withdrawal by Subject|8|||
105498101|NCT02663908|363834319|FG001|Overall Study|Withdrawal by Subject|5|||
105498102|NCT02663908|363834318|FG000|Overall Study|Lost to Follow-up|1|||
105498103|NCT02663908|363834319|FG001|Overall Study|Lost to Follow-up|5|||
105498104|NCT02663908|363834318|FG000|Overall Study|Adverse Event|13|||
105498105|NCT02663908|363834319|FG001|Overall Study|Adverse Event|11|||
105498106|NCT02663908|363834318|FG000|Overall Study|Protocol Violation|1|||
105498107|NCT02663908|363834319|FG001|Overall Study|Protocol Violation|2|||
105498108|NCT02663908|363834318|FG000|Overall Study|Lack of therapeutic response|2|||
105498109|NCT02663908|363834319|FG001|Overall Study|Lack of therapeutic response|0|||
105498110|NCT02663908|363834318|FG000|Overall Study|COVID-19|1|||
105498111|NCT02663908|363834319|FG001|Overall Study|COVID-19|0|||
105498112|NCT02663908|363834318|FG000|Overall Study|Site closed|1|||
105498113|NCT02663908|363834319|FG001|Overall Study|Site closed|0|||
105498114|NCT02663908|363834318|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
105498115|NCT02663908|363834319|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
105498116|NCT02663908|363834318|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
105498117|NCT02663908|363834319|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
105498118|NCT02663908|363834318|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
105498119|NCT02663908|363834319|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
105498120|NCT02663908|363834318|FG000|Overall Study|Death|1|||
105498121|NCT02663908|363834319|FG001|Overall Study|Death|0|||
105498122|NCT02663908|363834318|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
105498123|NCT02663908|363834319|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
105498124|NCT02663908|363834318|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
105498125|NCT02663908|363834319|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
105498126|NCT02742441|363836185|FG000|Overall Study|Lost to Follow-up|4|||
105498127|NCT02742441|363836186|FG001|Overall Study|Lost to Follow-up|4|||
105498128|NCT02742441|363836185|FG000|Overall Study|Withdrawal by Subject|2|||
105498129|NCT02742441|363836186|FG001|Overall Study|Withdrawal by Subject|2|||
105498130|NCT02742441|363836185|FG000|Overall Study|Adverse Event|0|||
105498131|NCT02742441|363836186|FG001|Overall Study|Adverse Event|2|||
105498132|NCT02975336|363836190|FG000|DBPC (52 Weeks)|Adverse Event|16|||
105498133|NCT02975336|363836191|FG001|DBPC (52 Weeks)|Adverse Event|17|||
105498134|NCT02975336|363836192|FG002|DBPC (52 Weeks)|Adverse Event|13|||
105498135|NCT02975336|363836193|FG003|DBPC (52 Weeks)|Adverse Event|18|||
105498136|NCT02975336|363836194|FG004|DBPC (52 Weeks)|Adverse Event|0|||
105498137|NCT02975336|363836195|FG005|DBPC (52 Weeks)|Adverse Event|0|||
105498138|NCT02975336|363836196|FG006|DBPC (52 Weeks)|Adverse Event|0|||
105498139|NCT02975336|363836197|FG007|DBPC (52 Weeks)|Adverse Event|0|||
105498140|NCT02975336|363836190|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
105498141|NCT02975336|363836191|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
105498142|NCT02975336|363836192|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
105498143|NCT02975336|363836193|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
105498144|NCT02975336|363836194|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
105498145|NCT02975336|363836195|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
105498146|NCT02975336|363836196|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
105498147|NCT02975336|363836197|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
105498148|NCT02975336|363836190|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
105498149|NCT02975336|363836191|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
105498150|NCT02975336|363836192|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
105498151|NCT02975336|363836193|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
105583395|NCT01318811|364133886|FG000|Overall Study|Physician Decision|1|||
105583396|NCT01318811|364133887|FG001|Overall Study|Physician Decision|1|||
105583397|NCT01318811|364133886|FG000|Overall Study|CRRT stopped for head CT|0|||
105583398|NCT01318811|364133887|FG001|Overall Study|CRRT stopped for head CT|1|||
105498152|NCT02975336|363836194|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
105498153|NCT02975336|363836195|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
105498154|NCT02975336|363836196|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
105498155|NCT02975336|363836197|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
105498156|NCT02975336|363836190|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
105498157|NCT02975336|363836191|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
105498158|NCT02975336|363836192|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
105498159|NCT02975336|363836193|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
105498160|NCT02975336|363836194|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
105498161|NCT02975336|363836195|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
105498162|NCT02975336|363836196|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
105498163|NCT02975336|363836197|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
105498164|NCT02975336|363836190|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
105498165|NCT02975336|363836191|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
105498166|NCT02975336|363836192|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
105498167|NCT02975336|363836193|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
105498168|NCT02975336|363836194|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
105498169|NCT02975336|363836195|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
105498170|NCT02975336|363836196|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
105498171|NCT02975336|363836197|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
105498172|NCT02975336|363836190|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
105498173|NCT02975336|363836191|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
105498174|NCT02975336|363836192|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
105498175|NCT02975336|363836193|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
105498176|NCT02975336|363836194|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
105498177|NCT02975336|363836195|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
105498178|NCT02975336|363836196|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
105498179|NCT02975336|363836197|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
105498180|NCT02975336|363836190|FG000|LTE (104 Weeks)|Adverse Event|0|||
105498181|NCT02975336|363836191|FG001|LTE (104 Weeks)|Adverse Event|0|||
105498182|NCT02975336|363836192|FG002|LTE (104 Weeks)|Adverse Event|0|||
105498183|NCT02975336|363836193|FG003|LTE (104 Weeks)|Adverse Event|0|||
105498184|NCT02975336|363836194|FG004|LTE (104 Weeks)|Adverse Event|7|||
105498185|NCT02975336|363836195|FG005|LTE (104 Weeks)|Adverse Event|4|||
105498186|NCT02975336|363836196|FG006|LTE (104 Weeks)|Adverse Event|2|||
105498187|NCT02975336|363836197|FG007|LTE (104 Weeks)|Adverse Event|0|||
105498188|NCT02975336|363836190|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
105498189|NCT02975336|363836191|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
105498190|NCT02975336|363836192|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
105498191|NCT02975336|363836193|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
105498192|NCT02975336|363836194|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
105498193|NCT02975336|363836195|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
105498194|NCT02975336|363836196|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
105498195|NCT02975336|363836197|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
105498196|NCT02975336|363836190|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
105498197|NCT02975336|363836191|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
105498198|NCT02975336|363836192|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
105498199|NCT02975336|363836193|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
105498200|NCT02975336|363836194|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
105498201|NCT02975336|363836195|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
105498202|NCT02975336|363836196|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
105498203|NCT02975336|363836197|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
105498204|NCT02975336|363836190|FG000|LTE (104 Weeks)|Other|0|||
105498205|NCT02975336|363836191|FG001|LTE (104 Weeks)|Other|0|||
105498206|NCT02975336|363836192|FG002|LTE (104 Weeks)|Other|0|||
105498207|NCT02975336|363836193|FG003|LTE (104 Weeks)|Other|0|||
105498208|NCT02975336|363836194|FG004|LTE (104 Weeks)|Other|55|||
105498209|NCT02975336|363836195|FG005|LTE (104 Weeks)|Other|63|||
105498210|NCT02975336|363836196|FG006|LTE (104 Weeks)|Other|76|||
105498211|NCT02975336|363836197|FG007|LTE (104 Weeks)|Other|72|||
105498212|NCT01863953|363836198|FG000|Overall Study|Adverse Event|0|||
105498213|NCT01863953|363836199|FG001|Overall Study|Adverse Event|0|||
105498214|NCT01863953|363836200|FG002|Overall Study|Adverse Event|1|||
105498215|NCT01868503|363836206|FG000|Overall Study|Withdrawal by Subject|1|||
105498216|NCT01868503|363836206|FG000|Overall Study|Protocol Violation|1|||
105498217|NCT00408629|363836207|FG000|Overall Study|Adverse Event|13|||
105498218|NCT00408629|363836208|FG001|Overall Study|Adverse Event|27|||
105498219|NCT00408629|363836207|FG000|Overall Study|Withdrawal by Subject|8|||
105498220|NCT00408629|363836208|FG001|Overall Study|Withdrawal by Subject|4|||
105498221|NCT00408629|363836207|FG000|Overall Study|Lost to Follow-up|1|||
105498222|NCT00408629|363836208|FG001|Overall Study|Lost to Follow-up|1|||
105498223|NCT00408629|363836207|FG000|Overall Study|Lack of Efficacy|63|||
105498224|NCT00408629|363836208|FG001|Overall Study|Lack of Efficacy|73|||
105498225|NCT00408629|363836207|FG000|Overall Study|Protocol Violation|1|||
105498226|NCT00408629|363836208|FG001|Overall Study|Protocol Violation|5|||
105498227|NCT00408629|363836207|FG000|Overall Study|Miscellaneous|11|||
105498228|NCT00408629|363836208|FG001|Overall Study|Miscellaneous|15|||
105498229|NCT01031706|363836217|FG000|Overall Study|Adverse Event|1|||
105498230|NCT01031706|363836218|FG001|Overall Study|Adverse Event|0|||
105415928|NCT00516893|363529346|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
105415929|NCT00516893|363529346|FG000|Overall Study|Relocated|1|||
105415930|NCT00516893|363529346|FG000|Overall Study|Pregnancy|1|||
105415931|NCT00516893|363529346|FG000|Overall Study|Received Medication From Another Study|1|||
105415932|NCT05659719|363529353|FG000|Overall Study|At sponsor's request|0|||
105415933|NCT05659719|363529354|FG001|Overall Study|At sponsor's request|0|||
105415934|NCT05659719|363529355|FG002|Overall Study|At sponsor's request|0|||
105415935|NCT05659719|363529356|FG003|Overall Study|At sponsor's request|95|||
105415936|NCT05659719|363529353|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
105415937|NCT05659719|363529354|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
105415938|NCT05659719|363529355|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
105415939|NCT05659719|363529356|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
105415940|NCT05659719|363529353|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
105415941|NCT05659719|363529354|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
105415942|NCT05659719|363529355|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
105415943|NCT05659719|363529356|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
105415944|NCT05659719|363529353|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
105415945|NCT05659719|363529354|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
105415946|NCT05659719|363529355|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
105415947|NCT05659719|363529356|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
105415948|NCT05659719|363529353|FG000|Overall Study|Lost to Follow-up|0|||
105415949|NCT05659719|363529354|FG001|Overall Study|Lost to Follow-up|0|||
105415950|NCT05659719|363529355|FG002|Overall Study|Lost to Follow-up|0|||
105415951|NCT05659719|363529356|FG003|Overall Study|Lost to Follow-up|2|||
105415952|NCT05659719|363529353|FG000|Overall Study|Moved to another observational study|0|||
105415953|NCT05659719|363529354|FG001|Overall Study|Moved to another observational study|0|||
105415954|NCT05659719|363529355|FG002|Overall Study|Moved to another observational study|0|||
105415955|NCT05659719|363529356|FG003|Overall Study|Moved to another observational study|1|||
105415956|NCT05659719|363529353|FG000|Overall Study|The child was enrolled in an interventional study|0|||
105415957|NCT05659719|363529354|FG001|Overall Study|The child was enrolled in an interventional study|0|||
105415958|NCT05659719|363529355|FG002|Overall Study|The child was enrolled in an interventional study|0|||
105415959|NCT05659719|363529356|FG003|Overall Study|The child was enrolled in an interventional study|55|||
105415960|NCT05659719|363529353|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
105415961|NCT05659719|363529354|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
105415962|NCT05659719|363529355|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
105415963|NCT05659719|363529356|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
105415964|NCT05659719|363529353|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
105415965|NCT05659719|363529354|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
105415966|NCT05659719|363529355|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
105415967|NCT05659719|363529356|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
105415968|NCT01681186|363529357|FG000|Washout Period From Second Intervention|Adverse Event|0|||
105415969|NCT01681186|363529358|FG001|Washout Period From Second Intervention|Adverse Event|0|||
105415970|NCT01681186|363529359|FG002|Washout Period From Second Intervention|Adverse Event|0|||
105415971|NCT01681186|363529360|FG003|Washout Period From Second Intervention|Adverse Event|0|||
105415972|NCT01681186|363529361|FG004|Washout Period From Second Intervention|Adverse Event|0|||
105415973|NCT01681186|363529362|FG005|Washout Period From Second Intervention|Adverse Event|0|||
105415974|NCT01681186|363529363|FG006|Washout Period From Second Intervention|Adverse Event|1|||
105415975|NCT01681186|363529364|FG007|Washout Period From Second Intervention|Adverse Event|0|||
105415976|NCT01681186|363529357|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
105415977|NCT01681186|363529358|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
105415978|NCT01681186|363529359|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
105415979|NCT01681186|363529360|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
105415980|NCT01681186|363529361|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
105415981|NCT01681186|363529362|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
105415982|NCT01681186|363529363|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
105415983|NCT01681186|363529364|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
105415984|NCT01681186|363529357|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
105415985|NCT01681186|363529358|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
105415986|NCT01681186|363529359|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
105415987|NCT01681186|363529360|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
105415988|NCT01681186|363529361|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
105415989|NCT01681186|363529362|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
105415990|NCT01681186|363529363|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
105415991|NCT01681186|363529364|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
105415992|NCT01681186|363529357|FG000|Fourth Intervention|Protocol Violation|0|||
105415993|NCT01681186|363529358|FG001|Fourth Intervention|Protocol Violation|0|||
105415994|NCT01681186|363529359|FG002|Fourth Intervention|Protocol Violation|0|||
105415995|NCT01681186|363529360|FG003|Fourth Intervention|Protocol Violation|0|||
105415996|NCT01681186|363529361|FG004|Fourth Intervention|Protocol Violation|0|||
105498231|NCT01031706|363836217|FG000|Overall Study|Withdrawal by Subject|1|||
105498232|NCT01031706|363836218|FG001|Overall Study|Withdrawal by Subject|1|||
105498233|NCT03626168|363836219|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
105498234|NCT03626168|363836220|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
105498235|NCT03626168|363836219|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
105498236|NCT03626168|363836220|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
105498237|NCT03626168|363836219|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
105498238|NCT03626168|363836220|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
105498239|NCT00216476|363836221|FG000|Overall Study|Withdrawal by Subject|59|||
105498240|NCT00216476|363836222|FG001|Overall Study|Withdrawal by Subject|72|||
105498241|NCT00216476|363836223|FG002|Overall Study|Withdrawal by Subject|9|||
105498242|NCT00216476|363836221|FG000|Overall Study|Lost to Follow-up|10|||
105498243|NCT00216476|363836222|FG001|Overall Study|Lost to Follow-up|9|||
105498244|NCT00216476|363836223|FG002|Overall Study|Lost to Follow-up|1|||
105498245|NCT00216476|363836221|FG000|Overall Study|Adverse Event|6|||
105498246|NCT00216476|363836222|FG001|Overall Study|Adverse Event|10|||
105498247|NCT00216476|363836223|FG002|Overall Study|Adverse Event|1|||
105498248|NCT00216476|363836221|FG000|Overall Study|Lack of Efficacy|4|||
105498249|NCT00216476|363836222|FG001|Overall Study|Lack of Efficacy|3|||
105498250|NCT00216476|363836223|FG002|Overall Study|Lack of Efficacy|0|||
105498251|NCT00216476|363836221|FG000|Overall Study|Death|2|||
105498252|NCT00216476|363836222|FG001|Overall Study|Death|0|||
105498253|NCT00216476|363836223|FG002|Overall Study|Death|0|||
105498254|NCT00216476|363836221|FG000|Overall Study|Pregnancy|0|||
105498255|NCT00216476|363836222|FG001|Overall Study|Pregnancy|1|||
105498256|NCT00216476|363836223|FG002|Overall Study|Pregnancy|1|||
105498257|NCT00216476|363836221|FG000|Overall Study|Other|0|||
105498258|NCT00216476|363836222|FG001|Overall Study|Other|0|||
105498259|NCT00216476|363836223|FG002|Overall Study|Other|1|||
105498260|NCT00216476|363836221|FG000|Overall Study|Refuses Injection|11|||
105498261|NCT00216476|363836222|FG001|Overall Study|Refuses Injection|0|||
105498262|NCT00216476|363836223|FG002|Overall Study|Refuses Injection|0|||
105498263|NCT00216476|363836221|FG000|Overall Study|No Further Need for Treatment|3|||
105498264|NCT00216476|363836222|FG001|Overall Study|No Further Need for Treatment|4|||
105498265|NCT00216476|363836223|FG002|Overall Study|No Further Need for Treatment|1|||
105498266|NCT00216476|363836221|FG000|Overall Study|Non-compliance|0|||
105498267|NCT00216476|363836222|FG001|Overall Study|Non-compliance|4|||
105498268|NCT00216476|363836223|FG002|Overall Study|Non-compliance|1|||
105498269|NCT00216476|363836221|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
105498270|NCT00216476|363836222|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
105498271|NCT00216476|363836223|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
105498272|NCT00216476|363836221|FG000|Overall Study|Administrative Reasons|1|||
105498273|NCT00216476|363836222|FG001|Overall Study|Administrative Reasons|1|||
105498274|NCT00216476|363836223|FG002|Overall Study|Administrative Reasons|0|||
105498275|NCT00216476|363836221|FG000|Overall Study|Protocol Deviation|5|||
105498276|NCT00216476|363836222|FG001|Overall Study|Protocol Deviation|1|||
105498277|NCT00216476|363836223|FG002|Overall Study|Protocol Deviation|0|||
105498278|NCT00216476|363836221|FG000|Overall Study|Patient Moved|2|||
105498279|NCT00216476|363836222|FG001|Overall Study|Patient Moved|2|||
105498280|NCT00216476|363836223|FG002|Overall Study|Patient Moved|0|||
105498281|NCT01522248|363836226|FG000|Overall Study|Lost to Follow-up|1|||
105498282|NCT01522248|363836227|FG001|Overall Study|Lost to Follow-up|0|||
105498283|NCT03719586|363836228|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
105498284|NCT03719586|363836229|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
105415997|NCT01681186|363529362|FG005|Fourth Intervention|Protocol Violation|0|||
105415998|NCT01681186|363529363|FG006|Fourth Intervention|Protocol Violation|0|||
105498285|NCT03719586|363836230|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
105498286|NCT03719586|363836231|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
105498287|NCT00538291|363836233|FG000|Overall Study|Adverse Event|2|||
105498288|NCT00538291|363836233|FG000|Overall Study|Withdrawal by Subject|1|||
105498289|NCT01904058|363836234|FG000|Overall Study|Adverse Event|2|||
105498290|NCT01904058|363836235|FG001|Overall Study|Adverse Event|0|||
105498291|NCT01904058|363836236|FG002|Overall Study|Adverse Event|0|||
105583399|NCT01318811|364133886|FG000|Overall Study|Death|0|||
105583400|NCT01318811|364133887|FG001|Overall Study|Death|1|||
105415999|NCT01681186|363529364|FG007|Fourth Intervention|Protocol Violation|1|||
105498292|NCT01904058|363836237|FG003|Overall Study|Adverse Event|0|||
105498293|NCT01904058|363836234|FG000|Overall Study|Withdrawal by Subject|1|||
105498294|NCT01904058|363836235|FG001|Overall Study|Withdrawal by Subject|0|||
105498295|NCT01904058|363836236|FG002|Overall Study|Withdrawal by Subject|1|||
105498296|NCT01904058|363836237|FG003|Overall Study|Withdrawal by Subject|0|||
105498297|NCT01904058|363836234|FG000|Overall Study|Pregnancy|0|||
105498298|NCT01904058|363836235|FG001|Overall Study|Pregnancy|0|||
105498299|NCT01904058|363836236|FG002|Overall Study|Pregnancy|0|||
105498300|NCT01904058|363836237|FG003|Overall Study|Pregnancy|1|||
105498301|NCT03096483|363836238|FG000|Overall Study|Withdrawal by site|1|||
105498302|NCT01609231|363836244|FG000|Overall Study|Adverse Event|1|||
105498303|NCT01609231|363836245|FG001|Overall Study|Adverse Event|3|||
105498304|NCT01609231|363836244|FG000|Overall Study|Physician Decision|1|||
105498305|NCT01609231|363836245|FG001|Overall Study|Physician Decision|0|||
105498306|NCT01609231|363836244|FG000|Overall Study|Withdrawal by Subject|1|||
105498307|NCT01609231|363836245|FG001|Overall Study|Withdrawal by Subject|0|||
105498308|NCT02761733|363836248|FG000|Overall Study|Death|3|||
105498309|NCT02761733|363836249|FG001|Overall Study|Death|5|||
105498310|NCT02761733|363836250|FG002|Overall Study|Death|1|||
105498311|NCT02761733|363836251|FG003|Overall Study|Death|1|||
105498312|NCT02761733|363836248|FG000|Overall Study|Lost to Follow-up|6|||
105498313|NCT02761733|363836249|FG001|Overall Study|Lost to Follow-up|7|||
105498314|NCT02761733|363836250|FG002|Overall Study|Lost to Follow-up|0|||
105498315|NCT02761733|363836251|FG003|Overall Study|Lost to Follow-up|3|||
105498316|NCT02761733|363836248|FG000|Overall Study|Physician Decision|4|||
105498317|NCT02761733|363836249|FG001|Overall Study|Physician Decision|0|||
105498318|NCT02761733|363836250|FG002|Overall Study|Physician Decision|0|||
105498319|NCT02761733|363836251|FG003|Overall Study|Physician Decision|0|||
105498320|NCT02761733|363836248|FG000|Overall Study|Withdrawal by Subject|2|||
105498321|NCT02761733|363836249|FG001|Overall Study|Withdrawal by Subject|0|||
105498322|NCT02761733|363836250|FG002|Overall Study|Withdrawal by Subject|0|||
105498323|NCT02761733|363836251|FG003|Overall Study|Withdrawal by Subject|0|||
105498324|NCT02761733|363836248|FG000|Overall Study|Discharged from Study Site|10|||
105498325|NCT02761733|363836249|FG001|Overall Study|Discharged from Study Site|9|||
105498326|NCT02761733|363836250|FG002|Overall Study|Discharged from Study Site|25|||
105498327|NCT02761733|363836251|FG003|Overall Study|Discharged from Study Site|11|||
105498328|NCT02761733|363836248|FG000|Overall Study|Cognitive Impairment|5|||
105498329|NCT02761733|363836249|FG001|Overall Study|Cognitive Impairment|0|||
105498330|NCT02761733|363836250|FG002|Overall Study|Cognitive Impairment|1|||
105498331|NCT02761733|363836251|FG003|Overall Study|Cognitive Impairment|0|||
105498332|NCT00474760|363836252|FG000|Overall Study|Death|0|||
105498333|NCT00474760|363836253|FG001|Overall Study|Death|0|||
105498334|NCT00474760|363836254|FG002|Overall Study|Death|0|||
105498335|NCT00474760|363836255|FG003|Overall Study|Death|0|||
105498336|NCT00474760|363836256|FG004|Overall Study|Death|2|||
105498337|NCT00474760|363836257|FG005|Overall Study|Death|0|||
105498338|NCT00474760|363836258|FG006|Overall Study|Death|0|||
105498339|NCT00474760|363836252|FG000|Overall Study|Adverse Event|0|||
105498340|NCT00474760|363836253|FG001|Overall Study|Adverse Event|0|||
105498341|NCT00474760|363836254|FG002|Overall Study|Adverse Event|0|||
105498342|NCT00474760|363836255|FG003|Overall Study|Adverse Event|0|||
105498343|NCT00474760|363836256|FG004|Overall Study|Adverse Event|1|||
105498344|NCT00474760|363836257|FG005|Overall Study|Adverse Event|7|||
105498345|NCT00474760|363836258|FG006|Overall Study|Adverse Event|0|||
105498346|NCT00474760|363836252|FG000|Overall Study|Laboratory abnormality|0|||
105498347|NCT00474760|363836253|FG001|Overall Study|Laboratory abnormality|0|||
105498348|NCT00474760|363836254|FG002|Overall Study|Laboratory abnormality|0|||
105498349|NCT00474760|363836255|FG003|Overall Study|Laboratory abnormality|0|||
105498350|NCT00474760|363836256|FG004|Overall Study|Laboratory abnormality|0|||
105498351|NCT00474760|363836257|FG005|Overall Study|Laboratory abnormality|1|||
105498352|NCT00474760|363836258|FG006|Overall Study|Laboratory abnormality|0|||
105498353|NCT00474760|363836252|FG000|Overall Study|Withdrawal by Subject|0|||
105498354|NCT00474760|363836253|FG001|Overall Study|Withdrawal by Subject|0|||
105498355|NCT00474760|363836254|FG002|Overall Study|Withdrawal by Subject|0|||
105498356|NCT00474760|363836255|FG003|Overall Study|Withdrawal by Subject|1|||
105498357|NCT00474760|363836256|FG004|Overall Study|Withdrawal by Subject|0|||
105498358|NCT00474760|363836257|FG005|Overall Study|Withdrawal by Subject|1|||
105498359|NCT00474760|363836258|FG006|Overall Study|Withdrawal by Subject|1|||
105498360|NCT00474760|363836252|FG000|Overall Study|Other|0|||
105498361|NCT00474760|363836253|FG001|Overall Study|Other|1|||
105498362|NCT00474760|363836254|FG002|Overall Study|Other|0|||
105498363|NCT00474760|363836255|FG003|Overall Study|Other|0|||
105498364|NCT00474760|363836256|FG004|Overall Study|Other|1|||
105498365|NCT00474760|363836257|FG005|Overall Study|Other|0|||
105498366|NCT00474760|363836258|FG006|Overall Study|Other|0|||
105498367|NCT00474760|363836252|FG000|Overall Study|Progressive disease|3|||
105498368|NCT00474760|363836253|FG001|Overall Study|Progressive disease|2|||
105498369|NCT00474760|363836254|FG002|Overall Study|Progressive disease|3|||
105498370|NCT00474760|363836255|FG003|Overall Study|Progressive disease|2|||
105583401|NCT01318811|364133886|FG000|Overall Study|CRRT stopped for head MRI|0|||
105583402|NCT01318811|364133887|FG001|Overall Study|CRRT stopped for head MRI|1|||
105583403|NCT00131911|364133888|FG000|Overall Study|Withdrawal by Subject|1|||
105583404|NCT00131911|364133889|FG001|Overall Study|Withdrawal by Subject|0|||
105583405|NCT03682536|364133896|FG000|Randomization|Withdrawal by Subject|0|||
105583406|NCT03682536|364133897|FG001|Randomization|Withdrawal by Subject|2|||
105583407|NCT03682536|364133896|FG000|Treatment|Other Reasons|8|||
105583408|NCT03682536|364133897|FG001|Treatment|Other Reasons|7|||
105583409|NCT03682536|364133896|FG000|Treatment|Physician Decision|5|||
105583410|NCT03682536|364133897|FG001|Treatment|Physician Decision|5|||
105583411|NCT03682536|364133896|FG000|Treatment|Protocol Violation|1|||
105583412|NCT03682536|364133897|FG001|Treatment|Protocol Violation|0|||
105416000|NCT02290691|363529365|FG000|Overall Study|Noncompliance|0|||
105416001|NCT02290691|363529366|FG001|Overall Study|Noncompliance|1|||
105416002|NCT02290691|363529365|FG000|Overall Study|Withdrawal by Subject|1|||
105416003|NCT02290691|363529366|FG001|Overall Study|Withdrawal by Subject|1|||
105416004|NCT02290691|363529365|FG000|Overall Study|Lost to Follow-up|7|||
105583413|NCT03682536|364133896|FG000|Treatment|Study Terminated by Sponsor|1|||
105583414|NCT03682536|364133897|FG001|Treatment|Study Terminated by Sponsor|2|||
105583415|NCT03682536|364133896|FG000|Treatment|Lost to Follow-up|0|||
105583416|NCT03682536|364133897|FG001|Treatment|Lost to Follow-up|1|||
105583417|NCT03682536|364133896|FG000|Treatment|Withdrawal by Subject|16|||
105583418|NCT03682536|364133897|FG001|Treatment|Withdrawal by Subject|18|||
105583419|NCT03682536|364133896|FG000|Treatment|Lack of Efficacy|41|||
105583420|NCT03682536|364133897|FG001|Treatment|Lack of Efficacy|68|||
105583421|NCT03682536|364133896|FG000|Treatment|Disease Progression|9|||
105583422|NCT03682536|364133897|FG001|Treatment|Disease Progression|7|||
105583423|NCT03682536|364133896|FG000|Treatment|Adverse Event|9|||
105583424|NCT03682536|364133897|FG001|Treatment|Adverse Event|5|||
105583425|NCT03682536|364133896|FG000|Treatment|Death|14|||
105583426|NCT03682536|364133897|FG001|Treatment|Death|13|||
105583427|NCT04529538|364133898|FG000|Overall Study|Lost to Follow-up|3|||
105583428|NCT04529538|364133899|FG001|Overall Study|Lost to Follow-up|2|||
105583429|NCT04529538|364133900|FG002|Overall Study|Lost to Follow-up|1|||
105583430|NCT04529538|364133901|FG003|Overall Study|Lost to Follow-up|0|||
105583431|NCT04529538|364133902|FG004|Overall Study|Lost to Follow-up|1|||
105583432|NCT04529538|364133903|FG005|Overall Study|Lost to Follow-up|1|||
105583433|NCT04529538|364133904|FG006|Overall Study|Lost to Follow-up|2|||
105583434|NCT04529538|364133905|FG007|Overall Study|Lost to Follow-up|0|||
105583435|NCT04529538|364133898|FG000|Overall Study|Not eligible at enrollment|0|||
105583436|NCT04529538|364133899|FG001|Overall Study|Not eligible at enrollment|1|||
105583437|NCT04529538|364133900|FG002|Overall Study|Not eligible at enrollment|2|||
105583438|NCT04529538|364133901|FG003|Overall Study|Not eligible at enrollment|1|||
105583439|NCT04529538|364133902|FG004|Overall Study|Not eligible at enrollment|0|||
105583440|NCT04529538|364133903|FG005|Overall Study|Not eligible at enrollment|0|||
105583441|NCT04529538|364133904|FG006|Overall Study|Not eligible at enrollment|0|||
105583442|NCT04529538|364133905|FG007|Overall Study|Not eligible at enrollment|1|||
105583443|NCT04529538|364133898|FG000|Overall Study|Withdrawal by Subject|0|||
105583444|NCT04529538|364133899|FG001|Overall Study|Withdrawal by Subject|1|||
105583445|NCT04529538|364133900|FG002|Overall Study|Withdrawal by Subject|1|||
105583446|NCT04529538|364133901|FG003|Overall Study|Withdrawal by Subject|2|||
105583447|NCT04529538|364133902|FG004|Overall Study|Withdrawal by Subject|0|||
105583448|NCT04529538|364133903|FG005|Overall Study|Withdrawal by Subject|2|||
105583449|NCT04529538|364133904|FG006|Overall Study|Withdrawal by Subject|3|||
105583450|NCT04529538|364133905|FG007|Overall Study|Withdrawal by Subject|0|||
105583451|NCT04529538|364133898|FG000|Overall Study|Other|0|||
105583452|NCT04529538|364133899|FG001|Overall Study|Other|1|||
105583453|NCT04529538|364133900|FG002|Overall Study|Other|0|||
105583454|NCT04529538|364133901|FG003|Overall Study|Other|0|||
105583455|NCT04529538|364133902|FG004|Overall Study|Other|0|||
105583456|NCT04529538|364133903|FG005|Overall Study|Other|0|||
105583457|NCT04529538|364133904|FG006|Overall Study|Other|0|||
105583458|NCT04529538|364133905|FG007|Overall Study|Other|0|||
105583459|NCT04529538|364133898|FG000|Overall Study|Adverse Event|0|||
105583460|NCT04529538|364133899|FG001|Overall Study|Adverse Event|0|||
105583461|NCT04529538|364133900|FG002|Overall Study|Adverse Event|0|||
105583462|NCT04529538|364133901|FG003|Overall Study|Adverse Event|1|||
105583463|NCT04529538|364133902|FG004|Overall Study|Adverse Event|0|||
105583464|NCT04529538|364133903|FG005|Overall Study|Adverse Event|0|||
105583465|NCT04529538|364133904|FG006|Overall Study|Adverse Event|0|||
105416005|NCT02290691|363529366|FG001|Overall Study|Lost to Follow-up|7|||
105583466|NCT04529538|364133905|FG007|Overall Study|Adverse Event|0|||
105583467|NCT04529538|364133898|FG000|Overall Study|Protocol Deviation|0|||
105583468|NCT04529538|364133899|FG001|Overall Study|Protocol Deviation|0|||
105583469|NCT04529538|364133900|FG002|Overall Study|Protocol Deviation|0|||
105583470|NCT04529538|364133901|FG003|Overall Study|Protocol Deviation|1|||
105583471|NCT04529538|364133902|FG004|Overall Study|Protocol Deviation|0|||
105583472|NCT04529538|364133903|FG005|Overall Study|Protocol Deviation|0|||
105583473|NCT04529538|364133904|FG006|Overall Study|Protocol Deviation|0|||
105583474|NCT04529538|364133905|FG007|Overall Study|Protocol Deviation|0|||
105416006|NCT01986231|363529373|FG000|Overall Study|Adverse Event|1|||
105416007|NCT04848220|363529374|FG000|Overall Study|Unable to proceed to study procedure|0|||
105416008|NCT04848220|363529375|FG001|Overall Study|Unable to proceed to study procedure|1|||
105416009|NCT04848220|363529376|FG002|Overall Study|Unable to proceed to study procedure|0|||
105416010|NCT04848220|363529374|FG000|Overall Study|Fractional flow not significant|0|||
105416011|NCT04848220|363529375|FG001|Overall Study|Fractional flow not significant|1|||
105416012|NCT04848220|363529376|FG002|Overall Study|Fractional flow not significant|0|||
105416013|NCT02923830|363529377|FG000|Overall Study|Physician Decision|13|||
105416014|NCT02923830|363529378|FG001|Overall Study|Physician Decision|15|||
105416015|NCT00837265|363529381|FG000|Pilot Phase|Withdrawal by Subject|0|||
105498371|NCT00474760|363836256|FG004|Overall Study|Progressive disease|8|||
105498372|NCT00474760|363836257|FG005|Overall Study|Progressive disease|20|||
105498373|NCT00474760|363836258|FG006|Overall Study|Progressive disease|7|||
105498374|NCT00474760|363836252|FG000|Overall Study|Terminated by sponsor|0|||
105498375|NCT00474760|363836253|FG001|Overall Study|Terminated by sponsor|0|||
105498376|NCT00474760|363836254|FG002|Overall Study|Terminated by sponsor|0|||
105498377|NCT00474760|363836255|FG003|Overall Study|Terminated by sponsor|0|||
105498378|NCT00474760|363836256|FG004|Overall Study|Terminated by sponsor|0|||
105498379|NCT00474760|363836257|FG005|Overall Study|Terminated by sponsor|0|||
105498380|NCT00474760|363836258|FG006|Overall Study|Terminated by sponsor|2|||
105498381|NCT04295772|363836259|FG000|Overall Study|Protocol Violation|1|||
105498382|NCT04295772|363836260|FG001|Overall Study|Protocol Violation|0|||
105498383|NCT04295772|363836259|FG000|Overall Study|Ongoing for safety monitoring|14|||
105498384|NCT04295772|363836260|FG001|Overall Study|Ongoing for safety monitoring|1|||
105498385|NCT04295772|363836259|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
105498386|NCT04295772|363836260|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
105498387|NCT03608254|363836274|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
105498388|NCT03608254|363836274|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
105498389|NCT00579098|363836275|FG000|Overall Study|Lost to Follow-up|2|||
105498390|NCT00579098|363836276|FG001|Overall Study|Lost to Follow-up|0|||
105498391|NCT00579098|363836275|FG000|Overall Study|Adverse Event|2|||
105498392|NCT00579098|363836276|FG001|Overall Study|Adverse Event|3|||
105498393|NCT00579098|363836275|FG000|Overall Study|Withdrawal by Subject|2|||
105498394|NCT00579098|363836276|FG001|Overall Study|Withdrawal by Subject|3|||
105498395|NCT00579098|363836275|FG000|Overall Study|AF returned after ablation|3|||
105498396|NCT00579098|363836276|FG001|Overall Study|AF returned after ablation|2|||
105498397|NCT00066729|363836279|FG000|Overall Study|Lost to Follow-up|1|||
105498398|NCT00066729|363836279|FG000|Overall Study|Disease progression|1|||
105498399|NCT00338104|363836283|FG000|Overall Study|Protocol Violation|2|||
105498400|NCT00338104|363836284|FG001|Overall Study|Protocol Violation|1|||
105498401|NCT00338104|363836285|FG002|Overall Study|Protocol Violation|3|||
105498402|NCT00633750|363836286|FG000|Overall Study|Adverse Event|2|||
105498403|NCT00633750|363836286|FG000|Overall Study|Withdrawal by Subject|3|||
105498404|NCT00569270|363836290|FG000|Period: First Intervention|Protocol Violation|0|||
105498405|NCT00569270|363836291|FG001|Period: First Intervention|Protocol Violation|1|||
105498406|NCT00447005|363836292|FG000|Overall Study|Adverse Event|1|||
105498407|NCT00447005|363836292|FG000|Overall Study|Lack of Efficacy|11|||
105498408|NCT00492531|363836293|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
105498409|NCT00492531|363836294|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
105498410|NCT02628938|363836295|FG000|Overall Study|Did not attend the follow up recall|2|||
105498411|NCT02628938|363836296|FG001|Overall Study|Did not attend the follow up recall|2|||
105498412|NCT02628938|363836297|FG002|Overall Study|Did not attend the follow up recall|1|||
105498413|NCT02628938|363836295|FG000|Overall Study|Failure to comply with the instructions|3|||
105498414|NCT02628938|363836296|FG001|Overall Study|Failure to comply with the instructions|0|||
105498415|NCT02628938|363836297|FG002|Overall Study|Failure to comply with the instructions|3|||
105498416|NCT00586625|363836298|FG000|Overall Study|Adverse Event|6|||
105498417|NCT00586625|363836299|FG001|Overall Study|Adverse Event|6|||
105498418|NCT00586625|363836298|FG000|Overall Study|Protocol Violation|3|||
105498419|NCT00586625|363836299|FG001|Overall Study|Protocol Violation|0|||
105498420|NCT00586625|363836298|FG000|Overall Study|Withdrawal by Subject|32|||
105498421|NCT00586625|363836299|FG001|Overall Study|Withdrawal by Subject|10|||
105498422|NCT00586625|363836298|FG000|Overall Study|Subject non-compliance|0|||
105498423|NCT00586625|363836299|FG001|Overall Study|Subject non-compliance|1|||
105416016|NCT00837265|363529382|FG001|Pilot Phase|Withdrawal by Subject|2|||
105416017|NCT00837265|363529383|FG002|Pilot Phase|Withdrawal by Subject|3|||
105498424|NCT00586625|363836298|FG000|Overall Study|Subject unable to return for visit|2|||
105498425|NCT00586625|363836299|FG001|Overall Study|Subject unable to return for visit|0|||
105498426|NCT02728596|363836300|FG000|Overall Study|Refusal unrelated to adverse event|3|||
105498427|NCT02728596|363836301|FG001|Overall Study|Refusal unrelated to adverse event|6|||
105498428|NCT02728596|363836302|FG002|Overall Study|Refusal unrelated to adverse event|7|||
105498429|NCT02728596|363836303|FG003|Overall Study|Refusal unrelated to adverse event|7|||
105498430|NCT02728596|363836300|FG000|Overall Study|Death|44|||
105498431|NCT02728596|363836301|FG001|Overall Study|Death|42|||
105498432|NCT02728596|363836302|FG002|Overall Study|Death|123|||
105416018|NCT00837265|363529384|FG003|Pilot Phase|Withdrawal by Subject|2|||
105416019|NCT00837265|363529385|FG004|Pilot Phase|Withdrawal by Subject|0|||
105416020|NCT00837265|363529386|FG005|Pilot Phase|Withdrawal by Subject|0|||
105416021|NCT00837265|363529387|FG006|Pilot Phase|Withdrawal by Subject|0|||
105416022|NCT00837265|363529381|FG000|Pilot Phase|Decision of the investigator|2|||
105416023|NCT00837265|363529382|FG001|Pilot Phase|Decision of the investigator|1|||
105416024|NCT00837265|363529383|FG002|Pilot Phase|Decision of the investigator|0|||
105416025|NCT00837265|363529384|FG003|Pilot Phase|Decision of the investigator|0|||
105416026|NCT00837265|363529385|FG004|Pilot Phase|Decision of the investigator|0|||
105416027|NCT00837265|363529386|FG005|Pilot Phase|Decision of the investigator|0|||
105416028|NCT00837265|363529387|FG006|Pilot Phase|Decision of the investigator|0|||
105416029|NCT00837265|363529381|FG000|Pilot Phase|Adverse Event|1|||
105416030|NCT00837265|363529382|FG001|Pilot Phase|Adverse Event|0|||
105416031|NCT00837265|363529383|FG002|Pilot Phase|Adverse Event|0|||
105416032|NCT00837265|363529384|FG003|Pilot Phase|Adverse Event|0|||
105416033|NCT00837265|363529385|FG004|Pilot Phase|Adverse Event|0|||
105416034|NCT00837265|363529386|FG005|Pilot Phase|Adverse Event|0|||
105416035|NCT00837265|363529387|FG006|Pilot Phase|Adverse Event|0|||
105416036|NCT00837265|363529381|FG000|Pilot Phase|Disease progression|0|||
105416037|NCT00837265|363529382|FG001|Pilot Phase|Disease progression|0|||
105416038|NCT00837265|363529383|FG002|Pilot Phase|Disease progression|0|||
105416039|NCT00837265|363529384|FG003|Pilot Phase|Disease progression|1|||
105416040|NCT00837265|363529385|FG004|Pilot Phase|Disease progression|0|||
105416041|NCT00837265|363529386|FG005|Pilot Phase|Disease progression|0|||
105416042|NCT00837265|363529387|FG006|Pilot Phase|Disease progression|0|||
105416043|NCT00837265|363529381|FG000|Pilot Phase|Participant left the city|0|||
105416044|NCT00837265|363529382|FG001|Pilot Phase|Participant left the city|0|||
105416045|NCT00837265|363529383|FG002|Pilot Phase|Participant left the city|0|||
105416046|NCT00837265|363529384|FG003|Pilot Phase|Participant left the city|1|||
105416047|NCT00837265|363529385|FG004|Pilot Phase|Participant left the city|0|||
105416048|NCT00837265|363529386|FG005|Pilot Phase|Participant left the city|0|||
105416049|NCT00837265|363529387|FG006|Pilot Phase|Participant left the city|0|||
105416050|NCT00837265|363529381|FG000|Main Phase|Withdrawal by Subject|0|||
105416051|NCT00837265|363529382|FG001|Main Phase|Withdrawal by Subject|0|||
105416052|NCT00837265|363529383|FG002|Main Phase|Withdrawal by Subject|0|||
105416053|NCT00837265|363529384|FG003|Main Phase|Withdrawal by Subject|0|||
105416054|NCT00837265|363529385|FG004|Main Phase|Withdrawal by Subject|4|||
105416055|NCT00837265|363529386|FG005|Main Phase|Withdrawal by Subject|2|||
105416056|NCT00837265|363529387|FG006|Main Phase|Withdrawal by Subject|1|||
105416057|NCT00837265|363529381|FG000|Main Phase|Decision of the investigator|0|||
105416058|NCT00837265|363529382|FG001|Main Phase|Decision of the investigator|0|||
105416059|NCT00837265|363529383|FG002|Main Phase|Decision of the investigator|0|||
105416060|NCT00837265|363529384|FG003|Main Phase|Decision of the investigator|0|||
105416061|NCT00837265|363529385|FG004|Main Phase|Decision of the investigator|0|||
105416062|NCT00837265|363529386|FG005|Main Phase|Decision of the investigator|2|||
105416063|NCT00837265|363529387|FG006|Main Phase|Decision of the investigator|1|||
105416064|NCT00837265|363529381|FG000|Main Phase|Adverse Event|0|||
105416065|NCT00837265|363529382|FG001|Main Phase|Adverse Event|0|||
105416066|NCT00837265|363529383|FG002|Main Phase|Adverse Event|0|||
105416067|NCT00837265|363529384|FG003|Main Phase|Adverse Event|0|||
105416068|NCT00837265|363529385|FG004|Main Phase|Adverse Event|0|||
105416069|NCT00837265|363529386|FG005|Main Phase|Adverse Event|1|||
105416070|NCT00837265|363529387|FG006|Main Phase|Adverse Event|0|||
105416071|NCT00837265|363529381|FG000|Main Phase|Death|0|||
105416072|NCT00837265|363529382|FG001|Main Phase|Death|0|||
105416073|NCT00837265|363529383|FG002|Main Phase|Death|0|||
105416074|NCT00837265|363529384|FG003|Main Phase|Death|0|||
105416075|NCT00837265|363529385|FG004|Main Phase|Death|2|||
105416076|NCT00837265|363529386|FG005|Main Phase|Death|0|||
105416077|NCT00837265|363529387|FG006|Main Phase|Death|1|||
105416078|NCT00837265|363529381|FG000|Main Phase|Lost to Follow-up|0|||
105416079|NCT00837265|363529382|FG001|Main Phase|Lost to Follow-up|0|||
105416080|NCT00837265|363529383|FG002|Main Phase|Lost to Follow-up|0|||
105416081|NCT00837265|363529384|FG003|Main Phase|Lost to Follow-up|0|||
105416082|NCT00837265|363529385|FG004|Main Phase|Lost to Follow-up|1|||
105416083|NCT00837265|363529386|FG005|Main Phase|Lost to Follow-up|0|||
105416084|NCT00837265|363529387|FG006|Main Phase|Lost to Follow-up|0|||
105416085|NCT00837265|363529381|FG000|Main Phase|Principal investigator resignation|0|||
105416086|NCT00837265|363529382|FG001|Main Phase|Principal investigator resignation|0|||
105416087|NCT00837265|363529383|FG002|Main Phase|Principal investigator resignation|0|||
105416088|NCT00837265|363529384|FG003|Main Phase|Principal investigator resignation|0|||
105416089|NCT00837265|363529385|FG004|Main Phase|Principal investigator resignation|2|||
105583475|NCT04529538|364133898|FG000|Overall Study|Physician Decision|0|||
105416090|NCT00837265|363529386|FG005|Main Phase|Principal investigator resignation|0|||
105416091|NCT00837265|363529387|FG006|Main Phase|Principal investigator resignation|0|||
105416092|NCT00837265|363529381|FG000|Main Phase|Participant's personal reason|0|||
105583476|NCT04529538|364133899|FG001|Overall Study|Physician Decision|0|||
105416093|NCT00837265|363529382|FG001|Main Phase|Participant's personal reason|0|||
105416094|NCT00837265|363529383|FG002|Main Phase|Participant's personal reason|0|||
105416095|NCT00837265|363529384|FG003|Main Phase|Participant's personal reason|0|||
105583477|NCT04529538|364133900|FG002|Overall Study|Physician Decision|0|||
105583478|NCT04529538|364133901|FG003|Overall Study|Physician Decision|0|||
105498433|NCT02728596|363836303|FG003|Overall Study|Death|68|||
105498434|NCT03113916|363836304|FG000|Overall Study|Withdrawal by Subject|9|||
105498435|NCT03113916|363836305|FG001|Overall Study|Withdrawal by Subject|7|||
105498436|NCT03113916|363836304|FG000|Overall Study|Pregnancy|1|||
105498437|NCT03113916|363836305|FG001|Overall Study|Pregnancy|3|||
105498438|NCT03113916|363836304|FG000|Overall Study|Lost to Follow-up|1|||
105498439|NCT03113916|363836305|FG001|Overall Study|Lost to Follow-up|2|||
105498440|NCT00241358|363836311|FG000|Overall Study|Determined to be not ineligible|0|||
105498441|NCT00241358|363836312|FG001|Overall Study|Determined to be not ineligible|1|||
105498442|NCT00241358|363836313|FG002|Overall Study|Determined to be not ineligible|1|||
105498443|NCT04729621|363836314|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
105498444|NCT04729621|363836315|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
105498445|NCT04729621|363836316|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
105498446|NCT04729621|363836317|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
105498447|NCT04729621|363836318|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
105498448|NCT04729621|363836314|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
105498449|NCT04729621|363836315|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
105498450|NCT04729621|363836316|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
105498451|NCT04729621|363836317|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
105498452|NCT04729621|363836318|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
105498453|NCT04729621|363836314|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
105498454|NCT04729621|363836315|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
105498455|NCT04729621|363836316|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
105498456|NCT04729621|363836317|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
105498457|NCT04729621|363836318|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
105498458|NCT04729621|363836314|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
105498459|NCT04729621|363836315|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
105498460|NCT04729621|363836316|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
105498461|NCT04729621|363836317|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
105498462|NCT04729621|363836318|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
105498463|NCT04729621|363836314|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
105498464|NCT04729621|363836315|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
105498465|NCT04729621|363836316|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
105498466|NCT04729621|363836317|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
105498467|NCT04729621|363836318|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
105498468|NCT04729621|363836314|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
105498469|NCT04729621|363836315|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
105498470|NCT04729621|363836316|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
105498471|NCT04729621|363836317|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
105498472|NCT04729621|363836318|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
105498473|NCT03439657|363836319|FG000|Overall Study|Adverse Event|2|||
105498474|NCT03439657|363836320|FG001|Overall Study|Adverse Event|3|||
105498475|NCT03439657|363836319|FG000|Overall Study|Lost to Follow-up|1|||
105498476|NCT03439657|363836320|FG001|Overall Study|Lost to Follow-up|0|||
105498477|NCT03439657|363836319|FG000|Overall Study|Protocol Violation|1|||
105498478|NCT03439657|363836320|FG001|Overall Study|Protocol Violation|1|||
105498479|NCT03439657|363836319|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
105498480|NCT03439657|363836320|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
105498481|NCT03308786|363836325|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
105498482|NCT00347360|363836336|FG000|Overall Study|Adverse Event|1|||
105498483|NCT00347360|363836337|FG001|Overall Study|Adverse Event|2|||
105498484|NCT00347360|363836338|FG002|Overall Study|Adverse Event|0|||
105498485|NCT00347360|363836339|FG003|Overall Study|Adverse Event|4|||
105498486|NCT00347360|363836340|FG004|Overall Study|Adverse Event|1|||
105498487|NCT00347360|363836341|FG005|Overall Study|Adverse Event|2|||
105498488|NCT00347360|363836342|FG006|Overall Study|Adverse Event|2|||
105498489|NCT00347360|363836343|FG007|Overall Study|Adverse Event|0|||
105583479|NCT04529538|364133902|FG004|Overall Study|Physician Decision|0|||
105583480|NCT04529538|364133903|FG005|Overall Study|Physician Decision|1|||
105583481|NCT04529538|364133904|FG006|Overall Study|Physician Decision|0|||
105583482|NCT04529538|364133905|FG007|Overall Study|Physician Decision|1|||
105498490|NCT00347360|363836344|FG008|Overall Study|Adverse Event|2|||
105498491|NCT00347360|363836345|FG009|Overall Study|Adverse Event|3|||
105498492|NCT00347360|363836346|FG010|Overall Study|Adverse Event|3|||
105498493|NCT00347360|363836347|FG011|Overall Study|Adverse Event|1|||
105498494|NCT00347360|363836348|FG012|Overall Study|Adverse Event|3|||
105498495|NCT00347360|363836349|FG013|Overall Study|Adverse Event|2|||
105498496|NCT00347360|363836350|FG014|Overall Study|Adverse Event|2|||
105498497|NCT00347360|363836336|FG000|Overall Study|Lost to Follow-up|0|||
105498498|NCT00347360|363836337|FG001|Overall Study|Lost to Follow-up|0|||
105498499|NCT00347360|363836338|FG002|Overall Study|Lost to Follow-up|0|||
105498500|NCT00347360|363836339|FG003|Overall Study|Lost to Follow-up|2|||
105498501|NCT00347360|363836340|FG004|Overall Study|Lost to Follow-up|1|||
105498502|NCT00347360|363836341|FG005|Overall Study|Lost to Follow-up|1|||
105498503|NCT00347360|363836342|FG006|Overall Study|Lost to Follow-up|0|||
105498504|NCT00347360|363836343|FG007|Overall Study|Lost to Follow-up|1|||
105498505|NCT00347360|363836344|FG008|Overall Study|Lost to Follow-up|1|||
105498506|NCT00347360|363836345|FG009|Overall Study|Lost to Follow-up|2|||
105498507|NCT00347360|363836346|FG010|Overall Study|Lost to Follow-up|0|||
105498508|NCT00347360|363836347|FG011|Overall Study|Lost to Follow-up|0|||
105498509|NCT00347360|363836348|FG012|Overall Study|Lost to Follow-up|1|||
105498510|NCT00347360|363836349|FG013|Overall Study|Lost to Follow-up|0|||
105498511|NCT00347360|363836350|FG014|Overall Study|Lost to Follow-up|0|||
105498512|NCT00347360|363836336|FG000|Overall Study|Protocol Violation|2|||
105498513|NCT00347360|363836337|FG001|Overall Study|Protocol Violation|3|||
105498514|NCT00347360|363836338|FG002|Overall Study|Protocol Violation|1|||
105498515|NCT00347360|363836339|FG003|Overall Study|Protocol Violation|2|||
105498516|NCT00347360|363836340|FG004|Overall Study|Protocol Violation|1|||
105498517|NCT00347360|363836341|FG005|Overall Study|Protocol Violation|2|||
105498518|NCT00347360|363836342|FG006|Overall Study|Protocol Violation|0|||
105498519|NCT00347360|363836343|FG007|Overall Study|Protocol Violation|0|||
105498520|NCT00347360|363836344|FG008|Overall Study|Protocol Violation|1|||
105498521|NCT00347360|363836345|FG009|Overall Study|Protocol Violation|2|||
105498522|NCT00347360|363836346|FG010|Overall Study|Protocol Violation|0|||
105498523|NCT00347360|363836347|FG011|Overall Study|Protocol Violation|0|||
105498524|NCT00347360|363836348|FG012|Overall Study|Protocol Violation|0|||
105498525|NCT00347360|363836349|FG013|Overall Study|Protocol Violation|1|||
105498526|NCT00347360|363836350|FG014|Overall Study|Protocol Violation|0|||
105498527|NCT00347360|363836336|FG000|Overall Study|Withdrawal by Subject|0|||
105498528|NCT00347360|363836337|FG001|Overall Study|Withdrawal by Subject|1|||
105498529|NCT00347360|363836338|FG002|Overall Study|Withdrawal by Subject|2|||
105498530|NCT00347360|363836339|FG003|Overall Study|Withdrawal by Subject|4|||
105498531|NCT00347360|363836340|FG004|Overall Study|Withdrawal by Subject|1|||
105498532|NCT00347360|363836341|FG005|Overall Study|Withdrawal by Subject|2|||
105498533|NCT00347360|363836342|FG006|Overall Study|Withdrawal by Subject|1|||
105498534|NCT00347360|363836343|FG007|Overall Study|Withdrawal by Subject|1|||
105498535|NCT00347360|363836344|FG008|Overall Study|Withdrawal by Subject|1|||
105498536|NCT00347360|363836345|FG009|Overall Study|Withdrawal by Subject|1|||
105498537|NCT00347360|363836346|FG010|Overall Study|Withdrawal by Subject|0|||
105498538|NCT00347360|363836347|FG011|Overall Study|Withdrawal by Subject|3|||
105498539|NCT00347360|363836348|FG012|Overall Study|Withdrawal by Subject|4|||
105498540|NCT00347360|363836349|FG013|Overall Study|Withdrawal by Subject|2|||
105498541|NCT00347360|363836350|FG014|Overall Study|Withdrawal by Subject|1|||
105498542|NCT00347360|363836336|FG000|Overall Study|Lack of Efficacy|1|||
105498543|NCT00347360|363836337|FG001|Overall Study|Lack of Efficacy|1|||
105498544|NCT00347360|363836338|FG002|Overall Study|Lack of Efficacy|3|||
105498545|NCT00347360|363836339|FG003|Overall Study|Lack of Efficacy|1|||
105498546|NCT00347360|363836340|FG004|Overall Study|Lack of Efficacy|0|||
105498547|NCT00347360|363836341|FG005|Overall Study|Lack of Efficacy|1|||
105498548|NCT00347360|363836342|FG006|Overall Study|Lack of Efficacy|0|||
105498549|NCT00347360|363836343|FG007|Overall Study|Lack of Efficacy|1|||
105498550|NCT00347360|363836344|FG008|Overall Study|Lack of Efficacy|1|||
105498551|NCT00347360|363836345|FG009|Overall Study|Lack of Efficacy|0|||
105498552|NCT00347360|363836346|FG010|Overall Study|Lack of Efficacy|0|||
105498553|NCT00347360|363836347|FG011|Overall Study|Lack of Efficacy|0|||
105498554|NCT00347360|363836348|FG012|Overall Study|Lack of Efficacy|0|||
105498555|NCT00347360|363836349|FG013|Overall Study|Lack of Efficacy|0|||
105498556|NCT00347360|363836350|FG014|Overall Study|Lack of Efficacy|0|||
105498557|NCT00347360|363836336|FG000|Overall Study|Reason not listed/blank|1|||
105498558|NCT00347360|363836337|FG001|Overall Study|Reason not listed/blank|0|||
105583483|NCT03289455|364133908|FG000|Overall Study|Death|1|||
105498559|NCT00347360|363836338|FG002|Overall Study|Reason not listed/blank|0|||
105498560|NCT00347360|363836339|FG003|Overall Study|Reason not listed/blank|0|||
105498561|NCT00347360|363836340|FG004|Overall Study|Reason not listed/blank|0|||
105498562|NCT00347360|363836341|FG005|Overall Study|Reason not listed/blank|0|||
105498563|NCT00347360|363836342|FG006|Overall Study|Reason not listed/blank|1|||
105498564|NCT00347360|363836343|FG007|Overall Study|Reason not listed/blank|0|||
105498565|NCT00347360|363836344|FG008|Overall Study|Reason not listed/blank|0|||
105498566|NCT00347360|363836345|FG009|Overall Study|Reason not listed/blank|0|||
105498567|NCT00347360|363836346|FG010|Overall Study|Reason not listed/blank|0|||
105498568|NCT00347360|363836347|FG011|Overall Study|Reason not listed/blank|0|||
105498569|NCT00347360|363836348|FG012|Overall Study|Reason not listed/blank|0|||
105498570|NCT00347360|363836349|FG013|Overall Study|Reason not listed/blank|1|||
105583484|NCT03289455|364133909|FG001|Overall Study|Death|0|||
105498571|NCT00347360|363836350|FG014|Overall Study|Reason not listed/blank|0|||
105498572|NCT00347360|363836336|FG000|Overall Study|Per sponsors instruction|0|||
105498573|NCT00347360|363836337|FG001|Overall Study|Per sponsors instruction|1|||
105498574|NCT00347360|363836338|FG002|Overall Study|Per sponsors instruction|0|||
105498575|NCT00347360|363836339|FG003|Overall Study|Per sponsors instruction|0|||
105498576|NCT00347360|363836340|FG004|Overall Study|Per sponsors instruction|0|||
105498577|NCT00347360|363836341|FG005|Overall Study|Per sponsors instruction|0|||
105498578|NCT00347360|363836342|FG006|Overall Study|Per sponsors instruction|0|||
105498579|NCT00347360|363836343|FG007|Overall Study|Per sponsors instruction|0|||
105498580|NCT00347360|363836344|FG008|Overall Study|Per sponsors instruction|0|||
105498581|NCT00347360|363836345|FG009|Overall Study|Per sponsors instruction|0|||
105498582|NCT00347360|363836346|FG010|Overall Study|Per sponsors instruction|0|||
105498583|NCT00347360|363836347|FG011|Overall Study|Per sponsors instruction|0|||
105498584|NCT00347360|363836348|FG012|Overall Study|Per sponsors instruction|0|||
105498585|NCT00347360|363836349|FG013|Overall Study|Per sponsors instruction|0|||
105498586|NCT00347360|363836350|FG014|Overall Study|Per sponsors instruction|0|||
105498587|NCT00347360|363836336|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
105498588|NCT00347360|363836337|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
105498589|NCT00347360|363836338|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
105498590|NCT00347360|363836339|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
105498591|NCT00347360|363836340|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
105498592|NCT00347360|363836341|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
105498593|NCT00347360|363836342|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
105498594|NCT00347360|363836343|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
105498595|NCT00347360|363836344|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
105498596|NCT00347360|363836345|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
105498597|NCT00347360|363836346|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
105498598|NCT00347360|363836347|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
105498599|NCT00347360|363836348|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
105498600|NCT00347360|363836349|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
105498601|NCT00347360|363836350|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
105498602|NCT00347360|363836336|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
105498603|NCT00347360|363836337|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
105498604|NCT00347360|363836338|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
105498605|NCT00347360|363836339|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
105498606|NCT00347360|363836340|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
105498607|NCT00347360|363836341|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
105498608|NCT00347360|363836342|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
105498609|NCT00347360|363836343|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
105498610|NCT00347360|363836344|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
105498611|NCT00347360|363836345|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
105498612|NCT00347360|363836346|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
105498613|NCT00347360|363836347|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
105498614|NCT00347360|363836348|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
105498615|NCT00347360|363836349|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
105498616|NCT00347360|363836350|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
105498617|NCT00347360|363836336|FG000|Overall Study|Abnormal lab values|0|||
105498618|NCT00347360|363836337|FG001|Overall Study|Abnormal lab values|0|||
105498619|NCT00347360|363836338|FG002|Overall Study|Abnormal lab values|0|||
105498620|NCT00347360|363836339|FG003|Overall Study|Abnormal lab values|0|||
105498621|NCT00347360|363836340|FG004|Overall Study|Abnormal lab values|0|||
105498622|NCT00347360|363836341|FG005|Overall Study|Abnormal lab values|0|||
105498623|NCT00347360|363836342|FG006|Overall Study|Abnormal lab values|1|||
105498624|NCT00347360|363836343|FG007|Overall Study|Abnormal lab values|0|||
105498625|NCT00347360|363836344|FG008|Overall Study|Abnormal lab values|0|||
105498626|NCT00347360|363836345|FG009|Overall Study|Abnormal lab values|0|||
105498627|NCT00347360|363836346|FG010|Overall Study|Abnormal lab values|0|||
105498628|NCT00347360|363836347|FG011|Overall Study|Abnormal lab values|0|||
105498629|NCT00347360|363836348|FG012|Overall Study|Abnormal lab values|0|||
105498630|NCT00347360|363836349|FG013|Overall Study|Abnormal lab values|0|||
105498631|NCT00347360|363836350|FG014|Overall Study|Abnormal lab values|0|||
105498632|NCT00347360|363836336|FG000|Overall Study|PI recommended early withdrawal|0|||
105498633|NCT00347360|363836337|FG001|Overall Study|PI recommended early withdrawal|0|||
105498634|NCT00347360|363836338|FG002|Overall Study|PI recommended early withdrawal|0|||
105498635|NCT00347360|363836339|FG003|Overall Study|PI recommended early withdrawal|0|||
105498636|NCT00347360|363836340|FG004|Overall Study|PI recommended early withdrawal|0|||
105498637|NCT00347360|363836341|FG005|Overall Study|PI recommended early withdrawal|0|||
105498638|NCT00347360|363836342|FG006|Overall Study|PI recommended early withdrawal|0|||
105498639|NCT00347360|363836343|FG007|Overall Study|PI recommended early withdrawal|0|||
105498640|NCT00347360|363836344|FG008|Overall Study|PI recommended early withdrawal|0|||
105498641|NCT00347360|363836345|FG009|Overall Study|PI recommended early withdrawal|1|||
105416096|NCT00837265|363529385|FG004|Main Phase|Participant's personal reason|1|||
105416097|NCT00837265|363529386|FG005|Main Phase|Participant's personal reason|0|||
105416098|NCT00837265|363529387|FG006|Main Phase|Participant's personal reason|0|||
105416099|NCT01751906|363529394|FG000|Overall Study|Lost to Follow-up|151|||
105416100|NCT01751906|363529395|FG001|Overall Study|Lost to Follow-up|68|||
105416101|NCT01751906|363529394|FG000|Overall Study|Withdrawal by Subject|22|||
105416102|NCT01751906|363529395|FG001|Overall Study|Withdrawal by Subject|18|||
105416103|NCT01751906|363529394|FG000|Overall Study|Physician Decision|5|||
105416104|NCT01751906|363529395|FG001|Overall Study|Physician Decision|2|||
105416105|NCT01751906|363529394|FG000|Overall Study|Death|84|||
105416106|NCT01751906|363529395|FG001|Overall Study|Death|43|||
105416107|NCT01751906|363529394|FG000|Overall Study|Denied on premises for follow-up by law|1|||
105416108|NCT01751906|363529395|FG001|Overall Study|Denied on premises for follow-up by law|0|||
105416109|NCT01110330|363529398|FG000|Overall Study|Adverse Event|0|||
105416110|NCT01110330|363529399|FG001|Overall Study|Adverse Event|4|||
105416111|NCT01110330|363529400|FG002|Overall Study|Adverse Event|3|||
105416112|NCT01110330|363529398|FG000|Overall Study|Lack of Efficacy|3|||
105416113|NCT01110330|363529399|FG001|Overall Study|Lack of Efficacy|1|||
105416114|NCT01110330|363529400|FG002|Overall Study|Lack of Efficacy|1|||
105416115|NCT01110330|363529398|FG000|Overall Study|Lost to Follow-up|9|||
105416116|NCT01110330|363529399|FG001|Overall Study|Lost to Follow-up|10|||
105416117|NCT01110330|363529400|FG002|Overall Study|Lost to Follow-up|15|||
105416118|NCT01110330|363529398|FG000|Overall Study|Physician Decision|0|||
105416119|NCT01110330|363529399|FG001|Overall Study|Physician Decision|1|||
105416120|NCT01110330|363529400|FG002|Overall Study|Physician Decision|0|||
105416121|NCT01110330|363529398|FG000|Overall Study|Protocol Violation|2|||
105416122|NCT01110330|363529399|FG001|Overall Study|Protocol Violation|0|||
105416123|NCT01110330|363529400|FG002|Overall Study|Protocol Violation|4|||
105416124|NCT01110330|363529398|FG000|Overall Study|Withdrawal by Subject|0|||
105416125|NCT01110330|363529399|FG001|Overall Study|Withdrawal by Subject|6|||
105416126|NCT01110330|363529400|FG002|Overall Study|Withdrawal by Subject|2|||
105416127|NCT01110330|363529398|FG000|Overall Study|Other|1|||
105416128|NCT01110330|363529399|FG001|Overall Study|Other|1|||
105416129|NCT01110330|363529400|FG002|Overall Study|Other|1|||
105416130|NCT04644276|363529410|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
105416131|NCT04644276|363529411|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
105416132|NCT04644276|363529412|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
105416133|NCT02388165|363529413|FG000|Overall Study|Study terminated by sponsor|5|||
105416134|NCT02388165|363529414|FG001|Overall Study|Study terminated by sponsor|5|||
105416135|NCT02388165|363529413|FG000|Overall Study|Other|11|||
105416136|NCT02388165|363529414|FG001|Overall Study|Other|13|||
105416137|NCT02388165|363529413|FG000|Overall Study|No longer meet eligibility criteria|40|||
105416138|NCT02388165|363529414|FG001|Overall Study|No longer meet eligibility criteria|43|||
105416139|NCT02388165|363529413|FG000|Overall Study|Withdrawal of consent|31|||
105416140|NCT02388165|363529414|FG001|Overall Study|Withdrawal of consent|32|||
105416141|NCT02388165|363529413|FG000|Overall Study|Lost to Follow-up|19|||
105416142|NCT02388165|363529414|FG001|Overall Study|Lost to Follow-up|20|||
105416143|NCT02388165|363529413|FG000|Overall Study|Death|13|||
105416144|NCT02388165|363529414|FG001|Overall Study|Death|10|||
105416145|NCT02388165|363529413|FG000|Overall Study|Adverse Event|3|||
105416146|NCT02388165|363529414|FG001|Overall Study|Adverse Event|5|||
105416147|NCT02388165|363529413|FG000|Overall Study|Did not meet entrance criteria|5|||
105416148|NCT02388165|363529414|FG001|Overall Study|Did not meet entrance criteria|2|||
105416149|NCT01474772|363529418|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
105416150|NCT01474772|363529419|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
105416151|NCT01474772|363529418|FG000|Period 1|AE not Related to Study Drug|1|||
105416152|NCT01474772|363529419|FG001|Period 1|AE not Related to Study Drug|0|||
105416153|NCT01474772|363529418|FG000|Period 1|Withdrawal by Subject|3|||
105416154|NCT01474772|363529419|FG001|Period 1|Withdrawal by Subject|1|||
105416155|NCT01474772|363529418|FG000|Period 1|Lost to Follow-up|1|||
105416156|NCT01474772|363529419|FG001|Period 1|Lost to Follow-up|0|||
105416157|NCT01474772|363529418|FG000|Period 1|Reason not Specified|1|||
105416158|NCT01474772|363529419|FG001|Period 1|Reason not Specified|1|||
105416159|NCT01474772|363529418|FG000|Washout|AE not Related to Study Drug|2|||
105416160|NCT01474772|363529419|FG001|Washout|AE not Related to Study Drug|0|||
105416161|NCT01474772|363529418|FG000|Washout|Withdrawal by Subject|1|||
105416162|NCT01474772|363529419|FG001|Washout|Withdrawal by Subject|0|||
105416163|NCT01474772|363529418|FG000|Washout|Lost to Follow-up|0|||
105416164|NCT01474772|363529419|FG001|Washout|Lost to Follow-up|1|||
105416165|NCT01474772|363529418|FG000|Washout|Reason not Specified|0|||
105416166|NCT01474772|363529419|FG001|Washout|Reason not Specified|1|||
105416167|NCT01474772|363529418|FG000|Period 2|Death|0|||
105416168|NCT01474772|363529419|FG001|Period 2|Death|1|||
105416169|NCT01474772|363529418|FG000|Period 2|AE Related to Study Drug|0|||
105416170|NCT01474772|363529419|FG001|Period 2|AE Related to Study Drug|1|||
105416171|NCT01474772|363529418|FG000|Period 2|AE not Related to Study Drug|4|||
105416172|NCT01474772|363529419|FG001|Period 2|AE not Related to Study Drug|1|||
105416173|NCT01474772|363529418|FG000|Period 2|Lack of Efficacy|1|||
105416174|NCT01474772|363529419|FG001|Period 2|Lack of Efficacy|0|||
105416175|NCT01474772|363529418|FG000|Period 2|Withdrawal by Subject|3|||
105416176|NCT01474772|363529419|FG001|Period 2|Withdrawal by Subject|4|||
105416177|NCT01474772|363529418|FG000|Period 2|Lost to Follow-up|1|||
105416178|NCT01474772|363529419|FG001|Period 2|Lost to Follow-up|1|||
105416179|NCT01474772|363529418|FG000|Period 2|Reason not Specified|0|||
105416180|NCT01474772|363529419|FG001|Period 2|Reason not Specified|2|||
105416181|NCT01474772|363529418|FG000|Follow-up|AE not Related to Study Drug|0|||
105416182|NCT01474772|363529419|FG001|Follow-up|AE not Related to Study Drug|1|||
105416183|NCT03286543|363529420|FG000|Consented|Screen failure before randomization|2|||
105416184|NCT03286543|363529421|FG001|Consented|Screen failure before randomization|0|||
105416185|NCT03286543|363529422|FG002|Consented|Screen failure before randomization|0|||
105416186|NCT03286543|363529420|FG000|Consented|Screen failure before enrollment|4|||
105416187|NCT03286543|363529421|FG001|Consented|Screen failure before enrollment|0|||
105416188|NCT03286543|363529422|FG002|Consented|Screen failure before enrollment|0|||
105416189|NCT03286543|363529420|FG000|Consented|TKA cancelled after enrollment|1|||
105416190|NCT03286543|363529421|FG001|Consented|TKA cancelled after enrollment|0|||
105416191|NCT03286543|363529422|FG002|Consented|TKA cancelled after enrollment|0|||
105416192|NCT03286543|363529420|FG000|Consented|Withdrawn from study|12|||
105416193|NCT03286543|363529421|FG001|Consented|Withdrawn from study|0|||
105416194|NCT03286543|363529422|FG002|Consented|Withdrawn from study|0|||
105416195|NCT03286543|363529420|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
105416196|NCT03286543|363529421|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
105416197|NCT03286543|363529422|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
105416198|NCT03286543|363529420|FG000|Study Enrollment|Withdrawn from study|0|||
105416199|NCT03286543|363529421|FG001|Study Enrollment|Withdrawn from study|6|||
105416200|NCT03286543|363529422|FG002|Study Enrollment|Withdrawn from study|6|||
105416201|NCT01463696|363529423|FG000|Overall Study|Adverse Event|0|||
105416202|NCT01463696|363529424|FG001|Overall Study|Adverse Event|1|||
105416203|NCT01463696|363529425|FG002|Overall Study|Adverse Event|0|||
105416204|NCT01463696|363529426|FG003|Overall Study|Adverse Event|2|||
105416205|NCT01463696|363529427|FG004|Overall Study|Adverse Event|0|||
105416206|NCT01463696|363529428|FG005|Overall Study|Adverse Event|1|||
105416207|NCT01463696|363529429|FG006|Overall Study|Adverse Event|3|||
105498642|NCT00347360|363836346|FG010|Overall Study|PI recommended early withdrawal|0|||
105498643|NCT00347360|363836347|FG011|Overall Study|PI recommended early withdrawal|0|||
105498644|NCT00347360|363836348|FG012|Overall Study|PI recommended early withdrawal|0|||
105498645|NCT00347360|363836349|FG013|Overall Study|PI recommended early withdrawal|0|||
105498646|NCT00347360|363836350|FG014|Overall Study|PI recommended early withdrawal|0|||
105498647|NCT00347360|363836336|FG000|Overall Study|Did not meet criteria before ABPM|0|||
105498648|NCT00347360|363836337|FG001|Overall Study|Did not meet criteria before ABPM|0|||
105498649|NCT00347360|363836338|FG002|Overall Study|Did not meet criteria before ABPM|0|||
105498650|NCT00347360|363836339|FG003|Overall Study|Did not meet criteria before ABPM|0|||
105498651|NCT00347360|363836340|FG004|Overall Study|Did not meet criteria before ABPM|0|||
105498652|NCT00347360|363836341|FG005|Overall Study|Did not meet criteria before ABPM|0|||
105498653|NCT00347360|363836342|FG006|Overall Study|Did not meet criteria before ABPM|0|||
105498654|NCT00347360|363836343|FG007|Overall Study|Did not meet criteria before ABPM|0|||
105498655|NCT00347360|363836344|FG008|Overall Study|Did not meet criteria before ABPM|0|||
105498656|NCT00347360|363836345|FG009|Overall Study|Did not meet criteria before ABPM|0|||
105498657|NCT00347360|363836346|FG010|Overall Study|Did not meet criteria before ABPM|1|||
105498658|NCT00347360|363836347|FG011|Overall Study|Did not meet criteria before ABPM|0|||
105498659|NCT00347360|363836348|FG012|Overall Study|Did not meet criteria before ABPM|0|||
105498660|NCT00347360|363836349|FG013|Overall Study|Did not meet criteria before ABPM|0|||
105498661|NCT00347360|363836350|FG014|Overall Study|Did not meet criteria before ABPM|0|||
105498662|NCT00347360|363836336|FG000|Overall Study|Randomized in error|0|||
105498663|NCT00347360|363836337|FG001|Overall Study|Randomized in error|0|||
105498664|NCT00347360|363836338|FG002|Overall Study|Randomized in error|0|||
105498665|NCT00347360|363836339|FG003|Overall Study|Randomized in error|0|||
105498666|NCT00347360|363836340|FG004|Overall Study|Randomized in error|0|||
105498667|NCT00347360|363836341|FG005|Overall Study|Randomized in error|0|||
105498668|NCT00347360|363836342|FG006|Overall Study|Randomized in error|0|||
105498669|NCT00347360|363836343|FG007|Overall Study|Randomized in error|0|||
105498670|NCT00347360|363836344|FG008|Overall Study|Randomized in error|0|||
105498671|NCT00347360|363836345|FG009|Overall Study|Randomized in error|0|||
105498672|NCT00347360|363836346|FG010|Overall Study|Randomized in error|0|||
105498673|NCT00347360|363836347|FG011|Overall Study|Randomized in error|1|||
105498674|NCT00347360|363836348|FG012|Overall Study|Randomized in error|0|||
105498675|NCT00347360|363836349|FG013|Overall Study|Randomized in error|0|||
105416208|NCT01463696|363529430|FG007|Overall Study|Adverse Event|2|||
105416209|NCT01463696|363529423|FG000|Overall Study|Lost to Follow-up|0|||
105416210|NCT01463696|363529424|FG001|Overall Study|Lost to Follow-up|0|||
105416211|NCT01463696|363529425|FG002|Overall Study|Lost to Follow-up|1|||
105416212|NCT01463696|363529426|FG003|Overall Study|Lost to Follow-up|0|||
105416213|NCT01463696|363529427|FG004|Overall Study|Lost to Follow-up|0|||
105416214|NCT01463696|363529428|FG005|Overall Study|Lost to Follow-up|0|||
105416215|NCT01463696|363529429|FG006|Overall Study|Lost to Follow-up|0|||
105416216|NCT01463696|363529430|FG007|Overall Study|Lost to Follow-up|0|||
105416217|NCT01463696|363529423|FG000|Overall Study|Progressive Disease|0|||
105416218|NCT01463696|363529424|FG001|Overall Study|Progressive Disease|1|||
105416219|NCT01463696|363529425|FG002|Overall Study|Progressive Disease|0|||
105416220|NCT01463696|363529426|FG003|Overall Study|Progressive Disease|1|||
105416221|NCT01463696|363529427|FG004|Overall Study|Progressive Disease|0|||
105416222|NCT01463696|363529428|FG005|Overall Study|Progressive Disease|1|||
105416223|NCT01463696|363529429|FG006|Overall Study|Progressive Disease|4|||
105416224|NCT01463696|363529430|FG007|Overall Study|Progressive Disease|2|||
105416225|NCT01463696|363529423|FG000|Overall Study|Withdrawal by Subject|0|||
105416226|NCT01463696|363529424|FG001|Overall Study|Withdrawal by Subject|0|||
105416227|NCT01463696|363529425|FG002|Overall Study|Withdrawal by Subject|0|||
105416228|NCT01463696|363529426|FG003|Overall Study|Withdrawal by Subject|1|||
105416229|NCT01463696|363529427|FG004|Overall Study|Withdrawal by Subject|1|||
105416230|NCT01463696|363529428|FG005|Overall Study|Withdrawal by Subject|1|||
105416231|NCT01463696|363529429|FG006|Overall Study|Withdrawal by Subject|2|||
105416232|NCT01463696|363529430|FG007|Overall Study|Withdrawal by Subject|0|||
105416233|NCT01463696|363529423|FG000|Overall Study|Not Treated|0|||
105416234|NCT01463696|363529424|FG001|Overall Study|Not Treated|0|||
105416235|NCT01463696|363529425|FG002|Overall Study|Not Treated|0|||
105416236|NCT01463696|363529426|FG003|Overall Study|Not Treated|0|||
105416237|NCT01463696|363529427|FG004|Overall Study|Not Treated|0|||
105416238|NCT01463696|363529428|FG005|Overall Study|Not Treated|0|||
105416239|NCT01463696|363529429|FG006|Overall Study|Not Treated|1|||
105416240|NCT01463696|363529430|FG007|Overall Study|Not Treated|0|||
105416241|NCT01450696|363529431|FG000|Overall Study|Never Treated|1|||
105416242|NCT01450696|363529432|FG001|Overall Study|Never Treated|1|||
105416243|NCT01450696|363529431|FG000|Overall Study|Death|77|||
105416244|NCT01450696|363529432|FG001|Overall Study|Death|84|||
105416245|NCT01450696|363529431|FG000|Overall Study|Lost to Follow-up|3|||
105416246|NCT01450696|363529432|FG001|Overall Study|Lost to Follow-up|3|||
105416247|NCT01450696|363529431|FG000|Overall Study|Non-Compliance|1|||
105416248|NCT01450696|363529432|FG001|Overall Study|Non-Compliance|0|||
105416249|NCT01450696|363529431|FG000|Overall Study|Withdrawal by Subject|13|||
105416250|NCT01450696|363529432|FG001|Overall Study|Withdrawal by Subject|2|||
105416251|NCT01450696|363529431|FG000|Overall Study|Study Terminated by Sponsor|53|||
105416252|NCT01450696|363529432|FG001|Overall Study|Study Terminated by Sponsor|58|||
105416253|NCT00967694|363529433|FG000|Overall Study|Withdrawal by Subject|6|||
105416254|NCT02321319|363529434|FG000|Overall Study|Product discontinued|5|||
105416255|NCT02249091|363529435|FG000|Overall Study|Lack of Efficacy|8|||
105416256|NCT02249091|363529436|FG001|Overall Study|Lack of Efficacy|3|||
105416257|NCT02249091|363529435|FG000|Overall Study|Physician Decision|4|||
105416258|NCT02249091|363529436|FG001|Overall Study|Physician Decision|1|||
105416259|NCT02249091|363529435|FG000|Overall Study|Withdrawal by Subject|2|||
105416260|NCT02249091|363529436|FG001|Overall Study|Withdrawal by Subject|2|||
105416261|NCT02249091|363529435|FG000|Overall Study|Death|3|||
105416262|NCT02249091|363529436|FG001|Overall Study|Death|4|||
105416263|NCT02249091|363529435|FG000|Overall Study|Adverse Event|1|||
105416264|NCT02249091|363529436|FG001|Overall Study|Adverse Event|0|||
105416265|NCT02249091|363529435|FG000|Overall Study|Stable disease with following SCT|0|||
105416266|NCT02249091|363529436|FG001|Overall Study|Stable disease with following SCT|1|||
105416267|NCT02249091|363529435|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
105416268|NCT02249091|363529436|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
105416269|NCT02249091|363529435|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
105416270|NCT02249091|363529436|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
105416271|NCT02249091|363529435|FG000|Overall Study|Refractory AML|1|||
105416272|NCT02249091|363529436|FG001|Overall Study|Refractory AML|1|||
105416273|NCT00433966|363529437|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
105416274|NCT00433966|363529438|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
105416275|NCT00433966|363529439|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
105416276|NCT00433966|363529440|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
105416277|NCT00433966|363529437|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
105416278|NCT00433966|363529438|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
105416279|NCT00433966|363529439|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
105416280|NCT00433966|363529440|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
105416281|NCT00433966|363529437|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
105416282|NCT00433966|363529438|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
105416283|NCT00433966|363529439|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
105416284|NCT00433966|363529440|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
105416285|NCT00433966|363529437|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
105416286|NCT00433966|363529438|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
105416287|NCT00433966|363529439|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
105416288|NCT00433966|363529440|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
105416289|NCT00433966|363529437|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
105416290|NCT00433966|363529438|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
105416291|NCT00433966|363529439|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
105416292|NCT00433966|363529440|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
105416293|NCT03905265|363529442|FG000|Overall Study|Withdrawal by Subject|1|||
105416294|NCT03905265|363529443|FG001|Overall Study|Withdrawal by Subject|1|||
105416295|NCT03905265|363529444|FG002|Overall Study|Withdrawal by Subject|0|||
105416296|NCT03905265|363529445|FG003|Overall Study|Withdrawal by Subject|0|||
105416297|NCT01265563|363529446|FG000|Overall Study|Withdrawal by Subject|0|||
105416298|NCT01265563|363529447|FG001|Overall Study|Withdrawal by Subject|1|||
105416299|NCT01265563|363529448|FG002|Overall Study|Withdrawal by Subject|1|||
105416300|NCT01265563|363529449|FG003|Overall Study|Withdrawal by Subject|0|||
105416301|NCT01265563|363529450|FG004|Overall Study|Withdrawal by Subject|2|||
105416302|NCT00606034|363529455|FG000|Overall Study|incarceration|1|||
105416303|NCT00632827|363529458|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
105416304|NCT00632827|363529458|FG000|Overall Study|Death|2|||
105416305|NCT00632827|363529458|FG000|Overall Study|Adverse Event|5|||
105416306|NCT00632827|363529458|FG000|Overall Study|Lost to Follow-up|1|||
105416307|NCT01257230|363529459|FG000|Overall Study|Not Treated|0|||
105416308|NCT01257230|363529460|FG001|Overall Study|Not Treated|0|||
105416309|NCT01257230|363529461|FG002|Overall Study|Not Treated|1|||
105416310|NCT01257230|363529459|FG000|Overall Study|Adverse Event|2|||
105416311|NCT01257230|363529460|FG001|Overall Study|Adverse Event|0|||
105416312|NCT01257230|363529461|FG002|Overall Study|Adverse Event|0|||
105416313|NCT01257230|363529459|FG000|Overall Study|Lack of Efficacy|0|||
105416314|NCT01257230|363529460|FG001|Overall Study|Lack of Efficacy|1|||
105416315|NCT01257230|363529461|FG002|Overall Study|Lack of Efficacy|0|||
105416316|NCT01257230|363529459|FG000|Overall Study|Protocol Violation|3|||
105416317|NCT01257230|363529460|FG001|Overall Study|Protocol Violation|0|||
105416318|NCT01257230|363529461|FG002|Overall Study|Protocol Violation|1|||
105416319|NCT01257230|363529459|FG000|Overall Study|Withdrawal by Subject|0|||
105416320|NCT01257230|363529460|FG001|Overall Study|Withdrawal by Subject|4|||
105416321|NCT01257230|363529461|FG002|Overall Study|Withdrawal by Subject|1|||
105416322|NCT01257230|363529459|FG000|Overall Study|Other reason not defined above|1|||
105416323|NCT01257230|363529460|FG001|Overall Study|Other reason not defined above|5|||
105416324|NCT01257230|363529461|FG002|Overall Study|Other reason not defined above|3|||
105416325|NCT01581021|363529462|FG000|Overall Study|Lost to Follow-up|4|||
105416326|NCT01581021|363529463|FG001|Overall Study|Lost to Follow-up|6|||
105416327|NCT01581021|363529462|FG000|Overall Study|More than 2 hooks in thoracic|3|||
105416328|NCT01581021|363529463|FG001|Overall Study|More than 2 hooks in thoracic|0|||
105416329|NCT01581021|363529462|FG000|Overall Study|Neuromuscular|2|||
105416330|NCT01581021|363529463|FG001|Overall Study|Neuromuscular|1|||
105416331|NCT01581021|363529462|FG000|Overall Study|Not Randomized|1|||
105416332|NCT01581021|363529463|FG001|Overall Study|Not Randomized|2|||
105416333|NCT01581021|363529462|FG000|Overall Study|Lenke 6 Classification|0|||
105416334|NCT01581021|363529463|FG001|Overall Study|Lenke 6 Classification|1|||
105416335|NCT01581021|363529462|FG000|Overall Study|Lack of Efficacy|0|||
105498676|NCT00347360|363836350|FG014|Overall Study|Randomized in error|0|||
105498677|NCT00347360|363836336|FG000|Overall Study|Failed inclusion criteria #4|0|||
105498678|NCT00347360|363836337|FG001|Overall Study|Failed inclusion criteria #4|0|||
105498679|NCT00347360|363836338|FG002|Overall Study|Failed inclusion criteria #4|0|||
105498680|NCT00347360|363836339|FG003|Overall Study|Failed inclusion criteria #4|0|||
105498681|NCT00347360|363836340|FG004|Overall Study|Failed inclusion criteria #4|0|||
105498682|NCT00347360|363836341|FG005|Overall Study|Failed inclusion criteria #4|0|||
105498683|NCT00347360|363836342|FG006|Overall Study|Failed inclusion criteria #4|0|||
105498684|NCT00347360|363836343|FG007|Overall Study|Failed inclusion criteria #4|0|||
105498685|NCT00347360|363836344|FG008|Overall Study|Failed inclusion criteria #4|0|||
105498686|NCT00347360|363836345|FG009|Overall Study|Failed inclusion criteria #4|0|||
105498687|NCT00347360|363836346|FG010|Overall Study|Failed inclusion criteria #4|0|||
105498688|NCT00347360|363836347|FG011|Overall Study|Failed inclusion criteria #4|1|||
105498689|NCT00347360|363836348|FG012|Overall Study|Failed inclusion criteria #4|0|||
105498690|NCT00347360|363836349|FG013|Overall Study|Failed inclusion criteria #4|0|||
105583485|NCT03289455|364133910|FG002|Overall Study|Death|0|||
105416336|NCT01581021|363529463|FG001|Overall Study|Lack of Efficacy|1|||
105416337|NCT00675441|363529464|FG000|Overall Study|Withdrawal by Subject|2|||
105416338|NCT00675441|363529464|FG000|Overall Study|Death|1|||
105416339|NCT03268954|363529473|FG000|Overall Study|Ongoing|23|||
105416340|NCT03268954|363529474|FG001|Overall Study|Ongoing|31|||
105416341|NCT03268954|363529473|FG000|Overall Study|Adverse Event|53|||
105583486|NCT03289455|364133908|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
105583487|NCT03289455|364133909|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
105583488|NCT03289455|364133910|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
105583489|NCT03289455|364133908|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
105583490|NCT03289455|364133909|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
105583491|NCT03289455|364133910|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
105583492|NCT03289455|364133908|FG000|Overall Study|Progressive disease|3|||
105583493|NCT03289455|364133909|FG001|Overall Study|Progressive disease|4|||
105583494|NCT03289455|364133910|FG002|Overall Study|Progressive disease|5|||
105583495|NCT00114959|364133913|FG000|Overall Study|Lack of Efficacy|6|||
105583496|NCT00114959|364133913|FG000|Overall Study|Physician Decision|1|||
105583497|NCT00114959|364133913|FG000|Overall Study|Death|1|||
105583498|NCT03251378|364133916|FG000|Overall Study|Death|3|||
105583499|NCT03251378|364133917|FG001|Overall Study|Death|2|||
105583500|NCT03251378|364133918|FG002|Overall Study|Death|3|||
105583501|NCT03251378|364133919|FG003|Overall Study|Death|30|||
105583502|NCT03251378|364133920|FG004|Overall Study|Death|24|||
105583503|NCT03251378|364133921|FG005|Overall Study|Death|12|||
105583504|NCT03251378|364133922|FG006|Overall Study|Death|12|||
105583505|NCT03251378|364133916|FG000|Overall Study|Lost to Follow-up|0|||
105583506|NCT03251378|364133917|FG001|Overall Study|Lost to Follow-up|0|||
105583507|NCT03251378|364133918|FG002|Overall Study|Lost to Follow-up|1|||
105583508|NCT03251378|364133919|FG003|Overall Study|Lost to Follow-up|3|||
105583509|NCT03251378|364133920|FG004|Overall Study|Lost to Follow-up|0|||
105583510|NCT03251378|364133921|FG005|Overall Study|Lost to Follow-up|0|||
105583511|NCT03251378|364133922|FG006|Overall Study|Lost to Follow-up|0|||
105583512|NCT03251378|364133916|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
105583513|NCT03251378|364133917|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
105583514|NCT03251378|364133918|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
105583515|NCT03251378|364133919|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
105583516|NCT03251378|364133920|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
105583517|NCT03251378|364133921|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
105583518|NCT03251378|364133922|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
105583519|NCT03251378|364133916|FG000|Overall Study|Progressive disease|2|||
105583520|NCT03251378|364133917|FG001|Overall Study|Progressive disease|0|||
105583521|NCT03251378|364133918|FG002|Overall Study|Progressive disease|0|||
105583522|NCT03251378|364133919|FG003|Overall Study|Progressive disease|1|||
105583523|NCT03251378|364133920|FG004|Overall Study|Progressive disease|0|||
105583524|NCT03251378|364133921|FG005|Overall Study|Progressive disease|0|||
105583525|NCT03251378|364133922|FG006|Overall Study|Progressive disease|0|||
105583526|NCT03251378|364133916|FG000|Overall Study|Physician Decision|0|||
105583527|NCT03251378|364133917|FG001|Overall Study|Physician Decision|2|||
105583528|NCT03251378|364133918|FG002|Overall Study|Physician Decision|0|||
105583529|NCT03251378|364133919|FG003|Overall Study|Physician Decision|0|||
105583530|NCT03251378|364133920|FG004|Overall Study|Physician Decision|0|||
105583531|NCT03251378|364133921|FG005|Overall Study|Physician Decision|0|||
105583532|NCT03251378|364133922|FG006|Overall Study|Physician Decision|0|||
105416342|NCT03268954|363529474|FG001|Overall Study|Adverse Event|62|||
105416343|NCT03268954|363529473|FG000|Overall Study|Withdrawal by Subject|25|||
105416344|NCT03268954|363529474|FG001|Overall Study|Withdrawal by Subject|16|||
105416345|NCT03268954|363529473|FG000|Overall Study|Progressive Disease|61|||
105416346|NCT03268954|363529474|FG001|Overall Study|Progressive Disease|48|||
105416347|NCT03268954|363529473|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
105416348|NCT03268954|363529474|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
105416349|NCT03268954|363529473|FG000|Overall Study|Reason not Specified|40|||
105416350|NCT03268954|363529474|FG001|Overall Study|Reason not Specified|40|||
105416351|NCT02684058|363529475|FG000|Treatment Period|Progressive disease|4|||
105416352|NCT02684058|363529476|FG001|Treatment Period|Progressive disease|10|||
105416353|NCT02684058|363529477|FG002|Treatment Period|Progressive disease|19|||
105416354|NCT02684058|363529475|FG000|Treatment Period|Adverse Event|3|||
105416355|NCT02684058|363529476|FG001|Treatment Period|Adverse Event|8|||
105416356|NCT02684058|363529477|FG002|Treatment Period|Adverse Event|1|||
105416357|NCT02684058|363529475|FG000|Treatment Period|Physician Decision|5|||
105416358|NCT02684058|363529476|FG001|Treatment Period|Physician Decision|1|||
105416359|NCT02684058|363529477|FG002|Treatment Period|Physician Decision|2|||
105416360|NCT02684058|363529475|FG000|Treatment Period|New therapy for study indication|1|||
105583533|NCT03251378|364133916|FG000|Overall Study|Other|2|||
105583534|NCT03251378|364133917|FG001|Overall Study|Other|3|||
105583535|NCT03251378|364133918|FG002|Overall Study|Other|2|||
105416361|NCT02684058|363529476|FG001|Treatment Period|New therapy for study indication|0|||
105416362|NCT02684058|363529477|FG002|Treatment Period|New therapy for study indication|0|||
105583536|NCT03251378|364133919|FG003|Overall Study|Other|0|||
105583537|NCT03251378|364133920|FG004|Overall Study|Other|1|||
105583538|NCT03251378|364133921|FG005|Overall Study|Other|1|||
105416363|NCT02684058|363529475|FG000|Treatment Period|Protocol deviation|0|||
105416364|NCT02684058|363529476|FG001|Treatment Period|Protocol deviation|1|||
105416365|NCT02684058|363529477|FG002|Treatment Period|Protocol deviation|0|||
105416366|NCT02684058|363529475|FG000|Treatment Period|Subject/guardian decision|4|||
105416367|NCT02684058|363529476|FG001|Treatment Period|Subject/guardian decision|3|||
105416368|NCT02684058|363529477|FG002|Treatment Period|Subject/guardian decision|0|||
105416369|NCT02684058|363529475|FG000|Treatment Period|Death|0|||
105416370|NCT02684058|363529476|FG001|Treatment Period|Death|0|||
105416371|NCT02684058|363529477|FG002|Treatment Period|Death|2|||
105416372|NCT02684058|363529475|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
105416373|NCT02684058|363529476|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
105416374|NCT02684058|363529477|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
105416375|NCT02684058|363529475|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
105416376|NCT02684058|363529476|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
105416377|NCT02684058|363529477|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
105416378|NCT02684058|363529475|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
105416379|NCT02684058|363529476|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
105416380|NCT02684058|363529477|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
105416381|NCT02684058|363529475|FG000|Post-treatment Efficacy Follow-up|Death|0|||
105416382|NCT02684058|363529476|FG001|Post-treatment Efficacy Follow-up|Death|0|||
105416383|NCT02684058|363529477|FG002|Post-treatment Efficacy Follow-up|Death|3|||
105416384|NCT02684058|363529475|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
105416385|NCT02684058|363529476|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
105416386|NCT02684058|363529477|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
105416387|NCT02684058|363529475|FG000|Post-treatment Survival Follow-up|Death|0|||
105416388|NCT02684058|363529476|FG001|Post-treatment Survival Follow-up|Death|0|||
105416389|NCT02684058|363529477|FG002|Post-treatment Survival Follow-up|Death|7|||
105416390|NCT02684058|363529475|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
105416391|NCT02684058|363529476|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
105416392|NCT02684058|363529477|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
105416393|NCT02684058|363529475|FG000|Crossover Treatment Period|Progressive disease|0|||
105416394|NCT02684058|363529476|FG001|Crossover Treatment Period|Progressive disease|1|||
105416395|NCT02684058|363529477|FG002|Crossover Treatment Period|Progressive disease|0|||
105416396|NCT02524275|363529478|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
105416397|NCT04283994|363529487|FG000|Overall Study|Death|11|||
105416398|NCT04283994|363529488|FG001|Overall Study|Death|20|||
105416399|NCT04283994|363529489|FG002|Overall Study|Death|11|||
105416400|NCT04283994|363529490|FG003|Overall Study|Death|0|||
105416401|NCT04283994|363529491|FG004|Overall Study|Death|0|||
105416402|NCT04283994|363529492|FG005|Overall Study|Death|0|||
105416403|NCT04283994|363529493|FG006|Overall Study|Death|0|||
105416404|NCT04283994|363529487|FG000|Overall Study|Withdrawal by Subject|16|||
105416405|NCT04283994|363529488|FG001|Overall Study|Withdrawal by Subject|4|||
105416406|NCT04283994|363529489|FG002|Overall Study|Withdrawal by Subject|6|||
105416407|NCT04283994|363529490|FG003|Overall Study|Withdrawal by Subject|1|||
105416408|NCT04283994|363529491|FG004|Overall Study|Withdrawal by Subject|0|||
105416409|NCT04283994|363529492|FG005|Overall Study|Withdrawal by Subject|1|||
105416410|NCT04283994|363529493|FG006|Overall Study|Withdrawal by Subject|0|||
105416411|NCT00782171|363531117|FG000|Overall Study|Lost to Follow-up|2|||
105416412|NCT00782171|363531118|FG001|Overall Study|Lost to Follow-up|2|||
105416413|NCT00782171|363531117|FG000|Overall Study|Withdrawal by Subject|2|||
105416414|NCT00782171|363531118|FG001|Overall Study|Withdrawal by Subject|1|||
105416415|NCT00782171|363531117|FG000|Overall Study|complications|3|||
105416416|NCT00782171|363531118|FG001|Overall Study|complications|1|||
105416417|NCT00782171|363531117|FG000|Overall Study|others|7|||
105416418|NCT00782171|363531118|FG001|Overall Study|others|9|||
105416419|NCT00782171|363531117|FG000|Overall Study|not eligible|8|||
105416420|NCT00782171|363531118|FG001|Overall Study|not eligible|6|||
105416421|NCT04493424|363531126|FG000|Overall Study|Termination of the trial by the sponsor|89|||
105416422|NCT04493424|363531126|FG000|Overall Study|Withdrawal by Subject|9|||
105416423|NCT04493424|363531126|FG000|Overall Study|Lost to Follow-up|2|||
105416424|NCT04493424|363531126|FG000|Overall Study|Lack of Efficacy|3|||
105416425|NCT04493424|363531126|FG000|Overall Study|Adverse Event|5|||
105416426|NCT01340625|363531127|FG000|First Intervention|Adverse Event|1|||
105416427|NCT01340625|363531128|FG001|First Intervention|Adverse Event|0|||
105416428|NCT01340625|363531127|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
105416429|NCT01340625|363531128|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
105583539|NCT03251378|364133922|FG006|Overall Study|Other|1|||
105583540|NCT03251378|364133916|FG000|Overall Study|Other|0|||
105583541|NCT03251378|364133917|FG001|Overall Study|Other|0|||
105583542|NCT03251378|364133918|FG002|Overall Study|Other|0|||
105583543|NCT03251378|364133919|FG003|Overall Study|Other|4|||
105583544|NCT03251378|364133920|FG004|Overall Study|Other|13|||
105583545|NCT03251378|364133921|FG005|Overall Study|Other|0|||
105583546|NCT03251378|364133922|FG006|Overall Study|Other|0|||
105583547|NCT04060680|364133923|FG000|Overall Study|Unsuccessful implant|17|||
105583548|NCT04060680|364133924|FG001|Overall Study|Unsuccessful implant|2|||
105583549|NCT04060680|364133923|FG000|Overall Study|Adverse Event|3|||
105583550|NCT04060680|364133924|FG001|Overall Study|Adverse Event|0|||
105583551|NCT04060680|364133923|FG000|Overall Study|Death|2|||
105583552|NCT04060680|364133924|FG001|Overall Study|Death|0|||
105583553|NCT04060680|364133923|FG000|Overall Study|Study product no longer in use|1|||
105583554|NCT04060680|364133924|FG001|Overall Study|Study product no longer in use|0|||
105583555|NCT04060680|364133923|FG000|Overall Study|Withdrawal by Subject|1|||
105583556|NCT04060680|364133924|FG001|Overall Study|Withdrawal by Subject|0|||
105583557|NCT01007552|364133925|FG000|Overall Study|Withdrawal by Subject|1|||
105583558|NCT03621982|364133926|FG000|Overall Study|Withdrawal by Subject|1|||
105583559|NCT03621982|364133927|FG001|Overall Study|Withdrawal by Subject|0|||
105583560|NCT03621982|364133928|FG002|Overall Study|Withdrawal by Subject|0|||
105583561|NCT03621982|364133929|FG003|Overall Study|Withdrawal by Subject|1|||
105416454|NCT05243745|363531135|FG000|Overall Study|Withdrawal by Subject|0|||
105416455|NCT05243745|363531136|FG001|Overall Study|Withdrawal by Subject|0|||
105416456|NCT05243745|363531137|FG002|Overall Study|Withdrawal by Subject|0|||
105416457|NCT05243745|363531138|FG003|Overall Study|Withdrawal by Subject|1|||
105416458|NCT05243745|363531135|FG000|Overall Study|Unable to Attend Visit 6|0|||
105416459|NCT05243745|363531136|FG001|Overall Study|Unable to Attend Visit 6|0|||
105416460|NCT05243745|363531137|FG002|Overall Study|Unable to Attend Visit 6|1|||
105416461|NCT05243745|363531138|FG003|Overall Study|Unable to Attend Visit 6|0|||
105416462|NCT00734604|363531139|FG000|Overall Study|Adverse Event|0|||
105416463|NCT00734604|363531140|FG001|Overall Study|Adverse Event|2|||
105416464|NCT00734604|363531141|FG002|Overall Study|Adverse Event|0|||
105416465|NCT00734604|363531142|FG003|Overall Study|Adverse Event|2|||
105416466|NCT00734604|363531143|FG004|Overall Study|Adverse Event|1|||
105416467|NCT00734604|363531144|FG005|Overall Study|Adverse Event|1|||
105416468|NCT00734604|363531139|FG000|Overall Study|Serious Adverse Event|1|||
105416469|NCT00734604|363531140|FG001|Overall Study|Serious Adverse Event|0|||
105416470|NCT00734604|363531141|FG002|Overall Study|Serious Adverse Event|1|||
105416471|NCT00734604|363531142|FG003|Overall Study|Serious Adverse Event|2|||
105416472|NCT00734604|363531143|FG004|Overall Study|Serious Adverse Event|0|||
105416473|NCT00734604|363531144|FG005|Overall Study|Serious Adverse Event|1|||
105416474|NCT00734604|363531139|FG000|Overall Study|Lost to Follow-up|1|||
105416475|NCT00734604|363531140|FG001|Overall Study|Lost to Follow-up|2|||
105416476|NCT00734604|363531141|FG002|Overall Study|Lost to Follow-up|2|||
105416477|NCT00734604|363531142|FG003|Overall Study|Lost to Follow-up|4|||
105416478|NCT00734604|363531143|FG004|Overall Study|Lost to Follow-up|2|||
105416479|NCT00734604|363531144|FG005|Overall Study|Lost to Follow-up|3|||
105416480|NCT00734604|363531139|FG000|Overall Study|Physician Decision|0|||
105416481|NCT00734604|363531140|FG001|Overall Study|Physician Decision|1|||
105416482|NCT00734604|363531141|FG002|Overall Study|Physician Decision|1|||
105416483|NCT00734604|363531142|FG003|Overall Study|Physician Decision|0|||
105416484|NCT00734604|363531143|FG004|Overall Study|Physician Decision|0|||
105416485|NCT00734604|363531144|FG005|Overall Study|Physician Decision|0|||
105416486|NCT00734604|363531139|FG000|Overall Study|Protocol Violation|0|||
105416487|NCT00734604|363531140|FG001|Overall Study|Protocol Violation|2|||
105416488|NCT00734604|363531141|FG002|Overall Study|Protocol Violation|0|||
105416489|NCT00734604|363531142|FG003|Overall Study|Protocol Violation|0|||
105416490|NCT00734604|363531143|FG004|Overall Study|Protocol Violation|1|||
105416491|NCT00734604|363531144|FG005|Overall Study|Protocol Violation|0|||
105416492|NCT00734604|363531139|FG000|Overall Study|Sponsor Decision|1|||
105416493|NCT00734604|363531140|FG001|Overall Study|Sponsor Decision|2|||
105416494|NCT00734604|363531141|FG002|Overall Study|Sponsor Decision|1|||
105416495|NCT00734604|363531142|FG003|Overall Study|Sponsor Decision|0|||
105416496|NCT00734604|363531143|FG004|Overall Study|Sponsor Decision|2|||
105416497|NCT00734604|363531144|FG005|Overall Study|Sponsor Decision|0|||
105416498|NCT00734604|363531139|FG000|Overall Study|Withdrawal by Subject|0|||
105416499|NCT00734604|363531140|FG001|Overall Study|Withdrawal by Subject|2|||
105416500|NCT00734604|363531141|FG002|Overall Study|Withdrawal by Subject|0|||
105416501|NCT00734604|363531142|FG003|Overall Study|Withdrawal by Subject|1|||
105416502|NCT00734604|363531143|FG004|Overall Study|Withdrawal by Subject|2|||
105416503|NCT00734604|363531144|FG005|Overall Study|Withdrawal by Subject|1|||
105416504|NCT00734604|363531139|FG000|Overall Study|Lack of Efficacy|0|||
105416505|NCT00734604|363531140|FG001|Overall Study|Lack of Efficacy|1|||
105416506|NCT00734604|363531141|FG002|Overall Study|Lack of Efficacy|1|||
105416507|NCT00734604|363531142|FG003|Overall Study|Lack of Efficacy|0|||
105416508|NCT00734604|363531143|FG004|Overall Study|Lack of Efficacy|0|||
105416509|NCT00734604|363531144|FG005|Overall Study|Lack of Efficacy|0|||
105416510|NCT00176488|363531155|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
105416511|NCT00327015|363531156|FG000|Overall Study|Lack of Efficacy|18|||
105416512|NCT00327015|363531157|FG001|Overall Study|Lack of Efficacy|18|||
105416513|NCT00327015|363531158|FG002|Overall Study|Lack of Efficacy|35|||
105416514|NCT00327015|363531159|FG003|Overall Study|Lack of Efficacy|29|||
105416515|NCT00327015|363531156|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
105583562|NCT03621982|364133930|FG004|Overall Study|Withdrawal by Subject|0|||
105583563|NCT03621982|364133931|FG005|Overall Study|Withdrawal by Subject|1|||
105583564|NCT03621982|364133932|FG006|Overall Study|Withdrawal by Subject|1|||
105583565|NCT03621982|364133933|FG007|Overall Study|Withdrawal by Subject|0|||
105583566|NCT03621982|364133934|FG008|Overall Study|Withdrawal by Subject|1|||
105583567|NCT03621982|364133935|FG009|Overall Study|Withdrawal by Subject|0|||
105583568|NCT03621982|364133936|FG010|Overall Study|Withdrawal by Subject|2|||
105583569|NCT03621982|364133937|FG011|Overall Study|Withdrawal by Subject|1|||
105583570|NCT03621982|364133938|FG012|Overall Study|Withdrawal by Subject|2|||
105583571|NCT03621982|364133939|FG013|Overall Study|Withdrawal by Subject|2|||
105583572|NCT03621982|364133926|FG000|Overall Study|Investigator/Sponsor decision|0|||
105416516|NCT00327015|363531157|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
105416517|NCT00327015|363531158|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
105416518|NCT00327015|363531159|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
105416519|NCT00327015|363531156|FG000|Overall Study|Lost to Follow-up|22|||
105416520|NCT00327015|363531157|FG001|Overall Study|Lost to Follow-up|23|||
105416521|NCT00327015|363531158|FG002|Overall Study|Lost to Follow-up|29|||
105416522|NCT00327015|363531159|FG003|Overall Study|Lost to Follow-up|22|||
105416523|NCT00327015|363531156|FG000|Overall Study|Adverse Event|14|||
105416524|NCT00327015|363531157|FG001|Overall Study|Adverse Event|10|||
105416525|NCT00327015|363531158|FG002|Overall Study|Adverse Event|14|||
105416526|NCT00327015|363531159|FG003|Overall Study|Adverse Event|14|||
105416527|NCT00327015|363531156|FG000|Overall Study|Subject no longer meets study criteria|4|||
105416528|NCT00327015|363531157|FG001|Overall Study|Subject no longer meets study criteria|2|||
105416529|NCT00327015|363531158|FG002|Overall Study|Subject no longer meets study criteria|8|||
105416530|NCT00327015|363531159|FG003|Overall Study|Subject no longer meets study criteria|7|||
105416531|NCT00327015|363531156|FG000|Overall Study|Poor/Noncompliance|11|||
105416532|NCT00327015|363531157|FG001|Overall Study|Poor/Noncompliance|8|||
105416533|NCT00327015|363531158|FG002|Overall Study|Poor/Noncompliance|4|||
105416534|NCT00327015|363531159|FG003|Overall Study|Poor/Noncompliance|5|||
105416535|NCT00327015|363531156|FG000|Overall Study|Physician Decision|0|||
105416536|NCT00327015|363531157|FG001|Overall Study|Physician Decision|1|||
105416537|NCT00327015|363531158|FG002|Overall Study|Physician Decision|3|||
105416538|NCT00327015|363531159|FG003|Overall Study|Physician Decision|2|||
105416539|NCT00327015|363531156|FG000|Overall Study|Death|1|||
105416540|NCT00327015|363531157|FG001|Overall Study|Death|2|||
105416541|NCT00327015|363531158|FG002|Overall Study|Death|2|||
105416542|NCT00327015|363531159|FG003|Overall Study|Death|3|||
105416543|NCT00327015|363531156|FG000|Overall Study|Pregnancy|0|||
105416544|NCT00327015|363531157|FG001|Overall Study|Pregnancy|2|||
105416545|NCT00327015|363531158|FG002|Overall Study|Pregnancy|1|||
105416546|NCT00327015|363531159|FG003|Overall Study|Pregnancy|1|||
105416547|NCT00327015|363531156|FG000|Overall Study|Administrative Reason by Sponsor|1|||
105416548|NCT00327015|363531157|FG001|Overall Study|Administrative Reason by Sponsor|2|||
105416549|NCT00327015|363531158|FG002|Overall Study|Administrative Reason by Sponsor|2|||
105416550|NCT00327015|363531159|FG003|Overall Study|Administrative Reason by Sponsor|1|||
105416551|NCT00459875|363531160|FG000|Overall Study|Ineligible participant|1|||
105416552|NCT00459875|363531160|FG000|Overall Study|Adverse Event|2|||
105416553|NCT02557100|363531169|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
105416554|NCT02557100|363531170|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
105416555|NCT02557100|363531171|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
105416556|NCT02557100|363531169|FG000|Single Blind Treatment Period|Death|0|||
105416557|NCT02557100|363531170|FG001|Single Blind Treatment Period|Death|1|||
105416558|NCT02557100|363531171|FG002|Single Blind Treatment Period|Death|0|||
105416559|NCT02557100|363531169|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
105416560|NCT02557100|363531170|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
105416561|NCT02557100|363531171|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
105416562|NCT02557100|363531169|FG000|Single Blind Treatment Period|Adverse Event|0|||
105416563|NCT02557100|363531170|FG001|Single Blind Treatment Period|Adverse Event|1|||
105416564|NCT02557100|363531171|FG002|Single Blind Treatment Period|Adverse Event|0|||
105416565|NCT02557100|363531169|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
105416566|NCT02557100|363531170|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
105416567|NCT02557100|363531171|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
105416568|NCT02557100|363531169|FG000|Cumulative Abatacept Period|Other Reasons|0|||
105416569|NCT02557100|363531170|FG001|Cumulative Abatacept Period|Other Reasons|0|||
105416570|NCT02557100|363531171|FG002|Cumulative Abatacept Period|Other Reasons|1|||
105416571|NCT02557100|363531169|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
105416572|NCT02557100|363531170|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
105416573|NCT02557100|363531171|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
105416574|NCT02557100|363531169|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
105583573|NCT03621982|364133927|FG001|Overall Study|Investigator/Sponsor decision|0|||
105583574|NCT03621982|364133928|FG002|Overall Study|Investigator/Sponsor decision|0|||
105583575|NCT03621982|364133929|FG003|Overall Study|Investigator/Sponsor decision|0|||
105583576|NCT03621982|364133930|FG004|Overall Study|Investigator/Sponsor decision|0|||
105498691|NCT00347360|363836350|FG014|Overall Study|Failed inclusion criteria #4|0|||
105498692|NCT00347360|363836336|FG000|Overall Study|Prolonged duration between visits|0|||
105416575|NCT02557100|363531170|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
105416576|NCT02557100|363531171|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
105416577|NCT00394251|363531172|FG000|Overall Study|Adverse Event|7|||
105416578|NCT00394251|363531173|FG001|Overall Study|Adverse Event|5|||
105416579|NCT00394251|363531172|FG000|Overall Study|Unacceptable Toxicity|20|||
105416580|NCT00394251|363531173|FG001|Overall Study|Unacceptable Toxicity|18|||
105416581|NCT00394251|363531172|FG000|Overall Study|Physician Decision|1|||
105416582|NCT00394251|363531173|FG001|Overall Study|Physician Decision|1|||
105416583|NCT00394251|363531172|FG000|Overall Study|Protocol Violation|0|||
105416584|NCT00394251|363531173|FG001|Overall Study|Protocol Violation|1|||
105416585|NCT00394251|363531172|FG000|Overall Study|Withdrawal by Subject|7|||
105416586|NCT00394251|363531173|FG001|Overall Study|Withdrawal by Subject|11|||
105416587|NCT00394251|363531172|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
105416588|NCT00394251|363531173|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
105416589|NCT03206970|363531174|FG000|Overall Study|Death|21|||
105416590|NCT03206970|363531174|FG000|Overall Study|Withdrawal by Subject|13|||
105416591|NCT03206970|363531174|FG000|Overall Study|Lost to Follow-up|3|||
105416592|NCT03206970|363531174|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
105416593|NCT01814878|363531175|FG000|Overall Study|Adverse Event|16|||
105416594|NCT01814878|363531176|FG001|Overall Study|Adverse Event|5|||
105416595|NCT01814878|363531175|FG000|Overall Study|Withdrawal by Subject|20|||
105416596|NCT01814878|363531176|FG001|Overall Study|Withdrawal by Subject|16|||
105416597|NCT01814878|363531175|FG000|Overall Study|Protocol Violation|5|||
105416598|NCT01814878|363531176|FG001|Overall Study|Protocol Violation|5|||
105416599|NCT01814878|363531175|FG000|Overall Study|Physician Decision|3|||
105416600|NCT01814878|363531176|FG001|Overall Study|Physician Decision|1|||
105416601|NCT01814878|363531175|FG000|Overall Study|Screening failure (drop-out)|0|||
105416602|NCT01814878|363531176|FG001|Overall Study|Screening failure (drop-out)|3|||
105416603|NCT01814878|363531175|FG000|Overall Study|Other|2|||
105416604|NCT01814878|363531176|FG001|Overall Study|Other|0|||
105416605|NCT01289353|363531177|FG000|Overall Study|Lost to Follow-up|2|||
105416606|NCT03299881|363531178|FG000|Overall Study|Study Termination|17|||
105416607|NCT03299881|363531179|FG001|Overall Study|Study Termination|13|||
105416608|NCT01549886|363531180|FG000|Overall Study|Sponsor's decision|2|||
105416609|NCT01549886|363531181|FG001|Overall Study|Sponsor's decision|3|||
105416610|NCT00006164|363531182|FG000|Overall Study|Withdrew or lost to follow-up|70|||
105416611|NCT00006164|363531183|FG001|Overall Study|Withdrew or lost to follow-up|81|||
105416612|NCT00633074|363531184|FG000|Overall Study|Adverse Event|1|||
105416613|NCT00633074|363531185|FG001|Overall Study|Adverse Event|0|||
105416614|NCT00223808|363531186|FG000|Overall Study|<5 hrs therapy before discharge|3|||
105416615|NCT00223808|363531187|FG001|Overall Study|<5 hrs therapy before discharge|5|||
105416616|NCT00223808|363531188|FG002|Overall Study|<5 hrs therapy before discharge|5|||
105416617|NCT03195660|363531189|FG000|Overall Study|The study was terminated|2|||
105416618|NCT06422364|363531190|FG000|Overall Study|Withdrawn due to study closure|0|||
105416619|NCT06422364|363531191|FG001|Overall Study|Withdrawn due to study closure|2|||
105416620|NCT04484649|363531193|FG000|Overall Study|Lost to Follow-up|2|||
105416621|NCT04484649|363531194|FG001|Overall Study|Lost to Follow-up|1|||
105416622|NCT04484649|363531193|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
105416623|NCT04484649|363531194|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
105416624|NCT03883165|363531197|FG000|Overall Study|Withdrawal by Subject|4|||
105416625|NCT03883165|363531198|FG001|Overall Study|Withdrawal by Subject|3|||
105416626|NCT05730335|363531199|FG000|Overall Study|Lost to Follow-up|8|||
105416627|NCT05730335|363531199|FG000|Overall Study|Withdrawal by Subject|6|||
105416628|NCT03831191|363531202|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
105416629|NCT03831191|363531203|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
105416630|NCT03831191|363531204|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
105416631|NCT03831191|363531205|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
105416632|NCT03831191|363531206|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
105416633|NCT03831191|363531207|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
105416634|NCT03831191|363531208|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
105416635|NCT03831191|363531209|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
105416636|NCT03831191|363531210|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
105416637|NCT03831191|363531211|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
105416638|NCT03831191|363531212|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
105416639|NCT03831191|363531213|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
105626696|NCT04186819|364298168|FG000|Overall Study|Lost to Follow-up|1|||
105416640|NCT03831191|363531214|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
105416641|NCT03831191|363531215|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
105416642|NCT03831191|363531216|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
105416643|NCT03831191|363531202|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
105416644|NCT03831191|363531203|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
105416645|NCT03831191|363531204|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105416646|NCT03831191|363531205|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105583577|NCT03621982|364133931|FG005|Overall Study|Investigator/Sponsor decision|0|||
105583578|NCT03621982|364133932|FG006|Overall Study|Investigator/Sponsor decision|0|||
105583579|NCT03621982|364133933|FG007|Overall Study|Investigator/Sponsor decision|0|||
105583580|NCT03621982|364133934|FG008|Overall Study|Investigator/Sponsor decision|0|||
105583581|NCT03621982|364133935|FG009|Overall Study|Investigator/Sponsor decision|0|||
105583582|NCT03621982|364133936|FG010|Overall Study|Investigator/Sponsor decision|0|||
105583583|NCT03621982|364133937|FG011|Overall Study|Investigator/Sponsor decision|4|||
105583584|NCT03621982|364133938|FG012|Overall Study|Investigator/Sponsor decision|0|||
105583585|NCT03621982|364133939|FG013|Overall Study|Investigator/Sponsor decision|2|||
105583586|NCT03621982|364133926|FG000|Overall Study|Death|2|||
105583587|NCT03621982|364133927|FG001|Overall Study|Death|4|||
105583588|NCT03621982|364133928|FG002|Overall Study|Death|4|||
105583589|NCT03621982|364133929|FG003|Overall Study|Death|3|||
105583590|NCT03621982|364133930|FG004|Overall Study|Death|8|||
105583591|NCT03621982|364133931|FG005|Overall Study|Death|4|||
105583592|NCT03621982|364133932|FG006|Overall Study|Death|6|||
105583593|NCT03621982|364133933|FG007|Overall Study|Death|3|||
105583594|NCT03621982|364133934|FG008|Overall Study|Death|0|||
105583595|NCT03621982|364133935|FG009|Overall Study|Death|3|||
105583596|NCT03621982|364133936|FG010|Overall Study|Death|8|||
105583597|NCT03621982|364133937|FG011|Overall Study|Death|4|||
105583598|NCT03621982|364133938|FG012|Overall Study|Death|2|||
105583599|NCT03621982|364133939|FG013|Overall Study|Death|2|||
105583600|NCT03621982|364133926|FG000|Overall Study|Lost to Follow-up|0|||
105583601|NCT03621982|364133927|FG001|Overall Study|Lost to Follow-up|0|||
105583602|NCT03621982|364133928|FG002|Overall Study|Lost to Follow-up|1|||
105583603|NCT03621982|364133929|FG003|Overall Study|Lost to Follow-up|0|||
105583604|NCT03621982|364133930|FG004|Overall Study|Lost to Follow-up|0|||
105583605|NCT03621982|364133931|FG005|Overall Study|Lost to Follow-up|0|||
105583606|NCT03621982|364133932|FG006|Overall Study|Lost to Follow-up|1|||
105583607|NCT03621982|364133933|FG007|Overall Study|Lost to Follow-up|0|||
105583608|NCT03621982|364133934|FG008|Overall Study|Lost to Follow-up|0|||
105583609|NCT03621982|364133935|FG009|Overall Study|Lost to Follow-up|1|||
105583610|NCT03621982|364133936|FG010|Overall Study|Lost to Follow-up|0|||
105583611|NCT03621982|364133937|FG011|Overall Study|Lost to Follow-up|0|||
105583612|NCT03621982|364133938|FG012|Overall Study|Lost to Follow-up|0|||
105583613|NCT03621982|364133939|FG013|Overall Study|Lost to Follow-up|0|||
105583614|NCT02753530|364133940|FG000|Overall Study|Adverse Event|7|||
105583615|NCT02753530|364133941|FG001|Overall Study|Adverse Event|1|||
105583616|NCT02753530|364133940|FG000|Overall Study|Death|0|||
105583617|NCT02753530|364133941|FG001|Overall Study|Death|1|||
105583618|NCT02753530|364133940|FG000|Overall Study|Physician Decision|0|||
105583619|NCT02753530|364133941|FG001|Overall Study|Physician Decision|1|||
105583620|NCT02753530|364133940|FG000|Overall Study|Protocol Violation|1|||
105583621|NCT02753530|364133941|FG001|Overall Study|Protocol Violation|0|||
105583622|NCT02753530|364133940|FG000|Overall Study|Withdrawal by Subject|4|||
105583623|NCT02753530|364133941|FG001|Overall Study|Withdrawal by Subject|3|||
105583624|NCT00731042|364135230|FG000|Second Intervention|Did not meet inclusion criteria|0|||
105583625|NCT00731042|364135231|FG001|Second Intervention|Did not meet inclusion criteria|2|||
105583626|NCT00231179|364135234|FG000|Overall Study|Lost to Follow-up|21|||
105583627|NCT00231179|364135235|FG001|Overall Study|Lost to Follow-up|21|||
105583628|NCT00231179|364135234|FG000|Overall Study|Withdrawal by Subject|3|||
105583629|NCT00231179|364135235|FG001|Overall Study|Withdrawal by Subject|3|||
105583630|NCT03531905|364135238|FG000|Overall Study|Withdrawal by Subject|3|||
105583631|NCT03531905|364135239|FG001|Overall Study|Withdrawal by Subject|3|||
105583632|NCT03531905|364135240|FG002|Overall Study|Withdrawal by Subject|2|||
105583633|NCT03531905|364135238|FG000|Overall Study|Lost to Follow-up|2|||
105583634|NCT03531905|364135239|FG001|Overall Study|Lost to Follow-up|2|||
105583635|NCT03531905|364135240|FG002|Overall Study|Lost to Follow-up|1|||
105583636|NCT03531905|364135238|FG000|Overall Study|Participant was out of town|1|||
105583637|NCT03531905|364135239|FG001|Overall Study|Participant was out of town|0|||
105583638|NCT03531905|364135240|FG002|Overall Study|Participant was out of town|0|||
105583639|NCT03531905|364135238|FG000|Overall Study|Could not speak with the participant|1|||
105583640|NCT03531905|364135239|FG001|Overall Study|Could not speak with the participant|0|||
105583641|NCT03531905|364135240|FG002|Overall Study|Could not speak with the participant|0|||
105583642|NCT01036087|364135242|FG000|Overall Study|Adverse Event|2|||
105583643|NCT01036087|364135242|FG000|Overall Study|Lack of Efficacy|1|||
105583644|NCT01174550|364135246|FG000|Overall Study|Death|75|||
105583645|NCT01174550|364135247|FG001|Overall Study|Death|74|||
105583646|NCT01174550|364135246|FG000|Overall Study|Lost to Follow-up|652|||
105583647|NCT01174550|364135247|FG001|Overall Study|Lost to Follow-up|510|||
105583648|NCT01174550|364135246|FG000|Overall Study|Withdrawal by Subject|543|||
105583649|NCT01174550|364135247|FG001|Overall Study|Withdrawal by Subject|289|||
105583650|NCT02123966|364135248|FG000|Overall Study|Intercurrent Illness|1|||
105583651|NCT01536262|364135249|FG000|Overall Study|Adverse Event|6|||
105583652|NCT01536262|364135250|FG001|Overall Study|Adverse Event|1|||
105583653|NCT01536262|364135251|FG002|Overall Study|Adverse Event|2|||
105416647|NCT03831191|363531206|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105498693|NCT00347360|363836337|FG001|Overall Study|Prolonged duration between visits|0|||
105498694|NCT00347360|363836338|FG002|Overall Study|Prolonged duration between visits|0|||
105498695|NCT00347360|363836339|FG003|Overall Study|Prolonged duration between visits|0|||
105498696|NCT00347360|363836340|FG004|Overall Study|Prolonged duration between visits|0|||
105498697|NCT00347360|363836341|FG005|Overall Study|Prolonged duration between visits|0|||
105498698|NCT00347360|363836342|FG006|Overall Study|Prolonged duration between visits|0|||
105498699|NCT00347360|363836343|FG007|Overall Study|Prolonged duration between visits|0|||
105498700|NCT00347360|363836344|FG008|Overall Study|Prolonged duration between visits|0|||
105498701|NCT00347360|363836345|FG009|Overall Study|Prolonged duration between visits|0|||
105498702|NCT00347360|363836346|FG010|Overall Study|Prolonged duration between visits|0|||
105498703|NCT00347360|363836347|FG011|Overall Study|Prolonged duration between visits|0|||
105498704|NCT00347360|363836348|FG012|Overall Study|Prolonged duration between visits|1|||
105498705|NCT00347360|363836349|FG013|Overall Study|Prolonged duration between visits|0|||
105498706|NCT00347360|363836350|FG014|Overall Study|Prolonged duration between visits|0|||
105498707|NCT00347360|363836336|FG000|Overall Study|Subject left town, ran out of study drug|0|||
105498708|NCT00347360|363836337|FG001|Overall Study|Subject left town, ran out of study drug|0|||
105498709|NCT00347360|363836338|FG002|Overall Study|Subject left town, ran out of study drug|0|||
105498710|NCT00347360|363836339|FG003|Overall Study|Subject left town, ran out of study drug|0|||
105498711|NCT00347360|363836340|FG004|Overall Study|Subject left town, ran out of study drug|0|||
105498712|NCT00347360|363836341|FG005|Overall Study|Subject left town, ran out of study drug|0|||
105498713|NCT00347360|363836342|FG006|Overall Study|Subject left town, ran out of study drug|0|||
105498714|NCT00347360|363836343|FG007|Overall Study|Subject left town, ran out of study drug|0|||
105498715|NCT00347360|363836344|FG008|Overall Study|Subject left town, ran out of study drug|0|||
105498716|NCT00347360|363836345|FG009|Overall Study|Subject left town, ran out of study drug|0|||
105498717|NCT00347360|363836346|FG010|Overall Study|Subject left town, ran out of study drug|0|||
105498718|NCT00347360|363836347|FG011|Overall Study|Subject left town, ran out of study drug|0|||
105498719|NCT00347360|363836348|FG012|Overall Study|Subject left town, ran out of study drug|0|||
105498720|NCT00347360|363836349|FG013|Overall Study|Subject left town, ran out of study drug|1|||
105498721|NCT00347360|363836350|FG014|Overall Study|Subject left town, ran out of study drug|0|||
105498722|NCT00347360|363836336|FG000|Overall Study|Subject refuse to sign updated consent|0|||
105498723|NCT00347360|363836337|FG001|Overall Study|Subject refuse to sign updated consent|0|||
105498724|NCT00347360|363836338|FG002|Overall Study|Subject refuse to sign updated consent|0|||
105498725|NCT00347360|363836339|FG003|Overall Study|Subject refuse to sign updated consent|0|||
105498726|NCT00347360|363836340|FG004|Overall Study|Subject refuse to sign updated consent|0|||
105498727|NCT00347360|363836341|FG005|Overall Study|Subject refuse to sign updated consent|0|||
105498728|NCT00347360|363836342|FG006|Overall Study|Subject refuse to sign updated consent|0|||
105498729|NCT00347360|363836343|FG007|Overall Study|Subject refuse to sign updated consent|0|||
105498730|NCT00347360|363836344|FG008|Overall Study|Subject refuse to sign updated consent|0|||
105498731|NCT00347360|363836345|FG009|Overall Study|Subject refuse to sign updated consent|0|||
105498732|NCT00347360|363836346|FG010|Overall Study|Subject refuse to sign updated consent|0|||
105498733|NCT00347360|363836347|FG011|Overall Study|Subject refuse to sign updated consent|0|||
105498734|NCT00347360|363836348|FG012|Overall Study|Subject refuse to sign updated consent|0|||
105498735|NCT00347360|363836349|FG013|Overall Study|Subject refuse to sign updated consent|0|||
105498736|NCT00347360|363836350|FG014|Overall Study|Subject refuse to sign updated consent|1|||
105498737|NCT00347360|363836336|FG000|Overall Study|Visits conflicted with new job|0|||
105498738|NCT00347360|363836337|FG001|Overall Study|Visits conflicted with new job|0|||
105498739|NCT00347360|363836338|FG002|Overall Study|Visits conflicted with new job|0|||
105498740|NCT00347360|363836339|FG003|Overall Study|Visits conflicted with new job|0|||
105498741|NCT00347360|363836340|FG004|Overall Study|Visits conflicted with new job|0|||
105498742|NCT00347360|363836341|FG005|Overall Study|Visits conflicted with new job|0|||
105498743|NCT00347360|363836342|FG006|Overall Study|Visits conflicted with new job|1|||
105498744|NCT00347360|363836343|FG007|Overall Study|Visits conflicted with new job|0|||
105498745|NCT00347360|363836344|FG008|Overall Study|Visits conflicted with new job|0|||
105498746|NCT00347360|363836345|FG009|Overall Study|Visits conflicted with new job|0|||
105498747|NCT00347360|363836346|FG010|Overall Study|Visits conflicted with new job|0|||
105498748|NCT00347360|363836347|FG011|Overall Study|Visits conflicted with new job|0|||
105498749|NCT00347360|363836348|FG012|Overall Study|Visits conflicted with new job|0|||
105498750|NCT00347360|363836349|FG013|Overall Study|Visits conflicted with new job|0|||
105498751|NCT00347360|363836350|FG014|Overall Study|Visits conflicted with new job|0|||
105498752|NCT00913380|363836351|FG000|Clinical Outcomes|Lost to Follow-up|6|||
105498753|NCT00913380|363836352|FG001|Clinical Outcomes|Lost to Follow-up|6|||
105498754|NCT01999868|363836353|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
105498755|NCT01999868|363836354|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
105498756|NCT01999868|363836355|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
105498757|NCT01999868|363836353|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
105498758|NCT01999868|363836354|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
105498759|NCT01999868|363836355|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
105416648|NCT03831191|363531207|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105416649|NCT03831191|363531208|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105416650|NCT03831191|363531209|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105416651|NCT03831191|363531210|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105416652|NCT03831191|363531211|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105416653|NCT03831191|363531212|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105416654|NCT03831191|363531213|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105416655|NCT03831191|363531214|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105416656|NCT03831191|363531215|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105416657|NCT03831191|363531216|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105416658|NCT03831191|363531202|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
105416659|NCT03831191|363531203|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
105416660|NCT03831191|363531204|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
105416661|NCT03831191|363531205|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
105416662|NCT03831191|363531206|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
105416663|NCT03831191|363531207|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
105416664|NCT03831191|363531208|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
105416665|NCT03831191|363531209|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
105416666|NCT03831191|363531210|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
105416667|NCT03831191|363531211|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
105416668|NCT03831191|363531212|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
105416669|NCT03831191|363531213|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
105416670|NCT03831191|363531214|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
105416671|NCT03831191|363531215|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
105416672|NCT03831191|363531216|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
105416673|NCT03831191|363531202|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
105416674|NCT03831191|363531203|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
105416675|NCT03831191|363531204|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
105416676|NCT03831191|363531205|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
105416677|NCT03831191|363531206|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
105416678|NCT03831191|363531207|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
105416679|NCT03831191|363531208|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
105416680|NCT03831191|363531209|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
105416681|NCT03831191|363531210|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
105416682|NCT03831191|363531211|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
105416683|NCT03831191|363531212|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
105416684|NCT03831191|363531213|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
105416685|NCT03831191|363531214|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
105416686|NCT03831191|363531215|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
105416687|NCT03831191|363531216|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
105416688|NCT03831191|363531202|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
105416689|NCT03831191|363531203|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
105416690|NCT03831191|363531204|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
105416691|NCT03831191|363531205|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
105416692|NCT03831191|363531206|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105416693|NCT03831191|363531207|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105416694|NCT03831191|363531208|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105416695|NCT03831191|363531209|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105416696|NCT03831191|363531210|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105416697|NCT03831191|363531211|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105416698|NCT03831191|363531212|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105416699|NCT03831191|363531213|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105416700|NCT03831191|363531214|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105416701|NCT03831191|363531215|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105416702|NCT03831191|363531216|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105416703|NCT03831191|363531202|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
105416704|NCT03831191|363531203|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
105416705|NCT03831191|363531204|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
105416706|NCT03831191|363531205|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
105416707|NCT03831191|363531206|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105416708|NCT03831191|363531207|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105416709|NCT03831191|363531208|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105416710|NCT03831191|363531209|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105416711|NCT03831191|363531210|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105416712|NCT03831191|363531211|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105416713|NCT03831191|363531212|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105416714|NCT03831191|363531213|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105416715|NCT03831191|363531214|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105416716|NCT03831191|363531215|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105416717|NCT03831191|363531216|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105583654|NCT01536262|364135249|FG000|Overall Study|Withdrawal by Subject|1|||
105583655|NCT01536262|364135250|FG001|Overall Study|Withdrawal by Subject|1|||
105583656|NCT01536262|364135251|FG002|Overall Study|Withdrawal by Subject|0|||
105583657|NCT01536262|364135249|FG000|Overall Study|Other than stated above|1|||
105583658|NCT01536262|364135250|FG001|Overall Study|Other than stated above|0|||
105583659|NCT01536262|364135251|FG002|Overall Study|Other than stated above|0|||
105583660|NCT00465361|364135253|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
105583661|NCT02459587|364135258|FG000|3-Month Follow-up Assessment|Death|0|||
105583662|NCT02459587|364135259|FG001|3-Month Follow-up Assessment|Death|2|||
105583663|NCT02459587|364135258|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
105583664|NCT02459587|364135259|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
105583665|NCT02459587|364135258|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
105583666|NCT02459587|364135259|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
105583667|NCT02459587|364135258|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
105583668|NCT02459587|364135259|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
105583669|NCT02459587|364135258|FG000|6-month Follow-up Assessment|Death|2|||
105583670|NCT02459587|364135259|FG001|6-month Follow-up Assessment|Death|1|||
105583671|NCT02459587|364135258|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
105583672|NCT02459587|364135259|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
105583673|NCT02459587|364135258|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
105583674|NCT02459587|364135259|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
105583675|NCT02459587|364135258|FG000|12-month Follow-up Assessment|Death|2|||
105583676|NCT02459587|364135259|FG001|12-month Follow-up Assessment|Death|0|||
105583677|NCT02459587|364135258|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
105583678|NCT02459587|364135259|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
105583679|NCT02459587|364135258|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
105583680|NCT02459587|364135259|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
105583681|NCT02459587|364135258|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
105583682|NCT02459587|364135259|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
105583683|NCT00515086|364135260|FG000|Overall Study|Adverse Event|1|||
105583684|NCT00515086|364135261|FG001|Overall Study|Adverse Event|1|||
105583685|NCT00515086|364135262|FG002|Overall Study|Adverse Event|2|||
105583686|NCT00515086|364135263|FG003|Overall Study|Adverse Event|3|||
105583687|NCT00515086|364135260|FG000|Overall Study|Administrative|1|||
105583688|NCT00515086|364135261|FG001|Overall Study|Administrative|1|||
105583689|NCT00515086|364135262|FG002|Overall Study|Administrative|0|||
105583690|NCT00515086|364135263|FG003|Overall Study|Administrative|0|||
105583691|NCT00515086|364135260|FG000|Overall Study|Withdrawal by Subject|1|||
105583692|NCT00515086|364135261|FG001|Overall Study|Withdrawal by Subject|0|||
105583693|NCT00515086|364135262|FG002|Overall Study|Withdrawal by Subject|0|||
105583694|NCT00515086|364135263|FG003|Overall Study|Withdrawal by Subject|1|||
105416718|NCT03831191|363531202|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
105416719|NCT03831191|363531203|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
105416720|NCT03831191|363531204|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
105416721|NCT03831191|363531205|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
105416722|NCT03831191|363531206|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
105416723|NCT03831191|363531207|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
105416724|NCT03831191|363531208|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
105416725|NCT03831191|363531209|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
105416726|NCT03831191|363531210|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
105416727|NCT03831191|363531211|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
105416728|NCT03831191|363531212|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
105416729|NCT03831191|363531213|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
105416730|NCT03831191|363531214|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
105416731|NCT03831191|363531215|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
105416732|NCT03831191|363531216|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
105416733|NCT03831191|363531202|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
105416734|NCT03831191|363531203|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
105416735|NCT03831191|363531204|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
105416736|NCT03831191|363531205|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
105416737|NCT03831191|363531206|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
105416738|NCT03831191|363531207|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
105416739|NCT03831191|363531208|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
105416740|NCT03831191|363531209|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
105583695|NCT00515086|364135260|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
105583696|NCT00515086|364135261|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105583697|NCT00515086|364135262|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
105583698|NCT00515086|364135263|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
105583699|NCT00515086|364135260|FG000|Overall Study|Lost to Follow-up|1|||
105583700|NCT00515086|364135261|FG001|Overall Study|Lost to Follow-up|0|||
105583701|NCT00515086|364135262|FG002|Overall Study|Lost to Follow-up|0|||
105583702|NCT00515086|364135263|FG003|Overall Study|Lost to Follow-up|0|||
105416741|NCT03831191|363531210|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
105416742|NCT03831191|363531211|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
105416743|NCT03831191|363531212|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
105416744|NCT03831191|363531213|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
105416745|NCT03831191|363531214|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
105416746|NCT03831191|363531215|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
105416747|NCT03831191|363531216|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
105416748|NCT03831191|363531202|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105416749|NCT03831191|363531203|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105416750|NCT03831191|363531204|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105416751|NCT03831191|363531205|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105416752|NCT03831191|363531206|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105416753|NCT03831191|363531207|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105416754|NCT03831191|363531208|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105416755|NCT03831191|363531209|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105416756|NCT03831191|363531210|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105416757|NCT03831191|363531211|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105416758|NCT03831191|363531212|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105416759|NCT03831191|363531213|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105416760|NCT03831191|363531214|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105416761|NCT03831191|363531215|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105416762|NCT03831191|363531216|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
105416763|NCT03831191|363531202|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105416764|NCT03831191|363531203|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105416765|NCT03831191|363531204|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105416766|NCT03831191|363531205|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105416767|NCT03831191|363531206|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105416768|NCT03831191|363531207|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105416769|NCT03831191|363531208|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105416770|NCT03831191|363531209|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105416771|NCT03831191|363531210|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105416772|NCT03831191|363531211|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105416773|NCT03831191|363531212|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105416774|NCT03831191|363531213|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105416775|NCT03831191|363531214|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105416776|NCT03831191|363531215|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105498760|NCT01999868|363836353|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
105498761|NCT01999868|363836354|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
105498762|NCT01999868|363836355|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
105498763|NCT01999868|363836353|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
105498764|NCT01999868|363836354|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
105498765|NCT01999868|363836355|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
105498766|NCT01999868|363836353|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
105498767|NCT01999868|363836354|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
105498768|NCT01999868|363836355|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
105498769|NCT01999868|363836353|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
105498770|NCT01999868|363836354|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
105498771|NCT01999868|363836355|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
105498772|NCT01999868|363836353|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
105498773|NCT01999868|363836354|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
105498774|NCT01999868|363836355|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
105498775|NCT01999868|363836353|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
105498776|NCT01999868|363836354|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
105498777|NCT01999868|363836355|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
105498778|NCT01999868|363836353|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
105498779|NCT01999868|363836354|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
105498780|NCT01999868|363836355|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
105498781|NCT01999868|363836353|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
105498782|NCT01999868|363836354|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
105498783|NCT01999868|363836355|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
105416777|NCT03831191|363531216|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
105416778|NCT03070171|363531217|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
105416779|NCT03070171|363531218|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
105416780|NCT03070171|363531217|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
105416781|NCT03070171|363531218|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
105416782|NCT01471028|363531222|FG000|VTI-208|Adverse Event|39|||
105416783|NCT01471028|363531223|FG001|VTI-208|Adverse Event|41|||
105416784|NCT01471028|363531222|FG000|VTI-208|Withdrawal by Subject|0|||
105416785|NCT01471028|363531223|FG001|VTI-208|Withdrawal by Subject|2|||
105416786|NCT01471028|363531222|FG000|VTI-208|Lost to Follow-up|1|||
105416787|NCT01471028|363531223|FG001|VTI-208|Lost to Follow-up|1|||
105416788|NCT01471028|363531222|FG000|VTI-208E|Death|7|||
105416789|NCT01471028|363531223|FG001|VTI-208E|Death|10|||
105416790|NCT01471028|363531222|FG000|VTI-208E|Withdrawal by Subject|1|||
105416791|NCT01471028|363531223|FG001|VTI-208E|Withdrawal by Subject|0|||
105416792|NCT01471028|363531222|FG000|VTI-208E|Lost to Follow-up|0|||
105416793|NCT01471028|363531223|FG001|VTI-208E|Lost to Follow-up|2|||
105416794|NCT05411822|363531224|FG000|Overall Study|Withdrawal by Subject|2|||
105416795|NCT05411822|363531225|FG001|Overall Study|Withdrawal by Subject|1|||
105416796|NCT04826094|363531226|FG000|Overall Study|Lost to Follow-up|2|||
105416797|NCT04826094|363531227|FG001|Overall Study|Lost to Follow-up|1|||
105416798|NCT04826094|363531228|FG002|Overall Study|Lost to Follow-up|0|||
105416799|NCT04826094|363531229|FG003|Overall Study|Lost to Follow-up|0|||
105416800|NCT04826094|363531230|FG004|Overall Study|Lost to Follow-up|1|||
105416801|NCT04826094|363531231|FG005|Overall Study|Lost to Follow-up|3|||
105416802|NCT04826094|363531232|FG006|Overall Study|Lost to Follow-up|1|||
105416803|NCT04826094|363531233|FG007|Overall Study|Lost to Follow-up|1|||
105416804|NCT04826094|363531226|FG000|Overall Study|Participant withdrew consent|1|||
105416805|NCT04826094|363531227|FG001|Overall Study|Participant withdrew consent|0|||
105416806|NCT04826094|363531228|FG002|Overall Study|Participant withdrew consent|0|||
105416807|NCT04826094|363531229|FG003|Overall Study|Participant withdrew consent|1|||
105416808|NCT04826094|363531230|FG004|Overall Study|Participant withdrew consent|1|||
105416809|NCT04826094|363531231|FG005|Overall Study|Participant withdrew consent|1|||
105416810|NCT04826094|363531232|FG006|Overall Study|Participant withdrew consent|0|||
105416811|NCT04826094|363531233|FG007|Overall Study|Participant withdrew consent|1|||
105416812|NCT04826094|363531226|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
105416813|NCT04826094|363531227|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
105416814|NCT04826094|363531228|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
105416815|NCT04826094|363531229|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
105416816|NCT04826094|363531230|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
105416817|NCT04826094|363531231|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
105416818|NCT04826094|363531232|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
105416819|NCT04826094|363531233|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
105416820|NCT04826094|363531226|FG000|Overall Study|Withdrawn by Investigator|0|||
105416821|NCT04826094|363531227|FG001|Overall Study|Withdrawn by Investigator|0|||
105416822|NCT04826094|363531228|FG002|Overall Study|Withdrawn by Investigator|0|||
105416823|NCT04826094|363531229|FG003|Overall Study|Withdrawn by Investigator|0|||
105416824|NCT04826094|363531230|FG004|Overall Study|Withdrawn by Investigator|0|||
105416825|NCT04826094|363531231|FG005|Overall Study|Withdrawn by Investigator|1|||
105416826|NCT04826094|363531232|FG006|Overall Study|Withdrawn by Investigator|0|||
105416827|NCT04826094|363531233|FG007|Overall Study|Withdrawn by Investigator|1|||
105416828|NCT04826094|363531226|FG000|Overall Study|Other: Moved from area|1|||
105416829|NCT04826094|363531227|FG001|Overall Study|Other: Moved from area|1|||
105416830|NCT04826094|363531228|FG002|Overall Study|Other: Moved from area|1|||
105416831|NCT04826094|363531229|FG003|Overall Study|Other: Moved from area|0|||
105416832|NCT04826094|363531230|FG004|Overall Study|Other: Moved from area|0|||
105416833|NCT04826094|363531231|FG005|Overall Study|Other: Moved from area|0|||
105416834|NCT04826094|363531232|FG006|Overall Study|Other: Moved from area|0|||
105416835|NCT04826094|363531233|FG007|Overall Study|Other: Moved from area|0|||
105416836|NCT04826094|363531226|FG000|Overall Study|Other: Declined|0|||
105416837|NCT04826094|363531227|FG001|Overall Study|Other: Declined|0|||
105416838|NCT04826094|363531228|FG002|Overall Study|Other: Declined|0|||
105416839|NCT04826094|363531229|FG003|Overall Study|Other: Declined|0|||
105416840|NCT04826094|363531230|FG004|Overall Study|Other: Declined|1|||
105416841|NCT04826094|363531231|FG005|Overall Study|Other: Declined|0|||
105416842|NCT04826094|363531232|FG006|Overall Study|Other: Declined|0|||
105416843|NCT04826094|363531233|FG007|Overall Study|Other: Declined|0|||
105416844|NCT04826094|363531226|FG000|Overall Study|Other: Vaccine not administered|0|||
105416845|NCT04826094|363531227|FG001|Overall Study|Other: Vaccine not administered|0|||
105416846|NCT04826094|363531228|FG002|Overall Study|Other: Vaccine not administered|1|||
105416847|NCT04826094|363531229|FG003|Overall Study|Other: Vaccine not administered|0|||
105416848|NCT04826094|363531230|FG004|Overall Study|Other: Vaccine not administered|0|||
105416849|NCT04826094|363531231|FG005|Overall Study|Other: Vaccine not administered|1|||
105416850|NCT04826094|363531232|FG006|Overall Study|Other: Vaccine not administered|1|||
105416851|NCT04826094|363531233|FG007|Overall Study|Other: Vaccine not administered|3|||
105416852|NCT04445519|363531234|FG000|Overall Study|Due to adaptive design|3|||
105416853|NCT04445519|363531235|FG001|Overall Study|Due to adaptive design|0|||
105416854|NCT04445519|363531236|FG002|Overall Study|Due to adaptive design|0|||
105416855|NCT04445519|363531234|FG000|Overall Study|Lost to Follow-up|0|||
105416856|NCT04445519|363531235|FG001|Overall Study|Lost to Follow-up|1|||
105498784|NCT01999868|363836353|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
105498785|NCT01999868|363836354|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
105498786|NCT01999868|363836355|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
105498787|NCT01999868|363836353|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
105498788|NCT01999868|363836354|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
105498789|NCT01999868|363836355|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
105498790|NCT01999868|363836353|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
105498791|NCT01999868|363836354|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
105498792|NCT01999868|363836355|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
105498793|NCT01999868|363836353|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
105498794|NCT01999868|363836354|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
105498795|NCT01999868|363836355|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
105498796|NCT01999868|363836353|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
105498797|NCT01999868|363836354|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
105498798|NCT01999868|363836355|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
105498799|NCT01187433|363836361|FG000|Overall Study|Protocol Violation|6|||
105498800|NCT01187433|363836362|FG001|Overall Study|Protocol Violation|2|||
105498801|NCT01187433|363836361|FG000|Overall Study|Withdrawal by Subject|5|||
105498802|NCT01187433|363836362|FG001|Overall Study|Withdrawal by Subject|2|||
105498803|NCT00302107|363836363|FG000|Overall Study|Lost to Follow-up|6|||
105498804|NCT00302107|363836364|FG001|Overall Study|Lost to Follow-up|5|||
105498805|NCT00302107|363836363|FG000|Overall Study|Protocol Violation|1|||
105498806|NCT00302107|363836364|FG001|Overall Study|Protocol Violation|0|||
105498807|NCT00302107|363836363|FG000|Overall Study|Relocation|0|||
105498808|NCT00302107|363836364|FG001|Overall Study|Relocation|1|||
105498809|NCT00302107|363836363|FG000|Overall Study|Withdrawal by Subject|0|||
105498810|NCT00302107|363836364|FG001|Overall Study|Withdrawal by Subject|3|||
105498811|NCT00302107|363836363|FG000|Overall Study|Adverse Event|1|||
105498812|NCT00302107|363836364|FG001|Overall Study|Adverse Event|0|||
105498813|NCT01790932|363836365|FG000|Overall Study|Disease Progression|41|||
105498814|NCT01790932|363836365|FG000|Overall Study|Adverse Event|7|||
105498815|NCT01790932|363836365|FG000|Overall Study|Physician Decision|1|||
105498816|NCT01790932|363836365|FG000|Overall Study|Withdrawal by Subject|1|||
105498817|NCT00678080|363836366|FG000|Overall Study|Physician Decision|2|||
105498818|NCT00678080|363836367|FG001|Overall Study|Physician Decision|0|||
105498819|NCT00678080|363836366|FG000|Overall Study|Lost to Follow-up|1|||
105498820|NCT00678080|363836367|FG001|Overall Study|Lost to Follow-up|0|||
105498821|NCT00678080|363836366|FG000|Overall Study|Withdrawal by Subject|0|||
105498822|NCT00678080|363836367|FG001|Overall Study|Withdrawal by Subject|1|||
105498823|NCT01752985|363836368|FG000|Treatment Period|Subject request to discontinue treatment|1|||
105498824|NCT01752985|363836369|FG001|Treatment Period|Subject request to discontinue treatment|0|||
105498825|NCT01752985|363836370|FG002|Treatment Period|Subject request to discontinue treatment|1|||
105498826|NCT01752985|363836368|FG000|Treatment Period|Subject no longer meets study criteria|0|||
105498827|NCT01752985|363836369|FG001|Treatment Period|Subject no longer meets study criteria|1|||
105498828|NCT01752985|363836370|FG002|Treatment Period|Subject no longer meets study criteria|1|||
105498829|NCT01752985|363836368|FG000|Treatment Period|Adverse Event|2|||
105498830|NCT01752985|363836369|FG001|Treatment Period|Adverse Event|1|||
105498831|NCT01752985|363836370|FG002|Treatment Period|Adverse Event|2|||
105498832|NCT01752985|363836368|FG000|Treatment Period|Withdrawal by Subject|1|||
105498833|NCT01752985|363836369|FG001|Treatment Period|Withdrawal by Subject|1|||
105498834|NCT01752985|363836370|FG002|Treatment Period|Withdrawal by Subject|0|||
105498835|NCT01752985|363836368|FG000|Treatment Period|Lost to Follow-up|0|||
105498836|NCT01752985|363836369|FG001|Treatment Period|Lost to Follow-up|0|||
105498837|NCT01752985|363836370|FG002|Treatment Period|Lost to Follow-up|1|||
105498838|NCT03673046|363838763|FG000|Overall Study|Adverse Event|1|||
105498839|NCT03673046|363838764|FG001|Overall Study|Adverse Event|1|||
105498840|NCT03673046|363838763|FG000|Overall Study|Withdrawal by Subject|8|||
105498841|NCT03673046|363838764|FG001|Overall Study|Withdrawal by Subject|2|||
105498842|NCT03817879|363838765|FG000|Overall Study|Drop out|5|||
105498843|NCT03817879|363838766|FG001|Overall Study|Drop out|12|||
105498844|NCT03817879|363838765|FG000|Overall Study|Withdrawal by Subject|0|||
105498845|NCT03817879|363838766|FG001|Overall Study|Withdrawal by Subject|1|||
105498846|NCT01896050|363838769|FG000|Overall Study|Adverse Event|37|||
105498847|NCT01896050|363838770|FG001|Overall Study|Adverse Event|2|||
105498848|NCT01896050|363838769|FG000|Overall Study|Death|1|||
105498849|NCT01896050|363838770|FG001|Overall Study|Death|0|||
105498850|NCT03693300|363838771|FG000|Overall Study|Withdrawal by Subject|6|||
105498851|NCT03693300|363838772|FG001|Overall Study|Withdrawal by Subject|0|||
105498852|NCT03693300|363838771|FG000|Overall Study|Death|50|||
105583703|NCT00515086|364135260|FG000|Overall Study|Study drug no longer required|0|||
105498853|NCT03693300|363838772|FG001|Overall Study|Death|2|||
105498854|NCT03693300|363838771|FG000|Overall Study|Lost to Follow-up|2|||
105498855|NCT03693300|363838772|FG001|Overall Study|Lost to Follow-up|0|||
105583704|NCT00515086|364135261|FG001|Overall Study|Study drug no longer required|1|||
105583705|NCT00515086|364135262|FG002|Overall Study|Study drug no longer required|0|||
105583706|NCT00515086|364135263|FG003|Overall Study|Study drug no longer required|0|||
105583707|NCT00515086|364135260|FG000|Overall Study|Death|2|||
105583708|NCT00515086|364135261|FG001|Overall Study|Death|0|||
105583709|NCT00515086|364135262|FG002|Overall Study|Death|0|||
105583710|NCT00515086|364135263|FG003|Overall Study|Death|0|||
105583711|NCT01021332|364135264|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
105583712|NCT01021332|364135264|FG000|Overall Study|Adverse Event|43|||
105583713|NCT01021332|364135264|FG000|Overall Study|Lack of Efficacy|19|||
105583714|NCT01021332|364135264|FG000|Overall Study|Withdrawal of Consent|23|||
105583715|NCT01021332|364135264|FG000|Overall Study|Lost to Follow-up|4|||
105583716|NCT01021332|364135264|FG000|Overall Study|Protocol Violation|9|||
105583717|NCT01021332|364135264|FG000|Overall Study|Miscellaneous|3|||
105583718|NCT01403987|364135266|FG000|Overall Study|Residents forgot their secret PIN|18|||
105583719|NCT01403987|364135267|FG001|Overall Study|Residents forgot their secret PIN|17|||
105583720|NCT01403987|364135268|FG002|Overall Study|Residents forgot their secret PIN|18|||
105583721|NCT03302910|364135271|FG000|Overall Study|Protocol Violation|1|||
105583722|NCT03302910|364135272|FG001|Overall Study|Protocol Violation|0|||
105583723|NCT00278564|364135280|FG000|Overall Study|Lack of Efficacy|4|||
105583724|NCT01066156|364135283|FG000|Overall Study|ineligible|2|||
105583725|NCT01066156|364135283|FG000|Overall Study|Lost to Follow-up|7|||
105583726|NCT01066156|364135283|FG000|Overall Study|Withdrawal by Subject|1|||
105583727|NCT00570661|364135284|FG000|Overall Study|Disease worsening|5|||
105583728|NCT00570661|364135284|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
105583729|NCT00570661|364135284|FG000|Overall Study|Adverse Event|1|||
105583730|NCT02400307|364135285|FG000|Overall Study|Enrolled and Never Dosed|1|||
105583731|NCT02400307|364135286|FG001|Overall Study|Enrolled and Never Dosed|0|||
105583732|NCT03633903|364135287|FG000|Overall Study|Withdrawal by Subject|1|||
105583733|NCT03633903|364135288|FG001|Overall Study|Withdrawal by Subject|2|||
105583734|NCT03633903|364135287|FG000|Overall Study|Lost to Follow-up|5|||
105583735|NCT03633903|364135288|FG001|Overall Study|Lost to Follow-up|5|||
105583736|NCT00087490|364135289|FG000|Overall Study|Death|6|||
105583737|NCT00087490|364135290|FG001|Overall Study|Death|4|||
105583738|NCT00087490|364135289|FG000|Overall Study|Adverse Event|3|||
105583739|NCT00087490|364135290|FG001|Overall Study|Adverse Event|8|||
105583740|NCT00087490|364135289|FG000|Overall Study|Lack of Efficacy|0|||
105583741|NCT00087490|364135290|FG001|Overall Study|Lack of Efficacy|2|||
105583742|NCT00087490|364135289|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
105583743|NCT00087490|364135290|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
105583744|NCT00087490|364135289|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
105583745|NCT00087490|364135290|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
105583746|NCT00087490|364135289|FG000|Overall Study|Randomized but not treated|7|||
105583747|NCT00087490|364135290|FG001|Overall Study|Randomized but not treated|18|||
105583748|NCT03111095|364135291|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
105583749|NCT03111095|364135292|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
105583750|NCT03111095|364135291|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
105583751|NCT03111095|364135292|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
105583752|NCT01925170|364135293|FG000|Overall Study|Unverified cancer status|53|||
105583753|NCT03379233|364135294|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
105583754|NCT03379233|364135295|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
105416857|NCT04445519|363531236|FG002|Overall Study|Lost to Follow-up|4|||
105416858|NCT04445519|363531234|FG000|Overall Study|Sponsor or IRB Decision|0|||
105416859|NCT04445519|363531235|FG001|Overall Study|Sponsor or IRB Decision|1|||
105416860|NCT04445519|363531236|FG002|Overall Study|Sponsor or IRB Decision|2|||
105416861|NCT04445519|363531234|FG000|Overall Study|Withdrawal by Subject|0|||
105416862|NCT04445519|363531235|FG001|Overall Study|Withdrawal by Subject|3|||
105416863|NCT04445519|363531236|FG002|Overall Study|Withdrawal by Subject|3|||
105416864|NCT04445519|363531234|FG000|Overall Study|Adverse Event|0|||
105416865|NCT04445519|363531235|FG001|Overall Study|Adverse Event|8|||
105416866|NCT04445519|363531236|FG002|Overall Study|Adverse Event|6|||
105416867|NCT04445519|363531234|FG000|Overall Study|Other Reason|0|||
105583755|NCT02335268|364135300|FG000|Overall Study|Physician Decision|5|||
105583756|NCT02335268|364135301|FG001|Overall Study|Physician Decision|1|||
105583757|NCT02335268|364135300|FG000|Overall Study|Lack of Efficacy|2|||
105583758|NCT02335268|364135301|FG001|Overall Study|Lack of Efficacy|1|||
105583759|NCT02335268|364135300|FG000|Overall Study|Adverse Event|5|||
105583760|NCT02335268|364135301|FG001|Overall Study|Adverse Event|2|||
105583761|NCT02335268|364135300|FG000|Overall Study|increase blasts|2|||
105583762|NCT02335268|364135301|FG001|Overall Study|increase blasts|0|||
105583763|NCT02335268|364135300|FG000|Overall Study|Withdrawal by Subject|3|||
105583764|NCT02335268|364135301|FG001|Overall Study|Withdrawal by Subject|2|||
105416868|NCT04445519|363531235|FG001|Overall Study|Other Reason|1|||
105416869|NCT04445519|363531236|FG002|Overall Study|Other Reason|1|||
105416870|NCT04445519|363531234|FG000|Overall Study|Protocol Violation|0|||
105583765|NCT01767909|364135304|FG000|Overall Study|Withdrawal by Subject|4|||
105583766|NCT01767909|364135305|FG001|Overall Study|Withdrawal by Subject|7|||
105583767|NCT01767909|364135304|FG000|Overall Study|Adverse Event|3|||
105583768|NCT01767909|364135305|FG001|Overall Study|Adverse Event|1|||
105583769|NCT01767909|364135304|FG000|Overall Study|Withdrawal by Study Partner|3|||
105583770|NCT01767909|364135305|FG001|Overall Study|Withdrawal by Study Partner|1|||
105583771|NCT01767909|364135304|FG000|Overall Study|Non-Compliance|2|||
105583772|NCT01767909|364135305|FG001|Overall Study|Non-Compliance|0|||
105583773|NCT01767909|364135304|FG000|Overall Study|Perceived Lack of Efficacy|1|||
105583774|NCT01767909|364135305|FG001|Overall Study|Perceived Lack of Efficacy|0|||
105583775|NCT01767909|364135304|FG000|Overall Study|Investigator Recommendation|0|||
105583776|NCT01767909|364135305|FG001|Overall Study|Investigator Recommendation|1|||
105583777|NCT01767909|364135304|FG000|Overall Study|Lost to Follow-up|0|||
105583778|NCT01767909|364135305|FG001|Overall Study|Lost to Follow-up|1|||
105583779|NCT01767909|364135304|FG000|Overall Study|LP uncessessful|0|||
105583780|NCT01767909|364135305|FG001|Overall Study|LP uncessessful|1|||
105583781|NCT00333788|364135306|FG000|Overall Study|Adverse Event|44|||
105583782|NCT00333788|364135306|FG000|Overall Study|Lack of Efficacy|80|||
105583783|NCT00333788|364135306|FG000|Overall Study|Lost to Follow-up|2|||
105583784|NCT00333788|364135306|FG000|Overall Study|Withdrawal by Subject|24|||
105583785|NCT00333788|364135306|FG000|Overall Study|Other: Non-compliance|2|||
105583786|NCT00333788|364135306|FG000|Overall Study|Other: Moved|2|||
105583787|NCT00333788|364135306|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
105583788|NCT00333788|364135306|FG000|Overall Study|Other: Investigator decision|1|||
105583789|NCT00333788|364135306|FG000|Overall Study|Other: Quality of life concern|1|||
105583790|NCT00333788|364135306|FG000|Overall Study|Other: Sponsor decision|1|||
105583791|NCT00333788|364135306|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
105583792|NCT00333788|364135306|FG000|Overall Study|Other: Medical monitor decision|1|||
105583793|NCT00333788|364135306|FG000|Overall Study|Other: Physician decision|1|||
105583794|NCT00333788|364135306|FG000|Overall Study|Other: Signed consent for another study|1|||
105583795|NCT02956967|364135307|FG000|Overall Study|Adverse Event|3|||
105583796|NCT02956967|364135307|FG000|Overall Study|Reason non-related to neutropenia|10|||
105583797|NCT02956967|364135307|FG000|Overall Study|Lost to Follow-up|5|||
105583798|NCT02956967|364135307|FG000|Overall Study|Missing|1|||
105583799|NCT02956967|364135307|FG000|Overall Study|Termination of Nivestim administration|29|||
105583800|NCT04426006|364135319|FG000|Inclusion|Protocol Violation|1|||
105583801|NCT04426006|364135319|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
105583802|NCT04426006|364135319|FG000|Inclusion|Blood sample at inclusion not done|1|||
105583803|NCT04426006|364135319|FG000|3 Months|Lost to Follow-up|17|||
105583804|NCT04426006|364135319|FG000|12 Months|Lost to Follow-up|38|||
105583805|NCT05114590|364135321|FG000|Overall Study|Adverse Event|1|||
105583806|NCT05114590|364135321|FG000|Overall Study|Investigator decision|1|||
105583807|NCT05114590|364135321|FG000|Overall Study|Lost to Follow-up|5|||
105583808|NCT05114590|364135321|FG000|Overall Study|Withdrawal by Subject|5|||
105583809|NCT05114590|364135321|FG000|Overall Study|Other|2|||
105583810|NCT03590743|364135322|FG000|Overall Study|Withdrawal by Subject|0|||
105583811|NCT03590743|364135323|FG001|Overall Study|Withdrawal by Subject|1|||
105583812|NCT00604786|364135331|FG000|Overall Study|Lost to Follow-up|2|||
105583813|NCT00604786|364135332|FG001|Overall Study|Lost to Follow-up|0|||
105583814|NCT02698436|364135333|FG000|Overall Study|Adverse Event|1|||
105583815|NCT02698436|364135334|FG001|Overall Study|Adverse Event|0|||
105583816|NCT02698436|364135333|FG000|Overall Study|Withdrawal by Subject|3|||
105583817|NCT02698436|364135334|FG001|Overall Study|Withdrawal by Subject|3|||
105583818|NCT02698436|364135333|FG000|Overall Study|Lost to Follow-up|2|||
105583819|NCT02698436|364135334|FG001|Overall Study|Lost to Follow-up|4|||
105583820|NCT02698436|364135333|FG000|Overall Study|Non-compliance with study regimen|1|||
105583821|NCT02698436|364135334|FG001|Overall Study|Non-compliance with study regimen|0|||
105583822|NCT00429793|364135335|FG000|Overall Study|Improper pre-protocol treatment|3|||
105583823|NCT00429793|364135335|FG000|Overall Study|Required test not done|1|||
105583824|NCT00429793|364135335|FG000|Overall Study|Never treated|1|||
105583825|NCT00429793|364135335|FG000|Overall Study|Non-measurable|1|||
105583826|NCT01394991|364135336|FG000|Overall Study|Adverse Event|0|||
105583827|NCT01394991|364135337|FG001|Overall Study|Adverse Event|4|||
105583828|NCT01394991|364135336|FG000|Overall Study|Lack of Efficacy|5|||
105416871|NCT04445519|363531235|FG001|Overall Study|Protocol Violation|0|||
105583829|NCT01394991|364135337|FG001|Overall Study|Lack of Efficacy|7|||
105583830|NCT01394991|364135336|FG000|Overall Study|Lost to Follow-up|6|||
105583831|NCT01394991|364135337|FG001|Overall Study|Lost to Follow-up|8|||
105583832|NCT01394991|364135336|FG000|Overall Study|Physician Decision|1|||
105583833|NCT01394991|364135337|FG001|Overall Study|Physician Decision|3|||
105583834|NCT01394991|364135336|FG000|Overall Study|Protocol Violation|1|||
105583835|NCT01394991|364135337|FG001|Overall Study|Protocol Violation|1|||
105583836|NCT01394991|364135336|FG000|Overall Study|Withdrawal by Subject|20|||
105583837|NCT01394991|364135337|FG001|Overall Study|Withdrawal by Subject|17|||
105583838|NCT01394991|364135336|FG000|Overall Study|Chemotherapy Termination|10|||
105583839|NCT01394991|364135337|FG001|Overall Study|Chemotherapy Termination|15|||
105583840|NCT01394991|364135336|FG000|Overall Study|Disease Progression|7|||
105583841|NCT01394991|364135337|FG001|Overall Study|Disease Progression|7|||
105583842|NCT01394991|364135336|FG000|Overall Study|Prematurely Termination of Trial|9|||
105416872|NCT04445519|363531236|FG002|Overall Study|Protocol Violation|1|||
105416873|NCT00939029|363531240|FG000|Overall Study|Withdrawal by Subject|3|||
105416874|NCT00939029|363531241|FG001|Overall Study|Withdrawal by Subject|7|||
105416875|NCT00939029|363531240|FG000|Overall Study|Lost to Follow-up|3|||
105416876|NCT00939029|363531241|FG001|Overall Study|Lost to Follow-up|4|||
105416877|NCT00939029|363531240|FG000|Overall Study|Adverse Event|0|||
105416878|NCT00939029|363531241|FG001|Overall Study|Adverse Event|1|||
105416879|NCT01272037|363531242|FG000|Overall Study|Death|25|||
105416880|NCT01272037|363531243|FG001|Overall Study|Death|28|||
105416881|NCT01272037|363531242|FG000|Overall Study|Adverse Event|12|||
105416882|NCT01272037|363531243|FG001|Overall Study|Adverse Event|7|||
105416883|NCT01272037|363531242|FG000|Overall Study|Withdrawal by Subject|175|||
105416884|NCT01272037|363531243|FG001|Overall Study|Withdrawal by Subject|93|||
105416885|NCT01272037|363531242|FG000|Overall Study|Disease progression|70|||
105416886|NCT01272037|363531243|FG001|Overall Study|Disease progression|111|||
105416887|NCT01272037|363531242|FG000|Overall Study|Other reason|42|||
105416888|NCT01272037|363531243|FG001|Overall Study|Other reason|41|||
105416889|NCT01272037|363531242|FG000|Overall Study|Delinquent data|24|||
105416890|NCT01272037|363531243|FG001|Overall Study|Delinquent data|19|||
105416891|NCT01272037|363531242|FG000|Overall Study|Reason under review|33|||
105416892|NCT01272037|363531243|FG001|Overall Study|Reason under review|29|||
105416893|NCT01272037|363531242|FG000|Overall Study|On treatment|626|||
105416894|NCT01272037|363531243|FG001|Overall Study|On treatment|632|||
105416895|NCT01866111|363531244|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
105416896|NCT01866111|363531245|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
105416897|NCT01866111|363531246|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
105416898|NCT01866111|363531247|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
105416899|NCT01866111|363531244|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
105416900|NCT01866111|363531245|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
105416901|NCT01866111|363531246|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
105416902|NCT01866111|363531247|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
105416903|NCT01866111|363531244|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
105416904|NCT01866111|363531245|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
105416905|NCT01866111|363531246|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
105416906|NCT01866111|363531247|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
105416907|NCT01866111|363531244|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
105416908|NCT01866111|363531245|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
105416909|NCT01866111|363531246|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
105416910|NCT01866111|363531247|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
105416911|NCT01866111|363531244|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
105416912|NCT01866111|363531245|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
105416913|NCT01866111|363531246|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
105416914|NCT01866111|363531247|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
105416915|NCT01866111|363531244|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
105416916|NCT01866111|363531245|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
105416917|NCT01866111|363531246|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
105416918|NCT01866111|363531247|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
105416919|NCT01866111|363531244|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
105416920|NCT01866111|363531245|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
105416921|NCT01866111|363531246|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
105416922|NCT01866111|363531247|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
105416923|NCT01866111|363531244|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
105416924|NCT01866111|363531245|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
105416925|NCT01866111|363531246|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
105416926|NCT01866111|363531247|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
105416927|NCT01866111|363531244|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
105416928|NCT01866111|363531245|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
105416929|NCT01866111|363531246|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
105416930|NCT01866111|363531247|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
105416931|NCT01866111|363531244|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
105416932|NCT01866111|363531245|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
105416933|NCT01866111|363531246|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
105416934|NCT01866111|363531247|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
105416935|NCT01866111|363531244|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
105416936|NCT01866111|363531245|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
105583843|NCT01394991|364135337|FG001|Overall Study|Prematurely Termination of Trial|10|||
105416937|NCT01866111|363531246|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
105416938|NCT01866111|363531247|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
105416939|NCT01866111|363531244|FG000|Open-label Extension Study YKP3089C017|Death|1|||
105498856|NCT00150709|363838776|FG000|Overall Study|Protocol Violation|7|||
105498857|NCT00150709|363838777|FG001|Overall Study|Protocol Violation|8|||
105498858|NCT00150709|363838778|FG002|Overall Study|Protocol Violation|3|||
105498859|NCT00150709|363838779|FG003|Overall Study|Protocol Violation|1|||
105498860|NCT00150709|363838776|FG000|Overall Study|Adverse Event|8|||
105498861|NCT00150709|363838777|FG001|Overall Study|Adverse Event|2|||
105498862|NCT00150709|363838778|FG002|Overall Study|Adverse Event|2|||
105498863|NCT00150709|363838779|FG003|Overall Study|Adverse Event|3|||
105498864|NCT00150709|363838776|FG000|Overall Study|Lack of Efficacy|6|||
105498865|NCT00150709|363838777|FG001|Overall Study|Lack of Efficacy|11|||
105498866|NCT00150709|363838778|FG002|Overall Study|Lack of Efficacy|9|||
105498867|NCT00150709|363838779|FG003|Overall Study|Lack of Efficacy|0|||
105498868|NCT00150709|363838776|FG000|Overall Study|Withdrawal by Subject|7|||
105498869|NCT00150709|363838777|FG001|Overall Study|Withdrawal by Subject|10|||
105498870|NCT00150709|363838778|FG002|Overall Study|Withdrawal by Subject|5|||
105498871|NCT00150709|363838779|FG003|Overall Study|Withdrawal by Subject|0|||
105498872|NCT00150709|363838776|FG000|Overall Study|Lost to Follow-up|3|||
105498873|NCT00150709|363838777|FG001|Overall Study|Lost to Follow-up|2|||
105498874|NCT00150709|363838778|FG002|Overall Study|Lost to Follow-up|0|||
105498875|NCT00150709|363838779|FG003|Overall Study|Lost to Follow-up|0|||
105498876|NCT00150709|363838776|FG000|Overall Study|Sponsor decision|0|||
105498877|NCT00150709|363838777|FG001|Overall Study|Sponsor decision|0|||
105498878|NCT00150709|363838778|FG002|Overall Study|Sponsor decision|0|||
105498879|NCT00150709|363838779|FG003|Overall Study|Sponsor decision|1|||
105498880|NCT00150709|363838776|FG000|Overall Study|Site/Investigator discontinued the study|5|||
105498881|NCT00150709|363838777|FG001|Overall Study|Site/Investigator discontinued the study|5|||
105498882|NCT00150709|363838778|FG002|Overall Study|Site/Investigator discontinued the study|2|||
105498883|NCT00150709|363838779|FG003|Overall Study|Site/Investigator discontinued the study|0|||
105498884|NCT00150709|363838776|FG000|Overall Study|Decision of parent(s)|1|||
105498885|NCT00150709|363838777|FG001|Overall Study|Decision of parent(s)|2|||
105498886|NCT00150709|363838778|FG002|Overall Study|Decision of parent(s)|0|||
105498887|NCT00150709|363838779|FG003|Overall Study|Decision of parent(s)|0|||
105498888|NCT00150709|363838776|FG000|Overall Study|Decision of parent(s) and investigator|3|||
105498889|NCT00150709|363838777|FG001|Overall Study|Decision of parent(s) and investigator|0|||
105498890|NCT00150709|363838778|FG002|Overall Study|Decision of parent(s) and investigator|0|||
105498891|NCT00150709|363838779|FG003|Overall Study|Decision of parent(s) and investigator|0|||
105498892|NCT00150709|363838776|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
105498893|NCT00150709|363838777|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
105498894|NCT00150709|363838778|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
105498895|NCT00150709|363838779|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
105498896|NCT00150709|363838776|FG000|Overall Study|Investigator decision|1|||
105498897|NCT00150709|363838777|FG001|Overall Study|Investigator decision|0|||
105498898|NCT00150709|363838778|FG002|Overall Study|Investigator decision|0|||
105498899|NCT00150709|363838779|FG003|Overall Study|Investigator decision|1|||
105498900|NCT00150709|363838776|FG000|Overall Study|Subject relocated|2|||
105498901|NCT00150709|363838777|FG001|Overall Study|Subject relocated|2|||
105498902|NCT00150709|363838778|FG002|Overall Study|Subject relocated|1|||
105498903|NCT00150709|363838779|FG003|Overall Study|Subject relocated|0|||
105498904|NCT00150709|363838776|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
105498905|NCT00150709|363838777|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
105498906|NCT00150709|363838778|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
105498907|NCT00150709|363838779|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
105498908|NCT00150709|363838776|FG000|Overall Study|Convenience|0|||
105498909|NCT00150709|363838777|FG001|Overall Study|Convenience|1|||
105498910|NCT00150709|363838778|FG002|Overall Study|Convenience|0|||
105498911|NCT00150709|363838779|FG003|Overall Study|Convenience|0|||
105498912|NCT00150709|363838776|FG000|Overall Study|Subject entered new drug study|0|||
105498913|NCT00150709|363838777|FG001|Overall Study|Subject entered new drug study|1|||
105498914|NCT00150709|363838778|FG002|Overall Study|Subject entered new drug study|0|||
105498915|NCT00150709|363838779|FG003|Overall Study|Subject entered new drug study|0|||
105498916|NCT00150709|363838776|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
105498917|NCT00150709|363838777|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
105498918|NCT00150709|363838778|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
105498919|NCT00150709|363838779|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
105498920|NCT00150709|363838776|FG000|Overall Study|Lack of ease of swallowing|0|||
105498921|NCT00150709|363838777|FG001|Overall Study|Lack of ease of swallowing|1|||
105498922|NCT00150709|363838778|FG002|Overall Study|Lack of ease of swallowing|0|||
105498923|NCT00150709|363838779|FG003|Overall Study|Lack of ease of swallowing|0|||
105416940|NCT01866111|363531245|FG001|Open-label Extension Study YKP3089C017|Death|1|||
105416941|NCT01866111|363531246|FG002|Open-label Extension Study YKP3089C017|Death|3|||
105416942|NCT01866111|363531247|FG003|Open-label Extension Study YKP3089C017|Death|2|||
105416943|NCT01866111|363531244|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
105416944|NCT01866111|363531245|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
105416945|NCT01866111|363531246|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
105416946|NCT01866111|363531247|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
105416947|NCT01866111|363531244|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
105416948|NCT01866111|363531245|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
105416949|NCT01866111|363531246|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
105416950|NCT01866111|363531247|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
105416951|NCT01866111|363531244|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
105416952|NCT01866111|363531245|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
105416953|NCT01866111|363531246|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
105416954|NCT01866111|363531247|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
105416955|NCT00211757|363531251|FG000|Overall Study|Withdrawal by Subject|1|||
105416956|NCT00211757|363531252|FG001|Overall Study|Withdrawal by Subject|1|||
105416957|NCT00211757|363531251|FG000|Overall Study|Lack of Efficacy|0|||
105416958|NCT00211757|363531252|FG001|Overall Study|Lack of Efficacy|1|||
105416959|NCT03479541|363531256|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
105416960|NCT03479541|363531257|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
105416961|NCT03479541|363531258|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
105416962|NCT03479541|363531259|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
105416963|NCT03479541|363531256|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
105416964|NCT03479541|363531257|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
105416965|NCT03479541|363531258|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
105416966|NCT03479541|363531259|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
105416967|NCT03479541|363531256|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
105416968|NCT03479541|363531257|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
105416969|NCT03479541|363531258|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
105416970|NCT03479541|363531259|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
105416971|NCT03479541|363531256|FG000|Home Monitoring|Lost to Follow-up|0|||
105416972|NCT03479541|363531257|FG001|Home Monitoring|Lost to Follow-up|0|||
105416973|NCT03479541|363531258|FG002|Home Monitoring|Lost to Follow-up|8|||
105416974|NCT03479541|363531259|FG003|Home Monitoring|Lost to Follow-up|12|||
105416975|NCT03479541|363531256|FG000|Home Monitoring|Withdrawal by Subject|0|||
105416976|NCT03479541|363531257|FG001|Home Monitoring|Withdrawal by Subject|0|||
105416977|NCT03479541|363531258|FG002|Home Monitoring|Withdrawal by Subject|17|||
105416978|NCT03479541|363531259|FG003|Home Monitoring|Withdrawal by Subject|30|||
105416979|NCT03479541|363531256|FG000|Home Monitoring|Early Termination - PI Decision|0|||
105416980|NCT03479541|363531257|FG001|Home Monitoring|Early Termination - PI Decision|0|||
105416981|NCT03479541|363531258|FG002|Home Monitoring|Early Termination - PI Decision|4|||
105416982|NCT03479541|363531259|FG003|Home Monitoring|Early Termination - PI Decision|6|||
105416983|NCT00780143|363531261|FG000|Overall Study|Progressive disease|1|||
105416984|NCT00780143|363531261|FG000|Overall Study|Toxicity|1|||
105416985|NCT00780143|363531261|FG000|Overall Study|Adverse Event|1|||
105416986|NCT03559517|363531266|FG000|Overall Study|Withdrawal by Subject|1|||
105416987|NCT03559517|363531267|FG001|Overall Study|Withdrawal by Subject|0|||
105416988|NCT03559517|363531268|FG002|Overall Study|Withdrawal by Subject|0|||
105416989|NCT01846299|363531269|FG000|Overall Study|Physician Decision|4|||
105416990|NCT01846299|363531270|FG001|Overall Study|Physician Decision|2|||
105416991|NCT01846299|363531269|FG000|Overall Study|Protocol deviation|1|||
105416992|NCT01846299|363531270|FG001|Overall Study|Protocol deviation|0|||
105416993|NCT01846299|363531269|FG000|Overall Study|Death|1|||
105416994|NCT01846299|363531270|FG001|Overall Study|Death|2|||
105416995|NCT01846299|363531269|FG000|Overall Study|Lost to Follow-up|3|||
105416996|NCT01846299|363531270|FG001|Overall Study|Lost to Follow-up|0|||
105416997|NCT01846299|363531269|FG000|Overall Study|Withdrawal by Subject|1|||
105416998|NCT01846299|363531270|FG001|Overall Study|Withdrawal by Subject|6|||
105416999|NCT01846299|363531269|FG000|Overall Study|Adverse Event|2|||
105417000|NCT01846299|363531270|FG001|Overall Study|Adverse Event|0|||
105417001|NCT00107900|363531271|FG000|Overall Study|Adverse Event|3|||
105417002|NCT00107900|363531272|FG001|Overall Study|Adverse Event|2|||
105417003|NCT00107900|363531273|FG002|Overall Study|Adverse Event|10|||
105417004|NCT00107900|363531274|FG003|Overall Study|Adverse Event|3|||
105417005|NCT00107900|363531275|FG004|Overall Study|Adverse Event|5|||
105417006|NCT00107900|363531276|FG005|Overall Study|Adverse Event|3|||
105417007|NCT00107900|363531271|FG000|Overall Study|Death|0|||
105417008|NCT00107900|363531272|FG001|Overall Study|Death|0|||
105417009|NCT00107900|363531273|FG002|Overall Study|Death|0|||
105417010|NCT00107900|363531274|FG003|Overall Study|Death|0|||
105417011|NCT00107900|363531275|FG004|Overall Study|Death|1|||
105417012|NCT00107900|363531276|FG005|Overall Study|Death|0|||
105417013|NCT00107900|363531271|FG000|Overall Study|Lost to Follow-up|4|||
105417014|NCT00107900|363531272|FG001|Overall Study|Lost to Follow-up|1|||
105417015|NCT00107900|363531273|FG002|Overall Study|Lost to Follow-up|3|||
105417016|NCT00107900|363531274|FG003|Overall Study|Lost to Follow-up|2|||
105417017|NCT00107900|363531275|FG004|Overall Study|Lost to Follow-up|5|||
105417018|NCT00107900|363531276|FG005|Overall Study|Lost to Follow-up|5|||
105417019|NCT00107900|363531271|FG000|Overall Study|Protocol Violation|1|||
105417020|NCT00107900|363531272|FG001|Overall Study|Protocol Violation|0|||
105417021|NCT00107900|363531273|FG002|Overall Study|Protocol Violation|5|||
105417022|NCT00107900|363531274|FG003|Overall Study|Protocol Violation|5|||
105417023|NCT00107900|363531275|FG004|Overall Study|Protocol Violation|7|||
105417024|NCT00107900|363531276|FG005|Overall Study|Protocol Violation|0|||
105417025|NCT00107900|363531271|FG000|Overall Study|Withdrawal by Subject|1|||
105417026|NCT00107900|363531272|FG001|Overall Study|Withdrawal by Subject|0|||
105417027|NCT00107900|363531273|FG002|Overall Study|Withdrawal by Subject|5|||
105417028|NCT00107900|363531274|FG003|Overall Study|Withdrawal by Subject|0|||
105417029|NCT00107900|363531275|FG004|Overall Study|Withdrawal by Subject|1|||
105417030|NCT00107900|363531276|FG005|Overall Study|Withdrawal by Subject|1|||
105417031|NCT00107900|363531271|FG000|Overall Study|Administrative Reasons|1|||
105417032|NCT00107900|363531272|FG001|Overall Study|Administrative Reasons|0|||
105417033|NCT00107900|363531273|FG002|Overall Study|Administrative Reasons|2|||
105417034|NCT00107900|363531274|FG003|Overall Study|Administrative Reasons|2|||
105417035|NCT00107900|363531275|FG004|Overall Study|Administrative Reasons|2|||
105417036|NCT00107900|363531276|FG005|Overall Study|Administrative Reasons|0|||
105417037|NCT00082368|363531277|FG000|Overall Study|Not treated-pt had poor IV access|1|||
105417038|NCT04091581|363531280|FG000|Overall Study|Lost to Follow-up|0|||
105417039|NCT04091581|363531281|FG001|Overall Study|Lost to Follow-up|1|||
105417040|NCT01331837|363531282|FG000|Overall Study|Death|30|||
105417041|NCT01331837|363531283|FG001|Overall Study|Death|34|||
105417042|NCT01331837|363531282|FG000|Overall Study|Lost to Follow-up|3|||
105417043|NCT01331837|363531283|FG001|Overall Study|Lost to Follow-up|1|||
105417044|NCT01331837|363531282|FG000|Overall Study|Info not recorded|10|||
105417045|NCT01331837|363531283|FG001|Overall Study|Info not recorded|16|||
105417046|NCT01331837|363531282|FG000|Overall Study|Withdrawal by Subject|13|||
105417047|NCT01331837|363531283|FG001|Overall Study|Withdrawal by Subject|16|||
105417048|NCT02013206|363532753|FG000|Overall Study|Progressive disease (PD)|14|||
105417049|NCT02013206|363532754|FG001|Overall Study|Progressive disease (PD)|17|||
105417050|NCT02013206|363532753|FG000|Overall Study|Symptomatic deterioration|3|||
105417051|NCT02013206|363532754|FG001|Overall Study|Symptomatic deterioration|1|||
105417052|NCT02013206|363532753|FG000|Overall Study|Adverse Event|1|||
105417053|NCT02013206|363532754|FG001|Overall Study|Adverse Event|0|||
105417054|NCT02013206|363532753|FG000|Overall Study|Patient refusal|2|||
105417055|NCT02013206|363532754|FG001|Overall Study|Patient refusal|0|||
105417056|NCT02013206|363532753|FG000|Overall Study|Patient non-compliance|1|||
105417057|NCT02013206|363532754|FG001|Overall Study|Patient non-compliance|0|||
105417058|NCT02013206|363532753|FG000|Overall Study|Death|1|||
105417059|NCT02013206|363532754|FG001|Overall Study|Death|2|||
105417060|NCT02013206|363532753|FG000|Overall Study|Other reasons off treatment|5|||
105417061|NCT02013206|363532754|FG001|Overall Study|Other reasons off treatment|2|||
105417062|NCT05897242|363532762|FG000|Overall Study|Lost to Follow-up|6|||
105417063|NCT05897242|363532763|FG001|Overall Study|Lost to Follow-up|1|||
105417064|NCT05897242|363532762|FG000|Overall Study|Incomplete|1|||
105417065|NCT05897242|363532763|FG001|Overall Study|Incomplete|0|||
105417066|NCT05897242|363532762|FG000|Overall Study|Withdrawal by Subject|1|||
105417067|NCT05897242|363532763|FG001|Overall Study|Withdrawal by Subject|0|||
105417068|NCT05160415|363532764|FG000|Overall Study|Withdrawal by Subject|3|||
105417069|NCT01406938|363532765|FG000|Induction Period|Subject/guardian decision|6|||
105417070|NCT01406938|363532766|FG001|Induction Period|Subject/guardian decision|8|||
105417071|NCT01406938|363532767|FG002|Induction Period|Subject/guardian decision|0|||
105417072|NCT01406938|363532768|FG003|Induction Period|Subject/guardian decision|0|||
105417073|NCT01406938|363532769|FG004|Induction Period|Subject/guardian decision|0|||
105417074|NCT01406938|363532770|FG005|Induction Period|Subject/guardian decision|0|||
105417075|NCT01406938|363532765|FG000|Induction Period|Protocol deviation|1|||
105417076|NCT01406938|363532766|FG001|Induction Period|Protocol deviation|0|||
105417077|NCT01406938|363532767|FG002|Induction Period|Protocol deviation|0|||
105417078|NCT01406938|363532768|FG003|Induction Period|Protocol deviation|0|||
105417079|NCT01406938|363532769|FG004|Induction Period|Protocol deviation|0|||
105417080|NCT01406938|363532770|FG005|Induction Period|Protocol deviation|0|||
105417081|NCT01406938|363532765|FG000|Induction Period|Adverse Event|8|||
105417082|NCT01406938|363532766|FG001|Induction Period|Adverse Event|9|||
105417083|NCT01406938|363532767|FG002|Induction Period|Adverse Event|0|||
105417084|NCT01406938|363532768|FG003|Induction Period|Adverse Event|0|||
105417085|NCT01406938|363532769|FG004|Induction Period|Adverse Event|0|||
105417086|NCT01406938|363532770|FG005|Induction Period|Adverse Event|0|||
105417087|NCT01406938|363532765|FG000|Induction Period|Lack of Efficacy|1|||
105417088|NCT01406938|363532766|FG001|Induction Period|Lack of Efficacy|0|||
105417089|NCT01406938|363532767|FG002|Induction Period|Lack of Efficacy|0|||
105417090|NCT01406938|363532768|FG003|Induction Period|Lack of Efficacy|0|||
105417091|NCT01406938|363532769|FG004|Induction Period|Lack of Efficacy|0|||
105417092|NCT01406938|363532770|FG005|Induction Period|Lack of Efficacy|0|||
105417093|NCT01406938|363532765|FG000|Induction Period|Lost to Follow-up|2|||
105417094|NCT01406938|363532766|FG001|Induction Period|Lost to Follow-up|3|||
105417095|NCT01406938|363532767|FG002|Induction Period|Lost to Follow-up|0|||
105417096|NCT01406938|363532768|FG003|Induction Period|Lost to Follow-up|0|||
105417097|NCT01406938|363532769|FG004|Induction Period|Lost to Follow-up|0|||
105417098|NCT01406938|363532770|FG005|Induction Period|Lost to Follow-up|0|||
105417099|NCT01406938|363532765|FG000|Maintenance Period|Adverse Event|0|||
105417100|NCT01406938|363532766|FG001|Maintenance Period|Adverse Event|0|||
105417101|NCT01406938|363532767|FG002|Maintenance Period|Adverse Event|2|||
105417102|NCT01406938|363532768|FG003|Maintenance Period|Adverse Event|8|||
105417103|NCT01406938|363532769|FG004|Maintenance Period|Adverse Event|4|||
105417104|NCT01406938|363532770|FG005|Maintenance Period|Adverse Event|2|||
105417105|NCT01406938|363532765|FG000|Maintenance Period|Death|0|||
105417106|NCT01406938|363532766|FG001|Maintenance Period|Death|0|||
105417107|NCT01406938|363532767|FG002|Maintenance Period|Death|0|||
105417108|NCT01406938|363532768|FG003|Maintenance Period|Death|0|||
105417109|NCT01406938|363532769|FG004|Maintenance Period|Death|1|||
105417110|NCT01406938|363532770|FG005|Maintenance Period|Death|0|||
105417111|NCT01406938|363532765|FG000|Maintenance Period|Subject/guardian decision|0|||
105417112|NCT01406938|363532766|FG001|Maintenance Period|Subject/guardian decision|0|||
105417113|NCT01406938|363532767|FG002|Maintenance Period|Subject/guardian decision|11|||
105417114|NCT01406938|363532768|FG003|Maintenance Period|Subject/guardian decision|7|||
105417115|NCT01406938|363532769|FG004|Maintenance Period|Subject/guardian decision|10|||
105417116|NCT01406938|363532770|FG005|Maintenance Period|Subject/guardian decision|7|||
105417117|NCT01406938|363532765|FG000|Maintenance Period|Protocol Violation|0|||
105417118|NCT01406938|363532766|FG001|Maintenance Period|Protocol Violation|0|||
105417119|NCT01406938|363532767|FG002|Maintenance Period|Protocol Violation|2|||
105417120|NCT01406938|363532768|FG003|Maintenance Period|Protocol Violation|2|||
105417121|NCT01406938|363532769|FG004|Maintenance Period|Protocol Violation|2|||
105417122|NCT01406938|363532770|FG005|Maintenance Period|Protocol Violation|2|||
105417123|NCT01406938|363532765|FG000|Maintenance Period|Pregnancy|0|||
105417124|NCT01406938|363532766|FG001|Maintenance Period|Pregnancy|0|||
105417125|NCT01406938|363532767|FG002|Maintenance Period|Pregnancy|0|||
105417126|NCT01406938|363532768|FG003|Maintenance Period|Pregnancy|0|||
105417127|NCT01406938|363532769|FG004|Maintenance Period|Pregnancy|1|||
105417128|NCT01406938|363532770|FG005|Maintenance Period|Pregnancy|0|||
105417129|NCT01406938|363532765|FG000|Maintenance Period|Lost to Follow-up|0|||
105417130|NCT01406938|363532766|FG001|Maintenance Period|Lost to Follow-up|0|||
105417131|NCT01406938|363532767|FG002|Maintenance Period|Lost to Follow-up|0|||
105417132|NCT01406938|363532768|FG003|Maintenance Period|Lost to Follow-up|0|||
105417133|NCT01406938|363532769|FG004|Maintenance Period|Lost to Follow-up|4|||
105417134|NCT01406938|363532770|FG005|Maintenance Period|Lost to Follow-up|0|||
105417135|NCT01406938|363532765|FG000|Maintenance Period|Lack of Efficacy|0|||
105417136|NCT01406938|363532766|FG001|Maintenance Period|Lack of Efficacy|0|||
105417137|NCT01406938|363532767|FG002|Maintenance Period|Lack of Efficacy|2|||
105417138|NCT01406938|363532768|FG003|Maintenance Period|Lack of Efficacy|1|||
105417139|NCT01406938|363532769|FG004|Maintenance Period|Lack of Efficacy|3|||
105417140|NCT01406938|363532770|FG005|Maintenance Period|Lack of Efficacy|5|||
105417141|NCT01406938|363532765|FG000|Follow up|Lack of Efficacy|3|||
105417142|NCT01406938|363532766|FG001|Follow up|Lack of Efficacy|2|||
105417143|NCT01406938|363532767|FG002|Follow up|Lack of Efficacy|1|||
105417144|NCT01406938|363532768|FG003|Follow up|Lack of Efficacy|0|||
105417145|NCT01406938|363532769|FG004|Follow up|Lack of Efficacy|0|||
105417146|NCT01406938|363532770|FG005|Follow up|Lack of Efficacy|0|||
105417147|NCT01406938|363532765|FG000|Follow up|Patient/guardian decision|4|||
105417148|NCT01406938|363532766|FG001|Follow up|Patient/guardian decision|2|||
105417149|NCT01406938|363532767|FG002|Follow up|Patient/guardian decision|4|||
105417150|NCT01406938|363532768|FG003|Follow up|Patient/guardian decision|2|||
105417151|NCT01406938|363532769|FG004|Follow up|Patient/guardian decision|4|||
105417152|NCT01406938|363532770|FG005|Follow up|Patient/guardian decision|1|||
105417153|NCT01406938|363532765|FG000|Follow up|Protocol Violation|0|||
105417154|NCT01406938|363532766|FG001|Follow up|Protocol Violation|0|||
105417155|NCT01406938|363532767|FG002|Follow up|Protocol Violation|1|||
105417156|NCT01406938|363532768|FG003|Follow up|Protocol Violation|0|||
105417157|NCT01406938|363532769|FG004|Follow up|Protocol Violation|0|||
105417158|NCT01406938|363532770|FG005|Follow up|Protocol Violation|0|||
105417159|NCT01406938|363532765|FG000|Follow up|Physician Decision|0|||
105417160|NCT01406938|363532766|FG001|Follow up|Physician Decision|0|||
105417161|NCT01406938|363532767|FG002|Follow up|Physician Decision|2|||
105417162|NCT01406938|363532768|FG003|Follow up|Physician Decision|0|||
105417163|NCT01406938|363532769|FG004|Follow up|Physician Decision|3|||
105417164|NCT01406938|363532770|FG005|Follow up|Physician Decision|1|||
105417165|NCT01406938|363532765|FG000|Follow up|Lost to Follow-up|1|||
105417166|NCT01406938|363532766|FG001|Follow up|Lost to Follow-up|1|||
105417167|NCT01406938|363532767|FG002|Follow up|Lost to Follow-up|0|||
105498924|NCT00825682|363838780|FG000|Overall Study|personal reasons/ inconvenience|13|||
105498925|NCT00825682|363838781|FG001|Overall Study|personal reasons/ inconvenience|5|||
105498926|NCT00866788|363838782|FG000|Overall Study|Adverse Event|0|||
105498927|NCT00866788|363838783|FG001|Overall Study|Adverse Event|2|||
105498928|NCT00866788|363838784|FG002|Overall Study|Adverse Event|0|||
105498929|NCT00866788|363838785|FG003|Overall Study|Adverse Event|1|||
105498930|NCT00866788|363838782|FG000|Overall Study|Lost to Follow-up|1|||
105498931|NCT00866788|363838783|FG001|Overall Study|Lost to Follow-up|1|||
105498932|NCT00866788|363838784|FG002|Overall Study|Lost to Follow-up|0|||
105498933|NCT00866788|363838785|FG003|Overall Study|Lost to Follow-up|2|||
105498934|NCT00866788|363838782|FG000|Overall Study|Withdrawal by Subject|2|||
105498935|NCT00866788|363838783|FG001|Overall Study|Withdrawal by Subject|1|||
105498936|NCT00866788|363838784|FG002|Overall Study|Withdrawal by Subject|0|||
105498937|NCT00866788|363838785|FG003|Overall Study|Withdrawal by Subject|1|||
105498938|NCT00866788|363838782|FG000|Overall Study|Pregnancy|0|||
105498939|NCT00866788|363838783|FG001|Overall Study|Pregnancy|1|||
105498940|NCT00866788|363838784|FG002|Overall Study|Pregnancy|0|||
105498941|NCT00866788|363838785|FG003|Overall Study|Pregnancy|0|||
105498942|NCT00866788|363838782|FG000|Overall Study|Disease progression|3|||
105498943|NCT00866788|363838783|FG001|Overall Study|Disease progression|1|||
105498944|NCT00866788|363838784|FG002|Overall Study|Disease progression|1|||
105498945|NCT00866788|363838785|FG003|Overall Study|Disease progression|0|||
105498946|NCT00866788|363838782|FG000|Overall Study|Physician Decision|0|||
105498947|NCT00866788|363838783|FG001|Overall Study|Physician Decision|0|||
105498948|NCT00866788|363838784|FG002|Overall Study|Physician Decision|1|||
105498949|NCT00866788|363838785|FG003|Overall Study|Physician Decision|1|||
105498950|NCT00316719|363838786|FG000|Overall Study|Adverse Event|0|||
105498951|NCT00316719|363838787|FG001|Overall Study|Adverse Event|6|||
105498952|NCT00316719|363838786|FG000|Overall Study|Consent withdrawn|2|||
105498953|NCT00316719|363838787|FG001|Overall Study|Consent withdrawn|0|||
105498954|NCT05439941|363838791|FG000|Overall Study|Lack of Efficacy|8|||
105498955|NCT05439941|363838792|FG001|Overall Study|Lack of Efficacy|5|||
105498956|NCT05439941|363838793|FG002|Overall Study|Lack of Efficacy|3|||
105498957|NCT05439941|363838791|FG000|Overall Study|Treatment Failure|0|||
105498958|NCT05439941|363838792|FG001|Overall Study|Treatment Failure|1|||
105498959|NCT05439941|363838793|FG002|Overall Study|Treatment Failure|0|||
105498960|NCT05439941|363838791|FG000|Overall Study|Adverse Event|1|||
105498961|NCT05439941|363838792|FG001|Overall Study|Adverse Event|3|||
105498962|NCT05439941|363838793|FG002|Overall Study|Adverse Event|0|||
105498963|NCT05439941|363838791|FG000|Overall Study|Adverse Event - Parent Study|1|||
105498964|NCT05439941|363838792|FG001|Overall Study|Adverse Event - Parent Study|0|||
105498965|NCT05439941|363838793|FG002|Overall Study|Adverse Event - Parent Study|0|||
105498966|NCT05439941|363838791|FG000|Overall Study|Pregnancy|1|||
105498967|NCT05439941|363838792|FG001|Overall Study|Pregnancy|0|||
105498968|NCT05439941|363838793|FG002|Overall Study|Pregnancy|0|||
105498969|NCT05439941|363838791|FG000|Overall Study|Withdrawal by Subject|9|||
105498970|NCT05439941|363838792|FG001|Overall Study|Withdrawal by Subject|6|||
105498971|NCT05439941|363838793|FG002|Overall Study|Withdrawal by Subject|10|||
105498972|NCT05439941|363838791|FG000|Overall Study|Non-Compliance|1|||
105498973|NCT05439941|363838792|FG001|Overall Study|Non-Compliance|1|||
105498974|NCT05439941|363838793|FG002|Overall Study|Non-Compliance|1|||
105498975|NCT05439941|363838791|FG000|Overall Study|Lost to Follow-up|2|||
105498976|NCT05439941|363838792|FG001|Overall Study|Lost to Follow-up|2|||
105498977|NCT05439941|363838793|FG002|Overall Study|Lost to Follow-up|0|||
105498978|NCT05439941|363838791|FG000|Overall Study|Physician Decision|1|||
105498979|NCT05439941|363838792|FG001|Overall Study|Physician Decision|0|||
105498980|NCT05439941|363838793|FG002|Overall Study|Physician Decision|0|||
105498981|NCT05439941|363838791|FG000|Overall Study|Trial Termination by Sponsor|78|||
105498982|NCT05439941|363838792|FG001|Overall Study|Trial Termination by Sponsor|83|||
105498983|NCT05439941|363838793|FG002|Overall Study|Trial Termination by Sponsor|65|||
105498984|NCT05439941|363838791|FG000|Overall Study|Other than Reasons Listed|2|||
105498985|NCT05439941|363838792|FG001|Overall Study|Other than Reasons Listed|1|||
105498986|NCT05439941|363838793|FG002|Overall Study|Other than Reasons Listed|0|||
105498987|NCT00231842|363838794|FG000|Overall Study|Withdrawal by Subject|3|||
105498988|NCT00231842|363838794|FG000|Overall Study|Did not complete the last 3 cycle|8|||
105498989|NCT02422303|363838795|FG000|Overall Study|Lost to Follow-up|1|||
105498990|NCT02422303|363838796|FG001|Overall Study|Lost to Follow-up|1|||
105498991|NCT02899299|363838797|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
105498992|NCT02899299|363838798|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
105498993|NCT02899299|363838797|FG000|Pre-treatment|Participant withdrew consent|1|||
105498994|NCT02899299|363838798|FG001|Pre-treatment|Participant withdrew consent|11|||
105498995|NCT02899299|363838797|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
105498996|NCT02899299|363838798|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
105498997|NCT02899299|363838797|FG000|Pre-treatment|Not reported|0|||
105498998|NCT02899299|363838798|FG001|Pre-treatment|Not reported|1|||
105498999|NCT02899299|363838797|FG000|Treatment|Disease Progression|182|||
105499000|NCT02899299|363838798|FG001|Treatment|Disease Progression|43|||
105499001|NCT02899299|363838797|FG000|Treatment|Study Drug Toxicity|60|||
105583844|NCT00097370|364135338|FG000|Stage 1|Adverse Event|3|||
105417168|NCT01406938|363532768|FG003|Follow up|Lost to Follow-up|1|||
105417169|NCT01406938|363532769|FG004|Follow up|Lost to Follow-up|2|||
105417170|NCT01406938|363532770|FG005|Follow up|Lost to Follow-up|1|||
105417171|NCT00962741|363532772|FG000|Overall Study|Failed to return|3|||
105417172|NCT00962741|363532772|FG000|Overall Study|Lost to Follow-up|2|||
105417173|NCT00962741|363532772|FG000|Overall Study|Withdrawal by Subject|1|||
105417174|NCT00962741|363532772|FG000|Overall Study|Lack of Efficacy|1|||
105417175|NCT00962741|363532772|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
105417176|NCT03576066|363532775|FG000|Overall Study|Noncompliance with study drug|0|||
105417177|NCT03576066|363532776|FG001|Overall Study|Noncompliance with study drug|1|||
105417178|NCT00365105|363532777|FG000|Overall Study|Protocol Violation|5|||
105417179|NCT00365105|363532778|FG001|Overall Study|Protocol Violation|8|||
105417180|NCT05260073|363532779|FG000|Overall Study|Physician Decision|1|||
105417181|NCT05260073|363532779|FG000|Overall Study|Withdrawal by Subject|6|||
105417182|NCT05260073|363532779|FG000|Overall Study|Lost to Follow-up|14|||
105417183|NCT01843673|363532780|FG000|Overall Study|Lack of Efficacy|2|||
105417184|NCT01843673|363532780|FG000|Overall Study|Withdrawal by Subject|4|||
105417185|NCT00425698|363532781|FG000|Overall Study|Adverse Event|3|||
105417186|NCT00425698|363532782|FG001|Overall Study|Adverse Event|1|||
105417187|NCT00425698|363532781|FG000|Overall Study|Withdrawal by Subject|0|||
105417188|NCT00425698|363532782|FG001|Overall Study|Withdrawal by Subject|1|||
105417189|NCT02570152|363532785|FG000|Overall Study|Protocol Violation|2|||
105417190|NCT02570152|363532785|FG000|Overall Study|Migrated/moved from study area|13|||
105417191|NCT00960011|363532786|FG000|Overall Study|Death|5|||
105417192|NCT00960011|363532787|FG001|Overall Study|Death|0|||
105417193|NCT00960011|363532786|FG000|Overall Study|Lost to Follow-up|6|||
105417194|NCT00960011|363532787|FG001|Overall Study|Lost to Follow-up|2|||
105417195|NCT00313313|363532788|FG000|Overall Study|Lack of Efficacy|14|||
105417196|NCT00313313|363532789|FG001|Overall Study|Lack of Efficacy|9|||
105417197|NCT00313313|363532790|FG002|Overall Study|Lack of Efficacy|20|||
105417198|NCT00313313|363532788|FG000|Overall Study|Withdrawal of consent by subject|18|||
105417199|NCT00313313|363532789|FG001|Overall Study|Withdrawal of consent by subject|17|||
105417200|NCT00313313|363532790|FG002|Overall Study|Withdrawal of consent by subject|31|||
105417201|NCT00313313|363532788|FG000|Overall Study|Lost to Follow-up|10|||
105499002|NCT02899299|363838798|FG001|Treatment|Study Drug Toxicity|24|||
105499003|NCT02899299|363838797|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
105499004|NCT02899299|363838798|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
105499005|NCT02899299|363838797|FG000|Treatment|Participant request to discontinue Study treatment|4|||
105499006|NCT02899299|363838798|FG001|Treatment|Participant request to discontinue Study treatment|10|||
105499007|NCT02899299|363838797|FG000|Treatment|Participant withdrew consent|6|||
105499008|NCT02899299|363838798|FG001|Treatment|Participant withdrew consent|3|||
105499009|NCT02899299|363838797|FG000|Treatment|Lost to Follow-up|0|||
105499010|NCT02899299|363838798|FG001|Treatment|Lost to Follow-up|2|||
105499011|NCT02899299|363838797|FG000|Treatment|Maximum Clinical Benefit|11|||
105499012|NCT02899299|363838798|FG001|Treatment|Maximum Clinical Benefit|2|||
105499013|NCT02899299|363838797|FG000|Treatment|Poor/Non-compliance|1|||
105499014|NCT02899299|363838798|FG001|Treatment|Poor/Non-compliance|0|||
105499015|NCT02899299|363838797|FG000|Treatment|Participant no longer meets Study criteria|4|||
105499016|NCT02899299|363838798|FG001|Treatment|Participant no longer meets Study criteria|0|||
105499017|NCT02899299|363838797|FG000|Treatment|Administrative reason by Sponsor|2|||
105499018|NCT02899299|363838798|FG001|Treatment|Administrative reason by Sponsor|0|||
105499019|NCT02899299|363838797|FG000|Treatment|Other reasons|12|||
105499020|NCT02899299|363838798|FG001|Treatment|Other reasons|2|||
105499021|NCT02899299|363838797|FG000|Treatment|Not reported|7|||
105499022|NCT02899299|363838798|FG001|Treatment|Not reported|0|||
105499023|NCT02336373|363838802|FG000|Overall Study|Protocol closed early|4|||
105499024|NCT02336373|363838802|FG000|Overall Study|Physician Decision|14|||
105583845|NCT00097370|364135338|FG000|Stage 1|Withdrawal by Subject|1|||
105583846|NCT00097370|364135338|FG000|Stage 1|Lack of Efficacy|2|||
105583847|NCT00097370|364135338|FG000|Stage 2|Adverse Event|5|||
105583848|NCT00097370|364135338|FG000|Stage 2|Withdrawal by Subject|1|||
105417202|NCT00313313|363532789|FG001|Overall Study|Lost to Follow-up|7|||
105417203|NCT00313313|363532790|FG002|Overall Study|Lost to Follow-up|9|||
105417204|NCT00313313|363532788|FG000|Overall Study|Adverse Event|15|||
105417205|NCT00313313|363532789|FG001|Overall Study|Adverse Event|16|||
105417206|NCT00313313|363532790|FG002|Overall Study|Adverse Event|12|||
105417207|NCT00313313|363532788|FG000|Overall Study|Physician Decision|2|||
105417208|NCT00313313|363532789|FG001|Overall Study|Physician Decision|6|||
105417209|NCT00313313|363532790|FG002|Overall Study|Physician Decision|4|||
105417210|NCT00313313|363532788|FG000|Overall Study|Poor/Noncompliance|3|||
105417211|NCT00313313|363532789|FG001|Overall Study|Poor/Noncompliance|6|||
105499025|NCT03689530|363838805|FG000|Overall Study|Withdrawal by Subject|53|||
105499026|NCT03689530|363838806|FG001|Overall Study|Withdrawal by Subject|16|||
105499027|NCT01392443|363838808|FG000|Overall Study|Disease progression|30|||
105499028|NCT01392443|363838808|FG000|Overall Study|Adverse Event|24|||
105499029|NCT01392443|363838808|FG000|Overall Study|Death|7|||
105417212|NCT00313313|363532790|FG002|Overall Study|Poor/Noncompliance|2|||
105417213|NCT00313313|363532788|FG000|Overall Study|Pregnancy|1|||
105417214|NCT00313313|363532789|FG001|Overall Study|Pregnancy|2|||
105417215|NCT00313313|363532790|FG002|Overall Study|Pregnancy|0|||
105417216|NCT00313313|363532788|FG000|Overall Study|Death|0|||
105417217|NCT00313313|363532789|FG001|Overall Study|Death|0|||
105417218|NCT00313313|363532790|FG002|Overall Study|Death|2|||
105417219|NCT00313313|363532788|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
105417220|NCT00313313|363532789|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
105417221|NCT00313313|363532790|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
105417222|NCT01126268|363532793|FG000|Overall Study|Adverse Event|1|||
105417223|NCT01205061|363532794|FG000|Overall Study|Adverse Event|4|||
105417224|NCT01205061|363532794|FG000|Overall Study|Withdrawal by Subject|11|||
105417225|NCT01205061|363532794|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
105417226|NCT01205061|363532794|FG000|Overall Study|Lost to Follow-up|9|||
105417227|NCT01205061|363532794|FG000|Overall Study|Other|1|||
105417228|NCT00765037|363532795|FG000|Overall Study|Lost to Follow-up|5|||
105417229|NCT00765037|363532795|FG000|Overall Study|Adverse Event|1|||
105417230|NCT04026009|363532800|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105417231|NCT04026009|363532801|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105417232|NCT04026009|363532802|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
105417233|NCT04026009|363532803|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
105417234|NCT04026009|363532804|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
105417235|NCT04026009|363532800|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
105417236|NCT04026009|363532801|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
105417237|NCT04026009|363532802|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
105417238|NCT04026009|363532803|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
105417239|NCT04026009|363532804|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
105417240|NCT01988662|363532805|FG000|Overall Study|Subject/guardian decision|1|||
105417241|NCT01988662|363532806|FG001|Overall Study|Subject/guardian decision|1|||
105417242|NCT01988662|363532805|FG000|Overall Study|Adverse Event|3|||
105417243|NCT01988662|363532806|FG001|Overall Study|Adverse Event|1|||
105417244|NCT01177553|363532807|FG000|Overall Study|babies not yet 6 months of age|1|||
105417245|NCT01177553|363532808|FG001|Overall Study|babies not yet 6 months of age|0|||
105417246|NCT04752566|363532821|FG000|Overall Study|Protocol Violation|0|||
105417247|NCT04752566|363532822|FG001|Overall Study|Protocol Violation|1|||
105417248|NCT04752566|363532821|FG000|Overall Study|Death|1|||
105417249|NCT04752566|363532822|FG001|Overall Study|Death|0|||
105417250|NCT04752566|363532821|FG000|Overall Study|Adverse Event|1|||
105417251|NCT04752566|363532822|FG001|Overall Study|Adverse Event|0|||
105417252|NCT04752566|363532821|FG000|Overall Study|Withdrawal by Subject|2|||
105417253|NCT04752566|363532822|FG001|Overall Study|Withdrawal by Subject|0|||
105417254|NCT04752566|363532821|FG000|Overall Study|Physician Decision|1|||
105417255|NCT04752566|363532822|FG001|Overall Study|Physician Decision|1|||
105417256|NCT01126437|363532823|FG000|Overall Study|Not treated|11|||
105417257|NCT01126437|363532824|FG001|Overall Study|Not treated|18|||
105417258|NCT01126437|363532825|FG002|Overall Study|Not treated|19|||
105417259|NCT01126437|363532823|FG000|Overall Study|Sites with data irregularities/fraud|6|||
105417260|NCT01126437|363532824|FG001|Overall Study|Sites with data irregularities/fraud|6|||
105417261|NCT01126437|363532825|FG002|Overall Study|Sites with data irregularities/fraud|7|||
105417262|NCT01126437|363532823|FG000|Overall Study|Adverse Event|602|||
105417263|NCT01126437|363532824|FG001|Overall Study|Adverse Event|606|||
105417264|NCT01126437|363532825|FG002|Overall Study|Adverse Event|635|||
105417265|NCT01126437|363532823|FG000|Overall Study|Lack of Efficacy|65|||
105417266|NCT01126437|363532824|FG001|Overall Study|Lack of Efficacy|60|||
105417267|NCT01126437|363532825|FG002|Overall Study|Lack of Efficacy|59|||
105417268|NCT01126437|363532823|FG000|Overall Study|Protocol Violation|64|||
105417269|NCT01126437|363532824|FG001|Overall Study|Protocol Violation|66|||
105499030|NCT01392443|363838808|FG000|Overall Study|Withdrawal by Subject|5|||
105499031|NCT01392443|363838808|FG000|Overall Study|Lost to Follow-up|1|||
105499032|NCT01392443|363838808|FG000|Overall Study|Protocol Violation|1|||
105499033|NCT01977794|363838809|FG000|Overall Study|Adverse Event|2|||
105417270|NCT01126437|363532825|FG002|Overall Study|Protocol Violation|41|||
105417271|NCT01126437|363532823|FG000|Overall Study|Lost to Follow-up|52|||
105417272|NCT01126437|363532824|FG001|Overall Study|Lost to Follow-up|63|||
105417273|NCT01126437|363532825|FG002|Overall Study|Lost to Follow-up|55|||
105417274|NCT01126437|363532823|FG000|Overall Study|Withdrawal by Subject|331|||
105417275|NCT01126437|363532824|FG001|Overall Study|Withdrawal by Subject|335|||
105417276|NCT01126437|363532825|FG002|Overall Study|Withdrawal by Subject|319|||
105417277|NCT01126437|363532823|FG000|Overall Study|Other reason not specified|210|||
105417278|NCT01126437|363532824|FG001|Overall Study|Other reason not specified|176|||
105417279|NCT01126437|363532825|FG002|Overall Study|Other reason not specified|178|||
105417280|NCT03931382|363532826|FG000|Overall Study|Equipment malfunction|2|||
105417281|NCT03931382|363532827|FG001|Overall Study|Equipment malfunction|0|||
105417282|NCT03931382|363532828|FG002|Overall Study|Equipment malfunction|2|||
105499034|NCT01977794|363838810|FG001|Overall Study|Adverse Event|2|||
105499035|NCT01977794|363838809|FG000|Overall Study|Lost to Follow-up|2|||
105499036|NCT01977794|363838810|FG001|Overall Study|Lost to Follow-up|1|||
105499037|NCT01977794|363838809|FG000|Overall Study|Protocol Violation|1|||
105499038|NCT01977794|363838810|FG001|Overall Study|Protocol Violation|0|||
105499039|NCT01977794|363838809|FG000|Overall Study|Death|1|||
105499040|NCT01977794|363838810|FG001|Overall Study|Death|1|||
105499041|NCT01977794|363838809|FG000|Overall Study|Withdrew consent|2|||
105499042|NCT01977794|363838810|FG001|Overall Study|Withdrew consent|1|||
105499043|NCT01977794|363838809|FG000|Overall Study|Other|0|||
105499044|NCT01977794|363838810|FG001|Overall Study|Other|1|||
105499045|NCT02758171|363838816|FG000|Wash-out|Withdrawal by Subject|1|||
105499046|NCT02758171|363838817|FG001|Wash-out|Withdrawal by Subject|0|||
105499047|NCT02758171|363838816|FG000|Wash-out|Other reason|1|||
105499048|NCT02758171|363838817|FG001|Wash-out|Other reason|0|||
105499049|NCT01999114|363838818|FG000|Overall Study|Adverse Event|8|||
105499050|NCT01999114|363838819|FG001|Overall Study|Adverse Event|7|||
105499051|NCT01999114|363838820|FG002|Overall Study|Adverse Event|2|||
105499052|NCT01999114|363838821|FG003|Overall Study|Adverse Event|2|||
105499053|NCT01999114|363838822|FG004|Overall Study|Adverse Event|1|||
105499054|NCT01999114|363838818|FG000|Overall Study|Withdrawal by Subject|0|||
105499055|NCT01999114|363838819|FG001|Overall Study|Withdrawal by Subject|0|||
105499056|NCT01999114|363838820|FG002|Overall Study|Withdrawal by Subject|1|||
105499057|NCT01999114|363838821|FG003|Overall Study|Withdrawal by Subject|0|||
105499058|NCT01999114|363838822|FG004|Overall Study|Withdrawal by Subject|1|||
105499059|NCT01999114|363838818|FG000|Overall Study|Lost to Follow-up|0|||
105499060|NCT01999114|363838819|FG001|Overall Study|Lost to Follow-up|0|||
105499061|NCT01999114|363838820|FG002|Overall Study|Lost to Follow-up|1|||
105499062|NCT01999114|363838821|FG003|Overall Study|Lost to Follow-up|0|||
105499063|NCT01999114|363838822|FG004|Overall Study|Lost to Follow-up|0|||
105499064|NCT01999114|363838818|FG000|Overall Study|Administrative|0|||
105499065|NCT01999114|363838819|FG001|Overall Study|Administrative|0|||
105499066|NCT01999114|363838820|FG002|Overall Study|Administrative|1|||
105499067|NCT01999114|363838821|FG003|Overall Study|Administrative|1|||
105499068|NCT01999114|363838822|FG004|Overall Study|Administrative|2|||
105499069|NCT02248701|363838823|FG000|Overall Study|Withdrawal by Subject|2|||
105499070|NCT02248701|363838824|FG001|Overall Study|Withdrawal by Subject|1|||
105499071|NCT02248701|363838823|FG000|Overall Study|Physician Decision|0|||
105499072|NCT02248701|363838824|FG001|Overall Study|Physician Decision|1|||
105499073|NCT02248701|363838823|FG000|Overall Study|Adverse Event|1|||
105499074|NCT02248701|363838824|FG001|Overall Study|Adverse Event|0|||
105499075|NCT02248701|363838823|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
105499076|NCT02248701|363838824|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
105499077|NCT05085730|363838825|FG000|Overall Study|Withdrawal by Subject|4|||
105499078|NCT05085730|363838825|FG000|Overall Study|Physician Decision|1|||
105499079|NCT02038881|363838826|FG000|Overall Study|Withdrawal by Subject|0|||
105499080|NCT02038881|363838827|FG001|Overall Study|Withdrawal by Subject|0|||
105499081|NCT02038881|363838828|FG002|Overall Study|Withdrawal by Subject|1|||
105499082|NCT02038881|363838826|FG000|Overall Study|Lost to Follow-up|2|||
105499083|NCT02038881|363838827|FG001|Overall Study|Lost to Follow-up|0|||
105499084|NCT02038881|363838828|FG002|Overall Study|Lost to Follow-up|0|||
105499085|NCT02038881|363838826|FG000|Overall Study|incarcerated|1|||
105499086|NCT02038881|363838827|FG001|Overall Study|incarcerated|0|||
105499087|NCT02038881|363838828|FG002|Overall Study|incarcerated|0|||
105499088|NCT00333840|363838829|FG000|First-line Treatment Period|Adverse Event|38|||
105499089|NCT00333840|363838830|FG001|First-line Treatment Period|Adverse Event|37|||
105499090|NCT00333840|363838831|FG002|First-line Treatment Period|Adverse Event|0|||
105499091|NCT00333840|363838832|FG003|First-line Treatment Period|Adverse Event|0|||
105499092|NCT00333840|363838829|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
105499093|NCT00333840|363838830|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
105499094|NCT00333840|363838831|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
105499095|NCT00333840|363838832|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
105499096|NCT00333840|363838829|FG000|First-line Treatment Period|Abnormal procedure|2|||
105499097|NCT00333840|363838830|FG001|First-line Treatment Period|Abnormal procedure|0|||
105583849|NCT00097370|364135338|FG000|Stage 2|Lack of Efficacy|3|||
105583850|NCT00097370|364135338|FG000|Stage 2|Pregnancy|1|||
105583851|NCT00097370|364135338|FG000|Stage 2|Sponsor Terminated Study|2|||
105583852|NCT00097370|364135338|FG000|Stage 2|Lost to Follow-up|1|||
105499098|NCT00333840|363838831|FG002|First-line Treatment Period|Abnormal procedure|0|||
105583853|NCT00097370|364135338|FG000|Stage 3|Adverse Event|2|||
105499099|NCT00333840|363838832|FG003|First-line Treatment Period|Abnormal procedure|0|||
105499100|NCT00333840|363838829|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
105499101|NCT00333840|363838830|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
105499102|NCT00333840|363838831|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
105499103|NCT00333840|363838832|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
105499104|NCT00333840|363838829|FG000|First-line Treatment Period|No longer required study drug|21|||
105499105|NCT00333840|363838830|FG001|First-line Treatment Period|No longer required study drug|8|||
105583854|NCT00097370|364135338|FG000|Stage 3|Withdrawal by Subject|3|||
105417283|NCT03931382|363532826|FG000|Overall Study|Withdrawal by Subject|0|||
105417284|NCT03931382|363532827|FG001|Overall Study|Withdrawal by Subject|1|||
105417285|NCT03931382|363532828|FG002|Overall Study|Withdrawal by Subject|0|||
105417286|NCT02487654|363532831|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
105417287|NCT02487654|363532832|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
105417288|NCT02487654|363532831|FG000|Overall Study|Withdrawal by Subject|3|||
105417289|NCT02487654|363532832|FG001|Overall Study|Withdrawal by Subject|7|||
105417290|NCT06359028|363532833|FG000|Overall Study|Adverse Event|1|||
105417291|NCT06359028|363532834|FG001|Overall Study|Adverse Event|0|||
105417292|NCT06359028|363532833|FG000|Overall Study|Withdrawal by Subject|1|||
105417293|NCT06359028|363532834|FG001|Overall Study|Withdrawal by Subject|0|||
105417294|NCT00920387|363532837|FG000|Stage 1|Adverse Event|1|||
105417295|NCT00920387|363532838|FG001|Stage 1|Adverse Event|0|||
105417296|NCT00920387|363532839|FG002|Stage 1|Adverse Event|0|||
105417297|NCT06099223|363532841|FG000|Overall Study|Preoperative surveys missed|0|||
105417298|NCT06099223|363532842|FG001|Overall Study|Preoperative surveys missed|1|||
105417299|NCT02791516|363532843|FG000|Overall Study|Withdrawal by Subject|1|||
105417300|NCT02791516|363532844|FG001|Overall Study|Withdrawal by Subject|1|||
105417301|NCT01439971|363532845|FG000|Overall Study|Required number in cohort dosed|0|||
105417302|NCT01439971|363532846|FG001|Overall Study|Required number in cohort dosed|1|||
105417303|NCT01439971|363532847|FG002|Overall Study|Required number in cohort dosed|2|||
105499106|NCT00333840|363838831|FG002|First-line Treatment Period|No longer required study drug|0|||
105499107|NCT00333840|363838832|FG003|First-line Treatment Period|No longer required study drug|0|||
105499108|NCT00333840|363838829|FG000|First-line Treatment Period|Protocol Violation|17|||
105499109|NCT00333840|363838830|FG001|First-line Treatment Period|Protocol Violation|17|||
105499110|NCT00333840|363838831|FG002|First-line Treatment Period|Protocol Violation|0|||
105499111|NCT00333840|363838832|FG003|First-line Treatment Period|Protocol Violation|0|||
105499112|NCT00333840|363838829|FG000|First-line Treatment Period|Subject withdrew consent|57|||
105499113|NCT00333840|363838830|FG001|First-line Treatment Period|Subject withdrew consent|77|||
105499114|NCT00333840|363838831|FG002|First-line Treatment Period|Subject withdrew consent|0|||
105499115|NCT00333840|363838832|FG003|First-line Treatment Period|Subject withdrew consent|0|||
105499116|NCT00333840|363838829|FG000|First-line Treatment Period|Lost to Follow-up|15|||
105499117|NCT00333840|363838830|FG001|First-line Treatment Period|Lost to Follow-up|6|||
105499118|NCT00333840|363838831|FG002|First-line Treatment Period|Lost to Follow-up|0|||
105499119|NCT00333840|363838832|FG003|First-line Treatment Period|Lost to Follow-up|0|||
105499120|NCT00333840|363838829|FG000|First-line Treatment Period|Administrative problems|12|||
105499121|NCT00333840|363838830|FG001|First-line Treatment Period|Administrative problems|6|||
105499122|NCT00333840|363838831|FG002|First-line Treatment Period|Administrative problems|0|||
105499123|NCT00333840|363838832|FG003|First-line Treatment Period|Administrative problems|0|||
105499124|NCT00333840|363838829|FG000|First-line Treatment Period|Death|19|||
105499125|NCT00333840|363838830|FG001|First-line Treatment Period|Death|2|||
105499126|NCT00333840|363838831|FG002|First-line Treatment Period|Death|0|||
105499127|NCT00333840|363838832|FG003|First-line Treatment Period|Death|0|||
105499128|NCT00333840|363838829|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
105499129|NCT00333840|363838830|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
105499130|NCT00333840|363838831|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
105499131|NCT00333840|363838832|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
105499132|NCT00333840|363838829|FG000|Second-line Treatment Period|Adverse Event|0|||
105499133|NCT00333840|363838830|FG001|Second-line Treatment Period|Adverse Event|0|||
105499134|NCT00333840|363838831|FG002|Second-line Treatment Period|Adverse Event|3|||
105499135|NCT00333840|363838832|FG003|Second-line Treatment Period|Adverse Event|34|||
105499136|NCT00333840|363838829|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
105499137|NCT00333840|363838830|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
105499138|NCT00333840|363838831|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
105499139|NCT00333840|363838832|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
105499140|NCT00333840|363838829|FG000|Second-line Treatment Period|Abnormal procedure|0|||
105499141|NCT00333840|363838830|FG001|Second-line Treatment Period|Abnormal procedure|0|||
105499142|NCT00333840|363838831|FG002|Second-line Treatment Period|Abnormal procedure|0|||
105499143|NCT00333840|363838832|FG003|Second-line Treatment Period|Abnormal procedure|1|||
105499144|NCT00333840|363838829|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
105499145|NCT00333840|363838830|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
105499146|NCT00333840|363838831|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
105499147|NCT00333840|363838832|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
105417304|NCT01439971|363532848|FG003|Overall Study|Required number in cohort dosed|0|||
105417305|NCT01439971|363532849|FG004|Overall Study|Required number in cohort dosed|1|||
105417306|NCT00661726|363532858|FG000|Overall Study|Adverse Event|1|||
105417307|NCT02461290|363532859|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
105417308|NCT02461290|363532859|FG000|Overall Study|Lost to Follow-up|3|||
105417309|NCT00526656|363532860|FG000|Overall Study|Death|1|||
105417310|NCT00526656|363532860|FG000|Overall Study|Refused surgery|1|||
105417311|NCT03315793|363532862|FG000|Overall Study|Adverse Event|4|||
105417312|NCT03315793|363532863|FG001|Overall Study|Adverse Event|2|||
105417313|NCT03315793|363532862|FG000|Overall Study|Protocol Deviation|1|||
105417314|NCT03315793|363532863|FG001|Overall Study|Protocol Deviation|0|||
105417315|NCT03315793|363532862|FG000|Overall Study|Difficult for regular visit|0|||
105417316|NCT03315793|363532863|FG001|Overall Study|Difficult for regular visit|1|||
105417317|NCT03724981|363534656|FG000|First Device|Protocol Violation|1|||
105417318|NCT03724981|363534657|FG001|First Device|Protocol Violation|1|||
105417319|NCT01631747|363534658|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
105417320|NCT01631747|363534659|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
105417321|NCT01631747|363534658|FG000|Live Birth|Pregnancy Termination|1|||
105417322|NCT01631747|363534659|FG001|Live Birth|Pregnancy Termination|0|||
105417323|NCT01631747|363534658|FG000|Live Birth|MIscarriage|2|||
105417324|NCT01631747|363534659|FG001|Live Birth|MIscarriage|0|||
105417325|NCT01631747|363534658|FG000|Live Birth|Stillbirth|1|||
105417326|NCT01631747|363534659|FG001|Live Birth|Stillbirth|1|||
105417327|NCT01631747|363534658|FG000|One Year Infant Outcomes|Patient Refused|13|||
105417328|NCT01631747|363534659|FG001|One Year Infant Outcomes|Patient Refused|9|||
105417329|NCT01456195|363534660|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
105417330|NCT01456195|363534661|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
105417331|NCT01456195|363534662|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
105417332|NCT01456195|363534660|FG000|Overall Study|Lost to Follow-up|3|||
105417333|NCT01456195|363534661|FG001|Overall Study|Lost to Follow-up|1|||
105417334|NCT01456195|363534662|FG002|Overall Study|Lost to Follow-up|3|||
105417335|NCT01456195|363534660|FG000|Overall Study|Voluntary Withdrawal|5|||
105417336|NCT01456195|363534661|FG001|Overall Study|Voluntary Withdrawal|3|||
105417337|NCT01456195|363534662|FG002|Overall Study|Voluntary Withdrawal|7|||
105417338|NCT01456195|363534660|FG000|Overall Study|Lack of Efficacy|0|||
105417339|NCT01456195|363534661|FG001|Overall Study|Lack of Efficacy|1|||
105417340|NCT01456195|363534662|FG002|Overall Study|Lack of Efficacy|0|||
105417341|NCT01456195|363534660|FG000|Overall Study|Other Reasons|2|||
105417342|NCT01456195|363534661|FG001|Overall Study|Other Reasons|1|||
105417343|NCT01456195|363534662|FG002|Overall Study|Other Reasons|3|||
105417344|NCT02109432|363534663|FG000|Overall Study|Withdrawal by Subject|1|||
105417345|NCT03596047|363534670|FG000|Overall Study|Withdrawal by Subject|7|||
105417346|NCT03596047|363534671|FG001|Overall Study|Withdrawal by Subject|4|||
105417347|NCT03596047|363534670|FG000|Overall Study|Lost to Follow-up|0|||
105417348|NCT03596047|363534671|FG001|Overall Study|Lost to Follow-up|2|||
105417349|NCT00978380|363534673|FG000|Overall Study|Protocol Violation|2|||
105417350|NCT00978380|363534673|FG000|Overall Study|Withdrawal criteria|9|||
105417351|NCT00978380|363534673|FG000|Overall Study|Unclassified|8|||
105417352|NCT01443364|363534674|FG000|Overall Study|Lack of Efficacy|14|||
105417353|NCT01443364|363534674|FG000|Overall Study|Lost to Follow-up|3|||
105417354|NCT01443364|363534674|FG000|Overall Study|Withdrawal by Subject|5|||
105417355|NCT01443364|363534674|FG000|Overall Study|Other Reason|4|||
105417356|NCT01443364|363534674|FG000|Overall Study|SAE, non-fatal|6|||
105417357|NCT01443364|363534674|FG000|Overall Study|AE, non-serious non-fatal|8|||
105417358|NCT01443364|363534674|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
105417359|NCT00559845|363534675|FG000|Overall Study|Withdrew Consent|1|||
105417360|NCT00559845|363534675|FG000|Overall Study|Disease Progression|1|||
105417361|NCT00559845|363534675|FG000|Overall Study|Adverse Event|3|||
105417362|NCT00559845|363534675|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
105417363|NCT00559845|363534675|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
105417364|NCT00510718|363534676|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
105417365|NCT00510718|363534677|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
105417366|NCT00510718|363534676|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
105417367|NCT00510718|363534677|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
105417368|NCT00510718|363534676|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
105417369|NCT00510718|363534677|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
105499148|NCT00333840|363838829|FG000|Second-line Treatment Period|No longer required study drug|0|||
105499149|NCT00333840|363838830|FG001|Second-line Treatment Period|No longer required study drug|0|||
105499150|NCT00333840|363838831|FG002|Second-line Treatment Period|No longer required study drug|1|||
105499151|NCT00333840|363838832|FG003|Second-line Treatment Period|No longer required study drug|14|||
105499152|NCT00333840|363838829|FG000|Second-line Treatment Period|Protocol Violation|0|||
105499153|NCT00333840|363838830|FG001|Second-line Treatment Period|Protocol Violation|0|||
105499154|NCT00333840|363838831|FG002|Second-line Treatment Period|Protocol Violation|1|||
105417370|NCT00510718|363534676|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
105417371|NCT00510718|363534677|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
105417372|NCT00510718|363534676|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
105417373|NCT00510718|363534677|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
105417374|NCT00510718|363534676|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
105417375|NCT00510718|363534677|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
105417376|NCT06003777|363534683|FG000|Period 1|Adverse Event|0|||
105417377|NCT06003777|363534684|FG001|Period 1|Adverse Event|0|||
105417378|NCT06003777|363534685|FG002|Period 1|Adverse Event|1|||
105417379|NCT06003777|363534686|FG003|Period 1|Adverse Event|0|||
105417380|NCT06003777|363534687|FG004|Period 1|Adverse Event|0|||
105417381|NCT06003777|363534688|FG005|Period 1|Adverse Event|0|||
105417382|NCT06003777|363534689|FG006|Period 1|Adverse Event|0|||
105417383|NCT06003777|363534690|FG007|Period 1|Adverse Event|0|||
105417384|NCT06003777|363534691|FG008|Period 1|Adverse Event|0|||
105417385|NCT06003777|363534692|FG009|Period 1|Adverse Event|0|||
105417386|NCT06003777|363534693|FG010|Period 1|Adverse Event|0|||
105417387|NCT06003777|363534694|FG011|Period 1|Adverse Event|0|||
105417388|NCT06003777|363534683|FG000|Period 1|Withdrawal by Subject|0|||
105417389|NCT06003777|363534684|FG001|Period 1|Withdrawal by Subject|0|||
105417390|NCT06003777|363534685|FG002|Period 1|Withdrawal by Subject|0|||
105417391|NCT06003777|363534686|FG003|Period 1|Withdrawal by Subject|0|||
105417392|NCT06003777|363534687|FG004|Period 1|Withdrawal by Subject|1|||
105417393|NCT06003777|363534688|FG005|Period 1|Withdrawal by Subject|0|||
105417394|NCT06003777|363534689|FG006|Period 1|Withdrawal by Subject|0|||
105417395|NCT06003777|363534690|FG007|Period 1|Withdrawal by Subject|0|||
105417396|NCT06003777|363534691|FG008|Period 1|Withdrawal by Subject|0|||
105417397|NCT06003777|363534692|FG009|Period 1|Withdrawal by Subject|0|||
105417398|NCT06003777|363534693|FG010|Period 1|Withdrawal by Subject|0|||
105417399|NCT06003777|363534694|FG011|Period 1|Withdrawal by Subject|0|||
105417400|NCT06003777|363534683|FG000|Period 2|Withdrawal by Subject|0|||
105417401|NCT06003777|363534684|FG001|Period 2|Withdrawal by Subject|0|||
105417402|NCT06003777|363534685|FG002|Period 2|Withdrawal by Subject|0|||
105417403|NCT06003777|363534686|FG003|Period 2|Withdrawal by Subject|0|||
105417404|NCT06003777|363534687|FG004|Period 2|Withdrawal by Subject|0|||
105417405|NCT06003777|363534688|FG005|Period 2|Withdrawal by Subject|0|||
105417406|NCT06003777|363534689|FG006|Period 2|Withdrawal by Subject|0|||
105417407|NCT06003777|363534690|FG007|Period 2|Withdrawal by Subject|0|||
105417408|NCT06003777|363534691|FG008|Period 2|Withdrawal by Subject|1|||
105417409|NCT06003777|363534692|FG009|Period 2|Withdrawal by Subject|0|||
105417410|NCT06003777|363534693|FG010|Period 2|Withdrawal by Subject|0|||
105417411|NCT06003777|363534694|FG011|Period 2|Withdrawal by Subject|0|||
105417412|NCT06003777|363534683|FG000|Period 3|Adverse Event|0|||
105417413|NCT06003777|363534684|FG001|Period 3|Adverse Event|0|||
105417414|NCT06003777|363534685|FG002|Period 3|Adverse Event|0|||
105417415|NCT06003777|363534686|FG003|Period 3|Adverse Event|0|||
105417416|NCT06003777|363534687|FG004|Period 3|Adverse Event|0|||
105417417|NCT06003777|363534688|FG005|Period 3|Adverse Event|0|||
105417418|NCT06003777|363534689|FG006|Period 3|Adverse Event|1|||
105417419|NCT06003777|363534690|FG007|Period 3|Adverse Event|0|||
105417420|NCT06003777|363534691|FG008|Period 3|Adverse Event|0|||
105499155|NCT00333840|363838832|FG003|Second-line Treatment Period|Protocol Violation|10|||
105499156|NCT00333840|363838829|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
105499157|NCT00333840|363838830|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
105499158|NCT00333840|363838831|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
105499159|NCT00333840|363838832|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
105499160|NCT00333840|363838829|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
105499161|NCT00333840|363838830|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
105499162|NCT00333840|363838831|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
105499163|NCT00333840|363838832|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
105499164|NCT00333840|363838829|FG000|Second-line Treatment Period|Administrative problems|0|||
105499165|NCT00333840|363838830|FG001|Second-line Treatment Period|Administrative problems|0|||
105499166|NCT00333840|363838831|FG002|Second-line Treatment Period|Administrative problems|0|||
105499167|NCT00333840|363838832|FG003|Second-line Treatment Period|Administrative problems|7|||
105499168|NCT00333840|363838829|FG000|Second-line Treatment Period|Death|0|||
105499169|NCT00333840|363838830|FG001|Second-line Treatment Period|Death|0|||
105499170|NCT00333840|363838831|FG002|Second-line Treatment Period|Death|0|||
105499171|NCT00333840|363838832|FG003|Second-line Treatment Period|Death|9|||
105499172|NCT02357979|363838833|FG000|Overall Study|Lost to Follow-up|5|||
105583855|NCT00097370|364135338|FG000|Stage 3|Lack of Efficacy|1|||
105583856|NCT00097370|364135338|FG000|Stage 3|Sponsor Terminated Study|52|||
105499173|NCT02357979|363838834|FG001|Overall Study|Lost to Follow-up|5|||
105499174|NCT00845858|363838835|FG000|Overall Study|Withdrawal by Subject|5|||
105583857|NCT00097370|364135338|FG000|Stage 3|Lost to Follow-up|1|||
105417421|NCT06003777|363534692|FG009|Period 3|Adverse Event|0|||
105417422|NCT06003777|363534693|FG010|Period 3|Adverse Event|0|||
105417423|NCT06003777|363534694|FG011|Period 3|Adverse Event|0|||
105417424|NCT06003777|363534683|FG000|Period 4|No longer met eligibility criteria|0|||
105417425|NCT06003777|363534684|FG001|Period 4|No longer met eligibility criteria|0|||
105417426|NCT06003777|363534685|FG002|Period 4|No longer met eligibility criteria|1|||
105417427|NCT06003777|363534686|FG003|Period 4|No longer met eligibility criteria|0|||
105417428|NCT06003777|363534687|FG004|Period 4|No longer met eligibility criteria|0|||
105417429|NCT06003777|363534688|FG005|Period 4|No longer met eligibility criteria|0|||
105417430|NCT06003777|363534689|FG006|Period 4|No longer met eligibility criteria|0|||
105417431|NCT06003777|363534690|FG007|Period 4|No longer met eligibility criteria|0|||
105417432|NCT06003777|363534691|FG008|Period 4|No longer met eligibility criteria|0|||
105417433|NCT06003777|363534692|FG009|Period 4|No longer met eligibility criteria|0|||
105417434|NCT06003777|363534693|FG010|Period 4|No longer met eligibility criteria|0|||
105417435|NCT06003777|363534694|FG011|Period 4|No longer met eligibility criteria|0|||
105417436|NCT06003777|363534683|FG000|Period 4|Withdrawal by Subject|0|||
105417437|NCT06003777|363534684|FG001|Period 4|Withdrawal by Subject|1|||
105417438|NCT06003777|363534685|FG002|Period 4|Withdrawal by Subject|0|||
105417439|NCT06003777|363534686|FG003|Period 4|Withdrawal by Subject|0|||
105417440|NCT06003777|363534687|FG004|Period 4|Withdrawal by Subject|0|||
105417441|NCT06003777|363534688|FG005|Period 4|Withdrawal by Subject|0|||
105417442|NCT06003777|363534689|FG006|Period 4|Withdrawal by Subject|0|||
105417443|NCT06003777|363534690|FG007|Period 4|Withdrawal by Subject|0|||
105417444|NCT06003777|363534691|FG008|Period 4|Withdrawal by Subject|0|||
105417445|NCT06003777|363534692|FG009|Period 4|Withdrawal by Subject|0|||
105417446|NCT06003777|363534693|FG010|Period 4|Withdrawal by Subject|0|||
105417447|NCT06003777|363534694|FG011|Period 4|Withdrawal by Subject|0|||
105417448|NCT05319600|363534695|FG000|Overall Study|Withdrawal by Subject|1|||
105417449|NCT05319600|363534696|FG001|Overall Study|Withdrawal by Subject|0|||
105417450|NCT05319600|363534695|FG000|Overall Study|Lost to Follow-up|0|||
105417451|NCT05319600|363534696|FG001|Overall Study|Lost to Follow-up|4|||
105417452|NCT04590404|363534697|FG000|Overall Study|Death|16|||
105417453|NCT04590404|363534698|FG001|Overall Study|Death|17|||
105417454|NCT04590404|363534697|FG000|Overall Study|Withdrawal by Subject|7|||
105417455|NCT04590404|363534698|FG001|Overall Study|Withdrawal by Subject|2|||
105417456|NCT03525600|363534699|FG000|Overall Study|Adverse Event|9|||
105417457|NCT03525600|363534700|FG001|Overall Study|Adverse Event|6|||
105417458|NCT03525600|363534701|FG002|Overall Study|Adverse Event|5|||
105417459|NCT03525600|363534702|FG003|Overall Study|Adverse Event|3|||
105417460|NCT03525600|363534699|FG000|Overall Study|Lost to Follow-up|2|||
105417461|NCT03525600|363534700|FG001|Overall Study|Lost to Follow-up|4|||
105417462|NCT03525600|363534701|FG002|Overall Study|Lost to Follow-up|4|||
105417463|NCT03525600|363534702|FG003|Overall Study|Lost to Follow-up|0|||
105417464|NCT03525600|363534699|FG000|Overall Study|Physician Decision|1|||
105417465|NCT03525600|363534700|FG001|Overall Study|Physician Decision|0|||
105417466|NCT03525600|363534701|FG002|Overall Study|Physician Decision|2|||
105417467|NCT03525600|363534702|FG003|Overall Study|Physician Decision|0|||
105417468|NCT03525600|363534699|FG000|Overall Study|Consent withdrawal|36|||
105417469|NCT03525600|363534700|FG001|Overall Study|Consent withdrawal|20|||
105417470|NCT03525600|363534701|FG002|Overall Study|Consent withdrawal|6|||
105417471|NCT03525600|363534702|FG003|Overall Study|Consent withdrawal|13|||
105499175|NCT00845858|363838836|FG001|Overall Study|Withdrawal by Subject|1|||
105499176|NCT00845858|363838837|FG002|Overall Study|Withdrawal by Subject|1|||
105499177|NCT00845858|363838835|FG000|Overall Study|Adverse Event|3|||
105499178|NCT00845858|363838836|FG001|Overall Study|Adverse Event|8|||
105499179|NCT00845858|363838837|FG002|Overall Study|Adverse Event|4|||
105499180|NCT00845858|363838835|FG000|Overall Study|Protocol Violation|0|||
105499181|NCT00845858|363838836|FG001|Overall Study|Protocol Violation|0|||
105499182|NCT00845858|363838837|FG002|Overall Study|Protocol Violation|1|||
105499183|NCT00845858|363838835|FG000|Overall Study|not eligible|0|||
105499184|NCT00845858|363838836|FG001|Overall Study|not eligible|3|||
105499185|NCT00845858|363838837|FG002|Overall Study|not eligible|2|||
105499186|NCT03945214|363838838|FG000|Overall Study|Lost to Follow-up|3|||
105499187|NCT03945214|363838839|FG001|Overall Study|Lost to Follow-up|4|||
105499188|NCT03945214|363838840|FG002|Overall Study|Lost to Follow-up|7|||
105499189|NCT03945214|363838841|FG003|Overall Study|Lost to Follow-up|4|||
105499190|NCT00880542|363838845|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
105499191|NCT00880542|363838845|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
105499192|NCT00880542|363838845|FG000|REP: Surgical Resection|progressive disease|1|||
105499193|NCT05047770|363838846|FG000|Overall Study|Withdrawal by Subject|15|||
105499194|NCT05047770|363838847|FG001|Overall Study|Withdrawal by Subject|10|||
105499195|NCT05047770|363838848|FG002|Overall Study|Withdrawal by Subject|6|||
105499196|NCT05047770|363838849|FG003|Overall Study|Withdrawal by Subject|12|||
105499197|NCT05047770|363838846|FG000|Overall Study|Lost to Follow-up|7|||
105499198|NCT05047770|363838847|FG001|Overall Study|Lost to Follow-up|5|||
105499199|NCT05047770|363838848|FG002|Overall Study|Lost to Follow-up|12|||
105499200|NCT05047770|363838849|FG003|Overall Study|Lost to Follow-up|13|||
105499201|NCT05047770|363838846|FG000|Overall Study|Other|1|||
105499202|NCT05047770|363838847|FG001|Overall Study|Other|0|||
105417472|NCT03525600|363534699|FG000|Overall Study|Death|7|||
105417473|NCT03525600|363534700|FG001|Overall Study|Death|6|||
105417474|NCT03525600|363534701|FG002|Overall Study|Death|4|||
105417475|NCT03525600|363534702|FG003|Overall Study|Death|3|||
105417476|NCT03525600|363534699|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
105417477|NCT03525600|363534700|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
105417478|NCT03525600|363534701|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
105417479|NCT03525600|363534702|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
105417480|NCT03525600|363534699|FG000|Overall Study|Other|0|||
105417481|NCT03525600|363534700|FG001|Overall Study|Other|1|||
105499203|NCT05047770|363838848|FG002|Overall Study|Other|1|||
105417482|NCT03525600|363534701|FG002|Overall Study|Other|0|||
105417483|NCT03525600|363534702|FG003|Overall Study|Other|0|||
105417484|NCT01694121|363534703|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
105417485|NCT01694121|363534704|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
105417486|NCT03403361|363534705|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
105417487|NCT05129449|363534710|FG000|Overall Study|Protocol Violation|1|||
105417488|NCT00656058|363534712|FG000|Overall Study|Withdrawal by Subject|2|||
105417489|NCT00656058|363534712|FG000|Overall Study|Withdrawal by Subject|4|||
105417490|NCT00616018|363534713|FG000|Overall Study|Protocol Violation|3|||
105417491|NCT00350870|363534715|FG000|Overall Study|Withdrawal by Subject|21|||
105417492|NCT00350870|363534716|FG001|Overall Study|Withdrawal by Subject|17|||
105417493|NCT00350870|363534717|FG002|Overall Study|Withdrawal by Subject|15|||
105417494|NCT00350870|363534718|FG003|Overall Study|Withdrawal by Subject|14|||
105417495|NCT00350870|363534715|FG000|Overall Study|Physician Decision|1|||
105417496|NCT00350870|363534716|FG001|Overall Study|Physician Decision|0|||
105417497|NCT00350870|363534717|FG002|Overall Study|Physician Decision|1|||
105417498|NCT00350870|363534718|FG003|Overall Study|Physician Decision|1|||
105583858|NCT03073005|364135339|FG000|Overall Study|Death|6|||
105583859|NCT03073005|364135340|FG001|Overall Study|Death|0|||
105583860|NCT03073005|364135341|FG002|Overall Study|Death|7|||
105583861|NCT03073005|364135342|FG003|Overall Study|Death|0|||
105583862|NCT03073005|364135339|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
105583863|NCT03073005|364135340|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
105583864|NCT03073005|364135341|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
105583865|NCT03073005|364135342|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
105417507|NCT04700540|363534721|FG000|Overall Study|Withdrawal by Subject|12|||
105417508|NCT04700540|363534722|FG001|Overall Study|Withdrawal by Subject|8|||
105417509|NCT04700540|363534721|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
105417510|NCT04700540|363534722|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
105417511|NCT05248997|363534723|FG000|Overall Study|Lost to Follow-up|1|||
105417512|NCT05248997|363534724|FG001|Overall Study|Lost to Follow-up|1|||
105417513|NCT05248997|363534723|FG000|Overall Study|Randomized but not treated|32|||
105417514|NCT05248997|363534724|FG001|Overall Study|Randomized but not treated|25|||
105417515|NCT02265536|363534725|FG000|Overall Study|Adverse Event|1|||
105417516|NCT02265536|363534726|FG001|Overall Study|Adverse Event|0|||
105499204|NCT05047770|363838849|FG003|Overall Study|Other|0|||
105499205|NCT00074984|363838850|FG000|Overall Study|Death|1|||
105499206|NCT00074984|363838851|FG001|Overall Study|Death|2|||
105499207|NCT00074984|363838850|FG000|Overall Study|Withdrawal by Subject|2|||
105499208|NCT00074984|363838851|FG001|Overall Study|Withdrawal by Subject|3|||
105499209|NCT00074984|363838850|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
105499210|NCT00074984|363838851|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
105499211|NCT03758443|363838852|FG000|Induction Period|Adverse Event|2|||
105499212|NCT03758443|363838853|FG001|Induction Period|Adverse Event|4|||
105499213|NCT03758443|363838854|FG002|Induction Period|Adverse Event|2|||
105499214|NCT03758443|363838855|FG003|Induction Period|Adverse Event|3|||
105499215|NCT03758443|363838852|FG000|Induction Period|Physician Decision|1|||
105499216|NCT03758443|363838853|FG001|Induction Period|Physician Decision|1|||
105499217|NCT03758443|363838854|FG002|Induction Period|Physician Decision|3|||
105499218|NCT03758443|363838855|FG003|Induction Period|Physician Decision|0|||
105499219|NCT03758443|363838852|FG000|Induction Period|Protocol Violation|0|||
105499220|NCT03758443|363838853|FG001|Induction Period|Protocol Violation|0|||
105499221|NCT03758443|363838854|FG002|Induction Period|Protocol Violation|0|||
105499222|NCT03758443|363838855|FG003|Induction Period|Protocol Violation|1|||
105499223|NCT03758443|363838852|FG000|Induction Period|Withdrawal by Subject|3|||
105499224|NCT03758443|363838853|FG001|Induction Period|Withdrawal by Subject|2|||
105499225|NCT03758443|363838854|FG002|Induction Period|Withdrawal by Subject|2|||
105499226|NCT03758443|363838855|FG003|Induction Period|Withdrawal by Subject|4|||
105499227|NCT03758443|363838852|FG000|Extended Induction Period|Adverse Event|1|||
105499228|NCT03758443|363838853|FG001|Extended Induction Period|Adverse Event|1|||
105499229|NCT03758443|363838854|FG002|Extended Induction Period|Adverse Event|0|||
105499230|NCT03758443|363838855|FG003|Extended Induction Period|Adverse Event|1|||
105499231|NCT03758443|363838852|FG000|Extended Induction Period|Lost to Follow-up|1|||
105499232|NCT03758443|363838853|FG001|Extended Induction Period|Lost to Follow-up|0|||
105499233|NCT03758443|363838854|FG002|Extended Induction Period|Lost to Follow-up|0|||
105499234|NCT03758443|363838855|FG003|Extended Induction Period|Lost to Follow-up|0|||
105499235|NCT03758443|363838852|FG000|Extended Induction Period|Physician Decision|2|||
105417517|NCT02265536|363534727|FG002|Overall Study|Adverse Event|0|||
105417518|NCT02265536|363534728|FG003|Overall Study|Adverse Event|0|||
105417519|NCT02265536|363534729|FG004|Overall Study|Adverse Event|1|||
105499236|NCT03758443|363838853|FG001|Extended Induction Period|Physician Decision|1|||
105499237|NCT03758443|363838854|FG002|Extended Induction Period|Physician Decision|2|||
105499238|NCT03758443|363838855|FG003|Extended Induction Period|Physician Decision|2|||
105499239|NCT03758443|363838852|FG000|Extended Induction Period|Protocol Violation|0|||
105417520|NCT02265536|363534730|FG005|Overall Study|Adverse Event|0|||
105417521|NCT02265536|363534725|FG000|Overall Study|Physician Decision|0|||
105417522|NCT02265536|363534726|FG001|Overall Study|Physician Decision|0|||
105417523|NCT02265536|363534727|FG002|Overall Study|Physician Decision|0|||
105417524|NCT02265536|363534728|FG003|Overall Study|Physician Decision|0|||
105417525|NCT02265536|363534729|FG004|Overall Study|Physician Decision|2|||
105417526|NCT02265536|363534730|FG005|Overall Study|Physician Decision|0|||
105417527|NCT02265536|363534725|FG000|Overall Study|Withdrawal by Subject|0|||
105417528|NCT02265536|363534726|FG001|Overall Study|Withdrawal by Subject|3|||
105417529|NCT02265536|363534727|FG002|Overall Study|Withdrawal by Subject|0|||
105417530|NCT02265536|363534728|FG003|Overall Study|Withdrawal by Subject|0|||
105417531|NCT02265536|363534729|FG004|Overall Study|Withdrawal by Subject|0|||
105417532|NCT02265536|363534730|FG005|Overall Study|Withdrawal by Subject|0|||
105417533|NCT04730635|363534734|FG000|Overall Study|Lost to Follow-up|1|||
105417534|NCT04730635|363534735|FG001|Overall Study|Lost to Follow-up|0|||
105417535|NCT04730635|363534734|FG000|Overall Study|Withdrawal by Subject|0|||
105417536|NCT04730635|363534735|FG001|Overall Study|Withdrawal by Subject|1|||
105417537|NCT01974206|363534738|FG000|Overall Study|Did Not Take Study Drug|0|||
105417538|NCT01974206|363534739|FG001|Overall Study|Did Not Take Study Drug|1|||
105417539|NCT01974206|363534738|FG000|Overall Study|Physician Decision|1|||
105417540|NCT01974206|363534739|FG001|Overall Study|Physician Decision|0|||
105417541|NCT01974206|363534738|FG000|Overall Study|Withdrawal by Subject|3|||
105417542|NCT01974206|363534739|FG001|Overall Study|Withdrawal by Subject|0|||
105417543|NCT01974206|363534738|FG000|Overall Study|Lost to Follow-up|1|||
105417544|NCT01974206|363534739|FG001|Overall Study|Lost to Follow-up|0|||
105417545|NCT01974206|363534738|FG000|Overall Study|Death|1|||
105417546|NCT01974206|363534739|FG001|Overall Study|Death|0|||
105417547|NCT05005013|363534744|FG000|Overall Study|Withdrawal by Subject|5|||
105417548|NCT05005013|363534745|FG001|Overall Study|Withdrawal by Subject|1|||
105417549|NCT05005013|363534744|FG000|Overall Study|Lost to Follow-up|3|||
105417550|NCT05005013|363534745|FG001|Overall Study|Lost to Follow-up|1|||
105417551|NCT05005013|363534744|FG000|Overall Study|Ineligibility|1|||
105417552|NCT05005013|363534745|FG001|Overall Study|Ineligibility|1|||
105417553|NCT01202188|363534749|FG000|Overall Study|Protocol deviation|14|||
105417554|NCT01202188|363534750|FG001|Overall Study|Protocol deviation|8|||
105417555|NCT01202188|363534751|FG002|Overall Study|Protocol deviation|12|||
105417556|NCT01202188|363534752|FG003|Overall Study|Protocol deviation|10|||
105417557|NCT01202188|363534753|FG004|Overall Study|Protocol deviation|11|||
105417558|NCT01202188|363534749|FG000|Overall Study|Subject withdrew consent|12|||
105417559|NCT01202188|363534750|FG001|Overall Study|Subject withdrew consent|13|||
105417560|NCT01202188|363534751|FG002|Overall Study|Subject withdrew consent|22|||
105417561|NCT01202188|363534752|FG003|Overall Study|Subject withdrew consent|11|||
105417562|NCT01202188|363534753|FG004|Overall Study|Subject withdrew consent|13|||
105417563|NCT01202188|363534749|FG000|Overall Study|Adverse Event|5|||
105417564|NCT01202188|363534750|FG001|Overall Study|Adverse Event|23|||
105417565|NCT01202188|363534751|FG002|Overall Study|Adverse Event|13|||
105417566|NCT01202188|363534752|FG003|Overall Study|Adverse Event|10|||
105417567|NCT01202188|363534753|FG004|Overall Study|Adverse Event|10|||
105417568|NCT01202188|363534749|FG000|Overall Study|Administrative problems|3|||
105417569|NCT01202188|363534750|FG001|Overall Study|Administrative problems|2|||
105417570|NCT01202188|363534751|FG002|Overall Study|Administrative problems|1|||
105417571|NCT01202188|363534752|FG003|Overall Study|Administrative problems|1|||
105417572|NCT01202188|363534753|FG004|Overall Study|Administrative problems|2|||
105417573|NCT01202188|363534749|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105417574|NCT01202188|363534750|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
105417575|NCT01202188|363534751|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
105417576|NCT01202188|363534752|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
105417577|NCT01202188|363534753|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
105417578|NCT01202188|363534749|FG000|Overall Study|Lost to Follow-up|1|||
105417579|NCT01202188|363534750|FG001|Overall Study|Lost to Follow-up|1|||
105417580|NCT01202188|363534751|FG002|Overall Study|Lost to Follow-up|0|||
105417581|NCT01202188|363534752|FG003|Overall Study|Lost to Follow-up|4|||
105417582|NCT01202188|363534753|FG004|Overall Study|Lost to Follow-up|1|||
105417583|NCT01202188|363534749|FG000|Overall Study|Death|1|||
105417584|NCT01202188|363534750|FG001|Overall Study|Death|1|||
105417585|NCT01202188|363534751|FG002|Overall Study|Death|1|||
105417586|NCT01202188|363534752|FG003|Overall Study|Death|1|||
105417587|NCT01202188|363534753|FG004|Overall Study|Death|0|||
105417588|NCT01202188|363534749|FG000|Overall Study|Abnormal test procedure result (s)|0|||
105417589|NCT01202188|363534750|FG001|Overall Study|Abnormal test procedure result (s)|0|||
105417590|NCT01202188|363534751|FG002|Overall Study|Abnormal test procedure result (s)|2|||
105417591|NCT01202188|363534752|FG003|Overall Study|Abnormal test procedure result (s)|0|||
105417592|NCT01202188|363534753|FG004|Overall Study|Abnormal test procedure result (s)|0|||
105417593|NCT03763656|363534756|FG000|Overall Study|Physician Decision|1|||
105417594|NCT03763656|363534756|FG000|Overall Study|Protocol Violation|1|||
105417595|NCT03763656|363534756|FG000|Overall Study|Withdrawal by Subject|7|||
105417596|NCT00487942|363534757|FG000|Overall Study|Adverse Event|1|||
105417597|NCT00487942|363534758|FG001|Overall Study|Adverse Event|1|||
105417598|NCT00487942|363534759|FG002|Overall Study|Adverse Event|1|||
105417599|NCT00487942|363534760|FG003|Overall Study|Adverse Event|1|||
105417600|NCT00487942|363534757|FG000|Overall Study|Lost to Follow-up|1|||
105417601|NCT00487942|363534758|FG001|Overall Study|Lost to Follow-up|0|||
105417602|NCT00487942|363534759|FG002|Overall Study|Lost to Follow-up|0|||
105417603|NCT00487942|363534760|FG003|Overall Study|Lost to Follow-up|1|||
105417604|NCT00487942|363534757|FG000|Overall Study|Protocol Violation|1|||
105417605|NCT00487942|363534758|FG001|Overall Study|Protocol Violation|1|||
105417606|NCT00487942|363534759|FG002|Overall Study|Protocol Violation|0|||
105417607|NCT00487942|363534760|FG003|Overall Study|Protocol Violation|0|||
105417608|NCT00487942|363534757|FG000|Overall Study|Withdrawal by Subject|0|||
105417609|NCT00487942|363534758|FG001|Overall Study|Withdrawal by Subject|1|||
105417610|NCT00487942|363534759|FG002|Overall Study|Withdrawal by Subject|2|||
105417611|NCT00487942|363534760|FG003|Overall Study|Withdrawal by Subject|0|||
105417612|NCT01638013|363534761|FG000|Overall Study|Adverse Event|36|||
105417613|NCT01638013|363534762|FG001|Overall Study|Adverse Event|29|||
105417614|NCT01638013|363534763|FG002|Overall Study|Adverse Event|48|||
105417615|NCT01638013|363534761|FG000|Overall Study|Lack of Efficacy|39|||
105417616|NCT01638013|363534762|FG001|Overall Study|Lack of Efficacy|11|||
105417617|NCT01638013|363534763|FG002|Overall Study|Lack of Efficacy|14|||
105417618|NCT01638013|363534761|FG000|Overall Study|Protocol Violation|10|||
105417619|NCT01638013|363534762|FG001|Overall Study|Protocol Violation|7|||
105417620|NCT01638013|363534763|FG002|Overall Study|Protocol Violation|11|||
105417621|NCT01638013|363534761|FG000|Overall Study|Met discontinuation criteria|4|||
105417622|NCT01638013|363534762|FG001|Overall Study|Met discontinuation criteria|0|||
105417623|NCT01638013|363534763|FG002|Overall Study|Met discontinuation criteria|7|||
105417624|NCT01638013|363534761|FG000|Overall Study|Subject Lost to Follow up|1|||
105417625|NCT01638013|363534762|FG001|Overall Study|Subject Lost to Follow up|0|||
105417626|NCT01638013|363534763|FG002|Overall Study|Subject Lost to Follow up|1|||
105417627|NCT01638013|363534761|FG000|Overall Study|Miscellaneous|25|||
105417628|NCT01638013|363534762|FG001|Overall Study|Miscellaneous|19|||
105417629|NCT01638013|363534763|FG002|Overall Study|Miscellaneous|23|||
105417630|NCT01638013|363534761|FG000|Overall Study|Withdrawal of Consent|16|||
105417631|NCT01638013|363534762|FG001|Overall Study|Withdrawal of Consent|12|||
105417632|NCT01638013|363534763|FG002|Overall Study|Withdrawal of Consent|16|||
105417633|NCT01638013|363534761|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
105417634|NCT01638013|363534762|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
105417635|NCT01638013|363534763|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
105417636|NCT05463744|363534764|FG000|Treatment Period|Withdrawal by Subject|19|||
105417637|NCT05463744|363534765|FG001|Treatment Period|Withdrawal by Subject|16|||
105417638|NCT05463744|363534764|FG000|Treatment Period|Adverse Event|4|||
105417639|NCT05463744|363534765|FG001|Treatment Period|Adverse Event|4|||
105417640|NCT05463744|363534764|FG000|Treatment Period|Pregnancy|0|||
105417641|NCT05463744|363534765|FG001|Treatment Period|Pregnancy|3|||
105417642|NCT05463744|363534764|FG000|Treatment Period|Lost to Follow-up|1|||
105417643|NCT05463744|363534765|FG001|Treatment Period|Lost to Follow-up|3|||
105417644|NCT05463744|363534764|FG000|Treatment Period|Inadvertent enrollment|2|||
105417645|NCT05463744|363534765|FG001|Treatment Period|Inadvertent enrollment|1|||
105417646|NCT05463744|363534764|FG000|Treatment Period|Death|0|||
105417647|NCT05463744|363534765|FG001|Treatment Period|Death|1|||
105417648|NCT05463744|363534764|FG000|Treatment Period|Non-compliance with Study Drug|1|||
105417649|NCT05463744|363534765|FG001|Treatment Period|Non-compliance with Study Drug|0|||
105417650|NCT05463744|363534764|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
105417651|NCT05463744|363534765|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
105417652|NCT05463744|363534764|FG000|Treatment Period|Physician Decision|0|||
105417653|NCT05463744|363534765|FG001|Treatment Period|Physician Decision|1|||
105417654|NCT05463744|363534764|FG000|Follow-Up Period|Withdrawal by Subject|3|||
105417655|NCT05463744|363534765|FG001|Follow-Up Period|Withdrawal by Subject|1|||
105417656|NCT05463744|363534764|FG000|Follow-Up Period|Lost to Follow-up|1|||
105417657|NCT05463744|363534765|FG001|Follow-Up Period|Lost to Follow-up|1|||
105417658|NCT03551665|363534768|FG000|Overall Study|Lost to Follow-up|11|||
105417659|NCT03551665|363534769|FG001|Overall Study|Lost to Follow-up|2|||
105417660|NCT02640625|363536857|FG000|Overall Study|Adverse Event|1|||
105417661|NCT00790868|363536861|FG000|Overall Study|Withdrawal by Subject|4|||
105417662|NCT00790868|363536862|FG001|Overall Study|Withdrawal by Subject|5|||
105417663|NCT00790868|363536861|FG000|Overall Study|Lost to Follow-up|2|||
105417664|NCT00790868|363536862|FG001|Overall Study|Lost to Follow-up|12|||
105417665|NCT01579565|363536863|FG000|Randomized|Adverse Event|1|||
105417666|NCT01579565|363536864|FG001|Randomized|Adverse Event|3|||
105417667|NCT01579565|363536863|FG000|Randomized|Withdrawal by Subject|3|||
105417668|NCT01579565|363536864|FG001|Randomized|Withdrawal by Subject|0|||
105417669|NCT01579565|363536863|FG000|Randomized|inadequate preoperative pupil dilation|0|||
105417670|NCT01579565|363536864|FG001|Randomized|inadequate preoperative pupil dilation|1|||
105417671|NCT01579565|363536863|FG000|Randomized|prohibited preoperative eating|1|||
105417672|NCT01579565|363536864|FG001|Randomized|prohibited preoperative eating|0|||
105417673|NCT01579565|363536863|FG000|Randomized|prohibited preoperative medication|0|||
105417674|NCT01579565|363536864|FG001|Randomized|prohibited preoperative medication|1|||
105417675|NCT01579565|363536863|FG000|Treated|Physician Decision|0|||
105417676|NCT01579565|363536864|FG001|Treated|Physician Decision|1|||
105417677|NCT01579565|363536863|FG000|Treated|Lost to Follow-up|2|||
105417678|NCT01579565|363536864|FG001|Treated|Lost to Follow-up|1|||
105417679|NCT01579565|363536863|FG000|Treated|declined to return for final visit|0|||
105417680|NCT01579565|363536864|FG001|Treated|declined to return for final visit|1|||
105417681|NCT01380535|363536865|FG000|Overall Study|Adverse Event|3|||
105417682|NCT01380535|363536866|FG001|Overall Study|Adverse Event|3|||
105417683|NCT01380535|363536865|FG000|Overall Study|Death|3|||
105417684|NCT01380535|363536866|FG001|Overall Study|Death|0|||
105417685|NCT01380535|363536865|FG000|Overall Study|Study site closed|0|||
105417686|NCT01380535|363536866|FG001|Overall Study|Study site closed|5|||
105417687|NCT01380535|363536865|FG000|Overall Study|Withdrawal by Subject|1|||
105417688|NCT01380535|363536866|FG001|Overall Study|Withdrawal by Subject|2|||
105417689|NCT01380535|363536865|FG000|Overall Study|Protocol Violation|0|||
105417690|NCT01380535|363536866|FG001|Overall Study|Protocol Violation|2|||
105417691|NCT01380535|363536865|FG000|Overall Study|Lack of Efficacy|0|||
105417692|NCT01380535|363536866|FG001|Overall Study|Lack of Efficacy|3|||
105417693|NCT02867813|363536867|FG000|Overall Study|Withdrawal by Subject|57|||
105417694|NCT02867813|363536868|FG001|Overall Study|Withdrawal by Subject|56|||
105417695|NCT02867813|363536867|FG000|Overall Study|Decision by Sponsor|7|||
105417696|NCT02867813|363536868|FG001|Overall Study|Decision by Sponsor|7|||
105417697|NCT02867813|363536867|FG000|Overall Study|Lost to Follow-up|91|||
105417698|NCT02867813|363536868|FG001|Overall Study|Lost to Follow-up|78|||
105417699|NCT02867813|363536867|FG000|Overall Study|Missing|2|||
105417700|NCT02867813|363536868|FG001|Overall Study|Missing|1|||
105417701|NCT02867813|363536867|FG000|Overall Study|Death|294|||
105417702|NCT02867813|363536868|FG001|Overall Study|Death|268|||
105417703|NCT02791191|363536870|FG000|Overall Study|Adverse Event|2|||
105417704|NCT02791191|363536871|FG001|Overall Study|Adverse Event|4|||
105417705|NCT02791191|363536872|FG002|Overall Study|Adverse Event|5|||
105417706|NCT02791191|363536870|FG000|Overall Study|Lack of Efficacy|0|||
105417707|NCT02791191|363536871|FG001|Overall Study|Lack of Efficacy|1|||
105417708|NCT02791191|363536872|FG002|Overall Study|Lack of Efficacy|0|||
105417709|NCT02791191|363536870|FG000|Overall Study|Study Drug Non-Compliance|0|||
105417710|NCT02791191|363536871|FG001|Overall Study|Study Drug Non-Compliance|2|||
105417711|NCT02791191|363536872|FG002|Overall Study|Study Drug Non-Compliance|0|||
105417712|NCT02791191|363536870|FG000|Overall Study|Site Closed by Sponsor|1|||
105417713|NCT02791191|363536871|FG001|Overall Study|Site Closed by Sponsor|1|||
105417714|NCT02791191|363536872|FG002|Overall Study|Site Closed by Sponsor|3|||
105417715|NCT02791191|363536870|FG000|Overall Study|Progressive Disease|1|||
105417716|NCT02791191|363536871|FG001|Overall Study|Progressive Disease|0|||
105417717|NCT02791191|363536872|FG002|Overall Study|Progressive Disease|0|||
105417718|NCT02791191|363536870|FG000|Overall Study|Study Terminated by Sponsor|29|||
105417719|NCT02791191|363536871|FG001|Overall Study|Study Terminated by Sponsor|101|||
105417720|NCT02791191|363536872|FG002|Overall Study|Study Terminated by Sponsor|109|||
105417721|NCT02791191|363536870|FG000|Overall Study|Withdrawal by Subject|3|||
105417722|NCT02791191|363536871|FG001|Overall Study|Withdrawal by Subject|1|||
105417723|NCT02791191|363536872|FG002|Overall Study|Withdrawal by Subject|3|||
105417724|NCT02791191|363536870|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
105417725|NCT02791191|363536871|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
105417726|NCT02791191|363536872|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
105417727|NCT01691014|363536875|FG000|Overall Study|Premature Termination|1|||
105417728|NCT01691014|363536876|FG001|Overall Study|Premature Termination|6|||
105417729|NCT01691014|363536877|FG002|Overall Study|Premature Termination|0|||
105417730|NCT01691014|363536878|FG003|Overall Study|Premature Termination|3|||
105417731|NCT01691014|363536875|FG000|Overall Study|Other|0|||
105417732|NCT01691014|363536876|FG001|Overall Study|Other|0|||
105417733|NCT01691014|363536877|FG002|Overall Study|Other|2|||
105417734|NCT01691014|363536878|FG003|Overall Study|Other|0|||
105417735|NCT01691014|363536875|FG000|Overall Study|Withdrawal by Subject|0|||
105417736|NCT01691014|363536876|FG001|Overall Study|Withdrawal by Subject|1|||
105417737|NCT01691014|363536877|FG002|Overall Study|Withdrawal by Subject|1|||
105417738|NCT01691014|363536878|FG003|Overall Study|Withdrawal by Subject|1|||
105417739|NCT01691014|363536875|FG000|Overall Study|Adverse Event|0|||
105417740|NCT01691014|363536876|FG001|Overall Study|Adverse Event|5|||
105417741|NCT01691014|363536877|FG002|Overall Study|Adverse Event|1|||
105417742|NCT01691014|363536878|FG003|Overall Study|Adverse Event|1|||
105417743|NCT01691014|363536875|FG000|Overall Study|Lack of Efficacy|2|||
105417744|NCT01691014|363536876|FG001|Overall Study|Lack of Efficacy|3|||
105417745|NCT01691014|363536877|FG002|Overall Study|Lack of Efficacy|7|||
105499240|NCT03758443|363838853|FG001|Extended Induction Period|Protocol Violation|0|||
105417746|NCT01691014|363536878|FG003|Overall Study|Lack of Efficacy|0|||
105417747|NCT03372551|363536879|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
105417748|NCT03372551|363536880|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
105417749|NCT04439539|363536881|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
105417750|NCT04439539|363536882|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
105499241|NCT03758443|363838854|FG002|Extended Induction Period|Protocol Violation|0|||
105417751|NCT04439539|363536883|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
105499242|NCT03758443|363838855|FG003|Extended Induction Period|Protocol Violation|1|||
105499243|NCT03758443|363838852|FG000|Extended Induction Period|Withdrawal by Subject|8|||
105499244|NCT03758443|363838853|FG001|Extended Induction Period|Withdrawal by Subject|1|||
105499245|NCT03758443|363838854|FG002|Extended Induction Period|Withdrawal by Subject|7|||
105499246|NCT03758443|363838855|FG003|Extended Induction Period|Withdrawal by Subject|3|||
105499247|NCT03758443|363838852|FG000|Extended Induction Period|Miscellaneous|1|||
105499248|NCT03758443|363838853|FG001|Extended Induction Period|Miscellaneous|0|||
105499249|NCT03758443|363838854|FG002|Extended Induction Period|Miscellaneous|0|||
105499250|NCT03758443|363838855|FG003|Extended Induction Period|Miscellaneous|0|||
105499251|NCT03758443|363838852|FG000|Maintenance Period|Adverse Event|1|||
105499252|NCT03758443|363838853|FG001|Maintenance Period|Adverse Event|2|||
105499253|NCT03758443|363838854|FG002|Maintenance Period|Adverse Event|0|||
105499254|NCT03758443|363838855|FG003|Maintenance Period|Adverse Event|0|||
105499255|NCT03758443|363838852|FG000|Maintenance Period|Lost to Follow-up|0|||
105499256|NCT03758443|363838853|FG001|Maintenance Period|Lost to Follow-up|0|||
105499257|NCT03758443|363838854|FG002|Maintenance Period|Lost to Follow-up|0|||
105499258|NCT03758443|363838855|FG003|Maintenance Period|Lost to Follow-up|1|||
105499259|NCT03758443|363838852|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
105499260|NCT03758443|363838853|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
105499261|NCT03758443|363838854|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
105499262|NCT03758443|363838855|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
105499263|NCT03758443|363838852|FG000|Maintenance Period|Protocol Violation|0|||
105499264|NCT03758443|363838853|FG001|Maintenance Period|Protocol Violation|1|||
105499265|NCT03758443|363838854|FG002|Maintenance Period|Protocol Violation|0|||
105499266|NCT03758443|363838855|FG003|Maintenance Period|Protocol Violation|0|||
105499267|NCT03758443|363838852|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
105499268|NCT03758443|363838853|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
105499269|NCT03758443|363838854|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
105499270|NCT03758443|363838855|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
105499271|NCT03758443|363838852|FG000|Maintenance Period|Withdrawal by Subject|1|||
105499272|NCT03758443|363838853|FG001|Maintenance Period|Withdrawal by Subject|0|||
105499273|NCT03758443|363838854|FG002|Maintenance Period|Withdrawal by Subject|1|||
105499274|NCT03758443|363838855|FG003|Maintenance Period|Withdrawal by Subject|1|||
105499275|NCT03758443|363838852|FG000|Maintenance Period|Miscellaneous|0|||
105499276|NCT03758443|363838853|FG001|Maintenance Period|Miscellaneous|0|||
105499277|NCT03758443|363838854|FG002|Maintenance Period|Miscellaneous|1|||
105499278|NCT03758443|363838855|FG003|Maintenance Period|Miscellaneous|0|||
105499279|NCT01436396|363838856|FG000|Overall Study|Protocol Violation|7|||
105499280|NCT01436396|363838857|FG001|Overall Study|Protocol Violation|5|||
105499281|NCT01436396|363838856|FG000|Overall Study|Adverse Event|1|||
105499282|NCT01436396|363838857|FG001|Overall Study|Adverse Event|2|||
105499283|NCT01436396|363838856|FG000|Overall Study|Withdrawal by Subject|19|||
105499284|NCT01436396|363838857|FG001|Overall Study|Withdrawal by Subject|29|||
105499285|NCT01436396|363838856|FG000|Overall Study|Serious adverse event|2|||
105499286|NCT01436396|363838857|FG001|Overall Study|Serious adverse event|3|||
105499287|NCT01436396|363838856|FG000|Overall Study|Lost to Follow-up|3|||
105499288|NCT01436396|363838857|FG001|Overall Study|Lost to Follow-up|3|||
105499289|NCT02264639|363838860|FG000|Overall Study|Death (after completing single-dose phase)|1|||
105499290|NCT02264639|363838861|FG001|Overall Study|Death (after completing single-dose phase)|0|||
105499291|NCT02264639|363838862|FG002|Overall Study|Death (after completing single-dose phase)|0|||
105499292|NCT02264639|363838863|FG003|Overall Study|Death (after completing single-dose phase)|0|||
105499293|NCT02264639|363838864|FG004|Overall Study|Death (after completing single-dose phase)|0|||
105499294|NCT02264639|363838860|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
105499295|NCT02264639|363838861|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
105499296|NCT02264639|363838862|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
105499297|NCT02264639|363838863|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
105499298|NCT02264639|363838864|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
105499299|NCT02264639|363838860|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
105499300|NCT02264639|363838861|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
105499301|NCT02264639|363838862|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
105499302|NCT02264639|363838863|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
105499303|NCT02264639|363838864|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
105499304|NCT02264639|363838860|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
105499305|NCT02264639|363838861|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
105499306|NCT02264639|363838862|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
105499307|NCT02264639|363838863|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
105499308|NCT02264639|363838864|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
105499309|NCT01180647|363838865|FG000|Overall Study|Lost to Follow-up|5|||
105499310|NCT01180647|363838866|FG001|Overall Study|Lost to Follow-up|6|||
105499311|NCT00494299|363838869|FG000|Overall Study|Adverse Event|93|||
105499312|NCT00494299|363838870|FG001|Overall Study|Adverse Event|13|||
105417752|NCT04439539|363536881|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
105417753|NCT04439539|363536882|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
105417754|NCT04439539|363536883|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
105417755|NCT04439539|363536881|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
105417756|NCT04439539|363536882|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
105417757|NCT04439539|363536883|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
105417758|NCT02578680|363536886|FG000|Overall Study|Death|329|||
105417759|NCT02578680|363536887|FG001|Overall Study|Death|181|||
105417760|NCT02578680|363536886|FG000|Overall Study|Lost to Follow-up|3|||
105417761|NCT02578680|363536887|FG001|Overall Study|Lost to Follow-up|1|||
105417762|NCT02578680|363536886|FG000|Overall Study|Physician Decision|0|||
105417763|NCT02578680|363536887|FG001|Overall Study|Physician Decision|1|||
105417764|NCT02578680|363536886|FG000|Overall Study|Protocol Violation|1|||
105417765|NCT02578680|363536887|FG001|Overall Study|Protocol Violation|1|||
105417766|NCT02578680|363536886|FG000|Overall Study|Sponsor Decision|64|||
105417767|NCT02578680|363536887|FG001|Overall Study|Sponsor Decision|13|||
105417768|NCT02578680|363536886|FG000|Overall Study|Withdrawal by Subject|13|||
105417769|NCT02578680|363536887|FG001|Overall Study|Withdrawal by Subject|9|||
105417770|NCT03116828|363536888|FG000|Overall Study|Adverse Event|1|||
105417771|NCT03116828|363536889|FG001|Overall Study|Adverse Event|10|||
105417772|NCT03116828|363536888|FG000|Overall Study|Withdrawal by Subject|4|||
105417773|NCT03116828|363536889|FG001|Overall Study|Withdrawal by Subject|8|||
105417774|NCT03116828|363536888|FG000|Overall Study|OTHER|3|||
105417775|NCT03116828|363536889|FG001|Overall Study|OTHER|3|||
105417776|NCT04187144|363536892|FG000|Overall Study|Lost to Follow-up|12|||
105417777|NCT04187144|363536893|FG001|Overall Study|Lost to Follow-up|11|||
105417778|NCT04187144|363536892|FG000|Overall Study|Withdrawal by Subject|20|||
105417779|NCT04187144|363536893|FG001|Overall Study|Withdrawal by Subject|18|||
105417780|NCT04187144|363536892|FG000|Overall Study|Adverse Event|19|||
105417781|NCT04187144|363536893|FG001|Overall Study|Adverse Event|4|||
105417782|NCT04187144|363536892|FG000|Overall Study|Physician Decision|5|||
105417783|NCT04187144|363536893|FG001|Overall Study|Physician Decision|3|||
105417784|NCT04187144|363536892|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
105417785|NCT04187144|363536893|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
105417786|NCT04187144|363536892|FG000|Overall Study|Protocol Deviation|1|||
105417787|NCT04187144|363536893|FG001|Overall Study|Protocol Deviation|4|||
105417788|NCT01519791|363536894|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
105417789|NCT01519791|363536895|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
105417790|NCT01519791|363536894|FG000|Overall Study|Protocol Violation|6|||
105417791|NCT01519791|363536895|FG001|Overall Study|Protocol Violation|19|||
105417792|NCT01519791|363536894|FG000|Overall Study|Other Reason|87|||
105417793|NCT01519791|363536895|FG001|Overall Study|Other Reason|222|||
105417794|NCT01519791|363536894|FG000|Overall Study|subjects randomized in error|2|||
105417795|NCT01519791|363536895|FG001|Overall Study|subjects randomized in error|0|||
105417796|NCT01519791|363536894|FG000|Overall Study|Lack of Efficacy|16|||
105417797|NCT01519791|363536895|FG001|Overall Study|Lack of Efficacy|20|||
105417798|NCT01519791|363536894|FG000|Overall Study|SAE, non-fatal|6|||
105417799|NCT01519791|363536895|FG001|Overall Study|SAE, non-fatal|22|||
105417800|NCT01519791|363536894|FG000|Overall Study|AE, serious fatal|0|||
105417801|NCT01519791|363536895|FG001|Overall Study|AE, serious fatal|1|||
105417802|NCT01519791|363536894|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
105417803|NCT01519791|363536895|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
105417804|NCT01519791|363536894|FG000|Overall Study|AE, non-serious non-fatal|12|||
105417805|NCT01519791|363536895|FG001|Overall Study|AE, non-serious non-fatal|31|||
105417806|NCT01519791|363536894|FG000|Overall Study|Withdrawal by Subject|15|||
105417807|NCT01519791|363536895|FG001|Overall Study|Withdrawal by Subject|37|||
105417808|NCT01519791|363536894|FG000|Overall Study|Lost to Follow-up|6|||
105417809|NCT01519791|363536895|FG001|Overall Study|Lost to Follow-up|14|||
105417810|NCT00489424|363536897|FG000|Overall Study|Adverse Event|3|||
105417811|NCT00489424|363536898|FG001|Overall Study|Adverse Event|3|||
105417812|NCT00489424|363536899|FG002|Overall Study|Adverse Event|4|||
105417813|NCT00489424|363536897|FG000|Overall Study|Lack of Efficacy|1|||
105417814|NCT00489424|363536898|FG001|Overall Study|Lack of Efficacy|0|||
105417815|NCT00489424|363536899|FG002|Overall Study|Lack of Efficacy|0|||
105417816|NCT00489424|363536897|FG000|Overall Study|Administrative problems|0|||
105499313|NCT00494299|363838869|FG000|Overall Study|Lost to Follow-up|1|||
105417817|NCT00489424|363536898|FG001|Overall Study|Administrative problems|2|||
105417818|NCT00489424|363536899|FG002|Overall Study|Administrative problems|1|||
105417819|NCT00664560|363536900|FG000|Overall Study|Adverse Event|19|||
105417820|NCT00664560|363536901|FG001|Overall Study|Adverse Event|16|||
105417821|NCT00664560|363536902|FG002|Overall Study|Adverse Event|7|||
105417822|NCT00664560|363536900|FG000|Overall Study|Withdrawal by Subject|9|||
105417823|NCT00664560|363536901|FG001|Overall Study|Withdrawal by Subject|13|||
105417824|NCT00664560|363536902|FG002|Overall Study|Withdrawal by Subject|7|||
105417825|NCT00664560|363536900|FG000|Overall Study|Lost to Follow-up|0|||
105499314|NCT00494299|363838870|FG001|Overall Study|Lost to Follow-up|0|||
105417826|NCT00664560|363536901|FG001|Overall Study|Lost to Follow-up|2|||
105417827|NCT00664560|363536902|FG002|Overall Study|Lost to Follow-up|0|||
105417828|NCT00664560|363536900|FG000|Overall Study|Other|11|||
105417829|NCT00664560|363536901|FG001|Overall Study|Other|4|||
105417830|NCT00664560|363536902|FG002|Overall Study|Other|5|||
105417831|NCT00705250|363536903|FG000|Overall Study|Withdrawal by Subject|1|||
105417832|NCT00705250|363536903|FG000|Overall Study|Patient died in car accident|1|||
105417833|NCT03350035|363536908|FG000|Overall Study|Lack of Efficacy|2|||
105417834|NCT03350035|363536909|FG001|Overall Study|Lack of Efficacy|0|||
105417835|NCT03350035|363536910|FG002|Overall Study|Lack of Efficacy|0|||
105417836|NCT03350035|363536908|FG000|Overall Study|Subject discharged to hospice|0|||
105417837|NCT03350035|363536909|FG001|Overall Study|Subject discharged to hospice|0|||
105417838|NCT03350035|363536910|FG002|Overall Study|Subject discharged to hospice|1|||
105417839|NCT01545934|363536911|FG000|Overall Study|Withdrawal by Subject|4|||
105417840|NCT01545934|363536912|FG001|Overall Study|Withdrawal by Subject|3|||
105417841|NCT01545934|363536911|FG000|Overall Study|Lost to Follow-up|1|||
105417842|NCT01545934|363536912|FG001|Overall Study|Lost to Follow-up|0|||
105417843|NCT01610557|363536913|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
105417844|NCT01610557|363536914|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
105417845|NCT01610557|363536915|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
105417846|NCT01610557|363536916|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
105417847|NCT01610557|363536917|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
105417848|NCT01610557|363536913|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
105417849|NCT01610557|363536914|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
105417850|NCT01610557|363536915|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
105417851|NCT01610557|363536916|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
105417852|NCT01610557|363536917|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
105417853|NCT00713349|363536920|FG000|Overall Study|Protocol Violation|1|||
105417854|NCT03764631|363536921|FG000|Overall Study|Personal Reasons|3|||
105417855|NCT03764631|363536922|FG001|Overall Study|Personal Reasons|2|||
105417856|NCT03764631|363536921|FG000|Overall Study|Switching Therapy|3|||
105417857|NCT03764631|363536922|FG001|Overall Study|Switching Therapy|3|||
105417858|NCT03764631|363536921|FG000|Overall Study|Adverse Event|0|||
105417859|NCT03764631|363536922|FG001|Overall Study|Adverse Event|1|||
105417860|NCT03764631|363536921|FG000|Overall Study|Lost to Follow-up|33|||
105417861|NCT03764631|363536922|FG001|Overall Study|Lost to Follow-up|41|||
105417862|NCT03764631|363536921|FG000|Overall Study|No data as study site was closed|2|||
105417863|NCT03764631|363536922|FG001|Overall Study|No data as study site was closed|6|||
105417864|NCT00519376|363536923|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105417865|NCT00519376|363536924|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105417866|NCT00519376|363536925|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105417867|NCT00519376|363536926|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105417868|NCT00519376|363536927|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105417869|NCT00519376|363536928|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105417870|NCT00519376|363536929|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105417871|NCT00519376|363536930|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105417872|NCT00519376|363536931|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105417873|NCT00519376|363536932|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105417874|NCT00519376|363536933|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105417875|NCT00519376|363536934|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105417876|NCT00519376|363536935|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
105417877|NCT00519376|363536936|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105417878|NCT00519376|363536937|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105417879|NCT00519376|363536938|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105417880|NCT00519376|363536923|FG000|Treatment Period 4|Lost to Follow-up|0|||
105417881|NCT00519376|363536924|FG001|Treatment Period 4|Lost to Follow-up|0|||
105417882|NCT00519376|363536925|FG002|Treatment Period 4|Lost to Follow-up|1|||
105417883|NCT00519376|363536926|FG003|Treatment Period 4|Lost to Follow-up|0|||
105417884|NCT00519376|363536927|FG004|Treatment Period 4|Lost to Follow-up|0|||
105417885|NCT00519376|363536928|FG005|Treatment Period 4|Lost to Follow-up|0|||
105417886|NCT00519376|363536929|FG006|Treatment Period 4|Lost to Follow-up|0|||
105417887|NCT00519376|363536930|FG007|Treatment Period 4|Lost to Follow-up|0|||
105417888|NCT00519376|363536931|FG008|Treatment Period 4|Lost to Follow-up|0|||
105417889|NCT00519376|363536932|FG009|Treatment Period 4|Lost to Follow-up|0|||
105417890|NCT00519376|363536933|FG010|Treatment Period 4|Lost to Follow-up|0|||
105417891|NCT00519376|363536934|FG011|Treatment Period 4|Lost to Follow-up|0|||
105417892|NCT00519376|363536935|FG012|Treatment Period 4|Lost to Follow-up|0|||
105417893|NCT00519376|363536936|FG013|Treatment Period 4|Lost to Follow-up|0|||
105417894|NCT00519376|363536937|FG014|Treatment Period 4|Lost to Follow-up|0|||
105417895|NCT00519376|363536938|FG015|Treatment Period 4|Lost to Follow-up|0|||
105417896|NCT00245050|363536942|FG000|Overall Study|Adverse Event|3|||
105417897|NCT00245050|363536943|FG001|Overall Study|Adverse Event|2|||
105417898|NCT00695955|363536947|FG000|Cohort 1|Adverse Event|26|||
105417899|NCT00695955|363536947|FG000|Cohort 1|Protocol Violation|2|||
105417900|NCT00695955|363536947|FG000|Cohort 1|Lost to Follow-up|30|||
105417901|NCT00695955|363536947|FG000|Cohort 1|Withdrawal by Subject|25|||
105417902|NCT00695955|363536947|FG000|Cohort 1|Lack of Efficacy|3|||
105417903|NCT00695955|363536947|FG000|Cohort 1|Other|16|||
105417904|NCT00695955|363536947|FG000|Cohort 2|Adverse Event|24|||
105417905|NCT00695955|363536947|FG000|Cohort 2|Protocol Violation|5|||
105417906|NCT00695955|363536947|FG000|Cohort 2|Lost to Follow-up|38|||
105417907|NCT00695955|363536947|FG000|Cohort 2|Withdrawal by Subject|28|||
105417908|NCT00695955|363536947|FG000|Cohort 2|Lack of Efficacy|4|||
105417909|NCT00695955|363536947|FG000|Cohort 2|Other|5|||
105417910|NCT01972308|363536948|FG000|Overall Study|Withdrawal by Subject|0|||
105417911|NCT01972308|363536949|FG001|Overall Study|Withdrawal by Subject|1|||
105417912|NCT01972308|363536948|FG000|Overall Study|Lost to Follow-up|4|||
105417913|NCT01972308|363536949|FG001|Overall Study|Lost to Follow-up|6|||
105417914|NCT01972308|363536948|FG000|Overall Study|Death|4|||
105417915|NCT01972308|363536949|FG001|Overall Study|Death|1|||
105417916|NCT03655054|363536952|FG000|Overall Study|Lost to Follow-up|1|||
105417917|NCT04537208|363536956|FG000|Overall Study|Adverse Event|0|||
105417918|NCT04537208|363536957|FG001|Overall Study|Adverse Event|0|||
105417919|NCT04537208|363536958|FG002|Overall Study|Adverse Event|0|||
105417920|NCT04537208|363536959|FG003|Overall Study|Adverse Event|0|||
105417921|NCT04537208|363536960|FG004|Overall Study|Adverse Event|0|||
105417922|NCT04537208|363536961|FG005|Overall Study|Adverse Event|0|||
105417923|NCT04537208|363536962|FG006|Overall Study|Adverse Event|0|||
105417924|NCT04537208|363536963|FG007|Overall Study|Adverse Event|0|||
105417925|NCT04537208|363536964|FG008|Overall Study|Adverse Event|1|||
105417926|NCT04537208|363536965|FG009|Overall Study|Adverse Event|0|||
105417927|NCT04537208|363536966|FG010|Overall Study|Adverse Event|0|||
105417928|NCT04537208|363536956|FG000|Overall Study|Protocol deviation|0|||
105417929|NCT04537208|363536957|FG001|Overall Study|Protocol deviation|0|||
105417930|NCT04537208|363536958|FG002|Overall Study|Protocol deviation|2|||
105417931|NCT04537208|363536959|FG003|Overall Study|Protocol deviation|0|||
105417932|NCT04537208|363536960|FG004|Overall Study|Protocol deviation|0|||
105417933|NCT04537208|363536961|FG005|Overall Study|Protocol deviation|2|||
105417934|NCT04537208|363536962|FG006|Overall Study|Protocol deviation|4|||
105417935|NCT04537208|363536963|FG007|Overall Study|Protocol deviation|0|||
105417936|NCT04537208|363536964|FG008|Overall Study|Protocol deviation|1|||
105417937|NCT04537208|363536965|FG009|Overall Study|Protocol deviation|0|||
105417938|NCT04537208|363536966|FG010|Overall Study|Protocol deviation|2|||
105417939|NCT04537208|363536956|FG000|Overall Study|Withdrawal by Subject|4|||
105417940|NCT04537208|363536957|FG001|Overall Study|Withdrawal by Subject|2|||
105417941|NCT04537208|363536958|FG002|Overall Study|Withdrawal by Subject|1|||
105417942|NCT04537208|363536959|FG003|Overall Study|Withdrawal by Subject|3|||
105417943|NCT04537208|363536960|FG004|Overall Study|Withdrawal by Subject|5|||
105417944|NCT04537208|363536961|FG005|Overall Study|Withdrawal by Subject|1|||
105417945|NCT04537208|363536962|FG006|Overall Study|Withdrawal by Subject|6|||
105417946|NCT04537208|363536963|FG007|Overall Study|Withdrawal by Subject|1|||
105417947|NCT04537208|363536964|FG008|Overall Study|Withdrawal by Subject|7|||
105417948|NCT04537208|363536965|FG009|Overall Study|Withdrawal by Subject|2|||
105417949|NCT04537208|363536966|FG010|Overall Study|Withdrawal by Subject|4|||
105417950|NCT04537208|363536956|FG000|Overall Study|Lost to Follow-up|4|||
105417951|NCT04537208|363536957|FG001|Overall Study|Lost to Follow-up|1|||
105417952|NCT04537208|363536958|FG002|Overall Study|Lost to Follow-up|3|||
105417953|NCT04537208|363536959|FG003|Overall Study|Lost to Follow-up|4|||
105417954|NCT04537208|363536960|FG004|Overall Study|Lost to Follow-up|3|||
105417955|NCT04537208|363536961|FG005|Overall Study|Lost to Follow-up|2|||
105417956|NCT04537208|363536962|FG006|Overall Study|Lost to Follow-up|3|||
105417957|NCT04537208|363536963|FG007|Overall Study|Lost to Follow-up|2|||
105417958|NCT04537208|363536964|FG008|Overall Study|Lost to Follow-up|7|||
105417959|NCT04537208|363536965|FG009|Overall Study|Lost to Follow-up|2|||
105417960|NCT04537208|363536966|FG010|Overall Study|Lost to Follow-up|2|||
105417961|NCT02256384|363536971|FG000|Overall Study|Withdrawal by Subject|12|||
105417962|NCT02256384|363536971|FG000|Overall Study|Equipment not capturing data|2|||
105417963|NCT03888235|363536974|FG000|Overall Study|Lost to Follow-up|1|||
105417964|NCT03888235|363536975|FG001|Overall Study|Lost to Follow-up|1|||
105417965|NCT03888235|363536976|FG002|Overall Study|Lost to Follow-up|0|||
105417966|NCT04154345|363536980|FG000|Overall Study|Covid-19 pandemic|4|||
105417967|NCT01054560|363536981|FG000|Overall Study|Death|10|||
105417968|NCT01054560|363536982|FG001|Overall Study|Death|21|||
105417969|NCT01054560|363536981|FG000|Overall Study|Lost to Follow-up|2|||
105417970|NCT01054560|363536982|FG001|Overall Study|Lost to Follow-up|5|||
105417971|NCT01054560|363536981|FG000|Overall Study|Withdrawal by Subject|0|||
105417972|NCT01054560|363536982|FG001|Overall Study|Withdrawal by Subject|2|||
105417973|NCT01054560|363536981|FG000|Overall Study|Physician Decision|1|||
105417974|NCT01054560|363536982|FG001|Overall Study|Physician Decision|0|||
105417975|NCT04154605|363536990|FG000|Overall Study|Procedure Canceled|1|||
105417976|NCT04154605|363536991|FG001|Overall Study|Procedure Canceled|1|||
105417977|NCT04154605|363536990|FG000|Overall Study|Missed follow up|1|||
105417978|NCT04154605|363536991|FG001|Overall Study|Missed follow up|1|||
105417979|NCT04154605|363536990|FG000|Overall Study|Withdrawal by Subject|1|||
105417980|NCT04154605|363536991|FG001|Overall Study|Withdrawal by Subject|0|||
105417981|NCT01453205|363536998|FG000|Overall Study|Lost to Follow-up|3|||
105417982|NCT01453205|363536999|FG001|Overall Study|Lost to Follow-up|0|||
105417983|NCT01453205|363537000|FG002|Overall Study|Lost to Follow-up|1|||
105417984|NCT01453205|363536998|FG000|Overall Study|Withdrawal by Subject|8|||
105417985|NCT01453205|363536999|FG001|Overall Study|Withdrawal by Subject|3|||
105417986|NCT01453205|363537000|FG002|Overall Study|Withdrawal by Subject|0|||
105417987|NCT01453205|363536998|FG000|Overall Study|Death|24|||
105417988|NCT01453205|363536999|FG001|Overall Study|Death|22|||
105417989|NCT01453205|363537000|FG002|Overall Study|Death|18|||
105417990|NCT01453205|363536998|FG000|Overall Study|Other|45|||
105417991|NCT01453205|363536999|FG001|Overall Study|Other|27|||
105417992|NCT01453205|363537000|FG002|Overall Study|Other|35|||
105417993|NCT02602275|363537013|FG000|Day 1|Physician Decision|0|||
105417994|NCT02602275|363537014|FG001|Day 1|Physician Decision|1|||
105417995|NCT04262882|363537015|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
105417996|NCT04262882|363537016|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
105417997|NCT04262882|363537015|FG000|Overall Study|Lost to Follow-up|1|||
105417998|NCT04262882|363537016|FG001|Overall Study|Lost to Follow-up|0|||
105499315|NCT00494299|363838869|FG000|Overall Study|Physician Decision|0|||
105499316|NCT00494299|363838870|FG001|Overall Study|Physician Decision|2|||
105499317|NCT00494299|363838869|FG000|Overall Study|Protocol Violation|1|||
105499318|NCT00494299|363838870|FG001|Overall Study|Protocol Violation|2|||
105499319|NCT00494299|363838869|FG000|Overall Study|Withdrawal by Subject|8|||
105499320|NCT00494299|363838870|FG001|Overall Study|Withdrawal by Subject|3|||
105499321|NCT00494299|363838869|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
105499322|NCT00494299|363838870|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
105499323|NCT00494299|363838869|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
105499324|NCT00494299|363838870|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
105499325|NCT00494299|363838869|FG000|Overall Study|Site Closed by Sponsor|6|||
105499326|NCT00494299|363838870|FG001|Overall Study|Site Closed by Sponsor|0|||
105499327|NCT00494299|363838869|FG000|Overall Study|Protocol Driven Decision Point|11|||
105499328|NCT00494299|363838870|FG001|Overall Study|Protocol Driven Decision Point|22|||
105499329|NCT00113087|363838871|FG000|Overall Study|Death or Transplant|14|||
105499330|NCT00113087|363838872|FG001|Overall Study|Death or Transplant|16|||
105499331|NCT00113087|363838871|FG000|Overall Study|Family or MD withdrew subject|10|||
105499332|NCT00113087|363838872|FG001|Overall Study|Family or MD withdrew subject|5|||
105499333|NCT03212690|363838875|FG000|Overall Study|Protocol Violation|1|||
105499334|NCT03540030|363838880|FG000|Overall Study|Withdrawal by Subject|2|||
105499335|NCT03540030|363838881|FG001|Overall Study|Withdrawal by Subject|1|||
105499336|NCT03540030|363838880|FG000|Overall Study|screen fail|7|||
105499337|NCT03540030|363838881|FG001|Overall Study|screen fail|1|||
105499338|NCT03540030|363838880|FG000|Overall Study|never had surgery after signing consent|9|||
105499339|NCT03540030|363838881|FG001|Overall Study|never had surgery after signing consent|1|||
105499340|NCT03307785|363838882|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
105499341|NCT03307785|363838883|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
105499342|NCT03307785|363838884|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
105499343|NCT03307785|363838885|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
105499344|NCT03307785|363838886|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
105499345|NCT03307785|363838887|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
105499346|NCT03307785|363838888|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
105499347|NCT03307785|363838889|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
105499348|NCT03307785|363838890|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
105499349|NCT03307785|363838891|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
105499350|NCT03307785|363838892|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
105499351|NCT03307785|363838882|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
105499352|NCT03307785|363838883|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
105499353|NCT03307785|363838884|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
105499354|NCT03307785|363838885|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
105499355|NCT03307785|363838886|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
105499356|NCT03307785|363838887|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
105499357|NCT03307785|363838888|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
105499358|NCT03307785|363838889|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
105499359|NCT03307785|363838890|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
105499360|NCT03307785|363838891|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
105499361|NCT03307785|363838892|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
105499362|NCT03307785|363838882|FG000|Part A: Up to 28.5 Months|Death|4|||
105417999|NCT06107803|363537021|FG000|Overall Study|Adverse Event|1|||
105418000|NCT06107803|363537021|FG000|Overall Study|Withdrawal by Subject|2|||
105418001|NCT06107803|363537021|FG000|Overall Study|Protocol Violation|1|||
105418002|NCT03099174|363537023|FG000|Overall Study|Withdrawal by Subject|0|||
105499363|NCT03307785|363838883|FG001|Part A: Up to 28.5 Months|Death|4|||
105499364|NCT03307785|363838884|FG002|Part A: Up to 28.5 Months|Death|0|||
105499365|NCT03307785|363838885|FG003|Part A: Up to 28.5 Months|Death|0|||
105418003|NCT03099174|363537024|FG001|Overall Study|Withdrawal by Subject|0|||
105499366|NCT03307785|363838886|FG004|Part A: Up to 28.5 Months|Death|0|||
105499367|NCT03307785|363838887|FG005|Part A: Up to 28.5 Months|Death|0|||
105499368|NCT03307785|363838888|FG006|Part A: Up to 28.5 Months|Death|0|||
105499369|NCT03307785|363838889|FG007|Part A: Up to 28.5 Months|Death|0|||
105499370|NCT03307785|363838890|FG008|Part A: Up to 28.5 Months|Death|0|||
105499371|NCT03307785|363838891|FG009|Part A: Up to 28.5 Months|Death|0|||
105418004|NCT03099174|363537025|FG002|Overall Study|Withdrawal by Subject|1|||
105418005|NCT03099174|363537026|FG003|Overall Study|Withdrawal by Subject|0|||
105418006|NCT03099174|363537027|FG004|Overall Study|Withdrawal by Subject|2|||
105418007|NCT03099174|363537028|FG005|Overall Study|Withdrawal by Subject|2|||
105418008|NCT03099174|363537029|FG006|Overall Study|Withdrawal by Subject|1|||
105418009|NCT03099174|363537030|FG007|Overall Study|Withdrawal by Subject|4|||
105418010|NCT03099174|363537023|FG000|Overall Study|Adverse Event|0|||
105418011|NCT03099174|363537024|FG001|Overall Study|Adverse Event|1|||
105418012|NCT03099174|363537025|FG002|Overall Study|Adverse Event|1|||
105418013|NCT03099174|363537026|FG003|Overall Study|Adverse Event|2|||
105418014|NCT03099174|363537027|FG004|Overall Study|Adverse Event|5|||
105418015|NCT03099174|363537028|FG005|Overall Study|Adverse Event|3|||
105418016|NCT03099174|363537029|FG006|Overall Study|Adverse Event|6|||
105418017|NCT03099174|363537030|FG007|Overall Study|Adverse Event|4|||
105418018|NCT03099174|363537023|FG000|Overall Study|Other than listed|6|||
105418019|NCT03099174|363537024|FG001|Overall Study|Other than listed|6|||
105418020|NCT03099174|363537025|FG002|Overall Study|Other than listed|5|||
105418021|NCT03099174|363537026|FG003|Overall Study|Other than listed|6|||
105418022|NCT03099174|363537027|FG004|Overall Study|Other than listed|19|||
105418023|NCT03099174|363537028|FG005|Overall Study|Other than listed|10|||
105418024|NCT03099174|363537029|FG006|Overall Study|Other than listed|26|||
105418025|NCT03099174|363537030|FG007|Overall Study|Other than listed|23|||
105418026|NCT02378298|363537031|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
105418027|NCT02378298|363537032|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
105418028|NCT02378298|363537033|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
105418029|NCT02378298|363537031|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
105418030|NCT02378298|363537032|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
105418031|NCT02378298|363537033|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
105418032|NCT02378298|363537031|FG000|Surveillance (19-68 Weeks)|Death|1|||
105418033|NCT02378298|363537032|FG001|Surveillance (19-68 Weeks)|Death|0|||
105418034|NCT02378298|363537033|FG002|Surveillance (19-68 Weeks)|Death|0|||
105418035|NCT04934800|363537034|FG000|Overall Study|Other|1|||
105418036|NCT04934800|363537034|FG000|Overall Study|Withdrawal by Subject|5|||
105418037|NCT04934800|363537034|FG000|Overall Study|Lack of Efficacy|1|||
105418038|NCT04934800|363537034|FG000|Overall Study|Adverse Event|9|||
105418039|NCT04934800|363537034|FG000|Overall Study|Lost to Follow-up|5|||
105418040|NCT04934800|363537034|FG000|Overall Study|Enrolled but not treated|1|||
105418041|NCT00516906|363537035|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
105418042|NCT00516906|363537036|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
105418043|NCT00157196|363537041|FG000|Overall Study|Ongoing at data cut-off|9|||
105418044|NCT04210245|363537042|FG000|Overall Study|Adverse Event|0|||
105418045|NCT04210245|363537043|FG001|Overall Study|Adverse Event|3|||
105418046|NCT04210245|363537044|FG002|Overall Study|Adverse Event|6|||
105418047|NCT04210245|363537045|FG003|Overall Study|Adverse Event|0|||
105418048|NCT04210245|363537042|FG000|Overall Study|Withdrawal by Subject|0|||
105418049|NCT04210245|363537043|FG001|Overall Study|Withdrawal by Subject|1|||
105418050|NCT04210245|363537044|FG002|Overall Study|Withdrawal by Subject|4|||
105418051|NCT04210245|363537045|FG003|Overall Study|Withdrawal by Subject|4|||
105418052|NCT04210245|363537042|FG000|Overall Study|Lost to Follow-up|0|||
105418053|NCT04210245|363537043|FG001|Overall Study|Lost to Follow-up|1|||
105418054|NCT04210245|363537044|FG002|Overall Study|Lost to Follow-up|1|||
105418055|NCT04210245|363537045|FG003|Overall Study|Lost to Follow-up|1|||
105418056|NCT04210245|363537042|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
105418057|NCT04210245|363537043|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
105418058|NCT04210245|363537044|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
105418059|NCT04210245|363537045|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
105418060|NCT03941964|363537046|FG000|Overall Study|Adverse Event|1|||
105418061|NCT03941964|363537047|FG001|Overall Study|Adverse Event|8|||
105418062|NCT03941964|363537046|FG000|Overall Study|Progressive disease|7|||
105499372|NCT03307785|363838892|FG010|Part A: Up to 28.5 Months|Death|0|||
105499373|NCT03307785|363838882|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
105418063|NCT03941964|363537047|FG001|Overall Study|Progressive disease|3|||
105418064|NCT03941964|363537046|FG000|Overall Study|Lack of Efficacy|0|||
105418065|NCT03941964|363537047|FG001|Overall Study|Lack of Efficacy|1|||
105499374|NCT03307785|363838883|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
105499375|NCT03307785|363838884|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
105418066|NCT03941964|363537046|FG000|Overall Study|Death|3|||
105418067|NCT03941964|363537047|FG001|Overall Study|Death|1|||
105418068|NCT03941964|363537046|FG000|Overall Study|Withdrew consent|1|||
105418069|NCT03941964|363537047|FG001|Overall Study|Withdrew consent|3|||
105418070|NCT03941964|363537046|FG000|Overall Study|Physician Decision|9|||
105418071|NCT03941964|363537047|FG001|Overall Study|Physician Decision|2|||
105418072|NCT03941964|363537046|FG000|Overall Study|Other, not specified|2|||
105418073|NCT03941964|363537047|FG001|Overall Study|Other, not specified|1|||
105418074|NCT01802580|363537049|FG000|Overall Study|Physician Decision|1|||
105418075|NCT01802580|363537050|FG001|Overall Study|Physician Decision|0|||
105418076|NCT01802580|363537049|FG000|Overall Study|Protocol Violation|2|||
105418077|NCT01802580|363537050|FG001|Overall Study|Protocol Violation|0|||
105418078|NCT01802580|363537049|FG000|Overall Study|Withdrawal by Subject|5|||
105418079|NCT01802580|363537050|FG001|Overall Study|Withdrawal by Subject|6|||
105418080|NCT01802580|363537049|FG000|Overall Study|Other|1|||
105418081|NCT01802580|363537050|FG001|Overall Study|Other|3|||
105418082|NCT01802580|363537049|FG000|Overall Study|Lack of Efficacy|0|||
105418083|NCT01802580|363537050|FG001|Overall Study|Lack of Efficacy|2|||
105418084|NCT03285958|363538965|FG000|Overall Study|Lost to Follow-up|1|||
105418085|NCT03285958|363538966|FG001|Overall Study|Lost to Follow-up|1|||
105418086|NCT03285958|363538965|FG000|Overall Study|Withdrawal by Subject|1|||
105418087|NCT03285958|363538966|FG001|Overall Study|Withdrawal by Subject|0|||
105418088|NCT03285958|363538965|FG000|Overall Study|Not able to attend required orientation|3|||
105418089|NCT03285958|363538966|FG001|Overall Study|Not able to attend required orientation|0|||
105418090|NCT03100539|363538967|FG000|Overall Study|Lost to Follow-up|60|||
105418091|NCT03100539|363538968|FG001|Overall Study|Lost to Follow-up|54|||
105418092|NCT03100539|363538969|FG002|Overall Study|Lost to Follow-up|17|||
105418093|NCT03100539|363538967|FG000|Overall Study|Uncollected|8|||
105418094|NCT03100539|363538968|FG001|Overall Study|Uncollected|8|||
105418095|NCT03100539|363538969|FG002|Overall Study|Uncollected|0|||
105418096|NCT03100539|363538967|FG000|Overall Study|Ally Health|0|||
105418097|NCT03100539|363538968|FG001|Overall Study|Ally Health|0|||
105418098|NCT03100539|363538969|FG002|Overall Study|Ally Health|3|||
105418099|NCT03100539|363538967|FG000|Overall Study|Disinterest|0|||
105418100|NCT03100539|363538968|FG001|Overall Study|Disinterest|0|||
105418101|NCT03100539|363538969|FG002|Overall Study|Disinterest|22|||
105418102|NCT03100539|363538967|FG000|Overall Study|Veteran Health|0|||
105418103|NCT03100539|363538968|FG001|Overall Study|Veteran Health|0|||
105418104|NCT03100539|363538969|FG002|Overall Study|Veteran Health|8|||
105418105|NCT03100539|363538967|FG000|Overall Study|Moved|0|||
105418106|NCT03100539|363538968|FG001|Overall Study|Moved|0|||
105418107|NCT03100539|363538969|FG002|Overall Study|Moved|1|||
105418108|NCT03100539|363538967|FG000|Overall Study|Scheduling Conflicts|0|||
105418109|NCT03100539|363538968|FG001|Overall Study|Scheduling Conflicts|0|||
105418110|NCT03100539|363538969|FG002|Overall Study|Scheduling Conflicts|12|||
105418111|NCT00882583|363538973|FG000|Overall Study|Physician Decision|1|||
105418112|NCT00882583|363538974|FG001|Overall Study|Physician Decision|0|||
105418113|NCT00882583|363538973|FG000|Overall Study|Adverse Event|0|||
105418114|NCT00882583|363538974|FG001|Overall Study|Adverse Event|1|||
105418115|NCT02596958|363538976|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
105418116|NCT02596958|363538976|FG000|Overall Study|Cancer Progression|441|||
105418117|NCT02596958|363538976|FG000|Overall Study|Death From Cancer|112|||
105418118|NCT02596958|363538976|FG000|Overall Study|Death From Other Cause|33|||
105418119|NCT02596958|363538976|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
105418120|NCT02596958|363538976|FG000|Overall Study|Administrative Reasons/Other|231|||
105418121|NCT02596958|363538976|FG000|Overall Study|Lost to Follow-up|33|||
105418122|NCT02596958|363538976|FG000|Overall Study|Missing|32|||
105418123|NCT02596958|363538976|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
105418124|NCT01559259|363538977|FG000|Overall Study|Withdrawal by Subject|0|||
105418125|NCT01559259|363538978|FG001|Overall Study|Withdrawal by Subject|0|||
105418126|NCT01559259|363538979|FG002|Overall Study|Withdrawal by Subject|0|||
105418127|NCT01559259|363538980|FG003|Overall Study|Withdrawal by Subject|1|||
105418128|NCT01559259|363538981|FG004|Overall Study|Withdrawal by Subject|0|||
105418129|NCT01559259|363538977|FG000|Overall Study|Adverse Event|0|||
105418130|NCT01559259|363538978|FG001|Overall Study|Adverse Event|1|||
105418131|NCT01559259|363538979|FG002|Overall Study|Adverse Event|1|||
105418132|NCT01559259|363538980|FG003|Overall Study|Adverse Event|0|||
105418133|NCT01559259|363538981|FG004|Overall Study|Adverse Event|0|||
105418134|NCT01995669|363538982|FG000|Overall Study|Progression|2|||
105418135|NCT01995669|363538983|FG001|Overall Study|Progression|1|||
105418136|NCT01995669|363538984|FG002|Overall Study|Progression|1|||
105418137|NCT01995669|363538985|FG003|Overall Study|Progression|13|||
105418138|NCT01995669|363538982|FG000|Overall Study|Adverse Event|0|||
105418139|NCT01995669|363538983|FG001|Overall Study|Adverse Event|0|||
105418140|NCT01995669|363538984|FG002|Overall Study|Adverse Event|0|||
105418141|NCT01995669|363538985|FG003|Overall Study|Adverse Event|3|||
105418142|NCT01995669|363538982|FG000|Overall Study|Death|0|||
105418143|NCT01995669|363538983|FG001|Overall Study|Death|0|||
105418144|NCT01995669|363538984|FG002|Overall Study|Death|0|||
105418145|NCT01995669|363538985|FG003|Overall Study|Death|6|||
105418146|NCT01995669|363538982|FG000|Overall Study|Withdrawal by Subject|0|||
105418147|NCT01995669|363538983|FG001|Overall Study|Withdrawal by Subject|0|||
105418148|NCT01995669|363538984|FG002|Overall Study|Withdrawal by Subject|0|||
105418149|NCT01995669|363538985|FG003|Overall Study|Withdrawal by Subject|6|||
105418150|NCT01995669|363538982|FG000|Overall Study|Insurance Expired|0|||
105418151|NCT01995669|363538983|FG001|Overall Study|Insurance Expired|0|||
105418152|NCT01995669|363538984|FG002|Overall Study|Insurance Expired|0|||
105418153|NCT01995669|363538985|FG003|Overall Study|Insurance Expired|1|||
105418154|NCT00066703|363538986|FG000|Overall Study|Adverse Event|80|||
105418155|NCT00066703|363538987|FG001|Overall Study|Adverse Event|111|||
105418156|NCT00066703|363538986|FG000|Overall Study|Death|3|||
105418157|NCT00066703|363538987|FG001|Overall Study|Death|0|||
105418158|NCT00066703|363538986|FG000|Overall Study|Lack of Efficacy|114|||
105418159|NCT00066703|363538987|FG001|Overall Study|Lack of Efficacy|69|||
105418160|NCT00066703|363538986|FG000|Overall Study|Lost to Follow-up|31|||
105418161|NCT00066703|363538987|FG001|Overall Study|Lost to Follow-up|28|||
105418162|NCT00066703|363538986|FG000|Overall Study|Withdrawal by Subject|38|||
105418163|NCT00066703|363538987|FG001|Overall Study|Withdrawal by Subject|63|||
105418164|NCT00066703|363538986|FG000|Overall Study|Treatment ongoing|346|||
105418165|NCT00066703|363538987|FG001|Overall Study|Treatment ongoing|311|||
105418166|NCT05425732|363538988|FG000|Overall Study|Death|4|||
105418167|NCT05425732|363538989|FG001|Overall Study|Death|2|||
105418168|NCT05425732|363538990|FG002|Overall Study|Death|0|||
105418169|NCT05425732|363538991|FG003|Overall Study|Death|0|||
105418170|NCT05425732|363538988|FG000|Overall Study|Lost to Follow-up|10|||
105418171|NCT05425732|363538989|FG001|Overall Study|Lost to Follow-up|15|||
105418172|NCT05425732|363538990|FG002|Overall Study|Lost to Follow-up|5|||
105418173|NCT05425732|363538991|FG003|Overall Study|Lost to Follow-up|3|||
105418174|NCT05425732|363538988|FG000|Overall Study|Physician Decision|0|||
105418175|NCT05425732|363538989|FG001|Overall Study|Physician Decision|2|||
105418176|NCT05425732|363538990|FG002|Overall Study|Physician Decision|0|||
105418177|NCT05425732|363538991|FG003|Overall Study|Physician Decision|0|||
105418178|NCT05425732|363538988|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
105418179|NCT05425732|363538989|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
105418180|NCT05425732|363538990|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105418181|NCT05425732|363538991|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105418182|NCT05425732|363538988|FG000|Overall Study|Withdrawal by Subject|4|||
105418183|NCT05425732|363538989|FG001|Overall Study|Withdrawal by Subject|8|||
105418184|NCT05425732|363538990|FG002|Overall Study|Withdrawal by Subject|1|||
105418185|NCT05425732|363538991|FG003|Overall Study|Withdrawal by Subject|1|||
105418186|NCT05425732|363538988|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
105418187|NCT05425732|363538989|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
105418188|NCT05425732|363538990|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
105418189|NCT05425732|363538991|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
105418190|NCT03727646|363538992|FG000|Overall Study|Adverse Event|1|||
105418191|NCT03727646|363538993|FG001|Overall Study|Adverse Event|0|||
105418192|NCT04753658|363538994|FG000|Overall Study|Progressive disease|7|||
105418193|NCT04753658|363538994|FG000|Overall Study|Other|7|||
105418194|NCT04753658|363538994|FG000|Overall Study|Adverse Event|1|||
105418195|NCT00306293|363538996|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
105418196|NCT00306293|363538997|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
105418197|NCT00306293|363538996|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
105418198|NCT00306293|363538997|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
105418199|NCT00306293|363538996|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
105418200|NCT00306293|363538997|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
105418201|NCT00306293|363538996|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
105418202|NCT00306293|363538997|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
105418203|NCT00306293|363538996|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
105418204|NCT00306293|363538997|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
105418205|NCT00306293|363538996|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
105418206|NCT00306293|363538997|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
105418207|NCT00306293|363538996|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
105418208|NCT00306293|363538997|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
105418209|NCT00306293|363538996|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
105418210|NCT00306293|363538997|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
105418211|NCT00185380|363538998|FG000|Overall Study|Adverse Event|41|||
105418212|NCT00185380|363538999|FG001|Overall Study|Adverse Event|43|||
105418213|NCT00185380|363539000|FG002|Overall Study|Adverse Event|48|||
105418214|NCT00185380|363538998|FG000|Overall Study|Lost to Follow-up|0|||
105418215|NCT00185380|363538999|FG001|Overall Study|Lost to Follow-up|4|||
105418216|NCT00185380|363539000|FG002|Overall Study|Lost to Follow-up|3|||
105418217|NCT00185380|363538998|FG000|Overall Study|Pregnancy|1|||
105418218|NCT00185380|363538999|FG001|Overall Study|Pregnancy|4|||
105418219|NCT00185380|363539000|FG002|Overall Study|Pregnancy|0|||
105418220|NCT00185380|363538998|FG000|Overall Study|Protocol Violation|2|||
105418221|NCT00185380|363538999|FG001|Overall Study|Protocol Violation|2|||
105418222|NCT00185380|363539000|FG002|Overall Study|Protocol Violation|1|||
105418223|NCT00185380|363538998|FG000|Overall Study|Withdrawal by Subject|1|||
105418224|NCT00185380|363538999|FG001|Overall Study|Withdrawal by Subject|2|||
105418225|NCT00185380|363539000|FG002|Overall Study|Withdrawal by Subject|0|||
105418226|NCT00185380|363538998|FG000|Overall Study|Failed insertion|1|||
105418227|NCT00185380|363538999|FG001|Overall Study|Failed insertion|1|||
105418228|NCT00185380|363539000|FG002|Overall Study|Failed insertion|2|||
105418229|NCT00185380|363538998|FG000|Overall Study|Planned pregnancy|9|||
105418230|NCT00185380|363538999|FG001|Overall Study|Planned pregnancy|12|||
105418231|NCT00185380|363539000|FG002|Overall Study|Planned pregnancy|12|||
105418232|NCT00185380|363538998|FG000|Overall Study|No need for contraception|3|||
105418233|NCT00185380|363538999|FG001|Overall Study|No need for contraception|3|||
105418234|NCT00185380|363539000|FG002|Overall Study|No need for contraception|3|||
105418235|NCT00185380|363538998|FG000|Overall Study|Could not attend visits|2|||
105418236|NCT00185380|363538999|FG001|Overall Study|Could not attend visits|0|||
105418237|NCT00185380|363539000|FG002|Overall Study|Could not attend visits|4|||
105418238|NCT00185380|363538998|FG000|Overall Study|personal reason|6|||
105418239|NCT00185380|363538999|FG001|Overall Study|personal reason|1|||
105418240|NCT00185380|363539000|FG002|Overall Study|personal reason|1|||
105418241|NCT02998203|363539002|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
105418242|NCT02998203|363539003|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
105418243|NCT02998203|363539002|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
105418244|NCT02998203|363539003|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
105418245|NCT02589665|363539004|FG000|Induction Period|Did not receive drug|0|||
105418246|NCT02589665|363539005|FG001|Induction Period|Did not receive drug|0|||
105418247|NCT02589665|363539006|FG002|Induction Period|Did not receive drug|0|||
105418248|NCT02589665|363539007|FG003|Induction Period|Did not receive drug|1|||
105418249|NCT02589665|363539008|FG004|Induction Period|Did not receive drug|0|||
105418250|NCT02589665|363539009|FG005|Induction Period|Did not receive drug|0|||
105418251|NCT02589665|363539010|FG006|Induction Period|Did not receive drug|0|||
105418252|NCT02589665|363539011|FG007|Induction Period|Did not receive drug|0|||
105418253|NCT02589665|363539012|FG008|Induction Period|Did not receive drug|0|||
105418254|NCT02589665|363539013|FG009|Induction Period|Did not receive drug|0|||
105418255|NCT02589665|363539004|FG000|Induction Period|Adverse Event|3|||
105418256|NCT02589665|363539005|FG001|Induction Period|Adverse Event|0|||
105418257|NCT02589665|363539006|FG002|Induction Period|Adverse Event|2|||
105418258|NCT02589665|363539007|FG003|Induction Period|Adverse Event|2|||
105418259|NCT02589665|363539008|FG004|Induction Period|Adverse Event|0|||
105418260|NCT02589665|363539009|FG005|Induction Period|Adverse Event|0|||
105418261|NCT02589665|363539010|FG006|Induction Period|Adverse Event|0|||
105418262|NCT02589665|363539011|FG007|Induction Period|Adverse Event|0|||
105418263|NCT02589665|363539012|FG008|Induction Period|Adverse Event|0|||
105418264|NCT02589665|363539013|FG009|Induction Period|Adverse Event|0|||
105418265|NCT02589665|363539004|FG000|Induction Period|Withdrawal by Subject|0|||
105418266|NCT02589665|363539005|FG001|Induction Period|Withdrawal by Subject|1|||
105418267|NCT02589665|363539006|FG002|Induction Period|Withdrawal by Subject|0|||
105418268|NCT02589665|363539007|FG003|Induction Period|Withdrawal by Subject|1|||
105418269|NCT02589665|363539008|FG004|Induction Period|Withdrawal by Subject|0|||
105418270|NCT02589665|363539009|FG005|Induction Period|Withdrawal by Subject|0|||
105418271|NCT02589665|363539010|FG006|Induction Period|Withdrawal by Subject|0|||
105418272|NCT02589665|363539011|FG007|Induction Period|Withdrawal by Subject|0|||
105418273|NCT02589665|363539012|FG008|Induction Period|Withdrawal by Subject|0|||
105418274|NCT02589665|363539013|FG009|Induction Period|Withdrawal by Subject|0|||
105418275|NCT02589665|363539004|FG000|Induction Period|Protocol Violation|0|||
105418276|NCT02589665|363539005|FG001|Induction Period|Protocol Violation|1|||
105418277|NCT02589665|363539006|FG002|Induction Period|Protocol Violation|0|||
105418278|NCT02589665|363539007|FG003|Induction Period|Protocol Violation|0|||
105418279|NCT02589665|363539008|FG004|Induction Period|Protocol Violation|0|||
105418280|NCT02589665|363539009|FG005|Induction Period|Protocol Violation|0|||
105418281|NCT02589665|363539010|FG006|Induction Period|Protocol Violation|0|||
105418282|NCT02589665|363539011|FG007|Induction Period|Protocol Violation|0|||
105418283|NCT02589665|363539012|FG008|Induction Period|Protocol Violation|0|||
105418284|NCT02589665|363539013|FG009|Induction Period|Protocol Violation|0|||
105418285|NCT02589665|363539004|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105418286|NCT02589665|363539005|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105418287|NCT02589665|363539006|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105418288|NCT02589665|363539007|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105418289|NCT02589665|363539008|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
105418290|NCT02589665|363539009|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
105418291|NCT02589665|363539010|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
105418292|NCT02589665|363539011|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105418293|NCT02589665|363539012|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105418294|NCT02589665|363539013|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105583866|NCT03073005|364135339|FG000|Overall Study|Lost to Follow-up|2|||
105583867|NCT03073005|364135340|FG001|Overall Study|Lost to Follow-up|2|||
105583868|NCT03073005|364135341|FG002|Overall Study|Lost to Follow-up|1|||
105583869|NCT03073005|364135342|FG003|Overall Study|Lost to Follow-up|2|||
105583870|NCT03073005|364135339|FG000|Overall Study|Withdrawal by Subject|0|||
105583871|NCT03073005|364135340|FG001|Overall Study|Withdrawal by Subject|4|||
105583872|NCT03073005|364135341|FG002|Overall Study|Withdrawal by Subject|4|||
105583873|NCT03073005|364135342|FG003|Overall Study|Withdrawal by Subject|4|||
105583874|NCT02427646|364135343|FG000|Overall Study|Lack of Efficacy|2|||
105583875|NCT02427646|364135344|FG001|Overall Study|Lack of Efficacy|3|||
105583876|NCT02427646|364135343|FG000|Overall Study|Physician Decision|1|||
105583877|NCT02427646|364135344|FG001|Overall Study|Physician Decision|4|||
105583878|NCT02427646|364135343|FG000|Overall Study|Protocol Violation|3|||
105583879|NCT02427646|364135344|FG001|Overall Study|Protocol Violation|3|||
105583880|NCT02427646|364135343|FG000|Overall Study|Bothersome hand weakness|2|||
105583881|NCT02427646|364135344|FG001|Overall Study|Bothersome hand weakness|4|||
105583882|NCT02414828|364135345|FG000|Overall Study|Lost to Follow-up|0|||
105583883|NCT02414828|364135346|FG001|Overall Study|Lost to Follow-up|1|||
105583884|NCT02414828|364135347|FG002|Overall Study|Lost to Follow-up|1|||
105583885|NCT02414828|364135348|FG003|Overall Study|Lost to Follow-up|2|||
105583886|NCT01641861|364135349|FG000|Overall Study|Lost to Follow-up|21|||
105583887|NCT01641861|364135350|FG001|Overall Study|Lost to Follow-up|16|||
105583888|NCT01641861|364135349|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
105583889|NCT01641861|364135350|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
105583890|NCT01641861|364135349|FG000|Overall Study|Died due to drowning|0|||
105583891|NCT01641861|364135350|FG001|Overall Study|Died due to drowning|1|||
105583892|NCT01556243|364135351|FG000|Overall Study|Ineligible|34|||
105583893|NCT01556243|364135351|FG000|Overall Study|Converted to mastectomy|14|||
105583894|NCT01556243|364135351|FG000|Overall Study|Unable to achieve negative margins|2|||
105418295|NCT02589665|363539004|FG000|Maintenance Period|Withdrawal by Subject|0|||
105418296|NCT02589665|363539005|FG001|Maintenance Period|Withdrawal by Subject|0|||
105418297|NCT02589665|363539006|FG002|Maintenance Period|Withdrawal by Subject|0|||
105418298|NCT02589665|363539007|FG003|Maintenance Period|Withdrawal by Subject|0|||
105418299|NCT02589665|363539008|FG004|Maintenance Period|Withdrawal by Subject|4|||
105418300|NCT02589665|363539009|FG005|Maintenance Period|Withdrawal by Subject|2|||
105418301|NCT02589665|363539010|FG006|Maintenance Period|Withdrawal by Subject|4|||
105418302|NCT02589665|363539011|FG007|Maintenance Period|Withdrawal by Subject|0|||
105418303|NCT02589665|363539012|FG008|Maintenance Period|Withdrawal by Subject|0|||
105418304|NCT02589665|363539013|FG009|Maintenance Period|Withdrawal by Subject|0|||
105418305|NCT02589665|363539004|FG000|Maintenance Period|Lack of Efficacy|0|||
105418306|NCT02589665|363539005|FG001|Maintenance Period|Lack of Efficacy|0|||
105418307|NCT02589665|363539006|FG002|Maintenance Period|Lack of Efficacy|0|||
105418308|NCT02589665|363539007|FG003|Maintenance Period|Lack of Efficacy|0|||
105418309|NCT02589665|363539008|FG004|Maintenance Period|Lack of Efficacy|2|||
105418310|NCT02589665|363539009|FG005|Maintenance Period|Lack of Efficacy|1|||
105418311|NCT02589665|363539010|FG006|Maintenance Period|Lack of Efficacy|0|||
105418312|NCT02589665|363539011|FG007|Maintenance Period|Lack of Efficacy|0|||
105418313|NCT02589665|363539012|FG008|Maintenance Period|Lack of Efficacy|0|||
105418314|NCT02589665|363539013|FG009|Maintenance Period|Lack of Efficacy|0|||
105418315|NCT02589665|363539004|FG000|Maintenance Period|Adverse Event|0|||
105418316|NCT02589665|363539005|FG001|Maintenance Period|Adverse Event|0|||
105418317|NCT02589665|363539006|FG002|Maintenance Period|Adverse Event|0|||
105418318|NCT02589665|363539007|FG003|Maintenance Period|Adverse Event|0|||
105418319|NCT02589665|363539008|FG004|Maintenance Period|Adverse Event|0|||
105418320|NCT02589665|363539009|FG005|Maintenance Period|Adverse Event|0|||
105418321|NCT02589665|363539010|FG006|Maintenance Period|Adverse Event|2|||
105583895|NCT01556243|364135351|FG000|Overall Study|Withdrawal by Subject|16|||
105583896|NCT03253653|364135356|FG000|Overall Study|Withdrawal by Subject|4|||
105583897|NCT03253653|364135357|FG001|Overall Study|Withdrawal by Subject|1|||
105583898|NCT03253653|364135356|FG000|Overall Study|Protocol Violation|0|||
105583899|NCT03253653|364135357|FG001|Overall Study|Protocol Violation|5|||
105418322|NCT02589665|363539011|FG007|Maintenance Period|Adverse Event|0|||
105418323|NCT02589665|363539012|FG008|Maintenance Period|Adverse Event|0|||
105418324|NCT02589665|363539013|FG009|Maintenance Period|Adverse Event|0|||
105418325|NCT02589665|363539004|FG000|Maintenance Period|Lost to Follow-up|0|||
105418326|NCT02589665|363539005|FG001|Maintenance Period|Lost to Follow-up|0|||
105418327|NCT02589665|363539006|FG002|Maintenance Period|Lost to Follow-up|0|||
105418328|NCT02589665|363539007|FG003|Maintenance Period|Lost to Follow-up|0|||
105418329|NCT02589665|363539008|FG004|Maintenance Period|Lost to Follow-up|0|||
105418330|NCT02589665|363539009|FG005|Maintenance Period|Lost to Follow-up|1|||
105418331|NCT02589665|363539010|FG006|Maintenance Period|Lost to Follow-up|0|||
105418332|NCT02589665|363539011|FG007|Maintenance Period|Lost to Follow-up|0|||
105418333|NCT02589665|363539012|FG008|Maintenance Period|Lost to Follow-up|0|||
105418334|NCT02589665|363539013|FG009|Maintenance Period|Lost to Follow-up|0|||
105583900|NCT01115998|364136716|FG000|Overall Study|Lost to Follow-up|6|||
105583901|NCT01115998|364136717|FG001|Overall Study|Lost to Follow-up|6|||
105583902|NCT04096365|364136718|FG000|Overall Study|Adverse Event|1|||
105499376|NCT03307785|363838885|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
105499377|NCT03307785|363838886|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
105499378|NCT03307785|363838887|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
105499379|NCT03307785|363838888|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
105499380|NCT03307785|363838889|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
105499381|NCT03307785|363838890|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
105499382|NCT03307785|363838891|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
105499383|NCT03307785|363838892|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
105499384|NCT03307785|363838882|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
105499385|NCT03307785|363838883|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
105499386|NCT03307785|363838884|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
105499387|NCT03307785|363838885|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
105499388|NCT03307785|363838886|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
105499389|NCT03307785|363838887|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
105499390|NCT03307785|363838888|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
105499391|NCT03307785|363838889|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
105499392|NCT03307785|363838890|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
105499393|NCT03307785|363838891|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
105499394|NCT03307785|363838892|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
105499395|NCT03307785|363838882|FG000|Part B: Up to Approx. 66 Months|Death|0|||
105499396|NCT03307785|363838883|FG001|Part B: Up to Approx. 66 Months|Death|0|||
105499397|NCT03307785|363838884|FG002|Part B: Up to Approx. 66 Months|Death|7|||
105499398|NCT03307785|363838885|FG003|Part B: Up to Approx. 66 Months|Death|0|||
105499399|NCT03307785|363838886|FG004|Part B: Up to Approx. 66 Months|Death|0|||
105499400|NCT03307785|363838887|FG005|Part B: Up to Approx. 66 Months|Death|0|||
105499401|NCT03307785|363838888|FG006|Part B: Up to Approx. 66 Months|Death|0|||
105499402|NCT03307785|363838889|FG007|Part B: Up to Approx. 66 Months|Death|0|||
105499403|NCT03307785|363838890|FG008|Part B: Up to Approx. 66 Months|Death|0|||
105499404|NCT03307785|363838891|FG009|Part B: Up to Approx. 66 Months|Death|0|||
105499405|NCT03307785|363838892|FG010|Part B: Up to Approx. 66 Months|Death|0|||
105499406|NCT03307785|363838882|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
105499407|NCT03307785|363838883|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
105499408|NCT03307785|363838884|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
105499409|NCT03307785|363838885|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
105499410|NCT03307785|363838886|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
105499411|NCT03307785|363838887|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
105499412|NCT03307785|363838888|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
105499413|NCT03307785|363838889|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
105418335|NCT02589665|363539004|FG000|Maintenance Period|Physician Decision|0|||
105418336|NCT02589665|363539005|FG001|Maintenance Period|Physician Decision|0|||
105418337|NCT02589665|363539006|FG002|Maintenance Period|Physician Decision|0|||
105418338|NCT02589665|363539007|FG003|Maintenance Period|Physician Decision|0|||
105418339|NCT02589665|363539008|FG004|Maintenance Period|Physician Decision|0|||
105418340|NCT02589665|363539009|FG005|Maintenance Period|Physician Decision|1|||
105418341|NCT02589665|363539010|FG006|Maintenance Period|Physician Decision|0|||
105418342|NCT02589665|363539011|FG007|Maintenance Period|Physician Decision|0|||
105418343|NCT02589665|363539012|FG008|Maintenance Period|Physician Decision|0|||
105418344|NCT02589665|363539013|FG009|Maintenance Period|Physician Decision|0|||
105418345|NCT02589665|363539004|FG000|Maintenance Period|Reason Not Collected|0|||
105418346|NCT02589665|363539005|FG001|Maintenance Period|Reason Not Collected|0|||
105418347|NCT02589665|363539006|FG002|Maintenance Period|Reason Not Collected|0|||
105418348|NCT02589665|363539007|FG003|Maintenance Period|Reason Not Collected|0|||
105418349|NCT02589665|363539008|FG004|Maintenance Period|Reason Not Collected|0|||
105418350|NCT02589665|363539009|FG005|Maintenance Period|Reason Not Collected|1|||
105418351|NCT02589665|363539010|FG006|Maintenance Period|Reason Not Collected|1|||
105418352|NCT02589665|363539011|FG007|Maintenance Period|Reason Not Collected|0|||
105418353|NCT02589665|363539012|FG008|Maintenance Period|Reason Not Collected|0|||
105418354|NCT02589665|363539013|FG009|Maintenance Period|Reason Not Collected|0|||
105418355|NCT02589665|363539004|FG000|Induction Extension Period|Adverse Event|0|||
105418356|NCT02589665|363539005|FG001|Induction Extension Period|Adverse Event|0|||
105418357|NCT02589665|363539006|FG002|Induction Extension Period|Adverse Event|0|||
105499414|NCT03307785|363838890|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
105499415|NCT03307785|363838891|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
105499416|NCT03307785|363838892|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
105499417|NCT03307785|363838882|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
105418358|NCT02589665|363539007|FG003|Induction Extension Period|Adverse Event|0|||
105499418|NCT03307785|363838883|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
105499419|NCT03307785|363838884|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
105418359|NCT02589665|363539008|FG004|Induction Extension Period|Adverse Event|0|||
105418360|NCT02589665|363539009|FG005|Induction Extension Period|Adverse Event|0|||
105583903|NCT02107274|364136719|FG000|Treatment vs. Placebo|Adverse Event|3|||
105583904|NCT02107274|364136720|FG001|Treatment vs. Placebo|Adverse Event|0|||
105583905|NCT02107274|364136719|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
105583906|NCT02107274|364136720|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
105583907|NCT02107274|364136719|FG000|Control Phase|Lost to Follow-up|1|||
105583908|NCT02107274|364136720|FG001|Control Phase|Lost to Follow-up|1|||
105583909|NCT02107274|364136719|FG000|Control Phase|Death|2|||
105583910|NCT02107274|364136720|FG001|Control Phase|Death|0|||
105583911|NCT02107274|364136719|FG000|Control Phase|Adverse Event|0|||
105583912|NCT02107274|364136720|FG001|Control Phase|Adverse Event|1|||
105583913|NCT01021878|364136721|FG000|Overall Study|Lost to Follow-up|4|||
105583914|NCT01021878|364136722|FG001|Overall Study|Lost to Follow-up|3|||
105583915|NCT01021878|364136721|FG000|Overall Study|Death|0|||
105583916|NCT01021878|364136722|FG001|Overall Study|Death|1|||
105583917|NCT01021878|364136721|FG000|Overall Study|Adverse Event|6|||
105583918|NCT01021878|364136722|FG001|Overall Study|Adverse Event|5|||
105583919|NCT01021878|364136721|FG000|Overall Study|Transplantation|6|||
105583920|NCT01021878|364136722|FG001|Overall Study|Transplantation|1|||
105583921|NCT02403674|364136723|FG000|Base Study|Death|1|||
105583922|NCT02403674|364136724|FG001|Base Study|Death|4|||
105583923|NCT02403674|364136723|FG000|Base Study|Adverse Event|11|||
105583924|NCT02403674|364136724|FG001|Base Study|Adverse Event|26|||
105583925|NCT02403674|364136723|FG000|Base Study|Lack of Efficacy|31|||
105583926|NCT02403674|364136724|FG001|Base Study|Lack of Efficacy|23|||
105583927|NCT02403674|364136723|FG000|Base Study|Lost to Follow-up|6|||
105583928|NCT02403674|364136724|FG001|Base Study|Lost to Follow-up|8|||
105583929|NCT02403674|364136723|FG000|Base Study|Withdrawal by Subject|10|||
105583930|NCT02403674|364136724|FG001|Base Study|Withdrawal by Subject|17|||
105583931|NCT02403674|364136723|FG000|Base Study|Physician Decision|2|||
105583932|NCT02403674|364136724|FG001|Base Study|Physician Decision|2|||
105583933|NCT02403674|364136723|FG000|Base Study|Pregnancy|2|||
105583934|NCT02403674|364136724|FG001|Base Study|Pregnancy|2|||
105583935|NCT02403674|364136723|FG000|Base Study|Protocol Violation|8|||
105583936|NCT02403674|364136724|FG001|Base Study|Protocol Violation|4|||
105583937|NCT02403674|364136723|FG000|Base Study|Non-Compliance with study drug|1|||
105418361|NCT02589665|363539010|FG006|Induction Extension Period|Adverse Event|0|||
105418362|NCT02589665|363539011|FG007|Induction Extension Period|Adverse Event|0|||
105418363|NCT02589665|363539012|FG008|Induction Extension Period|Adverse Event|4|||
105418364|NCT02589665|363539013|FG009|Induction Extension Period|Adverse Event|0|||
105418365|NCT02589665|363539004|FG000|Induction Extension Period|Lack of Efficacy|0|||
105418366|NCT02589665|363539005|FG001|Induction Extension Period|Lack of Efficacy|0|||
105418367|NCT02589665|363539006|FG002|Induction Extension Period|Lack of Efficacy|0|||
105418368|NCT02589665|363539007|FG003|Induction Extension Period|Lack of Efficacy|0|||
105418369|NCT02589665|363539008|FG004|Induction Extension Period|Lack of Efficacy|0|||
105418370|NCT02589665|363539009|FG005|Induction Extension Period|Lack of Efficacy|0|||
105418371|NCT02589665|363539010|FG006|Induction Extension Period|Lack of Efficacy|0|||
105418372|NCT02589665|363539011|FG007|Induction Extension Period|Lack of Efficacy|0|||
105418373|NCT02589665|363539012|FG008|Induction Extension Period|Lack of Efficacy|3|||
105418374|NCT02589665|363539013|FG009|Induction Extension Period|Lack of Efficacy|0|||
105418375|NCT02589665|363539004|FG000|Induction Extension Period|Withdrawal by Subject|0|||
105418376|NCT02589665|363539005|FG001|Induction Extension Period|Withdrawal by Subject|0|||
105499420|NCT03307785|363838885|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
105499421|NCT03307785|363838886|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
105499422|NCT03307785|363838887|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
105499423|NCT03307785|363838888|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
105499424|NCT03307785|363838889|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
105499425|NCT03307785|363838890|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
105499426|NCT03307785|363838891|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
105499427|NCT03307785|363838892|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
105499428|NCT03307785|363838882|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
105499429|NCT03307785|363838883|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
105499430|NCT03307785|363838884|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
105499431|NCT03307785|363838885|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
105499432|NCT03307785|363838886|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
105583938|NCT02403674|364136724|FG001|Base Study|Non-Compliance with study drug|4|||
105583939|NCT02403674|364136723|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
105583940|NCT02403674|364136724|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
105583941|NCT02403674|364136723|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
105583942|NCT02403674|364136724|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
105583943|NCT02403674|364136723|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
105583944|NCT02403674|364136724|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
105583945|NCT02403674|364136723|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
105583946|NCT02403674|364136724|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
105626697|NCT04186819|364298168|FG000|Overall Study|Opted for EBRT|1|||
105418377|NCT02589665|363539006|FG002|Induction Extension Period|Withdrawal by Subject|0|||
105418378|NCT02589665|363539007|FG003|Induction Extension Period|Withdrawal by Subject|0|||
105418379|NCT02589665|363539008|FG004|Induction Extension Period|Withdrawal by Subject|0|||
105418380|NCT02589665|363539009|FG005|Induction Extension Period|Withdrawal by Subject|0|||
105418381|NCT02589665|363539010|FG006|Induction Extension Period|Withdrawal by Subject|0|||
105418382|NCT02589665|363539011|FG007|Induction Extension Period|Withdrawal by Subject|2|||
105418383|NCT02589665|363539012|FG008|Induction Extension Period|Withdrawal by Subject|3|||
105418384|NCT02589665|363539013|FG009|Induction Extension Period|Withdrawal by Subject|0|||
105418385|NCT02589665|363539004|FG000|Induction Extension Period|Physician Decision|0|||
105418386|NCT02589665|363539005|FG001|Induction Extension Period|Physician Decision|0|||
105418387|NCT02589665|363539006|FG002|Induction Extension Period|Physician Decision|0|||
105418388|NCT02589665|363539007|FG003|Induction Extension Period|Physician Decision|0|||
105418389|NCT02589665|363539008|FG004|Induction Extension Period|Physician Decision|0|||
105418390|NCT02589665|363539009|FG005|Induction Extension Period|Physician Decision|0|||
105418391|NCT02589665|363539010|FG006|Induction Extension Period|Physician Decision|0|||
105418392|NCT02589665|363539011|FG007|Induction Extension Period|Physician Decision|0|||
105418393|NCT02589665|363539012|FG008|Induction Extension Period|Physician Decision|1|||
105418394|NCT02589665|363539013|FG009|Induction Extension Period|Physician Decision|0|||
105418395|NCT02589665|363539004|FG000|Induction Extension Period|Reason Not Collected|0|||
105418396|NCT02589665|363539005|FG001|Induction Extension Period|Reason Not Collected|0|||
105418397|NCT02589665|363539006|FG002|Induction Extension Period|Reason Not Collected|0|||
105418398|NCT02589665|363539007|FG003|Induction Extension Period|Reason Not Collected|0|||
105418399|NCT02589665|363539008|FG004|Induction Extension Period|Reason Not Collected|0|||
105418400|NCT02589665|363539009|FG005|Induction Extension Period|Reason Not Collected|0|||
105418401|NCT02589665|363539010|FG006|Induction Extension Period|Reason Not Collected|0|||
105418402|NCT02589665|363539011|FG007|Induction Extension Period|Reason Not Collected|0|||
105418403|NCT02589665|363539012|FG008|Induction Extension Period|Reason Not Collected|1|||
105418404|NCT02589665|363539013|FG009|Induction Extension Period|Reason Not Collected|0|||
105418405|NCT02589665|363539004|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105418406|NCT02589665|363539005|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105499433|NCT03307785|363838887|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
105499434|NCT03307785|363838888|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
105499435|NCT03307785|363838889|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
105499436|NCT03307785|363838890|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
105499437|NCT03307785|363838891|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
105499438|NCT03307785|363838892|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
105499439|NCT03307785|363838882|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
105499440|NCT03307785|363838883|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
105499441|NCT03307785|363838884|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
105499442|NCT03307785|363838885|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
105583947|NCT02403674|364136723|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
105583948|NCT02403674|364136724|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
105583949|NCT02403674|364136723|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
105583950|NCT02403674|364136724|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
105583951|NCT02403674|364136723|FG000|Study Extension 1 (Open-Label)|Death|1|||
105583952|NCT02403674|364136724|FG001|Study Extension 1 (Open-Label)|Death|0|||
105583953|NCT02403674|364136723|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
105583954|NCT02403674|364136724|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
105583955|NCT02403674|364136723|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
105583956|NCT02403674|364136724|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
105583957|NCT02403674|364136723|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
105583958|NCT02403674|364136724|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
105583959|NCT02403674|364136723|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
105583960|NCT02403674|364136724|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
105583961|NCT02403674|364136723|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
105583962|NCT02403674|364136724|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
105583963|NCT02403674|364136723|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
105583964|NCT02403674|364136724|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
105583965|NCT02403674|364136723|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
105583966|NCT02403674|364136724|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
105583967|NCT02403674|364136723|FG000|Study Extension 2 (Open-Label)|Death|2|||
105583968|NCT02403674|364136724|FG001|Study Extension 2 (Open-Label)|Death|2|||
105583969|NCT02403674|364136723|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
105583970|NCT02403674|364136724|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
105583971|NCT02403674|364136723|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
105583972|NCT02403674|364136724|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
105583973|NCT02403674|364136723|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
105583974|NCT02403674|364136724|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
105626698|NCT04186819|364298168|FG000|Overall Study|Opted SBRT|1|||
105583975|NCT02403674|364136723|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
105583976|NCT02403674|364136724|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
105583977|NCT02403674|364136723|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
105583978|NCT02403674|364136724|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
105583979|NCT02403674|364136723|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
105583980|NCT02403674|364136724|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
105583981|NCT02403674|364136723|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
105583982|NCT02403674|364136724|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
105583983|NCT03487666|364136728|FG000|Overall Study|Disease progression|4|||
105583984|NCT03487666|364136729|FG001|Overall Study|Disease progression|2|||
105583985|NCT03487666|364136730|FG002|Overall Study|Disease progression|0|||
105583986|NCT03487666|364136728|FG000|Overall Study|Adverse Event|0|||
105583987|NCT03487666|364136729|FG001|Overall Study|Adverse Event|0|||
105583988|NCT03487666|364136730|FG002|Overall Study|Adverse Event|1|||
105583989|NCT05343455|364136733|FG000|Overall Study|Withdrawal by Subject|4|||
105583990|NCT05343455|364136734|FG001|Overall Study|Withdrawal by Subject|9|||
105583991|NCT05343455|364136735|FG002|Overall Study|Withdrawal by Subject|7|||
105583992|NCT05343455|364136733|FG000|Overall Study|Adverse Event|2|||
105418407|NCT02589665|363539006|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105418408|NCT02589665|363539007|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105418409|NCT02589665|363539008|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105418410|NCT02589665|363539009|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105418411|NCT02589665|363539010|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105418412|NCT02589665|363539011|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105418413|NCT02589665|363539012|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105439957|NCT01618695|363616638|FG000|Extension Phase|Withdrawal by Subject|43|||
105583993|NCT05343455|364136734|FG001|Overall Study|Adverse Event|1|||
105583994|NCT05343455|364136735|FG002|Overall Study|Adverse Event|2|||
105583995|NCT05343455|364136733|FG000|Overall Study|Lost to Follow-up|1|||
105439958|NCT01618695|363616639|FG001|Extension Phase|Withdrawal by Subject|48|||
105439959|NCT01618695|363616640|FG002|Extension Phase|Withdrawal by Subject|42|||
105439960|NCT01618695|363616641|FG003|Extension Phase|Withdrawal by Subject|33|||
105439961|NCT01618695|363616638|FG000|Extension Phase|Adverse Event|18|||
105439962|NCT01618695|363616639|FG001|Extension Phase|Adverse Event|16|||
105439963|NCT01618695|363616640|FG002|Extension Phase|Adverse Event|9|||
105439964|NCT01618695|363616641|FG003|Extension Phase|Adverse Event|20|||
105439965|NCT01618695|363616638|FG000|Extension Phase|Lost to Follow-up|2|||
105439966|NCT01618695|363616639|FG001|Extension Phase|Lost to Follow-up|1|||
105439967|NCT01618695|363616640|FG002|Extension Phase|Lost to Follow-up|1|||
105439968|NCT01618695|363616641|FG003|Extension Phase|Lost to Follow-up|1|||
105439969|NCT01618695|363616638|FG000|Extension Phase|Other than specified|13|||
105439970|NCT01618695|363616639|FG001|Extension Phase|Other than specified|18|||
105439971|NCT01618695|363616640|FG002|Extension Phase|Other than specified|13|||
105439972|NCT01618695|363616641|FG003|Extension Phase|Other than specified|18|||
105439973|NCT02454478|363616643|FG000|Overall Study|Incomplete DLT Evaluation|1|||
105439974|NCT03521141|363616649|FG000|Overall Study|Death|1|||
105439975|NCT03521141|363616650|FG001|Overall Study|Death|0|||
105439976|NCT03521141|363616651|FG002|Overall Study|Death|1|||
105439977|NCT04207749|363616662|FG000|Overall Study|Lost to Follow-up|0|||
105439978|NCT04207749|363616663|FG001|Overall Study|Lost to Follow-up|2|||
105439979|NCT04207749|363616662|FG000|Overall Study|Protocol Violation|0|||
105439980|NCT04207749|363616663|FG001|Overall Study|Protocol Violation|1|||
105439981|NCT04207749|363616662|FG000|Overall Study|Withdrawal by Subject|3|||
105439982|NCT04207749|363616663|FG001|Overall Study|Withdrawal by Subject|0|||
105439983|NCT04207749|363616662|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
105439984|NCT04207749|363616663|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
105439985|NCT00705367|363616666|FG000|Long-term Extension Period|Adverse Event|2|||
105439986|NCT00705367|363616667|FG001|Long-term Extension Period|Adverse Event|0|||
105439987|NCT00705367|363616666|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
105439988|NCT00705367|363616667|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
105439989|NCT00705367|363616666|FG000|Long-term Extension Period|Lack of Efficacy|1|||
105439990|NCT00705367|363616667|FG001|Long-term Extension Period|Lack of Efficacy|0|||
105439991|NCT00705367|363616666|FG000|Long-term Extension Period|No longer met study criteria|1|||
105439992|NCT00705367|363616667|FG001|Long-term Extension Period|No longer met study criteria|0|||
105439993|NCT00705367|363616666|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
105439994|NCT00705367|363616667|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
105439995|NCT01835223|363616668|FG000|Overall Study|Adverse Event|1|||
105439996|NCT01835223|363616669|FG001|Overall Study|Adverse Event|0|||
105439997|NCT01835223|363616668|FG000|Overall Study|Withdrawal by Subject|2|||
105439998|NCT01835223|363616669|FG001|Overall Study|Withdrawal by Subject|0|||
105418414|NCT02589665|363539013|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
105418415|NCT02589665|363539004|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
105418416|NCT02589665|363539005|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
105418417|NCT02589665|363539006|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
105418418|NCT02589665|363539007|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
105418419|NCT02589665|363539008|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
105418420|NCT02589665|363539009|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
105418421|NCT02589665|363539010|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
105418422|NCT02589665|363539011|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
105418423|NCT02589665|363539012|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
105418424|NCT02589665|363539013|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
105418425|NCT02589665|363539004|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
105418426|NCT02589665|363539005|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
105418427|NCT02589665|363539006|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
105418428|NCT02589665|363539007|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
105418429|NCT02589665|363539008|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
105418430|NCT02589665|363539009|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
105418431|NCT02589665|363539010|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
105418432|NCT02589665|363539011|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
105418433|NCT02589665|363539012|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
105418434|NCT02589665|363539013|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
105418435|NCT02589665|363539004|FG000|Maintenance Extension Period|Adverse Event|0|||
105418436|NCT02589665|363539005|FG001|Maintenance Extension Period|Adverse Event|0|||
105418437|NCT02589665|363539006|FG002|Maintenance Extension Period|Adverse Event|0|||
105418438|NCT02589665|363539007|FG003|Maintenance Extension Period|Adverse Event|0|||
105418439|NCT02589665|363539008|FG004|Maintenance Extension Period|Adverse Event|0|||
105418440|NCT02589665|363539009|FG005|Maintenance Extension Period|Adverse Event|0|||
105418441|NCT02589665|363539010|FG006|Maintenance Extension Period|Adverse Event|0|||
105418442|NCT02589665|363539011|FG007|Maintenance Extension Period|Adverse Event|0|||
105418443|NCT02589665|363539012|FG008|Maintenance Extension Period|Adverse Event|0|||
105418444|NCT02589665|363539013|FG009|Maintenance Extension Period|Adverse Event|2|||
105418445|NCT02589665|363539004|FG000|Maintenance Extension Period|Non-responder|0|||
105418446|NCT02589665|363539005|FG001|Maintenance Extension Period|Non-responder|0|||
105418447|NCT02589665|363539006|FG002|Maintenance Extension Period|Non-responder|0|||
105418448|NCT02589665|363539007|FG003|Maintenance Extension Period|Non-responder|0|||
105418449|NCT02589665|363539008|FG004|Maintenance Extension Period|Non-responder|0|||
105418450|NCT02589665|363539009|FG005|Maintenance Extension Period|Non-responder|0|||
105418451|NCT02589665|363539010|FG006|Maintenance Extension Period|Non-responder|0|||
105418452|NCT02589665|363539011|FG007|Maintenance Extension Period|Non-responder|0|||
105418453|NCT02589665|363539012|FG008|Maintenance Extension Period|Non-responder|0|||
105418454|NCT02589665|363539013|FG009|Maintenance Extension Period|Non-responder|1|||
105418455|NCT02199314|363539016|FG000|Overall Study|Withdrawal by Subject|6|||
105418456|NCT02199314|363539016|FG000|Overall Study|Physician Decision|10|||
105418457|NCT03842969|363539017|FG000|Overall Study|Participant declined follow-up visit|0|||
105418458|NCT03842969|363539018|FG001|Overall Study|Participant declined follow-up visit|1|||
105418459|NCT03842969|363539019|FG002|Overall Study|Participant declined follow-up visit|0|||
105418460|NCT03842969|363539017|FG000|Overall Study|Sponsor's decision|12|||
105418461|NCT03842969|363539018|FG001|Overall Study|Sponsor's decision|99|||
105418462|NCT03842969|363539019|FG002|Overall Study|Sponsor's decision|61|||
105418463|NCT03842969|363539017|FG000|Overall Study|Pregnancy|0|||
105418464|NCT03842969|363539018|FG001|Overall Study|Pregnancy|0|||
105418465|NCT03842969|363539019|FG002|Overall Study|Pregnancy|1|||
105418466|NCT03842969|363539017|FG000|Overall Study|Death|1|||
105418467|NCT03842969|363539018|FG001|Overall Study|Death|0|||
105418468|NCT03842969|363539019|FG002|Overall Study|Death|1|||
105499443|NCT03307785|363838886|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
105499444|NCT03307785|363838887|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
105499445|NCT03307785|363838888|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
105499446|NCT03307785|363838889|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
105418469|NCT03842969|363539017|FG000|Overall Study|Withdrawal by Subject|3|||
105418470|NCT03842969|363539018|FG001|Overall Study|Withdrawal by Subject|30|||
105418471|NCT03842969|363539019|FG002|Overall Study|Withdrawal by Subject|18|||
105418472|NCT03842969|363539017|FG000|Overall Study|Protocol Violation|1|||
105418473|NCT03842969|363539018|FG001|Overall Study|Protocol Violation|1|||
105418474|NCT03842969|363539019|FG002|Overall Study|Protocol Violation|0|||
105499447|NCT03307785|363838890|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
105418475|NCT03842969|363539017|FG000|Overall Study|Physician Decision|0|||
105418476|NCT03842969|363539018|FG001|Overall Study|Physician Decision|3|||
105418477|NCT03842969|363539019|FG002|Overall Study|Physician Decision|0|||
105418478|NCT03842969|363539017|FG000|Overall Study|Lost to Follow-up|0|||
105418479|NCT03842969|363539018|FG001|Overall Study|Lost to Follow-up|2|||
105418480|NCT03842969|363539019|FG002|Overall Study|Lost to Follow-up|0|||
105418481|NCT03842969|363539017|FG000|Overall Study|Adverse Event|0|||
105418482|NCT03842969|363539018|FG001|Overall Study|Adverse Event|2|||
105418483|NCT03842969|363539019|FG002|Overall Study|Adverse Event|0|||
105418484|NCT02650804|363539020|FG000|Overall Study|Adverse Event|3|||
105418485|NCT02650804|363539021|FG001|Overall Study|Adverse Event|2|||
105418486|NCT02650804|363539020|FG000|Overall Study|Death|1|||
105418487|NCT02650804|363539021|FG001|Overall Study|Death|2|||
105418488|NCT02650804|363539020|FG000|Overall Study|Progressive Disease|7|||
105418489|NCT02650804|363539021|FG001|Overall Study|Progressive Disease|10|||
105418490|NCT02650804|363539020|FG000|Overall Study|Physician Decision|0|||
105418491|NCT02650804|363539021|FG001|Overall Study|Physician Decision|2|||
105418492|NCT02650804|363539020|FG000|Overall Study|Withdrawal by Subject|1|||
105418493|NCT02650804|363539021|FG001|Overall Study|Withdrawal by Subject|4|||
105418494|NCT02650804|363539020|FG000|Overall Study|Symptomatic deterioration|5|||
105418495|NCT02650804|363539021|FG001|Overall Study|Symptomatic deterioration|7|||
105418496|NCT02650804|363539020|FG000|Overall Study|Protocol Violation|0|||
105418497|NCT02650804|363539021|FG001|Overall Study|Protocol Violation|1|||
105418498|NCT01044745|363539022|FG000|Overall Study|Ineiligible|2|||
105418499|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Adverse Event|76|||
105418500|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Adverse Event|0|||
105418501|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Adverse Event|0|||
105418502|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Death|3|||
105418503|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Death|0|||
105418504|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Death|0|||
105418505|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
105418506|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
105418507|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
105418508|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Physician Decision|9|||
105418509|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Physician Decision|0|||
105418510|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Physician Decision|0|||
105418511|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
105418512|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
105418513|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
105418514|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Disease progression|45|||
105418515|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Disease progression|0|||
105418516|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Disease progression|0|||
105418517|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
105418518|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
105418519|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
105418520|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
105418521|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
105418522|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
105418523|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
105418524|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
105418525|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
105418526|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
105418527|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
105418528|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
105418529|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
105418530|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
105418531|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
105418532|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
105418533|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
105418534|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
105418535|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
105418536|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
105418537|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
105418538|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
105418539|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
105418540|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
105418541|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
105418542|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
105418543|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
105418544|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Promotor request|1|||
105418545|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Promotor request|0|||
105418546|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Promotor request|0|||
105418547|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
105418548|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
105418549|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
105418550|NCT01461928|363539026|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
105418551|NCT01461928|363539027|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
105418552|NCT01461928|363539028|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
105418553|NCT01461928|363539026|FG000|Maintenance I (24 Months)|Death|3|||
105418554|NCT01461928|363539027|FG001|Maintenance I (24 Months)|Death|0|||
105418555|NCT01461928|363539028|FG002|Maintenance I (24 Months)|Death|0|||
105418556|NCT01461928|363539026|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
105418557|NCT01461928|363539027|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
105499448|NCT03307785|363838891|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
105499449|NCT03307785|363838892|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
105499450|NCT03307785|363838882|FG000|Part C: Up to Approx. 60 Months|Death|0|||
105499451|NCT03307785|363838883|FG001|Part C: Up to Approx. 60 Months|Death|0|||
105499452|NCT03307785|363838884|FG002|Part C: Up to Approx. 60 Months|Death|0|||
105499453|NCT03307785|363838885|FG003|Part C: Up to Approx. 60 Months|Death|2|||
105499454|NCT03307785|363838886|FG004|Part C: Up to Approx. 60 Months|Death|5|||
105499455|NCT03307785|363838887|FG005|Part C: Up to Approx. 60 Months|Death|0|||
105499456|NCT03307785|363838888|FG006|Part C: Up to Approx. 60 Months|Death|0|||
105499457|NCT03307785|363838889|FG007|Part C: Up to Approx. 60 Months|Death|0|||
105499458|NCT03307785|363838890|FG008|Part C: Up to Approx. 60 Months|Death|0|||
105499459|NCT03307785|363838891|FG009|Part C: Up to Approx. 60 Months|Death|0|||
105499460|NCT03307785|363838892|FG010|Part C: Up to Approx. 60 Months|Death|0|||
105499461|NCT03307785|363838882|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
105499462|NCT03307785|363838883|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
105499463|NCT03307785|363838884|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
105499464|NCT03307785|363838885|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
105499465|NCT03307785|363838886|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
105499466|NCT03307785|363838887|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
105499467|NCT03307785|363838888|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
105499468|NCT03307785|363838889|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
105499469|NCT03307785|363838890|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
105499470|NCT03307785|363838891|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
105499471|NCT03307785|363838892|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
105499472|NCT03307785|363838882|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
105499473|NCT03307785|363838883|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
105499474|NCT03307785|363838884|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
105499475|NCT03307785|363838885|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
105499476|NCT03307785|363838886|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
105499477|NCT03307785|363838887|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
105499478|NCT03307785|363838888|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
105499479|NCT03307785|363838889|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
105499480|NCT03307785|363838890|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
105499481|NCT03307785|363838891|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
105499482|NCT03307785|363838892|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
105499483|NCT03307785|363838882|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
105499484|NCT03307785|363838883|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
105499485|NCT03307785|363838884|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
105499486|NCT03307785|363838885|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
105499487|NCT03307785|363838886|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
105499488|NCT03307785|363838887|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
105499489|NCT03307785|363838888|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
105499490|NCT03307785|363838889|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
105499491|NCT03307785|363838890|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
105499492|NCT03307785|363838891|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
105499493|NCT03307785|363838892|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
105499494|NCT03307785|363838882|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
105499495|NCT03307785|363838883|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
105499496|NCT03307785|363838884|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
105499497|NCT03307785|363838885|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
105499498|NCT03307785|363838886|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
105499499|NCT03307785|363838887|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
105499500|NCT03307785|363838888|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
105499501|NCT03307785|363838889|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
105499502|NCT03307785|363838890|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
105499503|NCT03307785|363838891|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
105499504|NCT03307785|363838892|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
105499505|NCT03307785|363838882|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
105499506|NCT03307785|363838883|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
105418558|NCT01461928|363539028|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
105418559|NCT01461928|363539026|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
105418560|NCT01461928|363539027|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
105418561|NCT01461928|363539028|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
105418562|NCT01461928|363539026|FG000|Maintenance I (24 Months)|Diseases progression|91|||
105418563|NCT01461928|363539027|FG001|Maintenance I (24 Months)|Diseases progression|0|||
105418564|NCT01461928|363539028|FG002|Maintenance I (24 Months)|Diseases progression|0|||
105418565|NCT01461928|363539026|FG000|Maintenance I (24 Months)|Adverse Event|70|||
105418566|NCT01461928|363539027|FG001|Maintenance I (24 Months)|Adverse Event|0|||
105418567|NCT01461928|363539028|FG002|Maintenance I (24 Months)|Adverse Event|0|||
105418568|NCT01461928|363539026|FG000|Maintenance I (24 Months)|Physician Decision|9|||
105418569|NCT01461928|363539027|FG001|Maintenance I (24 Months)|Physician Decision|0|||
105418570|NCT01461928|363539028|FG002|Maintenance I (24 Months)|Physician Decision|0|||
105418571|NCT01461928|363539026|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
105418572|NCT01461928|363539027|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
105418573|NCT01461928|363539028|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
105418574|NCT01461928|363539026|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
105418575|NCT01461928|363539027|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
105418576|NCT01461928|363539028|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
105418577|NCT01461928|363539026|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
105418578|NCT01461928|363539027|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
105418579|NCT01461928|363539028|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
105418580|NCT01461928|363539026|FG000|Maintenance I (24 Months)|Not compliant|1|||
105418581|NCT01461928|363539027|FG001|Maintenance I (24 Months)|Not compliant|0|||
105418582|NCT01461928|363539028|FG002|Maintenance I (24 Months)|Not compliant|0|||
105418583|NCT01461928|363539026|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
105418584|NCT01461928|363539027|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
105418585|NCT01461928|363539028|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
105418586|NCT01461928|363539026|FG000|Maintenance II (15 Months)|Adverse Event|0|||
105418587|NCT01461928|363539027|FG001|Maintenance II (15 Months)|Adverse Event|2|||
105418588|NCT01461928|363539028|FG002|Maintenance II (15 Months)|Adverse Event|0|||
105418589|NCT01461928|363539026|FG000|Maintenance II (15 Months)|Death|0|||
105418590|NCT01461928|363539027|FG001|Maintenance II (15 Months)|Death|10|||
105418591|NCT01461928|363539028|FG002|Maintenance II (15 Months)|Death|8|||
105418592|NCT01461928|363539026|FG000|Maintenance II (15 Months)|Physician Decision|0|||
105418593|NCT01461928|363539027|FG001|Maintenance II (15 Months)|Physician Decision|0|||
105418594|NCT01461928|363539028|FG002|Maintenance II (15 Months)|Physician Decision|4|||
105418595|NCT01461928|363539026|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
105418596|NCT01461928|363539027|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
105418597|NCT01461928|363539028|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
105418598|NCT01461928|363539026|FG000|Maintenance II (15 Months)|Moved to another town|0|||
105499507|NCT03307785|363838884|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
105499508|NCT03307785|363838885|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
105499509|NCT03307785|363838886|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
105499510|NCT03307785|363838887|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
105499511|NCT03307785|363838888|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
105499512|NCT03307785|363838889|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
105499513|NCT03307785|363838890|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
105499514|NCT03307785|363838891|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
105499515|NCT03307785|363838892|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
105499516|NCT03307785|363838882|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
105499517|NCT03307785|363838883|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
105499518|NCT03307785|363838884|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
105499519|NCT03307785|363838885|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
105499520|NCT03307785|363838886|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
105499521|NCT03307785|363838887|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
105499522|NCT03307785|363838888|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
105499523|NCT03307785|363838889|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
105499524|NCT03307785|363838890|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
105499525|NCT03307785|363838891|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
105499526|NCT03307785|363838892|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
105499527|NCT03307785|363838882|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
105499528|NCT03307785|363838883|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
105499529|NCT03307785|363838884|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
105499530|NCT03307785|363838885|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
105499531|NCT03307785|363838886|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
105418599|NCT01461928|363539027|FG001|Maintenance II (15 Months)|Moved to another town|1|||
105418600|NCT01461928|363539028|FG002|Maintenance II (15 Months)|Moved to another town|0|||
105418601|NCT01461928|363539026|FG000|Maintenance II (15 Months)|Disease progression|0|||
105418602|NCT01461928|363539027|FG001|Maintenance II (15 Months)|Disease progression|0|||
105418603|NCT01461928|363539028|FG002|Maintenance II (15 Months)|Disease progression|3|||
105418604|NCT01461928|363539026|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
105418605|NCT01461928|363539027|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
105418606|NCT01461928|363539028|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
105418607|NCT01461928|363539026|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
105418608|NCT01461928|363539027|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
105418609|NCT01461928|363539028|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
105418610|NCT01461928|363539026|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
105418611|NCT01461928|363539027|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
105418612|NCT01461928|363539028|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
105418613|NCT01461928|363539026|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
105418614|NCT01461928|363539027|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
105418615|NCT01461928|363539028|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
105418616|NCT01461928|363539026|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
105418617|NCT01461928|363539027|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
105418618|NCT01461928|363539028|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
105418619|NCT01892436|363539029|FG000|Overall Study|Withdrawal by Subject|8|||
105418620|NCT01892436|363539030|FG001|Overall Study|Withdrawal by Subject|15|||
105418621|NCT01892436|363539031|FG002|Overall Study|Withdrawal by Subject|4|||
105418622|NCT01892436|363539032|FG003|Overall Study|Withdrawal by Subject|4|||
105418623|NCT01892436|363539029|FG000|Overall Study|Death|1|||
105418624|NCT01892436|363539030|FG001|Overall Study|Death|1|||
105418625|NCT01892436|363539031|FG002|Overall Study|Death|0|||
105418626|NCT01892436|363539032|FG003|Overall Study|Death|0|||
105418627|NCT01892436|363539029|FG000|Overall Study|Physician Decision|2|||
105418628|NCT01892436|363539030|FG001|Overall Study|Physician Decision|1|||
105418629|NCT01892436|363539031|FG002|Overall Study|Physician Decision|0|||
105418630|NCT01892436|363539032|FG003|Overall Study|Physician Decision|1|||
105418631|NCT01892436|363539029|FG000|Overall Study|Pregnancy|0|||
105418632|NCT01892436|363539030|FG001|Overall Study|Pregnancy|2|||
105418633|NCT01892436|363539031|FG002|Overall Study|Pregnancy|1|||
105418634|NCT01892436|363539032|FG003|Overall Study|Pregnancy|0|||
105418635|NCT01892436|363539029|FG000|Overall Study|Technical problems|2|||
105418636|NCT01892436|363539030|FG001|Overall Study|Technical problems|1|||
105418637|NCT01892436|363539031|FG002|Overall Study|Technical problems|1|||
105418638|NCT01892436|363539032|FG003|Overall Study|Technical problems|1|||
105418639|NCT01892436|363539029|FG000|Overall Study|Lack of Efficacy|1|||
105418640|NCT01892436|363539030|FG001|Overall Study|Lack of Efficacy|2|||
105418641|NCT01892436|363539031|FG002|Overall Study|Lack of Efficacy|2|||
105418642|NCT01892436|363539032|FG003|Overall Study|Lack of Efficacy|2|||
105418643|NCT01892436|363539029|FG000|Overall Study|Lost to Follow-up|1|||
105418644|NCT01892436|363539030|FG001|Overall Study|Lost to Follow-up|1|||
105418645|NCT01892436|363539031|FG002|Overall Study|Lost to Follow-up|1|||
105418646|NCT01892436|363539032|FG003|Overall Study|Lost to Follow-up|3|||
105418647|NCT01892436|363539029|FG000|Overall Study|non-compliance with treatment|1|||
105418648|NCT01892436|363539030|FG001|Overall Study|non-compliance with treatment|0|||
105418649|NCT01892436|363539031|FG002|Overall Study|non-compliance with treatment|0|||
105418650|NCT01892436|363539032|FG003|Overall Study|non-compliance with treatment|0|||
105418651|NCT01892436|363539029|FG000|Overall Study|Adverse Event|7|||
105418652|NCT01892436|363539030|FG001|Overall Study|Adverse Event|6|||
105418653|NCT01892436|363539031|FG002|Overall Study|Adverse Event|2|||
105418654|NCT01892436|363539032|FG003|Overall Study|Adverse Event|3|||
105418655|NCT00733291|363539037|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
105418656|NCT00733291|363539038|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
105418657|NCT00733291|363539039|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
105418658|NCT00733291|363539040|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
105418659|NCT02242435|363539043|FG000|Overall Study|Lost to Follow-up|3|||
105418660|NCT02242435|363539044|FG001|Overall Study|Lost to Follow-up|4|||
105418661|NCT02242435|363539043|FG000|Overall Study|Adverse Event|3|||
105418662|NCT02242435|363539044|FG001|Overall Study|Adverse Event|2|||
105418663|NCT02242435|363539043|FG000|Overall Study|Withdrawal by Subject|13|||
105418664|NCT02242435|363539044|FG001|Overall Study|Withdrawal by Subject|8|||
105499532|NCT03307785|363838887|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
105418665|NCT02242435|363539043|FG000|Overall Study|Death|0|||
105418666|NCT02242435|363539044|FG001|Overall Study|Death|1|||
105418667|NCT02242435|363539043|FG000|Overall Study|Protocol Violation|1|||
105418668|NCT02242435|363539044|FG001|Overall Study|Protocol Violation|0|||
105418669|NCT02242435|363539043|FG000|Overall Study|Physician Decision|0|||
105418670|NCT02242435|363539044|FG001|Overall Study|Physician Decision|1|||
105418671|NCT03895086|363539048|FG000|Overall Study|Early termination study|1|||
105418672|NCT03895086|363539049|FG001|Overall Study|Early termination study|0|||
105418673|NCT02759107|363539051|FG000|Overall Study|Adverse Event|0|||
105418674|NCT02759107|363539052|FG001|Overall Study|Adverse Event|0|||
105418675|NCT02759107|363539053|FG002|Overall Study|Adverse Event|0|||
105418676|NCT02759107|363539054|FG003|Overall Study|Adverse Event|0|||
105418677|NCT02759107|363539055|FG004|Overall Study|Adverse Event|0|||
105418678|NCT02759107|363539056|FG005|Overall Study|Adverse Event|0|||
105418679|NCT02759107|363539057|FG006|Overall Study|Adverse Event|0|||
105418680|NCT02759107|363539058|FG007|Overall Study|Adverse Event|0|||
105418681|NCT02759107|363539059|FG008|Overall Study|Adverse Event|0|||
105418682|NCT02759107|363539060|FG009|Overall Study|Adverse Event|0|||
105418683|NCT02759107|363539061|FG010|Overall Study|Adverse Event|0|||
105418684|NCT02759107|363539062|FG011|Overall Study|Adverse Event|0|||
105418685|NCT02759107|363539063|FG012|Overall Study|Adverse Event|2|||
105418686|NCT02759107|363539064|FG013|Overall Study|Adverse Event|0|||
105418687|NCT02759107|363539065|FG014|Overall Study|Adverse Event|0|||
105418688|NCT02759107|363539066|FG015|Overall Study|Adverse Event|1|||
105418689|NCT02759107|363539067|FG016|Overall Study|Adverse Event|0|||
105418690|NCT02759107|363539068|FG017|Overall Study|Adverse Event|2|||
105418691|NCT02759107|363539051|FG000|Overall Study|Scheduling Conflict|0|||
105418692|NCT02759107|363539052|FG001|Overall Study|Scheduling Conflict|0|||
105418693|NCT02759107|363539053|FG002|Overall Study|Scheduling Conflict|0|||
105418694|NCT02759107|363539054|FG003|Overall Study|Scheduling Conflict|0|||
105418695|NCT02759107|363539055|FG004|Overall Study|Scheduling Conflict|0|||
105418696|NCT02759107|363539056|FG005|Overall Study|Scheduling Conflict|0|||
105418697|NCT02759107|363539057|FG006|Overall Study|Scheduling Conflict|0|||
105418698|NCT02759107|363539058|FG007|Overall Study|Scheduling Conflict|0|||
105418699|NCT02759107|363539059|FG008|Overall Study|Scheduling Conflict|0|||
105418700|NCT02759107|363539060|FG009|Overall Study|Scheduling Conflict|1|||
105418701|NCT02759107|363539061|FG010|Overall Study|Scheduling Conflict|0|||
105418702|NCT02759107|363539062|FG011|Overall Study|Scheduling Conflict|0|||
105418703|NCT02759107|363539063|FG012|Overall Study|Scheduling Conflict|0|||
105418704|NCT02759107|363539064|FG013|Overall Study|Scheduling Conflict|0|||
105418705|NCT02759107|363539065|FG014|Overall Study|Scheduling Conflict|0|||
105418706|NCT02759107|363539066|FG015|Overall Study|Scheduling Conflict|0|||
105418707|NCT02759107|363539067|FG016|Overall Study|Scheduling Conflict|0|||
105418708|NCT02759107|363539068|FG017|Overall Study|Scheduling Conflict|0|||
105418709|NCT03095027|363539074|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
105418710|NCT03095027|363539075|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
105418711|NCT02974855|363539080|FG000|Overall Study|Adverse Event|0|||
105418712|NCT02974855|363539081|FG001|Overall Study|Adverse Event|1|||
105418713|NCT02974855|363539082|FG002|Overall Study|Adverse Event|0|||
105418714|NCT02974855|363539083|FG003|Overall Study|Adverse Event|1|||
105418715|NCT01681069|363539084|FG000|Overall Study|Withdrawal by Subject|4|||
105418716|NCT01681069|363539085|FG001|Overall Study|Withdrawal by Subject|5|||
105418717|NCT01681069|363539084|FG000|Overall Study|Protocol Violation|1|||
105418718|NCT01681069|363539085|FG001|Overall Study|Protocol Violation|1|||
105418719|NCT01681069|363539084|FG000|Overall Study|Adverse Event|0|||
105418720|NCT01681069|363539085|FG001|Overall Study|Adverse Event|1|||
105418721|NCT00923975|363539086|FG000|Overall Study|Did not meet inclusion criteria|1|||
105418722|NCT01032291|363539094|FG000|Safety Lead-in|Adverse Event|1|||
105418723|NCT01032291|363539095|FG001|Safety Lead-in|Adverse Event|0|||
105418724|NCT01032291|363539096|FG002|Safety Lead-in|Adverse Event|0|||
105418725|NCT01032291|363539094|FG000|Safety Lead-in|Death|1|||
105418726|NCT01032291|363539095|FG001|Safety Lead-in|Death|0|||
105418727|NCT01032291|363539096|FG002|Safety Lead-in|Death|0|||
105418728|NCT01032291|363539094|FG000|Proof of Concept|Adverse Event|0|||
105418729|NCT01032291|363539095|FG001|Proof of Concept|Adverse Event|5|||
105418730|NCT01032291|363539096|FG002|Proof of Concept|Adverse Event|1|||
105418731|NCT01032291|363539094|FG000|Proof of Concept|Death|0|||
105418732|NCT01032291|363539095|FG001|Proof of Concept|Death|1|||
105418733|NCT01032291|363539096|FG002|Proof of Concept|Death|2|||
105418734|NCT01032291|363539094|FG000|Proof of Concept|Lack of Efficacy|0|||
105418735|NCT01032291|363539095|FG001|Proof of Concept|Lack of Efficacy|1|||
105418736|NCT01032291|363539096|FG002|Proof of Concept|Lack of Efficacy|0|||
105418737|NCT01032291|363539094|FG000|Proof of Concept|Never Received Study Drug|0|||
105418738|NCT01032291|363539095|FG001|Proof of Concept|Never Received Study Drug|1|||
105418739|NCT01032291|363539096|FG002|Proof of Concept|Never Received Study Drug|0|||
105418740|NCT02449889|363539097|FG000|Overall Study|Adverse Event|1|||
105418741|NCT02449889|363539098|FG001|Overall Study|Adverse Event|2|||
105418742|NCT02449889|363539099|FG002|Overall Study|Adverse Event|0|||
105418743|NCT02449889|363539097|FG000|Overall Study|Protocol Violation|0|||
105418744|NCT02449889|363539098|FG001|Overall Study|Protocol Violation|4|||
105418745|NCT02449889|363539099|FG002|Overall Study|Protocol Violation|1|||
105418746|NCT00758264|363539100|FG000|Active Phase|Withdrawal by Subject|0|||
105418747|NCT00758264|363539101|FG001|Active Phase|Withdrawal by Subject|0|||
105418748|NCT00758264|363539102|FG002|Active Phase|Withdrawal by Subject|1|||
105418749|NCT00758264|363539100|FG000|Active Phase|Lost to Follow-up|1|||
105418750|NCT00758264|363539101|FG001|Active Phase|Lost to Follow-up|0|||
105499533|NCT03307785|363838888|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
105499534|NCT03307785|363838889|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
105499535|NCT03307785|363838890|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
105499536|NCT03307785|363838891|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
105499537|NCT03307785|363838892|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
105499538|NCT03307785|363838882|FG000|Part E: Up to 4.4 Months|Death|0|||
105499539|NCT03307785|363838883|FG001|Part E: Up to 4.4 Months|Death|0|||
105418751|NCT00758264|363539102|FG002|Active Phase|Lost to Follow-up|0|||
105418752|NCT00758264|363539100|FG000|Active Phase|Other|0|||
105418753|NCT00758264|363539101|FG001|Active Phase|Other|0|||
105418754|NCT00758264|363539102|FG002|Active Phase|Other|4|||
105418755|NCT03425006|363539103|FG000|Overall Study|Withdrawal by Subject|1|||
105499540|NCT03307785|363838884|FG002|Part E: Up to 4.4 Months|Death|0|||
105499541|NCT03307785|363838885|FG003|Part E: Up to 4.4 Months|Death|0|||
105418756|NCT03425006|363539103|FG000|Overall Study|Physician Decision|1|||
105418757|NCT03425006|363539103|FG000|Overall Study|Death|1|||
105418758|NCT01498575|363539104|FG000|Overall Sample|Withdrawal by Subject|60|||
105418759|NCT01498575|363539105|FG001|Overall Sample|Withdrawal by Subject|14|||
105418760|NCT01498575|363539104|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
105418761|NCT01498575|363539105|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
105418762|NCT01498575|363539104|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
105418763|NCT01498575|363539105|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
105418764|NCT02300558|363539107|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
105418765|NCT02300558|363539107|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
105418766|NCT02300558|363539107|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
105418767|NCT02300558|363539107|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
105418768|NCT01562314|363539118|FG000|Overall Study|Adverse Event|10|||
105418769|NCT01562314|363539119|FG001|Overall Study|Adverse Event|5|||
105499542|NCT03307785|363838886|FG004|Part E: Up to 4.4 Months|Death|0|||
105499543|NCT03307785|363838887|FG005|Part E: Up to 4.4 Months|Death|0|||
105499544|NCT03307785|363838888|FG006|Part E: Up to 4.4 Months|Death|1|||
105499545|NCT03307785|363838889|FG007|Part E: Up to 4.4 Months|Death|0|||
105499546|NCT03307785|363838890|FG008|Part E: Up to 4.4 Months|Death|0|||
105499547|NCT03307785|363838891|FG009|Part E: Up to 4.4 Months|Death|0|||
105499548|NCT03307785|363838892|FG010|Part E: Up to 4.4 Months|Death|0|||
105499549|NCT03307785|363838882|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
105499550|NCT03307785|363838883|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
105499551|NCT03307785|363838884|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
105499552|NCT03307785|363838885|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
105499553|NCT03307785|363838886|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
105499554|NCT03307785|363838887|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
105499555|NCT03307785|363838888|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
105499556|NCT03307785|363838889|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
105499557|NCT03307785|363838890|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
105499558|NCT03307785|363838891|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
105499559|NCT03307785|363838892|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
105499560|NCT03307785|363838882|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
105499561|NCT03307785|363838883|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
105499562|NCT03307785|363838884|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
105499563|NCT03307785|363838885|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
105499564|NCT03307785|363838886|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
105499565|NCT03307785|363838887|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
105499566|NCT03307785|363838888|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
105499567|NCT03307785|363838889|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
105499568|NCT03307785|363838890|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
105499569|NCT03307785|363838891|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
105499570|NCT03307785|363838892|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
105499571|NCT03666624|363838893|FG000|Overall Study|participant grieving over recent death of parent|1|||
105499572|NCT03666624|363838894|FG001|Overall Study|participant grieving over recent death of parent|0|||
105499573|NCT03021304|363838899|FG000|Overall Study|Lack of Efficacy|1|||
105499574|NCT04154930|363838906|FG000|Overall Study|Withdrawal by Subject|15|||
105499575|NCT04154930|363838907|FG001|Overall Study|Withdrawal by Subject|6|||
105499576|NCT04154930|363838906|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
105499577|NCT04154930|363838907|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
105499578|NCT04154930|363838906|FG000|Overall Study|Lost to Follow-up|14|||
105499579|NCT04154930|363838907|FG001|Overall Study|Lost to Follow-up|6|||
105499580|NCT04154930|363838906|FG000|Overall Study|Other|6|||
105499581|NCT04154930|363838907|FG001|Overall Study|Other|0|||
105499582|NCT00400764|363838909|FG000|Phase Ib|Adverse Event|1|||
105499583|NCT00400764|363838910|FG001|Phase Ib|Adverse Event|0|||
105499584|NCT00400764|363838911|FG002|Phase Ib|Adverse Event|0|||
105499585|NCT00400764|363838912|FG003|Phase Ib|Adverse Event|0|||
105499586|NCT00400764|363838913|FG004|Phase Ib|Adverse Event|0|||
105499587|NCT00400764|363838909|FG000|Phase Ib|Death|1|||
105499588|NCT00400764|363838910|FG001|Phase Ib|Death|0|||
105499589|NCT00400764|363838911|FG002|Phase Ib|Death|0|||
105499590|NCT00400764|363838912|FG003|Phase Ib|Death|0|||
105499591|NCT00400764|363838913|FG004|Phase Ib|Death|0|||
105499592|NCT00400764|363838909|FG000|Phase Ib|Disease Progression|4|||
105499593|NCT00400764|363838910|FG001|Phase Ib|Disease Progression|4|||
105499594|NCT00400764|363838911|FG002|Phase Ib|Disease Progression|0|||
105499595|NCT00400764|363838912|FG003|Phase Ib|Disease Progression|0|||
105499596|NCT00400764|363838913|FG004|Phase Ib|Disease Progression|0|||
105499597|NCT00400764|363838909|FG000|Phase II|Death|0|||
105499598|NCT00400764|363838910|FG001|Phase II|Death|0|||
105499599|NCT00400764|363838911|FG002|Phase II|Death|1|||
105499600|NCT00400764|363838912|FG003|Phase II|Death|2|||
105499601|NCT00400764|363838913|FG004|Phase II|Death|0|||
105499602|NCT00400764|363838909|FG000|Phase II|Lost to Follow-up|0|||
105499603|NCT00400764|363838910|FG001|Phase II|Lost to Follow-up|0|||
105499604|NCT00400764|363838911|FG002|Phase II|Lost to Follow-up|1|||
105499605|NCT00400764|363838912|FG003|Phase II|Lost to Follow-up|0|||
105499606|NCT00400764|363838913|FG004|Phase II|Lost to Follow-up|0|||
105499607|NCT00400764|363838909|FG000|Phase II|Physician Decision|0|||
105499608|NCT00400764|363838910|FG001|Phase II|Physician Decision|0|||
105499609|NCT00400764|363838911|FG002|Phase II|Physician Decision|1|||
105499610|NCT00400764|363838912|FG003|Phase II|Physician Decision|1|||
105499611|NCT00400764|363838913|FG004|Phase II|Physician Decision|0|||
105499612|NCT00400764|363838909|FG000|Phase II|Sponsor's decision to terminate|0|||
105499613|NCT00400764|363838910|FG001|Phase II|Sponsor's decision to terminate|0|||
105499614|NCT00400764|363838911|FG002|Phase II|Sponsor's decision to terminate|18|||
105499615|NCT00400764|363838912|FG003|Phase II|Sponsor's decision to terminate|22|||
105499616|NCT00400764|363838913|FG004|Phase II|Sponsor's decision to terminate|11|||
105499617|NCT00400764|363838909|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
105499618|NCT00400764|363838910|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
105499619|NCT00400764|363838911|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
105499620|NCT00400764|363838912|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
105499621|NCT00400764|363838913|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
105499622|NCT00400764|363838909|FG000|Phase II|Withdrawal by Subject|0|||
105499623|NCT00400764|363838910|FG001|Phase II|Withdrawal by Subject|0|||
105499624|NCT00400764|363838911|FG002|Phase II|Withdrawal by Subject|1|||
105499625|NCT00400764|363838912|FG003|Phase II|Withdrawal by Subject|1|||
105499626|NCT00400764|363838913|FG004|Phase II|Withdrawal by Subject|0|||
105499627|NCT00181155|363838918|FG000|Overall Study|Physician Decision|1|||
105499628|NCT00181155|363838919|FG001|Overall Study|Physician Decision|0|||
105499629|NCT00181155|363838918|FG000|Overall Study|Withdrawal by Subject|1|||
105499630|NCT00181155|363838919|FG001|Overall Study|Withdrawal by Subject|0|||
105499631|NCT02187744|363838924|FG000|Study|Participant refused further follow-up|1|||
105499632|NCT02187744|363838925|FG001|Study|Participant refused further follow-up|0|||
105499633|NCT02187744|363838924|FG000|Study|Other|2|||
105499634|NCT02187744|363838925|FG001|Study|Other|1|||
105499635|NCT02187744|363838924|FG000|Study|Lost to Follow-up|0|||
105499636|NCT02187744|363838925|FG001|Study|Lost to Follow-up|2|||
105418770|NCT01562314|363539118|FG000|Overall Study|Met Withdrawal Criteria|3|||
105418771|NCT01562314|363539119|FG001|Overall Study|Met Withdrawal Criteria|2|||
105418772|NCT01562314|363539118|FG000|Overall Study|Withdrawal by Subject|0|||
105418773|NCT01562314|363539119|FG001|Overall Study|Withdrawal by Subject|1|||
105418774|NCT02851797|363539120|FG000|Overall Study|Withdrawal by Subject|4|||
105418775|NCT02851797|363539121|FG001|Overall Study|Withdrawal by Subject|2|||
105418776|NCT02851797|363539120|FG000|Overall Study|Adverse Event|3|||
105418777|NCT02851797|363539121|FG001|Overall Study|Adverse Event|0|||
105418778|NCT00543803|363539123|FG000|Overall Study|Adverse Event|14|||
105418779|NCT00543803|363539123|FG000|Overall Study|Lack of Efficacy|22|||
105418780|NCT00543803|363539123|FG000|Overall Study|Lost to Follow-up|20|||
105418781|NCT00543803|363539123|FG000|Overall Study|Other|86|||
105418782|NCT03255967|363539136|FG000|Overall Study|Adverse Event|26|||
105418783|NCT03255967|363539137|FG001|Overall Study|Adverse Event|30|||
105418784|NCT03255967|363539136|FG000|Overall Study|Withdrawal by Subject|6|||
105418785|NCT03255967|363539137|FG001|Overall Study|Withdrawal by Subject|6|||
105418786|NCT03255967|363539136|FG000|Overall Study|Schedule conflict|6|||
105418787|NCT03255967|363539137|FG001|Overall Study|Schedule conflict|4|||
105418788|NCT03255967|363539136|FG000|Overall Study|POA did not sign consent form|2|||
105418789|NCT03255967|363539137|FG001|Overall Study|POA did not sign consent form|0|||
105418790|NCT00443053|363539138|FG000|Overall Study|Adverse Event|2|||
105418791|NCT00443053|363539139|FG001|Overall Study|Adverse Event|1|||
105418792|NCT00443053|363539138|FG000|Overall Study|Withdrawal by Subject|9|||
105418793|NCT00443053|363539139|FG001|Overall Study|Withdrawal by Subject|18|||
105418794|NCT00443053|363539138|FG000|Overall Study|Lost to Follow-up|4|||
105418795|NCT00443053|363539139|FG001|Overall Study|Lost to Follow-up|5|||
105418796|NCT00443053|363539138|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
105418797|NCT00443053|363539139|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
105418798|NCT00443053|363539138|FG000|Overall Study|Noncompliance|2|||
105418799|NCT00443053|363539139|FG001|Overall Study|Noncompliance|1|||
105418800|NCT00443053|363539138|FG000|Overall Study|Other|3|||
105418801|NCT00443053|363539139|FG001|Overall Study|Other|4|||
105418802|NCT00443053|363539138|FG000|Overall Study|Physician Decision|0|||
105418803|NCT00443053|363539139|FG001|Overall Study|Physician Decision|4|||
105418804|NCT00778258|363539140|FG000|Overall Study|Adverse Event|1|||
105418805|NCT00778258|363539141|FG001|Overall Study|Adverse Event|0|||
105418806|NCT00778258|363539142|FG002|Overall Study|Adverse Event|0|||
105418807|NCT00778258|363539143|FG003|Overall Study|Adverse Event|0|||
105418808|NCT00778258|363539144|FG004|Overall Study|Adverse Event|0|||
105418809|NCT00778258|363539145|FG005|Overall Study|Adverse Event|1|||
105418810|NCT00778258|363539146|FG006|Overall Study|Adverse Event|0|||
105418811|NCT00778258|363539147|FG007|Overall Study|Adverse Event|0|||
105418812|NCT00778258|363539148|FG008|Overall Study|Adverse Event|0|||
105418813|NCT00778258|363539140|FG000|Overall Study|Lost to Follow-up|0|||
105418814|NCT00778258|363539141|FG001|Overall Study|Lost to Follow-up|0|||
105418815|NCT00778258|363539142|FG002|Overall Study|Lost to Follow-up|2|||
105418816|NCT00778258|363539143|FG003|Overall Study|Lost to Follow-up|0|||
105418817|NCT00778258|363539144|FG004|Overall Study|Lost to Follow-up|0|||
105418818|NCT00778258|363539145|FG005|Overall Study|Lost to Follow-up|3|||
105418819|NCT00778258|363539146|FG006|Overall Study|Lost to Follow-up|2|||
105418820|NCT00778258|363539147|FG007|Overall Study|Lost to Follow-up|2|||
105418821|NCT00778258|363539148|FG008|Overall Study|Lost to Follow-up|0|||
105418822|NCT00778258|363539140|FG000|Overall Study|Withdrawal by Subject|6|||
105418823|NCT00778258|363539141|FG001|Overall Study|Withdrawal by Subject|2|||
105418824|NCT00778258|363539142|FG002|Overall Study|Withdrawal by Subject|8|||
105418825|NCT00778258|363539143|FG003|Overall Study|Withdrawal by Subject|2|||
105418826|NCT00778258|363539144|FG004|Overall Study|Withdrawal by Subject|0|||
105418827|NCT00778258|363539145|FG005|Overall Study|Withdrawal by Subject|6|||
105418828|NCT00778258|363539146|FG006|Overall Study|Withdrawal by Subject|12|||
105418829|NCT00778258|363539147|FG007|Overall Study|Withdrawal by Subject|12|||
105499637|NCT02187744|363838924|FG000|Study|Related adverse event, not serious|0|||
105499638|NCT02187744|363838925|FG001|Study|Related adverse event, not serious|2|||
105418830|NCT00778258|363539148|FG008|Overall Study|Withdrawal by Subject|4|||
105418831|NCT00778258|363539140|FG000|Overall Study|New Contraindication|0|||
105418832|NCT00778258|363539141|FG001|Overall Study|New Contraindication|0|||
105418833|NCT00778258|363539142|FG002|Overall Study|New Contraindication|0|||
105418834|NCT00778258|363539143|FG003|Overall Study|New Contraindication|0|||
105418835|NCT00778258|363539144|FG004|Overall Study|New Contraindication|0|||
105418836|NCT00778258|363539145|FG005|Overall Study|New Contraindication|0|||
105418837|NCT00778258|363539146|FG006|Overall Study|New Contraindication|0|||
105418838|NCT00778258|363539147|FG007|Overall Study|New Contraindication|1|||
105418839|NCT00778258|363539148|FG008|Overall Study|New Contraindication|0|||
105418840|NCT00778258|363539140|FG000|Overall Study|Non-compliance|0|||
105418841|NCT00778258|363539141|FG001|Overall Study|Non-compliance|0|||
105418842|NCT00778258|363539142|FG002|Overall Study|Non-compliance|0|||
105418843|NCT00778258|363539143|FG003|Overall Study|Non-compliance|1|||
105418844|NCT00778258|363539144|FG004|Overall Study|Non-compliance|0|||
105418845|NCT00778258|363539145|FG005|Overall Study|Non-compliance|0|||
105418846|NCT00778258|363539146|FG006|Overall Study|Non-compliance|0|||
105418847|NCT00778258|363539147|FG007|Overall Study|Non-compliance|0|||
105418848|NCT00778258|363539148|FG008|Overall Study|Non-compliance|0|||
105418849|NCT00778258|363539140|FG000|Overall Study|Other|0|||
105418850|NCT00778258|363539141|FG001|Overall Study|Other|0|||
105418851|NCT00778258|363539142|FG002|Overall Study|Other|0|||
105418852|NCT00778258|363539143|FG003|Overall Study|Other|0|||
105418853|NCT00778258|363539144|FG004|Overall Study|Other|0|||
105418854|NCT00778258|363539145|FG005|Overall Study|Other|0|||
105418855|NCT00778258|363539146|FG006|Overall Study|Other|1|||
105418856|NCT00778258|363539147|FG007|Overall Study|Other|0|||
105418857|NCT00778258|363539148|FG008|Overall Study|Other|0|||
105418858|NCT02438384|363539151|FG000|Overall Study|Lost to Follow-up|8|||
105418859|NCT02438384|363539152|FG001|Overall Study|Lost to Follow-up|6|||
105418860|NCT02438384|363539153|FG002|Overall Study|Lost to Follow-up|4|||
105418861|NCT03319953|363539154|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
105418862|NCT03319953|363539155|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
105418863|NCT03319953|363539156|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
105418864|NCT03319953|363539157|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
105418865|NCT03319953|363539154|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
105418866|NCT03319953|363539155|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
105418867|NCT03319953|363539156|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
105418868|NCT03319953|363539157|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
105439999|NCT01835223|363616668|FG000|Overall Study|Disease progression|2|||
105440000|NCT01835223|363616669|FG001|Overall Study|Disease progression|1|||
105440001|NCT01835223|363616668|FG000|Overall Study|Became Inelligible|4|||
105440002|NCT01835223|363616669|FG001|Overall Study|Became Inelligible|0|||
105440003|NCT01504841|363616670|FG000|Overall Study|Withdrawal by Subject|1|||
105440004|NCT01504841|363616671|FG001|Overall Study|Withdrawal by Subject|1|||
105440005|NCT01504841|363616672|FG002|Overall Study|Withdrawal by Subject|0|||
105440006|NCT03149055|363616673|FG000|Overall Study|Not treated|4|||
105440007|NCT03056339|363616683|FG000|Overall Study|Failed Requirements|0|||
105440008|NCT03056339|363616684|FG001|Overall Study|Failed Requirements|2|||
105440009|NCT03056339|363616685|FG002|Overall Study|Failed Requirements|7|||
105440010|NCT03056339|363616686|FG003|Overall Study|Failed Requirements|1|||
105440011|NCT01496469|363616687|FG000|Overall Study|Adverse Event|1|||
105440012|NCT01496469|363616688|FG001|Overall Study|Adverse Event|0|||
105440013|NCT01496469|363616687|FG000|Overall Study|Protocol Violation|2|||
105440014|NCT01496469|363616688|FG001|Overall Study|Protocol Violation|0|||
105440015|NCT01496469|363616687|FG000|Overall Study|Lost to Follow-up|1|||
105440016|NCT01496469|363616688|FG001|Overall Study|Lost to Follow-up|1|||
105440017|NCT01496469|363616687|FG000|Overall Study|Withdrawal by Subject|4|||
105440018|NCT01496469|363616688|FG001|Overall Study|Withdrawal by Subject|4|||
105440019|NCT01496469|363616687|FG000|Overall Study|BP exceeds protocol limits|1|||
105440020|NCT01496469|363616688|FG001|Overall Study|BP exceeds protocol limits|2|||
105440021|NCT01496469|363616687|FG000|Overall Study|Other|1|||
105440022|NCT01496469|363616688|FG001|Overall Study|Other|1|||
105440023|NCT00291018|363616689|FG000|Overall Study|Not Consented or Declined PAS|12|||
105440024|NCT00291018|363616690|FG001|Overall Study|Not Consented or Declined PAS|15|||
105440025|NCT00291018|363616691|FG002|Overall Study|Not Consented or Declined PAS|15|||
105440026|NCT00291018|363616689|FG000|Overall Study|Death|3|||
105440027|NCT00291018|363616690|FG001|Overall Study|Death|3|||
105440028|NCT00291018|363616691|FG002|Overall Study|Death|4|||
105440029|NCT00291018|363616689|FG000|Overall Study|Withdrawal by Subject|2|||
105440030|NCT00291018|363616690|FG001|Overall Study|Withdrawal by Subject|8|||
105440031|NCT00291018|363616691|FG002|Overall Study|Withdrawal by Subject|1|||
105440032|NCT00291018|363616689|FG000|Overall Study|Failures|5|||
105440033|NCT00291018|363616690|FG001|Overall Study|Failures|12|||
105440034|NCT00291018|363616691|FG002|Overall Study|Failures|5|||
105440035|NCT00291018|363616689|FG000|Overall Study|Lost to Follow-up|3|||
105440036|NCT00291018|363616690|FG001|Overall Study|Lost to Follow-up|4|||
105440037|NCT00291018|363616691|FG002|Overall Study|Lost to Follow-up|18|||
105440038|NCT00082407|363616694|FG000|Overall Study|Adverse Event|20|||
105440039|NCT00082407|363616695|FG001|Overall Study|Adverse Event|0|||
105440040|NCT00082407|363616694|FG000|Overall Study|Protocol Violation|14|||
105440041|NCT00082407|363616695|FG001|Overall Study|Protocol Violation|12|||
105440042|NCT00082407|363616694|FG000|Overall Study|Patient Decision|13|||
105440043|NCT00082407|363616695|FG001|Overall Study|Patient Decision|6|||
105440044|NCT00082407|363616694|FG000|Overall Study|Physician Decision|5|||
105440045|NCT00082407|363616695|FG001|Overall Study|Physician Decision|3|||
105440046|NCT00082407|363616694|FG000|Overall Study|Loss of Glucose Control|2|||
105440047|NCT00082407|363616695|FG001|Overall Study|Loss of Glucose Control|2|||
105418869|NCT01089413|363540910|FG000|Overall Study|Lost to Follow-up|1|||
105418870|NCT01089413|363540910|FG000|Overall Study|Progressive Disease|93|||
105418871|NCT01089413|363540910|FG000|Overall Study|Participant Withdrew Consent|1|||
105418872|NCT01089413|363540910|FG000|Overall Study|Unacceptable Toxicity|12|||
105418873|NCT01089413|363540910|FG000|Overall Study|Death|10|||
105418874|NCT01089413|363540910|FG000|Overall Study|Metastasectomy|13|||
105418875|NCT01089413|363540910|FG000|Overall Study|Other|71|||
105418876|NCT02513485|363540911|FG000|Overall Study|Adverse Event|1|||
105418877|NCT02513485|363540912|FG001|Overall Study|Adverse Event|0|||
105418878|NCT02039219|363540919|FG000|Treatment|Withdrawal by Subject|1|||
105418879|NCT02039219|363540920|FG001|Treatment|Withdrawal by Subject|0|||
105418880|NCT02039219|363540919|FG000|Treatment|Adverse Event|0|||
105418881|NCT02039219|363540920|FG001|Treatment|Adverse Event|1|||
105418882|NCT02039219|363540919|FG000|Treatment|Physician Decision|1|||
105418883|NCT02039219|363540920|FG001|Treatment|Physician Decision|0|||
105418884|NCT02039219|363540919|FG000|Treatment|Lost to Follow-up|0|||
105418885|NCT02039219|363540920|FG001|Treatment|Lost to Follow-up|1|||
105418886|NCT02039219|363540919|FG000|Treatment|Protocol Violation|1|||
105418887|NCT02039219|363540920|FG001|Treatment|Protocol Violation|0|||
105418888|NCT02039219|363540919|FG000|Treatment|Death|1|||
105418889|NCT02039219|363540920|FG001|Treatment|Death|0|||
105418890|NCT02039219|363540919|FG000|Follow up|Adverse Event|0|||
105418891|NCT02039219|363540920|FG001|Follow up|Adverse Event|1|||
105418892|NCT00129701|363540921|FG000|Overall Study|Withdrawal by Subject|33|||
105418893|NCT02750345|363540922|FG000|Intervention 1|Adverse Event|0|||
105418894|NCT02750345|363540923|FG001|Intervention 1|Adverse Event|0|||
105418895|NCT02750345|363540924|FG002|Intervention 1|Adverse Event|0|||
105418896|NCT02750345|363540925|FG003|Intervention 1|Adverse Event|0|||
105418897|NCT02750345|363540926|FG004|Intervention 1|Adverse Event|1|||
105418898|NCT02750345|363540927|FG005|Intervention 1|Adverse Event|0|||
105418899|NCT02650128|363540928|FG000|Overall Study|Death|2|||
105418900|NCT00191724|363540931|FG000|Overall Study|Adverse Event|0|||
105418901|NCT00191724|363540932|FG001|Overall Study|Adverse Event|0|||
105418902|NCT00191724|363540933|FG002|Overall Study|Adverse Event|1|||
105418903|NCT00191724|363540934|FG003|Overall Study|Adverse Event|0|||
105418904|NCT00191724|363540935|FG004|Overall Study|Adverse Event|0|||
105418905|NCT00191724|363540931|FG000|Overall Study|Lost to Follow-up|1|||
105418906|NCT00191724|363540932|FG001|Overall Study|Lost to Follow-up|1|||
105418907|NCT00191724|363540933|FG002|Overall Study|Lost to Follow-up|0|||
105418908|NCT00191724|363540934|FG003|Overall Study|Lost to Follow-up|2|||
105418909|NCT00191724|363540935|FG004|Overall Study|Lost to Follow-up|3|||
105418910|NCT00191724|363540931|FG000|Overall Study|Withdrawal by Subject|0|||
105418911|NCT00191724|363540932|FG001|Overall Study|Withdrawal by Subject|0|||
105418912|NCT00191724|363540933|FG002|Overall Study|Withdrawal by Subject|0|||
105418913|NCT00191724|363540934|FG003|Overall Study|Withdrawal by Subject|1|||
105418914|NCT00191724|363540935|FG004|Overall Study|Withdrawal by Subject|0|||
105418915|NCT00608023|363540936|FG000|Overall Study|Withdrawal by Subject|8|||
105418916|NCT00608023|363540937|FG001|Overall Study|Withdrawal by Subject|10|||
105418917|NCT00608023|363540938|FG002|Overall Study|Withdrawal by Subject|7|||
105418918|NCT00608023|363540936|FG000|Overall Study|Adverse Event|1|||
105418919|NCT00608023|363540937|FG001|Overall Study|Adverse Event|4|||
105418920|NCT00608023|363540938|FG002|Overall Study|Adverse Event|5|||
105418921|NCT00608023|363540936|FG000|Overall Study|Lost to Follow-up|2|||
105418922|NCT00608023|363540937|FG001|Overall Study|Lost to Follow-up|2|||
105418923|NCT00608023|363540938|FG002|Overall Study|Lost to Follow-up|1|||
105418924|NCT00608023|363540936|FG000|Overall Study|Protocol Violation|1|||
105418925|NCT00608023|363540937|FG001|Overall Study|Protocol Violation|3|||
105418926|NCT00608023|363540938|FG002|Overall Study|Protocol Violation|1|||
105418927|NCT00608023|363540936|FG000|Overall Study|Unknown reason|0|||
105418928|NCT00608023|363540937|FG001|Overall Study|Unknown reason|3|||
105418929|NCT00608023|363540938|FG002|Overall Study|Unknown reason|0|||
105418930|NCT00152477|363540953|FG000|Chemotherapy Period|Adverse Event|9|||
105418931|NCT00152477|363540954|FG001|Chemotherapy Period|Adverse Event|4|||
105418932|NCT00152477|363540955|FG002|Chemotherapy Period|Adverse Event|5|||
105418933|NCT00152477|363540953|FG000|Chemotherapy Period|Death|1|||
105418934|NCT00152477|363540954|FG001|Chemotherapy Period|Death|3|||
105418935|NCT00152477|363540955|FG002|Chemotherapy Period|Death|3|||
105418936|NCT00152477|363540953|FG000|Chemotherapy Period|Lack of Efficacy|4|||
105418937|NCT00152477|363540954|FG001|Chemotherapy Period|Lack of Efficacy|5|||
105418938|NCT00152477|363540955|FG002|Chemotherapy Period|Lack of Efficacy|6|||
105418939|NCT00152477|363540953|FG000|Chemotherapy Period|Lost to Follow-up|1|||
105418940|NCT00152477|363540954|FG001|Chemotherapy Period|Lost to Follow-up|0|||
105418941|NCT00152477|363540955|FG002|Chemotherapy Period|Lost to Follow-up|1|||
105418942|NCT00152477|363540953|FG000|Chemotherapy Period|Protocol Violation|1|||
105418943|NCT00152477|363540954|FG001|Chemotherapy Period|Protocol Violation|1|||
105418944|NCT00152477|363540955|FG002|Chemotherapy Period|Protocol Violation|0|||
105418945|NCT00152477|363540953|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
105418946|NCT00152477|363540954|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
105418947|NCT00152477|363540955|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
105418948|NCT00152477|363540953|FG000|Chemotherapy Period|Progression of Disease|6|||
105418949|NCT00152477|363540954|FG001|Chemotherapy Period|Progression of Disease|8|||
105418950|NCT00152477|363540955|FG002|Chemotherapy Period|Progression of Disease|4|||
105418951|NCT00152477|363540953|FG000|Chemotherapy Period|Investigator decision|0|||
105418952|NCT00152477|363540954|FG001|Chemotherapy Period|Investigator decision|0|||
105418953|NCT00152477|363540955|FG002|Chemotherapy Period|Investigator decision|1|||
105418954|NCT00152477|363540953|FG000|Chemotherapy Period|Patient condition worsened|1|||
105499639|NCT02187744|363838924|FG000|Study|Death|1|||
105418955|NCT00152477|363540954|FG001|Chemotherapy Period|Patient condition worsened|0|||
105418956|NCT00152477|363540955|FG002|Chemotherapy Period|Patient condition worsened|0|||
105418957|NCT00152477|363540953|FG000|Monotherapy Period|Adverse Event|1|||
105418958|NCT00152477|363540954|FG001|Monotherapy Period|Adverse Event|0|||
105418959|NCT00152477|363540955|FG002|Monotherapy Period|Adverse Event|5|||
105418960|NCT00152477|363540953|FG000|Monotherapy Period|Death|2|||
105418961|NCT00152477|363540954|FG001|Monotherapy Period|Death|0|||
105418962|NCT00152477|363540955|FG002|Monotherapy Period|Death|1|||
105418963|NCT00152477|363540953|FG000|Monotherapy Period|Lack of Efficacy|7|||
105418964|NCT00152477|363540954|FG001|Monotherapy Period|Lack of Efficacy|16|||
105418965|NCT00152477|363540955|FG002|Monotherapy Period|Lack of Efficacy|10|||
105418966|NCT00152477|363540953|FG000|Monotherapy Period|Protocol Violation|0|||
105418967|NCT00152477|363540954|FG001|Monotherapy Period|Protocol Violation|1|||
105418968|NCT00152477|363540955|FG002|Monotherapy Period|Protocol Violation|0|||
105418969|NCT00152477|363540953|FG000|Monotherapy Period|Withdrawal by Subject|0|||
105418970|NCT00152477|363540954|FG001|Monotherapy Period|Withdrawal by Subject|0|||
105418971|NCT00152477|363540955|FG002|Monotherapy Period|Withdrawal by Subject|4|||
105418972|NCT00152477|363540953|FG000|Monotherapy Period|Progression of Disease|5|||
105418973|NCT00152477|363540954|FG001|Monotherapy Period|Progression of Disease|11|||
105418974|NCT00152477|363540955|FG002|Monotherapy Period|Progression of Disease|12|||
105418975|NCT00152477|363540953|FG000|Monotherapy Period|Patient decision|0|||
105418976|NCT00152477|363540954|FG001|Monotherapy Period|Patient decision|1|||
105418977|NCT00152477|363540955|FG002|Monotherapy Period|Patient decision|1|||
105418978|NCT00152477|363540953|FG000|Monotherapy Period|Study personel decision|0|||
105418979|NCT00152477|363540954|FG001|Monotherapy Period|Study personel decision|0|||
105418980|NCT00152477|363540955|FG002|Monotherapy Period|Study personel decision|1|||
105418981|NCT03275246|363540962|FG000|Overall Study|Protocol Violation|5|||
105418982|NCT03275246|363540962|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
105418983|NCT00730041|363540963|FG000|Overall Study|Lost to Follow-up|0|||
105418984|NCT00730041|363540964|FG001|Overall Study|Lost to Follow-up|2|||
105418985|NCT02301546|363540967|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
105418986|NCT02301546|363540968|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
105418987|NCT02301546|363540967|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
105418988|NCT02301546|363540968|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
105418989|NCT02301546|363540967|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
105418990|NCT02301546|363540968|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
105418991|NCT02301546|363540967|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
105418992|NCT02301546|363540968|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
105418993|NCT02301546|363540967|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
105418994|NCT02301546|363540968|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
105418995|NCT02301546|363540967|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
105418996|NCT02301546|363540968|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
105418997|NCT02301546|363540967|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
105418998|NCT02301546|363540968|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
105418999|NCT05526781|363540971|FG000|Overall Study|Lost to Follow-up|1|||
105419000|NCT01801436|363540972|FG000|Overall Study|Withdrawal by Subject|3|||
105419001|NCT01801436|363540972|FG000|Overall Study|Adverse Event|2|||
105419002|NCT01801436|363540972|FG000|Overall Study|Progressive disease|4|||
105419003|NCT04085458|363540973|FG000|Overall Study|Other|1|||
105419004|NCT04085458|363540973|FG000|Overall Study|Withdrawal by Subject|2|||
105419005|NCT04085458|363540973|FG000|Overall Study|Adverse Event|2|||
105419006|NCT02447250|363540974|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
105419007|NCT02447250|363540974|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
105419008|NCT02447250|363540974|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
105419009|NCT03632993|363540975|FG000|Overall Study|Withdrawal by Subject|1|||
105419010|NCT03632993|363540976|FG001|Overall Study|Withdrawal by Subject|0|||
105419011|NCT03632993|363540977|FG002|Overall Study|Withdrawal by Subject|0|||
105419012|NCT03632993|363540978|FG003|Overall Study|Withdrawal by Subject|0|||
105419013|NCT03632993|363540979|FG004|Overall Study|Withdrawal by Subject|0|||
105419014|NCT03632993|363540980|FG005|Overall Study|Withdrawal by Subject|0|||
105419015|NCT03632993|363540981|FG006|Overall Study|Withdrawal by Subject|0|||
105419016|NCT03632993|363540982|FG007|Overall Study|Withdrawal by Subject|0|||
105419017|NCT03632993|363540983|FG008|Overall Study|Withdrawal by Subject|0|||
105419018|NCT03632993|363540984|FG009|Overall Study|Withdrawal by Subject|1|||
105419019|NCT03632993|363540975|FG000|Overall Study|Protocol Non-compliance|0|||
105499640|NCT02187744|363838925|FG001|Study|Death|0|||
105499641|NCT02187744|363838924|FG000|Study|Related adverse event, serious non-fatal|0|||
105419020|NCT03632993|363540976|FG001|Overall Study|Protocol Non-compliance|1|||
105419021|NCT03632993|363540977|FG002|Overall Study|Protocol Non-compliance|0|||
105419022|NCT03632993|363540978|FG003|Overall Study|Protocol Non-compliance|0|||
105419023|NCT03632993|363540979|FG004|Overall Study|Protocol Non-compliance|0|||
105419024|NCT03632993|363540980|FG005|Overall Study|Protocol Non-compliance|0|||
105419025|NCT03632993|363540981|FG006|Overall Study|Protocol Non-compliance|0|||
105419026|NCT03632993|363540982|FG007|Overall Study|Protocol Non-compliance|0|||
105419027|NCT03632993|363540983|FG008|Overall Study|Protocol Non-compliance|0|||
105419028|NCT03632993|363540984|FG009|Overall Study|Protocol Non-compliance|0|||
105419029|NCT03632993|363540975|FG000|Overall Study|Lost to Follow-up|0|||
105419030|NCT03632993|363540976|FG001|Overall Study|Lost to Follow-up|0|||
105419031|NCT03632993|363540977|FG002|Overall Study|Lost to Follow-up|0|||
105419032|NCT03632993|363540978|FG003|Overall Study|Lost to Follow-up|0|||
105499642|NCT02187744|363838925|FG001|Study|Related adverse event, serious non-fatal|1|||
105499643|NCT02187744|363838924|FG000|Treatment|Death|1|||
105499644|NCT02187744|363838925|FG001|Treatment|Death|0|||
105499645|NCT02187744|363838924|FG000|Treatment|Related adverse event, serious non-fatal|0|||
105499646|NCT02187744|363838925|FG001|Treatment|Related adverse event, serious non-fatal|1|||
105499647|NCT02187744|363838924|FG000|Treatment|Related adverse event, not serious|0|||
105499648|NCT02187744|363838925|FG001|Treatment|Related adverse event, not serious|2|||
105499649|NCT02187744|363838924|FG000|Treatment|Lost to Follow-up|0|||
105499650|NCT02187744|363838925|FG001|Treatment|Lost to Follow-up|1|||
105499651|NCT02187744|363838924|FG000|Treatment|Other|2|||
105499652|NCT02187744|363838925|FG001|Treatment|Other|0|||
105499653|NCT02187744|363838924|FG000|Treatment|Participant refused continued treatment|1|||
105499654|NCT02187744|363838925|FG001|Treatment|Participant refused continued treatment|1|||
105499655|NCT01788228|363838926|FG000|Overall Study|Migrated/moved from study area|1|||
105499656|NCT01788228|363838927|FG001|Overall Study|Migrated/moved from study area|0|||
105499657|NCT01972568|363838928|FG000|Overall Study|Other events|3|||
105499658|NCT01972568|363838929|FG001|Overall Study|Other events|0|||
105499659|NCT01972568|363838930|FG002|Overall Study|Other events|0|||
105499660|NCT01972568|363838928|FG000|Overall Study|Lack of Efficacy|0|||
105499661|NCT01972568|363838929|FG001|Overall Study|Lack of Efficacy|1|||
105499662|NCT01972568|363838930|FG002|Overall Study|Lack of Efficacy|2|||
105499663|NCT01972568|363838928|FG000|Overall Study|Protocol Violation|1|||
105499664|NCT01972568|363838929|FG001|Overall Study|Protocol Violation|2|||
105499665|NCT01972568|363838930|FG002|Overall Study|Protocol Violation|2|||
105499666|NCT01972568|363838928|FG000|Overall Study|Withdrawal by Subject|6|||
105499667|NCT01972568|363838929|FG001|Overall Study|Withdrawal by Subject|3|||
105499668|NCT01972568|363838930|FG002|Overall Study|Withdrawal by Subject|7|||
105499669|NCT01972568|363838928|FG000|Overall Study|Lost to Follow-up|1|||
105499670|NCT01972568|363838929|FG001|Overall Study|Lost to Follow-up|0|||
105499671|NCT01972568|363838930|FG002|Overall Study|Lost to Follow-up|0|||
105499672|NCT01972568|363838928|FG000|Overall Study|Adverse Event|5|||
105499673|NCT01972568|363838929|FG001|Overall Study|Adverse Event|6|||
105499674|NCT01972568|363838930|FG002|Overall Study|Adverse Event|5|||
105499675|NCT02572401|363838932|FG000|Overall Study|Lost to Follow-up|5|||
105499676|NCT02572401|363838933|FG001|Overall Study|Lost to Follow-up|8|||
105499677|NCT02572401|363838934|FG002|Overall Study|Lost to Follow-up|9|||
105499678|NCT02572401|363838935|FG003|Overall Study|Lost to Follow-up|9|||
105499679|NCT02572401|363838932|FG000|Overall Study|Death|0|||
105499680|NCT02572401|363838933|FG001|Overall Study|Death|0|||
105499681|NCT02572401|363838934|FG002|Overall Study|Death|0|||
105499682|NCT02572401|363838935|FG003|Overall Study|Death|1|||
105499683|NCT00370071|363838936|FG000|Overall Study|Withdrawal by Subject|2|||
105499684|NCT05147428|363838941|FG000|Overall Study|Removed prior to mailing|289|||
105499685|NCT05147428|363838942|FG001|Overall Study|Removed prior to mailing|306|||
105499686|NCT05147428|363838943|FG002|Overall Study|Removed prior to mailing|270|||
105499687|NCT05147428|363838941|FG000|Overall Study|Died or disenrolled during blackout period|239|||
105499688|NCT05147428|363838942|FG001|Overall Study|Died or disenrolled during blackout period|278|||
105499689|NCT05147428|363838943|FG002|Overall Study|Died or disenrolled during blackout period|273|||
105499690|NCT02206048|363840220|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
105499691|NCT01926015|363840221|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105499692|NCT01926015|363840222|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105499693|NCT01926015|363840221|FG000|Overall Study|Randomized not treated|2|||
105499694|NCT01926015|363840222|FG001|Overall Study|Randomized not treated|0|||
105499695|NCT00639678|363840223|FG000|Overall Study|Withdrawal by Subject|3|||
105419033|NCT03632993|363540979|FG004|Overall Study|Lost to Follow-up|0|||
105499696|NCT00639678|363840224|FG001|Overall Study|Withdrawal by Subject|0|||
105499697|NCT00639678|363840225|FG002|Overall Study|Withdrawal by Subject|4|||
105499698|NCT00639678|363840226|FG003|Overall Study|Withdrawal by Subject|0|||
105499699|NCT00639678|363840223|FG000|Overall Study|Lost to Follow-up|1|||
105499700|NCT00639678|363840224|FG001|Overall Study|Lost to Follow-up|0|||
105499701|NCT00639678|363840225|FG002|Overall Study|Lost to Follow-up|6|||
105499702|NCT00639678|363840226|FG003|Overall Study|Lost to Follow-up|0|||
105499703|NCT00639678|363840223|FG000|Overall Study|Adverse Event|0|||
105499704|NCT00639678|363840224|FG001|Overall Study|Adverse Event|1|||
105499705|NCT00639678|363840225|FG002|Overall Study|Adverse Event|0|||
105499706|NCT00639678|363840226|FG003|Overall Study|Adverse Event|0|||
105499707|NCT00639678|363840223|FG000|Overall Study|Lack of Compliance|0|||
105499708|NCT00639678|363840224|FG001|Overall Study|Lack of Compliance|0|||
105499709|NCT00639678|363840225|FG002|Overall Study|Lack of Compliance|1|||
105499710|NCT00639678|363840226|FG003|Overall Study|Lack of Compliance|0|||
105499711|NCT01816074|363840238|FG000|Phase 1|Time commitment issues|0|||
105499712|NCT01816074|363840239|FG001|Phase 1|Time commitment issues|0|||
105499713|NCT01816074|363840240|FG002|Phase 1|Time commitment issues|1|||
105499714|NCT01816074|363840241|FG003|Phase 1|Time commitment issues|0|||
105499715|NCT01816074|363840238|FG000|Phase 2|Time commitment Issues|0|||
105499716|NCT01816074|363840239|FG001|Phase 2|Time commitment Issues|2|||
105499717|NCT01816074|363840240|FG002|Phase 2|Time commitment Issues|0|||
105499718|NCT01816074|363840241|FG003|Phase 2|Time commitment Issues|0|||
105499719|NCT01816074|363840238|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
105499720|NCT01816074|363840239|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
105499721|NCT01816074|363840240|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
105499722|NCT01816074|363840241|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
105499723|NCT01816074|363840238|FG000|Phase 2|Physician Decision|0|||
105499724|NCT01816074|363840239|FG001|Phase 2|Physician Decision|0|||
105499725|NCT01816074|363840240|FG002|Phase 2|Physician Decision|0|||
105499726|NCT01816074|363840241|FG003|Phase 2|Physician Decision|1|||
105499727|NCT01816074|363840238|FG000|Phase 2|Withdrawal by Subject|1|||
105499728|NCT01816074|363840239|FG001|Phase 2|Withdrawal by Subject|0|||
105499729|NCT01816074|363840240|FG002|Phase 2|Withdrawal by Subject|0|||
105499730|NCT01816074|363840241|FG003|Phase 2|Withdrawal by Subject|0|||
105499731|NCT01303861|363840258|FG000|Overall Study|Lost to Follow-up|34|||
105499732|NCT01303861|363840259|FG001|Overall Study|Lost to Follow-up|14|||
105499733|NCT01303861|363840260|FG002|Overall Study|Lost to Follow-up|27|||
105499734|NCT01303861|363840261|FG003|Overall Study|Lost to Follow-up|31|||
105499735|NCT01303861|363840258|FG000|Overall Study|Lack of Efficacy|3|||
105499736|NCT01303861|363840259|FG001|Overall Study|Lack of Efficacy|2|||
105499737|NCT01303861|363840260|FG002|Overall Study|Lack of Efficacy|1|||
105499738|NCT01303861|363840261|FG003|Overall Study|Lack of Efficacy|0|||
105499739|NCT01303861|363840258|FG000|Overall Study|Withdrawal by Subject|16|||
105499740|NCT01303861|363840259|FG001|Overall Study|Withdrawal by Subject|8|||
105499741|NCT01303861|363840260|FG002|Overall Study|Withdrawal by Subject|8|||
105499742|NCT01303861|363840261|FG003|Overall Study|Withdrawal by Subject|23|||
105499743|NCT01303861|363840258|FG000|Overall Study|Adverse Event|4|||
105499744|NCT01303861|363840259|FG001|Overall Study|Adverse Event|1|||
105499745|NCT01303861|363840260|FG002|Overall Study|Adverse Event|0|||
105499746|NCT01303861|363840261|FG003|Overall Study|Adverse Event|5|||
105499747|NCT01303861|363840258|FG000|Overall Study|Pregnancy|1|||
105499748|NCT01303861|363840259|FG001|Overall Study|Pregnancy|0|||
105499749|NCT01303861|363840260|FG002|Overall Study|Pregnancy|0|||
105499750|NCT01303861|363840261|FG003|Overall Study|Pregnancy|0|||
105499751|NCT00573937|363840263|FG000|Overall Study|Study Terminated|0|||
105499752|NCT00573937|363840264|FG001|Overall Study|Study Terminated|1|||
105499753|NCT02476201|363840265|FG000|Overall Study|Unable to program MPP|9|||
105583996|NCT05343455|364136734|FG001|Overall Study|Lost to Follow-up|1|||
105499754|NCT02476201|363840265|FG000|Overall Study|Study echo not performed|5|||
105499755|NCT02476201|363840265|FG000|Overall Study|Adverse Event|4|||
105499756|NCT02476201|363840265|FG000|Overall Study|Death|2|||
105499757|NCT02476201|363840265|FG000|Overall Study|Lost to Follow-up|2|||
105499758|NCT02476201|363840265|FG000|Overall Study|MPP programmed to OFF|2|||
105499759|NCT02476201|363840265|FG000|Overall Study|Withdrawal by Subject|1|||
105499760|NCT02476201|363840265|FG000|Overall Study|Unsuccessful implant|1|||
105499761|NCT03650556|363840266|FG000|Overall Study|Death|2|||
105499762|NCT03650556|363840266|FG000|Overall Study|Withdrawal by Subject|20|||
105499763|NCT03650556|363840266|FG000|Overall Study|Physician Decision|2|||
105583997|NCT05343455|364136735|FG002|Overall Study|Lost to Follow-up|3|||
105583998|NCT05343455|364136733|FG000|Overall Study|Pregnancy|1|||
105499764|NCT03650556|363840266|FG000|Overall Study|Lost to Follow-up|8|||
105499765|NCT03650556|363840266|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
105499766|NCT03650556|363840266|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
105499767|NCT00491764|363840267|FG000|Overall Study|Adverse Event|1|||
105499768|NCT00491764|363840268|FG001|Overall Study|Adverse Event|2|||
105499769|NCT00491764|363840269|FG002|Overall Study|Adverse Event|4|||
105499770|NCT00491764|363840270|FG003|Overall Study|Adverse Event|4|||
105499771|NCT00491764|363840271|FG004|Overall Study|Adverse Event|0|||
105499772|NCT00491764|363840272|FG005|Overall Study|Adverse Event|1|||
105419034|NCT03632993|363540980|FG005|Overall Study|Lost to Follow-up|1|||
105419035|NCT03632993|363540981|FG006|Overall Study|Lost to Follow-up|0|||
105419036|NCT03632993|363540982|FG007|Overall Study|Lost to Follow-up|1|||
105419037|NCT03632993|363540983|FG008|Overall Study|Lost to Follow-up|0|||
105419038|NCT03632993|363540984|FG009|Overall Study|Lost to Follow-up|0|||
105419039|NCT03632993|363540975|FG000|Overall Study|Adverse Event|0|||
105419040|NCT03632993|363540976|FG001|Overall Study|Adverse Event|0|||
105583999|NCT05343455|364136734|FG001|Overall Study|Pregnancy|0|||
105419041|NCT03632993|363540977|FG002|Overall Study|Adverse Event|0|||
105419042|NCT03632993|363540978|FG003|Overall Study|Adverse Event|0|||
105419043|NCT03632993|363540979|FG004|Overall Study|Adverse Event|0|||
105419044|NCT03632993|363540980|FG005|Overall Study|Adverse Event|1|||
105419045|NCT03632993|363540981|FG006|Overall Study|Adverse Event|0|||
105419046|NCT03632993|363540982|FG007|Overall Study|Adverse Event|1|||
105419047|NCT03632993|363540983|FG008|Overall Study|Adverse Event|0|||
105419048|NCT03632993|363540984|FG009|Overall Study|Adverse Event|0|||
105419049|NCT02743949|363540987|FG000|Overall Study|Adverse Event|0|||
105419050|NCT02743949|363540988|FG001|Overall Study|Adverse Event|0|||
105419051|NCT02743949|363540989|FG002|Overall Study|Adverse Event|2|||
105419052|NCT02743949|363540987|FG000|Overall Study|Significant Protocol Deviation|2|||
105419053|NCT02743949|363540988|FG001|Overall Study|Significant Protocol Deviation|0|||
105419054|NCT02743949|363540989|FG002|Overall Study|Significant Protocol Deviation|1|||
105419055|NCT02743949|363540987|FG000|Overall Study|Voluntary Withdrawal|2|||
105419056|NCT02743949|363540988|FG001|Overall Study|Voluntary Withdrawal|1|||
105419057|NCT02743949|363540989|FG002|Overall Study|Voluntary Withdrawal|0|||
105419058|NCT01885208|363540992|FG000|Overall Study|Unclassified|32|||
105419059|NCT01885208|363540993|FG001|Overall Study|Unclassified|38|||
105419060|NCT00920218|363540994|FG000|Overall Study|Serious Adverse Event|2|||
105419061|NCT00920218|363540995|FG001|Overall Study|Serious Adverse Event|0|||
105419062|NCT00920218|363540996|FG002|Overall Study|Serious Adverse Event|2|||
105419063|NCT00920218|363540997|FG003|Overall Study|Serious Adverse Event|1|||
105419064|NCT00920218|363540994|FG000|Overall Study|Withdrawal by Subject|0|||
105419065|NCT00920218|363540995|FG001|Overall Study|Withdrawal by Subject|3|||
105419066|NCT00920218|363540996|FG002|Overall Study|Withdrawal by Subject|2|||
105419067|NCT00920218|363540997|FG003|Overall Study|Withdrawal by Subject|0|||
105419068|NCT00920218|363540994|FG000|Overall Study|Migrated/moved from study area|0|||
105419069|NCT00920218|363540995|FG001|Overall Study|Migrated/moved from study area|0|||
105419070|NCT00920218|363540996|FG002|Overall Study|Migrated/moved from study area|1|||
105419071|NCT00920218|363540997|FG003|Overall Study|Migrated/moved from study area|0|||
105419072|NCT00920218|363540994|FG000|Overall Study|Lost to Follow-up|0|||
105419073|NCT00920218|363540995|FG001|Overall Study|Lost to Follow-up|1|||
105419074|NCT00920218|363540996|FG002|Overall Study|Lost to Follow-up|0|||
105419075|NCT00920218|363540997|FG003|Overall Study|Lost to Follow-up|3|||
105419076|NCT00920218|363540994|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
105419077|NCT00920218|363540995|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
105419078|NCT00920218|363540996|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
105499773|NCT00491764|363840267|FG000|Overall Study|Lost to Follow-up|0|||
105499774|NCT00491764|363840268|FG001|Overall Study|Lost to Follow-up|1|||
105499775|NCT00491764|363840269|FG002|Overall Study|Lost to Follow-up|0|||
105499776|NCT00491764|363840270|FG003|Overall Study|Lost to Follow-up|1|||
105499777|NCT00491764|363840271|FG004|Overall Study|Lost to Follow-up|0|||
105499778|NCT00491764|363840272|FG005|Overall Study|Lost to Follow-up|3|||
105499779|NCT00491764|363840267|FG000|Overall Study|Withdrawal by Subject|2|||
105499780|NCT00491764|363840268|FG001|Overall Study|Withdrawal by Subject|3|||
105499781|NCT00491764|363840269|FG002|Overall Study|Withdrawal by Subject|1|||
105499782|NCT00491764|363840270|FG003|Overall Study|Withdrawal by Subject|2|||
105499783|NCT00491764|363840271|FG004|Overall Study|Withdrawal by Subject|2|||
105499784|NCT00491764|363840272|FG005|Overall Study|Withdrawal by Subject|4|||
105499785|NCT00491764|363840267|FG000|Overall Study|Non Compliance with the Protocol|1|||
105499786|NCT00491764|363840268|FG001|Overall Study|Non Compliance with the Protocol|0|||
105499787|NCT00491764|363840269|FG002|Overall Study|Non Compliance with the Protocol|0|||
105499788|NCT00491764|363840270|FG003|Overall Study|Non Compliance with the Protocol|0|||
105499789|NCT00491764|363840271|FG004|Overall Study|Non Compliance with the Protocol|0|||
105499790|NCT00491764|363840272|FG005|Overall Study|Non Compliance with the Protocol|0|||
105499791|NCT00491764|363840267|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
105499792|NCT00491764|363840268|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
105499793|NCT00491764|363840269|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
105499794|NCT00491764|363840270|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
105499795|NCT00491764|363840271|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
105584000|NCT05343455|364136735|FG002|Overall Study|Pregnancy|0|||
105584001|NCT05343455|364136733|FG000|Overall Study|Physician Decision|0|||
105419079|NCT00920218|363540997|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
105419080|NCT00920218|363540994|FG000|Overall Study|Other|0|||
105419081|NCT00920218|363540995|FG001|Overall Study|Other|0|||
105419082|NCT00920218|363540996|FG002|Overall Study|Other|1|||
105419083|NCT00920218|363540997|FG003|Overall Study|Other|0|||
105419084|NCT01328535|363540999|FG000|Overall Study|Ineligible|1|||
105419085|NCT01005316|363541000|FG000|Overall Study|Adverse Event|0|||
105419086|NCT01005316|363541001|FG001|Overall Study|Adverse Event|0|||
105419087|NCT01005316|363541002|FG002|Overall Study|Adverse Event|0|||
105419088|NCT01005316|363541003|FG003|Overall Study|Adverse Event|1|||
105419089|NCT01005316|363541000|FG000|Overall Study|Death|20|||
105419090|NCT01005316|363541001|FG001|Overall Study|Death|5|||
105419091|NCT01005316|363541002|FG002|Overall Study|Death|1|||
105419092|NCT01005316|363541003|FG003|Overall Study|Death|15|||
105419093|NCT01005316|363541000|FG000|Overall Study|Study Termination|5|||
105419094|NCT01005316|363541001|FG001|Overall Study|Study Termination|63|||
105419095|NCT01005316|363541002|FG002|Overall Study|Study Termination|9|||
105419096|NCT01005316|363541003|FG003|Overall Study|Study Termination|85|||
105419097|NCT01005316|363541000|FG000|Overall Study|Lost to Follow-up|1|||
105419098|NCT01005316|363541001|FG001|Overall Study|Lost to Follow-up|3|||
105419099|NCT01005316|363541002|FG002|Overall Study|Lost to Follow-up|0|||
105419100|NCT01005316|363541003|FG003|Overall Study|Lost to Follow-up|2|||
105419101|NCT01005316|363541000|FG000|Overall Study|Physician Decision|6|||
105419102|NCT01005316|363541001|FG001|Overall Study|Physician Decision|0|||
105419103|NCT01005316|363541002|FG002|Overall Study|Physician Decision|0|||
105419104|NCT01005316|363541003|FG003|Overall Study|Physician Decision|0|||
105419105|NCT01005316|363541000|FG000|Overall Study|Sponsor Decision|6|||
105419106|NCT01005316|363541001|FG001|Overall Study|Sponsor Decision|3|||
105419107|NCT01005316|363541002|FG002|Overall Study|Sponsor Decision|0|||
105419108|NCT01005316|363541003|FG003|Overall Study|Sponsor Decision|0|||
105419109|NCT01005316|363541000|FG000|Overall Study|Withdrawal by Subject|1|||
105419110|NCT01005316|363541001|FG001|Overall Study|Withdrawal by Subject|1|||
105419111|NCT01005316|363541002|FG002|Overall Study|Withdrawal by Subject|0|||
105419112|NCT01005316|363541003|FG003|Overall Study|Withdrawal by Subject|2|||
105419113|NCT01005316|363541000|FG000|Overall Study|Consented to Another Study|2|||
105419114|NCT01005316|363541001|FG001|Overall Study|Consented to Another Study|0|||
105419115|NCT01005316|363541002|FG002|Overall Study|Consented to Another Study|0|||
105419116|NCT01005316|363541003|FG003|Overall Study|Consented to Another Study|0|||
105419117|NCT01005316|363541000|FG000|Overall Study|Delisted|8|||
105419118|NCT01005316|363541001|FG001|Overall Study|Delisted|0|||
105419119|NCT01005316|363541002|FG002|Overall Study|Delisted|0|||
105419120|NCT01005316|363541003|FG003|Overall Study|Delisted|0|||
105419121|NCT01005316|363541000|FG000|Overall Study|Transferred Care|1|||
105499796|NCT00491764|363840272|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
105499797|NCT00491764|363840267|FG000|Overall Study|Administrative|1|||
105499798|NCT00491764|363840268|FG001|Overall Study|Administrative|0|||
105499799|NCT00491764|363840269|FG002|Overall Study|Administrative|2|||
105499800|NCT00491764|363840270|FG003|Overall Study|Administrative|1|||
105499801|NCT00491764|363840271|FG004|Overall Study|Administrative|0|||
105419122|NCT01005316|363541001|FG001|Overall Study|Transferred Care|0|||
105419123|NCT01005316|363541002|FG002|Overall Study|Transferred Care|1|||
105419124|NCT01005316|363541003|FG003|Overall Study|Transferred Care|3|||
105419125|NCT01005316|363541000|FG000|Overall Study|Retransplanted|0|||
105419126|NCT01005316|363541001|FG001|Overall Study|Retransplanted|1|||
105419127|NCT01005316|363541002|FG002|Overall Study|Retransplanted|0|||
105419128|NCT01005316|363541003|FG003|Overall Study|Retransplanted|0|||
105419129|NCT04417218|363541004|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
105419130|NCT04417218|363541005|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
105419131|NCT03224507|363541006|FG000|Overall Study|Death|3|||
105419132|NCT03224507|363541007|FG001|Overall Study|Death|0|||
105419133|NCT03224507|363541006|FG000|Overall Study|Lack of Efficacy|6|||
105419134|NCT03224507|363541007|FG001|Overall Study|Lack of Efficacy|0|||
105419135|NCT03224507|363541006|FG000|Overall Study|Withdrawal by Subject|6|||
105419136|NCT03224507|363541007|FG001|Overall Study|Withdrawal by Subject|0|||
105419137|NCT00873041|363541008|FG000|Core Study|Adverse Event|2|||
105419138|NCT00873041|363541009|FG001|Core Study|Adverse Event|3|||
105419139|NCT00873041|363541010|FG002|Core Study|Adverse Event|1|||
105419140|NCT00873041|363541008|FG000|Core Study|Withdrawal by Subject|1|||
105419141|NCT00873041|363541009|FG001|Core Study|Withdrawal by Subject|2|||
105419142|NCT00873041|363541010|FG002|Core Study|Withdrawal by Subject|2|||
105419143|NCT00873041|363541008|FG000|Core Study|Lost to Follow-up|3|||
105419144|NCT00873041|363541009|FG001|Core Study|Lost to Follow-up|1|||
105419145|NCT00873041|363541010|FG002|Core Study|Lost to Follow-up|0|||
105419146|NCT00873041|363541008|FG000|Core Study|Abnormal laboratory value|0|||
105419147|NCT00873041|363541009|FG001|Core Study|Abnormal laboratory value|0|||
105419148|NCT00873041|363541010|FG002|Core Study|Abnormal laboratory value|1|||
105499802|NCT00491764|363840272|FG005|Overall Study|Administrative|0|||
105419149|NCT00873041|363541008|FG000|Core Study|Protocol deviation|1|||
105419150|NCT00873041|363541009|FG001|Core Study|Protocol deviation|0|||
105419151|NCT00873041|363541010|FG002|Core Study|Protocol deviation|1|||
105419152|NCT00873041|363541008|FG000|Extension Study|Adverse Event|1|||
105419153|NCT00873041|363541009|FG001|Extension Study|Adverse Event|0|||
105419154|NCT00873041|363541010|FG002|Extension Study|Adverse Event|1|||
105499803|NCT01601132|363840273|FG000|Overall Study|Patient withdrew consent|1|||
105499804|NCT01601132|363840273|FG000|Overall Study|Protocol deviation|1|||
105499805|NCT01030536|363840279|FG000|Overall Study|Withdrawal by Subject|0|||
105419155|NCT00873041|363541008|FG000|Extension Study|Administrative reasons|0|||
105419156|NCT00873041|363541009|FG001|Extension Study|Administrative reasons|0|||
105419157|NCT00873041|363541010|FG002|Extension Study|Administrative reasons|1|||
105419158|NCT04295681|363541011|FG000|Overall Study|Eligibility error|1|||
105419159|NCT04295681|363541012|FG001|Overall Study|Eligibility error|3|||
105419160|NCT01106651|363541013|FG000|Overall Study|Adverse Event|17|||
105419161|NCT01106651|363541014|FG001|Overall Study|Adverse Event|9|||
105419162|NCT01106651|363541015|FG002|Overall Study|Adverse Event|23|||
105419163|NCT01106651|363541013|FG000|Overall Study|Lost to Follow-up|8|||
105419164|NCT01106651|363541014|FG001|Overall Study|Lost to Follow-up|2|||
105419165|NCT01106651|363541015|FG002|Overall Study|Lost to Follow-up|6|||
105419166|NCT01106651|363541013|FG000|Overall Study|Physician Decision|4|||
105419167|NCT01106651|363541014|FG001|Overall Study|Physician Decision|3|||
105419168|NCT01106651|363541015|FG002|Overall Study|Physician Decision|1|||
105419169|NCT01106651|363541013|FG000|Overall Study|Protocol Violation|1|||
105419170|NCT01106651|363541014|FG001|Overall Study|Protocol Violation|2|||
105419171|NCT01106651|363541015|FG002|Overall Study|Protocol Violation|1|||
105419172|NCT01106651|363541013|FG000|Overall Study|Withdrawal by Subject|14|||
105419173|NCT01106651|363541014|FG001|Overall Study|Withdrawal by Subject|7|||
105419174|NCT01106651|363541015|FG002|Overall Study|Withdrawal by Subject|4|||
105419175|NCT01106651|363541013|FG000|Overall Study|Noncompliance with study drug|1|||
105419176|NCT01106651|363541014|FG001|Overall Study|Noncompliance with study drug|0|||
105419177|NCT01106651|363541015|FG002|Overall Study|Noncompliance with study drug|2|||
105419178|NCT01106651|363541013|FG000|Overall Study|Other|34|||
105419179|NCT01106651|363541014|FG001|Overall Study|Other|31|||
105419180|NCT01106651|363541015|FG002|Overall Study|Other|21|||
105419181|NCT01106651|363541013|FG000|Overall Study|Death|0|||
105419182|NCT01106651|363541014|FG001|Overall Study|Death|3|||
105419183|NCT01106651|363541015|FG002|Overall Study|Death|0|||
105419184|NCT02135029|363541016|FG000|Overall Study|Adverse Event|2|||
105419185|NCT02135029|363541017|FG001|Overall Study|Adverse Event|2|||
105419186|NCT02135029|363541018|FG002|Overall Study|Adverse Event|2|||
105419187|NCT02135029|363541016|FG000|Overall Study|Lost to Follow-up|0|||
105419188|NCT02135029|363541017|FG001|Overall Study|Lost to Follow-up|1|||
105419189|NCT02135029|363541018|FG002|Overall Study|Lost to Follow-up|0|||
105419190|NCT02135029|363541016|FG000|Overall Study|Withdrawal by Subject|2|||
105419191|NCT02135029|363541017|FG001|Overall Study|Withdrawal by Subject|0|||
105419192|NCT02135029|363541018|FG002|Overall Study|Withdrawal by Subject|1|||
105419193|NCT02135029|363541016|FG000|Overall Study|Other|0|||
105419194|NCT02135029|363541017|FG001|Overall Study|Other|1|||
105419195|NCT02135029|363541018|FG002|Overall Study|Other|0|||
105419196|NCT02135029|363541016|FG000|Overall Study|Death|0|||
105419197|NCT02135029|363541017|FG001|Overall Study|Death|1|||
105419198|NCT02135029|363541018|FG002|Overall Study|Death|0|||
105419199|NCT03466099|363541022|FG000|Overall Study|Adverse Event|1|||
105419200|NCT03466099|363541023|FG001|Overall Study|Adverse Event|1|||
105419201|NCT03466099|363541024|FG002|Overall Study|Adverse Event|1|||
105419202|NCT03466099|363541022|FG000|Overall Study|Withdrawal by Subject|2|||
105419203|NCT03466099|363541023|FG001|Overall Study|Withdrawal by Subject|3|||
105419204|NCT03466099|363541024|FG002|Overall Study|Withdrawal by Subject|1|||
105419205|NCT03466099|363541022|FG000|Overall Study|Use of rescue medication|8|||
105419206|NCT03466099|363541023|FG001|Overall Study|Use of rescue medication|9|||
105419207|NCT03466099|363541024|FG002|Overall Study|Use of rescue medication|13|||
105419208|NCT03466099|363541022|FG000|Overall Study|Rescued without meeting criteria|4|||
105419209|NCT03466099|363541023|FG001|Overall Study|Rescued without meeting criteria|1|||
105419210|NCT03466099|363541024|FG002|Overall Study|Rescued without meeting criteria|1|||
105419211|NCT03466099|363541022|FG000|Overall Study|Subject compliance|2|||
105499806|NCT01030536|363840280|FG001|Overall Study|Withdrawal by Subject|0|||
105499807|NCT01030536|363840281|FG002|Overall Study|Withdrawal by Subject|1|||
105499808|NCT01030536|363840282|FG003|Overall Study|Withdrawal by Subject|0|||
105499809|NCT01030536|363840283|FG004|Overall Study|Withdrawal by Subject|0|||
105419212|NCT03466099|363541023|FG001|Overall Study|Subject compliance|0|||
105419213|NCT03466099|363541024|FG002|Overall Study|Subject compliance|0|||
105419214|NCT03466099|363541022|FG000|Overall Study|Worsening disease|0|||
105419215|NCT03466099|363541023|FG001|Overall Study|Worsening disease|0|||
105419216|NCT03466099|363541024|FG002|Overall Study|Worsening disease|1|||
105419217|NCT00075946|363541028|FG000|Overall Study|Path ineligible: undetermined histology|0|||
105419218|NCT00075946|363541029|FG001|Overall Study|Path ineligible: undetermined histology|0|||
105419219|NCT00075946|363541030|FG002|Overall Study|Path ineligible: undetermined histology|0|||
105499810|NCT01030536|363840279|FG000|Overall Study|undefined|1|||
105419220|NCT00075946|363541031|FG003|Overall Study|Path ineligible: undetermined histology|0|||
105419221|NCT00075946|363541032|FG004|Overall Study|Path ineligible: undetermined histology|6|||
105419222|NCT00075946|363541028|FG000|Overall Study|Did not achieve response after induction|0|||
105419223|NCT00075946|363541029|FG001|Overall Study|Did not achieve response after induction|0|||
105419224|NCT00075946|363541030|FG002|Overall Study|Did not achieve response after induction|0|||
105419225|NCT00075946|363541031|FG003|Overall Study|Did not achieve response after induction|0|||
105419226|NCT00075946|363541032|FG004|Overall Study|Did not achieve response after induction|182|||
105499811|NCT01030536|363840280|FG001|Overall Study|undefined|0|||
105499812|NCT01030536|363840281|FG002|Overall Study|undefined|1|||
105499813|NCT01030536|363840282|FG003|Overall Study|undefined|1|||
105499814|NCT01030536|363840283|FG004|Overall Study|undefined|0|||
105499815|NCT01030536|363840279|FG000|Overall Study|Adverse Event|0|||
105499816|NCT01030536|363840280|FG001|Overall Study|Adverse Event|3|||
105499817|NCT01030536|363840281|FG002|Overall Study|Adverse Event|1|||
105499818|NCT01030536|363840282|FG003|Overall Study|Adverse Event|0|||
105499819|NCT01030536|363840283|FG004|Overall Study|Adverse Event|1|||
105499820|NCT01030536|363840279|FG000|Overall Study|Progressive disease|6|||
105499821|NCT01030536|363840280|FG001|Overall Study|Progressive disease|2|||
105499822|NCT01030536|363840281|FG002|Overall Study|Progressive disease|3|||
105499823|NCT01030536|363840282|FG003|Overall Study|Progressive disease|2|||
105499824|NCT01030536|363840283|FG004|Overall Study|Progressive disease|0|||
105499825|NCT01030536|363840279|FG000|Overall Study|Death|0|||
105499826|NCT01030536|363840280|FG001|Overall Study|Death|1|||
105499827|NCT01030536|363840281|FG002|Overall Study|Death|0|||
105499828|NCT01030536|363840282|FG003|Overall Study|Death|0|||
105499829|NCT01030536|363840283|FG004|Overall Study|Death|0|||
105499830|NCT01189604|363840284|FG000|Overall Study|Impossible to visit|0|||
105499831|NCT01189604|363840285|FG001|Overall Study|Impossible to visit|0|||
105499832|NCT01189604|363840286|FG002|Overall Study|Impossible to visit|0|||
105499833|NCT01189604|363840287|FG003|Overall Study|Impossible to visit|0|||
105499834|NCT01189604|363840288|FG004|Overall Study|Impossible to visit|0|||
105499835|NCT01189604|363840289|FG005|Overall Study|Impossible to visit|1|||
105499836|NCT01189604|363840290|FG006|Overall Study|Impossible to visit|0|||
105499837|NCT01189604|363840284|FG000|Overall Study|Adverse Event|0|||
105499838|NCT01189604|363840285|FG001|Overall Study|Adverse Event|1|||
105499839|NCT01189604|363840286|FG002|Overall Study|Adverse Event|0|||
105499840|NCT01189604|363840287|FG003|Overall Study|Adverse Event|0|||
105499841|NCT01189604|363840288|FG004|Overall Study|Adverse Event|2|||
105499842|NCT01189604|363840289|FG005|Overall Study|Adverse Event|0|||
105499843|NCT01189604|363840290|FG006|Overall Study|Adverse Event|1|||
105499844|NCT01189604|363840284|FG000|Overall Study|Withdrawal by Subject|1|||
105499845|NCT01189604|363840285|FG001|Overall Study|Withdrawal by Subject|0|||
105499846|NCT01189604|363840286|FG002|Overall Study|Withdrawal by Subject|0|||
105499847|NCT01189604|363840287|FG003|Overall Study|Withdrawal by Subject|0|||
105499848|NCT01189604|363840288|FG004|Overall Study|Withdrawal by Subject|0|||
105499849|NCT01189604|363840289|FG005|Overall Study|Withdrawal by Subject|0|||
105499850|NCT01189604|363840290|FG006|Overall Study|Withdrawal by Subject|0|||
105499851|NCT02410551|363840291|FG000|Overall Study|Adverse Event|1|||
105499852|NCT02410551|363840291|FG000|Overall Study|Withdrawal by Subject|1|||
105499853|NCT02410551|363840291|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
105419227|NCT00075946|363541028|FG000|Overall Study|Incorrectly randomized (no response)|5|||
105419228|NCT00075946|363541029|FG001|Overall Study|Incorrectly randomized (no response)|5|||
105419229|NCT00075946|363541030|FG002|Overall Study|Incorrectly randomized (no response)|5|||
105419230|NCT00075946|363541031|FG003|Overall Study|Incorrectly randomized (no response)|1|||
105419231|NCT00075946|363541032|FG004|Overall Study|Incorrectly randomized (no response)|0|||
105419232|NCT00075946|363541028|FG000|Overall Study|Adverse Event|2|||
105419233|NCT00075946|363541029|FG001|Overall Study|Adverse Event|10|||
105419234|NCT00075946|363541030|FG002|Overall Study|Adverse Event|0|||
105419235|NCT00075946|363541031|FG003|Overall Study|Adverse Event|2|||
105419236|NCT00075946|363541032|FG004|Overall Study|Adverse Event|0|||
105419237|NCT00075946|363541028|FG000|Overall Study|Death|0|||
105419238|NCT00075946|363541029|FG001|Overall Study|Death|1|||
105419239|NCT00075946|363541030|FG002|Overall Study|Death|0|||
105419240|NCT00075946|363541031|FG003|Overall Study|Death|0|||
105419241|NCT00075946|363541032|FG004|Overall Study|Death|0|||
105419242|NCT00075946|363541028|FG000|Overall Study|Withdrawal by Subject|23|||
105419243|NCT00075946|363541029|FG001|Overall Study|Withdrawal by Subject|58|||
105419244|NCT00075946|363541030|FG002|Overall Study|Withdrawal by Subject|4|||
105419245|NCT00075946|363541031|FG003|Overall Study|Withdrawal by Subject|9|||
105419246|NCT00075946|363541032|FG004|Overall Study|Withdrawal by Subject|0|||
105419247|NCT00075946|363541028|FG000|Overall Study|Alternative therapy|16|||
105419248|NCT00075946|363541029|FG001|Overall Study|Alternative therapy|2|||
105419249|NCT00075946|363541030|FG002|Overall Study|Alternative therapy|5|||
105499854|NCT01419626|363840292|FG000|Overall Study|Protocol Violation|3|||
105499855|NCT01419626|363840293|FG001|Overall Study|Protocol Violation|2|||
105499856|NCT01419626|363840294|FG002|Overall Study|Protocol Violation|2|||
105499857|NCT01419626|363840292|FG000|Overall Study|Withdrawal by Subject|1|||
105499858|NCT01419626|363840293|FG001|Overall Study|Withdrawal by Subject|0|||
105419250|NCT00075946|363541031|FG003|Overall Study|Alternative therapy|0|||
105419251|NCT00075946|363541032|FG004|Overall Study|Alternative therapy|0|||
105419252|NCT00075946|363541028|FG000|Overall Study|Other complicating disease|7|||
105499859|NCT01419626|363840294|FG002|Overall Study|Withdrawal by Subject|0|||
105499860|NCT01419626|363840292|FG000|Overall Study|Lost to Follow-up|0|||
105499861|NCT01419626|363840293|FG001|Overall Study|Lost to Follow-up|1|||
105499862|NCT01419626|363840294|FG002|Overall Study|Lost to Follow-up|1|||
105499863|NCT01365052|363840295|FG000|Overall Study|Adverse Event|4|||
105499864|NCT01365052|363840296|FG001|Overall Study|Adverse Event|4|||
105419253|NCT00075946|363541029|FG001|Overall Study|Other complicating disease|13|||
105419254|NCT00075946|363541030|FG002|Overall Study|Other complicating disease|1|||
105419255|NCT00075946|363541031|FG003|Overall Study|Other complicating disease|4|||
105419256|NCT00075946|363541032|FG004|Overall Study|Other complicating disease|0|||
105419257|NCT00075946|363541028|FG000|Overall Study|No response to retreatment|23|||
105419258|NCT00075946|363541029|FG001|Overall Study|No response to retreatment|0|||
105419259|NCT00075946|363541030|FG002|Overall Study|No response to retreatment|2|||
105419260|NCT00075946|363541031|FG003|Overall Study|No response to retreatment|0|||
105419261|NCT00075946|363541032|FG004|Overall Study|No response to retreatment|0|||
105419262|NCT00075946|363541028|FG000|Overall Study|Time to progression less than 6 months|15|||
105419263|NCT00075946|363541029|FG001|Overall Study|Time to progression less than 6 months|30|||
105419264|NCT00075946|363541030|FG002|Overall Study|Time to progression less than 6 months|8|||
105419265|NCT00075946|363541031|FG003|Overall Study|Time to progression less than 6 months|3|||
105419266|NCT00075946|363541032|FG004|Overall Study|Time to progression less than 6 months|0|||
105419267|NCT00075946|363541028|FG000|Overall Study|Other|57|||
105419268|NCT00075946|363541029|FG001|Overall Study|Other|32|||
105419269|NCT00075946|363541030|FG002|Overall Study|Other|3|||
105419270|NCT00075946|363541031|FG003|Overall Study|Other|11|||
105419271|NCT00075946|363541032|FG004|Overall Study|Other|0|||
105419272|NCT00344318|363541035|FG000|Overall Study|Adverse Event|0|||
105419273|NCT00344318|363541036|FG001|Overall Study|Adverse Event|3|||
105419274|NCT00344318|363541037|FG002|Overall Study|Adverse Event|0|||
105419275|NCT00344318|363541038|FG003|Overall Study|Adverse Event|1|||
105419276|NCT00344318|363541035|FG000|Overall Study|Withdrawal by Subject|2|||
105419277|NCT00344318|363541036|FG001|Overall Study|Withdrawal by Subject|2|||
105419278|NCT00344318|363541037|FG002|Overall Study|Withdrawal by Subject|0|||
105419279|NCT00344318|363541038|FG003|Overall Study|Withdrawal by Subject|2|||
105419280|NCT00344318|363541035|FG000|Overall Study|Lost to Follow-up|2|||
105419281|NCT00344318|363541036|FG001|Overall Study|Lost to Follow-up|0|||
105419282|NCT00344318|363541037|FG002|Overall Study|Lost to Follow-up|1|||
105419283|NCT00344318|363541038|FG003|Overall Study|Lost to Follow-up|0|||
105419284|NCT03832322|363541039|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
105419285|NCT03832322|363541040|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
105419286|NCT01923363|363541042|FG000|Overall Study|Protocol Violation|1|||
105419287|NCT02247011|363541045|FG000|Overall Study|Poor quality of radiological results|125|||
105419288|NCT02152371|363541046|FG000|Overall Study|Adverse Event|6|||
105419289|NCT02152371|363541047|FG001|Overall Study|Adverse Event|2|||
105419290|NCT02152371|363541046|FG000|Overall Study|Withdrawal by Subject|3|||
105419291|NCT02152371|363541047|FG001|Overall Study|Withdrawal by Subject|7|||
105419292|NCT02152371|363541046|FG000|Overall Study|Protocol Violation|2|||
105419293|NCT02152371|363541047|FG001|Overall Study|Protocol Violation|3|||
105419294|NCT02152371|363541046|FG000|Overall Study|Lost to Follow-up|1|||
105419295|NCT02152371|363541047|FG001|Overall Study|Lost to Follow-up|0|||
105419296|NCT02152371|363541046|FG000|Overall Study|Lack of Efficacy|0|||
105419297|NCT02152371|363541047|FG001|Overall Study|Lack of Efficacy|1|||
105419298|NCT02152371|363541046|FG000|Overall Study|Physician Decision|0|||
105419299|NCT02152371|363541047|FG001|Overall Study|Physician Decision|2|||
105419300|NCT02152371|363541046|FG000|Overall Study|Reason Not Given|0|||
105419301|NCT02152371|363541047|FG001|Overall Study|Reason Not Given|1|||
105419302|NCT03194568|363541050|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
105419303|NCT03515551|363541053|FG000|Overall Study|Death|4|||
105419304|NCT03515551|363541054|FG001|Overall Study|Death|1|||
105419305|NCT03515551|363541055|FG002|Overall Study|Death|2|||
105419306|NCT03515551|363541056|FG003|Overall Study|Death|2|||
105419307|NCT03515551|363541057|FG004|Overall Study|Death|2|||
105419308|NCT03515551|363541058|FG005|Overall Study|Death|4|||
105419309|NCT03515551|363541059|FG006|Overall Study|Death|1|||
105419310|NCT03515551|363541053|FG000|Overall Study|Lost to Follow-up|0|||
105419311|NCT03515551|363541054|FG001|Overall Study|Lost to Follow-up|0|||
105419312|NCT03515551|363541055|FG002|Overall Study|Lost to Follow-up|1|||
105419313|NCT03515551|363541056|FG003|Overall Study|Lost to Follow-up|0|||
105419314|NCT03515551|363541057|FG004|Overall Study|Lost to Follow-up|0|||
105419315|NCT03515551|363541058|FG005|Overall Study|Lost to Follow-up|0|||
105419316|NCT03515551|363541059|FG006|Overall Study|Lost to Follow-up|0|||
105419317|NCT03515551|363541053|FG000|Overall Study|Withdrawal by Subject|0|||
105419318|NCT03515551|363541054|FG001|Overall Study|Withdrawal by Subject|1|||
105419319|NCT03515551|363541055|FG002|Overall Study|Withdrawal by Subject|0|||
105419320|NCT03515551|363541056|FG003|Overall Study|Withdrawal by Subject|0|||
105419321|NCT03515551|363541057|FG004|Overall Study|Withdrawal by Subject|0|||
105584002|NCT05343455|364136734|FG001|Overall Study|Physician Decision|0|||
105419322|NCT03515551|363541058|FG005|Overall Study|Withdrawal by Subject|0|||
105419323|NCT03515551|363541059|FG006|Overall Study|Withdrawal by Subject|1|||
105419324|NCT03515551|363541053|FG000|Overall Study|Study ended by sponsor|0|||
105419325|NCT03515551|363541054|FG001|Overall Study|Study ended by sponsor|0|||
105419326|NCT03515551|363541055|FG002|Overall Study|Study ended by sponsor|2|||
105419327|NCT03515551|363541056|FG003|Overall Study|Study ended by sponsor|1|||
105419328|NCT03515551|363541057|FG004|Overall Study|Study ended by sponsor|3|||
105419329|NCT03515551|363541058|FG005|Overall Study|Study ended by sponsor|0|||
105419330|NCT03515551|363541059|FG006|Overall Study|Study ended by sponsor|3|||
105419331|NCT03515551|363541053|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
105419332|NCT03515551|363541054|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
105419333|NCT03515551|363541055|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
105419334|NCT03515551|363541056|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
105419335|NCT03515551|363541057|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
105419336|NCT03515551|363541058|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
105419337|NCT03515551|363541059|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
105419338|NCT01301066|363541060|FG000|Overall Study|Lost to Follow-up|5|||
105419339|NCT01301066|363541061|FG001|Overall Study|Lost to Follow-up|11|||
105419340|NCT01301066|363541060|FG000|Overall Study|Protocol Violation|8|||
105419341|NCT01301066|363541061|FG001|Overall Study|Protocol Violation|7|||
105419342|NCT01301066|363541060|FG000|Overall Study|Withdrawal by Subject|4|||
105419343|NCT01301066|363541061|FG001|Overall Study|Withdrawal by Subject|9|||
105419344|NCT01301066|363541060|FG000|Overall Study|Adverse Event|6|||
105419345|NCT01301066|363541061|FG001|Overall Study|Adverse Event|6|||
105419346|NCT01301066|363541060|FG000|Overall Study|Sponsor Decision|2|||
105499865|NCT01145625|363840299|FG000|Overall Study|Lost to Follow-up|8|||
105499866|NCT01145625|363840300|FG001|Overall Study|Lost to Follow-up|9|||
105499867|NCT01145625|363840299|FG000|Overall Study|Adverse Event|6|||
105499868|NCT01145625|363840300|FG001|Overall Study|Adverse Event|4|||
105499869|NCT01145625|363840299|FG000|Overall Study|Protocol Violation|3|||
105499870|NCT01145625|363840300|FG001|Overall Study|Protocol Violation|1|||
105499871|NCT01145625|363840299|FG000|Overall Study|Withdrawal by Subject|7|||
105499872|NCT01145625|363840300|FG001|Overall Study|Withdrawal by Subject|16|||
105499873|NCT01145625|363840299|FG000|Overall Study|Pregnancy|0|||
105499874|NCT01145625|363840300|FG001|Overall Study|Pregnancy|1|||
105499875|NCT04889222|363840304|FG000|Overall Study|Did not meet eligibility criteria|8|||
105499876|NCT04889222|363840304|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
105499877|NCT04889222|363840304|FG000|Overall Study|Did not proceed due to time constraints|5|||
105499878|NCT01206166|363840313|FG000|Overall Study|No evaluable data|2|||
105499879|NCT01206166|363840314|FG001|Overall Study|No evaluable data|3|||
105499880|NCT02345226|363840315|FG000|Double-Blind Phase|Adverse Event|5|||
105499881|NCT02345226|363840316|FG001|Double-Blind Phase|Adverse Event|6|||
105499882|NCT02345226|363840315|FG000|Double-Blind Phase|Death|3|||
105499883|NCT02345226|363840316|FG001|Double-Blind Phase|Death|0|||
105499884|NCT02345226|363840315|FG000|Double-Blind Phase|Pregnancy|0|||
105499885|NCT02345226|363840316|FG001|Double-Blind Phase|Pregnancy|1|||
105499886|NCT02345226|363840315|FG000|Double-Blind Phase|Lack of Efficacy|1|||
105499887|NCT02345226|363840316|FG001|Double-Blind Phase|Lack of Efficacy|0|||
105499888|NCT02345226|363840315|FG000|Double-Blind Phase|Investigator's Discretion|4|||
105499889|NCT02345226|363840316|FG001|Double-Blind Phase|Investigator's Discretion|3|||
105499890|NCT02345226|363840315|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
105499891|NCT02345226|363840316|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
105499892|NCT02345226|363840315|FG000|Double-Blind Phase|Withdrew Consent|41|||
105499893|NCT02345226|363840316|FG001|Double-Blind Phase|Withdrew Consent|39|||
105499894|NCT02345226|363840315|FG000|Double-Blind Phase|Lost to Follow-up|12|||
105499895|NCT02345226|363840316|FG001|Double-Blind Phase|Lost to Follow-up|16|||
105499896|NCT02345226|363840315|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
105499897|NCT02345226|363840316|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
105499898|NCT02345226|363840315|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
105499899|NCT02345226|363840316|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
105499900|NCT03576495|363840324|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
105499901|NCT03576495|363840325|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
105499902|NCT02635776|363840326|FG000|Overall Study|Physician Decision|1|||
105499903|NCT02635776|363840327|FG001|Overall Study|Physician Decision|0|||
105499904|NCT02635776|363840326|FG000|Overall Study|Adverse Event|51|||
105499905|NCT02635776|363840327|FG001|Overall Study|Adverse Event|3|||
105499906|NCT02635776|363840326|FG000|Overall Study|Withdrawal by Subject|41|||
105499907|NCT02635776|363840327|FG001|Overall Study|Withdrawal by Subject|7|||
105499908|NCT02635776|363840326|FG000|Overall Study|Lost to Follow-up|4|||
105499909|NCT02635776|363840327|FG001|Overall Study|Lost to Follow-up|0|||
105499910|NCT02635776|363840326|FG000|Overall Study|Other reasons|5|||
105499911|NCT02635776|363840327|FG001|Overall Study|Other reasons|1|||
105499912|NCT03208127|363840328|FG000|Overall Study|Death|1|||
105499913|NCT00660673|363840329|FG000|Overall Study|Adverse Event|84|||
105499914|NCT00660673|363840329|FG000|Overall Study|Lack of Efficacy|7|||
105499915|NCT00660673|363840329|FG000|Overall Study|Withdrawal by Subject|22|||
105499916|NCT00660673|363840329|FG000|Overall Study|Administrative|2|||
105499917|NCT00660673|363840329|FG000|Overall Study|Protocol Violation|2|||
105499918|NCT00843856|363840334|FG000|Overall Study|Lost to Follow-up|1|||
105499919|NCT00843856|363840335|FG001|Overall Study|Lost to Follow-up|2|||
105499920|NCT04032652|363840336|FG000|Overall Study|The study was terminated and the PI has|1|||
105499921|NCT04032652|363840337|FG001|Overall Study|The study was terminated and the PI has|1|||
105499922|NCT00450255|363840338|FG000|Overall Study|Prior RFA ablation of liver|1|||
105419347|NCT01301066|363541061|FG001|Overall Study|Sponsor Decision|1|||
105419348|NCT01301066|363541060|FG000|Overall Study|Physician Decision|0|||
105419349|NCT01301066|363541061|FG001|Overall Study|Physician Decision|1|||
105419350|NCT01301066|363541060|FG000|Overall Study|Other|2|||
105419351|NCT01301066|363541061|FG001|Overall Study|Other|0|||
105419352|NCT01252186|363541062|FG000|Overall Study|Adverse Event|9|||
105419353|NCT01252186|363541063|FG001|Overall Study|Adverse Event|6|||
105419354|NCT01252186|363541064|FG002|Overall Study|Adverse Event|8|||
105419355|NCT01252186|363541062|FG000|Overall Study|Withdrawal by Subject|2|||
105419356|NCT01252186|363541063|FG001|Overall Study|Withdrawal by Subject|5|||
105419357|NCT01252186|363541064|FG002|Overall Study|Withdrawal by Subject|2|||
105419358|NCT01252186|363541062|FG000|Overall Study|Physician Decision|0|||
105419359|NCT01252186|363541063|FG001|Overall Study|Physician Decision|0|||
105419360|NCT01252186|363541064|FG002|Overall Study|Physician Decision|1|||
105419361|NCT01252186|363541062|FG000|Overall Study|Non-compliance|0|||
105419362|NCT01252186|363541063|FG001|Overall Study|Non-compliance|3|||
105419363|NCT01252186|363541064|FG002|Overall Study|Non-compliance|4|||
105419364|NCT01252186|363541062|FG000|Overall Study|Protocol Violation|0|||
105419365|NCT01252186|363541063|FG001|Overall Study|Protocol Violation|0|||
105419366|NCT01252186|363541064|FG002|Overall Study|Protocol Violation|1|||
105419367|NCT01252186|363541062|FG000|Overall Study|Pregnancy|2|||
105419368|NCT01252186|363541063|FG001|Overall Study|Pregnancy|2|||
105419369|NCT01252186|363541064|FG002|Overall Study|Pregnancy|0|||
105419370|NCT01252186|363541062|FG000|Overall Study|Sponsor Request|2|||
105419371|NCT01252186|363541063|FG001|Overall Study|Sponsor Request|1|||
105419372|NCT01252186|363541064|FG002|Overall Study|Sponsor Request|0|||
105419373|NCT01252186|363541062|FG000|Overall Study|Lost to Follow-up|10|||
105419374|NCT01252186|363541063|FG001|Overall Study|Lost to Follow-up|10|||
105419375|NCT01252186|363541064|FG002|Overall Study|Lost to Follow-up|11|||
105419376|NCT01252186|363541062|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
105419377|NCT01252186|363541063|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
105419378|NCT01252186|363541064|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
105419379|NCT00322452|363541065|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105419380|NCT00322452|363541066|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
105419381|NCT00322452|363541065|FG000|Overall Study|Lost to Follow-up|5|||
105419382|NCT00322452|363541066|FG001|Overall Study|Lost to Follow-up|2|||
105419383|NCT00322452|363541065|FG000|Overall Study|Withdrawal by Subject|19|||
105419384|NCT00322452|363541066|FG001|Overall Study|Withdrawal by Subject|46|||
105419385|NCT00322452|363541065|FG000|Overall Study|Death|223|||
105419386|NCT00322452|363541066|FG001|Overall Study|Death|227|||
105419387|NCT00350272|363541067|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
105419388|NCT00350272|363541068|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
105419389|NCT00350272|363541067|FG000|Blinded 12-Week Treatment|Death|1|||
105419390|NCT00350272|363541068|FG001|Blinded 12-Week Treatment|Death|0|||
105419391|NCT00350272|363541067|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
105419392|NCT00350272|363541068|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
105419393|NCT00350272|363541067|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
105419394|NCT00350272|363541068|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
105419395|NCT00350272|363541067|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
105419396|NCT00350272|363541068|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
105419397|NCT00350272|363541067|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
105419398|NCT00350272|363541068|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
105419399|NCT00350272|363541067|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
105419400|NCT00350272|363541068|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
105419401|NCT00350272|363541067|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
105419402|NCT00350272|363541068|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
105419403|NCT00350272|363541067|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
105419404|NCT00350272|363541068|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
105419405|NCT00350272|363541067|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
105419406|NCT00350272|363541068|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
105419407|NCT00350272|363541067|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
105419408|NCT00350272|363541068|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
105419409|NCT01795495|363541070|FG000|Overall Study|Protocol Violation|1|||
105419410|NCT01795495|363541071|FG001|Overall Study|Protocol Violation|0|||
105419411|NCT01795495|363541072|FG002|Overall Study|Protocol Violation|1|||
105419412|NCT01795495|363541070|FG000|Overall Study|Physician Decision|0|||
105419413|NCT01795495|363541071|FG001|Overall Study|Physician Decision|0|||
105419414|NCT01795495|363541072|FG002|Overall Study|Physician Decision|1|||
105419415|NCT01962987|363542471|FG000|Overall Study|Adverse Event|4|||
105419416|NCT01962987|363542472|FG001|Overall Study|Adverse Event|4|||
105419417|NCT01962987|363542473|FG002|Overall Study|Adverse Event|0|||
105419418|NCT01962987|363542471|FG000|Overall Study|Lost to Follow-up|0|||
105419419|NCT01962987|363542472|FG001|Overall Study|Lost to Follow-up|0|||
105419420|NCT01962987|363542473|FG002|Overall Study|Lost to Follow-up|1|||
105419421|NCT01962987|363542471|FG000|Overall Study|Non compliance with dosing requirements|4|||
105419422|NCT01962987|363542472|FG001|Overall Study|Non compliance with dosing requirements|2|||
105419423|NCT01962987|363542473|FG002|Overall Study|Non compliance with dosing requirements|0|||
105419424|NCT01962987|363542471|FG000|Overall Study|Miscellaneous|1|||
105419425|NCT01962987|363542472|FG001|Overall Study|Miscellaneous|9|||
105419426|NCT01962987|363542473|FG002|Overall Study|Miscellaneous|2|||
105419427|NCT01962987|363542471|FG000|Overall Study|Restricted medication|5|||
105419428|NCT01962987|363542472|FG001|Overall Study|Restricted medication|1|||
105419429|NCT01962987|363542473|FG002|Overall Study|Restricted medication|1|||
105419430|NCT01962987|363542471|FG000|Overall Study|Serious Adverse Event|1|||
105419431|NCT01962987|363542472|FG001|Overall Study|Serious Adverse Event|0|||
105419432|NCT01962987|363542473|FG002|Overall Study|Serious Adverse Event|0|||
105419433|NCT01962987|363542471|FG000|Overall Study|Withdrawal by Subject|11|||
105419434|NCT01962987|363542472|FG001|Overall Study|Withdrawal by Subject|10|||
105419435|NCT01962987|363542473|FG002|Overall Study|Withdrawal by Subject|6|||
105419436|NCT01962987|363542471|FG000|Overall Study|Randomized in Error|4|||
105419437|NCT01962987|363542472|FG001|Overall Study|Randomized in Error|2|||
105419438|NCT01962987|363542473|FG002|Overall Study|Randomized in Error|2|||
105419439|NCT00420004|363542480|FG000|Overall Study|Adverse Event|4|||
105419440|NCT00420004|363542481|FG001|Overall Study|Adverse Event|1|||
105419441|NCT00420004|363542482|FG002|Overall Study|Adverse Event|1|||
105419442|NCT00420004|363542480|FG000|Overall Study|Lack of Efficacy|5|||
105419443|NCT00420004|363542481|FG001|Overall Study|Lack of Efficacy|4|||
105419444|NCT00420004|363542482|FG002|Overall Study|Lack of Efficacy|1|||
105419445|NCT00420004|363542480|FG000|Overall Study|Lost to Follow-up|31|||
105419446|NCT00420004|363542481|FG001|Overall Study|Lost to Follow-up|12|||
105419447|NCT00420004|363542482|FG002|Overall Study|Lost to Follow-up|10|||
105419448|NCT00420004|363542480|FG000|Overall Study|Entry Criteria Not Met|0|||
105419449|NCT00420004|363542481|FG001|Overall Study|Entry Criteria Not Met|1|||
105419450|NCT00420004|363542482|FG002|Overall Study|Entry Criteria Not Met|0|||
105419451|NCT00420004|363542480|FG000|Overall Study|Physician Decision|14|||
105419452|NCT00420004|363542481|FG001|Overall Study|Physician Decision|4|||
105419453|NCT00420004|363542482|FG002|Overall Study|Physician Decision|2|||
105419454|NCT00420004|363542480|FG000|Overall Study|Protocol Violation|5|||
105419455|NCT00420004|363542481|FG001|Overall Study|Protocol Violation|4|||
105419456|NCT00420004|363542482|FG002|Overall Study|Protocol Violation|3|||
105419457|NCT00420004|363542480|FG000|Overall Study|Withdrawal by Subject|67|||
105419458|NCT00420004|363542481|FG001|Overall Study|Withdrawal by Subject|42|||
105419459|NCT00420004|363542482|FG002|Overall Study|Withdrawal by Subject|14|||
105419460|NCT00420004|363542480|FG000|Overall Study|Sponsor Decision|3|||
105419461|NCT00420004|363542481|FG001|Overall Study|Sponsor Decision|3|||
105419462|NCT00420004|363542482|FG002|Overall Study|Sponsor Decision|1|||
105419463|NCT01468207|363542483|FG000|Treatment Period 1|Adverse Event|1|||
105419464|NCT01468207|363542484|FG001|Treatment Period 1|Adverse Event|0|||
105419465|NCT01468207|363542485|FG002|Treatment Period 1|Adverse Event|0|||
105419466|NCT01468207|363542486|FG003|Treatment Period 1|Adverse Event|0|||
105419467|NCT01468207|363542487|FG004|Treatment Period 1|Adverse Event|0|||
105419468|NCT01468207|363542488|FG005|Treatment Period 1|Adverse Event|0|||
105419469|NCT01468207|363542483|FG000|Treatment Period 1|Protocol Violation|1|||
105419470|NCT01468207|363542484|FG001|Treatment Period 1|Protocol Violation|1|||
105419471|NCT01468207|363542485|FG002|Treatment Period 1|Protocol Violation|0|||
105419472|NCT01468207|363542486|FG003|Treatment Period 1|Protocol Violation|0|||
105419473|NCT01468207|363542487|FG004|Treatment Period 1|Protocol Violation|0|||
105419474|NCT01468207|363542488|FG005|Treatment Period 1|Protocol Violation|0|||
105419475|NCT01468207|363542483|FG000|Treatment Period 1|Withdrawal by Subject|5|||
105419476|NCT01468207|363542484|FG001|Treatment Period 1|Withdrawal by Subject|4|||
105419477|NCT01468207|363542485|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105419478|NCT01468207|363542486|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105419479|NCT01468207|363542487|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105419480|NCT01468207|363542488|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105419481|NCT01468207|363542483|FG000|Treatment Period 1|Lost to Follow-up|2|||
105419482|NCT01468207|363542484|FG001|Treatment Period 1|Lost to Follow-up|1|||
105419483|NCT01468207|363542485|FG002|Treatment Period 1|Lost to Follow-up|0|||
105499923|NCT01696071|363840344|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
105499924|NCT01696071|363840345|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
105499925|NCT01441180|363840347|FG000|Overall Study|Lost to Follow-up|1|||
105499926|NCT01441180|363840348|FG001|Overall Study|Lost to Follow-up|1|||
105419484|NCT01468207|363542486|FG003|Treatment Period 1|Lost to Follow-up|0|||
105419485|NCT01468207|363542487|FG004|Treatment Period 1|Lost to Follow-up|0|||
105419486|NCT01468207|363542488|FG005|Treatment Period 1|Lost to Follow-up|0|||
105499927|NCT01441180|363840349|FG002|Overall Study|Lost to Follow-up|1|||
105499928|NCT01441180|363840347|FG000|Overall Study|Discontinued|0|||
105419487|NCT01468207|363542483|FG000|Treatment Period 1|Other|0|||
105419488|NCT01468207|363542484|FG001|Treatment Period 1|Other|2|||
105419489|NCT01468207|363542485|FG002|Treatment Period 1|Other|0|||
105419490|NCT01468207|363542486|FG003|Treatment Period 1|Other|0|||
105419491|NCT01468207|363542487|FG004|Treatment Period 1|Other|0|||
105419492|NCT01468207|363542488|FG005|Treatment Period 1|Other|0|||
105419493|NCT01468207|363542483|FG000|Treatment Period 2|Adverse Event|0|||
105419494|NCT01468207|363542484|FG001|Treatment Period 2|Adverse Event|0|||
105419495|NCT01468207|363542485|FG002|Treatment Period 2|Adverse Event|6|||
105419496|NCT01468207|363542486|FG003|Treatment Period 2|Adverse Event|1|||
105419497|NCT01468207|363542487|FG004|Treatment Period 2|Adverse Event|2|||
105419498|NCT01468207|363542488|FG005|Treatment Period 2|Adverse Event|1|||
105419499|NCT01468207|363542483|FG000|Treatment Period 2|Lack of Efficacy|0|||
105419500|NCT01468207|363542484|FG001|Treatment Period 2|Lack of Efficacy|0|||
105419501|NCT01468207|363542485|FG002|Treatment Period 2|Lack of Efficacy|1|||
105419502|NCT01468207|363542486|FG003|Treatment Period 2|Lack of Efficacy|1|||
105419503|NCT01468207|363542487|FG004|Treatment Period 2|Lack of Efficacy|0|||
105419504|NCT01468207|363542488|FG005|Treatment Period 2|Lack of Efficacy|2|||
105419505|NCT01468207|363542483|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105419506|NCT01468207|363542484|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105419507|NCT01468207|363542485|FG002|Treatment Period 2|Withdrawal by Subject|5|||
105419508|NCT01468207|363542486|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105419509|NCT01468207|363542487|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105419510|NCT01468207|363542488|FG005|Treatment Period 2|Withdrawal by Subject|2|||
105419511|NCT01468207|363542483|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
105419512|NCT01468207|363542484|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
105419513|NCT01468207|363542485|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
105419514|NCT01468207|363542486|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
105419515|NCT01468207|363542487|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
105419516|NCT01468207|363542488|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
105419517|NCT01468207|363542483|FG000|Treatment Period 2|Lost to Follow-up|0|||
105419518|NCT01468207|363542484|FG001|Treatment Period 2|Lost to Follow-up|0|||
105419519|NCT01468207|363542485|FG002|Treatment Period 2|Lost to Follow-up|5|||
105419520|NCT01468207|363542486|FG003|Treatment Period 2|Lost to Follow-up|1|||
105419521|NCT01468207|363542487|FG004|Treatment Period 2|Lost to Follow-up|0|||
105419522|NCT01468207|363542488|FG005|Treatment Period 2|Lost to Follow-up|0|||
105419523|NCT01468207|363542483|FG000|Treatment Period 2|Other|0|||
105419524|NCT01468207|363542484|FG001|Treatment Period 2|Other|0|||
105419525|NCT01468207|363542485|FG002|Treatment Period 2|Other|5|||
105419526|NCT01468207|363542486|FG003|Treatment Period 2|Other|1|||
105419527|NCT01468207|363542487|FG004|Treatment Period 2|Other|1|||
105419528|NCT01468207|363542488|FG005|Treatment Period 2|Other|2|||
105419529|NCT00591149|363542489|FG000|Overall Study|Adverse Event|4|||
105419530|NCT00591149|363542489|FG000|Overall Study|Withdrawal by Subject|1|||
105419531|NCT00470093|363542490|FG000|Overall Study|Adverse Event|2|||
105419532|NCT04569136|363542500|FG000|Overall Study|Lost to Follow-up|2|||
105419533|NCT04569136|363542501|FG001|Overall Study|Lost to Follow-up|0|||
105419534|NCT04569136|363542502|FG002|Overall Study|Lost to Follow-up|1|||
105419535|NCT01466660|363542503|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
105419536|NCT01466660|363542504|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
105419537|NCT01466660|363542503|FG000|Overall Study|Worsening of underlying cancer disease|5|||
105419538|NCT01466660|363542504|FG001|Overall Study|Worsening of underlying cancer disease|2|||
105419539|NCT01466660|363542503|FG000|Overall Study|Other adverse event|19|||
105419540|NCT01466660|363542504|FG001|Overall Study|Other adverse event|18|||
105419541|NCT01466660|363542503|FG000|Overall Study|Protocol Violation|2|||
105419542|NCT01466660|363542504|FG001|Overall Study|Protocol Violation|1|||
105419543|NCT01466660|363542503|FG000|Overall Study|Refused continuation of trial medication|4|||
105419544|NCT01466660|363542504|FG001|Overall Study|Refused continuation of trial medication|3|||
105419545|NCT01466660|363542503|FG000|Overall Study|Other reason not defined above|10|||
105419546|NCT01466660|363542504|FG001|Overall Study|Other reason not defined above|8|||
105419547|NCT01973387|363542505|FG000|Overall Study|Adverse Event|14|||
105419548|NCT01973387|363542506|FG001|Overall Study|Adverse Event|4|||
105419549|NCT01973387|363542505|FG000|Overall Study|Withdrawal by Subject|7|||
105419550|NCT01973387|363542506|FG001|Overall Study|Withdrawal by Subject|4|||
105419551|NCT01973387|363542505|FG000|Overall Study|Study terminated by sponsor|63|||
105419552|NCT01973387|363542506|FG001|Overall Study|Study terminated by sponsor|0|||
105419553|NCT01973387|363542505|FG000|Overall Study|Progressive disease or relapse|16|||
105419554|NCT01973387|363542506|FG001|Overall Study|Progressive disease or relapse|5|||
105419555|NCT01973387|363542505|FG000|Overall Study|Death|4|||
105419556|NCT01973387|363542506|FG001|Overall Study|Death|3|||
105419557|NCT01973387|363542505|FG000|Overall Study|Randomized, not treated|2|||
105419558|NCT01973387|363542506|FG001|Overall Study|Randomized, not treated|2|||
105419559|NCT00888329|363542511|FG000|Overall Study|Physician Decision|6|||
105419560|NCT00888329|363542512|FG001|Overall Study|Physician Decision|9|||
105419561|NCT00778375|363542513|FG000|Overall Study|Ineligible|3|||
105499929|NCT01441180|363840348|FG001|Overall Study|Discontinued|0|||
105499930|NCT01441180|363840349|FG002|Overall Study|Discontinued|2|||
105499931|NCT01402011|363840352|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
105499932|NCT01402011|363840353|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
105419562|NCT01425359|363542517|FG000|Overall Study|Randomized but Not Treated|2|||
105419563|NCT01425359|363542518|FG001|Overall Study|Randomized but Not Treated|3|||
105419564|NCT01425359|363542517|FG000|Overall Study|Adverse Event|9|||
105419565|NCT01425359|363542518|FG001|Overall Study|Adverse Event|8|||
105419566|NCT01425359|363542517|FG000|Overall Study|Revascularization|0|||
105419567|NCT01425359|363542518|FG001|Overall Study|Revascularization|1|||
105419568|NCT01425359|363542517|FG000|Overall Study|Death|0|||
105584003|NCT05343455|364136735|FG002|Overall Study|Physician Decision|1|||
105584004|NCT05343455|364136733|FG000|Overall Study|Protocol Violation|0|||
105584005|NCT05343455|364136734|FG001|Overall Study|Protocol Violation|1|||
105584006|NCT05343455|364136735|FG002|Overall Study|Protocol Violation|1|||
105584007|NCT02297503|364136743|FG000|Overall Study|Withdrawal by Subject|1|||
105584008|NCT02297503|364136744|FG001|Overall Study|Withdrawal by Subject|1|||
105584009|NCT02297503|364136743|FG000|Overall Study|Protocol Violation|1|||
105584010|NCT02297503|364136744|FG001|Overall Study|Protocol Violation|0|||
105584011|NCT02297503|364136743|FG000|Overall Study|Pregnancy|0|||
105584012|NCT02297503|364136744|FG001|Overall Study|Pregnancy|1|||
105584013|NCT02297503|364136743|FG000|Overall Study|Lost to Follow-up|0|||
105584014|NCT02297503|364136744|FG001|Overall Study|Lost to Follow-up|1|||
105584015|NCT02297503|364136743|FG000|Overall Study|Medical reason|0|||
105584016|NCT02297503|364136744|FG001|Overall Study|Medical reason|1|||
105584017|NCT02748512|364136745|FG000|Overall Study|Lost to Follow-up|1|||
105584018|NCT02748512|364136746|FG001|Overall Study|Lost to Follow-up|1|||
105584019|NCT03169361|364136748|FG000|Overall Study|Protocol Violation|32|||
105584020|NCT00550732|364136753|FG000|Overall Study|Death|4|||
105584021|NCT00550732|364136753|FG000|Overall Study|Withdrawal by Subject|2|||
105584022|NCT00550732|364136753|FG000|Overall Study|Physician Decision|2|||
105584023|NCT00550732|364136753|FG000|Overall Study|Lost to Follow-up|1|||
105584024|NCT00550732|364136753|FG000|Overall Study|Palliative care|1|||
105584025|NCT00550732|364136753|FG000|Overall Study|Adverse Event|1|||
105584026|NCT00724061|364136767|FG000|Dose Escalation Phase|Adverse Event|2|||
105584027|NCT00724061|364136767|FG000|Dose Escalation Phase|Disease Progression|3|||
105584028|NCT00372567|364136768|FG000|Phase 3 Study|Adverse Event|5|||
105584029|NCT00372567|364136769|FG001|Phase 3 Study|Adverse Event|1|||
105584030|NCT00372567|364136770|FG002|Phase 3 Study|Adverse Event|1|||
105584031|NCT00372567|364136768|FG000|Phase 3 Study|Death|1|||
105584032|NCT00372567|364136769|FG001|Phase 3 Study|Death|1|||
105584033|NCT00372567|364136770|FG002|Phase 3 Study|Death|0|||
105584034|NCT00372567|364136768|FG000|Phase 3 Study|Protocol Violation|0|||
105584035|NCT00372567|364136769|FG001|Phase 3 Study|Protocol Violation|0|||
105584036|NCT00372567|364136770|FG002|Phase 3 Study|Protocol Violation|1|||
105584037|NCT00372567|364136768|FG000|Phase 3 Study|Objective progression or relapse|10|||
105584038|NCT00372567|364136769|FG001|Phase 3 Study|Objective progression or relapse|13|||
105584039|NCT00372567|364136770|FG002|Phase 3 Study|Objective progression or relapse|4|||
105584040|NCT00372567|364136768|FG000|Phase 3 Study|Global deterioration of health status|0|||
105584041|NCT00372567|364136769|FG001|Phase 3 Study|Global deterioration of health status|1|||
105584042|NCT00372567|364136770|FG002|Phase 3 Study|Global deterioration of health status|0|||
105584043|NCT00372567|364136768|FG000|Phase 3 Study|Other|2|||
105584044|NCT00372567|364136769|FG001|Phase 3 Study|Other|2|||
105584045|NCT00372567|364136770|FG002|Phase 3 Study|Other|1|||
105584046|NCT00372567|364136768|FG000|Phase 3 Study|study terminated by sponsor|13|||
105584047|NCT00372567|364136769|FG001|Phase 3 Study|study terminated by sponsor|8|||
105584048|NCT00372567|364136770|FG002|Phase 3 Study|study terminated by sponsor|5|||
105584049|NCT04796935|364136775|FG000|Overall Study|Withdrawal by Subject|0|||
105584050|NCT04796935|364136776|FG001|Overall Study|Withdrawal by Subject|1|||
105584051|NCT04796935|364136775|FG000|Overall Study|Physician Decision|0|||
105584052|NCT04796935|364136776|FG001|Overall Study|Physician Decision|1|||
105584053|NCT04796935|364136775|FG000|Overall Study|Device not available|1|||
105584054|NCT04796935|364136776|FG001|Overall Study|Device not available|0|||
105584055|NCT04796935|364136775|FG000|Overall Study|Trained provider not available|1|||
105584056|NCT04796935|364136776|FG001|Overall Study|Trained provider not available|0|||
105584057|NCT00410384|364136777|FG000|Overall Study|Withdrawal by Subject|28|||
105584058|NCT00410384|364136778|FG001|Overall Study|Withdrawal by Subject|17|||
105584059|NCT00410384|364136779|FG002|Overall Study|Withdrawal by Subject|20|||
105584060|NCT00410384|364136777|FG000|Overall Study|Adverse Event|23|||
105584061|NCT00410384|364136778|FG001|Overall Study|Adverse Event|18|||
105584062|NCT00410384|364136779|FG002|Overall Study|Adverse Event|23|||
105584063|NCT00410384|364136777|FG000|Overall Study|Lack of Efficacy|20|||
105584064|NCT00410384|364136778|FG001|Overall Study|Lack of Efficacy|12|||
105584065|NCT00410384|364136779|FG002|Overall Study|Lack of Efficacy|17|||
105584066|NCT00410384|364136777|FG000|Overall Study|Lack of Compliance|2|||
105584067|NCT00410384|364136778|FG001|Overall Study|Lack of Compliance|2|||
105584068|NCT00410384|364136779|FG002|Overall Study|Lack of Compliance|2|||
105584069|NCT00410384|364136777|FG000|Overall Study|Lost to Follow-up|4|||
105584070|NCT00410384|364136778|FG001|Overall Study|Lost to Follow-up|6|||
105584071|NCT00410384|364136779|FG002|Overall Study|Lost to Follow-up|6|||
105584072|NCT00410384|364136777|FG000|Overall Study|Protocol Violation|6|||
105584073|NCT00410384|364136778|FG001|Overall Study|Protocol Violation|6|||
105584074|NCT00410384|364136779|FG002|Overall Study|Protocol Violation|6|||
105584075|NCT00410384|364136777|FG000|Overall Study|Physician Decision|3|||
105584076|NCT00410384|364136778|FG001|Overall Study|Physician Decision|3|||
105584077|NCT00410384|364136779|FG002|Overall Study|Physician Decision|4|||
105584078|NCT00410384|364136777|FG000|Overall Study|Other|3|||
105584079|NCT00410384|364136778|FG001|Overall Study|Other|8|||
105584080|NCT00410384|364136779|FG002|Overall Study|Other|4|||
105584081|NCT00783718|364136782|FG000|Induction Phase|Adverse Event|4|||
105584082|NCT00783718|364136783|FG001|Induction Phase|Adverse Event|0|||
105584083|NCT00783718|364136784|FG002|Induction Phase|Adverse Event|7|||
105584084|NCT00783718|364136785|FG003|Induction Phase|Adverse Event|0|||
105584085|NCT00783718|364136786|FG004|Induction Phase|Adverse Event|0|||
105584086|NCT00783718|364136787|FG005|Induction Phase|Adverse Event|0|||
105584087|NCT00783718|364136788|FG006|Induction Phase|Adverse Event|0|||
105584088|NCT00783718|364136782|FG000|Induction Phase|Protocol Violation|1|||
105584089|NCT00783718|364136783|FG001|Induction Phase|Protocol Violation|1|||
105584090|NCT00783718|364136784|FG002|Induction Phase|Protocol Violation|6|||
105584091|NCT00783718|364136785|FG003|Induction Phase|Protocol Violation|0|||
105584092|NCT00783718|364136786|FG004|Induction Phase|Protocol Violation|0|||
105584093|NCT00783718|364136787|FG005|Induction Phase|Protocol Violation|0|||
105584094|NCT00783718|364136788|FG006|Induction Phase|Protocol Violation|0|||
105584095|NCT00783718|364136782|FG000|Induction Phase|Lack of Efficacy|5|||
105584096|NCT00783718|364136783|FG001|Induction Phase|Lack of Efficacy|2|||
105584097|NCT00783718|364136784|FG002|Induction Phase|Lack of Efficacy|14|||
105584098|NCT00783718|364136785|FG003|Induction Phase|Lack of Efficacy|0|||
105584099|NCT00783718|364136786|FG004|Induction Phase|Lack of Efficacy|0|||
105584100|NCT00783718|364136787|FG005|Induction Phase|Lack of Efficacy|0|||
105584101|NCT00783718|364136788|FG006|Induction Phase|Lack of Efficacy|0|||
105584102|NCT00783718|364136782|FG000|Induction Phase|Withdrawal by Subject|3|||
105584103|NCT00783718|364136783|FG001|Induction Phase|Withdrawal by Subject|4|||
105584104|NCT00783718|364136784|FG002|Induction Phase|Withdrawal by Subject|8|||
105584105|NCT00783718|364136785|FG003|Induction Phase|Withdrawal by Subject|0|||
105584106|NCT00783718|364136786|FG004|Induction Phase|Withdrawal by Subject|0|||
105584107|NCT00783718|364136787|FG005|Induction Phase|Withdrawal by Subject|0|||
105584108|NCT00783718|364136788|FG006|Induction Phase|Withdrawal by Subject|0|||
105584109|NCT00783718|364136782|FG000|Induction Phase|Lost to Follow-up|1|||
105584110|NCT00783718|364136783|FG001|Induction Phase|Lost to Follow-up|0|||
105584111|NCT00783718|364136784|FG002|Induction Phase|Lost to Follow-up|1|||
105584112|NCT00783718|364136785|FG003|Induction Phase|Lost to Follow-up|0|||
105584113|NCT00783718|364136786|FG004|Induction Phase|Lost to Follow-up|0|||
105584114|NCT00783718|364136787|FG005|Induction Phase|Lost to Follow-up|0|||
105584115|NCT00783718|364136788|FG006|Induction Phase|Lost to Follow-up|0|||
105584116|NCT00783718|364136782|FG000|Maintenance Phase|Adverse Event|12|||
105584117|NCT00783718|364136783|FG001|Maintenance Phase|Adverse Event|0|||
105584118|NCT00783718|364136784|FG002|Maintenance Phase|Adverse Event|0|||
105584119|NCT00783718|364136785|FG003|Maintenance Phase|Adverse Event|15|||
105584120|NCT00783718|364136786|FG004|Maintenance Phase|Adverse Event|7|||
105584121|NCT00783718|364136787|FG005|Maintenance Phase|Adverse Event|6|||
105584122|NCT00783718|364136788|FG006|Maintenance Phase|Adverse Event|16|||
105584123|NCT00783718|364136782|FG000|Maintenance Phase|Protocol Violation|1|||
105584124|NCT00783718|364136783|FG001|Maintenance Phase|Protocol Violation|0|||
105584125|NCT00783718|364136784|FG002|Maintenance Phase|Protocol Violation|0|||
105584126|NCT00783718|364136785|FG003|Maintenance Phase|Protocol Violation|0|||
105584127|NCT00783718|364136786|FG004|Maintenance Phase|Protocol Violation|0|||
105584128|NCT00783718|364136787|FG005|Maintenance Phase|Protocol Violation|0|||
105584129|NCT00783718|364136788|FG006|Maintenance Phase|Protocol Violation|2|||
105584130|NCT00783718|364136782|FG000|Maintenance Phase|Lack of Efficacy|83|||
105584131|NCT00783718|364136783|FG001|Maintenance Phase|Lack of Efficacy|0|||
105584132|NCT00783718|364136784|FG002|Maintenance Phase|Lack of Efficacy|0|||
105584133|NCT00783718|364136785|FG003|Maintenance Phase|Lack of Efficacy|61|||
105584134|NCT00783718|364136786|FG004|Maintenance Phase|Lack of Efficacy|31|||
105584135|NCT00783718|364136787|FG005|Maintenance Phase|Lack of Efficacy|33|||
105584136|NCT00783718|364136788|FG006|Maintenance Phase|Lack of Efficacy|155|||
105584137|NCT00783718|364136782|FG000|Maintenance Phase|Withdrawal by Subject|6|||
105584138|NCT00783718|364136783|FG001|Maintenance Phase|Withdrawal by Subject|0|||
105584139|NCT00783718|364136784|FG002|Maintenance Phase|Withdrawal by Subject|0|||
105584140|NCT00783718|364136785|FG003|Maintenance Phase|Withdrawal by Subject|2|||
105584141|NCT00783718|364136786|FG004|Maintenance Phase|Withdrawal by Subject|5|||
105584142|NCT00783718|364136787|FG005|Maintenance Phase|Withdrawal by Subject|2|||
105584143|NCT00783718|364136788|FG006|Maintenance Phase|Withdrawal by Subject|20|||
105584144|NCT00783718|364136782|FG000|Maintenance Phase|Lost to Follow-up|3|||
105584145|NCT00783718|364136783|FG001|Maintenance Phase|Lost to Follow-up|0|||
105584146|NCT00783718|364136784|FG002|Maintenance Phase|Lost to Follow-up|0|||
105584147|NCT00783718|364136785|FG003|Maintenance Phase|Lost to Follow-up|0|||
105584148|NCT00783718|364136786|FG004|Maintenance Phase|Lost to Follow-up|2|||
105584149|NCT00783718|364136787|FG005|Maintenance Phase|Lost to Follow-up|0|||
105584150|NCT00783718|364136788|FG006|Maintenance Phase|Lost to Follow-up|2|||
105584151|NCT02223182|364136793|FG000|Double-Blind Period|Adverse Event|0|||
105584152|NCT02223182|364136794|FG001|Double-Blind Period|Adverse Event|2|||
105584153|NCT02223182|364136795|FG002|Double-Blind Period|Adverse Event|1|||
105584154|NCT02223182|364136796|FG003|Double-Blind Period|Adverse Event|0|||
105584155|NCT02223182|364136793|FG000|Double-Blind Period|Withdrawal by Subject|1|||
105584156|NCT02223182|364136794|FG001|Double-Blind Period|Withdrawal by Subject|1|||
105584157|NCT02223182|364136795|FG002|Double-Blind Period|Withdrawal by Subject|1|||
105499933|NCT01402011|363840354|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
105499934|NCT01402011|363840352|FG000|Active Treatment Period|Withdrawal by Subject|1|||
105499935|NCT01402011|363840353|FG001|Active Treatment Period|Withdrawal by Subject|3|||
105499936|NCT01402011|363840354|FG002|Active Treatment Period|Withdrawal by Subject|0|||
105499937|NCT01402011|363840352|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
105499938|NCT01402011|363840353|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
105499939|NCT01402011|363840354|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
105499940|NCT03730012|363840355|FG000|Overall Study|Adverse Event|0|||
105499941|NCT03730012|363840356|FG001|Overall Study|Adverse Event|1|||
105499942|NCT03730012|363840355|FG000|Overall Study|Lack of Efficacy|1|||
105499943|NCT03730012|363840356|FG001|Overall Study|Lack of Efficacy|5|||
105499944|NCT03730012|363840355|FG000|Overall Study|Withdrawal by Subject|0|||
105499945|NCT03730012|363840356|FG001|Overall Study|Withdrawal by Subject|1|||
105499946|NCT03730012|363840355|FG000|Overall Study|Miscellaneous|2|||
105499947|NCT03730012|363840356|FG001|Overall Study|Miscellaneous|1|||
105499948|NCT04680052|363841801|FG000|Overall Study|Ongoing|244|||
105499949|NCT04680052|363841802|FG001|Overall Study|Ongoing|229|||
105499950|NCT04680052|363841803|FG002|Overall Study|Ongoing|39|||
105499951|NCT04680052|363841804|FG003|Overall Study|Ongoing|46|||
105499952|NCT04680052|363841801|FG000|Overall Study|Death|15|||
105499953|NCT04680052|363841802|FG001|Overall Study|Death|22|||
105499954|NCT04680052|363841803|FG002|Overall Study|Death|7|||
105499955|NCT04680052|363841804|FG003|Overall Study|Death|1|||
105499956|NCT04680052|363841801|FG000|Overall Study|Lost to Follow-up|3|||
105499957|NCT04680052|363841802|FG001|Overall Study|Lost to Follow-up|2|||
105499958|NCT04680052|363841803|FG002|Overall Study|Lost to Follow-up|0|||
105499959|NCT04680052|363841804|FG003|Overall Study|Lost to Follow-up|1|||
105499960|NCT04680052|363841801|FG000|Overall Study|Withdrawal by Subject|11|||
105499961|NCT04680052|363841802|FG001|Overall Study|Withdrawal by Subject|19|||
105499962|NCT04680052|363841803|FG002|Overall Study|Withdrawal by Subject|7|||
105499963|NCT04680052|363841804|FG003|Overall Study|Withdrawal by Subject|5|||
105499964|NCT04680052|363841801|FG000|Overall Study|Missing|0|||
105499965|NCT04680052|363841802|FG001|Overall Study|Missing|1|||
105499966|NCT04680052|363841803|FG002|Overall Study|Missing|0|||
105499967|NCT04680052|363841804|FG003|Overall Study|Missing|0|||
105499968|NCT04680052|363841801|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
105499969|NCT04680052|363841802|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
105499970|NCT04680052|363841803|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
105499971|NCT04680052|363841804|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
105499972|NCT04680052|363841801|FG000|Overall Study|Physician Decision|0|||
105499973|NCT04680052|363841802|FG001|Overall Study|Physician Decision|1|||
105499974|NCT04680052|363841803|FG002|Overall Study|Physician Decision|0|||
105499975|NCT04680052|363841804|FG003|Overall Study|Physician Decision|0|||
105499976|NCT02180724|363841805|FG000|Overall Study|Death|26|||
105499977|NCT02180724|363841806|FG001|Overall Study|Death|1|||
105499978|NCT02180724|363841805|FG000|Overall Study|Lost to Follow-up|3|||
105499979|NCT02180724|363841806|FG001|Overall Study|Lost to Follow-up|1|||
105499980|NCT02180724|363841805|FG000|Overall Study|Withdrawal by Subject|4|||
105499981|NCT02180724|363841806|FG001|Overall Study|Withdrawal by Subject|2|||
105499982|NCT02180724|363841805|FG000|Overall Study|PI Decision|5|||
105499983|NCT02180724|363841806|FG001|Overall Study|PI Decision|2|||
105499984|NCT02180724|363841805|FG000|Overall Study|Study terminated by sponsor|54|||
105499985|NCT02180724|363841806|FG001|Overall Study|Study terminated by sponsor|8|||
105499986|NCT01644565|363841807|FG000|Overall Study|Undisclosed Medical History|1|||
105499987|NCT01644565|363841808|FG001|Overall Study|Undisclosed Medical History|0|||
105499988|NCT01644565|363841809|FG002|Overall Study|Undisclosed Medical History|0|||
105499989|NCT01644565|363841810|FG003|Overall Study|Undisclosed Medical History|0|||
105499990|NCT01644565|363841811|FG004|Overall Study|Undisclosed Medical History|0|||
105499991|NCT01644565|363841812|FG005|Overall Study|Undisclosed Medical History|0|||
105499992|NCT01644565|363841813|FG006|Overall Study|Undisclosed Medical History|0|||
105499993|NCT01644565|363841814|FG007|Overall Study|Undisclosed Medical History|0|||
105499994|NCT01644565|363841815|FG008|Overall Study|Undisclosed Medical History|0|||
105499995|NCT01644565|363841807|FG000|Overall Study|Lost to Follow-up|0|||
105499996|NCT01644565|363841808|FG001|Overall Study|Lost to Follow-up|0|||
105584158|NCT02223182|364136796|FG003|Double-Blind Period|Withdrawal by Subject|0|||
105584159|NCT02223182|364136793|FG000|Double-Blind Period|Lost to Follow-up|0|||
105499997|NCT01644565|363841809|FG002|Overall Study|Lost to Follow-up|0|||
105499998|NCT01644565|363841810|FG003|Overall Study|Lost to Follow-up|1|||
105499999|NCT01644565|363841811|FG004|Overall Study|Lost to Follow-up|0|||
105500000|NCT01644565|363841812|FG005|Overall Study|Lost to Follow-up|0|||
105584160|NCT02223182|364136794|FG001|Double-Blind Period|Lost to Follow-up|1|||
105500001|NCT01644565|363841813|FG006|Overall Study|Lost to Follow-up|0|||
105500002|NCT01644565|363841814|FG007|Overall Study|Lost to Follow-up|2|||
105500003|NCT01644565|363841815|FG008|Overall Study|Lost to Follow-up|0|||
105500004|NCT01644565|363841807|FG000|Overall Study|Family emergency|0|||
105500005|NCT01644565|363841808|FG001|Overall Study|Family emergency|0|||
105500006|NCT01644565|363841809|FG002|Overall Study|Family emergency|0|||
105500007|NCT01644565|363841810|FG003|Overall Study|Family emergency|0|||
105419569|NCT01425359|363542518|FG001|Overall Study|Death|1|||
105419570|NCT01425359|363542517|FG000|Overall Study|Unsatisfactory Response|1|||
105419571|NCT01425359|363542518|FG001|Overall Study|Unsatisfactory Response|0|||
105419572|NCT01425359|363542517|FG000|Overall Study|Protocol Violation|1|||
105419573|NCT01425359|363542518|FG001|Overall Study|Protocol Violation|2|||
105419574|NCT01425359|363542517|FG000|Overall Study|Subject Withdrew Consent|1|||
105419575|NCT01425359|363542518|FG001|Overall Study|Subject Withdrew Consent|2|||
105419576|NCT01425359|363542517|FG000|Overall Study|Investigator's Discretion|2|||
105419577|NCT01425359|363542518|FG001|Overall Study|Investigator's Discretion|0|||
105419578|NCT01425359|363542517|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
105419579|NCT01425359|363542518|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
105419580|NCT01229254|363542519|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
105419581|NCT01229254|363542520|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
105419582|NCT01229254|363542521|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
105419583|NCT01229254|363542519|FG000|Overall Study|Adverse Event|4|||
105419584|NCT01229254|363542520|FG001|Overall Study|Adverse Event|5|||
105419585|NCT01229254|363542521|FG002|Overall Study|Adverse Event|3|||
105419586|NCT01229254|363542519|FG000|Overall Study|Lost to Follow-up|3|||
105419587|NCT01229254|363542520|FG001|Overall Study|Lost to Follow-up|0|||
105419588|NCT01229254|363542521|FG002|Overall Study|Lost to Follow-up|1|||
105419589|NCT01229254|363542519|FG000|Overall Study|Physician Decision|0|||
105419590|NCT01229254|363542520|FG001|Overall Study|Physician Decision|3|||
105419591|NCT01229254|363542521|FG002|Overall Study|Physician Decision|0|||
105419592|NCT01229254|363542519|FG000|Overall Study|Protocol Violation|4|||
105419593|NCT01229254|363542520|FG001|Overall Study|Protocol Violation|6|||
105419594|NCT01229254|363542521|FG002|Overall Study|Protocol Violation|5|||
105419595|NCT01229254|363542519|FG000|Overall Study|Withdrawal by Subject|1|||
105419596|NCT01229254|363542520|FG001|Overall Study|Withdrawal by Subject|0|||
105419597|NCT01229254|363542521|FG002|Overall Study|Withdrawal by Subject|1|||
105419598|NCT01229254|363542519|FG000|Overall Study|Non-compliance with Study Drug|0|||
105419599|NCT01229254|363542520|FG001|Overall Study|Non-compliance with Study Drug|1|||
105419600|NCT01229254|363542521|FG002|Overall Study|Non-compliance with Study Drug|1|||
105419601|NCT00521599|363542522|FG000|Overall Study|Adverse Event|5|||
105419602|NCT00521599|363542523|FG001|Overall Study|Adverse Event|7|||
105419603|NCT00521599|363542524|FG002|Overall Study|Adverse Event|6|||
105419604|NCT00521599|363542522|FG000|Overall Study|Treatment Failure|8|||
105419605|NCT00521599|363542523|FG001|Overall Study|Treatment Failure|9|||
105419606|NCT00521599|363542524|FG002|Overall Study|Treatment Failure|22|||
105419607|NCT00521599|363542522|FG000|Overall Study|Lost to Follow-up|2|||
105419608|NCT00521599|363542523|FG001|Overall Study|Lost to Follow-up|1|||
105419609|NCT00521599|363542524|FG002|Overall Study|Lost to Follow-up|2|||
105419610|NCT00521599|363542522|FG000|Overall Study|Withdrawal by Subject|3|||
105419611|NCT00521599|363542523|FG001|Overall Study|Withdrawal by Subject|5|||
105419612|NCT00521599|363542524|FG002|Overall Study|Withdrawal by Subject|1|||
105419613|NCT00521599|363542522|FG000|Overall Study|Withdrawal by subject treatment related|3|||
105419614|NCT00521599|363542523|FG001|Overall Study|Withdrawal by subject treatment related|1|||
105419615|NCT00521599|363542524|FG002|Overall Study|Withdrawal by subject treatment related|2|||
105419616|NCT00521599|363542522|FG000|Overall Study|Protocol Violation|2|||
105419617|NCT00521599|363542523|FG001|Overall Study|Protocol Violation|4|||
105419618|NCT00521599|363542524|FG002|Overall Study|Protocol Violation|2|||
105419619|NCT00521599|363542522|FG000|Overall Study|Did not meet protocol eligibility|2|||
105419620|NCT00521599|363542523|FG001|Overall Study|Did not meet protocol eligibility|2|||
105419621|NCT00521599|363542524|FG002|Overall Study|Did not meet protocol eligibility|1|||
105419622|NCT00244933|363542527|FG000|Overall Study|Not response evaluable|2|||
105419623|NCT03359785|363542528|FG000|Overall Study|Protocol Violation|0|||
105419624|NCT03359785|363542529|FG001|Overall Study|Protocol Violation|1|||
105419625|NCT03359785|363542530|FG002|Overall Study|Protocol Violation|0|||
105419626|NCT03359785|363542531|FG003|Overall Study|Protocol Violation|0|||
105419627|NCT03359785|363542528|FG000|Overall Study|Early study termination due to study pause|0|||
105419628|NCT03359785|363542529|FG001|Overall Study|Early study termination due to study pause|0|||
105419629|NCT03359785|363542530|FG002|Overall Study|Early study termination due to study pause|2|||
105500008|NCT01644565|363841811|FG004|Overall Study|Family emergency|1|||
105500009|NCT01644565|363841812|FG005|Overall Study|Family emergency|0|||
105419630|NCT03359785|363542531|FG003|Overall Study|Early study termination due to study pause|0|||
105419631|NCT03359785|363542528|FG000|Overall Study|Withdrawal by Subject|2|||
105419632|NCT03359785|363542529|FG001|Overall Study|Withdrawal by Subject|2|||
105419633|NCT03359785|363542530|FG002|Overall Study|Withdrawal by Subject|0|||
105419634|NCT03359785|363542531|FG003|Overall Study|Withdrawal by Subject|0|||
105419635|NCT03136497|363542532|FG000|Overall Study|Screen Failure|1|||
105419636|NCT03136497|363542533|FG001|Overall Study|Screen Failure|0|||
105419637|NCT03136497|363542534|FG002|Overall Study|Screen Failure|0|||
105419638|NCT01639339|363542538|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
105419639|NCT01639339|363542539|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
105500010|NCT01644565|363841813|FG006|Overall Study|Family emergency|0|||
105500011|NCT01644565|363841814|FG007|Overall Study|Family emergency|0|||
105500012|NCT01644565|363841815|FG008|Overall Study|Family emergency|0|||
105584161|NCT02223182|364136795|FG002|Double-Blind Period|Lost to Follow-up|0|||
105584162|NCT02223182|364136796|FG003|Double-Blind Period|Lost to Follow-up|0|||
105584163|NCT02223182|364136793|FG000|Double-Blind Period|Non Compliance|0|||
105584164|NCT02223182|364136794|FG001|Double-Blind Period|Non Compliance|0|||
105584165|NCT02223182|364136795|FG002|Double-Blind Period|Non Compliance|0|||
105584166|NCT02223182|364136796|FG003|Double-Blind Period|Non Compliance|1|||
105584167|NCT02223182|364136793|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
105584168|NCT02223182|364136794|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
105584169|NCT02223182|364136795|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
105584170|NCT02223182|364136796|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
105584171|NCT02223182|364136793|FG000|Open-Label 500 Period|Adverse Event|1|||
105584172|NCT02223182|364136794|FG001|Open-Label 500 Period|Adverse Event|0|||
105584173|NCT02223182|364136795|FG002|Open-Label 500 Period|Adverse Event|2|||
105584174|NCT02223182|364136796|FG003|Open-Label 500 Period|Adverse Event|1|||
105584175|NCT02223182|364136793|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
105584176|NCT02223182|364136794|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
105584177|NCT02223182|364136795|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
105584178|NCT02223182|364136796|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
105584179|NCT02223182|364136793|FG000|Open-Label 500 Period|Physician Decision|0|||
105584180|NCT02223182|364136794|FG001|Open-Label 500 Period|Physician Decision|0|||
105584181|NCT02223182|364136795|FG002|Open-Label 500 Period|Physician Decision|0|||
105584182|NCT02223182|364136796|FG003|Open-Label 500 Period|Physician Decision|1|||
105584183|NCT02223182|364136793|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
105584184|NCT02223182|364136794|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
105584185|NCT02223182|364136795|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
105584186|NCT02223182|364136796|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
105584187|NCT02223182|364136793|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
105584188|NCT02223182|364136794|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
105584189|NCT02223182|364136795|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
105584190|NCT02223182|364136796|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
105584191|NCT02223182|364136793|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
105584192|NCT02223182|364136794|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
105584193|NCT02223182|364136795|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
105584194|NCT02223182|364136796|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
105584195|NCT02223182|364136793|FG000|Open-Label 300 Period|Non Compliance|0|||
105584196|NCT02223182|364136794|FG001|Open-Label 300 Period|Non Compliance|2|||
105584197|NCT02223182|364136795|FG002|Open-Label 300 Period|Non Compliance|1|||
105584198|NCT02223182|364136796|FG003|Open-Label 300 Period|Non Compliance|0|||
105584199|NCT00235495|364136797|FG000|Overall Study|Death|52|||
105584200|NCT00235495|364136798|FG001|Overall Study|Death|42|||
105584201|NCT00235495|364136797|FG000|Overall Study|Withdrawal by Subject|5|||
105584202|NCT00235495|364136798|FG001|Overall Study|Withdrawal by Subject|3|||
105584203|NCT00235495|364136797|FG000|Overall Study|Lost to Follow-up|11|||
105584204|NCT00235495|364136798|FG001|Overall Study|Lost to Follow-up|13|||
105584205|NCT00235495|364136797|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
105584206|NCT00235495|364136798|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
105584207|NCT04482855|364136802|FG000|Overall Study|Lost to Follow-up|1|||
105584208|NCT04482855|364136803|FG001|Overall Study|Lost to Follow-up|0|||
105584209|NCT04482855|364136802|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
105584210|NCT04482855|364136803|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
105584211|NCT04482855|364136802|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
105584212|NCT04482855|364136803|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
105584213|NCT02696226|364136804|FG000|Overall Study|Study terminated - lack of enrollment|1|||
105584214|NCT02696226|364136805|FG001|Overall Study|Study terminated - lack of enrollment|0|||
105584215|NCT02696226|364136806|FG002|Overall Study|Study terminated - lack of enrollment|2|||
105584216|NCT02696226|364136807|FG003|Overall Study|Study terminated - lack of enrollment|0|||
105584217|NCT02909101|364136808|FG000|Overall Study|Lost to Follow-up|1|||
105584218|NCT02909101|364136809|FG001|Overall Study|Lost to Follow-up|1|||
105419640|NCT01639339|363542538|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
105419641|NCT01639339|363542539|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
105419642|NCT01639339|363542538|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
105419643|NCT01639339|363542539|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
105584219|NCT01221181|364136810|FG000|Overall Study|Lost to Follow-up|1|||
105584220|NCT02419755|364136811|FG000|Overall Study|Death|1|||
105584221|NCT02419755|364136812|FG001|Overall Study|Death|3|||
105584222|NCT02419755|364136811|FG000|Overall Study|Relapse|0|||
105584223|NCT02419755|364136812|FG001|Overall Study|Relapse|1|||
105584224|NCT02419755|364136811|FG000|Overall Study|Ineligible|1|||
105584225|NCT02419755|364136812|FG001|Overall Study|Ineligible|0|||
105584226|NCT02419755|364136811|FG000|Overall Study|Withdrawal by Subject|1|||
105419644|NCT01639339|363542538|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
105419645|NCT01639339|363542539|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
105419646|NCT01639339|363542538|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
105419647|NCT01639339|363542539|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
105419648|NCT01639339|363542538|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
105419649|NCT01639339|363542539|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
105419650|NCT01639339|363542538|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
105419651|NCT01639339|363542539|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
105419652|NCT01639339|363542538|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
105419653|NCT01639339|363542539|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
105419654|NCT01639339|363542538|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
105419655|NCT01639339|363542539|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
105419656|NCT01639339|363542538|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
105419657|NCT01639339|363542539|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
105419658|NCT00349921|363542540|FG000|First Spinal Injection|Physician Decision|1|||
105419659|NCT00349921|363542541|FG001|First Spinal Injection|Physician Decision|0|||
105419660|NCT00349921|363542542|FG002|First Spinal Injection|Physician Decision|0|||
105419661|NCT00349921|363542543|FG003|First Spinal Injection|Physician Decision|0|||
105419662|NCT00349921|363542540|FG000|First Spinal Injection|Adverse Event|0|||
105419663|NCT00349921|363542541|FG001|First Spinal Injection|Adverse Event|0|||
105419664|NCT00349921|363542542|FG002|First Spinal Injection|Adverse Event|1|||
105419665|NCT00349921|363542543|FG003|First Spinal Injection|Adverse Event|0|||
105419666|NCT03022097|363542545|FG000|Overall Study|Adverse Event|3|||
105419667|NCT03022097|363542546|FG001|Overall Study|Adverse Event|4|||
105419668|NCT03022097|363542547|FG002|Overall Study|Adverse Event|1|||
105419669|NCT03022097|363542548|FG003|Overall Study|Adverse Event|3|||
105419670|NCT03022097|363542545|FG000|Overall Study|Progressive Disease|2|||
105419671|NCT03022097|363542546|FG001|Overall Study|Progressive Disease|0|||
105419672|NCT03022097|363542547|FG002|Overall Study|Progressive Disease|5|||
105419673|NCT03022097|363542548|FG003|Overall Study|Progressive Disease|2|||
105419674|NCT03022097|363542545|FG000|Overall Study|Lack of Efficacy|0|||
105419675|NCT03022097|363542546|FG001|Overall Study|Lack of Efficacy|0|||
105419676|NCT03022097|363542547|FG002|Overall Study|Lack of Efficacy|3|||
105419677|NCT03022097|363542548|FG003|Overall Study|Lack of Efficacy|3|||
105419678|NCT03022097|363542545|FG000|Overall Study|Protocol Violation|1|||
105419679|NCT03022097|363542546|FG001|Overall Study|Protocol Violation|0|||
105419680|NCT03022097|363542547|FG002|Overall Study|Protocol Violation|1|||
105419681|NCT03022097|363542548|FG003|Overall Study|Protocol Violation|0|||
105419682|NCT03022097|363542545|FG000|Overall Study|Withdrawal by Subject|11|||
105419683|NCT03022097|363542546|FG001|Overall Study|Withdrawal by Subject|13|||
105419684|NCT03022097|363542547|FG002|Overall Study|Withdrawal by Subject|15|||
105419685|NCT03022097|363542548|FG003|Overall Study|Withdrawal by Subject|21|||
105419686|NCT03022097|363542545|FG000|Overall Study|Lost to Follow-up|0|||
105419687|NCT03022097|363542546|FG001|Overall Study|Lost to Follow-up|0|||
105419688|NCT03022097|363542547|FG002|Overall Study|Lost to Follow-up|1|||
105419689|NCT03022097|363542548|FG003|Overall Study|Lost to Follow-up|1|||
105419690|NCT03022097|363542545|FG000|Overall Study|Other|4|||
105419691|NCT03022097|363542546|FG001|Overall Study|Other|1|||
105419692|NCT03022097|363542547|FG002|Overall Study|Other|6|||
105419693|NCT03022097|363542548|FG003|Overall Study|Other|4|||
105419694|NCT03022097|363542545|FG000|Overall Study|Due to COVID-19 pandemic|0|||
105419695|NCT03022097|363542546|FG001|Overall Study|Due to COVID-19 pandemic|1|||
105419696|NCT03022097|363542547|FG002|Overall Study|Due to COVID-19 pandemic|0|||
105419697|NCT03022097|363542548|FG003|Overall Study|Due to COVID-19 pandemic|0|||
105419698|NCT01451931|363542551|FG000|Overall Study|Lost to Follow-up|17|||
105419699|NCT01451931|363542552|FG001|Overall Study|Lost to Follow-up|36|||
105419700|NCT01451931|363542553|FG002|Overall Study|Lost to Follow-up|21|||
105419701|NCT01451931|363542551|FG000|Overall Study|Withdrawal by Subject|16|||
105419702|NCT01451931|363542552|FG001|Overall Study|Withdrawal by Subject|22|||
105419703|NCT01451931|363542553|FG002|Overall Study|Withdrawal by Subject|22|||
105419704|NCT00503581|363542556|FG000|Overall Study|Study closed|3|||
105419705|NCT00503581|363542557|FG001|Overall Study|Study closed|4|||
105419706|NCT00503581|363542558|FG002|Overall Study|Study closed|2|||
105419707|NCT04376684|363542559|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
105419708|NCT04376684|363542560|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
105419709|NCT04376684|363542561|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
105419710|NCT04376684|363542562|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
105419711|NCT04376684|363542559|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
105419712|NCT04376684|363542560|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
105419713|NCT04376684|363542561|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
105419714|NCT04376684|363542562|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
105419715|NCT04376684|363542559|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
105419716|NCT04376684|363542560|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
105419717|NCT04376684|363542561|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
105419718|NCT04376684|363542562|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
105440048|NCT00082407|363616694|FG000|Overall Study|Death|2|||
105500013|NCT01644565|363841807|FG000|Overall Study|Relocation|0|||
105500014|NCT01644565|363841808|FG001|Overall Study|Relocation|0|||
105500015|NCT01644565|363841809|FG002|Overall Study|Relocation|0|||
105500016|NCT01644565|363841810|FG003|Overall Study|Relocation|0|||
105500017|NCT01644565|363841811|FG004|Overall Study|Relocation|0|||
105500018|NCT01644565|363841812|FG005|Overall Study|Relocation|0|||
105500019|NCT01644565|363841813|FG006|Overall Study|Relocation|0|||
105500020|NCT01644565|363841814|FG007|Overall Study|Relocation|0|||
105500021|NCT01644565|363841815|FG008|Overall Study|Relocation|1|||
105500022|NCT01313858|363841818|FG000|Overall Study|Premature Treatment Termination|251|||
105500023|NCT01313858|363841819|FG001|Overall Study|Premature Treatment Termination|219|||
105500024|NCT01313858|363841820|FG002|Overall Study|Premature Treatment Termination|191|||
105500025|NCT01313858|363841818|FG000|Overall Study|Lost to Follow-up|35|||
105500026|NCT01313858|363841819|FG001|Overall Study|Lost to Follow-up|51|||
105500027|NCT01313858|363841820|FG002|Overall Study|Lost to Follow-up|47|||
105500028|NCT04015336|363841823|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
105500029|NCT02924571|363841824|FG000|Overall Study|Lost to Follow-up|1|||
105500030|NCT02924571|363841825|FG001|Overall Study|Lost to Follow-up|1|||
105500031|NCT02924571|363841826|FG002|Overall Study|Lost to Follow-up|0|||
105500032|NCT00691301|363841829|FG000|Overall Study|Adverse Event|10|||
105500033|NCT00691301|363841829|FG000|Overall Study|Death|2|||
105500034|NCT00691301|363841829|FG000|Overall Study|Lack of Efficacy|32|||
105500035|NCT00691301|363841829|FG000|Overall Study|Withdrawal by Subject|4|||
105500036|NCT00691301|363841829|FG000|Overall Study|Concurrent illness|2|||
105500037|NCT00691301|363841829|FG000|Overall Study|other reason|3|||
105500038|NCT00691301|363841829|FG000|Overall Study|Did not initiate study treatment|1|||
105500039|NCT01823146|363841831|FG000|Overall Study|Withdrawal by Subject|0|||
105500040|NCT01823146|363841832|FG001|Overall Study|Withdrawal by Subject|1|||
105500041|NCT01823146|363841831|FG000|Overall Study|Lost to Follow-up|2|||
105500042|NCT01823146|363841832|FG001|Overall Study|Lost to Follow-up|1|||
105500043|NCT00463580|363841833|FG000|Overall Study|Lost to Follow-up|1|||
105500044|NCT00463580|363841834|FG001|Overall Study|Lost to Follow-up|0|||
105500045|NCT00463580|363841833|FG000|Overall Study|Schedule conflict|2|||
105500046|NCT00463580|363841834|FG001|Overall Study|Schedule conflict|0|||
105500047|NCT00463580|363841833|FG000|Overall Study|Medical/psychiatric complications|0|||
105500048|NCT00463580|363841834|FG001|Overall Study|Medical/psychiatric complications|2|||
105500049|NCT04638660|363841836|FG000|Overall Study|Withdrawal by Subject|2|||
105500050|NCT04638660|363841837|FG001|Overall Study|Withdrawal by Subject|0|||
105500051|NCT04638660|363841836|FG000|Overall Study|Lost to Follow-up|1|||
105500052|NCT04638660|363841837|FG001|Overall Study|Lost to Follow-up|0|||
105500053|NCT03917459|363841838|FG000|Overall Study|Adverse Event|1|||
105500054|NCT03917459|363841839|FG001|Overall Study|Adverse Event|0|||
105500055|NCT03917459|363841838|FG000|Overall Study|Withdrawal by Subject|0|||
105500056|NCT03917459|363841839|FG001|Overall Study|Withdrawal by Subject|1|||
105500057|NCT00736944|363841840|FG000|Induction|Death|1|||
105500058|NCT00736944|363841840|FG000|Definitive Treatment|Physician Decision|1|||
105500059|NCT05350410|363841841|FG000|Overall Study|Withdrawal by Subject|1|||
105500060|NCT00075218|363841849|FG000|Double-Blind Treatment|Adverse Event|23|||
105500061|NCT00075218|363841850|FG001|Double-Blind Treatment|Adverse Event|4|||
105500062|NCT00075218|363841851|FG002|Double-Blind Treatment|Adverse Event|0|||
105500063|NCT00075218|363841849|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
105500064|NCT00075218|363841850|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
105500065|NCT00075218|363841851|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
105500066|NCT00075218|363841849|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
105500067|NCT00075218|363841850|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
105500068|NCT00075218|363841851|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
105500069|NCT00075218|363841849|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
105500070|NCT00075218|363841850|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
105500071|NCT00075218|363841851|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
105500072|NCT00075218|363841849|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
105500073|NCT00075218|363841850|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
105500074|NCT00075218|363841851|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
105500075|NCT00075218|363841849|FG000|Double-Blind Treatment|No study medication taken|2|||
105500076|NCT00075218|363841850|FG001|Double-Blind Treatment|No study medication taken|0|||
105500077|NCT00075218|363841851|FG002|Double-Blind Treatment|No study medication taken|0|||
105500078|NCT00075218|363841849|FG000|Open-Label Treatment|Lack of Efficacy|0|||
105500079|NCT00075218|363841850|FG001|Open-Label Treatment|Lack of Efficacy|0|||
105584227|NCT02419755|364136812|FG001|Overall Study|Withdrawal by Subject|0|||
105584228|NCT01101542|364136813|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
105584229|NCT01101542|364136813|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
105500080|NCT00075218|363841851|FG002|Open-Label Treatment|Lack of Efficacy|174|||
105500081|NCT00075218|363841849|FG000|Open-Label Treatment|Adverse Event|0|||
105500082|NCT00075218|363841850|FG001|Open-Label Treatment|Adverse Event|0|||
105500083|NCT00075218|363841851|FG002|Open-Label Treatment|Adverse Event|51|||
105500084|NCT00075218|363841849|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
105500085|NCT00075218|363841850|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
105419719|NCT04376684|363542559|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
105419720|NCT04376684|363542560|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
105419721|NCT04376684|363542561|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
105419722|NCT04376684|363542562|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
105419723|NCT04376684|363542559|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
105419724|NCT04376684|363542560|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
105419725|NCT04376684|363542561|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
105419726|NCT04376684|363542562|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
105419727|NCT04376684|363542559|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
105419728|NCT04376684|363542560|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
105419729|NCT04376684|363542561|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
105419730|NCT04376684|363542562|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
105500086|NCT00075218|363841851|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
105500087|NCT00075218|363841849|FG000|Open-Label Treatment|Decision of Sponsor|0|||
105500088|NCT00075218|363841850|FG001|Open-Label Treatment|Decision of Sponsor|0|||
105500089|NCT00075218|363841851|FG002|Open-Label Treatment|Decision of Sponsor|8|||
105500090|NCT00075218|363841849|FG000|Open-Label Treatment|Protocol Violation|0|||
105500091|NCT00075218|363841850|FG001|Open-Label Treatment|Protocol Violation|0|||
105500092|NCT00075218|363841851|FG002|Open-Label Treatment|Protocol Violation|1|||
105500093|NCT00075218|363841849|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
105500094|NCT00075218|363841850|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
105500095|NCT00075218|363841851|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
105500096|NCT02601027|363841852|FG000|Registration to Surgery|Withdrawal by Subject|20|||
105500097|NCT02601027|363841853|FG001|Registration to Surgery|Withdrawal by Subject|10|||
105500098|NCT01393301|363841856|FG000|Overall Study|Lost to Follow-up|5|||
105500099|NCT01393301|363841857|FG001|Overall Study|Lost to Follow-up|3|||
105500100|NCT01393301|363841856|FG000|Overall Study|Withdrawal by Subject|2|||
105500101|NCT01393301|363841857|FG001|Overall Study|Withdrawal by Subject|0|||
105500102|NCT01393301|363841856|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
105500103|NCT01393301|363841857|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
105500104|NCT03840174|363841860|FG000|Overall Study|Withdrawal by Subject|1|||
105500105|NCT03840174|363841861|FG001|Overall Study|Withdrawal by Subject|0|||
105500106|NCT03840174|363841862|FG002|Overall Study|Withdrawal by Subject|0|||
105500107|NCT03840174|363841863|FG003|Overall Study|Withdrawal by Subject|0|||
105500108|NCT01719783|363841866|FG000|Dose 2|Physician Decision|1|||
105500109|NCT01719783|363841867|FG001|Dose 2|Physician Decision|0|||
105500110|NCT02716805|363841870|FG000|Overall Study|Progressive disease|2|||
105500111|NCT02716805|363841871|FG001|Overall Study|Progressive disease|0|||
105500112|NCT02716805|363841872|FG002|Overall Study|Progressive disease|0|||
105500113|NCT02716805|363841873|FG003|Overall Study|Progressive disease|0|||
105500114|NCT00066365|363841874|FG000|Overall Study|Adverse Event|1|||
105500115|NCT00066365|363841875|FG001|Overall Study|Adverse Event|0|||
105500116|NCT00066365|363841874|FG000|Overall Study|Lack of Efficacy|15|||
105500117|NCT00066365|363841875|FG001|Overall Study|Lack of Efficacy|12|||
105500118|NCT00066365|363841874|FG000|Overall Study|Physician Decision|1|||
105500119|NCT00066365|363841875|FG001|Overall Study|Physician Decision|0|||
105500120|NCT00066365|363841874|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
105500121|NCT00066365|363841875|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
105500122|NCT00066365|363841874|FG000|Overall Study|Ineligible|4|||
105500123|NCT00066365|363841875|FG001|Overall Study|Ineligible|2|||
105500124|NCT00239590|363841878|FG000|Randomized|Lost to Follow-up|0|||
105500125|NCT00239590|363841879|FG001|Randomized|Lost to Follow-up|1|||
105500126|NCT00239590|363841878|FG000|Randomized|Withdrawal by Subject|0|||
105500127|NCT00239590|363841879|FG001|Randomized|Withdrawal by Subject|1|||
105500128|NCT00239590|363841878|FG000|Completed Study Protocol|Adverse Event|1|||
105500129|NCT00239590|363841879|FG001|Completed Study Protocol|Adverse Event|1|||
105500130|NCT00239590|363841878|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
105584230|NCT01101542|364136813|FG000|Year 4 Surveillance Period|Other|287|||
105584231|NCT01101542|364136813|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
105584232|NCT01101542|364136813|FG000|Year 5 Surveillance Period|Pregnancy|1|||
105419731|NCT04376684|363542559|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
105419732|NCT04376684|363542560|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
105419733|NCT04376684|363542561|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
105419734|NCT04376684|363542562|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
105419735|NCT03219034|363542572|FG000|Overall Study|Lost to Follow-up|9|||
105500131|NCT00239590|363841879|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
105500132|NCT02058693|363841880|FG000|Phase 1|Withdrawal by Subject|3|||
105500133|NCT02058693|363841881|FG001|Phase 1|Withdrawal by Subject|2|||
105500134|NCT02058693|363841880|FG000|Phase 1|Adverse Event|0|||
105500135|NCT02058693|363841881|FG001|Phase 1|Adverse Event|1|||
105500136|NCT02058693|363841880|FG000|Phase 1|Lack of Efficacy|1|||
105500137|NCT02058693|363841881|FG001|Phase 1|Lack of Efficacy|0|||
105500138|NCT02058693|363841880|FG000|Phase 1|Physician Decision|1|||
105500139|NCT02058693|363841881|FG001|Phase 1|Physician Decision|1|||
105500140|NCT02058693|363841880|FG000|Phase 2|Withdrawal by Subject|0|||
105500141|NCT02058693|363841881|FG001|Phase 2|Withdrawal by Subject|2|||
105584233|NCT01101542|364136813|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
105584234|NCT01101542|364136813|FG000|Year 6 Surveillance Period|Pregnancy|1|||
105584235|NCT01101542|364136813|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
105584236|NCT00701311|364136814|FG000|Overall Study|Lack of Efficacy|3|||
105584237|NCT00701311|364136814|FG000|Overall Study|Adverse Event|3|||
105584238|NCT00701311|364136814|FG000|Overall Study|Withdrawal by Subject|2|||
105584239|NCT00670540|364136817|FG000|Overall Study|ineligible|17|||
105584240|NCT00670540|364136817|FG000|Overall Study|not living in France|348|||
105584241|NCT00670540|364136817|FG000|Overall Study|refused to participate|189|||
105584242|NCT00670540|364136817|FG000|Overall Study|controls randomised for no follow up|2770|||
105584243|NCT00670540|364136817|FG000|Overall Study|missing information inclusion criteria|1|||
105584244|NCT00814489|364136818|FG000|Overall Study|Other|2|||
105584245|NCT00814489|364136819|FG001|Overall Study|Other|0|||
105584246|NCT00814489|364136820|FG002|Overall Study|Other|1|||
105584247|NCT00901485|364136846|FG000|Overall Study|Lack of Efficacy|0|||
105584248|NCT00901485|364136847|FG001|Overall Study|Lack of Efficacy|2|||
105584249|NCT00901485|364136846|FG000|Overall Study|Withdrawal by Subject|1|||
105584250|NCT00901485|364136847|FG001|Overall Study|Withdrawal by Subject|2|||
105584251|NCT01929993|364138030|FG000|Overall Study|Protocol Violation|4|||
105584252|NCT01929993|364138031|FG001|Overall Study|Protocol Violation|6|||
105584253|NCT01929993|364138030|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
105584254|NCT01929993|364138031|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
105584255|NCT01852162|364138032|FG000|Overall Study|Adverse Event|1|||
105584256|NCT01852162|364138033|FG001|Overall Study|Adverse Event|0|||
105584257|NCT01852162|364138032|FG000|Overall Study|Withdrawal by Subject|3|||
105584258|NCT01852162|364138033|FG001|Overall Study|Withdrawal by Subject|1|||
105584259|NCT02268396|364138034|FG000|Overall Study|Adverse Event|3|||
105584260|NCT02268396|364138034|FG000|Overall Study|Administrative|2|||
105584261|NCT02268396|364138034|FG000|Overall Study|Withdrawal by Subject|1|||
105584262|NCT02268396|364138034|FG000|Overall Study|Lost to Follow-up|2|||
105584263|NCT02268396|364138034|FG000|Overall Study|Protocol-Specified Criteria|2|||
105584264|NCT02268396|364138034|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
105419736|NCT03219034|363542573|FG001|Overall Study|Lost to Follow-up|13|||
105419737|NCT03219034|363542572|FG000|Overall Study|Additional dental work needed|1|||
105419738|NCT03219034|363542573|FG001|Overall Study|Additional dental work needed|0|||
105419739|NCT03219034|363542572|FG000|Overall Study|UPPP Surgery|1|||
105584265|NCT02652130|364138037|FG000|Overall Study|Death|1|||
105584266|NCT02688621|364138040|FG000|Overall Study|Pregnancy|1|||
105584267|NCT02688621|364138041|FG001|Overall Study|Pregnancy|3|||
105584268|NCT02688621|364138040|FG000|Overall Study|Lost to Follow-up|38|||
105584269|NCT02688621|364138041|FG001|Overall Study|Lost to Follow-up|15|||
105584270|NCT02688621|364138040|FG000|Overall Study|Withdrawal by Subject|1|||
105584271|NCT02688621|364138041|FG001|Overall Study|Withdrawal by Subject|0|||
105584272|NCT03239210|364138042|FG000|Overall Study|Lost to Follow-up|2|||
105584273|NCT03239210|364138043|FG001|Overall Study|Lost to Follow-up|2|||
105584274|NCT03239210|364138042|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
105584275|NCT03239210|364138043|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
105584276|NCT03239210|364138042|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
105584277|NCT03239210|364138043|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
105584278|NCT03606460|364138046|FG000|Overall Study|Lost to Follow-up|1|||
105584279|NCT03606460|364138047|FG001|Overall Study|Lost to Follow-up|8|||
105584280|NCT03836664|364138051|FG000|Overall Study|Didn't complete forms and lost drug|3|||
105584281|NCT03836664|364138052|FG001|Overall Study|Didn't complete forms and lost drug|3|||
105584282|NCT02179918|364138057|FG000|Overall Study|Death|0|||
105584283|NCT02179918|364138058|FG001|Overall Study|Death|0|||
105584284|NCT02179918|364138059|FG002|Overall Study|Death|0|||
105584285|NCT02179918|364138060|FG003|Overall Study|Death|1|||
105584286|NCT02179918|364138061|FG004|Overall Study|Death|0|||
105584287|NCT02179918|364138057|FG000|Overall Study|Lost to Follow-up|0|||
105584288|NCT02179918|364138058|FG001|Overall Study|Lost to Follow-up|0|||
105584289|NCT02179918|364138059|FG002|Overall Study|Lost to Follow-up|1|||
105584290|NCT02179918|364138060|FG003|Overall Study|Lost to Follow-up|0|||
105584291|NCT02179918|364138061|FG004|Overall Study|Lost to Follow-up|0|||
105584292|NCT02179918|364138057|FG000|Overall Study|Progressive Disease|4|||
105584293|NCT02179918|364138058|FG001|Overall Study|Progressive Disease|1|||
105584294|NCT02179918|364138059|FG002|Overall Study|Progressive Disease|1|||
105584295|NCT02179918|364138060|FG003|Overall Study|Progressive Disease|2|||
105584296|NCT02179918|364138061|FG004|Overall Study|Progressive Disease|6|||
105584297|NCT02179918|364138057|FG000|Overall Study|Other|0|||
105584298|NCT02179918|364138058|FG001|Overall Study|Other|1|||
105584299|NCT02179918|364138059|FG002|Overall Study|Other|0|||
105584300|NCT02179918|364138060|FG003|Overall Study|Other|0|||
105584301|NCT02179918|364138061|FG004|Overall Study|Other|1|||
105584302|NCT02179918|364138057|FG000|Overall Study|Subject refused further follow-up|0|||
105584303|NCT02179918|364138058|FG001|Overall Study|Subject refused further follow-up|1|||
105584304|NCT02179918|364138059|FG002|Overall Study|Subject refused further follow-up|0|||
105584305|NCT02179918|364138060|FG003|Overall Study|Subject refused further follow-up|0|||
105419740|NCT03219034|363542573|FG001|Overall Study|UPPP Surgery|0|||
105500142|NCT03344796|363841888|FG000|Overall Study|Lost to Follow-up|0|||
105500143|NCT03344796|363841889|FG001|Overall Study|Lost to Follow-up|0|||
105500144|NCT03344796|363841890|FG002|Overall Study|Lost to Follow-up|0|||
105500145|NCT03344796|363841891|FG003|Overall Study|Lost to Follow-up|0|||
105500146|NCT03344796|363841892|FG004|Overall Study|Lost to Follow-up|0|||
105500147|NCT03344796|363841893|FG005|Overall Study|Lost to Follow-up|2|||
105500148|NCT00242216|363841907|FG000|Overall Study|Lost to Follow-up|12|||
105500149|NCT00242216|363841908|FG001|Overall Study|Lost to Follow-up|17|||
105500150|NCT00242216|363841907|FG000|Overall Study|Death|4|||
105500151|NCT00242216|363841908|FG001|Overall Study|Death|2|||
105500152|NCT00242216|363841907|FG000|Overall Study|Lack of Efficacy|1|||
105500153|NCT00242216|363841908|FG001|Overall Study|Lack of Efficacy|2|||
105500154|NCT00242216|363841907|FG000|Overall Study|no medicaiton dispensed|1|||
105500155|NCT00242216|363841908|FG001|Overall Study|no medicaiton dispensed|1|||
105500156|NCT02569671|363841909|FG000|Overall Study|Lost to Follow-up|2|||
105500157|NCT02569671|363841910|FG001|Overall Study|Lost to Follow-up|1|||
105500158|NCT02569671|363841909|FG000|Overall Study|Withdrawal by Subject|1|||
105500159|NCT02569671|363841910|FG001|Overall Study|Withdrawal by Subject|3|||
105500160|NCT05358444|363841911|FG000|Overall Study|Withdrawal by Subject|0|||
105500161|NCT05358444|363841912|FG001|Overall Study|Withdrawal by Subject|1|||
105500162|NCT05358444|363841911|FG000|Overall Study|Lost to Follow-up|0|||
105500163|NCT05358444|363841912|FG001|Overall Study|Lost to Follow-up|3|||
105500164|NCT01757535|363841913|FG000|Overall Study|Disease Relapse|151|||
105500165|NCT01757535|363841914|FG001|Overall Study|Disease Relapse|181|||
105500166|NCT01757535|363841913|FG000|Overall Study|Other Reasons|28|||
105500167|NCT01757535|363841914|FG001|Overall Study|Other Reasons|27|||
105500168|NCT01757535|363841913|FG000|Overall Study|Adverse Event|31|||
105500169|NCT01757535|363841914|FG001|Overall Study|Adverse Event|11|||
105500170|NCT01757535|363841913|FG000|Overall Study|Withdrew Consent|19|||
105500171|NCT01757535|363841914|FG001|Overall Study|Withdrew Consent|13|||
105500172|NCT01757535|363841913|FG000|Overall Study|Physician Decision|7|||
105500173|NCT01757535|363841914|FG001|Overall Study|Physician Decision|0|||
105500174|NCT01757535|363841913|FG000|Overall Study|Death|2|||
105500175|NCT01757535|363841914|FG001|Overall Study|Death|2|||
105500176|NCT03487549|363841917|FG000|Overall Study|Protocol Violation|0|||
105500177|NCT03487549|363841918|FG001|Overall Study|Protocol Violation|1|||
105500178|NCT03487549|363841917|FG000|Overall Study|Lost to Follow-up|2|||
105500179|NCT03487549|363841918|FG001|Overall Study|Lost to Follow-up|1|||
105500180|NCT03487549|363841917|FG000|Overall Study|Withdrawal by Subject|2|||
105500181|NCT03487549|363841918|FG001|Overall Study|Withdrawal by Subject|0|||
105500182|NCT02900976|363841919|FG000|Overall Study|Adverse Event|0|||
105500183|NCT02900976|363841920|FG001|Overall Study|Adverse Event|1|||
105500184|NCT02900976|363841919|FG000|Overall Study|Physician Decision|0|||
105500185|NCT02900976|363841920|FG001|Overall Study|Physician Decision|2|||
105500186|NCT02900976|363841919|FG000|Overall Study|Progressive disease|0|||
105500187|NCT02900976|363841920|FG001|Overall Study|Progressive disease|6|||
105500188|NCT04997304|363841922|FG000|Overall Study|Lost to Follow-up|11|||
105500189|NCT04997304|363841922|FG000|Overall Study|Death|1|||
105500190|NCT04997304|363841922|FG000|Overall Study|Withdrawal by Subject|14|||
105500191|NCT02110238|363843250|FG000|12 Week Pivotal Phase|Adverse Event|3|||
105500192|NCT02110238|363843251|FG001|12 Week Pivotal Phase|Adverse Event|0|||
105500193|NCT02110238|363843250|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
105500194|NCT02110238|363843251|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
105500195|NCT02110238|363843250|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
105500196|NCT02110238|363843251|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
105500197|NCT02110238|363843250|FG000|12 Week Pivotal Phase|Physician Decision|0|||
105500198|NCT02110238|363843251|FG001|12 Week Pivotal Phase|Physician Decision|2|||
105500199|NCT02110238|363843250|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
105500200|NCT02110238|363843251|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
105500201|NCT02110238|363843250|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
105500202|NCT02110238|363843251|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
105500203|NCT02110238|363843250|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
105500204|NCT02110238|363843251|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
105500205|NCT02110238|363843250|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
105500206|NCT02110238|363843251|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
105500207|NCT02110238|363843250|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
105500208|NCT02110238|363843251|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
105500209|NCT02110238|363843250|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
105500210|NCT02110238|363843251|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
105500211|NCT02110238|363843250|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
105500212|NCT02110238|363843251|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
105500213|NCT01773733|363843252|FG000|Overall Study|Adverse Event|3286|||
105500214|NCT01773733|363843253|FG001|Overall Study|Adverse Event|540|||
105500215|NCT01773733|363843252|FG000|Overall Study|Pregnancy|28|||
105500216|NCT01773733|363843253|FG001|Overall Study|Pregnancy|0|||
105500217|NCT01773733|363843252|FG000|Overall Study|Other different categories of not compl|55415|||
105500218|NCT01773733|363843253|FG001|Overall Study|Other different categories of not compl|7781|||
105500219|NCT03228433|363843254|FG000|Overall Study|Lost to Follow-up|1|||
105419741|NCT03219034|363542572|FG000|Overall Study|Dental sensitivity|0|||
105419742|NCT03219034|363542573|FG001|Overall Study|Dental sensitivity|1|||
105419743|NCT03219034|363542572|FG000|Overall Study|Death in family|0|||
105419744|NCT03219034|363542573|FG001|Overall Study|Death in family|1|||
105419745|NCT00118846|363542575|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
105419746|NCT00118846|363542576|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
105419747|NCT00118846|363542575|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
105419748|NCT00118846|363542576|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
105419749|NCT00118846|363542575|FG000|Overall Study|Physician Decision|1|||
105419750|NCT00118846|363542576|FG001|Overall Study|Physician Decision|0|||
105419751|NCT00118846|363542575|FG000|Overall Study|Medical condition|2|||
105419752|NCT00118846|363542576|FG001|Overall Study|Medical condition|2|||
105419753|NCT00118846|363542575|FG000|Overall Study|Lost to Follow-up|0|||
105419754|NCT00118846|363542576|FG001|Overall Study|Lost to Follow-up|2|||
105419755|NCT00118846|363542575|FG000|Overall Study|Personal reason|4|||
105419756|NCT00118846|363542576|FG001|Overall Study|Personal reason|5|||
105419757|NCT00457821|363542579|FG000|Part 2|Withdrawal by Subject|0|||
105419758|NCT00457821|363542580|FG001|Part 2|Withdrawal by Subject|0|||
105419759|NCT00457821|363542581|FG002|Part 2|Withdrawal by Subject|0|||
105419760|NCT00457821|363542582|FG003|Part 2|Withdrawal by Subject|0|||
105419761|NCT00457821|363542583|FG004|Part 2|Withdrawal by Subject|0|||
105419762|NCT00457821|363542584|FG005|Part 2|Withdrawal by Subject|0|||
105419763|NCT00457821|363542585|FG006|Part 2|Withdrawal by Subject|0|||
105419764|NCT00457821|363542586|FG007|Part 2|Withdrawal by Subject|1|||
105419765|NCT00578877|363542587|FG000|Overall Study|Lost to Follow-up|8|||
105419766|NCT00578877|363542588|FG001|Overall Study|Lost to Follow-up|10|||
105419767|NCT00578877|363542587|FG000|Overall Study|early discontinue|61|||
105419768|NCT00578877|363542588|FG001|Overall Study|early discontinue|101|||
105419769|NCT00578877|363542587|FG000|Overall Study|did not provide follow-up data|12|||
105419770|NCT00578877|363542588|FG001|Overall Study|did not provide follow-up data|17|||
105419771|NCT02438683|363542589|FG000|Overall Study|Adverse Event|1|||
105419772|NCT02438683|363542590|FG001|Overall Study|Adverse Event|0|||
105419773|NCT02438683|363542591|FG002|Overall Study|Adverse Event|0|||
105419774|NCT02438683|363542592|FG003|Overall Study|Adverse Event|0|||
105419775|NCT02438683|363542593|FG004|Overall Study|Adverse Event|0|||
105419776|NCT02438683|363542594|FG005|Overall Study|Adverse Event|0|||
105419777|NCT00721578|363542597|FG000|Overall Study|Death|1|||
105419778|NCT00721578|363542598|FG001|Overall Study|Death|1|||
105419779|NCT00721578|363542597|FG000|Overall Study|Withdrawal by Subject|1|||
105419780|NCT00721578|363542598|FG001|Overall Study|Withdrawal by Subject|1|||
105419781|NCT01330628|363542600|FG000|Overall Study|Death|2|||
105419782|NCT01330628|363542601|FG001|Overall Study|Death|3|||
105419783|NCT01330628|363542600|FG000|Overall Study|Lost to Follow-up|5|||
105419784|NCT01330628|363542601|FG001|Overall Study|Lost to Follow-up|6|||
105419785|NCT01330628|363542600|FG000|Overall Study|Adverse Event|44|||
105419786|NCT01330628|363542601|FG001|Overall Study|Adverse Event|25|||
105419787|NCT01330628|363542600|FG000|Overall Study|Withdrawn|18|||
105419788|NCT01330628|363542601|FG001|Overall Study|Withdrawn|6|||
105419789|NCT01330628|363542600|FG000|Overall Study|Didn't receive study treatment|1|||
105419790|NCT01330628|363542601|FG001|Overall Study|Didn't receive study treatment|0|||
105419791|NCT01357161|363542602|FG000|Part 1 (Open Label Run-in)|Death|5|||
105419792|NCT01357161|363542603|FG001|Part 1 (Open Label Run-in)|Death|0|||
105419793|NCT01357161|363542604|FG002|Part 1 (Open Label Run-in)|Death|0|||
105419794|NCT01357161|363542602|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
105419795|NCT01357161|363542603|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
105440049|NCT00082407|363616695|FG001|Overall Study|Death|1|||
105440050|NCT00082407|363616694|FG000|Overall Study|Lost to Follow-up|0|||
105440051|NCT00082407|363616695|FG001|Overall Study|Lost to Follow-up|3|||
105440052|NCT00630344|363616696|FG000|Overall Study|Adverse Event|5|||
105440053|NCT00630344|363616696|FG000|Overall Study|Progressive Disease|19|||
105440054|NCT00630344|363616696|FG000|Overall Study|Physician Decision|9|||
105440055|NCT00630344|363616696|FG000|Overall Study|Withdrawal by Subject|1|||
105440056|NCT00630344|363616696|FG000|Overall Study|Intercurrent Illness|1|||
105440057|NCT00630344|363616696|FG000|Overall Study|Other|1|||
105440058|NCT05362058|363616698|FG000|Treatment Period|Adverse Event|3|||
105440059|NCT05362058|363616699|FG001|Treatment Period|Adverse Event|3|||
105440060|NCT05362058|363616698|FG000|Treatment Period|Assigned treatment by mistake|3|||
105440061|NCT05362058|363616699|FG001|Treatment Period|Assigned treatment by mistake|4|||
105440062|NCT05362058|363616698|FG000|Treatment Period|Death|1|||
105440063|NCT05362058|363616699|FG001|Treatment Period|Death|1|||
105440064|NCT05362058|363616698|FG000|Treatment Period|Lost to Follow-up|6|||
105440065|NCT05362058|363616699|FG001|Treatment Period|Lost to Follow-up|3|||
105440066|NCT05362058|363616698|FG000|Treatment Period|Non-compliance with study drug|0|||
105440067|NCT05362058|363616699|FG001|Treatment Period|Non-compliance with study drug|1|||
105440068|NCT05362058|363616698|FG000|Treatment Period|Physician Decision|1|||
105440069|NCT05362058|363616699|FG001|Treatment Period|Physician Decision|0|||
105419796|NCT01357161|363542604|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
105419797|NCT01357161|363542602|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
105419798|NCT01357161|363542603|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
105419799|NCT01357161|363542604|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
105419800|NCT01357161|363542602|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
105419801|NCT01357161|363542603|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
105419802|NCT01357161|363542604|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
105419803|NCT01357161|363542602|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
105419804|NCT01357161|363542603|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
105419805|NCT01357161|363542604|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
105419806|NCT01357161|363542602|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
105419807|NCT01357161|363542603|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
105419808|NCT01357161|363542604|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
105419809|NCT01357161|363542602|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
105419810|NCT01357161|363542603|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
105419811|NCT01357161|363542604|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
105419812|NCT01357161|363542602|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
105419813|NCT01357161|363542603|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
105419814|NCT01357161|363542604|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
105419815|NCT01357161|363542602|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
105419816|NCT01357161|363542603|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
105419817|NCT01357161|363542604|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
105419818|NCT01357161|363542602|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
105419819|NCT01357161|363542603|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
105419820|NCT01357161|363542604|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
105419821|NCT01357161|363542602|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
105419822|NCT01357161|363542603|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
105419823|NCT01357161|363542604|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
105419824|NCT02910401|363542605|FG000|Overall Study|Study closure Study closure|0|||
105419825|NCT02910401|363542606|FG001|Overall Study|Study closure Study closure|0|||
105419826|NCT02910401|363542607|FG002|Overall Study|Study closure Study closure|2|||
105419827|NCT02910401|363542605|FG000|Overall Study|Physician Decision|1|||
105419828|NCT02910401|363542606|FG001|Overall Study|Physician Decision|0|||
105419829|NCT02910401|363542607|FG002|Overall Study|Physician Decision|0|||
105500220|NCT03228433|363843255|FG001|Overall Study|Lost to Follow-up|0|||
105500221|NCT03228433|363843256|FG002|Overall Study|Lost to Follow-up|0|||
105500222|NCT03228433|363843257|FG003|Overall Study|Lost to Follow-up|0|||
105500223|NCT03228433|363843258|FG004|Overall Study|Lost to Follow-up|0|||
105500224|NCT03228433|363843259|FG005|Overall Study|Lost to Follow-up|0|||
105500225|NCT03228433|363843254|FG000|Overall Study|Positive alcohol test|0|||
105419830|NCT03300024|363542609|FG000|Overall Study|Physician Decision|4|||
105419831|NCT03300024|363542610|FG001|Overall Study|Physician Decision|6|||
105500226|NCT03228433|363843255|FG001|Overall Study|Positive alcohol test|0|||
105500227|NCT03228433|363843256|FG002|Overall Study|Positive alcohol test|0|||
105500228|NCT03228433|363843257|FG003|Overall Study|Positive alcohol test|1|||
105500229|NCT03228433|363843258|FG004|Overall Study|Positive alcohol test|0|||
105500230|NCT03228433|363843259|FG005|Overall Study|Positive alcohol test|0|||
105500231|NCT00705289|363843260|FG000|Overall Study|Subject or treating physician's choice|131|||
105500232|NCT01330030|363843265|FG000|Overall Study|Lost to Follow-up|16|||
105500233|NCT01330030|363843266|FG001|Overall Study|Lost to Follow-up|17|||
105500234|NCT01146912|363843267|FG000|Overall Study|Already received influenza vaccination|817|||
105500235|NCT01146912|363843268|FG001|Overall Study|Already received influenza vaccination|822|||
105500236|NCT01146912|363843269|FG002|Overall Study|Already received influenza vaccination|13|||
105500237|NCT01146912|363843270|FG003|Overall Study|Already received influenza vaccination|15|||
105500238|NCT01146912|363843271|FG004|Overall Study|Already received influenza vaccination|41|||
105500239|NCT01146912|363843272|FG005|Overall Study|Already received influenza vaccination|61|||
105500240|NCT01146912|363843273|FG006|Overall Study|Already received influenza vaccination|56|||
105500241|NCT01146912|363843274|FG007|Overall Study|Already received influenza vaccination|0|||
105500242|NCT01146912|363843267|FG000|Overall Study|< 14 weeks gestational age|0|||
105500243|NCT01146912|363843268|FG001|Overall Study|< 14 weeks gestational age|0|||
105500244|NCT01146912|363843269|FG002|Overall Study|< 14 weeks gestational age|3|||
105500245|NCT01146912|363843270|FG003|Overall Study|< 14 weeks gestational age|2|||
105500246|NCT01146912|363843271|FG004|Overall Study|< 14 weeks gestational age|0|||
105500247|NCT01146912|363843272|FG005|Overall Study|< 14 weeks gestational age|0|||
105500248|NCT01146912|363843273|FG006|Overall Study|< 14 weeks gestational age|0|||
105500249|NCT01146912|363843274|FG007|Overall Study|< 14 weeks gestational age|0|||
105500250|NCT01146912|363843267|FG000|Overall Study|Duplicate patient|0|||
105500251|NCT01146912|363843268|FG001|Overall Study|Duplicate patient|0|||
105500252|NCT01146912|363843269|FG002|Overall Study|Duplicate patient|1|||
105500253|NCT01146912|363843270|FG003|Overall Study|Duplicate patient|0|||
105500254|NCT01146912|363843271|FG004|Overall Study|Duplicate patient|0|||
105500255|NCT01146912|363843272|FG005|Overall Study|Duplicate patient|0|||
105419832|NCT00098748|363542611|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
105419833|NCT00098748|363542612|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
105419834|NCT00098748|363542613|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
105419835|NCT00098748|363542611|FG000|Received Study Treatment|Death|2|||
105419836|NCT00098748|363542612|FG001|Received Study Treatment|Death|1|||
105419837|NCT00098748|363542613|FG002|Received Study Treatment|Death|2|||
105419838|NCT00098748|363542611|FG000|Received Study Treatment|Adverse Event|1|||
105419839|NCT00098748|363542612|FG001|Received Study Treatment|Adverse Event|2|||
105419840|NCT00098748|363542613|FG002|Received Study Treatment|Adverse Event|5|||
105419841|NCT00098748|363542611|FG000|Received Study Treatment|Lack of Efficacy|40|||
105419842|NCT00098748|363542612|FG001|Received Study Treatment|Lack of Efficacy|27|||
105419843|NCT00098748|363542613|FG002|Received Study Treatment|Lack of Efficacy|27|||
105419844|NCT00098748|363542611|FG000|Received Study Treatment|Other|2|||
105419845|NCT00098748|363542612|FG001|Received Study Treatment|Other|2|||
105419846|NCT00098748|363542613|FG002|Received Study Treatment|Other|6|||
105419847|NCT00098748|363542611|FG000|Received Study Treatment|Subject defaulted|3|||
105419848|NCT00098748|363542612|FG001|Received Study Treatment|Subject defaulted|4|||
105419849|NCT00098748|363542613|FG002|Received Study Treatment|Subject defaulted|4|||
105419850|NCT00098748|363542611|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
105419851|NCT00098748|363542612|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
105419852|NCT00098748|363542613|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
105419853|NCT00098748|363542611|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
105419854|NCT00098748|363542612|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
105419855|NCT00098748|363542613|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
105419856|NCT00098748|363542611|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
105419857|NCT00098748|363542612|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
105419858|NCT00098748|363542613|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
105419859|NCT00098748|363542611|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
105419860|NCT00098748|363542612|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
105419861|NCT00098748|363542613|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
105419862|NCT00098748|363542611|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
105419863|NCT00098748|363542612|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
105419864|NCT00098748|363542613|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
105419865|NCT01560637|363542616|FG000|Overall Study|Adverse Event|63|||
105419866|NCT01560637|363542616|FG000|Overall Study|Death|69|||
105419867|NCT01560637|363542616|FG000|Overall Study|Lost to Follow-up|8|||
105419868|NCT01560637|363542616|FG000|Overall Study|Protocol Violation|8|||
105419869|NCT01560637|363542616|FG000|Overall Study|Withdrawal by Subject|24|||
105419870|NCT01560637|363542616|FG000|Overall Study|Progressive Disease|20|||
105419871|NCT01560637|363542616|FG000|Overall Study|Other Reason Not Specified|6|||
105419872|NCT01170065|363542619|FG000|Overall Study|Adverse Event|17|||
105419873|NCT01170065|363542620|FG001|Overall Study|Adverse Event|50|||
105419874|NCT01170065|363542621|FG002|Overall Study|Adverse Event|10|||
105419875|NCT01170065|363542619|FG000|Overall Study|Lost to Follow-up|1|||
105419876|NCT01170065|363542620|FG001|Overall Study|Lost to Follow-up|4|||
105419877|NCT01170065|363542621|FG002|Overall Study|Lost to Follow-up|1|||
105419878|NCT01170065|363542619|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
105419879|NCT01170065|363542620|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
105419880|NCT01170065|363542621|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
105419881|NCT01170065|363542619|FG000|Overall Study|Reason other than specified|3|||
105419882|NCT01170065|363542620|FG001|Overall Study|Reason other than specified|8|||
105419883|NCT01170065|363542621|FG002|Overall Study|Reason other than specified|3|||
105419884|NCT01170065|363542619|FG000|Overall Study|Ongoing after planned observation time|5|||
105419885|NCT01170065|363542620|FG001|Overall Study|Ongoing after planned observation time|26|||
105419886|NCT01170065|363542621|FG002|Overall Study|Ongoing after planned observation time|10|||
105419887|NCT00511433|363544728|FG000|Overall Study|Adverse Event|5|||
105419888|NCT00511433|363544729|FG001|Overall Study|Adverse Event|0|||
105419889|NCT00511433|363544728|FG000|Overall Study|Other Reason|1|||
105419890|NCT00511433|363544729|FG001|Overall Study|Other Reason|1|||
105419891|NCT00496483|363544730|FG000|Overall Study|Not dosed|9|||
105419892|NCT00496483|363544730|FG000|Overall Study|Adverse Event|2|||
105419893|NCT00496483|363544730|FG000|Overall Study|Lack of Efficacy|1|||
105419894|NCT02908685|363544731|FG000|Part 1 OLE|Withdrawal by Subject|0|||
105419895|NCT02908685|363544732|FG001|Part 1 OLE|Withdrawal by Subject|0|||
105419896|NCT02908685|363544733|FG002|Part 1 OLE|Withdrawal by Subject|0|||
105419897|NCT02908685|363544734|FG003|Part 1 OLE|Withdrawal by Subject|0|||
105419898|NCT02908685|363544735|FG004|Part 1 OLE|Withdrawal by Subject|0|||
105419899|NCT02908685|363544736|FG005|Part 1 OLE|Withdrawal by Subject|0|||
105419900|NCT02908685|363544737|FG006|Part 1 OLE|Withdrawal by Subject|0|||
105419901|NCT02908685|363544738|FG007|Part 1 OLE|Withdrawal by Subject|0|||
105500256|NCT01146912|363843273|FG006|Overall Study|Duplicate patient|0|||
105500257|NCT01146912|363843274|FG007|Overall Study|Duplicate patient|0|||
105500258|NCT02609828|363843275|FG000|Overall Study|Adverse Event|8|||
105500259|NCT02609828|363843276|FG001|Overall Study|Adverse Event|1|||
105500260|NCT02609828|363843277|FG002|Overall Study|Adverse Event|0|||
105500261|NCT02609828|363843278|FG003|Overall Study|Adverse Event|6|||
105500262|NCT02609828|363843275|FG000|Overall Study|Death|15|||
105500263|NCT02609828|363843276|FG001|Overall Study|Death|1|||
105500264|NCT02609828|363843277|FG002|Overall Study|Death|1|||
105500265|NCT02609828|363843278|FG003|Overall Study|Death|19|||
105500266|NCT02609828|363843275|FG000|Overall Study|Insufficient clinical response|2|||
105500267|NCT02609828|363843276|FG001|Overall Study|Insufficient clinical response|1|||
105500268|NCT02609828|363843277|FG002|Overall Study|Insufficient clinical response|0|||
105500269|NCT02609828|363843278|FG003|Overall Study|Insufficient clinical response|0|||
105500270|NCT02609828|363843275|FG000|Overall Study|Lost to Follow-up|0|||
105500271|NCT02609828|363843276|FG001|Overall Study|Lost to Follow-up|0|||
105500272|NCT02609828|363843277|FG002|Overall Study|Lost to Follow-up|0|||
105500273|NCT02609828|363843278|FG003|Overall Study|Lost to Follow-up|1|||
105500274|NCT02609828|363843275|FG000|Overall Study|Protocol Violation|2|||
105500275|NCT02609828|363843276|FG001|Overall Study|Protocol Violation|0|||
105500276|NCT02609828|363843277|FG002|Overall Study|Protocol Violation|0|||
105500277|NCT02609828|363843278|FG003|Overall Study|Protocol Violation|1|||
105500278|NCT02609828|363843275|FG000|Overall Study|Withdrawal by Subject|12|||
105500279|NCT02609828|363843276|FG001|Overall Study|Withdrawal by Subject|1|||
105500280|NCT02609828|363843277|FG002|Overall Study|Withdrawal by Subject|0|||
105500281|NCT02609828|363843278|FG003|Overall Study|Withdrawal by Subject|10|||
105500282|NCT02609828|363843275|FG000|Overall Study|Other|3|||
105500283|NCT02609828|363843276|FG001|Overall Study|Other|0|||
105500284|NCT02609828|363843277|FG002|Overall Study|Other|0|||
105500285|NCT02609828|363843278|FG003|Overall Study|Other|6|||
105500286|NCT02609828|363843275|FG000|Overall Study|Randomized but not treated|1|||
105500287|NCT02609828|363843276|FG001|Overall Study|Randomized but not treated|0|||
105500288|NCT02609828|363843277|FG002|Overall Study|Randomized but not treated|0|||
105500289|NCT02609828|363843278|FG003|Overall Study|Randomized but not treated|0|||
105500290|NCT02980783|363843279|FG000|Overall Study|Lost to Follow-up|1|||
105500291|NCT02202980|363843280|FG000|Overall Study|Lack of Efficacy|1|||
105500292|NCT02202980|363843281|FG001|Overall Study|Lack of Efficacy|0|||
105500293|NCT02202980|363843282|FG002|Overall Study|Lack of Efficacy|7|||
105500294|NCT02202980|363843283|FG003|Overall Study|Lack of Efficacy|0|||
105500295|NCT02202980|363843284|FG004|Overall Study|Lack of Efficacy|3|||
105500296|NCT02202980|363843285|FG005|Overall Study|Lack of Efficacy|1|||
105500297|NCT02202980|363843286|FG006|Overall Study|Lack of Efficacy|11|||
105500298|NCT02202980|363843287|FG007|Overall Study|Lack of Efficacy|2|||
105500299|NCT02202980|363843288|FG008|Overall Study|Lack of Efficacy|2|||
105500300|NCT02202980|363843289|FG009|Overall Study|Lack of Efficacy|0|||
105500301|NCT02202980|363843290|FG010|Overall Study|Lack of Efficacy|0|||
105500302|NCT02202980|363843291|FG011|Overall Study|Lack of Efficacy|3|||
105500303|NCT02202980|363843292|FG012|Overall Study|Lack of Efficacy|10|||
105500304|NCT02202980|363843293|FG013|Overall Study|Lack of Efficacy|0|||
105500305|NCT02202980|363843280|FG000|Overall Study|Protocol Violation|0|||
105500306|NCT02202980|363843281|FG001|Overall Study|Protocol Violation|0|||
105500307|NCT02202980|363843282|FG002|Overall Study|Protocol Violation|0|||
105500308|NCT02202980|363843283|FG003|Overall Study|Protocol Violation|3|||
105500309|NCT02202980|363843284|FG004|Overall Study|Protocol Violation|3|||
105500310|NCT02202980|363843285|FG005|Overall Study|Protocol Violation|0|||
105500311|NCT02202980|363843286|FG006|Overall Study|Protocol Violation|0|||
105500312|NCT02202980|363843287|FG007|Overall Study|Protocol Violation|0|||
105500313|NCT02202980|363843288|FG008|Overall Study|Protocol Violation|0|||
105500314|NCT02202980|363843289|FG009|Overall Study|Protocol Violation|0|||
105500315|NCT02202980|363843290|FG010|Overall Study|Protocol Violation|0|||
105500316|NCT02202980|363843291|FG011|Overall Study|Protocol Violation|0|||
105500317|NCT02202980|363843292|FG012|Overall Study|Protocol Violation|0|||
105500318|NCT02202980|363843293|FG013|Overall Study|Protocol Violation|0|||
105500319|NCT02202980|363843280|FG000|Overall Study|Lost to Follow-up|0|||
105500320|NCT02202980|363843281|FG001|Overall Study|Lost to Follow-up|1|||
105500321|NCT02202980|363843282|FG002|Overall Study|Lost to Follow-up|1|||
105500322|NCT02202980|363843283|FG003|Overall Study|Lost to Follow-up|1|||
105500323|NCT02202980|363843284|FG004|Overall Study|Lost to Follow-up|0|||
105500324|NCT02202980|363843285|FG005|Overall Study|Lost to Follow-up|0|||
105500325|NCT02202980|363843286|FG006|Overall Study|Lost to Follow-up|0|||
105500326|NCT02202980|363843287|FG007|Overall Study|Lost to Follow-up|1|||
105500327|NCT02202980|363843288|FG008|Overall Study|Lost to Follow-up|1|||
105500328|NCT02202980|363843289|FG009|Overall Study|Lost to Follow-up|0|||
105500329|NCT02202980|363843290|FG010|Overall Study|Lost to Follow-up|0|||
105500330|NCT02202980|363843291|FG011|Overall Study|Lost to Follow-up|0|||
105500331|NCT02202980|363843292|FG012|Overall Study|Lost to Follow-up|1|||
105500332|NCT02202980|363843293|FG013|Overall Study|Lost to Follow-up|0|||
105500333|NCT02202980|363843280|FG000|Overall Study|Withdrew Consent|0|||
105419902|NCT02908685|363544739|FG008|Part 1 OLE|Withdrawal by Subject|0|||
105419903|NCT02908685|363544740|FG009|Part 1 OLE|Withdrawal by Subject|0|||
105419904|NCT02908685|363544741|FG010|Part 1 OLE|Withdrawal by Subject|2|||
105419905|NCT02908685|363544742|FG011|Part 1 OLE|Withdrawal by Subject|1|||
105419906|NCT02908685|363544743|FG012|Part 1 OLE|Withdrawal by Subject|0|||
105419907|NCT02908685|363544744|FG013|Part 1 OLE|Withdrawal by Subject|0|||
105419908|NCT02908685|363544731|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105419909|NCT02908685|363544732|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105419910|NCT02908685|363544733|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105419911|NCT02908685|363544734|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105419912|NCT02908685|363544735|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105419913|NCT02908685|363544736|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105419914|NCT02908685|363544737|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105419915|NCT02908685|363544738|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105419916|NCT02908685|363544739|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105419917|NCT02908685|363544740|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105419918|NCT02908685|363544741|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105419919|NCT02908685|363544742|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105419920|NCT02908685|363544743|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
105419921|NCT02908685|363544744|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
105419922|NCT02908685|363544731|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105419923|NCT02908685|363544732|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105419924|NCT02908685|363544733|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105419925|NCT02908685|363544734|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105419926|NCT02908685|363544735|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105419927|NCT02908685|363544736|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105419928|NCT02908685|363544737|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105419929|NCT02908685|363544738|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105419930|NCT02908685|363544739|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105419931|NCT02908685|363544740|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105419932|NCT02908685|363544741|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105419933|NCT02908685|363544742|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105419934|NCT02908685|363544743|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
105419935|NCT02908685|363544744|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105419936|NCT02908685|363544731|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105419937|NCT02908685|363544732|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105419938|NCT02908685|363544733|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105419939|NCT02908685|363544734|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105419940|NCT02908685|363544735|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105419941|NCT02908685|363544736|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105419942|NCT02908685|363544737|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105419943|NCT02908685|363544738|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105419944|NCT02908685|363544739|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105419945|NCT02908685|363544740|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105419946|NCT02908685|363544741|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105419947|NCT02908685|363544742|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105419948|NCT02908685|363544743|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
105419949|NCT02908685|363544744|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105419950|NCT02908685|363544731|FG000|Part 2 OLE: > Month 24|Death|0|||
105419951|NCT02908685|363544732|FG001|Part 2 OLE: > Month 24|Death|0|||
105419952|NCT02908685|363544733|FG002|Part 2 OLE: > Month 24|Death|0|||
105419953|NCT02908685|363544734|FG003|Part 2 OLE: > Month 24|Death|0|||
105419954|NCT02908685|363544735|FG004|Part 2 OLE: > Month 24|Death|0|||
105419955|NCT02908685|363544736|FG005|Part 2 OLE: > Month 24|Death|0|||
105419956|NCT02908685|363544737|FG006|Part 2 OLE: > Month 24|Death|0|||
105419957|NCT02908685|363544738|FG007|Part 2 OLE: > Month 24|Death|0|||
105419958|NCT02908685|363544739|FG008|Part 2 OLE: > Month 24|Death|0|||
105419959|NCT02908685|363544740|FG009|Part 2 OLE: > Month 24|Death|0|||
105419960|NCT02908685|363544741|FG010|Part 2 OLE: > Month 24|Death|0|||
105419961|NCT02908685|363544742|FG011|Part 2 OLE: > Month 24|Death|0|||
105419962|NCT02908685|363544743|FG012|Part 2 OLE: > Month 24|Death|1|||
105419963|NCT02908685|363544744|FG013|Part 2 OLE: > Month 24|Death|0|||
105419964|NCT02908685|363544731|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
105419965|NCT02908685|363544732|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
105419966|NCT02908685|363544733|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
105419967|NCT02908685|363544734|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
105419968|NCT02908685|363544735|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
105419969|NCT02908685|363544736|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
105419970|NCT02908685|363544737|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
105584306|NCT02179918|364138061|FG004|Overall Study|Subject refused further follow-up|1|||
105419971|NCT02908685|363544738|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
105419972|NCT02908685|363544739|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
105419973|NCT02908685|363544740|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
105419974|NCT02908685|363544741|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
105419975|NCT02908685|363544742|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
105419976|NCT02908685|363544743|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
105419977|NCT02908685|363544744|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
105419978|NCT02908685|363544731|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105419979|NCT02908685|363544732|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105419980|NCT02908685|363544733|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105419981|NCT02908685|363544734|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105419982|NCT02908685|363544735|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105419983|NCT02908685|363544736|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105500334|NCT02202980|363843281|FG001|Overall Study|Withdrew Consent|1|||
105500335|NCT02202980|363843282|FG002|Overall Study|Withdrew Consent|2|||
105500336|NCT02202980|363843283|FG003|Overall Study|Withdrew Consent|0|||
105500337|NCT02202980|363843284|FG004|Overall Study|Withdrew Consent|0|||
105500338|NCT02202980|363843285|FG005|Overall Study|Withdrew Consent|0|||
105500339|NCT02202980|363843286|FG006|Overall Study|Withdrew Consent|0|||
105500340|NCT02202980|363843287|FG007|Overall Study|Withdrew Consent|0|||
105500341|NCT02202980|363843288|FG008|Overall Study|Withdrew Consent|1|||
105500342|NCT02202980|363843289|FG009|Overall Study|Withdrew Consent|0|||
105500343|NCT02202980|363843290|FG010|Overall Study|Withdrew Consent|0|||
105500344|NCT02202980|363843291|FG011|Overall Study|Withdrew Consent|0|||
105500345|NCT02202980|363843292|FG012|Overall Study|Withdrew Consent|0|||
105500346|NCT02202980|363843293|FG013|Overall Study|Withdrew Consent|0|||
105500347|NCT01952145|363843294|FG000|Overall Study|Protocol Violation|2|||
105500348|NCT01952145|363843295|FG001|Overall Study|Protocol Violation|1|||
105500349|NCT01952145|363843294|FG000|Overall Study|Death|0|||
105500350|NCT01952145|363843295|FG001|Overall Study|Death|1|||
105500351|NCT01952145|363843294|FG000|Overall Study|Adverse Event|9|||
105500352|NCT01952145|363843295|FG001|Overall Study|Adverse Event|0|||
105500353|NCT01952145|363843294|FG000|Overall Study|Withdrawal Criteria|16|||
105419984|NCT02908685|363544737|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105419985|NCT02908685|363544738|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105419986|NCT02908685|363544739|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105419987|NCT02908685|363544740|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105419988|NCT02908685|363544741|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105419989|NCT02908685|363544742|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105419990|NCT02908685|363544743|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
105419991|NCT02908685|363544744|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
105419992|NCT01740089|363544745|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
105419993|NCT01740089|363544746|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
105419994|NCT01740089|363544747|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
105419995|NCT01740089|363544745|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
105419996|NCT01740089|363544746|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
105419997|NCT01740089|363544747|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
105419998|NCT01740089|363544745|FG000|After 12 Weeks|Lack of Efficacy|3|||
105419999|NCT01740089|363544746|FG001|After 12 Weeks|Lack of Efficacy|1|||
105420000|NCT01740089|363544747|FG002|After 12 Weeks|Lack of Efficacy|4|||
105420001|NCT01740089|363544745|FG000|After 12 Weeks|Adverse Event|2|||
105420002|NCT01740089|363544746|FG001|After 12 Weeks|Adverse Event|0|||
105420003|NCT01740089|363544747|FG002|After 12 Weeks|Adverse Event|5|||
105420004|NCT01740089|363544745|FG000|After 12 Weeks|Protocol Violation|1|||
105420005|NCT01740089|363544746|FG001|After 12 Weeks|Protocol Violation|1|||
105420006|NCT01740089|363544747|FG002|After 12 Weeks|Protocol Violation|1|||
105420007|NCT01740089|363544745|FG000|After 12 Weeks|Withdrawal by Subject|1|||
105420008|NCT01740089|363544746|FG001|After 12 Weeks|Withdrawal by Subject|1|||
105420009|NCT01740089|363544747|FG002|After 12 Weeks|Withdrawal by Subject|1|||
105420010|NCT00197145|363544748|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
105420011|NCT00197145|363544749|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
105420012|NCT00197145|363544748|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
105420013|NCT00197145|363544749|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
105420014|NCT00197145|363544748|FG000|Period 1: Randomized Treatment Phase|Other|2|||
105420015|NCT00197145|363544749|FG001|Period 1: Randomized Treatment Phase|Other|2|||
105420016|NCT00197145|363544748|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
105420017|NCT00197145|363544749|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
105420018|NCT00197145|363544748|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
105420019|NCT00197145|363544749|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
105420020|NCT00197145|363544748|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
105420021|NCT00197145|363544749|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
105500354|NCT01952145|363843295|FG001|Overall Study|Withdrawal Criteria|11|||
105500355|NCT01952145|363843294|FG000|Overall Study|Unclassified|1|||
105500356|NCT01952145|363843295|FG001|Overall Study|Unclassified|1|||
105420022|NCT00197145|363544748|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
105420023|NCT00197145|363544749|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
105420024|NCT00197145|363544748|FG000|Period 2 : Open Label Phase|Other|1|||
105420025|NCT00197145|363544749|FG001|Period 2 : Open Label Phase|Other|0|||
105420026|NCT01448824|363544750|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
105420027|NCT01448824|363544751|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
105420028|NCT01448824|363544752|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
105420029|NCT01448824|363544753|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
105420030|NCT01448824|363544754|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
105420031|NCT01448824|363544755|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
105420032|NCT01448824|363544756|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
105420033|NCT01448824|363544757|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
105420034|NCT01448824|363544750|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
105420035|NCT01448824|363544751|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
105420036|NCT01448824|363544752|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
105420037|NCT01448824|363544753|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
105420038|NCT01448824|363544754|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
105420039|NCT01448824|363544755|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
105420040|NCT01448824|363544756|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
105420041|NCT01448824|363544757|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
105420042|NCT01448824|363544750|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
105420043|NCT01448824|363544751|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
105420044|NCT01448824|363544752|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
105420045|NCT01448824|363544753|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
105420046|NCT01448824|363544754|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
105420047|NCT01448824|363544755|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
105420048|NCT01448824|363544756|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
105420049|NCT01448824|363544757|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
105420050|NCT01448824|363544750|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
105420051|NCT01448824|363544751|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
105420052|NCT01448824|363544752|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
105420053|NCT01448824|363544753|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
105420054|NCT01448824|363544754|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
105420055|NCT01448824|363544755|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
105420056|NCT01448824|363544756|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
105420057|NCT01448824|363544757|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
105420058|NCT01448824|363544750|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
105420059|NCT01448824|363544751|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
105420060|NCT01448824|363544752|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
105420061|NCT01448824|363544753|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
105420062|NCT01448824|363544754|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
105420063|NCT01448824|363544755|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
105420064|NCT01448824|363544756|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
105420065|NCT01448824|363544757|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
105420066|NCT01448824|363544750|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
105420067|NCT01448824|363544751|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
105420068|NCT01448824|363544752|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
105420069|NCT01448824|363544753|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
105420070|NCT01448824|363544754|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
105420071|NCT01448824|363544755|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
105420072|NCT01448824|363544756|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
105420073|NCT01448824|363544757|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
105420074|NCT01448824|363544750|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
105420075|NCT01448824|363544751|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
105420076|NCT01448824|363544752|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
105420077|NCT01448824|363544753|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
105420078|NCT01448824|363544754|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
105420079|NCT01448824|363544755|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
105420080|NCT01448824|363544756|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
105420081|NCT01448824|363544757|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
105420082|NCT01448824|363544750|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
105420083|NCT01448824|363544751|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
105420084|NCT01448824|363544752|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
105420085|NCT01448824|363544753|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
105420086|NCT01448824|363544754|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
105500357|NCT02747875|363843296|FG000|Overall Study|Physician Decision|1|||
105420087|NCT01448824|363544755|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
105420088|NCT01448824|363544756|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
105420089|NCT01448824|363544757|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
105420090|NCT02370537|363544760|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
105420091|NCT02370537|363544761|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
105420092|NCT02370537|363544762|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
105420093|NCT02370537|363544760|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
105420094|NCT02370537|363544761|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
105420095|NCT02370537|363544762|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
105420096|NCT02370537|363544760|FG000|Part B|Not randomised to receive treatment|1|||
105420097|NCT02370537|363544761|FG001|Part B|Not randomised to receive treatment|2|||
105420098|NCT02370537|363544762|FG002|Part B|Not randomised to receive treatment|259|||
105420099|NCT02370537|363544760|FG000|Part B|Withdrawal by Subject|0|||
105420100|NCT02370537|363544761|FG001|Part B|Withdrawal by Subject|1|||
105420101|NCT02370537|363544762|FG002|Part B|Withdrawal by Subject|0|||
105420102|NCT01952665|363544763|FG000|Overall Study|Physician Decision|3|||
105420103|NCT01952665|363544764|FG001|Overall Study|Physician Decision|2|||
105420104|NCT01952665|363544763|FG000|Overall Study|Lost to Follow-up|1|||
105420105|NCT01952665|363544764|FG001|Overall Study|Lost to Follow-up|2|||
105420106|NCT01952665|363544763|FG000|Overall Study|Adverse Event|2|||
105420107|NCT01952665|363544764|FG001|Overall Study|Adverse Event|1|||
105420108|NCT01952665|363544763|FG000|Overall Study|Protocol Violation|0|||
105420109|NCT01952665|363544764|FG001|Overall Study|Protocol Violation|1|||
105420110|NCT01537081|363544765|FG000|Overall Study|Adverse Event|5|||
105420111|NCT01537081|363544766|FG001|Overall Study|Adverse Event|2|||
105420112|NCT01537081|363544767|FG002|Overall Study|Adverse Event|2|||
105420113|NCT01537081|363544765|FG000|Overall Study|Lack of Efficacy|2|||
105420114|NCT01537081|363544766|FG001|Overall Study|Lack of Efficacy|1|||
105420115|NCT01537081|363544767|FG002|Overall Study|Lack of Efficacy|0|||
105420116|NCT01537081|363544765|FG000|Overall Study|Lost to Follow-up|17|||
105420117|NCT01537081|363544766|FG001|Overall Study|Lost to Follow-up|15|||
105420118|NCT01537081|363544767|FG002|Overall Study|Lost to Follow-up|9|||
105420119|NCT01537081|363544765|FG000|Overall Study|Protocol Violation|3|||
105420120|NCT01537081|363544766|FG001|Overall Study|Protocol Violation|2|||
105420121|NCT01537081|363544767|FG002|Overall Study|Protocol Violation|2|||
105420122|NCT01537081|363544765|FG000|Overall Study|Withdrawal by Subject|6|||
105420123|NCT01537081|363544766|FG001|Overall Study|Withdrawal by Subject|11|||
105420124|NCT01537081|363544767|FG002|Overall Study|Withdrawal by Subject|3|||
105420125|NCT01537081|363544765|FG000|Overall Study|Physician Decision|5|||
105420126|NCT01537081|363544766|FG001|Overall Study|Physician Decision|6|||
105420127|NCT01537081|363544767|FG002|Overall Study|Physician Decision|0|||
105420128|NCT01537081|363544765|FG000|Overall Study|Sponsor decision|0|||
105420129|NCT01537081|363544766|FG001|Overall Study|Sponsor decision|1|||
105420130|NCT01537081|363544767|FG002|Overall Study|Sponsor decision|0|||
105420131|NCT01537081|363544765|FG000|Overall Study|Assigned but never dosed|1|||
105420132|NCT01537081|363544766|FG001|Overall Study|Assigned but never dosed|0|||
105420133|NCT01537081|363544767|FG002|Overall Study|Assigned but never dosed|0|||
105420134|NCT01463111|363544768|FG000|Overall Study|Withdrawal by Subject|2|||
105420135|NCT01463111|363544768|FG000|Overall Study|Lost to Follow-up|5|||
105420136|NCT01463111|363544768|FG000|Overall Study|Physician Decision|2|||
105420137|NCT01159171|363544770|FG000|Overall Study|Adverse Event|11|||
105420138|NCT01159171|363544770|FG000|Overall Study|Progression of Disease|28|||
105420139|NCT01159171|363544770|FG000|Overall Study|Protocol Violation|1|||
105420140|NCT01159171|363544770|FG000|Overall Study|Need for Surgery|5|||
105420141|NCT01159171|363544770|FG000|Overall Study|Medical Decision|4|||
105420142|NCT01159171|363544770|FG000|Overall Study|Death|1|||
105420143|NCT02526524|363544774|FG000|Overall Study|Withdrawal by Subject|3|||
105420144|NCT02526524|363544775|FG001|Overall Study|Withdrawal by Subject|3|||
105420145|NCT02526524|363544776|FG002|Overall Study|Withdrawal by Subject|6|||
105420146|NCT02526524|363544777|FG003|Overall Study|Withdrawal by Subject|1|||
105420147|NCT02526524|363544778|FG004|Overall Study|Withdrawal by Subject|9|||
105420148|NCT02526524|363544779|FG005|Overall Study|Withdrawal by Subject|5|||
105420149|NCT02526524|363544774|FG000|Overall Study|Adverse Event|3|||
105420150|NCT02526524|363544775|FG001|Overall Study|Adverse Event|2|||
105420151|NCT02526524|363544776|FG002|Overall Study|Adverse Event|4|||
105420152|NCT02526524|363544777|FG003|Overall Study|Adverse Event|2|||
105420153|NCT02526524|363544778|FG004|Overall Study|Adverse Event|6|||
105420154|NCT02526524|363544779|FG005|Overall Study|Adverse Event|8|||
105420155|NCT02526524|363544774|FG000|Overall Study|Lost to Follow-up|2|||
105420156|NCT02526524|363544775|FG001|Overall Study|Lost to Follow-up|3|||
105420157|NCT02526524|363544776|FG002|Overall Study|Lost to Follow-up|8|||
105420158|NCT02526524|363544777|FG003|Overall Study|Lost to Follow-up|1|||
105420159|NCT02526524|363544778|FG004|Overall Study|Lost to Follow-up|2|||
105420160|NCT02526524|363544779|FG005|Overall Study|Lost to Follow-up|5|||
105420161|NCT02526524|363544774|FG000|Overall Study|Protocol Violation|3|||
105420162|NCT02526524|363544775|FG001|Overall Study|Protocol Violation|1|||
105420163|NCT02526524|363544776|FG002|Overall Study|Protocol Violation|5|||
105420164|NCT02526524|363544777|FG003|Overall Study|Protocol Violation|3|||
105500358|NCT02747875|363843297|FG001|Overall Study|Physician Decision|0|||
105500359|NCT02747875|363843296|FG000|Overall Study|Adverse Event|0|||
105500360|NCT02747875|363843297|FG001|Overall Study|Adverse Event|1|||
105500361|NCT02191137|363843298|FG000|Treatment|Death|4|||
105500362|NCT02191137|363843298|FG000|Treatment|Withdrawal by Subject|3|||
105500363|NCT02191137|363843298|FG000|Treatment|Adverse Event|2|||
105500364|NCT02191137|363843298|FG000|Treatment|Other|1|||
105500365|NCT02191137|363843298|FG000|Follow-up|Lost to Follow-up|2|||
105500366|NCT02191137|363843298|FG000|Follow-up|Ongoing/unknown|2|||
105500367|NCT02191137|363843298|FG000|Follow-up|Adverse Event|1|||
105500368|NCT00178633|363843299|FG000|Overall Study|Lost to Follow-up|6|||
105500369|NCT02590003|363843300|FG000|Overall Study|Death|1|||
105500370|NCT02590003|363843301|FG001|Overall Study|Death|2|||
105500371|NCT00696800|363843302|FG000|Overall Study|Adverse Event|16|||
105500372|NCT00696800|363843303|FG001|Overall Study|Adverse Event|3|||
105500373|NCT00696800|363843302|FG000|Overall Study|Insufficient compliance with medication|2|||
105500374|NCT00696800|363843303|FG001|Overall Study|Insufficient compliance with medication|1|||
105500375|NCT00696800|363843302|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
105500376|NCT00696800|363843303|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
105500377|NCT00696800|363843302|FG000|Overall Study|Insufficient ovarian response|4|||
105500378|NCT00696800|363843303|FG001|Overall Study|Insufficient ovarian response|1|||
105500379|NCT00696800|363843302|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
105500380|NCT00696800|363843303|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
105500381|NCT00696800|363843302|FG000|Overall Study|Too high ovarian response|6|||
105500382|NCT00696800|363843303|FG001|Overall Study|Too high ovarian response|1|||
105500383|NCT00696800|363843302|FG000|Overall Study|No/too few/bad quality oocytes|4|||
105500384|NCT00696800|363843303|FG001|Overall Study|No/too few/bad quality oocytes|3|||
105500385|NCT00696800|363843302|FG000|Overall Study|No/abnormal fertilization|11|||
105500386|NCT00696800|363843303|FG001|Overall Study|No/abnormal fertilization|13|||
105500387|NCT00696800|363843302|FG000|Overall Study|No/too few/bad quality embryos|24|||
105500388|NCT00696800|363843303|FG001|Overall Study|No/too few/bad quality embryos|18|||
105500389|NCT00696800|363843302|FG000|Overall Study|Other Reasons|5|||
105500390|NCT00696800|363843303|FG001|Overall Study|Other Reasons|3|||
105500391|NCT00696800|363843302|FG000|Overall Study|Not treated|1|||
105500392|NCT00696800|363843303|FG001|Overall Study|Not treated|2|||
105500393|NCT00762385|363843306|FG000|First Intervention|Lens Issue|1|||
105500394|NCT00762385|363843307|FG001|First Intervention|Lens Issue|1|||
105500395|NCT00762385|363843306|FG000|First Intervention|Lost to Follow-up|0|||
105500396|NCT00762385|363843307|FG001|First Intervention|Lost to Follow-up|2|||
105500397|NCT00762385|363843306|FG000|First Intervention|Ineligible|1|||
105500398|NCT00762385|363843307|FG001|First Intervention|Ineligible|0|||
105500399|NCT00762385|363843306|FG000|First Intervention|Protocol Violation|0|||
105500400|NCT00762385|363843307|FG001|First Intervention|Protocol Violation|1|||
105500401|NCT00762385|363843306|FG000|Second Intervention|Protocol Violation|3|||
105500402|NCT00762385|363843307|FG001|Second Intervention|Protocol Violation|3|||
105500403|NCT01065597|363843317|FG000|Overall Study|Adverse Event|1|||
105500404|NCT01781975|363843318|FG000|Overall Study|Death|1|||
105500405|NCT01781975|363843319|FG001|Overall Study|Death|0|||
105500406|NCT01781975|363843318|FG000|Overall Study|Withdrawal by Subject|1|||
105500407|NCT01781975|363843319|FG001|Overall Study|Withdrawal by Subject|1|||
105500408|NCT01622231|363843321|FG000|Overall Study|Physician Decision|1|||
105500409|NCT01622231|363843321|FG000|Overall Study|Withdrawal by Subject|1|||
105584307|NCT01627340|364138065|FG000|Overall Study|Adverse Event|1|||
105500410|NCT02404220|363843322|FG000|Overall Study|Adverse Event|0|||
105500411|NCT02404220|363843323|FG001|Overall Study|Adverse Event|0|||
105500412|NCT02404220|363843324|FG002|Overall Study|Adverse Event|1|||
105500413|NCT02404220|363843325|FG003|Overall Study|Adverse Event|0|||
105500414|NCT02404220|363843322|FG000|Overall Study|Death|5|||
105500415|NCT02404220|363843323|FG001|Overall Study|Death|5|||
105500416|NCT02404220|363843324|FG002|Overall Study|Death|3|||
105500417|NCT02404220|363843325|FG003|Overall Study|Death|8|||
105500418|NCT02404220|363843322|FG000|Overall Study|Progressive Disease|0|||
105500419|NCT02404220|363843323|FG001|Overall Study|Progressive Disease|0|||
105500420|NCT02404220|363843324|FG002|Overall Study|Progressive Disease|1|||
105500421|NCT02404220|363843325|FG003|Overall Study|Progressive Disease|1|||
105500422|NCT02404220|363843322|FG000|Overall Study|Study Terminated by Sponsor|0|||
105500423|NCT02404220|363843323|FG001|Overall Study|Study Terminated by Sponsor|0|||
105500424|NCT02404220|363843324|FG002|Overall Study|Study Terminated by Sponsor|2|||
105500425|NCT02404220|363843325|FG003|Overall Study|Study Terminated by Sponsor|1|||
105500426|NCT02404220|363843322|FG000|Overall Study|Withdrawal by Subject|0|||
105500427|NCT02404220|363843323|FG001|Overall Study|Withdrawal by Subject|1|||
105500428|NCT02404220|363843324|FG002|Overall Study|Withdrawal by Subject|0|||
105500429|NCT02404220|363843325|FG003|Overall Study|Withdrawal by Subject|0|||
105584308|NCT01627340|364138066|FG001|Overall Study|Adverse Event|0|||
105500430|NCT02404220|363843322|FG000|Overall Study|Enrolled but Never Treated|0|||
105500431|NCT02404220|363843323|FG001|Overall Study|Enrolled but Never Treated|2|||
105500432|NCT02404220|363843324|FG002|Overall Study|Enrolled but Never Treated|0|||
105500433|NCT02404220|363843325|FG003|Overall Study|Enrolled but Never Treated|0|||
105420165|NCT02526524|363544778|FG004|Overall Study|Protocol Violation|4|||
105420166|NCT02526524|363544779|FG005|Overall Study|Protocol Violation|3|||
105420167|NCT02526524|363544774|FG000|Overall Study|Loss of Glucose Control|0|||
105420168|NCT02526524|363544775|FG001|Overall Study|Loss of Glucose Control|0|||
105420169|NCT02526524|363544776|FG002|Overall Study|Loss of Glucose Control|3|||
105420170|NCT02526524|363544777|FG003|Overall Study|Loss of Glucose Control|0|||
105420171|NCT02526524|363544778|FG004|Overall Study|Loss of Glucose Control|2|||
105420172|NCT02526524|363544779|FG005|Overall Study|Loss of Glucose Control|0|||
105420173|NCT02526524|363544774|FG000|Overall Study|Physician Decision|0|||
105420174|NCT02526524|363544775|FG001|Overall Study|Physician Decision|0|||
105420175|NCT02526524|363544776|FG002|Overall Study|Physician Decision|0|||
105420176|NCT02526524|363544777|FG003|Overall Study|Physician Decision|0|||
105420177|NCT02526524|363544778|FG004|Overall Study|Physician Decision|1|||
105420178|NCT02526524|363544779|FG005|Overall Study|Physician Decision|0|||
105420179|NCT02526524|363544774|FG000|Overall Study|Sponsor Decision|1|||
105420180|NCT02526524|363544775|FG001|Overall Study|Sponsor Decision|0|||
105420181|NCT02526524|363544776|FG002|Overall Study|Sponsor Decision|0|||
105420182|NCT02526524|363544777|FG003|Overall Study|Sponsor Decision|0|||
105420183|NCT02526524|363544778|FG004|Overall Study|Sponsor Decision|0|||
105420184|NCT02526524|363544779|FG005|Overall Study|Sponsor Decision|0|||
105420185|NCT02264665|363544780|FG000|Overall Study|Other|0|||
105420186|NCT02264665|363544781|FG001|Overall Study|Other|0|||
105420187|NCT02264665|363544782|FG002|Overall Study|Other|3|||
105420188|NCT02264665|363544783|FG003|Overall Study|Other|0|||
105420189|NCT02264665|363544784|FG004|Overall Study|Other|0|||
105420190|NCT02264665|363544785|FG005|Overall Study|Other|0|||
105420191|NCT02264665|363544786|FG006|Overall Study|Other|0|||
105420192|NCT02264665|363544780|FG000|Overall Study|Death|9|||
105420193|NCT02264665|363544781|FG001|Overall Study|Death|8|||
105420194|NCT02264665|363544782|FG002|Overall Study|Death|13|||
105420195|NCT02264665|363544783|FG003|Overall Study|Death|5|||
105420196|NCT02264665|363544784|FG004|Overall Study|Death|0|||
105420197|NCT02264665|363544785|FG005|Overall Study|Death|0|||
105420198|NCT02264665|363544786|FG006|Overall Study|Death|1|||
105420199|NCT02264665|363544780|FG000|Overall Study|Lost to Follow-up|1|||
105420200|NCT02264665|363544781|FG001|Overall Study|Lost to Follow-up|0|||
105420201|NCT02264665|363544782|FG002|Overall Study|Lost to Follow-up|2|||
105420202|NCT02264665|363544783|FG003|Overall Study|Lost to Follow-up|1|||
105420203|NCT02264665|363544784|FG004|Overall Study|Lost to Follow-up|0|||
105420204|NCT02264665|363544785|FG005|Overall Study|Lost to Follow-up|0|||
105420205|NCT02264665|363544786|FG006|Overall Study|Lost to Follow-up|0|||
105420206|NCT02264665|363544780|FG000|Overall Study|Participant decision|0|||
105420207|NCT02264665|363544781|FG001|Overall Study|Participant decision|0|||
105420208|NCT02264665|363544782|FG002|Overall Study|Participant decision|0|||
105420209|NCT02264665|363544783|FG003|Overall Study|Participant decision|1|||
105420210|NCT02264665|363544784|FG004|Overall Study|Participant decision|0|||
105420211|NCT02264665|363544785|FG005|Overall Study|Participant decision|0|||
105420212|NCT02264665|363544786|FG006|Overall Study|Participant decision|0|||
105420213|NCT02264665|363544780|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
105420214|NCT02264665|363544781|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
105420215|NCT02264665|363544782|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
105420216|NCT02264665|363544783|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
105420217|NCT02264665|363544784|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
105420218|NCT02264665|363544785|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
105420219|NCT02264665|363544786|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
105420220|NCT02264665|363544780|FG000|Overall Study|Data Missing|0|||
105420221|NCT02264665|363544781|FG001|Overall Study|Data Missing|0|||
105420222|NCT02264665|363544782|FG002|Overall Study|Data Missing|1|||
105420223|NCT02264665|363544783|FG003|Overall Study|Data Missing|0|||
105420224|NCT02264665|363544784|FG004|Overall Study|Data Missing|0|||
105420225|NCT02264665|363544785|FG005|Overall Study|Data Missing|0|||
105420226|NCT02264665|363544786|FG006|Overall Study|Data Missing|0|||
105420227|NCT05312632|363544789|FG000|Overall Study|Adverse Event|12|||
105420228|NCT05312632|363544789|FG000|Overall Study|Withdrawal by Subject|10|||
105420229|NCT05312632|363544789|FG000|Overall Study|Lack of Efficacy|4|||
105420230|NCT05312632|363544789|FG000|Overall Study|Non-compliance with study procedures|9|||
105420231|NCT05312632|363544789|FG000|Overall Study|Other|4|||
105420232|NCT05289271|363544791|FG000|Overall Study|Mistakenly allocated, untreated|1|||
105420233|NCT05289271|363544792|FG001|Overall Study|Mistakenly allocated, untreated|0|||
105420234|NCT03389555|363544797|FG000|Overall Study|Protocol Violation|1|||
105420235|NCT03389555|363544798|FG001|Overall Study|Protocol Violation|3|||
105420236|NCT03389555|363544797|FG000|Overall Study|Death|1|||
105420237|NCT03389555|363544798|FG001|Overall Study|Death|0|||
105420238|NCT02516098|363544801|FG000|Period 1|Protocol Violation|1|||
105420239|NCT02516098|363544802|FG001|Period 1|Protocol Violation|0|||
105420240|NCT02516098|363544801|FG000|Washout After Period 1|Adverse Event|0|||
105420241|NCT02516098|363544802|FG001|Washout After Period 1|Adverse Event|1|||
105420242|NCT02516098|363544801|FG000|Period 2|Withdrawal by Subject|0|||
105420243|NCT02516098|363544802|FG001|Period 2|Withdrawal by Subject|1|||
105420244|NCT01734395|363544803|FG000|Overall Study|Other|65|||
105420245|NCT01734395|363544803|FG000|Overall Study|Lost to Follow-up|287|||
105420246|NCT01734395|363544803|FG000|Overall Study|Lack of Efficacy|5|||
105420247|NCT01734395|363544803|FG000|Overall Study|Adverse Event|40|||
105420248|NCT01734395|363544803|FG000|Overall Study|Withdrawal by Subject|10|||
105420249|NCT01734395|363544803|FG000|Overall Study|Missing the reasons for not completed|3|||
105420250|NCT01007435|363544804|FG000|Overall Study|Adverse Event|16|||
105420251|NCT01007435|363544805|FG001|Overall Study|Adverse Event|25|||
105420252|NCT01007435|363544806|FG002|Overall Study|Adverse Event|47|||
105420253|NCT01007435|363544807|FG003|Overall Study|Adverse Event|31|||
105420254|NCT01007435|363544804|FG000|Overall Study|Death|2|||
105420255|NCT01007435|363544805|FG001|Overall Study|Death|4|||
105420256|NCT01007435|363544806|FG002|Overall Study|Death|2|||
105420257|NCT01007435|363544807|FG003|Overall Study|Death|1|||
105420258|NCT01007435|363544804|FG000|Overall Study|Insufficient Therapeutic Response|21|||
105420259|NCT01007435|363544805|FG001|Overall Study|Insufficient Therapeutic Response|7|||
105420260|NCT01007435|363544806|FG002|Overall Study|Insufficient Therapeutic Response|2|||
105420261|NCT01007435|363544807|FG003|Overall Study|Insufficient Therapeutic Response|9|||
105420262|NCT01007435|363544804|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
105420263|NCT01007435|363544805|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
105420264|NCT01007435|363544806|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
105420265|NCT01007435|363544807|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
105420266|NCT01007435|363544804|FG000|Overall Study|Other Protocol Violation|2|||
105420267|NCT01007435|363544805|FG001|Overall Study|Other Protocol Violation|0|||
105420268|NCT01007435|363544806|FG002|Overall Study|Other Protocol Violation|1|||
105420269|NCT01007435|363544807|FG003|Overall Study|Other Protocol Violation|0|||
105420270|NCT01007435|363544804|FG000|Overall Study|Refused Treatment|13|||
105420271|NCT01007435|363544805|FG001|Overall Study|Refused Treatment|13|||
105420272|NCT01007435|363544806|FG002|Overall Study|Refused Treatment|5|||
105420273|NCT01007435|363544807|FG003|Overall Study|Refused Treatment|8|||
105420274|NCT01007435|363544804|FG000|Overall Study|Failure to Return|5|||
105420275|NCT01007435|363544805|FG001|Overall Study|Failure to Return|4|||
105420276|NCT01007435|363544806|FG002|Overall Study|Failure to Return|3|||
105420277|NCT01007435|363544807|FG003|Overall Study|Failure to Return|6|||
105420278|NCT01007435|363544804|FG000|Overall Study|Reason not Specified|1|||
105420279|NCT01007435|363544805|FG001|Overall Study|Reason not Specified|1|||
105420280|NCT01007435|363544806|FG002|Overall Study|Reason not Specified|2|||
105420281|NCT01007435|363544807|FG003|Overall Study|Reason not Specified|1|||
105420282|NCT00322023|363544808|FG000|Overall Study|various|0|||
105420283|NCT00322023|363544809|FG001|Overall Study|various|2|||
105420284|NCT00322023|363544810|FG002|Overall Study|various|6|||
105420285|NCT01846663|363544813|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
105420286|NCT01846663|363544814|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
105420287|NCT01846663|363544813|FG000|Overall Study|Withdrawal by Subject|1|||
105420288|NCT01846663|363544814|FG001|Overall Study|Withdrawal by Subject|0|||
105420289|NCT01846663|363544813|FG000|Overall Study|Adverse Event|1|||
105420290|NCT01846663|363544814|FG001|Overall Study|Adverse Event|2|||
105420291|NCT03077438|363544820|FG000|Overall Study|Protocol Violation|3|||
105420292|NCT03077438|363544821|FG001|Overall Study|Protocol Violation|5|||
105420293|NCT03077438|363544820|FG000|Overall Study|Withdrawal by Subject|3|||
105420294|NCT03077438|363544821|FG001|Overall Study|Withdrawal by Subject|6|||
105420295|NCT03077438|363544820|FG000|Overall Study|Lost to Follow-up|6|||
105420296|NCT03077438|363544821|FG001|Overall Study|Lost to Follow-up|3|||
105420297|NCT00813865|363544826|FG000|Overall Study|Failure to Respond|3|||
105420298|NCT00813865|363544826|FG000|Overall Study|Lost to Follow-up|3|||
105420299|NCT00813865|363544826|FG000|Overall Study|Withdrawal by Subject|1|||
105420300|NCT01626118|363544828|FG000|Overall Study|Lack of Efficacy|1|||
105420301|NCT01626118|363544829|FG001|Overall Study|Lack of Efficacy|0|||
105420302|NCT01626118|363544830|FG002|Overall Study|Lack of Efficacy|1|||
105420303|NCT01626118|363544831|FG003|Overall Study|Lack of Efficacy|3|||
105584309|NCT01627340|364138065|FG000|Overall Study|Lost to Follow-up|8|||
105420304|NCT01626118|363544828|FG000|Overall Study|Lost to Follow-up|1|||
105420305|NCT01626118|363544829|FG001|Overall Study|Lost to Follow-up|0|||
105420306|NCT01626118|363544830|FG002|Overall Study|Lost to Follow-up|0|||
105420307|NCT01626118|363544831|FG003|Overall Study|Lost to Follow-up|0|||
105420308|NCT01626118|363544828|FG000|Overall Study|Adverse Event|0|||
105420309|NCT01626118|363544829|FG001|Overall Study|Adverse Event|1|||
105420310|NCT01626118|363544830|FG002|Overall Study|Adverse Event|1|||
105420311|NCT01626118|363544831|FG003|Overall Study|Adverse Event|0|||
105420312|NCT01626118|363544828|FG000|Overall Study|Investigator Decision|0|||
105420313|NCT01626118|363544829|FG001|Overall Study|Investigator Decision|1|||
105420314|NCT01626118|363544830|FG002|Overall Study|Investigator Decision|0|||
105420315|NCT01626118|363544831|FG003|Overall Study|Investigator Decision|0|||
105420316|NCT03575065|363544834|FG000|Overall Study|Death|31|||
105420317|NCT03575065|363544835|FG001|Overall Study|Death|12|||
105420318|NCT03575065|363544834|FG000|Overall Study|Sponsor's Decision|28|||
105420319|NCT03575065|363544835|FG001|Overall Study|Sponsor's Decision|13|||
105420320|NCT03575065|363544834|FG000|Overall Study|Withdrawal by Subject|2|||
105420321|NCT03575065|363544835|FG001|Overall Study|Withdrawal by Subject|1|||
105420322|NCT03575065|363544834|FG000|Overall Study|Lost to Follow-up|1|||
105420323|NCT03575065|363544835|FG001|Overall Study|Lost to Follow-up|0|||
105420324|NCT02323126|363544840|FG000|Overall Study|Patient / guardian decision|0|||
105420325|NCT02323126|363544841|FG001|Overall Study|Patient / guardian decision|1|||
105420326|NCT02323126|363544842|FG002|Overall Study|Patient / guardian decision|2|||
105420327|NCT02323126|363544840|FG000|Overall Study|Progressive disease|14|||
105420328|NCT02323126|363544841|FG001|Overall Study|Progressive disease|8|||
105420329|NCT02323126|363544842|FG002|Overall Study|Progressive disease|14|||
105420330|NCT02323126|363544840|FG000|Overall Study|Physician Decision|0|||
105420331|NCT02323126|363544841|FG001|Overall Study|Physician Decision|1|||
105420332|NCT02323126|363544842|FG002|Overall Study|Physician Decision|3|||
105420333|NCT02323126|363544840|FG000|Overall Study|Death|1|||
105420334|NCT02323126|363544841|FG001|Overall Study|Death|1|||
105420335|NCT02323126|363544842|FG002|Overall Study|Death|4|||
105420336|NCT02323126|363544840|FG000|Overall Study|Adverse Event|3|||
105420337|NCT02323126|363544841|FG001|Overall Study|Adverse Event|5|||
105420338|NCT02323126|363544842|FG002|Overall Study|Adverse Event|7|||
105420339|NCT03333252|363544848|FG000|Overall Study|Adverse Event|10|||
105420340|NCT03333252|363544849|FG001|Overall Study|Adverse Event|6|||
105420341|NCT03333252|363544850|FG002|Overall Study|Adverse Event|5|||
105420342|NCT03333252|363544851|FG003|Overall Study|Adverse Event|2|||
105420343|NCT03333252|363544848|FG000|Overall Study|Death|1|||
105420344|NCT03333252|363544849|FG001|Overall Study|Death|3|||
105420345|NCT03333252|363544850|FG002|Overall Study|Death|0|||
105420346|NCT03333252|363544851|FG003|Overall Study|Death|0|||
105420347|NCT03333252|363544848|FG000|Overall Study|Lack of Efficacy|8|||
105420348|NCT03333252|363544849|FG001|Overall Study|Lack of Efficacy|4|||
105420349|NCT03333252|363544850|FG002|Overall Study|Lack of Efficacy|0|||
105420350|NCT03333252|363544851|FG003|Overall Study|Lack of Efficacy|7|||
105420351|NCT03333252|363544848|FG000|Overall Study|Lost to Follow-up|0|||
105420352|NCT03333252|363544849|FG001|Overall Study|Lost to Follow-up|5|||
105420353|NCT03333252|363544850|FG002|Overall Study|Lost to Follow-up|9|||
105420354|NCT03333252|363544851|FG003|Overall Study|Lost to Follow-up|3|||
105420355|NCT03333252|363544848|FG000|Overall Study|Withdrawal by Subject|14|||
105420356|NCT03333252|363544849|FG001|Overall Study|Withdrawal by Subject|24|||
105420357|NCT03333252|363544850|FG002|Overall Study|Withdrawal by Subject|11|||
105420358|NCT03333252|363544851|FG003|Overall Study|Withdrawal by Subject|17|||
105420359|NCT01421303|363544852|FG000|Overall Study|Lost to Follow-up|13|||
105420360|NCT01421303|363544852|FG000|Overall Study|Non compliance with study procedure|1|||
105420361|NCT01421303|363544852|FG000|Overall Study|Other|7|||
105420362|NCT01421303|363544852|FG000|Overall Study|Withdrawal by Subject|1|||
105420363|NCT01779856|363544855|FG000|Overall Study|Withdrawal by Subject|15|||
105420364|NCT01779856|363544855|FG000|Overall Study|Death|3|||
105420365|NCT01779856|363544855|FG000|Overall Study|Physician Decision|1|||
105420366|NCT01779856|363544855|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
105420367|NCT01779856|363544855|FG000|Overall Study|Delays in scheduling implant|1|||
105420368|NCT01779856|363544855|FG000|Overall Study|Subject ineligible for Implant|2|||
105420369|NCT01535599|363544856|FG000|Overall Study|Adverse Event|6|||
105420370|NCT01535599|363544857|FG001|Overall Study|Adverse Event|15|||
105420371|NCT01535599|363544856|FG000|Overall Study|Lost to Follow-up|3|||
105420372|NCT01535599|363544857|FG001|Overall Study|Lost to Follow-up|4|||
105420373|NCT01535599|363544856|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
105420374|NCT01535599|363544857|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
105420375|NCT01535599|363544856|FG000|Overall Study|Treatment Failure|33|||
105420376|NCT01535599|363544857|FG001|Overall Study|Treatment Failure|66|||
105420377|NCT01535599|363544856|FG000|Overall Study|BL Culture + for Group A Strep|0|||
105420378|NCT01535599|363544857|FG001|Overall Study|BL Culture + for Group A Strep|1|||
105420379|NCT01535599|363544856|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
105420380|NCT01535599|363544857|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
105420381|NCT01535599|363544856|FG000|Overall Study|Randomized in Error|2|||
105420382|NCT01535599|363544857|FG001|Overall Study|Randomized in Error|4|||
105420383|NCT01535599|363544856|FG000|Overall Study|Did not use product|1|||
105420384|NCT01535599|363544857|FG001|Overall Study|Did not use product|0|||
105500434|NCT03469934|363843328|FG000|Overall Study|Withdrawal by Subject|0|||
105420385|NCT01535599|363544856|FG000|Overall Study|Other|1|||
105420386|NCT01535599|363544857|FG001|Overall Study|Other|0|||
105420387|NCT01535599|363544856|FG000|Overall Study|Stopped medication|0|||
105420388|NCT01535599|363544857|FG001|Overall Study|Stopped medication|1|||
105420389|NCT01535599|363544856|FG000|Overall Study|Noncompliance|0|||
105420390|NCT01535599|363544857|FG001|Overall Study|Noncompliance|1|||
105420391|NCT03172325|363544858|FG000|Overall Study|Adverse Event|2|||
105420392|NCT03172325|363544859|FG001|Overall Study|Adverse Event|3|||
105420393|NCT03172325|363544858|FG000|Overall Study|Positive PPD|1|||
105420394|NCT03172325|363544859|FG001|Overall Study|Positive PPD|0|||
105420395|NCT03172325|363544858|FG000|Overall Study|Poor Compliance|1|||
105420396|NCT03172325|363544859|FG001|Overall Study|Poor Compliance|1|||
105420397|NCT00712725|363544862|FG000|Overall Study|Adverse Event|1|||
105584310|NCT01627340|364138066|FG001|Overall Study|Lost to Follow-up|4|||
105584311|NCT01627340|364138065|FG000|Overall Study|Pregnancy|1|||
105584312|NCT01627340|364138066|FG001|Overall Study|Pregnancy|0|||
105584313|NCT01627340|364138065|FG000|Overall Study|Withdrawal by Subject|2|||
105584314|NCT01627340|364138066|FG001|Overall Study|Withdrawal by Subject|0|||
105584315|NCT01272011|364138067|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
105584316|NCT01272011|364138068|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
105584317|NCT01272011|364138069|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
105584318|NCT00562965|364138070|FG000|Overall Study|Withdrawal by Subject|0|||
105584319|NCT00562965|364138071|FG001|Overall Study|Withdrawal by Subject|1|||
105584320|NCT00562965|364138070|FG000|Overall Study|Death|2|||
105584321|NCT00562965|364138071|FG001|Overall Study|Death|4|||
105584322|NCT00562965|364138070|FG000|Overall Study|Lost to Follow-up|1|||
105584323|NCT00562965|364138071|FG001|Overall Study|Lost to Follow-up|0|||
105584324|NCT00562965|364138070|FG000|Overall Study|Other|0|||
105584325|NCT00562965|364138071|FG001|Overall Study|Other|1|||
105584326|NCT00761774|364138078|FG000|Overall Study|Adverse Event|17|||
105584327|NCT00761774|364138078|FG000|Overall Study|Lack of Efficacy|37|||
105584328|NCT00761774|364138078|FG000|Overall Study|Lost to Follow-up|2|||
105584329|NCT00761774|364138078|FG000|Overall Study|Withdrawal by Subject|9|||
105584330|NCT00761774|364138078|FG000|Overall Study|Non-compliance|4|||
105584331|NCT00761774|364138078|FG000|Overall Study|End of study|2|||
105584332|NCT00761774|364138078|FG000|Overall Study|Reclassification of seizures|1|||
105584333|NCT00761774|364138078|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
105584334|NCT00761774|364138078|FG000|Overall Study|Sponsor decision|1|||
105584335|NCT00761774|364138078|FG000|Overall Study|Investigator clinical judgement|1|||
105584336|NCT00761774|364138078|FG000|Overall Study|Patient moved out of study area|1|||
105584337|NCT00761774|364138078|FG000|Overall Study|Coordinator leaving site|1|||
105584338|NCT00761774|364138078|FG000|Overall Study|Subject IP non-compliance|1|||
105584339|NCT00761774|364138078|FG000|Overall Study|IP stopped by hospital physician|1|||
105584340|NCT01077024|364138079|FG000|Overall Study|Lost to Follow-up|20|||
105584341|NCT01077024|364138080|FG001|Overall Study|Lost to Follow-up|14|||
105584342|NCT01077024|364138079|FG000|Overall Study|Withdrawal by Subject|0|||
105584343|NCT01077024|364138080|FG001|Overall Study|Withdrawal by Subject|2|||
105584344|NCT01077024|364138079|FG000|Overall Study|Incarcerated|7|||
105584345|NCT01077024|364138080|FG001|Overall Study|Incarcerated|8|||
105584346|NCT01077024|364138079|FG000|Overall Study|Other|4|||
105584347|NCT01077024|364138080|FG001|Overall Study|Other|4|||
105584348|NCT00965484|364138081|FG000|Overall Study|Protocol Violation|1|||
105584349|NCT00965484|364138081|FG000|Overall Study|Withdrawal by Subject|1|||
105584350|NCT02300311|364138084|FG000|Overall Study|Other than the reason specified|1|||
105584351|NCT02300311|364138085|FG001|Overall Study|Other than the reason specified|0|||
105584352|NCT02300311|364138084|FG000|Overall Study|Refused to continue taking medication|18|||
105584353|NCT02300311|364138085|FG001|Overall Study|Refused to continue taking medication|0|||
105584354|NCT00419003|364138086|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
105584355|NCT00419003|364138087|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
105584356|NCT00419003|364138086|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
105584357|NCT00419003|364138087|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
105584358|NCT00848211|364138088|FG000|Overall Study|Protocol Violation|0|||
105584359|NCT00848211|364138089|FG001|Overall Study|Protocol Violation|1|||
105584360|NCT00848211|364138090|FG002|Overall Study|Protocol Violation|1|||
105584361|NCT00848211|364138091|FG003|Overall Study|Protocol Violation|0|||
105584362|NCT00848211|364138088|FG000|Overall Study|Adverse Event|0|||
105584363|NCT00848211|364138089|FG001|Overall Study|Adverse Event|0|||
105584364|NCT00848211|364138090|FG002|Overall Study|Adverse Event|0|||
105584365|NCT00848211|364138091|FG003|Overall Study|Adverse Event|0|||
105584366|NCT00619151|364138097|FG000|Overall Study|Study terminated prior to followup|1|||
105584367|NCT00619151|364138098|FG001|Overall Study|Study terminated prior to followup|0|||
105584368|NCT00329303|364138101|FG000|Overall Study|Lack of Efficacy|1|||
105584369|NCT00329303|364138102|FG001|Overall Study|Lack of Efficacy|0|||
105420398|NCT00712725|363544863|FG001|Overall Study|Adverse Event|0|||
105584370|NCT00329303|364138101|FG000|Overall Study|Decision of the sponsor|0|||
105584371|NCT00329303|364138102|FG001|Overall Study|Decision of the sponsor|1|||
105584372|NCT00329303|364138101|FG000|Overall Study|Patient no longer available|1|||
105584373|NCT00329303|364138102|FG001|Overall Study|Patient no longer available|0|||
105584374|NCT00329303|364138101|FG000|Overall Study|Patient relocated|0|||
105584375|NCT00329303|364138102|FG001|Overall Study|Patient relocated|1|||
105584376|NCT01982760|364138103|FG000|Overall Study|Physician Decision|1|||
105584377|NCT01982760|364138104|FG001|Overall Study|Physician Decision|0|||
105584378|NCT00184028|364138106|FG000|Overall Study|Death|1|||
105584379|NCT00184028|364138106|FG000|Overall Study|Lack of Efficacy|4|||
105584380|NCT00184028|364138106|FG000|Overall Study|Adverse Event|2|||
105584381|NCT00184028|364138106|FG000|Overall Study|Withdrawal by Subject|1|||
105584382|NCT00184028|364138106|FG000|Overall Study|Non-compliance|2|||
105420399|NCT00712725|363544864|FG002|Overall Study|Adverse Event|0|||
105584383|NCT00859014|364138107|FG000|Overall Study|Death|4|||
105584384|NCT00859014|364138107|FG000|Overall Study|Lost to Follow-up|1|||
105420400|NCT00712725|363544865|FG003|Overall Study|Adverse Event|1|||
105420401|NCT00712725|363544866|FG004|Overall Study|Adverse Event|0|||
105420402|NCT00712725|363544867|FG005|Overall Study|Adverse Event|0|||
105420403|NCT00712725|363544868|FG006|Overall Study|Adverse Event|0|||
105420404|NCT00712725|363544869|FG007|Overall Study|Adverse Event|0|||
105420405|NCT00712725|363544862|FG000|Overall Study|Lost to Follow-up|3|||
105420406|NCT00712725|363544863|FG001|Overall Study|Lost to Follow-up|2|||
105420407|NCT00712725|363544864|FG002|Overall Study|Lost to Follow-up|1|||
105420408|NCT00712725|363544865|FG003|Overall Study|Lost to Follow-up|1|||
105420409|NCT00712725|363544866|FG004|Overall Study|Lost to Follow-up|2|||
105420410|NCT00712725|363544867|FG005|Overall Study|Lost to Follow-up|2|||
105420411|NCT00712725|363544868|FG006|Overall Study|Lost to Follow-up|3|||
105420412|NCT00712725|363544869|FG007|Overall Study|Lost to Follow-up|1|||
105420413|NCT00712725|363544862|FG000|Overall Study|Physician Decision|2|||
105420414|NCT00712725|363544863|FG001|Overall Study|Physician Decision|0|||
105420415|NCT00712725|363544864|FG002|Overall Study|Physician Decision|0|||
105420416|NCT00712725|363544865|FG003|Overall Study|Physician Decision|0|||
105420417|NCT00712725|363544866|FG004|Overall Study|Physician Decision|1|||
105420418|NCT00712725|363544867|FG005|Overall Study|Physician Decision|0|||
105420419|NCT00712725|363544868|FG006|Overall Study|Physician Decision|2|||
105420420|NCT00712725|363544869|FG007|Overall Study|Physician Decision|0|||
105420421|NCT00712725|363544862|FG000|Overall Study|Pregnancy|0|||
105420422|NCT00712725|363544863|FG001|Overall Study|Pregnancy|1|||
105420423|NCT00712725|363544864|FG002|Overall Study|Pregnancy|0|||
105420424|NCT00712725|363544865|FG003|Overall Study|Pregnancy|0|||
105420425|NCT00712725|363544866|FG004|Overall Study|Pregnancy|1|||
105420426|NCT00712725|363544867|FG005|Overall Study|Pregnancy|0|||
105420427|NCT00712725|363544868|FG006|Overall Study|Pregnancy|2|||
105420428|NCT00712725|363544869|FG007|Overall Study|Pregnancy|0|||
105420429|NCT00712725|363544862|FG000|Overall Study|Protocol Violation|2|||
105420430|NCT00712725|363544863|FG001|Overall Study|Protocol Violation|0|||
105420431|NCT00712725|363544864|FG002|Overall Study|Protocol Violation|1|||
105420432|NCT00712725|363544865|FG003|Overall Study|Protocol Violation|3|||
105420433|NCT00712725|363544866|FG004|Overall Study|Protocol Violation|2|||
105420434|NCT00712725|363544867|FG005|Overall Study|Protocol Violation|0|||
105420435|NCT00712725|363544868|FG006|Overall Study|Protocol Violation|1|||
105420436|NCT00712725|363544869|FG007|Overall Study|Protocol Violation|1|||
105420437|NCT00712725|363544862|FG000|Overall Study|Withdrawal by Subject|2|||
105420438|NCT00712725|363544863|FG001|Overall Study|Withdrawal by Subject|1|||
105420439|NCT00712725|363544864|FG002|Overall Study|Withdrawal by Subject|1|||
105420440|NCT00712725|363544865|FG003|Overall Study|Withdrawal by Subject|2|||
105420441|NCT00712725|363544866|FG004|Overall Study|Withdrawal by Subject|1|||
105420442|NCT00712725|363544867|FG005|Overall Study|Withdrawal by Subject|1|||
105420443|NCT00712725|363544868|FG006|Overall Study|Withdrawal by Subject|1|||
105420444|NCT00712725|363544869|FG007|Overall Study|Withdrawal by Subject|2|||
105420445|NCT00712725|363544862|FG000|Overall Study|Lack of Qualifying Event|16|||
105420446|NCT00712725|363544863|FG001|Overall Study|Lack of Qualifying Event|2|||
105420447|NCT00712725|363544864|FG002|Overall Study|Lack of Qualifying Event|6|||
105420448|NCT00712725|363544865|FG003|Overall Study|Lack of Qualifying Event|8|||
105420449|NCT00712725|363544866|FG004|Overall Study|Lack of Qualifying Event|11|||
105420450|NCT00712725|363544867|FG005|Overall Study|Lack of Qualifying Event|13|||
105420451|NCT00712725|363544868|FG006|Overall Study|Lack of Qualifying Event|11|||
105420452|NCT00712725|363544869|FG007|Overall Study|Lack of Qualifying Event|6|||
105420453|NCT00712725|363544862|FG000|Overall Study|Protocol Specified Criteria|3|||
105420454|NCT00712725|363544863|FG001|Overall Study|Protocol Specified Criteria|0|||
105420455|NCT00712725|363544864|FG002|Overall Study|Protocol Specified Criteria|1|||
105420456|NCT00712725|363544865|FG003|Overall Study|Protocol Specified Criteria|2|||
105420457|NCT00712725|363544866|FG004|Overall Study|Protocol Specified Criteria|1|||
105420458|NCT00712725|363544867|FG005|Overall Study|Protocol Specified Criteria|0|||
105420459|NCT00712725|363544868|FG006|Overall Study|Protocol Specified Criteria|2|||
105420460|NCT00712725|363544869|FG007|Overall Study|Protocol Specified Criteria|1|||
105420461|NCT02120300|363544870|FG000|Overall Study|Enrolled but Never Treated|2|||
105420462|NCT02120300|363544871|FG001|Overall Study|Enrolled but Never Treated|0|||
105420463|NCT02120300|363544872|FG002|Overall Study|Enrolled but Never Treated|0|||
105420464|NCT02120300|363544873|FG003|Overall Study|Enrolled but Never Treated|0|||
105420465|NCT02120300|363544870|FG000|Overall Study|Lack of Efficacy|0|||
105420466|NCT02120300|363544871|FG001|Overall Study|Lack of Efficacy|0|||
105420467|NCT02120300|363544872|FG002|Overall Study|Lack of Efficacy|0|||
105420468|NCT02120300|363544873|FG003|Overall Study|Lack of Efficacy|1|||
105420469|NCT02120300|363544870|FG000|Overall Study|Lost to Follow-up|1|||
105420470|NCT02120300|363544871|FG001|Overall Study|Lost to Follow-up|0|||
105420471|NCT02120300|363544872|FG002|Overall Study|Lost to Follow-up|0|||
105420472|NCT02120300|363544873|FG003|Overall Study|Lost to Follow-up|0|||
105420473|NCT02680041|363544874|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
105420474|NCT02680041|363544874|FG000|Overall Study|Lost to Follow-up|2|||
105420475|NCT00290771|363544878|FG000|Overall Study|Disease progression|95|||
105420476|NCT00290771|363544879|FG001|Overall Study|Disease progression|73|||
105420477|NCT00290771|363544878|FG000|Overall Study|Death|11|||
105420478|NCT00290771|363544879|FG001|Overall Study|Death|10|||
105420479|NCT00290771|363544878|FG000|Overall Study|Adverse Event|12|||
105584385|NCT02162732|364138108|FG000|Overall Study|Biopsy not performed.|18|||
105584386|NCT01354938|364138109|FG000|Overall Study|Lost to Follow-up|1|||
105584387|NCT01167023|364138110|FG000|Overall Study|Lost to Follow-up|0|||
105584388|NCT01167023|364138111|FG001|Overall Study|Lost to Follow-up|1|||
105584389|NCT01167023|364138112|FG002|Overall Study|Lost to Follow-up|1|||
105584390|NCT01167023|364138110|FG000|Overall Study|Screen Failure|0|||
105584391|NCT01167023|364138111|FG001|Overall Study|Screen Failure|1|||
105584392|NCT01167023|364138112|FG002|Overall Study|Screen Failure|0|||
105584393|NCT01167023|364138110|FG000|Overall Study|Sponsor Decision|0|||
105584394|NCT01167023|364138111|FG001|Overall Study|Sponsor Decision|1|||
105584395|NCT01167023|364138112|FG002|Overall Study|Sponsor Decision|0|||
105584396|NCT01167023|364138110|FG000|Overall Study|Withdrawal by Subject|0|||
105584397|NCT01167023|364138111|FG001|Overall Study|Withdrawal by Subject|0|||
105584398|NCT01167023|364138112|FG002|Overall Study|Withdrawal by Subject|1|||
105584399|NCT02049437|364138113|FG000|Period 1|Adverse Event|1|||
105584400|NCT02049437|364138114|FG001|Period 1|Adverse Event|1|||
105584401|NCT02049437|364138113|FG000|Period 1|Adverse Event|1|||
105584402|NCT02049437|364138114|FG001|Period 1|Adverse Event|0|||
105584403|NCT00630539|364138119|FG000|Overall Study|Adverse Event|1|||
105584404|NCT00630539|364138120|FG001|Overall Study|Adverse Event|3|||
105584405|NCT00630539|364138121|FG002|Overall Study|Adverse Event|1|||
105584406|NCT00630539|364138122|FG003|Overall Study|Adverse Event|2|||
105584407|NCT00630539|364138119|FG000|Overall Study|Withdrawal by Subject|0|||
105584408|NCT00630539|364138120|FG001|Overall Study|Withdrawal by Subject|1|||
105584409|NCT00630539|364138121|FG002|Overall Study|Withdrawal by Subject|0|||
105584410|NCT00630539|364138122|FG003|Overall Study|Withdrawal by Subject|1|||
105584411|NCT00578227|364138124|FG000|Overall Study|Lost to Follow-up|0|||
105584412|NCT00578227|364138125|FG001|Overall Study|Lost to Follow-up|1|||
105584413|NCT00578227|364138126|FG002|Overall Study|Lost to Follow-up|1|||
105584414|NCT00578227|364138124|FG000|Overall Study|Withdrawal by Subject|5|||
105584415|NCT00578227|364138125|FG001|Overall Study|Withdrawal by Subject|1|||
105584416|NCT00578227|364138126|FG002|Overall Study|Withdrawal by Subject|3|||
105584417|NCT04668144|364138127|FG000|Overall Study|Protocol Violation|0|||
105584418|NCT04668144|364138128|FG001|Overall Study|Protocol Violation|1|||
105584419|NCT04668144|364138129|FG002|Overall Study|Protocol Violation|2|||
105584420|NCT00577629|364138133|FG000|Treatment Period|Death|1|||
105584421|NCT00577629|364138133|FG000|Long Term Follow-Up|Death|15|||
105584422|NCT00577629|364138133|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
105584423|NCT00577629|364138133|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
105584424|NCT00577629|364138133|FG000|Long Term Follow-Up|Physician Decision|1|||
105584425|NCT01072929|364138134|FG000|Overall Study|Adverse Event|8|||
105584426|NCT01072929|364138135|FG001|Overall Study|Adverse Event|11|||
105584427|NCT01072929|364138136|FG002|Overall Study|Adverse Event|2|||
105584428|NCT01072929|364138134|FG000|Overall Study|Lack of Efficacy|7|||
105584429|NCT01072929|364138135|FG001|Overall Study|Lack of Efficacy|4|||
105584430|NCT01072929|364138136|FG002|Overall Study|Lack of Efficacy|0|||
105584431|NCT01072929|364138134|FG000|Overall Study|Withdrawal by Subject|7|||
105584432|NCT01072929|364138135|FG001|Overall Study|Withdrawal by Subject|15|||
105584433|NCT01072929|364138136|FG002|Overall Study|Withdrawal by Subject|3|||
105584434|NCT01072929|364138134|FG000|Overall Study|Protocol Violation|13|||
105584435|NCT01072929|364138135|FG001|Overall Study|Protocol Violation|11|||
105584436|NCT01072929|364138136|FG002|Overall Study|Protocol Violation|2|||
105584437|NCT01072929|364138134|FG000|Overall Study|Lost to Follow-up|8|||
105584438|NCT01072929|364138135|FG001|Overall Study|Lost to Follow-up|4|||
105584439|NCT01072929|364138136|FG002|Overall Study|Lost to Follow-up|1|||
105584440|NCT01072929|364138134|FG000|Overall Study|Noncompliance with study medication|0|||
105584441|NCT01072929|364138135|FG001|Overall Study|Noncompliance with study medication|3|||
105584442|NCT01072929|364138136|FG002|Overall Study|Noncompliance with study medication|0|||
105584443|NCT01072929|364138134|FG000|Overall Study|Noncompliance with study procedures|1|||
105584444|NCT01072929|364138135|FG001|Overall Study|Noncompliance with study procedures|0|||
105584445|NCT01072929|364138136|FG002|Overall Study|Noncompliance with study procedures|1|||
105584446|NCT01072929|364138134|FG000|Overall Study|Other|0|||
105584447|NCT01072929|364138135|FG001|Overall Study|Other|3|||
105584448|NCT01072929|364138136|FG002|Overall Study|Other|0|||
105584449|NCT02338609|364138139|FG000|Overall Study|Physician Decision|1|||
105584450|NCT02338609|364138139|FG000|Overall Study|Death|1|||
105584451|NCT00832780|364138140|FG000|Overall Study|Death|16|||
105584452|NCT00832780|364138140|FG000|Overall Study|Lost to Follow-up|4|||
105584453|NCT00832780|364138140|FG000|Overall Study|no reason given|2|||
105584454|NCT00832780|364138140|FG000|Overall Study|other complicating condition|2|||
105584455|NCT00832780|364138140|FG000|Overall Study|Physician Decision|1|||
105584456|NCT05705167|364138141|FG000|Overall Study|Randomised but not Treated|0|||
105584457|NCT05705167|364138142|FG001|Overall Study|Randomised but not Treated|2|||
105584458|NCT05705167|364138143|FG002|Overall Study|Randomised but not Treated|0|||
105584459|NCT05705167|364138144|FG003|Overall Study|Randomised but not Treated|7|||
105584460|NCT05705167|364138145|FG004|Overall Study|Randomised but not Treated|0|||
105584461|NCT05705167|364138146|FG005|Overall Study|Randomised but not Treated|0|||
105584462|NCT05705167|364138147|FG006|Overall Study|Randomised but not Treated|0|||
105584463|NCT05705167|364138141|FG000|Overall Study|Death|0|||
105420480|NCT00290771|363544879|FG001|Overall Study|Adverse Event|6|||
105420481|NCT00290771|363544878|FG000|Overall Study|Withdrawal by Subject|5|||
105420482|NCT00290771|363544879|FG001|Overall Study|Withdrawal by Subject|6|||
105420483|NCT00290771|363544878|FG000|Overall Study|Administrative problems|2|||
105420484|NCT00290771|363544879|FG001|Overall Study|Administrative problems|1|||
105420485|NCT00290771|363544878|FG000|Overall Study|Protocol Violation|2|||
105420486|NCT00290771|363544879|FG001|Overall Study|Protocol Violation|0|||
105420487|NCT00290771|363544878|FG000|Overall Study|Lost to Follow-up|0|||
105420488|NCT00290771|363544879|FG001|Overall Study|Lost to Follow-up|1|||
105420489|NCT00515294|363544883|FG000|Overall Study|Lost to Follow-up|3|||
105420490|NCT00515294|363544884|FG001|Overall Study|Lost to Follow-up|2|||
105420491|NCT00515294|363544885|FG002|Overall Study|Lost to Follow-up|3|||
105420492|NCT00515294|363544886|FG003|Overall Study|Lost to Follow-up|1|||
105420493|NCT00515294|363544883|FG000|Overall Study|Driver simulator problems|1|||
105420494|NCT00515294|363544884|FG001|Overall Study|Driver simulator problems|1|||
105420495|NCT00515294|363544885|FG002|Overall Study|Driver simulator problems|1|||
105420496|NCT00515294|363544886|FG003|Overall Study|Driver simulator problems|3|||
105420497|NCT00515294|363544883|FG000|Overall Study|Caffeine amount inaccurate|5|||
105420498|NCT00515294|363544884|FG001|Overall Study|Caffeine amount inaccurate|0|||
105420499|NCT00515294|363544885|FG002|Overall Study|Caffeine amount inaccurate|7|||
105420500|NCT00515294|363544886|FG003|Overall Study|Caffeine amount inaccurate|0|||
105420501|NCT00503776|363544890|FG000|Overall Study|Withdrawal by Subject|1|||
105420502|NCT00503776|363544891|FG001|Overall Study|Withdrawal by Subject|0|||
105420503|NCT00503776|363544892|FG002|Overall Study|Withdrawal by Subject|1|||
105420504|NCT00503776|363544893|FG003|Overall Study|Withdrawal by Subject|1|||
105420505|NCT00503776|363544890|FG000|Overall Study|Physician Decision|0|||
105420506|NCT00503776|363544891|FG001|Overall Study|Physician Decision|0|||
105420507|NCT00503776|363544892|FG002|Overall Study|Physician Decision|1|||
105500435|NCT03469934|363843329|FG001|Overall Study|Withdrawal by Subject|1|||
105500436|NCT02846324|363843337|FG000|Overall Study|Other|1|||
105500437|NCT02846324|363843338|FG001|Overall Study|Other|0|||
105500438|NCT02846324|363843339|FG002|Overall Study|Other|0|||
105500439|NCT02846324|363843340|FG003|Overall Study|Other|0|||
105500440|NCT02846324|363843337|FG000|Overall Study|Withdrawal by Subject|1|||
105500441|NCT02846324|363843338|FG001|Overall Study|Withdrawal by Subject|0|||
105500442|NCT02846324|363843339|FG002|Overall Study|Withdrawal by Subject|4|||
105500443|NCT02846324|363843340|FG003|Overall Study|Withdrawal by Subject|0|||
105500444|NCT00932126|363843341|FG000|Overall Study|Adverse Event|0|||
105500445|NCT00932126|363843342|FG001|Overall Study|Adverse Event|0|||
105500446|NCT00932126|363843343|FG002|Overall Study|Adverse Event|0|||
105500447|NCT00932126|363843344|FG003|Overall Study|Adverse Event|0|||
105500448|NCT00932126|363843345|FG004|Overall Study|Adverse Event|0|||
105500449|NCT00932126|363843346|FG005|Overall Study|Adverse Event|0|||
105500450|NCT00932126|363843347|FG006|Overall Study|Adverse Event|1|||
105500451|NCT00932126|363843348|FG007|Overall Study|Adverse Event|2|||
105500452|NCT00932126|363843341|FG000|Overall Study|Protocol Violation|0|||
105500453|NCT00932126|363843342|FG001|Overall Study|Protocol Violation|0|||
105500454|NCT00932126|363843343|FG002|Overall Study|Protocol Violation|0|||
105500455|NCT00932126|363843344|FG003|Overall Study|Protocol Violation|0|||
105500456|NCT00932126|363843345|FG004|Overall Study|Protocol Violation|1|||
105500457|NCT00932126|363843346|FG005|Overall Study|Protocol Violation|0|||
105584464|NCT05705167|364138142|FG001|Overall Study|Death|0|||
105420508|NCT00503776|363544893|FG003|Overall Study|Physician Decision|1|||
105420509|NCT02379988|363544894|FG000|Overall Study|Not eligible|1|||
105420510|NCT00107315|363544895|FG000|Overall Study|Disease Progression|9|||
105420511|NCT00107315|363544895|FG000|Overall Study|Adverse Event|4|||
105500458|NCT00932126|363843347|FG006|Overall Study|Protocol Violation|0|||
105500459|NCT00932126|363843348|FG007|Overall Study|Protocol Violation|0|||
105500460|NCT00932126|363843341|FG000|Overall Study|Withdrawal by Subject|0|||
105500461|NCT00932126|363843342|FG001|Overall Study|Withdrawal by Subject|0|||
105500462|NCT00932126|363843343|FG002|Overall Study|Withdrawal by Subject|1|||
105500463|NCT00932126|363843344|FG003|Overall Study|Withdrawal by Subject|0|||
105500464|NCT00932126|363843345|FG004|Overall Study|Withdrawal by Subject|0|||
105500465|NCT00932126|363843346|FG005|Overall Study|Withdrawal by Subject|0|||
105500466|NCT00932126|363843347|FG006|Overall Study|Withdrawal by Subject|0|||
105500467|NCT00932126|363843348|FG007|Overall Study|Withdrawal by Subject|1|||
105500468|NCT00932126|363843341|FG000|Overall Study|Objective progression or relapse|3|||
105500469|NCT00932126|363843342|FG001|Overall Study|Objective progression or relapse|3|||
105500470|NCT00932126|363843343|FG002|Overall Study|Objective progression or relapse|2|||
105500471|NCT00932126|363843344|FG003|Overall Study|Objective progression or relapse|3|||
105500472|NCT00932126|363843345|FG004|Overall Study|Objective progression or relapse|3|||
105500473|NCT00932126|363843346|FG005|Overall Study|Objective progression or relapse|3|||
105420512|NCT00107315|363544895|FG000|Overall Study|Withdrawal by Subject|2|||
105420513|NCT03650803|363544906|FG000|Overall Study|Lost to Follow-up|6|||
105420514|NCT02308163|363544907|FG000|Overall Study|Not fulfill eligible criteria|1|||
105420515|NCT02308163|363544908|FG001|Overall Study|Not fulfill eligible criteria|2|||
105420516|NCT02308163|363544909|FG002|Overall Study|Not fulfill eligible criteria|0|||
105584465|NCT05705167|364138143|FG002|Overall Study|Death|3|||
105584466|NCT05705167|364138144|FG003|Overall Study|Death|0|||
105584467|NCT05705167|364138145|FG004|Overall Study|Death|1|||
105584468|NCT05705167|364138146|FG005|Overall Study|Death|1|||
105584469|NCT05705167|364138147|FG006|Overall Study|Death|1|||
105584470|NCT05705167|364138141|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
105584471|NCT05705167|364138142|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
105584472|NCT05705167|364138143|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
105584473|NCT05705167|364138144|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
105584474|NCT05705167|364138145|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
105584475|NCT05705167|364138146|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
105584476|NCT05705167|364138147|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
105584477|NCT01256476|364139789|FG000|Overall Study|Adverse Event|2|||
105584478|NCT01256476|364139790|FG001|Overall Study|Adverse Event|1|||
105584479|NCT01256476|364139789|FG000|Overall Study|Withdrawal by Subject|2|||
105584480|NCT01256476|364139790|FG001|Overall Study|Withdrawal by Subject|1|||
105584481|NCT01256476|364139789|FG000|Overall Study|Lost to Follow-up|1|||
105584482|NCT01256476|364139790|FG001|Overall Study|Lost to Follow-up|2|||
105584483|NCT01256476|364139789|FG000|Overall Study|Persistent ALT or AST elevation|1|||
105584484|NCT01256476|364139790|FG001|Overall Study|Persistent ALT or AST elevation|0|||
105584485|NCT01256476|364139789|FG000|Overall Study|Physician Decision|0|||
105584486|NCT01256476|364139790|FG001|Overall Study|Physician Decision|1|||
105584487|NCT01256476|364139789|FG000|Overall Study|Subject non-compliance|0|||
105584488|NCT01256476|364139790|FG001|Overall Study|Subject non-compliance|1|||
105584489|NCT01256476|364139789|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
105584490|NCT01256476|364139790|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
105584491|NCT02485353|364139793|FG000|Overall Study|Death|1|||
105584492|NCT02485353|364139793|FG000|Overall Study|Disease Progression|1|||
105584493|NCT02788656|364139794|FG000|Overall Study|Withdrawal by Subject|1|||
105584494|NCT02788656|364139795|FG001|Overall Study|Withdrawal by Subject|0|||
105584495|NCT02271594|364139796|FG000|Overall Study|Study closed; recruiting failure|19|||
105584496|NCT02271594|364139797|FG001|Overall Study|Study closed; recruiting failure|12|||
105584497|NCT00088465|364139798|FG000|Overall Study|Withdrawal by Subject|290|||
105584498|NCT00088465|364139798|FG000|Overall Study|Adverse Event|77|||
105584499|NCT00088465|364139798|FG000|Overall Study|Lost to Follow-up|57|||
105584500|NCT00088465|364139798|FG000|Overall Study|Physician Decision|45|||
105584501|NCT00088465|364139798|FG000|Overall Study|Sponsor Decision|37|||
105584502|NCT00088465|364139798|FG000|Overall Study|Lack of Efficacy|27|||
105584503|NCT00088465|364139798|FG000|Overall Study|Protocol Violation|17|||
105584504|NCT00088465|364139798|FG000|Overall Study|Death|11|||
105584505|NCT00519779|364139799|FG000|Overall Study|Withdrawal by Subject|0|||
105584506|NCT00519779|364139800|FG001|Overall Study|Withdrawal by Subject|1|||
105584507|NCT01561079|364139801|FG000|Overall Study|Physician Decision|17|||
105584508|NCT01561079|364139801|FG000|Overall Study|Withdrawal by Subject|59|||
105584509|NCT01561079|364139801|FG000|Overall Study|Protocol Violation|2|||
105584510|NCT04531540|364139804|FG000|Overall Study|Adverse Event|1|||
105584511|NCT04531540|364139804|FG000|Overall Study|Protocol Violation|3|||
105584512|NCT04531540|364139804|FG000|Overall Study|Withdrawal by Subject|4|||
105584513|NCT04531540|364139804|FG000|Overall Study|Found to be Ineligible|1|||
105584514|NCT01575860|364139805|FG000|Overall Study|Withdrawal by Subject|1|||
105584515|NCT01575860|364139805|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
105584516|NCT00751790|364139806|FG000|Overall Study|Lost to Follow-up|1|||
105584517|NCT00751790|364139806|FG000|Overall Study|Death|3|||
105584518|NCT00751790|364139806|FG000|Overall Study|Withdrawal by Subject|1|||
105584519|NCT00180674|364139807|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
105584520|NCT00180674|364139807|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
105584521|NCT01106976|364139808|FG000|Overall Study|Lost to Follow-up|8|||
105584522|NCT01094743|364139809|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
105584523|NCT02851511|364139810|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
105584524|NCT02851511|364139811|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
105584525|NCT02851511|364139812|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
105584526|NCT02851511|364139813|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
105584527|NCT02851511|364139810|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
105584528|NCT02851511|364139811|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
105584529|NCT02851511|364139812|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
105584530|NCT02851511|364139813|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
105584531|NCT02851511|364139810|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
105584532|NCT02851511|364139811|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
105584533|NCT02851511|364139812|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
105584534|NCT02851511|364139813|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
105584535|NCT02851511|364139810|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
105584536|NCT02851511|364139811|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
105584537|NCT02851511|364139812|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
105500474|NCT00932126|363843347|FG006|Overall Study|Objective progression or relapse|3|||
105500475|NCT00932126|363843348|FG007|Overall Study|Objective progression or relapse|5|||
105500476|NCT00932126|363843341|FG000|Overall Study|Other|0|||
105500477|NCT00932126|363843342|FG001|Overall Study|Other|0|||
105500478|NCT00932126|363843343|FG002|Overall Study|Other|0|||
105500479|NCT00932126|363843344|FG003|Overall Study|Other|0|||
105500480|NCT00932126|363843345|FG004|Overall Study|Other|1|||
105500481|NCT00932126|363843346|FG005|Overall Study|Other|0|||
105500482|NCT00932126|363843347|FG006|Overall Study|Other|1|||
105500483|NCT00932126|363843348|FG007|Overall Study|Other|2|||
105500484|NCT01927627|363843350|FG000|Overall Study|Adverse Event|3|||
105500485|NCT01927627|363843350|FG000|Overall Study|Lack of Efficacy|1|||
105500486|NCT01927627|363843350|FG000|Overall Study|Financial Concerns|1|||
105500487|NCT00788073|363843351|FG000|STX209 Then Placebo|Adverse Event|1|||
105500488|NCT00788073|363843352|FG001|STX209 Then Placebo|Adverse Event|0|||
105500489|NCT00788073|363843351|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
105500490|NCT00788073|363843352|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
105500491|NCT00788073|363843351|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
105500492|NCT00788073|363843352|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
105500493|NCT00788073|363843351|FG000|STX209 Then Placebo|unable to return due to travel|0|||
105500494|NCT00788073|363843352|FG001|STX209 Then Placebo|unable to return due to travel|1|||
105500495|NCT00788073|363843351|FG000|Placebo Then STX209|Adverse Event|2|||
105500496|NCT00788073|363843352|FG001|Placebo Then STX209|Adverse Event|0|||
105500497|NCT00788073|363843351|FG000|Placebo Then STX209|Protocol Violation|0|||
105500498|NCT00788073|363843352|FG001|Placebo Then STX209|Protocol Violation|1|||
105500499|NCT01786148|363843353|FG000|Overall Study|Lost to Follow-up|21|||
105500500|NCT01786148|363843354|FG001|Overall Study|Lost to Follow-up|13|||
105500501|NCT01786148|363843353|FG000|Overall Study|Death|0|||
105500502|NCT01786148|363843354|FG001|Overall Study|Death|1|||
105500503|NCT01786148|363843353|FG000|Overall Study|Withdrawal by Subject|0|||
105500504|NCT01786148|363843354|FG001|Overall Study|Withdrawal by Subject|7|||
105500505|NCT01786148|363843353|FG000|Overall Study|Incarceration|1|||
105500506|NCT01786148|363843354|FG001|Overall Study|Incarceration|1|||
105500507|NCT00806351|363843356|FG000|Overall Study|Death|5|||
105500508|NCT00806351|363843357|FG001|Overall Study|Death|4|||
105500509|NCT02059408|363843360|FG000|Overall Study|Did not get tested|0|||
105500510|NCT02059408|363843361|FG001|Overall Study|Did not get tested|330|||
105500511|NCT02059408|363843362|FG002|Overall Study|Did not get tested|358|||
105500512|NCT00508755|363843363|FG000|Overall Study|Withdrawal by Subject|1|||
105500513|NCT01681472|363843364|FG000|Overall Study|Adverse Event|0|||
105500514|NCT01681472|363843365|FG001|Overall Study|Adverse Event|1|||
105500515|NCT01681472|363843366|FG002|Overall Study|Adverse Event|0|||
105500516|NCT01681472|363843367|FG003|Overall Study|Adverse Event|0|||
105500517|NCT04057365|363843368|FG000|Overall Study|Withdrawal by Subject|2|||
105500518|NCT04057365|363843369|FG001|Overall Study|Withdrawal by Subject|0|||
105500519|NCT00437983|363843371|FG000|Overall Study|Adverse Event|6|||
105500520|NCT00437983|363843372|FG001|Overall Study|Adverse Event|6|||
105500521|NCT00437983|363843371|FG000|Overall Study|Protocol Violation|2|||
105500522|NCT00437983|363843372|FG001|Overall Study|Protocol Violation|1|||
105500523|NCT00437983|363843371|FG000|Overall Study|Withdrawal by Subject|5|||
105500524|NCT00437983|363843372|FG001|Overall Study|Withdrawal by Subject|6|||
105500525|NCT01999179|363843373|FG000|Overall Study|Adverse Event|1|||
105500526|NCT01999179|363843373|FG000|Overall Study|Lost to Follow-up|1|||
105500527|NCT01999179|363843373|FG000|Overall Study|Change in Therapy|3|||
105500528|NCT01999179|363843373|FG000|Overall Study|New catheter|2|||
105500529|NCT04439201|363843374|FG000|Overall Study|Ineligible|2|||
105500530|NCT04439201|363843374|FG000|Overall Study|Never start protocol therapy|1|||
105500531|NCT04439201|363843374|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
105500532|NCT04439201|363843374|FG000|Overall Study|Mutation status not confirmed|4|||
105500533|NCT04439201|363843374|FG000|Overall Study|Adverse Event|1|||
105500534|NCT04439201|363843374|FG000|Overall Study|Death|7|||
105500535|NCT04439201|363843374|FG000|Overall Study|Withdrawal by Subject|2|||
105500536|NCT04439201|363843374|FG000|Overall Study|Disease progression|20|||
105500537|NCT04439201|363843374|FG000|Overall Study|Alternative therapy|1|||
105500538|NCT04439201|363843374|FG000|Overall Study|Physician Decision|1|||
105500539|NCT03100149|363843377|FG000|Overall Study|Adverse Event|0|||
105500540|NCT03100149|363843378|FG001|Overall Study|Adverse Event|1|||
105500541|NCT03100149|363843379|FG002|Overall Study|Adverse Event|0|||
105500542|NCT03100149|363843377|FG000|Overall Study|Participant Moved out of Country|0|||
105500543|NCT03100149|363843378|FG001|Overall Study|Participant Moved out of Country|0|||
105500544|NCT03100149|363843379|FG002|Overall Study|Participant Moved out of Country|1|||
105500545|NCT03100149|363843377|FG000|Overall Study|Withdrawal by Subject|0|||
105500546|NCT03100149|363843378|FG001|Overall Study|Withdrawal by Subject|3|||
105500547|NCT03100149|363843379|FG002|Overall Study|Withdrawal by Subject|1|||
105500548|NCT01453361|363843380|FG000|Overall Study|Disease Progression|6|||
105500549|NCT01453361|363843380|FG000|Overall Study|Screen-Failures|10|||
105500550|NCT03128047|363843381|FG000|Overall Study|Withdrawal by Subject|1|||
105584538|NCT02851511|364139813|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
105584539|NCT02851511|364139810|FG000|Phase I|Physician Decision|0|||
105420517|NCT02308163|363544910|FG003|Overall Study|Not fulfill eligible criteria|1|||
105420518|NCT02308163|363544911|FG004|Overall Study|Not fulfill eligible criteria|1|||
105420519|NCT02308163|363544907|FG000|Overall Study|Adverse Event|9|||
105420520|NCT02308163|363544908|FG001|Overall Study|Adverse Event|5|||
105420521|NCT02308163|363544909|FG002|Overall Study|Adverse Event|2|||
105420522|NCT02308163|363544910|FG003|Overall Study|Adverse Event|2|||
105420523|NCT02308163|363544911|FG004|Overall Study|Adverse Event|11|||
105420524|NCT02308163|363544907|FG000|Overall Study|Lack of Efficacy|11|||
105420525|NCT02308163|363544908|FG001|Overall Study|Lack of Efficacy|3|||
105420526|NCT02308163|363544909|FG002|Overall Study|Lack of Efficacy|8|||
105420527|NCT02308163|363544910|FG003|Overall Study|Lack of Efficacy|4|||
105420528|NCT02308163|363544911|FG004|Overall Study|Lack of Efficacy|6|||
105420529|NCT02308163|363544907|FG000|Overall Study|Withdrawal of consent|2|||
105420530|NCT02308163|363544908|FG001|Overall Study|Withdrawal of consent|3|||
105420531|NCT02308163|363544909|FG002|Overall Study|Withdrawal of consent|0|||
105420532|NCT02308163|363544910|FG003|Overall Study|Withdrawal of consent|2|||
105420533|NCT02308163|363544911|FG004|Overall Study|Withdrawal of consent|6|||
105420534|NCT02308163|363544907|FG000|Overall Study|Protocol Violation|3|||
105420535|NCT02308163|363544908|FG001|Overall Study|Protocol Violation|3|||
105420536|NCT02308163|363544909|FG002|Overall Study|Protocol Violation|3|||
105420537|NCT02308163|363544910|FG003|Overall Study|Protocol Violation|2|||
105420538|NCT02308163|363544911|FG004|Overall Study|Protocol Violation|5|||
105420539|NCT02308163|363544907|FG000|Overall Study|Lab data met discontinuation criteria|3|||
105420540|NCT02308163|363544908|FG001|Overall Study|Lab data met discontinuation criteria|0|||
105420541|NCT02308163|363544909|FG002|Overall Study|Lab data met discontinuation criteria|0|||
105420542|NCT02308163|363544910|FG003|Overall Study|Lab data met discontinuation criteria|2|||
105420543|NCT02308163|363544911|FG004|Overall Study|Lab data met discontinuation criteria|0|||
105420544|NCT02308163|363544907|FG000|Overall Study|Miscellaneous|2|||
105420545|NCT02308163|363544908|FG001|Overall Study|Miscellaneous|2|||
105420546|NCT02308163|363544909|FG002|Overall Study|Miscellaneous|1|||
105420547|NCT02308163|363544910|FG003|Overall Study|Miscellaneous|0|||
105420548|NCT02308163|363544911|FG004|Overall Study|Miscellaneous|5|||
105420549|NCT02226198|363546695|FG000|Lead-in Phase|Protocol Violation|1|||
105420550|NCT02226198|363546696|FG001|Lead-in Phase|Protocol Violation|0|||
105420551|NCT02226198|363546697|FG002|Lead-in Phase|Protocol Violation|0|||
105420552|NCT02226198|363546695|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
105420553|NCT02226198|363546696|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
105420554|NCT02226198|363546697|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
105420555|NCT01145352|363546698|FG000|Overall Study|Found to have been registered twice|6|||
105420556|NCT01145352|363546698|FG000|Overall Study|Treated before marketing approval|4|||
105420557|NCT01145352|363546698|FG000|Overall Study|Syringe formulation was used|1|||
105420558|NCT00413894|363546699|FG000|Overall Study|Withdrawal by Subject|10|||
105420559|NCT00413894|363546699|FG000|Overall Study|Administrative Reasons|1|||
105420560|NCT00413894|363546699|FG000|Overall Study|Hb <10 grams/deciliter|12|||
105420561|NCT00413894|363546699|FG000|Overall Study|Adverse Event|28|||
105420562|NCT00413894|363546699|FG000|Overall Study|Protocol Violation|11|||
105420563|NCT00413894|363546699|FG000|Overall Study|Other|18|||
105420564|NCT04225676|363546700|FG000|Overall Study|Physician Decision|1|||
105420565|NCT04225676|363546700|FG000|Overall Study|Lack of Efficacy|1|||
105420566|NCT04225676|363546700|FG000|Overall Study|Study terminated by sponsor|3|||
105420567|NCT03245736|363546701|FG000|Overall Study|Adverse Event|1|||
105420568|NCT03245736|363546701|FG000|Overall Study|Progressive Disease|4|||
105420569|NCT03327220|363546704|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
105420570|NCT03327220|363546705|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
105420571|NCT03327220|363546704|FG000|Overall Study|Investigator Decision|2|||
105420572|NCT03327220|363546705|FG001|Overall Study|Investigator Decision|0|||
105420573|NCT03327220|363546704|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
105420574|NCT03327220|363546705|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
105420575|NCT03327220|363546704|FG000|Overall Study|Fungal infection|1|||
105420576|NCT03327220|363546705|FG001|Overall Study|Fungal infection|0|||
105420577|NCT03327220|363546704|FG000|Overall Study|Discharged to Rehabilitation|0|||
105420578|NCT03327220|363546705|FG001|Overall Study|Discharged to Rehabilitation|1|||
105420579|NCT03327220|363546704|FG000|Overall Study|Missing|1|||
105420580|NCT03327220|363546705|FG001|Overall Study|Missing|0|||
105420581|NCT00523705|363546706|FG000|Overall Study|No time for study.|0|||
105420582|NCT00523705|363546707|FG001|Overall Study|No time for study.|1|||
105420583|NCT00368836|363546708|FG000|Phase II|Screen Failure|1|||
105420584|NCT00368836|363546708|FG000|Phase II|Withdrawal by Subject|1|||
105420585|NCT00368836|363546708|FG000|Phase II|unable to collect blood and/or breath|17|||
105420586|NCT00368836|363546708|FG000|Phase II|Protocol Violation|2|||
105420587|NCT01239381|363546709|FG000|Overall Study|Protocol Violation|1|||
105420588|NCT01239381|363546709|FG000|Overall Study|Withdrawal by Subject|1|||
105420589|NCT01345591|363546717|FG000|Overall Study|Lost to Follow-up|1|||
105420590|NCT00847665|363546718|FG000|Overall Study|Withdrawal by Subject|1|||
105420591|NCT00847665|363546719|FG001|Overall Study|Withdrawal by Subject|0|||
105420592|NCT00585546|363546726|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
105584540|NCT02851511|364139811|FG001|Phase I|Physician Decision|0|||
105584541|NCT02851511|364139812|FG002|Phase I|Physician Decision|0|||
105584542|NCT02851511|364139813|FG003|Phase I|Physician Decision|1|||
105584543|NCT02851511|364139810|FG000|Phase I|Withdrawal by Subject|2|||
105584544|NCT02851511|364139811|FG001|Phase I|Withdrawal by Subject|1|||
105584545|NCT02851511|364139812|FG002|Phase I|Withdrawal by Subject|0|||
105584546|NCT02851511|364139813|FG003|Phase I|Withdrawal by Subject|3|||
105584547|NCT02851511|364139810|FG000|Phase II|Physician Decision|18|||
105584548|NCT02851511|364139811|FG001|Phase II|Physician Decision|16|||
105584549|NCT02851511|364139812|FG002|Phase II|Physician Decision|0|||
105584550|NCT02851511|364139813|FG003|Phase II|Physician Decision|0|||
105584551|NCT02851511|364139810|FG000|Phase II|Withdrawal by Subject|18|||
105584552|NCT02851511|364139811|FG001|Phase II|Withdrawal by Subject|16|||
105584553|NCT02851511|364139812|FG002|Phase II|Withdrawal by Subject|0|||
105584554|NCT02851511|364139813|FG003|Phase II|Withdrawal by Subject|0|||
105584555|NCT02851511|364139810|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
105584556|NCT02851511|364139811|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
105584557|NCT02851511|364139812|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
105584558|NCT02851511|364139813|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
105584559|NCT02851511|364139810|FG000|Phase II|Lost to Follow-up|0|||
105584560|NCT02851511|364139811|FG001|Phase II|Lost to Follow-up|1|||
105584561|NCT02851511|364139812|FG002|Phase II|Lost to Follow-up|0|||
105584562|NCT02851511|364139813|FG003|Phase II|Lost to Follow-up|0|||
105584563|NCT00003377|364139814|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
105584564|NCT00003377|364139815|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
105500551|NCT00983437|363844517|FG000|Overall Study|Adverse Event|9|||
105500552|NCT00983437|363844517|FG000|Overall Study|Lack of Efficacy|1|||
105500553|NCT00983437|363844517|FG000|Overall Study|Withdrawal by Subject|8|||
105500554|NCT00983437|363844517|FG000|Overall Study|Noncompliance to Study Procedures|1|||
105500555|NCT00983437|363844517|FG000|Overall Study|Lost to Follow-up|2|||
105500556|NCT00983437|363844517|FG000|Overall Study|Other Reason|26|||
105500557|NCT01626456|363844520|FG000|Overall Study|Withdrawal by Subject|21|||
105500558|NCT01626456|363844521|FG001|Overall Study|Withdrawal by Subject|46|||
105500559|NCT01626456|363844520|FG000|Overall Study|Adverse Event|2|||
105500560|NCT01626456|363844521|FG001|Overall Study|Adverse Event|27|||
105500561|NCT01626456|363844520|FG000|Overall Study|Lost to Follow-up|2|||
105500562|NCT01626456|363844521|FG001|Overall Study|Lost to Follow-up|27|||
105500563|NCT01626456|363844520|FG000|Overall Study|Lack of Efficacy|6|||
105500564|NCT01626456|363844521|FG001|Overall Study|Lack of Efficacy|7|||
105500565|NCT01626456|363844520|FG000|Overall Study|Physician Decision|1|||
105500566|NCT01626456|363844521|FG001|Overall Study|Physician Decision|4|||
105500567|NCT01626456|363844520|FG000|Overall Study|Protocol Violation|1|||
105500568|NCT01626456|363844521|FG001|Overall Study|Protocol Violation|1|||
105500569|NCT01626456|363844520|FG000|Overall Study|Site Closure|2|||
105500570|NCT01626456|363844521|FG001|Overall Study|Site Closure|3|||
105500571|NCT01626456|363844520|FG000|Overall Study|Incarceration|0|||
105500572|NCT01626456|363844521|FG001|Overall Study|Incarceration|2|||
105500573|NCT00713323|363844522|FG000|Overall Study|Adverse Event|75|||
105500574|NCT00713323|363844522|FG000|Overall Study|Withdrawal by Subject|15|||
105500575|NCT00713323|363844522|FG000|Overall Study|Lost to Follow-up|11|||
105500576|NCT00713323|363844522|FG000|Overall Study|Lack of Efficacy|36|||
105500577|NCT00713323|363844522|FG000|Overall Study|Low creatine clearance at screening|1|||
105500578|NCT00713323|363844522|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
105500579|NCT00713323|363844522|FG000|Overall Study|Surgery cured allodynic pain|1|||
105500580|NCT00713323|363844522|FG000|Overall Study|Pain free|1|||
105500581|NCT00713323|363844522|FG000|Overall Study|Non-compliance|1|||
105500582|NCT00713323|363844522|FG000|Overall Study|Pain resolved|1|||
105500583|NCT00713323|363844522|FG000|Overall Study|Subject travelling to USA|1|||
105584565|NCT00003377|364139816|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
105584566|NCT00003377|364139817|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
105584567|NCT00003377|364139818|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
105584568|NCT00003377|364139814|FG000|Period II|Ureteral stent complications|0|||
105500584|NCT00713323|363844522|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
105500585|NCT00713323|363844522|FG000|Overall Study|Treatment that may interact with Sativex|1|||
105500586|NCT00506662|363844523|FG000|Overall Study|Adverse Event|0|||
105500587|NCT00506662|363844524|FG001|Overall Study|Adverse Event|2|||
105500588|NCT00506662|363844523|FG000|Overall Study|Lack of Efficacy|1|||
105500589|NCT00506662|363844524|FG001|Overall Study|Lack of Efficacy|0|||
105500590|NCT00506662|363844523|FG000|Overall Study|Protocol Violation|2|||
105500591|NCT00506662|363844524|FG001|Overall Study|Protocol Violation|4|||
105500592|NCT00506662|363844523|FG000|Overall Study|Trial terminated|10|||
105500593|NCT00506662|363844524|FG001|Overall Study|Trial terminated|16|||
105584569|NCT00003377|364139815|FG001|Period II|Ureteral stent complications|0|||
105584570|NCT00003377|364139816|FG002|Period II|Ureteral stent complications|0|||
105584571|NCT00003377|364139817|FG003|Period II|Ureteral stent complications|0|||
105500594|NCT00506662|363844523|FG000|Overall Study|Not recorded|4|||
105500595|NCT00506662|363844524|FG001|Overall Study|Not recorded|6|||
105584572|NCT00003377|364139818|FG004|Period II|Ureteral stent complications|1|||
105420593|NCT00585546|363546726|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
105420594|NCT01685801|363546732|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
105420595|NCT01685801|363546733|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
105420596|NCT01685801|363546734|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
105420597|NCT01685801|363546735|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
105420598|NCT01685801|363546732|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
105420599|NCT01685801|363546733|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
105420600|NCT01685801|363546734|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
105420601|NCT01685801|363546735|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
105420602|NCT00113399|363546736|FG000|Overall Study|Death|1|||
105420603|NCT00113399|363546737|FG001|Overall Study|Death|1|||
105420604|NCT00113399|363546736|FG000|Overall Study|Withdrawal by Subject|1|||
105420605|NCT00113399|363546737|FG001|Overall Study|Withdrawal by Subject|2|||
105420606|NCT00113399|363546736|FG000|Overall Study|Complete Response|0|||
105420607|NCT00113399|363546737|FG001|Overall Study|Complete Response|1|||
105420608|NCT00113399|363546736|FG000|Overall Study|Other|0|||
105420609|NCT00113399|363546737|FG001|Overall Study|Other|1|||
105420610|NCT00396136|363546738|FG000|Overall Study|Death|43|||
105420611|NCT00396136|363546738|FG000|Overall Study|Withdrawal by Subject|59|||
105420612|NCT00396136|363546738|FG000|Overall Study|Lost to Follow-up|15|||
105420613|NCT00396136|363546738|FG000|Overall Study|Study device explanted|8|||
105500596|NCT05096221|363844526|FG000|Part 2|Physician Decision|0|||
105500597|NCT05096221|363844527|FG001|Part 2|Physician Decision|1|||
105500598|NCT00434954|363844530|FG000|Overall Study|Adverse Event|17|||
105500599|NCT00434954|363844531|FG001|Overall Study|Adverse Event|2|||
105500600|NCT00434954|363844530|FG000|Overall Study|Entry criteria not met|14|||
105500601|NCT00434954|363844531|FG001|Overall Study|Entry criteria not met|16|||
105500602|NCT00434954|363844530|FG000|Overall Study|Lost to Follow-up|0|||
105500603|NCT00434954|363844531|FG001|Overall Study|Lost to Follow-up|1|||
105500604|NCT00434954|363844530|FG000|Overall Study|Physician Decision|6|||
105500605|NCT00434954|363844531|FG001|Overall Study|Physician Decision|3|||
105500606|NCT00434954|363844530|FG000|Overall Study|Protocol Violation|36|||
105500607|NCT00434954|363844531|FG001|Overall Study|Protocol Violation|27|||
105500608|NCT00434954|363844530|FG000|Overall Study|Sponsor decision|1|||
105500609|NCT00434954|363844531|FG001|Overall Study|Sponsor decision|0|||
105500610|NCT00434954|363844530|FG000|Overall Study|Subject decision|8|||
105500611|NCT00434954|363844531|FG001|Overall Study|Subject decision|22|||
105500612|NCT04891978|363844533|FG000|Baseline|Protocol Violation|2|||
105500613|NCT04891978|363844534|FG001|Baseline|Protocol Violation|1|||
105500614|NCT04891978|363844535|FG002|Baseline|Protocol Violation|0|||
105500615|NCT04891978|363844533|FG000|Baseline|Missing AIRQ|1|||
105500616|NCT04891978|363844534|FG001|Baseline|Missing AIRQ|0|||
105500617|NCT04891978|363844535|FG002|Baseline|Missing AIRQ|0|||
105500618|NCT04891978|363844533|FG000|Baseline|Did not attend a baseline visit|0|||
105500619|NCT04891978|363844534|FG001|Baseline|Did not attend a baseline visit|0|||
105500620|NCT04891978|363844535|FG002|Baseline|Did not attend a baseline visit|9|||
105500621|NCT01696695|363844536|FG000|Overall Study|Disease progression|373|||
105500622|NCT01696695|363844536|FG000|Overall Study|Death|29|||
105500623|NCT01696695|363844536|FG000|Overall Study|Adverse Event|74|||
105500624|NCT01696695|363844536|FG000|Overall Study|Withdrawal by Subject|92|||
105500625|NCT01696695|363844536|FG000|Overall Study|Lost to Follow-up|48|||
105500626|NCT01696695|363844536|FG000|Overall Study|Other|74|||
105500627|NCT01696695|363844536|FG000|Overall Study|Major Protocol Violation|192|||
105500628|NCT03570697|363844537|FG000|Overall Study|Lost to Follow-up|0|||
105500629|NCT03570697|363844538|FG001|Overall Study|Lost to Follow-up|1|||
105500630|NCT03570697|363844537|FG000|Overall Study|Death|2|||
105500631|NCT03570697|363844538|FG001|Overall Study|Death|0|||
105500632|NCT03570697|363844537|FG000|Overall Study|Withdrawal by Subject|4|||
105500633|NCT03570697|363844538|FG001|Overall Study|Withdrawal by Subject|2|||
105500634|NCT03173313|363844539|FG000|Overall Study|Lost to Follow-up|2|||
105500635|NCT03173313|363844540|FG001|Overall Study|Lost to Follow-up|3|||
105500636|NCT03173313|363844539|FG000|Overall Study|Withdrawal by Subject|0|||
105500637|NCT03173313|363844540|FG001|Overall Study|Withdrawal by Subject|1|||
105500638|NCT03173313|363844539|FG000|Overall Study|Death|5|||
105500639|NCT03173313|363844540|FG001|Overall Study|Death|0|||
105500640|NCT03173313|363844539|FG000|Overall Study|Physician Decision|1|||
105500641|NCT03173313|363844540|FG001|Overall Study|Physician Decision|0|||
105500642|NCT03173313|363844539|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
105500643|NCT03173313|363844540|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
105500644|NCT03173313|363844539|FG000|Overall Study|Bone Fracture|1|||
105500645|NCT03173313|363844540|FG001|Overall Study|Bone Fracture|0|||
105500646|NCT03863197|363844543|FG000|Overall Study|Lost to Follow-up|2|||
105420614|NCT04686084|363546739|FG000|Overall Study|Lost to Follow-up|1|||
105420615|NCT03350256|363546740|FG000|Overall Study|Inclusion/exclusion violation|4|||
105420616|NCT03350256|363546740|FG000|Overall Study|Recommended for other therapies|2|||
105420617|NCT03350256|363546740|FG000|Overall Study|Protocol Violation|3|||
105420618|NCT03350256|363546740|FG000|Overall Study|Non compliance|2|||
105500647|NCT03863197|363844544|FG001|Overall Study|Lost to Follow-up|3|||
105500648|NCT03863197|363844543|FG000|Overall Study|Withdrawal by Subject|4|||
105584573|NCT00953160|364139825|FG000|Overall Study|Lost to Follow-up|23|||
105584574|NCT00953160|364139825|FG000|Overall Study|Withdrawal by Subject|4|||
105584575|NCT04337489|364139827|FG000|Overall Study|Withdrawal by Subject|1|||
105584576|NCT01004263|364139828|FG000|Overall Study|Adverse Event|15|||
105584577|NCT01004263|364139828|FG000|Overall Study|Withdrawal by Subject|58|||
105584578|NCT01004263|364139828|FG000|Overall Study|Protocol Violation|10|||
105584579|NCT01004263|364139828|FG000|Overall Study|Lost to Follow-up|64|||
105584580|NCT01004263|364139828|FG000|Overall Study|Lack of Efficacy|13|||
105584581|NCT01004263|364139828|FG000|Overall Study|Pregnancy|2|||
105584582|NCT01004263|364139828|FG000|Overall Study|Physician Decision|15|||
105584583|NCT01004263|364139828|FG000|Overall Study|Lack of Qualifying Event|2|||
105584584|NCT02478359|364139829|FG000|Overall Study|Disenrolled from health plan|106|||
105584585|NCT02478359|364139830|FG001|Overall Study|Disenrolled from health plan|65|||
105584586|NCT01237678|364139831|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
105584587|NCT01237678|364139832|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
105584588|NCT01237678|364139833|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
105584589|NCT01237678|364139831|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
105584590|NCT01237678|364139832|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
105584591|NCT01237678|364139833|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
105584592|NCT01237678|364139831|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
105584593|NCT01237678|364139832|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
105584594|NCT01237678|364139833|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
105584595|NCT01237678|364139831|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
105584596|NCT01237678|364139832|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
105584597|NCT01237678|364139833|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
105584598|NCT01237678|364139831|FG000|Phase II|Adverse Event|0|||
105584599|NCT01237678|364139832|FG001|Phase II|Adverse Event|39|||
105584600|NCT01237678|364139833|FG002|Phase II|Adverse Event|9|||
105584601|NCT01237678|364139831|FG000|Phase II|Death|0|||
105584602|NCT01237678|364139832|FG001|Phase II|Death|0|||
105584603|NCT01237678|364139833|FG002|Phase II|Death|2|||
105584604|NCT01237678|364139831|FG000|Phase II|Lack of Efficacy|0|||
105584605|NCT01237678|364139832|FG001|Phase II|Lack of Efficacy|25|||
105584606|NCT01237678|364139833|FG002|Phase II|Lack of Efficacy|3|||
105584607|NCT01237678|364139831|FG000|Phase II|Withdrawal by Subject|0|||
105584608|NCT01237678|364139832|FG001|Phase II|Withdrawal by Subject|1|||
105584609|NCT01237678|364139833|FG002|Phase II|Withdrawal by Subject|5|||
105584610|NCT01237678|364139831|FG000|Phase II|Completed Cycles 4-6|0|||
105584611|NCT01237678|364139832|FG001|Phase II|Completed Cycles 4-6|11|||
105584612|NCT01237678|364139833|FG002|Phase II|Completed Cycles 4-6|21|||
105584613|NCT01237678|364139831|FG000|Phase II|Sponsor Decision/Study Closed|0|||
105584614|NCT01237678|364139832|FG001|Phase II|Sponsor Decision/Study Closed|18|||
105584615|NCT01237678|364139833|FG002|Phase II|Sponsor Decision/Study Closed|7|||
105584616|NCT01237678|364139831|FG000|Phase II|Randomized but were not treated|0|||
105584617|NCT01237678|364139832|FG001|Phase II|Randomized but were not treated|4|||
105584618|NCT01237678|364139833|FG002|Phase II|Randomized but were not treated|3|||
105584619|NCT00372528|364139834|FG000|Overall Study|Lack of Efficacy|1|||
105584620|NCT00372528|364139834|FG000|Overall Study|Adverse Event|1|||
105584621|NCT00372528|364139834|FG000|Overall Study|Study Terminated by Sponsor|18|||
105584622|NCT00372528|364139834|FG000|Overall Study|Other|1|||
105584623|NCT02034435|364139841|FG000|Overall Study|Withdrawal by Subject|1|||
105584624|NCT02034435|364139842|FG001|Overall Study|Withdrawal by Subject|0|||
105584625|NCT02034435|364139843|FG002|Overall Study|Withdrawal by Subject|0|||
105584626|NCT02034435|364139844|FG003|Overall Study|Withdrawal by Subject|0|||
105584627|NCT02034435|364139841|FG000|Overall Study|Illness|0|||
105584628|NCT02034435|364139842|FG001|Overall Study|Illness|2|||
105584629|NCT02034435|364139843|FG002|Overall Study|Illness|0|||
105584630|NCT02034435|364139844|FG003|Overall Study|Illness|0|||
105584631|NCT02034435|364139841|FG000|Overall Study|Inadequate IV access|1|||
105420619|NCT03350256|363546740|FG000|Overall Study|Denial by insurance|1|||
105584632|NCT02034435|364139842|FG001|Overall Study|Inadequate IV access|0|||
105584633|NCT02034435|364139843|FG002|Overall Study|Inadequate IV access|0|||
105584634|NCT02034435|364139844|FG003|Overall Study|Inadequate IV access|1|||
105584635|NCT01656759|364139845|FG000|Overall Study|Protocol Violation|2|||
105584636|NCT01656759|364139846|FG001|Overall Study|Protocol Violation|3|||
105420620|NCT03350256|363546740|FG000|Overall Study|Adverse Event|2|||
105420621|NCT03350256|363546740|FG000|Overall Study|Trial failure|12|||
105420622|NCT03350256|363546740|FG000|Overall Study|Did not proceed to permanent implant|3|||
105584637|NCT02531438|364139847|FG000|Overall Study|Adverse Event|7|||
105584638|NCT02531438|364139848|FG001|Overall Study|Adverse Event|9|||
105584639|NCT02531438|364139847|FG000|Overall Study|Lost to Follow-up|0|||
105420623|NCT03350256|363546740|FG000|Overall Study|Withdrawal by Subject|3|||
105420624|NCT03350256|363546740|FG000|Overall Study|Subject moving out of state|1|||
105584640|NCT02531438|364139848|FG001|Overall Study|Lost to Follow-up|3|||
105584641|NCT02531438|364139847|FG000|Overall Study|Withdrawal by Subject|7|||
105584642|NCT02531438|364139848|FG001|Overall Study|Withdrawal by Subject|8|||
105584643|NCT02531438|364139847|FG000|Overall Study|Physician Decision|0|||
105500649|NCT03863197|363844544|FG001|Overall Study|Withdrawal by Subject|0|||
105500650|NCT03863197|363844543|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
105500651|NCT03863197|363844544|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
105500652|NCT05338216|363844549|FG000|Overall Study|Withdrawal by Subject|1|||
105500653|NCT05338216|363844550|FG001|Overall Study|Withdrawal by Subject|1|||
105500654|NCT05224141|363844555|FG000|Overall Study|Ongoing|75|||
105500655|NCT05224141|363844556|FG001|Overall Study|Ongoing|88|||
105500656|NCT05224141|363844555|FG000|Overall Study|Withdrawal by Subject|2|||
105500657|NCT05224141|363844556|FG001|Overall Study|Withdrawal by Subject|4|||
105500658|NCT05224141|363844555|FG000|Overall Study|Death|153|||
105500659|NCT05224141|363844556|FG001|Overall Study|Death|138|||
105500660|NCT02589405|363844568|FG000|Overall Study|Adverse Event|3|||
105500661|NCT02589405|363844568|FG000|Overall Study|Withdrawal by Subject|1|||
105500662|NCT02905149|363844570|FG000|Overall Study|Lost to Follow-up|2|||
105500663|NCT02905149|363844571|FG001|Overall Study|Lost to Follow-up|0|||
105500664|NCT02329080|363844572|FG000|Overall Study|Adverse Event|1|||
105420625|NCT03350256|363546740|FG000|Overall Study|Lost to Follow-up|1|||
105420626|NCT03350256|363546740|FG000|Overall Study|Lack of Efficacy|2|||
105420627|NCT03622112|363546745|FG000|Overall Study|Withdrawal by Subject|6|||
105420628|NCT03622112|363546746|FG001|Overall Study|Withdrawal by Subject|2|||
105420629|NCT03622112|363546747|FG002|Overall Study|Withdrawal by Subject|4|||
105420630|NCT03622112|363546748|FG003|Overall Study|Withdrawal by Subject|2|||
105420631|NCT03622112|363546749|FG004|Overall Study|Withdrawal by Subject|1|||
105420632|NCT03622112|363546750|FG005|Overall Study|Withdrawal by Subject|2|||
105420633|NCT03622112|363546751|FG006|Overall Study|Withdrawal by Subject|2|||
105420634|NCT03622112|363546745|FG000|Overall Study|Death|0|||
105420635|NCT03622112|363546746|FG001|Overall Study|Death|0|||
105420636|NCT03622112|363546747|FG002|Overall Study|Death|0|||
105420637|NCT03622112|363546748|FG003|Overall Study|Death|1|||
105420638|NCT03622112|363546749|FG004|Overall Study|Death|0|||
105420639|NCT03622112|363546750|FG005|Overall Study|Death|0|||
105420640|NCT03622112|363546751|FG006|Overall Study|Death|0|||
105420641|NCT03622112|363546745|FG000|Overall Study|Lost to Follow-up|1|||
105420642|NCT03622112|363546746|FG001|Overall Study|Lost to Follow-up|1|||
105420643|NCT03622112|363546747|FG002|Overall Study|Lost to Follow-up|0|||
105420644|NCT03622112|363546748|FG003|Overall Study|Lost to Follow-up|0|||
105420645|NCT03622112|363546749|FG004|Overall Study|Lost to Follow-up|0|||
105420646|NCT03622112|363546750|FG005|Overall Study|Lost to Follow-up|0|||
105420647|NCT03622112|363546751|FG006|Overall Study|Lost to Follow-up|0|||
105420648|NCT03622112|363546745|FG000|Overall Study|Study-specific withdrawal criteria|10|||
105420649|NCT03622112|363546746|FG001|Overall Study|Study-specific withdrawal criteria|8|||
105420650|NCT03622112|363546747|FG002|Overall Study|Study-specific withdrawal criteria|7|||
105420651|NCT03622112|363546748|FG003|Overall Study|Study-specific withdrawal criteria|6|||
105420652|NCT03622112|363546749|FG004|Overall Study|Study-specific withdrawal criteria|4|||
105420653|NCT03622112|363546750|FG005|Overall Study|Study-specific withdrawal criteria|18|||
105420654|NCT03622112|363546751|FG006|Overall Study|Study-specific withdrawal criteria|4|||
105420655|NCT03622112|363546745|FG000|Overall Study|Protocol Violation|2|||
105420656|NCT03622112|363546746|FG001|Overall Study|Protocol Violation|0|||
105420657|NCT03622112|363546747|FG002|Overall Study|Protocol Violation|1|||
105420658|NCT03622112|363546748|FG003|Overall Study|Protocol Violation|1|||
105420659|NCT03622112|363546749|FG004|Overall Study|Protocol Violation|0|||
105420660|NCT03622112|363546750|FG005|Overall Study|Protocol Violation|0|||
105420661|NCT03622112|363546751|FG006|Overall Study|Protocol Violation|0|||
105420662|NCT03622112|363546745|FG000|Overall Study|Adverse Event|6|||
105420663|NCT03622112|363546746|FG001|Overall Study|Adverse Event|8|||
105420664|NCT03622112|363546747|FG002|Overall Study|Adverse Event|4|||
105420665|NCT03622112|363546748|FG003|Overall Study|Adverse Event|11|||
105420666|NCT03622112|363546749|FG004|Overall Study|Adverse Event|4|||
105420667|NCT03622112|363546750|FG005|Overall Study|Adverse Event|20|||
105420668|NCT03622112|363546751|FG006|Overall Study|Adverse Event|2|||
105420669|NCT03622112|363546745|FG000|Overall Study|Reason not specified|0|||
105420670|NCT03622112|363546746|FG001|Overall Study|Reason not specified|1|||
105420671|NCT03622112|363546747|FG002|Overall Study|Reason not specified|0|||
105420672|NCT03622112|363546748|FG003|Overall Study|Reason not specified|1|||
105500665|NCT02329080|363844572|FG000|Overall Study|Death|4|||
105500666|NCT02329080|363844572|FG000|Overall Study|Lack of Efficacy|22|||
105500667|NCT02329080|363844572|FG000|Overall Study|Lost to Follow-up|1|||
105500668|NCT02329080|363844572|FG000|Overall Study|Physician Decision|2|||
105420673|NCT03622112|363546749|FG004|Overall Study|Reason not specified|1|||
105420674|NCT03622112|363546750|FG005|Overall Study|Reason not specified|2|||
105420675|NCT03622112|363546751|FG006|Overall Study|Reason not specified|1|||
105420676|NCT01165320|363546752|FG000|Overall Study|Clinical adverse experience|2|||
105420677|NCT01165320|363546753|FG001|Overall Study|Clinical adverse experience|1|||
105420678|NCT01165320|363546754|FG002|Overall Study|Clinical adverse experience|0|||
105420679|NCT01165320|363546752|FG000|Overall Study|Laboratory adverse experience|1|||
105500669|NCT02329080|363844572|FG000|Overall Study|Partial response|4|||
105420680|NCT01165320|363546753|FG001|Overall Study|Laboratory adverse experience|0|||
105420681|NCT01165320|363546754|FG002|Overall Study|Laboratory adverse experience|0|||
105420682|NCT01165320|363546752|FG000|Overall Study|Lack of Efficacy|0|||
105420683|NCT01165320|363546753|FG001|Overall Study|Lack of Efficacy|2|||
105420684|NCT01165320|363546754|FG002|Overall Study|Lack of Efficacy|0|||
105420685|NCT01165320|363546752|FG000|Overall Study|Reason unknown|0|||
105420686|NCT01165320|363546753|FG001|Overall Study|Reason unknown|1|||
105420687|NCT01165320|363546754|FG002|Overall Study|Reason unknown|0|||
105420688|NCT03305419|363546755|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
105420689|NCT03305419|363546756|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
105420690|NCT03305419|363546757|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
105420691|NCT03305419|363546758|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
105420692|NCT03305419|363546759|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
105420693|NCT03305419|363546760|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
105420694|NCT03305419|363546761|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
105420695|NCT03305419|363546762|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
105420696|NCT03305419|363546755|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
105420697|NCT03305419|363546756|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
105420698|NCT03305419|363546757|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
105420699|NCT03305419|363546758|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
105420700|NCT03305419|363546759|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
105420701|NCT03305419|363546760|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
105420702|NCT03305419|363546761|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
105420703|NCT03305419|363546762|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
105420704|NCT03305419|363546755|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
105420705|NCT03305419|363546756|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
105420706|NCT03305419|363546757|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
105420707|NCT03305419|363546758|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
105420708|NCT03305419|363546759|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
105420709|NCT03305419|363546760|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
105420710|NCT03305419|363546761|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
105420711|NCT03305419|363546762|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
105420712|NCT03305419|363546755|FG000|Part B (14 Days)|Adverse Event|0|||
105420713|NCT03305419|363546756|FG001|Part B (14 Days)|Adverse Event|0|||
105420714|NCT03305419|363546757|FG002|Part B (14 Days)|Adverse Event|0|||
105420715|NCT03305419|363546758|FG003|Part B (14 Days)|Adverse Event|0|||
105420716|NCT03305419|363546759|FG004|Part B (14 Days)|Adverse Event|1|||
105420717|NCT03305419|363546760|FG005|Part B (14 Days)|Adverse Event|2|||
105420718|NCT03305419|363546761|FG006|Part B (14 Days)|Adverse Event|4|||
105420719|NCT03305419|363546762|FG007|Part B (14 Days)|Adverse Event|0|||
105420720|NCT03305419|363546755|FG000|Part B (14 Days)|Physician Decision|0|||
105420721|NCT03305419|363546756|FG001|Part B (14 Days)|Physician Decision|0|||
105420722|NCT03305419|363546757|FG002|Part B (14 Days)|Physician Decision|0|||
105420723|NCT03305419|363546758|FG003|Part B (14 Days)|Physician Decision|0|||
105420724|NCT03305419|363546759|FG004|Part B (14 Days)|Physician Decision|2|||
105420725|NCT03305419|363546760|FG005|Part B (14 Days)|Physician Decision|8|||
105420726|NCT03305419|363546761|FG006|Part B (14 Days)|Physician Decision|1|||
105420727|NCT03305419|363546762|FG007|Part B (14 Days)|Physician Decision|0|||
105420728|NCT02231892|363546768|FG000|Overall Study|Lost to Follow-up|1|||
105420729|NCT02231892|363546769|FG001|Overall Study|Lost to Follow-up|0|||
105420730|NCT02231892|363546770|FG002|Overall Study|Lost to Follow-up|3|||
105420731|NCT02231892|363546768|FG000|Overall Study|Withdrawal by Subject|4|||
105420732|NCT02231892|363546769|FG001|Overall Study|Withdrawal by Subject|3|||
105420733|NCT02231892|363546770|FG002|Overall Study|Withdrawal by Subject|15|||
105420734|NCT02231892|363546768|FG000|Overall Study|Physician Decision|0|||
105420735|NCT02231892|363546769|FG001|Overall Study|Physician Decision|2|||
105420736|NCT02231892|363546770|FG002|Overall Study|Physician Decision|4|||
105420737|NCT02231892|363546768|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
105420738|NCT02231892|363546769|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
105420739|NCT02231892|363546770|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
105420740|NCT02231892|363546768|FG000|Overall Study|Participant motor threshold was >83%|0|||
105420741|NCT02231892|363546769|FG001|Overall Study|Participant motor threshold was >83%|0|||
105420742|NCT02231892|363546770|FG002|Overall Study|Participant motor threshold was >83%|9|||
105420743|NCT02231892|363546768|FG000|Overall Study|Could not find motor threshold|2|||
105420744|NCT02231892|363546769|FG001|Overall Study|Could not find motor threshold|0|||
105420745|NCT02231892|363546770|FG002|Overall Study|Could not find motor threshold|1|||
105420746|NCT02231892|363546768|FG000|Overall Study|Could not find reliable motor hotspot|0|||
105420747|NCT02231892|363546769|FG001|Overall Study|Could not find reliable motor hotspot|0|||
105420748|NCT02231892|363546770|FG002|Overall Study|Could not find reliable motor hotspot|1|||
105420749|NCT00791479|363546779|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
105500670|NCT02329080|363844572|FG000|Overall Study|Complete response|4|||
105584644|NCT02531438|364139848|FG001|Overall Study|Physician Decision|1|||
105584645|NCT02531438|364139847|FG000|Overall Study|Death|6|||
105584646|NCT02531438|364139848|FG001|Overall Study|Death|3|||
105584647|NCT02531438|364139847|FG000|Overall Study|Randomized, but Not Treated|4|||
105584648|NCT02531438|364139848|FG001|Overall Study|Randomized, but Not Treated|0|||
105584649|NCT02531438|364139847|FG000|Overall Study|Missed EOT/PTE Visit|5|||
105584650|NCT02531438|364139848|FG001|Overall Study|Missed EOT/PTE Visit|2|||
105584651|NCT02531438|364139847|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
105584652|NCT02531438|364139848|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
105584653|NCT01124617|364139849|FG000|Overall Study|Adverse Event|5|||
105584654|NCT01124617|364139850|FG001|Overall Study|Adverse Event|2|||
105584655|NCT01124617|364139849|FG000|Overall Study|Lack of Efficacy|2|||
105584656|NCT01124617|364139850|FG001|Overall Study|Lack of Efficacy|1|||
105584657|NCT01124617|364139849|FG000|Overall Study|Protocol Violation|1|||
105584658|NCT01124617|364139850|FG001|Overall Study|Protocol Violation|1|||
105584659|NCT01124617|364139849|FG000|Overall Study|Withdrawal by Subject|9|||
105584660|NCT01124617|364139850|FG001|Overall Study|Withdrawal by Subject|1|||
105584661|NCT01124617|364139849|FG000|Overall Study|Other|2|||
105584662|NCT01124617|364139850|FG001|Overall Study|Other|1|||
105584663|NCT00945477|364139851|FG000|Overall Study|Adverse Event|3|||
105584664|NCT00945477|364139851|FG000|Overall Study|Lack of Efficacy|2|||
105584665|NCT00945477|364139851|FG000|Overall Study|Withdrawal by Subject|1|||
105584666|NCT00811187|364139852|FG000|Overall Study|Unable to place device / procedure abort|3|||
105584667|NCT00811187|364139853|FG001|Overall Study|Unable to place device / procedure abort|3|||
105584668|NCT03582137|364139857|FG000|Overall Study|Adverse Event|1|||
105584669|NCT03582137|364139858|FG001|Overall Study|Adverse Event|0|||
105584670|NCT02554513|364139859|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
105584671|NCT02554513|364139860|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
105584672|NCT02303574|364139861|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
105584673|NCT02303574|364139862|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
105584674|NCT02303574|364139863|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
105584675|NCT02303574|364139864|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
105584676|NCT02303574|364139865|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
105584677|NCT02303574|364139866|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
105584678|NCT02303574|364139867|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
105584679|NCT02303574|364139868|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
105584680|NCT02303574|364139869|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
105584681|NCT02303574|364139870|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
105584682|NCT02303574|364139861|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
105584683|NCT02303574|364139862|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
105584684|NCT02303574|364139863|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
105584685|NCT02303574|364139864|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
105584686|NCT02303574|364139865|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
105584687|NCT02303574|364139866|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
105584688|NCT02303574|364139867|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
105584689|NCT02303574|364139868|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
105584690|NCT02303574|364139869|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
105584691|NCT02303574|364139870|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
105420750|NCT00791479|363546780|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
105420751|NCT00791479|363546781|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
105420752|NCT00791479|363546782|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
105420753|NCT00791479|363546783|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
105420754|NCT00791479|363546784|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
105420755|NCT00791479|363546779|FG000|Overall Study|Adverse Event|0|||
105420756|NCT00791479|363546780|FG001|Overall Study|Adverse Event|1|||
105420757|NCT00791479|363546781|FG002|Overall Study|Adverse Event|0|||
105420758|NCT00791479|363546782|FG003|Overall Study|Adverse Event|2|||
105420759|NCT00791479|363546783|FG004|Overall Study|Adverse Event|0|||
105420760|NCT00791479|363546784|FG005|Overall Study|Adverse Event|1|||
105420761|NCT00791479|363546779|FG000|Overall Study|Lost to Follow-up|0|||
105420762|NCT00791479|363546780|FG001|Overall Study|Lost to Follow-up|1|||
105420763|NCT00791479|363546781|FG002|Overall Study|Lost to Follow-up|0|||
105584692|NCT01027871|364139875|FG000|Overall Study|Physician Decision|1|||
105584693|NCT01027871|364139876|FG001|Overall Study|Physician Decision|5|||
105584694|NCT01027871|364139877|FG002|Overall Study|Physician Decision|0|||
105584695|NCT01027871|364139875|FG000|Overall Study|Protocol Violation|0|||
105584696|NCT01027871|364139876|FG001|Overall Study|Protocol Violation|2|||
105584697|NCT01027871|364139877|FG002|Overall Study|Protocol Violation|2|||
105584698|NCT01027871|364139875|FG000|Overall Study|Withdrawal by Subject|1|||
105584699|NCT01027871|364139876|FG001|Overall Study|Withdrawal by Subject|2|||
105584700|NCT01027871|364139877|FG002|Overall Study|Withdrawal by Subject|2|||
105420764|NCT00791479|363546782|FG003|Overall Study|Lost to Follow-up|0|||
105584701|NCT01027871|364139875|FG000|Overall Study|Adverse Event|0|||
105584702|NCT01027871|364139876|FG001|Overall Study|Adverse Event|2|||
105584703|NCT01027871|364139877|FG002|Overall Study|Adverse Event|2|||
105584704|NCT01027871|364139875|FG000|Overall Study|Sponsor Decision|0|||
105584705|NCT01027871|364139876|FG001|Overall Study|Sponsor Decision|2|||
105584706|NCT01027871|364139877|FG002|Overall Study|Sponsor Decision|0|||
105584707|NCT01027871|364139875|FG000|Overall Study|Discontinued Prior to Treatment|0|||
105584708|NCT01027871|364139876|FG001|Overall Study|Discontinued Prior to Treatment|0|||
105584709|NCT01027871|364139877|FG002|Overall Study|Discontinued Prior to Treatment|1|||
105584710|NCT03782727|364139878|FG000|Overall Study|Lost to Follow-up|32|||
105584711|NCT05489224|364139879|FG000|Treatment Period I|Withdrawal by Subject|6|||
105584712|NCT05489224|364139880|FG001|Treatment Period I|Withdrawal by Subject|5|||
105584713|NCT05489224|364139881|FG002|Treatment Period I|Withdrawal by Subject|0|||
105584714|NCT05489224|364139879|FG000|Treatment Period I|Adverse Event|3|||
105584715|NCT05489224|364139880|FG001|Treatment Period I|Adverse Event|11|||
105584716|NCT05489224|364139881|FG002|Treatment Period I|Adverse Event|0|||
105584717|NCT05489224|364139879|FG000|Treatment Period I|Lost to Follow-up|0|||
105584718|NCT05489224|364139880|FG001|Treatment Period I|Lost to Follow-up|1|||
105584719|NCT05489224|364139881|FG002|Treatment Period I|Lost to Follow-up|0|||
105584720|NCT05489224|364139879|FG000|Treatment Period I|Physician Decision|0|||
105584721|NCT05489224|364139880|FG001|Treatment Period I|Physician Decision|1|||
105584722|NCT05489224|364139881|FG002|Treatment Period I|Physician Decision|0|||
105584723|NCT05489224|364139879|FG000|Treatment Period II up to Week 32|Ongoing|222|||
105584724|NCT05489224|364139880|FG001|Treatment Period II up to Week 32|Ongoing|107|||
105584725|NCT05489224|364139881|FG002|Treatment Period II up to Week 32|Ongoing|107|||
105584726|NCT05489224|364139879|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
105584727|NCT05489224|364139880|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
105584728|NCT05489224|364139881|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
105584729|NCT05489224|364139879|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
105584730|NCT05489224|364139880|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
105584731|NCT05489224|364139881|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
105584732|NCT04640571|364139883|FG000|Overall Study|Withdrawal by Subject|0|||
105584733|NCT04640571|364139884|FG001|Overall Study|Withdrawal by Subject|0|||
105584734|NCT04640571|364139885|FG002|Overall Study|Withdrawal by Subject|0|||
105584735|NCT04640571|364139886|FG003|Overall Study|Withdrawal by Subject|0|||
105584736|NCT04640571|364139887|FG004|Overall Study|Withdrawal by Subject|0|||
105584737|NCT04640571|364139888|FG005|Overall Study|Withdrawal by Subject|2|||
105584738|NCT01222247|364139893|FG000|Overall Study|Lost to Follow-up|2|||
105584739|NCT01222247|364139894|FG001|Overall Study|Lost to Follow-up|2|||
105584740|NCT04530344|364139895|FG000|Overall Study|Lost to Follow-up|3|||
105420765|NCT00791479|363546783|FG004|Overall Study|Lost to Follow-up|0|||
105420766|NCT00791479|363546784|FG005|Overall Study|Lost to Follow-up|1|||
105420767|NCT00791479|363546779|FG000|Overall Study|Protocol Violation|2|||
105420768|NCT00791479|363546780|FG001|Overall Study|Protocol Violation|1|||
105420769|NCT00791479|363546781|FG002|Overall Study|Protocol Violation|0|||
105420770|NCT00791479|363546782|FG003|Overall Study|Protocol Violation|1|||
105420771|NCT00791479|363546783|FG004|Overall Study|Protocol Violation|0|||
105420772|NCT00791479|363546784|FG005|Overall Study|Protocol Violation|0|||
105420773|NCT00791479|363546779|FG000|Overall Study|Withdrawal by Subject|0|||
105420774|NCT00791479|363546780|FG001|Overall Study|Withdrawal by Subject|0|||
105420775|NCT00791479|363546781|FG002|Overall Study|Withdrawal by Subject|0|||
105420776|NCT00791479|363546782|FG003|Overall Study|Withdrawal by Subject|1|||
105420777|NCT00791479|363546783|FG004|Overall Study|Withdrawal by Subject|0|||
105420778|NCT00791479|363546784|FG005|Overall Study|Withdrawal by Subject|1|||
105420779|NCT02186652|363546785|FG000|Overall Study|Lost to Follow-up|2|||
105420780|NCT02186652|363546786|FG001|Overall Study|Lost to Follow-up|0|||
105420781|NCT00744978|363546787|FG000|Period 1|Lost to Follow-up|1|||
105420782|NCT00744978|363546788|FG001|Period 1|Lost to Follow-up|0|||
105420783|NCT00744978|363546787|FG000|Period 1|Withdrawal by Subject|0|||
105420784|NCT00744978|363546788|FG001|Period 1|Withdrawal by Subject|2|||
105420785|NCT00744978|363546787|FG000|Period 1|Other|0|||
105420786|NCT00744978|363546788|FG001|Period 1|Other|2|||
105420787|NCT00744978|363546787|FG000|Period 1|Adverse Event|4|||
105420788|NCT00744978|363546788|FG001|Period 1|Adverse Event|0|||
105420789|NCT00744978|363546787|FG000|Period 1|Randomized but not Treated|1|||
105420790|NCT00744978|363546788|FG001|Period 1|Randomized but not Treated|1|||
105584741|NCT04530344|364139896|FG001|Overall Study|Lost to Follow-up|3|||
105584742|NCT04530344|364139897|FG002|Overall Study|Lost to Follow-up|3|||
105584743|NCT04530344|364139898|FG003|Overall Study|Lost to Follow-up|10|||
105584744|NCT04530344|364139895|FG000|Overall Study|Withdrawal by Subject|14|||
105584745|NCT04530344|364139896|FG001|Overall Study|Withdrawal by Subject|5|||
105584746|NCT04530344|364139897|FG002|Overall Study|Withdrawal by Subject|18|||
105420791|NCT00744978|363546787|FG000|Period 2|Adverse Event|0|||
105420792|NCT00744978|363546788|FG001|Period 2|Adverse Event|1|||
105420793|NCT00866047|363546789|FG000|Treatment Period|Progressive disease|13|||
105420794|NCT00866047|363546789|FG000|Treatment Period|Adverse Event|16|||
105420795|NCT00866047|363546789|FG000|Treatment Period|Physician Decision|14|||
105584747|NCT04530344|364139898|FG003|Overall Study|Withdrawal by Subject|33|||
105584748|NCT04530344|364139895|FG000|Overall Study|Adverse Event|0|||
105584749|NCT04530344|364139896|FG001|Overall Study|Adverse Event|0|||
105420796|NCT00866047|363546789|FG000|Treatment Period|Withdrawal by Subject|5|||
105420797|NCT00866047|363546789|FG000|Follow-up Period|Lost to Follow-up|5|||
105420798|NCT02928029|363546790|FG000|Overall Study|Withdrawal by Subject|0|||
105420799|NCT02928029|363546791|FG001|Overall Study|Withdrawal by Subject|1|||
105420800|NCT02928029|363546790|FG000|Overall Study|Radiological progression|1|||
105420801|NCT02928029|363546791|FG001|Overall Study|Radiological progression|0|||
105420802|NCT02928029|363546790|FG000|Overall Study|Clinical progression|1|||
105420803|NCT02928029|363546791|FG001|Overall Study|Clinical progression|2|||
105420804|NCT02928029|363546790|FG000|Overall Study|AE not related to clinical progression|1|||
105420805|NCT02928029|363546791|FG001|Overall Study|AE not related to clinical progression|1|||
105420806|NCT01610713|363546794|FG000|Overall Study|Adverse Event|3|||
105420807|NCT01610713|363546795|FG001|Overall Study|Adverse Event|0|||
105420808|NCT01610713|363546794|FG000|Overall Study|Lack of Efficacy|1|||
105420809|NCT01610713|363546795|FG001|Overall Study|Lack of Efficacy|0|||
105420810|NCT01610713|363546794|FG000|Overall Study|low mood and poor motivation|1|||
105420811|NCT01610713|363546795|FG001|Overall Study|low mood and poor motivation|0|||
105420812|NCT01610713|363546794|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
105420813|NCT01610713|363546795|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
105420814|NCT01610713|363546794|FG000|Overall Study|Lost to Follow-up|0|||
105420815|NCT01610713|363546795|FG001|Overall Study|Lost to Follow-up|1|||
105420816|NCT03703817|363546798|FG000|Overall Study|Not meeting eligibility criteria|7|||
105420817|NCT03703817|363546799|FG001|Overall Study|Not meeting eligibility criteria|4|||
105420818|NCT02778555|363546800|FG000|Overall Study|Withdrawal by Subject|55|||
105420819|NCT02778555|363546801|FG001|Overall Study|Withdrawal by Subject|32|||
105420820|NCT02778555|363546802|FG002|Overall Study|Withdrawal by Subject|107|||
105420821|NCT02509039|363546803|FG000|Overall Study|Adverse Event|0|||
105420822|NCT02509039|363546804|FG001|Overall Study|Adverse Event|1|||
105420823|NCT02509039|363546805|FG002|Overall Study|Adverse Event|1|||
105420824|NCT02509039|363546806|FG003|Overall Study|Adverse Event|1|||
105420825|NCT02509039|363546803|FG000|Overall Study|Withdrawal by Subject|0|||
105420826|NCT02509039|363546804|FG001|Overall Study|Withdrawal by Subject|0|||
105420827|NCT02509039|363546805|FG002|Overall Study|Withdrawal by Subject|1|||
105420828|NCT02509039|363546806|FG003|Overall Study|Withdrawal by Subject|0|||
105420829|NCT02509039|363546803|FG000|Overall Study|Progressive disease|2|||
105420830|NCT02509039|363546804|FG001|Overall Study|Progressive disease|2|||
105420831|NCT02509039|363546805|FG002|Overall Study|Progressive disease|1|||
105420832|NCT02509039|363546806|FG003|Overall Study|Progressive disease|5|||
105420833|NCT02509039|363546803|FG000|Overall Study|Study terminated by Sponsor|1|||
105420834|NCT02509039|363546804|FG001|Overall Study|Study terminated by Sponsor|0|||
105420835|NCT02509039|363546805|FG002|Overall Study|Study terminated by Sponsor|0|||
105420836|NCT02509039|363546806|FG003|Overall Study|Study terminated by Sponsor|0|||
105420837|NCT04659174|363546810|FG000|Overall Study|Sponsor decision to discontinue study|0|||
105420838|NCT04659174|363546811|FG001|Overall Study|Sponsor decision to discontinue study|2|||
105420839|NCT04659174|363546810|FG000|Overall Study|Lost to Follow-up|9|||
105420840|NCT04659174|363546811|FG001|Overall Study|Lost to Follow-up|11|||
105420841|NCT04659174|363546810|FG000|Overall Study|Adverse Event|8|||
105420842|NCT04659174|363546811|FG001|Overall Study|Adverse Event|5|||
105420843|NCT04659174|363546810|FG000|Overall Study|Withdrawal by Subject|17|||
105420844|NCT04659174|363546811|FG001|Overall Study|Withdrawal by Subject|33|||
105420845|NCT04659174|363546810|FG000|Overall Study|Progressive disease|0|||
105420846|NCT04659174|363546811|FG001|Overall Study|Progressive disease|2|||
105420847|NCT04659174|363546810|FG000|Overall Study|Other reasons|0|||
105420848|NCT04659174|363546811|FG001|Overall Study|Other reasons|2|||
105420849|NCT04659174|363546810|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
105420850|NCT04659174|363546811|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
105420851|NCT04659174|363546810|FG000|Overall Study|Alcohol or illegal drug use|0|||
105420852|NCT04659174|363546811|FG001|Overall Study|Alcohol or illegal drug use|3|||
105420853|NCT04659174|363546810|FG000|Overall Study|Violation of entry criteria|1|||
105420854|NCT04659174|363546811|FG001|Overall Study|Violation of entry criteria|0|||
105420855|NCT04659174|363546810|FG000|Overall Study|Death|0|||
105420856|NCT04659174|363546811|FG001|Overall Study|Death|1|||
105420857|NCT03276026|363546812|FG000|Overall Study|Protocol Violation|1|||
105420858|NCT03276026|363546813|FG001|Overall Study|Protocol Violation|0|||
105420859|NCT02901054|363546817|FG000|Overall Study|Physician Decision|1|||
105420860|NCT02901054|363546817|FG000|Overall Study|Withdrawal by Subject|3|||
105420861|NCT04049266|363546818|FG000|Overall Study|Adverse Event|16|||
105420862|NCT04049266|363546819|FG001|Overall Study|Adverse Event|9|||
105420863|NCT04049266|363546818|FG000|Overall Study|Non-compliance with study drug|0|||
105420864|NCT04049266|363546819|FG001|Overall Study|Non-compliance with study drug|3|||
105420865|NCT04049266|363546818|FG000|Overall Study|Withdrawal by Subject|6|||
105420866|NCT04049266|363546819|FG001|Overall Study|Withdrawal by Subject|10|||
105420867|NCT04049266|363546818|FG000|Overall Study|Lost to Follow-up|2|||
105420868|NCT04049266|363546819|FG001|Overall Study|Lost to Follow-up|2|||
105420869|NCT04049266|363546818|FG000|Overall Study|Progressive disease|11|||
105420870|NCT04049266|363546819|FG001|Overall Study|Progressive disease|2|||
105420871|NCT04049266|363546818|FG000|Overall Study|Physician Decision|1|||
105420872|NCT04049266|363546819|FG001|Overall Study|Physician Decision|0|||
105420873|NCT04049266|363546818|FG000|Overall Study|Patient moved out of state|1|||
105420874|NCT04049266|363546819|FG001|Overall Study|Patient moved out of state|0|||
105420875|NCT01534260|363546820|FG000|Overall Study|Adverse Event|1|||
105420876|NCT01534260|363546821|FG001|Overall Study|Adverse Event|8|||
105420877|NCT01534260|363546820|FG000|Overall Study|Death|2|||
105420878|NCT01534260|363546821|FG001|Overall Study|Death|0|||
105420879|NCT01534260|363546820|FG000|Overall Study|Lack of Efficacy|1|||
105420880|NCT01534260|363546821|FG001|Overall Study|Lack of Efficacy|1|||
105420881|NCT01534260|363546820|FG000|Overall Study|Withdrawal by Subject|1|||
105420882|NCT01534260|363546821|FG001|Overall Study|Withdrawal by Subject|3|||
105420883|NCT01534260|363546820|FG000|Overall Study|Disease Progression|8|||
105420884|NCT01534260|363546821|FG001|Overall Study|Disease Progression|6|||
105420885|NCT01534260|363546820|FG000|Overall Study|Physician Decision|3|||
105420886|NCT01534260|363546821|FG001|Overall Study|Physician Decision|1|||
105420887|NCT01534260|363546820|FG000|Overall Study|No treatment, per protocol|0|||
105420888|NCT01534260|363546821|FG001|Overall Study|No treatment, per protocol|1|||
105420889|NCT01703208|363546822|FG000|Overall Study|Death|61|||
105420890|NCT01703208|363546823|FG001|Overall Study|Death|48|||
105420891|NCT01703208|363546822|FG000|Overall Study|Lack of Efficacy|1|||
105420892|NCT01703208|363546823|FG001|Overall Study|Lack of Efficacy|2|||
105420893|NCT01703208|363546822|FG000|Overall Study|Lost to Follow-up|68|||
105420894|NCT01703208|363546823|FG001|Overall Study|Lost to Follow-up|62|||
105420895|NCT01703208|363546822|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105420896|NCT01703208|363546823|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105420897|NCT01703208|363546822|FG000|Overall Study|Excluded Medication|1|||
105420898|NCT01703208|363546823|FG001|Overall Study|Excluded Medication|2|||
105420899|NCT01703208|363546822|FG000|Overall Study|Site Discontinued Study Participation|23|||
105420900|NCT01703208|363546823|FG001|Overall Study|Site Discontinued Study Participation|27|||
105420901|NCT01703208|363546822|FG000|Overall Study|Physician Decision|11|||
105420902|NCT01703208|363546823|FG001|Overall Study|Physician Decision|13|||
105420903|NCT01703208|363546822|FG000|Overall Study|Progressive disease|2|||
105420904|NCT01703208|363546823|FG001|Overall Study|Progressive disease|2|||
105420905|NCT01703208|363546822|FG000|Overall Study|Protocol Violation|1|||
105420906|NCT01703208|363546823|FG001|Overall Study|Protocol Violation|1|||
105420907|NCT01703208|363546822|FG000|Overall Study|Study Terminated by Sponsor|1710|||
105420908|NCT01703208|363546823|FG001|Overall Study|Study Terminated by Sponsor|1716|||
105420909|NCT01703208|363546822|FG000|Overall Study|Withdrawal by Subject|205|||
105584750|NCT04530344|364139897|FG002|Overall Study|Adverse Event|0|||
105584751|NCT04530344|364139898|FG003|Overall Study|Adverse Event|1|||
105584752|NCT04530344|364139895|FG000|Overall Study|Lack of Efficacy|0|||
105584753|NCT04530344|364139896|FG001|Overall Study|Lack of Efficacy|0|||
105584754|NCT04530344|364139897|FG002|Overall Study|Lack of Efficacy|0|||
105584755|NCT04530344|364139898|FG003|Overall Study|Lack of Efficacy|1|||
105584756|NCT04530344|364139895|FG000|Overall Study|Physician Decision|0|||
105584757|NCT04530344|364139896|FG001|Overall Study|Physician Decision|0|||
105584758|NCT04530344|364139897|FG002|Overall Study|Physician Decision|1|||
105584759|NCT04530344|364139898|FG003|Overall Study|Physician Decision|1|||
105584760|NCT04530344|364139895|FG000|Overall Study|Pregnancy|0|||
105584761|NCT04530344|364139896|FG001|Overall Study|Pregnancy|0|||
105584762|NCT04530344|364139897|FG002|Overall Study|Pregnancy|2|||
105584763|NCT04530344|364139898|FG003|Overall Study|Pregnancy|1|||
105584764|NCT04530344|364139895|FG000|Overall Study|Protocol Violation|0|||
105584765|NCT04530344|364139896|FG001|Overall Study|Protocol Violation|0|||
105584766|NCT04530344|364139897|FG002|Overall Study|Protocol Violation|0|||
105584767|NCT04530344|364139898|FG003|Overall Study|Protocol Violation|1|||
105584768|NCT04530344|364139895|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
105584769|NCT04530344|364139896|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
105584770|NCT04530344|364139897|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
105584771|NCT04530344|364139898|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
105584772|NCT04530344|364139895|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
105584773|NCT04530344|364139896|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
105584774|NCT04530344|364139897|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
105584775|NCT04530344|364139898|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
105584776|NCT04530344|364139895|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
105584777|NCT04530344|364139896|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
105584778|NCT04530344|364139897|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
105584779|NCT04530344|364139898|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
105584780|NCT04530344|364139895|FG000|Overall Study|Personal Reasons|0|||
105584781|NCT04530344|364139896|FG001|Overall Study|Personal Reasons|0|||
105584782|NCT04530344|364139897|FG002|Overall Study|Personal Reasons|0|||
105584783|NCT04530344|364139898|FG003|Overall Study|Personal Reasons|1|||
105584784|NCT04530344|364139895|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
105584785|NCT04530344|364139896|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
105584786|NCT04530344|364139897|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
105584787|NCT04530344|364139898|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
105584788|NCT04736056|364139903|FG000|Overall Study|Death|0|||
105584789|NCT04736056|364139904|FG001|Overall Study|Death|0|||
105584790|NCT04736056|364139905|FG002|Overall Study|Death|0|||
105584791|NCT04736056|364139906|FG003|Overall Study|Death|1|||
105584792|NCT04736056|364139903|FG000|Overall Study|Lost to Follow-up|1|||
105584793|NCT04736056|364139904|FG001|Overall Study|Lost to Follow-up|0|||
105584794|NCT04736056|364139905|FG002|Overall Study|Lost to Follow-up|1|||
105584795|NCT04736056|364139906|FG003|Overall Study|Lost to Follow-up|1|||
105584796|NCT04736056|364139903|FG000|Overall Study|Withdrawal by Subject|2|||
105420910|NCT01703208|363546823|FG001|Overall Study|Withdrawal by Subject|209|||
105420911|NCT01703208|363546822|FG000|Overall Study|Adverse Event|14|||
105420912|NCT01703208|363546823|FG001|Overall Study|Adverse Event|19|||
105584797|NCT04736056|364139904|FG001|Overall Study|Withdrawal by Subject|0|||
105584798|NCT04736056|364139905|FG002|Overall Study|Withdrawal by Subject|0|||
105584799|NCT04736056|364139906|FG003|Overall Study|Withdrawal by Subject|0|||
105420913|NCT01703208|363546822|FG000|Overall Study|Technical Problems|0|||
105420914|NCT01703208|363546823|FG001|Overall Study|Technical Problems|1|||
105420915|NCT01703208|363546822|FG000|Overall Study|Protocol Deviation|2|||
105420916|NCT01703208|363546823|FG001|Overall Study|Protocol Deviation|0|||
105420917|NCT02359045|363546826|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
105420918|NCT02359045|363546827|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
105420919|NCT02359045|363546826|FG000|Overall Study|Lost to Follow-up|1|||
105420920|NCT02359045|363546827|FG001|Overall Study|Lost to Follow-up|1|||
105420921|NCT02359045|363546826|FG000|Overall Study|Adverse Event|0|||
105420922|NCT02359045|363546827|FG001|Overall Study|Adverse Event|1|||
105420923|NCT02099344|363546829|FG000|Overall Study|Physician Decision|1|||
105420924|NCT02099344|363546830|FG001|Overall Study|Physician Decision|0|||
105420925|NCT00404755|363546835|FG000|Phase I (Bupropion)|Adverse Event|3|||
105420926|NCT00404755|363546835|FG000|Phase I (Bupropion)|Other|1|||
105420927|NCT00404755|363546835|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
105420928|NCT02839720|363546836|FG000|Overall Study|Adverse Event|2|||
105584800|NCT04736056|364139903|FG000|Overall Study|Physician Decision|1|||
105420929|NCT02839720|363546836|FG000|Overall Study|Non-compliance|2|||
105584801|NCT04736056|364139904|FG001|Overall Study|Physician Decision|0|||
105584802|NCT04736056|364139905|FG002|Overall Study|Physician Decision|1|||
105584803|NCT04736056|364139906|FG003|Overall Study|Physician Decision|0|||
105584804|NCT04939428|364139907|FG000|Overall Study|Death|0|||
105420930|NCT02839720|363546836|FG000|Overall Study|Intercurrent Illness|1|||
105584805|NCT04939428|364139908|FG001|Overall Study|Death|1|||
105584806|NCT04939428|364139909|FG002|Overall Study|Death|0|||
105584807|NCT04939428|364139907|FG000|Overall Study|Lost to Follow-up|0|||
105584808|NCT04939428|364139908|FG001|Overall Study|Lost to Follow-up|5|||
105584809|NCT04939428|364139909|FG002|Overall Study|Lost to Follow-up|0|||
105584810|NCT04939428|364139907|FG000|Overall Study|Physician Decision|1|||
105584811|NCT04939428|364139908|FG001|Overall Study|Physician Decision|0|||
105584812|NCT04939428|364139909|FG002|Overall Study|Physician Decision|0|||
105584813|NCT04939428|364139907|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
105584814|NCT04939428|364139908|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105584815|NCT04939428|364139909|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105584816|NCT04939428|364139907|FG000|Overall Study|Withdrawal by Subject|10|||
105584817|NCT04939428|364139908|FG001|Overall Study|Withdrawal by Subject|11|||
105584818|NCT04939428|364139909|FG002|Overall Study|Withdrawal by Subject|0|||
105584819|NCT04939428|364139907|FG000|Overall Study|Unkown|6|||
105584820|NCT04939428|364139908|FG001|Overall Study|Unkown|3|||
105584821|NCT04939428|364139909|FG002|Overall Study|Unkown|0|||
105584822|NCT04939428|364139907|FG000|Overall Study|Discotinued per protocol|0|||
105584823|NCT04939428|364139908|FG001|Overall Study|Discotinued per protocol|0|||
105584824|NCT04939428|364139909|FG002|Overall Study|Discotinued per protocol|902|||
105584825|NCT02099539|364139915|FG000|Overall Study|Progressive Disease|3|||
105584826|NCT02099539|364139916|FG001|Overall Study|Progressive Disease|2|||
105584827|NCT02099539|364139917|FG002|Overall Study|Progressive Disease|2|||
105584828|NCT02099539|364139918|FG003|Overall Study|Progressive Disease|1|||
105584829|NCT02099539|364139919|FG004|Overall Study|Progressive Disease|4|||
105584830|NCT02099539|364139920|FG005|Overall Study|Progressive Disease|2|||
105584831|NCT02099539|364139921|FG006|Overall Study|Progressive Disease|0|||
105584832|NCT02099539|364139915|FG000|Overall Study|Adverse Event|0|||
105584833|NCT02099539|364139916|FG001|Overall Study|Adverse Event|0|||
105584834|NCT02099539|364139917|FG002|Overall Study|Adverse Event|1|||
105584835|NCT02099539|364139918|FG003|Overall Study|Adverse Event|1|||
105584836|NCT02099539|364139919|FG004|Overall Study|Adverse Event|0|||
105584837|NCT02099539|364139920|FG005|Overall Study|Adverse Event|0|||
105584838|NCT02099539|364139921|FG006|Overall Study|Adverse Event|0|||
105584839|NCT02099539|364139915|FG000|Overall Study|Physician Decision|0|||
105584840|NCT02099539|364139916|FG001|Overall Study|Physician Decision|0|||
105584841|NCT02099539|364139917|FG002|Overall Study|Physician Decision|0|||
105584842|NCT02099539|364139918|FG003|Overall Study|Physician Decision|0|||
105584843|NCT02099539|364139919|FG004|Overall Study|Physician Decision|0|||
105584844|NCT02099539|364139920|FG005|Overall Study|Physician Decision|1|||
105584845|NCT02099539|364139921|FG006|Overall Study|Physician Decision|0|||
105584846|NCT02696785|364139923|FG000|Blinded Treatment Period|Adverse Event|0|||
105584847|NCT02696785|364139924|FG001|Blinded Treatment Period|Adverse Event|1|||
105584848|NCT02696785|364139925|FG002|Blinded Treatment Period|Adverse Event|3|||
105584849|NCT02696785|364139926|FG003|Blinded Treatment Period|Adverse Event|0|||
105584850|NCT02696785|364139923|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
105584851|NCT02696785|364139924|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
105584852|NCT02696785|364139925|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
105420931|NCT02839720|363546836|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
105420932|NCT05151445|363546839|FG000|Overall Study|Withdrawal by Subject|3|||
105420933|NCT01967823|363548109|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
105420934|NCT02456636|363548113|FG000|Overall Study|Death|0|||
105420935|NCT02456636|363548114|FG001|Overall Study|Death|3|||
105420936|NCT02456636|363548115|FG002|Overall Study|Death|0|||
105420937|NCT02456636|363548113|FG000|Overall Study|Pregnancy|1|||
105420938|NCT02456636|363548114|FG001|Overall Study|Pregnancy|3|||
105420939|NCT02456636|363548115|FG002|Overall Study|Pregnancy|5|||
105420940|NCT02456636|363548113|FG000|Overall Study|Physician Decision|4|||
105420941|NCT02456636|363548114|FG001|Overall Study|Physician Decision|5|||
105420942|NCT02456636|363548115|FG002|Overall Study|Physician Decision|4|||
105420943|NCT02456636|363548113|FG000|Overall Study|Withdrawal by Subject|13|||
105420944|NCT02456636|363548114|FG001|Overall Study|Withdrawal by Subject|14|||
105420945|NCT02456636|363548115|FG002|Overall Study|Withdrawal by Subject|16|||
105420946|NCT02456636|363548113|FG000|Overall Study|Lost to Follow-up|50|||
105584853|NCT02696785|364139926|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
105584854|NCT02696785|364139923|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
105584855|NCT02696785|364139924|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
105584856|NCT02696785|364139925|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
105584857|NCT02696785|364139926|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
105584858|NCT02696785|364139923|FG000|Blinded Treatment Period|Screen Failure|1|||
105420947|NCT02456636|363548114|FG001|Overall Study|Lost to Follow-up|44|||
105420948|NCT02456636|363548115|FG002|Overall Study|Lost to Follow-up|50|||
105584859|NCT02696785|364139924|FG001|Blinded Treatment Period|Screen Failure|0|||
105584860|NCT02696785|364139925|FG002|Blinded Treatment Period|Screen Failure|0|||
105584861|NCT02696785|364139926|FG003|Blinded Treatment Period|Screen Failure|0|||
105584862|NCT02696785|364139923|FG000|Washout Period|Withdrawal by Subject|0|||
105420949|NCT01942161|363548116|FG000|Overall Study|Adverse Event|1|||
105420950|NCT01942161|363548117|FG001|Overall Study|Adverse Event|2|||
105420951|NCT01942161|363548118|FG002|Overall Study|Adverse Event|5|||
105420952|NCT01942161|363548116|FG000|Overall Study|Physician Decision|3|||
105420953|NCT01942161|363548117|FG001|Overall Study|Physician Decision|1|||
105420954|NCT01942161|363548118|FG002|Overall Study|Physician Decision|0|||
105420955|NCT01942161|363548116|FG000|Overall Study|Protocol Violation|1|||
105420956|NCT01942161|363548117|FG001|Overall Study|Protocol Violation|0|||
105420957|NCT01942161|363548118|FG002|Overall Study|Protocol Violation|0|||
105420958|NCT01942161|363548116|FG000|Overall Study|Withdrawal by Subject|3|||
105420959|NCT01942161|363548117|FG001|Overall Study|Withdrawal by Subject|3|||
105420960|NCT01942161|363548118|FG002|Overall Study|Withdrawal by Subject|1|||
105420961|NCT02379221|363548119|FG000|Overall Study|Lost to Follow-up|1|||
105420962|NCT02019108|363548120|FG000|Overall Study|Lost to Follow-up|5|||
105420963|NCT02019108|363548121|FG001|Overall Study|Lost to Follow-up|7|||
105420964|NCT02688088|363548123|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
105420965|NCT02688088|363548124|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
105420966|NCT02688088|363548125|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
105420967|NCT02688088|363548126|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
105420968|NCT02688088|363548127|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
105420969|NCT02688088|363548123|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
105420970|NCT02688088|363548124|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
105420971|NCT02688088|363548125|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
105420972|NCT02688088|363548126|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
105420973|NCT02688088|363548127|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
105420974|NCT02688088|363548123|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
105420975|NCT02688088|363548124|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
105420976|NCT02688088|363548125|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
105420977|NCT02688088|363548126|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
105420978|NCT02688088|363548127|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
105420979|NCT02688088|363548123|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
105420980|NCT02688088|363548124|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
105420981|NCT02688088|363548125|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
105420982|NCT02688088|363548126|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
105420983|NCT02688088|363548127|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
105420984|NCT02688088|363548123|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
105420985|NCT02688088|363548124|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
105500671|NCT00413244|363844576|FG000|Overall Study|Withdrawal by Subject|10|||
105500672|NCT00413244|363844577|FG001|Overall Study|Withdrawal by Subject|1|||
105500673|NCT00446251|363844584|FG000|Overall Study|On-study Transplants|2|||
105500674|NCT00446251|363844584|FG000|Overall Study|Rituximab Infusion Reaction|2|||
105500675|NCT00446251|363844584|FG000|Overall Study|Lost to Follow-up|1|||
105500676|NCT01042678|363844588|FG000|Overall Study|Physician Decision|1|||
105500677|NCT01042678|363844589|FG001|Overall Study|Physician Decision|0|||
105500678|NCT01042678|363844590|FG002|Overall Study|Physician Decision|0|||
105500679|NCT01042678|363844591|FG003|Overall Study|Physician Decision|0|||
105500680|NCT01042678|363844592|FG004|Overall Study|Physician Decision|0|||
105500681|NCT01042678|363844593|FG005|Overall Study|Physician Decision|0|||
105500682|NCT03725852|363844595|FG000|Overall Study|Death|1|||
105500683|NCT03725852|363844596|FG001|Overall Study|Death|0|||
105500684|NCT03725852|363844595|FG000|Overall Study|Withdrawal by Subject|1|||
105500685|NCT03725852|363844596|FG001|Overall Study|Withdrawal by Subject|0|||
105500686|NCT03725852|363844595|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
105500687|NCT03725852|363844596|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
105500688|NCT01058655|363844600|FG000|Overall Study|Withdrawal by Subject|1|||
105500689|NCT01058655|363844601|FG001|Overall Study|Withdrawal by Subject|0|||
105500690|NCT01058655|363844602|FG002|Overall Study|Withdrawal by Subject|3|||
105500691|NCT01058655|363844603|FG003|Overall Study|Withdrawal by Subject|4|||
105500692|NCT01058655|363844600|FG000|Overall Study|Prolonged Treatment Delay|0|||
105500693|NCT01058655|363844601|FG001|Overall Study|Prolonged Treatment Delay|0|||
105500694|NCT01058655|363844602|FG002|Overall Study|Prolonged Treatment Delay|0|||
105500695|NCT01058655|363844603|FG003|Overall Study|Prolonged Treatment Delay|2|||
105500696|NCT01058655|363844600|FG000|Overall Study|Symptomatic Deterioration|0|||
105500697|NCT01058655|363844601|FG001|Overall Study|Symptomatic Deterioration|0|||
105500698|NCT01058655|363844602|FG002|Overall Study|Symptomatic Deterioration|0|||
105500699|NCT01058655|363844603|FG003|Overall Study|Symptomatic Deterioration|1|||
105500700|NCT01058655|363844600|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
105500701|NCT01058655|363844601|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
105500702|NCT01058655|363844602|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
105500703|NCT01058655|363844603|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
105500704|NCT01058655|363844600|FG000|Overall Study|Death|0|||
105500705|NCT01058655|363844601|FG001|Overall Study|Death|1|||
105500706|NCT01058655|363844602|FG002|Overall Study|Death|1|||
105500707|NCT01058655|363844603|FG003|Overall Study|Death|0|||
105420986|NCT02688088|363548125|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
105420987|NCT02688088|363548126|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
105420988|NCT02688088|363548127|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
105420989|NCT02688088|363548123|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
105420990|NCT02688088|363548124|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
105420991|NCT02688088|363548125|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
105420992|NCT02688088|363548126|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
105420993|NCT02688088|363548127|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
105420994|NCT02688088|363548123|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
105420995|NCT02688088|363548124|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
105420996|NCT02688088|363548125|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
105420997|NCT02688088|363548126|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
105420998|NCT02688088|363548127|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
105420999|NCT02688088|363548123|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
105421000|NCT02688088|363548124|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
105421001|NCT02688088|363548125|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
105421002|NCT02688088|363548126|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
105421003|NCT02688088|363548127|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
105421004|NCT02688088|363548123|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
105421005|NCT02688088|363548124|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
105421006|NCT02688088|363548125|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
105421007|NCT02688088|363548126|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
105421008|NCT02688088|363548127|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
105421009|NCT01728077|363548130|FG000|Overall Study|Lack of Efficacy|3|||
105421010|NCT01728077|363548131|FG001|Overall Study|Lack of Efficacy|1|||
105421011|NCT01728077|363548130|FG000|Overall Study|Lost to Follow-up|1|||
105421012|NCT01728077|363548131|FG001|Overall Study|Lost to Follow-up|0|||
105421013|NCT01728077|363548130|FG000|Overall Study|Subject choice|2|||
105421014|NCT01728077|363548131|FG001|Overall Study|Subject choice|3|||
105421015|NCT01728077|363548130|FG000|Overall Study|Death|0|||
105421016|NCT01728077|363548131|FG001|Overall Study|Death|1|||
105421017|NCT01728077|363548130|FG000|Overall Study|Patient moving|1|||
105421018|NCT01728077|363548131|FG001|Overall Study|Patient moving|0|||
105421019|NCT01728077|363548130|FG000|Overall Study|Non compliance|1|||
105421020|NCT01728077|363548131|FG001|Overall Study|Non compliance|0|||
105421021|NCT02442310|363548132|FG000|Overall Study|Adverse Event|2|||
105421022|NCT02442310|363548132|FG000|Overall Study|Withdrawal by Subject|1|||
105421023|NCT00688324|363548133|FG000|Overall Study|Withdrawal by Subject|2|||
105421024|NCT00688324|363548133|FG000|Overall Study|Physician Decision|5|||
105421025|NCT00688324|363548133|FG000|Overall Study|Lost to Follow-up|1|||
105421026|NCT03176472|363548134|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
105421027|NCT03176472|363548135|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
105421028|NCT03176472|363548134|FG000|Double Blind Treatment Period|Adverse Event|0|||
105421029|NCT03176472|363548135|FG001|Double Blind Treatment Period|Adverse Event|5|||
105421030|NCT03176472|363548134|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
105421031|NCT03176472|363548135|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
105421032|NCT03176472|363548134|FG000|Double Blind Treatment Period|Physician Decision|0|||
105421033|NCT03176472|363548135|FG001|Double Blind Treatment Period|Physician Decision|1|||
105421034|NCT03176472|363548134|FG000|Double Blind Treatment Period|Protocol Violation|1|||
105421035|NCT03176472|363548135|FG001|Double Blind Treatment Period|Protocol Violation|0|||
105421036|NCT03176472|363548134|FG000|Double Blind Treatment Period|Not Provided|1|||
105421037|NCT03176472|363548135|FG001|Double Blind Treatment Period|Not Provided|0|||
105421038|NCT03176472|363548134|FG000|Open Label Extension|Withdrawal by Subject|3|||
105421039|NCT03176472|363548135|FG001|Open Label Extension|Withdrawal by Subject|4|||
105421040|NCT03176472|363548134|FG000|Open Label Extension|Adverse Event|2|||
105421041|NCT03176472|363548135|FG001|Open Label Extension|Adverse Event|4|||
105421042|NCT03176472|363548134|FG000|Open Label Extension|Lost to Follow-up|1|||
105421043|NCT03176472|363548135|FG001|Open Label Extension|Lost to Follow-up|2|||
105421044|NCT03176472|363548134|FG000|Open Label Extension|Protocol Violation|0|||
105421045|NCT03176472|363548135|FG001|Open Label Extension|Protocol Violation|1|||
105421046|NCT03176472|363548134|FG000|Open Label Extension|Not Provided|2|||
105421047|NCT03176472|363548135|FG001|Open Label Extension|Not Provided|1|||
105421048|NCT00596154|363548136|FG000|Overall Study|Not Evaluable|2|||
105421049|NCT01190475|363548140|FG000|Overall Study|Withdrawal by Subject|0|||
105421050|NCT01190475|363548141|FG001|Overall Study|Withdrawal by Subject|0|||
105421051|NCT01190475|363548142|FG002|Overall Study|Withdrawal by Subject|1|||
105421052|NCT00624585|363548143|FG000|Overall Study|Death|3|||
105421053|NCT00624585|363548143|FG000|Overall Study|Disease Progression|6|||
105421054|NCT00624585|363548143|FG000|Overall Study|Adverse Event|3|||
105421055|NCT03960580|363548144|FG000|Overall Study|Adverse Event|2|||
105421056|NCT03960580|363548145|FG001|Overall Study|Adverse Event|1|||
105421057|NCT03960580|363548146|FG002|Overall Study|Adverse Event|1|||
105421058|NCT03960580|363548144|FG000|Overall Study|Lost to Follow-up|1|||
105421059|NCT03960580|363548145|FG001|Overall Study|Lost to Follow-up|0|||
105421060|NCT03960580|363548146|FG002|Overall Study|Lost to Follow-up|0|||
105421061|NCT03960580|363548144|FG000|Overall Study|Lack of Efficacy|2|||
105421062|NCT03960580|363548145|FG001|Overall Study|Lack of Efficacy|1|||
105421063|NCT03960580|363548146|FG002|Overall Study|Lack of Efficacy|0|||
105421064|NCT03960580|363548144|FG000|Overall Study|Protocol Violation|0|||
105421065|NCT03960580|363548145|FG001|Overall Study|Protocol Violation|0|||
105421066|NCT03960580|363548146|FG002|Overall Study|Protocol Violation|1|||
105421067|NCT03960580|363548144|FG000|Overall Study|Withdrawal by Subject|1|||
105421068|NCT03960580|363548145|FG001|Overall Study|Withdrawal by Subject|1|||
105421069|NCT03960580|363548146|FG002|Overall Study|Withdrawal by Subject|1|||
105421070|NCT03960580|363548144|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
105421071|NCT03960580|363548145|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
105421072|NCT03960580|363548146|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
105421073|NCT00666588|363548149|FG000|Overall Study|ineligible|2|||
105421074|NCT00666588|363548150|FG001|Overall Study|ineligible|0|||
105421075|NCT00666588|363548151|FG002|Overall Study|ineligible|0|||
105421076|NCT00666588|363548152|FG003|Overall Study|ineligible|2|||
105421077|NCT00666588|363548149|FG000|Overall Study|inevaluable|2|||
105421078|NCT00666588|363548150|FG001|Overall Study|inevaluable|0|||
105421079|NCT00666588|363548151|FG002|Overall Study|inevaluable|0|||
105421080|NCT00666588|363548152|FG003|Overall Study|inevaluable|0|||
105421081|NCT04043234|363548153|FG000|Overall Study|Lost to Follow-up|1|||
105421082|NCT04043234|363548153|FG000|Overall Study|Withdrawal by Subject|1|||
105421083|NCT00385944|363548154|FG000|1st Maintenance Dose Period|Physician Decision|1|||
105421084|NCT00385944|363548155|FG001|1st Maintenance Dose Period|Physician Decision|0|||
105421085|NCT00385944|363548156|FG002|1st Maintenance Dose Period|Physician Decision|0|||
105421086|NCT00385944|363548154|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
105421087|NCT00385944|363548155|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
105421088|NCT00385944|363548156|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
105421089|NCT00385944|363548154|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
105421090|NCT00385944|363548155|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
105421091|NCT00385944|363548156|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
105421092|NCT00385944|363548154|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
105421093|NCT00385944|363548155|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
105421094|NCT00385944|363548156|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
105421095|NCT00889603|363548157|FG000|Overall Study|Adverse Event|7|||
105421096|NCT00889603|363548157|FG000|Overall Study|Death|3|||
105421097|NCT00889603|363548157|FG000|Overall Study|Lost to Follow-up|19|||
105421098|NCT00889603|363548157|FG000|Overall Study|No longer willing to participant in stud|4|||
105421099|NCT00889603|363548157|FG000|Overall Study|Other|4|||
105421100|NCT05427539|363548160|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
105421101|NCT05427539|363548161|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
105421102|NCT05427539|363548160|FG000|Period 1|Withdrawal by Subject|1|||
105421103|NCT05427539|363548161|FG001|Period 1|Withdrawal by Subject|0|||
105421104|NCT01349322|363548162|FG000|Overall Study|Protocol Violation|45|||
105421105|NCT01349322|363548163|FG001|Overall Study|Protocol Violation|47|||
105421106|NCT01271712|363548164|FG000|Double Blind Treatment|Death|2|||
105421107|NCT01271712|363548165|FG001|Double Blind Treatment|Death|0|||
105421108|NCT01271712|363548164|FG000|Double Blind Treatment|Lack of Efficacy|1|||
105421109|NCT01271712|363548165|FG001|Double Blind Treatment|Lack of Efficacy|0|||
105421110|NCT01271712|363548164|FG000|Double Blind Treatment|Adverse Event|9|||
105421111|NCT01271712|363548165|FG001|Double Blind Treatment|Adverse Event|4|||
105421112|NCT01271712|363548164|FG000|Double Blind Treatment|Progressive disease|23|||
105421113|NCT01271712|363548165|FG001|Double Blind Treatment|Progressive disease|3|||
105421114|NCT01271712|363548164|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
105421115|NCT01271712|363548165|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
105421116|NCT01271712|363548164|FG000|Double Blind Treatment|Non compliance with study drug|2|||
105421117|NCT01271712|363548165|FG001|Double Blind Treatment|Non compliance with study drug|0|||
105421118|NCT01271712|363548164|FG000|Double Blind Treatment|receive no study drug|1|||
105421119|NCT01271712|363548165|FG001|Double Blind Treatment|receive no study drug|0|||
105421120|NCT01271712|363548164|FG000|Open Label Treatment|Death|6|||
105421121|NCT01271712|363548165|FG001|Open Label Treatment|Death|5|||
105421122|NCT01271712|363548164|FG000|Open Label Treatment|Withdrawal by Subject|6|||
105421123|NCT01271712|363548165|FG001|Open Label Treatment|Withdrawal by Subject|11|||
105421124|NCT01271712|363548164|FG000|Open Label Treatment|Physician Decision|2|||
105421125|NCT01271712|363548165|FG001|Open Label Treatment|Physician Decision|0|||
105421126|NCT01271712|363548164|FG000|Open Label Treatment|Adverse Event|14|||
105421127|NCT01271712|363548165|FG001|Open Label Treatment|Adverse Event|8|||
105421128|NCT01271712|363548164|FG000|Open Label Treatment|Progressive disease|59|||
105421129|NCT01271712|363548165|FG001|Open Label Treatment|Progressive disease|32|||
105421130|NCT01271712|363548164|FG000|Open Label Treatment|transferred to rollover study|1|||
105421131|NCT01271712|363548165|FG001|Open Label Treatment|transferred to rollover study|0|||
105421132|NCT01271712|363548164|FG000|Open Label Treatment|Non-compliance with study drug|1|||
105421133|NCT01271712|363548165|FG001|Open Label Treatment|Non-compliance with study drug|0|||
105421134|NCT01271712|363548164|FG000|Open Label Treatment|Protocol Violation|0|||
105421135|NCT01271712|363548165|FG001|Open Label Treatment|Protocol Violation|1|||
105421136|NCT01271712|363548164|FG000|Open Label Treatment|Switching to other therapy|2|||
105421137|NCT01271712|363548165|FG001|Open Label Treatment|Switching to other therapy|1|||
105421138|NCT01271712|363548164|FG000|Safety Follow-up|Death|11|||
105421139|NCT01271712|363548165|FG001|Safety Follow-up|Death|7|||
105421140|NCT01271712|363548164|FG000|Safety Follow-up|Withdrawal by Subject|4|||
105421141|NCT01271712|363548165|FG001|Safety Follow-up|Withdrawal by Subject|2|||
105421142|NCT01271712|363548164|FG000|Safety Follow-up|Protocol Violation|1|||
105421143|NCT01271712|363548165|FG001|Safety Follow-up|Protocol Violation|1|||
105421144|NCT01271712|363548164|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
105421145|NCT01271712|363548165|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
105421146|NCT01271712|363548164|FG000|Safety Follow-up|No follow-up|1|||
105421147|NCT01271712|363548165|FG001|Safety Follow-up|No follow-up|1|||
105421148|NCT01271712|363548164|FG000|Safety Follow-up|Progressive disease|1|||
105421149|NCT01271712|363548165|FG001|Safety Follow-up|Progressive disease|0|||
105421150|NCT01271712|363548164|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
105421151|NCT01271712|363548165|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
105421152|NCT05593913|363548166|FG000|Overall Study|Insufficient image quality|39|||
105421153|NCT00724854|363548169|FG000|Overall Study|Lack of Efficacy|187|||
105421154|NCT00724854|363548170|FG001|Overall Study|Lack of Efficacy|13|||
105421155|NCT00724854|363548169|FG000|Overall Study|Lost to Follow-up|87|||
105421156|NCT00724854|363548170|FG001|Overall Study|Lost to Follow-up|10|||
105421157|NCT00724854|363548169|FG000|Overall Study|Adverse Event|62|||
105421158|NCT00724854|363548170|FG001|Overall Study|Adverse Event|4|||
105421159|NCT00724854|363548169|FG000|Overall Study|Other|42|||
105421160|NCT00724854|363548170|FG001|Overall Study|Other|3|||
105421161|NCT00724854|363548169|FG000|Overall Study|Death|11|||
105421162|NCT00724854|363548170|FG001|Overall Study|Death|0|||
105421163|NCT00724854|363548169|FG000|Overall Study|Change of treatment|7|||
105421164|NCT00724854|363548170|FG001|Overall Study|Change of treatment|0|||
105421165|NCT00724854|363548169|FG000|Overall Study|Withdrawal by Subject|5|||
105421166|NCT00724854|363548170|FG001|Overall Study|Withdrawal by Subject|0|||
105421167|NCT00724854|363548169|FG000|Overall Study|Adverse event + lack of efficacy|2|||
105421168|NCT00724854|363548170|FG001|Overall Study|Adverse event + lack of efficacy|1|||
105421169|NCT04470908|363548171|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
105421170|NCT00096226|363548172|FG000|Overall Study|Ineligible|2|||
105421171|NCT00096226|363548172|FG000|Overall Study|Protocol treatment not started|1|||
105421172|NCT05479097|363548176|FG000|Overall Study|Withdrawal by Subject|2|||
105421173|NCT04003207|363548179|FG000|Overall Study|Protocol Violation|1|||
105421174|NCT02979093|363548183|FG000|First Scan Session|Scanning data problems|1|||
105421175|NCT02979093|363548184|FG001|First Scan Session|Scanning data problems|2|||
105421176|NCT02979093|363548185|FG002|First Scan Session|Scanning data problems|2|||
105421177|NCT02979093|363548186|FG003|First Scan Session|Scanning data problems|0|||
105421178|NCT02979093|363548183|FG000|Second Scan Session|Scanning data problems|3|||
105421179|NCT02979093|363548184|FG001|Second Scan Session|Scanning data problems|0|||
105421180|NCT02979093|363548185|FG002|Second Scan Session|Scanning data problems|1|||
105421181|NCT02979093|363548186|FG003|Second Scan Session|Scanning data problems|3|||
105421182|NCT04173260|363548187|FG000|Overall Study|Early termination|4|||
105421183|NCT01096368|363548190|FG000|Overall Study|Death|0|||
105421184|NCT01096368|363548191|FG001|Overall Study|Death|1|||
105421185|NCT01096368|363548192|FG002|Overall Study|Death|0|||
105421186|NCT01096368|363548193|FG003|Overall Study|Death|0|||
105421187|NCT01096368|363548194|FG004|Overall Study|Death|0|||
105421188|NCT01096368|363548190|FG000|Overall Study|Physician Decision|0|||
105421189|NCT01096368|363548191|FG001|Overall Study|Physician Decision|13|||
105421190|NCT01096368|363548192|FG002|Overall Study|Physician Decision|2|||
105421191|NCT01096368|363548193|FG003|Overall Study|Physician Decision|4|||
105421192|NCT01096368|363548194|FG004|Overall Study|Physician Decision|6|||
105421193|NCT01096368|363548190|FG000|Overall Study|Withdrawal by Subject|0|||
105421194|NCT01096368|363548191|FG001|Overall Study|Withdrawal by Subject|52|||
105584863|NCT02696785|364139924|FG001|Washout Period|Withdrawal by Subject|1|||
105421195|NCT01096368|363548192|FG002|Overall Study|Withdrawal by Subject|0|||
105421196|NCT01096368|363548193|FG003|Overall Study|Withdrawal by Subject|10|||
105421197|NCT01096368|363548194|FG004|Overall Study|Withdrawal by Subject|14|||
105421198|NCT01096368|363548190|FG000|Overall Study|Ineligible|0|||
105421199|NCT01096368|363548191|FG001|Overall Study|Ineligible|3|||
105421200|NCT01096368|363548192|FG002|Overall Study|Ineligible|2|||
105421201|NCT01096368|363548193|FG003|Overall Study|Ineligible|0|||
105421202|NCT01096368|363548194|FG004|Overall Study|Ineligible|25|||
105421203|NCT01096368|363548190|FG000|Overall Study|Did not start treatment|0|||
105421204|NCT01096368|363548191|FG001|Overall Study|Did not start treatment|4|||
105421205|NCT01096368|363548192|FG002|Overall Study|Did not start treatment|4|||
105584864|NCT02696785|364139925|FG002|Washout Period|Withdrawal by Subject|0|||
105584865|NCT02696785|364139926|FG003|Washout Period|Withdrawal by Subject|0|||
105584866|NCT02696785|364139923|FG000|Washout Period|Lack of Efficacy|0|||
105584867|NCT02696785|364139924|FG001|Washout Period|Lack of Efficacy|1|||
105584868|NCT02696785|364139925|FG002|Washout Period|Lack of Efficacy|0|||
105584869|NCT02696785|364139926|FG003|Washout Period|Lack of Efficacy|0|||
105584870|NCT02696785|364139923|FG000|Extended Treatment Period|Adverse Event|2|||
105584871|NCT02696785|364139924|FG001|Extended Treatment Period|Adverse Event|3|||
105584872|NCT02696785|364139925|FG002|Extended Treatment Period|Adverse Event|2|||
105584873|NCT02696785|364139926|FG003|Extended Treatment Period|Adverse Event|1|||
105584874|NCT02696785|364139923|FG000|Extended Treatment Period|Lack of Efficacy|0|||
105584875|NCT02696785|364139924|FG001|Extended Treatment Period|Lack of Efficacy|1|||
105584876|NCT02696785|364139925|FG002|Extended Treatment Period|Lack of Efficacy|0|||
105584877|NCT02696785|364139926|FG003|Extended Treatment Period|Lack of Efficacy|0|||
105584878|NCT02696785|364139923|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
105584879|NCT02696785|364139924|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
105584880|NCT02696785|364139925|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
105584881|NCT02696785|364139926|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
105584882|NCT02696785|364139923|FG000|Follow-up Period|Adverse Event|0|||
105584883|NCT02696785|364139924|FG001|Follow-up Period|Adverse Event|0|||
105584884|NCT02696785|364139925|FG002|Follow-up Period|Adverse Event|8|||
105584885|NCT02696785|364139926|FG003|Follow-up Period|Adverse Event|2|||
105584886|NCT02696785|364139923|FG000|Follow-up Period|Lost to Follow-up|0|||
105584887|NCT02696785|364139924|FG001|Follow-up Period|Lost to Follow-up|0|||
105584888|NCT02696785|364139925|FG002|Follow-up Period|Lost to Follow-up|0|||
105584889|NCT02696785|364139926|FG003|Follow-up Period|Lost to Follow-up|1|||
105584890|NCT02696785|364139923|FG000|Follow-up Period|Lack of Efficacy|0|||
105584891|NCT02696785|364139924|FG001|Follow-up Period|Lack of Efficacy|0|||
105584892|NCT02696785|364139925|FG002|Follow-up Period|Lack of Efficacy|0|||
105584893|NCT02696785|364139926|FG003|Follow-up Period|Lack of Efficacy|1|||
105584894|NCT02696785|364139923|FG000|Follow-up Period|Withdrawal by Subject|1|||
105584895|NCT02696785|364139924|FG001|Follow-up Period|Withdrawal by Subject|0|||
105584896|NCT02696785|364139925|FG002|Follow-up Period|Withdrawal by Subject|5|||
105584897|NCT02696785|364139926|FG003|Follow-up Period|Withdrawal by Subject|4|||
105584898|NCT04863898|364139929|FG000|Overall Study|Away from study clinic during intervention training period|2|||
105584899|NCT04863898|364139929|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
105584900|NCT04863898|364139929|FG000|Overall Study|Lost to Follow-up|3|||
105584901|NCT04863898|364139929|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
105584902|NCT04863898|364139929|FG000|Overall Study|No longer employed at clinic|3|||
105584903|NCT02487446|364139930|FG000|Period 1|Physician Decision|0|||
105584904|NCT02487446|364139931|FG001|Period 1|Physician Decision|1|||
105584905|NCT02487446|364139930|FG000|Period 1|Lack of Efficacy|1|||
105584906|NCT02487446|364139931|FG001|Period 1|Lack of Efficacy|0|||
105584907|NCT02487446|364139930|FG000|Period 1|Protocol deviation|3|||
105584908|NCT02487446|364139931|FG001|Period 1|Protocol deviation|2|||
105584909|NCT02487446|364139930|FG000|Period 1|Lost to Follow-up|2|||
105584910|NCT02487446|364139931|FG001|Period 1|Lost to Follow-up|0|||
105584911|NCT02487446|364139930|FG000|Period 1|Withdrawal by Subject|2|||
105584912|NCT02487446|364139931|FG001|Period 1|Withdrawal by Subject|0|||
105584913|NCT02487446|364139930|FG000|Period 1|Adverse Event|5|||
105584914|NCT02487446|364139931|FG001|Period 1|Adverse Event|5|||
105584915|NCT02487446|364139930|FG000|Washout|Lost to Follow-up|0|||
105584916|NCT02487446|364139931|FG001|Washout|Lost to Follow-up|2|||
105584917|NCT02487446|364139930|FG000|Washout|Withdrawal by Subject|1|||
105584918|NCT02487446|364139931|FG001|Washout|Withdrawal by Subject|4|||
105584919|NCT02487446|364139930|FG000|Washout|Adverse Event|2|||
105584920|NCT02487446|364139931|FG001|Washout|Adverse Event|2|||
105584921|NCT02487446|364139930|FG000|Period 2|Protocol deviation|0|||
105584922|NCT02487446|364139931|FG001|Period 2|Protocol deviation|1|||
105421206|NCT01096368|363548193|FG003|Overall Study|Did not start treatment|0|||
105421207|NCT01096368|363548194|FG004|Overall Study|Did not start treatment|0|||
105421208|NCT01096368|363548190|FG000|Overall Study|Progressive disease|0|||
105421209|NCT01096368|363548191|FG001|Overall Study|Progressive disease|6|||
105584923|NCT02487446|364139930|FG000|Period 2|Lost to Follow-up|1|||
105421210|NCT01096368|363548192|FG002|Overall Study|Progressive disease|0|||
105421211|NCT01096368|363548193|FG003|Overall Study|Progressive disease|10|||
105421212|NCT01096368|363548194|FG004|Overall Study|Progressive disease|3|||
105584924|NCT02487446|364139931|FG001|Period 2|Lost to Follow-up|1|||
105584925|NCT02487446|364139930|FG000|Period 2|Withdrawal by Subject|1|||
105584926|NCT02487446|364139931|FG001|Period 2|Withdrawal by Subject|1|||
105584927|NCT02487446|364139930|FG000|Period 2|Adverse Event|6|||
105584928|NCT02487446|364139931|FG001|Period 2|Adverse Event|2|||
105584929|NCT02337361|364139936|FG000|3-month Follow-up|Lost to Follow-up|19|||
105584930|NCT02337361|364139937|FG001|3-month Follow-up|Lost to Follow-up|14|||
105584931|NCT02337361|364139936|FG000|6-month Follow-up|Lost to Follow-up|2|||
105584932|NCT02337361|364139937|FG001|6-month Follow-up|Lost to Follow-up|4|||
105584933|NCT05310084|364142000|FG000|Overall Study|Withdrawal by Subject|2|||
105584934|NCT05310084|364142001|FG001|Overall Study|Withdrawal by Subject|3|||
105584935|NCT05310084|364142000|FG000|Overall Study|Participant availability|0|||
105584936|NCT05310084|364142001|FG001|Overall Study|Participant availability|4|||
105584937|NCT05310084|364142000|FG000|Overall Study|Lost to Follow-up|1|||
105584938|NCT05310084|364142001|FG001|Overall Study|Lost to Follow-up|1|||
105584939|NCT05310084|364142000|FG000|Overall Study|Adverse Event|1|||
105584940|NCT05310084|364142001|FG001|Overall Study|Adverse Event|1|||
105500708|NCT01058655|363844600|FG000|Overall Study|Disease Progression|1|||
105500709|NCT01058655|363844601|FG001|Overall Study|Disease Progression|2|||
105500710|NCT01058655|363844602|FG002|Overall Study|Disease Progression|4|||
105500711|NCT01058655|363844603|FG003|Overall Study|Disease Progression|24|||
105500712|NCT01058655|363844600|FG000|Overall Study|Other|0|||
105500713|NCT01058655|363844601|FG001|Overall Study|Other|0|||
105500714|NCT01058655|363844602|FG002|Overall Study|Other|0|||
105500715|NCT01058655|363844603|FG003|Overall Study|Other|4|||
105500716|NCT04472429|363844606|FG000|Randomized Period|Ongoing|90|||
105500717|NCT04472429|363844607|FG001|Randomized Period|Ongoing|40|||
105500718|NCT04472429|363844608|FG002|Randomized Period|Ongoing|0|||
105500719|NCT04472429|363844606|FG000|Randomized Period|Death|52|||
105500720|NCT04472429|363844607|FG001|Randomized Period|Death|37|||
105500721|NCT04472429|363844608|FG002|Randomized Period|Death|0|||
105500722|NCT04472429|363844606|FG000|Randomized Period|Lost to Follow-up|4|||
105500723|NCT04472429|363844607|FG001|Randomized Period|Lost to Follow-up|0|||
105500724|NCT04472429|363844608|FG002|Randomized Period|Lost to Follow-up|0|||
105500725|NCT04472429|363844606|FG000|Randomized Period|Physician Decision|1|||
105500726|NCT04472429|363844607|FG001|Randomized Period|Physician Decision|2|||
105500727|NCT04472429|363844608|FG002|Randomized Period|Physician Decision|0|||
105500728|NCT04472429|363844606|FG000|Randomized Period|Withdrawal by Subject|6|||
105500729|NCT04472429|363844607|FG001|Randomized Period|Withdrawal by Subject|5|||
105500730|NCT04472429|363844608|FG002|Randomized Period|Withdrawal by Subject|0|||
105500731|NCT04472429|363844606|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
105500732|NCT04472429|363844607|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
105500733|NCT04472429|363844608|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
105500734|NCT04472429|363844606|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
105500735|NCT04472429|363844607|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
105500736|NCT04472429|363844608|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
105500737|NCT04472429|363844606|FG000|Open-label Monotherapy Period|Ongoing|0|||
105500738|NCT04472429|363844607|FG001|Open-label Monotherapy Period|Ongoing|0|||
105500739|NCT04472429|363844608|FG002|Open-label Monotherapy Period|Ongoing|32|||
105500740|NCT04472429|363844606|FG000|Open-label Monotherapy Period|Death|0|||
105500741|NCT04472429|363844607|FG001|Open-label Monotherapy Period|Death|0|||
105500742|NCT04472429|363844608|FG002|Open-label Monotherapy Period|Death|35|||
105500743|NCT04472429|363844606|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
105500744|NCT04472429|363844607|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
105500745|NCT04472429|363844608|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
105500746|NCT02319837|363844609|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
105500747|NCT02319837|363844610|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
105500748|NCT02319837|363844611|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
105500749|NCT02319837|363844609|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
105500750|NCT02319837|363844610|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
105500751|NCT02319837|363844611|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
105500752|NCT02319837|363844609|FG000|Study Treatment Phase|Adverse Event|73|||
105500753|NCT02319837|363844610|FG001|Study Treatment Phase|Adverse Event|36|||
105500754|NCT02319837|363844611|FG002|Study Treatment Phase|Adverse Event|63|||
105500755|NCT02319837|363844609|FG000|Study Treatment Phase|Development of castration resistance|0|||
105500756|NCT02319837|363844610|FG001|Study Treatment Phase|Development of castration resistance|2|||
105500757|NCT02319837|363844611|FG002|Study Treatment Phase|Development of castration resistance|0|||
105500758|NCT02319837|363844609|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
105500759|NCT02319837|363844610|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
105500760|NCT02319837|363844611|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
105500761|NCT02319837|363844609|FG000|Study Treatment Phase|Protocol Violation|2|||
105500762|NCT02319837|363844610|FG001|Study Treatment Phase|Protocol Violation|2|||
105500763|NCT02319837|363844611|FG002|Study Treatment Phase|Protocol Violation|1|||
105500764|NCT02319837|363844609|FG000|Study Treatment Phase|Lost to Follow-up|0|||
105500765|NCT02319837|363844610|FG001|Study Treatment Phase|Lost to Follow-up|1|||
105500766|NCT02319837|363844611|FG002|Study Treatment Phase|Lost to Follow-up|0|||
105500767|NCT02319837|363844609|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
105584941|NCT05310084|364142000|FG000|Overall Study|Randomized but not vaccinated|4|||
105584942|NCT05310084|364142001|FG001|Overall Study|Randomized but not vaccinated|2|||
105584943|NCT00924664|364142002|FG000|Overall Study|Adverse Event|23|||
105421213|NCT01096368|363548190|FG000|Overall Study|Other|0|||
105421214|NCT01096368|363548191|FG001|Overall Study|Other|0|||
105421215|NCT01096368|363548192|FG002|Overall Study|Other|1|||
105421216|NCT01096368|363548193|FG003|Overall Study|Other|0|||
105421217|NCT01096368|363548194|FG004|Overall Study|Other|0|||
105421218|NCT01096368|363548190|FG000|Overall Study|Treated with institutional review|0|||
105421219|NCT01096368|363548191|FG001|Overall Study|Treated with institutional review|0|||
105421220|NCT01096368|363548192|FG002|Overall Study|Treated with institutional review|0|||
105421221|NCT01096368|363548193|FG003|Overall Study|Treated with institutional review|0|||
105421222|NCT01096368|363548194|FG004|Overall Study|Treated with institutional review|1|||
105421223|NCT03070223|363548195|FG000|Overall Study|Lost to Follow-up|34|||
105421224|NCT03070223|363548196|FG001|Overall Study|Lost to Follow-up|27|||
105421225|NCT03070223|363548195|FG000|Overall Study|Withdrawal by Subject|12|||
105421226|NCT03070223|363548196|FG001|Overall Study|Withdrawal by Subject|22|||
105421227|NCT03070223|363548195|FG000|Overall Study|Protocol Violation|0|||
105421228|NCT03070223|363548196|FG001|Overall Study|Protocol Violation|1|||
105421229|NCT04644237|363548197|FG000|Overall Study|Death|3|||
105421230|NCT04644237|363548198|FG001|Overall Study|Death|2|||
105421231|NCT04644237|363548197|FG000|Overall Study|Adverse Event|15|||
105421232|NCT04644237|363548198|FG001|Overall Study|Adverse Event|12|||
105421233|NCT04644237|363548197|FG000|Overall Study|Progressive Disease|47|||
105421234|NCT04644237|363548198|FG001|Overall Study|Progressive Disease|19|||
105421235|NCT04644237|363548197|FG000|Overall Study|Clinical Progression|4|||
105421236|NCT04644237|363548198|FG001|Overall Study|Clinical Progression|1|||
105421237|NCT04644237|363548197|FG000|Overall Study|Withdrawal by Subject|1|||
105421238|NCT04644237|363548198|FG001|Overall Study|Withdrawal by Subject|2|||
105421239|NCT04644237|363548197|FG000|Overall Study|Physician Decision|3|||
105421240|NCT04644237|363548198|FG001|Overall Study|Physician Decision|0|||
105421241|NCT04644237|363548197|FG000|Overall Study|Other|1|||
105421242|NCT04644237|363548198|FG001|Overall Study|Other|0|||
105421243|NCT04644237|363548197|FG000|Overall Study|Randomized but not Treated|1|||
105421244|NCT04644237|363548198|FG001|Overall Study|Randomized but not Treated|0|||
105421245|NCT02118766|363548199|FG000|Overall Study|Adverse Event|7|||
105421246|NCT02118766|363548200|FG001|Overall Study|Adverse Event|2|||
105421247|NCT02118766|363548199|FG000|Overall Study|Withdrawal by Subject|3|||
105421248|NCT02118766|363548200|FG001|Overall Study|Withdrawal by Subject|6|||
105421249|NCT02118766|363548199|FG000|Overall Study|Lost to Follow-up|5|||
105421250|NCT02118766|363548200|FG001|Overall Study|Lost to Follow-up|4|||
105421251|NCT02118766|363548199|FG000|Overall Study|Withdrawal by parent/guardian|12|||
105421252|NCT02118766|363548200|FG001|Overall Study|Withdrawal by parent/guardian|18|||
105421253|NCT02118766|363548199|FG000|Overall Study|Other|3|||
105421254|NCT02118766|363548200|FG001|Overall Study|Other|1|||
105421255|NCT01691105|363548201|FG000|1 Month Follow-up|Lost to Follow-up|41|||
105421256|NCT01691105|363548202|FG001|1 Month Follow-up|Lost to Follow-up|38|||
105421257|NCT01691105|363548201|FG000|1 Month Follow-up|Death|2|||
105421258|NCT01691105|363548202|FG001|1 Month Follow-up|Death|3|||
105421259|NCT01691105|363548201|FG000|6 Month Follow-up|Lost to Follow-up|39|||
105421260|NCT01691105|363548202|FG001|6 Month Follow-up|Lost to Follow-up|58|||
105421261|NCT01691105|363548201|FG000|6 Month Follow-up|Death|13|||
105421262|NCT01691105|363548202|FG001|6 Month Follow-up|Death|13|||
105421263|NCT01691105|363548201|FG000|12 Month Follow-up|Lost to Follow-up|50|||
105421264|NCT01691105|363548202|FG001|12 Month Follow-up|Lost to Follow-up|71|||
105421265|NCT01691105|363548201|FG000|12 Month Follow-up|Death|22|||
105421266|NCT01691105|363548202|FG001|12 Month Follow-up|Death|30|||
105421267|NCT01691105|363548201|FG000|12 Month Biochemical Verification|Death|22|||
105421268|NCT01691105|363548202|FG001|12 Month Biochemical Verification|Death|30|||
105421269|NCT01691105|363548201|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
105421270|NCT01691105|363548202|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
105421271|NCT01691105|363548201|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
105421272|NCT01691105|363548202|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
105421273|NCT00541866|363548203|FG000|Overall Study|Adverse Event|3|||
105421274|NCT00541866|363548204|FG001|Overall Study|Adverse Event|0|||
105421275|NCT00541866|363548205|FG002|Overall Study|Adverse Event|0|||
105421276|NCT00541866|363548206|FG003|Overall Study|Adverse Event|0|||
105421277|NCT00541866|363548207|FG004|Overall Study|Adverse Event|0|||
105421278|NCT00541866|363548203|FG000|Overall Study|Death|1|||
105421279|NCT00541866|363548204|FG001|Overall Study|Death|0|||
105421280|NCT00541866|363548205|FG002|Overall Study|Death|0|||
105421281|NCT00541866|363548206|FG003|Overall Study|Death|0|||
105421282|NCT00541866|363548207|FG004|Overall Study|Death|0|||
105421283|NCT00541866|363548203|FG000|Overall Study|Lack of Efficacy|19|||
105421284|NCT00541866|363548204|FG001|Overall Study|Lack of Efficacy|15|||
105421285|NCT00541866|363548205|FG002|Overall Study|Lack of Efficacy|10|||
105421286|NCT00541866|363548206|FG003|Overall Study|Lack of Efficacy|12|||
105421287|NCT00541866|363548207|FG004|Overall Study|Lack of Efficacy|14|||
105421288|NCT00541866|363548203|FG000|Overall Study|Not Reported or Other|11|||
105421289|NCT00541866|363548204|FG001|Overall Study|Not Reported or Other|3|||
105584944|NCT00924664|364142003|FG001|Overall Study|Adverse Event|39|||
105584945|NCT00924664|364142002|FG000|Overall Study|Lack of Efficacy|10|||
105584946|NCT00924664|364142003|FG001|Overall Study|Lack of Efficacy|15|||
105584947|NCT00924664|364142002|FG000|Overall Study|Lost to Follow-up|10|||
105584948|NCT00924664|364142003|FG001|Overall Study|Lost to Follow-up|12|||
105584949|NCT00924664|364142002|FG000|Overall Study|Withdrawal by Subject|47|||
105584950|NCT00924664|364142003|FG001|Overall Study|Withdrawal by Subject|71|||
105584951|NCT00924664|364142002|FG000|Overall Study|Protocol Violation|2|||
105584952|NCT00924664|364142003|FG001|Overall Study|Protocol Violation|5|||
105584953|NCT00924664|364142002|FG000|Overall Study|Pregnancy|1|||
105584954|NCT00924664|364142003|FG001|Overall Study|Pregnancy|1|||
105584955|NCT00924664|364142002|FG000|Overall Study|Death|0|||
105584956|NCT00924664|364142003|FG001|Overall Study|Death|2|||
105584957|NCT00924664|364142002|FG000|Overall Study|Study terminated by sponsor|199|||
105584958|NCT00924664|364142003|FG001|Overall Study|Study terminated by sponsor|330|||
105584959|NCT00924664|364142002|FG000|Overall Study|Other|29|||
105584960|NCT00924664|364142003|FG001|Overall Study|Other|52|||
105584961|NCT00924664|364142002|FG000|Overall Study|Randomized but not Treated|1|||
105584962|NCT00924664|364142003|FG001|Overall Study|Randomized but not Treated|0|||
105584963|NCT01598987|364142004|FG000|Baseline to Month 12|Administrative problems|2|||
105584964|NCT01598987|364142004|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
105584965|NCT01598987|364142004|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
105584966|NCT01598987|364142004|FG000|Baseline to 24 Month|Administrative problems|2|||
105584967|NCT01598987|364142004|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
105584968|NCT02892409|364142005|FG000|Overall Study|Adverse Event|1|||
105584969|NCT02892409|364142006|FG001|Overall Study|Adverse Event|0|||
105584970|NCT02892409|364142005|FG000|Overall Study|Withdrawal by Subject|2|||
105584971|NCT02892409|364142006|FG001|Overall Study|Withdrawal by Subject|1|||
105584972|NCT05305040|364142007|FG000|Overall Study|Not Dosed|37|||
105584973|NCT05305040|364142008|FG001|Overall Study|Not Dosed|37|||
105584974|NCT05305040|364142007|FG000|Overall Study|Study Closure|34|||
105584975|NCT05305040|364142008|FG001|Overall Study|Study Closure|46|||
105584976|NCT05305040|364142007|FG000|Overall Study|Death|14|||
105584977|NCT05305040|364142008|FG001|Overall Study|Death|13|||
105584978|NCT05305040|364142007|FG000|Overall Study|Withdrawal by Subject|15|||
105584979|NCT05305040|364142008|FG001|Overall Study|Withdrawal by Subject|10|||
105584980|NCT05305040|364142007|FG000|Overall Study|Other|13|||
105584981|NCT05305040|364142008|FG001|Overall Study|Other|10|||
105584982|NCT05305040|364142007|FG000|Overall Study|Primary Malignancy Relapse|3|||
105584983|NCT05305040|364142008|FG001|Overall Study|Primary Malignancy Relapse|4|||
105584984|NCT05305040|364142007|FG000|Overall Study|Adverse Event|3|||
105584985|NCT05305040|364142008|FG001|Overall Study|Adverse Event|3|||
105584986|NCT05305040|364142007|FG000|Overall Study|Lost to Follow-up|2|||
105584987|NCT05305040|364142008|FG001|Overall Study|Lost to Follow-up|1|||
105584988|NCT05305040|364142007|FG000|Overall Study|Graft versus host disease|2|||
105584989|NCT05305040|364142008|FG001|Overall Study|Graft versus host disease|0|||
105584990|NCT05305040|364142007|FG000|Overall Study|Investigator's Decision|1|||
105584991|NCT05305040|364142008|FG001|Overall Study|Investigator's Decision|1|||
105584992|NCT05305040|364142007|FG000|Overall Study|COVID-19 Reasons|1|||
105584993|NCT05305040|364142008|FG001|Overall Study|COVID-19 Reasons|0|||
105584994|NCT01876043|364142009|FG000|Overall Study|Death|1|||
105584995|NCT01876043|364142009|FG000|Overall Study|Withdrawal by Subject|1|||
105584996|NCT01616563|364142010|FG000|Overall Study|Lost to Follow-up|40|||
105584997|NCT01033643|364142013|FG000|Overall Study|Withdrew Consent|0|||
105584998|NCT01033643|364142014|FG001|Overall Study|Withdrew Consent|3|||
105584999|NCT01033643|364142015|FG002|Overall Study|Withdrew Consent|0|||
105585000|NCT01033643|364142016|FG003|Overall Study|Withdrew Consent|0|||
105585001|NCT01033643|364142017|FG004|Overall Study|Withdrew Consent|0|||
105585002|NCT01033643|364142018|FG005|Overall Study|Withdrew Consent|1|||
105585003|NCT00852475|364142027|FG000|Overall Study|Lost to Follow-up|3|||
105585004|NCT00852475|364142028|FG001|Overall Study|Lost to Follow-up|4|||
105585005|NCT02028884|364142029|FG000|Double-blind Period|Adverse Event|5|||
105585006|NCT02028884|364142030|FG001|Double-blind Period|Adverse Event|3|||
105585007|NCT02028884|364142031|FG002|Double-blind Period|Adverse Event|0|||
105585008|NCT02028884|364142029|FG000|Double-blind Period|Eligibility Violation|1|||
105585009|NCT02028884|364142030|FG001|Double-blind Period|Eligibility Violation|0|||
105585010|NCT02028884|364142031|FG002|Double-blind Period|Eligibility Violation|0|||
105585011|NCT02028884|364142029|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
105585012|NCT02028884|364142030|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
105585013|NCT02028884|364142031|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
105585014|NCT02028884|364142029|FG000|Double-blind Period|Withdrawal by Subject|2|||
105585015|NCT02028884|364142030|FG001|Double-blind Period|Withdrawal by Subject|0|||
105585016|NCT02028884|364142031|FG002|Double-blind Period|Withdrawal by Subject|0|||
105585017|NCT02028884|364142029|FG000|Open-label Extension Period|Adverse Event|3|||
105585018|NCT02028884|364142030|FG001|Open-label Extension Period|Adverse Event|1|||
105585019|NCT02028884|364142031|FG002|Open-label Extension Period|Adverse Event|0|||
105585020|NCT02028884|364142029|FG000|Open-label Extension Period|Lack of Efficacy|3|||
105585021|NCT02028884|364142030|FG001|Open-label Extension Period|Lack of Efficacy|0|||
105585022|NCT02028884|364142031|FG002|Open-label Extension Period|Lack of Efficacy|0|||
105585023|NCT02028884|364142029|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
105585024|NCT02028884|364142030|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
105585025|NCT02028884|364142031|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
105585026|NCT02028884|364142029|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
105585027|NCT02028884|364142030|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
105585028|NCT02028884|364142031|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
105585029|NCT02028884|364142029|FG000|Open-label Extension Period|Switched to another treatment option|3|||
105585030|NCT02028884|364142030|FG001|Open-label Extension Period|Switched to another treatment option|0|||
105585031|NCT02028884|364142031|FG002|Open-label Extension Period|Switched to another treatment option|0|||
105585032|NCT00354029|364142032|FG000|Overall Study|Protocol Violation|4|||
105585033|NCT00354029|364142033|FG001|Overall Study|Protocol Violation|2|||
105585034|NCT00723294|364142034|FG000|Overall Study|Lobular histology|2|||
105585035|NCT00723294|364142034|FG000|Overall Study|>25% intraductal component|1|||
105585036|NCT00723294|364142034|FG000|Overall Study|No MRI tumor enhancement|1|||
105585037|NCT00723294|364142034|FG000|Overall Study|1.0-Tesla MRI|1|||
105585038|NCT00723294|364142034|FG000|Overall Study|No cryoabalation|2|||
105585039|NCT00723294|364142034|FG000|Overall Study|Did not undergo surgery|1|||
105421290|NCT00541866|363548205|FG002|Overall Study|Not Reported or Other|3|||
105421291|NCT00541866|363548206|FG003|Overall Study|Not Reported or Other|3|||
105421292|NCT00541866|363548207|FG004|Overall Study|Not Reported or Other|1|||
105421293|NCT00541866|363548203|FG000|Overall Study|Physician Decision|0|||
105421294|NCT00541866|363548204|FG001|Overall Study|Physician Decision|0|||
105421295|NCT00541866|363548205|FG002|Overall Study|Physician Decision|2|||
105421296|NCT00541866|363548206|FG003|Overall Study|Physician Decision|1|||
105421297|NCT00541866|363548207|FG004|Overall Study|Physician Decision|0|||
105421298|NCT00957944|363548208|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
105421299|NCT00957944|363548209|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
105500768|NCT02319837|363844610|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
105500769|NCT02319837|363844611|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
105500770|NCT02319837|363844609|FG000|Study Treatment Phase|Other|0|||
105500771|NCT02319837|363844610|FG001|Study Treatment Phase|Other|1|||
105500772|NCT02319837|363844611|FG002|Study Treatment Phase|Other|0|||
105500773|NCT02319837|363844609|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
105500774|NCT02319837|363844610|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
105500775|NCT02319837|363844611|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
105500776|NCT02319837|363844609|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
105500777|NCT02319837|363844610|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
105500778|NCT02319837|363844611|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
105500779|NCT02319837|363844609|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
105500780|NCT02319837|363844610|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
105500781|NCT02319837|363844611|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
105500782|NCT02319837|363844609|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
105500783|NCT02319837|363844610|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
105500784|NCT02319837|363844611|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
105500785|NCT02319837|363844609|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
105500786|NCT02319837|363844610|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
105500787|NCT02319837|363844611|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
105500788|NCT02319837|363844609|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
105500789|NCT02319837|363844610|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
105500790|NCT02319837|363844611|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
105500791|NCT02319837|363844609|FG000|Long-Term Follow-Up Phase|Death|33|||
105500792|NCT02319837|363844610|FG001|Long-Term Follow-Up Phase|Death|54|||
105500793|NCT02319837|363844611|FG002|Long-Term Follow-Up Phase|Death|42|||
105500794|NCT00753766|363844612|FG000|Overall Study|Physician Decision|1|||
105500795|NCT00753766|363844613|FG001|Overall Study|Physician Decision|0|||
105500796|NCT01313312|363844618|FG000|Overall Study|Adverse Event|5|||
105500797|NCT01313312|363844618|FG000|Overall Study|Withdrawal by Subject|18|||
105500798|NCT01313312|363844618|FG000|Overall Study|Lack of Efficacy|3|||
105500799|NCT01313312|363844618|FG000|Overall Study|Investigator Decision|1|||
105500800|NCT01313312|363844618|FG000|Overall Study|Observational Phase|1|||
105500801|NCT01313312|363844618|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
105500802|NCT01313312|363844618|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
105500803|NCT04203797|363844619|FG000|Overall Study|Adverse Event|1|||
105500804|NCT04203797|363844620|FG001|Overall Study|Adverse Event|0|||
105585040|NCT00723294|364142034|FG000|Overall Study|Treated prior to registration|1|||
105421300|NCT01468233|363548210|FG000|Treatment Period 1|Adverse Event|5|||
105421301|NCT01468233|363548211|FG001|Treatment Period 1|Adverse Event|3|||
105421302|NCT01468233|363548212|FG002|Treatment Period 1|Adverse Event|0|||
105421303|NCT01468233|363548213|FG003|Treatment Period 1|Adverse Event|0|||
105421304|NCT01468233|363548214|FG004|Treatment Period 1|Adverse Event|0|||
105421305|NCT01468233|363548215|FG005|Treatment Period 1|Adverse Event|0|||
105421306|NCT01468233|363548210|FG000|Treatment Period 1|Withdrawal by Subject|3|||
105421307|NCT01468233|363548211|FG001|Treatment Period 1|Withdrawal by Subject|4|||
105421308|NCT01468233|363548212|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105421309|NCT01468233|363548213|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105421310|NCT01468233|363548214|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105421311|NCT01468233|363548215|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105421312|NCT01468233|363548210|FG000|Treatment Period 1|Lost to Follow-up|3|||
105421313|NCT01468233|363548211|FG001|Treatment Period 1|Lost to Follow-up|0|||
105421314|NCT01468233|363548212|FG002|Treatment Period 1|Lost to Follow-up|0|||
105421315|NCT01468233|363548213|FG003|Treatment Period 1|Lost to Follow-up|0|||
105421316|NCT01468233|363548214|FG004|Treatment Period 1|Lost to Follow-up|0|||
105421317|NCT01468233|363548215|FG005|Treatment Period 1|Lost to Follow-up|0|||
105421318|NCT01468233|363548210|FG000|Treatment Period 1|Other|1|||
105421319|NCT01468233|363548211|FG001|Treatment Period 1|Other|1|||
105421320|NCT01468233|363548212|FG002|Treatment Period 1|Other|0|||
105421321|NCT01468233|363548213|FG003|Treatment Period 1|Other|0|||
105421322|NCT01468233|363548214|FG004|Treatment Period 1|Other|0|||
105421323|NCT01468233|363548215|FG005|Treatment Period 1|Other|0|||
105421324|NCT01468233|363548210|FG000|Treatment Period 2|Adverse Event|0|||
105421325|NCT01468233|363548211|FG001|Treatment Period 2|Adverse Event|0|||
105421326|NCT01468233|363548212|FG002|Treatment Period 2|Adverse Event|3|||
105421327|NCT01468233|363548213|FG003|Treatment Period 2|Adverse Event|0|||
105421328|NCT01468233|363548214|FG004|Treatment Period 2|Adverse Event|2|||
105421329|NCT01468233|363548215|FG005|Treatment Period 2|Adverse Event|1|||
105421330|NCT01468233|363548210|FG000|Treatment Period 2|Lack of Efficacy|0|||
105421331|NCT01468233|363548211|FG001|Treatment Period 2|Lack of Efficacy|0|||
105421332|NCT01468233|363548212|FG002|Treatment Period 2|Lack of Efficacy|9|||
105421333|NCT01468233|363548213|FG003|Treatment Period 2|Lack of Efficacy|2|||
105421334|NCT01468233|363548214|FG004|Treatment Period 2|Lack of Efficacy|0|||
105421335|NCT01468233|363548215|FG005|Treatment Period 2|Lack of Efficacy|1|||
105421336|NCT01468233|363548210|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105421337|NCT01468233|363548211|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105421338|NCT01468233|363548212|FG002|Treatment Period 2|Withdrawal by Subject|9|||
105421339|NCT01468233|363548213|FG003|Treatment Period 2|Withdrawal by Subject|1|||
105421340|NCT01468233|363548214|FG004|Treatment Period 2|Withdrawal by Subject|1|||
105421341|NCT01468233|363548215|FG005|Treatment Period 2|Withdrawal by Subject|1|||
105421342|NCT01468233|363548210|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
105421343|NCT01468233|363548211|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
105421344|NCT01468233|363548212|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
105421345|NCT01468233|363548213|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
105421346|NCT01468233|363548214|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
105421347|NCT01468233|363548215|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
105421348|NCT01468233|363548210|FG000|Treatment Period 2|Lost to Follow-up|0|||
105421349|NCT01468233|363548211|FG001|Treatment Period 2|Lost to Follow-up|0|||
105421350|NCT01468233|363548212|FG002|Treatment Period 2|Lost to Follow-up|3|||
105421351|NCT01468233|363548213|FG003|Treatment Period 2|Lost to Follow-up|0|||
105421352|NCT01468233|363548214|FG004|Treatment Period 2|Lost to Follow-up|2|||
105421353|NCT01468233|363548215|FG005|Treatment Period 2|Lost to Follow-up|0|||
105421354|NCT01468233|363548210|FG000|Treatment Period 2|Other|0|||
105421355|NCT01468233|363548211|FG001|Treatment Period 2|Other|0|||
105421356|NCT01468233|363548212|FG002|Treatment Period 2|Other|3|||
105421357|NCT01468233|363548213|FG003|Treatment Period 2|Other|0|||
105421358|NCT01468233|363548214|FG004|Treatment Period 2|Other|1|||
105421359|NCT01468233|363548215|FG005|Treatment Period 2|Other|0|||
105421360|NCT00522418|363548216|FG000|Overall Study|Local IRB Consent Violation|5|||
105421361|NCT00522418|363548217|FG001|Overall Study|Local IRB Consent Violation|5|||
105421362|NCT00522418|363548216|FG000|Overall Study|Early Study Termination|46|||
105500805|NCT04203797|363844619|FG000|Overall Study|Did not complete End of Study follow-up|1|||
105421363|NCT00522418|363548217|FG001|Overall Study|Early Study Termination|47|||
105421364|NCT00522418|363548216|FG000|Overall Study|Noncompliance|2|||
105421365|NCT00522418|363548217|FG001|Overall Study|Noncompliance|2|||
105421366|NCT00522418|363548216|FG000|Overall Study|Reason Not Specified|3|||
105421367|NCT00522418|363548217|FG001|Overall Study|Reason Not Specified|1|||
105421368|NCT00522418|363548216|FG000|Overall Study|Consent Withdraw|1|||
105421369|NCT00522418|363548217|FG001|Overall Study|Consent Withdraw|2|||
105421370|NCT00522418|363548216|FG000|Overall Study|Lack of Efficacy|0|||
105421371|NCT00522418|363548217|FG001|Overall Study|Lack of Efficacy|1|||
105421372|NCT01482169|363548218|FG000|Overall Study|Physician Decision|2|||
105421373|NCT01574157|363548219|FG000|Overall Study|Withdrawal by Subject|4|||
105421374|NCT01574157|363548220|FG001|Overall Study|Withdrawal by Subject|5|||
105421375|NCT01574157|363548219|FG000|Overall Study|Lost to Follow-up|0|||
105585041|NCT00723294|364142034|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
105585042|NCT00723294|364142034|FG000|Overall Study|Benign lesion|1|||
105585043|NCT00723294|364142034|FG000|Overall Study|Withdrawal by Subject|1|||
105585044|NCT00723294|364142034|FG000|Overall Study|No treatment due to probe failure|1|||
105585045|NCT01511536|364142035|FG000|Phase 1|Other|0|||
105585046|NCT01511536|364142036|FG001|Phase 1|Other|1|||
105585047|NCT01511536|364142037|FG002|Phase 1|Other|0|||
105585048|NCT01511536|364142035|FG000|Phase 2|Other|0|||
105585049|NCT01511536|364142036|FG001|Phase 2|Other|0|||
105585050|NCT01511536|364142037|FG002|Phase 2|Other|9|||
105585051|NCT01764386|364142038|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
105585052|NCT01764386|364142039|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
105585053|NCT01764386|364142038|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
105585054|NCT01764386|364142039|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
105585055|NCT01764386|364142038|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
105585056|NCT01764386|364142039|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
105585057|NCT01764386|364142038|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
105585058|NCT01764386|364142039|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
105585059|NCT01764386|364142038|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
105585060|NCT01764386|364142039|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
105585061|NCT01764386|364142038|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
105585062|NCT01764386|364142039|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
105585063|NCT01764386|364142038|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
105585064|NCT01764386|364142039|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
105585065|NCT01764386|364142038|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
105585066|NCT01764386|364142039|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
105585067|NCT02263885|364142044|FG000|Overall Study|Withdrawal by Subject|7|||
105585068|NCT02263885|364142044|FG000|Overall Study|Alternative Treatment|3|||
105585069|NCT03929302|364142047|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
105585070|NCT03929302|364142048|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
105585071|NCT03929302|364142049|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
105585072|NCT03929302|364142047|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
105585073|NCT03929302|364142048|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
105585074|NCT03929302|364142049|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
105585075|NCT03929302|364142047|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
105585076|NCT03929302|364142048|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
105585077|NCT03929302|364142049|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
105585078|NCT04170023|364142057|FG000|LTE Period|Withdrawal by Subject|1|||
105585079|NCT04170023|364142058|FG001|LTE Period|Withdrawal by Subject|0|||
105585080|NCT04170023|364142059|FG002|LTE Period|Withdrawal by Subject|0|||
105585081|NCT04170023|364142057|FG000|LTE Period|Study Termination|11|||
105585082|NCT04170023|364142058|FG001|LTE Period|Study Termination|11|||
105585083|NCT04170023|364142059|FG002|LTE Period|Study Termination|5|||
105585084|NCT03566680|364142063|FG000|Overall Study|Pregnancy|1|||
105585085|NCT03566680|364142063|FG000|Overall Study|Lost to Follow-up|13|||
105585086|NCT03566680|364142063|FG000|Overall Study|Withdrawal by Subject|3|||
105585087|NCT02374957|364142064|FG000|Overall Study|Patient did not complete forms correctly|1|||
105585088|NCT02374957|364142065|FG001|Overall Study|Patient did not complete forms correctly|0|||
105585089|NCT00688688|364142066|FG000|Overall Study|Eligibility criterion not met|7|||
105585090|NCT00688688|364142067|FG001|Overall Study|Eligibility criterion not met|7|||
105585091|NCT00688688|364142068|FG002|Overall Study|Eligibility criterion not met|10|||
105585092|NCT00688688|364142066|FG000|Overall Study|Adverse Event|52|||
105585093|NCT00688688|364142067|FG001|Overall Study|Adverse Event|51|||
105421376|NCT01574157|363548220|FG001|Overall Study|Lost to Follow-up|3|||
105421377|NCT02136680|363548228|FG000|Overall Study|No Longer Interested|1|||
105585094|NCT00688688|364142068|FG002|Overall Study|Adverse Event|50|||
105585095|NCT00688688|364142066|FG000|Overall Study|Lack of Efficacy|34|||
105585096|NCT00688688|364142067|FG001|Overall Study|Lack of Efficacy|25|||
105585097|NCT00688688|364142068|FG002|Overall Study|Lack of Efficacy|45|||
105421378|NCT02136680|363548229|FG001|Overall Study|No Longer Interested|1|||
105585098|NCT00688688|364142066|FG000|Overall Study|Withdrawal by Subject|66|||
105585099|NCT00688688|364142067|FG001|Overall Study|Withdrawal by Subject|75|||
105585100|NCT00688688|364142068|FG002|Overall Study|Withdrawal by Subject|65|||
105585101|NCT00688688|364142066|FG000|Overall Study|Lost to Follow-up|14|||
105585102|NCT00688688|364142067|FG001|Overall Study|Lost to Follow-up|7|||
105585103|NCT00688688|364142068|FG002|Overall Study|Lost to Follow-up|7|||
105585104|NCT00688688|364142066|FG000|Overall Study|Protocol Violation|6|||
105585105|NCT00688688|364142067|FG001|Overall Study|Protocol Violation|9|||
105585106|NCT00688688|364142068|FG002|Overall Study|Protocol Violation|11|||
105585107|NCT00688688|364142066|FG000|Overall Study|Randomized but never received study drug|1|||
105585108|NCT00688688|364142067|FG001|Overall Study|Randomized but never received study drug|0|||
105585109|NCT00688688|364142068|FG002|Overall Study|Randomized but never received study drug|0|||
105585110|NCT00688688|364142066|FG000|Overall Study|Non-compliance with study procedures|5|||
105585111|NCT00688688|364142067|FG001|Overall Study|Non-compliance with study procedures|3|||
105585112|NCT00688688|364142068|FG002|Overall Study|Non-compliance with study procedures|4|||
105585113|NCT00688688|364142066|FG000|Overall Study|Taking exclusionary medications|1|||
105585114|NCT00688688|364142067|FG001|Overall Study|Taking exclusionary medications|0|||
105585115|NCT00688688|364142068|FG002|Overall Study|Taking exclusionary medications|0|||
105585116|NCT00688688|364142066|FG000|Overall Study|Site closure|0|||
105585117|NCT00688688|364142067|FG001|Overall Study|Site closure|1|||
105585118|NCT00688688|364142068|FG002|Overall Study|Site closure|0|||
105585119|NCT00688688|364142066|FG000|Overall Study|Violation of exclusion criterion|0|||
105585120|NCT00688688|364142067|FG001|Overall Study|Violation of exclusion criterion|1|||
105585121|NCT00688688|364142068|FG002|Overall Study|Violation of exclusion criterion|0|||
105585122|NCT03283553|364142069|FG000|Patient Participant Flow|Death|5|||
105585123|NCT03283553|364142070|FG001|Patient Participant Flow|Death|10|||
105585124|NCT03283553|364142069|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
105585125|NCT03283553|364142070|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
105585126|NCT03283553|364142069|FG000|Patient Participant Flow|Lost to Follow-up|1|||
105585127|NCT03283553|364142070|FG001|Patient Participant Flow|Lost to Follow-up|1|||
105585128|NCT03283553|364142069|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
105585129|NCT03283553|364142070|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
105585130|NCT03283553|364142069|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
105585131|NCT03283553|364142070|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
105585132|NCT03283553|364142069|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
105585133|NCT03283553|364142070|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
105585134|NCT01719861|364142082|FG000|Cycle 1|Death|4|||
105585135|NCT01719861|364142082|FG000|Cycle 2|Death|1|||
105585136|NCT01606189|364142083|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
105585137|NCT01606189|364142084|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
105585138|NCT01606189|364142085|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
105585139|NCT01606189|364142086|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
105585140|NCT01606189|364142087|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
105585141|NCT01606189|364142088|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
105585142|NCT01606189|364142083|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
105585143|NCT01606189|364142084|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
105585144|NCT01606189|364142085|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
105585145|NCT01606189|364142086|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
105585146|NCT01606189|364142087|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
105585147|NCT01606189|364142088|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
105585148|NCT01605136|364142089|FG000|Study Period|Withdrawal by Subject|2|||
105585149|NCT01605136|364142090|FG001|Study Period|Withdrawal by Subject|0|||
105585150|NCT01605136|364142089|FG000|Study Period|Physician Decision|1|||
105585151|NCT01605136|364142090|FG001|Study Period|Physician Decision|1|||
105585152|NCT01605136|364142089|FG000|Study Period|Lost to Follow-up|0|||
105585153|NCT01605136|364142090|FG001|Study Period|Lost to Follow-up|2|||
105585154|NCT01605136|364142089|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
105585155|NCT01605136|364142090|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
105585156|NCT02929108|364142093|FG000|Overall Study|Hospice patient death|100|||
105585157|NCT02929108|364142094|FG001|Overall Study|Hospice patient death|64|||
105585158|NCT02929108|364142095|FG002|Overall Study|Hospice patient death|28|||
105585159|NCT02929108|364142096|FG003|Overall Study|Hospice patient death|46|||
105585160|NCT02929108|364142097|FG004|Overall Study|Hospice patient death|55|||
105585161|NCT02929108|364142098|FG005|Overall Study|Hospice patient death|28|||
105585162|NCT02929108|364142099|FG006|Overall Study|Hospice patient death|78|||
105585163|NCT01414166|364142100|FG000|Overall Study|Adverse Event|10|||
105585164|NCT01414166|364142101|FG001|Overall Study|Adverse Event|2|||
105585165|NCT01414166|364142100|FG000|Overall Study|Lost to Follow-up|4|||
105585166|NCT01414166|364142101|FG001|Overall Study|Lost to Follow-up|1|||
105585167|NCT01414166|364142100|FG000|Overall Study|Non-compliance with study drug|2|||
105585168|NCT01414166|364142101|FG001|Overall Study|Non-compliance with study drug|0|||
105585169|NCT01414166|364142100|FG000|Overall Study|Physician Decision|2|||
105585170|NCT01414166|364142101|FG001|Overall Study|Physician Decision|0|||
105585171|NCT01414166|364142100|FG000|Overall Study|Protocol Violation|2|||
105421379|NCT02136680|363548228|FG000|Overall Study|No longer receiving care at clinic|3|||
105421380|NCT02136680|363548229|FG001|Overall Study|No longer receiving care at clinic|5|||
105585172|NCT01414166|364142101|FG001|Overall Study|Protocol Violation|0|||
105585173|NCT01414166|364142100|FG000|Overall Study|Study terminated by Sponsor|68|||
105421381|NCT02136680|363548228|FG000|Overall Study|Moved away|5|||
105585174|NCT01414166|364142101|FG001|Overall Study|Study terminated by Sponsor|75|||
105585175|NCT01414166|364142100|FG000|Overall Study|Withdrawal by Subject|3|||
105585176|NCT01414166|364142101|FG001|Overall Study|Withdrawal by Subject|5|||
105585177|NCT04887285|364142104|FG000|Overall Study|Lost to Follow-up|0|||
105421382|NCT02136680|363548229|FG001|Overall Study|Moved away|4|||
105585178|NCT04887285|364142105|FG001|Overall Study|Lost to Follow-up|2|||
105585179|NCT04887285|364142106|FG002|Overall Study|Lost to Follow-up|3|||
105585180|NCT02084082|364142107|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
105421383|NCT02136680|363548228|FG000|Overall Study|Unable to schedule|17|||
105421384|NCT02136680|363548229|FG001|Overall Study|Unable to schedule|16|||
105421385|NCT02136680|363548228|FG000|Overall Study|Study ended before interview due|6|||
105421386|NCT02136680|363548229|FG001|Overall Study|Study ended before interview due|3|||
105421387|NCT01632241|363548230|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
105421388|NCT01632241|363548231|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
105421389|NCT01632241|363548230|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
105421390|NCT01632241|363548231|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
105421391|NCT01632241|363548230|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
105421392|NCT01632241|363548231|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
105421393|NCT01632241|363548230|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
105421394|NCT01632241|363548231|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
105421395|NCT01632241|363548230|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
105421396|NCT01632241|363548231|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
105421397|NCT01632241|363548230|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
105421398|NCT01632241|363548231|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
105421399|NCT01632241|363548230|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
105421400|NCT01632241|363548231|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
105421401|NCT01632241|363548230|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
105421402|NCT01632241|363548231|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
105421403|NCT01632241|363548230|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
105421404|NCT01632241|363548231|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
105421405|NCT01632241|363548230|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
105421406|NCT01632241|363548231|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
105421407|NCT01632241|363548230|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
105421408|NCT01632241|363548231|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
105421409|NCT01632241|363548230|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
105421410|NCT01632241|363548231|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
105421411|NCT01632241|363548230|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
105421412|NCT01632241|363548231|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
105421413|NCT01632241|363548230|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
105421414|NCT01632241|363548231|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
105421415|NCT00027378|363548232|FG000|Overall Study|Physician Decision|0|||
105421416|NCT00027378|363548233|FG001|Overall Study|Physician Decision|3|||
105421417|NCT05605691|363548234|FG000|Overall Study|Lost to Follow-up|1|||
105421418|NCT01288612|363549760|FG000|Overall Study|Unable to contact|11|||
105421419|NCT01288612|363549761|FG001|Overall Study|Unable to contact|16|||
105421420|NCT01288612|363549762|FG002|Overall Study|Unable to contact|20|||
105421421|NCT01288612|363549760|FG000|Overall Study|Declined|78|||
105421422|NCT01288612|363549761|FG001|Overall Study|Declined|63|||
105421423|NCT01288612|363549762|FG002|Overall Study|Declined|62|||
105421424|NCT01288612|363549760|FG000|Overall Study|Unable to intubate|0|||
105421425|NCT01288612|363549761|FG001|Overall Study|Unable to intubate|3|||
105421426|NCT01288612|363549762|FG002|Overall Study|Unable to intubate|0|||
105421427|NCT00871923|363549763|FG000|Overall Study|Death|1|||
105421428|NCT00871923|363549763|FG000|Overall Study|Withdrawal by Subject|1|||
105421429|NCT02982018|363549764|FG000|Overall Study|Incorrect Lens Dispensed|1|||
105421430|NCT02982018|363549765|FG001|Overall Study|Incorrect Lens Dispensed|0|||
105421431|NCT02982018|363549764|FG000|Overall Study|Protocol Violation|1|||
105421432|NCT02982018|363549765|FG001|Overall Study|Protocol Violation|1|||
105421433|NCT02982018|363549764|FG000|Overall Study|Adverse Event|1|||
105421434|NCT02982018|363549765|FG001|Overall Study|Adverse Event|1|||
105421435|NCT02982018|363549764|FG000|Overall Study|Lens Discomfort|2|||
105421436|NCT02982018|363549765|FG001|Overall Study|Lens Discomfort|0|||
105421437|NCT02982018|363549764|FG000|Overall Study|Withdrawal by Subject|0|||
105421438|NCT02982018|363549765|FG001|Overall Study|Withdrawal by Subject|1|||
105421439|NCT00132691|363549769|FG000|Overall Study|Lost to Follow-up|5|||
105421440|NCT00132691|363549770|FG001|Overall Study|Lost to Follow-up|8|||
105421441|NCT00132691|363549769|FG000|Overall Study|Missed 2-year visit|4|||
105421442|NCT00132691|363549770|FG001|Overall Study|Missed 2-year visit|4|||
105585181|NCT02084082|364142108|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
105585182|NCT02084082|364142109|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
105421443|NCT00132691|363549769|FG000|Overall Study|Death|2|||
105421444|NCT00132691|363549770|FG001|Overall Study|Death|0|||
105421445|NCT01739933|363549771|FG000|Overall Study|Death|89|||
105421446|NCT01739933|363549772|FG001|Overall Study|Death|86|||
105421447|NCT01739933|363549771|FG000|Overall Study|Withdrawal by Subject|10|||
105421448|NCT01739933|363549772|FG001|Overall Study|Withdrawal by Subject|8|||
105421449|NCT01739933|363549771|FG000|Overall Study|Lost to Follow-up|3|||
105421450|NCT01739933|363549772|FG001|Overall Study|Lost to Follow-up|10|||
105421451|NCT01739933|363549771|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
105421452|NCT01739933|363549772|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
105421453|NCT04098367|363549773|FG000|Overall Study|Adverse Event|0|||
105421454|NCT04098367|363549774|FG001|Overall Study|Adverse Event|0|||
105585183|NCT02084082|364142110|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
105585184|NCT02084082|364142107|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
105585185|NCT02084082|364142108|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
105585186|NCT02084082|364142109|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
105585187|NCT02084082|364142110|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
105585188|NCT04319094|364142116|FG000|Baseline|Lost to Follow-up|4|||
105585189|NCT04319094|364142117|FG001|Baseline|Lost to Follow-up|5|||
105585190|NCT04319094|364142116|FG000|Baseline|Protocol Violation|0|||
105585191|NCT04319094|364142117|FG001|Baseline|Protocol Violation|3|||
105585192|NCT04319094|364142116|FG000|Baseline|Withdrawal by Subject|2|||
105585193|NCT04319094|364142117|FG001|Baseline|Withdrawal by Subject|1|||
105585194|NCT04319094|364142116|FG000|Post-Intervention|Death|0|||
105585195|NCT04319094|364142117|FG001|Post-Intervention|Death|1|||
105585196|NCT04319094|364142116|FG000|Post-Intervention|Lost to Follow-up|4|||
105585197|NCT04319094|364142117|FG001|Post-Intervention|Lost to Follow-up|4|||
105585198|NCT04319094|364142116|FG000|Post-Intervention|Withdrawal by Subject|8|||
105585199|NCT04319094|364142117|FG001|Post-Intervention|Withdrawal by Subject|5|||
105585200|NCT04319094|364142116|FG000|Post-Intervention|Incomplete Data Collection|1|||
105585201|NCT04319094|364142117|FG001|Post-Intervention|Incomplete Data Collection|3|||
105585202|NCT04319094|364142116|FG000|3-month|Death|1|||
105585203|NCT04319094|364142117|FG001|3-month|Death|0|||
105585204|NCT04319094|364142116|FG000|3-month|Lost to Follow-up|2|||
105585205|NCT04319094|364142117|FG001|3-month|Lost to Follow-up|2|||
105585206|NCT04319094|364142116|FG000|3-month|Withdrawal by Subject|0|||
105585207|NCT04319094|364142117|FG001|3-month|Withdrawal by Subject|3|||
105585208|NCT04319094|364142116|FG000|3-month|Incomplete data collection|9|||
105585209|NCT04319094|364142117|FG001|3-month|Incomplete data collection|7|||
105585210|NCT04319094|364142116|FG000|6-month|Lost to Follow-up|1|||
105585211|NCT04319094|364142117|FG001|6-month|Lost to Follow-up|1|||
105585212|NCT04319094|364142116|FG000|6-month|Withdrawal by Subject|0|||
105585213|NCT04319094|364142117|FG001|6-month|Withdrawal by Subject|3|||
105585214|NCT04319094|364142116|FG000|6-month|Incomplete data collection|14|||
105585215|NCT04319094|364142117|FG001|6-month|Incomplete data collection|9|||
105585216|NCT04319094|364142116|FG000|9-month|Lost to Follow-up|8|||
105585217|NCT04319094|364142117|FG001|9-month|Lost to Follow-up|4|||
105585218|NCT04319094|364142116|FG000|9-month|Withdrawal by Subject|0|||
105585219|NCT04319094|364142117|FG001|9-month|Withdrawal by Subject|1|||
105585220|NCT04319094|364142116|FG000|9-month|Incomplete data collection|8|||
105585221|NCT04319094|364142117|FG001|9-month|Incomplete data collection|5|||
105585222|NCT04319094|364142116|FG000|12-month|Lost to Follow-up|11|||
105585223|NCT04319094|364142117|FG001|12-month|Lost to Follow-up|8|||
105585224|NCT01321073|364142118|FG000|Overall Study|Did not attempt implant|4|||
105585225|NCT01321073|364142118|FG000|Overall Study|Death|3|||
105585226|NCT04639947|364142119|FG000|Overall Study|Screen fail|1|||
105585227|NCT00654238|364142124|FG000|Overall Study|Screen Failures|4|||
105585228|NCT00877851|364142125|FG000|Overall Study|Lost to Follow-up|5|||
105585229|NCT00877851|364142126|FG001|Overall Study|Lost to Follow-up|5|||
105585230|NCT00877851|364142125|FG000|Overall Study|computer problem|3|||
105585231|NCT00877851|364142126|FG001|Overall Study|computer problem|0|||
105585232|NCT00877851|364142125|FG000|Overall Study|no longer interested in participating|1|||
105585233|NCT00877851|364142126|FG001|Overall Study|no longer interested in participating|0|||
105585234|NCT03424239|364142127|FG000|Overall Study|Withdrawal by Subject|2|||
105585235|NCT00819234|364142135|FG000|Overall Study|Withdrawal by Subject|8|||
105585236|NCT00819234|364142136|FG001|Overall Study|Withdrawal by Subject|13|||
105585237|NCT00819234|364142137|FG002|Overall Study|Withdrawal by Subject|6|||
105585238|NCT00819234|364142138|FG003|Overall Study|Withdrawal by Subject|3|||
105585239|NCT00819234|364142139|FG004|Overall Study|Withdrawal by Subject|0|||
105585240|NCT00819234|364142140|FG005|Overall Study|Withdrawal by Subject|4|||
105585241|NCT00819234|364142141|FG006|Overall Study|Withdrawal by Subject|4|||
105585242|NCT00819234|364142142|FG007|Overall Study|Withdrawal by Subject|8|||
105585243|NCT00819234|364142143|FG008|Overall Study|Withdrawal by Subject|5|||
105585244|NCT00819234|364142144|FG009|Overall Study|Withdrawal by Subject|3|||
105585245|NCT00819234|364142135|FG000|Overall Study|Adverse Event|0|||
105585246|NCT00819234|364142136|FG001|Overall Study|Adverse Event|0|||
105585247|NCT00819234|364142137|FG002|Overall Study|Adverse Event|1|||
105585248|NCT00819234|364142138|FG003|Overall Study|Adverse Event|0|||
105585249|NCT00819234|364142139|FG004|Overall Study|Adverse Event|0|||
105585250|NCT00819234|364142140|FG005|Overall Study|Adverse Event|2|||
105585251|NCT00819234|364142141|FG006|Overall Study|Adverse Event|0|||
105585252|NCT00819234|364142142|FG007|Overall Study|Adverse Event|0|||
105585253|NCT00819234|364142143|FG008|Overall Study|Adverse Event|0|||
105585254|NCT00819234|364142144|FG009|Overall Study|Adverse Event|0|||
105585255|NCT00819234|364142135|FG000|Overall Study|Physician Decision|0|||
105585256|NCT00819234|364142136|FG001|Overall Study|Physician Decision|0|||
105585257|NCT00819234|364142137|FG002|Overall Study|Physician Decision|0|||
105585258|NCT00819234|364142138|FG003|Overall Study|Physician Decision|1|||
105585259|NCT00819234|364142139|FG004|Overall Study|Physician Decision|0|||
105585260|NCT00819234|364142140|FG005|Overall Study|Physician Decision|0|||
105585261|NCT00819234|364142141|FG006|Overall Study|Physician Decision|0|||
105585262|NCT00819234|364142142|FG007|Overall Study|Physician Decision|0|||
105585263|NCT00819234|364142143|FG008|Overall Study|Physician Decision|0|||
105585264|NCT00819234|364142144|FG009|Overall Study|Physician Decision|2|||
105421455|NCT04098367|363549775|FG002|Overall Study|Adverse Event|1|||
105421456|NCT04098367|363549773|FG000|Overall Study|Lost to Follow-up|1|||
105421457|NCT04098367|363549774|FG001|Overall Study|Lost to Follow-up|5|||
105421458|NCT04098367|363549775|FG002|Overall Study|Lost to Follow-up|2|||
105421459|NCT04098367|363549773|FG000|Overall Study|Withdrawal by Subject|0|||
105421460|NCT04098367|363549774|FG001|Overall Study|Withdrawal by Subject|0|||
105421461|NCT04098367|363549775|FG002|Overall Study|Withdrawal by Subject|1|||
105421462|NCT04098367|363549773|FG000|Overall Study|Sick . Could not attend visit|1|||
105421463|NCT04098367|363549774|FG001|Overall Study|Sick . Could not attend visit|0|||
105421464|NCT04098367|363549775|FG002|Overall Study|Sick . Could not attend visit|0|||
105421465|NCT01231321|363549783|FG000|Overall Study|Adverse Event|3|||
105421466|NCT01231321|363549783|FG000|Overall Study|Lack of Efficacy|2|||
105421467|NCT04021524|363549784|FG000|Overall Study|Change in surgical intervention|0|||
105421468|NCT04021524|363549785|FG001|Overall Study|Change in surgical intervention|1|||
105421469|NCT05275010|363549786|FG000|Overall Study|Reason Not Specified|4|||
105421470|NCT05275010|363549787|FG001|Overall Study|Reason Not Specified|1|||
105421471|NCT05275010|363549786|FG000|Overall Study|Withdrawal by Subject|1|||
105421472|NCT05275010|363549787|FG001|Overall Study|Withdrawal by Subject|0|||
105421473|NCT05275010|363549786|FG000|Overall Study|Lost to Follow-up|0|||
105421474|NCT05275010|363549787|FG001|Overall Study|Lost to Follow-up|1|||
105421475|NCT01921218|363549790|FG000|Overall Study|Death|2|||
105421476|NCT01921218|363549791|FG001|Overall Study|Death|1|||
105421477|NCT01921218|363549790|FG000|Overall Study|Withdrawal by Subject|0|||
105421478|NCT01921218|363549791|FG001|Overall Study|Withdrawal by Subject|2|||
105421479|NCT01921218|363549790|FG000|Overall Study|Kidney transplant|1|||
105421480|NCT01921218|363549791|FG001|Overall Study|Kidney transplant|1|||
105421481|NCT02545517|363549792|FG000|Overall Study|Death|2|||
105421482|NCT02545517|363549793|FG001|Overall Study|Death|2|||
105421483|NCT02545517|363549794|FG002|Overall Study|Death|1|||
105421484|NCT02545517|363549792|FG000|Overall Study|Lost to Follow-up|14|||
105421485|NCT02545517|363549793|FG001|Overall Study|Lost to Follow-up|13|||
105421486|NCT02545517|363549794|FG002|Overall Study|Lost to Follow-up|17|||
105421487|NCT02545517|363549792|FG000|Overall Study|Protocol Violation|0|||
105421488|NCT02545517|363549793|FG001|Overall Study|Protocol Violation|1|||
105421489|NCT02545517|363549794|FG002|Overall Study|Protocol Violation|1|||
105421490|NCT02545517|363549792|FG000|Overall Study|Withdrawal by Subject|5|||
105421491|NCT02545517|363549793|FG001|Overall Study|Withdrawal by Subject|8|||
105421492|NCT02545517|363549794|FG002|Overall Study|Withdrawal by Subject|9|||
105421493|NCT02545517|363549792|FG000|Overall Study|Administrative reason|5|||
105421494|NCT02545517|363549793|FG001|Overall Study|Administrative reason|6|||
105421495|NCT02545517|363549794|FG002|Overall Study|Administrative reason|10|||
105421496|NCT02545517|363549792|FG000|Overall Study|Other|2|||
105421497|NCT02545517|363549793|FG001|Overall Study|Other|4|||
105421498|NCT02545517|363549794|FG002|Overall Study|Other|3|||
105421499|NCT00006046|363549795|FG000|Overall Study|Adverse Event|3|||
105421500|NCT00006046|363549796|FG001|Overall Study|Adverse Event|0|||
105421501|NCT00006046|363549797|FG002|Overall Study|Adverse Event|0|||
105421502|NCT00006046|363549798|FG003|Overall Study|Adverse Event|0|||
105421503|NCT00006046|363549799|FG004|Overall Study|Adverse Event|0|||
105421504|NCT00006046|363549795|FG000|Overall Study|Disease Progression|2|||
105421505|NCT00006046|363549796|FG001|Overall Study|Disease Progression|0|||
105421506|NCT00006046|363549797|FG002|Overall Study|Disease Progression|0|||
105421507|NCT00006046|363549798|FG003|Overall Study|Disease Progression|0|||
105421508|NCT00006046|363549799|FG004|Overall Study|Disease Progression|0|||
105421509|NCT03361189|363549802|FG000|Overall Study|Received heart transplant|1|||
105421510|NCT03361189|363549803|FG001|Overall Study|Received heart transplant|0|||
105421511|NCT03361189|363549802|FG000|Overall Study|Pacemake replacement|0|||
105421512|NCT03361189|363549803|FG001|Overall Study|Pacemake replacement|1|||
105421513|NCT01155466|363549807|FG000|Overall Study|Adverse Event|13|||
105421514|NCT01155466|363549808|FG001|Overall Study|Adverse Event|15|||
105421515|NCT01155466|363549809|FG002|Overall Study|Adverse Event|6|||
105421516|NCT01155466|363549810|FG003|Overall Study|Adverse Event|17|||
105421517|NCT01155466|363549811|FG004|Overall Study|Adverse Event|18|||
105421518|NCT01155466|363549807|FG000|Overall Study|Lost to Follow-up|0|||
105421519|NCT01155466|363549808|FG001|Overall Study|Lost to Follow-up|0|||
105421520|NCT01155466|363549809|FG002|Overall Study|Lost to Follow-up|0|||
105421521|NCT01155466|363549810|FG003|Overall Study|Lost to Follow-up|0|||
105421522|NCT01155466|363549811|FG004|Overall Study|Lost to Follow-up|2|||
105421523|NCT01155466|363549807|FG000|Overall Study|Withdrawal by Subject|7|||
105421524|NCT01155466|363549808|FG001|Overall Study|Withdrawal by Subject|5|||
105421525|NCT01155466|363549809|FG002|Overall Study|Withdrawal by Subject|9|||
105585265|NCT00819234|364142135|FG000|Overall Study|Protocol Violation|0|||
105421526|NCT01155466|363549810|FG003|Overall Study|Withdrawal by Subject|4|||
105421527|NCT01155466|363549811|FG004|Overall Study|Withdrawal by Subject|4|||
105421528|NCT01155466|363549807|FG000|Overall Study|Protocol Violation|0|||
105421529|NCT01155466|363549808|FG001|Overall Study|Protocol Violation|0|||
105421530|NCT01155466|363549809|FG002|Overall Study|Protocol Violation|2|||
105421531|NCT01155466|363549810|FG003|Overall Study|Protocol Violation|0|||
105421532|NCT01155466|363549811|FG004|Overall Study|Protocol Violation|1|||
105421533|NCT01155466|363549807|FG000|Overall Study|Administrative|0|||
105421534|NCT01155466|363549808|FG001|Overall Study|Administrative|3|||
105421535|NCT01155466|363549809|FG002|Overall Study|Administrative|0|||
105421536|NCT01155466|363549810|FG003|Overall Study|Administrative|0|||
105421537|NCT01155466|363549811|FG004|Overall Study|Administrative|0|||
105421538|NCT01155466|363549807|FG000|Overall Study|Randomized not treated|2|||
105421539|NCT01155466|363549808|FG001|Overall Study|Randomized not treated|2|||
105421540|NCT01155466|363549809|FG002|Overall Study|Randomized not treated|3|||
105421541|NCT01155466|363549810|FG003|Overall Study|Randomized not treated|0|||
105421542|NCT01155466|363549811|FG004|Overall Study|Randomized not treated|2|||
105421543|NCT00590824|363549812|FG000|Overall Study|Disease could not be resected|0|||
105421544|NCT00590824|363549813|FG001|Overall Study|Disease could not be resected|2|||
105421545|NCT00590824|363549814|FG002|Overall Study|Disease could not be resected|1|||
105421546|NCT00590824|363549815|FG003|Overall Study|Disease could not be resected|0|||
105421547|NCT00590824|363549812|FG000|Overall Study|Adverse Event|0|||
105421548|NCT00590824|363549813|FG001|Overall Study|Adverse Event|0|||
105421549|NCT00590824|363549814|FG002|Overall Study|Adverse Event|0|||
105421550|NCT00590824|363549815|FG003|Overall Study|Adverse Event|1|||
105421551|NCT01895543|363549816|FG000|Overall Study|Withdrawal by Subject|43|||
105421552|NCT01895543|363549816|FG000|Overall Study|Lost to Follow-up|25|||
105421553|NCT01895543|363549816|FG000|Overall Study|Adverse Event|28|||
105421554|NCT01895543|363549816|FG000|Overall Study|Subject's substantial non-compliance|6|||
105421555|NCT01895543|363549816|FG000|Overall Study|Protocol Violation|1|||
105421556|NCT01895543|363549816|FG000|Overall Study|Physician Decision|2|||
105421557|NCT01895543|363549816|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
105421558|NCT00557310|363549818|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
105421559|NCT00557310|363549818|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
105421560|NCT00557310|363549818|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
105421561|NCT00557310|363549818|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
105421562|NCT00557310|363549818|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
105421563|NCT00557310|363549818|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
105421564|NCT02649218|363549823|FG000|Overall Study|Adverse Event|8|||
105421565|NCT02649218|363549823|FG000|Overall Study|Lack of Efficacy|8|||
105421566|NCT02649218|363549823|FG000|Overall Study|Pregnancy|3|||
105421567|NCT02649218|363549823|FG000|Overall Study|Protocol Violation|3|||
105421568|NCT02649218|363549823|FG000|Overall Study|Physician Decision|1|||
105421569|NCT02649218|363549823|FG000|Overall Study|Withdrawal by Subject|2|||
105421570|NCT05145322|363549826|FG000|Overall Study|Lost to Follow-up|4|||
105421571|NCT05145322|363549827|FG001|Overall Study|Lost to Follow-up|5|||
105421572|NCT04584346|363549828|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
105421573|NCT04584346|363549829|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
105421574|NCT04239222|363549830|FG000|Baseline|Withdrawal by Subject|0|||
105421575|NCT04239222|363549831|FG001|Baseline|Withdrawal by Subject|0|||
105421576|NCT04239222|363549832|FG002|Baseline|Withdrawal by Subject|1|||
105421577|NCT04239222|363549833|FG003|Baseline|Withdrawal by Subject|1|||
105421578|NCT04239222|363549830|FG000|First Foot Assignment|Withdrawal by Subject|0|||
105421579|NCT04239222|363549831|FG001|First Foot Assignment|Withdrawal by Subject|0|||
105421580|NCT04239222|363549832|FG002|First Foot Assignment|Withdrawal by Subject|1|||
105421581|NCT04239222|363549833|FG003|First Foot Assignment|Withdrawal by Subject|0|||
105421582|NCT04239222|363549830|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
105421583|NCT04239222|363549831|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
105421584|NCT04239222|363549832|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
105421585|NCT04239222|363549833|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
105421586|NCT00468676|363549839|FG000|Overall Study|Lost to Follow-up|14|||
105421587|NCT00468676|363549840|FG001|Overall Study|Lost to Follow-up|11|||
105421588|NCT00468676|363549839|FG000|Overall Study|Death|2|||
105421589|NCT00468676|363549840|FG001|Overall Study|Death|1|||
105421590|NCT00090233|363549841|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
105421591|NCT00090233|363549842|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
105421592|NCT00090233|363549841|FG000|Overall Study|Adverse Event|214|||
105421593|NCT00090233|363549842|FG001|Overall Study|Adverse Event|198|||
105421594|NCT00090233|363549841|FG000|Overall Study|Lost to Follow-up|68|||
105421595|NCT00090233|363549842|FG001|Overall Study|Lost to Follow-up|95|||
105421596|NCT00090233|363549841|FG000|Overall Study|Protocol Violation|960|||
105421597|NCT00090233|363549842|FG001|Overall Study|Protocol Violation|1022|||
105421598|NCT00090233|363549841|FG000|Overall Study|Withdrawal by Subject|182|||
105421599|NCT00090233|363549842|FG001|Overall Study|Withdrawal by Subject|211|||
105421600|NCT00090233|363549841|FG000|Overall Study|Moved|203|||
105421601|NCT00090233|363549842|FG001|Overall Study|Moved|189|||
105421602|NCT00090233|363549841|FG000|Overall Study|Other|1211|||
105421603|NCT00090233|363549842|FG001|Overall Study|Other|1160|||
105421604|NCT00090233|363549841|FG000|Overall Study|Data not available at data cut-off point|1552|||
105421605|NCT00090233|363549842|FG001|Overall Study|Data not available at data cut-off point|1563|||
105421606|NCT04863248|363549843|FG000|Overall Study|Sponsor Terminated|4|||
105421607|NCT04863248|363549844|FG001|Overall Study|Sponsor Terminated|1|||
105421608|NCT04863248|363549843|FG000|Overall Study|Death|0|||
105421609|NCT04863248|363549844|FG001|Overall Study|Death|1|||
105421610|NCT04863248|363549843|FG000|Overall Study|Withdrawal by Subject|0|||
105421611|NCT04863248|363549844|FG001|Overall Study|Withdrawal by Subject|1|||
105421612|NCT01779869|363549845|FG000|Overall Study|Physician Decision|2|||
105421613|NCT00790647|363549861|FG000|Overall Study|Adverse Event|1|||
105421614|NCT02437409|363549862|FG000|Overall Study|Withdrawal by Subject|3|||
105421615|NCT02437409|363549862|FG000|Overall Study|Screening failure|12|||
105421616|NCT01944098|363549863|FG000|Overall Study|Physician Decision|1|||
105421617|NCT01944098|363549864|FG001|Overall Study|Physician Decision|0|||
105421618|NCT05032690|363549865|FG000|Period 1|Adverse Event|0|||
105421619|NCT05032690|363549866|FG001|Period 1|Adverse Event|1|||
105421620|NCT05032690|363549867|FG002|Period 1|Adverse Event|0|||
105421621|NCT05032690|363549868|FG003|Period 1|Adverse Event|0|||
105421622|NCT05032690|363549865|FG000|Period 1|Withdrawal by Subject|1|||
105421623|NCT05032690|363549866|FG001|Period 1|Withdrawal by Subject|0|||
105421624|NCT05032690|363549867|FG002|Period 1|Withdrawal by Subject|0|||
105421625|NCT05032690|363549868|FG003|Period 1|Withdrawal by Subject|0|||
105421626|NCT05032690|363549865|FG000|Period 1|No longer meets eligibility criteria|0|||
105500806|NCT04203797|363844620|FG001|Overall Study|Did not complete End of Study follow-up|0|||
105500807|NCT00287365|363844621|FG000|Overall Study|sample not acquired|13|||
105500808|NCT01235689|363844622|FG000|Overall Study|Adverse Event|12|||
105500809|NCT01235689|363844623|FG001|Overall Study|Adverse Event|16|||
105500810|NCT01235689|363844622|FG000|Overall Study|Lack of Efficacy|12|||
105500811|NCT01235689|363844623|FG001|Overall Study|Lack of Efficacy|5|||
105500812|NCT01235689|363844622|FG000|Overall Study|Withdrawal by Subject|3|||
105500813|NCT01235689|363844623|FG001|Overall Study|Withdrawal by Subject|4|||
105500814|NCT01235689|363844622|FG000|Overall Study|Lost to Follow-up|1|||
105500815|NCT01235689|363844623|FG001|Overall Study|Lost to Follow-up|2|||
105500816|NCT01235689|363844622|FG000|Overall Study|Miscellaneous|1|||
105500817|NCT01235689|363844623|FG001|Overall Study|Miscellaneous|5|||
105500818|NCT00415168|363844624|FG000|Overall Study|Death|26|||
105500819|NCT00415168|363844624|FG000|Overall Study|Lost to Follow-up|3|||
105500820|NCT00415168|363844624|FG000|Overall Study|Physician Decision|13|||
105500821|NCT00415168|363844624|FG000|Overall Study|Sponsor Decision|4|||
105500822|NCT00415168|363844624|FG000|Overall Study|Withdrawal by Subject|6|||
105500823|NCT01484275|363844625|FG000|Overall Study|Study terminated by sponsor|28|||
105500824|NCT01484275|363844626|FG001|Overall Study|Study terminated by sponsor|32|||
105500825|NCT01484275|363844625|FG000|Overall Study|Other|10|||
105500826|NCT01484275|363844626|FG001|Overall Study|Other|0|||
105500827|NCT01484275|363844625|FG000|Overall Study|Death|3|||
105500828|NCT01484275|363844626|FG001|Overall Study|Death|4|||
105500829|NCT01484275|363844625|FG000|Overall Study|Withdrawal by Subject|1|||
105500830|NCT01484275|363844626|FG001|Overall Study|Withdrawal by Subject|5|||
105500831|NCT01484275|363844625|FG000|Overall Study|Lost to Follow-up|1|||
105500832|NCT01484275|363844626|FG001|Overall Study|Lost to Follow-up|1|||
105500833|NCT00389597|363844631|FG000|Overall Study|Lost to Follow-up|8|||
105500834|NCT00389597|363844632|FG001|Overall Study|Lost to Follow-up|6|||
105500835|NCT00389597|363844633|FG002|Overall Study|Lost to Follow-up|4|||
105500836|NCT00389597|363844634|FG003|Overall Study|Lost to Follow-up|6|||
105500837|NCT00003487|363844635|FG000|Overall Study|Not evaluable|2|||
105500838|NCT02564796|363844638|FG000|Overall Study|Physician Decision|2|||
105500839|NCT02564796|363844639|FG001|Overall Study|Physician Decision|2|||
105500840|NCT00002651|363845716|FG000|Induction|Adverse Event|44|||
105500841|NCT00002651|363845717|FG001|Induction|Adverse Event|0|||
105500842|NCT00002651|363845718|FG002|Induction|Adverse Event|0|||
105500843|NCT00002651|363845716|FG000|Induction|Refusal unrelated to adverse event|50|||
105421627|NCT05032690|363549866|FG001|Period 1|No longer meets eligibility criteria|1|||
105421628|NCT05032690|363549867|FG002|Period 1|No longer meets eligibility criteria|0|||
105421629|NCT05032690|363549868|FG003|Period 1|No longer meets eligibility criteria|0|||
105421630|NCT05032690|363549865|FG000|Period 2|Adverse Event|1|||
105421631|NCT05032690|363549866|FG001|Period 2|Adverse Event|0|||
105421632|NCT05032690|363549867|FG002|Period 2|Adverse Event|0|||
105421633|NCT05032690|363549868|FG003|Period 2|Adverse Event|0|||
105421634|NCT05032690|363549865|FG000|Period 2|Withdrawal by Subject|0|||
105421635|NCT05032690|363549866|FG001|Period 2|Withdrawal by Subject|1|||
105421636|NCT05032690|363549867|FG002|Period 2|Withdrawal by Subject|0|||
105500844|NCT00002651|363845717|FG001|Induction|Refusal unrelated to adverse event|0|||
105500845|NCT00002651|363845718|FG002|Induction|Refusal unrelated to adverse event|0|||
105500846|NCT00002651|363845716|FG000|Induction|Progression/relapse|274|||
105500847|NCT00002651|363845717|FG001|Induction|Progression/relapse|0|||
105500848|NCT00002651|363845718|FG002|Induction|Progression/relapse|0|||
105500849|NCT00002651|363845716|FG000|Induction|Death|62|||
105500850|NCT00002651|363845717|FG001|Induction|Death|0|||
105500851|NCT00002651|363845718|FG002|Induction|Death|0|||
105500852|NCT00002651|363845716|FG000|Induction|Other|823|||
105500853|NCT00002651|363845717|FG001|Induction|Other|0|||
105500854|NCT00002651|363845718|FG002|Induction|Other|0|||
105500855|NCT00002651|363845716|FG000|Induction|not eligible|90|||
105500856|NCT00002651|363845717|FG001|Induction|not eligible|0|||
105500857|NCT00002651|363845718|FG002|Induction|not eligible|0|||
105500858|NCT00002651|363845716|FG000|Consolidation and Randomization|Adverse Event|0|||
105500859|NCT00002651|363845717|FG001|Consolidation and Randomization|Adverse Event|36|||
105500860|NCT00002651|363845718|FG002|Consolidation and Randomization|Adverse Event|14|||
105500861|NCT00002651|363845716|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
105500862|NCT00002651|363845717|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
105500863|NCT00002651|363845718|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
105500864|NCT00002651|363845716|FG000|Consolidation and Randomization|Progression/relapse|0|||
105500865|NCT00002651|363845717|FG001|Consolidation and Randomization|Progression/relapse|295|||
105500866|NCT00002651|363845718|FG002|Consolidation and Randomization|Progression/relapse|298|||
105500867|NCT00002651|363845716|FG000|Consolidation and Randomization|Death|0|||
105500868|NCT00002651|363845717|FG001|Consolidation and Randomization|Death|38|||
105500869|NCT00002651|363845718|FG002|Consolidation and Randomization|Death|48|||
105500870|NCT00002651|363845716|FG000|Consolidation and Randomization|Other|0|||
105500871|NCT00002651|363845717|FG001|Consolidation and Randomization|Other|314|||
105500872|NCT00002651|363845718|FG002|Consolidation and Randomization|Other|313|||
105500873|NCT00002651|363845716|FG000|Consolidation and Randomization|not eligible|0|||
105500874|NCT00002651|363845717|FG001|Consolidation and Randomization|not eligible|102|||
105500875|NCT00002651|363845718|FG002|Consolidation and Randomization|not eligible|112|||
105500876|NCT03750955|363845719|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
105500877|NCT03750955|363845720|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
105500878|NCT03750955|363845719|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
105500879|NCT03750955|363845720|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
105500880|NCT03345914|363845723|FG000|Overall Study|Transition to another study at week 16|80|||
105500881|NCT03345914|363845724|FG001|Overall Study|Transition to another study at week 16|86|||
105500882|NCT03345914|363845725|FG002|Overall Study|Transition to another study at week 16|78|||
105500883|NCT03345914|363845723|FG000|Overall Study|Transition to OLE during follow-up|37|||
105500884|NCT03345914|363845724|FG001|Overall Study|Transition to OLE during follow-up|33|||
105500885|NCT03345914|363845725|FG002|Overall Study|Transition to OLE during follow-up|39|||
105500886|NCT03345914|363845723|FG000|Overall Study|Physician Decision|0|||
105500887|NCT03345914|363845724|FG001|Overall Study|Physician Decision|1|||
105500888|NCT03345914|363845725|FG002|Overall Study|Physician Decision|1|||
105500889|NCT03345914|363845723|FG000|Overall Study|Withdrawal by Subject|5|||
105500890|NCT03345914|363845724|FG001|Overall Study|Withdrawal by Subject|1|||
105500891|NCT03345914|363845725|FG002|Overall Study|Withdrawal by Subject|2|||
105500892|NCT03345914|363845723|FG000|Overall Study|Other|1|||
105500893|NCT03345914|363845724|FG001|Overall Study|Other|1|||
105500894|NCT03345914|363845725|FG002|Overall Study|Other|1|||
105500895|NCT03345914|363845723|FG000|Overall Study|Ongoing|0|||
105500896|NCT03345914|363845724|FG001|Overall Study|Ongoing|0|||
105500897|NCT03345914|363845725|FG002|Overall Study|Ongoing|1|||
105500898|NCT01776840|363845730|FG000|Overall Study|Lost to Follow-up|12|||
105500899|NCT01776840|363845731|FG001|Overall Study|Lost to Follow-up|7|||
105500900|NCT01776840|363845730|FG000|Overall Study|Withdrawal by Subject|32|||
105500901|NCT01776840|363845731|FG001|Overall Study|Withdrawal by Subject|48|||
105500902|NCT01776840|363845730|FG000|Overall Study|Sponsor decision|89|||
105500903|NCT01776840|363845731|FG001|Overall Study|Sponsor decision|87|||
105500904|NCT00939640|363845733|FG000|Overall Study|Physician Decision|1|||
105500905|NCT01443078|363845734|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
105500906|NCT01443078|363845734|FG000|Overall Study|Withdrawal by Subject|1|||
105500907|NCT01443078|363845734|FG000|Overall Study|Patient had brain mets|1|||
105500908|NCT05213481|363845739|FG000|Overall Study|Adverse Event|3|||
105500909|NCT05213481|363845739|FG000|Overall Study|Lost to Follow-up|1|||
105500910|NCT03822182|363845742|FG000|Overall Study|Protocol Violation|0|||
105500911|NCT03822182|363845743|FG001|Overall Study|Protocol Violation|1|||
105500912|NCT03822182|363845744|FG002|Overall Study|Protocol Violation|1|||
105500913|NCT03855228|363845747|FG000|Overall Study|Adverse Event|2|||
105500914|NCT03855228|363845748|FG001|Overall Study|Adverse Event|4|||
105500915|NCT03855228|363845749|FG002|Overall Study|Adverse Event|4|||
105500916|NCT03855228|363845750|FG003|Overall Study|Adverse Event|8|||
105500917|NCT03855228|363845747|FG000|Overall Study|Treatment Failure|1|||
105500918|NCT03855228|363845748|FG001|Overall Study|Treatment Failure|2|||
105500919|NCT03855228|363845749|FG002|Overall Study|Treatment Failure|1|||
105500920|NCT03855228|363845750|FG003|Overall Study|Treatment Failure|8|||
105500921|NCT03855228|363845747|FG000|Overall Study|Lost to Follow-up|0|||
105500922|NCT03855228|363845748|FG001|Overall Study|Lost to Follow-up|0|||
105500923|NCT03855228|363845749|FG002|Overall Study|Lost to Follow-up|0|||
105500924|NCT03855228|363845750|FG003|Overall Study|Lost to Follow-up|1|||
105500925|NCT03855228|363845747|FG000|Overall Study|Protocol Violation|0|||
105500926|NCT03855228|363845748|FG001|Overall Study|Protocol Violation|1|||
105500927|NCT03855228|363845749|FG002|Overall Study|Protocol Violation|2|||
105585266|NCT00819234|364142136|FG001|Overall Study|Protocol Violation|0|||
105421637|NCT05032690|363549868|FG003|Period 2|Withdrawal by Subject|0|||
105421638|NCT05032690|363549865|FG000|Period 2|No longer meets eligibility criteria|0|||
105421639|NCT05032690|363549866|FG001|Period 2|No longer meets eligibility criteria|1|||
105421640|NCT05032690|363549867|FG002|Period 2|No longer meets eligibility criteria|0|||
105421641|NCT05032690|363549868|FG003|Period 2|No longer meets eligibility criteria|0|||
105421642|NCT05032690|363549865|FG000|Period 3|Adverse Event|0|||
105421643|NCT05032690|363549866|FG001|Period 3|Adverse Event|1|||
105421644|NCT05032690|363549867|FG002|Period 3|Adverse Event|0|||
105421645|NCT05032690|363549868|FG003|Period 3|Adverse Event|0|||
105421646|NCT04926831|363549869|FG000|Overall Study|Withdrawal by Subject|2|||
105421647|NCT04926831|363549869|FG000|Overall Study|Adverse Event|2|||
105421648|NCT04669262|363549870|FG000|Overall Study|Withdrawal by Subject|0|||
105421649|NCT04669262|363549871|FG001|Overall Study|Withdrawal by Subject|0|||
105421650|NCT04669262|363549872|FG002|Overall Study|Withdrawal by Subject|0|||
105421651|NCT04669262|363549873|FG003|Overall Study|Withdrawal by Subject|1|||
105421652|NCT04669262|363549870|FG000|Overall Study|Randomized but Not Treated|0|||
105421653|NCT04669262|363549871|FG001|Overall Study|Randomized but Not Treated|1|||
105421654|NCT04669262|363549872|FG002|Overall Study|Randomized but Not Treated|0|||
105421655|NCT04669262|363549873|FG003|Overall Study|Randomized but Not Treated|0|||
105421656|NCT02298179|363549874|FG000|Overall Study|Lost to Follow-up|0|||
105421657|NCT02298179|363549875|FG001|Overall Study|Lost to Follow-up|0|||
105421658|NCT02298179|363549876|FG002|Overall Study|Lost to Follow-up|1|||
105421659|NCT02298179|363549877|FG003|Overall Study|Lost to Follow-up|0|||
105421660|NCT02298179|363549878|FG004|Overall Study|Lost to Follow-up|0|||
105421661|NCT02298179|363549879|FG005|Overall Study|Lost to Follow-up|0|||
105421662|NCT02298179|363549880|FG006|Overall Study|Lost to Follow-up|0|||
105421663|NCT02298179|363549881|FG007|Overall Study|Lost to Follow-up|1|||
105421664|NCT02298179|363549882|FG008|Overall Study|Lost to Follow-up|0|||
105421665|NCT02298179|363549883|FG009|Overall Study|Lost to Follow-up|0|||
105421666|NCT02298179|363549884|FG010|Overall Study|Lost to Follow-up|0|||
105421667|NCT02298179|363549885|FG011|Overall Study|Lost to Follow-up|0|||
105421668|NCT02701777|363549886|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
105421669|NCT02701777|363549887|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
105421670|NCT02701777|363549888|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
105421671|NCT02701777|363549889|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
105421672|NCT02701777|363549886|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
105421673|NCT02701777|363549887|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
105421674|NCT02701777|363549888|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
105421675|NCT02701777|363549889|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
105421676|NCT00737568|363549894|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
105421677|NCT00737568|363549895|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
105421678|NCT00737568|363549894|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
105421679|NCT00737568|363549895|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
105421680|NCT00737568|363549894|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
105421681|NCT00737568|363549895|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
105421682|NCT00737568|363549894|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
105421683|NCT00737568|363549895|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
105421684|NCT00737568|363549894|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
105421685|NCT00737568|363549895|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
105421686|NCT00737568|363549894|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
105421687|NCT00737568|363549895|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
105421688|NCT00737568|363549894|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
105421689|NCT00737568|363549895|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
105421690|NCT00737568|363549894|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
105421691|NCT00737568|363549895|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
105421692|NCT00737568|363549894|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
105421693|NCT00737568|363549895|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
105585267|NCT00819234|364142137|FG002|Overall Study|Protocol Violation|1|||
105421694|NCT01457014|363549896|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
105421695|NCT01457014|363549897|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
105421696|NCT01457014|363549898|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
105421697|NCT01457014|363549899|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
105421698|NCT01457014|363549896|FG000|First Night|Withdrawal by Subject|3|||
105421699|NCT01457014|363549897|FG001|First Night|Withdrawal by Subject|0|||
105421700|NCT01457014|363549898|FG002|First Night|Withdrawal by Subject|0|||
105421701|NCT01457014|363549899|FG003|First Night|Withdrawal by Subject|0|||
105421702|NCT00294645|363549900|FG000|Overall Study|Death|10|||
105421703|NCT00294645|363549901|FG001|Overall Study|Death|18|||
105421704|NCT00294645|363549900|FG000|Overall Study|Lost to Follow-up|1|||
105421705|NCT00294645|363549901|FG001|Overall Study|Lost to Follow-up|10|||
105421706|NCT00294645|363549900|FG000|Overall Study|Withdrawal by Subject|18|||
105585268|NCT00819234|364142138|FG003|Overall Study|Protocol Violation|0|||
105585269|NCT00819234|364142139|FG004|Overall Study|Protocol Violation|0|||
105585270|NCT00819234|364142140|FG005|Overall Study|Protocol Violation|0|||
105585271|NCT00819234|364142141|FG006|Overall Study|Protocol Violation|0|||
105585272|NCT00819234|364142142|FG007|Overall Study|Protocol Violation|0|||
105585273|NCT00819234|364142143|FG008|Overall Study|Protocol Violation|0|||
105421707|NCT00294645|363549901|FG001|Overall Study|Withdrawal by Subject|34|||
105421708|NCT00294645|363549900|FG000|Overall Study|Physician Decision|15|||
105421709|NCT00294645|363549901|FG001|Overall Study|Physician Decision|20|||
105421710|NCT00294645|363549900|FG000|Overall Study|Other|4|||
105421711|NCT00294645|363549901|FG001|Overall Study|Other|10|||
105421712|NCT00428220|363552075|FG000|Overall Study|Participant died|8|||
105421713|NCT00428220|363552075|FG000|Overall Study|Global deterioration of health status|7|||
105421714|NCT00428220|363552075|FG000|Overall Study|Lost to Follow-up|4|||
105421715|NCT00428220|363552075|FG000|Overall Study|Objective progression or relapse|123|||
105421716|NCT00428220|363552075|FG000|Overall Study|Participant refused continued treatment|7|||
105421717|NCT00428220|363552075|FG000|Overall Study|Adverse Event|51|||
105421718|NCT00428220|363552075|FG000|Overall Study|Other|23|||
105421719|NCT00983515|363552076|FG000|Ritonavir Alone|liver panel out of range|6|||
105421720|NCT00983515|363552076|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
105421721|NCT01730339|363552079|FG000|Overall Study|Withdrawal by Subject|3|||
105421722|NCT01730339|363552080|FG001|Overall Study|Withdrawal by Subject|2|||
105421723|NCT01730339|363552079|FG000|Overall Study|Lost to Follow-up|1|||
105421724|NCT01730339|363552080|FG001|Overall Study|Lost to Follow-up|1|||
105421725|NCT01730339|363552079|FG000|Overall Study|Un-specified|1|||
105421726|NCT01730339|363552080|FG001|Overall Study|Un-specified|0|||
105421727|NCT04143217|363552083|FG000|Overall Study|Withdrawal by Subject|42|||
105421728|NCT04143217|363552083|FG000|Overall Study|Adverse Event|29|||
105421729|NCT04143217|363552083|FG000|Overall Study|Lost to Follow-up|29|||
105421730|NCT04143217|363552083|FG000|Overall Study|Lack of Efficacy|15|||
105421731|NCT04143217|363552083|FG000|Overall Study|Physician Decision|1|||
105421732|NCT04143217|363552083|FG000|Overall Study|Non-Compliance With Study Drug|6|||
105421733|NCT04143217|363552083|FG000|Overall Study|Other, Multiple Categories|11|||
105421734|NCT00539513|363552084|FG000|Overall Study|Withdrawal by Subject|2|||
105421735|NCT00539513|363552085|FG001|Overall Study|Withdrawal by Subject|1|||
105421736|NCT00539513|363552084|FG000|Overall Study|Lost to Follow-up|0|||
105421737|NCT00539513|363552085|FG001|Overall Study|Lost to Follow-up|1|||
105421738|NCT00316693|363552086|FG000|Overall Study|Adverse Event|6|||
105421739|NCT00316693|363552087|FG001|Overall Study|Adverse Event|1|||
105421740|NCT00316693|363552086|FG000|Overall Study|Protocol Violation|1|||
105421741|NCT00316693|363552087|FG001|Overall Study|Protocol Violation|0|||
105421742|NCT00316693|363552086|FG000|Overall Study|Withdrawal by Subject|6|||
105421743|NCT00316693|363552087|FG001|Overall Study|Withdrawal by Subject|6|||
105421744|NCT00316693|363552086|FG000|Overall Study|Lost to Follow-up|26|||
105421745|NCT00316693|363552087|FG001|Overall Study|Lost to Follow-up|34|||
105421746|NCT00316693|363552086|FG000|Overall Study|Other|38|||
105421747|NCT00316693|363552087|FG001|Overall Study|Other|44|||
105421748|NCT03002818|363552089|FG000|Overall Study|Decision of the investigator|1|||
105421749|NCT01328041|363552090|FG000|Overall Study|Adverse Event|7|||
105421750|NCT01328041|363552090|FG000|Overall Study|Lack of Efficacy|27|||
105421751|NCT01328041|363552090|FG000|Overall Study|Protocol Violation|7|||
105421752|NCT01328041|363552090|FG000|Overall Study|Lost to Follow-up|7|||
105421753|NCT01328041|363552090|FG000|Overall Study|Physician Decision|2|||
105421754|NCT01328041|363552090|FG000|Overall Study|Withdrawal by Subject|7|||
105421755|NCT03283098|363552091|FG000|Overall Study|Withdrawal by Subject|0|||
105421756|NCT03283098|363552092|FG001|Overall Study|Withdrawal by Subject|1|||
105421757|NCT01606787|363552093|FG000|Overall Study|Withdrawal by Subject|4|||
105421758|NCT01606787|363552094|FG001|Overall Study|Withdrawal by Subject|5|||
105421759|NCT01606787|363552093|FG000|Overall Study|Surgery canceled|0|||
105421760|NCT01606787|363552094|FG001|Overall Study|Surgery canceled|2|||
105421761|NCT00347438|363552113|FG000|Overall Study|Withdrawal by Subject|1|||
105421762|NCT00347438|363552113|FG000|Overall Study|Physician Decision|1|||
105421763|NCT03920293|363552114|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
105421764|NCT03920293|363552115|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
105421765|NCT03920293|363552114|FG000|Randomized-Controlled Period|Physician Decision|1|||
105421766|NCT03920293|363552115|FG001|Randomized-Controlled Period|Physician Decision|2|||
105421767|NCT03920293|363552114|FG000|Randomized-Controlled Period|Adverse Event|0|||
105421768|NCT03920293|363552115|FG001|Randomized-Controlled Period|Adverse Event|2|||
105421769|NCT03920293|363552114|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
105421770|NCT03920293|363552115|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
105421771|NCT03920293|363552114|FG000|Randomized-Controlled Period|Death|2|||
105421772|NCT03920293|363552115|FG001|Randomized-Controlled Period|Death|0|||
105421773|NCT03920293|363552114|FG000|Randomized-Controlled Period|Protocol Violation|1|||
105585274|NCT00819234|364142144|FG009|Overall Study|Protocol Violation|0|||
105421774|NCT03920293|363552115|FG001|Randomized-Controlled Period|Protocol Violation|0|||
105585275|NCT00819234|364142135|FG000|Overall Study|Lost to Follow-up|2|||
105585276|NCT00819234|364142136|FG001|Overall Study|Lost to Follow-up|2|||
105585277|NCT00819234|364142137|FG002|Overall Study|Lost to Follow-up|0|||
105585278|NCT00819234|364142138|FG003|Overall Study|Lost to Follow-up|2|||
105585279|NCT00819234|364142139|FG004|Overall Study|Lost to Follow-up|1|||
105585280|NCT00819234|364142140|FG005|Overall Study|Lost to Follow-up|1|||
105585281|NCT00819234|364142141|FG006|Overall Study|Lost to Follow-up|1|||
105585282|NCT00819234|364142142|FG007|Overall Study|Lost to Follow-up|1|||
105585283|NCT00819234|364142143|FG008|Overall Study|Lost to Follow-up|1|||
105585284|NCT00819234|364142144|FG009|Overall Study|Lost to Follow-up|2|||
105585285|NCT02926937|364142149|FG000|Overall Study|Adverse Event|0|||
105585286|NCT02926937|364142150|FG001|Overall Study|Adverse Event|1|||
105585287|NCT02926937|364142151|FG002|Overall Study|Adverse Event|1|||
105585288|NCT02926937|364142149|FG000|Overall Study|Poor Compliance to Protocol|1|||
105585289|NCT02926937|364142150|FG001|Overall Study|Poor Compliance to Protocol|0|||
105585290|NCT02926937|364142151|FG002|Overall Study|Poor Compliance to Protocol|0|||
105585291|NCT02926937|364142149|FG000|Overall Study|Lost to Follow-up|4|||
105585292|NCT02926937|364142150|FG001|Overall Study|Lost to Follow-up|5|||
105585293|NCT02926937|364142151|FG002|Overall Study|Lost to Follow-up|0|||
105585294|NCT02926937|364142149|FG000|Overall Study|At the Participant's own Request|11|||
105585295|NCT02926937|364142150|FG001|Overall Study|At the Participant's own Request|5|||
105585296|NCT02926937|364142151|FG002|Overall Study|At the Participant's own Request|8|||
105585297|NCT02926937|364142149|FG000|Overall Study|Reason not Specified|3|||
105585298|NCT02926937|364142150|FG001|Overall Study|Reason not Specified|4|||
105585299|NCT02926937|364142151|FG002|Overall Study|Reason not Specified|2|||
105585300|NCT01559090|364142154|FG000|Stage I|Withdrawal by Subject|2|||
105585301|NCT01559090|364142155|FG001|Stage I|Withdrawal by Subject|2|||
105585302|NCT01559090|364142156|FG002|Stage I|Withdrawal by Subject|3|||
105585303|NCT01559090|364142154|FG000|Stage II|Withdrawal by Subject|1|||
105585304|NCT01559090|364142155|FG001|Stage II|Withdrawal by Subject|0|||
105585305|NCT01559090|364142156|FG002|Stage II|Withdrawal by Subject|0|||
105585306|NCT00062868|364142157|FG000|Dose Level 1|Death|2|||
105585307|NCT00062868|364142158|FG001|Dose Level 1|Death|0|||
105585308|NCT00062868|364142159|FG002|Dose Level 1|Death|0|||
105585309|NCT00062868|364142160|FG003|Dose Level 1|Death|2|||
105585310|NCT00062868|364142161|FG004|Dose Level 1|Death|0|||
105585311|NCT00062868|364142162|FG005|Dose Level 1|Death|0|||
105585312|NCT00062868|364142163|FG006|Dose Level 1|Death|3|||
105585313|NCT00062868|364142164|FG007|Dose Level 1|Death|0|||
105585314|NCT00062868|364142165|FG008|Dose Level 1|Death|0|||
105585315|NCT00062868|364142166|FG009|Dose Level 1|Death|0|||
105585316|NCT00062868|364142167|FG010|Dose Level 1|Death|0|||
105585317|NCT00062868|364142168|FG011|Dose Level 1|Death|0|||
105585318|NCT00062868|364142169|FG012|Dose Level 1|Death|0|||
105585319|NCT00062868|364142170|FG013|Dose Level 1|Death|0|||
105585320|NCT00062868|364142171|FG014|Dose Level 1|Death|0|||
105585321|NCT00062868|364142172|FG015|Dose Level 1|Death|0|||
105585322|NCT00062868|364142173|FG016|Dose Level 1|Death|0|||
105585323|NCT00062868|364142174|FG017|Dose Level 1|Death|0|||
105585324|NCT00062868|364142175|FG018|Dose Level 1|Death|7|||
105585325|NCT00062868|364142176|FG019|Dose Level 1|Death|0|||
105585326|NCT00062868|364142177|FG020|Dose Level 1|Death|1|||
105585327|NCT00062868|364142157|FG000|Dose Level 1|Lost to Follow-up|0|||
105585328|NCT00062868|364142158|FG001|Dose Level 1|Lost to Follow-up|0|||
105585329|NCT00062868|364142159|FG002|Dose Level 1|Lost to Follow-up|0|||
105585330|NCT00062868|364142160|FG003|Dose Level 1|Lost to Follow-up|0|||
105585331|NCT00062868|364142161|FG004|Dose Level 1|Lost to Follow-up|0|||
105585332|NCT00062868|364142162|FG005|Dose Level 1|Lost to Follow-up|0|||
105585333|NCT00062868|364142163|FG006|Dose Level 1|Lost to Follow-up|0|||
105585334|NCT00062868|364142164|FG007|Dose Level 1|Lost to Follow-up|0|||
105585335|NCT00062868|364142165|FG008|Dose Level 1|Lost to Follow-up|0|||
105585336|NCT00062868|364142166|FG009|Dose Level 1|Lost to Follow-up|0|||
105421775|NCT03920293|363552114|FG000|Randomized-Controlled Period|Noncompliance|1|||
105421776|NCT03920293|363552115|FG001|Randomized-Controlled Period|Noncompliance|0|||
105421777|NCT03920293|363552114|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
105585337|NCT00062868|364142167|FG010|Dose Level 1|Lost to Follow-up|0|||
105585338|NCT00062868|364142168|FG011|Dose Level 1|Lost to Follow-up|0|||
105585339|NCT00062868|364142169|FG012|Dose Level 1|Lost to Follow-up|1|||
105585340|NCT00062868|364142170|FG013|Dose Level 1|Lost to Follow-up|0|||
105585341|NCT00062868|364142171|FG014|Dose Level 1|Lost to Follow-up|0|||
105585342|NCT00062868|364142172|FG015|Dose Level 1|Lost to Follow-up|0|||
105585343|NCT00062868|364142173|FG016|Dose Level 1|Lost to Follow-up|0|||
105585344|NCT00062868|364142174|FG017|Dose Level 1|Lost to Follow-up|0|||
105585345|NCT00062868|364142175|FG018|Dose Level 1|Lost to Follow-up|2|||
105585346|NCT00062868|364142176|FG019|Dose Level 1|Lost to Follow-up|0|||
105585347|NCT00062868|364142177|FG020|Dose Level 1|Lost to Follow-up|1|||
105585348|NCT00062868|364142157|FG000|Dose Level 2|Death|0|||
105585349|NCT00062868|364142158|FG001|Dose Level 2|Death|3|||
105585350|NCT00062868|364142159|FG002|Dose Level 2|Death|0|||
105585351|NCT00062868|364142160|FG003|Dose Level 2|Death|0|||
105585352|NCT00062868|364142161|FG004|Dose Level 2|Death|2|||
105585353|NCT00062868|364142162|FG005|Dose Level 2|Death|0|||
105585354|NCT00062868|364142163|FG006|Dose Level 2|Death|0|||
105585355|NCT00062868|364142164|FG007|Dose Level 2|Death|0|||
105585356|NCT00062868|364142165|FG008|Dose Level 2|Death|0|||
105585357|NCT00062868|364142166|FG009|Dose Level 2|Death|0|||
105585358|NCT00062868|364142167|FG010|Dose Level 2|Death|1|||
105585359|NCT00062868|364142168|FG011|Dose Level 2|Death|0|||
105585360|NCT00062868|364142169|FG012|Dose Level 2|Death|0|||
105585361|NCT00062868|364142170|FG013|Dose Level 2|Death|0|||
105585362|NCT00062868|364142171|FG014|Dose Level 2|Death|0|||
105585363|NCT00062868|364142172|FG015|Dose Level 2|Death|0|||
105585364|NCT00062868|364142173|FG016|Dose Level 2|Death|2|||
105585365|NCT00062868|364142174|FG017|Dose Level 2|Death|0|||
105585366|NCT00062868|364142175|FG018|Dose Level 2|Death|0|||
105585367|NCT00062868|364142176|FG019|Dose Level 2|Death|0|||
105585368|NCT00062868|364142177|FG020|Dose Level 2|Death|0|||
105585369|NCT00062868|364142157|FG000|Dose Level 2|Lost to Follow-up|0|||
105585370|NCT00062868|364142158|FG001|Dose Level 2|Lost to Follow-up|0|||
105585371|NCT00062868|364142159|FG002|Dose Level 2|Lost to Follow-up|0|||
105585372|NCT00062868|364142160|FG003|Dose Level 2|Lost to Follow-up|0|||
105585373|NCT00062868|364142161|FG004|Dose Level 2|Lost to Follow-up|0|||
105585374|NCT00062868|364142162|FG005|Dose Level 2|Lost to Follow-up|0|||
105585375|NCT00062868|364142163|FG006|Dose Level 2|Lost to Follow-up|0|||
105585376|NCT00062868|364142164|FG007|Dose Level 2|Lost to Follow-up|0|||
105585377|NCT00062868|364142165|FG008|Dose Level 2|Lost to Follow-up|0|||
105585378|NCT00062868|364142166|FG009|Dose Level 2|Lost to Follow-up|0|||
105585379|NCT00062868|364142167|FG010|Dose Level 2|Lost to Follow-up|0|||
105585380|NCT00062868|364142168|FG011|Dose Level 2|Lost to Follow-up|0|||
105585381|NCT00062868|364142169|FG012|Dose Level 2|Lost to Follow-up|0|||
105585382|NCT00062868|364142170|FG013|Dose Level 2|Lost to Follow-up|1|||
105585383|NCT00062868|364142171|FG014|Dose Level 2|Lost to Follow-up|0|||
105585384|NCT00062868|364142172|FG015|Dose Level 2|Lost to Follow-up|0|||
105585385|NCT00062868|364142173|FG016|Dose Level 2|Lost to Follow-up|1|||
105585386|NCT00062868|364142174|FG017|Dose Level 2|Lost to Follow-up|0|||
105585387|NCT00062868|364142175|FG018|Dose Level 2|Lost to Follow-up|0|||
105585388|NCT00062868|364142176|FG019|Dose Level 2|Lost to Follow-up|0|||
105585389|NCT00062868|364142177|FG020|Dose Level 2|Lost to Follow-up|0|||
105585390|NCT00062868|364142157|FG000|Dose Level 3|Death|0|||
105585391|NCT00062868|364142158|FG001|Dose Level 3|Death|0|||
105585392|NCT00062868|364142159|FG002|Dose Level 3|Death|0|||
105585393|NCT00062868|364142160|FG003|Dose Level 3|Death|0|||
105585394|NCT00062868|364142161|FG004|Dose Level 3|Death|0|||
105585395|NCT00062868|364142162|FG005|Dose Level 3|Death|0|||
105585396|NCT00062868|364142163|FG006|Dose Level 3|Death|0|||
105585397|NCT00062868|364142164|FG007|Dose Level 3|Death|0|||
105585398|NCT00062868|364142165|FG008|Dose Level 3|Death|0|||
105585399|NCT00062868|364142166|FG009|Dose Level 3|Death|0|||
105585400|NCT00062868|364142167|FG010|Dose Level 3|Death|0|||
105585401|NCT00062868|364142168|FG011|Dose Level 3|Death|1|||
105585402|NCT00062868|364142169|FG012|Dose Level 3|Death|0|||
105585403|NCT00062868|364142170|FG013|Dose Level 3|Death|0|||
105585404|NCT00062868|364142171|FG014|Dose Level 3|Death|0|||
105585405|NCT00062868|364142172|FG015|Dose Level 3|Death|0|||
105585406|NCT00062868|364142173|FG016|Dose Level 3|Death|0|||
105585407|NCT00062868|364142174|FG017|Dose Level 3|Death|1|||
105585408|NCT00062868|364142175|FG018|Dose Level 3|Death|0|||
105585409|NCT00062868|364142176|FG019|Dose Level 3|Death|0|||
105585410|NCT00062868|364142177|FG020|Dose Level 3|Death|0|||
105585411|NCT00062868|364142157|FG000|Dose Level 3|Lost to Follow-up|0|||
105585412|NCT00062868|364142158|FG001|Dose Level 3|Lost to Follow-up|0|||
105585413|NCT00062868|364142159|FG002|Dose Level 3|Lost to Follow-up|0|||
105585414|NCT00062868|364142160|FG003|Dose Level 3|Lost to Follow-up|0|||
105585415|NCT00062868|364142161|FG004|Dose Level 3|Lost to Follow-up|0|||
105585416|NCT00062868|364142162|FG005|Dose Level 3|Lost to Follow-up|0|||
105585417|NCT00062868|364142163|FG006|Dose Level 3|Lost to Follow-up|0|||
105585418|NCT00062868|364142164|FG007|Dose Level 3|Lost to Follow-up|0|||
105585419|NCT00062868|364142165|FG008|Dose Level 3|Lost to Follow-up|0|||
105585420|NCT00062868|364142166|FG009|Dose Level 3|Lost to Follow-up|0|||
105585421|NCT00062868|364142167|FG010|Dose Level 3|Lost to Follow-up|0|||
105585422|NCT00062868|364142168|FG011|Dose Level 3|Lost to Follow-up|0|||
105585423|NCT00062868|364142169|FG012|Dose Level 3|Lost to Follow-up|0|||
105585424|NCT00062868|364142170|FG013|Dose Level 3|Lost to Follow-up|0|||
105585425|NCT00062868|364142171|FG014|Dose Level 3|Lost to Follow-up|1|||
105585426|NCT00062868|364142172|FG015|Dose Level 3|Lost to Follow-up|0|||
105585427|NCT00062868|364142173|FG016|Dose Level 3|Lost to Follow-up|0|||
105585428|NCT00062868|364142174|FG017|Dose Level 3|Lost to Follow-up|0|||
105585429|NCT00062868|364142175|FG018|Dose Level 3|Lost to Follow-up|0|||
105585430|NCT00062868|364142176|FG019|Dose Level 3|Lost to Follow-up|0|||
105585431|NCT00062868|364142177|FG020|Dose Level 3|Lost to Follow-up|0|||
105585432|NCT00062868|364142157|FG000|Dose Level 3|Withdrew|0|||
105585433|NCT00062868|364142158|FG001|Dose Level 3|Withdrew|0|||
105585434|NCT00062868|364142159|FG002|Dose Level 3|Withdrew|2|||
105585435|NCT00062868|364142160|FG003|Dose Level 3|Withdrew|0|||
105585436|NCT00062868|364142161|FG004|Dose Level 3|Withdrew|0|||
105585437|NCT00062868|364142162|FG005|Dose Level 3|Withdrew|0|||
105585438|NCT00062868|364142163|FG006|Dose Level 3|Withdrew|0|||
105585439|NCT00062868|364142164|FG007|Dose Level 3|Withdrew|0|||
105585440|NCT00062868|364142165|FG008|Dose Level 3|Withdrew|0|||
105585441|NCT00062868|364142166|FG009|Dose Level 3|Withdrew|0|||
105585442|NCT00062868|364142167|FG010|Dose Level 3|Withdrew|0|||
105585443|NCT00062868|364142168|FG011|Dose Level 3|Withdrew|0|||
105585444|NCT00062868|364142169|FG012|Dose Level 3|Withdrew|0|||
105585445|NCT00062868|364142170|FG013|Dose Level 3|Withdrew|0|||
105585446|NCT00062868|364142171|FG014|Dose Level 3|Withdrew|0|||
105585447|NCT00062868|364142172|FG015|Dose Level 3|Withdrew|0|||
105585448|NCT00062868|364142173|FG016|Dose Level 3|Withdrew|0|||
105585449|NCT00062868|364142174|FG017|Dose Level 3|Withdrew|0|||
105585450|NCT00062868|364142175|FG018|Dose Level 3|Withdrew|0|||
105421778|NCT03920293|363552115|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
105421779|NCT03920293|363552114|FG000|Open- Label Extension Period|Death|3|||
105421780|NCT03920293|363552115|FG001|Open- Label Extension Period|Death|3|||
105421781|NCT03920293|363552114|FG000|Open- Label Extension Period|Physician Decision|5|||
105421782|NCT03920293|363552115|FG001|Open- Label Extension Period|Physician Decision|3|||
105421783|NCT03920293|363552114|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
105421784|NCT03920293|363552115|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
105421785|NCT00693017|363552116|FG000|Overall Study|Sponsor Decision|2|||
105421786|NCT00693017|363552117|FG001|Overall Study|Sponsor Decision|1|||
105421787|NCT00693017|363552116|FG000|Overall Study|Death|0|||
105421788|NCT00693017|363552117|FG001|Overall Study|Death|1|||
105421789|NCT01082874|363552118|FG000|Overall Study|Lost to Follow-up|10|||
105421790|NCT01082874|363552119|FG001|Overall Study|Lost to Follow-up|10|||
105421791|NCT01082874|363552120|FG002|Overall Study|Lost to Follow-up|6|||
105421792|NCT01082874|363552121|FG003|Overall Study|Lost to Follow-up|10|||
105421793|NCT01082874|363552118|FG000|Overall Study|Withdrawal by Subject|1|||
105421794|NCT01082874|363552119|FG001|Overall Study|Withdrawal by Subject|2|||
105421795|NCT01082874|363552120|FG002|Overall Study|Withdrawal by Subject|5|||
105421796|NCT01082874|363552121|FG003|Overall Study|Withdrawal by Subject|3|||
105421797|NCT00090142|363552126|FG000|Treatment Period I|Lost to Follow-up|1|||
105421798|NCT00090142|363552127|FG001|Treatment Period I|Lost to Follow-up|2|||
105421799|NCT00090142|363552126|FG000|Treatment Period I|Protocol Violation|2|||
105421800|NCT00090142|363552127|FG001|Treatment Period I|Protocol Violation|0|||
105421801|NCT00090142|363552126|FG000|Treatment Period I|Withdrawal by Subject|2|||
105421802|NCT00090142|363552127|FG001|Treatment Period I|Withdrawal by Subject|0|||
105421803|NCT00090142|363552126|FG000|Treatment Period I|Other|0|||
105421804|NCT00090142|363552127|FG001|Treatment Period I|Other|1|||
105421805|NCT00090142|363552126|FG000|Treatment Period II|Other|1|||
105421806|NCT00090142|363552127|FG001|Treatment Period II|Other|0|||
105421807|NCT00354107|363552128|FG000|Overall Study|Adverse Event|2|||
105421808|NCT00354107|363552128|FG000|Overall Study|Physician Decision|2|||
105421809|NCT00354107|363552128|FG000|Overall Study|Withdrawal by Subject|1|||
105421810|NCT02754141|363552132|FG000|Overall Study|Disease progression|11|||
105421811|NCT02754141|363552133|FG001|Overall Study|Disease progression|7|||
105421812|NCT02754141|363552134|FG002|Overall Study|Disease progression|8|||
105421813|NCT02754141|363552135|FG003|Overall Study|Disease progression|5|||
105421814|NCT02754141|363552136|FG004|Overall Study|Disease progression|7|||
105421815|NCT02754141|363552137|FG005|Overall Study|Disease progression|7|||
105421816|NCT02754141|363552138|FG006|Overall Study|Disease progression|7|||
105421817|NCT02754141|363552139|FG007|Overall Study|Disease progression|6|||
105421818|NCT02754141|363552140|FG008|Overall Study|Disease progression|11|||
105585451|NCT00062868|364142176|FG019|Dose Level 3|Withdrew|0|||
105585452|NCT00062868|364142177|FG020|Dose Level 3|Withdrew|0|||
105585453|NCT01734811|364142178|FG000|Overall Study|Lost to Follow-up|2|||
105585454|NCT01734811|364142179|FG001|Overall Study|Lost to Follow-up|3|||
105585455|NCT01734811|364142178|FG000|Overall Study|Withdrawal by Subject|2|||
105585456|NCT01734811|364142179|FG001|Overall Study|Withdrawal by Subject|0|||
105585457|NCT00725010|364142182|FG000|Overall Study|Toxicity|9|||
105585458|NCT00725010|364142182|FG000|Overall Study|Tumor Progression|7|||
105421819|NCT02754141|363552141|FG009|Overall Study|Disease progression|16|||
105421820|NCT02754141|363552142|FG010|Overall Study|Disease progression|18|||
105421821|NCT02754141|363552143|FG011|Overall Study|Disease progression|13|||
105421822|NCT02754141|363552144|FG012|Overall Study|Disease progression|10|||
105421823|NCT02754141|363552145|FG013|Overall Study|Disease progression|12|||
105421824|NCT02754141|363552146|FG014|Overall Study|Disease progression|12|||
105421825|NCT02754141|363552147|FG015|Overall Study|Disease progression|14|||
105421826|NCT02754141|363552148|FG016|Overall Study|Disease progression|0|||
105421827|NCT02754141|363552149|FG017|Overall Study|Disease progression|1|||
105421828|NCT02754141|363552132|FG000|Overall Study|Study drug toxicity|1|||
105421829|NCT02754141|363552133|FG001|Overall Study|Study drug toxicity|1|||
105421830|NCT02754141|363552134|FG002|Overall Study|Study drug toxicity|0|||
105421831|NCT02754141|363552135|FG003|Overall Study|Study drug toxicity|0|||
105585459|NCT00725010|364142182|FG000|Overall Study|Withdrawal by Subject|2|||
105585460|NCT00725010|364142182|FG000|Overall Study|Death|1|||
105585461|NCT00725010|364142182|FG000|Overall Study|Lost to Follow-up|1|||
105585462|NCT00725010|364142182|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
105585463|NCT00725010|364142182|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
105585464|NCT00725010|364142182|FG000|Overall Study|No further documentation|1|||
105585465|NCT00725010|364142182|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
105585466|NCT01290094|364142183|FG000|Overall Study|Withdrawal by Subject|1|||
105585467|NCT01290094|364142183|FG000|Overall Study|Lost to Follow-up|5|||
105585468|NCT00445692|364142184|FG000|Overall Study|Adverse Event|11|||
105585469|NCT00445692|364142184|FG000|Overall Study|Lack of Efficacy|5|||
105585470|NCT03425539|364142190|FG000|Overall Study|Randomized but not treated|0|||
105585471|NCT03425539|364142191|FG001|Overall Study|Randomized but not treated|1|||
105585472|NCT03425539|364142190|FG000|Overall Study|Adverse Event|2|||
105585473|NCT03425539|364142191|FG001|Overall Study|Adverse Event|2|||
105585474|NCT03425539|364142190|FG000|Overall Study|Withdrawal by Subject|3|||
105585475|NCT03425539|364142191|FG001|Overall Study|Withdrawal by Subject|0|||
105585476|NCT03425539|364142190|FG000|Overall Study|Lost to Follow-up|0|||
105585477|NCT03425539|364142191|FG001|Overall Study|Lost to Follow-up|1|||
105585478|NCT00681811|364142194|FG000|Overall Study|Adverse Event|1|||
105585479|NCT00681811|364142195|FG001|Overall Study|Adverse Event|1|||
105585480|NCT00681811|364142194|FG000|Overall Study|Withdrawal by Subject|2|||
105585481|NCT00681811|364142195|FG001|Overall Study|Withdrawal by Subject|2|||
105585482|NCT00681811|364142194|FG000|Overall Study|Non-compliance|0|||
105585483|NCT00681811|364142195|FG001|Overall Study|Non-compliance|1|||
105585484|NCT01866917|364142196|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
105585485|NCT01866917|364142197|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
105585486|NCT01712685|364142198|FG000|Overall Study|pt declined to participate before trmt|1|||
105585487|NCT01449929|364142202|FG000|Randomization Phase 96 Week|Adverse Event|5|||
105585488|NCT01449929|364142203|FG001|Randomization Phase 96 Week|Adverse Event|13|||
105585489|NCT01449929|364142204|FG002|Randomization Phase 96 Week|Adverse Event|0|||
105585490|NCT01449929|364142202|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
105585491|NCT01449929|364142203|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
105585492|NCT01449929|364142204|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
105585493|NCT01449929|364142202|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
105585494|NCT01449929|364142203|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
105585495|NCT01449929|364142204|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
105585496|NCT01449929|364142202|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
105585497|NCT01449929|364142203|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
105585498|NCT01449929|364142204|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
105585499|NCT01449929|364142202|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
105585500|NCT01449929|364142203|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
105585501|NCT01449929|364142204|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
105585502|NCT01449929|364142202|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
105585503|NCT01449929|364142203|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
105585504|NCT01449929|364142204|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
105585505|NCT01449929|364142202|FG000|Randomization Phase 96 Week|Physician Decision|2|||
105585506|NCT01449929|364142203|FG001|Randomization Phase 96 Week|Physician Decision|3|||
105585507|NCT01449929|364142204|FG002|Randomization Phase 96 Week|Physician Decision|0|||
105585508|NCT01449929|364142202|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
105585509|NCT01449929|364142203|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
105585510|NCT01449929|364142204|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
105585511|NCT01449929|364142202|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
105585512|NCT01449929|364142203|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
105421832|NCT02754141|363552136|FG004|Overall Study|Study drug toxicity|0|||
105421833|NCT02754141|363552137|FG005|Overall Study|Study drug toxicity|0|||
105421834|NCT02754141|363552138|FG006|Overall Study|Study drug toxicity|0|||
105585513|NCT01449929|364142204|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
105585514|NCT01449929|364142202|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
105585515|NCT01449929|364142203|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
105585516|NCT01449929|364142204|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
105585517|NCT01449929|364142202|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
105585518|NCT01449929|364142203|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
105585519|NCT01449929|364142204|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
105585520|NCT00432159|364144182|FG000|Overall Study|Death|0|||
105585521|NCT00432159|364144183|FG001|Overall Study|Death|1|||
105585522|NCT00432159|364144184|FG002|Overall Study|Death|0|||
105585523|NCT00432159|364144185|FG003|Overall Study|Death|0|||
105585524|NCT00432159|364144186|FG004|Overall Study|Death|0|||
105421835|NCT02754141|363552139|FG007|Overall Study|Study drug toxicity|0|||
105585525|NCT00432159|364144182|FG000|Overall Study|Failure|9|||
105585526|NCT00432159|364144183|FG001|Overall Study|Failure|5|||
105585527|NCT00432159|364144184|FG002|Overall Study|Failure|3|||
105585528|NCT00432159|364144185|FG003|Overall Study|Failure|2|||
105421836|NCT02754141|363552140|FG008|Overall Study|Study drug toxicity|0|||
105585529|NCT00432159|364144186|FG004|Overall Study|Failure|3|||
105421837|NCT02754141|363552141|FG009|Overall Study|Study drug toxicity|0|||
105421838|NCT02754141|363552142|FG010|Overall Study|Study drug toxicity|2|||
105421839|NCT02754141|363552143|FG011|Overall Study|Study drug toxicity|1|||
105421840|NCT02754141|363552144|FG012|Overall Study|Study drug toxicity|1|||
105421841|NCT02754141|363552145|FG013|Overall Study|Study drug toxicity|0|||
105421842|NCT02754141|363552146|FG014|Overall Study|Study drug toxicity|0|||
105421843|NCT02754141|363552147|FG015|Overall Study|Study drug toxicity|0|||
105421844|NCT02754141|363552148|FG016|Overall Study|Study drug toxicity|0|||
105421845|NCT02754141|363552149|FG017|Overall Study|Study drug toxicity|0|||
105421846|NCT02754141|363552132|FG000|Overall Study|AE unrelated to study drug|1|||
105421847|NCT02754141|363552133|FG001|Overall Study|AE unrelated to study drug|1|||
105421848|NCT02754141|363552134|FG002|Overall Study|AE unrelated to study drug|0|||
105421849|NCT02754141|363552135|FG003|Overall Study|AE unrelated to study drug|1|||
105421850|NCT02754141|363552136|FG004|Overall Study|AE unrelated to study drug|3|||
105421851|NCT02754141|363552137|FG005|Overall Study|AE unrelated to study drug|2|||
105421852|NCT02754141|363552138|FG006|Overall Study|AE unrelated to study drug|1|||
105421853|NCT02754141|363552139|FG007|Overall Study|AE unrelated to study drug|0|||
105421854|NCT02754141|363552140|FG008|Overall Study|AE unrelated to study drug|0|||
105421855|NCT02754141|363552141|FG009|Overall Study|AE unrelated to study drug|0|||
105421856|NCT02754141|363552142|FG010|Overall Study|AE unrelated to study drug|0|||
105421857|NCT02754141|363552143|FG011|Overall Study|AE unrelated to study drug|0|||
105421858|NCT02754141|363552144|FG012|Overall Study|AE unrelated to study drug|0|||
105421859|NCT02754141|363552145|FG013|Overall Study|AE unrelated to study drug|0|||
105421860|NCT02754141|363552146|FG014|Overall Study|AE unrelated to study drug|0|||
105421861|NCT02754141|363552147|FG015|Overall Study|AE unrelated to study drug|0|||
105421862|NCT02754141|363552148|FG016|Overall Study|AE unrelated to study drug|0|||
105421863|NCT02754141|363552149|FG017|Overall Study|AE unrelated to study drug|0|||
105421864|NCT02754141|363552132|FG000|Overall Study|Request to discontinue|0|||
105421865|NCT02754141|363552133|FG001|Overall Study|Request to discontinue|0|||
105421866|NCT02754141|363552134|FG002|Overall Study|Request to discontinue|0|||
105421867|NCT02754141|363552135|FG003|Overall Study|Request to discontinue|0|||
105421868|NCT02754141|363552136|FG004|Overall Study|Request to discontinue|0|||
105421869|NCT02754141|363552137|FG005|Overall Study|Request to discontinue|0|||
105421870|NCT02754141|363552138|FG006|Overall Study|Request to discontinue|0|||
105421871|NCT02754141|363552139|FG007|Overall Study|Request to discontinue|0|||
105421872|NCT02754141|363552140|FG008|Overall Study|Request to discontinue|1|||
105421873|NCT02754141|363552141|FG009|Overall Study|Request to discontinue|0|||
105421874|NCT02754141|363552142|FG010|Overall Study|Request to discontinue|0|||
105421875|NCT02754141|363552143|FG011|Overall Study|Request to discontinue|0|||
105421876|NCT02754141|363552144|FG012|Overall Study|Request to discontinue|0|||
105421877|NCT02754141|363552145|FG013|Overall Study|Request to discontinue|1|||
105421878|NCT02754141|363552146|FG014|Overall Study|Request to discontinue|1|||
105421879|NCT02754141|363552147|FG015|Overall Study|Request to discontinue|0|||
105421880|NCT02754141|363552148|FG016|Overall Study|Request to discontinue|0|||
105421881|NCT02754141|363552149|FG017|Overall Study|Request to discontinue|0|||
105421882|NCT02754141|363552132|FG000|Overall Study|Withdrew consent|0|||
105421883|NCT02754141|363552133|FG001|Overall Study|Withdrew consent|0|||
105421884|NCT02754141|363552134|FG002|Overall Study|Withdrew consent|0|||
105421885|NCT02754141|363552135|FG003|Overall Study|Withdrew consent|0|||
105421886|NCT02754141|363552136|FG004|Overall Study|Withdrew consent|0|||
105421887|NCT02754141|363552137|FG005|Overall Study|Withdrew consent|0|||
105421888|NCT02754141|363552138|FG006|Overall Study|Withdrew consent|0|||
105421889|NCT02754141|363552139|FG007|Overall Study|Withdrew consent|0|||
105421890|NCT02754141|363552140|FG008|Overall Study|Withdrew consent|0|||
105421891|NCT02754141|363552141|FG009|Overall Study|Withdrew consent|1|||
105421892|NCT02754141|363552142|FG010|Overall Study|Withdrew consent|0|||
105421893|NCT02754141|363552143|FG011|Overall Study|Withdrew consent|0|||
105421894|NCT02754141|363552144|FG012|Overall Study|Withdrew consent|0|||
105421895|NCT02754141|363552145|FG013|Overall Study|Withdrew consent|0|||
105421896|NCT02754141|363552146|FG014|Overall Study|Withdrew consent|0|||
105421897|NCT02754141|363552147|FG015|Overall Study|Withdrew consent|0|||
105421898|NCT02754141|363552148|FG016|Overall Study|Withdrew consent|0|||
105421899|NCT02754141|363552149|FG017|Overall Study|Withdrew consent|0|||
105421900|NCT02754141|363552132|FG000|Overall Study|Maximum clinical benefit|0|||
105421901|NCT02754141|363552133|FG001|Overall Study|Maximum clinical benefit|0|||
105421902|NCT02754141|363552134|FG002|Overall Study|Maximum clinical benefit|0|||
105421903|NCT02754141|363552135|FG003|Overall Study|Maximum clinical benefit|1|||
105421904|NCT02754141|363552136|FG004|Overall Study|Maximum clinical benefit|0|||
105421905|NCT02754141|363552137|FG005|Overall Study|Maximum clinical benefit|0|||
105421906|NCT02754141|363552138|FG006|Overall Study|Maximum clinical benefit|0|||
105421907|NCT02754141|363552139|FG007|Overall Study|Maximum clinical benefit|0|||
105421908|NCT02754141|363552140|FG008|Overall Study|Maximum clinical benefit|0|||
105421909|NCT02754141|363552141|FG009|Overall Study|Maximum clinical benefit|0|||
105421910|NCT02754141|363552142|FG010|Overall Study|Maximum clinical benefit|0|||
105421911|NCT02754141|363552143|FG011|Overall Study|Maximum clinical benefit|0|||
105421912|NCT02754141|363552144|FG012|Overall Study|Maximum clinical benefit|0|||
105421913|NCT02754141|363552145|FG013|Overall Study|Maximum clinical benefit|0|||
105421914|NCT02754141|363552146|FG014|Overall Study|Maximum clinical benefit|0|||
105421915|NCT02754141|363552147|FG015|Overall Study|Maximum clinical benefit|0|||
105421916|NCT02754141|363552148|FG016|Overall Study|Maximum clinical benefit|0|||
105421917|NCT02754141|363552149|FG017|Overall Study|Maximum clinical benefit|0|||
105421918|NCT02754141|363552132|FG000|Overall Study|No longer meets study criteria|0|||
105421919|NCT02754141|363552133|FG001|Overall Study|No longer meets study criteria|0|||
105421920|NCT02754141|363552134|FG002|Overall Study|No longer meets study criteria|0|||
105421921|NCT02754141|363552135|FG003|Overall Study|No longer meets study criteria|1|||
105421922|NCT02754141|363552136|FG004|Overall Study|No longer meets study criteria|0|||
105421923|NCT02754141|363552137|FG005|Overall Study|No longer meets study criteria|0|||
105421924|NCT02754141|363552138|FG006|Overall Study|No longer meets study criteria|0|||
105421925|NCT02754141|363552139|FG007|Overall Study|No longer meets study criteria|0|||
105421926|NCT02754141|363552140|FG008|Overall Study|No longer meets study criteria|0|||
105421927|NCT02754141|363552141|FG009|Overall Study|No longer meets study criteria|0|||
105421928|NCT02754141|363552142|FG010|Overall Study|No longer meets study criteria|0|||
105421929|NCT02754141|363552143|FG011|Overall Study|No longer meets study criteria|0|||
105421930|NCT02754141|363552144|FG012|Overall Study|No longer meets study criteria|0|||
105421931|NCT02754141|363552145|FG013|Overall Study|No longer meets study criteria|0|||
105421932|NCT02754141|363552146|FG014|Overall Study|No longer meets study criteria|0|||
105421933|NCT02754141|363552147|FG015|Overall Study|No longer meets study criteria|0|||
105421934|NCT02754141|363552148|FG016|Overall Study|No longer meets study criteria|0|||
105421935|NCT02754141|363552149|FG017|Overall Study|No longer meets study criteria|0|||
105421936|NCT02754141|363552132|FG000|Overall Study|Other reasons|0|||
105421937|NCT02754141|363552133|FG001|Overall Study|Other reasons|0|||
105421938|NCT02754141|363552134|FG002|Overall Study|Other reasons|0|||
105421939|NCT02754141|363552135|FG003|Overall Study|Other reasons|0|||
105421940|NCT02754141|363552136|FG004|Overall Study|Other reasons|0|||
105421941|NCT02754141|363552137|FG005|Overall Study|Other reasons|0|||
105421942|NCT02754141|363552138|FG006|Overall Study|Other reasons|0|||
105421943|NCT02754141|363552139|FG007|Overall Study|Other reasons|1|||
105421944|NCT02754141|363552140|FG008|Overall Study|Other reasons|0|||
105421945|NCT02754141|363552141|FG009|Overall Study|Other reasons|0|||
105421946|NCT02754141|363552142|FG010|Overall Study|Other reasons|0|||
105421947|NCT02754141|363552143|FG011|Overall Study|Other reasons|0|||
105421948|NCT02754141|363552144|FG012|Overall Study|Other reasons|2|||
105421949|NCT02754141|363552145|FG013|Overall Study|Other reasons|0|||
105421950|NCT02754141|363552146|FG014|Overall Study|Other reasons|0|||
105421951|NCT02754141|363552147|FG015|Overall Study|Other reasons|0|||
105421952|NCT02754141|363552148|FG016|Overall Study|Other reasons|0|||
105421953|NCT02754141|363552149|FG017|Overall Study|Other reasons|0|||
105421954|NCT02754141|363552132|FG000|Overall Study|Completed treatment as per protocol|0|||
105421955|NCT02754141|363552133|FG001|Overall Study|Completed treatment as per protocol|1|||
105421956|NCT02754141|363552134|FG002|Overall Study|Completed treatment as per protocol|0|||
105421957|NCT02754141|363552135|FG003|Overall Study|Completed treatment as per protocol|0|||
105421958|NCT02754141|363552136|FG004|Overall Study|Completed treatment as per protocol|0|||
105421959|NCT02754141|363552137|FG005|Overall Study|Completed treatment as per protocol|0|||
105421960|NCT02754141|363552138|FG006|Overall Study|Completed treatment as per protocol|0|||
105421961|NCT02754141|363552139|FG007|Overall Study|Completed treatment as per protocol|0|||
105421962|NCT02754141|363552140|FG008|Overall Study|Completed treatment as per protocol|0|||
105421963|NCT02754141|363552141|FG009|Overall Study|Completed treatment as per protocol|0|||
105421964|NCT02754141|363552142|FG010|Overall Study|Completed treatment as per protocol|0|||
105421965|NCT02754141|363552143|FG011|Overall Study|Completed treatment as per protocol|0|||
105421966|NCT02754141|363552144|FG012|Overall Study|Completed treatment as per protocol|1|||
105421967|NCT02754141|363552145|FG013|Overall Study|Completed treatment as per protocol|0|||
105421968|NCT02754141|363552146|FG014|Overall Study|Completed treatment as per protocol|0|||
105421969|NCT02754141|363552147|FG015|Overall Study|Completed treatment as per protocol|0|||
105421970|NCT02754141|363552148|FG016|Overall Study|Completed treatment as per protocol|0|||
105421971|NCT02754141|363552149|FG017|Overall Study|Completed treatment as per protocol|0|||
105421972|NCT02754141|363552132|FG000|Overall Study|Not completing monotherapy|0|||
105421973|NCT02754141|363552133|FG001|Overall Study|Not completing monotherapy|0|||
105421974|NCT02754141|363552134|FG002|Overall Study|Not completing monotherapy|0|||
105421975|NCT02754141|363552135|FG003|Overall Study|Not completing monotherapy|0|||
105421976|NCT02754141|363552136|FG004|Overall Study|Not completing monotherapy|0|||
105421977|NCT02754141|363552137|FG005|Overall Study|Not completing monotherapy|0|||
105421978|NCT02754141|363552138|FG006|Overall Study|Not completing monotherapy|0|||
105421979|NCT02754141|363552139|FG007|Overall Study|Not completing monotherapy|0|||
105421980|NCT02754141|363552140|FG008|Overall Study|Not completing monotherapy|0|||
105421981|NCT02754141|363552141|FG009|Overall Study|Not completing monotherapy|0|||
105421982|NCT02754141|363552142|FG010|Overall Study|Not completing monotherapy|0|||
105421983|NCT02754141|363552143|FG011|Overall Study|Not completing monotherapy|0|||
105421984|NCT02754141|363552144|FG012|Overall Study|Not completing monotherapy|0|||
105421985|NCT02754141|363552145|FG013|Overall Study|Not completing monotherapy|1|||
105421986|NCT02754141|363552146|FG014|Overall Study|Not completing monotherapy|0|||
105421987|NCT02754141|363552147|FG015|Overall Study|Not completing monotherapy|0|||
105421988|NCT02754141|363552148|FG016|Overall Study|Not completing monotherapy|0|||
105421989|NCT02754141|363552149|FG017|Overall Study|Not completing monotherapy|0|||
105421990|NCT03344549|363552150|FG000|Overall Study|Withdrawal by Subject|3|||
105421991|NCT03344549|363552151|FG001|Overall Study|Withdrawal by Subject|2|||
105421992|NCT03344549|363552150|FG000|Overall Study|Dialysis|2|||
105421993|NCT03344549|363552151|FG001|Overall Study|Dialysis|0|||
105421994|NCT03344549|363552150|FG000|Overall Study|Cancer|1|||
105421995|NCT03344549|363552151|FG001|Overall Study|Cancer|0|||
105421996|NCT03344549|363552150|FG000|Overall Study|Lack of electronic device|1|||
105421997|NCT03344549|363552151|FG001|Overall Study|Lack of electronic device|0|||
105421998|NCT03344549|363552150|FG000|Overall Study|Transportation difficulty|0|||
105421999|NCT03344549|363552151|FG001|Overall Study|Transportation difficulty|13|||
105422000|NCT00676520|363552152|FG000|Overall Study|Withdrawal by Subject|163|||
105422001|NCT00676520|363552152|FG000|Overall Study|Lost to Follow-up|162|||
105422002|NCT00676520|363552152|FG000|Overall Study|Death|159|||
105422003|NCT00676520|363552152|FG000|Overall Study|Physician Decision|20|||
105422004|NCT00676520|363552152|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
105422005|NCT00676520|363552152|FG000|Overall Study|Other Reason|18|||
105422006|NCT02210689|363552156|FG000|Overall Study|Withdrawal by Subject|7|||
105422007|NCT02210689|363552157|FG001|Overall Study|Withdrawal by Subject|4|||
105422008|NCT02210689|363552158|FG002|Overall Study|Withdrawal by Subject|2|||
105422009|NCT02210689|363552156|FG000|Overall Study|Adverse Event|0|||
105422010|NCT02210689|363552157|FG001|Overall Study|Adverse Event|1|||
105422011|NCT02210689|363552158|FG002|Overall Study|Adverse Event|0|||
105422012|NCT02210689|363552156|FG000|Overall Study|Protocol Violation|1|||
105422013|NCT02210689|363552157|FG001|Overall Study|Protocol Violation|0|||
105422014|NCT02210689|363552158|FG002|Overall Study|Protocol Violation|0|||
105422015|NCT02210689|363552156|FG000|Overall Study|Lost to Follow-up|11|||
105422016|NCT02210689|363552157|FG001|Overall Study|Lost to Follow-up|9|||
105422017|NCT02210689|363552158|FG002|Overall Study|Lost to Follow-up|5|||
105422018|NCT02210689|363552156|FG000|Overall Study|Pregnancy|0|||
105422019|NCT02210689|363552157|FG001|Overall Study|Pregnancy|1|||
105422020|NCT02210689|363552158|FG002|Overall Study|Pregnancy|0|||
105422021|NCT02210689|363552156|FG000|Overall Study|Lack of Efficacy|0|||
105422022|NCT02210689|363552157|FG001|Overall Study|Lack of Efficacy|1|||
105422023|NCT02210689|363552158|FG002|Overall Study|Lack of Efficacy|5|||
105422024|NCT02210689|363552156|FG000|Overall Study|Prohibited medication|2|||
105422025|NCT02210689|363552157|FG001|Overall Study|Prohibited medication|8|||
105422026|NCT02210689|363552158|FG002|Overall Study|Prohibited medication|1|||
105422027|NCT02210689|363552156|FG000|Overall Study|Negative Nugent score at baseline|6|||
105422028|NCT02210689|363552157|FG001|Overall Study|Negative Nugent score at baseline|2|||
105422029|NCT02210689|363552158|FG002|Overall Study|Negative Nugent score at baseline|2|||
105422030|NCT02210689|363552156|FG000|Overall Study|Other|25|||
105422031|NCT02210689|363552157|FG001|Overall Study|Other|21|||
105422032|NCT02210689|363552158|FG002|Overall Study|Other|8|||
105422033|NCT01778049|363552167|FG000|Open Label Treatment Period|Adverse Event|5|||
105422034|NCT01778049|363552168|FG001|Open Label Treatment Period|Adverse Event|15|||
105422035|NCT01778049|363552169|FG002|Open Label Treatment Period|Adverse Event|0|||
105422036|NCT01778049|363552170|FG003|Open Label Treatment Period|Adverse Event|0|||
105422037|NCT01778049|363552171|FG004|Open Label Treatment Period|Adverse Event|0|||
105422038|NCT01778049|363552172|FG005|Open Label Treatment Period|Adverse Event|0|||
105422039|NCT01778049|363552167|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
105422040|NCT01778049|363552168|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
105422041|NCT01778049|363552169|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
105422042|NCT01778049|363552170|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
105422043|NCT01778049|363552171|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
105500928|NCT03855228|363845750|FG003|Overall Study|Protocol Violation|1|||
105500929|NCT03855228|363845747|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
105500930|NCT03855228|363845748|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
105500931|NCT03855228|363845749|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
105500932|NCT03855228|363845750|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
105500933|NCT01893203|363845752|FG000|Overall Study|Withdrawal by Subject|1|||
105500934|NCT00722800|363845753|FG000|Overall Study|Withdrawal by Subject|1|||
105500935|NCT00722800|363845754|FG001|Overall Study|Withdrawal by Subject|0|||
105500936|NCT00722800|363845753|FG000|Overall Study|Physician Decision|1|||
105500937|NCT00722800|363845754|FG001|Overall Study|Physician Decision|0|||
105500938|NCT02130297|363845757|FG000|Overall Study|Lost to Follow-up|4|||
105500939|NCT01387789|363845758|FG000|Overall Study|Adverse Event|5|||
105500940|NCT01387789|363845758|FG000|Overall Study|Lack of Efficacy|2|||
105500941|NCT01387789|363845758|FG000|Overall Study|Lost to Follow-up|1|||
105500942|NCT00306189|363845759|FG000|Overall Study|Physician Decision|0|||
105500943|NCT00306189|363845760|FG001|Overall Study|Physician Decision|0|||
105585530|NCT00432159|364144182|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
105585531|NCT00432159|364144183|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
105585532|NCT00432159|364144184|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
105585533|NCT00432159|364144185|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
105585534|NCT00432159|364144186|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
105585535|NCT03660943|364144188|FG000|Overall Study|Adverse Event|5|||
105585536|NCT03660943|364144189|FG001|Overall Study|Adverse Event|3|||
105585537|NCT03660943|364144188|FG000|Overall Study|Death|0|||
105585538|NCT03660943|364144189|FG001|Overall Study|Death|2|||
105585539|NCT03660943|364144188|FG000|Overall Study|Lost to Follow-up|7|||
105585540|NCT03660943|364144189|FG001|Overall Study|Lost to Follow-up|3|||
105585541|NCT03660943|364144188|FG000|Overall Study|Protocol Violation|3|||
105585542|NCT03660943|364144189|FG001|Overall Study|Protocol Violation|5|||
105585543|NCT03660943|364144188|FG000|Overall Study|Withdrawal by Subject|8|||
105585544|NCT03660943|364144189|FG001|Overall Study|Withdrawal by Subject|15|||
105585545|NCT03660943|364144188|FG000|Overall Study|Lack of Efficacy|9|||
105585546|NCT03660943|364144189|FG001|Overall Study|Lack of Efficacy|12|||
105585547|NCT03660943|364144188|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
105585548|NCT03660943|364144189|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
105585549|NCT04610684|364144193|FG000|Study Treatment|Withdrawal by Subject|1|||
105585550|NCT04610684|364144193|FG000|Study Treatment|Disease Progression|2|||
105585551|NCT04610684|364144193|FG000|Follow up|Death|2|||
105585552|NCT04610684|364144193|FG000|Follow up|Withdrawal by Subject|1|||
105585553|NCT02065245|364144194|FG000|Infusion 1|Lost to Follow-up|0|||
105585554|NCT02065245|364144195|FG001|Infusion 1|Lost to Follow-up|0|||
105585555|NCT02065245|364144196|FG002|Infusion 1|Lost to Follow-up|0|||
105585556|NCT02065245|364144197|FG003|Infusion 1|Lost to Follow-up|0|||
105585557|NCT02065245|364144198|FG004|Infusion 1|Lost to Follow-up|0|||
105585558|NCT02065245|364144199|FG005|Infusion 1|Lost to Follow-up|0|||
105585559|NCT02065245|364144200|FG006|Infusion 1|Lost to Follow-up|1|||
105585560|NCT02065245|364144194|FG000|Infusion 1|Death|0|||
105585561|NCT02065245|364144195|FG001|Infusion 1|Death|0|||
105585562|NCT02065245|364144196|FG002|Infusion 1|Death|1|||
105585563|NCT02065245|364144197|FG003|Infusion 1|Death|0|||
105585564|NCT02065245|364144198|FG004|Infusion 1|Death|1|||
105585565|NCT02065245|364144199|FG005|Infusion 1|Death|0|||
105422044|NCT01778049|363552172|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
105422045|NCT01778049|363552167|FG000|Open Label Treatment Period|Protocol Violation|5|||
105585566|NCT02065245|364144200|FG006|Infusion 1|Death|0|||
105585567|NCT02065245|364144194|FG000|Infusion 2|Death|0|||
105585568|NCT02065245|364144195|FG001|Infusion 2|Death|0|||
105585569|NCT02065245|364144196|FG002|Infusion 2|Death|0|||
105585570|NCT02065245|364144197|FG003|Infusion 2|Death|0|||
105585571|NCT02065245|364144198|FG004|Infusion 2|Death|0|||
105585572|NCT02065245|364144199|FG005|Infusion 2|Death|0|||
105585573|NCT02065245|364144200|FG006|Infusion 2|Death|1|||
105585574|NCT02065245|364144194|FG000|Infusion 3|Lost to Follow-up|1|||
105585575|NCT02065245|364144195|FG001|Infusion 3|Lost to Follow-up|1|||
105585576|NCT02065245|364144196|FG002|Infusion 3|Lost to Follow-up|0|||
105585577|NCT02065245|364144197|FG003|Infusion 3|Lost to Follow-up|0|||
105585578|NCT02065245|364144198|FG004|Infusion 3|Lost to Follow-up|0|||
105585579|NCT02065245|364144199|FG005|Infusion 3|Lost to Follow-up|0|||
105585580|NCT02065245|364144200|FG006|Infusion 3|Lost to Follow-up|0|||
105585581|NCT03201757|364144205|FG000|Overall Study|Withdrawal by Subject|133|||
105585582|NCT03201757|364144205|FG000|Overall Study|Adverse Event|44|||
105585583|NCT03201757|364144205|FG000|Overall Study|Lost to Follow-up|37|||
105585584|NCT03201757|364144205|FG000|Overall Study|Pregnancy|2|||
105585585|NCT03201757|364144205|FG000|Overall Study|Lack of Efficacy|1|||
105585586|NCT03201757|364144205|FG000|Overall Study|Protocol Violation|20|||
105585587|NCT03201757|364144205|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
105585588|NCT03201757|364144205|FG000|Overall Study|Not Yet Determined|5|||
105585589|NCT03201757|364144205|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
105585590|NCT03201757|364144205|FG000|Overall Study|Other|20|||
105585591|NCT03738241|364144206|FG000|Overall Study|Withdrawal by Subject|0|||
105422046|NCT01778049|363552168|FG001|Open Label Treatment Period|Protocol Violation|5|||
105585592|NCT03738241|364144207|FG001|Overall Study|Withdrawal by Subject|0|||
105585593|NCT03738241|364144208|FG002|Overall Study|Withdrawal by Subject|0|||
105585594|NCT03738241|364144209|FG003|Overall Study|Withdrawal by Subject|0|||
105585595|NCT03738241|364144210|FG004|Overall Study|Withdrawal by Subject|0|||
105585596|NCT03738241|364144211|FG005|Overall Study|Withdrawal by Subject|0|||
105585597|NCT03738241|364144212|FG006|Overall Study|Withdrawal by Subject|0|||
105422047|NCT01778049|363552169|FG002|Open Label Treatment Period|Protocol Violation|0|||
105585598|NCT03738241|364144213|FG007|Overall Study|Withdrawal by Subject|0|||
105585599|NCT03738241|364144214|FG008|Overall Study|Withdrawal by Subject|0|||
105585600|NCT03738241|364144215|FG009|Overall Study|Withdrawal by Subject|1|||
105585601|NCT03738241|364144206|FG000|Overall Study|Physician Decision|0|||
105585602|NCT03738241|364144207|FG001|Overall Study|Physician Decision|0|||
105585603|NCT03738241|364144208|FG002|Overall Study|Physician Decision|0|||
105585604|NCT03738241|364144209|FG003|Overall Study|Physician Decision|0|||
105422048|NCT01778049|363552170|FG003|Open Label Treatment Period|Protocol Violation|0|||
105422049|NCT01778049|363552171|FG004|Open Label Treatment Period|Protocol Violation|0|||
105422050|NCT01778049|363552172|FG005|Open Label Treatment Period|Protocol Violation|0|||
105422051|NCT01778049|363552167|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
105422052|NCT01778049|363552168|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
105422053|NCT01778049|363552169|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
105422054|NCT01778049|363552170|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
105422055|NCT01778049|363552171|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
105422056|NCT01778049|363552172|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
105422057|NCT01778049|363552167|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
105422058|NCT01778049|363552168|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
105422059|NCT01778049|363552169|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
105422060|NCT01778049|363552170|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
105422061|NCT01778049|363552171|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
105422062|NCT01778049|363552172|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
105422063|NCT01778049|363552167|FG000|Open Label Treatment Period|Not treated|2|||
105422064|NCT01778049|363552168|FG001|Open Label Treatment Period|Not treated|1|||
105422065|NCT01778049|363552169|FG002|Open Label Treatment Period|Not treated|0|||
105422066|NCT01778049|363552170|FG003|Open Label Treatment Period|Not treated|0|||
105422067|NCT01778049|363552171|FG004|Open Label Treatment Period|Not treated|0|||
105422068|NCT01778049|363552172|FG005|Open Label Treatment Period|Not treated|0|||
105422069|NCT01778049|363552167|FG000|Open Label Treatment Period|Other reason not defined above|77|||
105422070|NCT01778049|363552168|FG001|Open Label Treatment Period|Other reason not defined above|94|||
105422071|NCT01778049|363552169|FG002|Open Label Treatment Period|Other reason not defined above|0|||
105422072|NCT01778049|363552170|FG003|Open Label Treatment Period|Other reason not defined above|0|||
105422073|NCT01778049|363552171|FG004|Open Label Treatment Period|Other reason not defined above|0|||
105422074|NCT01778049|363552172|FG005|Open Label Treatment Period|Other reason not defined above|0|||
105422075|NCT01778049|363552167|FG000|Double Blind Treatment Period|Adverse Event|0|||
105422076|NCT01778049|363552168|FG001|Double Blind Treatment Period|Adverse Event|0|||
105422077|NCT01778049|363552169|FG002|Double Blind Treatment Period|Adverse Event|4|||
105422078|NCT01778049|363552170|FG003|Double Blind Treatment Period|Adverse Event|5|||
105422079|NCT01778049|363552171|FG004|Double Blind Treatment Period|Adverse Event|3|||
105422080|NCT01778049|363552172|FG005|Double Blind Treatment Period|Adverse Event|2|||
105422081|NCT01778049|363552167|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
105422082|NCT01778049|363552168|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
105422083|NCT01778049|363552169|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
105422084|NCT01778049|363552170|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
105422085|NCT01778049|363552171|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
105422086|NCT01778049|363552172|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
105422087|NCT01778049|363552167|FG000|Double Blind Treatment Period|Protocol Violation|0|||
105422088|NCT01778049|363552168|FG001|Double Blind Treatment Period|Protocol Violation|0|||
105422089|NCT01778049|363552169|FG002|Double Blind Treatment Period|Protocol Violation|2|||
105422090|NCT01778049|363552170|FG003|Double Blind Treatment Period|Protocol Violation|0|||
105422091|NCT01778049|363552171|FG004|Double Blind Treatment Period|Protocol Violation|0|||
105422092|NCT01778049|363552172|FG005|Double Blind Treatment Period|Protocol Violation|0|||
105422093|NCT01778049|363552167|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
105422094|NCT01778049|363552168|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
105422095|NCT01778049|363552169|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
105422096|NCT01778049|363552170|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
105422097|NCT01778049|363552171|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
105422098|NCT01778049|363552172|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
105422099|NCT01778049|363552167|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
105422100|NCT01778049|363552168|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
105422101|NCT01778049|363552169|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
105422102|NCT01778049|363552170|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
105422103|NCT01778049|363552171|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
105422104|NCT01778049|363552172|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
105422105|NCT01778049|363552167|FG000|Double Blind Treatment Period|Not treated|0|||
105422106|NCT01778049|363552168|FG001|Double Blind Treatment Period|Not treated|0|||
105422107|NCT01778049|363552169|FG002|Double Blind Treatment Period|Not treated|0|||
105422108|NCT01778049|363552170|FG003|Double Blind Treatment Period|Not treated|2|||
105422109|NCT01778049|363552171|FG004|Double Blind Treatment Period|Not treated|2|||
105422110|NCT01778049|363552172|FG005|Double Blind Treatment Period|Not treated|0|||
105422111|NCT01778049|363552167|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
105422112|NCT01778049|363552168|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
105422113|NCT01778049|363552169|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
105422114|NCT01778049|363552170|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
105422115|NCT01778049|363552171|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
105422116|NCT01778049|363552172|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
105422117|NCT03773133|363552173|FG000|Overall Study|Screen Failure|8|||
105422118|NCT03943550|363552174|FG000|Overall Study|Adverse Event|0|||
105422119|NCT03943550|363552175|FG001|Overall Study|Adverse Event|0|||
105422120|NCT03943550|363552176|FG002|Overall Study|Adverse Event|1|||
105422121|NCT03943550|363552174|FG000|Overall Study|Lost to Follow-up|0|||
105422122|NCT03943550|363552175|FG001|Overall Study|Lost to Follow-up|0|||
105422123|NCT03943550|363552176|FG002|Overall Study|Lost to Follow-up|1|||
105422124|NCT03943550|363552174|FG000|Overall Study|Progressive Disease|0|||
105422125|NCT03943550|363552175|FG001|Overall Study|Progressive Disease|0|||
105422126|NCT03943550|363552176|FG002|Overall Study|Progressive Disease|2|||
105422127|NCT03943550|363552174|FG000|Overall Study|Participant Moved Out of the Country|0|||
105422128|NCT03943550|363552175|FG001|Overall Study|Participant Moved Out of the Country|1|||
105422129|NCT03943550|363552176|FG002|Overall Study|Participant Moved Out of the Country|0|||
105422130|NCT00223977|363552177|FG000|Overall Study|Adverse Event|7|||
105422131|NCT00223977|363552178|FG001|Overall Study|Adverse Event|10|||
105422132|NCT00223977|363552179|FG002|Overall Study|Adverse Event|0|||
105422133|NCT00223977|363552177|FG000|Overall Study|Protocol Violation|0|||
105422134|NCT00223977|363552178|FG001|Overall Study|Protocol Violation|0|||
105422135|NCT00223977|363552179|FG002|Overall Study|Protocol Violation|1|||
105422136|NCT00223977|363552177|FG000|Overall Study|Withdrawal by Subject|1|||
105422137|NCT00223977|363552178|FG001|Overall Study|Withdrawal by Subject|1|||
105422138|NCT00223977|363552179|FG002|Overall Study|Withdrawal by Subject|2|||
105422139|NCT00223977|363552177|FG000|Overall Study|Other|1|||
105422140|NCT00223977|363552178|FG001|Overall Study|Other|0|||
105422141|NCT00223977|363552179|FG002|Overall Study|Other|0|||
105422142|NCT00367744|363552181|FG000|Overall Study|Lost to Follow-up|4|||
105422143|NCT00367744|363552182|FG001|Overall Study|Lost to Follow-up|5|||
105422144|NCT03664674|363552184|FG000|Overall Study|Adverse Event|1|||
105422145|NCT03664674|363552185|FG001|Overall Study|Adverse Event|1|||
105422146|NCT03664674|363552184|FG000|Overall Study|Physician Decision|0|||
105422147|NCT03664674|363552185|FG001|Overall Study|Physician Decision|1|||
105422148|NCT03664674|363552184|FG000|Overall Study|Withdrawal by Subject|2|||
105422149|NCT03664674|363552185|FG001|Overall Study|Withdrawal by Subject|0|||
105422150|NCT02174523|363552187|FG000|Overall Study|Withdrawal by Subject|1|||
105422151|NCT02174523|363552188|FG001|Overall Study|Withdrawal by Subject|0|||
105422152|NCT03894969|363552197|FG000|Overall Study|Adverse Event|0|||
105422153|NCT03894969|363552198|FG001|Overall Study|Adverse Event|2|||
105422154|NCT03894969|363552199|FG002|Overall Study|Adverse Event|0|||
105422155|NCT03894969|363552200|FG003|Overall Study|Adverse Event|1|||
105422156|NCT03894969|363552201|FG004|Overall Study|Adverse Event|2|||
105422157|NCT03894969|363552197|FG000|Overall Study|Lost to Follow-up|3|||
105422158|NCT03894969|363552198|FG001|Overall Study|Lost to Follow-up|1|||
105422159|NCT03894969|363552199|FG002|Overall Study|Lost to Follow-up|1|||
105422160|NCT03894969|363552200|FG003|Overall Study|Lost to Follow-up|0|||
105422161|NCT03894969|363552201|FG004|Overall Study|Lost to Follow-up|0|||
105422162|NCT03894969|363552197|FG000|Overall Study|Withdrawal by Subject|2|||
105422163|NCT03894969|363552198|FG001|Overall Study|Withdrawal by Subject|1|||
105422164|NCT03894969|363552199|FG002|Overall Study|Withdrawal by Subject|3|||
105422165|NCT03894969|363552200|FG003|Overall Study|Withdrawal by Subject|4|||
105422166|NCT03894969|363552201|FG004|Overall Study|Withdrawal by Subject|8|||
105422167|NCT03894969|363552197|FG000|Overall Study|Other|0|||
105422168|NCT03894969|363552198|FG001|Overall Study|Other|0|||
105422169|NCT03894969|363552199|FG002|Overall Study|Other|0|||
105422170|NCT03894969|363552200|FG003|Overall Study|Other|0|||
105422171|NCT03894969|363552201|FG004|Overall Study|Other|3|||
105422172|NCT03894969|363552197|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
105422173|NCT03894969|363552198|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
105422174|NCT03894969|363552199|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
105422175|NCT03894969|363552200|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
105422176|NCT03894969|363552201|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
105422177|NCT03894969|363552197|FG000|Overall Study|Solicited Adverse Event|0|||
105422178|NCT03894969|363552198|FG001|Overall Study|Solicited Adverse Event|1|||
105422179|NCT03894969|363552199|FG002|Overall Study|Solicited Adverse Event|0|||
105422180|NCT03894969|363552200|FG003|Overall Study|Solicited Adverse Event|0|||
105422181|NCT03894969|363552201|FG004|Overall Study|Solicited Adverse Event|0|||
105422182|NCT00951080|363552203|FG000|Overall Study|Adverse Event|3|||
105422183|NCT00951080|363552204|FG001|Overall Study|Adverse Event|3|||
105422184|NCT00951080|363552203|FG000|Overall Study|Lost to Follow-up|0|||
105422185|NCT00951080|363552204|FG001|Overall Study|Lost to Follow-up|1|||
105422186|NCT00951080|363552203|FG000|Overall Study|Physician Decision|4|||
105422187|NCT00951080|363552204|FG001|Overall Study|Physician Decision|1|||
105422188|NCT00951080|363552203|FG000|Overall Study|Other|19|||
105422189|NCT00951080|363552204|FG001|Overall Study|Other|22|||
105422190|NCT01960998|363552205|FG000|Overall Study|Lost to Follow-up|3|||
105500944|NCT00306189|363845761|FG002|Overall Study|Physician Decision|0|||
105422191|NCT01960998|363552206|FG001|Overall Study|Lost to Follow-up|7|||
105422192|NCT01960998|363552205|FG000|Overall Study|Death|0|||
105422193|NCT01960998|363552206|FG001|Overall Study|Death|1|||
105422194|NCT01960998|363552205|FG000|Overall Study|Withdrawal by Subject|8|||
105422195|NCT01960998|363552206|FG001|Overall Study|Withdrawal by Subject|2|||
105422196|NCT01960998|363552205|FG000|Overall Study|lost computer access|0|||
105422197|NCT01960998|363552206|FG001|Overall Study|lost computer access|1|||
105422198|NCT01713283|363552209|FG000|Overall Study|Lack of Efficacy|10|||
105422199|NCT01713283|363552210|FG001|Overall Study|Lack of Efficacy|2|||
105422200|NCT01713283|363552209|FG000|Overall Study|Lost to Follow-up|1|||
105422201|NCT01713283|363552210|FG001|Overall Study|Lost to Follow-up|1|||
105422202|NCT00835640|363552216|FG000|Second Intervention|Protocol Violation|1|||
105422203|NCT00835640|363552217|FG001|Second Intervention|Protocol Violation|0|||
105422204|NCT00812006|363552218|FG000|Overall Study|Lost to Follow-up|0|||
105422205|NCT00812006|363552219|FG001|Overall Study|Lost to Follow-up|0|||
105422206|NCT00812006|363552220|FG002|Overall Study|Lost to Follow-up|2|||
105422207|NCT00812006|363552218|FG000|Overall Study|Physician Decision|0|||
105422208|NCT00812006|363552219|FG001|Overall Study|Physician Decision|0|||
105422209|NCT00812006|363552220|FG002|Overall Study|Physician Decision|1|||
105422210|NCT00812006|363552218|FG000|Overall Study|Withdrawal by Subject|2|||
105422211|NCT00812006|363552219|FG001|Overall Study|Withdrawal by Subject|1|||
105422212|NCT00812006|363552220|FG002|Overall Study|Withdrawal by Subject|1|||
105422213|NCT00812006|363552218|FG000|Overall Study|Lack of Qualifying Event|4|||
105422214|NCT00812006|363552219|FG001|Overall Study|Lack of Qualifying Event|2|||
105422215|NCT00812006|363552220|FG002|Overall Study|Lack of Qualifying Event|2|||
105422216|NCT01824823|363552221|FG000|Overall Study|Lack of Efficacy|1|||
105422217|NCT01824823|363552222|FG001|Overall Study|Lack of Efficacy|1|||
105422218|NCT01824823|363552221|FG000|Overall Study|Off-treatment reason not submitted|1|||
105422219|NCT01824823|363552222|FG001|Overall Study|Off-treatment reason not submitted|0|||
105422220|NCT03263923|363552223|FG000|Overall Study|Withdrawal by Subject|10|||
105422221|NCT03263923|363552224|FG001|Overall Study|Withdrawal by Subject|8|||
105422222|NCT03263923|363552223|FG000|Overall Study|Lost to Follow-up|15|||
105422223|NCT03263923|363552224|FG001|Overall Study|Lost to Follow-up|13|||
105422224|NCT01939002|363552228|FG000|Overall Study|Adverse Event|13|||
105422225|NCT01939002|363552229|FG001|Overall Study|Adverse Event|13|||
105422226|NCT01939002|363552228|FG000|Overall Study|Withdrawal by Subject|5|||
105422227|NCT01939002|363552229|FG001|Overall Study|Withdrawal by Subject|3|||
105422228|NCT01939002|363552228|FG000|Overall Study|Other|1|||
105422229|NCT01939002|363552229|FG001|Overall Study|Other|2|||
105422230|NCT00075725|363552232|FG000|Overall Study|Adverse Event|6|||
105422231|NCT00075725|363552233|FG001|Overall Study|Adverse Event|6|||
105422232|NCT00075725|363552234|FG002|Overall Study|Adverse Event|20|||
105422233|NCT00075725|363552235|FG003|Overall Study|Adverse Event|8|||
105422234|NCT00075725|363552236|FG004|Overall Study|Adverse Event|4|||
105422235|NCT00075725|363552237|FG005|Overall Study|Adverse Event|38|||
105422236|NCT00075725|363552238|FG006|Overall Study|Adverse Event|3|||
105422237|NCT00075725|363552239|FG007|Overall Study|Adverse Event|51|||
105422238|NCT00075725|363552240|FG008|Overall Study|Adverse Event|15|||
105422239|NCT00075725|363552241|FG009|Overall Study|Adverse Event|4|||
105422240|NCT00075725|363552242|FG010|Overall Study|Adverse Event|2|||
105422241|NCT00075725|363552243|FG011|Overall Study|Adverse Event|2|||
105422242|NCT00075725|363552232|FG000|Overall Study|Death|3|||
105422243|NCT00075725|363552233|FG001|Overall Study|Death|5|||
105422244|NCT00075725|363552234|FG002|Overall Study|Death|10|||
105422245|NCT00075725|363552235|FG003|Overall Study|Death|2|||
105422246|NCT00075725|363552236|FG004|Overall Study|Death|3|||
105422247|NCT00075725|363552237|FG005|Overall Study|Death|25|||
105422248|NCT00075725|363552238|FG006|Overall Study|Death|4|||
105422249|NCT00075725|363552239|FG007|Overall Study|Death|22|||
105422250|NCT00075725|363552240|FG008|Overall Study|Death|14|||
105422251|NCT00075725|363552241|FG009|Overall Study|Death|4|||
105422252|NCT00075725|363552242|FG010|Overall Study|Death|3|||
105422253|NCT00075725|363552243|FG011|Overall Study|Death|0|||
105422254|NCT00075725|363552232|FG000|Overall Study|Lost to Follow-up|1|||
105422255|NCT00075725|363552233|FG001|Overall Study|Lost to Follow-up|1|||
105422256|NCT00075725|363552234|FG002|Overall Study|Lost to Follow-up|4|||
105422257|NCT00075725|363552235|FG003|Overall Study|Lost to Follow-up|1|||
105422258|NCT00075725|363552236|FG004|Overall Study|Lost to Follow-up|0|||
105422259|NCT00075725|363552237|FG005|Overall Study|Lost to Follow-up|13|||
105422260|NCT00075725|363552238|FG006|Overall Study|Lost to Follow-up|2|||
105422261|NCT00075725|363552239|FG007|Overall Study|Lost to Follow-up|4|||
105422262|NCT00075725|363552240|FG008|Overall Study|Lost to Follow-up|1|||
105422263|NCT00075725|363552241|FG009|Overall Study|Lost to Follow-up|0|||
105422264|NCT00075725|363552242|FG010|Overall Study|Lost to Follow-up|0|||
105422265|NCT00075725|363552243|FG011|Overall Study|Lost to Follow-up|0|||
105422266|NCT00075725|363552232|FG000|Overall Study|Physician Decision|2|||
105422267|NCT00075725|363552233|FG001|Overall Study|Physician Decision|6|||
105422268|NCT00075725|363552234|FG002|Overall Study|Physician Decision|5|||
105422269|NCT00075725|363552235|FG003|Overall Study|Physician Decision|8|||
105422270|NCT00075725|363552236|FG004|Overall Study|Physician Decision|4|||
105422271|NCT00075725|363552237|FG005|Overall Study|Physician Decision|19|||
105422272|NCT00075725|363552238|FG006|Overall Study|Physician Decision|3|||
105585605|NCT03738241|364144210|FG004|Overall Study|Physician Decision|0|||
105585606|NCT03738241|364144211|FG005|Overall Study|Physician Decision|0|||
105585607|NCT03738241|364144212|FG006|Overall Study|Physician Decision|0|||
105585608|NCT03738241|364144213|FG007|Overall Study|Physician Decision|0|||
105585609|NCT03738241|364144214|FG008|Overall Study|Physician Decision|1|||
105585610|NCT03738241|364144215|FG009|Overall Study|Physician Decision|0|||
105585611|NCT03738241|364144206|FG000|Overall Study|Adverse Event|1|||
105585612|NCT03738241|364144207|FG001|Overall Study|Adverse Event|0|||
105585613|NCT03738241|364144208|FG002|Overall Study|Adverse Event|0|||
105585614|NCT03738241|364144209|FG003|Overall Study|Adverse Event|0|||
105585615|NCT03738241|364144210|FG004|Overall Study|Adverse Event|0|||
105585616|NCT03738241|364144211|FG005|Overall Study|Adverse Event|0|||
105585617|NCT03738241|364144212|FG006|Overall Study|Adverse Event|0|||
105585618|NCT03738241|364144213|FG007|Overall Study|Adverse Event|0|||
105585619|NCT03738241|364144214|FG008|Overall Study|Adverse Event|0|||
105585620|NCT03738241|364144215|FG009|Overall Study|Adverse Event|0|||
105585621|NCT04541186|364144218|FG000|Main Study|Adverse Event|0|||
105585622|NCT04541186|364144219|FG001|Main Study|Adverse Event|0|||
105585623|NCT04541186|364144220|FG002|Main Study|Adverse Event|4|||
105585624|NCT04541186|364144221|FG003|Main Study|Adverse Event|0|||
105585625|NCT04541186|364144222|FG004|Main Study|Adverse Event|0|||
105585626|NCT04541186|364144218|FG000|Main Study|Investigator Decision|0|||
105585627|NCT04541186|364144219|FG001|Main Study|Investigator Decision|0|||
105585628|NCT04541186|364144220|FG002|Main Study|Investigator Decision|1|||
105585629|NCT04541186|364144221|FG003|Main Study|Investigator Decision|1|||
105585630|NCT04541186|364144222|FG004|Main Study|Investigator Decision|0|||
105585631|NCT04541186|364144218|FG000|Main Study|Withdrawal by Subject|1|||
105585632|NCT04541186|364144219|FG001|Main Study|Withdrawal by Subject|1|||
105585633|NCT04541186|364144220|FG002|Main Study|Withdrawal by Subject|0|||
105585634|NCT04541186|364144221|FG003|Main Study|Withdrawal by Subject|0|||
105585635|NCT04541186|364144222|FG004|Main Study|Withdrawal by Subject|0|||
105585636|NCT04541186|364144218|FG000|Main Study|COVID-19-related Dose Interruption|0|||
105585637|NCT04541186|364144219|FG001|Main Study|COVID-19-related Dose Interruption|0|||
105585638|NCT04541186|364144220|FG002|Main Study|COVID-19-related Dose Interruption|0|||
105585639|NCT04541186|364144221|FG003|Main Study|COVID-19-related Dose Interruption|0|||
105585640|NCT04541186|364144222|FG004|Main Study|COVID-19-related Dose Interruption|1|||
105585641|NCT04541186|364144218|FG000|Main Study|Randomized in Error Not Treated|0|||
105585642|NCT04541186|364144219|FG001|Main Study|Randomized in Error Not Treated|0|||
105585643|NCT04541186|364144220|FG002|Main Study|Randomized in Error Not Treated|1|||
105585644|NCT04541186|364144221|FG003|Main Study|Randomized in Error Not Treated|0|||
105585645|NCT04541186|364144222|FG004|Main Study|Randomized in Error Not Treated|0|||
105585646|NCT04541186|364144218|FG000|Fibrate Expansion Study|Other than Specified|0|||
105585647|NCT04541186|364144219|FG001|Fibrate Expansion Study|Other than Specified|0|||
105585648|NCT04541186|364144220|FG002|Fibrate Expansion Study|Other than Specified|0|||
105585649|NCT04541186|364144221|FG003|Fibrate Expansion Study|Other than Specified|0|||
105585650|NCT04541186|364144222|FG004|Fibrate Expansion Study|Other than Specified|1|||
105585651|NCT02256969|364144223|FG000|Overall Study|Screenfailed or withdrew|2|||
105585652|NCT02256969|364144224|FG001|Overall Study|Screenfailed or withdrew|1|||
105585653|NCT02256969|364144225|FG002|Overall Study|Screenfailed or withdrew|1|||
105585654|NCT00691028|364144227|FG000|Open-label Period|Adverse Event|0|||
105585655|NCT00691028|364144228|FG001|Open-label Period|Adverse Event|0|||
105585656|NCT00691028|364144229|FG002|Open-label Period|Adverse Event|0|||
105585657|NCT00691028|364144230|FG003|Open-label Period|Adverse Event|16|||
105585658|NCT00691028|364144227|FG000|Open-label Period|Withdrawal by Subject|0|||
105585659|NCT00691028|364144228|FG001|Open-label Period|Withdrawal by Subject|0|||
105585660|NCT00691028|364144229|FG002|Open-label Period|Withdrawal by Subject|0|||
105585661|NCT00691028|364144230|FG003|Open-label Period|Withdrawal by Subject|3|||
105585662|NCT00691028|364144227|FG000|Open-label Period|not come to a hospital|0|||
105585663|NCT00691028|364144228|FG001|Open-label Period|not come to a hospital|0|||
105585664|NCT00691028|364144229|FG002|Open-label Period|not come to a hospital|0|||
105585665|NCT00691028|364144230|FG003|Open-label Period|not come to a hospital|1|||
105585666|NCT00691028|364144227|FG000|Double-blind Period|Adverse Event|8|||
105585667|NCT00691028|364144228|FG001|Double-blind Period|Adverse Event|9|||
105585668|NCT00691028|364144229|FG002|Double-blind Period|Adverse Event|6|||
105585669|NCT00691028|364144230|FG003|Double-blind Period|Adverse Event|0|||
105585670|NCT00691028|364144227|FG000|Double-blind Period|Lack of Efficacy|4|||
105585671|NCT00691028|364144228|FG001|Double-blind Period|Lack of Efficacy|3|||
105422273|NCT00075725|363552239|FG007|Overall Study|Physician Decision|17|||
105422274|NCT00075725|363552240|FG008|Overall Study|Physician Decision|5|||
105422275|NCT00075725|363552241|FG009|Overall Study|Physician Decision|0|||
105422276|NCT00075725|363552242|FG010|Overall Study|Physician Decision|1|||
105585672|NCT00691028|364144229|FG002|Double-blind Period|Lack of Efficacy|2|||
105585673|NCT00691028|364144230|FG003|Double-blind Period|Lack of Efficacy|0|||
105585674|NCT00691028|364144227|FG000|Double-blind Period|Withdrawal by Subject|1|||
105585675|NCT00691028|364144228|FG001|Double-blind Period|Withdrawal by Subject|0|||
105422277|NCT00075725|363552243|FG011|Overall Study|Physician Decision|0|||
105585676|NCT00691028|364144229|FG002|Double-blind Period|Withdrawal by Subject|1|||
105422278|NCT00075725|363552232|FG000|Overall Study|Pregnancy|0|||
105422279|NCT00075725|363552233|FG001|Overall Study|Pregnancy|0|||
105422280|NCT00075725|363552234|FG002|Overall Study|Pregnancy|0|||
105422281|NCT00075725|363552235|FG003|Overall Study|Pregnancy|0|||
105422282|NCT00075725|363552236|FG004|Overall Study|Pregnancy|0|||
105422283|NCT00075725|363552237|FG005|Overall Study|Pregnancy|1|||
105422284|NCT00075725|363552238|FG006|Overall Study|Pregnancy|0|||
105422285|NCT00075725|363552239|FG007|Overall Study|Pregnancy|1|||
105422286|NCT00075725|363552240|FG008|Overall Study|Pregnancy|0|||
105422287|NCT00075725|363552241|FG009|Overall Study|Pregnancy|0|||
105422288|NCT00075725|363552242|FG010|Overall Study|Pregnancy|0|||
105422289|NCT00075725|363552243|FG011|Overall Study|Pregnancy|0|||
105422290|NCT00075725|363552232|FG000|Overall Study|Protocol Violation|1|||
105422291|NCT00075725|363552233|FG001|Overall Study|Protocol Violation|1|||
105422292|NCT00075725|363552234|FG002|Overall Study|Protocol Violation|0|||
105422293|NCT00075725|363552235|FG003|Overall Study|Protocol Violation|3|||
105422294|NCT00075725|363552236|FG004|Overall Study|Protocol Violation|3|||
105422295|NCT00075725|363552237|FG005|Overall Study|Protocol Violation|2|||
105422296|NCT00075725|363552238|FG006|Overall Study|Protocol Violation|1|||
105422297|NCT00075725|363552239|FG007|Overall Study|Protocol Violation|2|||
105422298|NCT00075725|363552240|FG008|Overall Study|Protocol Violation|3|||
105422299|NCT00075725|363552241|FG009|Overall Study|Protocol Violation|0|||
105422300|NCT00075725|363552242|FG010|Overall Study|Protocol Violation|0|||
105422301|NCT00075725|363552243|FG011|Overall Study|Protocol Violation|1|||
105422302|NCT00075725|363552232|FG000|Overall Study|Withdrawal by Subject|12|||
105422303|NCT00075725|363552233|FG001|Overall Study|Withdrawal by Subject|3|||
105422304|NCT00075725|363552234|FG002|Overall Study|Withdrawal by Subject|6|||
105422305|NCT00075725|363552235|FG003|Overall Study|Withdrawal by Subject|10|||
105422306|NCT00075725|363552236|FG004|Overall Study|Withdrawal by Subject|6|||
105422307|NCT00075725|363552237|FG005|Overall Study|Withdrawal by Subject|27|||
105422308|NCT00075725|363552238|FG006|Overall Study|Withdrawal by Subject|7|||
105422309|NCT00075725|363552239|FG007|Overall Study|Withdrawal by Subject|31|||
105422310|NCT00075725|363552240|FG008|Overall Study|Withdrawal by Subject|10|||
105422311|NCT00075725|363552241|FG009|Overall Study|Withdrawal by Subject|2|||
105422312|NCT00075725|363552242|FG010|Overall Study|Withdrawal by Subject|0|||
105422313|NCT00075725|363552243|FG011|Overall Study|Withdrawal by Subject|0|||
105422314|NCT00075725|363552232|FG000|Overall Study|Disease Progression, all other reasons|17|||
105422315|NCT00075725|363552233|FG001|Overall Study|Disease Progression, all other reasons|5|||
105422316|NCT00075725|363552234|FG002|Overall Study|Disease Progression, all other reasons|33|||
105422317|NCT00075725|363552235|FG003|Overall Study|Disease Progression, all other reasons|6|||
105422318|NCT00075725|363552236|FG004|Overall Study|Disease Progression, all other reasons|21|||
105422319|NCT00075725|363552237|FG005|Overall Study|Disease Progression, all other reasons|59|||
105422320|NCT00075725|363552238|FG006|Overall Study|Disease Progression, all other reasons|20|||
105422321|NCT00075725|363552239|FG007|Overall Study|Disease Progression, all other reasons|46|||
105422322|NCT00075725|363552240|FG008|Overall Study|Disease Progression, all other reasons|21|||
105422323|NCT00075725|363552241|FG009|Overall Study|Disease Progression, all other reasons|4|||
105422324|NCT00075725|363552242|FG010|Overall Study|Disease Progression, all other reasons|0|||
105422325|NCT00075725|363552243|FG011|Overall Study|Disease Progression, all other reasons|5|||
105422326|NCT00075725|363552232|FG000|Overall Study|Patient off treatment|0|||
105422327|NCT00075725|363552233|FG001|Overall Study|Patient off treatment|0|||
105422328|NCT00075725|363552234|FG002|Overall Study|Patient off treatment|1|||
105422329|NCT00075725|363552235|FG003|Overall Study|Patient off treatment|2|||
105422330|NCT00075725|363552236|FG004|Overall Study|Patient off treatment|1|||
105422331|NCT00075725|363552237|FG005|Overall Study|Patient off treatment|0|||
105422332|NCT00075725|363552238|FG006|Overall Study|Patient off treatment|0|||
105422333|NCT00075725|363552239|FG007|Overall Study|Patient off treatment|2|||
105422334|NCT00075725|363552240|FG008|Overall Study|Patient off treatment|1|||
105422335|NCT00075725|363552241|FG009|Overall Study|Patient off treatment|0|||
105422336|NCT00075725|363552242|FG010|Overall Study|Patient off treatment|0|||
105422337|NCT00075725|363552243|FG011|Overall Study|Patient off treatment|0|||
105422338|NCT00075725|363552232|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
105422339|NCT00075725|363552233|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
105422340|NCT00075725|363552234|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
105422341|NCT00075725|363552235|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
105422342|NCT00075725|363552236|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
105422343|NCT00075725|363552237|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
105422344|NCT00075725|363552238|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
105422345|NCT00075725|363552239|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
105422346|NCT00075725|363552240|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
105422347|NCT00075725|363552241|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
105422348|NCT00075725|363552242|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
105422349|NCT00075725|363552243|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
105422350|NCT00075725|363552232|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
105422351|NCT00075725|363552233|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
105422352|NCT00075725|363552234|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
105422353|NCT00075725|363552235|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
105422354|NCT00075725|363552236|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
105422355|NCT00075725|363552237|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
105422356|NCT00075725|363552238|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
105422357|NCT00075725|363552239|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
105422358|NCT00075725|363552240|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
105422359|NCT00075725|363552241|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
105422360|NCT00075725|363552242|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
105422361|NCT00075725|363552243|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
105422362|NCT00075725|363552232|FG000|Overall Study|Pt non compliant with therapy|2|||
105422363|NCT00075725|363552233|FG001|Overall Study|Pt non compliant with therapy|1|||
105422364|NCT00075725|363552234|FG002|Overall Study|Pt non compliant with therapy|1|||
105422365|NCT00075725|363552235|FG003|Overall Study|Pt non compliant with therapy|0|||
105422366|NCT00075725|363552236|FG004|Overall Study|Pt non compliant with therapy|2|||
105422367|NCT00075725|363552237|FG005|Overall Study|Pt non compliant with therapy|14|||
105422368|NCT00075725|363552238|FG006|Overall Study|Pt non compliant with therapy|2|||
105422369|NCT00075725|363552239|FG007|Overall Study|Pt non compliant with therapy|5|||
105422370|NCT00075725|363552240|FG008|Overall Study|Pt non compliant with therapy|3|||
105422371|NCT00075725|363552241|FG009|Overall Study|Pt non compliant with therapy|0|||
105422372|NCT00075725|363552242|FG010|Overall Study|Pt non compliant with therapy|0|||
105422373|NCT00075725|363552243|FG011|Overall Study|Pt non compliant with therapy|0|||
105422374|NCT00075725|363552232|FG000|Overall Study|Pt age out of range for treatment|0|||
105422375|NCT00075725|363552233|FG001|Overall Study|Pt age out of range for treatment|1|||
105422376|NCT00075725|363552234|FG002|Overall Study|Pt age out of range for treatment|0|||
105422377|NCT00075725|363552235|FG003|Overall Study|Pt age out of range for treatment|0|||
105422378|NCT00075725|363552236|FG004|Overall Study|Pt age out of range for treatment|0|||
105422379|NCT00075725|363552237|FG005|Overall Study|Pt age out of range for treatment|1|||
105422380|NCT00075725|363552238|FG006|Overall Study|Pt age out of range for treatment|0|||
105422381|NCT00075725|363552239|FG007|Overall Study|Pt age out of range for treatment|1|||
105422382|NCT00075725|363552240|FG008|Overall Study|Pt age out of range for treatment|0|||
105422383|NCT00075725|363552241|FG009|Overall Study|Pt age out of range for treatment|0|||
105422384|NCT00075725|363552242|FG010|Overall Study|Pt age out of range for treatment|0|||
105422385|NCT00075725|363552243|FG011|Overall Study|Pt age out of range for treatment|0|||
105422386|NCT00075725|363552232|FG000|Overall Study|Insurance issues|0|||
105422387|NCT00075725|363552233|FG001|Overall Study|Insurance issues|1|||
105422388|NCT00075725|363552234|FG002|Overall Study|Insurance issues|0|||
105422389|NCT00075725|363552235|FG003|Overall Study|Insurance issues|1|||
105422390|NCT00075725|363552236|FG004|Overall Study|Insurance issues|1|||
105422391|NCT00075725|363552237|FG005|Overall Study|Insurance issues|1|||
105422392|NCT00075725|363552238|FG006|Overall Study|Insurance issues|0|||
105422393|NCT00075725|363552239|FG007|Overall Study|Insurance issues|1|||
105422394|NCT00075725|363552240|FG008|Overall Study|Insurance issues|0|||
105422395|NCT00075725|363552241|FG009|Overall Study|Insurance issues|0|||
105422396|NCT00075725|363552242|FG010|Overall Study|Insurance issues|0|||
105422397|NCT00075725|363552243|FG011|Overall Study|Insurance issues|0|||
105422398|NCT00075725|363552232|FG000|Overall Study|MRD positive after extended ind|0|||
105422399|NCT00075725|363552233|FG001|Overall Study|MRD positive after extended ind|1|||
105422400|NCT00075725|363552234|FG002|Overall Study|MRD positive after extended ind|1|||
105422401|NCT00075725|363552235|FG003|Overall Study|MRD positive after extended ind|0|||
105422402|NCT00075725|363552236|FG004|Overall Study|MRD positive after extended ind|1|||
105422403|NCT00075725|363552237|FG005|Overall Study|MRD positive after extended ind|2|||
105422404|NCT00075725|363552238|FG006|Overall Study|MRD positive after extended ind|0|||
105422405|NCT00075725|363552239|FG007|Overall Study|MRD positive after extended ind|1|||
105422406|NCT00075725|363552240|FG008|Overall Study|MRD positive after extended ind|0|||
105422407|NCT00075725|363552241|FG009|Overall Study|MRD positive after extended ind|0|||
105422408|NCT00075725|363552242|FG010|Overall Study|MRD positive after extended ind|0|||
105422409|NCT00075725|363552243|FG011|Overall Study|MRD positive after extended ind|0|||
105422410|NCT00075725|363552232|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
105422411|NCT00075725|363552233|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
105422412|NCT00075725|363552234|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
105422413|NCT00075725|363552235|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
105422414|NCT00075725|363552236|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
105422415|NCT00075725|363552237|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
105422416|NCT00075725|363552238|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
105422417|NCT00075725|363552239|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
105422418|NCT00075725|363552240|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
105422419|NCT00075725|363552241|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
105422420|NCT00075725|363552242|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
105422421|NCT00075725|363552243|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
105422422|NCT00075725|363552232|FG000|Overall Study|Inevaluable|1|||
105422423|NCT00075725|363552233|FG001|Overall Study|Inevaluable|1|||
105422424|NCT00075725|363552234|FG002|Overall Study|Inevaluable|4|||
105422425|NCT00075725|363552235|FG003|Overall Study|Inevaluable|2|||
105422426|NCT00075725|363552236|FG004|Overall Study|Inevaluable|2|||
105422427|NCT00075725|363552237|FG005|Overall Study|Inevaluable|9|||
105422428|NCT00075725|363552238|FG006|Overall Study|Inevaluable|1|||
105422429|NCT00075725|363552239|FG007|Overall Study|Inevaluable|11|||
105422430|NCT00075725|363552240|FG008|Overall Study|Inevaluable|2|||
105422431|NCT00075725|363552241|FG009|Overall Study|Inevaluable|0|||
105422432|NCT00075725|363552242|FG010|Overall Study|Inevaluable|1|||
105422433|NCT00075725|363552243|FG011|Overall Study|Inevaluable|0|||
105422434|NCT00075725|363552232|FG000|Overall Study|Other|4|||
105422435|NCT00075725|363552233|FG001|Overall Study|Other|2|||
105422436|NCT00075725|363552234|FG002|Overall Study|Other|1|||
105422437|NCT00075725|363552235|FG003|Overall Study|Other|1|||
105422438|NCT00075725|363552236|FG004|Overall Study|Other|1|||
105422439|NCT00075725|363552237|FG005|Overall Study|Other|4|||
105422440|NCT00075725|363552238|FG006|Overall Study|Other|2|||
105422441|NCT00075725|363552239|FG007|Overall Study|Other|9|||
105422442|NCT00075725|363552240|FG008|Overall Study|Other|2|||
105422443|NCT00075725|363552241|FG009|Overall Study|Other|1|||
105422444|NCT00075725|363552242|FG010|Overall Study|Other|0|||
105422445|NCT00075725|363552243|FG011|Overall Study|Other|3|||
105422446|NCT00075725|363552232|FG000|Overall Study|Pt trying to find a BM donor|0|||
105422447|NCT00075725|363552233|FG001|Overall Study|Pt trying to find a BM donor|1|||
105422448|NCT00075725|363552234|FG002|Overall Study|Pt trying to find a BM donor|0|||
105422449|NCT00075725|363552235|FG003|Overall Study|Pt trying to find a BM donor|0|||
105422450|NCT00075725|363552236|FG004|Overall Study|Pt trying to find a BM donor|0|||
105422451|NCT00075725|363552237|FG005|Overall Study|Pt trying to find a BM donor|0|||
105422452|NCT00075725|363552238|FG006|Overall Study|Pt trying to find a BM donor|0|||
105422453|NCT00075725|363552239|FG007|Overall Study|Pt trying to find a BM donor|0|||
105422454|NCT00075725|363552240|FG008|Overall Study|Pt trying to find a BM donor|0|||
105422455|NCT00075725|363552241|FG009|Overall Study|Pt trying to find a BM donor|0|||
105422456|NCT00075725|363552242|FG010|Overall Study|Pt trying to find a BM donor|0|||
105422457|NCT00075725|363552243|FG011|Overall Study|Pt trying to find a BM donor|0|||
105422458|NCT00075725|363552232|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
105422459|NCT00075725|363552233|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
105422460|NCT00075725|363552234|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
105422461|NCT00075725|363552235|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
105422462|NCT00075725|363552236|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
105422463|NCT00075725|363552237|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
105422464|NCT00075725|363552238|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
105422465|NCT00075725|363552239|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
105422466|NCT00075725|363552240|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
105422467|NCT00075725|363552241|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
105422468|NCT00075725|363552242|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
105422469|NCT00075725|363552243|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
105422470|NCT00075725|363552232|FG000|Overall Study|Unsuccessful institutional transfer|0|||
105422471|NCT00075725|363552233|FG001|Overall Study|Unsuccessful institutional transfer|0|||
105422472|NCT00075725|363552234|FG002|Overall Study|Unsuccessful institutional transfer|2|||
105422473|NCT00075725|363552235|FG003|Overall Study|Unsuccessful institutional transfer|0|||
105422474|NCT00075725|363552236|FG004|Overall Study|Unsuccessful institutional transfer|0|||
105422475|NCT00075725|363552237|FG005|Overall Study|Unsuccessful institutional transfer|0|||
105422476|NCT00075725|363552238|FG006|Overall Study|Unsuccessful institutional transfer|0|||
105422477|NCT00075725|363552239|FG007|Overall Study|Unsuccessful institutional transfer|0|||
105422478|NCT00075725|363552240|FG008|Overall Study|Unsuccessful institutional transfer|0|||
105422479|NCT00075725|363552241|FG009|Overall Study|Unsuccessful institutional transfer|1|||
105422480|NCT00075725|363552242|FG010|Overall Study|Unsuccessful institutional transfer|0|||
105422481|NCT00075725|363552243|FG011|Overall Study|Unsuccessful institutional transfer|0|||
105422482|NCT00075725|363552232|FG000|Overall Study|specimen(s) not submitted|0|||
105422483|NCT00075725|363552233|FG001|Overall Study|specimen(s) not submitted|0|||
105422484|NCT00075725|363552234|FG002|Overall Study|specimen(s) not submitted|2|||
105422485|NCT00075725|363552235|FG003|Overall Study|specimen(s) not submitted|0|||
105422486|NCT00075725|363552236|FG004|Overall Study|specimen(s) not submitted|0|||
105422487|NCT00075725|363552237|FG005|Overall Study|specimen(s) not submitted|0|||
105422488|NCT00075725|363552238|FG006|Overall Study|specimen(s) not submitted|0|||
105422489|NCT00075725|363552239|FG007|Overall Study|specimen(s) not submitted|0|||
105422490|NCT00075725|363552240|FG008|Overall Study|specimen(s) not submitted|0|||
105422491|NCT00075725|363552241|FG009|Overall Study|specimen(s) not submitted|0|||
105422492|NCT00075725|363552242|FG010|Overall Study|specimen(s) not submitted|0|||
105422493|NCT00075725|363552243|FG011|Overall Study|specimen(s) not submitted|0|||
105422494|NCT00075725|363552232|FG000|Overall Study|Pt went to transplant|0|||
105422495|NCT00075725|363552233|FG001|Overall Study|Pt went to transplant|0|||
105422496|NCT00075725|363552234|FG002|Overall Study|Pt went to transplant|0|||
105422497|NCT00075725|363552235|FG003|Overall Study|Pt went to transplant|1|||
105422498|NCT00075725|363552236|FG004|Overall Study|Pt went to transplant|0|||
105422499|NCT00075725|363552237|FG005|Overall Study|Pt went to transplant|1|||
105422500|NCT00075725|363552238|FG006|Overall Study|Pt went to transplant|0|||
105422501|NCT00075725|363552239|FG007|Overall Study|Pt went to transplant|0|||
105422502|NCT00075725|363552240|FG008|Overall Study|Pt went to transplant|0|||
105422503|NCT00075725|363552241|FG009|Overall Study|Pt went to transplant|0|||
105422504|NCT00075725|363552242|FG010|Overall Study|Pt went to transplant|0|||
105422505|NCT00075725|363552243|FG011|Overall Study|Pt went to transplant|0|||
105422506|NCT00075725|363552232|FG000|Overall Study|Pt received additional steroids|0|||
105422507|NCT00075725|363552233|FG001|Overall Study|Pt received additional steroids|0|||
105422508|NCT00075725|363552234|FG002|Overall Study|Pt received additional steroids|0|||
105422509|NCT00075725|363552235|FG003|Overall Study|Pt received additional steroids|1|||
105422510|NCT00075725|363552236|FG004|Overall Study|Pt received additional steroids|0|||
105422511|NCT00075725|363552237|FG005|Overall Study|Pt received additional steroids|0|||
105422512|NCT00075725|363552238|FG006|Overall Study|Pt received additional steroids|0|||
105422513|NCT00075725|363552239|FG007|Overall Study|Pt received additional steroids|0|||
105422514|NCT00075725|363552240|FG008|Overall Study|Pt received additional steroids|0|||
105422515|NCT00075725|363552241|FG009|Overall Study|Pt received additional steroids|0|||
105422516|NCT00075725|363552242|FG010|Overall Study|Pt received additional steroids|0|||
105422517|NCT00075725|363552243|FG011|Overall Study|Pt received additional steroids|0|||
105422518|NCT00075725|363552232|FG000|Overall Study|Pt relocated|0|||
105422519|NCT00075725|363552233|FG001|Overall Study|Pt relocated|0|||
105422520|NCT00075725|363552234|FG002|Overall Study|Pt relocated|0|||
105422521|NCT00075725|363552235|FG003|Overall Study|Pt relocated|2|||
105422522|NCT00075725|363552236|FG004|Overall Study|Pt relocated|0|||
105422523|NCT00075725|363552237|FG005|Overall Study|Pt relocated|1|||
105422524|NCT00075725|363552238|FG006|Overall Study|Pt relocated|1|||
105422525|NCT00075725|363552239|FG007|Overall Study|Pt relocated|2|||
105422526|NCT00075725|363552240|FG008|Overall Study|Pt relocated|1|||
105422527|NCT00075725|363552241|FG009|Overall Study|Pt relocated|0|||
105422528|NCT00075725|363552242|FG010|Overall Study|Pt relocated|0|||
105422529|NCT00075725|363552243|FG011|Overall Study|Pt relocated|0|||
105422530|NCT00075725|363552232|FG000|Overall Study|Institution Terminated|0|||
105422531|NCT00075725|363552233|FG001|Overall Study|Institution Terminated|0|||
105422532|NCT00075725|363552234|FG002|Overall Study|Institution Terminated|0|||
105422533|NCT00075725|363552235|FG003|Overall Study|Institution Terminated|0|||
105422534|NCT00075725|363552236|FG004|Overall Study|Institution Terminated|1|||
105422535|NCT00075725|363552237|FG005|Overall Study|Institution Terminated|0|||
105422536|NCT00075725|363552238|FG006|Overall Study|Institution Terminated|0|||
105422537|NCT00075725|363552239|FG007|Overall Study|Institution Terminated|3|||
105422538|NCT00075725|363552240|FG008|Overall Study|Institution Terminated|0|||
105422539|NCT00075725|363552241|FG009|Overall Study|Institution Terminated|0|||
105422540|NCT00075725|363552242|FG010|Overall Study|Institution Terminated|0|||
105422541|NCT00075725|363552243|FG011|Overall Study|Institution Terminated|0|||
105422542|NCT00075725|363552232|FG000|Overall Study|Study Closure|1|||
105422543|NCT00075725|363552233|FG001|Overall Study|Study Closure|0|||
105422544|NCT00075725|363552234|FG002|Overall Study|Study Closure|0|||
105422545|NCT00075725|363552235|FG003|Overall Study|Study Closure|0|||
105422546|NCT00075725|363552236|FG004|Overall Study|Study Closure|1|||
105422547|NCT00075725|363552237|FG005|Overall Study|Study Closure|3|||
105422548|NCT00075725|363552238|FG006|Overall Study|Study Closure|0|||
105422549|NCT00075725|363552239|FG007|Overall Study|Study Closure|1|||
105422550|NCT00075725|363552240|FG008|Overall Study|Study Closure|0|||
105422551|NCT00075725|363552241|FG009|Overall Study|Study Closure|0|||
105422552|NCT00075725|363552242|FG010|Overall Study|Study Closure|0|||
105422553|NCT00075725|363552243|FG011|Overall Study|Study Closure|0|||
105422554|NCT00075725|363552232|FG000|Overall Study|Other complications|0|||
105585677|NCT00691028|364144230|FG003|Double-blind Period|Withdrawal by Subject|0|||
105585678|NCT00691028|364144227|FG000|Double-blind Period|not come to a hospital.|0|||
105585679|NCT00691028|364144228|FG001|Double-blind Period|not come to a hospital.|1|||
105585680|NCT00691028|364144229|FG002|Double-blind Period|not come to a hospital.|0|||
105422555|NCT00075725|363552233|FG001|Overall Study|Other complications|0|||
105422556|NCT00075725|363552234|FG002|Overall Study|Other complications|0|||
105422557|NCT00075725|363552235|FG003|Overall Study|Other complications|0|||
105585681|NCT00691028|364144230|FG003|Double-blind Period|not come to a hospital.|0|||
105422558|NCT00075725|363552236|FG004|Overall Study|Other complications|0|||
105422559|NCT00075725|363552237|FG005|Overall Study|Other complications|1|||
105422560|NCT00075725|363552238|FG006|Overall Study|Other complications|0|||
105422561|NCT00075725|363552239|FG007|Overall Study|Other complications|0|||
105422562|NCT00075725|363552240|FG008|Overall Study|Other complications|0|||
105422563|NCT00075725|363552241|FG009|Overall Study|Other complications|0|||
105422564|NCT00075725|363552242|FG010|Overall Study|Other complications|0|||
105422565|NCT00075725|363552243|FG011|Overall Study|Other complications|0|||
105422566|NCT00075725|363552232|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
105422567|NCT00075725|363552233|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
105422568|NCT00075725|363552234|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
105422569|NCT00075725|363552235|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
105422570|NCT00075725|363552236|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
105422571|NCT00075725|363552237|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
105422572|NCT00075725|363552238|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
105422573|NCT00075725|363552239|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
105422574|NCT00075725|363552240|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
105422575|NCT00075725|363552241|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
105422576|NCT00075725|363552242|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
105422577|NCT00075725|363552243|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
105422578|NCT00075725|363552232|FG000|Overall Study|Pt incarcerated|0|||
105422579|NCT00075725|363552233|FG001|Overall Study|Pt incarcerated|0|||
105422580|NCT00075725|363552234|FG002|Overall Study|Pt incarcerated|0|||
105422581|NCT00075725|363552235|FG003|Overall Study|Pt incarcerated|0|||
105422582|NCT00075725|363552236|FG004|Overall Study|Pt incarcerated|0|||
105422583|NCT00075725|363552237|FG005|Overall Study|Pt incarcerated|0|||
105422584|NCT00075725|363552238|FG006|Overall Study|Pt incarcerated|0|||
105422585|NCT00075725|363552239|FG007|Overall Study|Pt incarcerated|1|||
105422586|NCT00075725|363552240|FG008|Overall Study|Pt incarcerated|0|||
105422587|NCT00075725|363552241|FG009|Overall Study|Pt incarcerated|0|||
105422588|NCT00075725|363552242|FG010|Overall Study|Pt incarcerated|0|||
105422589|NCT00075725|363552243|FG011|Overall Study|Pt incarcerated|0|||
105422590|NCT03372460|363552244|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
105422591|NCT03372460|363552245|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
105422592|NCT02499900|363552246|FG000|Core Study Period|Other|1|||
105422593|NCT02499900|363552247|FG001|Core Study Period|Other|4|||
105422594|NCT02499900|363552246|FG000|Core Study Period|Lost to Follow-up|1|||
105422595|NCT02499900|363552247|FG001|Core Study Period|Lost to Follow-up|2|||
105422596|NCT02499900|363552246|FG000|Core Study Period|Per sponsor request|0|||
105422597|NCT02499900|363552247|FG001|Core Study Period|Per sponsor request|1|||
105422598|NCT02499900|363552246|FG000|Core Study Period|Pregnancy|1|||
105422599|NCT02499900|363552247|FG001|Core Study Period|Pregnancy|0|||
105422600|NCT02499900|363552246|FG000|Core Study Period|Protocol Violation|3|||
105422601|NCT02499900|363552247|FG001|Core Study Period|Protocol Violation|0|||
105422602|NCT02499900|363552246|FG000|Core Study Period|Withdrawal by Subject|11|||
105422603|NCT02499900|363552247|FG001|Core Study Period|Withdrawal by Subject|10|||
105422604|NCT02499900|363552246|FG000|Core Study Period|Adverse Event|18|||
105422605|NCT02499900|363552247|FG001|Core Study Period|Adverse Event|14|||
105422606|NCT02499900|363552246|FG000|Core Study Period|Death|0|||
105422607|NCT02499900|363552247|FG001|Core Study Period|Death|1|||
105422608|NCT02499900|363552246|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
105422609|NCT02499900|363552247|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
105422610|NCT02499900|363552246|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
105422611|NCT02499900|363552247|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
105422612|NCT02499900|363552246|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
105422613|NCT02499900|363552247|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
105422614|NCT02499900|363552246|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
105422615|NCT02499900|363552247|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
105422616|NCT02499900|363552246|FG000|Extension Study Period|Adverse Event|2|||
105422617|NCT02499900|363552247|FG001|Extension Study Period|Adverse Event|4|||
105422618|NCT02499900|363552246|FG000|Extension Study Period|Withdrawal by Subject|5|||
105422619|NCT02499900|363552247|FG001|Extension Study Period|Withdrawal by Subject|2|||
105422620|NCT02499900|363552246|FG000|Extension Study Period|Physician Decision|2|||
105422621|NCT02499900|363552247|FG001|Extension Study Period|Physician Decision|5|||
105422622|NCT02499900|363552246|FG000|Extension Study Period|Pregnancy|1|||
105422623|NCT02499900|363552247|FG001|Extension Study Period|Pregnancy|2|||
105422624|NCT02499900|363552246|FG000|Extension Study Period|Lost to Follow-up|2|||
105422625|NCT02499900|363552247|FG001|Extension Study Period|Lost to Follow-up|5|||
105422626|NCT02499900|363552246|FG000|Extension Study Period|Other|0|||
105422627|NCT02499900|363552247|FG001|Extension Study Period|Other|2|||
105422628|NCT04065074|363552250|FG000|Overall Study|Adverse Event|1|||
105422629|NCT04065074|363552250|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
105422630|NCT03222973|363552251|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
105422631|NCT03222973|363552252|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
105422632|NCT03222973|363552253|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
105422633|NCT03222973|363552254|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
105422634|NCT03222973|363552251|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
105422635|NCT03222973|363552252|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
105422636|NCT03222973|363552253|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
105500945|NCT00306189|363845762|FG003|Overall Study|Physician Decision|1|||
105585682|NCT01427907|364144236|FG000|Overall Study|Withdrawal by Subject|3|||
105585683|NCT01427907|364144237|FG001|Overall Study|Withdrawal by Subject|4|||
105585684|NCT00582790|364144242|FG000|Overall Study|Rapid progression of disease|1|||
105585685|NCT00748969|364144244|FG000|Overall Study|Withdrawal by Subject|1|||
105585686|NCT00748969|364144245|FG001|Overall Study|Withdrawal by Subject|0|||
105585687|NCT00748969|364144244|FG000|Overall Study|Withdrawal by Subject|0|||
105585688|NCT00748969|364144245|FG001|Overall Study|Withdrawal by Subject|1|||
105585689|NCT00463151|364144246|FG000|Overall Study|Adverse Event|0|||
105585690|NCT00463151|364144247|FG001|Overall Study|Adverse Event|0|||
105585691|NCT00463151|364144248|FG002|Overall Study|Adverse Event|1|||
105585692|NCT00463151|364144249|FG003|Overall Study|Adverse Event|0|||
105585693|NCT00463151|364144246|FG000|Overall Study|Lack of Efficacy|2|||
105585694|NCT00463151|364144247|FG001|Overall Study|Lack of Efficacy|5|||
105585695|NCT00463151|364144248|FG002|Overall Study|Lack of Efficacy|2|||
105585696|NCT00463151|364144249|FG003|Overall Study|Lack of Efficacy|5|||
105585697|NCT00463151|364144246|FG000|Overall Study|Protocol Violation|0|||
105585698|NCT00463151|364144247|FG001|Overall Study|Protocol Violation|0|||
105585699|NCT00463151|364144248|FG002|Overall Study|Protocol Violation|0|||
105585700|NCT00463151|364144249|FG003|Overall Study|Protocol Violation|1|||
105585701|NCT00463151|364144246|FG000|Overall Study|Withdrawal by Subject|0|||
105585702|NCT00463151|364144247|FG001|Overall Study|Withdrawal by Subject|0|||
105585703|NCT00463151|364144248|FG002|Overall Study|Withdrawal by Subject|0|||
105585704|NCT00463151|364144249|FG003|Overall Study|Withdrawal by Subject|1|||
105585705|NCT05349084|364144250|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
105585706|NCT01880554|364144251|FG000|Overall Study|Protocol Violation|14|||
105585707|NCT01880554|364144251|FG000|Overall Study|Simon's design requirements|2|||
105585708|NCT00972543|364144252|FG000|Overall Study|Adverse Event|1|||
105585709|NCT00972543|364144253|FG001|Overall Study|Adverse Event|0|||
105585710|NCT00972543|364144252|FG000|Overall Study|Early study termination by sponsor|4|||
105585711|NCT00972543|364144253|FG001|Overall Study|Early study termination by sponsor|1|||
105585712|NCT04537949|364144256|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
105585713|NCT04537949|364144257|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
105585714|NCT04537949|364144258|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
105585715|NCT04537949|364144259|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
105585716|NCT04537949|364144260|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
105585717|NCT04537949|364144261|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
105585718|NCT04537949|364144262|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
105585719|NCT04537949|364144263|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
105585720|NCT04537949|364144256|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
105585721|NCT04537949|364144257|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
105585722|NCT04537949|364144258|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
105585723|NCT04537949|364144259|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
105585724|NCT04537949|364144260|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
105585725|NCT04537949|364144261|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
105585726|NCT04537949|364144262|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
105585727|NCT04537949|364144263|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
105585728|NCT04537949|364144256|FG000|Follow-up Phase|Lost to Follow-up|0|||
105585729|NCT04537949|364144257|FG001|Follow-up Phase|Lost to Follow-up|3|||
105585730|NCT04537949|364144258|FG002|Follow-up Phase|Lost to Follow-up|0|||
105585731|NCT04537949|364144259|FG003|Follow-up Phase|Lost to Follow-up|0|||
105585732|NCT04537949|364144260|FG004|Follow-up Phase|Lost to Follow-up|0|||
105585733|NCT04537949|364144261|FG005|Follow-up Phase|Lost to Follow-up|0|||
105585734|NCT04537949|364144262|FG006|Follow-up Phase|Lost to Follow-up|0|||
105585735|NCT04537949|364144263|FG007|Follow-up Phase|Lost to Follow-up|0|||
105585736|NCT04537949|364144256|FG000|Follow-up Phase|personal reasons|0|||
105585737|NCT04537949|364144257|FG001|Follow-up Phase|personal reasons|0|||
105585738|NCT04537949|364144258|FG002|Follow-up Phase|personal reasons|0|||
105585739|NCT04537949|364144259|FG003|Follow-up Phase|personal reasons|1|||
105585740|NCT04537949|364144260|FG004|Follow-up Phase|personal reasons|1|||
105585741|NCT04537949|364144261|FG005|Follow-up Phase|personal reasons|0|||
105585742|NCT04537949|364144262|FG006|Follow-up Phase|personal reasons|0|||
105585743|NCT04537949|364144263|FG007|Follow-up Phase|personal reasons|0|||
105585744|NCT04537949|364144256|FG000|Follow-up Phase|Withdrawal by Subject|0|||
105585745|NCT04537949|364144257|FG001|Follow-up Phase|Withdrawal by Subject|0|||
105585746|NCT04537949|364144258|FG002|Follow-up Phase|Withdrawal by Subject|0|||
105585747|NCT04537949|364144259|FG003|Follow-up Phase|Withdrawal by Subject|0|||
105585748|NCT04537949|364144260|FG004|Follow-up Phase|Withdrawal by Subject|1|||
105585749|NCT04537949|364144261|FG005|Follow-up Phase|Withdrawal by Subject|0|||
105585750|NCT04537949|364144262|FG006|Follow-up Phase|Withdrawal by Subject|0|||
105585751|NCT04537949|364144263|FG007|Follow-up Phase|Withdrawal by Subject|0|||
105585752|NCT04003974|364144265|FG000|Overall Study|Missing|1|||
105585753|NCT04003974|364144266|FG001|Overall Study|Missing|0|||
105585754|NCT04003974|364144265|FG000|Overall Study|Withdrawal by Subject|0|||
105585755|NCT04003974|364144266|FG001|Overall Study|Withdrawal by Subject|2|||
105585756|NCT04296942|364144267|FG000|Overall Study|Study closure by sponsor|1|||
105585757|NCT04296942|364144268|FG001|Overall Study|Study closure by sponsor|0|||
105585758|NCT04296942|364144269|FG002|Overall Study|Study closure by sponsor|0|||
105585759|NCT01579578|364144270|FG000|Overall Study|Death|4|||
105585760|NCT01579578|364144271|FG001|Overall Study|Death|1|||
105585761|NCT01579578|364144270|FG000|Overall Study|Lost to Follow-up|1|||
105585762|NCT01579578|364144271|FG001|Overall Study|Lost to Follow-up|1|||
105585763|NCT01579578|364144270|FG000|Overall Study|Withdrawal by Subject|2|||
105585764|NCT01579578|364144271|FG001|Overall Study|Withdrawal by Subject|1|||
105585765|NCT01579578|364144270|FG000|Overall Study|Eligibility criteria|3|||
105585766|NCT01579578|364144271|FG001|Overall Study|Eligibility criteria|9|||
105585767|NCT01579578|364144270|FG000|Overall Study|Ongoing|3|||
105585768|NCT01579578|364144271|FG001|Overall Study|Ongoing|0|||
105585769|NCT00335153|364144272|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
105585770|NCT00335153|364144272|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
105585771|NCT00335153|364144272|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
105585772|NCT00335153|364144272|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
105585773|NCT00335153|364144272|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
105585774|NCT00335153|364144272|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
105585775|NCT00335153|364144272|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
105585776|NCT00335153|364144272|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
105585777|NCT00335153|364144272|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
105585778|NCT00335153|364144272|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
105585779|NCT02825043|364144275|FG000|Overall Study|Lost to Follow-up|4|||
105585780|NCT00558753|364144278|FG000|Overall Study|Lost to Follow-up|5|||
105585781|NCT00558753|364144279|FG001|Overall Study|Lost to Follow-up|7|||
105585782|NCT03704298|364144280|FG000|Overall Study|Death|3|||
105585783|NCT03704298|364144281|FG001|Overall Study|Death|1|||
105585784|NCT03704298|364144282|FG002|Overall Study|Death|1|||
105585785|NCT03704298|364144283|FG003|Overall Study|Death|0|||
105585786|NCT03704298|364144280|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
105585787|NCT03704298|364144281|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
105585788|NCT03704298|364144282|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
105585789|NCT03704298|364144283|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
105585790|NCT03704298|364144280|FG000|Overall Study|Withdrawal by Subject|1|||
105585791|NCT03704298|364144281|FG001|Overall Study|Withdrawal by Subject|0|||
105585792|NCT03704298|364144282|FG002|Overall Study|Withdrawal by Subject|0|||
105585793|NCT03704298|364144283|FG003|Overall Study|Withdrawal by Subject|0|||
105585794|NCT03704298|364144280|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
105585795|NCT03704298|364144281|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
105585796|NCT03704298|364144282|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
105585797|NCT03704298|364144283|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
105585798|NCT00821236|364144284|FG000|Overall Study|Lost to Follow-up|3|||
105585799|NCT00052962|364144285|FG000|Overall Study|Not evaluable|0|||
105585800|NCT00052962|364144286|FG001|Overall Study|Not evaluable|2|||
105585801|NCT00052962|364144285|FG000|Overall Study|Not randomized/not evaluable|1|||
105585802|NCT00052962|364144286|FG001|Overall Study|Not randomized/not evaluable|0|||
105585803|NCT00770211|364144289|FG000|Overall Study|Lost to Follow-up|1|||
105585804|NCT00770211|364144290|FG001|Overall Study|Lost to Follow-up|0|||
105585805|NCT00770211|364144289|FG000|Overall Study|Withdrawal by Subject|0|||
105585806|NCT00770211|364144290|FG001|Overall Study|Withdrawal by Subject|2|||
105585807|NCT04739423|364144292|FG000|Overall Study|Protocol Violation|0|||
105585808|NCT04739423|364144293|FG001|Overall Study|Protocol Violation|1|||
105585809|NCT04739423|364144294|FG002|Overall Study|Protocol Violation|0|||
105585810|NCT04739423|364144295|FG003|Overall Study|Protocol Violation|0|||
105585811|NCT04739423|364144296|FG004|Overall Study|Protocol Violation|0|||
105585812|NCT04739423|364144297|FG005|Overall Study|Protocol Violation|0|||
105585813|NCT04739423|364144292|FG000|Overall Study|Adverse Event|0|||
105585814|NCT04739423|364144293|FG001|Overall Study|Adverse Event|0|||
105585815|NCT04739423|364144294|FG002|Overall Study|Adverse Event|1|||
105585816|NCT04739423|364144295|FG003|Overall Study|Adverse Event|0|||
105585817|NCT04739423|364144296|FG004|Overall Study|Adverse Event|1|||
105585818|NCT04739423|364144297|FG005|Overall Study|Adverse Event|0|||
105585819|NCT04739423|364144292|FG000|Overall Study|Withdrawal by Subject|0|||
105585820|NCT04739423|364144293|FG001|Overall Study|Withdrawal by Subject|0|||
105585821|NCT04739423|364144294|FG002|Overall Study|Withdrawal by Subject|0|||
105585822|NCT04739423|364144295|FG003|Overall Study|Withdrawal by Subject|0|||
105585823|NCT04739423|364144296|FG004|Overall Study|Withdrawal by Subject|0|||
105585824|NCT04739423|364144297|FG005|Overall Study|Withdrawal by Subject|1|||
105585825|NCT03212365|364144300|FG000|Overall Study|Discharged prior to Xa level|12|||
105585826|NCT03212365|364144301|FG001|Overall Study|Discharged prior to Xa level|8|||
105585827|NCT03212365|364144300|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
105585828|NCT03212365|364144301|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
105422637|NCT03222973|363552254|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
105422638|NCT03222973|363552251|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
105422639|NCT03222973|363552252|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
105422640|NCT03222973|363552253|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
105422641|NCT03222973|363552254|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
105422642|NCT03222973|363552251|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
105422643|NCT03222973|363552252|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
105422644|NCT03222973|363552253|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
105422645|NCT03222973|363552254|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
105422646|NCT03222973|363552251|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
105422647|NCT03222973|363552252|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
105422648|NCT03222973|363552253|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
105422649|NCT03222973|363552254|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
105422650|NCT03222973|363552251|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
105422651|NCT03222973|363552252|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
105422652|NCT03222973|363552253|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
105422653|NCT03222973|363552254|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
105422654|NCT03222973|363552251|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
105422655|NCT03222973|363552252|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
105422656|NCT03222973|363552253|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
105422657|NCT03222973|363552254|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
105422658|NCT03222973|363552251|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
105422659|NCT03222973|363552252|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
105422660|NCT03222973|363552253|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
105422661|NCT03222973|363552254|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
105422662|NCT03222973|363552251|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
105422663|NCT03222973|363552252|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
105422664|NCT03222973|363552253|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
105422665|NCT03222973|363552254|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
105422666|NCT03222973|363552251|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
105422667|NCT03222973|363552252|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
105422668|NCT03222973|363552253|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
105422669|NCT03222973|363552254|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
105422670|NCT03222973|363552251|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
105422671|NCT03222973|363552252|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
105422672|NCT03222973|363552253|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
105422673|NCT03222973|363552254|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
105422674|NCT03222973|363552251|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
105422675|NCT03222973|363552252|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
105422676|NCT03222973|363552253|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
105422677|NCT03222973|363552254|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
105422678|NCT00789581|363554150|FG000|AC Therapy|Adverse Event|2|||
105422679|NCT00789581|363554151|FG001|AC Therapy|Adverse Event|3|||
105422680|NCT00789581|363554150|FG000|AC Therapy|Withdrawal by Subject|4|||
105422681|NCT00789581|363554151|FG001|AC Therapy|Withdrawal by Subject|7|||
105422682|NCT00789581|363554150|FG000|AC Therapy|Disease recurrence|3|||
105422683|NCT00789581|363554151|FG001|AC Therapy|Disease recurrence|1|||
105422684|NCT00789581|363554150|FG000|AC Therapy|Intercurrent Illness|1|||
105422685|NCT00789581|363554151|FG001|AC Therapy|Intercurrent Illness|0|||
105422686|NCT00789581|363554150|FG000|AC Therapy|Never Treated|1|||
105422687|NCT00789581|363554151|FG001|AC Therapy|Never Treated|4|||
105422688|NCT00789581|363554150|FG000|AC Therapy|Other|0|||
105422689|NCT00789581|363554151|FG001|AC Therapy|Other|2|||
105422690|NCT00789581|363554150|FG000|Adjuvant Therapy|Never treated|2|||
105422691|NCT00789581|363554151|FG001|Adjuvant Therapy|Never treated|2|||
105422692|NCT00789581|363554150|FG000|Adjuvant Therapy|Adverse Event|20|||
105422693|NCT00789581|363554151|FG001|Adjuvant Therapy|Adverse Event|44|||
105422694|NCT00789581|363554150|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
105422695|NCT00789581|363554151|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
105422696|NCT00789581|363554150|FG000|Adjuvant Therapy|Disease recurrence|2|||
105422697|NCT00789581|363554151|FG001|Adjuvant Therapy|Disease recurrence|1|||
105422698|NCT00789581|363554150|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
105422699|NCT00789581|363554151|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
105422700|NCT00789581|363554150|FG000|Adjuvant Therapy|Protocol Violation|1|||
105422701|NCT00789581|363554151|FG001|Adjuvant Therapy|Protocol Violation|1|||
105422702|NCT00789581|363554150|FG000|Adjuvant Therapy|Other|0|||
105422703|NCT00789581|363554151|FG001|Adjuvant Therapy|Other|1|||
105422704|NCT01257568|363554158|FG000|Overall Study|Lost to Follow-up|2|||
105422705|NCT01257568|363554158|FG000|Overall Study|Withdrawal by Subject|6|||
105422706|NCT01257568|363554158|FG000|Overall Study|Terminated|1|||
105422707|NCT01257568|363554158|FG000|Overall Study|Component Revision|24|||
105422708|NCT03392883|363554161|FG000|Overall Study|Lost to Follow-up|122|||
105422709|NCT03392883|363554162|FG001|Overall Study|Lost to Follow-up|13|||
105422710|NCT03392883|363554163|FG002|Overall Study|Lost to Follow-up|9|||
105585829|NCT03212365|364144300|FG000|Overall Study|Refused study medication|3|||
105585830|NCT03212365|364144301|FG001|Overall Study|Refused study medication|0|||
105585831|NCT03212365|364144300|FG000|Overall Study|Initiated heparin infusion on floor|1|||
105585832|NCT03212365|364144301|FG001|Overall Study|Initiated heparin infusion on floor|1|||
105585833|NCT03212365|364144300|FG000|Overall Study|Unexpected return to OR|1|||
105585834|NCT03212365|364144301|FG001|Overall Study|Unexpected return to OR|1|||
105585835|NCT03212365|364144300|FG000|Overall Study|Medication distribution error|1|||
105585836|NCT03212365|364144301|FG001|Overall Study|Medication distribution error|0|||
105585837|NCT03212365|364144300|FG000|Overall Study|Required epidural placement|1|||
105585838|NCT03212365|364144301|FG001|Overall Study|Required epidural placement|0|||
105585839|NCT03212365|364144300|FG000|Overall Study|Withdrawal by Subject|0|||
105585840|NCT03212365|364144301|FG001|Overall Study|Withdrawal by Subject|1|||
105585841|NCT03212365|364144300|FG000|Overall Study|developed acute renal failure|0|||
105585842|NCT03212365|364144301|FG001|Overall Study|developed acute renal failure|1|||
105585843|NCT04438785|364144302|FG000|Overall Study|change of weight, give up intervention|2|||
105585844|NCT04438785|364144303|FG001|Overall Study|change of weight, give up intervention|10|||
105585845|NCT04011033|364144304|FG000|Overall Study|Physician Decision|2|||
105585846|NCT04011033|364144305|FG001|Overall Study|Physician Decision|3|||
105585847|NCT04011033|364144304|FG000|Overall Study|Withdrawal by Subject|1|||
105585848|NCT04011033|364144305|FG001|Overall Study|Withdrawal by Subject|0|||
105585849|NCT05550337|364144306|FG000|Overall Study|Lack of Efficacy|0|||
105585850|NCT05550337|364144307|FG001|Overall Study|Lack of Efficacy|0|||
105585851|NCT05550337|364144308|FG002|Overall Study|Lack of Efficacy|1|||
105585852|NCT05550337|364144306|FG000|Overall Study|Adverse Event|1|||
105585853|NCT05550337|364144307|FG001|Overall Study|Adverse Event|5|||
105585854|NCT05550337|364144308|FG002|Overall Study|Adverse Event|0|||
105585855|NCT05550337|364144306|FG000|Overall Study|Withdrawal by Subject|8|||
105585856|NCT05550337|364144307|FG001|Overall Study|Withdrawal by Subject|14|||
105585857|NCT05550337|364144308|FG002|Overall Study|Withdrawal by Subject|10|||
105585858|NCT05550337|364144306|FG000|Overall Study|Pregnancy|0|||
105585859|NCT05550337|364144307|FG001|Overall Study|Pregnancy|0|||
105585860|NCT05550337|364144308|FG002|Overall Study|Pregnancy|1|||
105585861|NCT05550337|364144306|FG000|Overall Study|Protocol Violation|1|||
105585862|NCT05550337|364144307|FG001|Overall Study|Protocol Violation|3|||
105585863|NCT05550337|364144308|FG002|Overall Study|Protocol Violation|4|||
105585864|NCT05550337|364144306|FG000|Overall Study|Physician Decision|2|||
105585865|NCT05550337|364144307|FG001|Overall Study|Physician Decision|1|||
105585866|NCT05550337|364144308|FG002|Overall Study|Physician Decision|1|||
105585867|NCT05550337|364144306|FG000|Overall Study|Lost to Follow-up|16|||
105585868|NCT05550337|364144307|FG001|Overall Study|Lost to Follow-up|11|||
105585869|NCT05550337|364144308|FG002|Overall Study|Lost to Follow-up|11|||
105585870|NCT02027935|364144310|FG000|Overall Study|Death|1|||
105585871|NCT02027935|364144310|FG000|Overall Study|Lack of Efficacy|5|||
105585872|NCT02027935|364144310|FG000|Overall Study|Study Closure|1|||
105585873|NCT03115346|364144311|FG000|Overall Study|Did not have AAA surgery|28|||
105585874|NCT03115346|364144312|FG001|Overall Study|Did not have AAA surgery|15|||
105585875|NCT03115346|364144311|FG000|Overall Study|Death|3|||
105585876|NCT03115346|364144312|FG001|Overall Study|Death|1|||
105585877|NCT03115346|364144311|FG000|Overall Study|Withdrawal by Subject|0|||
105585878|NCT03115346|364144312|FG001|Overall Study|Withdrawal by Subject|3|||
105585879|NCT03115346|364144311|FG000|Overall Study|Lost to Follow-up|0|||
105585880|NCT03115346|364144312|FG001|Overall Study|Lost to Follow-up|3|||
105585881|NCT00689104|364144313|FG000|Overall Study|Eligibility criterion not met|5|||
105585882|NCT00689104|364144314|FG001|Overall Study|Eligibility criterion not met|8|||
105585883|NCT00689104|364144315|FG002|Overall Study|Eligibility criterion not met|0|||
105585884|NCT00689104|364144316|FG003|Overall Study|Eligibility criterion not met|4|||
105585885|NCT00689104|364144313|FG000|Overall Study|Adverse Event|13|||
105585886|NCT00689104|364144314|FG001|Overall Study|Adverse Event|25|||
105585887|NCT00689104|364144315|FG002|Overall Study|Adverse Event|16|||
105585888|NCT00689104|364144316|FG003|Overall Study|Adverse Event|24|||
105585889|NCT00689104|364144313|FG000|Overall Study|Lack of Efficacy|5|||
105585890|NCT00689104|364144314|FG001|Overall Study|Lack of Efficacy|6|||
105585891|NCT00689104|364144315|FG002|Overall Study|Lack of Efficacy|2|||
105585892|NCT00689104|364144316|FG003|Overall Study|Lack of Efficacy|3|||
105585893|NCT00689104|364144313|FG000|Overall Study|Withdrawal by Subject|12|||
105585894|NCT00689104|364144314|FG001|Overall Study|Withdrawal by Subject|11|||
105585895|NCT00689104|364144315|FG002|Overall Study|Withdrawal by Subject|18|||
105585896|NCT00689104|364144316|FG003|Overall Study|Withdrawal by Subject|11|||
105585897|NCT00689104|364144313|FG000|Overall Study|Lost to Follow-up|4|||
105585898|NCT00689104|364144314|FG001|Overall Study|Lost to Follow-up|3|||
105422711|NCT03392883|363554161|FG000|Overall Study|Death|4|||
105585899|NCT00689104|364144315|FG002|Overall Study|Lost to Follow-up|2|||
105585900|NCT00689104|364144316|FG003|Overall Study|Lost to Follow-up|5|||
105585901|NCT00689104|364144313|FG000|Overall Study|Protocol Violation|2|||
105585902|NCT00689104|364144314|FG001|Overall Study|Protocol Violation|3|||
105585903|NCT00689104|364144315|FG002|Overall Study|Protocol Violation|5|||
105585904|NCT00689104|364144316|FG003|Overall Study|Protocol Violation|3|||
105585905|NCT00689104|364144313|FG000|Overall Study|Randomized but never received study drug|2|||
105585906|NCT00689104|364144314|FG001|Overall Study|Randomized but never received study drug|1|||
105585907|NCT00689104|364144315|FG002|Overall Study|Randomized but never received study drug|1|||
105585908|NCT00689104|364144316|FG003|Overall Study|Randomized but never received study drug|0|||
105585909|NCT00689104|364144313|FG000|Overall Study|Physician Decision|1|||
105585910|NCT00689104|364144314|FG001|Overall Study|Physician Decision|0|||
105585911|NCT00689104|364144315|FG002|Overall Study|Physician Decision|0|||
105585912|NCT00689104|364144316|FG003|Overall Study|Physician Decision|0|||
105585913|NCT00689104|364144313|FG000|Overall Study|Non-compliance with study procedures|0|||
105585914|NCT00689104|364144314|FG001|Overall Study|Non-compliance with study procedures|0|||
105585915|NCT00689104|364144315|FG002|Overall Study|Non-compliance with study procedures|1|||
105585916|NCT00689104|364144316|FG003|Overall Study|Non-compliance with study procedures|0|||
105585917|NCT04873817|364144317|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
105585918|NCT04873817|364144317|FG000|Overall Study|Lost to Follow-up|4|||
105585919|NCT04873817|364144317|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
105585920|NCT04873817|364144317|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
105585921|NCT04873817|364144317|FG000|Overall Study|Other Reasons|3|||
105585922|NCT01836458|364144318|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
105585923|NCT01836458|364144319|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105585924|NCT01836458|364144320|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
105585925|NCT01836458|364144321|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
105585926|NCT01140347|364144329|FG000|Overall Study|Lost to Follow-up|5|||
105585927|NCT01140347|364144330|FG001|Overall Study|Lost to Follow-up|6|||
105585928|NCT01140347|364144329|FG000|Overall Study|Withdrawal by Subject|13|||
105585929|NCT01140347|364144330|FG001|Overall Study|Withdrawal by Subject|8|||
105585930|NCT01871285|364144331|FG000|First Intervention (1 Day)|Adverse Event|1|||
105585931|NCT01871285|364144332|FG001|First Intervention (1 Day)|Adverse Event|0|||
105585932|NCT01871285|364144333|FG002|First Intervention (1 Day)|Adverse Event|0|||
105585933|NCT01871285|364144334|FG003|First Intervention (1 Day)|Adverse Event|0|||
105585934|NCT01871285|364144331|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
105585935|NCT01871285|364144332|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
105585936|NCT01871285|364144333|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
105585937|NCT01871285|364144334|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
105585938|NCT01959880|364144335|FG000|Overall Study|Withdrawal by Subject|11|||
105585939|NCT01959880|364144336|FG001|Overall Study|Withdrawal by Subject|13|||
105585940|NCT01959880|364144337|FG002|Overall Study|Withdrawal by Subject|8|||
105585941|NCT01959880|364144338|FG003|Overall Study|Withdrawal by Subject|7|||
105585942|NCT01959880|364144335|FG000|Overall Study|Death|1|||
105585943|NCT01959880|364144336|FG001|Overall Study|Death|10|||
105585944|NCT01959880|364144337|FG002|Overall Study|Death|1|||
105585945|NCT01959880|364144338|FG003|Overall Study|Death|2|||
105585946|NCT01959880|364144335|FG000|Overall Study|Lost to Follow-up|95|||
105585947|NCT01959880|364144336|FG001|Overall Study|Lost to Follow-up|18|||
105585948|NCT01959880|364144337|FG002|Overall Study|Lost to Follow-up|15|||
105585949|NCT01959880|364144338|FG003|Overall Study|Lost to Follow-up|8|||
105585950|NCT01959880|364144335|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
105585951|NCT01959880|364144336|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
105585952|NCT01959880|364144337|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
105585953|NCT01959880|364144338|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
105585954|NCT01959880|364144335|FG000|Overall Study|Study completed early-FDA approved|1003|||
105585955|NCT01959880|364144336|FG001|Overall Study|Study completed early-FDA approved|311|||
105585956|NCT01959880|364144337|FG002|Overall Study|Study completed early-FDA approved|179|||
105585957|NCT01959880|364144338|FG003|Overall Study|Study completed early-FDA approved|152|||
105585958|NCT01919619|364144339|FG000|Overall Study|Physician Decision|1|||
105585959|NCT01919619|364144340|FG001|Overall Study|Physician Decision|1|||
105585960|NCT02449044|364144341|FG000|Overall Study|Lost to Follow-up|2|||
105585961|NCT02449044|364144341|FG000|Overall Study|Withdrawal by Subject|13|||
105585962|NCT02449044|364144341|FG000|Overall Study|Adverse Event|30|||
105585963|NCT02449044|364144341|FG000|Overall Study|Met Withdrawal Criteria|7|||
105585964|NCT02449044|364144341|FG000|Overall Study|Physician Decision|9|||
105585965|NCT02449044|364144341|FG000|Overall Study|Sponsor Discontinued Trial|3|||
105585966|NCT02501811|364144342|FG000|Overall Study|Death|1|||
105585967|NCT02501811|364144343|FG001|Overall Study|Death|3|||
105585968|NCT02501811|364144344|FG002|Overall Study|Death|2|||
105585969|NCT02501811|364144345|FG003|Overall Study|Death|3|||
105585970|NCT02501811|364144342|FG000|Overall Study|Withdrawal by Subject|3|||
105585971|NCT02501811|364144343|FG001|Overall Study|Withdrawal by Subject|3|||
105585972|NCT02501811|364144344|FG002|Overall Study|Withdrawal by Subject|2|||
105585973|NCT02501811|364144345|FG003|Overall Study|Withdrawal by Subject|3|||
105585974|NCT02501811|364144342|FG000|Overall Study|Lost to Follow-up|0|||
105585975|NCT02501811|364144343|FG001|Overall Study|Lost to Follow-up|0|||
105585976|NCT02501811|364144344|FG002|Overall Study|Lost to Follow-up|2|||
105585977|NCT02501811|364144345|FG003|Overall Study|Lost to Follow-up|1|||
105585978|NCT00662909|364144346|FG000|Overall Study|Adverse Event|17|||
105585979|NCT00662909|364144347|FG001|Overall Study|Adverse Event|18|||
105585980|NCT00662909|364144348|FG002|Overall Study|Adverse Event|19|||
105585981|NCT00662909|364144346|FG000|Overall Study|Lack of Efficacy|9|||
105585982|NCT00662909|364144347|FG001|Overall Study|Lack of Efficacy|1|||
105585983|NCT00662909|364144348|FG002|Overall Study|Lack of Efficacy|5|||
105585984|NCT00662909|364144346|FG000|Overall Study|Withdrawal by Subject|29|||
105585985|NCT00662909|364144347|FG001|Overall Study|Withdrawal by Subject|22|||
105585986|NCT00662909|364144348|FG002|Overall Study|Withdrawal by Subject|16|||
105585987|NCT00662909|364144346|FG000|Overall Study|Lost to Follow-up|2|||
105585988|NCT00662909|364144347|FG001|Overall Study|Lost to Follow-up|9|||
105585989|NCT00662909|364144348|FG002|Overall Study|Lost to Follow-up|3|||
105585990|NCT00662909|364144346|FG000|Overall Study|Protocol Violation|7|||
105585991|NCT00662909|364144347|FG001|Overall Study|Protocol Violation|4|||
105585992|NCT00662909|364144348|FG002|Overall Study|Protocol Violation|5|||
105585993|NCT00662909|364144346|FG000|Overall Study|Randomized- never received study drug|1|||
105585994|NCT00662909|364144347|FG001|Overall Study|Randomized- never received study drug|0|||
105585995|NCT00662909|364144348|FG002|Overall Study|Randomized- never received study drug|0|||
105585996|NCT00662909|364144346|FG000|Overall Study|Non-compliance with study procedures|3|||
105585997|NCT00662909|364144347|FG001|Overall Study|Non-compliance with study procedures|3|||
105585998|NCT00662909|364144348|FG002|Overall Study|Non-compliance with study procedures|2|||
105585999|NCT00662909|364144346|FG000|Overall Study|Physician Decision|1|||
105586000|NCT00662909|364144347|FG001|Overall Study|Physician Decision|1|||
105586001|NCT00662909|364144348|FG002|Overall Study|Physician Decision|2|||
105586002|NCT00662909|364144346|FG000|Overall Study|Eligibility criterion not met|0|||
105586003|NCT00662909|364144347|FG001|Overall Study|Eligibility criterion not met|1|||
105586004|NCT00662909|364144348|FG002|Overall Study|Eligibility criterion not met|1|||
105586005|NCT02206685|364145618|FG000|Overall Study|Surgery cancelled/changed|2|||
105586006|NCT02206685|364145619|FG001|Overall Study|Surgery cancelled/changed|3|||
105586007|NCT02206685|364145618|FG000|Overall Study|Withdrawal by Subject|1|||
105586008|NCT02206685|364145619|FG001|Overall Study|Withdrawal by Subject|2|||
105586009|NCT02206685|364145618|FG000|Overall Study|Protocol Violation|2|||
105586010|NCT02206685|364145619|FG001|Overall Study|Protocol Violation|2|||
105586011|NCT00093795|364145620|FG000|Overall Study|No follow up data|20|||
105586012|NCT00093795|364145621|FG001|Overall Study|No follow up data|16|||
105586013|NCT00093795|364145622|FG002|Overall Study|No follow up data|17|||
105586014|NCT02347943|364145624|FG000|Overall Study|Study was cancelled|140|||
105586015|NCT02347943|364145625|FG001|Overall Study|Study was cancelled|67|||
105586016|NCT02347943|364145626|FG002|Overall Study|Study was cancelled|45|||
105586017|NCT00303303|364145629|FG000|Overall Study|Withdrawal by Subject|0|||
105586018|NCT00303303|364145630|FG001|Overall Study|Withdrawal by Subject|0|||
105586019|NCT00303303|364145631|FG002|Overall Study|Withdrawal by Subject|1|||
105586020|NCT00480441|364145632|FG000|Screening|Not Eligible|37|||
105586021|NCT00480441|364145633|FG001|Screening|Not Eligible|0|||
105586022|NCT00480441|364145634|FG002|Screening|Not Eligible|0|||
105586023|NCT00480441|364145632|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
105586024|NCT00480441|364145633|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
105586025|NCT00480441|364145634|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
105586026|NCT00480441|364145632|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
105586027|NCT00480441|364145633|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
105586028|NCT00480441|364145634|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
105586029|NCT00480441|364145632|FG000|Baseline Functional MRI|physical contraindication|4|||
105586030|NCT00480441|364145633|FG001|Baseline Functional MRI|physical contraindication|0|||
105586031|NCT00480441|364145634|FG002|Baseline Functional MRI|physical contraindication|0|||
105586032|NCT00480441|364145632|FG000|Randomization|Lost to Follow-up|0|||
105586033|NCT00480441|364145633|FG001|Randomization|Lost to Follow-up|7|||
105586034|NCT00480441|364145634|FG002|Randomization|Lost to Follow-up|2|||
105586035|NCT02334306|364145635|FG000|Double-blind Period|Adverse Event|0|||
105586036|NCT02334306|364145636|FG001|Double-blind Period|Adverse Event|1|||
105586037|NCT02334306|364145635|FG000|Double-blind Period|Withdrawal by Subject|1|||
105586038|NCT02334306|364145636|FG001|Double-blind Period|Withdrawal by Subject|1|||
105586039|NCT01687270|364145637|FG000|Overall Study|Lack of Efficacy|11|||
105586040|NCT01687270|364145637|FG000|Overall Study|Lost to Follow-up|1|||
105586041|NCT00465985|364145638|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
105586042|NCT00465985|364145639|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
105586043|NCT00465985|364145638|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
105586044|NCT00465985|364145639|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
105586045|NCT00465985|364145638|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
105586046|NCT00465985|364145639|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
105586047|NCT00465985|364145638|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
105586048|NCT00465985|364145639|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
105586049|NCT03302156|364145640|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
105586050|NCT03302156|364145641|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
105586051|NCT03302156|364145642|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
105586052|NCT03532178|364145643|FG000|First Period|Withdrawal by Subject|1|||
105586053|NCT03532178|364145644|FG001|First Period|Withdrawal by Subject|3|||
105586054|NCT03532178|364145643|FG000|First Period|technical issues in data collection Technical issues|0|||
105586055|NCT03532178|364145644|FG001|First Period|technical issues in data collection Technical issues|1|||
105586056|NCT03532178|364145643|FG000|Second Period|Withdrawal by Subject|1|||
105586057|NCT03532178|364145644|FG001|Second Period|Withdrawal by Subject|1|||
105586058|NCT03532178|364145643|FG000|Second Period|Technical issues|0|||
105586059|NCT03532178|364145644|FG001|Second Period|Technical issues|1|||
105586060|NCT00293462|364145645|FG000|Overall Study|Withdrawal by Subject|4|||
105422712|NCT03392883|363554162|FG001|Overall Study|Death|0|||
105422713|NCT03392883|363554163|FG002|Overall Study|Death|0|||
105422714|NCT03392883|363554161|FG000|Overall Study|Lack of Efficacy|29|||
105422715|NCT03392883|363554162|FG001|Overall Study|Lack of Efficacy|0|||
105422716|NCT03392883|363554163|FG002|Overall Study|Lack of Efficacy|0|||
105422717|NCT03392883|363554161|FG000|Overall Study|Withdrawal by Subject|180|||
105422718|NCT03392883|363554162|FG001|Overall Study|Withdrawal by Subject|0|||
105422719|NCT03392883|363554163|FG002|Overall Study|Withdrawal by Subject|0|||
105422720|NCT03392883|363554161|FG000|Overall Study|Adverse Event|1|||
105422721|NCT03392883|363554162|FG001|Overall Study|Adverse Event|0|||
105422722|NCT03392883|363554163|FG002|Overall Study|Adverse Event|0|||
105422723|NCT02251717|363554164|FG000|Overall Study|Adverse Event|0|||
105422724|NCT02251717|363554165|FG001|Overall Study|Adverse Event|1|||
105422725|NCT02251717|363554164|FG000|Overall Study|Withdrew Consent|1|||
105422726|NCT02251717|363554165|FG001|Overall Study|Withdrew Consent|0|||
105422727|NCT00908115|363554175|FG000|Overall Study|Other|14|||
105422728|NCT00445939|363554176|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
105422729|NCT00445939|363554177|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
105422730|NCT00445939|363554178|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
105422731|NCT00445939|363554179|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
105422732|NCT00445939|363554176|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
105422733|NCT00445939|363554177|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
105422734|NCT00445939|363554178|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
105422735|NCT00445939|363554179|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
105422736|NCT00489736|363554180|FG000|Overall Study|Lack of Efficacy|53|||
105422737|NCT00489736|363554181|FG001|Overall Study|Lack of Efficacy|14|||
105422738|NCT00489736|363554180|FG000|Overall Study|Adverse Event|32|||
105422739|NCT00489736|363554181|FG001|Overall Study|Adverse Event|45|||
105422740|NCT00489736|363554180|FG000|Overall Study|Poor compliance|6|||
105422741|NCT00489736|363554181|FG001|Overall Study|Poor compliance|2|||
105422742|NCT00489736|363554180|FG000|Overall Study|Not coded/ Not pre-specified|5|||
105422743|NCT00489736|363554181|FG001|Overall Study|Not coded/ Not pre-specified|8|||
105422744|NCT01691885|363554183|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
105422745|NCT01691885|363554184|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
105422746|NCT01691885|363554183|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
105422747|NCT01691885|363554184|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
105422748|NCT02075047|363554197|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
105422749|NCT02075047|363554198|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
105422750|NCT02075047|363554197|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
105586061|NCT00293462|364145646|FG001|Overall Study|Withdrawal by Subject|3|||
105586062|NCT00293462|364145647|FG002|Overall Study|Withdrawal by Subject|8|||
105422751|NCT02075047|363554198|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
105422752|NCT02075047|363554197|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
105422753|NCT02075047|363554198|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
105422754|NCT02075047|363554197|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
105422755|NCT02075047|363554198|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
105422756|NCT02075047|363554197|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
105422757|NCT02075047|363554198|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
105422758|NCT02075047|363554197|FG000|Treatment Phase (4 Weeks)|Other|1|||
105422759|NCT02075047|363554198|FG001|Treatment Phase (4 Weeks)|Other|1|||
105422760|NCT02075047|363554197|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
105422761|NCT02075047|363554198|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
105422762|NCT02075047|363554197|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
105422763|NCT02075047|363554198|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
105422764|NCT02075047|363554197|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
105422765|NCT02075047|363554198|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
105422766|NCT02075047|363554197|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
105586063|NCT00293462|364145645|FG000|Overall Study|Death|1|||
105422767|NCT02075047|363554198|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
105422768|NCT02075047|363554197|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
105422769|NCT02075047|363554198|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
105422770|NCT02075047|363554197|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
105422771|NCT02075047|363554198|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
105422772|NCT02075047|363554197|FG000|Follow up Phase (5 Weeks)|Other|1|||
105422773|NCT02075047|363554198|FG001|Follow up Phase (5 Weeks)|Other|2|||
105422774|NCT02075047|363554197|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
105422775|NCT02075047|363554198|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
105422776|NCT00823212|363554199|FG000|Overall Study|Death|8|||
105422777|NCT00823212|363554200|FG001|Overall Study|Death|10|||
105422778|NCT00823212|363554199|FG000|Overall Study|Withdrawal by Subject|6|||
105422779|NCT00823212|363554200|FG001|Overall Study|Withdrawal by Subject|1|||
105422780|NCT00823212|363554199|FG000|Overall Study|Incarcerated|0|||
105422781|NCT00823212|363554200|FG001|Overall Study|Incarcerated|1|||
105422782|NCT00823212|363554199|FG000|Overall Study|Missed 12-month visit|21|||
105422783|NCT00823212|363554200|FG001|Overall Study|Missed 12-month visit|21|||
105422784|NCT03770728|363554201|FG000|Overall Study|Adverse Event|1|||
105422785|NCT03770728|363554202|FG001|Overall Study|Adverse Event|0|||
105422786|NCT03770728|363554203|FG002|Overall Study|Adverse Event|1|||
105422787|NCT03770728|363554204|FG003|Overall Study|Adverse Event|0|||
105422788|NCT03770728|363554201|FG000|Overall Study|Poor compliance to protocol|0|||
105422789|NCT03770728|363554202|FG001|Overall Study|Poor compliance to protocol|0|||
105422790|NCT03770728|363554203|FG002|Overall Study|Poor compliance to protocol|1|||
105422791|NCT03770728|363554204|FG003|Overall Study|Poor compliance to protocol|0|||
105422792|NCT03770728|363554201|FG000|Overall Study|Withdrawal by Subject|13|||
105422793|NCT03770728|363554202|FG001|Overall Study|Withdrawal by Subject|8|||
105422794|NCT03770728|363554203|FG002|Overall Study|Withdrawal by Subject|9|||
105422795|NCT03770728|363554204|FG003|Overall Study|Withdrawal by Subject|13|||
105422796|NCT03770728|363554201|FG000|Overall Study|Other than specified|24|||
105422797|NCT03770728|363554202|FG001|Overall Study|Other than specified|23|||
105422798|NCT03770728|363554203|FG002|Overall Study|Other than specified|21|||
105422799|NCT03770728|363554204|FG003|Overall Study|Other than specified|22|||
105422800|NCT02324205|363554205|FG000|Overall Study|Withdrawal by Subject|37|||
105422801|NCT03006458|363554212|FG000|First Intervention|Unsatisfied Vision|0|||
105422802|NCT03006458|363554213|FG001|First Intervention|Unsatisfied Vision|3|||
105422803|NCT00855933|363554214|FG000|Overall Study|Withdrawal by Subject|0|||
105422804|NCT00855933|363554215|FG001|Overall Study|Withdrawal by Subject|1|||
105422805|NCT02851407|363554216|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105422806|NCT02851407|363554217|FG001|Overall Study|Withdrawal by parent/guardian|7|||
105422807|NCT02851407|363554216|FG000|Overall Study|Protocol deviation|0|||
105422808|NCT02851407|363554217|FG001|Overall Study|Protocol deviation|1|||
105422809|NCT02851407|363554216|FG000|Overall Study|Transferred to another hospital to continue|1|||
105422810|NCT02851407|363554217|FG001|Overall Study|Transferred to another hospital to continue|0|||
105422811|NCT02851407|363554216|FG000|Overall Study|Other Death|30|||
105422812|NCT02851407|363554217|FG001|Overall Study|Other Death|20|||
105422813|NCT02851407|363554216|FG000|Overall Study|Adverse event, serious fatal|6|||
105422814|NCT02851407|363554217|FG001|Overall Study|Adverse event, serious fatal|8|||
105422815|NCT02851407|363554216|FG000|Overall Study|Consent withdrawn by participant|5|||
105422816|NCT02851407|363554217|FG001|Overall Study|Consent withdrawn by participant|3|||
105422817|NCT02851407|363554216|FG000|Overall Study|Screen failure|2|||
105422818|NCT02851407|363554217|FG001|Overall Study|Screen failure|1|||
105422819|NCT02851407|363554216|FG000|Overall Study|Disease relapse|9|||
105422820|NCT02851407|363554217|FG001|Overall Study|Disease relapse|6|||
105422821|NCT02851407|363554216|FG000|Overall Study|Physician Decision|7|||
105422822|NCT02851407|363554217|FG001|Overall Study|Physician Decision|6|||
105422823|NCT02851407|363554216|FG000|Overall Study|Transferred to hospital closer to home|0|||
105422824|NCT02851407|363554217|FG001|Overall Study|Transferred to hospital closer to home|1|||
105422825|NCT02851407|363554216|FG000|Overall Study|Enrolled in an investigational study|0|||
105422826|NCT02851407|363554217|FG001|Overall Study|Enrolled in an investigational study|1|||
105422827|NCT02851407|363554216|FG000|Overall Study|Early recovery|1|||
105422828|NCT02851407|363554217|FG001|Overall Study|Early recovery|0|||
105422829|NCT02851407|363554216|FG000|Overall Study|Adverse event, non-fatal|7|||
105422830|NCT02851407|363554217|FG001|Overall Study|Adverse event, non-fatal|5|||
105422831|NCT02851407|363554216|FG000|Overall Study|Lost to Follow-up|0|||
105422832|NCT02851407|363554217|FG001|Overall Study|Lost to Follow-up|2|||
105422833|NCT00580034|363554223|FG000|Overall Study|Toxicity|10|||
105422834|NCT00580034|363554224|FG001|Overall Study|Toxicity|0|||
105422835|NCT03305081|363554226|FG000|Overall Study|Lost to Follow-up|10|||
105422836|NCT03305081|363554227|FG001|Overall Study|Lost to Follow-up|15|||
105422837|NCT00433160|363554230|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
105422838|NCT00433160|363554231|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
105422839|NCT00433160|363554230|FG000|52-Week Double-Blind (DB) Period|Death|0|||
105422840|NCT00433160|363554231|FG001|52-Week Double-Blind (DB) Period|Death|0|||
105422841|NCT00433160|363554230|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
105422842|NCT00433160|363554231|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
105422843|NCT00433160|363554230|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
105422844|NCT00433160|363554231|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
105422845|NCT00433160|363554230|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
105422846|NCT00433160|363554231|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
105422847|NCT00433160|363554230|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
105422848|NCT00433160|363554231|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
105422849|NCT00433160|363554230|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
105422850|NCT00433160|363554231|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
105422851|NCT00433160|363554230|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
105422852|NCT00433160|363554231|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
105422853|NCT00433160|363554230|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
105422854|NCT00433160|363554231|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
105422855|NCT00433160|363554230|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
105422856|NCT00433160|363554231|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
105422857|NCT00433160|363554230|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
105422858|NCT00433160|363554231|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
105422859|NCT00433160|363554230|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
105422860|NCT00433160|363554231|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
105422861|NCT00433160|363554230|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
105422862|NCT00433160|363554231|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
105422863|NCT00433160|363554230|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
105422864|NCT00433160|363554231|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
105422865|NCT00433160|363554230|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
105422866|NCT00433160|363554231|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
105422867|NCT00433160|363554230|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
105422868|NCT00433160|363554231|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
105422869|NCT00570037|363554232|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
105422870|NCT00570037|363554233|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
105422871|NCT01571284|363554234|FG000|Overall Study|Participant's decision|84|||
105422872|NCT01571284|363554234|FG000|Overall Study|Lost to Follow-up|3|||
105422873|NCT01571284|363554234|FG000|Overall Study|Enrolled but not treated|2|||
105422874|NCT01571284|363554234|FG000|Overall Study|Other than specified above|80|||
105422875|NCT02825420|363554235|FG000|Overall Study|Death|30|||
105422876|NCT02825420|363554236|FG001|Overall Study|Death|12|||
105422877|NCT02825420|363554235|FG000|Overall Study|Progressive disease|6|||
105422878|NCT02825420|363554236|FG001|Overall Study|Progressive disease|1|||
105422879|NCT02825420|363554235|FG000|Overall Study|Lost to Follow-up|2|||
105422880|NCT02825420|363554236|FG001|Overall Study|Lost to Follow-up|2|||
105422881|NCT02825420|363554235|FG000|Overall Study|Withdrawal by Subject|1|||
105422882|NCT02825420|363554236|FG001|Overall Study|Withdrawal by Subject|1|||
105422883|NCT02825420|363554235|FG000|Overall Study|Protocol amendment not signed|1|||
105422884|NCT02825420|363554236|FG001|Overall Study|Protocol amendment not signed|1|||
105422885|NCT02825420|363554235|FG000|Overall Study|Physician Decision|1|||
105422886|NCT02825420|363554236|FG001|Overall Study|Physician Decision|0|||
105422887|NCT02825420|363554235|FG000|Overall Study|Did not receive PLD|2|||
105422888|NCT02825420|363554236|FG001|Overall Study|Did not receive PLD|0|||
105422889|NCT02080481|363554237|FG000|Overall Study|Never received a block.|1|||
105422890|NCT02080481|363554238|FG001|Overall Study|Never received a block.|0|||
105422891|NCT04027049|363554239|FG000|Overall Study|Withdrawn by family|1|||
105422892|NCT04027049|363554240|FG001|Overall Study|Withdrawn by family|0|||
105422893|NCT04027049|363554239|FG000|Overall Study|Participant safety|1|||
105422894|NCT04027049|363554240|FG001|Overall Study|Participant safety|0|||
105422895|NCT02439450|363554241|FG000|Overall Study|Adverse Event|4|||
105422896|NCT02439450|363554242|FG001|Overall Study|Adverse Event|1|||
105422897|NCT02439450|363554243|FG002|Overall Study|Adverse Event|0|||
105422898|NCT02439450|363554244|FG003|Overall Study|Adverse Event|0|||
105422899|NCT02439450|363554241|FG000|Overall Study|Withdrawal by Subject|1|||
105422900|NCT02439450|363554242|FG001|Overall Study|Withdrawal by Subject|2|||
105422901|NCT02439450|363554243|FG002|Overall Study|Withdrawal by Subject|0|||
105422902|NCT02439450|363554244|FG003|Overall Study|Withdrawal by Subject|0|||
105422903|NCT02439450|363554241|FG000|Overall Study|Death|3|||
105422904|NCT02439450|363554242|FG001|Overall Study|Death|0|||
105422905|NCT02439450|363554243|FG002|Overall Study|Death|0|||
105422906|NCT02439450|363554244|FG003|Overall Study|Death|1|||
105422907|NCT02439450|363554241|FG000|Overall Study|Progressive Disease|18|||
105422908|NCT02439450|363554242|FG001|Overall Study|Progressive Disease|41|||
105422909|NCT02439450|363554243|FG002|Overall Study|Progressive Disease|2|||
105422910|NCT02439450|363554244|FG003|Overall Study|Progressive Disease|3|||
105422911|NCT02323204|363554246|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
105422912|NCT02323204|363554247|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
105422913|NCT02323204|363554248|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
105422914|NCT02323204|363554249|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
105422915|NCT02323204|363554246|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
105422916|NCT02323204|363554247|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
105422917|NCT02323204|363554248|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
105422918|NCT02323204|363554249|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
105422919|NCT02323204|363554246|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
105422920|NCT02323204|363554247|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
105422921|NCT02323204|363554248|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
105422922|NCT02323204|363554249|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
105422923|NCT02323204|363554246|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
105586064|NCT00293462|364145646|FG001|Overall Study|Death|0|||
105586065|NCT00293462|364145647|FG002|Overall Study|Death|0|||
105586066|NCT00293462|364145645|FG000|Overall Study|Lost to Follow-up|0|||
105586067|NCT00293462|364145646|FG001|Overall Study|Lost to Follow-up|1|||
105586068|NCT00293462|364145647|FG002|Overall Study|Lost to Follow-up|0|||
105586069|NCT00293462|364145645|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
105586070|NCT00293462|364145646|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
105586071|NCT00293462|364145647|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
105586072|NCT00293462|364145645|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
105586073|NCT00293462|364145646|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
105586074|NCT00293462|364145647|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
105586075|NCT00293462|364145645|FG000|Overall Study|Refuse Radiation Treatment|1|||
105586076|NCT00293462|364145646|FG001|Overall Study|Refuse Radiation Treatment|0|||
105586077|NCT00293462|364145647|FG002|Overall Study|Refuse Radiation Treatment|0|||
105586078|NCT00293462|364145645|FG000|Overall Study|No Show|0|||
105586079|NCT00293462|364145646|FG001|Overall Study|No Show|0|||
105586080|NCT00293462|364145647|FG002|Overall Study|No Show|1|||
105586081|NCT00293462|364145645|FG000|Overall Study|Went back to his home country|0|||
105586082|NCT00293462|364145646|FG001|Overall Study|Went back to his home country|0|||
105586083|NCT00293462|364145647|FG002|Overall Study|Went back to his home country|1|||
105586084|NCT00293462|364145645|FG000|Overall Study|Blood clot after chemotherapy|0|||
105586085|NCT00293462|364145646|FG001|Overall Study|Blood clot after chemotherapy|0|||
105586086|NCT00293462|364145647|FG002|Overall Study|Blood clot after chemotherapy|1|||
105586087|NCT00293462|364145645|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
105586088|NCT00293462|364145646|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
105586089|NCT00293462|364145647|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
105586090|NCT00293462|364145645|FG000|Overall Study|Possible Tracheostomy leakage|0|||
105586091|NCT00293462|364145646|FG001|Overall Study|Possible Tracheostomy leakage|1|||
105586092|NCT00293462|364145647|FG002|Overall Study|Possible Tracheostomy leakage|0|||
105586093|NCT00293462|364145645|FG000|Overall Study|Low radiation dose in oral cavity|0|||
105586094|NCT00293462|364145646|FG001|Overall Study|Low radiation dose in oral cavity|1|||
105586095|NCT00293462|364145647|FG002|Overall Study|Low radiation dose in oral cavity|0|||
105586096|NCT00293462|364145645|FG000|Overall Study|Physician Decision|0|||
105586097|NCT00293462|364145646|FG001|Overall Study|Physician Decision|1|||
105586098|NCT00293462|364145647|FG002|Overall Study|Physician Decision|0|||
105586099|NCT02950545|364145650|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
105586100|NCT02950545|364145651|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
105586101|NCT02950545|364145652|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
105586102|NCT02950545|364145653|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
105586103|NCT02950545|364145654|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
105586104|NCT02950545|364145655|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
105586105|NCT02950545|364145650|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
105586106|NCT02950545|364145651|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
105586107|NCT02950545|364145652|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
105586108|NCT02950545|364145653|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
105586109|NCT02950545|364145654|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
105586110|NCT02950545|364145655|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
105586111|NCT02950545|364145650|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
105586112|NCT02950545|364145651|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
105586113|NCT02950545|364145652|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
105586114|NCT02950545|364145653|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
105586115|NCT02950545|364145654|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
105586116|NCT02950545|364145655|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
105586117|NCT02950545|364145650|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
105586118|NCT02950545|364145651|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
105586119|NCT02950545|364145652|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
105586120|NCT02950545|364145653|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
105586121|NCT02950545|364145654|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
105586122|NCT02950545|364145655|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
105586123|NCT02950545|364145650|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
105586124|NCT02950545|364145651|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
105586125|NCT02950545|364145652|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
105586126|NCT02950545|364145653|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
105586127|NCT02950545|364145654|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
105586128|NCT02950545|364145655|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
105586129|NCT03255941|364145656|FG000|Overall Study|Not eligible or refused injection|37|||
105586130|NCT03255941|364145657|FG001|Overall Study|Not eligible or refused injection|44|||
105586131|NCT03255941|364145658|FG002|Overall Study|Not eligible or refused injection|5|||
105586132|NCT03255941|364145659|FG003|Overall Study|Not eligible or refused injection|6|||
105586133|NCT03255941|364145656|FG000|Overall Study|Did not complete exit interview|1|||
105586134|NCT03255941|364145657|FG001|Overall Study|Did not complete exit interview|2|||
105586135|NCT03255941|364145658|FG002|Overall Study|Did not complete exit interview|0|||
105586136|NCT03255941|364145659|FG003|Overall Study|Did not complete exit interview|0|||
105586137|NCT00372060|364145660|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
105586138|NCT00372060|364145661|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
105586139|NCT00372060|364145660|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
105586140|NCT00372060|364145661|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
105586141|NCT00372060|364145660|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
105422924|NCT02323204|363554247|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
105422925|NCT02323204|363554248|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
105422926|NCT02323204|363554249|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
105422927|NCT02323204|363554246|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
105422928|NCT02323204|363554247|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
105422929|NCT02323204|363554248|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
105500946|NCT00306189|363845759|FG000|Overall Study|Adverse Event|3|||
105500947|NCT00306189|363845760|FG001|Overall Study|Adverse Event|3|||
105500948|NCT00306189|363845761|FG002|Overall Study|Adverse Event|2|||
105500949|NCT00306189|363845762|FG003|Overall Study|Adverse Event|2|||
105500950|NCT00306189|363845759|FG000|Overall Study|Withdrawal by Subject|4|||
105500951|NCT00306189|363845760|FG001|Overall Study|Withdrawal by Subject|2|||
105500952|NCT00306189|363845761|FG002|Overall Study|Withdrawal by Subject|8|||
105500953|NCT00306189|363845762|FG003|Overall Study|Withdrawal by Subject|1|||
105500954|NCT00306189|363845759|FG000|Overall Study|Ineligibility determined|1|||
105500955|NCT00306189|363845760|FG001|Overall Study|Ineligibility determined|1|||
105500956|NCT00306189|363845761|FG002|Overall Study|Ineligibility determined|1|||
105500957|NCT00306189|363845762|FG003|Overall Study|Ineligibility determined|1|||
105500958|NCT00306189|363845759|FG000|Overall Study|Other|1|||
105500959|NCT00306189|363845760|FG001|Overall Study|Other|0|||
105500960|NCT00306189|363845761|FG002|Overall Study|Other|0|||
105500961|NCT00306189|363845762|FG003|Overall Study|Other|0|||
105500962|NCT01548287|363845763|FG000|Screening|No reason provided|0|||
105500963|NCT01548287|363845764|FG001|Screening|No reason provided|0|||
105500964|NCT01548287|363845765|FG002|Screening|No reason provided|0|||
105500965|NCT01548287|363845766|FG003|Screening|No reason provided|0|||
105500966|NCT01548287|363845767|FG004|Screening|No reason provided|9|||
105500967|NCT01548287|363845763|FG000|Screening|Did not meet eligibility criteria|0|||
105500968|NCT01548287|363845764|FG001|Screening|Did not meet eligibility criteria|0|||
105500969|NCT01548287|363845765|FG002|Screening|Did not meet eligibility criteria|0|||
105500970|NCT01548287|363845766|FG003|Screening|Did not meet eligibility criteria|0|||
105500971|NCT01548287|363845767|FG004|Screening|Did not meet eligibility criteria|74|||
105500972|NCT01548287|363845763|FG000|Randomized Period|Did not meet inclusion criteria|0|||
105500973|NCT01548287|363845764|FG001|Randomized Period|Did not meet inclusion criteria|0|||
105500974|NCT01548287|363845765|FG002|Randomized Period|Did not meet inclusion criteria|2|||
105500975|NCT01548287|363845766|FG003|Randomized Period|Did not meet inclusion criteria|0|||
105500976|NCT01548287|363845767|FG004|Randomized Period|Did not meet inclusion criteria|0|||
105500977|NCT01548287|363845763|FG000|Randomized Period|Adverse Event|0|||
105500978|NCT01548287|363845764|FG001|Randomized Period|Adverse Event|2|||
105500979|NCT01548287|363845765|FG002|Randomized Period|Adverse Event|5|||
105500980|NCT01548287|363845766|FG003|Randomized Period|Adverse Event|0|||
105500981|NCT01548287|363845767|FG004|Randomized Period|Adverse Event|0|||
105500982|NCT00259610|363845768|FG000|Overall Study|Withdrawal by Subject|33|||
105500983|NCT00259610|363845769|FG001|Overall Study|Withdrawal by Subject|25|||
105500984|NCT00259610|363845770|FG002|Overall Study|Withdrawal by Subject|29|||
105500985|NCT00259610|363845771|FG003|Overall Study|Withdrawal by Subject|19|||
105500986|NCT00259610|363845768|FG000|Overall Study|Lost to Follow-up|19|||
105500987|NCT00259610|363845769|FG001|Overall Study|Lost to Follow-up|8|||
105500988|NCT00259610|363845770|FG002|Overall Study|Lost to Follow-up|18|||
105500989|NCT00259610|363845771|FG003|Overall Study|Lost to Follow-up|15|||
105500990|NCT00259610|363845768|FG000|Overall Study|Physician Decision|6|||
105500991|NCT00259610|363845769|FG001|Overall Study|Physician Decision|4|||
105500992|NCT00259610|363845770|FG002|Overall Study|Physician Decision|7|||
105500993|NCT00259610|363845771|FG003|Overall Study|Physician Decision|2|||
105500994|NCT00259610|363845768|FG000|Overall Study|Death|1|||
105500995|NCT00259610|363845769|FG001|Overall Study|Death|1|||
105500996|NCT00259610|363845770|FG002|Overall Study|Death|2|||
105500997|NCT00259610|363845771|FG003|Overall Study|Death|0|||
105500998|NCT00259610|363845768|FG000|Overall Study|non medical reason|6|||
105500999|NCT00259610|363845769|FG001|Overall Study|non medical reason|2|||
105501000|NCT00259610|363845770|FG002|Overall Study|non medical reason|10|||
105501001|NCT00259610|363845771|FG003|Overall Study|non medical reason|3|||
105501002|NCT00259610|363845768|FG000|Overall Study|Adverse Event|3|||
105501003|NCT00259610|363845769|FG001|Overall Study|Adverse Event|4|||
105501004|NCT00259610|363845770|FG002|Overall Study|Adverse Event|5|||
105501005|NCT00259610|363845771|FG003|Overall Study|Adverse Event|2|||
105586142|NCT00372060|364145661|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
105586143|NCT00372060|364145660|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
105586144|NCT00372060|364145661|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
105586145|NCT00372060|364145660|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
105586146|NCT00372060|364145661|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
105586147|NCT00372060|364145660|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
105586148|NCT00372060|364145661|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
105586149|NCT03398356|364145665|FG000|Before Treatment|Lost to Follow-up|1|||
105586150|NCT03398356|364145666|FG001|Before Treatment|Lost to Follow-up|2|||
105586151|NCT03398356|364145667|FG002|Before Treatment|Lost to Follow-up|0|||
105586152|NCT03398356|364145665|FG000|Before Treatment|drug intolerance|2|||
105586153|NCT03398356|364145666|FG001|Before Treatment|drug intolerance|1|||
105586154|NCT03398356|364145667|FG002|Before Treatment|drug intolerance|0|||
105586155|NCT03398356|364145665|FG000|Before Treatment|Withdrawal by Subject|0|||
105586156|NCT03398356|364145666|FG001|Before Treatment|Withdrawal by Subject|5|||
105586157|NCT03398356|364145667|FG002|Before Treatment|Withdrawal by Subject|0|||
105586158|NCT03398356|364145665|FG000|Before Treatment|Physician Decision|0|||
105586159|NCT03398356|364145666|FG001|Before Treatment|Physician Decision|0|||
105586160|NCT03398356|364145667|FG002|Before Treatment|Physician Decision|11|||
105586161|NCT03398356|364145665|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
105586162|NCT03398356|364145666|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
105586163|NCT03398356|364145667|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
105586164|NCT02412761|364145669|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
105586165|NCT02412761|364145670|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
105586166|NCT02412761|364145671|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
105586167|NCT02412761|364145672|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
105586168|NCT02412761|364145673|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
105586169|NCT02412761|364145674|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
105586170|NCT01813422|364145675|FG000|Overall Study|Withdrawal by Subject|14|||
105586171|NCT01813422|364145676|FG001|Overall Study|Withdrawal by Subject|8|||
105586172|NCT01813422|364145675|FG000|Overall Study|Death|2|||
105586173|NCT01813422|364145676|FG001|Overall Study|Death|3|||
105586174|NCT01813422|364145675|FG000|Overall Study|Sponsor Decision|2|||
105586175|NCT01813422|364145676|FG001|Overall Study|Sponsor Decision|1|||
105586176|NCT01813422|364145675|FG000|Overall Study|Lost to Follow-up|2|||
105586177|NCT01813422|364145676|FG001|Overall Study|Lost to Follow-up|4|||
105586178|NCT04889118|364145678|FG000|Overall Study|Death|33|||
105586179|NCT04889118|364145679|FG001|Overall Study|Death|37|||
105586180|NCT04889118|364145678|FG000|Overall Study|Ongoing in Study|31|||
105586181|NCT04889118|364145679|FG001|Overall Study|Ongoing in Study|30|||
105586182|NCT00601640|364145682|FG000|Overall Study|Withdrawal by Subject|3|||
105586183|NCT00601640|364145683|FG001|Overall Study|Withdrawal by Subject|0|||
105586184|NCT00601640|364145684|FG002|Overall Study|Withdrawal by Subject|7|||
105586185|NCT00601640|364145682|FG000|Overall Study|Death|1|||
105586186|NCT00601640|364145683|FG001|Overall Study|Death|0|||
105586187|NCT00601640|364145684|FG002|Overall Study|Death|0|||
105586188|NCT00601640|364145682|FG000|Overall Study|Adverse Event|0|||
105586189|NCT00601640|364145683|FG001|Overall Study|Adverse Event|4|||
105586190|NCT00601640|364145684|FG002|Overall Study|Adverse Event|2|||
105586191|NCT00601640|364145682|FG000|Overall Study|intercurrent illness|1|||
105586192|NCT00601640|364145683|FG001|Overall Study|intercurrent illness|0|||
105586193|NCT00601640|364145684|FG002|Overall Study|intercurrent illness|0|||
105586194|NCT00601640|364145682|FG000|Overall Study|change in eligibility status|0|||
105586195|NCT00601640|364145683|FG001|Overall Study|change in eligibility status|1|||
105586196|NCT00601640|364145684|FG002|Overall Study|change in eligibility status|1|||
105586197|NCT00530777|364145685|FG000|Overall Study|Lost to Follow-up|0|||
105586198|NCT00530777|364145686|FG001|Overall Study|Lost to Follow-up|1|||
105586199|NCT00530777|364145685|FG000|Overall Study|Death|1|||
105586200|NCT00530777|364145686|FG001|Overall Study|Death|2|||
105586201|NCT00530777|364145685|FG000|Overall Study|Physician Decision|1|||
105586202|NCT00530777|364145686|FG001|Overall Study|Physician Decision|0|||
105586203|NCT00530777|364145685|FG000|Overall Study|Withdrawal by Subject|0|||
105586204|NCT00530777|364145686|FG001|Overall Study|Withdrawal by Subject|1|||
105586205|NCT00530777|364145685|FG000|Overall Study|Unable to adhere to visit schedule|5|||
105586206|NCT00530777|364145686|FG001|Overall Study|Unable to adhere to visit schedule|1|||
105586207|NCT01582243|364145691|FG000|Overall Study|Withdrawal by Subject|1|||
105586208|NCT01582243|364145691|FG000|Overall Study|Adverse Event|1|||
105586209|NCT01582243|364145691|FG000|Overall Study|Lost to Follow-up|1|||
105586210|NCT02096003|364145694|FG000|Overall Study|Protocol Violation|0|||
105586211|NCT02096003|364145695|FG001|Overall Study|Protocol Violation|2|||
105586212|NCT02096003|364145694|FG000|Overall Study|additional surgery|2|||
105586213|NCT02096003|364145695|FG001|Overall Study|additional surgery|1|||
105586214|NCT01008748|364145696|FG000|Overall Study|Lost to Follow-up|80|||
105586215|NCT01008748|364145696|FG000|Overall Study|Other|1|||
105586216|NCT01872611|364145698|FG000|Overall Study|Adverse Event|3|||
105586217|NCT01872611|364145699|FG001|Overall Study|Adverse Event|1|||
105586218|NCT01872611|364145698|FG000|Overall Study|Adverse Event, prior to treatment|0|||
105586219|NCT01872611|364145699|FG001|Overall Study|Adverse Event, prior to treatment|1|||
105586220|NCT01872611|364145698|FG000|Overall Study|Death|0|||
105586221|NCT01872611|364145699|FG001|Overall Study|Death|1|||
105586222|NCT01872611|364145698|FG000|Overall Study|Death, prior to treatment|0|||
105586223|NCT01872611|364145699|FG001|Overall Study|Death, prior to treatment|1|||
105586224|NCT01872611|364145698|FG000|Overall Study|Lost to Follow-up|8|||
105586225|NCT01872611|364145699|FG001|Overall Study|Lost to Follow-up|1|||
105586226|NCT01872611|364145698|FG000|Overall Study|Physician Decision|1|||
105586227|NCT01872611|364145699|FG001|Overall Study|Physician Decision|0|||
105586228|NCT01872611|364145698|FG000|Overall Study|Withdrawal by Subject|6|||
105586229|NCT01872611|364145699|FG001|Overall Study|Withdrawal by Subject|1|||
105586230|NCT01872611|364145698|FG000|Overall Study|Reason not provided|6|||
105586231|NCT01872611|364145699|FG001|Overall Study|Reason not provided|6|||
105586232|NCT04088188|364145706|FG000|Overall Study|Withdrawal by Subject|2|||
105586233|NCT04088188|364145707|FG001|Overall Study|Withdrawal by Subject|0|||
105586234|NCT04088188|364145706|FG000|Overall Study|Adverse Event|2|||
105586235|NCT04088188|364145707|FG001|Overall Study|Adverse Event|0|||
105586236|NCT03124108|364145708|FG000|Overall Study|Adverse Event|0|||
105586237|NCT03124108|364145709|FG001|Overall Study|Adverse Event|1|||
105586238|NCT03124108|364145710|FG002|Overall Study|Adverse Event|0|||
105586239|NCT00631917|364145711|FG000|Overall Study|Adverse Event|34|||
105586240|NCT00631917|364145712|FG001|Overall Study|Adverse Event|45|||
105586241|NCT00631917|364145711|FG000|Overall Study|Abnormal laboratory value(s)|2|||
105586242|NCT00631917|364145712|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105586243|NCT00631917|364145711|FG000|Overall Study|Abnormal test procedure result(s)|3|||
105586244|NCT00631917|364145712|FG001|Overall Study|Abnormal test procedure result(s)|2|||
105586245|NCT00631917|364145711|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
105586246|NCT00631917|364145712|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
105586247|NCT00631917|364145711|FG000|Overall Study|No longer required study drug|0|||
105586248|NCT00631917|364145712|FG001|Overall Study|No longer required study drug|1|||
105586249|NCT00631917|364145711|FG000|Overall Study|Protocol deviation|6|||
105586250|NCT00631917|364145712|FG001|Overall Study|Protocol deviation|5|||
105586251|NCT00631917|364145711|FG000|Overall Study|Subject withdrew consent|25|||
105586252|NCT00631917|364145712|FG001|Overall Study|Subject withdrew consent|33|||
105586253|NCT00631917|364145711|FG000|Overall Study|Lost to Follow-up|7|||
105586254|NCT00631917|364145712|FG001|Overall Study|Lost to Follow-up|7|||
105586255|NCT00631917|364145711|FG000|Overall Study|Administrative problems|2|||
105586256|NCT00631917|364145712|FG001|Overall Study|Administrative problems|0|||
105586257|NCT00631917|364145711|FG000|Overall Study|Death|1|||
105586258|NCT00631917|364145712|FG001|Overall Study|Death|0|||
105586259|NCT02403323|364145713|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
105586260|NCT02403323|364145714|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
105586261|NCT02403323|364145715|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
105586262|NCT02403323|364145713|FG000|Part 1: Open Label Extension Period|Death|3|||
105586263|NCT02403323|364145714|FG001|Part 1: Open Label Extension Period|Death|0|||
105586264|NCT02403323|364145715|FG002|Part 1: Open Label Extension Period|Death|0|||
105586265|NCT02403323|364145713|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
105586266|NCT02403323|364145714|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
105586267|NCT02403323|364145715|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
105586268|NCT02403323|364145713|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
105586269|NCT02403323|364145714|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
105586270|NCT02403323|364145715|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
105586271|NCT02403323|364145713|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
105586272|NCT02403323|364145714|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
105586273|NCT02403323|364145715|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
105586274|NCT02403323|364145713|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
105586275|NCT02403323|364145714|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
105586276|NCT02403323|364145715|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
105586277|NCT02403323|364145713|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
105586278|NCT02403323|364145714|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
105586279|NCT02403323|364145715|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
105586280|NCT02403323|364145713|FG000|Part 1: Open Label Extension Period|Other|1|||
105586281|NCT02403323|364145714|FG001|Part 1: Open Label Extension Period|Other|0|||
105586282|NCT02403323|364145715|FG002|Part 1: Open Label Extension Period|Other|0|||
105586283|NCT02403323|364145713|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
105586284|NCT02403323|364145714|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
105586285|NCT02403323|364145715|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
105586286|NCT02403323|364145713|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
105586287|NCT02403323|364145714|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
105586288|NCT02403323|364145715|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
105586289|NCT02403323|364145713|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
105586290|NCT02403323|364145714|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
105422930|NCT02323204|363554249|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
105422931|NCT02323204|363554246|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
105422932|NCT02323204|363554247|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
105422933|NCT02323204|363554248|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
105422934|NCT02323204|363554249|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
105422935|NCT02323204|363554246|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
105422936|NCT02323204|363554247|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
105422937|NCT02323204|363554248|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
105422938|NCT02323204|363554249|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
105422939|NCT02323204|363554246|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
105422940|NCT02323204|363554247|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
105422941|NCT02323204|363554248|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
105422942|NCT02323204|363554249|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
105422943|NCT02323204|363554246|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
105422944|NCT02323204|363554247|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
105422945|NCT02323204|363554248|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
105422946|NCT02323204|363554249|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
105422947|NCT03576755|363554255|FG000|Overall Study|Withdrawal by Subject|1|||
105422948|NCT03576755|363554256|FG001|Overall Study|Withdrawal by Subject|0|||
105422949|NCT03576755|363554257|FG002|Overall Study|Withdrawal by Subject|0|||
105422950|NCT03576755|363554258|FG003|Overall Study|Withdrawal by Subject|0|||
105422951|NCT03444766|363554259|FG000|Overall Study|Other Reasons|2|||
105422952|NCT03444766|363554259|FG000|Overall Study|Participant Withdrew Consent|5|||
105422953|NCT03444766|363554259|FG000|Overall Study|Lost to Follow-up|2|||
105422954|NCT03444766|363554259|FG000|Overall Study|Death|2|||
105422955|NCT03444766|363554259|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
105422956|NCT03444766|363554259|FG000|Overall Study|Disease Progression|49|||
105422957|NCT02788201|363554260|FG000|Overall Study|Death|1|||
105422958|NCT02788201|363554261|FG001|Overall Study|Death|1|||
105422959|NCT02788201|363554262|FG002|Overall Study|Death|1|||
105422960|NCT02788201|363554263|FG003|Overall Study|Death|1|||
105422961|NCT02788201|363554264|FG004|Overall Study|Death|0|||
105422962|NCT02788201|363554265|FG005|Overall Study|Death|1|||
105422963|NCT02788201|363554260|FG000|Overall Study|Ineligible|0|||
105422964|NCT02788201|363554261|FG001|Overall Study|Ineligible|0|||
105422965|NCT02788201|363554262|FG002|Overall Study|Ineligible|0|||
105422966|NCT02788201|363554263|FG003|Overall Study|Ineligible|0|||
105422967|NCT02788201|363554264|FG004|Overall Study|Ineligible|0|||
105422968|NCT02788201|363554265|FG005|Overall Study|Ineligible|1|||
105422969|NCT02788201|363554260|FG000|Overall Study|Withdrawal by Subject|0|||
105422970|NCT02788201|363554261|FG001|Overall Study|Withdrawal by Subject|0|||
105422971|NCT02788201|363554262|FG002|Overall Study|Withdrawal by Subject|0|||
105422972|NCT02788201|363554263|FG003|Overall Study|Withdrawal by Subject|0|||
105422973|NCT02788201|363554264|FG004|Overall Study|Withdrawal by Subject|0|||
105422974|NCT02788201|363554265|FG005|Overall Study|Withdrawal by Subject|1|||
105422975|NCT01852825|363554266|FG000|Overall Study|Withdrawal by Subject|2|||
105422976|NCT01852825|363554267|FG001|Overall Study|Withdrawal by Subject|0|||
105422977|NCT01852825|363554268|FG002|Overall Study|Withdrawal by Subject|0|||
105422978|NCT01081301|363554272|FG000|Overall Study|Bereaved|3|||
105422979|NCT01081301|363554272|FG000|Overall Study|Too busy|5|||
105422980|NCT01081301|363554272|FG000|Overall Study|Patient too ill|2|||
105422981|NCT01081301|363554272|FG000|Overall Study|Lost to Follow-up|4|||
105422982|NCT02446418|363554273|FG000|Overall Study|Adverse Event|4|||
105422983|NCT02446418|363554274|FG001|Overall Study|Adverse Event|8|||
105422984|NCT02446418|363554273|FG000|Overall Study|Physician Decision|5|||
105422985|NCT02446418|363554274|FG001|Overall Study|Physician Decision|1|||
105422986|NCT02446418|363554273|FG000|Overall Study|Withdrawal by Subject|3|||
105422987|NCT02446418|363554274|FG001|Overall Study|Withdrawal by Subject|3|||
105422988|NCT02446418|363554273|FG000|Overall Study|Lost to Follow-up|2|||
105422989|NCT02446418|363554274|FG001|Overall Study|Lost to Follow-up|2|||
105422990|NCT02446418|363554273|FG000|Overall Study|Protocol Violation|1|||
105422991|NCT02446418|363554274|FG001|Overall Study|Protocol Violation|2|||
105422992|NCT02446418|363554273|FG000|Overall Study|Lack of Efficacy|2|||
105422993|NCT02446418|363554274|FG001|Overall Study|Lack of Efficacy|0|||
105422994|NCT02446418|363554273|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
105422995|NCT02446418|363554274|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
105422996|NCT01095653|363554279|FG000|Overall Study|Lack of Efficacy|3|||
105422997|NCT01095653|363554280|FG001|Overall Study|Lack of Efficacy|0|||
105422998|NCT01095653|363554281|FG002|Overall Study|Lack of Efficacy|0|||
105422999|NCT01095653|363554279|FG000|Overall Study|Adverse Event|1|||
105423000|NCT01095653|363554280|FG001|Overall Study|Adverse Event|4|||
105423001|NCT01095653|363554281|FG002|Overall Study|Adverse Event|4|||
105423002|NCT01095653|363554279|FG000|Overall Study|Lost to Follow-up|1|||
105423003|NCT01095653|363554280|FG001|Overall Study|Lost to Follow-up|0|||
105423004|NCT01095653|363554281|FG002|Overall Study|Lost to Follow-up|4|||
105423005|NCT01095653|363554279|FG000|Overall Study|Withdrawal by Subject|4|||
105501006|NCT00259610|363845768|FG000|Overall Study|Serious Adverse Event|8|||
105501007|NCT00259610|363845769|FG001|Overall Study|Serious Adverse Event|2|||
105501008|NCT00259610|363845770|FG002|Overall Study|Serious Adverse Event|2|||
105501009|NCT00259610|363845771|FG003|Overall Study|Serious Adverse Event|2|||
105501010|NCT00945893|363845773|FG000|Overall Study|Lost to Follow-up|2|||
105501011|NCT00945893|363845774|FG001|Overall Study|Lost to Follow-up|8|||
105501012|NCT00945893|363845773|FG000|Overall Study|Withdrawal of consent|1|||
105501013|NCT00945893|363845774|FG001|Overall Study|Withdrawal of consent|2|||
105501014|NCT03113071|363845775|FG000|Overall Study|Withdrawal by Subject|1|||
105501015|NCT03113071|363845776|FG001|Overall Study|Withdrawal by Subject|0|||
105501016|NCT01787331|363845779|FG000|Overall Study|Physician Decision|1|||
105501017|NCT01787331|363845779|FG000|Overall Study|Withdrawal by Subject|1|||
105501018|NCT03583697|363845781|FG000|Overall Study|Withdrawal by Subject|0|||
105501019|NCT03583697|363845782|FG001|Overall Study|Withdrawal by Subject|0|||
105501020|NCT03583697|363845783|FG002|Overall Study|Withdrawal by Subject|1|||
105501021|NCT03583697|363845781|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
105501022|NCT03583697|363845782|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
105501023|NCT03583697|363845783|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
105501024|NCT03607487|363845784|FG000|Overall Study|Withdrawal by Subject|2|||
105501025|NCT03607487|363845785|FG001|Overall Study|Withdrawal by Subject|0|||
105501026|NCT03607487|363845786|FG002|Overall Study|Withdrawal by Subject|0|||
105501027|NCT03607487|363845787|FG003|Overall Study|Withdrawal by Subject|1|||
105501028|NCT02867592|363845791|FG000|Overall Study|Adverse Event|3|||
105501029|NCT02867592|363845792|FG001|Overall Study|Adverse Event|0|||
105501030|NCT02867592|363845793|FG002|Overall Study|Adverse Event|2|||
105501031|NCT02867592|363845794|FG003|Overall Study|Adverse Event|1|||
105501032|NCT02867592|363845795|FG004|Overall Study|Adverse Event|1|||
105501033|NCT02867592|363845796|FG005|Overall Study|Adverse Event|5|||
105501034|NCT02867592|363845791|FG000|Overall Study|Death|0|||
105501035|NCT02867592|363845792|FG001|Overall Study|Death|0|||
105501036|NCT02867592|363845793|FG002|Overall Study|Death|0|||
105501037|NCT02867592|363845794|FG003|Overall Study|Death|1|||
105501038|NCT02867592|363845795|FG004|Overall Study|Death|0|||
105501039|NCT02867592|363845796|FG005|Overall Study|Death|1|||
105501040|NCT02867592|363845791|FG000|Overall Study|Lack of Efficacy|8|||
105501041|NCT02867592|363845792|FG001|Overall Study|Lack of Efficacy|10|||
105501042|NCT02867592|363845793|FG002|Overall Study|Lack of Efficacy|8|||
105501043|NCT02867592|363845794|FG003|Overall Study|Lack of Efficacy|8|||
105501044|NCT02867592|363845795|FG004|Overall Study|Lack of Efficacy|12|||
105501045|NCT02867592|363845796|FG005|Overall Study|Lack of Efficacy|17|||
105501046|NCT02867592|363845791|FG000|Overall Study|Physician Decision|1|||
105501047|NCT02867592|363845792|FG001|Overall Study|Physician Decision|2|||
105501048|NCT02867592|363845793|FG002|Overall Study|Physician Decision|2|||
105501049|NCT02867592|363845794|FG003|Overall Study|Physician Decision|0|||
105501050|NCT02867592|363845795|FG004|Overall Study|Physician Decision|5|||
105501051|NCT02867592|363845796|FG005|Overall Study|Physician Decision|1|||
105501052|NCT02867592|363845791|FG000|Overall Study|Protocol Violation|0|||
105501053|NCT02867592|363845792|FG001|Overall Study|Protocol Violation|0|||
105501054|NCT02867592|363845793|FG002|Overall Study|Protocol Violation|0|||
105501055|NCT02867592|363845794|FG003|Overall Study|Protocol Violation|0|||
105501056|NCT02867592|363845795|FG004|Overall Study|Protocol Violation|1|||
105501057|NCT02867592|363845796|FG005|Overall Study|Protocol Violation|1|||
105501058|NCT02867592|363845791|FG000|Overall Study|Withdrawal by Subject|0|||
105501059|NCT02867592|363845792|FG001|Overall Study|Withdrawal by Subject|1|||
105501060|NCT02867592|363845793|FG002|Overall Study|Withdrawal by Subject|0|||
105501061|NCT02867592|363845794|FG003|Overall Study|Withdrawal by Subject|1|||
105501062|NCT02867592|363845795|FG004|Overall Study|Withdrawal by Subject|3|||
105501063|NCT02867592|363845796|FG005|Overall Study|Withdrawal by Subject|3|||
105501064|NCT02867592|363845791|FG000|Overall Study|Ineligible|1|||
105501065|NCT02867592|363845792|FG001|Overall Study|Ineligible|1|||
105501066|NCT02867592|363845793|FG002|Overall Study|Ineligible|0|||
105501067|NCT02867592|363845794|FG003|Overall Study|Ineligible|0|||
105501068|NCT02867592|363845795|FG004|Overall Study|Ineligible|2|||
105501069|NCT02867592|363845796|FG005|Overall Study|Ineligible|0|||
105501070|NCT02867592|363845791|FG000|Overall Study|No Treatment|1|||
105501071|NCT02867592|363845792|FG001|Overall Study|No Treatment|0|||
105501072|NCT02867592|363845793|FG002|Overall Study|No Treatment|0|||
105501073|NCT02867592|363845794|FG003|Overall Study|No Treatment|0|||
105501074|NCT02867592|363845795|FG004|Overall Study|No Treatment|0|||
105501075|NCT02867592|363845796|FG005|Overall Study|No Treatment|0|||
105501076|NCT02867592|363845791|FG000|Overall Study|Still on Therapy|0|||
105501077|NCT02867592|363845792|FG001|Overall Study|Still on Therapy|0|||
105501078|NCT02867592|363845793|FG002|Overall Study|Still on Therapy|0|||
105501079|NCT02867592|363845794|FG003|Overall Study|Still on Therapy|0|||
105501080|NCT02867592|363845795|FG004|Overall Study|Still on Therapy|1|||
105501081|NCT02867592|363845796|FG005|Overall Study|Still on Therapy|0|||
105501082|NCT02867592|363845791|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
105586291|NCT02403323|364145715|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
105423006|NCT01095653|363554280|FG001|Overall Study|Withdrawal by Subject|5|||
105423007|NCT01095653|363554281|FG002|Overall Study|Withdrawal by Subject|3|||
105423008|NCT01095653|363554279|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
105423009|NCT01095653|363554280|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
105423010|NCT01095653|363554281|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
105423011|NCT01166373|363554282|FG000|Overall Study|Lost to Follow-up|3|||
105423012|NCT01166373|363554283|FG001|Overall Study|Lost to Follow-up|2|||
105423013|NCT01166373|363554284|FG002|Overall Study|Lost to Follow-up|2|||
105423014|NCT01166373|363554285|FG003|Overall Study|Lost to Follow-up|2|||
105423015|NCT01166373|363554282|FG000|Overall Study|Withdrawal by Subject|1|||
105423016|NCT01166373|363554283|FG001|Overall Study|Withdrawal by Subject|2|||
105423017|NCT01166373|363554284|FG002|Overall Study|Withdrawal by Subject|2|||
105423018|NCT01166373|363554285|FG003|Overall Study|Withdrawal by Subject|3|||
105423019|NCT01166373|363554282|FG000|Overall Study|Physician Decision|1|||
105423020|NCT01166373|363554283|FG001|Overall Study|Physician Decision|0|||
105423021|NCT01166373|363554284|FG002|Overall Study|Physician Decision|0|||
105423022|NCT01166373|363554285|FG003|Overall Study|Physician Decision|0|||
105423023|NCT02752958|363554286|FG000|Overall Study|Adverse Event|3|||
105423024|NCT02752958|363554286|FG000|Overall Study|Lost to Follow-up|1|||
105423025|NCT02752958|363554286|FG000|Overall Study|Protocol Violation|1|||
105423026|NCT02752958|363554286|FG000|Overall Study|Withdrawal by Subject|2|||
105423027|NCT02752958|363554286|FG000|Overall Study|Other (Reason not specified)|2|||
105423028|NCT03746600|363554287|FG000|Overall Study|Withdrawal by Subject|3|||
105423029|NCT03746600|363554288|FG001|Overall Study|Withdrawal by Subject|3|||
105423030|NCT03746600|363554287|FG000|Overall Study|dismissed from study|1|||
105423031|NCT03746600|363554288|FG001|Overall Study|dismissed from study|0|||
105423032|NCT03746600|363554287|FG000|Overall Study|Lost to Follow-up|1|||
105423033|NCT03746600|363554288|FG001|Overall Study|Lost to Follow-up|0|||
105423034|NCT00977938|363554289|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
105423035|NCT00977938|363554290|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
105423036|NCT00977938|363554291|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
105423037|NCT00977938|363554292|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
105423038|NCT00977938|363554289|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
105423039|NCT00977938|363554290|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
105423040|NCT00977938|363554291|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
105423041|NCT00977938|363554292|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
105423042|NCT00977938|363554289|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
105423043|NCT00977938|363554290|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
105423044|NCT00977938|363554291|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
105423045|NCT00977938|363554292|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
105423046|NCT00977938|363554289|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
105423047|NCT00977938|363554290|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
105423048|NCT00977938|363554291|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
105423049|NCT00977938|363554292|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
105423050|NCT00977938|363554289|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
105423051|NCT00977938|363554290|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
105423052|NCT00977938|363554291|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
105423053|NCT00977938|363554292|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
105423054|NCT00977938|363554289|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
105423055|NCT00977938|363554290|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
105423056|NCT00977938|363554291|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
105423057|NCT00977938|363554292|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
105423058|NCT02374814|363554303|FG000|Overall Study|Lost to Follow-up|1|||
105586292|NCT02403323|364145713|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
105423059|NCT02374814|363554304|FG001|Overall Study|Lost to Follow-up|1|||
105423060|NCT02374814|363554305|FG002|Overall Study|Lost to Follow-up|0|||
105423061|NCT02374814|363554306|FG003|Overall Study|Lost to Follow-up|1|||
105423062|NCT02374814|363554307|FG004|Overall Study|Lost to Follow-up|0|||
105423063|NCT02374814|363554308|FG005|Overall Study|Lost to Follow-up|0|||
105423064|NCT02374814|363554303|FG000|Overall Study|Withdrawal by Subject|0|||
105423065|NCT02374814|363554304|FG001|Overall Study|Withdrawal by Subject|0|||
105423066|NCT02374814|363554305|FG002|Overall Study|Withdrawal by Subject|1|||
105423067|NCT02374814|363554306|FG003|Overall Study|Withdrawal by Subject|1|||
105423068|NCT02374814|363554307|FG004|Overall Study|Withdrawal by Subject|0|||
105423069|NCT02374814|363554308|FG005|Overall Study|Withdrawal by Subject|0|||
105423070|NCT00884039|363554309|FG000|Overall Study|Withdrawal by Subject|0|||
105423071|NCT00884039|363554310|FG001|Overall Study|Withdrawal by Subject|1|||
105423072|NCT00884039|363554309|FG000|Overall Study|Lack of Efficacy|2|||
105423073|NCT00884039|363554310|FG001|Overall Study|Lack of Efficacy|0|||
105423074|NCT02182440|363554311|FG000|Overall Study|Adverse Event|0|||
105423075|NCT02182440|363554312|FG001|Overall Study|Adverse Event|1|||
105423076|NCT02182440|363554313|FG002|Overall Study|Adverse Event|0|||
105423077|NCT02182440|363554314|FG003|Overall Study|Adverse Event|0|||
105586293|NCT02403323|364145714|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
105586294|NCT02403323|364145715|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
105586295|NCT02403323|364145713|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
105586296|NCT02403323|364145714|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
105586297|NCT02403323|364145715|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
105586298|NCT02403323|364145713|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
105586299|NCT02403323|364145714|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
105586300|NCT02403323|364145715|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
105586301|NCT02403323|364145713|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
105586302|NCT02403323|364145714|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
105586303|NCT02403323|364145715|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
105586304|NCT02403323|364145713|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
105586305|NCT02403323|364145714|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
105586306|NCT02403323|364145715|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
105586307|NCT02403323|364145713|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
105586308|NCT02403323|364145714|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
105586309|NCT02403323|364145715|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
105586310|NCT02403323|364145713|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
105586311|NCT02403323|364145714|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
105586312|NCT02403323|364145715|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
105586313|NCT04824131|364145718|FG000|CAB LA Oral Phase|Adverse Event|1|||
105586314|NCT04824131|364145718|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
105586315|NCT04824131|364145718|FG000|Step 3|Withdrawal by Subject|2|||
105586316|NCT00121199|364145719|FG000|Overall Study|Adverse Event|11|||
105586317|NCT00121199|364145719|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
105586318|NCT00121199|364145719|FG000|Overall Study|Progression/Relapse|1|||
105586319|NCT00121199|364145719|FG000|Overall Study|Death|3|||
105586320|NCT00121199|364145719|FG000|Overall Study|Other - Not Protocol Specified|3|||
105586321|NCT00121199|364145719|FG000|Overall Study|Ineligible|9|||
105586322|NCT02820051|364145723|FG000|Overall Study|Lost to Follow-up|7|||
105586323|NCT02820051|364145724|FG001|Overall Study|Lost to Follow-up|4|||
105586324|NCT01723774|364145725|FG000|Neoadjuvant|Ki67 > 10%|4|||
105586325|NCT01723774|364145726|FG001|Neoadjuvant|Ki67 > 10%|0|||
105586326|NCT01723774|364145727|FG002|Neoadjuvant|Ki67 > 10%|10|||
105586327|NCT01723774|364145728|FG003|Neoadjuvant|Ki67 > 10%|0|||
105586328|NCT01723774|364145725|FG000|Neoadjuvant|Withdrawal by Subject|3|||
105586329|NCT01723774|364145726|FG001|Neoadjuvant|Withdrawal by Subject|1|||
105586330|NCT01723774|364145727|FG002|Neoadjuvant|Withdrawal by Subject|0|||
105586331|NCT01723774|364145728|FG003|Neoadjuvant|Withdrawal by Subject|0|||
105586332|NCT01723774|364145725|FG000|Neoadjuvant|Disease progression|0|||
105586333|NCT01723774|364145726|FG001|Neoadjuvant|Disease progression|1|||
105586334|NCT01723774|364145727|FG002|Neoadjuvant|Disease progression|1|||
105586335|NCT01723774|364145728|FG003|Neoadjuvant|Disease progression|0|||
105586336|NCT01723774|364145725|FG000|Neoadjuvant|Adverse Event|0|||
105586337|NCT01723774|364145726|FG001|Neoadjuvant|Adverse Event|1|||
105586338|NCT01723774|364145727|FG002|Neoadjuvant|Adverse Event|2|||
105586339|NCT01723774|364145728|FG003|Neoadjuvant|Adverse Event|0|||
105586340|NCT01723774|364145725|FG000|Neoadjuvant|High estradiol|0|||
105586341|NCT01723774|364145726|FG001|Neoadjuvant|High estradiol|1|||
105586342|NCT01723774|364145727|FG002|Neoadjuvant|High estradiol|0|||
105586343|NCT01723774|364145728|FG003|Neoadjuvant|High estradiol|0|||
105586344|NCT04956692|364145729|FG000|Overall Study|Death|115|||
105586345|NCT04956692|364145730|FG001|Overall Study|Death|47|||
105586346|NCT04956692|364145729|FG000|Overall Study|Lost to Follow-up|0|||
105586347|NCT04956692|364145730|FG001|Overall Study|Lost to Follow-up|1|||
105423078|NCT02182440|363554311|FG000|Overall Study|Death|31|||
105423079|NCT02182440|363554312|FG001|Overall Study|Death|8|||
105423080|NCT02182440|363554313|FG002|Overall Study|Death|5|||
105423081|NCT02182440|363554314|FG003|Overall Study|Death|16|||
105423082|NCT02182440|363554311|FG000|Overall Study|Protocol Violation|0|||
105423083|NCT02182440|363554312|FG001|Overall Study|Protocol Violation|1|||
105423084|NCT02182440|363554313|FG002|Overall Study|Protocol Violation|0|||
105423085|NCT02182440|363554314|FG003|Overall Study|Protocol Violation|0|||
105423086|NCT02182440|363554311|FG000|Overall Study|Physician Decision|1|||
105423087|NCT02182440|363554312|FG001|Overall Study|Physician Decision|0|||
105423088|NCT02182440|363554313|FG002|Overall Study|Physician Decision|0|||
105423089|NCT02182440|363554314|FG003|Overall Study|Physician Decision|0|||
105586348|NCT04956692|364145729|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
105586349|NCT04956692|364145730|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105586350|NCT04956692|364145729|FG000|Overall Study|Withdrawal by Subject|5|||
105586351|NCT04956692|364145730|FG001|Overall Study|Withdrawal by Subject|2|||
105586352|NCT04956692|364145729|FG000|Overall Study|Ongoing in Study|236|||
105586353|NCT04956692|364145730|FG001|Overall Study|Ongoing in Study|123|||
105586354|NCT00614744|364145736|FG000|Overall Study|Lost to Follow-up|5|||
105586355|NCT00614744|364145737|FG001|Overall Study|Lost to Follow-up|4|||
105423090|NCT02182440|363554311|FG000|Overall Study|Withdrawal by Subject|1|||
105586356|NCT00614744|364145736|FG000|Overall Study|Incomplete for Behavior Issues|0|||
105586357|NCT00614744|364145737|FG001|Overall Study|Incomplete for Behavior Issues|2|||
105586358|NCT01822821|364145740|FG000|Overall Study|Eligible surgery cancelled|1|||
105586359|NCT01822821|364145741|FG001|Overall Study|Eligible surgery cancelled|1|||
105586360|NCT01822821|364145740|FG000|Overall Study|Other reasons|1|||
105586361|NCT01822821|364145741|FG001|Overall Study|Other reasons|0|||
105586362|NCT02042443|364145742|FG000|Overall Study|Adverse Event|2|||
105586363|NCT02042443|364145743|FG001|Overall Study|Adverse Event|1|||
105586364|NCT02042443|364145742|FG000|Overall Study|Withdrawal by Subject|0|||
105586365|NCT02042443|364145743|FG001|Overall Study|Withdrawal by Subject|1|||
105586366|NCT02042443|364145742|FG000|Overall Study|Progression|21|||
105586367|NCT02042443|364145743|FG001|Overall Study|Progression|17|||
105586368|NCT02042443|364145742|FG000|Overall Study|not protocol specified|1|||
105586369|NCT02042443|364145743|FG001|Overall Study|not protocol specified|1|||
105586370|NCT02042443|364145742|FG000|Overall Study|Not eligible/not analyzable|3|||
105586371|NCT02042443|364145743|FG001|Overall Study|Not eligible/not analyzable|6|||
105586372|NCT02320253|364145745|FG000|Overall Study|Withdrawal by Subject|3|||
105586373|NCT02320253|364145746|FG001|Overall Study|Withdrawal by Subject|0|||
105586374|NCT02320253|364145747|FG002|Overall Study|Withdrawal by Subject|0|||
105586375|NCT02320253|364145745|FG000|Overall Study|Lost to Follow-up|2|||
105586376|NCT02320253|364145746|FG001|Overall Study|Lost to Follow-up|2|||
105586377|NCT02320253|364145747|FG002|Overall Study|Lost to Follow-up|1|||
105586378|NCT02320253|364145745|FG000|Overall Study|Death|1|||
105586379|NCT02320253|364145746|FG001|Overall Study|Death|0|||
105586380|NCT02320253|364145747|FG002|Overall Study|Death|1|||
105586381|NCT05750745|364145748|FG000|Overall Study|Adverse Event|1|||
105586382|NCT05750745|364145749|FG001|Overall Study|Adverse Event|0|||
105586383|NCT05750745|364145750|FG002|Overall Study|Adverse Event|0|||
105586384|NCT05750745|364145748|FG000|Overall Study|Protocol Violation|1|||
105586385|NCT05750745|364145749|FG001|Overall Study|Protocol Violation|0|||
105586386|NCT05750745|364145750|FG002|Overall Study|Protocol Violation|0|||
105586387|NCT05750745|364145748|FG000|Overall Study|Withdrawal by Subject|0|||
105586388|NCT05750745|364145749|FG001|Overall Study|Withdrawal by Subject|1|||
105586389|NCT05750745|364145750|FG002|Overall Study|Withdrawal by Subject|0|||
105586390|NCT04794179|364145751|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
105586391|NCT04794179|364145752|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
105586392|NCT05780047|364145753|FG000|Overall Study|Did not submit baseline urine test kit|226|||
105586393|NCT05780047|364145753|FG000|Overall Study|Lost to Follow-up|34|||
105586394|NCT05780047|364145753|FG000|Overall Study|Did not submit second urine test kit|124|||
105586395|NCT01458275|364145754|FG000|Overall Study|Adverse Event|3|||
105586396|NCT01458275|364145755|FG001|Overall Study|Adverse Event|4|||
105586397|NCT01458275|364145756|FG002|Overall Study|Adverse Event|1|||
105586398|NCT01458275|364145754|FG000|Overall Study|Lost to Follow-up|3|||
105586399|NCT01458275|364145755|FG001|Overall Study|Lost to Follow-up|2|||
105586400|NCT01458275|364145756|FG002|Overall Study|Lost to Follow-up|5|||
105586401|NCT01458275|364145754|FG000|Overall Study|Protocol Violation|5|||
105586402|NCT01458275|364145755|FG001|Overall Study|Protocol Violation|5|||
105586403|NCT01458275|364145756|FG002|Overall Study|Protocol Violation|2|||
105586404|NCT01458275|364145754|FG000|Overall Study|Withdrawal by Subject|3|||
105586405|NCT01458275|364145755|FG001|Overall Study|Withdrawal by Subject|2|||
105586406|NCT01458275|364145756|FG002|Overall Study|Withdrawal by Subject|1|||
105586407|NCT02189863|364145757|FG000|First 2 Weeks|Motion Sickness|4|||
105586408|NCT02189863|364145758|FG001|First 2 Weeks|Motion Sickness|2|||
105586409|NCT03697460|364145759|FG000|Overall Study|Withdrawal by Subject|3|||
105586410|NCT04949399|364145760|FG000|Overall Study|Lost to Follow-up|11|||
105586411|NCT04949399|364145761|FG001|Overall Study|Lost to Follow-up|6|||
105586412|NCT04949399|364145760|FG000|Overall Study|Withdrawal by Subject|2|||
105586413|NCT04949399|364145761|FG001|Overall Study|Withdrawal by Subject|3|||
105586414|NCT01515319|364145762|FG000|Overall Study|Withdrawal by Subject|0|||
105586415|NCT01515319|364145763|FG001|Overall Study|Withdrawal by Subject|0|||
105423091|NCT02182440|363554312|FG001|Overall Study|Withdrawal by Subject|1|||
105423092|NCT02182440|363554313|FG002|Overall Study|Withdrawal by Subject|3|||
105586416|NCT01515319|364145764|FG002|Overall Study|Withdrawal by Subject|0|||
105586417|NCT01515319|364145765|FG003|Overall Study|Withdrawal by Subject|0|||
105586418|NCT01515319|364145766|FG004|Overall Study|Withdrawal by Subject|0|||
105586419|NCT01515319|364145767|FG005|Overall Study|Withdrawal by Subject|0|||
105586420|NCT01515319|364145768|FG006|Overall Study|Withdrawal by Subject|1|||
105586421|NCT01515319|364145769|FG007|Overall Study|Withdrawal by Subject|0|||
105586422|NCT01515319|364145770|FG008|Overall Study|Withdrawal by Subject|0|||
105423093|NCT02182440|363554314|FG003|Overall Study|Withdrawal by Subject|4|||
105586423|NCT01515319|364145771|FG009|Overall Study|Withdrawal by Subject|0|||
105586424|NCT01515319|364145762|FG000|Overall Study|Adverse Event|0|||
105586425|NCT01515319|364145763|FG001|Overall Study|Adverse Event|0|||
105586426|NCT01515319|364145764|FG002|Overall Study|Adverse Event|0|||
105586427|NCT01515319|364145765|FG003|Overall Study|Adverse Event|0|||
105586428|NCT01515319|364145766|FG004|Overall Study|Adverse Event|0|||
105586429|NCT01515319|364145767|FG005|Overall Study|Adverse Event|0|||
105423094|NCT02182440|363554311|FG000|Overall Study|different, e.g adm other hospital|12|||
105423095|NCT02182440|363554312|FG001|Overall Study|different, e.g adm other hospital|3|||
105423096|NCT02182440|363554313|FG002|Overall Study|different, e.g adm other hospital|3|||
105423097|NCT02182440|363554314|FG003|Overall Study|different, e.g adm other hospital|10|||
105423098|NCT00624819|363554315|FG000|Follow-up Period: Year 4|Parents decision|0|||
105423099|NCT00624819|363554316|FG001|Follow-up Period: Year 4|Parents decision|0|||
105423100|NCT00624819|363554317|FG002|Follow-up Period: Year 4|Parents decision|1|||
105423101|NCT00624819|363554318|FG003|Follow-up Period: Year 4|Parents decision|0|||
105423102|NCT00624819|363554315|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
105423103|NCT00624819|363554316|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
105423104|NCT00624819|363554317|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
105423105|NCT00624819|363554318|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
105423106|NCT01440517|363556309|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
105423107|NCT00642174|363556317|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
105423108|NCT00642174|363556318|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
105423109|NCT00896363|363556319|FG000|Overall Study|Adverse Event|3|||
105423110|NCT00896363|363556320|FG001|Overall Study|Adverse Event|4|||
105423111|NCT00896363|363556321|FG002|Overall Study|Adverse Event|2|||
105423112|NCT00896363|363556319|FG000|Overall Study|Lack of Efficacy|0|||
105423113|NCT00896363|363556320|FG001|Overall Study|Lack of Efficacy|2|||
105423114|NCT00896363|363556321|FG002|Overall Study|Lack of Efficacy|1|||
105423115|NCT00896363|363556319|FG000|Overall Study|Withdrawal by Subject|3|||
105423116|NCT00896363|363556320|FG001|Overall Study|Withdrawal by Subject|5|||
105423117|NCT00896363|363556321|FG002|Overall Study|Withdrawal by Subject|5|||
105423118|NCT00416715|363556322|FG000|Overall Study|Not evaluable for joint aches|7|||
105423119|NCT00416715|363556322|FG000|Overall Study|Vitamin D levels not evaluable|8|||
105423120|NCT03505788|363556323|FG000|Overall Study|Lost to Follow-up|2|||
105423121|NCT03505788|363556324|FG001|Overall Study|Lost to Follow-up|1|||
105423122|NCT03505788|363556323|FG000|Overall Study|Withdrawal by Subject|1|||
105423123|NCT03505788|363556324|FG001|Overall Study|Withdrawal by Subject|3|||
105423124|NCT03505788|363556323|FG000|Overall Study|Physician Decision|0|||
105423125|NCT03505788|363556324|FG001|Overall Study|Physician Decision|1|||
105423126|NCT00496197|363556328|FG000|Overall Study|Discontinued study due to death|43|||
105423127|NCT00496197|363556328|FG000|Overall Study|Adverse Event|13|||
105423128|NCT00496197|363556328|FG000|Overall Study|Does not meet entrance criteria|5|||
105423129|NCT00496197|363556328|FG000|Overall Study|Insufficient clinical response|3|||
105423130|NCT00496197|363556328|FG000|Overall Study|Insufficient bacteriological response|10|||
105423131|NCT00496197|363556328|FG000|Overall Study|Lost to Follow-up|11|||
105423132|NCT00496197|363556328|FG000|Overall Study|Withdrawal by Subject|11|||
105423133|NCT00496197|363556328|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
105423134|NCT00496197|363556328|FG000|Overall Study|Other|14|||
105423135|NCT00496197|363556328|FG000|Overall Study|Protocol Violation|8|||
105423136|NCT00320255|363556331|FG000|Overall Study|Lack of Efficacy|1|||
105423137|NCT00320255|363556332|FG001|Overall Study|Lack of Efficacy|0|||
105423138|NCT00320255|363556333|FG002|Overall Study|Lack of Efficacy|0|||
105423139|NCT00320255|363556334|FG003|Overall Study|Lack of Efficacy|0|||
105423140|NCT00320255|363556335|FG004|Overall Study|Lack of Efficacy|0|||
105423141|NCT00320255|363556336|FG005|Overall Study|Lack of Efficacy|0|||
105423142|NCT00320255|363556331|FG000|Overall Study|Adverse Event|5|||
105423143|NCT00320255|363556332|FG001|Overall Study|Adverse Event|2|||
105423144|NCT00320255|363556333|FG002|Overall Study|Adverse Event|3|||
105423145|NCT00320255|363556334|FG003|Overall Study|Adverse Event|2|||
105423146|NCT00320255|363556335|FG004|Overall Study|Adverse Event|0|||
105423147|NCT00320255|363556336|FG005|Overall Study|Adverse Event|0|||
105423148|NCT00320255|363556331|FG000|Overall Study|Withdrawal by Subject|1|||
105423149|NCT00320255|363556332|FG001|Overall Study|Withdrawal by Subject|2|||
105423150|NCT00320255|363556333|FG002|Overall Study|Withdrawal by Subject|2|||
105423151|NCT00320255|363556334|FG003|Overall Study|Withdrawal by Subject|4|||
105423152|NCT00320255|363556335|FG004|Overall Study|Withdrawal by Subject|0|||
105423153|NCT00320255|363556336|FG005|Overall Study|Withdrawal by Subject|0|||
105423154|NCT00320255|363556331|FG000|Overall Study|Poor compliance/noncompliance|1|||
105423155|NCT00320255|363556332|FG001|Overall Study|Poor compliance/noncompliance|1|||
105423156|NCT00320255|363556333|FG002|Overall Study|Poor compliance/noncompliance|0|||
105423157|NCT00320255|363556334|FG003|Overall Study|Poor compliance/noncompliance|1|||
105423158|NCT00320255|363556335|FG004|Overall Study|Poor compliance/noncompliance|0|||
105423159|NCT00320255|363556336|FG005|Overall Study|Poor compliance/noncompliance|0|||
105423160|NCT00320255|363556331|FG000|Overall Study|No longer meets study criteria|0|||
105423161|NCT00320255|363556332|FG001|Overall Study|No longer meets study criteria|0|||
105423162|NCT00320255|363556333|FG002|Overall Study|No longer meets study criteria|0|||
105423163|NCT00320255|363556334|FG003|Overall Study|No longer meets study criteria|1|||
105423164|NCT00320255|363556335|FG004|Overall Study|No longer meets study criteria|0|||
105586430|NCT01515319|364145768|FG006|Overall Study|Adverse Event|0|||
105423165|NCT00320255|363556336|FG005|Overall Study|No longer meets study criteria|0|||
105423166|NCT00320255|363556331|FG000|Overall Study|Other|3|||
105423167|NCT00320255|363556332|FG001|Overall Study|Other|2|||
105423168|NCT00320255|363556333|FG002|Overall Study|Other|1|||
105586431|NCT01515319|364145769|FG007|Overall Study|Adverse Event|0|||
105586432|NCT01515319|364145770|FG008|Overall Study|Adverse Event|3|||
105586433|NCT01515319|364145771|FG009|Overall Study|Adverse Event|0|||
105586434|NCT01515319|364145762|FG000|Overall Study|Protocol Violation|0|||
105586435|NCT01515319|364145763|FG001|Overall Study|Protocol Violation|0|||
105586436|NCT01515319|364145764|FG002|Overall Study|Protocol Violation|0|||
105586437|NCT01515319|364145765|FG003|Overall Study|Protocol Violation|0|||
105586438|NCT01515319|364145766|FG004|Overall Study|Protocol Violation|0|||
105586439|NCT01515319|364145767|FG005|Overall Study|Protocol Violation|0|||
105586440|NCT01515319|364145768|FG006|Overall Study|Protocol Violation|0|||
105586441|NCT01515319|364145769|FG007|Overall Study|Protocol Violation|0|||
105586442|NCT01515319|364145770|FG008|Overall Study|Protocol Violation|2|||
105586443|NCT01515319|364145771|FG009|Overall Study|Protocol Violation|0|||
105586444|NCT04159506|364145772|FG000|Overall Study|Lost to Follow-up|2|||
105586445|NCT04159506|364145773|FG001|Overall Study|Lost to Follow-up|5|||
105586446|NCT02401529|364147287|FG000|Overall Study|Lost to Follow-up|2|||
105586447|NCT02401529|364147288|FG001|Overall Study|Lost to Follow-up|1|||
105586448|NCT02401529|364147287|FG000|Overall Study|Physician Decision|2|||
105586449|NCT02401529|364147288|FG001|Overall Study|Physician Decision|6|||
105586450|NCT02401529|364147287|FG000|Overall Study|Protocol Violation|5|||
105586451|NCT02401529|364147288|FG001|Overall Study|Protocol Violation|0|||
105586452|NCT02491411|364147289|FG000|Overall Study|Physician Decision|4|||
105586453|NCT04034238|364147290|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
105586454|NCT04034238|364147291|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
105586455|NCT04034238|364147292|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
105586456|NCT04034238|364147293|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
105586457|NCT04034238|364147290|FG000|Dose Escalation Phase|Screen failures|0|||
105586458|NCT04034238|364147291|FG001|Dose Escalation Phase|Screen failures|0|||
105586459|NCT04034238|364147292|FG002|Dose Escalation Phase|Screen failures|0|||
105586460|NCT04034238|364147293|FG003|Dose Escalation Phase|Screen failures|2|||
105586461|NCT04034238|364147290|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
105586462|NCT04034238|364147291|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
105586463|NCT04034238|364147292|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
105586464|NCT04034238|364147293|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
105586465|NCT04034238|364147290|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
105586466|NCT04034238|364147291|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
105586467|NCT04034238|364147292|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
105586468|NCT04034238|364147293|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
105586469|NCT01304706|364147294|FG000|Overall Study|Adverse Event|2|||
105586470|NCT01304706|364147294|FG000|Overall Study|Lack of Efficacy|1|||
105586471|NCT01304706|364147294|FG000|Overall Study|Death|3|||
105586472|NCT01304706|364147294|FG000|Overall Study|Withdrawal by Subject|3|||
105586473|NCT01304706|364147294|FG000|Overall Study|Lost to Follow-up|7|||
105586474|NCT01304706|364147294|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
105586475|NCT04978363|364147298|FG000|Overall Study|Other medical issues unrelated to the study|0|||
105586476|NCT04978363|364147299|FG001|Overall Study|Other medical issues unrelated to the study|0|||
105423169|NCT00320255|363556334|FG003|Overall Study|Other|0|||
105423170|NCT00320255|363556335|FG004|Overall Study|Other|0|||
105423171|NCT00320255|363556336|FG005|Overall Study|Other|0|||
105423172|NCT04195438|363556342|FG000|Overall Study|Withdrawal by Subject|1|||
105423173|NCT01774097|363556343|FG000|Overall Study|Withdrawal by Subject|1|||
105423174|NCT01774097|363556344|FG001|Overall Study|Withdrawal by Subject|1|||
105423175|NCT01774097|363556343|FG000|Overall Study|Adverse Event|1|||
105423176|NCT01774097|363556344|FG001|Overall Study|Adverse Event|1|||
105423177|NCT00613925|363556345|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
105423178|NCT00613925|363556346|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
105423179|NCT00543296|363556349|FG000|Overall Study|Physician Decision|7|||
105423180|NCT00934947|363556352|FG000|Overall Study|Adverse Event|0|||
105423181|NCT00934947|363556353|FG001|Overall Study|Adverse Event|2|||
105423182|NCT03447314|363556359|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
105423183|NCT03447314|363556360|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
105423184|NCT03447314|363556361|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
105423185|NCT03447314|363556362|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
105423186|NCT03447314|363556363|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
105586477|NCT04978363|364147300|FG002|Overall Study|Other medical issues unrelated to the study|0|||
105586478|NCT04978363|364147301|FG003|Overall Study|Other medical issues unrelated to the study|0|||
105586479|NCT04978363|364147302|FG004|Overall Study|Other medical issues unrelated to the study|1|||
105586480|NCT04978363|364147303|FG005|Overall Study|Other medical issues unrelated to the study|0|||
105586481|NCT04978363|364147304|FG006|Overall Study|Other medical issues unrelated to the study|0|||
105586482|NCT04978363|364147305|FG007|Overall Study|Other medical issues unrelated to the study|0|||
105586483|NCT04978363|364147306|FG008|Overall Study|Other medical issues unrelated to the study|0|||
105586484|NCT04978363|364147307|FG009|Overall Study|Other medical issues unrelated to the study|0|||
105423187|NCT03447314|363556364|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
105423188|NCT03447314|363556365|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
105423189|NCT03447314|363556366|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105423190|NCT03447314|363556367|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105423191|NCT03447314|363556368|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105423192|NCT03447314|363556369|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
105423193|NCT03447314|363556370|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
105423194|NCT03447314|363556371|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105423195|NCT03447314|363556372|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105423196|NCT03447314|363556373|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105423197|NCT03447314|363556374|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105423198|NCT03447314|363556375|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105423199|NCT03447314|363556376|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105423200|NCT03447314|363556359|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
105423201|NCT03447314|363556360|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105423202|NCT03447314|363556361|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
105423203|NCT03447314|363556362|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105423204|NCT03447314|363556363|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105423205|NCT03447314|363556364|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
105423206|NCT03447314|363556365|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
105423207|NCT03447314|363556366|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105423208|NCT03447314|363556367|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105423209|NCT03447314|363556368|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105423210|NCT03447314|363556369|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105423211|NCT03447314|363556370|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105423212|NCT03447314|363556371|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105423213|NCT03447314|363556372|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105423214|NCT03447314|363556373|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105423215|NCT03447314|363556374|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105423216|NCT03447314|363556375|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105423217|NCT03447314|363556376|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105423218|NCT03447314|363556359|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423219|NCT03447314|363556360|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423220|NCT03447314|363556361|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
105423221|NCT03447314|363556362|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423222|NCT03447314|363556363|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423223|NCT03447314|363556364|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423224|NCT03447314|363556365|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423225|NCT03447314|363556366|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423226|NCT03447314|363556367|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423227|NCT03447314|363556368|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423228|NCT03447314|363556369|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423229|NCT03447314|363556370|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423230|NCT03447314|363556371|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423231|NCT03447314|363556372|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423232|NCT03447314|363556373|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423233|NCT03447314|363556374|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423234|NCT03447314|363556375|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423235|NCT03447314|363556376|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105423236|NCT03447314|363556359|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423237|NCT03447314|363556360|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423238|NCT03447314|363556361|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
105423239|NCT03447314|363556362|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423240|NCT03447314|363556363|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423241|NCT03447314|363556364|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423242|NCT03447314|363556365|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423243|NCT03447314|363556366|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423244|NCT03447314|363556367|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423245|NCT03447314|363556368|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423246|NCT03447314|363556369|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423247|NCT03447314|363556370|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423248|NCT03447314|363556371|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423249|NCT03447314|363556372|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423250|NCT03447314|363556373|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423251|NCT03447314|363556374|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423252|NCT03447314|363556375|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423253|NCT03447314|363556376|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105423254|NCT03447314|363556359|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423255|NCT03447314|363556360|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423256|NCT03447314|363556361|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423257|NCT03447314|363556362|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423258|NCT03447314|363556363|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423259|NCT03447314|363556364|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423260|NCT03447314|363556365|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423261|NCT03447314|363556366|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423262|NCT03447314|363556367|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423263|NCT03447314|363556368|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423264|NCT03447314|363556369|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
105423265|NCT03447314|363556370|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423266|NCT03447314|363556371|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423267|NCT03447314|363556372|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423268|NCT03447314|363556373|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423269|NCT03447314|363556374|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423270|NCT03447314|363556375|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423271|NCT03447314|363556376|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105423272|NCT03447314|363556359|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423273|NCT03447314|363556360|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423274|NCT03447314|363556361|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423275|NCT03447314|363556362|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
105423276|NCT03447314|363556363|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423277|NCT03447314|363556364|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
105423278|NCT03447314|363556365|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423279|NCT03447314|363556366|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423280|NCT03447314|363556367|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423281|NCT03447314|363556368|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423282|NCT03447314|363556369|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423283|NCT03447314|363556370|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423284|NCT03447314|363556371|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423285|NCT03447314|363556372|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423286|NCT03447314|363556373|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423287|NCT03447314|363556374|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423288|NCT03447314|363556375|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423289|NCT03447314|363556376|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105423290|NCT01920568|363556377|FG000|Overall Study|Adverse Event|27|||
105423291|NCT01920568|363556378|FG001|Overall Study|Adverse Event|8|||
105423292|NCT01920568|363556377|FG000|Overall Study|Protocol Violation|5|||
105423293|NCT01920568|363556378|FG001|Overall Study|Protocol Violation|3|||
105423294|NCT01920568|363556377|FG000|Overall Study|Lost to Follow-up|2|||
105423295|NCT01920568|363556378|FG001|Overall Study|Lost to Follow-up|2|||
105423296|NCT01920568|363556377|FG000|Overall Study|Physician Decision|13|||
105423297|NCT01920568|363556378|FG001|Overall Study|Physician Decision|4|||
105423298|NCT01920568|363556377|FG000|Overall Study|Withdrawal by Subject|79|||
105423299|NCT01920568|363556378|FG001|Overall Study|Withdrawal by Subject|55|||
105423300|NCT01920568|363556377|FG000|Overall Study|Death due to disease progression|25|||
105423301|NCT01920568|363556378|FG001|Overall Study|Death due to disease progression|12|||
105423302|NCT01818258|363556380|FG000|Overall Study|Death|3|||
105423303|NCT01818258|363556381|FG001|Overall Study|Death|0|||
105423304|NCT01818258|363556380|FG000|Overall Study|Withdrawal by Subject|0|||
105423305|NCT01818258|363556381|FG001|Overall Study|Withdrawal by Subject|1|||
105423306|NCT01818258|363556380|FG000|Overall Study|Lost to Follow-up|0|||
105423307|NCT01818258|363556381|FG001|Overall Study|Lost to Follow-up|1|||
105423308|NCT01818258|363556380|FG000|Overall Study|Unable to Travel to Clinic|0|||
105423309|NCT01818258|363556381|FG001|Overall Study|Unable to Travel to Clinic|1|||
105423310|NCT02891681|363556383|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
105586485|NCT04978363|364147308|FG010|Overall Study|Other medical issues unrelated to the study|0|||
105586486|NCT04978363|364147298|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
105586487|NCT04978363|364147299|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
105586488|NCT04978363|364147300|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
105586489|NCT04978363|364147301|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
105586490|NCT04978363|364147302|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
105586491|NCT04978363|364147303|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
105586492|NCT04978363|364147304|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
105586493|NCT04978363|364147305|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
105586494|NCT04978363|364147306|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
105586495|NCT04978363|364147307|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
105586496|NCT04978363|364147308|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
105586497|NCT04978363|364147298|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
105586498|NCT04978363|364147299|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
105586499|NCT04978363|364147300|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
105586500|NCT04978363|364147301|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
105586501|NCT04978363|364147302|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
105586502|NCT04978363|364147303|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
105586503|NCT04978363|364147304|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
105586504|NCT04978363|364147305|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
105586505|NCT04978363|364147306|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
105586506|NCT04978363|364147307|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
105586507|NCT04978363|364147308|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
105586508|NCT01251614|364147309|FG000|Overall Study|Adverse Event|1|||
105586509|NCT01251614|364147310|FG001|Overall Study|Adverse Event|0|||
105586510|NCT01251614|364147311|FG002|Overall Study|Adverse Event|1|||
105586511|NCT01251614|364147309|FG000|Overall Study|Lack of Efficacy|1|||
105586512|NCT01251614|364147310|FG001|Overall Study|Lack of Efficacy|9|||
105586513|NCT01251614|364147311|FG002|Overall Study|Lack of Efficacy|4|||
105586514|NCT01251614|364147309|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
105586515|NCT01251614|364147310|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
105586516|NCT01251614|364147311|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
105586517|NCT01251614|364147309|FG000|Overall Study|Pregnancy|0|||
105586518|NCT01251614|364147310|FG001|Overall Study|Pregnancy|0|||
105586519|NCT01251614|364147311|FG002|Overall Study|Pregnancy|2|||
105586520|NCT01251614|364147309|FG000|Overall Study|Loss of Disease Control|0|||
105586521|NCT01251614|364147310|FG001|Overall Study|Loss of Disease Control|1|||
105586522|NCT01251614|364147311|FG002|Overall Study|Loss of Disease Control|0|||
105586523|NCT01251614|364147309|FG000|Overall Study|Withdrawal by Subject|0|||
105586524|NCT01251614|364147310|FG001|Overall Study|Withdrawal by Subject|2|||
105586525|NCT01251614|364147311|FG002|Overall Study|Withdrawal by Subject|1|||
105586526|NCT01251614|364147309|FG000|Overall Study|Lost to Follow-up|0|||
105586527|NCT01251614|364147310|FG001|Overall Study|Lost to Follow-up|1|||
105586528|NCT01251614|364147311|FG002|Overall Study|Lost to Follow-up|0|||
105586529|NCT04672460|364147312|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
105586530|NCT04672460|364147313|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
105586531|NCT04672460|364147312|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
105586532|NCT04672460|364147313|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
105586533|NCT04672460|364147312|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
105586534|NCT04672460|364147313|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
105586535|NCT04672460|364147312|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
105586536|NCT04672460|364147313|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
105586537|NCT04672460|364147312|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
105586538|NCT04672460|364147313|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
105586539|NCT04672460|364147312|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
105586540|NCT04672460|364147313|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
105586541|NCT04672460|364147312|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
105586542|NCT04672460|364147313|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
105586543|NCT04672460|364147312|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
105586544|NCT04672460|364147313|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
105586545|NCT04672460|364147312|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
105586546|NCT04672460|364147313|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
105586547|NCT04672460|364147312|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
105586548|NCT04672460|364147313|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
105586549|NCT04672460|364147312|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
105586550|NCT04672460|364147313|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
105586551|NCT04672460|364147312|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
105586552|NCT04672460|364147313|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
105586553|NCT04672460|364147312|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
105586554|NCT04672460|364147313|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
105586555|NCT04672460|364147312|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
105586556|NCT04672460|364147313|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
105586557|NCT04672460|364147312|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
105586558|NCT04672460|364147313|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
105586559|NCT04672460|364147312|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
105586560|NCT04672460|364147313|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
105586561|NCT04672460|364147312|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
105586562|NCT04672460|364147313|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
105586563|NCT00049517|364147314|FG000|Induction|Disease progression|0|||
105586564|NCT00049517|364147315|FG001|Induction|Disease progression|0|||
105586565|NCT00049517|364147316|FG002|Induction|Disease progression|0|||
105586566|NCT00049517|364147317|FG003|Induction|Disease progression|0|||
105586567|NCT00049517|364147318|FG004|Induction|Disease progression|18|||
105586568|NCT00049517|364147319|FG005|Induction|Disease progression|11|||
105586569|NCT00049517|364147314|FG000|Induction|Adverse Event|0|||
105586570|NCT00049517|364147315|FG001|Induction|Adverse Event|0|||
105586571|NCT00049517|364147316|FG002|Induction|Adverse Event|0|||
105586572|NCT00049517|364147317|FG003|Induction|Adverse Event|0|||
105586573|NCT00049517|364147318|FG004|Induction|Adverse Event|5|||
105586574|NCT00049517|364147319|FG005|Induction|Adverse Event|7|||
105586575|NCT00049517|364147314|FG000|Induction|Death|0|||
105586576|NCT00049517|364147315|FG001|Induction|Death|0|||
105586577|NCT00049517|364147316|FG002|Induction|Death|0|||
105586578|NCT00049517|364147317|FG003|Induction|Death|0|||
105586579|NCT00049517|364147318|FG004|Induction|Death|9|||
105586580|NCT00049517|364147319|FG005|Induction|Death|6|||
105586581|NCT00049517|364147314|FG000|Induction|Withdrawal by Subject|0|||
105586582|NCT00049517|364147315|FG001|Induction|Withdrawal by Subject|0|||
105586583|NCT00049517|364147316|FG002|Induction|Withdrawal by Subject|0|||
105586584|NCT00049517|364147317|FG003|Induction|Withdrawal by Subject|0|||
105586585|NCT00049517|364147318|FG004|Induction|Withdrawal by Subject|1|||
105586586|NCT00049517|364147319|FG005|Induction|Withdrawal by Subject|3|||
105586587|NCT00049517|364147314|FG000|Induction|Alternative therapy|0|||
105586588|NCT00049517|364147315|FG001|Induction|Alternative therapy|0|||
105586589|NCT00049517|364147316|FG002|Induction|Alternative therapy|0|||
105586590|NCT00049517|364147317|FG003|Induction|Alternative therapy|0|||
105586591|NCT00049517|364147318|FG004|Induction|Alternative therapy|2|||
105586592|NCT00049517|364147319|FG005|Induction|Alternative therapy|2|||
105586593|NCT00049517|364147314|FG000|Induction|Other complicating disease|0|||
105586594|NCT00049517|364147315|FG001|Induction|Other complicating disease|0|||
105586595|NCT00049517|364147316|FG002|Induction|Other complicating disease|0|||
105586596|NCT00049517|364147317|FG003|Induction|Other complicating disease|0|||
105586597|NCT00049517|364147318|FG004|Induction|Other complicating disease|3|||
105586598|NCT00049517|364147319|FG005|Induction|Other complicating disease|0|||
105586599|NCT00049517|364147314|FG000|Induction|Reasons not reported|0|||
105586600|NCT00049517|364147315|FG001|Induction|Reasons not reported|0|||
105586601|NCT00049517|364147316|FG002|Induction|Reasons not reported|0|||
105586602|NCT00049517|364147317|FG003|Induction|Reasons not reported|0|||
105586603|NCT00049517|364147318|FG004|Induction|Reasons not reported|22|||
105586604|NCT00049517|364147319|FG005|Induction|Reasons not reported|25|||
105586605|NCT00049517|364147314|FG000|Conditioning/Transplant|Disease progression|14|||
105586606|NCT00049517|364147315|FG001|Conditioning/Transplant|Disease progression|6|||
105586607|NCT00049517|364147316|FG002|Conditioning/Transplant|Disease progression|10|||
105586608|NCT00049517|364147317|FG003|Conditioning/Transplant|Disease progression|6|||
105586609|NCT00049517|364147318|FG004|Conditioning/Transplant|Disease progression|0|||
105586610|NCT00049517|364147319|FG005|Conditioning/Transplant|Disease progression|0|||
105586611|NCT00049517|364147314|FG000|Conditioning/Transplant|Adverse Event|2|||
105586612|NCT00049517|364147315|FG001|Conditioning/Transplant|Adverse Event|1|||
105586613|NCT00049517|364147316|FG002|Conditioning/Transplant|Adverse Event|4|||
105586614|NCT00049517|364147317|FG003|Conditioning/Transplant|Adverse Event|8|||
105586615|NCT00049517|364147318|FG004|Conditioning/Transplant|Adverse Event|0|||
105586616|NCT00049517|364147319|FG005|Conditioning/Transplant|Adverse Event|0|||
105586617|NCT00049517|364147314|FG000|Conditioning/Transplant|Death|1|||
105586618|NCT00049517|364147315|FG001|Conditioning/Transplant|Death|0|||
105586619|NCT00049517|364147316|FG002|Conditioning/Transplant|Death|0|||
105586620|NCT00049517|364147317|FG003|Conditioning/Transplant|Death|2|||
105586621|NCT00049517|364147318|FG004|Conditioning/Transplant|Death|0|||
105586622|NCT00049517|364147319|FG005|Conditioning/Transplant|Death|0|||
105586623|NCT00049517|364147314|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
105586624|NCT00049517|364147315|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
105586625|NCT00049517|364147316|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
105423311|NCT02891681|363556384|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
105423312|NCT02891681|363556385|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
105423313|NCT02891681|363556383|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
105423314|NCT02891681|363556384|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
105423315|NCT02891681|363556385|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
105423316|NCT02891681|363556383|FG000|Overall Study|Taken off study after first imaging appointment|1|||
105423317|NCT02891681|363556384|FG001|Overall Study|Taken off study after first imaging appointment|0|||
105423318|NCT02891681|363556385|FG002|Overall Study|Taken off study after first imaging appointment|0|||
105423319|NCT01342965|363556387|FG000|Overall Study|Death|58|||
105423320|NCT01342965|363556388|FG001|Overall Study|Death|57|||
105423321|NCT01342965|363556387|FG000|Overall Study|Lost to Follow-up|5|||
105423322|NCT01342965|363556388|FG001|Overall Study|Lost to Follow-up|3|||
105423323|NCT01342965|363556387|FG000|Overall Study|Other Reasons- Unspecified|44|||
105423324|NCT01342965|363556388|FG001|Overall Study|Other Reasons- Unspecified|38|||
105423325|NCT01342965|363556387|FG000|Overall Study|Withdrawal by Subject|2|||
105423326|NCT01342965|363556388|FG001|Overall Study|Withdrawal by Subject|9|||
105423327|NCT01327053|363556404|FG000|Overall Study|Adverse Event|23|||
105423328|NCT01327053|363556405|FG001|Overall Study|Adverse Event|57|||
105423329|NCT01327053|363556404|FG000|Overall Study|Patient/guardian decision|11|||
105423330|NCT01327053|363556405|FG001|Overall Study|Patient/guardian decision|35|||
105423331|NCT01327053|363556404|FG000|Overall Study|Physician Decision|10|||
105423332|NCT01327053|363556405|FG001|Overall Study|Physician Decision|14|||
105423333|NCT01327053|363556404|FG000|Overall Study|Death|1|||
105423334|NCT01327053|363556405|FG001|Overall Study|Death|5|||
105423335|NCT01327053|363556404|FG000|Overall Study|Lost to Follow-up|2|||
105423336|NCT01327053|363556405|FG001|Overall Study|Lost to Follow-up|4|||
105423337|NCT01327053|363556404|FG000|Overall Study|Non-compliance with study treatment|0|||
105423338|NCT01327053|363556405|FG001|Overall Study|Non-compliance with study treatment|5|||
105423339|NCT01327053|363556404|FG000|Overall Study|Study terminated by Sponsor|1|||
105423340|NCT01327053|363556405|FG001|Overall Study|Study terminated by Sponsor|3|||
105501083|NCT02867592|363845792|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
105501084|NCT02867592|363845793|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
105501085|NCT02867592|363845794|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
105501086|NCT02867592|363845795|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
105501087|NCT02867592|363845796|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
105501088|NCT02867592|363845791|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
105501089|NCT02867592|363845792|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
105501090|NCT02867592|363845793|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
105501091|NCT02867592|363845794|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
105501092|NCT02867592|363845795|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
105501093|NCT02867592|363845796|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
105501094|NCT04560998|363845797|FG000|Overall Study|Withdrawal by Subject|18|||
105501095|NCT04560998|363845798|FG001|Overall Study|Withdrawal by Subject|12|||
105501096|NCT04560998|363845797|FG000|Overall Study|Lost to Follow-up|8|||
105501097|NCT04560998|363845798|FG001|Overall Study|Lost to Follow-up|5|||
105501098|NCT04560998|363845797|FG000|Overall Study|Physician Decision|4|||
105501099|NCT04560998|363845798|FG001|Overall Study|Physician Decision|0|||
105501100|NCT00717093|363847055|FG000|Overall Study|Adverse Event|19|||
105501101|NCT00717093|363847056|FG001|Overall Study|Adverse Event|9|||
105501102|NCT00717093|363847055|FG000|Overall Study|Lack of Efficacy|3|||
105501103|NCT00717093|363847056|FG001|Overall Study|Lack of Efficacy|13|||
105501104|NCT00717093|363847055|FG000|Overall Study|Lost to Follow-up|9|||
105501105|NCT00717093|363847056|FG001|Overall Study|Lost to Follow-up|6|||
105501106|NCT00717093|363847055|FG000|Overall Study|Withdrawal by Subject|12|||
105501107|NCT00717093|363847056|FG001|Overall Study|Withdrawal by Subject|19|||
105501108|NCT00717093|363847055|FG000|Overall Study|Other|0|||
105501109|NCT00717093|363847056|FG001|Overall Study|Other|1|||
105423341|NCT01327053|363556404|FG000|Overall Study|Progressive disease|31|||
105423342|NCT01327053|363556405|FG001|Overall Study|Progressive disease|26|||
105423343|NCT01327053|363556404|FG000|Overall Study|Protocol Violation|0|||
105423344|NCT01327053|363556405|FG001|Overall Study|Protocol Violation|1|||
105423345|NCT01327053|363556404|FG000|Overall Study|Untreated|0|||
105423346|NCT01327053|363556405|FG001|Overall Study|Untreated|1|||
105423347|NCT02233738|363556406|FG000|Overall Study|Lost to Follow-up|5|||
105423348|NCT02233738|363556407|FG001|Overall Study|Lost to Follow-up|12|||
105423349|NCT02233738|363556406|FG000|Overall Study|Death|0|||
105423350|NCT02233738|363556407|FG001|Overall Study|Death|1|||
105423351|NCT02233738|363556406|FG000|Overall Study|Withdrawal by Subject|0|||
105423352|NCT02233738|363556407|FG001|Overall Study|Withdrawal by Subject|1|||
105423353|NCT02233738|363556406|FG000|Overall Study|Did not return after Baseline|3|||
105423354|NCT02233738|363556407|FG001|Overall Study|Did not return after Baseline|2|||
105423355|NCT00096174|363556408|FG000|Overall Study|Lack of Efficacy|9|||
105423356|NCT00096174|363556408|FG000|Overall Study|Adverse Event|15|||
105423357|NCT00096174|363556408|FG000|Overall Study|Death|6|||
105423358|NCT00096174|363556408|FG000|Overall Study|Withdrawal by Subject|15|||
105423359|NCT00096174|363556408|FG000|Overall Study|Not started protocol therapy|3|||
105423360|NCT00096174|363556408|FG000|Overall Study|Ineligible|6|||
105423361|NCT00096174|363556408|FG000|Overall Study|other reason|8|||
105423362|NCT04706273|363556409|FG000|Overall Study|Withdrawal by Subject|27|||
105423363|NCT04706273|363556409|FG000|Overall Study|Physician Decision|1|||
105423364|NCT04706273|363556409|FG000|Overall Study|Lost to Follow-up|42|||
105423365|NCT04706273|363556409|FG000|Overall Study|Death|85|||
105423366|NCT04706273|363556409|FG000|Overall Study|Amputation that removes study device|2|||
105423367|NCT04706273|363556409|FG000|Overall Study|Surgical bypass|3|||
105423368|NCT04706273|363556409|FG000|Overall Study|Changing hospital|23|||
105423369|NCT04706273|363556409|FG000|Overall Study|Unable to attend hospital|2|||
105423370|NCT03549871|363556410|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
105423371|NCT03549871|363556411|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
105423372|NCT03549871|363556410|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
105423373|NCT03549871|363556411|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
105423374|NCT03549871|363556410|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
105423375|NCT03549871|363556411|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
105423376|NCT03549871|363556410|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
105423377|NCT03549871|363556411|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
105423378|NCT03549871|363556410|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
105423379|NCT03549871|363556411|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
105423380|NCT03549871|363556410|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
105423381|NCT03549871|363556411|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
105423382|NCT03549871|363556410|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
105423383|NCT03549871|363556411|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
105423384|NCT03549871|363556410|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
105423385|NCT03549871|363556411|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
105423386|NCT03549871|363556410|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
105423387|NCT03549871|363556411|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
105423388|NCT03549871|363556410|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
105423389|NCT03549871|363556411|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
105423390|NCT03549871|363556410|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
105423391|NCT03549871|363556411|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
105423392|NCT01133626|363556413|FG000|Overall Study|Adverse Event|0|||
105423393|NCT01133626|363556414|FG001|Overall Study|Adverse Event|1|||
105423394|NCT01133626|363556415|FG002|Overall Study|Adverse Event|0|||
105423395|NCT01133626|363556413|FG000|Overall Study|Withdrawal by Subject|1|||
105423396|NCT01133626|363556414|FG001|Overall Study|Withdrawal by Subject|2|||
105423397|NCT01133626|363556415|FG002|Overall Study|Withdrawal by Subject|2|||
105423398|NCT01133626|363556413|FG000|Overall Study|Other|0|||
105423399|NCT01133626|363556414|FG001|Overall Study|Other|2|||
105423400|NCT01133626|363556415|FG002|Overall Study|Other|0|||
105423401|NCT00759356|363556416|FG000|Overall Study|Adverse Event|0|||
105423402|NCT00759356|363556417|FG001|Overall Study|Adverse Event|1|||
105423403|NCT00759356|363556416|FG000|Overall Study|Withdrawal by Subject|0|||
105423404|NCT00759356|363556417|FG001|Overall Study|Withdrawal by Subject|2|||
105423405|NCT00759356|363556416|FG000|Overall Study|Subject was unable to return|1|||
105423406|NCT00759356|363556417|FG001|Overall Study|Subject was unable to return|0|||
105423407|NCT03199053|363556418|FG000|ST Period|Withdrawal by Subject|2|||
105423408|NCT03199053|363556419|FG001|ST Period|Withdrawal by Subject|4|||
105423409|NCT03199053|363556420|FG002|ST Period|Withdrawal by Subject|6|||
105423410|NCT03199053|363556418|FG000|ST Period|Withdrawal by parent/guardian|1|||
105423411|NCT03199053|363556419|FG001|ST Period|Withdrawal by parent/guardian|1|||
105423412|NCT03199053|363556420|FG002|ST Period|Withdrawal by parent/guardian|1|||
105423413|NCT03199053|363556418|FG000|ST Period|Lost to Follow-up|2|||
105423414|NCT03199053|363556419|FG001|ST Period|Lost to Follow-up|0|||
105423415|NCT03199053|363556420|FG002|ST Period|Lost to Follow-up|1|||
105423416|NCT03199053|363556418|FG000|LT Period|Withdrawal by Subject|1|||
105423417|NCT03199053|363556419|FG001|LT Period|Withdrawal by Subject|3|||
105423418|NCT03199053|363556420|FG002|LT Period|Withdrawal by Subject|3|||
105423419|NCT03199053|363556418|FG000|LT Period|Withdrawal by parent/guardian|0|||
105423420|NCT03199053|363556419|FG001|LT Period|Withdrawal by parent/guardian|0|||
105423421|NCT03199053|363556420|FG002|LT Period|Withdrawal by parent/guardian|1|||
105423422|NCT03199053|363556418|FG000|LT Period|Lost to Follow-up|0|||
105423423|NCT03199053|363556419|FG001|LT Period|Lost to Follow-up|1|||
105423424|NCT03199053|363556420|FG002|LT Period|Lost to Follow-up|1|||
105423425|NCT03199053|363556418|FG000|LT Period|Miscellaneous|0|||
105423426|NCT03199053|363556419|FG001|LT Period|Miscellaneous|0|||
105423427|NCT03199053|363556420|FG002|LT Period|Miscellaneous|2|||
105423428|NCT03199053|363556418|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
105423429|NCT03199053|363556419|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
105423430|NCT03199053|363556420|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
105423431|NCT03199053|363556418|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
105423432|NCT03199053|363556419|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
105423433|NCT03199053|363556420|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
105423434|NCT03199053|363556418|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
105423435|NCT03199053|363556419|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
105423436|NCT03199053|363556420|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
105423437|NCT03199053|363556418|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
105423438|NCT03199053|363556419|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
105423439|NCT03199053|363556420|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
105423440|NCT03298984|363556423|FG000|Overall Study|Physician Decision|1|||
105423441|NCT03298984|363556424|FG001|Overall Study|Physician Decision|0|||
105423442|NCT03298984|363556425|FG002|Overall Study|Physician Decision|0|||
105423443|NCT03298984|363556426|FG003|Overall Study|Physician Decision|6|||
105423444|NCT03298984|363556423|FG000|Overall Study|Lack of Efficacy|0|||
105423445|NCT03298984|363556424|FG001|Overall Study|Lack of Efficacy|1|||
105423446|NCT03298984|363556425|FG002|Overall Study|Lack of Efficacy|1|||
105423447|NCT03298984|363556426|FG003|Overall Study|Lack of Efficacy|4|||
105423448|NCT03298984|363556423|FG000|Overall Study|Relapsed disease (following remission)|0|||
105423449|NCT03298984|363556424|FG001|Overall Study|Relapsed disease (following remission)|0|||
105423450|NCT03298984|363556425|FG002|Overall Study|Relapsed disease (following remission)|1|||
105423451|NCT03298984|363556426|FG003|Overall Study|Relapsed disease (following remission)|1|||
105423452|NCT03298984|363556423|FG000|Overall Study|Adverse Event|0|||
105423453|NCT03298984|363556424|FG001|Overall Study|Adverse Event|0|||
105423454|NCT03298984|363556425|FG002|Overall Study|Adverse Event|0|||
105423455|NCT03298984|363556426|FG003|Overall Study|Adverse Event|1|||
105423456|NCT03298984|363556423|FG000|Overall Study|Death|0|||
105423457|NCT03298984|363556424|FG001|Overall Study|Death|0|||
105423458|NCT03298984|363556425|FG002|Overall Study|Death|0|||
105423459|NCT03298984|363556426|FG003|Overall Study|Death|2|||
105423460|NCT03298984|363556423|FG000|Overall Study|Insurance Company Decision|0|||
105423461|NCT03298984|363556424|FG001|Overall Study|Insurance Company Decision|0|||
105423462|NCT03298984|363556425|FG002|Overall Study|Insurance Company Decision|0|||
105423463|NCT03298984|363556426|FG003|Overall Study|Insurance Company Decision|1|||
105423464|NCT02403635|363556427|FG000|Overall Study|Not eligible|9|||
105423465|NCT00235391|363556429|FG000|Overall Study|Adverse Event|4|||
105423466|NCT00235391|363556430|FG001|Overall Study|Adverse Event|5|||
105423467|NCT00235391|363556431|FG002|Overall Study|Adverse Event|10|||
105423468|NCT00235391|363556432|FG003|Overall Study|Adverse Event|72|||
105423469|NCT00235391|363556433|FG004|Overall Study|Adverse Event|5|||
105423470|NCT00235391|363556434|FG005|Overall Study|Adverse Event|2|||
105423471|NCT00235391|363556429|FG000|Overall Study|Abnormal laboratory value(s)|3|||
105423472|NCT00235391|363556430|FG001|Overall Study|Abnormal laboratory value(s)|5|||
105423473|NCT00235391|363556431|FG002|Overall Study|Abnormal laboratory value(s)|4|||
105423474|NCT00235391|363556432|FG003|Overall Study|Abnormal laboratory value(s)|27|||
105423475|NCT00235391|363556433|FG004|Overall Study|Abnormal laboratory value(s)|1|||
105423476|NCT00235391|363556434|FG005|Overall Study|Abnormal laboratory value(s)|2|||
105423477|NCT00235391|363556429|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105423478|NCT00235391|363556430|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105423479|NCT00235391|363556431|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
105423480|NCT00235391|363556432|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
105423481|NCT00235391|363556433|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
105423482|NCT00235391|363556434|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
105423483|NCT00235391|363556429|FG000|Overall Study|Condition no longer requires treatment|3|||
105423484|NCT00235391|363556430|FG001|Overall Study|Condition no longer requires treatment|0|||
105423485|NCT00235391|363556431|FG002|Overall Study|Condition no longer requires treatment|0|||
105423486|NCT00235391|363556432|FG003|Overall Study|Condition no longer requires treatment|11|||
105423487|NCT00235391|363556433|FG004|Overall Study|Condition no longer requires treatment|1|||
105423488|NCT00235391|363556434|FG005|Overall Study|Condition no longer requires treatment|0|||
105423489|NCT00235391|363556429|FG000|Overall Study|Protocol deviation|0|||
105423490|NCT00235391|363556430|FG001|Overall Study|Protocol deviation|0|||
105423491|NCT00235391|363556431|FG002|Overall Study|Protocol deviation|1|||
105423492|NCT00235391|363556432|FG003|Overall Study|Protocol deviation|11|||
105423493|NCT00235391|363556433|FG004|Overall Study|Protocol deviation|0|||
105423494|NCT00235391|363556434|FG005|Overall Study|Protocol deviation|0|||
105423495|NCT00235391|363556429|FG000|Overall Study|Withdrawal by Subject|2|||
105423496|NCT00235391|363556430|FG001|Overall Study|Withdrawal by Subject|3|||
105423497|NCT00235391|363556431|FG002|Overall Study|Withdrawal by Subject|3|||
105423498|NCT00235391|363556432|FG003|Overall Study|Withdrawal by Subject|61|||
105423499|NCT00235391|363556433|FG004|Overall Study|Withdrawal by Subject|5|||
105423500|NCT00235391|363556434|FG005|Overall Study|Withdrawal by Subject|0|||
105423501|NCT00235391|363556429|FG000|Overall Study|Lost to Follow-up|0|||
105423502|NCT00235391|363556430|FG001|Overall Study|Lost to Follow-up|3|||
105423503|NCT00235391|363556431|FG002|Overall Study|Lost to Follow-up|3|||
105423504|NCT00235391|363556432|FG003|Overall Study|Lost to Follow-up|16|||
105423505|NCT00235391|363556433|FG004|Overall Study|Lost to Follow-up|0|||
105423506|NCT00235391|363556434|FG005|Overall Study|Lost to Follow-up|0|||
105423507|NCT00235391|363556429|FG000|Overall Study|Administrative problems|0|||
105423508|NCT00235391|363556430|FG001|Overall Study|Administrative problems|0|||
105423509|NCT00235391|363556431|FG002|Overall Study|Administrative problems|0|||
105423510|NCT00235391|363556432|FG003|Overall Study|Administrative problems|1|||
105423511|NCT00235391|363556433|FG004|Overall Study|Administrative problems|0|||
105423512|NCT00235391|363556434|FG005|Overall Study|Administrative problems|0|||
105423513|NCT00235391|363556429|FG000|Overall Study|Death|0|||
105423514|NCT00235391|363556430|FG001|Overall Study|Death|0|||
105423515|NCT00235391|363556431|FG002|Overall Study|Death|1|||
105423516|NCT00235391|363556432|FG003|Overall Study|Death|4|||
105423517|NCT00235391|363556433|FG004|Overall Study|Death|0|||
105423518|NCT00235391|363556434|FG005|Overall Study|Death|0|||
105423519|NCT01323270|363556435|FG000|Overall Study|Withdrawal by Subject|19|||
105423520|NCT01323270|363556436|FG001|Overall Study|Withdrawal by Subject|10|||
105423521|NCT01323270|363556435|FG000|Overall Study|Protocol Violation|9|||
105423522|NCT01323270|363556436|FG001|Overall Study|Protocol Violation|7|||
105423523|NCT01323270|363556435|FG000|Overall Study|Lost to Follow-up|4|||
105423524|NCT01323270|363556436|FG001|Overall Study|Lost to Follow-up|6|||
105423525|NCT01323270|363556435|FG000|Overall Study|Adverse Event|8|||
105423526|NCT01323270|363556436|FG001|Overall Study|Adverse Event|0|||
105423527|NCT01323270|363556435|FG000|Overall Study|Other|0|||
105423528|NCT01323270|363556436|FG001|Overall Study|Other|3|||
105423529|NCT01323270|363556435|FG000|Overall Study|Physician Decision|0|||
105423530|NCT01323270|363556436|FG001|Overall Study|Physician Decision|2|||
105423531|NCT01323270|363556435|FG000|Overall Study|Not eligible|1|||
105423532|NCT01323270|363556436|FG001|Overall Study|Not eligible|1|||
105423533|NCT01323270|363556435|FG000|Overall Study|Death|1|||
105423534|NCT01323270|363556436|FG001|Overall Study|Death|0|||
105423535|NCT01323270|363556435|FG000|Overall Study|Randomized, but not vaccinated|1|||
105423536|NCT01323270|363556436|FG001|Overall Study|Randomized, but not vaccinated|0|||
105423537|NCT02229214|363556450|FG000|Overall Study|Adverse Event|2|||
105423538|NCT02229214|363556451|FG001|Overall Study|Adverse Event|0|||
105423539|NCT02229214|363556450|FG000|Overall Study|Withdrawal by Subject|4|||
105423540|NCT02229214|363556451|FG001|Overall Study|Withdrawal by Subject|0|||
105423541|NCT01133405|363556454|FG000|Period 1|Withdrawal by Subject|0|||
105423542|NCT01133405|363556455|FG001|Period 1|Withdrawal by Subject|1|||
105423543|NCT01133405|363556456|FG002|Period 1|Withdrawal by Subject|0|||
105423544|NCT01133405|363556457|FG003|Period 1|Withdrawal by Subject|1|||
105423545|NCT01133405|363556458|FG004|Period 1|Withdrawal by Subject|0|||
105423546|NCT01133405|363556459|FG005|Period 1|Withdrawal by Subject|1|||
105423547|NCT01133405|363556460|FG006|Period 1|Withdrawal by Subject|0|||
105423548|NCT01133405|363556461|FG007|Period 1|Withdrawal by Subject|0|||
105423549|NCT01133405|363556462|FG008|Period 1|Withdrawal by Subject|0|||
105423550|NCT01133405|363556463|FG009|Period 1|Withdrawal by Subject|0|||
105423551|NCT01133405|363556454|FG000|Period 1|Physician Decision|0|||
105423552|NCT01133405|363556455|FG001|Period 1|Physician Decision|0|||
105423553|NCT01133405|363556456|FG002|Period 1|Physician Decision|0|||
105423554|NCT01133405|363556457|FG003|Period 1|Physician Decision|1|||
105423555|NCT01133405|363556458|FG004|Period 1|Physician Decision|0|||
105423556|NCT01133405|363556459|FG005|Period 1|Physician Decision|0|||
105423557|NCT01133405|363556460|FG006|Period 1|Physician Decision|0|||
105423558|NCT01133405|363556461|FG007|Period 1|Physician Decision|0|||
105423559|NCT01133405|363556462|FG008|Period 1|Physician Decision|0|||
105423560|NCT01133405|363556463|FG009|Period 1|Physician Decision|0|||
105423561|NCT01133405|363556454|FG000|Period 1|Discontinued after randomization|1|||
105423562|NCT01133405|363556455|FG001|Period 1|Discontinued after randomization|0|||
105423563|NCT01133405|363556456|FG002|Period 1|Discontinued after randomization|0|||
105423564|NCT01133405|363556457|FG003|Period 1|Discontinued after randomization|0|||
105423565|NCT01133405|363556458|FG004|Period 1|Discontinued after randomization|0|||
105423566|NCT01133405|363556459|FG005|Period 1|Discontinued after randomization|0|||
105423567|NCT01133405|363556460|FG006|Period 1|Discontinued after randomization|1|||
105423568|NCT01133405|363556461|FG007|Period 1|Discontinued after randomization|0|||
105423569|NCT01133405|363556462|FG008|Period 1|Discontinued after randomization|0|||
105423570|NCT01133405|363556463|FG009|Period 1|Discontinued after randomization|0|||
105423571|NCT01133405|363556454|FG000|Period 1|Received drug only in period 2|0|||
105423572|NCT01133405|363556455|FG001|Period 1|Received drug only in period 2|1|||
105423573|NCT01133405|363556456|FG002|Period 1|Received drug only in period 2|0|||
105423574|NCT01133405|363556457|FG003|Period 1|Received drug only in period 2|2|||
105423575|NCT01133405|363556458|FG004|Period 1|Received drug only in period 2|0|||
105423576|NCT01133405|363556459|FG005|Period 1|Received drug only in period 2|1|||
105423577|NCT01133405|363556460|FG006|Period 1|Received drug only in period 2|0|||
105423578|NCT01133405|363556461|FG007|Period 1|Received drug only in period 2|0|||
105423579|NCT01133405|363556462|FG008|Period 1|Received drug only in period 2|0|||
105423580|NCT01133405|363556463|FG009|Period 1|Received drug only in period 2|0|||
105423581|NCT01133405|363556454|FG000|Period 1|Received drug only in period 3|0|||
105423582|NCT01133405|363556455|FG001|Period 1|Received drug only in period 3|1|||
105423583|NCT01133405|363556456|FG002|Period 1|Received drug only in period 3|1|||
105423584|NCT01133405|363556457|FG003|Period 1|Received drug only in period 3|0|||
105423585|NCT01133405|363556458|FG004|Period 1|Received drug only in period 3|0|||
105423586|NCT01133405|363556459|FG005|Period 1|Received drug only in period 3|0|||
105423587|NCT01133405|363556460|FG006|Period 1|Received drug only in period 3|0|||
105423588|NCT01133405|363556461|FG007|Period 1|Received drug only in period 3|0|||
105423589|NCT01133405|363556462|FG008|Period 1|Received drug only in period 3|0|||
105423590|NCT01133405|363556463|FG009|Period 1|Received drug only in period 3|0|||
105423591|NCT01133405|363556454|FG000|Period 2|Adverse Event|0|||
105423592|NCT01133405|363556455|FG001|Period 2|Adverse Event|0|||
105423593|NCT01133405|363556456|FG002|Period 2|Adverse Event|1|||
105423594|NCT01133405|363556457|FG003|Period 2|Adverse Event|0|||
105423595|NCT01133405|363556458|FG004|Period 2|Adverse Event|0|||
105423596|NCT01133405|363556459|FG005|Period 2|Adverse Event|0|||
105423597|NCT01133405|363556460|FG006|Period 2|Adverse Event|0|||
105423598|NCT01133405|363556461|FG007|Period 2|Adverse Event|0|||
105423599|NCT01133405|363556462|FG008|Period 2|Adverse Event|0|||
105423600|NCT01133405|363556463|FG009|Period 2|Adverse Event|0|||
105423601|NCT01133405|363556454|FG000|Period 2|Withdrawal by Subject|0|||
105423602|NCT01133405|363556455|FG001|Period 2|Withdrawal by Subject|0|||
105423603|NCT01133405|363556456|FG002|Period 2|Withdrawal by Subject|0|||
105423604|NCT01133405|363556457|FG003|Period 2|Withdrawal by Subject|1|||
105423605|NCT01133405|363556458|FG004|Period 2|Withdrawal by Subject|0|||
105423606|NCT01133405|363556459|FG005|Period 2|Withdrawal by Subject|1|||
105423607|NCT01133405|363556460|FG006|Period 2|Withdrawal by Subject|0|||
105423608|NCT01133405|363556461|FG007|Period 2|Withdrawal by Subject|0|||
105423609|NCT01133405|363556462|FG008|Period 2|Withdrawal by Subject|0|||
105423610|NCT01133405|363556463|FG009|Period 2|Withdrawal by Subject|0|||
105423611|NCT01133405|363556454|FG000|Period 2|Entry Criteria Not Met|0|||
105423612|NCT01133405|363556455|FG001|Period 2|Entry Criteria Not Met|1|||
105423613|NCT01133405|363556456|FG002|Period 2|Entry Criteria Not Met|0|||
105423614|NCT01133405|363556457|FG003|Period 2|Entry Criteria Not Met|0|||
105423615|NCT01133405|363556458|FG004|Period 2|Entry Criteria Not Met|0|||
105586626|NCT00049517|364147317|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
105423616|NCT01133405|363556459|FG005|Period 2|Entry Criteria Not Met|0|||
105423617|NCT01133405|363556460|FG006|Period 2|Entry Criteria Not Met|0|||
105423618|NCT01133405|363556461|FG007|Period 2|Entry Criteria Not Met|0|||
105423619|NCT01133405|363556462|FG008|Period 2|Entry Criteria Not Met|0|||
105423620|NCT01133405|363556463|FG009|Period 2|Entry Criteria Not Met|0|||
105423621|NCT01133405|363556454|FG000|Period 2|Physician Decision|0|||
105423622|NCT01133405|363556455|FG001|Period 2|Physician Decision|0|||
105423623|NCT01133405|363556456|FG002|Period 2|Physician Decision|0|||
105423624|NCT01133405|363556457|FG003|Period 2|Physician Decision|0|||
105423625|NCT01133405|363556458|FG004|Period 2|Physician Decision|0|||
105423626|NCT01133405|363556459|FG005|Period 2|Physician Decision|1|||
105423627|NCT01133405|363556460|FG006|Period 2|Physician Decision|0|||
105423628|NCT01133405|363556461|FG007|Period 2|Physician Decision|0|||
105423629|NCT01133405|363556462|FG008|Period 2|Physician Decision|0|||
105423630|NCT01133405|363556463|FG009|Period 2|Physician Decision|0|||
105423631|NCT01238835|363556470|FG000|Overall Study|Death|124|||
105423632|NCT01238835|363556470|FG000|Overall Study|Withdrawal by Subject|9|||
105423633|NCT01238835|363556470|FG000|Overall Study|Lost to Follow-up|1|||
105423634|NCT01238835|363556470|FG000|Overall Study|Site early discontinuation|2|||
105423635|NCT02649855|363556474|FG000|Overall Study|Refused further treatment|2|||
105423636|NCT02649855|363556475|FG001|Overall Study|Refused further treatment|1|||
105423637|NCT02649855|363556476|FG002|Overall Study|Refused further treatment|1|||
105423638|NCT02649855|363556474|FG000|Overall Study|Withdrew consent|0|||
105423639|NCT02649855|363556475|FG001|Overall Study|Withdrew consent|1|||
105423640|NCT02649855|363556476|FG002|Overall Study|Withdrew consent|0|||
105423641|NCT02649855|363556474|FG000|Overall Study|Switched to alternative treatment|0|||
105423642|NCT02649855|363556475|FG001|Overall Study|Switched to alternative treatment|1|||
105423643|NCT02649855|363556476|FG002|Overall Study|Switched to alternative treatment|1|||
105423644|NCT02649855|363556474|FG000|Overall Study|Principal investigator discretion|0|||
105423645|NCT02649855|363556475|FG001|Overall Study|Principal investigator discretion|1|||
105423646|NCT02649855|363556476|FG002|Overall Study|Principal investigator discretion|1|||
105423647|NCT02649855|363556474|FG000|Overall Study|No treatment, per protocol|1|||
105423648|NCT02649855|363556475|FG001|Overall Study|No treatment, per protocol|0|||
105423649|NCT02649855|363556476|FG002|Overall Study|No treatment, per protocol|0|||
105423650|NCT02649855|363556474|FG000|Overall Study|Initiate new treatment|1|||
105423651|NCT02649855|363556475|FG001|Overall Study|Initiate new treatment|0|||
105423652|NCT02649855|363556476|FG002|Overall Study|Initiate new treatment|0|||
105423653|NCT01038713|363556477|FG000|Overall Study|Patient to hospice|1|||
105423654|NCT01038713|363556478|FG001|Overall Study|Patient to hospice|1|||
105423655|NCT01038713|363556479|FG002|Overall Study|Patient to hospice|1|||
105423656|NCT01038713|363556477|FG000|Overall Study|Lost to Follow-up|3|||
105423657|NCT01038713|363556478|FG001|Overall Study|Lost to Follow-up|0|||
105423658|NCT01038713|363556479|FG002|Overall Study|Lost to Follow-up|0|||
105423659|NCT01038713|363556477|FG000|Overall Study|Neuroendocrine Tumor|0|||
105423660|NCT01038713|363556478|FG001|Overall Study|Neuroendocrine Tumor|1|||
105423661|NCT01038713|363556479|FG002|Overall Study|Neuroendocrine Tumor|0|||
105423662|NCT01038713|363556477|FG000|Overall Study|died from PEP|0|||
105423663|NCT01038713|363556478|FG001|Overall Study|died from PEP|1|||
105423664|NCT01038713|363556479|FG002|Overall Study|died from PEP|0|||
105423665|NCT01038713|363556477|FG000|Overall Study|Autoimmune Pancreatitis|1|||
105423666|NCT01038713|363556478|FG001|Overall Study|Autoimmune Pancreatitis|0|||
105423667|NCT01038713|363556479|FG002|Overall Study|Autoimmune Pancreatitis|0|||
105423668|NCT02818036|363556480|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
105423669|NCT02818036|363556481|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
105423670|NCT02818036|363556480|FG000|Overall Study|Withdrawal by Subject|1|||
105423671|NCT02818036|363556481|FG001|Overall Study|Withdrawal by Subject|0|||
105423672|NCT01154283|363556482|FG000|0-6 Weeks|Withdrawal by Subject|7|||
105423673|NCT01154283|363556483|FG001|0-6 Weeks|Withdrawal by Subject|2|||
105423674|NCT01154283|363556482|FG000|0-6 Weeks|Death|0|||
105423675|NCT01154283|363556483|FG001|0-6 Weeks|Death|1|||
105423676|NCT01154283|363556482|FG000|7-12 Weeks|Death|1|||
105423677|NCT01154283|363556483|FG001|7-12 Weeks|Death|0|||
105423678|NCT01154283|363556482|FG000|7-12 Weeks|Withdrawal by Subject|0|||
105423679|NCT01154283|363556483|FG001|7-12 Weeks|Withdrawal by Subject|1|||
105423680|NCT01527383|363556484|FG000|Overall Study|Adverse Event|5|||
105423681|NCT01527383|363556485|FG001|Overall Study|Adverse Event|0|||
105423682|NCT01527383|363556484|FG000|Overall Study|Lost to Follow-up|3|||
105423683|NCT01527383|363556485|FG001|Overall Study|Lost to Follow-up|0|||
105423684|NCT01527383|363556484|FG000|Overall Study|Physician Decision|2|||
105423685|NCT01527383|363556485|FG001|Overall Study|Physician Decision|0|||
105423686|NCT01527383|363556484|FG000|Overall Study|Pregnancy|1|||
105423687|NCT01527383|363556485|FG001|Overall Study|Pregnancy|0|||
105423688|NCT01527383|363556484|FG000|Overall Study|Protocol Violation|1|||
105423689|NCT01527383|363556485|FG001|Overall Study|Protocol Violation|0|||
105423690|NCT01527383|363556484|FG000|Overall Study|Screen failure|1|||
105423691|NCT01527383|363556485|FG001|Overall Study|Screen failure|0|||
105423692|NCT01527383|363556484|FG000|Overall Study|Participant moved|0|||
105423693|NCT01527383|363556485|FG001|Overall Study|Participant moved|1|||
105423694|NCT01527383|363556484|FG000|Overall Study|Withdrawal by Subject|2|||
105423695|NCT01527383|363556485|FG001|Overall Study|Withdrawal by Subject|3|||
105423696|NCT05599451|363558709|FG000|Overall Study|Not randomized|11|||
105423697|NCT05599451|363558710|FG001|Overall Study|Not randomized|0|||
105423698|NCT05599451|363558711|FG002|Overall Study|Not randomized|0|||
105423699|NCT05599451|363558712|FG003|Overall Study|Not randomized|0|||
105423700|NCT05599451|363558713|FG004|Overall Study|Not randomized|0|||
105423701|NCT05599451|363558709|FG000|Overall Study|Physician Decision|0|||
105423702|NCT05599451|363558710|FG001|Overall Study|Physician Decision|0|||
105423703|NCT05599451|363558711|FG002|Overall Study|Physician Decision|0|||
105423704|NCT05599451|363558712|FG003|Overall Study|Physician Decision|1|||
105423705|NCT05599451|363558713|FG004|Overall Study|Physician Decision|0|||
105423706|NCT02723006|363558714|FG000|Overall Study|Withdrawal by Subject|0|||
105423707|NCT02723006|363558715|FG001|Overall Study|Withdrawal by Subject|1|||
105423708|NCT02723006|363558716|FG002|Overall Study|Withdrawal by Subject|1|||
105423709|NCT02723006|363558714|FG000|Overall Study|Study Terminated by Sponsor|1|||
105586627|NCT00049517|364147318|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
105586628|NCT00049517|364147319|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
105586629|NCT00049517|364147314|FG000|Conditioning/Transplant|Alternative therapy|4|||
105586630|NCT00049517|364147315|FG001|Conditioning/Transplant|Alternative therapy|4|||
105586631|NCT00049517|364147316|FG002|Conditioning/Transplant|Alternative therapy|2|||
105586632|NCT00049517|364147317|FG003|Conditioning/Transplant|Alternative therapy|1|||
105586633|NCT00049517|364147318|FG004|Conditioning/Transplant|Alternative therapy|1|||
105586634|NCT00049517|364147319|FG005|Conditioning/Transplant|Alternative therapy|0|||
105586635|NCT00049517|364147314|FG000|Conditioning/Transplant|Other complicating disease|2|||
105586636|NCT00049517|364147315|FG001|Conditioning/Transplant|Other complicating disease|0|||
105586637|NCT00049517|364147316|FG002|Conditioning/Transplant|Other complicating disease|0|||
105586638|NCT00049517|364147317|FG003|Conditioning/Transplant|Other complicating disease|4|||
105586639|NCT00049517|364147318|FG004|Conditioning/Transplant|Other complicating disease|0|||
105586640|NCT00049517|364147319|FG005|Conditioning/Transplant|Other complicating disease|1|||
105586641|NCT00049517|364147314|FG000|Conditioning/Transplant|Reasons not reported|25|||
105586642|NCT00049517|364147315|FG001|Conditioning/Transplant|Reasons not reported|31|||
105586643|NCT00049517|364147316|FG002|Conditioning/Transplant|Reasons not reported|18|||
105586644|NCT00049517|364147317|FG003|Conditioning/Transplant|Reasons not reported|15|||
105586645|NCT00049517|364147318|FG004|Conditioning/Transplant|Reasons not reported|5|||
105586646|NCT00049517|364147319|FG005|Conditioning/Transplant|Reasons not reported|5|||
105586647|NCT00079937|364147320|FG000|Overall Study|Adverse Event|2|||
105586648|NCT00079937|364147321|FG001|Overall Study|Adverse Event|1|||
105586649|NCT00079937|364147320|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105586650|NCT00079937|364147321|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105586651|NCT00079937|364147320|FG000|Overall Study|Subject no longer requires study drug|3|||
105586652|NCT00079937|364147321|FG001|Overall Study|Subject no longer requires study drug|0|||
105586653|NCT00079937|364147320|FG000|Overall Study|Protocol Violation|8|||
105586654|NCT00079937|364147321|FG001|Overall Study|Protocol Violation|6|||
105586655|NCT00079937|364147320|FG000|Overall Study|Withdrawal by Subject|21|||
105586656|NCT00079937|364147321|FG001|Overall Study|Withdrawal by Subject|7|||
105586657|NCT00079937|364147320|FG000|Overall Study|Lost to Follow-up|12|||
105586658|NCT00079937|364147321|FG001|Overall Study|Lost to Follow-up|5|||
105586659|NCT00079937|364147320|FG000|Overall Study|Administrative problems|22|||
105586660|NCT00079937|364147321|FG001|Overall Study|Administrative problems|11|||
105586661|NCT01106287|364147322|FG000|Overall Study|Adverse Event|1|||
105586662|NCT01106287|364147323|FG001|Overall Study|Adverse Event|0|||
105586663|NCT01106287|364147324|FG002|Overall Study|Adverse Event|0|||
105586664|NCT01106287|364147325|FG003|Overall Study|Adverse Event|0|||
105586665|NCT04730947|364147326|FG000|Overall Study|Withdrawal by Subject|0|||
105586666|NCT04730947|364147327|FG001|Overall Study|Withdrawal by Subject|1|||
105586667|NCT01460381|364147330|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
105586668|NCT01460381|364147331|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
105586669|NCT01684046|364147332|FG000|Period 1, First 30 Days|Adverse Event|0|||
105586670|NCT01684046|364147333|FG001|Period 1, First 30 Days|Adverse Event|2|||
105586671|NCT05074498|364147334|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
105586672|NCT05074498|364147335|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
105586673|NCT05074498|364147336|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
105586674|NCT05074498|364147337|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
105586675|NCT05074498|364147338|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
105586676|NCT05074498|364147339|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
105586677|NCT05074498|364147334|FG000|Part 1 (Upto Day 104)|Other|1|||
105586678|NCT05074498|364147335|FG001|Part 1 (Upto Day 104)|Other|0|||
105586679|NCT05074498|364147336|FG002|Part 1 (Upto Day 104)|Other|0|||
105586680|NCT05074498|364147337|FG003|Part 1 (Upto Day 104)|Other|0|||
105586681|NCT05074498|364147338|FG004|Part 1 (Upto Day 104)|Other|0|||
105586682|NCT05074498|364147339|FG005|Part 1 (Upto Day 104)|Other|0|||
105586683|NCT05074498|364147334|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
105586684|NCT05074498|364147335|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
105586685|NCT05074498|364147336|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
105586686|NCT05074498|364147337|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
105586687|NCT05074498|364147338|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
105586688|NCT05074498|364147339|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
105586689|NCT05074498|364147334|FG000|Part 2 (Upto Day 104)|Death|0|||
105586690|NCT05074498|364147335|FG001|Part 2 (Upto Day 104)|Death|0|||
105586691|NCT05074498|364147336|FG002|Part 2 (Upto Day 104)|Death|0|||
105586692|NCT05074498|364147337|FG003|Part 2 (Upto Day 104)|Death|0|||
105586693|NCT05074498|364147338|FG004|Part 2 (Upto Day 104)|Death|1|||
105586694|NCT05074498|364147339|FG005|Part 2 (Upto Day 104)|Death|0|||
105586695|NCT05074498|364147334|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
105586696|NCT05074498|364147335|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
105586697|NCT05074498|364147336|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
105586698|NCT05074498|364147337|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
105586699|NCT05074498|364147338|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
105586700|NCT05074498|364147339|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
105423710|NCT02723006|363558715|FG001|Overall Study|Study Terminated by Sponsor|6|||
105423711|NCT02723006|363558716|FG002|Overall Study|Study Terminated by Sponsor|6|||
105423712|NCT01514240|363558717|FG000|Overall Study|Adverse Event|4|||
105423713|NCT01514240|363558718|FG001|Overall Study|Adverse Event|4|||
105423714|NCT01514240|363558717|FG000|Overall Study|Subject Decision|2|||
105423715|NCT01514240|363558718|FG001|Overall Study|Subject Decision|7|||
105423716|NCT00303446|363558719|FG000|Overall Study|Withdrawal by Subject|2|||
105423717|NCT00303446|363558720|FG001|Overall Study|Withdrawal by Subject|2|||
105423718|NCT00303446|363558719|FG000|Overall Study|Death|0|||
105423719|NCT00303446|363558720|FG001|Overall Study|Death|1|||
105423720|NCT00303446|363558719|FG000|Overall Study|Physician Decision|0|||
105423721|NCT00303446|363558720|FG001|Overall Study|Physician Decision|1|||
105423722|NCT04258995|363558721|FG000|Overall Study|Lost to Follow-up|1|||
105423723|NCT04258995|363558722|FG001|Overall Study|Lost to Follow-up|1|||
105423724|NCT00549900|363558723|FG000|Overall Study|Adverse Event|1|||
105423725|NCT00711113|363558728|FG000|Overall Study|Lost to Follow-up|9|||
105423726|NCT00711113|363558728|FG000|Overall Study|Implant lost|2|||
105423727|NCT03356977|363558729|FG000|Overall Study|Lost to Follow-up|3|||
105423728|NCT03356977|363558729|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105423729|NCT05438602|363558730|FG000|Treatment (15 Days)|Adverse Event|2|||
105423730|NCT05438602|363558731|FG001|Treatment (15 Days)|Adverse Event|1|||
105423731|NCT05438602|363558732|FG002|Treatment (15 Days)|Adverse Event|3|||
105423732|NCT05438602|363558730|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
105423733|NCT05438602|363558731|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
105423734|NCT05438602|363558732|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
105423735|NCT05438602|363558730|FG000|Treatment (15 Days)|Other|0|||
105423736|NCT05438602|363558731|FG001|Treatment (15 Days)|Other|0|||
105423737|NCT05438602|363558732|FG002|Treatment (15 Days)|Other|1|||
105423738|NCT05438602|363558730|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
105423739|NCT05438602|363558731|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
105423740|NCT05438602|363558732|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
105423741|NCT05438602|363558730|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
105423742|NCT05438602|363558731|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
105423743|NCT05438602|363558732|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
105423744|NCT05438602|363558730|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
105423745|NCT05438602|363558731|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
105423746|NCT05438602|363558732|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
105423747|NCT05438602|363558730|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
105423748|NCT05438602|363558731|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
105423749|NCT05438602|363558732|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
105423750|NCT05438602|363558730|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
105423751|NCT05438602|363558731|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
105423752|NCT05438602|363558732|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
105423753|NCT05438602|363558730|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
105423754|NCT05438602|363558731|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
105423755|NCT05438602|363558732|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
105423756|NCT05438602|363558730|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
105423757|NCT05438602|363558731|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
105423758|NCT05438602|363558732|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
105423759|NCT00798317|363558737|FG000|Overall Study|Physician Decision|0|||
105423760|NCT00798317|363558738|FG001|Overall Study|Physician Decision|1|||
105423761|NCT00798317|363558737|FG000|Overall Study|Withdrawal by Subject|5|||
105423762|NCT00798317|363558738|FG001|Overall Study|Withdrawal by Subject|4|||
105423763|NCT00798317|363558737|FG000|Overall Study|Lost to Follow-up|2|||
105423764|NCT00798317|363558738|FG001|Overall Study|Lost to Follow-up|2|||
105423765|NCT00798317|363558737|FG000|Overall Study|Adverse Event|2|||
105423766|NCT00798317|363558738|FG001|Overall Study|Adverse Event|0|||
105423767|NCT00798317|363558737|FG000|Overall Study|Death|1|||
105423768|NCT00798317|363558738|FG001|Overall Study|Death|0|||
105423769|NCT00378599|363558739|FG000|Overall Study|Adverse Event|38|||
105423770|NCT00378599|363558739|FG000|Overall Study|Protocol Violation|2|||
105423771|NCT00378599|363558739|FG000|Overall Study|Treatment failure|7|||
105423772|NCT00378599|363558739|FG000|Overall Study|Withdrawal by Subject|5|||
105423773|NCT03812185|363558743|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
105423774|NCT02576535|363558753|FG000|Overall Study|Withdrawal by Subject|2|||
105423775|NCT01529515|363558756|FG000|TRANSITION PHASE|Adverse Event|16|||
105423776|NCT01529515|363558757|FG001|TRANSITION PHASE|Adverse Event|0|||
105423777|NCT01529515|363558758|FG002|TRANSITION PHASE|Adverse Event|0|||
105586701|NCT05074498|364147334|FG000|Part 2 (Upto Day 104)|Other|0|||
105423778|NCT01529515|363558759|FG003|TRANSITION PHASE|Adverse Event|0|||
105423779|NCT01529515|363558756|FG000|TRANSITION PHASE|Death|1|||
105423780|NCT01529515|363558757|FG001|TRANSITION PHASE|Death|0|||
105423781|NCT01529515|363558758|FG002|TRANSITION PHASE|Death|0|||
105423782|NCT01529515|363558759|FG003|TRANSITION PHASE|Death|0|||
105423783|NCT01529515|363558756|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
105423784|NCT01529515|363558757|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
105423785|NCT01529515|363558758|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
105586702|NCT05074498|364147335|FG001|Part 2 (Upto Day 104)|Other|0|||
105586703|NCT05074498|364147336|FG002|Part 2 (Upto Day 104)|Other|0|||
105586704|NCT05074498|364147337|FG003|Part 2 (Upto Day 104)|Other|0|||
105586705|NCT05074498|364147338|FG004|Part 2 (Upto Day 104)|Other|1|||
105586706|NCT05074498|364147339|FG005|Part 2 (Upto Day 104)|Other|0|||
105586707|NCT00946114|364147344|FG000|Overall Study|Death|5|||
105586708|NCT00946114|364147345|FG001|Overall Study|Death|2|||
105586709|NCT00946114|364147344|FG000|Overall Study|Other|1|||
105586710|NCT00946114|364147345|FG001|Overall Study|Other|0|||
105586711|NCT00946114|364147344|FG000|Overall Study|Withdrawal by Subject|2|||
105586712|NCT00946114|364147345|FG001|Overall Study|Withdrawal by Subject|0|||
105586713|NCT04454567|364147353|FG000|Overall Study|Study Terminated by Sponsor|1|||
105586714|NCT04454567|364147354|FG001|Overall Study|Study Terminated by Sponsor|1|||
105586715|NCT01323660|364147356|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
105586716|NCT01323660|364147357|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
105586717|NCT01323660|364147358|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
105586718|NCT01323660|364147359|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
105586719|NCT01323660|364147360|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
105586720|NCT01323660|364147361|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
105586721|NCT01323660|364147356|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
105586722|NCT01323660|364147357|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
105586723|NCT01323660|364147358|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
105586724|NCT01323660|364147359|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
105586725|NCT01323660|364147360|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
105586726|NCT01323660|364147361|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
105586727|NCT01323660|364147356|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
105586728|NCT01323660|364147357|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
105586729|NCT01323660|364147358|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
105586730|NCT01323660|364147359|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
105586731|NCT01323660|364147360|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
105586732|NCT01323660|364147361|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
105586733|NCT01323660|364147356|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
105586734|NCT01323660|364147357|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
105586735|NCT01323660|364147358|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
105586736|NCT01323660|364147359|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
105586737|NCT01323660|364147360|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
105586738|NCT01323660|364147361|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
105586739|NCT01323660|364147356|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105586740|NCT01323660|364147357|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105586741|NCT01323660|364147358|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105586742|NCT01323660|364147359|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105586743|NCT01323660|364147360|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
105586744|NCT01323660|364147361|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105586745|NCT01323660|364147356|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
105586746|NCT01323660|364147357|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
105586747|NCT01323660|364147358|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
105586748|NCT01323660|364147359|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
105586749|NCT01323660|364147360|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
105586750|NCT01323660|364147361|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
105586751|NCT01323660|364147356|FG000|Washout Period (14 Days)|Adverse Event|0|||
105586752|NCT01323660|364147357|FG001|Washout Period (14 Days)|Adverse Event|0|||
105586753|NCT01323660|364147358|FG002|Washout Period (14 Days)|Adverse Event|0|||
105586754|NCT01323660|364147359|FG003|Washout Period (14 Days)|Adverse Event|0|||
105586755|NCT01323660|364147360|FG004|Washout Period (14 Days)|Adverse Event|1|||
105586756|NCT01323660|364147361|FG005|Washout Period (14 Days)|Adverse Event|0|||
105586757|NCT01323660|364147356|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
105586758|NCT01323660|364147357|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
105586759|NCT01323660|364147358|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
105586760|NCT01323660|364147359|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
105586761|NCT01323660|364147360|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
105586762|NCT01323660|364147361|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
105586763|NCT01323660|364147356|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
105586764|NCT01323660|364147357|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
105586765|NCT01323660|364147358|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
105586766|NCT01323660|364147359|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
105586767|NCT01323660|364147360|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
105586768|NCT01323660|364147361|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
105586769|NCT01323660|364147356|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
105586770|NCT01323660|364147357|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
105586771|NCT01323660|364147358|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
105586772|NCT01323660|364147359|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
105586773|NCT01323660|364147360|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
105586774|NCT01323660|364147361|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
105586775|NCT01323660|364147356|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
105586776|NCT01323660|364147357|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
105586777|NCT01323660|364147358|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
105586778|NCT01323660|364147359|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
105586779|NCT01323660|364147360|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
105586780|NCT01323660|364147361|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
105586781|NCT01323660|364147356|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
105586782|NCT01323660|364147357|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
105586783|NCT01323660|364147358|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
105586784|NCT01323660|364147359|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
105586785|NCT01323660|364147360|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
105586786|NCT01323660|364147361|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
105586787|NCT01323660|364147356|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
105586788|NCT01323660|364147357|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
105586789|NCT01323660|364147358|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
105586790|NCT01323660|364147359|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105586791|NCT01323660|364147360|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
105586792|NCT01323660|364147361|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105586793|NCT00051311|364147367|FG000|Overall Study|Starting new study|0|||
105586794|NCT00051311|364147368|FG001|Overall Study|Starting new study|1|||
105586795|NCT00051311|364147367|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
105586796|NCT00051311|364147368|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
105586797|NCT00051311|364147367|FG000|Overall Study|Death of recipient|8|||
105586798|NCT00051311|364147368|FG001|Overall Study|Death of recipient|8|||
105586799|NCT00051311|364147367|FG000|Overall Study|Recipient taken off study|4|||
105586800|NCT00051311|364147368|FG001|Overall Study|Recipient taken off study|4|||
105586801|NCT02390557|364147382|FG000|Wave 2|Survey non-respondent|72|||
105586802|NCT02390557|364147383|FG001|Wave 2|Survey non-respondent|41|||
105586803|NCT02390557|364147384|FG002|Wave 2|Survey non-respondent|23|||
105586804|NCT03278028|364147388|FG000|Overall Study|Lost to Follow-up|1|||
105586805|NCT03278028|364147389|FG001|Overall Study|Lost to Follow-up|0|||
105586806|NCT03278028|364147388|FG000|Overall Study|Withdrawal by Subject|3|||
105586807|NCT03278028|364147389|FG001|Overall Study|Withdrawal by Subject|1|||
105586808|NCT03278028|364147388|FG000|Overall Study|Pregnancy|0|||
105586809|NCT03278028|364147389|FG001|Overall Study|Pregnancy|1|||
105586810|NCT01360840|364147394|FG000|Overall Study|Ongoing at data cut-off|10|||
105586811|NCT01360840|364147395|FG001|Overall Study|Ongoing at data cut-off|10|||
105586812|NCT01360840|364147396|FG002|Overall Study|Ongoing at data cut-off|9|||
105586813|NCT02240680|364147398|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
105586814|NCT02240680|364147399|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
105586815|NCT02240680|364147400|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
105586816|NCT02240680|364147401|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
105586817|NCT02240680|364147398|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
105586818|NCT02240680|364147399|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
105586819|NCT02240680|364147400|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
105586820|NCT02240680|364147401|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
105586821|NCT02240680|364147398|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
105586822|NCT02240680|364147399|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
105586823|NCT02240680|364147400|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
105586824|NCT02240680|364147401|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
105586825|NCT02240680|364147398|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
105586826|NCT02240680|364147399|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
105423786|NCT01529515|363558759|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
105423787|NCT01529515|363558756|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
105586827|NCT02240680|364147400|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
105586828|NCT02240680|364147401|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
105586829|NCT02240680|364147398|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
105586830|NCT02240680|364147399|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
105586831|NCT02240680|364147400|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
105586832|NCT02240680|364147401|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
105586833|NCT02240680|364147398|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
105586834|NCT02240680|364147399|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
105586835|NCT02240680|364147400|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
105586836|NCT02240680|364147401|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
105586837|NCT02240680|364147398|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
105586838|NCT02240680|364147399|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
105586839|NCT02240680|364147400|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
105423788|NCT01529515|363558757|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
105423789|NCT01529515|363558758|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
105423790|NCT01529515|363558759|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
105423791|NCT01529515|363558756|FG000|TRANSITION PHASE|Protocol Violation|4|||
105423792|NCT01529515|363558757|FG001|TRANSITION PHASE|Protocol Violation|0|||
105423793|NCT01529515|363558758|FG002|TRANSITION PHASE|Protocol Violation|0|||
105423794|NCT01529515|363558759|FG003|TRANSITION PHASE|Protocol Violation|0|||
105423795|NCT01529515|363558756|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
105423796|NCT01529515|363558757|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
105423797|NCT01529515|363558758|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
105423798|NCT01529515|363558759|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
105423799|NCT01529515|363558756|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
105423800|NCT01529515|363558757|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
105423801|NCT01529515|363558758|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
105423802|NCT01529515|363558759|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
105423803|NCT01529515|363558756|FG000|TRANSITION PHASE|Other|9|||
105423804|NCT01529515|363558757|FG001|TRANSITION PHASE|Other|0|||
105423805|NCT01529515|363558758|FG002|TRANSITION PHASE|Other|0|||
105423806|NCT01529515|363558759|FG003|TRANSITION PHASE|Other|0|||
105423807|NCT01529515|363558756|FG000|MAINTENANCE PHASE|Adverse Event|0|||
105423808|NCT01529515|363558757|FG001|MAINTENANCE PHASE|Adverse Event|10|||
105423809|NCT01529515|363558758|FG002|MAINTENANCE PHASE|Adverse Event|0|||
105423810|NCT01529515|363558759|FG003|MAINTENANCE PHASE|Adverse Event|0|||
105423811|NCT01529515|363558756|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
105423812|NCT01529515|363558757|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
105423813|NCT01529515|363558758|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
105423814|NCT01529515|363558759|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
105423815|NCT01529515|363558756|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
105423816|NCT01529515|363558757|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
105423817|NCT01529515|363558758|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
105423818|NCT01529515|363558759|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
105423819|NCT01529515|363558756|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
105423820|NCT01529515|363558757|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
105423821|NCT01529515|363558758|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
105423822|NCT01529515|363558759|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
105423823|NCT01529515|363558756|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
105423824|NCT01529515|363558757|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
105423825|NCT01529515|363558758|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
105423826|NCT01529515|363558759|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
105423827|NCT01529515|363558756|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
105423828|NCT01529515|363558757|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
105423829|NCT01529515|363558758|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
105423830|NCT01529515|363558759|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
105423831|NCT01529515|363558756|FG000|MAINTENANCE PHASE|Other|0|||
105423832|NCT01529515|363558757|FG001|MAINTENANCE PHASE|Other|10|||
105423833|NCT01529515|363558758|FG002|MAINTENANCE PHASE|Other|0|||
105423834|NCT01529515|363558759|FG003|MAINTENANCE PHASE|Other|0|||
105423835|NCT01529515|363558756|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
105423836|NCT01529515|363558757|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
105423837|NCT01529515|363558758|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
105423838|NCT01529515|363558759|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
105423839|NCT01529515|363558756|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
105423840|NCT01529515|363558757|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
105423841|NCT01529515|363558758|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
105423842|NCT01529515|363558759|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
105423843|NCT01529515|363558756|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
105423844|NCT01529515|363558757|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
105423845|NCT01529515|363558758|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
105423846|NCT01529515|363558759|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
105423847|NCT01529515|363558756|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
105423848|NCT01529515|363558757|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
105423849|NCT01529515|363558758|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
105423850|NCT01529515|363558759|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
105423851|NCT01529515|363558756|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
105423852|NCT01529515|363558757|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
105423853|NCT01529515|363558758|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
105423854|NCT01529515|363558759|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
105423855|NCT01529515|363558756|FG000|DOUBLE BLIND PHASE|Other|0|||
105423856|NCT01529515|363558757|FG001|DOUBLE BLIND PHASE|Other|0|||
105423857|NCT01529515|363558758|FG002|DOUBLE BLIND PHASE|Other|9|||
105423858|NCT01529515|363558759|FG003|DOUBLE BLIND PHASE|Other|2|||
105423859|NCT03334851|363558761|FG000|Overall Study|Other|0|||
105423860|NCT03334851|363558762|FG001|Overall Study|Other|0|||
105423861|NCT03334851|363558763|FG002|Overall Study|Other|0|||
105423862|NCT03334851|363558764|FG003|Overall Study|Other|0|||
105423863|NCT03334851|363558765|FG004|Overall Study|Other|0|||
105423864|NCT03334851|363558766|FG005|Overall Study|Other|0|||
105586840|NCT02240680|364147401|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
105586841|NCT02240680|364147398|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
105586842|NCT02240680|364147399|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
105586843|NCT02240680|364147400|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
105586844|NCT02240680|364147401|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
105586845|NCT00647348|364147402|FG000|Overall Study|Lost to Follow-up|3|||
105586846|NCT00647348|364147403|FG001|Overall Study|Lost to Follow-up|6|||
105586847|NCT01417000|364147404|FG000|Overall Study|Death|59|||
105586848|NCT01417000|364147405|FG001|Overall Study|Death|28|||
105586849|NCT01417000|364147404|FG000|Overall Study|Lost to Follow-up|1|||
105586850|NCT01417000|364147405|FG001|Overall Study|Lost to Follow-up|0|||
105586851|NCT01417000|364147404|FG000|Overall Study|Study Terminated by Sponsor|1|||
105586852|NCT01417000|364147405|FG001|Overall Study|Study Terminated by Sponsor|1|||
105586853|NCT01657682|364147412|FG000|Overall Study|Lost to Follow-up|1|||
105586854|NCT01657682|364147413|FG001|Overall Study|Lost to Follow-up|0|||
105586855|NCT01657682|364147414|FG002|Overall Study|Lost to Follow-up|0|||
105586856|NCT01657682|364147412|FG000|Overall Study|Withdrawal by Subject|0|||
105586857|NCT01657682|364147413|FG001|Overall Study|Withdrawal by Subject|1|||
105586858|NCT01657682|364147414|FG002|Overall Study|Withdrawal by Subject|1|||
105586859|NCT01657682|364147412|FG000|Overall Study|Adverse Event|0|||
105586860|NCT01657682|364147413|FG001|Overall Study|Adverse Event|1|||
105586861|NCT01657682|364147414|FG002|Overall Study|Adverse Event|0|||
105586862|NCT00958009|364147419|FG000|Overall Study|Adverse Event|1|||
105586863|NCT00958009|364147419|FG000|Overall Study|Subject found device difficult to use|1|||
105586864|NCT00282438|364147428|FG000|Overall Study|Lack of Efficacy|1|||
105586865|NCT00282438|364147429|FG001|Overall Study|Lack of Efficacy|0|||
105586866|NCT00282438|364147428|FG000|Overall Study|Death|0|||
105586867|NCT00282438|364147429|FG001|Overall Study|Death|1|||
105586868|NCT02138916|364147434|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
105586869|NCT02138916|364147435|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
105586870|NCT02138916|364147436|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
105586871|NCT02138916|364147434|FG000|Overall Study|Death|14|||
105586872|NCT02138916|364147435|FG001|Overall Study|Death|11|||
105586873|NCT02138916|364147436|FG002|Overall Study|Death|12|||
105586874|NCT02138916|364147434|FG000|Overall Study|Withdrawal by Subject|27|||
105586875|NCT02138916|364147435|FG001|Overall Study|Withdrawal by Subject|31|||
105586876|NCT02138916|364147436|FG002|Overall Study|Withdrawal by Subject|32|||
105586877|NCT02138916|364147434|FG000|Overall Study|Study specific withdrawal criteria|0|||
105586878|NCT02138916|364147435|FG001|Overall Study|Study specific withdrawal criteria|0|||
105586879|NCT02138916|364147436|FG002|Overall Study|Study specific withdrawal criteria|1|||
105586880|NCT02138916|364147434|FG000|Overall Study|incorrect enrolment|1|||
105586881|NCT02138916|364147435|FG001|Overall Study|incorrect enrolment|1|||
105586882|NCT02138916|364147436|FG002|Overall Study|incorrect enrolment|0|||
105586883|NCT02138916|364147434|FG000|Overall Study|Severe non-compliance|1|||
105586884|NCT02138916|364147435|FG001|Overall Study|Severe non-compliance|2|||
105586885|NCT02138916|364147436|FG002|Overall Study|Severe non-compliance|1|||
105586886|NCT02138916|364147434|FG000|Overall Study|Lost to Follow-up|4|||
105586887|NCT02138916|364147435|FG001|Overall Study|Lost to Follow-up|2|||
105586888|NCT02138916|364147436|FG002|Overall Study|Lost to Follow-up|3|||
105586889|NCT02138916|364147434|FG000|Overall Study|Adverse Event|4|||
105586890|NCT02138916|364147435|FG001|Overall Study|Adverse Event|4|||
105586891|NCT02138916|364147436|FG002|Overall Study|Adverse Event|3|||
105586892|NCT03005288|364147440|FG000|Overall Study|Withdrawal by Subject|7|||
105586893|NCT03005288|364147441|FG001|Overall Study|Withdrawal by Subject|5|||
105586894|NCT03005288|364147440|FG000|Overall Study|Lost to Follow-up|0|||
105586895|NCT03005288|364147441|FG001|Overall Study|Lost to Follow-up|1|||
105586896|NCT03005288|364147440|FG000|Overall Study|Adverse Event|5|||
105586897|NCT03005288|364147441|FG001|Overall Study|Adverse Event|0|||
105586898|NCT03005288|364147440|FG000|Overall Study|Protocol deviation|0|||
105586899|NCT03005288|364147441|FG001|Overall Study|Protocol deviation|1|||
105423865|NCT03334851|363558767|FG006|Overall Study|Other|0|||
105423866|NCT03334851|363558768|FG007|Overall Study|Other|1|||
105423867|NCT03334851|363558769|FG008|Overall Study|Other|0|||
105423868|NCT03334851|363558770|FG009|Overall Study|Other|0|||
105586900|NCT03005288|364147440|FG000|Overall Study|Physician Decision|0|||
105586901|NCT03005288|364147441|FG001|Overall Study|Physician Decision|1|||
105586902|NCT01190176|364147442|FG000|Overall Study|Withdrawal by Subject|1|||
105586903|NCT01190176|364147442|FG000|Overall Study|Lost to Follow-up|1|||
105586904|NCT02081391|364147443|FG000|12-hour Treatment|Withdrawal by Subject|3|||
105423869|NCT03334851|363558771|FG010|Overall Study|Other|0|||
105423870|NCT03334851|363558772|FG011|Overall Study|Other|0|||
105423871|NCT03334851|363558773|FG012|Overall Study|Other|0|||
105423872|NCT03334851|363558761|FG000|Overall Study|Adverse Event|0|||
105423873|NCT03334851|363558762|FG001|Overall Study|Adverse Event|0|||
105423874|NCT03334851|363558763|FG002|Overall Study|Adverse Event|0|||
105586905|NCT02081391|364147444|FG001|12-hour Treatment|Withdrawal by Subject|2|||
105586906|NCT02081391|364147445|FG002|12-hour Treatment|Withdrawal by Subject|0|||
105586907|NCT02081391|364147446|FG003|12-hour Treatment|Withdrawal by Subject|0|||
105423875|NCT03334851|363558764|FG003|Overall Study|Adverse Event|0|||
105423876|NCT03334851|363558765|FG004|Overall Study|Adverse Event|0|||
105423877|NCT03334851|363558766|FG005|Overall Study|Adverse Event|0|||
105423878|NCT03334851|363558767|FG006|Overall Study|Adverse Event|0|||
105423879|NCT03334851|363558768|FG007|Overall Study|Adverse Event|1|||
105423880|NCT03334851|363558769|FG008|Overall Study|Adverse Event|0|||
105423881|NCT03334851|363558770|FG009|Overall Study|Adverse Event|0|||
105423882|NCT03334851|363558771|FG010|Overall Study|Adverse Event|0|||
105423883|NCT03334851|363558772|FG011|Overall Study|Adverse Event|0|||
105423884|NCT03334851|363558773|FG012|Overall Study|Adverse Event|0|||
105423885|NCT03334851|363558761|FG000|Overall Study|Withdrawal by Subject|0|||
105423886|NCT03334851|363558762|FG001|Overall Study|Withdrawal by Subject|0|||
105423887|NCT03334851|363558763|FG002|Overall Study|Withdrawal by Subject|0|||
105423888|NCT03334851|363558764|FG003|Overall Study|Withdrawal by Subject|0|||
105423889|NCT03334851|363558765|FG004|Overall Study|Withdrawal by Subject|0|||
105423890|NCT03334851|363558766|FG005|Overall Study|Withdrawal by Subject|0|||
105423891|NCT03334851|363558767|FG006|Overall Study|Withdrawal by Subject|0|||
105423892|NCT03334851|363558768|FG007|Overall Study|Withdrawal by Subject|0|||
105423893|NCT03334851|363558769|FG008|Overall Study|Withdrawal by Subject|0|||
105586908|NCT02081391|364147443|FG000|12-hour Treatment|Physician Decision|4|||
105586909|NCT02081391|364147444|FG001|12-hour Treatment|Physician Decision|1|||
105423894|NCT03334851|363558770|FG009|Overall Study|Withdrawal by Subject|0|||
105423895|NCT03334851|363558771|FG010|Overall Study|Withdrawal by Subject|1|||
105423896|NCT03334851|363558772|FG011|Overall Study|Withdrawal by Subject|0|||
105423897|NCT03334851|363558773|FG012|Overall Study|Withdrawal by Subject|1|||
105423898|NCT03334851|363558761|FG000|Overall Study|Lost to Follow-up|0|||
105423899|NCT03334851|363558762|FG001|Overall Study|Lost to Follow-up|0|||
105423900|NCT03334851|363558763|FG002|Overall Study|Lost to Follow-up|0|||
105423901|NCT03334851|363558764|FG003|Overall Study|Lost to Follow-up|0|||
105423902|NCT03334851|363558765|FG004|Overall Study|Lost to Follow-up|0|||
105423903|NCT03334851|363558766|FG005|Overall Study|Lost to Follow-up|0|||
105423904|NCT03334851|363558767|FG006|Overall Study|Lost to Follow-up|0|||
105423905|NCT03334851|363558768|FG007|Overall Study|Lost to Follow-up|0|||
105423906|NCT03334851|363558769|FG008|Overall Study|Lost to Follow-up|0|||
105423907|NCT03334851|363558770|FG009|Overall Study|Lost to Follow-up|0|||
105423908|NCT03334851|363558771|FG010|Overall Study|Lost to Follow-up|2|||
105423909|NCT03334851|363558772|FG011|Overall Study|Lost to Follow-up|1|||
105423910|NCT03334851|363558773|FG012|Overall Study|Lost to Follow-up|0|||
105423911|NCT02534935|363558774|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
105423912|NCT02534935|363558775|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
105423913|NCT02534935|363558776|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
105423914|NCT02534935|363558774|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
105423915|NCT02534935|363558775|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
105423916|NCT02534935|363558776|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
105423917|NCT02534935|363558774|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
105423918|NCT02534935|363558775|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
105423919|NCT02534935|363558776|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
105423920|NCT02534935|363558774|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
105423921|NCT02534935|363558775|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
105423922|NCT02534935|363558776|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
105423923|NCT02534935|363558774|FG000|Stage 1: 24 Months|Adverse Event|0|||
105423924|NCT02534935|363558775|FG001|Stage 1: 24 Months|Adverse Event|2|||
105423925|NCT02534935|363558776|FG002|Stage 1: 24 Months|Adverse Event|0|||
105423926|NCT02534935|363558774|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
105423927|NCT02534935|363558775|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
105423928|NCT02534935|363558776|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
105423929|NCT02534935|363558774|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
105423930|NCT02534935|363558775|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
105423931|NCT02534935|363558776|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
105423932|NCT01069861|363558777|FG000|Overall Study|Death|1|||
105423933|NCT01069861|363558777|FG000|Overall Study|Adverse Event|1|||
105423934|NCT01069861|363558777|FG000|Overall Study|Did not meet entrance criteria|1|||
105423935|NCT03555981|363558778|FG000|Overall Study|Lost to Follow-up|0|||
105423936|NCT03555981|363558779|FG001|Overall Study|Lost to Follow-up|2|||
105423937|NCT03272828|363558780|FG000|Overall Study|Lost to Follow-up|7|||
105423938|NCT03272828|363558781|FG001|Overall Study|Lost to Follow-up|7|||
105423939|NCT03272828|363558780|FG000|Overall Study|Withdrawal by Subject|2|||
105423940|NCT03272828|363558781|FG001|Overall Study|Withdrawal by Subject|0|||
105423941|NCT03272828|363558780|FG000|Overall Study|Deceased|1|||
105423942|NCT03272828|363558781|FG001|Overall Study|Deceased|1|||
105423943|NCT03272828|363558780|FG000|Overall Study|Failed implant|1|||
105423944|NCT03272828|363558781|FG001|Overall Study|Failed implant|2|||
105423945|NCT04600076|363558784|FG000|Overall Study|Lost to Follow-up|3|||
105423946|NCT00252694|363558785|FG000|Overall Study|Withdrawal by Subject|83|||
105423947|NCT00252694|363558786|FG001|Overall Study|Withdrawal by Subject|91|||
105586910|NCT02081391|364147445|FG002|12-hour Treatment|Physician Decision|0|||
105423948|NCT00252694|363558785|FG000|Overall Study|Death|36|||
105423949|NCT00252694|363558786|FG001|Overall Study|Death|34|||
105423950|NCT00252694|363558785|FG000|Overall Study|Mostly Lost to Follow Up|8|||
105423951|NCT00252694|363558786|FG001|Overall Study|Mostly Lost to Follow Up|13|||
105423952|NCT00252694|363558785|FG000|Overall Study|Patient Moving|17|||
105423953|NCT00252694|363558786|FG001|Overall Study|Patient Moving|16|||
105423954|NCT00683917|363558789|FG000|Overall Study|Study prematurely terminated|10|||
105423955|NCT04422561|363558802|FG000|Overall Study|Lost to Follow-up|25|||
105423956|NCT04422561|363558803|FG001|Overall Study|Lost to Follow-up|11|||
105423957|NCT03640052|363558804|FG000|Overall Study|Lost to Follow-up|0|||
105423958|NCT03640052|363558805|FG001|Overall Study|Lost to Follow-up|1|||
105423959|NCT03640052|363558806|FG002|Overall Study|Lost to Follow-up|0|||
105423960|NCT03640052|363558807|FG003|Overall Study|Lost to Follow-up|0|||
105423961|NCT03640052|363558808|FG004|Overall Study|Lost to Follow-up|0|||
105423962|NCT01666119|363558809|FG000|Overall Study|Adverse Event|6|||
105423963|NCT01666119|363558809|FG000|Overall Study|Withdrawal by Subject|16|||
105423964|NCT01666119|363558809|FG000|Overall Study|Lost to Follow-up|7|||
105423965|NCT01666119|363558809|FG000|Overall Study|non compliance with study medication, pa|18|||
105423966|NCT01666119|363558809|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
105423967|NCT00937404|363558810|FG000|Overall Study|Protocol Violation|1|||
105423968|NCT00937404|363558810|FG000|Overall Study|Withdrawal by Subject|1|||
105423969|NCT00230282|363558814|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
105423970|NCT00230282|363558814|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
105423971|NCT00230282|363558814|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
105423972|NCT00230282|363558814|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
105423973|NCT03349645|363558823|FG000|Overall Study|Sponsor Terminated Study|75|||
105423974|NCT03349645|363558823|FG000|Overall Study|Withdrawal by Subject|4|||
105423975|NCT03349645|363558823|FG000|Overall Study|Protocol Violation|1|||
105423976|NCT03349645|363558823|FG000|Overall Study|Other|2|||
105423977|NCT00871117|363558826|FG000|Overall Study|Lost to Follow-up|5|||
105423978|NCT00871117|363558827|FG001|Overall Study|Lost to Follow-up|6|||
105423979|NCT00871117|363558826|FG000|Overall Study|Other|0|||
105423980|NCT00871117|363558827|FG001|Overall Study|Other|4|||
105423981|NCT01218100|363558828|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
105423982|NCT01218100|363558829|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
105423983|NCT01218100|363558830|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
105423984|NCT01218100|363558831|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
105423985|NCT01218100|363558828|FG000|Overall Study|Adverse Event|4|||
105423986|NCT01218100|363558829|FG001|Overall Study|Adverse Event|6|||
105423987|NCT01218100|363558830|FG002|Overall Study|Adverse Event|6|||
105423988|NCT01218100|363558831|FG003|Overall Study|Adverse Event|7|||
105423989|NCT01218100|363558828|FG000|Overall Study|Lack of Efficacy|9|||
105423990|NCT01218100|363558829|FG001|Overall Study|Lack of Efficacy|6|||
105423991|NCT01218100|363558830|FG002|Overall Study|Lack of Efficacy|5|||
105423992|NCT01218100|363558831|FG003|Overall Study|Lack of Efficacy|12|||
105423993|NCT01218100|363558828|FG000|Overall Study|Protocol Violation|0|||
105423994|NCT01218100|363558829|FG001|Overall Study|Protocol Violation|0|||
105423995|NCT01218100|363558830|FG002|Overall Study|Protocol Violation|1|||
105423996|NCT01218100|363558831|FG003|Overall Study|Protocol Violation|1|||
105423997|NCT01218100|363558828|FG000|Overall Study|Withdrawal by Subject|5|||
105423998|NCT01218100|363558829|FG001|Overall Study|Withdrawal by Subject|2|||
105423999|NCT01218100|363558830|FG002|Overall Study|Withdrawal by Subject|6|||
105424000|NCT01218100|363558831|FG003|Overall Study|Withdrawal by Subject|7|||
105424001|NCT01218100|363558828|FG000|Overall Study|Lost to Follow-up|3|||
105424002|NCT01218100|363558829|FG001|Overall Study|Lost to Follow-up|8|||
105424003|NCT01218100|363558830|FG002|Overall Study|Lost to Follow-up|2|||
105424004|NCT01218100|363558831|FG003|Overall Study|Lost to Follow-up|1|||
105424005|NCT01218100|363558828|FG000|Overall Study|Other Reason|2|||
105424006|NCT01218100|363558829|FG001|Overall Study|Other Reason|2|||
105424007|NCT01218100|363558830|FG002|Overall Study|Other Reason|6|||
105424008|NCT01218100|363558831|FG003|Overall Study|Other Reason|4|||
105424009|NCT03385265|363558832|FG000|Overall Study|Withdrawal by Subject|5|||
105424010|NCT03385265|363558833|FG001|Overall Study|Withdrawal by Subject|2|||
105424011|NCT03385265|363558834|FG002|Overall Study|Withdrawal by Subject|5|||
105424012|NCT03385265|363558835|FG003|Overall Study|Withdrawal by Subject|2|||
105424013|NCT01118520|363558837|FG000|Overall Study|AAA repair|9|||
105424014|NCT01118520|363558838|FG001|Overall Study|AAA repair|7|||
105424015|NCT01118520|363558839|FG002|Overall Study|AAA repair|9|||
105424016|NCT01118520|363558837|FG000|Overall Study|Adverse Event|3|||
105424017|NCT01118520|363558838|FG001|Overall Study|Adverse Event|3|||
105424018|NCT01118520|363558839|FG002|Overall Study|Adverse Event|3|||
105424019|NCT01118520|363558837|FG000|Overall Study|Withdrawal by Subject|8|||
105424020|NCT01118520|363558838|FG001|Overall Study|Withdrawal by Subject|13|||
105424021|NCT01118520|363558839|FG002|Overall Study|Withdrawal by Subject|8|||
105424022|NCT00413920|363558860|FG000|Overall Study|Adverse Event|9|||
105424023|NCT00413920|363558861|FG001|Overall Study|Adverse Event|11|||
105586911|NCT02081391|364147446|FG003|12-hour Treatment|Physician Decision|0|||
105586912|NCT02081391|364147443|FG000|12-hour Treatment|Lack of Efficacy|3|||
105586913|NCT02081391|364147444|FG001|12-hour Treatment|Lack of Efficacy|0|||
105586914|NCT02081391|364147445|FG002|12-hour Treatment|Lack of Efficacy|0|||
105586915|NCT02081391|364147446|FG003|12-hour Treatment|Lack of Efficacy|0|||
105586916|NCT02081391|364147443|FG000|12-hour Treatment|Adverse Event|4|||
105586917|NCT02081391|364147444|FG001|12-hour Treatment|Adverse Event|2|||
105586918|NCT02081391|364147445|FG002|12-hour Treatment|Adverse Event|0|||
105586919|NCT02081391|364147446|FG003|12-hour Treatment|Adverse Event|0|||
105586920|NCT02081391|364147443|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
105586921|NCT02081391|364147444|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
105424024|NCT00413920|363558860|FG000|Overall Study|Lack of Efficacy|11|||
105424025|NCT00413920|363558861|FG001|Overall Study|Lack of Efficacy|9|||
105586922|NCT02081391|364147445|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
105586923|NCT02081391|364147446|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
105586924|NCT02081391|364147443|FG000|12-hour Treatment|Further reasons|2|||
105586925|NCT02081391|364147444|FG001|12-hour Treatment|Further reasons|1|||
105586926|NCT02081391|364147445|FG002|12-hour Treatment|Further reasons|0|||
105586927|NCT02081391|364147446|FG003|12-hour Treatment|Further reasons|0|||
105586928|NCT02081391|364147443|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
105586929|NCT02081391|364147444|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
105586930|NCT02081391|364147445|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
105586931|NCT02081391|364147446|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
105586932|NCT02081391|364147443|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
105586933|NCT02081391|364147444|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
105586934|NCT02081391|364147445|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
105586935|NCT02081391|364147446|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
105586936|NCT02081391|364147443|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
105424026|NCT00413920|363558860|FG000|Overall Study|Death|3|||
105424027|NCT00413920|363558861|FG001|Overall Study|Death|5|||
105424028|NCT00413920|363558860|FG000|Overall Study|Graft Loss|5|||
105424029|NCT00413920|363558861|FG001|Overall Study|Graft Loss|3|||
105424030|NCT02434354|363558862|FG000|Overall Study|screen fail|3|||
105424031|NCT03730961|363558863|FG000|Overall Study|Adverse Event|0|||
105424032|NCT03730961|363558864|FG001|Overall Study|Adverse Event|1|||
105424033|NCT04465877|363558870|FG000|Overall Study|Noncompliant with study requirements|0|||
105424034|NCT04465877|363558871|FG001|Overall Study|Noncompliant with study requirements|0|||
105424035|NCT04465877|363558872|FG002|Overall Study|Noncompliant with study requirements|1|||
105424036|NCT04465877|363558873|FG003|Overall Study|Noncompliant with study requirements|0|||
105424037|NCT03762616|363558874|FG000|Overall Study|Protocol Violation|2|||
105424038|NCT03831880|363558875|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
105424039|NCT03831880|363558876|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
105424040|NCT03831880|363558875|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
105424041|NCT03831880|363558876|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
105424042|NCT03958656|363558879|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
105424043|NCT03958656|363558880|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
105424044|NCT03958656|363558881|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
105424045|NCT03958656|363558882|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
105424046|NCT03958656|363558879|FG000|Overall Study|No longer meets eligibility criteria|0|||
105424047|NCT03958656|363558880|FG001|Overall Study|No longer meets eligibility criteria|0|||
105424048|NCT03958656|363558881|FG002|Overall Study|No longer meets eligibility criteria|1|||
105424049|NCT03958656|363558882|FG003|Overall Study|No longer meets eligibility criteria|0|||
105424050|NCT03958656|363558879|FG000|Overall Study|Started anti-cancer treatment|0|||
105424051|NCT03958656|363558880|FG001|Overall Study|Started anti-cancer treatment|0|||
105424052|NCT03958656|363558881|FG002|Overall Study|Started anti-cancer treatment|1|||
105424053|NCT03958656|363558882|FG003|Overall Study|Started anti-cancer treatment|0|||
105424054|NCT04346108|363558883|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
105424055|NCT04346108|363558884|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
105424056|NCT04346108|363558885|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
105424057|NCT04346108|363558883|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
105424058|NCT04346108|363558884|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
105424059|NCT04346108|363558885|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
105424060|NCT03158012|363558886|FG000|Overall Study|Withdrawal by Subject|0|||
105424061|NCT03158012|363558887|FG001|Overall Study|Withdrawal by Subject|1|||
105424062|NCT01598753|363558888|FG000|Overall Study|Adverse Event|1|||
105424063|NCT01598753|363558889|FG001|Overall Study|Adverse Event|9|||
105586937|NCT02081391|364147444|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
105586938|NCT02081391|364147445|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
105424064|NCT01598753|363558890|FG002|Overall Study|Adverse Event|1|||
105424065|NCT01598753|363558891|FG003|Overall Study|Adverse Event|7|||
105424066|NCT01598753|363558888|FG000|Overall Study|Lost to Follow-up|4|||
105424067|NCT01598753|363558889|FG001|Overall Study|Lost to Follow-up|3|||
105424068|NCT01598753|363558890|FG002|Overall Study|Lost to Follow-up|7|||
105424069|NCT01598753|363558891|FG003|Overall Study|Lost to Follow-up|5|||
105424070|NCT01598753|363558888|FG000|Overall Study|Physician Decision|0|||
105424071|NCT01598753|363558889|FG001|Overall Study|Physician Decision|1|||
105424072|NCT01598753|363558890|FG002|Overall Study|Physician Decision|0|||
105424073|NCT01598753|363558891|FG003|Overall Study|Physician Decision|2|||
105424074|NCT01598753|363558888|FG000|Overall Study|Withdrawal by Subject|7|||
105424075|NCT01598753|363558889|FG001|Overall Study|Withdrawal by Subject|2|||
105424076|NCT01598753|363558890|FG002|Overall Study|Withdrawal by Subject|0|||
105424077|NCT01598753|363558891|FG003|Overall Study|Withdrawal by Subject|1|||
105424078|NCT04508751|363558894|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
105424079|NCT04508751|363558895|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
105424080|NCT04508751|363558896|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
105424081|NCT00072293|363558897|FG000|Overall Study|Lost to Follow-up|1|||
105424082|NCT00072293|363558898|FG001|Overall Study|Lost to Follow-up|1|||
105424083|NCT00072293|363558897|FG000|Overall Study|Withdrawal by Subject|0|||
105424084|NCT00072293|363558898|FG001|Overall Study|Withdrawal by Subject|1|||
105424085|NCT01166958|363558899|FG000|Overall Study|Withdrawal by Subject|1|||
105424086|NCT01166958|363558900|FG001|Overall Study|Withdrawal by Subject|0|||
105424087|NCT02680574|363558901|FG000|Overall Study|Death|137|||
105424088|NCT02680574|363558902|FG001|Overall Study|Death|137|||
105424089|NCT02680574|363558901|FG000|Overall Study|Withdrawal by Subject|17|||
105424090|NCT02680574|363558902|FG001|Overall Study|Withdrawal by Subject|9|||
105424091|NCT02680574|363558901|FG000|Overall Study|Lost to Follow-up|4|||
105424092|NCT02680574|363558902|FG001|Overall Study|Lost to Follow-up|6|||
105424093|NCT04209114|363558903|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
105424094|NCT04209114|363558904|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
105424095|NCT04209114|363558905|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
105424096|NCT04209114|363558903|FG000|Pre-Treatment Phase|Other reasons|0|||
105424097|NCT04209114|363558904|FG001|Pre-Treatment Phase|Other reasons|0|||
105424098|NCT04209114|363558905|FG002|Pre-Treatment Phase|Other reasons|1|||
105424099|NCT04209114|363558903|FG000|Pre-Treatment Phase|Death|0|||
105424100|NCT04209114|363558904|FG001|Pre-Treatment Phase|Death|0|||
105424101|NCT04209114|363558905|FG002|Pre-Treatment Phase|Death|1|||
105424102|NCT04209114|363558903|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
105424103|NCT04209114|363558904|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
105424104|NCT04209114|363558905|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
105424105|NCT04209114|363558903|FG000|Treatment Phase|Other reasons|5|||
105424106|NCT04209114|363558904|FG001|Treatment Phase|Other reasons|3|||
105424107|NCT04209114|363558905|FG002|Treatment Phase|Other reasons|0|||
105424108|NCT04209114|363558903|FG000|Treatment Phase|Lost to Follow-up|1|||
105424109|NCT04209114|363558904|FG001|Treatment Phase|Lost to Follow-up|0|||
105424110|NCT04209114|363558905|FG002|Treatment Phase|Lost to Follow-up|0|||
105424111|NCT04209114|363558903|FG000|Treatment Phase|Participant withdrew consent|1|||
105424112|NCT04209114|363558904|FG001|Treatment Phase|Participant withdrew consent|0|||
105424113|NCT04209114|363558905|FG002|Treatment Phase|Participant withdrew consent|0|||
105424114|NCT04209114|363558903|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
105424115|NCT04209114|363558904|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
105424116|NCT04209114|363558905|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
105424117|NCT04209114|363558903|FG000|Treatment Phase|Death|4|||
105424118|NCT04209114|363558904|FG001|Treatment Phase|Death|1|||
105424119|NCT04209114|363558905|FG002|Treatment Phase|Death|0|||
105424120|NCT04209114|363558903|FG000|Treatment Phase|Study drug toxicity|4|||
105424121|NCT04209114|363558904|FG001|Treatment Phase|Study drug toxicity|6|||
105424122|NCT04209114|363558905|FG002|Treatment Phase|Study drug toxicity|0|||
105424123|NCT04209114|363558903|FG000|Treatment Phase|Disease progression|6|||
105424124|NCT04209114|363558904|FG001|Treatment Phase|Disease progression|9|||
105424125|NCT04209114|363558905|FG002|Treatment Phase|Disease progression|0|||
105424126|NCT02826421|363558908|FG000|Overall Study|Adverse Event|1|||
105424127|NCT02826421|363558909|FG001|Overall Study|Adverse Event|0|||
105424128|NCT02826421|363558910|FG002|Overall Study|Adverse Event|0|||
105424129|NCT02826421|363558911|FG003|Overall Study|Adverse Event|1|||
105424130|NCT02826421|363558908|FG000|Overall Study|Withdrawal by Subject|1|||
105424131|NCT02826421|363558909|FG001|Overall Study|Withdrawal by Subject|3|||
105424132|NCT02826421|363558910|FG002|Overall Study|Withdrawal by Subject|1|||
105424133|NCT02826421|363558911|FG003|Overall Study|Withdrawal by Subject|1|||
105424134|NCT02826421|363558908|FG000|Overall Study|Reason not given|1|||
105424135|NCT02826421|363558909|FG001|Overall Study|Reason not given|0|||
105424136|NCT02826421|363558910|FG002|Overall Study|Reason not given|1|||
105424137|NCT02826421|363558911|FG003|Overall Study|Reason not given|0|||
105424138|NCT00642369|363561176|FG000|Overall Study|Adverse Event|2|||
105424139|NCT00642369|363561177|FG001|Overall Study|Adverse Event|3|||
105424140|NCT00642369|363561176|FG000|Overall Study|Withdrawal by Subject|1|||
105424141|NCT00642369|363561177|FG001|Overall Study|Withdrawal by Subject|0|||
105424142|NCT00642369|363561176|FG000|Overall Study|misdiagnosis|0|||
105424143|NCT00642369|363561177|FG001|Overall Study|misdiagnosis|1|||
105424144|NCT00642369|363561176|FG000|Overall Study|Lack of Efficacy|2|||
105424145|NCT00642369|363561177|FG001|Overall Study|Lack of Efficacy|2|||
105424146|NCT00996281|363561179|FG000|Overall Study|Adverse Event|75|||
105424147|NCT00996281|363561180|FG001|Overall Study|Adverse Event|37|||
105424148|NCT00996281|363561179|FG000|Overall Study|Major Protocol Deviation|6|||
105424149|NCT00996281|363561180|FG001|Overall Study|Major Protocol Deviation|7|||
105424150|NCT00996281|363561179|FG000|Overall Study|Lost to Follow-up|14|||
105424151|NCT00996281|363561180|FG001|Overall Study|Lost to Follow-up|16|||
105424152|NCT00996281|363561179|FG000|Overall Study|Withdrawal by Subject|31|||
105424153|NCT00996281|363561180|FG001|Overall Study|Withdrawal by Subject|20|||
105424154|NCT00996281|363561179|FG000|Overall Study|Lack of Efficacy|0|||
105424155|NCT00996281|363561180|FG001|Overall Study|Lack of Efficacy|2|||
105424156|NCT00996281|363561179|FG000|Overall Study|Other|5|||
105424157|NCT00996281|363561180|FG001|Overall Study|Other|7|||
105424158|NCT03383783|363561181|FG000|Overall Study|Withdrawal by Subject|2|||
105424159|NCT00794365|363561182|FG000|Overall Study|Lost to Follow-up|38|||
105424160|NCT00794365|363561182|FG000|Overall Study|Other|17|||
105424161|NCT00794365|363561182|FG000|Overall Study|Poor Compliance|11|||
105424162|NCT00794365|363561182|FG000|Overall Study|Adverse Event|10|||
105424163|NCT00794365|363561182|FG000|Overall Study|Lack of Efficacy|3|||
105424164|NCT00856206|363561183|FG000|Overall Study|Protocol Violation|6|||
105424165|NCT00856206|363561184|FG001|Overall Study|Protocol Violation|18|||
105424166|NCT00856206|363561183|FG000|Overall Study|Adverse Event|10|||
105424167|NCT00856206|363561184|FG001|Overall Study|Adverse Event|46|||
105424168|NCT00856206|363561183|FG000|Overall Study|Lack of Efficacy|1|||
105424169|NCT00856206|363561184|FG001|Overall Study|Lack of Efficacy|2|||
105424170|NCT00856206|363561183|FG000|Overall Study|Withdrawal by Subject|15|||
105424171|NCT00856206|363561184|FG001|Overall Study|Withdrawal by Subject|36|||
105424172|NCT00856206|363561183|FG000|Overall Study|Lost to Follow-up|13|||
105424173|NCT00856206|363561184|FG001|Overall Study|Lost to Follow-up|39|||
105424174|NCT00856206|363561183|FG000|Overall Study|Death|2|||
105424175|NCT00856206|363561184|FG001|Overall Study|Death|2|||
105424176|NCT00856206|363561183|FG000|Overall Study|Decision by the Sponsor|4|||
105424177|NCT00856206|363561184|FG001|Overall Study|Decision by the Sponsor|8|||
105424178|NCT00856206|363561183|FG000|Overall Study|Other than specified above|3|||
105424179|NCT00856206|363561184|FG001|Overall Study|Other than specified above|10|||
105424180|NCT01170598|363561188|FG000|Overall Study|Withdrawal by Subject|1|||
105424181|NCT01170598|363561188|FG000|Overall Study|Death|3|||
105424182|NCT01170598|363561188|FG000|Overall Study|Lost to Follow-up|1|||
105424183|NCT01170598|363561188|FG000|Overall Study|Refused|1|||
105424184|NCT02119156|363561189|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
105424185|NCT02119156|363561190|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
105424186|NCT02119156|363561191|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
105424187|NCT02119156|363561189|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
105424188|NCT02119156|363561190|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
105424189|NCT02119156|363561191|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
105424190|NCT02119156|363561189|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
105424191|NCT02119156|363561190|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
105424192|NCT02119156|363561191|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
105424193|NCT02119156|363561189|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
105424194|NCT02119156|363561190|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
105424195|NCT02119156|363561191|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
105424196|NCT02119156|363561189|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
105424197|NCT02119156|363561190|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
105424198|NCT02119156|363561191|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
105424199|NCT00350623|363561194|FG000|Overall Study|Lost to Follow-up|8|||
105424200|NCT00350623|363561195|FG001|Overall Study|Lost to Follow-up|3|||
105424201|NCT00350623|363561196|FG002|Overall Study|Lost to Follow-up|4|||
105424202|NCT00350623|363561194|FG000|Overall Study|Withdrawal by Subject|0|||
105424203|NCT00350623|363561195|FG001|Overall Study|Withdrawal by Subject|1|||
105424204|NCT00350623|363561196|FG002|Overall Study|Withdrawal by Subject|1|||
105424205|NCT00350623|363561194|FG000|Overall Study|patient traveling outside the country|0|||
105424206|NCT00350623|363561195|FG001|Overall Study|patient traveling outside the country|0|||
105424207|NCT00350623|363561196|FG002|Overall Study|patient traveling outside the country|1|||
105501110|NCT00717093|363847055|FG000|Overall Study|Randomized but not treated|1|||
105586939|NCT02081391|364147446|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
105586940|NCT02081391|364147443|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
105586941|NCT02081391|364147444|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
105586942|NCT02081391|364147445|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
105586943|NCT02081391|364147446|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
105586944|NCT02081391|364147443|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
105586945|NCT02081391|364147444|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
105586946|NCT02081391|364147445|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
105586947|NCT02081391|364147446|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
105586948|NCT02081391|364147443|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
105586949|NCT02081391|364147444|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
105586950|NCT02081391|364147445|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
105586951|NCT02081391|364147446|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
105586952|NCT01450943|364148922|FG000|Overall Study|Screen failure, loss to follow-up|2|||
105586953|NCT01450943|364148923|FG001|Overall Study|Screen failure, loss to follow-up|7|||
105586954|NCT01450943|364148924|FG002|Overall Study|Screen failure, loss to follow-up|6|||
105586955|NCT01345292|364148925|FG000|Overall Study|Withdrawal by Subject|2|||
105586956|NCT01345292|364148926|FG001|Overall Study|Withdrawal by Subject|0|||
105586957|NCT01345292|364148927|FG002|Overall Study|Withdrawal by Subject|1|||
105586958|NCT05458102|364148930|FG000|Overall Study|Withdrew consent|2|||
105586959|NCT05458102|364148931|FG001|Overall Study|Withdrew consent|0|||
105586960|NCT05458102|364148930|FG000|Overall Study|Adverse Event|1|||
105586961|NCT05458102|364148931|FG001|Overall Study|Adverse Event|0|||
105586962|NCT05458102|364148930|FG000|Overall Study|Enrolled but never treated|1|||
105586963|NCT05458102|364148931|FG001|Overall Study|Enrolled but never treated|0|||
105586964|NCT05458102|364148930|FG000|Overall Study|Protocol Violation|1|||
105586965|NCT05458102|364148931|FG001|Overall Study|Protocol Violation|0|||
105586966|NCT03101592|364148935|FG000|Overall Study|participant files could not be located|111|||
105586967|NCT03101592|364148936|FG001|Overall Study|participant files could not be located|170|||
105586968|NCT03101592|364148937|FG002|Overall Study|participant files could not be located|118|||
105586969|NCT01528709|364148938|FG000|Overall Study|Death|2|||
105586970|NCT01528709|364148939|FG001|Overall Study|Death|0|||
105586971|NCT01528709|364148938|FG000|Overall Study|Withdrawal by Subject|10|||
105586972|NCT01528709|364148939|FG001|Overall Study|Withdrawal by Subject|15|||
105586973|NCT01528709|364148938|FG000|Overall Study|allergy|1|||
105586974|NCT01528709|364148939|FG001|Overall Study|allergy|0|||
105586975|NCT05124899|364148942|FG000|Overall Study|Lost to Follow-up|3|||
105586976|NCT03432533|364148945|FG000|Overall Study|Lost to Follow-up|1|||
105586977|NCT03432533|364148946|FG001|Overall Study|Lost to Follow-up|2|||
105586978|NCT03432533|364148945|FG000|Overall Study|Withdrawal by Subject|14|||
105586979|NCT03432533|364148946|FG001|Overall Study|Withdrawal by Subject|9|||
105586980|NCT01648283|364148947|FG000|Overall Study|Withdrawal by Subject|14|||
105586981|NCT01653743|364148949|FG000|Overall Study|Withdrawal by Subject|1|||
105586982|NCT01653743|364148950|FG001|Overall Study|Withdrawal by Subject|0|||
105586983|NCT01653743|364148949|FG000|Overall Study|Investigator discretion|3|||
105586984|NCT01653743|364148950|FG001|Overall Study|Investigator discretion|0|||
105586985|NCT03382821|364148955|FG000|Overall Study|Did not receive allocated intervention.|0|||
105586986|NCT03382821|364148956|FG001|Overall Study|Did not receive allocated intervention.|3|||
105586987|NCT01674569|364148964|FG000|Overall Study|Adverse Event|0|||
105586988|NCT01674569|364148965|FG001|Overall Study|Adverse Event|2|||
105586989|NCT01674569|364148966|FG002|Overall Study|Adverse Event|0|||
105586990|NCT01674569|364148967|FG003|Overall Study|Adverse Event|1|||
105586991|NCT01674569|364148968|FG004|Overall Study|Adverse Event|2|||
105586992|NCT01674569|364148969|FG005|Overall Study|Adverse Event|2|||
105586993|NCT01674569|364148964|FG000|Overall Study|Protocol Violation|0|||
105586994|NCT01674569|364148965|FG001|Overall Study|Protocol Violation|1|||
105586995|NCT01674569|364148966|FG002|Overall Study|Protocol Violation|1|||
105586996|NCT01674569|364148967|FG003|Overall Study|Protocol Violation|0|||
105586997|NCT01674569|364148968|FG004|Overall Study|Protocol Violation|0|||
105586998|NCT01674569|364148969|FG005|Overall Study|Protocol Violation|0|||
105586999|NCT01674569|364148964|FG000|Overall Study|Withdrawal by Subject|0|||
105587000|NCT01674569|364148965|FG001|Overall Study|Withdrawal by Subject|0|||
105587001|NCT01674569|364148966|FG002|Overall Study|Withdrawal by Subject|1|||
105587002|NCT01674569|364148967|FG003|Overall Study|Withdrawal by Subject|0|||
105587003|NCT01674569|364148968|FG004|Overall Study|Withdrawal by Subject|0|||
105587004|NCT01674569|364148969|FG005|Overall Study|Withdrawal by Subject|0|||
105587005|NCT05650333|364148974|FG000|Treatment Period (7 Days)|Adverse Event|1|||
105587006|NCT01649427|364148975|FG000|Overall Study|Adverse Event|1|||
105587007|NCT01649427|364148976|FG001|Overall Study|Adverse Event|1|||
105587008|NCT01649427|364148975|FG000|Overall Study|Withdrawal by Subject|8|||
105587009|NCT01649427|364148976|FG001|Overall Study|Withdrawal by Subject|7|||
105587010|NCT01649427|364148975|FG000|Overall Study|Lost to Follow-up|0|||
105587011|NCT01649427|364148976|FG001|Overall Study|Lost to Follow-up|1|||
105587012|NCT01649427|364148975|FG000|Overall Study|Graft loss|0|||
105587013|NCT01649427|364148976|FG001|Overall Study|Graft loss|1|||
105587014|NCT01649427|364148975|FG000|Overall Study|Surgical problems during nephrectomy|2|||
105424208|NCT02780856|363561199|FG000|Overall Study|Lost to Follow-up|1|||
105424209|NCT02685748|363561202|FG000|Overall Study|Withdrawal by Subject|3|||
105424210|NCT02685748|363561203|FG001|Overall Study|Withdrawal by Subject|2|||
105424211|NCT04126564|363561204|FG000|Overall Study|Withdrawal by Subject|0|||
105424212|NCT04126564|363561205|FG001|Overall Study|Withdrawal by Subject|2|||
105424213|NCT04126564|363561204|FG000|Overall Study|Lost to Follow-up|0|||
105424214|NCT04126564|363561205|FG001|Overall Study|Lost to Follow-up|1|||
105424215|NCT03500172|363561206|FG000|Period 1: Baseline Randomization|Death|0|||
105424216|NCT03500172|363561207|FG001|Period 1: Baseline Randomization|Death|0|||
105424217|NCT03500172|363561208|FG002|Period 1: Baseline Randomization|Death|0|||
105424218|NCT03500172|363561209|FG003|Period 1: Baseline Randomization|Death|0|||
105424219|NCT03500172|363561210|FG004|Period 1: Baseline Randomization|Death|0|||
105424220|NCT03500172|363561211|FG005|Period 1: Baseline Randomization|Death|0|||
105424221|NCT03500172|363561212|FG006|Period 1: Baseline Randomization|Death|0|||
105424222|NCT03500172|363561213|FG007|Period 1: Baseline Randomization|Death|0|||
105424223|NCT03500172|363561214|FG008|Period 1: Baseline Randomization|Death|0|||
105424224|NCT03500172|363561215|FG009|Period 1: Baseline Randomization|Death|2|||
105424225|NCT03500172|363561216|FG010|Period 1: Baseline Randomization|Death|0|||
105424226|NCT03500172|363561206|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
105424227|NCT03500172|363561207|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
105424228|NCT03500172|363561208|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
105424229|NCT03500172|363561209|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
105424230|NCT03500172|363561210|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
105424231|NCT03500172|363561211|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
105424232|NCT03500172|363561212|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
105424233|NCT03500172|363561213|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
105424234|NCT03500172|363561214|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
105424235|NCT03500172|363561215|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
105424236|NCT03500172|363561216|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
105424237|NCT03500172|363561206|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
105424238|NCT03500172|363561207|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
105424239|NCT03500172|363561208|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
105424240|NCT03500172|363561209|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
105424241|NCT03500172|363561210|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
105424242|NCT03500172|363561211|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
105424243|NCT03500172|363561212|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
105424244|NCT03500172|363561213|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
105424245|NCT03500172|363561214|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
105424246|NCT03500172|363561215|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
105424247|NCT03500172|363561216|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
105424248|NCT03500172|363561206|FG000|Period 2: Re-Randomization|Death|0|||
105424249|NCT03500172|363561207|FG001|Period 2: Re-Randomization|Death|0|||
105424250|NCT03500172|363561208|FG002|Period 2: Re-Randomization|Death|0|||
105424251|NCT03500172|363561209|FG003|Period 2: Re-Randomization|Death|4|||
105424252|NCT03500172|363561210|FG004|Period 2: Re-Randomization|Death|2|||
105424253|NCT03500172|363561211|FG005|Period 2: Re-Randomization|Death|0|||
105424254|NCT03500172|363561212|FG006|Period 2: Re-Randomization|Death|5|||
105424255|NCT03500172|363561213|FG007|Period 2: Re-Randomization|Death|2|||
105424256|NCT03500172|363561214|FG008|Period 2: Re-Randomization|Death|0|||
105424257|NCT03500172|363561215|FG009|Period 2: Re-Randomization|Death|0|||
105424258|NCT03500172|363561216|FG010|Period 2: Re-Randomization|Death|0|||
105424259|NCT02536300|363561220|FG000|Overall Study|Investigator's Discretion|17|||
105424260|NCT02536300|363561221|FG001|Overall Study|Investigator's Discretion|11|||
105424261|NCT02536300|363561222|FG002|Overall Study|Investigator's Discretion|2|||
105424262|NCT02536300|363561220|FG000|Overall Study|Progressive Disease|11|||
105424263|NCT02536300|363561221|FG001|Overall Study|Progressive Disease|7|||
105424264|NCT02536300|363561222|FG002|Overall Study|Progressive Disease|6|||
105424265|NCT02536300|363561220|FG000|Overall Study|Study Terminated by Sponsor|6|||
105424266|NCT02536300|363561221|FG001|Overall Study|Study Terminated by Sponsor|4|||
105424267|NCT02536300|363561222|FG002|Overall Study|Study Terminated by Sponsor|7|||
105424268|NCT02536300|363561220|FG000|Overall Study|Death|7|||
105424269|NCT02536300|363561221|FG001|Overall Study|Death|0|||
105424270|NCT02536300|363561222|FG002|Overall Study|Death|5|||
105424271|NCT02536300|363561220|FG000|Overall Study|Withdrew Consent|4|||
105424272|NCT02536300|363561221|FG001|Overall Study|Withdrew Consent|2|||
105424273|NCT02536300|363561222|FG002|Overall Study|Withdrew Consent|0|||
105587015|NCT01649427|364148976|FG001|Overall Study|Surgical problems during nephrectomy|2|||
105424274|NCT02536300|363561220|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
105424275|NCT02536300|363561221|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
105424276|NCT02536300|363561222|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
105424277|NCT02536300|363561220|FG000|Overall Study|Enrolled but Never Treated|0|||
105424278|NCT02536300|363561221|FG001|Overall Study|Enrolled but Never Treated|0|||
105424279|NCT02536300|363561222|FG002|Overall Study|Enrolled but Never Treated|1|||
105424280|NCT02536300|363561220|FG000|Overall Study|Non-compliance With Study Drug|1|||
105424281|NCT02536300|363561221|FG001|Overall Study|Non-compliance With Study Drug|0|||
105424282|NCT02536300|363561222|FG002|Overall Study|Non-compliance With Study Drug|0|||
105424283|NCT02536300|363561220|FG000|Overall Study|Protocol Violation|0|||
105424284|NCT02536300|363561221|FG001|Overall Study|Protocol Violation|1|||
105424285|NCT02536300|363561222|FG002|Overall Study|Protocol Violation|0|||
105424286|NCT03028480|363561226|FG000|Overall Study|No revisit after the first prescription date|2|||
105424287|NCT03028480|363561226|FG000|Overall Study|Did not use the drug|1|||
105424288|NCT03028480|363561226|FG000|Overall Study|Violation of the enrollment deadline|10|||
105424289|NCT03028480|363561226|FG000|Overall Study|Case report forms were not collected|21|||
105424290|NCT00585221|363561229|FG000|Overall Study|Protocol Violation|8|||
105424291|NCT02585830|363561230|FG000|Overall Study|Withdrawal by Subject|3|||
105424292|NCT00969761|363561231|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
105424293|NCT00969761|363561232|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105424294|NCT00969761|363561233|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105424295|NCT00969761|363561234|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
105424296|NCT00969761|363561235|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105424297|NCT00969761|363561236|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105424298|NCT00969761|363561237|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105424299|NCT00969761|363561238|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105424300|NCT00969761|363561239|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
105424301|NCT00969761|363561240|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
105424302|NCT00969761|363561241|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105424303|NCT00969761|363561242|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105424304|NCT00969761|363561231|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105424305|NCT00969761|363561232|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105424306|NCT00969761|363561233|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
105424307|NCT00969761|363561234|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105424308|NCT00969761|363561235|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105424309|NCT00969761|363561236|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105424310|NCT00969761|363561237|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105424311|NCT00969761|363561238|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105424312|NCT00969761|363561239|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105424313|NCT00969761|363561240|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105424314|NCT00969761|363561241|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105424315|NCT00969761|363561242|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105424316|NCT00969761|363561231|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105424317|NCT00969761|363561232|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105424318|NCT00969761|363561233|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
105424319|NCT00969761|363561234|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105424320|NCT00969761|363561235|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105424321|NCT00969761|363561236|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105424322|NCT00969761|363561237|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105424323|NCT00969761|363561238|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105424324|NCT00969761|363561239|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105424325|NCT00969761|363561240|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105424326|NCT00969761|363561241|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105424327|NCT00969761|363561242|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105424328|NCT00969761|363561231|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105424329|NCT00969761|363561232|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105424330|NCT00969761|363561233|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105424331|NCT00969761|363561234|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105424332|NCT00969761|363561235|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105424333|NCT00969761|363561236|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105424334|NCT00969761|363561237|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105424335|NCT00969761|363561238|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105424336|NCT00969761|363561239|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
105424337|NCT00969761|363561240|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105424338|NCT00969761|363561241|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105501111|NCT00717093|363847056|FG001|Overall Study|Randomized but not treated|0|||
105424339|NCT00969761|363561242|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105424340|NCT00969761|363561231|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
105424341|NCT00969761|363561232|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
105424342|NCT00969761|363561233|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
105424343|NCT00969761|363561234|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
105424344|NCT00969761|363561235|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
105424345|NCT00969761|363561236|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
105424346|NCT00969761|363561237|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
105424347|NCT00969761|363561238|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
105424348|NCT00969761|363561239|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
105424349|NCT00969761|363561240|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
105424350|NCT00969761|363561241|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
105424351|NCT00969761|363561242|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
105424352|NCT00969761|363561231|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
105424353|NCT00969761|363561232|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
105424354|NCT00969761|363561233|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
105424355|NCT00969761|363561234|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
105424356|NCT00969761|363561235|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
105424357|NCT00969761|363561236|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
105424358|NCT00969761|363561237|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
105424359|NCT00969761|363561238|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
105424360|NCT00969761|363561239|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
105424361|NCT00969761|363561240|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
105424362|NCT00969761|363561241|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
105424363|NCT00969761|363561242|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
105424364|NCT01080768|363561243|FG000|Overall Study|Protocol Deviation|2|||
105424365|NCT01080768|363561244|FG001|Overall Study|Protocol Deviation|1|||
105424366|NCT00246025|363561249|FG000|Overall Study|Adverse Event|7|||
105424367|NCT00246025|363561250|FG001|Overall Study|Adverse Event|9|||
105424368|NCT00246025|363561251|FG002|Overall Study|Adverse Event|9|||
105424369|NCT00246025|363561252|FG003|Overall Study|Adverse Event|10|||
105424370|NCT00246025|363561249|FG000|Overall Study|Withdrawal by Subject|3|||
105424371|NCT00246025|363561250|FG001|Overall Study|Withdrawal by Subject|0|||
105424372|NCT00246025|363561251|FG002|Overall Study|Withdrawal by Subject|1|||
105424373|NCT00246025|363561252|FG003|Overall Study|Withdrawal by Subject|2|||
105424374|NCT00246025|363561249|FG000|Overall Study|unsuitable medical history was found|0|||
105424375|NCT00246025|363561250|FG001|Overall Study|unsuitable medical history was found|0|||
105424376|NCT00246025|363561251|FG002|Overall Study|unsuitable medical history was found|0|||
105424377|NCT00246025|363561252|FG003|Overall Study|unsuitable medical history was found|1|||
105424378|NCT00931723|363561255|FG000|Overall Study|Withdrawal by Subject|11|||
105424379|NCT00931723|363561256|FG001|Overall Study|Withdrawal by Subject|13|||
105424380|NCT00931723|363561255|FG000|Overall Study|Adverse Event|6|||
105424381|NCT00931723|363561256|FG001|Overall Study|Adverse Event|13|||
105424382|NCT00931723|363561255|FG000|Overall Study|Lithium found in blood|0|||
105424383|NCT00931723|363561256|FG001|Overall Study|Lithium found in blood|1|||
105424384|NCT00931723|363561255|FG000|Overall Study|Condition under investigation worsened|1|||
105424385|NCT00931723|363561256|FG001|Overall Study|Condition under investigation worsened|2|||
105424386|NCT00931723|363561255|FG000|Overall Study|Lost to Follow-up|1|||
105424387|NCT00931723|363561256|FG001|Overall Study|Lost to Follow-up|2|||
105424388|NCT00931723|363561255|FG000|Overall Study|Study-specific discontinuation criteria|1|||
105424389|NCT00931723|363561256|FG001|Overall Study|Study-specific discontinuation criteria|1|||
105424390|NCT00931723|363561255|FG000|Overall Study|Severe non-compliance to protocol|2|||
105424391|NCT00931723|363561256|FG001|Overall Study|Severe non-compliance to protocol|0|||
105424392|NCT00931723|363561255|FG000|Overall Study|Safety reasons|0|||
105424393|NCT00931723|363561256|FG001|Overall Study|Safety reasons|1|||
105424394|NCT00931723|363561255|FG000|Overall Study|Took prohibited concomitant medication|0|||
105424395|NCT00931723|363561256|FG001|Overall Study|Took prohibited concomitant medication|1|||
105424396|NCT00931723|363561255|FG000|Overall Study|Lack or insufficient theraputic response|2|||
105424397|NCT00931723|363561256|FG001|Overall Study|Lack or insufficient theraputic response|5|||
105424398|NCT00931723|363561255|FG000|Overall Study|Sponsor decision|1|||
105424399|NCT00931723|363561256|FG001|Overall Study|Sponsor decision|0|||
105424400|NCT00931723|363561255|FG000|Overall Study|Late hospital discharge|1|||
105424401|NCT00931723|363561256|FG001|Overall Study|Late hospital discharge|0|||
105424402|NCT00772369|363561258|FG000|Overall Study|Did not return record release form|1|||
105424403|NCT01774253|363561259|FG000|Overall Study|Lack of Efficacy|4|||
105424404|NCT01774253|363561259|FG000|Overall Study|Physician Decision|2|||
105424405|NCT01774253|363561259|FG000|Overall Study|Withdrawal by Subject|2|||
105424406|NCT01774253|363561259|FG000|Overall Study|Death|1|||
105424407|NCT00554619|363561260|FG000|Overall Study|Adverse Event|1|||
105424408|NCT00554619|363561260|FG000|Overall Study|Physician Decision|1|||
105424409|NCT00554619|363561260|FG000|Overall Study|Liver Function Test Abnormality|1|||
105587016|NCT00764868|364148981|FG000|Overall Study|Adverse Event|18|||
105587017|NCT00764868|364148981|FG000|Overall Study|Withdrawal by Subject|31|||
105587018|NCT00764868|364148981|FG000|Overall Study|Non-compliance|16|||
105587019|NCT00764868|364148981|FG000|Overall Study|Lost to Follow-up|25|||
105587020|NCT00764868|364148981|FG000|Overall Study|Lack of Efficacy|5|||
105587021|NCT00764868|364148981|FG000|Overall Study|Subject moved|7|||
105587022|NCT00764868|364148981|FG000|Overall Study|Pregnancy|3|||
105587023|NCT00764868|364148981|FG000|Overall Study|Prohibited medication|1|||
105587024|NCT00764868|364148981|FG000|Overall Study|Out of town|1|||
105587025|NCT00764868|364148981|FG000|Overall Study|Misuse and compliance of study drug|1|||
105587026|NCT00764868|364148981|FG000|Overall Study|Subject sent to boarding school|1|||
105587027|NCT00764868|364148981|FG000|Overall Study|Met an exclusion criteria|1|||
105587028|NCT00764868|364148981|FG000|Overall Study|Positive drug screen|2|||
105587029|NCT00764868|364148981|FG000|Overall Study|Sponsor requested withdrawal|1|||
105587030|NCT01823341|364148986|FG000|Overall Study|Failed run-in|7|||
105587031|NCT01823341|364148986|FG000|Overall Study|Withdrawal by Subject|7|||
105587032|NCT01823341|364148986|FG000|Overall Study|Adverse Event|1|||
105587033|NCT01737268|364148990|FG000|Overall Study|Adverse Event|6|||
105587034|NCT01737268|364148990|FG000|Overall Study|Worsening of Target Disease|2|||
105587035|NCT01737268|364148990|FG000|Overall Study|In consideration of the patient's safety|1|||
105587036|NCT00665561|364148993|FG000|Overall Study|Death recorded on subject summary pages|75|||
105587037|NCT00665561|364148994|FG001|Overall Study|Death recorded on subject summary pages|75|||
105587038|NCT00665561|364148993|FG000|Overall Study|Does not meet entrance criteria|19|||
105587039|NCT00665561|364148994|FG001|Overall Study|Does not meet entrance criteria|21|||
105587040|NCT00665561|364148993|FG000|Overall Study|Lost to Follow-up|203|||
105587041|NCT00665561|364148994|FG001|Overall Study|Lost to Follow-up|264|||
105587042|NCT00665561|364148993|FG000|Overall Study|Withdrawal by Subject|74|||
105587043|NCT00665561|364148994|FG001|Overall Study|Withdrawal by Subject|65|||
105587044|NCT00665561|364148993|FG000|Overall Study|Other|123|||
105587045|NCT00665561|364148994|FG001|Overall Study|Other|108|||
105587046|NCT00665561|364148993|FG000|Overall Study|Site closed|8|||
105587047|NCT00665561|364148994|FG001|Overall Study|Site closed|0|||
105587048|NCT00665561|364148993|FG000|Overall Study|Withdrawn due to pregnancy|0|||
105587049|NCT00665561|364148994|FG001|Overall Study|Withdrawn due to pregnancy|1|||
105587050|NCT03824236|364148998|FG000|Overall Study|Lost to Follow-up|0|||
105587051|NCT03824236|364148999|FG001|Overall Study|Lost to Follow-up|0|||
105587052|NCT03824236|364149000|FG002|Overall Study|Lost to Follow-up|1|||
105587053|NCT01143077|364149003|FG000|Overall Study|Lack of Efficacy|0|||
105587054|NCT01143077|364149004|FG001|Overall Study|Lack of Efficacy|2|||
105587055|NCT01143077|364149005|FG002|Overall Study|Lack of Efficacy|1|||
105587056|NCT01143077|364149003|FG000|Overall Study|Adverse Event|5|||
105587057|NCT01143077|364149004|FG001|Overall Study|Adverse Event|6|||
105587058|NCT01143077|364149005|FG002|Overall Study|Adverse Event|5|||
105587059|NCT01143077|364149003|FG000|Overall Study|Lost to Follow-up|2|||
105587060|NCT01143077|364149004|FG001|Overall Study|Lost to Follow-up|3|||
105587061|NCT01143077|364149005|FG002|Overall Study|Lost to Follow-up|4|||
105587062|NCT01143077|364149003|FG000|Overall Study|Protocol Violation|2|||
105587063|NCT01143077|364149004|FG001|Overall Study|Protocol Violation|0|||
105587064|NCT01143077|364149005|FG002|Overall Study|Protocol Violation|0|||
105587065|NCT01143077|364149003|FG000|Overall Study|Withdrawal by Subject|4|||
105587066|NCT01143077|364149004|FG001|Overall Study|Withdrawal by Subject|3|||
105587067|NCT01143077|364149005|FG002|Overall Study|Withdrawal by Subject|3|||
105587068|NCT01143077|364149003|FG000|Overall Study|Non-compliance with study drug|0|||
105587069|NCT01143077|364149004|FG001|Overall Study|Non-compliance with study drug|1|||
105587070|NCT01143077|364149005|FG002|Overall Study|Non-compliance with study drug|1|||
105587071|NCT01143077|364149003|FG000|Overall Study|Administrative|1|||
105587072|NCT01143077|364149004|FG001|Overall Study|Administrative|0|||
105587073|NCT01143077|364149005|FG002|Overall Study|Administrative|0|||
105587074|NCT01143077|364149003|FG000|Overall Study|Principal Investigator Decision|2|||
105587075|NCT01143077|364149004|FG001|Overall Study|Principal Investigator Decision|0|||
105587076|NCT01143077|364149005|FG002|Overall Study|Principal Investigator Decision|1|||
105587077|NCT01333514|364149006|FG000|Overall Study|Withdrawal by Subject|1|||
105587078|NCT01333514|364149007|FG001|Overall Study|Withdrawal by Subject|0|||
105587079|NCT00389519|364149010|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
105587080|NCT00389519|364149011|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
105587081|NCT00389519|364149012|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
105587082|NCT00389519|364149013|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
105587083|NCT00389519|364149010|FG000|Placebo Run-In|Withdrawal by Subject|19|||
105587084|NCT00389519|364149011|FG001|Placebo Run-In|Withdrawal by Subject|0|||
105587085|NCT00389519|364149012|FG002|Placebo Run-In|Withdrawal by Subject|0|||
105587086|NCT00389519|364149013|FG003|Placebo Run-In|Withdrawal by Subject|0|||
105587087|NCT00389519|364149010|FG000|Placebo Run-In|Reason not specified|40|||
105587088|NCT00389519|364149011|FG001|Placebo Run-In|Reason not specified|0|||
105587089|NCT00389519|364149012|FG002|Placebo Run-In|Reason not specified|0|||
105587090|NCT00389519|364149013|FG003|Placebo Run-In|Reason not specified|0|||
105587091|NCT00389519|364149010|FG000|Randomized|Did not receive study drug|2|||
105424410|NCT02240368|363561264|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
105424411|NCT02240368|363561265|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
105424412|NCT02240368|363561266|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
105587092|NCT00389519|364149011|FG001|Randomized|Did not receive study drug|0|||
105587093|NCT00389519|364149012|FG002|Randomized|Did not receive study drug|0|||
105587094|NCT00389519|364149013|FG003|Randomized|Did not receive study drug|0|||
105587095|NCT00389519|364149010|FG000|Treated|Adverse Event|1|||
105587096|NCT00389519|364149011|FG001|Treated|Adverse Event|0|||
105587097|NCT00389519|364149012|FG002|Treated|Adverse Event|0|||
105587098|NCT00389519|364149013|FG003|Treated|Adverse Event|2|||
105587099|NCT00389519|364149010|FG000|Treated|Reason not specified|1|||
105587100|NCT00389519|364149011|FG001|Treated|Reason not specified|1|||
105587101|NCT00389519|364149012|FG002|Treated|Reason not specified|0|||
105587102|NCT00389519|364149013|FG003|Treated|Reason not specified|2|||
105587103|NCT02014558|364149014|FG000|Overall Study|Never Received Study Drug|0|||
105587104|NCT02014558|364149015|FG001|Overall Study|Never Received Study Drug|0|||
105587105|NCT02014558|364149016|FG002|Overall Study|Never Received Study Drug|0|||
105587106|NCT02014558|364149017|FG003|Overall Study|Never Received Study Drug|0|||
105587107|NCT02014558|364149018|FG004|Overall Study|Never Received Study Drug|1|||
105587108|NCT02014558|364149019|FG005|Overall Study|Never Received Study Drug|0|||
105587109|NCT02014558|364149020|FG006|Overall Study|Never Received Study Drug|1|||
105587110|NCT02014558|364149021|FG007|Overall Study|Never Received Study Drug|0|||
105587111|NCT02014558|364149022|FG008|Overall Study|Never Received Study Drug|2|||
105587112|NCT02014558|364149023|FG009|Overall Study|Never Received Study Drug|0|||
105587113|NCT02014558|364149024|FG010|Overall Study|Never Received Study Drug|2|||
105587114|NCT02014558|364149025|FG011|Overall Study|Never Received Study Drug|2|||
105587115|NCT02014558|364149026|FG012|Overall Study|Never Received Study Drug|0|||
105587116|NCT02014558|364149014|FG000|Overall Study|Adverse Event|0|||
105587117|NCT02014558|364149015|FG001|Overall Study|Adverse Event|0|||
105587118|NCT02014558|364149016|FG002|Overall Study|Adverse Event|0|||
105587119|NCT02014558|364149017|FG003|Overall Study|Adverse Event|0|||
105587120|NCT02014558|364149018|FG004|Overall Study|Adverse Event|1|||
105587121|NCT02014558|364149019|FG005|Overall Study|Adverse Event|0|||
105587122|NCT02014558|364149020|FG006|Overall Study|Adverse Event|0|||
105587123|NCT02014558|364149021|FG007|Overall Study|Adverse Event|0|||
105587124|NCT02014558|364149022|FG008|Overall Study|Adverse Event|2|||
105587125|NCT02014558|364149023|FG009|Overall Study|Adverse Event|2|||
105587126|NCT02014558|364149024|FG010|Overall Study|Adverse Event|5|||
105587127|NCT02014558|364149025|FG011|Overall Study|Adverse Event|21|||
105587128|NCT02014558|364149026|FG012|Overall Study|Adverse Event|3|||
105587129|NCT02014558|364149014|FG000|Overall Study|Death|1|||
105587130|NCT02014558|364149015|FG001|Overall Study|Death|0|||
105587131|NCT02014558|364149016|FG002|Overall Study|Death|0|||
105587132|NCT02014558|364149017|FG003|Overall Study|Death|0|||
105587133|NCT02014558|364149018|FG004|Overall Study|Death|0|||
105587134|NCT02014558|364149019|FG005|Overall Study|Death|0|||
105587135|NCT02014558|364149020|FG006|Overall Study|Death|1|||
105587136|NCT02014558|364149021|FG007|Overall Study|Death|1|||
105587137|NCT02014558|364149022|FG008|Overall Study|Death|2|||
105587138|NCT02014558|364149023|FG009|Overall Study|Death|5|||
105587139|NCT02014558|364149024|FG010|Overall Study|Death|5|||
105587140|NCT02014558|364149025|FG011|Overall Study|Death|19|||
105587141|NCT02014558|364149026|FG012|Overall Study|Death|2|||
105587142|NCT02014558|364149014|FG000|Overall Study|Lack of Efficacy|1|||
105587143|NCT02014558|364149015|FG001|Overall Study|Lack of Efficacy|2|||
105587144|NCT02014558|364149016|FG002|Overall Study|Lack of Efficacy|1|||
105424413|NCT02240368|363561264|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
105424414|NCT02240368|363561265|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
105424415|NCT02240368|363561266|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
105424416|NCT00907803|363561267|FG000|Overall Study|Withdrawal of consent - long commute|1|||
105424417|NCT00907803|363561268|FG001|Overall Study|Withdrawal of consent - long commute|0|||
105587145|NCT02014558|364149017|FG003|Overall Study|Lack of Efficacy|1|||
105587146|NCT02014558|364149018|FG004|Overall Study|Lack of Efficacy|0|||
105587147|NCT02014558|364149019|FG005|Overall Study|Lack of Efficacy|0|||
105424418|NCT00907803|363561269|FG002|Overall Study|Withdrawal of consent - long commute|0|||
105587148|NCT02014558|364149020|FG006|Overall Study|Lack of Efficacy|1|||
105587149|NCT02014558|364149021|FG007|Overall Study|Lack of Efficacy|3|||
105587150|NCT02014558|364149022|FG008|Overall Study|Lack of Efficacy|3|||
105587151|NCT02014558|364149023|FG009|Overall Study|Lack of Efficacy|3|||
105587152|NCT02014558|364149024|FG010|Overall Study|Lack of Efficacy|16|||
105587153|NCT02014558|364149025|FG011|Overall Study|Lack of Efficacy|8|||
105587154|NCT02014558|364149026|FG012|Overall Study|Lack of Efficacy|5|||
105587155|NCT02014558|364149014|FG000|Overall Study|Lost to Follow-up|0|||
105587156|NCT02014558|364149015|FG001|Overall Study|Lost to Follow-up|0|||
105587157|NCT02014558|364149016|FG002|Overall Study|Lost to Follow-up|0|||
105587158|NCT02014558|364149017|FG003|Overall Study|Lost to Follow-up|0|||
105587159|NCT02014558|364149018|FG004|Overall Study|Lost to Follow-up|0|||
105587160|NCT02014558|364149019|FG005|Overall Study|Lost to Follow-up|0|||
105424419|NCT00907803|363561267|FG000|Overall Study|Adverse Event|2|||
105424420|NCT00907803|363561268|FG001|Overall Study|Adverse Event|0|||
105424421|NCT00907803|363561269|FG002|Overall Study|Adverse Event|0|||
105424422|NCT00907803|363561267|FG000|Overall Study|Withdrawal by Subject|0|||
105424423|NCT00907803|363561268|FG001|Overall Study|Withdrawal by Subject|1|||
105424424|NCT00907803|363561269|FG002|Overall Study|Withdrawal by Subject|0|||
105424425|NCT00907803|363561267|FG000|Overall Study|Lost to Follow-up|0|||
105424426|NCT00907803|363561268|FG001|Overall Study|Lost to Follow-up|1|||
105424427|NCT00907803|363561269|FG002|Overall Study|Lost to Follow-up|0|||
105424428|NCT00907803|363561267|FG000|Overall Study|Protocol Violation|0|||
105424429|NCT00907803|363561268|FG001|Overall Study|Protocol Violation|1|||
105424430|NCT00907803|363561269|FG002|Overall Study|Protocol Violation|0|||
105424431|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Death|1|||
105424432|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Death|1|||
105424433|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Death|0|||
105424434|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Death|0|||
105424435|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Death|1|||
105424436|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Death|0|||
105424437|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Death|0|||
105424438|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Death|0|||
105424439|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Death|0|||
105424440|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Death|0|||
105424441|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
105424442|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
105424443|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
105424444|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
105424445|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
105424446|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
105424447|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
105424448|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
105424449|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
105424450|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
105424451|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105424452|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105424453|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105424454|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105424455|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
105424456|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105424457|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105424458|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105424459|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105424460|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105424461|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
105424462|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105424463|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105424464|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105424465|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105424466|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105424467|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105424468|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105424469|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105424470|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105424471|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
105424472|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
105424473|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
105424474|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
105424475|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
105424476|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
105424477|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
105424478|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
105424479|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
105424480|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
105424481|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
105424482|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
105424483|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
105424484|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
105424485|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
105424486|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
105424487|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
105424488|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
105424489|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
105424490|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
105424491|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
105424492|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
105424493|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
105424494|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
105424495|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
105424496|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
105424497|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
105424498|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
105424499|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
105424500|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
105424501|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
105424502|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
105424503|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
105424504|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105424505|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
105424506|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105424507|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105424508|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105424509|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105424510|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105424511|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
105424512|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
105424513|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
105424514|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
105424515|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
105424516|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
105424517|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
105424518|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
105424519|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
105424520|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
105424521|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
105424522|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
105424523|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105424524|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
105424525|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
105424526|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105424527|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105424528|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105424529|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105424530|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105424531|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424532|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424533|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
105424534|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424535|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
105424536|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424537|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424538|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424539|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424540|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424541|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
105424542|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
105424543|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
105424544|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
105424545|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
105424546|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
105424547|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
105424548|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
105424549|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
105424550|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
105424551|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424552|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424553|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424554|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
105424555|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
105424556|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424557|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424558|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424559|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424560|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424561|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
105424562|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105424563|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
105424564|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
105424565|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
105424566|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105424567|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105424568|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105424569|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105424570|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105424571|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
105424572|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424573|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424574|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424575|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
105424576|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424577|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424578|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424579|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424580|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105424581|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424582|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424583|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424584|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424585|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
105424586|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424587|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424588|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424589|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424590|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424591|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105424592|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
105424593|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105424594|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105424595|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
105424596|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105424597|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105424598|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105424599|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105424600|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105424601|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
105424602|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105424603|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105424604|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105424605|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
105424606|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105424607|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105424608|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105424609|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105424610|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105424611|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
105424612|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
105424613|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
105424614|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
105424615|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
105424616|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
105424617|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
105424618|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
105424619|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
105424620|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
105424621|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Other|5|||
105424622|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Other|1|||
105424623|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Other|0|||
105424624|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Other|3|||
105424625|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Other|0|||
105424626|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Other|0|||
105424627|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Other|0|||
105424628|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Other|0|||
105424629|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Other|0|||
105424630|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Other|0|||
105424631|NCT03352557|363561270|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
105424632|NCT03352557|363561271|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
105424633|NCT03352557|363561272|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
105424634|NCT03352557|363561273|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
105424635|NCT03352557|363561274|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
105424636|NCT03352557|363561275|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
105424637|NCT03352557|363561276|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
105424638|NCT03352557|363561277|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
105424639|NCT03352557|363561278|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
105424640|NCT03352557|363561279|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
105424641|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|Death|0|||
105424642|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|Death|0|||
105424643|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|Death|0|||
105424644|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|Death|0|||
105424645|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|Death|0|||
105424646|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|Death|1|||
105424647|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|Death|0|||
105424648|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|Death|1|||
105424649|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|Death|1|||
105424650|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|Death|1|||
105424651|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105424652|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105424653|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105424654|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105424655|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105424656|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
105424657|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105424658|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105424659|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105424660|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105424661|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105424662|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105424663|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105424664|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105424665|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105587161|NCT02014558|364149020|FG006|Overall Study|Lost to Follow-up|0|||
105587162|NCT02014558|364149021|FG007|Overall Study|Lost to Follow-up|0|||
105587163|NCT02014558|364149022|FG008|Overall Study|Lost to Follow-up|0|||
105587164|NCT02014558|364149023|FG009|Overall Study|Lost to Follow-up|0|||
105587165|NCT02014558|364149024|FG010|Overall Study|Lost to Follow-up|1|||
105587166|NCT02014558|364149025|FG011|Overall Study|Lost to Follow-up|0|||
105587167|NCT02014558|364149026|FG012|Overall Study|Lost to Follow-up|0|||
105587168|NCT02014558|364149014|FG000|Overall Study|Progressive Disease|1|||
105587169|NCT02014558|364149015|FG001|Overall Study|Progressive Disease|0|||
105587170|NCT02014558|364149016|FG002|Overall Study|Progressive Disease|1|||
105587171|NCT02014558|364149017|FG003|Overall Study|Progressive Disease|1|||
105587172|NCT02014558|364149018|FG004|Overall Study|Progressive Disease|1|||
105587173|NCT02014558|364149019|FG005|Overall Study|Progressive Disease|2|||
105587174|NCT02014558|364149020|FG006|Overall Study|Progressive Disease|1|||
105587175|NCT02014558|364149021|FG007|Overall Study|Progressive Disease|6|||
105587176|NCT02014558|364149022|FG008|Overall Study|Progressive Disease|5|||
105587177|NCT02014558|364149023|FG009|Overall Study|Progressive Disease|6|||
105587178|NCT02014558|364149024|FG010|Overall Study|Progressive Disease|22|||
105587179|NCT02014558|364149025|FG011|Overall Study|Progressive Disease|31|||
105587180|NCT02014558|364149026|FG012|Overall Study|Progressive Disease|6|||
105587181|NCT02014558|364149014|FG000|Overall Study|Withdrawal by Subject|0|||
105587182|NCT02014558|364149015|FG001|Overall Study|Withdrawal by Subject|0|||
105587183|NCT02014558|364149016|FG002|Overall Study|Withdrawal by Subject|0|||
105587184|NCT02014558|364149017|FG003|Overall Study|Withdrawal by Subject|0|||
105587185|NCT02014558|364149018|FG004|Overall Study|Withdrawal by Subject|1|||
105587186|NCT02014558|364149019|FG005|Overall Study|Withdrawal by Subject|0|||
105587187|NCT02014558|364149020|FG006|Overall Study|Withdrawal by Subject|0|||
105587188|NCT02014558|364149021|FG007|Overall Study|Withdrawal by Subject|0|||
105587189|NCT02014558|364149022|FG008|Overall Study|Withdrawal by Subject|0|||
105587190|NCT02014558|364149023|FG009|Overall Study|Withdrawal by Subject|2|||
105587191|NCT02014558|364149024|FG010|Overall Study|Withdrawal by Subject|6|||
105587192|NCT02014558|364149025|FG011|Overall Study|Withdrawal by Subject|10|||
105587193|NCT02014558|364149026|FG012|Overall Study|Withdrawal by Subject|0|||
105587194|NCT02014558|364149014|FG000|Overall Study|Miscellaneous|2|||
105587195|NCT02014558|364149015|FG001|Overall Study|Miscellaneous|1|||
105587196|NCT02014558|364149016|FG002|Overall Study|Miscellaneous|1|||
105587197|NCT02014558|364149017|FG003|Overall Study|Miscellaneous|1|||
105587198|NCT02014558|364149018|FG004|Overall Study|Miscellaneous|0|||
105587199|NCT02014558|364149019|FG005|Overall Study|Miscellaneous|1|||
105587200|NCT02014558|364149020|FG006|Overall Study|Miscellaneous|0|||
105424666|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105424667|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105424668|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105587201|NCT02014558|364149021|FG007|Overall Study|Miscellaneous|1|||
105587202|NCT02014558|364149022|FG008|Overall Study|Miscellaneous|1|||
105587203|NCT02014558|364149023|FG009|Overall Study|Miscellaneous|3|||
105587204|NCT02014558|364149024|FG010|Overall Study|Miscellaneous|12|||
105587205|NCT02014558|364149025|FG011|Overall Study|Miscellaneous|11|||
105587206|NCT02014558|364149026|FG012|Overall Study|Miscellaneous|1|||
105587207|NCT04155424|364149037|FG000|Overall Study|Other than specified|3|||
105587208|NCT04155424|364149037|FG000|Overall Study|Withdrawal by Subject|1|||
105587209|NCT04155424|364149037|FG000|Overall Study|Adverse Event|1|||
105587210|NCT05567952|364150431|FG000|Overall Study|Lost to Follow-up|3|||
105587211|NCT05567952|364150432|FG001|Overall Study|Lost to Follow-up|2|||
105587212|NCT05567952|364150431|FG000|Overall Study|Withdrawal by Subject|6|||
105587213|NCT05567952|364150432|FG001|Overall Study|Withdrawal by Subject|3|||
105587214|NCT05567952|364150431|FG000|Overall Study|Other|3|||
105587215|NCT05567952|364150432|FG001|Overall Study|Other|1|||
105587216|NCT04213846|364150434|FG000|Overall Study|Withdrawal by Subject|7|||
105587217|NCT04213846|364150435|FG001|Overall Study|Withdrawal by Subject|6|||
105587218|NCT04213846|364150434|FG000|Overall Study|Lost to Follow-up|15|||
105587219|NCT04213846|364150435|FG001|Overall Study|Lost to Follow-up|21|||
105587220|NCT04423393|364150439|FG000|Overall Study|Withdrawal by Subject|0|||
105587221|NCT04423393|364150440|FG001|Overall Study|Withdrawal by Subject|0|||
105424669|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
105424670|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105587222|NCT04423393|364150441|FG002|Overall Study|Withdrawal by Subject|0|||
105587223|NCT04423393|364150442|FG003|Overall Study|Withdrawal by Subject|0|||
105587224|NCT04423393|364150443|FG004|Overall Study|Withdrawal by Subject|0|||
105587225|NCT04423393|364150444|FG005|Overall Study|Withdrawal by Subject|1|||
105587226|NCT04423393|364150445|FG006|Overall Study|Withdrawal by Subject|0|||
105587227|NCT04423393|364150446|FG007|Overall Study|Withdrawal by Subject|0|||
105587228|NCT04423393|364150447|FG008|Overall Study|Withdrawal by Subject|0|||
105587229|NCT04423393|364150448|FG009|Overall Study|Withdrawal by Subject|0|||
105587230|NCT04423393|364150449|FG010|Overall Study|Withdrawal by Subject|0|||
105587231|NCT04423393|364150450|FG011|Overall Study|Withdrawal by Subject|0|||
105587232|NCT04423393|364150451|FG012|Overall Study|Withdrawal by Subject|0|||
105587233|NCT04423393|364150452|FG013|Overall Study|Withdrawal by Subject|1|||
105587234|NCT04423393|364150453|FG014|Overall Study|Withdrawal by Subject|0|||
105587235|NCT04423393|364150454|FG015|Overall Study|Withdrawal by Subject|0|||
105587236|NCT04423393|364150455|FG016|Overall Study|Withdrawal by Subject|0|||
105587237|NCT04423393|364150456|FG017|Overall Study|Withdrawal by Subject|0|||
105587238|NCT04423393|364150439|FG000|Overall Study|Sponsor Decision|0|||
105587239|NCT04423393|364150440|FG001|Overall Study|Sponsor Decision|0|||
105587240|NCT04423393|364150441|FG002|Overall Study|Sponsor Decision|0|||
105587241|NCT04423393|364150442|FG003|Overall Study|Sponsor Decision|0|||
105587242|NCT04423393|364150443|FG004|Overall Study|Sponsor Decision|0|||
105587243|NCT04423393|364150444|FG005|Overall Study|Sponsor Decision|0|||
105587244|NCT04423393|364150445|FG006|Overall Study|Sponsor Decision|0|||
105587245|NCT04423393|364150446|FG007|Overall Study|Sponsor Decision|0|||
105587246|NCT04423393|364150447|FG008|Overall Study|Sponsor Decision|0|||
105587247|NCT04423393|364150448|FG009|Overall Study|Sponsor Decision|0|||
105587248|NCT04423393|364150449|FG010|Overall Study|Sponsor Decision|0|||
105587249|NCT04423393|364150450|FG011|Overall Study|Sponsor Decision|0|||
105587250|NCT04423393|364150451|FG012|Overall Study|Sponsor Decision|0|||
105587251|NCT04423393|364150452|FG013|Overall Study|Sponsor Decision|1|||
105587252|NCT04423393|364150453|FG014|Overall Study|Sponsor Decision|0|||
105587253|NCT04423393|364150454|FG015|Overall Study|Sponsor Decision|0|||
105587254|NCT04423393|364150455|FG016|Overall Study|Sponsor Decision|0|||
105587255|NCT04423393|364150456|FG017|Overall Study|Sponsor Decision|0|||
105424671|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
105424672|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
105424673|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
105501112|NCT01560403|363847057|FG000|Overall Study|Lost to Follow-up|0|||
105501113|NCT01560403|363847058|FG001|Overall Study|Lost to Follow-up|1|||
105501114|NCT00094172|363847059|FG000|Overall Study|Adverse Event|0|||
105501115|NCT00094172|363847060|FG001|Overall Study|Adverse Event|1|||
105501116|NCT00094172|363847059|FG000|Overall Study|Lost to Follow-up|2|||
105501117|NCT00094172|363847060|FG001|Overall Study|Lost to Follow-up|0|||
105501118|NCT00094172|363847059|FG000|Overall Study|Protocol Violation|0|||
105501119|NCT00094172|363847060|FG001|Overall Study|Protocol Violation|1|||
105501120|NCT00094172|363847059|FG000|Overall Study|Withdrawal by Subject|10|||
105501121|NCT00094172|363847060|FG001|Overall Study|Withdrawal by Subject|5|||
105501122|NCT00094172|363847059|FG000|Overall Study|Primary endpoint met.|1|||
105501123|NCT00094172|363847060|FG001|Overall Study|Primary endpoint met.|0|||
105501124|NCT00094172|363847059|FG000|Overall Study|Started other MS therapy due to disease|1|||
105501125|NCT00094172|363847060|FG001|Overall Study|Started other MS therapy due to disease|0|||
105501126|NCT00533897|363847064|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
105501127|NCT00533897|363847065|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
105501128|NCT00533897|363847066|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
105501129|NCT00533897|363847067|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
105501130|NCT00533897|363847068|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
105501131|NCT00533897|363847069|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
105501132|NCT00533897|363847070|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
105501133|NCT00533897|363847071|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
105501134|NCT00533897|363847064|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
105501135|NCT00533897|363847065|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
105501136|NCT00533897|363847066|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
105501137|NCT00533897|363847067|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
105501138|NCT00533897|363847068|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
105501139|NCT00533897|363847069|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
105501140|NCT00533897|363847070|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
105501141|NCT00533897|363847071|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
105501142|NCT00533897|363847064|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
105501143|NCT00533897|363847065|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
105501144|NCT00533897|363847066|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
105501145|NCT00533897|363847067|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
105501146|NCT00533897|363847068|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
105501147|NCT00533897|363847069|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
105501148|NCT00533897|363847070|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
105501149|NCT00533897|363847071|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
105501150|NCT00533897|363847064|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
105501151|NCT00533897|363847065|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
105501152|NCT00533897|363847066|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
105501153|NCT00533897|363847067|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
105501154|NCT00533897|363847068|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
105501155|NCT00533897|363847069|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
105501156|NCT00533897|363847070|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
105501157|NCT00533897|363847071|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
105424674|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
105424675|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
105424676|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
105424677|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
105424678|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
105424679|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
105424680|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
105424681|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105424682|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105424683|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105424684|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105424685|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105424686|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
105424687|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105424688|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
105424689|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
105424690|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
105424691|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105424692|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105424693|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105424694|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105424695|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105424696|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
105424697|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105424698|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
105424699|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
105424700|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105424701|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
105424702|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
105424703|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
105424704|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
105424705|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
105424706|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
105424707|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
105424708|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
105424709|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
105424710|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
105424711|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424712|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424713|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424714|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424715|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424716|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424717|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424718|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105424719|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
105424720|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
105424721|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105424722|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105424723|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105424724|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105424725|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105424726|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105424727|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105424728|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
105424729|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105424730|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105424731|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105424732|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105424733|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105424734|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105424735|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105424736|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105424737|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105424738|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
105424739|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105424740|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105424741|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424742|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424743|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424744|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424745|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424746|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424747|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424748|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
105424749|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
105424750|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105424751|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105424752|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105424753|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105424754|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105424755|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105424756|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
105424757|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105424758|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105424759|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
105424760|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105424761|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105424762|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105424763|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105424764|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105424765|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105424766|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105424767|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105424768|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105424769|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105424770|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
105424771|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105424772|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105424773|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105424774|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105424775|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105424776|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105424777|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105424778|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105424779|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
105424780|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
105424781|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
105424782|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
105424783|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
105424784|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
105424785|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
105424786|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
105587256|NCT04091672|364150457|FG000|Overall Study|Death|6|||
105587257|NCT04091672|364150458|FG001|Overall Study|Death|6|||
105587258|NCT04091672|364150457|FG000|Overall Study|Lost to Follow-up|7|||
105587259|NCT04091672|364150458|FG001|Overall Study|Lost to Follow-up|7|||
105587260|NCT04091672|364150457|FG000|Overall Study|Withdrawal by Subject|3|||
105587261|NCT04091672|364150458|FG001|Overall Study|Withdrawal by Subject|3|||
105587262|NCT04091672|364150457|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
105587263|NCT04091672|364150458|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
105587264|NCT05296629|364150459|FG000|Overall Study|Withdrawal by Subject|3|||
105587265|NCT05296629|364150460|FG001|Overall Study|Withdrawal by Subject|10|||
105587266|NCT05296629|364150461|FG002|Overall Study|Withdrawal by Subject|4|||
105587267|NCT05296629|364150459|FG000|Overall Study|Lost to Follow-up|2|||
105424787|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
105424788|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
105424789|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
105424790|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
105424791|NCT03352557|363561270|FG000|LTE Period: Week 80 to Week 173|Other|0|||
105424792|NCT03352557|363561271|FG001|LTE Period: Week 80 to Week 173|Other|0|||
105424793|NCT03352557|363561272|FG002|LTE Period: Week 80 to Week 173|Other|0|||
105424794|NCT03352557|363561273|FG003|LTE Period: Week 80 to Week 173|Other|0|||
105424795|NCT03352557|363561274|FG004|LTE Period: Week 80 to Week 173|Other|0|||
105424796|NCT03352557|363561275|FG005|LTE Period: Week 80 to Week 173|Other|0|||
105424797|NCT03352557|363561276|FG006|LTE Period: Week 80 to Week 173|Other|0|||
105424798|NCT03352557|363561277|FG007|LTE Period: Week 80 to Week 173|Other|1|||
105424799|NCT03352557|363561278|FG008|LTE Period: Week 80 to Week 173|Other|0|||
105424800|NCT03352557|363561279|FG009|LTE Period: Week 80 to Week 173|Other|0|||
105424801|NCT04612842|363561284|FG000|Overall Study|Lost to Follow-up|20|||
105424802|NCT04612842|363561285|FG001|Overall Study|Lost to Follow-up|11|||
105424803|NCT04612842|363561284|FG000|Overall Study|Withdrawal by Subject|26|||
105424804|NCT04612842|363561285|FG001|Overall Study|Withdrawal by Subject|15|||
105424805|NCT04612842|363561284|FG000|Overall Study|Death|2|||
105424806|NCT04612842|363561285|FG001|Overall Study|Death|2|||
105424807|NCT01338610|363561288|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
105424808|NCT01338610|363561289|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
105424809|NCT01338610|363561290|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
105424810|NCT01338610|363561288|FG000|Overall Study|Protocol Violation|1|||
105424811|NCT01338610|363561289|FG001|Overall Study|Protocol Violation|0|||
105424812|NCT01338610|363561290|FG002|Overall Study|Protocol Violation|1|||
105424813|NCT01338610|363561288|FG000|Overall Study|Adverse Event|3|||
105424814|NCT01338610|363561289|FG001|Overall Study|Adverse Event|0|||
105424815|NCT01338610|363561290|FG002|Overall Study|Adverse Event|0|||
105424816|NCT01414205|363561291|FG000|Overall Study|Death|5|||
105424817|NCT01414205|363561292|FG001|Overall Study|Death|1|||
105424818|NCT01414205|363561291|FG000|Overall Study|Lost to Follow-up|1|||
105424819|NCT01414205|363561292|FG001|Overall Study|Lost to Follow-up|4|||
105424820|NCT01414205|363561291|FG000|Overall Study|Physician Decision|0|||
105424821|NCT01414205|363561292|FG001|Overall Study|Physician Decision|1|||
105424822|NCT01414205|363561291|FG000|Overall Study|Randomized but not Treated|1|||
105501158|NCT00533897|363847064|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
105501159|NCT00533897|363847065|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
105501160|NCT00533897|363847066|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
105501161|NCT00533897|363847067|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
105501162|NCT00533897|363847068|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
105501163|NCT00533897|363847069|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
105501164|NCT00533897|363847070|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
105501165|NCT00533897|363847071|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
105501166|NCT00533897|363847064|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
105501167|NCT00533897|363847065|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
105501168|NCT00533897|363847066|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
105501169|NCT00533897|363847067|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
105501170|NCT00533897|363847068|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
105501171|NCT00533897|363847069|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
105501172|NCT00533897|363847070|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
105501173|NCT00533897|363847071|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
105501174|NCT00533897|363847064|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
105501175|NCT00533897|363847065|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
105501176|NCT00533897|363847066|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
105501177|NCT00533897|363847067|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
105501178|NCT00533897|363847068|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
105501179|NCT00533897|363847069|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
105501180|NCT00533897|363847070|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
105587268|NCT05296629|364150460|FG001|Overall Study|Lost to Follow-up|7|||
105587269|NCT05296629|364150461|FG002|Overall Study|Lost to Follow-up|1|||
105424823|NCT01414205|363561292|FG001|Overall Study|Randomized but not Treated|1|||
105424824|NCT02046226|363561293|FG000|Overall Study|Lost to Follow-up|7|||
105424825|NCT00171925|363561294|FG000|Overall Study|Adverse Event|10|||
105424826|NCT00171925|363561295|FG001|Overall Study|Adverse Event|6|||
105424827|NCT00171925|363561294|FG000|Overall Study|Protocol Violation|1|||
105424828|NCT00171925|363561295|FG001|Overall Study|Protocol Violation|1|||
105424829|NCT00171925|363561294|FG000|Overall Study|Withdrawal by Subject|6|||
105424830|NCT00171925|363561295|FG001|Overall Study|Withdrawal by Subject|9|||
105424831|NCT00171925|363561294|FG000|Overall Study|Lost to Follow-up|2|||
105424832|NCT00171925|363561295|FG001|Overall Study|Lost to Follow-up|2|||
105424833|NCT00171925|363561294|FG000|Overall Study|Administrative problems|10|||
105424834|NCT00171925|363561295|FG001|Overall Study|Administrative problems|11|||
105424835|NCT00171925|363561294|FG000|Overall Study|Death|1|||
105424836|NCT00171925|363561295|FG001|Overall Study|Death|2|||
105424837|NCT02692040|363561296|FG000|Overall Study|Protocol Violation|0|||
105424838|NCT02692040|363561297|FG001|Overall Study|Protocol Violation|0|||
105424839|NCT02692040|363561298|FG002|Overall Study|Protocol Violation|0|||
105424840|NCT02692040|363561299|FG003|Overall Study|Protocol Violation|0|||
105424841|NCT02692040|363561300|FG004|Overall Study|Protocol Violation|0|||
105424842|NCT02692040|363561301|FG005|Overall Study|Protocol Violation|0|||
105424843|NCT02692040|363561302|FG006|Overall Study|Protocol Violation|0|||
105424844|NCT02692040|363561303|FG007|Overall Study|Protocol Violation|0|||
105424845|NCT02692040|363561304|FG008|Overall Study|Protocol Violation|0|||
105424846|NCT02692040|363561305|FG009|Overall Study|Protocol Violation|0|||
105424847|NCT02692040|363561306|FG010|Overall Study|Protocol Violation|0|||
105424848|NCT02692040|363561307|FG011|Overall Study|Protocol Violation|0|||
105424849|NCT02692040|363561308|FG012|Overall Study|Protocol Violation|1|||
105424850|NCT02692040|363561309|FG013|Overall Study|Protocol Violation|0|||
105424851|NCT02692040|363561310|FG014|Overall Study|Protocol Violation|0|||
105424852|NCT02692040|363561311|FG015|Overall Study|Protocol Violation|0|||
105424853|NCT02692040|363561312|FG016|Overall Study|Protocol Violation|0|||
105424854|NCT02692040|363561296|FG000|Overall Study|Adverse Event|0|||
105424855|NCT02692040|363561297|FG001|Overall Study|Adverse Event|0|||
105424856|NCT02692040|363561298|FG002|Overall Study|Adverse Event|0|||
105424857|NCT02692040|363561299|FG003|Overall Study|Adverse Event|0|||
105424858|NCT02692040|363561300|FG004|Overall Study|Adverse Event|0|||
105424859|NCT02692040|363561301|FG005|Overall Study|Adverse Event|0|||
105424860|NCT02692040|363561302|FG006|Overall Study|Adverse Event|0|||
105424861|NCT02692040|363561303|FG007|Overall Study|Adverse Event|0|||
105424862|NCT02692040|363561304|FG008|Overall Study|Adverse Event|0|||
105424863|NCT02692040|363561305|FG009|Overall Study|Adverse Event|0|||
105424864|NCT02692040|363561306|FG010|Overall Study|Adverse Event|0|||
105424865|NCT02692040|363561307|FG011|Overall Study|Adverse Event|0|||
105424866|NCT02692040|363561308|FG012|Overall Study|Adverse Event|0|||
105424867|NCT02692040|363561309|FG013|Overall Study|Adverse Event|3|||
105424868|NCT02692040|363561310|FG014|Overall Study|Adverse Event|1|||
105424869|NCT02692040|363561311|FG015|Overall Study|Adverse Event|1|||
105424870|NCT02692040|363561312|FG016|Overall Study|Adverse Event|0|||
105424871|NCT02590562|363561318|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
105424872|NCT01457950|363561319|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
105424873|NCT01457950|363561320|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
105424874|NCT01457950|363561321|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
105424875|NCT01457950|363561322|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
105424876|NCT01457950|363561319|FG000|Double-Blind Phase|Protocol Violation|2|||
105424877|NCT01457950|363561320|FG001|Double-Blind Phase|Protocol Violation|1|||
105424878|NCT01457950|363561321|FG002|Double-Blind Phase|Protocol Violation|0|||
105424879|NCT01457950|363561322|FG003|Double-Blind Phase|Protocol Violation|0|||
105424880|NCT01457950|363561319|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
105424881|NCT01457950|363561320|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
105424882|NCT01457950|363561321|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
105424883|NCT01457950|363561322|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
105424884|NCT01457950|363561319|FG000|Open-Label Phase|Adverse Event|0|||
105424885|NCT01457950|363561320|FG001|Open-Label Phase|Adverse Event|0|||
105424886|NCT01457950|363561321|FG002|Open-Label Phase|Adverse Event|0|||
105424887|NCT01457950|363561322|FG003|Open-Label Phase|Adverse Event|1|||
105424888|NCT01457950|363561319|FG000|Open-Label Phase|Protocol Violation|0|||
105424889|NCT01457950|363561320|FG001|Open-Label Phase|Protocol Violation|0|||
105424890|NCT01457950|363561321|FG002|Open-Label Phase|Protocol Violation|0|||
105424891|NCT01457950|363561322|FG003|Open-Label Phase|Protocol Violation|1|||
105424892|NCT01457950|363561319|FG000|Open-Label Phase|Withdrawal by Subject|0|||
105424893|NCT01457950|363561320|FG001|Open-Label Phase|Withdrawal by Subject|0|||
105424894|NCT01457950|363561321|FG002|Open-Label Phase|Withdrawal by Subject|2|||
105424895|NCT01457950|363561322|FG003|Open-Label Phase|Withdrawal by Subject|0|||
105424896|NCT00681564|363561329|FG000|Overall Study|Lost to Follow-up|6|||
105424897|NCT00681564|363561330|FG001|Overall Study|Lost to Follow-up|6|||
105424898|NCT00681564|363561329|FG000|Overall Study|Withdrawal by Subject|0|||
105424899|NCT00681564|363561330|FG001|Overall Study|Withdrawal by Subject|1|||
105424900|NCT00681564|363561329|FG000|Overall Study|Death|0|||
105424901|NCT00681564|363561330|FG001|Overall Study|Death|1|||
105424902|NCT02141490|363561331|FG000|Overall Study|Screening failures|4|||
105424903|NCT02141490|363561332|FG001|Overall Study|Screening failures|0|||
105424904|NCT02141490|363561333|FG002|Overall Study|Screening failures|0|||
105424905|NCT01253265|363561334|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
105424906|NCT01253265|363561335|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
105424907|NCT01253265|363561336|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
105424908|NCT01253265|363561337|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
105424909|NCT01253265|363561338|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
105424910|NCT01253265|363561334|FG000|Overall Study|Withdrawal by Subject|0|||
105424911|NCT01253265|363561335|FG001|Overall Study|Withdrawal by Subject|0|||
105424912|NCT01253265|363561336|FG002|Overall Study|Withdrawal by Subject|0|||
105424913|NCT01253265|363561337|FG003|Overall Study|Withdrawal by Subject|0|||
105424914|NCT01253265|363561338|FG004|Overall Study|Withdrawal by Subject|1|||
105424915|NCT00711802|363561342|FG000|Overall Study|Not treated (no further detail)|2|||
105424916|NCT00711802|363561343|FG001|Overall Study|Not treated (no further detail)|1|||
105424917|NCT00711802|363561344|FG002|Overall Study|Not treated (no further detail)|2|||
105424918|NCT00711802|363561345|FG003|Overall Study|Not treated (no further detail)|0|||
105424919|NCT00711802|363561346|FG004|Overall Study|Not treated (no further detail)|2|||
105424920|NCT00711802|363561347|FG005|Overall Study|Not treated (no further detail)|0|||
105424921|NCT00711802|363561348|FG006|Overall Study|Not treated (no further detail)|0|||
105424922|NCT00711802|363561349|FG007|Overall Study|Not treated (no further detail)|0|||
105424923|NCT00711802|363561342|FG000|Overall Study|Adverse Event|0|||
105424924|NCT00711802|363561343|FG001|Overall Study|Adverse Event|0|||
105424925|NCT00711802|363561344|FG002|Overall Study|Adverse Event|0|||
105424926|NCT00711802|363561345|FG003|Overall Study|Adverse Event|0|||
105424927|NCT00711802|363561346|FG004|Overall Study|Adverse Event|1|||
105424928|NCT00711802|363561347|FG005|Overall Study|Adverse Event|1|||
105424929|NCT00711802|363561348|FG006|Overall Study|Adverse Event|0|||
105424930|NCT00711802|363561349|FG007|Overall Study|Adverse Event|0|||
105424931|NCT00711802|363561342|FG000|Overall Study|Microbiological failure|0|||
105424932|NCT00711802|363561343|FG001|Overall Study|Microbiological failure|1|||
105424933|NCT00711802|363561344|FG002|Overall Study|Microbiological failure|0|||
105424934|NCT00711802|363561345|FG003|Overall Study|Microbiological failure|0|||
105424935|NCT00711802|363561346|FG004|Overall Study|Microbiological failure|0|||
105424936|NCT00711802|363561347|FG005|Overall Study|Microbiological failure|1|||
105424937|NCT00711802|363561348|FG006|Overall Study|Microbiological failure|0|||
105424938|NCT00711802|363561349|FG007|Overall Study|Microbiological failure|0|||
105424939|NCT00711802|363561342|FG000|Overall Study|Protocol Violation|0|||
105424940|NCT00711802|363561343|FG001|Overall Study|Protocol Violation|0|||
105424941|NCT00711802|363561344|FG002|Overall Study|Protocol Violation|0|||
105424942|NCT00711802|363561345|FG003|Overall Study|Protocol Violation|1|||
105424943|NCT00711802|363561346|FG004|Overall Study|Protocol Violation|0|||
105424944|NCT00711802|363561347|FG005|Overall Study|Protocol Violation|0|||
105424945|NCT00711802|363561348|FG006|Overall Study|Protocol Violation|0|||
105424946|NCT00711802|363561349|FG007|Overall Study|Protocol Violation|0|||
105424947|NCT00711802|363561342|FG000|Overall Study|Physician Decision|0|||
105424948|NCT00711802|363561343|FG001|Overall Study|Physician Decision|2|||
105424949|NCT00711802|363561344|FG002|Overall Study|Physician Decision|0|||
105424950|NCT00711802|363561345|FG003|Overall Study|Physician Decision|0|||
105424951|NCT00711802|363561346|FG004|Overall Study|Physician Decision|0|||
105424952|NCT00711802|363561347|FG005|Overall Study|Physician Decision|0|||
105424953|NCT00711802|363561348|FG006|Overall Study|Physician Decision|0|||
105424954|NCT00711802|363561349|FG007|Overall Study|Physician Decision|0|||
105424955|NCT00711802|363561342|FG000|Overall Study|Withdrawal by Subject|0|||
105424956|NCT00711802|363561343|FG001|Overall Study|Withdrawal by Subject|1|||
105424957|NCT00711802|363561344|FG002|Overall Study|Withdrawal by Subject|0|||
105424958|NCT00711802|363561345|FG003|Overall Study|Withdrawal by Subject|1|||
105424959|NCT00711802|363561346|FG004|Overall Study|Withdrawal by Subject|0|||
105424960|NCT00711802|363561347|FG005|Overall Study|Withdrawal by Subject|0|||
105424961|NCT00711802|363561348|FG006|Overall Study|Withdrawal by Subject|0|||
105424962|NCT00711802|363561349|FG007|Overall Study|Withdrawal by Subject|0|||
105424963|NCT00711802|363561342|FG000|Overall Study|Lost to Follow-up|0|||
105424964|NCT00711802|363561343|FG001|Overall Study|Lost to Follow-up|0|||
105424965|NCT00711802|363561344|FG002|Overall Study|Lost to Follow-up|3|||
105424966|NCT00711802|363561345|FG003|Overall Study|Lost to Follow-up|1|||
105424967|NCT00711802|363561346|FG004|Overall Study|Lost to Follow-up|10|||
105424968|NCT00711802|363561347|FG005|Overall Study|Lost to Follow-up|6|||
105424969|NCT00711802|363561348|FG006|Overall Study|Lost to Follow-up|4|||
105424970|NCT00711802|363561349|FG007|Overall Study|Lost to Follow-up|2|||
105424971|NCT00711802|363561342|FG000|Overall Study|Reason not reported|0|||
105424972|NCT00711802|363561343|FG001|Overall Study|Reason not reported|1|||
105424973|NCT00711802|363561344|FG002|Overall Study|Reason not reported|1|||
105424974|NCT00711802|363561345|FG003|Overall Study|Reason not reported|0|||
105424975|NCT00711802|363561346|FG004|Overall Study|Reason not reported|1|||
105424976|NCT00711802|363561347|FG005|Overall Study|Reason not reported|0|||
105424977|NCT00711802|363561348|FG006|Overall Study|Reason not reported|1|||
105424978|NCT00711802|363561349|FG007|Overall Study|Reason not reported|0|||
105424979|NCT02436408|363561351|FG000|Overall Study|Death|1|||
105424980|NCT01300819|363561352|FG000|Overall Study|Adverse Event|9|||
105424981|NCT01300819|363561353|FG001|Overall Study|Adverse Event|27|||
105424982|NCT01300819|363561352|FG000|Overall Study|Lack of Efficacy|2|||
105424983|NCT01300819|363561353|FG001|Overall Study|Lack of Efficacy|1|||
105424984|NCT01300819|363561352|FG000|Overall Study|Withdrawal by Subject|10|||
105424985|NCT01300819|363561353|FG001|Overall Study|Withdrawal by Subject|12|||
105424986|NCT01300819|363561352|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
105424987|NCT01300819|363561353|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
105424988|NCT01300819|363561352|FG000|Overall Study|Refusal to down titrate study drug|0|||
105424989|NCT01300819|363561353|FG001|Overall Study|Refusal to down titrate study drug|1|||
105424990|NCT01300819|363561352|FG000|Overall Study|Administrative reason|0|||
105424991|NCT01300819|363561353|FG001|Overall Study|Administrative reason|1|||
105424992|NCT01300819|363561352|FG000|Overall Study|Safety follow up not done by mistake|0|||
105424993|NCT01300819|363561353|FG001|Overall Study|Safety follow up not done by mistake|1|||
105424994|NCT01300819|363561352|FG000|Overall Study|Follow up call was not done|1|||
105424995|NCT01300819|363561353|FG001|Overall Study|Follow up call was not done|0|||
105424996|NCT00042432|363561359|FG000|Overall Study|Adverse Event|4|||
105424997|NCT00042432|363561360|FG001|Overall Study|Adverse Event|1|||
105424998|NCT00042432|363561359|FG000|Overall Study|Withdrawal by Subject|1|||
105424999|NCT00042432|363561360|FG001|Overall Study|Withdrawal by Subject|3|||
105425000|NCT00042432|363561359|FG000|Overall Study|Death|0|||
105425001|NCT00042432|363561360|FG001|Overall Study|Death|2|||
105425002|NCT00042432|363561359|FG000|Overall Study|Ineligibility determined|1|||
105425003|NCT00042432|363561360|FG001|Overall Study|Ineligibility determined|0|||
105425004|NCT00042432|363561359|FG000|Overall Study|Initiation of maintenance dialysis|1|||
105425005|NCT00042432|363561360|FG001|Overall Study|Initiation of maintenance dialysis|1|||
105425006|NCT00042432|363561359|FG000|Overall Study|Other|2|||
105425007|NCT00042432|363561360|FG001|Overall Study|Other|0|||
105425008|NCT01287221|363561364|FG000|Overall Study|Lack of Perceived Benefit|1|||
105425009|NCT01287221|363561365|FG001|Overall Study|Lack of Perceived Benefit|1|||
105425010|NCT01287221|363561364|FG000|Overall Study|Adverse Event|3|||
105425011|NCT01287221|363561365|FG001|Overall Study|Adverse Event|3|||
105425012|NCT01287221|363561364|FG000|Overall Study|Withdrawal by Subject|0|||
105425013|NCT01287221|363561365|FG001|Overall Study|Withdrawal by Subject|1|||
105425014|NCT01444027|363561366|FG000|Overall Study|Withdrawal by Subject|4|||
105425015|NCT01444027|363561367|FG001|Overall Study|Withdrawal by Subject|10|||
105425016|NCT01444027|363561368|FG002|Overall Study|Withdrawal by Subject|24|||
105425017|NCT01444027|363561366|FG000|Overall Study|Lost to Follow-up|26|||
105425018|NCT01444027|363561367|FG001|Overall Study|Lost to Follow-up|20|||
105425019|NCT01444027|363561368|FG002|Overall Study|Lost to Follow-up|14|||
105425020|NCT02966795|363561370|FG000|Overall Study|Patient Left the Country|0|||
105425021|NCT02966795|363561371|FG001|Overall Study|Patient Left the Country|1|||
105425022|NCT00432744|363561372|FG000|Months 0-6|Withdrawal by Subject|4|||
105425023|NCT00432744|363561373|FG001|Months 0-6|Withdrawal by Subject|4|||
105425024|NCT00432744|363561372|FG000|Months 0-6|Too disabled to score|1|||
105425025|NCT00432744|363561373|FG001|Months 0-6|Too disabled to score|0|||
105425026|NCT00432744|363561372|FG000|Months 7 - 12|Withdrawal by Subject|1|||
105425027|NCT00432744|363561373|FG001|Months 7 - 12|Withdrawal by Subject|0|||
105425028|NCT00432744|363561372|FG000|Months 7 - 12|Too disabled to score|0|||
105425029|NCT00432744|363561373|FG001|Months 7 - 12|Too disabled to score|1|||
105425030|NCT01416441|363561374|FG000|Overall Study|Lost to Follow-up|5|||
105425031|NCT01416441|363561374|FG000|Overall Study|Adverse Event|6|||
105425032|NCT01416441|363561374|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
105425033|NCT01416441|363561374|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
105425034|NCT01416441|363561374|FG000|Overall Study|Investigator Withdrew Subject|2|||
105425035|NCT01416441|363561374|FG000|Overall Study|Subject Withdrew Consent|12|||
105425036|NCT01416441|363561374|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
105425037|NCT01319721|363561385|FG000|Overall Study|Lost to Follow-up|1|||
105425038|NCT01319721|363561386|FG001|Overall Study|Lost to Follow-up|6|||
105425039|NCT01360398|363561387|FG000|Overall Study|Withdrawal by Subject|14|||
105425040|NCT01360398|363561387|FG000|Overall Study|Other|7|||
105425041|NCT01360398|363561387|FG000|Overall Study|Migrated/moved from study area|1|||
105425042|NCT00737711|363561388|FG000|Overall Study|Adverse Event|2|||
105425043|NCT00737711|363561388|FG000|Overall Study|Death|8|||
105425044|NCT00737711|363561388|FG000|Overall Study|Failure to return|4|||
105425045|NCT00737711|363561388|FG000|Overall Study|Protocol Violation|1|||
105425046|NCT00737711|363561388|FG000|Overall Study|Withdrawal by Subject|5|||
105425047|NCT00737711|363561388|FG000|Overall Study|Blood transfusion|6|||
105425048|NCT00737711|363561388|FG000|Overall Study|Other|5|||
105425049|NCT01263015|363563237|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
105425050|NCT01263015|363563238|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
105425051|NCT01263015|363563237|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
105425052|NCT01263015|363563238|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
105425053|NCT01263015|363563237|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
105425054|NCT01263015|363563238|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
105425055|NCT01263015|363563237|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
105425056|NCT01263015|363563238|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
105425057|NCT01263015|363563237|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
105425058|NCT01263015|363563238|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
105425059|NCT01263015|363563237|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
105425060|NCT01263015|363563238|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
105425061|NCT01263015|363563237|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
105425062|NCT01263015|363563238|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
105425063|NCT01263015|363563237|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
105425064|NCT01263015|363563238|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
105425065|NCT01263015|363563237|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
105425066|NCT01263015|363563238|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
105425067|NCT01263015|363563237|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
105425068|NCT01263015|363563238|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
105425069|NCT01263015|363563237|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
105425070|NCT01263015|363563238|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
105425071|NCT01263015|363563237|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
105425072|NCT01263015|363563238|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
105425073|NCT01460719|363563241|FG000|Overall Study|Adverse Event|1|||
105425074|NCT01460719|363563241|FG000|Overall Study|Withdrawal by Subject|1|||
105425075|NCT04035564|363563242|FG000|Overall Study|Protocol Violation|1|||
105425076|NCT04035564|363563243|FG001|Overall Study|Protocol Violation|2|||
105425077|NCT04035564|363563242|FG000|Overall Study|No laboratory available|2|||
105425078|NCT04035564|363563243|FG001|Overall Study|No laboratory available|2|||
105425079|NCT04035564|363563242|FG000|Overall Study|Guardian declined consent|1|||
105425080|NCT04035564|363563243|FG001|Overall Study|Guardian declined consent|2|||
105425081|NCT02838901|363563244|FG000|Overall Study|Withdrawal by Subject|1|||
105425082|NCT02838901|363563245|FG001|Overall Study|Withdrawal by Subject|1|||
105425083|NCT02838901|363563244|FG000|Overall Study|Lost to Follow-up|1|||
105425084|NCT02838901|363563245|FG001|Overall Study|Lost to Follow-up|1|||
105425085|NCT00149994|363563246|FG000|Overall Study|Administrative problems:|1|||
105425086|NCT00149994|363563247|FG001|Overall Study|Administrative problems:|0|||
105425087|NCT00149994|363563246|FG000|Overall Study|Protocol Violation|0|||
105425088|NCT00149994|363563247|FG001|Overall Study|Protocol Violation|1|||
105425089|NCT03405935|363563249|FG000|Overall Study|Adverse Event|3|||
105425090|NCT03405935|363563249|FG000|Overall Study|Death|2|||
105425091|NCT03405935|363563249|FG000|Overall Study|Withdrawal by Subject|1|||
105425092|NCT03405935|363563249|FG000|Overall Study|Lost to Follow-up|2|||
105425093|NCT04979897|363563250|FG000|Overall Study|Death|1|||
105425094|NCT04979897|363563251|FG001|Overall Study|Death|8|||
105425095|NCT04979897|363563250|FG000|Overall Study|Lost to Follow-up|111|||
105425096|NCT04979897|363563251|FG001|Overall Study|Lost to Follow-up|56|||
105425097|NCT04979897|363563250|FG000|Overall Study|Withdrawal by Subject|7|||
105425098|NCT04979897|363563251|FG001|Overall Study|Withdrawal by Subject|2|||
105425099|NCT01224821|363563252|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
105425100|NCT01224821|363563252|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
105425101|NCT01224821|363563252|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
105425102|NCT01224821|363563252|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
105425103|NCT01224821|363563252|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
105425104|NCT01224821|363563252|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
105425105|NCT01224821|363563252|FG000|Long-Term Follow-Up|Death|2|||
105425106|NCT01224821|363563252|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
105425107|NCT03538444|363563253|FG000|Overall Study|opioid withdrawal|1|||
105425108|NCT03538444|363563254|FG001|Overall Study|opioid withdrawal|0|||
105425109|NCT02435680|363563256|FG000|Overall Study|Physician Decision|3|||
105425110|NCT02435680|363563257|FG001|Overall Study|Physician Decision|0|||
105425111|NCT02435680|363563258|FG002|Overall Study|Physician Decision|0|||
105425112|NCT02435680|363563256|FG000|Overall Study|subject / guardian decision|0|||
105425113|NCT02435680|363563257|FG001|Overall Study|subject / guardian decision|3|||
105425114|NCT02435680|363563258|FG002|Overall Study|subject / guardian decision|2|||
105425115|NCT02435680|363563256|FG000|Overall Study|Adverse Event|8|||
105425116|NCT02435680|363563257|FG001|Overall Study|Adverse Event|3|||
105425117|NCT02435680|363563258|FG002|Overall Study|Adverse Event|2|||
105425118|NCT02435680|363563256|FG000|Overall Study|progressive disease|10|||
105425119|NCT02435680|363563257|FG001|Overall Study|progressive disease|7|||
105425120|NCT02435680|363563258|FG002|Overall Study|progressive disease|11|||
105425121|NCT02435680|363563256|FG000|Overall Study|not treated|0|||
105425122|NCT02435680|363563257|FG001|Overall Study|not treated|0|||
105425123|NCT02435680|363563258|FG002|Overall Study|not treated|1|||
105425124|NCT02509052|363563259|FG000|Overall Study|Non compliance|0|||
105425125|NCT02509052|363563260|FG001|Overall Study|Non compliance|0|||
105425126|NCT02509052|363563261|FG002|Overall Study|Non compliance|1|||
105425127|NCT01904149|363563262|FG000|Overall Study|Adverse Event|3|||
105425128|NCT01904149|363563263|FG001|Overall Study|Adverse Event|4|||
105425129|NCT01904149|363563264|FG002|Overall Study|Adverse Event|0|||
105425130|NCT01904149|363563265|FG003|Overall Study|Adverse Event|1|||
105425131|NCT01904149|363563266|FG004|Overall Study|Adverse Event|1|||
105425132|NCT01904149|363563267|FG005|Overall Study|Adverse Event|2|||
105425133|NCT01904149|363563262|FG000|Overall Study|Lack of Efficacy|0|||
105425134|NCT01904149|363563263|FG001|Overall Study|Lack of Efficacy|3|||
105425135|NCT01904149|363563264|FG002|Overall Study|Lack of Efficacy|1|||
105425136|NCT01904149|363563265|FG003|Overall Study|Lack of Efficacy|3|||
105425137|NCT01904149|363563266|FG004|Overall Study|Lack of Efficacy|3|||
105425138|NCT01904149|363563267|FG005|Overall Study|Lack of Efficacy|1|||
105425139|NCT01904149|363563262|FG000|Overall Study|Withdrawal by Subject|1|||
105425140|NCT01904149|363563263|FG001|Overall Study|Withdrawal by Subject|3|||
105425141|NCT01904149|363563264|FG002|Overall Study|Withdrawal by Subject|1|||
105425142|NCT01904149|363563265|FG003|Overall Study|Withdrawal by Subject|0|||
105425143|NCT01904149|363563266|FG004|Overall Study|Withdrawal by Subject|1|||
105425144|NCT01904149|363563267|FG005|Overall Study|Withdrawal by Subject|0|||
105425145|NCT01904149|363563262|FG000|Overall Study|Protocol Violation|0|||
105425146|NCT01904149|363563263|FG001|Overall Study|Protocol Violation|1|||
105425147|NCT01904149|363563264|FG002|Overall Study|Protocol Violation|0|||
105425148|NCT01904149|363563265|FG003|Overall Study|Protocol Violation|0|||
105425149|NCT01904149|363563266|FG004|Overall Study|Protocol Violation|0|||
105425150|NCT01904149|363563267|FG005|Overall Study|Protocol Violation|0|||
105425151|NCT01904149|363563262|FG000|Overall Study|non compliance with study drug|1|||
105425152|NCT01904149|363563263|FG001|Overall Study|non compliance with study drug|0|||
105425153|NCT01904149|363563264|FG002|Overall Study|non compliance with study drug|0|||
105425154|NCT01904149|363563265|FG003|Overall Study|non compliance with study drug|0|||
105425155|NCT01904149|363563266|FG004|Overall Study|non compliance with study drug|0|||
105425156|NCT01904149|363563267|FG005|Overall Study|non compliance with study drug|0|||
105425157|NCT00068250|363563268|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
105425158|NCT00068250|363563269|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
105425159|NCT00068250|363563270|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
105425160|NCT00068250|363563271|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
105425161|NCT02098369|363563273|FG000|Overall Study|Withdrawal by Subject|1|||
105425162|NCT02098369|363563274|FG001|Overall Study|Withdrawal by Subject|5|||
105425163|NCT02098369|363563275|FG002|Overall Study|Withdrawal by Subject|0|||
105425164|NCT02098369|363563273|FG000|Overall Study|Lost to Follow-up|5|||
105425165|NCT02098369|363563274|FG001|Overall Study|Lost to Follow-up|1|||
105425166|NCT02098369|363563275|FG002|Overall Study|Lost to Follow-up|3|||
105425167|NCT02098369|363563273|FG000|Overall Study|Death|1|||
105425168|NCT02098369|363563274|FG001|Overall Study|Death|1|||
105425169|NCT02098369|363563275|FG002|Overall Study|Death|1|||
105425170|NCT02098369|363563273|FG000|Overall Study|Other|0|||
105425171|NCT02098369|363563274|FG001|Overall Study|Other|2|||
105425172|NCT02098369|363563275|FG002|Overall Study|Other|1|||
105425173|NCT03362931|363563276|FG000|Overall Study|Adverse Event|1|||
105425174|NCT03362931|363563276|FG000|Overall Study|Death|2|||
105425175|NCT02927925|363563281|FG000|Overall Study|Death|16|||
105425176|NCT02927925|363563281|FG000|Overall Study|Physician Decision|1|||
105425177|NCT02927925|363563281|FG000|Overall Study|Withdrawal by Subject|11|||
105425178|NCT02927925|363563281|FG000|Overall Study|Other|3|||
105425179|NCT02927925|363563281|FG000|Overall Study|Disease progression at clinical cutoff|1|||
105425180|NCT01643850|363563289|FG000|Overall Study|Withdrawal by Subject|0|||
105425181|NCT01643850|363563290|FG001|Overall Study|Withdrawal by Subject|0|||
105425182|NCT01643850|363563291|FG002|Overall Study|Withdrawal by Subject|0|||
105425183|NCT01643850|363563292|FG003|Overall Study|Withdrawal by Subject|0|||
105425184|NCT01643850|363563293|FG004|Overall Study|Withdrawal by Subject|1|||
105425185|NCT01643850|363563294|FG005|Overall Study|Withdrawal by Subject|0|||
105425186|NCT01643850|363563295|FG006|Overall Study|Withdrawal by Subject|0|||
105425187|NCT01643850|363563296|FG007|Overall Study|Withdrawal by Subject|0|||
105425188|NCT01643850|363563297|FG008|Overall Study|Withdrawal by Subject|0|||
105425189|NCT01643850|363563289|FG000|Overall Study|Lost to Follow-up|0|||
105425190|NCT01643850|363563290|FG001|Overall Study|Lost to Follow-up|0|||
105425191|NCT01643850|363563291|FG002|Overall Study|Lost to Follow-up|0|||
105425192|NCT01643850|363563292|FG003|Overall Study|Lost to Follow-up|0|||
105425193|NCT01643850|363563293|FG004|Overall Study|Lost to Follow-up|0|||
105425194|NCT01643850|363563294|FG005|Overall Study|Lost to Follow-up|0|||
105425195|NCT01643850|363563295|FG006|Overall Study|Lost to Follow-up|1|||
105425196|NCT01643850|363563296|FG007|Overall Study|Lost to Follow-up|0|||
105425197|NCT01643850|363563297|FG008|Overall Study|Lost to Follow-up|1|||
105425198|NCT01643850|363563289|FG000|Overall Study|Adverse Event|0|||
105425199|NCT01643850|363563290|FG001|Overall Study|Adverse Event|0|||
105425200|NCT01643850|363563291|FG002|Overall Study|Adverse Event|0|||
105425201|NCT01643850|363563292|FG003|Overall Study|Adverse Event|0|||
105425202|NCT01643850|363563293|FG004|Overall Study|Adverse Event|1|||
105425203|NCT01643850|363563294|FG005|Overall Study|Adverse Event|0|||
105425204|NCT01643850|363563295|FG006|Overall Study|Adverse Event|0|||
105425205|NCT01643850|363563296|FG007|Overall Study|Adverse Event|0|||
105425206|NCT01643850|363563297|FG008|Overall Study|Adverse Event|0|||
105425207|NCT01643850|363563289|FG000|Overall Study|Administrative Problems|0|||
105425208|NCT01643850|363563290|FG001|Overall Study|Administrative Problems|0|||
105425209|NCT01643850|363563291|FG002|Overall Study|Administrative Problems|1|||
105425210|NCT01643850|363563292|FG003|Overall Study|Administrative Problems|0|||
105425211|NCT01643850|363563293|FG004|Overall Study|Administrative Problems|1|||
105425212|NCT01643850|363563294|FG005|Overall Study|Administrative Problems|0|||
105425213|NCT01643850|363563295|FG006|Overall Study|Administrative Problems|0|||
105425214|NCT01643850|363563296|FG007|Overall Study|Administrative Problems|0|||
105425215|NCT01643850|363563297|FG008|Overall Study|Administrative Problems|0|||
105425216|NCT03054350|363563298|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
105425217|NCT03054350|363563299|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
105425218|NCT03054350|363563300|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
105425219|NCT03054350|363563301|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
105425220|NCT03054350|363563302|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
105425221|NCT03054350|363563303|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
105425222|NCT03054350|363563298|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
105425223|NCT03054350|363563299|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
105425224|NCT03054350|363563300|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
105425225|NCT03054350|363563301|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
105425226|NCT03054350|363563302|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
105425227|NCT03054350|363563303|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
105425228|NCT03054350|363563298|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
105425229|NCT03054350|363563299|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
105425230|NCT03054350|363563300|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
105425231|NCT03054350|363563301|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
105425232|NCT03054350|363563302|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
105425233|NCT03054350|363563303|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
105425234|NCT03054350|363563298|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
105425235|NCT03054350|363563299|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
105425236|NCT03054350|363563300|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
105425237|NCT03054350|363563301|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
105425238|NCT03054350|363563302|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
105425239|NCT03054350|363563303|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
105425240|NCT03510468|363563309|FG000|Overall Study|Lost to Follow-up|1|||
105425241|NCT03510468|363563309|FG000|Overall Study|Adverse Event|5|||
105425242|NCT03510468|363563309|FG000|Overall Study|Physician Decision|1|||
105425243|NCT03510468|363563309|FG000|Overall Study|non-compliant with treatment|2|||
105425244|NCT03510468|363563309|FG000|Overall Study|Missed visit|1|||
105425245|NCT05426031|363563310|FG000|Overall Study|Circulatory Arrest|3|||
105425246|NCT05426031|363563311|FG001|Overall Study|Circulatory Arrest|2|||
105425247|NCT02419131|363563312|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
105425248|NCT02419131|363563313|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
105425249|NCT02419131|363563314|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
105425250|NCT02419131|363563312|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
105425251|NCT02419131|363563313|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
105425252|NCT02419131|363563314|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
105425253|NCT03242772|363563315|FG000|Overall Study|Lost to Follow-up|2|||
105425254|NCT03242772|363563316|FG001|Overall Study|Lost to Follow-up|0|||
105425255|NCT03242772|363563315|FG000|Overall Study|Physician Decision|0|||
105425256|NCT03242772|363563316|FG001|Overall Study|Physician Decision|1|||
105425257|NCT03242772|363563315|FG000|Overall Study|Withdrawal by Subject|1|||
105425258|NCT03242772|363563316|FG001|Overall Study|Withdrawal by Subject|0|||
105587270|NCT05296629|364150459|FG000|Overall Study|Adverse Event|0|||
105587271|NCT05296629|364150460|FG001|Overall Study|Adverse Event|4|||
105587272|NCT05296629|364150461|FG002|Overall Study|Adverse Event|2|||
105587273|NCT05296629|364150459|FG000|Overall Study|Protocol Violation|0|||
105587274|NCT05296629|364150460|FG001|Overall Study|Protocol Violation|2|||
105587275|NCT05296629|364150461|FG002|Overall Study|Protocol Violation|0|||
105587276|NCT01939158|364150464|FG000|Overall Study|Adverse Event|1|||
105587277|NCT01939158|364150465|FG001|Overall Study|Adverse Event|0|||
105587278|NCT01939158|364150466|FG002|Overall Study|Adverse Event|0|||
105587279|NCT01939158|364150467|FG003|Overall Study|Adverse Event|0|||
105587280|NCT01939158|364150464|FG000|Overall Study|Withdrawal by Subject|22|||
105587281|NCT01939158|364150465|FG001|Overall Study|Withdrawal by Subject|25|||
105587282|NCT01939158|364150466|FG002|Overall Study|Withdrawal by Subject|15|||
105587283|NCT01939158|364150467|FG003|Overall Study|Withdrawal by Subject|17|||
105587284|NCT01939158|364150464|FG000|Overall Study|Migrated/moved from study area|5|||
105587285|NCT01939158|364150465|FG001|Overall Study|Migrated/moved from study area|7|||
105587286|NCT01939158|364150466|FG002|Overall Study|Migrated/moved from study area|3|||
105587287|NCT01939158|364150467|FG003|Overall Study|Migrated/moved from study area|6|||
105587288|NCT01939158|364150464|FG000|Overall Study|Lost to Follow-up|18|||
105587289|NCT01939158|364150465|FG001|Overall Study|Lost to Follow-up|17|||
105587290|NCT01939158|364150466|FG002|Overall Study|Lost to Follow-up|17|||
105587291|NCT01939158|364150467|FG003|Overall Study|Lost to Follow-up|17|||
105587292|NCT01939158|364150464|FG000|Overall Study|Death|0|||
105587293|NCT01939158|364150465|FG001|Overall Study|Death|0|||
105425259|NCT04677660|363563317|FG000|Overall Study|Lost to Follow-up|0|||
105425260|NCT04677660|363563318|FG001|Overall Study|Lost to Follow-up|2|||
105425261|NCT04677660|363563317|FG000|Overall Study|Withdrawal by Subject|0|||
105425262|NCT04677660|363563318|FG001|Overall Study|Withdrawal by Subject|1|||
105425263|NCT04677660|363563317|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
105425264|NCT04677660|363563318|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
105425265|NCT03060512|363563319|FG000|Overall Study|Adverse Event|4|||
105425266|NCT03060512|363563320|FG001|Overall Study|Adverse Event|6|||
105425267|NCT03060512|363563319|FG000|Overall Study|Lost to Follow-up|1|||
105425268|NCT03060512|363563320|FG001|Overall Study|Lost to Follow-up|1|||
105425269|NCT03060512|363563319|FG000|Overall Study|Withdrawal by Subject|1|||
105425270|NCT03060512|363563320|FG001|Overall Study|Withdrawal by Subject|0|||
105425271|NCT03060512|363563319|FG000|Overall Study|Non-compliance with study medication|1|||
105425272|NCT03060512|363563320|FG001|Overall Study|Non-compliance with study medication|2|||
105425273|NCT00089986|363563321|FG000|Overall Study|Adverse Event|6|||
105425274|NCT00089986|363563322|FG001|Overall Study|Adverse Event|9|||
105425275|NCT00089986|363563323|FG002|Overall Study|Adverse Event|6|||
105425276|NCT00089986|363563321|FG000|Overall Study|Lost to Follow-up|3|||
105425277|NCT00089986|363563322|FG001|Overall Study|Lost to Follow-up|1|||
105425278|NCT00089986|363563323|FG002|Overall Study|Lost to Follow-up|1|||
105587294|NCT01939158|364150466|FG002|Overall Study|Death|1|||
105587295|NCT01939158|364150467|FG003|Overall Study|Death|1|||
105425279|NCT00089986|363563321|FG000|Overall Study|Protocol Violation|0|||
105425280|NCT00089986|363563322|FG001|Overall Study|Protocol Violation|1|||
105425281|NCT00089986|363563323|FG002|Overall Study|Protocol Violation|0|||
105425282|NCT00089986|363563321|FG000|Overall Study|Patient transferred to another hospital|2|||
105587296|NCT01939158|364150464|FG000|Overall Study|No longer meets eligibility criteria|0|||
105425283|NCT00089986|363563322|FG001|Overall Study|Patient transferred to another hospital|1|||
105425284|NCT00089986|363563323|FG002|Overall Study|Patient transferred to another hospital|0|||
105425285|NCT00089986|363563321|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
105587297|NCT01939158|364150465|FG001|Overall Study|No longer meets eligibility criteria|0|||
105587298|NCT01939158|364150466|FG002|Overall Study|No longer meets eligibility criteria|1|||
105425286|NCT00089986|363563322|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
105425287|NCT00089986|363563323|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
105425288|NCT00089986|363563321|FG000|Overall Study|Hemohlobin stopping rule|0|||
105425289|NCT00089986|363563322|FG001|Overall Study|Hemohlobin stopping rule|1|||
105425290|NCT00089986|363563323|FG002|Overall Study|Hemohlobin stopping rule|0|||
105425291|NCT00089986|363563321|FG000|Overall Study|Investigator decision to withdrew|0|||
105425292|NCT00089986|363563322|FG001|Overall Study|Investigator decision to withdrew|1|||
105425293|NCT00089986|363563323|FG002|Overall Study|Investigator decision to withdrew|0|||
105425294|NCT00089986|363563321|FG000|Overall Study|Enrollment in another study|0|||
105425295|NCT00089986|363563322|FG001|Overall Study|Enrollment in another study|1|||
105425296|NCT00089986|363563323|FG002|Overall Study|Enrollment in another study|0|||
105425297|NCT00089986|363563321|FG000|Overall Study|Family decision|0|||
105425298|NCT00089986|363563322|FG001|Overall Study|Family decision|1|||
105425299|NCT00089986|363563323|FG002|Overall Study|Family decision|0|||
105425300|NCT00089986|363563321|FG000|Overall Study|Do not resuscitate (DNR)|0|||
105425301|NCT00089986|363563322|FG001|Overall Study|Do not resuscitate (DNR)|0|||
105425302|NCT00089986|363563323|FG002|Overall Study|Do not resuscitate (DNR)|1|||
105425303|NCT00089986|363563321|FG000|Overall Study|Withdrawal by Subject|3|||
105425304|NCT00089986|363563322|FG001|Overall Study|Withdrawal by Subject|6|||
105425305|NCT00089986|363563323|FG002|Overall Study|Withdrawal by Subject|2|||
105425306|NCT00241631|363563331|FG000|Run in (2 Weeks)|Physician Decision|3|||
105425307|NCT00241631|363563332|FG001|Run in (2 Weeks)|Physician Decision|3|||
105425308|NCT00241631|363563331|FG000|Phase 1 (4 Weeks)|sore throat|1|||
105425309|NCT00241631|363563332|FG001|Phase 1 (4 Weeks)|sore throat|0|||
105425310|NCT00241631|363563331|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
105425311|NCT00241631|363563332|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
105425312|NCT00241631|363563331|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
105425313|NCT00241631|363563332|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
105425314|NCT00241631|363563331|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
105425315|NCT00241631|363563332|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
105425316|NCT02437305|363563333|FG000|Overall Study|Lost to Follow-up|18|||
105425317|NCT02437305|363563334|FG001|Overall Study|Lost to Follow-up|12|||
105425318|NCT01071200|363563337|FG000|Overall Study|Lack of ovarian response|1|||
105425319|NCT01071200|363563338|FG001|Overall Study|Lack of ovarian response|1|||
105425320|NCT01071200|363563337|FG000|Overall Study|No fertilization|4|||
105425321|NCT01071200|363563338|FG001|Overall Study|No fertilization|0|||
105425322|NCT01071200|363563337|FG000|Overall Study|No oocytes retrieved|1|||
105425323|NCT01071200|363563338|FG001|Overall Study|No oocytes retrieved|1|||
105425324|NCT01071200|363563337|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
105425325|NCT01071200|363563338|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
105425326|NCT01071200|363563337|FG000|Overall Study|No viable embryos|0|||
105425327|NCT01071200|363563338|FG001|Overall Study|No viable embryos|1|||
105425328|NCT00853125|363563339|FG000|Overall Study|Study participant's donor was CMV +|1|||
105425329|NCT03023826|363563345|FG000|Period 1|Withdrawal by Subject|0|||
105425330|NCT03023826|363563346|FG001|Period 1|Withdrawal by Subject|0|||
105425331|NCT03023826|363563347|FG002|Period 1|Withdrawal by Subject|0|||
105425332|NCT03023826|363563348|FG003|Period 1|Withdrawal by Subject|0|||
105425333|NCT03023826|363563349|FG004|Period 1|Withdrawal by Subject|1|||
105425334|NCT03023826|363563350|FG005|Period 1|Withdrawal by Subject|0|||
105425335|NCT02498067|363563351|FG000|Overall Study|Lost to Follow-up|22|||
105425336|NCT02498067|363563351|FG000|Overall Study|Did not meet inclusion criteria|11|||
105425337|NCT02460783|363563354|FG000|Overall Study|Withdrawal by Subject|1|||
105425338|NCT02460783|363563355|FG001|Overall Study|Withdrawal by Subject|3|||
105425339|NCT02460783|363563354|FG000|Overall Study|Lost to Follow-up|1|||
105425340|NCT02460783|363563355|FG001|Overall Study|Lost to Follow-up|1|||
105425341|NCT01646645|363563356|FG000|Overall Study|No Treated|1|||
105425342|NCT01646645|363563356|FG000|Overall Study|Inevaluable Donor|29|||
105425343|NCT03754582|363563357|FG000|Treatment Phase|Adverse Event|0|||
105425344|NCT03754582|363563358|FG001|Treatment Phase|Adverse Event|1|||
105425345|NCT03754582|363563359|FG002|Treatment Phase|Adverse Event|0|||
105425346|NCT03754582|363563357|FG000|Follow-up Phase|Other|0|||
105425347|NCT03754582|363563358|FG001|Follow-up Phase|Other|0|||
105425348|NCT03754582|363563359|FG002|Follow-up Phase|Other|1|||
105425349|NCT02847858|363563362|FG000|Overall Study|Lost to Follow-up|401|||
105425350|NCT02847858|363563363|FG001|Overall Study|Lost to Follow-up|269|||
105425351|NCT02594098|363563364|FG000|Overall Study|Lack of Efficacy|17|||
105425352|NCT02594098|363563365|FG001|Overall Study|Lack of Efficacy|6|||
105425353|NCT02594098|363563364|FG000|Overall Study|Withdrawal by Subject|1|||
105425354|NCT02594098|363563365|FG001|Overall Study|Withdrawal by Subject|3|||
105425355|NCT02594098|363563364|FG000|Overall Study|Terminated participation|6|||
105425356|NCT02594098|363563365|FG001|Overall Study|Terminated participation|2|||
105425357|NCT02594098|363563364|FG000|Overall Study|Seek alternative treatment|2|||
105425358|NCT02594098|363563365|FG001|Overall Study|Seek alternative treatment|1|||
105425359|NCT02594098|363563364|FG000|Overall Study|Other|0|||
105425360|NCT02594098|363563365|FG001|Overall Study|Other|1|||
105425361|NCT02210221|363563366|FG000|Overall Study|Lack of Efficacy|7|||
105425362|NCT02210221|363563366|FG000|Overall Study|Withdrawal by Subject|43|||
105587299|NCT01939158|364150467|FG003|Overall Study|No longer meets eligibility criteria|0|||
105587300|NCT01939158|364150464|FG000|Overall Study|Other|1|||
105587301|NCT01939158|364150465|FG001|Overall Study|Other|3|||
105587302|NCT01939158|364150466|FG002|Overall Study|Other|4|||
105587303|NCT01939158|364150467|FG003|Overall Study|Other|3|||
105587304|NCT00940017|364150471|FG000|Overall Study|did not meet entrance criteria|3|||
105587305|NCT00940017|364150471|FG000|Overall Study|Adverse Event|1|||
105587306|NCT02949271|364150474|FG000|Overall Study|Lack of Efficacy|5|||
105587307|NCT02949271|364150475|FG001|Overall Study|Lack of Efficacy|4|||
105587308|NCT02949271|364150474|FG000|Overall Study|Lost to Follow-up|3|||
105587309|NCT02949271|364150475|FG001|Overall Study|Lost to Follow-up|6|||
105587310|NCT02949271|364150474|FG000|Overall Study|Physician Decision|5|||
105587311|NCT02949271|364150475|FG001|Overall Study|Physician Decision|5|||
105587312|NCT02949271|364150474|FG000|Overall Study|Protocol Violation|6|||
105587313|NCT02949271|364150475|FG001|Overall Study|Protocol Violation|3|||
105587314|NCT02949271|364150474|FG000|Overall Study|Withdrawal by Subject|1|||
105587315|NCT02949271|364150475|FG001|Overall Study|Withdrawal by Subject|0|||
105587316|NCT02949271|364150474|FG000|Overall Study|Delivered prior to intervention|7|||
105587317|NCT02949271|364150475|FG001|Overall Study|Delivered prior to intervention|9|||
105587318|NCT02949271|364150474|FG000|Overall Study|Outside the window for cervical dilation|2|||
105587319|NCT02949271|364150475|FG001|Overall Study|Outside the window for cervical dilation|3|||
105587320|NCT01097655|364150476|FG000|Overall Study|Withdrawal by Subject|1|||
105587321|NCT01097655|364150476|FG000|Overall Study|Subject Documented Twice|1|||
105587322|NCT01097655|364150476|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
105587323|NCT03303105|364150478|FG000|Overall Study|Adverse Event|0|||
105587324|NCT03303105|364150479|FG001|Overall Study|Adverse Event|2|||
105587325|NCT03303105|364150478|FG000|Overall Study|Lack of Efficacy|1|||
105587326|NCT03303105|364150479|FG001|Overall Study|Lack of Efficacy|0|||
105587327|NCT03303105|364150478|FG000|Overall Study|Protocol Violation|1|||
105587328|NCT03303105|364150479|FG001|Overall Study|Protocol Violation|0|||
105587329|NCT03303105|364150478|FG000|Overall Study|Withdrawal by Subject|0|||
105587330|NCT03303105|364150479|FG001|Overall Study|Withdrawal by Subject|2|||
105587331|NCT02790606|364150488|FG000|Overall Study|Death|27|||
105587332|NCT02790606|364150488|FG000|Overall Study|Lost to Follow-up|4|||
105587333|NCT02790606|364150488|FG000|Overall Study|Physician Decision|3|||
105587334|NCT02790606|364150488|FG000|Overall Study|Withdrawal by Subject|1|||
105587335|NCT02735915|364150489|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
105587336|NCT02735915|364150489|FG000|Overall Study|Withdrawal following SAE|2|||
105587337|NCT02735915|364150489|FG000|Overall Study|Withdrawal by Subject|1|||
105587338|NCT01789203|364150490|FG000|Overall Study|Adverse Event|2|||
105587339|NCT01789203|364150491|FG001|Overall Study|Adverse Event|2|||
105587340|NCT01789203|364150490|FG000|Overall Study|Withdrawal by Subject|1|||
105587341|NCT01789203|364150491|FG001|Overall Study|Withdrawal by Subject|0|||
105587342|NCT01789203|364150490|FG000|Overall Study|Death|1|||
105587343|NCT01789203|364150491|FG001|Overall Study|Death|0|||
105587344|NCT01789203|364150490|FG000|Overall Study|Protocol Violation|2|||
105587345|NCT01789203|364150491|FG001|Overall Study|Protocol Violation|1|||
105587346|NCT01789203|364150490|FG000|Overall Study|Other|1|||
105587347|NCT01789203|364150491|FG001|Overall Study|Other|1|||
105587348|NCT01789203|364150490|FG000|Overall Study|patient non-adherent|2|||
105587349|NCT01789203|364150491|FG001|Overall Study|patient non-adherent|0|||
105587350|NCT05328973|364150492|FG000|Overall Study|Withdrawal by Subject|0|||
105587351|NCT05328973|364150493|FG001|Overall Study|Withdrawal by Subject|1|||
105425363|NCT00033540|363563373|FG000|Overall Study|Adverse Event|14|||
105587352|NCT00498186|364150499|FG000|Overall Study|Protocol Violation|10|||
105587353|NCT00498186|364150499|FG000|Overall Study|Lack of Efficacy|31|||
105587354|NCT00498186|364150499|FG000|Overall Study|Adverse Event|89|||
105587355|NCT00498186|364150499|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
105587356|NCT00498186|364150499|FG000|Overall Study|Withdrawal by Subject|18|||
105425364|NCT00033540|363563373|FG000|Overall Study|Death|1|||
105425365|NCT00033540|363563373|FG000|Overall Study|Progression|26|||
105587357|NCT00498186|364150499|FG000|Overall Study|Lost to Follow-up|3|||
105587358|NCT00498186|364150499|FG000|Overall Study|Other|10|||
105587359|NCT00448864|364150500|FG000|Overall Study|Death|1|||
105587360|NCT00448864|364150501|FG001|Overall Study|Death|0|||
105587361|NCT00448864|364150502|FG002|Overall Study|Death|0|||
105425366|NCT00033540|363563373|FG000|Overall Study|Withdrawal by Subject|6|||
105425367|NCT00033540|363563373|FG000|Overall Study|Other|5|||
105425368|NCT00033540|363563373|FG000|Overall Study|Ineligible|3|||
105425369|NCT00033540|363563373|FG000|Overall Study|Never received treatment|2|||
105425370|NCT00405964|363563374|FG000|Overall Study|Treatment Failure|17|||
105425371|NCT00405964|363563375|FG001|Overall Study|Treatment Failure|45|||
105425372|NCT00405964|363563374|FG000|Overall Study|Adverse Event|7|||
105425373|NCT00405964|363563375|FG001|Overall Study|Adverse Event|16|||
105425374|NCT00405964|363563374|FG000|Overall Study|Lost to Follow-up|5|||
105425375|NCT00405964|363563375|FG001|Overall Study|Lost to Follow-up|5|||
105425376|NCT00405964|363563374|FG000|Overall Study|Withdrawal by Subject|19|||
105587362|NCT00448864|364150500|FG000|Overall Study|Lost to Follow-up|3|||
105587363|NCT00448864|364150501|FG001|Overall Study|Lost to Follow-up|1|||
105587364|NCT00448864|364150502|FG002|Overall Study|Lost to Follow-up|0|||
105587365|NCT00448864|364150500|FG000|Overall Study|Physician Decision|1|||
105587366|NCT00448864|364150501|FG001|Overall Study|Physician Decision|0|||
105587367|NCT00448864|364150502|FG002|Overall Study|Physician Decision|1|||
105587368|NCT00448864|364150500|FG000|Overall Study|Withdrawal by Subject|0|||
105587369|NCT00448864|364150501|FG001|Overall Study|Withdrawal by Subject|2|||
105587370|NCT00448864|364150502|FG002|Overall Study|Withdrawal by Subject|0|||
105587371|NCT00448864|364150500|FG000|Overall Study|Protocol Violation|0|||
105587372|NCT00448864|364150501|FG001|Overall Study|Protocol Violation|2|||
105587373|NCT00448864|364150502|FG002|Overall Study|Protocol Violation|0|||
105587374|NCT01390857|364150503|FG000|Overall Study|Protocol Violation|2|||
105587375|NCT01390857|364150503|FG000|Overall Study|Lost to Follow-up|1|||
105587376|NCT01390857|364150503|FG000|Overall Study|No Visit after the First Visit|7|||
105587377|NCT01123161|364150504|FG000|Overall Study|Lost to Follow-up|1|||
105587378|NCT01123161|364150505|FG001|Overall Study|Lost to Follow-up|0|||
105587379|NCT01123161|364150504|FG000|Overall Study|Withdrawal by Subject|1|||
105587380|NCT01123161|364150505|FG001|Overall Study|Withdrawal by Subject|0|||
105587381|NCT02757885|364150506|FG000|Overall Study|Screen Failures|4|||
105587382|NCT01175707|364150508|FG000|Overall Study|Adverse Event|4|||
105587383|NCT01175707|364150509|FG001|Overall Study|Adverse Event|6|||
105587384|NCT05349864|364150519|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
105587385|NCT05349864|364150520|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
105587386|NCT00763282|364150523|FG000|Overall Study|Withdrawal by Subject|6|||
105587387|NCT00763282|364150524|FG001|Overall Study|Withdrawal by Subject|5|||
105587388|NCT00763282|364150523|FG000|Overall Study|Death|4|||
105587389|NCT00763282|364150524|FG001|Overall Study|Death|3|||
105587390|NCT00763282|364150523|FG000|Overall Study|Lost to Follow-up|22|||
105587391|NCT00763282|364150524|FG001|Overall Study|Lost to Follow-up|26|||
105587392|NCT00742274|364150525|FG000|Overall Study|Death|1|||
105587393|NCT00742274|364150526|FG001|Overall Study|Death|0|||
105587394|NCT00742274|364150525|FG000|Overall Study|Withdrawal by Subject|1|||
105587395|NCT00742274|364150526|FG001|Overall Study|Withdrawal by Subject|2|||
105587396|NCT00742274|364150525|FG000|Overall Study|Removed for medical reasons|1|||
105587397|NCT00742274|364150526|FG001|Overall Study|Removed for medical reasons|1|||
105587398|NCT01928940|364150527|FG000|Overall Study|Adverse Event|0|||
105587399|NCT01928940|364150528|FG001|Overall Study|Adverse Event|1|||
105587400|NCT01599325|364150531|FG000|Primary Parent Phase|Adverse Event|5|||
105587401|NCT01599325|364150531|FG000|Primary Parent Phase|Disease Progression|7|||
105587402|NCT01599325|364150531|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
105587403|NCT01599325|364150531|FG000|Primary Parent Phase|Death|13|||
105587404|NCT01599325|364150531|FG000|Primary Parent Phase|Protocol Violation|1|||
105587405|NCT01599325|364150531|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
105587406|NCT01599325|364150531|FG000|Primary Parent Phase|Other|2|||
105587407|NCT01599325|364150531|FG000|Extension Phase|Study Closure|1|||
105587408|NCT01599325|364150531|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
105587409|NCT01599325|364150531|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
105587410|NCT01599325|364150531|FG000|Extension Phase|Disease Progression|1|||
105587411|NCT01599325|364150531|FG000|Extension Phase|Withdrawal by Subject|8|||
105587412|NCT01352507|364150532|FG000|Treatment Period 1|Adverse Event|3|||
105587413|NCT01352507|364150533|FG001|Treatment Period 1|Adverse Event|0|||
105587414|NCT01352507|364150532|FG000|Treatment Period 1|Lost to Follow-up|3|||
105587415|NCT01352507|364150533|FG001|Treatment Period 1|Lost to Follow-up|4|||
105587416|NCT01352507|364150532|FG000|Treatment Period 1|Withdrawal by Subject|7|||
105587417|NCT01352507|364150533|FG001|Treatment Period 1|Withdrawal by Subject|5|||
105587418|NCT01352507|364150532|FG000|Treatment Period 1|Physician Decision|1|||
105587419|NCT01352507|364150533|FG001|Treatment Period 1|Physician Decision|0|||
105587420|NCT01352507|364150532|FG000|Washout Period|Withdrawal by Subject|0|||
105587421|NCT01352507|364150533|FG001|Washout Period|Withdrawal by Subject|1|||
105587422|NCT01352507|364150532|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
105587423|NCT01352507|364150533|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
105587424|NCT01352507|364150532|FG000|Treatment Period 2|Withdrawal by Subject|4|||
105587425|NCT01352507|364150533|FG001|Treatment Period 2|Withdrawal by Subject|3|||
105587426|NCT01352507|364150532|FG000|Treatment Period 2|Lack of Efficacy|1|||
105587427|NCT01352507|364150533|FG001|Treatment Period 2|Lack of Efficacy|0|||
105425377|NCT00405964|363563375|FG001|Overall Study|Withdrawal by Subject|23|||
105587428|NCT02365298|364150534|FG000|Period 2|incorrect Rx dispensed|1|||
105587429|NCT02365298|364150535|FG001|Period 2|incorrect Rx dispensed|0|||
105587430|NCT02365298|364150534|FG000|Period 2|Discontinued at request of Sponsor|1|||
105587431|NCT02365298|364150535|FG001|Period 2|Discontinued at request of Sponsor|0|||
105587432|NCT02365298|364150534|FG000|Period 2|Test Article longer available|0|||
105587433|NCT02365298|364150535|FG001|Period 2|Test Article longer available|1|||
105425378|NCT00405964|363563374|FG000|Overall Study|Protocol Violation|11|||
105587434|NCT02365298|364150534|FG000|Period 2|Protocol Violation|0|||
105587435|NCT02365298|364150535|FG001|Period 2|Protocol Violation|1|||
105587436|NCT01763047|364150538|FG000|Period 1|Test Article Not Available|4|||
105587437|NCT01763047|364150539|FG001|Period 1|Test Article Not Available|1|||
105587438|NCT01763047|364150538|FG000|Period 1|Protocol Violation|4|||
105425379|NCT00405964|363563375|FG001|Overall Study|Protocol Violation|6|||
105425380|NCT00066469|363563378|FG000|Overall Study|Death|3|||
105425381|NCT00066469|363563378|FG000|Overall Study|Lack of Efficacy|9|||
105425382|NCT00066469|363563378|FG000|Overall Study|Lost to Follow-up|1|||
105425383|NCT00066469|363563378|FG000|Overall Study|Physician Decision|1|||
105425384|NCT00066469|363563378|FG000|Overall Study|Withdrawal by Subject|1|||
105425385|NCT00066469|363563378|FG000|Overall Study|ineligible|1|||
105425386|NCT00882908|363563379|FG000|Overall Study|Adverse Event|0|||
105425387|NCT00882908|363563380|FG001|Overall Study|Adverse Event|0|||
105425388|NCT00882908|363563381|FG002|Overall Study|Adverse Event|1|||
105425389|NCT00882908|363563382|FG003|Overall Study|Adverse Event|0|||
105425390|NCT00882908|363563383|FG004|Overall Study|Adverse Event|1|||
105425391|NCT00882908|363563379|FG000|Overall Study|Lost to Follow-up|3|||
105425392|NCT00882908|363563380|FG001|Overall Study|Lost to Follow-up|5|||
105425393|NCT00882908|363563381|FG002|Overall Study|Lost to Follow-up|3|||
105425394|NCT00882908|363563382|FG003|Overall Study|Lost to Follow-up|1|||
105425395|NCT00882908|363563383|FG004|Overall Study|Lost to Follow-up|2|||
105425396|NCT00882908|363563379|FG000|Overall Study|Protocol Violation|0|||
105425397|NCT00882908|363563380|FG001|Overall Study|Protocol Violation|1|||
105425398|NCT00882908|363563381|FG002|Overall Study|Protocol Violation|0|||
105425399|NCT00882908|363563382|FG003|Overall Study|Protocol Violation|0|||
105425400|NCT00882908|363563383|FG004|Overall Study|Protocol Violation|0|||
105425401|NCT00882908|363563379|FG000|Overall Study|Withdrawal by Subject|0|||
105425402|NCT00882908|363563380|FG001|Overall Study|Withdrawal by Subject|0|||
105425403|NCT00882908|363563381|FG002|Overall Study|Withdrawal by Subject|3|||
105425404|NCT00882908|363563382|FG003|Overall Study|Withdrawal by Subject|5|||
105425405|NCT00882908|363563383|FG004|Overall Study|Withdrawal by Subject|2|||
105425406|NCT00882908|363563379|FG000|Overall Study|Subject reached a virologic endpoint|0|||
105425407|NCT00882908|363563380|FG001|Overall Study|Subject reached a virologic endpoint|0|||
105425408|NCT00882908|363563381|FG002|Overall Study|Subject reached a virologic endpoint|0|||
105425409|NCT00882908|363563382|FG003|Overall Study|Subject reached a virologic endpoint|0|||
105425410|NCT00882908|363563383|FG004|Overall Study|Subject reached a virologic endpoint|1|||
105425411|NCT00882908|363563379|FG000|Overall Study|Study terminated in error|0|||
105425412|NCT00882908|363563380|FG001|Overall Study|Study terminated in error|0|||
105425413|NCT00882908|363563381|FG002|Overall Study|Study terminated in error|0|||
105425414|NCT00882908|363563382|FG003|Overall Study|Study terminated in error|1|||
105425415|NCT00882908|363563383|FG004|Overall Study|Study terminated in error|0|||
105425416|NCT02981407|363563387|FG000|Overall Study|Withdrawal by Subject|2|||
105425417|NCT02981407|363563388|FG001|Overall Study|Withdrawal by Subject|0|||
105425418|NCT00355342|363563389|FG000|Overall Study|Adverse Event|13|||
105425419|NCT00355342|363563390|FG001|Overall Study|Adverse Event|15|||
105425420|NCT00355342|363563389|FG000|Overall Study|Lost to Follow-up|4|||
105425421|NCT00355342|363563390|FG001|Overall Study|Lost to Follow-up|2|||
105425422|NCT00355342|363563389|FG000|Overall Study|Withdrawal by Subject|14|||
105425423|NCT00355342|363563390|FG001|Overall Study|Withdrawal by Subject|11|||
105425424|NCT00355342|363563389|FG000|Overall Study|Sponsor terminated study|2|||
105425425|NCT00355342|363563390|FG001|Overall Study|Sponsor terminated study|2|||
105425426|NCT00355342|363563389|FG000|Overall Study|Overcompliant-PI discretion|1|||
105425427|NCT00355342|363563390|FG001|Overall Study|Overcompliant-PI discretion|0|||
105425428|NCT00355342|363563389|FG000|Overall Study|Use of prohibited medication|1|||
105425429|NCT00355342|363563390|FG001|Overall Study|Use of prohibited medication|0|||
105425430|NCT00355342|363563389|FG000|Overall Study|COPD exacerbation|1|||
105425431|NCT00355342|363563390|FG001|Overall Study|COPD exacerbation|1|||
105425432|NCT00355342|363563389|FG000|Overall Study|Dispensed wrong study drug kit|1|||
105425433|NCT00355342|363563390|FG001|Overall Study|Dispensed wrong study drug kit|0|||
105425434|NCT00355342|363563389|FG000|Overall Study|Non-compliance with Dexa scans|1|||
105425435|NCT00355342|363563390|FG001|Overall Study|Non-compliance with Dexa scans|0|||
105425436|NCT00355342|363563389|FG000|Overall Study|Withdrawal by participant and physician|1|||
105425437|NCT00355342|363563390|FG001|Overall Study|Withdrawal by participant and physician|0|||
105425438|NCT00355342|363563389|FG000|Overall Study|Participant relocated|0|||
105425439|NCT00355342|363563390|FG001|Overall Study|Participant relocated|1|||
105425440|NCT00355342|363563389|FG000|Overall Study|Participant discontinued study drug|0|||
105425441|NCT00355342|363563390|FG001|Overall Study|Participant discontinued study drug|1|||
105587439|NCT01763047|364150539|FG001|Period 1|Protocol Violation|4|||
105425442|NCT00355342|363563389|FG000|Overall Study|Study management|0|||
105425443|NCT00355342|363563390|FG001|Overall Study|Study management|1|||
105425444|NCT00355342|363563389|FG000|Overall Study|Protocol Violation|0|||
105425445|NCT00355342|363563390|FG001|Overall Study|Protocol Violation|1|||
105425446|NCT00355342|363563389|FG000|Overall Study|Use of protocol excluded medication|0|||
105587440|NCT01763047|364150538|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
105425447|NCT00355342|363563390|FG001|Overall Study|Use of protocol excluded medication|1|||
105425448|NCT00495521|363563391|FG000|Overall Study|Physician Decision|0|||
105425449|NCT00495521|363563392|FG001|Overall Study|Physician Decision|1|||
105425450|NCT04096820|363563406|FG000|Overall Study|Did not return for intervention|2|||
105425451|NCT04096820|363563406|FG000|Overall Study|Death|1|||
105425452|NCT04068519|363563407|FG000|Dose Verification|Death|15|||
105587441|NCT01763047|364150539|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
105587442|NCT01763047|364150538|FG000|Period 1|Adverse Event|0|||
105587443|NCT01763047|364150539|FG001|Period 1|Adverse Event|1|||
105587444|NCT01763047|364150538|FG000|Period 1|Unsatisfactory Visual Response|0|||
105587445|NCT01763047|364150539|FG001|Period 1|Unsatisfactory Visual Response|3|||
105587446|NCT01763047|364150538|FG000|Period 1|Lens Power Not Available|0|||
105587447|NCT01763047|364150539|FG001|Period 1|Lens Power Not Available|1|||
105587448|NCT01763047|364150538|FG000|Period 1|Study Site office Closed|0|||
105587449|NCT01763047|364150539|FG001|Period 1|Study Site office Closed|1|||
105587450|NCT01763047|364150538|FG000|Period 2|Lens Discomfort|1|||
105587451|NCT01763047|364150539|FG001|Period 2|Lens Discomfort|0|||
105587452|NCT01763047|364150538|FG000|Period 2|No longer meets Eligibility Criteria|1|||
105587453|NCT01763047|364150539|FG001|Period 2|No longer meets Eligibility Criteria|0|||
105587454|NCT01763047|364150538|FG000|Period 2|Study Site office Closed|1|||
105587455|NCT01763047|364150539|FG001|Period 2|Study Site office Closed|1|||
105587456|NCT01763047|364150538|FG000|Period 2|Unsatisfactory Visual Response|1|||
105587457|NCT01763047|364150539|FG001|Period 2|Unsatisfactory Visual Response|1|||
105587458|NCT01763047|364150538|FG000|Period 2|Protocol Violation|0|||
105587459|NCT01763047|364150539|FG001|Period 2|Protocol Violation|2|||
105587460|NCT01763047|364150538|FG000|Period 2|Unsatisfactory lens Fitting|0|||
105587461|NCT01763047|364150539|FG001|Period 2|Unsatisfactory lens Fitting|1|||
105587462|NCT00916006|364150542|FG000|Overall Study|Adverse Event|1|||
105587463|NCT00916006|364150543|FG001|Overall Study|Adverse Event|1|||
105587464|NCT00916006|364150542|FG000|Overall Study|Withdrawal by Subject|2|||
105587465|NCT00916006|364150543|FG001|Overall Study|Withdrawal by Subject|5|||
105587466|NCT00916006|364150542|FG000|Overall Study|Protocol Violation|0|||
105587467|NCT00916006|364150543|FG001|Overall Study|Protocol Violation|1|||
105587468|NCT02775435|364150551|FG000|Overall Study|Adverse Event|32|||
105587469|NCT02775435|364150552|FG001|Overall Study|Adverse Event|27|||
105587470|NCT02775435|364150551|FG000|Overall Study|Lost to Follow-up|2|||
105587471|NCT02775435|364150552|FG001|Overall Study|Lost to Follow-up|2|||
105587472|NCT02775435|364150551|FG000|Overall Study|Sponsor decision|44|||
105587473|NCT02775435|364150552|FG001|Overall Study|Sponsor decision|19|||
105587474|NCT02775435|364150551|FG000|Overall Study|Withdrawal by Subject|4|||
105587475|NCT02775435|364150552|FG001|Overall Study|Withdrawal by Subject|9|||
105587476|NCT02775435|364150551|FG000|Overall Study|Death|196|||
105587477|NCT02775435|364150552|FG001|Overall Study|Death|224|||
105587478|NCT00783692|364150557|FG000|Induction Phase|Adverse Event|7|||
105587479|NCT00783692|364150558|FG001|Induction Phase|Adverse Event|9|||
105587480|NCT00783692|364150559|FG002|Induction Phase|Adverse Event|24|||
105587481|NCT00783692|364150560|FG003|Induction Phase|Adverse Event|0|||
105587482|NCT00783692|364150561|FG004|Induction Phase|Adverse Event|0|||
105587483|NCT00783692|364150562|FG005|Induction Phase|Adverse Event|0|||
105587484|NCT00783692|364150563|FG006|Induction Phase|Adverse Event|0|||
105587485|NCT00783692|364150557|FG000|Induction Phase|Protocol Violation|0|||
105587486|NCT00783692|364150558|FG001|Induction Phase|Protocol Violation|0|||
105587487|NCT00783692|364150559|FG002|Induction Phase|Protocol Violation|1|||
105587488|NCT00783692|364150560|FG003|Induction Phase|Protocol Violation|0|||
105587489|NCT00783692|364150561|FG004|Induction Phase|Protocol Violation|0|||
105587490|NCT00783692|364150562|FG005|Induction Phase|Protocol Violation|0|||
105587491|NCT00783692|364150563|FG006|Induction Phase|Protocol Violation|0|||
105587492|NCT00783692|364150557|FG000|Induction Phase|Lack of Efficacy|1|||
105587493|NCT00783692|364150558|FG001|Induction Phase|Lack of Efficacy|3|||
105587494|NCT00783692|364150559|FG002|Induction Phase|Lack of Efficacy|28|||
105587495|NCT00783692|364150560|FG003|Induction Phase|Lack of Efficacy|0|||
105587496|NCT00783692|364150561|FG004|Induction Phase|Lack of Efficacy|0|||
105587497|NCT00783692|364150562|FG005|Induction Phase|Lack of Efficacy|0|||
105587498|NCT00783692|364150563|FG006|Induction Phase|Lack of Efficacy|0|||
105587499|NCT00783692|364150557|FG000|Induction Phase|Withdrawal by Subject|3|||
105587500|NCT00783692|364150558|FG001|Induction Phase|Withdrawal by Subject|9|||
105587501|NCT00783692|364150559|FG002|Induction Phase|Withdrawal by Subject|16|||
105587502|NCT00783692|364150560|FG003|Induction Phase|Withdrawal by Subject|0|||
105587503|NCT00783692|364150561|FG004|Induction Phase|Withdrawal by Subject|0|||
105587504|NCT00783692|364150562|FG005|Induction Phase|Withdrawal by Subject|0|||
105587505|NCT00783692|364150563|FG006|Induction Phase|Withdrawal by Subject|0|||
105587506|NCT00783692|364150557|FG000|Induction Phase|Lost to Follow-up|0|||
105587507|NCT00783692|364150558|FG001|Induction Phase|Lost to Follow-up|0|||
105587508|NCT00783692|364150559|FG002|Induction Phase|Lost to Follow-up|3|||
105587509|NCT00783692|364150560|FG003|Induction Phase|Lost to Follow-up|0|||
105587510|NCT00783692|364150561|FG004|Induction Phase|Lost to Follow-up|0|||
105587511|NCT00783692|364150562|FG005|Induction Phase|Lost to Follow-up|0|||
105587512|NCT00783692|364150563|FG006|Induction Phase|Lost to Follow-up|0|||
105587513|NCT00783692|364150557|FG000|Induction Phase|Other|0|||
105587514|NCT00783692|364150558|FG001|Induction Phase|Other|0|||
105587515|NCT00783692|364150559|FG002|Induction Phase|Other|2|||
105587516|NCT00783692|364150560|FG003|Induction Phase|Other|0|||
105587517|NCT00783692|364150561|FG004|Induction Phase|Other|0|||
105587518|NCT00783692|364150562|FG005|Induction Phase|Other|0|||
105587519|NCT00783692|364150563|FG006|Induction Phase|Other|0|||
105587520|NCT00783692|364150557|FG000|Maintenance Phase|Adverse Event|7|||
105587521|NCT00783692|364150558|FG001|Maintenance Phase|Adverse Event|0|||
105587522|NCT00783692|364150559|FG002|Maintenance Phase|Adverse Event|0|||
105587523|NCT00783692|364150560|FG003|Maintenance Phase|Adverse Event|15|||
105587524|NCT00783692|364150561|FG004|Maintenance Phase|Adverse Event|12|||
105587525|NCT00783692|364150562|FG005|Maintenance Phase|Adverse Event|9|||
105587526|NCT00783692|364150563|FG006|Maintenance Phase|Adverse Event|38|||
105587527|NCT00783692|364150557|FG000|Maintenance Phase|Protocol Violation|0|||
105587528|NCT00783692|364150558|FG001|Maintenance Phase|Protocol Violation|0|||
105587529|NCT00783692|364150559|FG002|Maintenance Phase|Protocol Violation|0|||
105587530|NCT00783692|364150560|FG003|Maintenance Phase|Protocol Violation|1|||
105587531|NCT00783692|364150561|FG004|Maintenance Phase|Protocol Violation|2|||
105587532|NCT00783692|364150562|FG005|Maintenance Phase|Protocol Violation|3|||
105587533|NCT00783692|364150563|FG006|Maintenance Phase|Protocol Violation|4|||
105587534|NCT00783692|364150557|FG000|Maintenance Phase|Lack of Efficacy|79|||
105587535|NCT00783692|364150558|FG001|Maintenance Phase|Lack of Efficacy|0|||
105587536|NCT00783692|364150559|FG002|Maintenance Phase|Lack of Efficacy|0|||
105587537|NCT00783692|364150560|FG003|Maintenance Phase|Lack of Efficacy|64|||
105587538|NCT00783692|364150561|FG004|Maintenance Phase|Lack of Efficacy|58|||
105587539|NCT00783692|364150562|FG005|Maintenance Phase|Lack of Efficacy|48|||
105587540|NCT00783692|364150563|FG006|Maintenance Phase|Lack of Efficacy|177|||
105587541|NCT00783692|364150557|FG000|Maintenance Phase|Withdrawal by Subject|7|||
105587542|NCT00783692|364150558|FG001|Maintenance Phase|Withdrawal by Subject|0|||
105587543|NCT00783692|364150559|FG002|Maintenance Phase|Withdrawal by Subject|0|||
105587544|NCT00783692|364150560|FG003|Maintenance Phase|Withdrawal by Subject|7|||
105587545|NCT00783692|364150561|FG004|Maintenance Phase|Withdrawal by Subject|6|||
105587546|NCT00783692|364150562|FG005|Maintenance Phase|Withdrawal by Subject|9|||
105587547|NCT00783692|364150563|FG006|Maintenance Phase|Withdrawal by Subject|24|||
105587548|NCT00783692|364150557|FG000|Maintenance Phase|Lost to Follow-up|2|||
105587549|NCT00783692|364150558|FG001|Maintenance Phase|Lost to Follow-up|0|||
105587550|NCT00783692|364150559|FG002|Maintenance Phase|Lost to Follow-up|0|||
105587551|NCT00783692|364150560|FG003|Maintenance Phase|Lost to Follow-up|1|||
105587552|NCT00783692|364150561|FG004|Maintenance Phase|Lost to Follow-up|3|||
105587553|NCT00783692|364150562|FG005|Maintenance Phase|Lost to Follow-up|2|||
105587554|NCT00783692|364150563|FG006|Maintenance Phase|Lost to Follow-up|5|||
105587555|NCT00783692|364150557|FG000|Maintenance Phase|Other|0|||
105587556|NCT00783692|364150558|FG001|Maintenance Phase|Other|0|||
105587557|NCT00783692|364150559|FG002|Maintenance Phase|Other|0|||
105587558|NCT00783692|364150560|FG003|Maintenance Phase|Other|1|||
105587559|NCT00783692|364150561|FG004|Maintenance Phase|Other|0|||
105587560|NCT00783692|364150562|FG005|Maintenance Phase|Other|1|||
105587561|NCT00783692|364150563|FG006|Maintenance Phase|Other|1|||
105587562|NCT01096056|364150566|FG000|Overall Study|Lost to Follow-up|0|||
105587563|NCT01096056|364150567|FG001|Overall Study|Lost to Follow-up|1|||
105587564|NCT03717194|364150569|FG000|Overall Study|Withdrawal by Subject|2|||
105587565|NCT03717194|364150570|FG001|Overall Study|Withdrawal by Subject|4|||
105587566|NCT03717194|364150569|FG000|Overall Study|Adverse Event|1|||
105587567|NCT03717194|364150570|FG001|Overall Study|Adverse Event|1|||
105587568|NCT03563053|364150571|FG000|Overall Study|Withdrawal by Subject|17|||
105587569|NCT03563053|364150571|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
105587570|NCT03563053|364150571|FG000|Overall Study|Adverse Event|3|||
105587571|NCT03563053|364150571|FG000|Overall Study|Physician Decision|1|||
105587572|NCT03563053|364150571|FG000|Overall Study|study terminated by sponsor|71|||
105587573|NCT03677375|364150573|FG000|Overall Study|Incomplete procedure|8|||
105587574|NCT03677375|364150573|FG000|Overall Study|Adverse Event|3|||
105587575|NCT03677375|364150573|FG000|Overall Study|Physician Decision|1|||
105587576|NCT00836810|364150574|FG000|Overall Study|New diagnosis|1|||
105587577|NCT00836810|364150575|FG001|Overall Study|New diagnosis|0|||
105587578|NCT02040844|364150576|FG000|Overall Study|Adverse Event|0|||
105587579|NCT02040844|364150577|FG001|Overall Study|Adverse Event|0|||
105587580|NCT02040844|364150578|FG002|Overall Study|Adverse Event|1|||
105587581|NCT02040844|364150576|FG000|Overall Study|Withdrawal by Subject|16|||
105587582|NCT02040844|364150577|FG001|Overall Study|Withdrawal by Subject|22|||
105587583|NCT02040844|364150578|FG002|Overall Study|Withdrawal by Subject|25|||
105587584|NCT02040844|364150576|FG000|Overall Study|Lost to Follow-up|12|||
105425453|NCT04068519|363563407|FG000|Dose Verification|Withdrawal by Subject|1|||
105587585|NCT02040844|364150577|FG001|Overall Study|Lost to Follow-up|9|||
105587586|NCT02040844|364150578|FG002|Overall Study|Lost to Follow-up|13|||
105587587|NCT02040844|364150576|FG000|Overall Study|Missing|13|||
105587588|NCT02040844|364150577|FG001|Overall Study|Missing|3|||
105587589|NCT02040844|364150578|FG002|Overall Study|Missing|2|||
105587590|NCT02040844|364150576|FG000|Overall Study|Non-specified|8|||
105587591|NCT02040844|364150577|FG001|Overall Study|Non-specified|2|||
105587592|NCT02040844|364150578|FG002|Overall Study|Non-specified|5|||
105587593|NCT02040844|364150576|FG000|Overall Study|Concomitant medication|1|||
105425454|NCT04068519|363563407|FG000|Pharmacokinetic Sub-study|Death|35|||
105587594|NCT02040844|364150577|FG001|Overall Study|Concomitant medication|3|||
105587595|NCT02040844|364150578|FG002|Overall Study|Concomitant medication|1|||
105587596|NCT00946192|364150579|FG000|Overall Study|Lost to Follow-up|6|||
105587597|NCT00946192|364150580|FG001|Overall Study|Lost to Follow-up|11|||
105587598|NCT00946192|364150581|FG002|Overall Study|Lost to Follow-up|9|||
105587599|NCT00946192|364150579|FG000|Overall Study|Withdrawal by Subject|10|||
105587600|NCT00946192|364150580|FG001|Overall Study|Withdrawal by Subject|7|||
105587601|NCT00946192|364150581|FG002|Overall Study|Withdrawal by Subject|3|||
105587602|NCT00946192|364150579|FG000|Overall Study|Did not start medication|2|||
105587603|NCT00946192|364150580|FG001|Overall Study|Did not start medication|0|||
105587604|NCT00946192|364150581|FG002|Overall Study|Did not start medication|0|||
105587605|NCT04580407|364150582|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
105587606|NCT05567159|364150583|FG000|Overall Study|Adverse Event|4|||
105587607|NCT05567159|364150583|FG000|Overall Study|Physician Decision|3|||
105587608|NCT05567159|364150583|FG000|Overall Study|Protocol deviation|1|||
105587609|NCT03158948|364152952|FG000|Overall Study|Death|1|||
105587610|NCT03158948|364152953|FG001|Overall Study|Death|1|||
105587611|NCT03158948|364152954|FG002|Overall Study|Death|3|||
105587612|NCT03158948|364152955|FG003|Overall Study|Death|2|||
105587613|NCT03158948|364152952|FG000|Overall Study|Physician Decision|0|||
105587614|NCT03158948|364152953|FG001|Overall Study|Physician Decision|0|||
105587615|NCT03158948|364152954|FG002|Overall Study|Physician Decision|0|||
105587616|NCT03158948|364152955|FG003|Overall Study|Physician Decision|1|||
105587617|NCT02153788|364152956|FG000|Overall Study|Physician Decision|2|||
105587618|NCT02153788|364152957|FG001|Overall Study|Physician Decision|1|||
105587619|NCT00256308|364152960|FG000|Overall Study|Death|2|||
105587620|NCT01195675|364152964|FG000|Overall Study|Adverse Event|1|||
105587621|NCT01195675|364152964|FG000|Overall Study|Withdrawal by Subject|2|||
105587622|NCT00072475|364152965|FG000|Overall Study|Adverse Event|44|||
105587623|NCT00072475|364152965|FG000|Overall Study|Death|3|||
105587624|NCT00072475|364152965|FG000|Overall Study|Withdrawal by Subject|46|||
105587625|NCT00072475|364152965|FG000|Overall Study|Patient/Investigator Decision|4|||
105587626|NCT01211665|364152966|FG000|Overall Study|Withdrawal by Subject|1|||
105587627|NCT01211665|364152967|FG001|Overall Study|Withdrawal by Subject|0|||
105587628|NCT01211665|364152966|FG000|Overall Study|Death|1|||
105587629|NCT01211665|364152967|FG001|Overall Study|Death|0|||
105587630|NCT00495469|364152970|FG000|Overall Study|Adverse Event|0|||
105587631|NCT00495469|364152971|FG001|Overall Study|Adverse Event|1|||
105425455|NCT04068519|363563407|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
105587632|NCT00495469|364152972|FG002|Overall Study|Adverse Event|3|||
105587633|NCT00495469|364152973|FG003|Overall Study|Adverse Event|0|||
105587634|NCT00495469|364152974|FG004|Overall Study|Adverse Event|1|||
105587635|NCT00495469|364152975|FG005|Overall Study|Adverse Event|1|||
105587636|NCT00495469|364152976|FG006|Overall Study|Adverse Event|1|||
105587637|NCT00495469|364152970|FG000|Overall Study|Lost to Follow-up|1|||
105587638|NCT00495469|364152971|FG001|Overall Study|Lost to Follow-up|1|||
105587639|NCT00495469|364152972|FG002|Overall Study|Lost to Follow-up|3|||
105587640|NCT00495469|364152973|FG003|Overall Study|Lost to Follow-up|1|||
105587641|NCT00495469|364152974|FG004|Overall Study|Lost to Follow-up|0|||
105587642|NCT00495469|364152975|FG005|Overall Study|Lost to Follow-up|0|||
105587643|NCT00495469|364152976|FG006|Overall Study|Lost to Follow-up|0|||
105587644|NCT00495469|364152970|FG000|Overall Study|Protocol Violation|0|||
105587645|NCT00495469|364152971|FG001|Overall Study|Protocol Violation|0|||
105587646|NCT00495469|364152972|FG002|Overall Study|Protocol Violation|0|||
105587647|NCT00495469|364152973|FG003|Overall Study|Protocol Violation|0|||
105587648|NCT00495469|364152974|FG004|Overall Study|Protocol Violation|1|||
105587649|NCT00495469|364152975|FG005|Overall Study|Protocol Violation|2|||
105587650|NCT00495469|364152976|FG006|Overall Study|Protocol Violation|0|||
105587651|NCT00495469|364152970|FG000|Overall Study|Withdrawal by Subject|5|||
105587652|NCT00495469|364152971|FG001|Overall Study|Withdrawal by Subject|3|||
105587653|NCT00495469|364152972|FG002|Overall Study|Withdrawal by Subject|1|||
105587654|NCT00495469|364152973|FG003|Overall Study|Withdrawal by Subject|3|||
105587655|NCT00495469|364152974|FG004|Overall Study|Withdrawal by Subject|3|||
105587656|NCT00495469|364152975|FG005|Overall Study|Withdrawal by Subject|2|||
105587657|NCT00495469|364152976|FG006|Overall Study|Withdrawal by Subject|3|||
105587658|NCT00495469|364152970|FG000|Overall Study|Lack of Efficacy|0|||
105587659|NCT00495469|364152971|FG001|Overall Study|Lack of Efficacy|0|||
105587660|NCT00495469|364152972|FG002|Overall Study|Lack of Efficacy|0|||
105425456|NCT04068519|363563407|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
105425457|NCT04068519|363563407|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
105425458|NCT04068519|363563407|FG000|Indication Expansion|Death|152|||
105425459|NCT04068519|363563407|FG000|Indication Expansion|Withdrawal by Subject|10|||
105425460|NCT04068519|363563407|FG000|Indication Expansion|Lost to Follow-up|7|||
105587661|NCT00495469|364152973|FG003|Overall Study|Lack of Efficacy|0|||
105587662|NCT00495469|364152974|FG004|Overall Study|Lack of Efficacy|0|||
105587663|NCT00495469|364152975|FG005|Overall Study|Lack of Efficacy|0|||
105587664|NCT00495469|364152976|FG006|Overall Study|Lack of Efficacy|1|||
105587665|NCT00495469|364152970|FG000|Overall Study|Liver function test abnormality|0|||
105587666|NCT00495469|364152971|FG001|Overall Study|Liver function test abnormality|1|||
105587667|NCT00495469|364152972|FG002|Overall Study|Liver function test abnormality|0|||
105587668|NCT00495469|364152973|FG003|Overall Study|Liver function test abnormality|0|||
105425461|NCT00840060|363564856|FG000|Overall Study|Withdrawal by Subject|1|||
105587669|NCT00495469|364152974|FG004|Overall Study|Liver function test abnormality|0|||
105587670|NCT00495469|364152975|FG005|Overall Study|Liver function test abnormality|0|||
105587671|NCT00495469|364152976|FG006|Overall Study|Liver function test abnormality|0|||
105587672|NCT00495469|364152970|FG000|Overall Study|ST depression at randomisation in ECG|0|||
105587673|NCT00495469|364152971|FG001|Overall Study|ST depression at randomisation in ECG|1|||
105587674|NCT00495469|364152972|FG002|Overall Study|ST depression at randomisation in ECG|0|||
105587675|NCT00495469|364152973|FG003|Overall Study|ST depression at randomisation in ECG|0|||
105587676|NCT00495469|364152974|FG004|Overall Study|ST depression at randomisation in ECG|0|||
105587677|NCT00495469|364152975|FG005|Overall Study|ST depression at randomisation in ECG|0|||
105587678|NCT00495469|364152976|FG006|Overall Study|ST depression at randomisation in ECG|0|||
105587679|NCT02501629|364152977|FG000|Overall Study|Death|0|||
105587680|NCT02501629|364152978|FG001|Overall Study|Death|1|||
105587681|NCT02501629|364152977|FG000|Overall Study|Withdrawn from study by sponsor|1|||
105587682|NCT02501629|364152978|FG001|Overall Study|Withdrawn from study by sponsor|0|||
105587683|NCT02501629|364152977|FG000|Overall Study|Early termination by sponsor|1|||
105587684|NCT02501629|364152978|FG001|Overall Study|Early termination by sponsor|0|||
105587685|NCT02501629|364152977|FG000|Overall Study|Withdrawal by Subject|3|||
105587686|NCT02501629|364152978|FG001|Overall Study|Withdrawal by Subject|5|||
105587687|NCT02501629|364152977|FG000|Overall Study|Subject did not return to site|0|||
105587688|NCT02501629|364152978|FG001|Overall Study|Subject did not return to site|1|||
105587689|NCT00886613|364152979|FG000|Overall Study|Protocol deviation (Part B)|1|||
105587690|NCT00886613|364152980|FG001|Overall Study|Protocol deviation (Part B)|0|||
105587691|NCT00886613|364152981|FG002|Overall Study|Protocol deviation (Part B)|0|||
105587692|NCT00886613|364152979|FG000|Overall Study|Lost to follow-up (Part B)|1|||
105587693|NCT00886613|364152980|FG001|Overall Study|Lost to follow-up (Part B)|0|||
105587694|NCT00886613|364152981|FG002|Overall Study|Lost to follow-up (Part B)|1|||
105587695|NCT00886613|364152979|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
105587696|NCT00886613|364152980|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
105587697|NCT00886613|364152981|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
105587698|NCT03710564|364152982|FG000|Overall Study|Study Terminated by Sponsor|104|||
105587699|NCT03710564|364152983|FG001|Overall Study|Study Terminated by Sponsor|55|||
105425462|NCT00840060|363564857|FG001|Overall Study|Withdrawal by Subject|0|||
105425463|NCT00840060|363564856|FG000|Overall Study|Change in emotional/behavioral status|0|||
105425464|NCT00840060|363564857|FG001|Overall Study|Change in emotional/behavioral status|1|||
105425465|NCT03187834|363564859|FG000|Overall Study|Lost to Follow-up|0|||
105425466|NCT03187834|363564860|FG001|Overall Study|Lost to Follow-up|1|||
105425467|NCT03187834|363564861|FG002|Overall Study|Lost to Follow-up|2|||
105425468|NCT03187834|363564862|FG003|Overall Study|Lost to Follow-up|2|||
105425469|NCT03187834|363564859|FG000|Overall Study|Had invalid anthropometric measurements|5|||
105425470|NCT03187834|363564860|FG001|Overall Study|Had invalid anthropometric measurements|3|||
105425471|NCT03187834|363564861|FG002|Overall Study|Had invalid anthropometric measurements|4|||
105425472|NCT03187834|363564862|FG003|Overall Study|Had invalid anthropometric measurements|2|||
105425473|NCT00076336|363564869|FG000|Overall Study|Death|13|||
105425474|NCT00076336|363564870|FG001|Overall Study|Death|17|||
105425475|NCT00076336|363564869|FG000|Overall Study|Adverse Event|4|||
105425476|NCT00076336|363564870|FG001|Overall Study|Adverse Event|4|||
105425477|NCT00076336|363564869|FG000|Overall Study|Lost to Follow-up|4|||
105425478|NCT00076336|363564870|FG001|Overall Study|Lost to Follow-up|4|||
105425479|NCT00076336|363564869|FG000|Overall Study|Non-Compliance|2|||
105425480|NCT00076336|363564870|FG001|Overall Study|Non-Compliance|0|||
105425481|NCT00076336|363564869|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
105425482|NCT00076336|363564870|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
105425483|NCT00076336|363564869|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
105425484|NCT00076336|363564870|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
105425485|NCT00076336|363564869|FG000|Overall Study|Liver Transplantation|3|||
105425486|NCT00076336|363564870|FG001|Overall Study|Liver Transplantation|3|||
105425487|NCT00076336|363564869|FG000|Overall Study|Virologic Breakthrough|14|||
105587700|NCT03710564|364152982|FG000|Overall Study|Withdrawal by Subject|57|||
105587701|NCT03710564|364152983|FG001|Overall Study|Withdrawal by Subject|25|||
105587702|NCT03710564|364152982|FG000|Overall Study|Death|10|||
105587703|NCT03710564|364152983|FG001|Overall Study|Death|4|||
105587704|NCT03710564|364152982|FG000|Overall Study|Lost to Follow-up|5|||
105587705|NCT03710564|364152983|FG001|Overall Study|Lost to Follow-up|4|||
105587706|NCT03710564|364152982|FG000|Overall Study|Protocol Violation|3|||
105587707|NCT03710564|364152983|FG001|Overall Study|Protocol Violation|2|||
105587708|NCT03710564|364152982|FG000|Overall Study|Adverse Event|3|||
105587709|NCT03710564|364152983|FG001|Overall Study|Adverse Event|0|||
105425488|NCT00076336|363564870|FG001|Overall Study|Virologic Breakthrough|16|||
105425489|NCT00076336|363564869|FG000|Overall Study|Treatment failure|4|||
105425490|NCT00076336|363564870|FG001|Overall Study|Treatment failure|5|||
105425491|NCT01007123|363564871|FG000|Overall Study|Adverse Event|3|||
105425492|NCT01007123|363564872|FG001|Overall Study|Adverse Event|4|||
105425493|NCT01007123|363564873|FG002|Overall Study|Adverse Event|7|||
105425494|NCT01007123|363564874|FG003|Overall Study|Adverse Event|1|||
105587710|NCT03710564|364152982|FG000|Overall Study|Physician Decision|2|||
105587711|NCT03710564|364152983|FG001|Overall Study|Physician Decision|3|||
105587712|NCT00797225|364152987|FG000|Weeks 1 to 12|Adverse Event|0|||
105587713|NCT00797225|364152988|FG001|Weeks 1 to 12|Adverse Event|0|||
105587714|NCT00797225|364152989|FG002|Weeks 1 to 12|Adverse Event|1|||
105587715|NCT00797225|364152990|FG003|Weeks 1 to 12|Adverse Event|0|||
105587716|NCT00797225|364152991|FG004|Weeks 1 to 12|Adverse Event|0|||
105587717|NCT00797225|364152992|FG005|Weeks 1 to 12|Adverse Event|0|||
105587718|NCT00797225|364152993|FG006|Weeks 1 to 12|Adverse Event|0|||
105587719|NCT00797225|364152994|FG007|Weeks 1 to 12|Adverse Event|0|||
105587720|NCT00797225|364152987|FG000|Weeks 1 to 12|Non-compliance|0|||
105587721|NCT00797225|364152988|FG001|Weeks 1 to 12|Non-compliance|1|||
105587722|NCT00797225|364152989|FG002|Weeks 1 to 12|Non-compliance|0|||
105587723|NCT00797225|364152990|FG003|Weeks 1 to 12|Non-compliance|0|||
105587724|NCT00797225|364152991|FG004|Weeks 1 to 12|Non-compliance|0|||
105587725|NCT00797225|364152992|FG005|Weeks 1 to 12|Non-compliance|0|||
105587726|NCT00797225|364152993|FG006|Weeks 1 to 12|Non-compliance|0|||
105587727|NCT00797225|364152994|FG007|Weeks 1 to 12|Non-compliance|0|||
105587728|NCT00797225|364152987|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
105587729|NCT00797225|364152988|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
105587730|NCT00797225|364152989|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
105587731|NCT00797225|364152990|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
105587732|NCT00797225|364152991|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
105587733|NCT00797225|364152992|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
105587734|NCT00797225|364152993|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
105587735|NCT00797225|364152994|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
105587736|NCT00797225|364152987|FG000|Weeks 1 to 12|Sponsor Decision|1|||
105587737|NCT00797225|364152988|FG001|Weeks 1 to 12|Sponsor Decision|0|||
105587738|NCT00797225|364152989|FG002|Weeks 1 to 12|Sponsor Decision|0|||
105587739|NCT00797225|364152990|FG003|Weeks 1 to 12|Sponsor Decision|0|||
105587740|NCT00797225|364152991|FG004|Weeks 1 to 12|Sponsor Decision|0|||
105587741|NCT00797225|364152992|FG005|Weeks 1 to 12|Sponsor Decision|0|||
105587742|NCT00797225|364152993|FG006|Weeks 1 to 12|Sponsor Decision|0|||
105587743|NCT00797225|364152994|FG007|Weeks 1 to 12|Sponsor Decision|0|||
105587744|NCT00797225|364152987|FG000|Weeks 13 to 24|Non-compliance|0|||
105587745|NCT00797225|364152988|FG001|Weeks 13 to 24|Non-compliance|2|||
105587746|NCT00797225|364152989|FG002|Weeks 13 to 24|Non-compliance|0|||
105587747|NCT00797225|364152990|FG003|Weeks 13 to 24|Non-compliance|0|||
105587748|NCT00797225|364152991|FG004|Weeks 13 to 24|Non-compliance|0|||
105587749|NCT00797225|364152992|FG005|Weeks 13 to 24|Non-compliance|0|||
105587750|NCT00797225|364152993|FG006|Weeks 13 to 24|Non-compliance|0|||
105587751|NCT00797225|364152994|FG007|Weeks 13 to 24|Non-compliance|0|||
105587752|NCT00797225|364152987|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
105587753|NCT00797225|364152988|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
105587754|NCT00797225|364152989|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
105587755|NCT00797225|364152990|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
105587756|NCT00797225|364152991|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
105587757|NCT00797225|364152992|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
105587758|NCT00797225|364152993|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
105587759|NCT00797225|364152994|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
105587760|NCT00797225|364152987|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
105587761|NCT00797225|364152988|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
105587762|NCT00797225|364152989|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
105587763|NCT00797225|364152990|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
105587764|NCT00797225|364152991|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
105425495|NCT01007123|363564871|FG000|Overall Study|Lack of Efficacy|1|||
105425496|NCT01007123|363564872|FG001|Overall Study|Lack of Efficacy|0|||
105425497|NCT01007123|363564873|FG002|Overall Study|Lack of Efficacy|1|||
105587765|NCT00797225|364152992|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
105587766|NCT00797225|364152993|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
105587767|NCT00797225|364152994|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
105587768|NCT00797225|364152987|FG000|Weeks 13 to 24|Adverse Event|0|||
105587769|NCT00797225|364152988|FG001|Weeks 13 to 24|Adverse Event|1|||
105587770|NCT00797225|364152989|FG002|Weeks 13 to 24|Adverse Event|0|||
105587771|NCT00797225|364152990|FG003|Weeks 13 to 24|Adverse Event|0|||
105587772|NCT00797225|364152991|FG004|Weeks 13 to 24|Adverse Event|0|||
105587773|NCT00797225|364152992|FG005|Weeks 13 to 24|Adverse Event|0|||
105587774|NCT00797225|364152993|FG006|Weeks 13 to 24|Adverse Event|1|||
105587775|NCT00797225|364152994|FG007|Weeks 13 to 24|Adverse Event|0|||
105587776|NCT00797225|364152987|FG000|Weeks 13 to 24|Sponsor Decision|0|||
105587777|NCT00797225|364152988|FG001|Weeks 13 to 24|Sponsor Decision|0|||
105587778|NCT00797225|364152989|FG002|Weeks 13 to 24|Sponsor Decision|0|||
105587779|NCT00797225|364152990|FG003|Weeks 13 to 24|Sponsor Decision|0|||
105587780|NCT00797225|364152991|FG004|Weeks 13 to 24|Sponsor Decision|0|||
105587781|NCT00797225|364152992|FG005|Weeks 13 to 24|Sponsor Decision|0|||
105587782|NCT00797225|364152993|FG006|Weeks 13 to 24|Sponsor Decision|1|||
105587783|NCT00797225|364152994|FG007|Weeks 13 to 24|Sponsor Decision|0|||
105587784|NCT02954055|364152995|FG000|Overall Study|Did not initiate therapy|6|||
105587785|NCT02954055|364152996|FG001|Overall Study|Did not initiate therapy|1|||
105425498|NCT01007123|363564874|FG003|Overall Study|Lack of Efficacy|4|||
105425499|NCT01007123|363564871|FG000|Overall Study|Protocol Violation|1|||
105425500|NCT01007123|363564872|FG001|Overall Study|Protocol Violation|1|||
105425501|NCT01007123|363564873|FG002|Overall Study|Protocol Violation|2|||
105425502|NCT01007123|363564874|FG003|Overall Study|Protocol Violation|1|||
105425503|NCT01007123|363564871|FG000|Overall Study|Withdrawal by Subject|1|||
105425504|NCT01007123|363564872|FG001|Overall Study|Withdrawal by Subject|0|||
105425505|NCT01007123|363564873|FG002|Overall Study|Withdrawal by Subject|1|||
105425506|NCT01007123|363564874|FG003|Overall Study|Withdrawal by Subject|0|||
105425507|NCT01007123|363564871|FG000|Overall Study|Lost to Follow-up|0|||
105425508|NCT01007123|363564872|FG001|Overall Study|Lost to Follow-up|1|||
105425509|NCT01007123|363564873|FG002|Overall Study|Lost to Follow-up|0|||
105425510|NCT01007123|363564874|FG003|Overall Study|Lost to Follow-up|0|||
105425511|NCT00524589|363564875|FG000|Overall Study|Withdrawal by Subject|2|||
105425512|NCT00524589|363564875|FG000|Overall Study|Disease Progression|16|||
105425513|NCT01344538|363564876|FG000|Overall Study|Adverse Event|1|||
105425514|NCT01344538|363564877|FG001|Overall Study|Adverse Event|1|||
105425515|NCT01344538|363564876|FG000|Overall Study|Lost to Follow-up|1|||
105425516|NCT01344538|363564877|FG001|Overall Study|Lost to Follow-up|0|||
105425517|NCT01655381|363564878|FG000|Overall Study|Investigator Decision|1|||
105425518|NCT01655381|363564878|FG000|Overall Study|Moved to Another City|1|||
105425519|NCT01655381|363564878|FG000|Overall Study|Insufficient Treatment Response|1|||
105425520|NCT00445848|363564881|FG000|Overall Study|Adverse Event|14|||
105425521|NCT00445848|363564881|FG000|Overall Study|Withdrawal by Subject|4|||
105425522|NCT00445848|363564881|FG000|Overall Study|Progression|62|||
105425523|NCT00445848|363564881|FG000|Overall Study|Other-Not protocol specified|5|||
105425524|NCT01777542|363564884|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
105425525|NCT01777542|363564885|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
105425526|NCT00869050|363564889|FG000|Overall Study|Screen Failure|3|||
105425527|NCT01994863|363564890|FG000|Period 1|Adverse Event|4|||
105425528|NCT01994863|363564891|FG001|Period 1|Adverse Event|0|||
105425529|NCT01994863|363564890|FG000|Period 1|Withdrawal by Subject|1|||
105425530|NCT01994863|363564891|FG001|Period 1|Withdrawal by Subject|0|||
105425531|NCT01994863|363564890|FG000|Period 1|Trial stopped by sponsor|1|||
105425532|NCT01994863|363564891|FG001|Period 1|Trial stopped by sponsor|3|||
105425533|NCT01994863|363564890|FG000|Period 1|Lack of Efficacy|1|||
105425534|NCT01994863|363564891|FG001|Period 1|Lack of Efficacy|0|||
105425535|NCT01994863|363564890|FG000|Period 2|Adverse Event|0|||
105425536|NCT01994863|363564891|FG001|Period 2|Adverse Event|1|||
105425537|NCT01994863|363564890|FG000|Period 2|Lack of Efficacy|0|||
105425538|NCT01994863|363564891|FG001|Period 2|Lack of Efficacy|2|||
105425539|NCT01994863|363564890|FG000|Period 2|Withdrawal by Subject|1|||
105425540|NCT01994863|363564891|FG001|Period 2|Withdrawal by Subject|1|||
105425541|NCT03946124|363564892|FG000|Overall Study|Withdrawal by Subject|19|||
105425542|NCT01062841|363564894|FG000|Overall Study|Indwelling Device Removed|41|||
105425543|NCT01062841|363564895|FG001|Overall Study|Indwelling Device Removed|48|||
105425544|NCT01062841|363564894|FG000|Overall Study|Death|3|||
105425545|NCT01062841|363564895|FG001|Overall Study|Death|5|||
105425546|NCT01062841|363564894|FG000|Overall Study|Withdrawal by Subject|2|||
105425547|NCT01062841|363564895|FG001|Overall Study|Withdrawal by Subject|0|||
105425548|NCT01062841|363564894|FG000|Overall Study|Withdrawal by Study|3|||
105425549|NCT01062841|363564895|FG001|Overall Study|Withdrawal by Study|0|||
105425550|NCT00916058|363564896|FG000|Phase 1|Screen Failure|0|||
105425551|NCT00916058|363564897|FG001|Phase 1|Screen Failure|0|||
105425552|NCT00916058|363564898|FG002|Phase 1|Screen Failure|0|||
105425553|NCT00916058|363564899|FG003|Phase 1|Screen Failure|0|||
105425554|NCT00916058|363564900|FG004|Phase 1|Screen Failure|0|||
105425555|NCT00916058|363564901|FG005|Phase 1|Screen Failure|1|||
105425556|NCT00916058|363564902|FG006|Phase 1|Screen Failure|0|||
105425557|NCT00916058|363564896|FG000|Phase 2|Screen Failure|0|||
105425558|NCT00916058|363564897|FG001|Phase 2|Screen Failure|0|||
105425559|NCT00916058|363564898|FG002|Phase 2|Screen Failure|0|||
105425560|NCT00916058|363564899|FG003|Phase 2|Screen Failure|0|||
105425561|NCT00916058|363564900|FG004|Phase 2|Screen Failure|0|||
105425562|NCT00916058|363564901|FG005|Phase 2|Screen Failure|0|||
105425563|NCT00916058|363564902|FG006|Phase 2|Screen Failure|3|||
105425564|NCT01089023|363564903|FG000|Overall Study|Lost to Follow-up|3|||
105425565|NCT01089023|363564903|FG000|Overall Study|Adverse Event|1|||
105425566|NCT01089023|363564903|FG000|Overall Study|Withdrawal by Subject|1|||
105425567|NCT01089023|363564903|FG000|Overall Study|Protocol Violation|1|||
105425568|NCT01089023|363564903|FG000|Overall Study|Lack of Efficacy|1|||
105425569|NCT01767493|363564909|FG000|Overall Study|screen failures|3|||
105425570|NCT01865812|363564910|FG000|Primary Treatment Phase|Adverse Event|2|||
105425571|NCT01865812|363564911|FG001|Primary Treatment Phase|Adverse Event|0|||
105425572|NCT01865812|363564910|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
105425573|NCT01865812|363564911|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
105425574|NCT01865812|363564910|FG000|Long-term Safety Extension Phase|Pruritus|0|||
105425575|NCT01865812|363564911|FG001|Long-term Safety Extension Phase|Pruritus|3|||
105425576|NCT01865812|363564910|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
105425577|NCT01865812|363564911|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
105425578|NCT01865812|363564910|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
105425579|NCT01865812|363564911|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
105425580|NCT01819129|363564914|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
105425581|NCT01819129|363564915|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
105425582|NCT01819129|363564914|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
105425583|NCT01819129|363564915|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
105425584|NCT01819129|363564914|FG000|Overall Study|Other, Subject moved out of the country|0|||
105425585|NCT01819129|363564915|FG001|Overall Study|Other, Subject moved out of the country|1|||
105425586|NCT01819129|363564914|FG000|Overall Study|Withdrawal by Subject|15|||
105425587|NCT01819129|363564915|FG001|Overall Study|Withdrawal by Subject|15|||
105425588|NCT01819129|363564914|FG000|Overall Study|Lost to Follow-up|5|||
105425589|NCT01819129|363564915|FG001|Overall Study|Lost to Follow-up|2|||
105425590|NCT01819129|363564914|FG000|Overall Study|Lack of Efficacy|0|||
105425591|NCT01819129|363564915|FG001|Overall Study|Lack of Efficacy|1|||
105425592|NCT01819129|363564914|FG000|Overall Study|Adverse Event|1|||
105425593|NCT01819129|363564915|FG001|Overall Study|Adverse Event|4|||
105425594|NCT01819129|363564914|FG000|Overall Study|Death|1|||
105425595|NCT01819129|363564915|FG001|Overall Study|Death|1|||
105425596|NCT01819129|363564914|FG000|Overall Study|Withdrawal Criteria|20|||
105425597|NCT01819129|363564915|FG001|Overall Study|Withdrawal Criteria|15|||
105425598|NCT02836873|363564916|FG000|Overall Study|Protocol Violation|0|||
105425599|NCT02836873|363564917|FG001|Overall Study|Protocol Violation|1|||
105425600|NCT02836873|363564916|FG000|Overall Study|Adverse Event|1|||
105425601|NCT02836873|363564917|FG001|Overall Study|Adverse Event|4|||
105425602|NCT02836873|363564916|FG000|Overall Study|Withdrawal by Subject|2|||
105425603|NCT02836873|363564917|FG001|Overall Study|Withdrawal by Subject|2|||
105425604|NCT02836873|363564916|FG000|Overall Study|Lost to Follow-up|1|||
105425605|NCT02836873|363564917|FG001|Overall Study|Lost to Follow-up|3|||
105425606|NCT02836873|363564916|FG000|Overall Study|Physician Decision|0|||
105425607|NCT02836873|363564917|FG001|Overall Study|Physician Decision|1|||
105425608|NCT02836873|363564916|FG000|Overall Study|Other|1|||
105425609|NCT02836873|363564917|FG001|Overall Study|Other|0|||
105425610|NCT02914548|363564920|FG000|Overall Study|Adverse Event|15|||
105425611|NCT02914548|363564921|FG001|Overall Study|Adverse Event|7|||
105425612|NCT02914548|363564922|FG002|Overall Study|Adverse Event|15|||
105425613|NCT02914548|363564920|FG000|Overall Study|Physician Decision|2|||
105425614|NCT02914548|363564921|FG001|Overall Study|Physician Decision|2|||
105425615|NCT02914548|363564922|FG002|Overall Study|Physician Decision|0|||
105425616|NCT02914548|363564920|FG000|Overall Study|Protocol Violation|1|||
105425617|NCT02914548|363564921|FG001|Overall Study|Protocol Violation|0|||
105425618|NCT02914548|363564922|FG002|Overall Study|Protocol Violation|0|||
105425619|NCT02914548|363564920|FG000|Overall Study|Withdrawal by Subject|3|||
105425620|NCT02914548|363564921|FG001|Overall Study|Withdrawal by Subject|4|||
105425621|NCT02914548|363564922|FG002|Overall Study|Withdrawal by Subject|4|||
105425622|NCT02914548|363564920|FG000|Overall Study|>40% of body surface area|0|||
105425623|NCT02914548|363564921|FG001|Overall Study|>40% of body surface area|1|||
105425624|NCT02914548|363564922|FG002|Overall Study|>40% of body surface area|1|||
105425625|NCT02142283|363564923|FG000|Overall Study|Death|20|||
105425626|NCT02142283|363564924|FG001|Overall Study|Death|18|||
105425627|NCT02142283|363564923|FG000|Overall Study|Withdrawal by Subject|1|||
105425628|NCT02142283|363564924|FG001|Overall Study|Withdrawal by Subject|3|||
105425629|NCT00747344|363564925|FG000|Controlled Period|Adverse Event|3|||
105425630|NCT00747344|363564926|FG001|Controlled Period|Adverse Event|0|||
105425631|NCT00747344|363564927|FG002|Controlled Period|Adverse Event|0|||
105425632|NCT00747344|363564928|FG003|Controlled Period|Adverse Event|0|||
105425633|NCT00747344|363564925|FG000|Controlled Period|Lack of Efficacy|2|||
105425634|NCT00747344|363564926|FG001|Controlled Period|Lack of Efficacy|1|||
105425635|NCT00747344|363564927|FG002|Controlled Period|Lack of Efficacy|0|||
105425636|NCT00747344|363564928|FG003|Controlled Period|Lack of Efficacy|0|||
105425637|NCT00747344|363564925|FG000|Controlled Period|Other|0|||
105425638|NCT00747344|363564926|FG001|Controlled Period|Other|3|||
105425639|NCT00747344|363564927|FG002|Controlled Period|Other|0|||
105425640|NCT00747344|363564928|FG003|Controlled Period|Other|0|||
105425641|NCT00747344|363564925|FG000|After Controlled Period|Adverse Event|0|||
105425642|NCT00747344|363564926|FG001|After Controlled Period|Adverse Event|0|||
105425643|NCT00747344|363564927|FG002|After Controlled Period|Adverse Event|0|||
105587786|NCT01119703|364152997|FG000|Overall Study|Adverse Event|0|||
105587787|NCT01119703|364152998|FG001|Overall Study|Adverse Event|1|||
105425644|NCT00747344|363564928|FG003|After Controlled Period|Adverse Event|1|||
105425645|NCT00765882|363564929|FG000|Overall Study|Adverse Event|10|||
105425646|NCT00765882|363564930|FG001|Overall Study|Adverse Event|21|||
105425647|NCT00765882|363564931|FG002|Overall Study|Adverse Event|20|||
105425648|NCT00765882|363564929|FG000|Overall Study|Lack of Efficacy|4|||
105425649|NCT00765882|363564930|FG001|Overall Study|Lack of Efficacy|0|||
105425650|NCT00765882|363564931|FG002|Overall Study|Lack of Efficacy|1|||
105425651|NCT00765882|363564929|FG000|Overall Study|Protocol Violation|4|||
105425652|NCT00765882|363564930|FG001|Overall Study|Protocol Violation|3|||
105425653|NCT00765882|363564931|FG002|Overall Study|Protocol Violation|1|||
105425654|NCT00765882|363564929|FG000|Overall Study|Withdrawal by Subject|2|||
105587788|NCT01511250|364152999|FG000|Overall Study|Withdrawal of Consent|1|||
105587789|NCT01511250|364153000|FG001|Overall Study|Withdrawal of Consent|0|||
105587790|NCT01511250|364153001|FG002|Overall Study|Withdrawal of Consent|0|||
105587791|NCT01511250|364153002|FG003|Overall Study|Withdrawal of Consent|0|||
105587792|NCT01511250|364153003|FG004|Overall Study|Withdrawal of Consent|0|||
105425655|NCT00765882|363564930|FG001|Overall Study|Withdrawal by Subject|6|||
105425656|NCT00765882|363564931|FG002|Overall Study|Withdrawal by Subject|6|||
105425657|NCT00765882|363564929|FG000|Overall Study|Lost to Follow-up|1|||
105425658|NCT00765882|363564930|FG001|Overall Study|Lost to Follow-up|9|||
105425659|NCT00765882|363564931|FG002|Overall Study|Lost to Follow-up|6|||
105425660|NCT00765882|363564929|FG000|Overall Study|Other Reason|3|||
105425661|NCT00765882|363564930|FG001|Overall Study|Other Reason|1|||
105425662|NCT00765882|363564931|FG002|Overall Study|Other Reason|2|||
105425663|NCT01605227|363564935|FG000|Overall Study|Did not receive study treatment|2|||
105425664|NCT01605227|363564936|FG001|Overall Study|Did not receive study treatment|3|||
105425665|NCT01605227|363564935|FG000|Overall Study|Adverse Event|228|||
105425666|NCT01605227|363564936|FG001|Overall Study|Adverse Event|42|||
105425667|NCT01605227|363564935|FG000|Overall Study|Progressive Disease|132|||
105425668|NCT01605227|363564936|FG001|Overall Study|Progressive Disease|128|||
105425669|NCT01605227|363564935|FG000|Overall Study|Clinical Deterioration|227|||
105425670|NCT01605227|363564936|FG001|Overall Study|Clinical Deterioration|133|||
105425671|NCT01605227|363564935|FG000|Overall Study|Lost to Follow-up|1|||
105425672|NCT01605227|363564936|FG001|Overall Study|Lost to Follow-up|0|||
105425673|NCT01605227|363564935|FG000|Overall Study|Protocol Violation|1|||
105425674|NCT01605227|363564936|FG001|Overall Study|Protocol Violation|0|||
105425675|NCT01605227|363564935|FG000|Overall Study|Physician Decision|9|||
105425676|NCT01605227|363564936|FG001|Overall Study|Physician Decision|7|||
105425677|NCT01605227|363564935|FG000|Overall Study|Withdrawal by Subject|18|||
105425678|NCT01605227|363564936|FG001|Overall Study|Withdrawal by Subject|14|||
105425679|NCT01605227|363564935|FG000|Overall Study|Sponsor Decision|2|||
105425680|NCT01605227|363564936|FG001|Overall Study|Sponsor Decision|0|||
105425681|NCT01605227|363564935|FG000|Overall Study|Started New Therapy|1|||
105425682|NCT01605227|363564936|FG001|Overall Study|Started New Therapy|0|||
105425683|NCT01605227|363564935|FG000|Overall Study|Subject Decision|0|||
105425684|NCT01605227|363564936|FG001|Overall Study|Subject Decision|1|||
105425685|NCT01605227|363564935|FG000|Overall Study|Dose Held >6 weeks|0|||
105425686|NCT01605227|363564936|FG001|Overall Study|Dose Held >6 weeks|1|||
105425687|NCT02961790|363564942|FG000|Overall Study|Canceled|4|||
105425688|NCT02961790|363564943|FG001|Overall Study|Canceled|5|||
105425689|NCT02961790|363564944|FG002|Overall Study|Canceled|1|||
105425690|NCT02961790|363564945|FG003|Overall Study|Canceled|4|||
105425691|NCT02961790|363564942|FG000|Overall Study|without baseline data|4|||
105425692|NCT02961790|363564943|FG001|Overall Study|without baseline data|0|||
105425693|NCT02961790|363564944|FG002|Overall Study|without baseline data|1|||
105425694|NCT02961790|363564945|FG003|Overall Study|without baseline data|0|||
105425695|NCT02961790|363564942|FG000|Overall Study|without post baseline data|7|||
105425696|NCT02961790|363564943|FG001|Overall Study|without post baseline data|6|||
105425697|NCT02961790|363564944|FG002|Overall Study|without post baseline data|4|||
105425698|NCT02961790|363564945|FG003|Overall Study|without post baseline data|1|||
105425699|NCT01009346|363564950|FG000|Overall Study|Adverse Event|4|||
105425700|NCT03366103|363564951|FG000|Overall Study|Disease Progression|3|||
105425701|NCT03366103|363564952|FG001|Overall Study|Disease Progression|1|||
105425702|NCT03366103|363564953|FG002|Overall Study|Disease Progression|0|||
105425703|NCT03366103|363564951|FG000|Overall Study|Adverse Event|0|||
105425704|NCT03366103|363564952|FG001|Overall Study|Adverse Event|1|||
105425705|NCT03366103|363564953|FG002|Overall Study|Adverse Event|0|||
105425706|NCT01036529|363564954|FG000|Overall Study|Adverse Event|0|||
105425707|NCT01036529|363564955|FG001|Overall Study|Adverse Event|1|||
105425708|NCT01036529|363564954|FG000|Overall Study|Lost to Follow-up|0|||
105425709|NCT01036529|363564955|FG001|Overall Study|Lost to Follow-up|1|||
105587793|NCT01511250|364153004|FG005|Overall Study|Withdrawal of Consent|0|||
105425710|NCT01036529|363564954|FG000|Overall Study|Physician Decision|1|||
105425711|NCT01036529|363564955|FG001|Overall Study|Physician Decision|0|||
105425712|NCT01036529|363564954|FG000|Overall Study|Withdrawal by Subject|1|||
105425713|NCT01036529|363564955|FG001|Overall Study|Withdrawal by Subject|1|||
105425714|NCT01036529|363564954|FG000|Overall Study|Sponsor study termination|11|||
105425715|NCT01036529|363564955|FG001|Overall Study|Sponsor study termination|12|||
105425716|NCT00541099|363564956|FG000|Overall Study|Ineligible|3|||
105425717|NCT03271047|363564958|FG000|Phase 1b: Dose Finding Period|Death|8|||
105425718|NCT03271047|363564959|FG001|Phase 1b: Dose Finding Period|Death|8|||
105425719|NCT03271047|363564960|FG002|Phase 1b: Dose Finding Period|Death|0|||
105425720|NCT03271047|363564961|FG003|Phase 1b: Dose Finding Period|Death|0|||
105425721|NCT03271047|363564958|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
105425722|NCT03271047|363564959|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
105425723|NCT03271047|363564960|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
105425724|NCT03271047|363564961|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
105425725|NCT03271047|363564958|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
105587794|NCT01511250|364153005|FG006|Overall Study|Withdrawal of Consent|0|||
105425726|NCT03271047|363564959|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
105425727|NCT03271047|363564960|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
105425728|NCT03271047|363564961|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
105425729|NCT03271047|363564958|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
105425730|NCT03271047|363564959|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
105425731|NCT03271047|363564960|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
105425732|NCT03271047|363564961|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
105425733|NCT03271047|363564958|FG000|Randomized Phase 2 Period|Other|0|||
105425734|NCT03271047|363564959|FG001|Randomized Phase 2 Period|Other|0|||
105425735|NCT03271047|363564960|FG002|Randomized Phase 2 Period|Other|0|||
105425736|NCT03271047|363564961|FG003|Randomized Phase 2 Period|Other|1|||
105425737|NCT03271047|363564958|FG000|Randomized Phase 2 Period|Death|0|||
105425738|NCT03271047|363564959|FG001|Randomized Phase 2 Period|Death|0|||
105425739|NCT03271047|363564960|FG002|Randomized Phase 2 Period|Death|20|||
105425740|NCT03271047|363564961|FG003|Randomized Phase 2 Period|Death|21|||
105425741|NCT03271047|363564958|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
105425742|NCT03271047|363564959|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
105425743|NCT03271047|363564960|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
105425744|NCT03271047|363564961|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
105425745|NCT03271047|363564958|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
105425746|NCT03271047|363564959|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
105425747|NCT03271047|363564960|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
105425748|NCT03271047|363564961|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
105425749|NCT03271047|363564958|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
105425750|NCT03271047|363564959|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
105425751|NCT03271047|363564960|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
105425752|NCT03271047|363564961|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
105425753|NCT02305849|363564963|FG000|Overall Study|Adverse Event|10|||
105425754|NCT02305849|363564964|FG001|Overall Study|Adverse Event|12|||
105425755|NCT02305849|363564965|FG002|Overall Study|Adverse Event|7|||
105425756|NCT02305849|363564966|FG003|Overall Study|Adverse Event|3|||
105425757|NCT02305849|363564963|FG000|Overall Study|Lack of Efficacy|10|||
105425758|NCT02305849|363564964|FG001|Overall Study|Lack of Efficacy|6|||
105425759|NCT02305849|363564965|FG002|Overall Study|Lack of Efficacy|3|||
105425760|NCT02305849|363564966|FG003|Overall Study|Lack of Efficacy|9|||
105425761|NCT02305849|363564963|FG000|Overall Study|Withdrawal by Subject|2|||
105425762|NCT02305849|363564964|FG001|Overall Study|Withdrawal by Subject|2|||
105425763|NCT02305849|363564965|FG002|Overall Study|Withdrawal by Subject|1|||
105425764|NCT02305849|363564966|FG003|Overall Study|Withdrawal by Subject|4|||
105425765|NCT02305849|363564963|FG000|Overall Study|Lost to Follow-up|0|||
105425766|NCT02305849|363564964|FG001|Overall Study|Lost to Follow-up|2|||
105425767|NCT02305849|363564965|FG002|Overall Study|Lost to Follow-up|0|||
105425768|NCT02305849|363564966|FG003|Overall Study|Lost to Follow-up|0|||
105425769|NCT02305849|363564963|FG000|Overall Study|Protocol Violation|3|||
105425770|NCT02305849|363564964|FG001|Overall Study|Protocol Violation|2|||
105425771|NCT02305849|363564965|FG002|Overall Study|Protocol Violation|1|||
105425772|NCT02305849|363564966|FG003|Overall Study|Protocol Violation|1|||
105425773|NCT02305849|363564963|FG000|Overall Study|Lab data met discontinuation criteria|0|||
105425774|NCT02305849|363564964|FG001|Overall Study|Lab data met discontinuation criteria|1|||
105425775|NCT02305849|363564965|FG002|Overall Study|Lab data met discontinuation criteria|2|||
105425776|NCT02305849|363564966|FG003|Overall Study|Lab data met discontinuation criteria|1|||
105425777|NCT02305849|363564963|FG000|Overall Study|Miscellaneous|1|||
105425778|NCT02305849|363564964|FG001|Overall Study|Miscellaneous|2|||
105425779|NCT02305849|363564965|FG002|Overall Study|Miscellaneous|4|||
105425780|NCT02305849|363564966|FG003|Overall Study|Miscellaneous|1|||
105425781|NCT02305849|363564963|FG000|Overall Study|Not fulfill eligibility criteria|1|||
105425782|NCT02305849|363564964|FG001|Overall Study|Not fulfill eligibility criteria|1|||
105425783|NCT02305849|363564965|FG002|Overall Study|Not fulfill eligibility criteria|0|||
105425784|NCT02305849|363564966|FG003|Overall Study|Not fulfill eligibility criteria|0|||
105425785|NCT03777917|363564967|FG000|Overall Study|Withdrawal by Subject|1|||
105425786|NCT03777917|363564968|FG001|Overall Study|Withdrawal by Subject|0|||
105425787|NCT03777917|363564967|FG000|Overall Study|Physician Decision|1|||
105425788|NCT03777917|363564968|FG001|Overall Study|Physician Decision|0|||
105425789|NCT03777917|363564967|FG000|Overall Study|Lost to Follow-up|6|||
105425790|NCT03777917|363564968|FG001|Overall Study|Lost to Follow-up|2|||
105425791|NCT03777917|363564967|FG000|Overall Study|Other|1|||
105425792|NCT03777917|363564968|FG001|Overall Study|Other|0|||
105425793|NCT01853072|363564969|FG000|Overall Study|Adverse event prior to treatment|0|||
105425794|NCT01853072|363564970|FG001|Overall Study|Adverse event prior to treatment|1|||
105425795|NCT01853072|363564969|FG000|Overall Study|Adverse Event|0|||
105425796|NCT01853072|363564970|FG001|Overall Study|Adverse Event|3|||
105425797|NCT01853072|363564969|FG000|Overall Study|Death|1|||
105501181|NCT00533897|363847071|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
105501182|NCT00533897|363847064|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
105587795|NCT01511250|364153006|FG007|Overall Study|Withdrawal of Consent|1|||
105587796|NCT01511250|364153007|FG008|Overall Study|Withdrawal of Consent|1|||
105587797|NCT01511250|364153008|FG009|Overall Study|Withdrawal of Consent|0|||
105587798|NCT01511250|364152999|FG000|Overall Study|Sponsor/Investigator Decision|1|||
105587799|NCT01511250|364153000|FG001|Overall Study|Sponsor/Investigator Decision|0|||
105587800|NCT01511250|364153001|FG002|Overall Study|Sponsor/Investigator Decision|0|||
105587801|NCT01511250|364153002|FG003|Overall Study|Sponsor/Investigator Decision|0|||
105587802|NCT01511250|364153003|FG004|Overall Study|Sponsor/Investigator Decision|0|||
105587803|NCT01511250|364153004|FG005|Overall Study|Sponsor/Investigator Decision|0|||
105587804|NCT01511250|364153005|FG006|Overall Study|Sponsor/Investigator Decision|0|||
105587805|NCT01511250|364153006|FG007|Overall Study|Sponsor/Investigator Decision|0|||
105587806|NCT01511250|364153007|FG008|Overall Study|Sponsor/Investigator Decision|0|||
105587807|NCT01511250|364153008|FG009|Overall Study|Sponsor/Investigator Decision|0|||
105587808|NCT01511250|364152999|FG000|Overall Study|Lost to Follow-up|7|||
105587809|NCT01511250|364153000|FG001|Overall Study|Lost to Follow-up|3|||
105587810|NCT01511250|364153001|FG002|Overall Study|Lost to Follow-up|3|||
105587811|NCT01511250|364153002|FG003|Overall Study|Lost to Follow-up|3|||
105587812|NCT01511250|364153003|FG004|Overall Study|Lost to Follow-up|0|||
105501183|NCT00533897|363847065|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
105501184|NCT00533897|363847066|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
105501185|NCT00533897|363847067|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
105501186|NCT00533897|363847068|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
105501187|NCT00533897|363847069|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
105501188|NCT00533897|363847070|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
105501189|NCT00533897|363847071|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
105501190|NCT00533897|363847064|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
105501191|NCT00533897|363847065|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
105501192|NCT00533897|363847066|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
105501193|NCT00533897|363847067|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
105501194|NCT00533897|363847068|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
105501195|NCT00533897|363847069|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
105501196|NCT00533897|363847070|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
105501197|NCT00533897|363847071|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
105501198|NCT00533897|363847064|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
105501199|NCT00533897|363847065|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
105501200|NCT00533897|363847066|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
105501201|NCT00533897|363847067|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
105501202|NCT00533897|363847068|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
105501203|NCT00533897|363847069|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
105501204|NCT00533897|363847070|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
105501205|NCT00533897|363847071|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
105501206|NCT00533897|363847064|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
105501207|NCT00533897|363847065|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
105501208|NCT00533897|363847066|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
105501209|NCT00533897|363847067|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
105501210|NCT00533897|363847068|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
105501211|NCT00533897|363847069|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
105501212|NCT00533897|363847070|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
105501213|NCT00533897|363847071|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
105501214|NCT00533897|363847064|FG000|Long Term Extension (LTE)|Death|0|||
105501215|NCT00533897|363847065|FG001|Long Term Extension (LTE)|Death|0|||
105501216|NCT00533897|363847066|FG002|Long Term Extension (LTE)|Death|0|||
105501217|NCT00533897|363847067|FG003|Long Term Extension (LTE)|Death|0|||
105501218|NCT00533897|363847068|FG004|Long Term Extension (LTE)|Death|0|||
105501219|NCT00533897|363847069|FG005|Long Term Extension (LTE)|Death|0|||
105501220|NCT00533897|363847070|FG006|Long Term Extension (LTE)|Death|1|||
105501221|NCT00533897|363847071|FG007|Long Term Extension (LTE)|Death|3|||
105501222|NCT00533897|363847064|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
105501223|NCT00533897|363847065|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
105501224|NCT00533897|363847066|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
105501225|NCT00533897|363847067|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
105501226|NCT00533897|363847068|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
105501227|NCT00533897|363847069|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
105501228|NCT00533897|363847070|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
105501229|NCT00533897|363847071|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
105501230|NCT00533897|363847064|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
105501231|NCT00533897|363847065|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
105501232|NCT00533897|363847066|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
105587813|NCT01511250|364153004|FG005|Overall Study|Lost to Follow-up|0|||
105587814|NCT01511250|364153005|FG006|Overall Study|Lost to Follow-up|2|||
105587815|NCT01511250|364153006|FG007|Overall Study|Lost to Follow-up|3|||
105587816|NCT01511250|364153007|FG008|Overall Study|Lost to Follow-up|13|||
105587817|NCT01511250|364153008|FG009|Overall Study|Lost to Follow-up|5|||
105587818|NCT01511250|364152999|FG000|Overall Study|Protocol Violation|0|||
105587819|NCT01511250|364153000|FG001|Overall Study|Protocol Violation|2|||
105587820|NCT01511250|364153001|FG002|Overall Study|Protocol Violation|1|||
105587821|NCT01511250|364153002|FG003|Overall Study|Protocol Violation|0|||
105587822|NCT01511250|364153003|FG004|Overall Study|Protocol Violation|0|||
105587823|NCT01511250|364153004|FG005|Overall Study|Protocol Violation|0|||
105587824|NCT01511250|364153005|FG006|Overall Study|Protocol Violation|0|||
105587825|NCT01511250|364153006|FG007|Overall Study|Protocol Violation|0|||
105587826|NCT01511250|364153007|FG008|Overall Study|Protocol Violation|0|||
105587827|NCT01511250|364153008|FG009|Overall Study|Protocol Violation|0|||
105587828|NCT03404843|364153012|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
105587829|NCT03404843|364153013|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
105587830|NCT02974010|364153014|FG000|Overall Study|Lost to Follow-up|3|||
105587831|NCT02974010|364153015|FG001|Overall Study|Lost to Follow-up|1|||
105425798|NCT01853072|363564970|FG001|Overall Study|Death|4|||
105425799|NCT01853072|363564969|FG000|Overall Study|Lost to Follow-up|0|||
105425800|NCT01853072|363564970|FG001|Overall Study|Lost to Follow-up|3|||
105425801|NCT01853072|363564969|FG000|Overall Study|Non-compliance with study drug|0|||
105425802|NCT01853072|363564970|FG001|Overall Study|Non-compliance with study drug|1|||
105425803|NCT01853072|363564969|FG000|Overall Study|Physician Decision|1|||
105425804|NCT01853072|363564970|FG001|Overall Study|Physician Decision|1|||
105425805|NCT01853072|363564969|FG000|Overall Study|Withdrawal by Subject|1|||
105425806|NCT01853072|363564970|FG001|Overall Study|Withdrawal by Subject|2|||
105425807|NCT01853072|363564969|FG000|Overall Study|Reason not specified|9|||
105425808|NCT01853072|363564970|FG001|Overall Study|Reason not specified|6|||
105425809|NCT02653495|363564977|FG000|Overall Study|Lost to Follow-up|2|||
105425810|NCT02653495|363564978|FG001|Overall Study|Lost to Follow-up|0|||
105425811|NCT02653495|363564977|FG000|Overall Study|Screening Failure|10|||
105425812|NCT02653495|363564978|FG001|Overall Study|Screening Failure|0|||
105425813|NCT00787930|363564979|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
105425814|NCT03158272|363564980|FG000|Overall Study|Disease progression|3|||
105425815|NCT03158272|363564981|FG001|Overall Study|Disease progression|3|||
105425816|NCT03158272|363564982|FG002|Overall Study|Disease progression|4|||
105425817|NCT03158272|363564983|FG003|Overall Study|Disease progression|6|||
105425818|NCT03158272|363564980|FG000|Overall Study|Death|0|||
105425819|NCT03158272|363564981|FG001|Overall Study|Death|0|||
105425820|NCT03158272|363564982|FG002|Overall Study|Death|1|||
105425821|NCT03158272|363564983|FG003|Overall Study|Death|0|||
105425822|NCT03158272|363564980|FG000|Overall Study|Other reasons|0|||
105425823|NCT03158272|363564981|FG001|Overall Study|Other reasons|0|||
105587832|NCT02974010|364153016|FG002|Overall Study|Lost to Follow-up|0|||
105587833|NCT02974010|364153017|FG003|Overall Study|Lost to Follow-up|0|||
105587834|NCT02974010|364153014|FG000|Overall Study|Withdrawal by Subject|2|||
105587835|NCT02974010|364153015|FG001|Overall Study|Withdrawal by Subject|1|||
105587836|NCT02974010|364153016|FG002|Overall Study|Withdrawal by Subject|0|||
105587837|NCT02974010|364153017|FG003|Overall Study|Withdrawal by Subject|0|||
105587838|NCT02974010|364153014|FG000|Overall Study|Adverse Event|0|||
105587839|NCT02974010|364153015|FG001|Overall Study|Adverse Event|1|||
105587840|NCT02974010|364153016|FG002|Overall Study|Adverse Event|0|||
105587841|NCT02974010|364153017|FG003|Overall Study|Adverse Event|0|||
105587842|NCT02974010|364153014|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
105587843|NCT02974010|364153015|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
105587844|NCT02974010|364153016|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
105587845|NCT02974010|364153017|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
105587846|NCT02974010|364153014|FG000|Overall Study|Lack of Efficacy|0|||
105587847|NCT02974010|364153015|FG001|Overall Study|Lack of Efficacy|0|||
105587848|NCT02974010|364153016|FG002|Overall Study|Lack of Efficacy|1|||
105587849|NCT02974010|364153017|FG003|Overall Study|Lack of Efficacy|0|||
105587850|NCT02095158|364153018|FG000|Overall Study|Adverse Event|14|||
105587851|NCT02095158|364153018|FG000|Overall Study|Lack of Efficacy|3|||
105587852|NCT02095158|364153018|FG000|Overall Study|Pregnancy|1|||
105587853|NCT02095158|364153018|FG000|Overall Study|Lost to Follow-up|20|||
105425824|NCT03158272|363564982|FG002|Overall Study|Other reasons|1|||
105425825|NCT03158272|363564983|FG003|Overall Study|Other reasons|0|||
105587854|NCT02095158|364153018|FG000|Overall Study|Personal Reasons|35|||
105587855|NCT02095158|364153018|FG000|Overall Study|Protocol Violation|1|||
105425826|NCT03158272|363564980|FG000|Overall Study|Adverse event unrelated to the drug|0|||
105425827|NCT03158272|363564981|FG001|Overall Study|Adverse event unrelated to the drug|1|||
105425828|NCT03158272|363564982|FG002|Overall Study|Adverse event unrelated to the drug|0|||
105587856|NCT02095158|364153018|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105425829|NCT03158272|363564983|FG003|Overall Study|Adverse event unrelated to the drug|0|||
105425830|NCT01048866|363564984|FG000|Overall Study|Adverse Event|1|||
105425831|NCT01048866|363564985|FG001|Overall Study|Adverse Event|0|||
105425832|NCT01048866|363564984|FG000|Overall Study|Protocol Violation|1|||
105425833|NCT01048866|363564985|FG001|Overall Study|Protocol Violation|0|||
105425834|NCT01048866|363564984|FG000|Overall Study|Physician Decision|1|||
105425835|NCT01048866|363564985|FG001|Overall Study|Physician Decision|0|||
105425836|NCT01048866|363564984|FG000|Overall Study|Withdrawal by Subject|0|||
105425837|NCT01048866|363564985|FG001|Overall Study|Withdrawal by Subject|2|||
105425838|NCT01048866|363564984|FG000|Overall Study|Lost to Follow-up|0|||
105425839|NCT01048866|363564985|FG001|Overall Study|Lost to Follow-up|2|||
105425840|NCT01048866|363564984|FG000|Overall Study|Other|1|||
105425841|NCT01048866|363564985|FG001|Overall Study|Other|1|||
105425842|NCT04030247|363567088|FG000|Overall Study|Withdrawal by Subject|4|||
105425843|NCT04030247|363567088|FG000|Overall Study|Lost to Follow-up|13|||
105425844|NCT00509093|363567089|FG000|Overall Study|Adverse Event|10|||
105425845|NCT00509093|363567089|FG000|Overall Study|Disease Progression|9|||
105425846|NCT00509093|363567089|FG000|Overall Study|Transformed into MDS|1|||
105425847|NCT00509093|363567089|FG000|Overall Study|Withdrawal by Subject|3|||
105425848|NCT00509093|363567089|FG000|Overall Study|Physician Decision|1|||
105425849|NCT00953524|363567090|FG000|Overall Study|Adverse Event|2|||
105425850|NCT00953524|363567091|FG001|Overall Study|Adverse Event|0|||
105425851|NCT00953524|363567092|FG002|Overall Study|Adverse Event|1|||
105425852|NCT00953524|363567093|FG003|Overall Study|Adverse Event|2|||
105425853|NCT00953524|363567090|FG000|Overall Study|Protocol Violation|18|||
105425854|NCT00953524|363567091|FG001|Overall Study|Protocol Violation|10|||
105425855|NCT00953524|363567092|FG002|Overall Study|Protocol Violation|11|||
105425856|NCT00953524|363567093|FG003|Overall Study|Protocol Violation|6|||
105425857|NCT00953524|363567090|FG000|Overall Study|Lost to Follow-up|0|||
105425858|NCT00953524|363567091|FG001|Overall Study|Lost to Follow-up|1|||
105425859|NCT00953524|363567092|FG002|Overall Study|Lost to Follow-up|1|||
105425860|NCT00953524|363567093|FG003|Overall Study|Lost to Follow-up|0|||
105425861|NCT00953524|363567090|FG000|Overall Study|Withdrawal by Subject|2|||
105425862|NCT00953524|363567091|FG001|Overall Study|Withdrawal by Subject|4|||
105425863|NCT00953524|363567092|FG002|Overall Study|Withdrawal by Subject|1|||
105425864|NCT00953524|363567093|FG003|Overall Study|Withdrawal by Subject|0|||
105425865|NCT03784846|363567100|FG000|Pre-COVID Study|Lost to Follow-up|3|||
105425866|NCT03784846|363567101|FG001|Pre-COVID Study|Lost to Follow-up|3|||
105425867|NCT03784846|363567102|FG002|Pre-COVID Study|Lost to Follow-up|2|||
105425868|NCT03784846|363567100|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
105425869|NCT03784846|363567101|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
105425870|NCT03784846|363567102|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
105425871|NCT03784846|363567100|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
105425872|NCT03784846|363567101|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
105425873|NCT03784846|363567102|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
105425874|NCT03784846|363567100|FG000|Post-COVID Study|Lost to Follow-up|3|||
105425875|NCT03784846|363567101|FG001|Post-COVID Study|Lost to Follow-up|5|||
105425876|NCT03784846|363567102|FG002|Post-COVID Study|Lost to Follow-up|1|||
105425877|NCT03784846|363567100|FG000|Post-COVID Study|Withdrawal by Subject|1|||
105425878|NCT03784846|363567101|FG001|Post-COVID Study|Withdrawal by Subject|2|||
105425879|NCT03784846|363567102|FG002|Post-COVID Study|Withdrawal by Subject|0|||
105425880|NCT02334683|363567103|FG000|First 12 Week Period|Lost to Follow-up|1|||
105425881|NCT02334683|363567104|FG001|First 12 Week Period|Lost to Follow-up|0|||
105425882|NCT02334683|363567103|FG000|Second 12 Week Period|Adverse Event|0|||
105425883|NCT02334683|363567104|FG001|Second 12 Week Period|Adverse Event|1|||
105425884|NCT01396265|363567106|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
105425885|NCT03421743|363567110|FG000|Overall Study|Lack of Efficacy|1|||
105425886|NCT03421743|363567111|FG001|Overall Study|Lack of Efficacy|0|||
105425887|NCT03421743|363567110|FG000|Overall Study|Adverse Event|2|||
105425888|NCT03421743|363567111|FG001|Overall Study|Adverse Event|1|||
105425889|NCT03421743|363567110|FG000|Overall Study|Withdrawal by Subject|0|||
105425890|NCT03421743|363567111|FG001|Overall Study|Withdrawal by Subject|1|||
105425891|NCT00435162|363567112|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
105425892|NCT00435162|363567113|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
105425893|NCT00435162|363567114|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
105425894|NCT00435162|363567115|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
105425895|NCT00435162|363567116|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
105425896|NCT00435162|363567117|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
105425897|NCT01765426|363567118|FG000|Overall Study|Lost to Follow-up|0|||
105425898|NCT01765426|363567119|FG001|Overall Study|Lost to Follow-up|1|||
105425899|NCT01765426|363567120|FG002|Overall Study|Lost to Follow-up|0|||
105425900|NCT01765426|363567121|FG003|Overall Study|Lost to Follow-up|0|||
105425901|NCT02230683|363567123|FG000|Overall Study|Adverse Event|1|||
105425902|NCT02310230|363567132|FG000|Overall Study|Physician Decision|1|||
105425903|NCT02310230|363567133|FG001|Overall Study|Physician Decision|3|||
105425904|NCT02310230|363567132|FG000|Overall Study|monitor baseline taken after induction|2|||
105425905|NCT02310230|363567133|FG001|Overall Study|monitor baseline taken after induction|7|||
105425906|NCT02310230|363567132|FG000|Overall Study|Poor signal quality|5|||
105425907|NCT02310230|363567133|FG001|Overall Study|Poor signal quality|8|||
105425908|NCT02310230|363567132|FG000|Overall Study|Case cancelled|1|||
105425909|NCT02310230|363567133|FG001|Overall Study|Case cancelled|0|||
105587857|NCT01941316|364153019|FG000|Overall Study|Adverse Event|0|||
105587858|NCT01941316|364153020|FG001|Overall Study|Adverse Event|1|||
105587859|NCT01941316|364153021|FG002|Overall Study|Adverse Event|0|||
105587860|NCT01941316|364153022|FG003|Overall Study|Adverse Event|7|||
105587861|NCT01941316|364153019|FG000|Overall Study|Progressive Disease|3|||
105587862|NCT01941316|364153020|FG001|Overall Study|Progressive Disease|6|||
105587863|NCT01941316|364153021|FG002|Overall Study|Progressive Disease|2|||
105587864|NCT01941316|364153022|FG003|Overall Study|Progressive Disease|29|||
105587865|NCT01941316|364153019|FG000|Overall Study|Withdrawal by Subject|0|||
105587866|NCT01941316|364153020|FG001|Overall Study|Withdrawal by Subject|2|||
105587867|NCT01941316|364153021|FG002|Overall Study|Withdrawal by Subject|1|||
105587868|NCT01941316|364153022|FG003|Overall Study|Withdrawal by Subject|8|||
105587869|NCT01941316|364153019|FG000|Overall Study|Death|0|||
105587870|NCT01941316|364153020|FG001|Overall Study|Death|0|||
105587871|NCT01941316|364153021|FG002|Overall Study|Death|0|||
105587872|NCT01941316|364153022|FG003|Overall Study|Death|3|||
105587873|NCT01941316|364153019|FG000|Overall Study|Physician Decision|0|||
105587874|NCT01941316|364153020|FG001|Overall Study|Physician Decision|0|||
105587875|NCT01941316|364153021|FG002|Overall Study|Physician Decision|0|||
105587876|NCT01941316|364153022|FG003|Overall Study|Physician Decision|3|||
105587877|NCT01941316|364153019|FG000|Overall Study|Protocol Violation|0|||
105587878|NCT01941316|364153020|FG001|Overall Study|Protocol Violation|0|||
105587879|NCT01941316|364153021|FG002|Overall Study|Protocol Violation|0|||
105425910|NCT02231762|363567134|FG000|Combination Phase|Adverse Event|10|||
105425911|NCT02231762|363567135|FG001|Combination Phase|Adverse Event|0|||
105425912|NCT02231762|363567136|FG002|Combination Phase|Adverse Event|0|||
105425913|NCT02231762|363567137|FG003|Combination Phase|Adverse Event|0|||
105425914|NCT02231762|363567134|FG000|Combination Phase|Withdrawal by Subject|2|||
105425915|NCT02231762|363567135|FG001|Combination Phase|Withdrawal by Subject|0|||
105425916|NCT02231762|363567136|FG002|Combination Phase|Withdrawal by Subject|0|||
105425917|NCT02231762|363567137|FG003|Combination Phase|Withdrawal by Subject|0|||
105425918|NCT02231762|363567134|FG000|Combination Phase|Disease Progression|6|||
105425919|NCT02231762|363567135|FG001|Combination Phase|Disease Progression|0|||
105425920|NCT02231762|363567136|FG002|Combination Phase|Disease Progression|0|||
105425921|NCT02231762|363567137|FG003|Combination Phase|Disease Progression|0|||
105425922|NCT02231762|363567134|FG000|Combination Phase|Did not meet inclusion criteria|1|||
105425923|NCT02231762|363567135|FG001|Combination Phase|Did not meet inclusion criteria|0|||
105425924|NCT02231762|363567136|FG002|Combination Phase|Did not meet inclusion criteria|0|||
105425925|NCT02231762|363567137|FG003|Combination Phase|Did not meet inclusion criteria|0|||
105425926|NCT02231762|363567134|FG000|Combination Phase|Protocol Violation|1|||
105425927|NCT02231762|363567135|FG001|Combination Phase|Protocol Violation|0|||
105425928|NCT02231762|363567136|FG002|Combination Phase|Protocol Violation|0|||
105425929|NCT02231762|363567137|FG003|Combination Phase|Protocol Violation|0|||
105425930|NCT02231762|363567134|FG000|Maintenance Phase|Disease progression|0|||
105425931|NCT02231762|363567135|FG001|Maintenance Phase|Disease progression|3|||
105425932|NCT02231762|363567136|FG002|Maintenance Phase|Disease progression|4|||
105425933|NCT02231762|363567137|FG003|Maintenance Phase|Disease progression|3|||
105425934|NCT02231762|363567134|FG000|Maintenance Phase|Adverse Event|0|||
105425935|NCT02231762|363567135|FG001|Maintenance Phase|Adverse Event|0|||
105425936|NCT02231762|363567136|FG002|Maintenance Phase|Adverse Event|1|||
105425937|NCT02231762|363567137|FG003|Maintenance Phase|Adverse Event|2|||
105425938|NCT01697462|363567138|FG000|Overall Study|Disease Progression|1|||
105425939|NCT01697462|363567138|FG000|Overall Study|Adverse Event|6|||
105425940|NCT01697462|363567138|FG000|Overall Study|Lost to Follow-up|21|||
105425941|NCT01697462|363567138|FG000|Overall Study|Withdrawal by Subject|12|||
105425942|NCT01697462|363567138|FG000|Overall Study|Investigator Decision|21|||
105425943|NCT01697462|363567138|FG000|Overall Study|Death|1|||
105587880|NCT01941316|364153022|FG003|Overall Study|Protocol Violation|3|||
105587881|NCT01941316|364153019|FG000|Overall Study|Intercurrent illness|0|||
105587882|NCT01941316|364153020|FG001|Overall Study|Intercurrent illness|0|||
105587883|NCT01941316|364153021|FG002|Overall Study|Intercurrent illness|0|||
105587884|NCT01941316|364153022|FG003|Overall Study|Intercurrent illness|1|||
105587885|NCT01941316|364153019|FG000|Overall Study|Other, not specified|0|||
105587886|NCT01941316|364153020|FG001|Overall Study|Other, not specified|0|||
105587887|NCT01941316|364153021|FG002|Overall Study|Other, not specified|0|||
105587888|NCT01941316|364153022|FG003|Overall Study|Other, not specified|1|||
105587889|NCT00320489|364153023|FG000|Overall Study|Adverse Event|26|||
105425944|NCT01697462|363567138|FG000|Overall Study|Other|10|||
105425945|NCT01697462|363567138|FG000|Overall Study|Missing|5|||
105425946|NCT01371643|363567143|FG000|Overall Study|Withdrawal by Subject|3|||
105425947|NCT01371643|363567144|FG001|Overall Study|Withdrawal by Subject|0|||
105587890|NCT00320489|364153024|FG001|Overall Study|Adverse Event|25|||
105587891|NCT00320489|364153023|FG000|Overall Study|Clinical Relapse|26|||
105587892|NCT00320489|364153024|FG001|Overall Study|Clinical Relapse|20|||
105587893|NCT00320489|364153023|FG000|Overall Study|Death|0|||
105425948|NCT00168103|363567145|FG000|Overall Study|Withdrawal by Subject|1|||
105425949|NCT00168103|363567146|FG001|Overall Study|Withdrawal by Subject|2|||
105587894|NCT00320489|364153024|FG001|Overall Study|Death|2|||
105587895|NCT00320489|364153023|FG000|Overall Study|Entry Criteria Exclusion|2|||
105587896|NCT00320489|364153024|FG001|Overall Study|Entry Criteria Exclusion|4|||
105587897|NCT00320489|364153023|FG000|Overall Study|Lack of Efficacy|16|||
105587898|NCT00320489|364153024|FG001|Overall Study|Lack of Efficacy|7|||
105587899|NCT00320489|364153023|FG000|Overall Study|Lost to Follow-up|21|||
105587900|NCT00320489|364153024|FG001|Overall Study|Lost to Follow-up|22|||
105587901|NCT00320489|364153023|FG000|Overall Study|Physician Decision|8|||
105587902|NCT00320489|364153024|FG001|Overall Study|Physician Decision|8|||
105587903|NCT00320489|364153023|FG000|Overall Study|Protocol Violation|4|||
105587904|NCT00320489|364153024|FG001|Overall Study|Protocol Violation|4|||
105587905|NCT00320489|364153023|FG000|Overall Study|Sponsor Decision|3|||
105587906|NCT00320489|364153024|FG001|Overall Study|Sponsor Decision|3|||
105587907|NCT00320489|364153023|FG000|Overall Study|Withdrawal by Subject|39|||
105587908|NCT00320489|364153024|FG001|Overall Study|Withdrawal by Subject|41|||
105587909|NCT02282527|364153025|FG000|Overall Study|Lost to Follow-up|0|||
105587910|NCT02282527|364153026|FG001|Overall Study|Lost to Follow-up|1|||
105587911|NCT02282527|364153025|FG000|Overall Study|Lack of home health aid|1|||
105587912|NCT02282527|364153026|FG001|Overall Study|Lack of home health aid|0|||
105587913|NCT00941031|364153027|FG000|Induction Period|Lack of Efficacy|2|||
105587914|NCT00941031|364153028|FG001|Induction Period|Lack of Efficacy|1|||
105587915|NCT00941031|364153029|FG002|Induction Period|Lack of Efficacy|0|||
105587916|NCT00941031|364153030|FG003|Induction Period|Lack of Efficacy|5|||
105587917|NCT00941031|364153031|FG004|Induction Period|Lack of Efficacy|0|||
105587918|NCT00941031|364153032|FG005|Induction Period|Lack of Efficacy|0|||
105587919|NCT00941031|364153033|FG006|Induction Period|Lack of Efficacy|0|||
105587920|NCT00941031|364153027|FG000|Induction Period|Withdrawal by Subject|1|||
105587921|NCT00941031|364153028|FG001|Induction Period|Withdrawal by Subject|2|||
105587922|NCT00941031|364153029|FG002|Induction Period|Withdrawal by Subject|2|||
105587923|NCT00941031|364153030|FG003|Induction Period|Withdrawal by Subject|2|||
105587924|NCT00941031|364153031|FG004|Induction Period|Withdrawal by Subject|0|||
105587925|NCT00941031|364153032|FG005|Induction Period|Withdrawal by Subject|0|||
105587926|NCT00941031|364153033|FG006|Induction Period|Withdrawal by Subject|0|||
105587927|NCT00941031|364153027|FG000|Induction Period|Adminstative Problems|1|||
105587928|NCT00941031|364153028|FG001|Induction Period|Adminstative Problems|1|||
105587929|NCT00941031|364153029|FG002|Induction Period|Adminstative Problems|1|||
105587930|NCT00941031|364153030|FG003|Induction Period|Adminstative Problems|0|||
105587931|NCT00941031|364153031|FG004|Induction Period|Adminstative Problems|0|||
105587932|NCT00941031|364153032|FG005|Induction Period|Adminstative Problems|0|||
105587933|NCT00941031|364153033|FG006|Induction Period|Adminstative Problems|0|||
105587934|NCT00941031|364153027|FG000|Induction Period|Adverse Event|1|||
105587935|NCT00941031|364153028|FG001|Induction Period|Adverse Event|0|||
105587936|NCT00941031|364153029|FG002|Induction Period|Adverse Event|3|||
105587937|NCT00941031|364153030|FG003|Induction Period|Adverse Event|2|||
105587938|NCT00941031|364153031|FG004|Induction Period|Adverse Event|0|||
105587939|NCT00941031|364153032|FG005|Induction Period|Adverse Event|0|||
105587940|NCT00941031|364153033|FG006|Induction Period|Adverse Event|0|||
105587941|NCT00941031|364153027|FG000|Maintenance Period|Withdrawal by Subject|0|||
105587942|NCT00941031|364153028|FG001|Maintenance Period|Withdrawal by Subject|0|||
105587943|NCT00941031|364153029|FG002|Maintenance Period|Withdrawal by Subject|0|||
105587944|NCT00941031|364153030|FG003|Maintenance Period|Withdrawal by Subject|0|||
105587945|NCT00941031|364153031|FG004|Maintenance Period|Withdrawal by Subject|6|||
105587946|NCT00941031|364153032|FG005|Maintenance Period|Withdrawal by Subject|2|||
105587947|NCT00941031|364153033|FG006|Maintenance Period|Withdrawal by Subject|13|||
105587948|NCT00941031|364153027|FG000|Maintenance Period|Administrative Problems|0|||
105587949|NCT00941031|364153028|FG001|Maintenance Period|Administrative Problems|0|||
105587950|NCT00941031|364153029|FG002|Maintenance Period|Administrative Problems|0|||
105587951|NCT00941031|364153030|FG003|Maintenance Period|Administrative Problems|0|||
105587952|NCT00941031|364153031|FG004|Maintenance Period|Administrative Problems|1|||
105587953|NCT00941031|364153032|FG005|Maintenance Period|Administrative Problems|0|||
105587954|NCT00941031|364153033|FG006|Maintenance Period|Administrative Problems|1|||
105587955|NCT00941031|364153027|FG000|Maintenance Period|Protocol Violation|0|||
105587956|NCT00941031|364153028|FG001|Maintenance Period|Protocol Violation|0|||
105587957|NCT00941031|364153029|FG002|Maintenance Period|Protocol Violation|0|||
105587958|NCT00941031|364153030|FG003|Maintenance Period|Protocol Violation|0|||
105587959|NCT00941031|364153031|FG004|Maintenance Period|Protocol Violation|0|||
105587960|NCT00941031|364153032|FG005|Maintenance Period|Protocol Violation|0|||
105587961|NCT00941031|364153033|FG006|Maintenance Period|Protocol Violation|1|||
105587962|NCT00941031|364153027|FG000|Maintenance Period|Adverse Event|0|||
105587963|NCT00941031|364153028|FG001|Maintenance Period|Adverse Event|0|||
105587964|NCT00941031|364153029|FG002|Maintenance Period|Adverse Event|0|||
105587965|NCT00941031|364153030|FG003|Maintenance Period|Adverse Event|0|||
105587966|NCT00941031|364153031|FG004|Maintenance Period|Adverse Event|0|||
105587967|NCT00941031|364153032|FG005|Maintenance Period|Adverse Event|2|||
105587968|NCT00941031|364153033|FG006|Maintenance Period|Adverse Event|8|||
105587969|NCT00941031|364153027|FG000|Maintenance Period|Lost to Follow-up|0|||
105587970|NCT00941031|364153028|FG001|Maintenance Period|Lost to Follow-up|0|||
105587971|NCT00941031|364153029|FG002|Maintenance Period|Lost to Follow-up|0|||
105587972|NCT00941031|364153030|FG003|Maintenance Period|Lost to Follow-up|0|||
105587973|NCT00941031|364153031|FG004|Maintenance Period|Lost to Follow-up|2|||
105587974|NCT00941031|364153032|FG005|Maintenance Period|Lost to Follow-up|2|||
105587975|NCT00941031|364153033|FG006|Maintenance Period|Lost to Follow-up|7|||
105587976|NCT00941031|364153027|FG000|Maintenance Period|Lack of Efficacy|0|||
105587977|NCT00941031|364153028|FG001|Maintenance Period|Lack of Efficacy|0|||
105425950|NCT00168103|363567147|FG002|Overall Study|Withdrawal by Subject|1|||
105425951|NCT00168103|363567148|FG003|Overall Study|Withdrawal by Subject|0|||
105587978|NCT00941031|364153029|FG002|Maintenance Period|Lack of Efficacy|0|||
105587979|NCT00941031|364153030|FG003|Maintenance Period|Lack of Efficacy|0|||
105587980|NCT00941031|364153031|FG004|Maintenance Period|Lack of Efficacy|0|||
105587981|NCT00941031|364153032|FG005|Maintenance Period|Lack of Efficacy|0|||
105587982|NCT00941031|364153033|FG006|Maintenance Period|Lack of Efficacy|13|||
105587983|NCT04555044|364153034|FG000|Overall Study|Adverse Event|0|||
105587984|NCT04555044|364153035|FG001|Overall Study|Adverse Event|1|||
105587985|NCT02107014|364153038|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
105587986|NCT03761784|364153040|FG000|Overall Study|Adverse Event|4|||
105587987|NCT03761784|364153041|FG001|Overall Study|Adverse Event|0|||
105587988|NCT03761784|364153040|FG000|Overall Study|Lost to Follow-up|10|||
105587989|NCT03761784|364153041|FG001|Overall Study|Lost to Follow-up|7|||
105587990|NCT03761784|364153040|FG000|Overall Study|Pregnancy|1|||
105587991|NCT03761784|364153041|FG001|Overall Study|Pregnancy|0|||
105587992|NCT03761784|364153040|FG000|Overall Study|Protocol Violation|2|||
105587993|NCT03761784|364153041|FG001|Overall Study|Protocol Violation|0|||
105587994|NCT03761784|364153040|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
105587995|NCT03761784|364153041|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
105587996|NCT03761784|364153040|FG000|Overall Study|Withdrawal by Subject|9|||
105587997|NCT03761784|364153041|FG001|Overall Study|Withdrawal by Subject|4|||
105587998|NCT03761784|364153040|FG000|Overall Study|Physician Decision|1|||
105587999|NCT03761784|364153041|FG001|Overall Study|Physician Decision|0|||
105588000|NCT03761784|364153040|FG000|Overall Study|Other Than Specified|1|||
105588001|NCT03761784|364153041|FG001|Overall Study|Other Than Specified|0|||
105588002|NCT05487703|364153045|FG000|Overall Study|Other|19|||
105588003|NCT05487703|364153045|FG000|Overall Study|Participant not well|5|||
105588004|NCT05487703|364153045|FG000|Overall Study|Insurance Reasons|6|||
105588005|NCT05487703|364153045|FG000|Overall Study|Physician Decision|19|||
105588006|NCT05487703|364153045|FG000|Overall Study|Lack of Efficacy|60|||
105425952|NCT00168103|363567145|FG000|Overall Study|Lost to Follow-up|1|||
105425953|NCT00168103|363567146|FG001|Overall Study|Lost to Follow-up|3|||
105425954|NCT00168103|363567147|FG002|Overall Study|Lost to Follow-up|0|||
105425955|NCT00168103|363567148|FG003|Overall Study|Lost to Follow-up|0|||
105425956|NCT00989235|363567149|FG000|Overall Study|Death|0|||
105425957|NCT00989235|363567150|FG001|Overall Study|Death|1|||
105425958|NCT00989235|363567149|FG000|Overall Study|Adverse Event|0|||
105425959|NCT00989235|363567150|FG001|Overall Study|Adverse Event|1|||
105425960|NCT00989235|363567149|FG000|Overall Study|Lack of Efficacy|1|||
105425961|NCT00989235|363567150|FG001|Overall Study|Lack of Efficacy|0|||
105425962|NCT00989235|363567149|FG000|Overall Study|Withdrawal of Consent|1|||
105425963|NCT00989235|363567150|FG001|Overall Study|Withdrawal of Consent|1|||
105425964|NCT00989235|363567149|FG000|Overall Study|Desire to Become Pregnant|1|||
105425965|NCT00989235|363567150|FG001|Overall Study|Desire to Become Pregnant|0|||
105425966|NCT00989235|363567149|FG000|Overall Study|Randomized by Mistake|0|||
105425967|NCT00989235|363567150|FG001|Overall Study|Randomized by Mistake|2|||
105425968|NCT00989235|363567149|FG000|Overall Study|Lost to Follow-up|0|||
105425969|NCT00989235|363567150|FG001|Overall Study|Lost to Follow-up|1|||
105425970|NCT03249935|363567151|FG000|Overall Study|Discharged from facility early|36|||
105425971|NCT03249935|363567151|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
105425972|NCT03249935|363567151|FG000|Overall Study|Protocol Violation|5|||
105425973|NCT03593681|363567152|FG000|Overall Study|Inadequate sample collected|12|||
105588007|NCT03852433|364153046|FG000|Overall Study|Withdrawal of consent|5|||
105588008|NCT03852433|364153047|FG001|Overall Study|Withdrawal of consent|8|||
105588009|NCT03852433|364153048|FG002|Overall Study|Withdrawal of consent|1|||
105425974|NCT03593681|363567152|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
105588010|NCT03852433|364153049|FG003|Overall Study|Withdrawal of consent|1|||
105588011|NCT03852433|364153046|FG000|Overall Study|Adverse Event|1|||
105588012|NCT03852433|364153047|FG001|Overall Study|Adverse Event|1|||
105588013|NCT03852433|364153048|FG002|Overall Study|Adverse Event|1|||
105588014|NCT03852433|364153049|FG003|Overall Study|Adverse Event|1|||
105425975|NCT03593681|363567152|FG000|Overall Study|Protocol Violation|3|||
105425976|NCT03593681|363567152|FG000|Overall Study|Withdrawal by Subject|3|||
105425977|NCT03593681|363567152|FG000|Overall Study|Procedure not attempted|3|||
105425978|NCT03593681|363567152|FG000|Overall Study|Adverse Event|2|||
105425979|NCT03593681|363567152|FG000|Overall Study|Physician Decision|1|||
105425980|NCT02214225|363567153|FG000|Overall Study|Lost to Follow-up|46|||
105425981|NCT02214225|363567154|FG001|Overall Study|Lost to Follow-up|18|||
105425982|NCT02214225|363567155|FG002|Overall Study|Lost to Follow-up|18|||
105425983|NCT02214225|363567153|FG000|Overall Study|Withdrawal by Subject|2|||
105425984|NCT02214225|363567154|FG001|Overall Study|Withdrawal by Subject|0|||
105425985|NCT02214225|363567155|FG002|Overall Study|Withdrawal by Subject|2|||
105425986|NCT02214225|363567153|FG000|Overall Study|Death|5|||
105425987|NCT02214225|363567154|FG001|Overall Study|Death|0|||
105425988|NCT02214225|363567155|FG002|Overall Study|Death|1|||
105425989|NCT02214225|363567153|FG000|Overall Study|randomized in error, not vaccinated|2|||
105425990|NCT02214225|363567154|FG001|Overall Study|randomized in error, not vaccinated|1|||
105425991|NCT02214225|363567155|FG002|Overall Study|randomized in error, not vaccinated|1|||
105425992|NCT00717522|363567156|FG000|Overall Study|Disease Progression|5|||
105425993|NCT00717522|363567156|FG000|Overall Study|Adverse Event|1|||
105425994|NCT00717522|363567156|FG000|Overall Study|Death|1|||
105425995|NCT01669421|363567157|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
105425996|NCT01669421|363567157|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
105425997|NCT01286987|363567158|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
105425998|NCT01286987|363567159|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
105425999|NCT01286987|363567160|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
105426000|NCT01286987|363567161|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
105426001|NCT01286987|363567162|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
105426002|NCT01286987|363567163|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
105426003|NCT01286987|363567164|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
105426004|NCT01286987|363567165|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
105426005|NCT01286987|363567166|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
105426006|NCT01286987|363567167|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
105426007|NCT01286987|363567168|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
105426008|NCT01286987|363567169|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
105426009|NCT01286987|363567170|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
105426010|NCT01286987|363567171|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
105426011|NCT01286987|363567172|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
105426012|NCT01286987|363567158|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
105426013|NCT01286987|363567159|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
105426014|NCT01286987|363567160|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
105426015|NCT01286987|363567161|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
105426016|NCT01286987|363567162|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
105426017|NCT01286987|363567163|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
105426018|NCT01286987|363567164|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
105426019|NCT01286987|363567165|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
105426020|NCT01286987|363567166|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
105426021|NCT01286987|363567167|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
105426022|NCT01286987|363567168|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
105426023|NCT01286987|363567169|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
105426024|NCT01286987|363567170|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
105426025|NCT01286987|363567171|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
105426026|NCT01286987|363567172|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
105426027|NCT01286987|363567158|FG000|Part 1: Dose Escalation|Physician Decision|0|||
105426028|NCT01286987|363567159|FG001|Part 1: Dose Escalation|Physician Decision|0|||
105426029|NCT01286987|363567160|FG002|Part 1: Dose Escalation|Physician Decision|0|||
105426030|NCT01286987|363567161|FG003|Part 1: Dose Escalation|Physician Decision|0|||
105426031|NCT01286987|363567162|FG004|Part 1: Dose Escalation|Physician Decision|1|||
105426032|NCT01286987|363567163|FG005|Part 1: Dose Escalation|Physician Decision|0|||
105426033|NCT01286987|363567164|FG006|Part 1: Dose Escalation|Physician Decision|0|||
105426034|NCT01286987|363567165|FG007|Part 1: Dose Escalation|Physician Decision|0|||
105426035|NCT01286987|363567166|FG008|Part 1: Dose Escalation|Physician Decision|0|||
105426036|NCT01286987|363567167|FG009|Part 1: Dose Escalation|Physician Decision|0|||
105426037|NCT01286987|363567168|FG010|Part 1: Dose Escalation|Physician Decision|0|||
105426038|NCT01286987|363567169|FG011|Part 1: Dose Escalation|Physician Decision|0|||
105588015|NCT03852433|364153046|FG000|Overall Study|Lost to Follow-up|0|||
105426039|NCT01286987|363567170|FG012|Part 1: Dose Escalation|Physician Decision|0|||
105426040|NCT01286987|363567171|FG013|Part 1: Dose Escalation|Physician Decision|0|||
105426041|NCT01286987|363567172|FG014|Part 1: Dose Escalation|Physician Decision|0|||
105426042|NCT01286987|363567158|FG000|Part 2: Dose Expansion|Death|0|||
105426043|NCT01286987|363567159|FG001|Part 2: Dose Expansion|Death|0|||
105426044|NCT01286987|363567160|FG002|Part 2: Dose Expansion|Death|0|||
105426045|NCT01286987|363567161|FG003|Part 2: Dose Expansion|Death|0|||
105588016|NCT03852433|364153047|FG001|Overall Study|Lost to Follow-up|1|||
105426046|NCT01286987|363567162|FG004|Part 2: Dose Expansion|Death|0|||
105426047|NCT01286987|363567163|FG005|Part 2: Dose Expansion|Death|0|||
105426048|NCT01286987|363567164|FG006|Part 2: Dose Expansion|Death|0|||
105426049|NCT01286987|363567165|FG007|Part 2: Dose Expansion|Death|0|||
105426050|NCT01286987|363567166|FG008|Part 2: Dose Expansion|Death|0|||
105426051|NCT01286987|363567167|FG009|Part 2: Dose Expansion|Death|0|||
105426052|NCT01286987|363567168|FG010|Part 2: Dose Expansion|Death|0|||
105426053|NCT01286987|363567169|FG011|Part 2: Dose Expansion|Death|0|||
105426054|NCT01286987|363567170|FG012|Part 2: Dose Expansion|Death|1|||
105426055|NCT01286987|363567171|FG013|Part 2: Dose Expansion|Death|1|||
105426056|NCT01286987|363567172|FG014|Part 2: Dose Expansion|Death|0|||
105426057|NCT01286987|363567158|FG000|Part 2: Dose Expansion|Physician Decision|0|||
105426058|NCT01286987|363567159|FG001|Part 2: Dose Expansion|Physician Decision|0|||
105426059|NCT01286987|363567160|FG002|Part 2: Dose Expansion|Physician Decision|0|||
105426060|NCT01286987|363567161|FG003|Part 2: Dose Expansion|Physician Decision|0|||
105426061|NCT01286987|363567162|FG004|Part 2: Dose Expansion|Physician Decision|0|||
105426062|NCT01286987|363567163|FG005|Part 2: Dose Expansion|Physician Decision|0|||
105426063|NCT01286987|363567164|FG006|Part 2: Dose Expansion|Physician Decision|0|||
105426064|NCT01286987|363567165|FG007|Part 2: Dose Expansion|Physician Decision|0|||
105426065|NCT01286987|363567166|FG008|Part 2: Dose Expansion|Physician Decision|0|||
105426066|NCT01286987|363567167|FG009|Part 2: Dose Expansion|Physician Decision|0|||
105426067|NCT01286987|363567168|FG010|Part 2: Dose Expansion|Physician Decision|1|||
105426068|NCT01286987|363567169|FG011|Part 2: Dose Expansion|Physician Decision|1|||
105426069|NCT01286987|363567170|FG012|Part 2: Dose Expansion|Physician Decision|0|||
105426070|NCT01286987|363567171|FG013|Part 2: Dose Expansion|Physician Decision|1|||
105426071|NCT01286987|363567172|FG014|Part 2: Dose Expansion|Physician Decision|0|||
105426072|NCT01286987|363567158|FG000|Part 2: Dose Expansion|Other|0|||
105426073|NCT01286987|363567159|FG001|Part 2: Dose Expansion|Other|0|||
105426074|NCT01286987|363567160|FG002|Part 2: Dose Expansion|Other|0|||
105426075|NCT01286987|363567161|FG003|Part 2: Dose Expansion|Other|0|||
105426076|NCT01286987|363567162|FG004|Part 2: Dose Expansion|Other|0|||
105426077|NCT01286987|363567163|FG005|Part 2: Dose Expansion|Other|0|||
105426078|NCT01286987|363567164|FG006|Part 2: Dose Expansion|Other|0|||
105426079|NCT01286987|363567165|FG007|Part 2: Dose Expansion|Other|0|||
105426080|NCT01286987|363567166|FG008|Part 2: Dose Expansion|Other|0|||
105426081|NCT01286987|363567167|FG009|Part 2: Dose Expansion|Other|0|||
105426082|NCT01286987|363567168|FG010|Part 2: Dose Expansion|Other|0|||
105426083|NCT01286987|363567169|FG011|Part 2: Dose Expansion|Other|0|||
105426084|NCT01286987|363567170|FG012|Part 2: Dose Expansion|Other|0|||
105426085|NCT01286987|363567171|FG013|Part 2: Dose Expansion|Other|1|||
105426086|NCT01286987|363567172|FG014|Part 2: Dose Expansion|Other|0|||
105426087|NCT01286987|363567158|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
105426088|NCT01286987|363567159|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
105426089|NCT01286987|363567160|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
105426090|NCT01286987|363567161|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
105426091|NCT01286987|363567162|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
105426092|NCT01286987|363567163|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
105426093|NCT01286987|363567164|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
105426094|NCT01286987|363567165|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
105426095|NCT01286987|363567166|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
105426096|NCT01286987|363567167|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
105426097|NCT01286987|363567168|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
105426098|NCT01286987|363567169|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
105426099|NCT01286987|363567170|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
105426100|NCT01286987|363567171|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
105426101|NCT01286987|363567172|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
105426102|NCT01286987|363567158|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
105426103|NCT01286987|363567159|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
105426104|NCT01286987|363567160|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
105426105|NCT01286987|363567161|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
105426106|NCT01286987|363567162|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
105426107|NCT01286987|363567163|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
105426108|NCT01286987|363567164|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
105426109|NCT01286987|363567165|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
105426110|NCT01286987|363567166|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
105426111|NCT01286987|363567167|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
105426112|NCT01286987|363567168|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
105426113|NCT01286987|363567169|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
105426114|NCT01286987|363567170|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
105426115|NCT01286987|363567171|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
105426116|NCT01286987|363567172|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
105426117|NCT01286987|363567158|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105426118|NCT01286987|363567159|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105426119|NCT01286987|363567160|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105588017|NCT03852433|364153048|FG002|Overall Study|Lost to Follow-up|0|||
105426120|NCT01286987|363567161|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105426121|NCT01286987|363567162|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105426122|NCT01286987|363567163|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105426123|NCT01286987|363567164|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105426124|NCT01286987|363567165|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105426125|NCT01286987|363567166|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105426126|NCT01286987|363567167|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105426127|NCT01286987|363567168|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
105426128|NCT01286987|363567169|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105426129|NCT01286987|363567170|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105426130|NCT01286987|363567171|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105426131|NCT01286987|363567172|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105426132|NCT04662073|363567179|FG000|Overall Study|Withdrawal by Subject|1|||
105426133|NCT04662073|363567180|FG001|Overall Study|Withdrawal by Subject|0|||
105426134|NCT02370641|363567183|FG000|Overall Study|dropped study|4|||
105426135|NCT02370641|363567184|FG001|Overall Study|dropped study|2|||
105426136|NCT02699450|363567189|FG000|Overall Study|Death|2|||
105426137|NCT02699450|363567190|FG001|Overall Study|Death|1|||
105426138|NCT02699450|363567191|FG002|Overall Study|Death|2|||
105426139|NCT02699450|363567189|FG000|Overall Study|Met Criteria for Study Exit|0|||
105426140|NCT02699450|363567190|FG001|Overall Study|Met Criteria for Study Exit|0|||
105426141|NCT02699450|363567191|FG002|Overall Study|Met Criteria for Study Exit|1|||
105426142|NCT02699450|363567189|FG000|Overall Study|Protocol Violation|4|||
105426143|NCT02699450|363567190|FG001|Overall Study|Protocol Violation|3|||
105426144|NCT02699450|363567191|FG002|Overall Study|Protocol Violation|5|||
105426145|NCT02699450|363567189|FG000|Overall Study|Lost to Follow-up|3|||
105426146|NCT02699450|363567190|FG001|Overall Study|Lost to Follow-up|0|||
105426147|NCT02699450|363567191|FG002|Overall Study|Lost to Follow-up|5|||
105426148|NCT02699450|363567189|FG000|Overall Study|Physician Decision|2|||
105426149|NCT02699450|363567190|FG001|Overall Study|Physician Decision|0|||
105426150|NCT02699450|363567191|FG002|Overall Study|Physician Decision|0|||
105426151|NCT02699450|363567189|FG000|Overall Study|Withdrawal by Subject|3|||
105426152|NCT02699450|363567190|FG001|Overall Study|Withdrawal by Subject|1|||
105426153|NCT02699450|363567191|FG002|Overall Study|Withdrawal by Subject|2|||
105426154|NCT02699450|363567189|FG000|Overall Study|Adverse Event|1|||
105426155|NCT02699450|363567190|FG001|Overall Study|Adverse Event|0|||
105426156|NCT02699450|363567191|FG002|Overall Study|Adverse Event|0|||
105426157|NCT02410824|363567192|FG000|First Intervention (One Week)|Headache|0|||
105426158|NCT02410824|363567193|FG001|First Intervention (One Week)|Headache|1|||
105426159|NCT02782325|363567194|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
105426160|NCT02782325|363567195|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
105426161|NCT02782325|363567196|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
105426162|NCT02782325|363567194|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
105426163|NCT02782325|363567195|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
105426164|NCT02782325|363567196|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
105426165|NCT01816906|363567197|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
105426166|NCT01816906|363567198|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
105426167|NCT01816906|363567197|FG000|Six Months|Lost to Follow-up|14|||
105426168|NCT01816906|363567198|FG001|Six Months|Lost to Follow-up|16|||
105426169|NCT01816906|363567197|FG000|12 Months|Adverse Event|2|||
105426170|NCT01816906|363567198|FG001|12 Months|Adverse Event|2|||
105426171|NCT01816906|363567197|FG000|12 Months|Death|0|||
105426172|NCT01816906|363567198|FG001|12 Months|Death|2|||
105426173|NCT01816906|363567197|FG000|12 Months|Lost to Follow-up|2|||
105426174|NCT01816906|363567198|FG001|12 Months|Lost to Follow-up|1|||
105426175|NCT00746733|363567199|FG000|Second Intervention|Adverse Event|1|||
105426176|NCT00746733|363567200|FG001|Second Intervention|Adverse Event|0|||
105426177|NCT00746733|363567199|FG000|Third Intervention|Withdrawal by Subject|1|||
105426178|NCT00746733|363567200|FG001|Third Intervention|Withdrawal by Subject|1|||
105426179|NCT00787137|363567205|FG000|Overall Study|Study Termination|0|||
105426180|NCT00787137|363567206|FG001|Overall Study|Study Termination|0|||
105426181|NCT00787137|363567207|FG002|Overall Study|Study Termination|1|||
105426182|NCT02395055|363567213|FG000|Overall Study|Withdrawal by Subject|7|||
105426183|NCT02395055|363567214|FG001|Overall Study|Withdrawal by Subject|3|||
105426184|NCT01628367|363567217|FG000|Overall Study|Adverse Event|1|||
105426185|NCT01628367|363567218|FG001|Overall Study|Adverse Event|0|||
105426186|NCT02513823|363567219|FG000|Overall Study|Lost to Follow-up|4|||
105426187|NCT02513823|363567219|FG000|Overall Study|Physician Decision|1|||
105426188|NCT00740714|363567220|FG000|Overall Study|Withdrawal by Subject|17|||
105426189|NCT00740714|363567221|FG001|Overall Study|Withdrawal by Subject|19|||
105426190|NCT00740714|363567222|FG002|Overall Study|Withdrawal by Subject|29|||
105426191|NCT02743780|363567223|FG000|Part 3 (7 Days)|Adverse Event|0|||
105426192|NCT02743780|363567224|FG001|Part 3 (7 Days)|Adverse Event|0|||
105426193|NCT02743780|363567225|FG002|Part 3 (7 Days)|Adverse Event|1|||
105501233|NCT00533897|363847067|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
105588018|NCT03852433|364153049|FG003|Overall Study|Lost to Follow-up|1|||
105588019|NCT03852433|364153046|FG000|Overall Study|Pregnancy|0|||
105588020|NCT03852433|364153047|FG001|Overall Study|Pregnancy|1|||
105588021|NCT03852433|364153048|FG002|Overall Study|Pregnancy|1|||
105588022|NCT03852433|364153049|FG003|Overall Study|Pregnancy|0|||
105588023|NCT03852433|364153046|FG000|Overall Study|Protocol Violation|0|||
105588024|NCT03852433|364153047|FG001|Overall Study|Protocol Violation|0|||
105588025|NCT03852433|364153048|FG002|Overall Study|Protocol Violation|1|||
105588026|NCT03852433|364153049|FG003|Overall Study|Protocol Violation|1|||
105588027|NCT03852433|364153046|FG000|Overall Study|Death|0|||
105588028|NCT03852433|364153047|FG001|Overall Study|Death|0|||
105588029|NCT03852433|364153048|FG002|Overall Study|Death|1|||
105426194|NCT02743780|363567226|FG003|Part 3 (7 Days)|Adverse Event|0|||
105426195|NCT02743780|363567227|FG004|Part 3 (7 Days)|Adverse Event|0|||
105426196|NCT00394901|363567228|FG000|Baseline Phase|Protocol Violation|0|||
105588030|NCT03852433|364153049|FG003|Overall Study|Death|0|||
105588031|NCT03852433|364153046|FG000|Overall Study|Lack of Efficacy|0|||
105588032|NCT03852433|364153047|FG001|Overall Study|Lack of Efficacy|1|||
105588033|NCT03852433|364153048|FG002|Overall Study|Lack of Efficacy|0|||
105588034|NCT03852433|364153049|FG003|Overall Study|Lack of Efficacy|0|||
105588035|NCT03852433|364153046|FG000|Overall Study|Non-compliance with study drug|0|||
105588036|NCT03852433|364153047|FG001|Overall Study|Non-compliance with study drug|0|||
105588037|NCT03852433|364153048|FG002|Overall Study|Non-compliance with study drug|0|||
105588038|NCT03852433|364153049|FG003|Overall Study|Non-compliance with study drug|1|||
105588039|NCT03852433|364153046|FG000|Overall Study|Physician Decision|1|||
105588040|NCT03852433|364153047|FG001|Overall Study|Physician Decision|0|||
105588041|NCT03852433|364153048|FG002|Overall Study|Physician Decision|0|||
105588042|NCT03852433|364153049|FG003|Overall Study|Physician Decision|0|||
105426197|NCT00394901|363567229|FG001|Baseline Phase|Protocol Violation|0|||
105426198|NCT00394901|363567230|FG002|Baseline Phase|Protocol Violation|1|||
105426199|NCT00394901|363567231|FG003|Baseline Phase|Protocol Violation|0|||
105426200|NCT00394901|363567228|FG000|Double-blind Phase|Adverse Event|5|||
105426201|NCT00394901|363567229|FG001|Double-blind Phase|Adverse Event|7|||
105426202|NCT00394901|363567230|FG002|Double-blind Phase|Adverse Event|16|||
105426203|NCT00394901|363567231|FG003|Double-blind Phase|Adverse Event|20|||
105426204|NCT00394901|363567228|FG000|Double-blind Phase|Lack of Efficacy|6|||
105426205|NCT00394901|363567229|FG001|Double-blind Phase|Lack of Efficacy|4|||
105426206|NCT00394901|363567230|FG002|Double-blind Phase|Lack of Efficacy|1|||
105426207|NCT00394901|363567231|FG003|Double-blind Phase|Lack of Efficacy|3|||
105426208|NCT00394901|363567228|FG000|Double-blind Phase|Withdrawal by Subject|2|||
105426209|NCT00394901|363567229|FG001|Double-blind Phase|Withdrawal by Subject|0|||
105426210|NCT00394901|363567230|FG002|Double-blind Phase|Withdrawal by Subject|0|||
105426211|NCT00394901|363567231|FG003|Double-blind Phase|Withdrawal by Subject|0|||
105426212|NCT00394901|363567228|FG000|Double-blind Phase|Lost to Follow-up|0|||
105426213|NCT00394901|363567229|FG001|Double-blind Phase|Lost to Follow-up|0|||
105426214|NCT00394901|363567230|FG002|Double-blind Phase|Lost to Follow-up|0|||
105426215|NCT00394901|363567231|FG003|Double-blind Phase|Lost to Follow-up|1|||
105426216|NCT00394901|363567228|FG000|Double-blind Phase|Protocol Violation|0|||
105426217|NCT00394901|363567229|FG001|Double-blind Phase|Protocol Violation|0|||
105426218|NCT00394901|363567230|FG002|Double-blind Phase|Protocol Violation|0|||
105426219|NCT00394901|363567231|FG003|Double-blind Phase|Protocol Violation|1|||
105426220|NCT00394901|363567228|FG000|Double-blind Phase|Death|1|||
105426221|NCT00394901|363567229|FG001|Double-blind Phase|Death|0|||
105588043|NCT03852433|364153046|FG000|Overall Study|Randomized but never treated|1|||
105588044|NCT03852433|364153047|FG001|Overall Study|Randomized but never treated|0|||
105588045|NCT03852433|364153048|FG002|Overall Study|Randomized but never treated|0|||
105588046|NCT03852433|364153049|FG003|Overall Study|Randomized but never treated|0|||
105588047|NCT02616263|364153050|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
105588048|NCT02616263|364153051|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
105588049|NCT02616263|364153050|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
105588050|NCT02616263|364153051|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
105588051|NCT02616263|364153050|FG000|6 Month to 1.5 Year|Death|1|||
105426222|NCT00394901|363567230|FG002|Double-blind Phase|Death|0|||
105426223|NCT00394901|363567231|FG003|Double-blind Phase|Death|0|||
105426224|NCT00394901|363567228|FG000|Double-blind Phase|Subject's Personal Reason|1|||
105426225|NCT00394901|363567229|FG001|Double-blind Phase|Subject's Personal Reason|0|||
105426226|NCT00394901|363567230|FG002|Double-blind Phase|Subject's Personal Reason|0|||
105426227|NCT00394901|363567231|FG003|Double-blind Phase|Subject's Personal Reason|1|||
105426228|NCT00394901|363567228|FG000|Double-blind Phase|Lack of Compliance|0|||
105426229|NCT00394901|363567229|FG001|Double-blind Phase|Lack of Compliance|3|||
105588052|NCT02616263|364153051|FG001|6 Month to 1.5 Year|Death|0|||
105426230|NCT00394901|363567230|FG002|Double-blind Phase|Lack of Compliance|0|||
105426231|NCT00394901|363567231|FG003|Double-blind Phase|Lack of Compliance|0|||
105588053|NCT02616263|364153050|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
105588054|NCT02616263|364153051|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
105588055|NCT02616263|364153050|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
105588056|NCT02616263|364153051|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
105588057|NCT02616263|364153050|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
105588058|NCT02616263|364153051|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
105588059|NCT03168438|364153052|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
105588060|NCT03168438|364153053|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
105588061|NCT02939183|364153056|FG000|Overall Study|Death|0|||
105588062|NCT02939183|364153057|FG001|Overall Study|Death|0|||
105588063|NCT02939183|364153058|FG002|Overall Study|Death|1|||
105588064|NCT02939183|364153059|FG003|Overall Study|Death|0|||
105588065|NCT02939183|364153060|FG004|Overall Study|Death|0|||
105588066|NCT02939183|364153061|FG005|Overall Study|Death|2|||
105588067|NCT02939183|364153062|FG006|Overall Study|Death|1|||
105588068|NCT02939183|364153063|FG007|Overall Study|Death|0|||
105588069|NCT02939183|364153064|FG008|Overall Study|Death|0|||
105588070|NCT02939183|364153056|FG000|Overall Study|Sponsor decision|0|||
105426232|NCT00394901|363567228|FG000|Double-blind Phase|Entry into another study was found|0|||
105426233|NCT00394901|363567229|FG001|Double-blind Phase|Entry into another study was found|0|||
105426234|NCT00394901|363567230|FG002|Double-blind Phase|Entry into another study was found|1|||
105426235|NCT00394901|363567231|FG003|Double-blind Phase|Entry into another study was found|0|||
105426236|NCT00394901|363567228|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
105588071|NCT02939183|364153057|FG001|Overall Study|Sponsor decision|1|||
105588072|NCT02939183|364153058|FG002|Overall Study|Sponsor decision|0|||
105588073|NCT02939183|364153059|FG003|Overall Study|Sponsor decision|1|||
105588074|NCT02939183|364153060|FG004|Overall Study|Sponsor decision|2|||
105588075|NCT02939183|364153061|FG005|Overall Study|Sponsor decision|0|||
105588076|NCT02939183|364153062|FG006|Overall Study|Sponsor decision|3|||
105588077|NCT02939183|364153063|FG007|Overall Study|Sponsor decision|1|||
105588078|NCT02939183|364153064|FG008|Overall Study|Sponsor decision|4|||
105588079|NCT02939183|364153056|FG000|Overall Study|Withdrawal by Subject|0|||
105588080|NCT02939183|364153057|FG001|Overall Study|Withdrawal by Subject|2|||
105588081|NCT02939183|364153058|FG002|Overall Study|Withdrawal by Subject|0|||
105588082|NCT02939183|364153059|FG003|Overall Study|Withdrawal by Subject|1|||
105588083|NCT02939183|364153060|FG004|Overall Study|Withdrawal by Subject|0|||
105588084|NCT02939183|364153061|FG005|Overall Study|Withdrawal by Subject|0|||
105588085|NCT02939183|364153062|FG006|Overall Study|Withdrawal by Subject|2|||
105588086|NCT02939183|364153063|FG007|Overall Study|Withdrawal by Subject|2|||
105588087|NCT02939183|364153064|FG008|Overall Study|Withdrawal by Subject|2|||
105588088|NCT02939183|364153056|FG000|Overall Study|Not treated due to adverse event|0|||
105588089|NCT02939183|364153057|FG001|Overall Study|Not treated due to adverse event|0|||
105588090|NCT02939183|364153058|FG002|Overall Study|Not treated due to adverse event|0|||
105588091|NCT02939183|364153059|FG003|Overall Study|Not treated due to adverse event|1|||
105588092|NCT02939183|364153060|FG004|Overall Study|Not treated due to adverse event|0|||
105588093|NCT02939183|364153061|FG005|Overall Study|Not treated due to adverse event|0|||
105588094|NCT02939183|364153062|FG006|Overall Study|Not treated due to adverse event|1|||
105588095|NCT02939183|364153063|FG007|Overall Study|Not treated due to adverse event|0|||
105588096|NCT02939183|364153064|FG008|Overall Study|Not treated due to adverse event|0|||
105588097|NCT03396913|364153073|FG000|Overall Study|Lost to Follow-up|0|||
105588098|NCT03396913|364153074|FG001|Overall Study|Lost to Follow-up|6|||
105588099|NCT01007149|364153076|FG000|Overall Study|Administrative problems|0|||
105588100|NCT01007149|364153077|FG001|Overall Study|Administrative problems|1|||
105588101|NCT01348087|364153078|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
105588102|NCT01348087|364153078|FG000|Overall Study|Administrative problems|79|||
105588103|NCT01348087|364153078|FG000|Overall Study|protocol deviation|1|||
105588104|NCT01348087|364153078|FG000|Overall Study|Lost to Follow-up|1|||
105588105|NCT01348087|364153078|FG000|Overall Study|Subject withdrew consent|7|||
105588106|NCT01348087|364153078|FG000|Overall Study|Adverse Event|25|||
105588107|NCT00462943|364153079|FG000|Overall Study|Failure to achieve a response|5|||
105588108|NCT00462943|364153080|FG001|Overall Study|Failure to achieve a response|5|||
105426237|NCT00394901|363567229|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
105426238|NCT00394901|363567230|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
105588109|NCT00462943|364153081|FG002|Overall Study|Failure to achieve a response|1|||
105588110|NCT00462943|364153079|FG000|Overall Study|Adverse Event|6|||
105588111|NCT00462943|364153080|FG001|Overall Study|Adverse Event|4|||
105588112|NCT00462943|364153081|FG002|Overall Study|Adverse Event|1|||
105588113|NCT00462943|364153079|FG000|Overall Study|Protocol Violation|1|||
105588114|NCT00462943|364153080|FG001|Overall Study|Protocol Violation|0|||
105588115|NCT00462943|364153081|FG002|Overall Study|Protocol Violation|0|||
105588116|NCT00462943|364153079|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
105588117|NCT00462943|364153080|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
105588118|NCT00462943|364153081|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
105588119|NCT00462943|364153079|FG000|Overall Study|Disease Progression|15|||
105588120|NCT00462943|364153080|FG001|Overall Study|Disease Progression|15|||
105588121|NCT00462943|364153081|FG002|Overall Study|Disease Progression|9|||
105588122|NCT00462943|364153079|FG000|Overall Study|Death|5|||
105588123|NCT00462943|364153080|FG001|Overall Study|Death|2|||
105588124|NCT00462943|364153081|FG002|Overall Study|Death|7|||
105588125|NCT00462943|364153079|FG000|Overall Study|Stem Cell Transplant|1|||
105588126|NCT00462943|364153080|FG001|Overall Study|Stem Cell Transplant|1|||
105588127|NCT00462943|364153081|FG002|Overall Study|Stem Cell Transplant|0|||
105588128|NCT00462943|364153079|FG000|Overall Study|Bone Marrow Transplant|1|||
105588129|NCT00462943|364153080|FG001|Overall Study|Bone Marrow Transplant|0|||
105588130|NCT00462943|364153081|FG002|Overall Study|Bone Marrow Transplant|0|||
105588131|NCT00462943|364153079|FG000|Overall Study|Required Lymphocyte Infusion|1|||
105588132|NCT00462943|364153080|FG001|Overall Study|Required Lymphocyte Infusion|0|||
105588133|NCT00462943|364153081|FG002|Overall Study|Required Lymphocyte Infusion|0|||
105588134|NCT00462943|364153079|FG000|Overall Study|Transplant - not specified|1|||
105588135|NCT00462943|364153080|FG001|Overall Study|Transplant - not specified|0|||
105588136|NCT00462943|364153081|FG002|Overall Study|Transplant - not specified|1|||
105588137|NCT00462943|364153079|FG000|Overall Study|Physician Decision|1|||
105588138|NCT00462943|364153080|FG001|Overall Study|Physician Decision|0|||
105588139|NCT00462943|364153081|FG002|Overall Study|Physician Decision|0|||
105588140|NCT00462943|364153079|FG000|Overall Study|Withdrawal by Subject|0|||
105588141|NCT00462943|364153080|FG001|Overall Study|Withdrawal by Subject|1|||
105588142|NCT00462943|364153081|FG002|Overall Study|Withdrawal by Subject|0|||
105588143|NCT00768066|364153088|FG000|Overall Study|Did not receive study product injection.|3|||
105588144|NCT00768066|364153089|FG001|Overall Study|Did not receive study product injection.|3|||
105588145|NCT00768066|364153090|FG002|Overall Study|Did not receive study product injection.|0|||
105588146|NCT04831775|364153091|FG000|Overall Study|Lost to Follow-up|11|||
105588147|NCT04831775|364153092|FG001|Overall Study|Lost to Follow-up|13|||
105588148|NCT03369951|364153094|FG000|Overall Study|Withdrawal by Subject|3|||
105588149|NCT03369951|364153094|FG000|Overall Study|Death|1|||
105588150|NCT03369951|364153094|FG000|Overall Study|Lost to Follow-up|1|||
105588151|NCT03369951|364153094|FG000|Overall Study|Protocol Violation|1|||
105588152|NCT03499600|364153096|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
105588153|NCT03499600|364153097|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
105588154|NCT01729871|364153098|FG000|Overall Study|Adverse Event|7|||
105588155|NCT01729871|364153099|FG001|Overall Study|Adverse Event|7|||
105588156|NCT01729871|364153098|FG000|Overall Study|Death|0|||
105588157|NCT01729871|364153099|FG001|Overall Study|Death|1|||
105588158|NCT01729871|364153098|FG000|Overall Study|Lack of Efficacy|0|||
105588159|NCT01729871|364153099|FG001|Overall Study|Lack of Efficacy|1|||
105588160|NCT01729871|364153098|FG000|Overall Study|Physician Decision|0|||
105588161|NCT01729871|364153099|FG001|Overall Study|Physician Decision|2|||
105588162|NCT01729871|364153098|FG000|Overall Study|Protocol Violation|1|||
105588163|NCT01729871|364153099|FG001|Overall Study|Protocol Violation|0|||
105588164|NCT01729871|364153098|FG000|Overall Study|Withdrawal by Subject|0|||
105588165|NCT01729871|364153099|FG001|Overall Study|Withdrawal by Subject|3|||
105588166|NCT01729871|364153098|FG000|Overall Study|Other|4|||
105588167|NCT01729871|364153099|FG001|Overall Study|Other|9|||
105588168|NCT00630864|364153102|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
105588169|NCT00630864|364153102|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
105588170|NCT03722446|364153103|FG000|Overall Study|Protocol Violation|15|||
105588171|NCT03722446|364153104|FG001|Overall Study|Protocol Violation|2|||
105588172|NCT00430677|364153107|FG000|Short-term Period|Death|1|||
105588173|NCT00430677|364153108|FG001|Short-term Period|Death|1|||
105588174|NCT00430677|364153109|FG002|Short-term Period|Death|5|||
105588175|NCT00430677|364153107|FG000|Short-term Period|Adverse Event|15|||
105588176|NCT00430677|364153108|FG001|Short-term Period|Adverse Event|13|||
105588177|NCT00430677|364153109|FG002|Short-term Period|Adverse Event|9|||
105588178|NCT00430677|364153107|FG000|Short-term Period|Lack of Efficacy|5|||
105588179|NCT00430677|364153108|FG001|Short-term Period|Lack of Efficacy|6|||
105588180|NCT00430677|364153109|FG002|Short-term Period|Lack of Efficacy|4|||
105588181|NCT00430677|364153107|FG000|Short-term Period|Withdrawal by Subject|1|||
105588182|NCT00430677|364153108|FG001|Short-term Period|Withdrawal by Subject|1|||
105588183|NCT00430677|364153109|FG002|Short-term Period|Withdrawal by Subject|2|||
105588184|NCT00430677|364153107|FG000|Short-term Period|Participant no longer met study criteria|1|||
105588185|NCT00430677|364153108|FG001|Short-term Period|Participant no longer met study criteria|1|||
105588186|NCT00430677|364153109|FG002|Short-term Period|Participant no longer met study criteria|2|||
105426239|NCT00394901|363567231|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
105588187|NCT00430677|364153107|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
105588188|NCT00430677|364153108|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
105588189|NCT00430677|364153109|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
105588190|NCT00430677|364153107|FG000|Short-term Period|Pregnancy|0|||
105588191|NCT00430677|364153108|FG001|Short-term Period|Pregnancy|2|||
105426240|NCT01460407|363567235|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
105588192|NCT00430677|364153109|FG002|Short-term Period|Pregnancy|0|||
105588193|NCT00430677|364153107|FG000|Long-term Extension Period|Death|1|||
105588194|NCT00430677|364153108|FG001|Long-term Extension Period|Death|0|||
105588195|NCT00430677|364153109|FG002|Long-term Extension Period|Death|0|||
105588196|NCT00430677|364153107|FG000|Long-term Extension Period|Adverse Event|3|||
105588197|NCT00430677|364153108|FG001|Long-term Extension Period|Adverse Event|2|||
105426241|NCT01460407|363567236|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
105426242|NCT01352741|363567237|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
105426243|NCT01352741|363567238|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
105426244|NCT01352741|363567237|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
105426245|NCT01352741|363567238|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
105426246|NCT01352741|363567237|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
105426247|NCT01352741|363567238|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
105426248|NCT01352741|363567237|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
105426249|NCT01352741|363567238|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
105426250|NCT01352741|363567237|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
105426251|NCT01352741|363567238|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
105426252|NCT01352741|363567237|FG000|Open-label Tapentadol Titration Period|Other|4|||
105426253|NCT01352741|363567238|FG001|Open-label Tapentadol Titration Period|Other|0|||
105426254|NCT01352741|363567237|FG000|Double-blind Comparative Period|Protocol Violation|2|||
105426255|NCT01352741|363567238|FG001|Double-blind Comparative Period|Protocol Violation|0|||
105426256|NCT01352741|363567237|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
105426257|NCT01352741|363567238|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
105426258|NCT01352741|363567237|FG000|Double-blind Comparative Period|Adverse Event|16|||
105426259|NCT01352741|363567238|FG001|Double-blind Comparative Period|Adverse Event|17|||
105426260|NCT01352741|363567237|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
105426261|NCT01352741|363567238|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
105426262|NCT01352741|363567237|FG000|Double-blind Comparative Period|Death|0|||
105426263|NCT01352741|363567238|FG001|Double-blind Comparative Period|Death|1|||
105426264|NCT01352741|363567237|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
105426265|NCT01352741|363567238|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
105426266|NCT01352741|363567237|FG000|Double-blind Comparative Period|Other|1|||
105426267|NCT01352741|363567238|FG001|Double-blind Comparative Period|Other|2|||
105426268|NCT01352741|363567237|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
105426269|NCT01352741|363567238|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
105426270|NCT01352741|363567237|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
105426271|NCT01352741|363567238|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
105426272|NCT01352741|363567237|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
105426273|NCT01352741|363567238|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
105426274|NCT01352741|363567237|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
105426275|NCT01352741|363567238|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
105426276|NCT04070326|363567239|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
105426277|NCT04070326|363567240|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
105426278|NCT01367704|363567244|FG000|Overall Study|Lost to Follow-up|47|||
105426279|NCT01367704|363567245|FG001|Overall Study|Lost to Follow-up|161|||
105426280|NCT01886690|363567246|FG000|Overall Study|Protocol Violation|0|||
105426281|NCT01886690|363567247|FG001|Overall Study|Protocol Violation|1|||
105426282|NCT01886690|363567246|FG000|Overall Study|Personal Reasons|0|||
105426283|NCT01886690|363567247|FG001|Overall Study|Personal Reasons|1|||
105426284|NCT01140568|363567248|FG000|Overall Study|disease progression|31|||
105426285|NCT01140568|363567248|FG000|Overall Study|Withdrawal by Subject|1|||
105426286|NCT01140568|363567248|FG000|Overall Study|Screen Fail|4|||
105426287|NCT00953680|363567250|FG000|Period 1|Withdrawal by Subject|0|||
105426288|NCT00953680|363567251|FG001|Period 1|Withdrawal by Subject|1|||
105426289|NCT02193087|363567252|FG000|Overall Study|Adverse Event|2|||
105426290|NCT02193087|363567253|FG001|Overall Study|Adverse Event|0|||
105426291|NCT02193087|363567254|FG002|Overall Study|Adverse Event|0|||
105426292|NCT02193087|363567255|FG003|Overall Study|Adverse Event|11|||
105426293|NCT02193087|363567252|FG000|Overall Study|Lost to Follow-up|14|||
105426294|NCT02193087|363567253|FG001|Overall Study|Lost to Follow-up|6|||
105426295|NCT02193087|363567254|FG002|Overall Study|Lost to Follow-up|4|||
105426296|NCT02193087|363567255|FG003|Overall Study|Lost to Follow-up|37|||
105426297|NCT02193087|363567252|FG000|Overall Study|Protocol Violation|2|||
105426298|NCT02193087|363567253|FG001|Overall Study|Protocol Violation|0|||
105426299|NCT02193087|363567254|FG002|Overall Study|Protocol Violation|1|||
105426300|NCT02193087|363567255|FG003|Overall Study|Protocol Violation|2|||
105426301|NCT02193087|363567252|FG000|Overall Study|Withdrawal by Subject|10|||
105426302|NCT02193087|363567253|FG001|Overall Study|Withdrawal by Subject|3|||
105426303|NCT02193087|363567254|FG002|Overall Study|Withdrawal by Subject|1|||
105426304|NCT02193087|363567255|FG003|Overall Study|Withdrawal by Subject|19|||
105426305|NCT02193087|363567252|FG000|Overall Study|Other Reason Not Specified|7|||
105426306|NCT02193087|363567253|FG001|Overall Study|Other Reason Not Specified|2|||
105426307|NCT02193087|363567254|FG002|Overall Study|Other Reason Not Specified|1|||
105426308|NCT02193087|363567255|FG003|Overall Study|Other Reason Not Specified|9|||
105426309|NCT02193087|363567252|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
105426310|NCT02193087|363567253|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
105426311|NCT02193087|363567254|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
105426312|NCT02193087|363567255|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
105426313|NCT01510145|363567256|FG000|Overall Study|Adverse Event|6|||
105426314|NCT01510145|363567256|FG000|Overall Study|Lost to Follow-up|5|||
105426315|NCT01510145|363567256|FG000|Overall Study|Withdrawal by Subject|6|||
105426316|NCT01510145|363567256|FG000|Overall Study|Relative reported subject withdrew|1|||
105426317|NCT02279719|363567258|FG000|Overall Study|Patients randomized but never treated|0|||
105426318|NCT02279719|363567259|FG001|Overall Study|Patients randomized but never treated|0|||
105426319|NCT02279719|363567260|FG002|Overall Study|Patients randomized but never treated|0|||
105426320|NCT02279719|363567261|FG003|Overall Study|Patients randomized but never treated|0|||
105426321|NCT02279719|363567262|FG004|Overall Study|Patients randomized but never treated|3|||
105426322|NCT02279719|363567263|FG005|Overall Study|Patients randomized but never treated|0|||
105426323|NCT02279719|363567264|FG006|Overall Study|Patients randomized but never treated|3|||
105426324|NCT01453946|363567265|FG000|Overall Study|Did not receive drug for the taper phase|1|||
105426325|NCT01453946|363567265|FG000|Overall Study|Protocol Violation|2|||
105426326|NCT01453946|363567265|FG000|Overall Study|Lack of Efficacy|3|||
105426327|NCT01453946|363567265|FG000|Overall Study|Adverse Event|3|||
105426328|NCT00846040|363567266|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
105426329|NCT00846040|363567267|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
105426330|NCT00846040|363567268|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
105426331|NCT00846040|363567266|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
105426332|NCT00846040|363567267|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
105426333|NCT00846040|363567268|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
105426334|NCT00546260|363567269|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
105426335|NCT00546260|363567270|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
105426336|NCT02725593|363567273|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
105426337|NCT02725593|363567274|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
105426338|NCT02725593|363567273|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
105426339|NCT02725593|363567274|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
105426340|NCT02725593|363567273|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
105426341|NCT02725593|363567274|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
105426342|NCT02725593|363567273|FG000|Long Term Extension|Withdrawal by Subject|1|||
105426343|NCT02725593|363567274|FG001|Long Term Extension|Withdrawal by Subject|3|||
105426344|NCT03220581|363569480|FG000|Overall Study|Withdrawal by Subject|0|||
105426345|NCT03220581|363569481|FG001|Overall Study|Withdrawal by Subject|1|||
105426346|NCT03220581|363569480|FG000|Overall Study|Lost to Follow-up|3|||
105426347|NCT03220581|363569481|FG001|Overall Study|Lost to Follow-up|6|||
105426348|NCT01146652|363569482|FG000|Overall Study|Adverse Event|506|||
105426349|NCT01146652|363569483|FG001|Overall Study|Adverse Event|15|||
105426350|NCT01146652|363569482|FG000|Overall Study|Lack of Efficacy|91|||
105426351|NCT01146652|363569483|FG001|Overall Study|Lack of Efficacy|7|||
105426352|NCT01146652|363569482|FG000|Overall Study|Poor compliance to protocol|38|||
105426353|NCT01146652|363569483|FG001|Overall Study|Poor compliance to protocol|1|||
105426354|NCT01146652|363569482|FG000|Overall Study|Other unspecified reasons|314|||
105426355|NCT01146652|363569483|FG001|Overall Study|Other unspecified reasons|22|||
105426356|NCT01146652|363569482|FG000|Overall Study|Enrolled but not treated|2|||
105426357|NCT01146652|363569483|FG001|Overall Study|Enrolled but not treated|0|||
105426358|NCT00919867|363569484|FG000|First Intervention|Withdrawal by Subject|0|||
105426359|NCT00919867|363569485|FG001|First Intervention|Withdrawal by Subject|0|||
105426360|NCT00919867|363569486|FG002|First Intervention|Withdrawal by Subject|1|||
105426361|NCT00919867|363569487|FG003|First Intervention|Withdrawal by Subject|0|||
105426362|NCT00919867|363569488|FG004|First Intervention|Withdrawal by Subject|0|||
105426363|NCT00919867|363569489|FG005|First Intervention|Withdrawal by Subject|0|||
105426364|NCT00919867|363569484|FG000|First Intervention|Physician Decision|0|||
105426365|NCT00919867|363569485|FG001|First Intervention|Physician Decision|0|||
105426366|NCT00919867|363569486|FG002|First Intervention|Physician Decision|0|||
105426367|NCT00919867|363569487|FG003|First Intervention|Physician Decision|0|||
105426368|NCT00919867|363569488|FG004|First Intervention|Physician Decision|0|||
105426369|NCT00919867|363569489|FG005|First Intervention|Physician Decision|1|||
105426370|NCT01185964|363569490|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
105426371|NCT01185964|363569491|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
105426372|NCT01185964|363569492|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
105426373|NCT01185964|363569493|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
105588198|NCT00430677|364153109|FG002|Long-term Extension Period|Adverse Event|5|||
105426374|NCT01185964|363569490|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
105426375|NCT01185964|363569491|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
105426376|NCT01185964|363569492|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
105426377|NCT01185964|363569493|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
105426378|NCT01185964|363569490|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
105426379|NCT01185964|363569491|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
105426380|NCT01185964|363569492|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
105426381|NCT01185964|363569493|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
105426382|NCT01185964|363569490|FG000|Phase 1b and Phase 2|Adverse Event|1|||
105426383|NCT01185964|363569491|FG001|Phase 1b and Phase 2|Adverse Event|0|||
105588199|NCT00430677|364153107|FG000|Long-term Extension Period|Lack of Efficacy|5|||
105588200|NCT00430677|364153108|FG001|Long-term Extension Period|Lack of Efficacy|3|||
105588201|NCT00430677|364153109|FG002|Long-term Extension Period|Lack of Efficacy|8|||
105588202|NCT00430677|364153107|FG000|Long-term Extension Period|Lost to Follow-up|1|||
105588203|NCT00430677|364153108|FG001|Long-term Extension Period|Lost to Follow-up|1|||
105588204|NCT00430677|364153109|FG002|Long-term Extension Period|Lost to Follow-up|1|||
105588205|NCT00430677|364153107|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
105588206|NCT00430677|364153108|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
105588207|NCT00430677|364153109|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
105588208|NCT00430677|364153107|FG000|Long-term Extension Period|Pregnancy|1|||
105588209|NCT00430677|364153108|FG001|Long-term Extension Period|Pregnancy|1|||
105588210|NCT00430677|364153109|FG002|Long-term Extension Period|Pregnancy|0|||
105588211|NCT00430677|364153107|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
105588212|NCT00430677|364153108|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
105588213|NCT00430677|364153109|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
105588214|NCT00430677|364153107|FG000|Long-term Extension Period|Other|2|||
105588215|NCT00430677|364153108|FG001|Long-term Extension Period|Other|1|||
105588216|NCT00430677|364153109|FG002|Long-term Extension Period|Other|1|||
105588217|NCT00430677|364153107|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
105588218|NCT00430677|364153108|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
105588219|NCT00430677|364153109|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
105588220|NCT01555762|364153110|FG000|Overall Study|No information on Bevacizumab intake|11|||
105588221|NCT01555762|364153110|FG000|Overall Study|Missing start date of infusion|8|||
105588222|NCT01555762|364153110|FG000|Overall Study|75 years old or more ticked No|1|||
105588223|NCT01555762|364153110|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
105588224|NCT01555762|364153110|FG000|Overall Study|Death linked to progression of disease|165|||
105588225|NCT01555762|364153110|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
105588226|NCT01555762|364153110|FG000|Overall Study|Investigator's decision|10|||
105588227|NCT01555762|364153110|FG000|Overall Study|Participant not wishing to continue|5|||
105588228|NCT01555762|364153110|FG000|Overall Study|Missing data|1|||
105588229|NCT01555762|364153110|FG000|Overall Study|Death linked to an adverse event|14|||
105588230|NCT02068885|364153111|FG000|Overall Study|Withdrew|3|||
105588231|NCT02068885|364153112|FG001|Overall Study|Withdrew|5|||
105588232|NCT02068885|364153113|FG002|Overall Study|Withdrew|8|||
105588233|NCT00828919|364153114|FG000|Overall Study|Death|0|||
105588234|NCT00828919|364153115|FG001|Overall Study|Death|1|||
105588235|NCT00828919|364153116|FG002|Overall Study|Death|2|||
105588236|NCT00828919|364153117|FG003|Overall Study|Death|0|||
105588237|NCT00828919|364153118|FG004|Overall Study|Death|0|||
105588238|NCT00828919|364153114|FG000|Overall Study|Adverse Event|2|||
105588239|NCT00828919|364153115|FG001|Overall Study|Adverse Event|2|||
105588240|NCT00828919|364153116|FG002|Overall Study|Adverse Event|2|||
105588241|NCT00828919|364153117|FG003|Overall Study|Adverse Event|1|||
105588242|NCT00828919|364153118|FG004|Overall Study|Adverse Event|3|||
105588243|NCT00828919|364153114|FG000|Overall Study|Objective progression or relapse|4|||
105588244|NCT00828919|364153115|FG001|Overall Study|Objective progression or relapse|4|||
105588245|NCT00828919|364153116|FG002|Overall Study|Objective progression or relapse|11|||
105588246|NCT00828919|364153117|FG003|Overall Study|Objective progression or relapse|0|||
105588247|NCT00828919|364153118|FG004|Overall Study|Objective progression or relapse|5|||
105426384|NCT01185964|363569492|FG002|Phase 1b and Phase 2|Adverse Event|2|||
105426385|NCT01185964|363569493|FG003|Phase 1b and Phase 2|Adverse Event|0|||
105426386|NCT01185964|363569490|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
105426387|NCT01185964|363569491|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
105426388|NCT01185964|363569492|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
105426389|NCT01185964|363569493|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
105426390|NCT01185964|363569490|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
105426391|NCT01185964|363569491|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
105426392|NCT01185964|363569492|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
105426393|NCT01185964|363569493|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
105426394|NCT01185964|363569490|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
105426395|NCT01185964|363569491|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
105426396|NCT01185964|363569492|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
105426397|NCT01185964|363569493|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
105426398|NCT01185964|363569490|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
105426399|NCT01185964|363569491|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
105426400|NCT01185964|363569492|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
105588248|NCT00828919|364153114|FG000|Overall Study|No longer willing to participate in study|0|||
105588249|NCT00828919|364153115|FG001|Overall Study|No longer willing to participate in study|0|||
105588250|NCT00828919|364153116|FG002|Overall Study|No longer willing to participate in study|2|||
105588251|NCT00828919|364153117|FG003|Overall Study|No longer willing to participate in study|0|||
105588252|NCT00828919|364153118|FG004|Overall Study|No longer willing to participate in study|0|||
105501234|NCT00533897|363847068|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
105501235|NCT00533897|363847069|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
105501236|NCT00533897|363847070|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
105501237|NCT00533897|363847071|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
105501238|NCT00533897|363847064|FG000|Long Term Extension (LTE)|Adverse Event|0|||
105501239|NCT00533897|363847065|FG001|Long Term Extension (LTE)|Adverse Event|0|||
105501240|NCT00533897|363847066|FG002|Long Term Extension (LTE)|Adverse Event|0|||
105501241|NCT00533897|363847067|FG003|Long Term Extension (LTE)|Adverse Event|0|||
105501242|NCT00533897|363847068|FG004|Long Term Extension (LTE)|Adverse Event|0|||
105501243|NCT00533897|363847069|FG005|Long Term Extension (LTE)|Adverse Event|0|||
105501244|NCT00533897|363847070|FG006|Long Term Extension (LTE)|Adverse Event|2|||
105501245|NCT00533897|363847071|FG007|Long Term Extension (LTE)|Adverse Event|5|||
105501246|NCT00533897|363847064|FG000|Long Term Extension (LTE)|Pregnancy|0|||
105501247|NCT00533897|363847065|FG001|Long Term Extension (LTE)|Pregnancy|0|||
105501248|NCT00533897|363847066|FG002|Long Term Extension (LTE)|Pregnancy|0|||
105501249|NCT00533897|363847067|FG003|Long Term Extension (LTE)|Pregnancy|0|||
105501250|NCT00533897|363847068|FG004|Long Term Extension (LTE)|Pregnancy|0|||
105501251|NCT00533897|363847069|FG005|Long Term Extension (LTE)|Pregnancy|0|||
105501252|NCT00533897|363847070|FG006|Long Term Extension (LTE)|Pregnancy|0|||
105501253|NCT00533897|363847071|FG007|Long Term Extension (LTE)|Pregnancy|2|||
105501254|NCT00533897|363847064|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
105501255|NCT00533897|363847065|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
105501256|NCT00533897|363847066|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
105501257|NCT00533897|363847067|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
105501258|NCT00533897|363847068|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
105501259|NCT00533897|363847069|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
105501260|NCT00533897|363847070|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
105501261|NCT00533897|363847071|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
105501262|NCT00533897|363847064|FG000|Long Term Extension (LTE)|Other|0|||
105501263|NCT00533897|363847065|FG001|Long Term Extension (LTE)|Other|0|||
105501264|NCT00533897|363847066|FG002|Long Term Extension (LTE)|Other|0|||
105501265|NCT00533897|363847067|FG003|Long Term Extension (LTE)|Other|0|||
105501266|NCT00533897|363847068|FG004|Long Term Extension (LTE)|Other|0|||
105501267|NCT00533897|363847069|FG005|Long Term Extension (LTE)|Other|0|||
105501268|NCT00533897|363847070|FG006|Long Term Extension (LTE)|Other|1|||
105501269|NCT00533897|363847071|FG007|Long Term Extension (LTE)|Other|6|||
105501270|NCT02555683|363847073|FG000|Overall Study|Physician Decision|1|||
105501271|NCT02555683|363847074|FG001|Overall Study|Physician Decision|0|||
105501272|NCT02555683|363847075|FG002|Overall Study|Physician Decision|2|||
105501273|NCT02555683|363847073|FG000|Overall Study|Lost to Follow-up|2|||
105501274|NCT02555683|363847074|FG001|Overall Study|Lost to Follow-up|1|||
105501275|NCT02555683|363847075|FG002|Overall Study|Lost to Follow-up|2|||
105501276|NCT02555683|363847073|FG000|Overall Study|Technical Problems|1|||
105501277|NCT02555683|363847074|FG001|Overall Study|Technical Problems|1|||
105501278|NCT02555683|363847075|FG002|Overall Study|Technical Problems|0|||
105501279|NCT02555683|363847073|FG000|Overall Study|Protocol deviation|0|||
105501280|NCT02555683|363847074|FG001|Overall Study|Protocol deviation|1|||
105501281|NCT02555683|363847075|FG002|Overall Study|Protocol deviation|0|||
105501282|NCT02555683|363847073|FG000|Overall Study|Lack of Efficacy|2|||
105501283|NCT02555683|363847074|FG001|Overall Study|Lack of Efficacy|0|||
105501284|NCT02555683|363847075|FG002|Overall Study|Lack of Efficacy|0|||
105501285|NCT02555683|363847073|FG000|Overall Study|Death|0|||
105501286|NCT02555683|363847074|FG001|Overall Study|Death|1|||
105501287|NCT02555683|363847075|FG002|Overall Study|Death|2|||
105501288|NCT02555683|363847073|FG000|Overall Study|Adverse Event|1|||
105501289|NCT02555683|363847074|FG001|Overall Study|Adverse Event|0|||
105501290|NCT02555683|363847075|FG002|Overall Study|Adverse Event|1|||
105501291|NCT02555683|363847073|FG000|Overall Study|Subject/guardian decision|12|||
105501292|NCT02555683|363847074|FG001|Overall Study|Subject/guardian decision|12|||
105501293|NCT02555683|363847075|FG002|Overall Study|Subject/guardian decision|22|||
105501294|NCT02555683|363847073|FG000|Overall Study|Death post Treatment/safety period|0|||
105501295|NCT02555683|363847074|FG001|Overall Study|Death post Treatment/safety period|1|||
105501296|NCT02555683|363847075|FG002|Overall Study|Death post Treatment/safety period|0|||
105501297|NCT05074667|363847076|FG000|Overall Study|Death|1|||
105501298|NCT05074667|363847076|FG000|Overall Study|Withdrawal by Subject|4|||
105501299|NCT05074667|363847076|FG000|Overall Study|Lost to Follow-up|10|||
105501300|NCT00491075|363847077|FG000|Overall Study|Withdrawal by Subject|1|||
105501301|NCT00491075|363847077|FG000|Overall Study|Physician Decision|1|||
105501302|NCT00827502|363847078|FG000|Overall Study|randomized but not treated|11|||
105501303|NCT00827502|363847078|FG000|Overall Study|Adverse Event|1|||
105501304|NCT00827502|363847078|FG000|Overall Study|Lost to Follow-up|4|||
105501305|NCT00827502|363847078|FG000|Overall Study|Withdrawal by Subject|5|||
105501306|NCT04678661|363847079|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
105501307|NCT04678661|363847080|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
105588253|NCT00828919|364153114|FG000|Overall Study|Insufficient Clinical Response|0|||
105588254|NCT00828919|364153115|FG001|Overall Study|Insufficient Clinical Response|1|||
105588255|NCT00828919|364153116|FG002|Overall Study|Insufficient Clinical Response|2|||
105426401|NCT01185964|363569493|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
105426402|NCT01920893|363569494|FG000|Overall Study|Adverse Event|5|||
105426403|NCT01920893|363569495|FG001|Overall Study|Adverse Event|2|||
105426404|NCT01920893|363569494|FG000|Overall Study|Lack of Efficacy|2|||
105426405|NCT01920893|363569495|FG001|Overall Study|Lack of Efficacy|0|||
105426406|NCT03440918|363569496|FG000|Overall Study|Protocol Violation|0|||
105426407|NCT03440918|363569497|FG001|Overall Study|Protocol Violation|16|||
105426408|NCT04962230|363569509|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
105426409|NCT04962230|363569509|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
105588256|NCT00828919|364153117|FG003|Overall Study|Insufficient Clinical Response|0|||
105588257|NCT00828919|364153118|FG004|Overall Study|Insufficient Clinical Response|0|||
105588258|NCT00828919|364153114|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
105426410|NCT02118597|363569510|FG000|Overall Study|Sponsor terminated the study|14|||
105426411|NCT02118597|363569510|FG000|Overall Study|Serious Adverse Event|1|||
105426412|NCT02118597|363569510|FG000|Overall Study|Investigator's decision|1|||
105426413|NCT02275117|363569514|FG000|Overall Study|Adverse Event|0|||
105426414|NCT02275117|363569515|FG001|Overall Study|Adverse Event|0|||
105426415|NCT02275117|363569516|FG002|Overall Study|Adverse Event|0|||
105426416|NCT02275117|363569517|FG003|Overall Study|Adverse Event|0|||
105426417|NCT02275117|363569518|FG004|Overall Study|Adverse Event|1|||
105426418|NCT02275117|363569514|FG000|Overall Study|Lack of Efficacy|6|||
105426419|NCT02275117|363569515|FG001|Overall Study|Lack of Efficacy|7|||
105426420|NCT02275117|363569516|FG002|Overall Study|Lack of Efficacy|5|||
105426421|NCT02275117|363569517|FG003|Overall Study|Lack of Efficacy|2|||
105426422|NCT02275117|363569518|FG004|Overall Study|Lack of Efficacy|10|||
105426423|NCT02275117|363569514|FG000|Overall Study|Lost to Follow-up|11|||
105426424|NCT02275117|363569515|FG001|Overall Study|Lost to Follow-up|16|||
105426425|NCT02275117|363569516|FG002|Overall Study|Lost to Follow-up|15|||
105426426|NCT02275117|363569517|FG003|Overall Study|Lost to Follow-up|16|||
105588259|NCT00828919|364153115|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
105588260|NCT00828919|364153116|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
105588261|NCT00828919|364153117|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
105588262|NCT00828919|364153118|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
105588263|NCT00828919|364153114|FG000|Overall Study|Other|1|||
105588264|NCT00828919|364153115|FG001|Overall Study|Other|0|||
105588265|NCT00828919|364153116|FG002|Overall Study|Other|1|||
105588266|NCT00828919|364153117|FG003|Overall Study|Other|1|||
105588267|NCT00828919|364153118|FG004|Overall Study|Other|0|||
105588268|NCT00828919|364153114|FG000|Overall Study|Lost to Follow-up|0|||
105588269|NCT00828919|364153115|FG001|Overall Study|Lost to Follow-up|1|||
105588270|NCT00828919|364153116|FG002|Overall Study|Lost to Follow-up|0|||
105588271|NCT00828919|364153117|FG003|Overall Study|Lost to Follow-up|0|||
105588272|NCT00828919|364153118|FG004|Overall Study|Lost to Follow-up|0|||
105588273|NCT01562743|364153121|FG000|Overall Study|Adverse Event|29|||
105588274|NCT01562743|364153121|FG000|Overall Study|Lack of Efficacy|3|||
105588275|NCT01562743|364153121|FG000|Overall Study|Withdrawal by Subject|13|||
105588276|NCT01562743|364153121|FG000|Overall Study|Protocol Violation|1|||
105588277|NCT01562743|364153121|FG000|Overall Study|Discontinuation criteria|2|||
105588278|NCT01562743|364153121|FG000|Overall Study|Lost to Follow-up|2|||
105588279|NCT01562743|364153121|FG000|Overall Study|Physician Decision|2|||
105588280|NCT03015740|364153122|FG000|Overall Study|Adverse Event|1|||
105588281|NCT03015740|364153123|FG001|Overall Study|Adverse Event|0|||
105588282|NCT03015740|364153124|FG002|Overall Study|Adverse Event|0|||
105588283|NCT03015740|364153122|FG000|Overall Study|Death|3|||
105588284|NCT03015740|364153123|FG001|Overall Study|Death|5|||
105588285|NCT03015740|364153124|FG002|Overall Study|Death|0|||
105588286|NCT03015740|364153122|FG000|Overall Study|Withdrawal by Subject|2|||
105588287|NCT03015740|364153123|FG001|Overall Study|Withdrawal by Subject|0|||
105588288|NCT03015740|364153124|FG002|Overall Study|Withdrawal by Subject|0|||
105426427|NCT02275117|363569518|FG004|Overall Study|Lost to Follow-up|8|||
105426428|NCT02275117|363569514|FG000|Overall Study|Physician Decision|0|||
105426429|NCT02275117|363569515|FG001|Overall Study|Physician Decision|1|||
105426430|NCT02275117|363569516|FG002|Overall Study|Physician Decision|1|||
105588289|NCT01518257|364154669|FG000|Overall Study|Lost to Follow-up|1|||
105588290|NCT01518257|364154670|FG001|Overall Study|Lost to Follow-up|0|||
105588291|NCT01518257|364154669|FG000|Overall Study|Other Miscellaneous Reason|1|||
105588292|NCT01518257|364154670|FG001|Overall Study|Other Miscellaneous Reason|0|||
105588293|NCT02333630|364154676|FG000|Overall Study|Lost to Follow-up|5|||
105588294|NCT02333630|364154677|FG001|Overall Study|Lost to Follow-up|2|||
105588295|NCT01289119|364154678|FG000|Overall Study|Adverse Event|2|||
105588296|NCT01289119|364154679|FG001|Overall Study|Adverse Event|1|||
105426431|NCT02275117|363569517|FG003|Overall Study|Physician Decision|0|||
105426432|NCT02275117|363569518|FG004|Overall Study|Physician Decision|1|||
105426433|NCT02275117|363569514|FG000|Overall Study|Protocol Violation|1|||
105588297|NCT01289119|364154680|FG002|Overall Study|Adverse Event|0|||
105588298|NCT01289119|364154681|FG003|Overall Study|Adverse Event|2|||
105588299|NCT01289119|364154682|FG004|Overall Study|Adverse Event|1|||
105588300|NCT01289119|364154683|FG005|Overall Study|Adverse Event|0|||
105588301|NCT01289119|364154678|FG000|Overall Study|Major Protocol Deviation|2|||
105588302|NCT01289119|364154679|FG001|Overall Study|Major Protocol Deviation|1|||
105588303|NCT01289119|364154680|FG002|Overall Study|Major Protocol Deviation|3|||
105588304|NCT01289119|364154681|FG003|Overall Study|Major Protocol Deviation|0|||
105588305|NCT01289119|364154682|FG004|Overall Study|Major Protocol Deviation|2|||
105588306|NCT01289119|364154683|FG005|Overall Study|Major Protocol Deviation|1|||
105588307|NCT01289119|364154678|FG000|Overall Study|Lost to Follow-up|0|||
105588308|NCT01289119|364154679|FG001|Overall Study|Lost to Follow-up|3|||
105588309|NCT01289119|364154680|FG002|Overall Study|Lost to Follow-up|0|||
105588310|NCT01289119|364154681|FG003|Overall Study|Lost to Follow-up|0|||
105588311|NCT01289119|364154682|FG004|Overall Study|Lost to Follow-up|0|||
105588312|NCT01289119|364154683|FG005|Overall Study|Lost to Follow-up|1|||
105588313|NCT01289119|364154678|FG000|Overall Study|Withdrawal by Subject|4|||
105588314|NCT01289119|364154679|FG001|Overall Study|Withdrawal by Subject|2|||
105588315|NCT01289119|364154680|FG002|Overall Study|Withdrawal by Subject|4|||
105588316|NCT01289119|364154681|FG003|Overall Study|Withdrawal by Subject|3|||
105588317|NCT01289119|364154682|FG004|Overall Study|Withdrawal by Subject|1|||
105588318|NCT01289119|364154683|FG005|Overall Study|Withdrawal by Subject|1|||
105588319|NCT01289119|364154678|FG000|Overall Study|Pregnancy|0|||
105588320|NCT01289119|364154679|FG001|Overall Study|Pregnancy|1|||
105588321|NCT01289119|364154680|FG002|Overall Study|Pregnancy|0|||
105588322|NCT01289119|364154681|FG003|Overall Study|Pregnancy|0|||
105588323|NCT01289119|364154682|FG004|Overall Study|Pregnancy|0|||
105588324|NCT01289119|364154683|FG005|Overall Study|Pregnancy|0|||
105588325|NCT01289119|364154678|FG000|Overall Study|Lack of Efficacy|0|||
105588326|NCT01289119|364154679|FG001|Overall Study|Lack of Efficacy|1|||
105588327|NCT01289119|364154680|FG002|Overall Study|Lack of Efficacy|1|||
105588328|NCT01289119|364154681|FG003|Overall Study|Lack of Efficacy|1|||
105588329|NCT01289119|364154682|FG004|Overall Study|Lack of Efficacy|1|||
105588330|NCT01289119|364154683|FG005|Overall Study|Lack of Efficacy|1|||
105588331|NCT01289119|364154678|FG000|Overall Study|Other|1|||
105588332|NCT01289119|364154679|FG001|Overall Study|Other|0|||
105588333|NCT01289119|364154680|FG002|Overall Study|Other|1|||
105588334|NCT01289119|364154681|FG003|Overall Study|Other|0|||
105588335|NCT01289119|364154682|FG004|Overall Study|Other|0|||
105588336|NCT01289119|364154683|FG005|Overall Study|Other|0|||
105588337|NCT03646669|364154684|FG000|Overall Study|Withdrawal by Subject|5|||
105588338|NCT03646669|364154685|FG001|Overall Study|Withdrawal by Subject|0|||
105588339|NCT00672256|364154686|FG000|Overall Study|PI dropped, bad data|44|||
105588340|NCT00058058|364154687|FG000|Overall Study|Withdrawal by Subject|4|||
105588341|NCT00058058|364154687|FG000|Overall Study|Ineligible|20|||
105588342|NCT00058058|364154687|FG000|Overall Study|Claustrophobic|5|||
105588343|NCT00058058|364154687|FG000|Overall Study|technical issues|6|||
105588344|NCT00058058|364154687|FG000|Overall Study|Poor positioning, illness,pain|3|||
105588345|NCT04759131|364154690|FG000|Overall Study|Investigator's discretion|1|||
105588346|NCT04759131|364154691|FG001|Overall Study|Investigator's discretion|0|||
105588347|NCT04759131|364154690|FG000|Overall Study|Subject withdrawal|1|||
105588348|NCT04759131|364154691|FG001|Overall Study|Subject withdrawal|0|||
105588349|NCT01149681|364154692|FG000|Overall Study|Withdrawal by Subject|7|||
105588350|NCT01149681|364154692|FG000|Overall Study|Progressive disease|1|||
105588351|NCT01149681|364154692|FG000|Overall Study|Physician Decision|2|||
105588352|NCT01149681|364154692|FG000|Overall Study|adverse events nonrelated study drug|2|||
105588353|NCT03999554|364154697|FG000|Overall Study|Lost to Follow-up|4|||
105588354|NCT03999554|364154698|FG001|Overall Study|Lost to Follow-up|5|||
105588355|NCT03999554|364154699|FG002|Overall Study|Lost to Follow-up|4|||
105588356|NCT03999554|364154700|FG003|Overall Study|Lost to Follow-up|5|||
105426434|NCT02275117|363569515|FG001|Overall Study|Protocol Violation|0|||
105426435|NCT02275117|363569516|FG002|Overall Study|Protocol Violation|1|||
105426436|NCT02275117|363569517|FG003|Overall Study|Protocol Violation|1|||
105426437|NCT02275117|363569518|FG004|Overall Study|Protocol Violation|0|||
105426438|NCT02275117|363569514|FG000|Overall Study|Withdrawal by Subject|6|||
105426439|NCT02275117|363569515|FG001|Overall Study|Withdrawal by Subject|4|||
105588357|NCT03999554|364154701|FG004|Overall Study|Lost to Follow-up|8|||
105588358|NCT03999554|364154697|FG000|Overall Study|Protocol Violation|0|||
105588359|NCT03999554|364154698|FG001|Overall Study|Protocol Violation|0|||
105588360|NCT03999554|364154699|FG002|Overall Study|Protocol Violation|5|||
105588361|NCT03999554|364154700|FG003|Overall Study|Protocol Violation|0|||
105588362|NCT03999554|364154701|FG004|Overall Study|Protocol Violation|0|||
105588363|NCT03999554|364154697|FG000|Overall Study|Pregnancy|0|||
105588364|NCT03999554|364154698|FG001|Overall Study|Pregnancy|0|||
105588365|NCT03999554|364154699|FG002|Overall Study|Pregnancy|1|||
105588366|NCT03999554|364154700|FG003|Overall Study|Pregnancy|0|||
105588367|NCT03999554|364154701|FG004|Overall Study|Pregnancy|0|||
105426440|NCT02275117|363569516|FG002|Overall Study|Withdrawal by Subject|7|||
105588368|NCT03999554|364154697|FG000|Overall Study|Withdrawal by Subject|2|||
105588369|NCT03999554|364154698|FG001|Overall Study|Withdrawal by Subject|2|||
105588370|NCT03999554|364154699|FG002|Overall Study|Withdrawal by Subject|2|||
105588371|NCT03999554|364154700|FG003|Overall Study|Withdrawal by Subject|1|||
105588372|NCT03999554|364154701|FG004|Overall Study|Withdrawal by Subject|1|||
105588373|NCT03999554|364154697|FG000|Overall Study|failure to comply with protocol requirements|0|||
105588374|NCT03999554|364154698|FG001|Overall Study|failure to comply with protocol requirements|0|||
105588375|NCT03999554|364154699|FG002|Overall Study|failure to comply with protocol requirements|0|||
105588376|NCT03999554|364154700|FG003|Overall Study|failure to comply with protocol requirements|1|||
105588377|NCT03999554|364154701|FG004|Overall Study|failure to comply with protocol requirements|0|||
105588378|NCT03006341|364154702|FG000|Overall Study|Not linked in the EMR|25069|||
105588379|NCT03006341|364154703|FG001|Overall Study|Not linked in the EMR|67505|||
105588380|NCT03006341|364154704|FG002|Overall Study|Not linked in the EMR|30993|||
105588381|NCT03006341|364154705|FG003|Overall Study|Not linked in the EMR|10685|||
105588382|NCT04582877|364154706|FG000|Overall Study|Did not use device measurement|5|||
105588383|NCT04582877|364154706|FG000|Overall Study|No fractional flow reserve test results|2|||
105588384|NCT04582877|364154706|FG000|Overall Study|Protocol Violation|1|||
105588385|NCT00003656|364154707|FG000|Overall Study|Adverse Event|0|||
105588386|NCT00003656|364154708|FG001|Overall Study|Adverse Event|1|||
105588387|NCT03055767|364154709|FG000|Open-Label Period|Lost to Follow-up|0|||
105588388|NCT03055767|364154710|FG001|Open-Label Period|Lost to Follow-up|0|||
105588389|NCT03055767|364154711|FG002|Open-Label Period|Lost to Follow-up|2|||
105588390|NCT03055767|364154712|FG003|Open-Label Period|Lost to Follow-up|0|||
105588391|NCT03055767|364154709|FG000|Open-Label Period|Withdrawal by Subject|0|||
105588392|NCT03055767|364154710|FG001|Open-Label Period|Withdrawal by Subject|0|||
105588393|NCT03055767|364154711|FG002|Open-Label Period|Withdrawal by Subject|0|||
105588394|NCT03055767|364154712|FG003|Open-Label Period|Withdrawal by Subject|1|||
105588395|NCT03686683|364154715|FG000|Overall Study|Withdrawal by Subject|52|||
105588396|NCT03686683|364154716|FG001|Overall Study|Withdrawal by Subject|32|||
105588397|NCT03686683|364154715|FG000|Overall Study|Lost to Follow-up|23|||
105588398|NCT03686683|364154716|FG001|Overall Study|Lost to Follow-up|19|||
105588399|NCT03686683|364154715|FG000|Overall Study|Adverse Event|1|||
105588400|NCT03686683|364154716|FG001|Overall Study|Adverse Event|0|||
105588401|NCT03686683|364154715|FG000|Overall Study|Death|10|||
105588402|NCT03686683|364154716|FG001|Overall Study|Death|5|||
105588403|NCT03686683|364154715|FG000|Overall Study|Progressive Disease|1|||
105588404|NCT03686683|364154716|FG001|Overall Study|Progressive Disease|1|||
105588405|NCT03686683|364154715|FG000|Overall Study|Noncompliance|1|||
105588406|NCT03686683|364154716|FG001|Overall Study|Noncompliance|0|||
105588407|NCT03686683|364154715|FG000|Overall Study|Physician Decision|1|||
105588408|NCT03686683|364154716|FG001|Overall Study|Physician Decision|1|||
105588409|NCT03686683|364154715|FG000|Overall Study|Screen fail post-randomization|1|||
105588410|NCT03686683|364154716|FG001|Overall Study|Screen fail post-randomization|0|||
105588411|NCT03686683|364154715|FG000|Overall Study|Protocol Violation|3|||
105588412|NCT03686683|364154716|FG001|Overall Study|Protocol Violation|0|||
105588413|NCT03686683|364154715|FG000|Overall Study|No data available|1|||
105588414|NCT03686683|364154716|FG001|Overall Study|No data available|0|||
105588415|NCT01770860|364154717|FG000|Overall Study|Withdrawal by Subject|4|||
105588416|NCT01770860|364154717|FG000|Overall Study|Lost to Follow-up|1|||
105588417|NCT01770860|364154717|FG000|Overall Study|Administrative decision made by the PI|1|||
105588418|NCT02397889|364154723|FG000|Overall Study|Physician Decision|1|||
105588419|NCT02397889|364154724|FG001|Overall Study|Physician Decision|0|||
105588420|NCT01190150|364154736|FG000|First Treatment|Withdrawal by Subject|1|||
105588421|NCT01190150|364154737|FG001|First Treatment|Withdrawal by Subject|0|||
105588422|NCT01190150|364154736|FG000|Washout|Withdrawal by Subject|0|||
105588423|NCT01190150|364154737|FG001|Washout|Withdrawal by Subject|1|||
105588424|NCT01190150|364154736|FG000|Washout|Difficulty in adherence|0|||
105588425|NCT01190150|364154737|FG001|Washout|Difficulty in adherence|1|||
105588426|NCT01664104|364154744|FG000|Overall Study|Adverse Event|6|||
105588427|NCT01664104|364154744|FG000|Overall Study|Lack of Efficacy|2|||
105588428|NCT01664104|364154744|FG000|Overall Study|Withdrawal by Subject|1|||
105588429|NCT01664104|364154744|FG000|Overall Study|Lost to Follow-up|4|||
105588430|NCT01664104|364154744|FG000|Overall Study|Other|1|||
105588431|NCT01664104|364154744|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
105588432|NCT01446003|364154752|FG000|Period 1|Protocol Violation|2|||
105588433|NCT01446003|364154753|FG001|Period 1|Protocol Violation|0|||
105588434|NCT01446003|364154752|FG000|Period 2|Adverse Event|1|||
105588435|NCT01446003|364154753|FG001|Period 2|Adverse Event|0|||
105588436|NCT00318656|364154754|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
105588437|NCT00318656|364154755|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
105588438|NCT00318656|364154754|FG000|Overall Study|Did not receive any treatment|0|||
105588439|NCT00318656|364154755|FG001|Overall Study|Did not receive any treatment|1|||
105588440|NCT03905135|364154756|FG000|Dose Escalation|Adverse Event|1|||
105588441|NCT03905135|364154757|FG001|Dose Escalation|Adverse Event|1|||
105588442|NCT03905135|364154756|FG000|Dose Escalation|Progressive disease|3|||
105588443|NCT03905135|364154757|FG001|Dose Escalation|Progressive disease|1|||
105588444|NCT03905135|364154756|FG000|Dose Escalation|Intercurrent illness|1|||
105588445|NCT03905135|364154757|FG001|Dose Escalation|Intercurrent illness|0|||
105588446|NCT00490555|364154758|FG000|Overall Study|noncompliant with drug administration|0|||
105588447|NCT00490555|364154759|FG001|Overall Study|noncompliant with drug administration|0|||
105588448|NCT00490555|364154760|FG002|Overall Study|noncompliant with drug administration|2|||
105588449|NCT00490555|364154761|FG003|Overall Study|noncompliant with drug administration|0|||
105588450|NCT04550039|364154762|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
105588451|NCT04550039|364154763|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
105588452|NCT04550039|364154762|FG000|Overall Study|patient self-withdrew from study|0|||
105588453|NCT04550039|364154763|FG001|Overall Study|patient self-withdrew from study|1|||
105588454|NCT01656304|364154764|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
105588455|NCT00828945|364154765|FG000|Overall Study|Death|4|||
105588456|NCT00828945|364154765|FG000|Overall Study|Participant was missing|1|||
105588457|NCT00828945|364154765|FG000|Overall Study|Other|36|||
105588458|NCT04888585|364154770|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
105588459|NCT04888585|364154771|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
105588460|NCT04888585|364154772|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
105588461|NCT04888585|364154773|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
105588462|NCT04888585|364154774|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
105588463|NCT04888585|364154775|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
105588464|NCT04888585|364154776|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
105588465|NCT04888585|364154777|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
105588466|NCT04888585|364154778|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
105588467|NCT04888585|364154779|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
105588468|NCT04888585|364154780|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
105588469|NCT04888585|364154770|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
105588470|NCT04888585|364154771|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
105588471|NCT04888585|364154772|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
105588472|NCT04888585|364154773|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
105588473|NCT04888585|364154774|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
105588474|NCT04888585|364154775|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
105588475|NCT04888585|364154776|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
105588476|NCT04888585|364154777|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
105588477|NCT04888585|364154778|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
105588478|NCT04888585|364154779|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
105588479|NCT04888585|364154780|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
105588480|NCT04888585|364154770|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
105588481|NCT04888585|364154771|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
105588482|NCT04888585|364154772|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
105588483|NCT04888585|364154773|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
105588484|NCT04888585|364154774|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
105588485|NCT04888585|364154775|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
105588486|NCT04888585|364154776|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
105588487|NCT04888585|364154777|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
105588488|NCT04888585|364154778|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
105588489|NCT04888585|364154779|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
105588490|NCT04888585|364154780|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
105588491|NCT04888585|364154770|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
105588492|NCT04888585|364154771|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
105588493|NCT04888585|364154772|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
105588494|NCT04888585|364154773|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
105588495|NCT04888585|364154774|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
105588496|NCT04888585|364154775|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
105588497|NCT04888585|364154776|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
105588498|NCT04888585|364154777|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
105588499|NCT04888585|364154778|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
105588500|NCT04888585|364154779|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
105588501|NCT04888585|364154780|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
105588502|NCT04888585|364154770|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
105588503|NCT04888585|364154771|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
105588504|NCT04888585|364154772|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
105588505|NCT04888585|364154773|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
105588506|NCT04888585|364154774|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
105588507|NCT04888585|364154775|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
105588508|NCT04888585|364154776|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
105588509|NCT04888585|364154777|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
105588510|NCT04888585|364154778|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
105588511|NCT04888585|364154779|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
105588512|NCT04888585|364154780|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
105588513|NCT04888585|364154770|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
105588514|NCT04888585|364154771|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
105588515|NCT04888585|364154772|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
105588516|NCT04888585|364154773|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
105588517|NCT04888585|364154774|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
105501308|NCT04678661|363847079|FG000|Overall Study|Protocol Violation|2|||
105501309|NCT04678661|363847080|FG001|Overall Study|Protocol Violation|0|||
105501310|NCT04678661|363847079|FG000|Overall Study|Withdrawal by Subject|1|||
105501311|NCT04678661|363847080|FG001|Overall Study|Withdrawal by Subject|0|||
105501312|NCT04678661|363847079|FG000|Overall Study|Lost to Follow-up|2|||
105501313|NCT04678661|363847080|FG001|Overall Study|Lost to Follow-up|0|||
105501314|NCT04678661|363847079|FG000|Overall Study|Death|2|||
105501315|NCT04678661|363847080|FG001|Overall Study|Death|0|||
105501316|NCT01705730|363847081|FG000|Overall Study|Lack of Efficacy|1|||
105501317|NCT01705730|363847081|FG000|Overall Study|Adverse Event|3|||
105501318|NCT01705730|363847081|FG000|Overall Study|Lost to Follow-up|1|||
105501319|NCT01705730|363847081|FG000|Overall Study|Reason not Specified|4|||
105501320|NCT03068455|363847082|FG000|Pre-treatment Period|Disease progression|0|||
105501321|NCT03068455|363847083|FG001|Pre-treatment Period|Disease progression|1|||
105501322|NCT03068455|363847082|FG000|Pre-treatment Period|Participant withdrew consent|1|||
105501323|NCT03068455|363847083|FG001|Pre-treatment Period|Participant withdrew consent|1|||
105501324|NCT03068455|363847082|FG000|Pre-treatment Period|Poor/non-compliance|0|||
105501325|NCT03068455|363847083|FG001|Pre-treatment Period|Poor/non-compliance|1|||
105501326|NCT03068455|363847082|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
105501327|NCT03068455|363847083|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
105501328|NCT03068455|363847082|FG000|Pre-treatment Period|Not reported|2|||
105501329|NCT03068455|363847083|FG001|Pre-treatment Period|Not reported|1|||
105501330|NCT03068455|363847082|FG000|Treatment Period|Disease progression|166|||
105501331|NCT03068455|363847083|FG001|Treatment Period|Disease progression|208|||
105501332|NCT03068455|363847082|FG000|Treatment Period|Study drug toxicity|317|||
105501333|NCT03068455|363847083|FG001|Treatment Period|Study drug toxicity|104|||
105501334|NCT03068455|363847082|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
105501335|NCT03068455|363847083|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
105501336|NCT03068455|363847082|FG000|Treatment Period|Participant request to stop therapy|33|||
105501337|NCT03068455|363847083|FG001|Treatment Period|Participant request to stop therapy|20|||
105501338|NCT03068455|363847082|FG000|Treatment Period|Participant withdrew consent|5|||
105501339|NCT03068455|363847083|FG001|Treatment Period|Participant withdrew consent|10|||
105501340|NCT03068455|363847082|FG000|Treatment Period|Poor/non-compliance|3|||
105501341|NCT03068455|363847083|FG001|Treatment Period|Poor/non-compliance|0|||
105501342|NCT03068455|363847082|FG000|Treatment Period|Participant no longer meets study criteria|1|||
105501343|NCT03068455|363847083|FG001|Treatment Period|Participant no longer meets study criteria|3|||
105501344|NCT03068455|363847082|FG000|Treatment Period|Other reasons|12|||
105501345|NCT03068455|363847083|FG001|Treatment Period|Other reasons|4|||
105501346|NCT00493025|363847086|FG000|Overall Study|Physician Decision|19|||
105501347|NCT01876420|363847087|FG000|Overall Study|Missed 30 day visit|1|||
105501348|NCT04457336|363847088|FG000|Period 2: Part A|Withdrawal by Subject|0|||
105501349|NCT04457336|363847089|FG001|Period 2: Part A|Withdrawal by Subject|1|||
105501350|NCT04457336|363847090|FG002|Period 2: Part A|Withdrawal by Subject|1|||
105501351|NCT04457336|363847091|FG003|Period 2: Part A|Withdrawal by Subject|1|||
105501352|NCT04457336|363847092|FG004|Period 2: Part A|Withdrawal by Subject|0|||
105501353|NCT04457336|363847093|FG005|Period 2: Part A|Withdrawal by Subject|0|||
105501354|NCT04457336|363847094|FG006|Period 2: Part A|Withdrawal by Subject|0|||
105501355|NCT04457336|363847095|FG007|Period 2: Part A|Withdrawal by Subject|0|||
105501356|NCT04457336|363847088|FG000|Period 2: Part A|Adverse Event|0|||
105501357|NCT04457336|363847089|FG001|Period 2: Part A|Adverse Event|0|||
105501358|NCT04457336|363847090|FG002|Period 2: Part A|Adverse Event|1|||
105501359|NCT04457336|363847091|FG003|Period 2: Part A|Adverse Event|1|||
105501360|NCT04457336|363847092|FG004|Period 2: Part A|Adverse Event|0|||
105501361|NCT04457336|363847093|FG005|Period 2: Part A|Adverse Event|0|||
105501362|NCT04457336|363847094|FG006|Period 2: Part A|Adverse Event|0|||
105501363|NCT04457336|363847095|FG007|Period 2: Part A|Adverse Event|0|||
105501364|NCT04457336|363847088|FG000|Period 2: Part A|Study Terminated|0|||
105501365|NCT04457336|363847089|FG001|Period 2: Part A|Study Terminated|0|||
105501366|NCT04457336|363847090|FG002|Period 2: Part A|Study Terminated|1|||
105501367|NCT04457336|363847091|FG003|Period 2: Part A|Study Terminated|0|||
105501368|NCT04457336|363847092|FG004|Period 2: Part A|Study Terminated|0|||
105501369|NCT04457336|363847093|FG005|Period 2: Part A|Study Terminated|0|||
105501370|NCT04457336|363847094|FG006|Period 2: Part A|Study Terminated|0|||
105501371|NCT04457336|363847095|FG007|Period 2: Part A|Study Terminated|0|||
105501372|NCT04457336|363847088|FG000|Period 2: Part A|Protocol Violation|0|||
105501373|NCT04457336|363847089|FG001|Period 2: Part A|Protocol Violation|1|||
105588518|NCT04888585|364154775|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
105588519|NCT04888585|364154776|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
105588520|NCT04888585|364154777|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
105588521|NCT04888585|364154778|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
105588522|NCT04888585|364154779|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
105588523|NCT04888585|364154780|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
105588524|NCT04888585|364154770|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
105588525|NCT04888585|364154771|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
105588526|NCT04888585|364154772|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
105588527|NCT04888585|364154773|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
105588528|NCT04888585|364154774|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
105588529|NCT04888585|364154775|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
105588530|NCT04888585|364154776|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
105588531|NCT04888585|364154777|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
105588532|NCT04888585|364154778|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
105588533|NCT04888585|364154779|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
105588534|NCT04888585|364154780|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
105588535|NCT04888585|364154770|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
105588536|NCT04888585|364154771|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
105588537|NCT04888585|364154772|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
105588538|NCT04888585|364154773|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
105588539|NCT04888585|364154774|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
105588540|NCT04888585|364154775|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
105588541|NCT04888585|364154776|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
105588542|NCT04888585|364154777|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
105588543|NCT04888585|364154778|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
105588544|NCT04888585|364154779|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
105588545|NCT04888585|364154780|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
105588546|NCT03822351|364154781|FG000|Overall Study|Death|27|||
105588547|NCT03822351|364154782|FG001|Overall Study|Death|23|||
105588548|NCT03822351|364154783|FG002|Overall Study|Death|24|||
105588549|NCT03822351|364154781|FG000|Overall Study|Lost to Follow-up|6|||
105588550|NCT03822351|364154782|FG001|Overall Study|Lost to Follow-up|2|||
105588551|NCT03822351|364154783|FG002|Overall Study|Lost to Follow-up|1|||
105588552|NCT03822351|364154781|FG000|Overall Study|Withdrawal by Subject|10|||
105588553|NCT03822351|364154782|FG001|Overall Study|Withdrawal by Subject|4|||
105588554|NCT03822351|364154783|FG002|Overall Study|Withdrawal by Subject|6|||
105588555|NCT03822351|364154781|FG000|Overall Study|Progressive Disease|2|||
105588556|NCT03822351|364154782|FG001|Overall Study|Progressive Disease|1|||
105588557|NCT03822351|364154783|FG002|Overall Study|Progressive Disease|0|||
105588558|NCT03822351|364154781|FG000|Overall Study|Not Treated|1|||
105588559|NCT03822351|364154782|FG001|Overall Study|Not Treated|1|||
105588560|NCT03822351|364154783|FG002|Overall Study|Not Treated|1|||
105588561|NCT03568162|364154784|FG000|Overall Study|Adverse Event|0|||
105588562|NCT03568162|364154785|FG001|Overall Study|Adverse Event|1|||
105588563|NCT03568162|364154786|FG002|Overall Study|Adverse Event|2|||
105588564|NCT03568162|364154787|FG003|Overall Study|Adverse Event|0|||
105588565|NCT03568162|364154788|FG004|Overall Study|Adverse Event|0|||
105588566|NCT03568162|364154789|FG005|Overall Study|Adverse Event|1|||
105588567|NCT03568162|364154784|FG000|Overall Study|Death|0|||
105588568|NCT03568162|364154785|FG001|Overall Study|Death|0|||
105588569|NCT03568162|364154786|FG002|Overall Study|Death|0|||
105588570|NCT03568162|364154787|FG003|Overall Study|Death|0|||
105588571|NCT03568162|364154788|FG004|Overall Study|Death|1|||
105588572|NCT03568162|364154789|FG005|Overall Study|Death|0|||
105588573|NCT03568162|364154784|FG000|Overall Study|Lost to Follow-up|3|||
105426441|NCT02275117|363569517|FG003|Overall Study|Withdrawal by Subject|3|||
105426442|NCT02275117|363569518|FG004|Overall Study|Withdrawal by Subject|3|||
105426443|NCT02275117|363569514|FG000|Overall Study|Terminated by Sponsor|4|||
105426444|NCT02275117|363569515|FG001|Overall Study|Terminated by Sponsor|4|||
105426445|NCT02275117|363569516|FG002|Overall Study|Terminated by Sponsor|4|||
105588574|NCT03568162|364154785|FG001|Overall Study|Lost to Follow-up|2|||
105588575|NCT03568162|364154786|FG002|Overall Study|Lost to Follow-up|4|||
105588576|NCT03568162|364154787|FG003|Overall Study|Lost to Follow-up|2|||
105588577|NCT03568162|364154788|FG004|Overall Study|Lost to Follow-up|3|||
105588578|NCT03568162|364154789|FG005|Overall Study|Lost to Follow-up|2|||
105588579|NCT03568162|364154784|FG000|Overall Study|Physician Decision|0|||
105588580|NCT03568162|364154785|FG001|Overall Study|Physician Decision|1|||
105588581|NCT03568162|364154786|FG002|Overall Study|Physician Decision|1|||
105588582|NCT03568162|364154787|FG003|Overall Study|Physician Decision|0|||
105588583|NCT03568162|364154788|FG004|Overall Study|Physician Decision|1|||
105426446|NCT02275117|363569517|FG003|Overall Study|Terminated by Sponsor|6|||
105588584|NCT03568162|364154789|FG005|Overall Study|Physician Decision|0|||
105588585|NCT03568162|364154784|FG000|Overall Study|Pregnancy|0|||
105426447|NCT02275117|363569518|FG004|Overall Study|Terminated by Sponsor|4|||
105426448|NCT02275117|363569514|FG000|Overall Study|Worsening of Study Indication|0|||
105426449|NCT02275117|363569515|FG001|Overall Study|Worsening of Study Indication|1|||
105426450|NCT02275117|363569516|FG002|Overall Study|Worsening of Study Indication|2|||
105426451|NCT02275117|363569517|FG003|Overall Study|Worsening of Study Indication|0|||
105426452|NCT02275117|363569518|FG004|Overall Study|Worsening of Study Indication|0|||
105426453|NCT02275117|363569514|FG000|Overall Study|Study Burden|5|||
105426454|NCT02275117|363569515|FG001|Overall Study|Study Burden|4|||
105426455|NCT02275117|363569516|FG002|Overall Study|Study Burden|7|||
105426456|NCT02275117|363569517|FG003|Overall Study|Study Burden|5|||
105426457|NCT02275117|363569518|FG004|Overall Study|Study Burden|7|||
105426458|NCT02275117|363569514|FG000|Overall Study|Other|1|||
105426459|NCT02275117|363569515|FG001|Overall Study|Other|0|||
105426460|NCT02275117|363569516|FG002|Overall Study|Other|0|||
105426461|NCT02275117|363569517|FG003|Overall Study|Other|0|||
105426462|NCT02275117|363569518|FG004|Overall Study|Other|2|||
105426463|NCT02014480|363569521|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
105426464|NCT02014480|363569522|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
105426465|NCT02014480|363569523|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
105426466|NCT02014480|363569524|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
105426467|NCT02014480|363569525|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
105426468|NCT02014480|363569526|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
105426469|NCT02014480|363569521|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105426470|NCT02014480|363569522|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
105426471|NCT02014480|363569523|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105426472|NCT02014480|363569524|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
105426473|NCT02014480|363569525|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
105426474|NCT02014480|363569526|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105426475|NCT02014480|363569521|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105426476|NCT02014480|363569522|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105426477|NCT02014480|363569523|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
105426478|NCT02014480|363569524|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105426479|NCT02014480|363569525|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105426480|NCT02014480|363569526|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105426481|NCT02014480|363569521|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
105426482|NCT02014480|363569522|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
105426483|NCT02014480|363569523|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
105426484|NCT02014480|363569524|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
105426485|NCT02014480|363569525|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105426486|NCT02014480|363569526|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105426487|NCT02014480|363569521|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105426488|NCT02014480|363569522|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
105426489|NCT02014480|363569523|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105426490|NCT02014480|363569524|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105426491|NCT02014480|363569525|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105426492|NCT02014480|363569526|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105426493|NCT02014480|363569521|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
105426494|NCT02014480|363569522|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
105426495|NCT02014480|363569523|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
105426496|NCT02014480|363569524|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
105426497|NCT02014480|363569525|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
105426498|NCT02014480|363569526|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
105426499|NCT02014480|363569521|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105426500|NCT02014480|363569522|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105426501|NCT02014480|363569523|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105426502|NCT02014480|363569524|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105426503|NCT02014480|363569525|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105426504|NCT02014480|363569526|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
105426505|NCT02763254|363569529|FG000|Overall Study|Adverse Event|1|||
105426506|NCT01149486|363569530|FG000|First Intervention|Adverse Event|0|||
105426507|NCT01149486|363569531|FG001|First Intervention|Adverse Event|1|||
105426508|NCT01135914|363569532|FG000|Overall Study|Withdrawal by Subject|1|||
105426509|NCT01135914|363569533|FG001|Overall Study|Withdrawal by Subject|3|||
105426510|NCT01135914|363569534|FG002|Overall Study|Withdrawal by Subject|6|||
105426511|NCT01135914|363569532|FG000|Overall Study|Lost to Follow-up|1|||
105426512|NCT01135914|363569533|FG001|Overall Study|Lost to Follow-up|0|||
105426513|NCT01135914|363569534|FG002|Overall Study|Lost to Follow-up|1|||
105426514|NCT01135914|363569532|FG000|Overall Study|Protocol Violation|0|||
105426515|NCT01135914|363569533|FG001|Overall Study|Protocol Violation|0|||
105426516|NCT01135914|363569534|FG002|Overall Study|Protocol Violation|3|||
105426517|NCT01135914|363569532|FG000|Overall Study|Lack of Efficacy|2|||
105426518|NCT01135914|363569533|FG001|Overall Study|Lack of Efficacy|1|||
105426519|NCT01135914|363569534|FG002|Overall Study|Lack of Efficacy|10|||
105426520|NCT01135914|363569532|FG000|Overall Study|Adverse Event|0|||
105426521|NCT01135914|363569533|FG001|Overall Study|Adverse Event|1|||
105426522|NCT01135914|363569534|FG002|Overall Study|Adverse Event|2|||
105426523|NCT02078102|363569537|FG000|Overall Study|Adverse Event|1|||
105426524|NCT02078102|363569538|FG001|Overall Study|Adverse Event|0|||
105426525|NCT02078102|363569537|FG000|Overall Study|Withdrawal by Subject|1|||
105426526|NCT02078102|363569538|FG001|Overall Study|Withdrawal by Subject|0|||
105426527|NCT02078102|363569537|FG000|Overall Study|Physician Decision|0|||
105426528|NCT02078102|363569538|FG001|Overall Study|Physician Decision|1|||
105426529|NCT02185014|363569539|FG000|Overall Study|Adverse Event|18|||
105426530|NCT02185014|363569539|FG000|Overall Study|Withdrew Consent|8|||
105426531|NCT02185014|363569539|FG000|Overall Study|Lost to Follow-up|4|||
105426532|NCT02185014|363569539|FG000|Overall Study|Lack of Efficacy|14|||
105426533|NCT02185014|363569539|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
105426534|NCT02185014|363569539|FG000|Overall Study|Subject Noncompliance|1|||
105426535|NCT02185014|363569539|FG000|Overall Study|Other|4|||
105588586|NCT03568162|364154785|FG001|Overall Study|Pregnancy|0|||
105588587|NCT03568162|364154786|FG002|Overall Study|Pregnancy|0|||
105588588|NCT03568162|364154787|FG003|Overall Study|Pregnancy|1|||
105588589|NCT03568162|364154788|FG004|Overall Study|Pregnancy|0|||
105588590|NCT03568162|364154789|FG005|Overall Study|Pregnancy|0|||
105588591|NCT03568162|364154784|FG000|Overall Study|Protocol Violation|1|||
105588592|NCT03568162|364154785|FG001|Overall Study|Protocol Violation|0|||
105588593|NCT03568162|364154786|FG002|Overall Study|Protocol Violation|1|||
105588594|NCT03568162|364154787|FG003|Overall Study|Protocol Violation|1|||
105588595|NCT03568162|364154788|FG004|Overall Study|Protocol Violation|1|||
105588596|NCT03568162|364154789|FG005|Overall Study|Protocol Violation|1|||
105588597|NCT03568162|364154784|FG000|Overall Study|Withdrawal by Subject|15|||
105588598|NCT03568162|364154785|FG001|Overall Study|Withdrawal by Subject|15|||
105588599|NCT03568162|364154786|FG002|Overall Study|Withdrawal by Subject|26|||
105588600|NCT03568162|364154787|FG003|Overall Study|Withdrawal by Subject|22|||
105588601|NCT03568162|364154788|FG004|Overall Study|Withdrawal by Subject|6|||
105588602|NCT03568162|364154789|FG005|Overall Study|Withdrawal by Subject|9|||
105588603|NCT03568162|364154784|FG000|Overall Study|Others|3|||
105588604|NCT03568162|364154785|FG001|Overall Study|Others|4|||
105588605|NCT03568162|364154786|FG002|Overall Study|Others|1|||
105588606|NCT03568162|364154787|FG003|Overall Study|Others|4|||
105588607|NCT03568162|364154788|FG004|Overall Study|Others|2|||
105588608|NCT03568162|364154789|FG005|Overall Study|Others|1|||
105588609|NCT02908464|364154790|FG000|Overall Study|Withdrawal by Subject|2|||
105588610|NCT02908464|364154791|FG001|Overall Study|Withdrawal by Subject|1|||
105588611|NCT02908464|364154790|FG000|Overall Study|Found ineligible after randomization|0|||
105588612|NCT02908464|364154791|FG001|Overall Study|Found ineligible after randomization|2|||
105588613|NCT03102242|364154792|FG000|Overall Study|Adverse Event|2|||
105588614|NCT01137292|364154793|FG000|Overall Study|Death|30|||
105588615|NCT01137292|364154793|FG000|Overall Study|Adverse Event|3|||
105588616|NCT01137292|364154793|FG000|Overall Study|Lack of Efficacy|13|||
105588617|NCT01137292|364154793|FG000|Overall Study|Lost to Follow-up|1|||
105588618|NCT01137292|364154793|FG000|Overall Study|Other|7|||
105588619|NCT00477412|364154798|FG000|Overall Study|Death|0|||
105588620|NCT00477412|364154799|FG001|Overall Study|Death|0|||
105588621|NCT00477412|364154800|FG002|Overall Study|Death|0|||
105588622|NCT00477412|364154801|FG003|Overall Study|Death|4|||
105588623|NCT00477412|364154798|FG000|Overall Study|Lost to Follow-up|0|||
105588624|NCT00477412|364154799|FG001|Overall Study|Lost to Follow-up|0|||
105588625|NCT00477412|364154800|FG002|Overall Study|Lost to Follow-up|0|||
105588626|NCT00477412|364154801|FG003|Overall Study|Lost to Follow-up|1|||
105588627|NCT00477412|364154798|FG000|Overall Study|Withdrawal by Subject|0|||
105588628|NCT00477412|364154799|FG001|Overall Study|Withdrawal by Subject|0|||
105588629|NCT00477412|364154800|FG002|Overall Study|Withdrawal by Subject|0|||
105588630|NCT00477412|364154801|FG003|Overall Study|Withdrawal by Subject|2|||
105588631|NCT00477412|364154798|FG000|Overall Study|Second Malignancy|0|||
105588632|NCT00477412|364154799|FG001|Overall Study|Second Malignancy|0|||
105588633|NCT00477412|364154800|FG002|Overall Study|Second Malignancy|0|||
105588634|NCT00477412|364154801|FG003|Overall Study|Second Malignancy|1|||
105588635|NCT00477412|364154798|FG000|Overall Study|Adverse Event|1|||
105588636|NCT00477412|364154799|FG001|Overall Study|Adverse Event|0|||
105588637|NCT00477412|364154800|FG002|Overall Study|Adverse Event|1|||
105588638|NCT00477412|364154801|FG003|Overall Study|Adverse Event|0|||
105588639|NCT00868231|364156711|FG000|Treatment Period 1|Adverse Event|0|||
105588640|NCT00868231|364156712|FG001|Treatment Period 1|Adverse Event|0|||
105588641|NCT00868231|364156713|FG002|Treatment Period 1|Adverse Event|0|||
105588642|NCT00868231|364156714|FG003|Treatment Period 1|Adverse Event|0|||
105588643|NCT00868231|364156715|FG004|Treatment Period 1|Adverse Event|1|||
105588644|NCT00868231|364156716|FG005|Treatment Period 1|Adverse Event|0|||
105588645|NCT00868231|364156711|FG000|Treatment Period 2|Adverse Event|1|||
105588646|NCT00868231|364156712|FG001|Treatment Period 2|Adverse Event|0|||
105588647|NCT00868231|364156713|FG002|Treatment Period 2|Adverse Event|0|||
105588648|NCT00868231|364156714|FG003|Treatment Period 2|Adverse Event|0|||
105588649|NCT00868231|364156715|FG004|Treatment Period 2|Adverse Event|0|||
105588650|NCT00868231|364156716|FG005|Treatment Period 2|Adverse Event|0|||
105588651|NCT00868231|364156711|FG000|Treatment Period 3|Adverse Event|0|||
105588652|NCT00868231|364156712|FG001|Treatment Period 3|Adverse Event|0|||
105588653|NCT00868231|364156713|FG002|Treatment Period 3|Adverse Event|1|||
105588654|NCT00868231|364156714|FG003|Treatment Period 3|Adverse Event|0|||
105588655|NCT00868231|364156715|FG004|Treatment Period 3|Adverse Event|0|||
105588656|NCT00868231|364156716|FG005|Treatment Period 3|Adverse Event|0|||
105588657|NCT02321540|364156717|FG000|Overall Study|Death|0|||
105588658|NCT02321540|364156718|FG001|Overall Study|Death|1|||
105588659|NCT02321540|364156717|FG000|Overall Study|Progression|3|||
105588660|NCT02321540|364156718|FG001|Overall Study|Progression|9|||
105588661|NCT03255018|364156719|FG000|Overall Study|Death on study|0|||
105588662|NCT03255018|364156720|FG001|Overall Study|Death on study|5|||
105588663|NCT03255018|364156719|FG000|Overall Study|Withdrawal by Subject|0|||
105588664|NCT03255018|364156720|FG001|Overall Study|Withdrawal by Subject|2|||
105588665|NCT00938340|364156721|FG000|Overall Study|Withdrawal by Subject|3|||
105588666|NCT00938340|364156721|FG000|Overall Study|Protocol Violation|1|||
105426536|NCT03093974|363569540|FG000|Overall Study|Withdrawal by Subject|32|||
105426537|NCT03093974|363569541|FG001|Overall Study|Withdrawal by Subject|27|||
105426538|NCT03093974|363569540|FG000|Overall Study|Adverse Event|17|||
105426539|NCT03093974|363569541|FG001|Overall Study|Adverse Event|24|||
105426540|NCT03093974|363569540|FG000|Overall Study|Death|0|||
105426541|NCT03093974|363569541|FG001|Overall Study|Death|1|||
105501374|NCT04457336|363847090|FG002|Period 2: Part A|Protocol Violation|0|||
105426542|NCT03093974|363569540|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105426543|NCT03093974|363569541|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105426544|NCT03093974|363569540|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
105426545|NCT03093974|363569541|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
105426546|NCT03093974|363569540|FG000|Overall Study|Lost to Follow-up|0|||
105426547|NCT03093974|363569541|FG001|Overall Study|Lost to Follow-up|1|||
105501375|NCT04457336|363847091|FG003|Period 2: Part A|Protocol Violation|0|||
105501376|NCT04457336|363847092|FG004|Period 2: Part A|Protocol Violation|0|||
105501377|NCT04457336|363847093|FG005|Period 2: Part A|Protocol Violation|0|||
105501378|NCT04457336|363847094|FG006|Period 2: Part A|Protocol Violation|0|||
105501379|NCT04457336|363847095|FG007|Period 2: Part A|Protocol Violation|0|||
105501380|NCT04457336|363847088|FG000|Period 2: Part A|Lost to Follow-up|0|||
105501381|NCT04457336|363847089|FG001|Period 2: Part A|Lost to Follow-up|1|||
105501382|NCT04457336|363847090|FG002|Period 2: Part A|Lost to Follow-up|0|||
105501383|NCT04457336|363847091|FG003|Period 2: Part A|Lost to Follow-up|0|||
105501384|NCT04457336|363847092|FG004|Period 2: Part A|Lost to Follow-up|0|||
105501385|NCT04457336|363847093|FG005|Period 2: Part A|Lost to Follow-up|0|||
105501386|NCT04457336|363847094|FG006|Period 2: Part A|Lost to Follow-up|0|||
105501387|NCT04457336|363847095|FG007|Period 2: Part A|Lost to Follow-up|0|||
105501388|NCT04457336|363847088|FG000|Period 2: Part A|Other|0|||
105501389|NCT04457336|363847089|FG001|Period 2: Part A|Other|1|||
105501390|NCT04457336|363847090|FG002|Period 2: Part A|Other|0|||
105501391|NCT04457336|363847091|FG003|Period 2: Part A|Other|0|||
105501392|NCT04457336|363847092|FG004|Period 2: Part A|Other|0|||
105426548|NCT03093974|363569540|FG000|Overall Study|Other|1|||
105426549|NCT03093974|363569541|FG001|Overall Study|Other|2|||
105426550|NCT01813721|363569545|FG000|Overall Study|Ineligibility determined|63|||
105426551|NCT01813721|363569545|FG000|Overall Study|Withdrawal by Subject|1|||
105426552|NCT01479595|363569550|FG000|Overall Study|Protocol deviation|0|||
105426553|NCT01479595|363569551|FG001|Overall Study|Protocol deviation|1|||
105426554|NCT01479595|363569550|FG000|Overall Study|Adverse Event|2|||
105426555|NCT01479595|363569551|FG001|Overall Study|Adverse Event|1|||
105426556|NCT02255565|363569552|FG000|Overall Study|Withdrawal by Subject|0|||
105426557|NCT02255565|363569553|FG001|Overall Study|Withdrawal by Subject|1|||
105426558|NCT02255565|363569554|FG002|Overall Study|Withdrawal by Subject|0|||
105426559|NCT02133664|363569555|FG000|Overall Study|Lost to Follow-up|2|||
105501393|NCT04457336|363847093|FG005|Period 2: Part A|Other|0|||
105501394|NCT04457336|363847094|FG006|Period 2: Part A|Other|0|||
105501395|NCT04457336|363847095|FG007|Period 2: Part A|Other|0|||
105501396|NCT04457336|363847088|FG000|Period 2: Part A|Physician Decision|0|||
105426560|NCT02133664|363569556|FG001|Overall Study|Lost to Follow-up|1|||
105426561|NCT02133664|363569555|FG000|Overall Study|Adverse Event|3|||
105426562|NCT02133664|363569556|FG001|Overall Study|Adverse Event|6|||
105426563|NCT00810901|363569557|FG000|Overall Study|Lost to Follow-up|88|||
105426564|NCT00810901|363569558|FG001|Overall Study|Lost to Follow-up|58|||
105426565|NCT03906656|363569559|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
105501397|NCT04457336|363847089|FG001|Period 2: Part A|Physician Decision|0|||
105501398|NCT04457336|363847090|FG002|Period 2: Part A|Physician Decision|0|||
105501399|NCT04457336|363847091|FG003|Period 2: Part A|Physician Decision|1|||
105426566|NCT03906656|363569560|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
105426567|NCT03906656|363569559|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
105426568|NCT03906656|363569560|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
105426569|NCT03906656|363569559|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
105501400|NCT04457336|363847092|FG004|Period 2: Part A|Physician Decision|0|||
105426570|NCT03906656|363569560|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
105426571|NCT03906656|363569559|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
105426572|NCT03906656|363569560|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
105426573|NCT03906656|363569559|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
105426574|NCT03906656|363569560|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
105426575|NCT03906656|363569559|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
105426576|NCT03906656|363569560|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
105501401|NCT04457336|363847093|FG005|Period 2: Part A|Physician Decision|0|||
105501402|NCT04457336|363847094|FG006|Period 2: Part A|Physician Decision|0|||
105501403|NCT04457336|363847095|FG007|Period 2: Part A|Physician Decision|0|||
105501404|NCT04457336|363847088|FG000|Period 3: Part B|Study Terminated|0|||
105501405|NCT04457336|363847089|FG001|Period 3: Part B|Study Terminated|0|||
105501406|NCT04457336|363847090|FG002|Period 3: Part B|Study Terminated|0|||
105501407|NCT04457336|363847091|FG003|Period 3: Part B|Study Terminated|0|||
105501408|NCT04457336|363847092|FG004|Period 3: Part B|Study Terminated|1|||
105588667|NCT00938340|364156721|FG000|Overall Study|Adverse Event|1|||
105588668|NCT04353037|364156722|FG000|Overall Study|Lost to Follow-up|0|||
105588669|NCT04353037|364156723|FG001|Overall Study|Lost to Follow-up|1|||
105588670|NCT04353037|364156724|FG002|Overall Study|Lost to Follow-up|2|||
105588671|NCT04353037|364156725|FG003|Overall Study|Lost to Follow-up|3|||
105588672|NCT04353037|364156722|FG000|Overall Study|Withdrawal by Subject|0|||
105588673|NCT04353037|364156723|FG001|Overall Study|Withdrawal by Subject|2|||
105588674|NCT04353037|364156724|FG002|Overall Study|Withdrawal by Subject|3|||
105588675|NCT04353037|364156725|FG003|Overall Study|Withdrawal by Subject|5|||
105588676|NCT04353037|364156722|FG000|Overall Study|Adverse Event|0|||
105588677|NCT04353037|364156723|FG001|Overall Study|Adverse Event|0|||
105588678|NCT04353037|364156724|FG002|Overall Study|Adverse Event|2|||
105588679|NCT04353037|364156725|FG003|Overall Study|Adverse Event|0|||
105588680|NCT04353037|364156722|FG000|Overall Study|Exposure Change|0|||
105588681|NCT04353037|364156723|FG001|Overall Study|Exposure Change|0|||
105588682|NCT04353037|364156724|FG002|Overall Study|Exposure Change|0|||
105588683|NCT04353037|364156725|FG003|Overall Study|Exposure Change|2|||
105588684|NCT03635112|364156726|FG000|Overall Study|Adverse Event|5|||
105588685|NCT03635112|364156727|FG001|Overall Study|Adverse Event|9|||
105588686|NCT03635112|364156728|FG002|Overall Study|Adverse Event|14|||
105588687|NCT03635112|364156726|FG000|Overall Study|Lost to Follow-up|1|||
105588688|NCT03635112|364156727|FG001|Overall Study|Lost to Follow-up|0|||
105588689|NCT03635112|364156728|FG002|Overall Study|Lost to Follow-up|1|||
105588690|NCT03635112|364156726|FG000|Overall Study|Physician Decision|5|||
105588691|NCT03635112|364156727|FG001|Overall Study|Physician Decision|7|||
105588692|NCT03635112|364156728|FG002|Overall Study|Physician Decision|5|||
105588693|NCT03635112|364156726|FG000|Overall Study|Protocol Violation|0|||
105588694|NCT03635112|364156727|FG001|Overall Study|Protocol Violation|0|||
105588695|NCT03635112|364156728|FG002|Overall Study|Protocol Violation|1|||
105588696|NCT03635112|364156726|FG000|Overall Study|Study Terminated by Sponsor|11|||
105588697|NCT03635112|364156727|FG001|Overall Study|Study Terminated by Sponsor|17|||
105588698|NCT03635112|364156728|FG002|Overall Study|Study Terminated by Sponsor|21|||
105588699|NCT03635112|364156726|FG000|Overall Study|Withdrawal by Subject|4|||
105588700|NCT03635112|364156727|FG001|Overall Study|Withdrawal by Subject|9|||
105588701|NCT03635112|364156728|FG002|Overall Study|Withdrawal by Subject|7|||
105588702|NCT03635112|364156726|FG000|Overall Study|Miscellaneous|0|||
105588703|NCT03635112|364156727|FG001|Overall Study|Miscellaneous|0|||
105588704|NCT03635112|364156728|FG002|Overall Study|Miscellaneous|1|||
105588705|NCT02993471|364156731|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
105588706|NCT02993471|364156731|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
105588707|NCT00335556|364156732|FG000|Overall Study|Death|0|||
105588708|NCT00335556|364156733|FG001|Overall Study|Death|5|||
105588709|NCT00335556|364156734|FG002|Overall Study|Death|0|||
105588710|NCT00335556|364156735|FG003|Overall Study|Death|0|||
105588711|NCT00335556|364156736|FG004|Overall Study|Death|1|||
105588712|NCT00335556|364156737|FG005|Overall Study|Death|0|||
105588713|NCT00335556|364156732|FG000|Overall Study|Lack of Efficacy|0|||
105588714|NCT00335556|364156733|FG001|Overall Study|Lack of Efficacy|19|||
105588715|NCT00335556|364156734|FG002|Overall Study|Lack of Efficacy|3|||
105588716|NCT00335556|364156735|FG003|Overall Study|Lack of Efficacy|3|||
105588717|NCT00335556|364156736|FG004|Overall Study|Lack of Efficacy|0|||
105588718|NCT00335556|364156737|FG005|Overall Study|Lack of Efficacy|1|||
105588719|NCT00335556|364156732|FG000|Overall Study|Physician Decision|0|||
105588720|NCT00335556|364156733|FG001|Overall Study|Physician Decision|6|||
105588721|NCT00335556|364156734|FG002|Overall Study|Physician Decision|2|||
105588722|NCT00335556|364156735|FG003|Overall Study|Physician Decision|1|||
105588723|NCT00335556|364156736|FG004|Overall Study|Physician Decision|0|||
105588724|NCT00335556|364156737|FG005|Overall Study|Physician Decision|0|||
105588725|NCT00335556|364156732|FG000|Overall Study|Ineligible|2|||
105588726|NCT00335556|364156733|FG001|Overall Study|Ineligible|0|||
105588727|NCT00335556|364156734|FG002|Overall Study|Ineligible|0|||
105588728|NCT00335556|364156735|FG003|Overall Study|Ineligible|0|||
105588729|NCT00335556|364156736|FG004|Overall Study|Ineligible|0|||
105588730|NCT00335556|364156737|FG005|Overall Study|Ineligible|0|||
105588731|NCT00335556|364156732|FG000|Overall Study|Refusal of further protocol therapy|0|||
105588732|NCT00335556|364156733|FG001|Overall Study|Refusal of further protocol therapy|4|||
105588733|NCT00335556|364156734|FG002|Overall Study|Refusal of further protocol therapy|0|||
105588734|NCT00335556|364156735|FG003|Overall Study|Refusal of further protocol therapy|1|||
105588735|NCT00335556|364156736|FG004|Overall Study|Refusal of further protocol therapy|0|||
105588736|NCT00335556|364156737|FG005|Overall Study|Refusal of further protocol therapy|0|||
105588737|NCT01878890|364156738|FG000|Overall Study|Protocol Violation|0|||
105588738|NCT01878890|364156739|FG001|Overall Study|Protocol Violation|1|||
105588739|NCT01878890|364156740|FG002|Overall Study|Protocol Violation|0|||
105588740|NCT01878890|364156741|FG003|Overall Study|Protocol Violation|0|||
105588741|NCT03178201|364156743|FG000|Overall Study|Off study|5|||
105588742|NCT00567164|364156744|FG000|Overall Study|Withdrawal by Subject|171|||
105588743|NCT00567164|364156745|FG001|Overall Study|Withdrawal by Subject|21|||
105588744|NCT00567164|364156746|FG002|Overall Study|Withdrawal by Subject|17|||
105588745|NCT00567164|364156744|FG000|Overall Study|Protocol Violation|23|||
105588746|NCT00567164|364156745|FG001|Overall Study|Protocol Violation|4|||
105426577|NCT03906656|363569559|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
105426578|NCT03906656|363569560|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
105426579|NCT03906656|363569559|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
105588747|NCT00567164|364156746|FG002|Overall Study|Protocol Violation|2|||
105588748|NCT00567164|364156744|FG000|Overall Study|Adverse Event|92|||
105588749|NCT00567164|364156745|FG001|Overall Study|Adverse Event|13|||
105588750|NCT00567164|364156746|FG002|Overall Study|Adverse Event|9|||
105588751|NCT00567164|364156744|FG000|Overall Study|Death|0|||
105588752|NCT00567164|364156745|FG001|Overall Study|Death|0|||
105588753|NCT00567164|364156746|FG002|Overall Study|Death|1|||
105588754|NCT00567164|364156744|FG000|Overall Study|Lost to Follow-up|202|||
105588755|NCT00567164|364156745|FG001|Overall Study|Lost to Follow-up|23|||
105588756|NCT00567164|364156746|FG002|Overall Study|Lost to Follow-up|21|||
105588757|NCT00567164|364156744|FG000|Overall Study|Pregnancy|20|||
105588758|NCT00567164|364156745|FG001|Overall Study|Pregnancy|4|||
105588759|NCT00567164|364156746|FG002|Overall Study|Pregnancy|6|||
105588760|NCT00567164|364156744|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
105588761|NCT00567164|364156745|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
105588762|NCT00567164|364156746|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
105588763|NCT00567164|364156744|FG000|Overall Study|Missing|1|||
105588764|NCT00567164|364156745|FG001|Overall Study|Missing|0|||
105588765|NCT00567164|364156746|FG002|Overall Study|Missing|0|||
105588766|NCT03441984|364156747|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
105588767|NCT03441984|364156748|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
105588768|NCT03441984|364156749|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
105588769|NCT03441984|364156750|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
105588770|NCT03441984|364156751|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
105588771|NCT03441984|364156752|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
105426580|NCT03906656|363569560|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
105426581|NCT03906656|363569559|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
105426582|NCT03906656|363569560|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
105426583|NCT03906656|363569559|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
105426584|NCT03906656|363569560|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
105426585|NCT03906656|363569559|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
105426586|NCT03906656|363569560|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
105426587|NCT03906656|363569559|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
105426588|NCT03906656|363569560|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
105426589|NCT03906656|363569559|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
105426590|NCT03906656|363569560|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
105426591|NCT03906656|363569559|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
105426592|NCT03906656|363569560|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
105426593|NCT03906656|363569559|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
105426594|NCT03906656|363569560|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
105426595|NCT03906656|363569559|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
105426596|NCT03906656|363569560|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
105426597|NCT03906656|363569559|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
105426598|NCT03906656|363569560|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
105426599|NCT03906656|363569559|FG000|Home Use 2 (3 Months)|Death|2|||
105426600|NCT03906656|363569560|FG001|Home Use 2 (3 Months)|Death|0|||
105426601|NCT03906656|363569559|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
105426602|NCT03906656|363569560|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
105426603|NCT03906656|363569559|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
105426604|NCT03906656|363569560|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
105588772|NCT03441984|364156753|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
105588773|NCT03441984|364156754|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
105426605|NCT02120365|363569567|FG000|Overall Study|Withdrawal by Subject|0|||
105426606|NCT02120365|363569568|FG001|Overall Study|Withdrawal by Subject|0|||
105426607|NCT02120365|363569569|FG002|Overall Study|Withdrawal by Subject|2|||
105426608|NCT02120365|363569570|FG003|Overall Study|Withdrawal by Subject|4|||
105426609|NCT02120365|363569571|FG004|Overall Study|Withdrawal by Subject|0|||
105426610|NCT02120365|363569572|FG005|Overall Study|Withdrawal by Subject|2|||
105426611|NCT00581828|363569574|FG000|Overall Study|Protocol Violation|1|||
105426612|NCT01129882|363569575|FG000|Overall Study|Adverse Event|39|||
105426613|NCT01129882|363569575|FG000|Overall Study|Death|6|||
105426614|NCT01129882|363569575|FG000|Overall Study|Lack of Efficacy|5|||
105426615|NCT01129882|363569575|FG000|Overall Study|Lost to Follow-up|13|||
105426616|NCT01129882|363569575|FG000|Overall Study|Physician Decision|27|||
105426617|NCT01129882|363569575|FG000|Overall Study|Protocol Deviation|3|||
105426618|NCT01129882|363569575|FG000|Overall Study|Withdrawal Criteria Met|19|||
105588774|NCT03441984|364156755|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
105588775|NCT03441984|364156756|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
105588776|NCT03441984|364156757|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
105588777|NCT03441984|364156758|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
105588778|NCT02430532|364156759|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
105588779|NCT02430532|364156760|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
105588780|NCT02430532|364156759|FG000|Overall Study|Consent Withdrawn|0|||
105588781|NCT02430532|364156760|FG001|Overall Study|Consent Withdrawn|2|||
105588782|NCT02430532|364156759|FG000|Overall Study|Adverse Event|0|||
105588783|NCT02430532|364156760|FG001|Overall Study|Adverse Event|1|||
105588784|NCT01670019|364156763|FG000|Overall Study|Adverse Event|3|||
105588785|NCT01670019|364156764|FG001|Overall Study|Adverse Event|0|||
105588786|NCT01670019|364156763|FG000|Overall Study|Withdrawal by Subject|6|||
105588787|NCT01670019|364156764|FG001|Overall Study|Withdrawal by Subject|0|||
105588788|NCT03537651|364156765|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
105588789|NCT03537651|364156765|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
105588790|NCT03537651|364156765|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
105588791|NCT03537651|364156765|FG000|Part A (Up to 96 Weeks)|Other|1|||
105588792|NCT03537651|364156765|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
105588793|NCT03537651|364156765|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
105588794|NCT03537651|364156765|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
105588795|NCT03537651|364156765|FG000|Part B (Up to 192 Weeks)|Other|1|||
105588796|NCT02524288|364156766|FG000|Overall Study|Adverse Event|115|||
105588797|NCT02524288|364156766|FG000|Overall Study|Lost to Follow-up|216|||
105588798|NCT02524288|364156766|FG000|Overall Study|Non-Compliance With Protocol|32|||
105588799|NCT02524288|364156766|FG000|Overall Study|Non-Compliance With Study Drug|14|||
105588800|NCT02524288|364156766|FG000|Overall Study|Pregnancy Wish|6|||
105588801|NCT02524288|364156766|FG000|Overall Study|Protocol Violation|6|||
105588802|NCT02524288|364156766|FG000|Overall Study|Screen Failure|2|||
105588803|NCT02524288|364156766|FG000|Overall Study|Site Discontinued Study Participation|1|||
105588804|NCT02524288|364156766|FG000|Overall Study|Study Terminated By Sponsor|1417|||
105588805|NCT02524288|364156766|FG000|Overall Study|Subject Moved|32|||
105588806|NCT02524288|364156766|FG000|Overall Study|Withdrawal by Subject|76|||
105588807|NCT02524288|364156766|FG000|Overall Study|Pregnancy|22|||
105588808|NCT02524288|364156766|FG000|Overall Study|Physician Decision|2|||
105588809|NCT00517933|364156767|FG000|Period 1|Death|2|||
105588810|NCT00517933|364156768|FG001|Period 1|Death|1|||
105588811|NCT00517933|364156767|FG000|Period 1|Adverse Event|4|||
105588812|NCT00517933|364156768|FG001|Period 1|Adverse Event|4|||
105588813|NCT00517933|364156767|FG000|Period 1|Lost to Follow-up|2|||
105588814|NCT00517933|364156768|FG001|Period 1|Lost to Follow-up|0|||
105588815|NCT00517933|364156767|FG000|Period 1|Underwent lung transplant|0|||
105588816|NCT00517933|364156768|FG001|Period 1|Underwent lung transplant|1|||
105588817|NCT00517933|364156767|FG000|Period 2|Death|2|||
105588818|NCT00517933|364156768|FG001|Period 2|Death|4|||
105588819|NCT00517933|364156767|FG000|Period 2|Adverse Event|2|||
105588820|NCT00517933|364156768|FG001|Period 2|Adverse Event|4|||
105588821|NCT00517933|364156767|FG000|Period 2|Physician Decision|1|||
105588822|NCT00517933|364156768|FG001|Period 2|Physician Decision|0|||
105588823|NCT00517933|364156767|FG000|Period 2|Withdrawal by Subject|1|||
105588824|NCT00517933|364156768|FG001|Period 2|Withdrawal by Subject|3|||
105588825|NCT00517933|364156767|FG000|Period 2|Underwent lung transplant|0|||
105588826|NCT00517933|364156768|FG001|Period 2|Underwent lung transplant|2|||
105588827|NCT01467700|364156769|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
105588828|NCT01467700|364156770|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
105588829|NCT01467700|364156771|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
105588830|NCT01467700|364156772|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
105588831|NCT01467700|364156769|FG000|Overall Study|Major Protocol Deviation|3|||
105588832|NCT01467700|364156770|FG001|Overall Study|Major Protocol Deviation|3|||
105588833|NCT01467700|364156771|FG002|Overall Study|Major Protocol Deviation|2|||
105588834|NCT01467700|364156772|FG003|Overall Study|Major Protocol Deviation|3|||
105588835|NCT01467700|364156769|FG000|Overall Study|Lost to Follow-up|6|||
105588836|NCT01467700|364156770|FG001|Overall Study|Lost to Follow-up|5|||
105588837|NCT01467700|364156771|FG002|Overall Study|Lost to Follow-up|2|||
105588838|NCT01467700|364156772|FG003|Overall Study|Lost to Follow-up|3|||
105588839|NCT01467700|364156769|FG000|Overall Study|Voluntary Withdrawal|5|||
105588840|NCT01467700|364156770|FG001|Overall Study|Voluntary Withdrawal|7|||
105588841|NCT01467700|364156771|FG002|Overall Study|Voluntary Withdrawal|6|||
105426619|NCT01129882|363569575|FG000|Overall Study|Trial Termination by Sponsor|6|||
105426620|NCT01129882|363569575|FG000|Overall Study|Withdrawal by Subject|160|||
105588842|NCT01467700|364156772|FG003|Overall Study|Voluntary Withdrawal|2|||
105588843|NCT01467700|364156769|FG000|Overall Study|Study Termination|6|||
105588844|NCT01467700|364156770|FG001|Overall Study|Study Termination|5|||
105588845|NCT01467700|364156771|FG002|Overall Study|Study Termination|10|||
105588846|NCT01467700|364156772|FG003|Overall Study|Study Termination|7|||
105588847|NCT01467700|364156769|FG000|Overall Study|Pregnancy|0|||
105588848|NCT01467700|364156770|FG001|Overall Study|Pregnancy|1|||
105588849|NCT01467700|364156771|FG002|Overall Study|Pregnancy|1|||
105588850|NCT01467700|364156772|FG003|Overall Study|Pregnancy|0|||
105426621|NCT00392808|363569578|FG000|Overall Study|Lost to Follow-up|3|||
105426622|NCT00392808|363569579|FG001|Overall Study|Lost to Follow-up|2|||
105426623|NCT00392808|363569580|FG002|Overall Study|Lost to Follow-up|1|||
105426624|NCT00392808|363569581|FG003|Overall Study|Lost to Follow-up|2|||
105426625|NCT00392808|363569578|FG000|Overall Study|Unable to withdraw blood|3|||
105426626|NCT00392808|363569579|FG001|Overall Study|Unable to withdraw blood|1|||
105426627|NCT00392808|363569580|FG002|Overall Study|Unable to withdraw blood|1|||
105426628|NCT00392808|363569581|FG003|Overall Study|Unable to withdraw blood|2|||
105426629|NCT00320372|363569584|FG000|Overall Study|Physician Decision|4|||
105426630|NCT00320372|363569585|FG001|Overall Study|Physician Decision|7|||
105426631|NCT00320372|363569584|FG000|Overall Study|Death|7|||
105426632|NCT00320372|363569585|FG001|Overall Study|Death|8|||
105426633|NCT00320372|363569584|FG000|Overall Study|Withdrawal by Subject|55|||
105426634|NCT00320372|363569585|FG001|Overall Study|Withdrawal by Subject|37|||
105426635|NCT00320372|363569584|FG000|Overall Study|Non-Compliance|40|||
105426636|NCT00320372|363569585|FG001|Overall Study|Non-Compliance|39|||
105426637|NCT00320372|363569584|FG000|Overall Study|Did not Meet (I/E)|3|||
105426638|NCT00320372|363569585|FG001|Overall Study|Did not Meet (I/E)|1|||
105426639|NCT00320372|363569584|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
105426640|NCT00320372|363569585|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
105426641|NCT00930969|363569587|FG000|Overall Study|Death|5|||
105426642|NCT00930969|363569587|FG000|Overall Study|Lost to Follow-up|1|||
105426643|NCT00930969|363569587|FG000|Overall Study|Physician Decision|13|||
105426644|NCT00930969|363569587|FG000|Overall Study|Withdrawal by Subject|19|||
105426645|NCT00657150|363569588|FG000|Overall Study|Adverse Event|19|||
105426646|NCT00657150|363569589|FG001|Overall Study|Adverse Event|10|||
105426647|NCT00657150|363569588|FG000|Overall Study|Non-compliant with protocol|5|||
105426648|NCT00657150|363569589|FG001|Overall Study|Non-compliant with protocol|9|||
105426649|NCT00657150|363569588|FG000|Overall Study|Lost to Follow-up|2|||
105426650|NCT00657150|363569589|FG001|Overall Study|Lost to Follow-up|0|||
105426651|NCT00657150|363569588|FG000|Overall Study|Withdrawal by Subject|51|||
105426652|NCT00657150|363569589|FG001|Overall Study|Withdrawal by Subject|36|||
105426653|NCT00657150|363569588|FG000|Overall Study|Other|38|||
105426654|NCT00657150|363569589|FG001|Overall Study|Other|38|||
105426655|NCT00657150|363569588|FG000|Treatment|Adverse Event|60|||
105426656|NCT00657150|363569589|FG001|Treatment|Adverse Event|53|||
105426657|NCT00657150|363569588|FG000|Treatment|Non-compliant with protocol|10|||
105426658|NCT00657150|363569589|FG001|Treatment|Non-compliant with protocol|9|||
105426659|NCT00657150|363569588|FG000|Treatment|Lost to Follow-up|1|||
105426660|NCT00657150|363569589|FG001|Treatment|Lost to Follow-up|0|||
105426661|NCT00657150|363569588|FG000|Treatment|Withdrawal by Subject|23|||
105426662|NCT00657150|363569589|FG001|Treatment|Withdrawal by Subject|20|||
105426663|NCT00657150|363569588|FG000|Treatment|Other|13|||
105426664|NCT00657150|363569589|FG001|Treatment|Other|15|||
105426665|NCT00993499|363569594|FG000|Run-in Period (8 Days)|Adverse Event|0|||
105426666|NCT00993499|363569595|FG001|Run-in Period (8 Days)|Adverse Event|1|||
105426667|NCT00993499|363569596|FG002|Run-in Period (8 Days)|Adverse Event|0|||
105426668|NCT00993499|363569597|FG003|Run-in Period (8 Days)|Adverse Event|0|||
105426669|NCT00993499|363569598|FG004|Run-in Period (8 Days)|Adverse Event|0|||
105426670|NCT00993499|363569599|FG005|Run-in Period (8 Days)|Adverse Event|0|||
105426671|NCT00993499|363569594|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
105426672|NCT00993499|363569595|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
105426673|NCT00993499|363569596|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
105426674|NCT00993499|363569597|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
105426675|NCT00993499|363569598|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
105426676|NCT00993499|363569599|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
105426677|NCT00993499|363569594|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
105426678|NCT00993499|363569595|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
105426679|NCT00993499|363569596|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
105426680|NCT00993499|363569597|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
105426681|NCT00993499|363569598|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
105426682|NCT00993499|363569599|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
105426683|NCT00993499|363569594|FG000|Run-in Period (8 Days)|Progressive disease|0|||
105426684|NCT00993499|363569595|FG001|Run-in Period (8 Days)|Progressive disease|1|||
105426685|NCT00993499|363569596|FG002|Run-in Period (8 Days)|Progressive disease|1|||
105426686|NCT00993499|363569597|FG003|Run-in Period (8 Days)|Progressive disease|0|||
105426687|NCT00993499|363569598|FG004|Run-in Period (8 Days)|Progressive disease|0|||
105426688|NCT00993499|363569599|FG005|Run-in Period (8 Days)|Progressive disease|0|||
105426689|NCT00993499|363569594|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
105426690|NCT00993499|363569595|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
105426691|NCT00993499|363569596|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
105426692|NCT00993499|363569597|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
105426693|NCT00993499|363569598|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
105426694|NCT00993499|363569599|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
105426695|NCT00993499|363569594|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
105426696|NCT00993499|363569595|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
105426697|NCT00993499|363569596|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
105426698|NCT00993499|363569597|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
105426699|NCT00993499|363569598|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
105426700|NCT00993499|363569599|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
105426701|NCT00993499|363569594|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
105426702|NCT00993499|363569595|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
105426703|NCT00993499|363569596|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
105426704|NCT00993499|363569597|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
105426705|NCT00993499|363569598|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
105426706|NCT00993499|363569599|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
105426707|NCT00993499|363569594|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
105426708|NCT00993499|363569595|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
105426709|NCT00993499|363569596|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
105426710|NCT00993499|363569597|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
105426711|NCT00993499|363569598|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
105426712|NCT00993499|363569599|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
105426713|NCT00993499|363569594|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
105426714|NCT00993499|363569595|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
105426715|NCT00993499|363569596|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
105426716|NCT00993499|363569597|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
105426717|NCT00993499|363569598|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
105426718|NCT00993499|363569599|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
105426719|NCT00993499|363569594|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
105426720|NCT00993499|363569595|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
105426721|NCT00993499|363569596|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
105426722|NCT00993499|363569597|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
105426723|NCT00993499|363569598|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
105426724|NCT00993499|363569599|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
105426725|NCT00993499|363569594|FG000|Discontinued After Starting Course 3|DLT|1|||
105426726|NCT00993499|363569595|FG001|Discontinued After Starting Course 3|DLT|0|||
105426727|NCT00993499|363569596|FG002|Discontinued After Starting Course 3|DLT|2|||
105426728|NCT00993499|363569597|FG003|Discontinued After Starting Course 3|DLT|1|||
105426729|NCT00993499|363569598|FG004|Discontinued After Starting Course 3|DLT|0|||
105426730|NCT00993499|363569599|FG005|Discontinued After Starting Course 3|DLT|0|||
105426731|NCT00993499|363569594|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
105426732|NCT00993499|363569595|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
105426733|NCT00993499|363569596|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
105426734|NCT00993499|363569597|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
105426735|NCT00993499|363569598|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
105426736|NCT00993499|363569599|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
105426737|NCT00624780|363569608|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
105426738|NCT00624780|363569609|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
105426739|NCT00624780|363569610|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
105426740|NCT00624780|363569611|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
105501409|NCT04457336|363847093|FG005|Period 3: Part B|Study Terminated|10|||
105501410|NCT04457336|363847094|FG006|Period 3: Part B|Study Terminated|13|||
105501411|NCT04457336|363847095|FG007|Period 3: Part B|Study Terminated|0|||
105501412|NCT04457336|363847088|FG000|Period 3: Part B|Withdrawal by Subject|0|||
105501413|NCT04457336|363847089|FG001|Period 3: Part B|Withdrawal by Subject|0|||
105501414|NCT04457336|363847090|FG002|Period 3: Part B|Withdrawal by Subject|0|||
105501415|NCT04457336|363847091|FG003|Period 3: Part B|Withdrawal by Subject|0|||
105501416|NCT04457336|363847092|FG004|Period 3: Part B|Withdrawal by Subject|0|||
105501417|NCT04457336|363847093|FG005|Period 3: Part B|Withdrawal by Subject|1|||
105501418|NCT04457336|363847094|FG006|Period 3: Part B|Withdrawal by Subject|2|||
105501419|NCT04457336|363847095|FG007|Period 3: Part B|Withdrawal by Subject|0|||
105501420|NCT04457336|363847088|FG000|Period 4: Part C|Study Terminated|0|||
105501421|NCT04457336|363847089|FG001|Period 4: Part C|Study Terminated|0|||
105501422|NCT04457336|363847090|FG002|Period 4: Part C|Study Terminated|0|||
105501423|NCT04457336|363847091|FG003|Period 4: Part C|Study Terminated|0|||
105501424|NCT04457336|363847092|FG004|Period 4: Part C|Study Terminated|0|||
105501425|NCT04457336|363847093|FG005|Period 4: Part C|Study Terminated|0|||
105501426|NCT04457336|363847094|FG006|Period 4: Part C|Study Terminated|0|||
105501427|NCT04457336|363847095|FG007|Period 4: Part C|Study Terminated|30|||
105501428|NCT04457336|363847088|FG000|Period 4: Part C|Adverse Event|0|||
105501429|NCT04457336|363847089|FG001|Period 4: Part C|Adverse Event|0|||
105501430|NCT04457336|363847090|FG002|Period 4: Part C|Adverse Event|0|||
105426741|NCT00624780|363569612|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
105426742|NCT00624780|363569613|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
105426743|NCT00624780|363569608|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
105426744|NCT00624780|363569609|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
105426745|NCT00624780|363569610|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
105426746|NCT00624780|363569611|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
105426747|NCT00624780|363569612|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
105426748|NCT00624780|363569613|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
105426749|NCT00624780|363569608|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
105426750|NCT00624780|363569609|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
105426751|NCT00624780|363569610|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
105426752|NCT00624780|363569611|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
105426753|NCT00624780|363569612|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
105426754|NCT00624780|363569613|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
105426755|NCT00624780|363569608|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
105426756|NCT00624780|363569609|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
105426757|NCT00624780|363569610|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
105426758|NCT00624780|363569611|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
105426759|NCT00624780|363569612|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
105426760|NCT00624780|363569613|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
105426761|NCT00624780|363569608|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
105426762|NCT00624780|363569609|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
105426763|NCT00624780|363569610|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
105426764|NCT00624780|363569611|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
105426765|NCT00624780|363569612|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
105426766|NCT00624780|363569613|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
105426767|NCT00624780|363569608|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
105426768|NCT00624780|363569609|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
105426769|NCT00624780|363569610|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
105426770|NCT00624780|363569611|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
105426771|NCT00624780|363569612|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
105426772|NCT00624780|363569613|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
105426773|NCT00624780|363569608|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
105426774|NCT00624780|363569609|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
105426775|NCT00624780|363569610|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
105426776|NCT00624780|363569611|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
105426777|NCT00624780|363569612|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
105426778|NCT00624780|363569613|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
105426779|NCT00624780|363569608|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
105426780|NCT00624780|363569609|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
105426781|NCT00624780|363569610|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
105426782|NCT00624780|363569611|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
105426783|NCT00624780|363569612|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
105426784|NCT00624780|363569613|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
105426785|NCT00624780|363569608|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
105426786|NCT00624780|363569609|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
105426787|NCT00624780|363569610|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
105426788|NCT00624780|363569611|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
105426789|NCT00624780|363569612|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
105426790|NCT00624780|363569613|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
105426791|NCT00624780|363569608|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
105426792|NCT00624780|363569609|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
105426793|NCT00624780|363569610|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
105426794|NCT00624780|363569611|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
105501431|NCT04457336|363847091|FG003|Period 4: Part C|Adverse Event|0|||
105501432|NCT04457336|363847092|FG004|Period 4: Part C|Adverse Event|0|||
105501433|NCT04457336|363847093|FG005|Period 4: Part C|Adverse Event|0|||
105501434|NCT04457336|363847094|FG006|Period 4: Part C|Adverse Event|0|||
105501435|NCT04457336|363847095|FG007|Period 4: Part C|Adverse Event|2|||
105501436|NCT04457336|363847088|FG000|Period 4: Part C|Site Terminated|0|||
105501437|NCT04457336|363847089|FG001|Period 4: Part C|Site Terminated|0|||
105426795|NCT00624780|363569612|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
105426796|NCT00624780|363569613|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
105426797|NCT00624780|363569608|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
105426798|NCT00624780|363569609|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
105426799|NCT00624780|363569610|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
105426800|NCT00624780|363569611|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
105501438|NCT04457336|363847090|FG002|Period 4: Part C|Site Terminated|0|||
105501439|NCT04457336|363847091|FG003|Period 4: Part C|Site Terminated|0|||
105426801|NCT00624780|363569612|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
105588851|NCT01467700|364156769|FG000|Overall Study|Lack of Efficacy|2|||
105588852|NCT01467700|364156770|FG001|Overall Study|Lack of Efficacy|0|||
105588853|NCT01467700|364156771|FG002|Overall Study|Lack of Efficacy|2|||
105588854|NCT01467700|364156772|FG003|Overall Study|Lack of Efficacy|1|||
105588855|NCT01467700|364156769|FG000|Overall Study|Reason not Specified|1|||
105588856|NCT01467700|364156770|FG001|Overall Study|Reason not Specified|3|||
105588857|NCT01467700|364156771|FG002|Overall Study|Reason not Specified|2|||
105588858|NCT01467700|364156772|FG003|Overall Study|Reason not Specified|8|||
105588859|NCT03686384|364156773|FG000|Overall Study|Lack of Efficacy|4|||
105588860|NCT03686384|364156774|FG001|Overall Study|Lack of Efficacy|13|||
105588861|NCT03686384|364156773|FG000|Overall Study|Lost to Follow-up|3|||
105588862|NCT03686384|364156774|FG001|Overall Study|Lost to Follow-up|0|||
105588863|NCT03686384|364156773|FG000|Overall Study|Physician Decision|0|||
105588864|NCT03686384|364156774|FG001|Overall Study|Physician Decision|1|||
105588865|NCT03686384|364156773|FG000|Overall Study|Took prohibited medication|0|||
105588866|NCT03686384|364156774|FG001|Overall Study|Took prohibited medication|1|||
105588867|NCT05015478|364156777|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
105588868|NCT05015478|364156778|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
105588869|NCT05015478|364156779|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
105588870|NCT05015478|364156780|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
105588871|NCT01018511|364156782|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
105588872|NCT01018511|364156783|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
105588873|NCT01018511|364156784|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
105588874|NCT01018511|364156785|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
105588875|NCT01018511|364156782|FG000|Overall Study|Adverse Event|5|||
105588876|NCT01018511|364156783|FG001|Overall Study|Adverse Event|9|||
105588877|NCT01018511|364156784|FG002|Overall Study|Adverse Event|13|||
105588878|NCT01018511|364156785|FG003|Overall Study|Adverse Event|10|||
105588879|NCT01018511|364156782|FG000|Overall Study|Lack of Efficacy|4|||
105588880|NCT01018511|364156783|FG001|Overall Study|Lack of Efficacy|1|||
105588881|NCT01018511|364156784|FG002|Overall Study|Lack of Efficacy|1|||
105588882|NCT01018511|364156785|FG003|Overall Study|Lack of Efficacy|2|||
105588883|NCT01018511|364156782|FG000|Overall Study|Withdrawal by Subject|6|||
105588884|NCT01018511|364156783|FG001|Overall Study|Withdrawal by Subject|5|||
105588885|NCT01018511|364156784|FG002|Overall Study|Withdrawal by Subject|11|||
105588886|NCT01018511|364156785|FG003|Overall Study|Withdrawal by Subject|9|||
105588887|NCT01018511|364156782|FG000|Overall Study|Lost to Follow-up|0|||
105588888|NCT01018511|364156783|FG001|Overall Study|Lost to Follow-up|0|||
105588889|NCT01018511|364156784|FG002|Overall Study|Lost to Follow-up|1|||
105588890|NCT01018511|364156785|FG003|Overall Study|Lost to Follow-up|0|||
105588891|NCT01018511|364156782|FG000|Overall Study|Protocol Violation|5|||
105588892|NCT01018511|364156783|FG001|Overall Study|Protocol Violation|8|||
105588893|NCT01018511|364156784|FG002|Overall Study|Protocol Violation|7|||
105588894|NCT01018511|364156785|FG003|Overall Study|Protocol Violation|9|||
105588895|NCT01018511|364156782|FG000|Overall Study|Miscellaneous|0|||
105588896|NCT01018511|364156783|FG001|Overall Study|Miscellaneous|2|||
105588897|NCT01018511|364156784|FG002|Overall Study|Miscellaneous|0|||
105588898|NCT01018511|364156785|FG003|Overall Study|Miscellaneous|0|||
105588899|NCT01740557|364156786|FG000|Overall Study|Ineligible|1|||
105588900|NCT01740557|364156786|FG000|Overall Study|Screen failure|1|||
105588901|NCT01268566|364156787|FG000|Overall Study|Lost to Follow-up|1|||
105588902|NCT01268566|364156787|FG000|Overall Study|Withdrawal by Subject|12|||
105588903|NCT01268566|364156787|FG000|Overall Study|Death|30|||
105588904|NCT00881335|364156791|FG000|Overall Study|Lost to Follow-up|3|||
105588905|NCT00881335|364156792|FG001|Overall Study|Lost to Follow-up|2|||
105588906|NCT01913340|364156793|FG000|Overall Study|Death|2|||
105426802|NCT00624780|363569613|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
105426803|NCT00624780|363569608|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
105426804|NCT00624780|363569609|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
105426805|NCT00624780|363569610|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
105426806|NCT00624780|363569611|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
105588907|NCT01913340|364156794|FG001|Overall Study|Death|5|||
105588908|NCT01913340|364156793|FG000|Overall Study|Lost to Follow-up|1|||
105588909|NCT01913340|364156794|FG001|Overall Study|Lost to Follow-up|1|||
105588910|NCT02784704|364156795|FG000|Overall Study|Adverse Event|4|||
105588911|NCT02784704|364156796|FG001|Overall Study|Adverse Event|2|||
105588912|NCT02784704|364156795|FG000|Overall Study|Lost to Follow-up|6|||
105426807|NCT00624780|363569612|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
105426808|NCT00624780|363569613|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
105588913|NCT02784704|364156796|FG001|Overall Study|Lost to Follow-up|4|||
105588914|NCT02784704|364156795|FG000|Overall Study|Withdrawal by Subject|1|||
105588915|NCT02784704|364156796|FG001|Overall Study|Withdrawal by Subject|3|||
105588916|NCT02784704|364156795|FG000|Overall Study|Subject Non Compliance|2|||
105588917|NCT02784704|364156796|FG001|Overall Study|Subject Non Compliance|0|||
105588918|NCT00603538|364156797|FG000|Overall Study|Adverse Event|0|||
105588919|NCT00603538|364156798|FG001|Overall Study|Adverse Event|4|||
105588920|NCT00603538|364156799|FG002|Overall Study|Adverse Event|2|||
105588921|NCT00603538|364156797|FG000|Overall Study|Objective progression or relapse|3|||
105588922|NCT00603538|364156798|FG001|Overall Study|Objective progression or relapse|0|||
105588923|NCT00603538|364156799|FG002|Overall Study|Objective progression or relapse|0|||
105588924|NCT00117988|364156801|FG000|Overall Study|Death|3|||
105588925|NCT00117988|364156801|FG000|Overall Study|Adverse Event|1|||
105588926|NCT05196737|364156803|FG000|Non-intervention Week|Lost to Follow-up|2|||
105588927|NCT05196737|364156803|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
105588928|NCT00813488|364156804|FG000|Titration Period 1|Adverse Event|6|||
105588929|NCT00813488|364156805|FG001|Titration Period 1|Adverse Event|1|||
105588930|NCT00813488|364156804|FG000|Titration Period 1|Lack of Efficacy|9|||
105588931|NCT00813488|364156805|FG001|Titration Period 1|Lack of Efficacy|7|||
105588932|NCT00813488|364156804|FG000|Titration Period 1|Withdrawal by Subject|2|||
105588933|NCT00813488|364156805|FG001|Titration Period 1|Withdrawal by Subject|2|||
105588934|NCT00813488|364156804|FG000|Titration Period 1|Protocol Violation|4|||
105588935|NCT00813488|364156805|FG001|Titration Period 1|Protocol Violation|3|||
105588936|NCT00813488|364156804|FG000|Titration Period 1|Non-compliance to study medication|4|||
105588937|NCT00813488|364156805|FG001|Titration Period 1|Non-compliance to study medication|1|||
105588938|NCT00813488|364156804|FG000|Titration Period 1|Non-compliance to study procedures|2|||
105588939|NCT00813488|364156805|FG001|Titration Period 1|Non-compliance to study procedures|2|||
105588940|NCT00813488|364156804|FG000|Titration Period 1|Technical Difficulties|0|||
105588941|NCT00813488|364156805|FG001|Titration Period 1|Technical Difficulties|1|||
105588942|NCT00813488|364156804|FG000|Titration Period 2|Adverse Event|2|||
105588943|NCT00813488|364156805|FG001|Titration Period 2|Adverse Event|3|||
105588944|NCT00813488|364156804|FG000|Titration Period 2|Lack of Efficacy|8|||
105588945|NCT00813488|364156805|FG001|Titration Period 2|Lack of Efficacy|4|||
105588946|NCT00813488|364156804|FG000|Titration Period 2|Protocol Violation|3|||
105588947|NCT00813488|364156805|FG001|Titration Period 2|Protocol Violation|2|||
105588948|NCT00813488|364156804|FG000|Titration Period 2|Lost to Follow-up|1|||
105588949|NCT00813488|364156805|FG001|Titration Period 2|Lost to Follow-up|0|||
105588950|NCT00813488|364156804|FG000|Titration Period 2|Non-compliance with study procedures|2|||
105588951|NCT00813488|364156805|FG001|Titration Period 2|Non-compliance with study procedures|1|||
105588952|NCT00813488|364156804|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
105588953|NCT00813488|364156805|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
105588954|NCT00813488|364156804|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
105588955|NCT00813488|364156805|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
105588956|NCT00813488|364156804|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
105588957|NCT00813488|364156805|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
105588958|NCT00813488|364156804|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
105588959|NCT00813488|364156805|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
105588960|NCT00813488|364156804|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
105426809|NCT00624780|363569608|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
105426810|NCT00624780|363569609|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
105426811|NCT00624780|363569610|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
105426812|NCT00624780|363569611|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
105426813|NCT00624780|363569612|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
105426814|NCT00624780|363569613|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
105426815|NCT00624780|363569608|FG000|Follow-up (Week 26)|Death|0|||
105426816|NCT00624780|363569609|FG001|Follow-up (Week 26)|Death|0|||
105588961|NCT00813488|364156805|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
105588962|NCT00813488|364156804|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
105588963|NCT00813488|364156805|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
105588964|NCT00813488|364156804|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
105426817|NCT00624780|363569610|FG002|Follow-up (Week 26)|Death|1|||
105426818|NCT00624780|363569611|FG003|Follow-up (Week 26)|Death|0|||
105426819|NCT00624780|363569612|FG004|Follow-up (Week 26)|Death|0|||
105426820|NCT00624780|363569613|FG005|Follow-up (Week 26)|Death|0|||
105588965|NCT00813488|364156805|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
105588966|NCT00813488|364156804|FG000|Double-blind Treatment Period 2|Other|1|||
105588967|NCT00813488|364156805|FG001|Double-blind Treatment Period 2|Other|0|||
105588968|NCT00813488|364156804|FG000|Open-label Extension|Adverse Event|1|||
105588969|NCT00813488|364156805|FG001|Open-label Extension|Adverse Event|2|||
105588970|NCT00813488|364156804|FG000|Open-label Extension|Lack of Efficacy|3|||
105588971|NCT00813488|364156805|FG001|Open-label Extension|Lack of Efficacy|0|||
105588972|NCT00813488|364156804|FG000|Open-label Extension|Withdrawal by Subject|0|||
105426821|NCT00624780|363569608|FG000|Follow-up (Week 26)|Adverse Event|0|||
105426822|NCT00624780|363569609|FG001|Follow-up (Week 26)|Adverse Event|0|||
105426823|NCT00624780|363569610|FG002|Follow-up (Week 26)|Adverse Event|0|||
105426824|NCT00624780|363569611|FG003|Follow-up (Week 26)|Adverse Event|0|||
105588973|NCT00813488|364156805|FG001|Open-label Extension|Withdrawal by Subject|2|||
105588974|NCT00813488|364156804|FG000|Open-label Extension|Protocol Violation|1|||
105588975|NCT00813488|364156805|FG001|Open-label Extension|Protocol Violation|2|||
105426825|NCT00624780|363569612|FG004|Follow-up (Week 26)|Adverse Event|1|||
105588976|NCT00813488|364156804|FG000|Open-label Extension|Non-compliance study medication|4|||
105588977|NCT00813488|364156805|FG001|Open-label Extension|Non-compliance study medication|0|||
105588978|NCT00813488|364156804|FG000|Open-label Extension|Non-compliance study procedures|2|||
105588979|NCT00813488|364156805|FG001|Open-label Extension|Non-compliance study procedures|1|||
105588980|NCT00813488|364156804|FG000|Open-label Extension|Other|1|||
105588981|NCT00813488|364156805|FG001|Open-label Extension|Other|0|||
105588982|NCT03971357|364156806|FG000|Overall Study|Lack of Efficacy|0|||
105588983|NCT03971357|364156807|FG001|Overall Study|Lack of Efficacy|1|||
105588984|NCT00819910|364156808|FG000|Overall Study|Adverse Event|0|||
105588985|NCT00819910|364156809|FG001|Overall Study|Adverse Event|0|||
105588986|NCT00819910|364156810|FG002|Overall Study|Adverse Event|2|||
105588987|NCT00819910|364156811|FG003|Overall Study|Adverse Event|1|||
105588988|NCT00819910|364156808|FG000|Overall Study|Withdrawal by Subject|1|||
105588989|NCT00819910|364156809|FG001|Overall Study|Withdrawal by Subject|1|||
105588990|NCT00819910|364156810|FG002|Overall Study|Withdrawal by Subject|1|||
105588991|NCT00819910|364156811|FG003|Overall Study|Withdrawal by Subject|0|||
105588992|NCT00819910|364156808|FG000|Overall Study|Lost to Follow-up|1|||
105588993|NCT00819910|364156809|FG001|Overall Study|Lost to Follow-up|0|||
105588994|NCT00819910|364156810|FG002|Overall Study|Lost to Follow-up|0|||
105588995|NCT00819910|364156811|FG003|Overall Study|Lost to Follow-up|0|||
105588996|NCT00871429|364156812|FG000|Overall Study|Lost to Follow-up|6|||
105588997|NCT00871429|364156812|FG000|Overall Study|Withdrawal by Subject|17|||
105588998|NCT00871429|364156812|FG000|Overall Study|Questionnaire not completed|1|||
105588999|NCT01772719|364156813|FG000|Overall Study|Withdrawal by Subject|3|||
105589000|NCT01772719|364156813|FG000|Overall Study|Adverse Event|2|||
105589001|NCT01772719|364156813|FG000|Overall Study|Protocol Violation|1|||
105589002|NCT01772719|364156813|FG000|Overall Study|Lost to Follow-up|1|||
105589003|NCT01311713|364156814|FG000|Overall Study|Death|0|||
105589004|NCT01311713|364156815|FG001|Overall Study|Death|0|||
105589005|NCT01311713|364156816|FG002|Overall Study|Death|1|||
105589006|NCT01311713|364156817|FG003|Overall Study|Death|1|||
105589007|NCT01311713|364156818|FG004|Overall Study|Death|0|||
105589008|NCT01311713|364156819|FG005|Overall Study|Death|1|||
105589009|NCT01311713|364156820|FG006|Overall Study|Death|0|||
105589010|NCT01311713|364156814|FG000|Overall Study|Adverse Event|0|||
105589011|NCT01311713|364156815|FG001|Overall Study|Adverse Event|1|||
105589012|NCT01311713|364156816|FG002|Overall Study|Adverse Event|0|||
105589013|NCT01311713|364156817|FG003|Overall Study|Adverse Event|2|||
105589014|NCT01311713|364156818|FG004|Overall Study|Adverse Event|0|||
105589015|NCT01311713|364156819|FG005|Overall Study|Adverse Event|0|||
105589016|NCT01311713|364156820|FG006|Overall Study|Adverse Event|2|||
105589017|NCT01311713|364156814|FG000|Overall Study|Withdrawal by Subject|0|||
105589018|NCT01311713|364156815|FG001|Overall Study|Withdrawal by Subject|1|||
105589019|NCT01311713|364156816|FG002|Overall Study|Withdrawal by Subject|1|||
105589020|NCT01311713|364156817|FG003|Overall Study|Withdrawal by Subject|0|||
105589021|NCT01311713|364156818|FG004|Overall Study|Withdrawal by Subject|0|||
105589022|NCT01311713|364156819|FG005|Overall Study|Withdrawal by Subject|1|||
105589023|NCT01311713|364156820|FG006|Overall Study|Withdrawal by Subject|2|||
105589024|NCT01311713|364156814|FG000|Overall Study|Disease progression|3|||
105589025|NCT01311713|364156815|FG001|Overall Study|Disease progression|4|||
105589026|NCT01311713|364156816|FG002|Overall Study|Disease progression|3|||
105589027|NCT01311713|364156817|FG003|Overall Study|Disease progression|2|||
105589028|NCT01311713|364156818|FG004|Overall Study|Disease progression|4|||
105589029|NCT01311713|364156819|FG005|Overall Study|Disease progression|4|||
105589030|NCT01311713|364156820|FG006|Overall Study|Disease progression|5|||
105589031|NCT01311713|364156814|FG000|Overall Study|Lost to Follow-up|0|||
105589032|NCT01311713|364156815|FG001|Overall Study|Lost to Follow-up|0|||
105589033|NCT01311713|364156816|FG002|Overall Study|Lost to Follow-up|1|||
105589034|NCT01311713|364156817|FG003|Overall Study|Lost to Follow-up|0|||
105426826|NCT00624780|363569613|FG005|Follow-up (Week 26)|Adverse Event|0|||
105426827|NCT00624780|363569608|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
105589035|NCT01311713|364156818|FG004|Overall Study|Lost to Follow-up|0|||
105589036|NCT01311713|364156819|FG005|Overall Study|Lost to Follow-up|0|||
105589037|NCT01311713|364156820|FG006|Overall Study|Lost to Follow-up|0|||
105589038|NCT01311713|364156814|FG000|Overall Study|Stopped taking study medication|0|||
105589039|NCT01311713|364156815|FG001|Overall Study|Stopped taking study medication|0|||
105589040|NCT01311713|364156816|FG002|Overall Study|Stopped taking study medication|0|||
105426828|NCT00624780|363569609|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
105426829|NCT00624780|363569610|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
105426830|NCT00624780|363569611|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
105589041|NCT01311713|364156817|FG003|Overall Study|Stopped taking study medication|1|||
105589042|NCT01311713|364156818|FG004|Overall Study|Stopped taking study medication|1|||
105589043|NCT01311713|364156819|FG005|Overall Study|Stopped taking study medication|0|||
105589044|NCT01311713|364156820|FG006|Overall Study|Stopped taking study medication|0|||
105589045|NCT01311713|364156814|FG000|Overall Study|Enrolled but not treated|0|||
105589046|NCT01311713|364156815|FG001|Overall Study|Enrolled but not treated|0|||
105589047|NCT01311713|364156816|FG002|Overall Study|Enrolled but not treated|1|||
105589048|NCT01311713|364156817|FG003|Overall Study|Enrolled but not treated|0|||
105589049|NCT01311713|364156818|FG004|Overall Study|Enrolled but not treated|0|||
105589050|NCT01311713|364156819|FG005|Overall Study|Enrolled but not treated|0|||
105589051|NCT01311713|364156820|FG006|Overall Study|Enrolled but not treated|0|||
105589052|NCT01311713|364156814|FG000|Overall Study|Other than specified|0|||
105589053|NCT01311713|364156815|FG001|Overall Study|Other than specified|1|||
105589054|NCT01311713|364156816|FG002|Overall Study|Other than specified|2|||
105589055|NCT01311713|364156817|FG003|Overall Study|Other than specified|0|||
105589056|NCT01311713|364156818|FG004|Overall Study|Other than specified|0|||
105589057|NCT01311713|364156819|FG005|Overall Study|Other than specified|0|||
105589058|NCT01311713|364156820|FG006|Overall Study|Other than specified|0|||
105589059|NCT01981356|364156823|FG000|Overall Study|Lost to Follow-up|4|||
105589060|NCT01981356|364156824|FG001|Overall Study|Lost to Follow-up|1|||
105589061|NCT01981356|364156823|FG000|Overall Study|Withdrawal by Subject|1|||
105589062|NCT01981356|364156824|FG001|Overall Study|Withdrawal by Subject|1|||
105589063|NCT01981356|364156823|FG000|Overall Study|Protocol Violation|2|||
105589064|NCT01981356|364156824|FG001|Overall Study|Protocol Violation|0|||
105589065|NCT00751036|364156825|FG000|Overall Study|Disease Progression|28|||
105589066|NCT00751036|364156826|FG001|Overall Study|Disease Progression|29|||
105589067|NCT00751036|364156825|FG000|Overall Study|Adverse Event|6|||
105589068|NCT00751036|364156826|FG001|Overall Study|Adverse Event|4|||
105589069|NCT00751036|364156825|FG000|Overall Study|Administrative Problems|3|||
105589070|NCT00751036|364156826|FG001|Overall Study|Administrative Problems|4|||
105589071|NCT00751036|364156825|FG000|Overall Study|Withdrawal by Subject|5|||
105589072|NCT00751036|364156826|FG001|Overall Study|Withdrawal by Subject|2|||
105589073|NCT00751036|364156825|FG000|Overall Study|Death|3|||
105589074|NCT00751036|364156826|FG001|Overall Study|Death|3|||
105589075|NCT00751036|364156825|FG000|Overall Study|Lost to Follow-up|0|||
105589076|NCT00751036|364156826|FG001|Overall Study|Lost to Follow-up|1|||
105589077|NCT00751036|364156825|FG000|Overall Study|Protocol Violation|1|||
105589078|NCT00751036|364156826|FG001|Overall Study|Protocol Violation|0|||
105589079|NCT00751036|364156825|FG000|Overall Study|Missing end of Treatment Page|2|||
105589080|NCT00751036|364156826|FG001|Overall Study|Missing end of Treatment Page|3|||
105589081|NCT05460663|364156829|FG000|Overall Study|Withdrawal by Subject|2|||
105589082|NCT05460663|364156830|FG001|Overall Study|Withdrawal by Subject|5|||
105589083|NCT05273801|364156831|FG000|Overall Study|Physician Decision|1|||
105589084|NCT03820986|364156832|FG000|Overall Study|Death|177|||
105589085|NCT03820986|364156833|FG001|Overall Study|Death|156|||
105589086|NCT03820986|364156832|FG000|Overall Study|Lost to Follow-up|0|||
105589087|NCT03820986|364156833|FG001|Overall Study|Lost to Follow-up|1|||
105589088|NCT03820986|364156832|FG000|Overall Study|Withdrawal by Subject|8|||
105589089|NCT03820986|364156833|FG001|Overall Study|Withdrawal by Subject|3|||
105589090|NCT03820986|364156832|FG000|Overall Study|Ongoing|149|||
105589091|NCT03820986|364156833|FG001|Overall Study|Ongoing|180|||
105589092|NCT02013037|364156835|FG000|Overall Study|Death|6|||
105589093|NCT02013037|364156835|FG000|Overall Study|Withdrawal by Subject|1|||
105589094|NCT02013037|364156835|FG000|Overall Study|Awaiting Transplantation|7|||
105589095|NCT02013037|364156835|FG000|Overall Study|Transplanted without DSA|2|||
105589096|NCT02465359|364156836|FG000|Overall Study|Lack of Efficacy|1|||
105589097|NCT02465359|364156836|FG000|Overall Study|Withdrawal by Subject|1|||
105589098|NCT02465359|364156836|FG000|Overall Study|Adverse Event|1|||
105589099|NCT01244828|364156837|FG000|Overall Study|Adverse Event|37|||
105589100|NCT01244828|364156837|FG000|Overall Study|Withdrawal by Subject|31|||
105589101|NCT01244828|364156837|FG000|Overall Study|Lack of Efficacy|7|||
105589102|NCT01244828|364156837|FG000|Overall Study|Lost to Follow-up|2|||
105589103|NCT01244828|364156837|FG000|Overall Study|Other reason (not specified)|1|||
105589104|NCT02952261|364156838|FG000|Overall Study|Withdrawal by Subject|4|||
105589105|NCT02952261|364156839|FG001|Overall Study|Withdrawal by Subject|5|||
105589106|NCT02952261|364156838|FG000|Overall Study|Protocol Violation|1|||
105589107|NCT02952261|364156839|FG001|Overall Study|Protocol Violation|0|||
105589108|NCT05233085|364156840|FG000|Overall Study|Adverse Event|1|||
105589109|NCT05233085|364156841|FG001|Overall Study|Adverse Event|0|||
105589110|NCT05233085|364156842|FG002|Overall Study|Adverse Event|0|||
105589111|NCT05233085|364156843|FG003|Overall Study|Adverse Event|0|||
105589112|NCT02624778|364158174|FG000|Overall Study|Lost to Follow-up|0|||
105589113|NCT02624778|364158175|FG001|Overall Study|Lost to Follow-up|0|||
105589114|NCT02624778|364158176|FG002|Overall Study|Lost to Follow-up|1|||
105589115|NCT02624778|364158177|FG003|Overall Study|Lost to Follow-up|0|||
105589116|NCT02624778|364158178|FG004|Overall Study|Lost to Follow-up|0|||
105589117|NCT02624778|364158179|FG005|Overall Study|Lost to Follow-up|0|||
105589118|NCT02624778|364158180|FG006|Overall Study|Lost to Follow-up|0|||
105589119|NCT02624778|364158181|FG007|Overall Study|Lost to Follow-up|0|||
105589120|NCT02624778|364158182|FG008|Overall Study|Lost to Follow-up|0|||
105589121|NCT02624778|364158174|FG000|Overall Study|Withdrawal by Subject|0|||
105589122|NCT02624778|364158175|FG001|Overall Study|Withdrawal by Subject|1|||
105589123|NCT02624778|364158176|FG002|Overall Study|Withdrawal by Subject|0|||
105589124|NCT02624778|364158177|FG003|Overall Study|Withdrawal by Subject|0|||
105589125|NCT02624778|364158178|FG004|Overall Study|Withdrawal by Subject|0|||
105589126|NCT02624778|364158179|FG005|Overall Study|Withdrawal by Subject|1|||
105589127|NCT02624778|364158180|FG006|Overall Study|Withdrawal by Subject|1|||
105589128|NCT02624778|364158181|FG007|Overall Study|Withdrawal by Subject|1|||
105589129|NCT02624778|364158182|FG008|Overall Study|Withdrawal by Subject|1|||
105589130|NCT02624778|364158174|FG000|Overall Study|Adverse Event|0|||
105589131|NCT02624778|364158175|FG001|Overall Study|Adverse Event|0|||
105589132|NCT02624778|364158176|FG002|Overall Study|Adverse Event|0|||
105589133|NCT02624778|364158177|FG003|Overall Study|Adverse Event|0|||
105589134|NCT02624778|364158178|FG004|Overall Study|Adverse Event|0|||
105589135|NCT02624778|364158179|FG005|Overall Study|Adverse Event|0|||
105589136|NCT02624778|364158180|FG006|Overall Study|Adverse Event|0|||
105589137|NCT02624778|364158181|FG007|Overall Study|Adverse Event|0|||
105589138|NCT02624778|364158182|FG008|Overall Study|Adverse Event|2|||
105589139|NCT02624778|364158174|FG000|Overall Study|Death|0|||
105589140|NCT02624778|364158175|FG001|Overall Study|Death|0|||
105589141|NCT02624778|364158176|FG002|Overall Study|Death|0|||
105589142|NCT02624778|364158177|FG003|Overall Study|Death|0|||
105589143|NCT02624778|364158178|FG004|Overall Study|Death|0|||
105589144|NCT02624778|364158179|FG005|Overall Study|Death|0|||
105589145|NCT02624778|364158180|FG006|Overall Study|Death|1|||
105589146|NCT02624778|364158181|FG007|Overall Study|Death|0|||
105589147|NCT02624778|364158182|FG008|Overall Study|Death|0|||
105589148|NCT02624778|364158174|FG000|Overall Study|Physician Decision|0|||
105589149|NCT02624778|364158175|FG001|Overall Study|Physician Decision|0|||
105589150|NCT02624778|364158176|FG002|Overall Study|Physician Decision|0|||
105589151|NCT02624778|364158177|FG003|Overall Study|Physician Decision|0|||
105589152|NCT02624778|364158178|FG004|Overall Study|Physician Decision|0|||
105589153|NCT02624778|364158179|FG005|Overall Study|Physician Decision|0|||
105589154|NCT02624778|364158180|FG006|Overall Study|Physician Decision|0|||
105589155|NCT02624778|364158181|FG007|Overall Study|Physician Decision|3|||
105589156|NCT02624778|364158182|FG008|Overall Study|Physician Decision|3|||
105589157|NCT04476043|364158183|FG000|Overall Study|Withdrawal by Subject|1|||
105589158|NCT04476043|364158184|FG001|Overall Study|Withdrawal by Subject|3|||
105589159|NCT04476043|364158185|FG002|Overall Study|Withdrawal by Subject|4|||
105589160|NCT04476043|364158186|FG003|Overall Study|Withdrawal by Subject|1|||
105589161|NCT04476043|364158183|FG000|Overall Study|Lost to Follow-up|1|||
105589162|NCT04476043|364158184|FG001|Overall Study|Lost to Follow-up|1|||
105589163|NCT04476043|364158185|FG002|Overall Study|Lost to Follow-up|2|||
105589164|NCT04476043|364158186|FG003|Overall Study|Lost to Follow-up|1|||
105589165|NCT04476043|364158183|FG000|Overall Study|Adverse Event|2|||
105589166|NCT04476043|364158184|FG001|Overall Study|Adverse Event|0|||
105589167|NCT04476043|364158185|FG002|Overall Study|Adverse Event|1|||
105589168|NCT04476043|364158186|FG003|Overall Study|Adverse Event|0|||
105589169|NCT04476043|364158183|FG000|Overall Study|Protocol Violation|0|||
105589170|NCT04476043|364158184|FG001|Overall Study|Protocol Violation|1|||
105589171|NCT04476043|364158185|FG002|Overall Study|Protocol Violation|0|||
105589172|NCT04476043|364158186|FG003|Overall Study|Protocol Violation|0|||
105589173|NCT00587288|364158187|FG000|Overall Study|Adverse Event|0|||
105589174|NCT00587288|364158188|FG001|Overall Study|Adverse Event|1|||
105589175|NCT00587288|364158187|FG000|Overall Study|Lack of Efficacy|2|||
105589176|NCT00587288|364158188|FG001|Overall Study|Lack of Efficacy|8|||
105589177|NCT00587288|364158187|FG000|Overall Study|Protocol Violation|1|||
105589178|NCT00587288|364158188|FG001|Overall Study|Protocol Violation|0|||
105589179|NCT00797862|364158189|FG000|Overall Study|Adverse Event|86|||
105589180|NCT00797862|364158190|FG001|Overall Study|Adverse Event|44|||
105589181|NCT00797862|364158191|FG002|Overall Study|Adverse Event|58|||
105589182|NCT00797862|364158189|FG000|Overall Study|Abnormal Test Procedure Result|0|||
105589183|NCT00797862|364158190|FG001|Overall Study|Abnormal Test Procedure Result|1|||
105589184|NCT00797862|364158191|FG002|Overall Study|Abnormal Test Procedure Result|1|||
105589185|NCT00797862|364158189|FG000|Overall Study|Lack of Efficacy|1|||
105589186|NCT00797862|364158190|FG001|Overall Study|Lack of Efficacy|7|||
105589187|NCT00797862|364158191|FG002|Overall Study|Lack of Efficacy|6|||
105589188|NCT00797862|364158189|FG000|Overall Study|No longer required study medication|1|||
105426831|NCT00624780|363569612|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
105589189|NCT00797862|364158190|FG001|Overall Study|No longer required study medication|0|||
105426832|NCT00624780|363569613|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
105589190|NCT00797862|364158191|FG002|Overall Study|No longer required study medication|0|||
105589191|NCT00797862|364158189|FG000|Overall Study|Withdrawal by Subject|14|||
105589192|NCT00797862|364158190|FG001|Overall Study|Withdrawal by Subject|7|||
105589193|NCT00797862|364158191|FG002|Overall Study|Withdrawal by Subject|7|||
105589194|NCT00797862|364158189|FG000|Overall Study|Lost to Follow-up|11|||
105589195|NCT00797862|364158190|FG001|Overall Study|Lost to Follow-up|0|||
105589196|NCT00797862|364158191|FG002|Overall Study|Lost to Follow-up|5|||
105589197|NCT00797862|364158189|FG000|Overall Study|Administrative Problem|4|||
105589198|NCT00797862|364158190|FG001|Overall Study|Administrative Problem|0|||
105426833|NCT00624780|363569608|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
105589199|NCT00797862|364158191|FG002|Overall Study|Administrative Problem|0|||
105589200|NCT00797862|364158189|FG000|Overall Study|Protocol Violation|4|||
105589201|NCT00797862|364158190|FG001|Overall Study|Protocol Violation|6|||
105589202|NCT00797862|364158191|FG002|Overall Study|Protocol Violation|8|||
105589203|NCT00797862|364158189|FG000|Overall Study|Mis-randomized|3|||
105589204|NCT00797862|364158190|FG001|Overall Study|Mis-randomized|3|||
105426834|NCT00624780|363569609|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
105426835|NCT00624780|363569610|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
105426836|NCT00624780|363569611|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
105426837|NCT00624780|363569612|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
105426838|NCT00624780|363569613|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
105426839|NCT00624780|363569608|FG000|Follow-up (Week 26)|Other|1|||
105426840|NCT00624780|363569609|FG001|Follow-up (Week 26)|Other|1|||
105426841|NCT00624780|363569610|FG002|Follow-up (Week 26)|Other|0|||
105426842|NCT00624780|363569611|FG003|Follow-up (Week 26)|Other|0|||
105426843|NCT00624780|363569612|FG004|Follow-up (Week 26)|Other|0|||
105426844|NCT00624780|363569613|FG005|Follow-up (Week 26)|Other|0|||
105426845|NCT01515475|363569614|FG000|Overall Study|Lost to Follow-up|20|||
105426846|NCT01515475|363569615|FG001|Overall Study|Lost to Follow-up|15|||
105426847|NCT01515475|363569616|FG002|Overall Study|Lost to Follow-up|12|||
105426848|NCT01515475|363569617|FG003|Overall Study|Lost to Follow-up|12|||
105426849|NCT01420627|363569618|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
105426850|NCT02759315|363569624|FG000|Overall Study|Adverse Event|0|||
105426851|NCT02759315|363569625|FG001|Overall Study|Adverse Event|0|||
105426852|NCT02759315|363569626|FG002|Overall Study|Adverse Event|0|||
105426853|NCT02759315|363569627|FG003|Overall Study|Adverse Event|1|||
105426854|NCT02759315|363569628|FG004|Overall Study|Adverse Event|0|||
105426855|NCT02759315|363569624|FG000|Overall Study|Death|0|||
105426856|NCT02759315|363569625|FG001|Overall Study|Death|0|||
105426857|NCT02759315|363569626|FG002|Overall Study|Death|1|||
105426858|NCT02759315|363569627|FG003|Overall Study|Death|0|||
105426859|NCT02759315|363569628|FG004|Overall Study|Death|0|||
105426860|NCT02759315|363569624|FG000|Overall Study|Lost to Follow-up|2|||
105426861|NCT02759315|363569625|FG001|Overall Study|Lost to Follow-up|0|||
105426862|NCT02759315|363569626|FG002|Overall Study|Lost to Follow-up|4|||
105426863|NCT02759315|363569627|FG003|Overall Study|Lost to Follow-up|0|||
105426864|NCT02759315|363569628|FG004|Overall Study|Lost to Follow-up|0|||
105426865|NCT02759315|363569624|FG000|Overall Study|Protocol Violation|0|||
105426866|NCT02759315|363569625|FG001|Overall Study|Protocol Violation|1|||
105426867|NCT02759315|363569626|FG002|Overall Study|Protocol Violation|0|||
105426868|NCT02759315|363569627|FG003|Overall Study|Protocol Violation|0|||
105426869|NCT02759315|363569628|FG004|Overall Study|Protocol Violation|0|||
105426870|NCT02759315|363569624|FG000|Overall Study|Study terminated prior to completion|2|||
105426871|NCT02759315|363569625|FG001|Overall Study|Study terminated prior to completion|0|||
105426872|NCT02759315|363569626|FG002|Overall Study|Study terminated prior to completion|5|||
105426873|NCT02759315|363569627|FG003|Overall Study|Study terminated prior to completion|0|||
105426874|NCT02759315|363569628|FG004|Overall Study|Study terminated prior to completion|1|||
105426875|NCT00461305|363569631|FG000|Treatment|Adverse Event|26|||
105426876|NCT00461305|363569632|FG001|Treatment|Adverse Event|3|||
105426877|NCT00461305|363569631|FG000|Treatment|Lost to Follow-up|4|||
105426878|NCT00461305|363569632|FG001|Treatment|Lost to Follow-up|2|||
105426879|NCT00461305|363569631|FG000|Treatment|Protocol Violation|13|||
105426880|NCT00461305|363569632|FG001|Treatment|Protocol Violation|2|||
105426881|NCT00461305|363569631|FG000|Treatment|Withdrawal by Subject|48|||
105426882|NCT00461305|363569632|FG001|Treatment|Withdrawal by Subject|2|||
105426883|NCT00461305|363569631|FG000|Treatment|Never dispensed|5|||
105426884|NCT00461305|363569632|FG001|Treatment|Never dispensed|0|||
105426885|NCT00461305|363569631|FG000|Treatment|Study drug not taken|1|||
105426886|NCT00461305|363569632|FG001|Treatment|Study drug not taken|0|||
105426887|NCT00461305|363569631|FG000|Treatment|Partially missing diary|2|||
105426888|NCT00461305|363569632|FG001|Treatment|Partially missing diary|0|||
105426889|NCT00461305|363569631|FG000|Treatment|Other (missing drug etc)|2|||
105426890|NCT00461305|363569632|FG001|Treatment|Other (missing drug etc)|0|||
105426891|NCT00461305|363569631|FG000|Continued Treatment|Adverse Event|26|||
105426892|NCT00461305|363569632|FG001|Continued Treatment|Adverse Event|0|||
105426893|NCT00461305|363569631|FG000|Continued Treatment|Lost to Follow-up|4|||
105426894|NCT00461305|363569632|FG001|Continued Treatment|Lost to Follow-up|0|||
105426895|NCT00461305|363569631|FG000|Continued Treatment|Protocol Violation|13|||
105426896|NCT00461305|363569632|FG001|Continued Treatment|Protocol Violation|0|||
105426897|NCT00461305|363569631|FG000|Continued Treatment|Withdrawal by Subject|48|||
105426898|NCT00461305|363569632|FG001|Continued Treatment|Withdrawal by Subject|0|||
105426899|NCT00461305|363569631|FG000|Continued Treatment|Partially missing diary|2|||
105426900|NCT00461305|363569632|FG001|Continued Treatment|Partially missing diary|0|||
105426901|NCT00461305|363569631|FG000|Continued Treatment|Other (missing drug etc)|2|||
105426902|NCT00461305|363569632|FG001|Continued Treatment|Other (missing drug etc)|0|||
105426903|NCT03464422|363569633|FG000|Overall Study|Lost to Follow-up|2|||
105589205|NCT00797862|364158191|FG002|Overall Study|Mis-randomized|1|||
105426904|NCT03464422|363569633|FG000|Overall Study|Withdrawal by Subject|2|||
105426905|NCT03353922|363569636|FG000|Overall Study|Withdrawal by Subject|1|||
105426906|NCT03353922|363569637|FG001|Overall Study|Withdrawal by Subject|0|||
105426907|NCT03353922|363569638|FG002|Overall Study|Withdrawal by Subject|1|||
105426908|NCT03353922|363569639|FG003|Overall Study|Withdrawal by Subject|1|||
105426909|NCT03353922|363569640|FG004|Overall Study|Withdrawal by Subject|0|||
105426910|NCT03353922|363569641|FG005|Overall Study|Withdrawal by Subject|0|||
105426911|NCT03353922|363569636|FG000|Overall Study|Adverse Event|0|||
105426912|NCT03353922|363569637|FG001|Overall Study|Adverse Event|1|||
105426913|NCT03353922|363569638|FG002|Overall Study|Adverse Event|0|||
105426914|NCT03353922|363569639|FG003|Overall Study|Adverse Event|0|||
105426915|NCT03353922|363569640|FG004|Overall Study|Adverse Event|0|||
105426916|NCT03353922|363569641|FG005|Overall Study|Adverse Event|0|||
105426917|NCT03688555|363569642|FG000|Treatment Period|Adverse Event|0|||
105426918|NCT03688555|363569643|FG001|Treatment Period|Adverse Event|0|||
105426919|NCT03688555|363569644|FG002|Treatment Period|Adverse Event|1|||
105426920|NCT01896271|363569645|FG000|Overall Study|Physician Decision|10|||
105426921|NCT01294462|363569646|FG000|Overall Study|Lost to Follow-up|1|||
105426922|NCT01294462|363569647|FG001|Overall Study|Lost to Follow-up|0|||
105426923|NCT01294462|363569646|FG000|Overall Study|Withdrawal by Subject|65|||
105426924|NCT01294462|363569647|FG001|Overall Study|Withdrawal by Subject|63|||
105426925|NCT05028517|363569648|FG000|Overall Study|Lost to Follow-up|13|||
105426926|NCT05028517|363569649|FG001|Overall Study|Lost to Follow-up|20|||
105426927|NCT05028517|363569650|FG002|Overall Study|Lost to Follow-up|12|||
105426928|NCT05028517|363569648|FG000|Overall Study|Withdrawal by Subject|0|||
105426929|NCT05028517|363569649|FG001|Overall Study|Withdrawal by Subject|0|||
105426930|NCT05028517|363569650|FG002|Overall Study|Withdrawal by Subject|1|||
105426931|NCT02256267|363569651|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
105426932|NCT02256267|363569651|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
105426933|NCT04342689|363569654|FG000|Overall Study|Withdrawal by Subject|32|||
105426934|NCT04342689|363569655|FG001|Overall Study|Withdrawal by Subject|33|||
105426935|NCT04342689|363569654|FG000|Overall Study|Lost to Follow-up|10|||
105426936|NCT04342689|363569655|FG001|Overall Study|Lost to Follow-up|12|||
105426937|NCT00526110|363569662|FG000|Overall Study|Adverse Event|2|||
105426938|NCT00526110|363569663|FG001|Overall Study|Adverse Event|9|||
105426939|NCT00526110|363569662|FG000|Overall Study|Disease Progression|0|||
105426940|NCT00526110|363569663|FG001|Overall Study|Disease Progression|19|||
105426941|NCT00526110|363569662|FG000|Overall Study|Maximal Response|0|||
105426942|NCT00526110|363569663|FG001|Overall Study|Maximal Response|6|||
105426943|NCT00526110|363569662|FG000|Overall Study|Withdrawal by Subject|0|||
105426944|NCT00526110|363569663|FG001|Overall Study|Withdrawal by Subject|2|||
105426945|NCT00526110|363569662|FG000|Overall Study|Poor Tolerance|0|||
105426946|NCT00526110|363569663|FG001|Overall Study|Poor Tolerance|5|||
105426947|NCT01400243|363569664|FG000|Overall Study|Protocol Violation|8|||
105426948|NCT01400243|363569665|FG001|Overall Study|Protocol Violation|11|||
105426949|NCT03618628|363569666|FG000|Overall Study|Death|1|||
105426950|NCT03618628|363569666|FG000|Overall Study|Lost to Follow-up|1|||
105426951|NCT01741532|363569668|FG000|Overall Study|Adverse Event|4|||
105426952|NCT01741532|363569669|FG001|Overall Study|Adverse Event|0|||
105426953|NCT01741532|363569668|FG000|Overall Study|Withdrawal by Subject|1|||
105426954|NCT01741532|363569669|FG001|Overall Study|Withdrawal by Subject|1|||
105426955|NCT01741532|363569668|FG000|Overall Study|Protocol Violation|0|||
105426956|NCT01741532|363569669|FG001|Overall Study|Protocol Violation|1|||
105426957|NCT01741532|363569668|FG000|Overall Study|Worsening of the disease|3|||
105426958|NCT01741532|363569669|FG001|Overall Study|Worsening of the disease|1|||
105426959|NCT01741532|363569668|FG000|Overall Study|Sponsor decision|1|||
105426960|NCT01741532|363569669|FG001|Overall Study|Sponsor decision|0|||
105426961|NCT01741532|363569668|FG000|Overall Study|Medical event|1|||
105426962|NCT01741532|363569669|FG001|Overall Study|Medical event|0|||
105426963|NCT00475865|363569670|FG000|Overall Study|Adverse Event|0|||
105426964|NCT00475865|363569671|FG001|Overall Study|Adverse Event|3|||
105426965|NCT00475865|363569672|FG002|Overall Study|Adverse Event|4|||
105426966|NCT00475865|363569670|FG000|Overall Study|Lack of Efficacy|1|||
105426967|NCT00475865|363569671|FG001|Overall Study|Lack of Efficacy|0|||
105426968|NCT00475865|363569672|FG002|Overall Study|Lack of Efficacy|0|||
105426969|NCT00475865|363569670|FG000|Overall Study|Progressive disease|0|||
105426970|NCT00475865|363569671|FG001|Overall Study|Progressive disease|1|||
105426971|NCT00475865|363569672|FG002|Overall Study|Progressive disease|2|||
105426972|NCT00475865|363569670|FG000|Overall Study|Participant did not wish to continue|1|||
105426973|NCT00475865|363569671|FG001|Overall Study|Participant did not wish to continue|0|||
105426974|NCT00475865|363569672|FG002|Overall Study|Participant did not wish to continue|0|||
105426975|NCT00475865|363569670|FG000|Overall Study|Other than above|0|||
105426976|NCT00475865|363569671|FG001|Overall Study|Other than above|1|||
105426977|NCT00475865|363569672|FG002|Overall Study|Other than above|0|||
105426978|NCT02741570|363569675|FG000|Pre-Treatment Period|Other reasons|0|||
105426979|NCT02741570|363569676|FG001|Pre-Treatment Period|Other reasons|3|||
105426980|NCT02741570|363569675|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
105426981|NCT02741570|363569676|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
105426982|NCT02741570|363569675|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
105426983|NCT02741570|363569676|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
105426984|NCT02741570|363569675|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
105426985|NCT02741570|363569676|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
105426986|NCT02741570|363569675|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
105426987|NCT02741570|363569676|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
105426988|NCT02741570|363569675|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
105589206|NCT00531479|364158192|FG000|Overall Study|Death|68|||
105589207|NCT00531479|364158193|FG001|Overall Study|Death|71|||
105589208|NCT00531479|364158192|FG000|Overall Study|Lost to Follow-up|0|||
105589209|NCT00531479|364158193|FG001|Overall Study|Lost to Follow-up|2|||
105589210|NCT00531479|364158192|FG000|Overall Study|Other|0|||
105589211|NCT00531479|364158193|FG001|Overall Study|Other|1|||
105589212|NCT00531479|364158192|FG000|Overall Study|Withdrawal by Subject|6|||
105589213|NCT00531479|364158193|FG001|Overall Study|Withdrawal by Subject|6|||
105589214|NCT00531479|364158192|FG000|Overall Study|Did not receive treatment|2|||
105589215|NCT00531479|364158193|FG001|Overall Study|Did not receive treatment|3|||
105589216|NCT01240356|364158197|FG000|Overall Study|Withdrawal by Subject|2|||
105589217|NCT01240356|364158198|FG001|Overall Study|Withdrawal by Subject|0|||
105589218|NCT01240356|364158197|FG000|Overall Study|MRI contraindication|1|||
105589219|NCT01240356|364158198|FG001|Overall Study|MRI contraindication|0|||
105589220|NCT01306331|364158199|FG000|Overall Study|Adverse Event|28|||
105589221|NCT01306331|364158200|FG001|Overall Study|Adverse Event|25|||
105589222|NCT01306331|364158199|FG000|Overall Study|Lost to Follow-up|321|||
105589223|NCT01306331|364158200|FG001|Overall Study|Lost to Follow-up|323|||
105589224|NCT01306331|364158199|FG000|Overall Study|Physician Decision|26|||
105589225|NCT01306331|364158200|FG001|Overall Study|Physician Decision|22|||
105589226|NCT01306331|364158199|FG000|Overall Study|Pregnancy|136|||
105589227|NCT01306331|364158200|FG001|Overall Study|Pregnancy|151|||
105589228|NCT01306331|364158199|FG000|Overall Study|Protocol Violation|154|||
105589229|NCT01306331|364158200|FG001|Overall Study|Protocol Violation|124|||
105589230|NCT01306331|364158199|FG000|Overall Study|Withdrawal by Subject|163|||
105589231|NCT01306331|364158200|FG001|Overall Study|Withdrawal by Subject|152|||
105589232|NCT01306331|364158199|FG000|Overall Study|Not sexually active|29|||
105589233|NCT01306331|364158200|FG001|Overall Study|Not sexually active|28|||
105589234|NCT01306331|364158199|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
105589235|NCT01306331|364158200|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
105589236|NCT01306331|364158199|FG000|Overall Study|Other|34|||
105589237|NCT01306331|364158200|FG001|Overall Study|Other|32|||
105589238|NCT00409708|364158204|FG000|Treatment|Abnormal test procedure result(s)|1|||
105589239|NCT00409708|364158205|FG001|Treatment|Abnormal test procedure result(s)|0|||
105589240|NCT00409708|364158204|FG000|Treatment|Lack of Efficacy|0|||
105589241|NCT00409708|364158205|FG001|Treatment|Lack of Efficacy|1|||
105589242|NCT00409708|364158204|FG000|Treatment|Protocol Violation|6|||
105589243|NCT00409708|364158205|FG001|Treatment|Protocol Violation|2|||
105589244|NCT00409708|364158204|FG000|Treatment|Withdrawal by Subject|3|||
105589245|NCT00409708|364158205|FG001|Treatment|Withdrawal by Subject|8|||
105589246|NCT00409708|364158204|FG000|Treatment|Lost to Follow-up|0|||
105589247|NCT00409708|364158205|FG001|Treatment|Lost to Follow-up|6|||
105589248|NCT00409708|364158204|FG000|Treatment|Administrative problems|5|||
105589249|NCT00409708|364158205|FG001|Treatment|Administrative problems|0|||
105589250|NCT00409708|364158204|FG000|Washout|Lack of Efficacy|9|||
105589251|NCT00409708|364158205|FG001|Washout|Lack of Efficacy|1|||
105589252|NCT00409708|364158204|FG000|Washout|Protocol Violation|0|||
105589253|NCT00409708|364158205|FG001|Washout|Protocol Violation|1|||
105589254|NCT00409708|364158204|FG000|Washout|Withdrawal by Subject|11|||
105589255|NCT00409708|364158205|FG001|Washout|Withdrawal by Subject|5|||
105589256|NCT00409708|364158204|FG000|Washout|Lost to Follow-up|1|||
105589257|NCT00409708|364158205|FG001|Washout|Lost to Follow-up|3|||
105589258|NCT01456780|364158207|FG000|Overall Study|Lost to Follow-up|3|||
105589259|NCT01456780|364158208|FG001|Overall Study|Lost to Follow-up|3|||
105589260|NCT01456780|364158209|FG002|Overall Study|Lost to Follow-up|0|||
105589261|NCT00926393|364158212|FG000|Overall Study|Withdrawal by Subject|1|||
105589262|NCT00926393|364158213|FG001|Overall Study|Withdrawal by Subject|2|||
105589263|NCT00926393|364158212|FG000|Overall Study|Adverse Event|1|||
105589264|NCT00926393|364158213|FG001|Overall Study|Adverse Event|1|||
105589265|NCT00984282|364158214|FG000|Double Blind Treatment|Adverse Event|40|||
105589266|NCT00984282|364158215|FG001|Double Blind Treatment|Adverse Event|6|||
105589267|NCT00984282|364158214|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
105589268|NCT00984282|364158215|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
105589269|NCT00984282|364158214|FG000|Double Blind Treatment|Physician Decision|1|||
105589270|NCT00984282|364158215|FG001|Double Blind Treatment|Physician Decision|2|||
105589271|NCT00984282|364158214|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
105589272|NCT00984282|364158215|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
105589273|NCT00984282|364158214|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
105589274|NCT00984282|364158215|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
105589275|NCT00984282|364158214|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
105589276|NCT00984282|364158215|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
105589277|NCT00984282|364158214|FG000|Double Blind Treatment|Lost to Follow-up|3|||
105589278|NCT00984282|364158215|FG001|Double Blind Treatment|Lost to Follow-up|0|||
105589279|NCT00984282|364158214|FG000|Double Blind Treatment|Death|8|||
105589280|NCT00984282|364158215|FG001|Double Blind Treatment|Death|4|||
105589281|NCT00984282|364158214|FG000|Double Blind Treatment|Not treated|0|||
105589282|NCT00984282|364158215|FG001|Double Blind Treatment|Not treated|1|||
105589283|NCT00984282|364158214|FG000|Double Blind Treatment|Switched to commercial drug|6|||
105426989|NCT02741570|363569676|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
105426990|NCT02741570|363569675|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
105426991|NCT02741570|363569676|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
105426992|NCT02741570|363569675|FG000|Pre-Treatment Period|Death|0|||
105426993|NCT02741570|363569676|FG001|Pre-Treatment Period|Death|1|||
105426994|NCT02741570|363569675|FG000|Pre-Treatment Period|Disease progression|0|||
105426995|NCT02741570|363569676|FG001|Pre-Treatment Period|Disease progression|1|||
105426996|NCT02741570|363569675|FG000|Treatment Period|Other reasons|47|||
105426997|NCT02741570|363569676|FG001|Treatment Period|Other reasons|12|||
105426998|NCT02741570|363569675|FG000|Treatment Period|Poor/non-compliance|0|||
105426999|NCT02741570|363569676|FG001|Treatment Period|Poor/non-compliance|2|||
105427000|NCT02741570|363569675|FG000|Treatment Period|Maximum clinical benefit|4|||
105427001|NCT02741570|363569676|FG001|Treatment Period|Maximum clinical benefit|6|||
105427002|NCT02741570|363569675|FG000|Treatment Period|Lost to Follow-up|1|||
105427003|NCT02741570|363569676|FG001|Treatment Period|Lost to Follow-up|3|||
105427004|NCT02741570|363569675|FG000|Treatment Period|Participant withdrew consent|9|||
105427005|NCT02741570|363569676|FG001|Treatment Period|Participant withdrew consent|13|||
105427006|NCT02741570|363569675|FG000|Treatment Period|Participant request to discontinue treatment|8|||
105427007|NCT02741570|363569676|FG001|Treatment Period|Participant request to discontinue treatment|23|||
105427008|NCT02741570|363569675|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
105427009|NCT02741570|363569676|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
105427010|NCT02741570|363569675|FG000|Treatment Period|Death|9|||
105427011|NCT02741570|363569676|FG001|Treatment Period|Death|7|||
105427012|NCT02741570|363569675|FG000|Treatment Period|Study drug toxicity|55|||
105427013|NCT02741570|363569676|FG001|Treatment Period|Study drug toxicity|47|||
105427014|NCT02741570|363569675|FG000|Treatment Period|Disease progression|294|||
105427015|NCT02741570|363569676|FG001|Treatment Period|Disease progression|301|||
105427016|NCT02741570|363569675|FG000|Treatment Period|Administrative reason by sponsor|0|||
105427017|NCT02741570|363569676|FG001|Treatment Period|Administrative reason by sponsor|1|||
105427018|NCT02279498|363569677|FG000|Overall Study|Adverse Event|3|||
105427019|NCT02279498|363569678|FG001|Overall Study|Adverse Event|0|||
105427020|NCT02279498|363569677|FG000|Overall Study|Lack of Efficacy|4|||
105427021|NCT02279498|363569678|FG001|Overall Study|Lack of Efficacy|0|||
105427022|NCT02279498|363569677|FG000|Overall Study|Lost to Follow-up|0|||
105427023|NCT02279498|363569678|FG001|Overall Study|Lost to Follow-up|1|||
105427024|NCT02279498|363569677|FG000|Overall Study|Withdrawal by Subject|9|||
105427025|NCT02279498|363569678|FG001|Overall Study|Withdrawal by Subject|2|||
105427026|NCT02279498|363569677|FG000|Overall Study|Undefined|2|||
105427027|NCT02279498|363569678|FG001|Overall Study|Undefined|1|||
105427028|NCT03294135|363570878|FG000|Overall Study|Serious Adverse Event|1|||
105427029|NCT03294135|363570879|FG001|Overall Study|Serious Adverse Event|0|||
105427030|NCT03294135|363570880|FG002|Overall Study|Serious Adverse Event|0|||
105427031|NCT03294135|363570878|FG000|Overall Study|Lost to Follow-up|1|||
105427032|NCT03294135|363570879|FG001|Overall Study|Lost to Follow-up|0|||
105427033|NCT03294135|363570880|FG002|Overall Study|Lost to Follow-up|1|||
105427034|NCT03294135|363570878|FG000|Overall Study|Withdrawal by Subject|0|||
105427035|NCT03294135|363570879|FG001|Overall Study|Withdrawal by Subject|0|||
105427036|NCT03294135|363570880|FG002|Overall Study|Withdrawal by Subject|1|||
105427037|NCT03294135|363570878|FG000|Overall Study|Other|2|||
105427038|NCT03294135|363570879|FG001|Overall Study|Other|0|||
105427039|NCT03294135|363570880|FG002|Overall Study|Other|0|||
105427040|NCT01510184|363570881|FG000|Overall Study|Sponsor discretion|28|||
105427041|NCT01510184|363570882|FG001|Overall Study|Sponsor discretion|28|||
105427042|NCT01510184|363570881|FG000|Overall Study|Death|1|||
105427043|NCT01510184|363570882|FG001|Overall Study|Death|2|||
105427044|NCT01510184|363570881|FG000|Overall Study|Withdrawal by Subject|1|||
105427045|NCT01510184|363570882|FG001|Overall Study|Withdrawal by Subject|4|||
105427046|NCT01510184|363570881|FG000|Overall Study|Other|0|||
105427047|NCT01510184|363570882|FG001|Overall Study|Other|1|||
105427048|NCT00054691|363570883|FG000|Overall Study|Unmeasurable Disease|2|||
105427049|NCT00054691|363570883|FG000|Overall Study|Noncompliant|1|||
105427050|NCT00694096|363570890|FG000|Overall Study|Withdrawal by Subject|5|||
105427051|NCT00260065|363570894|FG000|Overall Study|Progressive Disease|22|||
105427052|NCT00260065|363570894|FG000|Overall Study|Adverse Event|17|||
105427053|NCT00260065|363570894|FG000|Overall Study|Death|13|||
105427054|NCT00260065|363570894|FG000|Overall Study|Withdrawal by Subject|13|||
105427055|NCT00260065|363570894|FG000|Overall Study|Physician Decision|19|||
105427056|NCT00260065|363570894|FG000|Overall Study|Not otherwise specified|8|||
105427057|NCT00260065|363570894|FG000|Overall Study|Medication Noncompliance|1|||
105427058|NCT01390779|363570895|FG000|Overall Study|Physician Decision|1|||
105427059|NCT03351114|363570896|FG000|Overall Study|Withdrawal by Subject|1|||
105427060|NCT01665430|363570897|FG000|Overall Study|Adverse Event|1|||
105427061|NCT01665430|363570897|FG000|Overall Study|Withdrawal by Subject|6|||
105427062|NCT01665430|363570897|FG000|Overall Study|Other Unspecified|2|||
105427063|NCT03987932|363570906|FG000|Overall Study|Lost to Follow-up|2|||
105589284|NCT00984282|364158215|FG001|Double Blind Treatment|Switched to commercial drug|1|||
105427064|NCT03987932|363570907|FG001|Overall Study|Lost to Follow-up|1|||
105427065|NCT03987932|363570908|FG002|Overall Study|Lost to Follow-up|1|||
105427066|NCT03987932|363570906|FG000|Overall Study|Non-study related elective surgery|0|||
105427067|NCT03987932|363570907|FG001|Overall Study|Non-study related elective surgery|0|||
105427068|NCT03987932|363570908|FG002|Overall Study|Non-study related elective surgery|1|||
105427069|NCT01799239|363570912|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
105427070|NCT01799239|363570913|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
105427071|NCT01799239|363570912|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
105427072|NCT01799239|363570913|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
105427073|NCT01799239|363570912|FG000|Period 1 (7 Days)|Protocol Violation|0|||
105427074|NCT01799239|363570913|FG001|Period 1 (7 Days)|Protocol Violation|1|||
105427075|NCT01799239|363570912|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
105427076|NCT01799239|363570913|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
105427077|NCT01799239|363570912|FG000|Period 2 (7 Days)|Protocol Violation|1|||
105427078|NCT01799239|363570913|FG001|Period 2 (7 Days)|Protocol Violation|0|||
105427079|NCT01561755|363570918|FG000|Overall Study|Lost to Follow-up|0|||
105427080|NCT01561755|363570919|FG001|Overall Study|Lost to Follow-up|1|||
105427081|NCT03630302|363570920|FG000|Surgery|hardware issue prevented LFP recordings|1|||
105427082|NCT03630302|363570920|FG000|3 Month Visit|Adverse Event|2|||
105427083|NCT03630302|363570920|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
105427084|NCT02813668|363570924|FG000|Overall Study|Death|4|||
105427085|NCT02813668|363570924|FG000|Overall Study|Lost to Follow-up|509|||
105427086|NCT02813668|363570924|FG000|Overall Study|Withdrawal by Subject|148|||
105427087|NCT02813668|363570924|FG000|Overall Study|No longer at worksite|85|||
105427088|NCT02813668|363570924|FG000|Overall Study|Medical reasons not related to the study|4|||
105427089|NCT00598078|363570931|FG000|Period 2 (Day 2)|Adverse Event|1|||
105427090|NCT00598078|363570932|FG001|Period 2 (Day 2)|Adverse Event|0|||
105427091|NCT01866423|363570934|FG000|Overall Study|Lack of Efficacy|3|||
105427092|NCT01866423|363570934|FG000|Overall Study|Sponsor Decision|1|||
105427093|NCT02387164|363570935|FG000|Overall Study|Lost to Follow-up|2|||
105427094|NCT02387164|363570936|FG001|Overall Study|Lost to Follow-up|0|||
105427095|NCT02387164|363570935|FG000|Overall Study|Diagnosed|1|||
105427096|NCT02387164|363570936|FG001|Overall Study|Diagnosed|2|||
105427097|NCT01996592|363570937|FG000|Overall Study|no response to text/no diary entry|32|||
105427098|NCT01996592|363570937|FG000|Overall Study|change in surgical date|4|||
105427099|NCT01996592|363570937|FG000|Overall Study|Withdrawal by Subject|5|||
105427100|NCT01996592|363570937|FG000|Overall Study|change in mode of delivery|4|||
105427101|NCT00343915|363570938|FG000|Primary Study|Withdrawal by Subject|1|||
105427102|NCT00343915|363570939|FG001|Primary Study|Withdrawal by Subject|0|||
105427103|NCT00343915|363570938|FG000|Primary Study|Lost to Follow-up|2|||
105427104|NCT00343915|363570939|FG001|Primary Study|Lost to Follow-up|3|||
105427105|NCT00343915|363570938|FG000|Primary Study|Other|1|||
105427106|NCT00343915|363570939|FG001|Primary Study|Other|0|||
105427107|NCT01344629|363570942|FG000|Crossover Period 2|Withdrawal by Subject|0|||
105427108|NCT01344629|363570943|FG001|Crossover Period 2|Withdrawal by Subject|1|||
105427109|NCT02370095|363570944|FG000|Overall Study|Withdrawal by Subject|0|||
105427110|NCT02370095|363570945|FG001|Overall Study|Withdrawal by Subject|1|||
105427111|NCT01133275|363570946|FG000|Overall Study|Withdrawal by Subject|1|||
105427112|NCT01133275|363570946|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
105427113|NCT00700102|363570947|FG000|Overall Study|Died|394|||
105427114|NCT00700102|363570948|FG001|Overall Study|Died|385|||
105427115|NCT00700102|363570947|FG000|Overall Study|Lost to Follow-up|8|||
105427116|NCT00700102|363570948|FG001|Overall Study|Lost to Follow-up|10|||
105427117|NCT02525939|363570953|FG000|Overall Study|Lost to Follow-up|27|||
105427118|NCT02525939|363570954|FG001|Overall Study|Lost to Follow-up|24|||
105427119|NCT02525939|363570953|FG000|Overall Study|Physician Decision|0|||
105427120|NCT02525939|363570954|FG001|Overall Study|Physician Decision|1|||
105427121|NCT02525939|363570953|FG000|Overall Study|Withdrawal by Subject|24|||
105427122|NCT02525939|363570954|FG001|Overall Study|Withdrawal by Subject|39|||
105427123|NCT02525939|363570953|FG000|Overall Study|Death|180|||
105427124|NCT02525939|363570954|FG001|Overall Study|Death|179|||
105427125|NCT01667562|363570955|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
105427126|NCT01667562|363570956|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
105427127|NCT01667562|363570955|FG000|Erlotinib Phase|Lost to Follow-up|0|||
105427128|NCT01667562|363570956|FG001|Erlotinib Phase|Lost to Follow-up|1|||
105427129|NCT01667562|363570955|FG000|Erlotinib Phase|Adverse Event|0|||
105427130|NCT01667562|363570956|FG001|Erlotinib Phase|Adverse Event|1|||
105427131|NCT01667562|363570955|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
105427132|NCT01667562|363570956|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
105427133|NCT01028716|363570960|FG000|Overall Study|Physician Decision|1|||
105427134|NCT02130986|363570961|FG000|Overall Study|Withdrawal by Subject|4|||
105427135|NCT02130986|363570962|FG001|Overall Study|Withdrawal by Subject|4|||
105427136|NCT02130986|363570961|FG000|Overall Study|Lost to Follow-up|151|||
105427137|NCT02130986|363570962|FG001|Overall Study|Lost to Follow-up|160|||
105427138|NCT05590000|363570963|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
105427139|NCT00762996|363570964|FG000|Period One|Protocol Violation|0|||
105427140|NCT00762996|363570965|FG001|Period One|Protocol Violation|0|||
105427141|NCT00762996|363570966|FG002|Period One|Protocol Violation|1|||
105427142|NCT00762996|363570967|FG003|Period One|Protocol Violation|0|||
105427143|NCT00762996|363570964|FG000|Period One|ineligible|0|||
105427144|NCT00762996|363570965|FG001|Period One|ineligible|0|||
105427145|NCT00762996|363570966|FG002|Period One|ineligible|1|||
105427146|NCT00762996|363570967|FG003|Period One|ineligible|1|||
105427147|NCT00762996|363570964|FG000|Period One|Adverse Event|0|||
105427148|NCT00762996|363570965|FG001|Period One|Adverse Event|0|||
105427149|NCT00762996|363570966|FG002|Period One|Adverse Event|1|||
105427150|NCT00762996|363570967|FG003|Period One|Adverse Event|0|||
105427151|NCT00762996|363570964|FG000|Period One|Withdrawal by Subject|0|||
105427152|NCT00762996|363570965|FG001|Period One|Withdrawal by Subject|0|||
105427153|NCT00762996|363570966|FG002|Period One|Withdrawal by Subject|1|||
105427154|NCT00762996|363570967|FG003|Period One|Withdrawal by Subject|0|||
105427155|NCT00536874|363570968|FG000|Overall Study|Adverse Event|1|||
105427156|NCT00536874|363570968|FG000|Overall Study|Death|2|||
105427157|NCT00536874|363570968|FG000|Overall Study|Withdrawal by Subject|1|||
105427158|NCT04063787|363570970|FG000|Overall Study|Inadequate Doppler data|4|||
105427159|NCT04063787|363570970|FG000|Overall Study|Lost to Follow-up|2|||
105427160|NCT04063787|363570970|FG000|Overall Study|Death|3|||
105427161|NCT01174004|363570972|FG000|Overall Study|Adverse Event|2|||
105427162|NCT01174004|363570973|FG001|Overall Study|Adverse Event|10|||
105427163|NCT01174004|363570972|FG000|Overall Study|Withdrawal by Subject|2|||
105427164|NCT01174004|363570973|FG001|Overall Study|Withdrawal by Subject|3|||
105427165|NCT01174004|363570972|FG000|Overall Study|At Discretion of Sponsor|2|||
105427166|NCT01174004|363570973|FG001|Overall Study|At Discretion of Sponsor|2|||
105427167|NCT01174004|363570972|FG000|Overall Study|Protocol Violation|0|||
105427168|NCT01174004|363570973|FG001|Overall Study|Protocol Violation|1|||
105427169|NCT01174004|363570972|FG000|Overall Study|Physician Decision|1|||
105427170|NCT01174004|363570973|FG001|Overall Study|Physician Decision|0|||
105427171|NCT00434759|363570981|FG000|Overall Study|Lack of Efficacy|5|||
105427172|NCT00434759|363570982|FG001|Overall Study|Lack of Efficacy|4|||
105427173|NCT00434759|363570981|FG000|Overall Study|Withdrawal by Subject|17|||
105427174|NCT00434759|363570982|FG001|Overall Study|Withdrawal by Subject|1|||
105427175|NCT00434759|363570981|FG000|Overall Study|family affairs|2|||
105427176|NCT00434759|363570982|FG001|Overall Study|family affairs|0|||
105427177|NCT02761694|363570987|FG000|Overall Study|Lack of Efficacy|0|||
105427178|NCT02761694|363570988|FG001|Overall Study|Lack of Efficacy|0|||
105427179|NCT02761694|363570989|FG002|Overall Study|Lack of Efficacy|0|||
105427180|NCT02761694|363570990|FG003|Overall Study|Lack of Efficacy|0|||
105427181|NCT02761694|363570991|FG004|Overall Study|Lack of Efficacy|0|||
105427182|NCT02761694|363570992|FG005|Overall Study|Lack of Efficacy|0|||
105427183|NCT02761694|363570993|FG006|Overall Study|Lack of Efficacy|6|||
105427184|NCT02761694|363570994|FG007|Overall Study|Lack of Efficacy|0|||
105427185|NCT02761694|363570995|FG008|Overall Study|Lack of Efficacy|0|||
105427186|NCT02761694|363570996|FG009|Overall Study|Lack of Efficacy|1|||
105427187|NCT02761694|363570997|FG010|Overall Study|Lack of Efficacy|1|||
105427188|NCT02761694|363570998|FG011|Overall Study|Lack of Efficacy|4|||
105427189|NCT02761694|363570987|FG000|Overall Study|Death|0|||
105427190|NCT02761694|363570988|FG001|Overall Study|Death|0|||
105427191|NCT02761694|363570989|FG002|Overall Study|Death|0|||
105427192|NCT02761694|363570990|FG003|Overall Study|Death|0|||
105427193|NCT02761694|363570991|FG004|Overall Study|Death|0|||
105427194|NCT02761694|363570992|FG005|Overall Study|Death|0|||
105427195|NCT02761694|363570993|FG006|Overall Study|Death|2|||
105427196|NCT02761694|363570994|FG007|Overall Study|Death|0|||
105427197|NCT02761694|363570995|FG008|Overall Study|Death|2|||
105427198|NCT02761694|363570996|FG009|Overall Study|Death|2|||
105427199|NCT02761694|363570997|FG010|Overall Study|Death|1|||
105427200|NCT02761694|363570998|FG011|Overall Study|Death|0|||
105427201|NCT02761694|363570987|FG000|Overall Study|Physician Decision|0|||
105427202|NCT02761694|363570988|FG001|Overall Study|Physician Decision|0|||
105427203|NCT02761694|363570989|FG002|Overall Study|Physician Decision|0|||
105427204|NCT02761694|363570990|FG003|Overall Study|Physician Decision|0|||
105427205|NCT02761694|363570991|FG004|Overall Study|Physician Decision|0|||
105427206|NCT02761694|363570992|FG005|Overall Study|Physician Decision|0|||
105427207|NCT02761694|363570993|FG006|Overall Study|Physician Decision|1|||
105427208|NCT02761694|363570994|FG007|Overall Study|Physician Decision|0|||
105427209|NCT02761694|363570995|FG008|Overall Study|Physician Decision|0|||
105427210|NCT02761694|363570996|FG009|Overall Study|Physician Decision|0|||
105427211|NCT02761694|363570997|FG010|Overall Study|Physician Decision|0|||
105427212|NCT02761694|363570998|FG011|Overall Study|Physician Decision|0|||
105427213|NCT02761694|363570987|FG000|Overall Study|Withdrawal by Subject|0|||
105427214|NCT02761694|363570988|FG001|Overall Study|Withdrawal by Subject|0|||
105427215|NCT02761694|363570989|FG002|Overall Study|Withdrawal by Subject|0|||
105427216|NCT02761694|363570990|FG003|Overall Study|Withdrawal by Subject|1|||
105427217|NCT02761694|363570991|FG004|Overall Study|Withdrawal by Subject|0|||
105427218|NCT02761694|363570992|FG005|Overall Study|Withdrawal by Subject|0|||
105427219|NCT02761694|363570993|FG006|Overall Study|Withdrawal by Subject|4|||
105427220|NCT02761694|363570994|FG007|Overall Study|Withdrawal by Subject|0|||
105427221|NCT02761694|363570995|FG008|Overall Study|Withdrawal by Subject|2|||
105427222|NCT02761694|363570996|FG009|Overall Study|Withdrawal by Subject|1|||
105501440|NCT04457336|363847092|FG004|Period 4: Part C|Site Terminated|0|||
105589285|NCT00984282|364158214|FG000|Double Blind Treatment|protocol driven decision point|1|||
105589286|NCT00984282|364158215|FG001|Double Blind Treatment|protocol driven decision point|1|||
105589287|NCT00984282|364158214|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
105589288|NCT00984282|364158215|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
105589289|NCT00984282|364158214|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
105589290|NCT00984282|364158215|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
105589291|NCT00984282|364158214|FG000|Open-label Treatment|Adverse Event|20|||
105589292|NCT00984282|364158215|FG001|Open-label Treatment|Adverse Event|30|||
105589293|NCT00984282|364158214|FG000|Open-label Treatment|Withdrawal by Subject|6|||
105589294|NCT00984282|364158215|FG001|Open-label Treatment|Withdrawal by Subject|21|||
105589295|NCT00984282|364158214|FG000|Open-label Treatment|Death|7|||
105589296|NCT00984282|364158215|FG001|Open-label Treatment|Death|15|||
105589297|NCT00984282|364158214|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
105589298|NCT00984282|364158215|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
105589299|NCT00984282|364158214|FG000|Open-label Treatment|Lost to Follow-up|1|||
105589300|NCT00984282|364158215|FG001|Open-label Treatment|Lost to Follow-up|1|||
105589301|NCT00984282|364158214|FG000|Open-label Treatment|Patient convenience|1|||
105589302|NCT00984282|364158215|FG001|Open-label Treatment|Patient convenience|0|||
105589303|NCT00984282|364158214|FG000|Open-label Treatment|Non-compliant with study medication|1|||
105589304|NCT00984282|364158215|FG001|Open-label Treatment|Non-compliant with study medication|0|||
105589305|NCT00984282|364158214|FG000|Open-label Treatment|Target lesion removed|0|||
105589306|NCT00984282|364158215|FG001|Open-label Treatment|Target lesion removed|1|||
105589307|NCT00984282|364158214|FG000|Open-label Treatment|Protocol driven decision point|1|||
105589308|NCT00984282|364158215|FG001|Open-label Treatment|Protocol driven decision point|1|||
105589309|NCT00984282|364158214|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
105589310|NCT00984282|364158215|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
105589311|NCT00984282|364158214|FG000|Open-label Treatment|Switched to commercial drug|6|||
105589312|NCT00984282|364158215|FG001|Open-label Treatment|Switched to commercial drug|7|||
105589313|NCT00984282|364158214|FG000|Open-label Treatment|Physician Decision|1|||
105589314|NCT00984282|364158215|FG001|Open-label Treatment|Physician Decision|0|||
105589315|NCT00984282|364158214|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
105589316|NCT00984282|364158215|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
105589317|NCT00984282|364158214|FG000|Long Term Follow-up|Death|27|||
105589318|NCT00984282|364158215|FG001|Long Term Follow-up|Death|68|||
105589319|NCT00984282|364158214|FG000|Long Term Follow-up|Lost to Follow-up|3|||
105589320|NCT00984282|364158215|FG001|Long Term Follow-up|Lost to Follow-up|6|||
105589321|NCT00984282|364158214|FG000|Long Term Follow-up|Protocol driven decision point|25|||
105589322|NCT00984282|364158215|FG001|Long Term Follow-up|Protocol driven decision point|26|||
105589323|NCT00984282|364158214|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
105589324|NCT00984282|364158215|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
105589325|NCT00984282|364158214|FG000|Long Term Follow-up|Switched to commercial drug|4|||
105589326|NCT00984282|364158215|FG001|Long Term Follow-up|Switched to commercial drug|2|||
105589327|NCT00984282|364158214|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
105589328|NCT00984282|364158215|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
105589329|NCT02223793|364158216|FG000|Overall Study|Lost to Follow-up|10|||
105589330|NCT02223793|364158217|FG001|Overall Study|Lost to Follow-up|1|||
105427223|NCT02761694|363570997|FG010|Overall Study|Withdrawal by Subject|0|||
105427224|NCT02761694|363570998|FG011|Overall Study|Withdrawal by Subject|0|||
105427225|NCT02761694|363570987|FG000|Overall Study|Lost to Follow-up|0|||
105427226|NCT02761694|363570988|FG001|Overall Study|Lost to Follow-up|0|||
105427227|NCT02761694|363570989|FG002|Overall Study|Lost to Follow-up|0|||
105427228|NCT02761694|363570990|FG003|Overall Study|Lost to Follow-up|0|||
105427229|NCT02761694|363570991|FG004|Overall Study|Lost to Follow-up|0|||
105427230|NCT02761694|363570992|FG005|Overall Study|Lost to Follow-up|0|||
105427231|NCT02761694|363570993|FG006|Overall Study|Lost to Follow-up|1|||
105427232|NCT02761694|363570994|FG007|Overall Study|Lost to Follow-up|0|||
105427233|NCT02761694|363570995|FG008|Overall Study|Lost to Follow-up|0|||
105427234|NCT02761694|363570996|FG009|Overall Study|Lost to Follow-up|0|||
105427235|NCT02761694|363570997|FG010|Overall Study|Lost to Follow-up|0|||
105427236|NCT02761694|363570998|FG011|Overall Study|Lost to Follow-up|1|||
105589331|NCT02223793|364158218|FG002|Overall Study|Lost to Follow-up|2|||
105589332|NCT02223793|364158216|FG000|Overall Study|Withdrawal by Subject|3|||
105589333|NCT02223793|364158217|FG001|Overall Study|Withdrawal by Subject|2|||
105589334|NCT02223793|364158218|FG002|Overall Study|Withdrawal by Subject|3|||
105589335|NCT02223793|364158216|FG000|Overall Study|Moved/studycenter unable to participate|4|||
105589336|NCT02223793|364158217|FG001|Overall Study|Moved/studycenter unable to participate|6|||
105589337|NCT02223793|364158218|FG002|Overall Study|Moved/studycenter unable to participate|8|||
105427237|NCT02761694|363570987|FG000|Overall Study|Adverse Event|0|||
105427238|NCT02761694|363570988|FG001|Overall Study|Adverse Event|0|||
105427239|NCT02761694|363570989|FG002|Overall Study|Adverse Event|0|||
105427240|NCT02761694|363570990|FG003|Overall Study|Adverse Event|0|||
105427241|NCT02761694|363570991|FG004|Overall Study|Adverse Event|0|||
105589338|NCT00151996|364158219|FG000|Overall Study|Adverse Event|3|||
105589339|NCT00151996|364158220|FG001|Overall Study|Adverse Event|2|||
105589340|NCT00151996|364158219|FG000|Overall Study|Withdrawal by Subject|1|||
105589341|NCT00151996|364158220|FG001|Overall Study|Withdrawal by Subject|1|||
105589342|NCT00151996|364158219|FG000|Overall Study|Protocol Violation|1|||
105589343|NCT00151996|364158220|FG001|Overall Study|Protocol Violation|2|||
105589344|NCT00151996|364158219|FG000|Overall Study|Sponsor's decision|0|||
105589345|NCT00151996|364158220|FG001|Overall Study|Sponsor's decision|2|||
105589346|NCT00315055|364158222|FG000|Overall Study|Protocol Violation|2|||
105589347|NCT00315055|364158223|FG001|Overall Study|Protocol Violation|4|||
105427242|NCT02761694|363570992|FG005|Overall Study|Adverse Event|0|||
105427243|NCT02761694|363570993|FG006|Overall Study|Adverse Event|1|||
105427244|NCT02761694|363570994|FG007|Overall Study|Adverse Event|0|||
105427245|NCT02761694|363570995|FG008|Overall Study|Adverse Event|1|||
105427246|NCT02761694|363570996|FG009|Overall Study|Adverse Event|0|||
105427247|NCT02761694|363570997|FG010|Overall Study|Adverse Event|0|||
105427248|NCT02761694|363570998|FG011|Overall Study|Adverse Event|1|||
105427249|NCT02761694|363570987|FG000|Overall Study|Other|4|||
105427250|NCT02761694|363570988|FG001|Overall Study|Other|4|||
105427251|NCT02761694|363570989|FG002|Overall Study|Other|1|||
105427252|NCT02761694|363570990|FG003|Overall Study|Other|2|||
105427253|NCT02761694|363570991|FG004|Overall Study|Other|3|||
105427254|NCT02761694|363570992|FG005|Overall Study|Other|3|||
105427255|NCT02761694|363570993|FG006|Overall Study|Other|18|||
105427256|NCT02761694|363570994|FG007|Overall Study|Other|8|||
105427257|NCT02761694|363570995|FG008|Overall Study|Other|0|||
105427258|NCT02761694|363570996|FG009|Overall Study|Other|1|||
105427259|NCT02761694|363570997|FG010|Overall Study|Other|1|||
105427260|NCT02761694|363570998|FG011|Overall Study|Other|0|||
105427261|NCT00844805|363571003|FG000|Treatment Phase|Adverse Event|5|||
105427262|NCT00844805|363571004|FG001|Treatment Phase|Adverse Event|1|||
105427263|NCT00844805|363571005|FG002|Treatment Phase|Adverse Event|0|||
105427264|NCT00844805|363571006|FG003|Treatment Phase|Adverse Event|0|||
105427265|NCT00844805|363571003|FG000|Treatment Phase|Withdrawal by Subject|3|||
105427266|NCT00844805|363571004|FG001|Treatment Phase|Withdrawal by Subject|4|||
105427267|NCT00844805|363571005|FG002|Treatment Phase|Withdrawal by Subject|0|||
105427268|NCT00844805|363571006|FG003|Treatment Phase|Withdrawal by Subject|0|||
105427269|NCT00844805|363571003|FG000|Treatment Phase|Noncompliance With Protocol|1|||
105427270|NCT00844805|363571004|FG001|Treatment Phase|Noncompliance With Protocol|0|||
105427271|NCT00844805|363571005|FG002|Treatment Phase|Noncompliance With Protocol|0|||
105427272|NCT00844805|363571006|FG003|Treatment Phase|Noncompliance With Protocol|0|||
105427273|NCT00844805|363571003|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
105427274|NCT00844805|363571004|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
105427275|NCT00844805|363571005|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
105427276|NCT00844805|363571006|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
105427277|NCT00844805|363571003|FG000|Follow-Up Phase|Adverse Event|0|||
105427278|NCT00844805|363571004|FG001|Follow-Up Phase|Adverse Event|0|||
105427279|NCT00844805|363571005|FG002|Follow-Up Phase|Adverse Event|1|||
105427280|NCT00844805|363571006|FG003|Follow-Up Phase|Adverse Event|0|||
105427281|NCT00844805|363571003|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
105427282|NCT00844805|363571004|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
105427283|NCT00844805|363571005|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
105427284|NCT00844805|363571006|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
105427285|NCT00844805|363571003|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
105427286|NCT00844805|363571004|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
105427287|NCT00844805|363571005|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
105427288|NCT00844805|363571006|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
105427289|NCT00844805|363571003|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
105427290|NCT00844805|363571004|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
105427291|NCT00844805|363571005|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
105427292|NCT00844805|363571006|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
105427293|NCT00844805|363571003|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
105427294|NCT00844805|363571004|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
105427295|NCT00844805|363571005|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
105427296|NCT00844805|363571006|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
105427297|NCT03553498|363571014|FG000|Overall Study|Missing primary outcome|1|||
105427298|NCT03553498|363571015|FG001|Overall Study|Missing primary outcome|2|||
105427299|NCT01100567|363571016|FG000|Overall Study|Withdrawal by Subject|5|||
105427300|NCT01100567|363571017|FG001|Overall Study|Withdrawal by Subject|8|||
105427301|NCT01100567|363571016|FG000|Overall Study|Early Hospital Discharge|6|||
105589348|NCT00315055|364158222|FG000|Overall Study|Lost to Follow-up|1|||
105589349|NCT00315055|364158223|FG001|Overall Study|Lost to Follow-up|1|||
105427302|NCT01100567|363571017|FG001|Overall Study|Early Hospital Discharge|4|||
105427303|NCT01100567|363571016|FG000|Overall Study|Lost to Follow-up|1|||
105427304|NCT01100567|363571017|FG001|Overall Study|Lost to Follow-up|2|||
105427305|NCT01100567|363571016|FG000|Overall Study|Physician Decision|0|||
105427306|NCT01100567|363571017|FG001|Overall Study|Physician Decision|1|||
105427307|NCT01100567|363571016|FG000|Overall Study|Deemed ineligible after consent|0|||
105427308|NCT01100567|363571017|FG001|Overall Study|Deemed ineligible after consent|1|||
105427309|NCT01498185|363571021|FG000|Overall Study|Adverse Event|0|||
105427310|NCT01498185|363571022|FG001|Overall Study|Adverse Event|0|||
105427311|NCT01498185|363571023|FG002|Overall Study|Adverse Event|0|||
105427312|NCT01498185|363571024|FG003|Overall Study|Adverse Event|1|||
105427313|NCT01498185|363571025|FG004|Overall Study|Adverse Event|0|||
105427314|NCT01498185|363571021|FG000|Overall Study|Withdrawal by Subject|1|||
105427315|NCT01498185|363571022|FG001|Overall Study|Withdrawal by Subject|1|||
105427316|NCT01498185|363571023|FG002|Overall Study|Withdrawal by Subject|0|||
105427317|NCT01498185|363571024|FG003|Overall Study|Withdrawal by Subject|2|||
105427318|NCT01498185|363571025|FG004|Overall Study|Withdrawal by Subject|1|||
105427319|NCT01498185|363571021|FG000|Overall Study|No longer met criteria, etc|0|||
105427320|NCT01498185|363571022|FG001|Overall Study|No longer met criteria, etc|0|||
105427321|NCT01498185|363571023|FG002|Overall Study|No longer met criteria, etc|0|||
105427322|NCT01498185|363571024|FG003|Overall Study|No longer met criteria, etc|0|||
105427323|NCT01498185|363571025|FG004|Overall Study|No longer met criteria, etc|2|||
105427324|NCT00946322|363571026|FG000|Pre-treatment|participant failure to follow up|1|||
105427325|NCT00946322|363571026|FG000|Post-treatment|participant failure to follow up|2|||
105427326|NCT02153346|363571027|FG000|Overall Study|Lost to Follow-up|11|||
105427327|NCT03697993|363571028|FG000|Overall Study|Became Ineligible after Enrollment|1|||
105427328|NCT03697993|363571029|FG001|Overall Study|Became Ineligible after Enrollment|3|||
105427329|NCT03697993|363571028|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
105427330|NCT03697993|363571029|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
105427331|NCT03697993|363571028|FG000|Overall Study|Lost to Follow-up|3|||
105427332|NCT03697993|363571029|FG001|Overall Study|Lost to Follow-up|0|||
105427333|NCT03697993|363571028|FG000|Overall Study|Physician Decision|4|||
105427334|NCT03697993|363571029|FG001|Overall Study|Physician Decision|0|||
105427335|NCT03697993|363571028|FG000|Overall Study|Initial Urine Culture Negative|0|||
105427336|NCT03697993|363571029|FG001|Overall Study|Initial Urine Culture Negative|1|||
105427337|NCT00758589|363572535|FG000|Overall Study|Adverse Event|3|||
105427338|NCT00758589|363572536|FG001|Overall Study|Adverse Event|2|||
105427339|NCT00758589|363572537|FG002|Overall Study|Adverse Event|5|||
105427340|NCT00758589|363572538|FG003|Overall Study|Adverse Event|4|||
105427341|NCT00758589|363572535|FG000|Overall Study|Withdrawal by Subject|0|||
105427342|NCT00758589|363572536|FG001|Overall Study|Withdrawal by Subject|1|||
105427343|NCT00758589|363572537|FG002|Overall Study|Withdrawal by Subject|1|||
105427344|NCT00758589|363572538|FG003|Overall Study|Withdrawal by Subject|1|||
105427345|NCT00758589|363572535|FG000|Overall Study|Palm stopped to work|0|||
105427346|NCT00758589|363572536|FG001|Overall Study|Palm stopped to work|0|||
105427347|NCT00758589|363572537|FG002|Overall Study|Palm stopped to work|0|||
105427348|NCT00758589|363572538|FG003|Overall Study|Palm stopped to work|1|||
105427349|NCT01350115|363572540|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
105427350|NCT01350115|363572541|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
105427351|NCT01350115|363572540|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
105427352|NCT01350115|363572541|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
105427353|NCT01350115|363572540|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
105427354|NCT01350115|363572541|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
105427355|NCT01103063|363572542|FG000|Overall Study|Adverse Event|3|||
105427356|NCT01103063|363572543|FG001|Overall Study|Adverse Event|1|||
105427357|NCT01103063|363572542|FG000|Overall Study|Lost to Follow-up|68|||
105427358|NCT01103063|363572543|FG001|Overall Study|Lost to Follow-up|51|||
105427359|NCT01103063|363572542|FG000|Overall Study|Withdrawal by Subject|60|||
105427360|NCT01103063|363572543|FG001|Overall Study|Withdrawal by Subject|15|||
105427361|NCT01103063|363572542|FG000|Overall Study|Other|16|||
105427362|NCT01103063|363572543|FG001|Overall Study|Other|11|||
105427363|NCT01103063|363572542|FG000|Overall Study|Protocol Violation|1|||
105427364|NCT01103063|363572543|FG001|Overall Study|Protocol Violation|0|||
105427365|NCT01103063|363572542|FG000|Overall Study|Study terminated by Sponsor|326|||
105427366|NCT01103063|363572543|FG001|Overall Study|Study terminated by Sponsor|342|||
105427367|NCT01103063|363572542|FG000|Overall Study|Death|3|||
105427368|NCT01103063|363572543|FG001|Overall Study|Death|1|||
105427369|NCT05320393|363572544|FG000|Overall Study|Withdrawal by Subject|1|||
105427370|NCT05320393|363572545|FG001|Overall Study|Withdrawal by Subject|0|||
105427371|NCT05320393|363572546|FG002|Overall Study|Withdrawal by Subject|2|||
105427372|NCT05320393|363572544|FG000|Overall Study|Lost to Follow-up|1|||
105427373|NCT05320393|363572545|FG001|Overall Study|Lost to Follow-up|2|||
105427374|NCT05320393|363572546|FG002|Overall Study|Lost to Follow-up|1|||
105427375|NCT05320393|363572544|FG000|Overall Study|Moved; too much driving|0|||
105427376|NCT05320393|363572545|FG001|Overall Study|Moved; too much driving|0|||
105427377|NCT05320393|363572546|FG002|Overall Study|Moved; too much driving|2|||
105427378|NCT05320393|363572544|FG000|Overall Study|Did not receive treatment|0|||
105427379|NCT05320393|363572545|FG001|Overall Study|Did not receive treatment|0|||
105427380|NCT05320393|363572546|FG002|Overall Study|Did not receive treatment|1|||
105427381|NCT01176565|363572551|FG000|Overall Study|Lost to Follow-up|12|||
105427382|NCT01176565|363572552|FG001|Overall Study|Lost to Follow-up|16|||
105427383|NCT01176565|363572551|FG000|Overall Study|Withdrawal by Subject|7|||
105427384|NCT01176565|363572552|FG001|Overall Study|Withdrawal by Subject|1|||
105427385|NCT01176565|363572551|FG000|Overall Study|Not Analyzed (any other reason)|1|||
105427386|NCT01176565|363572552|FG001|Overall Study|Not Analyzed (any other reason)|2|||
105427387|NCT01187446|363572553|FG000|Overall Study|Patient started non-protocol therapy|0|||
105427388|NCT01187446|363572554|FG001|Overall Study|Patient started non-protocol therapy|1|||
105427389|NCT01703117|363572558|FG000|Overall Study|Adverse Event|4|||
105427390|NCT01703117|363572559|FG001|Overall Study|Adverse Event|3|||
105427391|NCT01703117|363572558|FG000|Overall Study|Withdrawal by Subject|0|||
105427392|NCT01703117|363572559|FG001|Overall Study|Withdrawal by Subject|1|||
105427393|NCT00623545|363572560|FG000|Overall Study|Adverse Event|6|||
105427394|NCT00623545|363572560|FG000|Overall Study|Withdrawal by Subject|4|||
105427395|NCT01974752|363572562|FG000|Overall Study|Death|33|||
105427396|NCT01974752|363572563|FG001|Overall Study|Death|11|||
105427397|NCT01974752|363572562|FG000|Overall Study|Lost to Follow-up|2|||
105427398|NCT01974752|363572563|FG001|Overall Study|Lost to Follow-up|0|||
105427399|NCT01974752|363572562|FG000|Overall Study|Withdrawal by Subject|2|||
105427400|NCT01974752|363572563|FG001|Overall Study|Withdrawal by Subject|3|||
105427401|NCT01974752|363572562|FG000|Overall Study|Other Eligibility Criteria|0|||
105427402|NCT01974752|363572563|FG001|Overall Study|Other Eligibility Criteria|1|||
105427403|NCT00330928|363572566|FG000|Overall Study|Lost to Follow-up|6|||
105427404|NCT00330928|363572566|FG000|Overall Study|Physician Decision|9|||
105427405|NCT00330928|363572566|FG000|Overall Study|Death|1|||
105427406|NCT00330928|363572566|FG000|Overall Study|IVUS could not be performed.|1|||
105427407|NCT03541187|363572571|FG000|Overall Study|Lost to Follow-up|2|||
105427408|NCT03541187|363572572|FG001|Overall Study|Lost to Follow-up|6|||
105427409|NCT03541187|363572571|FG000|Overall Study|Pregnancy|0|||
105427410|NCT03541187|363572572|FG001|Overall Study|Pregnancy|1|||
105427411|NCT03541187|363572571|FG000|Overall Study|Withdrawal by Subject|6|||
105427412|NCT03541187|363572572|FG001|Overall Study|Withdrawal by Subject|2|||
105427413|NCT03541187|363572571|FG000|Overall Study|Moved out of town|1|||
105427414|NCT03541187|363572572|FG001|Overall Study|Moved out of town|0|||
105427415|NCT03541187|363572571|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
105427416|NCT03541187|363572572|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
105427417|NCT03541187|363572571|FG000|Overall Study|Did not meet randomization criteria|1|||
105427418|NCT03541187|363572572|FG001|Overall Study|Did not meet randomization criteria|1|||
105427419|NCT03541187|363572571|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
105427420|NCT03541187|363572572|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
105427421|NCT03541187|363572571|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
105427422|NCT03541187|363572572|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
105427423|NCT01369680|363572573|FG000|Overall Study|Lost to Follow-up|0|||
105427424|NCT01369680|363572574|FG001|Overall Study|Lost to Follow-up|0|||
105427425|NCT01369680|363572575|FG002|Overall Study|Lost to Follow-up|1|||
105427426|NCT01369680|363572576|FG003|Overall Study|Lost to Follow-up|2|||
105427427|NCT02088073|363572578|FG000|Acute Phase|Withdrawal by Subject|5|||
105427428|NCT02088073|363572579|FG001|Acute Phase|Withdrawal by Subject|0|||
105427429|NCT02088073|363572580|FG002|Acute Phase|Withdrawal by Subject|0|||
105427430|NCT02088073|363572581|FG003|Acute Phase|Withdrawal by Subject|0|||
105427431|NCT02088073|363572582|FG004|Acute Phase|Withdrawal by Subject|0|||
105427432|NCT02088073|363572578|FG000|Acute Phase|Hyperkalemia|2|||
105427433|NCT02088073|363572579|FG001|Acute Phase|Hyperkalemia|0|||
105427434|NCT02088073|363572580|FG002|Acute Phase|Hyperkalemia|0|||
105427435|NCT02088073|363572581|FG003|Acute Phase|Hyperkalemia|0|||
105427436|NCT02088073|363572582|FG004|Acute Phase|Hyperkalemia|0|||
105427437|NCT02088073|363572578|FG000|Maintanance Phase|Withdrawal by Subject|0|||
105427438|NCT02088073|363572579|FG001|Maintanance Phase|Withdrawal by Subject|2|||
105427439|NCT02088073|363572580|FG002|Maintanance Phase|Withdrawal by Subject|0|||
105427440|NCT02088073|363572581|FG003|Maintanance Phase|Withdrawal by Subject|0|||
105427441|NCT02088073|363572582|FG004|Maintanance Phase|Withdrawal by Subject|0|||
105427442|NCT02088073|363572578|FG000|Maintanance Phase|Adverse Event|0|||
105427443|NCT02088073|363572579|FG001|Maintanance Phase|Adverse Event|0|||
105427444|NCT02088073|363572580|FG002|Maintanance Phase|Adverse Event|3|||
105427445|NCT02088073|363572581|FG003|Maintanance Phase|Adverse Event|0|||
105427446|NCT02088073|363572582|FG004|Maintanance Phase|Adverse Event|1|||
105427447|NCT02088073|363572578|FG000|Maintanance Phase|Physician Decision|0|||
105427448|NCT02088073|363572579|FG001|Maintanance Phase|Physician Decision|0|||
105427449|NCT02088073|363572580|FG002|Maintanance Phase|Physician Decision|0|||
105427450|NCT02088073|363572581|FG003|Maintanance Phase|Physician Decision|0|||
105427451|NCT02088073|363572582|FG004|Maintanance Phase|Physician Decision|1|||
105427452|NCT02088073|363572578|FG000|Maintanance Phase|Sponsor's decision|0|||
105427453|NCT02088073|363572579|FG001|Maintanance Phase|Sponsor's decision|2|||
105427454|NCT02088073|363572580|FG002|Maintanance Phase|Sponsor's decision|0|||
105427455|NCT02088073|363572581|FG003|Maintanance Phase|Sponsor's decision|2|||
105427456|NCT02088073|363572582|FG004|Maintanance Phase|Sponsor's decision|1|||
105427457|NCT02088073|363572578|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
105427458|NCT02088073|363572579|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
105427459|NCT02088073|363572580|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
105427460|NCT02088073|363572581|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
105427461|NCT02088073|363572582|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
105427462|NCT02088073|363572578|FG000|Maintanance Phase|Miscellaneous|0|||
105427463|NCT02088073|363572579|FG001|Maintanance Phase|Miscellaneous|2|||
105427464|NCT02088073|363572580|FG002|Maintanance Phase|Miscellaneous|1|||
105427465|NCT02088073|363572581|FG003|Maintanance Phase|Miscellaneous|2|||
105427466|NCT02088073|363572582|FG004|Maintanance Phase|Miscellaneous|1|||
105427467|NCT02088073|363572578|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
105427468|NCT02088073|363572579|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
105427469|NCT02088073|363572580|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
105427470|NCT02088073|363572581|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
105427471|NCT02088073|363572582|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
105427472|NCT02088073|363572578|FG000|Maintanance Phase|Subject compliance|0|||
105427473|NCT02088073|363572579|FG001|Maintanance Phase|Subject compliance|1|||
105427474|NCT02088073|363572580|FG002|Maintanance Phase|Subject compliance|0|||
105427475|NCT02088073|363572581|FG003|Maintanance Phase|Subject compliance|0|||
105427476|NCT02088073|363572582|FG004|Maintanance Phase|Subject compliance|0|||
105427477|NCT02785458|363572583|FG000|1 Month|Withdrawal by Subject|2|||
105427478|NCT02785458|363572584|FG001|1 Month|Withdrawal by Subject|1|||
105427479|NCT02785458|363572583|FG000|1 Month|Lost to Follow-up|38|||
105427480|NCT02785458|363572584|FG001|1 Month|Lost to Follow-up|31|||
105427481|NCT02785458|363572583|FG000|1 Month|Deemed Ineligible|1|||
105427482|NCT02785458|363572584|FG001|1 Month|Deemed Ineligible|0|||
105427483|NCT02785458|363572583|FG000|1 Month|Completed Evaluation by Baseline|42|||
105427484|NCT02785458|363572584|FG001|1 Month|Completed Evaluation by Baseline|39|||
105501441|NCT04457336|363847093|FG005|Period 4: Part C|Site Terminated|0|||
105501442|NCT04457336|363847094|FG006|Period 4: Part C|Site Terminated|0|||
105501443|NCT04457336|363847095|FG007|Period 4: Part C|Site Terminated|1|||
105501444|NCT04457336|363847088|FG000|Period 4: Part C|Other|0|||
105501445|NCT04457336|363847089|FG001|Period 4: Part C|Other|0|||
105501446|NCT04457336|363847090|FG002|Period 4: Part C|Other|0|||
105501447|NCT04457336|363847091|FG003|Period 4: Part C|Other|0|||
105501448|NCT04457336|363847092|FG004|Period 4: Part C|Other|0|||
105501449|NCT04457336|363847093|FG005|Period 4: Part C|Other|0|||
105501450|NCT04457336|363847094|FG006|Period 4: Part C|Other|0|||
105501451|NCT04457336|363847095|FG007|Period 4: Part C|Other|2|||
105501452|NCT04457336|363847088|FG000|Period 4: Part C|Withdrawal by Subject|0|||
105501453|NCT04457336|363847089|FG001|Period 4: Part C|Withdrawal by Subject|0|||
105501454|NCT04457336|363847090|FG002|Period 4: Part C|Withdrawal by Subject|0|||
105501455|NCT04457336|363847091|FG003|Period 4: Part C|Withdrawal by Subject|0|||
105501456|NCT04457336|363847092|FG004|Period 4: Part C|Withdrawal by Subject|0|||
105501457|NCT04457336|363847093|FG005|Period 4: Part C|Withdrawal by Subject|0|||
105501458|NCT04457336|363847094|FG006|Period 4: Part C|Withdrawal by Subject|0|||
105501459|NCT04457336|363847095|FG007|Period 4: Part C|Withdrawal by Subject|3|||
105501460|NCT04545060|363847099|FG000|Overall Study|Adverse Event|0|||
105501461|NCT04545060|363847100|FG001|Overall Study|Adverse Event|1|||
105501462|NCT04545060|363847099|FG000|Overall Study|Death|0|||
105501463|NCT04545060|363847100|FG001|Overall Study|Death|5|||
105501464|NCT04545060|363847099|FG000|Overall Study|Lost to Follow-up|10|||
105501465|NCT04545060|363847100|FG001|Overall Study|Lost to Follow-up|13|||
105501466|NCT04545060|363847099|FG000|Overall Study|Physician Decision|3|||
105501467|NCT04545060|363847100|FG001|Overall Study|Physician Decision|0|||
105501468|NCT04545060|363847099|FG000|Overall Study|Withdrawal by Subject|17|||
105501469|NCT04545060|363847100|FG001|Overall Study|Withdrawal by Subject|22|||
105501470|NCT00619177|363847101|FG000|Overall Study|Adverse Event|18|||
105501471|NCT00619177|363847101|FG000|Overall Study|Lost to Follow-up|2|||
105501472|NCT00619177|363847101|FG000|Overall Study|Lack of Efficacy|1|||
105501473|NCT00619177|363847101|FG000|Overall Study|Missing termination information|481|||
105501474|NCT00619177|363847101|FG000|Overall Study|Not specified reasons|6|||
105501475|NCT04203498|363847107|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
105501476|NCT04203498|363847108|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
105501477|NCT04203498|363847107|FG000|Overall Study|Withdrawal of patient consent|7|||
105501478|NCT04203498|363847108|FG001|Overall Study|Withdrawal of patient consent|2|||
105501479|NCT04203498|363847107|FG000|Overall Study|Adverse Event|4|||
105501480|NCT04203498|363847108|FG001|Overall Study|Adverse Event|1|||
105501481|NCT04203498|363847107|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
105501482|NCT04203498|363847108|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
105501483|NCT04203498|363847107|FG000|Overall Study|Did not receive IMP|2|||
105501484|NCT04203498|363847108|FG001|Overall Study|Did not receive IMP|0|||
105501485|NCT02121522|363847110|FG000|Overall Study|Adverse Event|1|||
105501486|NCT02362269|363847115|FG000|Overall Study|Moved|1|||
105501487|NCT02362269|363847116|FG001|Overall Study|Moved|0|||
105501488|NCT02362269|363847115|FG000|Overall Study|Lost to Follow-up|0|||
105501489|NCT02362269|363847116|FG001|Overall Study|Lost to Follow-up|6|||
105501490|NCT00892047|363847117|FG000|Overall Study|Adverse Event|2|||
105427485|NCT02785458|363572583|FG000|1 Month|Partial Interview|0|||
105427486|NCT02785458|363572584|FG001|1 Month|Partial Interview|4|||
105501491|NCT00892047|363847118|FG001|Overall Study|Adverse Event|2|||
105501492|NCT00892047|363847117|FG000|Overall Study|subject burden|2|||
105427487|NCT02785458|363572583|FG000|3 Months|Withdrawal by Subject|3|||
105427488|NCT02785458|363572584|FG001|3 Months|Withdrawal by Subject|1|||
105427489|NCT02785458|363572583|FG000|3 Months|Lost to Follow-up|25|||
105427490|NCT02785458|363572584|FG001|3 Months|Lost to Follow-up|21|||
105427491|NCT02785458|363572583|FG000|3 Months|Completed Evaluation at 1 Month|100|||
105427492|NCT02785458|363572584|FG001|3 Months|Completed Evaluation at 1 Month|89|||
105427493|NCT02046174|363572585|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
105427494|NCT02046174|363572586|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
105427495|NCT00086502|363572591|FG000|Overall Study|Adverse Event|11|||
105427496|NCT00086502|363572592|FG001|Overall Study|Adverse Event|2|||
105427497|NCT00086502|363572591|FG000|Overall Study|Lack of Efficacy|0|||
105427498|NCT00086502|363572592|FG001|Overall Study|Lack of Efficacy|2|||
105427499|NCT00086502|363572591|FG000|Overall Study|Lost to Follow-up|3|||
105427500|NCT00086502|363572592|FG001|Overall Study|Lost to Follow-up|1|||
105427501|NCT00086502|363572591|FG000|Overall Study|Physician Decision|1|||
105427502|NCT00086502|363572592|FG001|Overall Study|Physician Decision|1|||
105427503|NCT00086502|363572591|FG000|Overall Study|Pregnancy|0|||
105427504|NCT00086502|363572592|FG001|Overall Study|Pregnancy|1|||
105427505|NCT00086502|363572591|FG000|Overall Study|Protocol Violation|3|||
105427506|NCT00086502|363572592|FG001|Overall Study|Protocol Violation|3|||
105427507|NCT00086502|363572591|FG000|Overall Study|Withdrawal by Subject|5|||
105427508|NCT00086502|363572592|FG001|Overall Study|Withdrawal by Subject|6|||
105427509|NCT00086502|363572591|FG000|Overall Study|Patient Moved|1|||
105427510|NCT00086502|363572592|FG001|Overall Study|Patient Moved|1|||
105427511|NCT00086502|363572591|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
105427512|NCT00086502|363572592|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
105427513|NCT00086502|363572591|FG000|Overall Study|Patient Accidentally Unblinded|1|||
105427514|NCT00086502|363572592|FG001|Overall Study|Patient Accidentally Unblinded|0|||
105427515|NCT03412604|363572593|FG000|Overall Study|Withdrawal by Subject|1|||
105427516|NCT05545644|363572594|FG000|Overall Study|Lost to Follow-up|4|||
105427517|NCT05545644|363572595|FG001|Overall Study|Lost to Follow-up|3|||
105427518|NCT00610441|363572596|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
105427519|NCT00610441|363572597|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
105427520|NCT00610441|363572598|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
105427521|NCT00610441|363572599|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
105427522|NCT00610441|363572596|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
105427523|NCT00610441|363572597|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
105427524|NCT00610441|363572598|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
105427525|NCT00610441|363572599|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
105427526|NCT00610441|363572596|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
105427527|NCT00610441|363572597|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
105427528|NCT00610441|363572598|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
105427529|NCT00610441|363572599|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
105427530|NCT00610441|363572596|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
105427531|NCT00610441|363572597|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
105427532|NCT00610441|363572598|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
105427533|NCT00610441|363572599|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
105427534|NCT00610441|363572596|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
105427535|NCT00610441|363572597|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
105427536|NCT00610441|363572598|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
105427537|NCT00610441|363572599|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
105427538|NCT00610441|363572596|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
105427539|NCT00610441|363572597|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
105427540|NCT00610441|363572598|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
105427541|NCT00610441|363572599|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
105427542|NCT00610441|363572596|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
105427543|NCT00610441|363572597|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
105427544|NCT00610441|363572598|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
105427545|NCT00610441|363572599|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
105427546|NCT00610441|363572596|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
105427547|NCT00610441|363572597|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
105501493|NCT00892047|363847118|FG001|Overall Study|subject burden|3|||
105501494|NCT00892047|363847117|FG000|Overall Study|Lack of Efficacy|0|||
105501495|NCT00892047|363847118|FG001|Overall Study|Lack of Efficacy|2|||
105501496|NCT02106975|363847123|FG000|Overall Study|Death|25|||
105501497|NCT02106975|363847124|FG001|Overall Study|Death|39|||
105501498|NCT00005044|363847128|FG000|Overall Study|Protocol Violation|37|||
105501499|NCT00005044|363847129|FG001|Overall Study|Protocol Violation|46|||
105501500|NCT00005044|363847128|FG000|Overall Study|Withdrawal by Subject|1|||
105589350|NCT02359435|364158224|FG000|Overall Study|Lost to Follow-up|4|||
105427548|NCT00610441|363572598|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
105427549|NCT00610441|363572599|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
105501501|NCT00005044|363847129|FG001|Overall Study|Withdrawal by Subject|5|||
105501502|NCT00005044|363847128|FG000|Overall Study|No protocol treatment|0|||
105589351|NCT02359435|364158225|FG001|Overall Study|Lost to Follow-up|4|||
105589352|NCT01704846|364158229|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105589353|NCT01704846|364158230|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105589354|NCT00530335|364158231|FG000|Overall Study|Adverse Event|3|||
105589355|NCT00530335|364158231|FG000|Overall Study|Protocol Violation|1|||
105589356|NCT00530335|364158231|FG000|Overall Study|Withdrawal by Subject|1|||
105589357|NCT00530335|364158231|FG000|Overall Study|Physician Decision|1|||
105589358|NCT01649791|364158232|FG000|Overall Study|Disease Progression|2|||
105589359|NCT01649791|364158232|FG000|Overall Study|Adverse Event|1|||
105589360|NCT04577183|364158233|FG000|Overall Study|Death|1|||
105589361|NCT04577183|364158233|FG000|Overall Study|Withdrawal by Subject|3|||
105589362|NCT04577183|364158233|FG000|Overall Study|Early termination|2|||
105589363|NCT01168401|364158234|FG000|Overall Study|Lost to Follow-up|1|||
105589364|NCT01168401|364158235|FG001|Overall Study|Lost to Follow-up|1|||
105589365|NCT01168401|364158236|FG002|Overall Study|Lost to Follow-up|2|||
105589366|NCT01168401|364158237|FG003|Overall Study|Lost to Follow-up|1|||
105589367|NCT01168401|364158238|FG004|Overall Study|Lost to Follow-up|0|||
105589368|NCT01168401|364158239|FG005|Overall Study|Lost to Follow-up|0|||
105589369|NCT01168401|364158240|FG006|Overall Study|Lost to Follow-up|0|||
105589370|NCT01168401|364158241|FG007|Overall Study|Lost to Follow-up|0|||
105589371|NCT01168401|364158242|FG008|Overall Study|Lost to Follow-up|0|||
105589372|NCT01168401|364158243|FG009|Overall Study|Lost to Follow-up|0|||
105589373|NCT01168401|364158244|FG010|Overall Study|Lost to Follow-up|0|||
105589374|NCT01168401|364158234|FG000|Overall Study|Withdrawal by Subject|0|||
105589375|NCT01168401|364158235|FG001|Overall Study|Withdrawal by Subject|0|||
105589376|NCT01168401|364158236|FG002|Overall Study|Withdrawal by Subject|0|||
105589377|NCT01168401|364158237|FG003|Overall Study|Withdrawal by Subject|1|||
105589378|NCT01168401|364158238|FG004|Overall Study|Withdrawal by Subject|0|||
105589379|NCT01168401|364158239|FG005|Overall Study|Withdrawal by Subject|0|||
105589380|NCT01168401|364158240|FG006|Overall Study|Withdrawal by Subject|0|||
105589381|NCT01168401|364158241|FG007|Overall Study|Withdrawal by Subject|0|||
105589382|NCT01168401|364158242|FG008|Overall Study|Withdrawal by Subject|0|||
105589383|NCT01168401|364158243|FG009|Overall Study|Withdrawal by Subject|0|||
105589384|NCT01168401|364158244|FG010|Overall Study|Withdrawal by Subject|0|||
105589385|NCT03085017|364158247|FG000|Overall Study|Death|0|||
105589386|NCT03085017|364158248|FG001|Overall Study|Death|3|||
105589387|NCT00991276|364158257|FG000|First Intervention Period|Adverse Event|0|||
105589388|NCT00991276|364158258|FG001|First Intervention Period|Adverse Event|1|||
105589389|NCT00991276|364158259|FG002|First Intervention Period|Adverse Event|0|||
105589390|NCT00991276|364158260|FG003|First Intervention Period|Adverse Event|1|||
105589391|NCT00991276|364158261|FG004|First Intervention Period|Adverse Event|0|||
105589392|NCT00991276|364158262|FG005|First Intervention Period|Adverse Event|0|||
105589393|NCT00991276|364158257|FG000|First Intervention Period|Protocol Violation|0|||
105589394|NCT00991276|364158258|FG001|First Intervention Period|Protocol Violation|0|||
105589395|NCT00991276|364158259|FG002|First Intervention Period|Protocol Violation|0|||
105589396|NCT00991276|364158260|FG003|First Intervention Period|Protocol Violation|0|||
105589397|NCT00991276|364158261|FG004|First Intervention Period|Protocol Violation|2|||
105589398|NCT00991276|364158262|FG005|First Intervention Period|Protocol Violation|0|||
105589399|NCT00991276|364158257|FG000|First Intervention Period|Insufficient clinical response|0|||
105589400|NCT00991276|364158258|FG001|First Intervention Period|Insufficient clinical response|0|||
105427550|NCT00610441|363572596|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
105427551|NCT00610441|363572597|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
105427552|NCT00610441|363572598|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
105427553|NCT00610441|363572599|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
105427554|NCT01945775|363572600|FG000|Overall Study|Death|214|||
105427555|NCT01945775|363572601|FG001|Overall Study|Death|98|||
105589401|NCT00991276|364158259|FG002|First Intervention Period|Insufficient clinical response|0|||
105589402|NCT00991276|364158260|FG003|First Intervention Period|Insufficient clinical response|0|||
105589403|NCT00991276|364158261|FG004|First Intervention Period|Insufficient clinical response|1|||
105589404|NCT00991276|364158262|FG005|First Intervention Period|Insufficient clinical response|0|||
105589405|NCT00991276|364158257|FG000|First Intervention Period|Other|0|||
105589406|NCT00991276|364158258|FG001|First Intervention Period|Other|0|||
105589407|NCT00991276|364158259|FG002|First Intervention Period|Other|0|||
105589408|NCT00991276|364158260|FG003|First Intervention Period|Other|1|||
105589409|NCT00991276|364158261|FG004|First Intervention Period|Other|1|||
105589410|NCT00991276|364158262|FG005|First Intervention Period|Other|0|||
105589411|NCT00991276|364158257|FG000|First Intervention Period|Withdrawal by Subject|0|||
105589412|NCT00991276|364158258|FG001|First Intervention Period|Withdrawal by Subject|1|||
105589413|NCT00991276|364158259|FG002|First Intervention Period|Withdrawal by Subject|0|||
105589414|NCT00991276|364158260|FG003|First Intervention Period|Withdrawal by Subject|1|||
105589415|NCT00991276|364158261|FG004|First Intervention Period|Withdrawal by Subject|0|||
105589416|NCT00991276|364158262|FG005|First Intervention Period|Withdrawal by Subject|1|||
105589417|NCT00991276|364158257|FG000|First Intervention Period|Lost to Follow-up|0|||
105589418|NCT00991276|364158258|FG001|First Intervention Period|Lost to Follow-up|1|||
105427556|NCT01945775|363572600|FG000|Overall Study|Lost to Follow-up|12|||
105589419|NCT00991276|364158259|FG002|First Intervention Period|Lost to Follow-up|0|||
105589420|NCT00991276|364158260|FG003|First Intervention Period|Lost to Follow-up|1|||
105589421|NCT00991276|364158261|FG004|First Intervention Period|Lost to Follow-up|0|||
105589422|NCT00991276|364158262|FG005|First Intervention Period|Lost to Follow-up|0|||
105589423|NCT00991276|364158257|FG000|Second Intervention Period|Adverse Event|0|||
105427557|NCT01945775|363572601|FG001|Overall Study|Lost to Follow-up|7|||
105427558|NCT01945775|363572600|FG000|Overall Study|Withdrawal by Subject|11|||
105427559|NCT01945775|363572601|FG001|Overall Study|Withdrawal by Subject|21|||
105427560|NCT01945775|363572600|FG000|Overall Study|Other|50|||
105427561|NCT01945775|363572601|FG001|Overall Study|Other|18|||
105427562|NCT02876328|363572602|FG000|Overall Study|Death|2|||
105427563|NCT02876328|363572603|FG001|Overall Study|Death|1|||
105427564|NCT02876328|363572604|FG002|Overall Study|Death|3|||
105427565|NCT02876328|363572605|FG003|Overall Study|Death|0|||
105427566|NCT02876328|363572606|FG004|Overall Study|Death|0|||
105427567|NCT02876328|363572607|FG005|Overall Study|Death|0|||
105427568|NCT02876328|363572608|FG006|Overall Study|Death|1|||
105427569|NCT02876328|363572609|FG007|Overall Study|Death|3|||
105427570|NCT02876328|363572610|FG008|Overall Study|Death|0|||
105427571|NCT02876328|363572611|FG009|Overall Study|Death|1|||
105427572|NCT02876328|363572612|FG010|Overall Study|Death|1|||
105427573|NCT02876328|363572613|FG011|Overall Study|Death|0|||
105427574|NCT02876328|363572614|FG012|Overall Study|Death|0|||
105427575|NCT02876328|363572615|FG013|Overall Study|Death|0|||
105427576|NCT02876328|363572616|FG014|Overall Study|Death|0|||
105427577|NCT02876328|363572617|FG015|Overall Study|Death|0|||
105427578|NCT02876328|363572618|FG016|Overall Study|Death|1|||
105427579|NCT02876328|363572619|FG017|Overall Study|Death|1|||
105427580|NCT02876328|363572620|FG018|Overall Study|Death|0|||
105427581|NCT02876328|363572621|FG019|Overall Study|Death|0|||
105427582|NCT02876328|363572622|FG020|Overall Study|Death|0|||
105427583|NCT02876328|363572623|FG021|Overall Study|Death|1|||
105427584|NCT02876328|363572624|FG022|Overall Study|Death|0|||
105427585|NCT02876328|363572625|FG023|Overall Study|Death|0|||
105427586|NCT02876328|363572602|FG000|Overall Study|Withdrawal by Subject|0|||
105427587|NCT02876328|363572603|FG001|Overall Study|Withdrawal by Subject|2|||
105427588|NCT02876328|363572604|FG002|Overall Study|Withdrawal by Subject|3|||
105589424|NCT00991276|364158258|FG001|Second Intervention Period|Adverse Event|2|||
105589425|NCT00991276|364158259|FG002|Second Intervention Period|Adverse Event|0|||
105589426|NCT00991276|364158260|FG003|Second Intervention Period|Adverse Event|1|||
105589427|NCT00991276|364158261|FG004|Second Intervention Period|Adverse Event|1|||
105589428|NCT00991276|364158262|FG005|Second Intervention Period|Adverse Event|0|||
105589429|NCT00991276|364158257|FG000|Second Intervention Period|Protocol Violation|1|||
105589430|NCT00991276|364158258|FG001|Second Intervention Period|Protocol Violation|0|||
105589431|NCT00991276|364158259|FG002|Second Intervention Period|Protocol Violation|0|||
105589432|NCT00991276|364158260|FG003|Second Intervention Period|Protocol Violation|0|||
105589433|NCT00991276|364158261|FG004|Second Intervention Period|Protocol Violation|0|||
105589434|NCT00991276|364158262|FG005|Second Intervention Period|Protocol Violation|0|||
105589435|NCT00991276|364158257|FG000|Second Intervention Period|Other|0|||
105589436|NCT00991276|364158258|FG001|Second Intervention Period|Other|0|||
105589437|NCT00991276|364158259|FG002|Second Intervention Period|Other|0|||
105427589|NCT02876328|363572605|FG003|Overall Study|Withdrawal by Subject|3|||
105427590|NCT02876328|363572606|FG004|Overall Study|Withdrawal by Subject|0|||
105427591|NCT02876328|363572607|FG005|Overall Study|Withdrawal by Subject|1|||
105427592|NCT02876328|363572608|FG006|Overall Study|Withdrawal by Subject|0|||
105427593|NCT02876328|363572609|FG007|Overall Study|Withdrawal by Subject|1|||
105427594|NCT02876328|363572610|FG008|Overall Study|Withdrawal by Subject|1|||
105427595|NCT02876328|363572611|FG009|Overall Study|Withdrawal by Subject|2|||
105427596|NCT02876328|363572612|FG010|Overall Study|Withdrawal by Subject|0|||
105589438|NCT00991276|364158260|FG003|Second Intervention Period|Other|1|||
105589439|NCT00991276|364158261|FG004|Second Intervention Period|Other|0|||
105589440|NCT00991276|364158262|FG005|Second Intervention Period|Other|1|||
105589441|NCT00991276|364158257|FG000|Third Intervention Period|Protocol Violation|1|||
105589442|NCT00991276|364158258|FG001|Third Intervention Period|Protocol Violation|0|||
105589443|NCT00991276|364158259|FG002|Third Intervention Period|Protocol Violation|0|||
105589444|NCT00991276|364158260|FG003|Third Intervention Period|Protocol Violation|0|||
105427597|NCT02876328|363572613|FG011|Overall Study|Withdrawal by Subject|0|||
105427598|NCT02876328|363572614|FG012|Overall Study|Withdrawal by Subject|0|||
105427599|NCT02876328|363572615|FG013|Overall Study|Withdrawal by Subject|0|||
105427600|NCT02876328|363572616|FG014|Overall Study|Withdrawal by Subject|0|||
105427601|NCT02876328|363572617|FG015|Overall Study|Withdrawal by Subject|0|||
105427602|NCT02876328|363572618|FG016|Overall Study|Withdrawal by Subject|1|||
105427603|NCT02876328|363572619|FG017|Overall Study|Withdrawal by Subject|3|||
105427604|NCT02876328|363572620|FG018|Overall Study|Withdrawal by Subject|0|||
105427605|NCT02876328|363572621|FG019|Overall Study|Withdrawal by Subject|0|||
105427606|NCT02876328|363572622|FG020|Overall Study|Withdrawal by Subject|1|||
105427607|NCT02876328|363572623|FG021|Overall Study|Withdrawal by Subject|0|||
105427608|NCT02876328|363572624|FG022|Overall Study|Withdrawal by Subject|0|||
105427609|NCT02876328|363572625|FG023|Overall Study|Withdrawal by Subject|0|||
105427610|NCT02876328|363572602|FG000|Overall Study|Missed 12 Month Visit|15|||
105427611|NCT02876328|363572603|FG001|Overall Study|Missed 12 Month Visit|10|||
105427612|NCT02876328|363572604|FG002|Overall Study|Missed 12 Month Visit|11|||
105427613|NCT02876328|363572605|FG003|Overall Study|Missed 12 Month Visit|6|||
105427614|NCT02876328|363572606|FG004|Overall Study|Missed 12 Month Visit|10|||
105427615|NCT02876328|363572607|FG005|Overall Study|Missed 12 Month Visit|14|||
105427616|NCT02876328|363572608|FG006|Overall Study|Missed 12 Month Visit|3|||
105427617|NCT02876328|363572609|FG007|Overall Study|Missed 12 Month Visit|8|||
105427618|NCT02876328|363572610|FG008|Overall Study|Missed 12 Month Visit|9|||
105427619|NCT02876328|363572611|FG009|Overall Study|Missed 12 Month Visit|5|||
105427620|NCT02876328|363572612|FG010|Overall Study|Missed 12 Month Visit|4|||
105427621|NCT02876328|363572613|FG011|Overall Study|Missed 12 Month Visit|1|||
105427622|NCT02876328|363572614|FG012|Overall Study|Missed 12 Month Visit|5|||
105427623|NCT02876328|363572615|FG013|Overall Study|Missed 12 Month Visit|4|||
105427624|NCT02876328|363572616|FG014|Overall Study|Missed 12 Month Visit|4|||
105427625|NCT02876328|363572617|FG015|Overall Study|Missed 12 Month Visit|4|||
105427626|NCT02876328|363572618|FG016|Overall Study|Missed 12 Month Visit|3|||
105427627|NCT02876328|363572619|FG017|Overall Study|Missed 12 Month Visit|6|||
105427628|NCT02876328|363572620|FG018|Overall Study|Missed 12 Month Visit|2|||
105427629|NCT02876328|363572621|FG019|Overall Study|Missed 12 Month Visit|2|||
105427630|NCT02876328|363572622|FG020|Overall Study|Missed 12 Month Visit|11|||
105427631|NCT02876328|363572623|FG021|Overall Study|Missed 12 Month Visit|7|||
105427632|NCT02876328|363572624|FG022|Overall Study|Missed 12 Month Visit|1|||
105427633|NCT02876328|363572625|FG023|Overall Study|Missed 12 Month Visit|0|||
105427634|NCT01995552|363572626|FG000|Overall Study|Protocol Violation|1|||
105427635|NCT01995552|363572626|FG000|Overall Study|Lack of Efficacy|15|||
105427636|NCT01995552|363572626|FG000|Overall Study|Death|1|||
105427637|NCT03515941|363572627|FG000|Overall Study|Adverse Event|1|||
105427638|NCT03515941|363572628|FG001|Overall Study|Adverse Event|0|||
105427639|NCT00886119|363572631|FG000|Period 1|Did not meet inclusion criteria|1|||
105427640|NCT00886119|363572632|FG001|Period 1|Did not meet inclusion criteria|0|||
105427641|NCT03002623|363572633|FG000|Overall Study|Lost to Follow-up|1|||
105427642|NCT03002623|363572634|FG001|Overall Study|Lost to Follow-up|0|||
105427643|NCT03002623|363572633|FG000|Overall Study|Physician Decision|1|||
105427644|NCT03002623|363572634|FG001|Overall Study|Physician Decision|1|||
105427645|NCT00857948|363572637|FG000|Overall Study|Withdrawal by Subject|2|||
105427646|NCT00857948|363572638|FG001|Overall Study|Withdrawal by Subject|0|||
105427647|NCT00857948|363572639|FG002|Overall Study|Withdrawal by Subject|0|||
105427648|NCT00857948|363572640|FG003|Overall Study|Withdrawal by Subject|0|||
105427649|NCT00857948|363572637|FG000|Overall Study|Protocol Violation|1|||
105427650|NCT00857948|363572638|FG001|Overall Study|Protocol Violation|0|||
105427651|NCT00857948|363572639|FG002|Overall Study|Protocol Violation|1|||
105427652|NCT00857948|363572640|FG003|Overall Study|Protocol Violation|0|||
105427653|NCT00645528|363572643|FG000|Overall Study|Did not show up for Visit 2|7|||
105427654|NCT01011933|363572649|FG000|Overall Study|Wrong cell type|1|||
105427655|NCT01011933|363572649|FG000|Overall Study|Improper pre-protocol Rx|1|||
105427656|NCT01011933|363572649|FG000|Overall Study|Inadequate pathology|1|||
105427657|NCT01011933|363572649|FG000|Overall Study|Never treated|1|||
105427658|NCT00493636|363572650|FG000|Overall Study|Withdrawal by Subject|1|||
105427659|NCT00493636|363572651|FG001|Overall Study|Withdrawal by Subject|0|||
105427660|NCT00493636|363572650|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
105427661|NCT00493636|363572651|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
105427662|NCT00493636|363572650|FG000|Overall Study|Mis-randomization|1|||
105427663|NCT00493636|363572651|FG001|Overall Study|Mis-randomization|1|||
105427664|NCT01873729|363572652|FG000|Overall Study|Withdrawal by Subject|1|||
105427665|NCT02463032|363572653|FG000|Overall Study|Lack of Efficacy|61|||
105427666|NCT02463032|363572654|FG001|Overall Study|Lack of Efficacy|50|||
105427667|NCT02463032|363572653|FG000|Overall Study|Death|8|||
105427668|NCT02463032|363572654|FG001|Overall Study|Death|8|||
105427669|NCT02463032|363572653|FG000|Overall Study|Adverse Event|2|||
105427670|NCT02463032|363572654|FG001|Overall Study|Adverse Event|6|||
105427671|NCT00613080|363572655|FG000|Overall Study|Ineligible / no protocol treatment|11|||
105427672|NCT01066780|363572656|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
105427673|NCT01066780|363572657|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
105427674|NCT03757130|363572658|FG000|Overall Study|Lost to Follow-up|0|||
105427675|NCT03757130|363572659|FG001|Overall Study|Lost to Follow-up|0|||
105427676|NCT03757130|363572660|FG002|Overall Study|Lost to Follow-up|0|||
105427677|NCT03757130|363572661|FG003|Overall Study|Lost to Follow-up|1|||
105427678|NCT03757130|363572662|FG004|Overall Study|Lost to Follow-up|0|||
105427679|NCT03757130|363572663|FG005|Overall Study|Lost to Follow-up|0|||
105427680|NCT03757130|363572664|FG006|Overall Study|Lost to Follow-up|0|||
105427681|NCT03757130|363572665|FG007|Overall Study|Lost to Follow-up|1|||
105427682|NCT03757130|363572658|FG000|Overall Study|Withdrawal by Subject|0|||
105427683|NCT03757130|363572659|FG001|Overall Study|Withdrawal by Subject|0|||
105427684|NCT03757130|363572660|FG002|Overall Study|Withdrawal by Subject|0|||
105427685|NCT03757130|363572661|FG003|Overall Study|Withdrawal by Subject|0|||
105427686|NCT03757130|363572662|FG004|Overall Study|Withdrawal by Subject|0|||
105427687|NCT03757130|363572663|FG005|Overall Study|Withdrawal by Subject|0|||
105427688|NCT03757130|363572664|FG006|Overall Study|Withdrawal by Subject|1|||
105427689|NCT03757130|363572665|FG007|Overall Study|Withdrawal by Subject|0|||
105427690|NCT02360293|363572666|FG000|Overall Study|Lost to Follow-up|73|||
105427691|NCT02360293|363572667|FG001|Overall Study|Lost to Follow-up|95|||
105427692|NCT02360293|363572666|FG000|Overall Study|Withdrawal by Subject|2|||
105427693|NCT02360293|363572667|FG001|Overall Study|Withdrawal by Subject|1|||
105427694|NCT02360293|363572666|FG000|Overall Study|Excluded|1|||
105427695|NCT02360293|363572667|FG001|Overall Study|Excluded|0|||
105427696|NCT02726880|363572669|FG000|Overall Study|Withdrawal by Subject|2|||
105427697|NCT02726880|363572670|FG001|Overall Study|Withdrawal by Subject|0|||
105427698|NCT02726880|363572669|FG000|Overall Study|Lost to Follow-up|1|||
105427699|NCT02726880|363572670|FG001|Overall Study|Lost to Follow-up|3|||
105427700|NCT04316741|363572671|FG000|Baseline Enrollment|Lost to Follow-up|1|||
105427701|NCT04316741|363572672|FG001|Baseline Enrollment|Lost to Follow-up|1|||
105427702|NCT04316741|363572671|FG000|Immediate Post-Test|Lost to Follow-up|5|||
105427703|NCT04316741|363572672|FG001|Immediate Post-Test|Lost to Follow-up|1|||
105427704|NCT04316741|363572671|FG000|1-month Post-test|Lost to Follow-up|7|||
105427705|NCT04316741|363572672|FG001|1-month Post-test|Lost to Follow-up|2|||
105427706|NCT04316741|363572671|FG000|3-month Follow-up|Lost to Follow-up|10|||
105427707|NCT04316741|363572672|FG001|3-month Follow-up|Lost to Follow-up|2|||
105427708|NCT00787202|363572673|FG000|Overall Study|Adverse Event|3|||
105427709|NCT00787202|363572674|FG001|Overall Study|Adverse Event|2|||
105427710|NCT00787202|363572675|FG002|Overall Study|Adverse Event|0|||
105427711|NCT00787202|363572676|FG003|Overall Study|Adverse Event|0|||
105427712|NCT00787202|363572677|FG004|Overall Study|Adverse Event|2|||
105427713|NCT00787202|363572673|FG000|Overall Study|Lack of Efficacy|5|||
105427714|NCT00787202|363572674|FG001|Overall Study|Lack of Efficacy|6|||
105427715|NCT00787202|363572675|FG002|Overall Study|Lack of Efficacy|5|||
105427716|NCT00787202|363572676|FG003|Overall Study|Lack of Efficacy|2|||
105427717|NCT00787202|363572677|FG004|Overall Study|Lack of Efficacy|1|||
105427718|NCT00787202|363572673|FG000|Overall Study|Lost to Follow-up|1|||
105427719|NCT00787202|363572674|FG001|Overall Study|Lost to Follow-up|0|||
105427720|NCT00787202|363572675|FG002|Overall Study|Lost to Follow-up|0|||
105427721|NCT00787202|363572676|FG003|Overall Study|Lost to Follow-up|0|||
105427722|NCT00787202|363572677|FG004|Overall Study|Lost to Follow-up|0|||
105427723|NCT00787202|363572673|FG000|Overall Study|Withdrawal by Subject|2|||
105427724|NCT00787202|363572674|FG001|Overall Study|Withdrawal by Subject|2|||
105427725|NCT00787202|363572675|FG002|Overall Study|Withdrawal by Subject|2|||
105427726|NCT00787202|363572676|FG003|Overall Study|Withdrawal by Subject|0|||
105427727|NCT00787202|363572677|FG004|Overall Study|Withdrawal by Subject|0|||
105427728|NCT00787202|363572673|FG000|Overall Study|Protocol Violation|2|||
105427729|NCT00787202|363572674|FG001|Overall Study|Protocol Violation|1|||
105427730|NCT00787202|363572675|FG002|Overall Study|Protocol Violation|0|||
105427731|NCT00787202|363572676|FG003|Overall Study|Protocol Violation|0|||
105427732|NCT00787202|363572677|FG004|Overall Study|Protocol Violation|1|||
105427733|NCT00787202|363572673|FG000|Overall Study|Randomized, not treated|1|||
105427734|NCT00787202|363572674|FG001|Overall Study|Randomized, not treated|0|||
105427735|NCT00787202|363572675|FG002|Overall Study|Randomized, not treated|0|||
105427736|NCT00787202|363572676|FG003|Overall Study|Randomized, not treated|0|||
105427737|NCT00787202|363572677|FG004|Overall Study|Randomized, not treated|0|||
105427738|NCT02312219|363572678|FG000|Overall Study|Withdrawal by Subject|1|||
105427739|NCT02312219|363572679|FG001|Overall Study|Withdrawal by Subject|2|||
105427740|NCT02312219|363572678|FG000|Overall Study|could not schedule imaging in time|0|||
105427741|NCT02312219|363572679|FG001|Overall Study|could not schedule imaging in time|2|||
105427742|NCT02312219|363572678|FG000|Overall Study|Other|0|||
105427743|NCT02312219|363572679|FG001|Overall Study|Other|1|||
105427744|NCT02312219|363572678|FG000|Overall Study|Not randomized. Ineligible|0|||
105427745|NCT02312219|363572679|FG001|Overall Study|Not randomized. Ineligible|1|||
105427746|NCT01269385|363572680|FG000|Overall Study|Adverse Event|1|||
105427747|NCT01269385|363572681|FG001|Overall Study|Adverse Event|1|||
105427748|NCT01269385|363572682|FG002|Overall Study|Adverse Event|0|||
105427749|NCT01269385|363572683|FG003|Overall Study|Adverse Event|0|||
105427750|NCT04941807|363572685|FG000|Overall Study|Lost to Follow-up|1|||
105427751|NCT04941807|363572686|FG001|Overall Study|Lost to Follow-up|1|||
105427752|NCT03089944|363572687|FG000|Overall Study|Lost to Follow-up|8|||
105427753|NCT03089944|363572687|FG000|Overall Study|Withdrew Consent|2|||
105427754|NCT03089944|363572687|FG000|Overall Study|Adverse Event|1|||
105427755|NCT03089944|363572687|FG000|Overall Study|Other|1|||
105427756|NCT02278614|363572693|FG000|Overall Study|Withdrawal by Subject|3|||
105427757|NCT02278614|363572694|FG001|Overall Study|Withdrawal by Subject|5|||
105427758|NCT02278614|363572693|FG000|Overall Study|Adverse Event|1|||
105427759|NCT02278614|363572694|FG001|Overall Study|Adverse Event|0|||
105427760|NCT02278614|363572693|FG000|Overall Study|left eye was not eligible|1|||
105427761|NCT02278614|363572694|FG001|Overall Study|left eye was not eligible|0|||
105427762|NCT03759041|363572695|FG000|Overall Study|Withdrawal by Subject|4|||
105427763|NCT03759041|363572696|FG001|Overall Study|Withdrawal by Subject|10|||
105589445|NCT00991276|364158261|FG004|Third Intervention Period|Protocol Violation|0|||
105589446|NCT00991276|364158262|FG005|Third Intervention Period|Protocol Violation|0|||
105589447|NCT00991276|364158257|FG000|Third Intervention Period|Other|0|||
105589448|NCT00991276|364158258|FG001|Third Intervention Period|Other|0|||
105589449|NCT00991276|364158259|FG002|Third Intervention Period|Other|0|||
105589450|NCT00991276|364158260|FG003|Third Intervention Period|Other|0|||
105589451|NCT00991276|364158261|FG004|Third Intervention Period|Other|0|||
105589452|NCT00991276|364158262|FG005|Third Intervention Period|Other|1|||
105589453|NCT00991276|364158257|FG000|Third Intervention Period|Adverse Event|0|||
105589454|NCT00991276|364158258|FG001|Third Intervention Period|Adverse Event|0|||
105589455|NCT00991276|364158259|FG002|Third Intervention Period|Adverse Event|1|||
105589456|NCT00991276|364158260|FG003|Third Intervention Period|Adverse Event|0|||
105589457|NCT00991276|364158261|FG004|Third Intervention Period|Adverse Event|0|||
105589458|NCT00991276|364158262|FG005|Third Intervention Period|Adverse Event|0|||
105589459|NCT00991276|364158257|FG000|Third Intervention Period|Withdrawal by Subject|0|||
105589460|NCT00991276|364158258|FG001|Third Intervention Period|Withdrawal by Subject|0|||
105589461|NCT00991276|364158259|FG002|Third Intervention Period|Withdrawal by Subject|0|||
105589462|NCT00991276|364158260|FG003|Third Intervention Period|Withdrawal by Subject|1|||
105589463|NCT00991276|364158261|FG004|Third Intervention Period|Withdrawal by Subject|0|||
105589464|NCT00991276|364158262|FG005|Third Intervention Period|Withdrawal by Subject|0|||
105589465|NCT01720043|364158265|FG000|Overall Study|Withdrawal by Subject|1|||
105589466|NCT01688973|364158266|FG000|Overall Study|Ineligible|2|||
105589467|NCT01688973|364158267|FG001|Overall Study|Ineligible|3|||
105589468|NCT01124162|364158270|FG000|First Intervention|Adverse Event|2|||
105589469|NCT01124162|364158271|FG001|First Intervention|Adverse Event|0|||
105589470|NCT01124162|364158270|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
105589471|NCT01124162|364158271|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
105589472|NCT02680756|364158272|FG000|Overall Study|Adverse Event|10|||
105589473|NCT02680756|364158273|FG001|Overall Study|Adverse Event|2|||
105589474|NCT02680756|364158272|FG000|Overall Study|Lost to Follow-up|7|||
105589475|NCT02680756|364158273|FG001|Overall Study|Lost to Follow-up|6|||
105589476|NCT02680756|364158272|FG000|Overall Study|Withdrawal by Subject|5|||
105589477|NCT02680756|364158273|FG001|Overall Study|Withdrawal by Subject|5|||
105589478|NCT02680756|364158272|FG000|Overall Study|Physician Decision|4|||
105427764|NCT03759041|363572697|FG002|Overall Study|Withdrawal by Subject|10|||
105427765|NCT03759041|363572695|FG000|Overall Study|Adverse Event|1|||
105427766|NCT03759041|363572696|FG001|Overall Study|Adverse Event|3|||
105427767|NCT03759041|363572697|FG002|Overall Study|Adverse Event|4|||
105427768|NCT03759041|363572695|FG000|Overall Study|Lack of Efficacy|0|||
105427769|NCT03759041|363572696|FG001|Overall Study|Lack of Efficacy|0|||
105427770|NCT03759041|363572697|FG002|Overall Study|Lack of Efficacy|1|||
105427771|NCT03759041|363572695|FG000|Overall Study|Study Terminated by Sponsor|15|||
105427772|NCT03759041|363572696|FG001|Overall Study|Study Terminated by Sponsor|16|||
105427773|NCT03759041|363572697|FG002|Overall Study|Study Terminated by Sponsor|10|||
105427774|NCT03759041|363572695|FG000|Overall Study|Other reason for discontinuation|0|||
105427775|NCT03759041|363572696|FG001|Overall Study|Other reason for discontinuation|2|||
105427776|NCT03759041|363572697|FG002|Overall Study|Other reason for discontinuation|1|||
105427777|NCT03759041|363572695|FG000|Overall Study|Lost to Follow-up|7|||
105589479|NCT02680756|364158273|FG001|Overall Study|Physician Decision|1|||
105589480|NCT02680756|364158272|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
105589481|NCT02680756|364158273|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
105589482|NCT02680756|364158272|FG000|Overall Study|Blood transfusion for any reason|0|||
105589483|NCT02680756|364158273|FG001|Overall Study|Blood transfusion for any reason|1|||
105589484|NCT02680756|364158272|FG000|Overall Study|Death|1|||
105589485|NCT02680756|364158273|FG001|Overall Study|Death|0|||
105589486|NCT02680756|364158272|FG000|Overall Study|Protocol Violation|1|||
105589487|NCT02680756|364158273|FG001|Overall Study|Protocol Violation|0|||
105589488|NCT02680756|364158272|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
105589489|NCT02680756|364158273|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
105589490|NCT02680756|364158272|FG000|Overall Study|None of above or not recorded|3|||
105427778|NCT03759041|363572696|FG001|Overall Study|Lost to Follow-up|2|||
105589491|NCT02680756|364158273|FG001|Overall Study|None of above or not recorded|2|||
105589492|NCT03681691|364158275|FG000|Overall Study|COVID|1|||
105589493|NCT03681691|364158276|FG001|Overall Study|COVID|0|||
105589494|NCT03681691|364158275|FG000|Overall Study|prolonged bleeding|1|||
105589495|NCT03681691|364158276|FG001|Overall Study|prolonged bleeding|0|||
105589496|NCT03681691|364158275|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
105589497|NCT03681691|364158276|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
105589498|NCT01516892|364158280|FG000|Overall Study|Adverse Event|25|||
105589499|NCT01516892|364158280|FG000|Overall Study|Lack of Efficacy|35|||
105589500|NCT01516892|364158280|FG000|Overall Study|Pregnancy|5|||
105589501|NCT01516892|364158280|FG000|Overall Study|Lost to Follow-up|82|||
105589502|NCT01516892|364158280|FG000|Overall Study|Subject Withdrew Consent|92|||
105427779|NCT03759041|363572697|FG002|Overall Study|Lost to Follow-up|2|||
105427780|NCT03759041|363572695|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
105427781|NCT03759041|363572696|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
105427782|NCT03759041|363572697|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
105427783|NCT04384107|363572698|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
105427784|NCT04384107|363572699|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
105427785|NCT04384107|363572698|FG000|Overall Study|Lost to Follow-up|1|||
105427786|NCT04384107|363572699|FG001|Overall Study|Lost to Follow-up|0|||
105427787|NCT02698371|363572702|FG000|All Participants Flow|Lost to Follow-up|3|||
105427788|NCT02698371|363572702|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
105427789|NCT02698371|363572702|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
105427790|NCT02698371|363572702|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
105427791|NCT02698371|363572702|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
105427792|NCT02698371|363572702|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
105427793|NCT02698371|363572702|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
105427794|NCT03582813|363572703|FG000|Overall Study|Lost to Follow-up|18|||
105427795|NCT03582813|363572704|FG001|Overall Study|Lost to Follow-up|21|||
105427796|NCT03582813|363572703|FG000|Overall Study|Withdrawal by Subject|1|||
105427797|NCT03582813|363572704|FG001|Overall Study|Withdrawal by Subject|0|||
105427798|NCT01591863|363572705|FG000|Overall Study|Adverse Event|3|||
105427799|NCT01591863|363572705|FG000|Overall Study|Withdrawal by Subject|1|||
105427800|NCT01591863|363572705|FG000|Overall Study|recurrence|9|||
105427801|NCT01591863|363572705|FG000|Overall Study|Lack of Efficacy|1|||
105427802|NCT00969436|363572707|FG000|Overall Study|Protocol Violation|1|||
105427803|NCT00969436|363572708|FG001|Overall Study|Protocol Violation|3|||
105427804|NCT00969436|363572709|FG002|Overall Study|Protocol Violation|0|||
105427805|NCT00969436|363572707|FG000|Overall Study|Migrated/moved from study area|12|||
105427806|NCT00969436|363572708|FG001|Overall Study|Migrated/moved from study area|10|||
105427807|NCT00969436|363572709|FG002|Overall Study|Migrated/moved from study area|2|||
105427808|NCT00969436|363572707|FG000|Overall Study|Father - serious health problem|0|||
105427809|NCT00969436|363572708|FG001|Overall Study|Father - serious health problem|0|||
105427810|NCT00969436|363572709|FG002|Overall Study|Father - serious health problem|1|||
105427811|NCT00969436|363572707|FG000|Overall Study|Parents personal problem|0|||
105427812|NCT00969436|363572708|FG001|Overall Study|Parents personal problem|0|||
105427813|NCT00969436|363572709|FG002|Overall Study|Parents personal problem|1|||
105427814|NCT00969436|363572707|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
105427815|NCT00969436|363572708|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
105427816|NCT00969436|363572709|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
105427817|NCT00969436|363572707|FG000|Overall Study|Withdrawal by Subject|3|||
105427818|NCT00969436|363572708|FG001|Overall Study|Withdrawal by Subject|0|||
105427819|NCT00969436|363572709|FG002|Overall Study|Withdrawal by Subject|2|||
105427820|NCT00969436|363572707|FG000|Overall Study|Lost to Follow-up|8|||
105427821|NCT00969436|363572708|FG001|Overall Study|Lost to Follow-up|8|||
105427822|NCT00969436|363572709|FG002|Overall Study|Lost to Follow-up|5|||
105427823|NCT02366767|363572710|FG000|Overall Study|left for home after 1 day at camp|1|||
105427824|NCT02366767|363572711|FG001|Overall Study|left for home after 1 day at camp|0|||
105427825|NCT02242981|363572712|FG000|Overall Study|Withdrawal by Subject|1|||
105427826|NCT00459537|363572718|FG000|Overall Study|Adverse Event|1|||
105427827|NCT00459537|363572719|FG001|Overall Study|Adverse Event|6|||
105427828|NCT00459537|363572718|FG000|Overall Study|Lack of Efficacy|10|||
105427829|NCT00459537|363572719|FG001|Overall Study|Lack of Efficacy|11|||
105427830|NCT00459537|363572718|FG000|Overall Study|Withdrawal by Subject|20|||
105427831|NCT00459537|363572719|FG001|Overall Study|Withdrawal by Subject|26|||
105427832|NCT00459537|363572718|FG000|Overall Study|Lost to Follow-up|27|||
105427833|NCT00459537|363572719|FG001|Overall Study|Lost to Follow-up|30|||
105427834|NCT00459537|363572718|FG000|Overall Study|Administrative problems|3|||
105427835|NCT00459537|363572719|FG001|Overall Study|Administrative problems|0|||
105427836|NCT00459537|363572718|FG000|Overall Study|Protocol Violation|4|||
105427837|NCT00459537|363572719|FG001|Overall Study|Protocol Violation|3|||
105427838|NCT00459537|363572718|FG000|Overall Study|Missing|1|||
105427839|NCT00459537|363572719|FG001|Overall Study|Missing|0|||
105427840|NCT03159104|363572720|FG000|Overall Study|Violation of inclusion criteria|1|||
105427841|NCT03159104|363572721|FG001|Overall Study|Violation of inclusion criteria|2|||
105427842|NCT00456599|363572722|FG000|Overall Study|Non-compliance|1|||
105427843|NCT00456599|363572722|FG000|Overall Study|Withdrawal by Subject|2|||
105427844|NCT01999218|363572723|FG000|Overall Study|Hyperglycemia|18|||
105427845|NCT01999218|363572724|FG001|Overall Study|Hyperglycemia|17|||
105427846|NCT01999218|363572725|FG002|Overall Study|Hyperglycemia|17|||
105427847|NCT01999218|363572723|FG000|Overall Study|Lack of Efficacy|1|||
105427848|NCT01999218|363572724|FG001|Overall Study|Lack of Efficacy|0|||
105427849|NCT01999218|363572725|FG002|Overall Study|Lack of Efficacy|1|||
105589503|NCT01516892|364158280|FG000|Overall Study|Protocol Violation|60|||
105427850|NCT01999218|363572723|FG000|Overall Study|Lost to Follow-up|22|||
105427851|NCT01999218|363572724|FG001|Overall Study|Lost to Follow-up|17|||
105427852|NCT01999218|363572725|FG002|Overall Study|Lost to Follow-up|18|||
105427853|NCT01999218|363572723|FG000|Overall Study|Non-Compliance With Study Drug|6|||
105427854|NCT01999218|363572724|FG001|Overall Study|Non-Compliance With Study Drug|4|||
105427855|NCT01999218|363572725|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105427856|NCT01999218|363572723|FG000|Overall Study|Physician Decision|1|||
105427857|NCT01999218|363572724|FG001|Overall Study|Physician Decision|4|||
105427858|NCT01999218|363572725|FG002|Overall Study|Physician Decision|6|||
105427859|NCT01999218|363572723|FG000|Overall Study|Protocol Violation|4|||
105427860|NCT01999218|363572724|FG001|Overall Study|Protocol Violation|5|||
105427861|NCT01999218|363572725|FG002|Overall Study|Protocol Violation|4|||
105427862|NCT01999218|363572723|FG000|Overall Study|Screen failure|0|||
105427863|NCT01999218|363572724|FG001|Overall Study|Screen failure|1|||
105427864|NCT01999218|363572725|FG002|Overall Study|Screen failure|0|||
105427865|NCT01999218|363572723|FG000|Overall Study|Study Terminated By Sponsor|7|||
105427866|NCT01999218|363572724|FG001|Overall Study|Study Terminated By Sponsor|5|||
105427867|NCT01999218|363572725|FG002|Overall Study|Study Terminated By Sponsor|12|||
105427868|NCT01999218|363572723|FG000|Overall Study|Participant moves|2|||
105427869|NCT01999218|363572724|FG001|Overall Study|Participant moves|5|||
105427870|NCT01999218|363572725|FG002|Overall Study|Participant moves|3|||
105427871|NCT01999218|363572723|FG000|Overall Study|Withdrawal by Subject|28|||
105427872|NCT01999218|363572724|FG001|Overall Study|Withdrawal by Subject|29|||
105427873|NCT01999218|363572725|FG002|Overall Study|Withdrawal by Subject|34|||
105427874|NCT01999218|363572723|FG000|Overall Study|Creatinine/eGFR|0|||
105427875|NCT01999218|363572724|FG001|Overall Study|Creatinine/eGFR|0|||
105427876|NCT01999218|363572725|FG002|Overall Study|Creatinine/eGFR|1|||
105427877|NCT01999218|363572723|FG000|Overall Study|Death|7|||
105427878|NCT01999218|363572724|FG001|Overall Study|Death|1|||
105427879|NCT01999218|363572725|FG002|Overall Study|Death|2|||
105427880|NCT01999218|363572723|FG000|Overall Study|Excluded Medication|1|||
105427881|NCT01999218|363572724|FG001|Overall Study|Excluded Medication|1|||
105427882|NCT01999218|363572725|FG002|Overall Study|Excluded Medication|2|||
105427883|NCT01999218|363572723|FG000|Overall Study|Adverse Event|9|||
105427884|NCT01999218|363572724|FG001|Overall Study|Adverse Event|7|||
105427885|NCT01999218|363572725|FG002|Overall Study|Adverse Event|7|||
105427886|NCT01999218|363572723|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
105427887|NCT01999218|363572724|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
105427888|NCT01999218|363572725|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
105427889|NCT03959982|363574258|FG000|Overall Study|Withdrawal by Subject|1|||
105427890|NCT03959982|363574259|FG001|Overall Study|Withdrawal by Subject|0|||
105427891|NCT03959982|363574258|FG000|Overall Study|Physician Decision|2|||
105427892|NCT03959982|363574259|FG001|Overall Study|Physician Decision|0|||
105427893|NCT03959982|363574258|FG000|Overall Study|Lost to Follow-up|1|||
105427894|NCT03959982|363574259|FG001|Overall Study|Lost to Follow-up|0|||
105427895|NCT00387647|363574262|FG000|Overall Study|Death|18|||
105427896|NCT02191605|363574263|FG000|Overall Study|Lost to Follow-up|9|||
105427897|NCT02191605|363574264|FG001|Overall Study|Lost to Follow-up|4|||
105427898|NCT02191605|363574265|FG002|Overall Study|Lost to Follow-up|7|||
105427899|NCT02191605|363574266|FG003|Overall Study|Lost to Follow-up|3|||
105427900|NCT02191605|363574267|FG004|Overall Study|Lost to Follow-up|4|||
105427901|NCT01309269|363574268|FG000|Overall Study|Adverse Event|56|||
105427902|NCT01309269|363574268|FG000|Overall Study|Withdrawal by Subject|25|||
105427903|NCT01309269|363574268|FG000|Overall Study|Lack of Acceptance|15|||
105427904|NCT01309269|363574268|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
105427905|NCT01309269|363574268|FG000|Overall Study|Kidney Transplant|25|||
105427906|NCT01309269|363574268|FG000|Overall Study|Administrative Problems|141|||
105427907|NCT01309269|363574268|FG000|Overall Study|Other|256|||
105427908|NCT01309269|363574268|FG000|Overall Study|Other|1|||
105427909|NCT01309269|363574268|FG000|Overall Study|Study Completion Data Not Recorded|95|||
105427910|NCT01309269|363574268|FG000|Overall Study|Enrolled but not Treated|107|||
105427911|NCT03899064|363574269|FG000|Overall Study|Lost to Follow-up|1|||
105427912|NCT03899064|363574269|FG000|Overall Study|Protocol Violation|2|||
105427913|NCT03899064|363574269|FG000|Overall Study|Withdrawal by Subject|2|||
105427914|NCT03899064|363574269|FG000|Overall Study|Other|2|||
105427915|NCT03559699|363574272|FG000|Overall Study|Withdrawal by Subject|6|||
105427916|NCT03559699|363574272|FG000|Overall Study|Lost to Follow-up|1|||
105427917|NCT02080260|363574274|FG000|Overall Study|Death|18|||
105427918|NCT02080260|363574274|FG000|Overall Study|Withdrawal by Subject|1|||
105427919|NCT02654236|363574275|FG000|Overall Study|Withdrawal by Subject|0|||
105427920|NCT02654236|363574276|FG001|Overall Study|Withdrawal by Subject|0|||
105427921|NCT02654236|363574277|FG002|Overall Study|Withdrawal by Subject|2|||
105427922|NCT01930890|363574278|FG000|Overall Study|Study Termination|14|||
105427923|NCT01930890|363574279|FG001|Overall Study|Study Termination|28|||
105427924|NCT01930890|363574280|FG002|Overall Study|Study Termination|13|||
105427925|NCT01930890|363574281|FG003|Overall Study|Study Termination|25|||
105427926|NCT01930890|363574278|FG000|Overall Study|Death|0|||
105427927|NCT01930890|363574279|FG001|Overall Study|Death|0|||
105427928|NCT01930890|363574280|FG002|Overall Study|Death|0|||
105427929|NCT01930890|363574281|FG003|Overall Study|Death|1|||
105427930|NCT01930890|363574278|FG000|Overall Study|Investigator Decision|0|||
105427931|NCT01930890|363574279|FG001|Overall Study|Investigator Decision|1|||
105427932|NCT01930890|363574280|FG002|Overall Study|Investigator Decision|0|||
105427933|NCT01930890|363574281|FG003|Overall Study|Investigator Decision|0|||
105427934|NCT01930890|363574278|FG000|Overall Study|Consent Withdrawn|0|||
105427935|NCT01930890|363574279|FG001|Overall Study|Consent Withdrawn|3|||
105589504|NCT01516892|364158280|FG000|Overall Study|Other Miscellaneous Reasons|43|||
105589505|NCT01516892|364158280|FG000|Overall Study|Missing|1|||
105589506|NCT03613129|364158281|FG000|Pre-treatment Assessment|Protocol Violation|2|||
105589507|NCT03613129|364158282|FG001|Pre-treatment Assessment|Protocol Violation|0|||
105427936|NCT01930890|363574280|FG002|Overall Study|Consent Withdrawn|0|||
105427937|NCT01930890|363574281|FG003|Overall Study|Consent Withdrawn|1|||
105427938|NCT01930890|363574278|FG000|Overall Study|Adverse Event|0|||
105427939|NCT01930890|363574279|FG001|Overall Study|Adverse Event|1|||
105427940|NCT01930890|363574280|FG002|Overall Study|Adverse Event|0|||
105427941|NCT01930890|363574281|FG003|Overall Study|Adverse Event|0|||
105427942|NCT02091284|363574282|FG000|Overall Study|Withdrawal by Subject|2|||
105427943|NCT02091284|363574283|FG001|Overall Study|Withdrawal by Subject|1|||
105427944|NCT02091284|363574282|FG000|Overall Study|unreliable data|1|||
105427945|NCT02091284|363574283|FG001|Overall Study|unreliable data|0|||
105427946|NCT01340937|363574302|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
105427947|NCT01340937|363574303|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
105427948|NCT01340937|363574304|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
105427949|NCT01340937|363574305|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
105427950|NCT01340937|363574302|FG000|Period 1: Infant Series|Adverse Event|0|||
105427951|NCT01340937|363574303|FG001|Period 1: Infant Series|Adverse Event|1|||
105427952|NCT01340937|363574304|FG002|Period 1: Infant Series|Adverse Event|4|||
105427953|NCT01340937|363574305|FG003|Period 1: Infant Series|Adverse Event|0|||
105427954|NCT01340937|363574302|FG000|Period 1: Infant Series|Death|2|||
105427955|NCT01340937|363574303|FG001|Period 1: Infant Series|Death|0|||
105427956|NCT01340937|363574304|FG002|Period 1: Infant Series|Death|2|||
105427957|NCT01340937|363574305|FG003|Period 1: Infant Series|Death|0|||
105427958|NCT01340937|363574302|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
105427959|NCT01340937|363574303|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
105427960|NCT01340937|363574304|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
105427961|NCT01340937|363574305|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
105427962|NCT01340937|363574302|FG000|Period 1: Infant Series|Physician Decision|2|||
105427963|NCT01340937|363574303|FG001|Period 1: Infant Series|Physician Decision|3|||
105427964|NCT01340937|363574304|FG002|Period 1: Infant Series|Physician Decision|1|||
105427965|NCT01340937|363574305|FG003|Period 1: Infant Series|Physician Decision|0|||
105427966|NCT01340937|363574302|FG000|Period 1: Infant Series|Protocol Violation|1|||
105427967|NCT01340937|363574303|FG001|Period 1: Infant Series|Protocol Violation|4|||
105427968|NCT01340937|363574304|FG002|Period 1: Infant Series|Protocol Violation|4|||
105427969|NCT01340937|363574305|FG003|Period 1: Infant Series|Protocol Violation|3|||
105427970|NCT01340937|363574302|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
105427971|NCT01340937|363574303|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
105427972|NCT01340937|363574304|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
105427973|NCT01340937|363574305|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
105427974|NCT01340937|363574302|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
105427975|NCT01340937|363574303|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
105427976|NCT01340937|363574304|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
105427977|NCT01340937|363574305|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
105427978|NCT01340937|363574302|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
105427979|NCT01340937|363574303|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
105427980|NCT01340937|363574304|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
105427981|NCT01340937|363574305|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
105427982|NCT01340937|363574302|FG000|Period 2: Interim Period|Adverse Event|1|||
105427983|NCT01340937|363574303|FG001|Period 2: Interim Period|Adverse Event|0|||
105427984|NCT01340937|363574304|FG002|Period 2: Interim Period|Adverse Event|1|||
105427985|NCT01340937|363574305|FG003|Period 2: Interim Period|Adverse Event|0|||
105427986|NCT01340937|363574302|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
105427987|NCT01340937|363574303|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
105427988|NCT01340937|363574304|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
105427989|NCT01340937|363574305|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
105427990|NCT01340937|363574302|FG000|Period 2: Interim Period|Physician Decision|0|||
105427991|NCT01340937|363574303|FG001|Period 2: Interim Period|Physician Decision|1|||
105589508|NCT03613129|364158283|FG002|Pre-treatment Assessment|Protocol Violation|0|||
105589509|NCT03613129|364158284|FG003|Pre-treatment Assessment|Protocol Violation|0|||
105427992|NCT01340937|363574304|FG002|Period 2: Interim Period|Physician Decision|1|||
105427993|NCT01340937|363574305|FG003|Period 2: Interim Period|Physician Decision|0|||
105427994|NCT01340937|363574302|FG000|Period 2: Interim Period|Protocol Violation|5|||
105427995|NCT01340937|363574303|FG001|Period 2: Interim Period|Protocol Violation|3|||
105427996|NCT01340937|363574304|FG002|Period 2: Interim Period|Protocol Violation|6|||
105427997|NCT01340937|363574305|FG003|Period 2: Interim Period|Protocol Violation|3|||
105427998|NCT01340937|363574302|FG000|Period 2: Interim Period|Technical problems|4|||
105427999|NCT01340937|363574303|FG001|Period 2: Interim Period|Technical problems|4|||
105428000|NCT01340937|363574304|FG002|Period 2: Interim Period|Technical problems|6|||
105589510|NCT03613129|364158285|FG004|Pre-treatment Assessment|Protocol Violation|0|||
105428001|NCT01340937|363574305|FG003|Period 2: Interim Period|Technical problems|3|||
105428002|NCT01340937|363574302|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
105428003|NCT01340937|363574303|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
105428004|NCT01340937|363574304|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
105428005|NCT01340937|363574305|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
105428006|NCT01340937|363574302|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
105428007|NCT01340937|363574303|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
105428008|NCT01340937|363574304|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
105428009|NCT01340937|363574305|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
105428010|NCT01340937|363574302|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
105428011|NCT01340937|363574303|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
105428012|NCT01340937|363574304|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
105428013|NCT01340937|363574305|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
105428014|NCT01340937|363574302|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
105428015|NCT01340937|363574303|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
105428016|NCT01340937|363574304|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
105428017|NCT01340937|363574305|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
105428018|NCT04599166|363574309|FG000|Overall Study|Technological failure connecting to study app|80|||
105428019|NCT02317809|363574310|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
105428020|NCT02317809|363574311|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
105428021|NCT02317809|363574310|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
105428022|NCT02317809|363574311|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
105428023|NCT01030874|363574314|FG000|Overall Study|Withdrawal by Subject|1|||
105428024|NCT01030874|363574315|FG001|Overall Study|Withdrawal by Subject|0|||
105428025|NCT01030874|363574314|FG000|Overall Study|Discharged in first 2 weeks|17|||
105428026|NCT01030874|363574315|FG001|Overall Study|Discharged in first 2 weeks|16|||
105428027|NCT03106415|363574316|FG000|Phase 1|Withdrawal by Subject|1|||
105428028|NCT03106415|363574317|FG001|Phase 1|Withdrawal by Subject|0|||
105428029|NCT03106415|363574318|FG002|Phase 1|Withdrawal by Subject|0|||
105428030|NCT03106415|363574316|FG000|Phase 1|Adverse Event|1|||
105428031|NCT03106415|363574317|FG001|Phase 1|Adverse Event|1|||
105428032|NCT03106415|363574318|FG002|Phase 1|Adverse Event|0|||
105428033|NCT03106415|363574316|FG000|Phase 1|Protocol Violation|0|||
105428034|NCT03106415|363574317|FG001|Phase 1|Protocol Violation|1|||
105428035|NCT03106415|363574318|FG002|Phase 1|Protocol Violation|0|||
105428036|NCT01998893|363574322|FG000|Overall Study|Adverse Event|2|||
105428037|NCT01998893|363574322|FG000|Overall Study|Death|1|||
105428038|NCT01998893|363574322|FG000|Overall Study|Lost to Follow-up|8|||
105428039|NCT01998893|363574322|FG000|Overall Study|Physician Decision|2|||
105428040|NCT01998893|363574322|FG000|Overall Study|Protocol Violation|2|||
105428041|NCT01998893|363574322|FG000|Overall Study|Withdrawal by Subject|1|||
105428042|NCT01998893|363574322|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
105428043|NCT03276052|363574323|FG000|Overall Study|Withdrawal by Subject|5|||
105428044|NCT03276052|363574323|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
105428045|NCT01145053|363574324|FG000|Overall Study|Adverse Event|22|||
105428046|NCT01145053|363574324|FG000|Overall Study|Lost to Follow-up|28|||
105428047|NCT01145053|363574324|FG000|Overall Study|Withdrawal by Subject|25|||
105428048|NCT01145053|363574324|FG000|Overall Study|Other|18|||
105428049|NCT00867087|363574325|FG000|Overall Study|Other|1|||
105428050|NCT00867087|363574325|FG000|Overall Study|Withdrawal by Subject|4|||
105428051|NCT00867087|363574325|FG000|Overall Study|Death|37|||
105428052|NCT00293709|363574326|FG000|Overall Study|Other|47|||
105428053|NCT01804582|363574327|FG000|Overall Study|Lost to Follow-up|47|||
105428054|NCT01804582|363574328|FG001|Overall Study|Lost to Follow-up|56|||
105428055|NCT01804582|363574327|FG000|Overall Study|Physician Decision|2|||
105428056|NCT01804582|363574328|FG001|Overall Study|Physician Decision|0|||
105428057|NCT03883113|363574329|FG000|Overall Study|Physician Decision|4|||
105428058|NCT03883113|363574330|FG001|Overall Study|Physician Decision|2|||
105428059|NCT03883113|363574329|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
105428060|NCT03883113|363574330|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
105428061|NCT03883113|363574329|FG000|Overall Study|Pregnancy|1|||
105428062|NCT03883113|363574330|FG001|Overall Study|Pregnancy|0|||
105428063|NCT03883113|363574329|FG000|Overall Study|Adverse Event|0|||
105428064|NCT03883113|363574330|FG001|Overall Study|Adverse Event|1|||
105428065|NCT03883113|363574329|FG000|Overall Study|Withdrawal by Subject|1|||
105428066|NCT03883113|363574330|FG001|Overall Study|Withdrawal by Subject|2|||
105428067|NCT03883113|363574329|FG000|Overall Study|Lost to Follow-up|1|||
105428068|NCT03883113|363574330|FG001|Overall Study|Lost to Follow-up|0|||
105428069|NCT00900146|363574335|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
105428070|NCT00900146|363574336|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
105428071|NCT00900146|363574337|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
105501503|NCT00005044|363847129|FG001|Overall Study|No protocol treatment|1|||
105501504|NCT03546062|363847130|FG000|Overall Study|Adverse Event|6|||
105501505|NCT03546062|363847131|FG001|Overall Study|Adverse Event|5|||
105428072|NCT00900146|363574338|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
105428073|NCT00900146|363574339|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
105428074|NCT00900146|363574335|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
105428075|NCT00900146|363574336|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
105428076|NCT00900146|363574337|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
105428077|NCT00900146|363574338|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
105428078|NCT00900146|363574339|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
105428079|NCT00900146|363574335|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
105428080|NCT00900146|363574336|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
105428081|NCT00900146|363574337|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
105428082|NCT00900146|363574338|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
105428083|NCT00900146|363574339|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
105428084|NCT00900146|363574335|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
105428085|NCT00900146|363574336|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
105428086|NCT00900146|363574337|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
105428087|NCT00900146|363574338|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
105428088|NCT00900146|363574339|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
105428089|NCT00900146|363574335|FG000|Intermediate: Period III|Lost to Follow-up|2|||
105428090|NCT00900146|363574336|FG001|Intermediate: Period III|Lost to Follow-up|0|||
105428091|NCT00900146|363574337|FG002|Intermediate: Period III|Lost to Follow-up|0|||
105428092|NCT00900146|363574338|FG003|Intermediate: Period III|Lost to Follow-up|0|||
105428093|NCT00900146|363574339|FG004|Intermediate: Period III|Lost to Follow-up|1|||
105428094|NCT00900146|363574335|FG000|Intermediate: Period III|Administrative problems|85|||
105428095|NCT00900146|363574336|FG001|Intermediate: Period III|Administrative problems|92|||
105428096|NCT00900146|363574337|FG002|Intermediate: Period III|Administrative problems|84|||
105428097|NCT00900146|363574338|FG003|Intermediate: Period III|Administrative problems|90|||
105428098|NCT00900146|363574339|FG004|Intermediate: Period III|Administrative problems|163|||
105428099|NCT01143896|363574340|FG000|Overall Study|Did not complete Baseline Interview|5|||
105428100|NCT01143896|363574341|FG001|Overall Study|Did not complete Baseline Interview|4|||
105428101|NCT01143896|363574340|FG000|Overall Study|Lost to Follow-up|18|||
105428102|NCT01143896|363574341|FG001|Overall Study|Lost to Follow-up|13|||
105428103|NCT01143896|363574340|FG000|Overall Study|Withdrawal by Subject|13|||
105428104|NCT01143896|363574341|FG001|Overall Study|Withdrawal by Subject|5|||
105428105|NCT01143896|363574340|FG000|Overall Study|Death|6|||
105428106|NCT01143896|363574341|FG001|Overall Study|Death|3|||
105428107|NCT01304329|363574342|FG000|Third Intervention (3 Days)|Adverse Event|0|||
105428108|NCT01304329|363574343|FG001|Third Intervention (3 Days)|Adverse Event|1|||
105428109|NCT01304329|363574344|FG002|Third Intervention (3 Days)|Adverse Event|0|||
105428110|NCT01304329|363574345|FG003|Third Intervention (3 Days)|Adverse Event|0|||
105428111|NCT01304329|363574346|FG004|Third Intervention (3 Days)|Adverse Event|0|||
105428112|NCT01304329|363574347|FG005|Third Intervention (3 Days)|Adverse Event|0|||
105428113|NCT02068118|363574350|FG000|18-month Comparative Study Period|Death|90|||
105428114|NCT02068118|363574351|FG001|18-month Comparative Study Period|Death|97|||
105428115|NCT02068118|363574350|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
105428116|NCT02068118|363574351|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
105428117|NCT02068118|363574350|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
105428118|NCT02068118|363574351|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
105428119|NCT02068118|363574350|FG000|18-month Comparative Study Period|Heart transplant|9|||
105428120|NCT02068118|363574351|FG001|18-month Comparative Study Period|Heart transplant|15|||
105428121|NCT02068118|363574350|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
105428122|NCT02068118|363574351|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
105428123|NCT02068118|363574350|FG000|18-month Comparative Study Period|Hemiplegia|0|||
105428124|NCT02068118|363574351|FG001|18-month Comparative Study Period|Hemiplegia|1|||
105428125|NCT02068118|363574350|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
105428126|NCT02068118|363574351|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
105428127|NCT02068118|363574350|FG000|18-month Comparative Study Period|Move|0|||
105428128|NCT02068118|363574351|FG001|18-month Comparative Study Period|Move|1|||
105428129|NCT02068118|363574350|FG000|18-month Comparative Study Period|Hearing loss|0|||
105428130|NCT02068118|363574351|FG001|18-month Comparative Study Period|Hearing loss|1|||
105428131|NCT02068118|363574350|FG000|Extension Period|Death|0|||
105589511|NCT03613129|364158281|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
105589512|NCT03613129|364158282|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
105428132|NCT02068118|363574351|FG001|Extension Period|Death|2|||
105428133|NCT02068118|363574350|FG000|Extension Period|Withdrawal by Subject|1|||
105428134|NCT02068118|363574351|FG001|Extension Period|Withdrawal by Subject|0|||
105428135|NCT02068118|363574350|FG000|Extension Period|Heart transplant|1|||
105428136|NCT02068118|363574351|FG001|Extension Period|Heart transplant|0|||
105428137|NCT02068118|363574350|FG000|Extension Period|Wrong device use|0|||
105428138|NCT02068118|363574351|FG001|Extension Period|Wrong device use|1|||
105428139|NCT00334282|363574352|FG000|Overall Study|Lost to Follow-up|11|||
105428140|NCT00334282|363574353|FG001|Overall Study|Lost to Follow-up|5|||
105428141|NCT00334282|363574352|FG000|Overall Study|Withdrawal by Subject|17|||
105428142|NCT00334282|363574353|FG001|Overall Study|Withdrawal by Subject|3|||
105428143|NCT00334282|363574352|FG000|Overall Study|Death|194|||
105428144|NCT00334282|363574353|FG001|Overall Study|Death|100|||
105428145|NCT00468845|363574354|FG000|Overall Study|Adverse Event|9|||
105428146|NCT00468845|363574355|FG001|Overall Study|Adverse Event|14|||
105428147|NCT00468845|363574356|FG002|Overall Study|Adverse Event|11|||
105428148|NCT00468845|363574354|FG000|Overall Study|Lost to Follow-up|2|||
105428149|NCT00468845|363574355|FG001|Overall Study|Lost to Follow-up|1|||
105428150|NCT00468845|363574356|FG002|Overall Study|Lost to Follow-up|2|||
105428151|NCT00468845|363574354|FG000|Overall Study|Other|4|||
105428152|NCT00468845|363574355|FG001|Overall Study|Other|9|||
105428153|NCT00468845|363574356|FG002|Overall Study|Other|5|||
105428154|NCT00468845|363574354|FG000|Overall Study|No longer willing to participate|5|||
105428155|NCT00468845|363574355|FG001|Overall Study|No longer willing to participate|6|||
105428156|NCT00468845|363574356|FG002|Overall Study|No longer willing to participate|10|||
105428157|NCT00468845|363574354|FG000|Overall Study|Randomized, not treated|1|||
105428158|NCT00468845|363574355|FG001|Overall Study|Randomized, not treated|4|||
105428159|NCT00468845|363574356|FG002|Overall Study|Randomized, not treated|2|||
105428160|NCT00283868|363574357|FG000|Overall Study|Lost to Follow-up|7|||
105428161|NCT00283868|363574358|FG001|Overall Study|Lost to Follow-up|8|||
105428162|NCT01406015|363574359|FG000|Overall Study|Withdrawal by Subject|3|||
105428163|NCT01406015|363574360|FG001|Overall Study|Withdrawal by Subject|3|||
105428164|NCT02075632|363574366|FG000|Overall Study|Adverse Event|1|||
105428165|NCT02075632|363574367|FG001|Overall Study|Adverse Event|1|||
105428166|NCT02075632|363574366|FG000|Overall Study|Lost to Follow-up|0|||
105428167|NCT02075632|363574367|FG001|Overall Study|Lost to Follow-up|3|||
105428168|NCT02075632|363574366|FG000|Overall Study|Withdrawal by Subject|0|||
105428169|NCT02075632|363574367|FG001|Overall Study|Withdrawal by Subject|1|||
105428170|NCT01439074|363574368|FG000|Overall Study|Lost to Follow-up|3|||
105428171|NCT01439074|363574369|FG001|Overall Study|Lost to Follow-up|4|||
105428172|NCT01439074|363574368|FG000|Overall Study|Subject shedding|1|||
105428173|NCT01439074|363574369|FG001|Overall Study|Subject shedding|0|||
105428174|NCT01439074|363574368|FG000|Overall Study|Withdrawal by Subject|1|||
105428175|NCT01439074|363574369|FG001|Overall Study|Withdrawal by Subject|5|||
105428176|NCT01439074|363574368|FG000|Overall Study|Other|4|||
105428177|NCT01439074|363574369|FG001|Overall Study|Other|4|||
105428178|NCT02226549|363574370|FG000|Overall Study|Randomized but Never Treated|1|||
105428179|NCT02226549|363574371|FG001|Overall Study|Randomized but Never Treated|0|||
105428180|NCT02226549|363574370|FG000|Overall Study|Lost to Follow-up|0|||
105428181|NCT02226549|363574371|FG001|Overall Study|Lost to Follow-up|1|||
105428182|NCT00612508|363574372|FG000|Overall Study|Withdrawal by Subject|3|||
105428183|NCT00612508|363574373|FG001|Overall Study|Withdrawal by Subject|4|||
105428184|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
105428185|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
105428186|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
105428187|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
105428188|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
105428189|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
105428190|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
105428191|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
105428192|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
105428193|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
105428194|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
105428195|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
105428196|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
105428197|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
105428198|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
105428199|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
105428200|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
105428201|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
105428202|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
105428203|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
105428204|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
105428205|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
105428206|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
105428207|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
105428208|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
105428209|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
105428210|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
105501506|NCT03546062|363847132|FG002|Overall Study|Adverse Event|8|||
105589513|NCT03613129|364158283|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
105589514|NCT03613129|364158284|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
105428211|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
105428212|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
105428213|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
105428214|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
105428215|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
105428216|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
105428217|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
105428218|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
105428219|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
105428220|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
105428221|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
105428222|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
105428223|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
105428224|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
105428225|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
105428226|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
105428227|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
105428228|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
105428229|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
105428230|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
105428231|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
105428232|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
105428233|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
105428234|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
105428235|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
105428236|NCT02008357|363574374|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
105428237|NCT02008357|363574375|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
105428238|NCT02008357|363574374|FG000|Open-label Extension Period|Adverse Event|8|||
105428239|NCT02008357|363574375|FG001|Open-label Extension Period|Adverse Event|7|||
105428240|NCT02008357|363574374|FG000|Open-label Extension Period|Death|7|||
105428241|NCT02008357|363574375|FG001|Open-label Extension Period|Death|4|||
105428242|NCT02008357|363574374|FG000|Open-label Extension Period|Lack of Efficacy|9|||
105428243|NCT02008357|363574375|FG001|Open-label Extension Period|Lack of Efficacy|5|||
105428244|NCT02008357|363574374|FG000|Open-label Extension Period|Lost to Follow-up|2|||
105428245|NCT02008357|363574375|FG001|Open-label Extension Period|Lost to Follow-up|2|||
105428246|NCT02008357|363574374|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
105428247|NCT02008357|363574375|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
105428248|NCT02008357|363574374|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
105428249|NCT02008357|363574375|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
105428250|NCT02008357|363574374|FG000|Open-label Extension Period|Safety Risk|2|||
105428251|NCT02008357|363574375|FG001|Open-label Extension Period|Safety Risk|1|||
105428252|NCT02008357|363574374|FG000|Open-label Extension Period|Non-Compliance|0|||
105428253|NCT02008357|363574375|FG001|Open-label Extension Period|Non-Compliance|1|||
105428254|NCT02008357|363574374|FG000|Open-label Extension Period|Investigator Recommendation|0|||
105428255|NCT02008357|363574375|FG001|Open-label Extension Period|Investigator Recommendation|1|||
105428256|NCT02008357|363574374|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
105428257|NCT02008357|363574375|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
105428258|NCT02008357|363574374|FG000|Open-label Extension Period|Coordinating Center Request|2|||
105428259|NCT02008357|363574375|FG001|Open-label Extension Period|Coordinating Center Request|4|||
105428260|NCT02008357|363574374|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
105428261|NCT02008357|363574375|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
105428262|NCT02008357|363574374|FG000|Open-label Extension Period|Study Ended|20|||
105428263|NCT02008357|363574375|FG001|Open-label Extension Period|Study Ended|25|||
105428264|NCT02008357|363574374|FG000|Open-label Extension Period|Personal Reasons|0|||
105428265|NCT02008357|363574375|FG001|Open-label Extension Period|Personal Reasons|1|||
105428266|NCT02008357|363574374|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
105428267|NCT02008357|363574375|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
105428268|NCT02008357|363574374|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
105589515|NCT03613129|364158285|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
105589516|NCT01107626|364158288|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
105428269|NCT02008357|363574375|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
105428270|NCT02008357|363574374|FG000|Open-label Extension Period|Other|2|||
105428271|NCT02008357|363574375|FG001|Open-label Extension Period|Other|0|||
105428272|NCT00966719|363574376|FG000|Overall Study|Lost to Follow-up|6|||
105428273|NCT00966719|363574377|FG001|Overall Study|Lost to Follow-up|11|||
105428274|NCT00160199|363574378|FG000|Overall Study|Adverse Event|5|||
105428275|NCT00160199|363574379|FG001|Overall Study|Adverse Event|14|||
105428276|NCT00160199|363574378|FG000|Overall Study|Lack of Efficacy|0|||
105428277|NCT00160199|363574379|FG001|Overall Study|Lack of Efficacy|1|||
105428278|NCT00160199|363574378|FG000|Overall Study|Lost to Follow-up|7|||
105428279|NCT00160199|363574379|FG001|Overall Study|Lost to Follow-up|7|||
105428280|NCT00160199|363574378|FG000|Overall Study|Withdrawal by Subject|4|||
105428281|NCT00160199|363574379|FG001|Overall Study|Withdrawal by Subject|6|||
105428282|NCT00160199|363574378|FG000|Overall Study|Administrative|0|||
105428283|NCT00160199|363574379|FG001|Overall Study|Administrative|1|||
105428284|NCT00160199|363574378|FG000|Overall Study|Protocol Violation|8|||
105428285|NCT00160199|363574379|FG001|Overall Study|Protocol Violation|8|||
105428286|NCT02635347|363574382|FG000|Overall Study|Failed screening|20|||
105428287|NCT02635347|363574383|FG001|Overall Study|Failed screening|7|||
105428288|NCT03352453|363574384|FG000|Overall Study|Miscellaneous Reasons|1|||
105428289|NCT03352453|363574385|FG001|Overall Study|Miscellaneous Reasons|2|||
105428290|NCT03352453|363574384|FG000|Overall Study|Lack of Efficacy|1|||
105428291|NCT03352453|363574385|FG001|Overall Study|Lack of Efficacy|0|||
105428292|NCT03352453|363574384|FG000|Overall Study|Withdrawal by Subject|8|||
105428293|NCT03352453|363574385|FG001|Overall Study|Withdrawal by Subject|14|||
105428294|NCT03352453|363574384|FG000|Overall Study|Study Terminated by Sponsor|2|||
105428295|NCT03352453|363574385|FG001|Overall Study|Study Terminated by Sponsor|1|||
105428296|NCT03352453|363574384|FG000|Overall Study|Protocol Deviation|1|||
105428297|NCT03352453|363574385|FG001|Overall Study|Protocol Deviation|0|||
105428298|NCT03352453|363574384|FG000|Overall Study|Lost to Follow-up|7|||
105428299|NCT03352453|363574385|FG001|Overall Study|Lost to Follow-up|6|||
105428300|NCT03352453|363574384|FG000|Overall Study|Adverse Event|2|||
105428301|NCT03352453|363574385|FG001|Overall Study|Adverse Event|9|||
105428302|NCT00831701|363574396|FG000|Overall Study|Withdrawal by Subject|2|||
105428303|NCT00831701|363574397|FG001|Overall Study|Withdrawal by Subject|0|||
105428304|NCT00831701|363574396|FG000|Overall Study|Stone expulsion before first medication|2|||
105428305|NCT00831701|363574397|FG001|Overall Study|Stone expulsion before first medication|2|||
105428306|NCT00831701|363574396|FG000|Overall Study|Lost to Follow-up|1|||
105428307|NCT00831701|363574397|FG001|Overall Study|Lost to Follow-up|3|||
105428308|NCT02739321|363574404|FG000|Overall Study|Lack of Efficacy|1|||
105428309|NCT02739321|363574405|FG001|Overall Study|Lack of Efficacy|1|||
105428310|NCT02739321|363574404|FG000|Overall Study|Lost to Follow-up|1|||
105428311|NCT02739321|363574405|FG001|Overall Study|Lost to Follow-up|1|||
105428312|NCT02739321|363574404|FG000|Overall Study|Withdrawal by Subject|1|||
105428313|NCT02739321|363574405|FG001|Overall Study|Withdrawal by Subject|2|||
105428314|NCT02558400|363574406|FG000|Overall Study|Adverse Event|47|||
105428315|NCT02558400|363574407|FG001|Overall Study|Adverse Event|53|||
105428316|NCT02558400|363574408|FG002|Overall Study|Adverse Event|4|||
105428317|NCT02558400|363574406|FG000|Overall Study|Withdrawal by Subject|13|||
105428318|NCT02558400|363574407|FG001|Overall Study|Withdrawal by Subject|9|||
105428319|NCT02558400|363574408|FG002|Overall Study|Withdrawal by Subject|8|||
105428320|NCT02558400|363574406|FG000|Overall Study|Non-Compliant|0|||
105428321|NCT02558400|363574407|FG001|Overall Study|Non-Compliant|1|||
105428322|NCT02558400|363574408|FG002|Overall Study|Non-Compliant|3|||
105428323|NCT02558400|363574406|FG000|Overall Study|Lost to Follow-up|5|||
105428324|NCT02558400|363574407|FG001|Overall Study|Lost to Follow-up|5|||
105428325|NCT02558400|363574408|FG002|Overall Study|Lost to Follow-up|4|||
105428326|NCT02558400|363574406|FG000|Overall Study|Lack of Efficacy|0|||
105428327|NCT02558400|363574407|FG001|Overall Study|Lack of Efficacy|13|||
105428328|NCT02558400|363574408|FG002|Overall Study|Lack of Efficacy|1|||
105428329|NCT02558400|363574406|FG000|Overall Study|Disallowed Concurrent Medication|6|||
105428330|NCT02558400|363574407|FG001|Overall Study|Disallowed Concurrent Medication|7|||
105428331|NCT02558400|363574408|FG002|Overall Study|Disallowed Concurrent Medication|5|||
105428332|NCT02558400|363574406|FG000|Overall Study|Physician Decision|2|||
105428333|NCT02558400|363574407|FG001|Overall Study|Physician Decision|2|||
105428334|NCT02558400|363574408|FG002|Overall Study|Physician Decision|0|||
105428335|NCT02558400|363574406|FG000|Overall Study|Protocol Violation|6|||
105428336|NCT02558400|363574407|FG001|Overall Study|Protocol Violation|3|||
105428337|NCT02558400|363574408|FG002|Overall Study|Protocol Violation|8|||
105428338|NCT02558400|363574406|FG000|Overall Study|Death|0|||
105428339|NCT02558400|363574407|FG001|Overall Study|Death|1|||
105428340|NCT02558400|363574408|FG002|Overall Study|Death|0|||
105428341|NCT02558400|363574406|FG000|Overall Study|Ineligible for the study|0|||
105428342|NCT02558400|363574407|FG001|Overall Study|Ineligible for the study|2|||
105428343|NCT02558400|363574408|FG002|Overall Study|Ineligible for the study|0|||
105428344|NCT03966885|363576091|FG000|Overall Study|Death|1|||
105428345|NCT03966885|363576092|FG001|Overall Study|Death|0|||
105428346|NCT03966885|363576091|FG000|Overall Study|Lost to Follow-up|1|||
105428347|NCT03966885|363576092|FG001|Overall Study|Lost to Follow-up|2|||
105589517|NCT01107626|364158289|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
105589518|NCT01107626|364158290|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
105589519|NCT01107626|364158291|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
105589520|NCT01107626|364158288|FG000|Step 1: Induction Therapy|Adverse Event|198|||
105589521|NCT01107626|364158289|FG001|Step 1: Induction Therapy|Adverse Event|0|||
105589522|NCT01107626|364158290|FG002|Step 1: Induction Therapy|Adverse Event|0|||
105589523|NCT01107626|364158291|FG003|Step 1: Induction Therapy|Adverse Event|0|||
105589524|NCT01107626|364158288|FG000|Step 1: Induction Therapy|Death|62|||
105589525|NCT01107626|364158289|FG001|Step 1: Induction Therapy|Death|0|||
105589526|NCT01107626|364158290|FG002|Step 1: Induction Therapy|Death|0|||
105589527|NCT01107626|364158291|FG003|Step 1: Induction Therapy|Death|0|||
105589528|NCT01107626|364158288|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
105589529|NCT01107626|364158289|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
105589530|NCT01107626|364158290|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
105589531|NCT01107626|364158291|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
105589532|NCT01107626|364158288|FG000|Step 1: Induction Therapy|Complicating disease|13|||
105589533|NCT01107626|364158289|FG001|Step 1: Induction Therapy|Complicating disease|0|||
105589534|NCT01107626|364158290|FG002|Step 1: Induction Therapy|Complicating disease|0|||
105589535|NCT01107626|364158291|FG003|Step 1: Induction Therapy|Complicating disease|0|||
105589536|NCT01107626|364158288|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
105589537|NCT01107626|364158289|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
105589538|NCT01107626|364158290|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
105589539|NCT01107626|364158291|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
105589540|NCT01107626|364158288|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
105589541|NCT01107626|364158289|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
105589542|NCT01107626|364158290|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
105589543|NCT01107626|364158291|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
105589544|NCT01107626|364158288|FG000|Step 1: Induction Therapy|Non-compliance|4|||
105589545|NCT01107626|364158289|FG001|Step 1: Induction Therapy|Non-compliance|0|||
105589546|NCT01107626|364158290|FG002|Step 1: Induction Therapy|Non-compliance|0|||
105589547|NCT01107626|364158291|FG003|Step 1: Induction Therapy|Non-compliance|0|||
105589548|NCT01107626|364158288|FG000|Step 1: Induction Therapy|Pain|4|||
105589549|NCT01107626|364158289|FG001|Step 1: Induction Therapy|Pain|0|||
105589550|NCT01107626|364158290|FG002|Step 1: Induction Therapy|Pain|0|||
105589551|NCT01107626|364158291|FG003|Step 1: Induction Therapy|Pain|0|||
105589552|NCT01107626|364158288|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
105589553|NCT01107626|364158289|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
105589554|NCT01107626|364158290|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
105589555|NCT01107626|364158291|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
105589556|NCT01107626|364158288|FG000|Step 1: Induction Therapy|Hospice care|1|||
105589557|NCT01107626|364158289|FG001|Step 1: Induction Therapy|Hospice care|0|||
105589558|NCT01107626|364158290|FG002|Step 1: Induction Therapy|Hospice care|0|||
105589559|NCT01107626|364158291|FG003|Step 1: Induction Therapy|Hospice care|0|||
105589560|NCT01107626|364158288|FG000|Step 1: Induction Therapy|Physician Decision|1|||
105589561|NCT01107626|364158289|FG001|Step 1: Induction Therapy|Physician Decision|0|||
105589562|NCT01107626|364158290|FG002|Step 1: Induction Therapy|Physician Decision|0|||
105589563|NCT01107626|364158291|FG003|Step 1: Induction Therapy|Physician Decision|0|||
105589564|NCT01107626|364158288|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
105589565|NCT01107626|364158289|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
105589566|NCT01107626|364158290|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
105589567|NCT01107626|364158291|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
105589568|NCT01107626|364158288|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
105589569|NCT01107626|364158289|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
105589570|NCT01107626|364158290|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
105589571|NCT01107626|364158291|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
105589572|NCT01107626|364158288|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
105589573|NCT01107626|364158289|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
105589574|NCT01107626|364158290|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
105589575|NCT01107626|364158291|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
105589576|NCT01107626|364158288|FG000|Step 2: Maintenance Therapy|Death|0|||
105428348|NCT03966885|363576091|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
105428349|NCT03966885|363576092|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
105589577|NCT01107626|364158289|FG001|Step 2: Maintenance Therapy|Death|8|||
105589578|NCT01107626|364158290|FG002|Step 2: Maintenance Therapy|Death|2|||
105428350|NCT03966885|363576091|FG000|Overall Study|Moved from study area.|0|||
105589579|NCT01107626|364158291|FG003|Step 2: Maintenance Therapy|Death|13|||
105589580|NCT01107626|364158288|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
105589581|NCT01107626|364158289|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
105589582|NCT01107626|364158290|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
105589583|NCT01107626|364158291|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
105589584|NCT01107626|364158288|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
105589585|NCT01107626|364158289|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
105589586|NCT01107626|364158290|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
105589587|NCT01107626|364158291|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
105589588|NCT01107626|364158288|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
105589589|NCT01107626|364158289|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
105589590|NCT01107626|364158290|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
105589591|NCT01107626|364158291|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
105589592|NCT01107626|364158288|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
105589593|NCT01107626|364158289|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
105589594|NCT01107626|364158290|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
105589595|NCT01107626|364158291|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
105589596|NCT01107626|364158288|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
105589597|NCT01107626|364158289|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
105589598|NCT01107626|364158290|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
105589599|NCT01107626|364158291|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
105589600|NCT01107626|364158288|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
105589601|NCT01107626|364158289|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
105589602|NCT01107626|364158290|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
105589603|NCT01107626|364158291|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
105589604|NCT01107626|364158288|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
105589605|NCT01107626|364158289|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
105589606|NCT01107626|364158290|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
105589607|NCT01107626|364158291|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
105589608|NCT01107626|364158288|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
105589609|NCT01107626|364158289|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
105589610|NCT01107626|364158290|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
105589611|NCT01107626|364158291|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
105589612|NCT01107626|364158288|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
105589613|NCT01107626|364158289|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
105589614|NCT01107626|364158290|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
105589615|NCT01107626|364158291|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
105589616|NCT01107626|364158288|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
105589617|NCT01107626|364158289|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
105589618|NCT01107626|364158290|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
105589619|NCT01107626|364158291|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
105589620|NCT01107626|364158288|FG000|Step 2: Maintenance Therapy|Pain|0|||
105589621|NCT01107626|364158289|FG001|Step 2: Maintenance Therapy|Pain|0|||
105589622|NCT01107626|364158290|FG002|Step 2: Maintenance Therapy|Pain|0|||
105589623|NCT01107626|364158291|FG003|Step 2: Maintenance Therapy|Pain|1|||
105589624|NCT01107626|364158288|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
105589625|NCT01107626|364158289|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
105589626|NCT01107626|364158290|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
105589627|NCT01107626|364158291|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
105589628|NCT00711646|364158292|FG000|Overall Study|Adverse Event|6|||
105589629|NCT00711646|364158293|FG001|Overall Study|Adverse Event|1|||
105589630|NCT00711646|364158292|FG000|Overall Study|Withdrawal by Subject|4|||
105589631|NCT00711646|364158293|FG001|Overall Study|Withdrawal by Subject|0|||
105589632|NCT00711646|364158292|FG000|Overall Study|Protocol Violation|0|||
105589633|NCT00711646|364158293|FG001|Overall Study|Protocol Violation|1|||
105589634|NCT00711646|364158292|FG000|Overall Study|Lost to Follow-up|1|||
105589635|NCT00711646|364158293|FG001|Overall Study|Lost to Follow-up|0|||
105589636|NCT00711646|364158292|FG000|Overall Study|administrative decision|0|||
105589637|NCT00711646|364158293|FG001|Overall Study|administrative decision|1|||
105589638|NCT00711646|364158292|FG000|Overall Study|patient non-compliance|1|||
105589639|NCT00711646|364158293|FG001|Overall Study|patient non-compliance|0|||
105589640|NCT03107611|364158294|FG000|Overall Study|Adverse Event|1|||
105589641|NCT03107611|364158295|FG001|Overall Study|Adverse Event|0|||
105589642|NCT03107611|364158296|FG002|Overall Study|Adverse Event|2|||
105589643|NCT03107611|364158294|FG000|Overall Study|Lost to Follow-up|3|||
105589644|NCT03107611|364158295|FG001|Overall Study|Lost to Follow-up|3|||
105589645|NCT03107611|364158296|FG002|Overall Study|Lost to Follow-up|3|||
105589646|NCT03107611|364158294|FG000|Overall Study|Protocol Violation|0|||
105589647|NCT03107611|364158295|FG001|Overall Study|Protocol Violation|0|||
105589648|NCT03107611|364158296|FG002|Overall Study|Protocol Violation|1|||
105589649|NCT03107611|364158294|FG000|Overall Study|Withdrawal by Subject|1|||
105589650|NCT03107611|364158295|FG001|Overall Study|Withdrawal by Subject|0|||
105589651|NCT03107611|364158296|FG002|Overall Study|Withdrawal by Subject|1|||
105589652|NCT03107611|364158294|FG000|Overall Study|Worsening signs/symptoms|2|||
105589653|NCT03107611|364158295|FG001|Overall Study|Worsening signs/symptoms|1|||
105589654|NCT03107611|364158296|FG002|Overall Study|Worsening signs/symptoms|2|||
105589655|NCT01720446|364158297|FG000|Overall Study|Lost to Follow-up|12|||
105589656|NCT01720446|364158298|FG001|Overall Study|Lost to Follow-up|6|||
105589657|NCT01720446|364158299|FG002|Overall Study|Lost to Follow-up|16|||
105428351|NCT03966885|363576092|FG001|Overall Study|Moved from study area.|2|||
105428352|NCT02032407|363576093|FG000|Overall Study|Lost to Follow-up|2|||
105428353|NCT02032407|363576093|FG000|Overall Study|Pregnancy|1|||
105428354|NCT02032407|363576093|FG000|Overall Study|Other Miscellaneous Reasons|2|||
105428355|NCT03131596|363576109|FG000|Overall Study|Protocol Violation|3|||
105428356|NCT03131596|363576110|FG001|Overall Study|Protocol Violation|3|||
105428357|NCT03131596|363576109|FG000|Overall Study|Lost to Follow-up|3|||
105428358|NCT03131596|363576110|FG001|Overall Study|Lost to Follow-up|0|||
105428359|NCT00734071|363576113|FG000|Overall Study|Adverse Event|4|||
105428360|NCT00734071|363576114|FG001|Overall Study|Adverse Event|3|||
105428361|NCT00734071|363576113|FG000|Overall Study|Lack of Efficacy|3|||
105428362|NCT00734071|363576114|FG001|Overall Study|Lack of Efficacy|1|||
105428363|NCT00734071|363576113|FG000|Overall Study|Noncompliance|2|||
105428364|NCT00734071|363576114|FG001|Overall Study|Noncompliance|2|||
105428365|NCT00734071|363576113|FG000|Overall Study|Protocol Deviations|3|||
105428366|NCT00734071|363576114|FG001|Overall Study|Protocol Deviations|4|||
105428367|NCT00734071|363576113|FG000|Overall Study|Voluntary Withdrawal|9|||
105428368|NCT00734071|363576114|FG001|Overall Study|Voluntary Withdrawal|7|||
105428369|NCT00734071|363576113|FG000|Overall Study|Lost to Follow-up|16|||
105428370|NCT00734071|363576114|FG001|Overall Study|Lost to Follow-up|8|||
105428371|NCT00734071|363576113|FG000|Overall Study|Other|1|||
105428372|NCT00734071|363576114|FG001|Overall Study|Other|2|||
105428373|NCT04177355|363576116|FG000|Overall Study|Lost to Follow-up|0|||
105428374|NCT04177355|363576117|FG001|Overall Study|Lost to Follow-up|2|||
105428375|NCT04177355|363576118|FG002|Overall Study|Lost to Follow-up|0|||
105428376|NCT04177355|363576119|FG003|Overall Study|Lost to Follow-up|1|||
105428377|NCT04177355|363576120|FG004|Overall Study|Lost to Follow-up|2|||
105428378|NCT04177355|363576121|FG005|Overall Study|Lost to Follow-up|0|||
105428379|NCT04177355|363576122|FG006|Overall Study|Lost to Follow-up|1|||
105428380|NCT04177355|363576123|FG007|Overall Study|Lost to Follow-up|0|||
105428381|NCT04177355|363576124|FG008|Overall Study|Lost to Follow-up|0|||
105428382|NCT04177355|363576125|FG009|Overall Study|Lost to Follow-up|0|||
105428383|NCT04177355|363576126|FG010|Overall Study|Lost to Follow-up|0|||
105428384|NCT04177355|363576116|FG000|Overall Study|Withdrawal by Subject|0|||
105428385|NCT04177355|363576117|FG001|Overall Study|Withdrawal by Subject|0|||
105428386|NCT04177355|363576118|FG002|Overall Study|Withdrawal by Subject|0|||
105428387|NCT04177355|363576119|FG003|Overall Study|Withdrawal by Subject|1|||
105428388|NCT04177355|363576120|FG004|Overall Study|Withdrawal by Subject|1|||
105428389|NCT04177355|363576121|FG005|Overall Study|Withdrawal by Subject|0|||
105428390|NCT04177355|363576122|FG006|Overall Study|Withdrawal by Subject|0|||
105428391|NCT04177355|363576123|FG007|Overall Study|Withdrawal by Subject|0|||
105428392|NCT04177355|363576124|FG008|Overall Study|Withdrawal by Subject|1|||
105428393|NCT04177355|363576125|FG009|Overall Study|Withdrawal by Subject|0|||
105428394|NCT04177355|363576126|FG010|Overall Study|Withdrawal by Subject|0|||
105428395|NCT00541346|363576127|FG000|Follow-up|Adverse Event|1|||
105428396|NCT04411420|363576129|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
105428397|NCT04411420|363576130|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
105428398|NCT04411420|363576129|FG000|Survey Subset|Lost to Follow-up|134|||
105428399|NCT04411420|363576130|FG001|Survey Subset|Lost to Follow-up|120|||
105428400|NCT00240110|363576133|FG000|Overall Study|Lost to Follow-up|6|||
105428401|NCT00240110|363576134|FG001|Overall Study|Lost to Follow-up|7|||
105428402|NCT00583791|363576135|FG000|Overall Study|Other|67|||
105428403|NCT00583791|363576135|FG000|Overall Study|Death|6|||
105428404|NCT01278407|363576145|FG000|Confirmatory Phase|Adverse Event|5|||
105428405|NCT01278407|363576146|FG001|Confirmatory Phase|Adverse Event|10|||
105428406|NCT01278407|363576147|FG002|Confirmatory Phase|Adverse Event|1|||
105428407|NCT01278407|363576148|FG003|Confirmatory Phase|Adverse Event|0|||
105428408|NCT01278407|363576149|FG004|Confirmatory Phase|Adverse Event|0|||
105428409|NCT01278407|363576145|FG000|Confirmatory Phase|Participant's Choice|3|||
105428410|NCT01278407|363576146|FG001|Confirmatory Phase|Participant's Choice|5|||
105428411|NCT01278407|363576147|FG002|Confirmatory Phase|Participant's Choice|3|||
105428412|NCT01278407|363576148|FG003|Confirmatory Phase|Participant's Choice|0|||
105428413|NCT01278407|363576149|FG004|Confirmatory Phase|Participant's Choice|0|||
105428414|NCT01278407|363576145|FG000|Confirmatory Phase|Other|1|||
105428415|NCT01278407|363576146|FG001|Confirmatory Phase|Other|1|||
105428416|NCT01278407|363576147|FG002|Confirmatory Phase|Other|2|||
105428417|NCT01278407|363576148|FG003|Confirmatory Phase|Other|0|||
105428418|NCT01278407|363576149|FG004|Confirmatory Phase|Other|0|||
105428419|NCT01278407|363576145|FG000|Extension Phase|Adverse Event|0|||
105428420|NCT01278407|363576146|FG001|Extension Phase|Adverse Event|0|||
105428421|NCT01278407|363576147|FG002|Extension Phase|Adverse Event|0|||
105428422|NCT01278407|363576148|FG003|Extension Phase|Adverse Event|7|||
105428423|NCT01278407|363576149|FG004|Extension Phase|Adverse Event|16|||
105428424|NCT01278407|363576145|FG000|Extension Phase|Participant's Choice|0|||
105428425|NCT01278407|363576146|FG001|Extension Phase|Participant's Choice|0|||
105428426|NCT01278407|363576147|FG002|Extension Phase|Participant's Choice|0|||
105428427|NCT01278407|363576148|FG003|Extension Phase|Participant's Choice|4|||
105428428|NCT01278407|363576149|FG004|Extension Phase|Participant's Choice|11|||
105428429|NCT01278407|363576145|FG000|Extension Phase|Other|0|||
105428430|NCT01278407|363576146|FG001|Extension Phase|Other|0|||
105428431|NCT01278407|363576147|FG002|Extension Phase|Other|0|||
105428432|NCT01278407|363576148|FG003|Extension Phase|Other|1|||
105428433|NCT01278407|363576149|FG004|Extension Phase|Other|3|||
105428434|NCT03627065|363576150|FG000|Overall Study|Study Terminated by sponsor|1|||
105428435|NCT03627065|363576150|FG000|Overall Study|Withdrawal by Subject|2|||
105428436|NCT04524455|363576151|FG000|Overall Study|Death|3|||
105428437|NCT04524455|363576152|FG001|Overall Study|Death|3|||
105428438|NCT04524455|363576151|FG000|Overall Study|Decision by Sponsor|0|||
105428439|NCT04524455|363576152|FG001|Overall Study|Decision by Sponsor|2|||
105428440|NCT04524455|363576151|FG000|Overall Study|Withdrawal of Consent From Study|1|||
105428441|NCT04524455|363576152|FG001|Overall Study|Withdrawal of Consent From Study|0|||
105428442|NCT04524455|363576151|FG000|Overall Study|Lost to Follow-up|0|||
105428443|NCT04524455|363576152|FG001|Overall Study|Lost to Follow-up|1|||
105428444|NCT02804750|363576159|FG000|Period 1|Adverse Event|0|||
105428445|NCT02804750|363576160|FG001|Period 1|Adverse Event|2|||
105428446|NCT02804750|363576159|FG000|Period 1|Withdrawal by Subject|0|||
105428447|NCT02804750|363576160|FG001|Period 1|Withdrawal by Subject|1|||
105428448|NCT02804750|363576159|FG000|Period 2|Adverse Event|1|||
105428449|NCT02804750|363576160|FG001|Period 2|Adverse Event|0|||
105428450|NCT02804750|363576159|FG000|Period 3|Adverse Event|0|||
105501507|NCT01449539|363847137|FG000|Overall Study|Withdrawal by Subject|3|||
105501508|NCT01449539|363847137|FG000|Overall Study|Toxicity not study related|1|||
105501509|NCT02993757|363847138|FG000|Overall Study|Non compliance with the protocol|155|||
105501510|NCT02993757|363847139|FG001|Overall Study|Non compliance with the protocol|170|||
105501511|NCT02993757|363847138|FG000|Overall Study|Lost to Follow-up|1|||
105501512|NCT02993757|363847139|FG001|Overall Study|Lost to Follow-up|0|||
105501513|NCT02993757|363847138|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
105589658|NCT01720446|364158300|FG003|Overall Study|Lost to Follow-up|16|||
105589659|NCT01720446|364158297|FG000|Overall Study|Withdrawal by Subject|2|||
105589660|NCT01720446|364158298|FG001|Overall Study|Withdrawal by Subject|5|||
105589661|NCT01720446|364158299|FG002|Overall Study|Withdrawal by Subject|4|||
105589662|NCT01720446|364158300|FG003|Overall Study|Withdrawal by Subject|4|||
105589663|NCT01020838|364158301|FG000|Overall Study|Death|90|||
105589664|NCT01020838|364158301|FG000|Overall Study|Adverse Event|1|||
105589665|NCT01020838|364158301|FG000|Overall Study|Withdrawal by Subject|9|||
105589666|NCT01020838|364158301|FG000|Overall Study|Lost to Follow-up|6|||
105589667|NCT01020838|364158301|FG000|Overall Study|Most common: Study ended by sponsor|77|||
105589668|NCT00930813|364158302|FG000|Overall Study|Death|4|||
105589669|NCT00930813|364158303|FG001|Overall Study|Death|5|||
105589670|NCT00930813|364158302|FG000|Overall Study|Withdrawal by Subject|2|||
105589671|NCT00930813|364158303|FG001|Overall Study|Withdrawal by Subject|5|||
105589672|NCT00930813|364158302|FG000|Overall Study|Lost to Follow-up|2|||
105589673|NCT00930813|364158303|FG001|Overall Study|Lost to Follow-up|4|||
105589674|NCT02145182|364158305|FG000|Overall Study|Adverse Event|4|||
105589675|NCT02145182|364158306|FG001|Overall Study|Adverse Event|1|||
105589676|NCT02145182|364158305|FG000|Overall Study|Death|7|||
105589677|NCT02145182|364158306|FG001|Overall Study|Death|7|||
105589678|NCT02145182|364158305|FG000|Overall Study|Lost to Follow-up|2|||
105589679|NCT02145182|364158306|FG001|Overall Study|Lost to Follow-up|2|||
105589680|NCT02145182|364158305|FG000|Overall Study|Pre-transplant Withdrawal|0|||
105589681|NCT02145182|364158306|FG001|Overall Study|Pre-transplant Withdrawal|2|||
105589682|NCT02145182|364158305|FG000|Overall Study|Withdrawal by Subject|5|||
105589683|NCT02145182|364158306|FG001|Overall Study|Withdrawal by Subject|4|||
105589684|NCT00588666|364158307|FG000|Overall Study|Adverse Event|4|||
105589685|NCT01474538|364160601|FG000|Treatment Period 1|Death|1|||
105589686|NCT01474538|364160602|FG001|Treatment Period 1|Death|0|||
105589687|NCT01474538|364160601|FG000|Treatment Period 1|Physician Decision|1|||
105589688|NCT01474538|364160602|FG001|Treatment Period 1|Physician Decision|0|||
105589689|NCT01474538|364160601|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105589690|NCT01474538|364160602|FG001|Treatment Period 1|Withdrawal by Subject|3|||
105589691|NCT01474538|364160601|FG000|Treatment Period 1|Protocol Violation|0|||
105589692|NCT01474538|364160602|FG001|Treatment Period 1|Protocol Violation|1|||
105589693|NCT01474538|364160601|FG000|Treatment Period 2|Death|1|||
105589694|NCT01474538|364160602|FG001|Treatment Period 2|Death|0|||
105589695|NCT01474538|364160601|FG000|Treatment Period 2|Adverse Event|1|||
105501514|NCT02993757|363847139|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
105501515|NCT02935842|363847146|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
105501516|NCT02935842|363847147|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
105501517|NCT02935842|363847148|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
105589696|NCT01474538|364160602|FG001|Treatment Period 2|Adverse Event|1|||
105428451|NCT02804750|363576160|FG001|Period 3|Adverse Event|2|||
105589697|NCT01474538|364160601|FG000|Treatment Period 2|Withdrawal by Subject|2|||
105589698|NCT01474538|364160602|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105428452|NCT02804750|363576159|FG000|Period 4|Adverse Event|0|||
105428453|NCT02804750|363576160|FG001|Period 4|Adverse Event|5|||
105428454|NCT04431713|363576163|FG000|Overall Study|Withdrawal by Subject|2|||
105589699|NCT01474538|364160601|FG000|Treatment Period 2|Sponsor decision|1|||
105589700|NCT01474538|364160602|FG001|Treatment Period 2|Sponsor decision|0|||
105589701|NCT01474538|364160601|FG000|Treatment Period 2|Physician Decision|0|||
105428455|NCT04431713|363576164|FG001|Overall Study|Withdrawal by Subject|0|||
105428456|NCT04431713|363576163|FG000|Overall Study|Death|2|||
105428457|NCT04431713|363576164|FG001|Overall Study|Death|2|||
105428458|NCT00098722|363576165|FG000|Double Blind Phase|Adverse Event|7|||
105428459|NCT00098722|363576166|FG001|Double Blind Phase|Adverse Event|7|||
105428460|NCT00098722|363576167|FG002|Double Blind Phase|Adverse Event|3|||
105428461|NCT00098722|363576168|FG003|Double Blind Phase|Adverse Event|0|||
105428462|NCT00098722|363576169|FG004|Double Blind Phase|Adverse Event|0|||
105428463|NCT00098722|363576170|FG005|Double Blind Phase|Adverse Event|0|||
105428464|NCT00098722|363576171|FG006|Double Blind Phase|Adverse Event|0|||
105428465|NCT00098722|363576165|FG000|Double Blind Phase|Death|2|||
105428466|NCT00098722|363576166|FG001|Double Blind Phase|Death|5|||
105428467|NCT00098722|363576167|FG002|Double Blind Phase|Death|0|||
105428468|NCT00098722|363576168|FG003|Double Blind Phase|Death|0|||
105428469|NCT00098722|363576169|FG004|Double Blind Phase|Death|0|||
105428470|NCT00098722|363576170|FG005|Double Blind Phase|Death|0|||
105428471|NCT00098722|363576171|FG006|Double Blind Phase|Death|0|||
105428472|NCT00098722|363576165|FG000|Double Blind Phase|Lack of Efficacy|21|||
105428473|NCT00098722|363576166|FG001|Double Blind Phase|Lack of Efficacy|23|||
105428474|NCT00098722|363576167|FG002|Double Blind Phase|Lack of Efficacy|15|||
105428475|NCT00098722|363576168|FG003|Double Blind Phase|Lack of Efficacy|0|||
105428476|NCT00098722|363576169|FG004|Double Blind Phase|Lack of Efficacy|0|||
105428477|NCT00098722|363576170|FG005|Double Blind Phase|Lack of Efficacy|0|||
105428478|NCT00098722|363576171|FG006|Double Blind Phase|Lack of Efficacy|0|||
105428479|NCT00098722|363576165|FG000|Double Blind Phase|Participant defaulted|16|||
105428480|NCT00098722|363576166|FG001|Double Blind Phase|Participant defaulted|11|||
105428481|NCT00098722|363576167|FG002|Double Blind Phase|Participant defaulted|9|||
105428482|NCT00098722|363576168|FG003|Double Blind Phase|Participant defaulted|0|||
105428483|NCT00098722|363576169|FG004|Double Blind Phase|Participant defaulted|0|||
105428484|NCT00098722|363576170|FG005|Double Blind Phase|Participant defaulted|0|||
105428485|NCT00098722|363576171|FG006|Double Blind Phase|Participant defaulted|0|||
105428486|NCT00098722|363576165|FG000|Double Blind Phase|Pregnancy|1|||
105428487|NCT00098722|363576166|FG001|Double Blind Phase|Pregnancy|0|||
105428488|NCT00098722|363576167|FG002|Double Blind Phase|Pregnancy|0|||
105428489|NCT00098722|363576168|FG003|Double Blind Phase|Pregnancy|0|||
105428490|NCT00098722|363576169|FG004|Double Blind Phase|Pregnancy|0|||
105428491|NCT00098722|363576170|FG005|Double Blind Phase|Pregnancy|0|||
105428492|NCT00098722|363576171|FG006|Double Blind Phase|Pregnancy|0|||
105428493|NCT00098722|363576165|FG000|Double Blind Phase|Randomized, not treated|4|||
105428494|NCT00098722|363576166|FG001|Double Blind Phase|Randomized, not treated|3|||
105428495|NCT00098722|363576167|FG002|Double Blind Phase|Randomized, not treated|3|||
105428496|NCT00098722|363576168|FG003|Double Blind Phase|Randomized, not treated|0|||
105428497|NCT00098722|363576169|FG004|Double Blind Phase|Randomized, not treated|0|||
105428498|NCT00098722|363576170|FG005|Double Blind Phase|Randomized, not treated|0|||
105428499|NCT00098722|363576171|FG006|Double Blind Phase|Randomized, not treated|0|||
105428500|NCT00098722|363576165|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
105428501|NCT00098722|363576166|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
105428502|NCT00098722|363576167|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
105501518|NCT02935842|363847149|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
105501519|NCT02935842|363847146|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
105501520|NCT02935842|363847147|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
105501521|NCT02935842|363847148|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
105501522|NCT02935842|363847149|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
105501523|NCT02935842|363847146|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
105501524|NCT02935842|363847147|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
105501525|NCT02935842|363847148|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
105501526|NCT02935842|363847149|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
105501527|NCT02935842|363847146|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
105501528|NCT02935842|363847147|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
105501529|NCT02935842|363847148|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
105501530|NCT02935842|363847149|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
105501531|NCT02935842|363847146|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
105501532|NCT02935842|363847147|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
105428503|NCT00098722|363576168|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
105428504|NCT00098722|363576169|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
105428505|NCT00098722|363576170|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
105428506|NCT00098722|363576171|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
105428507|NCT00098722|363576165|FG000|Double Blind Phase|Other|7|||
105428508|NCT00098722|363576166|FG001|Double Blind Phase|Other|8|||
105501533|NCT02935842|363847148|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
105501534|NCT02935842|363847149|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
105428509|NCT00098722|363576167|FG002|Double Blind Phase|Other|7|||
105428510|NCT00098722|363576168|FG003|Double Blind Phase|Other|0|||
105428511|NCT00098722|363576169|FG004|Double Blind Phase|Other|0|||
105428512|NCT00098722|363576170|FG005|Double Blind Phase|Other|0|||
105428513|NCT00098722|363576171|FG006|Double Blind Phase|Other|0|||
105428514|NCT00098722|363576165|FG000|Open Label Phase|Adverse Event|0|||
105428515|NCT00098722|363576166|FG001|Open Label Phase|Adverse Event|0|||
105428516|NCT00098722|363576167|FG002|Open Label Phase|Adverse Event|0|||
105428517|NCT00098722|363576168|FG003|Open Label Phase|Adverse Event|5|||
105428518|NCT00098722|363576169|FG004|Open Label Phase|Adverse Event|0|||
105589702|NCT01474538|364160602|FG001|Treatment Period 2|Physician Decision|1|||
105589703|NCT01474538|364160601|FG000|Treatment Period 2|Protocol Violation|1|||
105589704|NCT01474538|364160602|FG001|Treatment Period 2|Protocol Violation|0|||
105589705|NCT00349908|364160606|FG000|Overall Study|Withdrawal by Subject|0|||
105589706|NCT00349908|364160607|FG001|Overall Study|Withdrawal by Subject|4|||
105589707|NCT04565249|364160608|FG000|Overall Study|Death|0|||
105589708|NCT04565249|364160609|FG001|Overall Study|Death|0|||
105589709|NCT04565249|364160610|FG002|Overall Study|Death|0|||
105589710|NCT04565249|364160611|FG003|Overall Study|Death|1|||
105589711|NCT03120676|364160612|FG000|Overall Study|Not treated|1|||
105589712|NCT01729819|364160616|FG000|Overall Study|Adverse Event|2|||
105589713|NCT01729819|364160617|FG001|Overall Study|Adverse Event|4|||
105589714|NCT01729819|364160616|FG000|Overall Study|Lack of Efficacy|1|||
105589715|NCT01729819|364160617|FG001|Overall Study|Lack of Efficacy|0|||
105589716|NCT01729819|364160616|FG000|Overall Study|Lost to Follow-up|2|||
105589717|NCT01729819|364160617|FG001|Overall Study|Lost to Follow-up|0|||
105589718|NCT01729819|364160616|FG000|Overall Study|Other reason|1|||
105589719|NCT01729819|364160617|FG001|Overall Study|Other reason|0|||
105589720|NCT01729819|364160616|FG000|Overall Study|Protocol Violation|0|||
105589721|NCT01729819|364160617|FG001|Overall Study|Protocol Violation|1|||
105589722|NCT01729819|364160616|FG000|Overall Study|Withdrawal by Subject|0|||
105589723|NCT01729819|364160617|FG001|Overall Study|Withdrawal by Subject|2|||
105589724|NCT01244984|364160618|FG000|Overall Study|Adverse Event|2|||
105589725|NCT01244984|364160619|FG001|Overall Study|Adverse Event|11|||
105589726|NCT01244984|364160620|FG002|Overall Study|Adverse Event|2|||
105589727|NCT01244984|364160618|FG000|Overall Study|Protocol Violation|1|||
105589728|NCT01244984|364160619|FG001|Overall Study|Protocol Violation|0|||
105589729|NCT01244984|364160620|FG002|Overall Study|Protocol Violation|0|||
105589730|NCT01244984|364160618|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
105589731|NCT01244984|364160619|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
105589732|NCT01244984|364160620|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
105589733|NCT01244984|364160618|FG000|Overall Study|Withdrawal by Subject|1|||
105589734|NCT01244984|364160619|FG001|Overall Study|Withdrawal by Subject|2|||
105589735|NCT01244984|364160620|FG002|Overall Study|Withdrawal by Subject|2|||
105589736|NCT02072226|364160625|FG000|Overall Study|Lost to Follow-up|11|||
105589737|NCT02072226|364160626|FG001|Overall Study|Lost to Follow-up|7|||
105589738|NCT02072226|364160625|FG000|Overall Study|Patient Non-compliance|2|||
105589739|NCT02072226|364160626|FG001|Overall Study|Patient Non-compliance|3|||
105589740|NCT02072226|364160625|FG000|Overall Study|Death|1|||
105589741|NCT02072226|364160626|FG001|Overall Study|Death|0|||
105589742|NCT02072226|364160625|FG000|Overall Study|Patient Withdrawal of Consent|1|||
105589743|NCT02072226|364160626|FG001|Overall Study|Patient Withdrawal of Consent|0|||
105428519|NCT00098722|363576170|FG005|Open Label Phase|Adverse Event|0|||
105428520|NCT00098722|363576171|FG006|Open Label Phase|Adverse Event|0|||
105428521|NCT00098722|363576165|FG000|Open Label Phase|Death|0|||
105428522|NCT00098722|363576166|FG001|Open Label Phase|Death|0|||
105428523|NCT00098722|363576167|FG002|Open Label Phase|Death|0|||
105428524|NCT00098722|363576168|FG003|Open Label Phase|Death|2|||
105428525|NCT00098722|363576169|FG004|Open Label Phase|Death|0|||
105428526|NCT00098722|363576170|FG005|Open Label Phase|Death|0|||
105428527|NCT00098722|363576171|FG006|Open Label Phase|Death|0|||
105428528|NCT00098722|363576165|FG000|Open Label Phase|Lack of Efficacy|0|||
105428529|NCT00098722|363576166|FG001|Open Label Phase|Lack of Efficacy|0|||
105428530|NCT00098722|363576167|FG002|Open Label Phase|Lack of Efficacy|0|||
105428531|NCT00098722|363576168|FG003|Open Label Phase|Lack of Efficacy|8|||
105428532|NCT00098722|363576169|FG004|Open Label Phase|Lack of Efficacy|0|||
105428533|NCT00098722|363576170|FG005|Open Label Phase|Lack of Efficacy|0|||
105428534|NCT00098722|363576171|FG006|Open Label Phase|Lack of Efficacy|0|||
105428535|NCT00098722|363576165|FG000|Open Label Phase|Pregnancy|0|||
105428536|NCT00098722|363576166|FG001|Open Label Phase|Pregnancy|0|||
105428537|NCT00098722|363576167|FG002|Open Label Phase|Pregnancy|0|||
105589744|NCT01268891|364160627|FG000|Overall Study|Adverse Event|3|||
105589745|NCT01268891|364160628|FG001|Overall Study|Adverse Event|7|||
105589746|NCT01268891|364160627|FG000|Overall Study|Lack of Efficacy|1|||
105589747|NCT01268891|364160628|FG001|Overall Study|Lack of Efficacy|0|||
105589748|NCT01268891|364160627|FG000|Overall Study|Withdrawal of Consent|3|||
105589749|NCT01268891|364160628|FG001|Overall Study|Withdrawal of Consent|1|||
105589750|NCT01268891|364160627|FG000|Overall Study|Administrative or other reason(s)|1|||
105428538|NCT00098722|363576168|FG003|Open Label Phase|Pregnancy|1|||
105589751|NCT01268891|364160628|FG001|Overall Study|Administrative or other reason(s)|0|||
105428539|NCT00098722|363576169|FG004|Open Label Phase|Pregnancy|0|||
105589752|NCT01838200|364160632|FG000|Overall Study|Adverse Event|0|||
105501535|NCT04545385|363847150|FG000|Overall Study|Withdrawal by Subject|2|||
105501536|NCT04545385|363847151|FG001|Overall Study|Withdrawal by Subject|0|||
105501537|NCT04545385|363847150|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
105501538|NCT04545385|363847151|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
105501539|NCT04545385|363847150|FG000|Overall Study|Study termination|10|||
105501540|NCT04545385|363847151|FG001|Overall Study|Study termination|10|||
105501541|NCT04545385|363847150|FG000|Overall Study|Sponsor decision|2|||
105501542|NCT04545385|363847151|FG001|Overall Study|Sponsor decision|2|||
105501543|NCT04545385|363847150|FG000|Overall Study|Other than specified|1|||
105501544|NCT04545385|363847151|FG001|Overall Study|Other than specified|0|||
105501545|NCT02151110|363847152|FG000|Overall Study|Withdrawal by Subject|0|||
105501546|NCT02151110|363847153|FG001|Overall Study|Withdrawal by Subject|0|||
105501547|NCT02151110|363847154|FG002|Overall Study|Withdrawal by Subject|0|||
105501548|NCT02151110|363847155|FG003|Overall Study|Withdrawal by Subject|0|||
105501549|NCT02151110|363847156|FG004|Overall Study|Withdrawal by Subject|0|||
105501550|NCT02151110|363847157|FG005|Overall Study|Withdrawal by Subject|0|||
105501551|NCT02151110|363847158|FG006|Overall Study|Withdrawal by Subject|0|||
105501552|NCT02151110|363847159|FG007|Overall Study|Withdrawal by Subject|1|||
105501553|NCT02151110|363847152|FG000|Overall Study|Lost to Follow-up|0|||
105501554|NCT02151110|363847153|FG001|Overall Study|Lost to Follow-up|0|||
105501555|NCT02151110|363847154|FG002|Overall Study|Lost to Follow-up|0|||
105501556|NCT02151110|363847155|FG003|Overall Study|Lost to Follow-up|0|||
105501557|NCT02151110|363847156|FG004|Overall Study|Lost to Follow-up|0|||
105428540|NCT00098722|363576170|FG005|Open Label Phase|Pregnancy|0|||
105428541|NCT00098722|363576171|FG006|Open Label Phase|Pregnancy|0|||
105428542|NCT00098722|363576165|FG000|Open Label Phase|Participant defaulted|0|||
105428543|NCT00098722|363576166|FG001|Open Label Phase|Participant defaulted|0|||
105428544|NCT00098722|363576167|FG002|Open Label Phase|Participant defaulted|0|||
105428545|NCT00098722|363576168|FG003|Open Label Phase|Participant defaulted|18|||
105428546|NCT00098722|363576169|FG004|Open Label Phase|Participant defaulted|0|||
105428547|NCT00098722|363576170|FG005|Open Label Phase|Participant defaulted|0|||
105428548|NCT00098722|363576171|FG006|Open Label Phase|Participant defaulted|0|||
105501558|NCT02151110|363847157|FG005|Overall Study|Lost to Follow-up|0|||
105501559|NCT02151110|363847158|FG006|Overall Study|Lost to Follow-up|0|||
105501560|NCT02151110|363847159|FG007|Overall Study|Lost to Follow-up|2|||
105501561|NCT00289783|363847165|FG000|Primary Phase|Adverse Event|10|||
105501562|NCT00289783|363847166|FG001|Primary Phase|Adverse Event|1|||
105501563|NCT00289783|363847165|FG000|Primary Phase|Protocol Violation|27|||
105428549|NCT00098722|363576165|FG000|Open Label Phase|Ongoing at cut-off date|0|||
105428550|NCT00098722|363576166|FG001|Open Label Phase|Ongoing at cut-off date|0|||
105428551|NCT00098722|363576167|FG002|Open Label Phase|Ongoing at cut-off date|0|||
105501564|NCT00289783|363847166|FG001|Primary Phase|Protocol Violation|6|||
105501565|NCT00289783|363847165|FG000|Primary Phase|Withdrawal by Subject|93|||
105501566|NCT00289783|363847166|FG001|Primary Phase|Withdrawal by Subject|40|||
105501567|NCT00289783|363847165|FG000|Primary Phase|Lost to Follow-up|60|||
105501568|NCT00289783|363847166|FG001|Primary Phase|Lost to Follow-up|14|||
105501569|NCT00289783|363847165|FG000|Primary Phase|Migration from the study area|26|||
105501570|NCT00289783|363847166|FG001|Primary Phase|Migration from the study area|10|||
105501571|NCT00289783|363847165|FG000|Primary Phase|Other|32|||
105501572|NCT00289783|363847166|FG001|Primary Phase|Other|12|||
105428552|NCT00098722|363576168|FG003|Open Label Phase|Ongoing at cut-off date|220|||
105428553|NCT00098722|363576169|FG004|Open Label Phase|Ongoing at cut-off date|50|||
105428554|NCT00098722|363576170|FG005|Open Label Phase|Ongoing at cut-off date|0|||
105428555|NCT00098722|363576171|FG006|Open Label Phase|Ongoing at cut-off date|0|||
105428556|NCT00098722|363576165|FG000|Open Label Phase|Other|0|||
105428557|NCT00098722|363576166|FG001|Open Label Phase|Other|0|||
105428558|NCT00098722|363576167|FG002|Open Label Phase|Other|0|||
105428559|NCT00098722|363576168|FG003|Open Label Phase|Other|18|||
105428560|NCT00098722|363576169|FG004|Open Label Phase|Other|0|||
105428561|NCT00098722|363576170|FG005|Open Label Phase|Other|0|||
105428562|NCT00098722|363576171|FG006|Open Label Phase|Other|0|||
105428563|NCT00098722|363576165|FG000|Observation Phase|Death|0|||
105428564|NCT00098722|363576166|FG001|Observation Phase|Death|0|||
105428565|NCT00098722|363576167|FG002|Observation Phase|Death|0|||
105428566|NCT00098722|363576168|FG003|Observation Phase|Death|0|||
105501573|NCT00289783|363847165|FG000|Fourth Dose Phase|Adverse Event|1|||
105501574|NCT00289783|363847166|FG001|Fourth Dose Phase|Adverse Event|0|||
105501575|NCT00289783|363847165|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
105428567|NCT00098722|363576169|FG004|Observation Phase|Death|0|||
105428568|NCT00098722|363576170|FG005|Observation Phase|Death|5|||
105428569|NCT00098722|363576171|FG006|Observation Phase|Death|3|||
105428570|NCT00098722|363576165|FG000|Observation Phase|Lack of Efficacy|0|||
105501576|NCT00289783|363847166|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
105501577|NCT00289783|363847165|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
105501578|NCT00289783|363847166|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
105428571|NCT00098722|363576166|FG001|Observation Phase|Lack of Efficacy|0|||
105428572|NCT00098722|363576167|FG002|Observation Phase|Lack of Efficacy|0|||
105501579|NCT00289783|363847165|FG000|Fourth Dose Phase|Migration from the study area|1|||
105501580|NCT00289783|363847166|FG001|Fourth Dose Phase|Migration from the study area|1|||
105428573|NCT00098722|363576168|FG003|Observation Phase|Lack of Efficacy|0|||
105428574|NCT00098722|363576169|FG004|Observation Phase|Lack of Efficacy|0|||
105428575|NCT00098722|363576170|FG005|Observation Phase|Lack of Efficacy|2|||
105428576|NCT00098722|363576171|FG006|Observation Phase|Lack of Efficacy|0|||
105428577|NCT00098722|363576165|FG000|Observation Phase|Participant defaulted|0|||
105428578|NCT00098722|363576166|FG001|Observation Phase|Participant defaulted|0|||
105428579|NCT00098722|363576167|FG002|Observation Phase|Participant defaulted|0|||
105428580|NCT00098722|363576168|FG003|Observation Phase|Participant defaulted|0|||
105428581|NCT00098722|363576169|FG004|Observation Phase|Participant defaulted|0|||
105428582|NCT00098722|363576170|FG005|Observation Phase|Participant defaulted|17|||
105428583|NCT00098722|363576171|FG006|Observation Phase|Participant defaulted|4|||
105428584|NCT00098722|363576165|FG000|Observation Phase|Other|0|||
105428585|NCT00098722|363576166|FG001|Observation Phase|Other|0|||
105428586|NCT00098722|363576167|FG002|Observation Phase|Other|0|||
105428587|NCT00098722|363576168|FG003|Observation Phase|Other|0|||
105428588|NCT00098722|363576169|FG004|Observation Phase|Other|0|||
105428589|NCT00098722|363576170|FG005|Observation Phase|Other|21|||
105428590|NCT00098722|363576171|FG006|Observation Phase|Other|10|||
105428591|NCT01156389|363576178|FG000|Overall Study|Elevated liver enzymes|4|||
105428592|NCT01156389|363576179|FG001|Overall Study|Elevated liver enzymes|0|||
105428593|NCT01156389|363576178|FG000|Overall Study|Vomiting|0|||
105428594|NCT01156389|363576179|FG001|Overall Study|Vomiting|1|||
105428595|NCT00046930|363576180|FG000|Overall Study|Ineligible|12|||
105428596|NCT00046930|363576181|FG001|Overall Study|Ineligible|4|||
105428597|NCT00440310|363576182|FG000|Overall Study|Lost to Follow-up|4|||
105428598|NCT00440310|363576183|FG001|Overall Study|Lost to Follow-up|5|||
105428599|NCT00440310|363576182|FG000|Overall Study|Protocol Violation|0|||
105428600|NCT00440310|363576183|FG001|Overall Study|Protocol Violation|1|||
105428601|NCT00440310|363576182|FG000|Overall Study|Withdrawal by Subject|15|||
105428602|NCT00440310|363576183|FG001|Overall Study|Withdrawal by Subject|14|||
105428603|NCT00440310|363576182|FG000|Overall Study|No Reply at EOS|7|||
105428604|NCT00440310|363576183|FG001|Overall Study|No Reply at EOS|7|||
105428605|NCT00440310|363576182|FG000|Overall Study|Other|1|||
105428606|NCT00440310|363576183|FG001|Overall Study|Other|0|||
105428607|NCT00440310|363576182|FG000|Overall Study|Status Unknown|1|||
105428608|NCT00440310|363576183|FG001|Overall Study|Status Unknown|3|||
105428609|NCT02469415|363576184|FG000|Overall Study|Withdrawal by Subject|1|||
105428610|NCT02469415|363576184|FG000|Overall Study|Investigational agent placed on hold|2|||
105428611|NCT03761394|363576188|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
105428612|NCT03761394|363576189|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
105428613|NCT03761394|363576190|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
105428614|NCT03761394|363576191|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
105428615|NCT03761394|363576188|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
105428616|NCT03761394|363576189|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
105428617|NCT03761394|363576190|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
105428618|NCT03761394|363576191|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
105428619|NCT03761394|363576188|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
105428620|NCT03761394|363576189|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
105428621|NCT03761394|363576190|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
105428622|NCT03761394|363576191|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
105428623|NCT03761394|363576188|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
105428624|NCT03761394|363576189|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
105428625|NCT03761394|363576190|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
105428626|NCT03761394|363576191|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
105428627|NCT01891344|363576192|FG000|Overall Study|Ongoing|6|||
105428628|NCT01891344|363576193|FG001|Overall Study|Ongoing|2|||
105428629|NCT01891344|363576194|FG002|Overall Study|Ongoing|0|||
105428630|NCT01891344|363576195|FG003|Overall Study|Ongoing|1|||
105428631|NCT01891344|363576196|FG004|Overall Study|Ongoing|4|||
105428632|NCT01891344|363576197|FG005|Overall Study|Ongoing|1|||
105428633|NCT01891344|363576198|FG006|Overall Study|Ongoing|0|||
105428634|NCT01891344|363576199|FG007|Overall Study|Ongoing|0|||
105428635|NCT00159913|363576201|FG000|Overall Study|Adverse Event|1|||
105428636|NCT00159913|363576202|FG001|Overall Study|Adverse Event|0|||
105428637|NCT00159913|363576203|FG002|Overall Study|Adverse Event|1|||
105428638|NCT00159913|363576204|FG003|Overall Study|Adverse Event|0|||
105428639|NCT00159913|363576201|FG000|Overall Study|Withdrawal by Subject|0|||
105428640|NCT00159913|363576202|FG001|Overall Study|Withdrawal by Subject|0|||
105428641|NCT00159913|363576203|FG002|Overall Study|Withdrawal by Subject|0|||
105428642|NCT00159913|363576204|FG003|Overall Study|Withdrawal by Subject|1|||
105428643|NCT00159913|363576201|FG000|Overall Study|Lost to Follow-up|0|||
105428644|NCT00159913|363576202|FG001|Overall Study|Lost to Follow-up|0|||
105428645|NCT00159913|363576203|FG002|Overall Study|Lost to Follow-up|0|||
105428646|NCT00159913|363576204|FG003|Overall Study|Lost to Follow-up|1|||
105501581|NCT00289783|363847165|FG000|Fourth Dose Phase|Other|22|||
105428647|NCT00159913|363576201|FG000|Overall Study|Protocol Violation|1|||
105428648|NCT00159913|363576202|FG001|Overall Study|Protocol Violation|0|||
105428649|NCT00159913|363576203|FG002|Overall Study|Protocol Violation|1|||
105428650|NCT00159913|363576204|FG003|Overall Study|Protocol Violation|0|||
105428651|NCT01874275|363576205|FG000|Overall Study|Lost to Follow-up|1|||
105428652|NCT01874275|363576206|FG001|Overall Study|Lost to Follow-up|0|||
105428653|NCT00545532|363576207|FG000|Overall Study|Withdrawal by Subject|1|||
105428654|NCT00545532|363576208|FG001|Overall Study|Withdrawal by Subject|3|||
105428655|NCT00545532|363576207|FG000|Overall Study|Lost to Follow-up|5|||
105428656|NCT00545532|363576208|FG001|Overall Study|Lost to Follow-up|6|||
105428657|NCT00545532|363576207|FG000|Overall Study|Death|0|||
105428658|NCT00545532|363576208|FG001|Overall Study|Death|1|||
105428659|NCT01719003|363576209|FG000|Overall Study|Non compliant with protocol|1|||
105428660|NCT01719003|363576210|FG001|Overall Study|Non compliant with protocol|1|||
105428661|NCT01719003|363576211|FG002|Overall Study|Non compliant with protocol|0|||
105428662|NCT01719003|363576212|FG003|Overall Study|Non compliant with protocol|1|||
105428663|NCT01719003|363576213|FG004|Overall Study|Non compliant with protocol|2|||
105428664|NCT01719003|363576214|FG005|Overall Study|Non compliant with protocol|1|||
105428665|NCT01719003|363576215|FG006|Overall Study|Non compliant with protocol|2|||
105428666|NCT01719003|363576216|FG007|Overall Study|Non compliant with protocol|3|||
105501582|NCT00289783|363847166|FG001|Fourth Dose Phase|Other|10|||
105501583|NCT00566995|363847167|FG000|Overall Study|Toxicity|4|||
105501584|NCT00566995|363847167|FG000|Overall Study|Withdrew consent|3|||
105501585|NCT00404235|363847168|FG000|Overall Study|Withdrawal by Subject|1|||
105501586|NCT00404235|363847169|FG001|Overall Study|Withdrawal by Subject|2|||
105501587|NCT01064310|363847170|FG000|Period 1|Adverse Event|7|||
105501588|NCT01064310|363847171|FG001|Period 1|Adverse Event|10|||
105501589|NCT01064310|363847172|FG002|Period 1|Adverse Event|0|||
105501590|NCT01064310|363847170|FG000|Period 1|Physician Decision|1|||
105501591|NCT01064310|363847171|FG001|Period 1|Physician Decision|0|||
105501592|NCT01064310|363847172|FG002|Period 1|Physician Decision|0|||
105501593|NCT01064310|363847170|FG000|Period 1|Withdrawal by Subject|2|||
105428667|NCT01719003|363576217|FG008|Overall Study|Non compliant with protocol|0|||
105428668|NCT01719003|363576209|FG000|Overall Study|Adverse Event|6|||
105428669|NCT01719003|363576210|FG001|Overall Study|Adverse Event|5|||
105428670|NCT01719003|363576211|FG002|Overall Study|Adverse Event|4|||
105428671|NCT01719003|363576212|FG003|Overall Study|Adverse Event|3|||
105428672|NCT01719003|363576213|FG004|Overall Study|Adverse Event|4|||
105428673|NCT01719003|363576214|FG005|Overall Study|Adverse Event|3|||
105428674|NCT01719003|363576215|FG006|Overall Study|Adverse Event|6|||
105428675|NCT01719003|363576216|FG007|Overall Study|Adverse Event|5|||
105428676|NCT01719003|363576217|FG008|Overall Study|Adverse Event|0|||
105428677|NCT01719003|363576209|FG000|Overall Study|Lost to Follow-up|0|||
105428678|NCT01719003|363576210|FG001|Overall Study|Lost to Follow-up|6|||
105428679|NCT01719003|363576211|FG002|Overall Study|Lost to Follow-up|7|||
105428680|NCT01719003|363576212|FG003|Overall Study|Lost to Follow-up|2|||
105428681|NCT01719003|363576213|FG004|Overall Study|Lost to Follow-up|3|||
105428682|NCT01719003|363576214|FG005|Overall Study|Lost to Follow-up|4|||
105428683|NCT01719003|363576215|FG006|Overall Study|Lost to Follow-up|3|||
105428684|NCT01719003|363576216|FG007|Overall Study|Lost to Follow-up|2|||
105428685|NCT01719003|363576217|FG008|Overall Study|Lost to Follow-up|2|||
105428686|NCT01719003|363576209|FG000|Overall Study|Refusal to continue, not due to AE|2|||
105428687|NCT01719003|363576210|FG001|Overall Study|Refusal to continue, not due to AE|5|||
105428688|NCT01719003|363576211|FG002|Overall Study|Refusal to continue, not due to AE|4|||
105428689|NCT01719003|363576212|FG003|Overall Study|Refusal to continue, not due to AE|4|||
105428690|NCT01719003|363576213|FG004|Overall Study|Refusal to continue, not due to AE|4|||
105428691|NCT01719003|363576214|FG005|Overall Study|Refusal to continue, not due to AE|3|||
105428692|NCT01719003|363576215|FG006|Overall Study|Refusal to continue, not due to AE|8|||
105428693|NCT01719003|363576216|FG007|Overall Study|Refusal to continue, not due to AE|7|||
105428694|NCT01719003|363576217|FG008|Overall Study|Refusal to continue, not due to AE|1|||
105428695|NCT01719003|363576209|FG000|Overall Study|Reason other than those specified|0|||
105428696|NCT01719003|363576210|FG001|Overall Study|Reason other than those specified|0|||
105428697|NCT01719003|363576211|FG002|Overall Study|Reason other than those specified|2|||
105428698|NCT01719003|363576212|FG003|Overall Study|Reason other than those specified|3|||
105428699|NCT01719003|363576213|FG004|Overall Study|Reason other than those specified|4|||
105428700|NCT01719003|363576214|FG005|Overall Study|Reason other than those specified|1|||
105428701|NCT01719003|363576215|FG006|Overall Study|Reason other than those specified|0|||
105501594|NCT01064310|363847171|FG001|Period 1|Withdrawal by Subject|2|||
105428702|NCT01719003|363576216|FG007|Overall Study|Reason other than those specified|3|||
105428703|NCT01719003|363576217|FG008|Overall Study|Reason other than those specified|1|||
105428704|NCT01719003|363576209|FG000|Overall Study|Lack of Efficacy|0|||
105428705|NCT01719003|363576210|FG001|Overall Study|Lack of Efficacy|0|||
105428706|NCT01719003|363576211|FG002|Overall Study|Lack of Efficacy|0|||
105428707|NCT01719003|363576212|FG003|Overall Study|Lack of Efficacy|0|||
105428708|NCT01719003|363576213|FG004|Overall Study|Lack of Efficacy|0|||
105428709|NCT01719003|363576214|FG005|Overall Study|Lack of Efficacy|0|||
105428710|NCT01719003|363576215|FG006|Overall Study|Lack of Efficacy|1|||
105501595|NCT01064310|363847172|FG002|Period 1|Withdrawal by Subject|0|||
105501596|NCT01064310|363847170|FG000|Period 1|Lack of Efficacy|3|||
105589753|NCT01838200|364160633|FG001|Overall Study|Adverse Event|2|||
105589754|NCT01838200|364160632|FG000|Overall Study|Progressive disease|3|||
105589755|NCT01838200|364160633|FG001|Overall Study|Progressive disease|0|||
105589756|NCT00269399|364160636|FG000|Overall Study|Lack of Efficacy|27|||
105589757|NCT00269399|364160637|FG001|Overall Study|Lack of Efficacy|10|||
105589758|NCT00269399|364160636|FG000|Overall Study|Adverse Event|10|||
105589759|NCT00269399|364160637|FG001|Overall Study|Adverse Event|4|||
105589760|NCT00269399|364160636|FG000|Overall Study|Withdrawal by Subject|2|||
105589761|NCT00269399|364160637|FG001|Overall Study|Withdrawal by Subject|5|||
105589762|NCT00269399|364160636|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
105589763|NCT00269399|364160637|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
105589764|NCT00269399|364160636|FG000|Overall Study|Other|0|||
105589765|NCT00269399|364160637|FG001|Overall Study|Other|4|||
105589766|NCT00269399|364160636|FG000|Overall Study|Development of exclusion criteria|0|||
105589767|NCT00269399|364160637|FG001|Overall Study|Development of exclusion criteria|1|||
105589768|NCT02049866|364160639|FG000|Overall Study|Withdrawal by Subject|1|||
105589769|NCT03721016|364160642|FG000|Overall Study|Adverse Event|0|||
105589770|NCT03721016|364160643|FG001|Overall Study|Adverse Event|1|||
105589771|NCT03721016|364160644|FG002|Overall Study|Adverse Event|1|||
105589772|NCT03721016|364160642|FG000|Overall Study|Withdrawal by Subject|8|||
105589773|NCT03721016|364160643|FG001|Overall Study|Withdrawal by Subject|16|||
105589774|NCT03721016|364160644|FG002|Overall Study|Withdrawal by Subject|13|||
105589775|NCT03721016|364160642|FG000|Overall Study|Lost to Follow-up|4|||
105589776|NCT03721016|364160643|FG001|Overall Study|Lost to Follow-up|6|||
105589777|NCT03721016|364160644|FG002|Overall Study|Lost to Follow-up|5|||
105589778|NCT03721016|364160642|FG000|Overall Study|Physician Decision|0|||
105589779|NCT03721016|364160643|FG001|Overall Study|Physician Decision|1|||
105589780|NCT03721016|364160644|FG002|Overall Study|Physician Decision|2|||
105428711|NCT01719003|363576216|FG007|Overall Study|Lack of Efficacy|0|||
105428712|NCT01719003|363576217|FG008|Overall Study|Lack of Efficacy|0|||
105589781|NCT03721016|364160642|FG000|Overall Study|Protocol Violation|0|||
105589782|NCT03721016|364160643|FG001|Overall Study|Protocol Violation|1|||
105589783|NCT03721016|364160644|FG002|Overall Study|Protocol Violation|0|||
105589784|NCT03721016|364160642|FG000|Overall Study|Site terminated by sponsor|3|||
105589785|NCT03721016|364160643|FG001|Overall Study|Site terminated by sponsor|7|||
105589786|NCT03721016|364160644|FG002|Overall Study|Site terminated by sponsor|6|||
105589787|NCT03721016|364160642|FG000|Overall Study|Subject exited early due to COVID-19|1|||
105589788|NCT03721016|364160643|FG001|Overall Study|Subject exited early due to COVID-19|0|||
105589789|NCT03721016|364160644|FG002|Overall Study|Subject exited early due to COVID-19|0|||
105589790|NCT04148937|364160645|FG000|Overall Study|Withdrawal by Subject|0|||
105589791|NCT04148937|364160646|FG001|Overall Study|Withdrawal by Subject|0|||
105589792|NCT04148937|364160647|FG002|Overall Study|Withdrawal by Subject|0|||
105589793|NCT04148937|364160648|FG003|Overall Study|Withdrawal by Subject|1|||
105589794|NCT04148937|364160649|FG004|Overall Study|Withdrawal by Subject|0|||
105589795|NCT04148937|364160650|FG005|Overall Study|Withdrawal by Subject|1|||
105589796|NCT04148937|364160651|FG006|Overall Study|Withdrawal by Subject|1|||
105589797|NCT04148937|364160652|FG007|Overall Study|Withdrawal by Subject|0|||
105589798|NCT04148937|364160645|FG000|Overall Study|Lost to Follow-up|0|||
105589799|NCT04148937|364160646|FG001|Overall Study|Lost to Follow-up|0|||
105589800|NCT04148937|364160647|FG002|Overall Study|Lost to Follow-up|1|||
105589801|NCT04148937|364160648|FG003|Overall Study|Lost to Follow-up|0|||
105589802|NCT04148937|364160649|FG004|Overall Study|Lost to Follow-up|0|||
105589803|NCT04148937|364160650|FG005|Overall Study|Lost to Follow-up|2|||
105589804|NCT04148937|364160651|FG006|Overall Study|Lost to Follow-up|0|||
105589805|NCT04148937|364160652|FG007|Overall Study|Lost to Follow-up|0|||
105589806|NCT01876511|364160655|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
105589807|NCT01876511|364160656|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
105589808|NCT01876511|364160657|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
105589809|NCT01876511|364160655|FG000|Overall Study|Death (unrelated)|3|||
105428713|NCT00689793|363576218|FG000|Overall Study|Lost to Follow-up|4|||
105428714|NCT00689793|363576219|FG001|Overall Study|Lost to Follow-up|5|||
105428715|NCT01100528|363576220|FG000|Overall Study|Death|1|||
105428716|NCT01100528|363576220|FG000|Overall Study|Withdrawal by Subject|2|||
105589810|NCT01876511|364160656|FG001|Overall Study|Death (unrelated)|0|||
105589811|NCT01876511|364160657|FG002|Overall Study|Death (unrelated)|2|||
105589812|NCT01876511|364160655|FG000|Overall Study|Drug-related Toxicity|5|||
105428717|NCT01299571|363576221|FG000|Overall Study|Protocol Violation|107|||
105428718|NCT04375397|363576222|FG000|Overall Study|Death|1|||
105428719|NCT04375397|363576223|FG001|Overall Study|Death|1|||
105589813|NCT01876511|364160656|FG001|Overall Study|Drug-related Toxicity|1|||
105589814|NCT01876511|364160657|FG002|Overall Study|Drug-related Toxicity|6|||
105589815|NCT01876511|364160655|FG000|Overall Study|Patient Decision|3|||
105589816|NCT01876511|364160656|FG001|Overall Study|Patient Decision|0|||
105589817|NCT01876511|364160657|FG002|Overall Study|Patient Decision|6|||
105589818|NCT01876511|364160655|FG000|Overall Study|Physician Decision|1|||
105589819|NCT01876511|364160656|FG001|Overall Study|Physician Decision|0|||
105589820|NCT01876511|364160657|FG002|Overall Study|Physician Decision|1|||
105589821|NCT02274493|364160660|FG000|Overall Study|Withdrawal by Subject|1|||
105428720|NCT04375397|363576222|FG000|Overall Study|Withdrew consent|2|||
105428721|NCT04375397|363576223|FG001|Overall Study|Withdrew consent|0|||
105428722|NCT04375397|363576222|FG000|Overall Study|Lost to Follow-up|6|||
105428723|NCT04375397|363576223|FG001|Overall Study|Lost to Follow-up|4|||
105428724|NCT04375397|363576222|FG000|Overall Study|Other, not specified|0|||
105428725|NCT04375397|363576223|FG001|Overall Study|Other, not specified|1|||
105428726|NCT00849875|363576224|FG000|Overall Study|Death|28|||
105428727|NCT00849875|363576224|FG000|Overall Study|Ongoing (unknown completion status)|11|||
105428728|NCT00849875|363576224|FG000|Overall Study|Others|6|||
105428729|NCT00849875|363576224|FG000|Overall Study|Lost to Follow-up|2|||
105428730|NCT00259298|363576226|FG000|Overall Study|Withdrawal by Subject|1|||
105428731|NCT00259298|363576226|FG000|Overall Study|Physician Decision|2|||
105428732|NCT01969500|363576227|FG000|Overall Study|Death|0|||
105428733|NCT01969500|363576228|FG001|Overall Study|Death|1|||
105428734|NCT01969500|363576227|FG000|Overall Study|extended hospitalization|1|||
105428735|NCT01969500|363576228|FG001|Overall Study|extended hospitalization|1|||
105428736|NCT02639338|363576229|FG000|Overall Study|Lost to Follow-up|2|||
105428737|NCT02639338|363576230|FG001|Overall Study|Lost to Follow-up|2|||
105428738|NCT02639338|363576229|FG000|Overall Study|Withdrew Consent|1|||
105428739|NCT02639338|363576230|FG001|Overall Study|Withdrew Consent|2|||
105428740|NCT02639338|363576229|FG000|Overall Study|Death|1|||
105428741|NCT02639338|363576230|FG001|Overall Study|Death|0|||
105428742|NCT02639338|363576229|FG000|Overall Study|Randomized but Not Treated|0|||
105428743|NCT02639338|363576230|FG001|Overall Study|Randomized but Not Treated|1|||
105428744|NCT01710527|363576235|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
105428745|NCT01710527|363576236|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
105428746|NCT01827332|363576239|FG000|Overall Study|Lost to Follow-up|2|||
105428747|NCT01827332|363576240|FG001|Overall Study|Lost to Follow-up|1|||
105428748|NCT01241760|363576245|FG000|Overall Study|Adverse Event|1|||
105428749|NCT01241760|363576246|FG001|Overall Study|Adverse Event|0|||
105428750|NCT01241760|363576245|FG000|Overall Study|Lost to Follow-up|18|||
105428751|NCT01241760|363576246|FG001|Overall Study|Lost to Follow-up|22|||
105428752|NCT01241760|363576245|FG000|Overall Study|Withdrawal by Subject|13|||
105428753|NCT01241760|363576246|FG001|Overall Study|Withdrawal by Subject|13|||
105428754|NCT01241760|363576245|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
105428755|NCT01241760|363576246|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
105428756|NCT01241760|363576245|FG000|Overall Study|Other|1|||
105428757|NCT01241760|363576246|FG001|Overall Study|Other|1|||
105428758|NCT01688921|363576247|FG000|Overall Study|Lost to Follow-up|7|||
105428759|NCT01688921|363576248|FG001|Overall Study|Lost to Follow-up|13|||
105428760|NCT01688921|363576247|FG000|Overall Study|Physician Decision|6|||
105428761|NCT01688921|363576248|FG001|Overall Study|Physician Decision|1|||
105428762|NCT01688921|363576247|FG000|Overall Study|Protocol Violation|0|||
105428763|NCT01688921|363576248|FG001|Overall Study|Protocol Violation|1|||
105428764|NCT01688921|363576247|FG000|Overall Study|informed consent|3|||
105428765|NCT01688921|363576248|FG001|Overall Study|informed consent|0|||
105428766|NCT02358044|363576249|FG000|Overall Study|Adverse Event|0|||
105428767|NCT02358044|363576250|FG001|Overall Study|Adverse Event|1|||
105428768|NCT02358044|363576249|FG000|Overall Study|Lost to Follow-up|2|||
105428769|NCT02358044|363576250|FG001|Overall Study|Lost to Follow-up|1|||
105428770|NCT02358044|363576249|FG000|Overall Study|Physician Decision|0|||
105428771|NCT02358044|363576250|FG001|Overall Study|Physician Decision|1|||
105428772|NCT02358044|363576249|FG000|Overall Study|Withdrawal by Subject|0|||
105428773|NCT02358044|363576250|FG001|Overall Study|Withdrawal by Subject|4|||
105428774|NCT01636713|363576252|FG000|Overall Study|Adverse Event|16|||
105428775|NCT01636713|363576253|FG001|Overall Study|Adverse Event|16|||
105428776|NCT01636713|363576254|FG002|Overall Study|Adverse Event|7|||
105428777|NCT01636713|363576252|FG000|Overall Study|Lack of Efficacy|6|||
105428778|NCT01636713|363576253|FG001|Overall Study|Lack of Efficacy|6|||
105428779|NCT01636713|363576254|FG002|Overall Study|Lack of Efficacy|2|||
105428780|NCT01636713|363576252|FG000|Overall Study|Protocol Violation|3|||
105428781|NCT01636713|363576253|FG001|Overall Study|Protocol Violation|0|||
105428782|NCT01636713|363576254|FG002|Overall Study|Protocol Violation|1|||
105428783|NCT01636713|363576252|FG000|Overall Study|Lost to Follow-up|0|||
105428784|NCT01636713|363576253|FG001|Overall Study|Lost to Follow-up|0|||
105428785|NCT01636713|363576254|FG002|Overall Study|Lost to Follow-up|1|||
105428786|NCT01636713|363576252|FG000|Overall Study|Withdrawal by Subject|5|||
105428787|NCT01636713|363576253|FG001|Overall Study|Withdrawal by Subject|4|||
105428788|NCT01636713|363576254|FG002|Overall Study|Withdrawal by Subject|8|||
105428789|NCT01636713|363576252|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
105428790|NCT01636713|363576253|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
105428791|NCT01636713|363576254|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
105428792|NCT03689244|363576255|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
105428793|NCT03689244|363576256|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
105428794|NCT03689244|363576257|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
105428795|NCT03689244|363576258|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
105428796|NCT03689244|363576255|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
105428797|NCT03689244|363576256|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
105428798|NCT03689244|363576257|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
105428799|NCT03689244|363576258|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
105428800|NCT03689244|363576255|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
105428801|NCT03689244|363576256|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
105428802|NCT03689244|363576257|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
105428803|NCT03689244|363576258|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
105428804|NCT03689244|363576255|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
105428805|NCT03689244|363576256|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
105428806|NCT03689244|363576257|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
105428807|NCT03689244|363576258|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
105428808|NCT03689244|363576255|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
105428809|NCT03689244|363576256|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
105589822|NCT04304534|364160661|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
105589823|NCT04304534|364160662|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
105589824|NCT04304534|364160663|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
105589825|NCT04304534|364160664|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
105589826|NCT04304534|364160661|FG000|Overall Study|Non-Compliance with study drug|0|||
105589827|NCT04304534|364160662|FG001|Overall Study|Non-Compliance with study drug|1|||
105589828|NCT04304534|364160663|FG002|Overall Study|Non-Compliance with study drug|1|||
105589829|NCT04304534|364160664|FG003|Overall Study|Non-Compliance with study drug|1|||
105589830|NCT04304534|364160661|FG000|Overall Study|Lost to Follow-up|0|||
105589831|NCT04304534|364160662|FG001|Overall Study|Lost to Follow-up|1|||
105589832|NCT04304534|364160663|FG002|Overall Study|Lost to Follow-up|2|||
105589833|NCT04304534|364160664|FG003|Overall Study|Lost to Follow-up|3|||
105589834|NCT04304534|364160661|FG000|Overall Study|Unspecific|4|||
105589835|NCT04304534|364160662|FG001|Overall Study|Unspecific|2|||
105589836|NCT04304534|364160663|FG002|Overall Study|Unspecific|2|||
105589837|NCT04304534|364160664|FG003|Overall Study|Unspecific|2|||
105589838|NCT04304534|364160661|FG000|Overall Study|Technical Problems|2|||
105589839|NCT04304534|364160662|FG001|Overall Study|Technical Problems|2|||
105589840|NCT04304534|364160663|FG002|Overall Study|Technical Problems|3|||
105589841|NCT04304534|364160664|FG003|Overall Study|Technical Problems|4|||
105589842|NCT04304534|364160661|FG000|Overall Study|Death|7|||
105589843|NCT04304534|364160662|FG001|Overall Study|Death|2|||
105589844|NCT04304534|364160663|FG002|Overall Study|Death|4|||
105589845|NCT04304534|364160664|FG003|Overall Study|Death|3|||
105589846|NCT04304534|364160661|FG000|Overall Study|Withdrawal by Subject|7|||
105589847|NCT04304534|364160662|FG001|Overall Study|Withdrawal by Subject|2|||
105589848|NCT04304534|364160663|FG002|Overall Study|Withdrawal by Subject|7|||
105589849|NCT04304534|364160664|FG003|Overall Study|Withdrawal by Subject|4|||
105589850|NCT04304534|364160661|FG000|Overall Study|Physician Decision|4|||
105589851|NCT04304534|364160662|FG001|Overall Study|Physician Decision|9|||
105589852|NCT04304534|364160663|FG002|Overall Study|Physician Decision|9|||
105589853|NCT04304534|364160664|FG003|Overall Study|Physician Decision|5|||
105589854|NCT04304534|364160661|FG000|Overall Study|Subject Decision|34|||
105589855|NCT04304534|364160662|FG001|Overall Study|Subject Decision|25|||
105589856|NCT04304534|364160663|FG002|Overall Study|Subject Decision|25|||
105589857|NCT04304534|364160664|FG003|Overall Study|Subject Decision|26|||
105589858|NCT04304534|364160661|FG000|Overall Study|Adverse Event|35|||
105428810|NCT03689244|363576257|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
105428811|NCT03689244|363576258|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
105428812|NCT03689244|363576255|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
105428813|NCT03689244|363576256|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
105428814|NCT03689244|363576257|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
105428815|NCT03689244|363576258|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
105428816|NCT03689244|363576255|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
105428817|NCT03689244|363576256|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
105428818|NCT03689244|363576257|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
105501597|NCT01064310|363847171|FG001|Period 1|Lack of Efficacy|5|||
105501598|NCT01064310|363847172|FG002|Period 1|Lack of Efficacy|0|||
105501599|NCT01064310|363847170|FG000|Period 1|Entered Open-label Period|1|||
105501600|NCT01064310|363847171|FG001|Period 1|Entered Open-label Period|1|||
105501601|NCT01064310|363847172|FG002|Period 1|Entered Open-label Period|0|||
105501602|NCT01064310|363847170|FG000|Period 2|Adverse Event|2|||
105501603|NCT01064310|363847171|FG001|Period 2|Adverse Event|1|||
105501604|NCT01064310|363847172|FG002|Period 2|Adverse Event|0|||
105501605|NCT01064310|363847170|FG000|Period 2|Physician Decision|0|||
105501606|NCT01064310|363847171|FG001|Period 2|Physician Decision|1|||
105501607|NCT01064310|363847172|FG002|Period 2|Physician Decision|0|||
105501608|NCT01064310|363847170|FG000|Period 2|Entered Open-label Period|1|||
105501609|NCT01064310|363847171|FG001|Period 2|Entered Open-label Period|0|||
105501610|NCT01064310|363847172|FG002|Period 2|Entered Open-label Period|0|||
105501611|NCT01064310|363847170|FG000|Period 2|Lack of Efficacy|1|||
105589859|NCT04304534|364160662|FG001|Overall Study|Adverse Event|40|||
105589860|NCT04304534|364160663|FG002|Overall Study|Adverse Event|39|||
105589861|NCT04304534|364160664|FG003|Overall Study|Adverse Event|44|||
105589862|NCT04012853|364160665|FG000|Overall Study|Withdrawal by Subject|1|||
105589863|NCT04012853|364160666|FG001|Overall Study|Withdrawal by Subject|1|||
105589864|NCT04012853|364160665|FG000|Overall Study|Protocol Violation|1|||
105589865|NCT04012853|364160666|FG001|Overall Study|Protocol Violation|0|||
105589866|NCT04012853|364160665|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
105589867|NCT04012853|364160666|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
105589868|NCT00580801|364160673|FG000|Overall Study|Physician Decision|1|||
105589869|NCT00580801|364160674|FG001|Overall Study|Physician Decision|0|||
105589870|NCT00580801|364160675|FG002|Overall Study|Physician Decision|0|||
105589871|NCT00580801|364160673|FG000|Overall Study|Adverse Event|2|||
105589872|NCT00580801|364160674|FG001|Overall Study|Adverse Event|0|||
105589873|NCT00580801|364160675|FG002|Overall Study|Adverse Event|0|||
105589874|NCT00580801|364160673|FG000|Overall Study|Lost to Follow-up|2|||
105589875|NCT00580801|364160674|FG001|Overall Study|Lost to Follow-up|0|||
105589876|NCT00580801|364160675|FG002|Overall Study|Lost to Follow-up|0|||
105589877|NCT00580801|364160673|FG000|Overall Study|Reached a virologic endpoint|0|||
105589878|NCT00580801|364160674|FG001|Overall Study|Reached a virologic endpoint|1|||
105589879|NCT00580801|364160675|FG002|Overall Study|Reached a virologic endpoint|2|||
105589880|NCT00580801|364160673|FG000|Overall Study|Participant non-compliant|0|||
105589881|NCT00580801|364160674|FG001|Overall Study|Participant non-compliant|0|||
105589882|NCT00580801|364160675|FG002|Overall Study|Participant non-compliant|1|||
105589883|NCT00580801|364160673|FG000|Overall Study|Travel|1|||
105589884|NCT00580801|364160674|FG001|Overall Study|Travel|0|||
105589885|NCT00580801|364160675|FG002|Overall Study|Travel|0|||
105589886|NCT00502593|364160676|FG000|Overall Study|Withdrawn unspecified reason|1|||
105589887|NCT00502593|364160677|FG001|Overall Study|Withdrawn unspecified reason|1|||
105589888|NCT00502593|364160678|FG002|Overall Study|Withdrawn unspecified reason|3|||
105589889|NCT00502593|364160679|FG003|Overall Study|Withdrawn unspecified reason|1|||
105589890|NCT00502593|364160680|FG004|Overall Study|Withdrawn unspecified reason|2|||
105589891|NCT00502593|364160681|FG005|Overall Study|Withdrawn unspecified reason|0|||
105589892|NCT00502593|364160682|FG006|Overall Study|Withdrawn unspecified reason|2|||
105589893|NCT00502593|364160683|FG007|Overall Study|Withdrawn unspecified reason|0|||
105589894|NCT00502593|364160684|FG008|Overall Study|Withdrawn unspecified reason|0|||
105589895|NCT00502593|364160685|FG009|Overall Study|Withdrawn unspecified reason|0|||
105589896|NCT00502593|364160686|FG010|Overall Study|Withdrawn unspecified reason|0|||
105589897|NCT00502593|364160687|FG011|Overall Study|Withdrawn unspecified reason|0|||
105589898|NCT00502593|364160676|FG000|Overall Study|Withdrawal by Subject|0|||
105589899|NCT00502593|364160677|FG001|Overall Study|Withdrawal by Subject|0|||
105589900|NCT00502593|364160678|FG002|Overall Study|Withdrawal by Subject|6|||
105589901|NCT00502593|364160679|FG003|Overall Study|Withdrawal by Subject|2|||
105589902|NCT00502593|364160680|FG004|Overall Study|Withdrawal by Subject|2|||
105589903|NCT00502593|364160681|FG005|Overall Study|Withdrawal by Subject|0|||
105589904|NCT00502593|364160682|FG006|Overall Study|Withdrawal by Subject|3|||
105589905|NCT00502593|364160683|FG007|Overall Study|Withdrawal by Subject|0|||
105589906|NCT00502593|364160684|FG008|Overall Study|Withdrawal by Subject|3|||
105589907|NCT00502593|364160685|FG009|Overall Study|Withdrawal by Subject|0|||
105589908|NCT00502593|364160686|FG010|Overall Study|Withdrawal by Subject|1|||
105589909|NCT00502593|364160687|FG011|Overall Study|Withdrawal by Subject|0|||
105589910|NCT00502593|364160676|FG000|Overall Study|Lost to Follow-up|2|||
105589911|NCT00502593|364160677|FG001|Overall Study|Lost to Follow-up|1|||
105589912|NCT00502593|364160678|FG002|Overall Study|Lost to Follow-up|1|||
105589913|NCT00502593|364160679|FG003|Overall Study|Lost to Follow-up|1|||
105589914|NCT00502593|364160680|FG004|Overall Study|Lost to Follow-up|0|||
105589915|NCT00502593|364160681|FG005|Overall Study|Lost to Follow-up|0|||
105589916|NCT00502593|364160682|FG006|Overall Study|Lost to Follow-up|0|||
105589917|NCT00502593|364160683|FG007|Overall Study|Lost to Follow-up|0|||
105589918|NCT00502593|364160684|FG008|Overall Study|Lost to Follow-up|3|||
105589919|NCT00502593|364160685|FG009|Overall Study|Lost to Follow-up|0|||
105589920|NCT00502593|364160686|FG010|Overall Study|Lost to Follow-up|1|||
105589921|NCT00502593|364160687|FG011|Overall Study|Lost to Follow-up|0|||
105589922|NCT00843193|364160688|FG000|Overall Study|Adverse Event|2|||
105589923|NCT00843193|364160689|FG001|Overall Study|Adverse Event|4|||
105589924|NCT00843193|364160688|FG000|Overall Study|Lack of Efficacy|1|||
105428819|NCT03689244|363576258|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
105428820|NCT03689244|363576255|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
105428821|NCT03689244|363576256|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
105589925|NCT00843193|364160689|FG001|Overall Study|Lack of Efficacy|1|||
105589926|NCT00843193|364160688|FG000|Overall Study|Protocol Violation|1|||
105589927|NCT00843193|364160689|FG001|Overall Study|Protocol Violation|2|||
105589928|NCT00843193|364160688|FG000|Overall Study|Lost to Follow-up|1|||
105428822|NCT03689244|363576257|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
105428823|NCT03689244|363576258|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
105589929|NCT00843193|364160689|FG001|Overall Study|Lost to Follow-up|0|||
105428824|NCT01822535|363576259|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
105428825|NCT01822535|363576260|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
105428826|NCT01822535|363576259|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
105428827|NCT01822535|363576260|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
105428828|NCT01822535|363576259|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
105428829|NCT01822535|363576260|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
105428830|NCT01739803|363576261|FG000|Overall Study|Lost to Follow-up|9|||
105428831|NCT01739803|363576262|FG001|Overall Study|Lost to Follow-up|6|||
105428832|NCT01522404|363576267|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
105428833|NCT01522404|363576268|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
105428834|NCT01522404|363576267|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
105428835|NCT01522404|363576268|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
105428836|NCT01522404|363576267|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
105428837|NCT01522404|363576268|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
105428838|NCT03734029|363576269|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
105428839|NCT03734029|363576270|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
105428840|NCT03734029|363576269|FG000|Overall Study|Adverse Event|60|||
105428841|NCT03734029|363576270|FG001|Overall Study|Adverse Event|14|||
105428842|NCT03734029|363576269|FG000|Overall Study|Withdrawal by Subject|12|||
105428843|NCT03734029|363576270|FG001|Overall Study|Withdrawal by Subject|11|||
105428844|NCT03734029|363576269|FG000|Overall Study|Clinical progression by investigator|10|||
105428845|NCT03734029|363576270|FG001|Overall Study|Clinical progression by investigator|8|||
105428846|NCT03734029|363576269|FG000|Overall Study|Death|5|||
105428847|NCT03734029|363576270|FG001|Overall Study|Death|2|||
105428848|NCT03734029|363576269|FG000|Overall Study|Physician Decision|4|||
105428849|NCT03734029|363576270|FG001|Overall Study|Physician Decision|3|||
105428850|NCT03734029|363576269|FG000|Overall Study|Other|2|||
105428851|NCT03734029|363576270|FG001|Overall Study|Other|0|||
105428852|NCT03734029|363576269|FG000|Overall Study|Lost to Follow-up|0|||
105428853|NCT03734029|363576270|FG001|Overall Study|Lost to Follow-up|1|||
105428854|NCT03734029|363576269|FG000|Overall Study|Randomized, but not treated|2|||
105428855|NCT03734029|363576270|FG001|Overall Study|Randomized, but not treated|12|||
105428856|NCT02525094|363576271|FG000|Overall Study|Lost to Follow-up|2|||
105428857|NCT02525094|363576272|FG001|Overall Study|Lost to Follow-up|1|||
105428858|NCT02525094|363576271|FG000|Overall Study|Withdrawal by Subject|5|||
105428859|NCT02525094|363576272|FG001|Overall Study|Withdrawal by Subject|6|||
105428860|NCT02525094|363576271|FG000|Overall Study|Not Treated|1|||
105428861|NCT02525094|363576272|FG001|Overall Study|Not Treated|1|||
105428862|NCT03081858|363578293|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
105428863|NCT03081858|363578294|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
105428864|NCT03081858|363578295|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
105428865|NCT03081858|363578296|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
105428866|NCT00664326|363578301|FG000|Overall Study|Adverse Event|14|||
105428867|NCT00664326|363578301|FG000|Overall Study|Noncompliance with study medication|3|||
105428868|NCT00664326|363578301|FG000|Overall Study|Withdrawal by Subject|1|||
105428869|NCT00664326|363578301|FG000|Overall Study|Physician Decision|1|||
105428870|NCT00664326|363578301|FG000|Overall Study|Other Reasons|3|||
105428871|NCT00664326|363578301|FG000|Overall Study|Death|2|||
105428872|NCT00664326|363578301|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
105428873|NCT00262847|363578302|FG000|Overall Study|Disease Progression|309|||
105428874|NCT00262847|363578303|FG001|Overall Study|Disease Progression|274|||
105428875|NCT00262847|363578304|FG002|Overall Study|Disease Progression|195|||
105428876|NCT00262847|363578302|FG000|Overall Study|Patient Refusal|41|||
105428877|NCT00262847|363578303|FG001|Overall Study|Patient Refusal|52|||
105428878|NCT00262847|363578304|FG002|Overall Study|Patient Refusal|47|||
105428879|NCT00262847|363578302|FG000|Overall Study|Adverse Event|74|||
105428880|NCT00262847|363578303|FG001|Overall Study|Adverse Event|88|||
105428881|NCT00262847|363578304|FG002|Overall Study|Adverse Event|108|||
105428882|NCT00262847|363578302|FG000|Overall Study|Death|8|||
105428883|NCT00262847|363578303|FG001|Overall Study|Death|8|||
105428884|NCT00262847|363578304|FG002|Overall Study|Death|11|||
105428885|NCT00262847|363578302|FG000|Overall Study|Concomitant disease|3|||
105428886|NCT00262847|363578303|FG001|Overall Study|Concomitant disease|2|||
105428887|NCT00262847|363578304|FG002|Overall Study|Concomitant disease|4|||
105428888|NCT00262847|363578302|FG000|Overall Study|Other Reasons|79|||
105428889|NCT00262847|363578303|FG001|Overall Study|Other Reasons|88|||
105428890|NCT00262847|363578304|FG002|Overall Study|Other Reasons|27|||
105428891|NCT00262847|363578302|FG000|Overall Study|Did not receive study treatment|4|||
105428892|NCT00262847|363578303|FG001|Overall Study|Did not receive study treatment|1|||
105501612|NCT01064310|363847171|FG001|Period 2|Lack of Efficacy|4|||
105501613|NCT01064310|363847172|FG002|Period 2|Lack of Efficacy|0|||
105501614|NCT01064310|363847170|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
105501615|NCT01064310|363847171|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
105501616|NCT01064310|363847172|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
105428893|NCT00262847|363578304|FG002|Overall Study|Did not receive study treatment|4|||
105428894|NCT05079477|363578305|FG000|Overall Study|Lost to Follow-up|2|||
105428895|NCT05079477|363578306|FG001|Overall Study|Lost to Follow-up|0|||
105428896|NCT05079477|363578305|FG000|Overall Study|Withdrawal by Subject|1|||
105428897|NCT05079477|363578306|FG001|Overall Study|Withdrawal by Subject|0|||
105428898|NCT05079477|363578305|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
105428899|NCT05079477|363578306|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
105428900|NCT05079477|363578305|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
105428901|NCT05079477|363578306|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
105428902|NCT05013424|363578309|FG000|Overall Study|Lost to Follow-up|1|||
105428903|NCT05013424|363578310|FG001|Overall Study|Lost to Follow-up|1|||
105428904|NCT05013424|363578311|FG002|Overall Study|Lost to Follow-up|1|||
105428905|NCT05013424|363578309|FG000|Overall Study|Withdrawal by Subject|0|||
105428906|NCT05013424|363578310|FG001|Overall Study|Withdrawal by Subject|1|||
105428907|NCT05013424|363578311|FG002|Overall Study|Withdrawal by Subject|0|||
105428908|NCT03654885|363578312|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
105428909|NCT03654885|363578313|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
105428910|NCT03654885|363578312|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
105428911|NCT03654885|363578313|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
105428912|NCT03654885|363578312|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
105428913|NCT03654885|363578313|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
105428914|NCT03654885|363578312|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
105428915|NCT03654885|363578313|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
105428916|NCT03654885|363578312|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
105428917|NCT03654885|363578313|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
105428918|NCT03654885|363578312|FG000|Overall Study|Adverse Event in Study Eye|3|||
105428919|NCT03654885|363578313|FG001|Overall Study|Adverse Event in Study Eye|0|||
105428920|NCT03654885|363578312|FG000|Overall Study|Consent Withdrawn|1|||
105428921|NCT03654885|363578313|FG001|Overall Study|Consent Withdrawn|0|||
105428922|NCT03654885|363578312|FG000|Overall Study|Death|3|||
105428923|NCT03654885|363578313|FG001|Overall Study|Death|1|||
105428924|NCT03654885|363578312|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
105428925|NCT03654885|363578313|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
105428926|NCT03654885|363578312|FG000|Overall Study|Lost to Follow-up|3|||
105428927|NCT03654885|363578313|FG001|Overall Study|Lost to Follow-up|3|||
105428928|NCT05275582|363578314|FG000|Overall Study|Lost to Follow-up|1|||
105428929|NCT05275582|363578315|FG001|Overall Study|Lost to Follow-up|0|||
105428930|NCT05275582|363578314|FG000|Overall Study|Withdrawal by Subject|0|||
105428931|NCT05275582|363578315|FG001|Overall Study|Withdrawal by Subject|2|||
105428932|NCT05275582|363578314|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
105428933|NCT05275582|363578315|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
105428934|NCT05275582|363578314|FG000|Overall Study|Death|1|||
105428935|NCT05275582|363578315|FG001|Overall Study|Death|0|||
105428936|NCT05275582|363578314|FG000|Overall Study|Protocol Violation|1|||
105428937|NCT05275582|363578315|FG001|Overall Study|Protocol Violation|0|||
105428938|NCT04732949|363578316|FG000|Overall Study|Withdrawal by Subject|23|||
105428939|NCT04732949|363578317|FG001|Overall Study|Withdrawal by Subject|27|||
105428940|NCT04732949|363578316|FG000|Overall Study|Protocol Violation|0|||
105428941|NCT04732949|363578317|FG001|Overall Study|Protocol Violation|1|||
105428942|NCT04732949|363578316|FG000|Overall Study|Non-compliance|0|||
105428943|NCT04732949|363578317|FG001|Overall Study|Non-compliance|2|||
105428944|NCT04732949|363578316|FG000|Overall Study|Physician Decision|2|||
105428945|NCT04732949|363578317|FG001|Overall Study|Physician Decision|1|||
105428946|NCT04732949|363578316|FG000|Overall Study|Serious adverse event (Fatal)|16|||
105428947|NCT04732949|363578317|FG001|Overall Study|Serious adverse event (Fatal)|18|||
105428948|NCT04732949|363578316|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
105428949|NCT04732949|363578317|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
105428950|NCT04732949|363578316|FG000|Overall Study|Non-serious adverse event|1|||
105428951|NCT04732949|363578317|FG001|Overall Study|Non-serious adverse event|3|||
105428952|NCT04732949|363578316|FG000|Overall Study|Lost to Follow-up|26|||
105428953|NCT04732949|363578317|FG001|Overall Study|Lost to Follow-up|27|||
105428954|NCT04732949|363578316|FG000|Overall Study|Other|6|||
105428955|NCT04732949|363578317|FG001|Overall Study|Other|3|||
105428956|NCT00289198|363578323|FG000|Overall Study|Adverse Event|0|||
105428957|NCT00289198|363578324|FG001|Overall Study|Adverse Event|2|||
105428958|NCT00289198|363578323|FG000|Overall Study|Protocol Violation|2|||
105428959|NCT00289198|363578324|FG001|Overall Study|Protocol Violation|1|||
105428960|NCT00289198|363578323|FG000|Overall Study|Withdrawal by Subject|4|||
105428961|NCT00289198|363578324|FG001|Overall Study|Withdrawal by Subject|1|||
105501617|NCT01064310|363847170|FG000|Open Label Pazopinib|Adverse Event|0|||
105428962|NCT00289198|363578323|FG000|Overall Study|Lack of Efficacy|2|||
105428963|NCT00289198|363578324|FG001|Overall Study|Lack of Efficacy|0|||
105428964|NCT00289198|363578323|FG000|Overall Study|Other: Low compliance|0|||
105428965|NCT00289198|363578324|FG001|Overall Study|Other: Low compliance|1|||
105428966|NCT00289198|363578323|FG000|Overall Study|Other: Physician's decision|0|||
105428967|NCT00289198|363578324|FG001|Overall Study|Other: Physician's decision|1|||
105428968|NCT00289198|363578323|FG000|Overall Study|Other: Unable to attend on schedule|2|||
105428969|NCT00289198|363578324|FG001|Overall Study|Other: Unable to attend on schedule|1|||
105428970|NCT00289198|363578323|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
105428971|NCT00289198|363578324|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
105428972|NCT00289198|363578323|FG000|Overall Study|Other: Impossible to come on visit|0|||
105428973|NCT00289198|363578324|FG001|Overall Study|Other: Impossible to come on visit|1|||
105428974|NCT03602885|363578325|FG000|Overall Study|Lost to Follow-up|3|||
105428975|NCT03602885|363578326|FG001|Overall Study|Lost to Follow-up|0|||
105428976|NCT02559414|363578327|FG000|Overall Study|Lost to Follow-up|0|||
105428977|NCT02559414|363578328|FG001|Overall Study|Lost to Follow-up|1|||
105428978|NCT02559414|363578329|FG002|Overall Study|Lost to Follow-up|0|||
105428979|NCT02559414|363578327|FG000|Overall Study|Withdrawal by Subject|1|||
105428980|NCT02559414|363578328|FG001|Overall Study|Withdrawal by Subject|0|||
105428981|NCT02559414|363578329|FG002|Overall Study|Withdrawal by Subject|1|||
105428982|NCT02559414|363578327|FG000|Overall Study|Other|0|||
105428983|NCT02559414|363578328|FG001|Overall Study|Other|1|||
105428984|NCT02559414|363578329|FG002|Overall Study|Other|1|||
105428985|NCT03369431|363578332|FG000|Overall Study|Lost to Follow-up|1|||
105428986|NCT03369431|363578333|FG001|Overall Study|Lost to Follow-up|3|||
105428987|NCT03369431|363578332|FG000|Overall Study|Withdrawal by Subject|2|||
105428988|NCT03369431|363578333|FG001|Overall Study|Withdrawal by Subject|3|||
105428989|NCT03369431|363578332|FG000|Overall Study|Protocol Violation|1|||
105428990|NCT03369431|363578333|FG001|Overall Study|Protocol Violation|1|||
105589930|NCT00843193|364160688|FG000|Overall Study|Physician Decision|0|||
105428992|NCT05323656|363578343|FG000|Overall Study|Still On-Treatment|6|||
105428993|NCT05323656|363578344|FG001|Overall Study|Still On-Treatment|6|||
105428994|NCT05323656|363578343|FG000|Overall Study|Progressive Disease|15|||
105428995|NCT05323656|363578344|FG001|Overall Study|Progressive Disease|14|||
105428996|NCT05323656|363578343|FG000|Overall Study|Adverse Event|2|||
105428997|NCT05323656|363578344|FG001|Overall Study|Adverse Event|3|||
105428998|NCT05323656|363578343|FG000|Overall Study|Death|1|||
105428999|NCT05323656|363578344|FG001|Overall Study|Death|2|||
105429000|NCT05323656|363578343|FG000|Overall Study|Withdrawal by Subject|1|||
105429001|NCT05323656|363578344|FG001|Overall Study|Withdrawal by Subject|0|||
105429002|NCT05323656|363578343|FG000|Overall Study|Clinical disease progression|0|||
105429003|NCT05323656|363578344|FG001|Overall Study|Clinical disease progression|1|||
105429004|NCT05323656|363578343|FG000|Overall Study|Patient and Investigator decision|1|||
105429005|NCT05323656|363578344|FG001|Overall Study|Patient and Investigator decision|0|||
105429006|NCT05323656|363578343|FG000|Overall Study|Physician Decision|0|||
105429007|NCT05323656|363578344|FG001|Overall Study|Physician Decision|1|||
105429008|NCT02285114|363578347|FG000|Main Phase|Investigator's Discretion|0|||
105429009|NCT02285114|363578348|FG001|Main Phase|Investigator's Discretion|2|||
105429010|NCT02285114|363578349|FG002|Main Phase|Investigator's Discretion|0|||
105429011|NCT02285114|363578350|FG003|Main Phase|Investigator's Discretion|0|||
105429012|NCT02285114|363578351|FG004|Main Phase|Investigator's Discretion|0|||
105429013|NCT02285114|363578352|FG005|Main Phase|Investigator's Discretion|0|||
105429014|NCT02285114|363578347|FG000|Main Phase|Enrolled but Never Treated|1|||
105429015|NCT02285114|363578348|FG001|Main Phase|Enrolled but Never Treated|0|||
105429016|NCT02285114|363578349|FG002|Main Phase|Enrolled but Never Treated|0|||
105429017|NCT02285114|363578350|FG003|Main Phase|Enrolled but Never Treated|0|||
105429018|NCT02285114|363578351|FG004|Main Phase|Enrolled but Never Treated|0|||
105429019|NCT02285114|363578352|FG005|Main Phase|Enrolled but Never Treated|0|||
105429020|NCT02285114|363578347|FG000|Main Phase|Withdrew Consent|0|||
105429021|NCT02285114|363578348|FG001|Main Phase|Withdrew Consent|0|||
105429022|NCT02285114|363578349|FG002|Main Phase|Withdrew Consent|1|||
105429023|NCT02285114|363578350|FG003|Main Phase|Withdrew Consent|0|||
105429024|NCT02285114|363578351|FG004|Main Phase|Withdrew Consent|0|||
105429025|NCT02285114|363578352|FG005|Main Phase|Withdrew Consent|0|||
105429026|NCT02285114|363578347|FG000|Extension Phase|Investigator's Discretion|0|||
105429027|NCT02285114|363578348|FG001|Extension Phase|Investigator's Discretion|0|||
105501618|NCT01064310|363847171|FG001|Open Label Pazopinib|Adverse Event|0|||
105429028|NCT02285114|363578349|FG002|Extension Phase|Investigator's Discretion|0|||
105429029|NCT02285114|363578350|FG003|Extension Phase|Investigator's Discretion|14|||
105429030|NCT02285114|363578351|FG004|Extension Phase|Investigator's Discretion|1|||
105429031|NCT02285114|363578352|FG005|Extension Phase|Investigator's Discretion|0|||
105429032|NCT02285114|363578347|FG000|Extension Phase|Lost to Follow-up|0|||
105429033|NCT02285114|363578348|FG001|Extension Phase|Lost to Follow-up|0|||
105429034|NCT02285114|363578349|FG002|Extension Phase|Lost to Follow-up|0|||
105429035|NCT02285114|363578350|FG003|Extension Phase|Lost to Follow-up|1|||
105501619|NCT01064310|363847172|FG002|Open Label Pazopinib|Adverse Event|12|||
105429036|NCT02285114|363578351|FG004|Extension Phase|Lost to Follow-up|1|||
105429037|NCT02285114|363578352|FG005|Extension Phase|Lost to Follow-up|0|||
105429038|NCT02285114|363578347|FG000|Extension Phase|Non-compliance with Study Drug|0|||
105429039|NCT02285114|363578348|FG001|Extension Phase|Non-compliance with Study Drug|0|||
105429040|NCT02285114|363578349|FG002|Extension Phase|Non-compliance with Study Drug|0|||
105429041|NCT02285114|363578350|FG003|Extension Phase|Non-compliance with Study Drug|2|||
105429042|NCT02285114|363578351|FG004|Extension Phase|Non-compliance with Study Drug|0|||
105429043|NCT02285114|363578352|FG005|Extension Phase|Non-compliance with Study Drug|0|||
105429044|NCT02285114|363578347|FG000|Extension Phase|Pregnancy|0|||
105429045|NCT02285114|363578348|FG001|Extension Phase|Pregnancy|0|||
105429046|NCT02285114|363578349|FG002|Extension Phase|Pregnancy|0|||
105429047|NCT02285114|363578350|FG003|Extension Phase|Pregnancy|1|||
105429048|NCT02285114|363578351|FG004|Extension Phase|Pregnancy|0|||
105429049|NCT02285114|363578352|FG005|Extension Phase|Pregnancy|0|||
105429050|NCT02781792|363578358|FG000|Overall Study|Adverse Event|1|||
105429051|NCT02781792|363578359|FG001|Overall Study|Adverse Event|2|||
105429052|NCT02781792|363578358|FG000|Overall Study|Withdrawal by Subject|3|||
105429053|NCT02781792|363578359|FG001|Overall Study|Withdrawal by Subject|1|||
105429054|NCT02781792|363578358|FG000|Overall Study|Lack of Efficacy|1|||
105429055|NCT02781792|363578359|FG001|Overall Study|Lack of Efficacy|1|||
105429056|NCT02781792|363578358|FG000|Overall Study|Hospice|0|||
105429057|NCT02781792|363578359|FG001|Overall Study|Hospice|1|||
105429058|NCT02838420|363578360|FG000|Overall Study|Ongoing in Study|113|||
105429059|NCT02838420|363578361|FG001|Overall Study|Ongoing in Study|45|||
105429060|NCT02838420|363578360|FG000|Overall Study|Lost to Follow-up|1|||
105429061|NCT02838420|363578361|FG001|Overall Study|Lost to Follow-up|0|||
105429062|NCT02838420|363578360|FG000|Overall Study|Withdrawal by Subject|3|||
105429063|NCT02838420|363578361|FG001|Overall Study|Withdrawal by Subject|4|||
105429064|NCT02838420|363578360|FG000|Overall Study|Death|8|||
105429065|NCT02838420|363578361|FG001|Overall Study|Death|13|||
105429066|NCT03554772|363578362|FG000|Overall Study|Lost to Follow-up|0|||
105429067|NCT03554772|363578363|FG001|Overall Study|Lost to Follow-up|0|||
105429068|NCT03554772|363578364|FG002|Overall Study|Lost to Follow-up|0|||
105429069|NCT03554772|363578365|FG003|Overall Study|Lost to Follow-up|2|||
105429070|NCT05136898|363578366|FG000|Overall Study|Adverse Event|2|||
105429071|NCT00520013|363578367|FG000|Overall Study|Withdrawal by Subject|0|||
105429072|NCT00520013|363578368|FG001|Overall Study|Withdrawal by Subject|0|||
105429073|NCT00520013|363578369|FG002|Overall Study|Withdrawal by Subject|1|||
105429074|NCT00520013|363578367|FG000|Overall Study|Adverse Event|2|||
105429075|NCT00520013|363578368|FG001|Overall Study|Adverse Event|10|||
105429076|NCT00520013|363578369|FG002|Overall Study|Adverse Event|7|||
105429077|NCT00520013|363578367|FG000|Overall Study|Progressive Disease|7|||
105429078|NCT00520013|363578368|FG001|Overall Study|Progressive Disease|3|||
105429079|NCT00520013|363578369|FG002|Overall Study|Progressive Disease|0|||
105429080|NCT00520013|363578367|FG000|Overall Study|Clinical Progression|3|||
105429081|NCT00520013|363578368|FG001|Overall Study|Clinical Progression|1|||
105429082|NCT00520013|363578369|FG002|Overall Study|Clinical Progression|0|||
105429083|NCT00520013|363578367|FG000|Overall Study|Death|0|||
105429084|NCT00520013|363578368|FG001|Overall Study|Death|1|||
105429085|NCT00520013|363578369|FG002|Overall Study|Death|0|||
105429086|NCT00520013|363578367|FG000|Overall Study|Physician Decision|0|||
105429087|NCT00520013|363578368|FG001|Overall Study|Physician Decision|0|||
105429088|NCT00520013|363578369|FG002|Overall Study|Physician Decision|3|||
105429089|NCT02969590|363578370|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
105429090|NCT02969590|363578371|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
105429091|NCT02969590|363578372|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
105429092|NCT00186537|363578373|FG000|Overall Study|Withdrawal by Subject|4|||
105429093|NCT00186537|363578374|FG001|Overall Study|Withdrawal by Subject|0|||
105429094|NCT00186537|363578375|FG002|Overall Study|Withdrawal by Subject|3|||
105429095|NCT00186537|363578373|FG000|Overall Study|ALT > 1.5 x ULN|3|||
105429096|NCT00186537|363578374|FG001|Overall Study|ALT > 1.5 x ULN|0|||
105429097|NCT00186537|363578375|FG002|Overall Study|ALT > 1.5 x ULN|0|||
105429098|NCT03684304|363578376|FG000|Overall Study|Lost to Follow-up|19|||
105429099|NCT03684304|363578377|FG001|Overall Study|Lost to Follow-up|17|||
105429100|NCT00824005|363578378|FG000|Overall Study|Death|0|||
105429101|NCT00824005|363578379|FG001|Overall Study|Death|1|||
105429102|NCT00824005|363578378|FG000|Overall Study|Lost to Follow-up|0|||
105429103|NCT00824005|363578379|FG001|Overall Study|Lost to Follow-up|1|||
105429104|NCT00431951|363578380|FG000|Overall Study|Inability to follow study procedures|1|||
105429105|NCT00431951|363578381|FG001|Overall Study|Inability to follow study procedures|0|||
105429106|NCT00431951|363578382|FG002|Overall Study|Inability to follow study procedures|1|||
105429107|NCT00431951|363578383|FG003|Overall Study|Inability to follow study procedures|2|||
105429108|NCT00431951|363578380|FG000|Overall Study|Lost to Follow-up|0|||
105429109|NCT00431951|363578381|FG001|Overall Study|Lost to Follow-up|1|||
105429110|NCT00431951|363578382|FG002|Overall Study|Lost to Follow-up|0|||
105429111|NCT00431951|363578383|FG003|Overall Study|Lost to Follow-up|0|||
105429112|NCT00431951|363578380|FG000|Overall Study|Withdrawal by Subject|0|||
105429113|NCT00431951|363578381|FG001|Overall Study|Withdrawal by Subject|1|||
105429114|NCT00431951|363578382|FG002|Overall Study|Withdrawal by Subject|0|||
105429115|NCT00431951|363578383|FG003|Overall Study|Withdrawal by Subject|0|||
105429116|NCT00431951|363578380|FG000|Overall Study|Adverse Event|0|||
105429117|NCT00431951|363578381|FG001|Overall Study|Adverse Event|0|||
105429118|NCT00431951|363578382|FG002|Overall Study|Adverse Event|1|||
105429119|NCT00431951|363578383|FG003|Overall Study|Adverse Event|0|||
105429120|NCT01143051|363578385|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
105429121|NCT01143051|363578386|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
105429122|NCT01143051|363578387|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
105429123|NCT01143051|363578388|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
105429124|NCT01143051|363578389|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
105429125|NCT01143051|363578390|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
105429126|NCT01143051|363578385|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
105429127|NCT01143051|363578386|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
105429128|NCT01143051|363578387|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
105429129|NCT01143051|363578388|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
105429130|NCT01143051|363578389|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
105429131|NCT01143051|363578390|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
105429132|NCT03458702|363578391|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
105429133|NCT03458702|363578392|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
105429134|NCT03458702|363578391|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
105429135|NCT03458702|363578392|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
105429136|NCT01484834|363578393|FG000|Overall Study|Lost to Follow-up|5|||
105429137|NCT01484834|363578394|FG001|Overall Study|Lost to Follow-up|8|||
105429138|NCT01484834|363578395|FG002|Overall Study|Lost to Follow-up|1|||
105429139|NCT01484834|363578396|FG003|Overall Study|Lost to Follow-up|4|||
105429140|NCT03532932|363578397|FG000|Overall Study|Protocol Deviation|33|||
105429141|NCT03532932|363578398|FG001|Overall Study|Protocol Deviation|31|||
105429142|NCT03532932|363578397|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
105429143|NCT03532932|363578398|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
105429144|NCT03532932|363578397|FG000|Overall Study|Withdrawal by Subject|2|||
105429145|NCT03532932|363578398|FG001|Overall Study|Withdrawal by Subject|0|||
105429146|NCT03532932|363578397|FG000|Overall Study|Lost to Follow-up|15|||
105429147|NCT03532932|363578398|FG001|Overall Study|Lost to Follow-up|9|||
105429148|NCT03532932|363578397|FG000|Overall Study|Adverse Event|4|||
105429149|NCT03532932|363578398|FG001|Overall Study|Adverse Event|3|||
105429150|NCT03532932|363578397|FG000|Overall Study|Death|0|||
105429151|NCT03532932|363578398|FG001|Overall Study|Death|2|||
105429152|NCT03532932|363578397|FG000|Overall Study|Other|11|||
105429153|NCT03532932|363578398|FG001|Overall Study|Other|16|||
105429154|NCT00096018|363578401|FG000|Overall Study|Became Ineligible (not treated)|0|||
105429155|NCT00096018|363578402|FG001|Overall Study|Became Ineligible (not treated)|3|||
105429156|NCT00096018|363578401|FG000|Overall Study|Miscellaneous (not treated)|0|||
105429157|NCT00096018|363578402|FG001|Overall Study|Miscellaneous (not treated)|2|||
105429158|NCT00096018|363578401|FG000|Overall Study|Adverse Event|0|||
105429159|NCT00096018|363578402|FG001|Overall Study|Adverse Event|5|||
105429160|NCT00096018|363578401|FG000|Overall Study|Death|0|||
105429161|NCT00096018|363578402|FG001|Overall Study|Death|1|||
105429162|NCT00096018|363578401|FG000|Overall Study|Withdrawal by Subject|0|||
105429163|NCT00096018|363578402|FG001|Overall Study|Withdrawal by Subject|2|||
105429164|NCT00096018|363578401|FG000|Overall Study|Miscellaneous|2|||
105429165|NCT00096018|363578402|FG001|Overall Study|Miscellaneous|1|||
105429166|NCT03968159|363578406|FG000|Overall Study|Adverse Event|4|||
105429167|NCT03968159|363578407|FG001|Overall Study|Adverse Event|4|||
105429168|NCT03968159|363578406|FG000|Overall Study|Lost to Follow-up|1|||
105429169|NCT03968159|363578407|FG001|Overall Study|Lost to Follow-up|1|||
105429170|NCT03968159|363578406|FG000|Overall Study|Use of prohibited medication|0|||
105429171|NCT03968159|363578407|FG001|Overall Study|Use of prohibited medication|1|||
105429172|NCT03968159|363578406|FG000|Overall Study|Protocol Violation|2|||
105429173|NCT03968159|363578407|FG001|Overall Study|Protocol Violation|2|||
105429174|NCT03968159|363578406|FG000|Overall Study|Withdrawal by Subject|4|||
105429175|NCT03968159|363578407|FG001|Overall Study|Withdrawal by Subject|6|||
105429176|NCT03968159|363578406|FG000|Overall Study|Lack of Efficacy|0|||
105429177|NCT03968159|363578407|FG001|Overall Study|Lack of Efficacy|1|||
105501620|NCT01064310|363847170|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
105501621|NCT01064310|363847171|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
105429178|NCT03968159|363578406|FG000|Overall Study|Not further specified|2|||
105429179|NCT03968159|363578407|FG001|Overall Study|Not further specified|0|||
105429180|NCT01635764|363578408|FG000|Overall Study|Adverse Event|46|||
105429181|NCT01635764|363578408|FG000|Overall Study|Lack of Efficacy|76|||
105429182|NCT01635764|363578408|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
105429183|NCT01635764|363578408|FG000|Overall Study|Protocol Deviation|1|||
105429184|NCT01635764|363578408|FG000|Overall Study|Withdrew Consent|67|||
105429185|NCT01635764|363578408|FG000|Overall Study|Lost to Follow-up|53|||
105429186|NCT01635764|363578408|FG000|Overall Study|Other|28|||
105429187|NCT02689076|363578409|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
105429188|NCT02689076|363578410|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
105429189|NCT02689076|363578411|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
105429190|NCT02689076|363578409|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
105429191|NCT02689076|363578410|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
105429192|NCT02689076|363578411|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
105429193|NCT02689076|363578409|FG000|Overall Study|Did not have an HIE match|2|||
105429194|NCT02689076|363578410|FG001|Overall Study|Did not have an HIE match|0|||
105429195|NCT02689076|363578411|FG002|Overall Study|Did not have an HIE match|0|||
105429196|NCT02689076|363578409|FG000|Overall Study|Death during non-VA encounter|2|||
105429197|NCT02689076|363578410|FG001|Overall Study|Death during non-VA encounter|5|||
105429198|NCT02689076|363578411|FG002|Overall Study|Death during non-VA encounter|0|||
105429199|NCT02689076|363578409|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
105429200|NCT02689076|363578410|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
105429201|NCT02689076|363578411|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
105429202|NCT02689076|363578409|FG000|Overall Study|Participant no longer active in VA system|1|||
105429203|NCT02689076|363578410|FG001|Overall Study|Participant no longer active in VA system|0|||
105429204|NCT02689076|363578411|FG002|Overall Study|Participant no longer active in VA system|0|||
105429205|NCT02689076|363578409|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
105429206|NCT02689076|363578410|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
105429207|NCT02689076|363578411|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
105429208|NCT00933244|363578412|FG000|Overall Study|Withdrawal by Subject|5|||
105429209|NCT00933244|363578413|FG001|Overall Study|Withdrawal by Subject|1|||
105429210|NCT00933244|363578414|FG002|Overall Study|Withdrawal by Subject|3|||
105429211|NCT02956850|363578415|FG000|Overall Study|Withdrawal by Subject|0|||
105429212|NCT02956850|363578416|FG001|Overall Study|Withdrawal by Subject|0|||
105429213|NCT02956850|363578417|FG002|Overall Study|Withdrawal by Subject|0|||
105429214|NCT02956850|363578418|FG003|Overall Study|Withdrawal by Subject|0|||
105429215|NCT02956850|363578419|FG004|Overall Study|Withdrawal by Subject|0|||
105429216|NCT02956850|363578420|FG005|Overall Study|Withdrawal by Subject|0|||
105429217|NCT02956850|363578421|FG006|Overall Study|Withdrawal by Subject|0|||
105429218|NCT02956850|363578422|FG007|Overall Study|Withdrawal by Subject|0|||
105429219|NCT02956850|363578423|FG008|Overall Study|Withdrawal by Subject|0|||
105429220|NCT02956850|363578424|FG009|Overall Study|Withdrawal by Subject|0|||
105429221|NCT02956850|363578425|FG010|Overall Study|Withdrawal by Subject|0|||
105429222|NCT02956850|363578426|FG011|Overall Study|Withdrawal by Subject|0|||
105429223|NCT02956850|363578427|FG012|Overall Study|Withdrawal by Subject|0|||
105429224|NCT02956850|363578428|FG013|Overall Study|Withdrawal by Subject|0|||
105429225|NCT02956850|363578429|FG014|Overall Study|Withdrawal by Subject|0|||
105429226|NCT02956850|363578430|FG015|Overall Study|Withdrawal by Subject|0|||
105429227|NCT02956850|363578431|FG016|Overall Study|Withdrawal by Subject|0|||
105429228|NCT02956850|363578432|FG017|Overall Study|Withdrawal by Subject|1|||
105429229|NCT00391391|363578433|FG000|Overall Study|Adverse Event|0|||
105429230|NCT00391391|363578434|FG001|Overall Study|Adverse Event|0|||
105429231|NCT00391391|363578435|FG002|Overall Study|Adverse Event|0|||
105429232|NCT00391391|363578436|FG003|Overall Study|Adverse Event|1|||
105429233|NCT00391391|363578433|FG000|Overall Study|Lost to Follow-up|1|||
105429234|NCT00391391|363578434|FG001|Overall Study|Lost to Follow-up|3|||
105429235|NCT00391391|363578435|FG002|Overall Study|Lost to Follow-up|7|||
105429236|NCT00391391|363578436|FG003|Overall Study|Lost to Follow-up|4|||
105429237|NCT00391391|363578433|FG000|Overall Study|Protocol Violation|2|||
105429238|NCT00391391|363578434|FG001|Overall Study|Protocol Violation|3|||
105429239|NCT00391391|363578435|FG002|Overall Study|Protocol Violation|6|||
105429240|NCT00391391|363578436|FG003|Overall Study|Protocol Violation|7|||
105429241|NCT00391391|363578433|FG000|Overall Study|Withdrawal by Subject|6|||
105429242|NCT00391391|363578434|FG001|Overall Study|Withdrawal by Subject|4|||
105429243|NCT00391391|363578435|FG002|Overall Study|Withdrawal by Subject|10|||
105429244|NCT00391391|363578436|FG003|Overall Study|Withdrawal by Subject|7|||
105429245|NCT02084238|363578437|FG000|Overall Study|Lost to Follow-up|2|||
105429246|NCT00693472|363578438|FG000|Part 1|Adverse Event|1|||
105429247|NCT00693472|363578439|FG001|Part 1|Adverse Event|1|||
105429248|NCT00693472|363578440|FG002|Part 1|Adverse Event|0|||
105429249|NCT00693472|363578441|FG003|Part 1|Adverse Event|0|||
105429250|NCT00693472|363578438|FG000|Part 1|Lost to Follow-up|0|||
105429251|NCT00693472|363578439|FG001|Part 1|Lost to Follow-up|1|||
105429252|NCT00693472|363578440|FG002|Part 1|Lost to Follow-up|0|||
105429253|NCT00693472|363578441|FG003|Part 1|Lost to Follow-up|0|||
105429254|NCT00693472|363578438|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
105429255|NCT00693472|363578439|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
105429256|NCT00693472|363578440|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
105429257|NCT00693472|363578441|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
105429258|NCT00693472|363578438|FG000|Part 2|Adverse Event|0|||
105429259|NCT00693472|363578439|FG001|Part 2|Adverse Event|0|||
105429260|NCT00693472|363578440|FG002|Part 2|Adverse Event|1|||
105589931|NCT00843193|364160689|FG001|Overall Study|Physician Decision|1|||
105429261|NCT00693472|363578441|FG003|Part 2|Adverse Event|0|||
105429262|NCT00693472|363578438|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
105429263|NCT00693472|363578439|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
105429264|NCT00693472|363578440|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
105429265|NCT00693472|363578441|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
105429266|NCT00353873|363578442|FG000|Overall Study|Protocol Violation|1|||
105429267|NCT00353873|363578443|FG001|Overall Study|Protocol Violation|2|||
105429268|NCT00353873|363578442|FG000|Overall Study|Exacerbation|1|||
105429269|NCT00353873|363578443|FG001|Overall Study|Exacerbation|0|||
105429270|NCT00353873|363578442|FG000|Overall Study|Adverse Event|1|||
105429271|NCT00353873|363578443|FG001|Overall Study|Adverse Event|0|||
105429272|NCT00353873|363578442|FG000|Overall Study|Physician Decision|2|||
105429273|NCT00353873|363578443|FG001|Overall Study|Physician Decision|0|||
105429274|NCT00353873|363578442|FG000|Overall Study|Withdrawal by Subject|1|||
105429275|NCT00353873|363578443|FG001|Overall Study|Withdrawal by Subject|1|||
105429276|NCT00837876|363578445|FG000|Overall Study|Death|2|||
105429277|NCT00837876|363578445|FG000|Overall Study|Adverse Event|7|||
105429278|NCT00837876|363578445|FG000|Overall Study|Physician Decision|1|||
105429279|NCT00837876|363578445|FG000|Overall Study|Withdrawal by Subject|3|||
105429280|NCT00837876|363578445|FG000|Overall Study|disease progression|24|||
105429281|NCT00453973|363578447|FG000|Overall Study|Adverse Event|4|||
105429282|NCT00453973|363578448|FG001|Overall Study|Adverse Event|9|||
105429283|NCT00453973|363578447|FG000|Overall Study|Withdrawal by Subject|7|||
105429284|NCT00453973|363578448|FG001|Overall Study|Withdrawal by Subject|6|||
105429285|NCT00453973|363578447|FG000|Overall Study|PI Decision|0|||
105429286|NCT00453973|363578448|FG001|Overall Study|PI Decision|2|||
105429287|NCT00453973|363578447|FG000|Overall Study|Relocation|1|||
105429288|NCT00453973|363578448|FG001|Overall Study|Relocation|0|||
105429289|NCT00453973|363578447|FG000|Overall Study|Renal transplant|1|||
105429290|NCT00453973|363578448|FG001|Overall Study|Renal transplant|1|||
105429291|NCT00453973|363578447|FG000|Overall Study|Site closed by sponsor|3|||
105429292|NCT00453973|363578448|FG001|Overall Study|Site closed by sponsor|0|||
105429293|NCT00453973|363578447|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
105429294|NCT00453973|363578448|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
105429295|NCT00276094|363578449|FG000|Overall Study|Adverse Event|15|||
105429296|NCT00276094|363578450|FG001|Overall Study|Adverse Event|13|||
105429297|NCT00276094|363578451|FG002|Overall Study|Adverse Event|11|||
105429298|NCT00276094|363578449|FG000|Overall Study|Withdrawal by Subject|14|||
105429299|NCT00276094|363578450|FG001|Overall Study|Withdrawal by Subject|14|||
105429300|NCT00276094|363578451|FG002|Overall Study|Withdrawal by Subject|12|||
105429301|NCT00276094|363578449|FG000|Overall Study|Protocol Violation|16|||
105429302|NCT00276094|363578450|FG001|Overall Study|Protocol Violation|7|||
105429303|NCT00276094|363578451|FG002|Overall Study|Protocol Violation|10|||
105429304|NCT00276094|363578449|FG000|Overall Study|Lost to Follow-up|8|||
105429305|NCT00276094|363578450|FG001|Overall Study|Lost to Follow-up|6|||
105429306|NCT00276094|363578451|FG002|Overall Study|Lost to Follow-up|4|||
105429307|NCT00276094|363578449|FG000|Overall Study|Other-Subject moved out of country|1|||
105429308|NCT00276094|363578450|FG001|Overall Study|Other-Subject moved out of country|0|||
105429309|NCT00276094|363578451|FG002|Overall Study|Other-Subject moved out of country|0|||
105429310|NCT00276094|363578449|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
105429311|NCT00276094|363578450|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
105429312|NCT00276094|363578451|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
105429313|NCT00276094|363578449|FG000|Overall Study|Other-Lack of efficacy|1|||
105429314|NCT00276094|363578450|FG001|Overall Study|Other-Lack of efficacy|0|||
105429315|NCT00276094|363578451|FG002|Overall Study|Other-Lack of efficacy|0|||
105429316|NCT00276094|363578449|FG000|Overall Study|Other-Refused follow-up visit|1|||
105429317|NCT00276094|363578450|FG001|Overall Study|Other-Refused follow-up visit|0|||
105429318|NCT00276094|363578451|FG002|Overall Study|Other-Refused follow-up visit|0|||
105429319|NCT00276094|363578449|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
105429320|NCT00276094|363578450|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
105429321|NCT00276094|363578451|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
105429322|NCT00276094|363578449|FG000|Overall Study|Other-Relocation|0|||
105429323|NCT00276094|363578450|FG001|Overall Study|Other-Relocation|1|||
105429324|NCT00276094|363578451|FG002|Overall Study|Other-Relocation|0|||
105429325|NCT00276094|363578449|FG000|Overall Study|Other-Study medication lost|0|||
105429326|NCT00276094|363578450|FG001|Overall Study|Other-Study medication lost|0|||
105589932|NCT00843193|364160688|FG000|Overall Study|Withdrawal by Subject|3|||
105589933|NCT00843193|364160689|FG001|Overall Study|Withdrawal by Subject|3|||
105589934|NCT04511650|364160690|FG000|Overall Study|Lost to Follow-up|1|||
105589935|NCT04511650|364160691|FG001|Overall Study|Lost to Follow-up|0|||
105429327|NCT00276094|363578451|FG002|Overall Study|Other-Study medication lost|1|||
105429328|NCT00530920|363578454|FG000|Overall Study|Randomized but not treated|0|||
105429329|NCT00530920|363578455|FG001|Overall Study|Randomized but not treated|2|||
105429330|NCT00530920|363578456|FG002|Overall Study|Randomized but not treated|0|||
105429331|NCT00530920|363578454|FG000|Overall Study|Adverse Event|0|||
105429332|NCT00530920|363578455|FG001|Overall Study|Adverse Event|0|||
105429333|NCT00530920|363578456|FG002|Overall Study|Adverse Event|3|||
105429334|NCT00530920|363578454|FG000|Overall Study|Withdrawal by Subject|0|||
105429335|NCT00530920|363578455|FG001|Overall Study|Withdrawal by Subject|0|||
105429336|NCT00530920|363578456|FG002|Overall Study|Withdrawal by Subject|1|||
105429337|NCT00685373|363578457|FG000|Overall Study|Adverse Event|3|||
105429338|NCT00685373|363578457|FG000|Overall Study|Withdrawal by Subject|5|||
105429339|NCT00685373|363578457|FG000|Overall Study|Lack of Efficacy|3|||
105429340|NCT00685373|363578457|FG000|Overall Study|Condition no longer requires study drug|1|||
105429341|NCT00685373|363578457|FG000|Overall Study|Lost to Follow-up|2|||
105429342|NCT00685373|363578457|FG000|Overall Study|Protocol Violation|1|||
105429343|NCT03461406|363578460|FG000|Overall Study|Death|1|||
105429344|NCT03461406|363578461|FG001|Overall Study|Death|2|||
105429345|NCT03461406|363578460|FG000|Overall Study|Consent Withdrawn by Participant|0|||
105429346|NCT03461406|363578461|FG001|Overall Study|Consent Withdrawn by Participant|1|||
105429347|NCT03461406|363578460|FG000|Overall Study|Screen Failure|3|||
105429348|NCT03461406|363578461|FG001|Overall Study|Screen Failure|1|||
105429349|NCT03461406|363578460|FG000|Overall Study|Reason not Specified|1|||
105429350|NCT03461406|363578461|FG001|Overall Study|Reason not Specified|3|||
105429351|NCT03461406|363578460|FG000|Overall Study|Lost to Follow-up|3|||
105429352|NCT03461406|363578461|FG001|Overall Study|Lost to Follow-up|0|||
105429353|NCT00525824|363578473|FG000|Overall Study|Adverse Event|7|||
105429354|NCT00525824|363578474|FG001|Overall Study|Adverse Event|11|||
105429355|NCT00525824|363578475|FG002|Overall Study|Adverse Event|6|||
105429356|NCT00525824|363578476|FG003|Overall Study|Adverse Event|7|||
105429357|NCT00525824|363578473|FG000|Overall Study|Withdrawal by Subject|5|||
105429358|NCT00525824|363578474|FG001|Overall Study|Withdrawal by Subject|9|||
105429359|NCT00525824|363578475|FG002|Overall Study|Withdrawal by Subject|3|||
105429360|NCT00525824|363578476|FG003|Overall Study|Withdrawal by Subject|4|||
105429361|NCT00525824|363578473|FG000|Overall Study|Lost to Follow-up|4|||
105429362|NCT00525824|363578474|FG001|Overall Study|Lost to Follow-up|2|||
105429363|NCT00525824|363578475|FG002|Overall Study|Lost to Follow-up|4|||
105429364|NCT00525824|363578476|FG003|Overall Study|Lost to Follow-up|0|||
105429365|NCT00525824|363578473|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
105429366|NCT00525824|363578474|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
105429367|NCT00525824|363578475|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
105429368|NCT00525824|363578476|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
105429369|NCT00525824|363578473|FG000|Overall Study|Severe non-compliance|0|||
105429370|NCT00525824|363578474|FG001|Overall Study|Severe non-compliance|1|||
105429371|NCT00525824|363578475|FG002|Overall Study|Severe non-compliance|1|||
105429372|NCT00525824|363578476|FG003|Overall Study|Severe non-compliance|1|||
105429373|NCT00525824|363578473|FG000|Overall Study|Safety reasons|1|||
105429374|NCT00525824|363578474|FG001|Overall Study|Safety reasons|0|||
105429375|NCT00525824|363578475|FG002|Overall Study|Safety reasons|1|||
105429376|NCT00525824|363578476|FG003|Overall Study|Safety reasons|0|||
105429377|NCT00525824|363578473|FG000|Overall Study|Other|1|||
105429378|NCT00525824|363578474|FG001|Overall Study|Other|3|||
105429379|NCT00525824|363578475|FG002|Overall Study|Other|3|||
105429380|NCT00525824|363578476|FG003|Overall Study|Other|1|||
105429381|NCT02621073|363578490|FG000|Overall Study|Lost to Follow-up|0|||
105429382|NCT02621073|363578491|FG001|Overall Study|Lost to Follow-up|1|||
105429383|NCT02621073|363578490|FG000|Overall Study|Physician Decision|3|||
105429384|NCT02621073|363578491|FG001|Overall Study|Physician Decision|2|||
105429385|NCT00151372|363579774|FG000|Overall Study|Death|12|||
105429386|NCT00151372|363579775|FG001|Overall Study|Death|11|||
105429387|NCT00151372|363579774|FG000|Overall Study|Lost to Follow-up|5|||
105429388|NCT00151372|363579775|FG001|Overall Study|Lost to Follow-up|5|||
105429389|NCT00151372|363579774|FG000|Overall Study|Too sick medically to continue|5|||
105429390|NCT00151372|363579775|FG001|Overall Study|Too sick medically to continue|6|||
105429391|NCT00151372|363579774|FG000|Overall Study|Withdrawal by Subject|7|||
105429392|NCT00151372|363579775|FG001|Overall Study|Withdrawal by Subject|7|||
105429393|NCT03320330|363579776|FG000|Overall Study|Lack of Efficacy|5|||
105429394|NCT03320330|363579777|FG001|Overall Study|Lack of Efficacy|5|||
105429395|NCT03320330|363579778|FG002|Overall Study|Lack of Efficacy|14|||
105429396|NCT03320330|363579776|FG000|Overall Study|Physician Decision|1|||
105429397|NCT03320330|363579777|FG001|Overall Study|Physician Decision|0|||
105429398|NCT03320330|363579778|FG002|Overall Study|Physician Decision|0|||
105429399|NCT03204890|363579780|FG000|Overall Study|Withdrawal by Subject|1|||
105429400|NCT03710876|363579781|FG000|Overall Study|Death|0|||
105429401|NCT03710876|363579782|FG001|Overall Study|Death|2|||
105429402|NCT03710876|363579781|FG000|Overall Study|Withdrawal by Subject|0|||
105429403|NCT03710876|363579782|FG001|Overall Study|Withdrawal by Subject|2|||
105429404|NCT03747120|363579785|FG000|Overall Study|treatment related toxicity|3|||
105429405|NCT03747120|363579786|FG001|Overall Study|treatment related toxicity|0|||
105429406|NCT03747120|363579787|FG002|Overall Study|treatment related toxicity|0|||
105429407|NCT03747120|363579785|FG000|Overall Study|Withdrawal by Subject|0|||
105429408|NCT03747120|363579786|FG001|Overall Study|Withdrawal by Subject|1|||
105429409|NCT03747120|363579787|FG002|Overall Study|Withdrawal by Subject|2|||
105429410|NCT01596335|363579788|FG000|Overall Study|exacerbation of primary disease|5|||
105429411|NCT01596335|363579789|FG001|Overall Study|exacerbation of primary disease|9|||
105429412|NCT00996801|363579790|FG000|Overall Study|Adverse Event|6|||
105429413|NCT00996801|363579791|FG001|Overall Study|Adverse Event|4|||
105429414|NCT00996801|363579792|FG002|Overall Study|Adverse Event|12|||
105429415|NCT00996801|363579793|FG003|Overall Study|Adverse Event|17|||
105429416|NCT00996801|363579794|FG004|Overall Study|Adverse Event|31|||
105429417|NCT00996801|363579795|FG005|Overall Study|Adverse Event|3|||
105429418|NCT00996801|363579790|FG000|Overall Study|Lack of Efficacy|3|||
105429419|NCT00996801|363579791|FG001|Overall Study|Lack of Efficacy|0|||
105429420|NCT00996801|363579792|FG002|Overall Study|Lack of Efficacy|1|||
105429421|NCT00996801|363579793|FG003|Overall Study|Lack of Efficacy|3|||
105429422|NCT00996801|363579794|FG004|Overall Study|Lack of Efficacy|0|||
105429423|NCT00996801|363579795|FG005|Overall Study|Lack of Efficacy|1|||
105429424|NCT00996801|363579790|FG000|Overall Study|Lost to Follow-up|0|||
105429425|NCT00996801|363579791|FG001|Overall Study|Lost to Follow-up|0|||
105429426|NCT00996801|363579792|FG002|Overall Study|Lost to Follow-up|0|||
105429427|NCT00996801|363579793|FG003|Overall Study|Lost to Follow-up|3|||
105429428|NCT00996801|363579794|FG004|Overall Study|Lost to Follow-up|3|||
105429429|NCT00996801|363579795|FG005|Overall Study|Lost to Follow-up|2|||
105429430|NCT00996801|363579790|FG000|Overall Study|Physician Decision|0|||
105429431|NCT00996801|363579791|FG001|Overall Study|Physician Decision|0|||
105429432|NCT00996801|363579792|FG002|Overall Study|Physician Decision|0|||
105429433|NCT00996801|363579793|FG003|Overall Study|Physician Decision|1|||
105429434|NCT00996801|363579794|FG004|Overall Study|Physician Decision|0|||
105429435|NCT00996801|363579795|FG005|Overall Study|Physician Decision|0|||
105429436|NCT00996801|363579790|FG000|Overall Study|Progressive Disease|0|||
105429437|NCT00996801|363579791|FG001|Overall Study|Progressive Disease|1|||
105429438|NCT00996801|363579792|FG002|Overall Study|Progressive Disease|0|||
105429439|NCT00996801|363579793|FG003|Overall Study|Progressive Disease|0|||
105429440|NCT00996801|363579794|FG004|Overall Study|Progressive Disease|0|||
105429441|NCT00996801|363579795|FG005|Overall Study|Progressive Disease|0|||
105429442|NCT00996801|363579790|FG000|Overall Study|Protocol Violation|3|||
105429443|NCT00996801|363579791|FG001|Overall Study|Protocol Violation|4|||
105429444|NCT00996801|363579792|FG002|Overall Study|Protocol Violation|1|||
105429445|NCT00996801|363579793|FG003|Overall Study|Protocol Violation|2|||
105429446|NCT00996801|363579794|FG004|Overall Study|Protocol Violation|3|||
105429447|NCT00996801|363579795|FG005|Overall Study|Protocol Violation|4|||
105429448|NCT00996801|363579790|FG000|Overall Study|Study Terminated by Sponsor|0|||
105429449|NCT00996801|363579791|FG001|Overall Study|Study Terminated by Sponsor|1|||
105429450|NCT00996801|363579792|FG002|Overall Study|Study Terminated by Sponsor|0|||
105429451|NCT00996801|363579793|FG003|Overall Study|Study Terminated by Sponsor|0|||
105429452|NCT00996801|363579794|FG004|Overall Study|Study Terminated by Sponsor|46|||
105429453|NCT00996801|363579795|FG005|Overall Study|Study Terminated by Sponsor|0|||
105429454|NCT00996801|363579790|FG000|Overall Study|Withdrawal by Subject|8|||
105429455|NCT00996801|363579791|FG001|Overall Study|Withdrawal by Subject|6|||
105429456|NCT00996801|363579792|FG002|Overall Study|Withdrawal by Subject|9|||
105429457|NCT00996801|363579793|FG003|Overall Study|Withdrawal by Subject|5|||
105429458|NCT00996801|363579794|FG004|Overall Study|Withdrawal by Subject|5|||
105429459|NCT00996801|363579795|FG005|Overall Study|Withdrawal by Subject|9|||
105429460|NCT01688739|363579796|FG000|Overall Study|Administrative Decision|1|||
105429461|NCT01688739|363579797|FG001|Overall Study|Administrative Decision|0|||
105429462|NCT01688739|363579798|FG002|Overall Study|Administrative Decision|0|||
105429463|NCT01688739|363579799|FG003|Overall Study|Administrative Decision|0|||
105429464|NCT01688739|363579800|FG004|Overall Study|Administrative Decision|0|||
105429465|NCT01688739|363579801|FG005|Overall Study|Administrative Decision|0|||
105429466|NCT01688739|363579802|FG006|Overall Study|Administrative Decision|0|||
105429467|NCT01688739|363579803|FG007|Overall Study|Administrative Decision|0|||
105429468|NCT01688739|363579804|FG008|Overall Study|Administrative Decision|0|||
105429469|NCT01688739|363579805|FG009|Overall Study|Administrative Decision|0|||
105429470|NCT01062061|363579806|FG000|Overall Study|Enrolled more than once|2|||
105429471|NCT01062061|363579806|FG000|Overall Study|Investigated before study start|13|||
105429472|NCT01062061|363579806|FG000|Overall Study|Outside chief indications|10|||
105429473|NCT01062061|363579806|FG000|Overall Study|Failed to meet inclusion criteria|2|||
105429474|NCT04191499|363579807|FG000|Overall Study|Adverse Event|1|||
105429475|NCT04191499|363579808|FG001|Overall Study|Adverse Event|0|||
105429476|NCT04191499|363579807|FG000|Overall Study|Death|42|||
105429477|NCT04191499|363579808|FG001|Overall Study|Death|55|||
105429478|NCT04191499|363579807|FG000|Overall Study|Lost to Follow-up|4|||
105429479|NCT04191499|363579808|FG001|Overall Study|Lost to Follow-up|1|||
105429480|NCT04191499|363579807|FG000|Overall Study|Physician Decision|1|||
105429481|NCT04191499|363579808|FG001|Overall Study|Physician Decision|0|||
105429482|NCT04191499|363579807|FG000|Overall Study|Progressive Disease|1|||
105429483|NCT04191499|363579808|FG001|Overall Study|Progressive Disease|0|||
105429484|NCT04191499|363579807|FG000|Overall Study|Symptomatic Deterioration|1|||
105429485|NCT04191499|363579808|FG001|Overall Study|Symptomatic Deterioration|0|||
105429486|NCT04191499|363579807|FG000|Overall Study|Withdrawal by Subject|7|||
105429487|NCT04191499|363579808|FG001|Overall Study|Withdrawal by Subject|11|||
105429488|NCT04191499|363579807|FG000|Overall Study|Ongoing in the study|104|||
105429489|NCT04191499|363579808|FG001|Overall Study|Ongoing in the study|97|||
105429490|NCT04912895|363579817|FG000|Overall Study|Unable to provide specimen|2|||
105429491|NCT04912895|363579818|FG001|Overall Study|Unable to provide specimen|0|||
105429492|NCT04912895|363579819|FG002|Overall Study|Unable to provide specimen|0|||
105429493|NCT04639219|363579820|FG000|Overall Study|Withdrawal by Subject|8|||
105429494|NCT04639219|363579820|FG000|Overall Study|Lost to Follow-up|6|||
105429495|NCT04639219|363579820|FG000|Overall Study|Death|55|||
105429496|NCT00931801|363579822|FG000|Overall Study|Adverse Event|0|||
105429497|NCT00931801|363579823|FG001|Overall Study|Adverse Event|0|||
105429498|NCT00931801|363579824|FG002|Overall Study|Adverse Event|1|||
105429499|NCT00931801|363579822|FG000|Overall Study|Lost to Follow-up|0|||
105429500|NCT00931801|363579823|FG001|Overall Study|Lost to Follow-up|1|||
105429501|NCT00931801|363579824|FG002|Overall Study|Lost to Follow-up|0|||
105429502|NCT00931801|363579822|FG000|Overall Study|Withdrawal by Subject|1|||
105429503|NCT00931801|363579823|FG001|Overall Study|Withdrawal by Subject|0|||
105429504|NCT00931801|363579824|FG002|Overall Study|Withdrawal by Subject|0|||
105429505|NCT00931801|363579822|FG000|Overall Study|Confirmed Virologic Failure|0|||
105429506|NCT00931801|363579823|FG001|Overall Study|Confirmed Virologic Failure|0|||
105429507|NCT00931801|363579824|FG002|Overall Study|Confirmed Virologic Failure|3|||
105429508|NCT03283150|363579826|FG000|Overall Study|Withdrawal by Subject|6|||
105429509|NCT03283150|363579827|FG001|Overall Study|Withdrawal by Subject|0|||
105429510|NCT03283150|363579828|FG002|Overall Study|Withdrawal by Subject|0|||
105429511|NCT05291936|363579829|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
105429512|NCT05291936|363579830|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
105429513|NCT05291936|363579829|FG000|Period 1|Withdrew Consent during study|1|||
105429514|NCT05291936|363579830|FG001|Period 1|Withdrew Consent during study|0|||
105429515|NCT05291936|363579829|FG000|Period 2|Adverse Event|0|||
105429516|NCT05291936|363579830|FG001|Period 2|Adverse Event|1|||
105429517|NCT05291936|363579829|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
105429518|NCT05291936|363579830|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
105429519|NCT02266875|363579831|FG000|Overall Study|Withdrawal by Subject|9|||
105429520|NCT02266875|363579832|FG001|Overall Study|Withdrawal by Subject|0|||
105429521|NCT02266875|363579831|FG000|Overall Study|Lost to Follow-up|2|||
105429522|NCT02266875|363579832|FG001|Overall Study|Lost to Follow-up|0|||
105429523|NCT02258529|363579833|FG000|Overall Study|Study Terminated by Sponsor|9|||
105429524|NCT02258529|363579833|FG000|Overall Study|Adverse Event|1|||
105429525|NCT00875056|363579837|FG000|Overall Study|Adverse Event|6|||
105429526|NCT00875056|363579838|FG001|Overall Study|Adverse Event|1|||
105429527|NCT00875056|363579839|FG002|Overall Study|Adverse Event|2|||
105429528|NCT00875056|363579837|FG000|Overall Study|Progressive Disease|14|||
105429529|NCT00875056|363579838|FG001|Overall Study|Progressive Disease|8|||
105429530|NCT00875056|363579839|FG002|Overall Study|Progressive Disease|3|||
105429531|NCT00875056|363579837|FG000|Overall Study|Withdrawal by Subject|3|||
105429532|NCT00875056|363579838|FG001|Overall Study|Withdrawal by Subject|0|||
105429533|NCT00875056|363579839|FG002|Overall Study|Withdrawal by Subject|1|||
105429534|NCT01318070|363579840|FG000|Overall Study|Adverse Event|1|||
105429535|NCT01318070|363579841|FG001|Overall Study|Adverse Event|1|||
105429536|NCT01318070|363579842|FG002|Overall Study|Adverse Event|5|||
105429537|NCT01318070|363579840|FG000|Overall Study|Withdrawal by Subject|0|||
105429538|NCT01318070|363579841|FG001|Overall Study|Withdrawal by Subject|1|||
105429539|NCT01318070|363579842|FG002|Overall Study|Withdrawal by Subject|1|||
105429540|NCT01318070|363579840|FG000|Overall Study|Lack of Efficacy|0|||
105429541|NCT01318070|363579841|FG001|Overall Study|Lack of Efficacy|0|||
105429542|NCT01318070|363579842|FG002|Overall Study|Lack of Efficacy|1|||
105429543|NCT01318070|363579840|FG000|Overall Study|Principal Investigator Discretion|1|||
105429544|NCT01318070|363579841|FG001|Overall Study|Principal Investigator Discretion|0|||
105429545|NCT01318070|363579842|FG002|Overall Study|Principal Investigator Discretion|0|||
105429546|NCT01920152|363579843|FG000|Overall Study|Withdrawal by Subject|1|||
105429547|NCT01920152|363579844|FG001|Overall Study|Withdrawal by Subject|2|||
105429548|NCT01167907|363579851|FG000|Overall Study|Protocol Violation|1|||
105429549|NCT01167907|363579852|FG001|Overall Study|Protocol Violation|0|||
105429550|NCT01167907|363579851|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
105429551|NCT01167907|363579852|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
105429552|NCT01839656|363579887|FG000|Overall Study|Withdrawal by Subject|1|||
105429553|NCT01839656|363579888|FG001|Overall Study|Withdrawal by Subject|1|||
105429554|NCT01839656|363579887|FG000|Overall Study|Adverse event, serious fatal|1|||
105429555|NCT01839656|363579888|FG001|Overall Study|Adverse event, serious fatal|4|||
105429556|NCT01839656|363579887|FG000|Overall Study|Early study closure|0|||
105429557|NCT01839656|363579888|FG001|Overall Study|Early study closure|11|||
105429558|NCT01839656|363579887|FG000|Overall Study|Adverse Event|1|||
105429559|NCT01839656|363579888|FG001|Overall Study|Adverse Event|0|||
105429560|NCT02383433|363579891|FG000|Overall Study|Disease progression|2|||
105429561|NCT02535416|363579892|FG000|Overall Study|Family bereavement overseas|1|||
105429562|NCT02535416|363579893|FG001|Overall Study|Family bereavement overseas|0|||
105429563|NCT02535416|363579894|FG002|Overall Study|Family bereavement overseas|0|||
105429564|NCT02535416|363579895|FG003|Overall Study|Family bereavement overseas|0|||
105429565|NCT02535416|363579896|FG004|Overall Study|Family bereavement overseas|0|||
105429566|NCT02535416|363579897|FG005|Overall Study|Family bereavement overseas|0|||
105429567|NCT02535416|363579898|FG006|Overall Study|Family bereavement overseas|0|||
105429568|NCT02535416|363579899|FG007|Overall Study|Family bereavement overseas|0|||
105429569|NCT02535416|363579900|FG008|Overall Study|Family bereavement overseas|0|||
105429570|NCT02920957|363579901|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
105429571|NCT02920957|363579902|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
105429572|NCT02920957|363579901|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
105429573|NCT02920957|363579902|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
105429574|NCT02920957|363579901|FG000|First Intervention : 1 Month|Adverse Event|1|||
105429575|NCT02920957|363579902|FG001|First Intervention : 1 Month|Adverse Event|0|||
105429576|NCT02920957|363579901|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
105429577|NCT02920957|363579902|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
105429578|NCT02210091|363579909|FG000|Overall Study|Physician Decision|0|||
105501622|NCT01064310|363847172|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
105501623|NCT01064310|363847170|FG000|Open Label Pazopinib|Physician Decision|0|||
105501624|NCT01064310|363847171|FG001|Open Label Pazopinib|Physician Decision|0|||
105501625|NCT01064310|363847172|FG002|Open Label Pazopinib|Physician Decision|20|||
105501626|NCT06934993|363847175|FG000|Overall Study|Withdrawal by Subject|29|||
105501627|NCT06934993|363847175|FG000|Overall Study|elevated postoperative creatinine level|11|||
105501628|NCT06934993|363847175|FG000|Overall Study|Death|3|||
105501629|NCT01890473|363848856|FG000|Overall Study|Lost to Follow-up|1|||
105501630|NCT01890473|363848857|FG001|Overall Study|Lost to Follow-up|0|||
105501631|NCT01890473|363848856|FG000|Overall Study|Poor/non-compliance|1|||
105501632|NCT01890473|363848857|FG001|Overall Study|Poor/non-compliance|0|||
105501633|NCT03166735|363848858|FG000|Overall Study|Not Treated|1|||
105501634|NCT03166735|363848859|FG001|Overall Study|Not Treated|0|||
105501635|NCT03166735|363848860|FG002|Overall Study|Not Treated|0|||
105501636|NCT03166735|363848861|FG003|Overall Study|Not Treated|0|||
105501637|NCT03166735|363848862|FG004|Overall Study|Not Treated|0|||
105501638|NCT03166735|363848858|FG000|Overall Study|follow-up not completed as planned|0|||
105501639|NCT03166735|363848859|FG001|Overall Study|follow-up not completed as planned|1|||
105501640|NCT03166735|363848860|FG002|Overall Study|follow-up not completed as planned|1|||
105501641|NCT03166735|363848861|FG003|Overall Study|follow-up not completed as planned|0|||
105501642|NCT03166735|363848862|FG004|Overall Study|follow-up not completed as planned|1|||
105501643|NCT03166735|363848858|FG000|Overall Study|Withdrawal by Subject|0|||
105501644|NCT03166735|363848859|FG001|Overall Study|Withdrawal by Subject|0|||
105501645|NCT03166735|363848860|FG002|Overall Study|Withdrawal by Subject|1|||
105501646|NCT03166735|363848861|FG003|Overall Study|Withdrawal by Subject|1|||
105501647|NCT03166735|363848862|FG004|Overall Study|Withdrawal by Subject|2|||
105501648|NCT03166735|363848858|FG000|Overall Study|Lost to Follow-up|0|||
105501649|NCT03166735|363848859|FG001|Overall Study|Lost to Follow-up|2|||
105501650|NCT03166735|363848860|FG002|Overall Study|Lost to Follow-up|1|||
105501651|NCT03166735|363848861|FG003|Overall Study|Lost to Follow-up|0|||
105501652|NCT03166735|363848862|FG004|Overall Study|Lost to Follow-up|1|||
105501653|NCT01020981|363848863|FG000|Overall Study|Did not return mailed survey|74|||
105501654|NCT01020981|363848864|FG001|Overall Study|Did not return mailed survey|58|||
105501655|NCT01020981|363848863|FG000|Overall Study|Survey returned undeliverable|8|||
105501656|NCT01020981|363848864|FG001|Overall Study|Survey returned undeliverable|32|||
105501657|NCT01020981|363848863|FG000|Overall Study|Participant declined to complete survey|2|||
105501658|NCT01020981|363848864|FG001|Overall Study|Participant declined to complete survey|0|||
105501659|NCT01086033|363848869|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
105501660|NCT01086033|363848869|FG000|Overall Study|Lost to Follow-up|86|||
105501661|NCT01086033|363848869|FG000|Overall Study|Adverse Event|42|||
105501662|NCT01086033|363848869|FG000|Overall Study|Withdrawal by Subject|41|||
105501663|NCT01086033|363848869|FG000|Overall Study|Other|14|||
105501664|NCT01086033|363848869|FG000|Overall Study|Other|13|||
105501665|NCT01086033|363848869|FG000|Overall Study|AE and Withdrew Consent|5|||
105501666|NCT01086033|363848869|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
105501667|NCT01086033|363848869|FG000|Overall Study|Withdrew consent and Other Reason|4|||
105501668|NCT01086033|363848869|FG000|Overall Study|AE and Lack of Efficacy|4|||
105501669|NCT01086033|363848869|FG000|Overall Study|Death|1|||
105501670|NCT01086033|363848869|FG000|Overall Study|AE and Lost to Follow-up|1|||
105501671|NCT01086033|363848869|FG000|Overall Study|AE and Other Reason|1|||
105501672|NCT01086033|363848869|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
105501673|NCT03355365|363848871|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
105501674|NCT03355365|363848872|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
105501675|NCT03355365|363848871|FG000|Year 1, First Intervention|Protocol Violation|1|||
105501676|NCT03355365|363848872|FG001|Year 1, First Intervention|Protocol Violation|0|||
105501677|NCT03355365|363848871|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
105501678|NCT03355365|363848872|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
105501679|NCT03355365|363848871|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
105501680|NCT03355365|363848872|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
105501681|NCT03355365|363848871|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
105501682|NCT03355365|363848872|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
105429579|NCT02210091|363579910|FG001|Overall Study|Physician Decision|1|||
105429580|NCT02210091|363579909|FG000|Overall Study|Withdrawal by Sponsor|0|||
105429581|NCT02210091|363579910|FG001|Overall Study|Withdrawal by Sponsor|1|||
105429582|NCT00897390|363579911|FG000|Overall Study|Adverse Event|2|||
105429583|NCT00897390|363579911|FG000|Overall Study|No Longer Met Study Criteria|1|||
105429584|NCT00897390|363579911|FG000|Overall Study|Personal Reasons|1|||
105429585|NCT00897390|363579911|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
105429586|NCT01831817|363579912|FG000|Overall Study|Lost to Follow-up|1|||
105429587|NCT01831817|363579913|FG001|Overall Study|Lost to Follow-up|0|||
105429588|NCT01831817|363579914|FG002|Overall Study|Lost to Follow-up|0|||
105429589|NCT01831817|363579915|FG003|Overall Study|Lost to Follow-up|0|||
105429590|NCT01831817|363579912|FG000|Overall Study|Withdrawl of Consent|3|||
105429591|NCT01831817|363579913|FG001|Overall Study|Withdrawl of Consent|0|||
105429592|NCT01831817|363579914|FG002|Overall Study|Withdrawl of Consent|0|||
105429593|NCT01831817|363579915|FG003|Overall Study|Withdrawl of Consent|0|||
105429594|NCT03647267|363581536|FG000|Overall Study|Lost to Follow-up|1|||
105429595|NCT03647267|363581537|FG001|Overall Study|Lost to Follow-up|0|||
105429596|NCT05565937|363581538|FG000|Overall Study|Adverse Event|0|||
105429597|NCT05565937|363581539|FG001|Overall Study|Adverse Event|1|||
105429598|NCT05565937|363581538|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
105429599|NCT05565937|363581539|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
105429600|NCT05565937|363581538|FG000|Overall Study|Lost to Follow-up|2|||
105429601|NCT05565937|363581539|FG001|Overall Study|Lost to Follow-up|0|||
105429602|NCT05565937|363581538|FG000|Overall Study|Pregnancy|0|||
105429603|NCT05565937|363581539|FG001|Overall Study|Pregnancy|2|||
105429604|NCT05565937|363581538|FG000|Overall Study|Anisometropia|0|||
105429605|NCT05565937|363581539|FG001|Overall Study|Anisometropia|1|||
105429606|NCT01022424|363581540|FG000|Overall Study|Adverse Event|1|||
105429607|NCT01022424|363581540|FG000|Overall Study|Physician Decision|1|||
105429608|NCT01022424|363581540|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
105429609|NCT00031460|363581544|FG000|Overall Study|Lost to Follow-up|0|||
105429610|NCT00031460|363581545|FG001|Overall Study|Lost to Follow-up|1|||
105429611|NCT00031460|363581544|FG000|Overall Study|Withdrawal by Subject|1|||
105429612|NCT00031460|363581545|FG001|Overall Study|Withdrawal by Subject|1|||
105429613|NCT00031460|363581544|FG000|Overall Study|Non-Compliant|1|||
105429614|NCT00031460|363581545|FG001|Overall Study|Non-Compliant|1|||
105429615|NCT00031460|363581544|FG000|Overall Study|Death|0|||
105429616|NCT00031460|363581545|FG001|Overall Study|Death|1|||
105429617|NCT00031460|363581544|FG000|Overall Study|Reactivation of Disease|5|||
105429618|NCT00031460|363581545|FG001|Overall Study|Reactivation of Disease|9|||
105429619|NCT00031460|363581544|FG000|Overall Study|Disruption of blinded drug supply|2|||
105429620|NCT00031460|363581545|FG001|Overall Study|Disruption of blinded drug supply|0|||
105429621|NCT00031460|363581544|FG000|Overall Study|Confirmed unevaluable|0|||
105429622|NCT00031460|363581545|FG001|Overall Study|Confirmed unevaluable|1|||
105429623|NCT03323736|363581546|FG000|Overall Study|Screen Failure|14|||
105429624|NCT03323736|363581547|FG001|Overall Study|Screen Failure|9|||
105429625|NCT03323736|363581548|FG002|Overall Study|Screen Failure|1|||
105429626|NCT03323736|363581546|FG000|Overall Study|Withdrawal Before Treatment|3|||
105429627|NCT03323736|363581547|FG001|Overall Study|Withdrawal Before Treatment|1|||
105429628|NCT03323736|363581548|FG002|Overall Study|Withdrawal Before Treatment|1|||
105429629|NCT03323736|363581546|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
105429630|NCT03323736|363581547|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
105429631|NCT03323736|363581548|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
105429632|NCT02210832|363581549|FG000|Overall Study|Pregnancy termination .|3|||
105429633|NCT02210832|363581550|FG001|Overall Study|Pregnancy termination .|4|||
105429634|NCT02210832|363581551|FG002|Overall Study|Pregnancy termination .|1|||
105429635|NCT02210832|363581549|FG000|Overall Study|Lost to Follow-up|26|||
105429636|NCT02210832|363581550|FG001|Overall Study|Lost to Follow-up|32|||
105429637|NCT02210832|363581551|FG002|Overall Study|Lost to Follow-up|17|||
105429638|NCT00799591|363581552|FG000|Overall Study|De-escalation of doses|20|||
105429639|NCT00799591|363581552|FG000|Overall Study|Death|14|||
105429640|NCT00799591|363581552|FG000|Overall Study|Technical failure|12|||
105429641|NCT00799591|363581552|FG000|Overall Study|Resistant germ|11|||
105429642|NCT00799591|363581552|FG000|Overall Study|New infection|4|||
105429643|NCT00799591|363581552|FG000|Overall Study|Resistance germ and technical failure|2|||
105429644|NCT00799591|363581552|FG000|Overall Study|Persistance of fever undetermined origin|1|||
105429645|NCT00799591|363581552|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
105589936|NCT04511650|364160692|FG002|Overall Study|Lost to Follow-up|0|||
105429646|NCT00799591|363581552|FG000|Overall Study|Infectious origin not probable|1|||
105429647|NCT00870194|363581557|FG000|Overall Study|Adverse Event|10|||
105429648|NCT00870194|363581558|FG001|Overall Study|Adverse Event|5|||
105429649|NCT00870194|363581557|FG000|Overall Study|Lack of Efficacy|0|||
105429650|NCT00870194|363581558|FG001|Overall Study|Lack of Efficacy|1|||
105429651|NCT00870194|363581557|FG000|Overall Study|Lost to Follow-up|2|||
105429652|NCT00870194|363581558|FG001|Overall Study|Lost to Follow-up|0|||
105429653|NCT00870194|363581557|FG000|Overall Study|Physician Decision|3|||
105429654|NCT00870194|363581558|FG001|Overall Study|Physician Decision|1|||
105429655|NCT00870194|363581557|FG000|Overall Study|Protocol Violation|3|||
105429656|NCT00870194|363581558|FG001|Overall Study|Protocol Violation|3|||
105429657|NCT00870194|363581557|FG000|Overall Study|Entry Criteria Not Met|1|||
105429658|NCT00870194|363581558|FG001|Overall Study|Entry Criteria Not Met|2|||
105429659|NCT00870194|363581557|FG000|Overall Study|Subject Decision|7|||
105429660|NCT00870194|363581558|FG001|Overall Study|Subject Decision|2|||
105429661|NCT02717130|363581559|FG000|Overall Study|Withdrawal by Subject|1|||
105429662|NCT02717130|363581559|FG000|Overall Study|Adverse Event|1|||
105429663|NCT02717130|363581559|FG000|Overall Study|Physician Decision|1|||
105429664|NCT02717130|363581559|FG000|Overall Study|Study Closure|4|||
105429665|NCT00554099|363581560|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
105429666|NCT00554099|363581561|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
105429667|NCT00554099|363581562|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
105429668|NCT00554099|363581560|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
105429669|NCT00554099|363581561|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
105429670|NCT00554099|363581562|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
105429671|NCT00554099|363581560|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
105429672|NCT00554099|363581561|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
105429673|NCT00554099|363581562|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
105429674|NCT00554099|363581560|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
105429675|NCT00554099|363581561|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
105429676|NCT00554099|363581562|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
105429677|NCT00554099|363581560|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
105429678|NCT00554099|363581561|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
105429679|NCT00554099|363581562|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
105429680|NCT00554099|363581560|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
105429681|NCT00554099|363581561|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
105429682|NCT00554099|363581562|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
105429683|NCT00554099|363581560|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
105429684|NCT00554099|363581561|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
105429685|NCT00554099|363581562|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
105429686|NCT00554099|363581560|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
105429687|NCT00554099|363581561|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
105429688|NCT00554099|363581562|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
105429689|NCT00554099|363581560|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
105429690|NCT00554099|363581561|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
105429691|NCT00554099|363581562|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
105429692|NCT01754194|363581563|FG000|Overall Study|Lost to Follow-up|39|||
105429693|NCT01754194|363581564|FG001|Overall Study|Lost to Follow-up|14|||
105429694|NCT01754194|363581563|FG000|Overall Study|Withdrawal by Subject|4|||
105429695|NCT01754194|363581564|FG001|Overall Study|Withdrawal by Subject|5|||
105429696|NCT01754194|363581563|FG000|Overall Study|Other|9|||
105429697|NCT01754194|363581564|FG001|Overall Study|Other|8|||
105429698|NCT00907296|363581565|FG000|Overall Study|Ineligibility Determined|1|||
105429699|NCT00907296|363581566|FG001|Overall Study|Ineligibility Determined|0|||
105429700|NCT00907296|363581567|FG002|Overall Study|Ineligibility Determined|0|||
105429701|NCT00907296|363581568|FG003|Overall Study|Ineligibility Determined|1|||
105429702|NCT00907296|363581569|FG004|Overall Study|Ineligibility Determined|0|||
105429703|NCT00907296|363581570|FG005|Overall Study|Ineligibility Determined|0|||
105429704|NCT00907296|363581571|FG006|Overall Study|Ineligibility Determined|0|||
105429705|NCT00907296|363581572|FG007|Overall Study|Ineligibility Determined|1|||
105429706|NCT00907296|363581573|FG008|Overall Study|Ineligibility Determined|0|||
105429707|NCT00907296|363581574|FG009|Overall Study|Ineligibility Determined|0|||
105429708|NCT00907296|363581565|FG000|Overall Study|Protocol Deviation|0|||
105429709|NCT00907296|363581566|FG001|Overall Study|Protocol Deviation|1|||
105429710|NCT00907296|363581567|FG002|Overall Study|Protocol Deviation|0|||
105429711|NCT00907296|363581568|FG003|Overall Study|Protocol Deviation|0|||
105429712|NCT00907296|363581569|FG004|Overall Study|Protocol Deviation|0|||
105429713|NCT00907296|363581570|FG005|Overall Study|Protocol Deviation|0|||
105429714|NCT00907296|363581571|FG006|Overall Study|Protocol Deviation|0|||
105429715|NCT00907296|363581572|FG007|Overall Study|Protocol Deviation|0|||
105429716|NCT00907296|363581573|FG008|Overall Study|Protocol Deviation|0|||
105429717|NCT00907296|363581574|FG009|Overall Study|Protocol Deviation|0|||
105429718|NCT00907296|363581565|FG000|Overall Study|Noncompliance|1|||
105589937|NCT04511650|364160690|FG000|Overall Study|Withdrawal by Subject|1|||
105589938|NCT04511650|364160691|FG001|Overall Study|Withdrawal by Subject|0|||
105429719|NCT00907296|363581566|FG001|Overall Study|Noncompliance|1|||
105429720|NCT00907296|363581567|FG002|Overall Study|Noncompliance|1|||
105429721|NCT00907296|363581568|FG003|Overall Study|Noncompliance|0|||
105429722|NCT00907296|363581569|FG004|Overall Study|Noncompliance|0|||
105429723|NCT00907296|363581570|FG005|Overall Study|Noncompliance|1|||
105429724|NCT00907296|363581571|FG006|Overall Study|Noncompliance|0|||
105429725|NCT00907296|363581572|FG007|Overall Study|Noncompliance|2|||
105429726|NCT00907296|363581573|FG008|Overall Study|Noncompliance|0|||
105429727|NCT00907296|363581574|FG009|Overall Study|Noncompliance|0|||
105429728|NCT00907296|363581565|FG000|Overall Study|Adverse Event|2|||
105429729|NCT00907296|363581566|FG001|Overall Study|Adverse Event|0|||
105429730|NCT00907296|363581567|FG002|Overall Study|Adverse Event|0|||
105429731|NCT00907296|363581568|FG003|Overall Study|Adverse Event|0|||
105429732|NCT00907296|363581569|FG004|Overall Study|Adverse Event|0|||
105429733|NCT00907296|363581570|FG005|Overall Study|Adverse Event|0|||
105429734|NCT00907296|363581571|FG006|Overall Study|Adverse Event|1|||
105429735|NCT00907296|363581572|FG007|Overall Study|Adverse Event|0|||
105429736|NCT00907296|363581573|FG008|Overall Study|Adverse Event|0|||
105429737|NCT00907296|363581574|FG009|Overall Study|Adverse Event|1|||
105429738|NCT00907296|363581565|FG000|Overall Study|Withdrawal by Subject|7|||
105429739|NCT00907296|363581566|FG001|Overall Study|Withdrawal by Subject|2|||
105429740|NCT00907296|363581567|FG002|Overall Study|Withdrawal by Subject|1|||
105429741|NCT00907296|363581568|FG003|Overall Study|Withdrawal by Subject|1|||
105429742|NCT00907296|363581569|FG004|Overall Study|Withdrawal by Subject|1|||
105429743|NCT00907296|363581570|FG005|Overall Study|Withdrawal by Subject|5|||
105429744|NCT00907296|363581571|FG006|Overall Study|Withdrawal by Subject|3|||
105429745|NCT00907296|363581572|FG007|Overall Study|Withdrawal by Subject|2|||
105429746|NCT00907296|363581573|FG008|Overall Study|Withdrawal by Subject|4|||
105501683|NCT03355365|363848871|FG000|Year 2, Crossover Intervention|severe COVID|0|||
105501684|NCT03355365|363848872|FG001|Year 2, Crossover Intervention|severe COVID|1|||
105501685|NCT03355365|363848871|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
105429747|NCT00907296|363581574|FG009|Overall Study|Withdrawal by Subject|2|||
105429748|NCT00907296|363581565|FG000|Overall Study|Lost to Follow-up|9|||
105429749|NCT00907296|363581566|FG001|Overall Study|Lost to Follow-up|1|||
105429750|NCT00907296|363581567|FG002|Overall Study|Lost to Follow-up|0|||
105429751|NCT00907296|363581568|FG003|Overall Study|Lost to Follow-up|2|||
105429752|NCT00907296|363581569|FG004|Overall Study|Lost to Follow-up|0|||
105429753|NCT00907296|363581570|FG005|Overall Study|Lost to Follow-up|3|||
105429754|NCT00907296|363581571|FG006|Overall Study|Lost to Follow-up|2|||
105429755|NCT00907296|363581572|FG007|Overall Study|Lost to Follow-up|2|||
105429756|NCT00907296|363581573|FG008|Overall Study|Lost to Follow-up|0|||
105429757|NCT00907296|363581574|FG009|Overall Study|Lost to Follow-up|4|||
105429758|NCT00707746|363581577|FG000|Treatment Period|Adverse Event|2|||
105429759|NCT00707746|363581578|FG001|Treatment Period|Adverse Event|4|||
105429760|NCT00707746|363581577|FG000|Treatment Period|Ineligibility|0|||
105429761|NCT00707746|363581578|FG001|Treatment Period|Ineligibility|1|||
105429762|NCT02322190|363581579|FG000|Overall Study|Death on study|1|||
105429763|NCT02322190|363581580|FG001|Overall Study|Death on study|0|||
105429764|NCT01685983|363581585|FG000|Overall Study|Adverse Event|7|||
105429765|NCT01685983|363581585|FG000|Overall Study|Death|1|||
105429766|NCT01685983|363581585|FG000|Overall Study|Withdrawal by Subject|19|||
105429767|NCT01685983|363581585|FG000|Overall Study|Protocol Violation|2|||
105429768|NCT01685983|363581585|FG000|Overall Study|Physician Decision|13|||
105429769|NCT01685983|363581585|FG000|Overall Study|Other|7|||
105429770|NCT01685983|363581585|FG000|Overall Study|Progressive Disease|32|||
105429771|NCT01685983|363581585|FG000|Overall Study|Noncompliance with Study Drug|1|||
105429772|NCT01443130|363581586|FG000|Overall Study|Lost to Follow-up|44|||
105429773|NCT01443130|363581587|FG001|Overall Study|Lost to Follow-up|42|||
105429774|NCT01443130|363581588|FG002|Overall Study|Lost to Follow-up|50|||
105429775|NCT01443130|363581589|FG003|Overall Study|Lost to Follow-up|23|||
105429776|NCT01443130|363581590|FG004|Overall Study|Lost to Follow-up|25|||
105429777|NCT01443130|363581591|FG005|Overall Study|Lost to Follow-up|21|||
105429778|NCT01443130|363581586|FG000|Overall Study|Death|0|||
105429779|NCT01443130|363581587|FG001|Overall Study|Death|1|||
105429780|NCT01443130|363581588|FG002|Overall Study|Death|0|||
105429781|NCT01443130|363581589|FG003|Overall Study|Death|7|||
105429782|NCT01443130|363581590|FG004|Overall Study|Death|10|||
105429783|NCT01443130|363581591|FG005|Overall Study|Death|8|||
105429784|NCT01443130|363581586|FG000|Overall Study|Adverse Event|2|||
105429785|NCT01443130|363581587|FG001|Overall Study|Adverse Event|1|||
105429786|NCT01443130|363581588|FG002|Overall Study|Adverse Event|1|||
105429787|NCT01443130|363581589|FG003|Overall Study|Adverse Event|0|||
105429788|NCT01443130|363581590|FG004|Overall Study|Adverse Event|0|||
105429789|NCT01443130|363581591|FG005|Overall Study|Adverse Event|0|||
105429790|NCT01443130|363581586|FG000|Overall Study|Protocol Violation|2|||
105501686|NCT03355365|363848872|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
105429791|NCT01443130|363581587|FG001|Overall Study|Protocol Violation|1|||
105429792|NCT01443130|363581588|FG002|Overall Study|Protocol Violation|3|||
105429793|NCT01443130|363581589|FG003|Overall Study|Protocol Violation|2|||
105429794|NCT01443130|363581590|FG004|Overall Study|Protocol Violation|2|||
105429795|NCT01443130|363581591|FG005|Overall Study|Protocol Violation|3|||
105429796|NCT01443130|363581586|FG000|Overall Study|Withdrawal by Subject|15|||
105429797|NCT01443130|363581587|FG001|Overall Study|Withdrawal by Subject|14|||
105429798|NCT01443130|363581588|FG002|Overall Study|Withdrawal by Subject|12|||
105429799|NCT01443130|363581589|FG003|Overall Study|Withdrawal by Subject|7|||
105429800|NCT01443130|363581590|FG004|Overall Study|Withdrawal by Subject|7|||
105429801|NCT01443130|363581591|FG005|Overall Study|Withdrawal by Subject|2|||
105429802|NCT01443130|363581586|FG000|Overall Study|Death of Subject's Infant|5|||
105429803|NCT01443130|363581587|FG001|Overall Study|Death of Subject's Infant|10|||
105589939|NCT04511650|364160692|FG002|Overall Study|Withdrawal by Subject|0|||
105589940|NCT04511650|364160690|FG000|Overall Study|reason not provided|0|||
105589941|NCT04511650|364160691|FG001|Overall Study|reason not provided|0|||
105589942|NCT04511650|364160692|FG002|Overall Study|reason not provided|1|||
105589943|NCT04511650|364160690|FG000|Overall Study|Death|1|||
105589944|NCT04511650|364160691|FG001|Overall Study|Death|1|||
105589945|NCT04511650|364160692|FG002|Overall Study|Death|1|||
105589946|NCT03601507|364160693|FG000|Overall Study|Adverse Event|1|||
105589947|NCT00197236|364160696|FG000|Overall Study|Adverse Event|1|||
105589948|NCT00197236|364160697|FG001|Overall Study|Adverse Event|0|||
105589949|NCT00197236|364160698|FG002|Overall Study|Adverse Event|1|||
105589950|NCT00197236|364160696|FG000|Overall Study|Lost to Follow-up|5|||
105589951|NCT00197236|364160697|FG001|Overall Study|Lost to Follow-up|14|||
105589952|NCT00197236|364160698|FG002|Overall Study|Lost to Follow-up|6|||
105589953|NCT00197236|364160696|FG000|Overall Study|Protocol Violation|0|||
105589954|NCT00197236|364160697|FG001|Overall Study|Protocol Violation|0|||
105589955|NCT00197236|364160698|FG002|Overall Study|Protocol Violation|1|||
105589956|NCT00197236|364160696|FG000|Overall Study|Withdrawal by Subject|7|||
105589957|NCT00197236|364160697|FG001|Overall Study|Withdrawal by Subject|3|||
105589958|NCT00197236|364160698|FG002|Overall Study|Withdrawal by Subject|11|||
105589959|NCT00197236|364160696|FG000|Overall Study|Study drug/medication expiration|1|||
105589960|NCT00197236|364160697|FG001|Overall Study|Study drug/medication expiration|0|||
105589961|NCT00197236|364160698|FG002|Overall Study|Study drug/medication expiration|3|||
105589962|NCT00197236|364160696|FG000|Overall Study|Returned out of specified time window|0|||
105589963|NCT00197236|364160697|FG001|Overall Study|Returned out of specified time window|0|||
105589964|NCT00197236|364160698|FG002|Overall Study|Returned out of specified time window|1|||
105589965|NCT03885596|364160699|FG000|Overall Study|Withdrawal by Subject|2|||
105589966|NCT03885596|364160700|FG001|Overall Study|Withdrawal by Subject|1|||
105589967|NCT03885596|364160701|FG002|Overall Study|Withdrawal by Subject|0|||
105589968|NCT03885596|364160702|FG003|Overall Study|Withdrawal by Subject|0|||
105589969|NCT01076335|364160703|FG000|Overall Study|Withdrawal by Subject|3|||
105589970|NCT01076335|364160703|FG000|Overall Study|Withdrawal without treatment|1|||
105589971|NCT01981850|364160704|FG000|Main Phase Stage 1|Death|2|||
105589972|NCT01981850|364160705|FG001|Main Phase Stage 1|Death|0|||
105429804|NCT01443130|363581588|FG002|Overall Study|Death of Subject's Infant|11|||
105429805|NCT01443130|363581589|FG003|Overall Study|Death of Subject's Infant|0|||
105429806|NCT01443130|363581590|FG004|Overall Study|Death of Subject's Infant|0|||
105429807|NCT01443130|363581591|FG005|Overall Study|Death of Subject's Infant|0|||
105501687|NCT00885846|363848879|FG000|Overall Study|Withdrawal by Subject|2|||
105501688|NCT00885846|363848880|FG001|Overall Study|Withdrawal by Subject|5|||
105501689|NCT00885846|363848881|FG002|Overall Study|Withdrawal by Subject|2|||
105429808|NCT02642965|363581593|FG000|Overall Study|Lack of Efficacy|4|||
105429809|NCT02642965|363581593|FG000|Overall Study|Physician Decision|9|||
105429810|NCT03077698|363581594|FG000|Progestin Monotherapy|Stable Disease|8|||
105429811|NCT03077698|363581595|FG001|Progestin Monotherapy|Stable Disease|0|||
105429812|NCT03077698|363581594|FG000|Progestin Monotherapy|Adverse Event|1|||
105501690|NCT01081678|363848884|FG000|Overall Study|Ineligibility Determined|0|||
105501691|NCT01081678|363848885|FG001|Overall Study|Ineligibility Determined|0|||
105501692|NCT01081678|363848886|FG002|Overall Study|Ineligibility Determined|1|||
105501693|NCT01081678|363848887|FG003|Overall Study|Ineligibility Determined|1|||
105501694|NCT01081678|363848884|FG000|Overall Study|Noncompliance|3|||
105501695|NCT01081678|363848885|FG001|Overall Study|Noncompliance|4|||
105501696|NCT01081678|363848886|FG002|Overall Study|Noncompliance|5|||
105501697|NCT01081678|363848887|FG003|Overall Study|Noncompliance|2|||
105501698|NCT01081678|363848884|FG000|Overall Study|Adverse Event|2|||
105501699|NCT01081678|363848885|FG001|Overall Study|Adverse Event|1|||
105501700|NCT01081678|363848886|FG002|Overall Study|Adverse Event|2|||
105501701|NCT01081678|363848887|FG003|Overall Study|Adverse Event|2|||
105501702|NCT01081678|363848884|FG000|Overall Study|Withdrawal by Subject|15|||
105501703|NCT01081678|363848885|FG001|Overall Study|Withdrawal by Subject|7|||
105501704|NCT01081678|363848886|FG002|Overall Study|Withdrawal by Subject|17|||
105501705|NCT01081678|363848887|FG003|Overall Study|Withdrawal by Subject|14|||
105501706|NCT01081678|363848884|FG000|Overall Study|Administrative Decision|1|||
105589973|NCT01981850|364160706|FG002|Main Phase Stage 1|Death|0|||
105589974|NCT01981850|364160707|FG003|Main Phase Stage 1|Death|0|||
105589975|NCT01981850|364160708|FG004|Main Phase Stage 1|Death|0|||
105589976|NCT01981850|364160709|FG005|Main Phase Stage 1|Death|0|||
105429813|NCT03077698|363581595|FG001|Progestin Monotherapy|Adverse Event|0|||
105501707|NCT01081678|363848885|FG001|Overall Study|Administrative Decision|0|||
105501708|NCT01081678|363848886|FG002|Overall Study|Administrative Decision|0|||
105501709|NCT01081678|363848887|FG003|Overall Study|Administrative Decision|1|||
105501710|NCT01081678|363848884|FG000|Overall Study|Lost to Follow-up|4|||
105501711|NCT01081678|363848885|FG001|Overall Study|Lost to Follow-up|1|||
105589977|NCT01981850|364160710|FG006|Main Phase Stage 1|Death|0|||
105589978|NCT01981850|364160711|FG007|Main Phase Stage 1|Death|0|||
105589979|NCT01981850|364160712|FG008|Main Phase Stage 1|Death|0|||
105589980|NCT01981850|364160713|FG009|Main Phase Stage 1|Death|0|||
105589981|NCT01981850|364160704|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
105429814|NCT03077698|363581594|FG000|Progestin Monotherapy|Death|1|||
105429815|NCT03077698|363581595|FG001|Progestin Monotherapy|Death|0|||
105429816|NCT03077698|363581594|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
105429817|NCT03077698|363581595|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
105429818|NCT03077698|363581594|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
105429819|NCT03077698|363581595|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
105429820|NCT03077698|363581594|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
105429821|NCT03077698|363581595|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
105429822|NCT03077698|363581594|FG000|Safety Follow Up|Withdrawal by Subject|2|||
105429823|NCT03077698|363581595|FG001|Safety Follow Up|Withdrawal by Subject|1|||
105429824|NCT03077698|363581594|FG000|Safety Follow Up|Transfer of care to hospice|1|||
105429825|NCT03077698|363581595|FG001|Safety Follow Up|Transfer of care to hospice|0|||
105429826|NCT04135859|363581597|FG000|Overall Study|Withdrawal by Subject|1|||
105429827|NCT04135859|363581598|FG001|Overall Study|Withdrawal by Subject|0|||
105429828|NCT04135859|363581597|FG000|Overall Study|Withdrawal due to screening failure|1|||
105429829|NCT04135859|363581598|FG001|Overall Study|Withdrawal due to screening failure|2|||
105429830|NCT04135859|363581597|FG000|Overall Study|Did not complete stress test|3|||
105429831|NCT04135859|363581598|FG001|Overall Study|Did not complete stress test|3|||
105429832|NCT04135859|363581597|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
105429833|NCT04135859|363581598|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
105429834|NCT00815191|363581599|FG000|Overall Study|Protocol Violation|1|||
105429835|NCT00815191|363581600|FG001|Overall Study|Protocol Violation|1|||
105429836|NCT00973102|363581603|FG000|Overall Study|Protocol Violation|1|||
105429837|NCT00973102|363581604|FG001|Overall Study|Protocol Violation|0|||
105429838|NCT00973102|363581603|FG000|Overall Study|Prisoner|0|||
105429839|NCT00973102|363581604|FG001|Overall Study|Prisoner|1|||
105429840|NCT02012686|363581607|FG000|Overall Study|muscle contraction|0|||
105429841|NCT02012686|363581608|FG001|Overall Study|muscle contraction|1|||
105429842|NCT02012686|363581607|FG000|Overall Study|electrocardiography monitoring noise|0|||
105429843|NCT02012686|363581608|FG001|Overall Study|electrocardiography monitoring noise|1|||
105429844|NCT01442064|363581609|FG000|Overall Study|Adverse Event|2|||
105429845|NCT01442064|363581610|FG001|Overall Study|Adverse Event|2|||
105429846|NCT01442064|363581611|FG002|Overall Study|Adverse Event|2|||
105429847|NCT01442064|363581612|FG003|Overall Study|Adverse Event|1|||
105429848|NCT01442064|363581613|FG004|Overall Study|Adverse Event|2|||
105429849|NCT01442064|363581614|FG005|Overall Study|Adverse Event|0|||
105429850|NCT01442064|363581609|FG000|Overall Study|Death|0|||
105429851|NCT01442064|363581610|FG001|Overall Study|Death|1|||
105429852|NCT01442064|363581611|FG002|Overall Study|Death|3|||
105429853|NCT01442064|363581612|FG003|Overall Study|Death|3|||
105429854|NCT01442064|363581613|FG004|Overall Study|Death|1|||
105429855|NCT01442064|363581614|FG005|Overall Study|Death|3|||
105429856|NCT01442064|363581609|FG000|Overall Study|Lost to Follow-up|5|||
105429857|NCT01442064|363581610|FG001|Overall Study|Lost to Follow-up|5|||
105429858|NCT01442064|363581611|FG002|Overall Study|Lost to Follow-up|1|||
105429859|NCT01442064|363581612|FG003|Overall Study|Lost to Follow-up|1|||
105429860|NCT01442064|363581613|FG004|Overall Study|Lost to Follow-up|3|||
105429861|NCT01442064|363581614|FG005|Overall Study|Lost to Follow-up|3|||
105429862|NCT01442064|363581609|FG000|Overall Study|Physician Decision|1|||
105429863|NCT01442064|363581610|FG001|Overall Study|Physician Decision|1|||
105429864|NCT01442064|363581611|FG002|Overall Study|Physician Decision|2|||
105429865|NCT01442064|363581612|FG003|Overall Study|Physician Decision|3|||
105429866|NCT01442064|363581613|FG004|Overall Study|Physician Decision|3|||
105429867|NCT01442064|363581614|FG005|Overall Study|Physician Decision|1|||
105429868|NCT01442064|363581609|FG000|Overall Study|Withdrawal by Subject|6|||
105429869|NCT01442064|363581610|FG001|Overall Study|Withdrawal by Subject|3|||
105429870|NCT01442064|363581611|FG002|Overall Study|Withdrawal by Subject|2|||
105429871|NCT01442064|363581612|FG003|Overall Study|Withdrawal by Subject|2|||
105429872|NCT01442064|363581613|FG004|Overall Study|Withdrawal by Subject|2|||
105429873|NCT01442064|363581614|FG005|Overall Study|Withdrawal by Subject|1|||
105429874|NCT01442064|363581609|FG000|Overall Study|Sponsor decision|82|||
105429875|NCT01442064|363581610|FG001|Overall Study|Sponsor decision|88|||
105429876|NCT01442064|363581611|FG002|Overall Study|Sponsor decision|92|||
105429877|NCT01442064|363581612|FG003|Overall Study|Sponsor decision|88|||
105429878|NCT01442064|363581613|FG004|Overall Study|Sponsor decision|95|||
105429879|NCT01442064|363581614|FG005|Overall Study|Sponsor decision|87|||
105429880|NCT01442064|363581609|FG000|Overall Study|Subject non-compliance|0|||
105429881|NCT01442064|363581610|FG001|Overall Study|Subject non-compliance|0|||
105429882|NCT01442064|363581611|FG002|Overall Study|Subject non-compliance|0|||
105429883|NCT01442064|363581612|FG003|Overall Study|Subject non-compliance|0|||
105429884|NCT01442064|363581613|FG004|Overall Study|Subject non-compliance|0|||
105429885|NCT01442064|363581614|FG005|Overall Study|Subject non-compliance|2|||
105429886|NCT01442064|363581609|FG000|Overall Study|Condition mandated other intervention|1|||
105429887|NCT01442064|363581610|FG001|Overall Study|Condition mandated other intervention|1|||
105429888|NCT01442064|363581611|FG002|Overall Study|Condition mandated other intervention|2|||
105429889|NCT01442064|363581612|FG003|Overall Study|Condition mandated other intervention|0|||
105501712|NCT01081678|363848886|FG002|Overall Study|Lost to Follow-up|4|||
105429890|NCT01442064|363581613|FG004|Overall Study|Condition mandated other intervention|0|||
105429891|NCT01442064|363581614|FG005|Overall Study|Condition mandated other intervention|2|||
105429892|NCT03099148|363581615|FG000|Wash-out|scheduling conflict|0|||
105429893|NCT03099148|363581616|FG001|Wash-out|scheduling conflict|1|||
105429894|NCT03099148|363581617|FG002|Wash-out|scheduling conflict|0|||
105429895|NCT03099148|363581618|FG003|Wash-out|scheduling conflict|0|||
105429896|NCT03099148|363581615|FG000|Wash-out|Adverse Event|0|||
105429897|NCT03099148|363581616|FG001|Wash-out|Adverse Event|1|||
105429898|NCT03099148|363581617|FG002|Wash-out|Adverse Event|0|||
105429899|NCT03099148|363581618|FG003|Wash-out|Adverse Event|0|||
105429900|NCT01703065|363581619|FG000|Overall Study|Lack of Efficacy|1|||
105429901|NCT01703065|363581620|FG001|Overall Study|Lack of Efficacy|0|||
105429902|NCT03242018|363581621|FG000|Overall Study|Adverse Event|7|||
105429903|NCT03242018|363581622|FG001|Overall Study|Adverse Event|7|||
105501713|NCT01081678|363848887|FG003|Overall Study|Lost to Follow-up|3|||
105501714|NCT01081678|363848884|FG000|Overall Study|Death|2|||
105501715|NCT01081678|363848885|FG001|Overall Study|Death|2|||
105501716|NCT01081678|363848886|FG002|Overall Study|Death|2|||
105501717|NCT01081678|363848887|FG003|Overall Study|Death|6|||
105501718|NCT01081678|363848884|FG000|Overall Study|Other|0|||
105501719|NCT01081678|363848885|FG001|Overall Study|Other|1|||
105501720|NCT01081678|363848886|FG002|Overall Study|Other|0|||
105501721|NCT01081678|363848887|FG003|Overall Study|Other|0|||
105429904|NCT03242018|363581623|FG002|Overall Study|Adverse Event|6|||
105429905|NCT03242018|363581621|FG000|Overall Study|Lost to Follow-up|2|||
105429906|NCT03242018|363581622|FG001|Overall Study|Lost to Follow-up|2|||
105429907|NCT03242018|363581623|FG002|Overall Study|Lost to Follow-up|2|||
105429908|NCT03242018|363581621|FG000|Overall Study|At the Participant's Own Request|5|||
105429909|NCT03242018|363581622|FG001|Overall Study|At the Participant's Own Request|1|||
105429910|NCT03242018|363581623|FG002|Overall Study|At the Participant's Own Request|4|||
105429911|NCT03242018|363581621|FG000|Overall Study|Reason Not Specified|3|||
105429912|NCT03242018|363581622|FG001|Overall Study|Reason Not Specified|4|||
105429913|NCT03242018|363581623|FG002|Overall Study|Reason Not Specified|1|||
105429914|NCT03242018|363581621|FG000|Overall Study|Study Terminated by Sponsor|1|||
105429915|NCT03242018|363581622|FG001|Overall Study|Study Terminated by Sponsor|0|||
105429916|NCT03242018|363581623|FG002|Overall Study|Study Terminated by Sponsor|1|||
105429917|NCT02365285|363581624|FG000|Overall Study|Physician Decision|0|||
105429918|NCT02365285|363581625|FG001|Overall Study|Physician Decision|1|||
105429919|NCT02365285|363581626|FG002|Overall Study|Physician Decision|1|||
105429920|NCT02365285|363581627|FG003|Overall Study|Physician Decision|0|||
105429921|NCT02365285|363581624|FG000|Overall Study|Adverse Event|0|||
105429922|NCT02365285|363581625|FG001|Overall Study|Adverse Event|0|||
105429923|NCT02365285|363581626|FG002|Overall Study|Adverse Event|0|||
105429924|NCT02365285|363581627|FG003|Overall Study|Adverse Event|2|||
105429925|NCT00490022|363581628|FG000|Overall Study|Adverse Event|0|||
105429926|NCT00490022|363581629|FG001|Overall Study|Adverse Event|2|||
105501722|NCT00963937|363848890|FG000|Overall Study|Protocol Violation|1|||
105501723|NCT00963937|363848891|FG001|Overall Study|Protocol Violation|1|||
105501724|NCT00963937|363848892|FG002|Overall Study|Protocol Violation|0|||
105501725|NCT00963937|363848890|FG000|Overall Study|Physician Decision|18|||
105429927|NCT00490022|363581628|FG000|Overall Study|Withdrawal by Subject|1|||
105501726|NCT00963937|363848891|FG001|Overall Study|Physician Decision|10|||
105501727|NCT00963937|363848892|FG002|Overall Study|Physician Decision|4|||
105501728|NCT02197520|363848893|FG000|Period 1|Withdrawal by Subject|1|||
105501729|NCT02197520|363848894|FG001|Period 1|Withdrawal by Subject|0|||
105429928|NCT00490022|363581629|FG001|Overall Study|Withdrawal by Subject|0|||
105429929|NCT00490022|363581628|FG000|Overall Study|Subject failed to disclose concommitant|0|||
105429930|NCT00490022|363581629|FG001|Overall Study|Subject failed to disclose concommitant|1|||
105501730|NCT02197520|363848893|FG000|Period 2|Adverse Event|0|||
105501731|NCT02197520|363848894|FG001|Period 2|Adverse Event|2|||
105501732|NCT02197520|363848893|FG000|Period 2|Withdrawal by Subject|1|||
105429931|NCT02124772|363581630|FG000|Overall Study|Lack of Efficacy|2|||
105429932|NCT02124772|363581631|FG001|Overall Study|Lack of Efficacy|0|||
105429933|NCT02124772|363581632|FG002|Overall Study|Lack of Efficacy|0|||
105429934|NCT02124772|363581633|FG003|Overall Study|Lack of Efficacy|1|||
105501733|NCT02197520|363848894|FG001|Period 2|Withdrawal by Subject|0|||
105429935|NCT02124772|363581634|FG004|Overall Study|Lack of Efficacy|2|||
105429936|NCT02124772|363581635|FG005|Overall Study|Lack of Efficacy|3|||
105429937|NCT02124772|363581636|FG006|Overall Study|Lack of Efficacy|0|||
105429938|NCT02124772|363581637|FG007|Overall Study|Lack of Efficacy|2|||
105429939|NCT02124772|363581638|FG008|Overall Study|Lack of Efficacy|0|||
105429940|NCT02124772|363581639|FG009|Overall Study|Lack of Efficacy|1|||
105429941|NCT02124772|363581640|FG010|Overall Study|Lack of Efficacy|0|||
105429942|NCT02124772|363581641|FG011|Overall Study|Lack of Efficacy|0|||
105429943|NCT02124772|363581642|FG012|Overall Study|Lack of Efficacy|1|||
105429944|NCT02124772|363581630|FG000|Overall Study|Adverse Event|1|||
105429945|NCT02124772|363581631|FG001|Overall Study|Adverse Event|4|||
105429946|NCT02124772|363581632|FG002|Overall Study|Adverse Event|1|||
105429947|NCT02124772|363581633|FG003|Overall Study|Adverse Event|5|||
105429948|NCT02124772|363581634|FG004|Overall Study|Adverse Event|2|||
105429949|NCT02124772|363581635|FG005|Overall Study|Adverse Event|1|||
105429950|NCT02124772|363581636|FG006|Overall Study|Adverse Event|1|||
105429951|NCT02124772|363581637|FG007|Overall Study|Adverse Event|5|||
105429952|NCT02124772|363581638|FG008|Overall Study|Adverse Event|0|||
105429953|NCT02124772|363581639|FG009|Overall Study|Adverse Event|3|||
105429954|NCT02124772|363581640|FG010|Overall Study|Adverse Event|1|||
105429955|NCT02124772|363581641|FG011|Overall Study|Adverse Event|3|||
105429956|NCT02124772|363581642|FG012|Overall Study|Adverse Event|1|||
105429957|NCT02124772|363581630|FG000|Overall Study|Withdrawal consent|0|||
105429958|NCT02124772|363581631|FG001|Overall Study|Withdrawal consent|1|||
105429959|NCT02124772|363581632|FG002|Overall Study|Withdrawal consent|1|||
105429960|NCT02124772|363581633|FG003|Overall Study|Withdrawal consent|1|||
105429961|NCT02124772|363581634|FG004|Overall Study|Withdrawal consent|0|||
105429962|NCT02124772|363581635|FG005|Overall Study|Withdrawal consent|1|||
105429963|NCT02124772|363581636|FG006|Overall Study|Withdrawal consent|1|||
105429964|NCT02124772|363581637|FG007|Overall Study|Withdrawal consent|0|||
105429965|NCT02124772|363581638|FG008|Overall Study|Withdrawal consent|0|||
105429966|NCT02124772|363581639|FG009|Overall Study|Withdrawal consent|1|||
105429967|NCT02124772|363581640|FG010|Overall Study|Withdrawal consent|0|||
105429968|NCT02124772|363581641|FG011|Overall Study|Withdrawal consent|1|||
105429969|NCT02124772|363581642|FG012|Overall Study|Withdrawal consent|0|||
105429970|NCT02124772|363581630|FG000|Overall Study|Investigator discretion|0|||
105429971|NCT02124772|363581631|FG001|Overall Study|Investigator discretion|2|||
105429972|NCT02124772|363581632|FG002|Overall Study|Investigator discretion|2|||
105429973|NCT02124772|363581633|FG003|Overall Study|Investigator discretion|1|||
105429974|NCT02124772|363581634|FG004|Overall Study|Investigator discretion|1|||
105429975|NCT02124772|363581635|FG005|Overall Study|Investigator discretion|0|||
105429976|NCT02124772|363581636|FG006|Overall Study|Investigator discretion|1|||
105429977|NCT02124772|363581637|FG007|Overall Study|Investigator discretion|0|||
105429978|NCT02124772|363581638|FG008|Overall Study|Investigator discretion|0|||
105429979|NCT02124772|363581639|FG009|Overall Study|Investigator discretion|1|||
105429980|NCT02124772|363581640|FG010|Overall Study|Investigator discretion|0|||
105429981|NCT02124772|363581641|FG011|Overall Study|Investigator discretion|1|||
105429982|NCT02124772|363581642|FG012|Overall Study|Investigator discretion|0|||
105429983|NCT02124772|363581630|FG000|Overall Study|Progressive disease|0|||
105429984|NCT02124772|363581631|FG001|Overall Study|Progressive disease|0|||
105429985|NCT02124772|363581632|FG002|Overall Study|Progressive disease|0|||
105429986|NCT02124772|363581633|FG003|Overall Study|Progressive disease|0|||
105429987|NCT02124772|363581634|FG004|Overall Study|Progressive disease|0|||
105429988|NCT02124772|363581635|FG005|Overall Study|Progressive disease|0|||
105429989|NCT02124772|363581636|FG006|Overall Study|Progressive disease|1|||
105429990|NCT02124772|363581637|FG007|Overall Study|Progressive disease|1|||
105429991|NCT02124772|363581638|FG008|Overall Study|Progressive disease|0|||
105429992|NCT02124772|363581639|FG009|Overall Study|Progressive disease|0|||
105429993|NCT02124772|363581640|FG010|Overall Study|Progressive disease|0|||
105429994|NCT02124772|363581641|FG011|Overall Study|Progressive disease|0|||
105429995|NCT02124772|363581642|FG012|Overall Study|Progressive disease|0|||
105429996|NCT02124772|363581630|FG000|Overall Study|Other|0|||
105429997|NCT02124772|363581631|FG001|Overall Study|Other|7|||
105429998|NCT02124772|363581632|FG002|Overall Study|Other|2|||
105429999|NCT02124772|363581633|FG003|Overall Study|Other|5|||
105430000|NCT02124772|363581634|FG004|Overall Study|Other|4|||
105430001|NCT02124772|363581635|FG005|Overall Study|Other|3|||
105430002|NCT02124772|363581636|FG006|Overall Study|Other|4|||
105430003|NCT02124772|363581637|FG007|Overall Study|Other|1|||
105430004|NCT02124772|363581638|FG008|Overall Study|Other|1|||
105430005|NCT02124772|363581639|FG009|Overall Study|Other|1|||
105430006|NCT02124772|363581640|FG010|Overall Study|Other|1|||
105430007|NCT02124772|363581641|FG011|Overall Study|Other|1|||
105430008|NCT02124772|363581642|FG012|Overall Study|Other|0|||
105430009|NCT01617447|363581643|FG000|Overall Study|Adverse Event|0|||
105430010|NCT01617447|363581644|FG001|Overall Study|Adverse Event|1|||
105430011|NCT01617447|363581643|FG000|Overall Study|Physician Decision|0|||
105430012|NCT01617447|363581644|FG001|Overall Study|Physician Decision|2|||
105430013|NCT02713529|363581645|FG000|Overall Study|Withdrawal by Subject|3|||
105430014|NCT02713529|363581646|FG001|Overall Study|Withdrawal by Subject|1|||
105430015|NCT02713529|363581647|FG002|Overall Study|Withdrawal by Subject|4|||
105430016|NCT02713529|363581648|FG003|Overall Study|Withdrawal by Subject|2|||
105430017|NCT02713529|363581649|FG004|Overall Study|Withdrawal by Subject|0|||
105430018|NCT02713529|363581650|FG005|Overall Study|Withdrawal by Subject|1|||
105430019|NCT02713529|363581651|FG006|Overall Study|Withdrawal by Subject|1|||
105430020|NCT02713529|363581645|FG000|Overall Study|Lost to Follow-up|1|||
105430021|NCT02713529|363581646|FG001|Overall Study|Lost to Follow-up|0|||
105589982|NCT01981850|364160705|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
105589983|NCT01981850|364160706|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
105589984|NCT01981850|364160707|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
105589985|NCT01981850|364160708|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
105589986|NCT01981850|364160709|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
105589987|NCT01981850|364160710|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
105589988|NCT01981850|364160711|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
105589989|NCT01981850|364160712|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
105589990|NCT01981850|364160713|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
105589991|NCT01981850|364160704|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
105589992|NCT01981850|364160705|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
105589993|NCT01981850|364160706|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
105589994|NCT01981850|364160707|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
105589995|NCT01981850|364160708|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
105589996|NCT01981850|364160709|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
105589997|NCT01981850|364160710|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
105589998|NCT01981850|364160711|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
105589999|NCT01981850|364160712|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
105590000|NCT01981850|364160713|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
105590001|NCT01981850|364160704|FG000|Main Phase Stage 1|Various reasons|0|||
105590002|NCT01981850|364160705|FG001|Main Phase Stage 1|Various reasons|0|||
105590003|NCT01981850|364160706|FG002|Main Phase Stage 1|Various reasons|2|||
105590004|NCT01981850|364160707|FG003|Main Phase Stage 1|Various reasons|0|||
105590005|NCT01981850|364160708|FG004|Main Phase Stage 1|Various reasons|0|||
105590006|NCT01981850|364160709|FG005|Main Phase Stage 1|Various reasons|0|||
105590007|NCT01981850|364160710|FG006|Main Phase Stage 1|Various reasons|0|||
105590008|NCT01981850|364160711|FG007|Main Phase Stage 1|Various reasons|0|||
105590009|NCT01981850|364160712|FG008|Main Phase Stage 1|Various reasons|0|||
105590010|NCT01981850|364160713|FG009|Main Phase Stage 1|Various reasons|0|||
105590011|NCT01981850|364160704|FG000|Main Phase Stage 2|Adverse Event|0|||
105590012|NCT01981850|364160705|FG001|Main Phase Stage 2|Adverse Event|0|||
105590013|NCT01981850|364160706|FG002|Main Phase Stage 2|Adverse Event|0|||
105590014|NCT01981850|364160707|FG003|Main Phase Stage 2|Adverse Event|0|||
105590015|NCT01981850|364160708|FG004|Main Phase Stage 2|Adverse Event|6|||
105590016|NCT01981850|364160709|FG005|Main Phase Stage 2|Adverse Event|5|||
105590017|NCT01981850|364160710|FG006|Main Phase Stage 2|Adverse Event|7|||
105590018|NCT01981850|364160711|FG007|Main Phase Stage 2|Adverse Event|0|||
105590019|NCT01981850|364160712|FG008|Main Phase Stage 2|Adverse Event|0|||
105590020|NCT01981850|364160713|FG009|Main Phase Stage 2|Adverse Event|0|||
105590021|NCT01981850|364160704|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
105590022|NCT01981850|364160705|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
105590023|NCT01981850|364160706|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
105590024|NCT01981850|364160707|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
105590025|NCT01981850|364160708|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
105590026|NCT01981850|364160709|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
105590027|NCT01981850|364160710|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
105590028|NCT01981850|364160711|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
105590029|NCT01981850|364160712|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
105590030|NCT01981850|364160713|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
105590031|NCT01981850|364160704|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
105590032|NCT01981850|364160705|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
105590033|NCT01981850|364160706|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
105430022|NCT02713529|363581647|FG002|Overall Study|Lost to Follow-up|1|||
105430023|NCT02713529|363581648|FG003|Overall Study|Lost to Follow-up|0|||
105430024|NCT02713529|363581649|FG004|Overall Study|Lost to Follow-up|0|||
105430025|NCT02713529|363581650|FG005|Overall Study|Lost to Follow-up|0|||
105430026|NCT02713529|363581651|FG006|Overall Study|Lost to Follow-up|0|||
105430027|NCT02713529|363581645|FG000|Overall Study|Death|3|||
105430028|NCT02713529|363581646|FG001|Overall Study|Death|3|||
105590034|NCT01981850|364160707|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
105430029|NCT02713529|363581647|FG002|Overall Study|Death|26|||
105590035|NCT01981850|364160708|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
105590036|NCT01981850|364160709|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
105590037|NCT01981850|364160710|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
105430030|NCT02713529|363581648|FG003|Overall Study|Death|27|||
105430031|NCT02713529|363581649|FG004|Overall Study|Death|3|||
105430032|NCT02713529|363581650|FG005|Overall Study|Death|13|||
105430033|NCT02713529|363581651|FG006|Overall Study|Death|3|||
105430034|NCT02576860|363581652|FG000|Overall Study|Adverse Event|6|||
105501734|NCT01254331|363848895|FG000|Initial Phase|Adverse Event|3|||
105501735|NCT01254331|363848895|FG000|Initial Phase|Withdrawal by Subject|1|||
105501736|NCT01254331|363848895|FG000|Initial Phase|Pregnancy|1|||
105501737|NCT01254331|363848895|FG000|Extension Phase|Lack of Efficacy|1|||
105501738|NCT01254331|363848895|FG000|Extension Phase|Lost to Follow-up|3|||
105501739|NCT05306977|363848896|FG000|Overall Study|Withdrawal by Subject|1|||
105501740|NCT01612858|363848897|FG000|Overall Study|Withdrawal by Subject|5|||
105501741|NCT01612858|363848898|FG001|Overall Study|Withdrawal by Subject|1|||
105501742|NCT03988088|363848901|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
105501743|NCT03988088|363848902|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
105501744|NCT03988088|363848903|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
105501745|NCT03988088|363848904|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
105501746|NCT03988088|363848901|FG000|Open-Label Addendum|Lost to Follow-up|0|||
105501747|NCT03988088|363848902|FG001|Open-Label Addendum|Lost to Follow-up|0|||
105501748|NCT03988088|363848903|FG002|Open-Label Addendum|Lost to Follow-up|1|||
105501749|NCT03988088|363848904|FG003|Open-Label Addendum|Lost to Follow-up|0|||
105501750|NCT04431453|363848905|FG000|Overall Study|Withdrew Consent|0|||
105501751|NCT04431453|363848906|FG001|Overall Study|Withdrew Consent|1|||
105501752|NCT04431453|363848907|FG002|Overall Study|Withdrew Consent|0|||
105501753|NCT04431453|363848908|FG003|Overall Study|Withdrew Consent|2|||
105501754|NCT04431453|363848909|FG004|Overall Study|Withdrew Consent|0|||
105501755|NCT04431453|363848910|FG005|Overall Study|Withdrew Consent|0|||
105501756|NCT04431453|363848911|FG006|Overall Study|Withdrew Consent|0|||
105501757|NCT04431453|363848912|FG007|Overall Study|Withdrew Consent|0|||
105501758|NCT04431453|363848905|FG000|Overall Study|Death|1|||
105501759|NCT04431453|363848906|FG001|Overall Study|Death|0|||
105501760|NCT04431453|363848907|FG002|Overall Study|Death|0|||
105501761|NCT04431453|363848908|FG003|Overall Study|Death|0|||
105501762|NCT04431453|363848909|FG004|Overall Study|Death|0|||
105501763|NCT04431453|363848910|FG005|Overall Study|Death|0|||
105501764|NCT04431453|363848911|FG006|Overall Study|Death|0|||
105501765|NCT04431453|363848912|FG007|Overall Study|Death|1|||
105501766|NCT04431453|363848905|FG000|Overall Study|Lost to Follow-up|0|||
105501767|NCT04431453|363848906|FG001|Overall Study|Lost to Follow-up|0|||
105501768|NCT04431453|363848907|FG002|Overall Study|Lost to Follow-up|1|||
105501769|NCT04431453|363848908|FG003|Overall Study|Lost to Follow-up|1|||
105501770|NCT04431453|363848909|FG004|Overall Study|Lost to Follow-up|0|||
105501771|NCT04431453|363848910|FG005|Overall Study|Lost to Follow-up|0|||
105501772|NCT04431453|363848911|FG006|Overall Study|Lost to Follow-up|0|||
105501773|NCT04431453|363848912|FG007|Overall Study|Lost to Follow-up|0|||
105501774|NCT04431453|363848905|FG000|Overall Study|Enrolled but Never Treated|0|||
105501775|NCT04431453|363848906|FG001|Overall Study|Enrolled but Never Treated|0|||
105501776|NCT04431453|363848907|FG002|Overall Study|Enrolled but Never Treated|0|||
105501777|NCT04431453|363848908|FG003|Overall Study|Enrolled but Never Treated|0|||
105501778|NCT04431453|363848909|FG004|Overall Study|Enrolled but Never Treated|1|||
105501779|NCT04431453|363848910|FG005|Overall Study|Enrolled but Never Treated|0|||
105501780|NCT04431453|363848911|FG006|Overall Study|Enrolled but Never Treated|0|||
105501781|NCT04431453|363848912|FG007|Overall Study|Enrolled but Never Treated|0|||
105501782|NCT02762578|363848921|FG000|Overall Study|Adverse Event|1|||
105501783|NCT02762578|363848922|FG001|Overall Study|Adverse Event|6|||
105501784|NCT02762578|363848921|FG000|Overall Study|Protocol Violation|4|||
105501785|NCT02762578|363848922|FG001|Overall Study|Protocol Violation|2|||
105501786|NCT02762578|363848921|FG000|Overall Study|Withdrawal by Subject|4|||
105501787|NCT02762578|363848922|FG001|Overall Study|Withdrawal by Subject|2|||
105501788|NCT02762578|363848921|FG000|Overall Study|Unclassified|6|||
105501789|NCT02762578|363848922|FG001|Overall Study|Unclassified|0|||
105501790|NCT01090492|363848923|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
105501791|NCT01090492|363848924|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
105501792|NCT01090492|363848925|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
105501793|NCT01090492|363848926|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
105501794|NCT01090492|363848927|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
105501795|NCT01090492|363848928|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
105501796|NCT01090492|363848929|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
105501797|NCT01090492|363848930|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
105501798|NCT01090492|363848923|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
105501799|NCT01090492|363848924|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
105501800|NCT01090492|363848925|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
105501801|NCT01090492|363848926|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
105501802|NCT01090492|363848927|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
105501803|NCT01090492|363848928|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
105501804|NCT01090492|363848929|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
105501805|NCT01090492|363848930|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
105501806|NCT01090492|363848923|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
105501807|NCT01090492|363848924|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
105430035|NCT02576860|363581653|FG001|Overall Study|Adverse Event|6|||
105430036|NCT02576860|363581652|FG000|Overall Study|Lost to Follow-up|5|||
105430037|NCT02576860|363581653|FG001|Overall Study|Lost to Follow-up|7|||
105430038|NCT02576860|363581652|FG000|Overall Study|Physician Decision|0|||
105430039|NCT02576860|363581653|FG001|Overall Study|Physician Decision|1|||
105430040|NCT02576860|363581652|FG000|Overall Study|Protocol Violation|0|||
105430041|NCT02576860|363581653|FG001|Overall Study|Protocol Violation|2|||
105430042|NCT02576860|363581652|FG000|Overall Study|Withdrawal by Subject|13|||
105430043|NCT02576860|363581653|FG001|Overall Study|Withdrawal by Subject|8|||
105430044|NCT02576860|363581652|FG000|Overall Study|Disallowed medication|1|||
105430045|NCT02576860|363581653|FG001|Overall Study|Disallowed medication|0|||
105430046|NCT02827500|363581654|FG000|Overall Study|Death|7|||
105430047|NCT02827500|363581655|FG001|Overall Study|Death|3|||
105430048|NCT02827500|363581654|FG000|Overall Study|Lost to Follow-up|1|||
105430049|NCT02827500|363581655|FG001|Overall Study|Lost to Follow-up|1|||
105430050|NCT02827500|363581654|FG000|Overall Study|Withdrawal by Subject|3|||
105430051|NCT02827500|363581655|FG001|Overall Study|Withdrawal by Subject|1|||
105430052|NCT02827500|363581654|FG000|Overall Study|Missing primary endpoint data|3|||
105430053|NCT02827500|363581655|FG001|Overall Study|Missing primary endpoint data|1|||
105430054|NCT02827500|363581654|FG000|Overall Study|Other|5|||
105430055|NCT02827500|363581655|FG001|Overall Study|Other|1|||
105430056|NCT00514020|363581656|FG000|Overall Study|Adverse Event|6|||
105430057|NCT00514020|363581656|FG000|Overall Study|Withdrawal by Subject|3|||
105430058|NCT00514020|363581656|FG000|Overall Study|Physician Decision|1|||
105430059|NCT00514020|363581656|FG000|Overall Study|disease progression|9|||
105430060|NCT00514020|363581656|FG000|Overall Study|other complicating disease|2|||
105430061|NCT00514020|363581656|FG000|Overall Study|patient went to radiation treatment|1|||
105430062|NCT00514020|363581656|FG000|Overall Study|"patients moved to the no tx group"|6|||
105430063|NCT03780959|363581660|FG000|Part 1|Adverse Event|1|||
105430064|NCT03780959|363581661|FG001|Part 1|Adverse Event|0|||
105430065|NCT03780959|363581662|FG002|Part 1|Adverse Event|0|||
105501808|NCT01090492|363848925|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
105501809|NCT01090492|363848926|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
105501810|NCT01090492|363848927|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
105501811|NCT01090492|363848928|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
105501812|NCT01090492|363848929|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
105501813|NCT01090492|363848930|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
105501814|NCT01090492|363848923|FG000|First Intervention Period (4 Weeks)|Other|0|||
105590038|NCT01981850|364160711|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
105590039|NCT01981850|364160712|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
105590040|NCT01981850|364160713|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
105590041|NCT01981850|364160704|FG000|Main Phase Stage 2|Various reasons|0|||
105590042|NCT01981850|364160705|FG001|Main Phase Stage 2|Various reasons|0|||
105590043|NCT01981850|364160706|FG002|Main Phase Stage 2|Various reasons|0|||
105590044|NCT01981850|364160707|FG003|Main Phase Stage 2|Various reasons|0|||
105590045|NCT01981850|364160708|FG004|Main Phase Stage 2|Various reasons|2|||
105590046|NCT01981850|364160709|FG005|Main Phase Stage 2|Various reasons|0|||
105590047|NCT01981850|364160710|FG006|Main Phase Stage 2|Various reasons|1|||
105590048|NCT01981850|364160711|FG007|Main Phase Stage 2|Various reasons|0|||
105590049|NCT01981850|364160712|FG008|Main Phase Stage 2|Various reasons|0|||
105590050|NCT01981850|364160713|FG009|Main Phase Stage 2|Various reasons|0|||
105590051|NCT01981850|364160704|FG000|Main Phase Stage 2|Progressive Disease|0|||
105590052|NCT01981850|364160705|FG001|Main Phase Stage 2|Progressive Disease|0|||
105590053|NCT01981850|364160706|FG002|Main Phase Stage 2|Progressive Disease|0|||
105590054|NCT01981850|364160707|FG003|Main Phase Stage 2|Progressive Disease|0|||
105590055|NCT01981850|364160708|FG004|Main Phase Stage 2|Progressive Disease|0|||
105590056|NCT01981850|364160709|FG005|Main Phase Stage 2|Progressive Disease|6|||
105590057|NCT01981850|364160710|FG006|Main Phase Stage 2|Progressive Disease|6|||
105590058|NCT01981850|364160711|FG007|Main Phase Stage 2|Progressive Disease|0|||
105590059|NCT01981850|364160712|FG008|Main Phase Stage 2|Progressive Disease|0|||
105590060|NCT01981850|364160713|FG009|Main Phase Stage 2|Progressive Disease|0|||
105430066|NCT03780959|363581660|FG000|Part 1|Withdrawal by Subject|1|||
105501815|NCT01090492|363848924|FG001|First Intervention Period (4 Weeks)|Other|0|||
105590061|NCT01981850|364160704|FG000|Open Label Extension (OLE)|Adverse Event|0|||
105590062|NCT01981850|364160705|FG001|Open Label Extension (OLE)|Adverse Event|0|||
105430067|NCT03780959|363581661|FG001|Part 1|Withdrawal by Subject|0|||
105430068|NCT03780959|363581662|FG002|Part 1|Withdrawal by Subject|0|||
105430069|NCT03780959|363581660|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
105430070|NCT03780959|363581661|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
105430071|NCT03780959|363581662|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
105590063|NCT01981850|364160706|FG002|Open Label Extension (OLE)|Adverse Event|0|||
105590064|NCT01981850|364160707|FG003|Open Label Extension (OLE)|Adverse Event|0|||
105430072|NCT03780959|363581660|FG000|Part 1|Response Status|2|||
105430073|NCT03780959|363581661|FG001|Part 1|Response Status|0|||
105590065|NCT01981850|364160708|FG004|Open Label Extension (OLE)|Adverse Event|0|||
105590066|NCT01981850|364160709|FG005|Open Label Extension (OLE)|Adverse Event|0|||
105590067|NCT01981850|364160710|FG006|Open Label Extension (OLE)|Adverse Event|0|||
105590068|NCT01981850|364160711|FG007|Open Label Extension (OLE)|Adverse Event|2|||
105590069|NCT01981850|364160712|FG008|Open Label Extension (OLE)|Adverse Event|1|||
105590070|NCT01981850|364160713|FG009|Open Label Extension (OLE)|Adverse Event|8|||
105590071|NCT01981850|364160704|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
105590072|NCT01981850|364160705|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
105590073|NCT01981850|364160706|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
105590074|NCT01981850|364160707|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
105590075|NCT01981850|364160708|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
105590076|NCT01981850|364160709|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
105590077|NCT01981850|364160710|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
105590078|NCT01981850|364160711|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
105590079|NCT01981850|364160712|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
105590080|NCT01981850|364160713|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
105590081|NCT01981850|364160704|FG000|Open Label Extension (OLE)|Various reasons|0|||
105590082|NCT01981850|364160705|FG001|Open Label Extension (OLE)|Various reasons|0|||
105590083|NCT01981850|364160706|FG002|Open Label Extension (OLE)|Various reasons|0|||
105590084|NCT01981850|364160707|FG003|Open Label Extension (OLE)|Various reasons|0|||
105590085|NCT01981850|364160708|FG004|Open Label Extension (OLE)|Various reasons|0|||
105590086|NCT01981850|364160709|FG005|Open Label Extension (OLE)|Various reasons|0|||
105590087|NCT01981850|364160710|FG006|Open Label Extension (OLE)|Various reasons|0|||
105590088|NCT01981850|364160711|FG007|Open Label Extension (OLE)|Various reasons|3|||
105590089|NCT01981850|364160712|FG008|Open Label Extension (OLE)|Various reasons|1|||
105590090|NCT01981850|364160713|FG009|Open Label Extension (OLE)|Various reasons|3|||
105590091|NCT01981850|364160704|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
105590092|NCT01981850|364160705|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
105590093|NCT01981850|364160706|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
105590094|NCT01981850|364160707|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
105590095|NCT01981850|364160708|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
105590096|NCT01981850|364160709|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
105590097|NCT01981850|364160710|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
105590098|NCT01981850|364160711|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
105590099|NCT01981850|364160712|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
105590100|NCT01981850|364160713|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
105590101|NCT01981850|364160704|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
105590102|NCT01981850|364160705|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
105590103|NCT01981850|364160706|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
105590104|NCT01981850|364160707|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
105590105|NCT01981850|364160708|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
105590106|NCT01981850|364160709|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
105590107|NCT01981850|364160710|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
105590108|NCT01981850|364160711|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
105590109|NCT01981850|364160712|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
105590110|NCT01981850|364160713|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
105590111|NCT01981850|364160704|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
105590112|NCT01981850|364160705|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
105590113|NCT01981850|364160706|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
105590114|NCT01981850|364160707|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
105590115|NCT01981850|364160708|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
105590116|NCT01981850|364160709|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
105590117|NCT01981850|364160710|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
105590118|NCT01981850|364160711|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
105590119|NCT01981850|364160712|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
105590120|NCT01981850|364160713|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
105590121|NCT01835899|364160714|FG000|Overall Study|Adverse Event|0|||
105590122|NCT01835899|364160715|FG001|Overall Study|Adverse Event|0|||
105590123|NCT01835899|364160716|FG002|Overall Study|Adverse Event|1|||
105430074|NCT03780959|363581662|FG002|Part 1|Response Status|0|||
105430075|NCT03780959|363581660|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
105430076|NCT03780959|363581661|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
105430077|NCT03780959|363581662|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
105590124|NCT01835899|364160714|FG000|Overall Study|Other than stated above|0|||
105590125|NCT01835899|364160715|FG001|Overall Study|Other than stated above|1|||
105590126|NCT01835899|364160716|FG002|Overall Study|Other than stated above|0|||
105590127|NCT03593070|364160717|FG000|Overall Study|administrative withdrawal|1|||
105590128|NCT03593070|364160718|FG001|Overall Study|administrative withdrawal|1|||
105590129|NCT04109118|364160719|FG000|Overall Study|Lost to Follow-up|3|||
105590130|NCT03235349|364160720|FG000|Overall Study|Adverse Event|1|||
105590131|NCT03235349|364160720|FG000|Overall Study|Other|1|||
105590132|NCT03643211|364160722|FG000|Overall Study|Contract violation/deficiency|12|||
105590133|NCT03643211|364160722|FG000|Overall Study|Invalid registration|3|||
105590134|NCT03643211|364160722|FG000|Overall Study|No treatment information|2|||
105590135|NCT03643211|364160722|FG000|Overall Study|No adverse event information - No revisit|4|||
105590136|NCT04523181|364160725|FG000|Overall Study|Withdrawal by Subject|4|||
105590137|NCT04523181|364160726|FG001|Overall Study|Withdrawal by Subject|5|||
105590138|NCT04523181|364160725|FG000|Overall Study|Lost to Follow-up|2|||
105590139|NCT04523181|364160726|FG001|Overall Study|Lost to Follow-up|3|||
105590140|NCT04523181|364160725|FG000|Overall Study|Physician Decision|1|||
105590141|NCT04523181|364160726|FG001|Overall Study|Physician Decision|0|||
105590142|NCT04523181|364160725|FG000|Overall Study|Transferred to external facility.|1|||
105590143|NCT04523181|364160726|FG001|Overall Study|Transferred to external facility.|1|||
105590144|NCT04305912|364160729|FG000|First Intervention|COVID-19 Suspension|2|||
105590145|NCT04305912|364160730|FG001|First Intervention|COVID-19 Suspension|0|||
105590146|NCT04305912|364160729|FG000|First Intervention|Withdrawal by Subject|0|||
105590147|NCT04305912|364160730|FG001|First Intervention|Withdrawal by Subject|1|||
105590148|NCT04305912|364160729|FG000|Second Intervention|Adverse Event|0|||
105590149|NCT04305912|364160730|FG001|Second Intervention|Adverse Event|1|||
105590150|NCT04886596|364160733|FG000|Overall Study|Adverse Event|73|||
105590151|NCT04886596|364160734|FG001|Overall Study|Adverse Event|78|||
105590152|NCT04886596|364160733|FG000|Overall Study|Lost to Follow-up|104|||
105590153|NCT04886596|364160734|FG001|Overall Study|Lost to Follow-up|104|||
105590154|NCT04886596|364160733|FG000|Overall Study|Ongoing|12095|||
105590155|NCT04886596|364160734|FG001|Overall Study|Ongoing|12107|||
105590156|NCT04886596|364160733|FG000|Overall Study|Consent withdrawal, not due to an (S)AE|162|||
105590157|NCT04886596|364160734|FG001|Overall Study|Consent withdrawal, not due to an (S)AE|173|||
105590158|NCT04886596|364160733|FG000|Overall Study|Migrated / Moved from the study area|17|||
105590159|NCT04886596|364160734|FG001|Overall Study|Migrated / Moved from the study area|14|||
105590160|NCT04886596|364160733|FG000|Overall Study|Unknown reason|16|||
105590161|NCT04886596|364160734|FG001|Overall Study|Unknown reason|23|||
105590162|NCT05096884|364160735|FG000|Overall Study|Excluded based on negative tilt table test|4|||
105590163|NCT05824351|364160736|FG000|Overall Study|Adverse Event|6|||
105590164|NCT04678830|364160737|FG000|Overall Study|Lack of Efficacy|2|||
105590165|NCT04678830|364160738|FG001|Overall Study|Lack of Efficacy|0|||
105590166|NCT04678830|364160737|FG000|Overall Study|Withdrawal by Subject|0|||
105590167|NCT04678830|364160738|FG001|Overall Study|Withdrawal by Subject|1|||
105590168|NCT01543685|364160741|FG000|Overall Study|Lack of Efficacy|1|||
105590169|NCT01543685|364160742|FG001|Overall Study|Lack of Efficacy|2|||
105590170|NCT01543685|364160743|FG002|Overall Study|Lack of Efficacy|2|||
105590171|NCT01543685|364160744|FG003|Overall Study|Lack of Efficacy|0|||
105590172|NCT01543685|364160745|FG004|Overall Study|Lack of Efficacy|2|||
105590173|NCT01543685|364160741|FG000|Overall Study|Adverse Event|2|||
105590174|NCT01543685|364160742|FG001|Overall Study|Adverse Event|1|||
105590175|NCT01543685|364160743|FG002|Overall Study|Adverse Event|0|||
105590176|NCT01543685|364160744|FG003|Overall Study|Adverse Event|0|||
105590177|NCT01543685|364160745|FG004|Overall Study|Adverse Event|2|||
105590178|NCT00124982|364160748|FG000|Short-term Period|Death|1|||
105590179|NCT00124982|364160749|FG001|Short-term Period|Death|1|||
105590180|NCT00124982|364160750|FG002|Short-term Period|Death|0|||
105590181|NCT00124982|364160748|FG000|Short-term Period|Adverse Event|17|||
105590182|NCT00124982|364160749|FG001|Short-term Period|Adverse Event|22|||
105590183|NCT00124982|364160750|FG002|Short-term Period|Adverse Event|0|||
105590184|NCT00124982|364160748|FG000|Short-term Period|Lack of Efficacy|32|||
105590185|NCT00124982|364160749|FG001|Short-term Period|Lack of Efficacy|73|||
105590186|NCT00124982|364160750|FG002|Short-term Period|Lack of Efficacy|0|||
105590187|NCT00124982|364160748|FG000|Short-term Period|Lost to Follow-up|8|||
105590188|NCT00124982|364160749|FG001|Short-term Period|Lost to Follow-up|5|||
105590189|NCT00124982|364160750|FG002|Short-term Period|Lost to Follow-up|0|||
105590190|NCT00124982|364160748|FG000|Short-term Period|Withdrawal of Consent|7|||
105590191|NCT00124982|364160749|FG001|Short-term Period|Withdrawal of Consent|9|||
105590192|NCT00124982|364160750|FG002|Short-term Period|Withdrawal of Consent|0|||
105590193|NCT00124982|364160748|FG000|Short-term Period|Poor/Non-compliance|3|||
105590194|NCT00124982|364160749|FG001|Short-term Period|Poor/Non-compliance|1|||
105590195|NCT00124982|364160750|FG002|Short-term Period|Poor/Non-compliance|0|||
105590196|NCT00124982|364160748|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
105590197|NCT00124982|364160749|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
105590198|NCT00124982|364160750|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
105590199|NCT00124982|364160748|FG000|Short-term Period|Participant Decision|1|||
105590200|NCT00124982|364160749|FG001|Short-term Period|Participant Decision|0|||
105590201|NCT00124982|364160750|FG002|Short-term Period|Participant Decision|0|||
105590202|NCT00124982|364160748|FG000|Short-term Period|Participant Chose Own Doctor|0|||
105590203|NCT00124982|364160749|FG001|Short-term Period|Participant Chose Own Doctor|1|||
105590204|NCT00124982|364160750|FG002|Short-term Period|Participant Chose Own Doctor|0|||
105590205|NCT00124982|364160748|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
105590206|NCT00124982|364160749|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
105590207|NCT00124982|364160750|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
105430078|NCT03780959|363581660|FG000|Part 2|Response Status|0|||
105430079|NCT03780959|363581661|FG001|Part 2|Response Status|18|||
105430080|NCT03780959|363581662|FG002|Part 2|Response Status|6|||
105430081|NCT02308488|363581665|FG000|Overall Study|Withdrawal by Subject|2|||
105430082|NCT01541917|363581666|FG000|Overall Study|Lost to Follow-up|2|||
105430083|NCT01541917|363581667|FG001|Overall Study|Lost to Follow-up|2|||
105430084|NCT01541917|363581666|FG000|Overall Study|Withdrawal by Subject|13|||
105430085|NCT01541917|363581667|FG001|Overall Study|Withdrawal by Subject|7|||
105430086|NCT01565564|363581673|FG000|Overall Study|Lost to Follow-up|5|||
105430087|NCT01565564|363581674|FG001|Overall Study|Lost to Follow-up|1|||
105430088|NCT00276614|363581679|FG000|Overall Study|Progression of disease under study|3|||
105430089|NCT05219669|363581682|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
105430090|NCT05219669|363581683|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
105430091|NCT05219669|363581684|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
105430092|NCT05219669|363581685|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
105430093|NCT05219669|363581686|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
105430094|NCT05219669|363581687|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
105430095|NCT02404649|363581688|FG000|Overall Study|Adverse Event|1|||
105430096|NCT02404649|363581689|FG001|Overall Study|Adverse Event|2|||
105501816|NCT01090492|363848925|FG002|First Intervention Period (4 Weeks)|Other|1|||
105501817|NCT01090492|363848926|FG003|First Intervention Period (4 Weeks)|Other|1|||
105501818|NCT01090492|363848927|FG004|First Intervention Period (4 Weeks)|Other|2|||
105501819|NCT01090492|363848928|FG005|First Intervention Period (4 Weeks)|Other|0|||
105501820|NCT01090492|363848929|FG006|First Intervention Period (4 Weeks)|Other|0|||
105501821|NCT01090492|363848930|FG007|First Intervention Period (4 Weeks)|Other|0|||
105501822|NCT01090492|363848923|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
105501823|NCT01090492|363848924|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
105501824|NCT01090492|363848925|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
105501825|NCT01090492|363848926|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
105501826|NCT01090492|363848927|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
105501827|NCT01090492|363848928|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
105501828|NCT01090492|363848929|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
105501829|NCT01090492|363848930|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
105501830|NCT01090492|363848923|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
105501831|NCT01090492|363848924|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
105501832|NCT01090492|363848925|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
105501833|NCT01090492|363848926|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
105501834|NCT01090492|363848927|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
105501835|NCT01090492|363848928|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
105501836|NCT01090492|363848929|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
105501837|NCT01090492|363848930|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
105501838|NCT01090492|363848923|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
105501839|NCT01090492|363848924|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
105501840|NCT01090492|363848925|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
105501841|NCT01090492|363848926|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
105501842|NCT01090492|363848927|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
105501843|NCT01090492|363848928|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
105501844|NCT01090492|363848929|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
105501845|NCT01090492|363848930|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
105501846|NCT01090492|363848923|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
105501847|NCT01090492|363848924|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
105501848|NCT01090492|363848925|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
105501849|NCT01090492|363848926|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
105501850|NCT01090492|363848927|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
105501851|NCT01090492|363848928|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
105501852|NCT01090492|363848929|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
105501853|NCT01090492|363848930|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
105501854|NCT01090492|363848923|FG000|Second Intervention Period (4 Weeks)|Other|0|||
105501855|NCT01090492|363848924|FG001|Second Intervention Period (4 Weeks)|Other|1|||
105501856|NCT01090492|363848925|FG002|Second Intervention Period (4 Weeks)|Other|1|||
105430097|NCT00330668|363581693|FG000|BID Dosing Period|Adverse Event|1|||
105430098|NCT00330668|363581693|FG000|BID Dosing Period|Lost to Follow-up|7|||
105430099|NCT00330668|363581693|FG000|BID Dosing Period|Non-Compliance|5|||
105501857|NCT01090492|363848926|FG003|Second Intervention Period (4 Weeks)|Other|0|||
105501858|NCT01090492|363848927|FG004|Second Intervention Period (4 Weeks)|Other|0|||
105501859|NCT01090492|363848928|FG005|Second Intervention Period (4 Weeks)|Other|0|||
105501860|NCT01090492|363848929|FG006|Second Intervention Period (4 Weeks)|Other|0|||
105501861|NCT01090492|363848930|FG007|Second Intervention Period (4 Weeks)|Other|0|||
105590208|NCT00124982|364160748|FG000|Short-term Period|Participant Had Lymphopenia|1|||
105430100|NCT00330668|363581693|FG000|BID Dosing Period|Withdrawal by Subject|19|||
105430101|NCT00330668|363581693|FG000|BID Dosing Period|Sponsor's decision|1|||
105430102|NCT00330668|363581693|FG000|BID Dosing Period|Other|3|||
105430103|NCT00330668|363581693|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
105430104|NCT00330668|363581693|FG000|QD Dosing Period|Other|1|||
105430105|NCT00330668|363581693|FG000|QD Dosing Period|Withdrawal by Subject|1|||
105430106|NCT00330668|363581693|FG000|QD Dosing Period|Lost to Follow-up|2|||
105430107|NCT01595581|363581694|FG000|Overall Study|Withdrawal by Subject|1|||
105430108|NCT01595581|363581695|FG001|Overall Study|Withdrawal by Subject|0|||
105430109|NCT02198235|363581698|FG000|Overall Study|Lost to Follow-up|3|||
105430110|NCT02198235|363581699|FG001|Overall Study|Lost to Follow-up|2|||
105430111|NCT02198235|363581700|FG002|Overall Study|Lost to Follow-up|2|||
105430112|NCT00447122|363581704|FG000|Overall Study|worsening medical condition -came off|0|||
105430113|NCT00447122|363581705|FG001|Overall Study|worsening medical condition -came off|1|||
105430114|NCT00447122|363581706|FG002|Overall Study|worsening medical condition -came off|0|||
105430115|NCT00447122|363581707|FG003|Overall Study|worsening medical condition -came off|0|||
105430116|NCT02440789|363581708|FG000|Overall Study|Withdrawal by Subject|3|||
105430117|NCT02440789|363581708|FG000|Overall Study|Not willing to adhere to reqs|1|||
105430118|NCT04573881|363581709|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
105430119|NCT02564978|363581714|FG000|Overall Study|Adverse Event|8|||
105430120|NCT02564978|363581714|FG000|Overall Study|Death|1|||
105430121|NCT02564978|363581714|FG000|Overall Study|Lost to Follow-up|1|||
105430122|NCT02564978|363581714|FG000|Overall Study|Withdrawal by Subject|15|||
105430123|NCT02564978|363581714|FG000|Overall Study|Early Study Closure|2|||
105430124|NCT02564978|363581714|FG000|Overall Study|Other Reason|5|||
105430125|NCT03684694|363581715|FG000|Phase 1|Withdrawal by Subject|1|||
105430126|NCT03684694|363581716|FG001|Phase 1|Withdrawal by Subject|0|||
105430127|NCT03684694|363581717|FG002|Phase 1|Withdrawal by Subject|0|||
105430128|NCT03684694|363581718|FG003|Phase 1|Withdrawal by Subject|0|||
105430129|NCT03684694|363581719|FG004|Phase 1|Withdrawal by Subject|0|||
105430130|NCT03684694|363581720|FG005|Phase 1|Withdrawal by Subject|0|||
105430131|NCT03684694|363581715|FG000|Phase 1|Investigator/Sponsor Decision|12|||
105430132|NCT03684694|363581716|FG001|Phase 1|Investigator/Sponsor Decision|2|||
105430133|NCT03684694|363581717|FG002|Phase 1|Investigator/Sponsor Decision|1|||
105430134|NCT03684694|363581718|FG003|Phase 1|Investigator/Sponsor Decision|0|||
105430135|NCT03684694|363581719|FG004|Phase 1|Investigator/Sponsor Decision|0|||
105430136|NCT03684694|363581720|FG005|Phase 1|Investigator/Sponsor Decision|0|||
105430137|NCT03684694|363581715|FG000|Phase 1|Death|24|||
105430138|NCT03684694|363581716|FG001|Phase 1|Death|0|||
105430139|NCT03684694|363581717|FG002|Phase 1|Death|3|||
105430140|NCT03684694|363581718|FG003|Phase 1|Death|0|||
105430141|NCT03684694|363581719|FG004|Phase 1|Death|0|||
105430142|NCT03684694|363581720|FG005|Phase 1|Death|0|||
105430143|NCT03684694|363581715|FG000|Phase 1|Lost to Follow-up|0|||
105430144|NCT03684694|363581716|FG001|Phase 1|Lost to Follow-up|0|||
105430145|NCT03684694|363581717|FG002|Phase 1|Lost to Follow-up|1|||
105430146|NCT03684694|363581718|FG003|Phase 1|Lost to Follow-up|0|||
105430147|NCT03684694|363581719|FG004|Phase 1|Lost to Follow-up|0|||
105430148|NCT03684694|363581720|FG005|Phase 1|Lost to Follow-up|0|||
105430149|NCT03684694|363581715|FG000|Phase 1|Miscellaneous|0|||
105430150|NCT03684694|363581716|FG001|Phase 1|Miscellaneous|1|||
105430151|NCT03684694|363581717|FG002|Phase 1|Miscellaneous|0|||
105430152|NCT03684694|363581718|FG003|Phase 1|Miscellaneous|0|||
105430153|NCT03684694|363581719|FG004|Phase 1|Miscellaneous|0|||
105430154|NCT03684694|363581720|FG005|Phase 1|Miscellaneous|0|||
105430155|NCT03684694|363581715|FG000|Phase 2|Withdrawal by Subject|0|||
105430156|NCT03684694|363581716|FG001|Phase 2|Withdrawal by Subject|0|||
105430157|NCT03684694|363581717|FG002|Phase 2|Withdrawal by Subject|0|||
105430158|NCT03684694|363581718|FG003|Phase 2|Withdrawal by Subject|0|||
105430159|NCT03684694|363581719|FG004|Phase 2|Withdrawal by Subject|0|||
105430160|NCT03684694|363581720|FG005|Phase 2|Withdrawal by Subject|1|||
105430161|NCT03684694|363581715|FG000|Phase 2|Investigator/Sponsor Decision|0|||
105430162|NCT03684694|363581716|FG001|Phase 2|Investigator/Sponsor Decision|0|||
105430163|NCT03684694|363581717|FG002|Phase 2|Investigator/Sponsor Decision|0|||
105501862|NCT01090492|363848923|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
105501863|NCT01090492|363848924|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
105501864|NCT01090492|363848925|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
105501865|NCT01090492|363848926|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
105430164|NCT03684694|363581718|FG003|Phase 2|Investigator/Sponsor Decision|17|||
105430165|NCT03684694|363581719|FG004|Phase 2|Investigator/Sponsor Decision|16|||
105430166|NCT03684694|363581720|FG005|Phase 2|Investigator/Sponsor Decision|6|||
105430167|NCT03684694|363581715|FG000|Phase 2|Death|0|||
105430168|NCT03684694|363581716|FG001|Phase 2|Death|0|||
105430169|NCT03684694|363581717|FG002|Phase 2|Death|0|||
105430170|NCT03684694|363581718|FG003|Phase 2|Death|28|||
105430171|NCT03684694|363581719|FG004|Phase 2|Death|14|||
105430172|NCT03684694|363581720|FG005|Phase 2|Death|3|||
105430173|NCT03684694|363581715|FG000|Phase 2|Lost to Follow-up|0|||
105430174|NCT03684694|363581716|FG001|Phase 2|Lost to Follow-up|0|||
105430175|NCT03684694|363581717|FG002|Phase 2|Lost to Follow-up|0|||
105430176|NCT03684694|363581718|FG003|Phase 2|Lost to Follow-up|1|||
105430177|NCT03684694|363581719|FG004|Phase 2|Lost to Follow-up|0|||
105430178|NCT03684694|363581720|FG005|Phase 2|Lost to Follow-up|0|||
105430179|NCT03684694|363581715|FG000|Phase 2|Miscellaneous|0|||
105430180|NCT03684694|363581716|FG001|Phase 2|Miscellaneous|0|||
105430181|NCT03684694|363581717|FG002|Phase 2|Miscellaneous|0|||
105430182|NCT03684694|363581718|FG003|Phase 2|Miscellaneous|3|||
105430183|NCT03684694|363581719|FG004|Phase 2|Miscellaneous|0|||
105430184|NCT03684694|363581720|FG005|Phase 2|Miscellaneous|0|||
105430185|NCT00203021|363583287|FG000|Overall Study|Death|4|||
105430186|NCT00203021|363583288|FG001|Overall Study|Death|1|||
105430187|NCT00203021|363583287|FG000|Overall Study|Adverse Event|10|||
105430188|NCT00203021|363583288|FG001|Overall Study|Adverse Event|5|||
105430189|NCT00203021|363583287|FG000|Overall Study|Withdrawal by Subject|45|||
105430190|NCT00203021|363583288|FG001|Overall Study|Withdrawal by Subject|48|||
105430191|NCT00203021|363583287|FG000|Overall Study|Lost to Follow-up|9|||
105430192|NCT00203021|363583288|FG001|Overall Study|Lost to Follow-up|7|||
105430193|NCT00203021|363583287|FG000|Overall Study|Other than specified|11|||
105430194|NCT00203021|363583288|FG001|Overall Study|Other than specified|16|||
105430195|NCT00471887|363583291|FG000|Overall Study|Adverse Event|9|||
105430196|NCT05160766|363583294|FG000|Overall Study|Adverse Event|0|||
105430197|NCT05160766|363583295|FG001|Overall Study|Adverse Event|1|||
105430198|NCT05160766|363583296|FG002|Overall Study|Adverse Event|0|||
105430199|NCT05160766|363583297|FG003|Overall Study|Adverse Event|0|||
105430200|NCT05160766|363583294|FG000|Overall Study|COVID-19 infection|0|||
105430201|NCT05160766|363583295|FG001|Overall Study|COVID-19 infection|1|||
105430202|NCT05160766|363583296|FG002|Overall Study|COVID-19 infection|0|||
105430203|NCT05160766|363583297|FG003|Overall Study|COVID-19 infection|0|||
105430204|NCT05160766|363583294|FG000|Overall Study|travel time|1|||
105430205|NCT05160766|363583295|FG001|Overall Study|travel time|0|||
105430206|NCT05160766|363583296|FG002|Overall Study|travel time|0|||
105430207|NCT05160766|363583297|FG003|Overall Study|travel time|1|||
105430208|NCT05160766|363583294|FG000|Overall Study|Withdrawal by Subject|3|||
105430209|NCT05160766|363583295|FG001|Overall Study|Withdrawal by Subject|5|||
105430210|NCT05160766|363583296|FG002|Overall Study|Withdrawal by Subject|4|||
105430211|NCT05160766|363583297|FG003|Overall Study|Withdrawal by Subject|2|||
105430212|NCT05160766|363583294|FG000|Overall Study|Death|0|||
105430213|NCT05160766|363583295|FG001|Overall Study|Death|0|||
105430214|NCT05160766|363583296|FG002|Overall Study|Death|2|||
105430215|NCT05160766|363583297|FG003|Overall Study|Death|5|||
105430216|NCT05160766|363583294|FG000|Overall Study|Lost to Follow-up|0|||
105430217|NCT05160766|363583295|FG001|Overall Study|Lost to Follow-up|0|||
105430218|NCT05160766|363583296|FG002|Overall Study|Lost to Follow-up|1|||
105430219|NCT05160766|363583297|FG003|Overall Study|Lost to Follow-up|2|||
105430220|NCT05160766|363583294|FG000|Overall Study|No show|0|||
105430221|NCT05160766|363583295|FG001|Overall Study|No show|0|||
105430222|NCT05160766|363583296|FG002|Overall Study|No show|1|||
105430223|NCT05160766|363583297|FG003|Overall Study|No show|1|||
105430224|NCT05160766|363583294|FG000|Overall Study|Physician Decision|0|||
105430225|NCT05160766|363583295|FG001|Overall Study|Physician Decision|0|||
105430226|NCT05160766|363583296|FG002|Overall Study|Physician Decision|0|||
105430227|NCT05160766|363583297|FG003|Overall Study|Physician Decision|1|||
105430228|NCT05160766|363583294|FG000|Overall Study|Protocol Violation|0|||
105430229|NCT05160766|363583295|FG001|Overall Study|Protocol Violation|0|||
105430230|NCT05160766|363583296|FG002|Overall Study|Protocol Violation|1|||
105430231|NCT05160766|363583297|FG003|Overall Study|Protocol Violation|0|||
105430232|NCT01266317|363583302|FG000|Overall Study|Withdrawal by Subject|2|||
105430233|NCT02753127|363583303|FG000|Overall Study|Lost to Follow-up|13|||
105430234|NCT02753127|363583304|FG001|Overall Study|Lost to Follow-up|11|||
105430235|NCT02753127|363583303|FG000|Overall Study|Withdrawal by Subject|37|||
105430236|NCT02753127|363583304|FG001|Overall Study|Withdrawal by Subject|47|||
105430237|NCT02753127|363583303|FG000|Overall Study|Other|3|||
105430238|NCT02753127|363583304|FG001|Overall Study|Other|8|||
105430239|NCT02753127|363583303|FG000|Overall Study|Hospice|0|||
105430240|NCT02753127|363583304|FG001|Overall Study|Hospice|2|||
105430241|NCT02351349|363583307|FG000|Overall Study|Withdrawal by Subject|2|||
105430242|NCT02351349|363583308|FG001|Overall Study|Withdrawal by Subject|3|||
105430243|NCT04271475|363583309|FG000|DB Period: Day 1 up to EODBT|Death|1|||
105430244|NCT04271475|363583310|FG001|DB Period: Day 1 up to EODBT|Death|0|||
105430245|NCT04271475|363583311|FG002|DB Period: Day 1 up to EODBT|Death|0|||
105430246|NCT04271475|363583312|FG003|DB Period: Day 1 up to EODBT|Death|0|||
105430247|NCT04271475|363583309|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
105430248|NCT04271475|363583310|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
105430249|NCT04271475|363583311|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
105430250|NCT04271475|363583312|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
105430251|NCT04271475|363583309|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
105430252|NCT04271475|363583310|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
105430253|NCT04271475|363583311|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
105430254|NCT04271475|363583312|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
105430255|NCT04271475|363583309|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
105430256|NCT04271475|363583310|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
105430257|NCT04271475|363583311|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
105590209|NCT00124982|364160749|FG001|Short-term Period|Participant Had Lymphopenia|0|||
105590210|NCT00124982|364160750|FG002|Short-term Period|Participant Had Lymphopenia|0|||
105590211|NCT00124982|364160748|FG000|Long-term Period|Death|0|||
105430258|NCT04271475|363583312|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
105430259|NCT04271475|363583309|FG000|DB Period: Day 1 up to EODBT|Other|8|||
105430260|NCT04271475|363583310|FG001|DB Period: Day 1 up to EODBT|Other|5|||
105430261|NCT04271475|363583311|FG002|DB Period: Day 1 up to EODBT|Other|0|||
105430262|NCT04271475|363583312|FG003|DB Period: Day 1 up to EODBT|Other|0|||
105430263|NCT04271475|363583309|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
105430264|NCT04271475|363583310|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
105430265|NCT04271475|363583311|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
105430266|NCT04271475|363583312|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
105430267|NCT04271475|363583309|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
105430268|NCT04271475|363583310|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
105430269|NCT04271475|363583311|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
105430270|NCT04271475|363583312|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
105430271|NCT06048367|363583313|FG000|Overall Study|Withdrawal by Subject|0|||
105430272|NCT06048367|363583314|FG001|Overall Study|Withdrawal by Subject|1|||
105430273|NCT06048367|363583315|FG002|Overall Study|Withdrawal by Subject|0|||
105430274|NCT06048367|363583316|FG003|Overall Study|Withdrawal by Subject|0|||
105430275|NCT06048367|363583317|FG004|Overall Study|Withdrawal by Subject|0|||
105430276|NCT06048367|363583313|FG000|Overall Study|Withdrawal by Subject|0|||
105430277|NCT06048367|363583314|FG001|Overall Study|Withdrawal by Subject|0|||
105430278|NCT06048367|363583315|FG002|Overall Study|Withdrawal by Subject|1|||
105430279|NCT06048367|363583316|FG003|Overall Study|Withdrawal by Subject|0|||
105430280|NCT06048367|363583317|FG004|Overall Study|Withdrawal by Subject|0|||
105430281|NCT06048367|363583313|FG000|Overall Study|Withdrawal by Subject|0|||
105430282|NCT06048367|363583314|FG001|Overall Study|Withdrawal by Subject|0|||
105430283|NCT06048367|363583315|FG002|Overall Study|Withdrawal by Subject|0|||
105430284|NCT06048367|363583316|FG003|Overall Study|Withdrawal by Subject|1|||
105430285|NCT06048367|363583317|FG004|Overall Study|Withdrawal by Subject|0|||
105430286|NCT06048367|363583313|FG000|Overall Study|Withdrawal by Subject|0|||
105430287|NCT06048367|363583314|FG001|Overall Study|Withdrawal by Subject|0|||
105430288|NCT06048367|363583315|FG002|Overall Study|Withdrawal by Subject|0|||
105430289|NCT06048367|363583316|FG003|Overall Study|Withdrawal by Subject|1|||
105430290|NCT06048367|363583317|FG004|Overall Study|Withdrawal by Subject|0|||
105430291|NCT06250738|363583318|FG000|Overall Study|Lost to Follow-up|1|||
105430292|NCT02936284|363583320|FG000|Overall Study|Withdrawal by Subject|3|||
105430293|NCT02936284|363583321|FG001|Overall Study|Withdrawal by Subject|1|||
105430294|NCT02936284|363583320|FG000|Overall Study|Lost to Follow-up|7|||
105430295|NCT02936284|363583321|FG001|Overall Study|Lost to Follow-up|8|||
105430296|NCT02046070|363583322|FG000|Overall Study|Progressive Disease|18|||
105430297|NCT02046070|363583323|FG001|Overall Study|Progressive Disease|11|||
105430298|NCT02046070|363583324|FG002|Overall Study|Progressive Disease|40|||
105430299|NCT02046070|363583322|FG000|Overall Study|Adverse Event|8|||
105430300|NCT02046070|363583323|FG001|Overall Study|Adverse Event|10|||
105430301|NCT02046070|363583324|FG002|Overall Study|Adverse Event|17|||
105430302|NCT02046070|363583322|FG000|Overall Study|Withdrawal by Subject|1|||
105430303|NCT02046070|363583323|FG001|Overall Study|Withdrawal by Subject|2|||
105430304|NCT02046070|363583324|FG002|Overall Study|Withdrawal by Subject|6|||
105430305|NCT02046070|363583322|FG000|Overall Study|Study Terminated by Sponsor|1|||
105430306|NCT02046070|363583323|FG001|Overall Study|Study Terminated by Sponsor|1|||
105430307|NCT02046070|363583324|FG002|Overall Study|Study Terminated by Sponsor|1|||
105430308|NCT02046070|363583322|FG000|Overall Study|Reason not Specified|4|||
105430309|NCT02046070|363583323|FG001|Overall Study|Reason not Specified|4|||
105430310|NCT02046070|363583324|FG002|Overall Study|Reason not Specified|6|||
105430311|NCT03681678|363583325|FG000|Overall Study|Lost to Follow-up|20|||
105430312|NCT04284813|363583326|FG000|Overall Study|Withdrawal by Subject|1|||
105430313|NCT02677844|363583327|FG000|Period 3|Withdrawal by Subject|0|||
105430314|NCT02677844|363583328|FG001|Period 3|Withdrawal by Subject|0|||
105430315|NCT02677844|363583329|FG002|Period 3|Withdrawal by Subject|0|||
105430316|NCT02677844|363583330|FG003|Period 3|Withdrawal by Subject|1|||
105430317|NCT02677844|363583331|FG004|Period 3|Withdrawal by Subject|0|||
105430318|NCT02677844|363583332|FG005|Period 3|Withdrawal by Subject|0|||
105430319|NCT02677844|363583333|FG006|Period 3|Withdrawal by Subject|0|||
105590212|NCT00124982|364160749|FG001|Long-term Period|Death|0|||
105590213|NCT00124982|364160750|FG002|Long-term Period|Death|1|||
105430320|NCT04094584|363583336|FG000|Overall Study|No interest in study|88|||
105430321|NCT04094584|363583336|FG000|Overall Study|Unwilling to undergo screening tests|36|||
105430322|NCT04094584|363583336|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
105430323|NCT04094584|363583336|FG000|Overall Study|Opioid use|7|||
105430324|NCT04094584|363583336|FG000|Overall Study|Need for major surgery in study period|4|||
105430325|NCT04094584|363583336|FG000|Overall Study|eligible but declined enrollment|4|||
105590214|NCT00124982|364160748|FG000|Long-term Period|Adverse Event|0|||
105590215|NCT00124982|364160749|FG001|Long-term Period|Adverse Event|0|||
105430326|NCT04094584|363583336|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
105430327|NCT04094584|363583336|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
105430328|NCT04094584|363583336|FG000|Overall Study|Lost to Follow-up|3|||
105430329|NCT04094584|363583336|FG000|Overall Study|Withdrawal by Subject|2|||
105430330|NCT00106691|363583337|FG000|Overall Study|Adverse Event|60|||
105430331|NCT00106691|363583338|FG001|Overall Study|Adverse Event|64|||
105430332|NCT00106691|363583337|FG000|Overall Study|Lost to Follow-up|23|||
105430333|NCT00106691|363583338|FG001|Overall Study|Lost to Follow-up|18|||
105430334|NCT00106691|363583337|FG000|Overall Study|Physician Decision|18|||
105430335|NCT00106691|363583338|FG001|Overall Study|Physician Decision|21|||
105430336|NCT00106691|363583337|FG000|Overall Study|Protocol Violation|13|||
105430337|NCT00106691|363583338|FG001|Overall Study|Protocol Violation|18|||
105430338|NCT00106691|363583337|FG000|Overall Study|Withdrawal by Subject|75|||
105430339|NCT00106691|363583338|FG001|Overall Study|Withdrawal by Subject|70|||
105430340|NCT00106691|363583337|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
105430341|NCT00106691|363583338|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
105430342|NCT00106691|363583337|FG000|Overall Study|QTc>480|3|||
105430343|NCT00106691|363583338|FG001|Overall Study|QTc>480|1|||
105430344|NCT00106691|363583337|FG000|Overall Study|mililtary deployment|2|||
105430345|NCT00106691|363583338|FG001|Overall Study|mililtary deployment|0|||
105430346|NCT00106691|363583337|FG000|Overall Study|Study Site Closing/PI Moved|1|||
105430347|NCT00106691|363583338|FG001|Overall Study|Study Site Closing/PI Moved|2|||
105430348|NCT00106691|363583337|FG000|Overall Study|Cardiologist recommendation|1|||
105590216|NCT00124982|364160750|FG002|Long-term Period|Adverse Event|17|||
105590217|NCT00124982|364160748|FG000|Long-term Period|Lack of Efficacy|0|||
105590218|NCT00124982|364160749|FG001|Long-term Period|Lack of Efficacy|0|||
105590219|NCT00124982|364160750|FG002|Long-term Period|Lack of Efficacy|46|||
105430349|NCT00106691|363583338|FG001|Overall Study|Cardiologist recommendation|0|||
105430350|NCT00106691|363583337|FG000|Overall Study|Pt. moved to another state|1|||
105430351|NCT00106691|363583338|FG001|Overall Study|Pt. moved to another state|0|||
105430352|NCT00106691|363583337|FG000|Overall Study|Taking exclusionary avodart|1|||
105430353|NCT00106691|363583338|FG001|Overall Study|Taking exclusionary avodart|0|||
105430354|NCT00106691|363583337|FG000|Overall Study|Not able to discontinue plavix|0|||
105430355|NCT00106691|363583338|FG001|Overall Study|Not able to discontinue plavix|1|||
105430356|NCT00791557|363583339|FG000|Overall Study|Adverse Event|1|||
105430357|NCT04957758|363583340|FG000|Overall Study|Adverse Event|1|||
105430358|NCT04957758|363583341|FG001|Overall Study|Adverse Event|0|||
105430359|NCT04957758|363583340|FG000|Overall Study|Lost to Follow-up|0|||
105430360|NCT04957758|363583341|FG001|Overall Study|Lost to Follow-up|2|||
105430361|NCT04957758|363583340|FG000|Overall Study|Withdrawal by Subject|4|||
105430362|NCT04957758|363583341|FG001|Overall Study|Withdrawal by Subject|2|||
105430363|NCT04957758|363583340|FG000|Overall Study|Protocol Violation|0|||
105430364|NCT04957758|363583341|FG001|Overall Study|Protocol Violation|1|||
105430365|NCT03344640|363583342|FG000|Overall Study|Adverse Event|1|||
105430366|NCT03344640|363583343|FG001|Overall Study|Adverse Event|0|||
105430367|NCT03344640|363583342|FG000|Overall Study|Physician Decision|1|||
105430368|NCT03344640|363583343|FG001|Overall Study|Physician Decision|1|||
105430369|NCT03344640|363583342|FG000|Overall Study|Withdrawal by Subject|1|||
105430370|NCT03344640|363583343|FG001|Overall Study|Withdrawal by Subject|2|||
105430371|NCT03344640|363583342|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
105430372|NCT03344640|363583343|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
105430373|NCT02573246|363583344|FG000|Overall Study|Lost to Follow-up|2|||
105430374|NCT02573246|363583345|FG001|Overall Study|Lost to Follow-up|0|||
105430375|NCT02573246|363583346|FG002|Overall Study|Lost to Follow-up|0|||
105430376|NCT02573246|363583347|FG003|Overall Study|Lost to Follow-up|0|||
105430377|NCT02573246|363583348|FG004|Overall Study|Lost to Follow-up|1|||
105430378|NCT02573246|363583344|FG000|Overall Study|Withdrawal by Subject|0|||
105590220|NCT00124982|364160748|FG000|Long-term Period|Lost to Follow-up|0|||
105590221|NCT00124982|364160749|FG001|Long-term Period|Lost to Follow-up|0|||
105590222|NCT00124982|364160750|FG002|Long-term Period|Lost to Follow-up|4|||
105590223|NCT00124982|364160748|FG000|Long-term Period|Withdrawal by Subject|0|||
105590224|NCT00124982|364160749|FG001|Long-term Period|Withdrawal by Subject|0|||
105430379|NCT02573246|363583345|FG001|Overall Study|Withdrawal by Subject|0|||
105430380|NCT02573246|363583346|FG002|Overall Study|Withdrawal by Subject|0|||
105430381|NCT02573246|363583347|FG003|Overall Study|Withdrawal by Subject|0|||
105430382|NCT02573246|363583348|FG004|Overall Study|Withdrawal by Subject|1|||
105430383|NCT02573246|363583344|FG000|Overall Study|Physician Decision|1|||
105430384|NCT02573246|363583345|FG001|Overall Study|Physician Decision|1|||
105430385|NCT02573246|363583346|FG002|Overall Study|Physician Decision|3|||
105430386|NCT02573246|363583347|FG003|Overall Study|Physician Decision|2|||
105430387|NCT02573246|363583348|FG004|Overall Study|Physician Decision|2|||
105430388|NCT01902888|363583352|FG000|Overall Study|Study Terminated|3|||
105430389|NCT00316888|363583353|FG000|Overall Study|Adverse Event|4|||
105430390|NCT00316888|363583354|FG001|Overall Study|Adverse Event|5|||
105590225|NCT00124982|364160750|FG002|Long-term Period|Withdrawal by Subject|16|||
105590226|NCT00124982|364160748|FG000|Long-term Period|Pregnancy|0|||
105590227|NCT00124982|364160749|FG001|Long-term Period|Pregnancy|0|||
105430391|NCT00316888|363583353|FG000|Overall Study|Withdrawal by Subject|2|||
105430392|NCT00316888|363583354|FG001|Overall Study|Withdrawal by Subject|2|||
105430393|NCT00316888|363583353|FG000|Overall Study|Not start protocol therapy|0|||
105430394|NCT00316888|363583354|FG001|Overall Study|Not start protocol therapy|1|||
105430395|NCT03149003|363583355|FG000|Overall Study|Randomized but not treated|0|||
105430396|NCT03149003|363583356|FG001|Overall Study|Randomized but not treated|1|||
105430397|NCT03149003|363583357|FG002|Overall Study|Randomized but not treated|18|||
105430398|NCT02758301|363583359|FG000|Overall Study|Death|12|||
105430399|NCT02758301|363583360|FG001|Overall Study|Death|0|||
105430400|NCT02758301|363583359|FG000|Overall Study|Physician Decision|10|||
105430401|NCT02758301|363583360|FG001|Overall Study|Physician Decision|1|||
105430402|NCT02758301|363583359|FG000|Overall Study|Withdrawal by Subject|5|||
105430403|NCT02758301|363583360|FG001|Overall Study|Withdrawal by Subject|6|||
105430404|NCT02758301|363583359|FG000|Overall Study|Lost to Follow-up|7|||
105430405|NCT02758301|363583360|FG001|Overall Study|Lost to Follow-up|0|||
105430406|NCT02758301|363583359|FG000|Overall Study|Protocol Violation|0|||
105430407|NCT02758301|363583360|FG001|Overall Study|Protocol Violation|1|||
105430408|NCT05239221|363583361|FG000|Overall Study|Adverse Event|0|||
105430409|NCT05239221|363583362|FG001|Overall Study|Adverse Event|0|||
105430410|NCT05239221|363583363|FG002|Overall Study|Adverse Event|0|||
105430411|NCT05239221|363583364|FG003|Overall Study|Adverse Event|0|||
105430412|NCT05239221|363583365|FG004|Overall Study|Adverse Event|0|||
105430413|NCT05239221|363583366|FG005|Overall Study|Adverse Event|0|||
105430414|NCT05239221|363583367|FG006|Overall Study|Adverse Event|1|||
105430415|NCT05239221|363583368|FG007|Overall Study|Adverse Event|0|||
105430416|NCT05239221|363583369|FG008|Overall Study|Adverse Event|0|||
105430417|NCT05239221|363583370|FG009|Overall Study|Adverse Event|0|||
105430418|NCT05239221|363583371|FG010|Overall Study|Adverse Event|1|||
105430419|NCT05239221|363583372|FG011|Overall Study|Adverse Event|1|||
105430420|NCT05239221|363583373|FG012|Overall Study|Adverse Event|0|||
105430421|NCT05239221|363583374|FG013|Overall Study|Adverse Event|0|||
105430422|NCT05239221|363583375|FG014|Overall Study|Adverse Event|0|||
105430423|NCT05239221|363583376|FG015|Overall Study|Adverse Event|0|||
105430424|NCT05239221|363583361|FG000|Overall Study|Withdrawal by Subject|0|||
105430425|NCT05239221|363583362|FG001|Overall Study|Withdrawal by Subject|0|||
105430426|NCT05239221|363583363|FG002|Overall Study|Withdrawal by Subject|0|||
105430427|NCT05239221|363583364|FG003|Overall Study|Withdrawal by Subject|0|||
105430428|NCT05239221|363583365|FG004|Overall Study|Withdrawal by Subject|0|||
105430429|NCT05239221|363583366|FG005|Overall Study|Withdrawal by Subject|0|||
105430430|NCT05239221|363583367|FG006|Overall Study|Withdrawal by Subject|0|||
105430431|NCT05239221|363583368|FG007|Overall Study|Withdrawal by Subject|0|||
105430432|NCT05239221|363583369|FG008|Overall Study|Withdrawal by Subject|0|||
105430433|NCT05239221|363583370|FG009|Overall Study|Withdrawal by Subject|0|||
105430434|NCT05239221|363583371|FG010|Overall Study|Withdrawal by Subject|1|||
105590228|NCT00124982|364160750|FG002|Long-term Period|Pregnancy|1|||
105590229|NCT00124982|364160748|FG000|Long-term Period|Poor/Non-compliance|0|||
105590230|NCT00124982|364160749|FG001|Long-term Period|Poor/Non-compliance|0|||
105590231|NCT00124982|364160750|FG002|Long-term Period|Poor/Non-compliance|2|||
105590232|NCT00124982|364160748|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
105590233|NCT00124982|364160749|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
105590234|NCT00124982|364160750|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
105590235|NCT00124982|364160748|FG000|Long-term Period|Neurologist Recommendation|0|||
105590236|NCT00124982|364160749|FG001|Long-term Period|Neurologist Recommendation|0|||
105430435|NCT05239221|363583372|FG011|Overall Study|Withdrawal by Subject|0|||
105430436|NCT05239221|363583373|FG012|Overall Study|Withdrawal by Subject|0|||
105430437|NCT05239221|363583374|FG013|Overall Study|Withdrawal by Subject|0|||
105430438|NCT05239221|363583375|FG014|Overall Study|Withdrawal by Subject|0|||
105501866|NCT01090492|363848927|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
105501867|NCT01090492|363848928|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
105501868|NCT01090492|363848929|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
105501869|NCT01090492|363848930|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
105501870|NCT01090492|363848923|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
105501871|NCT01090492|363848924|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
105501872|NCT01090492|363848925|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
105501873|NCT01090492|363848926|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
105501874|NCT01090492|363848927|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
105590237|NCT00124982|364160750|FG002|Long-term Period|Neurologist Recommendation|1|||
105430439|NCT05239221|363583376|FG015|Overall Study|Withdrawal by Subject|1|||
105430440|NCT00652899|363583377|FG000|Overall Study|Death|1|||
105430441|NCT00652899|363583377|FG000|Overall Study|Treating physician decision|1|||
105430442|NCT02900170|363583379|FG000|Overall Study|Lost to Follow-up|8|||
105430443|NCT01814670|363583382|FG000|Overall Study|Protocol Violation|12|||
105430444|NCT00780273|363583383|FG000|Overall Study|Death|1|||
105430445|NCT00780273|363583383|FG000|Overall Study|Lost to Follow-up|1|||
105430446|NCT03332160|363583384|FG000|Overall Study|Withdrawal by Subject|1|||
105430447|NCT03332160|363583385|FG001|Overall Study|Withdrawal by Subject|1|||
105430448|NCT03332160|363583384|FG000|Overall Study|Adverse Event|0|||
105430449|NCT03332160|363583385|FG001|Overall Study|Adverse Event|1|||
105430450|NCT03332160|363583384|FG000|Overall Study|Developed Exclusion Criteria|0|||
105430451|NCT03332160|363583385|FG001|Overall Study|Developed Exclusion Criteria|1|||
105430452|NCT03332160|363583384|FG000|Overall Study|Non-adherence to treatment|0|||
105430453|NCT03332160|363583385|FG001|Overall Study|Non-adherence to treatment|2|||
105430454|NCT01378429|363583387|FG000|Overall Study|Noncompliance with study drug|1|||
105430455|NCT01378429|363583388|FG001|Overall Study|Noncompliance with study drug|0|||
105430456|NCT02241187|363583391|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
105430457|NCT02356887|363583392|FG000|Overall Study|poor compliance|2|||
105430458|NCT01490294|363583393|FG000|Overall Study|Prematurely discontinuation|4|||
105430459|NCT01490294|363583394|FG001|Overall Study|Prematurely discontinuation|0|||
105430460|NCT01490294|363583395|FG002|Overall Study|Prematurely discontinuation|1|||
105430461|NCT01490294|363583396|FG003|Overall Study|Prematurely discontinuation|1|||
105430462|NCT01490294|363583393|FG000|Overall Study|Adverse Event|1|||
105430463|NCT01490294|363583394|FG001|Overall Study|Adverse Event|0|||
105430464|NCT01490294|363583395|FG002|Overall Study|Adverse Event|0|||
105430465|NCT01490294|363583396|FG003|Overall Study|Adverse Event|0|||
105430466|NCT00199888|363583397|FG000|Overall Study|Lost to Follow-up|1|||
105430467|NCT02544373|363583404|FG000|Overall Study|Lost to Follow-up|5|||
105430468|NCT02544373|363583405|FG001|Overall Study|Lost to Follow-up|3|||
105430469|NCT02544373|363583404|FG000|Overall Study|Withdrawal by Subject|8|||
105430470|NCT02544373|363583405|FG001|Overall Study|Withdrawal by Subject|2|||
105430471|NCT02299076|363583406|FG000|Overall Study|Fraudulent Entries|20|||
105430472|NCT02299076|363583407|FG001|Overall Study|Fraudulent Entries|14|||
105430473|NCT03474081|363583415|FG000|Overall Study|Adverse Event|6|||
105430474|NCT03474081|363583416|FG001|Overall Study|Adverse Event|3|||
105430475|NCT03474081|363583415|FG000|Overall Study|Lost to Follow-up|2|||
105430476|NCT03474081|363583416|FG001|Overall Study|Lost to Follow-up|1|||
105430477|NCT03474081|363583415|FG000|Overall Study|Physician Decision|3|||
105430478|NCT03474081|363583416|FG001|Overall Study|Physician Decision|2|||
105430479|NCT03474081|363583415|FG000|Overall Study|Withdrawal by Subject|5|||
105430480|NCT03474081|363583416|FG001|Overall Study|Withdrawal by Subject|7|||
105430481|NCT03474081|363583415|FG000|Overall Study|Investigator site closed|1|||
105430482|NCT03474081|363583416|FG001|Overall Study|Investigator site closed|0|||
105430483|NCT03172130|363584506|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
105430484|NCT03172130|363584507|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
105430485|NCT01825941|363584508|FG000|Overall Study|Lost to Follow-up|4|||
105430486|NCT01825941|363584509|FG001|Overall Study|Lost to Follow-up|1|||
105430487|NCT05065190|363584510|FG000|Overall Study|Other than listed|2|||
105430488|NCT05065190|363584511|FG001|Overall Study|Other than listed|12|||
105430489|NCT05065190|363584510|FG000|Overall Study|Lack of Efficacy|4|||
105430490|NCT05065190|363584511|FG001|Overall Study|Lack of Efficacy|0|||
105430491|NCT05065190|363584510|FG000|Overall Study|Adverse Event|1|||
105430492|NCT05065190|363584511|FG001|Overall Study|Adverse Event|10|||
105430493|NCT04938037|363584514|FG000|Overall Study|Lost to Follow-up|4|||
105430494|NCT04938037|363584515|FG001|Overall Study|Lost to Follow-up|3|||
105430495|NCT01806064|363584518|FG000|Overall Study|Randomized Not Enrolled|0|||
105430496|NCT01806064|363584519|FG001|Overall Study|Randomized Not Enrolled|0|||
105430497|NCT01806064|363584520|FG002|Overall Study|Randomized Not Enrolled|0|||
105430498|NCT01806064|363584521|FG003|Overall Study|Randomized Not Enrolled|1|||
105430499|NCT01806064|363584522|FG004|Overall Study|Randomized Not Enrolled|2|||
105430500|NCT00004445|363584524|FG000|Overall Study|Physician Decision|2|||
105430501|NCT00004445|363584524|FG000|Overall Study|Withdrawal by Subject|1|||
105430502|NCT03826342|363584525|FG000|Overall Study|Withdrawal by Subject|8|||
105430503|NCT03826342|363584526|FG001|Overall Study|Withdrawal by Subject|1|||
105430504|NCT03826342|363584525|FG000|Overall Study|Lost to Follow-up|7|||
105430505|NCT03826342|363584526|FG001|Overall Study|Lost to Follow-up|7|||
105430506|NCT03826342|363584525|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
105430507|NCT03826342|363584526|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
105430508|NCT00940485|363584532|FG000|Overall Study|HBeAb positive at Baseline|3|||
105430509|NCT00940485|363584533|FG001|Overall Study|HBeAb positive at Baseline|2|||
105430510|NCT00940485|363584532|FG000|Overall Study|Lost to Follow-up|2|||
105430511|NCT00940485|363584533|FG001|Overall Study|Lost to Follow-up|3|||
105430512|NCT00940485|363584532|FG000|Overall Study|Adverse Event|8|||
105430513|NCT00940485|363584533|FG001|Overall Study|Adverse Event|0|||
105430514|NCT00940485|363584532|FG000|Overall Study|Withdrawal by Subject|1|||
105501875|NCT01090492|363848928|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
105590238|NCT02163915|364160757|FG000|Overall Study|Withdrawal by Subject|2|||
105430515|NCT00940485|363584533|FG001|Overall Study|Withdrawal by Subject|1|||
105430516|NCT00940485|363584532|FG000|Overall Study|Others|1|||
105430517|NCT00940485|363584533|FG001|Overall Study|Others|1|||
105590239|NCT02163915|364160758|FG001|Overall Study|Withdrawal by Subject|0|||
105590240|NCT02163915|364160759|FG002|Overall Study|Withdrawal by Subject|2|||
105590241|NCT02163915|364160760|FG003|Overall Study|Withdrawal by Subject|2|||
105590242|NCT02163915|364160761|FG004|Overall Study|Withdrawal by Subject|2|||
105590243|NCT02163915|364160757|FG000|Overall Study|Study termination|1|||
105590244|NCT02163915|364160758|FG001|Overall Study|Study termination|0|||
105590245|NCT02163915|364160759|FG002|Overall Study|Study termination|0|||
105430526|NCT01610596|363584542|FG000|Overall Study|Lost to Follow-up|0|||
105430527|NCT01610596|363584543|FG001|Overall Study|Lost to Follow-up|1|||
105430528|NCT01519674|363584546|FG000|Overall Study|Adverse Event|3|||
105430529|NCT01519674|363584547|FG001|Overall Study|Adverse Event|3|||
105430530|NCT01519674|363584548|FG002|Overall Study|Adverse Event|0|||
105430531|NCT01519674|363584546|FG000|Overall Study|Lack of Efficacy|1|||
105430532|NCT01519674|363584547|FG001|Overall Study|Lack of Efficacy|1|||
105430533|NCT01519674|363584548|FG002|Overall Study|Lack of Efficacy|1|||
105430534|NCT01519674|363584546|FG000|Overall Study|Protocol Violation|0|||
105430535|NCT01519674|363584547|FG001|Overall Study|Protocol Violation|3|||
105430536|NCT01519674|363584548|FG002|Overall Study|Protocol Violation|1|||
105430537|NCT01519674|363584546|FG000|Overall Study|Withdrawal Criteria|7|||
105430538|NCT01519674|363584547|FG001|Overall Study|Withdrawal Criteria|2|||
105430539|NCT01519674|363584548|FG002|Overall Study|Withdrawal Criteria|7|||
105430540|NCT01519674|363584546|FG000|Overall Study|Unsclassified|10|||
105430541|NCT01519674|363584547|FG001|Overall Study|Unsclassified|4|||
105430542|NCT01519674|363584548|FG002|Overall Study|Unsclassified|3|||
105430543|NCT05288166|363584549|FG000|Overall Study|Adverse Event|1|||
105430544|NCT05288166|363584550|FG001|Overall Study|Adverse Event|0|||
105430545|NCT05288166|363584549|FG000|Overall Study|Lost to Follow-up|2|||
105430546|NCT05288166|363584550|FG001|Overall Study|Lost to Follow-up|0|||
105430547|NCT05288166|363584549|FG000|Overall Study|Physician Decision|0|||
105430548|NCT05288166|363584550|FG001|Overall Study|Physician Decision|2|||
105430549|NCT05288166|363584549|FG000|Overall Study|Screen Failure|1|||
105430550|NCT05288166|363584550|FG001|Overall Study|Screen Failure|1|||
105430551|NCT05288166|363584549|FG000|Overall Study|Withdrawal by Subject|4|||
105430552|NCT05288166|363584550|FG001|Overall Study|Withdrawal by Subject|2|||
105430553|NCT05288166|363584549|FG000|Overall Study|On Study Treatment|408|||
105430554|NCT05288166|363584550|FG001|Overall Study|On Study Treatment|418|||
105430555|NCT01565941|363584551|FG000|Overall Study|Withdrawn by parent/guardian|3|||
105430556|NCT01565941|363584552|FG001|Overall Study|Withdrawn by parent/guardian|2|||
105430557|NCT01565941|363584551|FG000|Overall Study|Randomized; did not receive intevention|8|||
105430558|NCT01565941|363584552|FG001|Overall Study|Randomized; did not receive intevention|2|||
105430559|NCT04047420|363584553|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
105430560|NCT04047420|363584553|FG000|Washout Period|Refused Participation|2|||
105430561|NCT01439126|363584557|FG000|Overall Study|Adverse Event|2|||
105430562|NCT01439126|363584558|FG001|Overall Study|Adverse Event|0|||
105430563|NCT01439126|363584557|FG000|Overall Study|Withdrawal by Subject|5|||
105430564|NCT01439126|363584558|FG001|Overall Study|Withdrawal by Subject|21|||
105430565|NCT01439126|363584557|FG000|Overall Study|Protocol Violation|6|||
105430566|NCT01439126|363584558|FG001|Overall Study|Protocol Violation|4|||
105430567|NCT01439126|363584557|FG000|Overall Study|Lost to Follow-up|6|||
105430568|NCT01439126|363584558|FG001|Overall Study|Lost to Follow-up|3|||
105430569|NCT01439126|363584557|FG000|Overall Study|Other-Use of prohibited treatment|0|||
105430570|NCT01439126|363584558|FG001|Overall Study|Other-Use of prohibited treatment|2|||
105430571|NCT01439126|363584557|FG000|Overall Study|Other-Miscellaneous|12|||
105430572|NCT01439126|363584558|FG001|Overall Study|Other-Miscellaneous|12|||
105430573|NCT03262116|363584560|FG000|Overall Study|Physician Decision|0|||
105430574|NCT03262116|363584561|FG001|Overall Study|Physician Decision|2|||
105430575|NCT03262116|363584562|FG002|Overall Study|Physician Decision|1|||
105430576|NCT03262116|363584563|FG003|Overall Study|Physician Decision|1|||
105430577|NCT03262116|363584564|FG004|Overall Study|Physician Decision|1|||
105430578|NCT03262116|363584565|FG005|Overall Study|Physician Decision|2|||
105430579|NCT02608450|363584566|FG000|Overall Study|Lost to Follow-up|39|||
105430580|NCT02608450|363584567|FG001|Overall Study|Lost to Follow-up|32|||
105430581|NCT02608450|363584566|FG000|Overall Study|Withdrawal by Subject|21|||
105430582|NCT02608450|363584567|FG001|Overall Study|Withdrawal by Subject|15|||
105430583|NCT02608450|363584566|FG000|Overall Study|Adverse Event|3|||
105430584|NCT02608450|363584567|FG001|Overall Study|Adverse Event|6|||
105430585|NCT02608450|363584566|FG000|Overall Study|Withdrawal by parent|2|||
105501876|NCT01090492|363848929|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
105430586|NCT02608450|363584567|FG001|Overall Study|Withdrawal by parent|3|||
105430587|NCT02608450|363584566|FG000|Overall Study|Lack of Efficacy|0|||
105430588|NCT02608450|363584567|FG001|Overall Study|Lack of Efficacy|3|||
105501877|NCT01090492|363848930|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
105590246|NCT02163915|364160760|FG003|Overall Study|Study termination|0|||
105430589|NCT02608450|363584566|FG000|Overall Study|Noncompliance with study drug|0|||
105430590|NCT02608450|363584567|FG001|Overall Study|Noncompliance with study drug|2|||
105430591|NCT02608450|363584566|FG000|Overall Study|Physician Decision|0|||
105430592|NCT02608450|363584567|FG001|Overall Study|Physician Decision|1|||
105430593|NCT02608450|363584566|FG000|Overall Study|Pregnancy|0|||
105430594|NCT02608450|363584567|FG001|Overall Study|Pregnancy|1|||
105430595|NCT02608450|363584566|FG000|Overall Study|Progressive disease|1|||
105430596|NCT02608450|363584567|FG001|Overall Study|Progressive disease|0|||
105430597|NCT02608450|363584566|FG000|Overall Study|Multiple reasons|0|||
105430598|NCT02608450|363584567|FG001|Overall Study|Multiple reasons|2|||
105430599|NCT00477269|363584571|FG000|Core Study|Adverse Event|6|||
105430600|NCT00477269|363584572|FG001|Core Study|Adverse Event|4|||
105430601|NCT00477269|363584573|FG002|Core Study|Adverse Event|0|||
105430602|NCT00477269|363584571|FG000|Core Study|Death|3|||
105430603|NCT00477269|363584572|FG001|Core Study|Death|3|||
105430604|NCT00477269|363584573|FG002|Core Study|Death|0|||
105430605|NCT00477269|363584571|FG000|Core Study|Withdrawn Consent|0|||
105430606|NCT00477269|363584572|FG001|Core Study|Withdrawn Consent|1|||
105430607|NCT00477269|363584573|FG002|Core Study|Withdrawn Consent|0|||
105430608|NCT00477269|363584571|FG000|Open Label Extension|Adverse Event|0|||
105430609|NCT00477269|363584572|FG001|Open Label Extension|Adverse Event|0|||
105430610|NCT00477269|363584573|FG002|Open Label Extension|Adverse Event|4|||
105430611|NCT00477269|363584571|FG000|Open Label Extension|Abnormal laboratory values|0|||
105430612|NCT00477269|363584572|FG001|Open Label Extension|Abnormal laboratory values|0|||
105430613|NCT00477269|363584573|FG002|Open Label Extension|Abnormal laboratory values|1|||
105430614|NCT00477269|363584571|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
105430615|NCT00477269|363584572|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
105430616|NCT00477269|363584573|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
105430617|NCT00477269|363584571|FG000|Open Label Extension|Adminiatrative problems|0|||
105430618|NCT00477269|363584572|FG001|Open Label Extension|Adminiatrative problems|0|||
105430619|NCT00477269|363584573|FG002|Open Label Extension|Adminiatrative problems|2|||
105430620|NCT00477269|363584571|FG000|Open Label Extension|Death|0|||
105430621|NCT00477269|363584572|FG001|Open Label Extension|Death|0|||
105430622|NCT00477269|363584573|FG002|Open Label Extension|Death|4|||
105430623|NCT03263780|363584574|FG000|Overall Study|Withdrawal by Subject|3|||
105430624|NCT03263780|363584574|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
105430625|NCT02449018|363584577|FG000|Overall Study|Abnormal laboratory value|0|||
105430626|NCT02449018|363584578|FG001|Overall Study|Abnormal laboratory value|1|||
105430627|NCT02449018|363584577|FG000|Overall Study|Administrative problems|1|||
105430628|NCT02449018|363584578|FG001|Overall Study|Administrative problems|0|||
105430629|NCT02449018|363584577|FG000|Overall Study|Adverse Event|5|||
105430630|NCT02449018|363584578|FG001|Overall Study|Adverse Event|1|||
105430631|NCT02449018|363584577|FG000|Overall Study|Protocol deviation|4|||
105430632|NCT02449018|363584578|FG001|Overall Study|Protocol deviation|0|||
105430633|NCT02449018|363584577|FG000|Overall Study|Patient decision|2|||
105430634|NCT02449018|363584578|FG001|Overall Study|Patient decision|0|||
105430635|NCT00094107|363584579|FG000|Overall Study|Lack of Efficacy|23|||
105430636|NCT00094107|363584579|FG000|Overall Study|Death|5|||
105430637|NCT00094107|363584579|FG000|Overall Study|Adverse Event|3|||
105430638|NCT00094107|363584579|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
105430639|NCT03426631|363584580|FG000|Overall Study|Lost to Follow-up|0|||
105430640|NCT03426631|363584581|FG001|Overall Study|Lost to Follow-up|1|||
105430641|NCT03831945|363584583|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
105430642|NCT03831945|363584584|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
105430643|NCT03831945|363584583|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
105430644|NCT03831945|363584584|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
105430645|NCT03831945|363584583|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
105430646|NCT03831945|363584584|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
105430647|NCT00806442|363584585|FG000|Overall Study|Lost to Follow-up|3|||
105430648|NCT00806442|363584586|FG001|Overall Study|Lost to Follow-up|2|||
105430649|NCT00806442|363584585|FG000|Overall Study|Withdrawal by Subject|1|||
105430650|NCT00806442|363584586|FG001|Overall Study|Withdrawal by Subject|5|||
105430651|NCT00654004|363584590|FG000|Overall Study|Lost to Follow-up|1|||
105430652|NCT00654004|363584591|FG001|Overall Study|Lost to Follow-up|0|||
105430653|NCT01264770|363584592|FG000|Overall Study|Not reported|0|||
105501878|NCT01768286|363848931|FG000|Overall Study|Randomized But Not Treated|0|||
105501879|NCT01768286|363848932|FG001|Overall Study|Randomized But Not Treated|0|||
105501880|NCT01768286|363848933|FG002|Overall Study|Randomized But Not Treated|1|||
105501881|NCT01768286|363848934|FG003|Overall Study|Randomized But Not Treated|0|||
105501882|NCT01768286|363848931|FG000|Overall Study|Lack of Efficacy|7|||
105501883|NCT01768286|363848932|FG001|Overall Study|Lack of Efficacy|4|||
105430654|NCT01264770|363584593|FG001|Overall Study|Not reported|0|||
105430655|NCT01264770|363584594|FG002|Overall Study|Not reported|1|||
105430656|NCT01264770|363584595|FG003|Overall Study|Not reported|0|||
105430657|NCT01264770|363584596|FG004|Overall Study|Not reported|0|||
105430658|NCT01264770|363584597|FG005|Overall Study|Not reported|0|||
105430659|NCT01264770|363584592|FG000|Overall Study|e.g., change in circumstances|8|||
105430660|NCT01264770|363584593|FG001|Overall Study|e.g., change in circumstances|3|||
105430661|NCT01264770|363584594|FG002|Overall Study|e.g., change in circumstances|3|||
105430662|NCT01264770|363584595|FG003|Overall Study|e.g., change in circumstances|3|||
105430663|NCT01264770|363584596|FG004|Overall Study|e.g., change in circumstances|4|||
105430664|NCT01264770|363584597|FG005|Overall Study|e.g., change in circumstances|4|||
105501884|NCT01768286|363848933|FG002|Overall Study|Lack of Efficacy|0|||
105430665|NCT01264770|363584592|FG000|Overall Study|Severe non-compliance to protocol|0|||
105430666|NCT01264770|363584593|FG001|Overall Study|Severe non-compliance to protocol|0|||
105430667|NCT01264770|363584594|FG002|Overall Study|Severe non-compliance to protocol|1|||
105430668|NCT01264770|363584595|FG003|Overall Study|Severe non-compliance to protocol|1|||
105430669|NCT01264770|363584596|FG004|Overall Study|Severe non-compliance to protocol|0|||
105430670|NCT01264770|363584597|FG005|Overall Study|Severe non-compliance to protocol|0|||
105430671|NCT01264770|363584592|FG000|Overall Study|Lack of therapeutic response|1|||
105430672|NCT01264770|363584593|FG001|Overall Study|Lack of therapeutic response|0|||
105430673|NCT01264770|363584594|FG002|Overall Study|Lack of therapeutic response|2|||
105430674|NCT01264770|363584595|FG003|Overall Study|Lack of therapeutic response|1|||
105430675|NCT01264770|363584596|FG004|Overall Study|Lack of therapeutic response|1|||
105430676|NCT01264770|363584597|FG005|Overall Study|Lack of therapeutic response|0|||
105430677|NCT01264770|363584592|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
105430678|NCT01264770|363584593|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
105430679|NCT01264770|363584594|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
105430680|NCT01264770|363584595|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
105430681|NCT01264770|363584596|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
105430682|NCT01264770|363584597|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
105430683|NCT01264770|363584592|FG000|Overall Study|Lost to Follow-up|0|||
105430684|NCT01264770|363584593|FG001|Overall Study|Lost to Follow-up|0|||
105430685|NCT01264770|363584594|FG002|Overall Study|Lost to Follow-up|1|||
105430686|NCT01264770|363584595|FG003|Overall Study|Lost to Follow-up|1|||
105430687|NCT01264770|363584596|FG004|Overall Study|Lost to Follow-up|0|||
105430688|NCT01264770|363584597|FG005|Overall Study|Lost to Follow-up|0|||
105430689|NCT01264770|363584592|FG000|Overall Study|Adverse Event|7|||
105430690|NCT01264770|363584593|FG001|Overall Study|Adverse Event|7|||
105430691|NCT01264770|363584594|FG002|Overall Study|Adverse Event|8|||
105430692|NCT01264770|363584595|FG003|Overall Study|Adverse Event|0|||
105430693|NCT01264770|363584596|FG004|Overall Study|Adverse Event|2|||
105430694|NCT01264770|363584597|FG005|Overall Study|Adverse Event|1|||
105430695|NCT00351273|363584602|FG000|Overall Study|Lost to Follow-up|1|||
105430696|NCT00351273|363584603|FG001|Overall Study|Lost to Follow-up|2|||
105430697|NCT00351273|363584604|FG002|Overall Study|Lost to Follow-up|5|||
105430698|NCT01977690|363584607|FG000|Overall Study|Withdrawal by Subject|0|||
105430699|NCT01977690|363584608|FG001|Overall Study|Withdrawal by Subject|4|||
105430700|NCT00952614|363584609|FG000|Overall Study|Death|3|||
105430701|NCT00952614|363584609|FG000|Overall Study|Lost to Follow-up|3|||
105430702|NCT00952614|363584609|FG000|Overall Study|other reason|1|||
105430703|NCT02644356|363584610|FG000|Overall Study|Withdrawal by Subject|2|||
105430704|NCT04023682|363584611|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
105430705|NCT01711866|363584613|FG000|Overall Study|Noncompliant|3|||
105430706|NCT01711866|363584613|FG000|Overall Study|Withdrawal by Subject|3|||
105430707|NCT01711866|363584613|FG000|Overall Study|Adverse Event|2|||
105430708|NCT02290938|363584614|FG000|Overall Study|Lost to Follow-up|14|||
105430709|NCT02290938|363584615|FG001|Overall Study|Lost to Follow-up|43|||
105430710|NCT00958217|363584616|FG000|Overall Study|Death|2|||
105430711|NCT00958217|363584617|FG001|Overall Study|Death|1|||
105430712|NCT00958217|363584616|FG000|Overall Study|Withdrawal by Subject|4|||
105430713|NCT00958217|363584617|FG001|Overall Study|Withdrawal by Subject|3|||
105430714|NCT00958217|363584616|FG000|Overall Study|Lost to Follow-up|17|||
105430715|NCT00958217|363584617|FG001|Overall Study|Lost to Follow-up|19|||
105430716|NCT00958217|363584616|FG000|Overall Study|Moved out of area|1|||
105430717|NCT00958217|363584617|FG001|Overall Study|Moved out of area|1|||
105430718|NCT00958217|363584616|FG000|Overall Study|Inpatient hospitalization|0|||
105430719|NCT00958217|363584617|FG001|Overall Study|Inpatient hospitalization|1|||
105430720|NCT01075984|363584620|FG000|Treatment Phase|Adverse Event|0|||
105430721|NCT01075984|363584621|FG001|Treatment Phase|Adverse Event|1|||
105430722|NCT01075984|363584622|FG002|Treatment Phase|Adverse Event|3|||
105430723|NCT01075984|363584623|FG003|Treatment Phase|Adverse Event|7|||
105430724|NCT01075984|363584624|FG004|Treatment Phase|Adverse Event|35|||
105430725|NCT01075984|363584620|FG000|Treatment Phase|Protocol Violation|0|||
105430726|NCT01075984|363584621|FG001|Treatment Phase|Protocol Violation|0|||
105430727|NCT01075984|363584622|FG002|Treatment Phase|Protocol Violation|1|||
105430728|NCT01075984|363584623|FG003|Treatment Phase|Protocol Violation|0|||
105430729|NCT01075984|363584624|FG004|Treatment Phase|Protocol Violation|3|||
105430730|NCT01075984|363584620|FG000|Treatment Phase|Withdrawal by Subject|0|||
105430731|NCT01075984|363584621|FG001|Treatment Phase|Withdrawal by Subject|0|||
105430732|NCT01075984|363584622|FG002|Treatment Phase|Withdrawal by Subject|2|||
105430733|NCT01075984|363584623|FG003|Treatment Phase|Withdrawal by Subject|0|||
105430734|NCT01075984|363584624|FG004|Treatment Phase|Withdrawal by Subject|15|||
105430735|NCT01075984|363584620|FG000|Treatment Phase|Treatment Failure|0|||
105501885|NCT01768286|363848934|FG003|Overall Study|Lack of Efficacy|1|||
105501886|NCT01768286|363848931|FG000|Overall Study|Withdrew Consent|0|||
105430736|NCT01075984|363584621|FG001|Treatment Phase|Treatment Failure|0|||
105501887|NCT01768286|363848932|FG001|Overall Study|Withdrew Consent|0|||
105501888|NCT01768286|363848933|FG002|Overall Study|Withdrew Consent|1|||
105430737|NCT01075984|363584622|FG002|Treatment Phase|Treatment Failure|1|||
105430738|NCT01075984|363584623|FG003|Treatment Phase|Treatment Failure|0|||
105430739|NCT01075984|363584624|FG004|Treatment Phase|Treatment Failure|5|||
105430740|NCT01075984|363584620|FG000|Treatment Phase|Progression of disease|0|||
105430741|NCT01075984|363584621|FG001|Treatment Phase|Progression of disease|0|||
105430742|NCT01075984|363584622|FG002|Treatment Phase|Progression of disease|0|||
105430743|NCT01075984|363584623|FG003|Treatment Phase|Progression of disease|0|||
105430744|NCT01075984|363584624|FG004|Treatment Phase|Progression of disease|2|||
105430745|NCT01075984|363584620|FG000|Follow-up Phase|Protocol Violation|0|||
105430746|NCT01075984|363584621|FG001|Follow-up Phase|Protocol Violation|0|||
105430747|NCT01075984|363584622|FG002|Follow-up Phase|Protocol Violation|1|||
105430748|NCT01075984|363584623|FG003|Follow-up Phase|Protocol Violation|0|||
105430749|NCT01075984|363584624|FG004|Follow-up Phase|Protocol Violation|3|||
105430750|NCT01075984|363584620|FG000|Follow-up Phase|Adverse Event|0|||
105430751|NCT01075984|363584621|FG001|Follow-up Phase|Adverse Event|0|||
105430752|NCT01075984|363584622|FG002|Follow-up Phase|Adverse Event|0|||
105430753|NCT01075984|363584623|FG003|Follow-up Phase|Adverse Event|2|||
105430754|NCT01075984|363584624|FG004|Follow-up Phase|Adverse Event|27|||
105430755|NCT01075984|363584620|FG000|Follow-up Phase|Administrative|0|||
105430756|NCT01075984|363584621|FG001|Follow-up Phase|Administrative|0|||
105430757|NCT01075984|363584622|FG002|Follow-up Phase|Administrative|0|||
105430758|NCT01075984|363584623|FG003|Follow-up Phase|Administrative|0|||
105430759|NCT01075984|363584624|FG004|Follow-up Phase|Administrative|1|||
105430760|NCT01075984|363584620|FG000|Follow-up Phase|Withdrawal by Subject|0|||
105430761|NCT01075984|363584621|FG001|Follow-up Phase|Withdrawal by Subject|0|||
105430762|NCT01075984|363584622|FG002|Follow-up Phase|Withdrawal by Subject|0|||
105430763|NCT01075984|363584623|FG003|Follow-up Phase|Withdrawal by Subject|0|||
105430764|NCT01075984|363584624|FG004|Follow-up Phase|Withdrawal by Subject|10|||
105430765|NCT01075984|363584620|FG000|Follow-up Phase|Progression of disease|0|||
105430766|NCT01075984|363584621|FG001|Follow-up Phase|Progression of disease|0|||
105430767|NCT01075984|363584622|FG002|Follow-up Phase|Progression of disease|0|||
105430768|NCT01075984|363584623|FG003|Follow-up Phase|Progression of disease|0|||
105430769|NCT01075984|363584624|FG004|Follow-up Phase|Progression of disease|2|||
105430770|NCT01075984|363584620|FG000|Follow-up Phase|Treatment failure|0|||
105430771|NCT01075984|363584621|FG001|Follow-up Phase|Treatment failure|0|||
105430772|NCT01075984|363584622|FG002|Follow-up Phase|Treatment failure|0|||
105430773|NCT01075984|363584623|FG003|Follow-up Phase|Treatment failure|0|||
105430774|NCT01075984|363584624|FG004|Follow-up Phase|Treatment failure|4|||
105430775|NCT02797184|363586389|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
105430776|NCT02797184|363586390|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
105430777|NCT04692077|363586391|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
105430778|NCT05149313|363586392|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
105430779|NCT05149313|363586393|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
105430780|NCT05149313|363586394|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
105430781|NCT05149313|363586395|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
105430782|NCT05149313|363586392|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
105430783|NCT05149313|363586393|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
105430784|NCT05149313|363586394|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
105430785|NCT05149313|363586395|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
105430786|NCT05149313|363586392|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
105430787|NCT05149313|363586393|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
105430788|NCT05149313|363586394|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
105430789|NCT05149313|363586395|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
105430790|NCT05149313|363586392|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
105430791|NCT05149313|363586393|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
105430792|NCT05149313|363586394|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
105430793|NCT05149313|363586395|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
105430794|NCT05149313|363586392|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
105430795|NCT05149313|363586393|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
105430796|NCT05149313|363586394|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
105430797|NCT05149313|363586395|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
105430798|NCT05149313|363586392|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
105430799|NCT05149313|363586393|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
105430800|NCT05149313|363586394|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
105430801|NCT05149313|363586395|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
105430802|NCT05149313|363586392|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
105501889|NCT01768286|363848934|FG003|Overall Study|Withdrew Consent|0|||
105430803|NCT05149313|363586393|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
105501890|NCT02083965|363848935|FG000|Treatment Period|Other|1|||
105430804|NCT05149313|363586394|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
105430805|NCT05149313|363586395|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
105430806|NCT05149313|363586392|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105430807|NCT05149313|363586393|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105430808|NCT05149313|363586394|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
105430809|NCT05149313|363586395|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
105430810|NCT05149313|363586392|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
105430811|NCT05149313|363586393|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
105430812|NCT05149313|363586394|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
105430813|NCT05149313|363586395|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
105430814|NCT05149313|363586392|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105430815|NCT05149313|363586393|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105430816|NCT05149313|363586394|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
105430817|NCT05149313|363586395|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105430818|NCT05149313|363586392|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
105430819|NCT05149313|363586393|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
105430820|NCT05149313|363586394|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
105430821|NCT05149313|363586395|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
105430822|NCT03199391|363586396|FG000|Overall Study|Death|1|||
105430823|NCT03199391|363586396|FG000|Overall Study|Lost to Follow-up|3|||
105430824|NCT03199391|363586396|FG000|Overall Study|Adverse Event|2|||
105430825|NCT03199391|363586396|FG000|Overall Study|Withdrawal by Subject|10|||
105501891|NCT02083965|363848936|FG001|Treatment Period|Other|0|||
105501892|NCT01602120|363848937|FG000|Overall Study|Adverse Event|3|||
105501893|NCT01602120|363848938|FG001|Overall Study|Adverse Event|6|||
105501894|NCT01602120|363848939|FG002|Overall Study|Adverse Event|0|||
105501895|NCT01602120|363848940|FG003|Overall Study|Adverse Event|2|||
105501896|NCT01602120|363848937|FG000|Overall Study|Death|0|||
105501897|NCT01602120|363848938|FG001|Overall Study|Death|4|||
105501898|NCT01602120|363848939|FG002|Overall Study|Death|0|||
105501899|NCT01602120|363848940|FG003|Overall Study|Death|0|||
105501900|NCT01602120|363848937|FG000|Overall Study|Lost to Follow-up|0|||
105501901|NCT01602120|363848938|FG001|Overall Study|Lost to Follow-up|1|||
105501902|NCT01602120|363848939|FG002|Overall Study|Lost to Follow-up|0|||
105501903|NCT01602120|363848940|FG003|Overall Study|Lost to Follow-up|1|||
105501904|NCT01602120|363848937|FG000|Overall Study|Protocol Violation|1|||
105501905|NCT01602120|363848938|FG001|Overall Study|Protocol Violation|1|||
105501906|NCT01602120|363848939|FG002|Overall Study|Protocol Violation|0|||
105501907|NCT01602120|363848940|FG003|Overall Study|Protocol Violation|0|||
105501908|NCT01602120|363848937|FG000|Overall Study|Non-compliance|0|||
105501909|NCT01602120|363848938|FG001|Overall Study|Non-compliance|3|||
105501910|NCT01602120|363848939|FG002|Overall Study|Non-compliance|0|||
105501911|NCT01602120|363848940|FG003|Overall Study|Non-compliance|1|||
105501912|NCT01602120|363848937|FG000|Overall Study|Withdrawal by Subject|8|||
105501913|NCT01602120|363848938|FG001|Overall Study|Withdrawal by Subject|17|||
105501914|NCT01602120|363848939|FG002|Overall Study|Withdrawal by Subject|0|||
105501915|NCT01602120|363848940|FG003|Overall Study|Withdrawal by Subject|3|||
105501916|NCT01602120|363848937|FG000|Overall Study|Study Terminated by Sponsor|12|||
105501917|NCT01602120|363848938|FG001|Overall Study|Study Terminated by Sponsor|24|||
105501918|NCT01602120|363848939|FG002|Overall Study|Study Terminated by Sponsor|17|||
105501919|NCT01602120|363848940|FG003|Overall Study|Study Terminated by Sponsor|44|||
105501920|NCT01602120|363848937|FG000|Overall Study|Physician Decision|2|||
105501921|NCT01602120|363848938|FG001|Overall Study|Physician Decision|3|||
105501922|NCT01602120|363848939|FG002|Overall Study|Physician Decision|0|||
105501923|NCT01602120|363848940|FG003|Overall Study|Physician Decision|0|||
105501924|NCT01602120|363848937|FG000|Overall Study|Unspecified Reason|3|||
105501925|NCT01602120|363848938|FG001|Overall Study|Unspecified Reason|1|||
105501926|NCT01602120|363848939|FG002|Overall Study|Unspecified Reason|0|||
105501927|NCT01602120|363848940|FG003|Overall Study|Unspecified Reason|2|||
105501928|NCT01611155|363848941|FG000|Overall Study|Adverse Event|1|||
105501929|NCT01611155|363848942|FG001|Overall Study|Adverse Event|1|||
105501930|NCT01611155|363848941|FG000|Overall Study|Refused further treatment|6|||
105501931|NCT01611155|363848942|FG001|Overall Study|Refused further treatment|4|||
105590247|NCT02163915|364160761|FG004|Overall Study|Study termination|2|||
105590248|NCT02163915|364160757|FG000|Overall Study|Physician Decision|0|||
105501932|NCT01611155|363848941|FG000|Overall Study|Disease progression|1|||
105501933|NCT01611155|363848942|FG001|Overall Study|Disease progression|0|||
105501934|NCT01611155|363848941|FG000|Overall Study|Withdrawal by Subject|1|||
105501935|NCT01611155|363848942|FG001|Overall Study|Withdrawal by Subject|0|||
105501936|NCT01611155|363848941|FG000|Overall Study|Alternative treatment|0|||
105501937|NCT01611155|363848942|FG001|Overall Study|Alternative treatment|1|||
105501938|NCT01611155|363848941|FG000|Overall Study|Ineligible patient|0|||
105501939|NCT01611155|363848942|FG001|Overall Study|Ineligible patient|1|||
105501940|NCT01534962|363848943|FG000|Overall Study|Randomized but did not start treatment|2|||
105501941|NCT01534962|363848944|FG001|Overall Study|Randomized but did not start treatment|0|||
105501942|NCT01534962|363848945|FG002|Overall Study|Randomized but did not start treatment|0|||
105590249|NCT02163915|364160758|FG001|Overall Study|Physician Decision|0|||
105590250|NCT02163915|364160759|FG002|Overall Study|Physician Decision|0|||
105590251|NCT02163915|364160760|FG003|Overall Study|Physician Decision|1|||
105590252|NCT02163915|364160761|FG004|Overall Study|Physician Decision|0|||
105590253|NCT01080131|364160763|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
105430826|NCT00490776|363586397|FG000|Overall Study|Withdrawal by Subject|1|||
105430827|NCT00490776|363586397|FG000|Overall Study|Administrative Problems|1|||
105430828|NCT00490776|363586397|FG000|Overall Study|Death|1|||
105430829|NCT00490776|363586397|FG000|Overall Study|New Cancer Therapy|1|||
105590254|NCT01080131|364160764|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
105590255|NCT01080131|364160763|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
105590256|NCT01080131|364160764|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
105590257|NCT01080131|364160763|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
105590258|NCT01080131|364160764|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
105590259|NCT01080131|364160763|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
105590260|NCT01080131|364160764|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
105590261|NCT01080131|364160763|FG000|Core Study (0- 12 Weeks)|Death|1|||
105590262|NCT01080131|364160764|FG001|Core Study (0- 12 Weeks)|Death|0|||
105590263|NCT01080131|364160763|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
105590264|NCT01080131|364160764|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
105430830|NCT00490776|363586397|FG000|Overall Study|Disease Progression|5|||
105430831|NCT04736628|363586400|FG000|Overall Study|Not treated|0|||
105430832|NCT04736628|363586401|FG001|Overall Study|Not treated|0|||
105430833|NCT04736628|363586402|FG002|Overall Study|Not treated|0|||
105430834|NCT04736628|363586403|FG003|Overall Study|Not treated|2|||
105430835|NCT04736628|363586400|FG000|Overall Study|Other reason than listed|1|||
105430836|NCT04736628|363586401|FG001|Overall Study|Other reason than listed|2|||
105430837|NCT04736628|363586402|FG002|Overall Study|Other reason than listed|2|||
105430838|NCT04736628|363586403|FG003|Overall Study|Other reason than listed|3|||
105430839|NCT04736628|363586400|FG000|Overall Study|Protocol deviation|0|||
105430840|NCT04736628|363586401|FG001|Overall Study|Protocol deviation|0|||
105430841|NCT04736628|363586402|FG002|Overall Study|Protocol deviation|0|||
105430842|NCT04736628|363586403|FG003|Overall Study|Protocol deviation|1|||
105430843|NCT04736628|363586400|FG000|Overall Study|Burden of study procedures|1|||
105430844|NCT04736628|363586401|FG001|Overall Study|Burden of study procedures|0|||
105430845|NCT04736628|363586402|FG002|Overall Study|Burden of study procedures|0|||
105430846|NCT04736628|363586403|FG003|Overall Study|Burden of study procedures|1|||
105430847|NCT04736628|363586400|FG000|Overall Study|Change of residence|0|||
105430848|NCT04736628|363586401|FG001|Overall Study|Change of residence|1|||
105430849|NCT04736628|363586402|FG002|Overall Study|Change of residence|0|||
105430850|NCT04736628|363586403|FG003|Overall Study|Change of residence|0|||
105430851|NCT04736628|363586400|FG000|Overall Study|Perceived lack of efficacy|1|||
105430852|NCT04736628|363586401|FG001|Overall Study|Perceived lack of efficacy|0|||
105430853|NCT04736628|363586402|FG002|Overall Study|Perceived lack of efficacy|0|||
105430854|NCT04736628|363586403|FG003|Overall Study|Perceived lack of efficacy|1|||
105430855|NCT04736628|363586400|FG000|Overall Study|Adverse Event|3|||
105430856|NCT04736628|363586401|FG001|Overall Study|Adverse Event|2|||
105430857|NCT04736628|363586402|FG002|Overall Study|Adverse Event|4|||
105430858|NCT04736628|363586403|FG003|Overall Study|Adverse Event|3|||
105430859|NCT03007745|363586408|FG000|Overall Study|Sleep test negative for OSA|53|||
105430860|NCT03007745|363586409|FG001|Overall Study|Sleep test negative for OSA|49|||
105430861|NCT03007745|363586408|FG000|Overall Study|Physician Decision|6|||
105430862|NCT03007745|363586409|FG001|Overall Study|Physician Decision|9|||
105430863|NCT03007745|363586408|FG000|Overall Study|Withdrawal by Subject|38|||
105430864|NCT03007745|363586409|FG001|Overall Study|Withdrawal by Subject|16|||
105430865|NCT03007745|363586408|FG000|Overall Study|Lost to Follow-up|19|||
105430866|NCT03007745|363586409|FG001|Overall Study|Lost to Follow-up|25|||
105430867|NCT03007745|363586408|FG000|Overall Study|Unable to login to website|17|||
105430868|NCT03007745|363586409|FG001|Overall Study|Unable to login to website|4|||
105430869|NCT03921554|363586412|FG000|Overall Study|Adverse Event|2|||
105430870|NCT03921554|363586412|FG000|Overall Study|Withdrawal by Subject|1|||
105590265|NCT01080131|364160763|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
105590266|NCT01080131|364160764|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
105430871|NCT03921554|363586412|FG000|Overall Study|Death|3|||
105430872|NCT01300351|363586419|FG000|Overall Study|Did not receive treatment|2|||
105430873|NCT01300351|363586420|FG001|Overall Study|Did not receive treatment|0|||
105430874|NCT01300351|363586419|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
105430875|NCT01300351|363586420|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
105430876|NCT01300351|363586419|FG000|Overall Study|Lost to Follow-up|0|||
105430877|NCT01300351|363586420|FG001|Overall Study|Lost to Follow-up|1|||
105430878|NCT01300351|363586419|FG000|Overall Study|Adverse Event|0|||
105430879|NCT01300351|363586420|FG001|Overall Study|Adverse Event|4|||
105430880|NCT01300351|363586419|FG000|Overall Study|Withdrawal by Subject|7|||
105430881|NCT01300351|363586420|FG001|Overall Study|Withdrawal by Subject|10|||
105430882|NCT00864851|363586428|FG000|Overall Study|Withdrawal by Subject|0|||
105590267|NCT01080131|364160763|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
105430883|NCT00864851|363586429|FG001|Overall Study|Withdrawal by Subject|1|||
105430884|NCT00864851|363586430|FG002|Overall Study|Withdrawal by Subject|0|||
105430885|NCT00864851|363586428|FG000|Overall Study|Physician Decision|1|||
105430886|NCT00864851|363586429|FG001|Overall Study|Physician Decision|0|||
105430887|NCT00864851|363586430|FG002|Overall Study|Physician Decision|0|||
105430888|NCT00864851|363586428|FG000|Overall Study|Death|1|||
105430889|NCT00864851|363586429|FG001|Overall Study|Death|0|||
105430890|NCT00864851|363586430|FG002|Overall Study|Death|0|||
105430891|NCT00864851|363586428|FG000|Overall Study|Patient uncooperative|1|||
105430892|NCT00864851|363586429|FG001|Overall Study|Patient uncooperative|0|||
105430893|NCT00864851|363586430|FG002|Overall Study|Patient uncooperative|0|||
105430894|NCT00413010|363586431|FG000|Overall Study|Adverse Event|8|||
105430895|NCT00413010|363586432|FG001|Overall Study|Adverse Event|4|||
105430896|NCT00413010|363586431|FG000|Overall Study|Laboratory abnormality|0|||
105430897|NCT00413010|363586432|FG001|Overall Study|Laboratory abnormality|2|||
105430898|NCT00413010|363586431|FG000|Overall Study|Lack of Efficacy|0|||
105430899|NCT00413010|363586432|FG001|Overall Study|Lack of Efficacy|3|||
105430900|NCT00413010|363586431|FG000|Overall Study|Lost to Follow-up|3|||
105430901|NCT00413010|363586432|FG001|Overall Study|Lost to Follow-up|0|||
105430902|NCT00413010|363586431|FG000|Overall Study|Withdrawal by Subject|7|||
105430903|NCT00413010|363586432|FG001|Overall Study|Withdrawal by Subject|2|||
105430904|NCT00413010|363586431|FG000|Overall Study|Due to termination of the study|54|||
105430905|NCT00413010|363586432|FG001|Overall Study|Due to termination of the study|52|||
105430906|NCT00708734|363586435|FG000|Overall Study|scheduling conflict|2|||
105430907|NCT00708734|363586435|FG000|Overall Study|moved|1|||
105430908|NCT00708734|363586435|FG000|Overall Study|leg injury|1|||
105430909|NCT00708734|363586435|FG000|Overall Study|knee replacement|1|||
105430910|NCT00708734|363586435|FG000|Overall Study|vertigo|1|||
105430911|NCT00708734|363586435|FG000|Overall Study|leg fracture|1|||
105430912|NCT01533922|363586436|FG000|Overall Study|Adverse Event|5|||
105430913|NCT01533922|363586437|FG001|Overall Study|Adverse Event|8|||
105430914|NCT01533922|363586438|FG002|Overall Study|Adverse Event|6|||
105430915|NCT01533922|363586439|FG003|Overall Study|Adverse Event|3|||
105430916|NCT01533922|363586440|FG004|Overall Study|Adverse Event|4|||
105430917|NCT01533922|363586436|FG000|Overall Study|Lack of Efficacy|0|||
105430918|NCT01533922|363586437|FG001|Overall Study|Lack of Efficacy|0|||
105430919|NCT01533922|363586438|FG002|Overall Study|Lack of Efficacy|1|||
105430920|NCT01533922|363586439|FG003|Overall Study|Lack of Efficacy|0|||
105430921|NCT01533922|363586440|FG004|Overall Study|Lack of Efficacy|0|||
105430922|NCT01533922|363586436|FG000|Overall Study|Protocol Violation|0|||
105430923|NCT01533922|363586437|FG001|Overall Study|Protocol Violation|3|||
105430924|NCT01533922|363586438|FG002|Overall Study|Protocol Violation|0|||
105430925|NCT01533922|363586439|FG003|Overall Study|Protocol Violation|0|||
105430926|NCT01533922|363586440|FG004|Overall Study|Protocol Violation|1|||
105430927|NCT01533922|363586436|FG000|Overall Study|Withdrawal by Subject|3|||
105430928|NCT01533922|363586437|FG001|Overall Study|Withdrawal by Subject|1|||
105430929|NCT01533922|363586438|FG002|Overall Study|Withdrawal by Subject|2|||
105430930|NCT01533922|363586439|FG003|Overall Study|Withdrawal by Subject|2|||
105430931|NCT01533922|363586440|FG004|Overall Study|Withdrawal by Subject|1|||
105430932|NCT01533922|363586436|FG000|Overall Study|Other reason not defined above|2|||
105430933|NCT01533922|363586437|FG001|Overall Study|Other reason not defined above|0|||
105430934|NCT01533922|363586438|FG002|Overall Study|Other reason not defined above|1|||
105430935|NCT01533922|363586439|FG003|Overall Study|Other reason not defined above|0|||
105430936|NCT01533922|363586440|FG004|Overall Study|Other reason not defined above|0|||
105430937|NCT03242252|363586445|FG000|Overall Study|At the Participant's own Request|18|||
105430938|NCT03242252|363586446|FG001|Overall Study|At the Participant's own Request|10|||
105430939|NCT03242252|363586447|FG002|Overall Study|At the Participant's own Request|15|||
105430940|NCT03242252|363586445|FG000|Overall Study|Adverse Event|8|||
105430941|NCT03242252|363586446|FG001|Overall Study|Adverse Event|6|||
105430942|NCT03242252|363586447|FG002|Overall Study|Adverse Event|9|||
105430943|NCT03242252|363586445|FG000|Overall Study|Poor Compliance to Protocol|0|||
105590268|NCT01080131|364160764|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
105590269|NCT01080131|364160763|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
105430944|NCT03242252|363586446|FG001|Overall Study|Poor Compliance to Protocol|2|||
105430945|NCT03242252|363586447|FG002|Overall Study|Poor Compliance to Protocol|3|||
105430946|NCT03242252|363586445|FG000|Overall Study|Study Terminated by Sponsor|1|||
105430947|NCT03242252|363586446|FG001|Overall Study|Study Terminated by Sponsor|0|||
105430948|NCT03242252|363586447|FG002|Overall Study|Study Terminated by Sponsor|0|||
105430949|NCT03242252|363586445|FG000|Overall Study|Reason not Specified|4|||
105430950|NCT03242252|363586446|FG001|Overall Study|Reason not Specified|4|||
105430951|NCT03242252|363586447|FG002|Overall Study|Reason not Specified|1|||
105430952|NCT03242252|363586445|FG000|Overall Study|Lost to Follow-up|5|||
105430953|NCT03242252|363586446|FG001|Overall Study|Lost to Follow-up|1|||
105430954|NCT03242252|363586447|FG002|Overall Study|Lost to Follow-up|4|||
105430955|NCT01659255|363586450|FG000|Overall Study|Adverse Event|0|||
105430956|NCT01659255|363586451|FG001|Overall Study|Adverse Event|0|||
105430957|NCT01659255|363586452|FG002|Overall Study|Adverse Event|0|||
105430958|NCT01659255|363586453|FG003|Overall Study|Adverse Event|0|||
105430959|NCT01659255|363586454|FG004|Overall Study|Adverse Event|0|||
105430960|NCT01659255|363586455|FG005|Overall Study|Adverse Event|1|||
105430961|NCT01659255|363586456|FG006|Overall Study|Adverse Event|1|||
105430962|NCT01659255|363586457|FG007|Overall Study|Adverse Event|0|||
105430963|NCT01659255|363586458|FG008|Overall Study|Adverse Event|0|||
105430964|NCT01659255|363586459|FG009|Overall Study|Adverse Event|1|||
105430965|NCT01659255|363586460|FG010|Overall Study|Adverse Event|0|||
105430966|NCT01659255|363586461|FG011|Overall Study|Adverse Event|1|||
105430967|NCT01659255|363586462|FG012|Overall Study|Adverse Event|0|||
105430968|NCT01659255|363586463|FG013|Overall Study|Adverse Event|2|||
105430969|NCT01659255|363586464|FG014|Overall Study|Adverse Event|0|||
105430970|NCT01659255|363586465|FG015|Overall Study|Adverse Event|1|||
105430971|NCT01659255|363586466|FG016|Overall Study|Adverse Event|0|||
105430972|NCT01659255|363586450|FG000|Overall Study|Death|0|||
105430973|NCT01659255|363586451|FG001|Overall Study|Death|1|||
105430974|NCT01659255|363586452|FG002|Overall Study|Death|0|||
105430975|NCT01659255|363586453|FG003|Overall Study|Death|0|||
105430976|NCT01659255|363586454|FG004|Overall Study|Death|0|||
105430977|NCT01659255|363586455|FG005|Overall Study|Death|0|||
105430978|NCT01659255|363586456|FG006|Overall Study|Death|0|||
105430979|NCT01659255|363586457|FG007|Overall Study|Death|1|||
105430980|NCT01659255|363586458|FG008|Overall Study|Death|1|||
105430981|NCT01659255|363586459|FG009|Overall Study|Death|0|||
105430982|NCT01659255|363586460|FG010|Overall Study|Death|0|||
105430983|NCT01659255|363586461|FG011|Overall Study|Death|0|||
105430984|NCT01659255|363586462|FG012|Overall Study|Death|1|||
105430985|NCT01659255|363586463|FG013|Overall Study|Death|1|||
105430986|NCT01659255|363586464|FG014|Overall Study|Death|2|||
105430987|NCT01659255|363586465|FG015|Overall Study|Death|1|||
105430988|NCT01659255|363586466|FG016|Overall Study|Death|0|||
105430989|NCT01659255|363586450|FG000|Overall Study|Progressive Disease|2|||
105430990|NCT01659255|363586451|FG001|Overall Study|Progressive Disease|0|||
105430991|NCT01659255|363586452|FG002|Overall Study|Progressive Disease|0|||
105430992|NCT01659255|363586453|FG003|Overall Study|Progressive Disease|0|||
105430993|NCT01659255|363586454|FG004|Overall Study|Progressive Disease|0|||
105430994|NCT01659255|363586455|FG005|Overall Study|Progressive Disease|0|||
105430995|NCT01659255|363586456|FG006|Overall Study|Progressive Disease|0|||
105430996|NCT01659255|363586457|FG007|Overall Study|Progressive Disease|1|||
105430997|NCT01659255|363586458|FG008|Overall Study|Progressive Disease|0|||
105430998|NCT01659255|363586459|FG009|Overall Study|Progressive Disease|2|||
105430999|NCT01659255|363586460|FG010|Overall Study|Progressive Disease|2|||
105431000|NCT01659255|363586461|FG011|Overall Study|Progressive Disease|3|||
105431001|NCT01659255|363586462|FG012|Overall Study|Progressive Disease|5|||
105431002|NCT01659255|363586463|FG013|Overall Study|Progressive Disease|13|||
105431003|NCT01659255|363586464|FG014|Overall Study|Progressive Disease|6|||
105431004|NCT01659255|363586465|FG015|Overall Study|Progressive Disease|2|||
105431005|NCT01659255|363586466|FG016|Overall Study|Progressive Disease|3|||
105431006|NCT01659255|363586450|FG000|Overall Study|Withdrew Consent|0|||
105431007|NCT01659255|363586451|FG001|Overall Study|Withdrew Consent|0|||
105431008|NCT01659255|363586452|FG002|Overall Study|Withdrew Consent|0|||
105431009|NCT01659255|363586453|FG003|Overall Study|Withdrew Consent|0|||
105431010|NCT01659255|363586454|FG004|Overall Study|Withdrew Consent|0|||
105431011|NCT01659255|363586455|FG005|Overall Study|Withdrew Consent|0|||
105501943|NCT01534962|363848946|FG003|Overall Study|Randomized but did not start treatment|1|||
105501944|NCT01534962|363848943|FG000|Overall Study|Discontinued at AF recurrence|35|||
105501945|NCT01534962|363848944|FG001|Overall Study|Discontinued at AF recurrence|26|||
105501946|NCT01534962|363848945|FG002|Overall Study|Discontinued at AF recurrence|24|||
105501947|NCT01534962|363848946|FG003|Overall Study|Discontinued at AF recurrence|31|||
105501948|NCT02004522|363848947|FG000|Overall Study|Adverse Event|55|||
105501949|NCT02004522|363848948|FG001|Overall Study|Adverse Event|6|||
105501950|NCT02004522|363848947|FG000|Overall Study|Withdrawal by Subject|13|||
105431012|NCT01659255|363586456|FG006|Overall Study|Withdrew Consent|0|||
105431013|NCT01659255|363586457|FG007|Overall Study|Withdrew Consent|0|||
105431014|NCT01659255|363586458|FG008|Overall Study|Withdrew Consent|0|||
105431015|NCT01659255|363586459|FG009|Overall Study|Withdrew Consent|0|||
105501951|NCT02004522|363848948|FG001|Overall Study|Withdrawal by Subject|7|||
105501952|NCT02004522|363848947|FG000|Overall Study|Death|12|||
105431016|NCT01659255|363586460|FG010|Overall Study|Withdrew Consent|1|||
105431017|NCT01659255|363586461|FG011|Overall Study|Withdrew Consent|0|||
105431018|NCT01659255|363586462|FG012|Overall Study|Withdrew Consent|0|||
105431019|NCT01659255|363586463|FG013|Overall Study|Withdrew Consent|1|||
105431020|NCT01659255|363586464|FG014|Overall Study|Withdrew Consent|0|||
105431021|NCT01659255|363586465|FG015|Overall Study|Withdrew Consent|0|||
105431022|NCT01659255|363586466|FG016|Overall Study|Withdrew Consent|0|||
105501953|NCT02004522|363848948|FG001|Overall Study|Death|3|||
105501954|NCT02004522|363848947|FG000|Overall Study|Physician Decision|3|||
105431023|NCT01659255|363586450|FG000|Overall Study|Investigator Decision|0|||
105431024|NCT01659255|363586451|FG001|Overall Study|Investigator Decision|0|||
105431025|NCT01659255|363586452|FG002|Overall Study|Investigator Decision|0|||
105431026|NCT01659255|363586453|FG003|Overall Study|Investigator Decision|0|||
105431027|NCT01659255|363586454|FG004|Overall Study|Investigator Decision|0|||
105431028|NCT01659255|363586455|FG005|Overall Study|Investigator Decision|0|||
105431029|NCT01659255|363586456|FG006|Overall Study|Investigator Decision|0|||
105431030|NCT01659255|363586457|FG007|Overall Study|Investigator Decision|0|||
105431031|NCT01659255|363586458|FG008|Overall Study|Investigator Decision|0|||
105431032|NCT01659255|363586459|FG009|Overall Study|Investigator Decision|0|||
105431033|NCT01659255|363586460|FG010|Overall Study|Investigator Decision|0|||
105431034|NCT01659255|363586461|FG011|Overall Study|Investigator Decision|0|||
105431035|NCT01659255|363586462|FG012|Overall Study|Investigator Decision|1|||
105431036|NCT01659255|363586463|FG013|Overall Study|Investigator Decision|1|||
105431037|NCT01659255|363586464|FG014|Overall Study|Investigator Decision|0|||
105431038|NCT01659255|363586465|FG015|Overall Study|Investigator Decision|0|||
105431039|NCT01659255|363586466|FG016|Overall Study|Investigator Decision|0|||
105431040|NCT01659255|363586450|FG000|Overall Study|Sponsor's Decision|0|||
105431041|NCT01659255|363586451|FG001|Overall Study|Sponsor's Decision|0|||
105431042|NCT01659255|363586452|FG002|Overall Study|Sponsor's Decision|0|||
105431043|NCT01659255|363586453|FG003|Overall Study|Sponsor's Decision|0|||
105431044|NCT01659255|363586454|FG004|Overall Study|Sponsor's Decision|0|||
105590270|NCT01080131|364160764|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
105590271|NCT01080131|364160763|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
105590272|NCT01080131|364160764|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
105590273|NCT01080131|364160763|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
105590274|NCT01080131|364160764|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
105590275|NCT01080131|364160763|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
105590276|NCT01080131|364160764|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
105590277|NCT01080131|364160763|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
105590278|NCT01080131|364160764|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
105590279|NCT04248829|364160769|FG000|Overall Study|Disease progression|44|||
105590280|NCT04248829|364160770|FG001|Overall Study|Disease progression|109|||
105431045|NCT01659255|363586455|FG005|Overall Study|Sponsor's Decision|0|||
105431046|NCT01659255|363586456|FG006|Overall Study|Sponsor's Decision|1|||
105431047|NCT01659255|363586457|FG007|Overall Study|Sponsor's Decision|0|||
105431048|NCT01659255|363586458|FG008|Overall Study|Sponsor's Decision|0|||
105431049|NCT01659255|363586459|FG009|Overall Study|Sponsor's Decision|0|||
105431050|NCT01659255|363586460|FG010|Overall Study|Sponsor's Decision|0|||
105431051|NCT01659255|363586461|FG011|Overall Study|Sponsor's Decision|0|||
105431052|NCT01659255|363586462|FG012|Overall Study|Sponsor's Decision|0|||
105431053|NCT01659255|363586463|FG013|Overall Study|Sponsor's Decision|0|||
105431054|NCT01659255|363586464|FG014|Overall Study|Sponsor's Decision|0|||
105431055|NCT01659255|363586465|FG015|Overall Study|Sponsor's Decision|0|||
105431056|NCT01659255|363586466|FG016|Overall Study|Sponsor's Decision|0|||
105431057|NCT01659255|363586450|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431058|NCT01659255|363586451|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431059|NCT01659255|363586452|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431060|NCT01659255|363586453|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431061|NCT01659255|363586454|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431062|NCT01659255|363586455|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431063|NCT01659255|363586456|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431064|NCT01659255|363586457|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431065|NCT01659255|363586458|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431066|NCT01659255|363586459|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431067|NCT01659255|363586460|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431068|NCT01659255|363586461|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431069|NCT01659255|363586462|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431070|NCT01659255|363586463|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431071|NCT01659255|363586464|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431072|NCT01659255|363586465|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
105431073|NCT01659255|363586466|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105431074|NCT01659255|363586450|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
105431075|NCT01659255|363586451|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
105431076|NCT01659255|363586452|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
105431077|NCT01659255|363586453|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
105431078|NCT01659255|363586454|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
105590281|NCT04248829|364160769|FG000|Overall Study|Adverse Event|19|||
105431079|NCT01659255|363586455|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
105431080|NCT01659255|363586456|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
105431081|NCT01659255|363586457|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
105431082|NCT01659255|363586458|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
105590282|NCT04248829|364160770|FG001|Overall Study|Adverse Event|18|||
105590283|NCT04248829|364160769|FG000|Overall Study|Withdrawal by Subject|11|||
105431083|NCT01659255|363586459|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
105431084|NCT01659255|363586460|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
105431085|NCT01659255|363586461|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
105431086|NCT01659255|363586462|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
105431087|NCT01659255|363586463|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
105431088|NCT01659255|363586464|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
105431089|NCT01659255|363586465|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
105431090|NCT01659255|363586466|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
105431091|NCT01842581|363586467|FG000|Overall Study|Adverse Event|6|||
105431092|NCT01842581|363586468|FG001|Overall Study|Adverse Event|4|||
105431093|NCT01842581|363586467|FG000|Overall Study|HE breakthrough|26|||
105431094|NCT01842581|363586468|FG001|Overall Study|HE breakthrough|13|||
105431095|NCT01842581|363586467|FG000|Overall Study|Liver transplant|2|||
105431096|NCT01842581|363586468|FG001|Overall Study|Liver transplant|0|||
105431097|NCT01842581|363586467|FG000|Overall Study|Lost to Follow-up|2|||
105431098|NCT01842581|363586468|FG001|Overall Study|Lost to Follow-up|5|||
105431099|NCT01842581|363586467|FG000|Overall Study|Withdrawal by Subject|5|||
105431100|NCT01842581|363586468|FG001|Overall Study|Withdrawal by Subject|7|||
105431101|NCT01842581|363586467|FG000|Overall Study|Other than specified|3|||
105431102|NCT01842581|363586468|FG001|Overall Study|Other than specified|1|||
105431103|NCT01287195|363586469|FG000|Overall Study|Withdrawal by Subject|2|||
105431104|NCT05432167|363586470|FG000|Overall Study|Adverse Event|0|||
105431105|NCT05432167|363586471|FG001|Overall Study|Adverse Event|2|||
105431106|NCT05432167|363586472|FG002|Overall Study|Adverse Event|1|||
105431107|NCT05432167|363586470|FG000|Overall Study|Lost to Follow-up|3|||
105431108|NCT05432167|363586471|FG001|Overall Study|Lost to Follow-up|3|||
105431109|NCT05432167|363586472|FG002|Overall Study|Lost to Follow-up|2|||
105431110|NCT05432167|363586470|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
105431111|NCT05432167|363586471|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
105431112|NCT05432167|363586472|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
105431113|NCT05432167|363586470|FG000|Overall Study|Physician Decision|1|||
105431114|NCT05432167|363586471|FG001|Overall Study|Physician Decision|0|||
105431115|NCT05432167|363586472|FG002|Overall Study|Physician Decision|0|||
105431116|NCT05432167|363586470|FG000|Overall Study|Withdrawal by Subject|7|||
105431117|NCT05432167|363586471|FG001|Overall Study|Withdrawal by Subject|4|||
105431118|NCT05432167|363586472|FG002|Overall Study|Withdrawal by Subject|11|||
105431119|NCT05432167|363586470|FG000|Overall Study|Other|0|||
105431120|NCT05432167|363586471|FG001|Overall Study|Other|0|||
105431121|NCT05432167|363586472|FG002|Overall Study|Other|1|||
105431122|NCT01267175|363586473|FG000|Overall Study|Withdrawal by Subject|1|||
105431123|NCT01267175|363586473|FG000|Overall Study|Lost to Follow-up|1|||
105431124|NCT00357656|363586475|FG000|Overall Study|Other, No surgery performed|0|||
105431125|NCT00357656|363586476|FG001|Overall Study|Other, No surgery performed|3|||
105431126|NCT01219933|363586477|FG000|Overall Study|Adverse Event|8|||
105431127|NCT01219933|363586477|FG000|Overall Study|No LDA reached|5|||
105431128|NCT01219933|363586477|FG000|Overall Study|No LDA maintained|7|||
105431129|NCT01219933|363586477|FG000|Overall Study|Lost to Follow-up|3|||
105431130|NCT01219933|363586477|FG000|Overall Study|GC free|1|||
105431131|NCT01219933|363586477|FG000|Overall Study|Withdrawal by Subject|5|||
105431132|NCT01219933|363586477|FG000|Overall Study|Protocol Violation|8|||
105431133|NCT01219933|363586477|FG000|Overall Study|Lack of Efficacy|1|||
105431134|NCT01177969|363586481|FG000|Overall Study|Protocol Violation|2|||
105431135|NCT01177969|363586482|FG001|Overall Study|Protocol Violation|1|||
105431136|NCT01177969|363586481|FG000|Overall Study|Withdrawal by Subject|1|||
105431137|NCT01177969|363586482|FG001|Overall Study|Withdrawal by Subject|2|||
105431138|NCT02855944|363586483|FG000|Period 1: Treatment|Ongoing|14|||
105431139|NCT02855944|363586484|FG001|Period 1: Treatment|Ongoing|0|||
105501955|NCT02004522|363848948|FG001|Overall Study|Physician Decision|4|||
105501956|NCT02004522|363848947|FG000|Overall Study|Protocol Violation|1|||
105501957|NCT02004522|363848948|FG001|Overall Study|Protocol Violation|0|||
105501958|NCT02004522|363848947|FG000|Overall Study|Other is reason listed by PI|4|||
105501959|NCT02004522|363848948|FG001|Overall Study|Other is reason listed by PI|1|||
105431140|NCT02855944|363586483|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
105431141|NCT02855944|363586484|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
105431142|NCT02855944|363586483|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
105431143|NCT02855944|363586484|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
105431144|NCT02636946|363586485|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
105431145|NCT02636946|363586486|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
105501960|NCT02004522|363848947|FG000|Overall Study|Never Dosed|2|||
105501961|NCT02004522|363848948|FG001|Overall Study|Never Dosed|4|||
105431146|NCT02636946|363586485|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
105431147|NCT02636946|363586486|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
105431148|NCT02636946|363586485|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
105431149|NCT02636946|363586486|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
105431150|NCT02636946|363586485|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
105431151|NCT02636946|363586486|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
105501962|NCT02004522|363848947|FG000|Overall Study|Disease Progression|35|||
105501963|NCT02004522|363848948|FG001|Overall Study|Disease Progression|31|||
105431152|NCT02636946|363586485|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
105431153|NCT02636946|363586486|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
105431154|NCT02636946|363586485|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
105431155|NCT02636946|363586486|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
105431156|NCT01283542|363586487|FG000|Main Phase|Acute or progressive vision loss|1|||
105431157|NCT01283542|363586487|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
105431158|NCT01283542|363586487|FG000|Main Phase|abnormal laboratory values|5|||
105431159|NCT01283542|363586487|FG000|Extension Phase|Physician Decision|1|||
105431160|NCT01283542|363586487|FG000|Extension Phase|Adverse Event|1|||
105431161|NCT01283542|363586487|FG000|Extension Phase|Administrative problems|1|||
105431162|NCT05059977|363586488|FG000|Overall Study|Withdrawal by Subject|0|||
105431163|NCT05059977|363586489|FG001|Overall Study|Withdrawal by Subject|0|||
105431164|NCT05059977|363586490|FG002|Overall Study|Withdrawal by Subject|1|||
105431165|NCT00121641|363586491|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
105431166|NCT00121641|363586492|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
105431167|NCT00121641|363586493|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
105590284|NCT04248829|364160770|FG001|Overall Study|Withdrawal by Subject|2|||
105590285|NCT04248829|364160769|FG000|Overall Study|Lost to Follow-up|0|||
105590286|NCT04248829|364160770|FG001|Overall Study|Lost to Follow-up|1|||
105590287|NCT04248829|364160769|FG000|Overall Study|Death|12|||
105590288|NCT04248829|364160770|FG001|Overall Study|Death|14|||
105590289|NCT04248829|364160769|FG000|Overall Study|Physician Decision|2|||
105590290|NCT04248829|364160770|FG001|Overall Study|Physician Decision|4|||
105590291|NCT04248829|364160769|FG000|Overall Study|Any reason not specifically recorded|0|||
105590292|NCT04248829|364160770|FG001|Overall Study|Any reason not specifically recorded|2|||
105590293|NCT02132702|364160771|FG000|Overall Study|Protocol Violation|2|||
105590294|NCT02132702|364160771|FG000|Overall Study|Adverse Event|3|||
105590295|NCT02132702|364160771|FG000|Overall Study|Withdrawal by Subject|3|||
105590296|NCT04697069|364160772|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
105590297|NCT04697069|364160773|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
105590298|NCT04697069|364160772|FG000|Overall Study|Study termination|2|||
105590299|NCT04697069|364160773|FG001|Overall Study|Study termination|1|||
105431168|NCT00121641|363586494|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
105431169|NCT00121641|363586495|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
105431170|NCT00121641|363586491|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
105431171|NCT00121641|363586492|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
105431172|NCT00121641|363586493|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
105431173|NCT00121641|363586494|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
105431174|NCT00121641|363586495|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
105431175|NCT00121641|363586491|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
105590300|NCT01867580|364160774|FG000|Overall Study|Withdrawal by Subject|2|||
105590301|NCT01867580|364160775|FG001|Overall Study|Withdrawal by Subject|3|||
105590302|NCT01867580|364160774|FG000|Overall Study|Physician Decision|17|||
105590303|NCT01867580|364160775|FG001|Overall Study|Physician Decision|12|||
105590304|NCT01867580|364160774|FG000|Overall Study|Lost to Follow-up|3|||
105590305|NCT01867580|364160775|FG001|Overall Study|Lost to Follow-up|5|||
105590306|NCT01867580|364160774|FG000|Overall Study|Sponsor terminated study|1|||
105590307|NCT01867580|364160775|FG001|Overall Study|Sponsor terminated study|0|||
105590308|NCT01867580|364160774|FG000|Overall Study|Missed follow-up assessment|2|||
105590309|NCT01867580|364160775|FG001|Overall Study|Missed follow-up assessment|1|||
105590310|NCT01867580|364160774|FG000|Overall Study|Interruption to therapy|3|||
105590311|NCT01867580|364160775|FG001|Overall Study|Interruption to therapy|0|||
105590312|NCT01867580|364160774|FG000|Overall Study|Osteomyelitis|0|||
105590313|NCT01867580|364160775|FG001|Overall Study|Osteomyelitis|1|||
105590314|NCT01867580|364160774|FG000|Overall Study|Continuation of therapy|0|||
105590315|NCT01867580|364160775|FG001|Overall Study|Continuation of therapy|1|||
105590316|NCT01867580|364160774|FG000|Overall Study|Wound recurrence|0|||
105590317|NCT01867580|364160775|FG001|Overall Study|Wound recurrence|1|||
105431176|NCT00121641|363586492|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
105431177|NCT00121641|363586493|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
105431178|NCT00121641|363586494|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
105431179|NCT00121641|363586495|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
105431180|NCT00121641|363586491|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
105590318|NCT00603447|364160776|FG000|Overall Study|Adverse Event|0|||
105590319|NCT00603447|364160777|FG001|Overall Study|Adverse Event|1|||
105590320|NCT00603447|364160778|FG002|Overall Study|Adverse Event|1|||
105431181|NCT00121641|363586492|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
105590321|NCT00603447|364160779|FG003|Overall Study|Adverse Event|2|||
105431182|NCT00121641|363586493|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
105590322|NCT00603447|364160780|FG004|Overall Study|Adverse Event|1|||
105590323|NCT00603447|364160781|FG005|Overall Study|Adverse Event|2|||
105590324|NCT00603447|364160782|FG006|Overall Study|Adverse Event|10|||
105590325|NCT00603447|364160776|FG000|Overall Study|Other|0|||
105590326|NCT00603447|364160777|FG001|Overall Study|Other|0|||
105590327|NCT00603447|364160778|FG002|Overall Study|Other|1|||
105590328|NCT00603447|364160779|FG003|Overall Study|Other|0|||
105431183|NCT00121641|363586494|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
105431184|NCT00121641|363586495|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
105431185|NCT00121641|363586491|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
105431186|NCT00121641|363586492|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
105431187|NCT00121641|363586493|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
105431188|NCT00121641|363586494|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
105431189|NCT00121641|363586495|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
105431190|NCT00121641|363586491|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
105431191|NCT00121641|363586492|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
105431192|NCT00121641|363586493|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
105431193|NCT00121641|363586494|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
105431194|NCT00121641|363586495|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
105431195|NCT00121641|363586491|FG000|24-week Short-term Treatment Period|Other Reason|1|||
105431196|NCT00121641|363586492|FG001|24-week Short-term Treatment Period|Other Reason|0|||
105431197|NCT00121641|363586493|FG002|24-week Short-term Treatment Period|Other Reason|0|||
105431198|NCT00121641|363586494|FG003|24-week Short-term Treatment Period|Other Reason|0|||
105431199|NCT00121641|363586495|FG004|24-week Short-term Treatment Period|Other Reason|0|||
105431200|NCT00121641|363586491|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
105431201|NCT00121641|363586492|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
105431202|NCT00121641|363586493|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
105431203|NCT00121641|363586494|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
105431204|NCT00121641|363586495|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
105431205|NCT00121641|363586491|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
105431206|NCT00121641|363586492|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
105431207|NCT00121641|363586493|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
105431208|NCT00121641|363586494|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
105431209|NCT00121641|363586495|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
105431210|NCT00121641|363586491|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
105431211|NCT00121641|363586492|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
105431212|NCT00121641|363586493|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
105431213|NCT00121641|363586494|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
105501964|NCT02004522|363848947|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
105501965|NCT02004522|363848948|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
105501966|NCT00191269|363848950|FG000|Overall Study|Protocol Violation|0|||
105501967|NCT00191269|363848951|FG001|Overall Study|Protocol Violation|2|||
105501968|NCT00191269|363848950|FG000|Overall Study|Adverse Event|1|||
105501969|NCT00191269|363848951|FG001|Overall Study|Adverse Event|4|||
105501970|NCT00191269|363848950|FG000|Overall Study|Progression of Disease|4|||
105501971|NCT00191269|363848951|FG001|Overall Study|Progression of Disease|42|||
105501972|NCT00191269|363848950|FG000|Overall Study|Lack of Efficacy|1|||
105501973|NCT00191269|363848951|FG001|Overall Study|Lack of Efficacy|5|||
105501974|NCT00191269|363848950|FG000|Overall Study|Withdrawal by Subject|0|||
105501975|NCT00191269|363848951|FG001|Overall Study|Withdrawal by Subject|1|||
105501976|NCT00191269|363848950|FG000|Overall Study|Pathologic Aggrevation|0|||
105501977|NCT00191269|363848951|FG001|Overall Study|Pathologic Aggrevation|1|||
105501978|NCT00191269|363848950|FG000|Overall Study|Physician Decision|0|||
105501979|NCT00191269|363848951|FG001|Overall Study|Physician Decision|3|||
105501980|NCT01201785|363848952|FG000|Overall Study|Lost to Follow-up|16|||
105501981|NCT00915278|363848953|FG000|Overall Study|Death|1|||
105501982|NCT00915278|363848954|FG001|Overall Study|Death|0|||
105501983|NCT00915278|363848955|FG002|Overall Study|Death|0|||
105501984|NCT00915278|363848956|FG003|Overall Study|Death|0|||
105501985|NCT00915278|363848957|FG004|Overall Study|Death|0|||
105501986|NCT00915278|363848958|FG005|Overall Study|Death|0|||
105501987|NCT00915278|363848953|FG000|Overall Study|Lost to Follow-up|0|||
105501988|NCT00915278|363848954|FG001|Overall Study|Lost to Follow-up|1|||
105501989|NCT00915278|363848955|FG002|Overall Study|Lost to Follow-up|0|||
105431214|NCT00121641|363586495|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
105431215|NCT00121641|363586491|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
105431216|NCT00121641|363586492|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
105501990|NCT00915278|363848956|FG003|Overall Study|Lost to Follow-up|0|||
105501991|NCT00915278|363848957|FG004|Overall Study|Lost to Follow-up|0|||
105501992|NCT00915278|363848958|FG005|Overall Study|Lost to Follow-up|0|||
105501993|NCT00915278|363848953|FG000|Overall Study|Withdrawal by Subject|0|||
105501994|NCT00915278|363848954|FG001|Overall Study|Withdrawal by Subject|1|||
105431217|NCT00121641|363586493|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
105431218|NCT00121641|363586494|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
105431219|NCT00121641|363586495|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
105431220|NCT00121641|363586491|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
105431221|NCT00121641|363586492|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
105431222|NCT00121641|363586493|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
105431223|NCT00121641|363586494|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
105431224|NCT00121641|363586495|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
105431225|NCT00121641|363586491|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
105431226|NCT00121641|363586492|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
105431227|NCT00121641|363586493|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
105431228|NCT00121641|363586494|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
105431229|NCT00121641|363586495|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
105431230|NCT00121641|363586491|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
105431231|NCT00121641|363586492|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
105431232|NCT00121641|363586493|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
105431233|NCT00121641|363586494|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
105431234|NCT00121641|363586495|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
105431235|NCT00121641|363586491|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
105431236|NCT00121641|363586492|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
105431237|NCT00121641|363586493|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
105431238|NCT00121641|363586494|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
105431239|NCT00121641|363586495|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
105431240|NCT00121641|363586491|FG000|48-month Short Term + Long Term Period|Death|0|||
105431241|NCT00121641|363586492|FG001|48-month Short Term + Long Term Period|Death|0|||
105431242|NCT00121641|363586493|FG002|48-month Short Term + Long Term Period|Death|0|||
105431243|NCT00121641|363586494|FG003|48-month Short Term + Long Term Period|Death|1|||
105431244|NCT00121641|363586495|FG004|48-month Short Term + Long Term Period|Death|0|||
105431245|NCT00121641|363586491|FG000|48-month Short Term + Long Term Period|Missing|0|||
105431246|NCT00121641|363586492|FG001|48-month Short Term + Long Term Period|Missing|0|||
105431247|NCT00121641|363586493|FG002|48-month Short Term + Long Term Period|Missing|1|||
105431248|NCT00121641|363586494|FG003|48-month Short Term + Long Term Period|Missing|0|||
105431249|NCT00121641|363586495|FG004|48-month Short Term + Long Term Period|Missing|0|||
105431250|NCT00121641|363586491|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
105431251|NCT00121641|363586492|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
105431252|NCT00121641|363586493|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
105431253|NCT00121641|363586494|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
105431254|NCT00121641|363586495|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
105431255|NCT02914561|363586503|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
105501995|NCT00915278|363848955|FG002|Overall Study|Withdrawal by Subject|0|||
105501996|NCT00915278|363848956|FG003|Overall Study|Withdrawal by Subject|0|||
105501997|NCT00915278|363848957|FG004|Overall Study|Withdrawal by Subject|1|||
105501998|NCT00915278|363848958|FG005|Overall Study|Withdrawal by Subject|4|||
105501999|NCT00915278|363848953|FG000|Overall Study|Adverse Event|4|||
105502000|NCT00915278|363848954|FG001|Overall Study|Adverse Event|1|||
105502001|NCT00915278|363848955|FG002|Overall Study|Adverse Event|0|||
105502002|NCT00915278|363848956|FG003|Overall Study|Adverse Event|0|||
105502003|NCT00915278|363848957|FG004|Overall Study|Adverse Event|0|||
105502004|NCT00915278|363848958|FG005|Overall Study|Adverse Event|0|||
105502005|NCT00915278|363848953|FG000|Overall Study|Progressive disease/clinical progression|0|||
105502006|NCT00915278|363848954|FG001|Overall Study|Progressive disease/clinical progression|0|||
105502007|NCT00915278|363848955|FG002|Overall Study|Progressive disease/clinical progression|0|||
105502008|NCT00915278|363848956|FG003|Overall Study|Progressive disease/clinical progression|3|||
105502009|NCT00915278|363848957|FG004|Overall Study|Progressive disease/clinical progression|1|||
105502010|NCT00915278|363848958|FG005|Overall Study|Progressive disease/clinical progression|2|||
105502011|NCT00915278|363848953|FG000|Overall Study|Infusion related AEs|0|||
105502012|NCT00915278|363848954|FG001|Overall Study|Infusion related AEs|0|||
105502013|NCT00915278|363848955|FG002|Overall Study|Infusion related AEs|0|||
105502014|NCT00915278|363848956|FG003|Overall Study|Infusion related AEs|0|||
105502015|NCT00915278|363848957|FG004|Overall Study|Infusion related AEs|0|||
105502016|NCT00915278|363848958|FG005|Overall Study|Infusion related AEs|2|||
105502017|NCT00915278|363848953|FG000|Overall Study|Admission to hospice|0|||
105502018|NCT00915278|363848954|FG001|Overall Study|Admission to hospice|0|||
105502019|NCT00915278|363848955|FG002|Overall Study|Admission to hospice|1|||
105502020|NCT00915278|363848956|FG003|Overall Study|Admission to hospice|0|||
105502021|NCT00915278|363848957|FG004|Overall Study|Admission to hospice|0|||
105502022|NCT00915278|363848958|FG005|Overall Study|Admission to hospice|0|||
105502023|NCT04528732|363848959|FG000|Overall Study|Death|1|||
105431256|NCT02914561|363586504|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
105431257|NCT02914561|363586505|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
105431258|NCT02914561|363586506|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
105431259|NCT02914561|363586507|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
105431260|NCT02914561|363586508|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
105431261|NCT02914561|363586509|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
105431262|NCT02914561|363586510|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
105431263|NCT02914561|363586511|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
105431264|NCT02914561|363586512|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
105431265|NCT02914561|363586513|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
105431266|NCT02914561|363586503|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
105431267|NCT02914561|363586504|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
105431268|NCT02914561|363586505|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
105431269|NCT02914561|363586506|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
105431270|NCT02914561|363586507|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
105431271|NCT02914561|363586508|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
105431272|NCT02914561|363586509|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
105431273|NCT02914561|363586510|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
105431274|NCT02914561|363586511|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
105431275|NCT02914561|363586512|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
105431276|NCT02914561|363586513|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
105431277|NCT02914561|363586503|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
105431278|NCT02914561|363586504|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
105431279|NCT02914561|363586505|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
105431280|NCT02914561|363586506|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
105431281|NCT02914561|363586507|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
105431282|NCT02914561|363586508|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
105431283|NCT02914561|363586509|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
105431284|NCT02914561|363586510|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
105431285|NCT02914561|363586511|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
105431286|NCT02914561|363586512|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
105431287|NCT02914561|363586513|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
105431288|NCT02914561|363586503|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
105431289|NCT02914561|363586504|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
105431290|NCT02914561|363586505|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
105431291|NCT02914561|363586506|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
105431292|NCT02914561|363586507|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
105431293|NCT02914561|363586508|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
105431294|NCT02914561|363586509|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
105431295|NCT02914561|363586510|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
105431296|NCT02914561|363586511|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
105431297|NCT02914561|363586512|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
105431298|NCT02914561|363586513|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
105431299|NCT02914561|363586503|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105431300|NCT02914561|363586504|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105431301|NCT02914561|363586505|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
105431302|NCT02914561|363586506|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105431303|NCT02914561|363586507|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105431304|NCT02914561|363586508|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
105431305|NCT02914561|363586509|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105431306|NCT02914561|363586510|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105431307|NCT02914561|363586511|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105431308|NCT02914561|363586512|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105431309|NCT02914561|363586513|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105431310|NCT02914561|363586503|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
105431311|NCT02914561|363586504|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105431312|NCT02914561|363586505|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105431313|NCT02914561|363586506|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105431314|NCT02914561|363586507|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105431315|NCT02914561|363586508|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105431316|NCT02914561|363586509|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105431317|NCT02914561|363586510|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105431318|NCT02914561|363586511|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105431319|NCT02914561|363586512|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105431320|NCT02914561|363586513|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105502024|NCT04528732|363848960|FG001|Overall Study|Death|0|||
105502025|NCT04528732|363848961|FG002|Overall Study|Death|1|||
105431321|NCT02914561|363586503|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105431322|NCT02914561|363586504|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105431323|NCT02914561|363586505|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
105431324|NCT02914561|363586506|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105431325|NCT02914561|363586507|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105431326|NCT02914561|363586508|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105431327|NCT02914561|363586509|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105431328|NCT02914561|363586510|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105431329|NCT02914561|363586511|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105431330|NCT02914561|363586512|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105431331|NCT02914561|363586513|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105431332|NCT02914561|363586503|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
105431333|NCT02914561|363586504|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
105431334|NCT02914561|363586505|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
105431335|NCT02914561|363586506|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
105431336|NCT02914561|363586507|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
105431337|NCT02914561|363586508|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
105431338|NCT02914561|363586509|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
105431339|NCT02914561|363586510|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
105431340|NCT02914561|363586511|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
105431341|NCT02914561|363586512|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
105431342|NCT02914561|363586513|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
105431343|NCT02914561|363586503|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
105431344|NCT02914561|363586504|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
105502026|NCT04528732|363848959|FG000|Overall Study|Lost to Follow-up|0|||
105502027|NCT04528732|363848960|FG001|Overall Study|Lost to Follow-up|1|||
105502028|NCT04528732|363848961|FG002|Overall Study|Lost to Follow-up|2|||
105502029|NCT00319501|363848962|FG000|Double-blind Period|Withdrawal by Subject|0|||
105502030|NCT00319501|363848963|FG001|Double-blind Period|Withdrawal by Subject|3|||
105502031|NCT00319501|363848962|FG000|Double-blind Period|Sponsor Request|1|||
105502032|NCT00319501|363848963|FG001|Double-blind Period|Sponsor Request|0|||
105502033|NCT00319501|363848962|FG000|Double-blind Period|Did not receive treatment|42|||
105502034|NCT00319501|363848963|FG001|Double-blind Period|Did not receive treatment|29|||
105502035|NCT00319501|363848962|FG000|Open-label Period|Adverse Event|5|||
105502036|NCT00319501|363848963|FG001|Open-label Period|Adverse Event|0|||
105502037|NCT00319501|363848962|FG000|Open-label Period|Protocol Violation|6|||
105502038|NCT00319501|363848963|FG001|Open-label Period|Protocol Violation|0|||
105502039|NCT00319501|363848962|FG000|Open-label Period|Withdrawal by Subject|38|||
105502040|NCT00319501|363848963|FG001|Open-label Period|Withdrawal by Subject|0|||
105502041|NCT00319501|363848962|FG000|Open-label Period|Principal Investigator decision|6|||
105502042|NCT00319501|363848963|FG001|Open-label Period|Principal Investigator decision|0|||
105502043|NCT00319501|363848962|FG000|Open-label Period|Sponsor request|12|||
105502044|NCT00319501|363848963|FG001|Open-label Period|Sponsor request|0|||
105502045|NCT00319501|363848962|FG000|Open-label Period|Lost to Follow-up|5|||
105502046|NCT00319501|363848963|FG001|Open-label Period|Lost to Follow-up|0|||
105502047|NCT00319501|363848962|FG000|Open-label Period|Did not receive treatment|33|||
105502048|NCT00319501|363848963|FG001|Open-label Period|Did not receive treatment|0|||
105502049|NCT00319501|363848962|FG000|Open-label Period|Other|11|||
105502050|NCT00319501|363848963|FG001|Open-label Period|Other|0|||
105502051|NCT00319501|363848962|FG000|Open-label Extension Period|Adverse Event|2|||
105502052|NCT00319501|363848963|FG001|Open-label Extension Period|Adverse Event|0|||
105502053|NCT00319501|363848962|FG000|Open-label Extension Period|Did not receive treatment|18|||
105502054|NCT00319501|363848963|FG001|Open-label Extension Period|Did not receive treatment|0|||
105502055|NCT00319501|363848962|FG000|Open-label Extension Period|Other|1|||
105502056|NCT00319501|363848963|FG001|Open-label Extension Period|Other|0|||
105502057|NCT00319501|363848962|FG000|Open-label Extension Period|Principal investigator decision|2|||
105502058|NCT00319501|363848963|FG001|Open-label Extension Period|Principal investigator decision|0|||
105502059|NCT00319501|363848962|FG000|Open-label Extension Period|Sponsor request|26|||
105502060|NCT00319501|363848963|FG001|Open-label Extension Period|Sponsor request|0|||
105502061|NCT00319501|363848962|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
105502062|NCT00319501|363848963|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
105431345|NCT02914561|363586505|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
105502063|NCT01702961|363848965|FG000|Overall Study|Additional treatment|3|||
105502064|NCT01702961|363848965|FG000|Overall Study|Progressive disease|5|||
105502065|NCT01702961|363848965|FG000|Overall Study|Relapse|20|||
105502066|NCT01702961|363848965|FG000|Overall Study|Death|6|||
105502067|NCT01702961|363848965|FG000|Overall Study|Lost to Follow-up|2|||
105502068|NCT01702961|363848965|FG000|Overall Study|Ongoing|11|||
105502069|NCT02229383|363848966|FG000|Overall Study|Adverse Event|7|||
105590329|NCT00603447|364160780|FG004|Overall Study|Other|3|||
105590330|NCT00603447|364160781|FG005|Overall Study|Other|0|||
105431346|NCT02914561|363586506|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
105431347|NCT02914561|363586507|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
105431348|NCT02914561|363586508|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
105431349|NCT02914561|363586509|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
105431350|NCT02914561|363586510|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
105431351|NCT02914561|363586511|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
105431352|NCT02914561|363586512|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
105431353|NCT02914561|363586513|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
105431354|NCT02914561|363586503|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
105431355|NCT02914561|363586504|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
105431356|NCT02914561|363586505|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
105431357|NCT02914561|363586506|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
105431358|NCT02914561|363586507|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
105431359|NCT02914561|363586508|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
105431360|NCT02914561|363586509|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
105431361|NCT02914561|363586510|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
105431362|NCT02914561|363586511|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
105431363|NCT02914561|363586512|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
105431364|NCT02914561|363586513|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
105431365|NCT02914561|363586503|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
105431366|NCT02914561|363586504|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
105431367|NCT02914561|363586505|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
105431368|NCT02914561|363586506|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
105431369|NCT02914561|363586507|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
105431370|NCT02914561|363586508|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
105431371|NCT02914561|363586509|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
105431372|NCT02914561|363586510|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
105431373|NCT02914561|363586511|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
105431374|NCT02914561|363586512|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
105431375|NCT02914561|363586513|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
105431376|NCT02914561|363586503|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105431377|NCT02914561|363586504|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105431378|NCT02914561|363586505|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105431379|NCT02914561|363586506|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105431380|NCT02914561|363586507|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105431381|NCT02914561|363586508|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105431382|NCT02914561|363586509|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
105431383|NCT02914561|363586510|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105431384|NCT02914561|363586511|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
105431385|NCT02914561|363586512|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105431386|NCT02914561|363586513|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
105431387|NCT02914561|363586503|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
105431388|NCT02914561|363586504|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
105431389|NCT02914561|363586505|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
105431390|NCT02914561|363586506|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
105431391|NCT02914561|363586507|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
105431392|NCT02914561|363586508|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
105431393|NCT02914561|363586509|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
105431394|NCT02914561|363586510|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
105431395|NCT02914561|363586511|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
105431396|NCT02914561|363586512|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
105431397|NCT02914561|363586513|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
105431398|NCT02914561|363586503|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105431399|NCT02914561|363586504|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105431400|NCT02914561|363586505|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105431401|NCT02914561|363586506|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105431402|NCT02914561|363586507|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105431403|NCT02914561|363586508|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105431404|NCT02914561|363586509|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
105431405|NCT02914561|363586510|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105431406|NCT02914561|363586511|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
105431407|NCT02914561|363586512|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105431408|NCT02914561|363586513|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105431409|NCT02914561|363586503|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105590331|NCT00603447|364160782|FG006|Overall Study|Other|13|||
105431410|NCT02914561|363586504|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105431411|NCT02914561|363586505|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105431412|NCT02914561|363586506|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105431413|NCT02914561|363586507|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105431414|NCT02914561|363586508|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105431415|NCT02914561|363586509|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105431416|NCT02914561|363586510|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105431417|NCT02914561|363586511|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
105431418|NCT02914561|363586512|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105431419|NCT02914561|363586513|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105431420|NCT02914561|363586503|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105431421|NCT02914561|363586504|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105431422|NCT02914561|363586505|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105431423|NCT02914561|363586506|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105431424|NCT02914561|363586507|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105431425|NCT02914561|363586508|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105431426|NCT02914561|363586509|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
105431427|NCT02914561|363586510|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105431428|NCT02914561|363586511|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105431429|NCT02914561|363586512|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105431430|NCT02914561|363586513|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105431431|NCT02914561|363586503|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105431432|NCT02914561|363586504|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105431433|NCT02914561|363586505|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105431434|NCT02914561|363586506|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105431435|NCT02914561|363586507|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105431436|NCT02914561|363586508|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105431437|NCT02914561|363586509|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105431438|NCT02914561|363586510|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105431439|NCT02914561|363586511|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
105431440|NCT02914561|363586512|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
105431441|NCT02914561|363586513|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
105431442|NCT03691779|363586516|FG000|Part B (24 Weeks)|Adverse Event|0|||
105431443|NCT03691779|363586517|FG001|Part B (24 Weeks)|Adverse Event|1|||
105431444|NCT03691779|363586516|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
105431445|NCT03691779|363586517|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
105431446|NCT00267150|363586520|FG000|Overall Study|Adverse Event|1|||
105431447|NCT01561963|363586521|FG000|Overall Study|Adverse Event|1|||
105431448|NCT03869333|363586522|FG000|Overall Study|Lost to Follow-up|1|||
105431449|NCT03869333|363586523|FG001|Overall Study|Lost to Follow-up|0|||
105431450|NCT03869333|363586524|FG002|Overall Study|Lost to Follow-up|0|||
105431451|NCT03869333|363586525|FG003|Overall Study|Lost to Follow-up|0|||
105431452|NCT03869333|363586522|FG000|Overall Study|Pregnancy|1|||
105431453|NCT03869333|363586523|FG001|Overall Study|Pregnancy|0|||
105431454|NCT03869333|363586524|FG002|Overall Study|Pregnancy|0|||
105431455|NCT03869333|363586525|FG003|Overall Study|Pregnancy|0|||
105431456|NCT03869333|363586522|FG000|Overall Study|Physician Decision|0|||
105431457|NCT03869333|363586523|FG001|Overall Study|Physician Decision|1|||
105431458|NCT03869333|363586524|FG002|Overall Study|Physician Decision|0|||
105431459|NCT03869333|363586525|FG003|Overall Study|Physician Decision|0|||
105431460|NCT02598128|363586526|FG000|Period A: Days -7 to -1|Adverse Event|1|||
105431461|NCT02598128|363586527|FG001|Period A: Days -7 to -1|Adverse Event|0|||
105431462|NCT02598128|363586528|FG002|Period A: Days -7 to -1|Adverse Event|0|||
105431463|NCT02598128|363586529|FG003|Period A: Days -7 to -1|Adverse Event|0|||
105431464|NCT01459913|363586532|FG000|Overall Study|Adverse Event|0|||
105431465|NCT01459913|363586533|FG001|Overall Study|Adverse Event|0|||
105431466|NCT01459913|363586534|FG002|Overall Study|Adverse Event|0|||
105431467|NCT01459913|363586535|FG003|Overall Study|Adverse Event|3|||
105431468|NCT01459913|363586532|FG000|Overall Study|Withdrawal by Subject|4|||
105431469|NCT01459913|363586533|FG001|Overall Study|Withdrawal by Subject|0|||
105431470|NCT01459913|363586534|FG002|Overall Study|Withdrawal by Subject|0|||
105590332|NCT00603447|364160776|FG000|Overall Study|Withdrew Consent|0|||
105590333|NCT00603447|364160777|FG001|Overall Study|Withdrew Consent|2|||
105590334|NCT00603447|364160778|FG002|Overall Study|Withdrew Consent|0|||
105431471|NCT01459913|363586535|FG003|Overall Study|Withdrawal by Subject|5|||
105431472|NCT01459913|363586532|FG000|Overall Study|Lost to Follow-up|7|||
105431473|NCT01459913|363586533|FG001|Overall Study|Lost to Follow-up|4|||
105431474|NCT01459913|363586534|FG002|Overall Study|Lost to Follow-up|1|||
105431475|NCT01459913|363586535|FG003|Overall Study|Lost to Follow-up|8|||
105431476|NCT01459913|363586532|FG000|Overall Study|Death|0|||
105431477|NCT01459913|363586533|FG001|Overall Study|Death|0|||
105590335|NCT00603447|364160779|FG003|Overall Study|Withdrew Consent|0|||
105431478|NCT01459913|363586534|FG002|Overall Study|Death|0|||
105431479|NCT01459913|363586535|FG003|Overall Study|Death|1|||
105431480|NCT01459913|363586532|FG000|Overall Study|Non- Compliance|0|||
105431481|NCT01459913|363586533|FG001|Overall Study|Non- Compliance|0|||
105431482|NCT01459913|363586534|FG002|Overall Study|Non- Compliance|0|||
105431483|NCT01459913|363586535|FG003|Overall Study|Non- Compliance|3|||
105431484|NCT01459913|363586532|FG000|Overall Study|Physician Decision|0|||
105431485|NCT01459913|363586533|FG001|Overall Study|Physician Decision|1|||
105431486|NCT01459913|363586534|FG002|Overall Study|Physician Decision|0|||
105431487|NCT01459913|363586535|FG003|Overall Study|Physician Decision|0|||
105431488|NCT01459913|363586532|FG000|Overall Study|Study Terminated by Sponsor|30|||
105431489|NCT01459913|363586533|FG001|Overall Study|Study Terminated by Sponsor|15|||
105431490|NCT01459913|363586534|FG002|Overall Study|Study Terminated by Sponsor|9|||
105431491|NCT01459913|363586535|FG003|Overall Study|Study Terminated by Sponsor|11|||
105431492|NCT01459913|363586532|FG000|Overall Study|Other|0|||
105431493|NCT01459913|363586533|FG001|Overall Study|Other|0|||
105431494|NCT01459913|363586534|FG002|Overall Study|Other|3|||
105431495|NCT01459913|363586535|FG003|Overall Study|Other|1|||
105431496|NCT01459913|363586532|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
105431497|NCT01459913|363586533|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
105431498|NCT01459913|363586534|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
105431499|NCT01459913|363586535|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
105431500|NCT01064687|363586536|FG000|Overall Study|Adverse Event|9|||
105431501|NCT01064687|363586537|FG001|Overall Study|Adverse Event|4|||
105431502|NCT01064687|363586538|FG002|Overall Study|Adverse Event|10|||
105431503|NCT01064687|363586539|FG003|Overall Study|Adverse Event|3|||
105431504|NCT01064687|363586536|FG000|Overall Study|Death|1|||
105431505|NCT01064687|363586537|FG001|Overall Study|Death|1|||
105431506|NCT01064687|363586538|FG002|Overall Study|Death|0|||
105431507|NCT01064687|363586539|FG003|Overall Study|Death|0|||
105431508|NCT01064687|363586536|FG000|Overall Study|Entry Criteria Not Met|3|||
105431509|NCT01064687|363586537|FG001|Overall Study|Entry Criteria Not Met|0|||
105431510|NCT01064687|363586538|FG002|Overall Study|Entry Criteria Not Met|0|||
105502070|NCT02229383|363848967|FG001|Overall Study|Adverse Event|4|||
105502071|NCT02229383|363848966|FG000|Overall Study|Death|0|||
105502072|NCT02229383|363848967|FG001|Overall Study|Death|1|||
105502073|NCT02229383|363848966|FG000|Overall Study|Lost to Follow-up|5|||
105502074|NCT02229383|363848967|FG001|Overall Study|Lost to Follow-up|3|||
105502075|NCT02229383|363848966|FG000|Overall Study|Withdrawal by Subject|4|||
105502076|NCT02229383|363848967|FG001|Overall Study|Withdrawal by Subject|6|||
105502077|NCT02229383|363848966|FG000|Overall Study|Did not receive treatment|1|||
105502078|NCT02229383|363848967|FG001|Overall Study|Did not receive treatment|0|||
105502079|NCT02229383|363848966|FG000|Overall Study|Other|3|||
105502080|NCT02229383|363848967|FG001|Overall Study|Other|8|||
105502081|NCT00674362|363848972|FG000|Double Blind|Adverse Event|6|||
105502082|NCT00674362|363848973|FG001|Double Blind|Adverse Event|6|||
105502083|NCT00674362|363848972|FG000|Double Blind|Lack of Efficacy|2|||
105502084|NCT00674362|363848973|FG001|Double Blind|Lack of Efficacy|6|||
105502085|NCT00674362|363848972|FG000|Double Blind|Loss of efficacy|0|||
105502086|NCT00674362|363848973|FG001|Double Blind|Loss of efficacy|1|||
105502087|NCT00674362|363848972|FG000|Double Blind|Withdrawal by Subject|4|||
105502088|NCT00674362|363848973|FG001|Double Blind|Withdrawal by Subject|3|||
105502089|NCT00674362|363848972|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
105502090|NCT00674362|363848973|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
105502091|NCT00674362|363848972|FG000|Double Blind|Other: Surgery|0|||
105502092|NCT00674362|363848973|FG001|Double Blind|Other: Surgery|1|||
105502093|NCT00674362|363848972|FG000|Open Label|Adverse Event|1|||
105502094|NCT00674362|363848973|FG001|Open Label|Adverse Event|0|||
105502095|NCT00674362|363848972|FG000|Open Label|Other: Subject moved to extension study|1|||
105502096|NCT00674362|363848973|FG001|Open Label|Other: Subject moved to extension study|0|||
105502097|NCT00668707|363848974|FG000|Overall Study|Cancer Recurrence|58|||
105502098|NCT00668707|363848975|FG001|Overall Study|Cancer Recurrence|58|||
105502099|NCT00668707|363848974|FG000|Overall Study|Withdrawal by Subject|117|||
105502100|NCT00668707|363848975|FG001|Overall Study|Withdrawal by Subject|100|||
105502101|NCT00668707|363848974|FG000|Overall Study|Lost to Follow-up|3|||
105502102|NCT00668707|363848975|FG001|Overall Study|Lost to Follow-up|6|||
105502103|NCT00668707|363848974|FG000|Overall Study|Protocol Violation|10|||
105502104|NCT00668707|363848975|FG001|Overall Study|Protocol Violation|12|||
105590336|NCT00603447|364160780|FG004|Overall Study|Withdrew Consent|1|||
105590337|NCT00603447|364160781|FG005|Overall Study|Withdrew Consent|0|||
105431511|NCT01064687|363586539|FG003|Overall Study|Entry Criteria Not Met|0|||
105502105|NCT00668707|363848974|FG000|Overall Study|Death|11|||
105431512|NCT01064687|363586536|FG000|Overall Study|Lack of Efficacy|1|||
105431513|NCT01064687|363586537|FG001|Overall Study|Lack of Efficacy|0|||
105431514|NCT01064687|363586538|FG002|Overall Study|Lack of Efficacy|2|||
105431515|NCT01064687|363586539|FG003|Overall Study|Lack of Efficacy|3|||
105431516|NCT01064687|363586536|FG000|Overall Study|Lost to Follow-up|7|||
105431517|NCT01064687|363586537|FG001|Overall Study|Lost to Follow-up|10|||
105431518|NCT01064687|363586538|FG002|Overall Study|Lost to Follow-up|13|||
105502106|NCT00668707|363848975|FG001|Overall Study|Death|4|||
105431519|NCT01064687|363586539|FG003|Overall Study|Lost to Follow-up|5|||
105431520|NCT01064687|363586536|FG000|Overall Study|Physician Decision|2|||
105431521|NCT01064687|363586537|FG001|Overall Study|Physician Decision|2|||
105431522|NCT01064687|363586538|FG002|Overall Study|Physician Decision|0|||
105431523|NCT01064687|363586539|FG003|Overall Study|Physician Decision|0|||
105431524|NCT01064687|363586536|FG000|Overall Study|Protocol Violation|1|||
105431525|NCT01064687|363586537|FG001|Overall Study|Protocol Violation|1|||
105431526|NCT01064687|363586538|FG002|Overall Study|Protocol Violation|0|||
105431527|NCT01064687|363586539|FG003|Overall Study|Protocol Violation|1|||
105431528|NCT01064687|363586536|FG000|Overall Study|Sponsor Decision|0|||
105431529|NCT01064687|363586537|FG001|Overall Study|Sponsor Decision|0|||
105431530|NCT01064687|363586538|FG002|Overall Study|Sponsor Decision|3|||
105431531|NCT01064687|363586539|FG003|Overall Study|Sponsor Decision|0|||
105431532|NCT01064687|363586536|FG000|Overall Study|Withdrawal by Subject|9|||
105431533|NCT01064687|363586537|FG001|Overall Study|Withdrawal by Subject|7|||
105431534|NCT01064687|363586538|FG002|Overall Study|Withdrawal by Subject|12|||
105431535|NCT01064687|363586539|FG003|Overall Study|Withdrawal by Subject|5|||
105431536|NCT01064687|363586536|FG000|Overall Study|Treatment Noncompliance|1|||
105431537|NCT01064687|363586537|FG001|Overall Study|Treatment Noncompliance|1|||
105431538|NCT01064687|363586538|FG002|Overall Study|Treatment Noncompliance|1|||
105431539|NCT01064687|363586539|FG003|Overall Study|Treatment Noncompliance|0|||
105431540|NCT03134183|363586540|FG000|Overall Study|Withdrawal by Subject|1|||
105431541|NCT03134183|363586541|FG001|Overall Study|Withdrawal by Subject|1|||
105431542|NCT01291277|363586543|FG000|Overall Study|Death|2|||
105431543|NCT01291277|363586544|FG001|Overall Study|Death|2|||
105431544|NCT01291277|363586543|FG000|Overall Study|Lost to Follow-up|3|||
105431545|NCT01291277|363586544|FG001|Overall Study|Lost to Follow-up|1|||
105431546|NCT01345682|363586545|FG000|Overall Study|Progressive disease per RECIST|226|||
105431547|NCT01345682|363586546|FG001|Overall Study|Progressive disease per RECIST|93|||
105431548|NCT01345682|363586545|FG000|Overall Study|Worsening of underlying cancer disease|23|||
105431549|NCT01345682|363586546|FG001|Overall Study|Worsening of underlying cancer disease|12|||
105431550|NCT01345682|363586545|FG000|Overall Study|Adverse Event|51|||
105431551|NCT01345682|363586546|FG001|Overall Study|Adverse Event|41|||
105431552|NCT01345682|363586545|FG000|Overall Study|Non-compliance with protocol|0|||
105431553|NCT01345682|363586546|FG001|Overall Study|Non-compliance with protocol|1|||
105431554|NCT01345682|363586545|FG000|Overall Study|Lost to Follow-up|0|||
105431555|NCT01345682|363586546|FG001|Overall Study|Lost to Follow-up|1|||
105431556|NCT01345682|363586545|FG000|Overall Study|Refused to continue trial medication|16|||
105431557|NCT01345682|363586546|FG001|Overall Study|Refused to continue trial medication|9|||
105431558|NCT01345682|363586545|FG000|Overall Study|Not treated|2|||
105431559|NCT01345682|363586546|FG001|Overall Study|Not treated|1|||
105431560|NCT01345682|363586545|FG000|Overall Study|Reason other than those specified above|4|||
105431561|NCT01345682|363586546|FG001|Overall Study|Reason other than those specified above|3|||
105431562|NCT02540291|363586554|FG000|Overall Study|Death|7|||
105431563|NCT02540291|363586555|FG001|Overall Study|Death|7|||
105431564|NCT02540291|363586556|FG002|Overall Study|Death|5|||
105431565|NCT02540291|363586557|FG003|Overall Study|Death|7|||
105431566|NCT02540291|363586554|FG000|Overall Study|Lost to Follow-up|0|||
105431567|NCT02540291|363586555|FG001|Overall Study|Lost to Follow-up|0|||
105431568|NCT02540291|363586556|FG002|Overall Study|Lost to Follow-up|1|||
105431569|NCT02540291|363586557|FG003|Overall Study|Lost to Follow-up|0|||
105431570|NCT02540291|363586554|FG000|Overall Study|Withdrawal Of Consent|0|||
105431571|NCT02540291|363586555|FG001|Overall Study|Withdrawal Of Consent|1|||
105431572|NCT02540291|363586556|FG002|Overall Study|Withdrawal Of Consent|0|||
105431573|NCT02540291|363586557|FG003|Overall Study|Withdrawal Of Consent|0|||
105431574|NCT02540291|363586554|FG000|Overall Study|Study Terminated By Sponsor|1|||
105431575|NCT02540291|363586555|FG001|Overall Study|Study Terminated By Sponsor|0|||
105431576|NCT02540291|363586556|FG002|Overall Study|Study Terminated By Sponsor|0|||
105431577|NCT02540291|363586557|FG003|Overall Study|Study Terminated By Sponsor|0|||
105431578|NCT02540291|363586554|FG000|Overall Study|Other|0|||
105431579|NCT02540291|363586555|FG001|Overall Study|Other|0|||
105431580|NCT02540291|363586556|FG002|Overall Study|Other|1|||
105431581|NCT02540291|363586557|FG003|Overall Study|Other|0|||
105431582|NCT01282294|363587467|FG000|Overall Study|Lost to Follow-up|14|||
105431583|NCT01282294|363587467|FG000|Overall Study|Screening failure|1|||
105431584|NCT01282294|363587467|FG000|Overall Study|Adverse Event|1|||
105431585|NCT01282294|363587467|FG000|Overall Study|Patient non-compliance|2|||
105431586|NCT01282294|363587467|FG000|Overall Study|Physician Decision|1|||
105431587|NCT01549873|363587468|FG000|Overall Study|Physician Decision|0|||
105431588|NCT01549873|363587469|FG001|Overall Study|Physician Decision|1|||
105431589|NCT03769311|363587470|FG000|Overall Study|Withdrawal by Subject|1|||
105431590|NCT04435600|363587471|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105431591|NCT04435600|363587472|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105431592|NCT04435600|363587473|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
105431593|NCT04435600|363587474|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105431594|NCT04435600|363587475|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105431595|NCT04435600|363587476|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105431596|NCT04435600|363587477|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105431597|NCT04435600|363587478|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105431598|NCT04435600|363587479|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105431599|NCT04435600|363587480|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105431600|NCT04435600|363587471|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105431601|NCT04435600|363587472|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105431602|NCT04435600|363587473|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105431603|NCT04435600|363587474|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105431604|NCT04435600|363587475|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105431605|NCT04435600|363587476|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105431606|NCT04435600|363587477|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105431607|NCT04435600|363587478|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105431608|NCT04435600|363587479|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105431609|NCT04435600|363587480|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
105431610|NCT04435600|363587471|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105431611|NCT04435600|363587472|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105431612|NCT04435600|363587473|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105431613|NCT04435600|363587474|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105431614|NCT04435600|363587475|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105431615|NCT04435600|363587476|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105431616|NCT04435600|363587477|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105431617|NCT04435600|363587478|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105431618|NCT04435600|363587479|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105431619|NCT04435600|363587480|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
105431620|NCT04435600|363587471|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
105431621|NCT04435600|363587472|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
105431622|NCT04435600|363587473|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
105431623|NCT04435600|363587474|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
105431624|NCT04435600|363587475|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
105431625|NCT04435600|363587476|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
105431626|NCT04435600|363587477|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
105431627|NCT04435600|363587478|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
105431628|NCT04435600|363587479|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
105431629|NCT04435600|363587480|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
105431630|NCT01657760|363587494|FG000|Overall Study|Withdrawal by Subject|0|||
105431631|NCT01657760|363587495|FG001|Overall Study|Withdrawal by Subject|0|||
105431632|NCT01657760|363587496|FG002|Overall Study|Withdrawal by Subject|0|||
105431633|NCT01657760|363587497|FG003|Overall Study|Withdrawal by Subject|1|||
105431634|NCT01657760|363587494|FG000|Overall Study|Physician Decision|1|||
105431635|NCT01657760|363587495|FG001|Overall Study|Physician Decision|1|||
105431636|NCT01657760|363587496|FG002|Overall Study|Physician Decision|1|||
105431637|NCT01657760|363587497|FG003|Overall Study|Physician Decision|2|||
105431638|NCT01113580|363587498|FG000|Overall Study|Protocol Violation|1|||
105431639|NCT01113580|363587499|FG001|Overall Study|Protocol Violation|0|||
105431640|NCT02212678|363587505|FG000|Overall Study|Adverse Event|1|||
105431641|NCT01068249|363587508|FG000|Overall Study|Death|1|||
105431642|NCT01068249|363587508|FG000|Overall Study|Withdrawal by Subject|3|||
105431643|NCT04619004|363587509|FG000|Overall Study|Death|114|||
105431644|NCT04619004|363587510|FG001|Overall Study|Death|28|||
105431645|NCT04619004|363587509|FG000|Overall Study|Lost to Follow-up|1|||
105431646|NCT04619004|363587510|FG001|Overall Study|Lost to Follow-up|1|||
105431647|NCT04619004|363587509|FG000|Overall Study|Withdrawal by Subject|24|||
105431648|NCT04619004|363587510|FG001|Overall Study|Withdrawal by Subject|7|||
105431649|NCT04619004|363587509|FG000|Overall Study|Other - Not specified|0|||
105431650|NCT04619004|363587510|FG001|Overall Study|Other - Not specified|1|||
105431651|NCT05601102|363587512|FG000|Overall Study|Death|1|||
105431652|NCT05601102|363587513|FG001|Overall Study|Death|2|||
105431653|NCT05601102|363587512|FG000|Overall Study|Withdrawal by Subject|1|||
105431654|NCT05601102|363587513|FG001|Overall Study|Withdrawal by Subject|1|||
105431655|NCT05601102|363587512|FG000|Overall Study|Lost to Follow-up|0|||
105431656|NCT05601102|363587513|FG001|Overall Study|Lost to Follow-up|2|||
105431657|NCT01114360|363587514|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
105431658|NCT01114360|363587515|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
105431659|NCT05824936|363587518|FG000|Overall Study|Lost to Follow-up|1|||
105431660|NCT00673881|363587519|FG000|Overall Study|Withdrawal by Subject|1|||
105431661|NCT03689712|363587520|FG000|Overall Study|Adverse Event|1|||
105431662|NCT03689712|363587521|FG001|Overall Study|Adverse Event|0|||
105431663|NCT03689712|363587520|FG000|Overall Study|Death|20|||
105502107|NCT03137537|363848980|FG000|Overall Study|Adverse Event|0|||
105502108|NCT03137537|363848981|FG001|Overall Study|Adverse Event|1|||
105431664|NCT03689712|363587521|FG001|Overall Study|Death|10|||
105431665|NCT03689712|363587520|FG000|Overall Study|Lost to Follow-up|6|||
105431666|NCT03689712|363587521|FG001|Overall Study|Lost to Follow-up|6|||
105502109|NCT00672646|363848982|FG000|Overall Study|Lost to Follow-up|0|||
105431667|NCT03689712|363587520|FG000|Overall Study|Other|1|||
105431668|NCT03689712|363587521|FG001|Overall Study|Other|0|||
105431669|NCT03689712|363587520|FG000|Overall Study|Patient Non-Compliance|0|||
105431670|NCT03689712|363587521|FG001|Overall Study|Patient Non-Compliance|1|||
105431671|NCT03689712|363587520|FG000|Overall Study|Withdrawal by Subject|20|||
105431672|NCT03689712|363587521|FG001|Overall Study|Withdrawal by Subject|4|||
105431673|NCT03689712|363587520|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
105431674|NCT03689712|363587521|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
105431675|NCT03689712|363587520|FG000|Overall Study|Randomized but not Treated|13|||
105431676|NCT03689712|363587521|FG001|Overall Study|Randomized but not Treated|7|||
105431677|NCT03689712|363587520|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
105431678|NCT03689712|363587521|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
105431679|NCT00895661|363587522|FG000|Overall Study|Death|1|||
105431680|NCT00895661|363587522|FG000|Overall Study|reason unknown|2|||
105431681|NCT02006069|363587525|FG000|Overall Study|MPP other programming|239|||
105431682|NCT02006069|363587526|FG001|Overall Study|MPP other programming|0|||
105431683|NCT02006069|363587525|FG000|Overall Study|RV only pacing|0|||
105431684|NCT02006069|363587526|FG001|Overall Study|RV only pacing|3|||
105431685|NCT02989805|363587527|FG000|Overall Study|invalid consent|6|||
105431686|NCT02989805|363587528|FG001|Overall Study|invalid consent|4|||
105431687|NCT02211313|363587529|FG000|Overall Study|Treatment Failure|5|||
105431688|NCT02211313|363587530|FG001|Overall Study|Treatment Failure|2|||
105431689|NCT02211313|363587529|FG000|Overall Study|No Follow up Questionnaires|1|||
105431690|NCT02211313|363587530|FG001|Overall Study|No Follow up Questionnaires|1|||
105431691|NCT00286221|363587531|FG000|Overall Study|Protocol Violation|2|||
105431692|NCT00286221|363587532|FG001|Overall Study|Protocol Violation|1|||
105431693|NCT00286221|363587533|FG002|Overall Study|Protocol Violation|6|||
105431694|NCT00286221|363587534|FG003|Overall Study|Protocol Violation|4|||
105431695|NCT00286221|363587531|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
105431696|NCT00286221|363587532|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
105431697|NCT00286221|363587533|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
105431698|NCT00286221|363587534|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
105431699|NCT00286221|363587531|FG000|Overall Study|Inability to trigger PCA|2|||
105431700|NCT00286221|363587532|FG001|Overall Study|Inability to trigger PCA|0|||
105431701|NCT00286221|363587533|FG002|Overall Study|Inability to trigger PCA|0|||
105431702|NCT00286221|363587534|FG003|Overall Study|Inability to trigger PCA|0|||
105431703|NCT00286221|363587531|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
105431704|NCT00286221|363587532|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
105431705|NCT00286221|363587533|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
105431706|NCT00286221|363587534|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
105431707|NCT01554514|363587535|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
105431708|NCT01554514|363587535|FG000|Overall Study|Physician Decision|1|||
105431709|NCT02553538|363587536|FG000|Overall Study|Could Not Reach by Telephone|133|||
105431710|NCT02553538|363587537|FG001|Overall Study|Could Not Reach by Telephone|0|||
105431711|NCT02553538|363587536|FG000|Overall Study|Died or Left Network|54|||
105431712|NCT02553538|363587537|FG001|Overall Study|Died or Left Network|56|||
105431713|NCT02690649|363587538|FG000|Overall Study|Withdrawal by Subject|1|||
105431714|NCT02690649|363587539|FG001|Overall Study|Withdrawal by Subject|1|||
105431715|NCT02690649|363587538|FG000|Overall Study|Protocol Violation|0|||
105431716|NCT02690649|363587539|FG001|Overall Study|Protocol Violation|3|||
105431717|NCT02276547|363587540|FG000|Overall Study|Death|2|||
105431718|NCT02276547|363587540|FG000|Overall Study|Explant|2|||
105431719|NCT02066129|363587543|FG000|Overall Study|Lost to Follow-up|13|||
105431720|NCT02066129|363587544|FG001|Overall Study|Lost to Follow-up|12|||
105431721|NCT02066129|363587543|FG000|Overall Study|Withdrawal by Subject|7|||
105431722|NCT02066129|363587544|FG001|Overall Study|Withdrawal by Subject|10|||
105431723|NCT02066129|363587543|FG000|Overall Study|Lack of Efficacy|8|||
105431724|NCT02066129|363587544|FG001|Overall Study|Lack of Efficacy|10|||
105431725|NCT02066129|363587543|FG000|Overall Study|Physician Decision|1|||
105431726|NCT02066129|363587544|FG001|Overall Study|Physician Decision|1|||
105431727|NCT02616393|363587545|FG000|Overall Study|Death|5|||
105431728|NCT02616393|363587546|FG001|Overall Study|Death|12|||
105431729|NCT02616393|363587547|FG002|Overall Study|Death|1|||
105431730|NCT02616393|363587545|FG000|Overall Study|Termination by Sponsor|4|||
105431731|NCT02616393|363587546|FG001|Overall Study|Termination by Sponsor|5|||
105431732|NCT02616393|363587547|FG002|Overall Study|Termination by Sponsor|2|||
105431733|NCT02616393|363587545|FG000|Overall Study|Other|3|||
105431734|NCT02616393|363587546|FG001|Overall Study|Other|0|||
105431735|NCT02616393|363587547|FG002|Overall Study|Other|0|||
105431736|NCT02616393|363587545|FG000|Overall Study|Withdrawal by Subject|1|||
105431737|NCT02616393|363587546|FG001|Overall Study|Withdrawal by Subject|1|||
105502110|NCT00672646|363848983|FG001|Overall Study|Lost to Follow-up|1|||
105502111|NCT00672646|363848984|FG002|Overall Study|Lost to Follow-up|2|||
105502112|NCT00672646|363848982|FG000|Overall Study|Withdrawal by Subject|0|||
105502113|NCT00672646|363848983|FG001|Overall Study|Withdrawal by Subject|0|||
105502114|NCT00672646|363848984|FG002|Overall Study|Withdrawal by Subject|1|||
105431738|NCT02616393|363587547|FG002|Overall Study|Withdrawal by Subject|0|||
105431739|NCT02616393|363587545|FG000|Overall Study|Lost to Follow-up|0|||
105431740|NCT02616393|363587546|FG001|Overall Study|Lost to Follow-up|2|||
105431741|NCT02616393|363587547|FG002|Overall Study|Lost to Follow-up|0|||
105431742|NCT02712424|363587548|FG000|Overall Study|Lost to Follow-up|34|||
105431743|NCT02712424|363587549|FG001|Overall Study|Lost to Follow-up|32|||
105431744|NCT00657371|363587550|FG000|Overall Study|Poor bowel preparation|15|||
105431745|NCT00657371|363587550|FG000|Overall Study|Unable to intubate the cecum|5|||
105431746|NCT00657371|363587550|FG000|Overall Study|Protocol Violation|2|||
105431747|NCT00657371|363587550|FG000|Overall Study|Device- related reasons|13|||
105431748|NCT00657371|363587550|FG000|Overall Study|Pre-existing medical condition|4|||
105431749|NCT01141478|363587551|FG000|Overall Study|Withdrawal by Subject|1|||
105431750|NCT01141478|363587552|FG001|Overall Study|Withdrawal by Subject|1|||
105431751|NCT00551291|363587553|FG000|Overall Study|Physician Decision|1|||
105431752|NCT01600053|363587554|FG000|Overall Study|Adverse Event|2|||
105431753|NCT01600053|363587554|FG000|Overall Study|trial will not meet the interim endpoint|9|||
105431754|NCT03230292|363587555|FG000|Overall Study|Adverse Event|1|||
105431755|NCT03230292|363587555|FG000|Overall Study|Protocol Violation|1|||
105431756|NCT03230292|363587555|FG000|Overall Study|Lost to Follow-up|1|||
105431757|NCT03230292|363587555|FG000|Overall Study|Withdrawal by Subject|3|||
105431758|NCT00661388|363587557|FG000|Overall Study|Adverse Event|14|||
105431759|NCT00661388|363587557|FG000|Overall Study|Protocol Violation|7|||
105431760|NCT00661388|363587557|FG000|Overall Study|Renal transplantation|1|||
105431761|NCT00661388|363587557|FG000|Overall Study|Dialysis initiation|1|||
105431762|NCT00661388|363587557|FG000|Overall Study|Administrative reasons|1|||
105431763|NCT01183468|363587559|FG000|Overall Study|Lost to Follow-up|2|||
105431764|NCT01183468|363587560|FG001|Overall Study|Lost to Follow-up|1|||
105431765|NCT01183468|363587561|FG002|Overall Study|Lost to Follow-up|0|||
105431766|NCT01183468|363587562|FG003|Overall Study|Lost to Follow-up|0|||
105431767|NCT01183468|363587559|FG000|Overall Study|Physician Decision|1|||
105431768|NCT01183468|363587560|FG001|Overall Study|Physician Decision|0|||
105431769|NCT01183468|363587561|FG002|Overall Study|Physician Decision|0|||
105431770|NCT01183468|363587562|FG003|Overall Study|Physician Decision|0|||
105431771|NCT01183468|363587559|FG000|Overall Study|Withdrawal by Subject|0|||
105431772|NCT01183468|363587560|FG001|Overall Study|Withdrawal by Subject|1|||
105431773|NCT01183468|363587561|FG002|Overall Study|Withdrawal by Subject|0|||
105431774|NCT01183468|363587562|FG003|Overall Study|Withdrawal by Subject|0|||
105431775|NCT04208087|363587563|FG000|Overall Study|Adverse Event|1|||
105431776|NCT04208087|363587564|FG001|Overall Study|Adverse Event|0|||
105431777|NCT04208087|363587565|FG002|Overall Study|Adverse Event|0|||
105431778|NCT04208087|363587566|FG003|Overall Study|Adverse Event|0|||
105431779|NCT04208087|363587567|FG004|Overall Study|Adverse Event|0|||
105431780|NCT04208087|363587563|FG000|Overall Study|Withdrawal by Subject|0|||
105431781|NCT04208087|363587564|FG001|Overall Study|Withdrawal by Subject|0|||
105431782|NCT04208087|363587565|FG002|Overall Study|Withdrawal by Subject|1|||
105431783|NCT04208087|363587566|FG003|Overall Study|Withdrawal by Subject|0|||
105431784|NCT04208087|363587567|FG004|Overall Study|Withdrawal by Subject|0|||
105431785|NCT04208087|363587563|FG000|Overall Study|Other|0|||
105431786|NCT04208087|363587564|FG001|Overall Study|Other|0|||
105431787|NCT04208087|363587565|FG002|Overall Study|Other|0|||
105431788|NCT04208087|363587566|FG003|Overall Study|Other|0|||
105431789|NCT04208087|363587567|FG004|Overall Study|Other|1|||
105431790|NCT01198509|363587568|FG000|Overall Study|Withdrawal by Subject|1|||
105431791|NCT01198509|363587569|FG001|Overall Study|Withdrawal by Subject|0|||
105431792|NCT01198509|363587570|FG002|Overall Study|Withdrawal by Subject|0|||
105431793|NCT01198509|363587571|FG003|Overall Study|Withdrawal by Subject|0|||
105431794|NCT01198509|363587572|FG004|Overall Study|Withdrawal by Subject|0|||
105431795|NCT01198509|363587573|FG005|Overall Study|Withdrawal by Subject|0|||
105431796|NCT01638559|363587574|FG000|Overall Study|Lost to Follow-up|1|||
105431797|NCT01638559|363587574|FG000|Overall Study|Withdrawal by Subject|1|||
105431798|NCT01638559|363587574|FG000|Overall Study|Subject declined to travel for biopsy|1|||
105431799|NCT00279812|363587587|FG000|Overall Study|Protocol Violation|1|||
105431800|NCT00279812|363587588|FG001|Overall Study|Protocol Violation|1|||
105431801|NCT00279812|363587589|FG002|Overall Study|Protocol Violation|0|||
105431802|NCT00279812|363587590|FG003|Overall Study|Protocol Violation|0|||
105431803|NCT00279812|363587591|FG004|Overall Study|Protocol Violation|1|||
105431804|NCT00279812|363587592|FG005|Overall Study|Protocol Violation|0|||
105431805|NCT00279812|363587587|FG000|Overall Study|Withdrawal by Subject|0|||
105431806|NCT00279812|363587588|FG001|Overall Study|Withdrawal by Subject|4|||
105431807|NCT00279812|363587589|FG002|Overall Study|Withdrawal by Subject|2|||
105502115|NCT00453063|363848988|FG000|Overall Study|Adverse Event|1|||
105431808|NCT00279812|363587590|FG003|Overall Study|Withdrawal by Subject|0|||
105431809|NCT00279812|363587591|FG004|Overall Study|Withdrawal by Subject|0|||
105431810|NCT00279812|363587592|FG005|Overall Study|Withdrawal by Subject|0|||
105431811|NCT00279812|363587587|FG000|Overall Study|Adverse Event|0|||
105431812|NCT00279812|363587588|FG001|Overall Study|Adverse Event|1|||
105431813|NCT00279812|363587589|FG002|Overall Study|Adverse Event|1|||
105502116|NCT00453063|363848989|FG001|Overall Study|Adverse Event|2|||
105502117|NCT00453063|363848988|FG000|Overall Study|Withdrawal by Subject|1|||
105502118|NCT00453063|363848989|FG001|Overall Study|Withdrawal by Subject|1|||
105502119|NCT00453063|363848988|FG000|Overall Study|Protocol Violation|1|||
105502120|NCT00453063|363848989|FG001|Overall Study|Protocol Violation|0|||
105431814|NCT00279812|363587590|FG003|Overall Study|Adverse Event|0|||
105431815|NCT00279812|363587591|FG004|Overall Study|Adverse Event|2|||
105431816|NCT00279812|363587592|FG005|Overall Study|Adverse Event|1|||
105431817|NCT04046250|363587593|FG000|Overall Study|Death|0|||
105431818|NCT04046250|363587594|FG001|Overall Study|Death|1|||
105431819|NCT04046250|363587593|FG000|Overall Study|Withdrawal by Subject|3|||
105431820|NCT04046250|363587594|FG001|Overall Study|Withdrawal by Subject|3|||
105431821|NCT01174173|363587595|FG000|Overall Study|drug-drug interaction|1|||
105431822|NCT01818284|363589327|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
105431823|NCT01818284|363589328|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
105431824|NCT01818284|363589327|FG000|Overall Study|Death|0|||
105431825|NCT01818284|363589328|FG001|Overall Study|Death|2|||
105431826|NCT04030962|363589329|FG000|Stage 2|Adverse Event|0|||
105431827|NCT04030962|363589330|FG001|Stage 2|Adverse Event|0|||
105431828|NCT04030962|363589331|FG002|Stage 2|Adverse Event|0|||
105431829|NCT04030962|363589332|FG003|Stage 2|Adverse Event|0|||
105431830|NCT04030962|363589333|FG004|Stage 2|Adverse Event|0|||
105431831|NCT04030962|363589334|FG005|Stage 2|Adverse Event|0|||
105431832|NCT04030962|363589335|FG006|Stage 2|Adverse Event|0|||
105431833|NCT04030962|363589336|FG007|Stage 2|Adverse Event|0|||
105431834|NCT04030962|363589337|FG008|Stage 2|Adverse Event|1|||
105431835|NCT04030962|363589338|FG009|Stage 2|Adverse Event|0|||
105431836|NCT04030962|363589339|FG010|Stage 2|Adverse Event|1|||
105431837|NCT04030962|363589340|FG011|Stage 2|Adverse Event|1|||
105431838|NCT04030962|363589341|FG012|Stage 2|Adverse Event|1|||
105431839|NCT04030962|363589329|FG000|Stage 2|Withdrawal by Subject|0|||
105431840|NCT04030962|363589330|FG001|Stage 2|Withdrawal by Subject|0|||
105431841|NCT04030962|363589331|FG002|Stage 2|Withdrawal by Subject|0|||
105431842|NCT04030962|363589332|FG003|Stage 2|Withdrawal by Subject|0|||
105431843|NCT04030962|363589333|FG004|Stage 2|Withdrawal by Subject|0|||
105431844|NCT04030962|363589334|FG005|Stage 2|Withdrawal by Subject|0|||
105431845|NCT04030962|363589335|FG006|Stage 2|Withdrawal by Subject|0|||
105431846|NCT04030962|363589336|FG007|Stage 2|Withdrawal by Subject|0|||
105431847|NCT04030962|363589337|FG008|Stage 2|Withdrawal by Subject|1|||
105431848|NCT04030962|363589338|FG009|Stage 2|Withdrawal by Subject|0|||
105431849|NCT04030962|363589339|FG010|Stage 2|Withdrawal by Subject|0|||
105431850|NCT04030962|363589340|FG011|Stage 2|Withdrawal by Subject|2|||
105431851|NCT04030962|363589341|FG012|Stage 2|Withdrawal by Subject|1|||
105431852|NCT04030962|363589329|FG000|Stage 2|Lost to Follow-up|0|||
105431853|NCT04030962|363589330|FG001|Stage 2|Lost to Follow-up|0|||
105431854|NCT04030962|363589331|FG002|Stage 2|Lost to Follow-up|0|||
105431855|NCT04030962|363589332|FG003|Stage 2|Lost to Follow-up|0|||
105431856|NCT04030962|363589333|FG004|Stage 2|Lost to Follow-up|0|||
105431857|NCT04030962|363589334|FG005|Stage 2|Lost to Follow-up|0|||
105431858|NCT04030962|363589335|FG006|Stage 2|Lost to Follow-up|0|||
105431859|NCT04030962|363589336|FG007|Stage 2|Lost to Follow-up|0|||
105431860|NCT04030962|363589337|FG008|Stage 2|Lost to Follow-up|1|||
105431861|NCT04030962|363589338|FG009|Stage 2|Lost to Follow-up|0|||
105431862|NCT04030962|363589339|FG010|Stage 2|Lost to Follow-up|0|||
105431863|NCT04030962|363589340|FG011|Stage 2|Lost to Follow-up|0|||
105431864|NCT04030962|363589341|FG012|Stage 2|Lost to Follow-up|0|||
105431865|NCT04030962|363589329|FG000|Stage 2|Technical Problems|0|||
105431866|NCT04030962|363589330|FG001|Stage 2|Technical Problems|0|||
105431867|NCT04030962|363589331|FG002|Stage 2|Technical Problems|0|||
105431868|NCT04030962|363589332|FG003|Stage 2|Technical Problems|0|||
105431869|NCT04030962|363589333|FG004|Stage 2|Technical Problems|0|||
105502121|NCT03128411|363848990|FG000|Treatment Phase|Adverse Event|21|||
105502122|NCT03128411|363848990|FG000|Treatment Phase|Physician Decision|1|||
105502123|NCT03128411|363848990|FG000|Treatment Phase|Other|2|||
105502124|NCT03128411|363848990|FG000|Long Term Follow-up Phase|Death|2|||
105431870|NCT04030962|363589334|FG005|Stage 2|Technical Problems|0|||
105431871|NCT04030962|363589335|FG006|Stage 2|Technical Problems|0|||
105431872|NCT04030962|363589336|FG007|Stage 2|Technical Problems|0|||
105431873|NCT04030962|363589337|FG008|Stage 2|Technical Problems|0|||
105431874|NCT04030962|363589338|FG009|Stage 2|Technical Problems|0|||
105431875|NCT04030962|363589339|FG010|Stage 2|Technical Problems|0|||
105431876|NCT04030962|363589340|FG011|Stage 2|Technical Problems|1|||
105431877|NCT04030962|363589341|FG012|Stage 2|Technical Problems|0|||
105431878|NCT01646203|363589342|FG000|Overall Study|Adverse Event|2|||
105431879|NCT01646203|363589343|FG001|Overall Study|Adverse Event|0|||
105431880|NCT01646203|363589344|FG002|Overall Study|Adverse Event|1|||
105431881|NCT01646203|363589342|FG000|Overall Study|Withdrawal by Subject|0|||
105431882|NCT01646203|363589343|FG001|Overall Study|Withdrawal by Subject|1|||
105502125|NCT00594659|363848991|FG000|Overall Study|Lost to Follow-up|13|||
105502126|NCT00594659|363848992|FG001|Overall Study|Lost to Follow-up|9|||
105431883|NCT01646203|363589344|FG002|Overall Study|Withdrawal by Subject|0|||
105431884|NCT01646203|363589342|FG000|Overall Study|Physician's Decision|0|||
105431885|NCT01646203|363589343|FG001|Overall Study|Physician's Decision|1|||
105431886|NCT01646203|363589344|FG002|Overall Study|Physician's Decision|0|||
105431887|NCT00385723|363589345|FG000|Overall Study|Lost to Follow-up|1|||
105431888|NCT00385723|363589346|FG001|Overall Study|Lost to Follow-up|1|||
105431889|NCT00385723|363589347|FG002|Overall Study|Lost to Follow-up|0|||
105431890|NCT00385723|363589345|FG000|Overall Study|Withdrawal by Subject|1|||
105431891|NCT00385723|363589346|FG001|Overall Study|Withdrawal by Subject|0|||
105431892|NCT00385723|363589347|FG002|Overall Study|Withdrawal by Subject|2|||
105431893|NCT03455829|363589348|FG000|Overall Study|Death|2|||
105431894|NCT03455829|363589349|FG001|Overall Study|Death|3|||
105431895|NCT03455829|363589350|FG002|Overall Study|Death|2|||
105431896|NCT03455829|363589351|FG003|Overall Study|Death|4|||
105431897|NCT03455829|363589352|FG004|Overall Study|Death|2|||
105431898|NCT03455829|363589348|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
105431899|NCT03455829|363589349|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
105431900|NCT03455829|363589350|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
105431901|NCT03455829|363589351|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
105431902|NCT03455829|363589352|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
105431903|NCT03455829|363589348|FG000|Overall Study|Disease progression|0|||
105431904|NCT03455829|363589349|FG001|Overall Study|Disease progression|0|||
105431905|NCT03455829|363589350|FG002|Overall Study|Disease progression|0|||
105431906|NCT03455829|363589351|FG003|Overall Study|Disease progression|1|||
105431907|NCT03455829|363589352|FG004|Overall Study|Disease progression|1|||
105431908|NCT02634606|363589354|FG000|Overall Study|unable to obtain the drug at start|13|||
105431909|NCT02648217|363589365|FG000|Overall Study|Adverse Event|0|||
105431910|NCT02648217|363589366|FG001|Overall Study|Adverse Event|1|||
105431911|NCT02648217|363589365|FG000|Overall Study|Lost to Follow-up|1|||
105431912|NCT02648217|363589366|FG001|Overall Study|Lost to Follow-up|1|||
105431913|NCT02648217|363589365|FG000|Overall Study|Withdrawal by Subject|4|||
105431914|NCT02648217|363589366|FG001|Overall Study|Withdrawal by Subject|3|||
105431915|NCT02648217|363589365|FG000|Overall Study|Unclassified|5|||
105431916|NCT02648217|363589366|FG001|Overall Study|Unclassified|0|||
105431917|NCT00549770|363589367|FG000|Overall Study|Protocol deviation|1|||
105431918|NCT00549770|363589368|FG001|Overall Study|Protocol deviation|1|||
105431919|NCT00549770|363589369|FG002|Overall Study|Protocol deviation|1|||
105431920|NCT00549770|363589370|FG003|Overall Study|Protocol deviation|2|||
105431921|NCT00549770|363589371|FG004|Overall Study|Protocol deviation|2|||
105431922|NCT00549770|363589372|FG005|Overall Study|Protocol deviation|2|||
105431923|NCT00549770|363589373|FG006|Overall Study|Protocol deviation|1|||
105431924|NCT00549770|363589374|FG007|Overall Study|Protocol deviation|2|||
105431925|NCT00549770|363589367|FG000|Overall Study|Administrative problems|0|||
105431926|NCT00549770|363589368|FG001|Overall Study|Administrative problems|1|||
105431927|NCT00549770|363589369|FG002|Overall Study|Administrative problems|0|||
105431928|NCT00549770|363589370|FG003|Overall Study|Administrative problems|0|||
105431929|NCT00549770|363589371|FG004|Overall Study|Administrative problems|0|||
105431930|NCT00549770|363589372|FG005|Overall Study|Administrative problems|0|||
105431931|NCT00549770|363589373|FG006|Overall Study|Administrative problems|0|||
105431932|NCT00549770|363589374|FG007|Overall Study|Administrative problems|1|||
105431933|NCT00549770|363589367|FG000|Overall Study|Lost to Follow-up|0|||
105431934|NCT00549770|363589368|FG001|Overall Study|Lost to Follow-up|0|||
105431935|NCT00549770|363589369|FG002|Overall Study|Lost to Follow-up|2|||
105431936|NCT00549770|363589370|FG003|Overall Study|Lost to Follow-up|2|||
105431937|NCT00549770|363589371|FG004|Overall Study|Lost to Follow-up|3|||
105431938|NCT00549770|363589372|FG005|Overall Study|Lost to Follow-up|2|||
105431939|NCT00549770|363589373|FG006|Overall Study|Lost to Follow-up|0|||
105431940|NCT00549770|363589374|FG007|Overall Study|Lost to Follow-up|0|||
105431941|NCT00549770|363589367|FG000|Overall Study|Withdrawal by Subject|4|||
105431942|NCT00549770|363589368|FG001|Overall Study|Withdrawal by Subject|6|||
105431943|NCT00549770|363589369|FG002|Overall Study|Withdrawal by Subject|4|||
105431944|NCT00549770|363589370|FG003|Overall Study|Withdrawal by Subject|5|||
105431945|NCT00549770|363589371|FG004|Overall Study|Withdrawal by Subject|6|||
105431946|NCT00549770|363589372|FG005|Overall Study|Withdrawal by Subject|6|||
105431947|NCT00549770|363589373|FG006|Overall Study|Withdrawal by Subject|4|||
105431948|NCT00549770|363589374|FG007|Overall Study|Withdrawal by Subject|9|||
105431949|NCT00549770|363589367|FG000|Overall Study|Lack of Efficacy|1|||
105431950|NCT00549770|363589368|FG001|Overall Study|Lack of Efficacy|0|||
105431951|NCT00549770|363589369|FG002|Overall Study|Lack of Efficacy|2|||
105431952|NCT00549770|363589370|FG003|Overall Study|Lack of Efficacy|3|||
105431953|NCT00549770|363589371|FG004|Overall Study|Lack of Efficacy|5|||
105431954|NCT00549770|363589372|FG005|Overall Study|Lack of Efficacy|1|||
105431955|NCT00549770|363589373|FG006|Overall Study|Lack of Efficacy|3|||
105431956|NCT00549770|363589374|FG007|Overall Study|Lack of Efficacy|8|||
105431957|NCT00549770|363589367|FG000|Overall Study|Abnormal test procedure results|0|||
105431958|NCT00549770|363589368|FG001|Overall Study|Abnormal test procedure results|0|||
105431959|NCT00549770|363589369|FG002|Overall Study|Abnormal test procedure results|0|||
105431960|NCT00549770|363589370|FG003|Overall Study|Abnormal test procedure results|2|||
105431961|NCT00549770|363589371|FG004|Overall Study|Abnormal test procedure results|0|||
105431962|NCT00549770|363589372|FG005|Overall Study|Abnormal test procedure results|1|||
105431963|NCT00549770|363589373|FG006|Overall Study|Abnormal test procedure results|1|||
105431964|NCT00549770|363589374|FG007|Overall Study|Abnormal test procedure results|1|||
105431965|NCT00549770|363589367|FG000|Overall Study|Abnormal laboratory values|0|||
105431966|NCT00549770|363589368|FG001|Overall Study|Abnormal laboratory values|0|||
105431967|NCT00549770|363589369|FG002|Overall Study|Abnormal laboratory values|0|||
105431968|NCT00549770|363589370|FG003|Overall Study|Abnormal laboratory values|0|||
105431969|NCT00549770|363589371|FG004|Overall Study|Abnormal laboratory values|0|||
105431970|NCT00549770|363589372|FG005|Overall Study|Abnormal laboratory values|1|||
105431971|NCT00549770|363589373|FG006|Overall Study|Abnormal laboratory values|0|||
105431972|NCT00549770|363589374|FG007|Overall Study|Abnormal laboratory values|0|||
105431973|NCT00549770|363589367|FG000|Overall Study|Adverse Event|1|||
105431974|NCT00549770|363589368|FG001|Overall Study|Adverse Event|3|||
105431975|NCT00549770|363589369|FG002|Overall Study|Adverse Event|1|||
105431976|NCT00549770|363589370|FG003|Overall Study|Adverse Event|2|||
105431977|NCT00549770|363589371|FG004|Overall Study|Adverse Event|1|||
105431978|NCT00549770|363589372|FG005|Overall Study|Adverse Event|0|||
105431979|NCT00549770|363589373|FG006|Overall Study|Adverse Event|5|||
105431980|NCT00549770|363589374|FG007|Overall Study|Adverse Event|4|||
105431981|NCT02392403|363589375|FG000|Overall Study|Adverse Event|1|||
105431982|NCT02392403|363589375|FG000|Overall Study|Death|1|||
105431983|NCT02392403|363589375|FG000|Overall Study|Withdrawal by Subject|1|||
105431984|NCT02335424|363589379|FG000|Overall Study|Withdrawal by Subject|19|||
105431985|NCT02335424|363589379|FG000|Overall Study|Adverse Event|25|||
105431986|NCT02335424|363589379|FG000|Overall Study|Death|273|||
105431987|NCT02335424|363589379|FG000|Overall Study|Lost to Follow-up|3|||
105431988|NCT02335424|363589379|FG000|Overall Study|Physician Decision|13|||
105431989|NCT02335424|363589379|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
105431990|NCT02335424|363589379|FG000|Overall Study|Protocol Violation|1|||
105431991|NCT02335424|363589379|FG000|Overall Study|Screen failure|1|||
105431992|NCT02776033|363589380|FG000|Overall Study|Withdrawal by Subject|0|||
105431993|NCT02776033|363589381|FG001|Overall Study|Withdrawal by Subject|0|||
105431994|NCT02776033|363589382|FG002|Overall Study|Withdrawal by Subject|2|||
105431995|NCT02776033|363589380|FG000|Overall Study|Physician Decision|2|||
105431996|NCT02776033|363589381|FG001|Overall Study|Physician Decision|0|||
105431997|NCT02776033|363589382|FG002|Overall Study|Physician Decision|0|||
105431998|NCT02776033|363589380|FG000|Overall Study|Lost to Follow-up|1|||
105431999|NCT02776033|363589381|FG001|Overall Study|Lost to Follow-up|0|||
105432000|NCT02776033|363589382|FG002|Overall Study|Lost to Follow-up|0|||
105432001|NCT02776033|363589380|FG000|Overall Study|Adverse Event|1|||
105432002|NCT02776033|363589381|FG001|Overall Study|Adverse Event|2|||
105432003|NCT02776033|363589382|FG002|Overall Study|Adverse Event|0|||
105432004|NCT00548717|363589383|FG000|Overall Study|Death|5|||
105432005|NCT00548717|363589384|FG001|Overall Study|Death|2|||
105432006|NCT00548717|363589383|FG000|Overall Study|Relapse|3|||
105432007|NCT00548717|363589384|FG001|Overall Study|Relapse|0|||
105432008|NCT00548717|363589383|FG000|Overall Study|Alternative treatment for GVHD|1|||
105432009|NCT00548717|363589384|FG001|Overall Study|Alternative treatment for GVHD|0|||
105432010|NCT00582738|363589391|FG000|Overall Study|Administrative Problems|7|||
105432011|NCT00582738|363589392|FG001|Overall Study|Administrative Problems|8|||
105432012|NCT00582738|363589391|FG000|Overall Study|Adverse Event|0|||
105432013|NCT00582738|363589392|FG001|Overall Study|Adverse Event|5|||
105432014|NCT00582738|363589391|FG000|Overall Study|Graft Lost|0|||
105432015|NCT00582738|363589392|FG001|Overall Study|Graft Lost|1|||
105432016|NCT00582738|363589391|FG000|Overall Study|Other|1|||
105432017|NCT00582738|363589392|FG001|Overall Study|Other|0|||
105432018|NCT00582738|363589391|FG000|Overall Study|Protocol Violation|1|||
105432019|NCT00582738|363589392|FG001|Overall Study|Protocol Violation|1|||
105432020|NCT00582738|363589391|FG000|Overall Study|Withdrawal by Subject|0|||
105432021|NCT00582738|363589392|FG001|Overall Study|Withdrawal by Subject|3|||
105432022|NCT00847015|363589394|FG000|Overall Study|Withdrawal by Subject|1|||
105432023|NCT00847015|363589394|FG000|Overall Study|declined any surgery|1|||
105432024|NCT00847015|363589394|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
105432025|NCT01943552|363589395|FG000|Overall Study|Adverse Event|3|||
105432026|NCT01943552|363589396|FG001|Overall Study|Adverse Event|2|||
105432027|NCT01943552|363589395|FG000|Overall Study|Withdrawal by Subject|6|||
105432028|NCT01943552|363589396|FG001|Overall Study|Withdrawal by Subject|6|||
105432029|NCT01943552|363589395|FG000|Overall Study|Other Reasons|16|||
105432030|NCT01943552|363589396|FG001|Overall Study|Other Reasons|17|||
105432031|NCT02715726|363589397|FG000|Overall Study|Adverse Event|2|||
105432032|NCT02715726|363589398|FG001|Overall Study|Adverse Event|6|||
105432033|NCT02715726|363589397|FG000|Overall Study|Protocol Violation|1|||
105432034|NCT02715726|363589398|FG001|Overall Study|Protocol Violation|0|||
105432035|NCT02715726|363589397|FG000|Overall Study|Death|2|||
105432036|NCT02715726|363589398|FG001|Overall Study|Death|1|||
105432037|NCT02715726|363589397|FG000|Overall Study|Participant moved|1|||
105432038|NCT02715726|363589398|FG001|Overall Study|Participant moved|3|||
105432039|NCT02715726|363589397|FG000|Overall Study|Other than specified above|11|||
105432040|NCT02715726|363589398|FG001|Overall Study|Other than specified above|15|||
105432041|NCT02715726|363589397|FG000|Overall Study|Randomized but not treated|1|||
105432042|NCT02715726|363589398|FG001|Overall Study|Randomized but not treated|2|||
105432043|NCT02445573|363589399|FG000|Overall Study|Withdrawal by Subject|1|||
105432044|NCT02445573|363589400|FG001|Overall Study|Withdrawal by Subject|1|||
105432045|NCT02445573|363589399|FG000|Overall Study|Lost to Follow-up|0|||
105432046|NCT02445573|363589400|FG001|Overall Study|Lost to Follow-up|1|||
105432047|NCT00635089|363589405|FG000|Overall Study|Adverse Event|7|||
105432048|NCT00635089|363589405|FG000|Overall Study|Lack of Efficacy|28|||
105432049|NCT00635089|363589405|FG000|Overall Study|Protocol Deviation|4|||
105432050|NCT00635089|363589405|FG000|Overall Study|Lost to Follow-up|8|||
105432051|NCT00635089|363589405|FG000|Overall Study|Other|31|||
105432052|NCT00869401|363589410|FG000|Overall Study|Withdrawal by Subject|0|||
105432053|NCT00869401|363589411|FG001|Overall Study|Withdrawal by Subject|0|||
105432054|NCT00869401|363589412|FG002|Overall Study|Withdrawal by Subject|0|||
105432055|NCT00869401|363589413|FG003|Overall Study|Withdrawal by Subject|5|||
105432056|NCT00869401|363589414|FG004|Overall Study|Withdrawal by Subject|3|||
105432057|NCT01147900|363589415|FG000|At Year 10|Lost to Follow-up|0|||
105432058|NCT01147900|363589416|FG001|At Year 10|Lost to Follow-up|1|||
105432059|NCT01147900|363589417|FG002|At Year 10|Lost to Follow-up|0|||
105432060|NCT03443427|363589419|FG000|Overall Study|Adverse Event|2|||
105432061|NCT03443427|363589420|FG001|Overall Study|Adverse Event|3|||
105432062|NCT03443427|363589419|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
105432063|NCT03443427|363589420|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
105432064|NCT03443427|363589419|FG000|Overall Study|Other|4|||
105432065|NCT03443427|363589420|FG001|Overall Study|Other|6|||
105432066|NCT00576472|363589421|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
105432067|NCT00576472|363589422|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
105432068|NCT00576472|363589423|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
105432069|NCT00576472|363589424|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
105432070|NCT00576472|363589425|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
105432071|NCT00576472|363589426|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
105432072|NCT00576472|363589427|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
105432073|NCT00576472|363589428|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
105432074|NCT00576472|363589429|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
105432075|NCT00576472|363589430|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
105432076|NCT00576472|363589431|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
105432077|NCT00576472|363589432|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
105432078|NCT00576472|363589433|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
105432079|NCT00576472|363589434|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
105432080|NCT00576472|363589435|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
105432081|NCT00576472|363589421|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
105432082|NCT00576472|363589422|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
105432083|NCT00576472|363589423|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
105432084|NCT00576472|363589424|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
105432085|NCT00576472|363589425|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
105432086|NCT00576472|363589426|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
105432087|NCT00576472|363589427|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
105432088|NCT00576472|363589428|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
105432089|NCT00576472|363589429|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
105432090|NCT00576472|363589430|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
105432091|NCT00576472|363589431|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
105432092|NCT00576472|363589432|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
105432093|NCT00576472|363589433|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
105432094|NCT00576472|363589434|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
105432095|NCT00576472|363589435|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
105432096|NCT00576472|363589421|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105432097|NCT00576472|363589422|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105432098|NCT00576472|363589423|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105432099|NCT00576472|363589424|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
105432100|NCT00576472|363589425|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105432101|NCT00576472|363589426|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105432102|NCT00576472|363589427|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105590338|NCT00603447|364160782|FG006|Overall Study|Withdrew Consent|1|||
105590339|NCT00798265|364160783|FG000|Overall Study|Lost to Follow-up|1|||
105432103|NCT00576472|363589428|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105432104|NCT00576472|363589429|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105432105|NCT00576472|363589430|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105432106|NCT00576472|363589431|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105432107|NCT00576472|363589432|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105432108|NCT00576472|363589433|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105590340|NCT00798265|364160784|FG001|Overall Study|Lost to Follow-up|10|||
105590341|NCT00798265|364160783|FG000|Overall Study|Study closing|7|||
105432109|NCT00576472|363589434|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105432110|NCT00576472|363589435|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105432111|NCT00576472|363589421|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
105432112|NCT00576472|363589422|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
105432113|NCT00576472|363589423|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
105432114|NCT00576472|363589424|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
105432115|NCT00576472|363589425|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
105432116|NCT00576472|363589426|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
105432117|NCT00576472|363589427|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
105432118|NCT00576472|363589428|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
105432119|NCT00576472|363589429|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
105432120|NCT00576472|363589430|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
105432121|NCT00576472|363589431|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
105432122|NCT00576472|363589432|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
105432123|NCT00576472|363589433|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
105432124|NCT00576472|363589434|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
105432125|NCT00576472|363589435|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
105432126|NCT00576472|363589421|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
105432127|NCT00576472|363589422|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
105432128|NCT00576472|363589423|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
105432129|NCT00576472|363589424|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
105432130|NCT00576472|363589425|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
105432131|NCT00576472|363589426|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
105432132|NCT00576472|363589427|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
105432133|NCT00576472|363589428|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
105502127|NCT00594659|363848993|FG002|Overall Study|Lost to Follow-up|7|||
105502128|NCT00142298|363848994|FG000|Overall Study|Adverse Event|10|||
105502129|NCT00142298|363848995|FG001|Overall Study|Adverse Event|10|||
105502130|NCT00142298|363848996|FG002|Overall Study|Adverse Event|1|||
105502131|NCT00142298|363848997|FG003|Overall Study|Adverse Event|5|||
105502132|NCT00142298|363848998|FG004|Overall Study|Adverse Event|2|||
105502133|NCT00142298|363848999|FG005|Overall Study|Adverse Event|2|||
105502134|NCT00142298|363849000|FG006|Overall Study|Adverse Event|0|||
105502135|NCT00142298|363849001|FG007|Overall Study|Adverse Event|0|||
105502136|NCT00142298|363849002|FG008|Overall Study|Adverse Event|0|||
105502137|NCT00142298|363849003|FG009|Overall Study|Adverse Event|0|||
105502138|NCT00142298|363848994|FG000|Overall Study|Clinical disease progression|1|||
105502139|NCT00142298|363848995|FG001|Overall Study|Clinical disease progression|0|||
105502140|NCT00142298|363848996|FG002|Overall Study|Clinical disease progression|0|||
105502141|NCT00142298|363848997|FG003|Overall Study|Clinical disease progression|0|||
105502142|NCT00142298|363848998|FG004|Overall Study|Clinical disease progression|0|||
105502143|NCT00142298|363848999|FG005|Overall Study|Clinical disease progression|0|||
105502144|NCT00142298|363849000|FG006|Overall Study|Clinical disease progression|0|||
105502145|NCT00142298|363849001|FG007|Overall Study|Clinical disease progression|0|||
105502146|NCT00142298|363849002|FG008|Overall Study|Clinical disease progression|0|||
105502147|NCT00142298|363849003|FG009|Overall Study|Clinical disease progression|0|||
105502148|NCT00142298|363848994|FG000|Overall Study|Death|1|||
105502149|NCT00142298|363848995|FG001|Overall Study|Death|1|||
105502150|NCT00142298|363848996|FG002|Overall Study|Death|1|||
105502151|NCT00142298|363848997|FG003|Overall Study|Death|0|||
105502152|NCT00142298|363848998|FG004|Overall Study|Death|0|||
105502153|NCT00142298|363848999|FG005|Overall Study|Death|6|||
105502154|NCT00142298|363849000|FG006|Overall Study|Death|0|||
105502155|NCT00142298|363849001|FG007|Overall Study|Death|0|||
105502156|NCT00142298|363849002|FG008|Overall Study|Death|0|||
105502157|NCT00142298|363849003|FG009|Overall Study|Death|0|||
105502158|NCT00142298|363848994|FG000|Overall Study|Lack of Efficacy|44|||
105502159|NCT00142298|363848995|FG001|Overall Study|Lack of Efficacy|62|||
105502160|NCT00142298|363848996|FG002|Overall Study|Lack of Efficacy|9|||
105502161|NCT00142298|363848997|FG003|Overall Study|Lack of Efficacy|12|||
105432134|NCT00576472|363589429|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
105502162|NCT00142298|363848998|FG004|Overall Study|Lack of Efficacy|1|||
105502163|NCT00142298|363848999|FG005|Overall Study|Lack of Efficacy|0|||
105502164|NCT00142298|363849000|FG006|Overall Study|Lack of Efficacy|0|||
105502165|NCT00142298|363849001|FG007|Overall Study|Lack of Efficacy|1|||
105502166|NCT00142298|363849002|FG008|Overall Study|Lack of Efficacy|0|||
105502167|NCT00142298|363849003|FG009|Overall Study|Lack of Efficacy|0|||
105502168|NCT00142298|363848994|FG000|Overall Study|Non-compliance|15|||
105502169|NCT00142298|363848995|FG001|Overall Study|Non-compliance|13|||
105432135|NCT00576472|363589430|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
105432136|NCT00576472|363589431|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
105432137|NCT00576472|363589432|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
105502170|NCT00142298|363848996|FG002|Overall Study|Non-compliance|0|||
105502171|NCT00142298|363848997|FG003|Overall Study|Non-compliance|6|||
105502172|NCT00142298|363848998|FG004|Overall Study|Non-compliance|1|||
105502173|NCT00142298|363848999|FG005|Overall Study|Non-compliance|0|||
105502174|NCT00142298|363849000|FG006|Overall Study|Non-compliance|0|||
105432138|NCT00576472|363589433|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
105432139|NCT00576472|363589434|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
105432140|NCT00576472|363589435|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
105432141|NCT00576472|363589421|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
105432142|NCT00576472|363589422|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
105432143|NCT00576472|363589423|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
105432144|NCT00576472|363589424|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
105432145|NCT00576472|363589425|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
105432146|NCT00576472|363589426|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
105432147|NCT00576472|363589427|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
105432148|NCT00576472|363589428|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
105432149|NCT00576472|363589429|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
105432150|NCT00576472|363589430|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
105432151|NCT00576472|363589431|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
105432152|NCT00576472|363589432|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
105432153|NCT00576472|363589433|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
105432154|NCT00576472|363589434|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
105432155|NCT00576472|363589435|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
105432156|NCT00576472|363589421|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
105432157|NCT00576472|363589422|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
105432158|NCT00576472|363589423|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
105432159|NCT00576472|363589424|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
105432160|NCT00576472|363589425|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
105432161|NCT00576472|363589426|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
105502175|NCT00142298|363849001|FG007|Overall Study|Non-compliance|3|||
105502176|NCT00142298|363849002|FG008|Overall Study|Non-compliance|3|||
105502177|NCT00142298|363849003|FG009|Overall Study|Non-compliance|0|||
105502178|NCT00142298|363848994|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
105502179|NCT00142298|363848995|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
105502180|NCT00142298|363848996|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
105502181|NCT00142298|363848997|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
105502182|NCT00142298|363848998|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
105502183|NCT00142298|363848999|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
105502184|NCT00142298|363849000|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
105502185|NCT00142298|363849001|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
105502186|NCT00142298|363849002|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
105502187|NCT00142298|363849003|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
105502188|NCT00142298|363848994|FG000|Overall Study|Pregnancy|4|||
105502189|NCT00142298|363848995|FG001|Overall Study|Pregnancy|4|||
105502190|NCT00142298|363848996|FG002|Overall Study|Pregnancy|2|||
105502191|NCT00142298|363848997|FG003|Overall Study|Pregnancy|3|||
105502192|NCT00142298|363848998|FG004|Overall Study|Pregnancy|0|||
105502193|NCT00142298|363848999|FG005|Overall Study|Pregnancy|0|||
105502194|NCT00142298|363849000|FG006|Overall Study|Pregnancy|0|||
105502195|NCT00142298|363849001|FG007|Overall Study|Pregnancy|0|||
105502196|NCT00142298|363849002|FG008|Overall Study|Pregnancy|1|||
105502197|NCT00142298|363849003|FG009|Overall Study|Pregnancy|0|||
105502198|NCT00142298|363848994|FG000|Overall Study|Virologic breakthrough|19|||
105502199|NCT00142298|363848995|FG001|Overall Study|Virologic breakthrough|23|||
105502200|NCT00142298|363848996|FG002|Overall Study|Virologic breakthrough|9|||
105502201|NCT00142298|363848997|FG003|Overall Study|Virologic breakthrough|7|||
105502202|NCT00142298|363848998|FG004|Overall Study|Virologic breakthrough|2|||
105502203|NCT00142298|363848999|FG005|Overall Study|Virologic breakthrough|3|||
105502204|NCT00142298|363849000|FG006|Overall Study|Virologic breakthrough|3|||
105502205|NCT00142298|363849001|FG007|Overall Study|Virologic breakthrough|0|||
105590342|NCT00798265|364160784|FG001|Overall Study|Study closing|6|||
105590343|NCT00798265|364160783|FG000|Overall Study|Withdrawal by Subject|0|||
105590344|NCT00798265|364160784|FG001|Overall Study|Withdrawal by Subject|1|||
105590345|NCT00798265|364160783|FG000|Overall Study|Screen failure|0|||
105590346|NCT00798265|364160784|FG001|Overall Study|Screen failure|1|||
105432162|NCT00576472|363589427|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
105432163|NCT00576472|363589428|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
105432164|NCT00576472|363589429|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
105432165|NCT00576472|363589430|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
105502206|NCT00142298|363849002|FG008|Overall Study|Virologic breakthrough|0|||
105502207|NCT00142298|363849003|FG009|Overall Study|Virologic breakthrough|0|||
105502208|NCT00142298|363848994|FG000|Overall Study|Other- not specified|0|||
105432166|NCT00576472|363589431|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
105432167|NCT00576472|363589432|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
105432168|NCT00576472|363589433|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
105432169|NCT00576472|363589434|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
105502209|NCT00142298|363848995|FG001|Overall Study|Other- not specified|3|||
105502210|NCT00142298|363848996|FG002|Overall Study|Other- not specified|0|||
105590347|NCT00359619|364162537|FG000|Overall Study|Adverse Event|0|||
105432170|NCT00576472|363589435|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
105432171|NCT00576472|363589421|FG000|MPH Cross Over Phase|Physician Decision|0|||
105432172|NCT00576472|363589422|FG001|MPH Cross Over Phase|Physician Decision|0|||
105432173|NCT00576472|363589423|FG002|MPH Cross Over Phase|Physician Decision|0|||
105432174|NCT00576472|363589424|FG003|MPH Cross Over Phase|Physician Decision|0|||
105432175|NCT00576472|363589425|FG004|MPH Cross Over Phase|Physician Decision|0|||
105432176|NCT00576472|363589426|FG005|MPH Cross Over Phase|Physician Decision|0|||
105432177|NCT00576472|363589427|FG006|MPH Cross Over Phase|Physician Decision|4|||
105432178|NCT00576472|363589428|FG007|MPH Cross Over Phase|Physician Decision|0|||
105432179|NCT00576472|363589429|FG008|MPH Cross Over Phase|Physician Decision|0|||
105432180|NCT00576472|363589430|FG009|MPH Cross Over Phase|Physician Decision|0|||
105432181|NCT00576472|363589431|FG010|MPH Cross Over Phase|Physician Decision|0|||
105432182|NCT00576472|363589432|FG011|MPH Cross Over Phase|Physician Decision|0|||
105432183|NCT00576472|363589433|FG012|MPH Cross Over Phase|Physician Decision|0|||
105432184|NCT00576472|363589434|FG013|MPH Cross Over Phase|Physician Decision|0|||
105432185|NCT00576472|363589435|FG014|MPH Cross Over Phase|Physician Decision|0|||
105432186|NCT00576472|363589421|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
105432187|NCT00576472|363589422|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
105432188|NCT00576472|363589423|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
105432189|NCT00576472|363589424|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
105432190|NCT00576472|363589425|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
105432191|NCT00576472|363589426|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
105432192|NCT00576472|363589427|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
105432193|NCT00576472|363589428|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
105432194|NCT00576472|363589429|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
105432195|NCT00576472|363589430|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
105432196|NCT00576472|363589431|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
105432197|NCT00576472|363589432|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
105432198|NCT00576472|363589433|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
105432199|NCT00576472|363589434|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
105432200|NCT00576472|363589435|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
105432201|NCT00576472|363589421|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105432202|NCT00576472|363589422|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105432203|NCT00576472|363589423|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105432204|NCT00576472|363589424|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105432205|NCT00576472|363589425|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105432206|NCT00576472|363589426|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105432207|NCT00576472|363589427|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105432208|NCT00576472|363589428|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105432209|NCT00576472|363589429|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105432210|NCT00576472|363589430|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105432211|NCT00576472|363589431|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105432212|NCT00576472|363589432|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105432213|NCT00576472|363589433|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105432214|NCT00576472|363589434|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
105432215|NCT00576472|363589435|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105432216|NCT00576472|363589421|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
105432217|NCT00576472|363589422|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
105432218|NCT00576472|363589423|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
105432219|NCT00576472|363589424|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
105432220|NCT00576472|363589425|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
105432221|NCT00576472|363589426|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
105432222|NCT00576472|363589427|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
105432223|NCT00576472|363589428|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
105432224|NCT00576472|363589429|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
105432225|NCT00576472|363589430|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
105432226|NCT00576472|363589431|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
105432227|NCT00576472|363589432|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
105432228|NCT00576472|363589433|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
105432229|NCT00576472|363589434|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
105432230|NCT00576472|363589435|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
105432231|NCT00576472|363589421|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
105432232|NCT00576472|363589422|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
105432233|NCT00576472|363589423|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
105432234|NCT00576472|363589424|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
105432235|NCT00576472|363589425|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
105432236|NCT00576472|363589426|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
105432237|NCT00576472|363589427|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
105590348|NCT00359619|364162538|FG001|Overall Study|Adverse Event|0|||
105590349|NCT00359619|364162539|FG002|Overall Study|Adverse Event|1|||
105590350|NCT00359619|364162540|FG003|Overall Study|Adverse Event|0|||
105590351|NCT00359619|364162541|FG004|Overall Study|Adverse Event|0|||
105590352|NCT00359619|364162542|FG005|Overall Study|Adverse Event|0|||
105590353|NCT00359619|364162543|FG006|Overall Study|Adverse Event|1|||
105590354|NCT00359619|364162537|FG000|Overall Study|Withdrawal by Subject|3|||
105590355|NCT00359619|364162538|FG001|Overall Study|Withdrawal by Subject|1|||
105590356|NCT00359619|364162539|FG002|Overall Study|Withdrawal by Subject|4|||
105590357|NCT00359619|364162540|FG003|Overall Study|Withdrawal by Subject|2|||
105590358|NCT00359619|364162541|FG004|Overall Study|Withdrawal by Subject|2|||
105590359|NCT00359619|364162542|FG005|Overall Study|Withdrawal by Subject|0|||
105590360|NCT00359619|364162543|FG006|Overall Study|Withdrawal by Subject|3|||
105590361|NCT00359619|364162537|FG000|Overall Study|Other|1|||
105590362|NCT00359619|364162538|FG001|Overall Study|Other|0|||
105590363|NCT00359619|364162539|FG002|Overall Study|Other|0|||
105590364|NCT00359619|364162540|FG003|Overall Study|Other|0|||
105590365|NCT00359619|364162541|FG004|Overall Study|Other|0|||
105590366|NCT00359619|364162542|FG005|Overall Study|Other|0|||
105590367|NCT00359619|364162543|FG006|Overall Study|Other|0|||
105590368|NCT00359619|364162537|FG000|Overall Study|Lost to Follow-up|4|||
105590369|NCT00359619|364162538|FG001|Overall Study|Lost to Follow-up|4|||
105590370|NCT00359619|364162539|FG002|Overall Study|Lost to Follow-up|2|||
105590371|NCT00359619|364162540|FG003|Overall Study|Lost to Follow-up|1|||
105590372|NCT00359619|364162541|FG004|Overall Study|Lost to Follow-up|1|||
105590373|NCT00359619|364162542|FG005|Overall Study|Lost to Follow-up|5|||
105590374|NCT00359619|364162543|FG006|Overall Study|Lost to Follow-up|0|||
105590375|NCT01419717|364162544|FG000|Overall Study|Protocol-specified Criteria|62|||
105590376|NCT01419717|364162544|FG000|Overall Study|Adverse Event|19|||
105590377|NCT01419717|364162544|FG000|Overall Study|Death|17|||
105590378|NCT01419717|364162544|FG000|Overall Study|Withdrawal by Subject|10|||
105590379|NCT01419717|364162544|FG000|Overall Study|Disease Progression|9|||
105590380|NCT01419717|364162544|FG000|Overall Study|Other|4|||
105590381|NCT01419717|364162544|FG000|Overall Study|Lost to Follow-up|2|||
105590382|NCT01419717|364162544|FG000|Overall Study|Administrative Decision|1|||
105590383|NCT01419717|364162544|FG000|Overall Study|Noncompliance|1|||
105590384|NCT02857283|364162545|FG000|First Exposure|Withdrawal by Subject|1|||
105590385|NCT02857283|364162546|FG001|First Exposure|Withdrawal by Subject|0|||
105590386|NCT04358549|364162549|FG000|Overall Study|Adverse Event|0|||
105590387|NCT04358549|364162550|FG001|Overall Study|Adverse Event|1|||
105590388|NCT04358549|364162549|FG000|Overall Study|Death|1|||
105590389|NCT04358549|364162550|FG001|Overall Study|Death|0|||
105590390|NCT04358549|364162549|FG000|Overall Study|Lost to Follow-up|2|||
105590391|NCT04358549|364162550|FG001|Overall Study|Lost to Follow-up|1|||
105590392|NCT04358549|364162549|FG000|Overall Study|Withdrawal by Subject|6|||
105590393|NCT04358549|364162550|FG001|Overall Study|Withdrawal by Subject|6|||
105590394|NCT04358549|364162549|FG000|Overall Study|Start remdesivir|1|||
105590395|NCT04358549|364162550|FG001|Overall Study|Start remdesivir|0|||
105590396|NCT01257503|364162557|FG000|Overall Study|Lost to Follow-up|7|||
105590397|NCT01257503|364162558|FG001|Overall Study|Lost to Follow-up|10|||
105590398|NCT01257503|364162557|FG000|Overall Study|Over 5 years old at enrollment|0|||
105590399|NCT01257503|364162558|FG001|Overall Study|Over 5 years old at enrollment|1|||
105590400|NCT01257503|364162557|FG000|Overall Study|strep culture positive at enrollment|1|||
105590401|NCT01257503|364162558|FG001|Overall Study|strep culture positive at enrollment|0|||
105590402|NCT02534896|364162567|FG000|Overall Study|Adverse Event|2|||
105590403|NCT02534896|364162568|FG001|Overall Study|Adverse Event|1|||
105590404|NCT02534896|364162569|FG002|Overall Study|Adverse Event|1|||
105590405|NCT02534896|364162567|FG000|Overall Study|Insufficient therapeutic response|2|||
105590406|NCT02534896|364162568|FG001|Overall Study|Insufficient therapeutic response|0|||
105590407|NCT02534896|364162569|FG002|Overall Study|Insufficient therapeutic response|0|||
105590408|NCT04381494|364162570|FG000|Overall Study|Early termination of trial|19|||
105590409|NCT04381494|364162570|FG000|Overall Study|Investigator's discretion|1|||
105432238|NCT00576472|363589428|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
105432239|NCT00576472|363589429|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
105432240|NCT00576472|363589430|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
105432241|NCT00576472|363589431|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
105432242|NCT00576472|363589432|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
105432243|NCT00576472|363589433|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
105432244|NCT00576472|363589434|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
105432245|NCT00576472|363589435|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
105432246|NCT00576472|363589421|FG000|MPH Home Maintenance Phase|Side effects|0|||
105432247|NCT00576472|363589422|FG001|MPH Home Maintenance Phase|Side effects|0|||
105590410|NCT04381494|364162570|FG000|Overall Study|Withdrawal by Subject|9|||
105590411|NCT04381494|364162570|FG000|Overall Study|NSCLC disease progression|4|||
105590412|NCT04381494|364162570|FG000|Overall Study|Device-Related Adverse Event|2|||
105590413|NCT03396835|364162571|FG000|Overall Study|Withdrawn prior to completion|1|||
105432248|NCT00576472|363589423|FG002|MPH Home Maintenance Phase|Side effects|0|||
105590414|NCT03396835|364162571|FG000|Overall Study|Did not meet criteria for data analysis|1|||
105590415|NCT03467724|364162578|FG000|Overall Study|Lost to Follow-up|5|||
105590416|NCT03467724|364162578|FG000|Overall Study|Withdrawal by Subject|1|||
105590417|NCT03467724|364162578|FG000|Overall Study|Protocol Violation|1|||
105590418|NCT03467724|364162578|FG000|Overall Study|Adverse Event|1|||
105590419|NCT04310579|364162579|FG000|Overall Study|Adverse Event|0|||
105590420|NCT04310579|364162580|FG001|Overall Study|Adverse Event|0|||
105432249|NCT00576472|363589424|FG003|MPH Home Maintenance Phase|Side effects|0|||
105432250|NCT00576472|363589425|FG004|MPH Home Maintenance Phase|Side effects|0|||
105432251|NCT00576472|363589426|FG005|MPH Home Maintenance Phase|Side effects|0|||
105432252|NCT00576472|363589427|FG006|MPH Home Maintenance Phase|Side effects|0|||
105432253|NCT00576472|363589428|FG007|MPH Home Maintenance Phase|Side effects|0|||
105432254|NCT00576472|363589429|FG008|MPH Home Maintenance Phase|Side effects|0|||
105432255|NCT00576472|363589430|FG009|MPH Home Maintenance Phase|Side effects|0|||
105432256|NCT00576472|363589431|FG010|MPH Home Maintenance Phase|Side effects|0|||
105432257|NCT00576472|363589432|FG011|MPH Home Maintenance Phase|Side effects|0|||
105432258|NCT00576472|363589433|FG012|MPH Home Maintenance Phase|Side effects|0|||
105432259|NCT00576472|363589434|FG013|MPH Home Maintenance Phase|Side effects|0|||
105432260|NCT00576472|363589435|FG014|MPH Home Maintenance Phase|Side effects|8|||
105432261|NCT00576472|363589421|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105432262|NCT00576472|363589422|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105432263|NCT00576472|363589423|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105432264|NCT00576472|363589424|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105432265|NCT00576472|363589425|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105432266|NCT00576472|363589426|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105432267|NCT00576472|363589427|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105432268|NCT00576472|363589428|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105432269|NCT00576472|363589429|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105432270|NCT00576472|363589430|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105432271|NCT00576472|363589431|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105432272|NCT00576472|363589432|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105432273|NCT00576472|363589433|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105432274|NCT00576472|363589434|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105432275|NCT00576472|363589435|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
105432276|NCT00576472|363589421|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
105432277|NCT00576472|363589422|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
105432278|NCT00576472|363589423|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
105432279|NCT00576472|363589424|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
105432280|NCT00576472|363589425|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
105432281|NCT00576472|363589426|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
105432282|NCT00576472|363589427|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
105432283|NCT00576472|363589428|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
105432284|NCT00576472|363589429|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
105432285|NCT00576472|363589430|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
105432286|NCT00576472|363589431|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
105432287|NCT00576472|363589432|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
105432288|NCT00576472|363589433|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
105432289|NCT00576472|363589434|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
105432290|NCT00576472|363589435|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
105432291|NCT00576472|363589421|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105432292|NCT00576472|363589422|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105432293|NCT00576472|363589423|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105432294|NCT00576472|363589424|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105432295|NCT00576472|363589425|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105432296|NCT00576472|363589426|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105432297|NCT00576472|363589427|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105432298|NCT00576472|363589428|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105432299|NCT00576472|363589429|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105432300|NCT00576472|363589430|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105432301|NCT00576472|363589431|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105432302|NCT00576472|363589432|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105432303|NCT00576472|363589433|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105502211|NCT00142298|363848997|FG003|Overall Study|Other- not specified|1|||
105502212|NCT00142298|363848998|FG004|Overall Study|Other- not specified|0|||
105502213|NCT00142298|363848999|FG005|Overall Study|Other- not specified|0|||
105502214|NCT00142298|363849000|FG006|Overall Study|Other- not specified|0|||
105502215|NCT00142298|363849001|FG007|Overall Study|Other- not specified|0|||
105502216|NCT00142298|363849002|FG008|Overall Study|Other- not specified|0|||
105502217|NCT00142298|363849003|FG009|Overall Study|Other- not specified|0|||
105502218|NCT00142298|363848994|FG000|Overall Study|Lost to Follow-up|0|||
105502219|NCT00142298|363848995|FG001|Overall Study|Lost to Follow-up|0|||
105590421|NCT04310579|364162581|FG002|Overall Study|Adverse Event|0|||
105502220|NCT00142298|363848996|FG002|Overall Study|Lost to Follow-up|0|||
105502221|NCT00142298|363848997|FG003|Overall Study|Lost to Follow-up|0|||
105502222|NCT00142298|363848998|FG004|Overall Study|Lost to Follow-up|0|||
105502223|NCT00142298|363848999|FG005|Overall Study|Lost to Follow-up|0|||
105502224|NCT00142298|363849000|FG006|Overall Study|Lost to Follow-up|2|||
105502225|NCT00142298|363849001|FG007|Overall Study|Lost to Follow-up|0|||
105502226|NCT00142298|363849002|FG008|Overall Study|Lost to Follow-up|0|||
105502227|NCT00142298|363849003|FG009|Overall Study|Lost to Follow-up|0|||
105502228|NCT00142298|363848994|FG000|Overall Study|Treatment Failure|0|||
105502229|NCT00142298|363848995|FG001|Overall Study|Treatment Failure|0|||
105502230|NCT00142298|363848996|FG002|Overall Study|Treatment Failure|0|||
105502231|NCT00142298|363848997|FG003|Overall Study|Treatment Failure|0|||
105502232|NCT00142298|363848998|FG004|Overall Study|Treatment Failure|0|||
105502233|NCT00142298|363848999|FG005|Overall Study|Treatment Failure|2|||
105502234|NCT00142298|363849000|FG006|Overall Study|Treatment Failure|2|||
105502235|NCT00142298|363849001|FG007|Overall Study|Treatment Failure|0|||
105502236|NCT00142298|363849002|FG008|Overall Study|Treatment Failure|0|||
105502237|NCT00142298|363849003|FG009|Overall Study|Treatment Failure|0|||
105502238|NCT01466153|363849004|FG000|Overall Study|Disease Progression|2|||
105502239|NCT01466153|363849005|FG001|Overall Study|Disease Progression|2|||
105502240|NCT01466153|363849006|FG002|Overall Study|Disease Progression|0|||
105502241|NCT01466153|363849004|FG000|Overall Study|Adverse Event|14|||
105502242|NCT01466153|363849005|FG001|Overall Study|Adverse Event|13|||
105502243|NCT01466153|363849006|FG002|Overall Study|Adverse Event|17|||
105502244|NCT01466153|363849004|FG000|Overall Study|Withdrawal of Consent|2|||
105502245|NCT01466153|363849005|FG001|Overall Study|Withdrawal of Consent|0|||
105502246|NCT01466153|363849006|FG002|Overall Study|Withdrawal of Consent|0|||
105502247|NCT01466153|363849004|FG000|Overall Study|Investigator Discretion|3|||
105502248|NCT01466153|363849005|FG001|Overall Study|Investigator Discretion|2|||
105502249|NCT01466153|363849006|FG002|Overall Study|Investigator Discretion|2|||
105502250|NCT01466153|363849004|FG000|Overall Study|Randomized-Not Treated|2|||
105502251|NCT01466153|363849005|FG001|Overall Study|Randomized-Not Treated|3|||
105502252|NCT01466153|363849006|FG002|Overall Study|Randomized-Not Treated|4|||
105502253|NCT01466153|363849004|FG000|Overall Study|Other-Unspecified|6|||
105502254|NCT01466153|363849005|FG001|Overall Study|Other-Unspecified|4|||
105502255|NCT01466153|363849006|FG002|Overall Study|Other-Unspecified|2|||
105502256|NCT00300274|363849010|FG000|Overall Study|Withdrawal by Subject|12|||
105502257|NCT00300274|363849011|FG001|Overall Study|Withdrawal by Subject|3|||
105502258|NCT00300274|363849012|FG002|Overall Study|Withdrawal by Subject|14|||
105502259|NCT00300274|363849010|FG000|Overall Study|Lost to Follow-up|3|||
105502260|NCT00300274|363849011|FG001|Overall Study|Lost to Follow-up|4|||
105502261|NCT00300274|363849012|FG002|Overall Study|Lost to Follow-up|5|||
105502262|NCT00300274|363849010|FG000|Overall Study|Death|31|||
105502263|NCT00300274|363849011|FG001|Overall Study|Death|20|||
105502264|NCT00300274|363849012|FG002|Overall Study|Death|25|||
105502265|NCT00300274|363849010|FG000|Overall Study|Re-transplant|0|||
105502266|NCT00300274|363849011|FG001|Overall Study|Re-transplant|0|||
105502267|NCT00300274|363849012|FG002|Overall Study|Re-transplant|1|||
105502268|NCT01980940|363849015|FG000|Overall Study|Protocol Violation|0|||
105502269|NCT01980940|363849016|FG001|Overall Study|Protocol Violation|0|||
105502270|NCT01980940|363849017|FG002|Overall Study|Protocol Violation|0|||
105502271|NCT01980940|363849018|FG003|Overall Study|Protocol Violation|0|||
105502272|NCT01980940|363849019|FG004|Overall Study|Protocol Violation|0|||
105502273|NCT01980940|363849020|FG005|Overall Study|Protocol Violation|2|||
105502274|NCT01980940|363849021|FG006|Overall Study|Protocol Violation|0|||
105502275|NCT01980940|363849022|FG007|Overall Study|Protocol Violation|0|||
105502276|NCT00660699|363849023|FG000|Overall Study|Withdrawal by Subject|2|||
105502277|NCT03320057|363850878|FG000|Overall Study|Lost to Follow-up|4|||
105502278|NCT03320057|363850879|FG001|Overall Study|Lost to Follow-up|17|||
105502279|NCT03320057|363850878|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
105502280|NCT03320057|363850879|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
105502281|NCT01367002|363850880|FG000|Overall Study|Withdrawal by Subject|1|||
105502282|NCT01367002|363850881|FG001|Overall Study|Withdrawal by Subject|0|||
105502283|NCT01367002|363850880|FG000|Overall Study|Physician Decision|0|||
105502284|NCT01367002|363850881|FG001|Overall Study|Physician Decision|2|||
105502285|NCT01516437|363850889|FG000|Overall Study|Reason not specified|0|||
105502286|NCT01516437|363850890|FG001|Overall Study|Reason not specified|0|||
105502287|NCT01516437|363850891|FG002|Overall Study|Reason not specified|1|||
105502288|NCT01516437|363850892|FG003|Overall Study|Reason not specified|1|||
105502289|NCT01543698|363850893|FG000|Phase 1b|Disease progression|2|||
105502290|NCT01543698|363850894|FG001|Phase 1b|Disease progression|4|||
105502291|NCT01543698|363850895|FG002|Phase 1b|Disease progression|3|||
105502292|NCT01543698|363850896|FG003|Phase 1b|Disease progression|2|||
105502293|NCT01543698|363850897|FG004|Phase 1b|Disease progression|10|||
105502294|NCT01543698|363850898|FG005|Phase 1b|Disease progression|6|||
105502295|NCT01543698|363850899|FG006|Phase 1b|Disease progression|5|||
105502296|NCT01543698|363850900|FG007|Phase 1b|Disease progression|3|||
105502297|NCT01543698|363850901|FG008|Phase 1b|Disease progression|4|||
105502298|NCT01543698|363850902|FG009|Phase 1b|Disease progression|5|||
105590422|NCT04310579|364162582|FG003|Overall Study|Adverse Event|0|||
105590423|NCT04310579|364162583|FG004|Overall Study|Adverse Event|0|||
105432304|NCT00576472|363589434|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105432305|NCT00576472|363589435|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
105432306|NCT02391961|363589438|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
105432307|NCT02391961|363589439|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
105432308|NCT02391961|363589438|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
105432309|NCT02391961|363589439|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
105432310|NCT02391961|363589438|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
105432311|NCT02391961|363589439|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
105432312|NCT02723175|363589442|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
105432313|NCT02723175|363589443|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
105432314|NCT02723175|363589442|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
105432315|NCT02723175|363589443|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
105432316|NCT03995355|363589444|FG000|Overall Study|Adverse Event|1|||
105432317|NCT03995355|363589445|FG001|Overall Study|Adverse Event|0|||
105432318|NCT03995355|363589444|FG000|Overall Study|Withdrawal by Subject|1|||
105432319|NCT03995355|363589445|FG001|Overall Study|Withdrawal by Subject|0|||
105432320|NCT03995355|363589444|FG000|Overall Study|Scheduling Issues|0|||
105432321|NCT03995355|363589445|FG001|Overall Study|Scheduling Issues|1|||
105432322|NCT01672866|363589457|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
105432323|NCT01672866|363589458|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
105432324|NCT01672866|363589459|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
105432325|NCT01672866|363589457|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
105432326|NCT01672866|363589458|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
105432327|NCT01672866|363589459|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
105432328|NCT01672866|363589457|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
105432329|NCT01672866|363589458|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
105432330|NCT01672866|363589459|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
105432331|NCT01672866|363589457|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
105432332|NCT01672866|363589458|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
105432333|NCT01672866|363589459|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
105432334|NCT01672866|363589457|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
105432335|NCT01672866|363589458|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
105432336|NCT01672866|363589459|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
105432337|NCT01672866|363589457|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
105432338|NCT01672866|363589458|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
105432339|NCT01672866|363589459|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
105432340|NCT01672866|363589457|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
105432341|NCT01672866|363589458|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
105432342|NCT01672866|363589459|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
105432343|NCT01672866|363589457|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
105432344|NCT01672866|363589458|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
105432345|NCT01672866|363589459|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
105432346|NCT01672866|363589457|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
105432347|NCT01672866|363589458|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
105432348|NCT01672866|363589459|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
105432349|NCT01672866|363589457|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
105432350|NCT01672866|363589458|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
105432351|NCT01672866|363589459|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
105432352|NCT01672866|363589457|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
105432353|NCT01672866|363589458|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
105432354|NCT01672866|363589459|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
105432355|NCT01672866|363589457|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
105432356|NCT01672866|363589458|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
105432357|NCT01672866|363589459|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
105432358|NCT01672866|363589457|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
105432359|NCT01672866|363589458|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
105432360|NCT01672866|363589459|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
105432361|NCT00619489|363589460|FG000|Overall Study|Adverse Event|0|||
105590424|NCT04310579|364162584|FG005|Overall Study|Adverse Event|0|||
105432362|NCT00619489|363589461|FG001|Overall Study|Adverse Event|7|||
105432363|NCT00619489|363589460|FG000|Overall Study|Withdrawal by Subject|1|||
105432364|NCT00619489|363589461|FG001|Overall Study|Withdrawal by Subject|1|||
105432365|NCT00619489|363589460|FG000|Overall Study|Lack of Efficacy|0|||
105432366|NCT00619489|363589461|FG001|Overall Study|Lack of Efficacy|11|||
105432367|NCT00619489|363589460|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
105432368|NCT00619489|363589461|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
105590425|NCT04310579|364162585|FG006|Overall Study|Adverse Event|2|||
105590426|NCT04310579|364162586|FG007|Overall Study|Adverse Event|0|||
105502299|NCT01543698|363850903|FG010|Phase 1b|Disease progression|1|||
105502300|NCT01543698|363850904|FG011|Phase 1b|Disease progression|0|||
105502301|NCT01543698|363850905|FG012|Phase 1b|Disease progression|0|||
105502302|NCT01543698|363850906|FG013|Phase 1b|Disease progression|0|||
105502303|NCT01543698|363850907|FG014|Phase 1b|Disease progression|0|||
105502304|NCT01543698|363850893|FG000|Phase 1b|Death|0|||
105502305|NCT01543698|363850894|FG001|Phase 1b|Death|0|||
105502306|NCT01543698|363850895|FG002|Phase 1b|Death|1|||
105502307|NCT01543698|363850896|FG003|Phase 1b|Death|1|||
105502308|NCT01543698|363850897|FG004|Phase 1b|Death|0|||
105502309|NCT01543698|363850898|FG005|Phase 1b|Death|0|||
105502310|NCT01543698|363850899|FG006|Phase 1b|Death|0|||
105502311|NCT01543698|363850900|FG007|Phase 1b|Death|0|||
105502312|NCT01543698|363850901|FG008|Phase 1b|Death|0|||
105502313|NCT01543698|363850902|FG009|Phase 1b|Death|0|||
105502314|NCT01543698|363850903|FG010|Phase 1b|Death|1|||
105502315|NCT01543698|363850904|FG011|Phase 1b|Death|0|||
105502316|NCT01543698|363850905|FG012|Phase 1b|Death|0|||
105502317|NCT01543698|363850906|FG013|Phase 1b|Death|0|||
105502318|NCT01543698|363850907|FG014|Phase 1b|Death|0|||
105502319|NCT01543698|363850893|FG000|Phase 1b|Withdrawal by Subject|0|||
105502320|NCT01543698|363850894|FG001|Phase 1b|Withdrawal by Subject|1|||
105502321|NCT01543698|363850895|FG002|Phase 1b|Withdrawal by Subject|0|||
105502322|NCT01543698|363850896|FG003|Phase 1b|Withdrawal by Subject|1|||
105502323|NCT01543698|363850897|FG004|Phase 1b|Withdrawal by Subject|0|||
105502324|NCT01543698|363850898|FG005|Phase 1b|Withdrawal by Subject|0|||
105502325|NCT01543698|363850899|FG006|Phase 1b|Withdrawal by Subject|1|||
105502326|NCT01543698|363850900|FG007|Phase 1b|Withdrawal by Subject|0|||
105502327|NCT01543698|363850901|FG008|Phase 1b|Withdrawal by Subject|0|||
105502328|NCT01543698|363850902|FG009|Phase 1b|Withdrawal by Subject|0|||
105502329|NCT01543698|363850903|FG010|Phase 1b|Withdrawal by Subject|0|||
105502330|NCT01543698|363850904|FG011|Phase 1b|Withdrawal by Subject|0|||
105502331|NCT01543698|363850905|FG012|Phase 1b|Withdrawal by Subject|0|||
105502332|NCT01543698|363850906|FG013|Phase 1b|Withdrawal by Subject|0|||
105502333|NCT01543698|363850907|FG014|Phase 1b|Withdrawal by Subject|0|||
105502334|NCT01543698|363850893|FG000|Phase 1b|Adverse Event|1|||
105502335|NCT01543698|363850894|FG001|Phase 1b|Adverse Event|0|||
105502336|NCT01543698|363850895|FG002|Phase 1b|Adverse Event|0|||
105502337|NCT01543698|363850896|FG003|Phase 1b|Adverse Event|1|||
105502338|NCT01543698|363850897|FG004|Phase 1b|Adverse Event|2|||
105502339|NCT01543698|363850898|FG005|Phase 1b|Adverse Event|2|||
105502340|NCT01543698|363850899|FG006|Phase 1b|Adverse Event|0|||
105502341|NCT01543698|363850900|FG007|Phase 1b|Adverse Event|0|||
105502342|NCT01543698|363850901|FG008|Phase 1b|Adverse Event|1|||
105502343|NCT01543698|363850902|FG009|Phase 1b|Adverse Event|1|||
105502344|NCT01543698|363850903|FG010|Phase 1b|Adverse Event|2|||
105590427|NCT04310579|364162587|FG008|Overall Study|Adverse Event|1|||
105590428|NCT04310579|364162588|FG009|Overall Study|Adverse Event|1|||
105590429|NCT04310579|364162589|FG010|Overall Study|Adverse Event|0|||
105590430|NCT04310579|364162579|FG000|Overall Study|Withdrawal by Subject|0|||
105590431|NCT04310579|364162580|FG001|Overall Study|Withdrawal by Subject|0|||
105590432|NCT04310579|364162581|FG002|Overall Study|Withdrawal by Subject|0|||
105590433|NCT04310579|364162582|FG003|Overall Study|Withdrawal by Subject|0|||
105590434|NCT04310579|364162583|FG004|Overall Study|Withdrawal by Subject|0|||
105590435|NCT04310579|364162584|FG005|Overall Study|Withdrawal by Subject|1|||
105590436|NCT04310579|364162585|FG006|Overall Study|Withdrawal by Subject|0|||
105590437|NCT04310579|364162586|FG007|Overall Study|Withdrawal by Subject|0|||
105590438|NCT04310579|364162587|FG008|Overall Study|Withdrawal by Subject|0|||
105590439|NCT04310579|364162588|FG009|Overall Study|Withdrawal by Subject|0|||
105590440|NCT04310579|364162589|FG010|Overall Study|Withdrawal by Subject|0|||
105590441|NCT04310579|364162579|FG000|Overall Study|Positive COVID-19 test|0|||
105590442|NCT04310579|364162580|FG001|Overall Study|Positive COVID-19 test|0|||
105590443|NCT04310579|364162581|FG002|Overall Study|Positive COVID-19 test|0|||
105590444|NCT04310579|364162582|FG003|Overall Study|Positive COVID-19 test|0|||
105590445|NCT04310579|364162583|FG004|Overall Study|Positive COVID-19 test|0|||
105590446|NCT04310579|364162584|FG005|Overall Study|Positive COVID-19 test|0|||
105590447|NCT04310579|364162585|FG006|Overall Study|Positive COVID-19 test|0|||
105502345|NCT01543698|363850904|FG011|Phase 1b|Adverse Event|0|||
105502346|NCT01543698|363850905|FG012|Phase 1b|Adverse Event|0|||
105502347|NCT01543698|363850906|FG013|Phase 1b|Adverse Event|0|||
105502348|NCT01543698|363850907|FG014|Phase 1b|Adverse Event|0|||
105502349|NCT01543698|363850893|FG000|Phase 1b|Administrative problems|1|||
105502350|NCT01543698|363850894|FG001|Phase 1b|Administrative problems|0|||
105502351|NCT01543698|363850895|FG002|Phase 1b|Administrative problems|0|||
105502352|NCT01543698|363850896|FG003|Phase 1b|Administrative problems|0|||
105502353|NCT01543698|363850897|FG004|Phase 1b|Administrative problems|1|||
105502354|NCT01543698|363850898|FG005|Phase 1b|Administrative problems|0|||
105502355|NCT01543698|363850899|FG006|Phase 1b|Administrative problems|0|||
105502356|NCT01543698|363850900|FG007|Phase 1b|Administrative problems|1|||
105502357|NCT01543698|363850901|FG008|Phase 1b|Administrative problems|0|||
105502358|NCT01543698|363850902|FG009|Phase 1b|Administrative problems|0|||
105502359|NCT01543698|363850903|FG010|Phase 1b|Administrative problems|2|||
105432369|NCT01751776|363589464|FG000|Overall Study|Adverse Event|0|||
105432370|NCT01751776|363589465|FG001|Overall Study|Adverse Event|0|||
105432371|NCT01751776|363589466|FG002|Overall Study|Adverse Event|0|||
105432372|NCT01751776|363589467|FG003|Overall Study|Adverse Event|0|||
105432373|NCT01751776|363589468|FG004|Overall Study|Adverse Event|0|||
105432374|NCT01751776|363589469|FG005|Overall Study|Adverse Event|0|||
105432375|NCT01751776|363589470|FG006|Overall Study|Adverse Event|4|||
105432376|NCT01751776|363589471|FG007|Overall Study|Adverse Event|2|||
105432377|NCT01751776|363589464|FG000|Overall Study|Consent withdrawn|0|||
105432378|NCT01751776|363589465|FG001|Overall Study|Consent withdrawn|0|||
105432379|NCT01751776|363589466|FG002|Overall Study|Consent withdrawn|0|||
105432380|NCT01751776|363589467|FG003|Overall Study|Consent withdrawn|0|||
105432381|NCT01751776|363589468|FG004|Overall Study|Consent withdrawn|0|||
105432382|NCT01751776|363589469|FG005|Overall Study|Consent withdrawn|0|||
105432383|NCT01751776|363589470|FG006|Overall Study|Consent withdrawn|0|||
105432384|NCT01751776|363589471|FG007|Overall Study|Consent withdrawn|1|||
105432385|NCT01751776|363589464|FG000|Overall Study|Other reason not specified above|0|||
105432386|NCT01751776|363589465|FG001|Overall Study|Other reason not specified above|0|||
105432387|NCT01751776|363589466|FG002|Overall Study|Other reason not specified above|0|||
105432388|NCT01751776|363589467|FG003|Overall Study|Other reason not specified above|0|||
105432389|NCT01751776|363589468|FG004|Overall Study|Other reason not specified above|0|||
105432390|NCT01751776|363589469|FG005|Overall Study|Other reason not specified above|0|||
105432391|NCT01751776|363589470|FG006|Overall Study|Other reason not specified above|0|||
105432392|NCT01751776|363589471|FG007|Overall Study|Other reason not specified above|1|||
105432393|NCT00160654|363589472|FG000|Overall Study|Adverse Event|14|||
105432394|NCT00160654|363589472|FG000|Overall Study|Lack of Efficacy|4|||
105432395|NCT00160654|363589472|FG000|Overall Study|Lost to Follow-up|2|||
105432396|NCT00160654|363589472|FG000|Overall Study|Intake of expired drug|7|||
105432397|NCT00160654|363589472|FG000|Overall Study|Psychological trauma|1|||
105432398|NCT00160654|363589472|FG000|Overall Study|Sponsor decision|1|||
105432399|NCT00160654|363589472|FG000|Overall Study|Patient met exclusion criteria|1|||
105432400|NCT00160654|363589472|FG000|Overall Study|Patient decision|1|||
105432401|NCT00160654|363589472|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
105432402|NCT00160654|363589472|FG000|Overall Study|Met exclusion criteria|1|||
105432403|NCT00162266|363589475|FG000|Double-Blind Period|Adverse Event|5|||
105432404|NCT00162266|363589476|FG001|Double-Blind Period|Adverse Event|9|||
105432405|NCT00162266|363589477|FG002|Double-Blind Period|Adverse Event|11|||
105432406|NCT00162266|363589478|FG003|Double-Blind Period|Adverse Event|0|||
105432407|NCT00162266|363589475|FG000|Double-Blind Period|Death|0|||
105432408|NCT00162266|363589476|FG001|Double-Blind Period|Death|1|||
105432409|NCT00162266|363589477|FG002|Double-Blind Period|Death|0|||
105432410|NCT00162266|363589478|FG003|Double-Blind Period|Death|0|||
105432411|NCT00162266|363589475|FG000|Double-Blind Period|Lost to Follow-up|1|||
105432412|NCT00162266|363589476|FG001|Double-Blind Period|Lost to Follow-up|2|||
105432413|NCT00162266|363589477|FG002|Double-Blind Period|Lost to Follow-up|0|||
105432414|NCT00162266|363589478|FG003|Double-Blind Period|Lost to Follow-up|0|||
105432415|NCT00162266|363589475|FG000|Double-Blind Period|Other Reason|1|||
105432416|NCT00162266|363589476|FG001|Double-Blind Period|Other Reason|0|||
105432417|NCT00162266|363589477|FG002|Double-Blind Period|Other Reason|1|||
105432418|NCT00162266|363589478|FG003|Double-Blind Period|Other Reason|0|||
105432419|NCT00162266|363589475|FG000|Double-Blind Period|Lack of Efficacy|13|||
105432420|NCT00162266|363589476|FG001|Double-Blind Period|Lack of Efficacy|17|||
105432421|NCT00162266|363589477|FG002|Double-Blind Period|Lack of Efficacy|30|||
105432422|NCT00162266|363589478|FG003|Double-Blind Period|Lack of Efficacy|0|||
105432423|NCT00162266|363589475|FG000|Double-Blind Period|Withdrawal by Subject|5|||
105432424|NCT00162266|363589476|FG001|Double-Blind Period|Withdrawal by Subject|2|||
105432425|NCT00162266|363589477|FG002|Double-Blind Period|Withdrawal by Subject|6|||
105432426|NCT00162266|363589478|FG003|Double-Blind Period|Withdrawal by Subject|0|||
105432427|NCT00162266|363589475|FG000|Open-Label Period|Death|0|||
105432428|NCT00162266|363589476|FG001|Open-Label Period|Death|0|||
105432429|NCT00162266|363589477|FG002|Open-Label Period|Death|0|||
105432430|NCT00162266|363589478|FG003|Open-Label Period|Death|7|||
105432431|NCT00162266|363589475|FG000|Open-Label Period|Adverse Event|0|||
105432432|NCT00162266|363589476|FG001|Open-Label Period|Adverse Event|0|||
105432433|NCT00162266|363589477|FG002|Open-Label Period|Adverse Event|0|||
105432434|NCT00162266|363589478|FG003|Open-Label Period|Adverse Event|46|||
105432435|NCT00162266|363589475|FG000|Open-Label Period|Lack of Efficacy|0|||
105432436|NCT00162266|363589476|FG001|Open-Label Period|Lack of Efficacy|0|||
105432437|NCT00162266|363589477|FG002|Open-Label Period|Lack of Efficacy|0|||
105432438|NCT00162266|363589478|FG003|Open-Label Period|Lack of Efficacy|26|||
105432439|NCT00162266|363589475|FG000|Open-Label Period|Lost to Follow-up|0|||
105432440|NCT00162266|363589476|FG001|Open-Label Period|Lost to Follow-up|0|||
105432441|NCT00162266|363589477|FG002|Open-Label Period|Lost to Follow-up|0|||
105432442|NCT00162266|363589478|FG003|Open-Label Period|Lost to Follow-up|3|||
105432443|NCT00162266|363589475|FG000|Open-Label Period|Withdrawal by Subject|0|||
105432444|NCT00162266|363589476|FG001|Open-Label Period|Withdrawal by Subject|0|||
105432445|NCT00162266|363589477|FG002|Open-Label Period|Withdrawal by Subject|0|||
105432446|NCT00162266|363589478|FG003|Open-Label Period|Withdrawal by Subject|31|||
105502360|NCT01543698|363850904|FG011|Phase 1b|Administrative problems|0|||
105502361|NCT01543698|363850905|FG012|Phase 1b|Administrative problems|0|||
105502362|NCT01543698|363850906|FG013|Phase 1b|Administrative problems|0|||
105502363|NCT01543698|363850907|FG014|Phase 1b|Administrative problems|0|||
105502364|NCT01543698|363850893|FG000|Phase 1b|Protocol Violation|2|||
105502365|NCT01543698|363850894|FG001|Phase 1b|Protocol Violation|0|||
105502366|NCT01543698|363850895|FG002|Phase 1b|Protocol Violation|0|||
105502367|NCT01543698|363850896|FG003|Phase 1b|Protocol Violation|0|||
105502368|NCT01543698|363850897|FG004|Phase 1b|Protocol Violation|0|||
105502369|NCT01543698|363850898|FG005|Phase 1b|Protocol Violation|0|||
105502370|NCT01543698|363850899|FG006|Phase 1b|Protocol Violation|0|||
105502371|NCT01543698|363850900|FG007|Phase 1b|Protocol Violation|0|||
105502372|NCT01543698|363850901|FG008|Phase 1b|Protocol Violation|0|||
105502373|NCT01543698|363850902|FG009|Phase 1b|Protocol Violation|0|||
105502374|NCT01543698|363850903|FG010|Phase 1b|Protocol Violation|0|||
105502375|NCT01543698|363850904|FG011|Phase 1b|Protocol Violation|0|||
105502376|NCT01543698|363850905|FG012|Phase 1b|Protocol Violation|0|||
105502377|NCT01543698|363850906|FG013|Phase 1b|Protocol Violation|0|||
105502378|NCT01543698|363850907|FG014|Phase 1b|Protocol Violation|0|||
105502379|NCT01543698|363850893|FG000|Phase 2|Protocol Violation|0|||
105502380|NCT01543698|363850894|FG001|Phase 2|Protocol Violation|0|||
105502381|NCT01543698|363850895|FG002|Phase 2|Protocol Violation|0|||
105502382|NCT01543698|363850896|FG003|Phase 2|Protocol Violation|0|||
105502383|NCT01543698|363850897|FG004|Phase 2|Protocol Violation|0|||
105502384|NCT01543698|363850898|FG005|Phase 2|Protocol Violation|0|||
105502385|NCT01543698|363850899|FG006|Phase 2|Protocol Violation|0|||
105502386|NCT01543698|363850900|FG007|Phase 2|Protocol Violation|0|||
105432447|NCT00162266|363589475|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
105432448|NCT00162266|363589476|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
105432449|NCT00162266|363589477|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
105432450|NCT00162266|363589478|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
105432451|NCT00162266|363589475|FG000|Open-Label Period|Other Reasons|0|||
105432452|NCT00162266|363589476|FG001|Open-Label Period|Other Reasons|0|||
105432453|NCT00162266|363589477|FG002|Open-Label Period|Other Reasons|0|||
105432454|NCT00162266|363589478|FG003|Open-Label Period|Other Reasons|15|||
105432455|NCT05098509|363589479|FG000|Overall Study|Withdrawal by Subject|0|||
105432456|NCT05098509|363589480|FG001|Overall Study|Withdrawal by Subject|0|||
105432457|NCT05098509|363589481|FG002|Overall Study|Withdrawal by Subject|1|||
105432458|NCT05098509|363589482|FG003|Overall Study|Withdrawal by Subject|0|||
105432459|NCT05098509|363589479|FG000|Overall Study|Early study termination|1|||
105432460|NCT05098509|363589480|FG001|Overall Study|Early study termination|1|||
105432461|NCT05098509|363589481|FG002|Overall Study|Early study termination|1|||
105432462|NCT05098509|363589482|FG003|Overall Study|Early study termination|0|||
105432463|NCT04033068|363589483|FG000|Overall Study|Withdrawal by Subject|0|||
105432464|NCT04033068|363589484|FG001|Overall Study|Withdrawal by Subject|0|||
105432465|NCT04033068|363589485|FG002|Overall Study|Withdrawal by Subject|1|||
105432466|NCT04033068|363589486|FG003|Overall Study|Withdrawal by Subject|0|||
105432467|NCT04033068|363589483|FG000|Overall Study|Lost to Follow-up|0|||
105432468|NCT04033068|363589484|FG001|Overall Study|Lost to Follow-up|1|||
105432469|NCT04033068|363589485|FG002|Overall Study|Lost to Follow-up|0|||
105432470|NCT04033068|363589486|FG003|Overall Study|Lost to Follow-up|0|||
105432471|NCT04033068|363589483|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
105432472|NCT04033068|363589484|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
105432473|NCT04033068|363589485|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
105432474|NCT04033068|363589486|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
105432475|NCT01105377|363589487|FG000|Overall Study|Withdrawal by Subject|0|||
105432476|NCT01105377|363589488|FG001|Overall Study|Withdrawal by Subject|1|||
105432477|NCT04232215|363589489|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
105432478|NCT04232215|363589490|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
105432479|NCT04268745|363589491|FG000|Overall Study|Lost to Follow-up|2|||
105502387|NCT01543698|363850901|FG008|Phase 2|Protocol Violation|0|||
105502388|NCT01543698|363850902|FG009|Phase 2|Protocol Violation|0|||
105502389|NCT01543698|363850903|FG010|Phase 2|Protocol Violation|0|||
105432480|NCT04268745|363589492|FG001|Overall Study|Lost to Follow-up|3|||
105432481|NCT04268745|363589491|FG000|Overall Study|Withdrawal by Subject|4|||
105432482|NCT04268745|363589492|FG001|Overall Study|Withdrawal by Subject|2|||
105432483|NCT04268745|363589491|FG000|Overall Study|Death in the family|1|||
105432484|NCT04268745|363589492|FG001|Overall Study|Death in the family|0|||
105432485|NCT03281304|363589493|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
105432486|NCT03281304|363589494|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
105432487|NCT03281304|363589493|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
105502390|NCT01543698|363850904|FG011|Phase 2|Protocol Violation|0|||
105502391|NCT01543698|363850905|FG012|Phase 2|Protocol Violation|1|||
105502392|NCT01543698|363850906|FG013|Phase 2|Protocol Violation|0|||
105502393|NCT01543698|363850907|FG014|Phase 2|Protocol Violation|0|||
105502394|NCT01543698|363850893|FG000|Phase 2|Disease progression|0|||
105502395|NCT01543698|363850894|FG001|Phase 2|Disease progression|0|||
105432488|NCT03281304|363589494|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
105432489|NCT03281304|363589493|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
105432490|NCT03281304|363589494|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
105432491|NCT03281304|363589493|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
105432492|NCT03281304|363589494|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
105432493|NCT03281304|363589493|FG000|Treatment Phase (up to 42 Months)|Death|0|||
105432494|NCT03281304|363589494|FG001|Treatment Phase (up to 42 Months)|Death|1|||
105432495|NCT03281304|363589493|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
105432496|NCT03281304|363589494|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
105432497|NCT03281304|363589493|FG000|Treatment Phase (up to 42 Months)|Other|0|||
105432498|NCT03281304|363589494|FG001|Treatment Phase (up to 42 Months)|Other|2|||
105432499|NCT03281304|363589493|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
105432500|NCT03281304|363589494|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
105432501|NCT00528996|363591219|FG000|Overall Study|Other reasons than listing|6|||
105432502|NCT00528996|363591220|FG001|Overall Study|Other reasons than listing|7|||
105432503|NCT00528996|363591221|FG002|Overall Study|Other reasons than listing|14|||
105432504|NCT00528996|363591222|FG003|Overall Study|Other reasons than listing|11|||
105432505|NCT00528996|363591223|FG004|Overall Study|Other reasons than listing|5|||
105432506|NCT00528996|363591219|FG000|Overall Study|Refused continue medication|16|||
105432507|NCT00528996|363591220|FG001|Overall Study|Refused continue medication|0|||
105432508|NCT00528996|363591221|FG002|Overall Study|Refused continue medication|3|||
105432509|NCT00528996|363591222|FG003|Overall Study|Refused continue medication|3|||
105432510|NCT00528996|363591223|FG004|Overall Study|Refused continue medication|6|||
105432511|NCT00528996|363591219|FG000|Overall Study|Lost to Follow-up|2|||
105432512|NCT00528996|363591220|FG001|Overall Study|Lost to Follow-up|0|||
105432513|NCT00528996|363591221|FG002|Overall Study|Lost to Follow-up|4|||
105432514|NCT00528996|363591222|FG003|Overall Study|Lost to Follow-up|1|||
105432515|NCT00528996|363591223|FG004|Overall Study|Lost to Follow-up|3|||
105432516|NCT00528996|363591219|FG000|Overall Study|Protocol Violation|1|||
105432517|NCT00528996|363591220|FG001|Overall Study|Protocol Violation|2|||
105432518|NCT00528996|363591221|FG002|Overall Study|Protocol Violation|3|||
105432519|NCT00528996|363591222|FG003|Overall Study|Protocol Violation|3|||
105432520|NCT00528996|363591223|FG004|Overall Study|Protocol Violation|2|||
105432521|NCT00528996|363591219|FG000|Overall Study|Lack of Efficacy|7|||
105432522|NCT00528996|363591220|FG001|Overall Study|Lack of Efficacy|2|||
105432523|NCT00528996|363591221|FG002|Overall Study|Lack of Efficacy|1|||
105432524|NCT00528996|363591222|FG003|Overall Study|Lack of Efficacy|3|||
105432525|NCT00528996|363591223|FG004|Overall Study|Lack of Efficacy|3|||
105502396|NCT01543698|363850895|FG002|Phase 2|Disease progression|0|||
105502397|NCT01543698|363850896|FG003|Phase 2|Disease progression|0|||
105502398|NCT01543698|363850897|FG004|Phase 2|Disease progression|0|||
105502399|NCT01543698|363850898|FG005|Phase 2|Disease progression|0|||
105502400|NCT01543698|363850899|FG006|Phase 2|Disease progression|0|||
105502401|NCT01543698|363850900|FG007|Phase 2|Disease progression|0|||
105502402|NCT01543698|363850901|FG008|Phase 2|Disease progression|0|||
105502403|NCT01543698|363850902|FG009|Phase 2|Disease progression|0|||
105502404|NCT01543698|363850903|FG010|Phase 2|Disease progression|0|||
105502405|NCT01543698|363850904|FG011|Phase 2|Disease progression|10|||
105502406|NCT01543698|363850905|FG012|Phase 2|Disease progression|21|||
105502407|NCT01543698|363850906|FG013|Phase 2|Disease progression|30|||
105502408|NCT01543698|363850907|FG014|Phase 2|Disease progression|25|||
105502409|NCT01543698|363850893|FG000|Phase 2|Death|0|||
105502410|NCT01543698|363850894|FG001|Phase 2|Death|0|||
105590448|NCT04310579|364162586|FG007|Overall Study|Positive COVID-19 test|0|||
105590449|NCT04310579|364162587|FG008|Overall Study|Positive COVID-19 test|0|||
105432526|NCT00528996|363591219|FG000|Overall Study|Adverse Event|32|||
105432527|NCT00528996|363591220|FG001|Overall Study|Adverse Event|13|||
105432528|NCT00528996|363591221|FG002|Overall Study|Adverse Event|18|||
105432529|NCT00528996|363591222|FG003|Overall Study|Adverse Event|29|||
105502411|NCT01543698|363850895|FG002|Phase 2|Death|0|||
105502412|NCT01543698|363850896|FG003|Phase 2|Death|0|||
105432530|NCT00528996|363591223|FG004|Overall Study|Adverse Event|18|||
105432531|NCT04544683|363591225|FG000|Overall Study|Lost to Follow-up|2|||
105432532|NCT04544683|363591225|FG000|Overall Study|Underwent cervical spine surgery|6|||
105432533|NCT01073930|363591226|FG000|Overall Study|Withdrawal by Subject|3|||
105432534|NCT01073930|363591227|FG001|Overall Study|Withdrawal by Subject|2|||
105432535|NCT01073930|363591226|FG000|Overall Study|Lost to Follow-up|0|||
105432536|NCT01073930|363591227|FG001|Overall Study|Lost to Follow-up|1|||
105432537|NCT01073930|363591226|FG000|Overall Study|Adverse Event|0|||
105432538|NCT01073930|363591227|FG001|Overall Study|Adverse Event|1|||
105432539|NCT01073930|363591226|FG000|Overall Study|Noncompliance with study drug|0|||
105432540|NCT01073930|363591227|FG001|Overall Study|Noncompliance with study drug|1|||
105432541|NCT01073930|363591226|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
105432542|NCT01073930|363591227|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
105502413|NCT01543698|363850897|FG004|Phase 2|Death|0|||
105502414|NCT01543698|363850898|FG005|Phase 2|Death|0|||
105502415|NCT01543698|363850899|FG006|Phase 2|Death|0|||
105502416|NCT01543698|363850900|FG007|Phase 2|Death|0|||
105432543|NCT02198794|363591228|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
105432544|NCT02198794|363591229|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
105432545|NCT02198794|363591230|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
105432546|NCT02198794|363591231|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
105432547|NCT02198794|363591228|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
105432548|NCT02198794|363591229|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
105432549|NCT02198794|363591230|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
105432550|NCT02198794|363591231|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
105432551|NCT02198794|363591228|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
105432552|NCT02198794|363591229|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
105432553|NCT02198794|363591230|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
105432554|NCT02198794|363591231|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
105432555|NCT02198794|363591228|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
105432556|NCT02198794|363591229|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
105432557|NCT02198794|363591230|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
105432558|NCT02198794|363591231|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
105432559|NCT02198794|363591228|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
105432560|NCT02198794|363591229|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
105432561|NCT02198794|363591230|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
105432562|NCT02198794|363591231|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
105432563|NCT02198794|363591228|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
105432564|NCT02198794|363591229|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
105432565|NCT02198794|363591230|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
105432566|NCT02198794|363591231|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
105432567|NCT02198794|363591228|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
105432568|NCT02198794|363591229|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
105432569|NCT02198794|363591230|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
105432570|NCT02198794|363591231|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
105432571|NCT02198794|363591228|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
105432572|NCT02198794|363591229|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
105432573|NCT02198794|363591230|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
105432574|NCT02198794|363591231|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
105432575|NCT02198794|363591228|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
105432576|NCT02198794|363591229|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
105432577|NCT02198794|363591230|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
105432578|NCT02198794|363591231|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
105432579|NCT02198794|363591228|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
105432580|NCT02198794|363591229|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
105432581|NCT02198794|363591230|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
105432582|NCT02198794|363591231|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
105432583|NCT02198794|363591228|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
105432584|NCT02198794|363591229|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
105432585|NCT02198794|363591230|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
105432586|NCT02198794|363591231|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
105432587|NCT02198794|363591228|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
105432588|NCT02198794|363591229|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
105432589|NCT02198794|363591230|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
105432590|NCT02198794|363591231|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
105432591|NCT02198794|363591228|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
105432592|NCT02198794|363591229|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
105432593|NCT02198794|363591230|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
105432594|NCT02198794|363591231|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
105432595|NCT02198794|363591228|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
105432596|NCT02198794|363591229|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
105432597|NCT02198794|363591230|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
105432598|NCT02198794|363591231|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
105432599|NCT02198794|363591228|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
105590450|NCT04310579|364162588|FG009|Overall Study|Positive COVID-19 test|0|||
105590451|NCT04310579|364162589|FG010|Overall Study|Positive COVID-19 test|1|||
105432600|NCT02198794|363591229|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
105432601|NCT02198794|363591230|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
105432602|NCT02198794|363591231|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
105432603|NCT02408523|363591232|FG000|Overall Study|Adverse Event|4|||
105432604|NCT02408523|363591233|FG001|Overall Study|Adverse Event|10|||
105432605|NCT02408523|363591232|FG000|Overall Study|Lack of Efficacy|0|||
105432606|NCT02408523|363591233|FG001|Overall Study|Lack of Efficacy|1|||
105432607|NCT02408523|363591232|FG000|Overall Study|Protocol Violation|1|||
105432608|NCT02408523|363591233|FG001|Overall Study|Protocol Violation|2|||
105432609|NCT02408523|363591232|FG000|Overall Study|Lost to Follow-up|2|||
105432610|NCT02408523|363591233|FG001|Overall Study|Lost to Follow-up|3|||
105432611|NCT02408523|363591232|FG000|Overall Study|Withdrawal by Subject|3|||
105432612|NCT02408523|363591233|FG001|Overall Study|Withdrawal by Subject|1|||
105432613|NCT02408523|363591232|FG000|Overall Study|Sponsor request|1|||
105432614|NCT02408523|363591233|FG001|Overall Study|Sponsor request|0|||
105432615|NCT02408523|363591232|FG000|Overall Study|Did not satisfy extension conditions|0|||
105432616|NCT02408523|363591233|FG001|Overall Study|Did not satisfy extension conditions|1|||
105432617|NCT02943915|363591234|FG000|Overall Study|Withdrawal by Subject|2|||
105432618|NCT02943915|363591235|FG001|Overall Study|Withdrawal by Subject|1|||
105432619|NCT02943915|363591236|FG002|Overall Study|Withdrawal by Subject|0|||
105432620|NCT02943915|363591237|FG003|Overall Study|Withdrawal by Subject|0|||
105432621|NCT02943915|363591234|FG000|Overall Study|Lost to Follow-up|3|||
105432622|NCT02943915|363591235|FG001|Overall Study|Lost to Follow-up|1|||
105432623|NCT02943915|363591236|FG002|Overall Study|Lost to Follow-up|0|||
105432624|NCT02943915|363591237|FG003|Overall Study|Lost to Follow-up|0|||
105432625|NCT02943915|363591234|FG000|Overall Study|excluded|0|||
105432626|NCT02943915|363591235|FG001|Overall Study|excluded|1|||
105432627|NCT02943915|363591236|FG002|Overall Study|excluded|0|||
105432628|NCT02943915|363591237|FG003|Overall Study|excluded|0|||
105432629|NCT00701805|363591238|FG000|Overall Study|Withdrawal by Subject|3|||
105432630|NCT00701805|363591239|FG001|Overall Study|Withdrawal by Subject|1|||
105432631|NCT00701805|363591240|FG002|Overall Study|Withdrawal by Subject|4|||
105432632|NCT00701805|363591241|FG003|Overall Study|Withdrawal by Subject|3|||
105432633|NCT00701805|363591238|FG000|Overall Study|Adverse Event|0|||
105432634|NCT00701805|363591239|FG001|Overall Study|Adverse Event|1|||
105432635|NCT00701805|363591240|FG002|Overall Study|Adverse Event|1|||
105432636|NCT00701805|363591241|FG003|Overall Study|Adverse Event|0|||
105432637|NCT00701805|363591238|FG000|Overall Study|Missed 7 consecutive doses|0|||
105432638|NCT00701805|363591239|FG001|Overall Study|Missed 7 consecutive doses|1|||
105432639|NCT00701805|363591240|FG002|Overall Study|Missed 7 consecutive doses|0|||
105432640|NCT00701805|363591241|FG003|Overall Study|Missed 7 consecutive doses|0|||
105432641|NCT00701805|363591238|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
105432642|NCT00701805|363591239|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
105432643|NCT00701805|363591240|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
105432644|NCT00701805|363591241|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
105432645|NCT00701805|363591238|FG000|Overall Study|Physician decision, change of therapy|0|||
105432646|NCT00701805|363591239|FG001|Overall Study|Physician decision, change of therapy|0|||
105432647|NCT00701805|363591240|FG002|Overall Study|Physician decision, change of therapy|0|||
105432648|NCT00701805|363591241|FG003|Overall Study|Physician decision, change of therapy|1|||
105432649|NCT00701805|363591238|FG000|Overall Study|Difficult to travel to dialysis site|0|||
105432650|NCT00701805|363591239|FG001|Overall Study|Difficult to travel to dialysis site|0|||
105432651|NCT00701805|363591240|FG002|Overall Study|Difficult to travel to dialysis site|1|||
105432652|NCT00701805|363591241|FG003|Overall Study|Difficult to travel to dialysis site|0|||
105432653|NCT00701805|363591238|FG000|Overall Study|Resumption criteria were not met|0|||
105432654|NCT00701805|363591239|FG001|Overall Study|Resumption criteria were not met|1|||
105432655|NCT00701805|363591240|FG002|Overall Study|Resumption criteria were not met|0|||
105432656|NCT00701805|363591241|FG003|Overall Study|Resumption criteria were not met|0|||
105432657|NCT02252965|363591245|FG000|Overall Study|Adverse Event|9|||
105432658|NCT02252965|363591246|FG001|Overall Study|Adverse Event|14|||
105432659|NCT02252965|363591245|FG000|Overall Study|Lost to Follow-up|16|||
105432660|NCT02252965|363591246|FG001|Overall Study|Lost to Follow-up|8|||
105432661|NCT02252965|363591245|FG000|Overall Study|Protocol Violation|4|||
105432662|NCT02252965|363591246|FG001|Overall Study|Protocol Violation|5|||
105432663|NCT02252965|363591245|FG000|Overall Study|Lack of Efficacy|0|||
105432664|NCT02252965|363591246|FG001|Overall Study|Lack of Efficacy|2|||
105432665|NCT02252965|363591245|FG000|Overall Study|Withdrawal by Subject|7|||
105432666|NCT02252965|363591246|FG001|Overall Study|Withdrawal by Subject|9|||
105432667|NCT02252965|363591245|FG000|Overall Study|Other|4|||
105432668|NCT02252965|363591246|FG001|Overall Study|Other|5|||
105432669|NCT02853435|363591247|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
105432670|NCT02853435|363591248|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
105432671|NCT02853435|363591249|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
105432672|NCT02853435|363591250|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
105432673|NCT02853435|363591251|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
105432674|NCT02853435|363591252|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
105432675|NCT04279613|363591260|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
105432676|NCT04279613|363591261|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
105432677|NCT04279613|363591262|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
105432678|NCT04279613|363591263|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
105432679|NCT04279613|363591264|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
105432680|NCT04279613|363591260|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
105432681|NCT04279613|363591261|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
105432682|NCT04279613|363591262|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
105432683|NCT04279613|363591263|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
105432684|NCT04279613|363591264|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
105432685|NCT04279613|363591260|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
105432686|NCT04279613|363591261|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
105432687|NCT04279613|363591262|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
105432688|NCT04279613|363591263|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
105432689|NCT04279613|363591264|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
105432690|NCT04279613|363591260|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
105432691|NCT04279613|363591261|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
105432692|NCT04279613|363591262|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
105432693|NCT04279613|363591263|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
105432694|NCT04279613|363591264|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
105432695|NCT04279613|363591260|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
105432696|NCT04279613|363591261|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
105432697|NCT04279613|363591262|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
105432698|NCT04279613|363591263|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
105432699|NCT04279613|363591264|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
105432700|NCT00527319|363591267|FG000|Overall Study|Withdrawal by Subject|5|||
105432701|NCT00527319|363591268|FG001|Overall Study|Withdrawal by Subject|0|||
105432702|NCT00527319|363591269|FG002|Overall Study|Withdrawal by Subject|1|||
105432703|NCT00527319|363591267|FG000|Overall Study|Lost to Follow-up|1|||
105432704|NCT00527319|363591268|FG001|Overall Study|Lost to Follow-up|0|||
105432705|NCT00527319|363591269|FG002|Overall Study|Lost to Follow-up|0|||
105432706|NCT00527319|363591267|FG000|Overall Study|Death|0|||
105432707|NCT00527319|363591268|FG001|Overall Study|Death|3|||
105432708|NCT00527319|363591269|FG002|Overall Study|Death|1|||
105432709|NCT00527319|363591267|FG000|Overall Study|Intercurrent Medical Illness|0|||
105432710|NCT00527319|363591268|FG001|Overall Study|Intercurrent Medical Illness|1|||
105432711|NCT00527319|363591269|FG002|Overall Study|Intercurrent Medical Illness|3|||
105432712|NCT00527319|363591267|FG000|Overall Study|Adverse Event|0|||
105502417|NCT01543698|363850901|FG008|Phase 2|Death|0|||
105502418|NCT01543698|363850902|FG009|Phase 2|Death|0|||
105502419|NCT01543698|363850903|FG010|Phase 2|Death|0|||
105502420|NCT01543698|363850904|FG011|Phase 2|Death|0|||
105502421|NCT01543698|363850905|FG012|Phase 2|Death|1|||
105502422|NCT01543698|363850906|FG013|Phase 2|Death|1|||
105502423|NCT01543698|363850907|FG014|Phase 2|Death|1|||
105502424|NCT01543698|363850893|FG000|Phase 2|Administrative problems|0|||
105502425|NCT01543698|363850894|FG001|Phase 2|Administrative problems|0|||
105502426|NCT01543698|363850895|FG002|Phase 2|Administrative problems|0|||
105502427|NCT01543698|363850896|FG003|Phase 2|Administrative problems|0|||
105502428|NCT01543698|363850897|FG004|Phase 2|Administrative problems|0|||
105502429|NCT01543698|363850898|FG005|Phase 2|Administrative problems|0|||
105502430|NCT01543698|363850899|FG006|Phase 2|Administrative problems|0|||
105502431|NCT01543698|363850900|FG007|Phase 2|Administrative problems|0|||
105502432|NCT01543698|363850901|FG008|Phase 2|Administrative problems|0|||
105502433|NCT01543698|363850902|FG009|Phase 2|Administrative problems|0|||
105502434|NCT01543698|363850903|FG010|Phase 2|Administrative problems|0|||
105502435|NCT01543698|363850904|FG011|Phase 2|Administrative problems|0|||
105502436|NCT01543698|363850905|FG012|Phase 2|Administrative problems|0|||
105502437|NCT01543698|363850906|FG013|Phase 2|Administrative problems|3|||
105502438|NCT01543698|363850907|FG014|Phase 2|Administrative problems|1|||
105502439|NCT01543698|363850893|FG000|Phase 2|Withdrawal by Subject|0|||
105502440|NCT01543698|363850894|FG001|Phase 2|Withdrawal by Subject|0|||
105502441|NCT01543698|363850895|FG002|Phase 2|Withdrawal by Subject|0|||
105502442|NCT01543698|363850896|FG003|Phase 2|Withdrawal by Subject|0|||
105502443|NCT01543698|363850897|FG004|Phase 2|Withdrawal by Subject|0|||
105502444|NCT01543698|363850898|FG005|Phase 2|Withdrawal by Subject|0|||
105502445|NCT01543698|363850899|FG006|Phase 2|Withdrawal by Subject|0|||
105502446|NCT01543698|363850900|FG007|Phase 2|Withdrawal by Subject|0|||
105502447|NCT01543698|363850901|FG008|Phase 2|Withdrawal by Subject|0|||
105502448|NCT01543698|363850902|FG009|Phase 2|Withdrawal by Subject|0|||
105502449|NCT01543698|363850903|FG010|Phase 2|Withdrawal by Subject|0|||
105502450|NCT01543698|363850904|FG011|Phase 2|Withdrawal by Subject|0|||
105502451|NCT01543698|363850905|FG012|Phase 2|Withdrawal by Subject|0|||
105502452|NCT01543698|363850906|FG013|Phase 2|Withdrawal by Subject|3|||
105502453|NCT01543698|363850907|FG014|Phase 2|Withdrawal by Subject|1|||
105502454|NCT01543698|363850893|FG000|Phase 2|Adverse Event|0|||
105432713|NCT00527319|363591268|FG001|Overall Study|Adverse Event|0|||
105432714|NCT00527319|363591269|FG002|Overall Study|Adverse Event|1|||
105432715|NCT02981524|363591276|FG000|Overall Study|Progressive Disease|14|||
105502455|NCT01543698|363850894|FG001|Phase 2|Adverse Event|0|||
105502456|NCT01543698|363850895|FG002|Phase 2|Adverse Event|0|||
105502457|NCT01543698|363850896|FG003|Phase 2|Adverse Event|0|||
105432716|NCT02981524|363591276|FG000|Overall Study|Death (unrelated)|1|||
105432717|NCT02981524|363591276|FG000|Overall Study|Treatment Related Toxicity|1|||
105432718|NCT02981524|363591276|FG000|Overall Study|Withdrawal by Subject|1|||
105502458|NCT01543698|363850897|FG004|Phase 2|Adverse Event|0|||
105502459|NCT01543698|363850898|FG005|Phase 2|Adverse Event|0|||
105502460|NCT01543698|363850899|FG006|Phase 2|Adverse Event|0|||
105502461|NCT01543698|363850900|FG007|Phase 2|Adverse Event|0|||
105502462|NCT01543698|363850901|FG008|Phase 2|Adverse Event|0|||
105502463|NCT01543698|363850902|FG009|Phase 2|Adverse Event|0|||
105502464|NCT01543698|363850903|FG010|Phase 2|Adverse Event|0|||
105502465|NCT01543698|363850904|FG011|Phase 2|Adverse Event|1|||
105502466|NCT01543698|363850905|FG012|Phase 2|Adverse Event|3|||
105502467|NCT01543698|363850906|FG013|Phase 2|Adverse Event|5|||
105502468|NCT01543698|363850907|FG014|Phase 2|Adverse Event|14|||
105502469|NCT00217620|363850908|FG000|Overall Study|Adverse Event|2|||
105502470|NCT00217620|363850908|FG000|Overall Study|Progression|31|||
105502471|NCT00217620|363850908|FG000|Overall Study|Not Protocol Specified|4|||
105502472|NCT00217620|363850908|FG000|Overall Study|Ineligible|13|||
105502473|NCT00217620|363850908|FG000|Overall Study|Never received treatment|1|||
105502474|NCT04092582|363850918|FG000|Overall Study|Death|1|||
105502475|NCT04092582|363850919|FG001|Overall Study|Death|1|||
105502476|NCT04092582|363850918|FG000|Overall Study|Withdrawal by Subject|4|||
105502477|NCT04092582|363850919|FG001|Overall Study|Withdrawal by Subject|1|||
105502478|NCT04092582|363850918|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
105502479|NCT04092582|363850919|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
105502480|NCT00560105|363850924|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
105502481|NCT00560105|363850925|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
105502482|NCT02400333|363850926|FG000|Overall Study|Withdrawal by Subject|0|||
105502483|NCT02400333|363850927|FG001|Overall Study|Withdrawal by Subject|1|||
105502484|NCT02400333|363850928|FG002|Overall Study|Withdrawal by Subject|0|||
105502485|NCT02400333|363850929|FG003|Overall Study|Withdrawal by Subject|1|||
105502486|NCT02400333|363850926|FG000|Overall Study|Protocol Violation|1|||
105502487|NCT02400333|363850927|FG001|Overall Study|Protocol Violation|0|||
105502488|NCT02400333|363850928|FG002|Overall Study|Protocol Violation|2|||
105502489|NCT02400333|363850929|FG003|Overall Study|Protocol Violation|1|||
105502490|NCT02468674|363850930|FG000|Overall Study|Adverse Event|0|||
105502491|NCT02468674|363850931|FG001|Overall Study|Adverse Event|0|||
105502492|NCT02468674|363850932|FG002|Overall Study|Adverse Event|0|||
105502493|NCT02468674|363850933|FG003|Overall Study|Adverse Event|1|||
105502494|NCT02468674|363850934|FG004|Overall Study|Adverse Event|0|||
105502495|NCT02468674|363850935|FG005|Overall Study|Adverse Event|1|||
105502496|NCT02468674|363850936|FG006|Overall Study|Adverse Event|0|||
105502497|NCT02468674|363850937|FG007|Overall Study|Adverse Event|0|||
105502498|NCT02468674|363850938|FG008|Overall Study|Adverse Event|0|||
105502499|NCT02468674|363850930|FG000|Overall Study|Lost to Follow-up|1|||
105502500|NCT02468674|363850931|FG001|Overall Study|Lost to Follow-up|0|||
105502501|NCT02468674|363850932|FG002|Overall Study|Lost to Follow-up|0|||
105502502|NCT02468674|363850933|FG003|Overall Study|Lost to Follow-up|0|||
105502503|NCT02468674|363850934|FG004|Overall Study|Lost to Follow-up|0|||
105502504|NCT02468674|363850935|FG005|Overall Study|Lost to Follow-up|0|||
105502505|NCT02468674|363850936|FG006|Overall Study|Lost to Follow-up|0|||
105502506|NCT02468674|363850937|FG007|Overall Study|Lost to Follow-up|1|||
105502507|NCT02468674|363850938|FG008|Overall Study|Lost to Follow-up|1|||
105502508|NCT02468674|363850930|FG000|Overall Study|Physician Decision|0|||
105502509|NCT02468674|363850931|FG001|Overall Study|Physician Decision|0|||
105432719|NCT00483041|363591278|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
105432720|NCT00483041|363591279|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
105432721|NCT00443781|363591280|FG000|Overall Study|Lost to Follow-up|10|||
105432722|NCT00443781|363591280|FG000|Overall Study|Physician Decision|2|||
105432723|NCT00443781|363591280|FG000|Overall Study|Protocol Violation|1|||
105432724|NCT00443781|363591280|FG000|Overall Study|Withdrawal by Subject|6|||
105432725|NCT00443781|363591280|FG000|Overall Study|Unable to comply with study follow up|2|||
105432726|NCT00443781|363591280|FG000|Overall Study|Investigator terminated participation|1|||
105432727|NCT00443781|363591280|FG000|Overall Study|Insurance not covered|2|||
105432728|NCT00443781|363591280|FG000|Overall Study|PD/FAD not done|1|||
105502510|NCT02468674|363850932|FG002|Overall Study|Physician Decision|0|||
105502511|NCT02468674|363850933|FG003|Overall Study|Physician Decision|0|||
105502512|NCT02468674|363850934|FG004|Overall Study|Physician Decision|0|||
105502513|NCT02468674|363850935|FG005|Overall Study|Physician Decision|0|||
105502514|NCT02468674|363850936|FG006|Overall Study|Physician Decision|1|||
105502515|NCT02468674|363850937|FG007|Overall Study|Physician Decision|0|||
105502516|NCT02468674|363850938|FG008|Overall Study|Physician Decision|0|||
105502517|NCT02468674|363850930|FG000|Overall Study|Patient/Guardian Decision|0|||
105502518|NCT02468674|363850931|FG001|Overall Study|Patient/Guardian Decision|0|||
105432729|NCT00430937|363591281|FG000|Overall Study|Adverse Event|3|||
105502519|NCT02468674|363850932|FG002|Overall Study|Patient/Guardian Decision|0|||
105502520|NCT02468674|363850933|FG003|Overall Study|Patient/Guardian Decision|0|||
105502521|NCT02468674|363850934|FG004|Overall Study|Patient/Guardian Decision|1|||
105502522|NCT02468674|363850935|FG005|Overall Study|Patient/Guardian Decision|0|||
105502523|NCT02468674|363850936|FG006|Overall Study|Patient/Guardian Decision|0|||
105502524|NCT02468674|363850937|FG007|Overall Study|Patient/Guardian Decision|2|||
105502525|NCT02468674|363850938|FG008|Overall Study|Patient/Guardian Decision|1|||
105432730|NCT00430937|363591282|FG001|Overall Study|Adverse Event|8|||
105502526|NCT02468674|363850930|FG000|Overall Study|Protocol Deviation|0|||
105432731|NCT00430937|363591281|FG000|Overall Study|Death|0|||
105432732|NCT00430937|363591282|FG001|Overall Study|Death|1|||
105432733|NCT00430937|363591281|FG000|Overall Study|Lost to Follow-up|6|||
105432734|NCT00430937|363591282|FG001|Overall Study|Lost to Follow-up|6|||
105432735|NCT00430937|363591281|FG000|Overall Study|Withdrawal by Subject|5|||
105432736|NCT00430937|363591282|FG001|Overall Study|Withdrawal by Subject|2|||
105432737|NCT00430937|363591281|FG000|Overall Study|Protocol Violation|3|||
105432738|NCT00430937|363591282|FG001|Overall Study|Protocol Violation|2|||
105502527|NCT02468674|363850931|FG001|Overall Study|Protocol Deviation|0|||
105502528|NCT02468674|363850932|FG002|Overall Study|Protocol Deviation|0|||
105432739|NCT00430937|363591281|FG000|Overall Study|Lack of Efficacy|6|||
105432740|NCT00430937|363591282|FG001|Overall Study|Lack of Efficacy|5|||
105432741|NCT00430937|363591281|FG000|Overall Study|Inappropriate enrollment|2|||
105432742|NCT00430937|363591282|FG001|Overall Study|Inappropriate enrollment|1|||
105432743|NCT00430937|363591281|FG000|Overall Study|Administrative reasons|1|||
105432744|NCT00430937|363591282|FG001|Overall Study|Administrative reasons|0|||
105432745|NCT00430937|363591281|FG000|Overall Study|Protocol discontinuation criteria met|1|||
105432746|NCT00430937|363591282|FG001|Overall Study|Protocol discontinuation criteria met|2|||
105432747|NCT00430937|363591281|FG000|Overall Study|Unable to classify|0|||
105432748|NCT00430937|363591282|FG001|Overall Study|Unable to classify|1|||
105432749|NCT01116427|363591283|FG000|Core Phase|Adverse Event|0|||
105432750|NCT01116427|363591284|FG001|Core Phase|Adverse Event|1|||
105432751|NCT01116427|363591283|FG000|Core Phase|Lost to Follow-up|1|||
105432752|NCT01116427|363591284|FG001|Core Phase|Lost to Follow-up|0|||
105432753|NCT01116427|363591283|FG000|Core Phase|Withdrawal by Subject|3|||
105432754|NCT01116427|363591284|FG001|Core Phase|Withdrawal by Subject|0|||
105432755|NCT01116427|363591283|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
105432756|NCT01116427|363591284|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
105432757|NCT01116427|363591283|FG000|Extension Phase|Adverse Event|1|||
105432758|NCT01116427|363591284|FG001|Extension Phase|Adverse Event|1|||
105432759|NCT01116427|363591283|FG000|Extension Phase|Lost to Follow-up|2|||
105432760|NCT01116427|363591284|FG001|Extension Phase|Lost to Follow-up|0|||
105432761|NCT01116427|363591283|FG000|Extension Phase|Withdrawal by Subject|5|||
105432762|NCT01116427|363591284|FG001|Extension Phase|Withdrawal by Subject|1|||
105432763|NCT01116427|363591283|FG000|Extension Phase|Not using appropriate birth control|1|||
105432764|NCT01116427|363591284|FG001|Extension Phase|Not using appropriate birth control|0|||
105432765|NCT02771626|363591285|FG000|Overall Study|Adverse Event|1|||
105432766|NCT02771626|363591286|FG001|Overall Study|Adverse Event|5|||
105432767|NCT02771626|363591287|FG002|Overall Study|Adverse Event|3|||
105432768|NCT02771626|363591288|FG003|Overall Study|Adverse Event|0|||
105432769|NCT02771626|363591289|FG004|Overall Study|Adverse Event|1|||
105432770|NCT02771626|363591290|FG005|Overall Study|Adverse Event|1|||
105432771|NCT02771626|363591285|FG000|Overall Study|Radiologic Disease Progression|6|||
105432772|NCT02771626|363591286|FG001|Overall Study|Radiologic Disease Progression|13|||
105432773|NCT02771626|363591287|FG002|Overall Study|Radiologic Disease Progression|10|||
105432774|NCT02771626|363591288|FG003|Overall Study|Radiologic Disease Progression|7|||
105432775|NCT02771626|363591289|FG004|Overall Study|Radiologic Disease Progression|28|||
105432776|NCT02771626|363591290|FG005|Overall Study|Radiologic Disease Progression|15|||
105432777|NCT02771626|363591285|FG000|Overall Study|Symptomatic Deterioration|0|||
105432778|NCT02771626|363591286|FG001|Overall Study|Symptomatic Deterioration|4|||
105432779|NCT02771626|363591287|FG002|Overall Study|Symptomatic Deterioration|2|||
105432780|NCT02771626|363591288|FG003|Overall Study|Symptomatic Deterioration|0|||
105432781|NCT02771626|363591289|FG004|Overall Study|Symptomatic Deterioration|5|||
105432782|NCT02771626|363591290|FG005|Overall Study|Symptomatic Deterioration|2|||
105502529|NCT02468674|363850933|FG003|Overall Study|Protocol Deviation|0|||
105432783|NCT02771626|363591285|FG000|Overall Study|Participant Request|0|||
105432784|NCT02771626|363591286|FG001|Overall Study|Participant Request|1|||
105432785|NCT02771626|363591287|FG002|Overall Study|Participant Request|0|||
105432786|NCT02771626|363591288|FG003|Overall Study|Participant Request|2|||
105432787|NCT02771626|363591289|FG004|Overall Study|Participant Request|0|||
105432788|NCT02771626|363591290|FG005|Overall Study|Participant Request|1|||
105432789|NCT02771626|363591285|FG000|Overall Study|Investigator Decision|0|||
105432790|NCT02771626|363591286|FG001|Overall Study|Investigator Decision|1|||
105432791|NCT02771626|363591287|FG002|Overall Study|Investigator Decision|0|||
105432792|NCT02771626|363591288|FG003|Overall Study|Investigator Decision|0|||
105502530|NCT02468674|363850934|FG004|Overall Study|Protocol Deviation|0|||
105432793|NCT02771626|363591289|FG004|Overall Study|Investigator Decision|1|||
105432794|NCT02771626|363591290|FG005|Overall Study|Investigator Decision|0|||
105432795|NCT02771626|363591285|FG000|Overall Study|Study Termination by Sponsor|0|||
105432796|NCT02771626|363591286|FG001|Overall Study|Study Termination by Sponsor|2|||
105432797|NCT02771626|363591287|FG002|Overall Study|Study Termination by Sponsor|1|||
105432798|NCT02771626|363591288|FG003|Overall Study|Study Termination by Sponsor|0|||
105432799|NCT02771626|363591289|FG004|Overall Study|Study Termination by Sponsor|1|||
105432800|NCT02771626|363591290|FG005|Overall Study|Study Termination by Sponsor|0|||
105432801|NCT02771626|363591285|FG000|Overall Study|Informed Consent Withdrawn|0|||
105432802|NCT02771626|363591286|FG001|Overall Study|Informed Consent Withdrawn|0|||
105432803|NCT02771626|363591287|FG002|Overall Study|Informed Consent Withdrawn|1|||
105432804|NCT02771626|363591288|FG003|Overall Study|Informed Consent Withdrawn|0|||
105432805|NCT02771626|363591289|FG004|Overall Study|Informed Consent Withdrawn|1|||
105432806|NCT02771626|363591290|FG005|Overall Study|Informed Consent Withdrawn|1|||
105432807|NCT02771626|363591285|FG000|Overall Study|Other, Not Specified|1|||
105432808|NCT02771626|363591286|FG001|Overall Study|Other, Not Specified|0|||
105432809|NCT02771626|363591287|FG002|Overall Study|Other, Not Specified|0|||
105432810|NCT02771626|363591288|FG003|Overall Study|Other, Not Specified|0|||
105432811|NCT02771626|363591289|FG004|Overall Study|Other, Not Specified|0|||
105432812|NCT02771626|363591290|FG005|Overall Study|Other, Not Specified|1|||
105432813|NCT00364533|363591295|FG000|Overall Study|Adverse Event|8|||
105432814|NCT00364533|363591296|FG001|Overall Study|Adverse Event|7|||
105432815|NCT00364533|363591297|FG002|Overall Study|Adverse Event|15|||
105432816|NCT00364533|363591298|FG003|Overall Study|Adverse Event|5|||
105432817|NCT00364533|363591299|FG004|Overall Study|Adverse Event|2|||
105432818|NCT00364533|363591295|FG000|Overall Study|Withdrawal by Subject|4|||
105432819|NCT00364533|363591296|FG001|Overall Study|Withdrawal by Subject|8|||
105432820|NCT00364533|363591297|FG002|Overall Study|Withdrawal by Subject|6|||
105432821|NCT00364533|363591298|FG003|Overall Study|Withdrawal by Subject|6|||
105432822|NCT00364533|363591299|FG004|Overall Study|Withdrawal by Subject|6|||
105432823|NCT00364533|363591295|FG000|Overall Study|Lack of Efficacy|22|||
105432824|NCT00364533|363591296|FG001|Overall Study|Lack of Efficacy|22|||
105432825|NCT00364533|363591297|FG002|Overall Study|Lack of Efficacy|21|||
105432826|NCT00364533|363591298|FG003|Overall Study|Lack of Efficacy|17|||
105432827|NCT00364533|363591299|FG004|Overall Study|Lack of Efficacy|42|||
105432828|NCT00364533|363591295|FG000|Overall Study|Subject discharged from hospital|4|||
105432829|NCT00364533|363591296|FG001|Overall Study|Subject discharged from hospital|1|||
105432830|NCT00364533|363591297|FG002|Overall Study|Subject discharged from hospital|2|||
105432831|NCT00364533|363591298|FG003|Overall Study|Subject discharged from hospital|3|||
105432832|NCT00364533|363591299|FG004|Overall Study|Subject discharged from hospital|1|||
105432833|NCT00364533|363591295|FG000|Overall Study|Variations in drug compliance|2|||
105432834|NCT00364533|363591296|FG001|Overall Study|Variations in drug compliance|1|||
105432835|NCT00364533|363591297|FG002|Overall Study|Variations in drug compliance|1|||
105432836|NCT00364533|363591298|FG003|Overall Study|Variations in drug compliance|0|||
105432837|NCT00364533|363591299|FG004|Overall Study|Variations in drug compliance|0|||
105432838|NCT00364533|363591295|FG000|Overall Study|Non-compliance|1|||
105432839|NCT00364533|363591296|FG001|Overall Study|Non-compliance|0|||
105432840|NCT00364533|363591297|FG002|Overall Study|Non-compliance|0|||
105432841|NCT00364533|363591298|FG003|Overall Study|Non-compliance|0|||
105432842|NCT00364533|363591299|FG004|Overall Study|Non-compliance|0|||
105432843|NCT00364533|363591295|FG000|Overall Study|Protocol Violation|1|||
105432844|NCT00364533|363591296|FG001|Overall Study|Protocol Violation|1|||
105432845|NCT00364533|363591297|FG002|Overall Study|Protocol Violation|0|||
105432846|NCT00364533|363591298|FG003|Overall Study|Protocol Violation|0|||
105432847|NCT00364533|363591299|FG004|Overall Study|Protocol Violation|0|||
105432848|NCT03157583|363591300|FG000|Overall Study|Other (did not meet study criteria)|1|||
105432849|NCT01302054|363591303|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
105432850|NCT01302054|363591304|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
105432851|NCT01302054|363591305|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
105432852|NCT01302054|363591303|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
105432853|NCT01302054|363591304|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
105432854|NCT01302054|363591305|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
105432855|NCT01302054|363591303|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
105432856|NCT01302054|363591304|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
105432857|NCT01302054|363591305|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
105432858|NCT01302054|363591303|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
105432859|NCT01302054|363591304|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
105432860|NCT01302054|363591305|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
105432861|NCT01302054|363591303|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
105590452|NCT01280591|364162593|FG000|Overall Study|Withdrawal by Subject|0|||
105590453|NCT01280591|364162594|FG001|Overall Study|Withdrawal by Subject|0|||
105432862|NCT01302054|363591304|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
105432863|NCT01302054|363591305|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
105432864|NCT01302054|363591303|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
105590454|NCT01280591|364162595|FG002|Overall Study|Withdrawal by Subject|0|||
105590455|NCT01280591|364162596|FG003|Overall Study|Withdrawal by Subject|2|||
105432865|NCT01302054|363591304|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
105432866|NCT01302054|363591305|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
105432867|NCT01302054|363591303|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
105432868|NCT01302054|363591304|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
105432869|NCT01302054|363591305|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
105432870|NCT01302054|363591303|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
105432871|NCT01302054|363591304|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
105432872|NCT01302054|363591305|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
105432873|NCT01302054|363591303|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
105432874|NCT01302054|363591304|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
105432875|NCT01302054|363591305|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
105432876|NCT01302054|363591303|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105432877|NCT01302054|363591304|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
105432878|NCT01302054|363591305|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
105432879|NCT01302054|363591303|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
105432880|NCT01302054|363591304|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
105432881|NCT01302054|363591305|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
105432882|NCT01302054|363591303|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
105432883|NCT01302054|363591304|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
105432884|NCT01302054|363591305|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
105432885|NCT01302054|363591303|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
105432886|NCT01302054|363591304|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
105432887|NCT01302054|363591305|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
105432888|NCT01302054|363591303|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
105432889|NCT01302054|363591304|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
105432890|NCT01302054|363591305|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
105432891|NCT01302054|363591303|FG000|Double-Blind Treatment Phase|Other|0|||
105432892|NCT01302054|363591304|FG001|Double-Blind Treatment Phase|Other|4|||
105432893|NCT01302054|363591305|FG002|Double-Blind Treatment Phase|Other|9|||
105432894|NCT02713867|363591306|FG000|Randomization|Other Reason|2|||
105432895|NCT02713867|363591307|FG001|Randomization|Other Reason|1|||
105432896|NCT02713867|363591306|FG000|Randomization|Participant Withdrew consent|0|||
105432897|NCT02713867|363591307|FG001|Randomization|Participant Withdrew consent|2|||
105432898|NCT02713867|363591306|FG000|Treatment Period|Other Reasons|22|||
105432899|NCT02713867|363591307|FG001|Treatment Period|Other Reasons|28|||
105432900|NCT02713867|363591306|FG000|Treatment Period|Administrative reason by sponsor|21|||
105432901|NCT02713867|363591307|FG001|Treatment Period|Administrative reason by sponsor|16|||
105432902|NCT02713867|363591306|FG000|Treatment Period|No longer meets study criteria|2|||
105432903|NCT02713867|363591307|FG001|Treatment Period|No longer meets study criteria|1|||
105432904|NCT02713867|363591306|FG000|Treatment Period|Poor/Non Compliance|1|||
105432905|NCT02713867|363591307|FG001|Treatment Period|Poor/Non Compliance|0|||
105432906|NCT02713867|363591306|FG000|Treatment Period|Maximum Clinical Benefit|5|||
105502531|NCT02468674|363850935|FG005|Overall Study|Protocol Deviation|0|||
105502532|NCT02468674|363850936|FG006|Overall Study|Protocol Deviation|0|||
105502533|NCT02468674|363850937|FG007|Overall Study|Protocol Deviation|1|||
105502534|NCT02468674|363850938|FG008|Overall Study|Protocol Deviation|1|||
105502535|NCT02280304|363850939|FG000|Overall Study|Lost to Follow-up|7|||
105502536|NCT02280304|363850940|FG001|Overall Study|Lost to Follow-up|8|||
105502537|NCT01550289|363850941|FG000|Overall Study|Protocol Violation|1|||
105502538|NCT01550289|363850942|FG001|Overall Study|Protocol Violation|0|||
105502539|NCT01550289|363850941|FG000|Overall Study|Lost to Follow-up|1|||
105502540|NCT01550289|363850942|FG001|Overall Study|Lost to Follow-up|1|||
105502541|NCT01550289|363850941|FG000|Overall Study|Withdrawal by Subject|11|||
105502542|NCT01550289|363850942|FG001|Overall Study|Withdrawal by Subject|3|||
105502543|NCT04645953|363850946|FG000|Overall Study|Lost to Follow-up|2|||
105502544|NCT04645953|363850947|FG001|Overall Study|Lost to Follow-up|1|||
105502545|NCT04645953|363850948|FG002|Overall Study|Lost to Follow-up|1|||
105502546|NCT04645953|363850946|FG000|Overall Study|Withdrawal by Subject|0|||
105502547|NCT04645953|363850947|FG001|Overall Study|Withdrawal by Subject|1|||
105502548|NCT04645953|363850948|FG002|Overall Study|Withdrawal by Subject|0|||
105502549|NCT04645953|363850946|FG000|Overall Study|Physician Decision|0|||
105502550|NCT04645953|363850947|FG001|Overall Study|Physician Decision|1|||
105502551|NCT04645953|363850948|FG002|Overall Study|Physician Decision|0|||
105502552|NCT04645953|363850946|FG000|Overall Study|Discontinued Prior to Dosing|0|||
105502553|NCT04645953|363850947|FG001|Overall Study|Discontinued Prior to Dosing|0|||
105502554|NCT04645953|363850948|FG002|Overall Study|Discontinued Prior to Dosing|2|||
105502555|NCT03741062|363850950|FG000|Overall Study|Protocol Violation|1|||
105502556|NCT03741062|363850951|FG001|Overall Study|Protocol Violation|0|||
105502557|NCT00762229|363850957|FG000|Overall Study|Lost to Follow-up|1|||
105502558|NCT00762229|363850958|FG001|Overall Study|Lost to Follow-up|1|||
105502559|NCT00762229|363850957|FG000|Overall Study|did not recveive intervention|0|||
105502560|NCT00762229|363850958|FG001|Overall Study|did not recveive intervention|1|||
105432907|NCT02713867|363591307|FG001|Treatment Period|Maximum Clinical Benefit|6|||
105502561|NCT00444912|363850961|FG000|Overall Study|Death|1|||
105502562|NCT00444912|363850962|FG001|Overall Study|Death|2|||
105432908|NCT02713867|363591306|FG000|Treatment Period|Withdrew consent|3|||
105432909|NCT02713867|363591307|FG001|Treatment Period|Withdrew consent|6|||
105432910|NCT02713867|363591306|FG000|Treatment Period|Requested to Discontinue|8|||
105502563|NCT00444912|363850961|FG000|Overall Study|Lost to Follow-up|1|||
105502564|NCT00444912|363850962|FG001|Overall Study|Lost to Follow-up|0|||
105502565|NCT00444912|363850961|FG000|Overall Study|Participant Failed Mobilization|1|||
105432911|NCT02713867|363591307|FG001|Treatment Period|Requested to Discontinue|8|||
105432912|NCT02713867|363591306|FG000|Treatment Period|AE unrelated to Study Drug|11|||
105590456|NCT01280591|364162593|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
105590457|NCT01280591|364162594|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
105590458|NCT01280591|364162595|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
105590459|NCT01280591|364162596|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
105590460|NCT02955069|364162597|FG000|Overall Study|Adverse Event|7|||
105590461|NCT02955069|364162598|FG001|Overall Study|Adverse Event|2|||
105590462|NCT02955069|364162597|FG000|Overall Study|Death|7|||
105590463|NCT02955069|364162598|FG001|Overall Study|Death|3|||
105590464|NCT02955069|364162597|FG000|Overall Study|Physician Decision|10|||
105590465|NCT02955069|364162598|FG001|Overall Study|Physician Decision|2|||
105590466|NCT02955069|364162597|FG000|Overall Study|Progressive disease|64|||
105590467|NCT02955069|364162598|FG001|Overall Study|Progressive disease|13|||
105590468|NCT02955069|364162597|FG000|Overall Study|Study terminated by sponsor|4|||
105590469|NCT02955069|364162598|FG001|Overall Study|Study terminated by sponsor|0|||
105590470|NCT02955069|364162597|FG000|Overall Study|Subject/Guardian decision|3|||
105590471|NCT02955069|364162598|FG001|Overall Study|Subject/Guardian decision|1|||
105590472|NCT01883492|364162604|FG000|Overall Study|Lost to Follow-up|3|||
105590473|NCT01883492|364162605|FG001|Overall Study|Lost to Follow-up|4|||
105590474|NCT01883492|364162604|FG000|Overall Study|Surgery on contra-lateral hip|0|||
105590475|NCT01883492|364162605|FG001|Overall Study|Surgery on contra-lateral hip|1|||
105590476|NCT01883492|364162604|FG000|Overall Study|Poor X-ray quality|7|||
105590477|NCT01883492|364162605|FG001|Overall Study|Poor X-ray quality|4|||
105590478|NCT01883492|364162604|FG000|Overall Study|Withdrawal by Subject|1|||
105590479|NCT01883492|364162605|FG001|Overall Study|Withdrawal by Subject|0|||
105590480|NCT01883492|364162604|FG000|Overall Study|inappropriate implant used|1|||
105590481|NCT01883492|364162605|FG001|Overall Study|inappropriate implant used|1|||
105590482|NCT01883492|364162604|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
105590483|NCT01883492|364162605|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
105590484|NCT02232178|364162606|FG000|Overall Study|Lost to Follow-up|0|||
105590485|NCT02232178|364162607|FG001|Overall Study|Lost to Follow-up|1|||
105432913|NCT02713867|363591307|FG001|Treatment Period|AE unrelated to Study Drug|10|||
105432914|NCT02713867|363591306|FG000|Treatment Period|Death|7|||
105432915|NCT02713867|363591307|FG001|Treatment Period|Death|3|||
105432916|NCT02713867|363591306|FG000|Treatment Period|Study Drug Toxicity|16|||
105432917|NCT02713867|363591307|FG001|Treatment Period|Study Drug Toxicity|19|||
105432918|NCT02713867|363591306|FG000|Treatment Period|Disease Progression|82|||
105432919|NCT02713867|363591307|FG001|Treatment Period|Disease Progression|83|||
105432920|NCT00908037|363591315|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105432921|NCT00908037|363591316|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105502566|NCT00444912|363850962|FG001|Overall Study|Participant Failed Mobilization|0|||
105502567|NCT01606007|363850963|FG000|Overall Study|Reason 'Other' in the protocol|0|||
105502568|NCT01606007|363850964|FG001|Overall Study|Reason 'Other' in the protocol|1|||
105502569|NCT01606007|363850965|FG002|Overall Study|Reason 'Other' in the protocol|1|||
105502570|NCT01606007|363850963|FG000|Overall Study|Pregnancy|0|||
105502571|NCT01606007|363850964|FG001|Overall Study|Pregnancy|1|||
105502572|NCT01606007|363850965|FG002|Overall Study|Pregnancy|1|||
105502573|NCT01606007|363850963|FG000|Overall Study|Withdrawal by Subject|8|||
105502574|NCT01606007|363850964|FG001|Overall Study|Withdrawal by Subject|6|||
105502575|NCT01606007|363850965|FG002|Overall Study|Withdrawal by Subject|1|||
105502576|NCT01606007|363850963|FG000|Overall Study|Adverse Event|0|||
105502577|NCT01606007|363850964|FG001|Overall Study|Adverse Event|1|||
105502578|NCT01606007|363850965|FG002|Overall Study|Adverse Event|1|||
105502579|NCT01606007|363850963|FG000|Overall Study|discontinue study treatment|0|||
105502580|NCT01606007|363850964|FG001|Overall Study|discontinue study treatment|2|||
105502581|NCT01606007|363850965|FG002|Overall Study|discontinue study treatment|1|||
105502582|NCT01606007|363850963|FG000|Overall Study|Lost to Follow-up|6|||
105502583|NCT01606007|363850964|FG001|Overall Study|Lost to Follow-up|8|||
105502584|NCT01606007|363850965|FG002|Overall Study|Lost to Follow-up|5|||
105502585|NCT01606007|363850963|FG000|Overall Study|Poor/Non-compliance|1|||
105502586|NCT01606007|363850964|FG001|Overall Study|Poor/Non-compliance|0|||
105502587|NCT01606007|363850965|FG002|Overall Study|Poor/Non-compliance|0|||
105502588|NCT03758066|363850966|FG000|Overall Study|Lost to Follow-up|14|||
105502589|NCT04138810|363850967|FG000|Overall Study|Withdrawal by Subject|0|||
105502590|NCT04138810|363850968|FG001|Overall Study|Withdrawal by Subject|1|||
105502591|NCT04138810|363850967|FG000|Overall Study|Subject cancelled surgery|1|||
105502592|NCT04138810|363850968|FG001|Overall Study|Subject cancelled surgery|0|||
105502593|NCT03478657|363850971|FG000|Overall Study|Withdrawal by Subject|0|||
105502594|NCT03478657|363850972|FG001|Overall Study|Withdrawal by Subject|1|||
105502595|NCT01702805|363850973|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
105502596|NCT01702805|363850974|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
105590486|NCT02232178|364162608|FG002|Overall Study|Lost to Follow-up|0|||
105590487|NCT02232178|364162606|FG000|Overall Study|ineligibility|0|||
105590488|NCT02232178|364162607|FG001|Overall Study|ineligibility|0|||
105590489|NCT02232178|364162608|FG002|Overall Study|ineligibility|1|||
105432922|NCT00908037|363591317|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105432923|NCT00908037|363591318|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105432924|NCT00908037|363591319|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
105432925|NCT00908037|363591320|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105432926|NCT00908037|363591321|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
105432927|NCT00908037|363591322|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105432928|NCT00908037|363591323|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
105432929|NCT00908037|363591324|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105432930|NCT00908037|363591325|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105432931|NCT00908037|363591326|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105432932|NCT00908037|363591315|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105432933|NCT00908037|363591316|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105432934|NCT00908037|363591317|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105432935|NCT00908037|363591318|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105432936|NCT00908037|363591319|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
105432937|NCT00908037|363591320|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105432938|NCT00908037|363591321|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105432939|NCT00908037|363591322|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105432940|NCT00908037|363591323|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
105432941|NCT00908037|363591324|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105432942|NCT00908037|363591325|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105432943|NCT00908037|363591326|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105432944|NCT00908037|363591315|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105432945|NCT00908037|363591316|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105432946|NCT00908037|363591317|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105432947|NCT00908037|363591318|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
105432948|NCT00908037|363591319|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105432949|NCT00908037|363591320|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105432950|NCT00908037|363591321|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
105432951|NCT00908037|363591322|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105432952|NCT00908037|363591323|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105432953|NCT00908037|363591324|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105432954|NCT00908037|363591325|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105432955|NCT00908037|363591326|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105432956|NCT00908037|363591315|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105432957|NCT00908037|363591316|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105432958|NCT00908037|363591317|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105432959|NCT00908037|363591318|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105432960|NCT00908037|363591319|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105432961|NCT00908037|363591320|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105432962|NCT00908037|363591321|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105432963|NCT00908037|363591322|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105432964|NCT00908037|363591323|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105432965|NCT00908037|363591324|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105432966|NCT00908037|363591325|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105432967|NCT00908037|363591326|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
105432968|NCT00908037|363591315|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105432969|NCT00908037|363591316|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105432970|NCT00908037|363591317|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105432971|NCT00908037|363591318|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105432972|NCT00908037|363591319|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105432973|NCT00908037|363591320|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105432974|NCT00908037|363591321|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105432975|NCT00908037|363591322|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105432976|NCT00908037|363591323|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105432977|NCT00908037|363591324|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
105432978|NCT00908037|363591325|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105432979|NCT00908037|363591326|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
105432980|NCT00908037|363591315|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105432981|NCT00908037|363591316|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105432982|NCT00908037|363591317|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105432983|NCT00908037|363591318|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105432984|NCT00908037|363591319|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105590490|NCT02232178|364162606|FG000|Overall Study|surgical complication|1|||
105432985|NCT00908037|363591320|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105432986|NCT00908037|363591321|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105432987|NCT00908037|363591322|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105432988|NCT00908037|363591323|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105432989|NCT00908037|363591324|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
105432990|NCT00908037|363591325|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105432991|NCT00908037|363591326|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105432992|NCT00908037|363591315|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105432993|NCT00908037|363591316|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105432994|NCT00908037|363591317|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105432995|NCT00908037|363591318|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105432996|NCT00908037|363591319|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105432997|NCT00908037|363591320|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105432998|NCT00908037|363591321|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105432999|NCT00908037|363591322|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105433000|NCT00908037|363591323|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105433001|NCT00908037|363591324|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105502597|NCT01702805|363850973|FG000|Overall Study|Incomplete Follow-up|18|||
105502598|NCT01702805|363850974|FG001|Overall Study|Incomplete Follow-up|15|||
105502599|NCT01702805|363850973|FG000|Overall Study|Vital Status Assessment Only|40|||
105502600|NCT01702805|363850974|FG001|Overall Study|Vital Status Assessment Only|39|||
105502601|NCT01702805|363850973|FG000|Overall Study|Lost to Follow-up|5|||
105502602|NCT01702805|363850974|FG001|Overall Study|Lost to Follow-up|5|||
105502603|NCT02571777|363850975|FG000|Overall Study|Subject/guardian decision|34|||
105502604|NCT02571777|363850976|FG001|Overall Study|Subject/guardian decision|26|||
105502605|NCT02571777|363850977|FG002|Overall Study|Subject/guardian decision|26|||
105502606|NCT02571777|363850978|FG003|Overall Study|Subject/guardian decision|25|||
105502607|NCT02571777|363850979|FG004|Overall Study|Subject/guardian decision|27|||
105502608|NCT02571777|363850975|FG000|Overall Study|Protocol Deviation|2|||
105502609|NCT02571777|363850976|FG001|Overall Study|Protocol Deviation|3|||
105502610|NCT02571777|363850977|FG002|Overall Study|Protocol Deviation|4|||
105502611|NCT02571777|363850978|FG003|Overall Study|Protocol Deviation|8|||
105502612|NCT02571777|363850979|FG004|Overall Study|Protocol Deviation|4|||
105502613|NCT02571777|363850975|FG000|Overall Study|Death|1|||
105502614|NCT02571777|363850976|FG001|Overall Study|Death|1|||
105502615|NCT02571777|363850977|FG002|Overall Study|Death|4|||
105502616|NCT02571777|363850978|FG003|Overall Study|Death|0|||
105502617|NCT02571777|363850979|FG004|Overall Study|Death|0|||
105502618|NCT02571777|363850975|FG000|Overall Study|Lost to Follow-up|1|||
105502619|NCT02571777|363850976|FG001|Overall Study|Lost to Follow-up|1|||
105502620|NCT02571777|363850977|FG002|Overall Study|Lost to Follow-up|2|||
105502621|NCT02571777|363850978|FG003|Overall Study|Lost to Follow-up|0|||
105502622|NCT02571777|363850979|FG004|Overall Study|Lost to Follow-up|1|||
105502623|NCT02571777|363850975|FG000|Overall Study|Physician Decision|1|||
105502624|NCT02571777|363850976|FG001|Overall Study|Physician Decision|7|||
105502625|NCT02571777|363850977|FG002|Overall Study|Physician Decision|5|||
105502626|NCT02571777|363850978|FG003|Overall Study|Physician Decision|2|||
105502627|NCT02571777|363850979|FG004|Overall Study|Physician Decision|4|||
105502628|NCT02571777|363850975|FG000|Overall Study|Pregnancy|0|||
105502629|NCT02571777|363850976|FG001|Overall Study|Pregnancy|0|||
105502630|NCT02571777|363850977|FG002|Overall Study|Pregnancy|0|||
105502631|NCT02571777|363850978|FG003|Overall Study|Pregnancy|2|||
105502632|NCT02571777|363850979|FG004|Overall Study|Pregnancy|0|||
105502633|NCT04515394|363850983|FG000|Overall Study|Participant did not receive treatment|1|||
105502634|NCT03330288|363850984|FG000|Overall Study|Other reason|1|||
105502635|NCT03330288|363850985|FG001|Overall Study|Other reason|1|||
105502636|NCT03330288|363850984|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
105502637|NCT03330288|363850985|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
105502638|NCT03330288|363850984|FG000|Overall Study|Adverse Event|1|||
105502639|NCT03330288|363850985|FG001|Overall Study|Adverse Event|0|||
105502640|NCT03330288|363850984|FG000|Overall Study|Withdrawal by Subject|1|||
105502641|NCT03330288|363850985|FG001|Overall Study|Withdrawal by Subject|0|||
105502642|NCT03330288|363850984|FG000|Overall Study|Lost to Follow-up|26|||
105502643|NCT03330288|363850985|FG001|Overall Study|Lost to Follow-up|7|||
105502644|NCT01416272|363850986|FG000|Overall Study|Unacceptable distance visual acuity|2|||
105502645|NCT01416272|363850986|FG000|Overall Study|Lost to Follow-up|1|||
105502646|NCT01416272|363850986|FG000|Overall Study|Study related complaints|1|||
105502647|NCT02693119|363850987|FG000|Open-Label Period|Withdrawal by Subject|0|||
105502648|NCT02693119|363850988|FG001|Open-Label Period|Withdrawal by Subject|1|||
105502649|NCT02571075|363850989|FG000|Overall Study|Lost to Follow-up|20|||
105590491|NCT02232178|364162607|FG001|Overall Study|surgical complication|0|||
105502650|NCT02571075|363850990|FG001|Overall Study|Lost to Follow-up|24|||
105590492|NCT02232178|364162608|FG002|Overall Study|surgical complication|0|||
105433002|NCT00908037|363591325|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
105433003|NCT00908037|363591326|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105433004|NCT00908037|363591315|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105433005|NCT00908037|363591316|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105433006|NCT00908037|363591317|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105433007|NCT00908037|363591318|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105433008|NCT00908037|363591319|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105433009|NCT00908037|363591320|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105433010|NCT00908037|363591321|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105433011|NCT00908037|363591322|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105433012|NCT00908037|363591323|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105433013|NCT00908037|363591324|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
105433014|NCT00908037|363591325|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105433015|NCT00908037|363591326|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105433016|NCT00908037|363591315|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105433017|NCT00908037|363591316|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105433018|NCT00908037|363591317|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105433019|NCT00908037|363591318|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105433020|NCT00908037|363591319|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105433021|NCT00908037|363591320|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105433022|NCT00908037|363591321|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105433023|NCT00908037|363591322|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105433024|NCT00908037|363591323|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105433025|NCT00908037|363591324|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105433026|NCT00908037|363591325|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
105433027|NCT00908037|363591326|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105433028|NCT00975143|363591328|FG000|Overall Study|Adverse Event|19|||
105433029|NCT00975143|363591329|FG001|Overall Study|Adverse Event|15|||
105433030|NCT00975143|363591328|FG000|Overall Study|Withdrawal by Subject|15|||
105433031|NCT00975143|363591329|FG001|Overall Study|Withdrawal by Subject|15|||
105433032|NCT00975143|363591328|FG000|Overall Study|Lost to Follow-up|20|||
105433033|NCT00975143|363591329|FG001|Overall Study|Lost to Follow-up|16|||
105433034|NCT00975143|363591328|FG000|Overall Study|Non-compliance|5|||
105433035|NCT00975143|363591329|FG001|Overall Study|Non-compliance|8|||
105433036|NCT00975143|363591328|FG000|Overall Study|Physician Decision|1|||
105433037|NCT00975143|363591329|FG001|Overall Study|Physician Decision|2|||
105433038|NCT00975143|363591328|FG000|Overall Study|Details not available|10|||
105433039|NCT00975143|363591329|FG001|Overall Study|Details not available|4|||
105433040|NCT01375608|363591332|FG000|Overall Study|Withdrawal by Subject|2|||
105433041|NCT01792518|363591337|FG000|Overall Study|Adverse Event|3|||
105433042|NCT01792518|363591338|FG001|Overall Study|Adverse Event|4|||
105433043|NCT01792518|363591337|FG000|Overall Study|Protocol Violation|0|||
105433044|NCT01792518|363591338|FG001|Overall Study|Protocol Violation|1|||
105433045|NCT01792518|363591337|FG000|Overall Study|Lost to Follow-up|3|||
105433046|NCT01792518|363591338|FG001|Overall Study|Lost to Follow-up|1|||
105433047|NCT01792518|363591337|FG000|Overall Study|Withdrawal by Subject|2|||
105433048|NCT01792518|363591338|FG001|Overall Study|Withdrawal by Subject|0|||
105433049|NCT01792518|363591337|FG000|Overall Study|Other Reason|0|||
105433050|NCT01792518|363591338|FG001|Overall Study|Other Reason|1|||
105433051|NCT04109976|363591341|FG000|Overall Study|Withdrawal by Subject|1|||
105433052|NCT04109976|363591342|FG001|Overall Study|Withdrawal by Subject|0|||
105433053|NCT00257660|363591343|FG000|Overall Study|Lack of Efficacy|5|||
105433054|NCT00257660|363591344|FG001|Overall Study|Lack of Efficacy|23|||
105433055|NCT00257660|363591343|FG000|Overall Study|Withdrawal by Subject|2|||
105433056|NCT00257660|363591344|FG001|Overall Study|Withdrawal by Subject|0|||
105433057|NCT00257660|363591343|FG000|Overall Study|Lost to Follow-up|1|||
105433058|NCT00257660|363591344|FG001|Overall Study|Lost to Follow-up|0|||
105433059|NCT00257660|363591343|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
105433060|NCT00257660|363591344|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
105433061|NCT00257660|363591343|FG000|Overall Study|No longer wanted to do blood draws|1|||
105433062|NCT00257660|363591344|FG001|Overall Study|No longer wanted to do blood draws|0|||
105433063|NCT00491608|363591345|FG000|Overall Study|Death|2|||
105433064|NCT00491608|363591345|FG000|Overall Study|Withdrawal by Subject|1|||
105433065|NCT00552760|363591348|FG000|Overall Study|Adverse Event|3|||
105433066|NCT00552760|363591349|FG001|Overall Study|Adverse Event|5|||
105433067|NCT00552760|363591348|FG000|Overall Study|Relapsed- Depressed Event|10|||
105433068|NCT00552760|363591349|FG001|Overall Study|Relapsed- Depressed Event|16|||
105433069|NCT00552760|363591348|FG000|Overall Study|Relapse- Manic Event|3|||
105433070|NCT00552760|363591349|FG001|Overall Study|Relapse- Manic Event|3|||
105433071|NCT00552760|363591348|FG000|Overall Study|Relapsed- Mixed Event|3|||
105433072|NCT00552760|363591349|FG001|Overall Study|Relapsed- Mixed Event|5|||
105433073|NCT00552760|363591348|FG000|Overall Study|Protocol Violation|0|||
105433074|NCT00552760|363591349|FG001|Overall Study|Protocol Violation|1|||
105433075|NCT00552760|363591348|FG000|Overall Study|Lost to Follow-up|1|||
105433076|NCT00552760|363591349|FG001|Overall Study|Lost to Follow-up|1|||
105433077|NCT00552760|363591348|FG000|Overall Study|Non-compliance|1|||
105433078|NCT00552760|363591349|FG001|Overall Study|Non-compliance|1|||
105433079|NCT00552760|363591348|FG000|Overall Study|Medical Condition|1|||
105433080|NCT00552760|363591349|FG001|Overall Study|Medical Condition|1|||
105433081|NCT00552760|363591348|FG000|Overall Study|Withdrawal by Subject|3|||
105433082|NCT00552760|363591349|FG001|Overall Study|Withdrawal by Subject|0|||
105433083|NCT00552760|363591348|FG000|Overall Study|Medication Change|1|||
105433084|NCT00552760|363591349|FG001|Overall Study|Medication Change|0|||
105433085|NCT00249613|363591350|FG000|12 Month Follow-up|Death|1|||
105433086|NCT00249613|363591351|FG001|12 Month Follow-up|Death|1|||
105433087|NCT00249613|363591350|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
105433088|NCT00249613|363591351|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
105433089|NCT00249613|363591350|FG000|12 Month Follow-up|Lost to Follow-up|10|||
105433090|NCT00249613|363591351|FG001|12 Month Follow-up|Lost to Follow-up|8|||
105433091|NCT00521222|363591352|FG000|Overall Study|Lost to Follow-up|0|||
105433092|NCT00521222|363591353|FG001|Overall Study|Lost to Follow-up|0|||
105433093|NCT00521222|363591354|FG002|Overall Study|Lost to Follow-up|1|||
105433094|NCT00521222|363591355|FG003|Overall Study|Lost to Follow-up|1|||
105433095|NCT00521222|363591352|FG000|Overall Study|Withdrawal by Subject|0|||
105433096|NCT00521222|363591353|FG001|Overall Study|Withdrawal by Subject|0|||
105433097|NCT00521222|363591354|FG002|Overall Study|Withdrawal by Subject|2|||
105433098|NCT00521222|363591355|FG003|Overall Study|Withdrawal by Subject|0|||
105433099|NCT00521222|363591352|FG000|Overall Study|Physician Decision|0|||
105433100|NCT00521222|363591353|FG001|Overall Study|Physician Decision|1|||
105433101|NCT00521222|363591354|FG002|Overall Study|Physician Decision|0|||
105433102|NCT00521222|363591355|FG003|Overall Study|Physician Decision|1|||
105433103|NCT03834220|363591366|FG000|Overall Study|Adverse Event|1|||
105433104|NCT03834220|363591367|FG001|Overall Study|Adverse Event|0|||
105433105|NCT03834220|363591368|FG002|Overall Study|Adverse Event|0|||
105433106|NCT03834220|363591366|FG000|Overall Study|Death|8|||
105433107|NCT03834220|363591367|FG001|Overall Study|Death|1|||
105433108|NCT03834220|363591368|FG002|Overall Study|Death|17|||
105433109|NCT03834220|363591366|FG000|Overall Study|Reason not Specified|9|||
105433110|NCT03834220|363591367|FG001|Overall Study|Reason not Specified|0|||
105433111|NCT03834220|363591368|FG002|Overall Study|Reason not Specified|6|||
105433112|NCT03834220|363591366|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
105433113|NCT03834220|363591367|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
105433114|NCT03834220|363591368|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
105433115|NCT03834220|363591366|FG000|Overall Study|Withdrawal of Consent|2|||
105433116|NCT03834220|363591367|FG001|Overall Study|Withdrawal of Consent|2|||
105433117|NCT03834220|363591368|FG002|Overall Study|Withdrawal of Consent|2|||
105433118|NCT02831933|363593207|FG000|Overall Study|Physician Decision|11|||
105433119|NCT00837759|363593208|FG000|Overall Study|Protocol Violation|3|||
105433120|NCT00837759|363593208|FG000|Overall Study|Lost to Follow-up|1|||
105433121|NCT01276223|363593209|FG000|Overall Study|Adverse Event|7|||
105433122|NCT01276223|363593210|FG001|Overall Study|Adverse Event|4|||
105433123|NCT01276223|363593211|FG002|Overall Study|Adverse Event|1|||
105433124|NCT01276223|363593209|FG000|Overall Study|Lost to Follow-up|0|||
105433125|NCT01276223|363593210|FG001|Overall Study|Lost to Follow-up|0|||
105433126|NCT01276223|363593211|FG002|Overall Study|Lost to Follow-up|1|||
105433127|NCT01276223|363593209|FG000|Overall Study|Other|0|||
105433128|NCT01276223|363593210|FG001|Overall Study|Other|0|||
105433129|NCT01276223|363593211|FG002|Overall Study|Other|1|||
105433130|NCT01276223|363593209|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
105433131|NCT01276223|363593210|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
105433132|NCT01276223|363593211|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
105433133|NCT01276223|363593209|FG000|Overall Study|Protocol Violation|1|||
105433134|NCT01276223|363593210|FG001|Overall Study|Protocol Violation|0|||
105433135|NCT01276223|363593211|FG002|Overall Study|Protocol Violation|0|||
105433136|NCT00802893|363593214|FG000|Overall Study|study terminated|3|||
105433137|NCT02868229|363593215|FG000|Overall Study|Adverse Event|1|||
105433138|NCT02868229|363593216|FG001|Overall Study|Adverse Event|0|||
105502651|NCT00868608|363850996|FG000|Overall Study|Withdrawal by Subject|3|||
105433139|NCT02868229|363593217|FG002|Overall Study|Adverse Event|0|||
105433140|NCT02868229|363593218|FG003|Overall Study|Adverse Event|1|||
105433141|NCT02868229|363593215|FG000|Overall Study|Death|0|||
105433142|NCT02868229|363593216|FG001|Overall Study|Death|0|||
105433143|NCT02868229|363593217|FG002|Overall Study|Death|1|||
105433144|NCT02868229|363593218|FG003|Overall Study|Death|1|||
105433145|NCT02868229|363593215|FG000|Overall Study|Missed dose|0|||
105433146|NCT02868229|363593216|FG001|Overall Study|Missed dose|0|||
105433147|NCT02868229|363593217|FG002|Overall Study|Missed dose|0|||
105433148|NCT02868229|363593218|FG003|Overall Study|Missed dose|3|||
105433149|NCT00680368|363593221|FG000|Overall Study|not supervised, not eligible|15|||
105433150|NCT01146288|363593222|FG000|First Intervention(1 Day)|Adverse Event|0|||
105433151|NCT01146288|363593223|FG001|First Intervention(1 Day)|Adverse Event|1|||
105433152|NCT03316950|363593225|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
105433153|NCT03316950|363593226|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
105433154|NCT03316950|363593227|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
105433155|NCT03316950|363593228|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
105433156|NCT03316950|363593225|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
105433157|NCT03316950|363593226|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
105433158|NCT03316950|363593227|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
105433159|NCT03316950|363593228|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
105433160|NCT03316950|363593225|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
105433161|NCT03316950|363593226|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
105433162|NCT03316950|363593227|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
105433163|NCT03316950|363593228|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
105433164|NCT01639755|363593231|FG000|Overall Study|Study Ongoing|15|||
105433165|NCT01639755|363593231|FG000|Overall Study|Patient had device explantation|4|||
105433166|NCT03629912|363593235|FG000|Overall Study|Lost to Follow-up|19|||
105433167|NCT03629912|363593236|FG001|Overall Study|Lost to Follow-up|7|||
105433168|NCT03629912|363593237|FG002|Overall Study|Lost to Follow-up|5|||
105433169|NCT03629912|363593238|FG003|Overall Study|Lost to Follow-up|1|||
105433170|NCT03629912|363593235|FG000|Overall Study|Withdrawal by Subject|6|||
105433171|NCT03629912|363593236|FG001|Overall Study|Withdrawal by Subject|0|||
105433172|NCT03629912|363593237|FG002|Overall Study|Withdrawal by Subject|1|||
105433173|NCT03629912|363593238|FG003|Overall Study|Withdrawal by Subject|2|||
105433174|NCT03629912|363593235|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
105433175|NCT03629912|363593236|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
105433176|NCT03629912|363593237|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
105433177|NCT03629912|363593238|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
105433178|NCT03629912|363593235|FG000|Overall Study|Death|1|||
105433179|NCT03629912|363593236|FG001|Overall Study|Death|0|||
105433180|NCT03629912|363593237|FG002|Overall Study|Death|0|||
105433181|NCT03629912|363593238|FG003|Overall Study|Death|0|||
105433182|NCT00687609|363593239|FG000|Overall Study|Physician Decision|1|||
105433183|NCT00687609|363593239|FG000|Overall Study|Withdrawal by Subject|2|||
105433184|NCT01475162|363593240|FG000|Overall Study|Physician Decision|1|||
105433185|NCT01475162|363593240|FG000|Overall Study|Death|10|||
105433186|NCT01475162|363593240|FG000|Overall Study|Study closed for safety|3|||
105433187|NCT00903331|363593241|FG000|Overall Study|Death|4|||
105433188|NCT00903331|363593242|FG001|Overall Study|Death|8|||
105433189|NCT00903331|363593241|FG000|Overall Study|Withdrawal of consent|1|||
105433190|NCT00903331|363593242|FG001|Overall Study|Withdrawal of consent|8|||
105433191|NCT00903331|363593241|FG000|Overall Study|Lung transplant|0|||
105433192|NCT00903331|363593242|FG001|Overall Study|Lung transplant|2|||
105433193|NCT00025155|363593245|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
105433194|NCT00025155|363593245|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
105433195|NCT00413374|363593246|FG000|Overall Study|Ineligible due to screening criteria.|3|||
105433196|NCT00413374|363593247|FG001|Overall Study|Ineligible due to screening criteria.|0|||
105433197|NCT00413374|363593246|FG000|Overall Study|Adverse Event|1|||
105433198|NCT00413374|363593247|FG001|Overall Study|Adverse Event|0|||
105433199|NCT00413374|363593246|FG000|Overall Study|Lost to Follow-up|1|||
105433200|NCT00413374|363593247|FG001|Overall Study|Lost to Follow-up|0|||
105433201|NCT00413374|363593246|FG000|Overall Study|Surgery|1|||
105433202|NCT00413374|363593247|FG001|Overall Study|Surgery|0|||
105433203|NCT01571453|363593249|FG000|Overall Study|Adverse Event|14|||
105433204|NCT01571453|363593250|FG001|Overall Study|Adverse Event|32|||
105433205|NCT01571453|363593249|FG000|Overall Study|Lack of Efficacy|8|||
105433206|NCT01571453|363593250|FG001|Overall Study|Lack of Efficacy|3|||
105433207|NCT01571453|363593249|FG000|Overall Study|Non-compliance|2|||
105433208|NCT01571453|363593250|FG001|Overall Study|Non-compliance|4|||
105433209|NCT01571453|363593249|FG000|Overall Study|Protocol Violation|1|||
105433210|NCT01571453|363593250|FG001|Overall Study|Protocol Violation|5|||
105433211|NCT01571453|363593249|FG000|Overall Study|Withdrawal of consent|5|||
105433212|NCT01571453|363593250|FG001|Overall Study|Withdrawal of consent|13|||
105433213|NCT01571453|363593249|FG000|Overall Study|Lost to Follow-up|4|||
105433214|NCT01571453|363593250|FG001|Overall Study|Lost to Follow-up|2|||
105433215|NCT01571453|363593249|FG000|Overall Study|Administrative or other reason(s)|4|||
105433216|NCT01571453|363593250|FG001|Overall Study|Administrative or other reason(s)|3|||
105433217|NCT00710385|363593255|FG000|Overall Study|Did not qualify|1|||
105433218|NCT00710385|363593255|FG000|Overall Study|Withdrawal by Subject|1|||
105433219|NCT00710385|363593255|FG000|Overall Study|Undisclosed back pain|1|||
105433220|NCT00710385|363593255|FG000|Overall Study|Physician Decision|1|||
105433221|NCT00710385|363593255|FG000|Overall Study|Undisclosed excessive methadone use|1|||
105433222|NCT04598269|363593258|FG000|Overall Study|Adverse Event|0|||
105433223|NCT04598269|363593259|FG001|Overall Study|Adverse Event|3|||
105433224|NCT04598269|363593258|FG000|Overall Study|Withdrawal by Subject|1|||
105433225|NCT04598269|363593259|FG001|Overall Study|Withdrawal by Subject|4|||
105433226|NCT04598269|363593258|FG000|Overall Study|Lost to Follow-up|1|||
105433227|NCT04598269|363593259|FG001|Overall Study|Lost to Follow-up|0|||
105433228|NCT04598269|363593258|FG000|Overall Study|Not Treated|2|||
105433229|NCT04598269|363593259|FG001|Overall Study|Not Treated|0|||
105433230|NCT00424190|363593260|FG000|Overall Study|Withdrew consent|3|||
105433231|NCT00424190|363593261|FG001|Overall Study|Withdrew consent|4|||
105433232|NCT00424190|363593260|FG000|Overall Study|Death|3|||
105433233|NCT00424190|363593261|FG001|Overall Study|Death|0|||
105433234|NCT00424190|363593260|FG000|Overall Study|Noncompliance|1|||
105433235|NCT00424190|363593261|FG001|Overall Study|Noncompliance|2|||
105433236|NCT00424190|363593260|FG000|Overall Study|Request of sponsor or investigator|0|||
105433237|NCT00424190|363593261|FG001|Overall Study|Request of sponsor or investigator|2|||
105433238|NCT00424190|363593260|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
105433239|NCT00424190|363593261|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
105433240|NCT00424190|363593260|FG000|Overall Study|Other|15|||
105433241|NCT00424190|363593261|FG001|Overall Study|Other|21|||
105433242|NCT02966015|363593263|FG000|Inclusion Visit|did not answer questionnaire|8|||
105433243|NCT02966015|363593264|FG001|Inclusion Visit|did not answer questionnaire|3|||
105433244|NCT03040986|363593269|FG000|Overall Study|Hospice|1|||
105433245|NCT03040986|363593270|FG001|Overall Study|Hospice|0|||
105433246|NCT03040986|363593269|FG000|Overall Study|Adverse Event|2|||
105433247|NCT03040986|363593270|FG001|Overall Study|Adverse Event|1|||
105433248|NCT03040986|363593269|FG000|Overall Study|Disease progression on study|3|||
105433249|NCT03040986|363593270|FG001|Overall Study|Disease progression on study|1|||
105433250|NCT00845065|363593272|FG000|Overall Study|Adverse Event|3|||
105433251|NCT00845065|363593273|FG001|Overall Study|Adverse Event|23|||
105433252|NCT00845065|363593272|FG000|Overall Study|Lack of Efficacy|43|||
105433253|NCT00845065|363593273|FG001|Overall Study|Lack of Efficacy|21|||
105433254|NCT00845065|363593272|FG000|Overall Study|Non-Medical Reasons|1|||
105433255|NCT00845065|363593273|FG001|Overall Study|Non-Medical Reasons|11|||
105433256|NCT02228096|363593277|FG000|Overall Study|Study terminated by Sponsor|24|||
105433257|NCT02228096|363593277|FG000|Overall Study|Lack of Efficacy|18|||
105433258|NCT02228096|363593277|FG000|Overall Study|Death|12|||
105433259|NCT02228096|363593277|FG000|Overall Study|Physician Decision|3|||
105433260|NCT02228096|363593277|FG000|Overall Study|Subject/guardian decision|2|||
105433261|NCT02228096|363593277|FG000|Overall Study|New therapy for study indication|1|||
105433262|NCT02228096|363593277|FG000|Overall Study|Enrolled, not infused|11|||
105433263|NCT00499746|363593278|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
105433264|NCT00499746|363593278|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
105433265|NCT00499746|363593278|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
105433266|NCT00499746|363593278|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
105433267|NCT01969721|363593279|FG000|Overall Study|Adverse Event|3|||
105433268|NCT01969721|363593280|FG001|Overall Study|Adverse Event|8|||
105433269|NCT01969721|363593281|FG002|Overall Study|Adverse Event|3|||
105433270|NCT01969721|363593282|FG003|Overall Study|Adverse Event|2|||
105433271|NCT01969721|363593279|FG000|Overall Study|Lack of Efficacy|0|||
105433272|NCT01969721|363593280|FG001|Overall Study|Lack of Efficacy|0|||
105433273|NCT01969721|363593281|FG002|Overall Study|Lack of Efficacy|1|||
105433274|NCT01969721|363593282|FG003|Overall Study|Lack of Efficacy|0|||
105433275|NCT01969721|363593279|FG000|Overall Study|Non compliant with protocol|1|||
105433276|NCT01969721|363593280|FG001|Overall Study|Non compliant with protocol|1|||
105433277|NCT01969721|363593281|FG002|Overall Study|Non compliant with protocol|0|||
105433278|NCT01969721|363593282|FG003|Overall Study|Non compliant with protocol|2|||
105433279|NCT01969721|363593279|FG000|Overall Study|Other not defined above|0|||
105433280|NCT01969721|363593280|FG001|Overall Study|Other not defined above|2|||
105433281|NCT01969721|363593281|FG002|Overall Study|Other not defined above|0|||
105433282|NCT01969721|363593282|FG003|Overall Study|Other not defined above|0|||
105433283|NCT01969721|363593279|FG000|Overall Study|Discontinued during washout periods.|0|||
105433284|NCT01969721|363593280|FG001|Overall Study|Discontinued during washout periods.|1|||
105433285|NCT01969721|363593281|FG002|Overall Study|Discontinued during washout periods.|1|||
105433286|NCT01969721|363593282|FG003|Overall Study|Discontinued during washout periods.|2|||
105433287|NCT02117349|363593284|FG000|Overall Study|Withdrawal by Subject|1|||
105433288|NCT02117349|363593285|FG001|Overall Study|Withdrawal by Subject|0|||
105433289|NCT02117349|363593284|FG000|Overall Study|Lost to Follow-up|1|||
105433290|NCT02117349|363593285|FG001|Overall Study|Lost to Follow-up|1|||
105433291|NCT02117349|363593284|FG000|Overall Study|Death|1|||
105433292|NCT02117349|363593285|FG001|Overall Study|Death|0|||
105433293|NCT02273960|363593286|FG000|Short Term Period|Lost to Follow-up|1|||
105433294|NCT02273960|363593287|FG001|Short Term Period|Lost to Follow-up|0|||
105433295|NCT02273960|363593288|FG002|Short Term Period|Lost to Follow-up|0|||
105433296|NCT02273960|363593289|FG003|Short Term Period|Lost to Follow-up|0|||
105433297|NCT02273960|363593286|FG000|Short Term Period|Lack of Efficacy|0|||
105433298|NCT02273960|363593287|FG001|Short Term Period|Lack of Efficacy|0|||
105433299|NCT02273960|363593288|FG002|Short Term Period|Lack of Efficacy|0|||
105433300|NCT02273960|363593289|FG003|Short Term Period|Lack of Efficacy|1|||
105433301|NCT02273960|363593286|FG000|Short Term Period|ST complete, not entering LTE|4|||
105433302|NCT02273960|363593287|FG001|Short Term Period|ST complete, not entering LTE|6|||
105433303|NCT02273960|363593288|FG002|Short Term Period|ST complete, not entering LTE|4|||
105433304|NCT02273960|363593289|FG003|Short Term Period|ST complete, not entering LTE|5|||
105433305|NCT02273960|363593286|FG000|Long Term Extension|Death|0|||
105433306|NCT02273960|363593287|FG001|Long Term Extension|Death|0|||
105433307|NCT02273960|363593288|FG002|Long Term Extension|Death|0|||
105433308|NCT02273960|363593289|FG003|Long Term Extension|Death|1|||
105433309|NCT01012323|363593290|FG000|Overall Study|Investigator Judgment|1|||
105433310|NCT00495755|363593291|FG000|Overall Study|Adverse Event|3|||
105433311|NCT01440881|363593294|FG000|Overall Study|Death|0|||
105433312|NCT01440881|363593295|FG001|Overall Study|Death|1|||
105433313|NCT02265796|363593296|FG000|Overall Study|Death|1|||
105433314|NCT02265796|363593297|FG001|Overall Study|Death|0|||
105433315|NCT02265796|363593296|FG000|Overall Study|started on excluded medication|1|||
105433316|NCT02265796|363593297|FG001|Overall Study|started on excluded medication|0|||
105433317|NCT02265796|363593296|FG000|Overall Study|Withdrawal by Subject|1|||
105433318|NCT02265796|363593297|FG001|Overall Study|Withdrawal by Subject|1|||
105433319|NCT02477553|363593298|FG000|Overall Study|Screening up-to-date|12|||
105433320|NCT02477553|363593299|FG001|Overall Study|Screening up-to-date|13|||
105433321|NCT02477553|363593298|FG000|Overall Study|No MD visit|1|||
105433322|NCT02477553|363593299|FG001|Overall Study|No MD visit|1|||
105433323|NCT02477553|363593298|FG000|Overall Study|Workup consistent w/CRC|1|||
105433324|NCT02477553|363593299|FG001|Overall Study|Workup consistent w/CRC|1|||
105433325|NCT02477553|363593298|FG000|Overall Study|Technical issues with intervention|2|||
105433326|NCT02477553|363593299|FG001|Overall Study|Technical issues with intervention|0|||
105433327|NCT02477553|363593298|FG000|Overall Study|Elevated risk for CRC|2|||
105433328|NCT02477553|363593299|FG001|Overall Study|Elevated risk for CRC|2|||
105433329|NCT02477553|363593298|FG000|Overall Study|MD advised against screening|1|||
105433330|NCT02477553|363593299|FG001|Overall Study|MD advised against screening|3|||
105433331|NCT02477553|363593298|FG000|Overall Study|patient deceased|1|||
105433332|NCT02477553|363593299|FG001|Overall Study|patient deceased|0|||
105433333|NCT02745535|363593302|FG000|Overall Study|Death|1|||
105433334|NCT02745535|363593302|FG000|Overall Study|Adverse Event|3|||
105502652|NCT00868608|363850997|FG001|Overall Study|Withdrawal by Subject|1|||
105502653|NCT00868608|363850998|FG002|Overall Study|Withdrawal by Subject|0|||
105502654|NCT00868608|363850996|FG000|Overall Study|Lost to Follow-up|3|||
105502655|NCT00868608|363850997|FG001|Overall Study|Lost to Follow-up|0|||
105502656|NCT00868608|363850998|FG002|Overall Study|Lost to Follow-up|1|||
105502657|NCT00868608|363850996|FG000|Overall Study|Death|16|||
105502658|NCT00868608|363850997|FG001|Overall Study|Death|2|||
105502659|NCT00868608|363850998|FG002|Overall Study|Death|4|||
105502660|NCT00868608|363850996|FG000|Overall Study|Other - Unspecified|1|||
105502661|NCT00868608|363850997|FG001|Overall Study|Other - Unspecified|0|||
105502662|NCT00868608|363850998|FG002|Overall Study|Other - Unspecified|0|||
105502663|NCT00911547|363850999|FG000|Overall Study|Adverse Event|8|||
105502664|NCT00911547|363851000|FG001|Overall Study|Adverse Event|27|||
105502665|NCT00911547|363851001|FG002|Overall Study|Adverse Event|11|||
105502666|NCT00911547|363851002|FG003|Overall Study|Adverse Event|6|||
105502667|NCT00911547|363850999|FG000|Overall Study|Lost to Follow-up|0|||
105502668|NCT00911547|363851000|FG001|Overall Study|Lost to Follow-up|0|||
105502669|NCT00911547|363851001|FG002|Overall Study|Lost to Follow-up|2|||
105502670|NCT00911547|363851002|FG003|Overall Study|Lost to Follow-up|1|||
105502671|NCT00911547|363850999|FG000|Overall Study|Protocol Violation|0|||
105502672|NCT00911547|363851000|FG001|Overall Study|Protocol Violation|5|||
105502673|NCT00911547|363851001|FG002|Overall Study|Protocol Violation|5|||
105502674|NCT00911547|363851002|FG003|Overall Study|Protocol Violation|1|||
105502675|NCT00911547|363850999|FG000|Overall Study|Withdrawal by Subject|3|||
105502676|NCT00911547|363851000|FG001|Overall Study|Withdrawal by Subject|10|||
105502677|NCT00911547|363851001|FG002|Overall Study|Withdrawal by Subject|4|||
105502678|NCT00911547|363851002|FG003|Overall Study|Withdrawal by Subject|8|||
105502679|NCT01128842|363851003|FG000|Overall Study|Adverse Event|1|||
105502680|NCT01128842|363851003|FG000|Overall Study|Disease Progression|6|||
105502681|NCT00667875|363851004|FG000|Overall Study|Adverse Event|0|||
105502682|NCT00667875|363851005|FG001|Overall Study|Adverse Event|2|||
105502683|NCT00667875|363851006|FG002|Overall Study|Adverse Event|6|||
105502684|NCT00667875|363851004|FG000|Overall Study|Withdrawal by Subject|10|||
105502685|NCT00667875|363851005|FG001|Overall Study|Withdrawal by Subject|9|||
105433335|NCT02745535|363593302|FG000|Overall Study|Lost to Follow-up|2|||
105433336|NCT01789606|363593303|FG000|Overall Study|Participant not Purchased the Product|0|||
105433337|NCT01789606|363593304|FG001|Overall Study|Participant not Purchased the Product|20|||
105433338|NCT01789606|363593303|FG000|Overall Study|Withdrawal by Subject|0|||
105433339|NCT01789606|363593304|FG001|Overall Study|Withdrawal by Subject|1|||
105502686|NCT00667875|363851006|FG002|Overall Study|Withdrawal by Subject|7|||
105502687|NCT02369016|363851007|FG000|Overall Study|AE associated with clinical disease progression|2|||
105502688|NCT02369016|363851008|FG001|Overall Study|AE associated with clinical disease progression|1|||
105502689|NCT02369016|363851007|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
105502690|NCT02369016|363851008|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
105502691|NCT02369016|363851007|FG000|Overall Study|Progressive disease - clinical progression|1|||
105502692|NCT02369016|363851008|FG001|Overall Study|Progressive disease - clinical progression|4|||
105502693|NCT02369016|363851007|FG000|Overall Study|withdrawal by patient|4|||
105502694|NCT02369016|363851008|FG001|Overall Study|withdrawal by patient|0|||
105502695|NCT02369016|363851007|FG000|Overall Study|Progressive disease - radiological progression|6|||
105502696|NCT02369016|363851008|FG001|Overall Study|Progressive disease - radiological progression|2|||
105502697|NCT00365508|363851020|FG000|Overall Study|Lost to Follow-up|139|||
105502698|NCT00365508|363851021|FG001|Overall Study|Lost to Follow-up|154|||
105502699|NCT01817530|363851024|FG000|Overall Study|Exclusionary Medication Received|0|||
105502700|NCT01817530|363851025|FG001|Overall Study|Exclusionary Medication Received|0|||
105502701|NCT01817530|363851026|FG002|Overall Study|Exclusionary Medication Received|0|||
105502702|NCT01817530|363851027|FG003|Overall Study|Exclusionary Medication Received|0|||
105502703|NCT01817530|363851028|FG004|Overall Study|Exclusionary Medication Received|1|||
105502704|NCT01817530|363851029|FG005|Overall Study|Exclusionary Medication Received|0|||
105502705|NCT01817530|363851030|FG006|Overall Study|Exclusionary Medication Received|0|||
105502706|NCT01817530|363851031|FG007|Overall Study|Exclusionary Medication Received|0|||
105502707|NCT01817530|363851024|FG000|Overall Study|Adverse Event|6|||
105502708|NCT01817530|363851025|FG001|Overall Study|Adverse Event|3|||
105502709|NCT01817530|363851026|FG002|Overall Study|Adverse Event|2|||
105502710|NCT01817530|363851027|FG003|Overall Study|Adverse Event|5|||
105502711|NCT01817530|363851028|FG004|Overall Study|Adverse Event|0|||
105502712|NCT01817530|363851029|FG005|Overall Study|Adverse Event|10|||
105502713|NCT01817530|363851030|FG006|Overall Study|Adverse Event|5|||
105502714|NCT01817530|363851031|FG007|Overall Study|Adverse Event|8|||
105502715|NCT01817530|363851024|FG000|Overall Study|Subject Noncompliant|3|||
105502716|NCT01817530|363851025|FG001|Overall Study|Subject Noncompliant|1|||
105502717|NCT01817530|363851026|FG002|Overall Study|Subject Noncompliant|0|||
105502718|NCT01817530|363851027|FG003|Overall Study|Subject Noncompliant|4|||
105502719|NCT01817530|363851028|FG004|Overall Study|Subject Noncompliant|0|||
105502720|NCT01817530|363851029|FG005|Overall Study|Subject Noncompliant|1|||
105502721|NCT01817530|363851030|FG006|Overall Study|Subject Noncompliant|1|||
105502722|NCT01817530|363851031|FG007|Overall Study|Subject Noncompliant|1|||
105502723|NCT01817530|363851024|FG000|Overall Study|Lack of Efficacy|1|||
105502724|NCT01817530|363851025|FG001|Overall Study|Lack of Efficacy|0|||
105502725|NCT01817530|363851026|FG002|Overall Study|Lack of Efficacy|0|||
105502726|NCT01817530|363851027|FG003|Overall Study|Lack of Efficacy|0|||
105502727|NCT01817530|363851028|FG004|Overall Study|Lack of Efficacy|0|||
105502728|NCT01817530|363851029|FG005|Overall Study|Lack of Efficacy|1|||
105502729|NCT01817530|363851030|FG006|Overall Study|Lack of Efficacy|0|||
105502730|NCT01817530|363851031|FG007|Overall Study|Lack of Efficacy|1|||
105502731|NCT01817530|363851024|FG000|Overall Study|Pregnancy|0|||
105502732|NCT01817530|363851025|FG001|Overall Study|Pregnancy|0|||
105502733|NCT01817530|363851026|FG002|Overall Study|Pregnancy|0|||
105502734|NCT01817530|363851027|FG003|Overall Study|Pregnancy|0|||
105502735|NCT01817530|363851028|FG004|Overall Study|Pregnancy|0|||
105502736|NCT01817530|363851029|FG005|Overall Study|Pregnancy|1|||
105502737|NCT01817530|363851030|FG006|Overall Study|Pregnancy|0|||
105502738|NCT01817530|363851031|FG007|Overall Study|Pregnancy|0|||
105502739|NCT01817530|363851024|FG000|Overall Study|Other|0|||
105502740|NCT01817530|363851025|FG001|Overall Study|Other|1|||
105502741|NCT01817530|363851026|FG002|Overall Study|Other|0|||
105502742|NCT01817530|363851027|FG003|Overall Study|Other|0|||
105502743|NCT01817530|363851028|FG004|Overall Study|Other|1|||
105502744|NCT01817530|363851029|FG005|Overall Study|Other|0|||
105502745|NCT01817530|363851030|FG006|Overall Study|Other|5|||
105502746|NCT01817530|363851031|FG007|Overall Study|Other|0|||
105502747|NCT01817530|363851024|FG000|Overall Study|Surgery or Invasive Intervention|1|||
105502748|NCT01817530|363851025|FG001|Overall Study|Surgery or Invasive Intervention|0|||
105502749|NCT01817530|363851026|FG002|Overall Study|Surgery or Invasive Intervention|0|||
105502750|NCT01817530|363851027|FG003|Overall Study|Surgery or Invasive Intervention|0|||
105502751|NCT01817530|363851028|FG004|Overall Study|Surgery or Invasive Intervention|1|||
105502752|NCT01817530|363851029|FG005|Overall Study|Surgery or Invasive Intervention|1|||
105502753|NCT01817530|363851030|FG006|Overall Study|Surgery or Invasive Intervention|1|||
105502754|NCT01817530|363851031|FG007|Overall Study|Surgery or Invasive Intervention|0|||
105502755|NCT01817530|363851024|FG000|Overall Study|Consent Withdrawn by Subject|3|||
105502756|NCT01817530|363851025|FG001|Overall Study|Consent Withdrawn by Subject|4|||
105502757|NCT01817530|363851026|FG002|Overall Study|Consent Withdrawn by Subject|7|||
105502758|NCT01817530|363851027|FG003|Overall Study|Consent Withdrawn by Subject|3|||
105502759|NCT01817530|363851028|FG004|Overall Study|Consent Withdrawn by Subject|5|||
105502760|NCT01817530|363851029|FG005|Overall Study|Consent Withdrawn by Subject|3|||
105502761|NCT01817530|363851030|FG006|Overall Study|Consent Withdrawn by Subject|3|||
105502762|NCT01817530|363851031|FG007|Overall Study|Consent Withdrawn by Subject|10|||
105502763|NCT01817530|363851024|FG000|Overall Study|Lost to Follow-up|1|||
105502764|NCT01817530|363851025|FG001|Overall Study|Lost to Follow-up|4|||
105502765|NCT01817530|363851026|FG002|Overall Study|Lost to Follow-up|2|||
105502766|NCT01817530|363851027|FG003|Overall Study|Lost to Follow-up|1|||
105502767|NCT01817530|363851028|FG004|Overall Study|Lost to Follow-up|3|||
105502768|NCT01817530|363851029|FG005|Overall Study|Lost to Follow-up|2|||
105502769|NCT01817530|363851030|FG006|Overall Study|Lost to Follow-up|8|||
105502770|NCT01817530|363851031|FG007|Overall Study|Lost to Follow-up|4|||
105502771|NCT03846804|363851032|FG000|Overall Study|Refused blood draw|1|||
105502772|NCT03846804|363851032|FG000|Overall Study|Protocol Violation|1|||
105502773|NCT02538029|363851033|FG000|Overall Study|unable to complete cognitive assessments|1|||
105502774|NCT02538029|363851034|FG001|Overall Study|unable to complete cognitive assessments|0|||
105502775|NCT02538029|363851035|FG002|Overall Study|unable to complete cognitive assessments|1|||
105502776|NCT00679432|363851036|FG000|Overall Study|Adverse Event|5|||
105502777|NCT00679432|363851037|FG001|Overall Study|Adverse Event|6|||
105502778|NCT00679432|363851038|FG002|Overall Study|Adverse Event|10|||
105502779|NCT00679432|363851039|FG003|Overall Study|Adverse Event|7|||
105502780|NCT00679432|363851036|FG000|Overall Study|Protocol Violation|1|||
105502781|NCT00679432|363851037|FG001|Overall Study|Protocol Violation|1|||
105502782|NCT00679432|363851038|FG002|Overall Study|Protocol Violation|2|||
105502783|NCT00679432|363851039|FG003|Overall Study|Protocol Violation|1|||
105502784|NCT00679432|363851036|FG000|Overall Study|Withdrawal by Subject|8|||
105502785|NCT00679432|363851037|FG001|Overall Study|Withdrawal by Subject|11|||
105502786|NCT00679432|363851038|FG002|Overall Study|Withdrawal by Subject|10|||
105502787|NCT00679432|363851039|FG003|Overall Study|Withdrawal by Subject|9|||
105502788|NCT00679432|363851036|FG000|Overall Study|Lost to Follow-up|1|||
105502789|NCT00679432|363851037|FG001|Overall Study|Lost to Follow-up|5|||
105502790|NCT00679432|363851038|FG002|Overall Study|Lost to Follow-up|4|||
105502791|NCT00679432|363851039|FG003|Overall Study|Lost to Follow-up|2|||
105502792|NCT00679432|363851036|FG000|Overall Study|Physician Decision|3|||
105502793|NCT00679432|363851037|FG001|Overall Study|Physician Decision|2|||
105502794|NCT00679432|363851038|FG002|Overall Study|Physician Decision|2|||
105502795|NCT00679432|363851039|FG003|Overall Study|Physician Decision|2|||
105502796|NCT00679432|363851036|FG000|Overall Study|Sponsor decision|1|||
105502797|NCT00679432|363851037|FG001|Overall Study|Sponsor decision|0|||
105502798|NCT00679432|363851038|FG002|Overall Study|Sponsor decision|0|||
105502799|NCT00679432|363851039|FG003|Overall Study|Sponsor decision|0|||
105502800|NCT00679432|363851036|FG000|Overall Study|Lack of Efficacy|13|||
105502801|NCT00679432|363851037|FG001|Overall Study|Lack of Efficacy|9|||
105502802|NCT00679432|363851038|FG002|Overall Study|Lack of Efficacy|14|||
105502803|NCT00679432|363851039|FG003|Overall Study|Lack of Efficacy|8|||
105502804|NCT00679432|363851036|FG000|Overall Study|Infectious colitis, normal histology|5|||
105502805|NCT00679432|363851037|FG001|Overall Study|Infectious colitis, normal histology|4|||
105590493|NCT01908634|364162611|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
105590494|NCT01908634|364162611|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
105590495|NCT05790408|364162613|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
105433340|NCT01789606|363593303|FG000|Overall Study|Ineligible|6|||
105433341|NCT01789606|363593304|FG001|Overall Study|Ineligible|2|||
105590496|NCT01048788|364162614|FG000|Overall Study|Adverse Event|5|||
105590497|NCT01048788|364162615|FG001|Overall Study|Adverse Event|1|||
105433342|NCT01789606|363593303|FG000|Overall Study|Administrative Reasons|17|||
105433343|NCT01789606|363593304|FG001|Overall Study|Administrative Reasons|6|||
105433344|NCT01789606|363593303|FG000|Overall Study|No Study Medication Taken|0|||
105433345|NCT01789606|363593304|FG001|Overall Study|No Study Medication Taken|1|||
105433346|NCT01789606|363593303|FG000|Overall Study|Protocol Violation|0|||
105433347|NCT01789606|363593304|FG001|Overall Study|Protocol Violation|55|||
105433348|NCT01789606|363593303|FG000|Overall Study|Adverse Event|0|||
105433349|NCT01789606|363593304|FG001|Overall Study|Adverse Event|3|||
105433350|NCT01789606|363593303|FG000|Overall Study|Lost to Follow-up|0|||
105433351|NCT01789606|363593304|FG001|Overall Study|Lost to Follow-up|14|||
105433352|NCT01789606|363593303|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
105433353|NCT01789606|363593304|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
105433354|NCT00849108|363593305|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
105433355|NCT00849108|363593306|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
105502806|NCT00679432|363851038|FG002|Overall Study|Infectious colitis, normal histology|8|||
105502807|NCT00679432|363851039|FG003|Overall Study|Infectious colitis, normal histology|3|||
105502808|NCT00679432|363851036|FG000|Overall Study|Randomization error, return to prior Rx|0|||
105502809|NCT00679432|363851037|FG001|Overall Study|Randomization error, return to prior Rx|0|||
105433356|NCT00849108|363593305|FG000|Cohort 2 Efficacy|Adverse Event|0|||
105433357|NCT00849108|363593306|FG001|Cohort 2 Efficacy|Adverse Event|1|||
105502810|NCT00679432|363851038|FG002|Overall Study|Randomization error, return to prior Rx|3|||
105502811|NCT00679432|363851039|FG003|Overall Study|Randomization error, return to prior Rx|0|||
105502812|NCT01785069|363851040|FG000|Overall Study|Implanted with nonstudy device|1|||
105502813|NCT01785069|363851041|FG001|Overall Study|Implanted with nonstudy device|2|||
105502814|NCT01785069|363851042|FG002|Overall Study|Implanted with nonstudy device|1|||
105433358|NCT00849108|363593305|FG000|Cohort 2 Efficacy|Other|0|||
105433359|NCT00849108|363593306|FG001|Cohort 2 Efficacy|Other|9|||
105433360|NCT02925728|363593310|FG000|Overall Study|Death|3|||
105433361|NCT02925728|363593311|FG001|Overall Study|Death|5|||
105433362|NCT02925728|363593310|FG000|Overall Study|Physician Decision|1|||
105433363|NCT02925728|363593311|FG001|Overall Study|Physician Decision|0|||
105433364|NCT02925728|363593310|FG000|Overall Study|Withdrawal by Subject|1|||
105433365|NCT02925728|363593311|FG001|Overall Study|Withdrawal by Subject|0|||
105433366|NCT02963701|363593312|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
105433367|NCT02963701|363593313|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
105433368|NCT03480009|363593316|FG000|Overall Study|Lost to Follow-up|4|||
105433369|NCT03480009|363593317|FG001|Overall Study|Lost to Follow-up|5|||
105433370|NCT03480009|363593318|FG002|Overall Study|Lost to Follow-up|4|||
105433371|NCT03480009|363593319|FG003|Overall Study|Lost to Follow-up|0|||
105433372|NCT00637572|363593320|FG000|Overall Study|Adverse Event|1|||
105433373|NCT00637572|363593321|FG001|Overall Study|Adverse Event|2|||
105433374|NCT00637572|363593320|FG000|Overall Study|Death|0|||
105433375|NCT00637572|363593321|FG001|Overall Study|Death|1|||
105433376|NCT00637572|363593320|FG000|Overall Study|Lost to Follow-up|0|||
105433377|NCT00637572|363593321|FG001|Overall Study|Lost to Follow-up|1|||
105433378|NCT00637572|363593320|FG000|Overall Study|Physician Decision|1|||
105433379|NCT00637572|363593321|FG001|Overall Study|Physician Decision|1|||
105433380|NCT00637572|363593320|FG000|Overall Study|Withdrawal by Subject|0|||
105433381|NCT00637572|363593321|FG001|Overall Study|Withdrawal by Subject|2|||
105433382|NCT00637572|363593320|FG000|Overall Study|Illicit Drug Use|1|||
105433383|NCT00637572|363593321|FG001|Overall Study|Illicit Drug Use|0|||
105433384|NCT00896649|363593322|FG000|Overall Study|Physician Decision|1|||
105433385|NCT00896649|363593322|FG000|Overall Study|Pregnancy|1|||
105433386|NCT00896649|363593322|FG000|Overall Study|missing documentation|1|||
105433387|NCT00896649|363593322|FG000|Overall Study|technical difficulties|2|||
105433388|NCT01563172|363593323|FG000|Overall Study|Adverse Event|5|||
105433389|NCT01563172|363593323|FG000|Overall Study|Lost to Follow-up|2|||
105433390|NCT01563172|363593323|FG000|Overall Study|Other (Protocol deviation)|5|||
105433391|NCT01563172|363593323|FG000|Overall Study|Other (Not specified)|1|||
105433392|NCT03652675|363593324|FG000|Overall Study|Lost to Follow-up|4|||
105433393|NCT03652675|363593325|FG001|Overall Study|Lost to Follow-up|4|||
105433394|NCT00324233|363593332|FG000|First Period|unable to insert catheter|1|||
105433395|NCT00324233|363593333|FG001|First Period|unable to insert catheter|0|||
105433396|NCT00324233|363593332|FG000|Second Period|unable to insert catheter|1|||
105433397|NCT00324233|363593333|FG001|Second Period|unable to insert catheter|1|||
105433398|NCT00324233|363593332|FG000|Second Period|Protocol Violation|4|||
105433399|NCT00324233|363593333|FG001|Second Period|Protocol Violation|6|||
105433400|NCT00483002|363593334|FG000|Overall Study|Adverse Event|68|||
105433401|NCT00483002|363593334|FG000|Overall Study|Lack of Efficacy|555|||
105433402|NCT00483002|363593334|FG000|Overall Study|Lost to Follow-up|962|||
105433403|NCT00483002|363593334|FG000|Overall Study|Other|2|||
105433404|NCT00483002|363593334|FG000|Overall Study|Other|967|||
105433405|NCT01624090|363593335|FG000|Overall Study|DLT, taken off therapy|0|||
105433406|NCT01624090|363593336|FG001|Overall Study|DLT, taken off therapy|1|||
105433407|NCT01624090|363593337|FG002|Overall Study|DLT, taken off therapy|0|||
105433408|NCT01624090|363593338|FG003|Overall Study|DLT, taken off therapy|0|||
105433409|NCT01624090|363593335|FG000|Overall Study|Withdrew prior to treatment|0|||
105433410|NCT01624090|363593336|FG001|Overall Study|Withdrew prior to treatment|1|||
105433411|NCT01624090|363593337|FG002|Overall Study|Withdrew prior to treatment|0|||
105433412|NCT01624090|363593338|FG003|Overall Study|Withdrew prior to treatment|0|||
105433413|NCT01624090|363593335|FG000|Overall Study|Died on study|0|||
105433414|NCT01624090|363593336|FG001|Overall Study|Died on study|0|||
105433415|NCT01624090|363593337|FG002|Overall Study|Died on study|2|||
105433416|NCT01624090|363593338|FG003|Overall Study|Died on study|0|||
105433417|NCT01624090|363593335|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
105502815|NCT01785069|363851043|FG003|Overall Study|Implanted with nonstudy device|0|||
105502816|NCT01785069|363851040|FG000|Overall Study|Death|0|||
105502817|NCT01785069|363851041|FG001|Overall Study|Death|0|||
105433418|NCT01624090|363593336|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
105433419|NCT01624090|363593337|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
105433420|NCT01624090|363593338|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
105433421|NCT01624090|363593335|FG000|Overall Study|Dose escalated|0|||
105433422|NCT01624090|363593336|FG001|Overall Study|Dose escalated|0|||
105433423|NCT01624090|363593337|FG002|Overall Study|Dose escalated|3|||
105433424|NCT01624090|363593338|FG003|Overall Study|Dose escalated|0|||
105433425|NCT00772109|363593339|FG000|Overall Study|Serious adverse event|1|||
105433426|NCT00772109|363593340|FG001|Overall Study|Serious adverse event|0|||
105433427|NCT00772109|363593341|FG002|Overall Study|Serious adverse event|1|||
105433428|NCT00772109|363593342|FG003|Overall Study|Serious adverse event|0|||
105433429|NCT00772109|363593339|FG000|Overall Study|Protocol Violation|5|||
105433430|NCT00772109|363593340|FG001|Overall Study|Protocol Violation|8|||
105433431|NCT00772109|363593341|FG002|Overall Study|Protocol Violation|7|||
105433432|NCT00772109|363593342|FG003|Overall Study|Protocol Violation|6|||
105433433|NCT00772109|363593339|FG000|Overall Study|Lost to Follow-up|7|||
105433434|NCT00772109|363593340|FG001|Overall Study|Lost to Follow-up|3|||
105433435|NCT00772109|363593341|FG002|Overall Study|Lost to Follow-up|5|||
105433436|NCT00772109|363593342|FG003|Overall Study|Lost to Follow-up|9|||
105433437|NCT00772109|363593339|FG000|Overall Study|Withdrawal by Subject|8|||
105433438|NCT00772109|363593340|FG001|Overall Study|Withdrawal by Subject|8|||
105433439|NCT00772109|363593341|FG002|Overall Study|Withdrawal by Subject|6|||
105433440|NCT00772109|363593342|FG003|Overall Study|Withdrawal by Subject|16|||
105433441|NCT00752726|363593343|FG000|Overall Study|Lost to Follow-up|2|||
105433442|NCT00752726|363593344|FG001|Overall Study|Lost to Follow-up|1|||
105433443|NCT00752726|363593343|FG000|Overall Study|Adverse Event|3|||
105433444|NCT00752726|363593344|FG001|Overall Study|Adverse Event|0|||
105433445|NCT00752726|363593343|FG000|Overall Study|Withdrawal by Subject|5|||
105433446|NCT00752726|363593344|FG001|Overall Study|Withdrawal by Subject|10|||
105433447|NCT00752726|363593343|FG000|Overall Study|Other Reason|1|||
105433448|NCT00752726|363593344|FG001|Overall Study|Other Reason|2|||
105433449|NCT00626405|363593348|FG000|Overall Study|Deemed Ineligible|1|||
105433450|NCT00626405|363593349|FG001|Overall Study|Deemed Ineligible|0|||
105433451|NCT00626405|363593348|FG000|Overall Study|Withdrawal by Subject|0|||
105433452|NCT00626405|363593349|FG001|Overall Study|Withdrawal by Subject|1|||
105433453|NCT01264419|363593350|FG000|Overall Study|Lost to Follow-up|3|||
105433454|NCT01161537|363595304|FG000|Part B|Withdrawal by Subject|2|||
105433455|NCT01629953|363595311|FG000|Overall Study|Death|3|||
105433456|NCT01629953|363595312|FG001|Overall Study|Death|1|||
105433457|NCT01629953|363595311|FG000|Overall Study|Lost to Follow-up|10|||
105433458|NCT01629953|363595312|FG001|Overall Study|Lost to Follow-up|14|||
105433459|NCT00720343|363595315|FG000|Overall Study|Lost to Follow-up|1|||
105433460|NCT00720343|363595316|FG001|Overall Study|Lost to Follow-up|0|||
105433461|NCT00720343|363595315|FG000|Overall Study|Protocol Violation|0|||
105433462|NCT00720343|363595316|FG001|Overall Study|Protocol Violation|2|||
105433463|NCT02008773|363595317|FG000|Overall Study|Adverse Event|3|||
105433464|NCT02008773|363595318|FG001|Overall Study|Adverse Event|3|||
105433465|NCT02008773|363595319|FG002|Overall Study|Adverse Event|1|||
105433466|NCT02008773|363595320|FG003|Overall Study|Adverse Event|2|||
105433467|NCT02008773|363595317|FG000|Overall Study|Medication Non-compliance|2|||
105433468|NCT02008773|363595318|FG001|Overall Study|Medication Non-compliance|1|||
105433469|NCT02008773|363595319|FG002|Overall Study|Medication Non-compliance|3|||
105433470|NCT02008773|363595320|FG003|Overall Study|Medication Non-compliance|2|||
105433471|NCT02008773|363595317|FG000|Overall Study|Withdrawal by Subject|8|||
105433472|NCT02008773|363595318|FG001|Overall Study|Withdrawal by Subject|4|||
105433473|NCT02008773|363595319|FG002|Overall Study|Withdrawal by Subject|7|||
105433474|NCT02008773|363595320|FG003|Overall Study|Withdrawal by Subject|6|||
105433475|NCT02008773|363595317|FG000|Overall Study|Lost to Follow-up|0|||
105433476|NCT02008773|363595318|FG001|Overall Study|Lost to Follow-up|1|||
105433477|NCT02008773|363595319|FG002|Overall Study|Lost to Follow-up|3|||
105433478|NCT02008773|363595320|FG003|Overall Study|Lost to Follow-up|2|||
105433479|NCT00707954|363595321|FG000|Overall Study|Physician Decision|0|||
105433480|NCT00707954|363595322|FG001|Overall Study|Physician Decision|0|||
105433481|NCT00707954|363595323|FG002|Overall Study|Physician Decision|0|||
105433482|NCT00707954|363595324|FG003|Overall Study|Physician Decision|0|||
105433483|NCT00707954|363595325|FG004|Overall Study|Physician Decision|1|||
105433484|NCT00306527|363595326|FG000|Overall Study|Lost to Follow-up|3|||
105433485|NCT00306527|363595327|FG001|Overall Study|Lost to Follow-up|4|||
105433486|NCT00306527|363595328|FG002|Overall Study|Lost to Follow-up|3|||
105433487|NCT00306527|363595329|FG003|Overall Study|Lost to Follow-up|0|||
105433488|NCT00306527|363595326|FG000|Overall Study|Withdrawal by Subject|2|||
105433489|NCT00306527|363595327|FG001|Overall Study|Withdrawal by Subject|3|||
105433490|NCT00306527|363595328|FG002|Overall Study|Withdrawal by Subject|0|||
105433491|NCT00306527|363595329|FG003|Overall Study|Withdrawal by Subject|3|||
105433492|NCT00306527|363595326|FG000|Overall Study|Adverse Event|0|||
105433493|NCT00306527|363595327|FG001|Overall Study|Adverse Event|0|||
105433494|NCT00306527|363595328|FG002|Overall Study|Adverse Event|1|||
105433495|NCT00306527|363595329|FG003|Overall Study|Adverse Event|1|||
105433496|NCT00306527|363595326|FG000|Overall Study|Death|1|||
105433497|NCT00306527|363595327|FG001|Overall Study|Death|0|||
105433498|NCT00306527|363595328|FG002|Overall Study|Death|1|||
105433499|NCT00306527|363595329|FG003|Overall Study|Death|2|||
105433500|NCT01918332|363595330|FG000|Overall Study|Adverse Event|0|||
105433501|NCT01918332|363595331|FG001|Overall Study|Adverse Event|0|||
105502818|NCT01785069|363851042|FG002|Overall Study|Death|2|||
105433502|NCT01918332|363595332|FG002|Overall Study|Adverse Event|0|||
105433503|NCT01918332|363595333|FG003|Overall Study|Adverse Event|1|||
105433504|NCT01918332|363595330|FG000|Overall Study|Withdrawal by Subject|2|||
105502819|NCT01785069|363851043|FG003|Overall Study|Death|0|||
105433505|NCT01918332|363595331|FG001|Overall Study|Withdrawal by Subject|3|||
105433506|NCT01918332|363595332|FG002|Overall Study|Withdrawal by Subject|2|||
105433507|NCT01918332|363595333|FG003|Overall Study|Withdrawal by Subject|3|||
105433508|NCT01918332|363595330|FG000|Overall Study|Protocol Violation|6|||
105433509|NCT01918332|363595331|FG001|Overall Study|Protocol Violation|2|||
105433510|NCT01918332|363595332|FG002|Overall Study|Protocol Violation|6|||
105433511|NCT01918332|363595333|FG003|Overall Study|Protocol Violation|3|||
105502820|NCT01785069|363851040|FG000|Overall Study|Subject choice|2|||
105433512|NCT01918332|363595330|FG000|Overall Study|lipid result by central lab did not meet|0|||
105433513|NCT01918332|363595331|FG001|Overall Study|lipid result by central lab did not meet|0|||
105433514|NCT01918332|363595332|FG002|Overall Study|lipid result by central lab did not meet|1|||
105433515|NCT01918332|363595333|FG003|Overall Study|lipid result by central lab did not meet|0|||
105433516|NCT02905006|363595334|FG000|Overall Study|Adverse Event|1|||
105433517|NCT02905006|363595335|FG001|Overall Study|Adverse Event|1|||
105433518|NCT02905006|363595336|FG002|Overall Study|Adverse Event|1|||
105433519|NCT02905006|363595337|FG003|Overall Study|Adverse Event|1|||
105433520|NCT02905006|363595338|FG004|Overall Study|Adverse Event|0|||
105433521|NCT02905006|363595339|FG005|Overall Study|Adverse Event|1|||
105433522|NCT02905006|363595334|FG000|Overall Study|Lack of Efficacy|1|||
105433523|NCT02905006|363595335|FG001|Overall Study|Lack of Efficacy|0|||
105433524|NCT02905006|363595336|FG002|Overall Study|Lack of Efficacy|0|||
105433525|NCT02905006|363595337|FG003|Overall Study|Lack of Efficacy|0|||
105433526|NCT02905006|363595338|FG004|Overall Study|Lack of Efficacy|0|||
105433527|NCT02905006|363595339|FG005|Overall Study|Lack of Efficacy|0|||
105433528|NCT02905006|363595334|FG000|Overall Study|Protocol Violation|2|||
105433529|NCT02905006|363595335|FG001|Overall Study|Protocol Violation|0|||
105433530|NCT02905006|363595336|FG002|Overall Study|Protocol Violation|0|||
105433531|NCT02905006|363595337|FG003|Overall Study|Protocol Violation|0|||
105433532|NCT02905006|363595338|FG004|Overall Study|Protocol Violation|0|||
105433533|NCT02905006|363595339|FG005|Overall Study|Protocol Violation|0|||
105433534|NCT02905006|363595334|FG000|Overall Study|Lost to Follow-up|0|||
105433535|NCT02905006|363595335|FG001|Overall Study|Lost to Follow-up|0|||
105433536|NCT02905006|363595336|FG002|Overall Study|Lost to Follow-up|0|||
105433537|NCT02905006|363595337|FG003|Overall Study|Lost to Follow-up|1|||
105433538|NCT02905006|363595338|FG004|Overall Study|Lost to Follow-up|1|||
105590498|NCT01048788|364162616|FG002|Overall Study|Adverse Event|1|||
105590499|NCT01048788|364162614|FG000|Overall Study|Lack of Efficacy|0|||
105590500|NCT01048788|364162615|FG001|Overall Study|Lack of Efficacy|0|||
105590501|NCT01048788|364162616|FG002|Overall Study|Lack of Efficacy|1|||
105590502|NCT01048788|364162614|FG000|Overall Study|Withdrawal by Subject|0|||
105590503|NCT01048788|364162615|FG001|Overall Study|Withdrawal by Subject|1|||
105590504|NCT01048788|364162616|FG002|Overall Study|Withdrawal by Subject|0|||
105590505|NCT00420316|364162617|FG000|Overall Study|Withdrawal by Subject|0|||
105590506|NCT00420316|364162618|FG001|Overall Study|Withdrawal by Subject|1|||
105590507|NCT00420316|364162617|FG000|Overall Study|Lost to Follow-up|12|||
105590508|NCT00420316|364162618|FG001|Overall Study|Lost to Follow-up|8|||
105590509|NCT05419557|364162619|FG000|Overall Study|Lost to Follow-up|11|||
105590510|NCT05419557|364162620|FG001|Overall Study|Lost to Follow-up|4|||
105590511|NCT01196988|364162622|FG000|Overall Study|Adverse Event|1|||
105590512|NCT01196988|364162623|FG001|Overall Study|Adverse Event|2|||
105590513|NCT01196988|364162624|FG002|Overall Study|Adverse Event|0|||
105433539|NCT02905006|363595339|FG005|Overall Study|Lost to Follow-up|0|||
105433540|NCT02905006|363595334|FG000|Overall Study|Withdrawal by Subject|0|||
105433541|NCT02905006|363595335|FG001|Overall Study|Withdrawal by Subject|0|||
105433542|NCT02905006|363595336|FG002|Overall Study|Withdrawal by Subject|1|||
105433543|NCT02905006|363595337|FG003|Overall Study|Withdrawal by Subject|1|||
105433544|NCT02905006|363595338|FG004|Overall Study|Withdrawal by Subject|0|||
105433545|NCT02905006|363595339|FG005|Overall Study|Withdrawal by Subject|1|||
105433546|NCT02905006|363595334|FG000|Overall Study|Screening exclusion criteria met|1|||
105433547|NCT02905006|363595335|FG001|Overall Study|Screening exclusion criteria met|0|||
105433548|NCT02905006|363595336|FG002|Overall Study|Screening exclusion criteria met|0|||
105433549|NCT02905006|363595337|FG003|Overall Study|Screening exclusion criteria met|0|||
105433550|NCT02905006|363595338|FG004|Overall Study|Screening exclusion criteria met|0|||
105433551|NCT02905006|363595339|FG005|Overall Study|Screening exclusion criteria met|0|||
105433552|NCT02905006|363595334|FG000|Overall Study|Lab withdrawal criterion met|0|||
105433553|NCT02905006|363595335|FG001|Overall Study|Lab withdrawal criterion met|1|||
105433554|NCT02905006|363595336|FG002|Overall Study|Lab withdrawal criterion met|2|||
105433555|NCT02905006|363595337|FG003|Overall Study|Lab withdrawal criterion met|2|||
105590514|NCT01196988|364162625|FG003|Overall Study|Adverse Event|0|||
105590515|NCT01196988|364162622|FG000|Overall Study|Withdrawal by Subject|5|||
105590516|NCT01196988|364162623|FG001|Overall Study|Withdrawal by Subject|1|||
105590517|NCT01196988|364162624|FG002|Overall Study|Withdrawal by Subject|4|||
105433556|NCT02905006|363595338|FG004|Overall Study|Lab withdrawal criterion met|2|||
105433557|NCT02905006|363595339|FG005|Overall Study|Lab withdrawal criterion met|1|||
105433558|NCT02905006|363595334|FG000|Overall Study|Positive for Tuberculosis|0|||
105433559|NCT02905006|363595335|FG001|Overall Study|Positive for Tuberculosis|1|||
105433560|NCT02905006|363595336|FG002|Overall Study|Positive for Tuberculosis|0|||
105433561|NCT02905006|363595337|FG003|Overall Study|Positive for Tuberculosis|0|||
105590518|NCT01196988|364162625|FG003|Overall Study|Withdrawal by Subject|0|||
105590519|NCT01196988|364162622|FG000|Overall Study|Lost to Follow-up|16|||
105433562|NCT02905006|363595338|FG004|Overall Study|Positive for Tuberculosis|0|||
105433563|NCT02905006|363595339|FG005|Overall Study|Positive for Tuberculosis|0|||
105433564|NCT02905006|363595334|FG000|Overall Study|Subject positive for Hep B|0|||
105590520|NCT01196988|364162623|FG001|Overall Study|Lost to Follow-up|29|||
105590521|NCT01196988|364162624|FG002|Overall Study|Lost to Follow-up|21|||
105433565|NCT02905006|363595335|FG001|Overall Study|Subject positive for Hep B|0|||
105433566|NCT02905006|363595336|FG002|Overall Study|Subject positive for Hep B|1|||
105433567|NCT02905006|363595337|FG003|Overall Study|Subject positive for Hep B|0|||
105433568|NCT02905006|363595338|FG004|Overall Study|Subject positive for Hep B|0|||
105433569|NCT02905006|363595339|FG005|Overall Study|Subject positive for Hep B|0|||
105433570|NCT02905006|363595334|FG000|Overall Study|Patient moved abroad|0|||
105433571|NCT02905006|363595335|FG001|Overall Study|Patient moved abroad|0|||
105433572|NCT02905006|363595336|FG002|Overall Study|Patient moved abroad|0|||
105433573|NCT02905006|363595337|FG003|Overall Study|Patient moved abroad|1|||
105433574|NCT02905006|363595338|FG004|Overall Study|Patient moved abroad|0|||
105433575|NCT02905006|363595339|FG005|Overall Study|Patient moved abroad|0|||
105433576|NCT02905006|363595334|FG000|Overall Study|Patient randomized by mistake|0|||
105433577|NCT02905006|363595335|FG001|Overall Study|Patient randomized by mistake|0|||
105433578|NCT02905006|363595336|FG002|Overall Study|Patient randomized by mistake|0|||
105502821|NCT01785069|363851041|FG001|Overall Study|Subject choice|2|||
105502822|NCT01785069|363851042|FG002|Overall Study|Subject choice|0|||
105502823|NCT01785069|363851043|FG003|Overall Study|Subject choice|1|||
105502824|NCT01785069|363851040|FG000|Overall Study|Lost to Follow-up|1|||
105502825|NCT01785069|363851041|FG001|Overall Study|Lost to Follow-up|2|||
105502826|NCT01785069|363851042|FG002|Overall Study|Lost to Follow-up|4|||
105502827|NCT01785069|363851043|FG003|Overall Study|Lost to Follow-up|1|||
105502828|NCT01785069|363851040|FG000|Overall Study|Reason not Specified|1|||
105502829|NCT01785069|363851041|FG001|Overall Study|Reason not Specified|2|||
105502830|NCT01785069|363851042|FG002|Overall Study|Reason not Specified|1|||
105502831|NCT01785069|363851043|FG003|Overall Study|Reason not Specified|4|||
105502832|NCT01785069|363851040|FG000|Overall Study|Not evaluable|7|||
105502833|NCT01785069|363851041|FG001|Overall Study|Not evaluable|4|||
105502834|NCT01785069|363851042|FG002|Overall Study|Not evaluable|5|||
105502835|NCT01785069|363851043|FG003|Overall Study|Not evaluable|8|||
105502836|NCT01995825|363852719|FG000|Overall Study|Withdrawal by Subject|1|||
105502837|NCT01995825|363852720|FG001|Overall Study|Withdrawal by Subject|0|||
105502838|NCT01897454|363852723|FG000|Overall Study|Withdrawal by Subject|1|||
105502839|NCT01871532|363852724|FG000|Overall Study|Withdrawal by Subject|1|||
105502840|NCT01871532|363852725|FG001|Overall Study|Withdrawal by Subject|2|||
105502841|NCT00283400|363852726|FG000|Overall Study|Withdrawal by Subject|1|||
105502842|NCT00283400|363852727|FG001|Overall Study|Withdrawal by Subject|1|||
105502843|NCT00283400|363852728|FG002|Overall Study|Withdrawal by Subject|0|||
105502844|NCT00283400|363852729|FG003|Overall Study|Withdrawal by Subject|0|||
105502845|NCT00283400|363852726|FG000|Overall Study|Death|1|||
105502846|NCT00283400|363852727|FG001|Overall Study|Death|0|||
105502847|NCT00283400|363852728|FG002|Overall Study|Death|1|||
105502848|NCT00283400|363852729|FG003|Overall Study|Death|0|||
105502849|NCT01034631|363852731|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
105502850|NCT01034631|363852732|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
105502851|NCT01034631|363852733|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
105502852|NCT01034631|363852731|FG000|Phase II|Not Evaluable per protocol|0|||
105502853|NCT01034631|363852732|FG001|Phase II|Not Evaluable per protocol|0|||
105502854|NCT01034631|363852733|FG002|Phase II|Not Evaluable per protocol|2|||
105590522|NCT01196988|364162625|FG003|Overall Study|Lost to Follow-up|1|||
105590523|NCT01196988|364162622|FG000|Overall Study|Other|2|||
105590524|NCT01196988|364162623|FG001|Overall Study|Other|0|||
105590525|NCT01196988|364162624|FG002|Overall Study|Other|0|||
105590526|NCT01196988|364162625|FG003|Overall Study|Other|0|||
105590527|NCT01233050|364162626|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
105590528|NCT01233050|364162627|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
105590529|NCT02281318|364162628|FG000|Overall Study|Adverse Event|2|||
105590530|NCT02281318|364162629|FG001|Overall Study|Adverse Event|2|||
105590531|NCT02281318|364162628|FG000|Overall Study|Lack of Efficacy|2|||
105590532|NCT02281318|364162629|FG001|Overall Study|Lack of Efficacy|0|||
105590533|NCT02281318|364162628|FG000|Overall Study|Lost to Follow-up|2|||
105590534|NCT02281318|364162629|FG001|Overall Study|Lost to Follow-up|1|||
105590535|NCT02281318|364162628|FG000|Overall Study|Physician Decision|2|||
105433579|NCT02905006|363595337|FG003|Overall Study|Patient randomized by mistake|0|||
105433580|NCT02905006|363595338|FG004|Overall Study|Patient randomized by mistake|0|||
105590536|NCT02281318|364162629|FG001|Overall Study|Physician Decision|0|||
105590537|NCT02281318|364162628|FG000|Overall Study|Withdrawal by Subject|6|||
105590538|NCT02281318|364162629|FG001|Overall Study|Withdrawal by Subject|2|||
105590539|NCT03102710|364162633|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
105590540|NCT03102710|364162634|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
105590541|NCT03102710|364162635|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
105590542|NCT03102710|364162633|FG000|Overall Study|Technical issues during final MRI scan|0|||
105590543|NCT03102710|364162634|FG001|Overall Study|Technical issues during final MRI scan|1|||
105590544|NCT03102710|364162635|FG002|Overall Study|Technical issues during final MRI scan|0|||
105590545|NCT03102710|364162633|FG000|Overall Study|Nausea during MRI scan|0|||
105590546|NCT03102710|364162634|FG001|Overall Study|Nausea during MRI scan|1|||
105590547|NCT03102710|364162635|FG002|Overall Study|Nausea during MRI scan|0|||
105433581|NCT02905006|363595339|FG005|Overall Study|Patient randomized by mistake|1|||
105433582|NCT01939366|363595340|FG000|Overall Study|Adverse Event|8|||
105433583|NCT01939366|363595341|FG001|Overall Study|Adverse Event|17|||
105433584|NCT01939366|363595342|FG002|Overall Study|Adverse Event|30|||
105433585|NCT01939366|363595343|FG003|Overall Study|Adverse Event|8|||
105433586|NCT01939366|363595344|FG004|Overall Study|Adverse Event|5|||
105433587|NCT01939366|363595340|FG000|Overall Study|Lack of Efficacy|2|||
105433588|NCT01939366|363595341|FG001|Overall Study|Lack of Efficacy|1|||
105433589|NCT01939366|363595342|FG002|Overall Study|Lack of Efficacy|1|||
105433590|NCT01939366|363595343|FG003|Overall Study|Lack of Efficacy|1|||
105433591|NCT01939366|363595344|FG004|Overall Study|Lack of Efficacy|3|||
105433592|NCT01939366|363595340|FG000|Overall Study|Lost to Follow-up|1|||
105433593|NCT01939366|363595341|FG001|Overall Study|Lost to Follow-up|1|||
105433594|NCT01939366|363595342|FG002|Overall Study|Lost to Follow-up|0|||
105433595|NCT01939366|363595343|FG003|Overall Study|Lost to Follow-up|0|||
105433596|NCT01939366|363595344|FG004|Overall Study|Lost to Follow-up|0|||
105433597|NCT01939366|363595340|FG000|Overall Study|Withdrawal by Subject|1|||
105433598|NCT01939366|363595341|FG001|Overall Study|Withdrawal by Subject|0|||
105433599|NCT01939366|363595342|FG002|Overall Study|Withdrawal by Subject|2|||
105433600|NCT01939366|363595343|FG003|Overall Study|Withdrawal by Subject|2|||
105433601|NCT01939366|363595344|FG004|Overall Study|Withdrawal by Subject|3|||
105433602|NCT01939366|363595340|FG000|Overall Study|Inclusion criteria not met|0|||
105433603|NCT01939366|363595341|FG001|Overall Study|Inclusion criteria not met|1|||
105433604|NCT01939366|363595342|FG002|Overall Study|Inclusion criteria not met|1|||
105433605|NCT01939366|363595343|FG003|Overall Study|Inclusion criteria not met|0|||
105433606|NCT01939366|363595344|FG004|Overall Study|Inclusion criteria not met|1|||
105433607|NCT01939366|363595340|FG000|Overall Study|Other|0|||
105433608|NCT01939366|363595341|FG001|Overall Study|Other|0|||
105433609|NCT01939366|363595342|FG002|Overall Study|Other|2|||
105433610|NCT01939366|363595343|FG003|Overall Study|Other|2|||
105433611|NCT01939366|363595344|FG004|Overall Study|Other|1|||
105433612|NCT01939366|363595340|FG000|Overall Study|Protocol Violation|0|||
105433613|NCT01939366|363595341|FG001|Overall Study|Protocol Violation|0|||
105433614|NCT01939366|363595342|FG002|Overall Study|Protocol Violation|0|||
105433615|NCT01939366|363595343|FG003|Overall Study|Protocol Violation|1|||
105433616|NCT01939366|363595344|FG004|Overall Study|Protocol Violation|0|||
105433617|NCT01939366|363595340|FG000|Overall Study|Sponsor decision|0|||
105433618|NCT01939366|363595341|FG001|Overall Study|Sponsor decision|0|||
105433619|NCT01939366|363595342|FG002|Overall Study|Sponsor decision|0|||
105433620|NCT01939366|363595343|FG003|Overall Study|Sponsor decision|0|||
105433621|NCT01939366|363595344|FG004|Overall Study|Sponsor decision|2|||
105433622|NCT01939366|363595340|FG000|Overall Study|GCP non-compliance at site|2|||
105433623|NCT01939366|363595341|FG001|Overall Study|GCP non-compliance at site|3|||
105433624|NCT01939366|363595342|FG002|Overall Study|GCP non-compliance at site|2|||
105433625|NCT01939366|363595343|FG003|Overall Study|GCP non-compliance at site|3|||
105433626|NCT01939366|363595344|FG004|Overall Study|GCP non-compliance at site|3|||
105433627|NCT02429791|363595348|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
105433628|NCT02429791|363595349|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
105433629|NCT02429791|363595348|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
105433630|NCT02429791|363595349|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
105433631|NCT02429791|363595348|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
105433632|NCT02429791|363595349|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
105433633|NCT02429791|363595348|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
105433634|NCT02429791|363595349|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
105433635|NCT02429791|363595348|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
105433636|NCT02429791|363595349|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
105433637|NCT02429791|363595348|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
105433638|NCT02429791|363595349|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
105433639|NCT02429791|363595348|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
105433640|NCT02429791|363595349|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
105433641|NCT02429791|363595348|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
105433642|NCT02429791|363595349|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
105433643|NCT02429791|363595348|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
105433644|NCT02429791|363595349|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
105433645|NCT02429791|363595348|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
105433646|NCT02429791|363595349|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
105433647|NCT02429791|363595348|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
105433648|NCT02429791|363595349|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
105433649|NCT02429791|363595348|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
105433650|NCT02429791|363595349|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
105433651|NCT02429791|363595348|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
105433652|NCT02429791|363595349|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
105433653|NCT02429791|363595348|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
105433654|NCT02429791|363595349|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
105433655|NCT02429791|363595348|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
105433656|NCT02429791|363595349|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
105433657|NCT02429791|363595348|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
105433658|NCT02429791|363595349|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
105433659|NCT02429791|363595348|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
105433660|NCT02429791|363595349|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
105433661|NCT02429791|363595348|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
105433662|NCT02429791|363595349|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
105433663|NCT00007020|363595350|FG000|Overall Study|Death|16|||
105433664|NCT00007020|363595350|FG000|Overall Study|Lost to Follow-up|13|||
105433665|NCT00007020|363595350|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
105433666|NCT00007020|363595350|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
105433667|NCT00007020|363595350|FG000|Overall Study|Pt cared for by outside physician|4|||
105433668|NCT00007020|363595350|FG000|Overall Study|No evidence of treatment|6|||
105433669|NCT00881504|363595351|FG000|Overall Study|Withdrawal by Subject|1|||
105433670|NCT02017522|363595352|FG000|Overall Study|Withdrawal by Subject|1|||
105433671|NCT01272869|363595353|FG000|Period 2 (14 Days)|Adverse Event|1|||
105433672|NCT01272869|363595354|FG001|Period 2 (14 Days)|Adverse Event|0|||
105433673|NCT01571232|363595355|FG000|Overall Study|Lost to Follow-up|0|||
105433674|NCT01571232|363595356|FG001|Overall Study|Lost to Follow-up|1|||
105433675|NCT01571232|363595355|FG000|Overall Study|Withdrawal by Subject|1|||
105433676|NCT01571232|363595356|FG001|Overall Study|Withdrawal by Subject|0|||
105433677|NCT01751139|363595357|FG000|Overall Study|Other|135|||
105433678|NCT01751139|363595357|FG000|Overall Study|Sponsor study termination|1609|||
105433679|NCT01751139|363595357|FG000|Overall Study|Lost to Follow-up|240|||
105433680|NCT01751139|363595357|FG000|Overall Study|Withdrawal by Subject|251|||
105433681|NCT01751139|363595357|FG000|Overall Study|Adverse Event|1|||
105433682|NCT01751139|363595357|FG000|Overall Study|Death|31|||
105433683|NCT01867086|363595359|FG000|Overall Study|Disease Progression|1|||
105433684|NCT02337634|363595360|FG000|Overall Study|Protocol Violation|3|||
105433685|NCT02337634|363595361|FG001|Overall Study|Protocol Violation|1|||
105433686|NCT02337634|363595360|FG000|Overall Study|Lost to Follow-up|1|||
105433687|NCT02337634|363595361|FG001|Overall Study|Lost to Follow-up|0|||
105433688|NCT01424566|363595362|FG000|Single-blind Treatment|Adverse Event|71|||
105433689|NCT01424566|363595363|FG001|Single-blind Treatment|Adverse Event|0|||
105433690|NCT01424566|363595364|FG002|Single-blind Treatment|Adverse Event|0|||
105433691|NCT01424566|363595362|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
105433692|NCT01424566|363595363|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
105433693|NCT01424566|363595364|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
105433694|NCT01424566|363595362|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
105433695|NCT01424566|363595363|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
105433696|NCT01424566|363595364|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
105433697|NCT01424566|363595362|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
105433698|NCT01424566|363595363|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
105433699|NCT01424566|363595364|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
105433700|NCT01424566|363595362|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
105433701|NCT01424566|363595363|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
105433702|NCT01424566|363595364|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
105502855|NCT01034631|363852731|FG000|Phase II|Determined Ineligible per protocol|0|||
105502856|NCT01034631|363852732|FG001|Phase II|Determined Ineligible per protocol|1|||
105502857|NCT01034631|363852733|FG002|Phase II|Determined Ineligible per protocol|0|||
105502858|NCT00354744|363852734|FG000|Overall Study|Adverse Event|2|||
105502859|NCT00354744|363852734|FG000|Overall Study|Death|2|||
105502860|NCT00354744|363852734|FG000|Overall Study|Lack of Efficacy|11|||
105502861|NCT00354744|363852734|FG000|Overall Study|Lost to Follow-up|2|||
105502862|NCT00354744|363852734|FG000|Overall Study|Physician Decision|11|||
105502863|NCT00354744|363852734|FG000|Overall Study|Withdrawal by Subject|14|||
105502864|NCT01193530|363852736|FG000|Overall Study|Withdrawal by Subject|2|||
105502865|NCT01193530|363852737|FG001|Overall Study|Withdrawal by Subject|2|||
105502866|NCT01193530|363852736|FG000|Overall Study|Began Contraindicated Therapy|1|||
105502867|NCT01193530|363852737|FG001|Overall Study|Began Contraindicated Therapy|0|||
105502868|NCT01193530|363852736|FG000|Overall Study|Lost Light Box|0|||
105502869|NCT01193530|363852737|FG001|Overall Study|Lost Light Box|1|||
105502870|NCT01193530|363852736|FG000|Overall Study|Returned home - out of state|0|||
105502871|NCT01193530|363852737|FG001|Overall Study|Returned home - out of state|1|||
105502872|NCT01193530|363852736|FG000|Overall Study|Non-Compliance|0|||
105502873|NCT01193530|363852737|FG001|Overall Study|Non-Compliance|1|||
105502874|NCT04218695|363852738|FG000|Overall Study|Adverse Event|1|||
105433703|NCT01424566|363595362|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
105433704|NCT01424566|363595363|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
105433705|NCT01424566|363595364|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
105433706|NCT01424566|363595362|FG000|Double-blind Treatment|Adverse Event|0|||
105433707|NCT01424566|363595363|FG001|Double-blind Treatment|Adverse Event|21|||
105433708|NCT01424566|363595364|FG002|Double-blind Treatment|Adverse Event|13|||
105433709|NCT01424566|363595362|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
105433710|NCT01424566|363595363|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
105433711|NCT01424566|363595364|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
105433712|NCT01424566|363595362|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
105433713|NCT01424566|363595363|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
105433714|NCT01424566|363595364|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
105433715|NCT01424566|363595362|FG000|Double-blind Treatment|Lack of Efficacy|0|||
105433716|NCT01424566|363595363|FG001|Double-blind Treatment|Lack of Efficacy|1|||
105433717|NCT01424566|363595364|FG002|Double-blind Treatment|Lack of Efficacy|1|||
105433718|NCT03344172|363595367|FG000|Overall Study|Received <1 dose of treatment|1|||
105433719|NCT03344172|363595368|FG001|Overall Study|Received <1 dose of treatment|0|||
105433720|NCT04676867|363595369|FG000|Overall Study|Screen failure|0|||
105433721|NCT04676867|363595370|FG001|Overall Study|Screen failure|0|||
105433722|NCT04676867|363595371|FG002|Overall Study|Screen failure|6|||
105433723|NCT04676867|363595372|FG003|Overall Study|Screen failure|2|||
105433724|NCT04676867|363595369|FG000|Overall Study|Death|0|||
105433725|NCT04676867|363595370|FG001|Overall Study|Death|0|||
105433726|NCT04676867|363595371|FG002|Overall Study|Death|1|||
105433727|NCT04676867|363595372|FG003|Overall Study|Death|0|||
105433728|NCT04676867|363595369|FG000|Overall Study|Withdrawal by Subject|2|||
105433729|NCT04676867|363595370|FG001|Overall Study|Withdrawal by Subject|2|||
105433730|NCT04676867|363595371|FG002|Overall Study|Withdrawal by Subject|4|||
105433731|NCT04676867|363595372|FG003|Overall Study|Withdrawal by Subject|4|||
105433732|NCT04676867|363595369|FG000|Overall Study|Lost to Follow-up|1|||
105433733|NCT04676867|363595370|FG001|Overall Study|Lost to Follow-up|0|||
105433734|NCT04676867|363595371|FG002|Overall Study|Lost to Follow-up|0|||
105433735|NCT04676867|363595372|FG003|Overall Study|Lost to Follow-up|0|||
105433736|NCT03779503|363595373|FG000|First Intervention|Adverse Event|0|||
105433737|NCT03779503|363595374|FG001|First Intervention|Adverse Event|1|||
105502875|NCT04218695|363852739|FG001|Overall Study|Adverse Event|0|||
105502876|NCT00395304|363852740|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105502877|NCT00395304|363852741|FG001|Treatment Period 1|Withdrawal by Subject|3|||
105502878|NCT00395304|363852742|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105502879|NCT00395304|363852743|FG003|Treatment Period 1|Withdrawal by Subject|2|||
105502880|NCT00395304|363852744|FG004|Treatment Period 1|Withdrawal by Subject|1|||
105502881|NCT00395304|363852745|FG005|Treatment Period 1|Withdrawal by Subject|1|||
105502882|NCT00395304|363852740|FG000|Treatment Period 1|Lost to Follow-up|1|||
105502883|NCT00395304|363852741|FG001|Treatment Period 1|Lost to Follow-up|0|||
105502884|NCT00395304|363852742|FG002|Treatment Period 1|Lost to Follow-up|0|||
105502885|NCT00395304|363852743|FG003|Treatment Period 1|Lost to Follow-up|1|||
105502886|NCT00395304|363852744|FG004|Treatment Period 1|Lost to Follow-up|0|||
105502887|NCT00395304|363852745|FG005|Treatment Period 1|Lost to Follow-up|1|||
105502888|NCT00395304|363852740|FG000|Treatment Period 1|Physician Decision|0|||
105502889|NCT00395304|363852741|FG001|Treatment Period 1|Physician Decision|1|||
105502890|NCT00395304|363852742|FG002|Treatment Period 1|Physician Decision|0|||
105502891|NCT00395304|363852743|FG003|Treatment Period 1|Physician Decision|0|||
105502892|NCT00395304|363852744|FG004|Treatment Period 1|Physician Decision|0|||
105502893|NCT00395304|363852745|FG005|Treatment Period 1|Physician Decision|0|||
105502894|NCT00395304|363852740|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105502895|NCT00395304|363852741|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105502896|NCT00395304|363852742|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105502897|NCT00395304|363852743|FG003|Treatment Period 2|Withdrawal by Subject|1|||
105502898|NCT00395304|363852744|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105502899|NCT00395304|363852745|FG005|Treatment Period 2|Withdrawal by Subject|2|||
105502900|NCT00395304|363852740|FG000|Treatment Period 2|Lost to Follow-up|0|||
105502901|NCT00395304|363852741|FG001|Treatment Period 2|Lost to Follow-up|3|||
105502902|NCT00395304|363852742|FG002|Treatment Period 2|Lost to Follow-up|0|||
105502903|NCT00395304|363852743|FG003|Treatment Period 2|Lost to Follow-up|0|||
105502904|NCT00395304|363852744|FG004|Treatment Period 2|Lost to Follow-up|0|||
105502905|NCT00395304|363852745|FG005|Treatment Period 2|Lost to Follow-up|0|||
105502906|NCT00395304|363852740|FG000|Treatment Period 2|Physician Decision|0|||
105502907|NCT00395304|363852741|FG001|Treatment Period 2|Physician Decision|0|||
105433738|NCT03779503|363595373|FG000|First Intervention|Withdrawal by Subject|1|||
105433739|NCT03779503|363595374|FG001|First Intervention|Withdrawal by Subject|0|||
105502908|NCT00395304|363852742|FG002|Treatment Period 2|Physician Decision|1|||
105502909|NCT00395304|363852743|FG003|Treatment Period 2|Physician Decision|0|||
105502910|NCT00395304|363852744|FG004|Treatment Period 2|Physician Decision|0|||
105502911|NCT00395304|363852745|FG005|Treatment Period 2|Physician Decision|0|||
105502912|NCT00395304|363852740|FG000|Treatment Period 2|Other|0|||
105502913|NCT00395304|363852741|FG001|Treatment Period 2|Other|1|||
105502914|NCT00395304|363852742|FG002|Treatment Period 2|Other|0|||
105433740|NCT02066415|363595375|FG000|Overall Study|Decision by Sponsor|5|||
105433741|NCT02066415|363595376|FG001|Overall Study|Decision by Sponsor|4|||
105433742|NCT02066415|363595377|FG002|Overall Study|Decision by Sponsor|2|||
105433743|NCT02066415|363595375|FG000|Overall Study|Withdrawal by Subject|9|||
105433744|NCT02066415|363595376|FG001|Overall Study|Withdrawal by Subject|1|||
105433745|NCT02066415|363595377|FG002|Overall Study|Withdrawal by Subject|4|||
105433746|NCT02066415|363595375|FG000|Overall Study|Lost to Follow-up|7|||
105433747|NCT02066415|363595376|FG001|Overall Study|Lost to Follow-up|2|||
105433748|NCT02066415|363595377|FG002|Overall Study|Lost to Follow-up|2|||
105433749|NCT02294734|363595380|FG000|Overall Study|Adverse Event|5|||
105433750|NCT02294734|363595381|FG001|Overall Study|Adverse Event|5|||
105433751|NCT02294734|363595380|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
105433752|NCT02294734|363595381|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
105433753|NCT02294734|363595380|FG000|Overall Study|Lost to Follow-up|2|||
105433754|NCT02294734|363595381|FG001|Overall Study|Lost to Follow-up|0|||
105433755|NCT02294734|363595380|FG000|Overall Study|Physician Decision|2|||
105502915|NCT00395304|363852743|FG003|Treatment Period 2|Other|0|||
105502916|NCT00395304|363852744|FG004|Treatment Period 2|Other|0|||
105502917|NCT00395304|363852745|FG005|Treatment Period 2|Other|0|||
105502918|NCT00395304|363852740|FG000|Treatment Period 3|Withdrawal by Subject|0|||
105502919|NCT00395304|363852741|FG001|Treatment Period 3|Withdrawal by Subject|0|||
105502920|NCT00395304|363852742|FG002|Treatment Period 3|Withdrawal by Subject|0|||
105502921|NCT00395304|363852743|FG003|Treatment Period 3|Withdrawal by Subject|1|||
105502922|NCT00395304|363852744|FG004|Treatment Period 3|Withdrawal by Subject|0|||
105502923|NCT00395304|363852745|FG005|Treatment Period 3|Withdrawal by Subject|1|||
105502924|NCT00395304|363852740|FG000|Treatment Period 3|Lost to Follow-up|1|||
105502925|NCT00395304|363852741|FG001|Treatment Period 3|Lost to Follow-up|1|||
105502926|NCT00395304|363852742|FG002|Treatment Period 3|Lost to Follow-up|0|||
105502927|NCT00395304|363852743|FG003|Treatment Period 3|Lost to Follow-up|0|||
105502928|NCT00395304|363852744|FG004|Treatment Period 3|Lost to Follow-up|0|||
105502929|NCT00395304|363852745|FG005|Treatment Period 3|Lost to Follow-up|0|||
105502930|NCT00395304|363852740|FG000|Treatment Period 3|Physician Decision|0|||
105502931|NCT00395304|363852741|FG001|Treatment Period 3|Physician Decision|1|||
105502932|NCT00395304|363852742|FG002|Treatment Period 3|Physician Decision|0|||
105502933|NCT00395304|363852743|FG003|Treatment Period 3|Physician Decision|0|||
105502934|NCT00395304|363852744|FG004|Treatment Period 3|Physician Decision|0|||
105502935|NCT00395304|363852745|FG005|Treatment Period 3|Physician Decision|0|||
105502936|NCT00395304|363852740|FG000|Treatment Period 3|Other|0|||
105502937|NCT00395304|363852741|FG001|Treatment Period 3|Other|0|||
105502938|NCT00395304|363852742|FG002|Treatment Period 3|Other|0|||
105502939|NCT00395304|363852743|FG003|Treatment Period 3|Other|1|||
105502940|NCT00395304|363852744|FG004|Treatment Period 3|Other|0|||
105502941|NCT00395304|363852745|FG005|Treatment Period 3|Other|0|||
105502942|NCT01945281|363852747|FG000|Overall Study|Adverse Event|1|||
105502943|NCT01945281|363852748|FG001|Overall Study|Adverse Event|0|||
105502944|NCT01945281|363852747|FG000|Overall Study|Death|3|||
105502945|NCT01945281|363852748|FG001|Overall Study|Death|3|||
105502946|NCT01945281|363852747|FG000|Overall Study|Physician Decision|1|||
105502947|NCT01945281|363852748|FG001|Overall Study|Physician Decision|1|||
105502948|NCT01945281|363852747|FG000|Overall Study|Technical Problems|1|||
105502949|NCT01945281|363852748|FG001|Overall Study|Technical Problems|0|||
105502950|NCT00934089|363852749|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
105502951|NCT00934089|363852750|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
105502952|NCT00934089|363852749|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
105502953|NCT00934089|363852750|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
105502954|NCT04401423|363852751|FG000|Overall Study|Withdrawal by Subject|3|||
105502955|NCT04401423|363852752|FG001|Overall Study|Withdrawal by Subject|1|||
105502956|NCT04401423|363852751|FG000|Overall Study|Physician Decision|2|||
105502957|NCT04401423|363852752|FG001|Overall Study|Physician Decision|1|||
105502958|NCT00003473|363852753|FG000|Overall Study|Three patients were not evaluable.|3|||
105502959|NCT00799383|363852758|FG000|Overall Study|Protocol Violation|1|||
105502960|NCT00799383|363852759|FG001|Overall Study|Protocol Violation|1|||
105502961|NCT00799383|363852758|FG000|Overall Study|Adverse Event|0|||
105502962|NCT00799383|363852759|FG001|Overall Study|Adverse Event|1|||
105433756|NCT02294734|363595381|FG001|Overall Study|Physician Decision|1|||
105433757|NCT02294734|363595380|FG000|Overall Study|Withdrawal by Subject|4|||
105502963|NCT00799383|363852758|FG000|Overall Study|Lost to Follow-up|1|||
105502964|NCT00799383|363852759|FG001|Overall Study|Lost to Follow-up|2|||
105502965|NCT00799383|363852758|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
105502966|NCT00799383|363852759|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
105502967|NCT00799383|363852758|FG000|Overall Study|Withdrawal by Subject|0|||
105502968|NCT00799383|363852759|FG001|Overall Study|Withdrawal by Subject|1|||
105502969|NCT00926328|363852765|FG000|Overall Study|Lost to Follow-up|12|||
105433758|NCT02294734|363595381|FG001|Overall Study|Withdrawal by Subject|2|||
105433759|NCT02809053|363595382|FG000|Overall Study|Death|0|||
105433760|NCT02809053|363595383|FG001|Overall Study|Death|1|||
105502970|NCT00926328|363852766|FG001|Overall Study|Lost to Follow-up|14|||
105502971|NCT00289133|363852767|FG000|Overall Study|Non-study device implanted|12|||
105502972|NCT00289133|363852768|FG001|Overall Study|Non-study device implanted|0|||
105502973|NCT00289133|363852767|FG000|Overall Study|Protocol Violation|32|||
105502974|NCT00289133|363852768|FG001|Overall Study|Protocol Violation|38|||
105433761|NCT02809053|363595382|FG000|Overall Study|Lost to Follow-up|3|||
105433762|NCT02809053|363595383|FG001|Overall Study|Lost to Follow-up|1|||
105433763|NCT02809053|363595382|FG000|Overall Study|Withdrawal by Subject|2|||
105433764|NCT02809053|363595383|FG001|Overall Study|Withdrawal by Subject|3|||
105433765|NCT02809053|363595382|FG000|Overall Study|Disease Progression|2|||
105433766|NCT02809053|363595383|FG001|Overall Study|Disease Progression|1|||
105433767|NCT00117793|363595388|FG000|Overall Study|Withdrawal by Subject|12|||
105433768|NCT01732913|363595393|FG000|Overall Study|Study Terminated by Sponsor|105|||
105433769|NCT01732913|363595394|FG001|Overall Study|Study Terminated by Sponsor|55|||
105433770|NCT01732913|363595393|FG000|Overall Study|Withdrawal by Subject|27|||
105433771|NCT01732913|363595394|FG001|Overall Study|Withdrawal by Subject|4|||
105433772|NCT01732913|363595393|FG000|Overall Study|Physician Decision|14|||
105433773|NCT01732913|363595394|FG001|Overall Study|Physician Decision|7|||
105433774|NCT01732913|363595393|FG000|Overall Study|Other|7|||
105433775|NCT01732913|363595394|FG001|Overall Study|Other|1|||
105433776|NCT01732913|363595393|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
105433777|NCT01732913|363595394|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
105433778|NCT01504204|363595397|FG000|Overall Study|Lost to Follow-up|1|||
105433779|NCT01504204|363595398|FG001|Overall Study|Lost to Follow-up|1|||
105433780|NCT01818492|363595399|FG000|Overall Study|Adverse Event|2|||
105433781|NCT01818492|363595399|FG000|Overall Study|Death|3|||
105433782|NCT01818492|363595399|FG000|Overall Study|Withdrawal by Subject|1|||
105433783|NCT01818492|363595399|FG000|Overall Study|Additional therapy when not allowed PP|4|||
105433784|NCT02049138|363595401|FG000|Overall Study|Adverse Event|46|||
105433785|NCT02049138|363595402|FG001|Overall Study|Adverse Event|25|||
105433786|NCT02049138|363595403|FG002|Overall Study|Adverse Event|1|||
105433787|NCT02049138|363595401|FG000|Overall Study|Withdrawal by Subject|57|||
105433788|NCT02049138|363595402|FG001|Overall Study|Withdrawal by Subject|21|||
105433789|NCT02049138|363595403|FG002|Overall Study|Withdrawal by Subject|5|||
105433790|NCT02049138|363595401|FG000|Overall Study|Lost to Follow-up|18|||
105433791|NCT02049138|363595402|FG001|Overall Study|Lost to Follow-up|5|||
105433792|NCT02049138|363595403|FG002|Overall Study|Lost to Follow-up|1|||
105502975|NCT00289133|363852767|FG000|Overall Study|Withdrawal by Subject|9|||
105502976|NCT00289133|363852768|FG001|Overall Study|Withdrawal by Subject|10|||
105502977|NCT00289133|363852767|FG000|Overall Study|Death|5|||
105502978|NCT00289133|363852768|FG001|Overall Study|Death|10|||
105502979|NCT00289133|363852767|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
105502980|NCT00289133|363852768|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
105502981|NCT00289133|363852767|FG000|Overall Study|Physician Decision|41|||
105502982|NCT00289133|363852768|FG001|Overall Study|Physician Decision|45|||
105502983|NCT00289133|363852767|FG000|Overall Study|Revision|8|||
105502984|NCT00289133|363852768|FG001|Overall Study|Revision|6|||
105502985|NCT00289133|363852767|FG000|Overall Study|Lost to Follow-up|92|||
105502986|NCT00289133|363852768|FG001|Overall Study|Lost to Follow-up|115|||
105502987|NCT01749137|363852777|FG000|Overall Study|Adverse Event|4|||
105502988|NCT01749137|363852778|FG001|Overall Study|Adverse Event|4|||
105502989|NCT01749137|363852777|FG000|Overall Study|Lost to Follow-up|2|||
105502990|NCT01749137|363852778|FG001|Overall Study|Lost to Follow-up|3|||
105502991|NCT01749137|363852777|FG000|Overall Study|Physician Decision|1|||
105502992|NCT01749137|363852778|FG001|Overall Study|Physician Decision|0|||
105502993|NCT01749137|363852777|FG000|Overall Study|Withdrawal by Subject|8|||
105502994|NCT01749137|363852778|FG001|Overall Study|Withdrawal by Subject|4|||
105502995|NCT03372096|363852783|FG000|Overall Study|Study Closed|8|||
105433793|NCT02049138|363595401|FG000|Overall Study|Lack of Efficacy|10|||
105433794|NCT02049138|363595402|FG001|Overall Study|Lack of Efficacy|26|||
105433795|NCT02049138|363595403|FG002|Overall Study|Lack of Efficacy|1|||
105433796|NCT02049138|363595401|FG000|Overall Study|Non-Compliance|15|||
105502996|NCT00040365|363852784|FG000|Overall Study|Death|1|||
105502997|NCT00040365|363852784|FG000|Overall Study|Progressive disease|7|||
105502998|NCT00040365|363852784|FG000|Overall Study|Lost to Follow-up|3|||
105502999|NCT00680017|363852787|FG000|Overall Study|Adverse Event|13|||
105503000|NCT00680017|363852788|FG001|Overall Study|Adverse Event|7|||
105503001|NCT00680017|363852787|FG000|Overall Study|Withdrawal by Subject|2|||
105503002|NCT00680017|363852788|FG001|Overall Study|Withdrawal by Subject|5|||
105503003|NCT00680017|363852787|FG000|Overall Study|Lost to Follow-up|2|||
105503004|NCT00680017|363852788|FG001|Overall Study|Lost to Follow-up|0|||
105503005|NCT01546207|363852789|FG000|Overall Study|Death|1|||
105503006|NCT01826604|363852790|FG000|Overall Study|Lost to Follow-up|8|||
105433797|NCT02049138|363595402|FG001|Overall Study|Non-Compliance|6|||
105433798|NCT02049138|363595403|FG002|Overall Study|Non-Compliance|0|||
105503007|NCT01826604|363852791|FG001|Overall Study|Lost to Follow-up|9|||
105503008|NCT01603355|363852792|FG000|Overall Study|Lack of Efficacy|2|||
105433799|NCT02049138|363595401|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
105433800|NCT02049138|363595402|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
105433801|NCT02049138|363595403|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
105433802|NCT02049138|363595401|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
105503009|NCT00612040|363852793|FG000|Overall Study|Adverse Event|0|||
105503010|NCT00612040|363852794|FG001|Overall Study|Adverse Event|2|||
105503011|NCT00612040|363852795|FG002|Overall Study|Adverse Event|1|||
105433803|NCT02049138|363595402|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
105433804|NCT02049138|363595403|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
105433805|NCT02049138|363595401|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
105433806|NCT02049138|363595402|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
105433807|NCT02049138|363595403|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
105433808|NCT02049138|363595401|FG000|Overall Study|Other|15|||
105433809|NCT02049138|363595402|FG001|Overall Study|Other|13|||
105433810|NCT02049138|363595403|FG002|Overall Study|Other|0|||
105433811|NCT02049138|363595401|FG000|Overall Study|Missing|0|||
105433812|NCT02049138|363595402|FG001|Overall Study|Missing|1|||
105433813|NCT02049138|363595403|FG002|Overall Study|Missing|0|||
105433814|NCT02428413|363595404|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
105433815|NCT02428413|363595405|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
105433816|NCT02428413|363595404|FG000|Overall Study|Protocol Violation|1|||
105433817|NCT02428413|363595405|FG001|Overall Study|Protocol Violation|2|||
105503012|NCT00612040|363852793|FG000|Overall Study|Protocol Violation|1|||
105503013|NCT00612040|363852794|FG001|Overall Study|Protocol Violation|2|||
105503014|NCT00612040|363852795|FG002|Overall Study|Protocol Violation|1|||
105503015|NCT00612040|363852793|FG000|Overall Study|Lack of Efficacy|2|||
105503016|NCT00612040|363852794|FG001|Overall Study|Lack of Efficacy|1|||
105503017|NCT00612040|363852795|FG002|Overall Study|Lack of Efficacy|0|||
105503018|NCT00612040|363852793|FG000|Overall Study|Unclassified|2|||
105503019|NCT00612040|363852794|FG001|Overall Study|Unclassified|2|||
105503020|NCT00612040|363852795|FG002|Overall Study|Unclassified|5|||
105503021|NCT05154578|363852796|FG000|Overall Study|Withdrawal by Subject|2|||
105503022|NCT05154578|363852797|FG001|Overall Study|Withdrawal by Subject|3|||
105503023|NCT05154578|363852798|FG002|Overall Study|Withdrawal by Subject|2|||
105503024|NCT05154578|363852799|FG003|Overall Study|Withdrawal by Subject|4|||
105503025|NCT05154578|363852800|FG004|Overall Study|Withdrawal by Subject|0|||
105503026|NCT05154578|363852796|FG000|Overall Study|Lost to Follow-up|0|||
105503027|NCT05154578|363852797|FG001|Overall Study|Lost to Follow-up|1|||
105503028|NCT05154578|363852798|FG002|Overall Study|Lost to Follow-up|0|||
105503029|NCT05154578|363852799|FG003|Overall Study|Lost to Follow-up|3|||
105503030|NCT05154578|363852800|FG004|Overall Study|Lost to Follow-up|0|||
105503031|NCT05154578|363852796|FG000|Overall Study|Adverse Event|0|||
105503032|NCT05154578|363852797|FG001|Overall Study|Adverse Event|0|||
105503033|NCT05154578|363852798|FG002|Overall Study|Adverse Event|0|||
105503034|NCT05154578|363852799|FG003|Overall Study|Adverse Event|1|||
105503035|NCT05154578|363852800|FG004|Overall Study|Adverse Event|0|||
105503036|NCT05154578|363852796|FG000|Overall Study|Relocated to another province|0|||
105503037|NCT05154578|363852797|FG001|Overall Study|Relocated to another province|0|||
105503038|NCT05154578|363852798|FG002|Overall Study|Relocated to another province|1|||
105503039|NCT05154578|363852799|FG003|Overall Study|Relocated to another province|0|||
105503040|NCT05154578|363852800|FG004|Overall Study|Relocated to another province|1|||
105503041|NCT05154578|363852796|FG000|Overall Study|Baby loss|0|||
105503042|NCT05154578|363852797|FG001|Overall Study|Baby loss|1|||
105503043|NCT05154578|363852798|FG002|Overall Study|Baby loss|0|||
105503044|NCT05154578|363852799|FG003|Overall Study|Baby loss|0|||
105503045|NCT05154578|363852800|FG004|Overall Study|Baby loss|0|||
105503046|NCT04572633|363852801|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
105503047|NCT00894166|363852802|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
105503048|NCT00894166|363852803|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
105503049|NCT00894166|363852804|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
105503050|NCT00894166|363852805|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
105503051|NCT00894166|363852806|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
105503052|NCT00894166|363852807|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
105503053|NCT00894166|363852808|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
105503054|NCT00894166|363852809|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
105503055|NCT00894166|363852802|FG000|Overall Study|Death|0|||
105503056|NCT00894166|363852803|FG001|Overall Study|Death|0|||
105503057|NCT00894166|363852804|FG002|Overall Study|Death|0|||
105503058|NCT00894166|363852805|FG003|Overall Study|Death|1|||
105503059|NCT00894166|363852806|FG004|Overall Study|Death|0|||
105503060|NCT00894166|363852807|FG005|Overall Study|Death|0|||
105503061|NCT00894166|363852808|FG006|Overall Study|Death|0|||
105503062|NCT00894166|363852809|FG007|Overall Study|Death|0|||
105433818|NCT02428413|363595404|FG000|Overall Study|Case Cancelled|2|||
105433819|NCT02428413|363595405|FG001|Overall Study|Case Cancelled|0|||
105503063|NCT01921387|363852812|FG000|Overall Study|Adverse Event|1|||
105503064|NCT01281865|363852817|FG000|Overall Study|Adverse Event|1|||
105503065|NCT01281865|363852818|FG001|Overall Study|Adverse Event|1|||
105503066|NCT01281865|363852817|FG000|Overall Study|Withdrawal by Subject|1|||
105433820|NCT02428413|363595404|FG000|Overall Study|Missed Cases|1|||
105433821|NCT02428413|363595405|FG001|Overall Study|Missed Cases|2|||
105503067|NCT01281865|363852818|FG001|Overall Study|Withdrawal by Subject|0|||
105503068|NCT01281865|363852817|FG000|Overall Study|Lack of Efficacy|1|||
105503069|NCT01281865|363852818|FG001|Overall Study|Lack of Efficacy|0|||
105503070|NCT02499783|363852819|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
105433822|NCT02428413|363595404|FG000|Overall Study|Nurse Refusal|1|||
105433823|NCT02428413|363595405|FG001|Overall Study|Nurse Refusal|0|||
105433824|NCT02925741|363595406|FG000|Overall Study|Withdrawal by Subject|11|||
105433825|NCT02925741|363595407|FG001|Overall Study|Withdrawal by Subject|0|||
105433826|NCT05086510|363595408|FG000|Overall Study|Lost to Follow-up|0|||
105433827|NCT05086510|363595409|FG001|Overall Study|Lost to Follow-up|2|||
105433828|NCT05086510|363595408|FG000|Overall Study|Death|0|||
105433829|NCT05086510|363595409|FG001|Overall Study|Death|2|||
105433830|NCT02613169|363595411|FG000|Overall Study|Withdrawal by Subject|4|||
105433831|NCT02613169|363595412|FG001|Overall Study|Withdrawal by Subject|1|||
105433832|NCT02613169|363595411|FG000|Overall Study|Lost to Follow-up|0|||
105433833|NCT02613169|363595412|FG001|Overall Study|Lost to Follow-up|5|||
105433834|NCT02613169|363595411|FG000|Overall Study|HIV|0|||
105433835|NCT02613169|363595412|FG001|Overall Study|HIV|2|||
105433836|NCT02613169|363595411|FG000|Overall Study|No TB infection endpoint|14|||
105433837|NCT02613169|363595412|FG001|Overall Study|No TB infection endpoint|9|||
105433838|NCT04891107|363595413|FG000|Overall Study|Physician Decision|1|||
105433839|NCT04891107|363595413|FG000|Overall Study|Withdrawal by Subject|1|||
105433840|NCT04891107|363595413|FG000|Overall Study|Screen failure after consent|1|||
105433841|NCT02453555|363595414|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
105433842|NCT02453555|363595415|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
105433843|NCT02453555|363595416|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
105433844|NCT02453555|363595417|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
105433845|NCT02453555|363595418|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
105433846|NCT02453555|363595419|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
105433847|NCT02453555|363595414|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
105433848|NCT02453555|363595415|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
105433849|NCT02453555|363595416|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
105433850|NCT02453555|363595417|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
105433851|NCT02453555|363595418|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
105433852|NCT02453555|363595419|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
105433853|NCT02453555|363595414|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
105433854|NCT02453555|363595415|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
105433855|NCT02453555|363595416|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
105433856|NCT02453555|363595417|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
105433857|NCT02453555|363595418|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
105433858|NCT02453555|363595419|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
105433859|NCT02453555|363595414|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
105433860|NCT02453555|363595415|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
105433861|NCT02453555|363595416|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
105433862|NCT02453555|363595417|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
105433863|NCT02453555|363595418|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
105433864|NCT02453555|363595419|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
105433865|NCT02453555|363595414|FG000|Extension Period|Adverse Event|0|||
105433866|NCT02453555|363595415|FG001|Extension Period|Adverse Event|0|||
105433867|NCT02453555|363595416|FG002|Extension Period|Adverse Event|1|||
105433868|NCT02453555|363595417|FG003|Extension Period|Adverse Event|2|||
105433869|NCT02453555|363595418|FG004|Extension Period|Adverse Event|1|||
105433870|NCT02453555|363595419|FG005|Extension Period|Adverse Event|1|||
105433871|NCT02453555|363595414|FG000|Extension Period|Protocol Violation|0|||
105433872|NCT02453555|363595415|FG001|Extension Period|Protocol Violation|0|||
105433873|NCT02453555|363595416|FG002|Extension Period|Protocol Violation|1|||
105433874|NCT02453555|363595417|FG003|Extension Period|Protocol Violation|0|||
105433875|NCT02453555|363595418|FG004|Extension Period|Protocol Violation|0|||
105433876|NCT02453555|363595419|FG005|Extension Period|Protocol Violation|0|||
105433877|NCT02453555|363595414|FG000|Extension Period|Withdrawal by Subject|0|||
105433878|NCT02453555|363595415|FG001|Extension Period|Withdrawal by Subject|0|||
105433879|NCT02453555|363595416|FG002|Extension Period|Withdrawal by Subject|1|||
105433880|NCT02453555|363595417|FG003|Extension Period|Withdrawal by Subject|0|||
105433881|NCT02453555|363595418|FG004|Extension Period|Withdrawal by Subject|0|||
105433882|NCT02453555|363595419|FG005|Extension Period|Withdrawal by Subject|0|||
105433883|NCT00444067|363595420|FG000|Overall Study|Lost to Follow-up|0|||
105433884|NCT00444067|363595421|FG001|Overall Study|Lost to Follow-up|1|||
105433885|NCT02528357|363595422|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433886|NCT02528357|363595423|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
105433887|NCT02528357|363595424|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433888|NCT02528357|363595425|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433889|NCT02528357|363595426|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433890|NCT02528357|363595427|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433891|NCT02528357|363595428|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433892|NCT02528357|363595429|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433893|NCT02528357|363595430|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433894|NCT02528357|363595431|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433895|NCT02528357|363595432|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433896|NCT02528357|363595433|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433897|NCT02528357|363595434|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433898|NCT02528357|363595435|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433899|NCT02528357|363595436|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433900|NCT02528357|363595437|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433901|NCT02528357|363595438|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433902|NCT02528357|363595439|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433903|NCT02528357|363595440|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105433904|NCT02528357|363595422|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433905|NCT02528357|363595423|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433906|NCT02528357|363595424|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433907|NCT02528357|363595425|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
105433908|NCT02528357|363595426|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433909|NCT02528357|363595427|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
105433910|NCT02528357|363595428|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433911|NCT02528357|363595429|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
105433912|NCT02528357|363595430|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433913|NCT02528357|363595431|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433914|NCT02528357|363595432|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433915|NCT02528357|363595433|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433916|NCT02528357|363595434|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433917|NCT02528357|363595435|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433918|NCT02528357|363595436|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433919|NCT02528357|363595437|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433920|NCT02528357|363595438|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433921|NCT02528357|363595439|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433922|NCT02528357|363595440|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105433923|NCT02528357|363595422|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105433924|NCT02528357|363595423|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105433925|NCT02528357|363595424|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
105433926|NCT02528357|363595425|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105433927|NCT02528357|363595426|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
105433928|NCT02528357|363595427|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105433929|NCT02528357|363595428|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
105433930|NCT02528357|363595429|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
105433931|NCT02528357|363595430|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105433932|NCT02528357|363595431|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105433933|NCT02528357|363595432|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105433934|NCT02528357|363595433|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105433935|NCT02528357|363595434|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105433936|NCT02528357|363595435|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105433937|NCT02528357|363595436|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105433938|NCT02528357|363595437|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105433939|NCT02528357|363595438|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105433940|NCT02528357|363595439|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105433941|NCT02528357|363595440|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105433942|NCT02528357|363595422|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433943|NCT02528357|363595423|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433944|NCT02528357|363595424|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433945|NCT02528357|363595425|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433946|NCT02528357|363595426|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
105433947|NCT02528357|363595427|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433948|NCT02528357|363595428|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433949|NCT02528357|363595429|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433950|NCT02528357|363595430|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433951|NCT02528357|363595431|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433952|NCT02528357|363595432|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433953|NCT02528357|363595433|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433954|NCT02528357|363595434|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433955|NCT02528357|363595435|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433956|NCT02528357|363595436|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433957|NCT02528357|363595437|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433958|NCT02528357|363595438|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433959|NCT02528357|363595439|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433960|NCT02528357|363595440|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105433961|NCT02528357|363595422|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433962|NCT02528357|363595423|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433963|NCT02528357|363595424|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433964|NCT02528357|363595425|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433965|NCT02528357|363595426|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433966|NCT02528357|363595427|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433967|NCT02528357|363595428|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433968|NCT02528357|363595429|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433969|NCT02528357|363595430|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433970|NCT02528357|363595431|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433971|NCT02528357|363595432|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433972|NCT02528357|363595433|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433973|NCT02528357|363595434|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433974|NCT02528357|363595435|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
105433975|NCT02528357|363595436|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
105433976|NCT02528357|363595437|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433977|NCT02528357|363595438|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433978|NCT02528357|363595439|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433979|NCT02528357|363595440|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105433980|NCT02528357|363595422|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433981|NCT02528357|363595423|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433982|NCT02528357|363595424|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433983|NCT02528357|363595425|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433984|NCT02528357|363595426|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433985|NCT02528357|363595427|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433986|NCT02528357|363595428|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433987|NCT02528357|363595429|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433988|NCT02528357|363595430|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433989|NCT02528357|363595431|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433990|NCT02528357|363595432|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433991|NCT02528357|363595433|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433992|NCT02528357|363595434|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433993|NCT02528357|363595435|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
105433994|NCT02528357|363595436|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433995|NCT02528357|363595437|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433996|NCT02528357|363595438|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433997|NCT02528357|363595439|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433998|NCT02528357|363595440|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105433999|NCT02528357|363595422|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105434000|NCT02528357|363595423|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105434001|NCT02528357|363595424|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105434002|NCT02528357|363595425|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105434003|NCT02528357|363595426|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105434004|NCT02528357|363595427|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105434005|NCT02528357|363595428|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105434006|NCT02528357|363595429|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105434007|NCT02528357|363595430|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105434008|NCT02528357|363595431|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105434009|NCT02528357|363595432|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
105503071|NCT02499783|363852820|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
105503072|NCT02499783|363852821|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
105503073|NCT02499783|363852819|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
105503074|NCT02499783|363852820|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
105503075|NCT02499783|363852821|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
105503076|NCT02499783|363852819|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
105503077|NCT02499783|363852820|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
105503078|NCT02499783|363852821|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
105503079|NCT02499783|363852819|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
105503080|NCT02499783|363852820|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
105503081|NCT02499783|363852821|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
105503082|NCT02499783|363852819|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
105434010|NCT02528357|363595433|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105434011|NCT02528357|363595434|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
105434012|NCT02528357|363595435|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
105434013|NCT02528357|363595436|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
105434014|NCT02528357|363595437|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105434015|NCT02528357|363595438|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105434016|NCT02528357|363595439|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105434017|NCT02528357|363595440|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105434018|NCT02528357|363595422|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434019|NCT02528357|363595423|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434020|NCT02528357|363595424|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434021|NCT02528357|363595425|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434022|NCT02528357|363595426|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434023|NCT02528357|363595427|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434024|NCT02528357|363595428|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434025|NCT02528357|363595429|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434026|NCT02528357|363595430|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
105434027|NCT02528357|363595431|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
105434028|NCT02528357|363595432|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434029|NCT02528357|363595433|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
105434030|NCT02528357|363595434|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
105434031|NCT02528357|363595435|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
105434032|NCT02528357|363595436|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
105434033|NCT02528357|363595437|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434034|NCT02528357|363595438|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434035|NCT02528357|363595439|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434036|NCT02528357|363595440|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434037|NCT02528357|363595422|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434038|NCT02528357|363595423|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434039|NCT02528357|363595424|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434040|NCT02528357|363595425|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434041|NCT02528357|363595426|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434042|NCT02528357|363595427|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434043|NCT02528357|363595428|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434044|NCT02528357|363595429|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434045|NCT02528357|363595430|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434046|NCT02528357|363595431|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434047|NCT02528357|363595432|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434048|NCT02528357|363595433|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434049|NCT02528357|363595434|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105503083|NCT02499783|363852820|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
105503084|NCT02499783|363852821|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
105503085|NCT02499783|363852819|FG000|DB Period: Weeks 0-8|Other|1|||
105503086|NCT02499783|363852820|FG001|DB Period: Weeks 0-8|Other|1|||
105503087|NCT02499783|363852821|FG002|DB Period: Weeks 0-8|Other|0|||
105503088|NCT02499783|363852819|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
105503089|NCT02499783|363852820|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
105503090|NCT02499783|363852821|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
105590548|NCT03102710|364162633|FG000|Overall Study|Subject unable to attend final session|0|||
105434050|NCT02528357|363595435|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434051|NCT02528357|363595436|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434052|NCT02528357|363595437|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434053|NCT02528357|363595438|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
105434054|NCT02528357|363595439|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434055|NCT02528357|363595440|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105434056|NCT02528357|363595422|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434057|NCT02528357|363595423|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105590549|NCT03102710|364162634|FG001|Overall Study|Subject unable to attend final session|1|||
105590550|NCT03102710|364162635|FG002|Overall Study|Subject unable to attend final session|0|||
105590551|NCT00920686|364162636|FG000|Overall Study|Lost to Follow-up|2|||
105590552|NCT00920686|364162637|FG001|Overall Study|Lost to Follow-up|3|||
105590553|NCT00920686|364162638|FG002|Overall Study|Lost to Follow-up|1|||
105590554|NCT00920686|364162636|FG000|Overall Study|Study drug dosing criteria not met|17|||
105590555|NCT00920686|364162637|FG001|Overall Study|Study drug dosing criteria not met|19|||
105590556|NCT00920686|364162638|FG002|Overall Study|Study drug dosing criteria not met|12|||
105590557|NCT05193318|364162640|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
105590558|NCT05193318|364162640|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
105590559|NCT01833065|364162641|FG000|Overall Study|Adverse Event|6|||
105590560|NCT01833065|364162642|FG001|Overall Study|Adverse Event|1|||
105590561|NCT01833065|364162643|FG002|Overall Study|Adverse Event|0|||
105590562|NCT01833065|364162644|FG003|Overall Study|Adverse Event|2|||
105590563|NCT01833065|364162645|FG004|Overall Study|Adverse Event|3|||
105590564|NCT01833065|364162641|FG000|Overall Study|Protocol Violation|1|||
105590565|NCT01833065|364162642|FG001|Overall Study|Protocol Violation|0|||
105590566|NCT01833065|364162643|FG002|Overall Study|Protocol Violation|0|||
105434058|NCT02528357|363595424|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434059|NCT02528357|363595425|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434060|NCT02528357|363595426|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434061|NCT02528357|363595427|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434062|NCT02528357|363595428|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434063|NCT02528357|363595429|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105590567|NCT01833065|364162644|FG003|Overall Study|Protocol Violation|0|||
105590568|NCT01833065|364162645|FG004|Overall Study|Protocol Violation|2|||
105590569|NCT01833065|364162641|FG000|Overall Study|Lost to Follow-up|1|||
105590570|NCT01833065|364162642|FG001|Overall Study|Lost to Follow-up|0|||
105590571|NCT01833065|364162643|FG002|Overall Study|Lost to Follow-up|0|||
105590572|NCT01833065|364162644|FG003|Overall Study|Lost to Follow-up|0|||
105590573|NCT01833065|364162645|FG004|Overall Study|Lost to Follow-up|3|||
105590574|NCT01833065|364162641|FG000|Overall Study|Withdrawal by Subject|6|||
105590575|NCT01833065|364162642|FG001|Overall Study|Withdrawal by Subject|2|||
105590576|NCT01833065|364162643|FG002|Overall Study|Withdrawal by Subject|4|||
105590577|NCT01833065|364162644|FG003|Overall Study|Withdrawal by Subject|3|||
105590578|NCT01833065|364162645|FG004|Overall Study|Withdrawal by Subject|11|||
105590579|NCT01833065|364162641|FG000|Overall Study|Subject's substantial non-compliance|0|||
105590580|NCT01833065|364162642|FG001|Overall Study|Subject's substantial non-compliance|1|||
105590581|NCT01833065|364162643|FG002|Overall Study|Subject's substantial non-compliance|0|||
105590582|NCT01833065|364162644|FG003|Overall Study|Subject's substantial non-compliance|0|||
105590583|NCT01833065|364162645|FG004|Overall Study|Subject's substantial non-compliance|0|||
105590584|NCT01833065|364162641|FG000|Overall Study|Trial terminated by sponsor|8|||
105590585|NCT01833065|364162642|FG001|Overall Study|Trial terminated by sponsor|8|||
105590586|NCT01833065|364162643|FG002|Overall Study|Trial terminated by sponsor|7|||
105590587|NCT01833065|364162644|FG003|Overall Study|Trial terminated by sponsor|3|||
105590588|NCT01833065|364162645|FG004|Overall Study|Trial terminated by sponsor|13|||
105590589|NCT01833065|364162641|FG000|Overall Study|Others|2|||
105590590|NCT01833065|364162642|FG001|Overall Study|Others|1|||
105590591|NCT01833065|364162643|FG002|Overall Study|Others|1|||
105590592|NCT01833065|364162644|FG003|Overall Study|Others|1|||
105590593|NCT01833065|364162645|FG004|Overall Study|Others|4|||
105590594|NCT00015457|364162654|FG000|First Intervention|Adverse Event|0|||
105434064|NCT02528357|363595430|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105590595|NCT00015457|364162655|FG001|First Intervention|Adverse Event|2|||
105590596|NCT00015457|364162654|FG000|First Intervention|Lack of Efficacy|0|||
105590597|NCT00015457|364162655|FG001|First Intervention|Lack of Efficacy|1|||
105590598|NCT00015457|364162654|FG000|Second Intervention|Withdrawal by Subject|1|||
105590599|NCT00015457|364162655|FG001|Second Intervention|Withdrawal by Subject|0|||
105590600|NCT03095508|364162656|FG000|Overall Study|Adverse Event|0|||
105590601|NCT03095508|364162657|FG001|Overall Study|Adverse Event|1|||
105590602|NCT01710514|364162658|FG000|Overall Study|Adverse Event|6|||
105590603|NCT01710514|364162659|FG001|Overall Study|Adverse Event|7|||
105434065|NCT02528357|363595431|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434066|NCT02528357|363595432|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434067|NCT02528357|363595433|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434068|NCT02528357|363595434|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434069|NCT02528357|363595435|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434070|NCT02528357|363595436|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434071|NCT02528357|363595437|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105434072|NCT02528357|363595438|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
105434073|NCT02528357|363595439|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
105434074|NCT02528357|363595440|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
105434075|NCT01455220|363595441|FG000|Overall Study|screen fail|30|||
105434076|NCT02438813|363595444|FG000|Overall Study|Patient Decision|59|||
105434077|NCT02438813|363595444|FG000|Overall Study|Patient Lost to Follow-Up|137|||
105434078|NCT02438813|363595444|FG000|Overall Study|Study Ended by Sponsor|80|||
105434079|NCT02438813|363595444|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
105434080|NCT00558272|363595449|FG000|Overall Study|Adverse Event|10|||
105434081|NCT00558272|363595450|FG001|Overall Study|Adverse Event|0|||
105434082|NCT00558272|363595449|FG000|Overall Study|Death|1|||
105434083|NCT00558272|363595450|FG001|Overall Study|Death|0|||
105434084|NCT00558272|363595449|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
105434085|NCT00558272|363595450|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
105434086|NCT00558272|363595449|FG000|Overall Study|AZ study team decision|0|||
105434087|NCT00558272|363595450|FG001|Overall Study|AZ study team decision|1|||
105434088|NCT00558272|363595449|FG000|Overall Study|Incorrectly enrolled|1|||
105434089|NCT00558272|363595450|FG001|Overall Study|Incorrectly enrolled|0|||
105434090|NCT00558272|363595449|FG000|Overall Study|Withdrawal by Subject|0|||
105434091|NCT00558272|363595450|FG001|Overall Study|Withdrawal by Subject|1|||
105434092|NCT00377364|363595451|FG000|Overall Study|Lost to Follow-up|1|||
105434093|NCT00377364|363595452|FG001|Overall Study|Lost to Follow-up|0|||
105434094|NCT00377364|363595451|FG000|Overall Study|Withdrawal by Subject|1|||
105434095|NCT00377364|363595452|FG001|Overall Study|Withdrawal by Subject|0|||
105434096|NCT02986854|363595453|FG000|Overall Study|Withdrawal by Subject|0|||
105434097|NCT02986854|363595454|FG001|Overall Study|Withdrawal by Subject|1|||
105434098|NCT02986854|363595455|FG002|Overall Study|Withdrawal by Subject|1|||
105434099|NCT02986854|363595453|FG000|Overall Study|Lost to Follow-up|3|||
105434100|NCT02986854|363595454|FG001|Overall Study|Lost to Follow-up|11|||
105434101|NCT02986854|363595455|FG002|Overall Study|Lost to Follow-up|2|||
105434102|NCT00086411|363595456|FG000|Overall Study|Lost to Follow-up|11|||
105434103|NCT00086411|363595457|FG001|Overall Study|Lost to Follow-up|11|||
105434104|NCT00086411|363595458|FG002|Overall Study|Lost to Follow-up|13|||
105434105|NCT00086411|363595459|FG003|Overall Study|Lost to Follow-up|12|||
105434106|NCT03442296|363595460|FG000|3 Month Follow-up|Death|3|||
105434107|NCT03442296|363595461|FG001|3 Month Follow-up|Death|1|||
105434108|NCT03442296|363595460|FG000|3 Month Follow-up|Lost to Follow-up|1|||
105434109|NCT03442296|363595461|FG001|3 Month Follow-up|Lost to Follow-up|1|||
105434110|NCT03442296|363595460|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
105434111|NCT03442296|363595461|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
105434112|NCT03442296|363595460|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
105434113|NCT03442296|363595461|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
105434114|NCT03442296|363595460|FG000|12 Month Follow-up|Incomplete measurement|1|||
105434115|NCT03442296|363595461|FG001|12 Month Follow-up|Incomplete measurement|1|||
105434116|NCT01266590|363597456|FG000|Overall Study|Adverse Event|3|||
105434117|NCT01266590|363597456|FG000|Overall Study|Lost to Follow-up|1|||
105434118|NCT01266590|363597456|FG000|Overall Study|Withdrawal by Subject|1|||
105434119|NCT01266590|363597456|FG000|Overall Study|Physician Decision|1|||
105434120|NCT06359080|363597457|FG000|Overall Study|Withdrawal by Subject|3|||
105434121|NCT01306656|363597458|FG000|Overall Study|Lost to Follow-up|1|||
105434122|NCT01306656|363597459|FG001|Overall Study|Lost to Follow-up|0|||
105434123|NCT01286077|363597460|FG000|Overall Study|Adverse Event|2|||
105434124|NCT01286077|363597461|FG001|Overall Study|Adverse Event|0|||
105590604|NCT01710514|364162658|FG000|Overall Study|Withdrawal by Subject|1|||
105590605|NCT01710514|364162659|FG001|Overall Study|Withdrawal by Subject|0|||
105590606|NCT01651949|364162662|FG000|Overall Study|Unknown status|4|||
105434125|NCT01286077|363597460|FG000|Overall Study|Death|1|||
105434126|NCT01286077|363597461|FG001|Overall Study|Death|0|||
105434127|NCT01286077|363597460|FG000|Overall Study|Protocol Violation|1|||
105434128|NCT01286077|363597461|FG001|Overall Study|Protocol Violation|1|||
105434129|NCT01286077|363597460|FG000|Overall Study|Withdrawal by Subject|0|||
105434130|NCT01286077|363597461|FG001|Overall Study|Withdrawal by Subject|2|||
105434131|NCT01286077|363597460|FG000|Overall Study|Intercurrent illness|1|||
105434132|NCT01286077|363597461|FG001|Overall Study|Intercurrent illness|0|||
105434133|NCT01286077|363597460|FG000|Overall Study|Non-compliance|1|||
105434134|NCT01286077|363597461|FG001|Overall Study|Non-compliance|0|||
105434135|NCT01286077|363597460|FG000|Overall Study|The subject starts with alternative MMY|0|||
105434136|NCT01286077|363597461|FG001|Overall Study|The subject starts with alternative MMY|3|||
105434137|NCT01286077|363597460|FG000|Overall Study|Patient's decision to stop treatment|3|||
105434138|NCT01286077|363597461|FG001|Overall Study|Patient's decision to stop treatment|0|||
105434139|NCT01286077|363597460|FG000|Overall Study|Progression of disease|0|||
105434140|NCT01286077|363597461|FG001|Overall Study|Progression of disease|1|||
105434141|NCT01286077|363597460|FG000|Overall Study|refill medication not received in time|1|||
105434142|NCT01286077|363597461|FG001|Overall Study|refill medication not received in time|0|||
105434143|NCT00771615|363597462|FG000|Overall Study|Withdrawal by Subject|0|||
105434144|NCT00771615|363597463|FG001|Overall Study|Withdrawal by Subject|1|||
105434145|NCT00771615|363597464|FG002|Overall Study|Withdrawal by Subject|0|||
105434146|NCT00771615|363597465|FG003|Overall Study|Withdrawal by Subject|0|||
105434147|NCT00771615|363597466|FG004|Overall Study|Withdrawal by Subject|0|||
105434148|NCT00771615|363597467|FG005|Overall Study|Withdrawal by Subject|0|||
105434149|NCT00771615|363597468|FG006|Overall Study|Withdrawal by Subject|0|||
105434150|NCT00771615|363597469|FG007|Overall Study|Withdrawal by Subject|1|||
105434151|NCT00771615|363597470|FG008|Overall Study|Withdrawal by Subject|0|||
105434152|NCT00771615|363597462|FG000|Overall Study|Lost to Follow-up|1|||
105434153|NCT00771615|363597463|FG001|Overall Study|Lost to Follow-up|1|||
105434154|NCT00771615|363597464|FG002|Overall Study|Lost to Follow-up|1|||
105434155|NCT00771615|363597465|FG003|Overall Study|Lost to Follow-up|1|||
105434156|NCT00771615|363597466|FG004|Overall Study|Lost to Follow-up|0|||
105434157|NCT00771615|363597467|FG005|Overall Study|Lost to Follow-up|1|||
105434158|NCT00771615|363597468|FG006|Overall Study|Lost to Follow-up|1|||
105434159|NCT00771615|363597469|FG007|Overall Study|Lost to Follow-up|0|||
105434160|NCT00771615|363597470|FG008|Overall Study|Lost to Follow-up|0|||
105434161|NCT02455076|363597471|FG000|Inpatient|Withdrawal by Subject|1|||
105434162|NCT02455076|363597472|FG001|Inpatient|Withdrawal by Subject|0|||
105434163|NCT02455076|363597473|FG002|Inpatient|Withdrawal by Subject|0|||
105434164|NCT02455076|363597474|FG003|Inpatient|Withdrawal by Subject|0|||
105434165|NCT02455076|363597475|FG004|Inpatient|Withdrawal by Subject|0|||
105434166|NCT02455076|363597471|FG000|Inpatient|Discharged <24 h after admission|0|||
105434167|NCT02455076|363597472|FG001|Inpatient|Discharged <24 h after admission|1|||
105434168|NCT02455076|363597473|FG002|Inpatient|Discharged <24 h after admission|0|||
105434169|NCT02455076|363597474|FG003|Inpatient|Discharged <24 h after admission|0|||
105434170|NCT02455076|363597475|FG004|Inpatient|Discharged <24 h after admission|0|||
105590607|NCT01651949|364162663|FG001|Overall Study|Unknown status|4|||
105590608|NCT01651949|364162664|FG002|Overall Study|Unknown status|0|||
105590609|NCT01651949|364162662|FG000|Overall Study|Lost to Follow-up|30|||
105590610|NCT01651949|364162663|FG001|Overall Study|Lost to Follow-up|56|||
105590611|NCT01651949|364162664|FG002|Overall Study|Lost to Follow-up|20|||
105590612|NCT01651949|364162662|FG000|Overall Study|Protocol Violation|0|||
105590613|NCT01651949|364162663|FG001|Overall Study|Protocol Violation|2|||
105590614|NCT01651949|364162664|FG002|Overall Study|Protocol Violation|1|||
105590615|NCT01651949|364162662|FG000|Overall Study|Physician Decision|0|||
105590616|NCT01651949|364162663|FG001|Overall Study|Physician Decision|2|||
105590617|NCT01651949|364162664|FG002|Overall Study|Physician Decision|0|||
105590618|NCT01651949|364162662|FG000|Overall Study|Adverse Event|0|||
105590619|NCT01651949|364162663|FG001|Overall Study|Adverse Event|2|||
105590620|NCT01651949|364162664|FG002|Overall Study|Adverse Event|1|||
105590621|NCT01651949|364162662|FG000|Overall Study|Screen failure|2|||
105590622|NCT01651949|364162663|FG001|Overall Study|Screen failure|2|||
105590623|NCT01651949|364162664|FG002|Overall Study|Screen failure|0|||
105590624|NCT01651949|364162662|FG000|Overall Study|Withdrawal by Subject|17|||
105434171|NCT02455076|363597471|FG000|Inpatient|Adverse Event|3|||
105434172|NCT02455076|363597472|FG001|Inpatient|Adverse Event|0|||
105434173|NCT02455076|363597473|FG002|Inpatient|Adverse Event|0|||
105503091|NCT02499783|363852819|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
105503092|NCT02499783|363852820|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
105503093|NCT02499783|363852821|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
105503094|NCT02499783|363852819|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
105503095|NCT02499783|363852820|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
105503096|NCT02499783|363852821|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
105503097|NCT02499783|363852819|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
105503098|NCT02499783|363852820|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
105503099|NCT02499783|363852821|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
105503100|NCT01866293|363852822|FG000|Overall Study|Adverse Event|2|||
105503101|NCT01540838|363852823|FG000|Overall Study|Open nasogastric tube|9|||
105503102|NCT01540838|363852824|FG001|Overall Study|Open nasogastric tube|7|||
105503103|NCT01540838|363852823|FG000|Overall Study|Treatment doses missing|8|||
105503104|NCT01540838|363852824|FG001|Overall Study|Treatment doses missing|12|||
105503105|NCT01540838|363852823|FG000|Overall Study|Additional antibiotic treatment|1|||
105434174|NCT02455076|363597474|FG003|Inpatient|Adverse Event|0|||
105434175|NCT02455076|363597475|FG004|Inpatient|Adverse Event|0|||
105434176|NCT02455076|363597471|FG000|Outpatient|Adverse Event|0|||
105434177|NCT02455076|363597472|FG001|Outpatient|Adverse Event|0|||
105434178|NCT02455076|363597473|FG002|Outpatient|Adverse Event|0|||
105434179|NCT02455076|363597474|FG003|Outpatient|Adverse Event|5|||
105434180|NCT02455076|363597475|FG004|Outpatient|Adverse Event|0|||
105434181|NCT02455076|363597471|FG000|Outpatient|Lost to Follow-up|0|||
105434182|NCT02455076|363597472|FG001|Outpatient|Lost to Follow-up|0|||
105434183|NCT02455076|363597473|FG002|Outpatient|Lost to Follow-up|0|||
105434184|NCT02455076|363597474|FG003|Outpatient|Lost to Follow-up|1|||
105434185|NCT02455076|363597475|FG004|Outpatient|Lost to Follow-up|12|||
105434186|NCT00859937|363597476|FG000|Overall Study|Protocol Violation|1|||
105434187|NCT00859937|363597477|FG001|Overall Study|Protocol Violation|0|||
105434188|NCT00151476|363597478|FG000|FAP Identified Subjects|Protocol Violation|0|||
105434189|NCT00151476|363597479|FG001|FAP Identified Subjects|Protocol Violation|1|||
105434190|NCT00151476|363597478|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
105434191|NCT00151476|363597479|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
105434192|NCT00151476|363597478|FG000|FAP Analyzed Subjects|Other study participation|0|||
105434193|NCT00151476|363597479|FG001|FAP Analyzed Subjects|Other study participation|1|||
105434194|NCT03446456|363597480|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
105434195|NCT03446456|363597481|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
105434196|NCT03446456|363597480|FG000|Overall Study|Lost to Follow-up|1|||
105434197|NCT03446456|363597481|FG001|Overall Study|Lost to Follow-up|3|||
105434198|NCT03446456|363597480|FG000|Overall Study|Participant failed the toxicology test|1|||
105434199|NCT03446456|363597481|FG001|Overall Study|Participant failed the toxicology test|0|||
105434200|NCT03446456|363597480|FG000|Overall Study|Break down of the experimental equipment|1|||
105434201|NCT03446456|363597481|FG001|Overall Study|Break down of the experimental equipment|0|||
105434202|NCT02478164|363597482|FG000|Overall Study|Lack of Efficacy|13|||
105434203|NCT02478164|363597482|FG000|Overall Study|Adverse Event|1|||
105434204|NCT02478164|363597482|FG000|Overall Study|Withdrawal by Subject|1|||
105434205|NCT02704689|363597487|FG000|Overall Study|Physician Decision|1|||
105434206|NCT02704689|363597487|FG000|Overall Study|Study device not implanted|2|||
105434207|NCT02428205|363597488|FG000|Overall Study|Lack of Efficacy|1|||
105434208|NCT02428205|363597489|FG001|Overall Study|Lack of Efficacy|0|||
105434209|NCT02428205|363597488|FG000|Overall Study|Lost to Follow-up|1|||
105434210|NCT02428205|363597489|FG001|Overall Study|Lost to Follow-up|1|||
105434211|NCT02428205|363597488|FG000|Overall Study|Worse behavior|0|||
105434212|NCT02428205|363597489|FG001|Overall Study|Worse behavior|1|||
105434213|NCT03194438|363597490|FG000|Overall Study|Withdrawal by Subject|2|||
105434214|NCT03266172|363597495|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
105434215|NCT03266172|363597496|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
105434216|NCT03266172|363597497|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
105434217|NCT03266172|363597495|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
105434218|NCT03266172|363597496|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
105434219|NCT03266172|363597497|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
105434220|NCT03266172|363597495|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
105434221|NCT03266172|363597496|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
105434222|NCT03266172|363597497|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
105434223|NCT03266172|363597495|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
105434224|NCT03266172|363597496|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
105434225|NCT03266172|363597497|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
105434226|NCT03266172|363597495|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
105434227|NCT03266172|363597496|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
105434228|NCT03266172|363597497|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
105434229|NCT03266172|363597495|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
105434230|NCT03266172|363597496|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
105434231|NCT03266172|363597497|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
105434232|NCT03743064|363597498|FG000|Overall Study|Adverse Event|7|||
105434233|NCT03743064|363597499|FG001|Overall Study|Adverse Event|9|||
105434234|NCT03743064|363597498|FG000|Overall Study|Death|25|||
105434235|NCT03743064|363597499|FG001|Overall Study|Death|28|||
105434236|NCT03743064|363597498|FG000|Overall Study|Lost to Follow-up|3|||
105434237|NCT03743064|363597499|FG001|Overall Study|Lost to Follow-up|6|||
105434238|NCT03743064|363597498|FG000|Overall Study|Withdrawal by Subject|28|||
105434239|NCT03743064|363597499|FG001|Overall Study|Withdrawal by Subject|25|||
105434240|NCT03743064|363597498|FG000|Overall Study|Physician Decision|2|||
105434241|NCT03743064|363597499|FG001|Overall Study|Physician Decision|4|||
105434242|NCT03743064|363597498|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
105434243|NCT03743064|363597499|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
105434244|NCT03006887|363597500|FG000|Overall Study|Adverse Event|1|||
105434245|NCT03836677|363597501|FG000|Period 1|Adverse Event|0|||
105434246|NCT03836677|363597502|FG001|Period 1|Adverse Event|1|||
105434247|NCT03836677|363597501|FG000|Period 2|Severe non-compliance to protocol|1|||
105434248|NCT03836677|363597502|FG001|Period 2|Severe non-compliance to protocol|0|||
105434249|NCT02096263|363597503|FG000|Overall Study|Adverse Event|1|||
105434250|NCT02096263|363597504|FG001|Overall Study|Adverse Event|0|||
105434251|NCT02096263|363597505|FG002|Overall Study|Adverse Event|1|||
105434252|NCT02096263|363597503|FG000|Overall Study|Lost to Follow-up|14|||
105434253|NCT02096263|363597504|FG001|Overall Study|Lost to Follow-up|18|||
105434254|NCT02096263|363597505|FG002|Overall Study|Lost to Follow-up|15|||
105434255|NCT02096263|363597503|FG000|Overall Study|Other|7|||
105434256|NCT02096263|363597504|FG001|Overall Study|Other|9|||
105434257|NCT02096263|363597505|FG002|Overall Study|Other|6|||
105434258|NCT02096263|363597503|FG000|Overall Study|Sponsor study termination|0|||
105434259|NCT02096263|363597504|FG001|Overall Study|Sponsor study termination|0|||
105434260|NCT02096263|363597505|FG002|Overall Study|Sponsor study termination|1|||
105434261|NCT02096263|363597503|FG000|Overall Study|Protocol Violation|7|||
105434262|NCT02096263|363597504|FG001|Overall Study|Protocol Violation|2|||
105434263|NCT02096263|363597505|FG002|Overall Study|Protocol Violation|8|||
105434264|NCT02096263|363597503|FG000|Overall Study|Withdrawal by Subject|5|||
105434265|NCT02096263|363597504|FG001|Overall Study|Withdrawal by Subject|7|||
105434266|NCT02096263|363597505|FG002|Overall Study|Withdrawal by Subject|8|||
105434267|NCT03322423|363597506|FG000|Period 1|Subject no longer eligible|0|||
105434268|NCT03322423|363597507|FG001|Period 1|Subject no longer eligible|1|||
105434269|NCT03322423|363597506|FG000|Period 1|Withdrawal by Subject|0|||
105434270|NCT03322423|363597507|FG001|Period 1|Withdrawal by Subject|1|||
105434271|NCT03322423|363597506|FG000|Period 1|Incorrect Lens Dispensed|1|||
105434272|NCT03322423|363597507|FG001|Period 1|Incorrect Lens Dispensed|0|||
105434273|NCT03322423|363597506|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
105434274|NCT03322423|363597507|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
105434275|NCT03322423|363597506|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
105434276|NCT03322423|363597507|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
105434277|NCT03322423|363597506|FG000|Period 2|Protocol Violation|1|||
105434278|NCT03322423|363597507|FG001|Period 2|Protocol Violation|0|||
105434279|NCT03322423|363597506|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
105434280|NCT03322423|363597507|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
105434281|NCT02976103|363597508|FG000|Overall Study|Withdrawal by Subject|1|||
105434282|NCT02976103|363597509|FG001|Overall Study|Withdrawal by Subject|0|||
105434283|NCT02976103|363597508|FG000|Overall Study|Lost to Follow-up|12|||
105434284|NCT02976103|363597509|FG001|Overall Study|Lost to Follow-up|8|||
105434285|NCT01985360|363597510|FG000|Overall Study|Withdrawal by Subject|4|||
105434286|NCT01985360|363597511|FG001|Overall Study|Withdrawal by Subject|0|||
105434287|NCT01985360|363597510|FG000|Overall Study|Lost to Follow-up|5|||
105434288|NCT01985360|363597511|FG001|Overall Study|Lost to Follow-up|3|||
105434289|NCT00079677|363597512|FG000|Overall Study|Adverse Event|5|||
105434290|NCT00079677|363597513|FG001|Overall Study|Adverse Event|6|||
105434291|NCT00079677|363597512|FG000|Overall Study|Lack of Efficacy|1|||
105434292|NCT00079677|363597513|FG001|Overall Study|Lack of Efficacy|0|||
105434293|NCT00079677|363597512|FG000|Overall Study|Lost to Follow-up|2|||
105434294|NCT00079677|363597513|FG001|Overall Study|Lost to Follow-up|2|||
105434295|NCT00079677|363597512|FG000|Overall Study|Physician Decision|3|||
105434296|NCT00079677|363597513|FG001|Overall Study|Physician Decision|0|||
105434297|NCT00079677|363597512|FG000|Overall Study|Protocol Violation|2|||
105434298|NCT00079677|363597513|FG001|Overall Study|Protocol Violation|3|||
105434299|NCT00079677|363597512|FG000|Overall Study|Withdrawal by Subject|5|||
105434300|NCT00079677|363597513|FG001|Overall Study|Withdrawal by Subject|3|||
105434301|NCT00079677|363597512|FG000|Overall Study|Miscellaneous|2|||
105434302|NCT00079677|363597513|FG001|Overall Study|Miscellaneous|0|||
105434303|NCT01300455|363597514|FG000|Washout|Withdrawal by Subject|1|||
105434304|NCT01300455|363597515|FG001|Washout|Withdrawal by Subject|0|||
105434305|NCT04881747|363597519|FG000|Period 2 Washout|Adverse Event|1|||
105434306|NCT04881747|363597520|FG001|Period 2 Washout|Adverse Event|0|||
105434307|NCT04881747|363597521|FG002|Period 2 Washout|Adverse Event|0|||
105434308|NCT04881747|363597522|FG003|Period 2 Washout|Adverse Event|0|||
105434309|NCT04881747|363597523|FG004|Period 2 Washout|Adverse Event|1|||
105434310|NCT04881747|363597524|FG005|Period 2 Washout|Adverse Event|0|||
105503106|NCT01540838|363852824|FG001|Overall Study|Additional antibiotic treatment|2|||
105434311|NCT04881747|363597519|FG000|Period 2 Washout|Withdrawal by Subject|1|||
105434312|NCT04881747|363597520|FG001|Period 2 Washout|Withdrawal by Subject|0|||
105434313|NCT04881747|363597521|FG002|Period 2 Washout|Withdrawal by Subject|0|||
105434314|NCT04881747|363597522|FG003|Period 2 Washout|Withdrawal by Subject|1|||
105434315|NCT04881747|363597523|FG004|Period 2 Washout|Withdrawal by Subject|0|||
105434316|NCT04881747|363597524|FG005|Period 2 Washout|Withdrawal by Subject|0|||
105434317|NCT01270256|363597525|FG000|Overall Study|Withdrawal by Subject|1|||
105434318|NCT01270256|363597526|FG001|Overall Study|Withdrawal by Subject|0|||
105434319|NCT02177838|363597527|FG000|Overall Study|Withdrawal by Subject|1|||
105434320|NCT02177838|363597527|FG000|Overall Study|Physician Decision|1|||
105434321|NCT02177838|363597527|FG000|Overall Study|Death|1|||
105434322|NCT02879578|363597528|FG000|Overall Study|Adverse Event|1|||
105434323|NCT02879578|363597529|FG001|Overall Study|Adverse Event|2|||
105434324|NCT02879578|363597530|FG002|Overall Study|Adverse Event|14|||
105434325|NCT02879578|363597528|FG000|Overall Study|Protocol Violation|0|||
105434326|NCT02879578|363597529|FG001|Overall Study|Protocol Violation|1|||
105434327|NCT02879578|363597530|FG002|Overall Study|Protocol Violation|1|||
105434328|NCT02879578|363597528|FG000|Overall Study|Withdrawal by Subject|8|||
105434329|NCT02879578|363597529|FG001|Overall Study|Withdrawal by Subject|6|||
105434330|NCT02879578|363597530|FG002|Overall Study|Withdrawal by Subject|9|||
105434331|NCT02879578|363597528|FG000|Overall Study|Lost to Follow-up|1|||
105434332|NCT02879578|363597529|FG001|Overall Study|Lost to Follow-up|0|||
105434333|NCT02879578|363597530|FG002|Overall Study|Lost to Follow-up|4|||
105434334|NCT02879578|363597528|FG000|Overall Study|Physician Decision|0|||
105434335|NCT02879578|363597529|FG001|Overall Study|Physician Decision|0|||
105434336|NCT02879578|363597530|FG002|Overall Study|Physician Decision|4|||
105434337|NCT00454649|363597533|FG000|Overall Study|Lack of Efficacy|2|||
105434338|NCT00454649|363597534|FG001|Overall Study|Lack of Efficacy|2|||
105434339|NCT00454649|363597535|FG002|Overall Study|Lack of Efficacy|10|||
105434340|NCT00454649|363597536|FG003|Overall Study|Lack of Efficacy|3|||
105434341|NCT00454649|363597537|FG004|Overall Study|Lack of Efficacy|0|||
105434342|NCT00454649|363597538|FG005|Overall Study|Lack of Efficacy|4|||
105434343|NCT00454649|363597539|FG006|Overall Study|Lack of Efficacy|5|||
105434344|NCT00454649|363597540|FG007|Overall Study|Lack of Efficacy|13|||
105434345|NCT00454649|363597541|FG008|Overall Study|Lack of Efficacy|10|||
105434346|NCT00454649|363597542|FG009|Overall Study|Lack of Efficacy|2|||
105434347|NCT00454649|363597533|FG000|Overall Study|Adverse Event|0|||
105434348|NCT00454649|363597534|FG001|Overall Study|Adverse Event|1|||
105434349|NCT00454649|363597535|FG002|Overall Study|Adverse Event|3|||
105434350|NCT00454649|363597536|FG003|Overall Study|Adverse Event|0|||
105434351|NCT00454649|363597537|FG004|Overall Study|Adverse Event|1|||
105434352|NCT00454649|363597538|FG005|Overall Study|Adverse Event|2|||
105434353|NCT00454649|363597539|FG006|Overall Study|Adverse Event|3|||
105434354|NCT00454649|363597540|FG007|Overall Study|Adverse Event|4|||
105434355|NCT00454649|363597541|FG008|Overall Study|Adverse Event|6|||
105434356|NCT00454649|363597542|FG009|Overall Study|Adverse Event|2|||
105434357|NCT00454649|363597533|FG000|Overall Study|Lost to Follow-up|0|||
105434358|NCT00454649|363597534|FG001|Overall Study|Lost to Follow-up|0|||
105434359|NCT00454649|363597535|FG002|Overall Study|Lost to Follow-up|1|||
105434360|NCT00454649|363597536|FG003|Overall Study|Lost to Follow-up|0|||
105434361|NCT00454649|363597537|FG004|Overall Study|Lost to Follow-up|0|||
105434362|NCT00454649|363597538|FG005|Overall Study|Lost to Follow-up|0|||
105434363|NCT00454649|363597539|FG006|Overall Study|Lost to Follow-up|1|||
105434364|NCT00454649|363597540|FG007|Overall Study|Lost to Follow-up|0|||
105434365|NCT00454649|363597541|FG008|Overall Study|Lost to Follow-up|0|||
105434366|NCT00454649|363597542|FG009|Overall Study|Lost to Follow-up|0|||
105434367|NCT00454649|363597533|FG000|Overall Study|Other|1|||
105434368|NCT00454649|363597534|FG001|Overall Study|Other|1|||
105434369|NCT00454649|363597535|FG002|Overall Study|Other|5|||
105434370|NCT00454649|363597536|FG003|Overall Study|Other|3|||
105434371|NCT00454649|363597537|FG004|Overall Study|Other|0|||
105503107|NCT01540838|363852823|FG000|Overall Study|Died before treatment initiation|1|||
105503108|NCT01540838|363852824|FG001|Overall Study|Died before treatment initiation|1|||
105503109|NCT01540838|363852823|FG000|Overall Study|Not BM. Other treatment|3|||
105503110|NCT01540838|363852824|FG001|Overall Study|Not BM. Other treatment|1|||
105503111|NCT00555971|363852825|FG000|Overall Study|Adverse Event|1|||
105503112|NCT00555971|363852826|FG001|Overall Study|Adverse Event|1|||
105503113|NCT02130570|363852827|FG000|Overall Study|Death|3|||
105503114|NCT02130570|363852828|FG001|Overall Study|Death|5|||
105503115|NCT02130570|363852827|FG000|Overall Study|Withdrawal by Subject|6|||
105503116|NCT02130570|363852828|FG001|Overall Study|Withdrawal by Subject|3|||
105503117|NCT02130570|363852827|FG000|Overall Study|Part of practice that discontinued study|0|||
105503118|NCT02130570|363852828|FG001|Overall Study|Part of practice that discontinued study|5|||
105503119|NCT01849783|363852829|FG000|Overall Study|Adverse Event|5|||
105503120|NCT01849783|363852829|FG000|Overall Study|Death|2|||
105503121|NCT01849783|363852829|FG000|Overall Study|Physician Decision|1|||
105503122|NCT01849783|363852829|FG000|Overall Study|Withdrawal by Subject|1|||
105503123|NCT01849783|363852829|FG000|Overall Study|Unable to comply|2|||
105503124|NCT01849783|363852829|FG000|Overall Study|Disease progression|11|||
105503125|NCT03948581|363852830|FG000|Overall Study|Lost to Follow-up|0|||
105503126|NCT03948581|363852831|FG001|Overall Study|Lost to Follow-up|1|||
105503127|NCT03641339|363852832|FG000|Overall Study|Physician Decision|1|||
105503128|NCT03641339|363852833|FG001|Overall Study|Physician Decision|0|||
105503129|NCT03641339|363852834|FG002|Overall Study|Physician Decision|0|||
105434372|NCT00454649|363597538|FG005|Overall Study|Other|0|||
105434373|NCT00454649|363597539|FG006|Overall Study|Other|0|||
105434374|NCT00454649|363597540|FG007|Overall Study|Other|0|||
105434375|NCT00454649|363597541|FG008|Overall Study|Other|3|||
105434376|NCT00454649|363597542|FG009|Overall Study|Other|1|||
105434377|NCT00454649|363597533|FG000|Overall Study|Withdrawal by Subject|0|||
105434378|NCT00454649|363597534|FG001|Overall Study|Withdrawal by Subject|0|||
105434379|NCT00454649|363597535|FG002|Overall Study|Withdrawal by Subject|0|||
105434380|NCT00454649|363597536|FG003|Overall Study|Withdrawal by Subject|0|||
105434381|NCT00454649|363597537|FG004|Overall Study|Withdrawal by Subject|0|||
105434382|NCT00454649|363597538|FG005|Overall Study|Withdrawal by Subject|1|||
105434383|NCT00454649|363597539|FG006|Overall Study|Withdrawal by Subject|0|||
105434384|NCT00454649|363597540|FG007|Overall Study|Withdrawal by Subject|2|||
105434385|NCT00454649|363597541|FG008|Overall Study|Withdrawal by Subject|1|||
105434386|NCT00454649|363597542|FG009|Overall Study|Withdrawal by Subject|0|||
105434387|NCT03203291|363597543|FG000|Overall Study|Withdrawal by Subject|1|||
105434388|NCT02540265|363597544|FG000|Overall Study|Lost to Follow-up|0|||
105434389|NCT02540265|363597545|FG001|Overall Study|Lost to Follow-up|0|||
105434390|NCT02540265|363597546|FG002|Overall Study|Lost to Follow-up|1|||
105434391|NCT04349033|363597547|FG000|Overall Study|Lost to Follow-up|3|||
105434392|NCT04349033|363597548|FG001|Overall Study|Lost to Follow-up|1|||
105434393|NCT04349033|363597549|FG002|Overall Study|Lost to Follow-up|1|||
105434394|NCT02014584|363597552|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
105434395|NCT02014584|363597553|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
105434396|NCT02014584|363597554|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
105434397|NCT02014584|363597555|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
105434398|NCT02014584|363597556|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
105434399|NCT02014584|363597557|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
105434400|NCT02014584|363597552|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
105434401|NCT02014584|363597553|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
105434402|NCT02014584|363597554|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
105434403|NCT02014584|363597555|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
105434404|NCT02014584|363597556|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
105434405|NCT02014584|363597557|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
105434406|NCT02014584|363597552|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
105434407|NCT02014584|363597553|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
105434408|NCT02014584|363597554|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
105434409|NCT02014584|363597555|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
105434410|NCT02014584|363597556|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
105434411|NCT02014584|363597557|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
105434412|NCT02014584|363597552|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
105434413|NCT02014584|363597553|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
105434414|NCT02014584|363597554|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
105434415|NCT02014584|363597555|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
105434416|NCT02014584|363597556|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
105434417|NCT02014584|363597557|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
105434418|NCT02014584|363597552|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
105434419|NCT02014584|363597553|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
105434420|NCT02014584|363597554|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
105434421|NCT02014584|363597555|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
105434422|NCT02014584|363597556|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
105434423|NCT02014584|363597557|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
105434424|NCT01972789|363597558|FG000|Overall Study|Adverse Event|11|||
105434425|NCT01972789|363597559|FG001|Overall Study|Adverse Event|4|||
105434426|NCT01972789|363597558|FG000|Overall Study|Subject withdrew consent|14|||
105434427|NCT01972789|363597559|FG001|Overall Study|Subject withdrew consent|12|||
105434428|NCT01972789|363597558|FG000|Overall Study|Lost to Follow-up|4|||
105434429|NCT01972789|363597559|FG001|Overall Study|Lost to Follow-up|7|||
105434430|NCT01972789|363597558|FG000|Overall Study|Death|7|||
105434431|NCT01972789|363597559|FG001|Overall Study|Death|5|||
105434432|NCT01972789|363597558|FG000|Overall Study|Protocol deviation|1|||
105434433|NCT01972789|363597559|FG001|Overall Study|Protocol deviation|0|||
105434434|NCT01972789|363597558|FG000|Overall Study|Physician Decision|3|||
105434435|NCT01972789|363597559|FG001|Overall Study|Physician Decision|2|||
105434436|NCT01704456|363597565|FG000|Overall Study|Lost to Follow-up|8|||
105434437|NCT01704456|363597566|FG001|Overall Study|Lost to Follow-up|14|||
105434438|NCT03596450|363597567|FG000|Overall Study|Death|9|||
105434439|NCT03596450|363597568|FG001|Overall Study|Death|9|||
105434440|NCT03596450|363597567|FG000|Overall Study|Protocol Violation|18|||
105434441|NCT03596450|363597568|FG001|Overall Study|Protocol Violation|26|||
105434442|NCT03596450|363597567|FG000|Overall Study|Lost to Follow-up|50|||
105434443|NCT03596450|363597568|FG001|Overall Study|Lost to Follow-up|56|||
105434444|NCT03596450|363597567|FG000|Overall Study|Adverse Event|14|||
105434445|NCT03596450|363597568|FG001|Overall Study|Adverse Event|7|||
105434446|NCT03596450|363597567|FG000|Overall Study|Withdrawal by Subject|38|||
105434447|NCT03596450|363597568|FG001|Overall Study|Withdrawal by Subject|36|||
105434448|NCT03596450|363597567|FG000|Overall Study|Accidentally Randomized|2|||
105434449|NCT03596450|363597568|FG001|Overall Study|Accidentally Randomized|0|||
105434450|NCT03596450|363597567|FG000|Overall Study|Other reasons|48|||
105434451|NCT03596450|363597568|FG001|Overall Study|Other reasons|53|||
105434452|NCT03596450|363597567|FG000|Overall Study|Pregnancy|2|||
105434453|NCT03596450|363597568|FG001|Overall Study|Pregnancy|0|||
105434454|NCT01403116|363597569|FG000|Overall Study|Adverse Event|7|||
105434455|NCT01403116|363597570|FG001|Overall Study|Adverse Event|4|||
105434456|NCT01403116|363597569|FG000|Overall Study|Lost to Follow-up|7|||
105434457|NCT01403116|363597570|FG001|Overall Study|Lost to Follow-up|5|||
105434458|NCT01403116|363597569|FG000|Overall Study|Withdrawal by Subject|12|||
105434459|NCT01403116|363597570|FG001|Overall Study|Withdrawal by Subject|15|||
105434460|NCT01403116|363597569|FG000|Overall Study|Non-compliance of study drug|3|||
105434461|NCT01403116|363597570|FG001|Overall Study|Non-compliance of study drug|0|||
105434462|NCT01403116|363597569|FG000|Overall Study|Protocol Violation|0|||
105434463|NCT01403116|363597570|FG001|Overall Study|Protocol Violation|1|||
105434464|NCT01403116|363597569|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
105434465|NCT01403116|363597570|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
105434466|NCT01403116|363597569|FG000|Overall Study|Hct >54%|2|||
105434467|NCT01403116|363597570|FG001|Overall Study|Hct >54%|0|||
105434468|NCT01403116|363597569|FG000|Overall Study|unable to keep appointments|0|||
105434469|NCT01403116|363597570|FG001|Overall Study|unable to keep appointments|2|||
105434470|NCT00042666|363597571|FG000|Overall Study|Adverse Event|2|||
105434471|NCT00042666|363597571|FG000|Overall Study|Death|4|||
105434472|NCT00042666|363597571|FG000|Overall Study|Protocol Violation|1|||
105434473|NCT00042666|363597571|FG000|Overall Study|Participant/Physician Perception|1|||
105434474|NCT00042666|363597571|FG000|Overall Study|Progressive Disease|41|||
105434475|NCT00042666|363597571|FG000|Overall Study|Other|1|||
105434476|NCT00042666|363597571|FG000|Overall Study|Other|4|||
105434477|NCT02039856|363597572|FG000|Overall Study|Death|5|||
105434478|NCT02039856|363597573|FG001|Overall Study|Death|3|||
105434479|NCT02039856|363597572|FG000|Overall Study|Partial survey completion|61|||
105434480|NCT02039856|363597573|FG001|Overall Study|Partial survey completion|26|||
105434481|NCT02039856|363597572|FG000|Overall Study|Lost to Follow-up|388|||
105434482|NCT02039856|363597573|FG001|Overall Study|Lost to Follow-up|206|||
105434483|NCT02039856|363597572|FG000|Overall Study|Withdrawal by Subject|1573|||
105434484|NCT02039856|363597573|FG001|Overall Study|Withdrawal by Subject|618|||
105434485|NCT02999633|363597574|FG000|Overall Study|Adverse Event|2|||
105434486|NCT02999633|363597574|FG000|Overall Study|Progressive disease|12|||
105434487|NCT03238924|363597575|FG000|Overall Study|Withdrawal by Subject|2|||
105434488|NCT03238924|363597576|FG001|Overall Study|Withdrawal by Subject|2|||
105434489|NCT02516228|363597578|FG000|Overall Study|Lost to Follow-up|1|||
105434490|NCT02516228|363597578|FG000|Overall Study|Withdrawal by Subject|1|||
105434491|NCT02516228|363597578|FG000|Overall Study|Physician Decision|1|||
105434492|NCT03908970|363597582|FG000|Overall Study|Adverse Event|7|||
105434493|NCT03908970|363597583|FG001|Overall Study|Adverse Event|21|||
105434494|NCT03908970|363597582|FG000|Overall Study|Physician Decision|1|||
105434495|NCT03908970|363597583|FG001|Overall Study|Physician Decision|4|||
105434496|NCT03908970|363597582|FG000|Overall Study|Withdrawal by Subject|9|||
105434497|NCT03908970|363597583|FG001|Overall Study|Withdrawal by Subject|22|||
105434498|NCT01983774|363597584|FG000|Overall Study|Lung Transplant|0|||
105434499|NCT01983774|363597585|FG001|Overall Study|Lung Transplant|1|||
105434500|NCT01983774|363597584|FG000|Overall Study|Lost to Follow-up|1|||
105434501|NCT01983774|363597585|FG001|Overall Study|Lost to Follow-up|0|||
105434502|NCT01274429|363597586|FG000|Overall Study|Study closed do to lack of funding|5|||
105434503|NCT01879072|363597588|FG000|Overall Study|Withdrawal by Subject|121|||
105434504|NCT01879072|363597588|FG000|Overall Study|Not Transplanted|30|||
105434505|NCT05327361|363597589|FG000|Overall Study|Lost to Follow-up|4|||
105434506|NCT01439373|363597595|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
105434507|NCT01439373|363597596|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
105434508|NCT01439373|363597595|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
105434509|NCT01439373|363597596|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
105434510|NCT04576897|363597601|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
105434511|NCT02593318|363597602|FG000|Overall Study|Withdrawal by Subject|1|||
105434512|NCT02593318|363597603|FG001|Overall Study|Withdrawal by Subject|1|||
105434513|NCT00527332|363597609|FG000|Overall Study|Protocol Violation|4|||
105434514|NCT00527332|363597610|FG001|Overall Study|Protocol Violation|8|||
105434515|NCT00527332|363597609|FG000|Overall Study|Withdrew consent|5|||
105434516|NCT00527332|363597610|FG001|Overall Study|Withdrew consent|1|||
105434517|NCT02666105|363597611|FG000|Overall Study|Death|1|||
105434518|NCT01078168|363597612|FG000|Overall Study|Physician Decision|0|||
105434519|NCT01078168|363597613|FG001|Overall Study|Physician Decision|1|||
105434520|NCT02503501|363599410|FG000|Overall Study|Physician Decision|1|||
105434521|NCT02503501|363599411|FG001|Overall Study|Physician Decision|0|||
105434522|NCT02503501|363599410|FG000|Overall Study|Protocol Violation|0|||
105434523|NCT02503501|363599411|FG001|Overall Study|Protocol Violation|1|||
105434524|NCT02503501|363599410|FG000|Overall Study|Withdrawal by Subject|0|||
105434525|NCT02503501|363599411|FG001|Overall Study|Withdrawal by Subject|2|||
105434526|NCT01740401|363599412|FG000|Overall Study|Progression of disease|6|||
105434527|NCT01740401|363599412|FG000|Overall Study|Adverse Event|2|||
105590625|NCT01651949|364162663|FG001|Overall Study|Withdrawal by Subject|18|||
105590626|NCT01651949|364162664|FG002|Overall Study|Withdrawal by Subject|9|||
105434528|NCT01740401|363599412|FG000|Overall Study|Did not reach primary endpoint|2|||
105434529|NCT02806960|363599413|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
105434530|NCT02806960|363599414|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
105434531|NCT02806960|363599415|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
105434532|NCT02806960|363599416|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
105434533|NCT02315560|363599417|FG000|Overall Study|noncompliance by subjects|3|||
105434534|NCT03667690|363599418|FG000|Overall Study|Adverse Event|0|||
105434535|NCT03667690|363599419|FG001|Overall Study|Adverse Event|3|||
105434536|NCT03667690|363599418|FG000|Overall Study|Death|22|||
105434537|NCT03667690|363599419|FG001|Overall Study|Death|21|||
105434538|NCT03667690|363599418|FG000|Overall Study|Lost to Follow-up|4|||
105434539|NCT03667690|363599419|FG001|Overall Study|Lost to Follow-up|5|||
105434540|NCT03667690|363599418|FG000|Overall Study|Withdrawal by Subject|7|||
105434541|NCT03667690|363599419|FG001|Overall Study|Withdrawal by Subject|8|||
105434542|NCT03667690|363599418|FG000|Overall Study|Subject could not return for additional investigational product|1|||
105434543|NCT03667690|363599419|FG001|Overall Study|Subject could not return for additional investigational product|0|||
105434544|NCT03667690|363599418|FG000|Overall Study|Subject discharged to hospice care|2|||
105434545|NCT03667690|363599419|FG001|Overall Study|Subject discharged to hospice care|0|||
105434546|NCT03667690|363599418|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
105434547|NCT03667690|363599419|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
105434548|NCT03667690|363599418|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
105434549|NCT03667690|363599419|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
105434550|NCT03667690|363599418|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
105434551|NCT03667690|363599419|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
105434552|NCT03667690|363599418|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
105434553|NCT03667690|363599419|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
105434554|NCT03667690|363599418|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
105434555|NCT03667690|363599419|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
105434556|NCT01209078|363599421|FG000|Overall Study|Adverse Event|5|||
105434557|NCT01209078|363599422|FG001|Overall Study|Adverse Event|0|||
105434558|NCT01209078|363599421|FG000|Overall Study|Lost to Follow-up|4|||
105434559|NCT01209078|363599422|FG001|Overall Study|Lost to Follow-up|0|||
105434560|NCT01209078|363599421|FG000|Overall Study|Physician Decision|5|||
105434561|NCT01209078|363599422|FG001|Overall Study|Physician Decision|2|||
105434562|NCT01209078|363599421|FG000|Overall Study|Withdrawal by Subject|2|||
105434563|NCT01209078|363599422|FG001|Overall Study|Withdrawal by Subject|1|||
105434564|NCT00924508|363599423|FG000|Overall Study|Withdrawal by Subject|3|||
105434565|NCT02100969|363599424|FG000|Overall Study|Did not pass screening phase|1|||
105434566|NCT02081599|363599425|FG000|Period 1：Double-blind Period|Adverse Event|3|||
105434567|NCT02081599|363599426|FG001|Period 1：Double-blind Period|Adverse Event|0|||
105434568|NCT02081599|363599425|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
105434569|NCT02081599|363599426|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
105434570|NCT02081599|363599425|FG000|Period 1：Double-blind Period|Physician Decision|1|||
105434571|NCT02081599|363599426|FG001|Period 1：Double-blind Period|Physician Decision|0|||
105434572|NCT02081599|363599425|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
105434573|NCT02081599|363599426|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
105434574|NCT02081599|363599425|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
105434575|NCT02081599|363599426|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
105434576|NCT02081599|363599425|FG000|Period 1：Double-blind Period|stopping criteria|1|||
105434577|NCT02081599|363599426|FG001|Period 1：Double-blind Period|stopping criteria|0|||
105434578|NCT02081599|363599425|FG000|Period 2：Open-label Period|Adverse Event|1|||
105434579|NCT02081599|363599426|FG001|Period 2：Open-label Period|Adverse Event|0|||
105434580|NCT02081599|363599425|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
105434581|NCT02081599|363599426|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
105434582|NCT02081599|363599425|FG000|Period 2：Open-label Period|Physician Decision|1|||
105434583|NCT02081599|363599426|FG001|Period 2：Open-label Period|Physician Decision|0|||
105434584|NCT02081599|363599425|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
105434585|NCT02081599|363599426|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
105434586|NCT01912339|363599427|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
105434587|NCT01912339|363599428|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
105434588|NCT01912339|363599429|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
105434589|NCT01912339|363599427|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
105434590|NCT01912339|363599428|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
105434591|NCT01912339|363599429|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
105434592|NCT01912339|363599427|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
105434593|NCT01912339|363599428|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
105434594|NCT01912339|363599429|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
105434595|NCT01912339|363599427|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
105434596|NCT01912339|363599428|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
105434597|NCT01912339|363599429|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
105434598|NCT01912339|363599427|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
105434599|NCT01912339|363599428|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
105434600|NCT01912339|363599429|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
105434601|NCT01912339|363599427|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
105434602|NCT01912339|363599428|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
105434603|NCT01912339|363599429|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
105434604|NCT01912339|363599427|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
105434605|NCT01912339|363599428|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
105434606|NCT01912339|363599429|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
105434607|NCT01912339|363599427|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
105434608|NCT01912339|363599428|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
105434609|NCT01912339|363599429|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
105434610|NCT01912339|363599427|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
105434611|NCT01912339|363599428|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
105434612|NCT01912339|363599429|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
105434613|NCT01912339|363599427|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
105434614|NCT01912339|363599428|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
105434615|NCT01912339|363599429|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
105434616|NCT01912339|363599427|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
105434617|NCT01912339|363599428|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
105434618|NCT01912339|363599429|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
105434619|NCT01912339|363599427|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
105434620|NCT01912339|363599428|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
105434621|NCT01912339|363599429|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
105434622|NCT01912339|363599427|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
105434623|NCT01912339|363599428|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
105434624|NCT01912339|363599429|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
105434625|NCT03459365|363599432|FG000|Overall Study|Withdrawal by Subject|6|||
105434626|NCT03459365|363599432|FG000|Overall Study|Protocol Violation|8|||
105434627|NCT01543776|363599433|FG000|Overall Study|Withdrawal by Subject|2|||
105434628|NCT01543776|363599434|FG001|Overall Study|Withdrawal by Subject|2|||
105434629|NCT00528801|363599437|FG000|Overall Study|Withdrawal by Subject|1|||
105434630|NCT00528801|363599438|FG001|Overall Study|Withdrawal by Subject|1|||
105434631|NCT00528801|363599437|FG000|Overall Study|Protocol Violation|11|||
105434632|NCT00528801|363599438|FG001|Overall Study|Protocol Violation|5|||
105434633|NCT00528801|363599437|FG000|Overall Study|Lost to Follow-up|15|||
105434634|NCT00528801|363599438|FG001|Overall Study|Lost to Follow-up|4|||
105434635|NCT00528801|363599437|FG000|Overall Study|Administrative Reasons|0|||
105434636|NCT00528801|363599438|FG001|Overall Study|Administrative Reasons|1|||
105434637|NCT03626545|363599440|FG000|Overall Study|Progressive disease|3|||
105434638|NCT03626545|363599441|FG001|Overall Study|Progressive disease|82|||
105434639|NCT03626545|363599442|FG002|Overall Study|Progressive disease|85|||
105434640|NCT03626545|363599440|FG000|Overall Study|Adverse Event|3|||
105434641|NCT03626545|363599441|FG001|Overall Study|Adverse Event|13|||
105434642|NCT03626545|363599442|FG002|Overall Study|Adverse Event|10|||
105434643|NCT03626545|363599440|FG000|Overall Study|Physician Decision|1|||
105434644|NCT03626545|363599441|FG001|Overall Study|Physician Decision|18|||
105434645|NCT03626545|363599442|FG002|Overall Study|Physician Decision|14|||
105434646|NCT03626545|363599440|FG000|Overall Study|Subject Decision|0|||
105434647|NCT03626545|363599441|FG001|Overall Study|Subject Decision|5|||
105434648|NCT03626545|363599442|FG002|Overall Study|Subject Decision|5|||
105434649|NCT03626545|363599440|FG000|Overall Study|Death|1|||
105434650|NCT03626545|363599441|FG001|Overall Study|Death|1|||
105434651|NCT03626545|363599442|FG002|Overall Study|Death|1|||
105434652|NCT03626545|363599440|FG000|Overall Study|Protocol Deviation|0|||
105434653|NCT03626545|363599441|FG001|Overall Study|Protocol Deviation|1|||
105434654|NCT03626545|363599442|FG002|Overall Study|Protocol Deviation|1|||
105434655|NCT03626545|363599440|FG000|Overall Study|Guardian Decision|0|||
105434656|NCT03626545|363599441|FG001|Overall Study|Guardian Decision|0|||
105434657|NCT03626545|363599442|FG002|Overall Study|Guardian Decision|1|||
105434658|NCT00679172|363599445|FG000|Overall Study|Non-compliance|1|||
105434659|NCT00679172|363599446|FG001|Overall Study|Non-compliance|1|||
105503130|NCT03641339|363852835|FG003|Overall Study|Physician Decision|0|||
105503131|NCT03641339|363852836|FG004|Overall Study|Physician Decision|0|||
105503132|NCT03641339|363852837|FG005|Overall Study|Physician Decision|0|||
105503133|NCT03641339|363852832|FG000|Overall Study|Withdrawal by Subject|0|||
105434660|NCT00679172|363599447|FG002|Overall Study|Non-compliance|0|||
105434661|NCT00679172|363599448|FG003|Overall Study|Non-compliance|1|||
105434662|NCT00679172|363599449|FG004|Overall Study|Non-compliance|0|||
105434663|NCT00679172|363599445|FG000|Overall Study|Other not specified|0|||
105434664|NCT00679172|363599446|FG001|Overall Study|Other not specified|0|||
105434665|NCT00679172|363599447|FG002|Overall Study|Other not specified|1|||
105503134|NCT03641339|363852833|FG001|Overall Study|Withdrawal by Subject|2|||
105434666|NCT00679172|363599448|FG003|Overall Study|Other not specified|0|||
105434667|NCT00679172|363599449|FG004|Overall Study|Other not specified|0|||
105434668|NCT02271945|363599451|FG000|Overall Study|Death|3|||
105434669|NCT02271945|363599452|FG001|Overall Study|Death|3|||
105434670|NCT02271945|363599451|FG000|Overall Study|Withdrawal by Subject|1|||
105434671|NCT02271945|363599452|FG001|Overall Study|Withdrawal by Subject|1|||
105434672|NCT02271945|363599451|FG000|Overall Study|Other|1|||
105434673|NCT02271945|363599452|FG001|Overall Study|Other|1|||
105434674|NCT00308074|363599453|FG000|Overall Study|Withdrawal by Subject|1|||
105434675|NCT03002311|363599454|FG000|Overall Study|Lost to Follow-up|13|||
105434676|NCT03002311|363599455|FG001|Overall Study|Lost to Follow-up|26|||
105434677|NCT03002311|363599454|FG000|Overall Study|Referral provider called to schedule app|3|||
105434678|NCT03002311|363599455|FG001|Overall Study|Referral provider called to schedule app|3|||
105434679|NCT03002311|363599454|FG000|Overall Study|Physician Decision|3|||
105434680|NCT03002311|363599455|FG001|Overall Study|Physician Decision|1|||
105434681|NCT03908476|363599456|FG000|Overall Study|Death|3|||
105434682|NCT03908476|363599457|FG001|Overall Study|Death|0|||
105434683|NCT03908476|363599456|FG000|Overall Study|Lost to Follow-up|3|||
105434684|NCT03908476|363599457|FG001|Overall Study|Lost to Follow-up|1|||
105434685|NCT03908476|363599456|FG000|Overall Study|Withdrawal by Subject|7|||
105434686|NCT03908476|363599457|FG001|Overall Study|Withdrawal by Subject|1|||
105434687|NCT03908476|363599456|FG000|Overall Study|Physician Decision|2|||
105434688|NCT03908476|363599457|FG001|Overall Study|Physician Decision|0|||
105434689|NCT03908476|363599456|FG000|Overall Study|System Explanted and not Replaced|4|||
105434690|NCT03908476|363599457|FG001|Overall Study|System Explanted and not Replaced|0|||
105434691|NCT03908476|363599456|FG000|Overall Study|Intrathecal Pump|1|||
105434692|NCT03908476|363599457|FG001|Overall Study|Intrathecal Pump|0|||
105434693|NCT03908476|363599456|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
105434694|NCT03908476|363599457|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
105434695|NCT01110382|363599459|FG000|Overall Study|Withdrawal by Subject|0|||
105434696|NCT01110382|363599460|FG001|Overall Study|Withdrawal by Subject|1|||
105434697|NCT01110382|363599459|FG000|Overall Study|Protocol Violation|0|||
105434698|NCT01110382|363599460|FG001|Overall Study|Protocol Violation|1|||
105434699|NCT00300365|363599464|FG000|Overall Study|Lost to Follow-up|1|||
105434700|NCT00300365|363599465|FG001|Overall Study|Lost to Follow-up|0|||
105434701|NCT00300365|363599464|FG000|Overall Study|Physician Decision|2|||
105434702|NCT00300365|363599465|FG001|Overall Study|Physician Decision|0|||
105434703|NCT00300365|363599464|FG000|Overall Study|Withdrawal by Subject|1|||
105434704|NCT00300365|363599465|FG001|Overall Study|Withdrawal by Subject|0|||
105434705|NCT00300365|363599464|FG000|Overall Study|Adverse Event|0|||
105434706|NCT00300365|363599465|FG001|Overall Study|Adverse Event|2|||
105434707|NCT01079936|363599466|FG000|Phase I: MTD|First Remission Status|2|||
105434708|NCT01079936|363599467|FG001|Phase I: MTD|First Remission Status|0|||
105434709|NCT01079936|363599468|FG002|Phase I: MTD|First Remission Status|0|||
105434710|NCT01079936|363599469|FG003|Phase I: MTD|First Remission Status|0|||
105434711|NCT01079936|363599470|FG004|Phase I: MTD|First Remission Status|0|||
105434712|NCT01079936|363599466|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
105434713|NCT01079936|363599467|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
105434714|NCT01079936|363599468|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
105434715|NCT01079936|363599469|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
105434716|NCT01079936|363599470|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
105434717|NCT01079936|363599466|FG000|Phase II|Adverse Event|0|||
105434718|NCT01079936|363599467|FG001|Phase II|Adverse Event|0|||
105434719|NCT01079936|363599468|FG002|Phase II|Adverse Event|1|||
105434720|NCT01079936|363599469|FG003|Phase II|Adverse Event|0|||
105434721|NCT01079936|363599470|FG004|Phase II|Adverse Event|0|||
105434722|NCT01079936|363599466|FG000|Phase II|Insurance Issue|0|||
105434723|NCT01079936|363599467|FG001|Phase II|Insurance Issue|0|||
105434724|NCT01079936|363599468|FG002|Phase II|Insurance Issue|0|||
105434725|NCT01079936|363599469|FG003|Phase II|Insurance Issue|0|||
105434726|NCT01079936|363599470|FG004|Phase II|Insurance Issue|1|||
105434727|NCT01422824|363599471|FG000|Overall Study|Case record form not evaluated|1|||
105434728|NCT01422824|363599471|FG000|Overall Study|Lost to Follow-up|37|||
105434729|NCT02421601|363599474|FG000|Overall Study|Adverse Event|4|||
105434730|NCT02421601|363599474|FG000|Overall Study|Lack of Efficacy|5|||
105434731|NCT02421601|363599474|FG000|Overall Study|Physician Decision|1|||
105434732|NCT02421601|363599474|FG000|Overall Study|Withdrawal by Subject|31|||
105503135|NCT03641339|363852834|FG002|Overall Study|Withdrawal by Subject|0|||
105434733|NCT02421601|363599474|FG000|Overall Study|Others|41|||
105434734|NCT01581619|363599475|FG000|Overall Study|Withdrawal by Subject|1|||
105434735|NCT01581619|363599475|FG000|Overall Study|Lost to Follow-up|1|||
105503136|NCT03641339|363852835|FG003|Overall Study|Withdrawal by Subject|2|||
105434736|NCT00290498|363599478|FG000|Overall Study|Death|2|||
105434737|NCT00290498|363599479|FG001|Overall Study|Death|0|||
105434738|NCT00290498|363599478|FG000|Overall Study|Physician Decision|1|||
105434739|NCT00290498|363599479|FG001|Overall Study|Physician Decision|0|||
105434740|NCT00290498|363599478|FG000|Overall Study|Withdrawal by Subject|1|||
105434741|NCT00290498|363599479|FG001|Overall Study|Withdrawal by Subject|0|||
105434742|NCT00290498|363599478|FG000|Overall Study|Ineligible|3|||
105434743|NCT00290498|363599479|FG001|Overall Study|Ineligible|0|||
105434744|NCT00290498|363599478|FG000|Overall Study|Non-Compliance|1|||
105434745|NCT00290498|363599479|FG001|Overall Study|Non-Compliance|0|||
105434746|NCT02250664|363599482|FG000|Overall Study|Lost to Follow-up|18|||
105434747|NCT02250664|363599483|FG001|Overall Study|Lost to Follow-up|28|||
105434748|NCT02250664|363599484|FG002|Overall Study|Lost to Follow-up|33|||
105434749|NCT02250664|363599482|FG000|Overall Study|Personal Reasons|7|||
105434750|NCT02250664|363599483|FG001|Overall Study|Personal Reasons|8|||
105434751|NCT02250664|363599484|FG002|Overall Study|Personal Reasons|14|||
105434752|NCT02250664|363599482|FG000|Overall Study|Adverse Event|6|||
105434753|NCT02250664|363599483|FG001|Overall Study|Adverse Event|3|||
105434754|NCT02250664|363599484|FG002|Overall Study|Adverse Event|8|||
105434755|NCT02250664|363599482|FG000|Overall Study|Incarcerated|2|||
105434756|NCT02250664|363599483|FG001|Overall Study|Incarcerated|1|||
105434757|NCT02250664|363599484|FG002|Overall Study|Incarcerated|2|||
105434758|NCT02250664|363599482|FG000|Overall Study|Withdrawal by Subject|0|||
105434759|NCT02250664|363599483|FG001|Overall Study|Withdrawal by Subject|1|||
105434760|NCT02250664|363599484|FG002|Overall Study|Withdrawal by Subject|2|||
105434761|NCT02250664|363599482|FG000|Overall Study|Death|0|||
105434762|NCT02250664|363599483|FG001|Overall Study|Death|1|||
105434763|NCT02250664|363599484|FG002|Overall Study|Death|1|||
105434764|NCT02250664|363599482|FG000|Overall Study|Physician Decision|1|||
105434765|NCT02250664|363599483|FG001|Overall Study|Physician Decision|3|||
105434766|NCT02250664|363599484|FG002|Overall Study|Physician Decision|1|||
105434767|NCT02250664|363599482|FG000|Overall Study|Protocol Violation|1|||
105434768|NCT02250664|363599483|FG001|Overall Study|Protocol Violation|0|||
105434769|NCT02250664|363599484|FG002|Overall Study|Protocol Violation|1|||
105434770|NCT02250664|363599482|FG000|Overall Study|Reason unknown|1|||
105434771|NCT02250664|363599483|FG001|Overall Study|Reason unknown|0|||
105434772|NCT02250664|363599484|FG002|Overall Study|Reason unknown|0|||
105434773|NCT03847909|363599486|FG000|Overall Study|Withdrawal by Subject|1|||
105434774|NCT03847909|363599487|FG001|Overall Study|Withdrawal by Subject|1|||
105434775|NCT01716104|363599488|FG000|Overall Study|Do not meet inclusion criteria|6|||
105434776|NCT01716104|363599489|FG001|Overall Study|Do not meet inclusion criteria|7|||
105434777|NCT02565810|363599490|FG000|Overall Study|Withdrawal by Subject|1|||
105434778|NCT04268173|363599491|FG000|Overall Study|Lost to Follow-up|75|||
105434779|NCT04268173|363599492|FG001|Overall Study|Lost to Follow-up|108|||
105434780|NCT00581360|363599495|FG000|Overall Study|Withdrawal by Subject|1|||
105434781|NCT04405245|363599496|FG000|Overall Study|Adverse Event|0|||
105434782|NCT04405245|363599497|FG001|Overall Study|Adverse Event|1|||
105434783|NCT04405245|363599498|FG002|Overall Study|Adverse Event|0|||
105434784|NCT00545103|363599499|FG000|Overall Study|Lack of Efficacy|48|||
105434785|NCT00545103|363599500|FG001|Overall Study|Lack of Efficacy|45|||
105434786|NCT00545103|363599501|FG002|Overall Study|Lack of Efficacy|31|||
105434787|NCT00545103|363599502|FG003|Overall Study|Lack of Efficacy|27|||
105434788|NCT00545103|363599499|FG000|Overall Study|Withdrawal by Subject|6|||
105434789|NCT00545103|363599500|FG001|Overall Study|Withdrawal by Subject|10|||
105434790|NCT00545103|363599501|FG002|Overall Study|Withdrawal by Subject|18|||
105434791|NCT00545103|363599502|FG003|Overall Study|Withdrawal by Subject|22|||
105434792|NCT00545103|363599499|FG000|Overall Study|Adverse Event|11|||
105434793|NCT00545103|363599500|FG001|Overall Study|Adverse Event|12|||
105434794|NCT00545103|363599501|FG002|Overall Study|Adverse Event|17|||
105434795|NCT00545103|363599502|FG003|Overall Study|Adverse Event|10|||
105434796|NCT00545103|363599499|FG000|Overall Study|Lost to Follow-up|4|||
105434797|NCT00545103|363599500|FG001|Overall Study|Lost to Follow-up|6|||
105434798|NCT00545103|363599501|FG002|Overall Study|Lost to Follow-up|3|||
105434799|NCT00545103|363599502|FG003|Overall Study|Lost to Follow-up|4|||
105434800|NCT00545103|363599499|FG000|Overall Study|Protocol Violation|1|||
105434801|NCT00545103|363599500|FG001|Overall Study|Protocol Violation|2|||
105434802|NCT00545103|363599501|FG002|Overall Study|Protocol Violation|3|||
105434803|NCT00545103|363599502|FG003|Overall Study|Protocol Violation|0|||
105434804|NCT00545103|363599499|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
105434805|NCT00545103|363599500|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
105434806|NCT00545103|363599501|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
105434807|NCT00545103|363599502|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
105434808|NCT00545103|363599499|FG000|Overall Study|Difficult to open package|0|||
105434809|NCT00545103|363599500|FG001|Overall Study|Difficult to open package|0|||
105434810|NCT00545103|363599501|FG002|Overall Study|Difficult to open package|0|||
105503137|NCT03641339|363852836|FG004|Overall Study|Withdrawal by Subject|0|||
105434811|NCT00545103|363599502|FG003|Overall Study|Difficult to open package|1|||
105434812|NCT00545103|363599499|FG000|Overall Study|Investigational product not taken|1|||
105434813|NCT00545103|363599500|FG001|Overall Study|Investigational product not taken|0|||
105434814|NCT00545103|363599501|FG002|Overall Study|Investigational product not taken|0|||
105434815|NCT00545103|363599502|FG003|Overall Study|Investigational product not taken|1|||
105434816|NCT00545103|363599499|FG000|Overall Study|Wish to start a family|0|||
105434817|NCT00545103|363599500|FG001|Overall Study|Wish to start a family|0|||
105434818|NCT00545103|363599501|FG002|Overall Study|Wish to start a family|0|||
105434819|NCT00545103|363599502|FG003|Overall Study|Wish to start a family|1|||
105434820|NCT00545103|363599499|FG000|Overall Study|Diverticulitis crisis|0|||
105434821|NCT00545103|363599500|FG001|Overall Study|Diverticulitis crisis|0|||
105434822|NCT00545103|363599501|FG002|Overall Study|Diverticulitis crisis|0|||
105434823|NCT00545103|363599502|FG003|Overall Study|Diverticulitis crisis|1|||
105434824|NCT00545103|363599499|FG000|Overall Study|Personal reasons|1|||
105434825|NCT00545103|363599500|FG001|Overall Study|Personal reasons|0|||
105434826|NCT00545103|363599501|FG002|Overall Study|Personal reasons|0|||
105434827|NCT00545103|363599502|FG003|Overall Study|Personal reasons|0|||
105434828|NCT00545103|363599499|FG000|Overall Study|Subject's decision|1|||
105434829|NCT00545103|363599500|FG001|Overall Study|Subject's decision|0|||
105434830|NCT00545103|363599501|FG002|Overall Study|Subject's decision|0|||
105434831|NCT00545103|363599502|FG003|Overall Study|Subject's decision|0|||
105434832|NCT00545103|363599499|FG000|Overall Study|Noncompliance|0|||
105434833|NCT00545103|363599500|FG001|Overall Study|Noncompliance|1|||
105434834|NCT00545103|363599501|FG002|Overall Study|Noncompliance|0|||
105434835|NCT00545103|363599502|FG003|Overall Study|Noncompliance|0|||
105434836|NCT00545103|363599499|FG000|Overall Study|Investigator decision|0|||
105434837|NCT00545103|363599500|FG001|Overall Study|Investigator decision|0|||
105434838|NCT00545103|363599501|FG002|Overall Study|Investigator decision|1|||
105434839|NCT00545103|363599502|FG003|Overall Study|Investigator decision|0|||
105434840|NCT00545103|363599499|FG000|Overall Study|Subject moved|0|||
105434841|NCT00545103|363599500|FG001|Overall Study|Subject moved|1|||
105434842|NCT00545103|363599501|FG002|Overall Study|Subject moved|0|||
105434843|NCT00545103|363599502|FG003|Overall Study|Subject moved|0|||
105434844|NCT00545103|363599499|FG000|Overall Study|Use of prohibited medication|0|||
105434845|NCT00545103|363599500|FG001|Overall Study|Use of prohibited medication|0|||
105434846|NCT00545103|363599501|FG002|Overall Study|Use of prohibited medication|1|||
105434847|NCT00545103|363599502|FG003|Overall Study|Use of prohibited medication|0|||
105434848|NCT00545103|363599499|FG000|Overall Study|Does not want to take study drug anymore|1|||
105434849|NCT00545103|363599500|FG001|Overall Study|Does not want to take study drug anymore|0|||
105434850|NCT00545103|363599501|FG002|Overall Study|Does not want to take study drug anymore|1|||
105434851|NCT00545103|363599502|FG003|Overall Study|Does not want to take study drug anymore|0|||
105434852|NCT00545103|363599499|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
105434853|NCT00545103|363599500|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
105434854|NCT00545103|363599501|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
105434855|NCT00545103|363599502|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
105434856|NCT00545103|363599499|FG000|Overall Study|Death|0|||
105434857|NCT00545103|363599500|FG001|Overall Study|Death|1|||
105434858|NCT00545103|363599501|FG002|Overall Study|Death|0|||
105434859|NCT00545103|363599502|FG003|Overall Study|Death|0|||
105434860|NCT01953913|363599503|FG000|Overall Study|Disease Progression|349|||
105434861|NCT01953913|363599503|FG000|Overall Study|Worsening of underlying cancer|22|||
105434862|NCT01953913|363599503|FG000|Overall Study|Adverse Event|20|||
105434863|NCT01953913|363599503|FG000|Overall Study|Protocol Violation|6|||
105434864|NCT01953913|363599503|FG000|Overall Study|Lost to Follow-up|4|||
105434865|NCT01953913|363599503|FG000|Overall Study|Withdrawal by Subject|32|||
105434866|NCT01953913|363599503|FG000|Overall Study|Other than listed|108|||
105434867|NCT01953913|363599503|FG000|Overall Study|Not Treated|1|||
105434868|NCT05026853|363599504|FG000|Overall Study|Cancelled appointment|1|||
105434869|NCT05026853|363599505|FG001|Overall Study|Cancelled appointment|0|||
105434870|NCT05026853|363599504|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
105434871|NCT05026853|363599505|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
105434872|NCT05026853|363599504|FG000|Overall Study|Did not complete 12-week survey|16|||
105434873|NCT05026853|363599505|FG001|Overall Study|Did not complete 12-week survey|16|||
105434874|NCT01353911|363599506|FG000|Overall Study|Lost to Follow-up|2|||
105434875|NCT01353911|363599507|FG001|Overall Study|Lost to Follow-up|6|||
105434876|NCT01353911|363599508|FG002|Overall Study|Lost to Follow-up|4|||
105434877|NCT01353911|363599509|FG003|Overall Study|Lost to Follow-up|0|||
105434878|NCT01353911|363599510|FG004|Overall Study|Lost to Follow-up|4|||
105434879|NCT01353911|363599511|FG005|Overall Study|Lost to Follow-up|4|||
105434880|NCT01353911|363599512|FG006|Overall Study|Lost to Follow-up|3|||
105434881|NCT01353911|363599513|FG007|Overall Study|Lost to Follow-up|6|||
105434882|NCT01353911|363599506|FG000|Overall Study|Withdrawal by Subject|2|||
105434883|NCT01353911|363599507|FG001|Overall Study|Withdrawal by Subject|3|||
105434884|NCT01353911|363599508|FG002|Overall Study|Withdrawal by Subject|4|||
105434885|NCT01353911|363599509|FG003|Overall Study|Withdrawal by Subject|2|||
105434886|NCT01353911|363599510|FG004|Overall Study|Withdrawal by Subject|2|||
105434887|NCT01353911|363599511|FG005|Overall Study|Withdrawal by Subject|3|||
105434888|NCT01353911|363599512|FG006|Overall Study|Withdrawal by Subject|3|||
105434889|NCT01353911|363599513|FG007|Overall Study|Withdrawal by Subject|9|||
105434890|NCT01353911|363599506|FG000|Overall Study|Status Not Recorded|4|||
105434891|NCT01353911|363599507|FG001|Overall Study|Status Not Recorded|0|||
105434892|NCT01353911|363599508|FG002|Overall Study|Status Not Recorded|1|||
105434893|NCT01353911|363599509|FG003|Overall Study|Status Not Recorded|0|||
105434894|NCT01353911|363599510|FG004|Overall Study|Status Not Recorded|0|||
105434895|NCT01353911|363599511|FG005|Overall Study|Status Not Recorded|0|||
105434896|NCT01353911|363599512|FG006|Overall Study|Status Not Recorded|0|||
105434897|NCT01353911|363599513|FG007|Overall Study|Status Not Recorded|0|||
105434898|NCT03233438|363599514|FG000|Overall Study|Lost to Follow-up|4|||
105434899|NCT03233438|363599515|FG001|Overall Study|Lost to Follow-up|9|||
105434900|NCT03233438|363599514|FG000|Overall Study|Withdrawal by Subject|2|||
105434901|NCT03233438|363599515|FG001|Overall Study|Withdrawal by Subject|1|||
105434902|NCT03233438|363599514|FG000|Overall Study|No recording of dalbavancin|0|||
105434903|NCT03233438|363599515|FG001|Overall Study|No recording of dalbavancin|1|||
105434904|NCT03429543|363599516|FG000|Overall Study|Adverse Event|1|||
105434905|NCT03429543|363599517|FG001|Overall Study|Adverse Event|1|||
105434906|NCT03429543|363599518|FG002|Overall Study|Adverse Event|0|||
105434907|NCT03429543|363599519|FG003|Overall Study|Adverse Event|0|||
105434908|NCT03429543|363599520|FG004|Overall Study|Adverse Event|0|||
105434909|NCT03429543|363599521|FG005|Overall Study|Adverse Event|2|||
105434910|NCT03429543|363599522|FG006|Overall Study|Adverse Event|0|||
105434911|NCT03429543|363599516|FG000|Overall Study|Lost to Follow-up|1|||
105434912|NCT03429543|363599517|FG001|Overall Study|Lost to Follow-up|0|||
105434913|NCT03429543|363599518|FG002|Overall Study|Lost to Follow-up|0|||
105434914|NCT03429543|363599519|FG003|Overall Study|Lost to Follow-up|0|||
105434915|NCT03429543|363599520|FG004|Overall Study|Lost to Follow-up|1|||
105434916|NCT03429543|363599521|FG005|Overall Study|Lost to Follow-up|0|||
105434917|NCT03429543|363599522|FG006|Overall Study|Lost to Follow-up|0|||
105434918|NCT03429543|363599516|FG000|Overall Study|Withdrawal by Subject|5|||
105434919|NCT03429543|363599517|FG001|Overall Study|Withdrawal by Subject|0|||
105434920|NCT03429543|363599518|FG002|Overall Study|Withdrawal by Subject|1|||
105434921|NCT03429543|363599519|FG003|Overall Study|Withdrawal by Subject|2|||
105434922|NCT03429543|363599520|FG004|Overall Study|Withdrawal by Subject|6|||
105434923|NCT03429543|363599521|FG005|Overall Study|Withdrawal by Subject|3|||
105434924|NCT03429543|363599522|FG006|Overall Study|Withdrawal by Subject|1|||
105434925|NCT03429543|363599516|FG000|Overall Study|Other reason than listed|0|||
105434926|NCT03429543|363599517|FG001|Overall Study|Other reason than listed|1|||
105434927|NCT03429543|363599518|FG002|Overall Study|Other reason than listed|0|||
105434928|NCT03429543|363599519|FG003|Overall Study|Other reason than listed|0|||
105434929|NCT03429543|363599520|FG004|Overall Study|Other reason than listed|4|||
105434930|NCT03429543|363599521|FG005|Overall Study|Other reason than listed|4|||
105434931|NCT03429543|363599522|FG006|Overall Study|Other reason than listed|0|||
105434932|NCT03429543|363599516|FG000|Overall Study|Not treated|0|||
105434933|NCT03429543|363599517|FG001|Overall Study|Not treated|0|||
105434934|NCT03429543|363599518|FG002|Overall Study|Not treated|0|||
105434935|NCT03429543|363599519|FG003|Overall Study|Not treated|0|||
105434936|NCT03429543|363599520|FG004|Overall Study|Not treated|1|||
105434937|NCT03429543|363599521|FG005|Overall Study|Not treated|0|||
105590627|NCT01191788|364162668|FG000|Overall Study|Lost to Follow-up|21|||
105434938|NCT03429543|363599522|FG006|Overall Study|Not treated|0|||
105434939|NCT00082381|363599523|FG000|Overall Study|Adverse Event|27|||
105434940|NCT00082381|363599524|FG001|Overall Study|Adverse Event|2|||
105434941|NCT00082381|363599523|FG000|Overall Study|Lost to Follow-up|5|||
105434942|NCT00082381|363599524|FG001|Overall Study|Lost to Follow-up|7|||
105434943|NCT00082381|363599523|FG000|Overall Study|Patient Decision|8|||
105434944|NCT00082381|363599524|FG001|Overall Study|Patient Decision|4|||
105434945|NCT00082381|363599523|FG000|Overall Study|Physician Decision|1|||
105434946|NCT00082381|363599524|FG001|Overall Study|Physician Decision|2|||
105434947|NCT00082381|363599523|FG000|Overall Study|Protocol Violation|10|||
105434948|NCT00082381|363599524|FG001|Overall Study|Protocol Violation|11|||
105434949|NCT00082381|363599523|FG000|Overall Study|Loss of Glucose Control|4|||
105434950|NCT00082381|363599524|FG001|Overall Study|Loss of Glucose Control|0|||
105590628|NCT01191788|364162669|FG001|Overall Study|Lost to Follow-up|22|||
105434951|NCT03022981|363599525|FG000|Overall Study|Adverse Event|0|||
105434952|NCT03022981|363599526|FG001|Overall Study|Adverse Event|1|||
105434953|NCT03022981|363599527|FG002|Overall Study|Adverse Event|0|||
105434954|NCT03022981|363599525|FG000|Overall Study|Investigator's Discretion|0|||
105434955|NCT03022981|363599526|FG001|Overall Study|Investigator's Discretion|1|||
105434956|NCT03022981|363599527|FG002|Overall Study|Investigator's Discretion|2|||
105434957|NCT03022981|363599525|FG000|Overall Study|Lost to Follow-up|6|||
105434958|NCT03022981|363599526|FG001|Overall Study|Lost to Follow-up|2|||
105434959|NCT03022981|363599527|FG002|Overall Study|Lost to Follow-up|1|||
105434960|NCT03022981|363599525|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105434961|NCT03022981|363599526|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105434962|NCT03022981|363599527|FG002|Overall Study|Non-Compliance With Study Drug|2|||
105434963|NCT03022981|363599525|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
105434964|NCT03022981|363599526|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
105434965|NCT03022981|363599527|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
105434966|NCT03688100|363599528|FG000|Overall Study|Lost to Follow-up|21|||
105434967|NCT03688100|363599529|FG001|Overall Study|Lost to Follow-up|15|||
105434968|NCT03688100|363599530|FG002|Overall Study|Lost to Follow-up|15|||
105434969|NCT03688100|363599531|FG003|Overall Study|Lost to Follow-up|18|||
105434970|NCT03688100|363599528|FG000|Overall Study|Withdrawal by Subject|19|||
105434971|NCT03688100|363599529|FG001|Overall Study|Withdrawal by Subject|16|||
105434972|NCT03688100|363599530|FG002|Overall Study|Withdrawal by Subject|0|||
105434973|NCT03688100|363599531|FG003|Overall Study|Withdrawal by Subject|0|||
105434974|NCT03688100|363599528|FG000|Overall Study|Death|36|||
105434975|NCT03688100|363599529|FG001|Overall Study|Death|27|||
105434976|NCT03688100|363599530|FG002|Overall Study|Death|0|||
105434977|NCT03688100|363599531|FG003|Overall Study|Death|0|||
105434978|NCT00924404|363599536|FG000|Overall Study|Lost to Follow-up|6|||
105434979|NCT00924404|363599537|FG001|Overall Study|Lost to Follow-up|4|||
105434980|NCT00295932|363599538|FG000|Overall Study|Not Treated|0|||
105434981|NCT00295932|363599539|FG001|Overall Study|Not Treated|0|||
105434982|NCT00295932|363599540|FG002|Overall Study|Not Treated|0|||
105434983|NCT00295932|363599541|FG003|Overall Study|Not Treated|0|||
105434984|NCT00295932|363599542|FG004|Overall Study|Not Treated|0|||
105434985|NCT00295932|363599543|FG005|Overall Study|Not Treated|0|||
105434986|NCT00295932|363599544|FG006|Overall Study|Not Treated|0|||
105434987|NCT00295932|363599545|FG007|Overall Study|Not Treated|0|||
105434988|NCT00295932|363599546|FG008|Overall Study|Not Treated|0|||
105434989|NCT00295932|363599547|FG009|Overall Study|Not Treated|0|||
105434990|NCT00295932|363599548|FG010|Overall Study|Not Treated|1|||
105434991|NCT00587847|363599549|FG000|Overall Study|Lack of Efficacy|5|||
105434992|NCT00587847|363599549|FG000|Overall Study|Adverse Event|2|||
105434993|NCT00343382|363599550|FG000|Overall Study|Adverse Event|2|||
105434994|NCT00343382|363599551|FG001|Overall Study|Adverse Event|10|||
105434995|NCT00343382|363599552|FG002|Overall Study|Adverse Event|7|||
105434996|NCT00343382|363599550|FG000|Overall Study|Withdrawal by Subject|1|||
105434997|NCT00343382|363599551|FG001|Overall Study|Withdrawal by Subject|2|||
105434998|NCT00343382|363599552|FG002|Overall Study|Withdrawal by Subject|6|||
105434999|NCT00343382|363599550|FG000|Overall Study|Other Reason Not Specified|1|||
105435000|NCT00343382|363599551|FG001|Overall Study|Other Reason Not Specified|2|||
105435001|NCT00343382|363599552|FG002|Overall Study|Other Reason Not Specified|4|||
105435002|NCT04032080|363599553|FG000|Overall Study|Death|6|||
105435003|NCT00884832|363599554|FG000|Overall Study|Withdrawal by Subject|0|||
105435004|NCT00884832|363599555|FG001|Overall Study|Withdrawal by Subject|1|||
105435005|NCT02337725|363599556|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
105435006|NCT02337725|363599557|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
105435007|NCT02337725|363599556|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
105435008|NCT02337725|363599557|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
105435009|NCT02337725|363599556|FG000|Overall Study|Major Protocol Deviation|0|||
105435010|NCT02337725|363599557|FG001|Overall Study|Major Protocol Deviation|1|||
105435011|NCT02337725|363599556|FG000|Overall Study|Voluntary Withdrawal|14|||
105435012|NCT02337725|363599557|FG001|Overall Study|Voluntary Withdrawal|3|||
105435013|NCT02337725|363599556|FG000|Overall Study|Lack of Efficacy|4|||
105435014|NCT02337725|363599557|FG001|Overall Study|Lack of Efficacy|0|||
105435015|NCT00500760|363599558|FG000|Overall Study|Death|32|||
105435016|NCT00500760|363599559|FG001|Overall Study|Death|15|||
105435017|NCT00500760|363599558|FG000|Overall Study|Withdrawal by Subject|5|||
105435018|NCT00500760|363599559|FG001|Overall Study|Withdrawal by Subject|7|||
105435019|NCT00500760|363599558|FG000|Overall Study|Administrative decision|2|||
105435020|NCT00500760|363599559|FG001|Overall Study|Administrative decision|0|||
105435021|NCT00500760|363599558|FG000|Overall Study|Lost to Follow-up|3|||
105435022|NCT00500760|363599559|FG001|Overall Study|Lost to Follow-up|0|||
105435023|NCT00500760|363599558|FG000|Overall Study|Other|1|||
105435024|NCT00500760|363599559|FG001|Overall Study|Other|2|||
105435025|NCT04566692|363599562|FG000|Overall Study|Adverse Event|2|||
105435026|NCT04566692|363599563|FG001|Overall Study|Adverse Event|0|||
105435027|NCT04566692|363599562|FG000|Overall Study|Withdrawal by Subject|1|||
105435028|NCT04566692|363599563|FG001|Overall Study|Withdrawal by Subject|1|||
105435029|NCT03157037|363599572|FG000|Overall Study|Death|1|||
105435030|NCT02102399|363599573|FG000|Overall Study|Withdrawal by Subject|6|||
105435031|NCT02102399|363599574|FG001|Overall Study|Withdrawal by Subject|4|||
105435032|NCT03101085|363599575|FG000|Overall Study|Lost to Follow-up|0|||
105435033|NCT03101085|363599576|FG001|Overall Study|Lost to Follow-up|1|||
105435034|NCT00695864|363599578|FG000|Placebo|Withdrawal by Subject|1|||
105435035|NCT00695864|363599578|FG000|Placebo|Physician Decision|4|||
105435036|NCT01183065|363599582|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
105435037|NCT01990859|363599588|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
105435038|NCT01990859|363599588|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
105435039|NCT02262754|363599590|FG000|Overall Study|Adverse Event|3|||
105435040|NCT02262754|363599591|FG001|Overall Study|Adverse Event|4|||
105435041|NCT02262754|363599592|FG002|Overall Study|Adverse Event|0|||
105435042|NCT02262754|363599590|FG000|Overall Study|Lack of Efficacy|2|||
105435043|NCT02262754|363599591|FG001|Overall Study|Lack of Efficacy|0|||
105435044|NCT02262754|363599592|FG002|Overall Study|Lack of Efficacy|1|||
105435045|NCT02262754|363599590|FG000|Overall Study|Lost to Follow-up|0|||
105435046|NCT02262754|363599591|FG001|Overall Study|Lost to Follow-up|0|||
105435047|NCT02262754|363599592|FG002|Overall Study|Lost to Follow-up|1|||
105435048|NCT02262754|363599590|FG000|Overall Study|No longer meets eligibility criteria|0|||
105435049|NCT02262754|363599591|FG001|Overall Study|No longer meets eligibility criteria|1|||
105435050|NCT02262754|363599592|FG002|Overall Study|No longer meets eligibility criteria|0|||
105435051|NCT02262754|363599590|FG000|Overall Study|Study terminated by sponsor|5|||
105435052|NCT02262754|363599591|FG001|Overall Study|Study terminated by sponsor|4|||
105435053|NCT02262754|363599592|FG002|Overall Study|Study terminated by sponsor|4|||
105435054|NCT02262754|363599590|FG000|Overall Study|Protocol Violation|1|||
105435055|NCT02262754|363599591|FG001|Overall Study|Protocol Violation|0|||
105435056|NCT02262754|363599592|FG002|Overall Study|Protocol Violation|0|||
105435057|NCT02262754|363599590|FG000|Overall Study|Withdrawal by Subject|1|||
105435058|NCT02262754|363599591|FG001|Overall Study|Withdrawal by Subject|0|||
105435059|NCT02262754|363599592|FG002|Overall Study|Withdrawal by Subject|1|||
105435060|NCT02262754|363599590|FG000|Overall Study|Other|4|||
105435061|NCT02262754|363599591|FG001|Overall Study|Other|0|||
105435062|NCT02262754|363599592|FG002|Overall Study|Other|2|||
105435063|NCT02720692|363601320|FG000|Overall Study|Withdrawal by Subject|3|||
105435064|NCT02720692|363601321|FG001|Overall Study|Withdrawal by Subject|0|||
105435065|NCT02720692|363601320|FG000|Overall Study|Physician Decision|1|||
105435066|NCT02720692|363601321|FG001|Overall Study|Physician Decision|0|||
105435067|NCT02720692|363601320|FG000|Overall Study|Lost to Follow-up|8|||
105435068|NCT02720692|363601321|FG001|Overall Study|Lost to Follow-up|3|||
105435069|NCT02720692|363601320|FG000|Overall Study|Subject unable to return for visit|1|||
105435070|NCT02720692|363601321|FG001|Overall Study|Subject unable to return for visit|0|||
105435071|NCT05011513|363601324|FG000|Overall Study|Death|0|||
105435072|NCT05011513|363601325|FG001|Overall Study|Death|1|||
105435073|NCT05011513|363601324|FG000|Overall Study|Lost to Follow-up|4|||
105435074|NCT05011513|363601325|FG001|Overall Study|Lost to Follow-up|0|||
105435075|NCT05011513|363601324|FG000|Overall Study|Withdrawal by Subject|18|||
105435076|NCT05011513|363601325|FG001|Overall Study|Withdrawal by Subject|17|||
105435077|NCT05011513|363601324|FG000|Overall Study|Other|4|||
105435078|NCT05011513|363601325|FG001|Overall Study|Other|2|||
105503138|NCT03641339|363852837|FG005|Overall Study|Withdrawal by Subject|1|||
105503139|NCT00621582|363852845|FG000|Overall Study|Adverse Event|7|||
105435079|NCT03878758|363601326|FG000|Overall Study|Withdrawal by Subject|1|||
105435080|NCT03878758|363601326|FG000|Overall Study|Protocol defined|2|||
105435081|NCT03878758|363601326|FG000|Overall Study|Improper consent documentation|1|||
105435082|NCT04599465|363601327|FG000|Overall Study|Physician Decision|1|||
105435083|NCT04599465|363601327|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
105435084|NCT00358436|363601328|FG000|Overall Study|Adverse Event|29|||
105435085|NCT00358436|363601329|FG001|Overall Study|Adverse Event|13|||
105435086|NCT00358436|363601328|FG000|Overall Study|Lack of Efficacy|34|||
105435087|NCT00358436|363601329|FG001|Overall Study|Lack of Efficacy|36|||
105435088|NCT00358436|363601328|FG000|Overall Study|Lost to Follow-up|11|||
105435089|NCT00358436|363601329|FG001|Overall Study|Lost to Follow-up|6|||
105435090|NCT00358436|363601328|FG000|Overall Study|Protocol Violation|8|||
105435091|NCT00358436|363601329|FG001|Overall Study|Protocol Violation|3|||
105435092|NCT00358436|363601328|FG000|Overall Study|Withdrawal by Subject|40|||
105435093|NCT00358436|363601329|FG001|Overall Study|Withdrawal by Subject|17|||
105435094|NCT00358436|363601328|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
105435095|NCT00358436|363601329|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
105435096|NCT00358436|363601328|FG000|Overall Study|COPD exacerbation|22|||
105503140|NCT00621582|363852845|FG000|Overall Study|Protocol Violation|57|||
105435097|NCT00358436|363601329|FG001|Overall Study|COPD exacerbation|10|||
105435098|NCT00358436|363601328|FG000|Overall Study|Other|6|||
105435099|NCT00358436|363601329|FG001|Overall Study|Other|1|||
105435100|NCT01041287|363601332|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
105435101|NCT01041287|363601333|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
105435102|NCT01041287|363601332|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
105435103|NCT01041287|363601333|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
105435104|NCT04327024|363601334|FG000|Overall Study|Death|1|||
105435105|NCT04327024|363601335|FG001|Overall Study|Death|2|||
105435106|NCT04327024|363601336|FG002|Overall Study|Death|1|||
105435107|NCT04327024|363601334|FG000|Overall Study|Non-compliance with study drug|0|||
105435108|NCT04327024|363601335|FG001|Overall Study|Non-compliance with study drug|1|||
105435109|NCT04327024|363601336|FG002|Overall Study|Non-compliance with study drug|0|||
105435110|NCT04327024|363601334|FG000|Overall Study|Withdrawal by Subject|1|||
105435111|NCT04327024|363601335|FG001|Overall Study|Withdrawal by Subject|1|||
105435112|NCT04327024|363601336|FG002|Overall Study|Withdrawal by Subject|2|||
105435113|NCT01673620|363601338|FG000|Overall Study|Adverse Event|1|||
105435114|NCT01673620|363601339|FG001|Overall Study|Adverse Event|0|||
105435115|NCT01597635|363601340|FG000|Part A|Adverse Event|3|||
105435116|NCT01597635|363601341|FG001|Part A|Adverse Event|0|||
105435117|NCT01597635|363601342|FG002|Part A|Adverse Event|0|||
105435118|NCT01597635|363601340|FG000|Part B|Adverse Event|0|||
105435119|NCT01597635|363601341|FG001|Part B|Adverse Event|0|||
105435120|NCT01597635|363601342|FG002|Part B|Adverse Event|1|||
105435121|NCT01597635|363601340|FG000|Part B|Protocol Violation|0|||
105435122|NCT01597635|363601341|FG001|Part B|Protocol Violation|1|||
105435123|NCT01597635|363601342|FG002|Part B|Protocol Violation|0|||
105435124|NCT01597635|363601340|FG000|Part B|Protocol-defined stopping criteria|0|||
105435125|NCT01597635|363601341|FG001|Part B|Protocol-defined stopping criteria|4|||
105435126|NCT01597635|363601342|FG002|Part B|Protocol-defined stopping criteria|3|||
105435127|NCT01597635|363601340|FG000|Part B|Withdrawal by Subject|0|||
105435128|NCT01597635|363601341|FG001|Part B|Withdrawal by Subject|1|||
105435129|NCT01597635|363601342|FG002|Part B|Withdrawal by Subject|0|||
105435130|NCT01192568|363601343|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
105435131|NCT01192568|363601344|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
105435132|NCT01192568|363601345|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
105435133|NCT01192568|363601346|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
105435134|NCT01192568|363601343|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
105435135|NCT01192568|363601344|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
105435136|NCT01192568|363601345|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
105435137|NCT01192568|363601346|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
105435138|NCT02593825|363601347|FG000|Intervention|Lost to Follow-up|10|||
105435139|NCT02593825|363601348|FG001|Intervention|Lost to Follow-up|12|||
105435140|NCT01206582|363601349|FG000|Overall Study|Withdrew prior to study|1|||
105435141|NCT01206582|363601350|FG001|Overall Study|Withdrew prior to study|0|||
105435142|NCT01206582|363601349|FG000|Overall Study|Discontinued intervention before week 8|1|||
105435143|NCT01206582|363601350|FG001|Overall Study|Discontinued intervention before week 8|2|||
105435144|NCT02522325|363601351|FG000|Overall Study|Adverse Event|0|||
105435145|NCT02522325|363601352|FG001|Overall Study|Adverse Event|1|||
105435146|NCT03416127|363601353|FG000|Overall Study|Withdrawal by Subject|0|||
105435147|NCT03416127|363601354|FG001|Overall Study|Withdrawal by Subject|1|||
105435148|NCT03416127|363601355|FG002|Overall Study|Withdrawal by Subject|1|||
105435149|NCT01971008|363601356|FG000|Overall Study|Protocol Violation|2|||
105435150|NCT01971008|363601357|FG001|Overall Study|Protocol Violation|1|||
105435151|NCT00417963|363601365|FG000|Overall Study|Lost to Follow-up|3|||
105435152|NCT00417963|363601365|FG000|Overall Study|Withdrawal by Subject|18|||
105435153|NCT00417963|363601365|FG000|Overall Study|Death|17|||
105435154|NCT00417963|363601365|FG000|Overall Study|Study device could not be deployed|3|||
105435155|NCT00568126|363601367|FG000|Overall Study|Adverse Event|3|||
105435156|NCT00568126|363601368|FG001|Overall Study|Adverse Event|0|||
105435157|NCT00568126|363601367|FG000|Overall Study|Withdrawal by Subject|2|||
105435158|NCT00568126|363601368|FG001|Overall Study|Withdrawal by Subject|3|||
105435159|NCT00568126|363601367|FG000|Overall Study|Lost to Follow-up|4|||
105435160|NCT00568126|363601368|FG001|Overall Study|Lost to Follow-up|3|||
105435161|NCT00568126|363601367|FG000|Overall Study|Lack of Efficacy|0|||
105435162|NCT00568126|363601368|FG001|Overall Study|Lack of Efficacy|1|||
105435163|NCT00568126|363601367|FG000|Overall Study|Physician Decision|2|||
105435164|NCT00568126|363601368|FG001|Overall Study|Physician Decision|2|||
105435165|NCT04395690|363601369|FG000|Overall Study|Lost to Follow-up|1|||
105435166|NCT04395690|363601370|FG001|Overall Study|Lost to Follow-up|1|||
105435167|NCT00434642|363601371|FG000|Blinded Treatment Phase|Adverse Event|12|||
105435168|NCT00434642|363601372|FG001|Blinded Treatment Phase|Adverse Event|58|||
105435169|NCT00434642|363601371|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
105435170|NCT00434642|363601372|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
105435171|NCT00434642|363601371|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
105435172|NCT00434642|363601372|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
105435173|NCT00434642|363601371|FG000|Blinded Treatment Phase|Physician Decision|19|||
105503141|NCT00621582|363852845|FG000|Overall Study|Lost to Follow-up|24|||
105435174|NCT00434642|363601372|FG001|Blinded Treatment Phase|Physician Decision|27|||
105435175|NCT00434642|363601371|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
105435176|NCT00434642|363601372|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
105435177|NCT00434642|363601371|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
105435178|NCT00434642|363601372|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
105435179|NCT00434642|363601371|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
105435180|NCT00434642|363601372|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
105435181|NCT00434642|363601371|FG000|Open-label Treatment Phase|Adverse Event|0|||
105435182|NCT00434642|363601372|FG001|Open-label Treatment Phase|Adverse Event|5|||
105435183|NCT00434642|363601371|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
105435184|NCT00434642|363601372|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
105435185|NCT01452919|363601373|FG000|Open-Label Treatment|Adverse Event|5|||
105435186|NCT01452919|363601374|FG001|Open-Label Treatment|Adverse Event|0|||
105435187|NCT01452919|363601375|FG002|Open-Label Treatment|Adverse Event|0|||
105435188|NCT01452919|363601373|FG000|Open-Label Treatment|Lost to Follow-up|4|||
105435189|NCT01452919|363601374|FG001|Open-Label Treatment|Lost to Follow-up|0|||
105435190|NCT01452919|363601375|FG002|Open-Label Treatment|Lost to Follow-up|0|||
105435191|NCT01452919|363601373|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
105435192|NCT01452919|363601374|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
105435193|NCT01452919|363601375|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
105435194|NCT01452919|363601373|FG000|Open-Label Treatment|Protocol Violation|4|||
105435195|NCT01452919|363601374|FG001|Open-Label Treatment|Protocol Violation|0|||
105435196|NCT01452919|363601375|FG002|Open-Label Treatment|Protocol Violation|0|||
105435197|NCT01452919|363601373|FG000|Open-Label Treatment|Sponsor Decision|1|||
105435198|NCT01452919|363601374|FG001|Open-Label Treatment|Sponsor Decision|0|||
105435199|NCT01452919|363601375|FG002|Open-Label Treatment|Sponsor Decision|0|||
105435200|NCT01452919|363601373|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
105435201|NCT01452919|363601374|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
105435202|NCT01452919|363601375|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
105435203|NCT01452919|363601373|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
105435204|NCT01452919|363601374|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
105435205|NCT01452919|363601375|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
105435206|NCT01452919|363601373|FG000|Randomization Treatment|Adverse Event|0|||
105435207|NCT01452919|363601374|FG001|Randomization Treatment|Adverse Event|0|||
105435208|NCT01452919|363601375|FG002|Randomization Treatment|Adverse Event|2|||
105435209|NCT01452919|363601373|FG000|Randomization Treatment|Sponsor Decision|0|||
105435210|NCT01452919|363601374|FG001|Randomization Treatment|Sponsor Decision|1|||
105435211|NCT01452919|363601375|FG002|Randomization Treatment|Sponsor Decision|0|||
105435212|NCT01452919|363601373|FG000|Randomization Treatment|Withdrawal by Subject|0|||
105435213|NCT01452919|363601374|FG001|Randomization Treatment|Withdrawal by Subject|1|||
105435214|NCT01452919|363601375|FG002|Randomization Treatment|Withdrawal by Subject|0|||
105435215|NCT01452919|363601373|FG000|Randomization Treatment|Subject is moving or has moved|0|||
105435216|NCT01452919|363601374|FG001|Randomization Treatment|Subject is moving or has moved|1|||
105435217|NCT01452919|363601375|FG002|Randomization Treatment|Subject is moving or has moved|0|||
105435218|NCT03149029|363601376|FG000|Overall Study|Adverse Event|2|||
105435219|NCT03149029|363601377|FG001|Overall Study|Adverse Event|0|||
105435220|NCT02516592|363601381|FG000|Overall Study|Patient withdrew consent|5|||
105435221|NCT02516592|363601382|FG001|Overall Study|Patient withdrew consent|2|||
105435222|NCT02516592|363601381|FG000|Overall Study|Protocol deviation|4|||
105435223|NCT02516592|363601382|FG001|Overall Study|Protocol deviation|4|||
105435224|NCT02516592|363601381|FG000|Overall Study|Lost to Follow-up|2|||
105435225|NCT02516592|363601382|FG001|Overall Study|Lost to Follow-up|3|||
105435226|NCT02516592|363601381|FG000|Overall Study|Patient/guardian decision|2|||
105435227|NCT02516592|363601382|FG001|Overall Study|Patient/guardian decision|1|||
105435228|NCT02516592|363601381|FG000|Overall Study|Adverse Event|1|||
105435229|NCT02516592|363601382|FG001|Overall Study|Adverse Event|2|||
105435230|NCT02516592|363601381|FG000|Overall Study|Abnormal test procedure result|1|||
105435231|NCT02516592|363601382|FG001|Overall Study|Abnormal test procedure result|0|||
105435232|NCT02516592|363601381|FG000|Overall Study|Death|1|||
105435233|NCT02516592|363601382|FG001|Overall Study|Death|1|||
105435234|NCT00231413|363601383|FG000|Overall Study|Non-serious AE|0|||
105435235|NCT00231413|363601384|FG001|Overall Study|Non-serious AE|0|||
105435236|NCT00231413|363601385|FG002|Overall Study|Non-serious AE|1|||
105435237|NCT00231413|363601386|FG003|Overall Study|Non-serious AE|0|||
105435238|NCT00231413|363601387|FG004|Overall Study|Non-serious AE|0|||
105435239|NCT00231413|363601388|FG005|Overall Study|Non-serious AE|0|||
105435240|NCT00231413|363601389|FG006|Overall Study|Non-serious AE|1|||
105435241|NCT00231413|363601383|FG000|Overall Study|Withdrawal by Subject|3|||
105435242|NCT00231413|363601384|FG001|Overall Study|Withdrawal by Subject|1|||
105435243|NCT00231413|363601385|FG002|Overall Study|Withdrawal by Subject|4|||
105435244|NCT00231413|363601386|FG003|Overall Study|Withdrawal by Subject|2|||
105435245|NCT00231413|363601387|FG004|Overall Study|Withdrawal by Subject|2|||
105435246|NCT00231413|363601388|FG005|Overall Study|Withdrawal by Subject|0|||
105590629|NCT03586167|364162670|FG000|Overall Study|Other|1|||
105590630|NCT03586167|364162671|FG001|Overall Study|Other|0|||
105590631|NCT01549652|364162672|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
105590632|NCT01549652|364162673|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
105590633|NCT01549652|364162674|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
105590634|NCT01549652|364162675|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
105590635|NCT01549652|364162672|FG000|Overall Study|Study Drug Titration Failure|5|||
105590636|NCT01549652|364162673|FG001|Overall Study|Study Drug Titration Failure|6|||
105590637|NCT01549652|364162674|FG002|Overall Study|Study Drug Titration Failure|0|||
105590638|NCT01549652|364162675|FG003|Overall Study|Study Drug Titration Failure|0|||
105590639|NCT01549652|364162672|FG000|Overall Study|Withdrawal Effect|0|||
105590640|NCT01549652|364162673|FG001|Overall Study|Withdrawal Effect|2|||
105590641|NCT01549652|364162674|FG002|Overall Study|Withdrawal Effect|0|||
105590642|NCT01549652|364162675|FG003|Overall Study|Withdrawal Effect|0|||
105590643|NCT01549652|364162672|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
105590644|NCT01549652|364162673|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
105590645|NCT01549652|364162674|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
105590646|NCT01549652|364162675|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
105590647|NCT01549652|364162672|FG000|Overall Study|Problem with Infusion|1|||
105435247|NCT00231413|363601389|FG006|Overall Study|Withdrawal by Subject|3|||
105435248|NCT00231413|363601383|FG000|Overall Study|Migrated/moved from study area|0|||
105435249|NCT00231413|363601384|FG001|Overall Study|Migrated/moved from study area|0|||
105435250|NCT00231413|363601385|FG002|Overall Study|Migrated/moved from study area|1|||
105435251|NCT00231413|363601386|FG003|Overall Study|Migrated/moved from study area|0|||
105435252|NCT00231413|363601387|FG004|Overall Study|Migrated/moved from study area|0|||
105435253|NCT00231413|363601388|FG005|Overall Study|Migrated/moved from study area|1|||
105435254|NCT00231413|363601389|FG006|Overall Study|Migrated/moved from study area|0|||
105435255|NCT00231413|363601383|FG000|Overall Study|Lost to Follow-up|4|||
105435256|NCT00231413|363601384|FG001|Overall Study|Lost to Follow-up|4|||
105435257|NCT00231413|363601385|FG002|Overall Study|Lost to Follow-up|1|||
105435258|NCT00231413|363601386|FG003|Overall Study|Lost to Follow-up|1|||
105435259|NCT00231413|363601387|FG004|Overall Study|Lost to Follow-up|1|||
105435260|NCT00231413|363601388|FG005|Overall Study|Lost to Follow-up|4|||
105435261|NCT00231413|363601389|FG006|Overall Study|Lost to Follow-up|0|||
105435262|NCT00231413|363601383|FG000|Overall Study|Pregnancy|1|||
105435263|NCT00231413|363601384|FG001|Overall Study|Pregnancy|0|||
105435264|NCT00231413|363601385|FG002|Overall Study|Pregnancy|0|||
105435265|NCT00231413|363601386|FG003|Overall Study|Pregnancy|0|||
105435266|NCT00231413|363601387|FG004|Overall Study|Pregnancy|0|||
105435267|NCT00231413|363601388|FG005|Overall Study|Pregnancy|0|||
105435268|NCT00231413|363601389|FG006|Overall Study|Pregnancy|0|||
105435269|NCT02708485|363601390|FG000|Overall Study|Withdrawal by Subject|3|||
105435270|NCT02708485|363601391|FG001|Overall Study|Withdrawal by Subject|2|||
105435271|NCT01641822|363601396|FG000|Run-in Phase|Noncompliance with study drug|1|||
105435272|NCT01641822|363601397|FG001|Run-in Phase|Noncompliance with study drug|0|||
105435273|NCT01641822|363601398|FG002|Run-in Phase|Noncompliance with study drug|0|||
105435274|NCT01641822|363601396|FG000|Run-in Phase|Adverse Event|3|||
105435275|NCT01641822|363601397|FG001|Run-in Phase|Adverse Event|0|||
105435276|NCT01641822|363601398|FG002|Run-in Phase|Adverse Event|0|||
105435277|NCT01641822|363601396|FG000|Run-in Phase|Withdrew consent|1|||
105435278|NCT01641822|363601397|FG001|Run-in Phase|Withdrew consent|0|||
105435279|NCT01641822|363601398|FG002|Run-in Phase|Withdrew consent|0|||
105435280|NCT01641822|363601396|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
105435281|NCT01641822|363601397|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
105435282|NCT01641822|363601398|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
105435283|NCT01641822|363601396|FG000|Comparative Phase|Noncompliance with study drug|0|||
105435284|NCT01641822|363601397|FG001|Comparative Phase|Noncompliance with study drug|1|||
105435285|NCT01641822|363601398|FG002|Comparative Phase|Noncompliance with study drug|0|||
105435286|NCT01641822|363601396|FG000|Comparative Phase|Investigator's discretion|0|||
105435287|NCT01641822|363601397|FG001|Comparative Phase|Investigator's discretion|0|||
105435288|NCT01641822|363601398|FG002|Comparative Phase|Investigator's discretion|1|||
105435289|NCT01641822|363601396|FG000|Comparative Phase|Pregnancy|0|||
105435290|NCT01641822|363601397|FG001|Comparative Phase|Pregnancy|0|||
105435291|NCT01641822|363601398|FG002|Comparative Phase|Pregnancy|1|||
105435292|NCT01641822|363601396|FG000|Comparative Phase|Adverse event, serious fatal|0|||
105435293|NCT01641822|363601397|FG001|Comparative Phase|Adverse event, serious fatal|1|||
105435294|NCT01641822|363601398|FG002|Comparative Phase|Adverse event, serious fatal|0|||
105435295|NCT01641822|363601396|FG000|Comparative Phase|Withdrew consent|0|||
105435296|NCT01641822|363601397|FG001|Comparative Phase|Withdrew consent|3|||
105435297|NCT01641822|363601398|FG002|Comparative Phase|Withdrew consent|7|||
105435298|NCT01641822|363601396|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
105435299|NCT01641822|363601397|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
105435300|NCT01641822|363601398|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
105435301|NCT00454584|363601399|FG000|Controlled Period|Adverse Event|5|||
105435302|NCT00454584|363601400|FG001|Controlled Period|Adverse Event|2|||
105435303|NCT00454584|363601401|FG002|Controlled Period|Adverse Event|1|||
105435304|NCT00454584|363601402|FG003|Controlled Period|Adverse Event|0|||
105435305|NCT00454584|363601403|FG004|Controlled Period|Adverse Event|0|||
105435306|NCT00454584|363601404|FG005|Controlled Period|Adverse Event|0|||
105435307|NCT00454584|363601399|FG000|Controlled Period|Lost to Follow-up|1|||
105435308|NCT00454584|363601400|FG001|Controlled Period|Lost to Follow-up|2|||
105435309|NCT00454584|363601401|FG002|Controlled Period|Lost to Follow-up|2|||
105435310|NCT00454584|363601402|FG003|Controlled Period|Lost to Follow-up|0|||
105435311|NCT00454584|363601403|FG004|Controlled Period|Lost to Follow-up|0|||
105435312|NCT00454584|363601404|FG005|Controlled Period|Lost to Follow-up|0|||
105435313|NCT00454584|363601399|FG000|Controlled Period|Other|5|||
105435314|NCT00454584|363601400|FG001|Controlled Period|Other|4|||
105435315|NCT00454584|363601401|FG002|Controlled Period|Other|2|||
105435316|NCT00454584|363601402|FG003|Controlled Period|Other|0|||
105435317|NCT00454584|363601403|FG004|Controlled Period|Other|0|||
105435318|NCT00454584|363601404|FG005|Controlled Period|Other|0|||
105435319|NCT00454584|363601399|FG000|After Controlled Period|Adverse Event|0|||
105435320|NCT00454584|363601400|FG001|After Controlled Period|Adverse Event|0|||
105435321|NCT00454584|363601401|FG002|After Controlled Period|Adverse Event|0|||
105435322|NCT00454584|363601402|FG003|After Controlled Period|Adverse Event|9|||
105435323|NCT00454584|363601403|FG004|After Controlled Period|Adverse Event|3|||
105435324|NCT00454584|363601404|FG005|After Controlled Period|Adverse Event|9|||
105435325|NCT00454584|363601399|FG000|After Controlled Period|Lack of Efficacy|0|||
105435326|NCT00454584|363601400|FG001|After Controlled Period|Lack of Efficacy|0|||
105435327|NCT00454584|363601401|FG002|After Controlled Period|Lack of Efficacy|0|||
105435328|NCT00454584|363601402|FG003|After Controlled Period|Lack of Efficacy|1|||
105435329|NCT00454584|363601403|FG004|After Controlled Period|Lack of Efficacy|0|||
105435330|NCT00454584|363601404|FG005|After Controlled Period|Lack of Efficacy|0|||
105435331|NCT00454584|363601399|FG000|After Controlled Period|Lost to Follow-up|0|||
105435332|NCT00454584|363601400|FG001|After Controlled Period|Lost to Follow-up|0|||
105435333|NCT00454584|363601401|FG002|After Controlled Period|Lost to Follow-up|0|||
105435334|NCT00454584|363601402|FG003|After Controlled Period|Lost to Follow-up|2|||
105435335|NCT00454584|363601403|FG004|After Controlled Period|Lost to Follow-up|4|||
105435336|NCT00454584|363601404|FG005|After Controlled Period|Lost to Follow-up|6|||
105435337|NCT00454584|363601399|FG000|After Controlled Period|Other|0|||
105435338|NCT00454584|363601400|FG001|After Controlled Period|Other|0|||
105435339|NCT00454584|363601401|FG002|After Controlled Period|Other|0|||
105435340|NCT00454584|363601402|FG003|After Controlled Period|Other|1|||
105435341|NCT00454584|363601403|FG004|After Controlled Period|Other|0|||
105435342|NCT00454584|363601404|FG005|After Controlled Period|Other|0|||
105435343|NCT00454584|363601399|FG000|After Controlled Period|Other|0|||
105435344|NCT00454584|363601400|FG001|After Controlled Period|Other|0|||
105435345|NCT00454584|363601401|FG002|After Controlled Period|Other|0|||
105435346|NCT00454584|363601402|FG003|After Controlled Period|Other|13|||
105435347|NCT00454584|363601403|FG004|After Controlled Period|Other|5|||
105435348|NCT00454584|363601404|FG005|After Controlled Period|Other|17|||
105435349|NCT01729208|363601405|FG000|Baseline|Physician Decision|5|||
105435350|NCT01729208|363601406|FG001|Baseline|Physician Decision|4|||
105435351|NCT01729208|363601405|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
105435352|NCT01729208|363601406|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
105435353|NCT01729208|363601405|FG000|12 Months Follow-up|Lost to Follow-up|3|||
105435354|NCT01729208|363601406|FG001|12 Months Follow-up|Lost to Follow-up|3|||
105435355|NCT01729208|363601405|FG000|24 Months Follow-up|Lost to Follow-up|3|||
105435356|NCT01729208|363601406|FG001|24 Months Follow-up|Lost to Follow-up|0|||
105435357|NCT01729208|363601405|FG000|36 Months Follow-up|Physician Decision|1|||
105435358|NCT01729208|363601406|FG001|36 Months Follow-up|Physician Decision|0|||
105435359|NCT01729208|363601405|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
105503142|NCT00621582|363852845|FG000|Overall Study|issues not identified by investigators|18|||
105435360|NCT01729208|363601406|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
105435361|NCT00494507|363601409|FG000|Double-Blind Phase|Adverse Event|2|||
105435362|NCT00494507|363601410|FG001|Double-Blind Phase|Adverse Event|0|||
105435363|NCT00494507|363601411|FG002|Double-Blind Phase|Adverse Event|1|||
105435364|NCT00494507|363601412|FG003|Double-Blind Phase|Adverse Event|0|||
105435365|NCT00494507|363601409|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
105435366|NCT00494507|363601410|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
105435367|NCT00494507|363601411|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
105435368|NCT00494507|363601412|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
105435369|NCT00494507|363601409|FG000|Double-Blind Phase|Subject Non-compliance|0|||
105435370|NCT00494507|363601410|FG001|Double-Blind Phase|Subject Non-compliance|0|||
105435371|NCT00494507|363601411|FG002|Double-Blind Phase|Subject Non-compliance|1|||
105435372|NCT00494507|363601412|FG003|Double-Blind Phase|Subject Non-compliance|0|||
105435373|NCT00494507|363601409|FG000|Double-Blind Phase|Negative DNA test|0|||
105435374|NCT00494507|363601410|FG001|Double-Blind Phase|Negative DNA test|0|||
105435375|NCT00494507|363601411|FG002|Double-Blind Phase|Negative DNA test|0|||
105435376|NCT00494507|363601412|FG003|Double-Blind Phase|Negative DNA test|1|||
105435377|NCT00494507|363601409|FG000|Open-Label Phase|Adverse Event|0|||
105435378|NCT00494507|363601410|FG001|Open-Label Phase|Adverse Event|1|||
105435379|NCT00494507|363601411|FG002|Open-Label Phase|Adverse Event|5|||
105435380|NCT00494507|363601412|FG003|Open-Label Phase|Adverse Event|3|||
105435381|NCT00494507|363601409|FG000|Open-Label Phase|Worsening Disease|0|||
105435382|NCT00494507|363601410|FG001|Open-Label Phase|Worsening Disease|0|||
105435383|NCT00494507|363601411|FG002|Open-Label Phase|Worsening Disease|0|||
105435384|NCT00494507|363601412|FG003|Open-Label Phase|Worsening Disease|2|||
105435385|NCT03689855|363601417|FG000|Overall Study|Adverse Event|3|||
105435386|NCT03689855|363601417|FG000|Overall Study|Withdrawal by Subject|1|||
105435387|NCT00129961|363601427|FG000|Overall Study|Adverse Event|1|||
105435388|NCT00129961|363601428|FG001|Overall Study|Adverse Event|0|||
105435389|NCT00129961|363601427|FG000|Overall Study|Death|1|||
105435390|NCT00129961|363601428|FG001|Overall Study|Death|1|||
105435391|NCT00129961|363601427|FG000|Overall Study|Withdrawal by Sponsor|14|||
105435392|NCT00129961|363601428|FG001|Overall Study|Withdrawal by Sponsor|20|||
105435393|NCT00129961|363601427|FG000|Overall Study|Physician Decision|1|||
105435394|NCT00129961|363601428|FG001|Overall Study|Physician Decision|0|||
105435395|NCT00129961|363601427|FG000|Overall Study|Withdrawal by Subject|2|||
105435396|NCT00129961|363601428|FG001|Overall Study|Withdrawal by Subject|1|||
105435397|NCT00129961|363601427|FG000|Overall Study|Missing Record|0|||
105435398|NCT00129961|363601428|FG001|Overall Study|Missing Record|1|||
105435399|NCT01600092|363601429|FG000|Overall Study|Adverse Event|2|||
105435400|NCT01600092|363601430|FG001|Overall Study|Adverse Event|0|||
105435401|NCT01600092|363601429|FG000|Overall Study|Lost to Follow-up|4|||
105435402|NCT01600092|363601430|FG001|Overall Study|Lost to Follow-up|6|||
105435403|NCT01600092|363601429|FG000|Overall Study|Withdrawal by parent/guardian|8|||
105435404|NCT01600092|363601430|FG001|Overall Study|Withdrawal by parent/guardian|6|||
105435405|NCT01600092|363601429|FG000|Overall Study|Physician Decision|1|||
105435406|NCT01600092|363601430|FG001|Overall Study|Physician Decision|1|||
105435407|NCT01600092|363601429|FG000|Overall Study|Randomized but not vaccinated|3|||
105435408|NCT01600092|363601430|FG001|Overall Study|Randomized but not vaccinated|3|||
105435409|NCT01927055|363601435|FG000|Open-label|Adverse Event|6|||
105435410|NCT01927055|363601436|FG001|Open-label|Adverse Event|0|||
105435411|NCT01927055|363601437|FG002|Open-label|Adverse Event|0|||
105435412|NCT01927055|363601435|FG000|Open-label|Withdrawal by Subject|1|||
105435413|NCT01927055|363601436|FG001|Open-label|Withdrawal by Subject|0|||
105435414|NCT01927055|363601437|FG002|Open-label|Withdrawal by Subject|0|||
105435415|NCT01927055|363601435|FG000|Open-label|Study Stopped|4|||
105435416|NCT01927055|363601436|FG001|Open-label|Study Stopped|0|||
105435417|NCT01927055|363601437|FG002|Open-label|Study Stopped|0|||
105435418|NCT01927055|363601435|FG000|Open-label|Supine Hypertension|4|||
105435419|NCT01927055|363601436|FG001|Open-label|Supine Hypertension|0|||
105435420|NCT01927055|363601437|FG002|Open-label|Supine Hypertension|0|||
105435421|NCT01927055|363601435|FG000|Open-label|Difficulty attending study visits|1|||
105435422|NCT01927055|363601436|FG001|Open-label|Difficulty attending study visits|0|||
105435423|NCT01927055|363601437|FG002|Open-label|Difficulty attending study visits|0|||
105435424|NCT01927055|363601435|FG000|Double-Blind|Adverse Event|0|||
105435425|NCT01927055|363601436|FG001|Double-Blind|Adverse Event|1|||
105435426|NCT01927055|363601437|FG002|Double-Blind|Adverse Event|1|||
105435427|NCT01927055|363601435|FG000|Double-Blind|Protocol Violation|0|||
105435428|NCT01927055|363601436|FG001|Double-Blind|Protocol Violation|0|||
105435429|NCT01927055|363601437|FG002|Double-Blind|Protocol Violation|1|||
105435430|NCT01927055|363601435|FG000|Double-Blind|Withdrawal by Subject|0|||
105435431|NCT01927055|363601436|FG001|Double-Blind|Withdrawal by Subject|2|||
105435432|NCT01927055|363601437|FG002|Double-Blind|Withdrawal by Subject|3|||
105435433|NCT01927055|363601435|FG000|Double-Blind|Study Stopped|0|||
105435434|NCT01927055|363601436|FG001|Double-Blind|Study Stopped|7|||
105435435|NCT01927055|363601437|FG002|Double-Blind|Study Stopped|7|||
105435436|NCT01927055|363601435|FG000|Double-Blind|Supine Hypertension|0|||
105435437|NCT01927055|363601436|FG001|Double-Blind|Supine Hypertension|0|||
105435438|NCT01927055|363601437|FG002|Double-Blind|Supine Hypertension|1|||
105435439|NCT01927055|363601435|FG000|Double-Blind|Extended Vacation|0|||
105435440|NCT01927055|363601436|FG001|Double-Blind|Extended Vacation|1|||
105435441|NCT01927055|363601437|FG002|Double-Blind|Extended Vacation|0|||
105435442|NCT01389323|363601438|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
105435443|NCT01389323|363601438|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
105435444|NCT01389323|363601438|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
105435445|NCT01389323|363601438|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
105435446|NCT01389323|363601438|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
105435447|NCT01389323|363601438|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
105435448|NCT01389323|363601438|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
105435449|NCT01389323|363601438|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
105435450|NCT01389323|363601438|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
105435451|NCT01389323|363601438|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
105435452|NCT01389323|363601438|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
105435453|NCT00718770|363601446|FG000|Overall Study|Adverse Event|1|||
105435454|NCT00718770|363601446|FG000|Overall Study|Lack of Efficacy|1|||
105435455|NCT00718770|363601446|FG000|Overall Study|Lack of Efficacy|1|||
105435456|NCT00718770|363601446|FG000|Overall Study|Adverse Event|1|||
105435457|NCT00718770|363601446|FG000|Overall Study|Lack of Efficacy|1|||
105435458|NCT00718770|363601446|FG000|Overall Study|Adverse Event|1|||
105435459|NCT00718770|363601446|FG000|Overall Study|Lack of Efficacy|1|||
105435460|NCT00718770|363601446|FG000|Overall Study|Adverse Event|1|||
105435461|NCT00498355|363601447|FG000|Overall Study|Lost to Follow-up|1|||
105435462|NCT01895309|363601448|FG000|Overall Study|Adverse Event|13|||
105435463|NCT01895309|363601449|FG001|Overall Study|Adverse Event|17|||
105435464|NCT01895309|363601448|FG000|Overall Study|Protocol Violation|1|||
105435465|NCT01895309|363601449|FG001|Overall Study|Protocol Violation|0|||
105435466|NCT01895309|363601448|FG000|Overall Study|Lack of Efficacy|1|||
105435467|NCT01895309|363601449|FG001|Overall Study|Lack of Efficacy|3|||
105435468|NCT01895309|363601448|FG000|Overall Study|Lost to Follow-up|1|||
105435469|NCT01895309|363601449|FG001|Overall Study|Lost to Follow-up|3|||
105435470|NCT01895309|363601448|FG000|Overall Study|Physician Decision|15|||
105435471|NCT01895309|363601449|FG001|Overall Study|Physician Decision|10|||
105435472|NCT01895309|363601448|FG000|Overall Study|Withdrawal by Subject|9|||
105435473|NCT01895309|363601449|FG001|Overall Study|Withdrawal by Subject|18|||
105435474|NCT04496453|363601450|FG000|Overall Study|Lost to Follow-up|6|||
105435475|NCT01555125|363601451|FG000|Induction Period|Lost to Follow-up|0|||
105435476|NCT01555125|363601452|FG001|Induction Period|Lost to Follow-up|2|||
105435477|NCT01555125|363601453|FG002|Induction Period|Lost to Follow-up|0|||
105435478|NCT01555125|363601454|FG003|Induction Period|Lost to Follow-up|0|||
105435479|NCT01555125|363601455|FG004|Induction Period|Lost to Follow-up|0|||
105435480|NCT01555125|363601451|FG000|Induction Period|Adverse Event|0|||
105435481|NCT01555125|363601452|FG001|Induction Period|Adverse Event|1|||
105435482|NCT01555125|363601453|FG002|Induction Period|Adverse Event|0|||
105435483|NCT01555125|363601454|FG003|Induction Period|Adverse Event|0|||
105435484|NCT01555125|363601455|FG004|Induction Period|Adverse Event|1|||
105435485|NCT01555125|363601451|FG000|Induction Period|Subject / guardian decision|0|||
105435486|NCT01555125|363601452|FG001|Induction Period|Subject / guardian decision|0|||
105435487|NCT01555125|363601453|FG002|Induction Period|Subject / guardian decision|0|||
105435488|NCT01555125|363601454|FG003|Induction Period|Subject / guardian decision|0|||
105435489|NCT01555125|363601455|FG004|Induction Period|Subject / guardian decision|2|||
105435490|NCT01555125|363601451|FG000|Induction Period|Death|1|||
105435491|NCT01555125|363601452|FG001|Induction Period|Death|0|||
105435492|NCT01555125|363601453|FG002|Induction Period|Death|0|||
105435493|NCT01555125|363601454|FG003|Induction Period|Death|0|||
105435494|NCT01555125|363601455|FG004|Induction Period|Death|0|||
105435495|NCT01555125|363601451|FG000|Maintenance Period|Adverse Event|1|||
105435496|NCT01555125|363601452|FG001|Maintenance Period|Adverse Event|1|||
105435497|NCT01555125|363601453|FG002|Maintenance Period|Adverse Event|0|||
105435498|NCT01555125|363601454|FG003|Maintenance Period|Adverse Event|0|||
105435499|NCT01555125|363601455|FG004|Maintenance Period|Adverse Event|0|||
105435500|NCT01555125|363601451|FG000|Maintenance Period|Subject / guardian decision|1|||
105435501|NCT01555125|363601452|FG001|Maintenance Period|Subject / guardian decision|2|||
105435502|NCT01555125|363601453|FG002|Maintenance Period|Subject / guardian decision|0|||
105435503|NCT01555125|363601454|FG003|Maintenance Period|Subject / guardian decision|0|||
105435504|NCT01555125|363601455|FG004|Maintenance Period|Subject / guardian decision|0|||
105435505|NCT01555125|363601451|FG000|Maintenance Period|Lost to Follow-up|2|||
105435506|NCT01555125|363601452|FG001|Maintenance Period|Lost to Follow-up|0|||
105435507|NCT01555125|363601453|FG002|Maintenance Period|Lost to Follow-up|0|||
105435508|NCT01555125|363601454|FG003|Maintenance Period|Lost to Follow-up|1|||
105435509|NCT01555125|363601455|FG004|Maintenance Period|Lost to Follow-up|0|||
105435510|NCT01555125|363601451|FG000|Maintenance Period|Lack of Efficacy|6|||
105435511|NCT01555125|363601452|FG001|Maintenance Period|Lack of Efficacy|1|||
105435512|NCT01555125|363601453|FG002|Maintenance Period|Lack of Efficacy|3|||
105435513|NCT01555125|363601454|FG003|Maintenance Period|Lack of Efficacy|0|||
105435514|NCT01555125|363601455|FG004|Maintenance Period|Lack of Efficacy|0|||
105435515|NCT01555125|363601451|FG000|Maintenance Period|Physician Decision|0|||
105435516|NCT01555125|363601452|FG001|Maintenance Period|Physician Decision|0|||
105435517|NCT01555125|363601453|FG002|Maintenance Period|Physician Decision|1|||
105435518|NCT01555125|363601454|FG003|Maintenance Period|Physician Decision|0|||
105435519|NCT01555125|363601455|FG004|Maintenance Period|Physician Decision|0|||
105435520|NCT01555125|363601451|FG000|Maintenance Period|Death|0|||
105435521|NCT01555125|363601452|FG001|Maintenance Period|Death|0|||
105435522|NCT01555125|363601453|FG002|Maintenance Period|Death|0|||
105435523|NCT01555125|363601454|FG003|Maintenance Period|Death|1|||
105435524|NCT01555125|363601455|FG004|Maintenance Period|Death|0|||
105435525|NCT01555125|363601451|FG000|Extension|Adverse Event|1|||
105435526|NCT01555125|363601452|FG001|Extension|Adverse Event|2|||
105435527|NCT01555125|363601453|FG002|Extension|Adverse Event|1|||
105435528|NCT01555125|363601454|FG003|Extension|Adverse Event|1|||
105435529|NCT01555125|363601455|FG004|Extension|Adverse Event|0|||
105435530|NCT01555125|363601451|FG000|Extension|Protocol deviation|1|||
105435531|NCT01555125|363601452|FG001|Extension|Protocol deviation|0|||
105435532|NCT01555125|363601453|FG002|Extension|Protocol deviation|0|||
105435533|NCT01555125|363601454|FG003|Extension|Protocol deviation|0|||
105435534|NCT01555125|363601455|FG004|Extension|Protocol deviation|0|||
105435535|NCT01555125|363601451|FG000|Extension|Lack of Efficacy|7|||
105435536|NCT01555125|363601452|FG001|Extension|Lack of Efficacy|6|||
105435537|NCT01555125|363601453|FG002|Extension|Lack of Efficacy|3|||
105435538|NCT01555125|363601454|FG003|Extension|Lack of Efficacy|0|||
105435539|NCT01555125|363601455|FG004|Extension|Lack of Efficacy|0|||
105435540|NCT01555125|363601451|FG000|Extension|Lost to Follow-up|2|||
105435541|NCT01555125|363601452|FG001|Extension|Lost to Follow-up|1|||
105435542|NCT01555125|363601453|FG002|Extension|Lost to Follow-up|2|||
105435543|NCT01555125|363601454|FG003|Extension|Lost to Follow-up|0|||
105435544|NCT01555125|363601455|FG004|Extension|Lost to Follow-up|0|||
105435545|NCT01555125|363601451|FG000|Extension|Study terminated by sponsor|32|||
105435546|NCT01555125|363601452|FG001|Extension|Study terminated by sponsor|33|||
105435547|NCT01555125|363601453|FG002|Extension|Study terminated by sponsor|16|||
105435548|NCT01555125|363601454|FG003|Extension|Study terminated by sponsor|20|||
105435549|NCT01555125|363601455|FG004|Extension|Study terminated by sponsor|0|||
105435550|NCT01555125|363601451|FG000|Extension|Subject/guardian decision|1|||
105435551|NCT01555125|363601452|FG001|Extension|Subject/guardian decision|9|||
105435552|NCT01555125|363601453|FG002|Extension|Subject/guardian decision|1|||
105435553|NCT01555125|363601454|FG003|Extension|Subject/guardian decision|0|||
105435554|NCT01555125|363601455|FG004|Extension|Subject/guardian decision|0|||
105435555|NCT01555125|363601451|FG000|Extension|Technical Problems|1|||
105435556|NCT01555125|363601452|FG001|Extension|Technical Problems|0|||
105435557|NCT01555125|363601453|FG002|Extension|Technical Problems|0|||
105435558|NCT01555125|363601454|FG003|Extension|Technical Problems|1|||
105435559|NCT01555125|363601455|FG004|Extension|Technical Problems|0|||
105435560|NCT01555125|363601451|FG000|Follow-Up Period|Lost to Follow-up|1|||
105435561|NCT01555125|363601452|FG001|Follow-Up Period|Lost to Follow-up|0|||
105435562|NCT01555125|363601453|FG002|Follow-Up Period|Lost to Follow-up|0|||
105435563|NCT01555125|363601454|FG003|Follow-Up Period|Lost to Follow-up|0|||
105435564|NCT01555125|363601455|FG004|Follow-Up Period|Lost to Follow-up|0|||
105435565|NCT01555125|363601451|FG000|Follow-Up Period|Subject / guardian decision|3|||
105435566|NCT01555125|363601452|FG001|Follow-Up Period|Subject / guardian decision|1|||
105435567|NCT01555125|363601453|FG002|Follow-Up Period|Subject / guardian decision|1|||
105435568|NCT01555125|363601454|FG003|Follow-Up Period|Subject / guardian decision|1|||
105435569|NCT01555125|363601455|FG004|Follow-Up Period|Subject / guardian decision|0|||
105435570|NCT02651220|363601456|FG000|Overall Study|Adverse Event|1|||
105435571|NCT02651220|363601457|FG001|Overall Study|Adverse Event|5|||
105435572|NCT02651220|363601458|FG002|Overall Study|Adverse Event|1|||
105435573|NCT02651220|363601456|FG000|Overall Study|Lost to Follow-up|8|||
105435574|NCT02651220|363601457|FG001|Overall Study|Lost to Follow-up|14|||
105435575|NCT02651220|363601458|FG002|Overall Study|Lost to Follow-up|14|||
105435576|NCT02651220|363601456|FG000|Overall Study|Non-Compliance with Study Drug|4|||
105435577|NCT02651220|363601457|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105435578|NCT02651220|363601458|FG002|Overall Study|Non-Compliance with Study Drug|1|||
105435579|NCT02651220|363601456|FG000|Overall Study|Pregnancy|1|||
105435580|NCT02651220|363601457|FG001|Overall Study|Pregnancy|0|||
105435581|NCT02651220|363601458|FG002|Overall Study|Pregnancy|1|||
105435582|NCT02651220|363601456|FG000|Overall Study|Protocol Violation|0|||
105435583|NCT02651220|363601457|FG001|Overall Study|Protocol Violation|0|||
105435584|NCT02651220|363601458|FG002|Overall Study|Protocol Violation|1|||
105435585|NCT02651220|363601456|FG000|Overall Study|Withdrawal by Subject|5|||
105435586|NCT02651220|363601457|FG001|Overall Study|Withdrawal by Subject|6|||
105435587|NCT02651220|363601458|FG002|Overall Study|Withdrawal by Subject|8|||
105435588|NCT02651220|363601456|FG000|Overall Study|Miscellaneous|4|||
105435589|NCT02651220|363601457|FG001|Overall Study|Miscellaneous|1|||
105435590|NCT02651220|363601458|FG002|Overall Study|Miscellaneous|2|||
105435591|NCT02651220|363601456|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105435592|NCT02651220|363601457|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
105435593|NCT02651220|363601458|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
105435594|NCT04058886|363601460|FG000|Overall Study|Withdrawal by Subject|4|||
105435595|NCT04058886|363601460|FG000|Overall Study|Inadequate deafness interpreter service|1|||
105435596|NCT01092663|363601471|FG000|Overall Study|Withdrawal by Subject|3|||
105435597|NCT01092663|363601472|FG001|Overall Study|Withdrawal by Subject|2|||
105435598|NCT01092663|363601471|FG000|Overall Study|Glucose >300mg/dL|1|||
105435599|NCT01092663|363601472|FG001|Overall Study|Glucose >300mg/dL|0|||
105503143|NCT02925117|363852849|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
105435600|NCT01092663|363601471|FG000|Overall Study|High fasting triglyceride|2|||
105435601|NCT01092663|363601472|FG001|Overall Study|High fasting triglyceride|0|||
105435602|NCT01092663|363601471|FG000|Overall Study|Adverse Event|1|||
105435603|NCT01092663|363601472|FG001|Overall Study|Adverse Event|1|||
105435604|NCT01092663|363601471|FG000|Overall Study|Protocol Violation|0|||
105435605|NCT01092663|363601472|FG001|Overall Study|Protocol Violation|1|||
105435606|NCT02409342|363601473|FG000|Overall Study|Death|211|||
105435607|NCT02409342|363601474|FG001|Overall Study|Death|201|||
105435608|NCT02409342|363601473|FG000|Overall Study|Withdrawal by Subject|24|||
105435609|NCT02409342|363601474|FG001|Overall Study|Withdrawal by Subject|17|||
105435610|NCT02409342|363601473|FG000|Overall Study|Study Terminated By Sponsor|48|||
105435611|NCT02409342|363601474|FG001|Overall Study|Study Terminated By Sponsor|59|||
105435612|NCT02409342|363601473|FG000|Overall Study|Lost to Follow-up|3|||
105435613|NCT02409342|363601474|FG001|Overall Study|Lost to Follow-up|5|||
105435614|NCT02409342|363601473|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
105435615|NCT02409342|363601474|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
105435616|NCT02409342|363601473|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
105435617|NCT02409342|363601474|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
105435618|NCT02409342|363601473|FG000|Overall Study|Sponsor Decision|1|||
105435619|NCT02409342|363601474|FG001|Overall Study|Sponsor Decision|0|||
105435620|NCT00788710|363601475|FG000|Overall Study|Adverse Event|1|||
105435621|NCT00788710|363601476|FG001|Overall Study|Adverse Event|3|||
105435622|NCT00788710|363601477|FG002|Overall Study|Adverse Event|4|||
105435623|NCT00788710|363601475|FG000|Overall Study|Lack of Efficacy|0|||
105435624|NCT00788710|363601476|FG001|Overall Study|Lack of Efficacy|0|||
105435625|NCT00788710|363601477|FG002|Overall Study|Lack of Efficacy|1|||
105435626|NCT00788710|363601475|FG000|Overall Study|Lost to Follow-up|0|||
105435627|NCT00788710|363601476|FG001|Overall Study|Lost to Follow-up|1|||
105435628|NCT00788710|363601477|FG002|Overall Study|Lost to Follow-up|0|||
105435629|NCT00788710|363601475|FG000|Overall Study|Physician Decision|2|||
105435630|NCT00788710|363601476|FG001|Overall Study|Physician Decision|1|||
105435631|NCT00788710|363601477|FG002|Overall Study|Physician Decision|0|||
105435632|NCT00788710|363601475|FG000|Overall Study|Protocol Violation|0|||
105435633|NCT00788710|363601476|FG001|Overall Study|Protocol Violation|1|||
105435634|NCT00788710|363601477|FG002|Overall Study|Protocol Violation|1|||
105435635|NCT00788710|363601475|FG000|Overall Study|Withdrawal by Subject|2|||
105435636|NCT00788710|363601476|FG001|Overall Study|Withdrawal by Subject|2|||
105435637|NCT00788710|363601477|FG002|Overall Study|Withdrawal by Subject|0|||
105435638|NCT04407234|363601478|FG000|Overall Study|Adverse Event|3|||
105435639|NCT04407234|363601479|FG001|Overall Study|Adverse Event|3|||
105435640|NCT00344500|363602941|FG000|Overall Study|Adverse Event|6|||
105435641|NCT00344500|363602942|FG001|Overall Study|Adverse Event|2|||
105435642|NCT00344500|363602943|FG002|Overall Study|Adverse Event|0|||
105435643|NCT00344500|363602941|FG000|Overall Study|Lost to Follow-up|5|||
105435644|NCT00344500|363602942|FG001|Overall Study|Lost to Follow-up|13|||
105435645|NCT00344500|363602943|FG002|Overall Study|Lost to Follow-up|1|||
105435646|NCT00344500|363602941|FG000|Overall Study|Withdrawal by Subject|7|||
105435647|NCT00344500|363602942|FG001|Overall Study|Withdrawal by Subject|10|||
105435648|NCT00344500|363602943|FG002|Overall Study|Withdrawal by Subject|0|||
105435649|NCT00344500|363602941|FG000|Overall Study|Protocol Violation|4|||
105435650|NCT00344500|363602942|FG001|Overall Study|Protocol Violation|7|||
105435651|NCT00344500|363602943|FG002|Overall Study|Protocol Violation|1|||
105435652|NCT00344500|363602941|FG000|Overall Study|Not Noted|1|||
105435653|NCT00344500|363602942|FG001|Overall Study|Not Noted|3|||
105435654|NCT00344500|363602943|FG002|Overall Study|Not Noted|0|||
105435655|NCT00126776|363602944|FG000|Overall Study|follow up complete on all patients|0|||
105435656|NCT00126776|363602945|FG001|Overall Study|follow up complete on all patients|0|||
105435657|NCT00599755|363602946|FG000|Overall Study|Adverse Event|11|||
105435658|NCT00599755|363602946|FG000|Overall Study|Withdrawal by Subject|2|||
105435659|NCT00599755|363602946|FG000|Overall Study|Progression of Disease|3|||
105435660|NCT00599755|363602946|FG000|Overall Study|Other Reason|2|||
105435661|NCT00599755|363602946|FG000|Overall Study|No data available|1|||
105435662|NCT00477152|363602948|FG000|Overall Study|Parent withdrew consent|2|||
105435663|NCT00477152|363602948|FG000|Overall Study|Adverse Event|1|||
105435664|NCT01023672|363602949|FG000|Overall Study|Worsening disease|2|||
105435665|NCT01023672|363602949|FG000|Overall Study|Death|1|||
105435666|NCT00448747|363602951|FG000|Overall Study|collapsed veins|1|||
105435667|NCT00448747|363602952|FG001|Overall Study|collapsed veins|0|||
105435668|NCT00387725|363602953|FG000|Overall Study|Adverse Event|0|||
105435669|NCT00387725|363602954|FG001|Overall Study|Adverse Event|0|||
105435670|NCT00387725|363602955|FG002|Overall Study|Adverse Event|0|||
105435671|NCT00387725|363602956|FG003|Overall Study|Adverse Event|1|||
105435672|NCT00387725|363602953|FG000|Overall Study|Protocol Violation|0|||
105435673|NCT00387725|363602954|FG001|Overall Study|Protocol Violation|1|||
105435674|NCT00387725|363602955|FG002|Overall Study|Protocol Violation|0|||
105435675|NCT00387725|363602956|FG003|Overall Study|Protocol Violation|0|||
105435676|NCT00387725|363602953|FG000|Overall Study|Withdrawal by Subject|1|||
105435677|NCT00387725|363602954|FG001|Overall Study|Withdrawal by Subject|0|||
105435678|NCT00387725|363602955|FG002|Overall Study|Withdrawal by Subject|1|||
105435679|NCT00387725|363602956|FG003|Overall Study|Withdrawal by Subject|0|||
105435680|NCT00387725|363602953|FG000|Overall Study|Parent/legal guardian request|0|||
105435681|NCT00387725|363602954|FG001|Overall Study|Parent/legal guardian request|0|||
105435682|NCT00387725|363602955|FG002|Overall Study|Parent/legal guardian request|1|||
105435683|NCT00387725|363602956|FG003|Overall Study|Parent/legal guardian request|1|||
105435684|NCT02678923|363602960|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
105435685|NCT02678923|363602961|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
105435686|NCT02678923|363602960|FG000|Overall Study|Withdrawal by Subject|3|||
105435687|NCT02678923|363602961|FG001|Overall Study|Withdrawal by Subject|2|||
105435688|NCT02678923|363602960|FG000|Overall Study|Lost to Follow-up|1|||
105435689|NCT02678923|363602961|FG001|Overall Study|Lost to Follow-up|0|||
105435690|NCT02678923|363602960|FG000|Overall Study|Did Not Return for Study Visits|1|||
105435691|NCT02678923|363602961|FG001|Overall Study|Did Not Return for Study Visits|0|||
105435692|NCT00902174|363602962|FG000|Overall Study|Adverse Event|27|||
105435693|NCT00902174|363602963|FG001|Overall Study|Adverse Event|7|||
105435694|NCT00902174|363602962|FG000|Overall Study|Lack of Efficacy|1|||
105435695|NCT00902174|363602963|FG001|Overall Study|Lack of Efficacy|5|||
105435696|NCT00902174|363602962|FG000|Overall Study|Death|2|||
105435697|NCT00902174|363602963|FG001|Overall Study|Death|2|||
105435698|NCT00902174|363602962|FG000|Overall Study|Withdrawal by Subject|2|||
105435699|NCT00902174|363602963|FG001|Overall Study|Withdrawal by Subject|1|||
105435700|NCT00902174|363602962|FG000|Overall Study|Abnormal labs|1|||
105435701|NCT00902174|363602963|FG001|Overall Study|Abnormal labs|1|||
105435702|NCT00902174|363602962|FG000|Overall Study|Protocol Violation|1|||
105435703|NCT00902174|363602963|FG001|Overall Study|Protocol Violation|1|||
105435704|NCT00902174|363602962|FG000|Overall Study|Administration problem|0|||
105435705|NCT00902174|363602963|FG001|Overall Study|Administration problem|1|||
105435706|NCT03129360|363602964|FG000|Overall Study|Did not meet entry criteria|0|||
105435707|NCT03129360|363602965|FG001|Overall Study|Did not meet entry criteria|2|||
105435708|NCT03129360|363602966|FG002|Overall Study|Did not meet entry criteria|1|||
105435709|NCT03129360|363602964|FG000|Overall Study|Excluded due to motion in scanner|1|||
105435710|NCT03129360|363602965|FG001|Overall Study|Excluded due to motion in scanner|0|||
105435711|NCT03129360|363602966|FG002|Overall Study|Excluded due to motion in scanner|0|||
105435712|NCT00764673|363602967|FG000|Overall Study|Death|1|||
105435713|NCT00764673|363602967|FG000|Overall Study|Lost to Follow-up|3|||
105435714|NCT00764673|363602967|FG000|Overall Study|Withdrawal by Subject|6|||
105435715|NCT00764673|363602967|FG000|Overall Study|Revision of Device|2|||
105435716|NCT01438177|363602969|FG000|Overall Study|Withdrawal by Subject|1|||
105435717|NCT01438177|363602969|FG000|Overall Study|Initiation of new therapy|1|||
105435718|NCT00084487|363602973|FG000|Overall Study|Death|1|||
105435719|NCT00565136|363602974|FG000|Overall Study|Lost to Follow-up|1|||
105435720|NCT00565136|363602974|FG000|Overall Study|Withdrawal by Subject|1|||
105435721|NCT00565136|363602974|FG000|Overall Study|Protocol Violation|1|||
105435722|NCT00619099|363602975|FG000|Overall Study|Progressive Disease|7|||
105435723|NCT00619099|363602976|FG001|Overall Study|Progressive Disease|5|||
105435724|NCT00619099|363602975|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
105435725|NCT00619099|363602976|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
105435726|NCT00619099|363602975|FG000|Overall Study|Adverse Event|4|||
105435727|NCT00619099|363602976|FG001|Overall Study|Adverse Event|3|||
105435728|NCT00619099|363602975|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
105435729|NCT00619099|363602976|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
105435730|NCT00619099|363602975|FG000|Overall Study|Withdrawal by Subject|10|||
105435731|NCT00619099|363602976|FG001|Overall Study|Withdrawal by Subject|2|||
105435732|NCT00619099|363602975|FG000|Overall Study|Physician Decision|9|||
105435733|NCT00619099|363602976|FG001|Overall Study|Physician Decision|6|||
105435734|NCT00084656|363602977|FG000|Overall Study|Other reasons|0|||
105435735|NCT00084656|363602978|FG001|Overall Study|Other reasons|12|||
105435736|NCT00084656|363602979|FG002|Overall Study|Other reasons|11|||
105435737|NCT00084656|363602977|FG000|Overall Study|Withdrawal by Subject|15|||
105435738|NCT00084656|363602978|FG001|Overall Study|Withdrawal by Subject|4|||
105435739|NCT00084656|363602979|FG002|Overall Study|Withdrawal by Subject|4|||
105435740|NCT00084656|363602977|FG000|Overall Study|Disease relapse|0|||
105435741|NCT00084656|363602978|FG001|Overall Study|Disease relapse|9|||
105435742|NCT00084656|363602979|FG002|Overall Study|Disease relapse|10|||
105435743|NCT00084656|363602977|FG000|Overall Study|Disease progression|9|||
105435744|NCT00084656|363602978|FG001|Overall Study|Disease progression|0|||
105435745|NCT00084656|363602979|FG002|Overall Study|Disease progression|0|||
105435746|NCT00084656|363602977|FG000|Overall Study|Lost to Follow-up|1|||
105435747|NCT00084656|363602978|FG001|Overall Study|Lost to Follow-up|0|||
105435748|NCT00084656|363602979|FG002|Overall Study|Lost to Follow-up|1|||
105435749|NCT02772978|363602980|FG000|Overall Study|Withdrawal by Subject|1|||
105435750|NCT02772978|363602981|FG001|Overall Study|Withdrawal by Subject|1|||
105435751|NCT00694304|363602982|FG000|Overall Study|Adverse Event|42|||
105435752|NCT00694304|363602982|FG000|Overall Study|Lack of Efficacy|35|||
105435753|NCT00694304|363602982|FG000|Overall Study|Non-compliance With Study Product|16|||
105435754|NCT00694304|363602982|FG000|Overall Study|Protocol Violation|6|||
105435755|NCT00694304|363602982|FG000|Overall Study|Withdrawal of Consent|61|||
105435756|NCT00694304|363602982|FG000|Overall Study|Lost to Follow-up|15|||
105435757|NCT00694304|363602982|FG000|Overall Study|Administrative or Other Reasons|32|||
105435758|NCT03550404|363602984|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
105435759|NCT03550404|363602985|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
105435760|NCT03550404|363602986|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
105435761|NCT03550404|363602984|FG000|Phase 2|Vacated position|1|||
105435762|NCT03550404|363602985|FG001|Phase 2|Vacated position|0|||
105435763|NCT03550404|363602986|FG002|Phase 2|Vacated position|0|||
105435764|NCT00576576|363602988|FG000|Overall Study|Lost to Follow-up|6|||
105435765|NCT00576576|363602988|FG000|Overall Study|Protocol Violation|1|||
105435766|NCT03517566|363602993|FG000|Overall Study|Adverse Event|5|||
105435767|NCT03517566|363602994|FG001|Overall Study|Adverse Event|2|||
105435768|NCT03517566|363602995|FG002|Overall Study|Adverse Event|2|||
105435769|NCT03517566|363602996|FG003|Overall Study|Adverse Event|8|||
105435770|NCT03517566|363602997|FG004|Overall Study|Adverse Event|7|||
105435771|NCT03517566|363602993|FG000|Overall Study|Lack of Efficacy|3|||
105435772|NCT03517566|363602994|FG001|Overall Study|Lack of Efficacy|2|||
105435773|NCT03517566|363602995|FG002|Overall Study|Lack of Efficacy|1|||
105435774|NCT03517566|363602996|FG003|Overall Study|Lack of Efficacy|1|||
105435775|NCT03517566|363602997|FG004|Overall Study|Lack of Efficacy|4|||
105435776|NCT03517566|363602993|FG000|Overall Study|Lost to Follow-up|3|||
105435777|NCT03517566|363602994|FG001|Overall Study|Lost to Follow-up|1|||
105435778|NCT03517566|363602995|FG002|Overall Study|Lost to Follow-up|1|||
105435779|NCT03517566|363602996|FG003|Overall Study|Lost to Follow-up|1|||
105435780|NCT03517566|363602997|FG004|Overall Study|Lost to Follow-up|0|||
105435781|NCT03517566|363602993|FG000|Overall Study|Physician Decision|1|||
105435782|NCT03517566|363602994|FG001|Overall Study|Physician Decision|1|||
105435783|NCT03517566|363602995|FG002|Overall Study|Physician Decision|0|||
105435784|NCT03517566|363602996|FG003|Overall Study|Physician Decision|1|||
105435785|NCT03517566|363602997|FG004|Overall Study|Physician Decision|0|||
105435786|NCT03517566|363602993|FG000|Overall Study|Pregnancy|0|||
105435787|NCT03517566|363602994|FG001|Overall Study|Pregnancy|1|||
105435788|NCT03517566|363602995|FG002|Overall Study|Pregnancy|0|||
105435789|NCT03517566|363602996|FG003|Overall Study|Pregnancy|0|||
105435790|NCT03517566|363602997|FG004|Overall Study|Pregnancy|0|||
105435791|NCT03517566|363602993|FG000|Overall Study|Protocol Deviation|0|||
105435792|NCT03517566|363602994|FG001|Overall Study|Protocol Deviation|1|||
105435793|NCT03517566|363602995|FG002|Overall Study|Protocol Deviation|0|||
105435794|NCT03517566|363602996|FG003|Overall Study|Protocol Deviation|1|||
105435795|NCT03517566|363602997|FG004|Overall Study|Protocol Deviation|1|||
105435796|NCT03517566|363602993|FG000|Overall Study|Study terminated by Sponsor|11|||
105435797|NCT03517566|363602994|FG001|Overall Study|Study terminated by Sponsor|5|||
105435798|NCT03517566|363602995|FG002|Overall Study|Study terminated by Sponsor|6|||
105435799|NCT03517566|363602996|FG003|Overall Study|Study terminated by Sponsor|14|||
105435800|NCT03517566|363602997|FG004|Overall Study|Study terminated by Sponsor|12|||
105435801|NCT03517566|363602993|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
105435802|NCT03517566|363602994|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
105435803|NCT03517566|363602995|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
105435804|NCT03517566|363602996|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
105435805|NCT03517566|363602997|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
105435806|NCT00671437|363602998|FG000|Overall Study|Progressive disease before C1 week 8|8|||
105435807|NCT00671437|363602998|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
105435808|NCT00671437|363602998|FG000|Overall Study|Adverse Event|3|||
105435809|NCT00671437|363602998|FG000|Overall Study|Ineligible post-hoc|1|||
105435810|NCT00590577|363602999|FG000|Overall Study|Lack of Efficacy|31|||
105435811|NCT00590577|363603000|FG001|Overall Study|Lack of Efficacy|28|||
105435812|NCT00590577|363603001|FG002|Overall Study|Lack of Efficacy|23|||
105435813|NCT00590577|363603002|FG003|Overall Study|Lack of Efficacy|45|||
105435814|NCT00590577|363602999|FG000|Overall Study|Withdrawal by Subject|23|||
105435815|NCT00590577|363603000|FG001|Overall Study|Withdrawal by Subject|28|||
105435816|NCT00590577|363603001|FG002|Overall Study|Withdrawal by Subject|30|||
105435817|NCT00590577|363603002|FG003|Overall Study|Withdrawal by Subject|26|||
105435818|NCT00590577|363602999|FG000|Overall Study|Adverse Event|10|||
105435819|NCT00590577|363603000|FG001|Overall Study|Adverse Event|10|||
105435820|NCT00590577|363603001|FG002|Overall Study|Adverse Event|13|||
105435821|NCT00590577|363603002|FG003|Overall Study|Adverse Event|11|||
105435822|NCT00590577|363602999|FG000|Overall Study|Lost to Follow-up|12|||
105435823|NCT00590577|363603000|FG001|Overall Study|Lost to Follow-up|6|||
105435824|NCT00590577|363603001|FG002|Overall Study|Lost to Follow-up|6|||
105435825|NCT00590577|363603002|FG003|Overall Study|Lost to Follow-up|9|||
105435826|NCT00590577|363602999|FG000|Overall Study|Pregnancy|0|||
105435827|NCT00590577|363603000|FG001|Overall Study|Pregnancy|1|||
105435828|NCT00590577|363603001|FG002|Overall Study|Pregnancy|0|||
105435829|NCT00590577|363603002|FG003|Overall Study|Pregnancy|0|||
105435830|NCT00590577|363602999|FG000|Overall Study|Various reasons|1|||
105435831|NCT00590577|363603000|FG001|Overall Study|Various reasons|3|||
105435832|NCT00590577|363603001|FG002|Overall Study|Various reasons|1|||
105435833|NCT00590577|363603002|FG003|Overall Study|Various reasons|2|||
105435834|NCT00932165|363603003|FG000|Overall Study|Lost to Follow-up|1|||
105435835|NCT03927404|363603004|FG000|Overall Study|Withdrawal by Subject|1|||
105435836|NCT00737633|363603006|FG000|Overall Study|Study terminated by sponsor|44|||
105435837|NCT00737633|363603007|FG001|Overall Study|Study terminated by sponsor|55|||
105435838|NCT00737633|363603006|FG000|Overall Study|Lost to Follow-up|0|||
105435839|NCT00737633|363603007|FG001|Overall Study|Lost to Follow-up|1|||
105503144|NCT02925117|363852850|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
105503145|NCT02925117|363852851|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
105503146|NCT02925117|363852852|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
105503147|NCT02925117|363852853|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
105503148|NCT02925117|363852854|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
105503149|NCT02925117|363852855|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
105503150|NCT02925117|363852856|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
105503151|NCT02925117|363852857|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
105503152|NCT02925117|363852858|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
105503153|NCT02925117|363852859|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
105503154|NCT02925117|363852860|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
105503155|NCT02925117|363852849|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
105503156|NCT02925117|363852850|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
105503157|NCT02925117|363852851|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
105503158|NCT02925117|363852852|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
105503159|NCT02925117|363852853|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
105503160|NCT02925117|363852854|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
105503161|NCT02925117|363852855|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
105590648|NCT01549652|364162673|FG001|Overall Study|Problem with Infusion|0|||
105435840|NCT00737633|363603006|FG000|Overall Study|protocol non-compliance|0|||
105435841|NCT00737633|363603007|FG001|Overall Study|protocol non-compliance|1|||
105435842|NCT01300260|363603012|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
105435843|NCT01300260|363603013|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
105435844|NCT01300260|363603012|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
105435845|NCT01300260|363603013|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
105435846|NCT01300260|363603012|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
105435847|NCT01300260|363603013|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
105435848|NCT01147848|363603018|FG000|Run-in Period|Screen Failure|623|||
105435849|NCT01147848|363603019|FG001|Run-in Period|Screen Failure|0|||
105435850|NCT01147848|363603020|FG002|Run-in Period|Screen Failure|0|||
105435851|NCT01147848|363603018|FG000|Run-in Period|Run-in Failure|135|||
105435852|NCT01147848|363603019|FG001|Run-in Period|Run-in Failure|0|||
105435853|NCT01147848|363603020|FG002|Run-in Period|Run-in Failure|0|||
105435854|NCT01147848|363603018|FG000|Randomized Phase|Adverse Event|0|||
105435855|NCT01147848|363603019|FG001|Randomized Phase|Adverse Event|6|||
105435856|NCT01147848|363603020|FG002|Randomized Phase|Adverse Event|8|||
105435857|NCT01147848|363603018|FG000|Randomized Phase|Lack of Efficacy|0|||
105435858|NCT01147848|363603019|FG001|Randomized Phase|Lack of Efficacy|20|||
105435859|NCT01147848|363603020|FG002|Randomized Phase|Lack of Efficacy|11|||
105435860|NCT01147848|363603018|FG000|Randomized Phase|Protocol Violation|0|||
105435861|NCT01147848|363603019|FG001|Randomized Phase|Protocol Violation|7|||
105435862|NCT01147848|363603020|FG002|Randomized Phase|Protocol Violation|10|||
105435863|NCT01147848|363603018|FG000|Randomized Phase|Lost to Follow-up|0|||
105435864|NCT01147848|363603019|FG001|Randomized Phase|Lost to Follow-up|5|||
105435865|NCT01147848|363603020|FG002|Randomized Phase|Lost to Follow-up|7|||
105435866|NCT01147848|363603018|FG000|Randomized Phase|Physician Decision|0|||
105435867|NCT01147848|363603019|FG001|Randomized Phase|Physician Decision|0|||
105435868|NCT01147848|363603020|FG002|Randomized Phase|Physician Decision|1|||
105435869|NCT01147848|363603018|FG000|Randomized Phase|Withdrawal by Subject|0|||
105435870|NCT01147848|363603019|FG001|Randomized Phase|Withdrawal by Subject|7|||
105435871|NCT01147848|363603020|FG002|Randomized Phase|Withdrawal by Subject|9|||
105435872|NCT03180307|363603021|FG000|Overall Study|Lost to Follow-up|2|||
105435873|NCT03180307|363603022|FG001|Overall Study|Lost to Follow-up|0|||
105435874|NCT03180307|363603021|FG000|Overall Study|Death|1|||
105435875|NCT03180307|363603022|FG001|Overall Study|Death|0|||
105435876|NCT03180307|363603021|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
105435877|NCT03180307|363603022|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
105435878|NCT04583956|363603036|FG000|Overall Study|Death|9|||
105435879|NCT04583956|363603037|FG001|Overall Study|Death|11|||
105435880|NCT04583956|363603036|FG000|Overall Study|Lost to Follow-up|7|||
105503162|NCT02925117|363852856|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
105503163|NCT02925117|363852857|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
105503164|NCT02925117|363852858|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
105503165|NCT02925117|363852859|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
105503166|NCT02925117|363852860|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
105435881|NCT04583956|363603037|FG001|Overall Study|Lost to Follow-up|9|||
105435882|NCT04583956|363603036|FG000|Overall Study|Protocol Violation|2|||
105435883|NCT04583956|363603037|FG001|Overall Study|Protocol Violation|0|||
105435884|NCT04583956|363603036|FG000|Overall Study|Withdrawal by Subject|0|||
105435885|NCT04583956|363603037|FG001|Overall Study|Withdrawal by Subject|2|||
105435886|NCT04583956|363603036|FG000|Overall Study|Randomized but not dosed|2|||
105435887|NCT04583956|363603037|FG001|Overall Study|Randomized but not dosed|3|||
105503167|NCT02925117|363852849|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
105503168|NCT02925117|363852850|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
105435888|NCT04583956|363603036|FG000|Overall Study|Withdrawal of consent before product administration|1|||
105435889|NCT04583956|363603037|FG001|Overall Study|Withdrawal of consent before product administration|0|||
105435890|NCT02332291|363603038|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
105435891|NCT02332291|363603039|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
105435892|NCT02332291|363603038|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
105435893|NCT02332291|363603039|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
105435894|NCT02332291|363603038|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
105435895|NCT02332291|363603039|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
105435896|NCT02332291|363603038|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
105435897|NCT02332291|363603039|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
105435898|NCT02332291|363603038|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
105435899|NCT02332291|363603039|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
105435900|NCT02332291|363603038|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
105435901|NCT02332291|363603039|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
105435902|NCT00727558|363603044|FG000|Overall Study|Lens issue|0|||
105435903|NCT00727558|363603045|FG001|Overall Study|Lens issue|1|||
105435904|NCT00727558|363603044|FG000|Overall Study|Adverse Event|0|||
105435905|NCT00727558|363603045|FG001|Overall Study|Adverse Event|1|||
105435906|NCT00727558|363603044|FG000|Overall Study|Subject unable to return for follow-up|1|||
105435907|NCT00727558|363603045|FG001|Overall Study|Subject unable to return for follow-up|1|||
105435908|NCT00727558|363603044|FG000|Overall Study|Lost to Follow-up|1|||
105435909|NCT00727558|363603045|FG001|Overall Study|Lost to Follow-up|0|||
105435910|NCT02456857|363603046|FG000|Overall Study|Disease Progression|4|||
105435911|NCT00781859|363603047|FG000|Overall Study|Adverse Event|2|||
105435912|NCT00781859|363603048|FG001|Overall Study|Adverse Event|2|||
105435913|NCT00781859|363603047|FG000|Overall Study|Withdrawal by Subject|8|||
105435914|NCT00781859|363603048|FG001|Overall Study|Withdrawal by Subject|4|||
105435915|NCT00781859|363603047|FG000|Overall Study|Lost to Follow-up|6|||
105435916|NCT00781859|363603048|FG001|Overall Study|Lost to Follow-up|3|||
105435917|NCT00781859|363603047|FG000|Overall Study|Death|3|||
105435918|NCT00781859|363603048|FG001|Overall Study|Death|0|||
105435919|NCT01220180|363603049|FG000|Overall Study|Lost to Follow-up|76|||
105435920|NCT01220180|363603049|FG000|Overall Study|Other|72|||
105435921|NCT01220180|363603049|FG000|Overall Study|Adverse Event|35|||
105435922|NCT01220180|363603049|FG000|Overall Study|Lack of Efficacy|22|||
105435923|NCT01220180|363603049|FG000|Overall Study|Death|1|||
105435924|NCT01220180|363603049|FG000|Overall Study|Randomized but not treated|1|||
105435925|NCT00348309|363603052|FG000|Overall Study|Adverse Event|56|||
105435926|NCT00348309|363603053|FG001|Overall Study|Adverse Event|28|||
105435927|NCT00348309|363603054|FG002|Overall Study|Adverse Event|63|||
105435928|NCT00348309|363603052|FG000|Overall Study|Lost to Follow-up|6|||
105435929|NCT00348309|363603053|FG001|Overall Study|Lost to Follow-up|7|||
105435930|NCT00348309|363603054|FG002|Overall Study|Lost to Follow-up|4|||
105435931|NCT00348309|363603052|FG000|Overall Study|Protocol Violation|7|||
105435932|NCT00348309|363603053|FG001|Overall Study|Protocol Violation|12|||
105435933|NCT00348309|363603054|FG002|Overall Study|Protocol Violation|7|||
105435934|NCT00348309|363603052|FG000|Overall Study|Withdrawal by Subject|33|||
105435935|NCT00348309|363603053|FG001|Overall Study|Withdrawal by Subject|37|||
105435936|NCT00348309|363603054|FG002|Overall Study|Withdrawal by Subject|40|||
105435937|NCT00348309|363603052|FG000|Overall Study|Non-compliance|8|||
105435938|NCT00348309|363603053|FG001|Overall Study|Non-compliance|6|||
105435939|NCT00348309|363603054|FG002|Overall Study|Non-compliance|8|||
105435940|NCT00348309|363603052|FG000|Overall Study|Death of caregiver|1|||
105435941|NCT00348309|363603053|FG001|Overall Study|Death of caregiver|0|||
105435942|NCT00348309|363603054|FG002|Overall Study|Death of caregiver|1|||
105435943|NCT00348309|363603052|FG000|Overall Study|Lack of insight, dementia|1|||
105435944|NCT00348309|363603053|FG001|Overall Study|Lack of insight, dementia|0|||
105435945|NCT00348309|363603054|FG002|Overall Study|Lack of insight, dementia|0|||
105435946|NCT00348309|363603052|FG000|Overall Study|Wrong bottle allocated|1|||
105435947|NCT00348309|363603053|FG001|Overall Study|Wrong bottle allocated|0|||
105435948|NCT00348309|363603054|FG002|Overall Study|Wrong bottle allocated|0|||
105435949|NCT00348309|363603052|FG000|Overall Study|Caregiver sick|1|||
105435950|NCT00348309|363603053|FG001|Overall Study|Caregiver sick|0|||
105435951|NCT00348309|363603054|FG002|Overall Study|Caregiver sick|0|||
105435952|NCT00348309|363603052|FG000|Overall Study|Use of prohibited medication|5|||
105435953|NCT00348309|363603053|FG001|Overall Study|Use of prohibited medication|2|||
105435954|NCT00348309|363603054|FG002|Overall Study|Use of prohibited medication|2|||
105435955|NCT00348309|363603052|FG000|Overall Study|Caregiver withdrawal|3|||
105435956|NCT00348309|363603053|FG001|Overall Study|Caregiver withdrawal|0|||
105435957|NCT00348309|363603054|FG002|Overall Study|Caregiver withdrawal|7|||
105435958|NCT00348309|363603052|FG000|Overall Study|Unable to complete ET visit|1|||
105435959|NCT00348309|363603053|FG001|Overall Study|Unable to complete ET visit|0|||
105435960|NCT00348309|363603054|FG002|Overall Study|Unable to complete ET visit|0|||
105435961|NCT00348309|363603052|FG000|Overall Study|PI closing medical practice|1|||
105435962|NCT00348309|363603053|FG001|Overall Study|PI closing medical practice|0|||
105435963|NCT00348309|363603054|FG002|Overall Study|PI closing medical practice|0|||
105435964|NCT00348309|363603052|FG000|Overall Study|Principal investigator's decision|1|||
105435965|NCT00348309|363603053|FG001|Overall Study|Principal investigator's decision|0|||
105435966|NCT00348309|363603054|FG002|Overall Study|Principal investigator's decision|0|||
105435967|NCT00348309|363603052|FG000|Overall Study|No disponibility of medication|1|||
105435968|NCT00348309|363603053|FG001|Overall Study|No disponibility of medication|0|||
105435969|NCT00348309|363603054|FG002|Overall Study|No disponibility of medication|0|||
105435970|NCT00348309|363603052|FG000|Overall Study|Worsened neurodegenerative disease|1|||
105435971|NCT00348309|363603053|FG001|Overall Study|Worsened neurodegenerative disease|0|||
105435972|NCT00348309|363603054|FG002|Overall Study|Worsened neurodegenerative disease|0|||
105435973|NCT00348309|363603052|FG000|Overall Study|Cognitive and behaviour worsening|2|||
105435974|NCT00348309|363603053|FG001|Overall Study|Cognitive and behaviour worsening|0|||
105435975|NCT00348309|363603054|FG002|Overall Study|Cognitive and behaviour worsening|0|||
105435976|NCT00348309|363603052|FG000|Overall Study|Worsening of alzheimer|1|||
105435977|NCT00348309|363603053|FG001|Overall Study|Worsening of alzheimer|0|||
105435978|NCT00348309|363603054|FG002|Overall Study|Worsening of alzheimer|1|||
105435979|NCT00348309|363603052|FG000|Overall Study|Did not appear in time for Visit 3|1|||
105435980|NCT00348309|363603053|FG001|Overall Study|Did not appear in time for Visit 3|0|||
105435981|NCT00348309|363603054|FG002|Overall Study|Did not appear in time for Visit 3|0|||
105435982|NCT00348309|363603052|FG000|Overall Study|Participant died|2|||
105435983|NCT00348309|363603053|FG001|Overall Study|Participant died|1|||
105435984|NCT00348309|363603054|FG002|Overall Study|Participant died|1|||
105435985|NCT00348309|363603052|FG000|Overall Study|Decision of sponsor|1|||
105435986|NCT00348309|363603053|FG001|Overall Study|Decision of sponsor|0|||
105435987|NCT00348309|363603054|FG002|Overall Study|Decision of sponsor|0|||
105435988|NCT00348309|363603052|FG000|Overall Study|Ineffectiveness of treatment|0|||
105435989|NCT00348309|363603053|FG001|Overall Study|Ineffectiveness of treatment|1|||
105435990|NCT00348309|363603054|FG002|Overall Study|Ineffectiveness of treatment|0|||
105435991|NCT00348309|363603052|FG000|Overall Study|A foul of exclusion criteria|0|||
105435992|NCT00348309|363603053|FG001|Overall Study|A foul of exclusion criteria|1|||
105435993|NCT00348309|363603054|FG002|Overall Study|A foul of exclusion criteria|0|||
105435994|NCT00348309|363603052|FG000|Overall Study|Participant was hospitalized|0|||
105435995|NCT00348309|363603053|FG001|Overall Study|Participant was hospitalized|1|||
105435996|NCT00348309|363603054|FG002|Overall Study|Participant was hospitalized|0|||
105435997|NCT00348309|363603052|FG000|Overall Study|Sponsor refuseal|0|||
105435998|NCT00348309|363603053|FG001|Overall Study|Sponsor refuseal|1|||
105435999|NCT00348309|363603054|FG002|Overall Study|Sponsor refuseal|1|||
105436000|NCT00348309|363603052|FG000|Overall Study|Forgot often medication|0|||
105436001|NCT00348309|363603053|FG001|Overall Study|Forgot often medication|1|||
105436002|NCT00348309|363603054|FG002|Overall Study|Forgot often medication|0|||
105436003|NCT00348309|363603052|FG000|Overall Study|Medical Monitor decision|0|||
105436004|NCT00348309|363603053|FG001|Overall Study|Medical Monitor decision|0|||
105436005|NCT00348309|363603054|FG002|Overall Study|Medical Monitor decision|1|||
105436006|NCT00348309|363603052|FG000|Overall Study|Increased dose of Aricept|0|||
105436007|NCT00348309|363603053|FG001|Overall Study|Increased dose of Aricept|0|||
105436008|NCT00348309|363603054|FG002|Overall Study|Increased dose of Aricept|1|||
105436009|NCT00348309|363603052|FG000|Overall Study|Site closure|0|||
105436010|NCT00348309|363603053|FG001|Overall Study|Site closure|0|||
105436011|NCT00348309|363603054|FG002|Overall Study|Site closure|1|||
105436012|NCT00348309|363603052|FG000|Overall Study|Adverse event not attended|0|||
105436013|NCT00348309|363603053|FG001|Overall Study|Adverse event not attended|0|||
105436014|NCT00348309|363603054|FG002|Overall Study|Adverse event not attended|1|||
105436015|NCT00348309|363603052|FG000|Overall Study|ECG abnormal|0|||
105436016|NCT00348309|363603053|FG001|Overall Study|ECG abnormal|0|||
105436017|NCT00348309|363603054|FG002|Overall Study|ECG abnormal|2|||
105436018|NCT00348309|363603052|FG000|Overall Study|Cardiologist recommendations|0|||
105436019|NCT00348309|363603053|FG001|Overall Study|Cardiologist recommendations|0|||
105436020|NCT00348309|363603054|FG002|Overall Study|Cardiologist recommendations|1|||
105436021|NCT00348309|363603052|FG000|Overall Study|HCV career|0|||
105436022|NCT00348309|363603053|FG001|Overall Study|HCV career|0|||
105436023|NCT00348309|363603054|FG002|Overall Study|HCV career|1|||
105436024|NCT01717326|363603055|FG000|Overall Study|Death|0|||
105436025|NCT01717326|363603056|FG001|Overall Study|Death|0|||
105436026|NCT01717326|363603057|FG002|Overall Study|Death|0|||
105436027|NCT01717326|363603058|FG003|Overall Study|Death|0|||
105436028|NCT01717326|363603059|FG004|Overall Study|Death|0|||
105436029|NCT01717326|363603060|FG005|Overall Study|Death|0|||
105436030|NCT01717326|363603061|FG006|Overall Study|Death|0|||
105436031|NCT01717326|363603062|FG007|Overall Study|Death|0|||
105436032|NCT01717326|363603063|FG008|Overall Study|Death|0|||
105503169|NCT02925117|363852851|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
105436033|NCT01717326|363603064|FG009|Overall Study|Death|0|||
105436034|NCT01717326|363603065|FG010|Overall Study|Death|1|||
105436035|NCT01717326|363603066|FG011|Overall Study|Death|0|||
105436036|NCT01717326|363603067|FG012|Overall Study|Death|0|||
105436037|NCT01717326|363603068|FG013|Overall Study|Death|0|||
105436038|NCT01717326|363603069|FG014|Overall Study|Death|0|||
105436039|NCT01717326|363603070|FG015|Overall Study|Death|0|||
105436040|NCT01717326|363603071|FG016|Overall Study|Death|0|||
105436041|NCT01717326|363603072|FG017|Overall Study|Death|0|||
105436042|NCT01717326|363603073|FG018|Overall Study|Death|0|||
105436043|NCT01717326|363603074|FG019|Overall Study|Death|0|||
105436044|NCT01717326|363603055|FG000|Overall Study|Lost to Follow-up|3|||
105436045|NCT01717326|363603056|FG001|Overall Study|Lost to Follow-up|0|||
105503170|NCT02925117|363852852|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
105503171|NCT02925117|363852853|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
105503172|NCT02925117|363852854|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
105503173|NCT02925117|363852855|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
105503174|NCT02925117|363852856|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
105503175|NCT02925117|363852857|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
105503176|NCT02925117|363852858|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
105503177|NCT02925117|363852859|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
105503178|NCT02925117|363852860|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
105503179|NCT02925117|363852849|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
105503180|NCT02925117|363852850|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
105503181|NCT02925117|363852851|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
105503182|NCT02925117|363852852|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
105503183|NCT02925117|363852853|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
105503184|NCT02925117|363852854|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
105503185|NCT02925117|363852855|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
105503186|NCT02925117|363852856|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
105503187|NCT02925117|363852857|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
105503188|NCT02925117|363852858|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
105503189|NCT02925117|363852859|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
105503190|NCT02925117|363852860|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
105503191|NCT02925117|363852849|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
105503192|NCT02925117|363852850|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
105503193|NCT02925117|363852851|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
105503194|NCT02925117|363852852|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
105503195|NCT02925117|363852853|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
105503196|NCT02925117|363852854|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
105503197|NCT02925117|363852855|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
105503198|NCT02925117|363852856|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
105503199|NCT02925117|363852857|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
105503200|NCT02925117|363852858|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
105503201|NCT02925117|363852859|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
105503202|NCT02925117|363852860|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
105503203|NCT02925117|363852849|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
105503204|NCT02925117|363852850|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
105503205|NCT02925117|363852851|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
105503206|NCT02925117|363852852|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
105503207|NCT02925117|363852853|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
105503208|NCT02925117|363852854|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
105503209|NCT02925117|363852855|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
105503210|NCT02925117|363852856|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
105503211|NCT02925117|363852857|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
105436046|NCT01717326|363603057|FG002|Overall Study|Lost to Follow-up|0|||
105436047|NCT01717326|363603058|FG003|Overall Study|Lost to Follow-up|2|||
105436048|NCT01717326|363603059|FG004|Overall Study|Lost to Follow-up|1|||
105436049|NCT01717326|363603060|FG005|Overall Study|Lost to Follow-up|0|||
105436050|NCT01717326|363603061|FG006|Overall Study|Lost to Follow-up|1|||
105436051|NCT01717326|363603062|FG007|Overall Study|Lost to Follow-up|0|||
105436052|NCT01717326|363603063|FG008|Overall Study|Lost to Follow-up|0|||
105436053|NCT01717326|363603064|FG009|Overall Study|Lost to Follow-up|0|||
105436054|NCT01717326|363603065|FG010|Overall Study|Lost to Follow-up|1|||
105436055|NCT01717326|363603066|FG011|Overall Study|Lost to Follow-up|0|||
105436056|NCT01717326|363603067|FG012|Overall Study|Lost to Follow-up|0|||
105436057|NCT01717326|363603068|FG013|Overall Study|Lost to Follow-up|0|||
105436058|NCT01717326|363603069|FG014|Overall Study|Lost to Follow-up|0|||
105436059|NCT01717326|363603070|FG015|Overall Study|Lost to Follow-up|2|||
105436060|NCT01717326|363603071|FG016|Overall Study|Lost to Follow-up|1|||
105436061|NCT01717326|363603072|FG017|Overall Study|Lost to Follow-up|0|||
105503212|NCT02925117|363852858|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
105503213|NCT02925117|363852859|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
105503214|NCT02925117|363852860|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
105436062|NCT01717326|363603073|FG018|Overall Study|Lost to Follow-up|2|||
105503215|NCT02925117|363852849|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
105503216|NCT02925117|363852850|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
105503217|NCT02925117|363852851|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
105436063|NCT01717326|363603074|FG019|Overall Study|Lost to Follow-up|3|||
105436064|NCT01717326|363603055|FG000|Overall Study|Physician Decision|0|||
105436065|NCT01717326|363603056|FG001|Overall Study|Physician Decision|0|||
105436066|NCT01717326|363603057|FG002|Overall Study|Physician Decision|0|||
105436067|NCT01717326|363603058|FG003|Overall Study|Physician Decision|0|||
105436068|NCT01717326|363603059|FG004|Overall Study|Physician Decision|0|||
105436069|NCT01717326|363603060|FG005|Overall Study|Physician Decision|0|||
105436070|NCT01717326|363603061|FG006|Overall Study|Physician Decision|0|||
105436071|NCT01717326|363603062|FG007|Overall Study|Physician Decision|0|||
105436072|NCT01717326|363603063|FG008|Overall Study|Physician Decision|0|||
105436073|NCT01717326|363603064|FG009|Overall Study|Physician Decision|1|||
105436074|NCT01717326|363603065|FG010|Overall Study|Physician Decision|0|||
105436075|NCT01717326|363603066|FG011|Overall Study|Physician Decision|0|||
105436076|NCT01717326|363603067|FG012|Overall Study|Physician Decision|0|||
105436077|NCT01717326|363603068|FG013|Overall Study|Physician Decision|0|||
105436078|NCT01717326|363603069|FG014|Overall Study|Physician Decision|0|||
105436079|NCT01717326|363603070|FG015|Overall Study|Physician Decision|0|||
105436080|NCT01717326|363603071|FG016|Overall Study|Physician Decision|0|||
105436081|NCT01717326|363603072|FG017|Overall Study|Physician Decision|0|||
105436082|NCT01717326|363603073|FG018|Overall Study|Physician Decision|0|||
105436083|NCT01717326|363603074|FG019|Overall Study|Physician Decision|0|||
105436084|NCT01717326|363603055|FG000|Overall Study|Protocol Violation|0|||
105436085|NCT01717326|363603056|FG001|Overall Study|Protocol Violation|0|||
105436086|NCT01717326|363603057|FG002|Overall Study|Protocol Violation|0|||
105436087|NCT01717326|363603058|FG003|Overall Study|Protocol Violation|0|||
105436088|NCT01717326|363603059|FG004|Overall Study|Protocol Violation|1|||
105436089|NCT01717326|363603060|FG005|Overall Study|Protocol Violation|0|||
105436090|NCT01717326|363603061|FG006|Overall Study|Protocol Violation|0|||
105436091|NCT01717326|363603062|FG007|Overall Study|Protocol Violation|0|||
105436092|NCT01717326|363603063|FG008|Overall Study|Protocol Violation|0|||
105436093|NCT01717326|363603064|FG009|Overall Study|Protocol Violation|0|||
105436094|NCT01717326|363603065|FG010|Overall Study|Protocol Violation|0|||
105436095|NCT01717326|363603066|FG011|Overall Study|Protocol Violation|0|||
105436096|NCT01717326|363603067|FG012|Overall Study|Protocol Violation|0|||
105436097|NCT01717326|363603068|FG013|Overall Study|Protocol Violation|0|||
105436098|NCT01717326|363603069|FG014|Overall Study|Protocol Violation|0|||
105436099|NCT01717326|363603070|FG015|Overall Study|Protocol Violation|0|||
105436100|NCT01717326|363603071|FG016|Overall Study|Protocol Violation|0|||
105436101|NCT01717326|363603072|FG017|Overall Study|Protocol Violation|0|||
105436102|NCT01717326|363603073|FG018|Overall Study|Protocol Violation|0|||
105436103|NCT01717326|363603074|FG019|Overall Study|Protocol Violation|0|||
105436104|NCT01717326|363603055|FG000|Overall Study|Withdrawal by Subject|0|||
105436105|NCT01717326|363603056|FG001|Overall Study|Withdrawal by Subject|1|||
105436106|NCT01717326|363603057|FG002|Overall Study|Withdrawal by Subject|0|||
105436107|NCT01717326|363603058|FG003|Overall Study|Withdrawal by Subject|0|||
105436108|NCT01717326|363603059|FG004|Overall Study|Withdrawal by Subject|0|||
105436109|NCT01717326|363603060|FG005|Overall Study|Withdrawal by Subject|0|||
105436110|NCT01717326|363603061|FG006|Overall Study|Withdrawal by Subject|0|||
105436111|NCT01717326|363603062|FG007|Overall Study|Withdrawal by Subject|0|||
105436112|NCT01717326|363603063|FG008|Overall Study|Withdrawal by Subject|0|||
105436113|NCT01717326|363603064|FG009|Overall Study|Withdrawal by Subject|1|||
105436114|NCT01717326|363603065|FG010|Overall Study|Withdrawal by Subject|0|||
105436115|NCT01717326|363603066|FG011|Overall Study|Withdrawal by Subject|0|||
105436116|NCT01717326|363603067|FG012|Overall Study|Withdrawal by Subject|1|||
105436117|NCT01717326|363603068|FG013|Overall Study|Withdrawal by Subject|0|||
105436118|NCT01717326|363603069|FG014|Overall Study|Withdrawal by Subject|0|||
105436119|NCT01717326|363603070|FG015|Overall Study|Withdrawal by Subject|1|||
105436120|NCT01717326|363603071|FG016|Overall Study|Withdrawal by Subject|0|||
105436121|NCT01717326|363603072|FG017|Overall Study|Withdrawal by Subject|0|||
105436122|NCT01717326|363603073|FG018|Overall Study|Withdrawal by Subject|2|||
105436123|NCT01717326|363603074|FG019|Overall Study|Withdrawal by Subject|3|||
105436124|NCT01067469|363603075|FG000|Overall Study|Withdrawal by Subject|0|||
105436125|NCT01067469|363603076|FG001|Overall Study|Withdrawal by Subject|1|||
105436126|NCT01067469|363603075|FG000|Overall Study|Disease Progression|0|||
105436127|NCT01067469|363603076|FG001|Overall Study|Disease Progression|1|||
105436128|NCT00629798|363603079|FG000|Overall Study|Not Treated|4|||
105436129|NCT02126839|363603081|FG000|Overall Study|Adverse Event|0|||
105436130|NCT02126839|363603082|FG001|Overall Study|Adverse Event|1|||
105436131|NCT02126839|363603081|FG000|Overall Study|Withdrawal by Subject|1|||
105436132|NCT02126839|363603082|FG001|Overall Study|Withdrawal by Subject|0|||
105436133|NCT02126839|363603081|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105436134|NCT02126839|363603082|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105436135|NCT02126839|363603081|FG000|Overall Study|Protocol Violation|2|||
105436136|NCT02126839|363603082|FG001|Overall Study|Protocol Violation|3|||
105436137|NCT02126839|363603081|FG000|Overall Study|Sponsor request|0|||
105436138|NCT02126839|363603082|FG001|Overall Study|Sponsor request|1|||
105436139|NCT02126839|363603081|FG000|Overall Study|Lost to Follow-up|1|||
105436140|NCT02126839|363603082|FG001|Overall Study|Lost to Follow-up|4|||
105436141|NCT02126839|363603081|FG000|Overall Study|Other|5|||
105436142|NCT02126839|363603082|FG001|Overall Study|Other|5|||
105436143|NCT02160145|363603085|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
105436144|NCT02160145|363603086|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
105436145|NCT02160145|363603087|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
105503218|NCT02925117|363852852|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
105503219|NCT02925117|363852853|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
105503220|NCT02925117|363852854|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
105503221|NCT02925117|363852855|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
105503222|NCT02925117|363852856|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
105503223|NCT02925117|363852857|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
105503224|NCT02925117|363852858|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
105503225|NCT02925117|363852859|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
105503226|NCT02925117|363852860|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
105503227|NCT02925117|363852849|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
105503228|NCT02925117|363852850|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
105503229|NCT02925117|363852851|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
105503230|NCT02925117|363852852|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
105503231|NCT02925117|363852853|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
105503232|NCT02925117|363852854|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
105503233|NCT02925117|363852855|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
105503234|NCT02925117|363852856|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
105503235|NCT02925117|363852857|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
105503236|NCT02925117|363852858|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
105503237|NCT02925117|363852859|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
105503238|NCT02925117|363852860|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
105503239|NCT00957580|363852863|FG000|Overall Study|Ongoing at data cut-off|0|||
105503240|NCT00957580|363852864|FG001|Overall Study|Ongoing at data cut-off|1|||
105503241|NCT00957580|363852865|FG002|Overall Study|Ongoing at data cut-off|0|||
105503242|NCT00957580|363852863|FG000|Overall Study|Enrolled but not treated|0|||
105503243|NCT00957580|363852864|FG001|Overall Study|Enrolled but not treated|1|||
105503244|NCT00957580|363852865|FG002|Overall Study|Enrolled but not treated|0|||
105503245|NCT00191139|363852866|FG000|Overall Study|Adverse Event|2|||
105503246|NCT00191139|363852867|FG001|Overall Study|Adverse Event|6|||
105503247|NCT00191139|363852866|FG000|Overall Study|Death|2|||
105503248|NCT00191139|363852867|FG001|Overall Study|Death|0|||
105503249|NCT00191139|363852866|FG000|Overall Study|Withdrawal by Subject|0|||
105503250|NCT00191139|363852867|FG001|Overall Study|Withdrawal by Subject|3|||
105503251|NCT00191139|363852866|FG000|Overall Study|Disease Progression|0|||
105436146|NCT02160145|363603085|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
105436147|NCT02160145|363603086|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
105436148|NCT02160145|363603087|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
105436149|NCT02160145|363603085|FG000|Randomized Double-blind Period|Subject decision|0|||
105436150|NCT02160145|363603086|FG001|Randomized Double-blind Period|Subject decision|21|||
105436151|NCT02160145|363603087|FG002|Randomized Double-blind Period|Subject decision|20|||
105436152|NCT02160145|363603085|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
105436153|NCT02160145|363603086|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
105436154|NCT02160145|363603087|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
105436155|NCT02160145|363603085|FG000|Randomized Double-blind Period|Physician Decision|0|||
105436156|NCT02160145|363603086|FG001|Randomized Double-blind Period|Physician Decision|7|||
105436157|NCT02160145|363603087|FG002|Randomized Double-blind Period|Physician Decision|5|||
105436158|NCT00566254|363603088|FG000|Overall Study|Adverse Event|3|||
105436159|NCT00566254|363603089|FG001|Overall Study|Adverse Event|1|||
105436160|NCT00566254|363603088|FG000|Overall Study|Protocol Violation|1|||
105436161|NCT00566254|363603089|FG001|Overall Study|Protocol Violation|3|||
105436162|NCT00566254|363603088|FG000|Overall Study|Withdrawal by Subject|1|||
105436163|NCT00566254|363603089|FG001|Overall Study|Withdrawal by Subject|2|||
105436164|NCT00566254|363603088|FG000|Overall Study|Lack of Efficacy|5|||
105436165|NCT00566254|363603089|FG001|Overall Study|Lack of Efficacy|6|||
105436166|NCT00566254|363603088|FG000|Overall Study|Other|0|||
105436167|NCT00566254|363603089|FG001|Overall Study|Other|2|||
105436168|NCT00761527|363603090|FG000|Overall Study|Adverse Event|3|||
105436169|NCT00761527|363603090|FG000|Overall Study|Poor Compliance|8|||
105436170|NCT00761527|363603090|FG000|Overall Study|Lost to Follow-up|9|||
105436171|NCT00761527|363603090|FG000|Overall Study|Unknown reason|2|||
105436172|NCT01748825|363603091|FG000|Dose Escalation|Refused further treatment|2|||
105503252|NCT00191139|363852867|FG001|Overall Study|Disease Progression|1|||
105503253|NCT00191139|363852866|FG000|Overall Study|Other|1|||
105503254|NCT00191139|363852867|FG001|Overall Study|Other|2|||
105503255|NCT00293033|363852868|FG000|Open-label Titration Period|Adverse Event|10|||
105503256|NCT00293033|363852868|FG000|Open-label Titration Period|Death|3|||
105503257|NCT00293033|363852868|FG000|Open-label Titration Period|Lack of Efficacy|5|||
105503258|NCT00293033|363852868|FG000|Open-label Titration Period|Protocol Violation|2|||
105503259|NCT00293033|363852868|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
105503260|NCT00293033|363852868|FG000|Open-label Titration Period|Noncompliance and other|27|||
105503261|NCT00293033|363852868|FG000|Double-blind Treatment Period|Adverse Event|3|||
105503262|NCT00293033|363852868|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
105436173|NCT01748825|363603092|FG001|Dose Escalation|Refused further treatment|2|||
105436174|NCT01748825|363603093|FG002|Dose Escalation|Refused further treatment|0|||
105436175|NCT01748825|363603094|FG003|Dose Escalation|Refused further treatment|0|||
105436176|NCT01748825|363603095|FG004|Dose Escalation|Refused further treatment|1|||
105436177|NCT01748825|363603096|FG005|Dose Escalation|Refused further treatment|2|||
105436178|NCT01748825|363603097|FG006|Dose Escalation|Refused further treatment|0|||
105436179|NCT01748825|363603098|FG007|Dose Escalation|Refused further treatment|0|||
105436180|NCT01748825|363603099|FG008|Dose Escalation|Refused further treatment|0|||
105436181|NCT01748825|363603100|FG009|Dose Escalation|Refused further treatment|0|||
105436182|NCT01748825|363603091|FG000|Dose Escalation|Switched to alternative treatment|0|||
105436183|NCT01748825|363603092|FG001|Dose Escalation|Switched to alternative treatment|0|||
105436184|NCT01748825|363603093|FG002|Dose Escalation|Switched to alternative treatment|0|||
105436185|NCT01748825|363603094|FG003|Dose Escalation|Switched to alternative treatment|1|||
105436186|NCT01748825|363603095|FG004|Dose Escalation|Switched to alternative treatment|0|||
105436187|NCT01748825|363603096|FG005|Dose Escalation|Switched to alternative treatment|0|||
105436188|NCT01748825|363603097|FG006|Dose Escalation|Switched to alternative treatment|0|||
105436189|NCT01748825|363603098|FG007|Dose Escalation|Switched to alternative treatment|0|||
105436190|NCT01748825|363603099|FG008|Dose Escalation|Switched to alternative treatment|0|||
105436191|NCT01748825|363603100|FG009|Dose Escalation|Switched to alternative treatment|0|||
105436192|NCT01748825|363603091|FG000|Dose Escalation|Adverse Event|0|||
105436193|NCT01748825|363603092|FG001|Dose Escalation|Adverse Event|0|||
105436194|NCT01748825|363603093|FG002|Dose Escalation|Adverse Event|0|||
105436195|NCT01748825|363603094|FG003|Dose Escalation|Adverse Event|0|||
105436196|NCT01748825|363603095|FG004|Dose Escalation|Adverse Event|0|||
105436197|NCT01748825|363603096|FG005|Dose Escalation|Adverse Event|0|||
105436198|NCT01748825|363603097|FG006|Dose Escalation|Adverse Event|1|||
105436199|NCT01748825|363603098|FG007|Dose Escalation|Adverse Event|0|||
105436200|NCT01748825|363603099|FG008|Dose Escalation|Adverse Event|0|||
105436201|NCT01748825|363603100|FG009|Dose Escalation|Adverse Event|0|||
105436202|NCT01748825|363603091|FG000|Dose Expansion|Refused further treatment|0|||
105436203|NCT01748825|363603092|FG001|Dose Expansion|Refused further treatment|0|||
105436204|NCT01748825|363603093|FG002|Dose Expansion|Refused further treatment|0|||
105436205|NCT01748825|363603094|FG003|Dose Expansion|Refused further treatment|0|||
105436206|NCT01748825|363603095|FG004|Dose Expansion|Refused further treatment|0|||
105436207|NCT01748825|363603096|FG005|Dose Expansion|Refused further treatment|0|||
105436208|NCT01748825|363603097|FG006|Dose Expansion|Refused further treatment|0|||
105436209|NCT01748825|363603098|FG007|Dose Expansion|Refused further treatment|0|||
105436210|NCT01748825|363603099|FG008|Dose Expansion|Refused further treatment|1|||
105436211|NCT01748825|363603100|FG009|Dose Expansion|Refused further treatment|1|||
105436212|NCT01748825|363603091|FG000|Dose Expansion|Switched to alternative treatment|0|||
105436213|NCT01748825|363603092|FG001|Dose Expansion|Switched to alternative treatment|0|||
105436214|NCT01748825|363603093|FG002|Dose Expansion|Switched to alternative treatment|0|||
105436215|NCT01748825|363603094|FG003|Dose Expansion|Switched to alternative treatment|0|||
105436216|NCT01748825|363603095|FG004|Dose Expansion|Switched to alternative treatment|0|||
105436217|NCT01748825|363603096|FG005|Dose Expansion|Switched to alternative treatment|0|||
105436218|NCT01748825|363603097|FG006|Dose Expansion|Switched to alternative treatment|0|||
105436219|NCT01748825|363603098|FG007|Dose Expansion|Switched to alternative treatment|0|||
105436220|NCT01748825|363603099|FG008|Dose Expansion|Switched to alternative treatment|0|||
105436221|NCT01748825|363603100|FG009|Dose Expansion|Switched to alternative treatment|1|||
105436222|NCT01748825|363603091|FG000|Dose Expansion|Adverse Event|0|||
105436223|NCT01748825|363603092|FG001|Dose Expansion|Adverse Event|0|||
105436224|NCT01748825|363603093|FG002|Dose Expansion|Adverse Event|0|||
105436225|NCT01748825|363603094|FG003|Dose Expansion|Adverse Event|0|||
105436226|NCT01748825|363603095|FG004|Dose Expansion|Adverse Event|0|||
105436227|NCT01748825|363603096|FG005|Dose Expansion|Adverse Event|0|||
105436228|NCT01748825|363603097|FG006|Dose Expansion|Adverse Event|0|||
105436229|NCT01748825|363603098|FG007|Dose Expansion|Adverse Event|0|||
105436230|NCT01748825|363603099|FG008|Dose Expansion|Adverse Event|0|||
105436231|NCT01748825|363603100|FG009|Dose Expansion|Adverse Event|3|||
105436232|NCT01748825|363603091|FG000|Dose Expansion|Physician Decision|0|||
105436233|NCT01748825|363603092|FG001|Dose Expansion|Physician Decision|0|||
105436234|NCT01748825|363603093|FG002|Dose Expansion|Physician Decision|0|||
105436235|NCT01748825|363603094|FG003|Dose Expansion|Physician Decision|0|||
105436236|NCT01748825|363603095|FG004|Dose Expansion|Physician Decision|0|||
105436237|NCT01748825|363603096|FG005|Dose Expansion|Physician Decision|0|||
105436238|NCT01748825|363603097|FG006|Dose Expansion|Physician Decision|0|||
105436239|NCT01748825|363603098|FG007|Dose Expansion|Physician Decision|0|||
105436240|NCT01748825|363603099|FG008|Dose Expansion|Physician Decision|1|||
105436241|NCT01748825|363603100|FG009|Dose Expansion|Physician Decision|0|||
105436242|NCT03848949|363603101|FG000|Overall Study|Lost to Follow-up|5|||
105436243|NCT03848949|363603102|FG001|Overall Study|Lost to Follow-up|7|||
105436244|NCT00619307|363603103|FG000|Overall Study|Adverse Event|0|||
105436245|NCT00619307|363603104|FG001|Overall Study|Adverse Event|1|||
105436246|NCT00619307|363603103|FG000|Overall Study|Lost to Follow-up|0|||
105436247|NCT00619307|363603104|FG001|Overall Study|Lost to Follow-up|1|||
105436248|NCT00619307|363603103|FG000|Overall Study|Protocol Violation|3|||
105436249|NCT00619307|363603104|FG001|Overall Study|Protocol Violation|0|||
105436250|NCT00619307|363603103|FG000|Overall Study|Withdrew consent|1|||
105436251|NCT00619307|363603104|FG001|Overall Study|Withdrew consent|0|||
105503263|NCT00293033|363852868|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
105436252|NCT00619307|363603103|FG000|Overall Study|Severe migraine|0|||
105436253|NCT00619307|363603104|FG001|Overall Study|Severe migraine|1|||
105436254|NCT00619307|363603103|FG000|Overall Study|MS attack plus steroids|0|||
105436255|NCT00619307|363603104|FG001|Overall Study|MS attack plus steroids|1|||
105436256|NCT02100475|363604779|FG000|Overall Study|Unclassified|1|||
105436257|NCT02100475|363604780|FG001|Overall Study|Unclassified|2|||
105436258|NCT02100475|363604779|FG000|Overall Study|Withdrawal criteria|1|||
105436259|NCT02100475|363604780|FG001|Overall Study|Withdrawal criteria|0|||
105436260|NCT03268941|363604781|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
105436261|NCT03268941|363604782|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
105436262|NCT03268941|363604783|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
105436263|NCT03268941|363604784|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
105436264|NCT03268941|363604785|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
105436265|NCT03268941|363604786|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
105436266|NCT03268941|363604787|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
105436267|NCT03268941|363604781|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
105436268|NCT03268941|363604782|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
105436269|NCT03268941|363604783|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
105436270|NCT03268941|363604784|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
105436271|NCT03268941|363604785|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
105436272|NCT03268941|363604786|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
105436273|NCT03268941|363604787|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
105436274|NCT03268941|363604781|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
105436275|NCT03268941|363604782|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
105436276|NCT03268941|363604783|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
105436277|NCT03268941|363604784|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
105436278|NCT03268941|363604785|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
105436279|NCT03268941|363604786|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
105436280|NCT03268941|363604787|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
105436281|NCT03268941|363604781|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
105436282|NCT03268941|363604782|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
105436283|NCT03268941|363604783|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
105436284|NCT03268941|363604784|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
105436285|NCT03268941|363604785|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
105436286|NCT03268941|363604786|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
105436287|NCT03268941|363604787|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
105436288|NCT03268941|363604781|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
105436289|NCT03268941|363604782|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
105436290|NCT03268941|363604783|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
105436291|NCT03268941|363604784|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
105436292|NCT03268941|363604785|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
105436293|NCT03268941|363604786|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
105436294|NCT03268941|363604787|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
105436295|NCT01949090|363604796|FG000|Overall Study|Serious Adverse Event|0|||
105436296|NCT01949090|363604797|FG001|Overall Study|Serious Adverse Event|1|||
105436297|NCT01949090|363604798|FG002|Overall Study|Serious Adverse Event|2|||
105436298|NCT01949090|363604799|FG003|Overall Study|Serious Adverse Event|0|||
105436299|NCT01949090|363604800|FG004|Overall Study|Serious Adverse Event|1|||
105436300|NCT01949090|363604796|FG000|Overall Study|Withdrawal by Subject|2|||
105436301|NCT01949090|363604797|FG001|Overall Study|Withdrawal by Subject|0|||
105436302|NCT01949090|363604798|FG002|Overall Study|Withdrawal by Subject|0|||
105436303|NCT01949090|363604799|FG003|Overall Study|Withdrawal by Subject|0|||
105436304|NCT01949090|363604800|FG004|Overall Study|Withdrawal by Subject|1|||
105436305|NCT01949090|363604796|FG000|Overall Study|Protocol non-compliance|0|||
105436306|NCT01949090|363604797|FG001|Overall Study|Protocol non-compliance|0|||
105436307|NCT01949090|363604798|FG002|Overall Study|Protocol non-compliance|0|||
105503264|NCT00293033|363852868|FG000|Double-blind Treatment Period|Noncompliance|4|||
105503265|NCT05248867|363852869|FG000|Double-blind Period|Lost to Follow-up|0|||
105503266|NCT05248867|363852870|FG001|Double-blind Period|Lost to Follow-up|3|||
105503267|NCT05248867|363852871|FG002|Double-blind Period|Lost to Follow-up|0|||
105503268|NCT05248867|363852872|FG003|Double-blind Period|Lost to Follow-up|0|||
105436308|NCT01949090|363604799|FG003|Overall Study|Protocol non-compliance|0|||
105436309|NCT01949090|363604800|FG004|Overall Study|Protocol non-compliance|1|||
105436310|NCT01949090|363604796|FG000|Overall Study|Lost to Follow-up|2|||
105436311|NCT01949090|363604797|FG001|Overall Study|Lost to Follow-up|1|||
105436312|NCT01949090|363604798|FG002|Overall Study|Lost to Follow-up|0|||
105436313|NCT01949090|363604799|FG003|Overall Study|Lost to Follow-up|1|||
105436314|NCT01949090|363604800|FG004|Overall Study|Lost to Follow-up|1|||
105436315|NCT00567359|363604801|FG000|Overall Study|Withdrawal by Subject|1|||
105436316|NCT00785980|363604802|FG000|7 Day Washout Period|Protocol Violation|3|||
105436317|NCT02241343|363604803|FG000|Overall Study|Adverse Event|1|||
105436318|NCT03927144|363604804|FG000|Core Phase|Adverse Event|9|||
105436319|NCT03927144|363604805|FG001|Core Phase|Adverse Event|5|||
105436320|NCT03927144|363604804|FG000|Core Phase|Lost to Follow-up|3|||
105436321|NCT03927144|363604805|FG001|Core Phase|Lost to Follow-up|2|||
105436322|NCT03927144|363604804|FG000|Core Phase|New Therapy for Study Indication|0|||
105436323|NCT03927144|363604805|FG001|Core Phase|New Therapy for Study Indication|1|||
105436324|NCT03927144|363604804|FG000|Core Phase|No Longer Clinically Benefiting|4|||
105436325|NCT03927144|363604805|FG001|Core Phase|No Longer Clinically Benefiting|4|||
105436326|NCT03927144|363604804|FG000|Core Phase|Physician Decision|2|||
105436327|NCT03927144|363604805|FG001|Core Phase|Physician Decision|8|||
105503269|NCT05248867|363852873|FG004|Double-blind Period|Lost to Follow-up|0|||
105503270|NCT05248867|363852874|FG005|Double-blind Period|Lost to Follow-up|0|||
105503271|NCT05248867|363852869|FG000|Double-blind Period|Withdrawal by Subject|5|||
105503272|NCT05248867|363852870|FG001|Double-blind Period|Withdrawal by Subject|14|||
105503273|NCT05248867|363852871|FG002|Double-blind Period|Withdrawal by Subject|0|||
105503274|NCT05248867|363852872|FG003|Double-blind Period|Withdrawal by Subject|0|||
105503275|NCT05248867|363852873|FG004|Double-blind Period|Withdrawal by Subject|0|||
105503276|NCT05248867|363852874|FG005|Double-blind Period|Withdrawal by Subject|0|||
105503277|NCT05248867|363852869|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
105503278|NCT05248867|363852870|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
105503279|NCT05248867|363852871|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
105503280|NCT05248867|363852872|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
105503281|NCT05248867|363852873|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
105503282|NCT05248867|363852874|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
105503283|NCT05248867|363852869|FG000|Double-blind Period|Other, not specified|3|||
105503284|NCT05248867|363852870|FG001|Double-blind Period|Other, not specified|8|||
105503285|NCT05248867|363852871|FG002|Double-blind Period|Other, not specified|0|||
105503286|NCT05248867|363852872|FG003|Double-blind Period|Other, not specified|0|||
105503287|NCT05248867|363852873|FG004|Double-blind Period|Other, not specified|0|||
105503288|NCT05248867|363852874|FG005|Double-blind Period|Other, not specified|0|||
105503289|NCT05248867|363852869|FG000|Open-label Period|Withdrawal by Subject|0|||
105503290|NCT05248867|363852870|FG001|Open-label Period|Withdrawal by Subject|0|||
105503291|NCT05248867|363852871|FG002|Open-label Period|Withdrawal by Subject|3|||
105503292|NCT05248867|363852872|FG003|Open-label Period|Withdrawal by Subject|1|||
105503293|NCT05248867|363852873|FG004|Open-label Period|Withdrawal by Subject|7|||
105503294|NCT05248867|363852874|FG005|Open-label Period|Withdrawal by Subject|9|||
105503295|NCT05248867|363852869|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
105503296|NCT05248867|363852870|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
105503297|NCT05248867|363852871|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
105503298|NCT05248867|363852872|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
105503299|NCT05248867|363852873|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
105503300|NCT05248867|363852874|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
105503301|NCT05248867|363852869|FG000|Open-label Period|Lost to Follow-up|0|||
105503302|NCT05248867|363852870|FG001|Open-label Period|Lost to Follow-up|0|||
105503303|NCT05248867|363852871|FG002|Open-label Period|Lost to Follow-up|0|||
105503304|NCT05248867|363852872|FG003|Open-label Period|Lost to Follow-up|0|||
105503305|NCT05248867|363852873|FG004|Open-label Period|Lost to Follow-up|5|||
105503306|NCT05248867|363852874|FG005|Open-label Period|Lost to Follow-up|2|||
105503307|NCT05248867|363852869|FG000|Open-label Period|COVID-19 Infection|0|||
105503308|NCT05248867|363852870|FG001|Open-label Period|COVID-19 Infection|0|||
105503309|NCT05248867|363852871|FG002|Open-label Period|COVID-19 Infection|0|||
105503310|NCT05248867|363852872|FG003|Open-label Period|COVID-19 Infection|0|||
105503311|NCT05248867|363852873|FG004|Open-label Period|COVID-19 Infection|1|||
105503312|NCT05248867|363852874|FG005|Open-label Period|COVID-19 Infection|0|||
105503313|NCT05248867|363852869|FG000|Open-label Period|Other, not specified|0|||
105503314|NCT05248867|363852870|FG001|Open-label Period|Other, not specified|0|||
105503315|NCT05248867|363852871|FG002|Open-label Period|Other, not specified|0|||
105503316|NCT05248867|363852872|FG003|Open-label Period|Other, not specified|0|||
105503317|NCT05248867|363852873|FG004|Open-label Period|Other, not specified|4|||
105503318|NCT05248867|363852874|FG005|Open-label Period|Other, not specified|0|||
105503319|NCT04362072|363852879|FG000|Treatment|Adverse Event|1|||
105503320|NCT04362072|363852879|FG000|Treatment|Death|9|||
105436328|NCT03927144|363604804|FG000|Core Phase|Protocol Violation|2|||
105436329|NCT03927144|363604805|FG001|Core Phase|Protocol Violation|2|||
105436330|NCT03927144|363604804|FG000|Core Phase|Withdrawal by Subject|16|||
105503321|NCT04362072|363852879|FG000|Treatment|Physician Decision|2|||
105503322|NCT04362072|363852879|FG000|Treatment|Progressive disease|27|||
105503323|NCT04362072|363852879|FG000|Treatment|Withdrawal by Subject|4|||
105503324|NCT04362072|363852879|FG000|Treatment|Global deterioration of health status|1|||
105503325|NCT04362072|363852879|FG000|Treatment|Switched to commercial Lorlatinib|13|||
105590649|NCT01549652|364162674|FG002|Overall Study|Problem with Infusion|0|||
105436331|NCT03927144|363604805|FG001|Core Phase|Withdrawal by Subject|40|||
105436332|NCT03927144|363604804|FG000|Extension Phase|Adverse Event|2|||
105436333|NCT03927144|363604805|FG001|Extension Phase|Adverse Event|1|||
105503326|NCT04362072|363852879|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
105436334|NCT03927144|363604804|FG000|Extension Phase|No longer clinically benefiting|4|||
105436335|NCT03927144|363604805|FG001|Extension Phase|No longer clinically benefiting|5|||
105436336|NCT03927144|363604804|FG000|Extension Phase|Pregnancy|1|||
105436337|NCT03927144|363604805|FG001|Extension Phase|Pregnancy|0|||
105436338|NCT03927144|363604804|FG000|Extension Phase|Protocol Violation|0|||
105436339|NCT03927144|363604805|FG001|Extension Phase|Protocol Violation|1|||
105436340|NCT03927144|363604804|FG000|Extension Phase|Withdrawal by Subject|8|||
105436341|NCT03927144|363604805|FG001|Extension Phase|Withdrawal by Subject|3|||
105436342|NCT02702414|363604808|FG000|Overall Study|Death|96|||
105436343|NCT02702414|363604809|FG001|Overall Study|Death|42|||
105436344|NCT02702414|363604808|FG000|Overall Study|Lost to Follow-up|0|||
105436345|NCT02702414|363604809|FG001|Overall Study|Lost to Follow-up|1|||
105436346|NCT02702414|363604808|FG000|Overall Study|Withdrawal by Subject|0|||
105436347|NCT02702414|363604809|FG001|Overall Study|Withdrawal by Subject|1|||
105436348|NCT02702414|363604808|FG000|Overall Study|Protocol Violation|1|||
105436349|NCT02702414|363604809|FG001|Overall Study|Protocol Violation|0|||
105436350|NCT02702414|363604808|FG000|Overall Study|Sponsor Decision|8|||
105436351|NCT02702414|363604809|FG001|Overall Study|Sponsor Decision|7|||
105436352|NCT02596230|363604810|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
105436353|NCT02596230|363604811|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
105436354|NCT02596230|363604812|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
105436355|NCT02596230|363604813|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
105436356|NCT02596230|363604814|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
105436357|NCT02596230|363604810|FG000|Objective 2, One Year|Lost to Follow-up|0|||
105436358|NCT02596230|363604811|FG001|Objective 2, One Year|Lost to Follow-up|41|||
105436359|NCT02596230|363604812|FG002|Objective 2, One Year|Lost to Follow-up|41|||
105436360|NCT02596230|363604813|FG003|Objective 2, One Year|Lost to Follow-up|32|||
105436361|NCT02596230|363604814|FG004|Objective 2, One Year|Lost to Follow-up|46|||
105436362|NCT02596230|363604810|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
105436363|NCT02596230|363604811|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
105436364|NCT02596230|363604812|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
105436365|NCT02596230|363604813|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
105436366|NCT02596230|363604814|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
105436367|NCT02596230|363604810|FG000|Objective 2, One Year|Adverse drug reaction|0|||
105436368|NCT02596230|363604811|FG001|Objective 2, One Year|Adverse drug reaction|1|||
105436369|NCT02596230|363604812|FG002|Objective 2, One Year|Adverse drug reaction|0|||
105436370|NCT02596230|363604813|FG003|Objective 2, One Year|Adverse drug reaction|0|||
105436371|NCT02596230|363604814|FG004|Objective 2, One Year|Adverse drug reaction|0|||
105436372|NCT02596230|363604810|FG000|Objective 2, One Year|Death|0|||
105436373|NCT02596230|363604811|FG001|Objective 2, One Year|Death|12|||
105436374|NCT02596230|363604812|FG002|Objective 2, One Year|Death|41|||
105436375|NCT02596230|363604813|FG003|Objective 2, One Year|Death|21|||
105436376|NCT02596230|363604814|FG004|Objective 2, One Year|Death|30|||
105436377|NCT02596230|363604810|FG000|Objective 2, One Year|Other|0|||
105436378|NCT02596230|363604811|FG001|Objective 2, One Year|Other|3|||
105436379|NCT02596230|363604812|FG002|Objective 2, One Year|Other|2|||
105436380|NCT02596230|363604813|FG003|Objective 2, One Year|Other|0|||
105436381|NCT02596230|363604814|FG004|Objective 2, One Year|Other|0|||
105436382|NCT02421588|363604816|FG000|Overall Study|Non-treatment-related AE|8|||
105436383|NCT02421588|363604817|FG001|Overall Study|Non-treatment-related AE|8|||
105436384|NCT02421588|363604816|FG000|Overall Study|Progressive disease|152|||
105436385|NCT02421588|363604817|FG001|Overall Study|Progressive disease|135|||
105436386|NCT02421588|363604816|FG000|Overall Study|Death|11|||
105436387|NCT02421588|363604817|FG001|Overall Study|Death|3|||
105436388|NCT02421588|363604816|FG000|Overall Study|Physician Decision|8|||
105436389|NCT02421588|363604817|FG001|Overall Study|Physician Decision|17|||
105436390|NCT02421588|363604816|FG000|Overall Study|Other reason not specified|3|||
105436391|NCT02421588|363604817|FG001|Overall Study|Other reason not specified|1|||
105436392|NCT02421588|363604816|FG000|Overall Study|Symptomatic deterioration|13|||
105436393|NCT02421588|363604817|FG001|Overall Study|Symptomatic deterioration|19|||
105436394|NCT02421588|363604816|FG000|Overall Study|Treatment-related AE|10|||
105436395|NCT02421588|363604817|FG001|Overall Study|Treatment-related AE|14|||
105436396|NCT02421588|363604816|FG000|Overall Study|Withdrawal by Subject|14|||
105436397|NCT02421588|363604817|FG001|Overall Study|Withdrawal by Subject|16|||
105436398|NCT02421588|363604816|FG000|Overall Study|Not treated|2|||
105436399|NCT02421588|363604817|FG001|Overall Study|Not treated|8|||
105436400|NCT00615030|363604818|FG000|Period I|Administrative problem|0|||
105436401|NCT00615030|363604819|FG001|Period I|Administrative problem|0|||
105436402|NCT00615030|363604820|FG002|Period I|Administrative problem|0|||
105436403|NCT00615030|363604821|FG003|Period I|Administrative problem|0|||
105436404|NCT00615030|363604822|FG004|Period I|Administrative problem|1|||
105436405|NCT00615030|363604823|FG005|Period I|Administrative problem|0|||
105436406|NCT00615030|363604824|FG006|Period I|Administrative problem|0|||
105436407|NCT00615030|363604825|FG007|Period I|Administrative problem|0|||
105436408|NCT00615030|363604826|FG008|Period I|Administrative problem|0|||
105436409|NCT00615030|363604827|FG009|Period I|Administrative problem|0|||
105503327|NCT04362072|363852879|FG000|Treatment|Other|3|||
105503328|NCT04362072|363852879|FG000|Follow up|Death|2|||
105503329|NCT04362072|363852879|FG000|Follow up|Other|2|||
105503330|NCT01133522|363852886|FG000|Overall Study|Withdrawal by Subject|0|||
105503331|NCT01133522|363852887|FG001|Overall Study|Withdrawal by Subject|1|||
105503332|NCT01133522|363852888|FG002|Overall Study|Withdrawal by Subject|0|||
105503333|NCT01133522|363852889|FG003|Overall Study|Withdrawal by Subject|1|||
105590650|NCT01549652|364162675|FG003|Overall Study|Problem with Infusion|0|||
105590651|NCT01549652|364162672|FG000|Overall Study|Titration Non-Compliance|1|||
105590652|NCT01549652|364162673|FG001|Overall Study|Titration Non-Compliance|3|||
105590653|NCT01549652|364162674|FG002|Overall Study|Titration Non-Compliance|4|||
105590654|NCT01549652|364162675|FG003|Overall Study|Titration Non-Compliance|5|||
105590655|NCT01549652|364162672|FG000|Overall Study|Titration Side Effects|0|||
105590656|NCT01549652|364162673|FG001|Overall Study|Titration Side Effects|0|||
105590657|NCT01549652|364162674|FG002|Overall Study|Titration Side Effects|6|||
105590658|NCT01549652|364162675|FG003|Overall Study|Titration Side Effects|3|||
105590659|NCT01549652|364162672|FG000|Overall Study|Withdrawal by Subject|0|||
105590660|NCT01549652|364162673|FG001|Overall Study|Withdrawal by Subject|0|||
105590661|NCT01549652|364162674|FG002|Overall Study|Withdrawal by Subject|5|||
105590662|NCT01549652|364162675|FG003|Overall Study|Withdrawal by Subject|3|||
105436410|NCT00615030|363604828|FG010|Period I|Administrative problem|0|||
105436411|NCT00615030|363604829|FG011|Period I|Administrative problem|0|||
105436412|NCT00615030|363604818|FG000|Period I|Protocol deviation|1|||
105436413|NCT00615030|363604819|FG001|Period I|Protocol deviation|0|||
105436414|NCT00615030|363604820|FG002|Period I|Protocol deviation|0|||
105436415|NCT00615030|363604821|FG003|Period I|Protocol deviation|0|||
105436416|NCT00615030|363604822|FG004|Period I|Protocol deviation|0|||
105436417|NCT00615030|363604823|FG005|Period I|Protocol deviation|0|||
105436418|NCT00615030|363604824|FG006|Period I|Protocol deviation|0|||
105436419|NCT00615030|363604825|FG007|Period I|Protocol deviation|0|||
105436420|NCT00615030|363604826|FG008|Period I|Protocol deviation|0|||
105436421|NCT00615030|363604827|FG009|Period I|Protocol deviation|0|||
105436422|NCT00615030|363604828|FG010|Period I|Protocol deviation|0|||
105436423|NCT00615030|363604829|FG011|Period I|Protocol deviation|0|||
105436424|NCT00615030|363604818|FG000|Period I|Subject withdrew consent|0|||
105436425|NCT00615030|363604819|FG001|Period I|Subject withdrew consent|0|||
105436426|NCT00615030|363604820|FG002|Period I|Subject withdrew consent|0|||
105436427|NCT00615030|363604821|FG003|Period I|Subject withdrew consent|0|||
105436428|NCT00615030|363604822|FG004|Period I|Subject withdrew consent|0|||
105436429|NCT00615030|363604823|FG005|Period I|Subject withdrew consent|0|||
105436430|NCT00615030|363604824|FG006|Period I|Subject withdrew consent|0|||
105436431|NCT00615030|363604825|FG007|Period I|Subject withdrew consent|0|||
105436432|NCT00615030|363604826|FG008|Period I|Subject withdrew consent|1|||
105436433|NCT00615030|363604827|FG009|Period I|Subject withdrew consent|0|||
105436434|NCT00615030|363604828|FG010|Period I|Subject withdrew consent|1|||
105436435|NCT00615030|363604829|FG011|Period I|Subject withdrew consent|1|||
105436436|NCT00615030|363604818|FG000|Period I|Abnormal laboratory value(s)|0|||
105436437|NCT00615030|363604819|FG001|Period I|Abnormal laboratory value(s)|0|||
105436438|NCT00615030|363604820|FG002|Period I|Abnormal laboratory value(s)|0|||
105436439|NCT00615030|363604821|FG003|Period I|Abnormal laboratory value(s)|0|||
105436440|NCT00615030|363604822|FG004|Period I|Abnormal laboratory value(s)|0|||
105436441|NCT00615030|363604823|FG005|Period I|Abnormal laboratory value(s)|1|||
105436442|NCT00615030|363604824|FG006|Period I|Abnormal laboratory value(s)|0|||
105436443|NCT00615030|363604825|FG007|Period I|Abnormal laboratory value(s)|0|||
105436444|NCT00615030|363604826|FG008|Period I|Abnormal laboratory value(s)|0|||
105436445|NCT00615030|363604827|FG009|Period I|Abnormal laboratory value(s)|0|||
105436446|NCT00615030|363604828|FG010|Period I|Abnormal laboratory value(s)|0|||
105436447|NCT00615030|363604829|FG011|Period I|Abnormal laboratory value(s)|0|||
105436448|NCT00615030|363604818|FG000|Period II|Adverse Event|0|||
105590663|NCT00383188|364162678|FG000|Overall Study|Adverse Event|4|||
105590664|NCT00383188|364162679|FG001|Overall Study|Adverse Event|7|||
105436449|NCT00615030|363604819|FG001|Period II|Adverse Event|0|||
105436450|NCT00615030|363604820|FG002|Period II|Adverse Event|1|||
105436451|NCT00615030|363604821|FG003|Period II|Adverse Event|0|||
105436452|NCT00615030|363604822|FG004|Period II|Adverse Event|0|||
105436453|NCT00615030|363604823|FG005|Period II|Adverse Event|0|||
105436454|NCT00615030|363604824|FG006|Period II|Adverse Event|0|||
105436455|NCT00615030|363604825|FG007|Period II|Adverse Event|0|||
105436456|NCT00615030|363604826|FG008|Period II|Adverse Event|1|||
105436457|NCT00615030|363604827|FG009|Period II|Adverse Event|0|||
105436458|NCT00615030|363604828|FG010|Period II|Adverse Event|0|||
105503334|NCT01133522|363852890|FG004|Overall Study|Withdrawal by Subject|0|||
105503335|NCT01133522|363852891|FG005|Overall Study|Withdrawal by Subject|0|||
105590665|NCT00383188|364162680|FG002|Overall Study|Adverse Event|9|||
105436459|NCT00615030|363604829|FG011|Period II|Adverse Event|0|||
105436460|NCT00615030|363604818|FG000|Period II|Subject withdrew consent|0|||
105436461|NCT00615030|363604819|FG001|Period II|Subject withdrew consent|0|||
105590666|NCT00383188|364162681|FG003|Overall Study|Adverse Event|8|||
105590667|NCT00383188|364162682|FG004|Overall Study|Adverse Event|8|||
105590668|NCT00383188|364162678|FG000|Overall Study|Lack of Efficacy|9|||
105436462|NCT00615030|363604820|FG002|Period II|Subject withdrew consent|0|||
105436463|NCT00615030|363604821|FG003|Period II|Subject withdrew consent|1|||
105436464|NCT00615030|363604822|FG004|Period II|Subject withdrew consent|0|||
105436465|NCT00615030|363604823|FG005|Period II|Subject withdrew consent|0|||
105436466|NCT00615030|363604824|FG006|Period II|Subject withdrew consent|1|||
105436467|NCT00615030|363604825|FG007|Period II|Subject withdrew consent|0|||
105436468|NCT00615030|363604826|FG008|Period II|Subject withdrew consent|0|||
105436469|NCT00615030|363604827|FG009|Period II|Subject withdrew consent|0|||
105436470|NCT00615030|363604828|FG010|Period II|Subject withdrew consent|0|||
105436471|NCT00615030|363604829|FG011|Period II|Subject withdrew consent|0|||
105436472|NCT00615030|363604818|FG000|Period III|Administrative problems|1|||
105436473|NCT00615030|363604819|FG001|Period III|Administrative problems|0|||
105436474|NCT00615030|363604820|FG002|Period III|Administrative problems|0|||
105436475|NCT00615030|363604821|FG003|Period III|Administrative problems|1|||
105436476|NCT00615030|363604822|FG004|Period III|Administrative problems|0|||
105436477|NCT00615030|363604823|FG005|Period III|Administrative problems|0|||
105436478|NCT00615030|363604824|FG006|Period III|Administrative problems|0|||
105436479|NCT00615030|363604825|FG007|Period III|Administrative problems|0|||
105436480|NCT00615030|363604826|FG008|Period III|Administrative problems|0|||
105436481|NCT00615030|363604827|FG009|Period III|Administrative problems|0|||
105436482|NCT00615030|363604828|FG010|Period III|Administrative problems|0|||
105436483|NCT00615030|363604829|FG011|Period III|Administrative problems|0|||
105436484|NCT03722524|363604833|FG000|Overall Study|Protocol Violation|86|||
105436485|NCT03722524|363604833|FG000|Overall Study|Adverse Event|7|||
105436486|NCT03722524|363604833|FG000|Overall Study|Lost to Follow-up|1|||
105436487|NCT03722524|363604833|FG000|Overall Study|Reason is not stated|1|||
105436488|NCT03722524|363604833|FG000|Overall Study|Physician Decision|1|||
105436489|NCT03722524|363604833|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
105436490|NCT01753401|363604834|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
105436491|NCT01753401|363604835|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
105436492|NCT01753401|363604836|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
105436493|NCT01753401|363604837|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
105436494|NCT01753401|363604834|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
105436495|NCT01753401|363604835|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
105436496|NCT01753401|363604836|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
105436497|NCT01753401|363604837|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
105436498|NCT01753401|363604834|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
105436499|NCT01753401|363604835|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
105436500|NCT01753401|363604836|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
105436501|NCT01753401|363604837|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
105436502|NCT01753401|363604834|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
105436503|NCT01753401|363604835|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
105436504|NCT01753401|363604836|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
105436505|NCT01753401|363604837|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
105436506|NCT01753401|363604834|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
105436507|NCT01753401|363604835|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
105436508|NCT01753401|363604836|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
105436509|NCT01753401|363604837|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
105436510|NCT01753401|363604834|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
105436511|NCT01753401|363604835|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
105436512|NCT01753401|363604836|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
105436513|NCT01753401|363604837|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
105436514|NCT01753401|363604834|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
105436515|NCT01753401|363604835|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
105436516|NCT01753401|363604836|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
105436517|NCT01753401|363604837|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
105436518|NCT00470418|363604838|FG000|Overall Study|Withdrawal by Subject|1|||
105436519|NCT00470418|363604839|FG001|Overall Study|Withdrawal by Subject|0|||
105436520|NCT00462748|363604842|FG000|Overall Study|Adverse Event|7|||
105436521|NCT00462748|363604843|FG001|Overall Study|Adverse Event|5|||
105436522|NCT00462748|363604844|FG002|Overall Study|Adverse Event|9|||
105436523|NCT00462748|363604842|FG000|Overall Study|Protocol Violation|0|||
105436524|NCT00462748|363604843|FG001|Overall Study|Protocol Violation|2|||
105436525|NCT00462748|363604844|FG002|Overall Study|Protocol Violation|1|||
105436526|NCT00462748|363604842|FG000|Overall Study|Withdrew consent|3|||
105436527|NCT00462748|363604843|FG001|Overall Study|Withdrew consent|3|||
105436528|NCT00462748|363604844|FG002|Overall Study|Withdrew consent|0|||
105436529|NCT00462748|363604842|FG000|Overall Study|Lost to Follow-up|1|||
105436530|NCT00462748|363604843|FG001|Overall Study|Lost to Follow-up|1|||
105436531|NCT00462748|363604844|FG002|Overall Study|Lost to Follow-up|1|||
105436532|NCT00462748|363604842|FG000|Overall Study|Discontinued after 41 days Rx|1|||
105436533|NCT00462748|363604843|FG001|Overall Study|Discontinued after 41 days Rx|0|||
105436534|NCT00462748|363604844|FG002|Overall Study|Discontinued after 41 days Rx|0|||
105436535|NCT02345330|363604846|FG000|Overall Study|Death|1|||
105436536|NCT02345330|363604846|FG000|Overall Study|Progressive Disease|2|||
105436537|NCT03615066|363604847|FG000|Main Study|Withdrew Consent|0|||
105436538|NCT03615066|363604848|FG001|Main Study|Withdrew Consent|1|||
105436539|NCT03615066|363604849|FG002|Main Study|Withdrew Consent|1|||
105436540|NCT03615066|363604847|FG000|Main Study|Lost to Follow-up|0|||
105436541|NCT03615066|363604848|FG001|Main Study|Lost to Follow-up|0|||
105436542|NCT03615066|363604849|FG002|Main Study|Lost to Follow-up|1|||
105436543|NCT03615066|363604847|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
105436544|NCT03615066|363604848|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
105436545|NCT03615066|363604849|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
105436546|NCT03615066|363604847|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
105436547|NCT03615066|363604848|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
105436548|NCT03615066|363604849|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
105436549|NCT03615066|363604847|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
105436550|NCT03615066|363604848|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
105436551|NCT03615066|363604849|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
105436552|NCT02437084|363604851|FG000|Overall Study|Withdrawal by Subject|2|||
105436553|NCT02437084|363604851|FG000|Overall Study|Physician Decision|1|||
105436554|NCT00454181|363604852|FG000|Overall Study|Adverse Event|1|||
105436555|NCT00454181|363604853|FG001|Overall Study|Adverse Event|1|||
105436556|NCT00454181|363604852|FG000|Overall Study|Lost to Follow-up|11|||
105436557|NCT00454181|363604853|FG001|Overall Study|Lost to Follow-up|1|||
105436558|NCT00454181|363604852|FG000|Overall Study|Protocol Violation|1|||
105436559|NCT00454181|363604853|FG001|Overall Study|Protocol Violation|1|||
105436560|NCT00454181|363604852|FG000|Overall Study|Withdrawal by Subject|2|||
105436561|NCT00454181|363604853|FG001|Overall Study|Withdrawal by Subject|0|||
105436562|NCT00109577|363604854|FG000|Overall Study|Withdrawal by Subject|3|||
105436563|NCT00109577|363604855|FG001|Overall Study|Withdrawal by Subject|3|||
105436564|NCT03729245|363604856|FG000|Overall Study|Lost to Follow-up|5|||
105436565|NCT03729245|363604857|FG001|Overall Study|Lost to Follow-up|6|||
105436566|NCT03729245|363604856|FG000|Overall Study|Withdrawal by Subject|16|||
105436567|NCT03729245|363604857|FG001|Overall Study|Withdrawal by Subject|19|||
105436568|NCT03729245|363604856|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
105436569|NCT03729245|363604857|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
105436570|NCT00885482|363604858|FG000|Overall Study|Pregnancy|1|||
105436571|NCT00885482|363604858|FG000|Overall Study|Lack of Efficacy|1|||
105436572|NCT00885482|363604858|FG000|Overall Study|Death|1|||
105436573|NCT00885482|363604858|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
105436574|NCT00129467|363604861|FG000|Received Intervention|Death|1|||
105436575|NCT00129467|363604862|FG001|Received Intervention|Death|1|||
105436576|NCT00129467|363604861|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
105436577|NCT00129467|363604862|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
105436578|NCT00129467|363604861|FG000|Received Intervention|Delirium|2|||
105436579|NCT00129467|363604862|FG001|Received Intervention|Delirium|0|||
105436580|NCT00129467|363604861|FG000|Received Intervention|Withdrawal by Subject|1|||
105436581|NCT00129467|363604862|FG001|Received Intervention|Withdrawal by Subject|0|||
105436582|NCT00129467|363604861|FG000|Received Intervention|Nausea|1|||
105436583|NCT00129467|363604862|FG001|Received Intervention|Nausea|0|||
105436584|NCT00129467|363604861|FG000|Received Intervention|Intolerance to citalopram|0|||
105436585|NCT00129467|363604862|FG001|Received Intervention|Intolerance to citalopram|1|||
105436586|NCT00129467|363604861|FG000|Received Intervention|Dizzyness, fatigue|0|||
105436587|NCT00129467|363604862|FG001|Received Intervention|Dizzyness, fatigue|1|||
105436588|NCT00129467|363604861|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
105436589|NCT00129467|363604862|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
105436590|NCT00129467|363604861|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
105436591|NCT00129467|363604862|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
105436592|NCT01532869|363604863|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
105436593|NCT01532869|363604864|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
105436594|NCT01532869|363604863|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
105436595|NCT01532869|363604864|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
105436596|NCT01532869|363604863|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
105436597|NCT01532869|363604864|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
105436598|NCT01532869|363604863|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
105436599|NCT01532869|363604864|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
105436600|NCT01532869|363604863|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
105436601|NCT01532869|363604864|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
105436602|NCT01532869|363604863|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
105590669|NCT00383188|364162679|FG001|Overall Study|Lack of Efficacy|3|||
105590670|NCT00383188|364162680|FG002|Overall Study|Lack of Efficacy|3|||
105436603|NCT01532869|363604864|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
105590671|NCT00383188|364162681|FG003|Overall Study|Lack of Efficacy|2|||
105436604|NCT01532869|363604863|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
105436605|NCT01532869|363604864|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
105436606|NCT01532869|363604863|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
105436607|NCT01532869|363604864|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
105436608|NCT01532869|363604863|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
105436609|NCT01532869|363604864|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
105436610|NCT01532869|363604863|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
105436611|NCT01532869|363604864|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
105436612|NCT01532869|363604863|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
105436613|NCT01532869|363604864|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
105436614|NCT01532869|363604863|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
105436615|NCT01532869|363604864|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
105436616|NCT01532869|363604863|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
105436617|NCT01532869|363604864|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
105436618|NCT01532869|363604863|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
105436619|NCT01532869|363604864|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
105436620|NCT01532869|363604863|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
105436621|NCT01532869|363604864|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
105436622|NCT01532869|363604863|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
105436623|NCT01532869|363604864|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
105436624|NCT01532869|363604863|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
105436625|NCT01532869|363604864|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
105436626|NCT01026220|363604865|FG000|Induction|Death|1|||
105436627|NCT01026220|363604866|FG001|Induction|Death|0|||
105436628|NCT01026220|363604867|FG002|Induction|Death|0|||
105436629|NCT01026220|363604865|FG000|Induction|Lack of Efficacy|2|||
105436630|NCT01026220|363604866|FG001|Induction|Lack of Efficacy|0|||
105436631|NCT01026220|363604867|FG002|Induction|Lack of Efficacy|0|||
105436632|NCT01026220|363604865|FG000|Induction|Physician Decision|12|||
105436633|NCT01026220|363604866|FG001|Induction|Physician Decision|0|||
105436634|NCT01026220|363604867|FG002|Induction|Physician Decision|0|||
105436635|NCT01026220|363604865|FG000|Induction|Withdrawal by Subject|9|||
105436636|NCT01026220|363604866|FG001|Induction|Withdrawal by Subject|0|||
105436637|NCT01026220|363604867|FG002|Induction|Withdrawal by Subject|0|||
105436638|NCT01026220|363604865|FG000|Induction|Ineligible|1|||
105436639|NCT01026220|363604866|FG001|Induction|Ineligible|0|||
105436640|NCT01026220|363604867|FG002|Induction|Ineligible|0|||
105436641|NCT01026220|363604865|FG000|Consolidation Maintenance|Death|0|||
105436642|NCT01026220|363604866|FG001|Consolidation Maintenance|Death|1|||
105436643|NCT01026220|363604867|FG002|Consolidation Maintenance|Death|0|||
105436644|NCT01026220|363604865|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
105436645|NCT01026220|363604866|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
105436646|NCT01026220|363604867|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
105436647|NCT01026220|363604865|FG000|Consolidation Maintenance|Physician Decision|0|||
105436648|NCT01026220|363604866|FG001|Consolidation Maintenance|Physician Decision|2|||
105436649|NCT01026220|363604867|FG002|Consolidation Maintenance|Physician Decision|7|||
105436650|NCT01026220|363604865|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
105436651|NCT01026220|363604866|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
105436652|NCT01026220|363604867|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
105436653|NCT00409344|363604868|FG000|Overall Study|no enrollment|0|||
105436654|NCT00409344|363604869|FG001|Overall Study|no enrollment|0|||
105436655|NCT02683668|363604875|FG000|Period 2|Withdrawal by Subject|0|||
105436656|NCT02683668|363604876|FG001|Period 2|Withdrawal by Subject|1|||
105436657|NCT02683668|363604877|FG002|Period 2|Withdrawal by Subject|0|||
105436658|NCT01805037|363604878|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
105436659|NCT01805037|363604879|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
105436660|NCT01805037|363604878|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
105436661|NCT01805037|363604879|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
105436662|NCT01805037|363604878|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
105436663|NCT01805037|363604879|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
105436664|NCT01805037|363604878|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
105436665|NCT01805037|363604879|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
105436666|NCT01805037|363604878|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
105436667|NCT01805037|363604879|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
105436668|NCT01805037|363604878|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
105436669|NCT01805037|363604879|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
105436670|NCT01805037|363604878|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
105436671|NCT01805037|363604879|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
105436672|NCT01805037|363604878|FG000|Follow Up (up to 3 Years)|Death|0|||
105436673|NCT01805037|363604879|FG001|Follow Up (up to 3 Years)|Death|2|||
105436674|NCT01805037|363604878|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
105436675|NCT01805037|363604879|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
105436676|NCT01805037|363604878|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
105436677|NCT01805037|363604879|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
105436678|NCT00844558|363604880|FG000|Overall Study|Withdrawal by Subject|9|||
105436679|NCT00844558|363604881|FG001|Overall Study|Withdrawal by Subject|2|||
105436680|NCT00844558|363604880|FG000|Overall Study|Death|1|||
105436681|NCT00844558|363604881|FG001|Overall Study|Death|0|||
105436682|NCT00844558|363604880|FG000|Overall Study|Protocol Violation|1|||
105436683|NCT00844558|363604881|FG001|Overall Study|Protocol Violation|1|||
105436684|NCT00844558|363604880|FG000|Overall Study|Lost to Follow-up|0|||
105436685|NCT00844558|363604881|FG001|Overall Study|Lost to Follow-up|1|||
105436686|NCT00844558|363604880|FG000|Overall Study|Physician Decision|1|||
105436687|NCT00844558|363604881|FG001|Overall Study|Physician Decision|0|||
105436688|NCT01229449|363604882|FG000|Overall Study|Withdrawal by Subject|0|||
105436689|NCT01229449|363604883|FG001|Overall Study|Withdrawal by Subject|3|||
105436690|NCT01229449|363604884|FG002|Overall Study|Withdrawal by Subject|0|||
105436691|NCT01229449|363604885|FG003|Overall Study|Withdrawal by Subject|1|||
105436692|NCT01229449|363604886|FG004|Overall Study|Withdrawal by Subject|1|||
105436693|NCT01229449|363604882|FG000|Overall Study|Lost to Follow-up|1|||
105436694|NCT01229449|363604883|FG001|Overall Study|Lost to Follow-up|1|||
105436695|NCT01229449|363604884|FG002|Overall Study|Lost to Follow-up|1|||
105436696|NCT01229449|363604885|FG003|Overall Study|Lost to Follow-up|0|||
105436697|NCT01229449|363604886|FG004|Overall Study|Lost to Follow-up|0|||
105436698|NCT01229449|363604882|FG000|Overall Study|Physician Decision|0|||
105436699|NCT01229449|363604883|FG001|Overall Study|Physician Decision|0|||
105436700|NCT01229449|363604884|FG002|Overall Study|Physician Decision|1|||
105436701|NCT01229449|363604885|FG003|Overall Study|Physician Decision|0|||
105436702|NCT01229449|363604886|FG004|Overall Study|Physician Decision|0|||
105436703|NCT00410605|363604887|FG000|Overall Study|Adverse Event|12|||
105436704|NCT00410605|363604887|FG000|Overall Study|Physician Decision|3|||
105436705|NCT00410605|363604887|FG000|Overall Study|Withdrawal by Subject|5|||
105436706|NCT00410605|363604887|FG000|Overall Study|Started Non-Protocol Therapy|3|||
105436707|NCT00410605|363604887|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
105436708|NCT00410605|363604887|FG000|Overall Study|Transferred to another Institution|1|||
105436709|NCT02726022|363604893|FG000|Overall Study|Adverse Event|14|||
105436710|NCT02726022|363604893|FG000|Overall Study|Treatment Failure|8|||
105436711|NCT02726022|363604893|FG000|Overall Study|Poor Compliance|13|||
105436712|NCT02726022|363604893|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
105436713|NCT02220712|363604894|FG000|Overall Study|Adverse Event|1|||
105436714|NCT02220712|363604894|FG000|Overall Study|Withdrawal by Subject|2|||
105436715|NCT02220712|363604894|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
105436716|NCT00760838|363604896|FG000|Overall Study|Adverse Event|1|||
105436717|NCT00760838|363604897|FG001|Overall Study|Adverse Event|1|||
105436718|NCT00760838|363604896|FG000|Overall Study|Lack of Efficacy|1|||
105436719|NCT00760838|363604897|FG001|Overall Study|Lack of Efficacy|0|||
105436720|NCT00760838|363604896|FG000|Overall Study|Lost to Follow-up|2|||
105436721|NCT00760838|363604897|FG001|Overall Study|Lost to Follow-up|0|||
105436722|NCT00760838|363604896|FG000|Overall Study|Withdrawal by Subject|1|||
105436723|NCT00760838|363604897|FG001|Overall Study|Withdrawal by Subject|1|||
105436724|NCT01545050|363604900|FG000|Overall Study|Lack of Efficacy|0|||
105436725|NCT01545050|363604901|FG001|Overall Study|Lack of Efficacy|0|||
105436726|NCT01545050|363604902|FG002|Overall Study|Lack of Efficacy|0|||
105436727|NCT01545050|363604903|FG003|Overall Study|Lack of Efficacy|3|||
105436728|NCT01545050|363604904|FG004|Overall Study|Lack of Efficacy|2|||
105436729|NCT01545050|363604900|FG000|Overall Study|Adverse Event|1|||
105436730|NCT01545050|363604901|FG001|Overall Study|Adverse Event|1|||
105436731|NCT01545050|363604902|FG002|Overall Study|Adverse Event|2|||
105436732|NCT01545050|363604903|FG003|Overall Study|Adverse Event|2|||
105436733|NCT01545050|363604904|FG004|Overall Study|Adverse Event|0|||
105436734|NCT01545050|363604900|FG000|Overall Study|Discontinued study treatment|1|||
105436735|NCT01545050|363604901|FG001|Overall Study|Discontinued study treatment|0|||
105436736|NCT01545050|363604902|FG002|Overall Study|Discontinued study treatment|0|||
105436737|NCT01545050|363604903|FG003|Overall Study|Discontinued study treatment|0|||
105436738|NCT01545050|363604904|FG004|Overall Study|Discontinued study treatment|0|||
105436739|NCT01545050|363604900|FG000|Overall Study|Withdrawal by Subject|1|||
105436740|NCT01545050|363604901|FG001|Overall Study|Withdrawal by Subject|0|||
105436741|NCT01545050|363604902|FG002|Overall Study|Withdrawal by Subject|0|||
105436742|NCT01545050|363604903|FG003|Overall Study|Withdrawal by Subject|2|||
105436743|NCT01545050|363604904|FG004|Overall Study|Withdrawal by Subject|1|||
105436744|NCT01545050|363604900|FG000|Overall Study|Participant no longer meets study criteria|0|||
105436745|NCT01545050|363604901|FG001|Overall Study|Participant no longer meets study criteria|2|||
105436746|NCT01545050|363604902|FG002|Overall Study|Participant no longer meets study criteria|0|||
105436747|NCT01545050|363604903|FG003|Overall Study|Participant no longer meets study criteria|0|||
105436748|NCT01545050|363604904|FG004|Overall Study|Participant no longer meets study criteria|1|||
105436749|NCT01545050|363604900|FG000|Overall Study|Administrative reason by sponsor|4|||
105436750|NCT01545050|363604901|FG001|Overall Study|Administrative reason by sponsor|2|||
105436751|NCT01545050|363604902|FG002|Overall Study|Administrative reason by sponsor|3|||
105436752|NCT01545050|363604903|FG003|Overall Study|Administrative reason by sponsor|5|||
105436753|NCT01545050|363604904|FG004|Overall Study|Administrative reason by sponsor|5|||
105436754|NCT02607228|363604905|FG000|Overall Study|Progressive Disease|4|||
105436755|NCT02607228|363604906|FG001|Overall Study|Progressive Disease|3|||
105436756|NCT02607228|363604907|FG002|Overall Study|Progressive Disease|1|||
105436757|NCT02607228|363604908|FG003|Overall Study|Progressive Disease|5|||
105436758|NCT02607228|363604909|FG004|Overall Study|Progressive Disease|4|||
105436759|NCT02607228|363604910|FG005|Overall Study|Progressive Disease|3|||
105436760|NCT02607228|363604911|FG006|Overall Study|Progressive Disease|1|||
105436761|NCT02607228|363604905|FG000|Overall Study|Adverse Event|1|||
105436762|NCT02607228|363604906|FG001|Overall Study|Adverse Event|0|||
105436763|NCT02607228|363604907|FG002|Overall Study|Adverse Event|1|||
105436764|NCT02607228|363604908|FG003|Overall Study|Adverse Event|0|||
105436765|NCT02607228|363604909|FG004|Overall Study|Adverse Event|1|||
105436766|NCT02607228|363604910|FG005|Overall Study|Adverse Event|1|||
105436767|NCT02607228|363604911|FG006|Overall Study|Adverse Event|1|||
105436768|NCT02607228|363604905|FG000|Overall Study|Investigator's Discretion|0|||
105436769|NCT02607228|363604906|FG001|Overall Study|Investigator's Discretion|0|||
105436770|NCT02607228|363604907|FG002|Overall Study|Investigator's Discretion|1|||
105436771|NCT02607228|363604908|FG003|Overall Study|Investigator's Discretion|0|||
105436772|NCT02607228|363604909|FG004|Overall Study|Investigator's Discretion|0|||
105436773|NCT02607228|363604910|FG005|Overall Study|Investigator's Discretion|1|||
105436774|NCT02607228|363604911|FG006|Overall Study|Investigator's Discretion|0|||
105436775|NCT02607228|363604905|FG000|Overall Study|Withdrew Consent|0|||
105436776|NCT02607228|363604906|FG001|Overall Study|Withdrew Consent|1|||
105436777|NCT02607228|363604907|FG002|Overall Study|Withdrew Consent|0|||
105436778|NCT02607228|363604908|FG003|Overall Study|Withdrew Consent|0|||
105436779|NCT02607228|363604909|FG004|Overall Study|Withdrew Consent|0|||
105436780|NCT02607228|363604910|FG005|Overall Study|Withdrew Consent|1|||
105436781|NCT02607228|363604911|FG006|Overall Study|Withdrew Consent|0|||
105436782|NCT02607228|363604905|FG000|Overall Study|Study Terminated by Sponsor|0|||
105436783|NCT02607228|363604906|FG001|Overall Study|Study Terminated by Sponsor|0|||
105436784|NCT02607228|363604907|FG002|Overall Study|Study Terminated by Sponsor|0|||
105436785|NCT02607228|363604908|FG003|Overall Study|Study Terminated by Sponsor|1|||
105436786|NCT02607228|363604909|FG004|Overall Study|Study Terminated by Sponsor|0|||
105436787|NCT02607228|363604910|FG005|Overall Study|Study Terminated by Sponsor|0|||
105436788|NCT02607228|363604911|FG006|Overall Study|Study Terminated by Sponsor|0|||
105436789|NCT03235089|363604918|FG000|Overall Study|Lost to Follow-up|1|||
105436790|NCT03235089|363604919|FG001|Overall Study|Lost to Follow-up|1|||
105436791|NCT03235089|363604918|FG000|Overall Study|Physician Decision|2|||
105436792|NCT03235089|363604919|FG001|Overall Study|Physician Decision|2|||
105436793|NCT03576716|363604923|FG000|Overall Study|Withdrawal by Subject|0|||
105436794|NCT03576716|363604924|FG001|Overall Study|Withdrawal by Subject|1|||
105436795|NCT02249182|363604925|FG000|Treatment Phase|Lost to Follow-up|4|||
105436796|NCT02249182|363604926|FG001|Treatment Phase|Lost to Follow-up|0|||
105436797|NCT02249182|363604927|FG002|Treatment Phase|Lost to Follow-up|0|||
105436798|NCT02249182|363604928|FG003|Treatment Phase|Lost to Follow-up|0|||
105436799|NCT02249182|363604929|FG004|Treatment Phase|Lost to Follow-up|0|||
105436800|NCT02188849|363604932|FG000|Overall Study|Lost to Follow-up|3|||
105436801|NCT02188849|363604933|FG001|Overall Study|Lost to Follow-up|8|||
105436802|NCT03916484|363604934|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
105436803|NCT03916484|363604935|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
105436804|NCT03916484|363604936|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
105436805|NCT03916484|363604937|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
105436806|NCT03916484|363604934|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
105436807|NCT03916484|363604935|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
105436808|NCT03916484|363604936|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
105436809|NCT03916484|363604937|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
105436810|NCT00504894|363604944|FG000|Overall Study|fMRI technical problems|1|||
105436811|NCT00504894|363604945|FG001|Overall Study|fMRI technical problems|1|||
105436812|NCT00504894|363604946|FG002|Overall Study|fMRI technical problems|0|||
105436813|NCT00504894|363604944|FG000|Overall Study|Withdrawal by Subject|0|||
105436814|NCT00504894|363604945|FG001|Overall Study|Withdrawal by Subject|1|||
105436815|NCT00504894|363604946|FG002|Overall Study|Withdrawal by Subject|0|||
105436816|NCT00504894|363604944|FG000|Overall Study|Infusion technical problems|0|||
105436817|NCT00504894|363604945|FG001|Overall Study|Infusion technical problems|1|||
105436818|NCT00504894|363604946|FG002|Overall Study|Infusion technical problems|0|||
105436819|NCT00504894|363604944|FG000|Overall Study|poor subject data|2|||
105436820|NCT00504894|363604945|FG001|Overall Study|poor subject data|0|||
105436821|NCT00504894|363604946|FG002|Overall Study|poor subject data|0|||
105436822|NCT04378114|363604948|FG000|Overall Study|Withdrawal by Subject|5|||
105436823|NCT01364389|363604949|FG000|Overall Study|Withdrawal by Subject|0|||
105436824|NCT01364389|363604950|FG001|Overall Study|Withdrawal by Subject|1|||
105436825|NCT01364389|363604951|FG002|Overall Study|Withdrawal by Subject|0|||
105436826|NCT01364389|363604949|FG000|Overall Study|Protocol deviation|0|||
105436827|NCT01364389|363604950|FG001|Overall Study|Protocol deviation|0|||
105436828|NCT01364389|363604951|FG002|Overall Study|Protocol deviation|1|||
105436829|NCT01364389|363604949|FG000|Overall Study|Administrative problems|1|||
105436830|NCT01364389|363604950|FG001|Overall Study|Administrative problems|0|||
105436831|NCT01364389|363604951|FG002|Overall Study|Administrative problems|0|||
105436832|NCT01364389|363604949|FG000|Overall Study|Adverse Event|1|||
105436833|NCT01364389|363604950|FG001|Overall Study|Adverse Event|0|||
105436834|NCT01364389|363604951|FG002|Overall Study|Adverse Event|0|||
105436835|NCT00765063|363607020|FG000|Overall Study|Lack of Efficacy|5|||
105436836|NCT00765063|363607020|FG000|Overall Study|Withdrawal by Subject|1|||
105436837|NCT00765063|363607020|FG000|Overall Study|Other|16|||
105436838|NCT00765063|363607020|FG000|Overall Study|Protocol Violation|6|||
105436839|NCT00765063|363607020|FG000|Overall Study|Adverse Event|4|||
105436840|NCT03614325|363607021|FG000|Overall Study|Withdrawal by Subject|0|||
105436841|NCT03614325|363607022|FG001|Overall Study|Withdrawal by Subject|2|||
105436842|NCT03614325|363607021|FG000|Overall Study|Surgery Cancelled|2|||
105436843|NCT03614325|363607022|FG001|Overall Study|Surgery Cancelled|1|||
105436844|NCT03614325|363607021|FG000|Overall Study|Lost to Follow-up|2|||
105436845|NCT03614325|363607022|FG001|Overall Study|Lost to Follow-up|1|||
105436846|NCT03614325|363607021|FG000|Overall Study|Surgery never scheduled|1|||
105436847|NCT03614325|363607022|FG001|Overall Study|Surgery never scheduled|0|||
105436848|NCT00321464|363607023|FG000|Overall Study|Death|169|||
105436849|NCT00321464|363607024|FG001|Overall Study|Death|174|||
105436850|NCT00321464|363607023|FG000|Overall Study|Disease progression|124|||
105436851|NCT00321464|363607024|FG001|Overall Study|Disease progression|124|||
105436852|NCT00321464|363607023|FG000|Overall Study|Withdrawal by Subject|117|||
105436853|NCT00321464|363607024|FG001|Overall Study|Withdrawal by Subject|118|||
105436854|NCT00321464|363607023|FG000|Overall Study|Participant request|57|||
105436855|NCT00321464|363607024|FG001|Overall Study|Participant request|61|||
105436856|NCT00321464|363607023|FG000|Overall Study|Adverse Event|43|||
105436857|NCT00321464|363607024|FG001|Overall Study|Adverse Event|28|||
105436858|NCT00321464|363607023|FG000|Overall Study|Physician Decision|15|||
105436859|NCT00321464|363607024|FG001|Overall Study|Physician Decision|14|||
105436860|NCT00321464|363607023|FG000|Overall Study|Noncompliance|4|||
105436861|NCT00321464|363607024|FG001|Overall Study|Noncompliance|10|||
105436862|NCT00321464|363607023|FG000|Overall Study|Lost to Follow-up|7|||
105436863|NCT00321464|363607024|FG001|Overall Study|Lost to Follow-up|8|||
105436864|NCT00321464|363607023|FG000|Overall Study|Protocol deviation|0|||
105436865|NCT00321464|363607024|FG001|Overall Study|Protocol deviation|2|||
105436866|NCT00321464|363607023|FG000|Overall Study|Ineligibility determined|2|||
105436867|NCT00321464|363607024|FG001|Overall Study|Ineligibility determined|1|||
105436868|NCT00321464|363607023|FG000|Overall Study|Other|21|||
105436869|NCT00321464|363607024|FG001|Overall Study|Other|18|||
105436870|NCT00652951|363607025|FG000|Booster Phase|Adverse event, non-fatal|0|||
105436871|NCT00652951|363607026|FG001|Booster Phase|Adverse event, non-fatal|1|||
105436872|NCT00652951|363607027|FG002|Booster Phase|Adverse event, non-fatal|0|||
105436873|NCT00652951|363607025|FG000|Booster Phase|Other|1|||
105436874|NCT00652951|363607026|FG001|Booster Phase|Other|0|||
105436875|NCT00652951|363607027|FG002|Booster Phase|Other|0|||
105436876|NCT01754493|363607028|FG000|Overall Study|Adverse Event|1|||
105436877|NCT01754493|363607028|FG000|Overall Study|Lost to Follow-up|3|||
105436878|NCT01754493|363607028|FG000|Overall Study|Withdrawal by Subject|1|||
105436879|NCT01754493|363607028|FG000|Overall Study|Moved out of town|1|||
105436880|NCT01754493|363607028|FG000|Overall Study|Scheduling conflict|1|||
105436881|NCT02489942|363607029|FG000|Overall Study|Request by patient|602|||
105436882|NCT02489942|363607029|FG000|Overall Study|Improvement/remission|157|||
105436883|NCT02489942|363607029|FG000|Overall Study|No change/Progressive disease|263|||
105436884|NCT02489942|363607029|FG000|Overall Study|Adverse Event|522|||
105436885|NCT02489942|363607029|FG000|Overall Study|Other personal reasons|1218|||
105436886|NCT02489942|363607029|FG000|Overall Study|Lost to Follow-up|456|||
105436887|NCT02489942|363607029|FG000|Overall Study|Not continuously investigated|7|||
105436888|NCT02489942|363607029|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
105436889|NCT02489942|363607029|FG000|Overall Study|Multiple registration|1|||
105436890|NCT02489942|363607029|FG000|Overall Study|No patient visit after entry|100|||
105436891|NCT02489942|363607029|FG000|Overall Study|No treatment with Jardiance|2|||
105436892|NCT02489942|363607029|FG000|Overall Study|Patient received Jardiance before registration|1|||
105436893|NCT02489942|363607029|FG000|Overall Study|No CRF collected|86|||
105436894|NCT00858208|363607030|FG000|Overall Study|Adverse Event|3|||
105436895|NCT00858208|363607030|FG000|Overall Study|Lost to Follow-up|26|||
105436896|NCT00858208|363607030|FG000|Overall Study|Participant refused|40|||
105436897|NCT00858208|363607030|FG000|Overall Study|Other|10|||
105590672|NCT00383188|364162682|FG004|Overall Study|Lack of Efficacy|6|||
105590673|NCT00383188|364162678|FG000|Overall Study|Other|3|||
105590674|NCT00383188|364162679|FG001|Overall Study|Other|1|||
105436898|NCT02702180|363607031|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
105436899|NCT02702180|363607032|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
105436900|NCT02702180|363607033|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105436901|NCT02702180|363607031|FG000|Double-blind Treatment Period|Adverse Event|0|||
105436902|NCT02702180|363607032|FG001|Double-blind Treatment Period|Adverse Event|0|||
105590675|NCT00383188|364162680|FG002|Overall Study|Other|0|||
105436903|NCT02702180|363607033|FG002|Double-blind Treatment Period|Adverse Event|1|||
105436904|NCT02702180|363607031|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
105436905|NCT02702180|363607032|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
105436906|NCT02702180|363607033|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
105436907|NCT02702180|363607031|FG000|Double-blind Treatment Period|Protocol Violation|0|||
105436908|NCT02702180|363607032|FG001|Double-blind Treatment Period|Protocol Violation|0|||
105436909|NCT02702180|363607033|FG002|Double-blind Treatment Period|Protocol Violation|2|||
105436910|NCT02702180|363607031|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
105436911|NCT02702180|363607032|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
105436912|NCT02702180|363607033|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
105436913|NCT02702180|363607031|FG000|Open-label Treatment Period|Withdrawn in error|0|||
105436914|NCT02702180|363607032|FG001|Open-label Treatment Period|Withdrawn in error|0|||
105436915|NCT02702180|363607033|FG002|Open-label Treatment Period|Withdrawn in error|1|||
105436916|NCT01393639|363607034|FG000|Overall Study|Protocol Violation|0|||
105436917|NCT01393639|363607035|FG001|Overall Study|Protocol Violation|0|||
105436918|NCT01393639|363607036|FG002|Overall Study|Protocol Violation|0|||
105436919|NCT01393639|363607037|FG003|Overall Study|Protocol Violation|1|||
105436920|NCT01393639|363607038|FG004|Overall Study|Protocol Violation|0|||
105436921|NCT01393639|363607039|FG005|Overall Study|Protocol Violation|0|||
105436922|NCT01393639|363607040|FG006|Overall Study|Protocol Violation|0|||
105436923|NCT01393639|363607034|FG000|Overall Study|Other|0|||
105436924|NCT01393639|363607035|FG001|Overall Study|Other|2|||
105436925|NCT01393639|363607036|FG002|Overall Study|Other|0|||
105436926|NCT01393639|363607037|FG003|Overall Study|Other|2|||
105436927|NCT01393639|363607038|FG004|Overall Study|Other|1|||
105436928|NCT01393639|363607039|FG005|Overall Study|Other|0|||
105436929|NCT01393639|363607040|FG006|Overall Study|Other|1|||
105436930|NCT01393639|363607034|FG000|Overall Study|Withdrawal by Subject|1|||
105436931|NCT01393639|363607035|FG001|Overall Study|Withdrawal by Subject|1|||
105436932|NCT01393639|363607036|FG002|Overall Study|Withdrawal by Subject|0|||
105436933|NCT01393639|363607037|FG003|Overall Study|Withdrawal by Subject|0|||
105436934|NCT01393639|363607038|FG004|Overall Study|Withdrawal by Subject|0|||
105436935|NCT01393639|363607039|FG005|Overall Study|Withdrawal by Subject|0|||
105436936|NCT01393639|363607040|FG006|Overall Study|Withdrawal by Subject|1|||
105436937|NCT01393639|363607034|FG000|Overall Study|Medication error without associated AE|0|||
105436938|NCT01393639|363607035|FG001|Overall Study|Medication error without associated AE|0|||
105436939|NCT01393639|363607036|FG002|Overall Study|Medication error without associated AE|0|||
105436940|NCT01393639|363607037|FG003|Overall Study|Medication error without associated AE|0|||
105436941|NCT01393639|363607038|FG004|Overall Study|Medication error without associated AE|0|||
105436942|NCT01393639|363607039|FG005|Overall Study|Medication error without associated AE|0|||
105436943|NCT01393639|363607040|FG006|Overall Study|Medication error without associated AE|1|||
105436944|NCT01393639|363607034|FG000|Overall Study|Lost to Follow-up|0|||
105436945|NCT01393639|363607035|FG001|Overall Study|Lost to Follow-up|1|||
105436946|NCT01393639|363607036|FG002|Overall Study|Lost to Follow-up|0|||
105436947|NCT01393639|363607037|FG003|Overall Study|Lost to Follow-up|0|||
105436948|NCT01393639|363607038|FG004|Overall Study|Lost to Follow-up|0|||
105436949|NCT01393639|363607039|FG005|Overall Study|Lost to Follow-up|0|||
105436950|NCT01393639|363607040|FG006|Overall Study|Lost to Follow-up|1|||
105436951|NCT01393639|363607034|FG000|Overall Study|Lack of Efficacy|0|||
105436952|NCT01393639|363607035|FG001|Overall Study|Lack of Efficacy|0|||
105436953|NCT01393639|363607036|FG002|Overall Study|Lack of Efficacy|0|||
105436954|NCT01393639|363607037|FG003|Overall Study|Lack of Efficacy|0|||
105436955|NCT01393639|363607038|FG004|Overall Study|Lack of Efficacy|0|||
105436956|NCT01393639|363607039|FG005|Overall Study|Lack of Efficacy|0|||
105436957|NCT01393639|363607040|FG006|Overall Study|Lack of Efficacy|1|||
105436958|NCT01393639|363607034|FG000|Overall Study|Adverse Event|2|||
105436959|NCT01393639|363607035|FG001|Overall Study|Adverse Event|3|||
105436960|NCT01393639|363607036|FG002|Overall Study|Adverse Event|1|||
105436961|NCT01393639|363607037|FG003|Overall Study|Adverse Event|2|||
105436962|NCT01393639|363607038|FG004|Overall Study|Adverse Event|0|||
105436963|NCT01393639|363607039|FG005|Overall Study|Adverse Event|2|||
105436964|NCT01393639|363607040|FG006|Overall Study|Adverse Event|3|||
105436965|NCT00372697|363607052|FG000|Overall Study|Protocol Violation|1|||
105436966|NCT00372697|363607053|FG001|Overall Study|Protocol Violation|1|||
105436967|NCT03221842|363607054|FG000|Period 1 (Open-label)|Adverse Event|4|||
105436968|NCT03221842|363607055|FG001|Period 1 (Open-label)|Adverse Event|0|||
105436969|NCT03221842|363607054|FG000|Period 1 (Open-label)|Physician Decision|2|||
105436970|NCT03221842|363607055|FG001|Period 1 (Open-label)|Physician Decision|0|||
105436971|NCT03221842|363607054|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
105436972|NCT03221842|363607055|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
105436973|NCT03221842|363607054|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
105436974|NCT03221842|363607055|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
105436975|NCT03221842|363607054|FG000|Period 1 (Open-label)|Other|2|||
105436976|NCT03221842|363607055|FG001|Period 1 (Open-label)|Other|0|||
105436977|NCT03221842|363607054|FG000|Period 2 (Randomized, Blinded)|Death|0|||
105436978|NCT03221842|363607055|FG001|Period 2 (Randomized, Blinded)|Death|1|||
105503336|NCT01133522|363852892|FG006|Overall Study|Withdrawal by Subject|0|||
105503337|NCT01133522|363852893|FG007|Overall Study|Withdrawal by Subject|0|||
105503338|NCT01133522|363852894|FG008|Overall Study|Withdrawal by Subject|0|||
105503339|NCT01133522|363852895|FG009|Overall Study|Withdrawal by Subject|0|||
105503340|NCT01133522|363852886|FG000|Overall Study|Physician Decision|0|||
105503341|NCT01133522|363852887|FG001|Overall Study|Physician Decision|0|||
105503342|NCT01133522|363852888|FG002|Overall Study|Physician Decision|0|||
105503343|NCT01133522|363852889|FG003|Overall Study|Physician Decision|0|||
105503344|NCT01133522|363852890|FG004|Overall Study|Physician Decision|1|||
105503345|NCT01133522|363852891|FG005|Overall Study|Physician Decision|0|||
105436979|NCT03221842|363607054|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
105436980|NCT03221842|363607055|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
105436981|NCT02504580|363607057|FG000|Overall Study|Other|1|||
105436982|NCT02504580|363607058|FG001|Overall Study|Other|0|||
105436983|NCT02504580|363607059|FG002|Overall Study|Other|0|||
105436984|NCT02504580|363607060|FG003|Overall Study|Other|2|||
105436985|NCT02504580|363607061|FG004|Overall Study|Other|1|||
105436986|NCT02504580|363607062|FG005|Overall Study|Other|1|||
105436987|NCT02504580|363607063|FG006|Overall Study|Other|1|||
105436988|NCT02504580|363607064|FG007|Overall Study|Other|2|||
105436989|NCT02504580|363607065|FG008|Overall Study|Other|0|||
105436990|NCT02504580|363607066|FG009|Overall Study|Other|0|||
105436991|NCT02504580|363607067|FG010|Overall Study|Other|0|||
105436992|NCT02504580|363607068|FG011|Overall Study|Other|2|||
105436993|NCT02504580|363607057|FG000|Overall Study|Subject refusal to continue|0|||
105436994|NCT02504580|363607058|FG001|Overall Study|Subject refusal to continue|1|||
105436995|NCT02504580|363607059|FG002|Overall Study|Subject refusal to continue|0|||
105436996|NCT02504580|363607060|FG003|Overall Study|Subject refusal to continue|0|||
105436997|NCT02504580|363607061|FG004|Overall Study|Subject refusal to continue|0|||
105436998|NCT02504580|363607062|FG005|Overall Study|Subject refusal to continue|0|||
105436999|NCT02504580|363607063|FG006|Overall Study|Subject refusal to continue|0|||
105437000|NCT02504580|363607064|FG007|Overall Study|Subject refusal to continue|0|||
105437001|NCT02504580|363607065|FG008|Overall Study|Subject refusal to continue|0|||
105437002|NCT02504580|363607066|FG009|Overall Study|Subject refusal to continue|0|||
105437003|NCT02504580|363607067|FG010|Overall Study|Subject refusal to continue|0|||
105437004|NCT02504580|363607068|FG011|Overall Study|Subject refusal to continue|0|||
105437005|NCT00704288|363607069|FG000|Overall Treatment Period|Adverse Event|11|||
105437006|NCT00704288|363607070|FG001|Overall Treatment Period|Adverse Event|8|||
105437007|NCT00704288|363607071|FG002|Overall Treatment Period|Adverse Event|22|||
105437008|NCT00704288|363607069|FG000|Overall Treatment Period|Death|0|||
105437009|NCT00704288|363607070|FG001|Overall Treatment Period|Death|0|||
105437010|NCT00704288|363607071|FG002|Overall Treatment Period|Death|1|||
105437011|NCT00704288|363607069|FG000|Overall Treatment Period|Physician Decision|0|||
105437012|NCT00704288|363607070|FG001|Overall Treatment Period|Physician Decision|2|||
105437013|NCT00704288|363607071|FG002|Overall Treatment Period|Physician Decision|0|||
105437014|NCT00704288|363607069|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
105437015|NCT00704288|363607070|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
105437016|NCT00704288|363607071|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
105437017|NCT00704288|363607069|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
105437018|NCT00704288|363607070|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
105437019|NCT00704288|363607071|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
105437020|NCT00704288|363607069|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
105437021|NCT00704288|363607070|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
105437022|NCT00704288|363607071|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
105437023|NCT00704288|363607069|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
105437024|NCT00704288|363607070|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
105437025|NCT00704288|363607071|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
105437026|NCT00704288|363607069|FG000|Overall Treatment Period|Roll-over to another study|1|||
105437027|NCT00704288|363607070|FG001|Overall Treatment Period|Roll-over to another study|0|||
105437028|NCT00704288|363607071|FG002|Overall Treatment Period|Roll-over to another study|4|||
105437029|NCT00704288|363607069|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
105437030|NCT00704288|363607070|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
105437031|NCT00704288|363607071|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
105437032|NCT00704288|363607069|FG000|Extended Post Treatment Follow Up Period|Death|41|||
105437033|NCT00704288|363607070|FG001|Extended Post Treatment Follow Up Period|Death|50|||
105437034|NCT00704288|363607071|FG002|Extended Post Treatment Follow Up Period|Death|93|||
105437035|NCT00704288|363607069|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
105437036|NCT00704288|363607070|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
105437037|NCT00704288|363607071|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
105503346|NCT01133522|363852892|FG006|Overall Study|Physician Decision|0|||
105503347|NCT01133522|363852893|FG007|Overall Study|Physician Decision|0|||
105437038|NCT00704288|363607069|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
105437039|NCT00704288|363607070|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
105437040|NCT00704288|363607071|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
105437041|NCT00704288|363607069|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
105503348|NCT01133522|363852894|FG008|Overall Study|Physician Decision|0|||
105503349|NCT01133522|363852895|FG009|Overall Study|Physician Decision|0|||
105503350|NCT00688753|363854273|FG000|Overall Study|Disease progression|55|||
105503351|NCT00688753|363854273|FG000|Overall Study|Missing|1|||
105503352|NCT00688753|363854273|FG000|Overall Study|Death|9|||
105503353|NCT00688753|363854273|FG000|Overall Study|Withdrawal by Subject|3|||
105503354|NCT00688753|363854273|FG000|Overall Study|Adverse Event|20|||
105503355|NCT00688753|363854273|FG000|Overall Study|Protocol Violation|1|||
105503356|NCT00688753|363854273|FG000|Overall Study|Lost to Follow-up|3|||
105503357|NCT05996718|363854274|FG000|Overall Study|Lost to Follow-up|3|||
105503358|NCT06956170|363854275|FG000|Overall Study|Death|2|||
105503359|NCT06956170|363854276|FG001|Overall Study|Death|1|||
105503360|NCT06956170|363854275|FG000|Overall Study|Withdrawal by Subject|1|||
105503361|NCT06956170|363854276|FG001|Overall Study|Withdrawal by Subject|0|||
105503362|NCT06956170|363854275|FG000|Overall Study|Ongoing|7|||
105503363|NCT06956170|363854276|FG001|Overall Study|Ongoing|10|||
105503364|NCT03281577|363854277|FG000|Overall Study|Adverse Event|0|||
105503365|NCT03281577|363854278|FG001|Overall Study|Adverse Event|0|||
105503366|NCT03281577|363854279|FG002|Overall Study|Adverse Event|0|||
105503367|NCT03281577|363854280|FG003|Overall Study|Adverse Event|1|||
105503368|NCT03281577|363854277|FG000|Overall Study|Withdrawal by Subject|1|||
105503369|NCT03281577|363854278|FG001|Overall Study|Withdrawal by Subject|0|||
105503370|NCT03281577|363854279|FG002|Overall Study|Withdrawal by Subject|0|||
105503371|NCT03281577|363854280|FG003|Overall Study|Withdrawal by Subject|0|||
105503372|NCT01606800|363854281|FG000|Overall Study|Adverse Event|3|||
105503373|NCT01606800|363854282|FG001|Overall Study|Adverse Event|1|||
105503374|NCT01606800|363854281|FG000|Overall Study|Participant withdrew consent|0|||
105503375|NCT01606800|363854282|FG001|Overall Study|Participant withdrew consent|1|||
105503376|NCT01606800|363854281|FG000|Overall Study|Missing completion status|2|||
105503377|NCT01606800|363854282|FG001|Overall Study|Missing completion status|0|||
105503378|NCT01687998|363854283|FG000|Overall Study|Withdrawal by Subject|49|||
105503379|NCT01687998|363854284|FG001|Overall Study|Withdrawal by Subject|51|||
105503380|NCT01687998|363854283|FG000|Overall Study|Known to be Alive at Study End|54|||
105503381|NCT01687998|363854284|FG001|Overall Study|Known to be Alive at Study End|62|||
105437042|NCT00704288|363607070|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
105437043|NCT00704288|363607071|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
105437044|NCT01055314|363607072|FG000|Overall Study|Adverse Event|7|||
105437045|NCT01055314|363607073|FG001|Overall Study|Adverse Event|4|||
105437046|NCT01055314|363607072|FG000|Overall Study|Death|2|||
105437047|NCT01055314|363607073|FG001|Overall Study|Death|1|||
105437048|NCT01055314|363607072|FG000|Overall Study|Lack of Efficacy|11|||
105437049|NCT01055314|363607073|FG001|Overall Study|Lack of Efficacy|19|||
105437050|NCT01055314|363607072|FG000|Overall Study|Physician Decision|10|||
105437051|NCT01055314|363607073|FG001|Overall Study|Physician Decision|5|||
105437052|NCT01055314|363607072|FG000|Overall Study|Withdrawal by Subject|1|||
105437053|NCT01055314|363607073|FG001|Overall Study|Withdrawal by Subject|0|||
105437054|NCT01055314|363607072|FG000|Overall Study|Ineligible|3|||
105437055|NCT01055314|363607073|FG001|Overall Study|Ineligible|5|||
105437056|NCT01055314|363607072|FG000|Overall Study|Refusal of further protocol therapy|10|||
105437057|NCT01055314|363607073|FG001|Overall Study|Refusal of further protocol therapy|4|||
105437058|NCT01055314|363607072|FG000|Overall Study|No treatment|1|||
105437059|NCT01055314|363607073|FG001|Overall Study|No treatment|0|||
105437060|NCT02462720|363607074|FG000|Part 2|Withdrawal by Subject|1|||
105437061|NCT02462720|363607075|FG001|Part 2|Withdrawal by Subject|0|||
105437062|NCT02462720|363607074|FG000|Part 2|Protocol Violation|0|||
105437063|NCT02462720|363607075|FG001|Part 2|Protocol Violation|1|||
105503382|NCT01687998|363854283|FG000|Overall Study|Lost to Follow-up|9|||
105503383|NCT01687998|363854284|FG001|Overall Study|Lost to Follow-up|7|||
105437064|NCT00527982|363607078|FG000|Overall Study|Physician Decision|1|||
105437065|NCT00527982|363607079|FG001|Overall Study|Physician Decision|0|||
105437066|NCT04680975|363607090|FG000|Overall Study|Adverse Event|3|||
105590676|NCT00383188|364162681|FG003|Overall Study|Other|2|||
105437067|NCT04680975|363607090|FG000|Overall Study|Death|1|||
105437068|NCT04680975|363607090|FG000|Overall Study|Progressive Disease|1|||
105437069|NCT04680975|363607090|FG000|Overall Study|Withdrawal by Subject|1|||
105437070|NCT01192412|363607091|FG000|Overall Study|Lost to Follow-up|2|||
105437071|NCT01192412|363607092|FG001|Overall Study|Lost to Follow-up|1|||
105503384|NCT00717197|363854287|FG000|Overall Study|Unable to purchase study drug|5|||
105503385|NCT00717197|363854287|FG000|Overall Study|Tumor Progression|1|||
105503386|NCT00717197|363854287|FG000|Overall Study|Physician Decision|1|||
105503387|NCT00443261|363854288|FG000|Overall Study|Death|1|||
105503388|NCT01594281|363854293|FG000|Interventional Core Phase|Protocol Deviation|1|||
105503389|NCT01594281|363854294|FG001|Interventional Core Phase|Protocol Deviation|0|||
105503390|NCT01594281|363854295|FG002|Interventional Core Phase|Protocol Deviation|0|||
105503391|NCT01594281|363854293|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
105503392|NCT01594281|363854294|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
105503393|NCT01594281|363854295|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
105503394|NCT01594281|363854293|FG000|Interventional Core Phase|Death|1|||
105503395|NCT01594281|363854294|FG001|Interventional Core Phase|Death|1|||
105503396|NCT01594281|363854295|FG002|Interventional Core Phase|Death|2|||
105503397|NCT01594281|363854293|FG000|Interventional Core Phase|Lost to Follow-up|1|||
105503398|NCT01594281|363854294|FG001|Interventional Core Phase|Lost to Follow-up|4|||
105503399|NCT01594281|363854295|FG002|Interventional Core Phase|Lost to Follow-up|1|||
105503400|NCT01594281|363854293|FG000|Interventional Core Phase|Adverse Event|4|||
105503401|NCT01594281|363854294|FG001|Interventional Core Phase|Adverse Event|4|||
105503402|NCT01594281|363854295|FG002|Interventional Core Phase|Adverse Event|4|||
105503403|NCT01594281|363854293|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
105503404|NCT01594281|363854294|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
105503405|NCT01594281|363854295|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
105503406|NCT01594281|363854293|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
105503407|NCT01594281|363854294|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
105503408|NCT01594281|363854295|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
105503409|NCT01594281|363854293|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
105503410|NCT01594281|363854294|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
105503411|NCT01594281|363854295|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
105503412|NCT01947582|363854301|FG000|Overall Study|Withdrawal by Subject|1|||
105437072|NCT01192412|363607091|FG000|Overall Study|Withdrawal by Subject|2|||
105437073|NCT01192412|363607092|FG001|Overall Study|Withdrawal by Subject|1|||
105437074|NCT01359943|363607093|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
105437075|NCT01359943|363607094|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
105437076|NCT01359943|363607095|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
105437077|NCT01359943|363607093|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
105437078|NCT01359943|363607094|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
105437079|NCT01359943|363607095|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
105437080|NCT01359943|363607093|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
105437081|NCT01359943|363607094|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
105437082|NCT01359943|363607095|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
105437083|NCT01359943|363607093|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
105437084|NCT01359943|363607094|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
105437085|NCT01359943|363607095|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
105437086|NCT01359943|363607093|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
105437087|NCT01359943|363607094|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
105437088|NCT01359943|363607095|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
105437089|NCT01359943|363607093|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
105437090|NCT01359943|363607094|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
105437091|NCT01359943|363607095|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
105437092|NCT01359943|363607093|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
105437093|NCT01359943|363607094|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
105437094|NCT01359943|363607095|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
105437095|NCT01359943|363607093|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
105437096|NCT01359943|363607094|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
105437097|NCT01359943|363607095|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
105437098|NCT01359943|363607093|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
105437099|NCT01359943|363607094|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
105437100|NCT01359943|363607095|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
105437101|NCT01359943|363607093|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
105437102|NCT01359943|363607094|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
105437103|NCT01359943|363607095|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
105437104|NCT01359943|363607093|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
105437105|NCT01359943|363607094|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
105437106|NCT01359943|363607095|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
105437107|NCT01359943|363607093|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
105437108|NCT01359943|363607094|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
105437109|NCT01359943|363607095|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
105437110|NCT01359943|363607093|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
105437111|NCT01359943|363607094|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
105437112|NCT01359943|363607095|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
105437113|NCT01359943|363607093|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
105503413|NCT03019185|363854302|FG000|Overall Study|Lost to Follow-up|3|||
105503414|NCT03019185|363854303|FG001|Overall Study|Lost to Follow-up|0|||
105437114|NCT01359943|363607094|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
105437115|NCT01359943|363607095|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
105437116|NCT01359943|363607093|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
105437117|NCT01359943|363607094|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
105437118|NCT01359943|363607095|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
105437119|NCT01329939|363607100|FG000|Overall Study|Lost to Follow-up|3|||
105437120|NCT01329939|363607101|FG001|Overall Study|Lost to Follow-up|0|||
105437121|NCT01329939|363607102|FG002|Overall Study|Lost to Follow-up|1|||
105437122|NCT01329939|363607103|FG003|Overall Study|Lost to Follow-up|2|||
105437123|NCT01329939|363607100|FG000|Overall Study|Withdrawal by Subject|0|||
105437124|NCT01329939|363607101|FG001|Overall Study|Withdrawal by Subject|1|||
105437125|NCT01329939|363607102|FG002|Overall Study|Withdrawal by Subject|0|||
105437126|NCT01329939|363607103|FG003|Overall Study|Withdrawal by Subject|0|||
105437127|NCT01329939|363607100|FG000|Overall Study|Adverse Event|0|||
105437128|NCT01329939|363607101|FG001|Overall Study|Adverse Event|0|||
105437129|NCT01329939|363607102|FG002|Overall Study|Adverse Event|0|||
105437130|NCT01329939|363607103|FG003|Overall Study|Adverse Event|3|||
105437131|NCT00320424|363607104|FG000|Overall Study|Adverse Event|3|||
105437132|NCT00320424|363607104|FG000|Overall Study|Other|3|||
105437133|NCT02942485|363607105|FG000|Overall Study|Lost to Follow-up|1|||
105437134|NCT02942485|363607106|FG001|Overall Study|Lost to Follow-up|0|||
105437135|NCT00989963|363607107|FG000|Overall Study|Adverse Event|1|||
105437136|NCT00989963|363607108|FG001|Overall Study|Adverse Event|1|||
105437137|NCT00989963|363607109|FG002|Overall Study|Adverse Event|1|||
105437138|NCT01240200|363607114|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
105437139|NCT01240200|363607115|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
105437140|NCT00719680|363607117|FG000|Overall Study|Adverse Event|1|||
105437141|NCT00719680|363607117|FG000|Overall Study|Lost to Follow-up|1|||
105437142|NCT00719680|363607117|FG000|Overall Study|Withdrawal by Subject|3|||
105437143|NCT02540668|363607118|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
105437144|NCT02540668|363607119|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
105437145|NCT03270891|363607120|FG000|Overall Study|Lost to Follow-up|3|||
105437146|NCT03270891|363607121|FG001|Overall Study|Lost to Follow-up|6|||
105437147|NCT03270891|363607122|FG002|Overall Study|Lost to Follow-up|0|||
105437148|NCT03270891|363607120|FG000|Overall Study|Withdrawal by Subject|1|||
105437149|NCT03270891|363607121|FG001|Overall Study|Withdrawal by Subject|0|||
105437150|NCT03270891|363607122|FG002|Overall Study|Withdrawal by Subject|0|||
105437151|NCT03270891|363607120|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
105437152|NCT03270891|363607121|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
105437153|NCT03270891|363607122|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
105437154|NCT04071158|363607124|FG000|Overall Study|Lost to Follow-up|1|||
105437155|NCT04071158|363607125|FG001|Overall Study|Lost to Follow-up|2|||
105437156|NCT04071158|363607126|FG002|Overall Study|Lost to Follow-up|3|||
105437157|NCT04071158|363607127|FG003|Overall Study|Lost to Follow-up|3|||
105437158|NCT04071158|363607128|FG004|Overall Study|Lost to Follow-up|5|||
105437159|NCT04071158|363607124|FG000|Overall Study|Randomized but not treated|2|||
105437160|NCT04071158|363607125|FG001|Overall Study|Randomized but not treated|2|||
105437161|NCT04071158|363607126|FG002|Overall Study|Randomized but not treated|0|||
105437162|NCT04071158|363607127|FG003|Overall Study|Randomized but not treated|0|||
105437163|NCT04071158|363607128|FG004|Overall Study|Randomized but not treated|0|||
105437164|NCT01178099|363607129|FG000|Overall Study|Physician Decision|0|||
105437165|NCT01178099|363607130|FG001|Overall Study|Physician Decision|1|||
105503415|NCT03019185|363854304|FG002|Overall Study|Lost to Follow-up|2|||
105503416|NCT03019185|363854302|FG000|Overall Study|Withdrawal by Subject|1|||
105437166|NCT01286740|363607131|FG000|Overall Study|Enrolled but not treated|1|||
105437167|NCT01286740|363607131|FG000|Overall Study|Protocol Violation|1|||
105437168|NCT01966445|363607135|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
105437169|NCT01966445|363607136|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
105437170|NCT01966445|363607137|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
105437171|NCT01966445|363607138|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
105437172|NCT01966445|363607139|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
105437173|NCT01966445|363607140|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
105437174|NCT01966445|363607141|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
105437175|NCT01966445|363607135|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
105437176|NCT01966445|363607136|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
105437177|NCT01966445|363607137|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
105437178|NCT01966445|363607138|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
105437179|NCT01966445|363607139|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
105437180|NCT01966445|363607140|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
105503417|NCT03019185|363854303|FG001|Overall Study|Withdrawal by Subject|1|||
105437181|NCT01966445|363607141|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
105437182|NCT01966445|363607135|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
105503418|NCT03019185|363854304|FG002|Overall Study|Withdrawal by Subject|0|||
105437183|NCT01966445|363607136|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
105437184|NCT01966445|363607137|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
105437185|NCT01966445|363607138|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
105437186|NCT01966445|363607139|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
105437187|NCT01966445|363607140|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
105437188|NCT01966445|363607141|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
105437189|NCT01966445|363607135|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
105437190|NCT01966445|363607136|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
105437191|NCT01966445|363607137|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
105437192|NCT01966445|363607138|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
105437193|NCT01966445|363607139|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
105437194|NCT01966445|363607140|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
105437195|NCT01966445|363607141|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
105437196|NCT01966445|363607135|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
105437197|NCT01966445|363607136|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
105437198|NCT01966445|363607137|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
105437199|NCT01966445|363607138|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
105437200|NCT01966445|363607139|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
105437201|NCT01966445|363607140|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
105437202|NCT01966445|363607141|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
105437203|NCT01374178|363607142|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
105437204|NCT01374178|363607143|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
105437205|NCT01374178|363607142|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
105437206|NCT01374178|363607143|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
105437207|NCT02760810|363607146|FG000|Overall Study|Protocol Violation|1|||
105437208|NCT00599638|363607147|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
105437209|NCT00599638|363607148|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
105437210|NCT00599638|363607149|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
105437211|NCT00599638|363607150|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
105437212|NCT00599638|363607147|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
105437213|NCT00599638|363607148|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
105437214|NCT00599638|363607149|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
105437215|NCT00599638|363607150|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
105437216|NCT00599638|363607147|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
105437217|NCT00599638|363607148|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
105437218|NCT00599638|363607149|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
105437219|NCT00599638|363607150|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
105437220|NCT00599638|363607147|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
105437221|NCT00599638|363607148|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
105437222|NCT00599638|363607149|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
105437223|NCT00599638|363607150|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
105437224|NCT00599638|363607147|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
105437225|NCT00599638|363607148|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
105437226|NCT00599638|363607149|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
105437227|NCT00599638|363607150|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
105437228|NCT00599638|363607147|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
105437229|NCT00599638|363607148|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
105437230|NCT00599638|363607149|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
105437231|NCT00599638|363607150|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
105437232|NCT00599638|363607147|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
105437233|NCT00599638|363607148|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
105437234|NCT00599638|363607149|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
105437235|NCT00599638|363607150|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
105437236|NCT00599638|363607147|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
105437237|NCT00599638|363607148|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
105437238|NCT00599638|363607149|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
105437239|NCT00599638|363607150|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
105437240|NCT00599638|363607147|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
105437241|NCT00599638|363607148|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
105437242|NCT00599638|363607149|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
105437243|NCT00599638|363607150|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
105437244|NCT02895945|363607154|FG000|Overall Study|Physician Decision|2|||
105437245|NCT02895945|363607155|FG001|Overall Study|Physician Decision|1|||
105437246|NCT02479139|363607163|FG000|Overall Study|Lost to Follow-up|2|||
105437247|NCT02479139|363607164|FG001|Overall Study|Lost to Follow-up|4|||
105437248|NCT02479139|363607165|FG002|Overall Study|Lost to Follow-up|4|||
105437249|NCT02479139|363607166|FG003|Overall Study|Lost to Follow-up|2|||
105437250|NCT02479139|363607167|FG004|Overall Study|Lost to Follow-up|3|||
105437251|NCT02479139|363607168|FG005|Overall Study|Lost to Follow-up|5|||
105437252|NCT02479139|363607163|FG000|Overall Study|Withdrew Consent|5|||
105437253|NCT02479139|363607164|FG001|Overall Study|Withdrew Consent|6|||
105437254|NCT02479139|363607165|FG002|Overall Study|Withdrew Consent|1|||
105437255|NCT02479139|363607166|FG003|Overall Study|Withdrew Consent|4|||
105437256|NCT02479139|363607167|FG004|Overall Study|Withdrew Consent|1|||
105437257|NCT02479139|363607168|FG005|Overall Study|Withdrew Consent|1|||
105437258|NCT02479139|363607163|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
105437259|NCT02479139|363607164|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
105437260|NCT02479139|363607165|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
105437261|NCT02479139|363607166|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
105437262|NCT02479139|363607167|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
105437263|NCT02479139|363607168|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
105437264|NCT02479139|363607163|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105437265|NCT02479139|363607164|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105437266|NCT02479139|363607165|FG002|Overall Study|Other Miscellaneous Reasons|1|||
105437267|NCT02479139|363607166|FG003|Overall Study|Other Miscellaneous Reasons|1|||
105437268|NCT02479139|363607167|FG004|Overall Study|Other Miscellaneous Reasons|1|||
105437269|NCT02479139|363607168|FG005|Overall Study|Other Miscellaneous Reasons|0|||
105437270|NCT03178669|363607169|FG000|Overall Study|Adverse Event|4|||
105437271|NCT03178669|363607170|FG001|Overall Study|Adverse Event|1|||
105437272|NCT03178669|363607171|FG002|Overall Study|Adverse Event|4|||
105437273|NCT03178669|363607172|FG003|Overall Study|Adverse Event|2|||
105437274|NCT03178669|363607173|FG004|Overall Study|Adverse Event|2|||
105437275|NCT03178669|363607169|FG000|Overall Study|Lack of Efficacy|0|||
105437276|NCT03178669|363607170|FG001|Overall Study|Lack of Efficacy|0|||
105437277|NCT03178669|363607171|FG002|Overall Study|Lack of Efficacy|2|||
105437278|NCT03178669|363607172|FG003|Overall Study|Lack of Efficacy|0|||
105437279|NCT03178669|363607173|FG004|Overall Study|Lack of Efficacy|1|||
105437280|NCT03178669|363607169|FG000|Overall Study|Physician Decision|0|||
105437281|NCT03178669|363607170|FG001|Overall Study|Physician Decision|0|||
105437282|NCT03178669|363607171|FG002|Overall Study|Physician Decision|0|||
105437283|NCT03178669|363607172|FG003|Overall Study|Physician Decision|0|||
105437284|NCT03178669|363607173|FG004|Overall Study|Physician Decision|1|||
105437285|NCT03178669|363607169|FG000|Overall Study|Withdrawal by Subject|1|||
105437286|NCT03178669|363607170|FG001|Overall Study|Withdrawal by Subject|0|||
105437287|NCT03178669|363607171|FG002|Overall Study|Withdrawal by Subject|1|||
105437288|NCT03178669|363607172|FG003|Overall Study|Withdrawal by Subject|1|||
105437289|NCT03178669|363607173|FG004|Overall Study|Withdrawal by Subject|0|||
105437290|NCT03178669|363607169|FG000|Overall Study|Lost to Follow-up|0|||
105437291|NCT03178669|363607170|FG001|Overall Study|Lost to Follow-up|0|||
105437292|NCT03178669|363607171|FG002|Overall Study|Lost to Follow-up|0|||
105437293|NCT03178669|363607172|FG003|Overall Study|Lost to Follow-up|1|||
105437294|NCT03178669|363607173|FG004|Overall Study|Lost to Follow-up|0|||
105437295|NCT01727336|363607174|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
105437296|NCT01727336|363607175|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
105437297|NCT01727336|363607176|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
105437298|NCT01727336|363607177|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
105437299|NCT01727336|363607178|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
105437300|NCT01727336|363607179|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
105437301|NCT01727336|363607174|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
105437302|NCT01727336|363607175|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
105437303|NCT01727336|363607176|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
105437304|NCT01727336|363607177|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
105437305|NCT01727336|363607178|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
105437306|NCT01727336|363607179|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
105437307|NCT01727336|363607174|FG000|Part 2 Blinded|Death|0|||
105437308|NCT01727336|363607175|FG001|Part 2 Blinded|Death|0|||
105437309|NCT01727336|363607176|FG002|Part 2 Blinded|Death|0|||
105437310|NCT01727336|363607177|FG003|Part 2 Blinded|Death|0|||
105437311|NCT01727336|363607178|FG004|Part 2 Blinded|Death|20|||
105437312|NCT01727336|363607179|FG005|Part 2 Blinded|Death|16|||
105437313|NCT01727336|363607174|FG000|Part 2 Blinded|Lack of Efficacy|0|||
105437314|NCT01727336|363607175|FG001|Part 2 Blinded|Lack of Efficacy|0|||
105437315|NCT01727336|363607176|FG002|Part 2 Blinded|Lack of Efficacy|0|||
105437316|NCT01727336|363607177|FG003|Part 2 Blinded|Lack of Efficacy|0|||
105437317|NCT01727336|363607178|FG004|Part 2 Blinded|Lack of Efficacy|42|||
105437318|NCT01727336|363607179|FG005|Part 2 Blinded|Lack of Efficacy|44|||
105437319|NCT01727336|363607174|FG000|Part 2 Blinded|Lost to Follow-up|0|||
105437320|NCT01727336|363607175|FG001|Part 2 Blinded|Lost to Follow-up|0|||
105437321|NCT01727336|363607176|FG002|Part 2 Blinded|Lost to Follow-up|0|||
105437322|NCT01727336|363607177|FG003|Part 2 Blinded|Lost to Follow-up|0|||
105437323|NCT01727336|363607178|FG004|Part 2 Blinded|Lost to Follow-up|0|||
105437324|NCT01727336|363607179|FG005|Part 2 Blinded|Lost to Follow-up|1|||
105437325|NCT01727336|363607174|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
105437326|NCT01727336|363607175|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
105437327|NCT01727336|363607176|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
105437328|NCT01727336|363607177|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
105437329|NCT01727336|363607178|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
105437330|NCT01727336|363607179|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
105437331|NCT01727336|363607174|FG000|Part 2 Blinded|use of prohibited medications|0|||
105437332|NCT01727336|363607175|FG001|Part 2 Blinded|use of prohibited medications|0|||
105437333|NCT01727336|363607176|FG002|Part 2 Blinded|use of prohibited medications|0|||
105437334|NCT01727336|363607177|FG003|Part 2 Blinded|use of prohibited medications|0|||
105437335|NCT01727336|363607178|FG004|Part 2 Blinded|use of prohibited medications|1|||
105437336|NCT01727336|363607179|FG005|Part 2 Blinded|use of prohibited medications|3|||
105437337|NCT00989781|363607184|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
105437338|NCT00989781|363607185|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
105437339|NCT01331291|363607186|FG000|Overall Study|Lack of Efficacy|2|||
105437340|NCT01331291|363607187|FG001|Overall Study|Lack of Efficacy|8|||
105437341|NCT01331291|363607186|FG000|Overall Study|Death|0|||
105437342|NCT01331291|363607187|FG001|Overall Study|Death|1|||
105437343|NCT00778895|363607190|FG000|Active Phase|Adverse Event|3|||
105437344|NCT00778895|363607191|FG001|Active Phase|Adverse Event|1|||
105437345|NCT00778895|363607192|FG002|Active Phase|Adverse Event|0|||
105437346|NCT00778895|363607190|FG000|Active Phase|Withdrawal by Subject|1|||
105437347|NCT00778895|363607191|FG001|Active Phase|Withdrawal by Subject|4|||
105437348|NCT00778895|363607192|FG002|Active Phase|Withdrawal by Subject|0|||
105437349|NCT00778895|363607190|FG000|Active Phase|Lost to Follow-up|1|||
105437350|NCT00778895|363607191|FG001|Active Phase|Lost to Follow-up|1|||
105437351|NCT00778895|363607192|FG002|Active Phase|Lost to Follow-up|0|||
105437352|NCT00778895|363607190|FG000|Active Phase|Other|2|||
105437353|NCT00778895|363607191|FG001|Active Phase|Other|0|||
105437354|NCT00778895|363607192|FG002|Active Phase|Other|0|||
105437355|NCT00778895|363607190|FG000|ESFU Phase|Adverse Event|2|||
105437356|NCT00778895|363607191|FG001|ESFU Phase|Adverse Event|1|||
105437357|NCT00778895|363607192|FG002|ESFU Phase|Adverse Event|0|||
105437358|NCT00778895|363607190|FG000|ESFU Phase|Withdrawal by Subject|1|||
105437359|NCT00778895|363607191|FG001|ESFU Phase|Withdrawal by Subject|4|||
105437360|NCT00778895|363607192|FG002|ESFU Phase|Withdrawal by Subject|0|||
105437361|NCT00778895|363607190|FG000|ESFU Phase|Lost to Follow-up|6|||
105437362|NCT00778895|363607191|FG001|ESFU Phase|Lost to Follow-up|7|||
105437363|NCT00778895|363607192|FG002|ESFU Phase|Lost to Follow-up|2|||
105437364|NCT00778895|363607190|FG000|ESFU Phase|Other|2|||
105437365|NCT00778895|363607191|FG001|ESFU Phase|Other|0|||
105437366|NCT00778895|363607192|FG002|ESFU Phase|Other|0|||
105437367|NCT02540993|363607193|FG000|Overall Study|Lost to Follow-up|5|||
105437368|NCT02540993|363607194|FG001|Overall Study|Lost to Follow-up|3|||
105437369|NCT02540993|363607193|FG000|Overall Study|Withdrawal by Subject|4|||
105437370|NCT02540993|363607194|FG001|Overall Study|Withdrawal by Subject|6|||
105437371|NCT02540993|363607193|FG000|Overall Study|GCP violations|33|||
105437372|NCT02540993|363607194|FG001|Overall Study|GCP violations|27|||
105437373|NCT05096312|363607199|FG000|Overall Study|Lost to Follow-up|2|||
105437374|NCT05096312|363607200|FG001|Overall Study|Lost to Follow-up|4|||
105437375|NCT05096312|363607199|FG000|Overall Study|Adverse Event|1|||
105437376|NCT05096312|363607200|FG001|Overall Study|Adverse Event|0|||
105437377|NCT03135210|363607201|FG000|Overall Study|Death|0|||
105437378|NCT03135210|363607202|FG001|Overall Study|Death|1|||
105503419|NCT03019185|363854302|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
105503420|NCT03019185|363854303|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
105437379|NCT00820222|363607204|FG000|Overall Study|Lost to Follow-up|10|||
105437380|NCT00820222|363607205|FG001|Overall Study|Lost to Follow-up|9|||
105437381|NCT00820222|363607204|FG000|Overall Study|Withdrawal by Subject|19|||
105437382|NCT00820222|363607205|FG001|Overall Study|Withdrawal by Subject|21|||
105437383|NCT00820222|363607204|FG000|Overall Study|Physician Decision|93|||
105437384|NCT00820222|363607205|FG001|Overall Study|Physician Decision|88|||
105437385|NCT00820222|363607204|FG000|Overall Study|Sponsor Terminated Study|43|||
105437386|NCT00820222|363607205|FG001|Overall Study|Sponsor Terminated Study|65|||
105437387|NCT00820222|363607204|FG000|Overall Study|Unkown|11|||
105437388|NCT00820222|363607205|FG001|Overall Study|Unkown|7|||
105437389|NCT04311463|363607206|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
105437390|NCT04311463|363607207|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
105437391|NCT04311463|363607206|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
105437392|NCT04311463|363607207|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
105437393|NCT04311463|363607206|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
105503421|NCT03019185|363854304|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
105503422|NCT03019185|363854302|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
105437394|NCT04311463|363607207|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
105437395|NCT00293020|363607212|FG000|Overall Study|Withdrawal by Subject|34|||
105437396|NCT00293020|363607212|FG000|Overall Study|Adverse Event|30|||
105437397|NCT00293020|363607212|FG000|Overall Study|Death|32|||
105437398|NCT00293020|363607212|FG000|Overall Study|Lack of Efficacy|12|||
105437399|NCT00293020|363607212|FG000|Overall Study|Lost to Follow-up|4|||
105437400|NCT00293020|363607212|FG000|Overall Study|Protocol Violation|6|||
105437401|NCT00293020|363607212|FG000|Overall Study|Physician Decision|21|||
105437402|NCT00293020|363607212|FG000|Overall Study|Other Reason|22|||
105437403|NCT00293020|363607212|FG000|Overall Study|No dose taken|1|||
105437404|NCT00666965|363607219|FG000|Overall Study|Adverse Event|0|||
105437405|NCT00666965|363607220|FG001|Overall Study|Adverse Event|2|||
105437406|NCT00666965|363607221|FG002|Overall Study|Adverse Event|1|||
105437407|NCT00666965|363607222|FG003|Overall Study|Adverse Event|9|||
105437408|NCT00666965|363607219|FG000|Overall Study|Lack of Efficacy|1|||
105437409|NCT00666965|363607220|FG001|Overall Study|Lack of Efficacy|1|||
105437410|NCT00666965|363607221|FG002|Overall Study|Lack of Efficacy|0|||
105437411|NCT00666965|363607222|FG003|Overall Study|Lack of Efficacy|0|||
105437412|NCT00666965|363607219|FG000|Overall Study|Protocol Violation|0|||
105437413|NCT00666965|363607220|FG001|Overall Study|Protocol Violation|0|||
105437414|NCT00666965|363607221|FG002|Overall Study|Protocol Violation|0|||
105437415|NCT00666965|363607222|FG003|Overall Study|Protocol Violation|2|||
105437416|NCT00666965|363607219|FG000|Overall Study|Discontinuation criteria|2|||
105437417|NCT00666965|363607220|FG001|Overall Study|Discontinuation criteria|1|||
105437418|NCT00666965|363607221|FG002|Overall Study|Discontinuation criteria|1|||
105437419|NCT00666965|363607222|FG003|Overall Study|Discontinuation criteria|2|||
105437420|NCT00666965|363607219|FG000|Overall Study|Withdrawal by Subject|0|||
105437421|NCT00666965|363607220|FG001|Overall Study|Withdrawal by Subject|0|||
105437422|NCT00666965|363607221|FG002|Overall Study|Withdrawal by Subject|0|||
105437423|NCT00666965|363607222|FG003|Overall Study|Withdrawal by Subject|2|||
105437424|NCT02202538|363607225|FG000|Overall Study|Withdrawal by Subject|5|||
105437425|NCT02202538|363607225|FG000|Overall Study|Did not meet all inclusion criteria|2|||
105437426|NCT02202538|363607225|FG000|Overall Study|Investigator Decision|1|||
105437427|NCT01457846|363607227|FG000|Overall Study|Death before treatment|1|||
105437428|NCT01457846|363607228|FG001|Overall Study|Death before treatment|2|||
105437429|NCT01457846|363607227|FG000|Overall Study|Did not receive treatment|0|||
105437430|NCT01457846|363607228|FG001|Overall Study|Did not receive treatment|1|||
105437431|NCT01457846|363607227|FG000|Overall Study|Death|27|||
105437432|NCT01457846|363607228|FG001|Overall Study|Death|16|||
105437433|NCT01457846|363607227|FG000|Overall Study|Unclassified reason for not completed|11|||
105437434|NCT01457846|363607228|FG001|Overall Study|Unclassified reason for not completed|10|||
105437435|NCT01457846|363607227|FG000|Overall Study|Withdrawal by Subject|1|||
105437436|NCT01457846|363607228|FG001|Overall Study|Withdrawal by Subject|1|||
105437437|NCT01457846|363607227|FG000|Overall Study|Lost to Follow-up|1|||
105437438|NCT01457846|363607228|FG001|Overall Study|Lost to Follow-up|0|||
105437439|NCT02161757|363607229|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
105437440|NCT02161757|363607230|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
105437441|NCT02161757|363607231|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
105437442|NCT02161757|363607229|FG000|Treatment Through Study Completion|Adverse Event|1|||
105437443|NCT02161757|363607230|FG001|Treatment Through Study Completion|Adverse Event|1|||
105437444|NCT02161757|363607231|FG002|Treatment Through Study Completion|Adverse Event|0|||
105437445|NCT02161757|363607229|FG000|Treatment Through Study Completion|Protocol Violation|0|||
105437446|NCT02161757|363607230|FG001|Treatment Through Study Completion|Protocol Violation|1|||
105437447|NCT02161757|363607231|FG002|Treatment Through Study Completion|Protocol Violation|2|||
105437448|NCT02161757|363607229|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
105437449|NCT02161757|363607230|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
105437450|NCT02161757|363607231|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
105437451|NCT02161757|363607229|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
105437452|NCT02161757|363607230|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
105437453|NCT02161757|363607231|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
105437454|NCT02161757|363607229|FG000|Treatment Through Study Completion|Other|20|||
105437455|NCT02161757|363607230|FG001|Treatment Through Study Completion|Other|19|||
105437456|NCT02161757|363607231|FG002|Treatment Through Study Completion|Other|12|||
105437457|NCT02161757|363607229|FG000|Treatment Through Study Completion|Death|2|||
105437458|NCT02161757|363607230|FG001|Treatment Through Study Completion|Death|1|||
105437459|NCT02161757|363607231|FG002|Treatment Through Study Completion|Death|1|||
105437460|NCT01361178|363607232|FG000|Overall Study|Death|13|||
105437461|NCT01361178|363607233|FG001|Overall Study|Death|0|||
105590677|NCT00383188|364162682|FG004|Overall Study|Other|6|||
105437462|NCT00383162|363607234|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
105437463|NCT00383162|363607235|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
105437464|NCT00383162|363607234|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
105437465|NCT00383162|363607235|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
105437466|NCT00383162|363607234|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
105437467|NCT00383162|363607235|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
105437468|NCT00383162|363607234|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
105437469|NCT00383162|363607235|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
105590678|NCT00383188|364162678|FG000|Overall Study|No longer willing to participate|1|||
105590679|NCT00383188|364162679|FG001|Overall Study|No longer willing to participate|0|||
105437470|NCT00383162|363607234|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
105437471|NCT00383162|363607235|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
105437472|NCT00383162|363607234|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
105437473|NCT00383162|363607235|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
105437474|NCT00383162|363607234|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
105437475|NCT00383162|363607235|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
105437476|NCT00383162|363607234|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
105437477|NCT00383162|363607235|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
105437478|NCT00383162|363607234|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
105437479|NCT00383162|363607235|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
105437480|NCT00495625|363609219|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
105437481|NCT00511134|363609220|FG000|Overall Study|Withdrawal by Subject|0|||
105437482|NCT00511134|363609221|FG001|Overall Study|Withdrawal by Subject|2|||
105437483|NCT02397057|363609222|FG000|Overall Study|Withdrawal by Subject|6|||
105437484|NCT02397057|363609223|FG001|Overall Study|Withdrawal by Subject|7|||
105437485|NCT02397057|363609222|FG000|Overall Study|Lost to Follow-up|4|||
105437486|NCT02397057|363609223|FG001|Overall Study|Lost to Follow-up|3|||
105437487|NCT02397057|363609222|FG000|Overall Study|Death|1|||
105437488|NCT02397057|363609223|FG001|Overall Study|Death|0|||
105437489|NCT02397057|363609222|FG000|Overall Study|Adverse Event|0|||
105437490|NCT02397057|363609223|FG001|Overall Study|Adverse Event|1|||
105437491|NCT02397057|363609222|FG000|Overall Study|Physician Decision|0|||
105437492|NCT02397057|363609223|FG001|Overall Study|Physician Decision|1|||
105437493|NCT02397057|363609222|FG000|Overall Study|Subject did not receive study drug|0|||
105437494|NCT02397057|363609223|FG001|Overall Study|Subject did not receive study drug|1|||
105437495|NCT02207491|363609224|FG000|Overall Study|Adverse Event|20|||
105437496|NCT02207491|363609225|FG001|Overall Study|Adverse Event|4|||
105437497|NCT02207491|363609224|FG000|Overall Study|Withdrawal by Subject|3|||
105437498|NCT02207491|363609225|FG001|Overall Study|Withdrawal by Subject|2|||
105437499|NCT02207491|363609224|FG000|Overall Study|Non-compliant|0|||
105437500|NCT02207491|363609225|FG001|Overall Study|Non-compliant|1|||
105437501|NCT02207491|363609224|FG000|Overall Study|Lost to Follow-up|0|||
105437502|NCT02207491|363609225|FG001|Overall Study|Lost to Follow-up|1|||
105437503|NCT02207491|363609224|FG000|Overall Study|Lack of Efficacy|3|||
105437504|NCT02207491|363609225|FG001|Overall Study|Lack of Efficacy|0|||
105437505|NCT02207491|363609224|FG000|Overall Study|Physician Decision|2|||
105437506|NCT02207491|363609225|FG001|Overall Study|Physician Decision|0|||
105437507|NCT02207491|363609224|FG000|Overall Study|Protocol Violation|3|||
105437508|NCT02207491|363609225|FG001|Overall Study|Protocol Violation|5|||
105437509|NCT00793325|363609226|FG000|Overall Study|Protocol Violation|18|||
105437510|NCT00793325|363609226|FG000|Overall Study|Lost to Follow-up|1|||
105437511|NCT00753454|363609227|FG000|Overall Study|Adverse Event|4|||
105437512|NCT00753454|363609227|FG000|Overall Study|Lack of Efficacy|1|||
105437513|NCT00753454|363609227|FG000|Overall Study|Lost to Follow-up|3|||
105437514|NCT00753454|363609227|FG000|Overall Study|Withdrawal by Subject|5|||
105437515|NCT00753454|363609227|FG000|Overall Study|Investigator Decision|1|||
105437516|NCT03916081|363609236|FG000|Overall Study|Adverse Event|1|||
105437517|NCT03916081|363609237|FG001|Overall Study|Adverse Event|0|||
105437518|NCT03916081|363609238|FG002|Overall Study|Adverse Event|0|||
105437519|NCT03916081|363609236|FG000|Overall Study|Physician Decision|0|||
105437520|NCT03916081|363609237|FG001|Overall Study|Physician Decision|0|||
105437521|NCT03916081|363609238|FG002|Overall Study|Physician Decision|1|||
105437522|NCT03916081|363609236|FG000|Overall Study|Lost to Follow-up|0|||
105437523|NCT03916081|363609237|FG001|Overall Study|Lost to Follow-up|1|||
105437524|NCT03916081|363609238|FG002|Overall Study|Lost to Follow-up|0|||
105437525|NCT03916081|363609236|FG000|Overall Study|Withdrawal by Subject|3|||
105437526|NCT03916081|363609237|FG001|Overall Study|Withdrawal by Subject|0|||
105437527|NCT03916081|363609238|FG002|Overall Study|Withdrawal by Subject|1|||
105437528|NCT03916081|363609236|FG000|Overall Study|Worsening of AD|0|||
105437529|NCT03916081|363609237|FG001|Overall Study|Worsening of AD|0|||
105437530|NCT03916081|363609238|FG002|Overall Study|Worsening of AD|1|||
105437531|NCT00465647|363609239|FG000|Overall Study|Administrative|2|||
105437532|NCT00465647|363609240|FG001|Overall Study|Administrative|2|||
105437533|NCT00465647|363609241|FG002|Overall Study|Administrative|3|||
105437534|NCT00465647|363609242|FG003|Overall Study|Administrative|2|||
105437535|NCT00465647|363609239|FG000|Overall Study|Adverse Event|2|||
105437536|NCT00465647|363609240|FG001|Overall Study|Adverse Event|0|||
105437537|NCT00465647|363609241|FG002|Overall Study|Adverse Event|3|||
105437538|NCT00465647|363609242|FG003|Overall Study|Adverse Event|2|||
105437539|NCT00465647|363609239|FG000|Overall Study|Withdrawal by Subject|1|||
105437540|NCT00465647|363609240|FG001|Overall Study|Withdrawal by Subject|2|||
105437541|NCT00465647|363609241|FG002|Overall Study|Withdrawal by Subject|2|||
105437542|NCT00465647|363609242|FG003|Overall Study|Withdrawal by Subject|7|||
105437543|NCT00465647|363609239|FG000|Overall Study|"The other reasons included loss of IV"|8|||
105437544|NCT00465647|363609240|FG001|Overall Study|"The other reasons included loss of IV"|4|||
105437545|NCT00465647|363609241|FG002|Overall Study|"The other reasons included loss of IV"|3|||
105437546|NCT00465647|363609242|FG003|Overall Study|"The other reasons included loss of IV"|2|||
105503423|NCT03019185|363854303|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
105503424|NCT03019185|363854304|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
105437547|NCT01240135|363609245|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
105437548|NCT01240135|363609246|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
105437549|NCT01240135|363609245|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
105437550|NCT01240135|363609246|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
105437551|NCT01887353|363609247|FG000|Overall Study|Study stopped early|4|||
105437552|NCT01887353|363609248|FG001|Overall Study|Study stopped early|3|||
105437553|NCT01371305|363609249|FG000|Overall Study|Adverse Event|0|||
105437554|NCT01371305|363609250|FG001|Overall Study|Adverse Event|0|||
105437555|NCT01371305|363609251|FG002|Overall Study|Adverse Event|0|||
105437556|NCT01371305|363609252|FG003|Overall Study|Adverse Event|2|||
105437557|NCT01371305|363609253|FG004|Overall Study|Adverse Event|1|||
105437558|NCT01371305|363609254|FG005|Overall Study|Adverse Event|0|||
105437559|NCT01371305|363609249|FG000|Overall Study|Study terminated by sponsor|0|||
105437560|NCT01371305|363609250|FG001|Overall Study|Study terminated by sponsor|0|||
105437561|NCT01371305|363609251|FG002|Overall Study|Study terminated by sponsor|0|||
105437562|NCT01371305|363609252|FG003|Overall Study|Study terminated by sponsor|0|||
105437563|NCT01371305|363609253|FG004|Overall Study|Study terminated by sponsor|3|||
105437564|NCT01371305|363609254|FG005|Overall Study|Study terminated by sponsor|1|||
105437565|NCT01371305|363609249|FG000|Overall Study|Subject request|0|||
105437566|NCT01371305|363609250|FG001|Overall Study|Subject request|0|||
105437567|NCT01371305|363609251|FG002|Overall Study|Subject request|0|||
105437568|NCT01371305|363609252|FG003|Overall Study|Subject request|0|||
105437569|NCT01371305|363609253|FG004|Overall Study|Subject request|0|||
105437570|NCT01371305|363609254|FG005|Overall Study|Subject request|1|||
105437571|NCT03624127|363609255|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
105437572|NCT03624127|363609256|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
105437573|NCT03624127|363609257|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
105437574|NCT03624127|363609255|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
105437575|NCT03624127|363609256|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
105437576|NCT03624127|363609257|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
105437577|NCT03624127|363609255|FG000|Treatment Week 0 - Week 16|Death|0|||
105437578|NCT03624127|363609256|FG001|Treatment Week 0 - Week 16|Death|1|||
105437579|NCT03624127|363609257|FG002|Treatment Week 0 - Week 16|Death|0|||
105437580|NCT03624127|363609255|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
105437581|NCT03624127|363609256|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
105437582|NCT03624127|363609257|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
105437583|NCT03624127|363609255|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
105437584|NCT03624127|363609256|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
105437585|NCT03624127|363609257|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
105437586|NCT03624127|363609255|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
105437587|NCT03624127|363609256|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
105437588|NCT03624127|363609257|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
105437589|NCT03624127|363609255|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
105437590|NCT03624127|363609256|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
105437591|NCT03624127|363609257|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
105437592|NCT03624127|363609255|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
105437593|NCT03624127|363609256|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
105437594|NCT03624127|363609257|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
105437595|NCT03624127|363609255|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
105437596|NCT03624127|363609256|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
105437597|NCT03624127|363609257|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
105437598|NCT03624127|363609255|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
105437599|NCT03624127|363609256|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
105437600|NCT03624127|363609257|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
105437601|NCT03624127|363609255|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
105437602|NCT03624127|363609256|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
105437603|NCT03624127|363609257|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
105437604|NCT03624127|363609255|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
105437605|NCT03624127|363609256|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
105503425|NCT01397890|363854305|FG000|Overall Study|Withdrawal by Subject|7|||
105503426|NCT01397890|363854306|FG001|Overall Study|Withdrawal by Subject|11|||
105437606|NCT03624127|363609257|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
105437607|NCT03624127|363609255|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
105437608|NCT03624127|363609256|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
105437609|NCT03624127|363609257|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
105437610|NCT03624127|363609255|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
105437611|NCT03624127|363609256|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
105437612|NCT03624127|363609257|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
105437613|NCT03624127|363609255|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
105437614|NCT03624127|363609256|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
105437615|NCT03624127|363609257|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
105437616|NCT03624127|363609255|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
105437617|NCT03624127|363609256|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
105437618|NCT03624127|363609257|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
105437619|NCT03624127|363609255|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
105437620|NCT03624127|363609256|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
105437621|NCT03624127|363609257|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
105437622|NCT03624127|363609255|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
105437623|NCT03624127|363609256|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
105437624|NCT03624127|363609257|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
105437625|NCT03624127|363609255|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
105437626|NCT03624127|363609256|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
105437627|NCT03624127|363609257|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
105437628|NCT03624127|363609255|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
105437629|NCT03624127|363609256|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
105437630|NCT03624127|363609257|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
105437631|NCT03624127|363609255|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
105437632|NCT03624127|363609256|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
105437633|NCT03624127|363609257|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
105437634|NCT00235716|363609258|FG000|Overall Study|Death|26|||
105437635|NCT00235716|363609259|FG001|Overall Study|Death|39|||
105437636|NCT00235716|363609260|FG002|Overall Study|Death|32|||
105437637|NCT00235716|363609261|FG003|Overall Study|Death|31|||
105437638|NCT00235716|363609258|FG000|Overall Study|Withdrawal by Subject|23|||
105437639|NCT00235716|363609259|FG001|Overall Study|Withdrawal by Subject|19|||
105437640|NCT00235716|363609260|FG002|Overall Study|Withdrawal by Subject|17|||
105437641|NCT00235716|363609261|FG003|Overall Study|Withdrawal by Subject|18|||
105437642|NCT00235716|363609258|FG000|Overall Study|Lost to Follow-up|12|||
105437643|NCT00235716|363609259|FG001|Overall Study|Lost to Follow-up|7|||
105437644|NCT00235716|363609260|FG002|Overall Study|Lost to Follow-up|14|||
105437645|NCT00235716|363609261|FG003|Overall Study|Lost to Follow-up|10|||
105437646|NCT00235716|363609258|FG000|Overall Study|Adverse Event|1|||
105437647|NCT00235716|363609259|FG001|Overall Study|Adverse Event|1|||
105437648|NCT00235716|363609260|FG002|Overall Study|Adverse Event|1|||
105437649|NCT00235716|363609261|FG003|Overall Study|Adverse Event|0|||
105437650|NCT00235716|363609258|FG000|Overall Study|Physician Decision|0|||
105437651|NCT00235716|363609259|FG001|Overall Study|Physician Decision|1|||
105437652|NCT00235716|363609260|FG002|Overall Study|Physician Decision|1|||
105437653|NCT00235716|363609261|FG003|Overall Study|Physician Decision|3|||
105437654|NCT04390841|363609262|FG000|Overall Study|Withdrawal by Subject|2|||
105437655|NCT00559988|363609263|FG000|Overall Study|Death|147|||
105437656|NCT00559988|363609264|FG001|Overall Study|Death|140|||
105437657|NCT00559988|363609263|FG000|Overall Study|Withdrawal by Subject|152|||
105437658|NCT00559988|363609264|FG001|Overall Study|Withdrawal by Subject|139|||
105437659|NCT00559988|363609263|FG000|Overall Study|Lost to Follow-up|42|||
105437660|NCT00559988|363609264|FG001|Overall Study|Lost to Follow-up|56|||
105437661|NCT00559988|363609263|FG000|Overall Study|ICD device explanted|10|||
105437662|NCT00559988|363609264|FG001|Overall Study|ICD device explanted|17|||
105437663|NCT02891382|363609265|FG000|Overall Study|Lost to Follow-up|3|||
105437664|NCT02891382|363609266|FG001|Overall Study|Lost to Follow-up|4|||
105437665|NCT02891382|363609267|FG002|Overall Study|Lost to Follow-up|5|||
105437666|NCT02891382|363609268|FG003|Overall Study|Lost to Follow-up|3|||
105437667|NCT02891382|363609269|FG004|Overall Study|Lost to Follow-up|4|||
105437668|NCT01455194|363609272|FG000|Overall Study|Screen Failure|20|||
105437669|NCT01455194|363609273|FG001|Overall Study|Screen Failure|0|||
105437670|NCT01455194|363609274|FG002|Overall Study|Screen Failure|0|||
105437671|NCT01455194|363609275|FG003|Overall Study|Screen Failure|0|||
105437672|NCT01455194|363609272|FG000|Overall Study|Randomisation Failure|90|||
105437673|NCT01455194|363609273|FG001|Overall Study|Randomisation Failure|0|||
105437674|NCT01455194|363609274|FG002|Overall Study|Randomisation Failure|0|||
105437675|NCT01455194|363609275|FG003|Overall Study|Randomisation Failure|0|||
105437676|NCT01455194|363609272|FG000|Overall Study|Deterioration in asthma|12|||
105437677|NCT01455194|363609273|FG001|Overall Study|Deterioration in asthma|6|||
105437678|NCT01455194|363609274|FG002|Overall Study|Deterioration in asthma|14|||
105437679|NCT01455194|363609275|FG003|Overall Study|Deterioration in asthma|9|||
105437680|NCT01455194|363609272|FG000|Overall Study|Adverse Event|1|||
105437681|NCT01455194|363609273|FG001|Overall Study|Adverse Event|1|||
105437682|NCT01455194|363609274|FG002|Overall Study|Adverse Event|1|||
105437683|NCT01455194|363609275|FG003|Overall Study|Adverse Event|3|||
105437684|NCT01455194|363609272|FG000|Overall Study|Withdrawal by Subject|21|||
105437685|NCT01455194|363609273|FG001|Overall Study|Withdrawal by Subject|16|||
105437686|NCT01455194|363609274|FG002|Overall Study|Withdrawal by Subject|12|||
105437687|NCT01455194|363609275|FG003|Overall Study|Withdrawal by Subject|9|||
105437688|NCT01455194|363609272|FG000|Overall Study|Lost to Follow-up|2|||
105437689|NCT01455194|363609273|FG001|Overall Study|Lost to Follow-up|0|||
105437690|NCT01455194|363609274|FG002|Overall Study|Lost to Follow-up|1|||
105437691|NCT01455194|363609275|FG003|Overall Study|Lost to Follow-up|1|||
105437692|NCT01455194|363609272|FG000|Overall Study|Pregnancy|0|||
105437693|NCT01455194|363609273|FG001|Overall Study|Pregnancy|1|||
105437694|NCT01455194|363609274|FG002|Overall Study|Pregnancy|1|||
105437695|NCT01455194|363609275|FG003|Overall Study|Pregnancy|0|||
105437696|NCT01455194|363609272|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
105437697|NCT01455194|363609273|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
105437698|NCT01455194|363609274|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
105437699|NCT01455194|363609275|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
105437700|NCT01455194|363609272|FG000|Overall Study|Miscellaneous|4|||
105437701|NCT01455194|363609273|FG001|Overall Study|Miscellaneous|5|||
105437702|NCT01455194|363609274|FG002|Overall Study|Miscellaneous|1|||
105437703|NCT01455194|363609275|FG003|Overall Study|Miscellaneous|4|||
105437704|NCT04356040|363609278|FG000|Overall Study|Death|2|||
105437705|NCT04356040|363609279|FG001|Overall Study|Death|0|||
105437706|NCT04356040|363609278|FG000|Overall Study|Lost to Follow-up|1|||
105437707|NCT04356040|363609279|FG001|Overall Study|Lost to Follow-up|0|||
105437708|NCT04356040|363609278|FG000|Overall Study|Physician Decision|0|||
105437709|NCT04356040|363609279|FG001|Overall Study|Physician Decision|1|||
105437710|NCT04356040|363609278|FG000|Overall Study|Withdrawal by Subject|13|||
105437711|NCT04356040|363609279|FG001|Overall Study|Withdrawal by Subject|1|||
105437712|NCT04356040|363609278|FG000|Overall Study|Enrollment Pause|10|||
105437713|NCT04356040|363609279|FG001|Overall Study|Enrollment Pause|0|||
105437714|NCT04356040|363609278|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
105437715|NCT04356040|363609279|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
105437716|NCT04356040|363609278|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
105437717|NCT04356040|363609279|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
105437718|NCT04356040|363609278|FG000|Overall Study|PI left institution|3|||
105437719|NCT04356040|363609279|FG001|Overall Study|PI left institution|0|||
105437720|NCT00416455|363609281|FG000|Overall Study|PET / CT not done|3|||
105437721|NCT00416455|363609282|FG001|Overall Study|PET / CT not done|5|||
105437722|NCT00416455|363609281|FG000|Overall Study|PET / CT poor quality|2|||
105437723|NCT00416455|363609282|FG001|Overall Study|PET / CT poor quality|1|||
105437724|NCT00416455|363609281|FG000|Overall Study|Inadequate pathology|11|||
105437725|NCT00416455|363609282|FG001|Overall Study|Inadequate pathology|2|||
105437726|NCT01128946|363609285|FG000|Period I|Protocol Violation|0|||
105437727|NCT01128946|363609286|FG001|Period I|Protocol Violation|1|||
105437728|NCT01128946|363609287|FG002|Period I|Protocol Violation|0|||
105437729|NCT01128946|363609288|FG003|Period I|Protocol Violation|0|||
105437730|NCT01128946|363609285|FG000|Period I|Withdrawal by Subject|0|||
105437731|NCT01128946|363609286|FG001|Period I|Withdrawal by Subject|0|||
105437732|NCT01128946|363609287|FG002|Period I|Withdrawal by Subject|1|||
105437733|NCT01128946|363609288|FG003|Period I|Withdrawal by Subject|1|||
105437734|NCT01128946|363609285|FG000|Period II|Protocol Violation|0|||
105437735|NCT01128946|363609286|FG001|Period II|Protocol Violation|1|||
105437736|NCT01128946|363609287|FG002|Period II|Protocol Violation|0|||
105437737|NCT01128946|363609288|FG003|Period II|Protocol Violation|0|||
105437738|NCT01128946|363609285|FG000|Period II|Withdrawal by Subject|0|||
105437739|NCT01128946|363609286|FG001|Period II|Withdrawal by Subject|0|||
105437740|NCT01128946|363609287|FG002|Period II|Withdrawal by Subject|0|||
105437741|NCT01128946|363609288|FG003|Period II|Withdrawal by Subject|1|||
105437742|NCT01128946|363609285|FG000|Period III|Protocol Violation|1|||
105437743|NCT01128946|363609286|FG001|Period III|Protocol Violation|0|||
105437744|NCT01128946|363609287|FG002|Period III|Protocol Violation|0|||
105437745|NCT01128946|363609288|FG003|Period III|Protocol Violation|0|||
105437746|NCT00621140|363609289|FG000|Overall Study|Adverse Event|4|||
105437747|NCT00621140|363609290|FG001|Overall Study|Adverse Event|5|||
105437748|NCT00621140|363609289|FG000|Overall Study|Lost to Follow-up|1|||
105437749|NCT00621140|363609290|FG001|Overall Study|Lost to Follow-up|2|||
105437750|NCT00621140|363609289|FG000|Overall Study|Withdrawal by Subject|4|||
105437751|NCT00621140|363609290|FG001|Overall Study|Withdrawal by Subject|6|||
105437752|NCT00621140|363609289|FG000|Overall Study|Other incl. lack of efficacy|6|||
105437753|NCT00621140|363609290|FG001|Overall Study|Other incl. lack of efficacy|5|||
105437754|NCT00360568|363609291|FG000|Overall Study|Adverse Event|1|||
105437755|NCT00360568|363609292|FG001|Overall Study|Adverse Event|2|||
105437756|NCT00360568|363609291|FG000|Overall Study|Lack of Efficacy|1|||
105437757|NCT00360568|363609292|FG001|Overall Study|Lack of Efficacy|0|||
105437758|NCT00360568|363609291|FG000|Overall Study|Withdrawal by Subject|0|||
105437759|NCT00360568|363609292|FG001|Overall Study|Withdrawal by Subject|3|||
105437760|NCT03565237|363609295|FG000|Overall Study|Non-compliance of Investigational Product|1|||
105437761|NCT03565237|363609295|FG000|Overall Study|Physician Decision|1|||
105437762|NCT02873338|363609299|FG000|Overall Study|Adverse Event|0|||
105437763|NCT02873338|363609300|FG001|Overall Study|Adverse Event|2|||
105437764|NCT02873338|363609301|FG002|Overall Study|Adverse Event|1|||
105437765|NCT02873338|363609299|FG000|Overall Study|Death|2|||
105437766|NCT02873338|363609300|FG001|Overall Study|Death|1|||
105437767|NCT02873338|363609301|FG002|Overall Study|Death|1|||
105437768|NCT02873338|363609299|FG000|Overall Study|Withdrawal by Subject|2|||
105437769|NCT02873338|363609300|FG001|Overall Study|Withdrawal by Subject|1|||
105437770|NCT02873338|363609301|FG002|Overall Study|Withdrawal by Subject|3|||
105437771|NCT02873338|363609299|FG000|Overall Study|Lack of Efficacy|0|||
105437772|NCT02873338|363609300|FG001|Overall Study|Lack of Efficacy|2|||
105437773|NCT02873338|363609301|FG002|Overall Study|Lack of Efficacy|0|||
105437774|NCT02873338|363609299|FG000|Overall Study|Other or Missing|14|||
105437775|NCT02873338|363609300|FG001|Overall Study|Other or Missing|15|||
105437776|NCT02873338|363609301|FG002|Overall Study|Other or Missing|13|||
105437777|NCT03657095|363609302|FG000|Overall Study|Withdrawal by Subject|1|||
105437778|NCT03657095|363609303|FG001|Overall Study|Withdrawal by Subject|1|||
105437779|NCT03657095|363609302|FG000|Overall Study|Adverse Event|0|||
105437780|NCT03657095|363609303|FG001|Overall Study|Adverse Event|3|||
105437781|NCT03657095|363609302|FG000|Overall Study|Study Terminated by Sponsor|58|||
105437782|NCT03657095|363609303|FG001|Overall Study|Study Terminated by Sponsor|49|||
105437783|NCT01008449|363609304|FG000|Overall Study|Lost to Follow-up|29|||
105437784|NCT01008449|363609305|FG001|Overall Study|Lost to Follow-up|19|||
105437785|NCT00847197|363609306|FG000|Overall Study|Adverse Event|21|||
105437786|NCT00847197|363609307|FG001|Overall Study|Adverse Event|3|||
105437787|NCT00847197|363609306|FG000|Overall Study|Protocol Violation|0|||
105437788|NCT00847197|363609307|FG001|Overall Study|Protocol Violation|1|||
105437789|NCT00847197|363609306|FG000|Overall Study|Withdrawal by Subject|3|||
105437790|NCT00847197|363609307|FG001|Overall Study|Withdrawal by Subject|1|||
105437791|NCT01140061|363609308|FG000|Part I|Adverse Event|1|||
105437792|NCT01140061|363609309|FG001|Part I|Adverse Event|0|||
105437793|NCT01140061|363609310|FG002|Part I|Adverse Event|0|||
105437794|NCT01140061|363609311|FG003|Part I|Adverse Event|0|||
105437795|NCT01140061|363609312|FG004|Part I|Adverse Event|0|||
105437796|NCT01140061|363609313|FG005|Part I|Adverse Event|0|||
105437797|NCT01140061|363609314|FG006|Part I|Adverse Event|0|||
105437798|NCT01140061|363609315|FG007|Part I|Adverse Event|0|||
105437799|NCT01140061|363609316|FG008|Part I|Adverse Event|0|||
105437800|NCT01140061|363609317|FG009|Part I|Adverse Event|0|||
105437801|NCT01140061|363609308|FG000|Extension|Laboratory Adverse Event|0|||
105437802|NCT01140061|363609309|FG001|Extension|Laboratory Adverse Event|0|||
105437803|NCT01140061|363609310|FG002|Extension|Laboratory Adverse Event|0|||
105437804|NCT01140061|363609311|FG003|Extension|Laboratory Adverse Event|0|||
105437805|NCT01140061|363609312|FG004|Extension|Laboratory Adverse Event|0|||
105437806|NCT01140061|363609313|FG005|Extension|Laboratory Adverse Event|0|||
105437807|NCT01140061|363609314|FG006|Extension|Laboratory Adverse Event|0|||
105437808|NCT01140061|363609315|FG007|Extension|Laboratory Adverse Event|0|||
105437809|NCT01140061|363609316|FG008|Extension|Laboratory Adverse Event|0|||
105437810|NCT01140061|363609317|FG009|Extension|Laboratory Adverse Event|1|||
105437811|NCT00622388|363609318|FG000|Overall Study|Disease Progression|47|||
105437812|NCT00622388|363609318|FG000|Overall Study|Adverse Event|6|||
105437813|NCT00622388|363609318|FG000|Overall Study|Protocol Violation|3|||
105437814|NCT00622388|363609318|FG000|Overall Study|Participant Refusal|1|||
105437815|NCT00622388|363609318|FG000|Overall Study|Death|3|||
105437816|NCT00622388|363609318|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
105437817|NCT00622388|363609318|FG000|Overall Study|Took Prohibited Medication|2|||
105437818|NCT00622388|363609318|FG000|Overall Study|Withdrew Consent|1|||
105437819|NCT00622388|363609318|FG000|Overall Study|Insurance Expired|1|||
105437820|NCT01894243|363609319|FG000|Overall Study|Adverse Event|0|||
105437821|NCT01894243|363609320|FG001|Overall Study|Adverse Event|1|||
105437822|NCT01894243|363609321|FG002|Overall Study|Adverse Event|2|||
105437823|NCT01894243|363609319|FG000|Overall Study|Death|0|||
105437824|NCT01894243|363609320|FG001|Overall Study|Death|0|||
105437825|NCT01894243|363609321|FG002|Overall Study|Death|3|||
105437826|NCT01894243|363609319|FG000|Overall Study|Lack of Efficacy|3|||
105437827|NCT01894243|363609320|FG001|Overall Study|Lack of Efficacy|3|||
105437828|NCT01894243|363609321|FG002|Overall Study|Lack of Efficacy|1|||
105437829|NCT01894243|363609319|FG000|Overall Study|Condition under investigation worsened|8|||
105437830|NCT01894243|363609320|FG001|Overall Study|Condition under investigation worsened|6|||
105437831|NCT01894243|363609321|FG002|Overall Study|Condition under investigation worsened|2|||
105437832|NCT01894243|363609319|FG000|Overall Study|Subject decision|1|||
105437833|NCT01894243|363609320|FG001|Overall Study|Subject decision|0|||
105437834|NCT01894243|363609321|FG002|Overall Study|Subject decision|0|||
105437835|NCT01894243|363609319|FG000|Overall Study|Other|1|||
105437836|NCT01894243|363609320|FG001|Overall Study|Other|0|||
105437837|NCT01894243|363609321|FG002|Overall Study|Other|0|||
105437838|NCT01299116|363609322|FG000|Overall Study|Lost to Follow-up|65|||
105437839|NCT01299116|363609323|FG001|Overall Study|Lost to Follow-up|9|||
105437840|NCT01299116|363609324|FG002|Overall Study|Lost to Follow-up|11|||
105437841|NCT00830180|363609326|FG000|Overall Study|Adverse Event|6|||
105437842|NCT00830180|363609326|FG000|Overall Study|Death|11|||
105437843|NCT00830180|363609326|FG000|Overall Study|Insufficient clinical response|1|||
105437844|NCT00830180|363609326|FG000|Overall Study|Withdrawal by Subject|5|||
105437845|NCT00830180|363609326|FG000|Overall Study|Progressive disease|2|||
105437846|NCT00830180|363609326|FG000|Overall Study|Other - Unspecified|1|||
105437847|NCT02687581|363609327|FG000|Overall Study|Withdrawal by Subject|1|||
105437848|NCT02687581|363609328|FG001|Overall Study|Withdrawal by Subject|0|||
105437849|NCT02687581|363609329|FG002|Overall Study|Withdrawal by Subject|0|||
105437850|NCT02687581|363609330|FG003|Overall Study|Withdrawal by Subject|1|||
105437851|NCT02687581|363609327|FG000|Overall Study|Lost to Follow-up|2|||
105437852|NCT02687581|363609328|FG001|Overall Study|Lost to Follow-up|2|||
105437853|NCT02687581|363609329|FG002|Overall Study|Lost to Follow-up|0|||
105437854|NCT02687581|363609330|FG003|Overall Study|Lost to Follow-up|0|||
105437855|NCT02687581|363609327|FG000|Overall Study|the device is too small for the patient.|1|||
105437856|NCT02687581|363609328|FG001|Overall Study|the device is too small for the patient.|0|||
105437857|NCT02687581|363609329|FG002|Overall Study|the device is too small for the patient.|0|||
105437858|NCT02687581|363609330|FG003|Overall Study|the device is too small for the patient.|0|||
105437859|NCT01114438|363609333|FG000|Overall Study|Adverse Event|10|||
105437860|NCT01114438|363609333|FG000|Overall Study|concomitant medication|1|||
105437861|NCT01114438|363609333|FG000|Overall Study|Physician Decision|1|||
105437862|NCT01114438|363609333|FG000|Overall Study|Withdrawal by Subject|2|||
105437863|NCT00488826|363609336|FG000|Overall Study|Withdrawal by Subject|40|||
105437864|NCT00488826|363609337|FG001|Overall Study|Withdrawal by Subject|35|||
105437865|NCT00488826|363609338|FG002|Overall Study|Withdrawal by Subject|19|||
105437866|NCT00488826|363609336|FG000|Overall Study|Protocol Violation|0|||
105437867|NCT00488826|363609337|FG001|Overall Study|Protocol Violation|0|||
105437868|NCT00488826|363609338|FG002|Overall Study|Protocol Violation|2|||
105437869|NCT00488826|363609336|FG000|Overall Study|Adverse Event|9|||
105437870|NCT00488826|363609337|FG001|Overall Study|Adverse Event|15|||
105437871|NCT00488826|363609338|FG002|Overall Study|Adverse Event|4|||
105437872|NCT00488826|363609336|FG000|Overall Study|Lost to Follow-up|5|||
105437873|NCT00488826|363609337|FG001|Overall Study|Lost to Follow-up|1|||
105437874|NCT00488826|363609338|FG002|Overall Study|Lost to Follow-up|0|||
105437875|NCT00488826|363609336|FG000|Overall Study|Protocol Deviations|2|||
105437876|NCT00488826|363609337|FG001|Overall Study|Protocol Deviations|1|||
105437877|NCT00488826|363609338|FG002|Overall Study|Protocol Deviations|1|||
105437878|NCT02725866|363609339|FG000|Overall Study|Failure to return|6|||
105437879|NCT02725866|363609339|FG000|Overall Study|Withdrew consent|3|||
105437880|NCT02725866|363609339|FG000|Overall Study|Insufficient virological response|1|||
105437881|NCT02725866|363609339|FG000|Overall Study|Other, not specified|4|||
105437882|NCT04667104|363609345|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
105437883|NCT04667104|363609346|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
105437884|NCT04667104|363609347|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
105437885|NCT03043651|363609348|FG000|Overall Study|Death|1|||
105437886|NCT03043651|363609348|FG000|Overall Study|Progressive Disease|2|||
105437887|NCT03043651|363609348|FG000|Overall Study|Adverse Event|2|||
105590680|NCT00383188|364162680|FG002|Overall Study|No longer willing to participate|1|||
105590681|NCT00383188|364162681|FG003|Overall Study|No longer willing to participate|0|||
105590682|NCT00383188|364162682|FG004|Overall Study|No longer willing to participate|2|||
105590683|NCT00383188|364162678|FG000|Overall Study|Lost to Follow-up|0|||
105590684|NCT00383188|364162679|FG001|Overall Study|Lost to Follow-up|0|||
105437888|NCT03043651|363609348|FG000|Overall Study|Withdrawal by Subject|4|||
105437889|NCT03043651|363609348|FG000|Overall Study|Study Terminated by Sponsor|39|||
105437890|NCT02974842|363609349|FG000|Overall Study|Withdrawal by Subject|4|||
105437891|NCT02974842|363609349|FG000|Overall Study|Screen failures|4|||
105437892|NCT00605345|363609360|FG000|Overall Study|Withdrawal by Subject|1|||
105437893|NCT00605345|363609361|FG001|Overall Study|Withdrawal by Subject|0|||
105437894|NCT00605345|363609360|FG000|Overall Study|Adverse Event|0|||
105437895|NCT00605345|363609361|FG001|Overall Study|Adverse Event|1|||
105437896|NCT00605345|363609360|FG000|Overall Study|Protocol Violation|0|||
105437897|NCT00605345|363609361|FG001|Overall Study|Protocol Violation|2|||
105437898|NCT02577016|363609362|FG000|Overall Study|Adverse Event|2|||
105437899|NCT02577016|363609363|FG001|Overall Study|Adverse Event|1|||
105437900|NCT02577016|363609362|FG000|Overall Study|Physician Decision|0|||
105437901|NCT02577016|363609363|FG001|Overall Study|Physician Decision|1|||
105437902|NCT03824587|363609364|FG000|Run-in Period|Screen Failure|0|||
105437903|NCT03824587|363609365|FG001|Run-in Period|Screen Failure|275|||
105437904|NCT03824587|363609364|FG000|Treatment Period|Adverse Event|4|||
105437905|NCT03824587|363609365|FG001|Treatment Period|Adverse Event|1|||
105437906|NCT03824587|363609364|FG000|Treatment Period|Withdrawal by Subject|0|||
105437907|NCT03824587|363609365|FG001|Treatment Period|Withdrawal by Subject|1|||
105437908|NCT03824587|363609364|FG000|Treatment Period|Kidney Transplant|1|||
105437909|NCT03824587|363609365|FG001|Treatment Period|Kidney Transplant|1|||
105437910|NCT00812565|363609366|FG000|Overall Study|Did Not Receive Study Medication|1|||
105437911|NCT00812565|363609367|FG001|Overall Study|Did Not Receive Study Medication|1|||
105437912|NCT00812565|363609368|FG002|Overall Study|Did Not Receive Study Medication|0|||
105437913|NCT00812565|363609369|FG003|Overall Study|Did Not Receive Study Medication|0|||
105437914|NCT00812565|363609370|FG004|Overall Study|Did Not Receive Study Medication|0|||
105437915|NCT00812565|363609371|FG005|Overall Study|Did Not Receive Study Medication|0|||
105437916|NCT00812565|363609372|FG006|Overall Study|Did Not Receive Study Medication|0|||
105437917|NCT00812565|363609373|FG007|Overall Study|Did Not Receive Study Medication|0|||
105437918|NCT00812565|363609366|FG000|Overall Study|Adverse Event|0|||
105437919|NCT00812565|363609367|FG001|Overall Study|Adverse Event|0|||
105437920|NCT00812565|363609368|FG002|Overall Study|Adverse Event|0|||
105437921|NCT00812565|363609369|FG003|Overall Study|Adverse Event|2|||
105437922|NCT00812565|363609370|FG004|Overall Study|Adverse Event|0|||
105437923|NCT00812565|363609371|FG005|Overall Study|Adverse Event|0|||
105437924|NCT00812565|363609372|FG006|Overall Study|Adverse Event|0|||
105437925|NCT00812565|363609373|FG007|Overall Study|Adverse Event|1|||
105437926|NCT00812565|363609366|FG000|Overall Study|Did Not Come to Study Visit|1|||
105437927|NCT00812565|363609367|FG001|Overall Study|Did Not Come to Study Visit|0|||
105437928|NCT00812565|363609368|FG002|Overall Study|Did Not Come to Study Visit|0|||
105437929|NCT00812565|363609369|FG003|Overall Study|Did Not Come to Study Visit|0|||
105437930|NCT00812565|363609370|FG004|Overall Study|Did Not Come to Study Visit|0|||
105437931|NCT00812565|363609371|FG005|Overall Study|Did Not Come to Study Visit|0|||
105437932|NCT00812565|363609372|FG006|Overall Study|Did Not Come to Study Visit|0|||
105437933|NCT00812565|363609373|FG007|Overall Study|Did Not Come to Study Visit|0|||
105437934|NCT00812565|363609366|FG000|Overall Study|Withdrawal of Consent|1|||
105437935|NCT00812565|363609367|FG001|Overall Study|Withdrawal of Consent|0|||
105437936|NCT00812565|363609368|FG002|Overall Study|Withdrawal of Consent|0|||
105437937|NCT00812565|363609369|FG003|Overall Study|Withdrawal of Consent|0|||
105437938|NCT00812565|363609370|FG004|Overall Study|Withdrawal of Consent|1|||
105437939|NCT00812565|363609371|FG005|Overall Study|Withdrawal of Consent|0|||
105437940|NCT00812565|363609372|FG006|Overall Study|Withdrawal of Consent|0|||
105437941|NCT00812565|363609373|FG007|Overall Study|Withdrawal of Consent|0|||
105437942|NCT00812565|363609366|FG000|Overall Study|Reason Not Specified|0|||
105437943|NCT00812565|363609367|FG001|Overall Study|Reason Not Specified|0|||
105437944|NCT00812565|363609368|FG002|Overall Study|Reason Not Specified|0|||
105437945|NCT00812565|363609369|FG003|Overall Study|Reason Not Specified|0|||
105437946|NCT00812565|363609370|FG004|Overall Study|Reason Not Specified|0|||
105437947|NCT00812565|363609371|FG005|Overall Study|Reason Not Specified|1|||
105437948|NCT00812565|363609372|FG006|Overall Study|Reason Not Specified|0|||
105437949|NCT00812565|363609373|FG007|Overall Study|Reason Not Specified|0|||
105437950|NCT00422383|363609374|FG000|Overall Study|Adverse Event|5|||
105437951|NCT00422383|363609375|FG001|Overall Study|Adverse Event|3|||
105437952|NCT00422383|363609376|FG002|Overall Study|Adverse Event|1|||
105437953|NCT00422383|363609377|FG003|Overall Study|Adverse Event|1|||
105437954|NCT00422383|363609378|FG004|Overall Study|Adverse Event|0|||
105437955|NCT00422383|363609374|FG000|Overall Study|Lack of Efficacy|4|||
105437956|NCT00422383|363609375|FG001|Overall Study|Lack of Efficacy|4|||
105437957|NCT00422383|363609376|FG002|Overall Study|Lack of Efficacy|2|||
105437958|NCT00422383|363609377|FG003|Overall Study|Lack of Efficacy|1|||
105437959|NCT00422383|363609378|FG004|Overall Study|Lack of Efficacy|1|||
105437960|NCT00422383|363609374|FG000|Overall Study|Lost to Follow-up|0|||
105437961|NCT00422383|363609375|FG001|Overall Study|Lost to Follow-up|1|||
105437962|NCT00422383|363609376|FG002|Overall Study|Lost to Follow-up|0|||
105437963|NCT00422383|363609377|FG003|Overall Study|Lost to Follow-up|0|||
105437964|NCT00422383|363609378|FG004|Overall Study|Lost to Follow-up|1|||
105437965|NCT00422383|363609374|FG000|Overall Study|Protocol Violation|1|||
105437966|NCT00422383|363609375|FG001|Overall Study|Protocol Violation|1|||
105437967|NCT00422383|363609376|FG002|Overall Study|Protocol Violation|1|||
105437968|NCT00422383|363609377|FG003|Overall Study|Protocol Violation|0|||
105437969|NCT00422383|363609378|FG004|Overall Study|Protocol Violation|0|||
105437970|NCT00422383|363609374|FG000|Overall Study|Withdrawal by Subject|5|||
105437971|NCT00422383|363609375|FG001|Overall Study|Withdrawal by Subject|5|||
105437972|NCT00422383|363609376|FG002|Overall Study|Withdrawal by Subject|0|||
105437973|NCT00422383|363609377|FG003|Overall Study|Withdrawal by Subject|0|||
105437974|NCT00422383|363609378|FG004|Overall Study|Withdrawal by Subject|1|||
105437975|NCT03755661|363609383|FG000|Overall Study|Lost to Follow-up|1|||
105437976|NCT03755661|363609384|FG001|Overall Study|Lost to Follow-up|0|||
105437977|NCT02277119|363609385|FG000|Overall Study|Lack of Efficacy|1|||
105437978|NCT02277119|363609386|FG001|Overall Study|Lack of Efficacy|1|||
105437979|NCT02277119|363609387|FG002|Overall Study|Lack of Efficacy|1|||
105437980|NCT02277119|363609385|FG000|Overall Study|Protocol Violation|2|||
105437981|NCT02277119|363609386|FG001|Overall Study|Protocol Violation|3|||
105437982|NCT02277119|363609387|FG002|Overall Study|Protocol Violation|7|||
105437983|NCT01793883|363609388|FG000|Overall Study|Withdrawal by Subject|3|||
105437984|NCT01793883|363609389|FG001|Overall Study|Withdrawal by Subject|7|||
105437985|NCT01793883|363609390|FG002|Overall Study|Withdrawal by Subject|3|||
105437986|NCT01793883|363609388|FG000|Overall Study|Subject noncompliance|0|||
105437987|NCT01793883|363609389|FG001|Overall Study|Subject noncompliance|1|||
105437988|NCT01793883|363609390|FG002|Overall Study|Subject noncompliance|1|||
105437989|NCT01793883|363609388|FG000|Overall Study|Lost to Follow-up|5|||
105437990|NCT01793883|363609389|FG001|Overall Study|Lost to Follow-up|1|||
105437991|NCT01793883|363609390|FG002|Overall Study|Lost to Follow-up|3|||
105437992|NCT01793883|363609388|FG000|Overall Study|Randomized in error|1|||
105437993|NCT01793883|363609389|FG001|Overall Study|Randomized in error|0|||
105437994|NCT01793883|363609390|FG002|Overall Study|Randomized in error|0|||
105437995|NCT01793883|363609388|FG000|Overall Study|Unable to complete spriometry|1|||
105437996|NCT01793883|363609389|FG001|Overall Study|Unable to complete spriometry|0|||
105503427|NCT01397890|363854305|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
105503428|NCT01397890|363854306|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
105503429|NCT01397890|363854305|FG000|Overall Study|Death|2|||
105503430|NCT01397890|363854306|FG001|Overall Study|Death|3|||
105503431|NCT01397890|363854305|FG000|Overall Study|Lost to Follow-up|1|||
105503432|NCT01397890|363854306|FG001|Overall Study|Lost to Follow-up|4|||
105503433|NCT01397890|363854305|FG000|Overall Study|Condition under Investigation Worsened|1|||
105503434|NCT01397890|363854306|FG001|Overall Study|Condition under Investigation Worsened|3|||
105503435|NCT01397890|363854305|FG000|Overall Study|Adverse Event|1|||
105503436|NCT01397890|363854306|FG001|Overall Study|Adverse Event|2|||
105503437|NCT01397890|363854305|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
105503438|NCT01397890|363854306|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
105503439|NCT01397890|363854305|FG000|Overall Study|Others|2|||
105503440|NCT01397890|363854306|FG001|Overall Study|Others|1|||
105503441|NCT04613375|363854307|FG000|Overall Study|Death|198|||
105503442|NCT04613375|363854307|FG000|Overall Study|Withdrawal by Subject|3|||
105503443|NCT00142935|363854311|FG000|Overall Study|Other reason|1|||
105503444|NCT00142935|363854312|FG001|Overall Study|Other reason|1|||
105503445|NCT00142935|363854313|FG002|Overall Study|Other reason|1|||
105503446|NCT00142935|363854311|FG000|Overall Study|Lost to Follow-up|2|||
105503447|NCT00142935|363854312|FG001|Overall Study|Lost to Follow-up|5|||
105503448|NCT00142935|363854313|FG002|Overall Study|Lost to Follow-up|5|||
105503449|NCT00142935|363854311|FG000|Overall Study|Death|0|||
105503450|NCT00142935|363854312|FG001|Overall Study|Death|2|||
105503451|NCT00142935|363854313|FG002|Overall Study|Death|1|||
105503452|NCT01180985|363854314|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
105503453|NCT01180985|363854315|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
105503454|NCT03727230|363854316|FG000|Overall Study|Lost to Follow-up|12|||
105503455|NCT03417219|363854320|FG000|Overall Study|Lost to Follow-up|0|||
105503456|NCT03417219|363854321|FG001|Overall Study|Lost to Follow-up|3|||
105503457|NCT00675948|363854323|FG000|Overall Study|Adverse Event|23|||
105503458|NCT00675948|363854324|FG001|Overall Study|Adverse Event|1|||
105503459|NCT00675948|363854323|FG000|Overall Study|Lack of Efficacy|3|||
105503460|NCT00675948|363854324|FG001|Overall Study|Lack of Efficacy|0|||
105503461|NCT00675948|363854323|FG000|Overall Study|Withdrawal by Subject|7|||
105503462|NCT00675948|363854324|FG001|Overall Study|Withdrawal by Subject|0|||
105503463|NCT00675948|363854323|FG000|Overall Study|Lost to Follow-up|2|||
105503464|NCT00675948|363854324|FG001|Overall Study|Lost to Follow-up|0|||
105503465|NCT00675948|363854323|FG000|Overall Study|Protocol Violation|1|||
105503466|NCT00675948|363854324|FG001|Overall Study|Protocol Violation|0|||
105503467|NCT00675948|363854323|FG000|Overall Study|Pain under control|1|||
105503468|NCT00675948|363854324|FG001|Overall Study|Pain under control|0|||
105503469|NCT00675948|363854323|FG000|Overall Study|Sponsor decision|0|||
105503470|NCT00675948|363854324|FG001|Overall Study|Sponsor decision|1|||
105503471|NCT00675948|363854323|FG000|Overall Study|Patient died|1|||
105503472|NCT00675948|363854324|FG001|Overall Study|Patient died|0|||
105503473|NCT00675948|363854323|FG000|Overall Study|Patient unable to comply with diaries|1|||
105503474|NCT00675948|363854324|FG001|Overall Study|Patient unable to comply with diaries|0|||
105503475|NCT00675948|363854323|FG000|Overall Study|Patient feels unable to take medication|0|||
105503476|NCT00675948|363854324|FG001|Overall Study|Patient feels unable to take medication|1|||
105503477|NCT04377620|363854325|FG000|Overall Study|Death|42|||
105503478|NCT04377620|363854326|FG001|Overall Study|Death|48|||
105503479|NCT04377620|363854327|FG002|Overall Study|Death|36|||
105503480|NCT04377620|363854325|FG000|Overall Study|Withdrawal by Subject|0|||
105503481|NCT04377620|363854326|FG001|Overall Study|Withdrawal by Subject|2|||
105503482|NCT04377620|363854327|FG002|Overall Study|Withdrawal by Subject|0|||
105503483|NCT02527161|363854328|FG000|Overall Study|Failed MRI|52|||
105503484|NCT02527161|363854328|FG000|Overall Study|Withdrawal by Subject|19|||
105503485|NCT02527161|363854328|FG000|Overall Study|Delay in or unfit for surgery|16|||
105503486|NCT02527161|363854328|FG000|Overall Study|MRI contraindication|6|||
105503487|NCT02527161|363854328|FG000|Overall Study|Consent violation|4|||
105503488|NCT02527161|363854328|FG000|Overall Study|Only Recruited to Part A|27|||
105590685|NCT00383188|364162680|FG002|Overall Study|Lost to Follow-up|0|||
105503489|NCT02527161|363854328|FG000|Overall Study|Physician Decision|1|||
105503490|NCT02527161|363854328|FG000|Overall Study|Adverse Event|1|||
105503491|NCT02527161|363854328|FG000|Overall Study|Lost to Follow-up|6|||
105503492|NCT02100514|363854329|FG000|Treatment Period|Adverse Event|0|||
105503493|NCT02100514|363854330|FG001|Treatment Period|Adverse Event|5|||
105503494|NCT02100514|363854331|FG002|Treatment Period|Adverse Event|0|||
105503495|NCT02100514|363854332|FG003|Treatment Period|Adverse Event|0|||
105503496|NCT02100514|363854333|FG004|Treatment Period|Adverse Event|0|||
105503497|NCT02100514|363854329|FG000|Treatment Period|Death|2|||
105503498|NCT02100514|363854330|FG001|Treatment Period|Death|2|||
105503499|NCT02100514|363854331|FG002|Treatment Period|Death|0|||
105503500|NCT02100514|363854332|FG003|Treatment Period|Death|0|||
105503501|NCT02100514|363854333|FG004|Treatment Period|Death|0|||
105503502|NCT02100514|363854329|FG000|Treatment Period|Lost to Follow-up|5|||
105503503|NCT02100514|363854330|FG001|Treatment Period|Lost to Follow-up|17|||
105503504|NCT02100514|363854331|FG002|Treatment Period|Lost to Follow-up|0|||
105503505|NCT02100514|363854332|FG003|Treatment Period|Lost to Follow-up|0|||
105503506|NCT02100514|363854333|FG004|Treatment Period|Lost to Follow-up|0|||
105503507|NCT02100514|363854329|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
105503508|NCT02100514|363854330|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
105503509|NCT02100514|363854331|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
105503510|NCT02100514|363854332|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
105503511|NCT02100514|363854333|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
105503512|NCT02100514|363854329|FG000|Treatment Period|Protocol Violation|1|||
105503513|NCT02100514|363854330|FG001|Treatment Period|Protocol Violation|1|||
105503514|NCT02100514|363854331|FG002|Treatment Period|Protocol Violation|0|||
105503515|NCT02100514|363854332|FG003|Treatment Period|Protocol Violation|0|||
105503516|NCT02100514|363854333|FG004|Treatment Period|Protocol Violation|0|||
105503517|NCT02100514|363854329|FG000|Treatment Period|Withdrawal by Subject|12|||
105503518|NCT02100514|363854330|FG001|Treatment Period|Withdrawal by Subject|37|||
105503519|NCT02100514|363854331|FG002|Treatment Period|Withdrawal by Subject|0|||
105503520|NCT02100514|363854332|FG003|Treatment Period|Withdrawal by Subject|0|||
105503521|NCT02100514|363854333|FG004|Treatment Period|Withdrawal by Subject|0|||
105503522|NCT02100514|363854329|FG000|Treatment Period|Other|9|||
105503523|NCT02100514|363854330|FG001|Treatment Period|Other|11|||
105503524|NCT02100514|363854331|FG002|Treatment Period|Other|0|||
105503525|NCT02100514|363854332|FG003|Treatment Period|Other|0|||
105503526|NCT02100514|363854333|FG004|Treatment Period|Other|0|||
105503527|NCT02100514|363854329|FG000|Extension Period|Withdrew consent|0|||
105503528|NCT02100514|363854330|FG001|Extension Period|Withdrew consent|0|||
105503529|NCT02100514|363854331|FG002|Extension Period|Withdrew consent|2|||
105503530|NCT02100514|363854332|FG003|Extension Period|Withdrew consent|0|||
105503531|NCT02100514|363854333|FG004|Extension Period|Withdrew consent|0|||
105503532|NCT02021331|363854334|FG000|Overall Study|Adverse Event|0|||
105503533|NCT02021331|363854335|FG001|Overall Study|Adverse Event|2|||
105503534|NCT00319553|363854336|FG000|Overall Study|Protocol Violation|1|||
105503535|NCT00319553|363854337|FG001|Overall Study|Protocol Violation|2|||
105503536|NCT00319553|363854336|FG000|Overall Study|Lost to Follow-up|2|||
105503537|NCT00319553|363854337|FG001|Overall Study|Lost to Follow-up|1|||
105503538|NCT00319553|363854336|FG000|Overall Study|Withdrawal by Subject|1|||
105503539|NCT00319553|363854337|FG001|Overall Study|Withdrawal by Subject|1|||
105503540|NCT01896102|363854338|FG000|Overall Study|Death|1|||
105503541|NCT01896102|363854338|FG000|Overall Study|Participant to receive allogenic transplant|2|||
105503542|NCT03733470|363854346|FG000|Overall Study|PI Decision|1|||
105503543|NCT03733470|363854347|FG001|Overall Study|PI Decision|1|||
105503544|NCT01007812|363854351|FG000|Period 1, One Week|Lost to Follow-up|0|||
105503545|NCT01007812|363854352|FG001|Period 1, One Week|Lost to Follow-up|1|||
105503546|NCT01007812|363854351|FG000|Period 1, One Week|Discomfort|1|||
105503547|NCT01007812|363854352|FG001|Period 1, One Week|Discomfort|0|||
105503548|NCT00781274|363854353|FG000|Overall Study|Withdrawal by Subject|2|||
105503549|NCT04502433|363854355|FG000|Overall Study|Death|2|||
105503550|NCT04502433|363854356|FG001|Overall Study|Death|4|||
105503551|NCT04502433|363854355|FG000|Overall Study|Lost to Follow-up|1|||
105503552|NCT04502433|363854356|FG001|Overall Study|Lost to Follow-up|0|||
105503553|NCT04502433|363854355|FG000|Overall Study|Physician Decision|0|||
105503554|NCT04502433|363854356|FG001|Overall Study|Physician Decision|1|||
105503555|NCT02699593|363854357|FG000|Period 1|Unsatisfactory Visual Response|0|||
105503556|NCT02699593|363854358|FG001|Period 1|Unsatisfactory Visual Response|1|||
105503557|NCT02699593|363854357|FG000|Period 1|Torn Contact Len|4|||
105503558|NCT02699593|363854358|FG001|Period 1|Torn Contact Len|3|||
105503559|NCT02699593|363854357|FG000|Period 1|Protocol Violation|0|||
105503560|NCT02699593|363854358|FG001|Period 1|Protocol Violation|1|||
105503561|NCT02699593|363854357|FG000|Period 1|Withdrawal by Subject|0|||
105503562|NCT02699593|363854358|FG001|Period 1|Withdrawal by Subject|1|||
105503563|NCT02699593|363854357|FG000|Period 1|Adverse Event|1|||
105503564|NCT02699593|363854358|FG001|Period 1|Adverse Event|1|||
105503565|NCT02699593|363854357|FG000|Period 2|Adverse Event|1|||
105503566|NCT02699593|363854358|FG001|Period 2|Adverse Event|1|||
105503567|NCT02699593|363854357|FG000|Period 2|Lost Contact Lens|0|||
105503568|NCT02699593|363854358|FG001|Period 2|Lost Contact Lens|1|||
105590686|NCT00383188|364162681|FG003|Overall Study|Lost to Follow-up|0|||
105590687|NCT00383188|364162682|FG004|Overall Study|Lost to Follow-up|1|||
105590688|NCT03523962|364162684|FG000|Closed Fractures|Death|86|||
105503569|NCT02699593|363854357|FG000|Period 2|Torn Contact Lens|1|||
105503570|NCT02699593|363854358|FG001|Period 2|Torn Contact Lens|0|||
105503571|NCT02015754|363854361|FG000|Overall Study|Disease progression|5|||
105503572|NCT02015754|363854361|FG000|Overall Study|Change in treatment modality|5|||
105503573|NCT02015754|363854361|FG000|Overall Study|Lost to Follow-up|1|||
105503574|NCT00478231|363854368|FG000|Overall Study|Death|7|||
105503575|NCT00478231|363854368|FG000|Overall Study|Lack of Efficacy|47|||
105503576|NCT00478231|363854368|FG000|Overall Study|Lost to Follow-up|7|||
105503577|NCT00478231|363854368|FG000|Overall Study|Withdrawal by Subject|6|||
105503578|NCT00478231|363854368|FG000|Overall Study|Other|9|||
105503579|NCT00478231|363854368|FG000|Overall Study|Adverse Event|5|||
105503580|NCT00478231|363854368|FG000|Overall Study|Randomized, not treated|3|||
105590689|NCT03523962|364162685|FG001|Closed Fractures|Death|71|||
105503581|NCT02405780|363854373|FG000|Period I|Adverse Event|8|||
105503582|NCT02405780|363854374|FG001|Period I|Adverse Event|0|||
105503583|NCT02405780|363854375|FG002|Period I|Adverse Event|3|||
105503584|NCT02405780|363854376|FG003|Period I|Adverse Event|7|||
105503585|NCT02405780|363854373|FG000|Period I|Medical reasons|1|||
105503586|NCT02405780|363854374|FG001|Period I|Medical reasons|1|||
105503587|NCT02405780|363854375|FG002|Period I|Medical reasons|0|||
105503588|NCT02405780|363854376|FG003|Period I|Medical reasons|1|||
105503589|NCT02405780|363854373|FG000|Period I|Screening Failure|1|||
105503590|NCT02405780|363854374|FG001|Period I|Screening Failure|0|||
105503591|NCT02405780|363854375|FG002|Period I|Screening Failure|1|||
105503592|NCT02405780|363854376|FG003|Period I|Screening Failure|0|||
105503593|NCT02405780|363854373|FG000|Period I|Withdrawal by Subject|9|||
105503594|NCT02405780|363854374|FG001|Period I|Withdrawal by Subject|1|||
105503595|NCT02405780|363854375|FG002|Period I|Withdrawal by Subject|3|||
105503596|NCT02405780|363854376|FG003|Period I|Withdrawal by Subject|4|||
105503597|NCT02405780|363854373|FG000|Period I|Non-compliance with study procedures|8|||
105503598|NCT02405780|363854374|FG001|Period I|Non-compliance with study procedures|6|||
105503599|NCT02405780|363854375|FG002|Period I|Non-compliance with study procedures|8|||
105503600|NCT02405780|363854376|FG003|Period I|Non-compliance with study procedures|11|||
105503601|NCT02405780|363854373|FG000|Period II|Adverse Event|3|||
105503602|NCT02405780|363854374|FG001|Period II|Adverse Event|5|||
105503603|NCT02405780|363854375|FG002|Period II|Adverse Event|4|||
105503604|NCT02405780|363854376|FG003|Period II|Adverse Event|11|||
105503605|NCT02405780|363854373|FG000|Period II|Medical reason|0|||
105503606|NCT02405780|363854374|FG001|Period II|Medical reason|1|||
105503607|NCT02405780|363854375|FG002|Period II|Medical reason|0|||
105503608|NCT02405780|363854376|FG003|Period II|Medical reason|0|||
105503609|NCT02405780|363854373|FG000|Period II|Pregnancy|0|||
105503610|NCT02405780|363854374|FG001|Period II|Pregnancy|0|||
105503611|NCT02405780|363854375|FG002|Period II|Pregnancy|1|||
105503612|NCT02405780|363854376|FG003|Period II|Pregnancy|0|||
105503613|NCT02405780|363854373|FG000|Period II|Withdrawal by Subject|7|||
105503614|NCT02405780|363854374|FG001|Period II|Withdrawal by Subject|4|||
105503615|NCT02405780|363854375|FG002|Period II|Withdrawal by Subject|0|||
105503616|NCT02405780|363854376|FG003|Period II|Withdrawal by Subject|3|||
105503617|NCT02405780|363854373|FG000|Period II|Non-compliance with study procedures|5|||
105503618|NCT02405780|363854374|FG001|Period II|Non-compliance with study procedures|2|||
105437997|NCT01793883|363609390|FG002|Overall Study|Unable to complete spriometry|0|||
105437998|NCT01793883|363609388|FG000|Overall Study|Unable to complete measurements|1|||
105437999|NCT01793883|363609389|FG001|Overall Study|Unable to complete measurements|0|||
105438000|NCT01793883|363609390|FG002|Overall Study|Unable to complete measurements|0|||
105438001|NCT01793883|363609388|FG000|Overall Study|Met exclusion criteria|1|||
105438002|NCT01793883|363609389|FG001|Overall Study|Met exclusion criteria|0|||
105438003|NCT01793883|363609390|FG002|Overall Study|Met exclusion criteria|0|||
105438004|NCT01793883|363609388|FG000|Overall Study|Dosing error|0|||
105438005|NCT01793883|363609389|FG001|Overall Study|Dosing error|1|||
105438006|NCT01793883|363609390|FG002|Overall Study|Dosing error|0|||
105438007|NCT01793883|363609388|FG000|Overall Study|Respiratory distress during spirometry|0|||
105438008|NCT01793883|363609389|FG001|Overall Study|Respiratory distress during spirometry|0|||
105438009|NCT01793883|363609390|FG002|Overall Study|Respiratory distress during spirometry|1|||
105438010|NCT04699461|363609391|FG000|Overall Study|Withdrawal by Subject|1|||
105438011|NCT04699461|363609392|FG001|Overall Study|Withdrawal by Subject|0|||
105438012|NCT04699461|363609391|FG000|Overall Study|Study termination by sponsor|2|||
105438013|NCT04699461|363609392|FG001|Overall Study|Study termination by sponsor|1|||
105438014|NCT04699461|363609391|FG000|Overall Study|Death|1|||
105438015|NCT04699461|363609392|FG001|Overall Study|Death|0|||
105438016|NCT04699461|363609391|FG000|Overall Study|Radiographic progression|0|||
105438017|NCT04699461|363609392|FG001|Overall Study|Radiographic progression|1|||
105438018|NCT02478255|363609393|FG000|Overall Study|Physician Decision|6|||
105438019|NCT02478255|363609394|FG001|Overall Study|Physician Decision|0|||
105438020|NCT02478255|363609393|FG000|Overall Study|Withdrawal by Subject|2|||
105503619|NCT02405780|363854375|FG002|Period II|Non-compliance with study procedures|7|||
105503620|NCT02405780|363854376|FG003|Period II|Non-compliance with study procedures|4|||
105503621|NCT00923156|363854377|FG000|Overall Study|Adverse Event|0|||
105503622|NCT00923156|363854378|FG001|Overall Study|Adverse Event|2|||
105503623|NCT00923156|363854379|FG002|Overall Study|Adverse Event|1|||
105503624|NCT00923156|363854377|FG000|Overall Study|Abnormal laboratory values|0|||
105503625|NCT00923156|363854378|FG001|Overall Study|Abnormal laboratory values|0|||
105503626|NCT00923156|363854379|FG002|Overall Study|Abnormal laboratory values|1|||
105503627|NCT00923156|363854377|FG000|Overall Study|Withdrawal by Subject|0|||
105503628|NCT00923156|363854378|FG001|Overall Study|Withdrawal by Subject|1|||
105503629|NCT00923156|363854379|FG002|Overall Study|Withdrawal by Subject|0|||
105503630|NCT00923156|363854377|FG000|Overall Study|Death|0|||
105438021|NCT02478255|363609394|FG001|Overall Study|Withdrawal by Subject|0|||
105438022|NCT03068767|363609400|FG000|Overall Study|Lost to Follow-up|7|||
105438023|NCT03068767|363609401|FG001|Overall Study|Lost to Follow-up|3|||
105438024|NCT03068767|363609400|FG000|Overall Study|Protocol Violation|3|||
105503631|NCT00923156|363854378|FG001|Overall Study|Death|1|||
105438025|NCT03068767|363609401|FG001|Overall Study|Protocol Violation|0|||
105438026|NCT01730586|363609404|FG000|Overall Study|Progressive Disease|2|||
105438027|NCT01730586|363609404|FG000|Overall Study|Inadequate Trial|8|||
105438028|NCT01730586|363609404|FG000|Overall Study|Adverse Event|2|||
105438029|NCT01730586|363609404|FG000|Overall Study|Hospice|1|||
105438030|NCT02921087|363609405|FG000|Overall Study|Withdrawal by Subject|0|||
105438031|NCT02921087|363609406|FG001|Overall Study|Withdrawal by Subject|1|||
105438032|NCT00687531|363609407|FG000|Overall Study|Did not meet protocol eligibility|104|||
105438033|NCT00687531|363609407|FG000|Overall Study|Adverse Event|5|||
105438034|NCT00687531|363609407|FG000|Overall Study|Lost to Follow-up|26|||
105438035|NCT00852241|363609408|FG000|Overall Study|Physician Decision|18|||
105438036|NCT00118430|363609416|FG000|Overall Study|Withdrawal by Subject|6|||
105438037|NCT00118430|363609417|FG001|Overall Study|Withdrawal by Subject|2|||
105438038|NCT00118430|363609418|FG002|Overall Study|Withdrawal by Subject|0|||
105438039|NCT00118430|363609416|FG000|Overall Study|Lost to Follow-up|15|||
105438040|NCT00118430|363609417|FG001|Overall Study|Lost to Follow-up|22|||
105438041|NCT00118430|363609418|FG002|Overall Study|Lost to Follow-up|28|||
105438042|NCT03890367|363609419|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105438043|NCT03890367|363609420|FG001|Overall Study|Withdrawal by parent/guardian|3|||
105438044|NCT03890367|363609421|FG002|Overall Study|Withdrawal by parent/guardian|0|||
105438045|NCT03890367|363609419|FG000|Overall Study|Protocol deviation|2|||
105438046|NCT03890367|363609420|FG001|Overall Study|Protocol deviation|2|||
105438047|NCT03890367|363609421|FG002|Overall Study|Protocol deviation|1|||
105438048|NCT03890367|363609419|FG000|Overall Study|Lost to Follow-up|1|||
105438049|NCT03890367|363609420|FG001|Overall Study|Lost to Follow-up|1|||
105438050|NCT03890367|363609421|FG002|Overall Study|Lost to Follow-up|0|||
105438051|NCT04412707|363609422|FG000|Cycle 1|Death|0|||
105438052|NCT04412707|363609423|FG001|Cycle 1|Death|3|||
105438053|NCT04412707|363609422|FG000|Cycle 1|Disease progression|1|||
105438054|NCT04412707|363609423|FG001|Cycle 1|Disease progression|2|||
105438055|NCT04412707|363609422|FG000|Cycle 2|Death|0|||
105438056|NCT04412707|363609423|FG001|Cycle 2|Death|1|||
105438057|NCT04412707|363609422|FG000|Cycle 2|Disease progression|3|||
105438058|NCT04412707|363609423|FG001|Cycle 2|Disease progression|0|||
105438059|NCT04412707|363609422|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
105438060|NCT04412707|363609423|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
105438061|NCT04412707|363609422|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
105438062|NCT04412707|363609423|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
105438063|NCT04412707|363609422|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
105438064|NCT04412707|363609423|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
105438065|NCT04412707|363609422|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
105438066|NCT04412707|363609423|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
105438067|NCT00547521|363609424|FG000|Short Term Study (4 Months)|Adverse Event|1|||
105438068|NCT00547521|363609425|FG001|Short Term Study (4 Months)|Adverse Event|0|||
105438069|NCT00547521|363609424|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
105438070|NCT00547521|363609425|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
105438071|NCT00547521|363609424|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
105438072|NCT00547521|363609425|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
105438073|NCT00547521|363609424|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
105438074|NCT00547521|363609425|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
105438075|NCT00547521|363609424|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
105438076|NCT00547521|363609425|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
105438077|NCT00547521|363609424|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
105438078|NCT00547521|363609425|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
105438079|NCT00547521|363609424|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
105438080|NCT00547521|363609425|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
105438081|NCT00547521|363609424|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
105438082|NCT00547521|363609425|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
105438083|NCT00547521|363609424|FG000|Long Term Extension (LTE) Study|Other|0|||
105438084|NCT00547521|363609425|FG001|Long Term Extension (LTE) Study|Other|2|||
105438085|NCT00547521|363609424|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
105438086|NCT00547521|363609425|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
105438087|NCT01216683|363611505|FG000|Induction|Never started treatment|0|||
105438088|NCT01216683|363611506|FG001|Induction|Never started treatment|6|||
105438089|NCT01216683|363611507|FG002|Induction|Never started treatment|3|||
105438090|NCT01216683|363611505|FG000|Induction|Lack of Efficacy|4|||
105438091|NCT01216683|363611506|FG001|Induction|Lack of Efficacy|3|||
105438092|NCT01216683|363611507|FG002|Induction|Lack of Efficacy|7|||
105438093|NCT01216683|363611505|FG000|Induction|Adverse Event|0|||
105438094|NCT01216683|363611506|FG001|Induction|Adverse Event|5|||
105438095|NCT01216683|363611507|FG002|Induction|Adverse Event|5|||
105438096|NCT01216683|363611505|FG000|Induction|Death|0|||
105438097|NCT01216683|363611506|FG001|Induction|Death|0|||
105438098|NCT01216683|363611507|FG002|Induction|Death|2|||
105438099|NCT01216683|363611505|FG000|Induction|Withdrawal by Subject|0|||
105438100|NCT01216683|363611506|FG001|Induction|Withdrawal by Subject|4|||
105438101|NCT01216683|363611507|FG002|Induction|Withdrawal by Subject|2|||
105438102|NCT01216683|363611505|FG000|Induction|Other disease|0|||
105438103|NCT01216683|363611506|FG001|Induction|Other disease|1|||
105438104|NCT01216683|363611507|FG002|Induction|Other disease|2|||
105438105|NCT01216683|363611505|FG000|Continuation|Lack of Efficacy|3|||
105438106|NCT01216683|363611506|FG001|Continuation|Lack of Efficacy|2|||
105438107|NCT01216683|363611507|FG002|Continuation|Lack of Efficacy|7|||
105438108|NCT01216683|363611505|FG000|Continuation|Adverse Event|5|||
105438109|NCT01216683|363611506|FG001|Continuation|Adverse Event|3|||
105438110|NCT01216683|363611507|FG002|Continuation|Adverse Event|16|||
105438111|NCT01216683|363611505|FG000|Continuation|Death|1|||
105438112|NCT01216683|363611506|FG001|Continuation|Death|0|||
105438113|NCT01216683|363611507|FG002|Continuation|Death|2|||
105438114|NCT01216683|363611505|FG000|Continuation|Withdrawal by Subject|4|||
105438115|NCT01216683|363611506|FG001|Continuation|Withdrawal by Subject|5|||
105438116|NCT01216683|363611507|FG002|Continuation|Withdrawal by Subject|9|||
105438117|NCT01216683|363611505|FG000|Continuation|Other diseases|0|||
105438118|NCT01216683|363611506|FG001|Continuation|Other diseases|2|||
105438119|NCT01216683|363611507|FG002|Continuation|Other diseases|1|||
105438120|NCT01216683|363611505|FG000|Continuation|Physician Decision|1|||
105438121|NCT01216683|363611506|FG001|Continuation|Physician Decision|0|||
105438122|NCT01216683|363611507|FG002|Continuation|Physician Decision|1|||
105438123|NCT01216683|363611505|FG000|Continuation|Non-compliance|1|||
105438124|NCT01216683|363611506|FG001|Continuation|Non-compliance|0|||
105438125|NCT01216683|363611507|FG002|Continuation|Non-compliance|1|||
105438126|NCT01216683|363611505|FG000|Continuation|Insurance change|0|||
105438127|NCT01216683|363611506|FG001|Continuation|Insurance change|1|||
105438128|NCT01216683|363611507|FG002|Continuation|Insurance change|0|||
105438129|NCT01216683|363611505|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
105438130|NCT01216683|363611506|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
105438131|NCT01216683|363611507|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
105438132|NCT01216683|363611505|FG000|Continuation|Not reported|0|||
105438133|NCT01216683|363611506|FG001|Continuation|Not reported|0|||
105438134|NCT01216683|363611507|FG002|Continuation|Not reported|1|||
105438135|NCT01216683|363611505|FG000|Continuation|Never started treatment|0|||
105438136|NCT01216683|363611506|FG001|Continuation|Never started treatment|1|||
105438137|NCT01216683|363611507|FG002|Continuation|Never started treatment|5|||
105438138|NCT03495102|363611508|FG000|Overall Study|Adverse Event|5|||
105438139|NCT03495102|363611509|FG001|Overall Study|Adverse Event|7|||
105503632|NCT00923156|363854379|FG002|Overall Study|Death|0|||
105503633|NCT00923156|363854377|FG000|Overall Study|Lack of Efficacy|0|||
105503634|NCT00923156|363854378|FG001|Overall Study|Lack of Efficacy|0|||
105503635|NCT00923156|363854379|FG002|Overall Study|Lack of Efficacy|1|||
105503636|NCT00939770|363854382|FG000|Overall Study|Adverse Event|1|||
105503637|NCT00939770|363854383|FG001|Overall Study|Adverse Event|1|||
105503638|NCT00939770|363854384|FG002|Overall Study|Adverse Event|0|||
105503639|NCT00939770|363854385|FG003|Overall Study|Adverse Event|0|||
105503640|NCT00939770|363854386|FG004|Overall Study|Adverse Event|6|||
105503641|NCT00939770|363854387|FG005|Overall Study|Adverse Event|2|||
105503642|NCT00939770|363854388|FG006|Overall Study|Adverse Event|1|||
105503643|NCT00939770|363854389|FG007|Overall Study|Adverse Event|1|||
105503644|NCT00939770|363854382|FG000|Overall Study|Lack of Efficacy|4|||
105438140|NCT03495102|363611510|FG002|Overall Study|Adverse Event|10|||
105438141|NCT03495102|363611508|FG000|Overall Study|Death|3|||
105438142|NCT03495102|363611509|FG001|Overall Study|Death|4|||
105438143|NCT03495102|363611510|FG002|Overall Study|Death|4|||
105438144|NCT03495102|363611508|FG000|Overall Study|Lost to Follow-up|15|||
105438145|NCT03495102|363611509|FG001|Overall Study|Lost to Follow-up|16|||
105438146|NCT03495102|363611510|FG002|Overall Study|Lost to Follow-up|17|||
105438147|NCT03495102|363611508|FG000|Overall Study|Physician Decision|2|||
105438148|NCT03495102|363611509|FG001|Overall Study|Physician Decision|0|||
105438149|NCT03495102|363611510|FG002|Overall Study|Physician Decision|2|||
105438150|NCT03495102|363611508|FG000|Overall Study|Withdrawal by Subject|25|||
105438151|NCT03495102|363611509|FG001|Overall Study|Withdrawal by Subject|36|||
105438152|NCT03495102|363611510|FG002|Overall Study|Withdrawal by Subject|18|||
105438153|NCT03495102|363611508|FG000|Overall Study|Protocol Violation|1|||
105503645|NCT00939770|363854383|FG001|Overall Study|Lack of Efficacy|6|||
105438154|NCT03495102|363611509|FG001|Overall Study|Protocol Violation|1|||
105438155|NCT03495102|363611510|FG002|Overall Study|Protocol Violation|0|||
105438156|NCT03495102|363611508|FG000|Overall Study|Site Closure|3|||
105438157|NCT03495102|363611509|FG001|Overall Study|Site Closure|1|||
105438158|NCT03495102|363611510|FG002|Overall Study|Site Closure|2|||
105503646|NCT00939770|363854384|FG002|Overall Study|Lack of Efficacy|13|||
105503647|NCT00939770|363854385|FG003|Overall Study|Lack of Efficacy|9|||
105503648|NCT00939770|363854386|FG004|Overall Study|Lack of Efficacy|16|||
105438159|NCT03495102|363611508|FG000|Overall Study|Non-compliance|1|||
105438160|NCT03495102|363611509|FG001|Overall Study|Non-compliance|0|||
105438161|NCT03495102|363611510|FG002|Overall Study|Non-compliance|0|||
105438162|NCT03495102|363611508|FG000|Overall Study|Participant Duplicated at Another Site|0|||
105438163|NCT03495102|363611509|FG001|Overall Study|Participant Duplicated at Another Site|0|||
105438164|NCT03495102|363611510|FG002|Overall Study|Participant Duplicated at Another Site|1|||
105438165|NCT03495102|363611508|FG000|Overall Study|Primary Care Physician Recommendation|0|||
105438166|NCT03495102|363611509|FG001|Overall Study|Primary Care Physician Recommendation|1|||
105438167|NCT03495102|363611510|FG002|Overall Study|Primary Care Physician Recommendation|0|||
105438168|NCT03495102|363611508|FG000|Overall Study|Relocated to Another Country|0|||
105438169|NCT03495102|363611509|FG001|Overall Study|Relocated to Another Country|1|||
105438170|NCT03495102|363611510|FG002|Overall Study|Relocated to Another Country|0|||
105438171|NCT03495102|363611508|FG000|Overall Study|Participant was in Rehabilitation|1|||
105438172|NCT03495102|363611509|FG001|Overall Study|Participant was in Rehabilitation|0|||
105438173|NCT03495102|363611510|FG002|Overall Study|Participant was in Rehabilitation|0|||
105438174|NCT00666224|363611518|FG000|Double-Blind|Adverse Event|15|||
105438175|NCT00666224|363611519|FG001|Double-Blind|Adverse Event|5|||
105438176|NCT00666224|363611518|FG000|Double-Blind|Lost to Follow-up|2|||
105438177|NCT00666224|363611519|FG001|Double-Blind|Lost to Follow-up|2|||
105438178|NCT00666224|363611518|FG000|Double-Blind|Withdrawal by Subject|18|||
105438179|NCT00666224|363611519|FG001|Double-Blind|Withdrawal by Subject|14|||
105438180|NCT00666224|363611518|FG000|Double-Blind|Physician Decision|0|||
105438181|NCT00666224|363611519|FG001|Double-Blind|Physician Decision|3|||
105438182|NCT00666224|363611518|FG000|Double-Blind|Sponsor decision|1|||
105438183|NCT00666224|363611519|FG001|Double-Blind|Sponsor decision|0|||
105438184|NCT00666224|363611518|FG000|Double-Blind|Pregnancy|3|||
105438185|NCT00666224|363611519|FG001|Double-Blind|Pregnancy|2|||
105438186|NCT00666224|363611518|FG000|Double-Blind|Noncompliance|1|||
105438187|NCT00666224|363611519|FG001|Double-Blind|Noncompliance|0|||
105438188|NCT00666224|363611518|FG000|Double-Blind|Death|1|||
105438189|NCT00666224|363611519|FG001|Double-Blind|Death|0|||
105438190|NCT00666224|363611518|FG000|Double-Blind|Undefined/Unknown|4|||
105438191|NCT00666224|363611519|FG001|Double-Blind|Undefined/Unknown|1|||
105438192|NCT00666224|363611518|FG000|Open-Label|Adverse Event|8|||
105438193|NCT00666224|363611519|FG001|Open-Label|Adverse Event|43|||
105438194|NCT00666224|363611518|FG000|Open-Label|Lost to Follow-up|4|||
105438195|NCT00666224|363611519|FG001|Open-Label|Lost to Follow-up|5|||
105438196|NCT00666224|363611518|FG000|Open-Label|Withdrawal by Subject|12|||
105438197|NCT00666224|363611519|FG001|Open-Label|Withdrawal by Subject|25|||
105438198|NCT00666224|363611518|FG000|Open-Label|Physician Decision|7|||
105438199|NCT00666224|363611519|FG001|Open-Label|Physician Decision|5|||
105438200|NCT00666224|363611518|FG000|Open-Label|Pregnancy|1|||
105438201|NCT00666224|363611519|FG001|Open-Label|Pregnancy|5|||
105438202|NCT00666224|363611518|FG000|Open-Label|Noncompliance|2|||
105438203|NCT00666224|363611519|FG001|Open-Label|Noncompliance|1|||
105438204|NCT00666224|363611518|FG000|Open-Label|Undefined/Unknown|1|||
105438205|NCT00666224|363611519|FG001|Open-Label|Undefined/Unknown|1|||
105438206|NCT02814175|363611520|FG000|Part 1|Adverse Event|2|||
105438207|NCT02814175|363611521|FG001|Part 1|Adverse Event|3|||
105438208|NCT02814175|363611522|FG002|Part 1|Adverse Event|0|||
105438209|NCT02814175|363611523|FG003|Part 1|Adverse Event|0|||
105438210|NCT02814175|363611524|FG004|Part 1|Adverse Event|0|||
105438211|NCT02814175|363611525|FG005|Part 1|Adverse Event|0|||
105438212|NCT02814175|363611520|FG000|Part 1|Withdrawal Consent|8|||
105438213|NCT02814175|363611521|FG001|Part 1|Withdrawal Consent|1|||
105438214|NCT02814175|363611522|FG002|Part 1|Withdrawal Consent|0|||
105438215|NCT02814175|363611523|FG003|Part 1|Withdrawal Consent|0|||
105438216|NCT02814175|363611524|FG004|Part 1|Withdrawal Consent|0|||
105438217|NCT02814175|363611525|FG005|Part 1|Withdrawal Consent|0|||
105438218|NCT02814175|363611520|FG000|Part 1|Lost to Follow-up|1|||
105438219|NCT02814175|363611521|FG001|Part 1|Lost to Follow-up|0|||
105438220|NCT02814175|363611522|FG002|Part 1|Lost to Follow-up|0|||
105438221|NCT02814175|363611523|FG003|Part 1|Lost to Follow-up|0|||
105438222|NCT02814175|363611524|FG004|Part 1|Lost to Follow-up|0|||
105438223|NCT02814175|363611525|FG005|Part 1|Lost to Follow-up|0|||
105438224|NCT02814175|363611520|FG000|Part 1|Lack of Efficacy|1|||
105438225|NCT02814175|363611521|FG001|Part 1|Lack of Efficacy|2|||
105438226|NCT02814175|363611522|FG002|Part 1|Lack of Efficacy|0|||
105438227|NCT02814175|363611523|FG003|Part 1|Lack of Efficacy|0|||
105438228|NCT02814175|363611524|FG004|Part 1|Lack of Efficacy|0|||
105438229|NCT02814175|363611525|FG005|Part 1|Lack of Efficacy|0|||
105438230|NCT02814175|363611520|FG000|Part 2|Adverse Event|0|||
105438231|NCT02814175|363611521|FG001|Part 2|Adverse Event|0|||
105438232|NCT02814175|363611522|FG002|Part 2|Adverse Event|0|||
105438233|NCT02814175|363611523|FG003|Part 2|Adverse Event|1|||
105438234|NCT02814175|363611524|FG004|Part 2|Adverse Event|1|||
105438235|NCT02814175|363611525|FG005|Part 2|Adverse Event|2|||
105438236|NCT02814175|363611520|FG000|Part 2|Withdrawal Consent|0|||
105438237|NCT02814175|363611521|FG001|Part 2|Withdrawal Consent|0|||
105438238|NCT02814175|363611522|FG002|Part 2|Withdrawal Consent|0|||
105438239|NCT02814175|363611523|FG003|Part 2|Withdrawal Consent|2|||
105438240|NCT02814175|363611524|FG004|Part 2|Withdrawal Consent|1|||
105438241|NCT02814175|363611525|FG005|Part 2|Withdrawal Consent|1|||
105438242|NCT02814175|363611520|FG000|Part 2|Lost to Follow-up|0|||
105438243|NCT02814175|363611521|FG001|Part 2|Lost to Follow-up|0|||
105438244|NCT02814175|363611522|FG002|Part 2|Lost to Follow-up|0|||
105438245|NCT02814175|363611523|FG003|Part 2|Lost to Follow-up|1|||
105438246|NCT02814175|363611524|FG004|Part 2|Lost to Follow-up|0|||
105503649|NCT00939770|363854387|FG005|Overall Study|Lack of Efficacy|8|||
105503650|NCT00939770|363854388|FG006|Overall Study|Lack of Efficacy|11|||
105503651|NCT00939770|363854389|FG007|Overall Study|Lack of Efficacy|1|||
105503652|NCT00939770|363854382|FG000|Overall Study|Lost to Follow-up|0|||
105503653|NCT00939770|363854383|FG001|Overall Study|Lost to Follow-up|0|||
105503654|NCT00939770|363854384|FG002|Overall Study|Lost to Follow-up|0|||
105503655|NCT00939770|363854385|FG003|Overall Study|Lost to Follow-up|0|||
105503656|NCT00939770|363854386|FG004|Overall Study|Lost to Follow-up|1|||
105503657|NCT00939770|363854387|FG005|Overall Study|Lost to Follow-up|0|||
105503658|NCT00939770|363854388|FG006|Overall Study|Lost to Follow-up|0|||
105503659|NCT00939770|363854389|FG007|Overall Study|Lost to Follow-up|0|||
105503660|NCT00939770|363854382|FG000|Overall Study|Physician Decision|0|||
105503661|NCT00939770|363854383|FG001|Overall Study|Physician Decision|0|||
105503662|NCT00939770|363854384|FG002|Overall Study|Physician Decision|2|||
105503663|NCT00939770|363854385|FG003|Overall Study|Physician Decision|0|||
105503664|NCT00939770|363854386|FG004|Overall Study|Physician Decision|7|||
105503665|NCT00939770|363854387|FG005|Overall Study|Physician Decision|1|||
105503666|NCT00939770|363854388|FG006|Overall Study|Physician Decision|0|||
105503667|NCT00939770|363854389|FG007|Overall Study|Physician Decision|6|||
105503668|NCT00939770|363854382|FG000|Overall Study|Protocol Violation|0|||
105503669|NCT00939770|363854383|FG001|Overall Study|Protocol Violation|0|||
105503670|NCT00939770|363854384|FG002|Overall Study|Protocol Violation|0|||
105503671|NCT00939770|363854385|FG003|Overall Study|Protocol Violation|0|||
105503672|NCT00939770|363854386|FG004|Overall Study|Protocol Violation|1|||
105503673|NCT00939770|363854387|FG005|Overall Study|Protocol Violation|0|||
105503674|NCT00939770|363854388|FG006|Overall Study|Protocol Violation|0|||
105503675|NCT00939770|363854389|FG007|Overall Study|Protocol Violation|0|||
105503676|NCT00939770|363854382|FG000|Overall Study|Withdrawal by Subject|0|||
105503677|NCT00939770|363854383|FG001|Overall Study|Withdrawal by Subject|1|||
105503678|NCT00939770|363854384|FG002|Overall Study|Withdrawal by Subject|5|||
105503679|NCT00939770|363854385|FG003|Overall Study|Withdrawal by Subject|2|||
105503680|NCT00939770|363854386|FG004|Overall Study|Withdrawal by Subject|6|||
105503681|NCT00939770|363854387|FG005|Overall Study|Withdrawal by Subject|0|||
105503682|NCT00939770|363854388|FG006|Overall Study|Withdrawal by Subject|2|||
105503683|NCT00939770|363854389|FG007|Overall Study|Withdrawal by Subject|2|||
105503684|NCT04066023|363854390|FG000|Overall Study|Adverse Event|0|||
105503685|NCT04066023|363854391|FG001|Overall Study|Adverse Event|0|||
105503686|NCT04066023|363854392|FG002|Overall Study|Adverse Event|1|||
105503687|NCT04066023|363854390|FG000|Overall Study|Sponsor decision|3|||
105503688|NCT04066023|363854391|FG001|Overall Study|Sponsor decision|6|||
105503689|NCT04066023|363854392|FG002|Overall Study|Sponsor decision|2|||
105503690|NCT04066023|363854390|FG000|Overall Study|Physician Decision|0|||
105503691|NCT04066023|363854391|FG001|Overall Study|Physician Decision|0|||
105503692|NCT04066023|363854392|FG002|Overall Study|Physician Decision|1|||
105503693|NCT04066023|363854390|FG000|Overall Study|Lost to Follow-up|0|||
105503694|NCT04066023|363854391|FG001|Overall Study|Lost to Follow-up|1|||
105503695|NCT04066023|363854392|FG002|Overall Study|Lost to Follow-up|1|||
105503696|NCT04066023|363854390|FG000|Overall Study|Noncompliance|0|||
105503697|NCT04066023|363854391|FG001|Overall Study|Noncompliance|1|||
105503698|NCT04066023|363854392|FG002|Overall Study|Noncompliance|1|||
105503699|NCT03338010|363854393|FG000|Overall Study|Withdrawal by Subject|14|||
105503700|NCT03338010|363854394|FG001|Overall Study|Withdrawal by Subject|8|||
105503701|NCT03338010|363854393|FG000|Overall Study|Lost to Follow-up|4|||
105503702|NCT03338010|363854394|FG001|Overall Study|Lost to Follow-up|2|||
105503703|NCT03338010|363854393|FG000|Overall Study|Adverse Event|3|||
105503704|NCT03338010|363854394|FG001|Overall Study|Adverse Event|2|||
105503705|NCT03338010|363854393|FG000|Overall Study|Physician Decision|2|||
105503706|NCT03338010|363854394|FG001|Overall Study|Physician Decision|2|||
105503707|NCT03338010|363854393|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105503708|NCT03338010|363854394|FG001|Overall Study|Non-Compliance with Study Drug|3|||
105503709|NCT03338010|363854393|FG000|Overall Study|Protocol Violation|0|||
105503710|NCT03338010|363854394|FG001|Overall Study|Protocol Violation|1|||
105503711|NCT00114530|363854399|FG000|Overall Study|Death|3|||
105503712|NCT00114530|363854400|FG001|Overall Study|Death|11|||
105503713|NCT00114530|363854399|FG000|Overall Study|Lost to Follow-up|1|||
105503714|NCT00114530|363854400|FG001|Overall Study|Lost to Follow-up|1|||
105503715|NCT00114530|363854399|FG000|Overall Study|Physician Decision|1|||
105503716|NCT00114530|363854400|FG001|Overall Study|Physician Decision|1|||
105503717|NCT00114530|363854399|FG000|Overall Study|Withdrawal by Subject|2|||
105503718|NCT00114530|363854400|FG001|Overall Study|Withdrawal by Subject|6|||
105503719|NCT00114530|363854399|FG000|Overall Study|Breast Cancer|1|||
105503720|NCT00114530|363854400|FG001|Overall Study|Breast Cancer|0|||
105503721|NCT00114530|363854399|FG000|Overall Study|Subject decision after endpoint failure|0|||
105503722|NCT00114530|363854400|FG001|Overall Study|Subject decision after endpoint failure|1|||
105503723|NCT00114530|363854399|FG000|Overall Study|Ineligible|1|||
105503724|NCT00114530|363854400|FG001|Overall Study|Ineligible|0|||
105503725|NCT01385566|363855769|FG000|Overall Study|Lost to Follow-up|1|||
105503726|NCT01385566|363855770|FG001|Overall Study|Lost to Follow-up|0|||
105503727|NCT01385566|363855771|FG002|Overall Study|Lost to Follow-up|0|||
105503728|NCT01385566|363855772|FG003|Overall Study|Lost to Follow-up|0|||
105503729|NCT01385566|363855773|FG004|Overall Study|Lost to Follow-up|0|||
105503730|NCT01385566|363855774|FG005|Overall Study|Lost to Follow-up|0|||
105503731|NCT01385566|363855769|FG000|Overall Study|Withdrawal by Subject|0|||
105503732|NCT01385566|363855770|FG001|Overall Study|Withdrawal by Subject|0|||
105503733|NCT01385566|363855771|FG002|Overall Study|Withdrawal by Subject|0|||
105503734|NCT01385566|363855772|FG003|Overall Study|Withdrawal by Subject|1|||
105503735|NCT01385566|363855773|FG004|Overall Study|Withdrawal by Subject|0|||
105503736|NCT01385566|363855774|FG005|Overall Study|Withdrawal by Subject|0|||
105503737|NCT00403234|363855775|FG000|Overall Study|Withdrawal by Subject|0|||
105503738|NCT00403234|363855776|FG001|Overall Study|Withdrawal by Subject|1|||
105503739|NCT00403234|363855777|FG002|Overall Study|Withdrawal by Subject|0|||
105503740|NCT00403234|363855778|FG003|Overall Study|Withdrawal by Subject|0|||
105503741|NCT00403234|363855775|FG000|Overall Study|Adverse Event|1|||
105503742|NCT00403234|363855776|FG001|Overall Study|Adverse Event|0|||
105503743|NCT00403234|363855777|FG002|Overall Study|Adverse Event|1|||
105503744|NCT00403234|363855778|FG003|Overall Study|Adverse Event|0|||
105503745|NCT00042289|363855784|FG000|Overall Study|Lost to Follow-up|3|||
105503746|NCT00042289|363855785|FG001|Overall Study|Lost to Follow-up|0|||
105503747|NCT00042289|363855786|FG002|Overall Study|Lost to Follow-up|0|||
105503748|NCT00042289|363855787|FG003|Overall Study|Lost to Follow-up|1|||
105503749|NCT00042289|363855788|FG004|Overall Study|Lost to Follow-up|3|||
105503750|NCT00042289|363855789|FG005|Overall Study|Lost to Follow-up|3|||
105503751|NCT00042289|363855790|FG006|Overall Study|Lost to Follow-up|6|||
105503752|NCT00042289|363855791|FG007|Overall Study|Lost to Follow-up|1|||
105503753|NCT00042289|363855792|FG008|Overall Study|Lost to Follow-up|1|||
105503754|NCT00042289|363855793|FG009|Overall Study|Lost to Follow-up|0|||
105503755|NCT00042289|363855794|FG010|Overall Study|Lost to Follow-up|0|||
105503756|NCT00042289|363855795|FG011|Overall Study|Lost to Follow-up|0|||
105503757|NCT00042289|363855796|FG012|Overall Study|Lost to Follow-up|0|||
105438247|NCT02814175|363611525|FG005|Part 2|Lost to Follow-up|0|||
105438248|NCT02814175|363611520|FG000|Part 2|Lack of Efficacy|0|||
105438249|NCT02814175|363611521|FG001|Part 2|Lack of Efficacy|0|||
105438250|NCT02814175|363611522|FG002|Part 2|Lack of Efficacy|0|||
105438251|NCT02814175|363611523|FG003|Part 2|Lack of Efficacy|0|||
105438252|NCT02814175|363611524|FG004|Part 2|Lack of Efficacy|0|||
105438253|NCT02814175|363611525|FG005|Part 2|Lack of Efficacy|3|||
105438254|NCT01450098|363611526|FG000|Period 3|Protocol Violation|0|||
105438255|NCT01450098|363611527|FG001|Period 3|Protocol Violation|1|||
105438256|NCT01450098|363611526|FG000|Period 3|Withdrawal by Subject|0|||
105438257|NCT01450098|363611527|FG001|Period 3|Withdrawal by Subject|2|||
105438258|NCT01363661|363611535|FG000|Overall Study|Adverse Event|9|||
105438259|NCT01363661|363611536|FG001|Overall Study|Adverse Event|2|||
105438260|NCT01363661|363611535|FG000|Overall Study|Withdrawal by Subject|1|||
105438261|NCT01363661|363611536|FG001|Overall Study|Withdrawal by Subject|1|||
105438262|NCT01363661|363611535|FG000|Overall Study|Protocol Violation|1|||
105438263|NCT01363661|363611536|FG001|Overall Study|Protocol Violation|0|||
105438264|NCT01363661|363611535|FG000|Overall Study|Lost to Follow-up|3|||
105438265|NCT01363661|363611536|FG001|Overall Study|Lost to Follow-up|1|||
105438266|NCT03775512|363611537|FG000|Overall Study|Death|1|||
105438267|NCT03775512|363611538|FG001|Overall Study|Death|1|||
105438268|NCT03775512|363611537|FG000|Overall Study|Withdrawal by Subject|7|||
105438269|NCT03775512|363611538|FG001|Overall Study|Withdrawal by Subject|4|||
105438270|NCT03775512|363611537|FG000|Overall Study|Lost to Follow-up|5|||
105438271|NCT03775512|363611538|FG001|Overall Study|Lost to Follow-up|5|||
105438272|NCT03775512|363611537|FG000|Overall Study|Excluded before Catheter insertion|14|||
105438273|NCT03775512|363611538|FG001|Overall Study|Excluded before Catheter insertion|5|||
105438274|NCT03775512|363611537|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
105438275|NCT03775512|363611538|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
105438276|NCT03775512|363611537|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
105438277|NCT03775512|363611538|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
105438278|NCT01378325|363611544|FG000|Overall Study|Protocol Violation|0|||
105438279|NCT01378325|363611545|FG001|Overall Study|Protocol Violation|1|||
105438280|NCT03464019|363611546|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
105438281|NCT03464019|363611547|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
105503758|NCT00042289|363855797|FG013|Overall Study|Lost to Follow-up|0|||
105438282|NCT03464019|363611548|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
105438283|NCT03464019|363611546|FG000|NODE-301 Part 1|Ablation|0|||
105438284|NCT03464019|363611547|FG001|NODE-301 Part 1|Ablation|0|||
105438285|NCT03464019|363611548|FG002|NODE-301 Part 1|Ablation|16|||
105438286|NCT03464019|363611546|FG000|NODE-301 Part 1|Test Dose Failure|0|||
105503759|NCT00042289|363855798|FG014|Overall Study|Lost to Follow-up|0|||
105503760|NCT00042289|363855799|FG015|Overall Study|Lost to Follow-up|1|||
105503761|NCT00042289|363855800|FG016|Overall Study|Lost to Follow-up|1|||
105503762|NCT00042289|363855801|FG017|Overall Study|Lost to Follow-up|0|||
105503763|NCT00042289|363855802|FG018|Overall Study|Lost to Follow-up|3|||
105503764|NCT00042289|363855803|FG019|Overall Study|Lost to Follow-up|2|||
105503765|NCT00042289|363855804|FG020|Overall Study|Lost to Follow-up|0|||
105438287|NCT03464019|363611547|FG001|NODE-301 Part 1|Test Dose Failure|0|||
105438288|NCT03464019|363611548|FG002|NODE-301 Part 1|Test Dose Failure|8|||
105438289|NCT03464019|363611546|FG000|NODE-301 Part 1|Adverse Event|0|||
105438290|NCT03464019|363611547|FG001|NODE-301 Part 1|Adverse Event|0|||
105438291|NCT03464019|363611548|FG002|NODE-301 Part 1|Adverse Event|5|||
105438292|NCT03464019|363611546|FG000|NODE-301 Part 1|Physician Decision|0|||
105438293|NCT03464019|363611547|FG001|NODE-301 Part 1|Physician Decision|0|||
105438294|NCT03464019|363611548|FG002|NODE-301 Part 1|Physician Decision|4|||
105438295|NCT03464019|363611546|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
105438296|NCT03464019|363611547|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
105438297|NCT03464019|363611548|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
105438298|NCT03464019|363611546|FG000|NODE-301 Part 1|Protocol Violation|0|||
105438299|NCT03464019|363611547|FG001|NODE-301 Part 1|Protocol Violation|0|||
105438300|NCT03464019|363611548|FG002|NODE-301 Part 1|Protocol Violation|2|||
105438301|NCT03464019|363611546|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
105438302|NCT03464019|363611547|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
105438303|NCT03464019|363611548|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
105438304|NCT03464019|363611546|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
105438305|NCT03464019|363611547|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
105438306|NCT03464019|363611548|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
105438307|NCT03464019|363611546|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
105438308|NCT03464019|363611547|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
105438309|NCT03464019|363611548|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
105438310|NCT03464019|363611546|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
105438311|NCT03464019|363611547|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
105438312|NCT03464019|363611548|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
105438313|NCT03464019|363611546|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
105438314|NCT03464019|363611547|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
105438315|NCT03464019|363611548|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
105438316|NCT03464019|363611546|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
105438317|NCT03464019|363611547|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
105438318|NCT03464019|363611548|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
105438319|NCT03464019|363611546|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
105438320|NCT03464019|363611547|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
105438321|NCT03464019|363611548|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
105438322|NCT03464019|363611546|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
105438323|NCT03464019|363611547|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
105438324|NCT03464019|363611548|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
105438325|NCT03464019|363611546|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
105438326|NCT03464019|363611547|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
105438327|NCT03464019|363611548|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
105438328|NCT03464019|363611546|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
105438329|NCT03464019|363611547|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
105438330|NCT03464019|363611548|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
105438331|NCT03464019|363611546|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
105438332|NCT03464019|363611547|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
105438333|NCT03464019|363611548|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
105438334|NCT03464019|363611546|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
105438335|NCT03464019|363611547|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
105438336|NCT03464019|363611548|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
105438337|NCT03464019|363611546|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
105438338|NCT03464019|363611547|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
105438339|NCT03464019|363611548|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
105438340|NCT03464019|363611546|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
105438341|NCT03464019|363611547|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
105438342|NCT03464019|363611548|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
105438343|NCT00193180|363611549|FG000|Overall Study|Lack of Efficacy|1|||
105438344|NCT00193180|363611549|FG000|Overall Study|Adverse Event|8|||
105438345|NCT00193180|363611549|FG000|Overall Study|Protocol Violation|1|||
105438346|NCT01357551|363611550|FG000|Overall Study|Withdrawal by Subject|6|||
105438347|NCT01357551|363611551|FG001|Overall Study|Withdrawal by Subject|4|||
105438348|NCT01357551|363611550|FG000|Overall Study|Death|0|||
105438349|NCT01357551|363611551|FG001|Overall Study|Death|1|||
105438350|NCT01357551|363611550|FG000|Overall Study|Lost to Follow-up|16|||
105438351|NCT01357551|363611551|FG001|Overall Study|Lost to Follow-up|6|||
105438352|NCT01272635|363611552|FG000|Overall Study|Lost to Follow-up|31|||
105438353|NCT01272635|363611553|FG001|Overall Study|Lost to Follow-up|20|||
105438354|NCT01272635|363611554|FG002|Overall Study|Lost to Follow-up|31|||
105438355|NCT01272635|363611555|FG003|Overall Study|Lost to Follow-up|23|||
105438356|NCT00891228|363611558|FG000|Overall Study|Adverse Event|0|||
105438357|NCT00891228|363611559|FG001|Overall Study|Adverse Event|2|||
105438358|NCT00891228|363611560|FG002|Overall Study|Adverse Event|3|||
105503766|NCT00042289|363855805|FG021|Overall Study|Lost to Follow-up|0|||
105503767|NCT00042289|363855806|FG022|Overall Study|Lost to Follow-up|0|||
105438359|NCT00891228|363611558|FG000|Overall Study|Withdrawal by Subject|2|||
105438360|NCT00891228|363611559|FG001|Overall Study|Withdrawal by Subject|4|||
105438361|NCT00891228|363611560|FG002|Overall Study|Withdrawal by Subject|5|||
105438362|NCT00891228|363611558|FG000|Overall Study|Protocol Violation|3|||
105438363|NCT00891228|363611559|FG001|Overall Study|Protocol Violation|1|||
105438364|NCT00891228|363611560|FG002|Overall Study|Protocol Violation|2|||
105438365|NCT00891228|363611558|FG000|Overall Study|Physician Decision|2|||
105438366|NCT00891228|363611559|FG001|Overall Study|Physician Decision|1|||
105438367|NCT00891228|363611560|FG002|Overall Study|Physician Decision|0|||
105438368|NCT00891228|363611558|FG000|Overall Study|Lost to Follow-up|4|||
105438369|NCT00891228|363611559|FG001|Overall Study|Lost to Follow-up|4|||
105438370|NCT00891228|363611560|FG002|Overall Study|Lost to Follow-up|5|||
105438371|NCT00891228|363611558|FG000|Overall Study|Pregnancy|0|||
105438372|NCT00891228|363611559|FG001|Overall Study|Pregnancy|1|||
105438373|NCT00891228|363611560|FG002|Overall Study|Pregnancy|0|||
105438374|NCT04541628|363611563|FG000|Overall Study|Study Terminated|1|||
105438375|NCT04541628|363611564|FG001|Overall Study|Study Terminated|1|||
105438376|NCT04541628|363611565|FG002|Overall Study|Study Terminated|1|||
105438377|NCT02141360|363611567|FG000|Overall Study|Withdrawal by Subject|6|||
105438378|NCT02141360|363611568|FG001|Overall Study|Withdrawal by Subject|0|||
105438379|NCT02141360|363611569|FG002|Overall Study|Withdrawal by Subject|0|||
105438380|NCT02141360|363611567|FG000|Overall Study|Study Terminated before Visit|1|||
105438381|NCT02141360|363611568|FG001|Overall Study|Study Terminated before Visit|0|||
105438382|NCT02141360|363611569|FG002|Overall Study|Study Terminated before Visit|0|||
105438383|NCT00455143|363611572|FG000|Overall Study|Physician Decision|1|||
105438384|NCT00455143|363611572|FG000|Overall Study|Withdrawal by Subject|1|||
105438385|NCT00455143|363611572|FG000|Overall Study|Staff was not avail to follow patient|2|||
105438386|NCT00455143|363611572|FG000|Overall Study|No longer met Inclusion Criteria|1|||
105438387|NCT00455143|363611572|FG000|Overall Study|Surgical time, staff not available|1|||
105438388|NCT01423916|363611573|FG000|Overall Study|Adverse Event|5|||
105438389|NCT01423916|363611574|FG001|Overall Study|Adverse Event|9|||
105438390|NCT01423916|363611575|FG002|Overall Study|Adverse Event|2|||
105438391|NCT01423916|363611573|FG000|Overall Study|Met Withdrawal Criteria|1|||
105438392|NCT01423916|363611574|FG001|Overall Study|Met Withdrawal Criteria|1|||
105438393|NCT01423916|363611575|FG002|Overall Study|Met Withdrawal Criteria|1|||
105438394|NCT01423916|363611573|FG000|Overall Study|Physician Decision|1|||
105438395|NCT01423916|363611574|FG001|Overall Study|Physician Decision|0|||
105438396|NCT01423916|363611575|FG002|Overall Study|Physician Decision|1|||
105438397|NCT01423916|363611573|FG000|Overall Study|Withdrawal by Subject|3|||
105438398|NCT01423916|363611574|FG001|Overall Study|Withdrawal by Subject|10|||
105438399|NCT01423916|363611575|FG002|Overall Study|Withdrawal by Subject|3|||
105438400|NCT01423916|363611573|FG000|Overall Study|Protocol Deviation|1|||
105438401|NCT01423916|363611574|FG001|Overall Study|Protocol Deviation|0|||
105438402|NCT01423916|363611575|FG002|Overall Study|Protocol Deviation|0|||
105438403|NCT04856904|363611576|FG000|Overall Study|Physician Decision|1|||
105438404|NCT04856904|363611577|FG001|Overall Study|Physician Decision|1|||
105438405|NCT04856904|363611576|FG000|Overall Study|Withdrawal by Subject|13|||
105438406|NCT04856904|363611577|FG001|Overall Study|Withdrawal by Subject|13|||
105438407|NCT04856904|363611576|FG000|Overall Study|Adverse Event|1|||
105438408|NCT04856904|363611577|FG001|Overall Study|Adverse Event|1|||
105438409|NCT04856904|363611576|FG000|Overall Study|Non-compliance with study drug|1|||
105438410|NCT04856904|363611577|FG001|Overall Study|Non-compliance with study drug|1|||
105438411|NCT04856904|363611576|FG000|Overall Study|Lost to Follow-up|4|||
105438412|NCT04856904|363611577|FG001|Overall Study|Lost to Follow-up|4|||
105438413|NCT04856904|363611576|FG000|Overall Study|Withdrawal by Subject|1|||
105438414|NCT04856904|363611577|FG001|Overall Study|Withdrawal by Subject|1|||
105438415|NCT04856904|363611576|FG000|Overall Study|Protocol Violation|1|||
105438416|NCT04856904|363611577|FG001|Overall Study|Protocol Violation|1|||
105438417|NCT00077649|363611578|FG000|Overall Study|Adverse Event|5|||
105438418|NCT00077649|363611579|FG001|Overall Study|Adverse Event|1|||
105438419|NCT00077649|363611580|FG002|Overall Study|Adverse Event|7|||
105438420|NCT00077649|363611581|FG003|Overall Study|Adverse Event|9|||
105438421|NCT00077649|363611578|FG000|Overall Study|Lack of Efficacy|5|||
105438422|NCT00077649|363611579|FG001|Overall Study|Lack of Efficacy|3|||
105438423|NCT00077649|363611580|FG002|Overall Study|Lack of Efficacy|3|||
105438424|NCT00077649|363611581|FG003|Overall Study|Lack of Efficacy|2|||
105438425|NCT00077649|363611578|FG000|Overall Study|Withdrawal by Subject|0|||
105438426|NCT00077649|363611579|FG001|Overall Study|Withdrawal by Subject|1|||
105438427|NCT00077649|363611580|FG002|Overall Study|Withdrawal by Subject|1|||
105438428|NCT00077649|363611581|FG003|Overall Study|Withdrawal by Subject|2|||
105438429|NCT00077649|363611578|FG000|Overall Study|Lost to Follow-up|2|||
105438430|NCT00077649|363611579|FG001|Overall Study|Lost to Follow-up|2|||
105438431|NCT00077649|363611580|FG002|Overall Study|Lost to Follow-up|3|||
105438432|NCT00077649|363611581|FG003|Overall Study|Lost to Follow-up|2|||
105438433|NCT00077649|363611578|FG000|Overall Study|Abnormality of Laboratory Test|1|||
105438434|NCT00077649|363611579|FG001|Overall Study|Abnormality of Laboratory Test|2|||
105438435|NCT00077649|363611580|FG002|Overall Study|Abnormality of Laboratory Test|1|||
105438436|NCT00077649|363611581|FG003|Overall Study|Abnormality of Laboratory Test|2|||
105503768|NCT00042289|363855807|FG023|Overall Study|Lost to Follow-up|0|||
105503769|NCT00042289|363855808|FG024|Overall Study|Lost to Follow-up|0|||
105503770|NCT00042289|363855809|FG025|Overall Study|Lost to Follow-up|0|||
105503771|NCT00042289|363855810|FG026|Overall Study|Lost to Follow-up|2|||
105503772|NCT00042289|363855811|FG027|Overall Study|Lost to Follow-up|2|||
105503773|NCT00042289|363855812|FG028|Overall Study|Lost to Follow-up|2|||
105503774|NCT00042289|363855813|FG029|Overall Study|Lost to Follow-up|0|||
105503775|NCT00042289|363855814|FG030|Overall Study|Lost to Follow-up|0|||
105503776|NCT00042289|363855815|FG031|Overall Study|Lost to Follow-up|2|||
105503777|NCT00042289|363855816|FG032|Overall Study|Lost to Follow-up|1|||
105503778|NCT00042289|363855817|FG033|Overall Study|Lost to Follow-up|1|||
105503779|NCT00042289|363855818|FG034|Overall Study|Lost to Follow-up|1|||
105503780|NCT00042289|363855819|FG035|Overall Study|Lost to Follow-up|2|||
105503781|NCT00042289|363855820|FG036|Overall Study|Lost to Follow-up|1|||
105503782|NCT00042289|363855821|FG037|Overall Study|Lost to Follow-up|1|||
105503783|NCT00042289|363855822|FG038|Overall Study|Lost to Follow-up|0|||
105503784|NCT00042289|363855823|FG039|Overall Study|Lost to Follow-up|5|||
105503785|NCT00042289|363855824|FG040|Overall Study|Lost to Follow-up|0|||
105503786|NCT00042289|363855825|FG041|Overall Study|Lost to Follow-up|2|||
105503787|NCT00042289|363855826|FG042|Overall Study|Lost to Follow-up|2|||
105503788|NCT00042289|363855827|FG043|Overall Study|Lost to Follow-up|0|||
105503789|NCT00042289|363855828|FG044|Overall Study|Lost to Follow-up|0|||
105503790|NCT00042289|363855829|FG045|Overall Study|Lost to Follow-up|1|||
105503791|NCT00042289|363855830|FG046|Overall Study|Lost to Follow-up|0|||
105503792|NCT00042289|363855784|FG000|Overall Study|Other reason|0|||
105503793|NCT00042289|363855785|FG001|Overall Study|Other reason|0|||
105503794|NCT00042289|363855786|FG002|Overall Study|Other reason|0|||
105503795|NCT00042289|363855787|FG003|Overall Study|Other reason|2|||
105503796|NCT00042289|363855788|FG004|Overall Study|Other reason|0|||
105503797|NCT00042289|363855789|FG005|Overall Study|Other reason|0|||
105503798|NCT00042289|363855790|FG006|Overall Study|Other reason|0|||
105503799|NCT00042289|363855791|FG007|Overall Study|Other reason|0|||
105503800|NCT00042289|363855792|FG008|Overall Study|Other reason|0|||
105503801|NCT00042289|363855793|FG009|Overall Study|Other reason|0|||
105503802|NCT00042289|363855794|FG010|Overall Study|Other reason|0|||
105503803|NCT00042289|363855795|FG011|Overall Study|Other reason|0|||
105503804|NCT00042289|363855796|FG012|Overall Study|Other reason|0|||
105503805|NCT00042289|363855797|FG013|Overall Study|Other reason|0|||
105503806|NCT00042289|363855798|FG014|Overall Study|Other reason|0|||
105503807|NCT00042289|363855799|FG015|Overall Study|Other reason|0|||
105503808|NCT00042289|363855800|FG016|Overall Study|Other reason|0|||
105438437|NCT00077649|363611578|FG000|Overall Study|Randomized but never dosed|1|||
105438438|NCT00077649|363611579|FG001|Overall Study|Randomized but never dosed|0|||
105438439|NCT00077649|363611580|FG002|Overall Study|Randomized but never dosed|0|||
105438440|NCT00077649|363611581|FG003|Overall Study|Randomized but never dosed|0|||
105438441|NCT01009086|363611587|FG000|Overall Study|Lack of Efficacy|16|||
105438442|NCT01009086|363611588|FG001|Overall Study|Lack of Efficacy|15|||
105438443|NCT01009086|363611589|FG002|Overall Study|Lack of Efficacy|9|||
105438444|NCT01009086|363611587|FG000|Overall Study|Lost to Follow-up|4|||
105438445|NCT01009086|363611588|FG001|Overall Study|Lost to Follow-up|5|||
105438446|NCT01009086|363611589|FG002|Overall Study|Lost to Follow-up|3|||
105438447|NCT01009086|363611587|FG000|Overall Study|Adverse Event|12|||
105438448|NCT01009086|363611588|FG001|Overall Study|Adverse Event|11|||
105438449|NCT01009086|363611589|FG002|Overall Study|Adverse Event|8|||
105438450|NCT01009086|363611587|FG000|Overall Study|Withdrawal by Subject|9|||
105438451|NCT01009086|363611588|FG001|Overall Study|Withdrawal by Subject|11|||
105438452|NCT01009086|363611589|FG002|Overall Study|Withdrawal by Subject|13|||
105438453|NCT01009086|363611587|FG000|Overall Study|Other|3|||
105438454|NCT01009086|363611588|FG001|Overall Study|Other|5|||
105438455|NCT01009086|363611589|FG002|Overall Study|Other|1|||
105503809|NCT00042289|363855801|FG017|Overall Study|Other reason|0|||
105503810|NCT00042289|363855802|FG018|Overall Study|Other reason|1|||
105503811|NCT00042289|363855803|FG019|Overall Study|Other reason|0|||
105503812|NCT00042289|363855804|FG020|Overall Study|Other reason|0|||
105590690|NCT03523962|364162686|FG002|Closed Fractures|Death|0|||
105438456|NCT01424228|363611590|FG000|Overall Study|Withdrawal by Subject|27|||
105438457|NCT01424228|363611591|FG001|Overall Study|Withdrawal by Subject|11|||
105438458|NCT01424228|363611590|FG000|Overall Study|Adverse Event|10|||
105438459|NCT01424228|363611591|FG001|Overall Study|Adverse Event|14|||
105503813|NCT00042289|363855805|FG021|Overall Study|Other reason|0|||
105503814|NCT00042289|363855806|FG022|Overall Study|Other reason|0|||
105503815|NCT00042289|363855807|FG023|Overall Study|Other reason|1|||
105503816|NCT00042289|363855808|FG024|Overall Study|Other reason|0|||
105503817|NCT00042289|363855809|FG025|Overall Study|Other reason|0|||
105503818|NCT00042289|363855810|FG026|Overall Study|Other reason|1|||
105503819|NCT00042289|363855811|FG027|Overall Study|Other reason|0|||
105503820|NCT00042289|363855812|FG028|Overall Study|Other reason|3|||
105503821|NCT00042289|363855813|FG029|Overall Study|Other reason|0|||
105503822|NCT00042289|363855814|FG030|Overall Study|Other reason|0|||
105503823|NCT00042289|363855815|FG031|Overall Study|Other reason|1|||
105590691|NCT03523962|364162687|FG003|Closed Fractures|Death|0|||
105503824|NCT00042289|363855816|FG032|Overall Study|Other reason|0|||
105503825|NCT00042289|363855817|FG033|Overall Study|Other reason|1|||
105503826|NCT00042289|363855818|FG034|Overall Study|Other reason|0|||
105503827|NCT00042289|363855819|FG035|Overall Study|Other reason|2|||
105503828|NCT00042289|363855820|FG036|Overall Study|Other reason|0|||
105503829|NCT00042289|363855821|FG037|Overall Study|Other reason|0|||
105503830|NCT00042289|363855822|FG038|Overall Study|Other reason|0|||
105503831|NCT00042289|363855823|FG039|Overall Study|Other reason|0|||
105503832|NCT00042289|363855824|FG040|Overall Study|Other reason|0|||
105503833|NCT00042289|363855825|FG041|Overall Study|Other reason|0|||
105503834|NCT00042289|363855826|FG042|Overall Study|Other reason|0|||
105503835|NCT00042289|363855827|FG043|Overall Study|Other reason|1|||
105503836|NCT00042289|363855828|FG044|Overall Study|Other reason|0|||
105438460|NCT01424228|363611590|FG000|Overall Study|Sponsor's decision|9|||
105438461|NCT01424228|363611591|FG001|Overall Study|Sponsor's decision|12|||
105438462|NCT01424228|363611590|FG000|Overall Study|Lack of Efficacy|5|||
105503837|NCT00042289|363855829|FG045|Overall Study|Other reason|0|||
105503838|NCT00042289|363855830|FG046|Overall Study|Other reason|0|||
105503839|NCT00042289|363855784|FG000|Overall Study|Severe debilitation, unable to continue|0|||
105503840|NCT00042289|363855785|FG001|Overall Study|Severe debilitation, unable to continue|0|||
105503841|NCT00042289|363855786|FG002|Overall Study|Severe debilitation, unable to continue|0|||
105438463|NCT01424228|363611591|FG001|Overall Study|Lack of Efficacy|7|||
105438464|NCT01424228|363611590|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
105438465|NCT01424228|363611591|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
105438466|NCT01424228|363611590|FG000|Overall Study|Non-compliance|2|||
105438467|NCT01424228|363611591|FG001|Overall Study|Non-compliance|0|||
105438468|NCT01424228|363611590|FG000|Overall Study|Worsening of symptoms|1|||
105438469|NCT01424228|363611591|FG001|Overall Study|Worsening of symptoms|0|||
105438470|NCT01424228|363611590|FG000|Overall Study|Unplanned journey|0|||
105438471|NCT01424228|363611591|FG001|Overall Study|Unplanned journey|1|||
105438472|NCT01336023|363611594|FG000|Week 0 to Week 26|Adverse Event|8|||
105438473|NCT01336023|363611595|FG001|Week 0 to Week 26|Adverse Event|10|||
105438474|NCT01336023|363611596|FG002|Week 0 to Week 26|Adverse Event|24|||
105438475|NCT01336023|363611594|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
105438476|NCT01336023|363611595|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
105438477|NCT01336023|363611596|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
105438478|NCT01336023|363611594|FG000|Week 0 to Week 26|Protocol Violation|1|||
105438479|NCT01336023|363611595|FG001|Week 0 to Week 26|Protocol Violation|2|||
105438480|NCT01336023|363611596|FG002|Week 0 to Week 26|Protocol Violation|0|||
105438481|NCT01336023|363611594|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
105438482|NCT01336023|363611595|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
105438483|NCT01336023|363611596|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
105438484|NCT01336023|363611594|FG000|Week 0 to Week 26|Unclassified|5|||
105438485|NCT01336023|363611595|FG001|Week 0 to Week 26|Unclassified|16|||
105438486|NCT01336023|363611596|FG002|Week 0 to Week 26|Unclassified|9|||
105438487|NCT01336023|363611594|FG000|Week 27 to 52|Adverse Event|1|||
105438488|NCT01336023|363611595|FG001|Week 27 to 52|Adverse Event|5|||
105438489|NCT01336023|363611596|FG002|Week 27 to 52|Adverse Event|2|||
105438490|NCT01336023|363611594|FG000|Week 27 to 52|Protocol Violation|0|||
105438491|NCT01336023|363611595|FG001|Week 27 to 52|Protocol Violation|2|||
105438492|NCT01336023|363611596|FG002|Week 27 to 52|Protocol Violation|1|||
105438493|NCT01336023|363611594|FG000|Week 27 to 52|Withdrawal Criteria|14|||
105438494|NCT01336023|363611595|FG001|Week 27 to 52|Withdrawal Criteria|19|||
105438495|NCT01336023|363611596|FG002|Week 27 to 52|Withdrawal Criteria|16|||
105438496|NCT01336023|363611594|FG000|Week 27 to 52|Unclassified|13|||
105503842|NCT00042289|363855787|FG003|Overall Study|Severe debilitation, unable to continue|0|||
105503843|NCT00042289|363855788|FG004|Overall Study|Severe debilitation, unable to continue|0|||
105503844|NCT00042289|363855789|FG005|Overall Study|Severe debilitation, unable to continue|0|||
105503845|NCT00042289|363855790|FG006|Overall Study|Severe debilitation, unable to continue|0|||
105503846|NCT00042289|363855791|FG007|Overall Study|Severe debilitation, unable to continue|0|||
105503847|NCT00042289|363855792|FG008|Overall Study|Severe debilitation, unable to continue|0|||
105503848|NCT00042289|363855793|FG009|Overall Study|Severe debilitation, unable to continue|0|||
105503849|NCT00042289|363855794|FG010|Overall Study|Severe debilitation, unable to continue|0|||
105503850|NCT00042289|363855795|FG011|Overall Study|Severe debilitation, unable to continue|0|||
105503851|NCT00042289|363855796|FG012|Overall Study|Severe debilitation, unable to continue|0|||
105503852|NCT00042289|363855797|FG013|Overall Study|Severe debilitation, unable to continue|0|||
105438497|NCT01336023|363611595|FG001|Week 27 to 52|Unclassified|18|||
105438498|NCT01336023|363611596|FG002|Week 27 to 52|Unclassified|9|||
105438499|NCT01853878|363611600|FG000|Overall Study|Recurrence|2|||
105438500|NCT01853878|363611601|FG001|Overall Study|Recurrence|0|||
105438501|NCT01853878|363611600|FG000|Overall Study|Adverse Event|2|||
105438502|NCT01853878|363611601|FG001|Overall Study|Adverse Event|0|||
105438503|NCT01853878|363611600|FG000|Overall Study|Withdrawal by Subject|3|||
105438504|NCT01853878|363611601|FG001|Overall Study|Withdrawal by Subject|1|||
105503853|NCT00042289|363855798|FG014|Overall Study|Severe debilitation, unable to continue|0|||
105438505|NCT01853878|363611600|FG000|Overall Study|Migrated/moved from the study area|1|||
105438506|NCT01853878|363611601|FG001|Overall Study|Migrated/moved from the study area|0|||
105438507|NCT01853878|363611600|FG000|Overall Study|Other|55|||
105438508|NCT01853878|363611601|FG001|Overall Study|Other|43|||
105438509|NCT03997825|363611602|FG000|Overall Study|Death|3|||
105438510|NCT03997825|363611602|FG000|Overall Study|Lost to Follow-up|10|||
105438511|NCT03997825|363611602|FG000|Overall Study|Withdrawal by Subject|3|||
105438512|NCT03997825|363611602|FG000|Overall Study|Refused participation|1|||
105438513|NCT03262441|363611607|FG000|Overall Study|Withdrawal by Subject|1|||
105438514|NCT05090852|363611610|FG000|Overall Study|Physician Decision|5|||
105438515|NCT01196416|363611611|FG000|Overall Study|Withdrawal by Subject|2|||
105503854|NCT00042289|363855799|FG015|Overall Study|Severe debilitation, unable to continue|0|||
105503855|NCT00042289|363855800|FG016|Overall Study|Severe debilitation, unable to continue|0|||
105503856|NCT00042289|363855801|FG017|Overall Study|Severe debilitation, unable to continue|0|||
105503857|NCT00042289|363855802|FG018|Overall Study|Severe debilitation, unable to continue|0|||
105503858|NCT00042289|363855803|FG019|Overall Study|Severe debilitation, unable to continue|0|||
105503859|NCT00042289|363855804|FG020|Overall Study|Severe debilitation, unable to continue|0|||
105503860|NCT00042289|363855805|FG021|Overall Study|Severe debilitation, unable to continue|1|||
105503861|NCT00042289|363855806|FG022|Overall Study|Severe debilitation, unable to continue|0|||
105503862|NCT00042289|363855807|FG023|Overall Study|Severe debilitation, unable to continue|1|||
105503863|NCT00042289|363855808|FG024|Overall Study|Severe debilitation, unable to continue|0|||
105503864|NCT00042289|363855809|FG025|Overall Study|Severe debilitation, unable to continue|0|||
105503865|NCT00042289|363855810|FG026|Overall Study|Severe debilitation, unable to continue|0|||
105503866|NCT00042289|363855811|FG027|Overall Study|Severe debilitation, unable to continue|1|||
105503867|NCT00042289|363855812|FG028|Overall Study|Severe debilitation, unable to continue|0|||
105503868|NCT00042289|363855813|FG029|Overall Study|Severe debilitation, unable to continue|0|||
105503869|NCT00042289|363855814|FG030|Overall Study|Severe debilitation, unable to continue|0|||
105503870|NCT00042289|363855815|FG031|Overall Study|Severe debilitation, unable to continue|1|||
105503871|NCT00042289|363855816|FG032|Overall Study|Severe debilitation, unable to continue|1|||
105503872|NCT00042289|363855817|FG033|Overall Study|Severe debilitation, unable to continue|0|||
105503873|NCT00042289|363855818|FG034|Overall Study|Severe debilitation, unable to continue|0|||
105503874|NCT00042289|363855819|FG035|Overall Study|Severe debilitation, unable to continue|0|||
105503875|NCT00042289|363855820|FG036|Overall Study|Severe debilitation, unable to continue|0|||
105503876|NCT00042289|363855821|FG037|Overall Study|Severe debilitation, unable to continue|0|||
105503877|NCT00042289|363855822|FG038|Overall Study|Severe debilitation, unable to continue|0|||
105503878|NCT00042289|363855823|FG039|Overall Study|Severe debilitation, unable to continue|0|||
105503879|NCT00042289|363855824|FG040|Overall Study|Severe debilitation, unable to continue|0|||
105503880|NCT00042289|363855825|FG041|Overall Study|Severe debilitation, unable to continue|0|||
105503881|NCT00042289|363855826|FG042|Overall Study|Severe debilitation, unable to continue|0|||
105503882|NCT00042289|363855827|FG043|Overall Study|Severe debilitation, unable to continue|0|||
105503883|NCT00042289|363855828|FG044|Overall Study|Severe debilitation, unable to continue|0|||
105503884|NCT00042289|363855829|FG045|Overall Study|Severe debilitation, unable to continue|0|||
105503885|NCT00042289|363855830|FG046|Overall Study|Severe debilitation, unable to continue|0|||
105503886|NCT00042289|363855784|FG000|Overall Study|Site closed|0|||
105503887|NCT00042289|363855785|FG001|Overall Study|Site closed|0|||
105503888|NCT00042289|363855786|FG002|Overall Study|Site closed|0|||
105503889|NCT00042289|363855787|FG003|Overall Study|Site closed|0|||
105503890|NCT00042289|363855788|FG004|Overall Study|Site closed|0|||
105503891|NCT00042289|363855789|FG005|Overall Study|Site closed|0|||
105503892|NCT00042289|363855790|FG006|Overall Study|Site closed|0|||
105503893|NCT00042289|363855791|FG007|Overall Study|Site closed|0|||
105438516|NCT03244826|363611612|FG000|Overall Study|Withdrawal by Subject|2|||
105503894|NCT00042289|363855792|FG008|Overall Study|Site closed|0|||
105503895|NCT00042289|363855793|FG009|Overall Study|Site closed|0|||
105503896|NCT00042289|363855794|FG010|Overall Study|Site closed|0|||
105503897|NCT00042289|363855795|FG011|Overall Study|Site closed|0|||
105503898|NCT00042289|363855796|FG012|Overall Study|Site closed|0|||
105503899|NCT00042289|363855797|FG013|Overall Study|Site closed|0|||
105503900|NCT00042289|363855798|FG014|Overall Study|Site closed|0|||
105503901|NCT00042289|363855799|FG015|Overall Study|Site closed|0|||
105503902|NCT00042289|363855800|FG016|Overall Study|Site closed|0|||
105503903|NCT00042289|363855801|FG017|Overall Study|Site closed|0|||
105503904|NCT00042289|363855802|FG018|Overall Study|Site closed|0|||
105503905|NCT00042289|363855803|FG019|Overall Study|Site closed|0|||
105503906|NCT00042289|363855804|FG020|Overall Study|Site closed|0|||
105503907|NCT00042289|363855805|FG021|Overall Study|Site closed|0|||
105503908|NCT00042289|363855806|FG022|Overall Study|Site closed|0|||
105503909|NCT00042289|363855807|FG023|Overall Study|Site closed|0|||
105503910|NCT00042289|363855808|FG024|Overall Study|Site closed|0|||
105503911|NCT00042289|363855809|FG025|Overall Study|Site closed|0|||
105503912|NCT00042289|363855810|FG026|Overall Study|Site closed|0|||
105503913|NCT00042289|363855811|FG027|Overall Study|Site closed|0|||
105503914|NCT00042289|363855812|FG028|Overall Study|Site closed|0|||
105438517|NCT03244826|363611613|FG001|Overall Study|Withdrawal by Subject|0|||
105438518|NCT03244826|363611612|FG000|Overall Study|Transplant delayed or withdrawn|12|||
105438519|NCT03244826|363611613|FG001|Overall Study|Transplant delayed or withdrawn|10|||
105590692|NCT03523962|364162684|FG000|Closed Fractures|Lost to Follow-up|62|||
105590693|NCT03523962|364162685|FG001|Closed Fractures|Lost to Follow-up|36|||
105590694|NCT03523962|364162686|FG002|Closed Fractures|Lost to Follow-up|0|||
105590695|NCT03523962|364162687|FG003|Closed Fractures|Lost to Follow-up|0|||
105590696|NCT03523962|364162684|FG000|Closed Fractures|Withdrawal by Subject|19|||
105590697|NCT03523962|364162685|FG001|Closed Fractures|Withdrawal by Subject|29|||
105590698|NCT03523962|364162686|FG002|Closed Fractures|Withdrawal by Subject|0|||
105590699|NCT03523962|364162687|FG003|Closed Fractures|Withdrawal by Subject|0|||
105590700|NCT03523962|364162684|FG000|Closed Fractures|Incarceration|1|||
105590701|NCT03523962|364162685|FG001|Closed Fractures|Incarceration|4|||
105590702|NCT03523962|364162686|FG002|Closed Fractures|Incarceration|0|||
105590703|NCT03523962|364162687|FG003|Closed Fractures|Incarceration|0|||
105590704|NCT03523962|364162684|FG000|Open Fractures|Death|0|||
105590705|NCT03523962|364162685|FG001|Open Fractures|Death|0|||
105590706|NCT03523962|364162686|FG002|Open Fractures|Death|11|||
105590707|NCT03523962|364162687|FG003|Open Fractures|Death|6|||
105590708|NCT03523962|364162684|FG000|Open Fractures|Lost to Follow-up|0|||
105590709|NCT03523962|364162685|FG001|Open Fractures|Lost to Follow-up|0|||
105590710|NCT03523962|364162686|FG002|Open Fractures|Lost to Follow-up|15|||
105590711|NCT03523962|364162687|FG003|Open Fractures|Lost to Follow-up|8|||
105590712|NCT03523962|364162684|FG000|Open Fractures|Withdrawal by Subject|0|||
105590713|NCT03523962|364162685|FG001|Open Fractures|Withdrawal by Subject|0|||
105590714|NCT03523962|364162686|FG002|Open Fractures|Withdrawal by Subject|6|||
105590715|NCT03523962|364162687|FG003|Open Fractures|Withdrawal by Subject|2|||
105590716|NCT03523962|364162684|FG000|Open Fractures|Incarceration|0|||
105590717|NCT03523962|364162685|FG001|Open Fractures|Incarceration|0|||
105590718|NCT03523962|364162686|FG002|Open Fractures|Incarceration|1|||
105590719|NCT03523962|364162687|FG003|Open Fractures|Incarceration|0|||
105590720|NCT01253226|364162688|FG000|Overall Study|Adverse Event|0|||
105590721|NCT01253226|364162689|FG001|Overall Study|Adverse Event|0|||
105590722|NCT01253226|364162690|FG002|Overall Study|Adverse Event|1|||
105590723|NCT01253226|364162691|FG003|Overall Study|Adverse Event|0|||
105590724|NCT01253226|364162692|FG004|Overall Study|Adverse Event|0|||
105590725|NCT01253226|364162688|FG000|Overall Study|Death|0|||
105438520|NCT02673684|363611614|FG000|Overall Study|Study not completed d/t loss of funding|9|||
105438521|NCT02673684|363611615|FG001|Overall Study|Study not completed d/t loss of funding|8|||
105438522|NCT02828020|363611619|FG000|Treatment Period|Adverse Event|3|||
105438523|NCT02828020|363611620|FG001|Treatment Period|Adverse Event|1|||
105438524|NCT02828020|363611621|FG002|Treatment Period|Adverse Event|1|||
105438525|NCT02828020|363611619|FG000|Treatment Period|Withdrawal of Consent|10|||
105438526|NCT02828020|363611620|FG001|Treatment Period|Withdrawal of Consent|14|||
105438527|NCT02828020|363611621|FG002|Treatment Period|Withdrawal of Consent|9|||
105438528|NCT02828020|363611619|FG000|Treatment Period|Lost to Follow-up|21|||
105438529|NCT02828020|363611620|FG001|Treatment Period|Lost to Follow-up|24|||
105438530|NCT02828020|363611621|FG002|Treatment Period|Lost to Follow-up|18|||
105438531|NCT02828020|363611619|FG000|Treatment Period|Lack of Qualifying Event|44|||
105438532|NCT02828020|363611620|FG001|Treatment Period|Lack of Qualifying Event|53|||
105438533|NCT02828020|363611621|FG002|Treatment Period|Lack of Qualifying Event|43|||
105438534|NCT02828020|363611619|FG000|Treatment Period|Pregnancy|0|||
105438535|NCT02828020|363611620|FG001|Treatment Period|Pregnancy|2|||
105438536|NCT02828020|363611621|FG002|Treatment Period|Pregnancy|0|||
105438537|NCT02828020|363611619|FG000|Treatment Period|Protocol Violation|2|||
105438538|NCT02828020|363611620|FG001|Treatment Period|Protocol Violation|4|||
105438539|NCT02828020|363611621|FG002|Treatment Period|Protocol Violation|7|||
105438540|NCT02828020|363611619|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
105438541|NCT02828020|363611620|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
105438542|NCT02828020|363611621|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
105438543|NCT02828020|363611619|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
105438544|NCT02828020|363611620|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
105438545|NCT02828020|363611621|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
105438546|NCT02828020|363611619|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
105438547|NCT02828020|363611620|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
105438548|NCT02828020|363611621|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
105438549|NCT02828020|363611619|FG000|Safety Follow-up Period|Protocol Violation|0|||
105438550|NCT02828020|363611620|FG001|Safety Follow-up Period|Protocol Violation|2|||
105438551|NCT02828020|363611621|FG002|Safety Follow-up Period|Protocol Violation|1|||
105438552|NCT02828020|363611619|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
105438553|NCT02828020|363611620|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
105438554|NCT02828020|363611621|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
105438555|NCT03688620|363611622|FG000|Overall Study|Other|0|||
105438556|NCT03688620|363611623|FG001|Overall Study|Other|0|||
105590726|NCT01253226|364162689|FG001|Overall Study|Death|1|||
105590727|NCT01253226|364162690|FG002|Overall Study|Death|0|||
105590728|NCT01253226|364162691|FG003|Overall Study|Death|0|||
105590729|NCT01253226|364162692|FG004|Overall Study|Death|0|||
105590730|NCT01253226|364162688|FG000|Overall Study|Physician Decision|0|||
105590731|NCT01253226|364162689|FG001|Overall Study|Physician Decision|0|||
105438557|NCT03688620|363611624|FG002|Overall Study|Other|1|||
105438558|NCT03688620|363611622|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
105438559|NCT03688620|363611623|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
105438560|NCT03688620|363611624|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
105438561|NCT03688620|363611622|FG000|Overall Study|Lost to Follow-up|16|||
105438562|NCT03688620|363611623|FG001|Overall Study|Lost to Follow-up|0|||
105438563|NCT03688620|363611624|FG002|Overall Study|Lost to Follow-up|1|||
105438564|NCT03688620|363611622|FG000|Overall Study|Withdrawal by Subject|0|||
105438565|NCT03688620|363611623|FG001|Overall Study|Withdrawal by Subject|0|||
105438566|NCT03688620|363611624|FG002|Overall Study|Withdrawal by Subject|6|||
105438567|NCT01008904|363611625|FG000|Overall Study|Lost to Follow-up|1|||
105438568|NCT01008904|363611625|FG000|Overall Study|Adverse Event|2|||
105438569|NCT01008904|363611625|FG000|Overall Study|unexpected unrelated surgery|1|||
105438570|NCT00379912|363611626|FG000|Overall Study|Lack of Efficacy|1|||
105438571|NCT00379912|363611627|FG001|Overall Study|Lack of Efficacy|0|||
105438572|NCT01138501|363611628|FG000|Overall Study|Protocol Violation|2|||
105438573|NCT01138501|363611628|FG000|Overall Study|Withdrawal by Subject|3|||
105438574|NCT02292706|363611633|FG000|Overall Study|Lost to Follow-up|20|||
105438575|NCT02292706|363611634|FG001|Overall Study|Lost to Follow-up|44|||
105438576|NCT02292706|363611635|FG002|Overall Study|Lost to Follow-up|24|||
105438577|NCT02292706|363611636|FG003|Overall Study|Lost to Follow-up|61|||
105438578|NCT02292706|363611637|FG004|Overall Study|Lost to Follow-up|21|||
105438579|NCT02292706|363611638|FG005|Overall Study|Lost to Follow-up|52|||
105438580|NCT02292706|363611639|FG006|Overall Study|Lost to Follow-up|25|||
105438581|NCT02292706|363611640|FG007|Overall Study|Lost to Follow-up|0|||
105438582|NCT02292706|363611633|FG000|Overall Study|Withdrew consent|15|||
105438583|NCT02292706|363611634|FG001|Overall Study|Withdrew consent|56|||
105438584|NCT02292706|363611635|FG002|Overall Study|Withdrew consent|43|||
105438585|NCT02292706|363611636|FG003|Overall Study|Withdrew consent|36|||
105438586|NCT02292706|363611637|FG004|Overall Study|Withdrew consent|13|||
105438587|NCT02292706|363611638|FG005|Overall Study|Withdrew consent|51|||
105438588|NCT02292706|363611639|FG006|Overall Study|Withdrew consent|20|||
105438589|NCT02292706|363611640|FG007|Overall Study|Withdrew consent|0|||
105438590|NCT02292706|363611633|FG000|Overall Study|Death|3|||
105438591|NCT02292706|363611634|FG001|Overall Study|Death|11|||
105438592|NCT02292706|363611635|FG002|Overall Study|Death|16|||
105438593|NCT02292706|363611636|FG003|Overall Study|Death|22|||
105438594|NCT02292706|363611637|FG004|Overall Study|Death|8|||
105438595|NCT02292706|363611638|FG005|Overall Study|Death|17|||
105438596|NCT02292706|363611639|FG006|Overall Study|Death|3|||
105438597|NCT02292706|363611640|FG007|Overall Study|Death|0|||
105438598|NCT02292706|363611633|FG000|Overall Study|Study terminated by sponsor|0|||
105438599|NCT02292706|363611634|FG001|Overall Study|Study terminated by sponsor|9|||
105438600|NCT02292706|363611635|FG002|Overall Study|Study terminated by sponsor|4|||
105438601|NCT02292706|363611636|FG003|Overall Study|Study terminated by sponsor|21|||
105438602|NCT02292706|363611637|FG004|Overall Study|Study terminated by sponsor|11|||
105438603|NCT02292706|363611638|FG005|Overall Study|Study terminated by sponsor|13|||
105438604|NCT02292706|363611639|FG006|Overall Study|Study terminated by sponsor|3|||
105438605|NCT02292706|363611640|FG007|Overall Study|Study terminated by sponsor|0|||
105438606|NCT02292706|363611633|FG000|Overall Study|Investigator's discretion|4|||
105438607|NCT02292706|363611634|FG001|Overall Study|Investigator's discretion|9|||
105438608|NCT02292706|363611635|FG002|Overall Study|Investigator's discretion|7|||
105438609|NCT02292706|363611636|FG003|Overall Study|Investigator's discretion|11|||
105438610|NCT02292706|363611637|FG004|Overall Study|Investigator's discretion|4|||
105438611|NCT02292706|363611638|FG005|Overall Study|Investigator's discretion|10|||
105438612|NCT02292706|363611639|FG006|Overall Study|Investigator's discretion|1|||
105438613|NCT02292706|363611640|FG007|Overall Study|Investigator's discretion|0|||
105438614|NCT02292706|363611633|FG000|Overall Study|Liver transplant|1|||
105438615|NCT02292706|363611634|FG001|Overall Study|Liver transplant|1|||
105503915|NCT00042289|363855813|FG029|Overall Study|Site closed|0|||
105503916|NCT00042289|363855814|FG030|Overall Study|Site closed|0|||
105438616|NCT02292706|363611635|FG002|Overall Study|Liver transplant|11|||
105438617|NCT02292706|363611636|FG003|Overall Study|Liver transplant|16|||
105438618|NCT02292706|363611637|FG004|Overall Study|Liver transplant|5|||
105438619|NCT02292706|363611638|FG005|Overall Study|Liver transplant|6|||
105438620|NCT02292706|363611639|FG006|Overall Study|Liver transplant|5|||
105503917|NCT00042289|363855815|FG031|Overall Study|Site closed|3|||
105438621|NCT02292706|363611640|FG007|Overall Study|Liver transplant|0|||
105438622|NCT02292706|363611633|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
105438623|NCT02292706|363611634|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
105438624|NCT02292706|363611635|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
105438625|NCT02292706|363611636|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
105438626|NCT02292706|363611637|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
105438627|NCT02292706|363611638|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
105438628|NCT02292706|363611639|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
105438629|NCT02292706|363611640|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
105438630|NCT02292706|363611633|FG000|Overall Study|Subject terminated by sponsor|1|||
105503918|NCT00042289|363855816|FG032|Overall Study|Site closed|0|||
105438631|NCT02292706|363611634|FG001|Overall Study|Subject terminated by sponsor|0|||
105438632|NCT02292706|363611635|FG002|Overall Study|Subject terminated by sponsor|0|||
105438633|NCT02292706|363611636|FG003|Overall Study|Subject terminated by sponsor|2|||
105438634|NCT02292706|363611637|FG004|Overall Study|Subject terminated by sponsor|1|||
105438635|NCT02292706|363611638|FG005|Overall Study|Subject terminated by sponsor|0|||
105438636|NCT02292706|363611639|FG006|Overall Study|Subject terminated by sponsor|0|||
105438637|NCT02292706|363611640|FG007|Overall Study|Subject terminated by sponsor|0|||
105438638|NCT02292706|363611633|FG000|Overall Study|Missing|0|||
105438639|NCT02292706|363611634|FG001|Overall Study|Missing|0|||
105438640|NCT02292706|363611635|FG002|Overall Study|Missing|1|||
105438641|NCT02292706|363611636|FG003|Overall Study|Missing|1|||
105438642|NCT02292706|363611637|FG004|Overall Study|Missing|0|||
105438643|NCT02292706|363611638|FG005|Overall Study|Missing|1|||
105438644|NCT02292706|363611639|FG006|Overall Study|Missing|0|||
105438645|NCT02292706|363611640|FG007|Overall Study|Missing|0|||
105438646|NCT02292706|363611633|FG000|Overall Study|Virologic relapse or reinfection|1|||
105438647|NCT02292706|363611634|FG001|Overall Study|Virologic relapse or reinfection|0|||
105438648|NCT02292706|363611635|FG002|Overall Study|Virologic relapse or reinfection|0|||
105438649|NCT02292706|363611636|FG003|Overall Study|Virologic relapse or reinfection|1|||
105438650|NCT02292706|363611637|FG004|Overall Study|Virologic relapse or reinfection|0|||
105438651|NCT02292706|363611638|FG005|Overall Study|Virologic relapse or reinfection|1|||
105438652|NCT02292706|363611639|FG006|Overall Study|Virologic relapse or reinfection|0|||
105438653|NCT02292706|363611640|FG007|Overall Study|Virologic relapse or reinfection|0|||
105438654|NCT01990612|363611641|FG000|Overall Study|Lost to Follow-up|2|||
105438655|NCT01990612|363611642|FG001|Overall Study|Lost to Follow-up|1|||
105438656|NCT01990612|363611641|FG000|Overall Study|Withdrawal by Subject|5|||
105438657|NCT01990612|363611642|FG001|Overall Study|Withdrawal by Subject|2|||
105438658|NCT01630889|363611645|FG000|Overall Study|Death|2|||
105438659|NCT01630889|363611645|FG000|Overall Study|Withdrawal by Subject|1|||
105438660|NCT01630889|363611645|FG000|Overall Study|Other than Specified|2|||
105438661|NCT01630889|363611645|FG000|Overall Study|Lost to Follow-up|4|||
105438662|NCT01630889|363611645|FG000|Overall Study|Other|1|||
105438663|NCT02980133|363611646|FG000|Overall Study|Other than specified|1|||
105438664|NCT02980133|363611647|FG001|Overall Study|Other than specified|1|||
105438665|NCT02980133|363611648|FG002|Overall Study|Other than specified|2|||
105438666|NCT02980133|363611649|FG003|Overall Study|Other than specified|2|||
105438667|NCT02980133|363611646|FG000|Overall Study|Lost to Follow-up|0|||
105438668|NCT02980133|363611647|FG001|Overall Study|Lost to Follow-up|0|||
105438669|NCT02980133|363611648|FG002|Overall Study|Lost to Follow-up|1|||
105438670|NCT02980133|363611649|FG003|Overall Study|Lost to Follow-up|3|||
105438671|NCT02980133|363611646|FG000|Overall Study|Protocol Violation|0|||
105438672|NCT02980133|363611647|FG001|Overall Study|Protocol Violation|1|||
105438673|NCT02980133|363611648|FG002|Overall Study|Protocol Violation|0|||
105438674|NCT02980133|363611649|FG003|Overall Study|Protocol Violation|0|||
105438675|NCT02980133|363611646|FG000|Overall Study|Withdrawal by parent/guardian|6|||
105438676|NCT02980133|363611647|FG001|Overall Study|Withdrawal by parent/guardian|3|||
105438677|NCT02980133|363611648|FG002|Overall Study|Withdrawal by parent/guardian|3|||
105438678|NCT02980133|363611649|FG003|Overall Study|Withdrawal by parent/guardian|1|||
105438679|NCT02980133|363611646|FG000|Overall Study|Withdrawal by Subject|0|||
105438680|NCT02980133|363611647|FG001|Overall Study|Withdrawal by Subject|0|||
105438681|NCT02980133|363611648|FG002|Overall Study|Withdrawal by Subject|1|||
105438682|NCT02980133|363611649|FG003|Overall Study|Withdrawal by Subject|0|||
105438683|NCT01345669|363611656|FG000|Overall Study|Primary tumour recurrence|53|||
105438684|NCT01345669|363611657|FG001|Overall Study|Primary tumour recurrence|32|||
105438685|NCT01345669|363611656|FG000|Overall Study|Second primary tumour|4|||
105503919|NCT00042289|363855817|FG033|Overall Study|Site closed|0|||
105503920|NCT00042289|363855818|FG034|Overall Study|Site closed|0|||
105503921|NCT00042289|363855819|FG035|Overall Study|Site closed|0|||
105503922|NCT00042289|363855820|FG036|Overall Study|Site closed|1|||
105503923|NCT00042289|363855821|FG037|Overall Study|Site closed|0|||
105503924|NCT00042289|363855822|FG038|Overall Study|Site closed|0|||
105503925|NCT00042289|363855823|FG039|Overall Study|Site closed|0|||
105503926|NCT00042289|363855824|FG040|Overall Study|Site closed|0|||
105503927|NCT00042289|363855825|FG041|Overall Study|Site closed|0|||
105503928|NCT00042289|363855826|FG042|Overall Study|Site closed|1|||
105503929|NCT00042289|363855827|FG043|Overall Study|Site closed|0|||
105438686|NCT01345669|363611657|FG001|Overall Study|Second primary tumour|3|||
105438687|NCT01345669|363611656|FG000|Overall Study|Adverse Event|63|||
105438688|NCT01345669|363611657|FG001|Overall Study|Adverse Event|9|||
105438689|NCT01345669|363611656|FG000|Overall Study|Protocol Violation|3|||
105438690|NCT01345669|363611657|FG001|Overall Study|Protocol Violation|1|||
105438691|NCT01345669|363611656|FG000|Overall Study|Lost to Follow-up|1|||
105503930|NCT00042289|363855828|FG044|Overall Study|Site closed|0|||
105503931|NCT00042289|363855829|FG045|Overall Study|Site closed|0|||
105503932|NCT00042289|363855830|FG046|Overall Study|Site closed|0|||
105438692|NCT01345669|363611657|FG001|Overall Study|Lost to Follow-up|1|||
105438693|NCT01345669|363611656|FG000|Overall Study|Withdrawal by Subject|52|||
105503933|NCT00042289|363855784|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
105590732|NCT01253226|364162690|FG002|Overall Study|Physician Decision|0|||
105590733|NCT01253226|364162691|FG003|Overall Study|Physician Decision|0|||
105590734|NCT01253226|364162692|FG004|Overall Study|Physician Decision|2|||
105590735|NCT01253226|364162688|FG000|Overall Study|Withdrawal by Subject|0|||
105438694|NCT01345669|363611657|FG001|Overall Study|Withdrawal by Subject|13|||
105438695|NCT01345669|363611656|FG000|Overall Study|Other Reasons|111|||
105438696|NCT01345669|363611657|FG001|Overall Study|Other Reasons|60|||
105438697|NCT01736618|363611661|FG000|Overall Study|Death|294|||
105438698|NCT01736618|363611661|FG000|Overall Study|Lost to Follow-up|193|||
105438699|NCT01736618|363611661|FG000|Overall Study|Withdrawal by Subject|54|||
105438700|NCT01736618|363611661|FG000|Overall Study|Subject unable to be followed at study location|223|||
105438701|NCT01736618|363611661|FG000|Overall Study|Physician Decision|33|||
105438702|NCT01736618|363611661|FG000|Overall Study|Transplant or removal of target organ|19|||
105438703|NCT01736618|363611661|FG000|Overall Study|Change in indication or condition|78|||
105438704|NCT01736618|363611661|FG000|Overall Study|Study device explant|103|||
105438705|NCT01736618|363611661|FG000|Overall Study|Unable to complete implant|2|||
105438706|NCT04167137|363611663|FG000|Overall Study|Disease progression|1|||
105438707|NCT04167137|363611664|FG001|Overall Study|Disease progression|1|||
105438708|NCT04167137|363611665|FG002|Overall Study|Disease progression|3|||
105438709|NCT04167137|363611666|FG003|Overall Study|Disease progression|3|||
105438710|NCT04167137|363611667|FG004|Overall Study|Disease progression|2|||
105438711|NCT04167137|363611668|FG005|Overall Study|Disease progression|3|||
105438712|NCT04167137|363611669|FG006|Overall Study|Disease progression|2|||
105438713|NCT04167137|363611670|FG007|Overall Study|Disease progression|2|||
105438714|NCT04167137|363611663|FG000|Overall Study|Withdrawal by Subject|1|||
105438715|NCT04167137|363611664|FG001|Overall Study|Withdrawal by Subject|0|||
105438716|NCT04167137|363611665|FG002|Overall Study|Withdrawal by Subject|0|||
105438717|NCT04167137|363611666|FG003|Overall Study|Withdrawal by Subject|1|||
105438718|NCT04167137|363611667|FG004|Overall Study|Withdrawal by Subject|0|||
105438719|NCT04167137|363611668|FG005|Overall Study|Withdrawal by Subject|2|||
105438720|NCT04167137|363611669|FG006|Overall Study|Withdrawal by Subject|1|||
105438721|NCT04167137|363611670|FG007|Overall Study|Withdrawal by Subject|0|||
105438722|NCT04167137|363611663|FG000|Overall Study|Adverse Event|0|||
105438723|NCT04167137|363611664|FG001|Overall Study|Adverse Event|0|||
105438724|NCT04167137|363611665|FG002|Overall Study|Adverse Event|0|||
105438725|NCT04167137|363611666|FG003|Overall Study|Adverse Event|0|||
105438726|NCT04167137|363611667|FG004|Overall Study|Adverse Event|0|||
105438727|NCT04167137|363611668|FG005|Overall Study|Adverse Event|1|||
105438728|NCT04167137|363611669|FG006|Overall Study|Adverse Event|0|||
105438729|NCT04167137|363611670|FG007|Overall Study|Adverse Event|1|||
105438730|NCT04167137|363611663|FG000|Overall Study|Physician Decision|0|||
105438731|NCT04167137|363611664|FG001|Overall Study|Physician Decision|0|||
105438732|NCT04167137|363611665|FG002|Overall Study|Physician Decision|0|||
105438733|NCT04167137|363611666|FG003|Overall Study|Physician Decision|1|||
105438734|NCT04167137|363611667|FG004|Overall Study|Physician Decision|0|||
105438735|NCT04167137|363611668|FG005|Overall Study|Physician Decision|0|||
105438736|NCT04167137|363611669|FG006|Overall Study|Physician Decision|1|||
105438737|NCT04167137|363611670|FG007|Overall Study|Physician Decision|0|||
105438738|NCT04167137|363611663|FG000|Overall Study|Death|0|||
105438739|NCT04167137|363611664|FG001|Overall Study|Death|1|||
105438740|NCT04167137|363611665|FG002|Overall Study|Death|0|||
105438741|NCT04167137|363611666|FG003|Overall Study|Death|0|||
105438742|NCT04167137|363611667|FG004|Overall Study|Death|0|||
105438743|NCT04167137|363611668|FG005|Overall Study|Death|0|||
105438744|NCT04167137|363611669|FG006|Overall Study|Death|0|||
105438745|NCT04167137|363611670|FG007|Overall Study|Death|0|||
105438746|NCT04167137|363611663|FG000|Overall Study|Study terminated by Sponsor|0|||
105438747|NCT04167137|363611664|FG001|Overall Study|Study terminated by Sponsor|0|||
105438748|NCT04167137|363611665|FG002|Overall Study|Study terminated by Sponsor|0|||
105438749|NCT04167137|363611666|FG003|Overall Study|Study terminated by Sponsor|0|||
105438750|NCT04167137|363611667|FG004|Overall Study|Study terminated by Sponsor|0|||
105438751|NCT04167137|363611668|FG005|Overall Study|Study terminated by Sponsor|0|||
105590736|NCT01253226|364162689|FG001|Overall Study|Withdrawal by Subject|0|||
105438752|NCT04167137|363611669|FG006|Overall Study|Study terminated by Sponsor|0|||
105438753|NCT04167137|363611670|FG007|Overall Study|Study terminated by Sponsor|1|||
105438754|NCT01431963|363611674|FG000|Overall Study|Adverse Event|18|||
105438755|NCT01431963|363611674|FG000|Overall Study|Lack of Efficacy|7|||
105438756|NCT01431963|363611674|FG000|Overall Study|Protocol Violation|1|||
105438757|NCT01431963|363611674|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
105438758|NCT01431963|363611674|FG000|Overall Study|Physician Decision|4|||
105438759|NCT01431963|363611674|FG000|Overall Study|Withdrawal by Subject|3|||
105438760|NCT03369236|363611675|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
105438761|NCT03369236|363611676|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
105438762|NCT03369236|363611675|FG000|Open-label Extension Period|Lack of Efficacy|2|||
105590737|NCT01253226|364162690|FG002|Overall Study|Withdrawal by Subject|0|||
105438763|NCT03369236|363611676|FG001|Open-label Extension Period|Lack of Efficacy|1|||
105438764|NCT03369236|363611675|FG000|Open-label Extension Period|Adverse Event|0|||
105438765|NCT03369236|363611676|FG001|Open-label Extension Period|Adverse Event|1|||
105503934|NCT00042289|363855785|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
105503935|NCT00042289|363855786|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
105503936|NCT00042289|363855787|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
105503937|NCT00042289|363855788|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
105503938|NCT00042289|363855789|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
105503939|NCT00042289|363855790|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
105503940|NCT00042289|363855791|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
105503941|NCT00042289|363855792|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
105503942|NCT00042289|363855793|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
105503943|NCT00042289|363855794|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
105503944|NCT00042289|363855795|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
105503945|NCT00042289|363855796|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
105503946|NCT00042289|363855797|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
105503947|NCT00042289|363855798|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
105503948|NCT00042289|363855799|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
105503949|NCT00042289|363855800|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
105503950|NCT00042289|363855801|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
105503951|NCT00042289|363855802|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
105503952|NCT00042289|363855803|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
105503953|NCT00042289|363855804|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
105503954|NCT00042289|363855805|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
105503955|NCT00042289|363855806|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
105503956|NCT00042289|363855807|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
105503957|NCT00042289|363855808|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
105503958|NCT00042289|363855809|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
105503959|NCT00042289|363855810|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
105503960|NCT00042289|363855811|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
105503961|NCT00042289|363855812|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
105503962|NCT00042289|363855813|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
105503963|NCT00042289|363855814|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
105503964|NCT00042289|363855815|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
105503965|NCT00042289|363855816|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
105503966|NCT00042289|363855817|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
105503967|NCT00042289|363855818|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
105503968|NCT00042289|363855819|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
105503969|NCT00042289|363855820|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
105503970|NCT00042289|363855821|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
105590738|NCT01253226|364162691|FG003|Overall Study|Withdrawal by Subject|1|||
105590739|NCT01253226|364162692|FG004|Overall Study|Withdrawal by Subject|0|||
105590740|NCT02482233|364162696|FG000|Overall Study|Lost to Follow-up|1|||
105590741|NCT02482233|364162697|FG001|Overall Study|Lost to Follow-up|1|||
105438766|NCT03369236|363611675|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
105438767|NCT03369236|363611676|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
105438768|NCT04230213|363611678|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
105438769|NCT04230213|363611679|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
105438770|NCT04230213|363611680|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
105438771|NCT04230213|363611678|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
105438772|NCT04230213|363611679|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
105438773|NCT04230213|363611680|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
105438774|NCT04230213|363611678|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
105438775|NCT04230213|363611679|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
105438776|NCT04230213|363611680|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
105438777|NCT04230213|363611678|FG000|TP2: Week 10 to Week 16|Other|0|||
105438778|NCT04230213|363611679|FG001|TP2: Week 10 to Week 16|Other|2|||
105438779|NCT04230213|363611680|FG002|TP2: Week 10 to Week 16|Other|1|||
105438780|NCT04230213|363611678|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
105438781|NCT04230213|363611679|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
105438782|NCT04230213|363611680|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
105438783|NCT04230213|363611678|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
105438784|NCT04230213|363611679|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
105438785|NCT04230213|363611680|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
105438786|NCT04230213|363611678|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
105438787|NCT04230213|363611679|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
105438788|NCT04230213|363611680|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
105438789|NCT04230213|363611678|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
105438790|NCT04230213|363611679|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
105438791|NCT04230213|363611680|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
105438792|NCT04230213|363611678|FG000|TP3: Week 16 to Week 22|Other|0|||
105438793|NCT04230213|363611679|FG001|TP3: Week 16 to Week 22|Other|1|||
105438794|NCT04230213|363611680|FG002|TP3: Week 16 to Week 22|Other|3|||
105438795|NCT04230213|363611678|FG000|TP4: Week 22 to Week 32|Other|0|||
105438796|NCT04230213|363611679|FG001|TP4: Week 22 to Week 32|Other|5|||
105438797|NCT04230213|363611680|FG002|TP4: Week 22 to Week 32|Other|5|||
105438798|NCT04230213|363611678|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
105438799|NCT04230213|363611679|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
105438800|NCT04230213|363611680|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
105438801|NCT04230213|363611678|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
105438802|NCT04230213|363611679|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
105438803|NCT04230213|363611680|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
105438804|NCT04230213|363611678|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
105438805|NCT04230213|363611679|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
105438806|NCT04230213|363611680|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
105438807|NCT04230213|363611678|FG000|Follow up: Week 32 to Week 36|Other|0|||
105438808|NCT04230213|363611679|FG001|Follow up: Week 32 to Week 36|Other|1|||
105438809|NCT04230213|363611680|FG002|Follow up: Week 32 to Week 36|Other|1|||
105438810|NCT02783599|363613354|FG000|Overall Study|Progressive disease|23|||
105438811|NCT02783599|363613354|FG000|Overall Study|Surgical Resection|10|||
105438812|NCT02783599|363613354|FG000|Overall Study|Adverse Event|4|||
105438813|NCT02783599|363613354|FG000|Overall Study|Physician Decision|2|||
105438814|NCT02783599|363613354|FG000|Overall Study|Death|1|||
105438815|NCT01815840|363613355|FG000|Overall Study|Missing|1|||
105438816|NCT01815840|363613356|FG001|Overall Study|Missing|0|||
105438817|NCT01815840|363613355|FG000|Overall Study|Withdrew Consent|31|||
105438818|NCT01815840|363613356|FG001|Overall Study|Withdrew Consent|30|||
105438819|NCT01815840|363613355|FG000|Overall Study|Administrative/Other|1|||
105438820|NCT01815840|363613356|FG001|Overall Study|Administrative/Other|3|||
105438821|NCT01815840|363613355|FG000|Overall Study|Adverse Event|10|||
105438822|NCT01815840|363613356|FG001|Overall Study|Adverse Event|16|||
105438823|NCT01815840|363613355|FG000|Overall Study|Death|2|||
105438824|NCT01815840|363613356|FG001|Overall Study|Death|2|||
105438825|NCT01815840|363613355|FG000|Overall Study|Disease progression|3|||
105438826|NCT01815840|363613356|FG001|Overall Study|Disease progression|2|||
105438827|NCT01815840|363613355|FG000|Overall Study|Investigators Decision|2|||
105438828|NCT01815840|363613356|FG001|Overall Study|Investigators Decision|3|||
105438829|NCT01815840|363613355|FG000|Overall Study|Lost to Follow-up|3|||
105438830|NCT01815840|363613356|FG001|Overall Study|Lost to Follow-up|6|||
105438831|NCT01815840|363613355|FG000|Overall Study|Refused Treatment|5|||
105438832|NCT01815840|363613356|FG001|Overall Study|Refused Treatment|1|||
105438833|NCT01815840|363613355|FG000|Overall Study|Sponsor Termination Treatment|1|||
105438834|NCT01815840|363613356|FG001|Overall Study|Sponsor Termination Treatment|0|||
105438835|NCT01832155|363613357|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
105438836|NCT01832155|363613358|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
105438837|NCT01832155|363613357|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
105438838|NCT01832155|363613358|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
105438839|NCT03387020|363613361|FG000|Overall Study|Adverse Event|0|||
105438840|NCT03387020|363613362|FG001|Overall Study|Adverse Event|2|||
105438841|NCT03387020|363613363|FG002|Overall Study|Adverse Event|0|||
105438842|NCT03387020|363613361|FG000|Overall Study|Withdrawal by Subject|2|||
105438843|NCT03387020|363613362|FG001|Overall Study|Withdrawal by Subject|0|||
105438844|NCT03387020|363613363|FG002|Overall Study|Withdrawal by Subject|0|||
105438845|NCT05249569|363613366|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
105438846|NCT03100058|363613372|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
105438847|NCT03100058|363613373|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
105438848|NCT03100058|363613374|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
105438849|NCT03100058|363613375|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
105438850|NCT03100058|363613376|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
105438851|NCT03100058|363613377|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
105438852|NCT03100058|363613378|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
105438853|NCT03100058|363613379|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
105438854|NCT03100058|363613380|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
105438855|NCT03100058|363613381|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
105438856|NCT03100058|363613382|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
105438857|NCT03100058|363613383|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
105438858|NCT03100058|363613384|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
105438859|NCT03100058|363613372|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
105438860|NCT03100058|363613373|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
105438861|NCT03100058|363613374|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
105438862|NCT03100058|363613375|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
105438863|NCT03100058|363613376|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
105438864|NCT03100058|363613377|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
105438865|NCT03100058|363613378|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
105438866|NCT03100058|363613379|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
105438867|NCT03100058|363613380|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
105438868|NCT03100058|363613381|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
105438869|NCT03100058|363613382|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
105438870|NCT03100058|363613383|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
105438871|NCT03100058|363613384|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
105438872|NCT03100058|363613372|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105438873|NCT03100058|363613373|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
105438874|NCT03100058|363613374|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
105438875|NCT03100058|363613375|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105438876|NCT03100058|363613376|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105438877|NCT03100058|363613377|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
105438878|NCT03100058|363613378|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
105438879|NCT03100058|363613379|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105438880|NCT03100058|363613380|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105438881|NCT03100058|363613381|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105438882|NCT03100058|363613382|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105438883|NCT03100058|363613383|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105438884|NCT03100058|363613384|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105438885|NCT03100058|363613372|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105438886|NCT03100058|363613373|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
105438887|NCT03100058|363613374|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
105438888|NCT03100058|363613375|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105438889|NCT03100058|363613376|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105438890|NCT03100058|363613377|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105438891|NCT03100058|363613378|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
105438892|NCT03100058|363613379|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105438893|NCT03100058|363613380|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
105438894|NCT03100058|363613381|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105438895|NCT03100058|363613382|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105438896|NCT03100058|363613383|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105438897|NCT03100058|363613384|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105438898|NCT03100058|363613372|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105438899|NCT03100058|363613373|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105438900|NCT03100058|363613374|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105438901|NCT03100058|363613375|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
105438902|NCT03100058|363613376|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105438903|NCT03100058|363613377|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105438904|NCT03100058|363613378|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105438905|NCT03100058|363613379|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
105438906|NCT03100058|363613380|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105438907|NCT03100058|363613381|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105438908|NCT03100058|363613382|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105438909|NCT03100058|363613383|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105438910|NCT03100058|363613384|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105438911|NCT03100058|363613372|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105438912|NCT03100058|363613373|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105438913|NCT03100058|363613374|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105438914|NCT03100058|363613375|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
105438915|NCT03100058|363613376|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105438916|NCT03100058|363613377|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105438917|NCT03100058|363613378|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
105438918|NCT03100058|363613379|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105438919|NCT03100058|363613380|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105438920|NCT03100058|363613381|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105438921|NCT03100058|363613382|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105438922|NCT03100058|363613383|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105503971|NCT00042289|363855822|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
105503972|NCT00042289|363855823|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
105503973|NCT00042289|363855824|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
105503974|NCT00042289|363855825|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
105503975|NCT00042289|363855826|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
105503976|NCT00042289|363855827|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
105503977|NCT00042289|363855828|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
105503978|NCT00042289|363855829|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
105503979|NCT00042289|363855830|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
105503980|NCT00042289|363855784|FG000|Overall Study|Protocol Violation|0|||
105503981|NCT00042289|363855785|FG001|Overall Study|Protocol Violation|0|||
105503982|NCT00042289|363855786|FG002|Overall Study|Protocol Violation|0|||
105503983|NCT00042289|363855787|FG003|Overall Study|Protocol Violation|0|||
105503984|NCT00042289|363855788|FG004|Overall Study|Protocol Violation|0|||
105503985|NCT00042289|363855789|FG005|Overall Study|Protocol Violation|1|||
105503986|NCT00042289|363855790|FG006|Overall Study|Protocol Violation|0|||
105503987|NCT00042289|363855791|FG007|Overall Study|Protocol Violation|1|||
105503988|NCT00042289|363855792|FG008|Overall Study|Protocol Violation|0|||
105503989|NCT00042289|363855793|FG009|Overall Study|Protocol Violation|0|||
105503990|NCT00042289|363855794|FG010|Overall Study|Protocol Violation|0|||
105503991|NCT00042289|363855795|FG011|Overall Study|Protocol Violation|0|||
105503992|NCT00042289|363855796|FG012|Overall Study|Protocol Violation|0|||
105503993|NCT00042289|363855797|FG013|Overall Study|Protocol Violation|0|||
105503994|NCT00042289|363855798|FG014|Overall Study|Protocol Violation|0|||
105503995|NCT00042289|363855799|FG015|Overall Study|Protocol Violation|0|||
105503996|NCT00042289|363855800|FG016|Overall Study|Protocol Violation|0|||
105503997|NCT00042289|363855801|FG017|Overall Study|Protocol Violation|0|||
105503998|NCT00042289|363855802|FG018|Overall Study|Protocol Violation|0|||
105503999|NCT00042289|363855803|FG019|Overall Study|Protocol Violation|0|||
105504000|NCT00042289|363855804|FG020|Overall Study|Protocol Violation|0|||
105504001|NCT00042289|363855805|FG021|Overall Study|Protocol Violation|0|||
105504002|NCT00042289|363855806|FG022|Overall Study|Protocol Violation|0|||
105504003|NCT00042289|363855807|FG023|Overall Study|Protocol Violation|1|||
105504004|NCT00042289|363855808|FG024|Overall Study|Protocol Violation|1|||
105504005|NCT00042289|363855809|FG025|Overall Study|Protocol Violation|0|||
105504006|NCT00042289|363855810|FG026|Overall Study|Protocol Violation|2|||
105504007|NCT00042289|363855811|FG027|Overall Study|Protocol Violation|0|||
105504008|NCT00042289|363855812|FG028|Overall Study|Protocol Violation|0|||
105504009|NCT00042289|363855813|FG029|Overall Study|Protocol Violation|0|||
105504010|NCT00042289|363855814|FG030|Overall Study|Protocol Violation|1|||
105504011|NCT00042289|363855815|FG031|Overall Study|Protocol Violation|0|||
105504012|NCT00042289|363855816|FG032|Overall Study|Protocol Violation|0|||
105504013|NCT00042289|363855817|FG033|Overall Study|Protocol Violation|0|||
105504014|NCT00042289|363855818|FG034|Overall Study|Protocol Violation|0|||
105504015|NCT00042289|363855819|FG035|Overall Study|Protocol Violation|0|||
105504016|NCT00042289|363855820|FG036|Overall Study|Protocol Violation|0|||
105504017|NCT00042289|363855821|FG037|Overall Study|Protocol Violation|0|||
105504018|NCT00042289|363855822|FG038|Overall Study|Protocol Violation|0|||
105504019|NCT00042289|363855823|FG039|Overall Study|Protocol Violation|0|||
105504020|NCT00042289|363855824|FG040|Overall Study|Protocol Violation|0|||
105504021|NCT00042289|363855825|FG041|Overall Study|Protocol Violation|1|||
105504022|NCT00042289|363855826|FG042|Overall Study|Protocol Violation|1|||
105504023|NCT00042289|363855827|FG043|Overall Study|Protocol Violation|1|||
105504024|NCT00042289|363855828|FG044|Overall Study|Protocol Violation|0|||
105504025|NCT00042289|363855829|FG045|Overall Study|Protocol Violation|0|||
105504026|NCT00042289|363855830|FG046|Overall Study|Protocol Violation|0|||
105504027|NCT00042289|363855784|FG000|Overall Study|Withdrawal by Subject|4|||
105504028|NCT00042289|363855785|FG001|Overall Study|Withdrawal by Subject|1|||
105504029|NCT00042289|363855786|FG002|Overall Study|Withdrawal by Subject|0|||
105504030|NCT00042289|363855787|FG003|Overall Study|Withdrawal by Subject|2|||
105504031|NCT00042289|363855788|FG004|Overall Study|Withdrawal by Subject|0|||
105504032|NCT00042289|363855789|FG005|Overall Study|Withdrawal by Subject|2|||
105504033|NCT00042289|363855790|FG006|Overall Study|Withdrawal by Subject|0|||
105504034|NCT00042289|363855791|FG007|Overall Study|Withdrawal by Subject|0|||
105504035|NCT00042289|363855792|FG008|Overall Study|Withdrawal by Subject|0|||
105504036|NCT00042289|363855793|FG009|Overall Study|Withdrawal by Subject|1|||
105504037|NCT00042289|363855794|FG010|Overall Study|Withdrawal by Subject|0|||
105504038|NCT00042289|363855795|FG011|Overall Study|Withdrawal by Subject|0|||
105504039|NCT00042289|363855796|FG012|Overall Study|Withdrawal by Subject|2|||
105504040|NCT00042289|363855797|FG013|Overall Study|Withdrawal by Subject|0|||
105504041|NCT00042289|363855798|FG014|Overall Study|Withdrawal by Subject|0|||
105504042|NCT00042289|363855799|FG015|Overall Study|Withdrawal by Subject|0|||
105504043|NCT00042289|363855800|FG016|Overall Study|Withdrawal by Subject|0|||
105504044|NCT00042289|363855801|FG017|Overall Study|Withdrawal by Subject|0|||
105504045|NCT00042289|363855802|FG018|Overall Study|Withdrawal by Subject|0|||
105504046|NCT00042289|363855803|FG019|Overall Study|Withdrawal by Subject|0|||
105504047|NCT00042289|363855804|FG020|Overall Study|Withdrawal by Subject|0|||
105504048|NCT00042289|363855805|FG021|Overall Study|Withdrawal by Subject|1|||
105504049|NCT00042289|363855806|FG022|Overall Study|Withdrawal by Subject|1|||
105504050|NCT00042289|363855807|FG023|Overall Study|Withdrawal by Subject|1|||
105504051|NCT00042289|363855808|FG024|Overall Study|Withdrawal by Subject|0|||
105504052|NCT00042289|363855809|FG025|Overall Study|Withdrawal by Subject|0|||
105504053|NCT00042289|363855810|FG026|Overall Study|Withdrawal by Subject|1|||
105504054|NCT00042289|363855811|FG027|Overall Study|Withdrawal by Subject|0|||
105504055|NCT00042289|363855812|FG028|Overall Study|Withdrawal by Subject|2|||
105504056|NCT00042289|363855813|FG029|Overall Study|Withdrawal by Subject|0|||
105504057|NCT00042289|363855814|FG030|Overall Study|Withdrawal by Subject|0|||
105504058|NCT00042289|363855815|FG031|Overall Study|Withdrawal by Subject|1|||
105504059|NCT00042289|363855816|FG032|Overall Study|Withdrawal by Subject|2|||
105504060|NCT00042289|363855817|FG033|Overall Study|Withdrawal by Subject|1|||
105504061|NCT00042289|363855818|FG034|Overall Study|Withdrawal by Subject|0|||
105504062|NCT00042289|363855819|FG035|Overall Study|Withdrawal by Subject|0|||
105504063|NCT00042289|363855820|FG036|Overall Study|Withdrawal by Subject|0|||
105504064|NCT00042289|363855821|FG037|Overall Study|Withdrawal by Subject|1|||
105504065|NCT00042289|363855822|FG038|Overall Study|Withdrawal by Subject|0|||
105504066|NCT00042289|363855823|FG039|Overall Study|Withdrawal by Subject|0|||
105504067|NCT00042289|363855824|FG040|Overall Study|Withdrawal by Subject|0|||
105504068|NCT00042289|363855825|FG041|Overall Study|Withdrawal by Subject|0|||
105504069|NCT00042289|363855826|FG042|Overall Study|Withdrawal by Subject|1|||
105504070|NCT00042289|363855827|FG043|Overall Study|Withdrawal by Subject|0|||
105504071|NCT00042289|363855828|FG044|Overall Study|Withdrawal by Subject|0|||
105504072|NCT00042289|363855829|FG045|Overall Study|Withdrawal by Subject|0|||
105504073|NCT00042289|363855830|FG046|Overall Study|Withdrawal by Subject|0|||
105504074|NCT01663532|363855833|FG000|Overall Study|Lost to Follow-up|9|||
105504075|NCT01663532|363855834|FG001|Overall Study|Lost to Follow-up|10|||
105504076|NCT01663532|363855833|FG000|Overall Study|Adverse Event|7|||
105504077|NCT01663532|363855834|FG001|Overall Study|Adverse Event|13|||
105504078|NCT01663532|363855833|FG000|Overall Study|Met Withdrawal Criteria|7|||
105504079|NCT01663532|363855834|FG001|Overall Study|Met Withdrawal Criteria|6|||
105504080|NCT01663532|363855833|FG000|Overall Study|Physician Decision|1|||
105504081|NCT01663532|363855834|FG001|Overall Study|Physician Decision|1|||
105504082|NCT01663532|363855833|FG000|Overall Study|Withdrawal by Subject|35|||
105504083|NCT01663532|363855834|FG001|Overall Study|Withdrawal by Subject|17|||
105504084|NCT01663532|363855833|FG000|Overall Study|Lack of Efficacy|15|||
105504085|NCT01663532|363855834|FG001|Overall Study|Lack of Efficacy|60|||
105504086|NCT03539081|363855840|FG000|Overall Study|Withdrawal by Subject|2|||
105504087|NCT03539081|363855841|FG001|Overall Study|Withdrawal by Subject|3|||
105504088|NCT03539081|363855842|FG002|Overall Study|Withdrawal by Subject|0|||
105504089|NCT03539081|363855840|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
105504090|NCT03539081|363855841|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
105504091|NCT03539081|363855842|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
105504092|NCT02025621|363855843|FG000|Overall Study|Withdrawal by Subject|1|||
105504093|NCT02025621|363855844|FG001|Overall Study|Withdrawal by Subject|0|||
105504094|NCT02025621|363855843|FG000|Overall Study|Death|0|||
105504095|NCT02025621|363855844|FG001|Overall Study|Death|1|||
105504096|NCT02025621|363855843|FG000|Overall Study|No longer eligible|10|||
105504097|NCT02025621|363855844|FG001|Overall Study|No longer eligible|15|||
105504098|NCT02025621|363855843|FG000|Overall Study|Surgery initiated before infusion|3|||
105504099|NCT02025621|363855844|FG001|Overall Study|Surgery initiated before infusion|3|||
105504100|NCT00739674|363855845|FG000|Overall Study|Screening failures|19|||
105504101|NCT00739674|363855846|FG001|Overall Study|Screening failures|17|||
105504102|NCT00739674|363855845|FG000|Overall Study|Site 212 removal|19|||
105504103|NCT00739674|363855846|FG001|Overall Study|Site 212 removal|13|||
105504104|NCT00739674|363855845|FG000|Overall Study|No follow-up data|33|||
105504105|NCT00739674|363855846|FG001|Overall Study|No follow-up data|18|||
105504106|NCT00739674|363855845|FG000|Overall Study|Dietician consultation >30 days|1|||
105504107|NCT00739674|363855846|FG001|Overall Study|Dietician consultation >30 days|9|||
105504108|NCT00739674|363855845|FG000|Overall Study|Adverse Event|22|||
105504109|NCT00739674|363855846|FG001|Overall Study|Adverse Event|13|||
105504110|NCT00739674|363855845|FG000|Overall Study|Death|1|||
105504111|NCT00739674|363855846|FG001|Overall Study|Death|0|||
105504112|NCT00739674|363855845|FG000|Overall Study|Lack of Efficacy|1|||
105504113|NCT00739674|363855846|FG001|Overall Study|Lack of Efficacy|0|||
105504114|NCT00739674|363855845|FG000|Overall Study|Lost to Follow-up|52|||
105504115|NCT00739674|363855846|FG001|Overall Study|Lost to Follow-up|30|||
105504116|NCT00739674|363855845|FG000|Overall Study|Protocol Violation|5|||
105504117|NCT00739674|363855846|FG001|Overall Study|Protocol Violation|5|||
105504118|NCT00739674|363855845|FG000|Overall Study|Withdrawal by Subject|9|||
105504119|NCT00739674|363855846|FG001|Overall Study|Withdrawal by Subject|9|||
105504120|NCT00739674|363855845|FG000|Overall Study|Reason missing|2|||
105504121|NCT00739674|363855846|FG001|Overall Study|Reason missing|0|||
105504122|NCT00739674|363855845|FG000|Overall Study|Clinic closed|6|||
105504123|NCT00739674|363855846|FG001|Overall Study|Clinic closed|4|||
105504124|NCT00739674|363855845|FG000|Overall Study|Patient moved|3|||
105504125|NCT00739674|363855846|FG001|Overall Study|Patient moved|2|||
105504126|NCT00739674|363855845|FG000|Overall Study|Non compliant|4|||
105504127|NCT00739674|363855846|FG001|Overall Study|Non compliant|0|||
105504128|NCT00739674|363855845|FG000|Overall Study|Unable to attend visit|3|||
105504129|NCT00739674|363855846|FG001|Overall Study|Unable to attend visit|1|||
105504130|NCT00739674|363855845|FG000|Overall Study|Home monitoring off meds|1|||
105504131|NCT00739674|363855846|FG001|Overall Study|Home monitoring off meds|0|||
105504132|NCT00739674|363855845|FG000|Overall Study|Erectile dysfunction|0|||
105504133|NCT00739674|363855846|FG001|Overall Study|Erectile dysfunction|1|||
105504134|NCT04805541|363855848|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
105504135|NCT04019288|363855849|FG000|Overall Study|Death|1|||
105504136|NCT04019288|363855850|FG001|Overall Study|Death|0|||
105504137|NCT04019288|363855851|FG002|Overall Study|Death|0|||
105504138|NCT01970397|363855852|FG000|Overall Study|Adverse Event|0|||
105504139|NCT01970397|363855853|FG001|Overall Study|Adverse Event|1|||
105504140|NCT01970397|363855852|FG000|Overall Study|Lost to Follow-up|0|||
105504141|NCT01970397|363855853|FG001|Overall Study|Lost to Follow-up|1|||
105504142|NCT01970397|363855852|FG000|Overall Study|Personal Reasons|1|||
105504143|NCT01970397|363855853|FG001|Overall Study|Personal Reasons|2|||
105504144|NCT01970397|363855852|FG000|Overall Study|Protocol Violation|1|||
105504145|NCT01970397|363855853|FG001|Overall Study|Protocol Violation|1|||
105504146|NCT00726986|363855854|FG000|Induction Phase|Adverse Event|4|||
105504147|NCT00726986|363855854|FG000|Induction Phase|Withdrawal by Subject|2|||
105504148|NCT00726986|363855854|FG000|Induction Phase|Death|2|||
105504149|NCT00726986|363855854|FG000|Induction Phase|Lack of Efficacy|5|||
105504150|NCT00726986|363855854|FG000|Induction Phase|Secondary Disease|2|||
105504151|NCT00726986|363855854|FG000|Maintenance Phase|Adverse Event|1|||
105504152|NCT00726986|363855854|FG000|Maintenance Phase|Lack of Efficacy|2|||
105504153|NCT00541931|363855855|FG000|Overall Study|Adverse Event|1|||
105504154|NCT00541931|363855856|FG001|Overall Study|Adverse Event|0|||
105504155|NCT00541931|363855855|FG000|Overall Study|Lost to Follow-up|3|||
105504156|NCT00541931|363855856|FG001|Overall Study|Lost to Follow-up|3|||
105504157|NCT00541931|363855855|FG000|Overall Study|Withdrawal by Subject|1|||
105504158|NCT00541931|363855856|FG001|Overall Study|Withdrawal by Subject|0|||
105504159|NCT00541931|363855855|FG000|Overall Study|Transportation Issue|0|||
105504160|NCT00541931|363855856|FG001|Overall Study|Transportation Issue|1|||
105504161|NCT02587234|363855861|FG000|Overall Study|Withdrawal by Subject|1|||
105504162|NCT02587234|363855862|FG001|Overall Study|Withdrawal by Subject|1|||
105504163|NCT02587234|363855861|FG000|Overall Study|Lost to Follow-up|0|||
105504164|NCT02587234|363855862|FG001|Overall Study|Lost to Follow-up|2|||
105504165|NCT00064337|363855863|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
105504166|NCT00064337|363855863|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
105504167|NCT00064337|363855863|FG000|PBSCC or Induction/PBSCC|Progression|3|||
105504168|NCT00064337|363855863|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
105504169|NCT00064337|363855863|FG000|PBSCC or Induction/PBSCC|Death|2|||
105504170|NCT00064337|363855863|FG000|Transplant|Adverse Event|9|||
105504171|NCT00064337|363855863|FG000|Transplant|Not protocol-specified|5|||
105504172|NCT00064337|363855863|FG000|Transplant|Death|3|||
105504173|NCT00064337|363855863|FG000|Transplant|Patient Refusal|2|||
105504174|NCT00064337|363855863|FG000|Transplant|Progression|2|||
105504175|NCT00064337|363855863|FG000|Maintenance|Adverse Event|3|||
105504176|NCT00064337|363855863|FG000|Maintenance|Progression|2|||
105504177|NCT00064337|363855863|FG000|Maintenance|On treatment at time of analysis|2|||
105504178|NCT00064337|363855863|FG000|Maintenance|Not protocol-specified|2|||
105504179|NCT00064337|363855863|FG000|Maintenance|Death|1|||
105504180|NCT02279420|363855864|FG000|Overall Study|Lost to Follow-up|23|||
105504181|NCT03068130|363855867|FG000|Overall Study|Adverse Event|19|||
105504182|NCT03068130|363855867|FG000|Overall Study|Death|14|||
105504183|NCT03068130|363855867|FG000|Overall Study|Lost to Follow-up|4|||
105504184|NCT03068130|363855867|FG000|Overall Study|Withdrawal by Subject|26|||
105504185|NCT03068130|363855867|FG000|Overall Study|Administrative Reasons|3|||
105504186|NCT03068130|363855867|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
105504187|NCT03068130|363855867|FG000|Overall Study|Study terminated by sponsor|194|||
105504188|NCT02763462|363855873|FG000|Overall Study|Protocol Violation|6|||
105504189|NCT00129272|363855874|FG000|Overall Study|Lost to Follow-up|12|||
105504190|NCT00129272|363855875|FG001|Overall Study|Lost to Follow-up|11|||
105504191|NCT00129272|363855874|FG000|Overall Study|Withdrawal by Subject|5|||
105504192|NCT00129272|363855875|FG001|Overall Study|Withdrawal by Subject|11|||
105504193|NCT01706146|363855878|FG000|Overall Study|Withdrawal by Subject|1|||
105504194|NCT01706146|363855878|FG000|Overall Study|Adverse Event|3|||
105504195|NCT01706146|363855878|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
105504196|NCT02582983|363855879|FG000|Overall Study|Death|3|||
105504197|NCT02582983|363855879|FG000|Overall Study|Withdrawal by Subject|2|||
105504198|NCT02582983|363855879|FG000|Overall Study|Adverse Event|1|||
105504199|NCT05209360|363855880|FG000|Overall Study|Withdrawal by Subject|0|||
105504200|NCT05209360|363855881|FG001|Overall Study|Withdrawal by Subject|0|||
105504201|NCT05209360|363855882|FG002|Overall Study|Withdrawal by Subject|1|||
105504202|NCT05209360|363855883|FG003|Overall Study|Withdrawal by Subject|0|||
105504203|NCT05209360|363855884|FG004|Overall Study|Withdrawal by Subject|0|||
105504204|NCT05209360|363855885|FG005|Overall Study|Withdrawal by Subject|0|||
105504205|NCT00724932|363855886|FG000|Overall Study|Lost to Follow-up|1|||
105504206|NCT00724932|363855887|FG001|Overall Study|Lost to Follow-up|0|||
105504207|NCT00724932|363855886|FG000|Overall Study|Not treated|4|||
105504208|NCT00724932|363855887|FG001|Overall Study|Not treated|3|||
105504209|NCT01387932|363855890|FG000|Randomized and Treated|Physician Decision|3|||
105504210|NCT01387932|363855891|FG001|Randomized and Treated|Physician Decision|2|||
105504211|NCT01387932|363855890|FG000|Randomized and Treated|Withdrawal by Subject|4|||
105504212|NCT01387932|363855891|FG001|Randomized and Treated|Withdrawal by Subject|2|||
105504213|NCT01387932|363855890|FG000|Survival Follow-up|Liver Transplant|24|||
105504214|NCT01387932|363855891|FG001|Survival Follow-up|Liver Transplant|28|||
105504215|NCT01387932|363855890|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
105504216|NCT01387932|363855891|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
105504217|NCT01387932|363855890|FG000|Survival Follow-up|Withdrawal by Subject|2|||
105504218|NCT01387932|363855891|FG001|Survival Follow-up|Withdrawal by Subject|4|||
105504219|NCT01387932|363855890|FG000|Survival Follow-up|Lost to Follow-up|6|||
105504220|NCT01387932|363855891|FG001|Survival Follow-up|Lost to Follow-up|5|||
105504221|NCT02465515|363855892|FG000|Overall Study|Investigator site closed|4|||
105504222|NCT02465515|363855893|FG001|Overall Study|Investigator site closed|5|||
105504223|NCT02465515|363855892|FG000|Overall Study|Withdrawal by Subject|74|||
105504224|NCT02465515|363855893|FG001|Overall Study|Withdrawal by Subject|43|||
105504225|NCT02465515|363855892|FG000|Overall Study|Physician Decision|8|||
105504226|NCT02465515|363855893|FG001|Overall Study|Physician Decision|12|||
105504227|NCT02465515|363855892|FG000|Overall Study|Lost to Follow-up|68|||
105504228|NCT02465515|363855893|FG001|Overall Study|Lost to Follow-up|51|||
105504229|NCT02657369|363855894|FG000|Overall Study|Death|27|||
105504230|NCT02657369|363855894|FG000|Overall Study|Study terminated by sponsor|7|||
105504231|NCT02639065|363855895|FG000|Study Treatment|Disease Progression|13|||
105504232|NCT02639065|363855895|FG000|Study Treatment|Adverse Event|9|||
105504233|NCT02639065|363855895|FG000|Study Treatment|Withdrawal by Subject|1|||
105504234|NCT02639065|363855895|FG000|Follow up|Subject refused to follow up|1|||
105504235|NCT02639065|363855895|FG000|Follow up|Symptomatic Deterioration|2|||
105504236|NCT02639065|363855895|FG000|Follow up|Death|2|||
105504237|NCT02639065|363855895|FG000|Follow up|Study Terminated|1|||
105504238|NCT02639065|363855895|FG000|Follow up|Disease Progression|3|||
105504239|NCT00824720|363855896|FG000|Overall Study|failed plug insertion|3|||
105504240|NCT00824720|363855897|FG001|Overall Study|failed plug insertion|1|||
105504241|NCT00824720|363855898|FG002|Overall Study|failed plug insertion|0|||
105504242|NCT00824720|363855896|FG000|Overall Study|Protocol Violation|0|||
105504243|NCT00824720|363855897|FG001|Overall Study|Protocol Violation|0|||
105504244|NCT00824720|363855898|FG002|Overall Study|Protocol Violation|1|||
105504245|NCT00873015|363855899|FG000|Overall Study|Withdrawal by Subject|0|||
105504246|NCT00873015|363855900|FG001|Overall Study|Withdrawal by Subject|1|||
105504247|NCT00873015|363855901|FG002|Overall Study|Withdrawal by Subject|0|||
105504248|NCT00873015|363855902|FG003|Overall Study|Withdrawal by Subject|0|||
105504249|NCT00345839|363855903|FG000|Overall Study|Withdrawal by Subject|91|||
105504250|NCT00345839|363855904|FG001|Overall Study|Withdrawal by Subject|98|||
105504251|NCT00345839|363855903|FG000|Overall Study|Lost to Follow-up|58|||
105504252|NCT00345839|363855904|FG001|Overall Study|Lost to Follow-up|61|||
105504253|NCT02339584|363855910|FG000|Overall Study|Adverse Event|11|||
105504254|NCT02339584|363855911|FG001|Overall Study|Adverse Event|7|||
105504255|NCT02339584|363855910|FG000|Overall Study|Lack of Efficacy|0|||
105504256|NCT02339584|363855911|FG001|Overall Study|Lack of Efficacy|1|||
105504257|NCT02339584|363855910|FG000|Overall Study|Physician Decision|1|||
105504258|NCT02339584|363855911|FG001|Overall Study|Physician Decision|2|||
105504259|NCT02339584|363855910|FG000|Overall Study|Protocol Violation|1|||
105504260|NCT02339584|363855911|FG001|Overall Study|Protocol Violation|1|||
105504261|NCT02339584|363855910|FG000|Overall Study|Withdrawal by Subject|2|||
105504262|NCT02339584|363855911|FG001|Overall Study|Withdrawal by Subject|4|||
105504263|NCT04094883|363855912|FG000|Overall Study|Withdrawal by Subject|1|||
105504264|NCT00826943|363855913|FG000|Overall Study|Withdrawal by Subject|0|||
105504265|NCT00826943|363855914|FG001|Overall Study|Withdrawal by Subject|0|||
105504266|NCT00826943|363855915|FG002|Overall Study|Withdrawal by Subject|0|||
105504267|NCT00826943|363855916|FG003|Overall Study|Withdrawal by Subject|0|||
105504268|NCT00826943|363855917|FG004|Overall Study|Withdrawal by Subject|1|||
105504269|NCT00826943|363855918|FG005|Overall Study|Withdrawal by Subject|0|||
105504270|NCT01348165|363855919|FG000|Overall Study|Adverse Event|0|||
105504271|NCT01348165|363855920|FG001|Overall Study|Adverse Event|0|||
105504272|NCT01348165|363855921|FG002|Overall Study|Adverse Event|0|||
105504273|NCT01348165|363855922|FG003|Overall Study|Adverse Event|0|||
105504274|NCT01348165|363855923|FG004|Overall Study|Adverse Event|0|||
105504275|NCT01348165|363855924|FG005|Overall Study|Adverse Event|0|||
105504276|NCT01348165|363855925|FG006|Overall Study|Adverse Event|1|||
105504277|NCT03278873|363855932|FG000|Overall Study|Withdrawal by Subject|0|||
105504278|NCT03278873|363855933|FG001|Overall Study|Withdrawal by Subject|1|||
105504279|NCT03278873|363855934|FG002|Overall Study|Withdrawal by Subject|0|||
105504280|NCT03278873|363855935|FG003|Overall Study|Withdrawal by Subject|0|||
105504281|NCT03278873|363855932|FG000|Overall Study|Sponsor's decision|0|||
105504282|NCT03278873|363855933|FG001|Overall Study|Sponsor's decision|1|||
105504283|NCT03278873|363855934|FG002|Overall Study|Sponsor's decision|0|||
105504284|NCT03278873|363855935|FG003|Overall Study|Sponsor's decision|0|||
105504285|NCT03278873|363855932|FG000|Overall Study|Early Termination|2|||
105504286|NCT03278873|363855933|FG001|Overall Study|Early Termination|6|||
105504287|NCT03278873|363855934|FG002|Overall Study|Early Termination|0|||
105504288|NCT03278873|363855935|FG003|Overall Study|Early Termination|4|||
105504289|NCT03278873|363855932|FG000|Overall Study|Lost to Follow-up|0|||
105504290|NCT03278873|363855933|FG001|Overall Study|Lost to Follow-up|0|||
105504291|NCT03278873|363855934|FG002|Overall Study|Lost to Follow-up|2|||
105504292|NCT03278873|363855935|FG003|Overall Study|Lost to Follow-up|0|||
105504293|NCT03278873|363855932|FG000|Overall Study|The patient decided to withdraw via email|1|||
105504294|NCT03278873|363855933|FG001|Overall Study|The patient decided to withdraw via email|0|||
105504295|NCT03278873|363855934|FG002|Overall Study|The patient decided to withdraw via email|0|||
105504296|NCT03278873|363855935|FG003|Overall Study|The patient decided to withdraw via email|0|||
105504297|NCT03278873|363855932|FG000|Overall Study|The patient was unresponsive to contact|0|||
105504298|NCT03278873|363855933|FG001|Overall Study|The patient was unresponsive to contact|0|||
105504299|NCT03278873|363855934|FG002|Overall Study|The patient was unresponsive to contact|0|||
105504300|NCT03278873|363855935|FG003|Overall Study|The patient was unresponsive to contact|4|||
105504301|NCT03278873|363855932|FG000|Overall Study|The patient wished to participate no longer|0|||
105504302|NCT03278873|363855933|FG001|Overall Study|The patient wished to participate no longer|1|||
105504303|NCT03278873|363855934|FG002|Overall Study|The patient wished to participate no longer|0|||
105504304|NCT03278873|363855935|FG003|Overall Study|The patient wished to participate no longer|0|||
105504305|NCT03278873|363855932|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
105504306|NCT03278873|363855933|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
105504307|NCT03278873|363855934|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
105504308|NCT03278873|363855935|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
105504309|NCT04731363|363855947|FG000|Overall Study|Could not obtain samples|0|||
105504310|NCT04731363|363855948|FG001|Overall Study|Could not obtain samples|1|||
105504311|NCT04731363|363855949|FG002|Overall Study|Could not obtain samples|0|||
105504312|NCT04731363|363855950|FG003|Overall Study|Could not obtain samples|0|||
105504313|NCT04731363|363855947|FG000|Overall Study|Physician Decision|0|||
105504314|NCT04731363|363855948|FG001|Overall Study|Physician Decision|1|||
105504315|NCT04731363|363855949|FG002|Overall Study|Physician Decision|0|||
105504316|NCT04731363|363855950|FG003|Overall Study|Physician Decision|0|||
105504317|NCT00115739|363857382|FG000|Overall Study|Lost to Follow-up|3|||
105504318|NCT00745823|363857385|FG000|Overall Study|Adverse Event|5|||
105504319|NCT00745823|363857386|FG001|Overall Study|Adverse Event|3|||
105504320|NCT00745823|363857385|FG000|Overall Study|Lack of Efficacy|20|||
105504321|NCT00745823|363857386|FG001|Overall Study|Lack of Efficacy|6|||
105504322|NCT00745823|363857385|FG000|Overall Study|Lost to Follow-up|10|||
105504323|NCT00745823|363857386|FG001|Overall Study|Lost to Follow-up|11|||
105504324|NCT00745823|363857385|FG000|Overall Study|Physician Decision|10|||
105504325|NCT00745823|363857386|FG001|Overall Study|Physician Decision|5|||
105504326|NCT00745823|363857385|FG000|Overall Study|Pregnancy|0|||
105504327|NCT00745823|363857386|FG001|Overall Study|Pregnancy|4|||
105504328|NCT00745823|363857385|FG000|Overall Study|Withdrawal by Subject|14|||
105504329|NCT00745823|363857386|FG001|Overall Study|Withdrawal by Subject|8|||
105504330|NCT00745823|363857385|FG000|Overall Study|Study Terminated by Sponsor|326|||
105504331|NCT00745823|363857386|FG001|Overall Study|Study Terminated by Sponsor|349|||
105504332|NCT00982137|363857387|FG000|Overall Study|Lost to Follow-up|0|||
105504333|NCT00982137|363857388|FG001|Overall Study|Lost to Follow-up|0|||
105504334|NCT00982137|363857389|FG002|Overall Study|Lost to Follow-up|0|||
105504335|NCT00982137|363857390|FG003|Overall Study|Lost to Follow-up|1|||
105504336|NCT00982137|363857387|FG000|Overall Study|Withdrawal by Subject|0|||
105504337|NCT00982137|363857388|FG001|Overall Study|Withdrawal by Subject|1|||
105504338|NCT00982137|363857389|FG002|Overall Study|Withdrawal by Subject|0|||
105504339|NCT00982137|363857390|FG003|Overall Study|Withdrawal by Subject|0|||
105504340|NCT04669600|363857391|FG000|Overall Study|Withdrawal by Subject|1|||
105504341|NCT04669600|363857391|FG000|Overall Study|Other|6|||
105504342|NCT02955602|363857392|FG000|Overall Study|Adverse Event|0|||
105504343|NCT02955602|363857393|FG001|Overall Study|Adverse Event|3|||
105504344|NCT02955602|363857394|FG002|Overall Study|Adverse Event|0|||
105504345|NCT02955602|363857392|FG000|Overall Study|Withdrawal of informed consent|1|||
105504346|NCT02955602|363857393|FG001|Overall Study|Withdrawal of informed consent|3|||
105504347|NCT02955602|363857394|FG002|Overall Study|Withdrawal of informed consent|2|||
105504348|NCT02955602|363857392|FG000|Overall Study|Lost to Follow-up|0|||
105504349|NCT02955602|363857393|FG001|Overall Study|Lost to Follow-up|0|||
105504350|NCT02955602|363857394|FG002|Overall Study|Lost to Follow-up|1|||
105504351|NCT02955602|363857392|FG000|Overall Study|Other|0|||
105504352|NCT02955602|363857393|FG001|Overall Study|Other|1|||
105504353|NCT02955602|363857394|FG002|Overall Study|Other|3|||
105504354|NCT00844831|363857397|FG000|Overall Study|Withdrawal by Subject|4|||
105504355|NCT00844831|363857397|FG000|Overall Study|Adverse Event|1|||
105504356|NCT00844831|363857397|FG000|Overall Study|Physician Decision|1|||
105504357|NCT02550106|363857406|FG000|Overall Study|Adverse Event|1|||
105504358|NCT02550106|363857406|FG000|Overall Study|Lack of Efficacy|3|||
105504359|NCT02550106|363857406|FG000|Overall Study|Protocol Violation|6|||
105504360|NCT02550106|363857406|FG000|Overall Study|Withdrawal by Subject|2|||
105504361|NCT02195583|363857407|FG000|Overall Study|Lost to Follow-up|1|||
105504362|NCT02195583|363857407|FG000|Overall Study|Withdrawal by Subject|4|||
105504363|NCT02195583|363857407|FG000|Overall Study|Adverse Event|2|||
105504364|NCT02195583|363857407|FG000|Overall Study|Other Reason|2|||
105504365|NCT01709513|363857408|FG000|Overall Study|Randomized but not treated|0|||
105504366|NCT01709513|363857409|FG001|Overall Study|Randomized but not treated|1|||
105504367|NCT01709513|363857410|FG002|Overall Study|Randomized but not treated|0|||
105504368|NCT01709513|363857408|FG000|Overall Study|Adverse Event|16|||
105504369|NCT01709513|363857409|FG001|Overall Study|Adverse Event|31|||
105504370|NCT01709513|363857410|FG002|Overall Study|Adverse Event|23|||
105504371|NCT01709513|363857408|FG000|Overall Study|Poor compliance to protocol|2|||
105504372|NCT01709513|363857409|FG001|Overall Study|Poor compliance to protocol|0|||
105504373|NCT01709513|363857410|FG002|Overall Study|Poor compliance to protocol|0|||
105504374|NCT01709513|363857408|FG000|Overall Study|Other|3|||
105504375|NCT01709513|363857409|FG001|Overall Study|Other|11|||
105504376|NCT01709513|363857410|FG002|Overall Study|Other|7|||
105504377|NCT01543958|363857411|FG000|Overall Study|Loss to follow-up|3|||
105504378|NCT01543958|363857411|FG000|Overall Study|ART initiation|1|||
105504379|NCT03305575|363857416|FG000|Overall Study|Physician Decision|1|||
105504380|NCT03305575|363857417|FG001|Overall Study|Physician Decision|0|||
105504381|NCT01389817|363857420|FG000|Overall Study|Physician Decision|1|||
105504382|NCT01389817|363857421|FG001|Overall Study|Physician Decision|0|||
105504383|NCT01389817|363857420|FG000|Overall Study|Lost to Follow-up|1|||
105504384|NCT01389817|363857421|FG001|Overall Study|Lost to Follow-up|0|||
105504385|NCT01389817|363857420|FG000|Overall Study|Withdrawal by Subject|2|||
105504386|NCT01389817|363857421|FG001|Overall Study|Withdrawal by Subject|0|||
105504387|NCT03486223|363857422|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
105504388|NCT03486223|363857423|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
105504389|NCT01819831|363857424|FG000|Overall Study|Withdrawal by Subject|1|||
105504390|NCT03130257|363857429|FG000|Overall Study|Withdrawal by Subject|1|||
105504391|NCT03130257|363857430|FG001|Overall Study|Withdrawal by Subject|0|||
105504392|NCT03130257|363857431|FG002|Overall Study|Withdrawal by Subject|2|||
105504393|NCT00044083|363857434|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
105504394|NCT00044083|363857435|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
105504395|NCT00044083|363857434|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
105504396|NCT00044083|363857435|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
105504397|NCT00044083|363857434|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
105504398|NCT00044083|363857435|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
105504399|NCT00044083|363857434|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
105504400|NCT00044083|363857435|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
105504401|NCT00044083|363857434|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
105504402|NCT00044083|363857435|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
105504403|NCT00044083|363857434|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
105504404|NCT00044083|363857435|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
105504405|NCT00044083|363857434|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
105504406|NCT00044083|363857435|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
105504407|NCT00044083|363857434|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
105504408|NCT00044083|363857435|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
105504409|NCT00044083|363857434|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
105504410|NCT00044083|363857435|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
105504411|NCT00044083|363857434|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
105504412|NCT00044083|363857435|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
105504413|NCT00288054|363857440|FG000|Overall Study|Protocol Violation|2|||
105504414|NCT00288054|363857440|FG000|Overall Study|Lack of Efficacy|16|||
105504415|NCT00288054|363857440|FG000|Overall Study|Adverse Event|3|||
105504416|NCT00288054|363857440|FG000|Overall Study|Withdrawal by Subject|1|||
105504417|NCT00288054|363857440|FG000|Overall Study|Not protocol specified|2|||
105504418|NCT01786668|363857444|FG000|Overall Study|Adverse Event|0|||
105504419|NCT01786668|363857445|FG001|Overall Study|Adverse Event|1|||
105504420|NCT01786668|363857446|FG002|Overall Study|Adverse Event|1|||
105504421|NCT01786668|363857447|FG003|Overall Study|Adverse Event|2|||
105504422|NCT01786668|363857444|FG000|Overall Study|Withdrawal by Subject|0|||
105504423|NCT01786668|363857445|FG001|Overall Study|Withdrawal by Subject|0|||
105504424|NCT01786668|363857446|FG002|Overall Study|Withdrawal by Subject|3|||
105504425|NCT01786668|363857447|FG003|Overall Study|Withdrawal by Subject|1|||
105504426|NCT01786668|363857444|FG000|Overall Study|Pregnancy|0|||
105504427|NCT01786668|363857445|FG001|Overall Study|Pregnancy|0|||
105504428|NCT01786668|363857446|FG002|Overall Study|Pregnancy|0|||
105504429|NCT01786668|363857447|FG003|Overall Study|Pregnancy|1|||
105504430|NCT01786668|363857444|FG000|Overall Study|Lost to Follow-up|1|||
105504431|NCT01786668|363857445|FG001|Overall Study|Lost to Follow-up|0|||
105504432|NCT01786668|363857446|FG002|Overall Study|Lost to Follow-up|1|||
105504433|NCT01786668|363857447|FG003|Overall Study|Lost to Follow-up|0|||
105504434|NCT01091974|363857448|FG000|Overall Study|Did not start intervention|3|||
105504435|NCT01091974|363857449|FG001|Overall Study|Did not start intervention|1|||
105504436|NCT01091974|363857450|FG002|Overall Study|Did not start intervention|3|||
105504437|NCT01091974|363857451|FG003|Overall Study|Did not start intervention|1|||
105504438|NCT01091974|363857448|FG000|Overall Study|resumed sleep medication|0|||
105504439|NCT01091974|363857449|FG001|Overall Study|resumed sleep medication|0|||
105504440|NCT01091974|363857450|FG002|Overall Study|resumed sleep medication|1|||
105504441|NCT01091974|363857451|FG003|Overall Study|resumed sleep medication|2|||
105504442|NCT01091974|363857448|FG000|Overall Study|Withdrawal by Subject|1|||
105504443|NCT01091974|363857449|FG001|Overall Study|Withdrawal by Subject|3|||
105504444|NCT01091974|363857450|FG002|Overall Study|Withdrawal by Subject|2|||
105504445|NCT01091974|363857451|FG003|Overall Study|Withdrawal by Subject|2|||
105504446|NCT01091974|363857448|FG000|Overall Study|side-effects|1|||
105504447|NCT01091974|363857449|FG001|Overall Study|side-effects|1|||
105504448|NCT01091974|363857450|FG002|Overall Study|side-effects|0|||
105504449|NCT01091974|363857451|FG003|Overall Study|side-effects|2|||
105504450|NCT00518284|363857460|FG000|Overall Study|Adverse Event|0|||
105504451|NCT00518284|363857461|FG001|Overall Study|Adverse Event|1|||
105504452|NCT00518284|363857462|FG002|Overall Study|Adverse Event|0|||
105504453|NCT00518284|363857463|FG003|Overall Study|Adverse Event|0|||
105504454|NCT00518284|363857460|FG000|Overall Study|Study Termination|0|||
105504455|NCT00518284|363857461|FG001|Overall Study|Study Termination|2|||
105504456|NCT00518284|363857462|FG002|Overall Study|Study Termination|1|||
105504457|NCT00518284|363857463|FG003|Overall Study|Study Termination|2|||
105504458|NCT03768414|363857464|FG000|Overall Study|Adverse Event or side effects|72|||
105504459|NCT03768414|363857465|FG001|Overall Study|Adverse Event or side effects|28|||
105504460|NCT03768414|363857464|FG000|Overall Study|Refusal unrelated to adverse event|33|||
105504461|NCT03768414|363857465|FG001|Overall Study|Refusal unrelated to adverse event|33|||
105504462|NCT03768414|363857464|FG000|Overall Study|Progression/relapse|132|||
105504463|NCT03768414|363857465|FG001|Overall Study|Progression/relapse|60|||
105504464|NCT03768414|363857464|FG000|Overall Study|Death|9|||
105504465|NCT03768414|363857465|FG001|Overall Study|Death|6|||
105504466|NCT03768414|363857464|FG000|Overall Study|Other - not protocol specified|45|||
105504467|NCT03768414|363857465|FG001|Overall Study|Other - not protocol specified|18|||
105504468|NCT03768414|363857464|FG000|Overall Study|Reason under review|3|||
105504469|NCT03768414|363857465|FG001|Overall Study|Reason under review|2|||
105504470|NCT04075266|363857466|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
105504471|NCT04075266|363857467|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
105504472|NCT04075266|363857466|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
105504473|NCT04075266|363857467|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
105504474|NCT01302834|363857468|FG000|Overall Study|Protocol Violation|17|||
105504475|NCT01302834|363857469|FG001|Overall Study|Protocol Violation|23|||
105504476|NCT01302834|363857468|FG000|Overall Study|HIV positive|1|||
105504477|NCT01302834|363857469|FG001|Overall Study|HIV positive|3|||
105504478|NCT01217801|363857470|FG000|Period 1|Protocol Violation|1|||
105504479|NCT01217801|363857471|FG001|Period 1|Protocol Violation|1|||
105504480|NCT01217801|363857470|FG000|Period 1|Withdrawal by Subject|0|||
105504481|NCT01217801|363857471|FG001|Period 1|Withdrawal by Subject|1|||
105504482|NCT05399641|363857472|FG000|Overall Study|Adverse Event|0|||
105504483|NCT05399641|363857473|FG001|Overall Study|Adverse Event|1|||
105504484|NCT05399641|363857474|FG002|Overall Study|Adverse Event|1|||
105504485|NCT05399641|363857472|FG000|Overall Study|Lost to Follow-up|1|||
105504486|NCT05399641|363857473|FG001|Overall Study|Lost to Follow-up|2|||
105504487|NCT05399641|363857474|FG002|Overall Study|Lost to Follow-up|2|||
105504488|NCT05399641|363857472|FG000|Overall Study|Physician Decision|1|||
105504489|NCT05399641|363857473|FG001|Overall Study|Physician Decision|3|||
105504490|NCT05399641|363857474|FG002|Overall Study|Physician Decision|3|||
105504491|NCT05399641|363857472|FG000|Overall Study|Withdrawal by Subject|4|||
105504492|NCT05399641|363857473|FG001|Overall Study|Withdrawal by Subject|11|||
105504493|NCT05399641|363857474|FG002|Overall Study|Withdrawal by Subject|7|||
105504494|NCT05399641|363857472|FG000|Overall Study|Reason not defined|3|||
105504495|NCT05399641|363857473|FG001|Overall Study|Reason not defined|5|||
105504496|NCT05399641|363857474|FG002|Overall Study|Reason not defined|6|||
105504497|NCT01300650|363857475|FG000|Overall Study|Adverse Event|1|||
105504498|NCT01201850|363857478|FG000|Overall Study|Tumor progression|4|||
105504499|NCT03386448|363857479|FG000|Overall Study|Adverse Event|0|||
105504500|NCT03386448|363857480|FG001|Overall Study|Adverse Event|2|||
105504501|NCT01146665|363857483|FG000|Overall Study|Withdrawal by Subject|10|||
105504502|NCT01146665|363857484|FG001|Overall Study|Withdrawal by Subject|16|||
105504503|NCT00816595|363857485|FG000|Overall Study|Withdrawal by Subject|2|||
105504504|NCT00816595|363857486|FG001|Overall Study|Withdrawal by Subject|0|||
105504505|NCT00751933|363857487|FG000|Overall Study|Withdrawal by Subject|0|||
105504506|NCT00751933|363857488|FG001|Overall Study|Withdrawal by Subject|1|||
105504507|NCT00751933|363857489|FG002|Overall Study|Withdrawal by Subject|0|||
105504508|NCT00751933|363857490|FG003|Overall Study|Withdrawal by Subject|0|||
105504509|NCT00751933|363857487|FG000|Overall Study|Physician Decision|0|||
105504510|NCT00751933|363857488|FG001|Overall Study|Physician Decision|0|||
105504511|NCT00751933|363857489|FG002|Overall Study|Physician Decision|1|||
105504512|NCT00751933|363857490|FG003|Overall Study|Physician Decision|1|||
105504513|NCT00001880|363857495|FG000|Overall Study|Death|14|||
105504514|NCT03298867|363857496|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
105504515|NCT03298867|363857497|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
105504516|NCT03298867|363857496|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
105504517|NCT03298867|363857497|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
105504518|NCT03298867|363857496|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
105504519|NCT03298867|363857497|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
105504520|NCT03298867|363857496|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
105504521|NCT03298867|363857497|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
105504522|NCT03298867|363857496|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
105504523|NCT03298867|363857497|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
105504524|NCT03298867|363857496|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
105504525|NCT03298867|363857497|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
105504526|NCT03298867|363857496|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
105504527|NCT03298867|363857497|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
105504528|NCT03298867|363857496|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
105504529|NCT03298867|363857497|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
105504530|NCT03298867|363857496|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
105504531|NCT03298867|363857497|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
105504532|NCT01382212|363857498|FG000|Overall Study|Kidney transplant|1|||
105504533|NCT01382212|363857498|FG000|Overall Study|Withdrew consent|1|||
105504534|NCT00743483|363857499|FG000|Baseline Period|Physician Decision|1|||
105504535|NCT00743483|363857499|FG000|Treatment Period|Adverse Event|1|||
105504536|NCT00228384|363857500|FG000|Overall Study|Death|9|||
105504537|NCT00228384|363857501|FG001|Overall Study|Death|3|||
105504538|NCT00228384|363857500|FG000|Overall Study|Lost to Follow-up|6|||
105504539|NCT00228384|363857501|FG001|Overall Study|Lost to Follow-up|10|||
105504540|NCT00228384|363857500|FG000|Overall Study|Surgical Intervention (bypass)|5|||
105504541|NCT00228384|363857501|FG001|Overall Study|Surgical Intervention (bypass)|5|||
105504542|NCT00228384|363857500|FG000|Overall Study|Withdrawal by Subject|9|||
105504543|NCT00228384|363857501|FG001|Overall Study|Withdrawal by Subject|10|||
105504544|NCT00228384|363857500|FG000|Overall Study|Physician Decision|0|||
105504545|NCT00228384|363857501|FG001|Overall Study|Physician Decision|1|||
105504546|NCT01084083|363857502|FG000|Overall Study|Adverse Event|5|||
105504547|NCT01084083|363857502|FG000|Overall Study|Death|1|||
105504548|NCT01084083|363857502|FG000|Overall Study|Withdrawal by Subject|2|||
105504549|NCT01084083|363857502|FG000|Overall Study|Complicating disease|1|||
105504550|NCT01084083|363857502|FG000|Overall Study|Other|2|||
105504551|NCT01084083|363857502|FG000|Overall Study|Never started assigned therapy|1|||
105504552|NCT01273597|363857503|FG000|Overall Study|Adverse Event|5|||
105504553|NCT01273597|363857503|FG000|Overall Study|Underwent Kidney Transplantation|2|||
105504554|NCT01273597|363857503|FG000|Overall Study|Reason Not Reported|1|||
105504555|NCT00873912|363857505|FG000|Overall Study|Withdrawal by Subject|1|||
105504556|NCT00873912|363857506|FG001|Overall Study|Withdrawal by Subject|0|||
105504557|NCT00873912|363857505|FG000|Overall Study|Lost to Follow-up|2|||
105504558|NCT00873912|363857506|FG001|Overall Study|Lost to Follow-up|0|||
105504559|NCT01088997|363857509|FG000|Overall Study|Physician Decision|1|||
105504560|NCT01088997|363857510|FG001|Overall Study|Physician Decision|1|||
105504561|NCT01088997|363857509|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
105504562|NCT01088997|363857510|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
105504563|NCT01088997|363857509|FG000|Overall Study|Excluded prior to receiving drug|1|||
105504564|NCT01088997|363857510|FG001|Overall Study|Excluded prior to receiving drug|1|||
105504565|NCT05243641|363857513|FG000|Overall Study|Adverse Event|3|||
105504566|NCT05243641|363857514|FG001|Overall Study|Adverse Event|0|||
105504567|NCT05243641|363857515|FG002|Overall Study|Adverse Event|0|||
105504568|NCT05243641|363857516|FG003|Overall Study|Adverse Event|1|||
105504569|NCT05243641|363857517|FG004|Overall Study|Adverse Event|0|||
105504570|NCT05243641|363857518|FG005|Overall Study|Adverse Event|0|||
105504571|NCT05243641|363857513|FG000|Overall Study|Disease progression|4|||
105504572|NCT05243641|363857514|FG001|Overall Study|Disease progression|0|||
105504573|NCT05243641|363857515|FG002|Overall Study|Disease progression|0|||
105504574|NCT05243641|363857516|FG003|Overall Study|Disease progression|2|||
105504575|NCT05243641|363857517|FG004|Overall Study|Disease progression|0|||
105504576|NCT05243641|363857518|FG005|Overall Study|Disease progression|0|||
105504577|NCT05695209|363857519|FG000|3-months|Withdrawal by Subject|2|||
105504578|NCT05695209|363857520|FG001|3-months|Withdrawal by Subject|0|||
105504579|NCT05695209|363857519|FG000|3-months|Unable to contact for 3-month data collection|0|||
105504580|NCT05695209|363857520|FG001|3-months|Unable to contact for 3-month data collection|1|||
105504581|NCT05695209|363857519|FG000|6-months|Lost to Follow-up|1|||
105504582|NCT05695209|363857520|FG001|6-months|Lost to Follow-up|1|||
105504583|NCT03749447|363858954|FG000|Overall Study|Adverse Event|11|||
105504584|NCT03749447|363858955|FG001|Overall Study|Adverse Event|3|||
105504585|NCT03749447|363858954|FG000|Overall Study|Death|1|||
105504586|NCT03749447|363858955|FG001|Overall Study|Death|1|||
105504587|NCT03749447|363858954|FG000|Overall Study|Lost to Follow-up|2|||
105504588|NCT03749447|363858955|FG001|Overall Study|Lost to Follow-up|2|||
105504589|NCT03749447|363858954|FG000|Overall Study|Reason Not Specified|0|||
105504590|NCT03749447|363858955|FG001|Overall Study|Reason Not Specified|3|||
105504591|NCT03749447|363858954|FG000|Overall Study|Physician Decision|4|||
105504592|NCT03749447|363858955|FG001|Overall Study|Physician Decision|3|||
105504593|NCT03749447|363858954|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
105504594|NCT03749447|363858955|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
105504595|NCT03749447|363858954|FG000|Overall Study|Study Terminated By Sponsor|112|||
105504596|NCT03749447|363858955|FG001|Overall Study|Study Terminated By Sponsor|105|||
105504597|NCT03749447|363858954|FG000|Overall Study|Withdrawal by Subject|12|||
105504598|NCT03749447|363858955|FG001|Overall Study|Withdrawal by Subject|6|||
105504599|NCT03749447|363858954|FG000|Overall Study|Non-compliance With Study Drug|0|||
105504600|NCT03749447|363858955|FG001|Overall Study|Non-compliance With Study Drug|1|||
105504601|NCT00967668|363858956|FG000|Overall Study|Withdrawal by Subject|13|||
105504602|NCT00967668|363858957|FG001|Overall Study|Withdrawal by Subject|8|||
105504603|NCT00967668|363858958|FG002|Overall Study|Withdrawal by Subject|8|||
105504604|NCT00967668|363858956|FG000|Overall Study|Death|0|||
105504605|NCT00967668|363858957|FG001|Overall Study|Death|2|||
105504606|NCT00967668|363858958|FG002|Overall Study|Death|4|||
105504607|NCT00967668|363858956|FG000|Overall Study|Removed due to behavior|1|||
105504608|NCT00967668|363858957|FG001|Overall Study|Removed due to behavior|1|||
105504609|NCT00967668|363858958|FG002|Overall Study|Removed due to behavior|2|||
105504610|NCT00967668|363858956|FG000|Overall Study|Refused Year 2|11|||
105504611|NCT00967668|363858957|FG001|Overall Study|Refused Year 2|6|||
105504612|NCT00967668|363858958|FG002|Overall Study|Refused Year 2|4|||
105504613|NCT00967668|363858956|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
105504614|NCT00967668|363858957|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
105504615|NCT00967668|363858958|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
105504616|NCT00967668|363858956|FG000|Overall Study|Lost to Follow-up|15|||
105504617|NCT00967668|363858957|FG001|Overall Study|Lost to Follow-up|9|||
105504618|NCT00967668|363858958|FG002|Overall Study|Lost to Follow-up|16|||
105504619|NCT00967668|363858956|FG000|Overall Study|Refused 12-mo assessment|3|||
105504620|NCT00967668|363858957|FG001|Overall Study|Refused 12-mo assessment|1|||
105504621|NCT00967668|363858958|FG002|Overall Study|Refused 12-mo assessment|9|||
105504622|NCT00967668|363858956|FG000|Overall Study|Pregnancy|1|||
105504623|NCT00967668|363858957|FG001|Overall Study|Pregnancy|0|||
105504624|NCT00967668|363858958|FG002|Overall Study|Pregnancy|0|||
105504625|NCT00259649|363858961|FG000|Overall Study|Lost to Follow-up|7|||
105504626|NCT00259649|363858961|FG000|Overall Study|irregular menses|3|||
105504627|NCT00709761|363858962|FG000|Overall Study|Withdrawal by Subject|8|||
105504628|NCT00709761|363858962|FG000|Overall Study|study closed/terminated|17|||
105504629|NCT00709761|363858962|FG000|Overall Study|Lost to Follow-up|2|||
105504630|NCT02200211|363858963|FG000|Overall Study|Lost to Follow-up|7|||
105504631|NCT02200211|363858964|FG001|Overall Study|Lost to Follow-up|7|||
105504632|NCT02200211|363858965|FG002|Overall Study|Lost to Follow-up|1|||
105504633|NCT02200211|363858966|FG003|Overall Study|Lost to Follow-up|2|||
105504634|NCT02200211|363858963|FG000|Overall Study|Withdrawal by Subject|1|||
105504635|NCT02200211|363858964|FG001|Overall Study|Withdrawal by Subject|0|||
105504636|NCT02200211|363858965|FG002|Overall Study|Withdrawal by Subject|0|||
105504637|NCT02200211|363858966|FG003|Overall Study|Withdrawal by Subject|0|||
105504638|NCT02469298|363858973|FG000|Overall Study|Protocol Violation|0|||
105504639|NCT02469298|363858974|FG001|Overall Study|Protocol Violation|1|||
105504640|NCT02469298|363858975|FG002|Overall Study|Protocol Violation|1|||
105504641|NCT02469298|363858976|FG003|Overall Study|Protocol Violation|0|||
105504642|NCT02469298|363858973|FG000|Overall Study|Lost to Follow-up|1|||
105504643|NCT02469298|363858974|FG001|Overall Study|Lost to Follow-up|0|||
105504644|NCT02469298|363858975|FG002|Overall Study|Lost to Follow-up|1|||
105504645|NCT02469298|363858976|FG003|Overall Study|Lost to Follow-up|0|||
105504646|NCT02469298|363858973|FG000|Overall Study|Physician Decision|0|||
105504647|NCT02469298|363858974|FG001|Overall Study|Physician Decision|0|||
105504648|NCT02469298|363858975|FG002|Overall Study|Physician Decision|0|||
105504649|NCT02469298|363858976|FG003|Overall Study|Physician Decision|1|||
105504650|NCT02469298|363858973|FG000|Overall Study|Withdrawal by Subject|0|||
105504651|NCT02469298|363858974|FG001|Overall Study|Withdrawal by Subject|0|||
105504652|NCT02469298|363858975|FG002|Overall Study|Withdrawal by Subject|0|||
105504653|NCT02469298|363858976|FG003|Overall Study|Withdrawal by Subject|1|||
105504654|NCT00787891|363858988|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
105504655|NCT00787891|363858989|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
105504656|NCT00787891|363858988|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
105504657|NCT00787891|363858989|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
105504658|NCT00787891|363858988|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
105504659|NCT00787891|363858989|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
105504660|NCT00787891|363858988|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
105504661|NCT00787891|363858989|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
105504662|NCT00787891|363858988|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
105504663|NCT00787891|363858989|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
105504664|NCT00787891|363858988|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
105504665|NCT00787891|363858989|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
105504666|NCT00787891|363858988|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
105504667|NCT00787891|363858989|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
105504668|NCT00787891|363858988|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
105504669|NCT00787891|363858989|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
105504670|NCT00787891|363858988|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
105504671|NCT00787891|363858989|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
105504672|NCT00787891|363858988|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
105504673|NCT00787891|363858989|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
105504674|NCT03797014|363858992|FG000|Overall Study|Withdrawal by Subject|1|||
105504675|NCT03797014|363858992|FG000|Overall Study|Lost to Follow-up|1|||
105504676|NCT03797014|363858992|FG000|Overall Study|Protocol Violation|1|||
105504677|NCT01434667|363859001|FG000|Overall Study|Lost to Follow-up|5|||
105504678|NCT01434667|363859002|FG001|Overall Study|Lost to Follow-up|10|||
105504679|NCT02165215|363859005|FG000|Induction Phase|Adverse Event|1|||
105504680|NCT02165215|363859006|FG001|Induction Phase|Adverse Event|0|||
105504681|NCT02165215|363859007|FG002|Induction Phase|Adverse Event|0|||
105504682|NCT02165215|363859005|FG000|Induction Phase|Withdrawal by Subject|10|||
105504683|NCT02165215|363859006|FG001|Induction Phase|Withdrawal by Subject|0|||
105504684|NCT02165215|363859007|FG002|Induction Phase|Withdrawal by Subject|0|||
105504685|NCT02165215|363859005|FG000|Induction Phase|Protocol Violation|1|||
105504686|NCT02165215|363859006|FG001|Induction Phase|Protocol Violation|0|||
105504687|NCT02165215|363859007|FG002|Induction Phase|Protocol Violation|0|||
105504688|NCT02165215|363859005|FG000|Induction Phase|Physician Decision|1|||
105504689|NCT02165215|363859006|FG001|Induction Phase|Physician Decision|0|||
105504690|NCT02165215|363859007|FG002|Induction Phase|Physician Decision|0|||
105504691|NCT02165215|363859005|FG000|Induction Phase|Lack of Efficacy|2|||
105504692|NCT02165215|363859006|FG001|Induction Phase|Lack of Efficacy|0|||
105504693|NCT02165215|363859007|FG002|Induction Phase|Lack of Efficacy|0|||
105504694|NCT02165215|363859005|FG000|Induction Phase|Non-Compliance|2|||
105504695|NCT02165215|363859006|FG001|Induction Phase|Non-Compliance|0|||
105504696|NCT02165215|363859007|FG002|Induction Phase|Non-Compliance|0|||
105504697|NCT02165215|363859005|FG000|Induction Phase|Lost to Follow-up|6|||
105504698|NCT02165215|363859006|FG001|Induction Phase|Lost to Follow-up|0|||
105504699|NCT02165215|363859007|FG002|Induction Phase|Lost to Follow-up|0|||
105504700|NCT02165215|363859005|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105504701|NCT02165215|363859006|FG001|Maintenance Phase|Withdrawal by Subject|7|||
105504702|NCT02165215|363859007|FG002|Maintenance Phase|Withdrawal by Subject|3|||
105504703|NCT02165215|363859005|FG000|Maintenance Phase|Multiple reasons|0|||
105504704|NCT02165215|363859006|FG001|Maintenance Phase|Multiple reasons|2|||
105504705|NCT02165215|363859007|FG002|Maintenance Phase|Multiple reasons|1|||
105504706|NCT02165215|363859005|FG000|Maintenance Phase|Lost to Follow-up|0|||
105504707|NCT02165215|363859006|FG001|Maintenance Phase|Lost to Follow-up|2|||
105504708|NCT02165215|363859007|FG002|Maintenance Phase|Lost to Follow-up|0|||
105504709|NCT02165215|363859005|FG000|Maintenance Phase|Adverse Event|0|||
105504710|NCT02165215|363859006|FG001|Maintenance Phase|Adverse Event|1|||
105504711|NCT02165215|363859007|FG002|Maintenance Phase|Adverse Event|1|||
105504712|NCT01877265|363859008|FG000|Treatment Period 1|Sponsor Decision|0|||
105504713|NCT01877265|363859009|FG001|Treatment Period 1|Sponsor Decision|0|||
105504714|NCT01877265|363859010|FG002|Treatment Period 1|Sponsor Decision|1|||
105504715|NCT01877265|363859011|FG003|Treatment Period 1|Sponsor Decision|0|||
105504716|NCT01877265|363859012|FG004|Treatment Period 1|Sponsor Decision|0|||
105504717|NCT01877265|363859013|FG005|Treatment Period 1|Sponsor Decision|0|||
105504718|NCT01877265|363859008|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
105504719|NCT01877265|363859009|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
105504720|NCT01877265|363859010|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
105504721|NCT01877265|363859011|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
105504722|NCT01877265|363859012|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
105504723|NCT01877265|363859013|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
105504724|NCT01877265|363859008|FG000|Treatment Period 3|Lost to Follow-up|1|||
105504725|NCT01877265|363859009|FG001|Treatment Period 3|Lost to Follow-up|0|||
105504726|NCT01877265|363859010|FG002|Treatment Period 3|Lost to Follow-up|0|||
105504727|NCT01877265|363859011|FG003|Treatment Period 3|Lost to Follow-up|0|||
105504728|NCT01877265|363859012|FG004|Treatment Period 3|Lost to Follow-up|0|||
105504729|NCT01877265|363859013|FG005|Treatment Period 3|Lost to Follow-up|0|||
105504730|NCT03535844|363859020|FG000|Overall Study|Withdrawal by Subject|0|||
105504731|NCT03535844|363859021|FG001|Overall Study|Withdrawal by Subject|1|||
105504732|NCT00297830|363859022|FG000|6 Month Visit|Death|1|||
105504733|NCT00297830|363859023|FG001|6 Month Visit|Death|0|||
105504734|NCT00297830|363859024|FG002|6 Month Visit|Death|2|||
105504735|NCT00297830|363859022|FG000|6 Month Visit|Withdrawal by Subject|2|||
105504736|NCT00297830|363859023|FG001|6 Month Visit|Withdrawal by Subject|1|||
105504737|NCT00297830|363859024|FG002|6 Month Visit|Withdrawal by Subject|1|||
105504738|NCT00297830|363859022|FG000|6 Month Visit|Adverse Event|0|||
105504739|NCT00297830|363859023|FG001|6 Month Visit|Adverse Event|1|||
105504740|NCT00297830|363859024|FG002|6 Month Visit|Adverse Event|0|||
105504741|NCT00297830|363859022|FG000|12 Month Visit|Lost to Follow-up|1|||
105504742|NCT00297830|363859023|FG001|12 Month Visit|Lost to Follow-up|0|||
105504743|NCT00297830|363859024|FG002|12 Month Visit|Lost to Follow-up|0|||
105504744|NCT00297830|363859022|FG000|12 Month Visit|Adverse Event|0|||
105504745|NCT00297830|363859023|FG001|12 Month Visit|Adverse Event|3|||
105504746|NCT00297830|363859024|FG002|12 Month Visit|Adverse Event|0|||
105504747|NCT00297830|363859022|FG000|12 Month Visit|Withdrawal by Subject|0|||
105504748|NCT00297830|363859023|FG001|12 Month Visit|Withdrawal by Subject|3|||
105504749|NCT00297830|363859024|FG002|12 Month Visit|Withdrawal by Subject|0|||
105504750|NCT02835820|363859025|FG000|Overall Study|Baseline Screen Failure|0|||
105504751|NCT02835820|363859026|FG001|Overall Study|Baseline Screen Failure|3|||
105504752|NCT00590720|363859027|FG000|Overall Study|Lost to Follow-up|1|||
105504753|NCT00590720|363859028|FG001|Overall Study|Lost to Follow-up|0|||
105504754|NCT00590720|363859027|FG000|Overall Study|Withdrawal by Subject|0|||
105504755|NCT00590720|363859028|FG001|Overall Study|Withdrawal by Subject|1|||
105504756|NCT01001377|363859032|FG000|Overall Study|Ineligibility determined|2|||
105504757|NCT01001377|363859033|FG001|Overall Study|Ineligibility determined|0|||
105504758|NCT01001377|363859032|FG000|Overall Study|Withdrawal by Subject|19|||
105504759|NCT01001377|363859033|FG001|Overall Study|Withdrawal by Subject|20|||
105504760|NCT01001377|363859032|FG000|Overall Study|Lost to Follow-up|14|||
105504761|NCT01001377|363859033|FG001|Overall Study|Lost to Follow-up|17|||
105504762|NCT01001377|363859032|FG000|Overall Study|Death|391|||
105504763|NCT01001377|363859033|FG001|Overall Study|Death|384|||
105504764|NCT03039283|363859038|FG000|Overall Study|Protocol Violation|2|||
105504765|NCT01056653|363859039|FG000|Overall Study|Lost to Follow-up|0|||
105504766|NCT01056653|363859040|FG001|Overall Study|Lost to Follow-up|0|||
105504767|NCT01056653|363859041|FG002|Overall Study|Lost to Follow-up|2|||
105504768|NCT03094169|363859042|FG000|Overall Study|Lack of Efficacy|0|||
105504769|NCT03094169|363859043|FG001|Overall Study|Lack of Efficacy|0|||
105504770|NCT03094169|363859044|FG002|Overall Study|Lack of Efficacy|0|||
105504771|NCT03094169|363859045|FG003|Overall Study|Lack of Efficacy|0|||
105504772|NCT03094169|363859046|FG004|Overall Study|Lack of Efficacy|0|||
105504773|NCT03094169|363859047|FG005|Overall Study|Lack of Efficacy|0|||
105504774|NCT03094169|363859048|FG006|Overall Study|Lack of Efficacy|0|||
105504775|NCT03094169|363859049|FG007|Overall Study|Lack of Efficacy|21|||
105504776|NCT03094169|363859042|FG000|Overall Study|Adverse Event|0|||
105504777|NCT03094169|363859043|FG001|Overall Study|Adverse Event|0|||
105504778|NCT03094169|363859044|FG002|Overall Study|Adverse Event|0|||
105504779|NCT03094169|363859045|FG003|Overall Study|Adverse Event|0|||
105504780|NCT03094169|363859046|FG004|Overall Study|Adverse Event|0|||
105504781|NCT03094169|363859047|FG005|Overall Study|Adverse Event|0|||
105504782|NCT03094169|363859048|FG006|Overall Study|Adverse Event|0|||
105504783|NCT03094169|363859049|FG007|Overall Study|Adverse Event|2|||
105504784|NCT03094169|363859042|FG000|Overall Study|Withdrawal by Subject|0|||
105504785|NCT03094169|363859043|FG001|Overall Study|Withdrawal by Subject|0|||
105504786|NCT03094169|363859044|FG002|Overall Study|Withdrawal by Subject|0|||
105504787|NCT03094169|363859045|FG003|Overall Study|Withdrawal by Subject|0|||
105504788|NCT03094169|363859046|FG004|Overall Study|Withdrawal by Subject|0|||
105504789|NCT03094169|363859047|FG005|Overall Study|Withdrawal by Subject|0|||
105504790|NCT03094169|363859048|FG006|Overall Study|Withdrawal by Subject|1|||
105504791|NCT03094169|363859049|FG007|Overall Study|Withdrawal by Subject|1|||
105504792|NCT03094169|363859042|FG000|Overall Study|Trial Termination|0|||
105504793|NCT03094169|363859043|FG001|Overall Study|Trial Termination|0|||
105504794|NCT03094169|363859044|FG002|Overall Study|Trial Termination|0|||
105504795|NCT03094169|363859045|FG003|Overall Study|Trial Termination|0|||
105504796|NCT03094169|363859046|FG004|Overall Study|Trial Termination|0|||
105504797|NCT03094169|363859047|FG005|Overall Study|Trial Termination|0|||
105504798|NCT03094169|363859048|FG006|Overall Study|Trial Termination|0|||
105504799|NCT03094169|363859049|FG007|Overall Study|Trial Termination|1|||
105504800|NCT00261807|363859050|FG000|Overall Study|Lost to Follow-up|2|||
105504801|NCT00261807|363859050|FG000|Overall Study|Adverse Event|2|||
105504802|NCT00261807|363859050|FG000|Overall Study|Death|1|||
105504803|NCT00261807|363859050|FG000|Overall Study|Protocol Violation|2|||
105504804|NCT04930965|363859052|FG000|Overall Study|Lost to Follow-up|7|||
105504805|NCT04930965|363859053|FG001|Overall Study|Lost to Follow-up|5|||
105504806|NCT01751178|363859056|FG000|Overall Study|Adverse Event|2|||
105504807|NCT01751178|363859057|FG001|Overall Study|Adverse Event|0|||
105504808|NCT01751178|363859058|FG002|Overall Study|Adverse Event|0|||
105504809|NCT01751178|363859056|FG000|Overall Study|Other Reason (unknown)|1|||
105504810|NCT01751178|363859057|FG001|Overall Study|Other Reason (unknown)|0|||
105504811|NCT01751178|363859058|FG002|Overall Study|Other Reason (unknown)|2|||
105504812|NCT00289991|363859059|FG000|Overall Study|Death|35|||
105504813|NCT00289991|363859060|FG001|Overall Study|Death|38|||
105504814|NCT00289991|363859059|FG000|Overall Study|Adverse Event|15|||
105504815|NCT00289991|363859060|FG001|Overall Study|Adverse Event|13|||
105590742|NCT04927975|364162698|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
105590743|NCT04927975|364162699|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
105590744|NCT04927975|364162700|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
105590745|NCT04927975|364162701|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
105590746|NCT04927975|364162702|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
105590747|NCT04927975|364162703|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
105590748|NCT04927975|364162698|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
105590749|NCT04927975|364162699|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
105590750|NCT04927975|364162700|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
105504816|NCT00289991|363859059|FG000|Overall Study|Failure of prophylaxis|1|||
105504817|NCT00289991|363859060|FG001|Overall Study|Failure of prophylaxis|1|||
105504818|NCT00289991|363859059|FG000|Overall Study|Fungal breakthrough infection|0|||
105504819|NCT00289991|363859060|FG001|Overall Study|Fungal breakthrough infection|1|||
105504820|NCT00289991|363859059|FG000|Overall Study|Lost to Follow-up|0|||
105504821|NCT00289991|363859060|FG001|Overall Study|Lost to Follow-up|1|||
105504822|NCT00289991|363859059|FG000|Overall Study|Withdrawal by Subject|2|||
105504823|NCT00289991|363859060|FG001|Overall Study|Withdrawal by Subject|12|||
105504824|NCT00289991|363859059|FG000|Overall Study|Other|5|||
105504825|NCT00289991|363859060|FG001|Overall Study|Other|14|||
105504826|NCT00801632|363859065|FG000|Overall Study|Re-transplant|1|||
105504827|NCT00968513|363859070|FG000|Overall Study|Death|4|||
105504828|NCT00968513|363859071|FG001|Overall Study|Death|10|||
105504829|NCT00968513|363859072|FG002|Overall Study|Death|15|||
105504830|NCT05537883|363859073|FG000|Overall Study|revisional surgery|4|||
105504831|NCT05537883|363859074|FG001|Overall Study|revisional surgery|2|||
105504832|NCT05537883|363859073|FG000|Overall Study|surgeries were cancelled|0|||
105504833|NCT05537883|363859074|FG001|Overall Study|surgeries were cancelled|2|||
105504834|NCT05537883|363859073|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
105504835|NCT05537883|363859074|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
105504836|NCT01328431|363859075|FG000|Baseline|Protocol Violation|0|||
105504837|NCT01328431|363859076|FG001|Baseline|Protocol Violation|2|||
105504838|NCT01328431|363859075|FG000|1 Month (1M)|Lost to Follow-up|55|||
105504839|NCT01328431|363859076|FG001|1 Month (1M)|Lost to Follow-up|58|||
105504840|NCT01328431|363859075|FG000|3 Month (3M)|Death|2|||
105504841|NCT01328431|363859076|FG001|3 Month (3M)|Death|2|||
105504842|NCT01328431|363859075|FG000|3 Month (3M)|Lost to Follow-up|75|||
105504843|NCT01328431|363859076|FG001|3 Month (3M)|Lost to Follow-up|70|||
105504844|NCT01328431|363859075|FG000|12 Month (12M)|Death|2|||
105504845|NCT01328431|363859076|FG001|12 Month (12M)|Death|6|||
105504846|NCT01328431|363859075|FG000|12 Month (12M)|Lost to Follow-up|82|||
105504847|NCT01328431|363859076|FG001|12 Month (12M)|Lost to Follow-up|91|||
105504848|NCT01306942|363859077|FG000|Phase I|Adverse Event|2|||
105504849|NCT01306942|363859078|FG001|Phase I|Adverse Event|2|||
105504850|NCT01306942|363859079|FG002|Phase I|Adverse Event|0|||
105504851|NCT01306942|363859080|FG003|Phase I|Adverse Event|0|||
105504852|NCT01306942|363859077|FG000|Phase I|Physician Decision|3|||
105504853|NCT01306942|363859078|FG001|Phase I|Physician Decision|1|||
105504854|NCT01306942|363859079|FG002|Phase I|Physician Decision|0|||
105504855|NCT01306942|363859080|FG003|Phase I|Physician Decision|0|||
105504856|NCT01306942|363859077|FG000|Phase II|Adverse Event|0|||
105504857|NCT01306942|363859078|FG001|Phase II|Adverse Event|0|||
105504858|NCT01306942|363859079|FG002|Phase II|Adverse Event|0|||
105504859|NCT01306942|363859080|FG003|Phase II|Adverse Event|6|||
105504860|NCT01306942|363859077|FG000|Phase II|Physician Decision|2|||
105504861|NCT01306942|363859078|FG001|Phase II|Physician Decision|0|||
105504862|NCT01306942|363859079|FG002|Phase II|Physician Decision|0|||
105504863|NCT01306942|363859080|FG003|Phase II|Physician Decision|5|||
105504864|NCT01306942|363859077|FG000|Phase II|Withdrawal by Subject|0|||
105504865|NCT01306942|363859078|FG001|Phase II|Withdrawal by Subject|0|||
105504866|NCT01306942|363859079|FG002|Phase II|Withdrawal by Subject|0|||
105504867|NCT01306942|363859080|FG003|Phase II|Withdrawal by Subject|2|||
105504868|NCT01306942|363859077|FG000|Phase II|Death|0|||
105504869|NCT01306942|363859078|FG001|Phase II|Death|0|||
105504870|NCT01306942|363859079|FG002|Phase II|Death|0|||
105504871|NCT01306942|363859080|FG003|Phase II|Death|1|||
105504872|NCT01306942|363859077|FG000|Phase II|Not finished treatment|0|||
105504873|NCT01306942|363859078|FG001|Phase II|Not finished treatment|0|||
105504874|NCT01306942|363859079|FG002|Phase II|Not finished treatment|0|||
105504875|NCT01306942|363859080|FG003|Phase II|Not finished treatment|1|||
105504876|NCT01306942|363859077|FG000|Phase II|Protocol Violation|0|||
105504877|NCT01306942|363859078|FG001|Phase II|Protocol Violation|0|||
105504878|NCT01306942|363859079|FG002|Phase II|Protocol Violation|0|||
105504879|NCT01306942|363859080|FG003|Phase II|Protocol Violation|1|||
105504880|NCT03953820|363859081|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
105504881|NCT03953820|363859082|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
105504882|NCT03953820|363859083|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
105590751|NCT04927975|364162701|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
105504883|NCT03953820|363859081|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
105504884|NCT03953820|363859082|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
105504885|NCT03953820|363859083|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
105504886|NCT01253408|363859089|FG000|Overall Study|Adverse Event|0|||
105504887|NCT01253408|363859090|FG001|Overall Study|Adverse Event|1|||
105504888|NCT01253408|363859091|FG002|Overall Study|Adverse Event|0|||
105504889|NCT02094677|363859092|FG000|Overall Study|Screening|3|||
105504890|NCT02094677|363859093|FG001|Overall Study|Screening|1|||
105504891|NCT03253744|363859094|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
105504892|NCT03253744|363859095|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
105504893|NCT03253744|363859096|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
105504894|NCT03253744|363859097|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
105504895|NCT04698187|363859100|FG000|Overall Study|Withdrawal by Subject|7|||
105504896|NCT04698187|363859100|FG000|Overall Study|Death|21|||
105504897|NCT04698187|363859100|FG000|Overall Study|Sponsor Decision|15|||
105504898|NCT04698187|363859100|FG000|Overall Study|In-transit Disease|1|||
105504899|NCT03478930|363860589|FG000|Overall Study|Adverse Event|0|||
105504900|NCT03478930|363860590|FG001|Overall Study|Adverse Event|1|||
105504901|NCT03478930|363860589|FG000|Overall Study|Lack of Efficacy|3|||
105504902|NCT03478930|363860590|FG001|Overall Study|Lack of Efficacy|3|||
105504903|NCT03478930|363860589|FG000|Overall Study|Withdrawal by Subject|6|||
105504904|NCT03478930|363860590|FG001|Overall Study|Withdrawal by Subject|5|||
105504905|NCT04189081|363860591|FG000|Overall Study|Lost to Follow-up|1|||
105504906|NCT04189081|363860592|FG001|Overall Study|Lost to Follow-up|0|||
105504907|NCT04189081|363860593|FG002|Overall Study|Lost to Follow-up|0|||
105504908|NCT04189081|363860591|FG000|Overall Study|Withdrawal by Subject|0|||
105504909|NCT04189081|363860592|FG001|Overall Study|Withdrawal by Subject|0|||
105504910|NCT04189081|363860593|FG002|Overall Study|Withdrawal by Subject|1|||
105504911|NCT00705484|363860597|FG000|Overall Study|Adverse Event|28|||
105504912|NCT00705484|363860598|FG001|Overall Study|Adverse Event|27|||
105504913|NCT00705484|363860597|FG000|Overall Study|Lost to Follow-up|169|||
105504914|NCT00705484|363860598|FG001|Overall Study|Lost to Follow-up|250|||
105504915|NCT00705484|363860597|FG000|Overall Study|Withdrawal by Subject|96|||
105504916|NCT00705484|363860598|FG001|Overall Study|Withdrawal by Subject|72|||
105504917|NCT00705484|363860597|FG000|Overall Study|Administrative|89|||
105504918|NCT00705484|363860598|FG001|Overall Study|Administrative|59|||
105504919|NCT02197247|363860599|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
105504920|NCT02197247|363860599|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
105504921|NCT02197247|363860599|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
105504922|NCT02197247|363860599|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
105504923|NCT02197247|363860599|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
105504924|NCT02197247|363860599|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
105504925|NCT02197247|363860599|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
105504926|NCT02197247|363860599|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
105504927|NCT01010061|363860608|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
105504928|NCT01010061|363860609|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
105504929|NCT01010061|363860608|FG000|Overall Study|Disease Progression|2|||
105504930|NCT01010061|363860609|FG001|Overall Study|Disease Progression|8|||
105504931|NCT01010061|363860608|FG000|Overall Study|Withdrew Consent|5|||
105504932|NCT01010061|363860609|FG001|Overall Study|Withdrew Consent|1|||
105504933|NCT01010061|363860608|FG000|Overall Study|Death|3|||
105504934|NCT01010061|363860609|FG001|Overall Study|Death|6|||
105504935|NCT01010061|363860608|FG000|Overall Study|Administrative/Other|0|||
105504936|NCT01010061|363860609|FG001|Overall Study|Administrative/Other|1|||
105504937|NCT01010061|363860608|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
105504938|NCT01010061|363860609|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
105504939|NCT01010061|363860608|FG000|Overall Study|Insufficient Therapeutic Response|1|||
105504940|NCT01010061|363860609|FG001|Overall Study|Insufficient Therapeutic Response|5|||
105504941|NCT01010061|363860608|FG000|Overall Study|Violation of Selection Criteria|0|||
105504942|NCT01010061|363860609|FG001|Overall Study|Violation of Selection Criteria|1|||
105504943|NCT01010061|363860608|FG000|Overall Study|Did Not Receive Treatment|2|||
105504944|NCT01010061|363860609|FG001|Overall Study|Did Not Receive Treatment|2|||
105504945|NCT00329238|363860610|FG000|Overall Study|Adverse Event|147|||
105504946|NCT00329238|363860611|FG001|Overall Study|Adverse Event|129|||
105504947|NCT00329238|363860610|FG000|Overall Study|Protocol Violation|23|||
105504948|NCT00329238|363860611|FG001|Overall Study|Protocol Violation|34|||
105504949|NCT00329238|363860610|FG000|Overall Study|Lost to Follow-up|2|||
105504950|NCT00329238|363860611|FG001|Overall Study|Lost to Follow-up|6|||
105504951|NCT00329238|363860610|FG000|Overall Study|Withdrawal by Subject|64|||
105504952|NCT00329238|363860611|FG001|Overall Study|Withdrawal by Subject|58|||
105504953|NCT00329238|363860610|FG000|Overall Study|Other reason (not specified)|40|||
105504954|NCT00329238|363860611|FG001|Overall Study|Other reason (not specified)|54|||
105504955|NCT05379231|363860612|FG000|Home Visit|Withdrawal by Subject|2|||
105504956|NCT05379231|363860612|FG000|In-lab Visit|Withdrawal by Subject|2|||
105504957|NCT02296320|363860618|FG000|Overall Study|Withdrawal by Subject|4|||
105504958|NCT02296320|363860619|FG001|Overall Study|Withdrawal by Subject|0|||
105504959|NCT02296320|363860620|FG002|Overall Study|Withdrawal by Subject|2|||
105504960|NCT02296320|363860618|FG000|Overall Study|Death|24|||
105504961|NCT02296320|363860619|FG001|Overall Study|Death|3|||
105504962|NCT02296320|363860620|FG002|Overall Study|Death|27|||
105504963|NCT02296320|363860618|FG000|Overall Study|Lost to Follow-up|5|||
105504964|NCT02296320|363860619|FG001|Overall Study|Lost to Follow-up|2|||
105504965|NCT02296320|363860620|FG002|Overall Study|Lost to Follow-up|7|||
105504966|NCT02296320|363860618|FG000|Overall Study|Not treated|2|||
105504967|NCT02296320|363860619|FG001|Overall Study|Not treated|0|||
105504968|NCT02296320|363860620|FG002|Overall Study|Not treated|0|||
105504969|NCT02296320|363860618|FG000|Overall Study|Not - specified|0|||
105504970|NCT02296320|363860619|FG001|Overall Study|Not - specified|0|||
105504971|NCT02296320|363860620|FG002|Overall Study|Not - specified|1|||
105504972|NCT00369824|363860629|FG000|Overall Study|Adverse Event|0|||
105504973|NCT00369824|363860630|FG001|Overall Study|Adverse Event|2|||
105504974|NCT00369824|363860631|FG002|Overall Study|Adverse Event|0|||
105504975|NCT00369824|363860632|FG003|Overall Study|Adverse Event|0|||
105504976|NCT00369824|363860633|FG004|Overall Study|Adverse Event|1|||
105504977|NCT00369824|363860634|FG005|Overall Study|Adverse Event|0|||
105504978|NCT00369824|363860629|FG000|Overall Study|Protocol Violation|0|||
105504979|NCT00369824|363860630|FG001|Overall Study|Protocol Violation|1|||
105504980|NCT00369824|363860631|FG002|Overall Study|Protocol Violation|0|||
105504981|NCT00369824|363860632|FG003|Overall Study|Protocol Violation|1|||
105504982|NCT00369824|363860633|FG004|Overall Study|Protocol Violation|1|||
105504983|NCT00369824|363860634|FG005|Overall Study|Protocol Violation|0|||
105504984|NCT00369824|363860629|FG000|Overall Study|Withdrawal by Subject|9|||
105504985|NCT00369824|363860630|FG001|Overall Study|Withdrawal by Subject|5|||
105504986|NCT00369824|363860631|FG002|Overall Study|Withdrawal by Subject|5|||
105504987|NCT00369824|363860632|FG003|Overall Study|Withdrawal by Subject|4|||
105504988|NCT00369824|363860633|FG004|Overall Study|Withdrawal by Subject|6|||
105504989|NCT00369824|363860634|FG005|Overall Study|Withdrawal by Subject|2|||
105504990|NCT00369824|363860629|FG000|Overall Study|Lost to Follow-up|6|||
105504991|NCT00369824|363860630|FG001|Overall Study|Lost to Follow-up|11|||
105504992|NCT00369824|363860631|FG002|Overall Study|Lost to Follow-up|7|||
105504993|NCT00369824|363860632|FG003|Overall Study|Lost to Follow-up|8|||
105504994|NCT00369824|363860633|FG004|Overall Study|Lost to Follow-up|9|||
105504995|NCT00369824|363860634|FG005|Overall Study|Lost to Follow-up|6|||
105504996|NCT00369824|363860629|FG000|Overall Study|Other|0|||
105504997|NCT00369824|363860630|FG001|Overall Study|Other|0|||
105504998|NCT00369824|363860631|FG002|Overall Study|Other|0|||
105504999|NCT00369824|363860632|FG003|Overall Study|Other|2|||
105505000|NCT00369824|363860633|FG004|Overall Study|Other|1|||
105505001|NCT00369824|363860634|FG005|Overall Study|Other|3|||
105505002|NCT01390649|363860635|FG000|Overall Study|Physician Decision|1|||
105505003|NCT02217878|363860636|FG000|Overall Study|required morphine due to chest pain|1|||
105505004|NCT02217878|363860637|FG001|Overall Study|required morphine due to chest pain|2|||
105590752|NCT04927975|364162702|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
105505005|NCT02217878|363860636|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
105590753|NCT04927975|364162703|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
105590754|NCT04927975|364162698|FG000|Period 1 (Baseline-Week 24)|Death|0|||
105590755|NCT04927975|364162699|FG001|Period 1 (Baseline-Week 24)|Death|0|||
105505006|NCT02217878|363860637|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
105505007|NCT03516812|363860638|FG000|Overall Study|Adverse Event|4|||
105505008|NCT03516812|363860638|FG000|Overall Study|Lack of Efficacy|2|||
105505009|NCT00622401|363860639|FG000|Overall Study|Disease progression prior to treatment|3|||
105505010|NCT00622401|363860640|FG001|Overall Study|Disease progression prior to treatment|2|||
105505011|NCT00622401|363860641|FG002|Overall Study|Disease progression prior to treatment|0|||
105505012|NCT03087643|363860642|FG000|Overall Study|Withdrawal by Subject|2|||
105505013|NCT03087643|363860643|FG001|Overall Study|Withdrawal by Subject|4|||
105505014|NCT03087643|363860642|FG000|Overall Study|Death|2|||
105505015|NCT03087643|363860643|FG001|Overall Study|Death|2|||
105505016|NCT02083783|363860644|FG000|Overall Study|Withdrawal by Subject|1|||
105505017|NCT02083783|363860645|FG001|Overall Study|Withdrawal by Subject|0|||
105505018|NCT01427972|363860652|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
105505019|NCT01427972|363860653|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
105505020|NCT01427972|363860654|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
105505021|NCT01427972|363860655|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
105505022|NCT01427972|363860656|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
105505023|NCT01427972|363860657|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
105505024|NCT01427972|363860658|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
105505025|NCT01427972|363860659|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
105505026|NCT01427972|363860660|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
105505027|NCT01427972|363860661|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
105505028|NCT01427972|363860662|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
105505029|NCT01427972|363860663|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
105590756|NCT04927975|364162700|FG002|Period 1 (Baseline-Week 24)|Death|0|||
105505030|NCT01427972|363860652|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
105505031|NCT01427972|363860653|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
105505032|NCT01427972|363860654|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
105505033|NCT01427972|363860655|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
105505034|NCT01427972|363860656|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
105505035|NCT01427972|363860657|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
105505036|NCT01427972|363860658|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
105505037|NCT01427972|363860659|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
105505038|NCT01427972|363860660|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
105505039|NCT01427972|363860661|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
105505040|NCT01427972|363860662|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
105505041|NCT01427972|363860663|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
105505042|NCT01427972|363860652|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
105505043|NCT01427972|363860653|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
105505044|NCT01427972|363860654|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
105505045|NCT01427972|363860655|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
105505046|NCT01427972|363860656|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
105505047|NCT01427972|363860657|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
105505048|NCT01427972|363860658|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
105505049|NCT01427972|363860659|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
105505050|NCT01427972|363860660|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
105505051|NCT01427972|363860661|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
105505052|NCT01427972|363860662|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
105505053|NCT01427972|363860663|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
105505054|NCT02021773|363860665|FG000|Overall Study|Adverse Event|1|||
105505055|NCT02021773|363860666|FG001|Overall Study|Adverse Event|4|||
105505056|NCT02021773|363860667|FG002|Overall Study|Adverse Event|3|||
105505057|NCT02021773|363860665|FG000|Overall Study|Lack of Efficacy|2|||
105505058|NCT02021773|363860666|FG001|Overall Study|Lack of Efficacy|2|||
105505059|NCT02021773|363860667|FG002|Overall Study|Lack of Efficacy|2|||
105505060|NCT02021773|363860665|FG000|Overall Study|Protocol Violation|2|||
105505061|NCT02021773|363860666|FG001|Overall Study|Protocol Violation|3|||
105505062|NCT02021773|363860667|FG002|Overall Study|Protocol Violation|1|||
105505063|NCT02021773|363860665|FG000|Overall Study|Withdrawal by Subject|3|||
105505064|NCT02021773|363860666|FG001|Overall Study|Withdrawal by Subject|4|||
105505065|NCT02021773|363860667|FG002|Overall Study|Withdrawal by Subject|5|||
105505066|NCT02021773|363860665|FG000|Overall Study|Lost to Follow-up|1|||
105505067|NCT02021773|363860666|FG001|Overall Study|Lost to Follow-up|3|||
105505068|NCT02021773|363860667|FG002|Overall Study|Lost to Follow-up|0|||
105505069|NCT02021773|363860665|FG000|Overall Study|Reason not specified|3|||
105505070|NCT02021773|363860666|FG001|Overall Study|Reason not specified|0|||
105505071|NCT02021773|363860667|FG002|Overall Study|Reason not specified|0|||
105505072|NCT00799422|363860672|FG000|First Week of Wear|Lost to Follow-up|0|||
105505073|NCT00799422|363860673|FG001|First Week of Wear|Lost to Follow-up|0|||
105505074|NCT00799422|363860674|FG002|First Week of Wear|Lost to Follow-up|1|||
105505075|NCT00799422|363860675|FG003|First Week of Wear|Lost to Follow-up|0|||
105505076|NCT00799422|363860676|FG004|First Week of Wear|Lost to Follow-up|0|||
105505077|NCT00799422|363860677|FG005|First Week of Wear|Lost to Follow-up|0|||
105505078|NCT00799422|363860672|FG000|First Week of Wear|Adverse Event|0|||
105505079|NCT00799422|363860673|FG001|First Week of Wear|Adverse Event|0|||
105505080|NCT00799422|363860674|FG002|First Week of Wear|Adverse Event|0|||
105505081|NCT00799422|363860675|FG003|First Week of Wear|Adverse Event|1|||
105505082|NCT00799422|363860676|FG004|First Week of Wear|Adverse Event|0|||
105505083|NCT00799422|363860677|FG005|First Week of Wear|Adverse Event|0|||
105505084|NCT00530946|363860678|FG000|Overall Study|Adverse Event|1|||
105505085|NCT00530946|363860679|FG001|Overall Study|Adverse Event|2|||
105505086|NCT00530946|363860680|FG002|Overall Study|Adverse Event|1|||
105505087|NCT00530946|363860681|FG003|Overall Study|Adverse Event|1|||
105505088|NCT00530946|363860678|FG000|Overall Study|Protocol Violation|0|||
105505089|NCT00530946|363860679|FG001|Overall Study|Protocol Violation|0|||
105505090|NCT00530946|363860680|FG002|Overall Study|Protocol Violation|0|||
105505091|NCT00530946|363860681|FG003|Overall Study|Protocol Violation|1|||
105505092|NCT00530946|363860678|FG000|Overall Study|Noncompliance|1|||
105505093|NCT00530946|363860679|FG001|Overall Study|Noncompliance|0|||
105505094|NCT00530946|363860680|FG002|Overall Study|Noncompliance|0|||
105505095|NCT00530946|363860681|FG003|Overall Study|Noncompliance|0|||
105505096|NCT00282984|363860682|FG000|Overall Study|Death|2|||
105505097|NCT00282984|363860683|FG001|Overall Study|Death|5|||
105505098|NCT00282984|363860682|FG000|Overall Study|Adverse Event|8|||
105505099|NCT00282984|363860683|FG001|Overall Study|Adverse Event|5|||
105505100|NCT00282984|363860682|FG000|Overall Study|Lack of Efficacy|0|||
105505101|NCT00282984|363860683|FG001|Overall Study|Lack of Efficacy|2|||
105505102|NCT00282984|363860682|FG000|Overall Study|Lost to Follow-up|14|||
105505103|NCT00282984|363860683|FG001|Overall Study|Lost to Follow-up|10|||
105505104|NCT00282984|363860682|FG000|Overall Study|Withdrawal by Participant|22|||
105505105|NCT00282984|363860683|FG001|Overall Study|Withdrawal by Participant|34|||
105505106|NCT00282984|363860682|FG000|Overall Study|Participant stopped study medication|2|||
105590757|NCT04927975|364162701|FG003|Period 1 (Baseline-Week 24)|Death|0|||
105505107|NCT00282984|363860683|FG001|Overall Study|Participant stopped study medication|2|||
105505108|NCT00282984|363860682|FG000|Overall Study|Participant only allowed phone follow-up|0|||
105505109|NCT00282984|363860683|FG001|Overall Study|Participant only allowed phone follow-up|1|||
105505110|NCT00282984|363860682|FG000|Overall Study|Participant used antipsychosis meds|0|||
105505111|NCT00282984|363860683|FG001|Overall Study|Participant used antipsychosis meds|1|||
105505112|NCT00282984|363860682|FG000|Overall Study|lack of motivation|1|||
105505113|NCT00282984|363860683|FG001|Overall Study|lack of motivation|0|||
105505114|NCT00282984|363860682|FG000|Overall Study|in prison|0|||
105505115|NCT00282984|363860683|FG001|Overall Study|in prison|1|||
105505116|NCT00282984|363860682|FG000|Overall Study|Protocol Violation|2|||
105505117|NCT00282984|363860683|FG001|Overall Study|Protocol Violation|0|||
105505118|NCT00087607|363860684|FG000|Overall Study|Adverse Event|14|||
105505119|NCT00087607|363860685|FG001|Overall Study|Adverse Event|24|||
105505120|NCT00087607|363860684|FG000|Overall Study|Death|0|||
105505121|NCT00087607|363860685|FG001|Overall Study|Death|1|||
105505122|NCT00087607|363860684|FG000|Overall Study|Insufficient Therapeutic Response|53|||
105505123|NCT00087607|363860685|FG001|Overall Study|Insufficient Therapeutic Response|42|||
105505124|NCT00087607|363860684|FG000|Overall Study|Failure to return|21|||
105505125|NCT00087607|363860685|FG001|Overall Study|Failure to return|17|||
105505126|NCT00087607|363860684|FG000|Overall Study|Withdrew Consent|12|||
105505127|NCT00087607|363860685|FG001|Overall Study|Withdrew Consent|16|||
105505128|NCT00087607|363860684|FG000|Overall Study|Administrative|12|||
105505129|NCT00087607|363860685|FG001|Overall Study|Administrative|12|||
105505130|NCT00087607|363860684|FG000|Overall Study|Refused Treatment|5|||
105505131|NCT00087607|363860685|FG001|Overall Study|Refused Treatment|7|||
105505132|NCT00087607|363860684|FG000|Overall Study|Other Protocol Violation|5|||
105505133|NCT00087607|363860685|FG001|Overall Study|Other Protocol Violation|2|||
105505134|NCT00087607|363860684|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
105505135|NCT00087607|363860685|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
105505136|NCT00190671|363860686|FG000|Overall Study|Satisfactory Response|4|||
105505137|NCT00190671|363860687|FG001|Overall Study|Satisfactory Response|7|||
105505138|NCT00190671|363860686|FG000|Overall Study|Lack of Efficacy|19|||
105505139|NCT00190671|363860687|FG001|Overall Study|Lack of Efficacy|24|||
105505140|NCT00190671|363860686|FG000|Overall Study|Death from Study Disease|1|||
105505141|NCT00190671|363860687|FG001|Overall Study|Death from Study Disease|1|||
105505142|NCT00190671|363860686|FG000|Overall Study|Adverse Event|3|||
105505143|NCT00190671|363860687|FG001|Overall Study|Adverse Event|2|||
105505144|NCT00190671|363860686|FG000|Overall Study|Clinical Relapse|0|||
105505145|NCT00190671|363860687|FG001|Overall Study|Clinical Relapse|1|||
105505146|NCT00190671|363860686|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
105505147|NCT00190671|363860687|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
105505148|NCT00190671|363860686|FG000|Overall Study|Death from Other Causes|0|||
105505149|NCT00190671|363860687|FG001|Overall Study|Death from Other Causes|2|||
105505150|NCT00190671|363860686|FG000|Overall Study|Protocol Violation|0|||
105505151|NCT00190671|363860687|FG001|Overall Study|Protocol Violation|1|||
105505152|NCT00190671|363860686|FG000|Overall Study|Withdrawal by Subject|0|||
105505153|NCT00190671|363860687|FG001|Overall Study|Withdrawal by Subject|2|||
105505154|NCT00457301|363860688|FG000|Overall Study|Withdrawal by Subject|3|||
105505155|NCT00457301|363860689|FG001|Overall Study|Withdrawal by Subject|3|||
105505156|NCT00457301|363860688|FG000|Overall Study|Censored out of the study|15|||
105505157|NCT00457301|363860689|FG001|Overall Study|Censored out of the study|14|||
105505158|NCT00457301|363860688|FG000|Overall Study|Death|5|||
105505159|NCT00457301|363860689|FG001|Overall Study|Death|7|||
105505160|NCT03322631|363860699|FG000|Overall Study|Withdrawal by Subject|0|||
105505161|NCT03322631|363860700|FG001|Overall Study|Withdrawal by Subject|1|||
105505162|NCT03322631|363860701|FG002|Overall Study|Withdrawal by Subject|0|||
105505163|NCT03322631|363860702|FG003|Overall Study|Withdrawal by Subject|0|||
105505164|NCT03322631|363860699|FG000|Overall Study|Adverse Event|0|||
105505165|NCT03322631|363860700|FG001|Overall Study|Adverse Event|0|||
105505166|NCT03322631|363860701|FG002|Overall Study|Adverse Event|1|||
105505167|NCT03322631|363860702|FG003|Overall Study|Adverse Event|0|||
105505168|NCT02412618|363860703|FG000|Overall Study|Withdrawal by Subject|1|||
105505169|NCT02412618|363860704|FG001|Overall Study|Withdrawal by Subject|1|||
105505170|NCT02412618|363860703|FG000|Overall Study|Expulsion|1|||
105505171|NCT02412618|363860704|FG001|Overall Study|Expulsion|1|||
105505172|NCT02378961|363860705|FG000|Overall Study|Lack of Efficacy|4|||
105505173|NCT02378961|363860706|FG001|Overall Study|Lack of Efficacy|2|||
105505174|NCT02378961|363860707|FG002|Overall Study|Lack of Efficacy|0|||
105505175|NCT02378961|363860708|FG003|Overall Study|Lack of Efficacy|1|||
105505176|NCT02378961|363860705|FG000|Overall Study|Death|0|||
105505177|NCT02378961|363860706|FG001|Overall Study|Death|0|||
105505178|NCT02378961|363860707|FG002|Overall Study|Death|1|||
105505179|NCT02378961|363860708|FG003|Overall Study|Death|0|||
105505180|NCT03408483|363860709|FG000|Overall Study|Physician Decision|3|||
105505181|NCT03408483|363860710|FG001|Overall Study|Physician Decision|3|||
105505182|NCT03408483|363860709|FG000|Overall Study|Lost to Follow-up|3|||
105505183|NCT03408483|363860710|FG001|Overall Study|Lost to Follow-up|0|||
105505184|NCT00291577|363860714|FG000|Overall Study|Adverse Event|1|||
105505185|NCT00291577|363860714|FG000|Overall Study|Other|4|||
105505186|NCT00291577|363860714|FG000|Overall Study|Withdrawal by Subject|2|||
105505187|NCT00291577|363860714|FG000|Overall Study|Lack of Efficacy|14|||
105505188|NCT00602797|363860715|FG000|Overall Study|Adverse Event|1|||
105505189|NCT04502693|363860716|FG000|Overall Study|Adverse Event|7|||
105505190|NCT04502693|363860717|FG001|Overall Study|Adverse Event|6|||
105505191|NCT04502693|363860718|FG002|Overall Study|Adverse Event|11|||
105505192|NCT04502693|363860719|FG003|Overall Study|Adverse Event|1|||
105505193|NCT04502693|363860716|FG000|Overall Study|Lost to Follow-up|32|||
105505194|NCT04502693|363860717|FG001|Overall Study|Lost to Follow-up|36|||
105505195|NCT04502693|363860718|FG002|Overall Study|Lost to Follow-up|69|||
105505196|NCT04502693|363860719|FG003|Overall Study|Lost to Follow-up|4|||
105505197|NCT04502693|363860716|FG000|Overall Study|Protocol Violation|8|||
105505198|NCT04502693|363860717|FG001|Overall Study|Protocol Violation|8|||
105505199|NCT04502693|363860718|FG002|Overall Study|Protocol Violation|16|||
105505200|NCT04502693|363860719|FG003|Overall Study|Protocol Violation|1|||
105505201|NCT04502693|363860716|FG000|Overall Study|Withdrawal by Subject|46|||
105505202|NCT04502693|363860717|FG001|Overall Study|Withdrawal by Subject|38|||
105505203|NCT04502693|363860718|FG002|Overall Study|Withdrawal by Subject|54|||
105505204|NCT04502693|363860719|FG003|Overall Study|Withdrawal by Subject|7|||
105505205|NCT04502693|363860716|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
105505206|NCT04502693|363860717|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
105505207|NCT04502693|363860718|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
105505208|NCT04502693|363860719|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105505209|NCT04502693|363860716|FG000|Overall Study|Other|1|||
105505210|NCT04502693|363860717|FG001|Overall Study|Other|0|||
105505211|NCT04502693|363860718|FG002|Overall Study|Other|1|||
105505212|NCT04502693|363860719|FG003|Overall Study|Other|1|||
105505213|NCT01587001|363860720|FG000|Overall Study|Lost to Follow-up|2|||
105505214|NCT01587001|363860721|FG001|Overall Study|Lost to Follow-up|0|||
105505215|NCT01587001|363860720|FG000|Overall Study|Insufficient samples to complete testing|4|||
105505216|NCT01587001|363860721|FG001|Overall Study|Insufficient samples to complete testing|1|||
105505217|NCT03724032|363860724|FG000|Overall Study|Physician Decision|1|||
105505218|NCT03724032|363860725|FG001|Overall Study|Physician Decision|0|||
105505219|NCT03724032|363860726|FG002|Overall Study|Physician Decision|0|||
105505220|NCT03724032|363860724|FG000|Overall Study|Protocol Violation|2|||
105505221|NCT03724032|363860725|FG001|Overall Study|Protocol Violation|2|||
105505222|NCT03724032|363860726|FG002|Overall Study|Protocol Violation|1|||
105505223|NCT03736447|363860727|FG000|Overall Study|Adverse Event|5|||
105505224|NCT03736447|363860728|FG001|Overall Study|Adverse Event|1|||
105505225|NCT03736447|363860727|FG000|Overall Study|Withdrawal by Subject|5|||
105505226|NCT03736447|363860728|FG001|Overall Study|Withdrawal by Subject|1|||
105505227|NCT03736447|363860727|FG000|Overall Study|Lost to Follow-up|1|||
105505228|NCT03736447|363860728|FG001|Overall Study|Lost to Follow-up|0|||
105505229|NCT03736447|363860727|FG000|Overall Study|Physician Decision|1|||
105505230|NCT03736447|363860728|FG001|Overall Study|Physician Decision|0|||
105505231|NCT03736447|363860727|FG000|Overall Study|Continued commitment to study treatment|3|||
105505232|NCT03736447|363860728|FG001|Overall Study|Continued commitment to study treatment|0|||
105505233|NCT03736447|363860727|FG000|Overall Study|Taste aversion to study product|0|||
105505234|NCT03736447|363860728|FG001|Overall Study|Taste aversion to study product|1|||
105505235|NCT03302234|363860729|FG000|Overall Study|Death|191|||
105505236|NCT03302234|363860730|FG001|Overall Study|Death|192|||
105505237|NCT03302234|363860729|FG000|Overall Study|Withdrawal by Subject|2|||
105505238|NCT03302234|363860730|FG001|Overall Study|Withdrawal by Subject|2|||
105505239|NCT03302234|363860729|FG000|Overall Study|Sponsor Decision|90|||
105505240|NCT03302234|363860730|FG001|Overall Study|Sponsor Decision|89|||
105505241|NCT03302234|363860729|FG000|Overall Study|Laryngeal carcinoma|0|||
105505242|NCT03302234|363860730|FG001|Overall Study|Laryngeal carcinoma|1|||
105505243|NCT03302234|363860729|FG000|Overall Study|Not Reported|1|||
105505244|NCT03302234|363860730|FG001|Overall Study|Not Reported|0|||
105505245|NCT02610725|363860732|FG000|Overall Study|Lost to Follow-up|197|||
105505246|NCT02610725|363860732|FG000|Overall Study|self-reported contraindication|9|||
105505247|NCT02302807|363860737|FG000|Overall Study|Withdrawal by Subject|28|||
105505248|NCT02302807|363860738|FG001|Overall Study|Withdrawal by Subject|11|||
105505249|NCT02302807|363860737|FG000|Overall Study|Lost to Follow-up|4|||
105505250|NCT02302807|363860738|FG001|Overall Study|Lost to Follow-up|6|||
105505251|NCT02302807|363860737|FG000|Overall Study|Death|397|||
105505252|NCT02302807|363860738|FG001|Overall Study|Death|385|||
105505253|NCT02302807|363860737|FG000|Overall Study|Study Terminated By Sponsor|35|||
105590758|NCT04927975|364162702|FG004|Period 1 (Baseline-Week 24)|Death|0|||
105505254|NCT02302807|363860738|FG001|Overall Study|Study Terminated By Sponsor|64|||
105505255|NCT02302807|363860737|FG000|Overall Study|Physician Decision|0|||
105505256|NCT02302807|363860738|FG001|Overall Study|Physician Decision|1|||
105505257|NCT02777333|363860741|FG000|Overall Study|Withdrawal by Subject|0|||
105505258|NCT02777333|363860742|FG001|Overall Study|Withdrawal by Subject|1|||
105505259|NCT02777333|363860741|FG000|Overall Study|Lost to Follow-up|0|||
105505260|NCT02777333|363860742|FG001|Overall Study|Lost to Follow-up|1|||
105505261|NCT03307967|363860743|FG000|Overall Study|Lost to Follow-up|4|||
105505262|NCT02801331|363860744|FG000|Overall Study|Transferred to another hospital|8|||
105505263|NCT02801331|363860745|FG001|Overall Study|Transferred to another hospital|7|||
105505264|NCT02801331|363860744|FG000|Overall Study|Withdrawal by Subject|0|||
105505265|NCT02801331|363860745|FG001|Overall Study|Withdrawal by Subject|4|||
105505266|NCT02801331|363860744|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
105505267|NCT02801331|363860745|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
105505268|NCT05475236|363860746|FG000|Overall Study|Withdrawal by Subject|0|||
105505269|NCT05475236|363860747|FG001|Overall Study|Withdrawal by Subject|1|||
105505270|NCT02513394|363860748|FG000|Overall Study|Withdrawal by Subject|11|||
105505271|NCT02513394|363860749|FG001|Overall Study|Withdrawal by Subject|23|||
105505272|NCT02513394|363860748|FG000|Overall Study|Ineligible|1|||
105505273|NCT02513394|363860749|FG001|Overall Study|Ineligible|0|||
105505274|NCT01798004|363862155|FG000|Overall Study|Death|2|||
105505275|NCT01798004|363862155|FG000|Overall Study|Lack of Efficacy|8|||
105505276|NCT01798004|363862155|FG000|Overall Study|Physician Decision|25|||
105505277|NCT01798004|363862155|FG000|Overall Study|Withdrawal by Subject|4|||
105505278|NCT01798004|363862155|FG000|Overall Study|Ineligible|4|||
105505279|NCT01798004|363862155|FG000|Overall Study|Patient/parent refusal|7|||
105505280|NCT01798004|363862155|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
105505281|NCT01798004|363862155|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
105505282|NCT01218113|363862158|FG000|Overall Study|Withdrawal by Subject|1|||
105505283|NCT01218113|363862159|FG001|Overall Study|Withdrawal by Subject|0|||
105505284|NCT01218113|363862160|FG002|Overall Study|Withdrawal by Subject|1|||
105505285|NCT01218113|363862158|FG000|Overall Study|Lost to Follow-up|4|||
105505286|NCT01218113|363862159|FG001|Overall Study|Lost to Follow-up|1|||
105505287|NCT01218113|363862160|FG002|Overall Study|Lost to Follow-up|4|||
105505288|NCT01218113|363862158|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
105505289|NCT01218113|363862159|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
105505290|NCT01218113|363862160|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
105505291|NCT04840615|363862163|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
105505292|NCT04840615|363862164|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
105505293|NCT04840615|363862165|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
105505294|NCT01918774|363862166|FG000|Overall Study|Lost prior to first CBTw session|4|||
105505295|NCT01918774|363862166|FG000|Overall Study|Lost to Follow-up|1|||
105505296|NCT01898806|363862169|FG000|Overall Study|Withdrawal by Subject|2|||
105505297|NCT01898806|363862169|FG000|Overall Study|Physician Decision|1|||
105505298|NCT01575769|363862173|FG000|Overall Study|Adverse Event|1|||
105505299|NCT01575769|363862173|FG000|Overall Study|Study terminated by sponsor|40|||
105505300|NCT01673867|363862174|FG000|Randomization|Adverse event unrelated to study drug|1|||
105505301|NCT01673867|363862175|FG001|Randomization|Adverse event unrelated to study drug|0|||
105505302|NCT01673867|363862174|FG000|Randomization|Participant request to discontinue study treatment|0|||
105505303|NCT01673867|363862175|FG001|Randomization|Participant request to discontinue study treatment|4|||
105505304|NCT01673867|363862174|FG000|Randomization|Withdrawal by participant|0|||
105505305|NCT01673867|363862175|FG001|Randomization|Withdrawal by participant|12|||
105505306|NCT01673867|363862174|FG000|Randomization|Lost to Follow-up|0|||
105505307|NCT01673867|363862175|FG001|Randomization|Lost to Follow-up|1|||
105505308|NCT01673867|363862174|FG000|Randomization|Participant no longer meets study criteria|4|||
105505309|NCT01673867|363862175|FG001|Randomization|Participant no longer meets study criteria|5|||
105505310|NCT01673867|363862174|FG000|Treatment|Disease Progression|208|||
105505311|NCT01673867|363862175|FG001|Treatment|Disease Progression|178|||
105505312|NCT01673867|363862174|FG000|Treatment|Study Drug Toxicity|23|||
105505313|NCT01673867|363862175|FG001|Treatment|Study Drug Toxicity|43|||
105505314|NCT01673867|363862174|FG000|Treatment|Death|2|||
105505315|NCT01673867|363862175|FG001|Treatment|Death|3|||
105505316|NCT01673867|363862174|FG000|Treatment|Adverse event unrelated to study drug|23|||
105505317|NCT01673867|363862175|FG001|Treatment|Adverse event unrelated to study drug|10|||
105505318|NCT01673867|363862174|FG000|Treatment|Participant request to discontinue study treatment|7|||
105505319|NCT01673867|363862175|FG001|Treatment|Participant request to discontinue study treatment|17|||
105505320|NCT01673867|363862174|FG000|Treatment|Withdrawal by participant|5|||
105505321|NCT01673867|363862175|FG001|Treatment|Withdrawal by participant|5|||
105505322|NCT01673867|363862174|FG000|Treatment|Maximum clinical benefit|1|||
105505323|NCT01673867|363862175|FG001|Treatment|Maximum clinical benefit|10|||
105505324|NCT01673867|363862174|FG000|Treatment|Participant no longer meets study criteria|2|||
105505325|NCT01673867|363862175|FG001|Treatment|Participant no longer meets study criteria|0|||
105505326|NCT01673867|363862174|FG000|Treatment|Administrative reason by sponsor|3|||
105505327|NCT01673867|363862175|FG001|Treatment|Administrative reason by sponsor|0|||
105505328|NCT01673867|363862174|FG000|Treatment|Other reason|11|||
105505329|NCT01673867|363862175|FG001|Treatment|Other reason|2|||
105505330|NCT01513343|363862182|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
105505331|NCT01513343|363862183|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
105505332|NCT01513343|363862182|FG000|Post Data Collection|Dropped/withdrew from study|7|||
105505333|NCT01513343|363862183|FG001|Post Data Collection|Dropped/withdrew from study|1|||
105505334|NCT01513343|363862182|FG000|Post Data Collection|Lost to Follow-up|10|||
105505335|NCT01513343|363862183|FG001|Post Data Collection|Lost to Follow-up|23|||
105505336|NCT01513343|363862182|FG000|6-month Follow-up|Lost to Follow-up|28|||
105505337|NCT01513343|363862183|FG001|6-month Follow-up|Lost to Follow-up|17|||
105505338|NCT01513343|363862182|FG000|12-month Follow-up|Lost to Follow-up|10|||
105505339|NCT01513343|363862183|FG001|12-month Follow-up|Lost to Follow-up|3|||
105505340|NCT04160195|363862194|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
105505341|NCT04160195|363862195|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
105505342|NCT01867424|363862197|FG000|Overall Study|Patient noncompliance|2|||
105505343|NCT01867424|363862198|FG001|Overall Study|Patient noncompliance|1|||
105505344|NCT03639935|363862199|FG000|Overall Study|Death|3|||
105505345|NCT03639935|363862199|FG000|Overall Study|Adverse Event|1|||
105505346|NCT03066804|363862204|FG000|Overall Study|Physician Decision|0|||
105505347|NCT03066804|363862205|FG001|Overall Study|Physician Decision|4|||
105505348|NCT03066804|363862204|FG000|Overall Study|Death|23|||
105505349|NCT03066804|363862205|FG001|Overall Study|Death|17|||
105505350|NCT03066804|363862204|FG000|Overall Study|Withdrawal by Subject|19|||
105505351|NCT03066804|363862205|FG001|Overall Study|Withdrawal by Subject|25|||
105505352|NCT03066804|363862204|FG000|Overall Study|Lost to Follow-up|2|||
105505353|NCT03066804|363862205|FG001|Overall Study|Lost to Follow-up|0|||
105505354|NCT03066804|363862204|FG000|Overall Study|Adverse Event|2|||
105505355|NCT03066804|363862205|FG001|Overall Study|Adverse Event|3|||
105505356|NCT03066804|363862204|FG000|Overall Study|Technical problems|5|||
105505357|NCT03066804|363862205|FG001|Overall Study|Technical problems|1|||
105505358|NCT03470441|363862212|FG000|Overall Study|Death|0|||
105505359|NCT03470441|363862213|FG001|Overall Study|Death|1|||
105505360|NCT03470441|363862214|FG002|Overall Study|Death|1|||
105505361|NCT03470441|363862215|FG003|Overall Study|Death|0|||
105505362|NCT03470441|363862212|FG000|Overall Study|Adverse Event|0|||
105505363|NCT03470441|363862213|FG001|Overall Study|Adverse Event|0|||
105505364|NCT03470441|363862214|FG002|Overall Study|Adverse Event|0|||
105505365|NCT03470441|363862215|FG003|Overall Study|Adverse Event|1|||
105505366|NCT03470441|363862212|FG000|Overall Study|Withdrawal by Subject|1|||
105505367|NCT03470441|363862213|FG001|Overall Study|Withdrawal by Subject|4|||
105505368|NCT03470441|363862214|FG002|Overall Study|Withdrawal by Subject|1|||
105505369|NCT03470441|363862215|FG003|Overall Study|Withdrawal by Subject|3|||
105505370|NCT03706079|363862216|FG000|Predecessor Study|Death|0|||
105505371|NCT03706079|363862217|FG001|Predecessor Study|Death|2|||
105505372|NCT03706079|363862218|FG002|Predecessor Study|Death|0|||
105505373|NCT03706079|363862219|FG003|Predecessor Study|Death|1|||
105505374|NCT03706079|363862220|FG004|Predecessor Study|Death|0|||
105505375|NCT03706079|363862221|FG005|Predecessor Study|Death|0|||
105505376|NCT03706079|363862216|FG000|Predecessor Study|Lost to Follow-up|5|||
105505377|NCT03706079|363862217|FG001|Predecessor Study|Lost to Follow-up|2|||
105505378|NCT03706079|363862218|FG002|Predecessor Study|Lost to Follow-up|0|||
105505379|NCT03706079|363862219|FG003|Predecessor Study|Lost to Follow-up|0|||
105505380|NCT03706079|363862220|FG004|Predecessor Study|Lost to Follow-up|1|||
105505381|NCT03706079|363862221|FG005|Predecessor Study|Lost to Follow-up|0|||
105505382|NCT03706079|363862216|FG000|Predecessor Study|Withdrawal by Subject|8|||
105505383|NCT03706079|363862217|FG001|Predecessor Study|Withdrawal by Subject|15|||
105505384|NCT03706079|363862218|FG002|Predecessor Study|Withdrawal by Subject|0|||
105505385|NCT03706079|363862219|FG003|Predecessor Study|Withdrawal by Subject|5|||
105505386|NCT03706079|363862220|FG004|Predecessor Study|Withdrawal by Subject|2|||
105505387|NCT03706079|363862221|FG005|Predecessor Study|Withdrawal by Subject|0|||
105505388|NCT03706079|363862216|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
105505389|NCT03706079|363862217|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
105505390|NCT03706079|363862218|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
105505391|NCT03706079|363862219|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
105505392|NCT03706079|363862220|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
105505393|NCT03706079|363862221|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
105505394|NCT03706079|363862216|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
105505395|NCT03706079|363862217|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
105505396|NCT03706079|363862218|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
105505397|NCT03706079|363862219|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
105505398|NCT03706079|363862220|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
105505399|NCT03706079|363862221|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
105505400|NCT03706079|363862216|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
105505401|NCT03706079|363862217|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
105505402|NCT03706079|363862218|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
105505403|NCT03706079|363862219|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
105505404|NCT03706079|363862220|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
105505405|NCT03706079|363862221|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
105505406|NCT03706079|363862216|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
105505407|NCT03706079|363862217|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
105505408|NCT03706079|363862218|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
105505409|NCT03706079|363862219|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
105505410|NCT03706079|363862220|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
105505411|NCT03706079|363862221|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
105505412|NCT03706079|363862216|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
105505413|NCT03706079|363862217|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
105505414|NCT03706079|363862218|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
105505415|NCT03706079|363862219|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
105505416|NCT03706079|363862220|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
105505417|NCT03706079|363862221|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
105505418|NCT03706079|363862216|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
105505419|NCT03706079|363862217|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
105505420|NCT03706079|363862218|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
105505421|NCT03706079|363862219|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
105505422|NCT03706079|363862220|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
105505423|NCT03706079|363862221|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
105505424|NCT03706079|363862216|FG000|Long Term Extension (DESTINATION)|Death|8|||
105505425|NCT03706079|363862217|FG001|Long Term Extension (DESTINATION)|Death|2|||
105505426|NCT03706079|363862218|FG002|Long Term Extension (DESTINATION)|Death|2|||
105505427|NCT03706079|363862219|FG003|Long Term Extension (DESTINATION)|Death|1|||
105505428|NCT03706079|363862220|FG004|Long Term Extension (DESTINATION)|Death|0|||
105505429|NCT03706079|363862221|FG005|Long Term Extension (DESTINATION)|Death|0|||
105505430|NCT05393895|363862222|FG000|Overall Study|Adverse Event|2|||
105505431|NCT05393895|363862223|FG001|Overall Study|Adverse Event|3|||
105505432|NCT05393895|363862222|FG000|Overall Study|Lost to Follow-up|4|||
105505433|NCT05393895|363862223|FG001|Overall Study|Lost to Follow-up|3|||
105505434|NCT05393895|363862222|FG000|Overall Study|Protocol Violation|1|||
105505435|NCT05393895|363862223|FG001|Overall Study|Protocol Violation|0|||
105505436|NCT05393895|363862222|FG000|Overall Study|Withdrawal by Subject|1|||
105505437|NCT05393895|363862223|FG001|Overall Study|Withdrawal by Subject|4|||
105505438|NCT01203098|363862228|FG000|Overall Study|Adverse Event|3|||
105505439|NCT01203098|363862229|FG001|Overall Study|Adverse Event|1|||
105505440|NCT01203098|363862230|FG002|Overall Study|Adverse Event|7|||
105505441|NCT01203098|363862228|FG000|Overall Study|Lost to Follow-up|0|||
105505442|NCT01203098|363862229|FG001|Overall Study|Lost to Follow-up|0|||
105505443|NCT01203098|363862230|FG002|Overall Study|Lost to Follow-up|1|||
105505444|NCT01203098|363862228|FG000|Overall Study|Physician Decision|2|||
105505445|NCT01203098|363862229|FG001|Overall Study|Physician Decision|2|||
105505446|NCT01203098|363862230|FG002|Overall Study|Physician Decision|0|||
105505447|NCT01203098|363862228|FG000|Overall Study|Withdrawal by Subject|1|||
105505448|NCT01203098|363862229|FG001|Overall Study|Withdrawal by Subject|1|||
105505449|NCT01203098|363862230|FG002|Overall Study|Withdrawal by Subject|3|||
105505450|NCT01447433|363862234|FG000|Overall Study|Lost to Follow-up|0|||
105505451|NCT01447433|363862235|FG001|Overall Study|Lost to Follow-up|2|||
105505452|NCT01447433|363862234|FG000|Overall Study|Withdrawal by Subject|3|||
105505453|NCT01447433|363862235|FG001|Overall Study|Withdrawal by Subject|3|||
105505454|NCT01447433|363862234|FG000|Overall Study|Protocol Violation|1|||
105505455|NCT01447433|363862235|FG001|Overall Study|Protocol Violation|1|||
105505456|NCT04447794|363862236|FG000|Overall Study|Lost to Follow-up|2|||
105505457|NCT04447794|363862237|FG001|Overall Study|Lost to Follow-up|3|||
105505458|NCT04447794|363862238|FG002|Overall Study|Lost to Follow-up|8|||
105505459|NCT04447794|363862236|FG000|Overall Study|Withdrawal by Subject|1|||
105505460|NCT04447794|363862237|FG001|Overall Study|Withdrawal by Subject|1|||
105505461|NCT04447794|363862238|FG002|Overall Study|Withdrawal by Subject|0|||
105505462|NCT01964430|363862239|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
105505463|NCT01964430|363862240|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
105505464|NCT01964430|363862239|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
105505465|NCT01964430|363862240|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
105505466|NCT01964430|363862239|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
105505467|NCT01964430|363862240|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
105505468|NCT01964430|363862239|FG000|Treatment Period|Adverse Event|71|||
105505469|NCT01964430|363862240|FG001|Treatment Period|Adverse Event|37|||
105505470|NCT01964430|363862239|FG000|Treatment Period|Withdrawal by Subject|36|||
105505471|NCT01964430|363862240|FG001|Treatment Period|Withdrawal by Subject|27|||
105505472|NCT01964430|363862239|FG000|Treatment Period|Death|1|||
105505473|NCT01964430|363862240|FG001|Treatment Period|Death|3|||
105505474|NCT01964430|363862239|FG000|Treatment Period|Protocol Deviation|0|||
105505475|NCT01964430|363862240|FG001|Treatment Period|Protocol Deviation|1|||
105505476|NCT01964430|363862239|FG000|Treatment Period|Physician Decision|5|||
105505477|NCT01964430|363862240|FG001|Treatment Period|Physician Decision|4|||
105505478|NCT01964430|363862239|FG000|Treatment Period|Disease Relapse|28|||
105505479|NCT01964430|363862240|FG001|Treatment Period|Disease Relapse|38|||
105505480|NCT01964430|363862239|FG000|Treatment Period|Other reasons|1|||
105505481|NCT01964430|363862240|FG001|Treatment Period|Other reasons|3|||
105505482|NCT01350492|363862241|FG000|Intervention|Lost to Follow-up|2|||
105505483|NCT01350492|363862242|FG001|Intervention|Lost to Follow-up|5|||
105505484|NCT01350492|363862241|FG000|Intervention|Withdrawal by Subject|3|||
105505485|NCT01350492|363862242|FG001|Intervention|Withdrawal by Subject|1|||
105505486|NCT01350492|363862241|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
105505487|NCT01350492|363862242|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
105505488|NCT01350492|363862241|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
105505489|NCT01350492|363862242|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
105505490|NCT00913497|363862243|FG000|Overall Study|Adverse Event|1|||
105505491|NCT00913497|363862243|FG000|Overall Study|Withdrawal by Subject|2|||
105505492|NCT02801396|363862244|FG000|Period 1|Withdrawal by Subject|0|||
105505493|NCT02801396|363862245|FG001|Period 1|Withdrawal by Subject|0|||
105505494|NCT02801396|363862246|FG002|Period 1|Withdrawal by Subject|0|||
105505495|NCT02801396|363862247|FG003|Period 1|Withdrawal by Subject|0|||
105505496|NCT02801396|363862248|FG004|Period 1|Withdrawal by Subject|1|||
105505497|NCT02801396|363862249|FG005|Period 1|Withdrawal by Subject|0|||
105505498|NCT03208244|363862252|FG000|Overall Study|Death|1|||
105505499|NCT01874054|363862254|FG000|Overall Study|Withdrawal by Subject|3|||
105505500|NCT01874054|363862254|FG000|Overall Study|Study Termination by Sponsor|42|||
105505501|NCT01874054|363862254|FG000|Overall Study|Lost to Follow-up|5|||
105505502|NCT01874054|363862254|FG000|Overall Study|Death|5|||
105505503|NCT00702923|363862255|FG000|Overall Study|Adverse Event|1|||
105505504|NCT02002091|363862257|FG000|Screening|Lost to Follow-up|10|||
105505505|NCT02002091|363862258|FG001|Screening|Lost to Follow-up|12|||
105505506|NCT02002091|363862257|FG000|Screening|Death|3|||
105505507|NCT02002091|363862258|FG001|Screening|Death|2|||
105505508|NCT00334958|363862259|FG000|Overall Study|Medication Noncompliance|0|||
105505509|NCT00334958|363862260|FG001|Overall Study|Medication Noncompliance|3|||
105505510|NCT00334958|363862259|FG000|Overall Study|Protocol Violation|2|||
105505511|NCT00334958|363862260|FG001|Overall Study|Protocol Violation|2|||
105505512|NCT00334958|363862259|FG000|Overall Study|Request of the investigator or sponsor|0|||
105505513|NCT00334958|363862260|FG001|Overall Study|Request of the investigator or sponsor|1|||
105505514|NCT00334958|363862259|FG000|Overall Study|Withdrawal by Subject|7|||
105505515|NCT00334958|363862260|FG001|Overall Study|Withdrawal by Subject|4|||
105505516|NCT00334958|363862259|FG000|Overall Study|Adverse Event|27|||
105505517|NCT00334958|363862260|FG001|Overall Study|Adverse Event|12|||
105505518|NCT00334958|363862259|FG000|Overall Study|Other|1|||
105505519|NCT00334958|363862260|FG001|Overall Study|Other|2|||
105505520|NCT01218243|363862269|FG000|Overall Study|Lack of Efficacy|1|||
105505521|NCT01218243|363862270|FG001|Overall Study|Lack of Efficacy|1|||
105505522|NCT01218243|363862269|FG000|Overall Study|Lost to Follow-up|3|||
105505523|NCT01218243|363862270|FG001|Overall Study|Lost to Follow-up|3|||
105505524|NCT01218243|363862269|FG000|Overall Study|Protocol Violation|5|||
105505525|NCT01218243|363862270|FG001|Overall Study|Protocol Violation|10|||
105505526|NCT03035409|363862276|FG000|Overall Study|Adverse Event|5|||
105505527|NCT03035409|363862276|FG000|Overall Study|Death|2|||
105505528|NCT03035409|363862276|FG000|Overall Study|Withdrawal by Subject|2|||
105505529|NCT03035409|363862276|FG000|Overall Study|Non compliance|4|||
105505530|NCT03035409|363862276|FG000|Overall Study|Patient was jittery|1|||
105505531|NCT03035409|363862276|FG000|Overall Study|Did not like Questionnaire|1|||
105505532|NCT03035409|363862276|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
105505533|NCT03035409|363862276|FG000|Overall Study|Did not like taking drugs|1|||
105505534|NCT01552694|363862278|FG000|Overall Study|Lost to Follow-up|0|||
105505535|NCT01552694|363862279|FG001|Overall Study|Lost to Follow-up|1|||
105505536|NCT01552694|363862278|FG000|Overall Study|Protocol Violation|0|||
105505537|NCT01552694|363862279|FG001|Overall Study|Protocol Violation|1|||
105505538|NCT03943147|363862281|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
105505539|NCT03943147|363862282|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
105505540|NCT03943147|363862281|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
105505541|NCT03943147|363862282|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
105505542|NCT03943147|363862281|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
105505543|NCT03943147|363862282|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
105505544|NCT03943147|363862281|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
105505545|NCT03943147|363862282|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
105505546|NCT03943147|363862281|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
105505547|NCT03943147|363862282|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
105505548|NCT03943147|363862281|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
105505549|NCT03943147|363862282|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
105505550|NCT02756013|363862283|FG000|Overall Study|Adverse Event|1|||
105505551|NCT02756013|363862283|FG000|Overall Study|Hypersensitivity|1|||
105505552|NCT01318993|363862284|FG000|Overall Study|Adverse Event|53|||
105505553|NCT01318993|363862284|FG000|Overall Study|Lack of Efficacy|121|||
105505554|NCT01318993|363862284|FG000|Overall Study|Protocol Violation|3|||
105505555|NCT01318993|363862284|FG000|Overall Study|Protocol based stopping criteria|6|||
105505556|NCT01318993|363862284|FG000|Overall Study|Study closed or terminated|174|||
105505557|NCT01318993|363862284|FG000|Overall Study|Lost to Follow-up|4|||
105505558|NCT01318993|363862284|FG000|Overall Study|Physician Decision|13|||
105505559|NCT01318993|363862284|FG000|Overall Study|Withdrawal by Subject|24|||
105505560|NCT00629707|363862287|FG000|Overall Study|Withdrawal by Subject|0|||
105505561|NCT00629707|363862288|FG001|Overall Study|Withdrawal by Subject|1|||
105505562|NCT00629707|363862287|FG000|Overall Study|Physician Decision|0|||
105505563|NCT00629707|363862288|FG001|Overall Study|Physician Decision|1|||
105505564|NCT04523220|363862290|FG000|Main Treatment Period|Physician Decision|1|||
105505565|NCT04523220|363862291|FG001|Main Treatment Period|Physician Decision|1|||
105505566|NCT04523220|363862292|FG002|Main Treatment Period|Physician Decision|0|||
105505567|NCT04523220|363862290|FG000|Main Treatment Period|Other|5|||
105505568|NCT04523220|363862291|FG001|Main Treatment Period|Other|2|||
105505569|NCT04523220|363862292|FG002|Main Treatment Period|Other|4|||
105505570|NCT04523220|363862290|FG000|Main Treatment Period|Subject Decision|5|||
105505571|NCT04523220|363862291|FG001|Main Treatment Period|Subject Decision|7|||
105505572|NCT04523220|363862292|FG002|Main Treatment Period|Subject Decision|3|||
105505573|NCT04523220|363862290|FG000|Main Treatment Period|Death|5|||
105505574|NCT04523220|363862291|FG001|Main Treatment Period|Death|11|||
105505575|NCT04523220|363862292|FG002|Main Treatment Period|Death|4|||
105505576|NCT04523220|363862290|FG000|Main Treatment Period|Adverse Event|11|||
105505577|NCT04523220|363862291|FG001|Main Treatment Period|Adverse Event|9|||
105505578|NCT04523220|363862292|FG002|Main Treatment Period|Adverse Event|9|||
105505579|NCT04523220|363862290|FG000|Main Treatment Period|Withdrawal by Subject|3|||
105505580|NCT04523220|363862291|FG001|Main Treatment Period|Withdrawal by Subject|3|||
105505581|NCT04523220|363862292|FG002|Main Treatment Period|Withdrawal by Subject|4|||
105505582|NCT04523220|363862290|FG000|Main Treatment Period|Study drug never adminstered|10|||
105505583|NCT04523220|363862291|FG001|Main Treatment Period|Study drug never adminstered|3|||
105505584|NCT04523220|363862292|FG002|Main Treatment Period|Study drug never adminstered|5|||
105505585|NCT04523220|363862290|FG000|Extension Treatment Period|Physician Decision|1|||
105505586|NCT04523220|363862291|FG001|Extension Treatment Period|Physician Decision|0|||
105505587|NCT04523220|363862292|FG002|Extension Treatment Period|Physician Decision|3|||
105505588|NCT04523220|363862290|FG000|Extension Treatment Period|Other|2|||
105590759|NCT04927975|364162703|FG005|Period 1 (Baseline-Week 24)|Death|1|||
105505589|NCT04523220|363862291|FG001|Extension Treatment Period|Other|6|||
105505590|NCT04523220|363862292|FG002|Extension Treatment Period|Other|6|||
105505591|NCT04523220|363862290|FG000|Extension Treatment Period|Subject Decision|5|||
105505592|NCT04523220|363862291|FG001|Extension Treatment Period|Subject Decision|2|||
105505593|NCT04523220|363862292|FG002|Extension Treatment Period|Subject Decision|4|||
105505594|NCT04523220|363862290|FG000|Extension Treatment Period|Death|6|||
105505595|NCT04523220|363862291|FG001|Extension Treatment Period|Death|4|||
105505596|NCT04523220|363862292|FG002|Extension Treatment Period|Death|7|||
105505597|NCT04523220|363862290|FG000|Extension Treatment Period|Adverse Event|6|||
105505598|NCT04523220|363862291|FG001|Extension Treatment Period|Adverse Event|7|||
105505599|NCT04523220|363862292|FG002|Extension Treatment Period|Adverse Event|9|||
105505600|NCT04523220|363862290|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
105505601|NCT04523220|363862291|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
105505602|NCT04523220|363862292|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
105505603|NCT04523220|363862290|FG000|Extension Treatment Period|Study drug never administered|0|||
105505604|NCT04523220|363862291|FG001|Extension Treatment Period|Study drug never administered|1|||
105505605|NCT04523220|363862292|FG002|Extension Treatment Period|Study drug never administered|0|||
105505606|NCT00571948|363862293|FG000|Overall Study|Lost to Follow-up|2|||
105505607|NCT00571948|363862294|FG001|Overall Study|Lost to Follow-up|0|||
105505608|NCT00571948|363862293|FG000|Overall Study|Withdrawal by Subject|1|||
105505609|NCT00571948|363862294|FG001|Overall Study|Withdrawal by Subject|2|||
105505610|NCT00571948|363862293|FG000|Overall Study|Protocol Violation|3|||
105505611|NCT00571948|363862294|FG001|Overall Study|Protocol Violation|3|||
105505612|NCT00571948|363862293|FG000|Overall Study|infant refused study meal|3|||
105505613|NCT00571948|363862294|FG001|Overall Study|infant refused study meal|4|||
105505614|NCT00571948|363862293|FG000|Overall Study|Parent were afraid of blood colection|2|||
105505615|NCT00571948|363862294|FG001|Overall Study|Parent were afraid of blood colection|5|||
105505616|NCT00481078|363862295|FG000|Overall Study|Progression of disease|11|||
105505617|NCT00481078|363862296|FG001|Overall Study|Progression of disease|11|||
105505618|NCT00481078|363862295|FG000|Overall Study|Adverse Event|15|||
105505619|NCT00481078|363862296|FG001|Overall Study|Adverse Event|3|||
105505620|NCT00481078|363862295|FG000|Overall Study|Death|5|||
105505621|NCT00481078|363862296|FG001|Overall Study|Death|3|||
105505622|NCT00481078|363862295|FG000|Overall Study|Intercurrent illness|1|||
105505623|NCT00481078|363862296|FG001|Overall Study|Intercurrent illness|0|||
105590760|NCT04927975|364162698|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
105505624|NCT00481078|363862295|FG000|Overall Study|Withdrawal by Subject|7|||
105505625|NCT00481078|363862296|FG001|Overall Study|Withdrawal by Subject|1|||
105505626|NCT00481078|363862295|FG000|Overall Study|Information not available|1|||
105505627|NCT00481078|363862296|FG001|Overall Study|Information not available|0|||
105505628|NCT00481078|363862295|FG000|Overall Study|Received other treatment|2|||
105505629|NCT00481078|363862296|FG001|Overall Study|Received other treatment|1|||
105505630|NCT00481078|363862295|FG000|Overall Study|Brain metastasis|0|||
105505631|NCT00481078|363862296|FG001|Overall Study|Brain metastasis|1|||
105505632|NCT01558271|363862297|FG000|Overall Study|Adverse Event|6|||
105505633|NCT01558271|363862298|FG001|Overall Study|Adverse Event|3|||
105505634|NCT01558271|363862299|FG002|Overall Study|Adverse Event|4|||
105505635|NCT01558271|363862297|FG000|Overall Study|Lost to Follow-up|1|||
105505636|NCT01558271|363862298|FG001|Overall Study|Lost to Follow-up|0|||
105505637|NCT01558271|363862299|FG002|Overall Study|Lost to Follow-up|0|||
105505638|NCT01558271|363862297|FG000|Overall Study|Protocol Violation|1|||
105505639|NCT01558271|363862298|FG001|Overall Study|Protocol Violation|0|||
105505640|NCT01558271|363862299|FG002|Overall Study|Protocol Violation|0|||
105505641|NCT01558271|363862297|FG000|Overall Study|Withdrawal by Subject|10|||
105505642|NCT01558271|363862298|FG001|Overall Study|Withdrawal by Subject|6|||
105505643|NCT01558271|363862299|FG002|Overall Study|Withdrawal by Subject|12|||
105505644|NCT01558271|363862297|FG000|Overall Study|Physician Decision|0|||
105505645|NCT01558271|363862298|FG001|Overall Study|Physician Decision|2|||
105505646|NCT01558271|363862299|FG002|Overall Study|Physician Decision|1|||
105505647|NCT01845831|363862300|FG000|Inpatient Phase|Withdrawal by Subject|1|||
105505648|NCT01845831|363862301|FG001|Inpatient Phase|Withdrawal by Subject|1|||
105505649|NCT01845831|363862302|FG002|Inpatient Phase|Withdrawal by Subject|0|||
105505650|NCT01845831|363862303|FG003|Inpatient Phase|Withdrawal by Subject|0|||
105505651|NCT01845831|363862304|FG004|Inpatient Phase|Withdrawal by Subject|0|||
105505652|NCT01197560|363862305|FG000|Overall Study|Adverse Event|6|||
105505653|NCT01197560|363862306|FG001|Overall Study|Adverse Event|8|||
105505654|NCT01197560|363862305|FG000|Overall Study|Death|3|||
105505655|NCT01197560|363862306|FG001|Overall Study|Death|5|||
105505656|NCT01197560|363862305|FG000|Overall Study|Withdrawal by Subject|1|||
105505657|NCT01197560|363862306|FG001|Overall Study|Withdrawal by Subject|1|||
105505658|NCT01197560|363862305|FG000|Overall Study|Disease progression|40|||
105505659|NCT01197560|363862306|FG001|Overall Study|Disease progression|35|||
105505660|NCT01197560|363862305|FG000|Overall Study|Miscellaneous|4|||
105505661|NCT01197560|363862306|FG001|Overall Study|Miscellaneous|3|||
105505662|NCT01197560|363862305|FG000|Overall Study|Missing|0|||
105505663|NCT01197560|363862306|FG001|Overall Study|Missing|1|||
105505664|NCT04404361|363862307|FG000|Overall Study|Death|12|||
105505665|NCT04404361|363862308|FG001|Overall Study|Death|12|||
105505666|NCT04404361|363862307|FG000|Overall Study|Withdrawal by Subject|13|||
105505667|NCT04404361|363862308|FG001|Overall Study|Withdrawal by Subject|5|||
105505668|NCT04404361|363862307|FG000|Overall Study|Lost to Follow-up|6|||
105505669|NCT04404361|363862308|FG001|Overall Study|Lost to Follow-up|3|||
105505670|NCT04404361|363862307|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
105505671|NCT04404361|363862308|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
105505672|NCT02862171|363862309|FG000|Overall Study|Death|1|||
105505673|NCT02862171|363862309|FG000|Overall Study|Lost to Follow-up|13|||
105505674|NCT02862171|363862309|FG000|Overall Study|Withdrawal by Subject|57|||
105505675|NCT02862171|363862309|FG000|Overall Study|Non-compliance|4|||
105505676|NCT02862171|363862309|FG000|Overall Study|HIV-1 seroconversion|18|||
105505677|NCT00558558|363862310|FG000|Overall Study|Unable to swallow|1|||
105505678|NCT00558558|363862310|FG000|Overall Study|Withdrawal by Subject|1|||
105505679|NCT00558558|363862310|FG000|Overall Study|Lack of Efficacy|4|||
105505680|NCT05766423|363862311|FG000|Overall Study|Withdrawal by Subject|1|||
105505681|NCT05766423|363862312|FG001|Overall Study|Withdrawal by Subject|0|||
105505682|NCT05766423|363862311|FG000|Overall Study|Consented, not scheduled|3|||
105505683|NCT05766423|363862312|FG001|Overall Study|Consented, not scheduled|5|||
105505684|NCT02323113|363864376|FG000|Overall Study|Adverse Event|3|||
105505685|NCT02323113|363864377|FG001|Overall Study|Adverse Event|3|||
105505686|NCT02323113|363864378|FG002|Overall Study|Adverse Event|2|||
105505687|NCT02323113|363864379|FG003|Overall Study|Adverse Event|5|||
105505688|NCT02323113|363864380|FG004|Overall Study|Adverse Event|8|||
105505689|NCT02323113|363864381|FG005|Overall Study|Adverse Event|3|||
105505690|NCT02323113|363864382|FG006|Overall Study|Adverse Event|6|||
105505691|NCT02323113|363864383|FG007|Overall Study|Adverse Event|0|||
105505692|NCT02323113|363864376|FG000|Overall Study|Progressive Disease|0|||
105505693|NCT02323113|363864377|FG001|Overall Study|Progressive Disease|1|||
105505694|NCT02323113|363864378|FG002|Overall Study|Progressive Disease|1|||
105505695|NCT02323113|363864379|FG003|Overall Study|Progressive Disease|0|||
105505696|NCT02323113|363864380|FG004|Overall Study|Progressive Disease|0|||
105505697|NCT02323113|363864381|FG005|Overall Study|Progressive Disease|3|||
105505698|NCT02323113|363864382|FG006|Overall Study|Progressive Disease|0|||
105505699|NCT02323113|363864383|FG007|Overall Study|Progressive Disease|0|||
105505700|NCT02323113|363864376|FG000|Overall Study|Symptomatic Deterioration|0|||
105505701|NCT02323113|363864377|FG001|Overall Study|Symptomatic Deterioration|0|||
105505702|NCT02323113|363864378|FG002|Overall Study|Symptomatic Deterioration|1|||
105505703|NCT02323113|363864379|FG003|Overall Study|Symptomatic Deterioration|0|||
105505704|NCT02323113|363864380|FG004|Overall Study|Symptomatic Deterioration|1|||
105505705|NCT02323113|363864381|FG005|Overall Study|Symptomatic Deterioration|0|||
105505706|NCT02323113|363864382|FG006|Overall Study|Symptomatic Deterioration|0|||
105505707|NCT02323113|363864383|FG007|Overall Study|Symptomatic Deterioration|0|||
105505708|NCT02323113|363864376|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
105505709|NCT02323113|363864377|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
105505710|NCT02323113|363864378|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
105505711|NCT02323113|363864379|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
105505712|NCT02323113|363864380|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
105505713|NCT02323113|363864381|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
105505714|NCT02323113|363864382|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
105505715|NCT02323113|363864383|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
105505716|NCT02323113|363864376|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
105505717|NCT02323113|363864377|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
105505718|NCT02323113|363864378|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
105505719|NCT02323113|363864379|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
105505720|NCT02323113|363864380|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
105505721|NCT02323113|363864381|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
105505722|NCT02323113|363864382|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
105505723|NCT02323113|363864383|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
105505724|NCT00126191|363864388|FG000|Overall Study|Physician Decision|0|||
105505725|NCT00126191|363864389|FG001|Overall Study|Physician Decision|1|||
105505726|NCT00126191|363864388|FG000|Overall Study|Death|0|||
105505727|NCT00126191|363864389|FG001|Overall Study|Death|1|||
105505728|NCT03003390|363864390|FG000|Overall Study|Physician Decision|2|||
105505729|NCT03003390|363864391|FG001|Overall Study|Physician Decision|0|||
105505730|NCT03003390|363864390|FG000|Overall Study|Parent refused intervention|2|||
105505731|NCT03003390|363864391|FG001|Overall Study|Parent refused intervention|0|||
105505732|NCT01433991|363864392|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
105505733|NCT01433991|363864393|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
105505734|NCT01433991|363864394|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
105505735|NCT01433991|363864395|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
105505736|NCT01433991|363864392|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
105505737|NCT01433991|363864393|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
105505738|NCT01433991|363864394|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
105505739|NCT01433991|363864395|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
105505740|NCT01433991|363864392|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
105505741|NCT01433991|363864393|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
105505742|NCT01433991|363864394|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
105505743|NCT01433991|363864395|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
105505744|NCT01433991|363864392|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
105505745|NCT01433991|363864393|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
105505746|NCT01433991|363864394|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
105505747|NCT01433991|363864395|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
105505748|NCT01433991|363864392|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
105505749|NCT01433991|363864393|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
105505750|NCT01433991|363864394|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
105505751|NCT01433991|363864395|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
105505752|NCT01433991|363864392|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
105505753|NCT01433991|363864393|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
105505754|NCT01433991|363864394|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
105505755|NCT01433991|363864395|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
105505756|NCT01433991|363864392|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
105505757|NCT01433991|363864393|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
105505758|NCT01433991|363864394|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
105505759|NCT01433991|363864395|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
105505760|NCT00612690|363864396|FG000|Overall Study|Lost to Follow-up|72|||
105505761|NCT00612690|363864397|FG001|Overall Study|Lost to Follow-up|98|||
105505762|NCT00612690|363864396|FG000|Overall Study|Withdrawal by Subject|32|||
105505763|NCT00612690|363864397|FG001|Overall Study|Withdrawal by Subject|20|||
105505764|NCT00612690|363864396|FG000|Overall Study|Withdrawal by Site|11|||
105505765|NCT00612690|363864397|FG001|Overall Study|Withdrawal by Site|0|||
105505766|NCT02980601|363864398|FG000|Overall Study|Lost to Follow-up|2|||
105505767|NCT02980601|363864399|FG001|Overall Study|Lost to Follow-up|2|||
105505768|NCT02980601|363864398|FG000|Overall Study|Death|0|||
105505769|NCT02980601|363864399|FG001|Overall Study|Death|1|||
105505770|NCT02980601|363864398|FG000|Overall Study|Graft loss|1|||
105590761|NCT04927975|364162699|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
105590762|NCT04927975|364162700|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
105590763|NCT04927975|364162701|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
105590764|NCT04927975|364162702|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
105505771|NCT02980601|363864399|FG001|Overall Study|Graft loss|0|||
105505772|NCT02980601|363864398|FG000|Overall Study|Failed to sign consent|2|||
105505773|NCT02980601|363864399|FG001|Overall Study|Failed to sign consent|0|||
105505774|NCT03000439|363864400|FG000|Open Label Part 1|Adverse Event|6|||
105505775|NCT03000439|363864401|FG001|Open Label Part 1|Adverse Event|0|||
105505776|NCT03000439|363864402|FG002|Open Label Part 1|Adverse Event|0|||
105505777|NCT03000439|363864403|FG003|Open Label Part 1|Adverse Event|0|||
105505778|NCT03000439|363864400|FG000|Open Label Part 1|Other|2|||
105505779|NCT03000439|363864401|FG001|Open Label Part 1|Other|0|||
105505780|NCT03000439|363864402|FG002|Open Label Part 1|Other|0|||
105505781|NCT03000439|363864403|FG003|Open Label Part 1|Other|0|||
105505782|NCT03000439|363864400|FG000|Open Label Part 1|Insufficient clinical response|16|||
105505783|NCT03000439|363864401|FG001|Open Label Part 1|Insufficient clinical response|0|||
105505784|NCT03000439|363864402|FG002|Open Label Part 1|Insufficient clinical response|0|||
105505785|NCT03000439|363864403|FG003|Open Label Part 1|Insufficient clinical response|0|||
105505786|NCT03000439|363864400|FG000|Open Label Part 2|Other|0|||
105505787|NCT03000439|363864401|FG001|Open Label Part 2|Other|5|||
105505788|NCT03000439|363864402|FG002|Open Label Part 2|Other|0|||
105505789|NCT03000439|363864403|FG003|Open Label Part 2|Other|0|||
105505790|NCT03000439|363864400|FG000|Open Label Part 2|Insufficient clinical response|0|||
105505791|NCT03000439|363864401|FG001|Open Label Part 2|Insufficient clinical response|12|||
105505792|NCT03000439|363864402|FG002|Open Label Part 2|Insufficient clinical response|0|||
105505793|NCT03000439|363864403|FG003|Open Label Part 2|Insufficient clinical response|0|||
105505794|NCT03000439|363864400|FG000|Double Blind Phase|Adverse Event|0|||
105505795|NCT03000439|363864401|FG001|Double Blind Phase|Adverse Event|0|||
105505796|NCT03000439|363864402|FG002|Double Blind Phase|Adverse Event|2|||
105505797|NCT03000439|363864403|FG003|Double Blind Phase|Adverse Event|1|||
105505798|NCT03000439|363864400|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
105505799|NCT03000439|363864401|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
105505800|NCT03000439|363864402|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
105505801|NCT03000439|363864403|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
105505802|NCT03000439|363864400|FG000|Double Blind Phase|Other|0|||
105505803|NCT03000439|363864401|FG001|Double Blind Phase|Other|0|||
105505804|NCT03000439|363864402|FG002|Double Blind Phase|Other|10|||
105505805|NCT03000439|363864403|FG003|Double Blind Phase|Other|11|||
105505806|NCT03000439|363864400|FG000|Double Blind Phase|Insufficient clinical response|0|||
105505807|NCT03000439|363864401|FG001|Double Blind Phase|Insufficient clinical response|0|||
105505808|NCT03000439|363864402|FG002|Double Blind Phase|Insufficient clinical response|0|||
105505809|NCT03000439|363864403|FG003|Double Blind Phase|Insufficient clinical response|2|||
105505810|NCT04487730|363864404|FG000|Overall Study|Withdrawal by Subject|3|||
105505811|NCT04487730|363864405|FG001|Overall Study|Withdrawal by Subject|1|||
105505812|NCT04487730|363864404|FG000|Overall Study|Lost to Follow-up|0|||
105505813|NCT04487730|363864405|FG001|Overall Study|Lost to Follow-up|1|||
105505814|NCT04487730|363864404|FG000|Overall Study|Physician Decision|0|||
105505815|NCT04487730|363864405|FG001|Overall Study|Physician Decision|1|||
105505816|NCT02954237|363864406|FG000|Overall Study|Withdrawal by Subject|25|||
105505817|NCT02954237|363864406|FG000|Overall Study|Missed visit|16|||
105505818|NCT02954237|363864406|FG000|Overall Study|Death|2|||
105505819|NCT00621985|363864407|FG000|Dexamethasone Admission|Adverse Event|1|||
105505820|NCT01153347|363864411|FG000|Overall Study|Withdrawal by Subject|7|||
105505821|NCT01153347|363864412|FG001|Overall Study|Withdrawal by Subject|7|||
105505822|NCT01153347|363864413|FG002|Overall Study|Withdrawal by Subject|7|||
105505823|NCT01153347|363864414|FG003|Overall Study|Withdrawal by Subject|7|||
105505824|NCT01153347|363864411|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105505825|NCT01153347|363864412|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
105505826|NCT01153347|363864413|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
105505827|NCT01153347|363864414|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
105505828|NCT01153347|363864411|FG000|Overall Study|Adverse Event|3|||
105505829|NCT01153347|363864412|FG001|Overall Study|Adverse Event|9|||
105590765|NCT04927975|364162703|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
105505830|NCT01153347|363864413|FG002|Overall Study|Adverse Event|21|||
105505831|NCT01153347|363864414|FG003|Overall Study|Adverse Event|7|||
105505832|NCT01153347|363864411|FG000|Overall Study|Severe non-compliance to protocol|6|||
105505833|NCT01153347|363864412|FG001|Overall Study|Severe non-compliance to protocol|7|||
105505834|NCT01153347|363864413|FG002|Overall Study|Severe non-compliance to protocol|4|||
105505835|NCT01153347|363864414|FG003|Overall Study|Severe non-compliance to protocol|3|||
105590766|NCT04927975|364162698|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
105505836|NCT01153347|363864411|FG000|Overall Study|Condition under investigation worsened|1|||
105505837|NCT01153347|363864412|FG001|Overall Study|Condition under investigation worsened|1|||
105505838|NCT01153347|363864413|FG002|Overall Study|Condition under investigation worsened|0|||
105505839|NCT01153347|363864414|FG003|Overall Study|Condition under investigation worsened|0|||
105505840|NCT01153347|363864411|FG000|Overall Study|Lack of Efficacy|2|||
105505841|NCT01153347|363864412|FG001|Overall Study|Lack of Efficacy|2|||
105505842|NCT01153347|363864413|FG002|Overall Study|Lack of Efficacy|0|||
105505843|NCT01153347|363864414|FG003|Overall Study|Lack of Efficacy|4|||
105505844|NCT01153347|363864411|FG000|Overall Study|Study-specific withdrawal criteria|4|||
105505845|NCT01153347|363864412|FG001|Overall Study|Study-specific withdrawal criteria|3|||
105505846|NCT01153347|363864413|FG002|Overall Study|Study-specific withdrawal criteria|1|||
105505847|NCT01153347|363864414|FG003|Overall Study|Study-specific withdrawal criteria|2|||
105505848|NCT01153347|363864411|FG000|Overall Study|Lost to Follow-up|4|||
105505849|NCT01153347|363864412|FG001|Overall Study|Lost to Follow-up|9|||
105505850|NCT01153347|363864413|FG002|Overall Study|Lost to Follow-up|11|||
105505851|NCT01153347|363864414|FG003|Overall Study|Lost to Follow-up|8|||
105505852|NCT01153347|363864411|FG000|Overall Study|Other|5|||
105505853|NCT01153347|363864412|FG001|Overall Study|Other|5|||
105505854|NCT01153347|363864413|FG002|Overall Study|Other|4|||
105505855|NCT01153347|363864414|FG003|Overall Study|Other|0|||
105505856|NCT01153347|363864411|FG000|Overall Study|Death|1|||
105505857|NCT01153347|363864412|FG001|Overall Study|Death|0|||
105505858|NCT01153347|363864413|FG002|Overall Study|Death|0|||
105505859|NCT01153347|363864414|FG003|Overall Study|Death|0|||
105505860|NCT00224042|363864415|FG000|Overall Study|Adverse Event|2|||
105505861|NCT00224042|363864416|FG001|Overall Study|Adverse Event|1|||
105505862|NCT00224042|363864415|FG000|Overall Study|Protocol Violation|0|||
105505863|NCT00224042|363864416|FG001|Overall Study|Protocol Violation|1|||
105505864|NCT00224042|363864415|FG000|Overall Study|Physician Decision|0|||
105505865|NCT00224042|363864416|FG001|Overall Study|Physician Decision|1|||
105505866|NCT00224042|363864415|FG000|Overall Study|Did not meet lab incusion criteria|2|||
105505867|NCT00224042|363864416|FG001|Overall Study|Did not meet lab incusion criteria|3|||
105505868|NCT00224042|363864415|FG000|Overall Study|Other|2|||
105505869|NCT00224042|363864416|FG001|Overall Study|Other|0|||
105505870|NCT00160693|363864417|FG000|Overall Study|Adverse Event|97|||
105505871|NCT00160693|363864417|FG000|Overall Study|Lack of Efficacy|30|||
105505872|NCT00160693|363864417|FG000|Overall Study|Protocol Violation|24|||
105505873|NCT00160693|363864417|FG000|Overall Study|Lost to Follow-up|15|||
105505874|NCT00160693|363864417|FG000|Overall Study|Withdrawal by Subject|54|||
105505875|NCT00160693|363864417|FG000|Overall Study|Study terminated by sponsor|15|||
105505876|NCT00133952|363864418|FG000|Overall Study|Adverse Event|1|||
105505877|NCT00133952|363864419|FG001|Overall Study|Adverse Event|2|||
105505878|NCT00133952|363864418|FG000|Overall Study|Death|3|||
105505879|NCT00133952|363864419|FG001|Overall Study|Death|2|||
105505880|NCT00133952|363864418|FG000|Overall Study|Lost to Follow-up|9|||
105505881|NCT00133952|363864419|FG001|Overall Study|Lost to Follow-up|14|||
105505882|NCT00133952|363864418|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
105505883|NCT00133952|363864419|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
105505884|NCT00133952|363864418|FG000|Overall Study|Protocol Violation|1|||
105505885|NCT00133952|363864419|FG001|Overall Study|Protocol Violation|1|||
105505886|NCT00133952|363864418|FG000|Overall Study|Withdrawal by Subject|20|||
105505887|NCT00133952|363864419|FG001|Overall Study|Withdrawal by Subject|4|||
105505888|NCT00133952|363864418|FG000|Overall Study|Physician Decision|4|||
105505889|NCT00133952|363864419|FG001|Overall Study|Physician Decision|3|||
105505890|NCT00133952|363864418|FG000|Overall Study|Sponsor Decision|0|||
105505891|NCT00133952|363864419|FG001|Overall Study|Sponsor Decision|1|||
105505892|NCT02853604|363864421|FG000|Overall Study|Withdrawal by Subject|12|||
105505893|NCT02853604|363864422|FG001|Overall Study|Withdrawal by Subject|35|||
105505894|NCT02853604|363864421|FG000|Overall Study|Lost to Follow-up|4|||
105505895|NCT02853604|363864422|FG001|Overall Study|Lost to Follow-up|8|||
105505896|NCT02853604|363864421|FG000|Overall Study|Death|1|||
105505897|NCT02853604|363864422|FG001|Overall Study|Death|5|||
105505898|NCT02853604|363864421|FG000|Overall Study|Miscellaneous|11|||
105505899|NCT02853604|363864422|FG001|Overall Study|Miscellaneous|2|||
105505900|NCT02853604|363864421|FG000|Overall Study|Progressive Disease|0|||
105505901|NCT02853604|363864422|FG001|Overall Study|Progressive Disease|2|||
105505902|NCT04213079|363864423|FG000|Overall Study|Lost to Follow-up|0|||
105505903|NCT04213079|363864424|FG001|Overall Study|Lost to Follow-up|2|||
105505904|NCT02193867|363864426|FG000|Overall Study|Death|2|||
105505905|NCT02193867|363864426|FG000|Overall Study|Sponsor Study Termination|2|||
105505906|NCT03616600|363864427|FG000|Overall Study|Withdrawal by Subject|1|||
105505907|NCT03616600|363864428|FG001|Overall Study|Withdrawal by Subject|0|||
105505908|NCT05386680|363864429|FG000|Overall Study|Guardian decision|2|||
105505909|NCT01847274|363864430|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
105505910|NCT01847274|363864431|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
105505911|NCT01847274|363864432|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
105505912|NCT01847274|363864433|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
105505913|NCT01847274|363864434|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
105505914|NCT01847274|363864435|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
105505915|NCT01847274|363864436|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
105505916|NCT01847274|363864437|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
105505917|NCT01847274|363864438|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
105505918|NCT01847274|363864439|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
105505919|NCT01847274|363864440|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
105505920|NCT01847274|363864430|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
105505921|NCT01847274|363864431|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
105505922|NCT01847274|363864432|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
105505923|NCT01847274|363864433|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
105505924|NCT01847274|363864434|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
105505925|NCT01847274|363864435|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
105505926|NCT01847274|363864436|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
105505927|NCT01847274|363864437|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
105505928|NCT01847274|363864438|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
105505929|NCT01847274|363864439|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
105505930|NCT01847274|363864440|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
105505931|NCT01847274|363864430|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
105505932|NCT01847274|363864431|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
105505933|NCT01847274|363864432|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
105505934|NCT01847274|363864433|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
105505935|NCT01847274|363864434|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
105505936|NCT01847274|363864435|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
105505937|NCT01847274|363864436|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
105505938|NCT01847274|363864437|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
105505939|NCT01847274|363864438|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
105505940|NCT01847274|363864439|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
105505941|NCT01847274|363864440|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
105505942|NCT01847274|363864430|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
105505943|NCT01847274|363864431|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
105505944|NCT01847274|363864432|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
105505945|NCT01847274|363864433|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
105505946|NCT01847274|363864434|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
105505947|NCT01847274|363864435|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
105505948|NCT01847274|363864436|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
105505949|NCT01847274|363864437|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
105505950|NCT01847274|363864438|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
105505951|NCT01847274|363864439|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
105505952|NCT01847274|363864440|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
105505953|NCT01847274|363864430|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
105505954|NCT01847274|363864431|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
105505955|NCT01847274|363864432|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
105505956|NCT01847274|363864433|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
105505957|NCT01847274|363864434|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
105505958|NCT01847274|363864435|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
105505959|NCT01847274|363864436|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
105505960|NCT01847274|363864437|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
105505961|NCT01847274|363864438|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
105505962|NCT01847274|363864439|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
105505963|NCT01847274|363864440|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
105505964|NCT01847274|363864430|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
105505965|NCT01847274|363864431|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
105505966|NCT01847274|363864432|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
105505967|NCT01847274|363864433|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
105505968|NCT01847274|363864434|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
105505969|NCT01847274|363864435|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
105505970|NCT01847274|363864436|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
105505971|NCT01847274|363864437|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
105505972|NCT01847274|363864438|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
105505973|NCT01847274|363864439|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
105505974|NCT01847274|363864440|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
105505975|NCT01847274|363864430|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
105505976|NCT01847274|363864431|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
105505977|NCT01847274|363864432|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
105505978|NCT01847274|363864433|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
105505979|NCT01847274|363864434|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
105505980|NCT01847274|363864435|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
105505981|NCT01847274|363864436|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
105505982|NCT01847274|363864437|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
105505983|NCT01847274|363864438|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
105505984|NCT01847274|363864439|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
105505985|NCT01847274|363864440|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
105505986|NCT01847274|363864430|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
105505987|NCT01847274|363864431|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
105505988|NCT01847274|363864432|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
105505989|NCT01847274|363864433|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
105505990|NCT01847274|363864434|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
105505991|NCT01847274|363864435|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
105505992|NCT01847274|363864436|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
105505993|NCT01847274|363864437|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
105505994|NCT01847274|363864438|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
105505995|NCT01847274|363864439|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
105505996|NCT01847274|363864440|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
105505997|NCT01847274|363864430|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
105505998|NCT01847274|363864431|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
105505999|NCT01847274|363864432|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
105506000|NCT01847274|363864433|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
105506001|NCT01847274|363864434|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
105506002|NCT01847274|363864435|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
105506003|NCT01847274|363864436|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
105506004|NCT01847274|363864437|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
105506005|NCT01847274|363864438|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
105506006|NCT01847274|363864439|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
105506007|NCT01847274|363864440|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
105506008|NCT01847274|363864430|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
105506009|NCT01847274|363864431|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
105506010|NCT01847274|363864432|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
105506011|NCT01847274|363864433|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
105506012|NCT01847274|363864434|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
105506013|NCT01847274|363864435|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
105506014|NCT01847274|363864436|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
105506015|NCT01847274|363864437|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
105506016|NCT01847274|363864438|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
105506017|NCT01847274|363864439|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
105506018|NCT01847274|363864440|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
105506019|NCT01847274|363864430|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
105506020|NCT01847274|363864431|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
105506021|NCT01847274|363864432|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
105506022|NCT01847274|363864433|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
105506023|NCT01847274|363864434|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
105506024|NCT01847274|363864435|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
105506025|NCT01847274|363864436|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
105506026|NCT01847274|363864437|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
105506027|NCT01847274|363864438|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
105506028|NCT01847274|363864439|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
105506029|NCT01847274|363864440|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
105506030|NCT01847274|363864430|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
105506031|NCT01847274|363864431|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
105506032|NCT01847274|363864432|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
105506033|NCT01847274|363864433|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
105506034|NCT01847274|363864434|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
105506035|NCT01847274|363864435|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
105506036|NCT01847274|363864436|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
105506037|NCT01847274|363864437|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
105506038|NCT01847274|363864438|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
105506039|NCT01847274|363864439|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
105506040|NCT01847274|363864440|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
105506041|NCT01847274|363864430|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
105506042|NCT01847274|363864431|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
105506043|NCT01847274|363864432|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
105506044|NCT01847274|363864433|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
105506045|NCT01847274|363864434|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
105506046|NCT01847274|363864435|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
105506047|NCT01847274|363864436|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
105506048|NCT01847274|363864437|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
105506049|NCT01847274|363864438|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
105506050|NCT01847274|363864439|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
105506051|NCT01847274|363864440|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
105506052|NCT01847274|363864430|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
105506053|NCT01847274|363864431|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
105506054|NCT01847274|363864432|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
105506055|NCT01847274|363864433|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
105506056|NCT01847274|363864434|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
105506057|NCT01847274|363864435|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
105506058|NCT01847274|363864436|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
105506059|NCT01847274|363864437|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
105506060|NCT01847274|363864438|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
105506061|NCT01847274|363864439|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
105506062|NCT01847274|363864440|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
105506063|NCT01847274|363864430|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
105506064|NCT01847274|363864431|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
105506065|NCT01847274|363864432|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
105506066|NCT01847274|363864433|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
105506067|NCT01847274|363864434|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
105506068|NCT01847274|363864435|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
105506069|NCT01847274|363864436|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
105506070|NCT01847274|363864437|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
105506071|NCT01847274|363864438|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
105506072|NCT01847274|363864439|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
105506073|NCT01847274|363864440|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
105506074|NCT01847274|363864430|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
105506075|NCT01847274|363864431|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
105506076|NCT01847274|363864432|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
105506077|NCT01847274|363864433|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
105506078|NCT01847274|363864434|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
105506079|NCT01847274|363864435|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
105506080|NCT01847274|363864436|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
105506081|NCT01847274|363864437|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
105506082|NCT01847274|363864438|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
105506083|NCT01847274|363864439|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
105506084|NCT01847274|363864440|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
105506085|NCT00601458|363864444|FG000|Overall Study|Dosing Error|1|||
105506086|NCT00601458|363864445|FG001|Overall Study|Dosing Error|0|||
105506087|NCT00601458|363864446|FG002|Overall Study|Dosing Error|0|||
105506088|NCT00601458|363864444|FG000|Overall Study|Incomplete Data|0|||
105506089|NCT00601458|363864445|FG001|Overall Study|Incomplete Data|2|||
105506090|NCT00601458|363864446|FG002|Overall Study|Incomplete Data|0|||
105506091|NCT00601458|363864444|FG000|Overall Study|Protocol Violation|3|||
105506092|NCT00601458|363864445|FG001|Overall Study|Protocol Violation|2|||
105506093|NCT00601458|363864446|FG002|Overall Study|Protocol Violation|1|||
105506094|NCT00601458|363864444|FG000|Overall Study|Early Termination|0|||
105506095|NCT00601458|363864445|FG001|Overall Study|Early Termination|1|||
105506096|NCT00601458|363864446|FG002|Overall Study|Early Termination|1|||
105506097|NCT03982368|363864447|FG000|Overall Study|Adverse Event|6|||
105506098|NCT03982368|363864448|FG001|Overall Study|Adverse Event|4|||
105506099|NCT03982368|363864449|FG002|Overall Study|Adverse Event|3|||
105506100|NCT03982368|363864447|FG000|Overall Study|Lost to Follow-up|2|||
105506101|NCT03982368|363864448|FG001|Overall Study|Lost to Follow-up|1|||
105506102|NCT03982368|363864449|FG002|Overall Study|Lost to Follow-up|0|||
105506103|NCT03982368|363864447|FG000|Overall Study|Withdrawal by Subject|1|||
105506104|NCT03982368|363864448|FG001|Overall Study|Withdrawal by Subject|2|||
105506105|NCT03982368|363864449|FG002|Overall Study|Withdrawal by Subject|0|||
105506106|NCT03982368|363864447|FG000|Overall Study|unknow|4|||
105506107|NCT03982368|363864448|FG001|Overall Study|unknow|0|||
105506108|NCT03982368|363864449|FG002|Overall Study|unknow|2|||
105506109|NCT05229406|363864452|FG000|Overall Study|Withdrawal by Subject|1|||
105590767|NCT04927975|364162699|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
105590768|NCT04927975|364162700|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
105506110|NCT05229406|363864453|FG001|Overall Study|Withdrawal by Subject|2|||
105506111|NCT01697566|363864457|FG000|Overall Study|Withdrawal by Subject|0|||
105506112|NCT01697566|363864458|FG001|Overall Study|Withdrawal by Subject|0|||
105506113|NCT01697566|363864459|FG002|Overall Study|Withdrawal by Subject|1|||
105506114|NCT01697566|363864460|FG003|Overall Study|Withdrawal by Subject|1|||
105506115|NCT01697566|363864457|FG000|Overall Study|Final biopsy not obtained|0|||
105506116|NCT01697566|363864458|FG001|Overall Study|Final biopsy not obtained|0|||
105506117|NCT01697566|363864459|FG002|Overall Study|Final biopsy not obtained|1|||
105506118|NCT01697566|363864460|FG003|Overall Study|Final biopsy not obtained|0|||
105506119|NCT03095612|363864461|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
105506120|NCT03095612|363864462|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
105506121|NCT03095612|363864463|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
105506122|NCT03095612|363864464|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
105506123|NCT03095612|363864465|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
105506124|NCT03095612|363864466|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
105506125|NCT03095612|363864467|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
105506126|NCT00036270|363864472|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
105506127|NCT00036270|363864473|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
105506128|NCT00036270|363864472|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
105506129|NCT00036270|363864473|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
105506130|NCT00036270|363864472|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
105506131|NCT00036270|363864473|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
105506132|NCT00036270|363864472|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
105506133|NCT00036270|363864473|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
105506134|NCT00036270|363864472|FG000|Study Treatment to 5 Year Report|Other|277|||
105506135|NCT00036270|363864473|FG001|Study Treatment to 5 Year Report|Other|288|||
105506136|NCT00036270|363864472|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
105506137|NCT00036270|363864473|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
105506138|NCT00036270|363864472|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
105506139|NCT00036270|363864473|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
105506140|NCT00036270|363864472|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
105506141|NCT00036270|363864473|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
105506142|NCT00036270|363864472|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
105506143|NCT00036270|363864473|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
105506144|NCT00036270|363864472|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
105506145|NCT00036270|363864473|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
105506146|NCT00036270|363864472|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
105506147|NCT00036270|363864473|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
105506148|NCT02591290|363864478|FG000|Overall Study|Withdrawal by Subject|2|||
105506149|NCT02516163|363864479|FG000|Overall Study|Withdrawal by Subject|1|||
105506150|NCT02516163|363864479|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
105506151|NCT02516163|363864479|FG000|Overall Study|Unfit/delay in surgery|3|||
105506152|NCT02516163|363864479|FG000|Overall Study|Use of incorrect measurement technique|5|||
105506153|NCT02516163|363864479|FG000|Overall Study|Data not recorded|2|||
105506154|NCT02516163|363864479|FG000|Overall Study|MRI contraindication exclusion|6|||
105506155|NCT01370356|363864484|FG000|Overall Study|Death|1|||
105506156|NCT01370356|363864485|FG001|Overall Study|Death|0|||
105506157|NCT01370356|363864484|FG000|Overall Study|Lack of Efficacy|6|||
105506158|NCT01370356|363864485|FG001|Overall Study|Lack of Efficacy|28|||
105506159|NCT01370356|363864484|FG000|Overall Study|Lost to Follow-up|76|||
105506160|NCT01370356|363864485|FG001|Overall Study|Lost to Follow-up|81|||
105506161|NCT01370356|363864484|FG000|Overall Study|Withdrawal by Subject|54|||
105506162|NCT01370356|363864485|FG001|Overall Study|Withdrawal by Subject|59|||
105506163|NCT01370356|363864484|FG000|Overall Study|Reason not specified|39|||
105506164|NCT01370356|363864485|FG001|Overall Study|Reason not specified|43|||
105506165|NCT01370356|363864484|FG000|Overall Study|Protocol Violation|3|||
105506166|NCT01370356|363864485|FG001|Overall Study|Protocol Violation|3|||
105506167|NCT01370356|363864484|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
105506168|NCT01370356|363864485|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
105506169|NCT01370356|363864484|FG000|Overall Study|AE Not Related to Study Drug|1|||
105506170|NCT01370356|363864485|FG001|Overall Study|AE Not Related to Study Drug|4|||
105506171|NCT00205881|363864486|FG000|Overall Study|Withdrawal by Subject|16|||
105506172|NCT01658072|363864493|FG000|Overall Study|Protocol Violation|4|||
105506173|NCT01658072|363864494|FG001|Overall Study|Protocol Violation|2|||
105506174|NCT02243696|363864506|FG000|Overall Study|Death|282|||
105506175|NCT02243696|363864506|FG000|Overall Study|Withdrawal by Subject|79|||
105506176|NCT02243696|363864506|FG000|Overall Study|Lost to Follow-up|57|||
105506177|NCT02243696|363864506|FG000|Overall Study|Subject No Longer has Study System|42|||
105506178|NCT02243696|363864506|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
105506179|NCT02243696|363864506|FG000|Overall Study|Study Terminated for EP PASSION|961|||
105506180|NCT00622284|363864507|FG000|Overall Study|Lack of Efficacy|45|||
105506181|NCT00622284|363864508|FG001|Overall Study|Lack of Efficacy|15|||
105506182|NCT00622284|363864507|FG000|Overall Study|Adverse Event|61|||
105506183|NCT00622284|363864508|FG001|Overall Study|Adverse Event|90|||
105506184|NCT00622284|363864507|FG000|Overall Study|Protocol Violation|12|||
105506185|NCT00622284|363864508|FG001|Overall Study|Protocol Violation|5|||
105506186|NCT00622284|363864507|FG000|Overall Study|Lost to Follow-up|11|||
105506187|NCT00622284|363864508|FG001|Overall Study|Lost to Follow-up|13|||
105506188|NCT00622284|363864507|FG000|Overall Study|Withdrawal by Subject|27|||
105506189|NCT00622284|363864508|FG001|Overall Study|Withdrawal by Subject|24|||
105506190|NCT00622284|363864507|FG000|Overall Study|Other reason (not specified)|33|||
105506191|NCT00622284|363864508|FG001|Overall Study|Other reason (not specified)|24|||
105506192|NCT01844518|363864514|FG000|Overall Study|Adverse Event|7|||
105506193|NCT01844518|363864515|FG001|Overall Study|Adverse Event|1|||
105506194|NCT01844518|363864514|FG000|Overall Study|Lack of Efficacy|17|||
105506195|NCT01844518|363864515|FG001|Overall Study|Lack of Efficacy|5|||
105506196|NCT01844518|363864514|FG000|Overall Study|Participant's request to discontinue|4|||
105506197|NCT01844518|363864515|FG001|Overall Study|Participant's request to discontinue|1|||
105506198|NCT01844518|363864514|FG000|Overall Study|Poor/Non-compliance|1|||
105506199|NCT01844518|363864515|FG001|Overall Study|Poor/Non-compliance|0|||
105506200|NCT01844518|363864514|FG000|Overall Study|No Longer Met Study Criteria|2|||
105506201|NCT01844518|363864515|FG001|Overall Study|No Longer Met Study Criteria|0|||
105506202|NCT01844518|363864514|FG000|Overall Study|Withdrawal by Subject|9|||
105506203|NCT01844518|363864515|FG001|Overall Study|Withdrawal by Subject|0|||
105506204|NCT01844518|363864514|FG000|Overall Study|Pregnancy|1|||
105506205|NCT01844518|363864515|FG001|Overall Study|Pregnancy|0|||
105506206|NCT02010775|363864516|FG000|Overall Study|Adverse Event|0|||
105506207|NCT02010775|363864517|FG001|Overall Study|Adverse Event|0|||
105506208|NCT02010775|363864518|FG002|Overall Study|Adverse Event|0|||
105506209|NCT02010775|363864519|FG003|Overall Study|Adverse Event|0|||
105506210|NCT02010775|363864520|FG004|Overall Study|Adverse Event|1|||
105506211|NCT02010775|363864516|FG000|Overall Study|Pregnancy|0|||
105506212|NCT02010775|363864517|FG001|Overall Study|Pregnancy|0|||
105506213|NCT02010775|363864518|FG002|Overall Study|Pregnancy|2|||
105506214|NCT02010775|363864519|FG003|Overall Study|Pregnancy|0|||
105506215|NCT02010775|363864520|FG004|Overall Study|Pregnancy|0|||
105506216|NCT02010775|363864516|FG000|Overall Study|Lost to Follow-up|2|||
105506217|NCT02010775|363864517|FG001|Overall Study|Lost to Follow-up|0|||
105506218|NCT02010775|363864518|FG002|Overall Study|Lost to Follow-up|0|||
105506219|NCT02010775|363864519|FG003|Overall Study|Lost to Follow-up|1|||
105506220|NCT02010775|363864520|FG004|Overall Study|Lost to Follow-up|1|||
105506221|NCT02010775|363864516|FG000|Overall Study|Personal Reasons|3|||
105506222|NCT02010775|363864517|FG001|Overall Study|Personal Reasons|3|||
105506223|NCT02010775|363864518|FG002|Overall Study|Personal Reasons|1|||
105506224|NCT02010775|363864519|FG003|Overall Study|Personal Reasons|2|||
105506225|NCT02010775|363864520|FG004|Overall Study|Personal Reasons|4|||
105506226|NCT00256750|363864521|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
105506227|NCT00256750|363864522|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
105506228|NCT00256750|363864523|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
105506229|NCT00256750|363864521|FG000|Transplanted Pre-Treatment|Other|2|||
105506230|NCT00256750|363864522|FG001|Transplanted Pre-Treatment|Other|0|||
105506231|NCT00256750|363864523|FG002|Transplanted Pre-Treatment|Other|0|||
105506232|NCT00256750|363864521|FG000|Transplanted Pre-Treatment|Death|1|||
105506233|NCT00256750|363864522|FG001|Transplanted Pre-Treatment|Death|0|||
105506234|NCT00256750|363864523|FG002|Transplanted Pre-Treatment|Death|0|||
105506235|NCT00256750|363864521|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
105506236|NCT00256750|363864522|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
105506237|NCT00256750|363864523|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
105506238|NCT00256750|363864521|FG000|Post-Transplant Treated (12 Months)|Death|3|||
105506239|NCT00256750|363864522|FG001|Post-Transplant Treated (12 Months)|Death|2|||
105506240|NCT00256750|363864523|FG002|Post-Transplant Treated (12 Months)|Death|4|||
105506241|NCT00256750|363864521|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
105506242|NCT00256750|363864522|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
105506243|NCT00256750|363864523|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
105506244|NCT00256750|363864521|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
105506245|NCT00256750|363864522|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
105590769|NCT04927975|364162701|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
105506246|NCT00256750|363864523|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
105506247|NCT00256750|363864521|FG000|Post-Transplant Treated (12 Months)|Other|5|||
105506248|NCT00256750|363864522|FG001|Post-Transplant Treated (12 Months)|Other|4|||
105506249|NCT00256750|363864523|FG002|Post-Transplant Treated (12 Months)|Other|2|||
105506250|NCT00256750|363864521|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
105506251|NCT00256750|363864522|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
105506252|NCT00256750|363864523|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
105506253|NCT00256750|363864521|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
105506254|NCT00256750|363864522|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
105506255|NCT00256750|363864523|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
105506256|NCT00256750|363864521|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
105506257|NCT00256750|363864522|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
105506258|NCT00256750|363864523|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
105506259|NCT00256750|363864521|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
105506260|NCT00256750|363864522|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
105506261|NCT00256750|363864523|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
105506262|NCT00256750|363864521|FG000|Post-Transplant Treated (24 Months)|Death|3|||
105506263|NCT00256750|363864522|FG001|Post-Transplant Treated (24 Months)|Death|0|||
105506264|NCT00256750|363864523|FG002|Post-Transplant Treated (24 Months)|Death|0|||
105506265|NCT00256750|363864521|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
105506266|NCT00256750|363864522|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
105506267|NCT00256750|363864523|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
105506268|NCT00256750|363864521|FG000|Post-Transplant Treated (24 Months)|Other|2|||
105506269|NCT00256750|363864522|FG001|Post-Transplant Treated (24 Months)|Other|0|||
105506270|NCT00256750|363864523|FG002|Post-Transplant Treated (24 Months)|Other|1|||
105506271|NCT00256750|363864521|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
105506272|NCT00256750|363864522|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
105506273|NCT00256750|363864523|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
105506274|NCT00256750|363864521|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
105506275|NCT00256750|363864522|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
105506276|NCT00256750|363864523|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
105506277|NCT00256750|363864521|FG000|Post-Transplant Treated (36 Months)|Death|0|||
105506278|NCT00256750|363864522|FG001|Post-Transplant Treated (36 Months)|Death|2|||
105506279|NCT00256750|363864523|FG002|Post-Transplant Treated (36 Months)|Death|1|||
105506280|NCT00256750|363864521|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
105506281|NCT00256750|363864522|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
105506282|NCT00256750|363864523|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
105506283|NCT00256750|363864521|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
105506284|NCT00256750|363864522|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
105506285|NCT00256750|363864523|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
105506286|NCT00256750|363864521|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
105506287|NCT00256750|363864522|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
105506288|NCT00256750|363864523|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
105506289|NCT00256750|363864521|FG000|Post-Transplant Treated (36 Months)|Other|0|||
105506290|NCT00256750|363864522|FG001|Post-Transplant Treated (36 Months)|Other|1|||
105506291|NCT00256750|363864523|FG002|Post-Transplant Treated (36 Months)|Other|1|||
105506292|NCT00256750|363864521|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
105506293|NCT00256750|363864522|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
105506294|NCT00256750|363864523|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
105506295|NCT00256750|363864521|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
105506296|NCT00256750|363864522|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
105506297|NCT00256750|363864523|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
105506298|NCT00256750|363864521|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
105506299|NCT00256750|363864522|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
105506300|NCT00256750|363864523|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
105506301|NCT00256750|363864521|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
105506302|NCT00256750|363864522|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
105506303|NCT00256750|363864523|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
105506304|NCT00256750|363864521|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
105506305|NCT00256750|363864522|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
105506306|NCT00256750|363864523|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
105506307|NCT00256750|363864521|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
105506308|NCT00256750|363864522|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
105506309|NCT00256750|363864523|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
105506310|NCT00256750|363864521|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
105506311|NCT00256750|363864522|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
105506312|NCT00256750|363864523|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
105506313|NCT00256750|363864521|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
105506314|NCT00256750|363864522|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
105506315|NCT00256750|363864523|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
105506316|NCT00256750|363864521|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
105506317|NCT00256750|363864522|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
105506318|NCT00256750|363864523|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
105506319|NCT00074152|363864524|FG000|Overall Study|Death|21|||
105506320|NCT00074152|363864525|FG001|Overall Study|Death|9|||
105506321|NCT00074152|363864524|FG000|Overall Study|Lack of Efficacy|34|||
105506322|NCT00074152|363864525|FG001|Overall Study|Lack of Efficacy|24|||
105506323|NCT02006719|363864526|FG000|Overall Study|Withdrawal by Subject|10|||
105506324|NCT02006719|363864527|FG001|Overall Study|Withdrawal by Subject|2|||
105506325|NCT02006719|363864526|FG000|Overall Study|Lost to Follow-up|5|||
105506326|NCT02006719|363864527|FG001|Overall Study|Lost to Follow-up|1|||
105506327|NCT02006719|363864526|FG000|Overall Study|Protocol Violation|2|||
105506328|NCT02006719|363864527|FG001|Overall Study|Protocol Violation|0|||
105506329|NCT02006719|363864526|FG000|Overall Study|Adverse Event|1|||
105506330|NCT02006719|363864527|FG001|Overall Study|Adverse Event|1|||
105506331|NCT02006719|363864526|FG000|Overall Study|Other/Unknown|0|||
105506332|NCT02006719|363864527|FG001|Overall Study|Other/Unknown|1|||
105506333|NCT03547583|363864528|FG000|Overall Study|Adverse Event|16|||
105506334|NCT03547583|363864529|FG001|Overall Study|Adverse Event|11|||
105506335|NCT03547583|363864530|FG002|Overall Study|Adverse Event|10|||
105506336|NCT03547583|363864528|FG000|Overall Study|Death|11|||
105506337|NCT03547583|363864529|FG001|Overall Study|Death|7|||
105506338|NCT03547583|363864530|FG002|Overall Study|Death|4|||
105506339|NCT03547583|363864528|FG000|Overall Study|Lost to Follow-up|1|||
105506340|NCT03547583|363864529|FG001|Overall Study|Lost to Follow-up|0|||
105506341|NCT03547583|363864530|FG002|Overall Study|Lost to Follow-up|0|||
105506342|NCT03547583|363864528|FG000|Overall Study|Non-compliance with study drug|0|||
105506343|NCT03547583|363864529|FG001|Overall Study|Non-compliance with study drug|0|||
105506344|NCT03547583|363864530|FG002|Overall Study|Non-compliance with study drug|1|||
105506345|NCT03547583|363864528|FG000|Overall Study|Physician Decision|1|||
105506346|NCT03547583|363864529|FG001|Overall Study|Physician Decision|0|||
105506347|NCT03547583|363864530|FG002|Overall Study|Physician Decision|3|||
105506348|NCT03547583|363864528|FG000|Overall Study|Protocol Violation|2|||
105506349|NCT03547583|363864529|FG001|Overall Study|Protocol Violation|1|||
105506350|NCT03547583|363864530|FG002|Overall Study|Protocol Violation|1|||
105506351|NCT03547583|363864528|FG000|Overall Study|Withdrawal by Subject|12|||
105506352|NCT03547583|363864529|FG001|Overall Study|Withdrawal by Subject|19|||
105506353|NCT03547583|363864530|FG002|Overall Study|Withdrawal by Subject|10|||
105506354|NCT03547583|363864528|FG000|Overall Study|Other|2|||
105506355|NCT03547583|363864529|FG001|Overall Study|Other|2|||
105506356|NCT03547583|363864530|FG002|Overall Study|Other|3|||
105506357|NCT00382252|363864531|FG000|Overall Study|Death|4|||
105506358|NCT00382252|363864531|FG000|Overall Study|Protocol Violation|8|||
105506359|NCT00382252|363864531|FG000|Overall Study|Not treated by RFA|1|||
105506360|NCT01737697|363864534|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
105506361|NCT01737697|363864535|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
105506362|NCT01737697|363864536|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
105506363|NCT01737697|363864537|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
105506364|NCT01737697|363864538|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
105506365|NCT01737697|363864539|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
105506366|NCT01737697|363864540|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
105506367|NCT01737697|363864541|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
105506368|NCT01737697|363864542|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
105506369|NCT01737697|363864543|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
105506370|NCT01737697|363864544|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
105506371|NCT01737697|363864545|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
105506372|NCT01737697|363864546|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
105506373|NCT01737697|363864547|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
105506374|NCT01737697|363864548|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
105506375|NCT01737697|363864534|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
105506376|NCT01737697|363864535|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
105506377|NCT01737697|363864536|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
105506378|NCT01737697|363864537|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
105506379|NCT01737697|363864538|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
105506380|NCT01737697|363864539|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
105506381|NCT01737697|363864540|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
105506382|NCT01737697|363864541|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
105506383|NCT01737697|363864542|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
105506384|NCT01737697|363864543|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
105506385|NCT01737697|363864544|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
105506386|NCT01737697|363864545|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
105506387|NCT01737697|363864546|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
105506388|NCT01737697|363864547|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
105506389|NCT01737697|363864548|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
105506390|NCT01737697|363864534|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
105506391|NCT01737697|363864535|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
105506392|NCT01737697|363864536|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
105506393|NCT01737697|363864537|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
105506394|NCT01737697|363864538|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
105506395|NCT01737697|363864539|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
105506396|NCT01737697|363864540|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
105506397|NCT01737697|363864541|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
105506398|NCT01737697|363864542|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
105506399|NCT01737697|363864543|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
105506400|NCT01737697|363864544|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
105506401|NCT01737697|363864545|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
105506402|NCT01737697|363864546|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
105506403|NCT01737697|363864547|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
105506404|NCT01737697|363864548|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
105506405|NCT01737697|363864534|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
105506406|NCT01737697|363864535|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
105506407|NCT01737697|363864536|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
105506408|NCT01737697|363864537|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
105506409|NCT01737697|363864538|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
105506410|NCT01737697|363864539|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
105506411|NCT01737697|363864540|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
105506412|NCT01737697|363864541|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
105506413|NCT01737697|363864542|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
105506414|NCT01737697|363864543|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
105506415|NCT01737697|363864544|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
105506416|NCT01737697|363864545|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
105506417|NCT01737697|363864546|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
105506418|NCT01737697|363864547|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
105506419|NCT01737697|363864548|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
105506420|NCT01737697|363864534|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
105506421|NCT01737697|363864535|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
105506422|NCT01737697|363864536|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
105506423|NCT01737697|363864537|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
105506424|NCT01737697|363864538|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
105506425|NCT01737697|363864539|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
105506426|NCT01737697|363864540|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
105506427|NCT01737697|363864541|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
105506428|NCT01737697|363864542|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
105506429|NCT01737697|363864543|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
105506430|NCT01737697|363864544|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
105506431|NCT01737697|363864545|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
105506432|NCT01737697|363864546|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
105506433|NCT01737697|363864547|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
105506434|NCT01737697|363864548|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
105506435|NCT01737697|363864534|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
105506436|NCT01737697|363864535|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
105506437|NCT01737697|363864536|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
105506438|NCT01737697|363864537|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
105506439|NCT01737697|363864538|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
105506440|NCT01737697|363864539|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
105506441|NCT01737697|363864540|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
105506442|NCT01737697|363864541|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
105506443|NCT01737697|363864542|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
105506444|NCT01737697|363864543|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
105506445|NCT01737697|363864544|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
105506446|NCT01737697|363864545|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
105506447|NCT01737697|363864546|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
105506448|NCT01737697|363864547|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
105506449|NCT01737697|363864548|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
105506450|NCT01737697|363864534|FG000|Subacute Phase|Adverse Event|0|||
105506451|NCT01737697|363864535|FG001|Subacute Phase|Adverse Event|0|||
105506452|NCT01737697|363864536|FG002|Subacute Phase|Adverse Event|0|||
105506453|NCT01737697|363864537|FG003|Subacute Phase|Adverse Event|0|||
105506454|NCT01737697|363864538|FG004|Subacute Phase|Adverse Event|0|||
105506455|NCT01737697|363864539|FG005|Subacute Phase|Adverse Event|1|||
105506456|NCT01737697|363864540|FG006|Subacute Phase|Adverse Event|1|||
105506457|NCT01737697|363864541|FG007|Subacute Phase|Adverse Event|1|||
105506458|NCT01737697|363864542|FG008|Subacute Phase|Adverse Event|1|||
105506459|NCT01737697|363864543|FG009|Subacute Phase|Adverse Event|1|||
105506460|NCT01737697|363864544|FG010|Subacute Phase|Adverse Event|4|||
105506461|NCT01737697|363864545|FG011|Subacute Phase|Adverse Event|1|||
105506462|NCT01737697|363864546|FG012|Subacute Phase|Adverse Event|1|||
105506463|NCT01737697|363864547|FG013|Subacute Phase|Adverse Event|0|||
105506464|NCT01737697|363864548|FG014|Subacute Phase|Adverse Event|0|||
105506465|NCT01737697|363864534|FG000|Subacute Phase|Withdrawal by Subject|0|||
105506466|NCT01737697|363864535|FG001|Subacute Phase|Withdrawal by Subject|0|||
105506467|NCT01737697|363864536|FG002|Subacute Phase|Withdrawal by Subject|0|||
105506468|NCT01737697|363864537|FG003|Subacute Phase|Withdrawal by Subject|0|||
105506469|NCT01737697|363864538|FG004|Subacute Phase|Withdrawal by Subject|0|||
105506470|NCT01737697|363864539|FG005|Subacute Phase|Withdrawal by Subject|1|||
105506471|NCT01737697|363864540|FG006|Subacute Phase|Withdrawal by Subject|0|||
105506472|NCT01737697|363864541|FG007|Subacute Phase|Withdrawal by Subject|2|||
105506473|NCT01737697|363864542|FG008|Subacute Phase|Withdrawal by Subject|0|||
105506474|NCT01737697|363864543|FG009|Subacute Phase|Withdrawal by Subject|1|||
105506475|NCT01737697|363864544|FG010|Subacute Phase|Withdrawal by Subject|0|||
105506476|NCT01737697|363864545|FG011|Subacute Phase|Withdrawal by Subject|1|||
105506477|NCT01737697|363864546|FG012|Subacute Phase|Withdrawal by Subject|1|||
105506478|NCT01737697|363864547|FG013|Subacute Phase|Withdrawal by Subject|1|||
105506479|NCT01737697|363864548|FG014|Subacute Phase|Withdrawal by Subject|0|||
105506480|NCT01737697|363864534|FG000|Subacute Phase|Lost to Follow-up|0|||
105506481|NCT01737697|363864535|FG001|Subacute Phase|Lost to Follow-up|0|||
105506482|NCT01737697|363864536|FG002|Subacute Phase|Lost to Follow-up|0|||
105506483|NCT01737697|363864537|FG003|Subacute Phase|Lost to Follow-up|0|||
105506484|NCT01737697|363864538|FG004|Subacute Phase|Lost to Follow-up|0|||
105506485|NCT01737697|363864539|FG005|Subacute Phase|Lost to Follow-up|0|||
105506486|NCT01737697|363864540|FG006|Subacute Phase|Lost to Follow-up|0|||
105506487|NCT01737697|363864541|FG007|Subacute Phase|Lost to Follow-up|0|||
105506488|NCT01737697|363864542|FG008|Subacute Phase|Lost to Follow-up|0|||
105506489|NCT01737697|363864543|FG009|Subacute Phase|Lost to Follow-up|0|||
105506490|NCT01737697|363864544|FG010|Subacute Phase|Lost to Follow-up|0|||
105506491|NCT01737697|363864545|FG011|Subacute Phase|Lost to Follow-up|0|||
105506492|NCT01737697|363864546|FG012|Subacute Phase|Lost to Follow-up|0|||
105506493|NCT01737697|363864547|FG013|Subacute Phase|Lost to Follow-up|0|||
105506494|NCT01737697|363864548|FG014|Subacute Phase|Lost to Follow-up|1|||
105506495|NCT01737697|363864534|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
105506496|NCT01737697|363864535|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
105506497|NCT01737697|363864536|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
105506498|NCT01737697|363864537|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
105506499|NCT01737697|363864538|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
105506500|NCT01737697|363864539|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
105506501|NCT01737697|363864540|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
105506502|NCT01737697|363864541|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
105506503|NCT01737697|363864542|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
105506504|NCT01737697|363864543|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
105506505|NCT01737697|363864544|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
105506506|NCT01737697|363864545|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
105506507|NCT01737697|363864546|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
105506508|NCT01737697|363864547|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
105506509|NCT01737697|363864548|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
105506510|NCT01737697|363864534|FG000|Subacute Phase|Protocol Violation|0|||
105506511|NCT01737697|363864535|FG001|Subacute Phase|Protocol Violation|0|||
105506512|NCT01737697|363864536|FG002|Subacute Phase|Protocol Violation|0|||
105506513|NCT01737697|363864537|FG003|Subacute Phase|Protocol Violation|0|||
105506514|NCT01737697|363864538|FG004|Subacute Phase|Protocol Violation|0|||
105506515|NCT01737697|363864539|FG005|Subacute Phase|Protocol Violation|1|||
105506516|NCT01737697|363864540|FG006|Subacute Phase|Protocol Violation|0|||
105506517|NCT01737697|363864541|FG007|Subacute Phase|Protocol Violation|0|||
105506518|NCT01737697|363864542|FG008|Subacute Phase|Protocol Violation|0|||
105506519|NCT01737697|363864543|FG009|Subacute Phase|Protocol Violation|0|||
105506520|NCT01737697|363864544|FG010|Subacute Phase|Protocol Violation|1|||
105506521|NCT01737697|363864545|FG011|Subacute Phase|Protocol Violation|0|||
105506522|NCT01737697|363864546|FG012|Subacute Phase|Protocol Violation|0|||
105506523|NCT01737697|363864547|FG013|Subacute Phase|Protocol Violation|0|||
105506524|NCT01737697|363864548|FG014|Subacute Phase|Protocol Violation|0|||
105506525|NCT01737697|363864534|FG000|Subacute Phase|Physician Decision|0|||
105506526|NCT01737697|363864535|FG001|Subacute Phase|Physician Decision|0|||
105506527|NCT01737697|363864536|FG002|Subacute Phase|Physician Decision|0|||
105506528|NCT01737697|363864537|FG003|Subacute Phase|Physician Decision|0|||
105506529|NCT01737697|363864538|FG004|Subacute Phase|Physician Decision|0|||
105506530|NCT01737697|363864539|FG005|Subacute Phase|Physician Decision|0|||
105506531|NCT01737697|363864540|FG006|Subacute Phase|Physician Decision|0|||
105506532|NCT01737697|363864541|FG007|Subacute Phase|Physician Decision|0|||
105506533|NCT01737697|363864542|FG008|Subacute Phase|Physician Decision|1|||
105506534|NCT01737697|363864543|FG009|Subacute Phase|Physician Decision|0|||
105506535|NCT01737697|363864544|FG010|Subacute Phase|Physician Decision|0|||
105506536|NCT01737697|363864545|FG011|Subacute Phase|Physician Decision|0|||
105506537|NCT01737697|363864546|FG012|Subacute Phase|Physician Decision|0|||
105506538|NCT01737697|363864547|FG013|Subacute Phase|Physician Decision|0|||
105506539|NCT01737697|363864548|FG014|Subacute Phase|Physician Decision|0|||
105506540|NCT01737697|363864534|FG000|Subacute Phase|Death|0|||
105506541|NCT01737697|363864535|FG001|Subacute Phase|Death|0|||
105506542|NCT01737697|363864536|FG002|Subacute Phase|Death|0|||
105506543|NCT01737697|363864537|FG003|Subacute Phase|Death|0|||
105506544|NCT01737697|363864538|FG004|Subacute Phase|Death|0|||
105506545|NCT01737697|363864539|FG005|Subacute Phase|Death|0|||
105506546|NCT01737697|363864540|FG006|Subacute Phase|Death|0|||
105506547|NCT01737697|363864541|FG007|Subacute Phase|Death|0|||
105506548|NCT01737697|363864542|FG008|Subacute Phase|Death|0|||
105506549|NCT01737697|363864543|FG009|Subacute Phase|Death|0|||
105506550|NCT01737697|363864544|FG010|Subacute Phase|Death|1|||
105506551|NCT01737697|363864545|FG011|Subacute Phase|Death|0|||
105506552|NCT01737697|363864546|FG012|Subacute Phase|Death|0|||
105506553|NCT01737697|363864547|FG013|Subacute Phase|Death|0|||
105506554|NCT01737697|363864548|FG014|Subacute Phase|Death|0|||
105506555|NCT05570500|363864555|FG000|Overall Study|Lost to Follow-up|7|||
105506556|NCT05570500|363864556|FG001|Overall Study|Lost to Follow-up|5|||
105506557|NCT01063868|363864557|FG000|Overall Study|Adverse Event|9|||
105506558|NCT01063868|363864558|FG001|Overall Study|Adverse Event|7|||
105506559|NCT01063868|363864557|FG000|Overall Study|Withdrawal by Subject|3|||
105506560|NCT01063868|363864558|FG001|Overall Study|Withdrawal by Subject|1|||
105506561|NCT01063868|363864557|FG000|Overall Study|Study Terminated By Sponsor|23|||
105506562|NCT01063868|363864558|FG001|Overall Study|Study Terminated By Sponsor|4|||
105506563|NCT04292743|363864559|FG000|Overall Study|Physician Decision|1|||
105506564|NCT04292743|363864560|FG001|Overall Study|Physician Decision|3|||
105506565|NCT04292743|363864561|FG002|Overall Study|Physician Decision|0|||
105506566|NCT04292743|363864562|FG003|Overall Study|Physician Decision|0|||
105506567|NCT04292743|363864559|FG000|Overall Study|Withdrawal by Subject|0|||
105506568|NCT04292743|363864560|FG001|Overall Study|Withdrawal by Subject|5|||
105506569|NCT04292743|363864561|FG002|Overall Study|Withdrawal by Subject|0|||
105506570|NCT04292743|363864562|FG003|Overall Study|Withdrawal by Subject|0|||
105506571|NCT04292743|363864559|FG000|Overall Study|Death|0|||
105506572|NCT04292743|363864560|FG001|Overall Study|Death|1|||
105506573|NCT04292743|363864561|FG002|Overall Study|Death|0|||
105506574|NCT04292743|363864562|FG003|Overall Study|Death|0|||
105506575|NCT04292743|363864559|FG000|Overall Study|Progression of Disease|2|||
105506576|NCT04292743|363864560|FG001|Overall Study|Progression of Disease|5|||
105506577|NCT04292743|363864561|FG002|Overall Study|Progression of Disease|0|||
105506578|NCT04292743|363864562|FG003|Overall Study|Progression of Disease|0|||
105506579|NCT04292743|363864559|FG000|Overall Study|No Treatment per protocol|0|||
105506580|NCT04292743|363864560|FG001|Overall Study|No Treatment per protocol|2|||
105506581|NCT04292743|363864561|FG002|Overall Study|No Treatment per protocol|0|||
105506582|NCT04292743|363864562|FG003|Overall Study|No Treatment per protocol|0|||
105506583|NCT05425745|363864563|FG000|Overall Study|Withdrawal of Consent|3|||
105506584|NCT05425745|363864564|FG001|Overall Study|Withdrawal of Consent|3|||
105506585|NCT05425745|363864563|FG000|Overall Study|Death|2|||
105506586|NCT05425745|363864564|FG001|Overall Study|Death|3|||
105506587|NCT05425745|363864563|FG000|Overall Study|Lost to Follow-up|1|||
105506588|NCT05425745|363864564|FG001|Overall Study|Lost to Follow-up|2|||
105506589|NCT05425745|363864563|FG000|Overall Study|Adverse Event|0|||
105506590|NCT05425745|363864564|FG001|Overall Study|Adverse Event|1|||
105506591|NCT05425745|363864563|FG000|Overall Study|Did not return for end of study visit|0|||
105506592|NCT05425745|363864564|FG001|Overall Study|Did not return for end of study visit|1|||
105506593|NCT05425745|363864563|FG000|Overall Study|End of study visit completed by phone|1|||
105506594|NCT05425745|363864564|FG001|Overall Study|End of study visit completed by phone|0|||
105506595|NCT05425745|363864563|FG000|Overall Study|Subject decision|1|||
105506596|NCT05425745|363864564|FG001|Overall Study|Subject decision|0|||
105506597|NCT02370160|363867381|FG000|Overall Study|Death|3|||
105506598|NCT02370160|363867382|FG001|Overall Study|Death|4|||
105506599|NCT02370160|363867383|FG002|Overall Study|Death|1|||
105506600|NCT02871297|363867388|FG000|Overall Study|Adverse Event|34|||
105506601|NCT02871297|363867388|FG000|Overall Study|Lack of Efficacy|10|||
105506602|NCT02871297|363867388|FG000|Overall Study|Non-compliance with study drug|15|||
105506603|NCT02871297|363867388|FG000|Overall Study|Protocol Violation|3|||
105506604|NCT02871297|363867388|FG000|Overall Study|Withdrawal by Subject|20|||
105506605|NCT02871297|363867388|FG000|Overall Study|Lost to Follow-up|13|||
105506606|NCT02871297|363867388|FG000|Overall Study|Rolled over to 13546A|2|||
105506607|NCT02871297|363867388|FG000|Overall Study|Other than specified|39|||
105506608|NCT04115839|363867394|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
105506609|NCT04115839|363867395|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
105506610|NCT04115839|363867396|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
105506611|NCT04115839|363867397|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
105506612|NCT04115839|363867398|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
105506613|NCT04115839|363867399|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
105506614|NCT04115839|363867400|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
105506615|NCT04115839|363867394|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
105506616|NCT04115839|363867395|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
105506617|NCT04115839|363867396|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
105506618|NCT04115839|363867397|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
105506619|NCT04115839|363867398|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
105506620|NCT04115839|363867399|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
105506621|NCT04115839|363867400|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
105506622|NCT04115839|363867394|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
105506623|NCT04115839|363867395|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
105506624|NCT04115839|363867396|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
105506625|NCT04115839|363867397|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
105506626|NCT04115839|363867398|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
105506627|NCT04115839|363867399|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
105506628|NCT04115839|363867400|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
105506629|NCT04115839|363867394|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
105506630|NCT04115839|363867395|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
105506631|NCT04115839|363867396|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
105506632|NCT04115839|363867397|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
105506633|NCT04115839|363867398|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
105506634|NCT04115839|363867399|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
105506635|NCT04115839|363867400|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
105506636|NCT04115839|363867394|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
105506637|NCT04115839|363867395|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
105506638|NCT04115839|363867396|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
105506639|NCT04115839|363867397|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
105506640|NCT04115839|363867398|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
105506641|NCT04115839|363867399|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
105506642|NCT04115839|363867400|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
105506643|NCT04115839|363867394|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
105506644|NCT04115839|363867395|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
105506645|NCT04115839|363867396|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
105506646|NCT04115839|363867397|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
105506647|NCT04115839|363867398|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
105506648|NCT04115839|363867399|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
105506649|NCT04115839|363867400|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
105506650|NCT02034110|363867401|FG000|Overall Study|Physician Decision|0|||
105506651|NCT02034110|363867402|FG001|Overall Study|Physician Decision|0|||
105506652|NCT02034110|363867403|FG002|Overall Study|Physician Decision|0|||
105506653|NCT02034110|363867404|FG003|Overall Study|Physician Decision|0|||
105506654|NCT02034110|363867405|FG004|Overall Study|Physician Decision|2|||
105506655|NCT02034110|363867406|FG005|Overall Study|Physician Decision|0|||
105506656|NCT02034110|363867407|FG006|Overall Study|Physician Decision|1|||
105506657|NCT02034110|363867408|FG007|Overall Study|Physician Decision|0|||
105506658|NCT02034110|363867401|FG000|Overall Study|Lost to Follow-up|1|||
105506659|NCT02034110|363867402|FG001|Overall Study|Lost to Follow-up|0|||
105506660|NCT02034110|363867403|FG002|Overall Study|Lost to Follow-up|0|||
105506661|NCT02034110|363867404|FG003|Overall Study|Lost to Follow-up|0|||
105506662|NCT02034110|363867405|FG004|Overall Study|Lost to Follow-up|1|||
105506663|NCT02034110|363867406|FG005|Overall Study|Lost to Follow-up|0|||
105506664|NCT02034110|363867407|FG006|Overall Study|Lost to Follow-up|1|||
105506665|NCT02034110|363867408|FG007|Overall Study|Lost to Follow-up|0|||
105506666|NCT02034110|363867401|FG000|Overall Study|Withdrawal by Subject|5|||
105506667|NCT02034110|363867402|FG001|Overall Study|Withdrawal by Subject|7|||
105506668|NCT02034110|363867403|FG002|Overall Study|Withdrawal by Subject|0|||
105506669|NCT02034110|363867404|FG003|Overall Study|Withdrawal by Subject|3|||
105506670|NCT02034110|363867405|FG004|Overall Study|Withdrawal by Subject|7|||
105506671|NCT02034110|363867406|FG005|Overall Study|Withdrawal by Subject|0|||
105506672|NCT02034110|363867407|FG006|Overall Study|Withdrawal by Subject|3|||
105506673|NCT02034110|363867408|FG007|Overall Study|Withdrawal by Subject|1|||
105506674|NCT02034110|363867401|FG000|Overall Study|Study closed by sponsor|6|||
105506675|NCT02034110|363867402|FG001|Overall Study|Study closed by sponsor|2|||
105506676|NCT02034110|363867403|FG002|Overall Study|Study closed by sponsor|0|||
105506677|NCT02034110|363867404|FG003|Overall Study|Study closed by sponsor|6|||
105506678|NCT02034110|363867405|FG004|Overall Study|Study closed by sponsor|7|||
105506679|NCT02034110|363867406|FG005|Overall Study|Study closed by sponsor|0|||
105506680|NCT02034110|363867407|FG006|Overall Study|Study closed by sponsor|42|||
105506681|NCT02034110|363867408|FG007|Overall Study|Study closed by sponsor|0|||
105506682|NCT00777608|363867409|FG000|Overall Study|Lost to Follow-up|1|||
105506683|NCT00777608|363867410|FG001|Overall Study|Lost to Follow-up|1|||
105506684|NCT00777608|363867409|FG000|Overall Study|Withdrawal by Subject|1|||
105506685|NCT00777608|363867410|FG001|Overall Study|Withdrawal by Subject|3|||
105506686|NCT00777608|363867409|FG000|Overall Study|Protocol Violation|1|||
105506687|NCT00777608|363867410|FG001|Overall Study|Protocol Violation|0|||
105506688|NCT00777608|363867409|FG000|Overall Study|Investigator Decision|1|||
105506689|NCT00777608|363867410|FG001|Overall Study|Investigator Decision|2|||
105506690|NCT01488370|363867415|FG000|Overall Study|Protocol Violation|0|||
105506691|NCT01488370|363867416|FG001|Overall Study|Protocol Violation|1|||
105506692|NCT01488370|363867417|FG002|Overall Study|Protocol Violation|1|||
105506693|NCT01471171|363867418|FG000|Treatment Period 1|Adverse Event|4|||
105506694|NCT01471171|363867419|FG001|Treatment Period 1|Adverse Event|1|||
105506695|NCT01471171|363867418|FG000|Treatment Period 2|Adverse Event|1|||
105506696|NCT01471171|363867419|FG001|Treatment Period 2|Adverse Event|0|||
105590770|NCT04927975|364162702|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
105506697|NCT01243892|363867420|FG000|Overall Study|Did not meet eligibility criteria|2|||
105506698|NCT01243892|363867421|FG001|Overall Study|Did not meet eligibility criteria|0|||
105506699|NCT04171531|363867423|FG000|Overall Study|Lost to Follow-up|4|||
105506700|NCT04171531|363867424|FG001|Overall Study|Lost to Follow-up|5|||
105506701|NCT04171531|363867423|FG000|Overall Study|Consent only through 6 months|1|||
105506702|NCT04171531|363867424|FG001|Overall Study|Consent only through 6 months|1|||
105506703|NCT04171531|363867423|FG000|Overall Study|Insurance did not cover procedure|0|||
105506704|NCT04171531|363867424|FG001|Overall Study|Insurance did not cover procedure|1|||
105506705|NCT04171531|363867423|FG000|Overall Study|Physician Decision|0|||
105506706|NCT04171531|363867424|FG001|Overall Study|Physician Decision|3|||
105506707|NCT04171531|363867423|FG000|Overall Study|Withdrawal by Subject|1|||
105506708|NCT04171531|363867424|FG001|Overall Study|Withdrawal by Subject|5|||
105506709|NCT02099708|363867425|FG000|Overall Study|Data Not Available|30|||
105506710|NCT02099708|363867425|FG000|Overall Study|Lost to Follow-up|141|||
105506711|NCT02099708|363867425|FG000|Overall Study|Other|29|||
105506712|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
105506713|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
105506714|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
105506715|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
105506716|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
105506717|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
105506718|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
105506719|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
105506720|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
105506721|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
105506722|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
105506723|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
105506724|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
105506725|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
105506726|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
105506727|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
105506728|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
105506729|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
105506730|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
105506731|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
105506732|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
105506733|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
105506734|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
105506735|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
105506736|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
105506737|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
105506738|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
105506739|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
105506740|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
105506741|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
105506742|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
105506743|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
105506744|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
105506745|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
105506746|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
105506747|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
105506748|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
105506749|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
105506750|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
105506751|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
105506752|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
105506753|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
105506754|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
105506755|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
105506756|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
105506757|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
105506758|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
105506759|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
105506760|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
105506761|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
105590771|NCT04927975|364162703|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
105506762|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
105506763|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
105506764|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
105506765|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
105506766|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
105506767|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
105506768|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
105506769|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
105506770|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
105506771|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
105506772|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
105506773|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
105506774|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
105506775|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
105506776|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
105506777|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
105506778|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
105506779|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
105506780|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
105506781|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
105506782|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Change of location|0|||
105506783|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Change of location|0|||
105506784|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Change of location|0|||
105506785|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Change of location|1|||
105506786|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Change of location|0|||
105506787|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
105506788|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
105506789|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
105506790|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
105506791|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
105506792|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
105506793|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
105506794|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
105506795|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
105506796|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
105506797|NCT00730405|363867431|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
105506798|NCT00730405|363867432|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
105506799|NCT00730405|363867433|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
105506800|NCT00730405|363867434|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
105506801|NCT00730405|363867435|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
105506802|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
105506803|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
105506804|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
105506805|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
105506806|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
105506807|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
105506808|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
105506809|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
105506810|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
105506811|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
105506812|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
105506813|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
105506814|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
105506815|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
105506816|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
105506817|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Death|0|||
105506818|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Death|1|||
105506819|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Death|0|||
105506820|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Death|1|||
105506821|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Death|0|||
105506822|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Change of location|1|||
105506823|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Change of location|1|||
105590772|NCT04776213|364162705|FG000|Overall Study|Other|1|||
105590773|NCT04776213|364162705|FG000|Overall Study|Withdrawal by Subject|7|||
105506824|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Change of location|0|||
105506825|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Change of location|1|||
105506826|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Change of location|0|||
105506827|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
105506828|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
105506829|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
105506830|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
105506831|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
105506832|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
105506833|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
105506834|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
105506835|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
105506836|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
105506837|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
105506838|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
105506839|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
105506840|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
105506841|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
105506842|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
105506843|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
105506844|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
105506845|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
105506846|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
105506847|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
105506848|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
105506849|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
105506850|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
105506851|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
105506852|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
105506853|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
105506854|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
105506855|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
105506856|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
105506857|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
105506858|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
105506859|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
105506860|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
105506861|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
105506862|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
105506863|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
105506864|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
105506865|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
105506866|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
105506867|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
105506868|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
105506869|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
105506870|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
105506871|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
105506872|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
105506873|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
105506874|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
105506875|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
105506876|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
105506877|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Missing|0|||
105506878|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Missing|0|||
105506879|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Missing|2|||
105506880|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Missing|0|||
105506881|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Missing|0|||
105506882|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
105506883|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
105506884|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
105590774|NCT04776213|364162705|FG000|Overall Study|Protocol Violation|1|||
105590775|NCT04776213|364162705|FG000|Overall Study|Lost to Follow-up|2|||
105506885|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
105506886|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
105590776|NCT00712166|364162706|FG000|Overall Study|Noncompliance|0|||
105590777|NCT00712166|364162707|FG001|Overall Study|Noncompliance|1|||
105506887|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
105506888|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
105506889|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
105506890|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
105506891|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
105506892|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
105506893|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
105506894|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
105506895|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
105506896|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
105506897|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
105506898|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
105506899|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
105506900|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
105506901|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
105506902|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
105506903|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
105506904|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
105506905|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
105506906|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
105506907|NCT00730405|363867431|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
105506908|NCT00730405|363867432|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
105506909|NCT00730405|363867433|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
105506910|NCT00730405|363867434|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
105506911|NCT00730405|363867435|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
105506912|NCT03851705|363867436|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
105506913|NCT03851705|363867437|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
105506914|NCT03851705|363867438|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
105506915|NCT03851705|363867439|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
105506916|NCT03851705|363867436|FG000|Part 1: Double-Blind Period|Other reason|1|||
105506917|NCT03851705|363867437|FG001|Part 1: Double-Blind Period|Other reason|0|||
105506918|NCT03851705|363867438|FG002|Part 1: Double-Blind Period|Other reason|0|||
105506919|NCT03851705|363867439|FG003|Part 1: Double-Blind Period|Other reason|0|||
105506920|NCT03851705|363867436|FG000|Part 2: Open-Label Period|Other reason|0|||
105506921|NCT03851705|363867437|FG001|Part 2: Open-Label Period|Other reason|0|||
105506922|NCT03851705|363867438|FG002|Part 2: Open-Label Period|Other reason|0|||
105506923|NCT03851705|363867439|FG003|Part 2: Open-Label Period|Other reason|1|||
105506924|NCT03851705|363867436|FG000|Part 2: Open-Label Period|Death|0|||
105506925|NCT03851705|363867437|FG001|Part 2: Open-Label Period|Death|0|||
105506926|NCT03851705|363867438|FG002|Part 2: Open-Label Period|Death|3|||
105506927|NCT03851705|363867439|FG003|Part 2: Open-Label Period|Death|0|||
105506928|NCT03851705|363867436|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
105506929|NCT03851705|363867437|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
105506930|NCT03851705|363867438|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
105506931|NCT03851705|363867439|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
105506932|NCT01496807|363867440|FG000|Overall Study|Progressive Disease|21|||
105506933|NCT01496807|363867440|FG000|Overall Study|Participant preference/toxicity|8|||
105506934|NCT01496807|363867440|FG000|Overall Study|Change in diagnosis|1|||
105506935|NCT05466682|363867444|FG000|Overall Study|Withdrawal by Subject|0|||
105506936|NCT05466682|363867445|FG001|Overall Study|Withdrawal by Subject|2|||
105506937|NCT05466682|363867444|FG000|Overall Study|Lost to Follow-up|2|||
105506938|NCT05466682|363867445|FG001|Overall Study|Lost to Follow-up|1|||
105506939|NCT03385564|363867449|FG000|Overall Study|Adverse Event|0|||
105506940|NCT03385564|363867450|FG001|Overall Study|Adverse Event|0|||
105506941|NCT03385564|363867451|FG002|Overall Study|Adverse Event|3|||
105506942|NCT03385564|363867452|FG003|Overall Study|Adverse Event|3|||
105506943|NCT03385564|363867449|FG000|Overall Study|Other than listed|0|||
105506944|NCT03385564|363867450|FG001|Overall Study|Other than listed|0|||
105506945|NCT03385564|363867451|FG002|Overall Study|Other than listed|0|||
105506946|NCT03385564|363867452|FG003|Overall Study|Other than listed|5|||
105506947|NCT03385564|363867449|FG000|Overall Study|Withdrawal by Subject|0|||
105506948|NCT03385564|363867450|FG001|Overall Study|Withdrawal by Subject|1|||
105506949|NCT03385564|363867451|FG002|Overall Study|Withdrawal by Subject|1|||
105506950|NCT03385564|363867452|FG003|Overall Study|Withdrawal by Subject|0|||
105506951|NCT03385564|363867449|FG000|Overall Study|Lack of Efficacy|0|||
105506952|NCT03385564|363867450|FG001|Overall Study|Lack of Efficacy|0|||
105506953|NCT03385564|363867451|FG002|Overall Study|Lack of Efficacy|0|||
105506954|NCT03385564|363867452|FG003|Overall Study|Lack of Efficacy|1|||
105506955|NCT03385564|363867449|FG000|Overall Study|Death|0|||
105506956|NCT03385564|363867450|FG001|Overall Study|Death|0|||
105506957|NCT03385564|363867451|FG002|Overall Study|Death|1|||
105506958|NCT03385564|363867452|FG003|Overall Study|Death|0|||
105506959|NCT01546883|363867453|FG000|Overall Study|Withdrawal by Subject|3|||
105506960|NCT01546883|363867453|FG000|Overall Study|Adverse Event|4|||
105506961|NCT01546883|363867453|FG000|Overall Study|Lost to Follow-up|2|||
105506962|NCT01546883|363867453|FG000|Overall Study|early closure of study|2|||
105506963|NCT01546883|363867453|FG000|Overall Study|other unrelated illness|1|||
105506964|NCT02256631|363867454|FG000|Overall Study|Lost to Follow-up|1|||
105506965|NCT02256631|363867455|FG001|Overall Study|Lost to Follow-up|1|||
105506966|NCT02256631|363867456|FG002|Overall Study|Lost to Follow-up|0|||
105506967|NCT02256631|363867457|FG003|Overall Study|Lost to Follow-up|2|||
105506968|NCT02256631|363867458|FG004|Overall Study|Lost to Follow-up|0|||
105506969|NCT02256631|363867459|FG005|Overall Study|Lost to Follow-up|4|||
105506970|NCT02256631|363867460|FG006|Overall Study|Lost to Follow-up|1|||
105506971|NCT02256631|363867454|FG000|Overall Study|Withdrawal by Subject|0|||
105506972|NCT02256631|363867455|FG001|Overall Study|Withdrawal by Subject|0|||
105506973|NCT02256631|363867456|FG002|Overall Study|Withdrawal by Subject|0|||
105506974|NCT02256631|363867457|FG003|Overall Study|Withdrawal by Subject|1|||
105506975|NCT02256631|363867458|FG004|Overall Study|Withdrawal by Subject|1|||
105506976|NCT02256631|363867459|FG005|Overall Study|Withdrawal by Subject|0|||
105506977|NCT02256631|363867460|FG006|Overall Study|Withdrawal by Subject|1|||
105506978|NCT02256631|363867454|FG000|Overall Study|Unable to get to clinic|0|||
105506979|NCT02256631|363867455|FG001|Overall Study|Unable to get to clinic|2|||
105506980|NCT02256631|363867456|FG002|Overall Study|Unable to get to clinic|0|||
105506981|NCT02256631|363867457|FG003|Overall Study|Unable to get to clinic|1|||
105506982|NCT02256631|363867458|FG004|Overall Study|Unable to get to clinic|0|||
105506983|NCT02256631|363867459|FG005|Overall Study|Unable to get to clinic|1|||
105506984|NCT02256631|363867460|FG006|Overall Study|Unable to get to clinic|2|||
105506985|NCT04967443|363867461|FG000|Open Label Treatment|Death|1|||
105506986|NCT04967443|363867462|FG001|Open Label Treatment|Death|0|||
105506987|NCT04967443|363867463|FG002|Open Label Treatment|Death|0|||
105506988|NCT04967443|363867464|FG003|Open Label Treatment|Death|0|||
105506989|NCT04967443|363867465|FG004|Open Label Treatment|Death|0|||
105506990|NCT04967443|363867466|FG005|Open Label Treatment|Death|0|||
105506991|NCT04967443|363867467|FG006|Open Label Treatment|Death|0|||
105506992|NCT04967443|363867468|FG007|Open Label Treatment|Death|0|||
105506993|NCT04967443|363867461|FG000|Open Label Treatment|Lost to Follow-up|0|||
105506994|NCT04967443|363867462|FG001|Open Label Treatment|Lost to Follow-up|0|||
105506995|NCT04967443|363867463|FG002|Open Label Treatment|Lost to Follow-up|1|||
105506996|NCT04967443|363867464|FG003|Open Label Treatment|Lost to Follow-up|0|||
105506997|NCT04967443|363867465|FG004|Open Label Treatment|Lost to Follow-up|0|||
105506998|NCT04967443|363867466|FG005|Open Label Treatment|Lost to Follow-up|0|||
105506999|NCT04967443|363867467|FG006|Open Label Treatment|Lost to Follow-up|0|||
105507000|NCT04967443|363867468|FG007|Open Label Treatment|Lost to Follow-up|0|||
105507001|NCT04967443|363867461|FG000|Open Label Treatment|Withdrawal by Subject|0|||
105507002|NCT04967443|363867462|FG001|Open Label Treatment|Withdrawal by Subject|1|||
105507003|NCT04967443|363867463|FG002|Open Label Treatment|Withdrawal by Subject|0|||
105507004|NCT04967443|363867464|FG003|Open Label Treatment|Withdrawal by Subject|1|||
105507005|NCT04967443|363867465|FG004|Open Label Treatment|Withdrawal by Subject|0|||
105507006|NCT04967443|363867466|FG005|Open Label Treatment|Withdrawal by Subject|1|||
105507007|NCT04967443|363867467|FG006|Open Label Treatment|Withdrawal by Subject|2|||
105507008|NCT04967443|363867468|FG007|Open Label Treatment|Withdrawal by Subject|3|||
105507009|NCT04967443|363867461|FG000|Follow-Up|Death|1|||
105507010|NCT04967443|363867462|FG001|Follow-Up|Death|0|||
105507011|NCT04967443|363867463|FG002|Follow-Up|Death|0|||
105507012|NCT04967443|363867464|FG003|Follow-Up|Death|0|||
105507013|NCT04967443|363867465|FG004|Follow-Up|Death|0|||
105507014|NCT04967443|363867466|FG005|Follow-Up|Death|0|||
105507015|NCT04967443|363867467|FG006|Follow-Up|Death|0|||
105507016|NCT04967443|363867468|FG007|Follow-Up|Death|0|||
105507017|NCT04967443|363867461|FG000|Follow-Up|Lost to Follow-up|0|||
105507018|NCT04967443|363867462|FG001|Follow-Up|Lost to Follow-up|0|||
105507019|NCT04967443|363867463|FG002|Follow-Up|Lost to Follow-up|1|||
105507020|NCT04967443|363867464|FG003|Follow-Up|Lost to Follow-up|1|||
105507021|NCT04967443|363867465|FG004|Follow-Up|Lost to Follow-up|0|||
105507022|NCT04967443|363867466|FG005|Follow-Up|Lost to Follow-up|0|||
105507023|NCT04967443|363867467|FG006|Follow-Up|Lost to Follow-up|0|||
105507024|NCT04967443|363867468|FG007|Follow-Up|Lost to Follow-up|0|||
105507025|NCT04967443|363867461|FG000|Follow-Up|Withdrawal by Subject|0|||
105507026|NCT04967443|363867462|FG001|Follow-Up|Withdrawal by Subject|1|||
105507027|NCT04967443|363867463|FG002|Follow-Up|Withdrawal by Subject|0|||
105507028|NCT04967443|363867464|FG003|Follow-Up|Withdrawal by Subject|1|||
105507029|NCT04967443|363867465|FG004|Follow-Up|Withdrawal by Subject|0|||
105507030|NCT04967443|363867466|FG005|Follow-Up|Withdrawal by Subject|1|||
105507031|NCT04967443|363867467|FG006|Follow-Up|Withdrawal by Subject|2|||
105507032|NCT04967443|363867468|FG007|Follow-Up|Withdrawal by Subject|3|||
105507033|NCT01654536|363867469|FG000|Overall Study|Lost to Follow-up|5|||
105507034|NCT01654536|363867470|FG001|Overall Study|Lost to Follow-up|5|||
105507035|NCT01654536|363867469|FG000|Overall Study|Physician Decision|12|||
105507036|NCT01654536|363867470|FG001|Overall Study|Physician Decision|8|||
105507037|NCT01654536|363867469|FG000|Overall Study|Withdrawal by Subject|27|||
105507038|NCT01654536|363867470|FG001|Overall Study|Withdrawal by Subject|25|||
105507039|NCT03334539|363867471|FG000|Overall Study|Adverse Event|3|||
105507040|NCT03334539|363867472|FG001|Overall Study|Adverse Event|5|||
105507041|NCT03334539|363867473|FG002|Overall Study|Adverse Event|0|||
105507042|NCT03334539|363867471|FG000|Overall Study|Withdrawal by Subject|0|||
105507043|NCT03334539|363867472|FG001|Overall Study|Withdrawal by Subject|1|||
105507044|NCT03334539|363867473|FG002|Overall Study|Withdrawal by Subject|1|||
105507045|NCT03334539|363867471|FG000|Overall Study|Administrative Reasons|1|||
105507046|NCT03334539|363867472|FG001|Overall Study|Administrative Reasons|0|||
105507047|NCT03334539|363867473|FG002|Overall Study|Administrative Reasons|0|||
105507048|NCT03334539|363867471|FG000|Overall Study|Hypertension Not Controlled|0|||
105507049|NCT03334539|363867472|FG001|Overall Study|Hypertension Not Controlled|1|||
105507050|NCT03334539|363867473|FG002|Overall Study|Hypertension Not Controlled|0|||
105507051|NCT00968201|363867476|FG000|Base Study - (Period II)|Adverse Event|8|||
105507052|NCT00968201|363867477|FG001|Base Study - (Period II)|Adverse Event|0|||
105507053|NCT00968201|363867478|FG002|Base Study - (Period II)|Adverse Event|16|||
105507054|NCT00968201|363867476|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
105507055|NCT00968201|363867477|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
105507056|NCT00968201|363867478|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
105507057|NCT00968201|363867476|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
105507058|NCT00968201|363867477|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
105507059|NCT00968201|363867478|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
105507060|NCT00968201|363867476|FG000|Base Study - (Period II)|Protocol Violation|12|||
105507061|NCT00968201|363867477|FG001|Base Study - (Period II)|Protocol Violation|0|||
105507062|NCT00968201|363867478|FG002|Base Study - (Period II)|Protocol Violation|12|||
105507063|NCT00968201|363867476|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
105507064|NCT00968201|363867477|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
105507065|NCT00968201|363867478|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
105507066|NCT00968201|363867476|FG000|Base Study - (Period II)|Site Error|0|||
105507067|NCT00968201|363867477|FG001|Base Study - (Period II)|Site Error|0|||
105507068|NCT00968201|363867478|FG002|Base Study - (Period II)|Site Error|1|||
105507069|NCT00968201|363867476|FG000|Extension Study - (Period III)|Adverse Event|0|||
105507070|NCT00968201|363867477|FG001|Extension Study - (Period III)|Adverse Event|5|||
105507071|NCT00968201|363867478|FG002|Extension Study - (Period III)|Adverse Event|22|||
105507072|NCT00968201|363867476|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
105507073|NCT00968201|363867477|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
105507074|NCT00968201|363867478|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
105507075|NCT00968201|363867476|FG000|Extension Study - (Period III)|Protocol Violation|0|||
105507076|NCT00968201|363867477|FG001|Extension Study - (Period III)|Protocol Violation|17|||
105507077|NCT00968201|363867478|FG002|Extension Study - (Period III)|Protocol Violation|14|||
105507078|NCT00968201|363867476|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
105507079|NCT00968201|363867477|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
105507080|NCT00968201|363867478|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
105507081|NCT00968201|363867476|FG000|Extension Study - (Period III)|Patient Relocated|0|||
105507082|NCT00968201|363867477|FG001|Extension Study - (Period III)|Patient Relocated|1|||
105507083|NCT00968201|363867478|FG002|Extension Study - (Period III)|Patient Relocated|1|||
105507084|NCT00968201|363867476|FG000|Extension Study - (Period III)|Noncompliance|0|||
105507085|NCT00968201|363867477|FG001|Extension Study - (Period III)|Noncompliance|0|||
105507086|NCT00968201|363867478|FG002|Extension Study - (Period III)|Noncompliance|3|||
105507087|NCT00968201|363867476|FG000|Extension Study - (Period III)|Other|0|||
105507088|NCT00968201|363867477|FG001|Extension Study - (Period III)|Other|0|||
105507089|NCT00968201|363867478|FG002|Extension Study - (Period III)|Other|2|||
105507090|NCT00968201|363867476|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
105507091|NCT00968201|363867477|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
105507092|NCT00968201|363867478|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
105507093|NCT02619175|363867479|FG000|Overall Study|Withdrawal by Subject|1|||
105507094|NCT02619175|363867480|FG001|Overall Study|Withdrawal by Subject|0|||
105507095|NCT02619175|363867479|FG000|Overall Study|foot pain|1|||
105507096|NCT02619175|363867480|FG001|Overall Study|foot pain|0|||
105507097|NCT00361569|363867481|FG000|Overall Study|Protocol Violation|3|||
105507098|NCT00361569|363867482|FG001|Overall Study|Protocol Violation|2|||
105507099|NCT00361569|363867483|FG002|Overall Study|Protocol Violation|4|||
105507100|NCT00361569|363867484|FG003|Overall Study|Protocol Violation|2|||
105507101|NCT00361569|363867481|FG000|Overall Study|Withdrawal by Subject|2|||
105507102|NCT00361569|363867482|FG001|Overall Study|Withdrawal by Subject|1|||
105507103|NCT00361569|363867483|FG002|Overall Study|Withdrawal by Subject|9|||
105507104|NCT00361569|363867484|FG003|Overall Study|Withdrawal by Subject|14|||
105507105|NCT00361569|363867481|FG000|Overall Study|Adverse Event|3|||
105507106|NCT00361569|363867482|FG001|Overall Study|Adverse Event|5|||
105507107|NCT00361569|363867483|FG002|Overall Study|Adverse Event|2|||
105507108|NCT00361569|363867484|FG003|Overall Study|Adverse Event|2|||
105507109|NCT00361569|363867481|FG000|Overall Study|Lost to Follow-up|2|||
105507110|NCT00361569|363867482|FG001|Overall Study|Lost to Follow-up|3|||
105507111|NCT00361569|363867483|FG002|Overall Study|Lost to Follow-up|3|||
105507112|NCT00361569|363867484|FG003|Overall Study|Lost to Follow-up|2|||
105507113|NCT00361569|363867481|FG000|Overall Study|Not specified by investigator|2|||
105507114|NCT00361569|363867482|FG001|Overall Study|Not specified by investigator|0|||
105507115|NCT00361569|363867483|FG002|Overall Study|Not specified by investigator|0|||
105507116|NCT00361569|363867484|FG003|Overall Study|Not specified by investigator|1|||
105507117|NCT03727347|363867485|FG000|Overall Study|Withdrawal by Subject|2|||
105507118|NCT03727347|363867485|FG000|Overall Study|Lost to Follow-up|1|||
105507119|NCT00211510|363867486|FG000|Overall Study|Physician Decision|3|||
105507120|NCT00211510|363867487|FG001|Overall Study|Physician Decision|1|||
105507121|NCT00211510|363867486|FG000|Overall Study|Withdrawal by Subject|3|||
105507122|NCT00211510|363867487|FG001|Overall Study|Withdrawal by Subject|1|||
105507123|NCT01487200|363867488|FG000|Overall Study|Withdrawal by Subject|0|||
105507124|NCT01487200|363867489|FG001|Overall Study|Withdrawal by Subject|1|||
105507125|NCT01487200|363867490|FG002|Overall Study|Withdrawal by Subject|0|||
105507126|NCT01487200|363867491|FG003|Overall Study|Withdrawal by Subject|0|||
105507127|NCT03288129|363867493|FG000|Overall Study|Adverse Event|10|||
105507128|NCT03288129|363867493|FG000|Overall Study|Lost to Follow-up|3|||
105507129|NCT03288129|363867493|FG000|Overall Study|Withdrawal by Subject|3|||
105507130|NCT03288129|363867493|FG000|Overall Study|Withdrawal of consent/assent|1|||
105507131|NCT03288129|363867493|FG000|Overall Study|Other|5|||
105507132|NCT02549937|363867497|FG000|Overall Study|Death|0|||
105507133|NCT02549937|363867498|FG001|Overall Study|Death|1|||
105507134|NCT02549937|363867499|FG002|Overall Study|Death|0|||
105507135|NCT02549937|363867500|FG003|Overall Study|Death|1|||
105507136|NCT02549937|363867501|FG004|Overall Study|Death|0|||
105507137|NCT02549937|363867502|FG005|Overall Study|Death|8|||
105507138|NCT02549937|363867503|FG006|Overall Study|Death|0|||
105507139|NCT02549937|363867504|FG007|Overall Study|Death|0|||
105507140|NCT02549937|363867505|FG008|Overall Study|Death|19|||
105507141|NCT02549937|363867497|FG000|Overall Study|No follow up required|3|||
105507142|NCT02549937|363867498|FG001|Overall Study|No follow up required|6|||
105507143|NCT02549937|363867499|FG002|Overall Study|No follow up required|3|||
105507144|NCT02549937|363867500|FG003|Overall Study|No follow up required|8|||
105507145|NCT02549937|363867501|FG004|Overall Study|No follow up required|12|||
105507146|NCT02549937|363867502|FG005|Overall Study|No follow up required|21|||
105507147|NCT02549937|363867503|FG006|Overall Study|No follow up required|9|||
105507148|NCT02549937|363867504|FG007|Overall Study|No follow up required|11|||
105507149|NCT02549937|363867505|FG008|Overall Study|No follow up required|0|||
105507150|NCT02549937|363867497|FG000|Overall Study|Other|0|||
105507151|NCT02549937|363867498|FG001|Overall Study|Other|0|||
105507152|NCT02549937|363867499|FG002|Overall Study|Other|0|||
105507153|NCT02549937|363867500|FG003|Overall Study|Other|0|||
105507154|NCT02549937|363867501|FG004|Overall Study|Other|1|||
105507155|NCT02549937|363867502|FG005|Overall Study|Other|0|||
105507156|NCT02549937|363867503|FG006|Overall Study|Other|3|||
105507157|NCT02549937|363867504|FG007|Overall Study|Other|2|||
105507158|NCT02549937|363867505|FG008|Overall Study|Other|3|||
105507159|NCT02549937|363867497|FG000|Overall Study|Lost to Follow-up|0|||
105507160|NCT02549937|363867498|FG001|Overall Study|Lost to Follow-up|0|||
105507161|NCT02549937|363867499|FG002|Overall Study|Lost to Follow-up|0|||
105507162|NCT02549937|363867500|FG003|Overall Study|Lost to Follow-up|0|||
105507163|NCT02549937|363867501|FG004|Overall Study|Lost to Follow-up|0|||
105507164|NCT02549937|363867502|FG005|Overall Study|Lost to Follow-up|0|||
105507165|NCT02549937|363867503|FG006|Overall Study|Lost to Follow-up|0|||
105507166|NCT02549937|363867504|FG007|Overall Study|Lost to Follow-up|0|||
105507167|NCT02549937|363867505|FG008|Overall Study|Lost to Follow-up|3|||
105507168|NCT02549937|363867497|FG000|Overall Study|Withdrawal by Subject|0|||
105507169|NCT02549937|363867498|FG001|Overall Study|Withdrawal by Subject|0|||
105507170|NCT02549937|363867499|FG002|Overall Study|Withdrawal by Subject|0|||
105507171|NCT02549937|363867500|FG003|Overall Study|Withdrawal by Subject|0|||
105507172|NCT02549937|363867501|FG004|Overall Study|Withdrawal by Subject|0|||
105507173|NCT02549937|363867502|FG005|Overall Study|Withdrawal by Subject|1|||
105507174|NCT02549937|363867503|FG006|Overall Study|Withdrawal by Subject|4|||
105507175|NCT02549937|363867504|FG007|Overall Study|Withdrawal by Subject|3|||
105507176|NCT02549937|363867505|FG008|Overall Study|Withdrawal by Subject|2|||
105507177|NCT02549937|363867497|FG000|Overall Study|Sponsor Decision|0|||
105507178|NCT02549937|363867498|FG001|Overall Study|Sponsor Decision|0|||
105507179|NCT02549937|363867499|FG002|Overall Study|Sponsor Decision|0|||
105507180|NCT02549937|363867500|FG003|Overall Study|Sponsor Decision|0|||
105507181|NCT02549937|363867501|FG004|Overall Study|Sponsor Decision|0|||
105507182|NCT02549937|363867502|FG005|Overall Study|Sponsor Decision|0|||
105507183|NCT02549937|363867503|FG006|Overall Study|Sponsor Decision|0|||
105507184|NCT02549937|363867504|FG007|Overall Study|Sponsor Decision|0|||
105507185|NCT02549937|363867505|FG008|Overall Study|Sponsor Decision|6|||
105507186|NCT00662012|363867506|FG000|Overall Study|Lost to Follow-up|85|||
105507187|NCT00662012|363867506|FG000|Overall Study|Death|1|||
105507188|NCT00662012|363867506|FG000|Overall Study|Withdrawal by Subject|1|||
105507189|NCT02144012|363867509|FG000|Overall Study|Adverse Event|1|||
105507190|NCT02144012|363867510|FG001|Overall Study|Adverse Event|0|||
105507191|NCT02144012|363867509|FG000|Overall Study|Death|1|||
105507192|NCT02144012|363867510|FG001|Overall Study|Death|0|||
105507193|NCT02144012|363867509|FG000|Overall Study|Withdrawal by Subject|11|||
105507194|NCT02144012|363867510|FG001|Overall Study|Withdrawal by Subject|3|||
105507195|NCT02144012|363867509|FG000|Overall Study|Study Terminated by Sponsor|18|||
105507196|NCT02144012|363867510|FG001|Overall Study|Study Terminated by Sponsor|12|||
105507197|NCT02144012|363867509|FG000|Overall Study|Other|3|||
105507198|NCT02144012|363867510|FG001|Overall Study|Other|0|||
105507199|NCT00317356|363867511|FG000|Overall Study|Adverse Event|0|||
105507200|NCT00317356|363867512|FG001|Overall Study|Adverse Event|0|||
105507201|NCT00317356|363867513|FG002|Overall Study|Adverse Event|1|||
105507202|NCT00317356|363867514|FG003|Overall Study|Adverse Event|0|||
105507203|NCT00317356|363867511|FG000|Overall Study|Lack of Efficacy|1|||
105507204|NCT00317356|363867512|FG001|Overall Study|Lack of Efficacy|1|||
105507205|NCT00317356|363867513|FG002|Overall Study|Lack of Efficacy|0|||
105507206|NCT00317356|363867514|FG003|Overall Study|Lack of Efficacy|3|||
105507207|NCT00317356|363867511|FG000|Overall Study|Physician Decision|0|||
105507208|NCT00317356|363867512|FG001|Overall Study|Physician Decision|1|||
105507209|NCT00317356|363867513|FG002|Overall Study|Physician Decision|0|||
105507210|NCT00317356|363867514|FG003|Overall Study|Physician Decision|0|||
105507211|NCT01949506|363867518|FG000|Overall Study|Physician Decision|1|||
105507212|NCT05059600|363867519|FG000|Overall Study|Enrolled but not Treated|10|||
105507213|NCT00621153|363867520|FG000|Overall Study|Safety Reason|8|||
105507214|NCT00621153|363867521|FG001|Overall Study|Safety Reason|7|||
105507215|NCT00621153|363867520|FG000|Overall Study|Adverse Event|3|||
105507216|NCT00621153|363867521|FG001|Overall Study|Adverse Event|2|||
105507217|NCT00621153|363867520|FG000|Overall Study|Lost to Follow-up|5|||
105507218|NCT00621153|363867521|FG001|Overall Study|Lost to Follow-up|1|||
105507219|NCT00621153|363867520|FG000|Overall Study|Withdrawal by Subject|4|||
105507220|NCT00621153|363867521|FG001|Overall Study|Withdrawal by Subject|5|||
105507221|NCT04212650|363867522|FG000|Overall Study|Withdrawal by Subject|1|||
105507222|NCT04212650|363867523|FG001|Overall Study|Withdrawal by Subject|0|||
105507223|NCT01446289|363867526|FG000|Overall Study|Withdrawal by Subject|1|||
105507224|NCT01446289|363867527|FG001|Overall Study|Withdrawal by Subject|0|||
105507225|NCT01446289|363867528|FG002|Overall Study|Withdrawal by Subject|1|||
105507226|NCT01446289|363867529|FG003|Overall Study|Withdrawal by Subject|0|||
105507227|NCT03919799|363867530|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
105507228|NCT03919799|363867531|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
105507229|NCT03919799|363867532|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
105507230|NCT03919799|363867533|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
105507231|NCT03919799|363867534|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
105507232|NCT03919799|363867530|FG000|DB Period (28 Weeks)|Adverse Event|1|||
105507233|NCT03919799|363867531|FG001|DB Period (28 Weeks)|Adverse Event|1|||
105507234|NCT03919799|363867532|FG002|DB Period (28 Weeks)|Adverse Event|1|||
105507235|NCT03919799|363867533|FG003|DB Period (28 Weeks)|Adverse Event|0|||
105507236|NCT03919799|363867534|FG004|DB Period (28 Weeks)|Adverse Event|0|||
105507237|NCT03919799|363867530|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
105507238|NCT03919799|363867531|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
105507239|NCT03919799|363867532|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
105507240|NCT03919799|363867533|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
105507241|NCT03919799|363867534|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
105507242|NCT03919799|363867530|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
105507243|NCT03919799|363867531|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
105507244|NCT03919799|363867532|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
105507245|NCT03919799|363867533|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
105507246|NCT03919799|363867534|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
105507247|NCT03919799|363867530|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
105507248|NCT03919799|363867531|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
105507249|NCT03919799|363867532|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
105507250|NCT03919799|363867533|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
105507251|NCT03919799|363867534|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
105507252|NCT03329573|363867536|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
105507253|NCT03329573|363867537|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
105507254|NCT03329573|363867538|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
105507255|NCT03329573|363867539|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
105507256|NCT03329573|363867536|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
105507257|NCT03329573|363867537|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
105507258|NCT03329573|363867538|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105507259|NCT03329573|363867539|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105507260|NCT03329573|363867536|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
105507261|NCT03329573|363867537|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
105507262|NCT03329573|363867538|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
105507263|NCT03329573|363867539|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
105507264|NCT03329573|363867536|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
105507265|NCT03329573|363867537|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
105507266|NCT03329573|363867538|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
105507267|NCT03329573|363867539|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
105507268|NCT00837811|363867542|FG000|Overall Study|Adverse Event|4|||
105507269|NCT00837811|363867543|FG001|Overall Study|Adverse Event|6|||
105507270|NCT00837811|363867544|FG002|Overall Study|Adverse Event|0|||
105507271|NCT00837811|363867542|FG000|Overall Study|Death|1|||
105507272|NCT00837811|363867543|FG001|Overall Study|Death|1|||
105507273|NCT00837811|363867544|FG002|Overall Study|Death|0|||
105507274|NCT00837811|363867542|FG000|Overall Study|Lack of Efficacy|0|||
105507275|NCT00837811|363867543|FG001|Overall Study|Lack of Efficacy|11|||
105507276|NCT00837811|363867544|FG002|Overall Study|Lack of Efficacy|0|||
105507277|NCT00837811|363867542|FG000|Overall Study|Lost to Follow-up|1|||
105507278|NCT00837811|363867543|FG001|Overall Study|Lost to Follow-up|3|||
105507279|NCT00837811|363867544|FG002|Overall Study|Lost to Follow-up|0|||
105507280|NCT00837811|363867542|FG000|Overall Study|Physician Decision|0|||
105507281|NCT00837811|363867543|FG001|Overall Study|Physician Decision|2|||
105507282|NCT00837811|363867544|FG002|Overall Study|Physician Decision|1|||
105507283|NCT00837811|363867542|FG000|Overall Study|Withdrawal by Subject|1|||
105507284|NCT00837811|363867543|FG001|Overall Study|Withdrawal by Subject|9|||
105507285|NCT00837811|363867544|FG002|Overall Study|Withdrawal by Subject|0|||
105507286|NCT00837811|363867542|FG000|Overall Study|Sponsor Decision|0|||
105507287|NCT00837811|363867543|FG001|Overall Study|Sponsor Decision|2|||
105507288|NCT00837811|363867544|FG002|Overall Study|Sponsor Decision|0|||
105507289|NCT02915016|363867545|FG000|Overall Study|Lost to Follow-up|4|||
105507290|NCT02915016|363867546|FG001|Overall Study|Lost to Follow-up|2|||
105507291|NCT02915016|363867547|FG002|Overall Study|Lost to Follow-up|5|||
105507292|NCT02915016|363867548|FG003|Overall Study|Lost to Follow-up|3|||
105507293|NCT02915016|363867549|FG004|Overall Study|Lost to Follow-up|5|||
105507294|NCT02915016|363867550|FG005|Overall Study|Lost to Follow-up|2|||
105507295|NCT02915016|363867551|FG006|Overall Study|Lost to Follow-up|8|||
105507296|NCT02915016|363867552|FG007|Overall Study|Lost to Follow-up|2|||
105507297|NCT02915016|363867545|FG000|Overall Study|Physician Decision|0|||
105507298|NCT02915016|363867546|FG001|Overall Study|Physician Decision|0|||
105507299|NCT02915016|363867547|FG002|Overall Study|Physician Decision|1|||
105507300|NCT02915016|363867548|FG003|Overall Study|Physician Decision|0|||
105507301|NCT02915016|363867549|FG004|Overall Study|Physician Decision|0|||
105507302|NCT02915016|363867550|FG005|Overall Study|Physician Decision|1|||
105507303|NCT02915016|363867551|FG006|Overall Study|Physician Decision|2|||
105507304|NCT02915016|363867552|FG007|Overall Study|Physician Decision|0|||
105507305|NCT02915016|363867545|FG000|Overall Study|Withdrawal by Subject|2|||
105507306|NCT02915016|363867546|FG001|Overall Study|Withdrawal by Subject|0|||
105507307|NCT02915016|363867547|FG002|Overall Study|Withdrawal by Subject|1|||
105507308|NCT02915016|363867548|FG003|Overall Study|Withdrawal by Subject|0|||
105507309|NCT02915016|363867549|FG004|Overall Study|Withdrawal by Subject|1|||
105507310|NCT02915016|363867550|FG005|Overall Study|Withdrawal by Subject|3|||
105507311|NCT02915016|363867551|FG006|Overall Study|Withdrawal by Subject|1|||
105507312|NCT02915016|363867552|FG007|Overall Study|Withdrawal by Subject|1|||
105507313|NCT02915016|363867545|FG000|Overall Study|Elected not to continue|0|||
105507314|NCT02915016|363867546|FG001|Overall Study|Elected not to continue|0|||
105507315|NCT02915016|363867547|FG002|Overall Study|Elected not to continue|0|||
105507316|NCT02915016|363867548|FG003|Overall Study|Elected not to continue|1|||
105507317|NCT02915016|363867549|FG004|Overall Study|Elected not to continue|0|||
105507318|NCT02915016|363867550|FG005|Overall Study|Elected not to continue|0|||
105507319|NCT02915016|363867551|FG006|Overall Study|Elected not to continue|1|||
105507320|NCT02915016|363867552|FG007|Overall Study|Elected not to continue|0|||
105507321|NCT02915016|363867545|FG000|Overall Study|HIV infection|1|||
105507322|NCT02915016|363867546|FG001|Overall Study|HIV infection|1|||
105507323|NCT02915016|363867547|FG002|Overall Study|HIV infection|1|||
105507324|NCT02915016|363867548|FG003|Overall Study|HIV infection|0|||
105507325|NCT02915016|363867549|FG004|Overall Study|HIV infection|1|||
105507326|NCT02915016|363867550|FG005|Overall Study|HIV infection|0|||
105507327|NCT02915016|363867551|FG006|Overall Study|HIV infection|0|||
105507328|NCT02915016|363867552|FG007|Overall Study|HIV infection|0|||
105507329|NCT02915016|363867545|FG000|Overall Study|Participant unable to adhere|0|||
105507330|NCT02915016|363867546|FG001|Overall Study|Participant unable to adhere|0|||
105507331|NCT02915016|363867547|FG002|Overall Study|Participant unable to adhere|0|||
105507332|NCT02915016|363867548|FG003|Overall Study|Participant unable to adhere|0|||
105507333|NCT02915016|363867549|FG004|Overall Study|Participant unable to adhere|0|||
105507334|NCT02915016|363867550|FG005|Overall Study|Participant unable to adhere|0|||
105507335|NCT02915016|363867551|FG006|Overall Study|Participant unable to adhere|0|||
105507336|NCT02915016|363867552|FG007|Overall Study|Participant unable to adhere|1|||
105507337|NCT02578316|363867553|FG000|Extension Phase|Progression of disease|6|||
105507338|NCT02166905|363867554|FG000|Overall Study|Withdrawal by Subject|1|||
105507339|NCT02166905|363867555|FG001|Overall Study|Withdrawal by Subject|0|||
105507340|NCT02166905|363867556|FG002|Overall Study|Withdrawal by Subject|0|||
105507341|NCT02166905|363867557|FG003|Overall Study|Withdrawal by Subject|0|||
105507342|NCT02617628|363867558|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
105507343|NCT02617628|363867559|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
105507344|NCT03904043|363867564|FG000|Overall Study|Adverse Event|1|||
105507345|NCT03904043|363867565|FG001|Overall Study|Adverse Event|1|||
105507346|NCT03904043|363867564|FG000|Overall Study|Withdrawal by Subject|1|||
105507347|NCT03904043|363867565|FG001|Overall Study|Withdrawal by Subject|0|||
105507348|NCT03904043|363867564|FG000|Overall Study|Non-compliance|1|||
105507349|NCT03904043|363867565|FG001|Overall Study|Non-compliance|0|||
105507350|NCT03904043|363867564|FG000|Overall Study|Did not start treatment|1|||
105507351|NCT03904043|363867565|FG001|Overall Study|Did not start treatment|0|||
105507352|NCT01713686|363869438|FG000|Overall Study|Lost to Follow-up|9|||
105507353|NCT01713686|363869438|FG000|Overall Study|Withdrawal by Subject|6|||
105507354|NCT03187197|363869441|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
105507355|NCT03187197|363869442|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
105507356|NCT03187197|363869443|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
105507357|NCT03187197|363869441|FG000|Overall Study|Withdrawal by Subject|8|||
105507358|NCT03187197|363869442|FG001|Overall Study|Withdrawal by Subject|63|||
105507359|NCT03187197|363869443|FG002|Overall Study|Withdrawal by Subject|4|||
105507360|NCT03187197|363869441|FG000|Overall Study|Lost to Follow-up|1|||
105507361|NCT03187197|363869442|FG001|Overall Study|Lost to Follow-up|60|||
105507362|NCT03187197|363869443|FG002|Overall Study|Lost to Follow-up|7|||
105507363|NCT03187197|363869441|FG000|Overall Study|Adverse Event|6|||
105507364|NCT03187197|363869442|FG001|Overall Study|Adverse Event|29|||
105507365|NCT03187197|363869443|FG002|Overall Study|Adverse Event|0|||
105507366|NCT03187197|363869441|FG000|Overall Study|Death|0|||
105507367|NCT03187197|363869442|FG001|Overall Study|Death|11|||
105507368|NCT03187197|363869443|FG002|Overall Study|Death|0|||
105507369|NCT03187197|363869441|FG000|Overall Study|Administrative problem|1|||
105507370|NCT03187197|363869442|FG001|Overall Study|Administrative problem|1|||
105507371|NCT03187197|363869443|FG002|Overall Study|Administrative problem|0|||
105507372|NCT03187197|363869441|FG000|Overall Study|Reason not listed|2|||
105507373|NCT03187197|363869442|FG001|Overall Study|Reason not listed|54|||
105507374|NCT03187197|363869443|FG002|Overall Study|Reason not listed|1|||
105507375|NCT03187197|363869441|FG000|Overall Study|Missing|1|||
105507376|NCT03187197|363869442|FG001|Overall Study|Missing|32|||
105507377|NCT03187197|363869443|FG002|Overall Study|Missing|3|||
105507378|NCT03187197|363869441|FG000|Overall Study|Status missing|2|||
105507379|NCT03187197|363869442|FG001|Overall Study|Status missing|33|||
105507380|NCT03187197|363869443|FG002|Overall Study|Status missing|3|||
105507381|NCT03187197|363869441|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
105507382|NCT03187197|363869442|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
105507383|NCT03187197|363869443|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
105507384|NCT02385045|363869444|FG000|Overall Study|Endoscopy could not be completed|4|||
105507385|NCT00381485|363869445|FG000|Open-Label Run-In Period|Adverse Event|9|||
105507386|NCT00381485|363869446|FG001|Open-Label Run-In Period|Adverse Event|0|||
105507387|NCT00381485|363869447|FG002|Open-Label Run-In Period|Adverse Event|0|||
105507388|NCT00381485|363869448|FG003|Open-Label Run-In Period|Adverse Event|0|||
105507389|NCT00381485|363869445|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
105507390|NCT00381485|363869446|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
105507391|NCT00381485|363869447|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
105507392|NCT00381485|363869448|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
105507393|NCT00381485|363869445|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
105507394|NCT00381485|363869446|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
105507395|NCT00381485|363869447|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
105507396|NCT00381485|363869448|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
105507397|NCT00381485|363869445|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
105507398|NCT00381485|363869446|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
105507399|NCT00381485|363869447|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
105507400|NCT00381485|363869448|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
105507401|NCT00381485|363869445|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
105507402|NCT00381485|363869446|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
105507403|NCT00381485|363869447|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
105507404|NCT00381485|363869448|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
105507405|NCT00381485|363869445|FG000|Open-Label Run-In Period|Treatment failure|1|||
105507406|NCT00381485|363869446|FG001|Open-Label Run-In Period|Treatment failure|0|||
105507407|NCT00381485|363869447|FG002|Open-Label Run-In Period|Treatment failure|0|||
105507408|NCT00381485|363869448|FG003|Open-Label Run-In Period|Treatment failure|0|||
105507409|NCT00381485|363869445|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105507410|NCT00381485|363869446|FG001|Double-Blind Treatment Period|Adverse Event|2|||
105507411|NCT00381485|363869447|FG002|Double-Blind Treatment Period|Adverse Event|2|||
105507412|NCT00381485|363869448|FG003|Double-Blind Treatment Period|Adverse Event|5|||
105507413|NCT00381485|363869445|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
105507414|NCT00381485|363869446|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
105507415|NCT00381485|363869447|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
105507416|NCT00381485|363869448|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
105507417|NCT00381485|363869445|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105507418|NCT00381485|363869446|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
105507419|NCT00381485|363869447|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
105507420|NCT00381485|363869448|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
105507421|NCT00381485|363869445|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
105507422|NCT00381485|363869446|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
105507423|NCT00381485|363869447|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
105507424|NCT00381485|363869448|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
105507425|NCT00381485|363869445|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
105507426|NCT00381485|363869446|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
105507427|NCT00381485|363869447|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
105507428|NCT00381485|363869448|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
105507429|NCT00381485|363869445|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
105507430|NCT00381485|363869446|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
105507431|NCT00381485|363869447|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
105507432|NCT00381485|363869448|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
105507433|NCT00381485|363869445|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
105507434|NCT00381485|363869446|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
105507435|NCT00381485|363869447|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
105507436|NCT00381485|363869448|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
105507437|NCT00381485|363869445|FG000|Double-Blind Treatment Period|Administrative|0|||
105507438|NCT00381485|363869446|FG001|Double-Blind Treatment Period|Administrative|1|||
105507439|NCT00381485|363869447|FG002|Double-Blind Treatment Period|Administrative|0|||
105507440|NCT00381485|363869448|FG003|Double-Blind Treatment Period|Administrative|1|||
105507441|NCT01235351|363869449|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
105507442|NCT01235351|363869450|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
105507443|NCT01648101|363869457|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
105507444|NCT01648101|363869458|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
105507445|NCT01648101|363869459|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
105507446|NCT01648101|363869457|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
105507447|NCT01648101|363869458|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
105507448|NCT01648101|363869459|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
105507449|NCT01648101|363869457|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
105507450|NCT01648101|363869458|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
105507451|NCT01648101|363869459|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
105507452|NCT01648101|363869457|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
105507453|NCT01648101|363869458|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
105507454|NCT01648101|363869459|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
105507455|NCT01648101|363869457|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
105507456|NCT01648101|363869458|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
105507457|NCT01648101|363869459|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
105507458|NCT01648101|363869457|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
105507459|NCT01648101|363869458|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
105507460|NCT01648101|363869459|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
105507461|NCT01648101|363869457|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
105507462|NCT01648101|363869458|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
105507463|NCT01648101|363869459|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
105507464|NCT01648101|363869457|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
105507465|NCT01648101|363869458|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
105507466|NCT01648101|363869459|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
105507467|NCT01648101|363869457|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
105507468|NCT01648101|363869458|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
105507469|NCT01648101|363869459|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
105507470|NCT01648101|363869457|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
105507471|NCT01648101|363869458|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
105507472|NCT01648101|363869459|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
105507473|NCT01648101|363869457|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
105507474|NCT01648101|363869458|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
105507475|NCT01648101|363869459|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
105507476|NCT03311724|363869474|FG000|Overall Study|Physician Decision|0|||
105507477|NCT03311724|363869475|FG001|Overall Study|Physician Decision|0|||
105507478|NCT03311724|363869476|FG002|Overall Study|Physician Decision|0|||
105507479|NCT03311724|363869477|FG003|Overall Study|Physician Decision|1|||
105507480|NCT03311724|363869474|FG000|Overall Study|Protocol Violation|1|||
105507481|NCT03311724|363869475|FG001|Overall Study|Protocol Violation|0|||
105590778|NCT04084769|364162709|FG000|Overall Study|Protocol Violation|1|||
105590779|NCT04084769|364162710|FG001|Overall Study|Protocol Violation|3|||
105590780|NCT04084769|364162711|FG002|Overall Study|Protocol Violation|0|||
105590781|NCT04084769|364162712|FG003|Overall Study|Protocol Violation|1|||
105590782|NCT04084769|364162709|FG000|Overall Study|Withdrawal by Subject|0|||
105590783|NCT04084769|364162710|FG001|Overall Study|Withdrawal by Subject|1|||
105590784|NCT04084769|364162711|FG002|Overall Study|Withdrawal by Subject|0|||
105590785|NCT04084769|364162712|FG003|Overall Study|Withdrawal by Subject|0|||
105590786|NCT04084769|364162709|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105507482|NCT03311724|363869476|FG002|Overall Study|Protocol Violation|1|||
105507483|NCT03311724|363869477|FG003|Overall Study|Protocol Violation|0|||
105507484|NCT03311724|363869474|FG000|Overall Study|Withdrawal by Subject|1|||
105507485|NCT03311724|363869475|FG001|Overall Study|Withdrawal by Subject|1|||
105507486|NCT03311724|363869476|FG002|Overall Study|Withdrawal by Subject|0|||
105507487|NCT03311724|363869477|FG003|Overall Study|Withdrawal by Subject|0|||
105507488|NCT03311724|363869474|FG000|Overall Study|Lost to Follow-up|1|||
105507489|NCT03311724|363869475|FG001|Overall Study|Lost to Follow-up|0|||
105507490|NCT03311724|363869476|FG002|Overall Study|Lost to Follow-up|0|||
105507491|NCT03311724|363869477|FG003|Overall Study|Lost to Follow-up|0|||
105507492|NCT03311724|363869474|FG000|Overall Study|Sponsor Decision|0|||
105507493|NCT03311724|363869475|FG001|Overall Study|Sponsor Decision|0|||
105507494|NCT03311724|363869476|FG002|Overall Study|Sponsor Decision|1|||
105507495|NCT03311724|363869477|FG003|Overall Study|Sponsor Decision|0|||
105507496|NCT02966028|363869479|FG000|Overall Study|Adverse Event|7|||
105507497|NCT02966028|363869480|FG001|Overall Study|Adverse Event|13|||
105507498|NCT02966028|363869481|FG002|Overall Study|Adverse Event|10|||
105507499|NCT02966028|363869479|FG000|Overall Study|Physician Decision|1|||
105507500|NCT02966028|363869480|FG001|Overall Study|Physician Decision|0|||
105507501|NCT02966028|363869481|FG002|Overall Study|Physician Decision|2|||
105507502|NCT02966028|363869479|FG000|Overall Study|Withdrawal by Subject|7|||
105507503|NCT02966028|363869480|FG001|Overall Study|Withdrawal by Subject|5|||
105507504|NCT02966028|363869481|FG002|Overall Study|Withdrawal by Subject|5|||
105507505|NCT02966028|363869479|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
105507506|NCT02966028|363869480|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
105507507|NCT02966028|363869481|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
105507508|NCT00599924|363869485|FG000|Overall Study|Lack of Efficacy|3|||
105507509|NCT00599924|363869486|FG001|Overall Study|Lack of Efficacy|5|||
105507510|NCT00599924|363869487|FG002|Overall Study|Lack of Efficacy|1|||
105507511|NCT00599924|363869488|FG003|Overall Study|Lack of Efficacy|2|||
105507512|NCT00599924|363869489|FG004|Overall Study|Lack of Efficacy|3|||
105507513|NCT00599924|363869490|FG005|Overall Study|Lack of Efficacy|2|||
105507514|NCT00599924|363869491|FG006|Overall Study|Lack of Efficacy|0|||
105507515|NCT00599924|363869485|FG000|Overall Study|Adverse Event|0|||
105507516|NCT00599924|363869486|FG001|Overall Study|Adverse Event|0|||
105507517|NCT00599924|363869487|FG002|Overall Study|Adverse Event|0|||
105507518|NCT00599924|363869488|FG003|Overall Study|Adverse Event|2|||
105507519|NCT00599924|363869489|FG004|Overall Study|Adverse Event|0|||
105507520|NCT00599924|363869490|FG005|Overall Study|Adverse Event|0|||
105507521|NCT00599924|363869491|FG006|Overall Study|Adverse Event|2|||
105507522|NCT00599924|363869485|FG000|Overall Study|Death|0|||
105507523|NCT00599924|363869486|FG001|Overall Study|Death|0|||
105507524|NCT00599924|363869487|FG002|Overall Study|Death|0|||
105590787|NCT04084769|364162710|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105590788|NCT04084769|364162711|FG002|Overall Study|Withdrawal by parent/guardian|0|||
105590789|NCT04084769|364162712|FG003|Overall Study|Withdrawal by parent/guardian|1|||
105590790|NCT04084769|364162709|FG000|Overall Study|Lost to Follow-up|2|||
105590791|NCT04084769|364162710|FG001|Overall Study|Lost to Follow-up|0|||
105590792|NCT04084769|364162711|FG002|Overall Study|Lost to Follow-up|0|||
105590793|NCT04084769|364162712|FG003|Overall Study|Lost to Follow-up|0|||
105590794|NCT01560949|364162714|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
105590795|NCT01560949|364162714|FG000|Surgery Phase|Physician Decision|3|||
105590796|NCT02486588|364162715|FG000|Overall Study|Randomized in error- ineligible|738|||
105590797|NCT02486588|364162716|FG001|Overall Study|Randomized in error- ineligible|750|||
105590798|NCT02486588|364162717|FG002|Overall Study|Randomized in error- ineligible|755|||
105590799|NCT02486588|364162718|FG003|Overall Study|Randomized in error- ineligible|738|||
105590800|NCT02486588|364162719|FG004|Overall Study|Randomized in error- ineligible|746|||
105590801|NCT02486588|364162720|FG005|Overall Study|Randomized in error- ineligible|746|||
105507525|NCT00599924|363869488|FG003|Overall Study|Death|2|||
105507526|NCT00599924|363869489|FG004|Overall Study|Death|0|||
105507527|NCT00599924|363869490|FG005|Overall Study|Death|2|||
105507528|NCT00599924|363869491|FG006|Overall Study|Death|1|||
105507529|NCT00599924|363869485|FG000|Overall Study|Protocol Violation|0|||
105507530|NCT00599924|363869486|FG001|Overall Study|Protocol Violation|0|||
105507531|NCT00599924|363869487|FG002|Overall Study|Protocol Violation|0|||
105507532|NCT00599924|363869488|FG003|Overall Study|Protocol Violation|1|||
105507533|NCT00599924|363869489|FG004|Overall Study|Protocol Violation|0|||
105507534|NCT00599924|363869490|FG005|Overall Study|Protocol Violation|0|||
105507535|NCT00599924|363869491|FG006|Overall Study|Protocol Violation|0|||
105507536|NCT00599924|363869485|FG000|Overall Study|Withdrawal by Subject|0|||
105507537|NCT00599924|363869486|FG001|Overall Study|Withdrawal by Subject|0|||
105507538|NCT00599924|363869487|FG002|Overall Study|Withdrawal by Subject|1|||
105507539|NCT00599924|363869488|FG003|Overall Study|Withdrawal by Subject|0|||
105507540|NCT00599924|363869489|FG004|Overall Study|Withdrawal by Subject|1|||
105507541|NCT00599924|363869490|FG005|Overall Study|Withdrawal by Subject|0|||
105507542|NCT00599924|363869491|FG006|Overall Study|Withdrawal by Subject|0|||
105507543|NCT00599924|363869485|FG000|Overall Study|Other|0|||
105507544|NCT00599924|363869486|FG001|Overall Study|Other|0|||
105507545|NCT00599924|363869487|FG002|Overall Study|Other|0|||
105507546|NCT00599924|363869488|FG003|Overall Study|Other|1|||
105507547|NCT00599924|363869489|FG004|Overall Study|Other|2|||
105507548|NCT00599924|363869490|FG005|Overall Study|Other|0|||
105507549|NCT00599924|363869491|FG006|Overall Study|Other|2|||
105507550|NCT01806298|363869492|FG000|Overall Study|Adverse Event|3|||
105507551|NCT01806298|363869492|FG000|Overall Study|Protocol Non-compliance|1|||
105507552|NCT01806298|363869492|FG000|Overall Study|Withdrawal by Subject|1|||
105507553|NCT01806298|363869492|FG000|Overall Study|Other|5|||
105507554|NCT03808545|363869493|FG000|Overall Study|Withdrawal by Subject|1|||
105507555|NCT03808545|363869494|FG001|Overall Study|Withdrawal by Subject|1|||
105507556|NCT00980057|363869495|FG000|Overall Study|Death|13|||
105507557|NCT00980057|363869496|FG001|Overall Study|Death|3|||
105507558|NCT00980057|363869495|FG000|Overall Study|Adverse Event|0|||
105507559|NCT00980057|363869496|FG001|Overall Study|Adverse Event|1|||
105507560|NCT00980057|363869495|FG000|Overall Study|Physician Decision|4|||
105507561|NCT00980057|363869496|FG001|Overall Study|Physician Decision|0|||
105507562|NCT00980057|363869495|FG000|Overall Study|Lost to Follow-up|1|||
105507563|NCT00980057|363869496|FG001|Overall Study|Lost to Follow-up|0|||
105507564|NCT00980057|363869495|FG000|Overall Study|Withdrawal by Subject|1|||
105507565|NCT00980057|363869496|FG001|Overall Study|Withdrawal by Subject|1|||
105507566|NCT00592384|363869502|FG000|Overall Study|Withdrawal by Subject|5|||
105507567|NCT00592384|363869503|FG001|Overall Study|Withdrawal by Subject|6|||
105507568|NCT00062374|363869504|FG000|Overall Study|Not treated|12|||
105507569|NCT03633695|363869508|FG000|Overall Study|Lost to Follow-up|4|||
105507570|NCT03633695|363869509|FG001|Overall Study|Lost to Follow-up|5|||
105507571|NCT03633695|363869508|FG000|Overall Study|Discontinued|8|||
105507572|NCT03633695|363869509|FG001|Overall Study|Discontinued|4|||
105507573|NCT00187486|363869512|FG000|Overall Study|Protocol Violation|1|||
105507574|NCT00684593|363869513|FG000|Overall Study|Adverse Event|0|||
105507575|NCT00684593|363869514|FG001|Overall Study|Adverse Event|2|||
105507576|NCT02380677|363869522|FG000|Overall Study|Adverse Event|0|||
105507577|NCT02380677|363869523|FG001|Overall Study|Adverse Event|0|||
105507578|NCT02380677|363869524|FG002|Overall Study|Adverse Event|0|||
105507579|NCT02380677|363869525|FG003|Overall Study|Adverse Event|1|||
105507580|NCT02380677|363869526|FG004|Overall Study|Adverse Event|1|||
105507581|NCT02380677|363869527|FG005|Overall Study|Adverse Event|4|||
105507582|NCT02380677|363869528|FG006|Overall Study|Adverse Event|2|||
105507583|NCT02380677|363869529|FG007|Overall Study|Adverse Event|2|||
105507584|NCT02380677|363869530|FG008|Overall Study|Adverse Event|2|||
105507585|NCT02380677|363869531|FG009|Overall Study|Adverse Event|1|||
105507586|NCT02380677|363869532|FG010|Overall Study|Adverse Event|2|||
105507587|NCT02380677|363869533|FG011|Overall Study|Adverse Event|1|||
105507588|NCT02380677|363869522|FG000|Overall Study|Physician Decision|1|||
105507589|NCT02380677|363869523|FG001|Overall Study|Physician Decision|0|||
105507590|NCT02380677|363869524|FG002|Overall Study|Physician Decision|1|||
105507591|NCT02380677|363869525|FG003|Overall Study|Physician Decision|1|||
105507592|NCT02380677|363869526|FG004|Overall Study|Physician Decision|0|||
105507593|NCT02380677|363869527|FG005|Overall Study|Physician Decision|0|||
105507594|NCT02380677|363869528|FG006|Overall Study|Physician Decision|0|||
105507595|NCT02380677|363869529|FG007|Overall Study|Physician Decision|0|||
105507596|NCT02380677|363869530|FG008|Overall Study|Physician Decision|0|||
105507597|NCT02380677|363869531|FG009|Overall Study|Physician Decision|0|||
105507598|NCT02380677|363869532|FG010|Overall Study|Physician Decision|0|||
105507599|NCT02380677|363869533|FG011|Overall Study|Physician Decision|0|||
105507600|NCT02380677|363869522|FG000|Overall Study|Lack of Efficacy|0|||
105507601|NCT02380677|363869523|FG001|Overall Study|Lack of Efficacy|1|||
105507602|NCT02380677|363869524|FG002|Overall Study|Lack of Efficacy|2|||
105507603|NCT02380677|363869525|FG003|Overall Study|Lack of Efficacy|0|||
105507604|NCT02380677|363869526|FG004|Overall Study|Lack of Efficacy|4|||
105507605|NCT02380677|363869527|FG005|Overall Study|Lack of Efficacy|1|||
105507606|NCT02380677|363869528|FG006|Overall Study|Lack of Efficacy|1|||
105507607|NCT02380677|363869529|FG007|Overall Study|Lack of Efficacy|2|||
105507608|NCT02380677|363869530|FG008|Overall Study|Lack of Efficacy|2|||
105507609|NCT02380677|363869531|FG009|Overall Study|Lack of Efficacy|0|||
105507610|NCT02380677|363869532|FG010|Overall Study|Lack of Efficacy|2|||
105507611|NCT02380677|363869533|FG011|Overall Study|Lack of Efficacy|1|||
105507612|NCT02380677|363869522|FG000|Overall Study|Withdrawal by Subject|0|||
105507613|NCT02380677|363869523|FG001|Overall Study|Withdrawal by Subject|0|||
105507614|NCT02380677|363869524|FG002|Overall Study|Withdrawal by Subject|0|||
105507615|NCT02380677|363869525|FG003|Overall Study|Withdrawal by Subject|0|||
105507616|NCT02380677|363869526|FG004|Overall Study|Withdrawal by Subject|0|||
105507617|NCT02380677|363869527|FG005|Overall Study|Withdrawal by Subject|0|||
105507618|NCT02380677|363869528|FG006|Overall Study|Withdrawal by Subject|0|||
105507619|NCT02380677|363869529|FG007|Overall Study|Withdrawal by Subject|0|||
105507620|NCT02380677|363869530|FG008|Overall Study|Withdrawal by Subject|0|||
105507621|NCT02380677|363869531|FG009|Overall Study|Withdrawal by Subject|1|||
105507622|NCT02380677|363869532|FG010|Overall Study|Withdrawal by Subject|0|||
105507623|NCT02380677|363869533|FG011|Overall Study|Withdrawal by Subject|3|||
105507624|NCT02380677|363869522|FG000|Overall Study|Other|0|||
105507625|NCT02380677|363869523|FG001|Overall Study|Other|0|||
105507626|NCT02380677|363869524|FG002|Overall Study|Other|0|||
105507627|NCT02380677|363869525|FG003|Overall Study|Other|1|||
105507628|NCT02380677|363869526|FG004|Overall Study|Other|1|||
105507629|NCT02380677|363869527|FG005|Overall Study|Other|1|||
105507630|NCT02380677|363869528|FG006|Overall Study|Other|0|||
105507631|NCT02380677|363869529|FG007|Overall Study|Other|0|||
105507632|NCT02380677|363869530|FG008|Overall Study|Other|0|||
105507633|NCT02380677|363869531|FG009|Overall Study|Other|0|||
105507634|NCT02380677|363869532|FG010|Overall Study|Other|0|||
105507635|NCT02380677|363869533|FG011|Overall Study|Other|0|||
105507636|NCT03217175|363869537|FG000|Overall Study|Physician Decision|4|||
105507637|NCT03217175|363869538|FG001|Overall Study|Physician Decision|1|||
105507638|NCT05035550|363869542|FG000|Overall Study|Withdrawal by Subject|3|||
105507639|NCT05035550|363869543|FG001|Overall Study|Withdrawal by Subject|0|||
105507640|NCT01396148|363869544|FG000|Overall Study|Patient Decision|1|||
105507641|NCT00840450|363869551|FG000|Overall Study|Adverse Event|1|||
105507642|NCT00840450|363869551|FG000|Overall Study|Lack of Efficacy|2|||
105507643|NCT02495168|363869552|FG000|Overall Study|Other than Specified|18|||
105507644|NCT02495168|363869553|FG001|Overall Study|Other than Specified|22|||
105507645|NCT02495168|363869554|FG002|Overall Study|Other than Specified|5|||
105507646|NCT02495168|363869552|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
105507647|NCT02495168|363869553|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
105507648|NCT02495168|363869554|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
105507649|NCT02495168|363869552|FG000|Overall Study|Physician Decision|1|||
105507650|NCT02495168|363869553|FG001|Overall Study|Physician Decision|1|||
105507651|NCT02495168|363869554|FG002|Overall Study|Physician Decision|0|||
105507652|NCT02495168|363869552|FG000|Overall Study|Lost to Follow-up|10|||
105507653|NCT02495168|363869553|FG001|Overall Study|Lost to Follow-up|6|||
105507654|NCT02495168|363869554|FG002|Overall Study|Lost to Follow-up|1|||
105507655|NCT02495168|363869552|FG000|Overall Study|Withdrawal by Subject|1|||
105507656|NCT02495168|363869553|FG001|Overall Study|Withdrawal by Subject|4|||
105507657|NCT02495168|363869554|FG002|Overall Study|Withdrawal by Subject|2|||
105507658|NCT02495168|363869552|FG000|Overall Study|Protocol Violation|0|||
105507659|NCT02495168|363869553|FG001|Overall Study|Protocol Violation|10|||
105507660|NCT02495168|363869554|FG002|Overall Study|Protocol Violation|1|||
105507661|NCT02495168|363869552|FG000|Overall Study|Adverse Event|4|||
105507662|NCT02495168|363869553|FG001|Overall Study|Adverse Event|8|||
105507663|NCT02495168|363869554|FG002|Overall Study|Adverse Event|3|||
105507664|NCT02495168|363869552|FG000|Overall Study|Lack of Efficacy|0|||
105507665|NCT02495168|363869553|FG001|Overall Study|Lack of Efficacy|0|||
105507666|NCT02495168|363869554|FG002|Overall Study|Lack of Efficacy|3|||
105507667|NCT01976338|363869555|FG000|Overall Study|Physician Decision|0|||
105507668|NCT01976338|363869556|FG001|Overall Study|Physician Decision|1|||
105507669|NCT01976338|363869555|FG000|Overall Study|Lost to Follow-up|3|||
105507670|NCT01976338|363869556|FG001|Overall Study|Lost to Follow-up|0|||
105507671|NCT01976338|363869555|FG000|Overall Study|Withdrawal by Subject|5|||
105507672|NCT01976338|363869556|FG001|Overall Study|Withdrawal by Subject|2|||
105507673|NCT01976338|363869555|FG000|Overall Study|Adverse Event|5|||
105507674|NCT01976338|363869556|FG001|Overall Study|Adverse Event|1|||
105507675|NCT04390191|363869559|FG000|Overall Study|Withdrawal by Subject|1|||
105507676|NCT04390191|363869560|FG001|Overall Study|Withdrawal by Subject|0|||
105507677|NCT02794883|363869561|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
105507678|NCT02794883|363869562|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
105507679|NCT02794883|363869563|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
105507680|NCT02794883|363869561|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
105507681|NCT02794883|363869562|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
105507682|NCT02794883|363869563|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
105507683|NCT02794883|363869561|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
105507684|NCT02794883|363869562|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
105507685|NCT02794883|363869563|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
105507686|NCT02794883|363869561|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
105507687|NCT02794883|363869562|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
105507688|NCT02794883|363869563|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
105507689|NCT02794883|363869561|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
105507690|NCT02794883|363869562|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
105507691|NCT02794883|363869563|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
105507692|NCT02794883|363869561|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
105507693|NCT02794883|363869562|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
105507694|NCT02794883|363869563|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
105507695|NCT02794883|363869561|FG000|Follow-up Period (up to 2 Years)|Death|12|||
105507696|NCT02794883|363869562|FG001|Follow-up Period (up to 2 Years)|Death|10|||
105507697|NCT02794883|363869563|FG002|Follow-up Period (up to 2 Years)|Death|10|||
105507698|NCT03978832|363869564|FG000|Overall Study|Adverse Event|1|||
105507699|NCT03978832|363869564|FG000|Overall Study|Lost to Follow-up|1|||
105507700|NCT03978832|363869564|FG000|Overall Study|Withdrawal by Subject|6|||
105507701|NCT03978832|363869564|FG000|Overall Study|Physician Decision|2|||
105507702|NCT03978832|363869564|FG000|Overall Study|did not pass screening criteria|44|||
105507703|NCT02864498|363869569|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
105507704|NCT02864498|363869570|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
105507705|NCT02864498|363869571|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
105507706|NCT02864498|363869569|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
105507707|NCT02864498|363869570|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
105507708|NCT02864498|363869571|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
105507709|NCT02864498|363869569|FG000|Overall Study|Investigator Discretion|0|||
105507710|NCT02864498|363869570|FG001|Overall Study|Investigator Discretion|2|||
105507711|NCT02864498|363869571|FG002|Overall Study|Investigator Discretion|1|||
105507712|NCT02864498|363869569|FG000|Overall Study|Lost to Follow-up|8|||
105507713|NCT02864498|363869570|FG001|Overall Study|Lost to Follow-up|6|||
105507714|NCT02864498|363869571|FG002|Overall Study|Lost to Follow-up|3|||
105507715|NCT02864498|363869569|FG000|Overall Study|Lack of Efficacy|5|||
105507716|NCT02864498|363869570|FG001|Overall Study|Lack of Efficacy|3|||
105507717|NCT02864498|363869571|FG002|Overall Study|Lack of Efficacy|3|||
105507718|NCT02864498|363869569|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
105507719|NCT02864498|363869570|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
105507720|NCT02864498|363869571|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
105507721|NCT02864498|363869569|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
105507722|NCT02864498|363869570|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
105507723|NCT02864498|363869571|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
105507724|NCT02864498|363869569|FG000|Overall Study|Subject moved out of the country.|0|||
105507725|NCT02864498|363869570|FG001|Overall Study|Subject moved out of the country.|0|||
105507726|NCT02864498|363869571|FG002|Overall Study|Subject moved out of the country.|1|||
105507727|NCT01812174|363869572|FG000|Overall Study|Death|1|||
105507728|NCT01812174|363869573|FG001|Overall Study|Death|0|||
105507729|NCT01812174|363869572|FG000|Overall Study|Protocol Violation|2|||
105507730|NCT01812174|363869573|FG001|Overall Study|Protocol Violation|0|||
105507731|NCT02627144|363869579|FG000|Overall Study|Serious adverse event|32|||
105507732|NCT02627144|363869579|FG000|Overall Study|Cancer progression|171|||
105507733|NCT02627144|363869579|FG000|Overall Study|Death from cancer|20|||
105507734|NCT02627144|363869579|FG000|Overall Study|Death from other cause|8|||
105507735|NCT02627144|363869579|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
105507736|NCT02627144|363869579|FG000|Overall Study|Administrative reasons|65|||
105507737|NCT02627144|363869579|FG000|Overall Study|Lost to Follow-up|8|||
105507738|NCT02627144|363869579|FG000|Overall Study|Enrolled, not treated|6|||
105507739|NCT02627144|363869579|FG000|Overall Study|Other|17|||
105507740|NCT00119106|363869580|FG000|Overall Study|HIV infected at baseline|179|||
105507741|NCT00119106|363869581|FG001|Overall Study|HIV infected at baseline|178|||
105507742|NCT00730132|363869582|FG000|Overall Study|Protocol Violation|154|||
105507743|NCT00730132|363869582|FG000|Overall Study|Death|1|||
105507744|NCT01051323|363869583|FG000|Overall Study|Discontinuation of treatment|103|||
105507745|NCT01051323|363869583|FG000|Overall Study|Transplantation|28|||
105507746|NCT01051323|363869583|FG000|Overall Study|Dialysis dependency|22|||
105507747|NCT01051323|363869583|FG000|Overall Study|Withdrawal by Subject|13|||
105507748|NCT01051323|363869583|FG000|Overall Study|Lost to Follow-up|31|||
105507749|NCT01051323|363869583|FG000|Overall Study|Death|129|||
105507750|NCT01051323|363869583|FG000|Overall Study|Hospitalization|28|||
105507751|NCT01051323|363869583|FG000|Overall Study|Other|148|||
105507752|NCT01051323|363869583|FG000|Overall Study|Missing|37|||
105507753|NCT01626391|363869584|FG000|Overall Study|Physician Decision|1|||
105507754|NCT01626391|363869585|FG001|Overall Study|Physician Decision|0|||
105507755|NCT01626391|363869584|FG000|Overall Study|Withdrawal by Subject|1|||
105507756|NCT01626391|363869585|FG001|Overall Study|Withdrawal by Subject|0|||
105507757|NCT00370032|363869588|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
105507758|NCT00370032|363869589|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
105507759|NCT00370032|363869588|FG000|Washout Period|Withdrawal by Subject|0|||
105507760|NCT00370032|363869589|FG001|Washout Period|Withdrawal by Subject|1|||
105507761|NCT00370032|363869588|FG000|Washout Period|Lost to Follow-up|0|||
105507762|NCT00370032|363869589|FG001|Washout Period|Lost to Follow-up|1|||
105507763|NCT00370032|363869588|FG000|Washout Period|Adverse Event|1|||
105507764|NCT00370032|363869589|FG001|Washout Period|Adverse Event|0|||
105507765|NCT00370032|363869588|FG000|Follow-up Period|Withdrawal by Subject|1|||
105507766|NCT00370032|363869589|FG001|Follow-up Period|Withdrawal by Subject|0|||
105507767|NCT01930123|363869590|FG000|Overall Study|Adverse Event|1|||
105507768|NCT01930123|363869591|FG001|Overall Study|Adverse Event|0|||
105507769|NCT01930123|363869590|FG000|Overall Study|Physician Decision|21|||
105507770|NCT01930123|363869591|FG001|Overall Study|Physician Decision|8|||
105507771|NCT01930123|363869590|FG000|Overall Study|Withdrawal by Subject|1|||
105507772|NCT01930123|363869591|FG001|Overall Study|Withdrawal by Subject|0|||
105507773|NCT01578187|363869592|FG000|Usability Phase|Withdrawal by Subject|1|||
105507774|NCT00496470|363869593|FG000|Overall Study|Adverse Event|8|||
105507775|NCT00496470|363869594|FG001|Overall Study|Adverse Event|10|||
105507776|NCT00496470|363869593|FG000|Overall Study|Withdrawal by Subject|5|||
105507777|NCT00496470|363869594|FG001|Overall Study|Withdrawal by Subject|12|||
105507778|NCT00496470|363869593|FG000|Overall Study|Incorrectly enrolled|13|||
105507779|NCT00496470|363869594|FG001|Overall Study|Incorrectly enrolled|5|||
105507780|NCT00496470|363869593|FG000|Overall Study|Other reason|0|||
105507781|NCT00496470|363869594|FG001|Overall Study|Other reason|2|||
105507782|NCT01709162|363869595|FG000|Overall Study|Disease progression|3|||
105507783|NCT01709162|363869596|FG001|Overall Study|Disease progression|3|||
105507784|NCT01709162|363869595|FG000|Overall Study|Study drug toxicity|2|||
105507785|NCT01709162|363869596|FG001|Overall Study|Study drug toxicity|0|||
105507786|NCT01709162|363869595|FG000|Overall Study|Administrative reason by sponsor|0|||
105507787|NCT01709162|363869596|FG001|Overall Study|Administrative reason by sponsor|1|||
105507788|NCT01709162|363869595|FG000|Overall Study|Other|1|||
105507789|NCT01709162|363869596|FG001|Overall Study|Other|0|||
105507790|NCT01709162|363869595|FG000|Overall Study|Withdrawal by Subject|0|||
105507791|NCT01709162|363869596|FG001|Overall Study|Withdrawal by Subject|1|||
105507792|NCT03310021|363869597|FG000|Overall Study|Withdrawal by Subject|0|||
105507793|NCT03310021|363869598|FG001|Overall Study|Withdrawal by Subject|0|||
105507794|NCT03310021|363869599|FG002|Overall Study|Withdrawal by Subject|0|||
105507795|NCT03310021|363869600|FG003|Overall Study|Withdrawal by Subject|0|||
105507796|NCT03310021|363869601|FG004|Overall Study|Withdrawal by Subject|0|||
105507797|NCT03310021|363869602|FG005|Overall Study|Withdrawal by Subject|0|||
105507798|NCT03310021|363869603|FG006|Overall Study|Withdrawal by Subject|1|||
105507799|NCT03310021|363869604|FG007|Overall Study|Withdrawal by Subject|0|||
105507800|NCT03310021|363869605|FG008|Overall Study|Withdrawal by Subject|0|||
105507801|NCT03310021|363869606|FG009|Overall Study|Withdrawal by Subject|0|||
105507802|NCT03310021|363869607|FG010|Overall Study|Withdrawal by Subject|0|||
105507803|NCT03310021|363869608|FG011|Overall Study|Withdrawal by Subject|0|||
105507804|NCT03310021|363869609|FG012|Overall Study|Withdrawal by Subject|0|||
105507805|NCT03310021|363869610|FG013|Overall Study|Withdrawal by Subject|0|||
105507806|NCT03310021|363869611|FG014|Overall Study|Withdrawal by Subject|0|||
105507807|NCT03310021|363869612|FG015|Overall Study|Withdrawal by Subject|0|||
105507808|NCT03310021|363869613|FG016|Overall Study|Withdrawal by Subject|0|||
105507809|NCT03310021|363869614|FG017|Overall Study|Withdrawal by Subject|0|||
105507810|NCT03310021|363869615|FG018|Overall Study|Withdrawal by Subject|0|||
105507811|NCT03310021|363869616|FG019|Overall Study|Withdrawal by Subject|0|||
105507812|NCT03310021|363869597|FG000|Overall Study|Lost to Follow-up|0|||
105507813|NCT03310021|363869598|FG001|Overall Study|Lost to Follow-up|0|||
105507814|NCT03310021|363869599|FG002|Overall Study|Lost to Follow-up|0|||
105507815|NCT03310021|363869600|FG003|Overall Study|Lost to Follow-up|0|||
105507816|NCT03310021|363869601|FG004|Overall Study|Lost to Follow-up|0|||
105507817|NCT03310021|363869602|FG005|Overall Study|Lost to Follow-up|0|||
105507818|NCT03310021|363869603|FG006|Overall Study|Lost to Follow-up|0|||
105507819|NCT03310021|363869604|FG007|Overall Study|Lost to Follow-up|0|||
105507820|NCT03310021|363869605|FG008|Overall Study|Lost to Follow-up|0|||
105507821|NCT03310021|363869606|FG009|Overall Study|Lost to Follow-up|0|||
105507822|NCT03310021|363869607|FG010|Overall Study|Lost to Follow-up|1|||
105507823|NCT03310021|363869608|FG011|Overall Study|Lost to Follow-up|0|||
105507824|NCT03310021|363869609|FG012|Overall Study|Lost to Follow-up|0|||
105507825|NCT03310021|363869610|FG013|Overall Study|Lost to Follow-up|0|||
105507826|NCT03310021|363869611|FG014|Overall Study|Lost to Follow-up|0|||
105507827|NCT03310021|363869612|FG015|Overall Study|Lost to Follow-up|0|||
105507828|NCT03310021|363869613|FG016|Overall Study|Lost to Follow-up|0|||
105507829|NCT03310021|363869614|FG017|Overall Study|Lost to Follow-up|0|||
105507830|NCT03310021|363869615|FG018|Overall Study|Lost to Follow-up|0|||
105507831|NCT03310021|363869616|FG019|Overall Study|Lost to Follow-up|0|||
105507832|NCT01233258|363869617|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
105507833|NCT01233258|363869618|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
105507834|NCT01233258|363869619|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
105507835|NCT01233258|363869620|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
105507836|NCT01233258|363869621|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
105507837|NCT01233258|363869622|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
105507838|NCT01233258|363869617|FG000|First Intervention (6 Months)|Protocol Violation|0|||
105507839|NCT01233258|363869618|FG001|First Intervention (6 Months)|Protocol Violation|0|||
105507840|NCT01233258|363869619|FG002|First Intervention (6 Months)|Protocol Violation|1|||
105507841|NCT01233258|363869620|FG003|First Intervention (6 Months)|Protocol Violation|0|||
105507842|NCT01233258|363869621|FG004|First Intervention (6 Months)|Protocol Violation|0|||
105507843|NCT01233258|363869622|FG005|First Intervention (6 Months)|Protocol Violation|0|||
105507844|NCT01233258|363869617|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
105507845|NCT01233258|363869618|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
105507846|NCT01233258|363869619|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
105507847|NCT01233258|363869620|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
105507848|NCT01233258|363869621|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
105507849|NCT01233258|363869622|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
105507850|NCT00880009|363869623|FG000|Overall Study|Study terminated by sponsor|14|||
105507851|NCT00880009|363869623|FG000|Overall Study|Withdrawal by Subject|1|||
105507852|NCT00880009|363869623|FG000|Overall Study|Protocol Violation|1|||
105507853|NCT00390468|363869624|FG000|Overall Study|Protocol Violation|2|||
105507854|NCT00390468|363869624|FG000|Overall Study|Lack of Efficacy|1|||
105507855|NCT04974697|363869635|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
105507856|NCT04974697|363869635|FG000|Overall Study|Lens discomfort|1|||
105507857|NCT04112784|363869638|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
105507858|NCT04112784|363869638|FG000|Overall Study|Screen Failures|4|||
105507859|NCT04659161|363869641|FG000|Overall Study|Adverse Event|10|||
105507860|NCT04659161|363869642|FG001|Overall Study|Adverse Event|6|||
105507861|NCT04659161|363869641|FG000|Overall Study|Withdrawal by Subject|13|||
105507862|NCT04659161|363869642|FG001|Overall Study|Withdrawal by Subject|12|||
105507863|NCT04659161|363869641|FG000|Overall Study|Other|9|||
105507864|NCT04659161|363869642|FG001|Overall Study|Other|8|||
105507865|NCT01929343|363869643|FG000|Overall Study|Physician Decision|0|||
105507866|NCT01929343|363869644|FG001|Overall Study|Physician Decision|2|||
105507867|NCT01929343|363869645|FG002|Overall Study|Physician Decision|0|||
105507868|NCT01929343|363869643|FG000|Overall Study|Withdrawal by Subject|1|||
105507869|NCT01929343|363869644|FG001|Overall Study|Withdrawal by Subject|0|||
105507870|NCT01929343|363869645|FG002|Overall Study|Withdrawal by Subject|0|||
105507871|NCT02216591|363869651|FG000|Overall Study|Lost to Follow-up|0|||
105507872|NCT02216591|363869652|FG001|Overall Study|Lost to Follow-up|1|||
105507873|NCT04518306|363869662|FG000|Double-Blind Period|Run in failure|0|||
105507874|NCT04518306|363869663|FG001|Double-Blind Period|Run in failure|0|||
105507875|NCT04518306|363869664|FG002|Double-Blind Period|Run in failure|1|||
105507876|NCT04518306|363869662|FG000|Double-Blind Period|Adverse Event|0|||
105507877|NCT04518306|363869663|FG001|Double-Blind Period|Adverse Event|2|||
105507878|NCT04518306|363869664|FG002|Double-Blind Period|Adverse Event|2|||
105507879|NCT04518306|363869662|FG000|Double-Blind Period|Lost to Follow-up|1|||
105507880|NCT04518306|363869663|FG001|Double-Blind Period|Lost to Follow-up|2|||
105507881|NCT04518306|363869664|FG002|Double-Blind Period|Lost to Follow-up|2|||
105507882|NCT04518306|363869662|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
105507883|NCT04518306|363869663|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
105507884|NCT04518306|363869664|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
105507885|NCT04518306|363869662|FG000|Double-Blind Period|Other|0|||
105507886|NCT04518306|363869663|FG001|Double-Blind Period|Other|2|||
105507887|NCT04518306|363869664|FG002|Double-Blind Period|Other|0|||
105507888|NCT04518306|363869662|FG000|Double-Blind Period|Missing|0|||
105507889|NCT04518306|363869663|FG001|Double-Blind Period|Missing|1|||
105507890|NCT04518306|363869664|FG002|Double-Blind Period|Missing|0|||
105507891|NCT05372419|363869665|FG000|Overall Study|Protocol Deviation|1|||
105507892|NCT05372419|363869665|FG000|Overall Study|Withdrawal by Subject|5|||
105507893|NCT05372419|363869665|FG000|Overall Study|Lost to Follow-up|7|||
105507894|NCT02324569|363870867|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
105507895|NCT02324569|363870868|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
105507896|NCT02324569|363870867|FG000|Overall Study|Voluntary Withdrawal|3|||
105507897|NCT02324569|363870868|FG001|Overall Study|Voluntary Withdrawal|6|||
105507898|NCT02324569|363870867|FG000|Overall Study|Lack of Efficacy|2|||
105507899|NCT02324569|363870868|FG001|Overall Study|Lack of Efficacy|3|||
105507900|NCT02324569|363870867|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
105507901|NCT02324569|363870868|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
105507902|NCT02324569|363870867|FG000|Overall Study|Inconvenient Schedule|2|||
105507903|NCT02324569|363870868|FG001|Overall Study|Inconvenient Schedule|0|||
105507904|NCT03156543|363870869|FG000|Overall Study|Withdrawal by Subject|1|||
105507905|NCT03156543|363870870|FG001|Overall Study|Withdrawal by Subject|0|||
105507906|NCT00674700|363870871|FG000|Year 1|Adverse Event|17|||
105507907|NCT00674700|363870872|FG001|Year 1|Adverse Event|20|||
105507908|NCT00674700|363870873|FG002|Year 1|Adverse Event|5|||
105507909|NCT00674700|363870871|FG000|Year 1|Withdrawal by Subject|7|||
105507910|NCT00674700|363870872|FG001|Year 1|Withdrawal by Subject|7|||
105507911|NCT00674700|363870873|FG002|Year 1|Withdrawal by Subject|6|||
105507912|NCT00674700|363870871|FG000|Year 1|Any other reason not above-mentioned|7|||
105507913|NCT00674700|363870872|FG001|Year 1|Any other reason not above-mentioned|7|||
105507914|NCT00674700|363870873|FG002|Year 1|Any other reason not above-mentioned|6|||
105507915|NCT00674700|363870871|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
105507916|NCT00674700|363870872|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
105507917|NCT00674700|363870873|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
105507918|NCT00674700|363870871|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
105507919|NCT00674700|363870872|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
105507920|NCT00674700|363870873|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
105507921|NCT00674700|363870871|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
105507922|NCT00674700|363870872|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
105507923|NCT00674700|363870873|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
105507924|NCT02601469|363870874|FG000|Overall Study|Enrolled in Error|1|||
105507925|NCT02601469|363870875|FG001|Overall Study|Enrolled in Error|0|||
105507926|NCT00630396|363870883|FG000|Overall Study|Death|4|||
105507927|NCT00630396|363870883|FG000|Overall Study|Lost to Follow-up|3|||
105507928|NCT00056316|363870884|FG000|Overall Study|Withdrawal by Subject|2|||
105507929|NCT00056316|363870885|FG001|Overall Study|Withdrawal by Subject|2|||
105507930|NCT00056316|363870884|FG000|Overall Study|Death/NH placement of pt|1|||
105507931|NCT00056316|363870885|FG001|Overall Study|Death/NH placement of pt|1|||
105507932|NCT04980040|363870886|FG000|Overall Study|Violated the Inclusion Criteria|260|||
105507933|NCT04980040|363870886|FG000|Overall Study|Violated the Administration & Dosage|225|||
105507934|NCT04980040|363870886|FG000|Overall Study|Lost to Safety-Follow-up|4|||
105507935|NCT04980040|363870886|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
105507936|NCT02161731|363870890|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
105507937|NCT02161731|363870891|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
105507938|NCT02161731|363870890|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
105507939|NCT02161731|363870891|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
105507940|NCT00691015|363870892|FG000|Overall Study|Refused further treatment|1|||
105507941|NCT01408485|363870893|FG000|Overall Study|Withdrawal by Subject|21|||
105507942|NCT02151591|363870894|FG000|Overall Study|Lost to Follow-up|6|||
105507943|NCT02151591|363870895|FG001|Overall Study|Lost to Follow-up|3|||
105507944|NCT00578812|363870896|FG000|Overall Study|Not treated|6|||
105507945|NCT00578812|363870897|FG001|Overall Study|Not treated|7|||
105507946|NCT01508650|363870903|FG000|Overall Study|Lost to Follow-up|0|||
105507947|NCT01508650|363870904|FG001|Overall Study|Lost to Follow-up|3|||
105507948|NCT00884312|363870905|FG000|Overall Study|Non-fatal Progressive Disease|0|||
105507949|NCT00884312|363870906|FG001|Overall Study|Non-fatal Progressive Disease|8|||
105507950|NCT00884312|363870905|FG000|Overall Study|Fatal Progressive Disease|0|||
105507951|NCT00884312|363870906|FG001|Overall Study|Fatal Progressive Disease|1|||
105507952|NCT00884312|363870905|FG000|Overall Study|Non-fatal Adverse Event|1|||
105507953|NCT00884312|363870906|FG001|Overall Study|Non-fatal Adverse Event|0|||
105507954|NCT00884312|363870905|FG000|Overall Study|Fatal Adverse Event|1|||
105507955|NCT00884312|363870906|FG001|Overall Study|Fatal Adverse Event|4|||
105507956|NCT00884312|363870905|FG000|Overall Study|Withdrawal by Subject|0|||
105507957|NCT00884312|363870906|FG001|Overall Study|Withdrawal by Subject|6|||
105507958|NCT00884312|363870905|FG000|Overall Study|Physician Decision|0|||
105507959|NCT00884312|363870906|FG001|Overall Study|Physician Decision|1|||
105507960|NCT00884312|363870905|FG000|Overall Study|Other|0|||
105507961|NCT00884312|363870906|FG001|Overall Study|Other|4|||
105507962|NCT00884312|363870905|FG000|Overall Study|Did Not Receive Study Drug|0|||
105507963|NCT00884312|363870906|FG001|Overall Study|Did Not Receive Study Drug|1|||
105507964|NCT03052725|363870908|FG000|Overall Study|Adverse Event|2|||
105507965|NCT03052725|363870909|FG001|Overall Study|Adverse Event|0|||
105507966|NCT03052725|363870908|FG000|Overall Study|Withdrawal by Subject|3|||
105507967|NCT03052725|363870909|FG001|Overall Study|Withdrawal by Subject|4|||
105507968|NCT03052725|363870908|FG000|Overall Study|Pregnancy|0|||
105507969|NCT03052725|363870909|FG001|Overall Study|Pregnancy|1|||
105507970|NCT03052725|363870908|FG000|Overall Study|Site closure|0|||
105507971|NCT03052725|363870909|FG001|Overall Study|Site closure|1|||
105507972|NCT03052725|363870908|FG000|Overall Study|Study terminated by sponsor|143|||
105507973|NCT03052725|363870909|FG001|Overall Study|Study terminated by sponsor|144|||
105507974|NCT00520936|363870910|FG000|Overall Study|Physician Decision|0|||
105507975|NCT00520936|363870911|FG001|Overall Study|Physician Decision|2|||
105507976|NCT00520936|363870912|FG002|Overall Study|Physician Decision|1|||
105507977|NCT00520936|363870913|FG003|Overall Study|Physician Decision|0|||
105507978|NCT00520936|363870914|FG004|Overall Study|Physician Decision|0|||
105507979|NCT00520936|363870915|FG005|Overall Study|Physician Decision|0|||
105507980|NCT00520936|363870916|FG006|Overall Study|Physician Decision|0|||
105507981|NCT00520936|363870917|FG007|Overall Study|Physician Decision|0|||
105507982|NCT00520936|363870910|FG000|Overall Study|Withdrawal by Subject|0|||
105507983|NCT00520936|363870911|FG001|Overall Study|Withdrawal by Subject|0|||
105507984|NCT00520936|363870912|FG002|Overall Study|Withdrawal by Subject|0|||
105507985|NCT00520936|363870913|FG003|Overall Study|Withdrawal by Subject|0|||
105507986|NCT00520936|363870914|FG004|Overall Study|Withdrawal by Subject|0|||
105507987|NCT00520936|363870915|FG005|Overall Study|Withdrawal by Subject|0|||
105507988|NCT00520936|363870916|FG006|Overall Study|Withdrawal by Subject|0|||
105507989|NCT00520936|363870917|FG007|Overall Study|Withdrawal by Subject|1|||
105507990|NCT00520936|363870910|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
105507991|NCT00520936|363870911|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
105507992|NCT00520936|363870912|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
105507993|NCT00520936|363870913|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
105507994|NCT00520936|363870914|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
105507995|NCT00520936|363870915|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
105507996|NCT00520936|363870916|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
105507997|NCT00520936|363870917|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
105507998|NCT00520936|363870910|FG000|Overall Study|Death|0|||
105507999|NCT00520936|363870911|FG001|Overall Study|Death|0|||
105508000|NCT00520936|363870912|FG002|Overall Study|Death|0|||
105508001|NCT00520936|363870913|FG003|Overall Study|Death|0|||
105508002|NCT00520936|363870914|FG004|Overall Study|Death|0|||
105508003|NCT00520936|363870915|FG005|Overall Study|Death|0|||
105508004|NCT00520936|363870916|FG006|Overall Study|Death|1|||
105508005|NCT00520936|363870917|FG007|Overall Study|Death|0|||
105508006|NCT00520936|363870910|FG000|Overall Study|Protocol Violation|0|||
105508007|NCT00520936|363870911|FG001|Overall Study|Protocol Violation|1|||
105508008|NCT00520936|363870912|FG002|Overall Study|Protocol Violation|1|||
105508009|NCT00520936|363870913|FG003|Overall Study|Protocol Violation|0|||
105508010|NCT00520936|363870914|FG004|Overall Study|Protocol Violation|1|||
105508011|NCT00520936|363870915|FG005|Overall Study|Protocol Violation|0|||
105508012|NCT00520936|363870916|FG006|Overall Study|Protocol Violation|1|||
105508013|NCT00520936|363870917|FG007|Overall Study|Protocol Violation|0|||
105508014|NCT03716024|363870918|FG000|Overall Study|Randomized, not Treated|7|||
105508015|NCT03716024|363870919|FG001|Overall Study|Randomized, not Treated|8|||
105508016|NCT03716024|363870918|FG000|Overall Study|Adverse Event|1|||
105508017|NCT03716024|363870919|FG001|Overall Study|Adverse Event|2|||
105508018|NCT03716024|363870918|FG000|Overall Study|Treatment Failure|1|||
105508019|NCT03716024|363870919|FG001|Overall Study|Treatment Failure|0|||
105508020|NCT03716024|363870918|FG000|Overall Study|Lost to Follow-up|2|||
105508021|NCT03716024|363870919|FG001|Overall Study|Lost to Follow-up|6|||
105508022|NCT03716024|363870918|FG000|Overall Study|Withdrawal by Subject|0|||
105508023|NCT03716024|363870919|FG001|Overall Study|Withdrawal by Subject|1|||
105508024|NCT03716024|363870918|FG000|Overall Study|Missing Reason|0|||
105508025|NCT03716024|363870919|FG001|Overall Study|Missing Reason|1|||
105508026|NCT00867568|363870920|FG000|Overall Study|Lack of Efficacy|10|||
105508027|NCT00867568|363870920|FG000|Overall Study|Adverse Event|4|||
105508028|NCT00867568|363870920|FG000|Overall Study|Withdrawal by Subject|1|||
105508029|NCT05275400|363870924|FG000|Treatment Period|Adverse Event|7|||
105508030|NCT05275400|363870925|FG001|Treatment Period|Adverse Event|1|||
105508031|NCT05275400|363870924|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
105508032|NCT05275400|363870925|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
105508033|NCT05275400|363870924|FG000|Treatment Period|Death|5|||
105508034|NCT05275400|363870925|FG001|Treatment Period|Death|2|||
105508035|NCT05275400|363870924|FG000|Treatment Period|Protocol Violation|1|||
105508036|NCT05275400|363870925|FG001|Treatment Period|Protocol Violation|0|||
105508037|NCT05275400|363870924|FG000|Treatment Period|Physician Decision|5|||
105508038|NCT05275400|363870925|FG001|Treatment Period|Physician Decision|4|||
105508039|NCT05275400|363870924|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
105508040|NCT05275400|363870925|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
105508041|NCT05275400|363870924|FG000|Treatment Period|Withdrawal by Subject|30|||
105508042|NCT05275400|363870925|FG001|Treatment Period|Withdrawal by Subject|12|||
105508043|NCT05275400|363870924|FG000|Treatment Period|Lost to Follow-up|1|||
105508044|NCT05275400|363870925|FG001|Treatment Period|Lost to Follow-up|5|||
105508045|NCT05275400|363870924|FG000|Treatment Period|Lack of Efficacy|1|||
105508046|NCT05275400|363870925|FG001|Treatment Period|Lack of Efficacy|0|||
105508047|NCT05275400|363870924|FG000|Treatment Period|Sponsor Decision|1|||
105508048|NCT05275400|363870925|FG001|Treatment Period|Sponsor Decision|0|||
105508049|NCT05275400|363870924|FG000|Follow-Up Period|Death|2|||
105508050|NCT05275400|363870925|FG001|Follow-Up Period|Death|0|||
105508051|NCT05275400|363870924|FG000|Follow-Up Period|Protocol Violation|1|||
105508052|NCT05275400|363870925|FG001|Follow-Up Period|Protocol Violation|0|||
105508053|NCT05275400|363870924|FG000|Follow-Up Period|Withdrawal by Subject|3|||
105508054|NCT05275400|363870925|FG001|Follow-Up Period|Withdrawal by Subject|0|||
105508055|NCT06333613|363870927|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
105508056|NCT00003479|363870928|FG000|Overall Study|Not evaluable|3|||
105508057|NCT01061177|363870930|FG000|Overall Study|Adverse Event|117|||
105508058|NCT01061177|363870930|FG000|Overall Study|Withdrawal by Subject|27|||
105508059|NCT01061177|363870930|FG000|Overall Study|Disease progression|17|||
105508060|NCT01061177|363870930|FG000|Overall Study|Protocol Violation|11|||
105508061|NCT01061177|363870930|FG000|Overall Study|Lost to Follow-up|9|||
105508062|NCT01061177|363870930|FG000|Overall Study|New cancer therapy|9|||
105508063|NCT01061177|363870930|FG000|Overall Study|Abnormal laboratory values|6|||
105508064|NCT01061177|363870930|FG000|Overall Study|Abnormal test procedure results|4|||
105508065|NCT01061177|363870930|FG000|Overall Study|Administratie problems|4|||
105508066|NCT01061177|363870930|FG000|Overall Study|Death|4|||
105508067|NCT02228460|363870932|FG000|Overall Study|Adverse Event|1|||
105508068|NCT02228460|363870932|FG000|Overall Study|Lost to Follow-up|1|||
105508069|NCT02220205|363870933|FG000|Overall Study|Withdrawal by Subject|1|||
105590802|NCT02685033|364162721|FG000|Overall Study|Withdrawal of Consent|0|||
105590803|NCT02685033|364162722|FG001|Overall Study|Withdrawal of Consent|1|||
105590804|NCT02685033|364162721|FG000|Overall Study|Lost to Follow-up|2|||
105590805|NCT02685033|364162722|FG001|Overall Study|Lost to Follow-up|1|||
105590806|NCT02685033|364162721|FG000|Overall Study|Adverse Event|1|||
105590807|NCT02685033|364162722|FG001|Overall Study|Adverse Event|0|||
105590808|NCT02931396|364162723|FG000|Overall Study|Lost to Follow-up|3|||
105590809|NCT02931396|364162724|FG001|Overall Study|Lost to Follow-up|0|||
105590810|NCT02931396|364162723|FG000|Overall Study|Withdrawal by Subject|2|||
105590811|NCT02931396|364162724|FG001|Overall Study|Withdrawal by Subject|0|||
105590812|NCT01304147|364162727|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
105590813|NCT01304147|364162728|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
105590814|NCT00708097|364162732|FG000|Period 1|Protocol Violation|0|||
105590815|NCT00708097|364162733|FG001|Period 1|Protocol Violation|1|||
105590816|NCT00708097|364162734|FG002|Period 1|Protocol Violation|0|||
105590817|NCT00708097|364162735|FG003|Period 1|Protocol Violation|2|||
105590818|NCT00708097|364162736|FG004|Period 1|Protocol Violation|0|||
105590819|NCT00708097|364162732|FG000|Period 1|Other Reason|0|||
105590820|NCT00708097|364162733|FG001|Period 1|Other Reason|0|||
105590821|NCT00708097|364162734|FG002|Period 1|Other Reason|0|||
105590822|NCT00708097|364162735|FG003|Period 1|Other Reason|0|||
105590823|NCT00708097|364162736|FG004|Period 1|Other Reason|1|||
105590824|NCT00708097|364162732|FG000|Period 2|Protocol Violation|0|||
105590825|NCT00708097|364162733|FG001|Period 2|Protocol Violation|1|||
105590826|NCT00708097|364162734|FG002|Period 2|Protocol Violation|1|||
105590827|NCT00708097|364162735|FG003|Period 2|Protocol Violation|1|||
105590828|NCT00708097|364162736|FG004|Period 2|Protocol Violation|0|||
105590829|NCT01537133|364164212|FG000|Overall Study|Withdrawal by Subject|2|||
105590830|NCT01537133|364164213|FG001|Overall Study|Withdrawal by Subject|0|||
105590831|NCT01537133|364164214|FG002|Overall Study|Withdrawal by Subject|0|||
105590832|NCT01537133|364164215|FG003|Overall Study|Withdrawal by Subject|0|||
105590833|NCT01537133|364164212|FG000|Overall Study|Lost to Follow-up|1|||
105590834|NCT01537133|364164213|FG001|Overall Study|Lost to Follow-up|0|||
105590835|NCT01537133|364164214|FG002|Overall Study|Lost to Follow-up|0|||
105590836|NCT01537133|364164215|FG003|Overall Study|Lost to Follow-up|0|||
105590837|NCT03895034|364164216|FG000|Overall Study|Lost to Follow-up|2|||
105590838|NCT03441360|364164222|FG000|Overall Study|Radiological disease progression|5|||
105590839|NCT03441360|364164223|FG001|Overall Study|Radiological disease progression|6|||
105590840|NCT03441360|364164224|FG002|Overall Study|Radiological disease progression|4|||
105590841|NCT03441360|364164222|FG000|Overall Study|Clinical disease progression|2|||
105590842|NCT03441360|364164223|FG001|Overall Study|Clinical disease progression|2|||
105590843|NCT03441360|364164224|FG002|Overall Study|Clinical disease progression|0|||
105590844|NCT03441360|364164222|FG000|Overall Study|Adverse Event|1|||
105590845|NCT03441360|364164223|FG001|Overall Study|Adverse Event|0|||
105590846|NCT03441360|364164224|FG002|Overall Study|Adverse Event|1|||
105590847|NCT00943605|364164225|FG000|Overall Study|Study termination|30|||
105590848|NCT00943605|364164226|FG001|Overall Study|Study termination|30|||
105590849|NCT03357341|364164227|FG000|Overall Study|Withdrawal by Subject|3|||
105590850|NCT03357341|364164228|FG001|Overall Study|Withdrawal by Subject|6|||
105590851|NCT03357341|364164227|FG000|Overall Study|Lost to Follow-up|4|||
105590852|NCT03357341|364164228|FG001|Overall Study|Lost to Follow-up|5|||
105590853|NCT03357341|364164227|FG000|Overall Study|Death|0|||
105590854|NCT03357341|364164228|FG001|Overall Study|Death|1|||
105590855|NCT00817635|364164229|FG000|Overall Study|Adverse Event|1|||
105590856|NCT00817635|364164230|FG001|Overall Study|Adverse Event|0|||
105590857|NCT00817635|364164231|FG002|Overall Study|Adverse Event|0|||
105590858|NCT00817635|364164232|FG003|Overall Study|Adverse Event|1|||
105590859|NCT00817635|364164233|FG004|Overall Study|Adverse Event|1|||
105590860|NCT00817635|364164229|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
105590861|NCT00817635|364164230|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
105590862|NCT00817635|364164231|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
105590863|NCT00817635|364164232|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
105590864|NCT00817635|364164233|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
105590865|NCT00817635|364164229|FG000|Overall Study|Withdrawal by Subject|2|||
105590866|NCT00817635|364164230|FG001|Overall Study|Withdrawal by Subject|1|||
105590867|NCT00817635|364164231|FG002|Overall Study|Withdrawal by Subject|0|||
105590868|NCT00817635|364164232|FG003|Overall Study|Withdrawal by Subject|1|||
105590869|NCT00817635|364164233|FG004|Overall Study|Withdrawal by Subject|2|||
105590870|NCT00817635|364164229|FG000|Overall Study|Lost to Follow-up|0|||
105590871|NCT00817635|364164230|FG001|Overall Study|Lost to Follow-up|1|||
105590872|NCT00817635|364164231|FG002|Overall Study|Lost to Follow-up|0|||
105590873|NCT00817635|364164232|FG003|Overall Study|Lost to Follow-up|1|||
105590874|NCT00817635|364164233|FG004|Overall Study|Lost to Follow-up|0|||
105590875|NCT00817635|364164229|FG000|Overall Study|Administrative Problems|0|||
105590876|NCT00817635|364164230|FG001|Overall Study|Administrative Problems|0|||
105590877|NCT00817635|364164231|FG002|Overall Study|Administrative Problems|0|||
105590878|NCT00817635|364164232|FG003|Overall Study|Administrative Problems|0|||
105590879|NCT00817635|364164233|FG004|Overall Study|Administrative Problems|1|||
105508070|NCT02220205|363870934|FG001|Overall Study|Withdrawal by Subject|0|||
105508071|NCT03706456|363870936|FG000|Overall Study|Adverse Event|1|||
105508072|NCT03706456|363870936|FG000|Overall Study|Lack of Efficacy|2|||
105508073|NCT02784431|363870937|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
105508074|NCT02784431|363870937|FG000|Overall Study|Early Study Termination|19|||
105508075|NCT02795832|363870938|FG000|Overall Study|Adverse Event|0|||
105508076|NCT02795832|363870939|FG001|Overall Study|Adverse Event|0|||
105508077|NCT02795832|363870940|FG002|Overall Study|Adverse Event|0|||
105508078|NCT02795832|363870941|FG003|Overall Study|Adverse Event|0|||
105508079|NCT02795832|363870942|FG004|Overall Study|Adverse Event|0|||
105508080|NCT02795832|363870943|FG005|Overall Study|Adverse Event|3|||
105508081|NCT02605824|363870944|FG000|Overall Study|Physician Decision|1|||
105508082|NCT02605824|363870945|FG001|Overall Study|Physician Decision|0|||
105508083|NCT00221403|363870946|FG000|Overall Study|Protocol Violation|1|||
105508084|NCT00221403|363870947|FG001|Overall Study|Protocol Violation|0|||
105508085|NCT00221403|363870948|FG002|Overall Study|Protocol Violation|0|||
105508086|NCT00221403|363870946|FG000|Overall Study|Physician Decision|1|||
105508087|NCT00221403|363870947|FG001|Overall Study|Physician Decision|0|||
105508088|NCT00221403|363870948|FG002|Overall Study|Physician Decision|0|||
105508089|NCT00221403|363870946|FG000|Overall Study|Withdrawal by Subject|0|||
105508090|NCT00221403|363870947|FG001|Overall Study|Withdrawal by Subject|3|||
105508091|NCT00221403|363870948|FG002|Overall Study|Withdrawal by Subject|0|||
105508092|NCT00221403|363870946|FG000|Overall Study|Lack of Efficacy|0|||
105508093|NCT00221403|363870947|FG001|Overall Study|Lack of Efficacy|1|||
105508094|NCT00221403|363870948|FG002|Overall Study|Lack of Efficacy|0|||
105508095|NCT00221403|363870946|FG000|Overall Study|Adverse Event|0|||
105508096|NCT00221403|363870947|FG001|Overall Study|Adverse Event|1|||
105508097|NCT00221403|363870948|FG002|Overall Study|Adverse Event|0|||
105508098|NCT02030041|363870949|FG000|Overall Study|Withdrawal by Subject|2|||
105508099|NCT02030041|363870950|FG001|Overall Study|Withdrawal by Subject|2|||
105508100|NCT02030041|363870951|FG002|Overall Study|Withdrawal by Subject|1|||
105508101|NCT05201703|363870953|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
105508102|NCT05201703|363870954|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
105508103|NCT05201703|363870953|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
105508104|NCT05201703|363870954|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
105508105|NCT00393029|363870960|FG000|Overall Study|Not treated|0|||
105508106|NCT00393029|363870961|FG001|Overall Study|Not treated|1|||
105508107|NCT03715530|363870962|FG000|Overall Study|Lost to Follow-up|3|||
105508108|NCT03715530|363870963|FG001|Overall Study|Lost to Follow-up|1|||
105508109|NCT03715530|363870964|FG002|Overall Study|Lost to Follow-up|2|||
105508110|NCT02197130|363870965|FG000|Overall Study|Adverse Event|13|||
105508111|NCT02197130|363870966|FG001|Overall Study|Adverse Event|4|||
105508112|NCT02197130|363870967|FG002|Overall Study|Adverse Event|23|||
105508113|NCT02197130|363870965|FG000|Overall Study|Death|0|||
105508114|NCT02197130|363870966|FG001|Overall Study|Death|1|||
105508115|NCT02197130|363870967|FG002|Overall Study|Death|0|||
105508116|NCT02197130|363870965|FG000|Overall Study|Lost to Follow-up|2|||
105508117|NCT02197130|363870966|FG001|Overall Study|Lost to Follow-up|0|||
105508118|NCT02197130|363870967|FG002|Overall Study|Lost to Follow-up|1|||
105508119|NCT02197130|363870965|FG000|Overall Study|Does not meet entrance criteria|0|||
105508120|NCT02197130|363870966|FG001|Overall Study|Does not meet entrance criteria|0|||
105508121|NCT02197130|363870967|FG002|Overall Study|Does not meet entrance criteria|1|||
105508122|NCT02197130|363870965|FG000|Overall Study|Withdrawal by Subject|0|||
105508123|NCT02197130|363870966|FG001|Overall Study|Withdrawal by Subject|3|||
105508124|NCT02197130|363870967|FG002|Overall Study|Withdrawal by Subject|4|||
105508125|NCT02197130|363870965|FG000|Overall Study|Other|1|||
105508126|NCT02197130|363870966|FG001|Overall Study|Other|0|||
105508127|NCT02197130|363870967|FG002|Overall Study|Other|3|||
105508128|NCT01594762|363870968|FG000|Overall Study|Withdrawal by Subject|1|||
105508129|NCT01594762|363870969|FG001|Overall Study|Withdrawal by Subject|0|||
105508130|NCT01594762|363870968|FG000|Overall Study|Lost to Follow-up|10|||
105508131|NCT01594762|363870969|FG001|Overall Study|Lost to Follow-up|10|||
105508132|NCT01962896|363870972|FG000|Overall Study|Lack of Efficacy|4|||
105508133|NCT02837783|363870973|FG000|Overall Study|Adverse Event|1|||
105508134|NCT02837783|363870974|FG001|Overall Study|Adverse Event|0|||
105508135|NCT02837783|363870973|FG000|Overall Study|Other, Not Specified|1|||
105508136|NCT02837783|363870974|FG001|Overall Study|Other, Not Specified|2|||
105508137|NCT03338998|363870976|FG000|Treatment Period|Withdrawal by Subject|1|||
105508138|NCT03338998|363870977|FG001|Treatment Period|Withdrawal by Subject|1|||
105508139|NCT03338998|363870976|FG000|Treatment Period|Adverse Event|0|||
105508140|NCT03338998|363870977|FG001|Treatment Period|Adverse Event|2|||
105508141|NCT03338998|363870976|FG000|Treatment Period|Protocol deviation|1|||
105508142|NCT03338998|363870977|FG001|Treatment Period|Protocol deviation|0|||
105508143|NCT03338998|363870976|FG000|Treatment Period|Physician Decision|2|||
105508144|NCT03338998|363870977|FG001|Treatment Period|Physician Decision|0|||
105508145|NCT03338998|363870976|FG000|Treatment Period|Subject failed swallow test|4|||
105590880|NCT00817635|364164229|FG000|Overall Study|Protocol Violation|5|||
105590881|NCT00817635|364164230|FG001|Overall Study|Protocol Violation|1|||
105590882|NCT00817635|364164231|FG002|Overall Study|Protocol Violation|3|||
105590883|NCT00817635|364164232|FG003|Overall Study|Protocol Violation|2|||
105590884|NCT00817635|364164233|FG004|Overall Study|Protocol Violation|3|||
105590885|NCT04464421|364164236|FG000|Overall Study|Lost to Follow-up|2|||
105590886|NCT04464421|364164237|FG001|Overall Study|Lost to Follow-up|2|||
105590887|NCT01167426|364164239|FG000|Overall Study|Lost to Follow-up|6|||
105590888|NCT01167426|364164239|FG000|Overall Study|Protocol Violation|1|||
105590889|NCT01167426|364164239|FG000|Overall Study|Withdrawal by Subject|2|||
105590890|NCT01167426|364164239|FG000|Overall Study|Sponsor Decision|1|||
105590891|NCT04176458|364164240|FG000|Overall Study|Covid 19|4|||
105590892|NCT00558363|364164241|FG000|Overall Study|Physician Decision|18|||
105590893|NCT00558363|364164242|FG001|Overall Study|Physician Decision|4|||
105590894|NCT00558363|364164241|FG000|Overall Study|Withdrawal by Subject|11|||
105590895|NCT00558363|364164242|FG001|Overall Study|Withdrawal by Subject|4|||
105590896|NCT00558363|364164241|FG000|Overall Study|Adverse Event|5|||
105590897|NCT00558363|364164242|FG001|Overall Study|Adverse Event|5|||
105590898|NCT00558363|364164241|FG000|Overall Study|Lack of Efficacy|2|||
105590899|NCT00558363|364164242|FG001|Overall Study|Lack of Efficacy|2|||
105590900|NCT00558363|364164241|FG000|Overall Study|Protocol Violation|2|||
105590901|NCT00558363|364164242|FG001|Overall Study|Protocol Violation|1|||
105590902|NCT00558363|364164241|FG000|Overall Study|Lost to Follow-up|0|||
105590903|NCT00558363|364164242|FG001|Overall Study|Lost to Follow-up|1|||
105590904|NCT00558363|364164241|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
105590905|NCT00558363|364164242|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
105590906|NCT00558363|364164241|FG000|Overall Study|Randomized in Error|1|||
105590907|NCT00558363|364164242|FG001|Overall Study|Randomized in Error|2|||
105590908|NCT00558363|364164241|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
105590909|NCT00558363|364164242|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
105590910|NCT01313182|364164243|FG000|Overall Study|Protocol Violation|66|||
105590911|NCT01313182|364164244|FG001|Overall Study|Protocol Violation|92|||
105590912|NCT02759731|364164245|FG000|Overall Study|Did not complete treatment.|8|||
105590913|NCT00957229|364164246|FG000|Study Start|Adverse Event|0|||
105590914|NCT00957229|364164247|FG001|Study Start|Adverse Event|3|||
105590915|NCT00957229|364164246|FG000|Study Start|Disease Progression|1|||
105590916|NCT00957229|364164247|FG001|Study Start|Disease Progression|0|||
105590917|NCT00957229|364164246|FG000|Reallocated to or Continued Vismodegib|Death|1|||
105590918|NCT00957229|364164247|FG001|Reallocated to or Continued Vismodegib|Death|1|||
105590919|NCT00957229|364164246|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
105590920|NCT00957229|364164247|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
105590921|NCT00606580|364164248|FG000|Overall Study|Lost to Follow-up|1|||
105590922|NCT00606580|364164249|FG001|Overall Study|Lost to Follow-up|1|||
105590923|NCT00606580|364164250|FG002|Overall Study|Lost to Follow-up|4|||
105590924|NCT00606580|364164248|FG000|Overall Study|Clinical failures|1|||
105590925|NCT00606580|364164249|FG001|Overall Study|Clinical failures|0|||
105590926|NCT00606580|364164250|FG002|Overall Study|Clinical failures|12|||
105590927|NCT00606580|364164248|FG000|Overall Study|Withdrawal by investigator|0|||
105590928|NCT00606580|364164249|FG001|Overall Study|Withdrawal by investigator|1|||
105590929|NCT00606580|364164250|FG002|Overall Study|Withdrawal by investigator|6|||
105590930|NCT00606580|364164248|FG000|Overall Study|Withdrawal by Subject|0|||
105590931|NCT00606580|364164249|FG001|Overall Study|Withdrawal by Subject|1|||
105590932|NCT00606580|364164250|FG002|Overall Study|Withdrawal by Subject|0|||
105590933|NCT02299635|364164252|FG000|Overall Study|Adverse Event|2|||
105590934|NCT02299635|364164252|FG000|Overall Study|Death|1|||
105590935|NCT02299635|364164252|FG000|Overall Study|Global deterioration of health status|1|||
105590936|NCT02299635|364164252|FG000|Overall Study|Objective progression or relapse|10|||
105590937|NCT02299635|364164252|FG000|Overall Study|Withdrawal by Subject|2|||
105590938|NCT02299635|364164252|FG000|Overall Study|Other|3|||
105590939|NCT00828672|364164253|FG000|Study Treatment|Lost to Follow-up|1|||
105590940|NCT00828672|364164254|FG001|Study Treatment|Lost to Follow-up|0|||
105590941|NCT00828672|364164253|FG000|Study Treatment|Adverse Event|0|||
105590942|NCT00828672|364164254|FG001|Study Treatment|Adverse Event|1|||
105590943|NCT00828672|364164253|FG000|Study Treatment|Complete response, no surgery|1|||
105590944|NCT00828672|364164254|FG001|Study Treatment|Complete response, no surgery|1|||
105590945|NCT00828672|364164253|FG000|Post-surgery (<30 Days)|No central review materials|0|||
105590946|NCT00828672|364164254|FG001|Post-surgery (<30 Days)|No central review materials|1|||
105590947|NCT01250002|364164255|FG000|Overall Study|Change to open surgical procedure|4|||
105590948|NCT01250002|364164256|FG001|Overall Study|Change to open surgical procedure|3|||
105590949|NCT02317705|364164257|FG000|Overall Study|Withdrawal by Subject|3|||
105590950|NCT02317705|364164257|FG000|Overall Study|Physician Decision|1|||
105590951|NCT02317705|364164257|FG000|Overall Study|Drug not usable|1|||
105590952|NCT02219490|364164258|FG000|Overall Study|Adverse Event|24|||
105590953|NCT02219490|364164258|FG000|Overall Study|Withdrew consent|96|||
105590954|NCT02219490|364164258|FG000|Overall Study|Lost to Follow-up|126|||
105590955|NCT02219490|364164258|FG000|Overall Study|COVID-19 infection|2|||
105590956|NCT02219490|364164258|FG000|Overall Study|COVID-19 logistical restrictions|33|||
105508146|NCT03338998|363870977|FG001|Treatment Period|Subject failed swallow test|0|||
105508147|NCT03338998|363870976|FG000|Safety Follow-Up Period|Adverse Event|0|||
105508148|NCT03338998|363870977|FG001|Safety Follow-Up Period|Adverse Event|1|||
105508149|NCT03338998|363870976|FG000|Safety Follow-Up Period|Protocol deviation|1|||
105508150|NCT03338998|363870977|FG001|Safety Follow-Up Period|Protocol deviation|0|||
105508151|NCT03338998|363870976|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
105508152|NCT03338998|363870977|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
105508153|NCT00039130|363870978|FG000|Overall Study|Adverse Event|11|||
105508154|NCT00039130|363870978|FG000|Overall Study|Death|9|||
105508155|NCT00039130|363870978|FG000|Overall Study|Withdrawal by Subject|3|||
105508156|NCT00039130|363870978|FG000|Overall Study|Progression|2|||
105508157|NCT00039130|363870978|FG000|Overall Study|Subsequent treatment|2|||
105508158|NCT00039130|363870978|FG000|Overall Study|Physician Decision|3|||
105508159|NCT00279305|363870981|FG000|Overall Study|Pregnancy|1|||
105508160|NCT00279305|363870982|FG001|Overall Study|Pregnancy|0|||
105508161|NCT00279305|363870981|FG000|Overall Study|Withdrawal by Subject|2|||
105508162|NCT00279305|363870982|FG001|Overall Study|Withdrawal by Subject|0|||
105508163|NCT00279305|363870981|FG000|Overall Study|Dificulting establishing IV|1|||
105508164|NCT00279305|363870982|FG001|Overall Study|Dificulting establishing IV|0|||
105508165|NCT00279305|363870981|FG000|Overall Study|FDA Safety Alert|4|||
105508166|NCT00279305|363870982|FG001|Overall Study|FDA Safety Alert|1|||
105508167|NCT03930797|363870985|FG000|Overall Study|Lost to Follow-up|3|||
105508168|NCT03930797|363870986|FG001|Overall Study|Lost to Follow-up|10|||
105508169|NCT04706091|363870987|FG000|Treatment 2|Withdrawal by Subject|1|||
105508170|NCT04706091|363870988|FG001|Treatment 2|Withdrawal by Subject|0|||
105508171|NCT02612727|363870989|FG000|Overall Study|Parent request|4|||
105508172|NCT02612727|363870990|FG001|Overall Study|Parent request|1|||
105508173|NCT02612727|363870989|FG000|Overall Study|Needed treatment incompatible with PT|1|||
105508174|NCT02612727|363870990|FG001|Overall Study|Needed treatment incompatible with PT|1|||
105508175|NCT02612727|363870989|FG000|Overall Study|Direct hyperbilirubinemia|0|||
105508176|NCT02612727|363870990|FG001|Overall Study|Direct hyperbilirubinemia|2|||
105508177|NCT00753415|363870994|FG000|Part A|Disease progression|1|||
105508178|NCT00753415|363870995|FG001|Part A|Disease progression|0|||
105508179|NCT00753415|363870996|FG002|Part A|Disease progression|1|||
105508180|NCT00753415|363870997|FG003|Part A|Disease progression|2|||
105508181|NCT00753415|363870998|FG004|Part A|Disease progression|0|||
105508182|NCT00753415|363870999|FG005|Part A|Disease progression|0|||
105508183|NCT00753415|363871000|FG006|Part A|Disease progression|0|||
105508184|NCT00753415|363871001|FG007|Part A|Disease progression|0|||
105508185|NCT00753415|363871002|FG008|Part A|Disease progression|0|||
105508186|NCT00753415|363871003|FG009|Part A|Disease progression|0|||
105508187|NCT00753415|363870994|FG000|Part A|Withdrawal by Subject|0|||
105508188|NCT00753415|363870995|FG001|Part A|Withdrawal by Subject|0|||
105508189|NCT00753415|363870996|FG002|Part A|Withdrawal by Subject|1|||
105508190|NCT00753415|363870997|FG003|Part A|Withdrawal by Subject|0|||
105508191|NCT00753415|363870998|FG004|Part A|Withdrawal by Subject|0|||
105508192|NCT00753415|363870999|FG005|Part A|Withdrawal by Subject|0|||
105508193|NCT00753415|363871000|FG006|Part A|Withdrawal by Subject|0|||
105508194|NCT00753415|363871001|FG007|Part A|Withdrawal by Subject|0|||
105508195|NCT00753415|363871002|FG008|Part A|Withdrawal by Subject|0|||
105508196|NCT00753415|363871003|FG009|Part A|Withdrawal by Subject|0|||
105508197|NCT00753415|363870994|FG000|Part B|Lost to Follow-up|0|||
105508198|NCT00753415|363870995|FG001|Part B|Lost to Follow-up|0|||
105508199|NCT00753415|363870996|FG002|Part B|Lost to Follow-up|0|||
105508200|NCT00753415|363870997|FG003|Part B|Lost to Follow-up|0|||
105508201|NCT00753415|363870998|FG004|Part B|Lost to Follow-up|0|||
105508202|NCT00753415|363870999|FG005|Part B|Lost to Follow-up|0|||
105508203|NCT00753415|363871000|FG006|Part B|Lost to Follow-up|0|||
105508204|NCT00753415|363871001|FG007|Part B|Lost to Follow-up|1|||
105508205|NCT00753415|363871002|FG008|Part B|Lost to Follow-up|1|||
105508206|NCT00753415|363871003|FG009|Part B|Lost to Follow-up|0|||
105508207|NCT00753415|363870994|FG000|Part B|Disease progression|0|||
105508208|NCT00753415|363870995|FG001|Part B|Disease progression|0|||
105508209|NCT00753415|363870996|FG002|Part B|Disease progression|0|||
105508210|NCT00753415|363870997|FG003|Part B|Disease progression|0|||
105508211|NCT00753415|363870998|FG004|Part B|Disease progression|0|||
105508212|NCT00753415|363870999|FG005|Part B|Disease progression|0|||
105508213|NCT00753415|363871000|FG006|Part B|Disease progression|0|||
105508214|NCT00753415|363871001|FG007|Part B|Disease progression|0|||
105508215|NCT00753415|363871002|FG008|Part B|Disease progression|2|||
105508216|NCT00753415|363871003|FG009|Part B|Disease progression|1|||
105508217|NCT01405456|363871008|FG000|Overall Study|Lost to Follow-up|2|||
105508218|NCT01405456|363871009|FG001|Overall Study|Lost to Follow-up|1|||
105508219|NCT01405456|363871008|FG000|Overall Study|Physician Decision|1|||
105508220|NCT01405456|363871009|FG001|Overall Study|Physician Decision|0|||
105508221|NCT00307294|363872583|FG000|Overall Study|Withdrawal by Subject|1|||
105508222|NCT01664533|363872584|FG000|Overall Study|Death|42|||
105508223|NCT01664533|363872584|FG000|Overall Study|Lost to Follow-up|3|||
105508224|NCT01664533|363872584|FG000|Overall Study|Study termination|9|||
105508225|NCT01664533|363872584|FG000|Overall Study|Protocol Violation|3|||
105590957|NCT02219490|364164258|FG000|Overall Study|Other, not specified|57|||
105590958|NCT03201809|364164266|FG000|Overall Study|Lost to Follow-up|2|||
105590959|NCT03201809|364164267|FG001|Overall Study|Lost to Follow-up|0|||
105590960|NCT02846415|364164269|FG000|Overall Study|Lost to Follow-up|2|||
105590961|NCT02846415|364164270|FG001|Overall Study|Lost to Follow-up|0|||
105590962|NCT02846415|364164269|FG000|Overall Study|Withdrawal by Subject|1|||
105590963|NCT02846415|364164270|FG001|Overall Study|Withdrawal by Subject|1|||
105590964|NCT00001575|364164271|FG000|Overall Study|Screening failures-Ph I portion|22|||
105590965|NCT00001575|364164271|FG000|Overall Study|Withdrawn/deaths|23|||
105590966|NCT01242085|364164282|FG000|Overall Study|Withdrawal by Subject|4|||
105590967|NCT01242085|364164283|FG001|Overall Study|Withdrawal by Subject|2|||
105590968|NCT01242085|364164284|FG002|Overall Study|Withdrawal by Subject|0|||
105590969|NCT01242085|364164282|FG000|Overall Study|medically unable to have surgery|4|||
105590970|NCT01242085|364164283|FG001|Overall Study|medically unable to have surgery|5|||
105590971|NCT01242085|364164284|FG002|Overall Study|medically unable to have surgery|0|||
105590972|NCT01806714|364164289|FG000|Overall Study|No functioning phone number|200|||
105590973|NCT01806714|364164290|FG001|Overall Study|No functioning phone number|170|||
105590974|NCT02469064|364164291|FG000|Overall Study|Request not to receive intervention.|1|||
105590975|NCT02469064|364164292|FG001|Overall Study|Request not to receive intervention.|3|||
105590976|NCT00678795|364164293|FG000|Overall Study|Adverse Event|7|||
105590977|NCT00678795|364164294|FG001|Overall Study|Adverse Event|3|||
105590978|NCT00678795|364164293|FG000|Overall Study|Withdrawal by Subject|3|||
105590979|NCT00678795|364164294|FG001|Overall Study|Withdrawal by Subject|0|||
105590980|NCT00678795|364164293|FG000|Overall Study|Protocol Violation|0|||
105590981|NCT00678795|364164294|FG001|Overall Study|Protocol Violation|1|||
105590982|NCT00678795|364164293|FG000|Overall Study|Lost to Follow-up|0|||
105590983|NCT00678795|364164294|FG001|Overall Study|Lost to Follow-up|1|||
105590984|NCT00678795|364164293|FG000|Overall Study|Lack of Efficacy|1|||
105590985|NCT00678795|364164294|FG001|Overall Study|Lack of Efficacy|1|||
105590986|NCT01120275|364164295|FG000|Overall Study|Adverse Event|3|||
105590987|NCT01120275|364164295|FG000|Overall Study|Progression|27|||
105590988|NCT01120275|364164295|FG000|Overall Study|Ineligible|3|||
105590989|NCT01120275|364164295|FG000|Overall Study|Withdrawal by Subject|1|||
105590990|NCT01120275|364164295|FG000|Overall Study|Refusal|1|||
105590991|NCT01120275|364164295|FG000|Overall Study|Not specific|1|||
105590992|NCT02512042|364164296|FG000|Overall Study|Adverse Event|0|||
105590993|NCT02512042|364164297|FG001|Overall Study|Adverse Event|4|||
105590994|NCT02512042|364164296|FG000|Overall Study|Withdrawal by Subject|6|||
105590995|NCT02512042|364164297|FG001|Overall Study|Withdrawal by Subject|6|||
105590996|NCT02512042|364164296|FG000|Overall Study|Non-compliance with study drug|1|||
105590997|NCT02512042|364164297|FG001|Overall Study|Non-compliance with study drug|2|||
105590998|NCT02512042|364164296|FG000|Overall Study|Lost to Follow-up|5|||
105590999|NCT02512042|364164297|FG001|Overall Study|Lost to Follow-up|2|||
105591000|NCT02512042|364164296|FG000|Overall Study|Other|11|||
105591001|NCT02512042|364164297|FG001|Overall Study|Other|11|||
105591002|NCT00746330|364164298|FG000|Period 1|Abnormal test procedure result|0|||
105591003|NCT00746330|364164299|FG001|Period 1|Abnormal test procedure result|0|||
105591004|NCT00746330|364164300|FG002|Period 1|Abnormal test procedure result|1|||
105591005|NCT00746330|364164301|FG003|Period 1|Abnormal test procedure result|0|||
105591006|NCT01839877|364164313|FG000|Overall Study|Protocol Violation|1|||
105591007|NCT01582945|364164315|FG000|Overall Study|Intolerable side-effects|1|||
105591008|NCT01582945|364164315|FG000|Overall Study|Scheduling conflicts|1|||
105591009|NCT01227707|364164316|FG000|Overall Study|Adverse Event|10|||
105591010|NCT01227707|364164316|FG000|Overall Study|Progression of disease|3|||
105591011|NCT01227707|364164316|FG000|Overall Study|Withdrawal by Subject|1|||
105591012|NCT01227707|364164316|FG000|Overall Study|Patient non-compliance|3|||
105591013|NCT01227707|364164316|FG000|Overall Study|Medical decision|6|||
105591014|NCT01227707|364164316|FG000|Overall Study|Death|1|||
105591015|NCT01155869|364164323|FG000|Overall Study|Lost to Follow-up|3|||
105591016|NCT01155869|364164324|FG001|Overall Study|Lost to Follow-up|1|||
105591017|NCT00554801|364164325|FG000|Overall Study|left area before completion|5|||
105591018|NCT00554801|364164326|FG001|Overall Study|left area before completion|0|||
105591019|NCT00554801|364164325|FG000|Overall Study|Withdrawal by Subject|14|||
105591020|NCT00554801|364164326|FG001|Overall Study|Withdrawal by Subject|0|||
105591021|NCT05826431|364164327|FG000|Overall Study|Withdrawal by Subject|1|||
105591022|NCT01093534|364164328|FG000|Overall Study|Adverse Event|2|||
105591023|NCT01093534|364164329|FG001|Overall Study|Adverse Event|5|||
105591024|NCT01093534|364164330|FG002|Overall Study|Adverse Event|2|||
105591025|NCT01093534|364164328|FG000|Overall Study|Lack of Efficacy|2|||
105591026|NCT01093534|364164329|FG001|Overall Study|Lack of Efficacy|1|||
105591027|NCT01093534|364164330|FG002|Overall Study|Lack of Efficacy|1|||
105591028|NCT01093534|364164328|FG000|Overall Study|Withdrawal by Subject|5|||
105591029|NCT01093534|364164329|FG001|Overall Study|Withdrawal by Subject|7|||
105591030|NCT01093534|364164330|FG002|Overall Study|Withdrawal by Subject|2|||
105591031|NCT01093534|364164328|FG000|Overall Study|Other|1|||
105591032|NCT01093534|364164329|FG001|Overall Study|Other|3|||
105591033|NCT01093534|364164330|FG002|Overall Study|Other|4|||
105591034|NCT00768651|364164331|FG000|Overall Study|Withdrawal by Subject|1|||
105591035|NCT04771273|364164332|FG000|Dose Escalation Period|Not treated with trial medication|0|||
105591036|NCT04771273|364164333|FG001|Dose Escalation Period|Not treated with trial medication|1|||
105591037|NCT04771273|364164334|FG002|Dose Escalation Period|Not treated with trial medication|1|||
105591038|NCT04771273|364164335|FG003|Dose Escalation Period|Not treated with trial medication|0|||
105591039|NCT04771273|364164332|FG000|Dose Escalation Period|Other reasons than listed|2|||
105591040|NCT04771273|364164333|FG001|Dose Escalation Period|Other reasons than listed|0|||
105591041|NCT04771273|364164334|FG002|Dose Escalation Period|Other reasons than listed|2|||
105591042|NCT04771273|364164335|FG003|Dose Escalation Period|Other reasons than listed|1|||
105591043|NCT04771273|364164332|FG000|Dose Escalation Period|Protocol Violation|0|||
105591044|NCT04771273|364164333|FG001|Dose Escalation Period|Protocol Violation|0|||
105591045|NCT04771273|364164334|FG002|Dose Escalation Period|Protocol Violation|3|||
105591046|NCT04771273|364164335|FG003|Dose Escalation Period|Protocol Violation|1|||
105591047|NCT04771273|364164332|FG000|Dose Escalation Period|Burden of study procedures|1|||
105591048|NCT04771273|364164333|FG001|Dose Escalation Period|Burden of study procedures|0|||
105591049|NCT04771273|364164334|FG002|Dose Escalation Period|Burden of study procedures|0|||
105591050|NCT04771273|364164335|FG003|Dose Escalation Period|Burden of study procedures|0|||
105508226|NCT00290888|363872586|FG000|Overall Study|Physician Decision|3|||
105508227|NCT00290888|363872587|FG001|Overall Study|Physician Decision|1|||
105508228|NCT01581931|363872588|FG000|Washout|Adverse Event|0|||
105508229|NCT01581931|363872589|FG001|Washout|Adverse Event|1|||
105508230|NCT00907777|363872590|FG000|Overall Study|Withdrawal by Subject|0|||
105508231|NCT00907777|363872591|FG001|Overall Study|Withdrawal by Subject|1|||
105508232|NCT02820753|363872596|FG000|2 Month|Withdrawal by Subject|3|||
105508233|NCT02820753|363872597|FG001|2 Month|Withdrawal by Subject|3|||
105508234|NCT02820753|363872596|FG000|2 Month|Lost to Follow-up|24|||
105508235|NCT02820753|363872597|FG001|2 Month|Lost to Follow-up|26|||
105508236|NCT02820753|363872596|FG000|2 Month|Stopped per NIH Hold|51|||
105508237|NCT02820753|363872597|FG001|2 Month|Stopped per NIH Hold|13|||
105508238|NCT02820753|363872596|FG000|6 Month|Withdrawal by Subject|2|||
105508239|NCT02820753|363872597|FG001|6 Month|Withdrawal by Subject|2|||
105508240|NCT02820753|363872596|FG000|6 Month|Lost to Follow-up|20|||
105508241|NCT02820753|363872597|FG001|6 Month|Lost to Follow-up|27|||
105508242|NCT02820753|363872596|FG000|6 Month|Stopped per NIH Hold|81|||
105508243|NCT02820753|363872597|FG001|6 Month|Stopped per NIH Hold|81|||
105508244|NCT02820753|363872596|FG000|6 Month|Death|0|||
105508245|NCT02820753|363872597|FG001|6 Month|Death|1|||
105508246|NCT00618072|363872598|FG000|Overall Study|Lost to Follow-up|2|||
105508247|NCT00618072|363872599|FG001|Overall Study|Lost to Follow-up|0|||
105508248|NCT00618072|363872600|FG002|Overall Study|Lost to Follow-up|3|||
105508249|NCT00618072|363872598|FG000|Overall Study|Physician Decision|0|||
105508250|NCT00618072|363872599|FG001|Overall Study|Physician Decision|1|||
105508251|NCT00618072|363872600|FG002|Overall Study|Physician Decision|1|||
105508252|NCT03292588|363872601|FG000|Overall Study|Death|1|||
105508253|NCT03292588|363872602|FG001|Overall Study|Death|0|||
105508254|NCT03292588|363872601|FG000|Overall Study|Lost to Follow-up|12|||
105508255|NCT03292588|363872602|FG001|Overall Study|Lost to Follow-up|16|||
105508256|NCT03292588|363872601|FG000|Overall Study|Physician Decision|0|||
105508257|NCT03292588|363872602|FG001|Overall Study|Physician Decision|1|||
105508258|NCT03292588|363872601|FG000|Overall Study|Withdrawal by Subject|4|||
105508259|NCT03292588|363872602|FG001|Overall Study|Withdrawal by Subject|4|||
105508260|NCT03292588|363872601|FG000|Overall Study|Move out of town|1|||
105508261|NCT03292588|363872602|FG001|Overall Study|Move out of town|0|||
105508262|NCT03292588|363872601|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
105508263|NCT03292588|363872602|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
105508264|NCT03766581|363872605|FG000|Randomization|Other reasons|2|||
105508265|NCT03766581|363872606|FG001|Randomization|Other reasons|1|||
105508266|NCT03766581|363872607|FG002|Randomization|Other reasons|0|||
105508267|NCT03766581|363872608|FG003|Randomization|Other reasons|1|||
105508268|NCT03766581|363872609|FG004|Randomization|Other reasons|0|||
105508269|NCT03766581|363872610|FG005|Randomization|Other reasons|0|||
105508270|NCT03766581|363872611|FG006|Randomization|Other reasons|0|||
105591051|NCT04771273|364164332|FG000|Dose Escalation Period|Change of residence|0|||
105508271|NCT03766581|363872612|FG007|Randomization|Other reasons|0|||
105508272|NCT03766581|363872605|FG000|Randomization|Participant no longer meets study criteria|5|||
105508273|NCT03766581|363872606|FG001|Randomization|Participant no longer meets study criteria|3|||
105508274|NCT03766581|363872607|FG002|Randomization|Participant no longer meets study criteria|4|||
105508275|NCT03766581|363872608|FG003|Randomization|Participant no longer meets study criteria|0|||
105508276|NCT03766581|363872609|FG004|Randomization|Participant no longer meets study criteria|2|||
105508277|NCT03766581|363872610|FG005|Randomization|Participant no longer meets study criteria|3|||
105508278|NCT03766581|363872611|FG006|Randomization|Participant no longer meets study criteria|0|||
105508279|NCT03766581|363872612|FG007|Randomization|Participant no longer meets study criteria|1|||
105508280|NCT03766581|363872605|FG000|Randomization|Participant request to discontinue study treatment|1|||
105508281|NCT03766581|363872606|FG001|Randomization|Participant request to discontinue study treatment|0|||
105508282|NCT03766581|363872607|FG002|Randomization|Participant request to discontinue study treatment|0|||
105508283|NCT03766581|363872608|FG003|Randomization|Participant request to discontinue study treatment|0|||
105508284|NCT03766581|363872609|FG004|Randomization|Participant request to discontinue study treatment|1|||
105508285|NCT03766581|363872610|FG005|Randomization|Participant request to discontinue study treatment|2|||
105508286|NCT03766581|363872611|FG006|Randomization|Participant request to discontinue study treatment|0|||
105508287|NCT03766581|363872612|FG007|Randomization|Participant request to discontinue study treatment|0|||
105508288|NCT03766581|363872605|FG000|Randomization|Participant withdrew consent|1|||
105508289|NCT03766581|363872606|FG001|Randomization|Participant withdrew consent|0|||
105508290|NCT03766581|363872607|FG002|Randomization|Participant withdrew consent|1|||
105508291|NCT03766581|363872608|FG003|Randomization|Participant withdrew consent|2|||
105508292|NCT03766581|363872609|FG004|Randomization|Participant withdrew consent|1|||
105508293|NCT03766581|363872610|FG005|Randomization|Participant withdrew consent|1|||
105508294|NCT03766581|363872611|FG006|Randomization|Participant withdrew consent|0|||
105508295|NCT03766581|363872612|FG007|Randomization|Participant withdrew consent|0|||
105508296|NCT03766581|363872605|FG000|Treatment|Adverse Event|82|||
105508297|NCT03766581|363872606|FG001|Treatment|Adverse Event|44|||
105508298|NCT03766581|363872607|FG002|Treatment|Adverse Event|47|||
105508299|NCT03766581|363872608|FG003|Treatment|Adverse Event|46|||
105508300|NCT03766581|363872609|FG004|Treatment|Adverse Event|50|||
105508301|NCT03766581|363872610|FG005|Treatment|Adverse Event|77|||
105508302|NCT03766581|363872611|FG006|Treatment|Adverse Event|5|||
105508303|NCT03766581|363872612|FG007|Treatment|Adverse Event|2|||
105508304|NCT03766581|363872605|FG000|Treatment|Participant request to discontinue treatment|34|||
105508305|NCT03766581|363872606|FG001|Treatment|Participant request to discontinue treatment|6|||
105508306|NCT03766581|363872607|FG002|Treatment|Participant request to discontinue treatment|10|||
105508307|NCT03766581|363872608|FG003|Treatment|Participant request to discontinue treatment|10|||
105508308|NCT03766581|363872609|FG004|Treatment|Participant request to discontinue treatment|14|||
105508309|NCT03766581|363872610|FG005|Treatment|Participant request to discontinue treatment|15|||
105508310|NCT03766581|363872611|FG006|Treatment|Participant request to discontinue treatment|0|||
105508311|NCT03766581|363872612|FG007|Treatment|Participant request to discontinue treatment|1|||
105508312|NCT03766581|363872605|FG000|Treatment|Participant withdrew consent|11|||
105508313|NCT03766581|363872606|FG001|Treatment|Participant withdrew consent|4|||
105508314|NCT03766581|363872607|FG002|Treatment|Participant withdrew consent|5|||
105508315|NCT03766581|363872608|FG003|Treatment|Participant withdrew consent|5|||
105508316|NCT03766581|363872609|FG004|Treatment|Participant withdrew consent|4|||
105508317|NCT03766581|363872610|FG005|Treatment|Participant withdrew consent|4|||
105508318|NCT03766581|363872611|FG006|Treatment|Participant withdrew consent|0|||
105508319|NCT03766581|363872612|FG007|Treatment|Participant withdrew consent|0|||
105508320|NCT03766581|363872605|FG000|Treatment|Death|1|||
105508321|NCT03766581|363872606|FG001|Treatment|Death|0|||
105508322|NCT03766581|363872607|FG002|Treatment|Death|0|||
105508323|NCT03766581|363872608|FG003|Treatment|Death|0|||
105508324|NCT03766581|363872609|FG004|Treatment|Death|0|||
105508325|NCT03766581|363872610|FG005|Treatment|Death|0|||
105508326|NCT03766581|363872611|FG006|Treatment|Death|0|||
105508327|NCT03766581|363872612|FG007|Treatment|Death|0|||
105508328|NCT03766581|363872605|FG000|Treatment|Lost to Follow-up|1|||
105508329|NCT03766581|363872606|FG001|Treatment|Lost to Follow-up|0|||
105508330|NCT03766581|363872607|FG002|Treatment|Lost to Follow-up|0|||
105508331|NCT03766581|363872608|FG003|Treatment|Lost to Follow-up|1|||
105508332|NCT03766581|363872609|FG004|Treatment|Lost to Follow-up|0|||
105508333|NCT03766581|363872610|FG005|Treatment|Lost to Follow-up|0|||
105508334|NCT03766581|363872611|FG006|Treatment|Lost to Follow-up|0|||
105508335|NCT03766581|363872612|FG007|Treatment|Lost to Follow-up|0|||
105508336|NCT03766581|363872605|FG000|Treatment|Poor/Non compliance|2|||
105508337|NCT03766581|363872606|FG001|Treatment|Poor/Non compliance|2|||
105508338|NCT03766581|363872607|FG002|Treatment|Poor/Non compliance|1|||
105508339|NCT03766581|363872608|FG003|Treatment|Poor/Non compliance|1|||
105508340|NCT03766581|363872609|FG004|Treatment|Poor/Non compliance|1|||
105508341|NCT03766581|363872610|FG005|Treatment|Poor/Non compliance|1|||
105508342|NCT03766581|363872611|FG006|Treatment|Poor/Non compliance|0|||
105508343|NCT03766581|363872612|FG007|Treatment|Poor/Non compliance|0|||
105508344|NCT03766581|363872605|FG000|Treatment|Participant no longer meets study criteria|9|||
105508345|NCT03766581|363872606|FG001|Treatment|Participant no longer meets study criteria|1|||
105508346|NCT03766581|363872607|FG002|Treatment|Participant no longer meets study criteria|5|||
105508347|NCT03766581|363872608|FG003|Treatment|Participant no longer meets study criteria|4|||
105508348|NCT03766581|363872609|FG004|Treatment|Participant no longer meets study criteria|4|||
105508349|NCT03766581|363872610|FG005|Treatment|Participant no longer meets study criteria|4|||
105508350|NCT03766581|363872611|FG006|Treatment|Participant no longer meets study criteria|2|||
105508351|NCT03766581|363872612|FG007|Treatment|Participant no longer meets study criteria|0|||
105508352|NCT03766581|363872605|FG000|Treatment|Other reasons|13|||
105508353|NCT03766581|363872606|FG001|Treatment|Other reasons|8|||
105508354|NCT03766581|363872607|FG002|Treatment|Other reasons|3|||
105508355|NCT03766581|363872608|FG003|Treatment|Other reasons|7|||
105508356|NCT03766581|363872609|FG004|Treatment|Other reasons|3|||
105508357|NCT03766581|363872610|FG005|Treatment|Other reasons|3|||
105508358|NCT03766581|363872611|FG006|Treatment|Other reasons|0|||
105591052|NCT04771273|364164333|FG001|Dose Escalation Period|Change of residence|0|||
105591053|NCT04771273|364164334|FG002|Dose Escalation Period|Change of residence|0|||
105591054|NCT04771273|364164335|FG003|Dose Escalation Period|Change of residence|1|||
105591055|NCT04771273|364164332|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
105591056|NCT04771273|364164333|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
105591057|NCT04771273|364164334|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
105591058|NCT04771273|364164335|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
105591059|NCT04771273|364164332|FG000|Dose Escalation Period|Adverse Event|8|||
105591060|NCT04771273|364164333|FG001|Dose Escalation Period|Adverse Event|9|||
105591061|NCT04771273|364164334|FG002|Dose Escalation Period|Adverse Event|12|||
105591062|NCT04771273|364164335|FG003|Dose Escalation Period|Adverse Event|2|||
105591063|NCT04771273|364164332|FG000|Maintenance Period|Other than listed|4|||
105591064|NCT04771273|364164333|FG001|Maintenance Period|Other than listed|2|||
105591065|NCT04771273|364164334|FG002|Maintenance Period|Other than listed|0|||
105591066|NCT04771273|364164335|FG003|Maintenance Period|Other than listed|3|||
105591067|NCT04771273|364164332|FG000|Maintenance Period|Burden of study procedures|1|||
105591068|NCT04771273|364164333|FG001|Maintenance Period|Burden of study procedures|0|||
105591069|NCT04771273|364164334|FG002|Maintenance Period|Burden of study procedures|0|||
105591070|NCT04771273|364164335|FG003|Maintenance Period|Burden of study procedures|0|||
105591071|NCT04771273|364164332|FG000|Maintenance Period|Change of residence|0|||
105591072|NCT04771273|364164333|FG001|Maintenance Period|Change of residence|1|||
105591073|NCT04771273|364164334|FG002|Maintenance Period|Change of residence|3|||
105591074|NCT04771273|364164335|FG003|Maintenance Period|Change of residence|0|||
105591075|NCT04771273|364164332|FG000|Maintenance Period|Perceived lack of efficacy|0|||
105591076|NCT04771273|364164333|FG001|Maintenance Period|Perceived lack of efficacy|0|||
105591077|NCT04771273|364164334|FG002|Maintenance Period|Perceived lack of efficacy|0|||
105591078|NCT04771273|364164335|FG003|Maintenance Period|Perceived lack of efficacy|1|||
105591079|NCT04771273|364164332|FG000|Maintenance Period|Adverse Event|4|||
105591080|NCT04771273|364164333|FG001|Maintenance Period|Adverse Event|5|||
105591081|NCT04771273|364164334|FG002|Maintenance Period|Adverse Event|5|||
105591082|NCT04771273|364164335|FG003|Maintenance Period|Adverse Event|0|||
105591083|NCT04436120|364164336|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
105591084|NCT04436120|364164337|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
105591085|NCT04436120|364164338|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
105591086|NCT04436120|364164339|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
105591087|NCT04436120|364164340|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
105591088|NCT04436120|364164341|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
105591089|NCT04436120|364164342|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
105591090|NCT05576662|364164343|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
105591091|NCT05576662|364164344|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
105591092|NCT05576662|364164343|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
105591093|NCT05576662|364164344|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
105591094|NCT05576662|364164343|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
105591095|NCT05576662|364164344|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
105591096|NCT05576662|364164343|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
105591097|NCT05576662|364164344|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
105591098|NCT03781804|364164345|FG000|Overall Study|Adverse Event|2|||
105591099|NCT03781804|364164346|FG001|Overall Study|Adverse Event|2|||
105591100|NCT03781804|364164347|FG002|Overall Study|Adverse Event|3|||
105591101|NCT03781804|364164345|FG000|Overall Study|Lost to Follow-up|1|||
105591102|NCT03781804|364164346|FG001|Overall Study|Lost to Follow-up|1|||
105591103|NCT03781804|364164347|FG002|Overall Study|Lost to Follow-up|2|||
105591104|NCT03781804|364164345|FG000|Overall Study|Lack of Efficacy|4|||
105591105|NCT03781804|364164346|FG001|Overall Study|Lack of Efficacy|2|||
105591106|NCT03781804|364164347|FG002|Overall Study|Lack of Efficacy|9|||
105591107|NCT03781804|364164345|FG000|Overall Study|Protocol Violation|0|||
105591108|NCT03781804|364164346|FG001|Overall Study|Protocol Violation|0|||
105591109|NCT03781804|364164347|FG002|Overall Study|Protocol Violation|1|||
105591110|NCT03781804|364164345|FG000|Overall Study|Withdrawal by Subject|0|||
105591111|NCT03781804|364164346|FG001|Overall Study|Withdrawal by Subject|1|||
105591112|NCT03781804|364164347|FG002|Overall Study|Withdrawal by Subject|1|||
105591113|NCT03781804|364164345|FG000|Overall Study|Reason not provided|2|||
105591114|NCT03781804|364164346|FG001|Overall Study|Reason not provided|2|||
105591115|NCT03781804|364164347|FG002|Overall Study|Reason not provided|0|||
105591116|NCT00337818|364164348|FG000|Overall Study|Lost to Follow-up|289|||
105591117|NCT00337818|364164349|FG001|Overall Study|Lost to Follow-up|91|||
105591118|NCT00337818|364164350|FG002|Overall Study|Lost to Follow-up|107|||
105591119|NCT00604721|364164353|FG000|Overall Study|Physician Decision|1|||
105591120|NCT00604721|364164353|FG000|Overall Study|Withdrawal by Subject|1|||
105591121|NCT00561574|364164354|FG000|Overall Study|Adverse Event|21|||
105591122|NCT00561574|364164355|FG001|Overall Study|Adverse Event|24|||
105591123|NCT00561574|364164354|FG000|Overall Study|Lack of Efficacy|11|||
105591124|NCT00561574|364164355|FG001|Overall Study|Lack of Efficacy|21|||
105591125|NCT00561574|364164354|FG000|Overall Study|Withdrawal by Subject|4|||
105591126|NCT00561574|364164355|FG001|Overall Study|Withdrawal by Subject|4|||
105591127|NCT00561574|364164354|FG000|Overall Study|Reason Unrelated to Trial|6|||
105591128|NCT00561574|364164355|FG001|Overall Study|Reason Unrelated to Trial|2|||
105591129|NCT00561574|364164354|FG000|Overall Study|Lost to Follow-up|1|||
105591130|NCT00561574|364164355|FG001|Overall Study|Lost to Follow-up|0|||
105591131|NCT00561574|364164354|FG000|Overall Study|Other|5|||
105591132|NCT00561574|364164355|FG001|Overall Study|Other|7|||
105591133|NCT03254394|364164356|FG000|Overall Study|Withdrawal by Subject|0|||
105591134|NCT03254394|364164357|FG001|Overall Study|Withdrawal by Subject|2|||
105591135|NCT02317016|364164360|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
105591136|NCT02317016|364164360|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
105591137|NCT02317016|364164360|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
105591138|NCT02317016|364164360|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
105591139|NCT02317016|364164360|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
105591140|NCT02317016|364164360|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
105591141|NCT02317016|364164360|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
105591142|NCT00536380|364164361|FG000|Overall Study|Adverse Event|0|||
105591143|NCT00536380|364164362|FG001|Overall Study|Adverse Event|2|||
105591144|NCT00536380|364164363|FG002|Overall Study|Adverse Event|2|||
105591145|NCT00536380|364164361|FG000|Overall Study|Lost to Follow-up|0|||
105591146|NCT00536380|364164362|FG001|Overall Study|Lost to Follow-up|0|||
105591147|NCT00536380|364164363|FG002|Overall Study|Lost to Follow-up|1|||
105591148|NCT00536380|364164361|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
105591149|NCT00536380|364164362|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
105591150|NCT00536380|364164363|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
105591151|NCT00536380|364164361|FG000|Overall Study|Withdrawal related to study drug|7|||
105591152|NCT00536380|364164362|FG001|Overall Study|Withdrawal related to study drug|5|||
105591153|NCT00536380|364164363|FG002|Overall Study|Withdrawal related to study drug|2|||
105591154|NCT00536380|364164361|FG000|Overall Study|Noncompliance with protocol|3|||
105591155|NCT00536380|364164362|FG001|Overall Study|Noncompliance with protocol|2|||
105508359|NCT03766581|363872612|FG007|Treatment|Other reasons|0|||
105508360|NCT02269241|363872613|FG000|Overall Study|Lost to Follow-up|269|||
105508361|NCT02269241|363872613|FG000|Overall Study|Withdrawal by Subject|155|||
105508362|NCT02269241|363872613|FG000|Overall Study|Protocol Violation|1|||
105508363|NCT02269241|363872613|FG000|Overall Study|Physician Decision|7|||
105508364|NCT02269241|363872613|FG000|Overall Study|Pregnancy|15|||
105508365|NCT02269241|363872613|FG000|Overall Study|Wish for pregnancy|5|||
105508366|NCT02269241|363872613|FG000|Overall Study|Development of an exclusion criteria|16|||
105508367|NCT02269241|363872613|FG000|Overall Study|Adverse Event|113|||
105508368|NCT02269241|363872613|FG000|Overall Study|At the specific request of the sponsor|20|||
105508369|NCT02269241|363872613|FG000|Overall Study|Several reasons not classified|53|||
105508370|NCT02269241|363872613|FG000|Overall Study|Screening failures|546|||
105508371|NCT02270957|363872614|FG000|Overall Study|Lack of Efficacy|2|||
105508372|NCT02270957|363872615|FG001|Overall Study|Lack of Efficacy|4|||
105508373|NCT02270957|363872614|FG000|Overall Study|Adverse Event|2|||
105508374|NCT02270957|363872615|FG001|Overall Study|Adverse Event|0|||
105508375|NCT04343261|363872616|FG000|Overall Study|Adverse Event|1|||
105508376|NCT04343261|363872616|FG000|Overall Study|received inadequate amount of antibodies|7|||
105508377|NCT02585960|363872617|FG000|PK/Safety Assessment Period|Physician Decision|0|||
105508378|NCT02585960|363872618|FG001|PK/Safety Assessment Period|Physician Decision|1|||
105508379|NCT02585960|363872619|FG002|PK/Safety Assessment Period|Physician Decision|0|||
105508380|NCT02585960|363872617|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
105508381|NCT02585960|363872618|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
105508382|NCT02585960|363872619|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
105508383|NCT02585960|363872617|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
105508384|NCT02585960|363872618|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
105508385|NCT02585960|363872619|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
105508386|NCT02585960|363872617|FG000|PK/Safety Assessment Period|Other|4|||
105591156|NCT00536380|364164363|FG002|Overall Study|Noncompliance with protocol|2|||
105591157|NCT00536380|364164361|FG000|Overall Study|Did not meet protocol eligibility|0|||
105591158|NCT00536380|364164362|FG001|Overall Study|Did not meet protocol eligibility|0|||
105508387|NCT02585960|363872618|FG001|PK/Safety Assessment Period|Other|4|||
105508388|NCT02585960|363872619|FG002|PK/Safety Assessment Period|Other|0|||
105508389|NCT02585960|363872617|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
105508390|NCT02585960|363872618|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
105508391|NCT02585960|363872619|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
105508392|NCT02585960|363872617|FG000|PK/Safety Assessment Period|Screen Failure|0|||
105508393|NCT02585960|363872618|FG001|PK/Safety Assessment Period|Screen Failure|0|||
105508394|NCT02585960|363872619|FG002|PK/Safety Assessment Period|Screen Failure|1|||
105591159|NCT00536380|364164363|FG002|Overall Study|Did not meet protocol eligibility|1|||
105591160|NCT00536380|364164361|FG000|Overall Study|Administrative|0|||
105591161|NCT00536380|364164362|FG001|Overall Study|Administrative|0|||
105591162|NCT00536380|364164363|FG002|Overall Study|Administrative|1|||
105591163|NCT03354390|364164366|FG000|Level 1|Death|2|||
105591164|NCT03354390|364164367|FG001|Level 1|Death|0|||
105591165|NCT03354390|364164368|FG002|Level 1|Death|0|||
105591166|NCT03354390|364164369|FG003|Level 1|Death|0|||
105591167|NCT03354390|364164366|FG000|Level 1|Physician Decision|1|||
105591168|NCT03354390|364164367|FG001|Level 1|Physician Decision|0|||
105591169|NCT03354390|364164368|FG002|Level 1|Physician Decision|0|||
105591170|NCT03354390|364164369|FG003|Level 1|Physician Decision|0|||
105591171|NCT03354390|364164366|FG000|Level 2|Physician Decision|0|||
105591172|NCT03354390|364164367|FG001|Level 2|Physician Decision|2|||
105591173|NCT03354390|364164368|FG002|Level 2|Physician Decision|0|||
105591174|NCT03354390|364164369|FG003|Level 2|Physician Decision|0|||
105591175|NCT03354390|364164366|FG000|Level 2|Lack of Efficacy|0|||
105591176|NCT03354390|364164367|FG001|Level 2|Lack of Efficacy|1|||
105508395|NCT02585960|363872617|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
105591177|NCT03354390|364164368|FG002|Level 2|Lack of Efficacy|0|||
105508396|NCT02585960|363872618|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
105508397|NCT02585960|363872619|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
105508398|NCT02585960|363872617|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
105508399|NCT02585960|363872618|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
105508400|NCT02585960|363872619|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
105508401|NCT00489541|363872620|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
105508402|NCT00489541|363872621|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
105508403|NCT00489541|363872620|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
105508404|NCT00489541|363872621|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
105508405|NCT00489541|363872620|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
105508406|NCT00489541|363872621|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
105508407|NCT00489541|363872620|FG000|12-Month Clinical Follow-up|Death|3|||
105508408|NCT00489541|363872621|FG001|12-Month Clinical Follow-up|Death|2|||
105508409|NCT00489541|363872620|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
105508410|NCT00489541|363872621|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
105508411|NCT00489541|363872620|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
105508412|NCT00489541|363872621|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
105508413|NCT02128113|363872624|FG000|Overall Study|Withdrawal by Subject|3|||
105508414|NCT02128113|363872625|FG001|Overall Study|Withdrawal by Subject|1|||
105508415|NCT02128113|363872626|FG002|Overall Study|Withdrawal by Subject|0|||
105508416|NCT02128113|363872624|FG000|Overall Study|Protocol Violation|0|||
105508417|NCT02128113|363872625|FG001|Overall Study|Protocol Violation|1|||
105508418|NCT02128113|363872626|FG002|Overall Study|Protocol Violation|0|||
105508419|NCT02128113|363872624|FG000|Overall Study|Surgery cancelled|0|||
105508420|NCT02128113|363872625|FG001|Overall Study|Surgery cancelled|1|||
105508421|NCT02128113|363872626|FG002|Overall Study|Surgery cancelled|0|||
105508422|NCT02128113|363872624|FG000|Overall Study|Adverse Event|0|||
105508423|NCT02128113|363872625|FG001|Overall Study|Adverse Event|0|||
105508424|NCT02128113|363872626|FG002|Overall Study|Adverse Event|1|||
105508425|NCT00299104|363872627|FG000|Treatment Period|Adverse Event|14|||
105508426|NCT00299104|363872628|FG001|Treatment Period|Adverse Event|9|||
105508427|NCT00299104|363872629|FG002|Treatment Period|Adverse Event|7|||
105508428|NCT00299104|363872627|FG000|Treatment Period|Death|1|||
105508429|NCT00299104|363872628|FG001|Treatment Period|Death|1|||
105508430|NCT00299104|363872629|FG002|Treatment Period|Death|1|||
105508431|NCT00299104|363872627|FG000|Treatment Period|Insufficient therapeutic response|34|||
105508432|NCT00299104|363872628|FG001|Treatment Period|Insufficient therapeutic response|13|||
105508433|NCT00299104|363872629|FG002|Treatment Period|Insufficient therapeutic response|8|||
105508434|NCT00299104|363872627|FG000|Treatment Period|Failure to return|9|||
105508435|NCT00299104|363872628|FG001|Treatment Period|Failure to return|8|||
105508436|NCT00299104|363872629|FG002|Treatment Period|Failure to return|8|||
105508437|NCT00299104|363872627|FG000|Treatment Period|Violation of selection criteria|1|||
105508438|NCT00299104|363872628|FG001|Treatment Period|Violation of selection criteria|2|||
105508439|NCT00299104|363872629|FG002|Treatment Period|Violation of selection criteria|0|||
105508440|NCT00299104|363872627|FG000|Treatment Period|Protocol Violation|1|||
105508441|NCT00299104|363872628|FG001|Treatment Period|Protocol Violation|1|||
105508442|NCT00299104|363872629|FG002|Treatment Period|Protocol Violation|0|||
105508443|NCT00299104|363872627|FG000|Treatment Period|Refused treatment|9|||
105508444|NCT00299104|363872628|FG001|Treatment Period|Refused treatment|2|||
105591178|NCT03354390|364164369|FG003|Level 2|Lack of Efficacy|0|||
105508445|NCT00299104|363872629|FG002|Treatment Period|Refused treatment|2|||
105508446|NCT00299104|363872627|FG000|Treatment Period|Withdrew consent|14|||
105508447|NCT00299104|363872628|FG001|Treatment Period|Withdrew consent|19|||
105508448|NCT00299104|363872629|FG002|Treatment Period|Withdrew consent|9|||
105591179|NCT03354390|364164366|FG000|Level 2|Lost to Follow-up|0|||
105591180|NCT03354390|364164367|FG001|Level 2|Lost to Follow-up|1|||
105508449|NCT00299104|363872627|FG000|Treatment Period|Administrative reasons|106|||
105508450|NCT00299104|363872628|FG001|Treatment Period|Administrative reasons|120|||
105591181|NCT03354390|364164368|FG002|Level 2|Lost to Follow-up|0|||
105591182|NCT03354390|364164369|FG003|Level 2|Lost to Follow-up|0|||
105508451|NCT00299104|363872629|FG002|Treatment Period|Administrative reasons|137|||
105508452|NCT00299104|363872627|FG000|Safety Follow-Up (SFU) Period|Death|3|||
105508453|NCT00299104|363872628|FG001|Safety Follow-Up (SFU) Period|Death|2|||
105508454|NCT00299104|363872629|FG002|Safety Follow-Up (SFU) Period|Death|1|||
105508455|NCT00299104|363872627|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
105508456|NCT00299104|363872628|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
105508457|NCT00299104|363872629|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
105508458|NCT00299104|363872627|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
105508459|NCT00299104|363872628|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
105508460|NCT00299104|363872629|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
105508461|NCT00299104|363872627|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
105508462|NCT00299104|363872628|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
105508463|NCT00299104|363872629|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
105508464|NCT00299104|363872627|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
105508465|NCT00299104|363872628|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
105508466|NCT00299104|363872629|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
105508467|NCT00299104|363872627|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
105508468|NCT00299104|363872628|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
105508469|NCT00299104|363872629|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
105508470|NCT00299104|363872627|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
105508471|NCT00299104|363872628|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
105508472|NCT00299104|363872629|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
105508473|NCT00299104|363872627|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
105508474|NCT00299104|363872628|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
105508475|NCT00299104|363872629|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
105508476|NCT00587054|363872630|FG000|Overall Study|Patient not treated|9|||
105508477|NCT03648541|363872640|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
105508478|NCT03648541|363872641|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
105508479|NCT03648541|363872640|FG000|Re-induction Period Only|Lack of Efficacy|7|||
105508480|NCT03648541|363872641|FG001|Re-induction Period Only|Lack of Efficacy|0|||
105508481|NCT03648541|363872640|FG000|Maintenance Period Only|Missing|0|||
105508482|NCT03648541|363872641|FG001|Maintenance Period Only|Missing|1|||
105508483|NCT03648541|363872640|FG000|Maintenance Period Only|Other not listed below|0|||
105508484|NCT03648541|363872641|FG001|Maintenance Period Only|Other not listed below|4|||
105508485|NCT03648541|363872640|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
105508486|NCT03648541|363872641|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
105508487|NCT03648541|363872640|FG000|Maintenance Period Only|Protocol Violation|0|||
105508488|NCT03648541|363872641|FG001|Maintenance Period Only|Protocol Violation|1|||
105508489|NCT03648541|363872640|FG000|Maintenance Period Only|Lack of Efficacy|0|||
105508490|NCT03648541|363872641|FG001|Maintenance Period Only|Lack of Efficacy|18|||
105508491|NCT03648541|363872640|FG000|Maintenance Period Only|Adverse Event|0|||
105508492|NCT03648541|363872641|FG001|Maintenance Period Only|Adverse Event|4|||
105508493|NCT03648541|363872640|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
105508494|NCT03648541|363872641|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
105508495|NCT04623216|363872644|FG000|Overall Study|Death|5|||
105508496|NCT04623216|363872645|FG001|Overall Study|Death|2|||
105508497|NCT04623216|363872646|FG002|Overall Study|Death|0|||
105508498|NCT04623216|363872647|FG003|Overall Study|Death|0|||
105508499|NCT04623216|363872644|FG000|Overall Study|Terminated by Sponsor|3|||
105508500|NCT04623216|363872645|FG001|Overall Study|Terminated by Sponsor|2|||
105508501|NCT04623216|363872646|FG002|Overall Study|Terminated by Sponsor|2|||
105508502|NCT04623216|363872647|FG003|Overall Study|Terminated by Sponsor|0|||
105508503|NCT04623216|363872644|FG000|Overall Study|Physician Decision|1|||
105508504|NCT04623216|363872645|FG001|Overall Study|Physician Decision|0|||
105508505|NCT04623216|363872646|FG002|Overall Study|Physician Decision|0|||
105508506|NCT04623216|363872647|FG003|Overall Study|Physician Decision|0|||
105508507|NCT01651039|363872648|FG000|Overall Study|Non-evaluables|5|||
105508508|NCT01651039|363872648|FG000|Overall Study|Physician Decision|2|||
105508509|NCT01651039|363872648|FG000|Overall Study|Withdrawal by Subject|1|||
105508510|NCT01651039|363872648|FG000|Overall Study|Progressive Disease|22|||
105508511|NCT01539538|363872649|FG000|Overall Study|Adverse Event|13|||
105508512|NCT01539538|363872650|FG001|Overall Study|Adverse Event|18|||
105508513|NCT01539538|363872649|FG000|Overall Study|Lack of Efficacy|13|||
105508514|NCT01539538|363872650|FG001|Overall Study|Lack of Efficacy|16|||
105508515|NCT01539538|363872649|FG000|Overall Study|Withdrawal by Subject|2|||
105508516|NCT01539538|363872650|FG001|Overall Study|Withdrawal by Subject|3|||
105508517|NCT01539538|363872649|FG000|Overall Study|PCA no longer required or PCA problem|3|||
105508518|NCT01539538|363872650|FG001|Overall Study|PCA no longer required or PCA problem|7|||
105508519|NCT03600818|363872654|FG000|Overall Study|Adverse Event|4|||
105508520|NCT03600818|363872655|FG001|Overall Study|Adverse Event|7|||
105508521|NCT03600818|363872654|FG000|Overall Study|Lack of Efficacy|9|||
105508522|NCT03600818|363872655|FG001|Overall Study|Lack of Efficacy|4|||
105591183|NCT03354390|364164366|FG000|Level 3|Death|0|||
105508523|NCT03600818|363872654|FG000|Overall Study|Withdrawal by Subject|4|||
105508524|NCT03600818|363872655|FG001|Overall Study|Withdrawal by Subject|3|||
105508525|NCT03600818|363872654|FG000|Overall Study|Other-unspecified|5|||
105508526|NCT03600818|363872655|FG001|Overall Study|Other-unspecified|3|||
105508527|NCT03600818|363872654|FG000|Overall Study|Randomized and not treated|0|||
105508528|NCT03600818|363872655|FG001|Overall Study|Randomized and not treated|1|||
105508529|NCT02059395|363872658|FG000|Overall Study|Lost to Follow-up|2|||
105508530|NCT02059395|363872659|FG001|Overall Study|Lost to Follow-up|4|||
105508531|NCT01909674|363872660|FG000|Overall Study|Withdrawal by Subject|5|||
105508532|NCT01909674|363872661|FG001|Overall Study|Withdrawal by Subject|2|||
105508533|NCT00847379|363872662|FG000|Overall Study|Study terminated by Sponsor|59|||
105508534|NCT00847379|363872663|FG001|Overall Study|Study terminated by Sponsor|57|||
105508535|NCT00847379|363872664|FG002|Overall Study|Study terminated by Sponsor|57|||
105508536|NCT00134082|363872665|FG000|Overall Study|Adverse Event|2|||
105508537|NCT00134082|363872665|FG000|Overall Study|Death|1|||
105508538|NCT00521014|363872666|FG000|Overall Study|Inevaluable, not treated|1|||
105508539|NCT02969369|363872667|FG000|Study|Adverse Event|1|||
105508540|NCT02969369|363872668|FG001|Study|Adverse Event|6|||
105508541|NCT02969369|363872667|FG000|Study|Lack of Efficacy|0|||
105508542|NCT02969369|363872668|FG001|Study|Lack of Efficacy|1|||
105508543|NCT02969369|363872667|FG000|Study|Lost to Follow-up|0|||
105508544|NCT02969369|363872668|FG001|Study|Lost to Follow-up|1|||
105508545|NCT02969369|363872667|FG000|Study|Withdrawal by Subject|3|||
105508546|NCT02969369|363872668|FG001|Study|Withdrawal by Subject|5|||
105508547|NCT02969369|363872667|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
105508548|NCT02969369|363872668|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
105508549|NCT02969369|363872667|FG000|Double-blind Period|Adverse Event|1|||
105508550|NCT02969369|363872668|FG001|Double-blind Period|Adverse Event|5|||
105508551|NCT02969369|363872667|FG000|Double-blind Period|Lost to Follow-up|0|||
105508552|NCT02969369|363872668|FG001|Double-blind Period|Lost to Follow-up|1|||
105508553|NCT02969369|363872667|FG000|Double-blind Period|Withdrawal by Subject|2|||
105508554|NCT02969369|363872668|FG001|Double-blind Period|Withdrawal by Subject|3|||
105508555|NCT02969369|363872667|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
105508556|NCT02969369|363872668|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
105508557|NCT02969369|363872667|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
105508558|NCT02969369|363872668|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
105508559|NCT02969369|363872667|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
105508560|NCT02969369|363872668|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
105508561|NCT02969369|363872667|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
105508562|NCT02969369|363872668|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
105508563|NCT02849678|363872669|FG000|Overall Study|Protocol Violation|3|||
105508564|NCT02849678|363872670|FG001|Overall Study|Protocol Violation|6|||
105508565|NCT00003499|363872674|FG000|Overall Study|Not evaluable|8|||
105508566|NCT01192516|363872675|FG000|Overall Study|Lost to Follow-up|7|||
105508567|NCT01192516|363872676|FG001|Overall Study|Lost to Follow-up|10|||
105508568|NCT01192516|363872677|FG002|Overall Study|Lost to Follow-up|7|||
105508569|NCT01192516|363872675|FG000|Overall Study|Withdrawal by Subject|4|||
105508570|NCT01192516|363872676|FG001|Overall Study|Withdrawal by Subject|4|||
105508571|NCT01192516|363872677|FG002|Overall Study|Withdrawal by Subject|1|||
105508572|NCT01192516|363872675|FG000|Overall Study|started new treatment|5|||
105508573|NCT01192516|363872676|FG001|Overall Study|started new treatment|1|||
105508574|NCT01192516|363872677|FG002|Overall Study|started new treatment|0|||
105508575|NCT01192516|363872675|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
105508576|NCT01192516|363872676|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
105508577|NCT01192516|363872677|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
105508578|NCT01256008|363872678|FG000|Overall Study|Lost to Follow-up|6|||
105508579|NCT01256008|363872679|FG001|Overall Study|Lost to Follow-up|4|||
105508580|NCT01256008|363872680|FG002|Overall Study|Lost to Follow-up|11|||
105508581|NCT01256008|363872678|FG000|Overall Study|Withdrawal by Subject|2|||
105508582|NCT01256008|363872679|FG001|Overall Study|Withdrawal by Subject|3|||
105508583|NCT01256008|363872680|FG002|Overall Study|Withdrawal by Subject|10|||
105508584|NCT02244606|363872681|FG000|Overall Study|Adverse Event|0|||
105508585|NCT02244606|363872682|FG001|Overall Study|Adverse Event|1|||
105508586|NCT02244606|363872683|FG002|Overall Study|Adverse Event|1|||
105508587|NCT02244606|363872684|FG003|Overall Study|Adverse Event|0|||
105508588|NCT02244606|363872681|FG000|Overall Study|Lost to Follow-up|2|||
105508589|NCT02244606|363872682|FG001|Overall Study|Lost to Follow-up|2|||
105508590|NCT02244606|363872683|FG002|Overall Study|Lost to Follow-up|1|||
105508591|NCT02244606|363872684|FG003|Overall Study|Lost to Follow-up|0|||
105508592|NCT02244606|363872681|FG000|Overall Study|Protocol Violation|0|||
105508593|NCT02244606|363872682|FG001|Overall Study|Protocol Violation|0|||
105508594|NCT02244606|363872683|FG002|Overall Study|Protocol Violation|0|||
105508595|NCT02244606|363872684|FG003|Overall Study|Protocol Violation|1|||
105508596|NCT02244606|363872681|FG000|Overall Study|Withdrawal by Subject|1|||
105508597|NCT02244606|363872682|FG001|Overall Study|Withdrawal by Subject|1|||
105508598|NCT02244606|363872683|FG002|Overall Study|Withdrawal by Subject|0|||
105591184|NCT03354390|364164367|FG001|Level 3|Death|0|||
105591185|NCT03354390|364164368|FG002|Level 3|Death|1|||
105591186|NCT03354390|364164369|FG003|Level 3|Death|0|||
105591187|NCT03354390|364164366|FG000|Level 3|Physician Decision|0|||
105591188|NCT03354390|364164367|FG001|Level 3|Physician Decision|0|||
105591189|NCT03354390|364164368|FG002|Level 3|Physician Decision|2|||
105591190|NCT03354390|364164369|FG003|Level 3|Physician Decision|0|||
105591191|NCT03354390|364164366|FG000|Level 4|Death|0|||
105591192|NCT03354390|364164367|FG001|Level 4|Death|0|||
105591193|NCT03354390|364164368|FG002|Level 4|Death|0|||
105591194|NCT03354390|364164369|FG003|Level 4|Death|3|||
105591195|NCT00613301|364165636|FG000|Overall Study|Adverse Event|49|||
105591196|NCT00613301|364165636|FG000|Overall Study|Lost to Follow-up|88|||
105591197|NCT00613301|364165636|FG000|Overall Study|Withdrawal by Subject|5|||
105591198|NCT00613301|364165636|FG000|Overall Study|Death|6|||
105591199|NCT00613301|364165636|FG000|Overall Study|Lack of Efficacy|13|||
105591200|NCT00613301|364165636|FG000|Overall Study|Physician Decision|2|||
105591201|NCT00613301|364165636|FG000|Overall Study|No data was collected|53|||
105591202|NCT00613301|364165636|FG000|Overall Study|Irregularly enrolled patients|12|||
105591203|NCT00762463|364165637|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
105591204|NCT00762463|364165638|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
105591205|NCT00762463|364165639|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
105591206|NCT00762463|364165640|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
105591207|NCT00762463|364165637|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
105591208|NCT00762463|364165638|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
105591209|NCT00762463|364165639|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
105591210|NCT00762463|364165640|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
105591211|NCT00762463|364165637|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
105591212|NCT00762463|364165638|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
105591213|NCT00762463|364165639|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
105591214|NCT00762463|364165640|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
105591215|NCT00762463|364165637|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
105591216|NCT00762463|364165638|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
105591217|NCT00762463|364165639|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
105591218|NCT00762463|364165640|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
105591219|NCT00762463|364165637|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
105591220|NCT00762463|364165638|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
105591221|NCT00762463|364165639|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
105591222|NCT00762463|364165640|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
105591223|NCT00762463|364165637|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
105591224|NCT00762463|364165638|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
105591225|NCT00762463|364165639|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
105591226|NCT00762463|364165640|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
105591227|NCT00762463|364165637|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
105591228|NCT00762463|364165638|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
105591229|NCT00762463|364165639|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
105591230|NCT00762463|364165640|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
105591231|NCT00762463|364165637|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
105591232|NCT00762463|364165638|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
105591233|NCT00762463|364165639|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
105591234|NCT00762463|364165640|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
105591235|NCT01118377|364165643|FG000|Overall Study|Did Not Receive Study Medication|1|||
105591236|NCT01118377|364165643|FG000|Overall Study|Death|38|||
105508599|NCT02244606|363872684|FG003|Overall Study|Withdrawal by Subject|0|||
105508600|NCT02244606|363872681|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
105508601|NCT02244606|363872682|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
105508602|NCT02244606|363872683|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
105508603|NCT02244606|363872684|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
105508604|NCT00378378|363872685|FG000|Overall Study|Withdrawal by Subject|0|||
105508605|NCT00378378|363872686|FG001|Overall Study|Withdrawal by Subject|1|||
105508606|NCT00378378|363872687|FG002|Overall Study|Withdrawal by Subject|0|||
105508607|NCT00378378|363872685|FG000|Overall Study|Treatment Failure|0|||
105508608|NCT00378378|363872686|FG001|Overall Study|Treatment Failure|0|||
105508609|NCT00378378|363872687|FG002|Overall Study|Treatment Failure|1|||
105508610|NCT00378378|363872685|FG000|Overall Study|Non-compliance with protocol|0|||
105508611|NCT00378378|363872686|FG001|Overall Study|Non-compliance with protocol|0|||
105508612|NCT00378378|363872687|FG002|Overall Study|Non-compliance with protocol|1|||
105508613|NCT03782792|363872688|FG000|Overall Study|Patient left the country|0|||
105508614|NCT03782792|363872689|FG001|Overall Study|Patient left the country|1|||
105508615|NCT03782792|363872688|FG000|Overall Study|Withdrawal by Subject|1|||
105508616|NCT03782792|363872689|FG001|Overall Study|Withdrawal by Subject|2|||
105508617|NCT05228132|363872700|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
105508618|NCT05228132|363872700|FG000|Overall Study|Adverse Event|3|||
105508619|NCT05228132|363872700|FG000|Overall Study|Lost to Follow-up|1|||
105508620|NCT05228132|363872700|FG000|Overall Study|Arteriovenous-fistula mature|1|||
105508621|NCT04270747|363872701|FG000|Through Week 16|Adverse Event|1|||
105508622|NCT04270747|363872702|FG001|Through Week 16|Adverse Event|2|||
105508623|NCT04270747|363872703|FG002|Through Week 16|Adverse Event|0|||
105508624|NCT04270747|363872701|FG000|Through Week 16|Death|0|||
105508625|NCT04270747|363872702|FG001|Through Week 16|Death|2|||
105508626|NCT04270747|363872703|FG002|Through Week 16|Death|0|||
105508627|NCT04270747|363872701|FG000|Through Week 16|Consent Withdrawn|3|||
105508628|NCT04270747|363872702|FG001|Through Week 16|Consent Withdrawn|3|||
105508629|NCT04270747|363872703|FG002|Through Week 16|Consent Withdrawn|0|||
105508630|NCT04270747|363872701|FG000|Through Week 16|Physician Decision|1|||
105508631|NCT04270747|363872702|FG001|Through Week 16|Physician Decision|1|||
105508632|NCT04270747|363872703|FG002|Through Week 16|Physician Decision|0|||
105508633|NCT04270747|363872701|FG000|Through Week 16|Lost to Follow-up|2|||
105508634|NCT04270747|363872702|FG001|Through Week 16|Lost to Follow-up|0|||
105508635|NCT04270747|363872703|FG002|Through Week 16|Lost to Follow-up|0|||
105508636|NCT04270747|363872701|FG000|Through Week 16|Protocol Violation|1|||
105508637|NCT04270747|363872702|FG001|Through Week 16|Protocol Violation|2|||
105508638|NCT04270747|363872703|FG002|Through Week 16|Protocol Violation|0|||
105508639|NCT04270747|363872701|FG000|Through Week 16|Protocol Specified Criteria|6|||
105508640|NCT04270747|363872702|FG001|Through Week 16|Protocol Specified Criteria|7|||
105508641|NCT04270747|363872703|FG002|Through Week 16|Protocol Specified Criteria|0|||
105508642|NCT04270747|363872701|FG000|Through Week 16|Miscellaneous|1|||
105508643|NCT04270747|363872702|FG001|Through Week 16|Miscellaneous|1|||
105508644|NCT04270747|363872703|FG002|Through Week 16|Miscellaneous|0|||
105508645|NCT04270747|363872701|FG000|Post Week 16|Adverse Event|7|||
105508646|NCT04270747|363872702|FG001|Post Week 16|Adverse Event|5|||
105508647|NCT04270747|363872703|FG002|Post Week 16|Adverse Event|1|||
105508648|NCT04270747|363872701|FG000|Post Week 16|Death|2|||
105508649|NCT04270747|363872702|FG001|Post Week 16|Death|0|||
105508650|NCT04270747|363872703|FG002|Post Week 16|Death|2|||
105508651|NCT04270747|363872701|FG000|Post Week 16|Consent Withdrawn|4|||
105508652|NCT04270747|363872702|FG001|Post Week 16|Consent Withdrawn|3|||
105508653|NCT04270747|363872703|FG002|Post Week 16|Consent Withdrawn|6|||
105508654|NCT04270747|363872701|FG000|Post Week 16|Physician Decision|3|||
105508655|NCT04270747|363872702|FG001|Post Week 16|Physician Decision|1|||
105508656|NCT04270747|363872703|FG002|Post Week 16|Physician Decision|1|||
105508657|NCT04270747|363872701|FG000|Post Week 16|Lost to Follow-up|2|||
105508658|NCT04270747|363872702|FG001|Post Week 16|Lost to Follow-up|1|||
105508659|NCT04270747|363872703|FG002|Post Week 16|Lost to Follow-up|0|||
105508660|NCT04270747|363872701|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
105508661|NCT04270747|363872702|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
105508662|NCT04270747|363872703|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
105508663|NCT04270747|363872701|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
105508664|NCT04270747|363872702|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
105508665|NCT04270747|363872703|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
105508666|NCT04270747|363872701|FG000|Post Week 16|Miscellaneous|1|||
105508667|NCT04270747|363872702|FG001|Post Week 16|Miscellaneous|0|||
105508668|NCT04270747|363872703|FG002|Post Week 16|Miscellaneous|1|||
105508669|NCT05025241|363872704|FG000|Screening|Failed Screening|5|||
105508670|NCT05025241|363872704|FG000|Treatment and Follow Up|Adverse Event|3|||
105508671|NCT04605484|363872705|FG000|Overall Study|Lost to Follow-up|0|||
105508672|NCT04605484|363872706|FG001|Overall Study|Lost to Follow-up|1|||
105508673|NCT04605484|363872707|FG002|Overall Study|Lost to Follow-up|1|||
105508674|NCT04605484|363872705|FG000|Overall Study|Other|0|||
105508675|NCT04605484|363872706|FG001|Overall Study|Other|1|||
105508676|NCT04605484|363872707|FG002|Overall Study|Other|0|||
105508677|NCT05683249|363872710|FG000|Overall Study|Adverse Event|3|||
105591237|NCT01118377|364165643|FG000|Overall Study|Failure to Return|3|||
105508678|NCT05683249|363872711|FG001|Overall Study|Adverse Event|1|||
105591238|NCT00739102|364165644|FG000|Overall Study|Death|5|||
105591239|NCT00739102|364165644|FG000|Overall Study|Withdrawal by Subject|10|||
105508679|NCT05683249|363872710|FG000|Overall Study|Lack of Efficacy|0|||
105508680|NCT05683249|363872711|FG001|Overall Study|Lack of Efficacy|2|||
105508681|NCT05683249|363872710|FG000|Overall Study|Lost to Follow-up|6|||
105508682|NCT05683249|363872711|FG001|Overall Study|Lost to Follow-up|5|||
105508683|NCT05683249|363872710|FG000|Overall Study|Non-compliance with Study Drug|2|||
105508684|NCT05683249|363872711|FG001|Overall Study|Non-compliance with Study Drug|0|||
105591240|NCT01368406|364165645|FG000|Overall Study|Lost to Follow-up|8|||
105508685|NCT05683249|363872710|FG000|Overall Study|Protocol Violation|6|||
105508686|NCT05683249|363872711|FG001|Overall Study|Protocol Violation|3|||
105508687|NCT05683249|363872710|FG000|Overall Study|Withdrawal by Subject|9|||
105508688|NCT05683249|363872711|FG001|Overall Study|Withdrawal by Subject|8|||
105508689|NCT05683249|363872710|FG000|Overall Study|Other|0|||
105508690|NCT05683249|363872711|FG001|Overall Study|Other|2|||
105508691|NCT01217814|363872713|FG000|Overall Study|Adverse Event|1|||
105508692|NCT01217814|363872714|FG001|Overall Study|Adverse Event|1|||
105508693|NCT01217814|363872715|FG002|Overall Study|Adverse Event|0|||
105508694|NCT01217814|363872713|FG000|Overall Study|Lack of Efficacy|0|||
105508695|NCT01217814|363872714|FG001|Overall Study|Lack of Efficacy|0|||
105508696|NCT01217814|363872715|FG002|Overall Study|Lack of Efficacy|1|||
105508697|NCT00729651|363872716|FG000|Overall Study|Withdrawal by Subject|5|||
105508698|NCT00729651|363872717|FG001|Overall Study|Withdrawal by Subject|6|||
105508699|NCT00729651|363872716|FG000|Overall Study|Lost to Follow-up|5|||
105508700|NCT00729651|363872717|FG001|Overall Study|Lost to Follow-up|4|||
105508701|NCT00729651|363872716|FG000|Overall Study|Protocol Violation|0|||
105508702|NCT00729651|363872717|FG001|Overall Study|Protocol Violation|1|||
105508703|NCT00729651|363872716|FG000|Overall Study|Adverse Event|7|||
105508704|NCT00729651|363872717|FG001|Overall Study|Adverse Event|3|||
105508705|NCT00729651|363872716|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
105508706|NCT00729651|363872717|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
105508707|NCT00729651|363872716|FG000|Overall Study|Subject's private reason|2|||
105508708|NCT00729651|363872717|FG001|Overall Study|Subject's private reason|0|||
105508709|NCT02925494|363872718|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
105508710|NCT02925494|363872719|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
105508711|NCT02925494|363872720|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
105508712|NCT02925494|363872721|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
105508713|NCT02925494|363872718|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
105508714|NCT02925494|363872719|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
105508715|NCT02925494|363872720|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
105508716|NCT02925494|363872721|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
105508717|NCT02925494|363872718|FG000|Post-Treatment Follow-Up Period|Other|1|||
105508718|NCT02925494|363872719|FG001|Post-Treatment Follow-Up Period|Other|4|||
105508719|NCT02925494|363872720|FG002|Post-Treatment Follow-Up Period|Other|3|||
105508720|NCT02925494|363872721|FG003|Post-Treatment Follow-Up Period|Other|6|||
105508721|NCT02925494|363872718|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
105508722|NCT02925494|363872719|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
105508723|NCT02925494|363872720|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
105508724|NCT02925494|363872721|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
105508725|NCT02925494|363872718|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
105508726|NCT02925494|363872719|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
105508727|NCT02925494|363872720|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
105508728|NCT02925494|363872721|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
105508729|NCT02925494|363872718|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
105508730|NCT02925494|363872719|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
105508731|NCT02925494|363872720|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
105508732|NCT02925494|363872721|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
105508733|NCT02925494|363872718|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
105508734|NCT02925494|363872719|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
105508735|NCT02925494|363872720|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
105508736|NCT02925494|363872721|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
105508737|NCT01637272|363872723|FG000|Overall Study|Adverse Event|6|||
105508738|NCT01637272|363872723|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105508739|NCT01637272|363872723|FG000|Overall Study|Withdrawal by Subject|3|||
105508740|NCT01637272|363872723|FG000|Overall Study|Lost to Follow-up|2|||
105508741|NCT01637272|363872723|FG000|Overall Study|completed core, did not enter ext. phase|4|||
105508742|NCT01637272|363872723|FG000|Overall Study|Administrative problems|1|||
105508743|NCT01637272|363872723|FG000|Overall Study|Protocol Violation|2|||
105508744|NCT01496612|363872724|FG000|1st Intervention|Adverse Event|1|||
105508745|NCT01496612|363872725|FG001|1st Intervention|Adverse Event|0|||
105508746|NCT01496612|363872724|FG000|1st Intervention|Withdrawal by Subject|1|||
105508747|NCT01496612|363872725|FG001|1st Intervention|Withdrawal by Subject|0|||
105508748|NCT04584645|363872726|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
105508749|NCT04584645|363872727|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
105508750|NCT01473836|363874078|FG000|Overall Study|Adverse Event|4|||
105508751|NCT01473836|363874078|FG000|Overall Study|Lack of Efficacy|1|||
105508752|NCT01473836|363874078|FG000|Overall Study|Does not meet entrance criteria|1|||
105508753|NCT03291808|363874079|FG000|Overall Study|Lost to Follow-up|6|||
105508754|NCT03291808|363874079|FG000|Overall Study|Research burden|4|||
105508755|NCT03462082|363874089|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
105508756|NCT03462082|363874090|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
105508757|NCT03462082|363874091|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
105508758|NCT03462082|363874092|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
105508759|NCT03462082|363874093|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
105508760|NCT03462082|363874094|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
105508761|NCT03462082|363874095|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
105508762|NCT03462082|363874096|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
105508763|NCT00284050|363874097|FG000|Overall Study|Adverse Event|1|||
105508764|NCT00284050|363874098|FG001|Overall Study|Adverse Event|1|||
105508765|NCT00284050|363874099|FG002|Overall Study|Adverse Event|1|||
105508766|NCT00284050|363874097|FG000|Overall Study|Lack of Efficacy|0|||
105508767|NCT00284050|363874098|FG001|Overall Study|Lack of Efficacy|1|||
105508768|NCT00284050|363874099|FG002|Overall Study|Lack of Efficacy|3|||
105508769|NCT00284050|363874097|FG000|Overall Study|Protocol Violation|0|||
105508770|NCT00284050|363874098|FG001|Overall Study|Protocol Violation|1|||
105508771|NCT00284050|363874099|FG002|Overall Study|Protocol Violation|2|||
105508772|NCT00284050|363874097|FG000|Overall Study|Withdrawal by Subject|2|||
105508773|NCT00284050|363874098|FG001|Overall Study|Withdrawal by Subject|2|||
105508774|NCT00284050|363874099|FG002|Overall Study|Withdrawal by Subject|2|||
105508775|NCT00284050|363874097|FG000|Overall Study|Lost to Follow-up|1|||
105508776|NCT00284050|363874098|FG001|Overall Study|Lost to Follow-up|0|||
105508777|NCT00284050|363874099|FG002|Overall Study|Lost to Follow-up|1|||
105508778|NCT00284050|363874097|FG000|Overall Study|Death|1|||
105508779|NCT00284050|363874098|FG001|Overall Study|Death|0|||
105508780|NCT00284050|363874099|FG002|Overall Study|Death|0|||
105508781|NCT00166114|363874100|FG000|Overall Study|Protocol Violation|2|||
105508782|NCT00166114|363874101|FG001|Overall Study|Protocol Violation|1|||
105508783|NCT00166114|363874100|FG000|Overall Study|Withdrawal by Subject|10|||
105508784|NCT00166114|363874101|FG001|Overall Study|Withdrawal by Subject|4|||
105508785|NCT00166114|363874100|FG000|Overall Study|Adverse Event|2|||
105508786|NCT00166114|363874101|FG001|Overall Study|Adverse Event|1|||
105508787|NCT02548650|363874112|FG000|Triple Therapy|Adverse Event|1|||
105508788|NCT02548650|363874113|FG001|Triple Therapy|Adverse Event|0|||
105508789|NCT02548650|363874112|FG000|Triple Therapy|Withdrawal by Subject|0|||
105508790|NCT02548650|363874113|FG001|Triple Therapy|Withdrawal by Subject|4|||
105508791|NCT02548650|363874112|FG000|Double Therapy|Adverse Event|1|||
105508792|NCT02548650|363874113|FG001|Double Therapy|Adverse Event|1|||
105508793|NCT02548650|363874112|FG000|Double Therapy|Withdrawal by Subject|0|||
105508794|NCT02548650|363874113|FG001|Double Therapy|Withdrawal by Subject|1|||
105508795|NCT01191801|363874114|FG000|Overall Study|Death|36|||
105508796|NCT01191801|363874115|FG001|Overall Study|Death|12|||
105508797|NCT01191801|363874114|FG000|Overall Study|Lack of Efficacy|176|||
105508798|NCT01191801|363874115|FG001|Overall Study|Lack of Efficacy|258|||
105508799|NCT01191801|363874114|FG000|Overall Study|Adverse Event|9|||
105508800|NCT01191801|363874115|FG001|Overall Study|Adverse Event|8|||
105508801|NCT01191801|363874114|FG000|Overall Study|Protocol Violation|2|||
105508802|NCT01191801|363874115|FG001|Overall Study|Protocol Violation|4|||
105508803|NCT01191801|363874114|FG000|Overall Study|Physician Decision|47|||
105508804|NCT01191801|363874115|FG001|Overall Study|Physician Decision|24|||
105508805|NCT01191801|363874114|FG000|Overall Study|Withdrawal by Subject|1|||
105508806|NCT01191801|363874115|FG001|Overall Study|Withdrawal by Subject|4|||
105508807|NCT01191801|363874114|FG000|Overall Study|Not Provided|45|||
105508808|NCT01191801|363874115|FG001|Overall Study|Not Provided|27|||
105508809|NCT02042183|363874122|FG000|Overall Study|Physician Decision|7|||
105508810|NCT02042183|363874123|FG001|Overall Study|Physician Decision|2|||
105508811|NCT02042183|363874122|FG000|Overall Study|Lack of Efficacy|4|||
105508812|NCT02042183|363874123|FG001|Overall Study|Lack of Efficacy|3|||
105508813|NCT02042183|363874122|FG000|Overall Study|Non-compliance with Study Drug|2|||
105508814|NCT02042183|363874123|FG001|Overall Study|Non-compliance with Study Drug|3|||
105508815|NCT02042183|363874122|FG000|Overall Study|Adverse Event|17|||
105508816|NCT02042183|363874123|FG001|Overall Study|Adverse Event|6|||
105508817|NCT02042183|363874122|FG000|Overall Study|Other|3|||
105508818|NCT02042183|363874123|FG001|Overall Study|Other|3|||
105508819|NCT02042183|363874122|FG000|Overall Study|Withdrawal by Subject|21|||
105508820|NCT02042183|363874123|FG001|Overall Study|Withdrawal by Subject|16|||
105508821|NCT02042183|363874122|FG000|Overall Study|Site Terminated by Sponsor|2|||
105508822|NCT02042183|363874123|FG001|Overall Study|Site Terminated by Sponsor|1|||
105508823|NCT02042183|363874122|FG000|Overall Study|Lost to Follow-up|9|||
105508824|NCT02042183|363874123|FG001|Overall Study|Lost to Follow-up|2|||
105508825|NCT01727297|363874124|FG000|Overall Study|Death|13|||
105508826|NCT01727297|363874125|FG001|Overall Study|Death|0|||
105508827|NCT01727297|363874124|FG000|Overall Study|Protocol Violation|1|||
105508828|NCT01727297|363874125|FG001|Overall Study|Protocol Violation|10|||
105508829|NCT01727297|363874124|FG000|Overall Study|Adverse Event|3|||
105508830|NCT01727297|363874125|FG001|Overall Study|Adverse Event|1|||
105508831|NCT01727297|363874124|FG000|Overall Study|Lost to Follow-up|11|||
105508832|NCT01727297|363874125|FG001|Overall Study|Lost to Follow-up|0|||
105508833|NCT01727297|363874124|FG000|Overall Study|Withdrawal by Subject|26|||
105508834|NCT01727297|363874125|FG001|Overall Study|Withdrawal by Subject|27|||
105508835|NCT01727297|363874124|FG000|Overall Study|Physician Decision|19|||
105508836|NCT01727297|363874125|FG001|Overall Study|Physician Decision|5|||
105508837|NCT01727297|363874124|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
105508838|NCT01727297|363874125|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
105508839|NCT00814164|363874133|FG000|Overall Study|Progression|7|||
105508840|NCT00814164|363874133|FG000|Overall Study|not stated|7|||
105508841|NCT00814164|363874133|FG000|Overall Study|Death|5|||
105508842|NCT00851747|363874135|FG000|Overall Study|Physician Decision|6|||
105508843|NCT00851747|363874136|FG001|Overall Study|Physician Decision|6|||
105508844|NCT00851747|363874137|FG002|Overall Study|Physician Decision|6|||
105508845|NCT02340975|363874138|FG000|Overall Study|Death|6|||
105508846|NCT02340975|363874139|FG001|Overall Study|Death|23|||
105508847|NCT02340975|363874140|FG002|Overall Study|Death|21|||
105508848|NCT02340975|363874141|FG003|Overall Study|Death|7|||
105508849|NCT02340975|363874142|FG004|Overall Study|Death|21|||
105508850|NCT02340975|363874143|FG005|Overall Study|Death|13|||
105508851|NCT02340975|363874138|FG000|Overall Study|Lost to Follow-up|0|||
105508852|NCT02340975|363874139|FG001|Overall Study|Lost to Follow-up|0|||
105508853|NCT02340975|363874140|FG002|Overall Study|Lost to Follow-up|0|||
105508854|NCT02340975|363874141|FG003|Overall Study|Lost to Follow-up|0|||
105508855|NCT02340975|363874142|FG004|Overall Study|Lost to Follow-up|2|||
105508856|NCT02340975|363874143|FG005|Overall Study|Lost to Follow-up|0|||
105508857|NCT02340975|363874138|FG000|Overall Study|Withdrawal by Subject|0|||
105508858|NCT02340975|363874139|FG001|Overall Study|Withdrawal by Subject|0|||
105508859|NCT02340975|363874140|FG002|Overall Study|Withdrawal by Subject|3|||
105508860|NCT02340975|363874141|FG003|Overall Study|Withdrawal by Subject|3|||
105508861|NCT02340975|363874142|FG004|Overall Study|Withdrawal by Subject|2|||
105508862|NCT02340975|363874143|FG005|Overall Study|Withdrawal by Subject|0|||
105508863|NCT02340975|363874138|FG000|Overall Study|Other|0|||
105508864|NCT02340975|363874139|FG001|Overall Study|Other|4|||
105508865|NCT02340975|363874140|FG002|Overall Study|Other|0|||
105508866|NCT02340975|363874141|FG003|Overall Study|Other|2|||
105508867|NCT02340975|363874142|FG004|Overall Study|Other|0|||
105508868|NCT02340975|363874143|FG005|Overall Study|Other|6|||
105508869|NCT02321800|363874144|FG000|Overall Study|Withdrawal by Subject|3|||
105508870|NCT02321800|363874145|FG001|Overall Study|Withdrawal by Subject|3|||
105508871|NCT02321800|363874144|FG000|Overall Study|Death|1|||
105508872|NCT02321800|363874145|FG001|Overall Study|Death|0|||
105508873|NCT02321800|363874144|FG000|Overall Study|Protocol Violation|1|||
105508874|NCT02321800|363874145|FG001|Overall Study|Protocol Violation|0|||
105508875|NCT02321800|363874144|FG000|Overall Study|Lost to Follow-up|10|||
105508876|NCT02321800|363874145|FG001|Overall Study|Lost to Follow-up|4|||
105508877|NCT02321800|363874144|FG000|Overall Study|Adverse Event|2|||
105508878|NCT02321800|363874145|FG001|Overall Study|Adverse Event|3|||
105508879|NCT02321800|363874144|FG000|Overall Study|Other, Miscellaneous|3|||
105508880|NCT02321800|363874145|FG001|Overall Study|Other, Miscellaneous|1|||
105508881|NCT01854710|363874149|FG000|Overall Study|Withdrawal by Subject|2|||
105508882|NCT01854710|363874150|FG001|Overall Study|Withdrawal by Subject|1|||
105508883|NCT01854710|363874151|FG002|Overall Study|Withdrawal by Subject|0|||
105508884|NCT01854710|363874152|FG003|Overall Study|Withdrawal by Subject|0|||
105508885|NCT01854710|363874153|FG004|Overall Study|Withdrawal by Subject|0|||
105508886|NCT01854710|363874154|FG005|Overall Study|Withdrawal by Subject|0|||
105508887|NCT01854710|363874149|FG000|Overall Study|CRI procedural error|2|||
105508888|NCT01854710|363874150|FG001|Overall Study|CRI procedural error|2|||
105508889|NCT01854710|363874151|FG002|Overall Study|CRI procedural error|2|||
105508890|NCT01854710|363874152|FG003|Overall Study|CRI procedural error|2|||
105508891|NCT01854710|363874153|FG004|Overall Study|CRI procedural error|2|||
105508892|NCT01854710|363874154|FG005|Overall Study|CRI procedural error|2|||
105508893|NCT00982878|363874155|FG000|Overall Study|Physician Decision|1|||
105508894|NCT03132220|363874156|FG000|Overall Study|Lost to Follow-up|17|||
105508895|NCT03132220|363874157|FG001|Overall Study|Lost to Follow-up|8|||
105508896|NCT03132220|363874156|FG000|Overall Study|Withdrawal by Subject|1|||
105508897|NCT03132220|363874157|FG001|Overall Study|Withdrawal by Subject|4|||
105508898|NCT01169493|363874158|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
105508899|NCT01169493|363874159|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
105508900|NCT01169493|363874160|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
105508901|NCT01169493|363874161|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
105508902|NCT01169493|363874162|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
105508903|NCT01169493|363874163|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
105508904|NCT01169493|363874158|FG000|Period 3 (6 Months)|Adverse Event|0|||
105508905|NCT01169493|363874159|FG001|Period 3 (6 Months)|Adverse Event|1|||
105508906|NCT01169493|363874160|FG002|Period 3 (6 Months)|Adverse Event|0|||
105508907|NCT01169493|363874161|FG003|Period 3 (6 Months)|Adverse Event|0|||
105508908|NCT01169493|363874162|FG004|Period 3 (6 Months)|Adverse Event|0|||
105508909|NCT01169493|363874163|FG005|Period 3 (6 Months)|Adverse Event|0|||
105508910|NCT01169493|363874158|FG000|Period 3 (6 Months)|Physician Decision|0|||
105508911|NCT01169493|363874159|FG001|Period 3 (6 Months)|Physician Decision|1|||
105591241|NCT01368406|364165646|FG001|Overall Study|Lost to Follow-up|4|||
105508912|NCT01169493|363874160|FG002|Period 3 (6 Months)|Physician Decision|1|||
105508913|NCT01169493|363874161|FG003|Period 3 (6 Months)|Physician Decision|0|||
105508914|NCT01169493|363874162|FG004|Period 3 (6 Months)|Physician Decision|0|||
105508915|NCT01169493|363874163|FG005|Period 3 (6 Months)|Physician Decision|0|||
105508916|NCT01336764|363874164|FG000|Overall Study|Withdrawal by Subject|5|||
105508917|NCT01336764|363874165|FG001|Overall Study|Withdrawal by Subject|5|||
105508918|NCT01906008|363874170|FG000|Overall Study|Lost to Follow-up|2|||
105508919|NCT01906008|363874171|FG001|Overall Study|Lost to Follow-up|0|||
105591242|NCT01368406|364165645|FG000|Overall Study|Withdrawal by Subject|8|||
105591243|NCT01368406|364165646|FG001|Overall Study|Withdrawal by Subject|4|||
105591244|NCT01368406|364165645|FG000|Overall Study|relapse of the disease|3|||
105591245|NCT01368406|364165646|FG001|Overall Study|relapse of the disease|2|||
105591246|NCT01368406|364165645|FG000|Overall Study|started working|2|||
105591247|NCT01368406|364165646|FG001|Overall Study|started working|3|||
105591248|NCT01466881|364165647|FG000|Overall Study|Ineligible|5|||
105591249|NCT01466881|364165647|FG000|Overall Study|Adverse Event|6|||
105591250|NCT01466881|364165647|FG000|Overall Study|Progression/relapse|20|||
105591251|NCT01466881|364165647|FG000|Overall Study|Death|4|||
105591252|NCT01466881|364165647|FG000|Overall Study|Other reason not protocol specified|5|||
105591253|NCT01101165|364165648|FG000|Period 1|Adverse Event|1|||
105591254|NCT01101165|364165649|FG001|Period 1|Adverse Event|2|||
105591255|NCT01101165|364165648|FG000|Period 1|Withdrawal by Subject|0|||
105591256|NCT01101165|364165649|FG001|Period 1|Withdrawal by Subject|2|||
105591257|NCT01101165|364165648|FG000|Period 1|Positive Drug Screen|0|||
105591258|NCT01101165|364165649|FG001|Period 1|Positive Drug Screen|1|||
105591259|NCT01101165|364165648|FG000|Period 1|Lost to Follow-up|1|||
105591260|NCT01101165|364165649|FG001|Period 1|Lost to Follow-up|0|||
105591261|NCT01101165|364165648|FG000|Period 2|Withdrawal by Subject|3|||
105591262|NCT01101165|364165649|FG001|Period 2|Withdrawal by Subject|1|||
105591263|NCT01101165|364165648|FG000|Period 2|Adverse Event|1|||
105591264|NCT01101165|364165649|FG001|Period 2|Adverse Event|0|||
105508920|NCT01906008|363874170|FG000|Overall Study|Oxaliplatin toxicity|2|||
105508921|NCT01906008|363874171|FG001|Overall Study|Oxaliplatin toxicity|0|||
105508922|NCT01906008|363874170|FG000|Overall Study|Protocol Violation|0|||
105508923|NCT01906008|363874171|FG001|Overall Study|Protocol Violation|1|||
105508924|NCT01906008|363874170|FG000|Overall Study|Withdrawal by Subject|1|||
105508925|NCT01906008|363874171|FG001|Overall Study|Withdrawal by Subject|5|||
105508926|NCT01906008|363874170|FG000|Overall Study|Did not start study med|3|||
105508927|NCT01906008|363874171|FG001|Overall Study|Did not start study med|4|||
105508928|NCT01906008|363874170|FG000|Overall Study|Oxaliplatin stops|10|||
105508929|NCT01906008|363874171|FG001|Overall Study|Oxaliplatin stops|8|||
105508930|NCT01906008|363874170|FG000|Overall Study|Hospice|1|||
105508931|NCT01906008|363874171|FG001|Overall Study|Hospice|0|||
105508932|NCT01906008|363874170|FG000|Overall Study|Physician Decision|3|||
105508933|NCT01906008|363874171|FG001|Overall Study|Physician Decision|3|||
105508934|NCT01906008|363874170|FG000|Overall Study|Lack of compliance of study med|5|||
105508935|NCT01906008|363874171|FG001|Overall Study|Lack of compliance of study med|3|||
105508936|NCT01906008|363874170|FG000|Overall Study|Adverse Event|0|||
105508937|NCT01906008|363874171|FG001|Overall Study|Adverse Event|3|||
105508938|NCT02088047|363874173|FG000|Overall Study|Withdrawal by Subject|1|||
105508939|NCT02088047|363874174|FG001|Overall Study|Withdrawal by Subject|0|||
105508940|NCT00660309|363874175|FG000|Overall Study|Adverse Event|2|||
105508941|NCT00660309|363874176|FG001|Overall Study|Adverse Event|0|||
105508942|NCT00660309|363874175|FG000|Overall Study|Withdrawal by Subject|0|||
105508943|NCT00660309|363874176|FG001|Overall Study|Withdrawal by Subject|3|||
105508944|NCT01442675|363874179|FG000|Overall Study|Protocol Violation|6|||
105508945|NCT01442675|363874179|FG000|Overall Study|Lost to Follow-up|2|||
105508946|NCT01442675|363874179|FG000|Overall Study|Withdrawal by Subject|4|||
105508947|NCT03366337|363874180|FG000|Overall Study|Lost to Follow-up|1|||
105508948|NCT03366337|363874181|FG001|Overall Study|Lost to Follow-up|0|||
105508949|NCT03366337|363874182|FG002|Overall Study|Lost to Follow-up|1|||
105508950|NCT03366337|363874183|FG003|Overall Study|Lost to Follow-up|0|||
105508951|NCT03366337|363874180|FG000|Overall Study|Withdrawal by Subject|2|||
105508952|NCT03366337|363874181|FG001|Overall Study|Withdrawal by Subject|0|||
105508953|NCT03366337|363874182|FG002|Overall Study|Withdrawal by Subject|1|||
105508954|NCT03366337|363874183|FG003|Overall Study|Withdrawal by Subject|1|||
105508955|NCT01537393|363874184|FG000|Overall Study|Exclude prior to study|32|||
105508956|NCT01537393|363874185|FG001|Overall Study|Exclude prior to study|44|||
105508957|NCT01537393|363874184|FG000|Overall Study|Death|20|||
105508958|NCT01537393|363874185|FG001|Overall Study|Death|32|||
105508959|NCT01537393|363874184|FG000|Overall Study|Withdrawal by Subject|18|||
105508960|NCT01537393|363874185|FG001|Overall Study|Withdrawal by Subject|17|||
105591265|NCT00831792|364165653|FG000|Overall Study|Not Eligible|3|||
105591266|NCT00831792|364165653|FG000|Overall Study|Adverse Event|1|||
105591267|NCT00831792|364165653|FG000|Overall Study|Death|1|||
105591268|NCT00831792|364165653|FG000|Overall Study|Lack of Efficacy|1|||
105508961|NCT01537393|363874184|FG000|Overall Study|Lost to Follow-up|53|||
105508962|NCT01537393|363874185|FG001|Overall Study|Lost to Follow-up|48|||
105591269|NCT01744691|364165654|FG000|Overall Study|Progressive Disease|18|||
105591270|NCT01744691|364165654|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
105508963|NCT01537393|363874184|FG000|Overall Study|Failure - Regrafted|28|||
105508964|NCT01537393|363874185|FG001|Overall Study|Failure - Regrafted|43|||
105508965|NCT01537393|363874184|FG000|Overall Study|Failure - Not regrafted|2|||
105508966|NCT01537393|363874185|FG001|Overall Study|Failure - Not regrafted|6|||
105508967|NCT01537393|363874184|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
105508968|NCT01537393|363874185|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
105591271|NCT01744691|364165654|FG000|Overall Study|Withdrawal of consent for treatment|3|||
105508969|NCT00459953|363874186|FG000|Overall Study|not analyzed-household member in study|1|||
105508970|NCT00459953|363874187|FG001|Overall Study|not analyzed-household member in study|1|||
105508971|NCT01049308|363874193|FG000|Pill Counts|Withdrawal by Subject|83|||
105508972|NCT03129100|363874194|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
105508973|NCT03129100|363874195|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
105508974|NCT03129100|363874196|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
105508975|NCT03129100|363874197|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
105508976|NCT03129100|363874198|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
105508977|NCT03129100|363874199|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
105508978|NCT03129100|363874200|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
105508979|NCT03129100|363874201|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
105508980|NCT03129100|363874202|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
105508981|NCT03129100|363874203|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
105508982|NCT03129100|363874204|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
105508983|NCT03129100|363874205|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
105508984|NCT03129100|363874206|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
105508985|NCT03129100|363874207|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
105508986|NCT03129100|363874208|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
105508987|NCT03129100|363874209|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
105508988|NCT03129100|363874210|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
105508989|NCT03129100|363874211|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
105508990|NCT03129100|363874212|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
105508991|NCT03129100|363874213|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
105508992|NCT03129100|363874214|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
105508993|NCT03129100|363874215|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
105508994|NCT03129100|363874216|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
105508995|NCT03129100|363874217|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
105508996|NCT03129100|363874218|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
105508997|NCT03129100|363874219|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
105508998|NCT03129100|363874194|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
105508999|NCT03129100|363874195|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509000|NCT03129100|363874196|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509001|NCT03129100|363874197|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509002|NCT03129100|363874198|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509003|NCT03129100|363874199|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509004|NCT03129100|363874200|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509005|NCT03129100|363874201|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509006|NCT03129100|363874202|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509007|NCT03129100|363874203|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509008|NCT03129100|363874204|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509009|NCT03129100|363874205|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509010|NCT03129100|363874206|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509011|NCT03129100|363874207|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509012|NCT03129100|363874208|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509013|NCT03129100|363874209|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509014|NCT03129100|363874210|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509015|NCT03129100|363874211|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509016|NCT03129100|363874212|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509017|NCT03129100|363874213|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509018|NCT03129100|363874214|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509019|NCT03129100|363874215|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509020|NCT03129100|363874216|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509021|NCT03129100|363874217|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509022|NCT03129100|363874218|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509023|NCT03129100|363874219|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
105509024|NCT03129100|363874194|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
105509025|NCT03129100|363874195|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
105509026|NCT03129100|363874196|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509027|NCT03129100|363874197|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509028|NCT03129100|363874198|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509029|NCT03129100|363874199|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105591272|NCT01744691|364165654|FG000|Overall Study|Physician Decision|4|||
105509030|NCT03129100|363874200|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509031|NCT03129100|363874201|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509032|NCT03129100|363874202|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509033|NCT03129100|363874203|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509034|NCT03129100|363874204|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509035|NCT03129100|363874205|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509036|NCT03129100|363874206|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509037|NCT03129100|363874207|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509038|NCT03129100|363874208|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509039|NCT03129100|363874209|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105591273|NCT04588480|364165655|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
105591274|NCT04588480|364165656|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
105591275|NCT04588480|364165657|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
105591276|NCT04588480|364165655|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
105591277|NCT04588480|364165656|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
105591278|NCT04588480|364165657|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
105591279|NCT00404079|364165662|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
105591280|NCT00404079|364165663|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
105591281|NCT00197015|364165672|FG000|Overall Study|Adverse Event|3|||
105591282|NCT00197015|364165673|FG001|Overall Study|Adverse Event|0|||
105591283|NCT00197015|364165674|FG002|Overall Study|Adverse Event|1|||
105591284|NCT00197015|364165672|FG000|Overall Study|Protocol Violation|0|||
105591285|NCT00197015|364165673|FG001|Overall Study|Protocol Violation|3|||
105591286|NCT00197015|364165674|FG002|Overall Study|Protocol Violation|3|||
105591287|NCT00197015|364165672|FG000|Overall Study|Withdrawal by Subject|17|||
105591288|NCT00197015|364165673|FG001|Overall Study|Withdrawal by Subject|37|||
105591289|NCT00197015|364165674|FG002|Overall Study|Withdrawal by Subject|34|||
105591290|NCT00197015|364165672|FG000|Overall Study|Lost to Follow-up|28|||
105591291|NCT00197015|364165673|FG001|Overall Study|Lost to Follow-up|46|||
105591292|NCT00197015|364165674|FG002|Overall Study|Lost to Follow-up|37|||
105591293|NCT00197015|364165672|FG000|Overall Study|Other|2|||
105591294|NCT00197015|364165673|FG001|Overall Study|Other|3|||
105591295|NCT00197015|364165674|FG002|Overall Study|Other|2|||
105591296|NCT03525119|364165678|FG000|Overall Study|Adverse Event|0|||
105591297|NCT03525119|364165679|FG001|Overall Study|Adverse Event|1|||
105591298|NCT03525119|364165680|FG002|Overall Study|Adverse Event|0|||
105591299|NCT03525119|364165678|FG000|Overall Study|Lost to Follow-up|32|||
105591300|NCT03525119|364165679|FG001|Overall Study|Lost to Follow-up|33|||
105591301|NCT03525119|364165680|FG002|Overall Study|Lost to Follow-up|37|||
105591302|NCT03525119|364165678|FG000|Overall Study|Withdrawal by Subject|5|||
105509040|NCT03129100|363874210|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509041|NCT03129100|363874211|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509042|NCT03129100|363874212|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509043|NCT03129100|363874213|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509044|NCT03129100|363874214|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509045|NCT03129100|363874215|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509046|NCT03129100|363874216|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509047|NCT03129100|363874217|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509048|NCT03129100|363874218|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509049|NCT03129100|363874219|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105509050|NCT03129100|363874194|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
105509051|NCT03129100|363874195|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
105509052|NCT03129100|363874196|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509053|NCT03129100|363874197|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509054|NCT03129100|363874198|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509055|NCT03129100|363874199|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509056|NCT03129100|363874200|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509057|NCT03129100|363874201|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509058|NCT03129100|363874202|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509059|NCT03129100|363874203|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509060|NCT03129100|363874204|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509061|NCT03129100|363874205|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509062|NCT03129100|363874206|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509063|NCT03129100|363874207|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509064|NCT03129100|363874208|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509065|NCT03129100|363874209|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509066|NCT03129100|363874210|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509067|NCT03129100|363874211|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509068|NCT03129100|363874212|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509069|NCT03129100|363874213|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509070|NCT03129100|363874214|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509071|NCT03129100|363874215|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509072|NCT03129100|363874216|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509073|NCT03129100|363874217|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509074|NCT03129100|363874218|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509075|NCT03129100|363874219|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
105509076|NCT03129100|363874194|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509077|NCT03129100|363874195|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
105509078|NCT03129100|363874196|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509079|NCT03129100|363874197|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
105591303|NCT03525119|364165679|FG001|Overall Study|Withdrawal by Subject|4|||
105591304|NCT03525119|364165680|FG002|Overall Study|Withdrawal by Subject|2|||
105509080|NCT03129100|363874198|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
105591305|NCT03525119|364165678|FG000|Overall Study|Reason not Specified|2|||
105591306|NCT03525119|364165679|FG001|Overall Study|Reason not Specified|1|||
105591307|NCT03525119|364165680|FG002|Overall Study|Reason not Specified|2|||
105591308|NCT03525119|364165678|FG000|Overall Study|Randomized but not Vaccinated|1|||
105591309|NCT03525119|364165679|FG001|Overall Study|Randomized but not Vaccinated|0|||
105591310|NCT03525119|364165680|FG002|Overall Study|Randomized but not Vaccinated|2|||
105591311|NCT01972152|364165681|FG000|First Treatment Visit|Lost to Follow-up|0|||
105591312|NCT01972152|364165682|FG001|First Treatment Visit|Lost to Follow-up|1|||
105591313|NCT01972152|364165683|FG002|First Treatment Visit|Lost to Follow-up|0|||
105591314|NCT01972152|364165684|FG003|First Treatment Visit|Lost to Follow-up|0|||
105591315|NCT01972152|364165685|FG004|First Treatment Visit|Lost to Follow-up|0|||
105591316|NCT01972152|364165686|FG005|First Treatment Visit|Lost to Follow-up|0|||
105591317|NCT01972152|364165681|FG000|Second Treatment Visit|Protocol Violation|0|||
105591318|NCT01972152|364165682|FG001|Second Treatment Visit|Protocol Violation|1|||
105591319|NCT01972152|364165683|FG002|Second Treatment Visit|Protocol Violation|0|||
105591320|NCT01972152|364165684|FG003|Second Treatment Visit|Protocol Violation|0|||
105591321|NCT01972152|364165685|FG004|Second Treatment Visit|Protocol Violation|0|||
105591322|NCT01972152|364165686|FG005|Second Treatment Visit|Protocol Violation|0|||
105591323|NCT00586339|364165687|FG000|Overall Study|Withdrawal by Subject|1|||
105591324|NCT00586339|364165688|FG001|Overall Study|Withdrawal by Subject|3|||
105591325|NCT00586339|364165689|FG002|Overall Study|Withdrawal by Subject|1|||
105591326|NCT00586339|364165687|FG000|Overall Study|Migrated/moved from study area|3|||
105591327|NCT00586339|364165688|FG001|Overall Study|Migrated/moved from study area|2|||
105591328|NCT00586339|364165689|FG002|Overall Study|Migrated/moved from study area|4|||
105591329|NCT00586339|364165687|FG000|Overall Study|Lost to Follow-up|3|||
105591330|NCT00586339|364165688|FG001|Overall Study|Lost to Follow-up|2|||
105591331|NCT00586339|364165689|FG002|Overall Study|Lost to Follow-up|1|||
105509081|NCT03129100|363874199|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509082|NCT03129100|363874200|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509083|NCT03129100|363874201|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509084|NCT03129100|363874202|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509085|NCT03129100|363874203|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509086|NCT03129100|363874204|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509087|NCT03129100|363874205|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509088|NCT03129100|363874206|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509089|NCT03129100|363874207|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509090|NCT03129100|363874208|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509091|NCT03129100|363874209|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509092|NCT03129100|363874210|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509093|NCT03129100|363874211|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509094|NCT03129100|363874212|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509095|NCT03129100|363874213|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509096|NCT03129100|363874214|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509097|NCT03129100|363874215|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509098|NCT03129100|363874216|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509099|NCT03129100|363874217|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509100|NCT03129100|363874218|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509101|NCT03129100|363874219|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
105509102|NCT03129100|363874194|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509103|NCT03129100|363874195|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509104|NCT03129100|363874196|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
105509105|NCT03129100|363874197|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
105509106|NCT03129100|363874198|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509107|NCT03129100|363874199|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
105509108|NCT03129100|363874200|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509109|NCT03129100|363874201|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509110|NCT03129100|363874202|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509111|NCT03129100|363874203|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509112|NCT03129100|363874204|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509113|NCT03129100|363874205|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509114|NCT03129100|363874206|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509115|NCT03129100|363874207|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105591332|NCT04163458|364165694|FG000|Overall Study|Protocol Deviation|7|||
105591333|NCT04163458|364165695|FG001|Overall Study|Protocol Deviation|13|||
105591334|NCT04163458|364165694|FG000|Overall Study|Adverse Event|5|||
105591335|NCT04163458|364165695|FG001|Overall Study|Adverse Event|8|||
105591336|NCT04163458|364165694|FG000|Overall Study|Due to COVID-19 pandemic|4|||
105591337|NCT04163458|364165695|FG001|Overall Study|Due to COVID-19 pandemic|2|||
105591338|NCT04163458|364165694|FG000|Overall Study|Participant withdrew consent|2|||
105591339|NCT04163458|364165695|FG001|Overall Study|Participant withdrew consent|3|||
105591340|NCT04163458|364165694|FG000|Overall Study|Randomization failure|2|||
105509116|NCT03129100|363874208|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509117|NCT03129100|363874209|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509118|NCT03129100|363874210|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509119|NCT03129100|363874211|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509120|NCT03129100|363874212|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509121|NCT03129100|363874213|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509122|NCT03129100|363874214|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509123|NCT03129100|363874215|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509124|NCT03129100|363874216|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509125|NCT03129100|363874217|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509126|NCT03129100|363874218|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509127|NCT03129100|363874219|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
105509128|NCT03129100|363874194|FG000|Period2 Extension Period (Group A and B)|Death|0|||
105509129|NCT03129100|363874195|FG001|Period2 Extension Period (Group A and B)|Death|0|||
105509130|NCT03129100|363874196|FG002|Period2 Extension Period (Group A and B)|Death|1|||
105509131|NCT03129100|363874197|FG003|Period2 Extension Period (Group A and B)|Death|0|||
105509132|NCT03129100|363874198|FG004|Period2 Extension Period (Group A and B)|Death|0|||
105509133|NCT03129100|363874199|FG005|Period2 Extension Period (Group A and B)|Death|0|||
105509134|NCT03129100|363874200|FG006|Period2 Extension Period (Group A and B)|Death|0|||
105509135|NCT03129100|363874201|FG007|Period2 Extension Period (Group A and B)|Death|0|||
105509136|NCT03129100|363874202|FG008|Period2 Extension Period (Group A and B)|Death|0|||
105509137|NCT03129100|363874203|FG009|Period2 Extension Period (Group A and B)|Death|0|||
105509138|NCT03129100|363874204|FG010|Period2 Extension Period (Group A and B)|Death|0|||
105509139|NCT03129100|363874205|FG011|Period2 Extension Period (Group A and B)|Death|0|||
105509140|NCT03129100|363874206|FG012|Period2 Extension Period (Group A and B)|Death|0|||
105509141|NCT03129100|363874207|FG013|Period2 Extension Period (Group A and B)|Death|0|||
105509142|NCT03129100|363874208|FG014|Period2 Extension Period (Group A and B)|Death|0|||
105509143|NCT03129100|363874209|FG015|Period2 Extension Period (Group A and B)|Death|0|||
105509144|NCT03129100|363874210|FG016|Period2 Extension Period (Group A and B)|Death|0|||
105509145|NCT03129100|363874211|FG017|Period2 Extension Period (Group A and B)|Death|0|||
105509146|NCT03129100|363874212|FG018|Period2 Extension Period (Group A and B)|Death|0|||
105509147|NCT03129100|363874213|FG019|Period2 Extension Period (Group A and B)|Death|0|||
105509148|NCT03129100|363874214|FG020|Period2 Extension Period (Group A and B)|Death|0|||
105509149|NCT03129100|363874215|FG021|Period2 Extension Period (Group A and B)|Death|0|||
105509150|NCT03129100|363874216|FG022|Period2 Extension Period (Group A and B)|Death|0|||
105509151|NCT03129100|363874217|FG023|Period2 Extension Period (Group A and B)|Death|0|||
105509152|NCT03129100|363874218|FG024|Period2 Extension Period (Group A and B)|Death|0|||
105509153|NCT03129100|363874219|FG025|Period2 Extension Period (Group A and B)|Death|0|||
105509154|NCT03129100|363874194|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509155|NCT03129100|363874195|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509156|NCT03129100|363874196|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
105509157|NCT03129100|363874197|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
105509158|NCT03129100|363874198|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
105509159|NCT03129100|363874199|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
105509160|NCT03129100|363874200|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
105509161|NCT03129100|363874201|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509162|NCT03129100|363874202|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509163|NCT03129100|363874203|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509164|NCT03129100|363874204|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509165|NCT03129100|363874205|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509166|NCT03129100|363874206|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509167|NCT03129100|363874207|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509168|NCT03129100|363874208|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509169|NCT03129100|363874209|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509170|NCT03129100|363874210|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509171|NCT03129100|363874211|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509172|NCT03129100|363874212|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509173|NCT03129100|363874213|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509174|NCT03129100|363874214|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509175|NCT03129100|363874215|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509176|NCT03129100|363874216|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509177|NCT03129100|363874217|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509178|NCT03129100|363874218|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509179|NCT03129100|363874219|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
105509180|NCT03129100|363874194|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509181|NCT03129100|363874195|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509182|NCT03129100|363874196|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
105509183|NCT03129100|363874197|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509184|NCT03129100|363874198|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509185|NCT03129100|363874199|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509186|NCT03129100|363874200|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509187|NCT03129100|363874201|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509188|NCT03129100|363874202|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509189|NCT03129100|363874203|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509190|NCT03129100|363874204|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509191|NCT03129100|363874205|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509192|NCT03129100|363874206|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509193|NCT03129100|363874207|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509194|NCT03129100|363874208|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509195|NCT03129100|363874209|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509196|NCT03129100|363874210|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509197|NCT03129100|363874211|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509198|NCT03129100|363874212|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509199|NCT03129100|363874213|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509200|NCT03129100|363874214|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509201|NCT03129100|363874215|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509202|NCT03129100|363874216|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509203|NCT03129100|363874217|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509204|NCT03129100|363874218|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509205|NCT03129100|363874219|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
105509206|NCT03129100|363874194|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509207|NCT03129100|363874195|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509208|NCT03129100|363874196|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
105509209|NCT03129100|363874197|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509210|NCT03129100|363874198|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509211|NCT03129100|363874199|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509212|NCT03129100|363874200|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509213|NCT03129100|363874201|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509214|NCT03129100|363874202|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509215|NCT03129100|363874203|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509216|NCT03129100|363874204|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509217|NCT03129100|363874205|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509218|NCT03129100|363874206|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509219|NCT03129100|363874207|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509220|NCT03129100|363874208|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509221|NCT03129100|363874209|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509222|NCT03129100|363874210|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509223|NCT03129100|363874211|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509224|NCT03129100|363874212|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509225|NCT03129100|363874213|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509226|NCT03129100|363874214|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509227|NCT03129100|363874215|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509228|NCT03129100|363874216|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509229|NCT03129100|363874217|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509230|NCT03129100|363874218|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509231|NCT03129100|363874219|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
105509232|NCT03129100|363874194|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509233|NCT03129100|363874195|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509234|NCT03129100|363874196|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
105509235|NCT03129100|363874197|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509236|NCT03129100|363874198|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509237|NCT03129100|363874199|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509238|NCT03129100|363874200|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509239|NCT03129100|363874201|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509240|NCT03129100|363874202|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509241|NCT03129100|363874203|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509242|NCT03129100|363874204|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509243|NCT03129100|363874205|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105591341|NCT04163458|364165695|FG001|Overall Study|Randomization failure|2|||
105591342|NCT04163458|364165694|FG000|Overall Study|Other|4|||
105591343|NCT04163458|364165695|FG001|Overall Study|Other|2|||
105591344|NCT04716933|364165697|FG000|Overall Study|Ongoing|46|||
105591345|NCT04716933|364165698|FG001|Overall Study|Ongoing|37|||
105591346|NCT04716933|364165697|FG000|Overall Study|Sponsor Decision|55|||
105591347|NCT04716933|364165698|FG001|Overall Study|Sponsor Decision|63|||
105591348|NCT02824432|364165699|FG000|Overall Study|Major Protocol Deviation|1|||
105591349|NCT02824432|364165700|FG001|Overall Study|Major Protocol Deviation|0|||
105591350|NCT00811057|364165703|FG000|Overall Study|Protocol Violation|5|||
105591351|NCT00811057|364165704|FG001|Overall Study|Protocol Violation|10|||
105591352|NCT00811057|364165705|FG002|Overall Study|Protocol Violation|10|||
105591353|NCT01837641|364165722|FG000|Overall Study|Sponsor decision|1|||
105591354|NCT01837641|364165723|FG001|Overall Study|Sponsor decision|0|||
105591355|NCT01837641|364165724|FG002|Overall Study|Sponsor decision|0|||
105591356|NCT01837641|364165725|FG003|Overall Study|Sponsor decision|0|||
105591357|NCT01837641|364165726|FG004|Overall Study|Sponsor decision|0|||
105591358|NCT01837641|364165727|FG005|Overall Study|Sponsor decision|1|||
105591359|NCT01837641|364165728|FG006|Overall Study|Sponsor decision|0|||
105591360|NCT01837641|364165729|FG007|Overall Study|Sponsor decision|0|||
105591361|NCT01837641|364165722|FG000|Overall Study|Adverse Event|0|||
105591362|NCT01837641|364165723|FG001|Overall Study|Adverse Event|0|||
105591363|NCT01837641|364165724|FG002|Overall Study|Adverse Event|0|||
105591364|NCT01837641|364165725|FG003|Overall Study|Adverse Event|0|||
105591365|NCT01837641|364165726|FG004|Overall Study|Adverse Event|0|||
105591366|NCT01837641|364165727|FG005|Overall Study|Adverse Event|1|||
105591367|NCT01837641|364165728|FG006|Overall Study|Adverse Event|0|||
105591368|NCT01837641|364165729|FG007|Overall Study|Adverse Event|0|||
105591369|NCT01837641|364165722|FG000|Overall Study|Withdrawal by Subject|0|||
105591370|NCT01837641|364165723|FG001|Overall Study|Withdrawal by Subject|0|||
105591371|NCT01837641|364165724|FG002|Overall Study|Withdrawal by Subject|0|||
105591372|NCT01837641|364165725|FG003|Overall Study|Withdrawal by Subject|0|||
105591373|NCT01837641|364165726|FG004|Overall Study|Withdrawal by Subject|1|||
105591374|NCT01837641|364165727|FG005|Overall Study|Withdrawal by Subject|0|||
105591375|NCT01837641|364165728|FG006|Overall Study|Withdrawal by Subject|1|||
105591376|NCT01837641|364165729|FG007|Overall Study|Withdrawal by Subject|0|||
105591377|NCT01838551|364165731|FG000|Overall Study|Adverse Event|16|||
105591378|NCT01838551|364165731|FG000|Overall Study|Death|1|||
105591379|NCT01838551|364165731|FG000|Overall Study|Lack of Efficacy|10|||
105591380|NCT01838551|364165731|FG000|Overall Study|Physician Decision|4|||
105591381|NCT01838551|364165731|FG000|Overall Study|Withdrawal by Subject|10|||
105591382|NCT01838551|364165731|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
105509244|NCT03129100|363874206|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509245|NCT03129100|363874207|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509246|NCT03129100|363874208|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509247|NCT03129100|363874209|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509248|NCT03129100|363874210|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509249|NCT03129100|363874211|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509250|NCT03129100|363874212|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509251|NCT03129100|363874213|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509252|NCT03129100|363874214|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509253|NCT03129100|363874215|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509254|NCT03129100|363874216|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509255|NCT03129100|363874217|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509256|NCT03129100|363874218|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509257|NCT03129100|363874219|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
105509258|NCT03129100|363874194|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509259|NCT03129100|363874195|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509260|NCT03129100|363874196|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509261|NCT03129100|363874197|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509262|NCT03129100|363874198|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
105591383|NCT01773122|364165732|FG000|Overall Study|Due to amended age eligibility criteria|3|||
105591384|NCT01773122|364165733|FG001|Overall Study|Due to amended age eligibility criteria|1|||
105591385|NCT01773122|364165734|FG002|Overall Study|Due to amended age eligibility criteria|0|||
105591386|NCT01773122|364165735|FG003|Overall Study|Due to amended age eligibility criteria|1|||
105591387|NCT02289560|364165736|FG000|Overall Study|Lost to Follow-up|6|||
105591388|NCT02289560|364165736|FG000|Overall Study|Alternative Treatment|4|||
105591389|NCT02289560|364165736|FG000|Overall Study|Inadequate Treatment|2|||
105591390|NCT02289560|364165736|FG000|Overall Study|Withdrawal by Subject|23|||
105591391|NCT02540213|364165737|FG000|Overall Study|Death/adverse event|18|||
105591392|NCT02540213|364165737|FG000|Overall Study|Administrative reasons|3|||
105591393|NCT02540213|364165737|FG000|Overall Study|Kidney transplant|3|||
105591394|NCT02540213|364165737|FG000|Overall Study|Lack of Efficacy|6|||
105591395|NCT02540213|364165737|FG000|Overall Study|Consent withdrawn|7|||
105591396|NCT02540213|364165737|FG000|Overall Study|Enrolled but not treated|2|||
105591397|NCT01144182|364165738|FG000|Overall Study|Death|5|||
105591398|NCT01144182|364165739|FG001|Overall Study|Death|6|||
105591399|NCT01144182|364165738|FG000|Overall Study|Withdrawal by Subject|3|||
105591400|NCT01144182|364165739|FG001|Overall Study|Withdrawal by Subject|6|||
105591401|NCT01144182|364165738|FG000|Overall Study|Lost to Follow-up|9|||
105591402|NCT01144182|364165739|FG001|Overall Study|Lost to Follow-up|9|||
105591403|NCT03264456|364165746|FG000|Overall Study|Withdrawal by Subject|3|||
105591404|NCT03264456|364165746|FG000|Overall Study|Lost to Follow-up|1|||
105591405|NCT03538054|364165747|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
105591406|NCT03538054|364165747|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
105591407|NCT03538054|364165747|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
105591408|NCT00299702|364165753|FG000|Overall Study|Death|1|||
105591409|NCT00299702|364165754|FG001|Overall Study|Death|0|||
105591410|NCT00299702|364165753|FG000|Overall Study|Adverse Event|0|||
105591411|NCT00299702|364165754|FG001|Overall Study|Adverse Event|4|||
105591412|NCT00299702|364165753|FG000|Overall Study|Lost to Follow-up|18|||
105591413|NCT00299702|364165754|FG001|Overall Study|Lost to Follow-up|10|||
105591414|NCT00299702|364165753|FG000|Overall Study|Withdrawal by Subject|25|||
105591415|NCT00299702|364165754|FG001|Overall Study|Withdrawal by Subject|23|||
105591416|NCT00299702|364165753|FG000|Overall Study|Pregnancy|0|||
105591417|NCT00299702|364165754|FG001|Overall Study|Pregnancy|1|||
105591418|NCT00299702|364165753|FG000|Overall Study|Insufficient Response|4|||
105591419|NCT00299702|364165754|FG001|Overall Study|Insufficient Response|3|||
105591420|NCT00299702|364165753|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
105591421|NCT00299702|364165754|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
105591422|NCT01278862|364165755|FG000|Overall Study|Lost to Follow-up|1|||
105591423|NCT01278862|364165756|FG001|Overall Study|Lost to Follow-up|1|||
105591424|NCT05025449|364167149|FG000|Overall Study|Withdrawal by Subject|1|||
105591425|NCT05025449|364167149|FG000|Overall Study|Patient emergently taken to operating room|1|||
105591426|NCT00569946|364167150|FG000|Overall Study|Adverse Event|16|||
105591427|NCT00569946|364167150|FG000|Overall Study|Objective Progression or Relapse|42|||
105591428|NCT00569946|364167150|FG000|Overall Study|Global Deterioration of Health Status|1|||
105591429|NCT01090024|364167151|FG000|Period 1|Met exclusion criteria|0|||
105591430|NCT01090024|364167152|FG001|Period 1|Met exclusion criteria|0|||
105591431|NCT01090024|364167153|FG002|Period 1|Met exclusion criteria|0|||
105591432|NCT01090024|364167154|FG003|Period 1|Met exclusion criteria|0|||
105591433|NCT01090024|364167155|FG004|Period 1|Met exclusion criteria|0|||
105591434|NCT01090024|364167156|FG005|Period 1|Met exclusion criteria|0|||
105591435|NCT01090024|364167157|FG006|Period 1|Met exclusion criteria|0|||
105591436|NCT01090024|364167158|FG007|Period 1|Met exclusion criteria|0|||
105591437|NCT01090024|364167159|FG008|Period 1|Met exclusion criteria|0|||
105591438|NCT01090024|364167160|FG009|Period 1|Met exclusion criteria|0|||
105591439|NCT01090024|364167161|FG010|Period 1|Met exclusion criteria|0|||
105591440|NCT01090024|364167162|FG011|Period 1|Met exclusion criteria|0|||
105591441|NCT01090024|364167163|FG012|Period 1|Met exclusion criteria|0|||
105591442|NCT01090024|364167164|FG013|Period 1|Met exclusion criteria|0|||
105591443|NCT01090024|364167165|FG014|Period 1|Met exclusion criteria|1|||
105591444|NCT01090024|364167166|FG015|Period 1|Met exclusion criteria|0|||
105591445|NCT01090024|364167167|FG016|Period 1|Met exclusion criteria|0|||
105591446|NCT01090024|364167168|FG017|Period 1|Met exclusion criteria|0|||
105591447|NCT01090024|364167151|FG000|Period 1|Adverse Event|0|||
105591448|NCT01090024|364167152|FG001|Period 1|Adverse Event|0|||
105591449|NCT01090024|364167153|FG002|Period 1|Adverse Event|0|||
105591450|NCT01090024|364167154|FG003|Period 1|Adverse Event|0|||
105591451|NCT01090024|364167155|FG004|Period 1|Adverse Event|0|||
105591452|NCT01090024|364167156|FG005|Period 1|Adverse Event|0|||
105591453|NCT01090024|364167157|FG006|Period 1|Adverse Event|0|||
105591454|NCT01090024|364167158|FG007|Period 1|Adverse Event|0|||
105591455|NCT01090024|364167159|FG008|Period 1|Adverse Event|0|||
105591456|NCT01090024|364167160|FG009|Period 1|Adverse Event|1|||
105591457|NCT01090024|364167161|FG010|Period 1|Adverse Event|0|||
105591458|NCT01090024|364167162|FG011|Period 1|Adverse Event|1|||
105591459|NCT01090024|364167163|FG012|Period 1|Adverse Event|0|||
105591460|NCT01090024|364167164|FG013|Period 1|Adverse Event|0|||
105591461|NCT01090024|364167165|FG014|Period 1|Adverse Event|0|||
105591462|NCT01090024|364167166|FG015|Period 1|Adverse Event|0|||
105591463|NCT01090024|364167167|FG016|Period 1|Adverse Event|0|||
105591464|NCT01090024|364167168|FG017|Period 1|Adverse Event|1|||
105591465|NCT01090024|364167151|FG000|Period 1|Withdrawal by Subject|0|||
105591466|NCT01090024|364167152|FG001|Period 1|Withdrawal by Subject|0|||
105591467|NCT01090024|364167153|FG002|Period 1|Withdrawal by Subject|0|||
105591468|NCT01090024|364167154|FG003|Period 1|Withdrawal by Subject|1|||
105591469|NCT01090024|364167155|FG004|Period 1|Withdrawal by Subject|0|||
105591470|NCT01090024|364167156|FG005|Period 1|Withdrawal by Subject|0|||
105591471|NCT01090024|364167157|FG006|Period 1|Withdrawal by Subject|0|||
105591472|NCT01090024|364167158|FG007|Period 1|Withdrawal by Subject|0|||
105591473|NCT01090024|364167159|FG008|Period 1|Withdrawal by Subject|0|||
105591474|NCT01090024|364167160|FG009|Period 1|Withdrawal by Subject|0|||
105509263|NCT03129100|363874199|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
105509264|NCT03129100|363874200|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
105509265|NCT03129100|363874201|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509266|NCT03129100|363874202|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509267|NCT03129100|363874203|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509268|NCT03129100|363874204|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509269|NCT03129100|363874205|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509270|NCT03129100|363874206|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509271|NCT03129100|363874207|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509272|NCT03129100|363874208|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509273|NCT03129100|363874209|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509274|NCT03129100|363874210|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509275|NCT03129100|363874211|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509276|NCT03129100|363874212|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509277|NCT03129100|363874213|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509278|NCT03129100|363874214|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509279|NCT03129100|363874215|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509280|NCT03129100|363874216|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509281|NCT03129100|363874217|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509282|NCT03129100|363874218|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509283|NCT03129100|363874219|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
105509284|NCT03129100|363874194|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509285|NCT03129100|363874195|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509286|NCT03129100|363874196|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509287|NCT03129100|363874197|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509288|NCT03129100|363874198|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509289|NCT03129100|363874199|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509290|NCT03129100|363874200|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509291|NCT03129100|363874201|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509292|NCT03129100|363874202|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509293|NCT03129100|363874203|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
105509294|NCT03129100|363874204|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509295|NCT03129100|363874205|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509296|NCT03129100|363874206|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509297|NCT03129100|363874207|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509298|NCT03129100|363874208|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509299|NCT03129100|363874209|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509300|NCT03129100|363874210|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509301|NCT03129100|363874211|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509302|NCT03129100|363874212|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509303|NCT03129100|363874213|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509304|NCT03129100|363874214|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509305|NCT03129100|363874215|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509306|NCT03129100|363874216|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509307|NCT03129100|363874217|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509308|NCT03129100|363874218|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509309|NCT03129100|363874219|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
105509310|NCT03129100|363874194|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509311|NCT03129100|363874195|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509312|NCT03129100|363874196|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509313|NCT03129100|363874197|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509314|NCT03129100|363874198|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509315|NCT03129100|363874199|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509316|NCT03129100|363874200|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509317|NCT03129100|363874201|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509318|NCT03129100|363874202|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509319|NCT03129100|363874203|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509320|NCT03129100|363874204|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509321|NCT03129100|363874205|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
105509322|NCT03129100|363874206|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509323|NCT03129100|363874207|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509324|NCT03129100|363874208|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105591475|NCT01090024|364167161|FG010|Period 1|Withdrawal by Subject|0|||
105591476|NCT01090024|364167162|FG011|Period 1|Withdrawal by Subject|0|||
105591477|NCT01090024|364167163|FG012|Period 1|Withdrawal by Subject|0|||
105591478|NCT01090024|364167164|FG013|Period 1|Withdrawal by Subject|0|||
105591479|NCT01090024|364167165|FG014|Period 1|Withdrawal by Subject|0|||
105591480|NCT01090024|364167166|FG015|Period 1|Withdrawal by Subject|0|||
105591481|NCT01090024|364167167|FG016|Period 1|Withdrawal by Subject|0|||
105591482|NCT01090024|364167168|FG017|Period 1|Withdrawal by Subject|0|||
105591483|NCT01090024|364167151|FG000|Period 1|Lost to Follow-up|0|||
105591484|NCT01090024|364167152|FG001|Period 1|Lost to Follow-up|1|||
105591485|NCT01090024|364167153|FG002|Period 1|Lost to Follow-up|0|||
105591486|NCT01090024|364167154|FG003|Period 1|Lost to Follow-up|0|||
105591487|NCT01090024|364167155|FG004|Period 1|Lost to Follow-up|0|||
105591488|NCT01090024|364167156|FG005|Period 1|Lost to Follow-up|0|||
105591489|NCT01090024|364167157|FG006|Period 1|Lost to Follow-up|0|||
105591490|NCT01090024|364167158|FG007|Period 1|Lost to Follow-up|0|||
105591491|NCT01090024|364167159|FG008|Period 1|Lost to Follow-up|0|||
105591492|NCT01090024|364167160|FG009|Period 1|Lost to Follow-up|0|||
105591493|NCT01090024|364167161|FG010|Period 1|Lost to Follow-up|0|||
105591494|NCT01090024|364167162|FG011|Period 1|Lost to Follow-up|0|||
105591495|NCT01090024|364167163|FG012|Period 1|Lost to Follow-up|0|||
105591496|NCT01090024|364167164|FG013|Period 1|Lost to Follow-up|0|||
105591497|NCT01090024|364167165|FG014|Period 1|Lost to Follow-up|0|||
105591498|NCT01090024|364167166|FG015|Period 1|Lost to Follow-up|0|||
105591499|NCT01090024|364167167|FG016|Period 1|Lost to Follow-up|0|||
105591500|NCT01090024|364167168|FG017|Period 1|Lost to Follow-up|0|||
105591501|NCT01090024|364167151|FG000|Period 2|Lost to Follow-up|0|||
105591502|NCT01090024|364167152|FG001|Period 2|Lost to Follow-up|0|||
105591503|NCT01090024|364167153|FG002|Period 2|Lost to Follow-up|0|||
105591504|NCT01090024|364167154|FG003|Period 2|Lost to Follow-up|1|||
105591505|NCT01090024|364167155|FG004|Period 2|Lost to Follow-up|0|||
105591506|NCT01090024|364167156|FG005|Period 2|Lost to Follow-up|0|||
105591507|NCT01090024|364167157|FG006|Period 2|Lost to Follow-up|0|||
105591508|NCT01090024|364167158|FG007|Period 2|Lost to Follow-up|0|||
105591509|NCT01090024|364167159|FG008|Period 2|Lost to Follow-up|0|||
105591510|NCT01090024|364167160|FG009|Period 2|Lost to Follow-up|0|||
105591511|NCT01090024|364167161|FG010|Period 2|Lost to Follow-up|0|||
105591512|NCT01090024|364167162|FG011|Period 2|Lost to Follow-up|0|||
105591513|NCT01090024|364167163|FG012|Period 2|Lost to Follow-up|0|||
105591514|NCT01090024|364167164|FG013|Period 2|Lost to Follow-up|0|||
105591515|NCT01090024|364167165|FG014|Period 2|Lost to Follow-up|0|||
105591516|NCT01090024|364167166|FG015|Period 2|Lost to Follow-up|0|||
105591517|NCT01090024|364167167|FG016|Period 2|Lost to Follow-up|0|||
105591518|NCT01090024|364167168|FG017|Period 2|Lost to Follow-up|0|||
105591519|NCT01090024|364167151|FG000|Period 2|Adverse Event|1|||
105591520|NCT01090024|364167152|FG001|Period 2|Adverse Event|0|||
105591521|NCT01090024|364167153|FG002|Period 2|Adverse Event|0|||
105591522|NCT01090024|364167154|FG003|Period 2|Adverse Event|0|||
105591523|NCT01090024|364167155|FG004|Period 2|Adverse Event|0|||
105591524|NCT01090024|364167156|FG005|Period 2|Adverse Event|0|||
105591525|NCT01090024|364167157|FG006|Period 2|Adverse Event|0|||
105591526|NCT01090024|364167158|FG007|Period 2|Adverse Event|0|||
105591527|NCT01090024|364167159|FG008|Period 2|Adverse Event|0|||
105591528|NCT01090024|364167160|FG009|Period 2|Adverse Event|0|||
105591529|NCT01090024|364167161|FG010|Period 2|Adverse Event|0|||
105591530|NCT01090024|364167162|FG011|Period 2|Adverse Event|0|||
105591531|NCT01090024|364167163|FG012|Period 2|Adverse Event|0|||
105591532|NCT01090024|364167164|FG013|Period 2|Adverse Event|0|||
105591533|NCT01090024|364167165|FG014|Period 2|Adverse Event|0|||
105591534|NCT01090024|364167166|FG015|Period 2|Adverse Event|0|||
105591535|NCT01090024|364167167|FG016|Period 2|Adverse Event|0|||
105591536|NCT01090024|364167168|FG017|Period 2|Adverse Event|0|||
105591537|NCT01090024|364167151|FG000|Period 3|Withdrawal by Subject|0|||
105591538|NCT01090024|364167152|FG001|Period 3|Withdrawal by Subject|0|||
105591539|NCT01090024|364167153|FG002|Period 3|Withdrawal by Subject|0|||
105591540|NCT01090024|364167154|FG003|Period 3|Withdrawal by Subject|0|||
105591541|NCT01090024|364167155|FG004|Period 3|Withdrawal by Subject|0|||
105591542|NCT01090024|364167156|FG005|Period 3|Withdrawal by Subject|0|||
105591543|NCT01090024|364167157|FG006|Period 3|Withdrawal by Subject|0|||
105591544|NCT01090024|364167158|FG007|Period 3|Withdrawal by Subject|0|||
105591545|NCT01090024|364167159|FG008|Period 3|Withdrawal by Subject|0|||
105591546|NCT01090024|364167160|FG009|Period 3|Withdrawal by Subject|0|||
105591547|NCT01090024|364167161|FG010|Period 3|Withdrawal by Subject|0|||
105591548|NCT01090024|364167162|FG011|Period 3|Withdrawal by Subject|0|||
105591549|NCT01090024|364167163|FG012|Period 3|Withdrawal by Subject|0|||
105591550|NCT01090024|364167164|FG013|Period 3|Withdrawal by Subject|0|||
105591551|NCT01090024|364167165|FG014|Period 3|Withdrawal by Subject|0|||
105591552|NCT01090024|364167166|FG015|Period 3|Withdrawal by Subject|1|||
105591553|NCT01090024|364167167|FG016|Period 3|Withdrawal by Subject|0|||
105591554|NCT01090024|364167168|FG017|Period 3|Withdrawal by Subject|0|||
105591555|NCT01090024|364167151|FG000|Period 3|Protocol Violation|0|||
105591556|NCT01090024|364167152|FG001|Period 3|Protocol Violation|0|||
105591557|NCT01090024|364167153|FG002|Period 3|Protocol Violation|0|||
105591558|NCT01090024|364167154|FG003|Period 3|Protocol Violation|0|||
105509325|NCT03129100|363874209|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509326|NCT03129100|363874210|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509327|NCT03129100|363874211|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509328|NCT03129100|363874212|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509329|NCT03129100|363874213|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509330|NCT03129100|363874214|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509331|NCT03129100|363874215|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509332|NCT03129100|363874216|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509333|NCT03129100|363874217|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509334|NCT03129100|363874218|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509335|NCT03129100|363874219|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
105509336|NCT03129100|363874194|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509337|NCT03129100|363874195|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509338|NCT03129100|363874196|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509339|NCT03129100|363874197|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509340|NCT03129100|363874198|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509341|NCT03129100|363874199|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509342|NCT03129100|363874200|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509343|NCT03129100|363874201|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509344|NCT03129100|363874202|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509345|NCT03129100|363874203|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509346|NCT03129100|363874204|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509347|NCT03129100|363874205|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
105509348|NCT03129100|363874206|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
105509349|NCT03129100|363874207|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
105509350|NCT03129100|363874208|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
105509351|NCT03129100|363874209|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509352|NCT03129100|363874210|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509353|NCT03129100|363874211|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509354|NCT03129100|363874212|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509355|NCT03129100|363874213|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509356|NCT03129100|363874214|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509357|NCT03129100|363874215|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509358|NCT03129100|363874216|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509359|NCT03129100|363874217|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509360|NCT03129100|363874218|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509361|NCT03129100|363874219|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
105509362|NCT03129100|363874194|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509363|NCT03129100|363874195|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509364|NCT03129100|363874196|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509365|NCT03129100|363874197|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509366|NCT03129100|363874198|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509367|NCT03129100|363874199|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509368|NCT03129100|363874200|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509369|NCT03129100|363874201|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509370|NCT03129100|363874202|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509371|NCT03129100|363874203|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509372|NCT03129100|363874204|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509373|NCT03129100|363874205|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
105509374|NCT03129100|363874206|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509375|NCT03129100|363874207|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
105509376|NCT03129100|363874208|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
105509377|NCT03129100|363874209|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509378|NCT03129100|363874210|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509379|NCT03129100|363874211|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509380|NCT03129100|363874212|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509381|NCT03129100|363874213|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509382|NCT03129100|363874214|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509383|NCT03129100|363874215|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509384|NCT03129100|363874216|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509385|NCT03129100|363874217|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509386|NCT03129100|363874218|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509387|NCT03129100|363874219|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
105509388|NCT03129100|363874194|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509389|NCT03129100|363874195|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509390|NCT03129100|363874196|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509391|NCT03129100|363874197|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509392|NCT03129100|363874198|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509393|NCT03129100|363874199|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509394|NCT03129100|363874200|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509395|NCT03129100|363874201|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509396|NCT03129100|363874202|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509397|NCT03129100|363874203|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509398|NCT03129100|363874204|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509399|NCT03129100|363874205|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509400|NCT03129100|363874206|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509401|NCT03129100|363874207|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509402|NCT03129100|363874208|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509403|NCT03129100|363874209|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
105509404|NCT03129100|363874210|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509405|NCT03129100|363874211|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509406|NCT03129100|363874212|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509407|NCT03129100|363874213|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509408|NCT03129100|363874214|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509409|NCT03129100|363874215|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509410|NCT03129100|363874216|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509411|NCT03129100|363874217|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509412|NCT03129100|363874218|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509413|NCT03129100|363874219|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
105509414|NCT03129100|363874194|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509415|NCT03129100|363874195|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509416|NCT03129100|363874196|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509417|NCT03129100|363874197|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509418|NCT03129100|363874198|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509419|NCT03129100|363874199|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509420|NCT03129100|363874200|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509421|NCT03129100|363874201|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509422|NCT03129100|363874202|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509423|NCT03129100|363874203|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509424|NCT03129100|363874204|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509425|NCT03129100|363874205|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509426|NCT03129100|363874206|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
105509427|NCT03129100|363874207|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509428|NCT03129100|363874208|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
105509429|NCT03129100|363874209|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
105509430|NCT03129100|363874210|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509431|NCT03129100|363874211|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509432|NCT03129100|363874212|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509433|NCT03129100|363874213|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509434|NCT03129100|363874214|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509435|NCT03129100|363874215|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509436|NCT03129100|363874216|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509437|NCT03129100|363874217|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509438|NCT03129100|363874218|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509439|NCT03129100|363874219|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
105509440|NCT03129100|363874194|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509441|NCT03129100|363874195|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509442|NCT03129100|363874196|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509443|NCT03129100|363874197|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509444|NCT03129100|363874198|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509445|NCT03129100|363874199|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509446|NCT03129100|363874200|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509447|NCT03129100|363874201|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509448|NCT03129100|363874202|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509449|NCT03129100|363874203|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509450|NCT03129100|363874204|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509451|NCT03129100|363874205|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509452|NCT03129100|363874206|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509453|NCT03129100|363874207|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509454|NCT03129100|363874208|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509455|NCT03129100|363874209|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509456|NCT03129100|363874210|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509457|NCT03129100|363874211|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
105509458|NCT03129100|363874212|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509459|NCT03129100|363874213|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
105509460|NCT03129100|363874214|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509461|NCT03129100|363874215|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509462|NCT03129100|363874216|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509463|NCT03129100|363874217|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509464|NCT03129100|363874218|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509465|NCT03129100|363874219|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105509466|NCT03129100|363874194|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509467|NCT03129100|363874195|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509468|NCT03129100|363874196|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509469|NCT03129100|363874197|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509470|NCT03129100|363874198|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509471|NCT03129100|363874199|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509472|NCT03129100|363874200|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509473|NCT03129100|363874201|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509474|NCT03129100|363874202|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509475|NCT03129100|363874203|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509476|NCT03129100|363874204|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509477|NCT03129100|363874205|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509478|NCT03129100|363874206|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509479|NCT03129100|363874207|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509480|NCT03129100|363874208|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509481|NCT03129100|363874209|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509482|NCT03129100|363874210|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509483|NCT03129100|363874211|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509484|NCT03129100|363874212|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509485|NCT03129100|363874213|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509486|NCT03129100|363874214|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
105509487|NCT03129100|363874215|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509488|NCT03129100|363874216|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509489|NCT03129100|363874217|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509490|NCT03129100|363874218|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509491|NCT03129100|363874219|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
105509492|NCT03129100|363874194|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
105509493|NCT03129100|363874195|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
105509494|NCT03129100|363874196|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
105509495|NCT03129100|363874197|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
105509496|NCT03129100|363874198|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
105509497|NCT03129100|363874199|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
105509498|NCT03129100|363874200|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
105509499|NCT03129100|363874201|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
105509500|NCT03129100|363874202|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
105509501|NCT03129100|363874203|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
105509502|NCT03129100|363874204|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
105509503|NCT03129100|363874205|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
105509504|NCT03129100|363874206|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
105509505|NCT03129100|363874207|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
105509506|NCT03129100|363874208|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
105509507|NCT03129100|363874209|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
105509508|NCT03129100|363874210|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
105509509|NCT03129100|363874211|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
105509510|NCT03129100|363874212|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
105509511|NCT03129100|363874213|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
105509512|NCT03129100|363874214|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
105509513|NCT03129100|363874215|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
105509514|NCT03129100|363874216|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
105509515|NCT03129100|363874217|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
105509516|NCT03129100|363874218|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
105509517|NCT03129100|363874219|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
105509518|NCT03129100|363874194|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509519|NCT03129100|363874195|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509520|NCT03129100|363874196|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509521|NCT03129100|363874197|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509522|NCT03129100|363874198|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509523|NCT03129100|363874199|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509524|NCT03129100|363874200|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509525|NCT03129100|363874201|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509526|NCT03129100|363874202|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509527|NCT03129100|363874203|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509528|NCT03129100|363874204|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509529|NCT03129100|363874205|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509530|NCT03129100|363874206|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509531|NCT03129100|363874207|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509532|NCT03129100|363874208|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509533|NCT03129100|363874209|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509534|NCT03129100|363874210|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509535|NCT03129100|363874211|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509536|NCT03129100|363874212|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509537|NCT03129100|363874213|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509538|NCT03129100|363874214|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
105509539|NCT03129100|363874215|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509540|NCT03129100|363874216|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509541|NCT03129100|363874217|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509542|NCT03129100|363874218|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509543|NCT03129100|363874219|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
105509544|NCT03129100|363874194|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
105509545|NCT03129100|363874195|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
105509546|NCT03129100|363874196|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
105509547|NCT03129100|363874197|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
105509548|NCT03129100|363874198|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
105509549|NCT03129100|363874199|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
105509550|NCT03129100|363874200|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
105509551|NCT03129100|363874201|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
105509552|NCT03129100|363874202|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
105509553|NCT03129100|363874203|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
105509554|NCT03129100|363874204|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
105509555|NCT03129100|363874205|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
105509556|NCT03129100|363874206|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
105509557|NCT03129100|363874207|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
105509558|NCT03129100|363874208|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
105509559|NCT03129100|363874209|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
105509560|NCT03129100|363874210|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
105509561|NCT03129100|363874211|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
105509562|NCT03129100|363874212|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
105591559|NCT01090024|364167155|FG004|Period 3|Protocol Violation|0|||
105591560|NCT01090024|364167156|FG005|Period 3|Protocol Violation|0|||
105509563|NCT03129100|363874213|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
105509564|NCT03129100|363874214|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
105509565|NCT03129100|363874215|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
105509566|NCT03129100|363874216|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
105509567|NCT03129100|363874217|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
105509568|NCT03129100|363874218|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
105509569|NCT03129100|363874219|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
105509570|NCT03129100|363874194|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509571|NCT03129100|363874195|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509572|NCT03129100|363874196|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509573|NCT03129100|363874197|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509574|NCT03129100|363874198|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509575|NCT03129100|363874199|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509576|NCT03129100|363874200|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509577|NCT03129100|363874201|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509578|NCT03129100|363874202|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509579|NCT03129100|363874203|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509580|NCT03129100|363874204|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509581|NCT03129100|363874205|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509582|NCT03129100|363874206|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509583|NCT03129100|363874207|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509584|NCT03129100|363874208|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509585|NCT03129100|363874209|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509586|NCT03129100|363874210|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509587|NCT03129100|363874211|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509588|NCT03129100|363874212|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509589|NCT03129100|363874213|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509590|NCT03129100|363874214|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105591561|NCT01090024|364167157|FG006|Period 3|Protocol Violation|0|||
105509591|NCT03129100|363874215|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509592|NCT03129100|363874216|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509593|NCT03129100|363874217|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
105509594|NCT03129100|363874218|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
105509595|NCT03129100|363874219|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
105509596|NCT03129100|363874194|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509597|NCT03129100|363874195|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509598|NCT03129100|363874196|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509599|NCT03129100|363874197|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509600|NCT03129100|363874198|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509601|NCT03129100|363874199|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509602|NCT03129100|363874200|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509603|NCT03129100|363874201|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509604|NCT03129100|363874202|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509605|NCT03129100|363874203|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509606|NCT03129100|363874204|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509607|NCT03129100|363874205|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509608|NCT03129100|363874206|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509609|NCT03129100|363874207|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509610|NCT03129100|363874208|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509611|NCT03129100|363874209|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509612|NCT03129100|363874210|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509613|NCT03129100|363874211|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509614|NCT03129100|363874212|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509615|NCT03129100|363874213|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509616|NCT03129100|363874214|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509617|NCT03129100|363874215|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509618|NCT03129100|363874216|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
105509619|NCT03129100|363874217|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
105509620|NCT03129100|363874218|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
105509621|NCT03129100|363874219|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
105509622|NCT03129100|363874194|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509623|NCT03129100|363874195|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509624|NCT03129100|363874196|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509625|NCT03129100|363874197|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509626|NCT03129100|363874198|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509627|NCT03129100|363874199|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509628|NCT03129100|363874200|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509629|NCT03129100|363874201|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509630|NCT03129100|363874202|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509631|NCT03129100|363874203|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509632|NCT03129100|363874204|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509633|NCT03129100|363874205|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509634|NCT03129100|363874206|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509635|NCT03129100|363874207|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509636|NCT03129100|363874208|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509637|NCT03129100|363874209|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509638|NCT03129100|363874210|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509639|NCT03129100|363874211|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509640|NCT03129100|363874212|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509641|NCT03129100|363874213|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509642|NCT03129100|363874214|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509643|NCT03129100|363874215|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509644|NCT03129100|363874216|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509645|NCT03129100|363874217|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509646|NCT03129100|363874218|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
105509647|NCT03129100|363874219|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
105509648|NCT03129100|363874194|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509649|NCT03129100|363874195|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509650|NCT03129100|363874196|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509651|NCT03129100|363874197|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509652|NCT03129100|363874198|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509653|NCT03129100|363874199|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509654|NCT03129100|363874200|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509655|NCT03129100|363874201|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105591562|NCT01090024|364167158|FG007|Period 3|Protocol Violation|0|||
105509656|NCT03129100|363874202|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509657|NCT03129100|363874203|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509658|NCT03129100|363874204|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509659|NCT03129100|363874205|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509660|NCT03129100|363874206|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509661|NCT03129100|363874207|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509662|NCT03129100|363874208|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509663|NCT03129100|363874209|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509664|NCT03129100|363874210|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509665|NCT03129100|363874211|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509666|NCT03129100|363874212|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509667|NCT03129100|363874213|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509668|NCT03129100|363874214|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509669|NCT03129100|363874215|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509670|NCT03129100|363874216|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509671|NCT03129100|363874217|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509672|NCT03129100|363874218|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
105509673|NCT03129100|363874219|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
105509674|NCT03129100|363874194|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
105509675|NCT03129100|363874195|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
105509676|NCT03129100|363874196|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
105509677|NCT03129100|363874197|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
105509678|NCT03129100|363874198|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
105509679|NCT03129100|363874199|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
105509680|NCT03129100|363874200|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
105509681|NCT03129100|363874201|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
105509682|NCT03129100|363874202|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
105509683|NCT03129100|363874203|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
105509684|NCT03129100|363874204|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
105509685|NCT03129100|363874205|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
105509686|NCT03129100|363874206|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
105509687|NCT03129100|363874207|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
105509688|NCT03129100|363874208|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
105509689|NCT03129100|363874209|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
105509690|NCT03129100|363874210|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
105509691|NCT03129100|363874211|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
105509692|NCT03129100|363874212|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
105509693|NCT03129100|363874213|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
105509694|NCT03129100|363874214|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
105509695|NCT03129100|363874215|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
105509696|NCT03129100|363874216|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
105509697|NCT03129100|363874217|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
105509698|NCT03129100|363874218|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
105509699|NCT03129100|363874219|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
105509700|NCT03845985|363874222|FG000|Overall Study|Lost to Follow-up|2|||
105509701|NCT03845985|363874223|FG001|Overall Study|Lost to Follow-up|1|||
105509702|NCT03845985|363874222|FG000|Overall Study|Physician Decision|1|||
105509703|NCT03845985|363874223|FG001|Overall Study|Physician Decision|0|||
105509704|NCT03845985|363874222|FG000|Overall Study|Withdrawal by Subject|4|||
105509705|NCT03845985|363874223|FG001|Overall Study|Withdrawal by Subject|1|||
105509706|NCT00843024|363874226|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
105509707|NCT00843024|363874227|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
105509708|NCT00843024|363874228|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
105509709|NCT00843024|363874229|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
105509710|NCT00843024|363874230|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
105509711|NCT00843024|363874231|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
105509712|NCT00843024|363874226|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
105509713|NCT00843024|363874227|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
105509714|NCT00843024|363874228|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
105509715|NCT00843024|363874229|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
105509716|NCT00843024|363874230|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
105509717|NCT00843024|363874231|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
105509718|NCT00843024|363874226|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
105509719|NCT00843024|363874227|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
105509720|NCT00843024|363874228|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
105509721|NCT00843024|363874229|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
105509722|NCT00843024|363874230|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
105509723|NCT00843024|363874231|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
105509724|NCT00843024|363874226|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
105509725|NCT00843024|363874227|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
105509726|NCT00843024|363874228|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
105509727|NCT00843024|363874229|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
105509728|NCT00843024|363874230|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
105509729|NCT00843024|363874231|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
105509730|NCT00843024|363874226|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
105509731|NCT00843024|363874227|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
105509732|NCT00843024|363874228|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
105509733|NCT00843024|363874229|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
105509734|NCT00843024|363874230|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
105509735|NCT00843024|363874231|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
105509736|NCT00843024|363874226|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
105509737|NCT00843024|363874227|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
105509738|NCT00843024|363874228|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
105509739|NCT00843024|363874229|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
105509740|NCT00843024|363874230|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
105509741|NCT00843024|363874231|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
105509742|NCT00843024|363874226|FG000|Single-blind Placebo Run-In Phase|Other|0|||
105509743|NCT00843024|363874227|FG001|Single-blind Placebo Run-In Phase|Other|1|||
105509744|NCT00843024|363874228|FG002|Single-blind Placebo Run-In Phase|Other|0|||
105509745|NCT00843024|363874229|FG003|Single-blind Placebo Run-In Phase|Other|0|||
105509746|NCT00843024|363874230|FG004|Single-blind Placebo Run-In Phase|Other|0|||
105509747|NCT00843024|363874231|FG005|Single-blind Placebo Run-In Phase|Other|0|||
105509748|NCT00843024|363874226|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
105509749|NCT00843024|363874227|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
105509750|NCT00843024|363874228|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
105509751|NCT00843024|363874229|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
105509752|NCT00843024|363874230|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
105509753|NCT00843024|363874231|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
105509754|NCT00843024|363874226|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
105509755|NCT00843024|363874227|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
105509756|NCT00843024|363874228|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
105509757|NCT00843024|363874229|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
105509758|NCT00843024|363874230|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
105509759|NCT00843024|363874231|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
105509760|NCT00843024|363874226|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105509761|NCT00843024|363874227|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105509762|NCT00843024|363874228|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105509763|NCT00843024|363874229|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
105509764|NCT00843024|363874230|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105509765|NCT00843024|363874231|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
105509766|NCT00843024|363874226|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
105509767|NCT00843024|363874227|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
105509768|NCT00843024|363874228|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
105509769|NCT00843024|363874229|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
105509770|NCT00843024|363874230|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
105509771|NCT00843024|363874231|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
105509772|NCT00843024|363874226|FG000|Double-blind Treatment Phase|Physician Decision|0|||
105509773|NCT00843024|363874227|FG001|Double-blind Treatment Phase|Physician Decision|0|||
105509774|NCT00843024|363874228|FG002|Double-blind Treatment Phase|Physician Decision|0|||
105509775|NCT00843024|363874229|FG003|Double-blind Treatment Phase|Physician Decision|3|||
105509776|NCT00843024|363874230|FG004|Double-blind Treatment Phase|Physician Decision|1|||
105509777|NCT00843024|363874231|FG005|Double-blind Treatment Phase|Physician Decision|1|||
105509778|NCT00843024|363874226|FG000|Double-blind Treatment Phase|Adverse Event|0|||
105509779|NCT00843024|363874227|FG001|Double-blind Treatment Phase|Adverse Event|0|||
105509780|NCT00843024|363874228|FG002|Double-blind Treatment Phase|Adverse Event|0|||
105509781|NCT00843024|363874229|FG003|Double-blind Treatment Phase|Adverse Event|0|||
105509782|NCT00843024|363874230|FG004|Double-blind Treatment Phase|Adverse Event|1|||
105509783|NCT00843024|363874231|FG005|Double-blind Treatment Phase|Adverse Event|1|||
105509784|NCT00843024|363874226|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
105509785|NCT00843024|363874227|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
105509786|NCT00843024|363874228|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
105509787|NCT00843024|363874229|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
105509788|NCT00843024|363874230|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
105509789|NCT00843024|363874231|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
105509790|NCT02439138|363874232|FG000|Overall Study|Adverse Event|1|||
105509791|NCT02439138|363874232|FG000|Overall Study|PI decision to terminate the study|2|||
105509792|NCT02521870|363874235|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
105591563|NCT01090024|364167159|FG008|Period 3|Protocol Violation|1|||
105509793|NCT02521870|363874236|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
105509794|NCT02521870|363874237|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
105509795|NCT02521870|363874238|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
105509796|NCT02521870|363874239|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
105509797|NCT02521870|363874240|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
105509798|NCT02521870|363874241|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
105509799|NCT02521870|363874242|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
105509800|NCT02521870|363874243|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
105509801|NCT02521870|363874244|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
105509802|NCT02521870|363874245|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
105509803|NCT02521870|363874246|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
105509804|NCT02521870|363874235|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
105509805|NCT02521870|363874236|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
105509806|NCT02521870|363874237|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
105509807|NCT02521870|363874238|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
105509808|NCT02521870|363874239|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
105509809|NCT02521870|363874240|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
105509810|NCT02521870|363874241|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
105509811|NCT02521870|363874242|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
105509812|NCT02521870|363874243|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
105509813|NCT02521870|363874244|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
105509814|NCT02521870|363874245|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
105509815|NCT02521870|363874246|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
105509816|NCT02521870|363874235|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
105509817|NCT02521870|363874236|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
105509818|NCT02521870|363874237|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
105509819|NCT02521870|363874238|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
105509820|NCT02521870|363874239|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
105509821|NCT02521870|363874240|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
105509822|NCT02521870|363874241|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
105509823|NCT02521870|363874242|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
105509824|NCT02521870|363874243|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
105509825|NCT02521870|363874244|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
105509826|NCT02521870|363874245|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
105509827|NCT02521870|363874246|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
105509828|NCT02521870|363874235|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
105509829|NCT02521870|363874236|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
105509830|NCT02521870|363874237|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
105509831|NCT02521870|363874238|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
105509832|NCT02521870|363874239|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
105509833|NCT02521870|363874240|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
105509834|NCT02521870|363874241|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
105509835|NCT02521870|363874242|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
105509836|NCT02521870|363874243|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
105509837|NCT02521870|363874244|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
105509838|NCT02521870|363874245|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
105509839|NCT02521870|363874246|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
105509840|NCT02521870|363874235|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
105509841|NCT02521870|363874236|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
105509842|NCT02521870|363874237|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
105509843|NCT02521870|363874238|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
105509844|NCT02521870|363874239|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
105509845|NCT02521870|363874240|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
105509846|NCT02521870|363874241|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
105509847|NCT02521870|363874242|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
105509848|NCT02521870|363874243|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
105509849|NCT02521870|363874244|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
105509850|NCT02521870|363874245|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
105509851|NCT02521870|363874246|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
105509852|NCT02521870|363874235|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
105509853|NCT02521870|363874236|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
105509854|NCT02521870|363874237|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
105509855|NCT02521870|363874238|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
105509856|NCT02521870|363874239|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
105509857|NCT02521870|363874240|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
105509858|NCT02521870|363874241|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
105509859|NCT02521870|363874242|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
105509860|NCT02521870|363874243|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
105509861|NCT02521870|363874244|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
105509862|NCT02521870|363874245|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
105509863|NCT02521870|363874246|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
105509864|NCT02521870|363874235|FG000|Phase 2: Dose Expansion|Death|0|||
105509865|NCT02521870|363874236|FG001|Phase 2: Dose Expansion|Death|0|||
105509866|NCT02521870|363874237|FG002|Phase 2: Dose Expansion|Death|0|||
105509867|NCT02521870|363874238|FG003|Phase 2: Dose Expansion|Death|0|||
105509868|NCT02521870|363874239|FG004|Phase 2: Dose Expansion|Death|1|||
105509869|NCT02521870|363874240|FG005|Phase 2: Dose Expansion|Death|1|||
105509870|NCT02521870|363874241|FG006|Phase 2: Dose Expansion|Death|3|||
105509871|NCT02521870|363874242|FG007|Phase 2: Dose Expansion|Death|1|||
105509872|NCT02521870|363874243|FG008|Phase 2: Dose Expansion|Death|1|||
105509873|NCT02521870|363874244|FG009|Phase 2: Dose Expansion|Death|5|||
105509874|NCT02521870|363874245|FG010|Phase 2: Dose Expansion|Death|2|||
105509875|NCT02521870|363874246|FG011|Phase 2: Dose Expansion|Death|2|||
105509876|NCT02521870|363874235|FG000|Phase 2: Dose Expansion|Other|0|||
105509877|NCT02521870|363874236|FG001|Phase 2: Dose Expansion|Other|0|||
105509878|NCT02521870|363874237|FG002|Phase 2: Dose Expansion|Other|0|||
105509879|NCT02521870|363874238|FG003|Phase 2: Dose Expansion|Other|0|||
105509880|NCT02521870|363874239|FG004|Phase 2: Dose Expansion|Other|10|||
105509881|NCT02521870|363874240|FG005|Phase 2: Dose Expansion|Other|3|||
105509882|NCT02521870|363874241|FG006|Phase 2: Dose Expansion|Other|2|||
105509883|NCT02521870|363874242|FG007|Phase 2: Dose Expansion|Other|0|||
105509884|NCT02521870|363874243|FG008|Phase 2: Dose Expansion|Other|10|||
105509885|NCT02521870|363874244|FG009|Phase 2: Dose Expansion|Other|5|||
105509886|NCT02521870|363874245|FG010|Phase 2: Dose Expansion|Other|1|||
105509887|NCT02521870|363874246|FG011|Phase 2: Dose Expansion|Other|7|||
105509888|NCT02521870|363874235|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105509889|NCT02521870|363874236|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105509890|NCT02521870|363874237|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105509891|NCT02521870|363874238|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105509892|NCT02521870|363874239|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
105509893|NCT02521870|363874240|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105509894|NCT02521870|363874241|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105509895|NCT02521870|363874242|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105509896|NCT02521870|363874243|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105509897|NCT02521870|363874244|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105509898|NCT02521870|363874245|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105509899|NCT02521870|363874246|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
105509900|NCT02521870|363874235|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
105509901|NCT02521870|363874236|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
105509902|NCT02521870|363874237|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
105509903|NCT02521870|363874238|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
105509904|NCT02521870|363874239|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
105509905|NCT02521870|363874240|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
105509906|NCT02521870|363874241|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
105509907|NCT02521870|363874242|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
105509908|NCT02521870|363874243|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
105509909|NCT02521870|363874244|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
105509910|NCT02521870|363874245|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
105509911|NCT02521870|363874246|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
105509912|NCT03200860|363874247|FG000|Overall Study|Withdrawal by Subject|1|||
105509913|NCT03200860|363874248|FG001|Overall Study|Withdrawal by Subject|0|||
105509914|NCT01744197|363874253|FG000|Overall Study|Received 1 patch|2|||
105509915|NCT01744197|363874254|FG001|Overall Study|Received 1 patch|1|||
105509916|NCT01744197|363874253|FG000|Overall Study|No patch received|2|||
105509917|NCT01744197|363874254|FG001|Overall Study|No patch received|2|||
105509918|NCT01325584|363874255|FG000|Overall Study|Death|1|||
105509919|NCT00887978|363874256|FG000|Overall Study|Adverse Event|18|||
105509920|NCT00887978|363874257|FG001|Overall Study|Adverse Event|5|||
105509921|NCT00887978|363874256|FG000|Overall Study|Clinical Worsening|4|||
105509922|NCT00887978|363874257|FG001|Overall Study|Clinical Worsening|4|||
105509923|NCT00887978|363874256|FG000|Overall Study|Death|2|||
105509924|NCT00887978|363874257|FG001|Overall Study|Death|3|||
105509925|NCT00887978|363874256|FG000|Overall Study|Withdrawal by Subject|1|||
105509926|NCT00887978|363874257|FG001|Overall Study|Withdrawal by Subject|2|||
105509927|NCT00887978|363874256|FG000|Overall Study|Lost to Follow-up|0|||
105509928|NCT00887978|363874257|FG001|Overall Study|Lost to Follow-up|1|||
105509929|NCT04600921|363874258|FG000|Overall Study|Withdrawal by Subject|3|||
105509930|NCT04600921|363874259|FG001|Overall Study|Withdrawal by Subject|5|||
105509931|NCT04600921|363874258|FG000|Overall Study|Death|0|||
105509932|NCT04600921|363874259|FG001|Overall Study|Death|1|||
105509933|NCT01892293|363876149|FG000|Overall Study|Apheresed but not treated|4|||
105509934|NCT02397278|363876152|FG000|Overall Study|Withdrawal by Subject|0|||
105591564|NCT01090024|364167160|FG009|Period 3|Protocol Violation|0|||
105509935|NCT02397278|363876153|FG001|Overall Study|Withdrawal by Subject|2|||
105509936|NCT02397278|363876152|FG000|Overall Study|Deemed ineligible following surgery|1|||
105509937|NCT02397278|363876153|FG001|Overall Study|Deemed ineligible following surgery|1|||
105509938|NCT00105469|363876154|FG000|Overall Study|Adverse Event|9|||
105509939|NCT00105469|363876155|FG001|Overall Study|Adverse Event|8|||
105591565|NCT01090024|364167161|FG010|Period 3|Protocol Violation|0|||
105509940|NCT00105469|363876154|FG000|Overall Study|Protocol Violation|4|||
105509941|NCT00105469|363876155|FG001|Overall Study|Protocol Violation|0|||
105509942|NCT00105469|363876154|FG000|Overall Study|Withdrawal by Subject|2|||
105509943|NCT00105469|363876155|FG001|Overall Study|Withdrawal by Subject|3|||
105509944|NCT00105469|363876154|FG000|Overall Study|Lost to Follow-up|1|||
105509945|NCT00105469|363876155|FG001|Overall Study|Lost to Follow-up|0|||
105509946|NCT00105469|363876154|FG000|Overall Study|Lack of Efficacy|2|||
105509947|NCT00105469|363876155|FG001|Overall Study|Lack of Efficacy|0|||
105509948|NCT00105469|363876154|FG000|Overall Study|Other Reason|4|||
105509949|NCT00105469|363876155|FG001|Overall Study|Other Reason|0|||
105509950|NCT01384760|363876161|FG000|Overall Study|Lost to Follow-up|0|||
105509951|NCT01384760|363876162|FG001|Overall Study|Lost to Follow-up|6|||
105509952|NCT01384760|363876161|FG000|Overall Study|Protocol Violation|16|||
105509953|NCT01384760|363876162|FG001|Overall Study|Protocol Violation|0|||
105509954|NCT01411774|363876167|FG000|Overall Study|Withdrawal by Subject|0|||
105509955|NCT01411774|363876168|FG001|Overall Study|Withdrawal by Subject|3|||
105509956|NCT00963547|363876169|FG000|Overall Study|Adverse Event|0|||
105509957|NCT00963547|363876170|FG001|Overall Study|Adverse Event|1|||
105509958|NCT00963547|363876171|FG002|Overall Study|Adverse Event|0|||
105509959|NCT00963547|363876172|FG003|Overall Study|Adverse Event|1|||
105509960|NCT00963547|363876173|FG004|Overall Study|Adverse Event|0|||
105509961|NCT00963547|363876174|FG005|Overall Study|Adverse Event|0|||
105509962|NCT00963547|363876175|FG006|Overall Study|Adverse Event|0|||
105509963|NCT00963547|363876169|FG000|Overall Study|Physician Decision|1|||
105509964|NCT00963547|363876170|FG001|Overall Study|Physician Decision|1|||
105509965|NCT00963547|363876171|FG002|Overall Study|Physician Decision|0|||
105509966|NCT00963547|363876172|FG003|Overall Study|Physician Decision|0|||
105509967|NCT00963547|363876173|FG004|Overall Study|Physician Decision|0|||
105509968|NCT00963547|363876174|FG005|Overall Study|Physician Decision|0|||
105509969|NCT00963547|363876175|FG006|Overall Study|Physician Decision|0|||
105509970|NCT00963547|363876169|FG000|Overall Study|Progressive Disease|3|||
105509971|NCT00963547|363876170|FG001|Overall Study|Progressive Disease|8|||
105509972|NCT00963547|363876171|FG002|Overall Study|Progressive Disease|9|||
105509973|NCT00963547|363876172|FG003|Overall Study|Progressive Disease|5|||
105509974|NCT00963547|363876173|FG004|Overall Study|Progressive Disease|0|||
105509975|NCT00963547|363876174|FG005|Overall Study|Progressive Disease|0|||
105509976|NCT00963547|363876175|FG006|Overall Study|Progressive Disease|0|||
105509977|NCT00963547|363876169|FG000|Overall Study|Withdrawal by Subject|0|||
105509978|NCT00963547|363876170|FG001|Overall Study|Withdrawal by Subject|0|||
105509979|NCT00963547|363876171|FG002|Overall Study|Withdrawal by Subject|3|||
105509980|NCT00963547|363876172|FG003|Overall Study|Withdrawal by Subject|0|||
105509981|NCT00963547|363876173|FG004|Overall Study|Withdrawal by Subject|0|||
105509982|NCT00963547|363876174|FG005|Overall Study|Withdrawal by Subject|0|||
105509983|NCT00963547|363876175|FG006|Overall Study|Withdrawal by Subject|0|||
105509984|NCT00963547|363876169|FG000|Overall Study|Reason Unknown|0|||
105509985|NCT00963547|363876170|FG001|Overall Study|Reason Unknown|1|||
105509986|NCT00963547|363876171|FG002|Overall Study|Reason Unknown|0|||
105509987|NCT00963547|363876172|FG003|Overall Study|Reason Unknown|0|||
105509988|NCT00963547|363876173|FG004|Overall Study|Reason Unknown|0|||
105509989|NCT00963547|363876174|FG005|Overall Study|Reason Unknown|0|||
105509990|NCT00963547|363876175|FG006|Overall Study|Reason Unknown|0|||
105509991|NCT01397084|363876176|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
105509992|NCT01397084|363876176|FG000|Overall Study|Protocol Violation|2|||
105509993|NCT01397084|363876176|FG000|Overall Study|Adverse Event|2|||
105509994|NCT01397084|363876176|FG000|Overall Study|Withdrawal by Subject|1|||
105509995|NCT01397084|363876176|FG000|Overall Study|Lost to Follow-up|1|||
105509996|NCT01397084|363876176|FG000|Overall Study|Used other proton pump inhibitor|1|||
105509997|NCT00790023|363876177|FG000|Overall Study|Adverse Event|2|||
105509998|NCT00790023|363876178|FG001|Overall Study|Adverse Event|1|||
105509999|NCT00790023|363876179|FG002|Overall Study|Adverse Event|4|||
105510000|NCT00790023|363876177|FG000|Overall Study|Protocol Violation|2|||
105510001|NCT00790023|363876178|FG001|Overall Study|Protocol Violation|4|||
105510002|NCT00790023|363876179|FG002|Overall Study|Protocol Violation|2|||
105510003|NCT00790023|363876177|FG000|Overall Study|Withdrawal by Subject|2|||
105510004|NCT00790023|363876178|FG001|Overall Study|Withdrawal by Subject|0|||
105510005|NCT00790023|363876179|FG002|Overall Study|Withdrawal by Subject|6|||
105510006|NCT00790023|363876177|FG000|Overall Study|Lost to Follow-up|0|||
105510007|NCT00790023|363876178|FG001|Overall Study|Lost to Follow-up|0|||
105510008|NCT00790023|363876179|FG002|Overall Study|Lost to Follow-up|1|||
105510009|NCT00790023|363876177|FG000|Overall Study|Other|5|||
105510010|NCT00790023|363876178|FG001|Overall Study|Other|5|||
105510011|NCT00790023|363876179|FG002|Overall Study|Other|8|||
105510012|NCT00004978|363876180|FG000|Overall Study|Death|107|||
105510013|NCT00004978|363876181|FG001|Overall Study|Death|116|||
105510014|NCT00004978|363876180|FG000|Overall Study|Lost to Follow-up|101|||
105591566|NCT01090024|364167162|FG011|Period 3|Protocol Violation|0|||
105510015|NCT00004978|363876181|FG001|Overall Study|Lost to Follow-up|108|||
105510016|NCT00004978|363876180|FG000|Overall Study|Withdrawal by Subject|17|||
105510017|NCT00004978|363876181|FG001|Overall Study|Withdrawal by Subject|26|||
105510018|NCT00004978|363876180|FG000|Overall Study|site closure - not in analysis cohort|19|||
105510019|NCT00004978|363876181|FG001|Overall Study|site closure - not in analysis cohort|20|||
105510020|NCT03761277|363876182|FG000|Enrollment to Implant|Screen Failure|17|||
105510021|NCT03761277|363876182|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
105510022|NCT03761277|363876182|FG000|Enrollment to Implant|Physician Decision|2|||
105510023|NCT03761277|363876182|FG000|Enrollment to Implant|Site Closure|3|||
105510024|NCT03761277|363876182|FG000|Enrollment to Implant|Sponsor Request|2|||
105510025|NCT03761277|363876182|FG000|Post-Implant to 6 Months|Adverse Event|2|||
105510026|NCT03761277|363876182|FG000|Post-Implant to 6 Months|Death|1|||
105510027|NCT03761277|363876182|FG000|Post-Implant to 6 Months|Site Closure|2|||
105510028|NCT03761277|363876182|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
105510029|NCT03761277|363876182|FG000|6 Months to 12 Months|Physician Decision|2|||
105510030|NCT03761277|363876182|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
105510031|NCT01652703|363876183|FG000|Overall Study|Withdrawal by Subject|0|||
105510032|NCT01652703|363876184|FG001|Overall Study|Withdrawal by Subject|1|||
105510033|NCT01652703|363876185|FG002|Overall Study|Withdrawal by Subject|3|||
105510034|NCT01652703|363876186|FG003|Overall Study|Withdrawal by Subject|1|||
105510035|NCT01652703|363876187|FG004|Overall Study|Withdrawal by Subject|0|||
105510036|NCT01652703|363876188|FG005|Overall Study|Withdrawal by Subject|1|||
105510037|NCT01652703|363876183|FG000|Overall Study|Other|0|||
105510038|NCT01652703|363876184|FG001|Overall Study|Other|0|||
105510039|NCT01652703|363876185|FG002|Overall Study|Other|0|||
105510040|NCT01652703|363876186|FG003|Overall Study|Other|1|||
105510041|NCT01652703|363876187|FG004|Overall Study|Other|1|||
105510042|NCT01652703|363876188|FG005|Overall Study|Other|1|||
105510043|NCT03555591|363876189|FG000|Overall Study|Protocol Violation|77|||
105510044|NCT00903695|363876190|FG000|Overall Study|medical exclusion after 1st testing|1|||
105510045|NCT00903695|363876191|FG001|Overall Study|medical exclusion after 1st testing|0|||
105510046|NCT00903695|363876190|FG000|Overall Study|lung cancer|1|||
105510047|NCT00903695|363876191|FG001|Overall Study|lung cancer|0|||
105510048|NCT01532414|363876192|FG000|Overall Study|Lost to Follow-up|3|||
105510049|NCT01532414|363876193|FG001|Overall Study|Lost to Follow-up|0|||
105510050|NCT01532414|363876194|FG002|Overall Study|Lost to Follow-up|1|||
105510051|NCT01532414|363876192|FG000|Overall Study|Withdrawal by Subject|3|||
105510052|NCT01532414|363876193|FG001|Overall Study|Withdrawal by Subject|0|||
105510053|NCT01532414|363876194|FG002|Overall Study|Withdrawal by Subject|0|||
105510054|NCT01532414|363876192|FG000|Overall Study|No V6 semen sample|0|||
105510055|NCT01532414|363876193|FG001|Overall Study|No V6 semen sample|1|||
105510056|NCT01532414|363876194|FG002|Overall Study|No V6 semen sample|0|||
105510057|NCT01532414|363876192|FG000|Overall Study|Adverse Event|0|||
105510058|NCT01532414|363876193|FG001|Overall Study|Adverse Event|1|||
105510059|NCT01532414|363876194|FG002|Overall Study|Adverse Event|1|||
105510060|NCT01532414|363876192|FG000|Overall Study|Unable to complete 24 hour PK|0|||
105510061|NCT01532414|363876193|FG001|Overall Study|Unable to complete 24 hour PK|0|||
105510062|NCT01532414|363876194|FG002|Overall Study|Unable to complete 24 hour PK|1|||
105510063|NCT01532414|363876192|FG000|Overall Study|Withdrawn by sponsor|1|||
105510064|NCT01532414|363876193|FG001|Overall Study|Withdrawn by sponsor|0|||
105510065|NCT01532414|363876194|FG002|Overall Study|Withdrawn by sponsor|0|||
105510066|NCT01751867|363876195|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
105510067|NCT01751867|363876196|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
105510068|NCT01751867|363876195|FG000|Overall Study|Diease Progression|4|||
105510069|NCT01751867|363876196|FG001|Overall Study|Diease Progression|18|||
105510070|NCT01751867|363876195|FG000|Overall Study|Adverse Event|8|||
105510071|NCT01751867|363876196|FG001|Overall Study|Adverse Event|15|||
105510072|NCT01751867|363876195|FG000|Overall Study|Poor Compliance|0|||
105510073|NCT01751867|363876196|FG001|Overall Study|Poor Compliance|5|||
105510074|NCT01751867|363876195|FG000|Overall Study|Withdrawal by Subject|3|||
105510075|NCT01751867|363876196|FG001|Overall Study|Withdrawal by Subject|1|||
105510076|NCT01751867|363876195|FG000|Overall Study|Physician Decision|4|||
105510077|NCT01751867|363876196|FG001|Overall Study|Physician Decision|7|||
105510078|NCT01751867|363876195|FG000|Overall Study|Protocol Violation|0|||
105510079|NCT01751867|363876196|FG001|Overall Study|Protocol Violation|2|||
105510080|NCT01751867|363876195|FG000|Overall Study|Death|0|||
105510081|NCT01751867|363876196|FG001|Overall Study|Death|5|||
105510082|NCT01751867|363876195|FG000|Overall Study|Other|11|||
105510083|NCT01751867|363876196|FG001|Overall Study|Other|37|||
105510084|NCT01751867|363876195|FG000|Overall Study|Randomized but not treated.|2|||
105510085|NCT01751867|363876196|FG001|Overall Study|Randomized but not treated.|1|||
105510086|NCT01806545|363876197|FG000|Overall Study|Adverse Event|2|||
105510087|NCT01806545|363876198|FG001|Overall Study|Adverse Event|3|||
105510088|NCT01806545|363876197|FG000|Overall Study|Lost to Follow-up|1|||
105510089|NCT01806545|363876198|FG001|Overall Study|Lost to Follow-up|0|||
105510090|NCT01806545|363876197|FG000|Overall Study|Withdrawal by Subject|3|||
105510091|NCT01806545|363876198|FG001|Overall Study|Withdrawal by Subject|2|||
105510092|NCT01059825|363876200|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
105510093|NCT01059825|363876201|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
105510094|NCT01059825|363876202|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
105510095|NCT01059825|363876203|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
105510096|NCT01059825|363876204|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
105510097|NCT01059825|363876205|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
105510098|NCT01059825|363876206|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
105510099|NCT01059825|363876200|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
105510100|NCT01059825|363876201|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
105510101|NCT01059825|363876202|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
105510102|NCT01059825|363876203|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
105510103|NCT01059825|363876204|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
105510104|NCT01059825|363876205|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
105510105|NCT01059825|363876206|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
105510106|NCT01059825|363876200|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
105510107|NCT01059825|363876201|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
105510108|NCT01059825|363876202|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
105510109|NCT01059825|363876203|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
105510110|NCT01059825|363876204|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
105510111|NCT01059825|363876205|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
105510112|NCT01059825|363876206|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
105510113|NCT01059825|363876200|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
105510114|NCT01059825|363876201|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
105510115|NCT01059825|363876202|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
105510116|NCT01059825|363876203|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
105510117|NCT01059825|363876204|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
105510118|NCT01059825|363876205|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
105510119|NCT01059825|363876206|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
105510120|NCT01059825|363876200|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
105510121|NCT01059825|363876201|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
105510122|NCT01059825|363876202|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
105510123|NCT01059825|363876203|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
105510124|NCT01059825|363876204|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
105510125|NCT01059825|363876205|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
105510126|NCT01059825|363876206|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
105510127|NCT01059825|363876200|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
105510128|NCT01059825|363876201|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
105510129|NCT01059825|363876202|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
105510130|NCT01059825|363876203|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
105510131|NCT01059825|363876204|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
105510132|NCT01059825|363876205|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
105510133|NCT01059825|363876206|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
105510134|NCT01059825|363876200|FG000|Treatment Period|Lost to Follow-up|2|||
105510135|NCT01059825|363876201|FG001|Treatment Period|Lost to Follow-up|1|||
105510136|NCT01059825|363876202|FG002|Treatment Period|Lost to Follow-up|0|||
105510137|NCT01059825|363876203|FG003|Treatment Period|Lost to Follow-up|1|||
105510138|NCT01059825|363876204|FG004|Treatment Period|Lost to Follow-up|2|||
105510139|NCT01059825|363876205|FG005|Treatment Period|Lost to Follow-up|0|||
105510140|NCT01059825|363876206|FG006|Treatment Period|Lost to Follow-up|0|||
105510141|NCT01059825|363876200|FG000|Treatment Period|Withdrawal by Subject|3|||
105510142|NCT01059825|363876201|FG001|Treatment Period|Withdrawal by Subject|0|||
105510143|NCT01059825|363876202|FG002|Treatment Period|Withdrawal by Subject|1|||
105510144|NCT01059825|363876203|FG003|Treatment Period|Withdrawal by Subject|5|||
105510145|NCT01059825|363876204|FG004|Treatment Period|Withdrawal by Subject|4|||
105510146|NCT01059825|363876205|FG005|Treatment Period|Withdrawal by Subject|1|||
105510147|NCT01059825|363876206|FG006|Treatment Period|Withdrawal by Subject|0|||
105510148|NCT01059825|363876200|FG000|Treatment Period|Other reason not specified|1|||
105510149|NCT01059825|363876201|FG001|Treatment Period|Other reason not specified|2|||
105510150|NCT01059825|363876202|FG002|Treatment Period|Other reason not specified|1|||
105510151|NCT01059825|363876203|FG003|Treatment Period|Other reason not specified|2|||
105510152|NCT01059825|363876204|FG004|Treatment Period|Other reason not specified|0|||
105510153|NCT01059825|363876205|FG005|Treatment Period|Other reason not specified|0|||
105510154|NCT01059825|363876206|FG006|Treatment Period|Other reason not specified|0|||
105510155|NCT01059825|363876200|FG000|Treatment Period|Protocol Violation|0|||
105510156|NCT01059825|363876201|FG001|Treatment Period|Protocol Violation|0|||
105510157|NCT01059825|363876202|FG002|Treatment Period|Protocol Violation|1|||
105510158|NCT01059825|363876203|FG003|Treatment Period|Protocol Violation|1|||
105510159|NCT01059825|363876204|FG004|Treatment Period|Protocol Violation|1|||
105510160|NCT01059825|363876205|FG005|Treatment Period|Protocol Violation|1|||
105591567|NCT01090024|364167163|FG012|Period 3|Protocol Violation|0|||
105591568|NCT01090024|364167164|FG013|Period 3|Protocol Violation|0|||
105591569|NCT01090024|364167165|FG014|Period 3|Protocol Violation|0|||
105591570|NCT01090024|364167166|FG015|Period 3|Protocol Violation|0|||
105591571|NCT01090024|364167167|FG016|Period 3|Protocol Violation|0|||
105591572|NCT01090024|364167168|FG017|Period 3|Protocol Violation|0|||
105591573|NCT01090024|364167151|FG000|Period 3|Adverse Event|0|||
105591574|NCT01090024|364167152|FG001|Period 3|Adverse Event|0|||
105591575|NCT01090024|364167153|FG002|Period 3|Adverse Event|0|||
105591576|NCT01090024|364167154|FG003|Period 3|Adverse Event|0|||
105591577|NCT01090024|364167155|FG004|Period 3|Adverse Event|0|||
105591578|NCT01090024|364167156|FG005|Period 3|Adverse Event|1|||
105591579|NCT01090024|364167157|FG006|Period 3|Adverse Event|0|||
105591580|NCT01090024|364167158|FG007|Period 3|Adverse Event|0|||
105591581|NCT01090024|364167159|FG008|Period 3|Adverse Event|0|||
105591582|NCT01090024|364167160|FG009|Period 3|Adverse Event|0|||
105591583|NCT01090024|364167161|FG010|Period 3|Adverse Event|0|||
105591584|NCT01090024|364167162|FG011|Period 3|Adverse Event|0|||
105591585|NCT01090024|364167163|FG012|Period 3|Adverse Event|0|||
105591586|NCT01090024|364167164|FG013|Period 3|Adverse Event|0|||
105591587|NCT01090024|364167165|FG014|Period 3|Adverse Event|0|||
105591588|NCT01090024|364167166|FG015|Period 3|Adverse Event|0|||
105591589|NCT01090024|364167167|FG016|Period 3|Adverse Event|0|||
105591590|NCT01090024|364167168|FG017|Period 3|Adverse Event|0|||
105591591|NCT00470626|364167169|FG000|Overall Study|Lost to Follow-up|10|||
105591592|NCT00470626|364167169|FG000|Overall Study|Withdrawal by Subject|7|||
105591593|NCT00777556|364167170|FG000|Overall Study|Inappropriate self-selection|34|||
105591594|NCT00777556|364167170|FG000|Overall Study|Dispensed but did not use product|12|||
105591595|NCT00777556|364167170|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
105591596|NCT01801930|364167173|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
105591597|NCT01801930|364167174|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
105591598|NCT01801930|364167175|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
105591599|NCT01801930|364167176|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
105591600|NCT01801930|364167173|FG000|Overall Study|DLT occurs|0|||
105591601|NCT01801930|364167174|FG001|Overall Study|DLT occurs|1|||
105510161|NCT01059825|363876206|FG006|Treatment Period|Protocol Violation|0|||
105510162|NCT01059825|363876200|FG000|Treatment Period|Adverse event related to study drug|1|||
105510163|NCT01059825|363876201|FG001|Treatment Period|Adverse event related to study drug|0|||
105510164|NCT01059825|363876202|FG002|Treatment Period|Adverse event related to study drug|1|||
105510165|NCT01059825|363876203|FG003|Treatment Period|Adverse event related to study drug|1|||
105510166|NCT01059825|363876204|FG004|Treatment Period|Adverse event related to study drug|0|||
105510167|NCT01059825|363876205|FG005|Treatment Period|Adverse event related to study drug|0|||
105510168|NCT01059825|363876206|FG006|Treatment Period|Adverse event related to study drug|0|||
105510169|NCT01059825|363876200|FG000|Treatment Period|Insufficient clinical response|3|||
105510170|NCT01059825|363876201|FG001|Treatment Period|Insufficient clinical response|0|||
105510171|NCT01059825|363876202|FG002|Treatment Period|Insufficient clinical response|0|||
105510172|NCT01059825|363876203|FG003|Treatment Period|Insufficient clinical response|0|||
105510173|NCT01059825|363876204|FG004|Treatment Period|Insufficient clinical response|0|||
105510174|NCT01059825|363876205|FG005|Treatment Period|Insufficient clinical response|0|||
105510175|NCT01059825|363876206|FG006|Treatment Period|Insufficient clinical response|0|||
105510176|NCT01059825|363876200|FG000|Treatment Period|Adverse event not related to study drug|0|||
105510177|NCT01059825|363876201|FG001|Treatment Period|Adverse event not related to study drug|1|||
105510178|NCT01059825|363876202|FG002|Treatment Period|Adverse event not related to study drug|2|||
105591602|NCT01801930|364167175|FG002|Overall Study|DLT occurs|0|||
105591603|NCT01801930|364167176|FG003|Overall Study|DLT occurs|0|||
105591604|NCT02236559|364167177|FG000|Overall Study|Met Exclusion|3|||
105591605|NCT02236559|364167178|FG001|Overall Study|Met Exclusion|6|||
105591606|NCT02236559|364167177|FG000|Overall Study|Did not Meet Inclusion|3|||
105591607|NCT02236559|364167178|FG001|Overall Study|Did not Meet Inclusion|3|||
105591608|NCT02236559|364167177|FG000|Overall Study|Subject Did Not Consent|4|||
105591609|NCT02236559|364167178|FG001|Overall Study|Subject Did Not Consent|2|||
105591610|NCT02236559|364167177|FG000|Overall Study|Physician Decision|1|||
105591611|NCT02236559|364167178|FG001|Overall Study|Physician Decision|1|||
105591612|NCT02236559|364167177|FG000|Overall Study|Withdrawal by Subject|1|||
105591613|NCT02236559|364167178|FG001|Overall Study|Withdrawal by Subject|0|||
105510179|NCT01059825|363876203|FG003|Treatment Period|Adverse event not related to study drug|1|||
105591614|NCT01259102|364167181|FG000|Overall Study|Adverse Event|1|||
105591615|NCT01259102|364167182|FG001|Overall Study|Adverse Event|0|||
105591616|NCT01259102|364167183|FG002|Overall Study|Adverse Event|1|||
105510180|NCT01059825|363876204|FG004|Treatment Period|Adverse event not related to study drug|1|||
105510181|NCT01059825|363876205|FG005|Treatment Period|Adverse event not related to study drug|1|||
105591617|NCT01259102|364167184|FG003|Overall Study|Adverse Event|1|||
105591618|NCT01259102|364167185|FG004|Overall Study|Adverse Event|0|||
105591619|NCT01259102|364167181|FG000|Overall Study|Other|0|||
105591620|NCT01259102|364167182|FG001|Overall Study|Other|0|||
105591621|NCT01259102|364167183|FG002|Overall Study|Other|1|||
105591622|NCT01259102|364167184|FG003|Overall Study|Other|1|||
105510182|NCT01059825|363876206|FG006|Treatment Period|Adverse event not related to study drug|0|||
105510183|NCT00429273|363876207|FG000|Overall Study|Lost to Follow-up|1|||
105510184|NCT00429273|363876208|FG001|Overall Study|Lost to Follow-up|2|||
105510185|NCT00429273|363876209|FG002|Overall Study|Lost to Follow-up|2|||
105510186|NCT00429273|363876207|FG000|Overall Study|Physician Decision|6|||
105510187|NCT00429273|363876208|FG001|Overall Study|Physician Decision|5|||
105510188|NCT00429273|363876209|FG002|Overall Study|Physician Decision|5|||
105510189|NCT00429273|363876207|FG000|Overall Study|Adverse Event|1|||
105510190|NCT00429273|363876208|FG001|Overall Study|Adverse Event|1|||
105510191|NCT00429273|363876209|FG002|Overall Study|Adverse Event|2|||
105510192|NCT01438957|363876210|FG000|Overall Study|Physician Decision|1|||
105510193|NCT01438957|363876211|FG001|Overall Study|Physician Decision|1|||
105510194|NCT01438957|363876212|FG002|Overall Study|Physician Decision|0|||
105510195|NCT01438957|363876213|FG003|Overall Study|Physician Decision|1|||
105510196|NCT01438957|363876214|FG004|Overall Study|Physician Decision|0|||
105510197|NCT00727025|363876218|FG000|Overall Study|Physician Decision|23|||
105510198|NCT02732119|363876219|FG000|Phase I|Adverse Event|1|||
105510199|NCT02732119|363876220|FG001|Phase I|Adverse Event|3|||
105510200|NCT02732119|363876221|FG002|Phase I|Adverse Event|1|||
105510201|NCT02732119|363876222|FG003|Phase I|Adverse Event|0|||
105510202|NCT02732119|363876223|FG004|Phase I|Adverse Event|0|||
105510203|NCT02732119|363876219|FG000|Phase I|Progressive disease|7|||
105510204|NCT02732119|363876220|FG001|Phase I|Progressive disease|3|||
105510205|NCT02732119|363876221|FG002|Phase I|Progressive disease|2|||
105510206|NCT02732119|363876222|FG003|Phase I|Progressive disease|0|||
105510207|NCT02732119|363876223|FG004|Phase I|Progressive disease|0|||
105510208|NCT02732119|363876219|FG000|Phase I|Protocol deviation|0|||
105510209|NCT02732119|363876220|FG001|Phase I|Protocol deviation|1|||
105510210|NCT02732119|363876221|FG002|Phase I|Protocol deviation|0|||
105510211|NCT02732119|363876222|FG003|Phase I|Protocol deviation|0|||
105510212|NCT02732119|363876223|FG004|Phase I|Protocol deviation|0|||
105510213|NCT02732119|363876219|FG000|Phase I|Physician Decision|0|||
105510214|NCT02732119|363876220|FG001|Phase I|Physician Decision|3|||
105510215|NCT02732119|363876221|FG002|Phase I|Physician Decision|4|||
105510216|NCT02732119|363876222|FG003|Phase I|Physician Decision|0|||
105510217|NCT02732119|363876223|FG004|Phase I|Physician Decision|0|||
105510218|NCT02732119|363876219|FG000|Phase II|Adverse Event|0|||
105510219|NCT02732119|363876220|FG001|Phase II|Adverse Event|0|||
105510220|NCT02732119|363876221|FG002|Phase II|Adverse Event|0|||
105510221|NCT02732119|363876222|FG003|Phase II|Adverse Event|3|||
105510222|NCT02732119|363876223|FG004|Phase II|Adverse Event|3|||
105510223|NCT02732119|363876219|FG000|Phase II|Death|0|||
105510224|NCT02732119|363876220|FG001|Phase II|Death|0|||
105510225|NCT02732119|363876221|FG002|Phase II|Death|0|||
105510226|NCT02732119|363876222|FG003|Phase II|Death|1|||
105510227|NCT02732119|363876223|FG004|Phase II|Death|0|||
105510228|NCT02732119|363876219|FG000|Phase II|Progressive dissease|0|||
105510229|NCT02732119|363876220|FG001|Phase II|Progressive dissease|0|||
105510230|NCT02732119|363876221|FG002|Phase II|Progressive dissease|0|||
105510231|NCT02732119|363876222|FG003|Phase II|Progressive dissease|30|||
105510232|NCT02732119|363876223|FG004|Phase II|Progressive dissease|23|||
105510233|NCT02732119|363876219|FG000|Phase II|Study terminated by sponsor|0|||
105510234|NCT02732119|363876220|FG001|Phase II|Study terminated by sponsor|0|||
105510235|NCT02732119|363876221|FG002|Phase II|Study terminated by sponsor|0|||
105510236|NCT02732119|363876222|FG003|Phase II|Study terminated by sponsor|2|||
105510237|NCT02732119|363876223|FG004|Phase II|Study terminated by sponsor|2|||
105510238|NCT02732119|363876219|FG000|Phase II|Other|0|||
105510239|NCT02732119|363876220|FG001|Phase II|Other|0|||
105510240|NCT02732119|363876221|FG002|Phase II|Other|0|||
105510241|NCT02732119|363876222|FG003|Phase II|Other|2|||
105510242|NCT02732119|363876223|FG004|Phase II|Other|0|||
105510243|NCT02732119|363876219|FG000|Phase II|Physician Decision|0|||
105510244|NCT02732119|363876220|FG001|Phase II|Physician Decision|0|||
105510245|NCT02732119|363876221|FG002|Phase II|Physician Decision|0|||
105510246|NCT02732119|363876222|FG003|Phase II|Physician Decision|8|||
105510247|NCT02732119|363876223|FG004|Phase II|Physician Decision|5|||
105510248|NCT02101060|363876224|FG000|Overall Study|Adverse Event|1|||
105510249|NCT02101060|363876225|FG001|Overall Study|Adverse Event|0|||
105510250|NCT02101060|363876224|FG000|Overall Study|Withdrawal by Subject|1|||
105510251|NCT02101060|363876225|FG001|Overall Study|Withdrawal by Subject|1|||
105510252|NCT02101060|363876224|FG000|Overall Study|Lost to Follow-up|3|||
105510253|NCT02101060|363876225|FG001|Overall Study|Lost to Follow-up|3|||
105510254|NCT00964860|363876226|FG000|Overall Study|Withdrawal by Subject|0|||
105510255|NCT00964860|363876227|FG001|Overall Study|Withdrawal by Subject|1|||
105510256|NCT00407797|363876230|FG000|Overall Study|Lost to Follow-up|2|||
105510257|NCT00407797|363876230|FG000|Overall Study|Adverse Event|6|||
105510258|NCT00407797|363876230|FG000|Overall Study|Other|7|||
105510259|NCT00407797|363876230|FG000|Overall Study|Withdrawal by Subject|3|||
105510260|NCT00553644|363876231|FG000|Overall Study|Adverse Event|17|||
105510261|NCT00553644|363876231|FG000|Overall Study|Withdrawal by Subject|4|||
105510262|NCT00553644|363876231|FG000|Overall Study|Physician Decision|1|||
105510263|NCT00553644|363876231|FG000|Overall Study|Alternative therapy|6|||
105591623|NCT01259102|364167185|FG004|Overall Study|Other|1|||
105510264|NCT01619423|363876232|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
105510265|NCT01619423|363876233|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
105510266|NCT01619423|363876234|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
105510267|NCT01619423|363876235|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
105510268|NCT00420927|363876236|FG000|Period 1|Adverse Event|19|||
105510269|NCT00420927|363876237|FG001|Period 1|Adverse Event|15|||
105510270|NCT00420927|363876238|FG002|Period 1|Adverse Event|0|||
105510271|NCT00420927|363876239|FG003|Period 1|Adverse Event|0|||
105510272|NCT00420927|363876240|FG004|Period 1|Adverse Event|0|||
105510273|NCT00420927|363876241|FG005|Period 1|Adverse Event|0|||
105510274|NCT00420927|363876242|FG006|Period 1|Adverse Event|0|||
105510275|NCT00420927|363876236|FG000|Period 1|Withdrawal by Subject|7|||
105510276|NCT00420927|363876237|FG001|Period 1|Withdrawal by Subject|12|||
105510277|NCT00420927|363876238|FG002|Period 1|Withdrawal by Subject|0|||
105510278|NCT00420927|363876239|FG003|Period 1|Withdrawal by Subject|0|||
105510279|NCT00420927|363876240|FG004|Period 1|Withdrawal by Subject|0|||
105510280|NCT00420927|363876241|FG005|Period 1|Withdrawal by Subject|0|||
105510281|NCT00420927|363876242|FG006|Period 1|Withdrawal by Subject|0|||
105510282|NCT00420927|363876236|FG000|Period 1|Lost to Follow-up|8|||
105510283|NCT00420927|363876237|FG001|Period 1|Lost to Follow-up|6|||
105510284|NCT00420927|363876238|FG002|Period 1|Lost to Follow-up|0|||
105510285|NCT00420927|363876239|FG003|Period 1|Lost to Follow-up|0|||
105510286|NCT00420927|363876240|FG004|Period 1|Lost to Follow-up|0|||
105510287|NCT00420927|363876241|FG005|Period 1|Lost to Follow-up|0|||
105510288|NCT00420927|363876242|FG006|Period 1|Lost to Follow-up|0|||
105510289|NCT00420927|363876236|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
105510290|NCT00420927|363876237|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
105510291|NCT00420927|363876238|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
105510292|NCT00420927|363876239|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
105510293|NCT00420927|363876240|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
105510294|NCT00420927|363876241|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
105510295|NCT00420927|363876242|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
105510296|NCT00420927|363876236|FG000|Period 1|Death|2|||
105510297|NCT00420927|363876237|FG001|Period 1|Death|0|||
105510298|NCT00420927|363876238|FG002|Period 1|Death|0|||
105510299|NCT00420927|363876239|FG003|Period 1|Death|0|||
105510300|NCT00420927|363876240|FG004|Period 1|Death|0|||
105510301|NCT00420927|363876241|FG005|Period 1|Death|0|||
105510302|NCT00420927|363876242|FG006|Period 1|Death|0|||
105510303|NCT00420927|363876236|FG000|Period 1|Subject moved/relocated|0|||
105510304|NCT00420927|363876237|FG001|Period 1|Subject moved/relocated|2|||
105510305|NCT00420927|363876238|FG002|Period 1|Subject moved/relocated|0|||
105510306|NCT00420927|363876239|FG003|Period 1|Subject moved/relocated|0|||
105510307|NCT00420927|363876240|FG004|Period 1|Subject moved/relocated|0|||
105510308|NCT00420927|363876241|FG005|Period 1|Subject moved/relocated|0|||
105510309|NCT00420927|363876242|FG006|Period 1|Subject moved/relocated|0|||
105510310|NCT00420927|363876236|FG000|Period 1|Noncompliant with study drug|1|||
105510311|NCT00420927|363876237|FG001|Period 1|Noncompliant with study drug|1|||
105510312|NCT00420927|363876238|FG002|Period 1|Noncompliant with study drug|0|||
105510313|NCT00420927|363876239|FG003|Period 1|Noncompliant with study drug|0|||
105510314|NCT00420927|363876240|FG004|Period 1|Noncompliant with study drug|0|||
105510315|NCT00420927|363876241|FG005|Period 1|Noncompliant with study drug|0|||
105510316|NCT00420927|363876242|FG006|Period 1|Noncompliant with study drug|0|||
105510317|NCT00420927|363876236|FG000|Period 1|Randomization error|1|||
105510318|NCT00420927|363876237|FG001|Period 1|Randomization error|0|||
105510319|NCT00420927|363876238|FG002|Period 1|Randomization error|0|||
105510320|NCT00420927|363876239|FG003|Period 1|Randomization error|0|||
105510321|NCT00420927|363876240|FG004|Period 1|Randomization error|0|||
105510322|NCT00420927|363876241|FG005|Period 1|Randomization error|0|||
105510323|NCT00420927|363876242|FG006|Period 1|Randomization error|0|||
105510324|NCT00420927|363876236|FG000|Period 1|Suspected tuberculosis/positive test|1|||
105510325|NCT00420927|363876237|FG001|Period 1|Suspected tuberculosis/positive test|1|||
105510326|NCT00420927|363876238|FG002|Period 1|Suspected tuberculosis/positive test|0|||
105510327|NCT00420927|363876239|FG003|Period 1|Suspected tuberculosis/positive test|0|||
105510328|NCT00420927|363876240|FG004|Period 1|Suspected tuberculosis/positive test|0|||
105510329|NCT00420927|363876241|FG005|Period 1|Suspected tuberculosis/positive test|0|||
105510330|NCT00420927|363876242|FG006|Period 1|Suspected tuberculosis/positive test|0|||
105510331|NCT00420927|363876236|FG000|Period 1|Study site closure|0|||
105510332|NCT00420927|363876237|FG001|Period 1|Study site closure|1|||
105510333|NCT00420927|363876238|FG002|Period 1|Study site closure|0|||
105510334|NCT00420927|363876239|FG003|Period 1|Study site closure|0|||
105510335|NCT00420927|363876240|FG004|Period 1|Study site closure|0|||
105510336|NCT00420927|363876241|FG005|Period 1|Study site closure|0|||
105510337|NCT00420927|363876242|FG006|Period 1|Study site closure|0|||
105510338|NCT00420927|363876236|FG000|Period 1|Subject received new diagnosis|0|||
105510339|NCT00420927|363876237|FG001|Period 1|Subject received new diagnosis|2|||
105510340|NCT00420927|363876238|FG002|Period 1|Subject received new diagnosis|0|||
105510341|NCT00420927|363876239|FG003|Period 1|Subject received new diagnosis|0|||
105510342|NCT00420927|363876240|FG004|Period 1|Subject received new diagnosis|0|||
105510343|NCT00420927|363876241|FG005|Period 1|Subject received new diagnosis|0|||
105510344|NCT00420927|363876242|FG006|Period 1|Subject received new diagnosis|0|||
105510345|NCT00420927|363876236|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
105510346|NCT00420927|363876237|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
105510347|NCT00420927|363876238|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
105510348|NCT00420927|363876239|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
105510349|NCT00420927|363876240|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
105510350|NCT00420927|363876241|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
105510351|NCT00420927|363876242|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
105510352|NCT00420927|363876236|FG000|Period 1|Failed to meet entry criteria|8|||
105510353|NCT00420927|363876237|FG001|Period 1|Failed to meet entry criteria|7|||
105510354|NCT00420927|363876238|FG002|Period 1|Failed to meet entry criteria|0|||
105510355|NCT00420927|363876239|FG003|Period 1|Failed to meet entry criteria|0|||
105510356|NCT00420927|363876240|FG004|Period 1|Failed to meet entry criteria|0|||
105510357|NCT00420927|363876241|FG005|Period 1|Failed to meet entry criteria|0|||
105510358|NCT00420927|363876242|FG006|Period 1|Failed to meet entry criteria|0|||
105510359|NCT00420927|363876236|FG000|Period 1|Took prohibited medication|1|||
105510360|NCT00420927|363876237|FG001|Period 1|Took prohibited medication|3|||
105510361|NCT00420927|363876238|FG002|Period 1|Took prohibited medication|0|||
105510362|NCT00420927|363876239|FG003|Period 1|Took prohibited medication|0|||
105510363|NCT00420927|363876240|FG004|Period 1|Took prohibited medication|0|||
105510364|NCT00420927|363876241|FG005|Period 1|Took prohibited medication|0|||
105510365|NCT00420927|363876242|FG006|Period 1|Took prohibited medication|0|||
105510366|NCT00420927|363876236|FG000|Period 2|Adverse Event|0|||
105510367|NCT00420927|363876237|FG001|Period 2|Adverse Event|0|||
105510368|NCT00420927|363876238|FG002|Period 2|Adverse Event|7|||
105510369|NCT00420927|363876239|FG003|Period 2|Adverse Event|3|||
105510370|NCT00420927|363876240|FG004|Period 2|Adverse Event|17|||
105510371|NCT00420927|363876241|FG005|Period 2|Adverse Event|6|||
105510372|NCT00420927|363876242|FG006|Period 2|Adverse Event|20|||
105510373|NCT00420927|363876236|FG000|Period 2|Withdrawal by Subject|0|||
105510374|NCT00420927|363876237|FG001|Period 2|Withdrawal by Subject|0|||
105510375|NCT00420927|363876238|FG002|Period 2|Withdrawal by Subject|1|||
105510376|NCT00420927|363876239|FG003|Period 2|Withdrawal by Subject|3|||
105510377|NCT00420927|363876240|FG004|Period 2|Withdrawal by Subject|11|||
105510378|NCT00420927|363876241|FG005|Period 2|Withdrawal by Subject|2|||
105510379|NCT00420927|363876242|FG006|Period 2|Withdrawal by Subject|12|||
105510380|NCT00420927|363876236|FG000|Period 2|Lost to Follow-up|0|||
105510381|NCT00420927|363876237|FG001|Period 2|Lost to Follow-up|0|||
105510382|NCT00420927|363876238|FG002|Period 2|Lost to Follow-up|2|||
105510383|NCT00420927|363876239|FG003|Period 2|Lost to Follow-up|2|||
105510384|NCT00420927|363876240|FG004|Period 2|Lost to Follow-up|6|||
105510385|NCT00420927|363876241|FG005|Period 2|Lost to Follow-up|3|||
105510386|NCT00420927|363876242|FG006|Period 2|Lost to Follow-up|9|||
105510387|NCT00420927|363876236|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
105510388|NCT00420927|363876237|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
105510389|NCT00420927|363876238|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
105510390|NCT00420927|363876239|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
105510391|NCT00420927|363876240|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
105510392|NCT00420927|363876241|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
105510393|NCT00420927|363876242|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
105510394|NCT00420927|363876236|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
105510395|NCT00420927|363876237|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
105510396|NCT00420927|363876238|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
105510397|NCT00420927|363876239|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
105510398|NCT00420927|363876240|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
105510399|NCT00420927|363876241|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
105510400|NCT00420927|363876242|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
105510401|NCT00420927|363876236|FG000|Period 2|Subject unable to find transportation|0|||
105510402|NCT00420927|363876237|FG001|Period 2|Subject unable to find transportation|0|||
105510403|NCT00420927|363876238|FG002|Period 2|Subject unable to find transportation|0|||
105510404|NCT00420927|363876239|FG003|Period 2|Subject unable to find transportation|0|||
105510405|NCT00420927|363876240|FG004|Period 2|Subject unable to find transportation|0|||
105510406|NCT00420927|363876241|FG005|Period 2|Subject unable to find transportation|0|||
105510407|NCT00420927|363876242|FG006|Period 2|Subject unable to find transportation|1|||
105510408|NCT00420927|363876236|FG000|Period 2|Physician Decision|0|||
105510409|NCT00420927|363876237|FG001|Period 2|Physician Decision|0|||
105510410|NCT00420927|363876238|FG002|Period 2|Physician Decision|0|||
105510411|NCT00420927|363876239|FG003|Period 2|Physician Decision|0|||
105510412|NCT00420927|363876240|FG004|Period 2|Physician Decision|1|||
105510413|NCT00420927|363876241|FG005|Period 2|Physician Decision|1|||
105510414|NCT00420927|363876242|FG006|Period 2|Physician Decision|0|||
105510415|NCT00420927|363876236|FG000|Period 2|Sponsor decision|0|||
105510416|NCT00420927|363876237|FG001|Period 2|Sponsor decision|0|||
105510417|NCT00420927|363876238|FG002|Period 2|Sponsor decision|1|||
105510418|NCT00420927|363876239|FG003|Period 2|Sponsor decision|0|||
105510419|NCT00420927|363876240|FG004|Period 2|Sponsor decision|0|||
105510420|NCT00420927|363876241|FG005|Period 2|Sponsor decision|0|||
105510421|NCT00420927|363876242|FG006|Period 2|Sponsor decision|1|||
105510422|NCT00420927|363876236|FG000|Period 2|Randomization error|0|||
105510423|NCT00420927|363876237|FG001|Period 2|Randomization error|0|||
105510424|NCT00420927|363876238|FG002|Period 2|Randomization error|0|||
105510425|NCT00420927|363876239|FG003|Period 2|Randomization error|0|||
105510426|NCT00420927|363876240|FG004|Period 2|Randomization error|1|||
105510427|NCT00420927|363876241|FG005|Period 2|Randomization error|1|||
105510428|NCT00420927|363876242|FG006|Period 2|Randomization error|0|||
105510429|NCT00420927|363876236|FG000|Period 2|Noncompliant with study drug|0|||
105510430|NCT00420927|363876237|FG001|Period 2|Noncompliant with study drug|0|||
105510431|NCT00420927|363876238|FG002|Period 2|Noncompliant with study drug|0|||
105510432|NCT00420927|363876239|FG003|Period 2|Noncompliant with study drug|1|||
105510433|NCT00420927|363876240|FG004|Period 2|Noncompliant with study drug|0|||
105510434|NCT00420927|363876241|FG005|Period 2|Noncompliant with study drug|0|||
105510435|NCT00420927|363876242|FG006|Period 2|Noncompliant with study drug|2|||
105510436|NCT00420927|363876236|FG000|Period 2|Methotrexate intolerance|0|||
105510437|NCT00420927|363876237|FG001|Period 2|Methotrexate intolerance|0|||
105510438|NCT00420927|363876238|FG002|Period 2|Methotrexate intolerance|0|||
105510439|NCT00420927|363876239|FG003|Period 2|Methotrexate intolerance|0|||
105510440|NCT00420927|363876240|FG004|Period 2|Methotrexate intolerance|0|||
105510441|NCT00420927|363876241|FG005|Period 2|Methotrexate intolerance|0|||
105510442|NCT00420927|363876242|FG006|Period 2|Methotrexate intolerance|1|||
105510443|NCT00420927|363876236|FG000|Period 2|Took prohibited medication|0|||
105510444|NCT00420927|363876237|FG001|Period 2|Took prohibited medication|0|||
105510445|NCT00420927|363876238|FG002|Period 2|Took prohibited medication|0|||
105510446|NCT00420927|363876239|FG003|Period 2|Took prohibited medication|0|||
105510447|NCT00420927|363876240|FG004|Period 2|Took prohibited medication|1|||
105510448|NCT00420927|363876241|FG005|Period 2|Took prohibited medication|0|||
105510449|NCT00420927|363876242|FG006|Period 2|Took prohibited medication|0|||
105510450|NCT03018704|363876243|FG000|Overall Study|Lost to Follow-up|1|||
105510451|NCT03018704|363876244|FG001|Overall Study|Lost to Follow-up|1|||
105510452|NCT00642460|363876245|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
105510453|NCT00642460|363876246|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
105510454|NCT00642460|363876247|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
105510455|NCT00642460|363876248|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
105510456|NCT00642460|363876249|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
105510457|NCT00642460|363876250|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
105510458|NCT00642460|363876245|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
105510459|NCT00642460|363876246|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
105510460|NCT00642460|363876247|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
105510461|NCT00642460|363876248|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
105510462|NCT00642460|363876249|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
105510463|NCT00642460|363876250|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
105510464|NCT00642460|363876245|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
105510465|NCT00642460|363876246|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
105510466|NCT00642460|363876247|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
105510467|NCT00642460|363876248|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
105510468|NCT00642460|363876249|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
105510469|NCT00642460|363876250|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
105510470|NCT00642460|363876245|FG000|Part II: Open-Label Up to Week 92|Death|0|||
105510471|NCT00642460|363876246|FG001|Part II: Open-Label Up to Week 92|Death|1|||
105510472|NCT00642460|363876247|FG002|Part II: Open-Label Up to Week 92|Death|0|||
105510473|NCT00642460|363876248|FG003|Part II: Open-Label Up to Week 92|Death|2|||
105510474|NCT00642460|363876249|FG004|Part II: Open-Label Up to Week 92|Death|0|||
105510475|NCT00642460|363876250|FG005|Part II: Open-Label Up to Week 92|Death|0|||
105510476|NCT00642460|363876245|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
105510477|NCT00642460|363876246|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
105510478|NCT00642460|363876247|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
105510479|NCT00642460|363876248|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
105510480|NCT00642460|363876249|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
105510481|NCT00642460|363876250|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
105510482|NCT00642460|363876245|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
105510483|NCT00642460|363876246|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
105510484|NCT00642460|363876247|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
105510485|NCT00642460|363876248|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
105510486|NCT00642460|363876249|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
105510487|NCT00642460|363876250|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
105510488|NCT00642460|363876245|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
105510489|NCT00642460|363876246|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
105510490|NCT00642460|363876247|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
105510491|NCT00642460|363876248|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
105510492|NCT00642460|363876249|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
105510493|NCT00642460|363876250|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
105510494|NCT00642460|363876245|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
105510495|NCT00642460|363876246|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
105510496|NCT00642460|363876247|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
105510497|NCT00642460|363876248|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
105510498|NCT00642460|363876249|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
105510499|NCT00642460|363876250|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
105510500|NCT00642460|363876245|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
105510501|NCT00642460|363876246|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
105510502|NCT00642460|363876247|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
105510503|NCT00642460|363876248|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
105510504|NCT00642460|363876249|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
105510505|NCT00642460|363876250|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
105510506|NCT00642460|363876245|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
105510507|NCT00642460|363876246|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
105510508|NCT00642460|363876247|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
105510509|NCT00642460|363876248|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
105510510|NCT00642460|363876249|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
105510511|NCT00642460|363876250|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
105510512|NCT00642460|363876245|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
105510513|NCT00642460|363876246|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
105510514|NCT00642460|363876247|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
105510515|NCT00642460|363876248|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
105510516|NCT00642460|363876249|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
105510517|NCT00642460|363876250|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
105510518|NCT00642460|363876245|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
105510519|NCT00642460|363876246|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
105510520|NCT00642460|363876247|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
105510521|NCT00642460|363876248|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
105510522|NCT00642460|363876249|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
105510523|NCT00642460|363876250|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
105510524|NCT00642460|363876245|FG000|Part III: Open-Label Up to Week 260|Other|0|||
105510525|NCT00642460|363876246|FG001|Part III: Open-Label Up to Week 260|Other|0|||
105510526|NCT00642460|363876247|FG002|Part III: Open-Label Up to Week 260|Other|0|||
105510527|NCT00642460|363876248|FG003|Part III: Open-Label Up to Week 260|Other|0|||
105510528|NCT00642460|363876249|FG004|Part III: Open-Label Up to Week 260|Other|2|||
105510529|NCT00642460|363876250|FG005|Part III: Open-Label Up to Week 260|Other|2|||
105510530|NCT00642460|363876245|FG000|Part III: Open-Label Up to Week 260|Death|0|||
105510531|NCT00642460|363876246|FG001|Part III: Open-Label Up to Week 260|Death|0|||
105510532|NCT00642460|363876247|FG002|Part III: Open-Label Up to Week 260|Death|0|||
105510533|NCT00642460|363876248|FG003|Part III: Open-Label Up to Week 260|Death|0|||
105510534|NCT00642460|363876249|FG004|Part III: Open-Label Up to Week 260|Death|0|||
105510535|NCT00642460|363876250|FG005|Part III: Open-Label Up to Week 260|Death|3|||
105510536|NCT00642460|363876245|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
105510537|NCT00642460|363876246|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
105510538|NCT00642460|363876247|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
105510539|NCT00642460|363876248|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
105510540|NCT00642460|363876249|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
105510541|NCT00642460|363876250|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
105510542|NCT00642460|363876245|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
105510543|NCT00642460|363876246|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
105510544|NCT00642460|363876247|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
105510545|NCT00642460|363876248|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
105510546|NCT00642460|363876249|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
105510547|NCT00642460|363876250|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
105510548|NCT02557646|363876253|FG000|Overall Study|Adverse Event|40|||
105510549|NCT02557646|363876253|FG000|Overall Study|Death|1|||
105510550|NCT02557646|363876253|FG000|Overall Study|Lack of Efficacy|186|||
105510551|NCT02557646|363876253|FG000|Overall Study|Withdrawal by Subject|18|||
105510552|NCT02557646|363876253|FG000|Overall Study|Lost to Follow-up|17|||
105510553|NCT02557646|363876253|FG000|Overall Study|Other|14|||
105510554|NCT00518986|363876254|FG000|Overall Study|Adverse Event|12|||
105510555|NCT00518986|363876255|FG001|Overall Study|Adverse Event|7|||
105510556|NCT00518986|363876254|FG000|Overall Study|Lack of Efficacy|0|||
105510557|NCT00518986|363876255|FG001|Overall Study|Lack of Efficacy|2|||
105510558|NCT00518986|363876254|FG000|Overall Study|Lost to Follow-up|3|||
105510559|NCT00518986|363876255|FG001|Overall Study|Lost to Follow-up|2|||
105510560|NCT00518986|363876254|FG000|Overall Study|Physician Decision|0|||
105510561|NCT00518986|363876255|FG001|Overall Study|Physician Decision|3|||
105510562|NCT00518986|363876254|FG000|Overall Study|Protocol Violation|5|||
105510563|NCT00518986|363876255|FG001|Overall Study|Protocol Violation|7|||
105510564|NCT00518986|363876254|FG000|Overall Study|Withdrawal by Subject|4|||
105510565|NCT00518986|363876255|FG001|Overall Study|Withdrawal by Subject|4|||
105510566|NCT00518986|363876254|FG000|Overall Study|Non-Specific|2|||
105510567|NCT00518986|363876255|FG001|Overall Study|Non-Specific|1|||
105510568|NCT02695329|363876256|FG000|Overall Study|Adverse Event|1|||
105510569|NCT02695329|363876257|FG001|Overall Study|Adverse Event|0|||
105510570|NCT02695329|363876256|FG000|Overall Study|Poor X-ray quality for measurement|4|||
105510571|NCT02695329|363876257|FG001|Overall Study|Poor X-ray quality for measurement|5|||
105510572|NCT02615145|363876259|FG000|Overall Study|Did Not Start Treatment|0|||
105510573|NCT02615145|363876260|FG001|Overall Study|Did Not Start Treatment|0|||
105510574|NCT02615145|363876261|FG002|Overall Study|Did Not Start Treatment|1|||
105510575|NCT02615145|363876262|FG003|Overall Study|Did Not Start Treatment|1|||
105510576|NCT02615145|363876259|FG000|Overall Study|Failure to Return|20|||
105510577|NCT02615145|363876260|FG001|Overall Study|Failure to Return|10|||
105510578|NCT02615145|363876261|FG002|Overall Study|Failure to Return|7|||
105510579|NCT02615145|363876262|FG003|Overall Study|Failure to Return|0|||
105510580|NCT02615145|363876259|FG000|Overall Study|Death|2|||
105510581|NCT02615145|363876260|FG001|Overall Study|Death|3|||
105510582|NCT02615145|363876261|FG002|Overall Study|Death|0|||
105510583|NCT02615145|363876262|FG003|Overall Study|Death|0|||
105510584|NCT02615145|363876259|FG000|Overall Study|Other, Not Specified|5|||
105510585|NCT02615145|363876260|FG001|Overall Study|Other, Not Specified|2|||
105510586|NCT02615145|363876261|FG002|Overall Study|Other, Not Specified|0|||
105510587|NCT02615145|363876262|FG003|Overall Study|Other, Not Specified|0|||
105510588|NCT00006237|363876263|FG000|Overall Study|Adverse Event|39|||
105510589|NCT00006237|363876264|FG001|Overall Study|Adverse Event|29|||
105510590|NCT00006237|363876263|FG000|Overall Study|Death|1|||
105510591|NCT00006237|363876264|FG001|Overall Study|Death|0|||
105510592|NCT00006237|363876263|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
105510593|NCT00006237|363876264|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
105510594|NCT00006237|363876263|FG000|Overall Study|Progression/relapse|54|||
105510595|NCT00006237|363876264|FG001|Overall Study|Progression/relapse|2|||
105510596|NCT00006237|363876263|FG000|Overall Study|Not eligible|9|||
105510597|NCT00006237|363876264|FG001|Overall Study|Not eligible|20|||
105510598|NCT00006237|363876263|FG000|Overall Study|Withdrawal by Subject|0|||
105510599|NCT00006237|363876264|FG001|Overall Study|Withdrawal by Subject|1|||
105510600|NCT00006237|363876263|FG000|Overall Study|Not protocol specified|14|||
105510601|NCT00006237|363876264|FG001|Overall Study|Not protocol specified|5|||
105510602|NCT00496054|363876271|FG000|Overall Study|Adverse Event|1|||
105510603|NCT00496054|363876271|FG000|Overall Study|Lost to Follow-up|7|||
105510604|NCT02207244|363876272|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
105510605|NCT02207244|363876273|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
105510606|NCT02207244|363876274|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
105510607|NCT02207244|363876275|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
105510608|NCT02207244|363876276|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
105510609|NCT02207244|363876277|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
105510610|NCT02207244|363876278|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
105510611|NCT02207244|363876279|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
105510612|NCT02207244|363876280|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
105510613|NCT02207244|363876281|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
105510614|NCT02207244|363876282|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
105510615|NCT02207244|363876272|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
105510616|NCT02207244|363876273|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
105510617|NCT02207244|363876274|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
105510618|NCT02207244|363876275|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
105510619|NCT02207244|363876276|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
105510620|NCT02207244|363876277|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
105510621|NCT02207244|363876278|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
105510622|NCT02207244|363876279|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
105510623|NCT02207244|363876280|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
105510624|NCT02207244|363876281|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
105591624|NCT01803646|364167186|FG000|Overall Study|Protocol Violation|1|||
105591625|NCT01803646|364167187|FG001|Overall Study|Protocol Violation|0|||
105591626|NCT01803646|364167186|FG000|Overall Study|Adverse Event|1|||
105510625|NCT02207244|363876282|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
105510626|NCT02207244|363876272|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
105510627|NCT02207244|363876273|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
105591627|NCT01803646|364167187|FG001|Overall Study|Adverse Event|1|||
105591628|NCT01803646|364167186|FG000|Overall Study|Withdrawal by Subject|9|||
105591629|NCT01803646|364167187|FG001|Overall Study|Withdrawal by Subject|6|||
105510628|NCT02207244|363876274|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
105510629|NCT02207244|363876275|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
105510630|NCT02207244|363876276|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
105510631|NCT02207244|363876277|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
105510632|NCT02207244|363876278|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
105510633|NCT02207244|363876279|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
105510634|NCT02207244|363876280|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
105510635|NCT02207244|363876281|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
105510636|NCT02207244|363876282|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
105510637|NCT02207244|363876272|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
105510638|NCT02207244|363876273|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
105510639|NCT02207244|363876274|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
105510640|NCT02207244|363876275|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
105510641|NCT02207244|363876276|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
105510642|NCT02207244|363876277|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
105510643|NCT02207244|363876278|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
105510644|NCT02207244|363876279|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
105510645|NCT02207244|363876280|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
105510646|NCT02207244|363876281|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
105510647|NCT02207244|363876282|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
105510648|NCT02207244|363876272|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
105510649|NCT02207244|363876273|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
105510650|NCT02207244|363876274|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
105510651|NCT02207244|363876275|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
105510652|NCT02207244|363876276|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
105510653|NCT02207244|363876277|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
105510654|NCT02207244|363876278|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
105510655|NCT02207244|363876279|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
105510656|NCT02207244|363876280|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
105510657|NCT02207244|363876281|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
105510658|NCT02207244|363876282|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
105510659|NCT02207244|363876272|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
105510660|NCT02207244|363876273|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
105510661|NCT02207244|363876274|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
105510662|NCT02207244|363876275|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
105510663|NCT02207244|363876276|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
105510664|NCT02207244|363876277|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
105510665|NCT02207244|363876278|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
105510666|NCT02207244|363876279|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
105510667|NCT02207244|363876280|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
105510668|NCT02207244|363876281|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
105510669|NCT02207244|363876282|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
105510670|NCT02207244|363876272|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
105510671|NCT02207244|363876273|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
105510672|NCT02207244|363876274|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
105510673|NCT02207244|363876275|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
105510674|NCT02207244|363876276|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
105510675|NCT02207244|363876277|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
105510676|NCT02207244|363876278|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
105510677|NCT02207244|363876279|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
105510678|NCT02207244|363876280|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
105510679|NCT02207244|363876281|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
105510680|NCT02207244|363876282|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
105510681|NCT02207244|363876272|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
105510682|NCT02207244|363876273|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
105510683|NCT02207244|363876274|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
105510684|NCT02207244|363876275|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
105510685|NCT02207244|363876276|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
105510686|NCT02207244|363876277|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
105510687|NCT02207244|363876278|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
105510688|NCT02207244|363876279|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
105510689|NCT02207244|363876280|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
105510690|NCT02207244|363876281|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
105510691|NCT02207244|363876282|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
105510692|NCT02207244|363876272|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
105591630|NCT01803646|364167186|FG000|Overall Study|Randomization error|1|||
105591631|NCT01803646|364167187|FG001|Overall Study|Randomization error|2|||
105591632|NCT01803646|364167186|FG000|Overall Study|Lost to Follow-up|5|||
105510693|NCT02207244|363876273|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
105510694|NCT02207244|363876274|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
105510695|NCT02207244|363876275|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
105510696|NCT02207244|363876276|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
105510697|NCT02207244|363876277|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
105510698|NCT02207244|363876278|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
105510699|NCT02207244|363876279|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
105510700|NCT02207244|363876280|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
105510701|NCT02207244|363876281|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
105510702|NCT02207244|363876282|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
105510703|NCT02207244|363876272|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
105510704|NCT02207244|363876273|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
105510705|NCT02207244|363876274|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
105510706|NCT02207244|363876275|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
105510707|NCT02207244|363876276|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
105510708|NCT02207244|363876277|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
105510709|NCT02207244|363876278|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
105510710|NCT02207244|363876279|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
105510711|NCT02207244|363876280|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
105510712|NCT02207244|363876281|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
105510713|NCT02207244|363876282|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
105510714|NCT02207244|363876272|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
105510715|NCT02207244|363876273|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
105510716|NCT02207244|363876274|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
105510717|NCT02207244|363876275|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
105510718|NCT02207244|363876276|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
105510719|NCT02207244|363876277|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
105510720|NCT02207244|363876278|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
105510721|NCT02207244|363876279|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
105510722|NCT02207244|363876280|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
105510723|NCT02207244|363876281|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
105510724|NCT02207244|363876282|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
105510725|NCT02207244|363876272|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
105510726|NCT02207244|363876273|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
105510727|NCT02207244|363876274|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
105510728|NCT02207244|363876275|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
105510729|NCT02207244|363876276|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
105510730|NCT02207244|363876277|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
105510731|NCT02207244|363876278|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
105510732|NCT02207244|363876279|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
105510733|NCT02207244|363876280|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
105510734|NCT02207244|363876281|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
105510735|NCT02207244|363876282|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
105510736|NCT02207244|363876272|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
105510737|NCT02207244|363876273|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
105510738|NCT02207244|363876274|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
105510739|NCT02207244|363876275|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
105510740|NCT02207244|363876276|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
105510741|NCT02207244|363876277|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
105510742|NCT02207244|363876278|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
105510743|NCT02207244|363876279|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
105510744|NCT02207244|363876280|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
105510745|NCT02207244|363876281|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
105510746|NCT02207244|363876282|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
105510747|NCT02207244|363876272|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
105510748|NCT02207244|363876273|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
105510749|NCT02207244|363876274|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
105510750|NCT02207244|363876275|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
105510751|NCT02207244|363876276|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
105510752|NCT02207244|363876277|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
105510753|NCT02207244|363876278|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
105510754|NCT02207244|363876279|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
105591633|NCT01803646|364167187|FG001|Overall Study|Lost to Follow-up|1|||
105510755|NCT02207244|363876280|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
105510756|NCT02207244|363876281|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
105510757|NCT02207244|363876282|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
105510758|NCT02207244|363876272|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
105510759|NCT02207244|363876273|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
105510760|NCT02207244|363876274|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
105510761|NCT02207244|363876275|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
105510762|NCT02207244|363876276|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
105510763|NCT02207244|363876277|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
105510764|NCT02207244|363876278|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
105510765|NCT02207244|363876279|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
105510766|NCT02207244|363876280|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
105510767|NCT02207244|363876281|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
105510768|NCT02207244|363876282|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
105510769|NCT02207244|363876272|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
105510770|NCT02207244|363876273|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
105510771|NCT02207244|363876274|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
105510772|NCT02207244|363876275|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
105510773|NCT02207244|363876276|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
105510774|NCT02207244|363876277|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
105510775|NCT02207244|363876278|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
105510776|NCT02207244|363876279|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
105510777|NCT02207244|363876280|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
105510778|NCT02207244|363876281|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
105510779|NCT02207244|363876282|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
105510780|NCT02207244|363876272|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
105510781|NCT02207244|363876273|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
105510782|NCT02207244|363876274|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
105510783|NCT02207244|363876275|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
105510784|NCT02207244|363876276|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
105510785|NCT02207244|363876277|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
105510786|NCT02207244|363876278|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
105510787|NCT02207244|363876279|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
105510788|NCT02207244|363876280|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
105510789|NCT02207244|363876281|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
105510790|NCT02207244|363876282|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
105510791|NCT02207244|363876272|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
105510792|NCT02207244|363876273|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
105510793|NCT02207244|363876274|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
105510794|NCT02207244|363876275|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
105510795|NCT02207244|363876276|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
105510796|NCT02207244|363876277|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
105510797|NCT02207244|363876278|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
105510798|NCT02207244|363876279|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
105510799|NCT02207244|363876280|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
105510800|NCT02207244|363876281|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
105510801|NCT02207244|363876282|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
105510802|NCT02207244|363876272|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
105510803|NCT02207244|363876273|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
105510804|NCT02207244|363876274|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
105510805|NCT02207244|363876275|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
105510806|NCT02207244|363876276|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
105510807|NCT02207244|363876277|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
105510808|NCT02207244|363876278|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
105510809|NCT02207244|363876279|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
105510810|NCT02207244|363876280|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
105510811|NCT02207244|363876281|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
105510812|NCT02207244|363876282|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
105510813|NCT02207244|363876272|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
105510814|NCT02207244|363876273|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
105510815|NCT02207244|363876274|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
105510816|NCT02207244|363876275|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
105510817|NCT02207244|363876276|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
105510818|NCT02207244|363876277|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
105510819|NCT02207244|363876278|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
105510820|NCT02207244|363876279|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
105510821|NCT02207244|363876280|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
105510822|NCT02207244|363876281|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
105510823|NCT02207244|363876282|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
105510824|NCT02207244|363876272|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
105510825|NCT02207244|363876273|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
105510826|NCT02207244|363876274|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
105510827|NCT02207244|363876275|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
105510828|NCT02207244|363876276|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
105510829|NCT02207244|363876277|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
105510830|NCT02207244|363876278|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
105510831|NCT02207244|363876279|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
105510832|NCT02207244|363876280|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
105510833|NCT02207244|363876281|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
105510834|NCT02207244|363876282|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
105510835|NCT02207244|363876272|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
105510836|NCT02207244|363876273|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
105510837|NCT02207244|363876274|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
105510838|NCT02207244|363876275|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
105510839|NCT02207244|363876276|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
105510840|NCT02207244|363876277|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
105510841|NCT02207244|363876278|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
105510842|NCT02207244|363876279|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
105510843|NCT02207244|363876280|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
105510844|NCT02207244|363876281|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
105510845|NCT02207244|363876282|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
105510846|NCT02207244|363876272|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
105510847|NCT02207244|363876273|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
105510848|NCT02207244|363876274|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
105510849|NCT02207244|363876275|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
105510850|NCT02207244|363876276|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
105510851|NCT02207244|363876277|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
105510852|NCT02207244|363876278|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
105510853|NCT02207244|363876279|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
105510854|NCT02207244|363876280|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
105510855|NCT02207244|363876281|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
105510856|NCT02207244|363876282|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
105510857|NCT02207244|363876272|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
105510858|NCT02207244|363876273|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
105510859|NCT02207244|363876274|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
105510860|NCT02207244|363876275|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
105510861|NCT02207244|363876276|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
105510862|NCT02207244|363876277|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
105510863|NCT02207244|363876278|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
105510864|NCT02207244|363876279|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
105510865|NCT02207244|363876280|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
105510866|NCT02207244|363876281|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
105510867|NCT02207244|363876282|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
105510868|NCT02207244|363876272|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
105510869|NCT02207244|363876273|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
105510870|NCT02207244|363876274|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
105510871|NCT02207244|363876275|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
105510872|NCT02207244|363876276|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
105510873|NCT02207244|363876277|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
105510874|NCT02207244|363876278|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
105510875|NCT02207244|363876279|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
105510876|NCT02207244|363876280|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
105510877|NCT02207244|363876281|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
105510878|NCT02207244|363876282|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
105510879|NCT02207244|363876272|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
105510880|NCT02207244|363876273|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
105510881|NCT02207244|363876274|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
105510882|NCT02207244|363876275|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
105510883|NCT02207244|363876276|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
105510884|NCT02207244|363876277|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
105510885|NCT02207244|363876278|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
105510886|NCT02207244|363876279|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
105510887|NCT02207244|363876280|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
105510888|NCT02207244|363876281|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
105510889|NCT02207244|363876282|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
105510890|NCT02207244|363876272|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
105510891|NCT02207244|363876273|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
105510892|NCT02207244|363876274|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
105510893|NCT02207244|363876275|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
105510894|NCT02207244|363876276|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
105510895|NCT02207244|363876277|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
105510896|NCT02207244|363876278|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
105510897|NCT02207244|363876279|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
105510898|NCT02207244|363876280|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
105510899|NCT02207244|363876281|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
105510900|NCT02207244|363876282|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
105510901|NCT02207244|363876272|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
105510902|NCT02207244|363876273|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
105510903|NCT02207244|363876274|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
105510904|NCT02207244|363876275|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
105510905|NCT02207244|363876276|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
105510906|NCT02207244|363876277|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
105510907|NCT02207244|363876278|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
105510908|NCT02207244|363876279|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
105510909|NCT02207244|363876280|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
105510910|NCT02207244|363876281|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
105510911|NCT02207244|363876282|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
105510912|NCT02207244|363876272|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
105510913|NCT02207244|363876273|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
105510914|NCT02207244|363876274|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
105510915|NCT02207244|363876275|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
105510916|NCT02207244|363876276|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
105510917|NCT02207244|363876277|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
105510918|NCT02207244|363876278|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
105510919|NCT02207244|363876279|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
105510920|NCT02207244|363876280|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
105510921|NCT02207244|363876281|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
105510922|NCT02207244|363876282|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
105510923|NCT01866930|363876283|FG000|Treatment Period|Other|1|||
105510924|NCT01866930|363876284|FG001|Treatment Period|Other|0|||
105510925|NCT01866930|363876283|FG000|Treatment Period|Death|0|||
105510926|NCT01866930|363876284|FG001|Treatment Period|Death|2|||
105510927|NCT01866930|363876283|FG000|Treatment Period|Poor/non compliance|0|||
105510928|NCT01866930|363876284|FG001|Treatment Period|Poor/non compliance|2|||
105510929|NCT01866930|363876283|FG000|Treatment Period|No longer meets study criteria|0|||
105510930|NCT01866930|363876284|FG001|Treatment Period|No longer meets study criteria|1|||
105510931|NCT01866930|363876283|FG000|Treatment Period|Withdrawal by Subject|2|||
105510932|NCT01866930|363876284|FG001|Treatment Period|Withdrawal by Subject|8|||
105510933|NCT01866930|363876283|FG000|Treatment Period|Lack of Efficacy|1|||
105510934|NCT01866930|363876284|FG001|Treatment Period|Lack of Efficacy|9|||
105510935|NCT01866930|363876283|FG000|Treatment Period|Adverse Event|4|||
105510936|NCT01866930|363876284|FG001|Treatment Period|Adverse Event|12|||
105510937|NCT01866930|363876283|FG000|Treatment Period|Lost to Follow-up|1|||
105510938|NCT01866930|363876284|FG001|Treatment Period|Lost to Follow-up|1|||
105510939|NCT01866930|363876283|FG000|Follow-up Period|Lost to Follow-up|1|||
105510940|NCT01866930|363876284|FG001|Follow-up Period|Lost to Follow-up|1|||
105510941|NCT01866930|363876283|FG000|Follow-up Period|Other|1|||
105510942|NCT01866930|363876284|FG001|Follow-up Period|Other|5|||
105510943|NCT01866930|363876283|FG000|Follow-up Period|No longer required per protocol|1|||
105510944|NCT01866930|363876284|FG001|Follow-up Period|No longer required per protocol|0|||
105510945|NCT01866930|363876283|FG000|Follow-up Period|Withdrawal by Subject|3|||
105510946|NCT01866930|363876284|FG001|Follow-up Period|Withdrawal by Subject|3|||
105510947|NCT03648983|363876285|FG000|Overall Study|Study was terminated due to PI departure|95|||
105510948|NCT03572062|363876286|FG000|Overall Study|Adverse Event|0|||
105510949|NCT03572062|363876287|FG001|Overall Study|Adverse Event|0|||
105510950|NCT03572062|363876288|FG002|Overall Study|Adverse Event|0|||
105510951|NCT03572062|363876289|FG003|Overall Study|Adverse Event|0|||
105510952|NCT03572062|363876290|FG004|Overall Study|Adverse Event|0|||
105510953|NCT03572062|363876291|FG005|Overall Study|Adverse Event|0|||
105510954|NCT03572062|363876292|FG006|Overall Study|Adverse Event|0|||
105510955|NCT03572062|363876293|FG007|Overall Study|Adverse Event|0|||
105510956|NCT03572062|363876294|FG008|Overall Study|Adverse Event|1|||
105510957|NCT03572062|363876295|FG009|Overall Study|Adverse Event|3|||
105510958|NCT03572062|363876286|FG000|Overall Study|Death|0|||
105510959|NCT03572062|363876287|FG001|Overall Study|Death|0|||
105510960|NCT03572062|363876288|FG002|Overall Study|Death|0|||
105510961|NCT03572062|363876289|FG003|Overall Study|Death|0|||
105510962|NCT03572062|363876290|FG004|Overall Study|Death|0|||
105510963|NCT03572062|363876291|FG005|Overall Study|Death|1|||
105510964|NCT03572062|363876292|FG006|Overall Study|Death|0|||
105510965|NCT03572062|363876293|FG007|Overall Study|Death|0|||
105510966|NCT03572062|363876294|FG008|Overall Study|Death|0|||
105510967|NCT03572062|363876295|FG009|Overall Study|Death|0|||
105510968|NCT03572062|363876286|FG000|Overall Study|Lost to Follow-up|0|||
105510969|NCT03572062|363876287|FG001|Overall Study|Lost to Follow-up|0|||
105510970|NCT03572062|363876288|FG002|Overall Study|Lost to Follow-up|0|||
105510971|NCT03572062|363876289|FG003|Overall Study|Lost to Follow-up|0|||
105510972|NCT03572062|363876290|FG004|Overall Study|Lost to Follow-up|0|||
105510973|NCT03572062|363876291|FG005|Overall Study|Lost to Follow-up|1|||
105510974|NCT03572062|363876292|FG006|Overall Study|Lost to Follow-up|1|||
105510975|NCT03572062|363876293|FG007|Overall Study|Lost to Follow-up|0|||
105510976|NCT03572062|363876294|FG008|Overall Study|Lost to Follow-up|0|||
105510977|NCT03572062|363876295|FG009|Overall Study|Lost to Follow-up|0|||
105510978|NCT03572062|363876286|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
105510979|NCT03572062|363876287|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
105510980|NCT03572062|363876288|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
105510981|NCT03572062|363876289|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
105510982|NCT03572062|363876290|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
105510983|NCT03572062|363876291|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
105510984|NCT03572062|363876292|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
105510985|NCT03572062|363876293|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
105510986|NCT03572062|363876294|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
105510987|NCT03572062|363876295|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
105510988|NCT03572062|363876286|FG000|Overall Study|Study Terminated By Sponsor|0|||
105510989|NCT03572062|363876287|FG001|Overall Study|Study Terminated By Sponsor|0|||
105510990|NCT03572062|363876288|FG002|Overall Study|Study Terminated By Sponsor|0|||
105510991|NCT03572062|363876289|FG003|Overall Study|Study Terminated By Sponsor|0|||
105510992|NCT03572062|363876290|FG004|Overall Study|Study Terminated By Sponsor|0|||
105510993|NCT03572062|363876291|FG005|Overall Study|Study Terminated By Sponsor|0|||
105510994|NCT03572062|363876292|FG006|Overall Study|Study Terminated By Sponsor|0|||
105510995|NCT03572062|363876293|FG007|Overall Study|Study Terminated By Sponsor|0|||
105510996|NCT03572062|363876294|FG008|Overall Study|Study Terminated By Sponsor|29|||
105510997|NCT03572062|363876295|FG009|Overall Study|Study Terminated By Sponsor|27|||
105510998|NCT03572062|363876286|FG000|Overall Study|Physician Decision|0|||
105510999|NCT03572062|363876287|FG001|Overall Study|Physician Decision|0|||
105511000|NCT03572062|363876288|FG002|Overall Study|Physician Decision|0|||
105511001|NCT03572062|363876289|FG003|Overall Study|Physician Decision|0|||
105511002|NCT03572062|363876290|FG004|Overall Study|Physician Decision|0|||
105511003|NCT03572062|363876291|FG005|Overall Study|Physician Decision|0|||
105511004|NCT03572062|363876292|FG006|Overall Study|Physician Decision|0|||
105511005|NCT03572062|363876293|FG007|Overall Study|Physician Decision|0|||
105511006|NCT03572062|363876294|FG008|Overall Study|Physician Decision|1|||
105511007|NCT03572062|363876295|FG009|Overall Study|Physician Decision|0|||
105511008|NCT03572062|363876286|FG000|Overall Study|Withdrawal by Subject|0|||
105511009|NCT03572062|363876287|FG001|Overall Study|Withdrawal by Subject|0|||
105511010|NCT03572062|363876288|FG002|Overall Study|Withdrawal by Subject|0|||
105511011|NCT03572062|363876289|FG003|Overall Study|Withdrawal by Subject|0|||
105511012|NCT03572062|363876290|FG004|Overall Study|Withdrawal by Subject|0|||
105511013|NCT03572062|363876291|FG005|Overall Study|Withdrawal by Subject|0|||
105511014|NCT03572062|363876292|FG006|Overall Study|Withdrawal by Subject|0|||
105511015|NCT03572062|363876293|FG007|Overall Study|Withdrawal by Subject|0|||
105511016|NCT03572062|363876294|FG008|Overall Study|Withdrawal by Subject|0|||
105511017|NCT03572062|363876295|FG009|Overall Study|Withdrawal by Subject|1|||
105511018|NCT03572062|363876286|FG000|Overall Study|Randomized But Not Treated|0|||
105511019|NCT03572062|363876287|FG001|Overall Study|Randomized But Not Treated|0|||
105511020|NCT03572062|363876288|FG002|Overall Study|Randomized But Not Treated|0|||
105511021|NCT03572062|363876289|FG003|Overall Study|Randomized But Not Treated|0|||
105511022|NCT03572062|363876290|FG004|Overall Study|Randomized But Not Treated|1|||
105511023|NCT03572062|363876291|FG005|Overall Study|Randomized But Not Treated|2|||
105511024|NCT03572062|363876292|FG006|Overall Study|Randomized But Not Treated|0|||
105511025|NCT03572062|363876293|FG007|Overall Study|Randomized But Not Treated|1|||
105511026|NCT03572062|363876294|FG008|Overall Study|Randomized But Not Treated|0|||
105511027|NCT03572062|363876295|FG009|Overall Study|Randomized But Not Treated|0|||
105511028|NCT01269463|363876296|FG000|First Intervention|Withdrawal by Subject|1|||
105511029|NCT01269463|363876297|FG001|First Intervention|Withdrawal by Subject|0|||
105511030|NCT01269463|363876296|FG000|First Intervention|Adverse Event|1|||
105511031|NCT01269463|363876297|FG001|First Intervention|Adverse Event|0|||
105511032|NCT01269463|363876296|FG000|First Intervention|Lack of Efficacy|0|||
105511033|NCT01269463|363876297|FG001|First Intervention|Lack of Efficacy|1|||
105511034|NCT01269463|363876296|FG000|First Intervention|Physician Decision|0|||
105511035|NCT01269463|363876297|FG001|First Intervention|Physician Decision|1|||
105511036|NCT04051008|363876298|FG000|Overall Study|Withdrawal by Subject|2|||
105591634|NCT01956669|364167189|FG000|Overall Study|Disease Progression|12|||
105591635|NCT01956669|364167190|FG001|Overall Study|Disease Progression|7|||
105591636|NCT01956669|364167191|FG002|Overall Study|Disease Progression|7|||
105591637|NCT01956669|364167192|FG003|Overall Study|Disease Progression|8|||
105591638|NCT01956669|364167193|FG004|Overall Study|Disease Progression|4|||
105591639|NCT01956669|364167194|FG005|Overall Study|Disease Progression|3|||
105591640|NCT01956669|364167195|FG006|Overall Study|Disease Progression|5|||
105591641|NCT01956669|364167189|FG000|Overall Study|Adverse Event|0|||
105591642|NCT01956669|364167190|FG001|Overall Study|Adverse Event|2|||
105591643|NCT01956669|364167191|FG002|Overall Study|Adverse Event|2|||
105591644|NCT01956669|364167192|FG003|Overall Study|Adverse Event|1|||
105591645|NCT01956669|364167193|FG004|Overall Study|Adverse Event|0|||
105591646|NCT01956669|364167194|FG005|Overall Study|Adverse Event|0|||
105591647|NCT01956669|364167195|FG006|Overall Study|Adverse Event|0|||
105591648|NCT01956669|364167189|FG000|Overall Study|Physician Decision|0|||
105591649|NCT01956669|364167190|FG001|Overall Study|Physician Decision|2|||
105591650|NCT01956669|364167191|FG002|Overall Study|Physician Decision|0|||
105591651|NCT01956669|364167192|FG003|Overall Study|Physician Decision|0|||
105591652|NCT01956669|364167193|FG004|Overall Study|Physician Decision|0|||
105591653|NCT01956669|364167194|FG005|Overall Study|Physician Decision|1|||
105591654|NCT01956669|364167195|FG006|Overall Study|Physician Decision|0|||
105591655|NCT01956669|364167189|FG000|Overall Study|Withdrawal by Subject|0|||
105591656|NCT01956669|364167190|FG001|Overall Study|Withdrawal by Subject|0|||
105591657|NCT01956669|364167191|FG002|Overall Study|Withdrawal by Subject|1|||
105511037|NCT04051008|363876299|FG001|Overall Study|Withdrawal by Subject|0|||
105511038|NCT04051008|363876300|FG002|Overall Study|Withdrawal by Subject|1|||
105511039|NCT00458211|363876301|FG000|Overall Study|Lack of Efficacy|12|||
105511040|NCT00458211|363876301|FG000|Overall Study|Withdrawal by Subject|2|||
105511041|NCT00458211|363876301|FG000|Overall Study|Protocol Violation|2|||
105511042|NCT04342897|363876302|FG000|Overall Study|Death|7|||
105511043|NCT04342897|363876303|FG001|Overall Study|Death|4|||
105511044|NCT04342897|363876302|FG000|Overall Study|Lost to Follow-up|6|||
105511045|NCT04342897|363876303|FG001|Overall Study|Lost to Follow-up|6|||
105511046|NCT04342897|363876302|FG000|Overall Study|Withdrawal by Subject|1|||
105511047|NCT04342897|363876303|FG001|Overall Study|Withdrawal by Subject|2|||
105511048|NCT00838578|363876304|FG000|Overall Study|Protocol Violation|2|||
105511049|NCT02142959|363876305|FG000|Overall Study|Adverse Event|1|||
105511050|NCT02142959|363876306|FG001|Overall Study|Adverse Event|0|||
105511051|NCT02142959|363876307|FG002|Overall Study|Adverse Event|0|||
105511052|NCT02142959|363876305|FG000|Overall Study|Death|0|||
105511053|NCT02142959|363876306|FG001|Overall Study|Death|1|||
105511054|NCT02142959|363876307|FG002|Overall Study|Death|0|||
105511055|NCT02142959|363876305|FG000|Overall Study|Withdrawal by Subject|3|||
105511056|NCT02142959|363876306|FG001|Overall Study|Withdrawal by Subject|1|||
105511057|NCT02142959|363876307|FG002|Overall Study|Withdrawal by Subject|3|||
105511058|NCT02142959|363876305|FG000|Overall Study|Administrative Reasons|1|||
105511059|NCT02142959|363876306|FG001|Overall Study|Administrative Reasons|0|||
105511060|NCT02142959|363876307|FG002|Overall Study|Administrative Reasons|1|||
105511061|NCT02142959|363876305|FG000|Overall Study|Missing|0|||
105511062|NCT02142959|363876306|FG001|Overall Study|Missing|1|||
105511063|NCT02142959|363876307|FG002|Overall Study|Missing|0|||
105511064|NCT02142959|363876305|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
105511065|NCT02142959|363876306|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
105511066|NCT02142959|363876307|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
105511067|NCT02142959|363876305|FG000|Overall Study|Patient didn't complete end of study visit|0|||
105511068|NCT02142959|363876306|FG001|Overall Study|Patient didn't complete end of study visit|0|||
105511069|NCT02142959|363876307|FG002|Overall Study|Patient didn't complete end of study visit|1|||
105511070|NCT03667924|363876308|FG000|Baseline Completed|Lost to Follow-up|0|||
105511071|NCT03667924|363876309|FG001|Baseline Completed|Lost to Follow-up|2|||
105511072|NCT03667924|363876310|FG002|Baseline Completed|Lost to Follow-up|0|||
105511073|NCT03667924|363876308|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
105591658|NCT01956669|364167192|FG003|Overall Study|Withdrawal by Subject|1|||
105591659|NCT01956669|364167193|FG004|Overall Study|Withdrawal by Subject|0|||
105591660|NCT01956669|364167194|FG005|Overall Study|Withdrawal by Subject|0|||
105511074|NCT03667924|363876309|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
105511075|NCT03667924|363876310|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
105591661|NCT01956669|364167195|FG006|Overall Study|Withdrawal by Subject|1|||
105591662|NCT01570751|364167196|FG000|Period A (16 Weeks)|Protocol Violation|1|||
105591663|NCT01570751|364167197|FG001|Period A (16 Weeks)|Protocol Violation|1|||
105591664|NCT01570751|364167196|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
105591665|NCT01570751|364167197|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
105591666|NCT01570751|364167196|FG000|Period A (16 Weeks)|Unclassified|2|||
105511076|NCT03667924|363876308|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
105591667|NCT01570751|364167197|FG001|Period A (16 Weeks)|Unclassified|3|||
105591668|NCT01570751|364167196|FG000|Period B (16 Weeks)|Adverse Event|1|||
105511077|NCT03667924|363876309|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
105511078|NCT03667924|363876310|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
105511079|NCT03667924|363876308|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
105511080|NCT03667924|363876309|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
105511081|NCT03667924|363876310|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
105511082|NCT03667924|363876308|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
105511083|NCT03667924|363876309|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
105511084|NCT03667924|363876310|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
105511085|NCT03667924|363876308|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
105511086|NCT03667924|363876309|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
105511087|NCT03667924|363876310|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
105511088|NCT03667924|363876308|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
105511089|NCT03667924|363876309|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
105511090|NCT03667924|363876310|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
105511091|NCT03031678|363876311|FG000|Overall Study|Study closed prior to completion|1|||
105511092|NCT00439244|363876312|FG000|Overall Study|Adverse Event|5|||
105511093|NCT00439244|363876313|FG001|Overall Study|Adverse Event|2|||
105511094|NCT00439244|363876314|FG002|Overall Study|Adverse Event|3|||
105511095|NCT00439244|363876312|FG000|Overall Study|Withdrawal by Subject|3|||
105511096|NCT00439244|363876313|FG001|Overall Study|Withdrawal by Subject|1|||
105511097|NCT00439244|363876314|FG002|Overall Study|Withdrawal by Subject|2|||
105511098|NCT00439244|363876312|FG000|Overall Study|Lost to Follow-up|2|||
105511099|NCT00439244|363876313|FG001|Overall Study|Lost to Follow-up|1|||
105511100|NCT00439244|363876314|FG002|Overall Study|Lost to Follow-up|2|||
105511101|NCT00439244|363876312|FG000|Overall Study|Death|0|||
105511102|NCT00439244|363876313|FG001|Overall Study|Death|1|||
105511103|NCT00439244|363876314|FG002|Overall Study|Death|0|||
105511104|NCT00439244|363876312|FG000|Overall Study|Protocol Violation|0|||
105511105|NCT00439244|363876313|FG001|Overall Study|Protocol Violation|1|||
105511106|NCT00439244|363876314|FG002|Overall Study|Protocol Violation|0|||
105511107|NCT00439244|363876312|FG000|Overall Study|Administrative problems|1|||
105511108|NCT00439244|363876313|FG001|Overall Study|Administrative problems|0|||
105511109|NCT00439244|363876314|FG002|Overall Study|Administrative problems|0|||
105511110|NCT03918447|363876317|FG000|Overall Study|Death|1|||
105511111|NCT03918447|363876318|FG001|Overall Study|Death|0|||
105511112|NCT03918447|363876317|FG000|Overall Study|Lost to Follow-up|13|||
105511113|NCT03918447|363876318|FG001|Overall Study|Lost to Follow-up|6|||
105511114|NCT03918447|363876317|FG000|Overall Study|Withdrawal by Subject|19|||
105511115|NCT03918447|363876318|FG001|Overall Study|Withdrawal by Subject|17|||
105511116|NCT03918447|363876317|FG000|Overall Study|Study Terminated by Sponsor|195|||
105511117|NCT03918447|363876318|FG001|Overall Study|Study Terminated by Sponsor|197|||
105511118|NCT03918447|363876317|FG000|Overall Study|Reason not Specified|0|||
105511119|NCT03918447|363876318|FG001|Overall Study|Reason not Specified|1|||
105511120|NCT03278613|363876319|FG000|Overall Study|Lost to Follow-up|3|||
105511121|NCT03278613|363876320|FG001|Overall Study|Lost to Follow-up|1|||
105511122|NCT00540514|363877711|FG000|Overall Study|Still on treatment|3|||
105511123|NCT00540514|363877712|FG001|Overall Study|Still on treatment|0|||
105511124|NCT00540514|363877711|FG000|Overall Study|Unacceptable Toxicity|61|||
105511125|NCT00540514|363877712|FG001|Overall Study|Unacceptable Toxicity|62|||
105511126|NCT00540514|363877711|FG000|Overall Study|Adverse Event|20|||
105511127|NCT00540514|363877712|FG001|Overall Study|Adverse Event|24|||
105511128|NCT00540514|363877711|FG000|Overall Study|Physician Decision|86|||
105511129|NCT00540514|363877712|FG001|Overall Study|Physician Decision|99|||
105511130|NCT00540514|363877711|FG000|Overall Study|Protocol Deviation|3|||
105511131|NCT00540514|363877712|FG001|Overall Study|Protocol Deviation|4|||
105511132|NCT00540514|363877711|FG000|Overall Study|Lost to Follow-up|1|||
105511133|NCT00540514|363877712|FG001|Overall Study|Lost to Follow-up|1|||
105511134|NCT00540514|363877711|FG000|Overall Study|Withdrawal by Subject|65|||
105511135|NCT00540514|363877712|FG001|Overall Study|Withdrawal by Subject|67|||
105511136|NCT00540514|363877711|FG000|Overall Study|Excluded prior to treatment|7|||
105511137|NCT00540514|363877712|FG001|Overall Study|Excluded prior to treatment|7|||
105511138|NCT00540514|363877711|FG000|Overall Study|Paclitaxel not available|0|||
105511139|NCT00540514|363877712|FG001|Overall Study|Paclitaxel not available|2|||
105511140|NCT02501473|363877715|FG000|Overall Study|Study Terminated|2|||
105511141|NCT02501473|363877716|FG001|Overall Study|Study Terminated|3|||
105511142|NCT02501473|363877717|FG002|Overall Study|Study Terminated|7|||
105511143|NCT02501473|363877718|FG003|Overall Study|Study Terminated|9|||
105511144|NCT02501473|363877719|FG004|Overall Study|Study Terminated|2|||
105511145|NCT02501473|363877720|FG005|Overall Study|Study Terminated|10|||
105511146|NCT02501473|363877721|FG006|Overall Study|Study Terminated|1|||
105511147|NCT02501473|363877722|FG007|Overall Study|Study Terminated|0|||
105511148|NCT02501473|363877715|FG000|Overall Study|Withdrawal by Subject|0|||
105511149|NCT02501473|363877716|FG001|Overall Study|Withdrawal by Subject|0|||
105511150|NCT02501473|363877717|FG002|Overall Study|Withdrawal by Subject|3|||
105511151|NCT02501473|363877718|FG003|Overall Study|Withdrawal by Subject|3|||
105511152|NCT02501473|363877719|FG004|Overall Study|Withdrawal by Subject|2|||
105511153|NCT02501473|363877720|FG005|Overall Study|Withdrawal by Subject|2|||
105511154|NCT02501473|363877721|FG006|Overall Study|Withdrawal by Subject|0|||
105511155|NCT02501473|363877722|FG007|Overall Study|Withdrawal by Subject|0|||
105511156|NCT02501473|363877715|FG000|Overall Study|Death|0|||
105511157|NCT02501473|363877716|FG001|Overall Study|Death|0|||
105511158|NCT02501473|363877717|FG002|Overall Study|Death|1|||
105511159|NCT02501473|363877718|FG003|Overall Study|Death|1|||
105511160|NCT02501473|363877719|FG004|Overall Study|Death|0|||
105511161|NCT02501473|363877720|FG005|Overall Study|Death|1|||
105511162|NCT02501473|363877721|FG006|Overall Study|Death|0|||
105511163|NCT02501473|363877722|FG007|Overall Study|Death|0|||
105511164|NCT02501473|363877715|FG000|Overall Study|Lost to Follow-up|1|||
105511165|NCT02501473|363877716|FG001|Overall Study|Lost to Follow-up|0|||
105511166|NCT02501473|363877717|FG002|Overall Study|Lost to Follow-up|1|||
105511167|NCT02501473|363877718|FG003|Overall Study|Lost to Follow-up|0|||
105511168|NCT02501473|363877719|FG004|Overall Study|Lost to Follow-up|0|||
105511169|NCT02501473|363877720|FG005|Overall Study|Lost to Follow-up|1|||
105511170|NCT02501473|363877721|FG006|Overall Study|Lost to Follow-up|0|||
105511171|NCT02501473|363877722|FG007|Overall Study|Lost to Follow-up|0|||
105511172|NCT02501473|363877715|FG000|Overall Study|Reason not specified|0|||
105511173|NCT02501473|363877716|FG001|Overall Study|Reason not specified|0|||
105511174|NCT02501473|363877717|FG002|Overall Study|Reason not specified|1|||
105511175|NCT02501473|363877718|FG003|Overall Study|Reason not specified|1|||
105511176|NCT02501473|363877719|FG004|Overall Study|Reason not specified|0|||
105511177|NCT02501473|363877720|FG005|Overall Study|Reason not specified|0|||
105511178|NCT02501473|363877721|FG006|Overall Study|Reason not specified|0|||
105511179|NCT02501473|363877722|FG007|Overall Study|Reason not specified|0|||
105511180|NCT03364023|363877724|FG000|Overall Study|Lost to Follow-up|3|||
105511181|NCT03364023|363877724|FG000|Overall Study|Death|14|||
105511182|NCT02891850|363877725|FG000|Overall Study|Adverse Event|3|||
105511183|NCT02891850|363877726|FG001|Overall Study|Adverse Event|0|||
105511184|NCT02891850|363877725|FG000|Overall Study|Death|0|||
105511185|NCT02891850|363877726|FG001|Overall Study|Death|4|||
105511186|NCT02891850|363877725|FG000|Overall Study|Physician Decision|1|||
105511187|NCT02891850|363877726|FG001|Overall Study|Physician Decision|0|||
105511188|NCT02891850|363877725|FG000|Overall Study|Pregnancy|1|||
105511189|NCT02891850|363877726|FG001|Overall Study|Pregnancy|0|||
105511190|NCT02891850|363877725|FG000|Overall Study|Withdrawal by Subject|2|||
105511191|NCT02891850|363877726|FG001|Overall Study|Withdrawal by Subject|3|||
105511192|NCT02674529|363877727|FG000|Overall Study|Lost to Follow-up|1|||
105511193|NCT02674529|363877728|FG001|Overall Study|Lost to Follow-up|2|||
105511194|NCT02674529|363877727|FG000|Overall Study|Withdrawal by Subject|2|||
105511195|NCT02674529|363877728|FG001|Overall Study|Withdrawal by Subject|1|||
105511196|NCT02674529|363877727|FG000|Overall Study|Physician Decision|0|||
105511197|NCT02674529|363877728|FG001|Overall Study|Physician Decision|1|||
105511198|NCT02674529|363877727|FG000|Overall Study|Protocol Violation|0|||
105511199|NCT02674529|363877728|FG001|Overall Study|Protocol Violation|1|||
105511200|NCT03602482|363877733|FG000|Overall Study|Withdrawal by Subject|6|||
105511201|NCT03602482|363877734|FG001|Overall Study|Withdrawal by Subject|7|||
105511202|NCT03602482|363877735|FG002|Overall Study|Withdrawal by Subject|0|||
105511203|NCT03602482|363877736|FG003|Overall Study|Withdrawal by Subject|0|||
105511204|NCT03098550|363877741|FG000|Overall Study|Disease Progression|30|||
105511205|NCT03098550|363877742|FG001|Overall Study|Disease Progression|19|||
105511206|NCT03098550|363877743|FG002|Overall Study|Disease Progression|41|||
105511207|NCT03098550|363877741|FG000|Overall Study|Study Drug Toxicity|2|||
105511208|NCT03098550|363877742|FG001|Overall Study|Study Drug Toxicity|1|||
105511209|NCT03098550|363877743|FG002|Overall Study|Study Drug Toxicity|0|||
105511210|NCT03098550|363877741|FG000|Overall Study|Death|1|||
105511211|NCT03098550|363877742|FG001|Overall Study|Death|0|||
105511212|NCT03098550|363877743|FG002|Overall Study|Death|0|||
105511213|NCT03098550|363877741|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
105511214|NCT03098550|363877742|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
105511215|NCT03098550|363877743|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
105511216|NCT03098550|363877741|FG000|Overall Study|Administrative reason by sponsor|0|||
105511217|NCT03098550|363877742|FG001|Overall Study|Administrative reason by sponsor|0|||
105511218|NCT03098550|363877743|FG002|Overall Study|Administrative reason by sponsor|1|||
105511219|NCT03098550|363877741|FG000|Overall Study|Other reasons|2|||
105511220|NCT03098550|363877742|FG001|Overall Study|Other reasons|0|||
105511221|NCT03098550|363877743|FG002|Overall Study|Other reasons|0|||
105511222|NCT01315678|363877757|FG000|Overall Study|Withdrawal by Subject|7|||
105511223|NCT01315678|363877758|FG001|Overall Study|Withdrawal by Subject|3|||
105511224|NCT01315678|363877757|FG000|Overall Study|Adverse Event|3|||
105511225|NCT01315678|363877758|FG001|Overall Study|Adverse Event|1|||
105511226|NCT01315678|363877757|FG000|Overall Study|Lost to Follow-up|1|||
105511227|NCT01315678|363877758|FG001|Overall Study|Lost to Follow-up|0|||
105511228|NCT01315678|363877757|FG000|Overall Study|similar reason to those listed above|3|||
105511229|NCT01315678|363877758|FG001|Overall Study|similar reason to those listed above|2|||
105511230|NCT00331682|363877765|FG000|Overall Study|Adverse Event|1|||
105511231|NCT00617123|363877768|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
105511232|NCT00617123|363877769|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
105511233|NCT00617123|363877768|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
105511234|NCT00617123|363877769|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
105511235|NCT00617123|363877768|FG000|Referral Screening Period|Adverse Event|0|||
105511236|NCT00617123|363877769|FG001|Referral Screening Period|Adverse Event|1|||
105511237|NCT00617123|363877768|FG000|Study Treatment Period|Withdrawal by Subject|8|||
105511238|NCT00617123|363877769|FG001|Study Treatment Period|Withdrawal by Subject|12|||
105511239|NCT00617123|363877768|FG000|Study Treatment Period|Adverse Event|7|||
105511240|NCT00617123|363877769|FG001|Study Treatment Period|Adverse Event|3|||
105511241|NCT00617123|363877768|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
105511242|NCT00617123|363877769|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
105511243|NCT00617123|363877768|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
105511244|NCT00617123|363877769|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
105511245|NCT05131646|363877772|FG000|Overall Study|Withdrawal by Subject|1|||
105511246|NCT05131646|363877773|FG001|Overall Study|Withdrawal by Subject|0|||
105511247|NCT05131646|363877774|FG002|Overall Study|Withdrawal by Subject|0|||
105511248|NCT03266107|363877775|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
105511249|NCT03266107|363877775|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
105511250|NCT03266107|363877775|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
105511251|NCT03266107|363877775|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
105511252|NCT00171730|363877779|FG000|Overall Study|Adverse Event|3|||
105511253|NCT00171730|363877779|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
105511254|NCT00171730|363877779|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
105511255|NCT00171730|363877779|FG000|Overall Study|Withdrawal by Subject|3|||
105511256|NCT01366209|363877780|FG000|Overall Study|Adverse Event|6|||
105511257|NCT01366209|363877781|FG001|Overall Study|Adverse Event|7|||
105511258|NCT01366209|363877780|FG000|Overall Study|Withdrawal by Subject|4|||
105511259|NCT01366209|363877781|FG001|Overall Study|Withdrawal by Subject|4|||
105511260|NCT01366209|363877780|FG000|Overall Study|Death|12|||
105511261|NCT01366209|363877781|FG001|Overall Study|Death|19|||
105511262|NCT01366209|363877780|FG000|Overall Study|Lung transplantation|6|||
105511263|NCT01366209|363877781|FG001|Overall Study|Lung transplantation|1|||
105511264|NCT01366209|363877780|FG000|Overall Study|Lost to Follow-up|2|||
105511265|NCT01366209|363877781|FG001|Overall Study|Lost to Follow-up|1|||
105511266|NCT01366209|363877780|FG000|Overall Study|Physician Decision|1|||
105511267|NCT01366209|363877781|FG001|Overall Study|Physician Decision|0|||
105511268|NCT01366209|363877780|FG000|Overall Study|Sponsors decision|0|||
105511269|NCT01366209|363877781|FG001|Overall Study|Sponsors decision|1|||
105511270|NCT01366209|363877780|FG000|Overall Study|Withdrew consent|4|||
105511271|NCT01366209|363877781|FG001|Overall Study|Withdrew consent|3|||
105511272|NCT02670837|363877782|FG000|Overall Study|Death|2|||
105511273|NCT02670837|363877783|FG001|Overall Study|Death|0|||
105511274|NCT02670837|363877784|FG002|Overall Study|Death|0|||
105511275|NCT01985867|363877785|FG000|Overall Study|Lost to Follow-up|3|||
105511276|NCT01985867|363877786|FG001|Overall Study|Lost to Follow-up|4|||
105511277|NCT01985867|363877785|FG000|Overall Study|Adverse Event|3|||
105511278|NCT01985867|363877786|FG001|Overall Study|Adverse Event|2|||
105511279|NCT01985867|363877785|FG000|Overall Study|Lack of Efficacy|1|||
105511280|NCT01985867|363877786|FG001|Overall Study|Lack of Efficacy|0|||
105511281|NCT01053221|363877787|FG000|Overall Study|The study was closed prematurely|5|||
105511282|NCT01053221|363877788|FG001|Overall Study|The study was closed prematurely|9|||
105511283|NCT02266225|363877789|FG000|Overall Study|Lost to Follow-up|2|||
105511284|NCT02266225|363877789|FG000|Overall Study|Death|1|||
105511285|NCT02266225|363877789|FG000|Overall Study|Withdrawal by Subject|13|||
105511286|NCT01465997|363877792|FG000|Overall Study|Adverse Event|12|||
105511287|NCT01465997|363877793|FG001|Overall Study|Adverse Event|22|||
105511288|NCT01465997|363877792|FG000|Overall Study|Lack of Efficacy|13|||
105511289|NCT01465997|363877793|FG001|Overall Study|Lack of Efficacy|1|||
105591669|NCT01570751|364167197|FG001|Period B (16 Weeks)|Adverse Event|0|||
105591670|NCT01570751|364167196|FG000|Period B (16 Weeks)|Protocol Violation|0|||
105591671|NCT01570751|364167197|FG001|Period B (16 Weeks)|Protocol Violation|1|||
105591672|NCT01072357|364167198|FG000|Overall Study|Lost to Follow-up|0|||
105591673|NCT01072357|364167199|FG001|Overall Study|Lost to Follow-up|1|||
105591674|NCT02131324|364167200|FG000|Overall Study|Withdrawal by Subject|1|||
105591675|NCT02131324|364167201|FG001|Overall Study|Withdrawal by Subject|2|||
105591676|NCT02131324|364167200|FG000|Overall Study|Lost to Follow-up|1|||
105591677|NCT02131324|364167201|FG001|Overall Study|Lost to Follow-up|1|||
105591678|NCT00891618|364167202|FG000|Overall Study|Withdrawal by Subject|1|||
105591679|NCT01693614|364167203|FG000|Overall Study|Adverse Event|7|||
105591680|NCT01693614|364167204|FG001|Overall Study|Adverse Event|11|||
105591681|NCT01693614|364167205|FG002|Overall Study|Adverse Event|5|||
105591682|NCT01693614|364167203|FG000|Overall Study|Disease progression|11|||
105591683|NCT01693614|364167204|FG001|Overall Study|Disease progression|8|||
105591684|NCT01693614|364167205|FG002|Overall Study|Disease progression|7|||
105591685|NCT01693614|364167203|FG000|Overall Study|Protocol Violation|5|||
105591686|NCT01693614|364167204|FG001|Overall Study|Protocol Violation|2|||
105591687|NCT01693614|364167205|FG002|Overall Study|Protocol Violation|1|||
105591688|NCT01693614|364167203|FG000|Overall Study|Death|1|||
105591689|NCT01693614|364167204|FG001|Overall Study|Death|0|||
105591690|NCT01693614|364167205|FG002|Overall Study|Death|0|||
105591691|NCT01693614|364167203|FG000|Overall Study|Physician Decision|1|||
105591692|NCT01693614|364167204|FG001|Overall Study|Physician Decision|1|||
105591693|NCT01693614|364167205|FG002|Overall Study|Physician Decision|4|||
105591694|NCT01693614|364167203|FG000|Overall Study|Withdrawal by subject/guardian|0|||
105591695|NCT01693614|364167204|FG001|Overall Study|Withdrawal by subject/guardian|0|||
105591696|NCT01693614|364167205|FG002|Overall Study|Withdrawal by subject/guardian|2|||
105591697|NCT01693614|364167203|FG000|Overall Study|Withdrawal by Subject|1|||
105591698|NCT01693614|364167204|FG001|Overall Study|Withdrawal by Subject|0|||
105591699|NCT01693614|364167205|FG002|Overall Study|Withdrawal by Subject|5|||
105591700|NCT02614560|364167211|FG000|Overall Study|Death|6|||
105591701|NCT02614560|364167212|FG001|Overall Study|Death|2|||
105591702|NCT00868192|364167214|FG000|Overall Study|Ineligible|4|||
105591703|NCT01695317|364167215|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
105591704|NCT01695317|364167216|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
105591705|NCT01695317|364167215|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
105591706|NCT01695317|364167216|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
105591707|NCT00798096|364167218|FG000|Overall Study|Ongoing|2|||
105591708|NCT00927823|364167219|FG000|Continuous Dosing Period|Death|0|||
105591709|NCT00927823|364167220|FG001|Continuous Dosing Period|Death|0|||
105591710|NCT00927823|364167221|FG002|Continuous Dosing Period|Death|6|||
105591711|NCT00927823|364167222|FG003|Continuous Dosing Period|Death|0|||
105591712|NCT00927823|364167219|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
105511290|NCT01465997|363877792|FG000|Overall Study|Protocol Violation|1|||
105511291|NCT01465997|363877793|FG001|Overall Study|Protocol Violation|4|||
105511292|NCT01465997|363877792|FG000|Overall Study|Lost to Follow-up|6|||
105511293|NCT01465997|363877793|FG001|Overall Study|Lost to Follow-up|9|||
105511294|NCT01465997|363877792|FG000|Overall Study|Withdrawal by Subject|32|||
105511295|NCT01465997|363877793|FG001|Overall Study|Withdrawal by Subject|35|||
105511296|NCT01465997|363877792|FG000|Overall Study|investigator's decision|1|||
105591713|NCT00927823|364167220|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
105591714|NCT00927823|364167221|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
105591715|NCT00927823|364167222|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
105591716|NCT00927823|364167219|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
105591717|NCT00927823|364167220|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
105591718|NCT00927823|364167221|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
105511297|NCT01465997|363877793|FG001|Overall Study|investigator's decision|1|||
105511298|NCT01465997|363877792|FG000|Overall Study|Death|0|||
105511299|NCT01465997|363877793|FG001|Overall Study|Death|1|||
105511300|NCT01465997|363877792|FG000|Overall Study|sponsor's decision|1|||
105511301|NCT01465997|363877793|FG001|Overall Study|sponsor's decision|1|||
105591719|NCT00927823|364167222|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
105591720|NCT00927823|364167219|FG000|Continuous Dosing Period|Other|1|||
105591721|NCT00927823|364167220|FG001|Continuous Dosing Period|Other|2|||
105591722|NCT00927823|364167221|FG002|Continuous Dosing Period|Other|9|||
105591723|NCT00927823|364167222|FG003|Continuous Dosing Period|Other|3|||
105591724|NCT03670602|364167227|FG000|Overall Study|Lost to Follow-up|1|||
105591725|NCT03670602|364167228|FG001|Overall Study|Lost to Follow-up|0|||
105591726|NCT03670602|364167227|FG000|Overall Study|Withdrawal by Subject|0|||
105591727|NCT03670602|364167228|FG001|Overall Study|Withdrawal by Subject|3|||
105591728|NCT03736785|364167229|FG000|Overall Study|Adverse Event|1|||
105591729|NCT03736785|364167230|FG001|Overall Study|Adverse Event|1|||
105591730|NCT03736785|364167231|FG002|Overall Study|Adverse Event|1|||
105511302|NCT01465997|363877792|FG000|Overall Study|subject withdrew consent|1|||
105591731|NCT03736785|364167229|FG000|Overall Study|Death|1|||
105591732|NCT03736785|364167230|FG001|Overall Study|Death|0|||
105591733|NCT03736785|364167231|FG002|Overall Study|Death|1|||
105511303|NCT01465997|363877793|FG001|Overall Study|subject withdrew consent|0|||
105511304|NCT01465997|363877792|FG000|Overall Study|local lab unblinded site|1|||
105511305|NCT01465997|363877793|FG001|Overall Study|local lab unblinded site|0|||
105511306|NCT01465997|363877792|FG000|Overall Study|withdrew before follow-up|0|||
105511307|NCT01465997|363877793|FG001|Overall Study|withdrew before follow-up|13|||
105511308|NCT01465997|363877792|FG000|Overall Study|decision by site staff|0|||
105511309|NCT01465997|363877793|FG001|Overall Study|decision by site staff|1|||
105511310|NCT01465997|363877792|FG000|Overall Study|subject left participation SP0993|0|||
105511311|NCT01465997|363877793|FG001|Overall Study|subject left participation SP0993|1|||
105511312|NCT02246660|363877794|FG000|Overall Study|Withdrawal by Subject|0|||
105511313|NCT02246660|363877795|FG001|Overall Study|Withdrawal by Subject|1|||
105511314|NCT02246660|363877796|FG002|Overall Study|Withdrawal by Subject|0|||
105511315|NCT02246660|363877794|FG000|Overall Study|Death|0|||
105511316|NCT02246660|363877795|FG001|Overall Study|Death|0|||
105511317|NCT02246660|363877796|FG002|Overall Study|Death|1|||
105511318|NCT01919723|363877802|FG000|Overall Study|Blood Samples Hemolyzed|2|||
105511319|NCT01919723|363877803|FG001|Overall Study|Blood Samples Hemolyzed|2|||
105511320|NCT02573311|363877804|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
105511321|NCT02573311|363877805|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
105511322|NCT02573311|363877804|FG000|Disposition for Part 2|Physician Decision|25|||
105511323|NCT02573311|363877805|FG001|Disposition for Part 2|Physician Decision|7|||
105511324|NCT02573311|363877804|FG000|Disposition for Part 2|Adverse Event|36|||
105511325|NCT02573311|363877805|FG001|Disposition for Part 2|Adverse Event|5|||
105511326|NCT02573311|363877804|FG000|Disposition for Part 2|Lost to Follow-up|76|||
105511327|NCT02573311|363877805|FG001|Disposition for Part 2|Lost to Follow-up|7|||
105511328|NCT02573311|363877804|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
105511329|NCT02573311|363877805|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
105511330|NCT02573311|363877804|FG000|Disposition for Part 2|Investigator decision|0|||
105511331|NCT02573311|363877805|FG001|Disposition for Part 2|Investigator decision|1|||
105511332|NCT02573311|363877804|FG000|Disposition for Part 2|Other than specified above|13|||
105511333|NCT02573311|363877805|FG001|Disposition for Part 2|Other than specified above|3|||
105511334|NCT00160251|363877807|FG000|Prior to Amendment 2|Adverse Event|2|||
105511335|NCT00160251|363877808|FG001|Prior to Amendment 2|Adverse Event|1|||
105511336|NCT00160251|363877809|FG002|Prior to Amendment 2|Adverse Event|3|||
105511337|NCT00160251|363877810|FG003|Prior to Amendment 2|Adverse Event|1|||
105511338|NCT00160251|363877811|FG004|Prior to Amendment 2|Adverse Event|1|||
105511339|NCT00160251|363877812|FG005|Prior to Amendment 2|Adverse Event|1|||
105591734|NCT03736785|364167229|FG000|Overall Study|Lost to Follow-up|0|||
105591735|NCT03736785|364167230|FG001|Overall Study|Lost to Follow-up|2|||
105591736|NCT03736785|364167231|FG002|Overall Study|Lost to Follow-up|3|||
105591737|NCT03736785|364167229|FG000|Overall Study|Non compliance with study drug|1|||
105591738|NCT03736785|364167230|FG001|Overall Study|Non compliance with study drug|1|||
105591739|NCT03736785|364167231|FG002|Overall Study|Non compliance with study drug|0|||
105591740|NCT03736785|364167229|FG000|Overall Study|Physician Decision|0|||
105591741|NCT03736785|364167230|FG001|Overall Study|Physician Decision|1|||
105591742|NCT03736785|364167231|FG002|Overall Study|Physician Decision|1|||
105591743|NCT03736785|364167229|FG000|Overall Study|Protocol Violation|1|||
105591744|NCT03736785|364167230|FG001|Overall Study|Protocol Violation|4|||
105591745|NCT03736785|364167231|FG002|Overall Study|Protocol Violation|3|||
105591746|NCT03736785|364167229|FG000|Overall Study|Sponsor Decision|1|||
105591747|NCT03736785|364167230|FG001|Overall Study|Sponsor Decision|0|||
105591748|NCT03736785|364167231|FG002|Overall Study|Sponsor Decision|0|||
105591749|NCT03736785|364167229|FG000|Overall Study|Unknown/Missing data|3|||
105591750|NCT03736785|364167230|FG001|Overall Study|Unknown/Missing data|2|||
105591751|NCT03736785|364167231|FG002|Overall Study|Unknown/Missing data|1|||
105591752|NCT03736785|364167229|FG000|Overall Study|Withdrawal by Subject|9|||
105591753|NCT03736785|364167230|FG001|Overall Study|Withdrawal by Subject|6|||
105591754|NCT03736785|364167231|FG002|Overall Study|Withdrawal by Subject|4|||
105591755|NCT02322216|364167232|FG000|Overall Study|Adverse Event|1|||
105591756|NCT02322216|364167233|FG001|Overall Study|Adverse Event|0|||
105591757|NCT02322216|364167232|FG000|Overall Study|Withdrawal by Subject|1|||
105511340|NCT00160251|363877813|FG006|Prior to Amendment 2|Adverse Event|1|||
105511341|NCT00160251|363877814|FG007|Prior to Amendment 2|Adverse Event|0|||
105591758|NCT02322216|364167233|FG001|Overall Study|Withdrawal by Subject|4|||
105591759|NCT03256344|364167239|FG000|Overall Study|Death|6|||
105591760|NCT03256344|364167240|FG001|Overall Study|Death|22|||
105511342|NCT00160251|363877807|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
105511343|NCT00160251|363877808|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
105511344|NCT00160251|363877809|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
105511345|NCT00160251|363877810|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
105511346|NCT00160251|363877811|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
105591761|NCT03256344|364167239|FG000|Overall Study|Withdrawal by Subject|3|||
105591762|NCT03256344|364167240|FG001|Overall Study|Withdrawal by Subject|3|||
105591763|NCT03256344|364167239|FG000|Overall Study|Sponsor Decision|1|||
105591764|NCT03256344|364167240|FG001|Overall Study|Sponsor Decision|0|||
105591765|NCT02057718|364167242|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
105591766|NCT02057718|364167243|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
105591767|NCT02057718|364167242|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
105591768|NCT02057718|364167243|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
105591769|NCT02057718|364167242|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
105591770|NCT02057718|364167243|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
105591771|NCT02057718|364167242|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
105591772|NCT02057718|364167243|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
105591773|NCT02057718|364167242|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
105591774|NCT02057718|364167243|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
105591775|NCT02057718|364167242|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
105591776|NCT02057718|364167243|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
105591777|NCT02057718|364167242|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
105591778|NCT02057718|364167243|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
105591779|NCT02057718|364167242|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
105591780|NCT02057718|364167243|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
105591781|NCT02057718|364167242|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
105591782|NCT02057718|364167243|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
105591783|NCT02057718|364167242|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
105591784|NCT02057718|364167243|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
105591785|NCT02057718|364167242|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
105591786|NCT02057718|364167243|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
105591787|NCT00880906|364167246|FG000|Overall Study|Lost to Follow-up|0|||
105591788|NCT00880906|364167247|FG001|Overall Study|Lost to Follow-up|1|||
105591789|NCT00880906|364167246|FG000|Overall Study|Did not meet criteria following patholog|12|||
105591790|NCT00880906|364167247|FG001|Overall Study|Did not meet criteria following patholog|6|||
105591791|NCT00544440|364167252|FG000|Overall Study|Other|1|||
105591792|NCT00544440|364167252|FG000|Overall Study|Adverse Event|1|||
105591793|NCT00544440|364167252|FG000|Overall Study|Withdrawal by Subject|2|||
105591794|NCT00544440|364167252|FG000|Overall Study|Subject Non-compliance|1|||
105591795|NCT00544440|364167252|FG000|Overall Study|Progressive Disease|47|||
105591796|NCT00544440|364167252|FG000|Overall Study|Other|5|||
105591797|NCT00591838|364167258|FG000|Overall Study|Withdrawal by Subject|0|||
105591798|NCT00591838|364167259|FG001|Overall Study|Withdrawal by Subject|0|||
105591799|NCT00591838|364167260|FG002|Overall Study|Withdrawal by Subject|0|||
105591800|NCT00591838|364167261|FG003|Overall Study|Withdrawal by Subject|1|||
105591801|NCT00591838|364167262|FG004|Overall Study|Withdrawal by Subject|0|||
105591802|NCT02982213|364167263|FG000|Overall Study|Did not complete follow up questionnaire|5|||
105591803|NCT02982213|364167264|FG001|Overall Study|Did not complete follow up questionnaire|1|||
105591804|NCT02596035|364167265|FG000|Overall Study|Disease Progression|64|||
105591805|NCT02596035|364167266|FG001|Overall Study|Disease Progression|32|||
105591806|NCT02596035|364167267|FG002|Overall Study|Disease Progression|1|||
105591807|NCT02596035|364167265|FG000|Overall Study|study drug toxicity|12|||
105591808|NCT02596035|364167266|FG001|Overall Study|study drug toxicity|3|||
105591809|NCT02596035|364167267|FG002|Overall Study|study drug toxicity|0|||
105591810|NCT02596035|364167265|FG000|Overall Study|AE unrelated to study drug|5|||
105591811|NCT02596035|364167266|FG001|Overall Study|AE unrelated to study drug|2|||
105591812|NCT02596035|364167267|FG002|Overall Study|AE unrelated to study drug|0|||
105591813|NCT02596035|364167265|FG000|Overall Study|participant request to discontinue study treatment|2|||
105591814|NCT02596035|364167266|FG001|Overall Study|participant request to discontinue study treatment|0|||
105591815|NCT02596035|364167267|FG002|Overall Study|participant request to discontinue study treatment|0|||
105591816|NCT02596035|364167265|FG000|Overall Study|participant withdrew consent|2|||
105591817|NCT02596035|364167266|FG001|Overall Study|participant withdrew consent|2|||
105591818|NCT02596035|364167267|FG002|Overall Study|participant withdrew consent|0|||
105591819|NCT02596035|364167265|FG000|Overall Study|Poor/Non Comlpiance|0|||
105591820|NCT02596035|364167266|FG001|Overall Study|Poor/Non Comlpiance|1|||
105591821|NCT02596035|364167267|FG002|Overall Study|Poor/Non Comlpiance|0|||
105591822|NCT02596035|364167265|FG000|Overall Study|participant no longer meets study criteria|1|||
105591823|NCT02596035|364167266|FG001|Overall Study|participant no longer meets study criteria|0|||
105591824|NCT02596035|364167267|FG002|Overall Study|participant no longer meets study criteria|0|||
105591825|NCT02596035|364167265|FG000|Overall Study|other reasons|11|||
105591826|NCT02596035|364167266|FG001|Overall Study|other reasons|4|||
105591827|NCT02596035|364167267|FG002|Overall Study|other reasons|0|||
105591828|NCT03098030|364167278|FG000|Overall Study|Death|10|||
105591829|NCT03098030|364167279|FG001|Overall Study|Death|156|||
105591830|NCT03098030|364167280|FG002|Overall Study|Death|156|||
105591831|NCT03098030|364167281|FG003|Overall Study|Death|82|||
105591832|NCT03098030|364167278|FG000|Overall Study|Withdrawal by Subject|0|||
105591833|NCT03098030|364167279|FG001|Overall Study|Withdrawal by Subject|7|||
105591834|NCT03098030|364167280|FG002|Overall Study|Withdrawal by Subject|8|||
105591835|NCT03098030|364167281|FG003|Overall Study|Withdrawal by Subject|2|||
105591836|NCT03098030|364167278|FG000|Overall Study|Lost to Follow-up|0|||
105511347|NCT00160251|363877812|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
105511348|NCT00160251|363877813|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
105511349|NCT00160251|363877814|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
105511350|NCT00160251|363877807|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
105511351|NCT00160251|363877808|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
105511352|NCT00160251|363877809|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
105511353|NCT00160251|363877810|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
105511354|NCT00160251|363877811|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
105511355|NCT00160251|363877812|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
105511356|NCT00160251|363877813|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
105511357|NCT00160251|363877814|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
105511358|NCT00160251|363877807|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
105511359|NCT00160251|363877808|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
105511360|NCT00160251|363877809|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
105511361|NCT00160251|363877810|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
105511362|NCT00160251|363877811|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
105511363|NCT00160251|363877812|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
105511364|NCT00160251|363877813|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
105511365|NCT00160251|363877814|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
105511366|NCT00160251|363877807|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
105511367|NCT00160251|363877808|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
105511368|NCT00160251|363877809|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
105511369|NCT00160251|363877810|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
105511370|NCT00160251|363877811|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
105511371|NCT00160251|363877812|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
105511372|NCT00160251|363877813|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
105511373|NCT00160251|363877814|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
105511374|NCT00160251|363877807|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
105511375|NCT00160251|363877808|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
105511376|NCT00160251|363877809|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
105511377|NCT00160251|363877810|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
105511378|NCT00160251|363877811|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
105511379|NCT00160251|363877812|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
105511380|NCT00160251|363877813|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
105511381|NCT00160251|363877814|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
105511382|NCT00160251|363877807|FG000|Post-amendment 2|Adverse Event|0|||
105511383|NCT00160251|363877808|FG001|Post-amendment 2|Adverse Event|0|||
105511384|NCT00160251|363877809|FG002|Post-amendment 2|Adverse Event|0|||
105511385|NCT00160251|363877810|FG003|Post-amendment 2|Adverse Event|0|||
105511386|NCT00160251|363877811|FG004|Post-amendment 2|Adverse Event|0|||
105511387|NCT00160251|363877812|FG005|Post-amendment 2|Adverse Event|0|||
105511388|NCT00160251|363877813|FG006|Post-amendment 2|Adverse Event|0|||
105511389|NCT00160251|363877814|FG007|Post-amendment 2|Adverse Event|20|||
105511390|NCT00160251|363877807|FG000|Post-amendment 2|Lack of Efficacy|0|||
105511391|NCT00160251|363877808|FG001|Post-amendment 2|Lack of Efficacy|0|||
105511392|NCT00160251|363877809|FG002|Post-amendment 2|Lack of Efficacy|0|||
105511393|NCT00160251|363877810|FG003|Post-amendment 2|Lack of Efficacy|0|||
105511394|NCT00160251|363877811|FG004|Post-amendment 2|Lack of Efficacy|0|||
105511395|NCT00160251|363877812|FG005|Post-amendment 2|Lack of Efficacy|0|||
105511396|NCT00160251|363877813|FG006|Post-amendment 2|Lack of Efficacy|0|||
105511397|NCT00160251|363877814|FG007|Post-amendment 2|Lack of Efficacy|24|||
105511398|NCT00160251|363877807|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
105511399|NCT00160251|363877808|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
105511400|NCT00160251|363877809|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
105511401|NCT00160251|363877810|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
105511402|NCT00160251|363877811|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
105511403|NCT00160251|363877812|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
105511404|NCT00160251|363877813|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
105511405|NCT00160251|363877814|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
105511406|NCT00211809|363877817|FG000|Overall Study|Lack of Efficacy|1|||
105511407|NCT00211809|363877817|FG000|Overall Study|Lost to Follow-up|2|||
105511408|NCT00211809|363877817|FG000|Overall Study|Pregnancy|1|||
105511409|NCT00211809|363877817|FG000|Overall Study|side effects|2|||
105511410|NCT03681405|363877818|FG000|Overall Study|Found to be ineligible after randomized|1|||
105511411|NCT03681405|363877819|FG001|Overall Study|Found to be ineligible after randomized|0|||
105511412|NCT01032837|363877820|FG000|Overall Study|Adverse event/internal illness|0|||
105511413|NCT01032837|363877821|FG001|Overall Study|Adverse event/internal illness|1|||
105511414|NCT01032837|363877822|FG002|Overall Study|Adverse event/internal illness|0|||
105511415|NCT01032837|363877823|FG003|Overall Study|Adverse event/internal illness|1|||
105511416|NCT01032837|363877820|FG000|Overall Study|Withdrew consent|0|||
105511417|NCT01032837|363877821|FG001|Overall Study|Withdrew consent|2|||
105511418|NCT01032837|363877822|FG002|Overall Study|Withdrew consent|0|||
105511419|NCT01032837|363877823|FG003|Overall Study|Withdrew consent|1|||
105511420|NCT01032837|363877820|FG000|Overall Study|Failed to return|0|||
105511421|NCT01032837|363877821|FG001|Overall Study|Failed to return|0|||
105511422|NCT01032837|363877822|FG002|Overall Study|Failed to return|1|||
105511423|NCT01032837|363877823|FG003|Overall Study|Failed to return|0|||
105511424|NCT01032837|363877820|FG000|Overall Study|Refused treatment|0|||
105511425|NCT01032837|363877821|FG001|Overall Study|Refused treatment|0|||
105511426|NCT01032837|363877822|FG002|Overall Study|Refused treatment|0|||
105511427|NCT01032837|363877823|FG003|Overall Study|Refused treatment|1|||
105511428|NCT01782222|363877824|FG000|Overall Study|Adverse Event|4|||
105511429|NCT01782222|363877825|FG001|Overall Study|Adverse Event|5|||
105511430|NCT01782222|363877826|FG002|Overall Study|Adverse Event|3|||
105511431|NCT01782222|363877824|FG000|Overall Study|Lack of Efficacy|2|||
105511432|NCT01782222|363877825|FG001|Overall Study|Lack of Efficacy|1|||
105511433|NCT01782222|363877826|FG002|Overall Study|Lack of Efficacy|0|||
105511434|NCT01782222|363877824|FG000|Overall Study|Protocol Violation|1|||
105511435|NCT01782222|363877825|FG001|Overall Study|Protocol Violation|0|||
105511436|NCT01782222|363877826|FG002|Overall Study|Protocol Violation|0|||
105511437|NCT01782222|363877824|FG000|Overall Study|Withdrawal by Subject|1|||
105511438|NCT01782222|363877825|FG001|Overall Study|Withdrawal by Subject|4|||
105511439|NCT01782222|363877826|FG002|Overall Study|Withdrawal by Subject|1|||
105511440|NCT01782222|363877824|FG000|Overall Study|Moved to other state|0|||
105511441|NCT01782222|363877825|FG001|Overall Study|Moved to other state|1|||
105511442|NCT01782222|363877826|FG002|Overall Study|Moved to other state|0|||
105511443|NCT01846416|363877829|FG000|Treatment Phase|Death|2|||
105511444|NCT01846416|363877830|FG001|Treatment Phase|Death|9|||
105511445|NCT01846416|363877831|FG002|Treatment Phase|Death|1|||
105511446|NCT01846416|363877829|FG000|Treatment Phase|Withdrawal by Subject|2|||
105511447|NCT01846416|363877830|FG001|Treatment Phase|Withdrawal by Subject|4|||
105511448|NCT01846416|363877831|FG002|Treatment Phase|Withdrawal by Subject|2|||
105511449|NCT01846416|363877829|FG000|Treatment Phase|Other|1|||
105511450|NCT01846416|363877830|FG001|Treatment Phase|Other|5|||
105511451|NCT01846416|363877831|FG002|Treatment Phase|Other|1|||
105511452|NCT01846416|363877829|FG000|Treatment Phase|Physician Decision|1|||
105511453|NCT01846416|363877830|FG001|Treatment Phase|Physician Decision|2|||
105511454|NCT01846416|363877831|FG002|Treatment Phase|Physician Decision|0|||
105511455|NCT01846416|363877829|FG000|Treatment Phase|Adverse Event|3|||
105511456|NCT01846416|363877830|FG001|Treatment Phase|Adverse Event|4|||
105511457|NCT01846416|363877831|FG002|Treatment Phase|Adverse Event|0|||
105511458|NCT01846416|363877829|FG000|Treatment Phase|Non-compliance|0|||
105511459|NCT01846416|363877830|FG001|Treatment Phase|Non-compliance|2|||
105511460|NCT01846416|363877831|FG002|Treatment Phase|Non-compliance|0|||
105511461|NCT01846416|363877829|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
105511462|NCT01846416|363877830|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
105511463|NCT01846416|363877831|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
105511464|NCT01846416|363877829|FG000|Treatment Phase|Progressive Disease|21|||
105511465|NCT01846416|363877830|FG001|Treatment Phase|Progressive Disease|63|||
105511466|NCT01846416|363877831|FG002|Treatment Phase|Progressive Disease|9|||
105511467|NCT01846416|363877829|FG000|Survival Follow-up|Death|21|||
105511468|NCT01846416|363877830|FG001|Survival Follow-up|Death|62|||
105511469|NCT01846416|363877831|FG002|Survival Follow-up|Death|9|||
105511470|NCT01846416|363877829|FG000|Survival Follow-up|Lost to Follow-up|0|||
105511471|NCT01846416|363877830|FG001|Survival Follow-up|Lost to Follow-up|2|||
105511472|NCT01846416|363877831|FG002|Survival Follow-up|Lost to Follow-up|2|||
105511473|NCT01846416|363877829|FG000|Survival Follow-up|Withdrawal by Subject|2|||
105511474|NCT01846416|363877830|FG001|Survival Follow-up|Withdrawal by Subject|7|||
105511475|NCT01846416|363877831|FG002|Survival Follow-up|Withdrawal by Subject|0|||
105511476|NCT01846416|363877829|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
105511477|NCT01846416|363877830|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
105511478|NCT01846416|363877831|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
105511479|NCT01846416|363877829|FG000|Survival Follow-up|Other|3|||
105511480|NCT01846416|363877830|FG001|Survival Follow-up|Other|1|||
105511481|NCT01846416|363877831|FG002|Survival Follow-up|Other|1|||
105511482|NCT00833794|363877832|FG000|Open-label Phase|Adverse Event|225|||
105511483|NCT00833794|363877833|FG001|Open-label Phase|Adverse Event|0|||
105511484|NCT00833794|363877832|FG000|Open-label Phase|Lack of Efficacy|28|||
105511485|NCT00833794|363877833|FG001|Open-label Phase|Lack of Efficacy|0|||
105511486|NCT00833794|363877832|FG000|Open-label Phase|Withdrawal by Subject|48|||
105511487|NCT00833794|363877833|FG001|Open-label Phase|Withdrawal by Subject|0|||
105511488|NCT00833794|363877832|FG000|Open-label Phase|Physician Decision|20|||
105511489|NCT00833794|363877833|FG001|Open-label Phase|Physician Decision|0|||
105511490|NCT00833794|363877832|FG000|Open-label Phase|Administrative reason|1|||
105511491|NCT00833794|363877833|FG001|Open-label Phase|Administrative reason|0|||
105511492|NCT00833794|363877832|FG000|Open-label Phase|Protocol Violation|47|||
105511493|NCT00833794|363877833|FG001|Open-label Phase|Protocol Violation|0|||
105511494|NCT00833794|363877832|FG000|Open-label Phase|Did not complete wash-out period|12|||
105511495|NCT00833794|363877833|FG001|Open-label Phase|Did not complete wash-out period|0|||
105511496|NCT00833794|363877832|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
105511497|NCT00833794|363877833|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
105511498|NCT00833794|363877832|FG000|Double-blind Phase|Adverse Event|44|||
105511499|NCT00833794|363877833|FG001|Double-blind Phase|Adverse Event|11|||
105511500|NCT00833794|363877832|FG000|Double-blind Phase|Lack of Efficacy|34|||
105511501|NCT00833794|363877833|FG001|Double-blind Phase|Lack of Efficacy|22|||
105511502|NCT00833794|363877832|FG000|Double-blind Phase|Withdrawal by Subject|23|||
105511503|NCT00833794|363877833|FG001|Double-blind Phase|Withdrawal by Subject|6|||
105511504|NCT00833794|363877832|FG000|Double-blind Phase|Physician Decision|4|||
105511505|NCT00833794|363877833|FG001|Double-blind Phase|Physician Decision|7|||
105511506|NCT00833794|363877832|FG000|Double-blind Phase|Administrative reason|1|||
105511507|NCT00833794|363877833|FG001|Double-blind Phase|Administrative reason|3|||
105511508|NCT02007109|363877834|FG000|Overall Study|Diary not returned or excluded|102|||
105511509|NCT02007109|363877834|FG000|Overall Study|Excluded - Age<7yo|9|||
105511510|NCT01950741|363877835|FG000|Overall Study|Lost to Follow-up|1|||
105511511|NCT01950741|363877835|FG000|Overall Study|Death|1|||
105511512|NCT01950741|363877835|FG000|Overall Study|Withdrawal by Subject|1|||
105511513|NCT01858389|363877838|FG000|Overall Study|Death|1|||
105511514|NCT01858389|363877839|FG001|Overall Study|Death|3|||
105511515|NCT01858389|363877838|FG000|Overall Study|Study terminated by sponsor|0|||
105511516|NCT01858389|363877839|FG001|Overall Study|Study terminated by sponsor|2|||
105511517|NCT01858389|363877838|FG000|Overall Study|Withdrawal by Subject|0|||
105511518|NCT01858389|363877839|FG001|Overall Study|Withdrawal by Subject|1|||
105511519|NCT01858389|363877838|FG000|Overall Study|Progressive disease|10|||
105511520|NCT01858389|363877839|FG001|Overall Study|Progressive disease|11|||
105511521|NCT01858389|363877838|FG000|Overall Study|Other|2|||
105511522|NCT01858389|363877839|FG001|Overall Study|Other|4|||
105511523|NCT01858389|363877838|FG000|Overall Study|Adverse Event|3|||
105511524|NCT01858389|363877839|FG001|Overall Study|Adverse Event|1|||
105511525|NCT01858389|363877838|FG000|Overall Study|Did not receive treatment|0|||
105511526|NCT01858389|363877839|FG001|Overall Study|Did not receive treatment|3|||
105511527|NCT00844896|363877840|FG000|Overall Study|Lost to Follow-up|12|||
105511528|NCT00844896|363877841|FG001|Overall Study|Lost to Follow-up|16|||
105511529|NCT00844896|363877840|FG000|Overall Study|Parents did not have time to complete|0|||
105511530|NCT00844896|363877841|FG001|Overall Study|Parents did not have time to complete|1|||
105511531|NCT01835587|363877842|FG000|Overall Study|Disease Recurrence or Relapse|0|||
105511532|NCT01835587|363877843|FG001|Overall Study|Disease Recurrence or Relapse|3|||
105511533|NCT01835587|363877844|FG002|Overall Study|Disease Recurrence or Relapse|0|||
105511534|NCT01835587|363877845|FG003|Overall Study|Disease Recurrence or Relapse|3|||
105511535|NCT01835587|363877842|FG000|Overall Study|Withdrawal by Subject|2|||
105511536|NCT01835587|363877843|FG001|Overall Study|Withdrawal by Subject|0|||
105511537|NCT01835587|363877844|FG002|Overall Study|Withdrawal by Subject|0|||
105511538|NCT01835587|363877845|FG003|Overall Study|Withdrawal by Subject|3|||
105511539|NCT01835587|363877842|FG000|Overall Study|Adverse Event|0|||
105511540|NCT01835587|363877843|FG001|Overall Study|Adverse Event|0|||
105511541|NCT01835587|363877844|FG002|Overall Study|Adverse Event|2|||
105511542|NCT01835587|363877845|FG003|Overall Study|Adverse Event|2|||
105511543|NCT01835587|363877842|FG000|Overall Study|Death|0|||
105511544|NCT01835587|363877843|FG001|Overall Study|Death|0|||
105511545|NCT01835587|363877844|FG002|Overall Study|Death|0|||
105511546|NCT01835587|363877845|FG003|Overall Study|Death|1|||
105511547|NCT01835587|363877842|FG000|Overall Study|Miscellaneous|0|||
105511548|NCT01835587|363877843|FG001|Overall Study|Miscellaneous|1|||
105511549|NCT01835587|363877844|FG002|Overall Study|Miscellaneous|0|||
105511550|NCT01835587|363877845|FG003|Overall Study|Miscellaneous|0|||
105511551|NCT05255068|363879082|FG000|Overall Study|Lost to Follow-up|0|||
105511552|NCT05255068|363879083|FG001|Overall Study|Lost to Follow-up|1|||
105511553|NCT00911820|363879089|FG000|Overall Study|RECIST progression|12|||
105511554|NCT00911820|363879090|FG001|Overall Study|RECIST progression|8|||
105511555|NCT00911820|363879089|FG000|Overall Study|Adverse Event|8|||
105511556|NCT00911820|363879090|FG001|Overall Study|Adverse Event|8|||
105511557|NCT00911820|363879089|FG000|Overall Study|Clinical Progression|7|||
105511558|NCT00911820|363879090|FG001|Overall Study|Clinical Progression|5|||
105511559|NCT00911820|363879089|FG000|Overall Study|Physician Decision|5|||
105511560|NCT00911820|363879090|FG001|Overall Study|Physician Decision|9|||
105511561|NCT00911820|363879089|FG000|Overall Study|Decline in Performance Status|4|||
105511562|NCT00911820|363879090|FG001|Overall Study|Decline in Performance Status|2|||
105511563|NCT00911820|363879089|FG000|Overall Study|Withdrawal by Subject|3|||
105511564|NCT00911820|363879090|FG001|Overall Study|Withdrawal by Subject|4|||
105511565|NCT00911820|363879089|FG000|Overall Study|Death|1|||
105511566|NCT00911820|363879090|FG001|Overall Study|Death|2|||
105591837|NCT03098030|364167279|FG001|Overall Study|Lost to Follow-up|0|||
105511567|NCT00911820|363879089|FG000|Overall Study|Pursue surgery|1|||
105511568|NCT00911820|363879090|FG001|Overall Study|Pursue surgery|1|||
105511569|NCT00911820|363879089|FG000|Overall Study|Pursue Radiation|1|||
105511570|NCT00911820|363879090|FG001|Overall Study|Pursue Radiation|0|||
105511571|NCT00911820|363879089|FG000|Overall Study|Still on Therapy|2|||
105511572|NCT00911820|363879090|FG001|Overall Study|Still on Therapy|2|||
105511573|NCT00911820|363879089|FG000|Overall Study|Pathology Not Confirmed|1|||
105511574|NCT00911820|363879090|FG001|Overall Study|Pathology Not Confirmed|0|||
105511575|NCT00911820|363879089|FG000|Overall Study|Withdraw before Receive Treatment|0|||
105511576|NCT00911820|363879090|FG001|Overall Study|Withdraw before Receive Treatment|2|||
105511577|NCT02990910|363879094|FG000|Overall Study|Lack of Efficacy|6|||
105511578|NCT02990910|363879095|FG001|Overall Study|Lack of Efficacy|10|||
105511579|NCT02155608|363879103|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
105511580|NCT02155608|363879104|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
105511581|NCT02155608|363879103|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
105511582|NCT02155608|363879104|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
105511583|NCT00660023|363879106|FG000|Overall Study|Adverse Event|2|||
105511584|NCT00660023|363879106|FG000|Overall Study|Death|8|||
105511585|NCT00660023|363879106|FG000|Overall Study|Blood Transfusion|5|||
105511586|NCT00660023|363879106|FG000|Overall Study|Renal Transplantation|3|||
105511587|NCT00660023|363879106|FG000|Overall Study|Withdrawal by Subject|1|||
105511588|NCT00660023|363879106|FG000|Overall Study|Missed Pregnancy Test|1|||
105511589|NCT00660023|363879106|FG000|Overall Study|Other Screening Failure|9|||
105511590|NCT00684307|363879107|FG000|Overall Study|Adverse Event|11|||
105511591|NCT00684307|363879108|FG001|Overall Study|Adverse Event|6|||
105511592|NCT00684307|363879109|FG002|Overall Study|Adverse Event|15|||
105511593|NCT00684307|363879110|FG003|Overall Study|Adverse Event|16|||
105511594|NCT00684307|363879111|FG004|Overall Study|Adverse Event|8|||
105511595|NCT00684307|363879107|FG000|Overall Study|Development of increasing Liver Function|0|||
105511596|NCT00684307|363879108|FG001|Overall Study|Development of increasing Liver Function|2|||
105511597|NCT00684307|363879109|FG002|Overall Study|Development of increasing Liver Function|0|||
105511598|NCT00684307|363879110|FG003|Overall Study|Development of increasing Liver Function|1|||
105511599|NCT00684307|363879111|FG004|Overall Study|Development of increasing Liver Function|0|||
105511600|NCT00684307|363879107|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
105511601|NCT00684307|363879108|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
105511602|NCT00684307|363879109|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
105511603|NCT00684307|363879110|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
105511604|NCT00684307|363879111|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
105511605|NCT00684307|363879107|FG000|Overall Study|Incorrect enrolment or randomization|4|||
105511606|NCT00684307|363879108|FG001|Overall Study|Incorrect enrolment or randomization|0|||
105511607|NCT00684307|363879109|FG002|Overall Study|Incorrect enrolment or randomization|0|||
105511608|NCT00684307|363879110|FG003|Overall Study|Incorrect enrolment or randomization|0|||
105511609|NCT00684307|363879111|FG004|Overall Study|Incorrect enrolment or randomization|0|||
105511610|NCT00684307|363879107|FG000|Overall Study|Interupted IP for more than 7 days|0|||
105511611|NCT00684307|363879108|FG001|Overall Study|Interupted IP for more than 7 days|4|||
105511612|NCT00684307|363879109|FG002|Overall Study|Interupted IP for more than 7 days|1|||
105511613|NCT00684307|363879110|FG003|Overall Study|Interupted IP for more than 7 days|3|||
105511614|NCT00684307|363879111|FG004|Overall Study|Interupted IP for more than 7 days|3|||
105511615|NCT00684307|363879107|FG000|Overall Study|Severe non compliance to protocol|1|||
105511616|NCT00684307|363879108|FG001|Overall Study|Severe non compliance to protocol|0|||
105511617|NCT00684307|363879109|FG002|Overall Study|Severe non compliance to protocol|0|||
105511618|NCT00684307|363879110|FG003|Overall Study|Severe non compliance to protocol|1|||
105511619|NCT00684307|363879111|FG004|Overall Study|Severe non compliance to protocol|2|||
105511620|NCT00684307|363879107|FG000|Overall Study|Participant not willing to continue|7|||
105511621|NCT00684307|363879108|FG001|Overall Study|Participant not willing to continue|10|||
105511622|NCT00684307|363879109|FG002|Overall Study|Participant not willing to continue|11|||
105511623|NCT00684307|363879110|FG003|Overall Study|Participant not willing to continue|5|||
105511624|NCT00684307|363879111|FG004|Overall Study|Participant not willing to continue|8|||
105511625|NCT00684307|363879107|FG000|Overall Study|Criteria from the CSR|0|||
105511626|NCT00684307|363879108|FG001|Overall Study|Criteria from the CSR|0|||
105511627|NCT00684307|363879109|FG002|Overall Study|Criteria from the CSR|1|||
105511628|NCT00684307|363879110|FG003|Overall Study|Criteria from the CSR|3|||
105511629|NCT00684307|363879111|FG004|Overall Study|Criteria from the CSR|3|||
105511630|NCT00759031|363879112|FG000|First Intervention (1 Day)|Physician Decision|1|||
105511631|NCT00759031|363879113|FG001|First Intervention (1 Day)|Physician Decision|0|||
105511632|NCT00759031|363879112|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
105511633|NCT00759031|363879113|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
105511634|NCT00759031|363879112|FG000|First Intervention (1 Day)|Screening failure|1|||
105511635|NCT00759031|363879113|FG001|First Intervention (1 Day)|Screening failure|0|||
105511636|NCT00309387|363879119|FG000|Overall Study|Death|72|||
105511637|NCT00309387|363879120|FG001|Overall Study|Death|73|||
105511638|NCT00309387|363879119|FG000|Overall Study|Lost to Follow-up|70|||
105511639|NCT00309387|363879120|FG001|Overall Study|Lost to Follow-up|86|||
105511640|NCT04532164|363879122|FG000|Overall Study|Adverse Event|1|||
105511641|NCT04532164|363879122|FG000|Overall Study|Protocol Violation|5|||
105511642|NCT04532164|363879122|FG000|Overall Study|Lost to Follow-up|1|||
105511643|NCT04532164|363879122|FG000|Overall Study|Found to be Ineligible|3|||
105511644|NCT04532164|363879122|FG000|Overall Study|Withdrawal by Subject|14|||
105511645|NCT02483520|363879123|FG000|Overall Study|Lost to Follow-up|3|||
105511646|NCT02483520|363879124|FG001|Overall Study|Lost to Follow-up|4|||
105511647|NCT02483520|363879123|FG000|Overall Study|Withdrawal by Subject|4|||
105511648|NCT02483520|363879124|FG001|Overall Study|Withdrawal by Subject|14|||
105511649|NCT02483520|363879123|FG000|Overall Study|Hospitalized|2|||
105511650|NCT02483520|363879124|FG001|Overall Study|Hospitalized|3|||
105511651|NCT02483520|363879123|FG000|Overall Study|Moved to LTC|2|||
105511652|NCT02483520|363879124|FG001|Overall Study|Moved to LTC|3|||
105511653|NCT02599129|363879125|FG000|Overall Study|Lack of Efficacy|2|||
105511654|NCT02599129|363879126|FG001|Overall Study|Lack of Efficacy|2|||
105511655|NCT02599129|363879125|FG000|Overall Study|Lost to Follow-up|1|||
105511656|NCT02599129|363879126|FG001|Overall Study|Lost to Follow-up|0|||
105511657|NCT02599129|363879125|FG000|Overall Study|Withdrawal by Subject|2|||
105511658|NCT02599129|363879126|FG001|Overall Study|Withdrawal by Subject|1|||
105511659|NCT01029795|363879133|FG000|Overall Study|Entry Criteria Not Met|2|||
105511660|NCT01029795|363879134|FG001|Overall Study|Entry Criteria Not Met|1|||
105511661|NCT01029795|363879133|FG000|Overall Study|Physician Decision|2|||
105511662|NCT01029795|363879134|FG001|Overall Study|Physician Decision|1|||
105511663|NCT01029795|363879133|FG000|Overall Study|Sponsor Decision|11|||
105511664|NCT01029795|363879134|FG001|Overall Study|Sponsor Decision|17|||
105511665|NCT01029795|363879133|FG000|Overall Study|Withdrawal by Subject|1|||
105511666|NCT01029795|363879134|FG001|Overall Study|Withdrawal by Subject|3|||
105511667|NCT03902574|363879144|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
105511668|NCT03902574|363879145|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
105511669|NCT03902574|363879146|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
105511670|NCT01401283|363879152|FG000|Overall Study|surgery cancelled|5|||
105511671|NCT01401283|363879153|FG001|Overall Study|surgery cancelled|8|||
105511672|NCT01401283|363879152|FG000|Overall Study|preoperative arrhythmia|5|||
105511673|NCT01401283|363879153|FG001|Overall Study|preoperative arrhythmia|0|||
105511674|NCT01401283|363879152|FG000|Overall Study|no central venous access|0|||
105511675|NCT01401283|363879153|FG001|Overall Study|no central venous access|1|||
105511676|NCT01401283|363879152|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
105511677|NCT01401283|363879153|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
105511678|NCT03489720|363879154|FG000|Overall Study|Withdrawal by Subject|2|||
105511679|NCT03489720|363879155|FG001|Overall Study|Withdrawal by Subject|0|||
105511680|NCT02064894|363879156|FG000|Overall Study|Withdrawal by Subject|43|||
105511681|NCT02064894|363879157|FG001|Overall Study|Withdrawal by Subject|102|||
105511682|NCT02064894|363879158|FG002|Overall Study|Withdrawal by Subject|115|||
105511683|NCT03521934|363879160|FG000|Overall Study|Death|65|||
105511684|NCT03521934|363879161|FG001|Overall Study|Death|73|||
105511685|NCT03521934|363879160|FG000|Overall Study|Withdrawal by Subject|18|||
105511686|NCT03521934|363879161|FG001|Overall Study|Withdrawal by Subject|23|||
105511687|NCT03521934|363879160|FG000|Overall Study|Site Terminated by Sponsor|39|||
105511688|NCT03521934|363879161|FG001|Overall Study|Site Terminated by Sponsor|35|||
105511689|NCT03521934|363879160|FG000|Overall Study|Study Terminated by Sponsor|483|||
105511690|NCT03521934|363879161|FG001|Overall Study|Study Terminated by Sponsor|477|||
105511691|NCT03521934|363879160|FG000|Overall Study|Reason not Specified|3|||
105511692|NCT03521934|363879161|FG001|Overall Study|Reason not Specified|6|||
105511693|NCT02709785|363879162|FG000|Overall Study|Withdrawal by Subject|1|||
105511694|NCT02709785|363879163|FG001|Overall Study|Withdrawal by Subject|2|||
105511695|NCT02709785|363879164|FG002|Overall Study|Withdrawal by Subject|1|||
105511696|NCT00299975|363879165|FG000|Overall Study|Adverse Event|1|||
105511697|NCT00299975|363879166|FG001|Overall Study|Adverse Event|0|||
105511698|NCT00299975|363879167|FG002|Overall Study|Adverse Event|2|||
105511699|NCT00299975|363879165|FG000|Overall Study|Pregnancy|0|||
105511700|NCT00299975|363879166|FG001|Overall Study|Pregnancy|0|||
105511701|NCT00299975|363879167|FG002|Overall Study|Pregnancy|1|||
105511702|NCT00299975|363879165|FG000|Overall Study|Lack of Efficacy|1|||
105511703|NCT00299975|363879166|FG001|Overall Study|Lack of Efficacy|0|||
105511704|NCT00299975|363879167|FG002|Overall Study|Lack of Efficacy|1|||
105511705|NCT00299975|363879165|FG000|Overall Study|Lost to Follow-up|1|||
105511706|NCT00299975|363879166|FG001|Overall Study|Lost to Follow-up|0|||
105591838|NCT03098030|364167280|FG002|Overall Study|Lost to Follow-up|2|||
105511707|NCT00299975|363879167|FG002|Overall Study|Lost to Follow-up|0|||
105511708|NCT00299975|363879165|FG000|Overall Study|Withdrawal by Subject|0|||
105511709|NCT00299975|363879166|FG001|Overall Study|Withdrawal by Subject|1|||
105511710|NCT00299975|363879167|FG002|Overall Study|Withdrawal by Subject|3|||
105511711|NCT00299975|363879165|FG000|Overall Study|Physician Decision|0|||
105511712|NCT00299975|363879166|FG001|Overall Study|Physician Decision|0|||
105511713|NCT00299975|363879167|FG002|Overall Study|Physician Decision|1|||
105511714|NCT00582166|363879171|FG000|Overall Study|Death|1|||
105511715|NCT00582166|363879171|FG000|Overall Study|Ineligible pathology|1|||
105591839|NCT03098030|364167281|FG003|Overall Study|Lost to Follow-up|1|||
105511716|NCT01606436|363879172|FG000|Overall Study|Withdrawal by Subject|0|||
105511717|NCT01606436|363879173|FG001|Overall Study|Withdrawal by Subject|0|||
105511718|NCT01606436|363879174|FG002|Overall Study|Withdrawal by Subject|1|||
105591840|NCT01726023|364167284|FG000|Overall Study|Death|1|||
105591841|NCT01726023|364167285|FG001|Overall Study|Death|1|||
105591842|NCT01726023|364167284|FG000|Overall Study|Lost to Follow-up|5|||
105511719|NCT01606436|363879175|FG003|Overall Study|Withdrawal by Subject|1|||
105511720|NCT01606436|363879176|FG004|Overall Study|Withdrawal by Subject|1|||
105511721|NCT01606436|363879177|FG005|Overall Study|Withdrawal by Subject|0|||
105511722|NCT01606436|363879172|FG000|Overall Study|Adverse Event|0|||
105511723|NCT01606436|363879173|FG001|Overall Study|Adverse Event|0|||
105511724|NCT01606436|363879174|FG002|Overall Study|Adverse Event|1|||
105511725|NCT01606436|363879175|FG003|Overall Study|Adverse Event|0|||
105511726|NCT01606436|363879176|FG004|Overall Study|Adverse Event|0|||
105511727|NCT01606436|363879177|FG005|Overall Study|Adverse Event|0|||
105511728|NCT01606436|363879172|FG000|Overall Study|Sponsor Decision|0|||
105511729|NCT01606436|363879173|FG001|Overall Study|Sponsor Decision|0|||
105511730|NCT01606436|363879174|FG002|Overall Study|Sponsor Decision|0|||
105511731|NCT01606436|363879175|FG003|Overall Study|Sponsor Decision|1|||
105511732|NCT01606436|363879176|FG004|Overall Study|Sponsor Decision|0|||
105511733|NCT01606436|363879177|FG005|Overall Study|Sponsor Decision|0|||
105511734|NCT00357968|363879178|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
105511735|NCT00357968|363879179|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
105511736|NCT00357968|363879178|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
105511737|NCT00357968|363879179|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
105511738|NCT00679302|363879186|FG000|Overall Study|Lost to Follow-up|8|||
105511739|NCT00679302|363879187|FG001|Overall Study|Lost to Follow-up|4|||
105511740|NCT00600483|363879188|FG000|Overall Study|Lost to Follow-up|26|||
105511741|NCT00600483|363879189|FG001|Overall Study|Lost to Follow-up|47|||
105511742|NCT00600483|363879188|FG000|Overall Study|Randomized but not treated|10|||
105511743|NCT00600483|363879189|FG001|Overall Study|Randomized but not treated|0|||
105511744|NCT02846779|363879203|FG000|Overall Study|Lost Enrollment|83|||
105511745|NCT02846779|363879204|FG001|Overall Study|Lost Enrollment|82|||
105511746|NCT02846779|363879205|FG002|Overall Study|Lost Enrollment|86|||
105511747|NCT02846779|363879203|FG000|Overall Study|Less than 31 days of follow-up|56|||
105511748|NCT02846779|363879204|FG001|Overall Study|Less than 31 days of follow-up|45|||
105511749|NCT02846779|363879205|FG002|Overall Study|Less than 31 days of follow-up|52|||
105511750|NCT00203996|363879206|FG000|Overall Study|Lost to Follow-up|0|||
105511751|NCT00203996|363879207|FG001|Overall Study|Lost to Follow-up|0|||
105511752|NCT00203996|363879208|FG002|Overall Study|Lost to Follow-up|0|||
105511753|NCT00203996|363879209|FG003|Overall Study|Lost to Follow-up|1|||
105511754|NCT00203996|363879210|FG004|Overall Study|Lost to Follow-up|0|||
105511755|NCT00203996|363879211|FG005|Overall Study|Lost to Follow-up|0|||
105511756|NCT00203996|363879212|FG006|Overall Study|Lost to Follow-up|0|||
105511757|NCT00203996|363879213|FG007|Overall Study|Lost to Follow-up|0|||
105511758|NCT00203996|363879214|FG008|Overall Study|Lost to Follow-up|0|||
105511759|NCT00203996|363879215|FG009|Overall Study|Lost to Follow-up|0|||
105511760|NCT00203996|363879206|FG000|Overall Study|Protocol Violation|0|||
105511761|NCT00203996|363879207|FG001|Overall Study|Protocol Violation|0|||
105511762|NCT00203996|363879208|FG002|Overall Study|Protocol Violation|0|||
105511763|NCT00203996|363879209|FG003|Overall Study|Protocol Violation|6|||
105511764|NCT00203996|363879210|FG004|Overall Study|Protocol Violation|1|||
105511765|NCT00203996|363879211|FG005|Overall Study|Protocol Violation|0|||
105511766|NCT00203996|363879212|FG006|Overall Study|Protocol Violation|0|||
105511767|NCT00203996|363879213|FG007|Overall Study|Protocol Violation|0|||
105511768|NCT00203996|363879214|FG008|Overall Study|Protocol Violation|0|||
105511769|NCT00203996|363879215|FG009|Overall Study|Protocol Violation|0|||
105511770|NCT00203996|363879206|FG000|Overall Study|Physician Decision|0|||
105511771|NCT00203996|363879207|FG001|Overall Study|Physician Decision|0|||
105511772|NCT00203996|363879208|FG002|Overall Study|Physician Decision|0|||
105511773|NCT00203996|363879209|FG003|Overall Study|Physician Decision|2|||
105511774|NCT00203996|363879210|FG004|Overall Study|Physician Decision|0|||
105591843|NCT01726023|364167285|FG001|Overall Study|Lost to Follow-up|10|||
105591844|NCT01726023|364167284|FG000|Overall Study|Other Eligibility criteria|7|||
105591845|NCT01726023|364167285|FG001|Overall Study|Other Eligibility criteria|7|||
105511775|NCT00203996|363879211|FG005|Overall Study|Physician Decision|0|||
105511776|NCT00203996|363879212|FG006|Overall Study|Physician Decision|0|||
105511777|NCT00203996|363879213|FG007|Overall Study|Physician Decision|0|||
105511778|NCT00203996|363879214|FG008|Overall Study|Physician Decision|0|||
105511779|NCT00203996|363879215|FG009|Overall Study|Physician Decision|1|||
105511780|NCT00203996|363879206|FG000|Overall Study|CPAP machine malfunction|0|||
105511781|NCT00203996|363879207|FG001|Overall Study|CPAP machine malfunction|0|||
105511782|NCT00203996|363879208|FG002|Overall Study|CPAP machine malfunction|0|||
105511783|NCT00203996|363879209|FG003|Overall Study|CPAP machine malfunction|1|||
105511784|NCT00203996|363879210|FG004|Overall Study|CPAP machine malfunction|0|||
105511785|NCT00203996|363879211|FG005|Overall Study|CPAP machine malfunction|0|||
105511786|NCT00203996|363879212|FG006|Overall Study|CPAP machine malfunction|0|||
105511787|NCT00203996|363879213|FG007|Overall Study|CPAP machine malfunction|0|||
105591846|NCT01726023|364167284|FG000|Overall Study|Withdrawal by Subject|16|||
105511788|NCT00203996|363879214|FG008|Overall Study|CPAP machine malfunction|0|||
105511789|NCT00203996|363879215|FG009|Overall Study|CPAP machine malfunction|0|||
105591847|NCT01726023|364167285|FG001|Overall Study|Withdrawal by Subject|8|||
105591848|NCT03394027|364167289|FG000|Overall Study|Ineligible|3|||
105591849|NCT03394027|364167290|FG001|Overall Study|Ineligible|1|||
105591850|NCT03394027|364167291|FG002|Overall Study|Ineligible|3|||
105591851|NCT03394027|364167289|FG000|Overall Study|Participant declined to participate before treatment started|0|||
105591852|NCT03394027|364167290|FG001|Overall Study|Participant declined to participate before treatment started|0|||
105591853|NCT03394027|364167291|FG002|Overall Study|Participant declined to participate before treatment started|1|||
105591854|NCT04858425|364167292|FG000|Overall Study|Adverse Event|2|||
105591855|NCT04858425|364167293|FG001|Overall Study|Adverse Event|2|||
105591856|NCT04858425|364167292|FG000|Overall Study|Withdrawal by Subject|3|||
105591857|NCT04858425|364167293|FG001|Overall Study|Withdrawal by Subject|1|||
105591858|NCT04858425|364167292|FG000|Overall Study|Lost to Follow-up|4|||
105591859|NCT04858425|364167293|FG001|Overall Study|Lost to Follow-up|2|||
105591860|NCT04858425|364167292|FG000|Overall Study|Lost to Follow-up|1|||
105591861|NCT04858425|364167293|FG001|Overall Study|Lost to Follow-up|0|||
105591862|NCT03368001|364167294|FG000|Allocation|Lost to Pretest|16|||
105591863|NCT03368001|364167295|FG001|Allocation|Lost to Pretest|25|||
105591864|NCT03368001|364167294|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
105591865|NCT03368001|364167295|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
105591866|NCT03368001|364167294|FG000|Posttest|Lost to Posttest|7|||
105591867|NCT03368001|364167295|FG001|Posttest|Lost to Posttest|11|||
105591868|NCT03368001|364167294|FG000|Posttest|Discontinued Intervention|6|||
105591869|NCT03368001|364167295|FG001|Posttest|Discontinued Intervention|19|||
105591870|NCT03368001|364167294|FG000|Follow-up|Lost to Follow-up|6|||
105591871|NCT03368001|364167295|FG001|Follow-up|Lost to Follow-up|3|||
105591872|NCT02197234|364167296|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
105591873|NCT02197234|364167296|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
105591874|NCT02197234|364167296|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
105591875|NCT02197234|364167296|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
105591876|NCT02197234|364167296|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
105591877|NCT02197234|364167296|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
105591878|NCT04391309|364167297|FG000|Overall Study|Death|1|||
105591879|NCT04391309|364167298|FG001|Overall Study|Death|1|||
105591880|NCT04391309|364167297|FG000|Overall Study|Lost to Follow-up|3|||
105591881|NCT04391309|364167298|FG001|Overall Study|Lost to Follow-up|2|||
105591882|NCT04391309|364167297|FG000|Overall Study|Withdrawal by Subject|2|||
105591883|NCT04391309|364167298|FG001|Overall Study|Withdrawal by Subject|2|||
105591884|NCT02781584|364167299|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
105591885|NCT02781584|364167300|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
105591886|NCT02781584|364167301|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
105591887|NCT02781584|364167302|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
105591888|NCT02781584|364167303|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
105591889|NCT02781584|364167304|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
105591890|NCT02781584|364167305|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
105591891|NCT02781584|364167306|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
105591892|NCT02781584|364167307|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
105591893|NCT02781584|364167308|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
105591894|NCT02781584|364167309|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
105591895|NCT02781584|364167310|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
105591896|NCT02781584|364167311|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
105591897|NCT02781584|364167299|FG000|Pre-treatment Phase|Adverse Event|0|||
105591898|NCT02781584|364167300|FG001|Pre-treatment Phase|Adverse Event|0|||
105591899|NCT02781584|364167301|FG002|Pre-treatment Phase|Adverse Event|0|||
105591900|NCT02781584|364167302|FG003|Pre-treatment Phase|Adverse Event|0|||
105591901|NCT02781584|364167303|FG004|Pre-treatment Phase|Adverse Event|0|||
105591902|NCT02781584|364167304|FG005|Pre-treatment Phase|Adverse Event|0|||
105591903|NCT02781584|364167305|FG006|Pre-treatment Phase|Adverse Event|0|||
105591904|NCT02781584|364167306|FG007|Pre-treatment Phase|Adverse Event|0|||
105591905|NCT02781584|364167307|FG008|Pre-treatment Phase|Adverse Event|0|||
105591906|NCT02781584|364167308|FG009|Pre-treatment Phase|Adverse Event|0|||
105591907|NCT02781584|364167309|FG010|Pre-treatment Phase|Adverse Event|0|||
105591908|NCT02781584|364167310|FG011|Pre-treatment Phase|Adverse Event|1|||
105591909|NCT02781584|364167311|FG012|Pre-treatment Phase|Adverse Event|0|||
105591910|NCT02781584|364167299|FG000|Treatment Phase|Withdrew Consent|0|||
105591911|NCT02781584|364167300|FG001|Treatment Phase|Withdrew Consent|0|||
105591912|NCT02781584|364167301|FG002|Treatment Phase|Withdrew Consent|0|||
105591913|NCT02781584|364167302|FG003|Treatment Phase|Withdrew Consent|0|||
105591914|NCT02781584|364167303|FG004|Treatment Phase|Withdrew Consent|0|||
105591915|NCT02781584|364167304|FG005|Treatment Phase|Withdrew Consent|1|||
105591916|NCT02781584|364167305|FG006|Treatment Phase|Withdrew Consent|0|||
105591917|NCT02781584|364167306|FG007|Treatment Phase|Withdrew Consent|0|||
105591918|NCT02781584|364167307|FG008|Treatment Phase|Withdrew Consent|0|||
105591919|NCT02781584|364167308|FG009|Treatment Phase|Withdrew Consent|0|||
105591920|NCT02781584|364167309|FG010|Treatment Phase|Withdrew Consent|1|||
105591921|NCT02781584|364167310|FG011|Treatment Phase|Withdrew Consent|2|||
105511790|NCT00203996|363879206|FG000|Overall Study|Scheduling issue|0|||
105511791|NCT00203996|363879207|FG001|Overall Study|Scheduling issue|0|||
105511792|NCT00203996|363879208|FG002|Overall Study|Scheduling issue|0|||
105511793|NCT00203996|363879209|FG003|Overall Study|Scheduling issue|0|||
105511794|NCT00203996|363879210|FG004|Overall Study|Scheduling issue|0|||
105511795|NCT00203996|363879211|FG005|Overall Study|Scheduling issue|0|||
105511796|NCT00203996|363879212|FG006|Overall Study|Scheduling issue|0|||
105511797|NCT00203996|363879213|FG007|Overall Study|Scheduling issue|2|||
105511798|NCT00203996|363879214|FG008|Overall Study|Scheduling issue|0|||
105511799|NCT00203996|363879215|FG009|Overall Study|Scheduling issue|0|||
105511800|NCT03064451|363879216|FG000|Overall Study|Lost to Follow-up|1|||
105511801|NCT03064451|363879216|FG000|Overall Study|Mapping Failure|4|||
105511802|NCT03064451|363879216|FG000|Overall Study|Exited prior to procedure|8|||
105511803|NCT03064451|363879216|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
105511804|NCT00850564|363879217|FG000|Overall Study|Withdrawal by Subject|2|||
105511805|NCT05355805|363879218|FG000|Overall Study|Lost to Follow-up|6|||
105511806|NCT05355805|363879219|FG001|Overall Study|Lost to Follow-up|11|||
105511807|NCT05355805|363879220|FG002|Overall Study|Lost to Follow-up|10|||
105511808|NCT05355805|363879221|FG003|Overall Study|Lost to Follow-up|6|||
105511809|NCT05355805|363879218|FG000|Overall Study|Decision by Sponsor|0|||
105511810|NCT05355805|363879219|FG001|Overall Study|Decision by Sponsor|0|||
105511811|NCT05355805|363879220|FG002|Overall Study|Decision by Sponsor|1|||
105511812|NCT05355805|363879221|FG003|Overall Study|Decision by Sponsor|0|||
105511813|NCT05355805|363879218|FG000|Overall Study|Withdrawal by Subject|7|||
105511814|NCT05355805|363879219|FG001|Overall Study|Withdrawal by Subject|14|||
105511815|NCT05355805|363879220|FG002|Overall Study|Withdrawal by Subject|15|||
105511816|NCT05355805|363879221|FG003|Overall Study|Withdrawal by Subject|13|||
105511817|NCT02167893|363879224|FG000|Overall Study|Investigator transferred|85|||
105511818|NCT02167893|363879224|FG000|Overall Study|Investigator health reasons|10|||
105511819|NCT02167893|363879224|FG000|Overall Study|Case report forms not collected|68|||
105511820|NCT00410046|363881259|FG000|Overall Study|Adverse Event|3|||
105511821|NCT00410046|363881259|FG000|Overall Study|Withdrawal by Subject|1|||
105511822|NCT00410046|363881259|FG000|Overall Study|Lost to Follow-up|1|||
105511823|NCT01549860|363881260|FG000|Overall Study|Withdrawal by Subject|1|||
105511824|NCT01549860|363881261|FG001|Overall Study|Withdrawal by Subject|0|||
105511825|NCT01549860|363881260|FG000|Overall Study|Physician Decision|1|||
105511826|NCT01549860|363881261|FG001|Overall Study|Physician Decision|1|||
105511827|NCT00482612|363881262|FG000|In-treatment Period|No study medication administered|0|||
105511828|NCT00482612|363881263|FG001|In-treatment Period|No study medication administered|0|||
105511829|NCT00482612|363881264|FG002|In-treatment Period|No study medication administered|1|||
105511830|NCT00482612|363881265|FG003|In-treatment Period|No study medication administered|0|||
105511831|NCT00482612|363881262|FG000|Follow-up Period|Other|4|||
105511832|NCT00482612|363881263|FG001|Follow-up Period|Other|2|||
105511833|NCT00482612|363881264|FG002|Follow-up Period|Other|1|||
105511834|NCT00482612|363881265|FG003|Follow-up Period|Other|2|||
105511835|NCT00482612|363881262|FG000|Follow-up Period|Lack of compliance|0|||
105511836|NCT00482612|363881263|FG001|Follow-up Period|Lack of compliance|0|||
105511837|NCT00482612|363881264|FG002|Follow-up Period|Lack of compliance|1|||
105511838|NCT00482612|363881265|FG003|Follow-up Period|Lack of compliance|0|||
105511839|NCT00482612|363881262|FG000|Follow-up Period|Lost to Follow-up|0|||
105511840|NCT00482612|363881263|FG001|Follow-up Period|Lost to Follow-up|4|||
105511841|NCT00482612|363881264|FG002|Follow-up Period|Lost to Follow-up|2|||
105511842|NCT00482612|363881265|FG003|Follow-up Period|Lost to Follow-up|1|||
105511843|NCT00482612|363881262|FG000|Follow-up Period|Adverse Event|4|||
105511844|NCT00482612|363881263|FG001|Follow-up Period|Adverse Event|7|||
105511845|NCT00482612|363881264|FG002|Follow-up Period|Adverse Event|9|||
105511846|NCT00482612|363881265|FG003|Follow-up Period|Adverse Event|0|||
105511847|NCT00482612|363881262|FG000|Follow-up Period|Lack of Efficacy|2|||
105511848|NCT00482612|363881263|FG001|Follow-up Period|Lack of Efficacy|0|||
105511849|NCT00482612|363881264|FG002|Follow-up Period|Lack of Efficacy|1|||
105511850|NCT00482612|363881265|FG003|Follow-up Period|Lack of Efficacy|0|||
105511851|NCT00482612|363881262|FG000|Follow-up Period|Withdrawal by Subject|3|||
105511852|NCT00482612|363881263|FG001|Follow-up Period|Withdrawal by Subject|5|||
105511853|NCT00482612|363881264|FG002|Follow-up Period|Withdrawal by Subject|7|||
105511854|NCT00482612|363881265|FG003|Follow-up Period|Withdrawal by Subject|2|||
105511855|NCT00482612|363881262|FG000|Follow-up Period|Reasons not related to trial|1|||
105511856|NCT00482612|363881263|FG001|Follow-up Period|Reasons not related to trial|0|||
105511857|NCT00482612|363881264|FG002|Follow-up Period|Reasons not related to trial|1|||
105511858|NCT00482612|363881265|FG003|Follow-up Period|Reasons not related to trial|3|||
105511859|NCT01366521|363881266|FG000|Overall Study|Adverse Event|1|||
105511860|NCT01366521|363881267|FG001|Overall Study|Adverse Event|0|||
105511861|NCT01366521|363881268|FG002|Overall Study|Adverse Event|0|||
105511862|NCT01366521|363881269|FG003|Overall Study|Adverse Event|0|||
105511863|NCT01366521|363881266|FG000|Overall Study|Protocol Violation|0|||
105511864|NCT01366521|363881267|FG001|Overall Study|Protocol Violation|0|||
105511865|NCT01366521|363881268|FG002|Overall Study|Protocol Violation|1|||
105511866|NCT01366521|363881269|FG003|Overall Study|Protocol Violation|0|||
105511867|NCT01366521|363881266|FG000|Overall Study|Physician Decision|0|||
105511868|NCT01366521|363881267|FG001|Overall Study|Physician Decision|0|||
105511869|NCT01366521|363881268|FG002|Overall Study|Physician Decision|1|||
105511870|NCT01366521|363881269|FG003|Overall Study|Physician Decision|0|||
105511871|NCT01366521|363881266|FG000|Overall Study|Withdrawal by Subject|0|||
105511872|NCT01366521|363881267|FG001|Overall Study|Withdrawal by Subject|1|||
105511873|NCT01366521|363881268|FG002|Overall Study|Withdrawal by Subject|0|||
105511874|NCT01366521|363881269|FG003|Overall Study|Withdrawal by Subject|0|||
105511875|NCT02430311|363881270|FG000|Part A|Adverse Event|0|||
105511876|NCT02430311|363881271|FG001|Part A|Adverse Event|1|||
105511877|NCT02430311|363881270|FG000|Part A|Withdrawal by Subject|1|||
105511878|NCT02430311|363881271|FG001|Part A|Withdrawal by Subject|0|||
105511879|NCT02430311|363881270|FG000|Part B|Meet study-specific withdrawal criteria|6|||
105511880|NCT02430311|363881271|FG001|Part B|Meet study-specific withdrawal criteria|6|||
105511881|NCT02430311|363881270|FG000|Part B|Withdrawal by Subject|2|||
105511882|NCT02430311|363881271|FG001|Part B|Withdrawal by Subject|2|||
105511883|NCT02430311|363881270|FG000|Part B|Adverse Event|1|||
105511884|NCT02430311|363881271|FG001|Part B|Adverse Event|0|||
105511885|NCT02430311|363881270|FG000|Part B|Death|1|||
105511886|NCT02430311|363881271|FG001|Part B|Death|0|||
105511887|NCT00543140|363881272|FG000|Overall Study|Lost to Follow-up|33|||
105511888|NCT00543140|363881272|FG000|Overall Study|Withdrawal by Subject|13|||
105511889|NCT00543140|363881272|FG000|Overall Study|Protocol Violation|10|||
105511890|NCT00543140|363881272|FG000|Overall Study|Insufficient weight loss|10|||
105511891|NCT00543140|363881272|FG000|Overall Study|SAE leading to explant of SAGB|3|||
105511892|NCT00543140|363881272|FG000|Overall Study|Death|1|||
105511893|NCT00543140|363881272|FG000|Overall Study|Subject moved|1|||
105511894|NCT00543140|363881272|FG000|Overall Study|Conversion to different procedure|1|||
105511895|NCT03506815|363881273|FG000|Overall Study|Adverse Event|8|||
105511896|NCT03506815|363881274|FG001|Overall Study|Adverse Event|0|||
105511897|NCT03506815|363881273|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
105511898|NCT03506815|363881274|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
105511899|NCT03506815|363881273|FG000|Overall Study|Protocol Violation|1|||
105511900|NCT03506815|363881274|FG001|Overall Study|Protocol Violation|0|||
105511901|NCT03506815|363881273|FG000|Overall Study|Elective Surgery|1|||
105511902|NCT03506815|363881274|FG001|Overall Study|Elective Surgery|0|||
105511903|NCT04160091|363881275|FG000|Overall Study|Terminated by Sponsor|7|||
105511904|NCT04160091|363881276|FG001|Overall Study|Terminated by Sponsor|3|||
105511905|NCT04160091|363881277|FG002|Overall Study|Terminated by Sponsor|5|||
105511906|NCT04160091|363881278|FG003|Overall Study|Terminated by Sponsor|2|||
105511907|NCT04160091|363881275|FG000|Overall Study|Noncompliance|0|||
105511908|NCT04160091|363881276|FG001|Overall Study|Noncompliance|0|||
105511909|NCT04160091|363881277|FG002|Overall Study|Noncompliance|0|||
105511910|NCT04160091|363881278|FG003|Overall Study|Noncompliance|1|||
105511911|NCT04160091|363881275|FG000|Overall Study|Withdrawal by Subject|0|||
105511912|NCT04160091|363881276|FG001|Overall Study|Withdrawal by Subject|0|||
105511913|NCT04160091|363881277|FG002|Overall Study|Withdrawal by Subject|0|||
105511914|NCT04160091|363881278|FG003|Overall Study|Withdrawal by Subject|1|||
105511915|NCT01599234|363881282|FG000|Overall Study|Adverse Event|9|||
105511916|NCT01599234|363881283|FG001|Overall Study|Adverse Event|5|||
105511917|NCT01599234|363881282|FG000|Overall Study|Withdrawal by Subject|2|||
105511918|NCT01599234|363881283|FG001|Overall Study|Withdrawal by Subject|1|||
105511919|NCT01599234|363881282|FG000|Overall Study|Lost to Follow-up|1|||
105511920|NCT01599234|363881283|FG001|Overall Study|Lost to Follow-up|2|||
105511921|NCT01599234|363881282|FG000|Overall Study|Lack of Efficacy|2|||
105511922|NCT01599234|363881283|FG001|Overall Study|Lack of Efficacy|4|||
105511923|NCT01599234|363881282|FG000|Overall Study|Unable to operate spray|1|||
105511924|NCT01599234|363881283|FG001|Overall Study|Unable to operate spray|0|||
105511925|NCT01599234|363881282|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
105511926|NCT01599234|363881283|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
105511927|NCT01599234|363881282|FG000|Overall Study|Death|1|||
105511928|NCT01599234|363881283|FG001|Overall Study|Death|0|||
105511929|NCT01599234|363881282|FG000|Overall Study|Patient would not stop driving|1|||
105511930|NCT01599234|363881283|FG001|Overall Study|Patient would not stop driving|0|||
105511931|NCT01599234|363881282|FG000|Overall Study|Contra-indication discovered|0|||
105511932|NCT01599234|363881283|FG001|Overall Study|Contra-indication discovered|1|||
105511933|NCT01599234|363881282|FG000|Overall Study|Pregnancy|0|||
105511934|NCT01599234|363881283|FG001|Overall Study|Pregnancy|1|||
105511935|NCT04626297|363881293|FG000|Overall Study|Adverse Event|5|||
105511936|NCT04626297|363881294|FG001|Overall Study|Adverse Event|3|||
105511937|NCT04626297|363881293|FG000|Overall Study|Lost to Follow-up|7|||
105511938|NCT04626297|363881294|FG001|Overall Study|Lost to Follow-up|3|||
105511939|NCT04626297|363881293|FG000|Overall Study|Protocol Violation|5|||
105511940|NCT04626297|363881294|FG001|Overall Study|Protocol Violation|1|||
105511941|NCT04626297|363881293|FG000|Overall Study|Withdrawal by Subject|20|||
105511942|NCT04626297|363881294|FG001|Overall Study|Withdrawal by Subject|6|||
105511943|NCT04626297|363881293|FG000|Overall Study|Sponsor decision|2|||
105511944|NCT04626297|363881294|FG001|Overall Study|Sponsor decision|1|||
105511945|NCT02170298|363881295|FG000|Overall Study|Withdrawal by Subject|0|||
105591922|NCT02781584|364167311|FG012|Treatment Phase|Withdrew Consent|0|||
105591923|NCT02781584|364167299|FG000|Treatment Phase|Adverse Event|0|||
105591924|NCT02781584|364167300|FG001|Treatment Phase|Adverse Event|0|||
105591925|NCT02781584|364167301|FG002|Treatment Phase|Adverse Event|0|||
105591926|NCT02781584|364167302|FG003|Treatment Phase|Adverse Event|0|||
105591927|NCT02781584|364167303|FG004|Treatment Phase|Adverse Event|0|||
105591928|NCT02781584|364167304|FG005|Treatment Phase|Adverse Event|0|||
105591929|NCT02781584|364167305|FG006|Treatment Phase|Adverse Event|0|||
105591930|NCT02781584|364167306|FG007|Treatment Phase|Adverse Event|1|||
105591931|NCT02781584|364167307|FG008|Treatment Phase|Adverse Event|0|||
105591932|NCT02781584|364167308|FG009|Treatment Phase|Adverse Event|0|||
105591933|NCT02781584|364167309|FG010|Treatment Phase|Adverse Event|0|||
105591934|NCT02781584|364167310|FG011|Treatment Phase|Adverse Event|0|||
105591935|NCT02781584|364167311|FG012|Treatment Phase|Adverse Event|0|||
105591936|NCT04340362|364167314|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
105591937|NCT02104765|364167319|FG000|Overall Study|Lost to Follow-up|0|||
105591938|NCT02104765|364167320|FG001|Overall Study|Lost to Follow-up|0|||
105591939|NCT02104765|364167321|FG002|Overall Study|Lost to Follow-up|1|||
105591940|NCT02104765|364167322|FG003|Overall Study|Lost to Follow-up|0|||
105591941|NCT02104765|364167323|FG004|Overall Study|Lost to Follow-up|0|||
105591942|NCT02104765|364167324|FG005|Overall Study|Lost to Follow-up|0|||
105591943|NCT02104765|364167325|FG006|Overall Study|Lost to Follow-up|0|||
105591944|NCT02104765|364167319|FG000|Overall Study|Withdrawal by Subject|0|||
105591945|NCT02104765|364167320|FG001|Overall Study|Withdrawal by Subject|0|||
105591946|NCT02104765|364167321|FG002|Overall Study|Withdrawal by Subject|0|||
105591947|NCT02104765|364167322|FG003|Overall Study|Withdrawal by Subject|1|||
105591948|NCT02104765|364167323|FG004|Overall Study|Withdrawal by Subject|1|||
105591949|NCT02104765|364167324|FG005|Overall Study|Withdrawal by Subject|0|||
105591950|NCT02104765|364167325|FG006|Overall Study|Withdrawal by Subject|1|||
105591951|NCT02357784|364167326|FG000|Overall Study|Withdrawal by Subject|1|||
105591952|NCT00995709|364167329|FG000|Overall Study|Adverse Event|4|||
105591953|NCT00995709|364167330|FG001|Overall Study|Adverse Event|2|||
105591954|NCT00995709|364167331|FG002|Overall Study|Adverse Event|0|||
105591955|NCT00995709|364167329|FG000|Overall Study|Lack of Efficacy|0|||
105591956|NCT00995709|364167330|FG001|Overall Study|Lack of Efficacy|1|||
105591957|NCT00995709|364167331|FG002|Overall Study|Lack of Efficacy|4|||
105591958|NCT00995709|364167329|FG000|Overall Study|Withdrawal by Subject|0|||
105591959|NCT00995709|364167330|FG001|Overall Study|Withdrawal by Subject|4|||
105591960|NCT00995709|364167331|FG002|Overall Study|Withdrawal by Subject|1|||
105591961|NCT00995709|364167329|FG000|Overall Study|Lost to Follow-up|1|||
105591962|NCT00995709|364167330|FG001|Overall Study|Lost to Follow-up|0|||
105591963|NCT00995709|364167331|FG002|Overall Study|Lost to Follow-up|0|||
105591964|NCT00995709|364167329|FG000|Overall Study|Death|0|||
105591965|NCT00995709|364167330|FG001|Overall Study|Death|1|||
105591966|NCT00995709|364167331|FG002|Overall Study|Death|0|||
105591967|NCT00995709|364167329|FG000|Overall Study|Protocol Violation|2|||
105591968|NCT00995709|364167330|FG001|Overall Study|Protocol Violation|1|||
105591969|NCT00995709|364167331|FG002|Overall Study|Protocol Violation|0|||
105591970|NCT02698241|364167334|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
105591971|NCT02698241|364167334|FG000|Overall Study|Screening not met|7|||
105591972|NCT02698241|364167334|FG000|Overall Study|Withdrawal by Subject|7|||
105591973|NCT02698241|364167334|FG000|Overall Study|Physician Decision|2|||
105591974|NCT02698241|364167334|FG000|Overall Study|Subject underwent system modification|2|||
105591975|NCT02698241|364167334|FG000|Overall Study|Lost to Follow-up|3|||
105511946|NCT02170298|363881296|FG001|Overall Study|Withdrawal by Subject|1|||
105511947|NCT02170298|363881295|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
105591976|NCT02698241|364167334|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
105511948|NCT02170298|363881296|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
105511949|NCT00885105|363881297|FG000|Overall Study|Withdrawal by Subject|0|||
105511950|NCT00885105|363881298|FG001|Overall Study|Withdrawal by Subject|8|||
105511951|NCT00885105|363881297|FG000|Overall Study|Adverse Event|1|||
105511952|NCT00885105|363881298|FG001|Overall Study|Adverse Event|0|||
105511953|NCT00885105|363881297|FG000|Overall Study|Protocol Violation|0|||
105511954|NCT00885105|363881298|FG001|Overall Study|Protocol Violation|2|||
105511955|NCT03020160|363881299|FG000|Overall Study|Withdrawal by Subject|1|||
105511956|NCT03020160|363881300|FG001|Overall Study|Withdrawal by Subject|0|||
105511957|NCT01513473|363881301|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
105511958|NCT01513473|363881302|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
105511959|NCT01513473|363881301|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
105511960|NCT01513473|363881302|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
105511961|NCT01513473|363881301|FG000|Main Trial (26 Weeks)|Unclassified|0|||
105511962|NCT01513473|363881302|FG001|Main Trial (26 Weeks)|Unclassified|2|||
105511963|NCT01513473|363881301|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
105511964|NCT01513473|363881302|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
105511965|NCT01513473|363881301|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
105511966|NCT01513473|363881302|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
105511967|NCT01350414|363881309|FG000|Overall Study|Lost to Follow-up|13|||
105511968|NCT01350414|363881309|FG000|Overall Study|Withdrawal by Subject|4|||
105511969|NCT01350414|363881309|FG000|Overall Study|Physician Decision|2|||
105511970|NCT04016285|363881310|FG000|Overall Study|Did not progress to surgery|2|||
105511971|NCT04016285|363881311|FG001|Overall Study|Did not progress to surgery|5|||
105511972|NCT04016285|363881310|FG000|Overall Study|Failed to collect outcome data|5|||
105511973|NCT04016285|363881311|FG001|Overall Study|Failed to collect outcome data|3|||
105511974|NCT00460408|363881315|FG000|Overall Study|Adverse Event|1|||
105511975|NCT00460408|363881316|FG001|Overall Study|Adverse Event|0|||
105511976|NCT00460408|363881317|FG002|Overall Study|Adverse Event|0|||
105511977|NCT00460408|363881318|FG003|Overall Study|Adverse Event|0|||
105511978|NCT00460408|363881315|FG000|Overall Study|Death|7|||
105511979|NCT00460408|363881316|FG001|Overall Study|Death|0|||
105511980|NCT00460408|363881317|FG002|Overall Study|Death|0|||
105511981|NCT00460408|363881318|FG003|Overall Study|Death|0|||
105511982|NCT00460408|363881315|FG000|Overall Study|Lost to Follow-up|11|||
105511983|NCT00460408|363881316|FG001|Overall Study|Lost to Follow-up|0|||
105511984|NCT00460408|363881317|FG002|Overall Study|Lost to Follow-up|1|||
105511985|NCT00460408|363881318|FG003|Overall Study|Lost to Follow-up|0|||
105511986|NCT00460408|363881315|FG000|Overall Study|Withdrawal by Subject|31|||
105511987|NCT00460408|363881316|FG001|Overall Study|Withdrawal by Subject|0|||
105511988|NCT00460408|363881317|FG002|Overall Study|Withdrawal by Subject|0|||
105511989|NCT00460408|363881318|FG003|Overall Study|Withdrawal by Subject|0|||
105511990|NCT00460408|363881315|FG000|Overall Study|Insufficient clinical response|5|||
105511991|NCT00460408|363881316|FG001|Overall Study|Insufficient clinical response|1|||
105511992|NCT00460408|363881317|FG002|Overall Study|Insufficient clinical response|5|||
105511993|NCT00460408|363881318|FG003|Overall Study|Insufficient clinical response|0|||
105511994|NCT00460408|363881315|FG000|Overall Study|Other|12|||
105511995|NCT00460408|363881316|FG001|Overall Study|Other|2|||
105511996|NCT00460408|363881317|FG002|Overall Study|Other|0|||
105511997|NCT00460408|363881318|FG003|Overall Study|Other|0|||
105511998|NCT01218204|363881325|FG000|Part B Washout|Adverse Event|0|||
105511999|NCT01218204|363881326|FG001|Part B Washout|Adverse Event|1|||
105512000|NCT01218204|363881327|FG002|Part B Washout|Adverse Event|0|||
105512001|NCT01218204|363881328|FG003|Part B Washout|Adverse Event|0|||
105512002|NCT01218204|363881325|FG000|Part B Washout|Lost to Follow-up|0|||
105512003|NCT01218204|363881326|FG001|Part B Washout|Lost to Follow-up|2|||
105512004|NCT01218204|363881327|FG002|Part B Washout|Lost to Follow-up|0|||
105512005|NCT01218204|363881328|FG003|Part B Washout|Lost to Follow-up|0|||
105512006|NCT01218204|363881325|FG000|Part B Washout|Physician Decision|0|||
105512007|NCT01218204|363881326|FG001|Part B Washout|Physician Decision|14|||
105512008|NCT01218204|363881327|FG002|Part B Washout|Physician Decision|0|||
105512009|NCT01218204|363881328|FG003|Part B Washout|Physician Decision|0|||
105512010|NCT01218204|363881325|FG000|Part B Washout|Withdrawal by Subject|0|||
105512011|NCT01218204|363881326|FG001|Part B Washout|Withdrawal by Subject|14|||
105512012|NCT01218204|363881327|FG002|Part B Washout|Withdrawal by Subject|0|||
105512013|NCT01218204|363881328|FG003|Part B Washout|Withdrawal by Subject|0|||
105512014|NCT01218204|363881325|FG000|Part B Washout|Reached defined stopping criteria|0|||
105512015|NCT01218204|363881326|FG001|Part B Washout|Reached defined stopping criteria|2|||
105512016|NCT01218204|363881327|FG002|Part B Washout|Reached defined stopping criteria|0|||
105512017|NCT01218204|363881328|FG003|Part B Washout|Reached defined stopping criteria|0|||
105512018|NCT01218204|363881325|FG000|Part B Washout|Did not meet continuation criteria|0|||
105512019|NCT01218204|363881326|FG001|Part B Washout|Did not meet continuation criteria|112|||
105512020|NCT01218204|363881327|FG002|Part B Washout|Did not meet continuation criteria|0|||
105512021|NCT01218204|363881328|FG003|Part B Washout|Did not meet continuation criteria|0|||
105512022|NCT01218204|363881325|FG000|Part B Run-in|Adverse Event|0|||
105512023|NCT01218204|363881326|FG001|Part B Run-in|Adverse Event|0|||
105512024|NCT01218204|363881327|FG002|Part B Run-in|Adverse Event|1|||
105512025|NCT01218204|363881328|FG003|Part B Run-in|Adverse Event|0|||
105512026|NCT01218204|363881325|FG000|Part B Run-in|Protocol Violation|0|||
105512027|NCT01218204|363881326|FG001|Part B Run-in|Protocol Violation|0|||
105512028|NCT01218204|363881327|FG002|Part B Run-in|Protocol Violation|2|||
105512029|NCT01218204|363881328|FG003|Part B Run-in|Protocol Violation|0|||
105512030|NCT01218204|363881325|FG000|Part B Run-in|Withdrawal by Subject|0|||
105512031|NCT01218204|363881326|FG001|Part B Run-in|Withdrawal by Subject|0|||
105512032|NCT01218204|363881327|FG002|Part B Run-in|Withdrawal by Subject|3|||
105512033|NCT01218204|363881328|FG003|Part B Run-in|Withdrawal by Subject|0|||
105512034|NCT01218204|363881325|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
105512035|NCT01218204|363881326|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
105512036|NCT01218204|363881327|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
105512037|NCT01218204|363881328|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
105512038|NCT01218204|363881325|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
105512039|NCT01218204|363881326|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
105512040|NCT01218204|363881327|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
105512041|NCT01218204|363881328|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
105512042|NCT00545168|363881329|FG000|Overall Study|Lost to Follow-up|5|||
105512043|NCT00545168|363881330|FG001|Overall Study|Lost to Follow-up|5|||
105591977|NCT02698241|364167334|FG000|Overall Study|geographic and licensing issue|1|||
105512044|NCT00545168|363881331|FG002|Overall Study|Lost to Follow-up|5|||
105512045|NCT00545168|363881329|FG000|Overall Study|Withdrawal by Subject|9|||
105512046|NCT00545168|363881330|FG001|Overall Study|Withdrawal by Subject|0|||
105512047|NCT00545168|363881331|FG002|Overall Study|Withdrawal by Subject|13|||
105512048|NCT00545168|363881329|FG000|Overall Study|Protocol Violation|1|||
105512049|NCT00545168|363881330|FG001|Overall Study|Protocol Violation|0|||
105512050|NCT00545168|363881331|FG002|Overall Study|Protocol Violation|1|||
105512051|NCT00545168|363881329|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
105512052|NCT00545168|363881330|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
105512053|NCT00545168|363881331|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
105512054|NCT02573350|363881332|FG000|Overall Study|Lost to Follow-up|2|||
105512055|NCT02573350|363881333|FG001|Overall Study|Lost to Follow-up|1|||
105512056|NCT02573350|363881332|FG000|Overall Study|Adverse Event|3|||
105512057|NCT02573350|363881333|FG001|Overall Study|Adverse Event|4|||
105512058|NCT02573350|363881332|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
105512059|NCT02573350|363881333|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
105512060|NCT02573350|363881332|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
105512061|NCT02573350|363881333|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
105512062|NCT02573350|363881332|FG000|Overall Study|Subject withdrew consent to participate|6|||
105512063|NCT02573350|363881333|FG001|Overall Study|Subject withdrew consent to participate|1|||
105512064|NCT02573350|363881332|FG000|Overall Study|Protocol Deviation|1|||
105512065|NCT02573350|363881333|FG001|Overall Study|Protocol Deviation|1|||
105512066|NCT00743340|363881337|FG000|Overall Study|Study medication non-compliance|1|||
105512067|NCT00743340|363881337|FG000|Overall Study|Lost to Follow-up|1|||
105512068|NCT00743340|363881337|FG000|Overall Study|Withdrawal from the Study|5|||
105512069|NCT00743340|363881337|FG000|Overall Study|Protocol Violation|1|||
105512070|NCT00743340|363881337|FG000|Overall Study|Virologic failure|8|||
105512071|NCT00743340|363881337|FG000|Overall Study|Pregnancy|1|||
105512072|NCT00743340|363881337|FG000|Overall Study|Rolled over to other Gilead Study|23|||
105512073|NCT00743340|363881337|FG000|Overall Study|Participant Relocated|1|||
105512074|NCT02708121|363881338|FG000|Overall Study|Withdrawn by Study Team|1|||
105512075|NCT02708121|363881339|FG001|Overall Study|Withdrawn by Study Team|1|||
105512076|NCT02708121|363881338|FG000|Overall Study|Withdrawal by Subject|0|||
105512077|NCT02708121|363881339|FG001|Overall Study|Withdrawal by Subject|4|||
105512078|NCT00127660|363881340|FG000|Overall Study|Protocol Violation|3|||
105512079|NCT00127660|363881341|FG001|Overall Study|Protocol Violation|3|||
105512080|NCT00127660|363881342|FG002|Overall Study|Protocol Violation|5|||
105512081|NCT00127660|363881343|FG003|Overall Study|Protocol Violation|0|||
105512082|NCT01987505|363881344|FG000|Overall Study|Other|9|||
105512083|NCT01987505|363881344|FG000|Overall Study|Withdrawal by Subject|2|||
105512084|NCT01987505|363881344|FG000|Overall Study|Other Reason|2|||
105512085|NCT01987505|363881344|FG000|Overall Study|Lost to Follow-up|15|||
105512086|NCT01987505|363881344|FG000|Overall Study|Investigator Decision|2|||
105512087|NCT01987505|363881344|FG000|Overall Study|Death|4|||
105512088|NCT01833520|363881345|FG000|Overall Study|Lack of Efficacy|3|||
105512089|NCT01833520|363881346|FG001|Overall Study|Lack of Efficacy|3|||
105512090|NCT01833520|363881347|FG002|Overall Study|Lack of Efficacy|8|||
105512091|NCT01833520|363881348|FG003|Overall Study|Lack of Efficacy|3|||
105512092|NCT02743520|363881349|FG000|Overall Study|Withdrawal by Subject|1|||
105512093|NCT01124422|363881350|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
105512094|NCT01124422|363881351|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
105512095|NCT01124422|363881352|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
105512096|NCT01124422|363881350|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
105512097|NCT01124422|363881351|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
105512098|NCT01124422|363881352|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
105512099|NCT01124422|363881350|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
105512100|NCT01124422|363881351|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
105512101|NCT01124422|363881352|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
105512102|NCT01124422|363881350|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
105512103|NCT01124422|363881351|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
105512104|NCT01124422|363881352|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
105512105|NCT01124422|363881350|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
105512106|NCT01124422|363881351|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
105512107|NCT01124422|363881352|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
105512108|NCT01124422|363881350|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
105512109|NCT01124422|363881351|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
105512110|NCT01124422|363881352|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
105512111|NCT01124422|363881350|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
105512112|NCT01124422|363881351|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
105512113|NCT01124422|363881352|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
105512114|NCT01124422|363881350|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
105512115|NCT01124422|363881351|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
105512116|NCT01124422|363881352|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
105512117|NCT01124422|363881350|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
105512118|NCT01124422|363881351|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
105512119|NCT01124422|363881352|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
105512120|NCT01124422|363881350|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
105512121|NCT01124422|363881351|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
105512122|NCT01124422|363881352|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
105512123|NCT00938639|363881353|FG000|Overall Study|Moved away from study area|0|||
105512124|NCT00938639|363881354|FG001|Overall Study|Moved away from study area|1|||
105512125|NCT00938639|363881353|FG000|Overall Study|Lost to Follow-up|1|||
105512126|NCT00938639|363881354|FG001|Overall Study|Lost to Follow-up|2|||
105512127|NCT00938639|363881353|FG000|Overall Study|Family issues|1|||
105512128|NCT00938639|363881354|FG001|Overall Study|Family issues|1|||
105512129|NCT00938639|363881353|FG000|Overall Study|Participant noncompliance|1|||
105512130|NCT00938639|363881354|FG001|Overall Study|Participant noncompliance|0|||
105512131|NCT02509156|363881355|FG000|Randomized Phase|Death|1|||
105512132|NCT02509156|363881356|FG001|Randomized Phase|Death|0|||
105512133|NCT02509156|363881355|FG000|Randomized Phase|Withdrawal by Subject|1|||
105512134|NCT02509156|363881356|FG001|Randomized Phase|Withdrawal by Subject|1|||
105512135|NCT01083576|363881357|FG000|Overall Study|Treatment Failure|6|||
105512136|NCT01083576|363881358|FG001|Overall Study|Treatment Failure|1|||
105512137|NCT02547649|363881359|FG000|Overall Study|Lost to Follow-up|3|||
105512138|NCT02547649|363881360|FG001|Overall Study|Lost to Follow-up|1|||
105512139|NCT02547649|363881361|FG002|Overall Study|Lost to Follow-up|1|||
105512140|NCT02547649|363881359|FG000|Overall Study|Not vaccinated|0|||
105512141|NCT02547649|363881360|FG001|Overall Study|Not vaccinated|0|||
105512142|NCT02547649|363881361|FG002|Overall Study|Not vaccinated|1|||
105512143|NCT02547649|363881359|FG000|Overall Study|Withdrawal by Subject|0|||
105512144|NCT02547649|363881360|FG001|Overall Study|Withdrawal by Subject|4|||
105512145|NCT02547649|363881361|FG002|Overall Study|Withdrawal by Subject|2|||
105512146|NCT00320411|363881366|FG000|Overall Study|No investigational product admin.|4|||
105512147|NCT02859454|363881369|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
105512148|NCT04294472|363881370|FG000|Overall Study|Adverse Event|0|||
105512149|NCT04294472|363881371|FG001|Overall Study|Adverse Event|1|||
105512150|NCT04294472|363881372|FG002|Overall Study|Adverse Event|1|||
105512151|NCT04294472|363881370|FG000|Overall Study|Randomized but not treated|0|||
105512152|NCT04294472|363881371|FG001|Overall Study|Randomized but not treated|1|||
105512153|NCT04294472|363881372|FG002|Overall Study|Randomized but not treated|1|||
105512154|NCT01683383|363881376|FG000|Overall Study|Infant was not transported|1|||
105512155|NCT01683383|363881377|FG001|Overall Study|Infant was not transported|0|||
105512156|NCT00855920|363881378|FG000|Overall Study|Protocol Violation|0|||
105512157|NCT00855920|363881379|FG001|Overall Study|Protocol Violation|0|||
105512158|NCT00855920|363881380|FG002|Overall Study|Protocol Violation|2|||
105512159|NCT00855920|363881378|FG000|Overall Study|Adverse Event|2|||
105512160|NCT00855920|363881379|FG001|Overall Study|Adverse Event|1|||
105512161|NCT00855920|363881380|FG002|Overall Study|Adverse Event|1|||
105512162|NCT00855920|363881378|FG000|Overall Study|Lack of Efficacy|2|||
105512163|NCT00855920|363881379|FG001|Overall Study|Lack of Efficacy|2|||
105512164|NCT00855920|363881380|FG002|Overall Study|Lack of Efficacy|2|||
105512165|NCT00855920|363881378|FG000|Overall Study|Withdrawal by Subject|2|||
105512166|NCT00855920|363881379|FG001|Overall Study|Withdrawal by Subject|3|||
105512167|NCT00855920|363881380|FG002|Overall Study|Withdrawal by Subject|2|||
105512168|NCT00855920|363881378|FG000|Overall Study|Lost to Follow-up|1|||
105512169|NCT00855920|363881379|FG001|Overall Study|Lost to Follow-up|0|||
105512170|NCT00855920|363881380|FG002|Overall Study|Lost to Follow-up|2|||
105512171|NCT00855920|363881378|FG000|Overall Study|Death|0|||
105512172|NCT00855920|363881379|FG001|Overall Study|Death|1|||
105512173|NCT00855920|363881380|FG002|Overall Study|Death|0|||
105512174|NCT00855920|363881378|FG000|Overall Study|Decision by the sponsor|0|||
105512175|NCT00855920|363881379|FG001|Overall Study|Decision by the sponsor|1|||
105512176|NCT00855920|363881380|FG002|Overall Study|Decision by the sponsor|1|||
105512177|NCT00855920|363881378|FG000|Overall Study|Other than specified above|1|||
105512178|NCT00855920|363881379|FG001|Overall Study|Other than specified above|1|||
105512179|NCT00855920|363881380|FG002|Overall Study|Other than specified above|1|||
105512180|NCT02496611|363881383|FG000|Overall Study|Lost to Follow-up|2|||
105512181|NCT02496611|363881384|FG001|Overall Study|Lost to Follow-up|1|||
105512182|NCT02496611|363881383|FG000|Overall Study|Withdrawal by Subject|5|||
105512183|NCT02496611|363881384|FG001|Overall Study|Withdrawal by Subject|2|||
105512184|NCT01365910|363881385|FG000|Overall Study|Withdrawal by Subject|7|||
105512185|NCT01365910|363881385|FG000|Overall Study|disease progression|18|||
105512186|NCT01365910|363881385|FG000|Overall Study|Adverse Event|3|||
105512187|NCT01365910|363881385|FG000|Overall Study|other complicating disease|1|||
105512188|NCT01365910|363881385|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
105512189|NCT02289417|363881386|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
105512190|NCT02289417|363881387|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
105512191|NCT02289417|363881388|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
105512192|NCT02289417|363881389|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
105591978|NCT02698241|364167334|FG000|Overall Study|Death|2|||
105512193|NCT02289417|363881390|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
105512194|NCT02289417|363881391|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
105512195|NCT02289417|363881392|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
105512196|NCT02289417|363881393|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
105512197|NCT02289417|363881394|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
105512198|NCT02289417|363881386|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
105512199|NCT02289417|363881387|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
105512200|NCT02289417|363881388|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
105512201|NCT02289417|363881389|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
105512202|NCT02289417|363881390|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
105512203|NCT02289417|363881391|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
105512204|NCT02289417|363881392|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
105512205|NCT02289417|363881393|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
105512206|NCT02289417|363881394|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
105512207|NCT02289417|363881386|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
105512208|NCT02289417|363881387|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
105512209|NCT02289417|363881388|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
105512210|NCT02289417|363881389|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
105512211|NCT02289417|363881390|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
105512212|NCT02289417|363881391|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
105512213|NCT02289417|363881392|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
105512214|NCT02289417|363881393|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
105512215|NCT02289417|363881394|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
105512216|NCT02289417|363881386|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
105512217|NCT02289417|363881387|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
105512218|NCT02289417|363881388|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
105512219|NCT02289417|363881389|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
105512220|NCT02289417|363881390|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
105512221|NCT02289417|363881391|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
105512222|NCT02289417|363881392|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
105512223|NCT02289417|363881393|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
105512224|NCT02289417|363881394|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
105512225|NCT02289417|363881386|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
105512226|NCT02289417|363881387|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
105512227|NCT02289417|363881388|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
105512228|NCT02289417|363881389|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
105512229|NCT02289417|363881390|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
105512230|NCT02289417|363881391|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
105512231|NCT02289417|363881392|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
105512232|NCT02289417|363881393|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
105512233|NCT02289417|363881394|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
105512234|NCT02289417|363881386|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
105512235|NCT02289417|363881387|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
105512236|NCT02289417|363881388|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
105512237|NCT02289417|363881389|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
105512238|NCT02289417|363881390|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
105512239|NCT02289417|363881391|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
105512240|NCT02289417|363881392|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
105512241|NCT02289417|363881393|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
105512242|NCT02289417|363881394|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
105512243|NCT02289417|363881386|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
105512244|NCT02289417|363881387|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
105512245|NCT02289417|363881388|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
105512246|NCT02289417|363881389|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
105512247|NCT02289417|363881390|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
105512248|NCT02289417|363881391|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
105512249|NCT02289417|363881392|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
105512250|NCT02289417|363881393|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
105512251|NCT02289417|363881394|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
105512252|NCT02289417|363881386|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
105512253|NCT02289417|363881387|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
105512254|NCT02289417|363881388|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
105512255|NCT02289417|363881389|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
105512256|NCT02289417|363881390|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
105512257|NCT02289417|363881391|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
105512258|NCT02289417|363881392|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
105591979|NCT02351180|364167335|FG000|Overall Study|Withdrawal by Subject|1|||
105512259|NCT02289417|363881393|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
105512260|NCT02289417|363881394|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
105512261|NCT02289417|363881386|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
105512262|NCT02289417|363881387|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
105512263|NCT02289417|363881388|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
105512264|NCT02289417|363881389|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
105512265|NCT02289417|363881390|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
105512266|NCT02289417|363881391|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
105512267|NCT02289417|363881392|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
105512268|NCT02289417|363881393|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
105512269|NCT02289417|363881394|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
105512270|NCT02289417|363881386|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
105512271|NCT02289417|363881387|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
105512272|NCT02289417|363881388|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
105512273|NCT02289417|363881389|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
105512274|NCT02289417|363881390|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
105512275|NCT02289417|363881391|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
105512276|NCT02289417|363881392|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
105512277|NCT02289417|363881393|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
105512278|NCT02289417|363881394|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
105512279|NCT02289417|363881386|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
105512280|NCT02289417|363881387|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
105512281|NCT02289417|363881388|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
105512282|NCT02289417|363881389|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
105512283|NCT02289417|363881390|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
105512284|NCT02289417|363881391|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
105512285|NCT02289417|363881392|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
105512286|NCT02289417|363881393|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
105512287|NCT02289417|363881394|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
105512288|NCT02289417|363881386|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
105512289|NCT02289417|363881387|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
105512290|NCT02289417|363881388|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
105512291|NCT02289417|363881389|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
105512292|NCT02289417|363881390|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
105512293|NCT02289417|363881391|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
105512294|NCT02289417|363881392|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
105512295|NCT02289417|363881393|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
105512296|NCT02289417|363881394|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
105512297|NCT02289417|363881386|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
105512298|NCT02289417|363881387|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
105512299|NCT02289417|363881388|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
105512300|NCT02289417|363881389|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
105512301|NCT02289417|363881390|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
105512302|NCT02289417|363881391|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
105512303|NCT02289417|363881392|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
105512304|NCT02289417|363881393|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
105512305|NCT02289417|363881394|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
105512306|NCT02289417|363881386|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
105512307|NCT02289417|363881387|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
105512308|NCT02289417|363881388|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
105512309|NCT02289417|363881389|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
105512310|NCT02289417|363881390|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
105512311|NCT02289417|363881391|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
105512312|NCT02289417|363881392|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
105512313|NCT02289417|363881393|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
105512314|NCT02289417|363881394|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
105512315|NCT03926169|363881395|FG000|Period A|Adverse Event|2|||
105512316|NCT03926169|363881396|FG001|Period A|Adverse Event|2|||
105512317|NCT03926169|363881397|FG002|Period A|Adverse Event|1|||
105512318|NCT03926169|363881395|FG000|Period A|Withdrawal by Subject|2|||
105512319|NCT03926169|363881396|FG001|Period A|Withdrawal by Subject|2|||
105512320|NCT03926169|363881397|FG002|Period A|Withdrawal by Subject|2|||
105512321|NCT03926169|363881395|FG000|Period A|Lost to Follow-up|3|||
105512322|NCT03926169|363881396|FG001|Period A|Lost to Follow-up|1|||
105512323|NCT03926169|363881397|FG002|Period A|Lost to Follow-up|0|||
105512324|NCT03926169|363881395|FG000|Period A|Lack of Efficacy|0|||
105512325|NCT03926169|363881396|FG001|Period A|Lack of Efficacy|2|||
105512326|NCT03926169|363881397|FG002|Period A|Lack of Efficacy|2|||
105512327|NCT03926169|363881395|FG000|Period A|COVID-19 Infection|0|||
105512328|NCT03926169|363881396|FG001|Period A|COVID-19 Infection|1|||
105591980|NCT02351180|364167336|FG001|Overall Study|Withdrawal by Subject|0|||
105512329|NCT03926169|363881397|FG002|Period A|COVID-19 Infection|0|||
105512330|NCT03926169|363881395|FG000|Period A|COVID-19 Logistical Restrictions|0|||
105512331|NCT03926169|363881396|FG001|Period A|COVID-19 Logistical Restrictions|2|||
105512332|NCT03926169|363881397|FG002|Period A|COVID-19 Logistical Restrictions|1|||
105512333|NCT03926169|363881395|FG000|Period A|Other, Not Specified|1|||
105512334|NCT03926169|363881396|FG001|Period A|Other, Not Specified|0|||
105512335|NCT03926169|363881397|FG002|Period A|Other, Not Specified|0|||
105512336|NCT03926169|363881395|FG000|Period B|Adverse Event|3|||
105512337|NCT03926169|363881396|FG001|Period B|Adverse Event|1|||
105512338|NCT03926169|363881397|FG002|Period B|Adverse Event|1|||
105512339|NCT03926169|363881395|FG000|Period B|Withdrawal by Subject|1|||
105512340|NCT03926169|363881396|FG001|Period B|Withdrawal by Subject|3|||
105512341|NCT03926169|363881397|FG002|Period B|Withdrawal by Subject|0|||
105512342|NCT03926169|363881395|FG000|Period B|Lack of Efficacy|3|||
105512343|NCT03926169|363881396|FG001|Period B|Lack of Efficacy|1|||
105512344|NCT03926169|363881397|FG002|Period B|Lack of Efficacy|1|||
105512345|NCT03926169|363881395|FG000|Period B|Lost to Follow-up|1|||
105512346|NCT03926169|363881396|FG001|Period B|Lost to Follow-up|1|||
105512347|NCT03926169|363881397|FG002|Period B|Lost to Follow-up|4|||
105512348|NCT03926169|363881395|FG000|Period B|Other, Not Specified|62|||
105512349|NCT03926169|363881396|FG001|Period B|Other, Not Specified|57|||
105512350|NCT03926169|363881397|FG002|Period B|Other, Not Specified|65|||
105512351|NCT01756898|363881401|FG000|Overall Study|Adverse Event|7|||
105512352|NCT01756898|363881402|FG001|Overall Study|Adverse Event|1|||
105512353|NCT01756898|363881403|FG002|Overall Study|Adverse Event|0|||
105512354|NCT01756898|363881404|FG003|Overall Study|Adverse Event|0|||
105512355|NCT01756898|363881401|FG000|Overall Study|Lack of Efficacy|4|||
105512356|NCT01756898|363881402|FG001|Overall Study|Lack of Efficacy|7|||
105512357|NCT01756898|363881403|FG002|Overall Study|Lack of Efficacy|6|||
105512358|NCT01756898|363881404|FG003|Overall Study|Lack of Efficacy|6|||
105512359|NCT01756898|363881401|FG000|Overall Study|Lost to Follow-up|2|||
105512360|NCT01756898|363881402|FG001|Overall Study|Lost to Follow-up|4|||
105512361|NCT01756898|363881403|FG002|Overall Study|Lost to Follow-up|2|||
105512362|NCT01756898|363881404|FG003|Overall Study|Lost to Follow-up|3|||
105512363|NCT01756898|363881401|FG000|Overall Study|Protocol Violation|1|||
105512364|NCT01756898|363881402|FG001|Overall Study|Protocol Violation|2|||
105512365|NCT01756898|363881403|FG002|Overall Study|Protocol Violation|2|||
105512366|NCT01756898|363881404|FG003|Overall Study|Protocol Violation|1|||
105512367|NCT01756898|363881401|FG000|Overall Study|Withdrew Consent|5|||
105512368|NCT01756898|363881402|FG001|Overall Study|Withdrew Consent|3|||
105512369|NCT01756898|363881403|FG002|Overall Study|Withdrew Consent|5|||
105512370|NCT01756898|363881404|FG003|Overall Study|Withdrew Consent|6|||
105512371|NCT01756898|363881401|FG000|Overall Study|Other|0|||
105512372|NCT01756898|363881402|FG001|Overall Study|Other|2|||
105512373|NCT01756898|363881403|FG002|Overall Study|Other|2|||
105512374|NCT01756898|363881404|FG003|Overall Study|Other|0|||
105512375|NCT01500694|363881405|FG000|Overall Study|Adverse Event|4|||
105512376|NCT01500694|363881406|FG001|Overall Study|Adverse Event|3|||
105512377|NCT01500694|363881405|FG000|Overall Study|Protocol Violation|0|||
105512378|NCT01500694|363881406|FG001|Overall Study|Protocol Violation|1|||
105512379|NCT01500694|363881405|FG000|Overall Study|Withdrawal by Subject|23|||
105512380|NCT01500694|363881406|FG001|Overall Study|Withdrawal by Subject|14|||
105512381|NCT01500694|363881405|FG000|Overall Study|Lost to Follow-up|2|||
105512382|NCT01500694|363881406|FG001|Overall Study|Lost to Follow-up|3|||
105512383|NCT01500694|363881405|FG000|Overall Study|Lack of Efficacy|14|||
105512384|NCT01500694|363881406|FG001|Overall Study|Lack of Efficacy|5|||
105512385|NCT01500694|363881405|FG000|Overall Study|Other|9|||
105512386|NCT01500694|363881406|FG001|Overall Study|Other|3|||
105512387|NCT00519831|363881411|FG000|Overall Study|Adverse Event|3|||
105512388|NCT00471328|363881412|FG000|Core Phase|Adverse Event|18|||
105512389|NCT00471328|363881413|FG001|Core Phase|Adverse Event|6|||
105512390|NCT00471328|363881412|FG000|Core Phase|Death|8|||
105512391|NCT00471328|363881413|FG001|Core Phase|Death|4|||
105512392|NCT00471328|363881412|FG000|Core Phase|Withdrawal by Subject|2|||
105512393|NCT00471328|363881413|FG001|Core Phase|Withdrawal by Subject|2|||
105512394|NCT00471328|363881412|FG000|Core Phase|Abnormal laboratory value|1|||
105512395|NCT00471328|363881413|FG001|Core Phase|Abnormal laboratory value|0|||
105512396|NCT00471328|363881412|FG000|Core Phase|Disease Progression|78|||
105512397|NCT00471328|363881413|FG001|Core Phase|Disease Progression|53|||
105512398|NCT00471328|363881412|FG000|Core Phase|Administrative Problem|0|||
105512399|NCT00471328|363881413|FG001|Core Phase|Administrative Problem|1|||
105512400|NCT00471328|363881412|FG000|Core Phase|Protocol Deviation|0|||
105512401|NCT00471328|363881413|FG001|Core Phase|Protocol Deviation|1|||
105512402|NCT00471328|363881412|FG000|Extension Phase|Adverse Event|3|||
105512403|NCT00471328|363881413|FG001|Extension Phase|Adverse Event|12|||
105512404|NCT00471328|363881412|FG000|Extension Phase|Withdrawal by Subject|0|||
105512405|NCT00471328|363881413|FG001|Extension Phase|Withdrawal by Subject|2|||
105512406|NCT00471328|363881412|FG000|Extension Phase|Death|1|||
105512407|NCT00471328|363881413|FG001|Extension Phase|Death|7|||
105512408|NCT00471328|363881412|FG000|Extension Phase|Protocol Deviation|3|||
105512409|NCT00471328|363881413|FG001|Extension Phase|Protocol Deviation|1|||
105512410|NCT00471328|363881412|FG000|Extension Phase|Treatment duration as per protocol|0|||
105591981|NCT01510912|364169256|FG000|Overall Study|Adverse Event|99|||
105591982|NCT01510912|364169256|FG000|Overall Study|Lack of Efficacy|12|||
105591983|NCT01510912|364169256|FG000|Overall Study|Non-compliance with trial drug|23|||
105591984|NCT01510912|364169256|FG000|Overall Study|Withdrawal by Subject|49|||
105591985|NCT01510912|364169256|FG000|Overall Study|Physician Decision|1|||
105591986|NCT01510912|364169256|FG000|Overall Study|Protocol Violation|27|||
105591987|NCT01510912|364169256|FG000|Overall Study|Lost to Follow-up|26|||
105591988|NCT01510912|364169256|FG000|Overall Study|Other, including joint replacement|5|||
105591989|NCT02380742|364169260|FG000|Overall Study|Withdrawal by Subject|1|||
105591990|NCT02380742|364169261|FG001|Overall Study|Withdrawal by Subject|0|||
105591991|NCT02689349|364169263|FG000|Overall Study|Not implanted|4|||
105591992|NCT02689349|364169264|FG001|Overall Study|Not implanted|0|||
105591993|NCT02689349|364169263|FG000|Overall Study|Withdrawal by Subject|9|||
105591994|NCT02689349|364169264|FG001|Overall Study|Withdrawal by Subject|0|||
105591995|NCT02930343|364169265|FG000|Overall Study|Lost to Follow-up|9|||
105591996|NCT02930343|364169266|FG001|Overall Study|Lost to Follow-up|7|||
105591997|NCT00954707|364169267|FG000|Overall Study|Death|34|||
105591998|NCT00954707|364169267|FG000|Overall Study|Withdrawal by Subject|100|||
105591999|NCT00954707|364169267|FG000|Overall Study|Lost to Follow-up|33|||
105592000|NCT00309452|364169268|FG000|Overall Study|Withdrawal by Subject|3|||
105592001|NCT00309452|364169269|FG001|Overall Study|Withdrawal by Subject|0|||
105592002|NCT01897233|364169274|FG000|Part B (24 Weeks)|Adverse Event|1|||
105592003|NCT01897233|364169274|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
105592004|NCT01897233|364169274|FG000|Part B (24 Weeks)|Physician Decision|1|||
105592005|NCT01977612|364169276|FG000|Overall Study|Lost to Follow-up|1|||
105592006|NCT01977612|364169277|FG001|Overall Study|Lost to Follow-up|1|||
105592007|NCT01451814|364169278|FG000|Overall Study|Withdrawal by Subject|1|||
105592008|NCT01451814|364169279|FG001|Overall Study|Withdrawal by Subject|1|||
105592009|NCT01451814|364169278|FG000|Overall Study|Lost to Follow-up|5|||
105592010|NCT01451814|364169279|FG001|Overall Study|Lost to Follow-up|4|||
105512411|NCT00471328|363881413|FG001|Extension Phase|Treatment duration as per protocol|1|||
105512412|NCT00471328|363881412|FG000|Extension Phase|Disease Progression|32|||
105512413|NCT00471328|363881413|FG001|Extension Phase|Disease Progression|44|||
105512414|NCT00471328|363881412|FG000|Extension Phase|New cancer Therapy|1|||
105512415|NCT00471328|363881413|FG001|Extension Phase|New cancer Therapy|0|||
105512416|NCT00471328|363881412|FG000|Extension Phase|Administrative Problem|1|||
105512417|NCT00471328|363881413|FG001|Extension Phase|Administrative Problem|0|||
105512418|NCT02854631|363881414|FG000|Overall Study|Adverse Event|1|||
105512419|NCT02854631|363881415|FG001|Overall Study|Adverse Event|2|||
105512420|NCT02854631|363881414|FG000|Overall Study|Withdrew Consent|3|||
105512421|NCT02854631|363881415|FG001|Overall Study|Withdrew Consent|2|||
105512422|NCT02854631|363881414|FG000|Overall Study|Investigator's Discretion|2|||
105512423|NCT02854631|363881415|FG001|Overall Study|Investigator's Discretion|0|||
105512424|NCT02854631|363881414|FG000|Overall Study|Death|12|||
105512425|NCT02854631|363881415|FG001|Overall Study|Death|8|||
105512426|NCT02854631|363881414|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
105512427|NCT02854631|363881415|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
105512428|NCT02854631|363881414|FG000|Overall Study|Protocol Violation|0|||
105512429|NCT02854631|363881415|FG001|Overall Study|Protocol Violation|1|||
105512430|NCT02854631|363881414|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
105512431|NCT02854631|363881415|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
105512432|NCT02854631|363881414|FG000|Overall Study|Lost to Follow-up|4|||
105512433|NCT02854631|363881415|FG001|Overall Study|Lost to Follow-up|2|||
105512434|NCT02233647|363881419|FG000|Overall Study|Adverse Event|1|||
105512435|NCT01605877|363881420|FG000|Overall Study|Withdrawal by Subject|1|||
105512436|NCT01918085|363881423|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
105512437|NCT01918085|363881424|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
105512438|NCT02132130|363881426|FG000|Overall Study|Lost to Follow-up|0|||
105512439|NCT02132130|363881427|FG001|Overall Study|Lost to Follow-up|2|||
105512440|NCT02132130|363881428|FG002|Overall Study|Lost to Follow-up|0|||
105592011|NCT01117480|364169280|FG000|Overall Study|Protocol Violation|8|||
105592012|NCT01117480|364169280|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
105512441|NCT02132130|363881429|FG003|Overall Study|Lost to Follow-up|0|||
105512442|NCT02132130|363881426|FG000|Overall Study|Withdrawal by Subject|0|||
105592013|NCT03646123|364169281|FG000|Overall Study|Patient transferred and not able to get testing completed|0|||
105512443|NCT02132130|363881427|FG001|Overall Study|Withdrawal by Subject|0|||
105512444|NCT02132130|363881428|FG002|Overall Study|Withdrawal by Subject|0|||
105512445|NCT02132130|363881429|FG003|Overall Study|Withdrawal by Subject|1|||
105512446|NCT03310775|363881434|FG000|Overall Study|Lost to Follow-up|2|||
105512447|NCT03310775|363881435|FG001|Overall Study|Lost to Follow-up|3|||
105592014|NCT03646123|364169282|FG001|Overall Study|Patient transferred and not able to get testing completed|1|||
105592015|NCT03646123|364169283|FG002|Overall Study|Patient transferred and not able to get testing completed|0|||
105592016|NCT03646123|364169281|FG000|Overall Study|Participant no longer met inclusion criteria and never received treatment|1|||
105592017|NCT03646123|364169282|FG001|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
105512448|NCT03310775|363881434|FG000|Overall Study|aggravation of depression|0|||
105512449|NCT03310775|363881435|FG001|Overall Study|aggravation of depression|1|||
105512450|NCT02760069|363881438|FG000|Overall Study|Withdrawal by Subject|0|||
105512451|NCT02760069|363881439|FG001|Overall Study|Withdrawal by Subject|1|||
105512452|NCT02760069|363881440|FG002|Overall Study|Withdrawal by Subject|1|||
105512453|NCT04656691|363881444|FG000|Overall Study|Adverse Event|1|||
105512454|NCT00793403|363883539|FG000|Overall Study|Other|73|||
105512455|NCT02468414|363883544|FG000|Overall Study|Early Study Termination by Sponsor|1|||
105512456|NCT02468414|363883545|FG001|Overall Study|Early Study Termination by Sponsor|0|||
105512457|NCT02468414|363883544|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
105512458|NCT02468414|363883545|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
105512459|NCT02468414|363883544|FG000|Overall Study|Screen Failure|1|||
105512460|NCT02468414|363883545|FG001|Overall Study|Screen Failure|0|||
105512461|NCT00573469|363883546|FG000|Overall Study|Adverse Event|1|||
105512462|NCT00573469|363883547|FG001|Overall Study|Adverse Event|1|||
105512463|NCT00573469|363883548|FG002|Overall Study|Adverse Event|1|||
105512464|NCT00573469|363883546|FG000|Overall Study|Withdrawal by Subject|0|||
105512465|NCT00573469|363883547|FG001|Overall Study|Withdrawal by Subject|2|||
105512466|NCT00573469|363883548|FG002|Overall Study|Withdrawal by Subject|0|||
105512467|NCT00573469|363883546|FG000|Overall Study|Other|5|||
105512468|NCT00573469|363883547|FG001|Overall Study|Other|1|||
105512469|NCT00573469|363883548|FG002|Overall Study|Other|3|||
105512470|NCT01338792|363883549|FG000|Overall Study|Adverse Event|2|||
105512471|NCT01338792|363883549|FG000|Overall Study|Death|1|||
105512472|NCT01338792|363883549|FG000|Overall Study|Withdrawal by Subject|1|||
105512473|NCT02989194|363883550|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
105512474|NCT02989194|363883551|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
105512475|NCT02989194|363883552|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
105512476|NCT02989194|363883550|FG000|Overall Study|Lost to Follow-up|0|||
105512477|NCT02989194|363883551|FG001|Overall Study|Lost to Follow-up|1|||
105512478|NCT02989194|363883552|FG002|Overall Study|Lost to Follow-up|0|||
105512479|NCT02989194|363883550|FG000|Overall Study|Withdrawal by Subject|0|||
105512480|NCT02989194|363883551|FG001|Overall Study|Withdrawal by Subject|1|||
105512481|NCT02989194|363883552|FG002|Overall Study|Withdrawal by Subject|0|||
105512482|NCT02670083|363883555|FG000|Overall Study|Adverse Event|16|||
105512483|NCT02670083|363883556|FG001|Overall Study|Adverse Event|13|||
105512484|NCT02670083|363883555|FG000|Overall Study|Death|4|||
105512485|NCT02670083|363883556|FG001|Overall Study|Death|6|||
105512486|NCT02670083|363883555|FG000|Overall Study|Lost to Follow-up|2|||
105512487|NCT02670083|363883556|FG001|Overall Study|Lost to Follow-up|2|||
105512488|NCT02670083|363883555|FG000|Overall Study|Multiple Reasons|9|||
105512489|NCT02670083|363883556|FG001|Overall Study|Multiple Reasons|9|||
105512490|NCT02670083|363883555|FG000|Overall Study|Physician Decision|0|||
105512491|NCT02670083|363883556|FG001|Overall Study|Physician Decision|2|||
105512492|NCT02670083|363883555|FG000|Overall Study|Study Terminated By Sponsor|257|||
105512493|NCT02670083|363883556|FG001|Overall Study|Study Terminated By Sponsor|254|||
105512494|NCT02670083|363883555|FG000|Overall Study|Symptomatic Deterioration|0|||
105512495|NCT02670083|363883556|FG001|Overall Study|Symptomatic Deterioration|2|||
105512496|NCT02670083|363883555|FG000|Overall Study|Withdrawal by Subject|32|||
105512497|NCT02670083|363883556|FG001|Overall Study|Withdrawal by Subject|31|||
105512498|NCT02670083|363883555|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105512499|NCT02670083|363883556|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105512500|NCT02014597|363883557|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
105512501|NCT02014597|363883558|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
105512502|NCT00381095|363883563|FG000|Overall Study|Death|3|||
105512503|NCT00381095|363883564|FG001|Overall Study|Death|4|||
105512504|NCT00381095|363883563|FG000|Overall Study|Lack of Efficacy|2|||
105512505|NCT00381095|363883564|FG001|Overall Study|Lack of Efficacy|4|||
105512506|NCT00381095|363883563|FG000|Overall Study|Other|2|||
105512507|NCT00381095|363883564|FG001|Overall Study|Other|2|||
105512508|NCT00381095|363883563|FG000|Overall Study|Protocol Violation|1|||
105512509|NCT00381095|363883564|FG001|Overall Study|Protocol Violation|1|||
105512510|NCT00381095|363883563|FG000|Overall Study|Withdrawal by Subject|3|||
105512511|NCT00381095|363883564|FG001|Overall Study|Withdrawal by Subject|3|||
105512512|NCT00381095|363883563|FG000|Overall Study|Adverse Event|2|||
105512513|NCT00381095|363883564|FG001|Overall Study|Adverse Event|7|||
105512514|NCT00617773|363883565|FG000|Overall Study|Physician Decision|1|||
105512515|NCT00617773|363883565|FG000|Overall Study|Lack of compliance with the protocol|1|||
105512516|NCT00617773|363883565|FG000|Overall Study|Withdrawal by Subject|1|||
105512517|NCT00617773|363883565|FG000|Overall Study|Death|1|||
105512518|NCT00617773|363883565|FG000|Overall Study|Progressive disease|19|||
105512519|NCT00617773|363883565|FG000|Overall Study|Protocol Violation|1|||
105512520|NCT01342796|363883568|FG000|Overall Study|Withdrawal by Subject|2|||
105512521|NCT01342796|363883569|FG001|Overall Study|Withdrawal by Subject|0|||
105512522|NCT01342796|363883568|FG000|Overall Study|Lost to Follow-up|0|||
105512523|NCT01342796|363883569|FG001|Overall Study|Lost to Follow-up|3|||
105512524|NCT01342796|363883568|FG000|Overall Study|Inappropriate enrollment|1|||
105512525|NCT01342796|363883569|FG001|Overall Study|Inappropriate enrollment|0|||
105512526|NCT02692716|363883571|FG000|Overall Study|Lost to Follow-up|2|||
105512527|NCT02692716|363883572|FG001|Overall Study|Lost to Follow-up|5|||
105512528|NCT02692716|363883571|FG000|Overall Study|Withdrawal by Subject|3|||
105512529|NCT02692716|363883572|FG001|Overall Study|Withdrawal by Subject|1|||
105512530|NCT02899988|363883573|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
105512531|NCT02899988|363883574|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
105512532|NCT02899988|363883575|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105512533|NCT02899988|363883576|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105512534|NCT02899988|363883577|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105512535|NCT02899988|363883578|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105512536|NCT02899988|363883579|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105512537|NCT02899988|363883580|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105512538|NCT02899988|363883581|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105512539|NCT02899988|363883582|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105512540|NCT02899988|363883583|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105512541|NCT02899988|363883573|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
105512542|NCT02899988|363883574|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
105512543|NCT02899988|363883575|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
105512544|NCT02899988|363883576|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
105512545|NCT02899988|363883577|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
105512546|NCT02899988|363883578|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
105512547|NCT02899988|363883579|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
105512548|NCT02899988|363883580|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
105512549|NCT02899988|363883581|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
105512550|NCT02899988|363883582|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
105512551|NCT02899988|363883583|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
105512552|NCT02899988|363883573|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
105512553|NCT02899988|363883574|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
105512554|NCT02899988|363883575|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
105512555|NCT02899988|363883576|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
105512556|NCT02899988|363883577|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
105512557|NCT02899988|363883578|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
105512558|NCT02899988|363883579|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
105512559|NCT02899988|363883580|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
105512560|NCT02899988|363883581|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
105512561|NCT02899988|363883582|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
105512562|NCT02899988|363883583|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
105512563|NCT02899988|363883573|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
105512564|NCT02899988|363883574|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
105512565|NCT02899988|363883575|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
105512566|NCT02899988|363883576|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
105512567|NCT02899988|363883577|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
105512568|NCT02899988|363883578|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
105512569|NCT02899988|363883579|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
105512570|NCT02899988|363883580|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
105512571|NCT02899988|363883581|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
105512572|NCT02899988|363883582|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
105512573|NCT02899988|363883583|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
105512574|NCT02899988|363883573|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
105512575|NCT02899988|363883574|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
105512576|NCT02899988|363883575|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
105512577|NCT02899988|363883576|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
105512578|NCT02899988|363883577|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
105512579|NCT02899988|363883578|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
105512580|NCT02899988|363883579|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
105512581|NCT02899988|363883580|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
105512582|NCT02899988|363883581|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
105512583|NCT02899988|363883582|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
105512584|NCT02899988|363883583|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
105512585|NCT02899988|363883573|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
105512586|NCT02899988|363883574|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
105512587|NCT02899988|363883575|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
105512588|NCT02899988|363883576|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
105512589|NCT02899988|363883577|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
105512590|NCT02899988|363883578|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
105512591|NCT02899988|363883579|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
105512592|NCT02899988|363883580|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
105512593|NCT02899988|363883581|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
105512594|NCT02899988|363883582|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
105512595|NCT02899988|363883583|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
105512596|NCT04492618|363883584|FG000|Overall Study|Withdrawal by Subject|1|||
105512597|NCT02433483|363883587|FG000|Overall Study|Unacceptable toxicity|1|||
105512598|NCT02433483|363883587|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
105512599|NCT02485301|363883591|FG000|Overall Study|Serious Adverse Events|2|||
105512600|NCT02485301|363883592|FG001|Overall Study|Serious Adverse Events|1|||
105512601|NCT02485301|363883591|FG000|Overall Study|Protocol Violation|0|||
105512602|NCT02485301|363883592|FG001|Overall Study|Protocol Violation|1|||
105512603|NCT02485301|363883591|FG000|Overall Study|Withdrawal by Subject|6|||
105512604|NCT02485301|363883592|FG001|Overall Study|Withdrawal by Subject|7|||
105512605|NCT02485301|363883591|FG000|Overall Study|Migrated/moved from study area|10|||
105512606|NCT02485301|363883592|FG001|Overall Study|Migrated/moved from study area|19|||
105512607|NCT02485301|363883591|FG000|Overall Study|Lost to Follow-up|17|||
105512608|NCT02485301|363883592|FG001|Overall Study|Lost to Follow-up|17|||
105512609|NCT02485301|363883591|FG000|Overall Study|Other|3|||
105512610|NCT02485301|363883592|FG001|Overall Study|Other|4|||
105512611|NCT03342690|363883593|FG000|Overall Study|Missing Information|9|||
105512612|NCT03342690|363883593|FG000|Overall Study|Protocol Violation|16|||
105512613|NCT00549302|363883594|FG000|Double-Blind|Death|2|||
105512614|NCT00549302|363883595|FG001|Double-Blind|Death|9|||
105512615|NCT00549302|363883596|FG002|Double-Blind|Death|0|||
105512616|NCT00549302|363883594|FG000|Double-Blind|Adverse Event|3|||
105512617|NCT00549302|363883595|FG001|Double-Blind|Adverse Event|16|||
105512618|NCT00549302|363883596|FG002|Double-Blind|Adverse Event|0|||
105512619|NCT00549302|363883594|FG000|Double-Blind|Withdrawal by Subject|3|||
105512620|NCT00549302|363883595|FG001|Double-Blind|Withdrawal by Subject|8|||
105512621|NCT00549302|363883596|FG002|Double-Blind|Withdrawal by Subject|0|||
105512622|NCT00549302|363883594|FG000|Double-Blind|Investigator Decision|1|||
105512623|NCT00549302|363883595|FG001|Double-Blind|Investigator Decision|5|||
105512624|NCT00549302|363883596|FG002|Double-Blind|Investigator Decision|0|||
105512625|NCT00549302|363883594|FG000|Double-Blind|Sponsor Decision|0|||
105512626|NCT00549302|363883595|FG001|Double-Blind|Sponsor Decision|1|||
105512627|NCT00549302|363883596|FG002|Double-Blind|Sponsor Decision|0|||
105512628|NCT00549302|363883594|FG000|Double-Blind|Lost to Follow-up|1|||
105512629|NCT00549302|363883595|FG001|Double-Blind|Lost to Follow-up|2|||
105512630|NCT00549302|363883596|FG002|Double-Blind|Lost to Follow-up|0|||
105512631|NCT00549302|363883594|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
105512632|NCT00549302|363883595|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
105512633|NCT00549302|363883596|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
105512634|NCT00549302|363883594|FG000|Double-Blind|New condition or starts new therapy|0|||
105512635|NCT00549302|363883595|FG001|Double-Blind|New condition or starts new therapy|2|||
105512636|NCT00549302|363883596|FG002|Double-Blind|New condition or starts new therapy|0|||
105512637|NCT00549302|363883594|FG000|Open-Label|Adverse Event|0|||
105512638|NCT00549302|363883595|FG001|Open-Label|Adverse Event|0|||
105512639|NCT00549302|363883596|FG002|Open-Label|Adverse Event|11|||
105512640|NCT00549302|363883594|FG000|Open-Label|Death|0|||
105512641|NCT00549302|363883595|FG001|Open-Label|Death|0|||
105512642|NCT00549302|363883596|FG002|Open-Label|Death|40|||
105512643|NCT00549302|363883594|FG000|Open-Label|Investigator Decision|0|||
105512644|NCT00549302|363883595|FG001|Open-Label|Investigator Decision|0|||
105512645|NCT00549302|363883596|FG002|Open-Label|Investigator Decision|5|||
105512646|NCT00549302|363883594|FG000|Open-Label|Lost to Follow-up|0|||
105512647|NCT00549302|363883595|FG001|Open-Label|Lost to Follow-up|0|||
105512648|NCT00549302|363883596|FG002|Open-Label|Lost to Follow-up|2|||
105512649|NCT00549302|363883594|FG000|Open-Label|Other|0|||
105512650|NCT00549302|363883595|FG001|Open-Label|Other|0|||
105512651|NCT00549302|363883596|FG002|Open-Label|Other|3|||
105512652|NCT00549302|363883594|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
105512653|NCT00549302|363883595|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
105512654|NCT00549302|363883596|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
105512655|NCT00549302|363883594|FG000|Open-Label|Withdrawal by Subject|0|||
105512656|NCT00549302|363883595|FG001|Open-Label|Withdrawal by Subject|0|||
105512657|NCT00549302|363883596|FG002|Open-Label|Withdrawal by Subject|6|||
105512658|NCT03585504|363883597|FG000|Overall Study|Lost to Follow-up|26|||
105512659|NCT03585504|363883598|FG001|Overall Study|Lost to Follow-up|29|||
105512660|NCT01414114|363883599|FG000|Overall Study|Adverse Event|2|||
105512661|NCT01414114|363883599|FG000|Overall Study|Withdrawal by Subject|1|||
105512662|NCT01414114|363883599|FG000|Overall Study|Other|2|||
105512663|NCT00105482|363883600|FG000|Overall Study|Adverse Event|1|||
105512664|NCT00105482|363883601|FG001|Overall Study|Adverse Event|1|||
105512665|NCT00105482|363883600|FG000|Overall Study|Lost to Follow-up|26|||
105512666|NCT00105482|363883601|FG001|Overall Study|Lost to Follow-up|17|||
105512667|NCT00105482|363883600|FG000|Overall Study|Withdrawal by Subject|0|||
105512668|NCT00105482|363883601|FG001|Overall Study|Withdrawal by Subject|1|||
105512669|NCT00105482|363883600|FG000|Overall Study|Lost Interest|29|||
105512670|NCT00105482|363883601|FG001|Overall Study|Lost Interest|32|||
105512671|NCT00105482|363883600|FG000|Overall Study|Scheduling Conflict|2|||
105512672|NCT00105482|363883601|FG001|Overall Study|Scheduling Conflict|3|||
105512673|NCT00105482|363883600|FG000|Overall Study|Withdrawn by PI|1|||
105512674|NCT00105482|363883601|FG001|Overall Study|Withdrawn by PI|1|||
105512675|NCT01749514|363883608|FG000|Overall Study|Lost to Follow-up|0|||
105512676|NCT01749514|363883609|FG001|Overall Study|Lost to Follow-up|0|||
105512677|NCT01749514|363883610|FG002|Overall Study|Lost to Follow-up|0|||
105512678|NCT01749514|363883611|FG003|Overall Study|Lost to Follow-up|0|||
105512679|NCT01749514|363883612|FG004|Overall Study|Lost to Follow-up|0|||
105512680|NCT01749514|363883613|FG005|Overall Study|Lost to Follow-up|0|||
105512681|NCT01749514|363883614|FG006|Overall Study|Lost to Follow-up|0|||
105512682|NCT01749514|363883615|FG007|Overall Study|Lost to Follow-up|1|||
105512683|NCT01749514|363883608|FG000|Overall Study|Withdrawal by Subject|0|||
105512684|NCT01749514|363883609|FG001|Overall Study|Withdrawal by Subject|0|||
105512685|NCT01749514|363883610|FG002|Overall Study|Withdrawal by Subject|0|||
105512686|NCT01749514|363883611|FG003|Overall Study|Withdrawal by Subject|0|||
105512687|NCT01749514|363883612|FG004|Overall Study|Withdrawal by Subject|0|||
105512688|NCT01749514|363883613|FG005|Overall Study|Withdrawal by Subject|1|||
105512689|NCT01749514|363883614|FG006|Overall Study|Withdrawal by Subject|0|||
105512690|NCT01749514|363883615|FG007|Overall Study|Withdrawal by Subject|1|||
105512691|NCT01749514|363883608|FG000|Overall Study|Not Reported|0|||
105512692|NCT01749514|363883609|FG001|Overall Study|Not Reported|0|||
105512693|NCT01749514|363883610|FG002|Overall Study|Not Reported|0|||
105512694|NCT01749514|363883611|FG003|Overall Study|Not Reported|0|||
105512695|NCT01749514|363883612|FG004|Overall Study|Not Reported|0|||
105512696|NCT01749514|363883613|FG005|Overall Study|Not Reported|0|||
105512697|NCT01749514|363883614|FG006|Overall Study|Not Reported|0|||
105512698|NCT01749514|363883615|FG007|Overall Study|Not Reported|5|||
105512699|NCT04983264|363883616|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
105512700|NCT04983264|363883617|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
105512701|NCT04983264|363883618|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
105512702|NCT04983264|363883616|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
105512703|NCT04983264|363883617|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
105512704|NCT04983264|363883618|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
105512705|NCT00010374|363883622|FG000|Overall Study|False positive phrenic nerve test|1|||
105512706|NCT01484197|363883626|FG000|Treatment Period 1|Adverse Event|1|||
105512707|NCT01484197|363883627|FG001|Treatment Period 1|Adverse Event|0|||
105512708|NCT01484197|363883628|FG002|Treatment Period 1|Adverse Event|0|||
105512709|NCT01484197|363883629|FG003|Treatment Period 1|Adverse Event|0|||
105512710|NCT01484197|363883626|FG000|Treatment Period 2|Subject withdrew consent|0|||
105512711|NCT01484197|363883627|FG001|Treatment Period 2|Subject withdrew consent|0|||
105512712|NCT01484197|363883628|FG002|Treatment Period 2|Subject withdrew consent|0|||
105512713|NCT01484197|363883629|FG003|Treatment Period 2|Subject withdrew consent|1|||
105512714|NCT01678911|363883630|FG000|Second Intervention|Lost to Follow-up|2|||
105512715|NCT01678911|363883631|FG001|Second Intervention|Lost to Follow-up|0|||
105512716|NCT00752232|363883634|FG000|Overall Study|Protocol Violation|0|||
105512717|NCT00752232|363883635|FG001|Overall Study|Protocol Violation|0|||
105512718|NCT00752232|363883636|FG002|Overall Study|Protocol Violation|0|||
105512719|NCT00752232|363883637|FG003|Overall Study|Protocol Violation|0|||
105512720|NCT00752232|363883638|FG004|Overall Study|Protocol Violation|0|||
105512721|NCT00752232|363883639|FG005|Overall Study|Protocol Violation|1|||
105512722|NCT00752232|363883640|FG006|Overall Study|Protocol Violation|0|||
105512723|NCT00752232|363883634|FG000|Overall Study|Caregiver request|2|||
105512724|NCT00752232|363883635|FG001|Overall Study|Caregiver request|0|||
105512725|NCT00752232|363883636|FG002|Overall Study|Caregiver request|0|||
105512726|NCT00752232|363883637|FG003|Overall Study|Caregiver request|0|||
105512727|NCT00752232|363883638|FG004|Overall Study|Caregiver request|1|||
105512728|NCT00752232|363883639|FG005|Overall Study|Caregiver request|0|||
105512729|NCT00752232|363883640|FG006|Overall Study|Caregiver request|0|||
105512730|NCT00752232|363883634|FG000|Overall Study|Investigator request|0|||
105512731|NCT00752232|363883635|FG001|Overall Study|Investigator request|0|||
105512732|NCT00752232|363883636|FG002|Overall Study|Investigator request|0|||
105512733|NCT00752232|363883637|FG003|Overall Study|Investigator request|0|||
105512734|NCT00752232|363883638|FG004|Overall Study|Investigator request|1|||
105512735|NCT00752232|363883639|FG005|Overall Study|Investigator request|0|||
105512736|NCT00752232|363883640|FG006|Overall Study|Investigator request|0|||
105512737|NCT00752232|363883634|FG000|Overall Study|Subject request|0|||
105512738|NCT00752232|363883635|FG001|Overall Study|Subject request|0|||
105512739|NCT00752232|363883636|FG002|Overall Study|Subject request|1|||
105512740|NCT00752232|363883637|FG003|Overall Study|Subject request|0|||
105512741|NCT00752232|363883638|FG004|Overall Study|Subject request|0|||
105512742|NCT00752232|363883639|FG005|Overall Study|Subject request|0|||
105512743|NCT00752232|363883640|FG006|Overall Study|Subject request|0|||
105512744|NCT00752232|363883634|FG000|Overall Study|Group home admission|0|||
105512745|NCT00752232|363883635|FG001|Overall Study|Group home admission|0|||
105512746|NCT00752232|363883636|FG002|Overall Study|Group home admission|0|||
105512747|NCT00752232|363883637|FG003|Overall Study|Group home admission|1|||
105512748|NCT00752232|363883638|FG004|Overall Study|Group home admission|0|||
105512749|NCT00752232|363883639|FG005|Overall Study|Group home admission|0|||
105512750|NCT00752232|363883640|FG006|Overall Study|Group home admission|0|||
105512751|NCT00752232|363883634|FG000|Overall Study|Caregiver could not attend the subject|0|||
105512752|NCT00752232|363883635|FG001|Overall Study|Caregiver could not attend the subject|0|||
105512753|NCT00752232|363883636|FG002|Overall Study|Caregiver could not attend the subject|0|||
105512754|NCT00752232|363883637|FG003|Overall Study|Caregiver could not attend the subject|0|||
105512755|NCT00752232|363883638|FG004|Overall Study|Caregiver could not attend the subject|1|||
105512756|NCT00752232|363883639|FG005|Overall Study|Caregiver could not attend the subject|0|||
105512757|NCT00752232|363883640|FG006|Overall Study|Caregiver could not attend the subject|0|||
105512758|NCT02268084|363883643|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
105512759|NCT02268084|363883644|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
105512760|NCT02268084|363883643|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
105512761|NCT02268084|363883644|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
105512762|NCT02603419|363883647|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
105512763|NCT02603419|363883648|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
105512764|NCT02603419|363883649|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
105512765|NCT02603419|363883650|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
105512766|NCT02603419|363883651|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
105512767|NCT02603419|363883652|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
105512768|NCT02603419|363883647|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
105512769|NCT02603419|363883648|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
105512770|NCT02603419|363883649|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
105512771|NCT02603419|363883650|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
105512772|NCT02603419|363883651|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
105512773|NCT02603419|363883652|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
105512774|NCT02603419|363883647|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
105512775|NCT02603419|363883648|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
105512776|NCT02603419|363883649|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
105512777|NCT02603419|363883650|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
105512778|NCT02603419|363883651|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
105512779|NCT02603419|363883652|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
105512780|NCT02603419|363883647|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
105512781|NCT02603419|363883648|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
105512782|NCT02603419|363883649|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
105512783|NCT02603419|363883650|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
105512784|NCT02603419|363883651|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
105512785|NCT02603419|363883652|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
105512786|NCT02603419|363883647|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
105512787|NCT02603419|363883648|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
105512788|NCT02603419|363883649|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
105512789|NCT02603419|363883650|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
105512790|NCT02603419|363883651|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
105512791|NCT02603419|363883652|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
105512792|NCT02603419|363883647|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
105512793|NCT02603419|363883648|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
105512794|NCT02603419|363883649|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
105512795|NCT02603419|363883650|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
105512796|NCT02603419|363883651|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
105512797|NCT02603419|363883652|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
105512798|NCT02603419|363883647|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
105512799|NCT02603419|363883648|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
105512800|NCT02603419|363883649|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
105512801|NCT02603419|363883650|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
105512802|NCT02603419|363883651|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
105512803|NCT02603419|363883652|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
105512804|NCT02603419|363883647|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
105512805|NCT02603419|363883648|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
105512806|NCT02603419|363883649|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
105512807|NCT02603419|363883650|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
105512808|NCT02603419|363883651|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
105512809|NCT02603419|363883652|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
105512810|NCT02603419|363883647|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
105512811|NCT02603419|363883648|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
105512812|NCT02603419|363883649|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
105512813|NCT02603419|363883650|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
105512814|NCT02603419|363883651|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
105512815|NCT02603419|363883652|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
105512816|NCT02603419|363883647|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
105512817|NCT02603419|363883648|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
105512818|NCT02603419|363883649|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
105512819|NCT02603419|363883650|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
105512820|NCT02603419|363883651|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
105512821|NCT02603419|363883652|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
105512822|NCT00040664|363883653|FG000|Overall Study|Adverse Event|12|||
105512823|NCT00040664|363883654|FG001|Overall Study|Adverse Event|3|||
105512824|NCT00040664|363883655|FG002|Overall Study|Adverse Event|2|||
105512825|NCT00040664|363883656|FG003|Overall Study|Adverse Event|7|||
105512826|NCT00040664|363883653|FG000|Overall Study|Lack of Efficacy|9|||
105512827|NCT00040664|363883654|FG001|Overall Study|Lack of Efficacy|2|||
105512828|NCT00040664|363883655|FG002|Overall Study|Lack of Efficacy|3|||
105512829|NCT00040664|363883656|FG003|Overall Study|Lack of Efficacy|4|||
105512830|NCT00040664|363883653|FG000|Overall Study|Insufficient CD4 response|1|||
105512831|NCT00040664|363883654|FG001|Overall Study|Insufficient CD4 response|0|||
105512832|NCT00040664|363883655|FG002|Overall Study|Insufficient CD4 response|1|||
105512833|NCT00040664|363883656|FG003|Overall Study|Insufficient CD4 response|0|||
105512834|NCT00040664|363883653|FG000|Overall Study|Lost to Follow-up|4|||
105512835|NCT00040664|363883654|FG001|Overall Study|Lost to Follow-up|2|||
105512836|NCT00040664|363883655|FG002|Overall Study|Lost to Follow-up|0|||
105512837|NCT00040664|363883656|FG003|Overall Study|Lost to Follow-up|2|||
105512838|NCT00040664|363883653|FG000|Overall Study|Protocol Violation|2|||
105512839|NCT00040664|363883654|FG001|Overall Study|Protocol Violation|1|||
105512840|NCT00040664|363883655|FG002|Overall Study|Protocol Violation|0|||
105512841|NCT00040664|363883656|FG003|Overall Study|Protocol Violation|1|||
105512842|NCT00040664|363883653|FG000|Overall Study|Withdrawal by Subject|7|||
105512843|NCT00040664|363883654|FG001|Overall Study|Withdrawal by Subject|0|||
105512844|NCT00040664|363883655|FG002|Overall Study|Withdrawal by Subject|3|||
105512845|NCT00040664|363883656|FG003|Overall Study|Withdrawal by Subject|4|||
105512846|NCT00040664|363883653|FG000|Overall Study|Pregnancy|3|||
105512847|NCT00040664|363883654|FG001|Overall Study|Pregnancy|0|||
105512848|NCT00040664|363883655|FG002|Overall Study|Pregnancy|0|||
105512849|NCT00040664|363883656|FG003|Overall Study|Pregnancy|3|||
105512850|NCT00040664|363883653|FG000|Overall Study|Medication adherence/compliance problems|8|||
105512851|NCT00040664|363883654|FG001|Overall Study|Medication adherence/compliance problems|2|||
105512852|NCT00040664|363883655|FG002|Overall Study|Medication adherence/compliance problems|1|||
105512853|NCT00040664|363883656|FG003|Overall Study|Medication adherence/compliance problems|5|||
105512854|NCT00040664|363883653|FG000|Overall Study|Poor taste|2|||
105512855|NCT00040664|363883654|FG001|Overall Study|Poor taste|0|||
105512856|NCT00040664|363883655|FG002|Overall Study|Poor taste|2|||
105512857|NCT00040664|363883656|FG003|Overall Study|Poor taste|0|||
105512858|NCT00040664|363883653|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
105512859|NCT00040664|363883654|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
105512860|NCT00040664|363883655|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
105512861|NCT00040664|363883656|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
105512862|NCT00040664|363883653|FG000|Overall Study|Change of formulation|2|||
105512863|NCT00040664|363883654|FG001|Overall Study|Change of formulation|2|||
105512864|NCT00040664|363883655|FG002|Overall Study|Change of formulation|0|||
105512865|NCT00040664|363883656|FG003|Overall Study|Change of formulation|0|||
105512866|NCT00040664|363883653|FG000|Overall Study|Non-viability of oral suspension|1|||
105512867|NCT00040664|363883654|FG001|Overall Study|Non-viability of oral suspension|0|||
105512868|NCT00040664|363883655|FG002|Overall Study|Non-viability of oral suspension|1|||
105512869|NCT00040664|363883656|FG003|Overall Study|Non-viability of oral suspension|0|||
105512870|NCT02013791|363883657|FG000|Period 1|Lost to Follow-up|0|||
105512871|NCT02013791|363883658|FG001|Period 1|Lost to Follow-up|0|||
105512872|NCT02013791|363883659|FG002|Period 1|Lost to Follow-up|0|||
105592018|NCT03646123|364169283|FG002|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
105592019|NCT03646123|364169281|FG000|Overall Study|Non-compliance to study protocol|1|||
105592020|NCT03646123|364169282|FG001|Overall Study|Non-compliance to study protocol|0|||
105592021|NCT03646123|364169283|FG002|Overall Study|Non-compliance to study protocol|0|||
105512873|NCT02013791|363883660|FG003|Period 1|Lost to Follow-up|1|||
105512874|NCT02013791|363883661|FG004|Period 1|Lost to Follow-up|0|||
105512875|NCT02013791|363883662|FG005|Period 1|Lost to Follow-up|0|||
105512876|NCT02013791|363883663|FG006|Period 1|Lost to Follow-up|1|||
105512877|NCT02013791|363883664|FG007|Period 1|Lost to Follow-up|1|||
105512878|NCT02013791|363883665|FG008|Period 1|Lost to Follow-up|0|||
105512879|NCT02013791|363883657|FG000|Period 1|Other Miscellaneous Reasons|0|||
105512880|NCT02013791|363883658|FG001|Period 1|Other Miscellaneous Reasons|2|||
105512881|NCT02013791|363883659|FG002|Period 1|Other Miscellaneous Reasons|0|||
105512882|NCT02013791|363883660|FG003|Period 1|Other Miscellaneous Reasons|0|||
105592022|NCT03646123|364169281|FG000|Overall Study|Ineligible due to progression during screening|0|||
105512883|NCT02013791|363883661|FG004|Period 1|Other Miscellaneous Reasons|0|||
105512884|NCT02013791|363883662|FG005|Period 1|Other Miscellaneous Reasons|0|||
105512885|NCT02013791|363883663|FG006|Period 1|Other Miscellaneous Reasons|0|||
105512886|NCT02013791|363883664|FG007|Period 1|Other Miscellaneous Reasons|0|||
105512887|NCT02013791|363883665|FG008|Period 1|Other Miscellaneous Reasons|0|||
105512888|NCT02505867|363883675|FG000|Overall Study|Lack of Efficacy|6|||
105512889|NCT02505867|363883676|FG001|Overall Study|Lack of Efficacy|6|||
105512890|NCT01862874|363883677|FG000|Overall Study|Randomized not treated|1|||
105512891|NCT01862874|363883678|FG001|Overall Study|Randomized not treated|0|||
105512892|NCT01862874|363883677|FG000|Overall Study|Adverse Event|0|||
105512893|NCT01862874|363883678|FG001|Overall Study|Adverse Event|3|||
105512894|NCT01862874|363883677|FG000|Overall Study|Lost to Follow-up|26|||
105512895|NCT01862874|363883678|FG001|Overall Study|Lost to Follow-up|29|||
105512896|NCT01862874|363883677|FG000|Overall Study|Physician Decision|5|||
105512897|NCT01862874|363883678|FG001|Overall Study|Physician Decision|3|||
105512898|NCT01862874|363883677|FG000|Overall Study|Withdrawn by parent/guardian|1|||
105512899|NCT01862874|363883678|FG001|Overall Study|Withdrawn by parent/guardian|1|||
105512900|NCT01862874|363883677|FG000|Overall Study|Withdrawal by Subject|46|||
105512901|NCT01862874|363883678|FG001|Overall Study|Withdrawal by Subject|40|||
105512902|NCT01862874|363883677|FG000|Overall Study|Death|0|||
105512903|NCT01862874|363883678|FG001|Overall Study|Death|1|||
105512904|NCT02634320|363883689|FG000|Overall Study|Adverse Event|2|||
105512905|NCT02634320|363883689|FG000|Overall Study|Lost to Follow-up|3|||
105512906|NCT02634320|363883689|FG000|Overall Study|Moved out of area|2|||
105512907|NCT02634320|363883689|FG000|Overall Study|Out of window for study visits|1|||
105512908|NCT02634320|363883689|FG000|Overall Study|Protocol Violation|1|||
105512909|NCT02634320|363883689|FG000|Overall Study|Withdrawal by Subject|5|||
105512910|NCT02634320|363883689|FG000|Overall Study|Lack of Efficacy|2|||
105512911|NCT00687323|363883690|FG000|Overall Study|Death|25|||
105512912|NCT00687323|363883690|FG000|Overall Study|Withdrawal by Subject|1|||
105512913|NCT00687323|363883690|FG000|Overall Study|Excluded from efficacy evaluations|6|||
105512914|NCT00687323|363883690|FG000|Overall Study|Screen failure|148|||
105512915|NCT03655691|363883694|FG000|Overall Study|Adverse Event|0|||
105512916|NCT03655691|363883695|FG001|Overall Study|Adverse Event|0|||
105512917|NCT03655691|363883696|FG002|Overall Study|Adverse Event|1|||
105512918|NCT03655691|363883694|FG000|Overall Study|Lost to Follow-up|1|||
105512919|NCT03655691|363883695|FG001|Overall Study|Lost to Follow-up|1|||
105512920|NCT03655691|363883696|FG002|Overall Study|Lost to Follow-up|2|||
105512921|NCT03655691|363883694|FG000|Overall Study|Protocol Violation|0|||
105512922|NCT03655691|363883695|FG001|Overall Study|Protocol Violation|1|||
105512923|NCT03655691|363883696|FG002|Overall Study|Protocol Violation|0|||
105512924|NCT03655691|363883694|FG000|Overall Study|Withdrawal by Subject|1|||
105512925|NCT03655691|363883695|FG001|Overall Study|Withdrawal by Subject|1|||
105512926|NCT03655691|363883696|FG002|Overall Study|Withdrawal by Subject|0|||
105512927|NCT01753856|363883697|FG000|Overall Study|Adverse Event|1|||
105512928|NCT01753856|363883698|FG001|Overall Study|Adverse Event|0|||
105512929|NCT01753856|363883697|FG000|Overall Study|Withdrawal by Subject|0|||
105512930|NCT01753856|363883698|FG001|Overall Study|Withdrawal by Subject|2|||
105512931|NCT01753856|363883697|FG000|Overall Study|Sponsor Decision|2|||
105512932|NCT01753856|363883698|FG001|Overall Study|Sponsor Decision|0|||
105512933|NCT04557371|363883699|FG000|Overall Study|Covid-19-related|0|||
105512934|NCT04557371|363883700|FG001|Overall Study|Covid-19-related|1|||
105512935|NCT04557371|363883701|FG002|Overall Study|Covid-19-related|0|||
105512936|NCT04557371|363883699|FG000|Overall Study|Withdrawal by Subject|0|||
105512937|NCT04557371|363883700|FG001|Overall Study|Withdrawal by Subject|1|||
105512938|NCT04557371|363883701|FG002|Overall Study|Withdrawal by Subject|0|||
105512939|NCT04557371|363883699|FG000|Overall Study|Adverse Event|1|||
105512940|NCT04557371|363883700|FG001|Overall Study|Adverse Event|0|||
105512941|NCT04557371|363883701|FG002|Overall Study|Adverse Event|0|||
105512942|NCT01943292|363885364|FG000|Overall Study|Withdrawal by Subject|1|||
105512943|NCT01943292|363885365|FG001|Overall Study|Withdrawal by Subject|0|||
105512944|NCT01943292|363885366|FG002|Overall Study|Withdrawal by Subject|0|||
105512945|NCT00638378|363885367|FG000|Overall Study|Death|2|||
105512946|NCT00638378|363885367|FG000|Overall Study|Adverse Event|1|||
105512947|NCT00638378|363885367|FG000|Overall Study|Disease progression|15|||
105512948|NCT00638378|363885367|FG000|Overall Study|Physician Decision|4|||
105512949|NCT00996216|363885368|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
105512950|NCT00996216|363885368|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
105512951|NCT00996216|363885368|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
105512952|NCT01852110|363885371|FG000|Overall Study|Adverse Event|12|||
105512953|NCT01852110|363885372|FG001|Overall Study|Adverse Event|5|||
105512954|NCT01852110|363885373|FG002|Overall Study|Adverse Event|0|||
105512955|NCT01852110|363885374|FG003|Overall Study|Adverse Event|0|||
105512956|NCT01852110|363885375|FG004|Overall Study|Adverse Event|0|||
105512957|NCT01852110|363885376|FG005|Overall Study|Adverse Event|0|||
105512958|NCT01852110|363885371|FG000|Overall Study|Lost to Follow-up|1|||
105512959|NCT01852110|363885372|FG001|Overall Study|Lost to Follow-up|3|||
105512960|NCT01852110|363885373|FG002|Overall Study|Lost to Follow-up|0|||
105512961|NCT01852110|363885374|FG003|Overall Study|Lost to Follow-up|0|||
105512962|NCT01852110|363885375|FG004|Overall Study|Lost to Follow-up|0|||
105512963|NCT01852110|363885376|FG005|Overall Study|Lost to Follow-up|0|||
105512964|NCT01852110|363885371|FG000|Overall Study|Non-compliance with Study Drug|2|||
105512965|NCT01852110|363885372|FG001|Overall Study|Non-compliance with Study Drug|1|||
105512966|NCT01852110|363885373|FG002|Overall Study|Non-compliance with Study Drug|0|||
105512967|NCT01852110|363885374|FG003|Overall Study|Non-compliance with Study Drug|0|||
105512968|NCT01852110|363885375|FG004|Overall Study|Non-compliance with Study Drug|0|||
105512969|NCT01852110|363885376|FG005|Overall Study|Non-compliance with Study Drug|0|||
105512970|NCT01852110|363885371|FG000|Overall Study|Physician Decision|1|||
105512971|NCT01852110|363885372|FG001|Overall Study|Physician Decision|0|||
105512972|NCT01852110|363885373|FG002|Overall Study|Physician Decision|0|||
105512973|NCT01852110|363885374|FG003|Overall Study|Physician Decision|0|||
105512974|NCT01852110|363885375|FG004|Overall Study|Physician Decision|0|||
105512975|NCT01852110|363885376|FG005|Overall Study|Physician Decision|0|||
105512976|NCT01852110|363885371|FG000|Overall Study|Protocol Violation|0|||
105512977|NCT01852110|363885372|FG001|Overall Study|Protocol Violation|1|||
105512978|NCT01852110|363885373|FG002|Overall Study|Protocol Violation|0|||
105512979|NCT01852110|363885374|FG003|Overall Study|Protocol Violation|0|||
105512980|NCT01852110|363885375|FG004|Overall Study|Protocol Violation|0|||
105512981|NCT01852110|363885376|FG005|Overall Study|Protocol Violation|0|||
105512982|NCT01852110|363885371|FG000|Overall Study|Study Terminated by Sponsor|30|||
105512983|NCT01852110|363885372|FG001|Overall Study|Study Terminated by Sponsor|32|||
105512984|NCT01852110|363885373|FG002|Overall Study|Study Terminated by Sponsor|0|||
105512985|NCT01852110|363885374|FG003|Overall Study|Study Terminated by Sponsor|0|||
105512986|NCT01852110|363885375|FG004|Overall Study|Study Terminated by Sponsor|0|||
105512987|NCT01852110|363885376|FG005|Overall Study|Study Terminated by Sponsor|0|||
105512988|NCT01852110|363885371|FG000|Overall Study|Withdrawal by Subject|4|||
105512989|NCT01852110|363885372|FG001|Overall Study|Withdrawal by Subject|4|||
105512990|NCT01852110|363885373|FG002|Overall Study|Withdrawal by Subject|0|||
105512991|NCT01852110|363885374|FG003|Overall Study|Withdrawal by Subject|0|||
105512992|NCT01852110|363885375|FG004|Overall Study|Withdrawal by Subject|0|||
105512993|NCT01852110|363885376|FG005|Overall Study|Withdrawal by Subject|0|||
105512994|NCT00842712|363885387|FG000|Safety Run-in Part|Adverse Event|0|||
105512995|NCT00842712|363885388|FG001|Safety Run-in Part|Adverse Event|1|||
105512996|NCT00842712|363885389|FG002|Safety Run-in Part|Adverse Event|0|||
105512997|NCT00842712|363885390|FG003|Safety Run-in Part|Adverse Event|0|||
105512998|NCT00842712|363885391|FG004|Safety Run-in Part|Adverse Event|0|||
105512999|NCT00842712|363885392|FG005|Safety Run-in Part|Adverse Event|0|||
105513000|NCT00842712|363885393|FG006|Safety Run-in Part|Adverse Event|0|||
105513001|NCT00842712|363885387|FG000|Safety Run-in Part|Progressive disease|3|||
105513002|NCT00842712|363885388|FG001|Safety Run-in Part|Progressive disease|1|||
105513003|NCT00842712|363885389|FG002|Safety Run-in Part|Progressive disease|0|||
105513004|NCT00842712|363885390|FG003|Safety Run-in Part|Progressive disease|1|||
105513005|NCT00842712|363885391|FG004|Safety Run-in Part|Progressive disease|0|||
105513006|NCT00842712|363885392|FG005|Safety Run-in Part|Progressive disease|0|||
105513007|NCT00842712|363885393|FG006|Safety Run-in Part|Progressive disease|0|||
105513008|NCT00842712|363885387|FG000|Randomized Part|Randomized but not treated|0|||
105513009|NCT00842712|363885388|FG001|Randomized Part|Randomized but not treated|0|||
105513010|NCT00842712|363885389|FG002|Randomized Part|Randomized but not treated|0|||
105513011|NCT00842712|363885390|FG003|Randomized Part|Randomized but not treated|0|||
105513012|NCT00842712|363885391|FG004|Randomized Part|Randomized but not treated|0|||
105513013|NCT00842712|363885392|FG005|Randomized Part|Randomized but not treated|1|||
105513014|NCT00842712|363885393|FG006|Randomized Part|Randomized but not treated|4|||
105513015|NCT00842712|363885387|FG000|Randomized Part|Ongoing at cut-off date|0|||
105513016|NCT00842712|363885388|FG001|Randomized Part|Ongoing at cut-off date|0|||
105513017|NCT00842712|363885389|FG002|Randomized Part|Ongoing at cut-off date|0|||
105513018|NCT00842712|363885390|FG003|Randomized Part|Ongoing at cut-off date|0|||
105513019|NCT00842712|363885391|FG004|Randomized Part|Ongoing at cut-off date|0|||
105513020|NCT00842712|363885392|FG005|Randomized Part|Ongoing at cut-off date|0|||
105513021|NCT00842712|363885393|FG006|Randomized Part|Ongoing at cut-off date|2|||
105513022|NCT02310568|363885395|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
105513023|NCT02310568|363885396|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
105513024|NCT02310568|363885397|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
105513025|NCT02310568|363885398|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
105513026|NCT02310568|363885399|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
105513027|NCT02310568|363885395|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
105513028|NCT02310568|363885396|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
105513029|NCT02310568|363885397|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
105513030|NCT02310568|363885398|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
105513031|NCT02310568|363885399|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
105513032|NCT02310568|363885395|FG000|Stage 1 ( 4 Weeks)|Other|1|||
105513033|NCT02310568|363885396|FG001|Stage 1 ( 4 Weeks)|Other|1|||
105513034|NCT02310568|363885397|FG002|Stage 1 ( 4 Weeks)|Other|0|||
105592023|NCT03646123|364169282|FG001|Overall Study|Ineligible due to progression during screening|0|||
105592024|NCT03646123|364169283|FG002|Overall Study|Ineligible due to progression during screening|1|||
105592025|NCT03646123|364169281|FG000|Overall Study|Withdrawal by Subject|2|||
105592026|NCT03646123|364169282|FG001|Overall Study|Withdrawal by Subject|1|||
105592027|NCT03646123|364169283|FG002|Overall Study|Withdrawal by Subject|3|||
105592028|NCT03646123|364169281|FG000|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
105592029|NCT03646123|364169282|FG001|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
105592030|NCT03646123|364169283|FG002|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|1|||
105592031|NCT03646123|364169281|FG000|Overall Study|Death|2|||
105592032|NCT03646123|364169282|FG001|Overall Study|Death|1|||
105592033|NCT03646123|364169283|FG002|Overall Study|Death|1|||
105513035|NCT02310568|363885398|FG003|Stage 1 ( 4 Weeks)|Other|0|||
105513036|NCT02310568|363885399|FG004|Stage 1 ( 4 Weeks)|Other|0|||
105513037|NCT02310568|363885395|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
105513038|NCT02310568|363885396|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
105513039|NCT02310568|363885397|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
105513040|NCT02310568|363885398|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
105513041|NCT02310568|363885399|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
105513042|NCT02310568|363885395|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
105513043|NCT02310568|363885396|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
105513044|NCT02310568|363885397|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
105513045|NCT02310568|363885398|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
105513046|NCT02310568|363885399|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
105513047|NCT02310568|363885395|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
105513048|NCT02310568|363885396|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
105513049|NCT02310568|363885397|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
105513050|NCT02310568|363885398|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
105513051|NCT02310568|363885399|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
105513052|NCT02310568|363885395|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
105513053|NCT02310568|363885396|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
105513054|NCT02310568|363885397|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
105513055|NCT02310568|363885398|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
105513056|NCT02310568|363885399|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
105513057|NCT02310568|363885395|FG000|Stage 2 (4 Weeks)|Other|0|||
105513058|NCT02310568|363885396|FG001|Stage 2 (4 Weeks)|Other|1|||
105513059|NCT02310568|363885397|FG002|Stage 2 (4 Weeks)|Other|1|||
105513060|NCT02310568|363885398|FG003|Stage 2 (4 Weeks)|Other|0|||
105513061|NCT02310568|363885399|FG004|Stage 2 (4 Weeks)|Other|0|||
105513062|NCT02310568|363885395|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
105513063|NCT02310568|363885396|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
105513064|NCT02310568|363885397|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
105513065|NCT02310568|363885398|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
105513066|NCT02310568|363885399|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
105513067|NCT02310568|363885395|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
105513068|NCT02310568|363885396|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
105513069|NCT02310568|363885397|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
105513070|NCT02310568|363885398|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
105513071|NCT02310568|363885399|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
105513072|NCT02310568|363885395|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
105513073|NCT02310568|363885396|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
105513074|NCT02310568|363885397|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
105592034|NCT03646123|364169281|FG000|Overall Study|Lost to Follow-up|4|||
105592035|NCT03646123|364169282|FG001|Overall Study|Lost to Follow-up|7|||
105592036|NCT03646123|364169283|FG002|Overall Study|Lost to Follow-up|6|||
105513075|NCT02310568|363885398|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
105513076|NCT02310568|363885399|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
105513077|NCT00720434|363885406|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
105513078|NCT00720434|363885407|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
105513079|NCT00720434|363885408|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
105513080|NCT00720434|363885409|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
105513081|NCT00720434|363885406|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
105592037|NCT03646123|364169281|FG000|Overall Study|Participants in long term follow-up|0|||
105592038|NCT03646123|364169282|FG001|Overall Study|Participants in long term follow-up|48|||
105592039|NCT03646123|364169283|FG002|Overall Study|Participants in long term follow-up|144|||
105513082|NCT00720434|363885407|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
105513083|NCT00720434|363885408|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
105513084|NCT00720434|363885409|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
105513085|NCT00720434|363885406|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
105513086|NCT00720434|363885407|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
105513087|NCT00720434|363885408|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
105513088|NCT00720434|363885409|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
105513089|NCT00720434|363885406|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
105513090|NCT00720434|363885407|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
105513091|NCT00720434|363885408|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
105513092|NCT00720434|363885409|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
105513093|NCT00720434|363885406|FG000|Open-Label Period (Week 5-72)|Other|4|||
105513094|NCT00720434|363885407|FG001|Open-Label Period (Week 5-72)|Other|3|||
105513095|NCT00720434|363885408|FG002|Open-Label Period (Week 5-72)|Other|3|||
105513096|NCT00720434|363885409|FG003|Open-Label Period (Week 5-72)|Other|2|||
105513097|NCT00754624|363885410|FG000|Overall Study|Adverse Event|16|||
105513098|NCT00754624|363885410|FG000|Overall Study|Death|1|||
105513099|NCT00754624|363885410|FG000|Overall Study|Physician Decision|8|||
105513100|NCT00754624|363885410|FG000|Overall Study|Protocol Violation|1|||
105513101|NCT00754624|363885410|FG000|Overall Study|Withdrawal by Subject|28|||
105513102|NCT00754624|363885410|FG000|Overall Study|Various|12|||
105513103|NCT00754624|363885410|FG000|Overall Study|Lost to Follow-up|3|||
105513104|NCT01104493|363885411|FG000|Overall Study|Lost to Follow-up|0|||
105513105|NCT01104493|363885412|FG001|Overall Study|Lost to Follow-up|2|||
105513106|NCT02782780|363885424|FG000|Overall Study|dropped out after randomization.|7|||
105513107|NCT02782780|363885425|FG001|Overall Study|dropped out after randomization.|5|||
105513108|NCT02782780|363885424|FG000|Overall Study|Protocol Violation|0|||
105513109|NCT02782780|363885425|FG001|Overall Study|Protocol Violation|2|||
105513110|NCT03562481|363885426|FG000|First Intervention|Lost to Follow-up|1|||
105513111|NCT03562481|363885427|FG001|First Intervention|Lost to Follow-up|0|||
105513112|NCT02664441|363885428|FG000|Randomization|Withdrawal by Subject|0|||
105513113|NCT02664441|363885429|FG001|Randomization|Withdrawal by Subject|1|||
105513114|NCT02664441|363885428|FG000|36-week Randomized Trial|Adverse Event|2|||
105513115|NCT02664441|363885429|FG001|36-week Randomized Trial|Adverse Event|0|||
105513116|NCT02664441|363885428|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
105513117|NCT02664441|363885429|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
105513118|NCT02664441|363885428|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
105513119|NCT02664441|363885429|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
105513120|NCT02664441|363885428|FG000|18-week Open Label Extension|Adverse Event|1|||
105513121|NCT02664441|363885429|FG001|18-week Open Label Extension|Adverse Event|0|||
105513122|NCT02664441|363885428|FG000|18-week Open Label Extension|Physician Decision|1|||
105513123|NCT02664441|363885429|FG001|18-week Open Label Extension|Physician Decision|0|||
105513124|NCT02664441|363885428|FG000|18-week Open Label Extension|Death|1|||
105513125|NCT02664441|363885429|FG001|18-week Open Label Extension|Death|0|||
105513126|NCT02664441|363885428|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
105513127|NCT02664441|363885429|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
105513128|NCT03654651|363885430|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
105513129|NCT03654651|363885431|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
105513130|NCT03510884|363885432|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
105513131|NCT03510884|363885433|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
105513132|NCT03510884|363885434|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
105513133|NCT03510884|363885435|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
105513134|NCT03510884|363885432|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
105513135|NCT03510884|363885433|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
105513136|NCT03510884|363885434|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
105513137|NCT03510884|363885435|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
105513138|NCT03510884|363885432|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
105513139|NCT03510884|363885433|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
105513140|NCT03510884|363885434|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
105513141|NCT03510884|363885435|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
105513142|NCT03510884|363885432|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
105513143|NCT03510884|363885433|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
105513144|NCT03510884|363885434|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
105513145|NCT03510884|363885435|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
105513146|NCT03510884|363885432|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
105513147|NCT03510884|363885433|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
105513148|NCT03510884|363885434|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
105513149|NCT03510884|363885435|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
105513150|NCT03510884|363885432|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
105513151|NCT03510884|363885433|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
105513152|NCT03510884|363885434|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
105513153|NCT03510884|363885435|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
105513154|NCT03510884|363885432|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
105513155|NCT03510884|363885433|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
105513156|NCT03510884|363885434|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
105513157|NCT03510884|363885435|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
105513158|NCT03510884|363885432|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
105513159|NCT03510884|363885433|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
105513160|NCT03510884|363885434|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
105513161|NCT03510884|363885435|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
105513162|NCT03510884|363885432|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
105513163|NCT03510884|363885433|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
105513164|NCT03510884|363885434|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
105513165|NCT03510884|363885435|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
105513166|NCT03510884|363885432|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
105513167|NCT03510884|363885433|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
105513168|NCT03510884|363885434|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
105513169|NCT03510884|363885435|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
105513170|NCT00856284|363885436|FG000|Overall Study|Hyperglycemic rescue|231|||
105513171|NCT00856284|363885437|FG001|Overall Study|Hyperglycemic rescue|201|||
105513172|NCT00856284|363885438|FG002|Overall Study|Hyperglycemic rescue|235|||
105513173|NCT00856284|363885436|FG000|Overall Study|Adverse Event|60|||
105513174|NCT00856284|363885437|FG001|Overall Study|Adverse Event|74|||
105513175|NCT00856284|363885438|FG002|Overall Study|Adverse Event|82|||
105513176|NCT00856284|363885436|FG000|Overall Study|Major protocol deviation|24|||
105513177|NCT00856284|363885437|FG001|Overall Study|Major protocol deviation|16|||
105513178|NCT00856284|363885438|FG002|Overall Study|Major protocol deviation|15|||
105513179|NCT00856284|363885436|FG000|Overall Study|Lost to Follow-up|20|||
105513180|NCT00856284|363885437|FG001|Overall Study|Lost to Follow-up|22|||
105513181|NCT00856284|363885438|FG002|Overall Study|Lost to Follow-up|28|||
105513182|NCT00856284|363885436|FG000|Overall Study|Voluntary withdrawal|48|||
105513183|NCT00856284|363885437|FG001|Overall Study|Voluntary withdrawal|52|||
105513184|NCT00856284|363885438|FG002|Overall Study|Voluntary withdrawal|62|||
105513185|NCT00856284|363885436|FG000|Overall Study|Pregnancy|1|||
105513186|NCT00856284|363885437|FG001|Overall Study|Pregnancy|2|||
105513187|NCT00856284|363885438|FG002|Overall Study|Pregnancy|0|||
105513188|NCT00856284|363885436|FG000|Overall Study|Investigator discretion|9|||
105513189|NCT00856284|363885437|FG001|Overall Study|Investigator discretion|8|||
105513190|NCT00856284|363885438|FG002|Overall Study|Investigator discretion|10|||
105513191|NCT00856284|363885436|FG000|Overall Study|Other|15|||
105513192|NCT00856284|363885437|FG001|Overall Study|Other|17|||
105513193|NCT00856284|363885438|FG002|Overall Study|Other|14|||
105513194|NCT00856284|363885436|FG000|Overall Study|Randomized in error|0|||
105513195|NCT00856284|363885437|FG001|Overall Study|Randomized in error|0|||
105513196|NCT00856284|363885438|FG002|Overall Study|Randomized in error|1|||
105513197|NCT05620563|363885441|FG000|Overall Study|Adverse Event|3|||
105513198|NCT05620563|363885442|FG001|Overall Study|Adverse Event|1|||
105513199|NCT05620563|363885441|FG000|Overall Study|Lost to Follow-up|0|||
105513200|NCT05620563|363885442|FG001|Overall Study|Lost to Follow-up|2|||
105513201|NCT05620563|363885441|FG000|Overall Study|Protocol Deviation|1|||
105513202|NCT05620563|363885442|FG001|Overall Study|Protocol Deviation|2|||
105513203|NCT05620563|363885441|FG000|Overall Study|Withdrawal by Subject|3|||
105513204|NCT05620563|363885442|FG001|Overall Study|Withdrawal by Subject|3|||
105513205|NCT05620563|363885441|FG000|Overall Study|Physician Decision|0|||
105513206|NCT05620563|363885442|FG001|Overall Study|Physician Decision|1|||
105513207|NCT00085631|363885443|FG000|Overall Study|Missing Data|4|||
105513208|NCT00085631|363885444|FG001|Overall Study|Missing Data|11|||
105513209|NCT00085631|363885445|FG002|Overall Study|Missing Data|7|||
105513210|NCT00411645|363885446|FG000|Overall Study|Consent Withdrawn|13|||
105513211|NCT00411645|363885447|FG001|Overall Study|Consent Withdrawn|22|||
105513212|NCT00411645|363885446|FG000|Overall Study|Death|56|||
105513213|NCT00411645|363885447|FG001|Overall Study|Death|135|||
105513214|NCT00411645|363885446|FG000|Overall Study|Investigator/Sponsor Decision|10|||
105513215|NCT00411645|363885447|FG001|Overall Study|Investigator/Sponsor Decision|7|||
105513216|NCT00411645|363885446|FG000|Overall Study|Lost to Follow-up|2|||
105513217|NCT00411645|363885447|FG001|Overall Study|Lost to Follow-up|0|||
105513218|NCT04118166|363885450|FG000|Overall Study|Adverse Event|1|||
105513219|NCT02288559|363885459|FG000|Overall Study|Adverse Event|1|||
105513220|NCT02288559|363885460|FG001|Overall Study|Adverse Event|1|||
105513221|NCT02288559|363885461|FG002|Overall Study|Adverse Event|5|||
105513222|NCT02288559|363885462|FG003|Overall Study|Adverse Event|0|||
105513223|NCT02288559|363885459|FG000|Overall Study|Death|0|||
105513224|NCT02288559|363885460|FG001|Overall Study|Death|0|||
105513225|NCT02288559|363885461|FG002|Overall Study|Death|1|||
105513226|NCT02288559|363885462|FG003|Overall Study|Death|0|||
105513227|NCT02288559|363885459|FG000|Overall Study|Lost to Follow-up|0|||
105513228|NCT02288559|363885460|FG001|Overall Study|Lost to Follow-up|0|||
105513229|NCT02288559|363885461|FG002|Overall Study|Lost to Follow-up|0|||
105513230|NCT02288559|363885462|FG003|Overall Study|Lost to Follow-up|1|||
105513231|NCT02288559|363885459|FG000|Overall Study|Withdrawal by Subject|0|||
105513232|NCT02288559|363885460|FG001|Overall Study|Withdrawal by Subject|0|||
105513233|NCT02288559|363885461|FG002|Overall Study|Withdrawal by Subject|2|||
105513234|NCT02288559|363885462|FG003|Overall Study|Withdrawal by Subject|1|||
105513235|NCT02288559|363885459|FG000|Overall Study|Reason Not Specified|0|||
105513236|NCT02288559|363885460|FG001|Overall Study|Reason Not Specified|0|||
105513237|NCT02288559|363885461|FG002|Overall Study|Reason Not Specified|3|||
105513238|NCT02288559|363885462|FG003|Overall Study|Reason Not Specified|0|||
105513239|NCT01402492|363885464|FG000|Overall Study|Withdrawal by Subject|17|||
105513240|NCT01402492|363885465|FG001|Overall Study|Withdrawal by Subject|11|||
105513241|NCT01402492|363885466|FG002|Overall Study|Withdrawal by Subject|11|||
105513242|NCT01402492|363885464|FG000|Overall Study|Adverse Event|2|||
105513243|NCT01402492|363885465|FG001|Overall Study|Adverse Event|3|||
105513244|NCT01402492|363885466|FG002|Overall Study|Adverse Event|4|||
105513245|NCT01402492|363885464|FG000|Overall Study|Physician Decision|0|||
105513246|NCT01402492|363885465|FG001|Overall Study|Physician Decision|3|||
105513247|NCT01402492|363885466|FG002|Overall Study|Physician Decision|0|||
105513248|NCT01402492|363885464|FG000|Overall Study|Incarcerated (N=3)|2|||
105513249|NCT01402492|363885465|FG001|Overall Study|Incarcerated (N=3)|0|||
105513250|NCT01402492|363885466|FG002|Overall Study|Incarcerated (N=3)|1|||
105513251|NCT00673465|363885470|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
105513252|NCT00673465|363885471|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
105513253|NCT00673465|363885472|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
105513254|NCT00673465|363885473|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
105513255|NCT00673465|363885474|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
105513256|NCT00673465|363885475|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
105513257|NCT00673465|363885476|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
105513258|NCT00673465|363885477|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
105513259|NCT00673465|363885478|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
105513260|NCT00673465|363885479|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
105513261|NCT00673465|363885480|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
105513262|NCT00673465|363885481|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
105513263|NCT00673465|363885470|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
105513264|NCT00673465|363885471|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
105513265|NCT00673465|363885472|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
105513266|NCT00673465|363885473|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
105513267|NCT00673465|363885474|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
105513268|NCT00673465|363885475|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
105513269|NCT00673465|363885476|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
105513270|NCT00673465|363885477|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
105513271|NCT00673465|363885478|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
105513272|NCT00673465|363885479|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
105513273|NCT00673465|363885480|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
105513274|NCT00673465|363885481|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
105513275|NCT00553514|363885482|FG000|Overall Study|Protocol deviation|0|||
105513276|NCT00553514|363885483|FG001|Overall Study|Protocol deviation|0|||
105513277|NCT00553514|363885484|FG002|Overall Study|Protocol deviation|0|||
105513278|NCT00553514|363885485|FG003|Overall Study|Protocol deviation|1|||
105513279|NCT00553514|363885486|FG004|Overall Study|Protocol deviation|0|||
105513280|NCT00553514|363885482|FG000|Overall Study|Lack of ovarian response|4|||
105513281|NCT00553514|363885483|FG001|Overall Study|Lack of ovarian response|5|||
105513282|NCT00553514|363885484|FG002|Overall Study|Lack of ovarian response|5|||
105513283|NCT00553514|363885485|FG003|Overall Study|Lack of ovarian response|5|||
105513284|NCT00553514|363885486|FG004|Overall Study|Lack of ovarian response|6|||
105513285|NCT00553514|363885482|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
105513286|NCT00553514|363885483|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
105513287|NCT00553514|363885484|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
105513288|NCT00553514|363885485|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
105513289|NCT00553514|363885486|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
105513290|NCT00553514|363885482|FG000|Overall Study|Risk of multiple pregnancy|0|||
105513291|NCT00553514|363885483|FG001|Overall Study|Risk of multiple pregnancy|2|||
105513292|NCT00553514|363885484|FG002|Overall Study|Risk of multiple pregnancy|0|||
105513293|NCT00553514|363885485|FG003|Overall Study|Risk of multiple pregnancy|1|||
105513294|NCT00553514|363885486|FG004|Overall Study|Risk of multiple pregnancy|0|||
105513295|NCT00553514|363885482|FG000|Overall Study|Other|1|||
105513296|NCT00553514|363885483|FG001|Overall Study|Other|1|||
105513297|NCT00553514|363885484|FG002|Overall Study|Other|0|||
105513298|NCT00553514|363885485|FG003|Overall Study|Other|0|||
105513299|NCT00553514|363885486|FG004|Overall Study|Other|1|||
105513300|NCT03944954|363885494|FG000|Overall Study|Withdrawal by Subject|22|||
105513301|NCT03944954|363885495|FG001|Overall Study|Withdrawal by Subject|4|||
105513302|NCT03944954|363885494|FG000|Overall Study|Lost to Follow-up|18|||
105513303|NCT03944954|363885495|FG001|Overall Study|Lost to Follow-up|0|||
105513304|NCT03944954|363885494|FG000|Overall Study|Failed Medical Screening|7|||
105592040|NCT00464672|364169287|FG000|Overall Study|withdrawal of consent|0|||
105592041|NCT00464672|364169288|FG001|Overall Study|withdrawal of consent|0|||
105592042|NCT00464672|364169289|FG002|Overall Study|withdrawal of consent|0|||
105513305|NCT03944954|363885495|FG001|Overall Study|Failed Medical Screening|0|||
105513306|NCT00371137|363885496|FG000|Overall Study|Adverse Event|20|||
105513307|NCT00371137|363885497|FG001|Overall Study|Adverse Event|35|||
105513308|NCT00371137|363885498|FG002|Overall Study|Adverse Event|42|||
105513309|NCT00371137|363885496|FG000|Overall Study|Withdrawal by Subject|11|||
105513310|NCT00371137|363885497|FG001|Overall Study|Withdrawal by Subject|10|||
105513311|NCT00371137|363885498|FG002|Overall Study|Withdrawal by Subject|15|||
105513312|NCT00371137|363885496|FG000|Overall Study|Lost to Follow-up|6|||
105513313|NCT00371137|363885497|FG001|Overall Study|Lost to Follow-up|3|||
105513314|NCT00371137|363885498|FG002|Overall Study|Lost to Follow-up|5|||
105513315|NCT00371137|363885496|FG000|Overall Study|Lack of Efficacy|30|||
105513316|NCT00371137|363885497|FG001|Overall Study|Lack of Efficacy|12|||
105513317|NCT00371137|363885498|FG002|Overall Study|Lack of Efficacy|13|||
105513318|NCT00371137|363885496|FG000|Overall Study|Sponsor Decision|2|||
105513319|NCT00371137|363885497|FG001|Overall Study|Sponsor Decision|1|||
105513320|NCT00371137|363885498|FG002|Overall Study|Sponsor Decision|2|||
105513321|NCT00371137|363885496|FG000|Overall Study|Physician Decision|1|||
105513322|NCT00371137|363885497|FG001|Overall Study|Physician Decision|1|||
105513323|NCT00371137|363885498|FG002|Overall Study|Physician Decision|1|||
105513324|NCT00371137|363885496|FG000|Overall Study|Protocol Violation|2|||
105513325|NCT00371137|363885497|FG001|Overall Study|Protocol Violation|1|||
105513326|NCT00371137|363885498|FG002|Overall Study|Protocol Violation|1|||
105513327|NCT03798483|363885499|FG000|Overall Study|Lost to Follow-up|2|||
105513328|NCT02643082|363885500|FG000|Period 1|Adverse Event|1|||
105513329|NCT02643082|363885501|FG001|Period 1|Adverse Event|0|||
105513330|NCT00276744|363885502|FG000|PART A|Reason unknown|98|||
105513331|NCT02725710|363885506|FG000|Overall Study|Lost to Follow-up|1|||
105513332|NCT02725710|363885507|FG001|Overall Study|Lost to Follow-up|0|||
105513333|NCT00640601|363885508|FG000|Overall Study|Adverse Event|43|||
105513334|NCT00640601|363885508|FG000|Overall Study|Withdrawal by Subject|20|||
105513335|NCT00640601|363885508|FG000|Overall Study|Protocol Violation|6|||
105513336|NCT00640601|363885508|FG000|Overall Study|Lack of Efficacy|16|||
105513337|NCT00640601|363885508|FG000|Overall Study|Lost to Follow-up|9|||
105513338|NCT00640601|363885508|FG000|Overall Study|Physician Decision|8|||
105513339|NCT00640601|363885508|FG000|Overall Study|treatment naive, combination therapy|10|||
105513340|NCT01666782|363885511|FG000|Overall Study|Received 2 doses of vaccine|0|||
105513341|NCT01666782|363885512|FG001|Overall Study|Received 2 doses of vaccine|1|||
105513342|NCT01666782|363885511|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
105513343|NCT01666782|363885512|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
105513344|NCT04786990|363885513|FG000|Overall Study|Withdrawal by Subject|1|||
105513345|NCT04786990|363885513|FG000|Overall Study|Adverse Event|1|||
105513346|NCT04786990|363885513|FG000|Overall Study|Lost to Follow-up|1|||
105513347|NCT04786990|363885513|FG000|Overall Study|Noncompliance|1|||
105513348|NCT04786990|363885513|FG000|Overall Study|Unable to complete site visits|1|||
105513349|NCT04786990|363885513|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
105513350|NCT01405742|363885534|FG000|Overall Study|Lost to Follow-up|1|||
105513351|NCT01405742|363885535|FG001|Overall Study|Lost to Follow-up|0|||
105513352|NCT03965962|363885537|FG000|Overall Study|Adverse Event|1|||
105513353|NCT03965962|363885538|FG001|Overall Study|Adverse Event|0|||
105513354|NCT03965962|363885539|FG002|Overall Study|Adverse Event|0|||
105513355|NCT03965962|363885540|FG003|Overall Study|Adverse Event|0|||
105513356|NCT03965962|363885537|FG000|Overall Study|Protocol Violation|21|||
105513357|NCT03965962|363885538|FG001|Overall Study|Protocol Violation|4|||
105513358|NCT03965962|363885539|FG002|Overall Study|Protocol Violation|10|||
105513359|NCT03965962|363885540|FG003|Overall Study|Protocol Violation|5|||
105513360|NCT03965962|363885537|FG000|Overall Study|Lost to Follow-up|0|||
105513361|NCT03965962|363885538|FG001|Overall Study|Lost to Follow-up|1|||
105513362|NCT03965962|363885539|FG002|Overall Study|Lost to Follow-up|0|||
105513363|NCT03965962|363885540|FG003|Overall Study|Lost to Follow-up|0|||
105513364|NCT03965962|363885537|FG000|Overall Study|Withdrawal by Subject|3|||
105513365|NCT03965962|363885538|FG001|Overall Study|Withdrawal by Subject|0|||
105513366|NCT03965962|363885539|FG002|Overall Study|Withdrawal by Subject|0|||
105513367|NCT03965962|363885540|FG003|Overall Study|Withdrawal by Subject|1|||
105513368|NCT01782495|363885541|FG000|Overall Study|Adverse Event|0|||
105513369|NCT01782495|363885542|FG001|Overall Study|Adverse Event|0|||
105513370|NCT01782495|363885543|FG002|Overall Study|Adverse Event|0|||
105513371|NCT01782495|363885544|FG003|Overall Study|Adverse Event|0|||
105513372|NCT01782495|363885545|FG004|Overall Study|Adverse Event|0|||
105513373|NCT01782495|363885546|FG005|Overall Study|Adverse Event|0|||
105513374|NCT01782495|363885547|FG006|Overall Study|Adverse Event|0|||
105513375|NCT01782495|363885548|FG007|Overall Study|Adverse Event|2|||
105513376|NCT01782495|363885549|FG008|Overall Study|Adverse Event|0|||
105513377|NCT01782495|363885550|FG009|Overall Study|Adverse Event|0|||
105513378|NCT01782495|363885551|FG010|Overall Study|Adverse Event|0|||
105513379|NCT01782495|363885541|FG000|Overall Study|Withdrew Consent|0|||
105513380|NCT01782495|363885542|FG001|Overall Study|Withdrew Consent|1|||
105513381|NCT01782495|363885543|FG002|Overall Study|Withdrew Consent|0|||
105513382|NCT01782495|363885544|FG003|Overall Study|Withdrew Consent|0|||
105513383|NCT01782495|363885545|FG004|Overall Study|Withdrew Consent|0|||
105513384|NCT01782495|363885546|FG005|Overall Study|Withdrew Consent|0|||
105513385|NCT01782495|363885547|FG006|Overall Study|Withdrew Consent|0|||
105513386|NCT01782495|363885548|FG007|Overall Study|Withdrew Consent|1|||
105513387|NCT01782495|363885549|FG008|Overall Study|Withdrew Consent|0|||
105513388|NCT01782495|363885550|FG009|Overall Study|Withdrew Consent|0|||
105513389|NCT01782495|363885551|FG010|Overall Study|Withdrew Consent|0|||
105513390|NCT00580606|363885554|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
105513391|NCT00580606|363885555|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
105513392|NCT00580606|363885554|FG000|Open Label (OL)|Withdrawal by Subject|4|||
105513393|NCT00580606|363885555|FG001|Open Label (OL)|Withdrawal by Subject|6|||
105513394|NCT00580606|363885554|FG000|Open Label (OL)|Dosing Symptoms|0|||
105513395|NCT00580606|363885555|FG001|Open Label (OL)|Dosing Symptoms|1|||
105513396|NCT00580606|363885554|FG000|Open Label (OL)|Lost to Follow-up|0|||
105513397|NCT00580606|363885555|FG001|Open Label (OL)|Lost to Follow-up|1|||
105513398|NCT00580606|363885554|FG000|Open Label (OL)|Pregnancy|0|||
105513399|NCT00580606|363885555|FG001|Open Label (OL)|Pregnancy|1|||
105513400|NCT00580606|363885554|FG000|Open Label (OL)|Non-compliance|2|||
105513401|NCT00580606|363885555|FG001|Open Label (OL)|Non-compliance|0|||
105513402|NCT00580606|363885554|FG000|Open Label (OL)|Physician Decision|1|||
105513403|NCT00580606|363885555|FG001|Open Label (OL)|Physician Decision|1|||
105513404|NCT00580606|363885554|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
105513405|NCT00580606|363885555|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
105513406|NCT04203238|363887150|FG000|Overall Study|Withdrawal by Subject|1|||
105513407|NCT04203238|363887151|FG001|Overall Study|Withdrawal by Subject|1|||
105513408|NCT04203238|363887150|FG000|Overall Study|Covid-19|3|||
105513409|NCT04203238|363887151|FG001|Overall Study|Covid-19|0|||
105513410|NCT01955733|363887152|FG000|Period 1|Lost to Follow-up|1|||
105513411|NCT01955733|363887153|FG001|Period 1|Lost to Follow-up|0|||
105513412|NCT01955733|363887154|FG002|Period 1|Lost to Follow-up|0|||
105513413|NCT01955733|363887152|FG000|Period 2|Adverse Event|1|||
105513414|NCT01955733|363887153|FG001|Period 2|Adverse Event|0|||
105513415|NCT01955733|363887154|FG002|Period 2|Adverse Event|0|||
105513416|NCT01955733|363887152|FG000|Period 2|Physician Decision|0|||
105513417|NCT01955733|363887153|FG001|Period 2|Physician Decision|0|||
105513418|NCT01955733|363887154|FG002|Period 2|Physician Decision|1|||
105513419|NCT01955733|363887152|FG000|Period 2|Withdrawal by Subject|1|||
105513420|NCT01955733|363887153|FG001|Period 2|Withdrawal by Subject|3|||
105513421|NCT01955733|363887154|FG002|Period 2|Withdrawal by Subject|2|||
105513422|NCT01955733|363887152|FG000|Period 2|Study terminated by sponsor|8|||
105513423|NCT01955733|363887153|FG001|Period 2|Study terminated by sponsor|14|||
105513424|NCT01955733|363887154|FG002|Period 2|Study terminated by sponsor|16|||
105513425|NCT01955733|363887152|FG000|Period 2|Lost to Follow-up|2|||
105513426|NCT01955733|363887153|FG001|Period 2|Lost to Follow-up|0|||
105513427|NCT01955733|363887154|FG002|Period 2|Lost to Follow-up|0|||
105513428|NCT01955733|363887152|FG000|Period 2|Other not defined above|0|||
105513429|NCT01955733|363887153|FG001|Period 2|Other not defined above|2|||
105513430|NCT01955733|363887154|FG002|Period 2|Other not defined above|2|||
105513431|NCT01134783|363887155|FG000|Overall Study|Pregnancy|16|||
105513432|NCT01134783|363887156|FG001|Overall Study|Pregnancy|8|||
105513433|NCT01134783|363887155|FG000|Overall Study|Withdrawal by Subject|15|||
105513434|NCT01134783|363887156|FG001|Overall Study|Withdrawal by Subject|9|||
105513435|NCT01134783|363887155|FG000|Overall Study|Lost to Follow-up|5|||
105513436|NCT01134783|363887156|FG001|Overall Study|Lost to Follow-up|20|||
105513437|NCT04221009|363887157|FG000|Overall Study|Withdrawal by Subject|4|||
105513438|NCT00793598|363887158|FG000|Overall Study|Patient Request|0|||
105513439|NCT00793598|363887159|FG001|Overall Study|Patient Request|1|||
105513440|NCT00793598|363887160|FG002|Overall Study|Patient Request|0|||
105513441|NCT00793598|363887161|FG003|Overall Study|Patient Request|0|||
105513442|NCT00793598|363887162|FG004|Overall Study|Patient Request|0|||
105513443|NCT00793598|363887163|FG005|Overall Study|Patient Request|0|||
105513444|NCT00793598|363887164|FG006|Overall Study|Patient Request|0|||
105513445|NCT00793598|363887165|FG007|Overall Study|Patient Request|0|||
105513446|NCT00793598|363887158|FG000|Overall Study|Protocol Violation|0|||
105513447|NCT00793598|363887159|FG001|Overall Study|Protocol Violation|0|||
105513448|NCT00793598|363887160|FG002|Overall Study|Protocol Violation|0|||
105513449|NCT00793598|363887161|FG003|Overall Study|Protocol Violation|0|||
105513450|NCT00793598|363887162|FG004|Overall Study|Protocol Violation|0|||
105513451|NCT00793598|363887163|FG005|Overall Study|Protocol Violation|0|||
105513452|NCT00793598|363887164|FG006|Overall Study|Protocol Violation|0|||
105513453|NCT00793598|363887165|FG007|Overall Study|Protocol Violation|1|||
105513454|NCT00793598|363887158|FG000|Overall Study|Subject not dosed|0|||
105513455|NCT00793598|363887159|FG001|Overall Study|Subject not dosed|0|||
105513456|NCT00793598|363887160|FG002|Overall Study|Subject not dosed|0|||
105513457|NCT00793598|363887161|FG003|Overall Study|Subject not dosed|0|||
105513458|NCT00793598|363887162|FG004|Overall Study|Subject not dosed|0|||
105513459|NCT00793598|363887163|FG005|Overall Study|Subject not dosed|1|||
105513460|NCT00793598|363887164|FG006|Overall Study|Subject not dosed|0|||
105513461|NCT00793598|363887165|FG007|Overall Study|Subject not dosed|0|||
105513462|NCT01438424|363887166|FG000|Overall Study|Continuing treatment|29|||
105513463|NCT01438424|363887166|FG000|Overall Study|Minimal virologic response|95|||
105513464|NCT01438424|363887166|FG000|Overall Study|Not identified|55|||
105513465|NCT01438424|363887166|FG000|Overall Study|Withdrawal by Subject|104|||
105513466|NCT01438424|363887166|FG000|Overall Study|Progression of chronic hepatitis B|22|||
105513467|NCT01438424|363887166|FG000|Overall Study|Death|22|||
105513468|NCT01438424|363887166|FG000|Overall Study|Adverse Event|17|||
105513469|NCT01438424|363887166|FG000|Overall Study|Lost to Follow-up|17|||
105513470|NCT01438424|363887166|FG000|Overall Study|Abnormal laboratory test result|14|||
105513471|NCT01438424|363887166|FG000|Overall Study|Need for drug prohibited by protocol|14|||
105513472|NCT01438424|363887166|FG000|Overall Study|Pregnancy|7|||
105513473|NCT01438424|363887166|FG000|Overall Study|No longer met inclusion criteria|1|||
105513474|NCT01438424|363887166|FG000|Overall Study|Participant noncompliance|20|||
105513475|NCT04232124|363887167|FG000|Overall Study|Lost to Follow-up|3|||
105513476|NCT02329730|363887173|FG000|Overall Study|Protocol Violation|0|||
105513477|NCT02329730|363887174|FG001|Overall Study|Protocol Violation|0|||
105513478|NCT02329730|363887175|FG002|Overall Study|Protocol Violation|0|||
105513479|NCT02329730|363887176|FG003|Overall Study|Protocol Violation|0|||
105513480|NCT02329730|363887177|FG004|Overall Study|Protocol Violation|2|||
105513481|NCT02329730|363887178|FG005|Overall Study|Protocol Violation|2|||
105513482|NCT02329730|363887179|FG006|Overall Study|Protocol Violation|0|||
105513483|NCT02329730|363887180|FG007|Overall Study|Protocol Violation|0|||
105513484|NCT02329730|363887181|FG008|Overall Study|Protocol Violation|0|||
105513485|NCT02329730|363887182|FG009|Overall Study|Protocol Violation|0|||
105513486|NCT02329730|363887183|FG010|Overall Study|Protocol Violation|0|||
105513487|NCT02329730|363887184|FG011|Overall Study|Protocol Violation|0|||
105513488|NCT02329730|363887173|FG000|Overall Study|Withdrawal by Subject|0|||
105513489|NCT02329730|363887174|FG001|Overall Study|Withdrawal by Subject|0|||
105513490|NCT02329730|363887175|FG002|Overall Study|Withdrawal by Subject|0|||
105513491|NCT02329730|363887176|FG003|Overall Study|Withdrawal by Subject|0|||
105513492|NCT02329730|363887177|FG004|Overall Study|Withdrawal by Subject|1|||
105513493|NCT02329730|363887178|FG005|Overall Study|Withdrawal by Subject|0|||
105513494|NCT02329730|363887179|FG006|Overall Study|Withdrawal by Subject|1|||
105513495|NCT02329730|363887180|FG007|Overall Study|Withdrawal by Subject|1|||
105513496|NCT02329730|363887181|FG008|Overall Study|Withdrawal by Subject|1|||
105513497|NCT02329730|363887182|FG009|Overall Study|Withdrawal by Subject|1|||
105513498|NCT02329730|363887183|FG010|Overall Study|Withdrawal by Subject|0|||
105513499|NCT02329730|363887184|FG011|Overall Study|Withdrawal by Subject|0|||
105513500|NCT02154490|363887185|FG000|Overall Study|No tissue submitted|23|||
105513501|NCT02154490|363887185|FG000|Overall Study|No biomarker results|167|||
105513502|NCT02154490|363887185|FG000|Overall Study|Not assigned to a sub-study|270|||
105513503|NCT02154490|363887185|FG000|Overall Study|Did not register to a sub-study|749|||
105513504|NCT04876274|363887186|FG000|Overall Study|Lost to Follow-up|9|||
105513505|NCT04876274|363887187|FG001|Overall Study|Lost to Follow-up|12|||
105513506|NCT04326231|363887188|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
105513507|NCT00449540|363887189|FG000|Pretreatment Phase|No migraine experienced|66|||
105513508|NCT00449540|363887190|FG001|Pretreatment Phase|No migraine experienced|0|||
105513509|NCT00449540|363887191|FG002|Pretreatment Phase|No migraine experienced|0|||
105513510|NCT00449540|363887189|FG000|Treatment Phase|did not experience or treat migraine|0|||
105513511|NCT00449540|363887190|FG001|Treatment Phase|did not experience or treat migraine|20|||
105513512|NCT00449540|363887191|FG002|Treatment Phase|did not experience or treat migraine|17|||
105513513|NCT02551731|363887196|FG000|Overall Study|Withdrawal by Subject|2|||
105513514|NCT01750242|363887197|FG000|Overall Study|Unreadable Images|3|||
105513515|NCT02069366|363887198|FG000|Overall Study|Lost to Follow-up|0|||
105513516|NCT02069366|363887199|FG001|Overall Study|Lost to Follow-up|0|||
105513517|NCT02069366|363887200|FG002|Overall Study|Lost to Follow-up|1|||
105513518|NCT02069366|363887201|FG003|Overall Study|Lost to Follow-up|0|||
105513519|NCT02069366|363887202|FG004|Overall Study|Lost to Follow-up|0|||
105513520|NCT02069366|363887203|FG005|Overall Study|Lost to Follow-up|2|||
105513521|NCT02069366|363887198|FG000|Overall Study|Protocol Violation|0|||
105513522|NCT02069366|363887199|FG001|Overall Study|Protocol Violation|0|||
105513523|NCT02069366|363887200|FG002|Overall Study|Protocol Violation|1|||
105513524|NCT02069366|363887201|FG003|Overall Study|Protocol Violation|0|||
105513525|NCT02069366|363887202|FG004|Overall Study|Protocol Violation|0|||
105513526|NCT02069366|363887203|FG005|Overall Study|Protocol Violation|0|||
105513527|NCT02069366|363887198|FG000|Overall Study|Withdrawal by Subject|1|||
105513528|NCT02069366|363887199|FG001|Overall Study|Withdrawal by Subject|0|||
105513529|NCT02069366|363887200|FG002|Overall Study|Withdrawal by Subject|1|||
105513530|NCT02069366|363887201|FG003|Overall Study|Withdrawal by Subject|2|||
105513531|NCT02069366|363887202|FG004|Overall Study|Withdrawal by Subject|0|||
105513532|NCT02069366|363887203|FG005|Overall Study|Withdrawal by Subject|0|||
105513533|NCT04649060|363887211|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
105513534|NCT04649060|363887212|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
105513535|NCT04649060|363887211|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
105513536|NCT04649060|363887212|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
105513537|NCT04649060|363887211|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
105513538|NCT04649060|363887212|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
105513539|NCT04649060|363887211|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
105513540|NCT04649060|363887212|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
105513541|NCT04649060|363887211|FG000|Arm A/Arm B Treatment|Patient Request|1|||
105513542|NCT04649060|363887212|FG001|Arm A/Arm B Treatment|Patient Request|0|||
105513543|NCT04649060|363887211|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
105513544|NCT04649060|363887212|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
105513545|NCT04649060|363887211|FG000|Arm A/Arm B Treatment|Other|1|||
105513546|NCT04649060|363887212|FG001|Arm A/Arm B Treatment|Other|0|||
105513547|NCT04649060|363887211|FG000|Crossover (Arm B)|Adverse Event|0|||
105513548|NCT04649060|363887212|FG001|Crossover (Arm B)|Adverse Event|1|||
105513549|NCT04649060|363887211|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
105513550|NCT04649060|363887212|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
105513551|NCT02706691|363887213|FG000|Overall Study|Adverse Event|1|||
105513552|NCT03033394|363887214|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
105513553|NCT03033394|363887214|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
105513554|NCT03033394|363887214|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
105513555|NCT03033394|363887214|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
105513556|NCT03033394|363887214|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
105513557|NCT03167411|363887215|FG000|Overall Study|Adverse Event|0|||
105513558|NCT03167411|363887216|FG001|Overall Study|Adverse Event|1|||
105513559|NCT01830972|363887220|FG000|Part II|Withdrawal by Subject|2|||
105513560|NCT01830972|363887221|FG001|Part II|Withdrawal by Subject|2|||
105513561|NCT01830972|363887220|FG000|Part III|Withdrawal by Subject|1|||
105513562|NCT01830972|363887221|FG001|Part III|Withdrawal by Subject|0|||
105513563|NCT01830972|363887220|FG000|Part III|Noncompliance|1|||
105513564|NCT01830972|363887221|FG001|Part III|Noncompliance|0|||
105513565|NCT01830972|363887220|FG000|Part IV|Withdrawal by Subject|2|||
105513566|NCT01830972|363887221|FG001|Part IV|Withdrawal by Subject|1|||
105513567|NCT01830972|363887220|FG000|Part IV|Non-Compliance|1|||
105513568|NCT01830972|363887221|FG001|Part IV|Non-Compliance|0|||
105513569|NCT02117648|363887222|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
105513570|NCT02117648|363887222|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
105513571|NCT02117648|363887222|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
105513572|NCT02117648|363887222|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
105513573|NCT02117648|363887222|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
105513574|NCT02117648|363887222|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
105513575|NCT02117648|363887222|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
105513576|NCT02117648|363887222|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
105513577|NCT02117648|363887222|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
105513578|NCT02117648|363887222|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
105513579|NCT02117648|363887222|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
105513580|NCT01426373|363887223|FG000|Overall Study|Adverse Event|6|||
105513581|NCT01426373|363887223|FG000|Overall Study|Lost to Follow-up|14|||
105513582|NCT01426373|363887223|FG000|Overall Study|Participant Convenience|10|||
105513583|NCT01426373|363887223|FG000|Overall Study|Miscellaneous Reasons|4|||
105513584|NCT00587639|363887224|FG000|Overall Study|Withdrawal by Subject|1|||
105513585|NCT04997161|363887231|FG000|Overall Study|Study terminated by sponsor|3|||
105592043|NCT00464672|364169290|FG003|Overall Study|withdrawal of consent|1|||
105592044|NCT00464672|364169291|FG004|Overall Study|withdrawal of consent|9|||
105592045|NCT00464672|364169292|FG005|Overall Study|withdrawal of consent|4|||
105592046|NCT00464672|364169287|FG000|Overall Study|Lost to Follow-up|25|||
105592047|NCT00464672|364169288|FG001|Overall Study|Lost to Follow-up|10|||
105592048|NCT00464672|364169289|FG002|Overall Study|Lost to Follow-up|0|||
105592049|NCT00464672|364169290|FG003|Overall Study|Lost to Follow-up|0|||
105592050|NCT00464672|364169291|FG004|Overall Study|Lost to Follow-up|1|||
105592051|NCT00464672|364169292|FG005|Overall Study|Lost to Follow-up|0|||
105592052|NCT04580303|364169293|FG000|Overall Study|Adverse Event|0|||
105592053|NCT04580303|364169294|FG001|Overall Study|Adverse Event|1|||
105592054|NCT04580303|364169295|FG002|Overall Study|Adverse Event|0|||
105592055|NCT04580303|364169296|FG003|Overall Study|Adverse Event|0|||
105513586|NCT02532972|363887232|FG000|Overall Study|Withdrawal by Subject|1|||
105513587|NCT01417234|363887235|FG000|Overall Study|Subject non-compliant|3|||
105513588|NCT00023764|363887236|FG000|Overall Study|Other|1|||
105513589|NCT00023764|363887236|FG000|Overall Study|Adverse Event|4|||
105513590|NCT00023764|363887236|FG000|Overall Study|Withdrawal by Subject|1|||
105513591|NCT00023764|363887236|FG000|Overall Study|Progression of disease|6|||
105513592|NCT00023764|363887236|FG000|Overall Study|patient received other treatment|1|||
105513593|NCT00023764|363887236|FG000|Overall Study|delay in obtaining staging images|1|||
105513594|NCT02407704|363887241|FG000|Overall Study|Lost to Follow-up|0|||
105592056|NCT04580303|364169293|FG000|Overall Study|Withdrawal by Subject|0|||
105592057|NCT04580303|364169294|FG001|Overall Study|Withdrawal by Subject|0|||
105592058|NCT04580303|364169295|FG002|Overall Study|Withdrawal by Subject|1|||
105513595|NCT02407704|363887242|FG001|Overall Study|Lost to Follow-up|0|||
105513596|NCT02407704|363887243|FG002|Overall Study|Lost to Follow-up|0|||
105513597|NCT02407704|363887244|FG003|Overall Study|Lost to Follow-up|2|||
105513598|NCT02407704|363887241|FG000|Overall Study|Protocol Violation|0|||
105513599|NCT02407704|363887242|FG001|Overall Study|Protocol Violation|0|||
105513600|NCT02407704|363887243|FG002|Overall Study|Protocol Violation|0|||
105513601|NCT02407704|363887244|FG003|Overall Study|Protocol Violation|1|||
105513602|NCT02407704|363887241|FG000|Overall Study|Withdrawal by Subject|0|||
105513603|NCT02407704|363887242|FG001|Overall Study|Withdrawal by Subject|0|||
105513604|NCT02407704|363887243|FG002|Overall Study|Withdrawal by Subject|1|||
105513605|NCT02407704|363887244|FG003|Overall Study|Withdrawal by Subject|0|||
105513606|NCT02730455|363887246|FG000|Overall Study|Death|5|||
105513607|NCT02730455|363887247|FG001|Overall Study|Death|6|||
105513608|NCT02730455|363887248|FG002|Overall Study|Death|4|||
105592059|NCT04580303|364169296|FG003|Overall Study|Withdrawal by Subject|0|||
105592060|NCT00241644|364169297|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
105592061|NCT00241644|364169298|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
105592062|NCT00241644|364169299|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
105592063|NCT00241644|364169300|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
105592064|NCT00241644|364169297|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
105592065|NCT00241644|364169298|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
105592066|NCT00241644|364169299|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
105592067|NCT00241644|364169300|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
105592068|NCT00241644|364169297|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
105592069|NCT00241644|364169298|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
105513609|NCT02730455|363887246|FG000|Overall Study|Consent withdrawn|2|||
105513610|NCT02730455|363887247|FG001|Overall Study|Consent withdrawn|4|||
105513611|NCT02730455|363887248|FG002|Overall Study|Consent withdrawn|1|||
105513612|NCT02730455|363887246|FG000|Overall Study|Lost to Follow-up|3|||
105513613|NCT02730455|363887247|FG001|Overall Study|Lost to Follow-up|1|||
105513614|NCT02730455|363887248|FG002|Overall Study|Lost to Follow-up|4|||
105513615|NCT02730455|363887246|FG000|Overall Study|Other|1|||
105513616|NCT02730455|363887247|FG001|Overall Study|Other|1|||
105513617|NCT02730455|363887248|FG002|Overall Study|Other|2|||
105513618|NCT02730455|363887246|FG000|Overall Study|Other|2|||
105513619|NCT02730455|363887247|FG001|Overall Study|Other|2|||
105513620|NCT02730455|363887248|FG002|Overall Study|Other|0|||
105513621|NCT05227027|363887257|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
105513622|NCT05227027|363887258|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
105513623|NCT01018186|363887259|FG000|2-week Run-in Period|Protocol Violation|1|||
105513624|NCT01018186|363887260|FG001|2-week Run-in Period|Protocol Violation|0|||
105513625|NCT01018186|363887261|FG002|2-week Run-in Period|Protocol Violation|0|||
105513626|NCT01018186|363887262|FG003|2-week Run-in Period|Protocol Violation|0|||
105513627|NCT01018186|363887259|FG000|2-week Run-in Period|Lost to Follow-up|2|||
105513628|NCT01018186|363887260|FG001|2-week Run-in Period|Lost to Follow-up|0|||
105513629|NCT01018186|363887261|FG002|2-week Run-in Period|Lost to Follow-up|0|||
105513630|NCT01018186|363887262|FG003|2-week Run-in Period|Lost to Follow-up|0|||
105513631|NCT01018186|363887259|FG000|2-week Run-in Period|Physician Decision|3|||
105513632|NCT01018186|363887260|FG001|2-week Run-in Period|Physician Decision|0|||
105513633|NCT01018186|363887261|FG002|2-week Run-in Period|Physician Decision|0|||
105513634|NCT01018186|363887262|FG003|2-week Run-in Period|Physician Decision|0|||
105513635|NCT01018186|363887259|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
105513636|NCT01018186|363887260|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
105513637|NCT01018186|363887261|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
105513638|NCT01018186|363887262|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
105513639|NCT01018186|363887259|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
105513640|NCT01018186|363887260|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
105513641|NCT01018186|363887261|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
105592070|NCT00241644|364169299|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
105592071|NCT00241644|364169300|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
105592072|NCT00241644|364169297|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
105592073|NCT00241644|364169298|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
105592074|NCT00241644|364169299|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
105592075|NCT00241644|364169300|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
105513642|NCT01018186|363887262|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
105513643|NCT01018186|363887259|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
105513644|NCT01018186|363887260|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
105513645|NCT01018186|363887261|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
105513646|NCT01018186|363887262|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
105513647|NCT01018186|363887259|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
105513648|NCT01018186|363887260|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
105513649|NCT01018186|363887261|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
105513650|NCT01018186|363887262|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
105513651|NCT01018186|363887259|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
105513652|NCT01018186|363887260|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
105513653|NCT01018186|363887261|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
105513654|NCT01018186|363887262|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
105513655|NCT01018186|363887259|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
105513656|NCT01018186|363887260|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
105513657|NCT01018186|363887261|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
105513658|NCT01018186|363887262|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
105513659|NCT01018186|363887259|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
105513660|NCT01018186|363887260|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
105513661|NCT01018186|363887261|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
105513662|NCT01018186|363887262|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
105513663|NCT01018186|363887259|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
105513664|NCT01018186|363887260|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
105513665|NCT01018186|363887261|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
105513666|NCT01018186|363887262|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
105513667|NCT01018186|363887259|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
105513668|NCT01018186|363887260|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
105513669|NCT01018186|363887261|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
105513670|NCT01018186|363887262|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
105513671|NCT03049280|363887263|FG000|Overall Study|Physician Decision|1|||
105513672|NCT03552198|363887264|FG000|Overall Study|Lost to Follow-up|42|||
105513673|NCT03552198|363887265|FG001|Overall Study|Lost to Follow-up|48|||
105513674|NCT03552198|363887266|FG002|Overall Study|Lost to Follow-up|15|||
105513675|NCT03552198|363887267|FG003|Overall Study|Lost to Follow-up|19|||
105513676|NCT03552198|363887264|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
105513677|NCT03552198|363887265|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
105513678|NCT03552198|363887266|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
105513679|NCT03552198|363887267|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
105513680|NCT03552198|363887264|FG000|Overall Study|Did not receive air alerts|1|||
105513681|NCT03552198|363887265|FG001|Overall Study|Did not receive air alerts|0|||
105513682|NCT03552198|363887266|FG002|Overall Study|Did not receive air alerts|0|||
105513683|NCT03552198|363887267|FG003|Overall Study|Did not receive air alerts|1|||
105513684|NCT03235154|363887268|FG000|Overall Study|Withdrawal by Subject|1|||
105513685|NCT03235154|363887268|FG000|Overall Study|Adverse Event|1|||
105513686|NCT03235154|363887268|FG000|Overall Study|Lost to Follow-up|2|||
105513687|NCT00996307|363887269|FG000|Overall Study|Adverse Event|0|||
105513688|NCT00996307|363887270|FG001|Overall Study|Adverse Event|1|||
105513689|NCT00996307|363887271|FG002|Overall Study|Adverse Event|0|||
105513690|NCT00996307|363887272|FG003|Overall Study|Adverse Event|0|||
105513691|NCT00996307|363887269|FG000|Overall Study|Withdrawal by Subject|3|||
105513692|NCT00996307|363887270|FG001|Overall Study|Withdrawal by Subject|2|||
105513693|NCT00996307|363887271|FG002|Overall Study|Withdrawal by Subject|5|||
105513694|NCT00996307|363887272|FG003|Overall Study|Withdrawal by Subject|5|||
105513695|NCT00996307|363887269|FG000|Overall Study|Lost to Follow-up|13|||
105513696|NCT00996307|363887270|FG001|Overall Study|Lost to Follow-up|13|||
105513697|NCT00996307|363887271|FG002|Overall Study|Lost to Follow-up|7|||
105513698|NCT00996307|363887272|FG003|Overall Study|Lost to Follow-up|15|||
105513699|NCT00996307|363887269|FG000|Overall Study|Administrative reason|0|||
105513700|NCT00996307|363887270|FG001|Overall Study|Administrative reason|1|||
105513701|NCT00996307|363887271|FG002|Overall Study|Administrative reason|0|||
105513702|NCT00996307|363887272|FG003|Overall Study|Administrative reason|0|||
105513703|NCT00996307|363887269|FG000|Overall Study|Unable to classify|4|||
105513704|NCT00996307|363887270|FG001|Overall Study|Unable to classify|0|||
105513705|NCT00996307|363887271|FG002|Overall Study|Unable to classify|2|||
105513706|NCT00996307|363887272|FG003|Overall Study|Unable to classify|1|||
105513707|NCT02850965|363887273|FG000|Overall Study|Other than listed|3|||
105513708|NCT02850965|363887274|FG001|Overall Study|Other than listed|4|||
105592076|NCT00241644|364169297|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
105513709|NCT02850965|363887273|FG000|Overall Study|Protocol Violation|0|||
105513710|NCT02850965|363887274|FG001|Overall Study|Protocol Violation|2|||
105513711|NCT02850965|363887273|FG000|Overall Study|Lost to Follow-up|5|||
105513712|NCT02850965|363887274|FG001|Overall Study|Lost to Follow-up|3|||
105513713|NCT02850965|363887273|FG000|Overall Study|Lack of Efficacy|4|||
105513714|NCT02850965|363887274|FG001|Overall Study|Lack of Efficacy|8|||
105513715|NCT02850965|363887273|FG000|Overall Study|Adverse Event|3|||
105513716|NCT02850965|363887274|FG001|Overall Study|Adverse Event|2|||
105513717|NCT02850965|363887273|FG000|Overall Study|Withdrawal by Subject|3|||
105513718|NCT02850965|363887274|FG001|Overall Study|Withdrawal by Subject|4|||
105513719|NCT02850965|363887273|FG000|Overall Study|Physician Decision|0|||
105513720|NCT02850965|363887274|FG001|Overall Study|Physician Decision|1|||
105513721|NCT02850965|363887273|FG000|Overall Study|Randomized but not treated|0|||
105513722|NCT02850965|363887274|FG001|Overall Study|Randomized but not treated|1|||
105513723|NCT02788357|363887277|FG000|Overall Study|Lost to Follow-up|3|||
105513724|NCT02788357|363887278|FG001|Overall Study|Lost to Follow-up|0|||
105513725|NCT00927784|363887279|FG000|Overall Study|Death|1|||
105513726|NCT00927784|363887280|FG001|Overall Study|Death|0|||
105513727|NCT00927784|363887279|FG000|Overall Study|Withdrawal by Subject|1|||
105513728|NCT00927784|363887280|FG001|Overall Study|Withdrawal by Subject|0|||
105513729|NCT00881712|363887281|FG000|Overall Study|Death|1|||
105513730|NCT00881712|363887282|FG001|Overall Study|Death|0|||
105513731|NCT00881712|363887283|FG002|Overall Study|Death|0|||
105513732|NCT00881712|363887281|FG000|Overall Study|Withdrawal by Subject|1|||
105513733|NCT00881712|363887282|FG001|Overall Study|Withdrawal by Subject|0|||
105513734|NCT00881712|363887283|FG002|Overall Study|Withdrawal by Subject|0|||
105513735|NCT01324999|363887284|FG000|Overall Study|Adverse Event|3|||
105513736|NCT01324999|363887284|FG000|Overall Study|Withdrawal by Subject|2|||
105513737|NCT01691781|363887291|FG000|Overall Study|Withdrawal by Subject|4|||
105513738|NCT01691781|363887292|FG001|Overall Study|Withdrawal by Subject|3|||
105513739|NCT01691781|363887291|FG000|Overall Study|Physician Decision|1|||
105513740|NCT01691781|363887292|FG001|Overall Study|Physician Decision|1|||
105513741|NCT01691781|363887291|FG000|Overall Study|Protocol Violation|2|||
105513742|NCT01691781|363887292|FG001|Overall Study|Protocol Violation|2|||
105513743|NCT01691781|363887291|FG000|Overall Study|Adverse Event|0|||
105513744|NCT01691781|363887292|FG001|Overall Study|Adverse Event|1|||
105513745|NCT03978520|363887293|FG000|Overall Study|Adverse Event|2|||
105513746|NCT03978520|363887294|FG001|Overall Study|Adverse Event|5|||
105513747|NCT03978520|363887295|FG002|Overall Study|Adverse Event|3|||
105513748|NCT03978520|363887296|FG003|Overall Study|Adverse Event|5|||
105513749|NCT03978520|363887297|FG004|Overall Study|Adverse Event|6|||
105513750|NCT03978520|363887293|FG000|Overall Study|Withdrawal by Subject|10|||
105513751|NCT03978520|363887294|FG001|Overall Study|Withdrawal by Subject|4|||
105513752|NCT03978520|363887295|FG002|Overall Study|Withdrawal by Subject|5|||
105513753|NCT03978520|363887296|FG003|Overall Study|Withdrawal by Subject|6|||
105513754|NCT03978520|363887297|FG004|Overall Study|Withdrawal by Subject|5|||
105513755|NCT03978520|363887293|FG000|Overall Study|Lost to Follow-up|2|||
105513756|NCT03978520|363887294|FG001|Overall Study|Lost to Follow-up|2|||
105513757|NCT03978520|363887295|FG002|Overall Study|Lost to Follow-up|2|||
105513758|NCT03978520|363887296|FG003|Overall Study|Lost to Follow-up|0|||
105513759|NCT03978520|363887297|FG004|Overall Study|Lost to Follow-up|1|||
105513760|NCT03978520|363887293|FG000|Overall Study|COVID-19 infection|0|||
105513761|NCT03978520|363887294|FG001|Overall Study|COVID-19 infection|1|||
105513762|NCT03978520|363887295|FG002|Overall Study|COVID-19 infection|0|||
105513763|NCT03978520|363887296|FG003|Overall Study|COVID-19 infection|0|||
105513764|NCT03978520|363887297|FG004|Overall Study|COVID-19 infection|0|||
105513765|NCT03978520|363887293|FG000|Overall Study|Other, not specified|9|||
105513766|NCT03978520|363887294|FG001|Overall Study|Other, not specified|4|||
105513767|NCT03978520|363887295|FG002|Overall Study|Other, not specified|1|||
105513768|NCT03978520|363887296|FG003|Overall Study|Other, not specified|1|||
105513769|NCT03978520|363887297|FG004|Overall Study|Other, not specified|2|||
105513770|NCT03978520|363887293|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
105513771|NCT03978520|363887294|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
105513772|NCT03978520|363887295|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
105513773|NCT03978520|363887296|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
105513774|NCT03978520|363887297|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
105513775|NCT00230607|363887298|FG000|Overall Study|Other|3|||
105513776|NCT01927367|363887301|FG000|Overall Study|Withdrawal by Subject|7|||
105513777|NCT01927367|363887302|FG001|Overall Study|Withdrawal by Subject|4|||
105513778|NCT01927367|363887301|FG000|Overall Study|No baseline data|0|||
105513779|NCT01927367|363887302|FG001|Overall Study|No baseline data|1|||
105513780|NCT00598832|363887303|FG000|Overall Study|Lack of Efficacy|3|||
105513781|NCT00598832|363887304|FG001|Overall Study|Lack of Efficacy|7|||
105513782|NCT00598832|363887303|FG000|Overall Study|Adverse Event|6|||
105513783|NCT00598832|363887304|FG001|Overall Study|Adverse Event|2|||
105513784|NCT00598832|363887303|FG000|Overall Study|Withdrawal by Subject|25|||
105513785|NCT00598832|363887304|FG001|Overall Study|Withdrawal by Subject|36|||
105513786|NCT00598832|363887303|FG000|Overall Study|Protocol Violation|0|||
105513787|NCT00598832|363887304|FG001|Overall Study|Protocol Violation|2|||
105513788|NCT00598832|363887303|FG000|Overall Study|Lost to Follow-up|24|||
105513789|NCT00598832|363887304|FG001|Overall Study|Lost to Follow-up|29|||
105513790|NCT00598832|363887303|FG000|Overall Study|Pregnancy|2|||
105513791|NCT00598832|363887304|FG001|Overall Study|Pregnancy|2|||
105513792|NCT00598832|363887303|FG000|Overall Study|Physician Decision|1|||
105513793|NCT00598832|363887304|FG001|Overall Study|Physician Decision|4|||
105513794|NCT00598832|363887303|FG000|Overall Study|Non compliance|1|||
105513795|NCT00598832|363887304|FG001|Overall Study|Non compliance|0|||
105513796|NCT00071513|363887305|FG000|Intervention Component|Withdrawal by Subject|2|||
105513797|NCT00071513|363887306|FG001|Intervention Component|Withdrawal by Subject|3|||
105592077|NCT00241644|364169298|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
105592078|NCT00241644|364169299|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
105592079|NCT00241644|364169300|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
105592080|NCT00241644|364169297|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
105592081|NCT00241644|364169298|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
105592082|NCT00241644|364169299|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
105592083|NCT00241644|364169300|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
105592084|NCT00241644|364169297|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
105592085|NCT00241644|364169298|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
105592086|NCT00241644|364169299|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
105592087|NCT00241644|364169300|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
105592088|NCT00241644|364169297|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
105592089|NCT00241644|364169298|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
105592090|NCT00241644|364169299|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
105592091|NCT00241644|364169300|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
105592092|NCT00241644|364169297|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
105592093|NCT00241644|364169298|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
105592094|NCT00241644|364169299|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
105592095|NCT00241644|364169300|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
105592096|NCT00241644|364169297|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
105592097|NCT00241644|364169298|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
105592098|NCT00241644|364169299|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
105592099|NCT00241644|364169300|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
105592100|NCT00241644|364169297|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
105592101|NCT00241644|364169298|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
105592102|NCT00241644|364169299|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
105592103|NCT00241644|364169300|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
105592104|NCT00241644|364169297|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
105513798|NCT00071513|363887305|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
105513799|NCT00071513|363887306|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
105513800|NCT01648205|363887312|FG000|Placebo|Pregnancy|1|||
105513801|NCT01648205|363887312|FG000|Placebo|Withdrawal by Subject|1|||
105513802|NCT01648205|363887312|FG000|Placebo|Protocol Violation|2|||
105513803|NCT01648205|363887312|FG000|Ranolazine|Death|1|||
105513804|NCT01648205|363887312|FG000|Ranolazine|Withdrawal by Subject|1|||
105513805|NCT01648205|363887312|FG000|Ranolazine|Protocol Violation|3|||
105513806|NCT03547687|363887314|FG000|Overall Study|Withdrawal by Subject|1|||
105513807|NCT03547687|363887314|FG000|Overall Study|Death|1|||
105513808|NCT00646776|363887317|FG000|Overall Study|Adverse Event|1|||
105513809|NCT00646776|363887318|FG001|Overall Study|Adverse Event|9|||
105513810|NCT00646776|363887317|FG000|Overall Study|Investigator discretion|0|||
105513811|NCT00646776|363887318|FG001|Overall Study|Investigator discretion|4|||
105513812|NCT02260921|363887321|FG000|Overall Study|Adverse Event|1|||
105513813|NCT02260921|363887322|FG001|Overall Study|Adverse Event|0|||
105513814|NCT02260921|363887321|FG000|Overall Study|Lost to Follow-up|4|||
105513815|NCT02260921|363887322|FG001|Overall Study|Lost to Follow-up|3|||
105513816|NCT02260921|363887321|FG000|Overall Study|Withdraw Consent|4|||
105513817|NCT02260921|363887322|FG001|Overall Study|Withdraw Consent|1|||
105513818|NCT02260921|363887321|FG000|Overall Study|Death|1|||
105513819|NCT02260921|363887322|FG001|Overall Study|Death|0|||
105513820|NCT02260921|363887321|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
105513821|NCT02260921|363887322|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
105513822|NCT00126568|363887323|FG000|Overall Study|Death|2|||
105513823|NCT01244425|363887325|FG000|Overall Study|Withdrawal by Subject|2|||
105513824|NCT01244425|363887326|FG001|Overall Study|Withdrawal by Subject|2|||
105513825|NCT01244425|363887325|FG000|Overall Study|Adverse Event|1|||
105513826|NCT01244425|363887326|FG001|Overall Study|Adverse Event|1|||
105513827|NCT01482884|363887329|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
105513828|NCT01482884|363887330|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
105513829|NCT01482884|363887329|FG000|Overall Study|Protocol Violation|1|||
105513830|NCT01482884|363887330|FG001|Overall Study|Protocol Violation|0|||
105513831|NCT01482884|363887329|FG000|Overall Study|Lost to Follow-up|2|||
105513832|NCT01482884|363887330|FG001|Overall Study|Lost to Follow-up|2|||
105513833|NCT01482884|363887329|FG000|Overall Study|Lack of Efficacy|0|||
105592105|NCT00241644|364169298|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
105592106|NCT00241644|364169299|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
105513834|NCT01482884|363887330|FG001|Overall Study|Lack of Efficacy|1|||
105513835|NCT01482884|363887329|FG000|Overall Study|Adverse Event|2|||
105513836|NCT01482884|363887330|FG001|Overall Study|Adverse Event|1|||
105513837|NCT01482884|363887329|FG000|Overall Study|Withdrawal by Subject|8|||
105513838|NCT01482884|363887330|FG001|Overall Study|Withdrawal by Subject|13|||
105513839|NCT02547454|363887331|FG000|Overall Study|Due to hemodialysis|53|||
105513840|NCT02547454|363887331|FG000|Overall Study|Due to transplantation|1|||
105513841|NCT02547454|363887331|FG000|Overall Study|Due to no further need to treat|4|||
105513842|NCT02547454|363887331|FG000|Overall Study|Death|38|||
105513843|NCT02547454|363887331|FG000|Overall Study|Lost to Follow-up|26|||
105513844|NCT02547454|363887331|FG000|Overall Study|Other|39|||
105513845|NCT02547454|363887331|FG000|Overall Study|No data|11|||
105513846|NCT02345850|363889176|FG000|Overall Study|Not transplanted|10|||
105513847|NCT02345850|363889177|FG001|Overall Study|Not transplanted|5|||
105513848|NCT02345850|363889178|FG002|Overall Study|Not transplanted|4|||
105513849|NCT02345850|363889176|FG000|Overall Study|Lost to Follow-up|2|||
105592107|NCT00241644|364169300|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
105592108|NCT00241644|364169297|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
105592109|NCT00241644|364169298|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
105592110|NCT00241644|364169299|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
105513850|NCT02345850|363889177|FG001|Overall Study|Lost to Follow-up|3|||
105513851|NCT02345850|363889178|FG002|Overall Study|Lost to Follow-up|2|||
105513852|NCT02345850|363889176|FG000|Overall Study|Withdrawal by Subject|1|||
105513853|NCT02345850|363889177|FG001|Overall Study|Withdrawal by Subject|0|||
105513854|NCT02345850|363889178|FG002|Overall Study|Withdrawal by Subject|0|||
105513855|NCT02373202|363889179|FG000|Overall Study|Adverse Event|2|||
105513856|NCT02373202|363889180|FG001|Overall Study|Adverse Event|5|||
105513857|NCT02373202|363889181|FG002|Overall Study|Adverse Event|2|||
105513858|NCT02373202|363889182|FG003|Overall Study|Adverse Event|1|||
105513859|NCT02373202|363889179|FG000|Overall Study|Lack of Efficacy|0|||
105513860|NCT02373202|363889180|FG001|Overall Study|Lack of Efficacy|0|||
105513861|NCT02373202|363889181|FG002|Overall Study|Lack of Efficacy|1|||
105513862|NCT02373202|363889182|FG003|Overall Study|Lack of Efficacy|0|||
105513863|NCT02373202|363889179|FG000|Overall Study|Other|0|||
105513864|NCT02373202|363889180|FG001|Overall Study|Other|1|||
105513865|NCT02373202|363889181|FG002|Overall Study|Other|0|||
105513866|NCT02373202|363889182|FG003|Overall Study|Other|0|||
105513867|NCT00848081|363889184|FG000|Overall Study|Adverse Event|6|||
105513868|NCT00848081|363889185|FG001|Overall Study|Adverse Event|7|||
105592111|NCT00241644|364169300|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
105592112|NCT00543725|364169301|FG000|Overall Study|Adverse Event|18|||
105592113|NCT00543725|364169302|FG001|Overall Study|Adverse Event|27|||
105592114|NCT00543725|364169301|FG000|Overall Study|Sponsor's Decision|0|||
105592115|NCT00543725|364169302|FG001|Overall Study|Sponsor's Decision|1|||
105592116|NCT00543725|364169301|FG000|Overall Study|Subject Non-Compliant|4|||
105592117|NCT00543725|364169302|FG001|Overall Study|Subject Non-Compliant|4|||
105592118|NCT00543725|364169301|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
105513869|NCT00848081|363889184|FG000|Overall Study|Protocol Violation|8|||
105513870|NCT00848081|363889185|FG001|Overall Study|Protocol Violation|5|||
105513871|NCT00848081|363889184|FG000|Overall Study|Lost to Follow-up|1|||
105513872|NCT00848081|363889185|FG001|Overall Study|Lost to Follow-up|0|||
105513873|NCT00848081|363889184|FG000|Overall Study|Physician Decision|0|||
105513874|NCT00848081|363889185|FG001|Overall Study|Physician Decision|3|||
105513875|NCT00848081|363889184|FG000|Overall Study|Withdrawal by Subject|5|||
105513876|NCT00848081|363889185|FG001|Overall Study|Withdrawal by Subject|3|||
105513877|NCT00464087|363889189|FG000|Overall Study|No PCI per inclusion criteria|0|||
105513878|NCT00464087|363889190|FG001|Overall Study|No PCI per inclusion criteria|0|||
105513879|NCT00464087|363889191|FG002|Overall Study|No PCI per inclusion criteria|29|||
105513880|NCT00609492|363889193|FG000|Overall Study|Withdrawal by Subject|0|||
105513881|NCT00609492|363889194|FG001|Overall Study|Withdrawal by Subject|2|||
105513882|NCT00609492|363889195|FG002|Overall Study|Withdrawal by Subject|3|||
105513883|NCT00609492|363889193|FG000|Overall Study|Lost to Follow-up|1|||
105513884|NCT00609492|363889194|FG001|Overall Study|Lost to Follow-up|1|||
105513885|NCT00609492|363889195|FG002|Overall Study|Lost to Follow-up|4|||
105513886|NCT01224431|363889196|FG000|Overall Study|not randomized|0|||
105513887|NCT01224431|363889197|FG001|Overall Study|not randomized|4|||
105513888|NCT01224431|363889196|FG000|Overall Study|no video record|0|||
105513889|NCT01224431|363889197|FG001|Overall Study|no video record|1|||
105513890|NCT02057406|363889198|FG000|Overall Study|Physician Decision|0|||
105513891|NCT02057406|363889199|FG001|Overall Study|Physician Decision|0|||
105592119|NCT00543725|364169302|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
105592120|NCT00543725|364169301|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
105513892|NCT02057406|363889200|FG002|Overall Study|Physician Decision|2|||
105513893|NCT02057406|363889198|FG000|Overall Study|Withdrawal by Subject|0|||
105513894|NCT02057406|363889199|FG001|Overall Study|Withdrawal by Subject|2|||
105513895|NCT02057406|363889200|FG002|Overall Study|Withdrawal by Subject|0|||
105513896|NCT02057406|363889198|FG000|Overall Study|Lost to Follow-up|0|||
105513897|NCT02057406|363889199|FG001|Overall Study|Lost to Follow-up|0|||
105513898|NCT02057406|363889200|FG002|Overall Study|Lost to Follow-up|1|||
105513899|NCT02057406|363889198|FG000|Overall Study|Death|1|||
105513900|NCT02057406|363889199|FG001|Overall Study|Death|0|||
105513901|NCT02057406|363889200|FG002|Overall Study|Death|0|||
105513902|NCT02057406|363889198|FG000|Overall Study|Protocol Violation|0|||
105513903|NCT02057406|363889199|FG001|Overall Study|Protocol Violation|1|||
105513904|NCT02057406|363889200|FG002|Overall Study|Protocol Violation|0|||
105513905|NCT02057406|363889198|FG000|Overall Study|Patient transportation issues|0|||
105513906|NCT02057406|363889199|FG001|Overall Study|Patient transportation issues|0|||
105513907|NCT02057406|363889200|FG002|Overall Study|Patient transportation issues|1|||
105513908|NCT03824912|363889208|FG000|Overall Study|Lost to Follow-up|18|||
105513909|NCT03824912|363889209|FG001|Overall Study|Lost to Follow-up|15|||
105513910|NCT03824912|363889210|FG002|Overall Study|Lost to Follow-up|8|||
105513911|NCT03824912|363889208|FG000|Overall Study|Negative Baseline Culture Result|118|||
105513912|NCT03824912|363889209|FG001|Overall Study|Negative Baseline Culture Result|112|||
105513913|NCT03824912|363889210|FG002|Overall Study|Negative Baseline Culture Result|57|||
105513914|NCT03824912|363889208|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105513915|NCT03824912|363889209|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105513916|NCT03824912|363889210|FG002|Overall Study|Non-Compliance with Study Drug|1|||
105513917|NCT03824912|363889208|FG000|Overall Study|Protocol Violation|1|||
105513918|NCT03824912|363889209|FG001|Overall Study|Protocol Violation|4|||
105513919|NCT03824912|363889210|FG002|Overall Study|Protocol Violation|1|||
105513920|NCT03824912|363889208|FG000|Overall Study|Withdrawal by Subject|3|||
105513921|NCT03824912|363889209|FG001|Overall Study|Withdrawal by Subject|2|||
105513922|NCT03824912|363889210|FG002|Overall Study|Withdrawal by Subject|1|||
105513923|NCT03824912|363889208|FG000|Overall Study|Participation in another study|0|||
105513924|NCT03824912|363889209|FG001|Overall Study|Participation in another study|1|||
105513925|NCT03824912|363889210|FG002|Overall Study|Participation in another study|0|||
105513926|NCT01349790|363889217|FG000|Overall Study|Investigator Judgement|3|||
105513927|NCT01349790|363889217|FG000|Overall Study|Death|2|||
105513928|NCT01349790|363889217|FG000|Overall Study|Withdrawal by Patient|2|||
105513929|NCT01349790|363889217|FG000|Overall Study|Adverse Event|1|||
105513930|NCT01349790|363889217|FG000|Overall Study|Lost to Follow-up|1|||
105513931|NCT02692703|363889220|FG000|Overall Study|Lost to Follow-up|1|||
105513932|NCT02692703|363889220|FG000|Overall Study|Other|1|||
105513933|NCT05048784|363889221|FG000|Period 1|Adverse Event|3|||
105513934|NCT05048784|363889222|FG001|Period 1|Adverse Event|1|||
105513935|NCT05048784|363889223|FG002|Period 1|Adverse Event|0|||
105513936|NCT05048784|363889224|FG003|Period 1|Adverse Event|0|||
105513937|NCT05048784|363889221|FG000|Period 2|Lost to Follow-up|0|||
105513938|NCT05048784|363889222|FG001|Period 2|Lost to Follow-up|1|||
105513939|NCT05048784|363889223|FG002|Period 2|Lost to Follow-up|0|||
105513940|NCT05048784|363889224|FG003|Period 2|Lost to Follow-up|0|||
105513941|NCT03519932|363889225|FG000|First Intervention|Adverse Event|1|||
105513942|NCT03519932|363889226|FG001|First Intervention|Adverse Event|3|||
105513943|NCT02254486|363889227|FG000|Overall Study|Adverse Event|1|||
105513944|NCT02254486|363889228|FG001|Overall Study|Adverse Event|1|||
105513945|NCT02254486|363889227|FG000|Overall Study|Lack of Efficacy|1|||
105513946|NCT02254486|363889228|FG001|Overall Study|Lack of Efficacy|0|||
105513947|NCT02254486|363889227|FG000|Overall Study|Lost to Follow-up|2|||
105513948|NCT02254486|363889228|FG001|Overall Study|Lost to Follow-up|4|||
105513949|NCT02254486|363889227|FG000|Overall Study|Protocol Violation|1|||
105513950|NCT02254486|363889228|FG001|Overall Study|Protocol Violation|2|||
105513951|NCT02254486|363889227|FG000|Overall Study|Withdrawal by Subject|17|||
105513952|NCT02254486|363889228|FG001|Overall Study|Withdrawal by Subject|15|||
105513953|NCT02254486|363889227|FG000|Overall Study|GFR<60mL/min|16|||
105513954|NCT02254486|363889228|FG001|Overall Study|GFR<60mL/min|21|||
105513955|NCT02254486|363889227|FG000|Overall Study|Various|12|||
105513956|NCT02254486|363889228|FG001|Overall Study|Various|12|||
105513957|NCT04166435|363889229|FG000|Overall Study|2 patients ineligible for response|2|||
105513958|NCT00267046|363889232|FG000|Overall Study|Disease progression|4|||
105513959|NCT00267046|363889233|FG001|Overall Study|Disease progression|2|||
105513960|NCT00267046|363889232|FG000|Overall Study|Chemotoxicity|2|||
105513961|NCT00267046|363889233|FG001|Overall Study|Chemotoxicity|0|||
105513962|NCT00267046|363889232|FG000|Overall Study|Open-label palifermin|2|||
105513963|NCT00267046|363889233|FG001|Overall Study|Open-label palifermin|7|||
105513964|NCT00267046|363889232|FG000|Overall Study|Surgery|3|||
105513965|NCT00267046|363889233|FG001|Overall Study|Surgery|1|||
105513966|NCT00267046|363889232|FG000|Overall Study|Withdrawal by Subject|1|||
105513967|NCT00267046|363889233|FG001|Overall Study|Withdrawal by Subject|0|||
105513968|NCT00267046|363889232|FG000|Overall Study|Radiation|0|||
105513969|NCT00267046|363889233|FG001|Overall Study|Radiation|1|||
105513970|NCT00865124|363889234|FG000|Overall Study|Physician Decision|2|||
105513971|NCT00865124|363889235|FG001|Overall Study|Physician Decision|1|||
105513972|NCT00865124|363889236|FG002|Overall Study|Physician Decision|0|||
105513973|NCT00865124|363889234|FG000|Overall Study|Withdrawn consent|2|||
105513974|NCT00865124|363889235|FG001|Overall Study|Withdrawn consent|0|||
105513975|NCT00865124|363889236|FG002|Overall Study|Withdrawn consent|0|||
105513976|NCT01425281|363889238|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
105513977|NCT01425281|363889239|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
105513978|NCT01425281|363889238|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
105513979|NCT01425281|363889239|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
105513980|NCT01425281|363889238|FG000|At 180-day Clinical Follow-up|Death|0|||
105513981|NCT01425281|363889239|FG001|At 180-day Clinical Follow-up|Death|1|||
105513982|NCT01425281|363889238|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
105513983|NCT01425281|363889239|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
105513984|NCT01425281|363889238|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
105513985|NCT01425281|363889239|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
105513986|NCT01425281|363889238|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
105513987|NCT01425281|363889239|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
105513988|NCT01425281|363889238|FG000|At 2-year Clinical Follow-up|Death|2|||
105513989|NCT01425281|363889239|FG001|At 2-year Clinical Follow-up|Death|0|||
105513990|NCT01425281|363889238|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
105513991|NCT01425281|363889239|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
105513992|NCT01425281|363889238|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
105513993|NCT01425281|363889239|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
105513994|NCT01425281|363889238|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
105513995|NCT01425281|363889239|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
105513996|NCT01425281|363889238|FG000|At 3-year Clinical Follow-up|Death|2|||
105513997|NCT01425281|363889239|FG001|At 3-year Clinical Follow-up|Death|3|||
105513998|NCT01425281|363889238|FG000|At 4-year Clinical Follow-up|Death|7|||
105513999|NCT01425281|363889239|FG001|At 4-year Clinical Follow-up|Death|3|||
105514000|NCT01425281|363889238|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
105514001|NCT01425281|363889239|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
105514002|NCT01425281|363889238|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
105514003|NCT01425281|363889239|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
105514004|NCT01425281|363889238|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
105514005|NCT01425281|363889239|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
105514006|NCT01425281|363889238|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
105514007|NCT01425281|363889239|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
105514008|NCT01425281|363889238|FG000|At 5-year Clinical Follow-up|Death|2|||
105514009|NCT01425281|363889239|FG001|At 5-year Clinical Follow-up|Death|0|||
105514010|NCT01425281|363889238|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
105514011|NCT01425281|363889239|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
105514012|NCT01425281|363889238|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
105514013|NCT01425281|363889239|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
105514014|NCT01425281|363889238|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
105514015|NCT01425281|363889239|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
105514016|NCT01979016|363889242|FG000|Overall Study|Withdrawal by Subject|2|||
105514017|NCT01979016|363889243|FG001|Overall Study|Withdrawal by Subject|0|||
105514018|NCT01979016|363889242|FG000|Overall Study|Adverse Event|0|||
105514019|NCT01979016|363889243|FG001|Overall Study|Adverse Event|1|||
105514020|NCT01828281|363889244|FG000|Overall Study|Withdrawal by Subject|1|||
105514021|NCT01828281|363889245|FG001|Overall Study|Withdrawal by Subject|0|||
105514022|NCT01442493|363889246|FG000|Overall Study|withdrawn from study|3|||
105514023|NCT01442493|363889247|FG001|Overall Study|withdrawn from study|2|||
105514024|NCT03454893|363889248|FG000|Overall Study|Study Terminated by the Sponsor|5|||
105514025|NCT03454893|363889248|FG000|Overall Study|Did not pass screening|4|||
105514026|NCT01986985|363889254|FG000|Overall Study|Withdrawal by Subject|4|||
105514027|NCT01986985|363889254|FG000|Overall Study|Scan not completed due to malfunction|3|||
105514028|NCT03303079|363889256|FG000|Overall Study|Adverse Event|0|||
105514029|NCT03303079|363889257|FG001|Overall Study|Adverse Event|1|||
105514030|NCT03303079|363889258|FG002|Overall Study|Adverse Event|3|||
105514031|NCT03303079|363889256|FG000|Overall Study|Protocol Violation|5|||
105514032|NCT03303079|363889257|FG001|Overall Study|Protocol Violation|4|||
105514033|NCT03303079|363889258|FG002|Overall Study|Protocol Violation|7|||
105514034|NCT03303079|363889256|FG000|Overall Study|Withdrawal by Subject|2|||
105514035|NCT03303079|363889257|FG001|Overall Study|Withdrawal by Subject|4|||
105514036|NCT03303079|363889258|FG002|Overall Study|Withdrawal by Subject|2|||
105514037|NCT03303079|363889256|FG000|Overall Study|Other than specified|0|||
105514038|NCT03303079|363889257|FG001|Overall Study|Other than specified|2|||
105514039|NCT03303079|363889258|FG002|Overall Study|Other than specified|0|||
105514040|NCT01314443|363889259|FG000|Overall Study|Withdrawal by Subject|2|||
105514041|NCT01314443|363889260|FG001|Overall Study|Withdrawal by Subject|1|||
105514042|NCT01314443|363889261|FG002|Overall Study|Withdrawal by Subject|1|||
105514043|NCT01314443|363889262|FG003|Overall Study|Withdrawal by Subject|1|||
105514044|NCT01314443|363889259|FG000|Overall Study|Protocol Violation|2|||
105514045|NCT01314443|363889260|FG001|Overall Study|Protocol Violation|2|||
105514046|NCT01314443|363889261|FG002|Overall Study|Protocol Violation|1|||
105514047|NCT01314443|363889262|FG003|Overall Study|Protocol Violation|1|||
105514048|NCT00759954|363889265|FG000|Overall Study|Personal reason|1|||
105514049|NCT00759954|363889266|FG001|Overall Study|Personal reason|0|||
105514050|NCT00759954|363889265|FG000|Overall Study|Adverse Event|1|||
105514051|NCT00759954|363889266|FG001|Overall Study|Adverse Event|2|||
105514052|NCT01961323|363889269|FG000|Overall Study|Withdrawal by Subject|7|||
105514053|NCT01961323|363889269|FG000|Overall Study|Lost to Follow-up|8|||
105514054|NCT01961323|363889269|FG000|Overall Study|screen failure|34|||
105514055|NCT03315208|363889270|FG000|Overall Study|Lost to Follow-up|11|||
105514056|NCT03315208|363889271|FG001|Overall Study|Lost to Follow-up|6|||
105514057|NCT03315208|363889270|FG000|Overall Study|Withdrawal by Subject|2|||
105514058|NCT03315208|363889271|FG001|Overall Study|Withdrawal by Subject|0|||
105514059|NCT02875860|363889277|FG000|Overall Study|Withdrawal by Subject|0|||
105514060|NCT02875860|363889278|FG001|Overall Study|Withdrawal by Subject|1|||
105514061|NCT02746874|363889279|FG000|Overall Study|Withdrawal by Subject|0|||
105514062|NCT02746874|363889280|FG001|Overall Study|Withdrawal by Subject|1|||
105514063|NCT02746874|363889279|FG000|Overall Study|Surgery Date Changed|0|||
105514064|NCT02746874|363889280|FG001|Overall Study|Surgery Date Changed|2|||
105514065|NCT01881776|363889281|FG000|Overall Study|Lost to Follow-up|1|||
105514066|NCT01881776|363889282|FG001|Overall Study|Lost to Follow-up|2|||
105514067|NCT01881776|363889283|FG002|Overall Study|Lost to Follow-up|1|||
105514068|NCT01881776|363889281|FG000|Overall Study|Protocol Violation|0|||
105514069|NCT01881776|363889282|FG001|Overall Study|Protocol Violation|2|||
105514070|NCT01881776|363889283|FG002|Overall Study|Protocol Violation|1|||
105514071|NCT02320149|363889284|FG000|Overall Study|Adverse Event|3|||
105514072|NCT02320149|363889285|FG001|Overall Study|Adverse Event|7|||
105514073|NCT02320149|363889284|FG000|Overall Study|Withdrawal of Consent|28|||
105514074|NCT02320149|363889285|FG001|Overall Study|Withdrawal of Consent|32|||
105514075|NCT02320149|363889284|FG000|Overall Study|Lost to Follow-up|21|||
105514076|NCT02320149|363889285|FG001|Overall Study|Lost to Follow-up|34|||
105514077|NCT02320149|363889284|FG000|Overall Study|Protocol Violation|2|||
105514078|NCT02320149|363889285|FG001|Overall Study|Protocol Violation|1|||
105514079|NCT02320149|363889284|FG000|Overall Study|Noncompliance with Study Treatment|7|||
105514080|NCT02320149|363889285|FG001|Overall Study|Noncompliance with Study Treatment|2|||
105514081|NCT02320149|363889284|FG000|Overall Study|Lack of Efficacy|0|||
105514082|NCT02320149|363889285|FG001|Overall Study|Lack of Efficacy|1|||
105514083|NCT02320149|363889284|FG000|Overall Study|Other Miscellaneous Reasons|2|||
105514084|NCT02320149|363889285|FG001|Overall Study|Other Miscellaneous Reasons|3|||
105514085|NCT00487747|363889289|FG000|Overall Study|Adverse Event|1|||
105514086|NCT00487747|363889289|FG000|Overall Study|Lost to Follow-up|9|||
105514087|NCT00487747|363889289|FG000|Overall Study|Lack of Efficacy|1|||
105514088|NCT02205814|363889318|FG000|Overall Study|Lost to Follow-up|0|||
105514089|NCT02205814|363889319|FG001|Overall Study|Lost to Follow-up|0|||
105514090|NCT02205814|363889320|FG002|Overall Study|Lost to Follow-up|0|||
105514091|NCT02205814|363889321|FG003|Overall Study|Lost to Follow-up|1|||
105514092|NCT02205814|363889318|FG000|Overall Study|Lack of Efficacy|1|||
105514093|NCT02205814|363889319|FG001|Overall Study|Lack of Efficacy|0|||
105514094|NCT02205814|363889320|FG002|Overall Study|Lack of Efficacy|1|||
105514095|NCT02205814|363889321|FG003|Overall Study|Lack of Efficacy|1|||
105514096|NCT02205814|363889318|FG000|Overall Study|Physician Decision|0|||
105514097|NCT02205814|363889319|FG001|Overall Study|Physician Decision|0|||
105514098|NCT02205814|363889320|FG002|Overall Study|Physician Decision|1|||
105514099|NCT02205814|363889321|FG003|Overall Study|Physician Decision|0|||
105514100|NCT02205814|363889318|FG000|Overall Study|Protocol Violation|1|||
105514101|NCT02205814|363889319|FG001|Overall Study|Protocol Violation|0|||
105514102|NCT02205814|363889320|FG002|Overall Study|Protocol Violation|0|||
105514103|NCT02205814|363889321|FG003|Overall Study|Protocol Violation|1|||
105514104|NCT02205814|363889318|FG000|Overall Study|Withdrawal by Subject|0|||
105514105|NCT02205814|363889319|FG001|Overall Study|Withdrawal by Subject|1|||
105514106|NCT02205814|363889320|FG002|Overall Study|Withdrawal by Subject|2|||
105514107|NCT02205814|363889321|FG003|Overall Study|Withdrawal by Subject|1|||
105514108|NCT02205814|363889318|FG000|Overall Study|not compliant with study procedures|0|||
105514109|NCT02205814|363889319|FG001|Overall Study|not compliant with study procedures|0|||
105514110|NCT02205814|363889320|FG002|Overall Study|not compliant with study procedures|1|||
105514111|NCT02205814|363889321|FG003|Overall Study|not compliant with study procedures|0|||
105514112|NCT04952402|363889322|FG000|Overall Study|Lost to Follow-up|1|||
105514113|NCT04952402|363889323|FG001|Overall Study|Lost to Follow-up|3|||
105514114|NCT04952402|363889322|FG000|Overall Study|Lack Of Venous Access|0|||
105514115|NCT04952402|363889323|FG001|Overall Study|Lack Of Venous Access|1|||
105514116|NCT04502589|363889326|FG000|Overall Study|Physician Decision|1|||
105514117|NCT04502589|363889327|FG001|Overall Study|Physician Decision|0|||
105514118|NCT01025752|363889328|FG000|Overall Study|Lost to Follow-up|7|||
105514119|NCT01025752|363889329|FG001|Overall Study|Lost to Follow-up|10|||
105514120|NCT01025752|363889328|FG000|Overall Study|Physician Decision|1|||
105514121|NCT01025752|363889329|FG001|Overall Study|Physician Decision|3|||
105514122|NCT03334448|363889332|FG000|Washout|Personal Reason|0|||
105514123|NCT03334448|363889333|FG001|Washout|Personal Reason|1|||
105514124|NCT03334448|363889334|FG002|Washout|Personal Reason|0|||
105514125|NCT03334448|363889335|FG003|Washout|Personal Reason|0|||
105514126|NCT03334448|363889332|FG000|Washout|Protocol Violation|0|||
105514127|NCT03334448|363889333|FG001|Washout|Protocol Violation|0|||
105514128|NCT03334448|363889334|FG002|Washout|Protocol Violation|0|||
105514129|NCT03334448|363889335|FG003|Washout|Protocol Violation|1|||
105514130|NCT01922089|363889337|FG000|Overall Study|Adverse Event|18|||
105514131|NCT01922089|363889338|FG001|Overall Study|Adverse Event|13|||
105592121|NCT00543725|364169302|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
105514132|NCT01922089|363889337|FG000|Overall Study|Protocol Deviation|10|||
105514133|NCT01922089|363889338|FG001|Overall Study|Protocol Deviation|7|||
105514134|NCT01922089|363889337|FG000|Overall Study|Withdrawal by Subject|3|||
105514135|NCT01922089|363889338|FG001|Overall Study|Withdrawal by Subject|4|||
105514136|NCT01922089|363889337|FG000|Overall Study|administrative problems|4|||
105514137|NCT01922089|363889338|FG001|Overall Study|administrative problems|1|||
105514138|NCT01922089|363889337|FG000|Overall Study|Physician Decision|2|||
105514139|NCT01922089|363889338|FG001|Overall Study|Physician Decision|3|||
105514140|NCT01922089|363889337|FG000|Overall Study|Death|2|||
105514141|NCT01922089|363889338|FG001|Overall Study|Death|1|||
105514142|NCT01922089|363889337|FG000|Overall Study|Lost to Follow-up|0|||
105514143|NCT01922089|363889338|FG001|Overall Study|Lost to Follow-up|1|||
105514144|NCT00573534|363889339|FG000|Overall Study|oppositional behavior|3|||
105514145|NCT00001723|363889340|FG000|Overall Study|Lack of Efficacy|6|||
105514146|NCT00001723|363889341|FG001|Overall Study|Lack of Efficacy|7|||
105514147|NCT00001723|363889340|FG000|Overall Study|Lack of family interest|4|||
105514148|NCT00001723|363889341|FG001|Overall Study|Lack of family interest|5|||
105514149|NCT00001723|363889340|FG000|Overall Study|Lost to Follow-up|2|||
105514150|NCT00001723|363889341|FG001|Overall Study|Lost to Follow-up|2|||
105514151|NCT00001723|363889340|FG000|Overall Study|medication intolerance|1|||
105514152|NCT00001723|363889341|FG001|Overall Study|medication intolerance|2|||
105514153|NCT00536198|363889343|FG000|Overall Study|Lost to Follow-up|15|||
105514154|NCT00536198|363889344|FG001|Overall Study|Lost to Follow-up|14|||
105514155|NCT00536198|363889343|FG000|Overall Study|Withdrawal by Subject|16|||
105514156|NCT00536198|363889344|FG001|Overall Study|Withdrawal by Subject|12|||
105514157|NCT00536198|363889343|FG000|Overall Study|Adverse Event|2|||
105514158|NCT00536198|363889344|FG001|Overall Study|Adverse Event|2|||
105514159|NCT00536198|363889343|FG000|Overall Study|Rescue|3|||
105514160|NCT00536198|363889344|FG001|Overall Study|Rescue|9|||
105514161|NCT00536198|363889343|FG000|Overall Study|Pregnancy|1|||
105514162|NCT00536198|363889344|FG001|Overall Study|Pregnancy|1|||
105514163|NCT00536198|363889343|FG000|Overall Study|Protocol Violation|0|||
105514164|NCT00536198|363889344|FG001|Overall Study|Protocol Violation|1|||
105514165|NCT02848651|363889350|FG000|Overall Study|Death|85|||
105514166|NCT02848651|363889350|FG000|Overall Study|Lost to Follow-up|1|||
105514167|NCT02848651|363889350|FG000|Overall Study|Non-Compliance|1|||
105514168|NCT02848651|363889350|FG000|Overall Study|Symptomatic Deterioration|1|||
105514169|NCT02848651|363889350|FG000|Overall Study|Physician Decision|4|||
105514170|NCT02848651|363889350|FG000|Overall Study|Withdrawal by Subject|14|||
105514171|NCT00750204|363889355|FG000|Overall Study|study halted prematurely|1|||
105514172|NCT00750204|363889356|FG001|Overall Study|study halted prematurely|1|||
105514173|NCT01905657|363889357|FG000|Overall Study|Adverse Event|23|||
105514174|NCT01905657|363889358|FG001|Overall Study|Adverse Event|17|||
105514175|NCT01905657|363889359|FG002|Overall Study|Adverse Event|18|||
105514176|NCT01905657|363889357|FG000|Overall Study|Clinical Progression|103|||
105514177|NCT01905657|363889358|FG001|Overall Study|Clinical Progression|78|||
105514178|NCT01905657|363889359|FG002|Overall Study|Clinical Progression|59|||
105514179|NCT01905657|363889357|FG000|Overall Study|Death|40|||
105514180|NCT01905657|363889358|FG001|Overall Study|Death|43|||
105514181|NCT01905657|363889359|FG002|Overall Study|Death|47|||
105514182|NCT01905657|363889357|FG000|Overall Study|Excluded Medication|13|||
105514183|NCT01905657|363889358|FG001|Overall Study|Excluded Medication|16|||
105514184|NCT01905657|363889359|FG002|Overall Study|Excluded Medication|9|||
105514185|NCT01905657|363889357|FG000|Overall Study|Lost to Follow-up|1|||
105514186|NCT01905657|363889358|FG001|Overall Study|Lost to Follow-up|2|||
105514187|NCT01905657|363889359|FG002|Overall Study|Lost to Follow-up|1|||
105514188|NCT01905657|363889357|FG000|Overall Study|Physician Decision|5|||
105514189|NCT01905657|363889358|FG001|Overall Study|Physician Decision|8|||
105514190|NCT01905657|363889359|FG002|Overall Study|Physician Decision|12|||
105514191|NCT01905657|363889357|FG000|Overall Study|Protocol Violation|2|||
105514192|NCT01905657|363889358|FG001|Overall Study|Protocol Violation|1|||
105514193|NCT01905657|363889359|FG002|Overall Study|Protocol Violation|1|||
105514194|NCT01905657|363889357|FG000|Overall Study|Screen Failure|0|||
105514195|NCT01905657|363889358|FG001|Overall Study|Screen Failure|1|||
105514196|NCT01905657|363889359|FG002|Overall Study|Screen Failure|0|||
105514197|NCT01905657|363889357|FG000|Overall Study|Withdrawal by Subject|15|||
105514198|NCT01905657|363889358|FG001|Overall Study|Withdrawal by Subject|21|||
105514199|NCT01905657|363889359|FG002|Overall Study|Withdrawal by Subject|53|||
105514200|NCT01905657|363889357|FG000|Overall Study|Sponsor Decision|1|||
105514201|NCT01905657|363889358|FG001|Overall Study|Sponsor Decision|0|||
105514202|NCT01905657|363889359|FG002|Overall Study|Sponsor Decision|0|||
105514203|NCT00524368|363891295|FG000|Overall Study|Adverse Event|10|||
105514204|NCT00524368|363891296|FG001|Overall Study|Adverse Event|12|||
105514205|NCT00524368|363891295|FG000|Overall Study|Lost to Follow-up|9|||
105514206|NCT00524368|363891296|FG001|Overall Study|Lost to Follow-up|13|||
105514207|NCT00524368|363891295|FG000|Overall Study|Withdrawal by Subject|4|||
105514208|NCT00524368|363891296|FG001|Overall Study|Withdrawal by Subject|5|||
105514209|NCT00524368|363891295|FG000|Overall Study|Non-compliant|8|||
105514210|NCT00524368|363891296|FG001|Overall Study|Non-compliant|9|||
105514211|NCT00524368|363891295|FG000|Overall Study|Reached a Virologic Endpoint|3|||
105514212|NCT00524368|363891296|FG001|Overall Study|Reached a Virologic Endpoint|2|||
105514213|NCT00524368|363891295|FG000|Overall Study|Sponsor's Decision|2|||
105514214|NCT00524368|363891296|FG001|Overall Study|Sponsor's Decision|0|||
105514215|NCT00524368|363891295|FG000|Overall Study|Ineligible to Continue the study|2|||
105514216|NCT00524368|363891296|FG001|Overall Study|Ineligible to Continue the study|5|||
105514217|NCT00524368|363891295|FG000|Overall Study|Other|3|||
105514218|NCT00524368|363891296|FG001|Overall Study|Other|2|||
105514219|NCT00733408|363891298|FG000|Overall Study|Adverse Event|4|||
105514220|NCT02239978|363891304|FG000|Overall Study|Withdrawal by Subject|2|||
105514221|NCT02239978|363891305|FG001|Overall Study|Withdrawal by Subject|0|||
105514222|NCT01991067|363891310|FG000|Overall Study|Lost to Follow-up|6|||
105514223|NCT01991067|363891311|FG001|Overall Study|Lost to Follow-up|5|||
105514224|NCT01752907|363891313|FG000|Overall Study|Withdrawal by Subject|4|||
105514225|NCT01752907|363891314|FG001|Overall Study|Withdrawal by Subject|10|||
105514226|NCT01752907|363891313|FG000|Overall Study|Lost to Follow-up|2|||
105514227|NCT01752907|363891314|FG001|Overall Study|Lost to Follow-up|1|||
105514228|NCT01752907|363891313|FG000|Overall Study|Decision by Sponsor|6|||
105514229|NCT01752907|363891314|FG001|Overall Study|Decision by Sponsor|9|||
105514230|NCT02425046|363891315|FG000|Overall Study|Lost to Follow-up|52|||
105514231|NCT02425046|363891316|FG001|Overall Study|Lost to Follow-up|50|||
105514232|NCT02425046|363891317|FG002|Overall Study|Lost to Follow-up|56|||
105514233|NCT02425046|363891315|FG000|Overall Study|Withdrawal by Subject|16|||
105514234|NCT02425046|363891316|FG001|Overall Study|Withdrawal by Subject|12|||
105514235|NCT02425046|363891317|FG002|Overall Study|Withdrawal by Subject|0|||
105514236|NCT01831544|363891321|FG000|Overall Study|Death|1|||
105514237|NCT01831544|363891321|FG000|Overall Study|Still on original MVAD device|2|||
105514238|NCT01413191|363891322|FG000|Overall Study|Lost to Follow-up|5|||
105514239|NCT01413191|363891322|FG000|Overall Study|Disease Progression|5|||
105514240|NCT01413191|363891322|FG000|Overall Study|Death|1|||
105514241|NCT01702454|363891323|FG000|Overall Study|Consent withdrawal|0|||
105592122|NCT00543725|364169301|FG000|Overall Study|Protocol Violation|0|||
105514242|NCT01702454|363891324|FG001|Overall Study|Consent withdrawal|1|||
105514243|NCT01702454|363891323|FG000|Overall Study|Migrated/moved from study area|0|||
105514244|NCT01702454|363891324|FG001|Overall Study|Migrated/moved from study area|1|||
105514245|NCT01702454|363891323|FG000|Overall Study|Lost to Follow-up|3|||
105514246|NCT01702454|363891324|FG001|Overall Study|Lost to Follow-up|6|||
105514247|NCT01327885|363891329|FG000|Overall Study|Disease progression-according to RECIST|173|||
105514248|NCT01327885|363891330|FG001|Overall Study|Disease progression-according to RECIST|165|||
105514249|NCT01327885|363891329|FG000|Overall Study|Clinical progression|24|||
105514250|NCT01327885|363891330|FG001|Overall Study|Clinical progression|27|||
105514251|NCT01327885|363891329|FG000|Overall Study|Adverse Event|14|||
105514252|NCT01327885|363891330|FG001|Overall Study|Adverse Event|10|||
105514253|NCT01327885|363891329|FG000|Overall Study|Subject choice|5|||
105514254|NCT01327885|363891330|FG001|Overall Study|Subject choice|10|||
105514255|NCT01327885|363891329|FG000|Overall Study|Other|8|||
105514256|NCT01327885|363891330|FG001|Overall Study|Other|6|||
105514257|NCT01327885|363891329|FG000|Overall Study|Withdrawal of consent from study|3|||
105514258|NCT01327885|363891330|FG001|Overall Study|Withdrawal of consent from study|4|||
105514259|NCT01327885|363891329|FG000|Overall Study|Not treated|1|||
105514260|NCT01327885|363891330|FG001|Overall Study|Not treated|1|||
105514261|NCT01327885|363891329|FG000|Overall Study|Administrative decision|0|||
105514262|NCT01327885|363891330|FG001|Overall Study|Administrative decision|1|||
105514263|NCT04271605|363891332|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
105514264|NCT02085785|363891333|FG000|Overall Study|Withdrawal by Subject|2|||
105514265|NCT02085785|363891334|FG001|Overall Study|Withdrawal by Subject|1|||
105514266|NCT02085785|363891333|FG000|Overall Study|Lost to Follow-up|0|||
105514267|NCT02085785|363891334|FG001|Overall Study|Lost to Follow-up|1|||
105514268|NCT00779467|363891335|FG000|Overall Study|Lack of Efficacy|11|||
105514269|NCT00779467|363891336|FG001|Overall Study|Lack of Efficacy|2|||
105514270|NCT00779467|363891337|FG002|Overall Study|Lack of Efficacy|6|||
105514271|NCT00779467|363891338|FG003|Overall Study|Lack of Efficacy|11|||
105514272|NCT00779467|363891335|FG000|Overall Study|failed inclusion criteria|3|||
105514273|NCT00779467|363891336|FG001|Overall Study|failed inclusion criteria|3|||
105514274|NCT00779467|363891337|FG002|Overall Study|failed inclusion criteria|1|||
105514275|NCT00779467|363891338|FG003|Overall Study|failed inclusion criteria|2|||
105514276|NCT00779467|363891335|FG000|Overall Study|missing data|1|||
105514277|NCT00779467|363891336|FG001|Overall Study|missing data|0|||
105514278|NCT00779467|363891337|FG002|Overall Study|missing data|1|||
105514279|NCT00779467|363891338|FG003|Overall Study|missing data|4|||
105514280|NCT00779467|363891335|FG000|Overall Study|technical issue|0|||
105514281|NCT00779467|363891336|FG001|Overall Study|technical issue|0|||
105514282|NCT00779467|363891337|FG002|Overall Study|technical issue|2|||
105514283|NCT00779467|363891338|FG003|Overall Study|technical issue|1|||
105514284|NCT00779467|363891335|FG000|Overall Study|unavailable research staff|0|||
105514285|NCT00779467|363891336|FG001|Overall Study|unavailable research staff|0|||
105514286|NCT00779467|363891337|FG002|Overall Study|unavailable research staff|0|||
105514287|NCT00779467|363891338|FG003|Overall Study|unavailable research staff|1|||
105514288|NCT01402544|363891351|FG000|Overall Study|Withdrawal by Subject|6|||
105514289|NCT02051608|363891353|FG000|Part 1: Double Blind Treatment|Death|3|||
105514290|NCT02051608|363891354|FG001|Part 1: Double Blind Treatment|Death|3|||
105514291|NCT02051608|363891355|FG002|Part 1: Double Blind Treatment|Death|0|||
105514292|NCT02051608|363891356|FG003|Part 1: Double Blind Treatment|Death|0|||
105514293|NCT02051608|363891353|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
105514294|NCT02051608|363891354|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
105514295|NCT02051608|363891355|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
105514296|NCT02051608|363891356|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
105514297|NCT02051608|363891353|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
105514298|NCT02051608|363891354|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
105514299|NCT02051608|363891355|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
105514300|NCT02051608|363891356|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
105514301|NCT02051608|363891353|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
105514302|NCT02051608|363891354|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
105514303|NCT02051608|363891355|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
105514304|NCT02051608|363891356|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
105514305|NCT02051608|363891353|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
105514306|NCT02051608|363891354|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
105514307|NCT02051608|363891355|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
105514308|NCT02051608|363891356|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
105514309|NCT02051608|363891353|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
105514310|NCT02051608|363891354|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
105514311|NCT02051608|363891355|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
105514312|NCT02051608|363891356|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
105514313|NCT02051608|363891353|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
105514314|NCT02051608|363891354|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
105514315|NCT02051608|363891355|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
105514316|NCT02051608|363891356|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
105514317|NCT02051608|363891353|FG000|Part 1: Double Blind Treatment|Other|6|||
105514318|NCT02051608|363891354|FG001|Part 1: Double Blind Treatment|Other|3|||
105514319|NCT02051608|363891355|FG002|Part 1: Double Blind Treatment|Other|0|||
105514320|NCT02051608|363891356|FG003|Part 1: Double Blind Treatment|Other|0|||
105514321|NCT02051608|363891353|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
105514322|NCT02051608|363891354|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
105514323|NCT02051608|363891355|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
105514324|NCT02051608|363891356|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
105514325|NCT02051608|363891353|FG000|Part 2: Open-label Extension|Adverse Event|0|||
105514326|NCT02051608|363891354|FG001|Part 2: Open-label Extension|Adverse Event|0|||
105514327|NCT02051608|363891355|FG002|Part 2: Open-label Extension|Adverse Event|6|||
105514328|NCT02051608|363891356|FG003|Part 2: Open-label Extension|Adverse Event|8|||
105514329|NCT02051608|363891353|FG000|Part 2: Open-label Extension|Death|0|||
105514330|NCT02051608|363891354|FG001|Part 2: Open-label Extension|Death|0|||
105514331|NCT02051608|363891355|FG002|Part 2: Open-label Extension|Death|7|||
105514332|NCT02051608|363891356|FG003|Part 2: Open-label Extension|Death|4|||
105514333|NCT02051608|363891353|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
105514334|NCT02051608|363891354|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
105514335|NCT02051608|363891355|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
105514336|NCT02051608|363891356|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
105514337|NCT02051608|363891353|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
105514338|NCT02051608|363891354|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
105514339|NCT02051608|363891355|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
105514340|NCT02051608|363891356|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
105514341|NCT02051608|363891353|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
105514342|NCT02051608|363891354|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
105514343|NCT02051608|363891355|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
105514344|NCT02051608|363891356|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
105514345|NCT02051608|363891353|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
105514346|NCT02051608|363891354|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
105514347|NCT02051608|363891355|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
105514348|NCT02051608|363891356|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
105514349|NCT02051608|363891353|FG000|Part 2: Open-label Extension|Physician Decision|0|||
105514350|NCT02051608|363891354|FG001|Part 2: Open-label Extension|Physician Decision|0|||
105514351|NCT02051608|363891355|FG002|Part 2: Open-label Extension|Physician Decision|8|||
105514352|NCT02051608|363891356|FG003|Part 2: Open-label Extension|Physician Decision|5|||
105514353|NCT02051608|363891353|FG000|Part 2: Open-label Extension|Other|0|||
105514354|NCT02051608|363891354|FG001|Part 2: Open-label Extension|Other|0|||
105514355|NCT02051608|363891355|FG002|Part 2: Open-label Extension|Other|9|||
105514356|NCT02051608|363891356|FG003|Part 2: Open-label Extension|Other|9|||
105514357|NCT03070782|363891359|FG000|Overall Study|Adverse Event|3|||
105514358|NCT03070782|363891360|FG001|Overall Study|Adverse Event|0|||
105514359|NCT03070782|363891361|FG002|Overall Study|Adverse Event|3|||
105514360|NCT03070782|363891362|FG003|Overall Study|Adverse Event|1|||
105514361|NCT03070782|363891363|FG004|Overall Study|Adverse Event|6|||
105514362|NCT03070782|363891364|FG005|Overall Study|Adverse Event|2|||
105514363|NCT03070782|363891359|FG000|Overall Study|Withdrawal by Subject|2|||
105514364|NCT03070782|363891360|FG001|Overall Study|Withdrawal by Subject|1|||
105514365|NCT03070782|363891361|FG002|Overall Study|Withdrawal by Subject|1|||
105514366|NCT03070782|363891362|FG003|Overall Study|Withdrawal by Subject|0|||
105514367|NCT03070782|363891363|FG004|Overall Study|Withdrawal by Subject|4|||
105514368|NCT03070782|363891364|FG005|Overall Study|Withdrawal by Subject|3|||
105514369|NCT03070782|363891359|FG000|Overall Study|Reason Not Specified|2|||
105514370|NCT03070782|363891360|FG001|Overall Study|Reason Not Specified|0|||
105514371|NCT03070782|363891361|FG002|Overall Study|Reason Not Specified|0|||
105514372|NCT03070782|363891362|FG003|Overall Study|Reason Not Specified|1|||
105514373|NCT03070782|363891363|FG004|Overall Study|Reason Not Specified|2|||
105514374|NCT03070782|363891364|FG005|Overall Study|Reason Not Specified|1|||
105514375|NCT03070782|363891359|FG000|Overall Study|Ineligibility|0|||
105514376|NCT03070782|363891360|FG001|Overall Study|Ineligibility|0|||
105514377|NCT03070782|363891361|FG002|Overall Study|Ineligibility|0|||
105514378|NCT03070782|363891362|FG003|Overall Study|Ineligibility|1|||
105514379|NCT03070782|363891363|FG004|Overall Study|Ineligibility|0|||
105514380|NCT03070782|363891364|FG005|Overall Study|Ineligibility|1|||
105514381|NCT03070782|363891359|FG000|Overall Study|Pregnancy|0|||
105514382|NCT03070782|363891360|FG001|Overall Study|Pregnancy|0|||
105514383|NCT03070782|363891361|FG002|Overall Study|Pregnancy|0|||
105514384|NCT03070782|363891362|FG003|Overall Study|Pregnancy|1|||
105592123|NCT00543725|364169302|FG001|Overall Study|Protocol Violation|1|||
105514385|NCT03070782|363891363|FG004|Overall Study|Pregnancy|0|||
105514386|NCT03070782|363891364|FG005|Overall Study|Pregnancy|0|||
105514387|NCT03070782|363891359|FG000|Overall Study|Investigator Judgement|0|||
105514388|NCT03070782|363891360|FG001|Overall Study|Investigator Judgement|0|||
105592124|NCT00543725|364169301|FG000|Overall Study|Withdrawal by Subject|4|||
105514389|NCT03070782|363891361|FG002|Overall Study|Investigator Judgement|0|||
105514390|NCT03070782|363891362|FG003|Overall Study|Investigator Judgement|1|||
105592125|NCT00543725|364169302|FG001|Overall Study|Withdrawal by Subject|13|||
105514391|NCT03070782|363891363|FG004|Overall Study|Investigator Judgement|0|||
105514392|NCT03070782|363891364|FG005|Overall Study|Investigator Judgement|0|||
105514393|NCT01980992|363891365|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
105514394|NCT01980992|363891366|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
105514395|NCT01980992|363891365|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
105514396|NCT01980992|363891366|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
105514397|NCT01980992|363891365|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
105514398|NCT01980992|363891366|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
105514399|NCT01980992|363891365|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
105514400|NCT01980992|363891366|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
105514401|NCT01980992|363891365|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
105514402|NCT01980992|363891366|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
105514403|NCT01980992|363891365|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
105514404|NCT01980992|363891366|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
105514405|NCT02927431|363891367|FG000|Overall Study|Withdrawal by Subject|0|||
105514406|NCT02927431|363891368|FG001|Overall Study|Withdrawal by Subject|0|||
105514407|NCT02927431|363891369|FG002|Overall Study|Withdrawal by Subject|1|||
105514408|NCT02651922|363891372|FG000|Overall Study|due to exclusion criteria|2|||
105514409|NCT01829191|363891373|FG000|Overall Study|Relocation|0|||
105514410|NCT01829191|363891374|FG001|Overall Study|Relocation|1|||
105514411|NCT01829191|363891373|FG000|Overall Study|Lens discomfort|0|||
105514412|NCT01829191|363891374|FG001|Overall Study|Lens discomfort|3|||
105514413|NCT01829191|363891373|FG000|Overall Study|Lens handling difficulty|1|||
105514414|NCT01829191|363891374|FG001|Overall Study|Lens handling difficulty|4|||
105514415|NCT01829191|363891373|FG000|Overall Study|Protocol Violation|4|||
105514416|NCT01829191|363891374|FG001|Overall Study|Protocol Violation|1|||
105514417|NCT01829191|363891373|FG000|Overall Study|Withdrawal by Subject|2|||
105514418|NCT01829191|363891374|FG001|Overall Study|Withdrawal by Subject|3|||
105514419|NCT01829191|363891373|FG000|Overall Study|Lost to Follow-up|0|||
105514420|NCT01829191|363891374|FG001|Overall Study|Lost to Follow-up|1|||
105514421|NCT01829191|363891373|FG000|Overall Study|Subject was fit for ortho - k|0|||
105514422|NCT01829191|363891374|FG001|Overall Study|Subject was fit for ortho - k|1|||
105514423|NCT01907815|363891375|FG000|Overall Study|Withdrawal by Subject|1|||
105514424|NCT01907815|363891376|FG001|Overall Study|Withdrawal by Subject|0|||
105514425|NCT01276353|363891377|FG000|Double-blind|Adverse Event|2|||
105514426|NCT01276353|363891378|FG001|Double-blind|Adverse Event|0|||
105514427|NCT01276353|363891377|FG000|Double-blind|Withdrawal by Subject|1|||
105514428|NCT01276353|363891378|FG001|Double-blind|Withdrawal by Subject|0|||
105514429|NCT01276353|363891377|FG000|Extension|Adverse Event|2|||
105514430|NCT01276353|363891378|FG001|Extension|Adverse Event|5|||
105514431|NCT01276353|363891377|FG000|Extension|Withdrawal by Subject|1|||
105514432|NCT01276353|363891378|FG001|Extension|Withdrawal by Subject|2|||
105514433|NCT01276353|363891377|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
105514434|NCT01276353|363891378|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
105514435|NCT01276353|363891377|FG000|Extension|Physician Decision|1|||
105514436|NCT01276353|363891378|FG001|Extension|Physician Decision|0|||
105514437|NCT01276353|363891377|FG000|Extension|Prohibited concomitant medications|0|||
105514438|NCT01276353|363891378|FG001|Extension|Prohibited concomitant medications|1|||
105514439|NCT03402386|363891380|FG000|Overall Study|Adverse Event|3|||
105514440|NCT03402386|363891380|FG000|Overall Study|Physician Decision|1|||
105514441|NCT03402386|363891380|FG000|Overall Study|Difficult to control Hb|2|||
105514442|NCT01574326|363891381|FG000|Overall Study|Randomized but not treated|0|||
105514443|NCT01574326|363891382|FG001|Overall Study|Randomized but not treated|1|||
105514444|NCT01574326|363891381|FG000|Overall Study|Withdrawal by Participant|2|||
105514445|NCT01574326|363891382|FG001|Overall Study|Withdrawal by Participant|4|||
105514446|NCT01574326|363891381|FG000|Overall Study|Physician Decision|5|||
105514447|NCT01574326|363891382|FG001|Overall Study|Physician Decision|3|||
105514448|NCT01574326|363891381|FG000|Overall Study|Adverse Event|1|||
105514449|NCT01574326|363891382|FG001|Overall Study|Adverse Event|3|||
105514450|NCT01574326|363891381|FG000|Overall Study|Other: Mainly kidney transplant|8|||
105514451|NCT01574326|363891382|FG001|Overall Study|Other: Mainly kidney transplant|8|||
105514452|NCT02485574|363891387|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
105514453|NCT00555321|363891390|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
105514454|NCT00555321|363891391|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
105514455|NCT00555321|363891392|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
105514456|NCT00555321|363891393|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
105514457|NCT00555321|363891394|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
105514458|NCT00555321|363891390|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
105514459|NCT00555321|363891391|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
105514460|NCT00555321|363891392|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
105514461|NCT00555321|363891393|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
105514462|NCT00555321|363891394|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
105592126|NCT00543725|364169301|FG000|Overall Study|Lost to Follow-up|15|||
105514463|NCT00555321|363891390|FG000|Treatment Phase up to 12-months|Death|2|||
105514464|NCT00555321|363891391|FG001|Treatment Phase up to 12-months|Death|1|||
105514465|NCT00555321|363891392|FG002|Treatment Phase up to 12-months|Death|4|||
105514466|NCT00555321|363891393|FG003|Treatment Phase up to 12-months|Death|0|||
105514467|NCT00555321|363891394|FG004|Treatment Phase up to 12-months|Death|0|||
105514468|NCT00555321|363891390|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
105514469|NCT00555321|363891391|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
105514470|NCT00555321|363891392|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
105514471|NCT00555321|363891393|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
105514472|NCT00555321|363891394|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
105514473|NCT00555321|363891390|FG000|Treatment Phase up to 12-months|Other Reason|1|||
105514474|NCT00555321|363891391|FG001|Treatment Phase up to 12-months|Other Reason|3|||
105514475|NCT00555321|363891392|FG002|Treatment Phase up to 12-months|Other Reason|2|||
105514476|NCT00555321|363891393|FG003|Treatment Phase up to 12-months|Other Reason|0|||
105514477|NCT00555321|363891394|FG004|Treatment Phase up to 12-months|Other Reason|0|||
105514478|NCT00555321|363891390|FG000|Treatment Phase up to 12-months|Never treated|2|||
105514479|NCT00555321|363891391|FG001|Treatment Phase up to 12-months|Never treated|3|||
105514480|NCT00555321|363891392|FG002|Treatment Phase up to 12-months|Never treated|1|||
105514481|NCT00555321|363891393|FG003|Treatment Phase up to 12-months|Never treated|0|||
105514482|NCT00555321|363891394|FG004|Treatment Phase up to 12-months|Never treated|4|||
105514483|NCT00555321|363891390|FG000|Long-term Extension Phase|Adverse Event|2|||
105514484|NCT00555321|363891391|FG001|Long-term Extension Phase|Adverse Event|5|||
105514485|NCT00555321|363891392|FG002|Long-term Extension Phase|Adverse Event|2|||
105514486|NCT00555321|363891393|FG003|Long-term Extension Phase|Adverse Event|1|||
105514487|NCT00555321|363891394|FG004|Long-term Extension Phase|Adverse Event|0|||
105514488|NCT00555321|363891390|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
105514489|NCT00555321|363891391|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
105514490|NCT00555321|363891392|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
105514491|NCT00555321|363891393|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
105514492|NCT00555321|363891394|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
105514493|NCT00555321|363891390|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
105514494|NCT00555321|363891391|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
105514495|NCT00555321|363891392|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
105514496|NCT00555321|363891393|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
105514497|NCT00555321|363891394|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
105514498|NCT00555321|363891390|FG000|Long-term Extension Phase|Death|2|||
105514499|NCT00555321|363891391|FG001|Long-term Extension Phase|Death|0|||
105514500|NCT00555321|363891392|FG002|Long-term Extension Phase|Death|0|||
105514501|NCT00555321|363891393|FG003|Long-term Extension Phase|Death|3|||
105514502|NCT00555321|363891394|FG004|Long-term Extension Phase|Death|0|||
105514503|NCT00555321|363891390|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
105514504|NCT00555321|363891391|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
105514505|NCT00555321|363891392|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
105514506|NCT00555321|363891393|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
105514507|NCT00555321|363891394|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
105514508|NCT00555321|363891390|FG000|Long-term Extension Phase|Other Reason|1|||
105514509|NCT00555321|363891391|FG001|Long-term Extension Phase|Other Reason|0|||
105514510|NCT00555321|363891392|FG002|Long-term Extension Phase|Other Reason|2|||
105514511|NCT00555321|363891393|FG003|Long-term Extension Phase|Other Reason|0|||
105514512|NCT00555321|363891394|FG004|Long-term Extension Phase|Other Reason|0|||
105514513|NCT00137046|363891395|FG000|Overall Study|Death|2|||
105514514|NCT00137046|363891396|FG001|Overall Study|Death|1|||
105514515|NCT00137046|363891395|FG000|Overall Study|Adverse Event|16|||
105514516|NCT00137046|363891396|FG001|Overall Study|Adverse Event|5|||
105514517|NCT00137046|363891395|FG000|Overall Study|Laboratory Abnormality|2|||
105514518|NCT00137046|363891396|FG001|Overall Study|Laboratory Abnormality|0|||
105514519|NCT00137046|363891395|FG000|Overall Study|Lack of Efficacy|13|||
105514520|NCT00137046|363891396|FG001|Overall Study|Lack of Efficacy|1|||
105514521|NCT00137046|363891395|FG000|Overall Study|Lost to Follow-up|8|||
105514522|NCT00137046|363891396|FG001|Overall Study|Lost to Follow-up|24|||
105514523|NCT00137046|363891395|FG000|Overall Study|Other|23|||
105514524|NCT00137046|363891396|FG001|Overall Study|Other|19|||
105514525|NCT00137046|363891395|FG000|Overall Study|Withdrawal by Subject|33|||
105514526|NCT00137046|363891396|FG001|Overall Study|Withdrawal by Subject|42|||
105592127|NCT00543725|364169302|FG001|Overall Study|Lost to Follow-up|11|||
105514527|NCT00137046|363891395|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
105514528|NCT00137046|363891396|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
105514529|NCT00137046|363891395|FG000|Overall Study|Withdrew prior to study treatment|1|||
105514530|NCT00137046|363891396|FG001|Overall Study|Withdrew prior to study treatment|1|||
105514531|NCT01288469|363891397|FG000|Overall Study|Adverse Event|4|||
105514532|NCT01288469|363891398|FG001|Overall Study|Adverse Event|1|||
105514533|NCT01288469|363891399|FG002|Overall Study|Adverse Event|1|||
105514534|NCT01288469|363891397|FG000|Overall Study|Poor compliance to protocol|0|||
105514535|NCT01288469|363891398|FG001|Overall Study|Poor compliance to protocol|1|||
105514536|NCT01288469|363891399|FG002|Overall Study|Poor compliance to protocol|0|||
105514537|NCT01288469|363891397|FG000|Overall Study|Participant Moved|1|||
105514538|NCT01288469|363891398|FG001|Overall Study|Participant Moved|0|||
105514539|NCT01288469|363891399|FG002|Overall Study|Participant Moved|0|||
105514540|NCT01288469|363891397|FG000|Overall Study|Consent withdrawn by subject|1|||
105514541|NCT01288469|363891398|FG001|Overall Study|Consent withdrawn by subject|1|||
105514542|NCT01288469|363891399|FG002|Overall Study|Consent withdrawn by subject|1|||
105514543|NCT01288469|363891397|FG000|Overall Study|Exclusion criteria finally met|1|||
105514544|NCT01288469|363891398|FG001|Overall Study|Exclusion criteria finally met|0|||
105514545|NCT01288469|363891399|FG002|Overall Study|Exclusion criteria finally met|0|||
105514546|NCT03672747|363891404|FG000|Overall Study|Lost to Follow-up|1|||
105514547|NCT03672747|363891405|FG001|Overall Study|Lost to Follow-up|1|||
105514548|NCT03672747|363891406|FG002|Overall Study|Lost to Follow-up|2|||
105514549|NCT03672747|363891407|FG003|Overall Study|Lost to Follow-up|2|||
105514550|NCT03672747|363891408|FG004|Overall Study|Lost to Follow-up|2|||
105514551|NCT03672747|363891409|FG005|Overall Study|Lost to Follow-up|1|||
105514552|NCT03694821|363891415|FG000|Overall Study|Study terminated|4|||
105514553|NCT03694821|363891416|FG001|Overall Study|Study terminated|8|||
105514554|NCT03694821|363891417|FG002|Overall Study|Study terminated|4|||
105514555|NCT04702997|363891422|FG000|Overall Study|Withdrawal by Subject|1|||
105514556|NCT04702997|363891423|FG001|Overall Study|Withdrawal by Subject|1|||
105514557|NCT03789318|363891426|FG000|Overall Study|Adverse Event|0|||
105514558|NCT03789318|363891427|FG001|Overall Study|Adverse Event|0|||
105514559|NCT03789318|363891428|FG002|Overall Study|Adverse Event|1|||
105514560|NCT03789318|363891429|FG003|Overall Study|Adverse Event|1|||
105514561|NCT03789318|363891430|FG004|Overall Study|Adverse Event|0|||
105514562|NCT03789318|363891426|FG000|Overall Study|Lost to Follow-up|0|||
105514563|NCT03789318|363891427|FG001|Overall Study|Lost to Follow-up|0|||
105514564|NCT03789318|363891428|FG002|Overall Study|Lost to Follow-up|1|||
105514565|NCT03789318|363891429|FG003|Overall Study|Lost to Follow-up|0|||
105514566|NCT03789318|363891430|FG004|Overall Study|Lost to Follow-up|0|||
105514567|NCT03789318|363891426|FG000|Overall Study|Withdrawal by Subject|0|||
105514568|NCT03789318|363891427|FG001|Overall Study|Withdrawal by Subject|0|||
105514569|NCT03789318|363891428|FG002|Overall Study|Withdrawal by Subject|1|||
105514570|NCT03789318|363891429|FG003|Overall Study|Withdrawal by Subject|0|||
105514571|NCT03789318|363891430|FG004|Overall Study|Withdrawal by Subject|0|||
105514572|NCT01535053|363891431|FG000|Overall Study|Ineligible|1|||
105514573|NCT01535053|363891432|FG001|Overall Study|Ineligible|2|||
105514574|NCT00512707|363891433|FG000|Overall Study|Lost to Follow-up|5|||
105514575|NCT00512707|363891434|FG001|Overall Study|Lost to Follow-up|11|||
105514576|NCT00512707|363891433|FG000|Overall Study|Developed skin irritation|2|||
105514577|NCT00512707|363891434|FG001|Overall Study|Developed skin irritation|1|||
105514578|NCT00512707|363891433|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
105514579|NCT00512707|363891434|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
105514580|NCT00512707|363891433|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
105514581|NCT00512707|363891434|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
105514582|NCT03700671|363891435|FG000|Overall Study|Lack of Efficacy|1|||
105514583|NCT03700671|363891436|FG001|Overall Study|Lack of Efficacy|2|||
105514584|NCT01937559|363891446|FG000|Overall Study|Physician Decision|3|||
105514585|NCT01937559|363891447|FG001|Overall Study|Physician Decision|3|||
105514586|NCT01937559|363891448|FG002|Overall Study|Physician Decision|0|||
105514587|NCT01937559|363891446|FG000|Overall Study|Withdrawal by Subject|6|||
105514588|NCT01937559|363891447|FG001|Overall Study|Withdrawal by Subject|4|||
105514589|NCT01937559|363891448|FG002|Overall Study|Withdrawal by Subject|0|||
105514590|NCT01937559|363891446|FG000|Overall Study|screen fail|2|||
105514591|NCT01937559|363891447|FG001|Overall Study|screen fail|4|||
105514592|NCT01937559|363891448|FG002|Overall Study|screen fail|0|||
105514593|NCT02879305|363891449|FG000|Overall Study|Investigator Site Closed|55|||
105514594|NCT02879305|363891450|FG001|Overall Study|Investigator Site Closed|57|||
105514595|NCT02879305|363891449|FG000|Overall Study|Withdrawal by Subject|44|||
105514596|NCT02879305|363891450|FG001|Overall Study|Withdrawal by Subject|42|||
105514597|NCT02879305|363891449|FG000|Overall Study|Lost to Follow-up|17|||
105514598|NCT02879305|363891450|FG001|Overall Study|Lost to Follow-up|12|||
105514599|NCT02879305|363891449|FG000|Overall Study|Other|1|||
105514600|NCT02879305|363891450|FG001|Overall Study|Other|0|||
105514601|NCT02961751|363892872|FG000|Overall Study|Lost to Follow-up|11|||
105514602|NCT02961751|363892872|FG000|Overall Study|Physician Decision|2|||
105514603|NCT02961751|363892872|FG000|Overall Study|Not Eligible at Enrollment|1|||
105514604|NCT02961751|363892872|FG000|Overall Study|Protocol Violation|1|||
105514605|NCT02392247|363892873|FG000|Overall Study|Withdrawal by Subject|1|||
105514606|NCT02392247|363892873|FG000|Overall Study|Surgery cancelled; no data|1|||
105514607|NCT00931762|363892875|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
105514608|NCT00931762|363892875|FG000|Overall Study|Administrative Problems|5|||
105514609|NCT00931762|363892875|FG000|Overall Study|Death|1|||
105514610|NCT00931762|363892875|FG000|Overall Study|Disease Progression|3|||
105514611|NCT00931762|363892875|FG000|Overall Study|Adverse Event (s)|11|||
105514612|NCT00931762|363892875|FG000|Overall Study|Subject withdrew consent|13|||
105514613|NCT00799487|363892886|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
105514614|NCT00799487|363892887|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
105514615|NCT00799487|363892888|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
105514616|NCT00799487|363892886|FG000|Dose Adjustment Period|Adverse Event|2|||
105514617|NCT00799487|363892887|FG001|Dose Adjustment Period|Adverse Event|0|||
105514618|NCT00799487|363892888|FG002|Dose Adjustment Period|Adverse Event|0|||
105514619|NCT00799487|363892886|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
105514620|NCT00799487|363892887|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
105514621|NCT00799487|363892888|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
105514622|NCT00799487|363892886|FG000|Dose Adjustment Period|Investigator Discretion|2|||
105514623|NCT00799487|363892887|FG001|Dose Adjustment Period|Investigator Discretion|0|||
105514624|NCT00799487|363892888|FG002|Dose Adjustment Period|Investigator Discretion|0|||
105514625|NCT00799487|363892886|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
105514626|NCT00799487|363892887|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
105514627|NCT00799487|363892888|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
105514628|NCT00799487|363892886|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
105514629|NCT00799487|363892887|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
105514630|NCT00799487|363892888|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
105514631|NCT00799487|363892886|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
105514632|NCT00799487|363892887|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
105514633|NCT00799487|363892888|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
105514634|NCT00799487|363892886|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
105514635|NCT00799487|363892887|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
105514636|NCT00799487|363892888|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
105514637|NCT00799487|363892886|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
105514638|NCT00799487|363892887|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
105514639|NCT00799487|363892888|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
105514640|NCT00799487|363892886|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
105514641|NCT00799487|363892887|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
105514642|NCT00799487|363892888|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
105514643|NCT00799487|363892886|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
105514644|NCT00799487|363892887|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
105514645|NCT00799487|363892888|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
105514646|NCT00799487|363892886|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
105514647|NCT00799487|363892887|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
105514648|NCT00799487|363892888|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
105514649|NCT03518073|363892889|FG000|Overall Study|Adverse Event|2|||
105514650|NCT03518073|363892890|FG001|Overall Study|Adverse Event|4|||
105514651|NCT03518073|363892891|FG002|Overall Study|Adverse Event|2|||
105514652|NCT03518073|363892889|FG000|Overall Study|Death|2|||
105514653|NCT03518073|363892890|FG001|Overall Study|Death|1|||
105514654|NCT03518073|363892891|FG002|Overall Study|Death|3|||
105514655|NCT03518073|363892889|FG000|Overall Study|Lost to Follow-up|1|||
105514656|NCT03518073|363892890|FG001|Overall Study|Lost to Follow-up|0|||
105514657|NCT03518073|363892891|FG002|Overall Study|Lost to Follow-up|1|||
105514658|NCT03518073|363892889|FG000|Overall Study|Physician Decision|5|||
105514659|NCT03518073|363892890|FG001|Overall Study|Physician Decision|0|||
105514660|NCT03518073|363892891|FG002|Overall Study|Physician Decision|2|||
105514661|NCT03518073|363892889|FG000|Overall Study|Progressive disease|1|||
105514662|NCT03518073|363892890|FG001|Overall Study|Progressive disease|1|||
105514663|NCT03518073|363892891|FG002|Overall Study|Progressive disease|1|||
105514664|NCT03518073|363892889|FG000|Overall Study|Protocol Violation|1|||
105514665|NCT03518073|363892890|FG001|Overall Study|Protocol Violation|0|||
105514666|NCT03518073|363892891|FG002|Overall Study|Protocol Violation|0|||
105514667|NCT03518073|363892889|FG000|Overall Study|Withdrawal by Subject|30|||
105514668|NCT03518073|363892890|FG001|Overall Study|Withdrawal by Subject|34|||
105514669|NCT03518073|363892891|FG002|Overall Study|Withdrawal by Subject|29|||
105514670|NCT03518073|363892889|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
105514671|NCT03518073|363892890|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
105514672|NCT03518073|363892891|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
105514673|NCT03518073|363892889|FG000|Overall Study|Covid-19|1|||
105514674|NCT03518073|363892890|FG001|Overall Study|Covid-19|2|||
105514675|NCT03518073|363892891|FG002|Overall Study|Covid-19|1|||
105514676|NCT03263442|363892892|FG000|Inpatient Phase|Death|1|||
105514677|NCT03263442|363892893|FG001|Inpatient Phase|Death|0|||
105514678|NCT03263442|363892892|FG000|Inpatient Phase|Withdrawal by Subject|1|||
105592128|NCT00543725|364169301|FG000|Overall Study|Other|3|||
105514679|NCT03263442|363892893|FG001|Inpatient Phase|Withdrawal by Subject|0|||
105514680|NCT03263442|363892892|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
105514681|NCT03263442|363892893|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
105514682|NCT03263442|363892892|FG000|1-month Follow-Up|Lost to Follow-up|1|||
105514683|NCT03263442|363892893|FG001|1-month Follow-Up|Lost to Follow-up|0|||
105514684|NCT03263442|363892892|FG000|3-month Follow-Up|Lost to Follow-up|1|||
105514685|NCT03263442|363892893|FG001|3-month Follow-Up|Lost to Follow-up|3|||
105514686|NCT03263442|363892892|FG000|6-month Follow-Up|Lost to Follow-up|2|||
105514687|NCT03263442|363892893|FG001|6-month Follow-Up|Lost to Follow-up|2|||
105514688|NCT00065507|363892894|FG000|Overall Study|Death|16|||
105514689|NCT00065507|363892895|FG001|Overall Study|Death|17|||
105514690|NCT00065507|363892894|FG000|Overall Study|Adverse Event|4|||
105514691|NCT00065507|363892895|FG001|Overall Study|Adverse Event|3|||
105514692|NCT00065507|363892894|FG000|Overall Study|Lack of Efficacy|0|||
105514693|NCT00065507|363892895|FG001|Overall Study|Lack of Efficacy|6|||
105514694|NCT00065507|363892894|FG000|Overall Study|Poor/Non-compliance|3|||
105514695|NCT00065507|363892895|FG001|Overall Study|Poor/Non-compliance|2|||
105514696|NCT00065507|363892894|FG000|Overall Study|Lost to Follow-up|3|||
105514697|NCT00065507|363892895|FG001|Overall Study|Lost to Follow-up|0|||
105514698|NCT00065507|363892894|FG000|Overall Study|Subject Withdrew Consent|2|||
105514699|NCT00065507|363892895|FG001|Overall Study|Subject Withdrew Consent|1|||
105514700|NCT00065507|363892894|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
105514701|NCT00065507|363892895|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
105514702|NCT02489344|363892896|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
105514703|NCT02489344|363892896|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
105514704|NCT02489344|363892896|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
105514705|NCT02489344|363892896|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
105514706|NCT04273217|363892897|FG000|Overall Study|Lost to Follow-up|0|||
105514707|NCT04273217|363892898|FG001|Overall Study|Lost to Follow-up|0|||
105514708|NCT04273217|363892899|FG002|Overall Study|Lost to Follow-up|0|||
105514709|NCT04273217|363892900|FG003|Overall Study|Lost to Follow-up|0|||
105514710|NCT04273217|363892901|FG004|Overall Study|Lost to Follow-up|0|||
105514711|NCT04273217|363892902|FG005|Overall Study|Lost to Follow-up|1|||
105514712|NCT04273217|363892897|FG000|Overall Study|Participant non-compliance|0|||
105514713|NCT04273217|363892898|FG001|Overall Study|Participant non-compliance|0|||
105514714|NCT04273217|363892899|FG002|Overall Study|Participant non-compliance|0|||
105514715|NCT04273217|363892900|FG003|Overall Study|Participant non-compliance|0|||
105514716|NCT04273217|363892901|FG004|Overall Study|Participant non-compliance|1|||
105514717|NCT04273217|363892902|FG005|Overall Study|Participant non-compliance|0|||
105514718|NCT04273217|363892897|FG000|Overall Study|Positive urine drug screen|1|||
105514719|NCT04273217|363892898|FG001|Overall Study|Positive urine drug screen|0|||
105514720|NCT04273217|363892899|FG002|Overall Study|Positive urine drug screen|1|||
105514721|NCT04273217|363892900|FG003|Overall Study|Positive urine drug screen|0|||
105514722|NCT04273217|363892901|FG004|Overall Study|Positive urine drug screen|0|||
105514723|NCT04273217|363892902|FG005|Overall Study|Positive urine drug screen|1|||
105514724|NCT03042533|363892905|FG000|Overall Study|MD left program|1|||
105514725|NCT03042533|363892906|FG001|Overall Study|MD left program|4|||
105514726|NCT03042533|363892907|FG002|Overall Study|MD left program|1|||
105514727|NCT01948050|363892908|FG000|Overall Study|Withdrawal by Subject|0|||
105514728|NCT01948050|363892909|FG001|Overall Study|Withdrawal by Subject|1|||
105514729|NCT02005445|363892910|FG000|Overall Study|Dual study enrollment|0|||
105514730|NCT02005445|363892911|FG001|Overall Study|Dual study enrollment|1|||
105514731|NCT01111149|363892912|FG000|Overall Study|Protocol Violation|1|||
105514732|NCT01111149|363892913|FG001|Overall Study|Protocol Violation|1|||
105514733|NCT01111149|363892914|FG002|Overall Study|Protocol Violation|2|||
105514734|NCT01111149|363892912|FG000|Overall Study|Withdrawal by Subject|1|||
105514735|NCT01111149|363892913|FG001|Overall Study|Withdrawal by Subject|0|||
105514736|NCT01111149|363892914|FG002|Overall Study|Withdrawal by Subject|2|||
105514737|NCT01156311|363892920|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
105514738|NCT01156311|363892921|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
105514739|NCT01156311|363892922|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
105514740|NCT01156311|363892923|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
105514741|NCT01156311|363892920|FG000|2-Month Monotherapy Period|Physician Decision|0|||
105514742|NCT01156311|363892921|FG001|2-Month Monotherapy Period|Physician Decision|1|||
105514743|NCT01156311|363892922|FG002|2-Month Monotherapy Period|Physician Decision|0|||
105514744|NCT01156311|363892923|FG003|2-Month Monotherapy Period|Physician Decision|0|||
105514745|NCT01156311|363892920|FG000|2-Month Monotherapy Period|Other|1|||
105514746|NCT01156311|363892921|FG001|2-Month Monotherapy Period|Other|0|||
105514747|NCT01156311|363892922|FG002|2-Month Monotherapy Period|Other|0|||
105514748|NCT01156311|363892923|FG003|2-Month Monotherapy Period|Other|0|||
105514749|NCT01156311|363892920|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
105514750|NCT01156311|363892921|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
105514751|NCT01156311|363892922|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
105514752|NCT01156311|363892923|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
105514753|NCT01156311|363892920|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
105514754|NCT01156311|363892921|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
105514755|NCT01156311|363892922|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
105514756|NCT01156311|363892923|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
105514757|NCT01156311|363892920|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
105514758|NCT01156311|363892921|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
105514759|NCT01156311|363892922|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
105514760|NCT01156311|363892923|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
105514761|NCT01156311|363892920|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
105592129|NCT00543725|364169302|FG001|Overall Study|Other|3|||
105592130|NCT00906698|364169303|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
105514762|NCT01156311|363892921|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
105514763|NCT01156311|363892922|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
105514764|NCT01156311|363892923|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
105514765|NCT01156311|363892920|FG000|6-month Add-on Therapy Period|Other|0|||
105514766|NCT01156311|363892921|FG001|6-month Add-on Therapy Period|Other|0|||
105514767|NCT01156311|363892922|FG002|6-month Add-on Therapy Period|Other|1|||
105514768|NCT01156311|363892923|FG003|6-month Add-on Therapy Period|Other|2|||
105514769|NCT00674661|363892924|FG000|Overall Study|Other|5|||
105514770|NCT00674661|363892925|FG001|Overall Study|Other|7|||
105514771|NCT00674661|363892924|FG000|Overall Study|Lost to Follow-up|6|||
105514772|NCT00674661|363892925|FG001|Overall Study|Lost to Follow-up|3|||
105514773|NCT00674661|363892924|FG000|Overall Study|Withdrawal by Subject|0|||
105514774|NCT00674661|363892925|FG001|Overall Study|Withdrawal by Subject|5|||
105514775|NCT01741701|363892926|FG000|Overall Study|Adverse Event|5|||
105514776|NCT01741701|363892927|FG001|Overall Study|Adverse Event|1|||
105514777|NCT01741701|363892926|FG000|Overall Study|Withdrawal by Subject|0|||
105514778|NCT01741701|363892927|FG001|Overall Study|Withdrawal by Subject|1|||
105514779|NCT00006903|363892928|FG000|Overall Study|Still receiving treatment|0|||
105514780|NCT00006903|363892929|FG001|Overall Study|Still receiving treatment|0|||
105514781|NCT00006903|363892930|FG002|Overall Study|Still receiving treatment|1|||
105514782|NCT00006903|363892928|FG000|Overall Study|Refused further treatment|0|||
105514783|NCT00006903|363892929|FG001|Overall Study|Refused further treatment|2|||
105514784|NCT00006903|363892930|FG002|Overall Study|Refused further treatment|1|||
105514785|NCT00006903|363892928|FG000|Overall Study|Adverse Event|0|||
105514786|NCT00006903|363892929|FG001|Overall Study|Adverse Event|0|||
105514787|NCT00006903|363892930|FG002|Overall Study|Adverse Event|1|||
105514788|NCT00006903|363892928|FG000|Overall Study|Death|0|||
105514789|NCT00006903|363892929|FG001|Overall Study|Death|1|||
105514790|NCT00006903|363892930|FG002|Overall Study|Death|0|||
105514791|NCT00006903|363892928|FG000|Overall Study|Patient never treated|0|||
105514792|NCT00006903|363892929|FG001|Overall Study|Patient never treated|0|||
105514793|NCT00006903|363892930|FG002|Overall Study|Patient never treated|1|||
105514794|NCT00006903|363892928|FG000|Overall Study|Ineligible|10|||
105514795|NCT00006903|363892929|FG001|Overall Study|Ineligible|1|||
105514796|NCT00006903|363892930|FG002|Overall Study|Ineligible|2|||
105514797|NCT02036294|363892936|FG000|Overall Study|Death|7|||
105514798|NCT02036294|363892937|FG001|Overall Study|Death|8|||
105514799|NCT02036294|363892936|FG000|Overall Study|Withdrawal by Subject|2|||
105514800|NCT02036294|363892937|FG001|Overall Study|Withdrawal by Subject|3|||
105514801|NCT00726661|363892938|FG000|Overall Study|Lost to Follow-up|36|||
105514802|NCT00726661|363892939|FG001|Overall Study|Lost to Follow-up|11|||
105514803|NCT00726661|363892938|FG000|Overall Study|Withdrawal by Subject|17|||
105514804|NCT00726661|363892939|FG001|Overall Study|Withdrawal by Subject|13|||
105514805|NCT00726661|363892938|FG000|Overall Study|Trial terminated by sponsor|214|||
105514806|NCT00726661|363892939|FG001|Overall Study|Trial terminated by sponsor|187|||
105514807|NCT00726661|363892938|FG000|Overall Study|Death|475|||
105514808|NCT00726661|363892939|FG001|Overall Study|Death|159|||
105514809|NCT00726661|363892938|FG000|Overall Study|Physician Decision|25|||
105514810|NCT00726661|363892939|FG001|Overall Study|Physician Decision|13|||
105514811|NCT00726661|363892938|FG000|Overall Study|Other|47|||
105514812|NCT00726661|363892939|FG001|Overall Study|Other|35|||
105514813|NCT00811473|363892940|FG000|Overall Study|Adverse Event|3|||
105514814|NCT00811473|363892941|FG001|Overall Study|Adverse Event|12|||
105514815|NCT00811473|363892940|FG000|Overall Study|Lost to Follow-up|5|||
105514816|NCT00811473|363892941|FG001|Overall Study|Lost to Follow-up|1|||
105592131|NCT00906698|364169304|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
105592132|NCT00906698|364169305|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
105592133|NCT00906698|364169306|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
105592134|NCT00906698|364169307|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
105514817|NCT00811473|363892940|FG000|Overall Study|Withdrawal by Subject|2|||
105514818|NCT00811473|363892941|FG001|Overall Study|Withdrawal by Subject|4|||
105514819|NCT00811473|363892940|FG000|Overall Study|Severe non-compliance to protocol|2|||
105514820|NCT00811473|363892941|FG001|Overall Study|Severe non-compliance to protocol|4|||
105514821|NCT00811473|363892940|FG000|Overall Study|Lack of therapeutic response|4|||
105592135|NCT00906698|364169308|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
105514822|NCT00811473|363892941|FG001|Overall Study|Lack of therapeutic response|1|||
105514823|NCT00811473|363892940|FG000|Overall Study|Condition under investigation worsened|1|||
105514824|NCT00811473|363892941|FG001|Overall Study|Condition under investigation worsened|3|||
105514825|NCT00811473|363892940|FG000|Overall Study|Other 2|4|||
105514826|NCT00811473|363892941|FG001|Overall Study|Other 2|1|||
105514827|NCT00811473|363892940|FG000|Overall Study|Incorrect Enrollment|1|||
105514828|NCT00811473|363892941|FG001|Overall Study|Incorrect Enrollment|0|||
105514829|NCT00811473|363892940|FG000|Overall Study|Safety Reasons|1|||
105514830|NCT00811473|363892941|FG001|Overall Study|Safety Reasons|0|||
105514831|NCT00563381|363892947|FG000|Overall Study|Adverse Event|264|||
105514832|NCT00563381|363892948|FG001|Overall Study|Adverse Event|292|||
105514833|NCT00563381|363892947|FG000|Overall Study|Protocol Violation|66|||
105514834|NCT00563381|363892948|FG001|Overall Study|Protocol Violation|74|||
105514835|NCT00563381|363892947|FG000|Overall Study|Lost to Follow-up|7|||
105514836|NCT00563381|363892948|FG001|Overall Study|Lost to Follow-up|15|||
105514837|NCT00563381|363892947|FG000|Overall Study|Withdrawal by Subject|192|||
105514838|NCT00563381|363892948|FG001|Overall Study|Withdrawal by Subject|209|||
105514839|NCT00563381|363892947|FG000|Overall Study|Lack of Efficacy|32|||
105514840|NCT00563381|363892948|FG001|Overall Study|Lack of Efficacy|24|||
105514841|NCT00563381|363892947|FG000|Overall Study|Individual different reasons|24|||
105514842|NCT00563381|363892948|FG001|Overall Study|Individual different reasons|34|||
105514843|NCT00110149|363892949|FG000|Overall Study|Physician Decision|3|||
105514844|NCT00667368|363892950|FG000|Overall Study|Lost to Follow-up|176|||
105514845|NCT00667368|363892951|FG001|Overall Study|Lost to Follow-up|155|||
105514846|NCT00667368|363892950|FG000|Overall Study|Discontinued early|24|||
105514847|NCT00667368|363892951|FG001|Overall Study|Discontinued early|17|||
105514848|NCT02452398|363892954|FG000|Overall Study|Adverse Event|1|||
105514849|NCT02452398|363892954|FG000|Overall Study|Lost to Follow-up|28|||
105514850|NCT02452398|363892954|FG000|Overall Study|Physician Decision|2|||
105514851|NCT02452398|363892954|FG000|Overall Study|Withdrawal by Subject|6|||
105514852|NCT02452398|363892954|FG000|Overall Study|Moved away|4|||
105514853|NCT01957644|363892955|FG000|Overall Study|Adverse Event|4|||
105514854|NCT01957644|363892956|FG001|Overall Study|Adverse Event|2|||
105514855|NCT01957644|363892957|FG002|Overall Study|Adverse Event|0|||
105514856|NCT01957644|363892958|FG003|Overall Study|Adverse Event|0|||
105514857|NCT01957644|363892959|FG004|Overall Study|Adverse Event|1|||
105514858|NCT01957644|363892955|FG000|Overall Study|Progressive disease / relapse|0|||
105514859|NCT01957644|363892956|FG001|Overall Study|Progressive disease / relapse|1|||
105514860|NCT01957644|363892957|FG002|Overall Study|Progressive disease / relapse|0|||
105514861|NCT01957644|363892958|FG003|Overall Study|Progressive disease / relapse|1|||
105514862|NCT01957644|363892959|FG004|Overall Study|Progressive disease / relapse|0|||
105514863|NCT01957644|363892955|FG000|Overall Study|Other reason|1|||
105514864|NCT01957644|363892956|FG001|Overall Study|Other reason|2|||
105514865|NCT01957644|363892957|FG002|Overall Study|Other reason|1|||
105514866|NCT01957644|363892958|FG003|Overall Study|Other reason|1|||
105514867|NCT01957644|363892959|FG004|Overall Study|Other reason|0|||
105514868|NCT01957644|363892955|FG000|Overall Study|Withdrawal by Subject|1|||
105514869|NCT01957644|363892956|FG001|Overall Study|Withdrawal by Subject|0|||
105514870|NCT01957644|363892957|FG002|Overall Study|Withdrawal by Subject|0|||
105514871|NCT01957644|363892958|FG003|Overall Study|Withdrawal by Subject|0|||
105514872|NCT01957644|363892959|FG004|Overall Study|Withdrawal by Subject|0|||
105514873|NCT01957644|363892955|FG000|Overall Study|Protocol Violation|0|||
105514874|NCT01957644|363892956|FG001|Overall Study|Protocol Violation|1|||
105514875|NCT01957644|363892957|FG002|Overall Study|Protocol Violation|0|||
105514876|NCT01957644|363892958|FG003|Overall Study|Protocol Violation|0|||
105514877|NCT01957644|363892959|FG004|Overall Study|Protocol Violation|0|||
105514878|NCT04044716|363892960|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
105514879|NCT04044716|363892961|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
105514880|NCT04044716|363892962|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
105514881|NCT04044716|363892960|FG000|Overall Study|Lost to Follow-up|2|||
105514882|NCT04044716|363892961|FG001|Overall Study|Lost to Follow-up|3|||
105514883|NCT04044716|363892962|FG002|Overall Study|Lost to Follow-up|0|||
105514884|NCT01867021|363892969|FG000|Overall Study|Adverse Event|0|||
105514885|NCT01867021|363892970|FG001|Overall Study|Adverse Event|1|||
105514886|NCT01867021|363892969|FG000|Overall Study|Not Eligible|0|||
105514887|NCT01867021|363892970|FG001|Overall Study|Not Eligible|1|||
105514888|NCT01867021|363892969|FG000|Overall Study|Death|1|||
105514889|NCT01867021|363892970|FG001|Overall Study|Death|0|||
105514890|NCT01867021|363892969|FG000|Overall Study|Lost to Follow-up|0|||
105514891|NCT01867021|363892970|FG001|Overall Study|Lost to Follow-up|2|||
105514892|NCT01867021|363892969|FG000|Overall Study|Withdrawal by Subject|1|||
105514893|NCT01867021|363892970|FG001|Overall Study|Withdrawal by Subject|6|||
105514894|NCT03060629|363892971|FG000|Overall Study|Death|4|||
105514895|NCT03060629|363892972|FG001|Overall Study|Death|5|||
105514896|NCT03060629|363892971|FG000|Overall Study|Withdrawal by Subject|50|||
105514897|NCT03060629|363892972|FG001|Overall Study|Withdrawal by Subject|35|||
105514898|NCT03060629|363892971|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
105514899|NCT03060629|363892972|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
105514900|NCT03060629|363892971|FG000|Overall Study|Participant Relocate|15|||
105514901|NCT03060629|363892972|FG001|Overall Study|Participant Relocate|15|||
105514902|NCT03060629|363892971|FG000|Overall Study|Unable to Contact Participant|34|||
105514903|NCT03060629|363892972|FG001|Overall Study|Unable to Contact Participant|23|||
105514904|NCT03060629|363892971|FG000|Overall Study|Investigator Decision|7|||
105514905|NCT03060629|363892972|FG001|Overall Study|Investigator Decision|7|||
105514906|NCT03060629|363892971|FG000|Overall Study|Study Terminated by Sponsor|1100|||
105514907|NCT03060629|363892972|FG001|Overall Study|Study Terminated by Sponsor|1123|||
105514908|NCT03060629|363892971|FG000|Overall Study|Other|4|||
105514909|NCT03060629|363892972|FG001|Overall Study|Other|4|||
105514910|NCT01714635|363892974|FG000|Overall Study|Discontinued|1|||
105514911|NCT01714635|363892975|FG001|Overall Study|Discontinued|0|||
105514912|NCT01714635|363892976|FG002|Overall Study|Discontinued|2|||
105514913|NCT01714635|363892974|FG000|Overall Study|Missed 6-month exam|1|||
105514914|NCT01714635|363892975|FG001|Overall Study|Missed 6-month exam|0|||
105514915|NCT01714635|363892976|FG002|Overall Study|Missed 6-month exam|0|||
105514916|NCT03198234|363892977|FG000|Overall Study|Relapse of primary disease|0|||
105514917|NCT03198234|363892978|FG001|Overall Study|Relapse of primary disease|1|||
105514918|NCT03198234|363892979|FG002|Overall Study|Relapse of primary disease|0|||
105514919|NCT02622321|363892980|FG000|Overall Study|Withdrawal by Subject|2|||
105514920|NCT02622321|363892981|FG001|Overall Study|Withdrawal by Subject|0|||
105514921|NCT02622321|363892982|FG002|Overall Study|Withdrawal by Subject|0|||
105514922|NCT02622321|363892983|FG003|Overall Study|Withdrawal by Subject|0|||
105514923|NCT02622321|363892980|FG000|Overall Study|Death|0|||
105514924|NCT02622321|363892981|FG001|Overall Study|Death|0|||
105514925|NCT02622321|363892982|FG002|Overall Study|Death|1|||
105514926|NCT02622321|363892983|FG003|Overall Study|Death|0|||
105514927|NCT02622321|363892980|FG000|Overall Study|Physician Decision|1|||
105514928|NCT02622321|363892981|FG001|Overall Study|Physician Decision|0|||
105514929|NCT02622321|363892982|FG002|Overall Study|Physician Decision|0|||
105514930|NCT02622321|363892983|FG003|Overall Study|Physician Decision|0|||
105514931|NCT00897104|363892984|FG000|Overall Study|Lost to Follow-up|12|||
105514932|NCT00897104|363892985|FG001|Overall Study|Lost to Follow-up|17|||
105514933|NCT00897104|363892986|FG002|Overall Study|Lost to Follow-up|2|||
105514934|NCT00897104|363892984|FG000|Overall Study|Pregnancy|0|||
105514935|NCT00897104|363892985|FG001|Overall Study|Pregnancy|1|||
105514936|NCT00897104|363892986|FG002|Overall Study|Pregnancy|0|||
105514937|NCT00897104|363892984|FG000|Overall Study|Protocol Violation|0|||
105514938|NCT00897104|363892985|FG001|Overall Study|Protocol Violation|1|||
105514939|NCT00897104|363892986|FG002|Overall Study|Protocol Violation|0|||
105514940|NCT00897104|363892984|FG000|Overall Study|Withdrawal by Subject|23|||
105514941|NCT00897104|363892985|FG001|Overall Study|Withdrawal by Subject|27|||
105514942|NCT00897104|363892986|FG002|Overall Study|Withdrawal by Subject|3|||
105514943|NCT00897104|363892984|FG000|Overall Study|Abnormal Prestudy Labs|2|||
105514944|NCT00897104|363892985|FG001|Overall Study|Abnormal Prestudy Labs|0|||
105514945|NCT00897104|363892986|FG002|Overall Study|Abnormal Prestudy Labs|0|||
105514946|NCT00897104|363892984|FG000|Overall Study|Abnormal Baseline ECG|2|||
105514947|NCT00897104|363892985|FG001|Overall Study|Abnormal Baseline ECG|2|||
105514948|NCT00897104|363892986|FG002|Overall Study|Abnormal Baseline ECG|0|||
105514949|NCT00897104|363892984|FG000|Overall Study|Need for Concom. Med.|0|||
105514950|NCT00897104|363892985|FG001|Overall Study|Need for Concom. Med.|1|||
105514951|NCT00897104|363892986|FG002|Overall Study|Need for Concom. Med.|1|||
105514952|NCT00897104|363892984|FG000|Overall Study|Lack of Migraine Attack|20|||
105514953|NCT00897104|363892985|FG001|Overall Study|Lack of Migraine Attack|22|||
105514954|NCT00897104|363892986|FG002|Overall Study|Lack of Migraine Attack|1|||
105514955|NCT00897104|363892984|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
105514956|NCT00897104|363892985|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
105514957|NCT00897104|363892986|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
105514958|NCT00897104|363892984|FG000|Overall Study|Other|3|||
105514959|NCT00897104|363892985|FG001|Overall Study|Other|0|||
105514960|NCT00897104|363892986|FG002|Overall Study|Other|0|||
105514961|NCT00897104|363892984|FG000|Overall Study|Protocol Violation|1|||
105514962|NCT00897104|363892985|FG001|Overall Study|Protocol Violation|0|||
105514963|NCT00897104|363892986|FG002|Overall Study|Protocol Violation|0|||
105514964|NCT00897104|363892984|FG000|Overall Study|Withdrawal by Subject|0|||
105514965|NCT00897104|363892985|FG001|Overall Study|Withdrawal by Subject|0|||
105514966|NCT00897104|363892986|FG002|Overall Study|Withdrawal by Subject|1|||
105514967|NCT01059799|363892990|FG000|Overall Study|Adverse Event|2|||
105514968|NCT01059799|363892991|FG001|Overall Study|Adverse Event|3|||
105514969|NCT01059799|363892990|FG000|Overall Study|Lack of Efficacy|1|||
105514970|NCT01059799|363892991|FG001|Overall Study|Lack of Efficacy|0|||
105514971|NCT01059799|363892990|FG000|Overall Study|Protocol Violation|3|||
105514972|NCT01059799|363892991|FG001|Overall Study|Protocol Violation|2|||
105514973|NCT01059799|363892990|FG000|Overall Study|Withdrawal criteria|13|||
105514974|NCT01059799|363892991|FG001|Overall Study|Withdrawal criteria|2|||
105514975|NCT01059799|363892990|FG000|Overall Study|Other|12|||
105514976|NCT01059799|363892991|FG001|Overall Study|Other|3|||
105514977|NCT00434330|363892994|FG000|Overall Study|Adverse Event|0|||
105514978|NCT00434330|363892995|FG001|Overall Study|Adverse Event|0|||
105514979|NCT00434330|363892996|FG002|Overall Study|Adverse Event|1|||
105514980|NCT00434330|363892997|FG003|Overall Study|Adverse Event|0|||
105514981|NCT00434330|363892998|FG004|Overall Study|Adverse Event|0|||
105514982|NCT00434330|363892999|FG005|Overall Study|Adverse Event|0|||
105514983|NCT00434330|363892994|FG000|Overall Study|Death|1|||
105514984|NCT00434330|363892995|FG001|Overall Study|Death|0|||
105514985|NCT00434330|363892996|FG002|Overall Study|Death|0|||
105514986|NCT00434330|363892997|FG003|Overall Study|Death|0|||
105514987|NCT00434330|363892998|FG004|Overall Study|Death|1|||
105514988|NCT00434330|363892999|FG005|Overall Study|Death|1|||
105514989|NCT00434330|363892994|FG000|Overall Study|Withdrawal by Subject|0|||
105514990|NCT00434330|363892995|FG001|Overall Study|Withdrawal by Subject|0|||
105514991|NCT00434330|363892996|FG002|Overall Study|Withdrawal by Subject|1|||
105514992|NCT00434330|363892997|FG003|Overall Study|Withdrawal by Subject|1|||
105514993|NCT00434330|363892998|FG004|Overall Study|Withdrawal by Subject|0|||
105514994|NCT00434330|363892999|FG005|Overall Study|Withdrawal by Subject|0|||
105514995|NCT00434330|363892994|FG000|Overall Study|Renal transplant|0|||
105514996|NCT00434330|363892995|FG001|Overall Study|Renal transplant|0|||
105514997|NCT00434330|363892996|FG002|Overall Study|Renal transplant|0|||
105514998|NCT00434330|363892997|FG003|Overall Study|Renal transplant|1|||
105514999|NCT00434330|363892998|FG004|Overall Study|Renal transplant|0|||
105515000|NCT00434330|363892999|FG005|Overall Study|Renal transplant|0|||
105515001|NCT00434330|363892994|FG000|Overall Study|Subject Not Compliant With Study|0|||
105515002|NCT00434330|363892995|FG001|Overall Study|Subject Not Compliant With Study|0|||
105515003|NCT00434330|363892996|FG002|Overall Study|Subject Not Compliant With Study|1|||
105515004|NCT00434330|363892997|FG003|Overall Study|Subject Not Compliant With Study|0|||
105515005|NCT00434330|363892998|FG004|Overall Study|Subject Not Compliant With Study|0|||
105515006|NCT00434330|363892999|FG005|Overall Study|Subject Not Compliant With Study|0|||
105515007|NCT02671422|363893001|FG000|Overall Study|Lost to Follow-up|1|||
105515008|NCT02671422|363893001|FG000|Overall Study|Adverse Event|68|||
105515009|NCT02671422|363893001|FG000|Overall Study|Lack of Efficacy|1|||
105515010|NCT02671422|363893001|FG000|Overall Study|Lost to Follow-up|4|||
105515011|NCT02671422|363893001|FG000|Overall Study|Withdrawal by Subject|7|||
105515012|NCT02671422|363893001|FG000|Overall Study|Progressive Disease|156|||
105515013|NCT02671422|363893001|FG000|Overall Study|Worsening of Disease|4|||
105515014|NCT02671422|363893001|FG000|Overall Study|Sponsor decision|5|||
105515015|NCT02671422|363893001|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
105515016|NCT02671422|363893001|FG000|Overall Study|Not treated with Vargatef®|3|||
105515017|NCT02671422|363893001|FG000|Overall Study|Other not defined above|3|||
105515018|NCT03036072|363893002|FG000|Overall Study|Death|0|||
105515019|NCT03036072|363893003|FG001|Overall Study|Death|1|||
105515020|NCT03036072|363893002|FG000|Overall Study|Withdrawal by Subject|0|||
105515021|NCT03036072|363893003|FG001|Overall Study|Withdrawal by Subject|1|||
105515022|NCT03036072|363893002|FG000|Overall Study|Physician Decision|0|||
105515023|NCT03036072|363893003|FG001|Overall Study|Physician Decision|1|||
105515024|NCT00662363|363893004|FG000|Overall Study|Withdrawal by Subject|6|||
105515025|NCT00662363|363893005|FG001|Overall Study|Withdrawal by Subject|5|||
105515026|NCT00662363|363893004|FG000|Overall Study|Adverse Event|0|||
105515027|NCT00662363|363893005|FG001|Overall Study|Adverse Event|3|||
105515028|NCT00662363|363893004|FG000|Overall Study|Discharged early from rehab|4|||
105515029|NCT00662363|363893005|FG001|Overall Study|Discharged early from rehab|1|||
105515030|NCT00662363|363893004|FG000|Overall Study|Protocol Violation|1|||
105515031|NCT00662363|363893005|FG001|Overall Study|Protocol Violation|1|||
105515032|NCT04080297|363893007|FG000|Overall Study|Adverse Event|1|||
105515033|NCT04080297|363893008|FG001|Overall Study|Adverse Event|3|||
105515034|NCT04080297|363893007|FG000|Overall Study|concurrent illness|1|||
105515035|NCT04080297|363893008|FG001|Overall Study|concurrent illness|0|||
105515036|NCT02744391|363893009|FG000|Overall Study|Lost to Follow-up|9|||
105515037|NCT02744391|363893009|FG000|Overall Study|Physician Decision|2|||
105515038|NCT02744391|363893009|FG000|Overall Study|Withdrawal by Subject|3|||
105515039|NCT02700815|363895526|FG000|Overall Study|Adverse Event|0|||
105515040|NCT02700815|363895527|FG001|Overall Study|Adverse Event|6|||
105515041|NCT02700815|363895528|FG002|Overall Study|Adverse Event|2|||
105515042|NCT02700815|363895529|FG003|Overall Study|Adverse Event|3|||
105515043|NCT02700815|363895526|FG000|Overall Study|Lack of Efficacy|0|||
105515044|NCT02700815|363895527|FG001|Overall Study|Lack of Efficacy|0|||
105515045|NCT02700815|363895528|FG002|Overall Study|Lack of Efficacy|1|||
105515046|NCT02700815|363895529|FG003|Overall Study|Lack of Efficacy|2|||
105515047|NCT02700815|363895526|FG000|Overall Study|Lost to Follow-up|1|||
105515048|NCT02700815|363895527|FG001|Overall Study|Lost to Follow-up|0|||
105515049|NCT02700815|363895528|FG002|Overall Study|Lost to Follow-up|0|||
105515050|NCT02700815|363895529|FG003|Overall Study|Lost to Follow-up|1|||
105515051|NCT02700815|363895526|FG000|Overall Study|Refusal to continue medication|0|||
105515052|NCT02700815|363895527|FG001|Overall Study|Refusal to continue medication|1|||
105515053|NCT02700815|363895528|FG002|Overall Study|Refusal to continue medication|0|||
105515054|NCT02700815|363895529|FG003|Overall Study|Refusal to continue medication|1|||
105515055|NCT02700815|363895526|FG000|Overall Study|Withdrawal by Subject|0|||
105515056|NCT02700815|363895527|FG001|Overall Study|Withdrawal by Subject|0|||
105515057|NCT02700815|363895528|FG002|Overall Study|Withdrawal by Subject|1|||
105515058|NCT02700815|363895529|FG003|Overall Study|Withdrawal by Subject|0|||
105515059|NCT03909295|363895531|FG000|Overall Study|Adverse Event|2|||
105515060|NCT03909295|363895531|FG000|Overall Study|Study terminated by sponsor|50|||
105515061|NCT01411228|363895532|FG000|Overall Study|Lost to Follow-up|0|||
105515062|NCT01411228|363895533|FG001|Overall Study|Lost to Follow-up|0|||
105515063|NCT01411228|363895534|FG002|Overall Study|Lost to Follow-up|1|||
105515064|NCT01411228|363895532|FG000|Overall Study|Withdrawal by Subject|1|||
105515065|NCT01411228|363895533|FG001|Overall Study|Withdrawal by Subject|0|||
105515066|NCT01411228|363895534|FG002|Overall Study|Withdrawal by Subject|0|||
105515067|NCT01199289|363895536|FG000|Overall Study|Ineligibility determined|2|||
105515068|NCT01199289|363895537|FG001|Overall Study|Ineligibility determined|1|||
105515069|NCT01199289|363895538|FG002|Overall Study|Ineligibility determined|0|||
105515070|NCT01199289|363895539|FG003|Overall Study|Ineligibility determined|0|||
105515071|NCT01199289|363895536|FG000|Overall Study|Protocol Violation|1|||
105515072|NCT01199289|363895537|FG001|Overall Study|Protocol Violation|0|||
105515073|NCT01199289|363895538|FG002|Overall Study|Protocol Violation|0|||
105515074|NCT01199289|363895539|FG003|Overall Study|Protocol Violation|1|||
105515075|NCT01199289|363895536|FG000|Overall Study|Noncompliance|1|||
105515076|NCT01199289|363895537|FG001|Overall Study|Noncompliance|0|||
105515077|NCT01199289|363895538|FG002|Overall Study|Noncompliance|2|||
105515078|NCT01199289|363895539|FG003|Overall Study|Noncompliance|0|||
105515079|NCT01199289|363895536|FG000|Overall Study|Adverse Event|0|||
105515080|NCT01199289|363895537|FG001|Overall Study|Adverse Event|3|||
105515081|NCT01199289|363895538|FG002|Overall Study|Adverse Event|1|||
105515082|NCT01199289|363895539|FG003|Overall Study|Adverse Event|4|||
105515083|NCT01199289|363895536|FG000|Overall Study|Full consent withdrawn|2|||
105515084|NCT01199289|363895537|FG001|Overall Study|Full consent withdrawn|2|||
105515085|NCT01199289|363895538|FG002|Overall Study|Full consent withdrawn|2|||
105515086|NCT01199289|363895539|FG003|Overall Study|Full consent withdrawn|3|||
105515087|NCT01199289|363895536|FG000|Overall Study|Administrative decision|0|||
105515088|NCT01199289|363895537|FG001|Overall Study|Administrative decision|0|||
105515089|NCT01199289|363895538|FG002|Overall Study|Administrative decision|0|||
105515090|NCT01199289|363895539|FG003|Overall Study|Administrative decision|1|||
105515091|NCT01199289|363895536|FG000|Overall Study|Lost to Follow-up|0|||
105515092|NCT01199289|363895537|FG001|Overall Study|Lost to Follow-up|0|||
105515093|NCT01199289|363895538|FG002|Overall Study|Lost to Follow-up|0|||
105515094|NCT01199289|363895539|FG003|Overall Study|Lost to Follow-up|1|||
105515095|NCT01199289|363895536|FG000|Overall Study|Protocol-specified criteria|3|||
105515096|NCT01199289|363895537|FG001|Overall Study|Protocol-specified criteria|0|||
105515097|NCT01199289|363895538|FG002|Overall Study|Protocol-specified criteria|0|||
105515098|NCT01199289|363895539|FG003|Overall Study|Protocol-specified criteria|1|||
105515099|NCT01199289|363895536|FG000|Overall Study|Pregnancy|0|||
105515100|NCT01199289|363895537|FG001|Overall Study|Pregnancy|1|||
105515101|NCT01199289|363895538|FG002|Overall Study|Pregnancy|0|||
105515102|NCT01199289|363895539|FG003|Overall Study|Pregnancy|1|||
105515103|NCT01946425|363895547|FG000|Overall Study|Protocol Violation|1|||
105515104|NCT01946425|363895548|FG001|Overall Study|Protocol Violation|0|||
105515105|NCT01946425|363895547|FG000|Overall Study|Withdrawal by Subject|1|||
105515106|NCT01946425|363895548|FG001|Overall Study|Withdrawal by Subject|0|||
105515107|NCT03247530|363895549|FG000|Overall Study|Withdrawal by caregiver|19|||
105515108|NCT03247530|363895550|FG001|Overall Study|Withdrawal by caregiver|8|||
105515109|NCT03247530|363895551|FG002|Overall Study|Withdrawal by caregiver|10|||
105515110|NCT03247530|363895549|FG000|Overall Study|Lost to Follow-up|3|||
105515111|NCT03247530|363895550|FG001|Overall Study|Lost to Follow-up|9|||
105515112|NCT03247530|363895551|FG002|Overall Study|Lost to Follow-up|6|||
105515113|NCT03247530|363895549|FG000|Overall Study|Adverse Event|2|||
105515114|NCT03247530|363895550|FG001|Overall Study|Adverse Event|5|||
105515115|NCT03247530|363895551|FG002|Overall Study|Adverse Event|2|||
105515116|NCT03247530|363895549|FG000|Overall Study|Failure to follow procedure|1|||
105515117|NCT03247530|363895550|FG001|Overall Study|Failure to follow procedure|1|||
105515118|NCT03247530|363895551|FG002|Overall Study|Failure to follow procedure|1|||
105515119|NCT03247530|363895549|FG000|Overall Study|Withdrawal by Subject|1|||
105515120|NCT03247530|363895550|FG001|Overall Study|Withdrawal by Subject|1|||
105515121|NCT03247530|363895551|FG002|Overall Study|Withdrawal by Subject|0|||
105515122|NCT03247530|363895549|FG000|Overall Study|Study medication misuse|0|||
105515123|NCT03247530|363895550|FG001|Overall Study|Study medication misuse|1|||
105515124|NCT03247530|363895551|FG002|Overall Study|Study medication misuse|0|||
105515125|NCT03247530|363895549|FG000|Overall Study|Other, multiple categories|1|||
105515126|NCT03247530|363895550|FG001|Overall Study|Other, multiple categories|3|||
105515127|NCT03247530|363895551|FG002|Overall Study|Other, multiple categories|1|||
105515128|NCT03274440|363895552|FG000|Overall Study|Time commitment too great|1|||
105515129|NCT03274440|363895553|FG001|Overall Study|Time commitment too great|0|||
105515130|NCT03274440|363895554|FG002|Overall Study|Time commitment too great|0|||
105515131|NCT03274440|363895555|FG003|Overall Study|Time commitment too great|1|||
105515132|NCT03274440|363895556|FG004|Overall Study|Time commitment too great|0|||
105515133|NCT03274440|363895557|FG005|Overall Study|Time commitment too great|0|||
105515134|NCT03414424|363895558|FG000|Overall Study|Screened out after consent|0|||
105515135|NCT03414424|363895559|FG001|Overall Study|Screened out after consent|2|||
105515136|NCT03414424|363895558|FG000|Overall Study|Lost to Follow-up|0|||
105515137|NCT03414424|363895559|FG001|Overall Study|Lost to Follow-up|1|||
105515138|NCT01113801|363895560|FG000|Overall Study|Adverse Event|4|||
105515139|NCT01113801|363895561|FG001|Overall Study|Adverse Event|0|||
105515140|NCT01113801|363895562|FG002|Overall Study|Adverse Event|2|||
105515141|NCT01113801|363895563|FG003|Overall Study|Adverse Event|6|||
105515142|NCT01113801|363895560|FG000|Overall Study|Death|4|||
105515143|NCT01113801|363895561|FG001|Overall Study|Death|5|||
105515144|NCT01113801|363895562|FG002|Overall Study|Death|3|||
105515145|NCT01113801|363895563|FG003|Overall Study|Death|4|||
105515146|NCT01113801|363895560|FG000|Overall Study|Protocol Violation|0|||
105515147|NCT01113801|363895561|FG001|Overall Study|Protocol Violation|1|||
105515148|NCT01113801|363895562|FG002|Overall Study|Protocol Violation|0|||
105515149|NCT01113801|363895563|FG003|Overall Study|Protocol Violation|0|||
105515150|NCT01113801|363895560|FG000|Overall Study|Withdrawal by Subject|9|||
105515151|NCT01113801|363895561|FG001|Overall Study|Withdrawal by Subject|7|||
105515152|NCT01113801|363895562|FG002|Overall Study|Withdrawal by Subject|7|||
105515153|NCT01113801|363895563|FG003|Overall Study|Withdrawal by Subject|8|||
105515154|NCT01113801|363895560|FG000|Overall Study|Physician Decision|2|||
105515155|NCT01113801|363895561|FG001|Overall Study|Physician Decision|2|||
105515156|NCT01113801|363895562|FG002|Overall Study|Physician Decision|3|||
105515157|NCT01113801|363895563|FG003|Overall Study|Physician Decision|3|||
105515158|NCT01113801|363895560|FG000|Overall Study|Sponsor Decision|15|||
105515159|NCT01113801|363895561|FG001|Overall Study|Sponsor Decision|21|||
105515160|NCT01113801|363895562|FG002|Overall Study|Sponsor Decision|20|||
105515161|NCT01113801|363895563|FG003|Overall Study|Sponsor Decision|15|||
105515162|NCT01113801|363895560|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
105515163|NCT01113801|363895561|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
105515164|NCT01113801|363895562|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
105515165|NCT01113801|363895563|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
105515166|NCT03527966|363895564|FG000|Overall Study|Lost to Follow-up|3|||
105515167|NCT03527966|363895565|FG001|Overall Study|Lost to Follow-up|0|||
105515168|NCT01506479|363895566|FG000|Overall Study|Lost to Follow-up|1|||
105515169|NCT01506479|363895567|FG001|Overall Study|Lost to Follow-up|2|||
105515170|NCT01506479|363895568|FG002|Overall Study|Lost to Follow-up|2|||
105515171|NCT01506479|363895566|FG000|Overall Study|Withdrawal by Subject|1|||
105515172|NCT01506479|363895567|FG001|Overall Study|Withdrawal by Subject|2|||
105515173|NCT01506479|363895568|FG002|Overall Study|Withdrawal by Subject|1|||
105515174|NCT01506479|363895566|FG000|Overall Study|Missing assessment|1|||
105515175|NCT01506479|363895567|FG001|Overall Study|Missing assessment|0|||
105515176|NCT01506479|363895568|FG002|Overall Study|Missing assessment|0|||
105515177|NCT01506479|363895566|FG000|Overall Study|Adverse Event|0|||
105515178|NCT01506479|363895567|FG001|Overall Study|Adverse Event|1|||
105515179|NCT01506479|363895568|FG002|Overall Study|Adverse Event|0|||
105515180|NCT00022633|363895570|FG000|Overall Study|Adverse Event|11|||
105515181|NCT00022633|363895571|FG001|Overall Study|Adverse Event|1|||
105515182|NCT00022633|363895570|FG000|Overall Study|Refusal unrelated to adverse event|1|||
105515183|NCT00022633|363895571|FG001|Overall Study|Refusal unrelated to adverse event|0|||
105515184|NCT00022633|363895570|FG000|Overall Study|Progression/relapse|9|||
105515185|NCT00022633|363895571|FG001|Overall Study|Progression/relapse|2|||
105515186|NCT00022633|363895570|FG000|Overall Study|Death|4|||
105515187|NCT00022633|363895571|FG001|Overall Study|Death|0|||
105515188|NCT00022633|363895570|FG000|Overall Study|Other - not protocol specified|3|||
105515189|NCT00022633|363895571|FG001|Overall Study|Other - not protocol specified|2|||
105515190|NCT00022633|363895570|FG000|Overall Study|Ineligible|4|||
105515191|NCT00022633|363895571|FG001|Overall Study|Ineligible|0|||
105515192|NCT00276159|363895572|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
105515193|NCT00372112|363895579|FG000|Overall Study|Adverse Event|0|||
105515194|NCT00372112|363895580|FG001|Overall Study|Adverse Event|1|||
105515195|NCT00372112|363895581|FG002|Overall Study|Adverse Event|1|||
105515196|NCT00372112|363895582|FG003|Overall Study|Adverse Event|1|||
105515197|NCT00372112|363895579|FG000|Overall Study|Withdrawal by Subject|0|||
105515198|NCT00372112|363895580|FG001|Overall Study|Withdrawal by Subject|0|||
105515199|NCT00372112|363895581|FG002|Overall Study|Withdrawal by Subject|2|||
105515200|NCT00372112|363895582|FG003|Overall Study|Withdrawal by Subject|1|||
105515201|NCT00372112|363895579|FG000|Overall Study|Exacerbation|0|||
105515202|NCT00372112|363895580|FG001|Overall Study|Exacerbation|0|||
105515203|NCT00372112|363895581|FG002|Overall Study|Exacerbation|0|||
105592136|NCT00906698|364169303|FG000|Overall Study|Adverse Event|0|||
105515204|NCT00372112|363895582|FG003|Overall Study|Exacerbation|1|||
105515205|NCT00372112|363895579|FG000|Overall Study|PR >240 at Visit 3|0|||
105515206|NCT00372112|363895580|FG001|Overall Study|PR >240 at Visit 3|0|||
105515207|NCT00372112|363895581|FG002|Overall Study|PR >240 at Visit 3|0|||
105592137|NCT00906698|364169304|FG001|Overall Study|Adverse Event|0|||
105515208|NCT00372112|363895582|FG003|Overall Study|PR >240 at Visit 3|1|||
105515209|NCT00372112|363895579|FG000|Overall Study|Hepatitis B|1|||
105515210|NCT00372112|363895580|FG001|Overall Study|Hepatitis B|0|||
105515211|NCT00372112|363895581|FG002|Overall Study|Hepatitis B|0|||
105515212|NCT00372112|363895582|FG003|Overall Study|Hepatitis B|0|||
105515213|NCT00372112|363895579|FG000|Overall Study|Other-protocol violation|0|||
105515214|NCT00372112|363895580|FG001|Overall Study|Other-protocol violation|0|||
105592138|NCT00906698|364169305|FG002|Overall Study|Adverse Event|2|||
105515215|NCT00372112|363895581|FG002|Overall Study|Other-protocol violation|1|||
105515216|NCT00372112|363895582|FG003|Overall Study|Other-protocol violation|0|||
105515217|NCT00356369|363895583|FG000|Active Phase|Withdrawal by Subject|2|||
105515218|NCT00356369|363895584|FG001|Active Phase|Withdrawal by Subject|1|||
105515219|NCT00429104|363895585|FG000|Overall Study|Protocol Violation|1|||
105515220|NCT01285310|363895588|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
105515221|NCT01285310|363895589|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
105515222|NCT01285310|363895590|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
105515223|NCT01285310|363895591|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
105515224|NCT01285310|363895592|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
105515225|NCT01285310|363895588|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
105515226|NCT01285310|363895589|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
105515227|NCT01285310|363895590|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
105515228|NCT01285310|363895591|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
105515229|NCT01285310|363895592|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
105515230|NCT01285310|363895588|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
105515231|NCT01285310|363895589|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
105515232|NCT01285310|363895590|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
105515233|NCT01285310|363895591|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
105515234|NCT01285310|363895592|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
105515235|NCT01285310|363895588|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
105515236|NCT01285310|363895589|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
105515237|NCT01285310|363895590|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
105515238|NCT01285310|363895591|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
105515239|NCT01285310|363895592|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
105515240|NCT01285310|363895588|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
105515241|NCT01285310|363895589|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
105515242|NCT01285310|363895590|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
105515243|NCT01285310|363895591|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
105515244|NCT01285310|363895592|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
105515245|NCT01285310|363895588|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
105515246|NCT01285310|363895589|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
105515247|NCT01285310|363895590|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
105515248|NCT01285310|363895591|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
105515249|NCT01285310|363895592|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
105515250|NCT01285310|363895588|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
105515251|NCT01285310|363895589|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
105515252|NCT01285310|363895590|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
105515253|NCT01285310|363895591|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
105515254|NCT01285310|363895592|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
105515255|NCT01285310|363895588|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
105515256|NCT01285310|363895589|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
105515257|NCT01285310|363895590|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
105515258|NCT01285310|363895591|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
105515259|NCT01285310|363895592|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
105515260|NCT01285310|363895588|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
105515261|NCT01285310|363895589|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
105515262|NCT01285310|363895590|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
105515263|NCT01285310|363895591|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
105515264|NCT01285310|363895592|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
105515265|NCT01285310|363895588|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
105515266|NCT01285310|363895589|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
105515267|NCT01285310|363895590|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
105515268|NCT01285310|363895591|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
105515269|NCT01285310|363895592|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
105515270|NCT01285310|363895588|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
105515271|NCT01285310|363895589|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
105515272|NCT01285310|363895590|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
105515273|NCT01285310|363895591|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
105515274|NCT01285310|363895592|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
105515275|NCT01285310|363895588|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
105515276|NCT01285310|363895589|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
105515277|NCT01285310|363895590|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
105515278|NCT01285310|363895591|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
105515279|NCT01285310|363895592|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
105515280|NCT01996982|363895595|FG000|Overall Study|PI/team left institution|7|||
105515281|NCT01896531|363895596|FG000|Overall Study|Death|57|||
105515282|NCT01896531|363895597|FG001|Overall Study|Death|59|||
105515283|NCT01896531|363895596|FG000|Overall Study|Lost to Follow-up|3|||
105515284|NCT01896531|363895597|FG001|Overall Study|Lost to Follow-up|0|||
105515285|NCT01896531|363895596|FG000|Overall Study|Non-compliance|0|||
105515286|NCT01896531|363895597|FG001|Overall Study|Non-compliance|1|||
105515287|NCT01896531|363895596|FG000|Overall Study|Study Ended by Sponsor|7|||
105515288|NCT01896531|363895597|FG001|Overall Study|Study Ended by Sponsor|20|||
105515289|NCT01896531|363895596|FG000|Overall Study|Withdrawal by Subject|3|||
105515290|NCT01896531|363895597|FG001|Overall Study|Withdrawal by Subject|2|||
105515291|NCT01896531|363895596|FG000|Overall Study|Death Prior to Treatment|1|||
105515292|NCT01896531|363895597|FG001|Overall Study|Death Prior to Treatment|0|||
105515293|NCT01195415|363895618|FG000|Overall Study|No repeat biopsy due to progression|2|||
105515294|NCT00533845|363895619|FG000|Overall Study|Physician Decision|1|||
105515295|NCT00533845|363895620|FG001|Overall Study|Physician Decision|0|||
105515296|NCT02659631|363895623|FG000|Overall Study|Lost to Follow-up|0|||
105515297|NCT02659631|363895624|FG001|Overall Study|Lost to Follow-up|0|||
105515298|NCT02659631|363895625|FG002|Overall Study|Lost to Follow-up|2|||
105515299|NCT02659631|363895626|FG003|Overall Study|Lost to Follow-up|0|||
105515300|NCT02659631|363895627|FG004|Overall Study|Lost to Follow-up|0|||
105515301|NCT02659631|363895628|FG005|Overall Study|Lost to Follow-up|1|||
105515302|NCT02659631|363895629|FG006|Overall Study|Lost to Follow-up|0|||
105515303|NCT02659631|363895630|FG007|Overall Study|Lost to Follow-up|0|||
105515304|NCT02659631|363895631|FG008|Overall Study|Lost to Follow-up|0|||
105515305|NCT02659631|363895632|FG009|Overall Study|Lost to Follow-up|0|||
105515306|NCT02659631|363895623|FG000|Overall Study|Withdrawal prior to treatment|0|||
105515307|NCT02659631|363895624|FG001|Overall Study|Withdrawal prior to treatment|0|||
105515308|NCT02659631|363895625|FG002|Overall Study|Withdrawal prior to treatment|0|||
105515309|NCT02659631|363895626|FG003|Overall Study|Withdrawal prior to treatment|0|||
105515310|NCT02659631|363895627|FG004|Overall Study|Withdrawal prior to treatment|1|||
105515311|NCT02659631|363895628|FG005|Overall Study|Withdrawal prior to treatment|0|||
105515312|NCT02659631|363895629|FG006|Overall Study|Withdrawal prior to treatment|0|||
105515313|NCT02659631|363895630|FG007|Overall Study|Withdrawal prior to treatment|0|||
105515314|NCT02659631|363895631|FG008|Overall Study|Withdrawal prior to treatment|0|||
105515315|NCT02659631|363895632|FG009|Overall Study|Withdrawal prior to treatment|0|||
105515316|NCT02659631|363895623|FG000|Overall Study|Participant refused further follow-up|0|||
105515317|NCT02659631|363895624|FG001|Overall Study|Participant refused further follow-up|0|||
105515318|NCT02659631|363895625|FG002|Overall Study|Participant refused further follow-up|0|||
105515319|NCT02659631|363895626|FG003|Overall Study|Participant refused further follow-up|1|||
105515320|NCT02659631|363895627|FG004|Overall Study|Participant refused further follow-up|0|||
105515321|NCT02659631|363895628|FG005|Overall Study|Participant refused further follow-up|0|||
105515322|NCT02659631|363895629|FG006|Overall Study|Participant refused further follow-up|0|||
105515323|NCT02659631|363895630|FG007|Overall Study|Participant refused further follow-up|0|||
105515324|NCT02659631|363895631|FG008|Overall Study|Participant refused further follow-up|1|||
105515325|NCT02659631|363895632|FG009|Overall Study|Participant refused further follow-up|0|||
105515326|NCT02659631|363895623|FG000|Overall Study|Death (follow-up phase)|1|||
105515327|NCT02659631|363895624|FG001|Overall Study|Death (follow-up phase)|2|||
105515328|NCT02659631|363895625|FG002|Overall Study|Death (follow-up phase)|1|||
105515329|NCT02659631|363895626|FG003|Overall Study|Death (follow-up phase)|1|||
105515330|NCT02659631|363895627|FG004|Overall Study|Death (follow-up phase)|3|||
105515331|NCT02659631|363895628|FG005|Overall Study|Death (follow-up phase)|2|||
105515332|NCT02659631|363895629|FG006|Overall Study|Death (follow-up phase)|0|||
105515333|NCT02659631|363895630|FG007|Overall Study|Death (follow-up phase)|3|||
105515334|NCT02659631|363895631|FG008|Overall Study|Death (follow-up phase)|1|||
105515335|NCT02659631|363895632|FG009|Overall Study|Death (follow-up phase)|0|||
105515336|NCT02659631|363895623|FG000|Overall Study|Death (treatment phase)|0|||
105515337|NCT02659631|363895624|FG001|Overall Study|Death (treatment phase)|0|||
105515338|NCT02659631|363895625|FG002|Overall Study|Death (treatment phase)|0|||
105515339|NCT02659631|363895626|FG003|Overall Study|Death (treatment phase)|0|||
105515340|NCT02659631|363895627|FG004|Overall Study|Death (treatment phase)|1|||
105515341|NCT02659631|363895628|FG005|Overall Study|Death (treatment phase)|0|||
105515342|NCT02659631|363895629|FG006|Overall Study|Death (treatment phase)|1|||
105515343|NCT02659631|363895630|FG007|Overall Study|Death (treatment phase)|0|||
105515344|NCT02659631|363895631|FG008|Overall Study|Death (treatment phase)|0|||
105515345|NCT02659631|363895632|FG009|Overall Study|Death (treatment phase)|0|||
105515346|NCT02377466|363895633|FG000|Overall Study|Other: Randomized and not treated|0|||
105515347|NCT02377466|363895634|FG001|Overall Study|Other: Randomized and not treated|2|||
105515348|NCT00005937|363895638|FG000|Overall Study|Lack of Efficacy|5|||
105515349|NCT00330616|363895640|FG000|Overall Study|Adverse Event|13|||
105515350|NCT00330616|363895640|FG000|Overall Study|Lack of Efficacy|1|||
105515351|NCT00330616|363895640|FG000|Overall Study|Lost to Follow-up|2|||
105515352|NCT00330616|363895640|FG000|Overall Study|Withdrawal by Subject|4|||
105515353|NCT00330616|363895640|FG000|Overall Study|Other|1|||
105515354|NCT00255047|363895643|FG000|Overall Study|Serious Adverse Events|2|||
105515355|NCT00255047|363895644|FG001|Overall Study|Serious Adverse Events|1|||
105515356|NCT00255047|363895645|FG002|Overall Study|Serious Adverse Events|2|||
105515357|NCT00255047|363895646|FG003|Overall Study|Serious Adverse Events|1|||
105515358|NCT00255047|363895643|FG000|Overall Study|Adverse Event|0|||
105515359|NCT00255047|363895644|FG001|Overall Study|Adverse Event|3|||
105515360|NCT00255047|363895645|FG002|Overall Study|Adverse Event|2|||
105515361|NCT00255047|363895646|FG003|Overall Study|Adverse Event|1|||
105515362|NCT00255047|363895643|FG000|Overall Study|Protocol Violation|13|||
105515363|NCT00255047|363895644|FG001|Overall Study|Protocol Violation|13|||
105515364|NCT00255047|363895645|FG002|Overall Study|Protocol Violation|16|||
105515365|NCT00255047|363895646|FG003|Overall Study|Protocol Violation|20|||
105515366|NCT00255047|363895643|FG000|Overall Study|Lost to Follow-up|9|||
105515367|NCT00255047|363895644|FG001|Overall Study|Lost to Follow-up|8|||
105515368|NCT00255047|363895645|FG002|Overall Study|Lost to Follow-up|5|||
105515369|NCT00255047|363895646|FG003|Overall Study|Lost to Follow-up|6|||
105515370|NCT00255047|363895643|FG000|Overall Study|Withdrawal by Subject|24|||
105515371|NCT00255047|363895644|FG001|Overall Study|Withdrawal by Subject|23|||
105515372|NCT00255047|363895645|FG002|Overall Study|Withdrawal by Subject|25|||
105515373|NCT00255047|363895646|FG003|Overall Study|Withdrawal by Subject|18|||
105515374|NCT01574612|363895647|FG000|Overall Study|Adverse Event|3|||
105515375|NCT01574612|363895647|FG000|Overall Study|non compliant with drug|2|||
105515376|NCT01574612|363895647|FG000|Overall Study|Withdrawal by Subject|1|||
105515377|NCT01574612|363895647|FG000|Overall Study|Lost to Follow-up|2|||
105515378|NCT01585194|363895650|FG000|Overall Study|Withdrawal by Subject|1|||
105515379|NCT01585194|363895650|FG000|Overall Study|Physician Decision|2|||
105515380|NCT01585194|363895650|FG000|Overall Study|Lack of insurance|1|||
105515381|NCT02860169|363895653|FG000|Part A|Withdrawal by Subject|1|||
105515382|NCT02860169|363895653|FG000|Part A|Other (Screening failure)|6|||
105515383|NCT02860169|363895653|FG000|Part A|Other (Survey not completed)|3|||
105515384|NCT02860169|363895653|FG000|Part A|Other (did not completed consent)|1|||
105515385|NCT02860169|363895653|FG000|Part B|Other (Screening failure)|10|||
105515386|NCT02860169|363895653|FG000|Part B|Withdrawal by Subject|1|||
105515387|NCT02860169|363895653|FG000|Part C|Other (Screening failure)|1|||
105515388|NCT01958008|363895659|FG000|Overall Study|Worsening of disease under study|0|||
105515389|NCT01958008|363895660|FG001|Overall Study|Worsening of disease under study|0|||
105515390|NCT01958008|363895661|FG002|Overall Study|Worsening of disease under study|1|||
105515391|NCT01958008|363895662|FG003|Overall Study|Worsening of disease under study|0|||
105515392|NCT01958008|363895659|FG000|Overall Study|Other adverse event|1|||
105515393|NCT01958008|363895660|FG001|Overall Study|Other adverse event|0|||
105515394|NCT01958008|363895661|FG002|Overall Study|Other adverse event|0|||
105515395|NCT01958008|363895662|FG003|Overall Study|Other adverse event|0|||
105515396|NCT00241280|363895663|FG000|Overall Study|Adverse Event|2|||
105515397|NCT00241280|363895664|FG001|Overall Study|Adverse Event|6|||
105515398|NCT00241280|363895663|FG000|Overall Study|Discomfort|11|||
105515399|NCT00241280|363895664|FG001|Overall Study|Discomfort|16|||
105515400|NCT00241280|363895663|FG000|Overall Study|Pregnancy|1|||
105515401|NCT00241280|363895664|FG001|Overall Study|Pregnancy|5|||
105515402|NCT00241280|363895663|FG000|Overall Study|Lost to Follow-up|5|||
105515403|NCT00241280|363895664|FG001|Overall Study|Lost to Follow-up|8|||
105515404|NCT00241280|363895663|FG000|Overall Study|Withdrawal by Subject|7|||
105515405|NCT00241280|363895664|FG001|Overall Study|Withdrawal by Subject|4|||
105515406|NCT00241280|363895663|FG000|Overall Study|Protocol Violation|4|||
105515407|NCT00241280|363895664|FG001|Overall Study|Protocol Violation|10|||
105515408|NCT00241280|363895663|FG000|Overall Study|Relocation|4|||
105515409|NCT00241280|363895664|FG001|Overall Study|Relocation|4|||
105515410|NCT00241280|363895663|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
105515411|NCT00241280|363895664|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
105515412|NCT00241280|363895663|FG000|Overall Study|Unsatisfactory Visual Response|1|||
105515413|NCT00241280|363895664|FG001|Overall Study|Unsatisfactory Visual Response|1|||
105515414|NCT00241280|363895663|FG000|Overall Study|Diabetic|1|||
105515415|NCT00241280|363895664|FG001|Overall Study|Diabetic|0|||
105515416|NCT00241280|363895663|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
105515417|NCT00241280|363895664|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
105515418|NCT00241280|363895663|FG000|Overall Study|Dispensed incorrect test article|1|||
105515419|NCT00241280|363895664|FG001|Overall Study|Dispensed incorrect test article|2|||
105515420|NCT00241280|363895663|FG000|Overall Study|Unacceptable Fit|0|||
105515421|NCT00241280|363895664|FG001|Overall Study|Unacceptable Fit|1|||
105515422|NCT00241280|363895663|FG000|Overall Study|Scheduling Conflict|0|||
105515423|NCT00241280|363895664|FG001|Overall Study|Scheduling Conflict|2|||
105515424|NCT00241280|363895663|FG000|Overall Study|History of Ocular Surgery|0|||
105515425|NCT00241280|363895664|FG001|Overall Study|History of Ocular Surgery|1|||
105515426|NCT00241280|363895663|FG000|Overall Study|Coating on Lens|1|||
105515427|NCT00241280|363895664|FG001|Overall Study|Coating on Lens|0|||
105515428|NCT00241280|363895663|FG000|Overall Study|Excessive Dryness|0|||
105515429|NCT00241280|363895664|FG001|Overall Study|Excessive Dryness|1|||
105515430|NCT00965718|363895665|FG000|Overall Study|Withdrawal by Subject|4|||
105515431|NCT01634360|363895666|FG000|Overall Study|Adverse Event|10|||
105515432|NCT01634360|363895667|FG001|Overall Study|Adverse Event|34|||
105515433|NCT01634360|363895666|FG000|Overall Study|subject withdrew consent|13|||
105515434|NCT01634360|363895667|FG001|Overall Study|subject withdrew consent|23|||
105515435|NCT01634360|363895666|FG000|Overall Study|Protocol Violation|1|||
105515436|NCT01634360|363895667|FG001|Overall Study|Protocol Violation|1|||
105515437|NCT01634360|363895666|FG000|Overall Study|Lack of Efficacy|4|||
105515438|NCT01634360|363895667|FG001|Overall Study|Lack of Efficacy|14|||
105515439|NCT01634360|363895666|FG000|Overall Study|Other|3|||
105515440|NCT01634360|363895667|FG001|Overall Study|Other|20|||
105592139|NCT00906698|364169306|FG003|Overall Study|Adverse Event|0|||
105515441|NCT01634360|363895666|FG000|Overall Study|Study termination by sponsor|18|||
105515442|NCT01634360|363895667|FG001|Overall Study|Study termination by sponsor|44|||
105515443|NCT03428360|363895668|FG000|Overall Study|Informed consent withdrawn|5|||
105515444|NCT03428360|363895668|FG000|Overall Study|Withdrawal by Subject|4|||
105515445|NCT03428360|363895668|FG000|Overall Study|Lost to Follow-up|5|||
105515446|NCT03428360|363895668|FG000|Overall Study|Physician Decision|2|||
105515447|NCT03428360|363895668|FG000|Overall Study|Informed consent withdrawn|5|||
105515448|NCT03428360|363895668|FG000|Overall Study|Study terminated by sponsor|10|||
105515449|NCT03428360|363895668|FG000|Overall Study|Non-compliant with study|1|||
105515450|NCT03428360|363895668|FG000|Overall Study|Non-compliant with study drug|3|||
105515451|NCT03428360|363895668|FG000|Overall Study|Death|3|||
105515452|NCT03428360|363895668|FG000|Overall Study|Adverse Event|1|||
105515453|NCT03428360|363895668|FG000|Overall Study|Not on antiepileptic drug|1|||
105515454|NCT02743871|363895669|FG000|Overall Study|Lost to Follow-up|0|||
105515455|NCT02743871|363895670|FG001|Overall Study|Lost to Follow-up|0|||
105515456|NCT02743871|363895671|FG002|Overall Study|Lost to Follow-up|0|||
105515457|NCT02743871|363895672|FG003|Overall Study|Lost to Follow-up|1|||
105515458|NCT02743871|363895673|FG004|Overall Study|Lost to Follow-up|0|||
105515459|NCT02743871|363895674|FG005|Overall Study|Lost to Follow-up|0|||
105515460|NCT02743871|363895675|FG006|Overall Study|Lost to Follow-up|1|||
105515461|NCT02743871|363895676|FG007|Overall Study|Lost to Follow-up|0|||
105515462|NCT02743871|363895677|FG008|Overall Study|Lost to Follow-up|0|||
105515463|NCT02743871|363895678|FG009|Overall Study|Lost to Follow-up|0|||
105515464|NCT02743871|363895679|FG010|Overall Study|Lost to Follow-up|0|||
105515465|NCT02743871|363895680|FG011|Overall Study|Lost to Follow-up|2|||
105515466|NCT02743871|363895681|FG012|Overall Study|Lost to Follow-up|0|||
105515467|NCT02743871|363895682|FG013|Overall Study|Lost to Follow-up|0|||
105515468|NCT02743871|363895669|FG000|Overall Study|Withdrawal by Subject|0|||
105515469|NCT02743871|363895670|FG001|Overall Study|Withdrawal by Subject|0|||
105515470|NCT02743871|363895671|FG002|Overall Study|Withdrawal by Subject|0|||
105515471|NCT02743871|363895672|FG003|Overall Study|Withdrawal by Subject|0|||
105515472|NCT02743871|363895673|FG004|Overall Study|Withdrawal by Subject|0|||
105515473|NCT02743871|363895674|FG005|Overall Study|Withdrawal by Subject|0|||
105515474|NCT02743871|363895675|FG006|Overall Study|Withdrawal by Subject|0|||
105515475|NCT02743871|363895676|FG007|Overall Study|Withdrawal by Subject|0|||
105515476|NCT02743871|363895677|FG008|Overall Study|Withdrawal by Subject|0|||
105515477|NCT02743871|363895678|FG009|Overall Study|Withdrawal by Subject|0|||
105515478|NCT02743871|363895679|FG010|Overall Study|Withdrawal by Subject|1|||
105515479|NCT02743871|363895680|FG011|Overall Study|Withdrawal by Subject|0|||
105515480|NCT02743871|363895681|FG012|Overall Study|Withdrawal by Subject|12|||
105515481|NCT02743871|363895682|FG013|Overall Study|Withdrawal by Subject|6|||
105515482|NCT02743871|363895669|FG000|Overall Study|Adverse Event|1|||
105515483|NCT02743871|363895670|FG001|Overall Study|Adverse Event|0|||
105515484|NCT02743871|363895671|FG002|Overall Study|Adverse Event|0|||
105515485|NCT02743871|363895672|FG003|Overall Study|Adverse Event|0|||
105515486|NCT02743871|363895673|FG004|Overall Study|Adverse Event|0|||
105515487|NCT02743871|363895674|FG005|Overall Study|Adverse Event|0|||
105515488|NCT02743871|363895675|FG006|Overall Study|Adverse Event|0|||
105515489|NCT02743871|363895676|FG007|Overall Study|Adverse Event|0|||
105515490|NCT02743871|363895677|FG008|Overall Study|Adverse Event|0|||
105515491|NCT02743871|363895678|FG009|Overall Study|Adverse Event|0|||
105515492|NCT02743871|363895679|FG010|Overall Study|Adverse Event|0|||
105515493|NCT02743871|363895680|FG011|Overall Study|Adverse Event|0|||
105515494|NCT02743871|363895681|FG012|Overall Study|Adverse Event|0|||
105515495|NCT02743871|363895682|FG013|Overall Study|Adverse Event|0|||
105515496|NCT02743871|363895669|FG000|Overall Study|Other|0|||
105515497|NCT02743871|363895670|FG001|Overall Study|Other|0|||
105515498|NCT02743871|363895671|FG002|Overall Study|Other|0|||
105515499|NCT02743871|363895672|FG003|Overall Study|Other|0|||
105515500|NCT02743871|363895673|FG004|Overall Study|Other|0|||
105515501|NCT02743871|363895674|FG005|Overall Study|Other|0|||
105515502|NCT02743871|363895675|FG006|Overall Study|Other|0|||
105515503|NCT02743871|363895676|FG007|Overall Study|Other|0|||
105515504|NCT02743871|363895677|FG008|Overall Study|Other|0|||
105515505|NCT02743871|363895678|FG009|Overall Study|Other|0|||
105515506|NCT02743871|363895679|FG010|Overall Study|Other|0|||
105515507|NCT02743871|363895680|FG011|Overall Study|Other|1|||
105515508|NCT02743871|363895681|FG012|Overall Study|Other|1|||
105515509|NCT02743871|363895682|FG013|Overall Study|Other|1|||
105515510|NCT02743871|363895669|FG000|Overall Study|Protocol Violation|0|||
105515511|NCT02743871|363895670|FG001|Overall Study|Protocol Violation|0|||
105515512|NCT02743871|363895671|FG002|Overall Study|Protocol Violation|0|||
105515513|NCT02743871|363895672|FG003|Overall Study|Protocol Violation|0|||
105515514|NCT02743871|363895673|FG004|Overall Study|Protocol Violation|0|||
105515515|NCT02743871|363895674|FG005|Overall Study|Protocol Violation|0|||
105515516|NCT02743871|363895675|FG006|Overall Study|Protocol Violation|0|||
105515517|NCT02743871|363895676|FG007|Overall Study|Protocol Violation|0|||
105515518|NCT02743871|363895677|FG008|Overall Study|Protocol Violation|0|||
105515519|NCT02743871|363895678|FG009|Overall Study|Protocol Violation|0|||
105515520|NCT02743871|363895679|FG010|Overall Study|Protocol Violation|0|||
105515521|NCT02743871|363895680|FG011|Overall Study|Protocol Violation|0|||
105515522|NCT02743871|363895681|FG012|Overall Study|Protocol Violation|2|||
105515523|NCT02743871|363895682|FG013|Overall Study|Protocol Violation|0|||
105515524|NCT04772755|363895686|FG000|Overall Study|Withdrawal by Subject|1|||
105515525|NCT04772755|363895687|FG001|Overall Study|Withdrawal by Subject|0|||
105515526|NCT04772755|363895686|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
105515527|NCT04772755|363895687|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
105515528|NCT01317160|363895689|FG000|Overall Study|Incorrect inclusion|1|||
105515529|NCT01317160|363895690|FG001|Overall Study|Incorrect inclusion|1|||
105515530|NCT01317160|363895689|FG000|Overall Study|Lost to Follow-up|3|||
105515531|NCT01317160|363895690|FG001|Overall Study|Lost to Follow-up|3|||
105515532|NCT01317160|363895689|FG000|Overall Study|Withdrawal by Subject|0|||
105515533|NCT01317160|363895690|FG001|Overall Study|Withdrawal by Subject|2|||
105515534|NCT01774968|363895694|FG000|Overall Study|Adverse Event|4|||
105515535|NCT01774968|363895695|FG001|Overall Study|Adverse Event|4|||
105515536|NCT01774968|363895694|FG000|Overall Study|Death|0|||
105515537|NCT01774968|363895695|FG001|Overall Study|Death|1|||
105515538|NCT01774968|363895694|FG000|Overall Study|Lost to Follow-up|1|||
105515539|NCT01774968|363895695|FG001|Overall Study|Lost to Follow-up|3|||
105515540|NCT01774968|363895694|FG000|Overall Study|Physician Decision|5|||
105515541|NCT01774968|363895695|FG001|Overall Study|Physician Decision|1|||
105515542|NCT01774968|363895694|FG000|Overall Study|Protocol Violation|14|||
105515543|NCT01774968|363895695|FG001|Overall Study|Protocol Violation|13|||
105515544|NCT01774968|363895694|FG000|Overall Study|Sponsor Decision|0|||
105515545|NCT01774968|363895695|FG001|Overall Study|Sponsor Decision|2|||
105515546|NCT01774968|363895694|FG000|Overall Study|Withdrawal by Subject|6|||
105515547|NCT01774968|363895695|FG001|Overall Study|Withdrawal by Subject|11|||
105515548|NCT03032705|363895696|FG000|Overall Study|Lost to Follow-up|16|||
105515549|NCT03032705|363895697|FG001|Overall Study|Lost to Follow-up|17|||
105515550|NCT03032705|363895696|FG000|Overall Study|did not quality|6|||
105515551|NCT03032705|363895697|FG001|Overall Study|did not quality|6|||
105515552|NCT00353262|363895698|FG000|Overall Study|Adverse Event|8|||
105515553|NCT00353262|363895698|FG000|Overall Study|Withdrawal by Subject|2|||
105515554|NCT00353262|363895698|FG000|Overall Study|Insufficient Therapeutic Response|13|||
105515555|NCT00353262|363895698|FG000|Overall Study|Progression|1|||
105515556|NCT00353262|363895698|FG000|Overall Study|Surgery|4|||
105515557|NCT00353262|363895698|FG000|Overall Study|Break from Chemotherapy|1|||
105515558|NCT02759471|363895699|FG000|Overall Study|discomfort|2|||
105515559|NCT02927080|363898189|FG000|Overall Study|Withdrawal by Subject|0|||
105515560|NCT02927080|363898190|FG001|Overall Study|Withdrawal by Subject|0|||
105515561|NCT02927080|363898191|FG002|Overall Study|Withdrawal by Subject|0|||
105515562|NCT02927080|363898192|FG003|Overall Study|Withdrawal by Subject|0|||
105515563|NCT02927080|363898193|FG004|Overall Study|Withdrawal by Subject|1|||
105515564|NCT02927080|363898194|FG005|Overall Study|Withdrawal by Subject|0|||
105515565|NCT02927080|363898195|FG006|Overall Study|Withdrawal by Subject|1|||
105515566|NCT02927080|363898196|FG007|Overall Study|Withdrawal by Subject|1|||
105515567|NCT02927080|363898197|FG008|Overall Study|Withdrawal by Subject|0|||
105515568|NCT02927080|363898198|FG009|Overall Study|Withdrawal by Subject|2|||
105515569|NCT02927080|363898189|FG000|Overall Study|Willingness to comply with protocol|0|||
105515570|NCT02927080|363898190|FG001|Overall Study|Willingness to comply with protocol|0|||
105515571|NCT02927080|363898191|FG002|Overall Study|Willingness to comply with protocol|0|||
105515572|NCT02927080|363898192|FG003|Overall Study|Willingness to comply with protocol|0|||
105515573|NCT02927080|363898193|FG004|Overall Study|Willingness to comply with protocol|0|||
105515574|NCT02927080|363898194|FG005|Overall Study|Willingness to comply with protocol|0|||
105515575|NCT02927080|363898195|FG006|Overall Study|Willingness to comply with protocol|0|||
105515576|NCT02927080|363898196|FG007|Overall Study|Willingness to comply with protocol|0|||
105515577|NCT02927080|363898197|FG008|Overall Study|Willingness to comply with protocol|0|||
105515578|NCT02927080|363898198|FG009|Overall Study|Willingness to comply with protocol|1|||
105515579|NCT02927080|363898189|FG000|Overall Study|Study terminated by Sponsor|0|||
105515580|NCT02927080|363898190|FG001|Overall Study|Study terminated by Sponsor|0|||
105515581|NCT02927080|363898191|FG002|Overall Study|Study terminated by Sponsor|0|||
105515582|NCT02927080|363898192|FG003|Overall Study|Study terminated by Sponsor|0|||
105515583|NCT02927080|363898193|FG004|Overall Study|Study terminated by Sponsor|0|||
105515584|NCT02927080|363898194|FG005|Overall Study|Study terminated by Sponsor|0|||
105515585|NCT02927080|363898195|FG006|Overall Study|Study terminated by Sponsor|6|||
105515586|NCT02927080|363898196|FG007|Overall Study|Study terminated by Sponsor|7|||
105515587|NCT02927080|363898197|FG008|Overall Study|Study terminated by Sponsor|2|||
105515588|NCT02927080|363898198|FG009|Overall Study|Study terminated by Sponsor|3|||
105515589|NCT02927080|363898189|FG000|Overall Study|Adverse Event|0|||
105515590|NCT02927080|363898190|FG001|Overall Study|Adverse Event|1|||
105515591|NCT02927080|363898191|FG002|Overall Study|Adverse Event|0|||
105515592|NCT02927080|363898192|FG003|Overall Study|Adverse Event|0|||
105515593|NCT02927080|363898193|FG004|Overall Study|Adverse Event|0|||
105515594|NCT02927080|363898194|FG005|Overall Study|Adverse Event|0|||
105515595|NCT02927080|363898195|FG006|Overall Study|Adverse Event|0|||
105515596|NCT02927080|363898196|FG007|Overall Study|Adverse Event|1|||
105515597|NCT02927080|363898197|FG008|Overall Study|Adverse Event|0|||
105515598|NCT02927080|363898198|FG009|Overall Study|Adverse Event|1|||
105515599|NCT02927080|363898189|FG000|Overall Study|Other|0|||
105515600|NCT02927080|363898190|FG001|Overall Study|Other|0|||
105515601|NCT02927080|363898191|FG002|Overall Study|Other|0|||
105515602|NCT02927080|363898192|FG003|Overall Study|Other|0|||
105515603|NCT02927080|363898193|FG004|Overall Study|Other|0|||
105515604|NCT02927080|363898194|FG005|Overall Study|Other|0|||
105515605|NCT02927080|363898195|FG006|Overall Study|Other|1|||
105515606|NCT02927080|363898196|FG007|Overall Study|Other|0|||
105515607|NCT02927080|363898197|FG008|Overall Study|Other|1|||
105515608|NCT02927080|363898198|FG009|Overall Study|Other|0|||
105515609|NCT03312933|363898201|FG000|Overall Study|Protocol Violation|15|||
105515610|NCT03312933|363898201|FG000|Overall Study|Lost to Follow-up|36|||
105515611|NCT03312933|363898201|FG000|Overall Study|Withdrawal by Subject|3|||
105515612|NCT00224055|363898207|FG000|Overall Study|Adverse Event|9|||
105515613|NCT00224055|363898208|FG001|Overall Study|Adverse Event|3|||
105515614|NCT00224055|363898207|FG000|Overall Study|Lost to Follow-up|1|||
105515615|NCT00224055|363898208|FG001|Overall Study|Lost to Follow-up|2|||
105515616|NCT00224055|363898207|FG000|Overall Study|Protocol Violation|1|||
105515617|NCT00224055|363898208|FG001|Overall Study|Protocol Violation|1|||
105515618|NCT00224055|363898207|FG000|Overall Study|Inclusion Violation|3|||
105515619|NCT00224055|363898208|FG001|Overall Study|Inclusion Violation|6|||
105515620|NCT00224055|363898207|FG000|Overall Study|Withdrawal by Subject|0|||
105515621|NCT00224055|363898208|FG001|Overall Study|Withdrawal by Subject|2|||
105515622|NCT00224055|363898207|FG000|Overall Study|Other|1|||
105515623|NCT00224055|363898208|FG001|Overall Study|Other|0|||
105515624|NCT02068443|363898209|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
105515625|NCT02068443|363898210|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
105515626|NCT02068443|363898211|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
105515627|NCT02068443|363898209|FG000|Overall Study|Voluntary Withdrawal|4|||
105515628|NCT02068443|363898210|FG001|Overall Study|Voluntary Withdrawal|0|||
105515629|NCT02068443|363898211|FG002|Overall Study|Voluntary Withdrawal|1|||
105515630|NCT02068443|363898209|FG000|Overall Study|Lack of Efficacy|2|||
105515631|NCT02068443|363898210|FG001|Overall Study|Lack of Efficacy|1|||
105515632|NCT02068443|363898211|FG002|Overall Study|Lack of Efficacy|0|||
105515633|NCT02068443|363898209|FG000|Overall Study|Other Reason Not Specified|1|||
105515634|NCT02068443|363898210|FG001|Overall Study|Other Reason Not Specified|0|||
105515635|NCT02068443|363898211|FG002|Overall Study|Other Reason Not Specified|0|||
105515636|NCT00664742|363898213|FG000|Overall Study|Withdrawn due to adverse events|3|||
105515637|NCT00664742|363898213|FG000|Overall Study|Withdrawal by Subject|31|||
105515638|NCT00664742|363898213|FG000|Overall Study|Lost to Follow-up|92|||
105515639|NCT02064868|363898216|FG000|Overall Study|Lost to Follow-up|14|||
105515640|NCT02064868|363898217|FG001|Overall Study|Lost to Follow-up|8|||
105515641|NCT02064868|363898216|FG000|Overall Study|Physician Decision|1|||
105515642|NCT02064868|363898217|FG001|Overall Study|Physician Decision|0|||
105515643|NCT02064868|363898216|FG000|Overall Study|Withdrawal by Subject|14|||
105515644|NCT02064868|363898217|FG001|Overall Study|Withdrawal by Subject|3|||
105515645|NCT02064868|363898216|FG000|Overall Study|Technical Problems or Missing|5|||
105515646|NCT02064868|363898217|FG001|Overall Study|Technical Problems or Missing|2|||
105515647|NCT03182829|363898218|FG000|Overall Study|Protocol Violation|12|||
105515648|NCT03182829|363898219|FG001|Overall Study|Protocol Violation|12|||
105515649|NCT03182829|363898218|FG000|Overall Study|Other|4|||
105515650|NCT03182829|363898219|FG001|Overall Study|Other|3|||
105515651|NCT02041286|363898224|FG000|Overall Study|Adverse Event|1|||
105515652|NCT00386776|363898225|FG000|Overall Study|Withdrawal by Subject|8|||
105515653|NCT02282020|363898226|FG000|Overall Study|Objective Disease Progression|128|||
105515654|NCT02282020|363898227|FG001|Overall Study|Objective Disease Progression|30|||
105515655|NCT02282020|363898226|FG000|Overall Study|Adverse Event|18|||
105515656|NCT02282020|363898227|FG001|Overall Study|Adverse Event|15|||
105515657|NCT02282020|363898226|FG000|Overall Study|Withdrawal by Subject|7|||
105515658|NCT02282020|363898227|FG001|Overall Study|Withdrawal by Subject|10|||
105515659|NCT02282020|363898226|FG000|Overall Study|Miscellaneous|5|||
105515660|NCT02282020|363898227|FG001|Overall Study|Miscellaneous|19|||
105515661|NCT02282020|363898226|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
105515662|NCT02282020|363898227|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
105515663|NCT02282020|363898226|FG000|Overall Study|Developed Discontinuation Criteria|0|||
105515664|NCT02282020|363898227|FG001|Overall Study|Developed Discontinuation Criteria|2|||
105515665|NCT02282020|363898226|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
105515666|NCT02282020|363898227|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
105515667|NCT01500629|363898228|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
105515668|NCT01500629|363898229|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
105515669|NCT00588848|363898230|FG000|Overall Study|Physician Decision|0|||
105515670|NCT00588848|363898231|FG001|Overall Study|Physician Decision|3|||
105515671|NCT02902965|363898232|FG000|Overall Study|Withdrawal by Subject|10|||
105515672|NCT03138889|363898233|FG000|Overall Study|Withdrawal by Subject|5|||
105515673|NCT03138889|363898234|FG001|Overall Study|Withdrawal by Subject|5|||
105515674|NCT03138889|363898235|FG002|Overall Study|Withdrawal by Subject|0|||
105515675|NCT03138889|363898236|FG003|Overall Study|Withdrawal by Subject|2|||
105592140|NCT00906698|364169307|FG004|Overall Study|Adverse Event|4|||
105592141|NCT00906698|364169308|FG005|Overall Study|Adverse Event|1|||
105592142|NCT00906698|364169303|FG000|Overall Study|Disease progression|3|||
105515676|NCT03138889|363898237|FG004|Overall Study|Withdrawal by Subject|1|||
105515677|NCT03138889|363898238|FG005|Overall Study|Withdrawal by Subject|3|||
105515678|NCT03138889|363898239|FG006|Overall Study|Withdrawal by Subject|0|||
105515679|NCT03138889|363898240|FG007|Overall Study|Withdrawal by Subject|1|||
105515680|NCT01963403|363898241|FG000|Overall Study|Lost to Follow-up|2|||
105515681|NCT01963403|363898242|FG001|Overall Study|Lost to Follow-up|3|||
105515682|NCT01963403|363898241|FG000|Overall Study|Implant removal|0|||
105515683|NCT01963403|363898242|FG001|Overall Study|Implant removal|1|||
105515684|NCT00589914|363898247|FG000|Overall Study|Adverse Event|19|||
105515685|NCT00589914|363898248|FG001|Overall Study|Adverse Event|10|||
105515686|NCT00589914|363898247|FG000|Overall Study|Death|2|||
105515687|NCT00589914|363898248|FG001|Overall Study|Death|0|||
105515688|NCT00589914|363898247|FG000|Overall Study|Lack of Efficacy|40|||
105515689|NCT00589914|363898248|FG001|Overall Study|Lack of Efficacy|43|||
105515690|NCT00589914|363898247|FG000|Overall Study|Lost to Follow-up|11|||
105515691|NCT00589914|363898248|FG001|Overall Study|Lost to Follow-up|18|||
105515692|NCT00589914|363898247|FG000|Overall Study|Pregnancy|1|||
105515693|NCT00589914|363898248|FG001|Overall Study|Pregnancy|0|||
105515694|NCT00589914|363898247|FG000|Overall Study|Withdrawal by Subject|55|||
105515695|NCT00589914|363898248|FG001|Overall Study|Withdrawal by Subject|49|||
105515696|NCT00589914|363898247|FG000|Overall Study|Other|22|||
105515697|NCT00589914|363898248|FG001|Overall Study|Other|17|||
105515698|NCT00531050|363898249|FG000|Part 1: Period 1|Adverse Event|0|||
105515699|NCT00531050|363898250|FG001|Part 1: Period 1|Adverse Event|1|||
105515700|NCT00531050|363898251|FG002|Part 1: Period 1|Adverse Event|0|||
105515701|NCT00531050|363898252|FG003|Part 1: Period 1|Adverse Event|0|||
105515702|NCT00531050|363898253|FG004|Part 1: Period 1|Adverse Event|0|||
105515703|NCT00531050|363898254|FG005|Part 1: Period 1|Adverse Event|0|||
105515704|NCT00531050|363898249|FG000|Part 1: Period 1|Protocol Deviation|0|||
105515705|NCT00531050|363898250|FG001|Part 1: Period 1|Protocol Deviation|0|||
105515706|NCT00531050|363898251|FG002|Part 1: Period 1|Protocol Deviation|0|||
105515707|NCT00531050|363898252|FG003|Part 1: Period 1|Protocol Deviation|1|||
105515708|NCT00531050|363898253|FG004|Part 1: Period 1|Protocol Deviation|0|||
105515709|NCT00531050|363898254|FG005|Part 1: Period 1|Protocol Deviation|0|||
105515710|NCT00531050|363898249|FG000|Part 1: Period 3|Adverse Event|1|||
105515711|NCT00531050|363898250|FG001|Part 1: Period 3|Adverse Event|0|||
105515712|NCT00531050|363898251|FG002|Part 1: Period 3|Adverse Event|0|||
105515713|NCT00531050|363898252|FG003|Part 1: Period 3|Adverse Event|0|||
105515714|NCT00531050|363898253|FG004|Part 1: Period 3|Adverse Event|0|||
105515715|NCT00531050|363898254|FG005|Part 1: Period 3|Adverse Event|0|||
105515716|NCT00531050|363898249|FG000|Part 2: Period 1|Adverse Event|0|||
105515717|NCT00531050|363898250|FG001|Part 2: Period 1|Adverse Event|0|||
105515718|NCT00531050|363898251|FG002|Part 2: Period 1|Adverse Event|0|||
105515719|NCT00531050|363898252|FG003|Part 2: Period 1|Adverse Event|0|||
105515720|NCT00531050|363898253|FG004|Part 2: Period 1|Adverse Event|0|||
105515721|NCT00531050|363898254|FG005|Part 2: Period 1|Adverse Event|1|||
105515722|NCT00531050|363898249|FG000|Part 2: Period 3|Abnormal test procedure|1|||
105515723|NCT00531050|363898250|FG001|Part 2: Period 3|Abnormal test procedure|0|||
105515724|NCT00531050|363898251|FG002|Part 2: Period 3|Abnormal test procedure|0|||
105515725|NCT00531050|363898252|FG003|Part 2: Period 3|Abnormal test procedure|0|||
105515726|NCT00531050|363898253|FG004|Part 2: Period 3|Abnormal test procedure|0|||
105515727|NCT00531050|363898254|FG005|Part 2: Period 3|Abnormal test procedure|1|||
105515728|NCT02233309|363898256|FG000|Overall Study|Physician Decision|5|||
105515729|NCT00232817|363898264|FG000|Overall Study|Protocol Violation|2|||
105515730|NCT00232817|363898265|FG001|Overall Study|Protocol Violation|1|||
105515731|NCT04481750|363898266|FG000|Period 1 (Fasted)|Adverse Event|0|||
105592143|NCT00906698|364169304|FG001|Overall Study|Disease progression|12|||
105515732|NCT04481750|363898267|FG001|Period 1 (Fasted)|Adverse Event|0|||
105515733|NCT04481750|363898268|FG002|Period 1 (Fasted)|Adverse Event|1|||
105515734|NCT04481750|363898269|FG003|Period 1 (Fasted)|Adverse Event|0|||
105515735|NCT04481750|363898270|FG004|Period 1 (Fasted)|Adverse Event|0|||
105515736|NCT04481750|363898271|FG005|Period 1 (Fasted)|Adverse Event|0|||
105515737|NCT04481750|363898272|FG006|Period 1 (Fasted)|Adverse Event|0|||
105592144|NCT00906698|364169305|FG002|Overall Study|Disease progression|4|||
105592145|NCT00906698|364169306|FG003|Overall Study|Disease progression|4|||
105515738|NCT04481750|363898273|FG007|Period 1 (Fasted)|Adverse Event|0|||
105515739|NCT04481750|363898274|FG008|Period 1 (Fasted)|Adverse Event|0|||
105515740|NCT04481750|363898275|FG009|Period 1 (Fasted)|Adverse Event|0|||
105515741|NCT04481750|363898276|FG010|Period 1 (Fasted)|Adverse Event|0|||
105515742|NCT00475176|363898277|FG000|Overall Study|Adverse Event|2|||
105515743|NCT00475176|363898277|FG000|Overall Study|Withdrawal by Subject|1|||
105515744|NCT00475176|363898277|FG000|Overall Study|Protocol Violation|1|||
105515745|NCT01585428|363898278|FG000|Overall Study|Death during treatment|1|||
105515746|NCT01585428|363898279|FG001|Overall Study|Death during treatment|0|||
105515747|NCT02436889|363898280|FG000|Overall Study|No improvement in symptoms|1|||
105515748|NCT02436889|363898281|FG001|Overall Study|No improvement in symptoms|0|||
105515749|NCT02436889|363898280|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
105515750|NCT02436889|363898281|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
105515751|NCT02169739|363898282|FG000|Overall Study|Lost to Follow-up|0|||
105515752|NCT02169739|363898283|FG001|Overall Study|Lost to Follow-up|4|||
105515753|NCT01484873|363898284|FG000|Overall Study|Withdrawal by Subject|2|||
105515754|NCT00100815|363898285|FG000|Overall Study|Progression|24|||
105515755|NCT00100815|363898285|FG000|Overall Study|Adverse Event|18|||
105515756|NCT00100815|363898285|FG000|Overall Study|Death|4|||
105515757|NCT00100815|363898285|FG000|Overall Study|Other|3|||
105515758|NCT02564042|363898286|FG000|Overall Study|Adverse Event|4|||
105515759|NCT02564042|363898287|FG001|Overall Study|Adverse Event|4|||
105515760|NCT02564042|363898288|FG002|Overall Study|Adverse Event|3|||
105515761|NCT02564042|363898289|FG003|Overall Study|Adverse Event|0|||
105515762|NCT02564042|363898290|FG004|Overall Study|Adverse Event|0|||
105515763|NCT02564042|363898291|FG005|Overall Study|Adverse Event|1|||
105515764|NCT02564042|363898286|FG000|Overall Study|Lost to Follow-up|1|||
105515765|NCT02564042|363898287|FG001|Overall Study|Lost to Follow-up|1|||
105515766|NCT02564042|363898288|FG002|Overall Study|Lost to Follow-up|1|||
105515767|NCT02564042|363898289|FG003|Overall Study|Lost to Follow-up|0|||
105515768|NCT02564042|363898290|FG004|Overall Study|Lost to Follow-up|1|||
105515769|NCT02564042|363898291|FG005|Overall Study|Lost to Follow-up|1|||
105515770|NCT02564042|363898286|FG000|Overall Study|Physician Decision|1|||
105515771|NCT02564042|363898287|FG001|Overall Study|Physician Decision|0|||
105515772|NCT02564042|363898288|FG002|Overall Study|Physician Decision|0|||
105515773|NCT02564042|363898289|FG003|Overall Study|Physician Decision|1|||
105515774|NCT02564042|363898290|FG004|Overall Study|Physician Decision|0|||
105515775|NCT02564042|363898291|FG005|Overall Study|Physician Decision|0|||
105515776|NCT02564042|363898286|FG000|Overall Study|Withdrawal by Subject|5|||
105515777|NCT02564042|363898287|FG001|Overall Study|Withdrawal by Subject|3|||
105515778|NCT02564042|363898288|FG002|Overall Study|Withdrawal by Subject|2|||
105515779|NCT02564042|363898289|FG003|Overall Study|Withdrawal by Subject|2|||
105515780|NCT02564042|363898290|FG004|Overall Study|Withdrawal by Subject|10|||
105515781|NCT02564042|363898291|FG005|Overall Study|Withdrawal by Subject|12|||
105515782|NCT01549392|363898293|FG000|Overall Study|Withdrawal by Subject|1|||
105515783|NCT01549392|363898294|FG001|Overall Study|Withdrawal by Subject|0|||
105515784|NCT02743806|363898295|FG000|Overall Study|Adverse Event|9|||
105515785|NCT02743806|363898295|FG000|Overall Study|Lost to Follow-up|8|||
105515786|NCT02743806|363898295|FG000|Overall Study|Voluntary Withdrawal|54|||
105515787|NCT02743806|363898295|FG000|Overall Study|Study Termination|65|||
105515788|NCT02743806|363898295|FG000|Overall Study|Pregnancy|6|||
105515789|NCT02743806|363898295|FG000|Overall Study|No Longer Clinically Benefiting|27|||
105515790|NCT02743806|363898295|FG000|Overall Study|Reason Not Specified|12|||
105515791|NCT01475331|363898297|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
105515792|NCT01475331|363898298|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
105515793|NCT01475331|363898297|FG000|Overall Study|excessive main duct communication|1|||
105515794|NCT01475331|363898298|FG001|Overall Study|excessive main duct communication|1|||
105515795|NCT01475331|363898297|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
105515796|NCT01475331|363898298|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
105515797|NCT01475331|363898297|FG000|Overall Study|Sign of malignancy during the procedure|2|||
105515798|NCT01475331|363898298|FG001|Overall Study|Sign of malignancy during the procedure|0|||
105515799|NCT01475331|363898297|FG000|Overall Study|cyst found to be prohibitively small|0|||
105515800|NCT01475331|363898298|FG001|Overall Study|cyst found to be prohibitively small|1|||
105515801|NCT01525550|363898299|FG000|Overall Study|Lost to Follow-up|8|||
105515802|NCT01525550|363898300|FG001|Overall Study|Lost to Follow-up|2|||
105515803|NCT01525550|363898299|FG000|Overall Study|Death|19|||
105515804|NCT01525550|363898300|FG001|Overall Study|Death|28|||
105515805|NCT01525550|363898299|FG000|Overall Study|Other|0|||
105515806|NCT01525550|363898300|FG001|Overall Study|Other|4|||
105515807|NCT01525550|363898299|FG000|Overall Study|Sponsor's Decision|30|||
105515808|NCT01525550|363898300|FG001|Overall Study|Sponsor's Decision|11|||
105515809|NCT01525550|363898299|FG000|Overall Study|Withdrawal by Subject|4|||
105515810|NCT01525550|363898300|FG001|Overall Study|Withdrawal by Subject|0|||
105515811|NCT01988103|363898302|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
105515812|NCT01988103|363898303|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
105515813|NCT01988103|363898304|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
105515814|NCT01988103|363898305|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
105515815|NCT01988103|363898306|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
105515816|NCT01988103|363898302|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
105515817|NCT01988103|363898303|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
105515818|NCT01988103|363898304|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
105515819|NCT01988103|363898305|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
105515820|NCT01988103|363898306|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
105515821|NCT01988103|363898302|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
105515822|NCT01988103|363898303|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
105515823|NCT01988103|363898304|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
105515824|NCT01988103|363898305|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
105515825|NCT01988103|363898306|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
105515826|NCT01988103|363898302|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
105515827|NCT01988103|363898303|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
105515828|NCT01988103|363898304|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
105515829|NCT01988103|363898305|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
105515830|NCT01988103|363898306|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
105515831|NCT01988103|363898302|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
105515832|NCT01988103|363898303|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
105515833|NCT01988103|363898304|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
105515834|NCT01988103|363898305|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
105515835|NCT01988103|363898306|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
105515836|NCT01988103|363898302|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
105515837|NCT01988103|363898303|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
105515838|NCT01988103|363898304|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
105515839|NCT01988103|363898305|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
105515840|NCT01988103|363898306|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
105515841|NCT01988103|363898302|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
105515842|NCT01988103|363898303|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
105515843|NCT01988103|363898304|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
105515844|NCT01988103|363898305|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
105515845|NCT01988103|363898306|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
105515846|NCT02289898|363898310|FG000|Overall Study|Death|5|||
105515847|NCT02289898|363898311|FG001|Overall Study|Death|4|||
105515848|NCT02289898|363898312|FG002|Overall Study|Death|3|||
105515849|NCT02289898|363898310|FG000|Overall Study|Physician Decision|2|||
105515850|NCT02289898|363898311|FG001|Overall Study|Physician Decision|5|||
105515851|NCT02289898|363898312|FG002|Overall Study|Physician Decision|2|||
105515852|NCT02289898|363898310|FG000|Overall Study|Withdrawal by Subject|0|||
105515853|NCT02289898|363898311|FG001|Overall Study|Withdrawal by Subject|4|||
105515854|NCT02289898|363898312|FG002|Overall Study|Withdrawal by Subject|1|||
105515855|NCT02289898|363898310|FG000|Overall Study|Adverse Event|3|||
105515856|NCT02289898|363898311|FG001|Overall Study|Adverse Event|5|||
105515857|NCT02289898|363898312|FG002|Overall Study|Adverse Event|5|||
105515858|NCT02289898|363898310|FG000|Overall Study|Disease progression|34|||
105515859|NCT02289898|363898311|FG001|Overall Study|Disease progression|28|||
105515860|NCT02289898|363898312|FG002|Overall Study|Disease progression|34|||
105515861|NCT02289898|363898310|FG000|Overall Study|Use of another anticancer therapy|0|||
105515862|NCT02289898|363898311|FG001|Overall Study|Use of another anticancer therapy|0|||
105515863|NCT02289898|363898312|FG002|Overall Study|Use of another anticancer therapy|1|||
105515864|NCT02289898|363898310|FG000|Overall Study|Other|8|||
105515865|NCT02289898|363898311|FG001|Overall Study|Other|7|||
105515866|NCT02289898|363898312|FG002|Overall Study|Other|10|||
105515867|NCT00644995|363898313|FG000|Overall Study|Lost to Follow-up|1|||
105515868|NCT00644995|363898314|FG001|Overall Study|Lost to Follow-up|4|||
105515869|NCT00644995|363898313|FG000|Overall Study|Refused|1|||
105515870|NCT00644995|363898314|FG001|Overall Study|Refused|0|||
105515871|NCT01601626|363898315|FG000|Overall Study|Death|1|||
105515872|NCT01601626|363898316|FG001|Overall Study|Death|1|||
105515873|NCT01601626|363898317|FG002|Overall Study|Death|1|||
105515874|NCT01601626|363898315|FG000|Overall Study|Lost to Follow-up|1|||
105515875|NCT01601626|363898316|FG001|Overall Study|Lost to Follow-up|2|||
105515876|NCT01601626|363898317|FG002|Overall Study|Lost to Follow-up|0|||
105515877|NCT01601626|363898315|FG000|Overall Study|Unable to Get to Clinic|0|||
105515878|NCT01601626|363898316|FG001|Overall Study|Unable to Get to Clinic|1|||
105515879|NCT01601626|363898317|FG002|Overall Study|Unable to Get to Clinic|0|||
105515880|NCT01601626|363898315|FG000|Overall Study|Withdrawal by Subject|0|||
105515881|NCT01601626|363898316|FG001|Overall Study|Withdrawal by Subject|1|||
105515882|NCT01601626|363898317|FG002|Overall Study|Withdrawal by Subject|1|||
105515883|NCT01601626|363898315|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
105515884|NCT01601626|363898316|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
105515885|NCT01601626|363898317|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
105515886|NCT02598076|363898318|FG000|Overall Study|Lost to Follow-up|2|||
105515887|NCT02598076|363898319|FG001|Overall Study|Lost to Follow-up|3|||
105515888|NCT01291173|363898320|FG000|Overall Study|Adverse Event|0|||
105515889|NCT01291173|363898321|FG001|Overall Study|Adverse Event|3|||
105515890|NCT01291173|363898322|FG002|Overall Study|Adverse Event|1|||
105515891|NCT01291173|363898323|FG003|Overall Study|Adverse Event|3|||
105515892|NCT01291173|363898320|FG000|Overall Study|Protocol Violation|7|||
105515893|NCT01291173|363898321|FG001|Overall Study|Protocol Violation|2|||
105515894|NCT01291173|363898322|FG002|Overall Study|Protocol Violation|2|||
105515895|NCT01291173|363898323|FG003|Overall Study|Protocol Violation|5|||
105515896|NCT01291173|363898320|FG000|Overall Study|Withdrawal by Subject|6|||
105515897|NCT01291173|363898321|FG001|Overall Study|Withdrawal by Subject|4|||
105515898|NCT01291173|363898322|FG002|Overall Study|Withdrawal by Subject|4|||
105515899|NCT01291173|363898323|FG003|Overall Study|Withdrawal by Subject|2|||
105515900|NCT01291173|363898320|FG000|Overall Study|Lost to Follow-up|4|||
105515901|NCT01291173|363898321|FG001|Overall Study|Lost to Follow-up|6|||
105515902|NCT01291173|363898322|FG002|Overall Study|Lost to Follow-up|3|||
105515903|NCT01291173|363898323|FG003|Overall Study|Lost to Follow-up|2|||
105515904|NCT01291173|363898320|FG000|Overall Study|Unable to meet visit schedule|0|||
105515905|NCT01291173|363898321|FG001|Overall Study|Unable to meet visit schedule|0|||
105515906|NCT01291173|363898322|FG002|Overall Study|Unable to meet visit schedule|1|||
105515907|NCT01291173|363898323|FG003|Overall Study|Unable to meet visit schedule|0|||
105515908|NCT01291173|363898320|FG000|Overall Study|Lack of compliance|0|||
105515909|NCT01291173|363898321|FG001|Overall Study|Lack of compliance|0|||
105515910|NCT01291173|363898322|FG002|Overall Study|Lack of compliance|0|||
105515911|NCT01291173|363898323|FG003|Overall Study|Lack of compliance|1|||
105515912|NCT01291173|363898320|FG000|Overall Study|Subject was unblinded|0|||
105515913|NCT01291173|363898321|FG001|Overall Study|Subject was unblinded|0|||
105515914|NCT01291173|363898322|FG002|Overall Study|Subject was unblinded|1|||
105515915|NCT01291173|363898323|FG003|Overall Study|Subject was unblinded|0|||
105515916|NCT01291173|363898320|FG000|Overall Study|Excluded therapy|0|||
105515917|NCT01291173|363898321|FG001|Overall Study|Excluded therapy|0|||
105515918|NCT01291173|363898322|FG002|Overall Study|Excluded therapy|1|||
105515919|NCT01291173|363898323|FG003|Overall Study|Excluded therapy|0|||
105515920|NCT00390858|363898326|FG000|Overall Study|Adverse Event|6|||
105515921|NCT00390858|363898327|FG001|Overall Study|Adverse Event|2|||
105515922|NCT00390858|363898326|FG000|Overall Study|Lack of Efficacy|0|||
105515923|NCT00390858|363898327|FG001|Overall Study|Lack of Efficacy|1|||
105515924|NCT00390858|363898326|FG000|Overall Study|Withdrawal by Subject|3|||
105515925|NCT00390858|363898327|FG001|Overall Study|Withdrawal by Subject|4|||
105515926|NCT00142584|363898328|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
105515927|NCT00142584|363898329|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
105515928|NCT00142584|363898328|FG000|Overall Study|Withdrawal by Subject|30|||
105515929|NCT00142584|363898329|FG001|Overall Study|Withdrawal by Subject|16|||
105515930|NCT00142584|363898328|FG000|Overall Study|Lost to Follow-up|22|||
105515931|NCT00142584|363898329|FG001|Overall Study|Lost to Follow-up|12|||
105515932|NCT00142584|363898328|FG000|Overall Study|Adverse Event|14|||
105515933|NCT00142584|363898329|FG001|Overall Study|Adverse Event|5|||
105515934|NCT00142584|363898328|FG000|Overall Study|Protocol Violation|4|||
105515935|NCT00142584|363898329|FG001|Overall Study|Protocol Violation|7|||
105515936|NCT00142584|363898328|FG000|Overall Study|Treatment Failure|2|||
105515937|NCT00142584|363898329|FG001|Overall Study|Treatment Failure|0|||
105515938|NCT01074450|363898330|FG000|First Intervention|Emesis in Dosing Interval|0|||
105515939|NCT01074450|363898331|FG001|First Intervention|Emesis in Dosing Interval|2|||
105515940|NCT01074450|363898330|FG000|Second Intervention|Protocol Violation|1|||
105515941|NCT01074450|363898331|FG001|Second Intervention|Protocol Violation|0|||
105515942|NCT01074450|363898330|FG000|Second Intervention|Physician Decision|0|||
105515943|NCT01074450|363898331|FG001|Second Intervention|Physician Decision|1|||
105515944|NCT01949051|363898332|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
105515945|NCT01949051|363898333|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
105515946|NCT01949051|363898334|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
105515947|NCT01949051|363898335|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
105515948|NCT01949051|363898336|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
105515949|NCT01949051|363898337|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
105515950|NCT01949051|363898332|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
105515951|NCT01949051|363898333|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105515952|NCT01949051|363898334|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105515953|NCT01949051|363898335|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105515954|NCT01949051|363898336|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105515955|NCT01949051|363898337|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105515956|NCT01949051|363898332|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
105515957|NCT01949051|363898333|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
105515958|NCT01949051|363898334|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
105515959|NCT01949051|363898335|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
105515960|NCT01949051|363898336|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
105515961|NCT01949051|363898337|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
105515962|NCT01949051|363898332|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
105515963|NCT01949051|363898333|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
105515964|NCT01949051|363898334|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
105515965|NCT01949051|363898335|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
105515966|NCT01949051|363898336|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
105515967|NCT01949051|363898337|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
105515968|NCT01949051|363898332|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
105515969|NCT01949051|363898333|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
105515970|NCT01949051|363898334|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
105515971|NCT01949051|363898335|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
105515972|NCT01949051|363898336|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
105515973|NCT01949051|363898337|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
105515974|NCT02049957|363898338|FG000|Overall Study|Progressive Disease|5|||
105515975|NCT02049957|363898339|FG001|Overall Study|Progressive Disease|4|||
105515976|NCT02049957|363898340|FG002|Overall Study|Progressive Disease|2|||
105515977|NCT02049957|363898341|FG003|Overall Study|Progressive Disease|2|||
105515978|NCT02049957|363898342|FG004|Overall Study|Progressive Disease|6|||
105515979|NCT02049957|363898343|FG005|Overall Study|Progressive Disease|35|||
105515980|NCT02049957|363898344|FG006|Overall Study|Progressive Disease|7|||
105515981|NCT02049957|363898345|FG007|Overall Study|Progressive Disease|26|||
105515982|NCT02049957|363898346|FG008|Overall Study|Progressive Disease|6|||
105515983|NCT02049957|363898338|FG000|Overall Study|Adverse Event|1|||
105515984|NCT02049957|363898339|FG001|Overall Study|Adverse Event|1|||
105515985|NCT02049957|363898340|FG002|Overall Study|Adverse Event|1|||
105515986|NCT02049957|363898341|FG003|Overall Study|Adverse Event|0|||
105515987|NCT02049957|363898342|FG004|Overall Study|Adverse Event|0|||
105515988|NCT02049957|363898343|FG005|Overall Study|Adverse Event|5|||
105515989|NCT02049957|363898344|FG006|Overall Study|Adverse Event|0|||
105515990|NCT02049957|363898345|FG007|Overall Study|Adverse Event|6|||
105515991|NCT02049957|363898346|FG008|Overall Study|Adverse Event|1|||
105515992|NCT02049957|363898338|FG000|Overall Study|Study Terminated by Sponsor|0|||
105515993|NCT02049957|363898339|FG001|Overall Study|Study Terminated by Sponsor|1|||
105515994|NCT02049957|363898340|FG002|Overall Study|Study Terminated by Sponsor|0|||
105515995|NCT02049957|363898341|FG003|Overall Study|Study Terminated by Sponsor|0|||
105515996|NCT02049957|363898342|FG004|Overall Study|Study Terminated by Sponsor|0|||
105515997|NCT02049957|363898343|FG005|Overall Study|Study Terminated by Sponsor|0|||
105515998|NCT02049957|363898344|FG006|Overall Study|Study Terminated by Sponsor|1|||
105515999|NCT02049957|363898345|FG007|Overall Study|Study Terminated by Sponsor|0|||
105516000|NCT02049957|363898346|FG008|Overall Study|Study Terminated by Sponsor|0|||
105516001|NCT02049957|363898338|FG000|Overall Study|Withdrawal by Subject|0|||
105516002|NCT02049957|363898339|FG001|Overall Study|Withdrawal by Subject|0|||
105516003|NCT02049957|363898340|FG002|Overall Study|Withdrawal by Subject|0|||
105516004|NCT02049957|363898341|FG003|Overall Study|Withdrawal by Subject|1|||
105516005|NCT02049957|363898342|FG004|Overall Study|Withdrawal by Subject|0|||
105516006|NCT02049957|363898343|FG005|Overall Study|Withdrawal by Subject|2|||
105516007|NCT02049957|363898344|FG006|Overall Study|Withdrawal by Subject|0|||
105516008|NCT02049957|363898345|FG007|Overall Study|Withdrawal by Subject|3|||
105516009|NCT02049957|363898346|FG008|Overall Study|Withdrawal by Subject|1|||
105516010|NCT02049957|363898338|FG000|Overall Study|Physician Decision|0|||
105516011|NCT02049957|363898339|FG001|Overall Study|Physician Decision|0|||
105516012|NCT02049957|363898340|FG002|Overall Study|Physician Decision|0|||
105516013|NCT02049957|363898341|FG003|Overall Study|Physician Decision|0|||
105516014|NCT02049957|363898342|FG004|Overall Study|Physician Decision|0|||
105516015|NCT02049957|363898343|FG005|Overall Study|Physician Decision|1|||
105516016|NCT02049957|363898344|FG006|Overall Study|Physician Decision|0|||
105516017|NCT02049957|363898345|FG007|Overall Study|Physician Decision|0|||
105516018|NCT02049957|363898346|FG008|Overall Study|Physician Decision|0|||
105516019|NCT00191789|363898347|FG000|Overall Study|Adverse Event|5|||
105516020|NCT00191789|363898347|FG000|Overall Study|Patient: Satisfactory Response|5|||
105516021|NCT00191789|363898347|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
105516022|NCT00191789|363898347|FG000|Overall Study|Withdrawal by Subject|4|||
105516023|NCT00191789|363898347|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
105516024|NCT00191789|363898347|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
105516025|NCT00191789|363898347|FG000|Overall Study|Death - Not Study-Drug Related|1|||
105516026|NCT01414075|363898348|FG000|Overall Study|Adverse Event|1|||
105516027|NCT01414075|363898349|FG001|Overall Study|Adverse Event|0|||
105516028|NCT01414075|363898350|FG002|Overall Study|Adverse Event|1|||
105516029|NCT01414075|363898351|FG003|Overall Study|Adverse Event|0|||
105516030|NCT01414075|363898348|FG000|Overall Study|Death|1|||
105516031|NCT01414075|363898349|FG001|Overall Study|Death|0|||
105516032|NCT01414075|363898350|FG002|Overall Study|Death|0|||
105516033|NCT01414075|363898351|FG003|Overall Study|Death|1|||
105516034|NCT01414075|363898348|FG000|Overall Study|Withdrawal by Subject|0|||
105516035|NCT01414075|363898349|FG001|Overall Study|Withdrawal by Subject|0|||
105516036|NCT01414075|363898350|FG002|Overall Study|Withdrawal by Subject|0|||
105516037|NCT01414075|363898351|FG003|Overall Study|Withdrawal by Subject|1|||
105516038|NCT01414075|363898348|FG000|Overall Study|Other than specified|1|||
105516039|NCT01414075|363898349|FG001|Overall Study|Other than specified|0|||
105516040|NCT01414075|363898350|FG002|Overall Study|Other than specified|1|||
105516041|NCT01414075|363898351|FG003|Overall Study|Other than specified|0|||
105516042|NCT02326025|363898356|FG000|Overall Study|Adverse Event|3|||
105516043|NCT02326025|363898357|FG001|Overall Study|Adverse Event|0|||
105516044|NCT02326025|363898356|FG000|Overall Study|Physician Decision|1|||
105516045|NCT02326025|363898357|FG001|Overall Study|Physician Decision|2|||
105516046|NCT02326025|363898356|FG000|Overall Study|Physician and Participant Decision|1|||
105516047|NCT02326025|363898357|FG001|Overall Study|Physician and Participant Decision|0|||
105516048|NCT02326025|363898356|FG000|Overall Study|Withdrawal by Subject|0|||
105516049|NCT02326025|363898357|FG001|Overall Study|Withdrawal by Subject|2|||
105516050|NCT02326025|363898356|FG000|Overall Study|Protocol Violation|0|||
105516051|NCT02326025|363898357|FG001|Overall Study|Protocol Violation|1|||
105516052|NCT02170051|363898358|FG000|Overall Study|Withdrawal by Subject|10|||
105516053|NCT02170051|363898359|FG001|Overall Study|Withdrawal by Subject|10|||
105516054|NCT02170051|363898358|FG000|Overall Study|Lost to Follow-up|1|||
105516055|NCT02170051|363898359|FG001|Overall Study|Lost to Follow-up|3|||
105516056|NCT00867009|363898367|FG000|Induction Period|Nonserious Adverse Event|5|||
105516057|NCT00867009|363898367|FG000|Induction Period|Serious Adverse Event|10|||
105516058|NCT00867009|363898367|FG000|Induction Period|Death due to serious adverse event|6|||
105516059|NCT00867009|363898367|FG000|Induction Period|Death due to Study Disease|4|||
105516060|NCT00867009|363898367|FG000|Induction Period|Protocol Violation|1|||
105516061|NCT00867009|363898367|FG000|Induction Period|Withdrawal by Subject|8|||
105516062|NCT00867009|363898367|FG000|Induction Period|Physician Decision|3|||
105516063|NCT00867009|363898367|FG000|Induction Period|Progressive Disease (PD)|25|||
105516064|NCT00867009|363898367|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
105516065|NCT00576927|363898368|FG000|Clinical Assessment|Lack of Efficacy|24|||
105516066|NCT00576927|363898368|FG000|Clinical Assessment|Death|1|||
105516067|NCT00576927|363898368|FG000|Clinical Assessment|Withdrawal by Subject|10|||
105516068|NCT00576927|363898368|FG000|Clinical Assessment|Physician Decision|1|||
105516069|NCT00576927|363898368|FG000|Baseline|Physician Decision|9|||
105516070|NCT00576927|363898368|FG000|Baseline|Medication Change by PCP of subject|1|||
105516071|NCT00576927|363898368|FG000|Baseline|Withdrawal by Subject|3|||
105516072|NCT00576927|363898368|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
105516073|NCT00576927|363898368|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
105516074|NCT00576927|363898368|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
105516075|NCT00576927|363898368|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
105516076|NCT00576927|363898368|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
105516077|NCT01850524|363898373|FG000|Overall Study|Lost to Follow-up|5|||
105516078|NCT01850524|363898374|FG001|Overall Study|Lost to Follow-up|10|||
105516079|NCT01850524|363898373|FG000|Overall Study|Withdrawal by Subject|24|||
105516080|NCT01850524|363898374|FG001|Overall Study|Withdrawal by Subject|22|||
105516081|NCT01850524|363898373|FG000|Overall Study|Reason not Specified|142|||
105516082|NCT01850524|363898374|FG001|Overall Study|Reason not Specified|141|||
105516083|NCT03915496|363898377|FG000|Overall Study|Adverse Event|2|||
105516084|NCT03915496|363898378|FG001|Overall Study|Adverse Event|1|||
105516085|NCT03915496|363898379|FG002|Overall Study|Adverse Event|2|||
105516086|NCT02480114|363898380|FG000|Overall Study|Not completing surveys|3|||
105516087|NCT02480114|363898381|FG001|Overall Study|Not completing surveys|2|||
105516088|NCT02480114|363898380|FG000|Overall Study|Withdrawal by Subject|2|||
105516089|NCT02480114|363898381|FG001|Overall Study|Withdrawal by Subject|4|||
105516090|NCT02480114|363898380|FG000|Overall Study|Disease progression|3|||
105516091|NCT02480114|363898381|FG001|Overall Study|Disease progression|0|||
105516092|NCT02480114|363898380|FG000|Overall Study|Improper completion of survey|1|||
105516093|NCT02480114|363898381|FG001|Overall Study|Improper completion of survey|1|||
105516094|NCT02480114|363898380|FG000|Overall Study|Not eligible|0|||
105516095|NCT02480114|363898381|FG001|Overall Study|Not eligible|1|||
105516096|NCT02663674|363898382|FG000|Overall Study|Lost to Follow-up|5|||
105516097|NCT02663674|363898383|FG001|Overall Study|Lost to Follow-up|4|||
105516098|NCT02663674|363898382|FG000|Overall Study|Withdrawal by Subject|1|||
105516099|NCT02663674|363898383|FG001|Overall Study|Withdrawal by Subject|4|||
105516100|NCT02663674|363898382|FG000|Overall Study|Physician Decision|1|||
105516101|NCT02663674|363898383|FG001|Overall Study|Physician Decision|1|||
105516102|NCT02663674|363898382|FG000|Overall Study|Other Event (Health Related)|0|||
105516103|NCT02663674|363898383|FG001|Overall Study|Other Event (Health Related)|1|||
105516104|NCT01031069|363898384|FG000|Overall Study|Serious Adverse Event|0|||
105516105|NCT01031069|363898385|FG001|Overall Study|Serious Adverse Event|1|||
105516106|NCT01031069|363898386|FG002|Overall Study|Serious Adverse Event|0|||
105516107|NCT01031069|363898387|FG003|Overall Study|Serious Adverse Event|0|||
105516108|NCT01031069|363898384|FG000|Overall Study|Withdrawal by Subject|2|||
105516109|NCT01031069|363898385|FG001|Overall Study|Withdrawal by Subject|3|||
105516110|NCT01031069|363898386|FG002|Overall Study|Withdrawal by Subject|18|||
105516111|NCT01031069|363898387|FG003|Overall Study|Withdrawal by Subject|18|||
105516112|NCT01031069|363898384|FG000|Overall Study|Migrated/moved from study area|1|||
105516113|NCT01031069|363898385|FG001|Overall Study|Migrated/moved from study area|2|||
105516114|NCT01031069|363898386|FG002|Overall Study|Migrated/moved from study area|1|||
105516115|NCT01031069|363898387|FG003|Overall Study|Migrated/moved from study area|1|||
105516116|NCT01031069|363898384|FG000|Overall Study|Lost to Follow-up|9|||
105516117|NCT01031069|363898385|FG001|Overall Study|Lost to Follow-up|5|||
105516118|NCT01031069|363898386|FG002|Overall Study|Lost to Follow-up|21|||
105516119|NCT01031069|363898387|FG003|Overall Study|Lost to Follow-up|15|||
105516120|NCT01031069|363898384|FG000|Overall Study|Other|0|||
105516121|NCT01031069|363898385|FG001|Overall Study|Other|0|||
105516122|NCT01031069|363898386|FG002|Overall Study|Other|1|||
105516123|NCT01031069|363898387|FG003|Overall Study|Other|0|||
105516124|NCT00477971|363898388|FG000|Overall Study|Disease progression|6|||
105516125|NCT00477971|363898389|FG001|Overall Study|Disease progression|0|||
105516126|NCT00477971|363898388|FG000|Overall Study|Withdrawal by Subject|3|||
105516127|NCT00477971|363898389|FG001|Overall Study|Withdrawal by Subject|1|||
105516128|NCT00477971|363898388|FG000|Overall Study|Adverse Event|3|||
105516129|NCT00477971|363898389|FG001|Overall Study|Adverse Event|0|||
105516130|NCT00477971|363898388|FG000|Overall Study|Death|2|||
105516131|NCT00477971|363898389|FG001|Overall Study|Death|4|||
105516132|NCT00477971|363898388|FG000|Overall Study|Alternative treatment|3|||
105516133|NCT00477971|363898389|FG001|Overall Study|Alternative treatment|1|||
105516134|NCT01404325|363900052|FG000|Overall Study|Lost to Follow-up|1|||
105516135|NCT01404325|363900053|FG001|Overall Study|Lost to Follow-up|0|||
105516136|NCT01404325|363900052|FG000|Overall Study|Death|2|||
105516137|NCT01404325|363900053|FG001|Overall Study|Death|0|||
105516138|NCT01404325|363900052|FG000|Overall Study|Graft loss/Retransplantation|1|||
105516139|NCT01404325|363900053|FG001|Overall Study|Graft loss/Retransplantation|0|||
105516140|NCT01404325|363900052|FG000|Overall Study|non-specified reason|0|||
105516141|NCT01404325|363900053|FG001|Overall Study|non-specified reason|2|||
105516142|NCT02141282|363900057|FG000|Overall Study|Adverse event, not related to progression|8|||
105516143|NCT02141282|363900058|FG001|Overall Study|Adverse event, not related to progression|1|||
105516144|NCT02141282|363900059|FG002|Overall Study|Adverse event, not related to progression|3|||
105516145|NCT02141282|363900060|FG003|Overall Study|Adverse event, not related to progression|1|||
105516146|NCT02141282|363900057|FG000|Overall Study|Adverse event, related to progression|1|||
105516147|NCT02141282|363900058|FG001|Overall Study|Adverse event, related to progression|0|||
105516148|NCT02141282|363900059|FG002|Overall Study|Adverse event, related to progression|2|||
105516149|NCT02141282|363900060|FG003|Overall Study|Adverse event, related to progression|0|||
105516150|NCT02141282|363900057|FG000|Overall Study|COVID-19 infection|1|||
105516151|NCT02141282|363900058|FG001|Overall Study|COVID-19 infection|0|||
105516152|NCT02141282|363900059|FG002|Overall Study|COVID-19 infection|0|||
105516153|NCT02141282|363900060|FG003|Overall Study|COVID-19 infection|0|||
105516154|NCT02141282|363900057|FG000|Overall Study|Lost to Follow-up|0|||
105516155|NCT02141282|363900058|FG001|Overall Study|Lost to Follow-up|0|||
105516156|NCT02141282|363900059|FG002|Overall Study|Lost to Follow-up|4|||
105516157|NCT02141282|363900060|FG003|Overall Study|Lost to Follow-up|2|||
105516158|NCT02141282|363900057|FG000|Overall Study|Other, not specified|14|||
105516159|NCT02141282|363900058|FG001|Overall Study|Other, not specified|11|||
105516160|NCT02141282|363900059|FG002|Overall Study|Other, not specified|23|||
105516161|NCT02141282|363900060|FG003|Overall Study|Other, not specified|9|||
105516162|NCT02141282|363900057|FG000|Overall Study|Progressive disease, Richter's|4|||
105516163|NCT02141282|363900058|FG001|Overall Study|Progressive disease, Richter's|1|||
105516164|NCT02141282|363900059|FG002|Overall Study|Progressive disease, Richter's|1|||
105516165|NCT02141282|363900060|FG003|Overall Study|Progressive disease, Richter's|1|||
105516166|NCT02141282|363900057|FG000|Overall Study|Progressive disease per protocol|12|||
105516167|NCT02141282|363900058|FG001|Overall Study|Progressive disease per protocol|7|||
105516168|NCT02141282|363900059|FG002|Overall Study|Progressive disease per protocol|9|||
105516169|NCT02141282|363900060|FG003|Overall Study|Progressive disease per protocol|2|||
105516170|NCT02141282|363900057|FG000|Overall Study|Stem cell transplant|1|||
105516171|NCT02141282|363900058|FG001|Overall Study|Stem cell transplant|0|||
105516172|NCT02141282|363900059|FG002|Overall Study|Stem cell transplant|1|||
105516173|NCT02141282|363900060|FG003|Overall Study|Stem cell transplant|0|||
105516174|NCT02141282|363900057|FG000|Overall Study|Study terminated by Sponsor|0|||
105516175|NCT02141282|363900058|FG001|Overall Study|Study terminated by Sponsor|1|||
105516176|NCT02141282|363900059|FG002|Overall Study|Study terminated by Sponsor|0|||
105516177|NCT02141282|363900060|FG003|Overall Study|Study terminated by Sponsor|0|||
105516178|NCT02141282|363900057|FG000|Overall Study|Subject non-compliance|0|||
105516179|NCT02141282|363900058|FG001|Overall Study|Subject non-compliance|0|||
105516180|NCT02141282|363900059|FG002|Overall Study|Subject non-compliance|1|||
105516181|NCT02141282|363900060|FG003|Overall Study|Subject non-compliance|0|||
105516182|NCT02141282|363900057|FG000|Overall Study|Withdrew consent|2|||
105516183|NCT02141282|363900058|FG001|Overall Study|Withdrew consent|0|||
105592146|NCT00906698|364169307|FG004|Overall Study|Disease progression|12|||
105516184|NCT02141282|363900059|FG002|Overall Study|Withdrew consent|4|||
105516185|NCT02141282|363900060|FG003|Overall Study|Withdrew consent|0|||
105592147|NCT00906698|364169308|FG005|Overall Study|Disease progression|4|||
105516186|NCT01986855|363900061|FG000|Overall Study|Adverse Event|1|||
105516187|NCT01986855|363900062|FG001|Overall Study|Adverse Event|0|||
105516188|NCT01986855|363900063|FG002|Overall Study|Adverse Event|0|||
105516189|NCT01986855|363900061|FG000|Overall Study|Death|3|||
105516190|NCT01986855|363900062|FG001|Overall Study|Death|4|||
105516191|NCT01986855|363900063|FG002|Overall Study|Death|4|||
105516192|NCT01986855|363900061|FG000|Overall Study|Lost to Follow-up|2|||
105516193|NCT01986855|363900062|FG001|Overall Study|Lost to Follow-up|1|||
105516194|NCT01986855|363900063|FG002|Overall Study|Lost to Follow-up|0|||
105516195|NCT01986855|363900061|FG000|Overall Study|Screen Failure|0|||
105516196|NCT01986855|363900062|FG001|Overall Study|Screen Failure|1|||
105516197|NCT01986855|363900063|FG002|Overall Study|Screen Failure|0|||
105516198|NCT01986855|363900061|FG000|Overall Study|Participant Moved|0|||
105516199|NCT01986855|363900062|FG001|Overall Study|Participant Moved|0|||
105516200|NCT01986855|363900063|FG002|Overall Study|Participant Moved|2|||
105516201|NCT01986855|363900061|FG000|Overall Study|Withdrawal by Subject|7|||
105516202|NCT01986855|363900062|FG001|Overall Study|Withdrawal by Subject|8|||
105516203|NCT01986855|363900063|FG002|Overall Study|Withdrawal by Subject|5|||
105516204|NCT02450903|363900064|FG000|Overall Study|Adverse Event|3|||
105516205|NCT02450903|363900064|FG000|Overall Study|Progressive disease|15|||
105516206|NCT02450903|363900064|FG000|Overall Study|Switched to commercial drug|1|||
105516207|NCT02450903|363900064|FG000|Overall Study|Subject/guardian decision|1|||
105516208|NCT02825992|363900065|FG000|Overall Study|Withdrawal by Subject|4|||
105516209|NCT02825992|363900065|FG000|Overall Study|Lost to Follow-up|2|||
105516210|NCT02825992|363900065|FG000|Overall Study|Procedure terminated|2|||
105516211|NCT04067544|363900069|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
105516212|NCT00418314|363900070|FG000|Overall Study|Withdrawal by Subject|1|||
105516213|NCT00418314|363900071|FG001|Overall Study|Withdrawal by Subject|2|||
105516214|NCT01320085|363900072|FG000|Overall Study|Disease Progression|26|||
105516215|NCT01320085|363900073|FG001|Overall Study|Disease Progression|93|||
105516216|NCT01320085|363900074|FG002|Overall Study|Disease Progression|17|||
105516217|NCT01320085|363900072|FG000|Overall Study|Adverse Event|12|||
105516218|NCT01320085|363900073|FG001|Overall Study|Adverse Event|20|||
105516219|NCT01320085|363900074|FG002|Overall Study|Adverse Event|5|||
105516220|NCT01320085|363900072|FG000|Overall Study|Withdrawal by Subject|2|||
105516221|NCT01320085|363900073|FG001|Overall Study|Withdrawal by Subject|4|||
105516222|NCT01320085|363900074|FG002|Overall Study|Withdrawal by Subject|1|||
105516223|NCT01320085|363900072|FG000|Overall Study|Protocol Deviation|1|||
105516224|NCT01320085|363900073|FG001|Overall Study|Protocol Deviation|0|||
105516225|NCT01320085|363900074|FG002|Overall Study|Protocol Deviation|1|||
105516226|NCT01320085|363900072|FG000|Overall Study|Administrative problems|0|||
105516227|NCT01320085|363900073|FG001|Overall Study|Administrative problems|0|||
105516228|NCT01320085|363900074|FG002|Overall Study|Administrative problems|1|||
105516229|NCT03316131|363900075|FG000|Treatment Period 2|Protocol deviation|1|||
105516230|NCT03316131|363900076|FG001|Treatment Period 2|Protocol deviation|0|||
105516231|NCT01409564|363900077|FG000|Overall Study|low medication compliance|4|||
105516232|NCT01409564|363900078|FG001|Overall Study|low medication compliance|3|||
105516233|NCT01409564|363900077|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
105516234|NCT01409564|363900078|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
105516235|NCT00710710|363900080|FG000|Overall Study|Consent withdrawn|2|||
105516236|NCT00710710|363900081|FG001|Overall Study|Consent withdrawn|2|||
105516237|NCT00710710|363900080|FG000|Overall Study|Protocol Violation|0|||
105516238|NCT00710710|363900081|FG001|Overall Study|Protocol Violation|1|||
105516239|NCT00710710|363900080|FG000|Overall Study|Adverse Event|3|||
105516240|NCT00710710|363900081|FG001|Overall Study|Adverse Event|3|||
105516241|NCT00710710|363900080|FG000|Overall Study|Progressive disease|40|||
105516242|NCT00710710|363900081|FG001|Overall Study|Progressive disease|38|||
105516243|NCT03045328|363900082|FG000|Overall Study|Withdrawal by Subject|2|||
105516244|NCT00715078|363900085|FG000|Overall Study|Death|29|||
105516245|NCT00715078|363900086|FG001|Overall Study|Death|36|||
105516246|NCT00715078|363900087|FG002|Overall Study|Death|36|||
105516247|NCT00715078|363900085|FG000|Overall Study|Withdrawal by Subject|1|||
105516248|NCT00715078|363900086|FG001|Overall Study|Withdrawal by Subject|0|||
105516249|NCT00715078|363900087|FG002|Overall Study|Withdrawal by Subject|1|||
105516250|NCT00715078|363900085|FG000|Overall Study|Unable to start due to disease prog.|0|||
105516251|NCT00715078|363900086|FG001|Overall Study|Unable to start due to disease prog.|0|||
105516252|NCT00715078|363900087|FG002|Overall Study|Unable to start due to disease prog.|1|||
105516253|NCT02511184|363900088|FG000|Overall Study|Death|1|||
105516254|NCT02511184|363900089|FG001|Overall Study|Death|0|||
105516255|NCT02511184|363900088|FG000|Overall Study|Lost to Follow-up|0|||
105516256|NCT02511184|363900089|FG001|Overall Study|Lost to Follow-up|1|||
105516257|NCT02511184|363900088|FG000|Overall Study|Study terminated by sponsor|1|||
105516258|NCT02511184|363900089|FG001|Overall Study|Study terminated by sponsor|5|||
105516259|NCT02511184|363900088|FG000|Overall Study|Withdrawal by Subject|0|||
105516260|NCT02511184|363900089|FG001|Overall Study|Withdrawal by Subject|1|||
105516261|NCT02904512|363900090|FG000|Overall Study|Withdrawal by Subject|1|||
105516262|NCT02904512|363900091|FG001|Overall Study|Withdrawal by Subject|0|||
105516263|NCT02904512|363900090|FG000|Overall Study|Transferred to ICU|1|||
105516264|NCT02904512|363900091|FG001|Overall Study|Transferred to ICU|0|||
105516265|NCT02904512|363900090|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
105516266|NCT02904512|363900091|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
105516267|NCT00157950|363900092|FG000|Overall Study|Death|1|||
105516268|NCT00157950|363900093|FG001|Overall Study|Death|0|||
105516269|NCT02892760|363900097|FG000|Overall Study|Withdrawal by Subject|3|||
105516270|NCT00293254|363900105|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
105516271|NCT00293254|363900106|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
105516272|NCT00293254|363900105|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
105516273|NCT00293254|363900106|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
105516274|NCT00293254|363900105|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
105516275|NCT00293254|363900106|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
105516276|NCT00293254|363900105|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
105516277|NCT00293254|363900106|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
105516278|NCT00293254|363900105|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
105516279|NCT00293254|363900106|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
105516280|NCT00293254|363900105|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
105516281|NCT00293254|363900106|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
105516282|NCT00293254|363900105|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
105516283|NCT00293254|363900106|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
105516284|NCT00293254|363900105|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
105516285|NCT00293254|363900106|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
105516286|NCT00293254|363900105|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
105516287|NCT00293254|363900106|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
105516288|NCT00293254|363900105|FG000|Extension - Double-Blind Week 49-156|Death|4|||
105516289|NCT00293254|363900106|FG001|Extension - Double-Blind Week 49-156|Death|1|||
105516290|NCT00293254|363900105|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
105516291|NCT00293254|363900106|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
105516292|NCT00293254|363900105|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
105516293|NCT00293254|363900106|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
105516294|NCT00293254|363900105|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
105516295|NCT00293254|363900106|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
105516296|NCT00293254|363900105|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
105516297|NCT00293254|363900106|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
105516298|NCT00293254|363900105|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
105516299|NCT00293254|363900106|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
105516300|NCT00293254|363900105|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
105516301|NCT00293254|363900106|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
105516302|NCT00293254|363900105|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
105516303|NCT00293254|363900106|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
105516304|NCT00293254|363900105|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
105516305|NCT00293254|363900106|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
105516306|NCT00293254|363900105|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
105516307|NCT00293254|363900106|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
105516308|NCT00293254|363900105|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
105516309|NCT00293254|363900106|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
105516310|NCT00293254|363900105|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
105516311|NCT00293254|363900106|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
105516312|NCT00293254|363900105|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
105516313|NCT00293254|363900106|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
105516314|NCT00293254|363900105|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
105516315|NCT00293254|363900106|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
105516316|NCT00293254|363900105|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
105516317|NCT00293254|363900106|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
105516318|NCT00293254|363900105|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
105516319|NCT00293254|363900106|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
105516320|NCT00293254|363900105|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
105516321|NCT00293254|363900106|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
105516322|NCT00293254|363900105|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
105516323|NCT00293254|363900106|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
105516324|NCT01463878|363900107|FG000|Overall Study|no longer met criteria for tube feed|2|||
105516325|NCT01463878|363900108|FG001|Overall Study|no longer met criteria for tube feed|2|||
105516326|NCT01034462|363900109|FG000|Overall Study|Adverse Event|7|||
105516327|NCT01034462|363900110|FG001|Overall Study|Adverse Event|17|||
105516328|NCT01034462|363900109|FG000|Overall Study|Lack of Efficacy|4|||
105516329|NCT01034462|363900110|FG001|Overall Study|Lack of Efficacy|4|||
105516330|NCT01034462|363900109|FG000|Overall Study|Protocol Violation|10|||
105516331|NCT01034462|363900110|FG001|Overall Study|Protocol Violation|7|||
105516332|NCT01034462|363900109|FG000|Overall Study|Withdrawal by Subject|9|||
105516333|NCT01034462|363900110|FG001|Overall Study|Withdrawal by Subject|8|||
105516334|NCT01034462|363900109|FG000|Overall Study|Lost to Follow-up|14|||
105516335|NCT01034462|363900110|FG001|Overall Study|Lost to Follow-up|16|||
105516336|NCT01034462|363900109|FG000|Overall Study|Other reasons|1|||
105516337|NCT01034462|363900110|FG001|Overall Study|Other reasons|2|||
105516338|NCT01594125|363900112|FG000|Overall Study|Withdrawal by Subject|1|||
105592148|NCT00906698|364169303|FG000|Overall Study|Withdrawal by Subject|0|||
105592149|NCT00906698|364169304|FG001|Overall Study|Withdrawal by Subject|0|||
105592150|NCT00906698|364169305|FG002|Overall Study|Withdrawal by Subject|0|||
105592151|NCT00906698|364169306|FG003|Overall Study|Withdrawal by Subject|0|||
105592152|NCT00906698|364169307|FG004|Overall Study|Withdrawal by Subject|1|||
105592153|NCT00906698|364169308|FG005|Overall Study|Withdrawal by Subject|0|||
105592154|NCT00906698|364169303|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
105592155|NCT00906698|364169304|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
105592156|NCT00906698|364169305|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
105592157|NCT00906698|364169306|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
105592158|NCT00906698|364169307|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
105592159|NCT00906698|364169308|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
105592160|NCT01027286|364169309|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
105592161|NCT01027286|364169310|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
105516339|NCT01594125|363900113|FG001|Overall Study|Withdrawal by Subject|0|||
105516340|NCT01594125|363900114|FG002|Overall Study|Withdrawal by Subject|0|||
105516341|NCT01594125|363900115|FG003|Overall Study|Withdrawal by Subject|1|||
105516342|NCT01594125|363900116|FG004|Overall Study|Withdrawal by Subject|0|||
105516343|NCT01594125|363900112|FG000|Overall Study|Progressive Disease|3|||
105516344|NCT01594125|363900113|FG001|Overall Study|Progressive Disease|12|||
105516345|NCT01594125|363900114|FG002|Overall Study|Progressive Disease|3|||
105516346|NCT01594125|363900115|FG003|Overall Study|Progressive Disease|3|||
105516347|NCT01594125|363900116|FG004|Overall Study|Progressive Disease|7|||
105516348|NCT00503009|363900117|FG000|Overall Study|Protocol Violation|1|||
105516349|NCT00503009|363900118|FG001|Overall Study|Protocol Violation|0|||
105516350|NCT00503009|363900119|FG002|Overall Study|Protocol Violation|1|||
105516351|NCT00503009|363900117|FG000|Overall Study|Withdrawal by Subject|0|||
105516352|NCT00503009|363900118|FG001|Overall Study|Withdrawal by Subject|1|||
105516353|NCT00503009|363900119|FG002|Overall Study|Withdrawal by Subject|1|||
105516354|NCT00503009|363900117|FG000|Overall Study|Physician Decision|0|||
105516355|NCT00503009|363900118|FG001|Overall Study|Physician Decision|1|||
105516356|NCT00503009|363900119|FG002|Overall Study|Physician Decision|1|||
105516357|NCT01349803|363900120|FG000|Overall Study|Adverse Event|0|||
105516358|NCT01349803|363900121|FG001|Overall Study|Adverse Event|0|||
105516359|NCT01349803|363900122|FG002|Overall Study|Adverse Event|0|||
105516360|NCT01349803|363900123|FG003|Overall Study|Adverse Event|2|||
105516361|NCT01349803|363900120|FG000|Overall Study|Withdrawal by Subject|1|||
105516362|NCT01349803|363900121|FG001|Overall Study|Withdrawal by Subject|0|||
105516363|NCT01349803|363900122|FG002|Overall Study|Withdrawal by Subject|0|||
105516364|NCT01349803|363900123|FG003|Overall Study|Withdrawal by Subject|0|||
105516365|NCT01349803|363900120|FG000|Overall Study|Protocol-specified criteria|0|||
105516366|NCT01349803|363900121|FG001|Overall Study|Protocol-specified criteria|1|||
105516367|NCT01349803|363900122|FG002|Overall Study|Protocol-specified criteria|3|||
105516368|NCT01349803|363900123|FG003|Overall Study|Protocol-specified criteria|0|||
105516369|NCT01356966|363900124|FG000|Overall Study|Withdrawal by Subject|1|||
105516370|NCT01356966|363900125|FG001|Overall Study|Withdrawal by Subject|2|||
105516371|NCT01356966|363900124|FG000|Overall Study|Physician Decision|1|||
105516372|NCT01356966|363900125|FG001|Overall Study|Physician Decision|0|||
105516373|NCT02289690|363900126|FG000|Overall Study|Adverse Event Related to Progression|0|||
105516374|NCT02289690|363900127|FG001|Overall Study|Adverse Event Related to Progression|1|||
105516375|NCT02289690|363900128|FG002|Overall Study|Adverse Event Related to Progression|1|||
105516376|NCT02289690|363900129|FG003|Overall Study|Adverse Event Related to Progression|0|||
105516377|NCT02289690|363900130|FG004|Overall Study|Adverse Event Related to Progression|1|||
105516378|NCT02289690|363900131|FG005|Overall Study|Adverse Event Related to Progression|0|||
105516379|NCT02289690|363900132|FG006|Overall Study|Adverse Event Related to Progression|1|||
105516380|NCT02289690|363900133|FG007|Overall Study|Adverse Event Related to Progression|0|||
105516381|NCT02289690|363900134|FG008|Overall Study|Adverse Event Related to Progression|0|||
105516382|NCT02289690|363900135|FG009|Overall Study|Adverse Event Related to Progression|0|||
105516383|NCT02289690|363900126|FG000|Overall Study|Withdrawal by Subject|1|||
105516384|NCT02289690|363900127|FG001|Overall Study|Withdrawal by Subject|0|||
105516385|NCT02289690|363900128|FG002|Overall Study|Withdrawal by Subject|0|||
105592162|NCT01027286|364169309|FG000|Overall Study|Lost to Follow-up|0|||
105592163|NCT01027286|364169310|FG001|Overall Study|Lost to Follow-up|1|||
105592164|NCT04044664|364169319|FG000|Stage 1|Adverse Event|3|||
105516386|NCT02289690|363900129|FG003|Overall Study|Withdrawal by Subject|0|||
105592165|NCT04044664|364169320|FG001|Stage 1|Adverse Event|3|||
105592166|NCT04044664|364169321|FG002|Stage 1|Adverse Event|1|||
105592167|NCT04044664|364169319|FG000|Stage 1|Lost to Follow-up|3|||
105592168|NCT04044664|364169320|FG001|Stage 1|Lost to Follow-up|2|||
105592169|NCT04044664|364169321|FG002|Stage 1|Lost to Follow-up|2|||
105516387|NCT02289690|363900130|FG004|Overall Study|Withdrawal by Subject|1|||
105516388|NCT02289690|363900131|FG005|Overall Study|Withdrawal by Subject|1|||
105516389|NCT02289690|363900132|FG006|Overall Study|Withdrawal by Subject|0|||
105516390|NCT02289690|363900133|FG007|Overall Study|Withdrawal by Subject|0|||
105516391|NCT02289690|363900134|FG008|Overall Study|Withdrawal by Subject|4|||
105592170|NCT04044664|364169319|FG000|Stage 1|Withdrawal by Subject|9|||
105592171|NCT04044664|364169320|FG001|Stage 1|Withdrawal by Subject|1|||
105592172|NCT04044664|364169321|FG002|Stage 1|Withdrawal by Subject|0|||
105592173|NCT04044664|364169319|FG000|Stage 1|noncompliance, personal reason|2|||
105592174|NCT04044664|364169320|FG001|Stage 1|noncompliance, personal reason|0|||
105592175|NCT04044664|364169321|FG002|Stage 1|noncompliance, personal reason|0|||
105592176|NCT04044664|364169319|FG000|Stage 1|randomization error|0|||
105592177|NCT04044664|364169320|FG001|Stage 1|randomization error|1|||
105592178|NCT04044664|364169321|FG002|Stage 1|randomization error|0|||
105592179|NCT04044664|364169319|FG000|Stage 2|Adverse Event|2|||
105592180|NCT04044664|364169320|FG001|Stage 2|Adverse Event|0|||
105592181|NCT04044664|364169321|FG002|Stage 2|Adverse Event|0|||
105592182|NCT04044664|364169319|FG000|Stage 2|Lost to Follow-up|3|||
105592183|NCT04044664|364169320|FG001|Stage 2|Lost to Follow-up|2|||
105592184|NCT04044664|364169321|FG002|Stage 2|Lost to Follow-up|1|||
105592185|NCT04044664|364169319|FG000|Stage 2|Withdrawal by Subject|3|||
105592186|NCT04044664|364169320|FG001|Stage 2|Withdrawal by Subject|0|||
105592187|NCT04044664|364169321|FG002|Stage 2|Withdrawal by Subject|0|||
105516392|NCT02289690|363900135|FG009|Overall Study|Withdrawal by Subject|2|||
105516393|NCT02289690|363900126|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
105516394|NCT02289690|363900127|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
105516395|NCT02289690|363900128|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
105516396|NCT02289690|363900129|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
105516397|NCT02289690|363900130|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
105516398|NCT02289690|363900131|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
105516399|NCT02289690|363900132|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
105516400|NCT02289690|363900133|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
105516401|NCT02289690|363900134|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
105516402|NCT02289690|363900135|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
105516403|NCT02289690|363900126|FG000|Overall Study|Lost to Follow-up|0|||
105516404|NCT02289690|363900127|FG001|Overall Study|Lost to Follow-up|0|||
105516405|NCT02289690|363900128|FG002|Overall Study|Lost to Follow-up|0|||
105516406|NCT02289690|363900129|FG003|Overall Study|Lost to Follow-up|0|||
105516407|NCT02289690|363900130|FG004|Overall Study|Lost to Follow-up|0|||
105516408|NCT02289690|363900131|FG005|Overall Study|Lost to Follow-up|0|||
105516409|NCT02289690|363900132|FG006|Overall Study|Lost to Follow-up|0|||
105516410|NCT02289690|363900133|FG007|Overall Study|Lost to Follow-up|1|||
105516411|NCT02289690|363900134|FG008|Overall Study|Lost to Follow-up|0|||
105516412|NCT02289690|363900135|FG009|Overall Study|Lost to Follow-up|2|||
105516413|NCT02289690|363900126|FG000|Overall Study|Death|0|||
105516414|NCT02289690|363900127|FG001|Overall Study|Death|0|||
105516415|NCT02289690|363900128|FG002|Overall Study|Death|0|||
105516416|NCT02289690|363900129|FG003|Overall Study|Death|0|||
105516417|NCT02289690|363900130|FG004|Overall Study|Death|0|||
105516418|NCT02289690|363900131|FG005|Overall Study|Death|0|||
105516419|NCT02289690|363900132|FG006|Overall Study|Death|0|||
105516420|NCT02289690|363900133|FG007|Overall Study|Death|49|||
105516421|NCT02289690|363900134|FG008|Overall Study|Death|45|||
105516422|NCT02289690|363900135|FG009|Overall Study|Death|41|||
105516423|NCT02289690|363900126|FG000|Overall Study|Sponsor Discontinued Study|0|||
105516424|NCT02289690|363900127|FG001|Overall Study|Sponsor Discontinued Study|0|||
105516425|NCT02289690|363900128|FG002|Overall Study|Sponsor Discontinued Study|0|||
105516426|NCT02289690|363900129|FG003|Overall Study|Sponsor Discontinued Study|0|||
105516427|NCT02289690|363900130|FG004|Overall Study|Sponsor Discontinued Study|0|||
105516428|NCT02289690|363900131|FG005|Overall Study|Sponsor Discontinued Study|0|||
105516429|NCT02289690|363900132|FG006|Overall Study|Sponsor Discontinued Study|0|||
105516430|NCT02289690|363900133|FG007|Overall Study|Sponsor Discontinued Study|9|||
105516431|NCT02289690|363900134|FG008|Overall Study|Sponsor Discontinued Study|7|||
105516432|NCT02289690|363900135|FG009|Overall Study|Sponsor Discontinued Study|15|||
105516433|NCT02289690|363900126|FG000|Overall Study|Other|0|||
105516434|NCT02289690|363900127|FG001|Overall Study|Other|0|||
105516435|NCT02289690|363900128|FG002|Overall Study|Other|0|||
105516436|NCT02289690|363900129|FG003|Overall Study|Other|1|||
105516437|NCT02289690|363900130|FG004|Overall Study|Other|1|||
105516438|NCT02289690|363900131|FG005|Overall Study|Other|0|||
105516439|NCT02289690|363900132|FG006|Overall Study|Other|1|||
105516440|NCT02289690|363900133|FG007|Overall Study|Other|2|||
105516441|NCT02289690|363900134|FG008|Overall Study|Other|3|||
105516442|NCT02289690|363900135|FG009|Overall Study|Other|1|||
105516443|NCT02066233|363900141|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
105516444|NCT02066233|363900142|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
105516445|NCT00103142|363900143|FG000|Overall Study|Adverse Event|1|||
105516446|NCT00103142|363900144|FG001|Overall Study|Adverse Event|0|||
105592188|NCT04044664|364169319|FG000|Stage 2|protocol deviation|1|||
105592189|NCT04044664|364169320|FG001|Stage 2|protocol deviation|0|||
105592190|NCT04044664|364169321|FG002|Stage 2|protocol deviation|0|||
105592191|NCT00545844|364169322|FG000|Overall Study|Lost to Follow-up|9|||
105516447|NCT00103142|363900143|FG000|Overall Study|Progression of disease|2|||
105516448|NCT00103142|363900144|FG001|Overall Study|Progression of disease|1|||
105592192|NCT00545844|364169322|FG000|Overall Study|Protocol Violation|1|||
105516449|NCT03227029|363900147|FG000|Overall Study|Child Wheezed (no treatment)|0|||
105516450|NCT03227029|363900148|FG001|Overall Study|Child Wheezed (no treatment)|1|||
105516451|NCT03227029|363900149|FG002|Overall Study|Child Wheezed (no treatment)|0|||
105516452|NCT03227029|363900147|FG000|Overall Study|No post RSV season visit due to COVID|3|||
105516453|NCT03227029|363900148|FG001|Overall Study|No post RSV season visit due to COVID|3|||
105516454|NCT03227029|363900149|FG002|Overall Study|No post RSV season visit due to COVID|2|||
105516455|NCT03227029|363900147|FG000|Overall Study|Not able to get to clinic|0|||
105516456|NCT03227029|363900148|FG001|Overall Study|Not able to get to clinic|0|||
105516457|NCT03227029|363900149|FG002|Overall Study|Not able to get to clinic|1|||
105516458|NCT03227029|363900147|FG000|Overall Study|Withdrawal by Subject|1|||
105516459|NCT03227029|363900148|FG001|Overall Study|Withdrawal by Subject|0|||
105516460|NCT03227029|363900149|FG002|Overall Study|Withdrawal by Subject|0|||
105516461|NCT03227029|363900147|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
105516462|NCT03227029|363900148|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
105516463|NCT03227029|363900149|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
105516464|NCT00558025|363900155|FG000|Overall Study|Adverse Event|1|||
105516465|NCT00558025|363900156|FG001|Overall Study|Adverse Event|1|||
105516466|NCT00558025|363900155|FG000|Overall Study|Withdrawal by Subject|2|||
105516467|NCT00558025|363900156|FG001|Overall Study|Withdrawal by Subject|2|||
105516468|NCT00558025|363900155|FG000|Overall Study|Protocol Violation|1|||
105516469|NCT00558025|363900156|FG001|Overall Study|Protocol Violation|0|||
105516470|NCT01782859|363900157|FG000|Overall Study|Protocol Violation|6|||
105516471|NCT01782859|363900158|FG001|Overall Study|Protocol Violation|6|||
105516472|NCT01782859|363900157|FG000|Overall Study|Withdrawal by Subject|0|||
105516473|NCT01782859|363900158|FG001|Overall Study|Withdrawal by Subject|1|||
105516474|NCT01957553|363900159|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
105516475|NCT01957553|363900160|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
105516476|NCT01957553|363900159|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
105516477|NCT01957553|363900160|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
105516478|NCT01957553|363900159|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
105516479|NCT01957553|363900160|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
105516480|NCT01957553|363900159|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
105516481|NCT01957553|363900160|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
105516482|NCT01957553|363900159|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
105516483|NCT01957553|363900160|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
105516484|NCT01957553|363900159|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
105516485|NCT01957553|363900160|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
105516486|NCT01957553|363900159|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
105516487|NCT01957553|363900160|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
105516488|NCT01957553|363900159|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
105516489|NCT01957553|363900160|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
105516490|NCT01957553|363900159|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
105516491|NCT01957553|363900160|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
105516492|NCT00732615|363900161|FG000|Overall Study|Withdrawal by Subject|3|||
105516493|NCT00732615|363900162|FG001|Overall Study|Withdrawal by Subject|1|||
105516494|NCT00732615|363900161|FG000|Overall Study|Lost to Follow-up|0|||
105516495|NCT00732615|363900162|FG001|Overall Study|Lost to Follow-up|1|||
105516496|NCT00732615|363900161|FG000|Overall Study|Adverse Event|0|||
105516497|NCT00732615|363900162|FG001|Overall Study|Adverse Event|2|||
105516498|NCT00732615|363900161|FG000|Overall Study|Physician Decision|3|||
105516499|NCT00732615|363900162|FG001|Overall Study|Physician Decision|0|||
105516500|NCT00732615|363900161|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
105516501|NCT00732615|363900162|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
105516502|NCT03128892|363900165|FG000|Overall Study|Withdrawal by Subject|2|||
105516503|NCT03128892|363900165|FG000|Overall Study|Physician Decision|1|||
105516504|NCT02999854|363900171|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
105516505|NCT02999854|363900172|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
105516506|NCT02999854|363900171|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
105516507|NCT02999854|363900172|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
105516508|NCT02999854|363900171|FG000|Active Study Phase (up to 18 Months)|Death|7|||
105516509|NCT02999854|363900172|FG001|Active Study Phase (up to 18 Months)|Death|5|||
105516510|NCT02999854|363900171|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
105516511|NCT02999854|363900172|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
105516512|NCT02999854|363900171|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
105516513|NCT02999854|363900172|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
105516514|NCT02999854|363900171|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
105516515|NCT02999854|363900172|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
105516516|NCT02999854|363900171|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
105516517|NCT02999854|363900172|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
105516518|NCT02999854|363900171|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
105516519|NCT02999854|363900172|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
105516520|NCT03171415|363900173|FG000|Overall Study|Lost to Follow-up|0|||
105516521|NCT03171415|363900174|FG001|Overall Study|Lost to Follow-up|0|||
105516522|NCT03171415|363900175|FG002|Overall Study|Lost to Follow-up|0|||
105516523|NCT03171415|363900176|FG003|Overall Study|Lost to Follow-up|0|||
105516524|NCT03171415|363900177|FG004|Overall Study|Lost to Follow-up|2|||
105516525|NCT01339429|363900178|FG000|Overall Study|Withdrawal by Subject|1|||
105516526|NCT01339429|363900178|FG000|Overall Study|Physician Decision|3|||
105516527|NCT04140292|363900179|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
105516528|NCT04140292|363900180|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
105516529|NCT00459667|363900181|FG000|Overall Study|Adverse Event|9|||
105516530|NCT00459667|363900182|FG001|Overall Study|Adverse Event|12|||
105516531|NCT00459667|363900183|FG002|Overall Study|Adverse Event|8|||
105516532|NCT00459667|363900181|FG000|Overall Study|Lost to Follow-up|5|||
105516533|NCT00459667|363900182|FG001|Overall Study|Lost to Follow-up|9|||
105516534|NCT00459667|363900183|FG002|Overall Study|Lost to Follow-up|3|||
105516535|NCT00459667|363900181|FG000|Overall Study|Pregnancy|1|||
105516536|NCT00459667|363900182|FG001|Overall Study|Pregnancy|1|||
105516537|NCT00459667|363900183|FG002|Overall Study|Pregnancy|1|||
105516538|NCT00459667|363900181|FG000|Overall Study|Protocol Violation|1|||
105516539|NCT00459667|363900182|FG001|Overall Study|Protocol Violation|0|||
105516540|NCT00459667|363900183|FG002|Overall Study|Protocol Violation|0|||
105516541|NCT00459667|363900181|FG000|Overall Study|Withdrawal by Subject|3|||
105516542|NCT00459667|363900182|FG001|Overall Study|Withdrawal by Subject|5|||
105516543|NCT00459667|363900183|FG002|Overall Study|Withdrawal by Subject|5|||
105516544|NCT00459667|363900181|FG000|Overall Study|Other disease modifying treatment|1|||
105516545|NCT00459667|363900182|FG001|Overall Study|Other disease modifying treatment|2|||
105516546|NCT00459667|363900183|FG002|Overall Study|Other disease modifying treatment|1|||
105516547|NCT00459667|363900181|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
105516548|NCT00459667|363900182|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
105516549|NCT00459667|363900183|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
105516550|NCT00459667|363900181|FG000|Overall Study|No treatment administered|6|||
105516551|NCT00459667|363900182|FG001|Overall Study|No treatment administered|3|||
105516552|NCT00459667|363900183|FG002|Overall Study|No treatment administered|1|||
105516553|NCT00396591|363900184|FG000|Overall Study|Disease Progression|13|||
105516554|NCT00396591|363900184|FG000|Overall Study|Adverse Event|2|||
105516555|NCT00396591|363900184|FG000|Overall Study|Participant request|1|||
105516556|NCT01013701|363900187|FG000|Overall Study|study prematurely terminated|7|||
105516557|NCT03241342|363900188|FG000|Overall Study|Adverse Event|5|||
105516558|NCT03241342|363900189|FG001|Overall Study|Adverse Event|8|||
105516559|NCT03241342|363900190|FG002|Overall Study|Adverse Event|4|||
105516560|NCT03241342|363900188|FG000|Overall Study|Lack of Efficacy|0|||
105516561|NCT03241342|363900189|FG001|Overall Study|Lack of Efficacy|0|||
105516562|NCT03241342|363900190|FG002|Overall Study|Lack of Efficacy|1|||
105516563|NCT03241342|363900188|FG000|Overall Study|noncompliance with study drug|2|||
105516564|NCT03241342|363900189|FG001|Overall Study|noncompliance with study drug|1|||
105516565|NCT03241342|363900190|FG002|Overall Study|noncompliance with study drug|1|||
105516566|NCT03241342|363900188|FG000|Overall Study|sponsor decision|0|||
105516567|NCT03241342|363900189|FG001|Overall Study|sponsor decision|1|||
105516568|NCT03241342|363900190|FG002|Overall Study|sponsor decision|2|||
105516569|NCT03241342|363900188|FG000|Overall Study|not reported|15|||
105516570|NCT03241342|363900189|FG001|Overall Study|not reported|21|||
105516571|NCT03241342|363900190|FG002|Overall Study|not reported|19|||
105516572|NCT00556712|363900191|FG000|Overall Study|Adverse Event|7|||
105516573|NCT00556712|363900192|FG001|Overall Study|Adverse Event|19|||
105516574|NCT00556712|363900191|FG000|Overall Study|Death|5|||
105516575|NCT00556712|363900192|FG001|Overall Study|Death|10|||
105516576|NCT00556712|363900191|FG000|Overall Study|Progressive Disease|383|||
105516577|NCT00556712|363900192|FG001|Overall Study|Progressive Disease|320|||
105516578|NCT00556712|363900191|FG000|Overall Study|Protocol Violation|3|||
105516579|NCT00556712|363900192|FG001|Overall Study|Protocol Violation|2|||
105516580|NCT00556712|363900191|FG000|Overall Study|Refused Treatment|17|||
105516581|NCT00556712|363900192|FG001|Overall Study|Refused Treatment|16|||
105516582|NCT00556712|363900191|FG000|Overall Study|Failure to Return|2|||
105516583|NCT00556712|363900192|FG001|Overall Study|Failure to Return|3|||
105516584|NCT00556712|363900191|FG000|Overall Study|Other|2|||
105516585|NCT00556712|363900192|FG001|Overall Study|Other|2|||
105516586|NCT00556712|363900191|FG000|Overall Study|Ongoing at Data Cutoff|32|||
105516587|NCT00556712|363900192|FG001|Overall Study|Ongoing at Data Cutoff|66|||
105516588|NCT01705652|363900193|FG000|Overall Study|Adverse Event|1|||
105516589|NCT01705652|363900194|FG001|Overall Study|Adverse Event|0|||
105516590|NCT01705652|363900193|FG000|Overall Study|Withdrawal by Subject|1|||
105516591|NCT01705652|363900194|FG001|Overall Study|Withdrawal by Subject|2|||
105516592|NCT01705652|363900193|FG000|Overall Study|non-compliance|1|||
105592193|NCT00545844|364169322|FG000|Overall Study|Withdrawal by Subject|2|||
105592194|NCT03383887|364169323|FG000|Overall Study|Lost to Follow-up|0|||
105516593|NCT01705652|363900194|FG001|Overall Study|non-compliance|1|||
105516594|NCT03334903|363900195|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
105516595|NCT03334903|363900196|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
105516596|NCT03334903|363900195|FG000|Overall Study|Protocol Violation|1|||
105516597|NCT03334903|363900196|FG001|Overall Study|Protocol Violation|3|||
105516598|NCT03334903|363900195|FG000|Overall Study|Surgery postponed|1|||
105516599|NCT03334903|363900196|FG001|Overall Study|Surgery postponed|0|||
105516600|NCT03334903|363900195|FG000|Overall Study|Adverse Event|1|||
105516601|NCT03334903|363900196|FG001|Overall Study|Adverse Event|1|||
105516602|NCT03334903|363900195|FG000|Overall Study|Withdrawal by Subject|0|||
105516603|NCT03334903|363900196|FG001|Overall Study|Withdrawal by Subject|1|||
105516604|NCT00180414|363901959|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
105516605|NCT00180414|363901960|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
105516606|NCT01084174|363901965|FG000|Overall Study|gastrointestinal symptoms|1|||
105516607|NCT01084174|363901966|FG001|Overall Study|gastrointestinal symptoms|1|||
105516608|NCT01084174|363901965|FG000|Overall Study|Eosinophilic esophagitis|0|||
105516609|NCT01084174|363901966|FG001|Overall Study|Eosinophilic esophagitis|1|||
105516610|NCT01084174|363901965|FG000|Overall Study|Anaphylaxis|0|||
105516611|NCT01084174|363901966|FG001|Overall Study|Anaphylaxis|1|||
105516612|NCT01084174|363901965|FG000|Overall Study|Participant noncompliance|0|||
105516613|NCT01084174|363901966|FG001|Overall Study|Participant noncompliance|1|||
105516614|NCT00708162|363901967|FG000|Randomized Phase|Randomized but Not Treated|7|||
105516615|NCT00708162|363901968|FG001|Randomized Phase|Randomized but Not Treated|5|||
105516616|NCT00708162|363901967|FG000|Randomized Phase|Participant Noncompliance|40|||
105516617|NCT00708162|363901968|FG001|Randomized Phase|Participant Noncompliance|32|||
105516618|NCT00708162|363901967|FG000|Randomized Phase|Lost to Follow-up|34|||
105516619|NCT00708162|363901968|FG001|Randomized Phase|Lost to Follow-up|34|||
105516620|NCT00708162|363901967|FG000|Randomized Phase|Withdrew Consent|31|||
105516621|NCT00708162|363901968|FG001|Randomized Phase|Withdrew Consent|22|||
105516622|NCT00708162|363901967|FG000|Randomized Phase|Lack of Efficacy|14|||
105516623|NCT00708162|363901968|FG001|Randomized Phase|Lack of Efficacy|19|||
105516624|NCT00708162|363901967|FG000|Randomized Phase|Protocol Violation|10|||
105516625|NCT00708162|363901968|FG001|Randomized Phase|Protocol Violation|11|||
105516626|NCT00708162|363901967|FG000|Randomized Phase|Adverse Event|8|||
105516627|NCT00708162|363901968|FG001|Randomized Phase|Adverse Event|12|||
105516628|NCT00708162|363901967|FG000|Randomized Phase|Investigator's Discretion|7|||
105516629|NCT00708162|363901968|FG001|Randomized Phase|Investigator's Discretion|10|||
105516630|NCT00708162|363901967|FG000|Randomized Phase|Death|2|||
105516631|NCT00708162|363901968|FG001|Randomized Phase|Death|9|||
105516632|NCT00708162|363901967|FG000|Randomized Phase|Pregnancy|3|||
105516633|NCT00708162|363901968|FG001|Randomized Phase|Pregnancy|0|||
105516634|NCT00708162|363901967|FG000|Open-Label Phase|Lost to Follow-up|10|||
105516635|NCT00708162|363901968|FG001|Open-Label Phase|Lost to Follow-up|8|||
105516636|NCT00708162|363901967|FG000|Open-Label Phase|Withdrew Consent|12|||
105516637|NCT00708162|363901968|FG001|Open-Label Phase|Withdrew Consent|6|||
105516638|NCT00708162|363901967|FG000|Open-Label Phase|Participant Noncompliance|7|||
105516639|NCT00708162|363901968|FG001|Open-Label Phase|Participant Noncompliance|7|||
105516640|NCT00708162|363901967|FG000|Open-Label Phase|Lack of Efficacy|7|||
105516641|NCT00708162|363901968|FG001|Open-Label Phase|Lack of Efficacy|4|||
105592195|NCT03383887|364169324|FG001|Overall Study|Lost to Follow-up|1|||
105516642|NCT00708162|363901967|FG000|Open-Label Phase|Investigator's Discretion|3|||
105516643|NCT00708162|363901968|FG001|Open-Label Phase|Investigator's Discretion|2|||
105516644|NCT00708162|363901967|FG000|Open-Label Phase|Death|3|||
105516645|NCT00708162|363901968|FG001|Open-Label Phase|Death|1|||
105516646|NCT00708162|363901967|FG000|Open-Label Phase|Adverse Event|1|||
105516647|NCT00708162|363901968|FG001|Open-Label Phase|Adverse Event|2|||
105516648|NCT00708162|363901967|FG000|Open-Label Phase|Other|1|||
105516649|NCT00708162|363901968|FG001|Open-Label Phase|Other|0|||
105516650|NCT01382446|363901969|FG000|Overall Study|Withdrawal by Subject|0|||
105516651|NCT01382446|363901970|FG001|Overall Study|Withdrawal by Subject|1|||
105516652|NCT01382446|363901969|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
105516653|NCT01382446|363901970|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
105516654|NCT02393547|363901971|FG000|Overall Study|Adverse Event|2|||
105516655|NCT02393547|363901971|FG000|Overall Study|Withdrawal by Subject|3|||
105516656|NCT02393547|363901971|FG000|Overall Study|Lost to Follow-up|1|||
105516657|NCT02707991|363901972|FG000|Overall Study|Protocol Violation|1|||
105516658|NCT02707991|363901973|FG001|Overall Study|Protocol Violation|0|||
105516659|NCT02707991|363901972|FG000|Overall Study|Became ineligible|0|||
105592196|NCT02701361|364169329|FG000|Overall Study|Lost to Follow-up|5|||
105592197|NCT02701361|364169330|FG001|Overall Study|Lost to Follow-up|2|||
105592198|NCT02701361|364169331|FG002|Overall Study|Lost to Follow-up|1|||
105516660|NCT02707991|363901973|FG001|Overall Study|Became ineligible|1|||
105516661|NCT00514540|363901974|FG000|First-Line Chemo|Withdrawal by Subject|1|||
105516662|NCT00514540|363901974|FG000|First-Line Chemo|Protocol Violation|7|||
105516663|NCT00514540|363901974|FG000|Second-Line|Physician/Patient Decision|31|||
105516664|NCT00770289|363901977|FG000|Overall Study|Other|6|||
105516665|NCT00422591|363901978|FG000|Overall Study|Physician Decision|4|||
105516666|NCT00422591|363901978|FG000|Overall Study|Withdrawal by Subject|2|||
105592199|NCT02701361|364169329|FG000|Overall Study|Withdrawal by Subject|4|||
105516667|NCT00993291|363901982|FG000|Overall Study|Withdrawal by Subject|1|||
105516668|NCT03566823|363901984|FG000|Overall Study|Lack of Efficacy|0|||
105516669|NCT03566823|363901985|FG001|Overall Study|Lack of Efficacy|1|||
105516670|NCT03566823|363901986|FG002|Overall Study|Lack of Efficacy|0|||
105516671|NCT03566823|363901984|FG000|Overall Study|Withdrawal by Subject|1|||
105516672|NCT03566823|363901985|FG001|Overall Study|Withdrawal by Subject|2|||
105516673|NCT03566823|363901986|FG002|Overall Study|Withdrawal by Subject|0|||
105516674|NCT03566823|363901984|FG000|Overall Study|Adverse Event|1|||
105516675|NCT03566823|363901985|FG001|Overall Study|Adverse Event|0|||
105516676|NCT03566823|363901986|FG002|Overall Study|Adverse Event|2|||
105516677|NCT02733367|363901987|FG000|Overall Study|Withdrawal by Subject|6|||
105516678|NCT01528254|363901988|FG000|Overall Study|Administrative problems|96|||
105516679|NCT01528254|363901989|FG001|Overall Study|Administrative problems|94|||
105516680|NCT01528254|363901988|FG000|Overall Study|Adverse Event|28|||
105516681|NCT01528254|363901989|FG001|Overall Study|Adverse Event|44|||
105516682|NCT01528254|363901988|FG000|Overall Study|Lost to Follow-up|17|||
105516683|NCT01528254|363901989|FG001|Overall Study|Lost to Follow-up|24|||
105516684|NCT01528254|363901988|FG000|Overall Study|Death|13|||
105516685|NCT01528254|363901989|FG001|Overall Study|Death|9|||
105516686|NCT01528254|363901988|FG000|Overall Study|Protocol deviation|9|||
105516687|NCT01528254|363901989|FG001|Overall Study|Protocol deviation|19|||
105516688|NCT01528254|363901988|FG000|Overall Study|New therapy for study indication|8|||
105516689|NCT01528254|363901989|FG001|Overall Study|New therapy for study indication|6|||
105516690|NCT01528254|363901988|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
105516691|NCT01528254|363901989|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
105516692|NCT01528254|363901988|FG000|Overall Study|Withdrawal by Subject|5|||
105516693|NCT01528254|363901989|FG001|Overall Study|Withdrawal by Subject|4|||
105516694|NCT01528254|363901988|FG000|Overall Study|Abnormal laboratory value(s)|3|||
105516695|NCT01528254|363901989|FG001|Overall Study|Abnormal laboratory value(s)|7|||
105516696|NCT01528254|363901988|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105516697|NCT01528254|363901989|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105516698|NCT01528254|363901988|FG000|Overall Study|No longer requires study drug|1|||
105516699|NCT01528254|363901989|FG001|Overall Study|No longer requires study drug|1|||
105516700|NCT01348347|363901990|FG000|Overall Study|Withdrawal by Subject|1|||
105516701|NCT01348347|363901991|FG001|Overall Study|Withdrawal by Subject|1|||
105516702|NCT01348347|363901992|FG002|Overall Study|Withdrawal by Subject|1|||
105516703|NCT01348347|363901990|FG000|Overall Study|Progressive disease|2|||
105516704|NCT01348347|363901991|FG001|Overall Study|Progressive disease|5|||
105516705|NCT01348347|363901992|FG002|Overall Study|Progressive disease|5|||
105516706|NCT00737282|363901996|FG000|Overall Study|Study prematurely terminated|175|||
105516707|NCT00467259|363901999|FG000|Overall Study|Adverse Event|24|||
105516708|NCT00467259|363902000|FG001|Overall Study|Adverse Event|90|||
105516709|NCT00467259|363901999|FG000|Overall Study|Protocol Violation|1|||
105516710|NCT00467259|363902000|FG001|Overall Study|Protocol Violation|7|||
105516711|NCT00467259|363901999|FG000|Overall Study|Withdrawal by Subject|34|||
105516712|NCT00467259|363902000|FG001|Overall Study|Withdrawal by Subject|108|||
105516713|NCT00467259|363901999|FG000|Overall Study|Physician Decision|0|||
105516714|NCT00467259|363902000|FG001|Overall Study|Physician Decision|2|||
105516715|NCT00467259|363901999|FG000|Overall Study|Lost to Follow-up|14|||
105516716|NCT00467259|363902000|FG001|Overall Study|Lost to Follow-up|34|||
105516717|NCT00467259|363901999|FG000|Overall Study|Site Closed|2|||
105516718|NCT00467259|363902000|FG001|Overall Study|Site Closed|1|||
105516719|NCT01129960|363902003|FG000|Overall Study|Withdrawal by Subject|3|||
105516720|NCT01129960|363902004|FG001|Overall Study|Withdrawal by Subject|0|||
105516721|NCT01129960|363902005|FG002|Overall Study|Withdrawal by Subject|3|||
105516722|NCT01129960|363902006|FG003|Overall Study|Withdrawal by Subject|2|||
105516723|NCT01129960|363902003|FG000|Overall Study|Lack of Efficacy|1|||
105516724|NCT01129960|363902004|FG001|Overall Study|Lack of Efficacy|1|||
105516725|NCT01129960|363902005|FG002|Overall Study|Lack of Efficacy|1|||
105516726|NCT01129960|363902006|FG003|Overall Study|Lack of Efficacy|1|||
105516727|NCT01129960|363902003|FG000|Overall Study|Adverse Event|23|||
105516728|NCT01129960|363902004|FG001|Overall Study|Adverse Event|16|||
105516729|NCT01129960|363902005|FG002|Overall Study|Adverse Event|16|||
105516730|NCT01129960|363902006|FG003|Overall Study|Adverse Event|7|||
105516731|NCT01129960|363902003|FG000|Overall Study|Protocol Violation|1|||
105516732|NCT01129960|363902004|FG001|Overall Study|Protocol Violation|2|||
105592200|NCT02701361|364169330|FG001|Overall Study|Withdrawal by Subject|0|||
105516733|NCT01129960|363902005|FG002|Overall Study|Protocol Violation|3|||
105516734|NCT01129960|363902006|FG003|Overall Study|Protocol Violation|0|||
105516735|NCT01129960|363902003|FG000|Overall Study|Lost to Follow-up|0|||
105516736|NCT01129960|363902004|FG001|Overall Study|Lost to Follow-up|2|||
105516737|NCT01129960|363902005|FG002|Overall Study|Lost to Follow-up|3|||
105516738|NCT01129960|363902006|FG003|Overall Study|Lost to Follow-up|3|||
105516739|NCT01129960|363902003|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
105516740|NCT01129960|363902004|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
105516741|NCT01129960|363902005|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
105516742|NCT01129960|363902006|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
105516743|NCT01129960|363902003|FG000|Overall Study|Physician Decision|1|||
105516744|NCT01129960|363902004|FG001|Overall Study|Physician Decision|0|||
105516745|NCT01129960|363902005|FG002|Overall Study|Physician Decision|0|||
105516746|NCT01129960|363902006|FG003|Overall Study|Physician Decision|0|||
105516747|NCT01129960|363902003|FG000|Overall Study|Pregnancy|1|||
105516748|NCT01129960|363902004|FG001|Overall Study|Pregnancy|0|||
105516749|NCT01129960|363902005|FG002|Overall Study|Pregnancy|0|||
105516750|NCT01129960|363902006|FG003|Overall Study|Pregnancy|0|||
105516751|NCT00165776|363902007|FG000|Overall Study|Lack of Efficacy|0|||
105516752|NCT00165776|363902008|FG001|Overall Study|Lack of Efficacy|0|||
105516753|NCT00165776|363902009|FG002|Overall Study|Lack of Efficacy|0|||
105516754|NCT00165776|363902010|FG003|Overall Study|Lack of Efficacy|1|||
105516755|NCT00165776|363902007|FG000|Overall Study|Withdrawal by Subject|4|||
105516756|NCT00165776|363902008|FG001|Overall Study|Withdrawal by Subject|1|||
105516757|NCT00165776|363902009|FG002|Overall Study|Withdrawal by Subject|2|||
105516758|NCT00165776|363902010|FG003|Overall Study|Withdrawal by Subject|0|||
105516759|NCT00165776|363902007|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
105516760|NCT00165776|363902008|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
105516761|NCT00165776|363902009|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
105516762|NCT00165776|363902010|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
105516763|NCT01340898|363902011|FG000|Primary Phase|Serious Adverse Events|0|||
105516764|NCT01340898|363902012|FG001|Primary Phase|Serious Adverse Events|0|||
105516765|NCT01340898|363902013|FG002|Primary Phase|Serious Adverse Events|1|||
105516766|NCT01340898|363902011|FG000|Primary Phase|Withdrawal by Subject|8|||
105516767|NCT01340898|363902012|FG001|Primary Phase|Withdrawal by Subject|7|||
105516768|NCT01340898|363902013|FG002|Primary Phase|Withdrawal by Subject|5|||
105516769|NCT01340898|363902011|FG000|Primary Phase|Migrated/moved from study area|4|||
105516770|NCT01340898|363902012|FG001|Primary Phase|Migrated/moved from study area|1|||
105516771|NCT01340898|363902013|FG002|Primary Phase|Migrated/moved from study area|0|||
105516772|NCT01340898|363902011|FG000|Primary Phase|Lost to Follow-up|4|||
105516773|NCT01340898|363902012|FG001|Primary Phase|Lost to Follow-up|1|||
105516774|NCT01340898|363902013|FG002|Primary Phase|Lost to Follow-up|0|||
105516775|NCT01340898|363902011|FG000|Booster Phase|Withdrawal by Subject|3|||
105516776|NCT01340898|363902012|FG001|Booster Phase|Withdrawal by Subject|0|||
105516777|NCT01340898|363902013|FG002|Booster Phase|Withdrawal by Subject|4|||
105516778|NCT01340898|363902011|FG000|Booster Phase|Migrated/moved from study area|3|||
105516779|NCT01340898|363902012|FG001|Booster Phase|Migrated/moved from study area|0|||
105516780|NCT01340898|363902013|FG002|Booster Phase|Migrated/moved from study area|0|||
105516781|NCT01340898|363902011|FG000|Booster Phase|Lost to Follow-up|4|||
105516782|NCT01340898|363902012|FG001|Booster Phase|Lost to Follow-up|2|||
105516783|NCT01340898|363902013|FG002|Booster Phase|Lost to Follow-up|3|||
105516784|NCT04900220|363902014|FG000|Overall Study|Lost to Follow-up|1|||
105516785|NCT04900220|363902015|FG001|Overall Study|Lost to Follow-up|1|||
105516786|NCT02028065|363902017|FG000|Randomization Through Start Treatment|Not treated|1|||
105516787|NCT02028065|363902018|FG001|Randomization Through Start Treatment|Not treated|3|||
105516788|NCT02028065|363902019|FG002|Randomization Through Start Treatment|Not treated|3|||
105516789|NCT02028065|363902017|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
105516790|NCT02028065|363902018|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
105516791|NCT02028065|363902019|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
105516792|NCT02028065|363902017|FG000|Treatment Through Study Completion|Physician Decision|1|||
105516793|NCT02028065|363902018|FG001|Treatment Through Study Completion|Physician Decision|0|||
105516794|NCT02028065|363902019|FG002|Treatment Through Study Completion|Physician Decision|0|||
105516795|NCT02028065|363902017|FG000|Treatment Through Study Completion|Protocol Violation|1|||
105516796|NCT02028065|363902018|FG001|Treatment Through Study Completion|Protocol Violation|4|||
105516797|NCT02028065|363902019|FG002|Treatment Through Study Completion|Protocol Violation|0|||
105516798|NCT02028065|363902017|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
105516799|NCT02028065|363902018|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
105516800|NCT02028065|363902019|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
105516801|NCT02028065|363902017|FG000|Treatment Through Study Completion|Adverse Event|3|||
105516802|NCT02028065|363902018|FG001|Treatment Through Study Completion|Adverse Event|3|||
105516803|NCT02028065|363902019|FG002|Treatment Through Study Completion|Adverse Event|5|||
105516804|NCT01414855|363902022|FG000|Overall Study|Death|17|||
105516805|NCT01414855|363902022|FG000|Overall Study|Lost to Follow-up|5|||
105516806|NCT01414855|363902022|FG000|Overall Study|Withdrawal by Subject|7|||
105516807|NCT04851314|363902026|FG000|Overall Study|Unable to complete research set-up procedures|0|||
105516808|NCT04851314|363902027|FG001|Overall Study|Unable to complete research set-up procedures|2|||
105516809|NCT04851314|363902026|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
105516810|NCT04851314|363902027|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
105516811|NCT00877383|363902028|FG000|Overall Study|Adverse Event|13|||
105516812|NCT00877383|363902029|FG001|Overall Study|Adverse Event|14|||
105516813|NCT00877383|363902028|FG000|Overall Study|Lost to Follow-up|5|||
105516814|NCT00877383|363902029|FG001|Overall Study|Lost to Follow-up|3|||
105516815|NCT00877383|363902028|FG000|Overall Study|Subject withdrew consent|3|||
105516816|NCT00877383|363902029|FG001|Overall Study|Subject withdrew consent|12|||
105516817|NCT00877383|363902028|FG000|Overall Study|Subject no longer requires study drug|2|||
105516818|NCT00877383|363902029|FG001|Overall Study|Subject no longer requires study drug|0|||
105516819|NCT00877383|363902028|FG000|Overall Study|Administrative problems|2|||
105516820|NCT00877383|363902029|FG001|Overall Study|Administrative problems|0|||
105516821|NCT00877383|363902028|FG000|Overall Study|Protocol deviation|2|||
105516822|NCT00877383|363902029|FG001|Overall Study|Protocol deviation|6|||
105516823|NCT00877383|363902028|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105516824|NCT00877383|363902029|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105516825|NCT00877383|363902028|FG000|Overall Study|Death|1|||
105516826|NCT00877383|363902029|FG001|Overall Study|Death|2|||
105516827|NCT04868890|363902030|FG000|Overall Study|Death|2|||
105516828|NCT04868890|363902031|FG001|Overall Study|Death|1|||
105516829|NCT04868890|363902030|FG000|Overall Study|Withdrawal by Subject|1|||
105516830|NCT04868890|363902031|FG001|Overall Study|Withdrawal by Subject|5|||
105516831|NCT03266094|363902032|FG000|Overall Study|Lost to Follow-up|1|||
105516832|NCT03266094|363902032|FG000|Overall Study|Withdrawal by Subject|1|||
105516833|NCT00459108|363902035|FG000|Overall Study|Withdrawal by Subject|5|||
105516834|NCT00459108|363902035|FG000|Overall Study|Adverse Event|3|||
105516835|NCT00459108|363902035|FG000|Overall Study|Death|2|||
105516836|NCT00459108|363902035|FG000|Overall Study|Progression|1|||
105516837|NCT00368355|363902036|FG000|Overall Study|Adverse Event|1|||
105516838|NCT00368355|363902037|FG001|Overall Study|Adverse Event|0|||
105516839|NCT00368355|363902036|FG000|Overall Study|Death|2|||
105516840|NCT00368355|363902037|FG001|Overall Study|Death|4|||
105516841|NCT00368355|363902036|FG000|Overall Study|Relapse|6|||
105516842|NCT00368355|363902037|FG001|Overall Study|Relapse|10|||
105516843|NCT00368355|363902036|FG000|Overall Study|Subsequent transplant|0|||
105516844|NCT00368355|363902037|FG001|Overall Study|Subsequent transplant|3|||
105516845|NCT00368355|363902036|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
105516846|NCT00368355|363902037|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
105516847|NCT01085591|363902043|FG000|Overall Study|Adverse Event|0|||
105516848|NCT01085591|363902044|FG001|Overall Study|Adverse Event|1|||
105516849|NCT01085591|363902045|FG002|Overall Study|Adverse Event|3|||
105516850|NCT01085591|363902043|FG000|Overall Study|Physician Decision|1|||
105516851|NCT01085591|363902044|FG001|Overall Study|Physician Decision|0|||
105516852|NCT01085591|363902045|FG002|Overall Study|Physician Decision|1|||
105516853|NCT01085591|363902043|FG000|Overall Study|Withdrawal by Subject|0|||
105516854|NCT01085591|363902044|FG001|Overall Study|Withdrawal by Subject|2|||
105516855|NCT01085591|363902045|FG002|Overall Study|Withdrawal by Subject|1|||
105516856|NCT01085591|363902043|FG000|Overall Study|Lost to Follow-up|0|||
105516857|NCT01085591|363902044|FG001|Overall Study|Lost to Follow-up|1|||
105516858|NCT01085591|363902045|FG002|Overall Study|Lost to Follow-up|1|||
105516859|NCT01085591|363902043|FG000|Overall Study|Protocol Violation|1|||
105516860|NCT01085591|363902044|FG001|Overall Study|Protocol Violation|1|||
105516861|NCT01085591|363902045|FG002|Overall Study|Protocol Violation|1|||
105516862|NCT01085591|363902043|FG000|Overall Study|Other|0|||
105516863|NCT01085591|363902044|FG001|Overall Study|Other|1|||
105516864|NCT01085591|363902045|FG002|Overall Study|Other|0|||
105516865|NCT01085591|363902043|FG000|Overall Study|Not Properly Consented|1|||
105516866|NCT01085591|363902044|FG001|Overall Study|Not Properly Consented|0|||
105516867|NCT01085591|363902045|FG002|Overall Study|Not Properly Consented|0|||
105516868|NCT01962207|363902050|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
105516869|NCT01962207|363902051|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
105516870|NCT01962207|363902052|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
105516871|NCT01962207|363902053|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
105516872|NCT01962207|363902050|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
105516873|NCT01962207|363902051|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
105516874|NCT01962207|363902052|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
105516875|NCT01962207|363902053|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
105516876|NCT01962207|363902050|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
105516877|NCT01962207|363902051|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
105516878|NCT01962207|363902052|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
105516879|NCT01962207|363902053|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
105516880|NCT01962207|363902050|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
105516881|NCT01962207|363902051|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
105516882|NCT01962207|363902052|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
105516883|NCT01962207|363902053|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
105516884|NCT01962207|363902050|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
105516885|NCT01962207|363902051|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
105516886|NCT01962207|363902052|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
105516887|NCT01962207|363902053|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
105516888|NCT01962207|363902050|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
105516889|NCT01962207|363902051|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
105516890|NCT01962207|363902052|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
105516891|NCT01962207|363902053|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
105516892|NCT00847704|363902054|FG000|Overall Study|Withdrawal by Subject|1|||
105516893|NCT00680043|363902057|FG000|Overall Study|Withdrawal by Subject|1|||
105516894|NCT00680043|363902058|FG001|Overall Study|Withdrawal by Subject|0|||
105516895|NCT00680043|363902059|FG002|Overall Study|Withdrawal by Subject|0|||
105516896|NCT00680043|363902057|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
105516897|NCT00680043|363902058|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
105516898|NCT00680043|363902059|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
105516899|NCT00680043|363902057|FG000|Overall Study|Renal Transplant|1|||
105516900|NCT00680043|363902058|FG001|Overall Study|Renal Transplant|0|||
105516901|NCT00680043|363902059|FG002|Overall Study|Renal Transplant|4|||
105516902|NCT02111850|363902061|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
105516903|NCT02111850|363902062|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
105516904|NCT02111850|363902063|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
105516905|NCT02111850|363902064|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
105516906|NCT02111850|363902065|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
105516907|NCT02111850|363902066|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
105516908|NCT02111850|363902067|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
105516909|NCT02111850|363902068|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
105516910|NCT02111850|363902069|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
105516911|NCT02111850|363902070|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
105516912|NCT02111850|363902071|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
105516913|NCT02625259|363902074|FG000|First Intervention (Day 1)|Other|0|||
105516914|NCT02625259|363902075|FG001|First Intervention (Day 1)|Other|0|||
105516915|NCT02625259|363902076|FG002|First Intervention (Day 1)|Other|1|||
105516916|NCT02625259|363902077|FG003|First Intervention (Day 1)|Other|0|||
105516917|NCT02625259|363902078|FG004|First Intervention (Day 1)|Other|0|||
105516918|NCT02625259|363902074|FG000|First Intervention (Day 1)|Adverse Event|2|||
105516919|NCT02625259|363902075|FG001|First Intervention (Day 1)|Adverse Event|1|||
105516920|NCT02625259|363902076|FG002|First Intervention (Day 1)|Adverse Event|0|||
105516921|NCT02625259|363902077|FG003|First Intervention (Day 1)|Adverse Event|0|||
105516922|NCT02625259|363902078|FG004|First Intervention (Day 1)|Adverse Event|0|||
105516923|NCT02625259|363902074|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
105516924|NCT02625259|363902075|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
105516925|NCT02625259|363902076|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
105516926|NCT02625259|363902077|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
105516927|NCT02625259|363902078|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
105516928|NCT03251079|363902084|FG000|Overall Study|Withdrawal by Subject|1|||
105516929|NCT01428453|363902087|FG000|Overall Study|Adverse Event|2|||
105516930|NCT01428453|363902088|FG001|Overall Study|Adverse Event|7|||
105516931|NCT01428453|363902087|FG000|Overall Study|Protocol Violation|1|||
105516932|NCT01428453|363902088|FG001|Overall Study|Protocol Violation|0|||
105516933|NCT01428453|363902087|FG000|Overall Study|Lost to Follow-up|0|||
105516934|NCT01428453|363902088|FG001|Overall Study|Lost to Follow-up|1|||
105516935|NCT01428453|363902087|FG000|Overall Study|Withdrawal by Subject|3|||
105516936|NCT01428453|363902088|FG001|Overall Study|Withdrawal by Subject|1|||
105516937|NCT02626520|363902090|FG000|Overall Study|Physician Decision|1|||
105516938|NCT02626520|363902091|FG001|Overall Study|Physician Decision|1|||
105516939|NCT02626520|363902090|FG000|Overall Study|Adverse Event|0|||
105516940|NCT02626520|363902091|FG001|Overall Study|Adverse Event|4|||
105516941|NCT02626520|363902090|FG000|Overall Study|Lack of Efficacy|0|||
105516942|NCT02626520|363902091|FG001|Overall Study|Lack of Efficacy|2|||
105516943|NCT02626520|363902090|FG000|Overall Study|Did not start protocol therapy|0|||
105516944|NCT02626520|363902091|FG001|Overall Study|Did not start protocol therapy|2|||
105516945|NCT02626520|363902090|FG000|Overall Study|Study terminated|0|||
105516946|NCT02626520|363902091|FG001|Overall Study|Study terminated|1|||
105516947|NCT01996709|363902092|FG000|Overall Study|Withdrawal by Subject|1|||
105516948|NCT01996709|363902093|FG001|Overall Study|Withdrawal by Subject|0|||
105516949|NCT01996709|363902092|FG000|Overall Study|Lost to Follow-up|3|||
105516950|NCT01996709|363902093|FG001|Overall Study|Lost to Follow-up|0|||
105516951|NCT01996709|363902092|FG000|Overall Study|Subject Non-Compliant|1|||
105516952|NCT01996709|363902093|FG001|Overall Study|Subject Non-Compliant|0|||
105516953|NCT01996709|363902092|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
105516954|NCT01996709|363902093|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
105516955|NCT02953314|363902094|FG000|Overall Study|Adverse Event|0|||
105516956|NCT02953314|363902095|FG001|Overall Study|Adverse Event|1|||
105516957|NCT02953314|363902094|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
105516958|NCT02953314|363902095|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
105516959|NCT00492115|363902096|FG000|Overall Study|Withdrawal by Subject|3|||
105516960|NCT00492115|363902097|FG001|Overall Study|Withdrawal by Subject|4|||
105516961|NCT03564145|363902100|FG000|Overall Study|Adverse Event|4|||
105516962|NCT03564145|363902100|FG000|Overall Study|Lost to Follow-up|21|||
105516963|NCT03564145|363902100|FG000|Overall Study|Protocol Violation|2|||
105516964|NCT03564145|363902100|FG000|Overall Study|Withdrawal by Subject|48|||
105516965|NCT03564145|363902100|FG000|Overall Study|Study Terminated by Sponsor|146|||
105516966|NCT03564145|363902100|FG000|Overall Study|Physician Decision|1|||
105516967|NCT03564145|363902100|FG000|Overall Study|Other Than Specified|1|||
105516968|NCT03564145|363902100|FG000|Overall Study|Pregnancy|1|||
105516969|NCT02045797|363902101|FG000|Overall Study|Adverse Event|3|||
105516970|NCT02045797|363902102|FG001|Overall Study|Adverse Event|1|||
105516971|NCT02045797|363902103|FG002|Overall Study|Adverse Event|0|||
105516972|NCT02045797|363902101|FG000|Overall Study|Lack of Efficacy|1|||
105516973|NCT02045797|363902102|FG001|Overall Study|Lack of Efficacy|0|||
105516974|NCT02045797|363902103|FG002|Overall Study|Lack of Efficacy|0|||
105516975|NCT02045797|363902101|FG000|Overall Study|Lost to Follow-up|2|||
105516976|NCT02045797|363902102|FG001|Overall Study|Lost to Follow-up|3|||
105516977|NCT02045797|363902103|FG002|Overall Study|Lost to Follow-up|1|||
105516978|NCT02045797|363902101|FG000|Overall Study|Physician Decision|0|||
105516979|NCT02045797|363902102|FG001|Overall Study|Physician Decision|1|||
105516980|NCT02045797|363902103|FG002|Overall Study|Physician Decision|0|||
105516981|NCT02045797|363902101|FG000|Overall Study|Withdrawal by Subject|1|||
105516982|NCT02045797|363902102|FG001|Overall Study|Withdrawal by Subject|2|||
105516983|NCT02045797|363902103|FG002|Overall Study|Withdrawal by Subject|0|||
105516984|NCT02200445|363902104|FG000|Overall Study|Lack of Efficacy|1|||
105516985|NCT02200445|363902105|FG001|Overall Study|Lack of Efficacy|2|||
105516986|NCT02200445|363902106|FG002|Overall Study|Lack of Efficacy|2|||
105516987|NCT02200445|363902104|FG000|Overall Study|Adverse Event|0|||
105516988|NCT02200445|363902105|FG001|Overall Study|Adverse Event|2|||
105516989|NCT02200445|363902106|FG002|Overall Study|Adverse Event|0|||
105516990|NCT01386554|363902107|FG000|Overall Study|Lost to Follow-up|0|||
105516991|NCT01386554|363902108|FG001|Overall Study|Lost to Follow-up|0|||
105516992|NCT01386554|363902109|FG002|Overall Study|Lost to Follow-up|1|||
105516993|NCT01386554|363902107|FG000|Overall Study|Adverse Event|2|||
105516994|NCT01386554|363902108|FG001|Overall Study|Adverse Event|5|||
105516995|NCT01386554|363902109|FG002|Overall Study|Adverse Event|2|||
105516996|NCT01386554|363902107|FG000|Overall Study|Progressive disease|1|||
105516997|NCT01386554|363902108|FG001|Overall Study|Progressive disease|2|||
105516998|NCT01386554|363902109|FG002|Overall Study|Progressive disease|2|||
105516999|NCT01386554|363902107|FG000|Overall Study|Administration of live vaccines|0|||
105517000|NCT01386554|363902108|FG001|Overall Study|Administration of live vaccines|1|||
105517001|NCT01386554|363902109|FG002|Overall Study|Administration of live vaccines|0|||
105517002|NCT01386554|363902107|FG000|Overall Study|Investigator discretion|0|||
105517003|NCT01386554|363902108|FG001|Overall Study|Investigator discretion|0|||
105517004|NCT01386554|363902109|FG002|Overall Study|Investigator discretion|1|||
105517005|NCT01386554|363902107|FG000|Overall Study|Reason not collected|0|||
105517006|NCT01386554|363902108|FG001|Overall Study|Reason not collected|1|||
105517007|NCT01386554|363902109|FG002|Overall Study|Reason not collected|0|||
105517008|NCT05286307|363902110|FG000|Overall Study|Incomplete outcome assessments|2|||
105517009|NCT05286307|363902111|FG001|Overall Study|Incomplete outcome assessments|1|||
105517010|NCT05286307|363902110|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
105517011|NCT05286307|363902111|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
105517012|NCT05286307|363902110|FG000|Overall Study|Lost to follow up at 6 months|25|||
105517013|NCT05286307|363902111|FG001|Overall Study|Lost to follow up at 6 months|35|||
105517014|NCT05286307|363902110|FG000|Overall Study|Study medication not available|1|||
105517015|NCT05286307|363902111|FG001|Overall Study|Study medication not available|1|||
105517016|NCT02554812|363902112|FG000|Overall Study|Adverse Event|2|||
105517017|NCT02554812|363902113|FG001|Overall Study|Adverse Event|5|||
105517018|NCT02554812|363902114|FG002|Overall Study|Adverse Event|3|||
105517019|NCT02554812|363902115|FG003|Overall Study|Adverse Event|0|||
105517020|NCT02554812|363902116|FG004|Overall Study|Adverse Event|5|||
105517021|NCT02554812|363902117|FG005|Overall Study|Adverse Event|0|||
105517022|NCT02554812|363902118|FG006|Overall Study|Adverse Event|1|||
105517023|NCT02554812|363902119|FG007|Overall Study|Adverse Event|6|||
105517024|NCT02554812|363902120|FG008|Overall Study|Adverse Event|2|||
105517025|NCT02554812|363902121|FG009|Overall Study|Adverse Event|2|||
105517026|NCT02554812|363902122|FG010|Overall Study|Adverse Event|1|||
105517027|NCT02554812|363902123|FG011|Overall Study|Adverse Event|2|||
105517028|NCT02554812|363902124|FG012|Overall Study|Adverse Event|0|||
105517029|NCT02554812|363902125|FG013|Overall Study|Adverse Event|3|||
105517030|NCT02554812|363902126|FG014|Overall Study|Adverse Event|2|||
105592201|NCT02701361|364169331|FG002|Overall Study|Withdrawal by Subject|0|||
105517031|NCT02554812|363902127|FG015|Overall Study|Adverse Event|1|||
105517032|NCT02554812|363902128|FG016|Overall Study|Adverse Event|0|||
105517033|NCT02554812|363902129|FG017|Overall Study|Adverse Event|1|||
105517034|NCT02554812|363902130|FG018|Overall Study|Adverse Event|0|||
105517035|NCT02554812|363902131|FG019|Overall Study|Adverse Event|0|||
105517036|NCT02554812|363902132|FG020|Overall Study|Adverse Event|0|||
105517037|NCT02554812|363902133|FG021|Overall Study|Adverse Event|2|||
105517038|NCT02554812|363902134|FG022|Overall Study|Adverse Event|1|||
105517039|NCT02554812|363902135|FG023|Overall Study|Adverse Event|1|||
105517040|NCT02554812|363902136|FG024|Overall Study|Adverse Event|1|||
105517041|NCT02554812|363902137|FG025|Overall Study|Adverse Event|2|||
105517042|NCT02554812|363902138|FG026|Overall Study|Adverse Event|1|||
105517043|NCT02554812|363902112|FG000|Overall Study|Death|1|||
105517044|NCT02554812|363902113|FG001|Overall Study|Death|2|||
105517045|NCT02554812|363902114|FG002|Overall Study|Death|2|||
105517046|NCT02554812|363902115|FG003|Overall Study|Death|2|||
105517047|NCT02554812|363902116|FG004|Overall Study|Death|0|||
105517048|NCT02554812|363902117|FG005|Overall Study|Death|1|||
105517049|NCT02554812|363902118|FG006|Overall Study|Death|1|||
105517050|NCT02554812|363902119|FG007|Overall Study|Death|1|||
105517051|NCT02554812|363902120|FG008|Overall Study|Death|0|||
105517052|NCT02554812|363902121|FG009|Overall Study|Death|0|||
105517053|NCT02554812|363902122|FG010|Overall Study|Death|0|||
105517054|NCT02554812|363902123|FG011|Overall Study|Death|0|||
105517055|NCT02554812|363902124|FG012|Overall Study|Death|0|||
105517056|NCT02554812|363902125|FG013|Overall Study|Death|0|||
105517057|NCT02554812|363902126|FG014|Overall Study|Death|1|||
105517058|NCT02554812|363902127|FG015|Overall Study|Death|1|||
105517059|NCT02554812|363902128|FG016|Overall Study|Death|1|||
105517060|NCT02554812|363902129|FG017|Overall Study|Death|0|||
105517061|NCT02554812|363902130|FG018|Overall Study|Death|1|||
105517062|NCT02554812|363902131|FG019|Overall Study|Death|2|||
105517063|NCT02554812|363902132|FG020|Overall Study|Death|0|||
105517064|NCT02554812|363902133|FG021|Overall Study|Death|1|||
105517065|NCT02554812|363902134|FG022|Overall Study|Death|1|||
105517066|NCT02554812|363902135|FG023|Overall Study|Death|0|||
105517067|NCT02554812|363902136|FG024|Overall Study|Death|0|||
105517068|NCT02554812|363902137|FG025|Overall Study|Death|0|||
105517069|NCT02554812|363902138|FG026|Overall Study|Death|0|||
105517070|NCT02554812|363902112|FG000|Overall Study|Lost to Follow-up|0|||
105517071|NCT02554812|363902113|FG001|Overall Study|Lost to Follow-up|1|||
105517072|NCT02554812|363902114|FG002|Overall Study|Lost to Follow-up|0|||
105517073|NCT02554812|363902115|FG003|Overall Study|Lost to Follow-up|0|||
105517074|NCT02554812|363902116|FG004|Overall Study|Lost to Follow-up|0|||
105517075|NCT02554812|363902117|FG005|Overall Study|Lost to Follow-up|0|||
105517076|NCT02554812|363902118|FG006|Overall Study|Lost to Follow-up|0|||
105517077|NCT02554812|363902119|FG007|Overall Study|Lost to Follow-up|0|||
105517078|NCT02554812|363902120|FG008|Overall Study|Lost to Follow-up|0|||
105517079|NCT02554812|363902121|FG009|Overall Study|Lost to Follow-up|0|||
105517080|NCT02554812|363902122|FG010|Overall Study|Lost to Follow-up|0|||
105517081|NCT02554812|363902123|FG011|Overall Study|Lost to Follow-up|0|||
105517082|NCT02554812|363902124|FG012|Overall Study|Lost to Follow-up|0|||
105517083|NCT02554812|363902125|FG013|Overall Study|Lost to Follow-up|0|||
105517084|NCT02554812|363902126|FG014|Overall Study|Lost to Follow-up|0|||
105517085|NCT02554812|363902127|FG015|Overall Study|Lost to Follow-up|0|||
105517086|NCT02554812|363902128|FG016|Overall Study|Lost to Follow-up|0|||
105517087|NCT02554812|363902129|FG017|Overall Study|Lost to Follow-up|0|||
105517088|NCT02554812|363902130|FG018|Overall Study|Lost to Follow-up|0|||
105517089|NCT02554812|363902131|FG019|Overall Study|Lost to Follow-up|0|||
105517090|NCT02554812|363902132|FG020|Overall Study|Lost to Follow-up|0|||
105517091|NCT02554812|363902133|FG021|Overall Study|Lost to Follow-up|0|||
105517092|NCT02554812|363902134|FG022|Overall Study|Lost to Follow-up|0|||
105517093|NCT02554812|363902135|FG023|Overall Study|Lost to Follow-up|0|||
105517094|NCT02554812|363902136|FG024|Overall Study|Lost to Follow-up|0|||
105517095|NCT02554812|363902137|FG025|Overall Study|Lost to Follow-up|0|||
105517096|NCT02554812|363902138|FG026|Overall Study|Lost to Follow-up|0|||
105592202|NCT02701361|364169329|FG000|Overall Study|timed out in rehab center|0|||
105592203|NCT02701361|364169330|FG001|Overall Study|timed out in rehab center|1|||
105592204|NCT02701361|364169331|FG002|Overall Study|timed out in rehab center|0|||
105592205|NCT02701361|364169329|FG000|Overall Study|incarceration|0|||
105517097|NCT02554812|363902112|FG000|Overall Study|Global deterioration of health status|4|||
105517098|NCT02554812|363902113|FG001|Overall Study|Global deterioration of health status|3|||
105517099|NCT02554812|363902114|FG002|Overall Study|Global deterioration of health status|3|||
105517100|NCT02554812|363902115|FG003|Overall Study|Global deterioration of health status|2|||
105517101|NCT02554812|363902116|FG004|Overall Study|Global deterioration of health status|5|||
105517102|NCT02554812|363902117|FG005|Overall Study|Global deterioration of health status|0|||
105517103|NCT02554812|363902118|FG006|Overall Study|Global deterioration of health status|2|||
105517104|NCT02554812|363902119|FG007|Overall Study|Global deterioration of health status|1|||
105517105|NCT02554812|363902120|FG008|Overall Study|Global deterioration of health status|1|||
105517106|NCT02554812|363902121|FG009|Overall Study|Global deterioration of health status|1|||
105517107|NCT02554812|363902122|FG010|Overall Study|Global deterioration of health status|2|||
105517108|NCT02554812|363902123|FG011|Overall Study|Global deterioration of health status|1|||
105517109|NCT02554812|363902124|FG012|Overall Study|Global deterioration of health status|0|||
105517110|NCT02554812|363902125|FG013|Overall Study|Global deterioration of health status|0|||
105517111|NCT02554812|363902126|FG014|Overall Study|Global deterioration of health status|0|||
105517112|NCT02554812|363902127|FG015|Overall Study|Global deterioration of health status|1|||
105517113|NCT02554812|363902128|FG016|Overall Study|Global deterioration of health status|0|||
105592206|NCT02701361|364169330|FG001|Overall Study|incarceration|0|||
105517114|NCT02554812|363902129|FG017|Overall Study|Global deterioration of health status|0|||
105517115|NCT02554812|363902130|FG018|Overall Study|Global deterioration of health status|0|||
105517116|NCT02554812|363902131|FG019|Overall Study|Global deterioration of health status|0|||
105517117|NCT02554812|363902132|FG020|Overall Study|Global deterioration of health status|0|||
105517118|NCT02554812|363902133|FG021|Overall Study|Global deterioration of health status|0|||
105517119|NCT02554812|363902134|FG022|Overall Study|Global deterioration of health status|0|||
105517120|NCT02554812|363902135|FG023|Overall Study|Global deterioration of health status|0|||
105517121|NCT02554812|363902136|FG024|Overall Study|Global deterioration of health status|0|||
105517122|NCT02554812|363902137|FG025|Overall Study|Global deterioration of health status|0|||
105517123|NCT02554812|363902138|FG026|Overall Study|Global deterioration of health status|0|||
105517124|NCT02554812|363902112|FG000|Overall Study|Progressive disease|20|||
105517125|NCT02554812|363902113|FG001|Overall Study|Progressive disease|16|||
105517126|NCT02554812|363902114|FG002|Overall Study|Progressive disease|19|||
105517127|NCT02554812|363902115|FG003|Overall Study|Progressive disease|18|||
105517128|NCT02554812|363902116|FG004|Overall Study|Progressive disease|21|||
105517129|NCT02554812|363902117|FG005|Overall Study|Progressive disease|15|||
105517130|NCT02554812|363902118|FG006|Overall Study|Progressive disease|6|||
105517131|NCT02554812|363902119|FG007|Overall Study|Progressive disease|13|||
105517132|NCT02554812|363902120|FG008|Overall Study|Progressive disease|6|||
105517133|NCT02554812|363902121|FG009|Overall Study|Progressive disease|6|||
105517134|NCT02554812|363902122|FG010|Overall Study|Progressive disease|8|||
105517135|NCT02554812|363902123|FG011|Overall Study|Progressive disease|8|||
105517136|NCT02554812|363902124|FG012|Overall Study|Progressive disease|6|||
105517137|NCT02554812|363902125|FG013|Overall Study|Progressive disease|10|||
105517138|NCT02554812|363902126|FG014|Overall Study|Progressive disease|20|||
105517139|NCT02554812|363902127|FG015|Overall Study|Progressive disease|6|||
105517140|NCT02554812|363902128|FG016|Overall Study|Progressive disease|3|||
105517141|NCT02554812|363902129|FG017|Overall Study|Progressive disease|3|||
105517142|NCT02554812|363902130|FG018|Overall Study|Progressive disease|11|||
105517143|NCT02554812|363902131|FG019|Overall Study|Progressive disease|7|||
105517144|NCT02554812|363902132|FG020|Overall Study|Progressive disease|11|||
105517145|NCT02554812|363902133|FG021|Overall Study|Progressive disease|6|||
105517146|NCT02554812|363902134|FG022|Overall Study|Progressive disease|9|||
105517147|NCT02554812|363902135|FG023|Overall Study|Progressive disease|9|||
105517148|NCT02554812|363902136|FG024|Overall Study|Progressive disease|4|||
105517149|NCT02554812|363902137|FG025|Overall Study|Progressive disease|5|||
105517150|NCT02554812|363902138|FG026|Overall Study|Progressive disease|5|||
105517151|NCT02554812|363902112|FG000|Overall Study|Other|0|||
105517152|NCT02554812|363902113|FG001|Overall Study|Other|0|||
105517153|NCT02554812|363902114|FG002|Overall Study|Other|2|||
105517154|NCT02554812|363902115|FG003|Overall Study|Other|3|||
105517155|NCT02554812|363902116|FG004|Overall Study|Other|2|||
105517156|NCT02554812|363902117|FG005|Overall Study|Other|1|||
105517157|NCT02554812|363902118|FG006|Overall Study|Other|0|||
105517158|NCT02554812|363902119|FG007|Overall Study|Other|0|||
105517159|NCT02554812|363902120|FG008|Overall Study|Other|1|||
105517160|NCT02554812|363902121|FG009|Overall Study|Other|1|||
105517161|NCT02554812|363902122|FG010|Overall Study|Other|0|||
105517162|NCT02554812|363902123|FG011|Overall Study|Other|0|||
105517163|NCT02554812|363902124|FG012|Overall Study|Other|1|||
105517164|NCT02554812|363902125|FG013|Overall Study|Other|0|||
105517165|NCT02554812|363902126|FG014|Overall Study|Other|1|||
105517166|NCT02554812|363902127|FG015|Overall Study|Other|0|||
105517167|NCT02554812|363902128|FG016|Overall Study|Other|0|||
105517168|NCT02554812|363902129|FG017|Overall Study|Other|0|||
105517169|NCT02554812|363902130|FG018|Overall Study|Other|0|||
105517170|NCT02554812|363902131|FG019|Overall Study|Other|0|||
105517171|NCT02554812|363902132|FG020|Overall Study|Other|0|||
105517172|NCT02554812|363902133|FG021|Overall Study|Other|2|||
105517173|NCT02554812|363902134|FG022|Overall Study|Other|0|||
105517174|NCT02554812|363902135|FG023|Overall Study|Other|0|||
105517175|NCT02554812|363902136|FG024|Overall Study|Other|0|||
105517176|NCT02554812|363902137|FG025|Overall Study|Other|0|||
105517177|NCT02554812|363902138|FG026|Overall Study|Other|0|||
105517178|NCT02554812|363902112|FG000|Overall Study|Withdrawal by Subject|1|||
105517179|NCT02554812|363902113|FG001|Overall Study|Withdrawal by Subject|0|||
105517180|NCT02554812|363902114|FG002|Overall Study|Withdrawal by Subject|0|||
105517181|NCT02554812|363902115|FG003|Overall Study|Withdrawal by Subject|2|||
105517182|NCT02554812|363902116|FG004|Overall Study|Withdrawal by Subject|2|||
105517183|NCT02554812|363902117|FG005|Overall Study|Withdrawal by Subject|3|||
105517184|NCT02554812|363902118|FG006|Overall Study|Withdrawal by Subject|0|||
105517185|NCT02554812|363902119|FG007|Overall Study|Withdrawal by Subject|0|||
105517186|NCT02554812|363902120|FG008|Overall Study|Withdrawal by Subject|1|||
105517187|NCT02554812|363902121|FG009|Overall Study|Withdrawal by Subject|1|||
105517188|NCT02554812|363902122|FG010|Overall Study|Withdrawal by Subject|0|||
105517189|NCT02554812|363902123|FG011|Overall Study|Withdrawal by Subject|1|||
105517190|NCT02554812|363902124|FG012|Overall Study|Withdrawal by Subject|1|||
105517191|NCT02554812|363902125|FG013|Overall Study|Withdrawal by Subject|1|||
105517192|NCT02554812|363902126|FG014|Overall Study|Withdrawal by Subject|1|||
105517193|NCT02554812|363902127|FG015|Overall Study|Withdrawal by Subject|1|||
105592207|NCT02701361|364169331|FG002|Overall Study|incarceration|1|||
105592208|NCT00975806|364169332|FG000|Overall Study|Adverse Event|2|||
105592209|NCT00975806|364169333|FG001|Overall Study|Adverse Event|1|||
105592210|NCT00975806|364169334|FG002|Overall Study|Adverse Event|2|||
105592211|NCT00975806|364169332|FG000|Overall Study|Disease Progression|1|||
105592212|NCT00975806|364169333|FG001|Overall Study|Disease Progression|5|||
105592213|NCT00975806|364169334|FG002|Overall Study|Disease Progression|1|||
105517194|NCT02554812|363902128|FG016|Overall Study|Withdrawal by Subject|3|||
105517195|NCT02554812|363902129|FG017|Overall Study|Withdrawal by Subject|1|||
105517196|NCT02554812|363902130|FG018|Overall Study|Withdrawal by Subject|0|||
105517197|NCT02554812|363902131|FG019|Overall Study|Withdrawal by Subject|2|||
105517198|NCT02554812|363902132|FG020|Overall Study|Withdrawal by Subject|0|||
105517199|NCT02554812|363902133|FG021|Overall Study|Withdrawal by Subject|1|||
105517200|NCT02554812|363902134|FG022|Overall Study|Withdrawal by Subject|0|||
105517201|NCT02554812|363902135|FG023|Overall Study|Withdrawal by Subject|1|||
105517202|NCT02554812|363902136|FG024|Overall Study|Withdrawal by Subject|0|||
105517203|NCT02554812|363902137|FG025|Overall Study|Withdrawal by Subject|0|||
105517204|NCT02554812|363902138|FG026|Overall Study|Withdrawal by Subject|1|||
105517205|NCT02554812|363902112|FG000|Overall Study|Physician Decision|1|||
105517206|NCT02554812|363902113|FG001|Overall Study|Physician Decision|0|||
105517207|NCT02554812|363902114|FG002|Overall Study|Physician Decision|0|||
105517208|NCT02554812|363902115|FG003|Overall Study|Physician Decision|1|||
105517209|NCT02554812|363902116|FG004|Overall Study|Physician Decision|0|||
105517210|NCT02554812|363902117|FG005|Overall Study|Physician Decision|1|||
105517211|NCT02554812|363902118|FG006|Overall Study|Physician Decision|0|||
105517212|NCT02554812|363902119|FG007|Overall Study|Physician Decision|0|||
105517213|NCT02554812|363902120|FG008|Overall Study|Physician Decision|0|||
105517214|NCT02554812|363902121|FG009|Overall Study|Physician Decision|0|||
105517215|NCT02554812|363902122|FG010|Overall Study|Physician Decision|1|||
105517216|NCT02554812|363902123|FG011|Overall Study|Physician Decision|0|||
105517217|NCT02554812|363902124|FG012|Overall Study|Physician Decision|0|||
105517218|NCT02554812|363902125|FG013|Overall Study|Physician Decision|0|||
105517219|NCT02554812|363902126|FG014|Overall Study|Physician Decision|0|||
105517220|NCT02554812|363902127|FG015|Overall Study|Physician Decision|0|||
105517221|NCT02554812|363902128|FG016|Overall Study|Physician Decision|1|||
105517222|NCT02554812|363902129|FG017|Overall Study|Physician Decision|1|||
105517223|NCT02554812|363902130|FG018|Overall Study|Physician Decision|0|||
105517224|NCT02554812|363902131|FG019|Overall Study|Physician Decision|1|||
105517225|NCT02554812|363902132|FG020|Overall Study|Physician Decision|1|||
105517226|NCT02554812|363902133|FG021|Overall Study|Physician Decision|0|||
105517227|NCT02554812|363902134|FG022|Overall Study|Physician Decision|1|||
105517228|NCT02554812|363902135|FG023|Overall Study|Physician Decision|0|||
105517229|NCT02554812|363902136|FG024|Overall Study|Physician Decision|0|||
105517230|NCT02554812|363902137|FG025|Overall Study|Physician Decision|0|||
105517231|NCT02554812|363902138|FG026|Overall Study|Physician Decision|0|||
105517232|NCT02554812|363902112|FG000|Overall Study|Study terminated by sponsor|0|||
105517233|NCT02554812|363902113|FG001|Overall Study|Study terminated by sponsor|0|||
105517234|NCT02554812|363902114|FG002|Overall Study|Study terminated by sponsor|0|||
105517235|NCT02554812|363902115|FG003|Overall Study|Study terminated by sponsor|0|||
105517236|NCT02554812|363902116|FG004|Overall Study|Study terminated by sponsor|0|||
105517237|NCT02554812|363902117|FG005|Overall Study|Study terminated by sponsor|0|||
105517238|NCT02554812|363902118|FG006|Overall Study|Study terminated by sponsor|0|||
105517239|NCT02554812|363902119|FG007|Overall Study|Study terminated by sponsor|0|||
105517240|NCT02554812|363902120|FG008|Overall Study|Study terminated by sponsor|0|||
105517241|NCT02554812|363902121|FG009|Overall Study|Study terminated by sponsor|0|||
105517242|NCT02554812|363902122|FG010|Overall Study|Study terminated by sponsor|0|||
105517243|NCT02554812|363902123|FG011|Overall Study|Study terminated by sponsor|0|||
105517244|NCT02554812|363902124|FG012|Overall Study|Study terminated by sponsor|0|||
105517245|NCT02554812|363902125|FG013|Overall Study|Study terminated by sponsor|0|||
105517246|NCT02554812|363902126|FG014|Overall Study|Study terminated by sponsor|0|||
105517247|NCT02554812|363902127|FG015|Overall Study|Study terminated by sponsor|0|||
105517248|NCT02554812|363902128|FG016|Overall Study|Study terminated by sponsor|0|||
105517249|NCT02554812|363902129|FG017|Overall Study|Study terminated by sponsor|0|||
105517250|NCT02554812|363902130|FG018|Overall Study|Study terminated by sponsor|0|||
105517251|NCT02554812|363902131|FG019|Overall Study|Study terminated by sponsor|0|||
105592214|NCT00975806|364169332|FG000|Overall Study|Withdrawal by Subject|1|||
105517252|NCT02554812|363902132|FG020|Overall Study|Study terminated by sponsor|0|||
105517253|NCT02554812|363902133|FG021|Overall Study|Study terminated by sponsor|0|||
105517254|NCT02554812|363902134|FG022|Overall Study|Study terminated by sponsor|0|||
105517255|NCT02554812|363902135|FG023|Overall Study|Study terminated by sponsor|0|||
105517256|NCT02554812|363902136|FG024|Overall Study|Study terminated by sponsor|1|||
105517257|NCT02554812|363902137|FG025|Overall Study|Study terminated by sponsor|0|||
105517258|NCT02554812|363902138|FG026|Overall Study|Study terminated by sponsor|0|||
105517259|NCT02554812|363902112|FG000|Overall Study|No longer meets eligibility criteria|0|||
105517260|NCT02554812|363902113|FG001|Overall Study|No longer meets eligibility criteria|1|||
105592215|NCT00975806|364169333|FG001|Overall Study|Withdrawal by Subject|0|||
105592216|NCT00975806|364169334|FG002|Overall Study|Withdrawal by Subject|0|||
105592217|NCT00975806|364169332|FG000|Overall Study|Death|0|||
105517261|NCT02554812|363902114|FG002|Overall Study|No longer meets eligibility criteria|0|||
105517262|NCT02554812|363902115|FG003|Overall Study|No longer meets eligibility criteria|0|||
105517263|NCT02554812|363902116|FG004|Overall Study|No longer meets eligibility criteria|0|||
105517264|NCT02554812|363902117|FG005|Overall Study|No longer meets eligibility criteria|0|||
105517265|NCT02554812|363902118|FG006|Overall Study|No longer meets eligibility criteria|0|||
105517266|NCT02554812|363902119|FG007|Overall Study|No longer meets eligibility criteria|0|||
105517267|NCT02554812|363902120|FG008|Overall Study|No longer meets eligibility criteria|0|||
105517268|NCT02554812|363902121|FG009|Overall Study|No longer meets eligibility criteria|0|||
105517269|NCT02554812|363902122|FG010|Overall Study|No longer meets eligibility criteria|0|||
105517270|NCT02554812|363902123|FG011|Overall Study|No longer meets eligibility criteria|0|||
105517271|NCT02554812|363902124|FG012|Overall Study|No longer meets eligibility criteria|0|||
105517272|NCT02554812|363902125|FG013|Overall Study|No longer meets eligibility criteria|0|||
105517273|NCT02554812|363902126|FG014|Overall Study|No longer meets eligibility criteria|0|||
105517274|NCT02554812|363902127|FG015|Overall Study|No longer meets eligibility criteria|0|||
105517275|NCT02554812|363902128|FG016|Overall Study|No longer meets eligibility criteria|0|||
105517276|NCT02554812|363902129|FG017|Overall Study|No longer meets eligibility criteria|0|||
105517277|NCT02554812|363902130|FG018|Overall Study|No longer meets eligibility criteria|0|||
105517278|NCT02554812|363902131|FG019|Overall Study|No longer meets eligibility criteria|0|||
105517279|NCT02554812|363902132|FG020|Overall Study|No longer meets eligibility criteria|0|||
105517280|NCT02554812|363902133|FG021|Overall Study|No longer meets eligibility criteria|0|||
105517281|NCT02554812|363902134|FG022|Overall Study|No longer meets eligibility criteria|0|||
105517282|NCT02554812|363902135|FG023|Overall Study|No longer meets eligibility criteria|0|||
105517283|NCT02554812|363902136|FG024|Overall Study|No longer meets eligibility criteria|0|||
105517284|NCT02554812|363902137|FG025|Overall Study|No longer meets eligibility criteria|0|||
105517285|NCT02554812|363902138|FG026|Overall Study|No longer meets eligibility criteria|0|||
105517286|NCT03804879|363903421|FG000|Overall Study|Adverse Event|3|||
105517287|NCT03804879|363903422|FG001|Overall Study|Adverse Event|0|||
105517288|NCT03804879|363903421|FG000|Overall Study|Study Terminated By Sponsor|10|||
105517289|NCT03804879|363903422|FG001|Overall Study|Study Terminated By Sponsor|12|||
105517290|NCT03804879|363903421|FG000|Overall Study|Withdrawal by Subject|3|||
105517291|NCT03804879|363903422|FG001|Overall Study|Withdrawal by Subject|1|||
105517292|NCT00708643|363903423|FG000|Overall Study|Adverse Event|0|||
105517293|NCT00708643|363903424|FG001|Overall Study|Adverse Event|1|||
105517294|NCT00788151|363903425|FG000|Overall Study|Other adverse event|0|||
105517295|NCT00788151|363903426|FG001|Overall Study|Other adverse event|2|||
105517296|NCT00788151|363903425|FG000|Overall Study|Protocol Violation|0|||
105517297|NCT00788151|363903426|FG001|Overall Study|Protocol Violation|1|||
105517298|NCT00788151|363903425|FG000|Overall Study|Withdrawal by Subject|13|||
105517299|NCT00788151|363903426|FG001|Overall Study|Withdrawal by Subject|6|||
105517300|NCT00788151|363903425|FG000|Overall Study|Enrolled but not treated|1|||
105517301|NCT00788151|363903426|FG001|Overall Study|Enrolled but not treated|1|||
105517302|NCT01647282|363903429|FG000|Overall Study|Physician Decision|7|||
105517303|NCT01647282|363903430|FG001|Overall Study|Physician Decision|5|||
105517304|NCT00227903|363903431|FG000|Overall Study|Withdrawal by Subject|2|||
105517305|NCT00227903|363903432|FG001|Overall Study|Withdrawal by Subject|5|||
105517306|NCT00227903|363903431|FG000|Overall Study|Subject moved out of area|1|||
105517307|NCT00227903|363903432|FG001|Overall Study|Subject moved out of area|2|||
105517308|NCT00227903|363903431|FG000|Overall Study|Lost to Follow-up|1|||
105517309|NCT00227903|363903432|FG001|Overall Study|Lost to Follow-up|3|||
105517310|NCT00227903|363903431|FG000|Overall Study|Miscarriage|1|||
105517311|NCT00227903|363903432|FG001|Overall Study|Miscarriage|0|||
105517312|NCT02345811|363903433|FG000|First Intervention|Withdrawal by Subject|1|||
105517313|NCT02345811|363903434|FG001|First Intervention|Withdrawal by Subject|1|||
105517314|NCT01244906|363903435|FG000|Overall Study|Death|2|||
105517315|NCT01244906|363903435|FG000|Overall Study|Progression of disease post treatment|6|||
105517316|NCT00849381|363903437|FG000|Overall Study|Adverse Event|1|||
105517317|NCT00849381|363903437|FG000|Overall Study|Lost to Follow-up|129|||
105517318|NCT00849381|363903437|FG000|Overall Study|Protocol Violation|5|||
105517319|NCT00849381|363903437|FG000|Overall Study|Withdrawal by Subject|6|||
105517320|NCT00849381|363903437|FG000|Overall Study|Other|4|||
105517321|NCT00723892|363903438|FG000|Overall Study|Participant not tracked|33|||
105517322|NCT00723892|363903439|FG001|Overall Study|Participant not tracked|35|||
105517323|NCT00723892|363903438|FG000|Overall Study|Virological criterion|24|||
105517324|NCT00723892|363903439|FG001|Overall Study|Virological criterion|9|||
105517325|NCT00723892|363903438|FG000|Overall Study|Withdrawal by Subject|6|||
105517326|NCT00723892|363903439|FG001|Overall Study|Withdrawal by Subject|9|||
105517327|NCT00723892|363903438|FG000|Overall Study|End planned|11|||
105517328|NCT00723892|363903439|FG001|Overall Study|End planned|7|||
105517329|NCT00723892|363903438|FG000|Overall Study|Bad tolerance|5|||
105517330|NCT00723892|363903439|FG001|Overall Study|Bad tolerance|5|||
105517331|NCT00723892|363903438|FG000|Overall Study|Multiple reasons|17|||
105517332|NCT00723892|363903439|FG001|Overall Study|Multiple reasons|12|||
105517333|NCT00723892|363903438|FG000|Overall Study|Other|6|||
105517334|NCT00723892|363903439|FG001|Overall Study|Other|3|||
105517335|NCT00723892|363903438|FG000|Overall Study|Study end|1|||
105517336|NCT00723892|363903439|FG001|Overall Study|Study end|3|||
105517337|NCT00723892|363903438|FG000|Overall Study|Weight loss|1|||
105517338|NCT00723892|363903439|FG001|Overall Study|Weight loss|3|||
105517339|NCT00723892|363903438|FG000|Overall Study|Alcohol abuse|0|||
105517340|NCT00723892|363903439|FG001|Overall Study|Alcohol abuse|1|||
105517341|NCT00723892|363903438|FG000|Overall Study|Intercurrent infection|2|||
105517342|NCT00723892|363903439|FG001|Overall Study|Intercurrent infection|0|||
105517343|NCT00723892|363903438|FG000|Overall Study|Drug addiction|1|||
105517344|NCT00723892|363903439|FG001|Overall Study|Drug addiction|0|||
105517345|NCT00303498|363903440|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
105517346|NCT00303498|363903441|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
105517347|NCT00303498|363903440|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
105517348|NCT00303498|363903441|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
105517349|NCT00303498|363903440|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
105517350|NCT00303498|363903441|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
105517351|NCT00303498|363903440|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
105517352|NCT00303498|363903441|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
105517353|NCT00303498|363903440|FG000|Run-In-Phase (10 Weeks)|Other|4|||
105517354|NCT00303498|363903441|FG001|Run-In-Phase (10 Weeks)|Other|1|||
105517355|NCT00303498|363903440|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
105517356|NCT00303498|363903441|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
105517357|NCT00303498|363903440|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
105517358|NCT00303498|363903441|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
105517359|NCT00303498|363903440|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
105517360|NCT00303498|363903441|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
105517361|NCT00303498|363903440|FG000|Maintenance Phase (24 Weeks)|Death|1|||
105517362|NCT00303498|363903441|FG001|Maintenance Phase (24 Weeks)|Death|0|||
105517363|NCT00303498|363903440|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
105517364|NCT00303498|363903441|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
105517365|NCT00303498|363903440|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
105517366|NCT00303498|363903441|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
105517367|NCT00303498|363903440|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
105517368|NCT00303498|363903441|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
105517369|NCT00303498|363903440|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
105517370|NCT00303498|363903441|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
105517371|NCT00303498|363903440|FG000|Maintenance Phase (24 Weeks)|Other|1|||
105517372|NCT00303498|363903441|FG001|Maintenance Phase (24 Weeks)|Other|0|||
105517373|NCT00303498|363903440|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
105517374|NCT00303498|363903441|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
105517375|NCT00303498|363903440|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
105517376|NCT00303498|363903441|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
105517377|NCT02618434|363903442|FG000|Overall Study|Withdrawal by Subject|0|||
105517378|NCT02618434|363903443|FG001|Overall Study|Withdrawal by Subject|2|||
105517379|NCT02618434|363903444|FG002|Overall Study|Withdrawal by Subject|3|||
105517380|NCT02618434|363903442|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
105517381|NCT02618434|363903443|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
105517382|NCT02618434|363903444|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
105517383|NCT02618434|363903442|FG000|Overall Study|Lost to Follow-up|3|||
105517384|NCT02618434|363903443|FG001|Overall Study|Lost to Follow-up|1|||
105517385|NCT02618434|363903444|FG002|Overall Study|Lost to Follow-up|3|||
105517386|NCT02618434|363903442|FG000|Overall Study|Adverse Event|1|||
105517387|NCT02618434|363903443|FG001|Overall Study|Adverse Event|0|||
105517388|NCT02618434|363903444|FG002|Overall Study|Adverse Event|12|||
105517389|NCT02618434|363903442|FG000|Overall Study|Physician Decision|0|||
105517390|NCT02618434|363903443|FG001|Overall Study|Physician Decision|1|||
105517391|NCT02618434|363903444|FG002|Overall Study|Physician Decision|0|||
105517392|NCT02618434|363903442|FG000|Overall Study|Protocol Violation|0|||
105517393|NCT02618434|363903443|FG001|Overall Study|Protocol Violation|0|||
105517394|NCT02618434|363903444|FG002|Overall Study|Protocol Violation|1|||
105517395|NCT02618434|363903442|FG000|Overall Study|Other, Multiple categories|1|||
105517396|NCT02618434|363903443|FG001|Overall Study|Other, Multiple categories|1|||
105517397|NCT02618434|363903444|FG002|Overall Study|Other, Multiple categories|1|||
105517398|NCT03590041|363903445|FG000|Overall Study|Protocol Violation|4|||
105517399|NCT03590041|363903446|FG001|Overall Study|Protocol Violation|3|||
105517400|NCT03590041|363903445|FG000|Overall Study|No session data recorded|14|||
105517401|NCT03590041|363903446|FG001|Overall Study|No session data recorded|2|||
105517402|NCT02772081|363903449|FG000|Overall Study|Physician Decision|1|||
105517403|NCT02772081|363903450|FG001|Overall Study|Physician Decision|1|||
105517404|NCT02772081|363903449|FG000|Overall Study|Death|1|||
105517405|NCT02772081|363903450|FG001|Overall Study|Death|1|||
105517406|NCT00498602|363903453|FG000|Overall Study|Death|0|||
105517407|NCT00498602|363903454|FG001|Overall Study|Death|0|||
105517408|NCT00498602|363903455|FG002|Overall Study|Death|0|||
105517409|NCT00498602|363903456|FG003|Overall Study|Death|0|||
105517410|NCT00498602|363903457|FG004|Overall Study|Death|0|||
105517411|NCT00498602|363903458|FG005|Overall Study|Death|1|||
105517412|NCT00498602|363903459|FG006|Overall Study|Death|0|||
105517413|NCT00498602|363903453|FG000|Overall Study|Lack of Efficacy|1|||
105517414|NCT00498602|363903454|FG001|Overall Study|Lack of Efficacy|0|||
105517415|NCT00498602|363903455|FG002|Overall Study|Lack of Efficacy|0|||
105517416|NCT00498602|363903456|FG003|Overall Study|Lack of Efficacy|0|||
105517417|NCT00498602|363903457|FG004|Overall Study|Lack of Efficacy|0|||
105517418|NCT00498602|363903458|FG005|Overall Study|Lack of Efficacy|0|||
105517419|NCT00498602|363903459|FG006|Overall Study|Lack of Efficacy|0|||
105517420|NCT00498602|363903453|FG000|Overall Study|Lost to Follow-up|0|||
105517421|NCT00498602|363903454|FG001|Overall Study|Lost to Follow-up|2|||
105517422|NCT00498602|363903455|FG002|Overall Study|Lost to Follow-up|0|||
105517423|NCT00498602|363903456|FG003|Overall Study|Lost to Follow-up|2|||
105517424|NCT00498602|363903457|FG004|Overall Study|Lost to Follow-up|0|||
105517425|NCT00498602|363903458|FG005|Overall Study|Lost to Follow-up|0|||
105517426|NCT00498602|363903459|FG006|Overall Study|Lost to Follow-up|0|||
105517427|NCT00498602|363903453|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
105517428|NCT00498602|363903454|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
105517429|NCT00498602|363903455|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
105517430|NCT00498602|363903456|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
105517431|NCT00498602|363903457|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
105517432|NCT00498602|363903458|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
105517433|NCT00498602|363903459|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
105517434|NCT00498602|363903453|FG000|Overall Study|AE not related to Study Drug|1|||
105517435|NCT00498602|363903454|FG001|Overall Study|AE not related to Study Drug|3|||
105517436|NCT00498602|363903455|FG002|Overall Study|AE not related to Study Drug|0|||
105517437|NCT00498602|363903456|FG003|Overall Study|AE not related to Study Drug|0|||
105517438|NCT00498602|363903457|FG004|Overall Study|AE not related to Study Drug|2|||
105517439|NCT00498602|363903458|FG005|Overall Study|AE not related to Study Drug|2|||
105517440|NCT00498602|363903459|FG006|Overall Study|AE not related to Study Drug|1|||
105517441|NCT00498602|363903453|FG000|Overall Study|Caregiver Request|2|||
105517442|NCT00498602|363903454|FG001|Overall Study|Caregiver Request|2|||
105517443|NCT00498602|363903455|FG002|Overall Study|Caregiver Request|2|||
105517444|NCT00498602|363903456|FG003|Overall Study|Caregiver Request|0|||
105517445|NCT00498602|363903457|FG004|Overall Study|Caregiver Request|1|||
105517446|NCT00498602|363903458|FG005|Overall Study|Caregiver Request|2|||
105517447|NCT00498602|363903459|FG006|Overall Study|Caregiver Request|0|||
105517448|NCT00498602|363903453|FG000|Overall Study|Investigator Request|0|||
105517449|NCT00498602|363903454|FG001|Overall Study|Investigator Request|0|||
105517450|NCT00498602|363903455|FG002|Overall Study|Investigator Request|1|||
105517451|NCT00498602|363903456|FG003|Overall Study|Investigator Request|0|||
105517452|NCT00498602|363903457|FG004|Overall Study|Investigator Request|0|||
105517453|NCT00498602|363903458|FG005|Overall Study|Investigator Request|0|||
105517454|NCT00498602|363903459|FG006|Overall Study|Investigator Request|0|||
105517455|NCT00498602|363903453|FG000|Overall Study|Subject Request|3|||
105517456|NCT00498602|363903454|FG001|Overall Study|Subject Request|0|||
105517457|NCT00498602|363903455|FG002|Overall Study|Subject Request|1|||
105517458|NCT00498602|363903456|FG003|Overall Study|Subject Request|1|||
105517459|NCT00498602|363903457|FG004|Overall Study|Subject Request|1|||
105517460|NCT00498602|363903458|FG005|Overall Study|Subject Request|4|||
105517461|NCT00498602|363903459|FG006|Overall Study|Subject Request|1|||
105517462|NCT00498602|363903453|FG000|Overall Study|Other|2|||
105517463|NCT00498602|363903454|FG001|Overall Study|Other|3|||
105517464|NCT00498602|363903455|FG002|Overall Study|Other|1|||
105592218|NCT00975806|364169333|FG001|Overall Study|Death|1|||
105592219|NCT00975806|364169334|FG002|Overall Study|Death|0|||
105592220|NCT00975806|364169332|FG000|Overall Study|Physician decision and disease related|1|||
105592221|NCT00975806|364169333|FG001|Overall Study|Physician decision and disease related|0|||
105517465|NCT00498602|363903456|FG003|Overall Study|Other|0|||
105517466|NCT00498602|363903457|FG004|Overall Study|Other|0|||
105517467|NCT00498602|363903458|FG005|Overall Study|Other|3|||
105517468|NCT00498602|363903459|FG006|Overall Study|Other|0|||
105517469|NCT03103919|363903463|FG000|Overall Study|Adverse Event|2|||
105517470|NCT03103919|363903464|FG001|Overall Study|Adverse Event|2|||
105517471|NCT00546637|363903465|FG000|Overall Study|Adverse Event|46|||
105517472|NCT00546637|363903466|FG001|Overall Study|Adverse Event|20|||
105517473|NCT00546637|363903465|FG000|Overall Study|Lack of Efficacy|5|||
105517474|NCT00546637|363903466|FG001|Overall Study|Lack of Efficacy|5|||
105517475|NCT00546637|363903465|FG000|Overall Study|Lost to Follow-up|2|||
105517476|NCT00546637|363903466|FG001|Overall Study|Lost to Follow-up|2|||
105517477|NCT00546637|363903465|FG000|Overall Study|Other|10|||
105517478|NCT00546637|363903466|FG001|Overall Study|Other|12|||
105517479|NCT00546637|363903465|FG000|Overall Study|Withdrawal by Subject|7|||
105592222|NCT00975806|364169334|FG002|Overall Study|Physician decision and disease related|1|||
105517480|NCT00546637|363903466|FG001|Overall Study|Withdrawal by Subject|9|||
105517481|NCT00546637|363903465|FG000|Overall Study|Randomized, but not treated|3|||
105517482|NCT00546637|363903466|FG001|Overall Study|Randomized, but not treated|1|||
105517483|NCT03998189|363903467|FG000|Overall Study|Lack of Efficacy|0|||
105517484|NCT03998189|363903468|FG001|Overall Study|Lack of Efficacy|1|||
105517485|NCT02728895|363903470|FG000|Overall Study|Other|1|||
105517486|NCT02728895|363903471|FG001|Overall Study|Other|2|||
105517487|NCT02728895|363903470|FG000|Overall Study|Withdrawal by Subject|0|||
105517488|NCT02728895|363903471|FG001|Overall Study|Withdrawal by Subject|3|||
105517489|NCT01846507|363903472|FG000|Overall Study|Lost to Follow-up|4|||
105517490|NCT01846507|363903472|FG000|Overall Study|Protocol Violation|1|||
105517491|NCT01846507|363903472|FG000|Overall Study|Missing data|2|||
105517492|NCT04984993|363903473|FG000|Overall Study|Withdrawal by Subject|8|||
105517493|NCT04984993|363903474|FG001|Overall Study|Withdrawal by Subject|2|||
105517494|NCT04984993|363903473|FG000|Overall Study|Lost to Follow-up|2|||
105517495|NCT04984993|363903474|FG001|Overall Study|Lost to Follow-up|2|||
105517496|NCT04984993|363903473|FG000|Overall Study|Both patients moved to another country|4|||
105517497|NCT04984993|363903474|FG001|Overall Study|Both patients moved to another country|0|||
105517498|NCT02865187|363903477|FG000|Overall Study|Lost to Follow-up|12|||
105517499|NCT02865187|363903478|FG001|Overall Study|Lost to Follow-up|7|||
105517500|NCT02865187|363903477|FG000|Overall Study|Adverse Event|1|||
105517501|NCT02865187|363903478|FG001|Overall Study|Adverse Event|0|||
105517502|NCT01110707|363903479|FG000|Overall Study|Protocol Violation|0|||
105517503|NCT01110707|363903480|FG001|Overall Study|Protocol Violation|3|||
105517504|NCT04577118|363903483|FG000|Overall Study|Withdrawal by Subject|4|||
105517505|NCT00333866|363903490|FG000|Overall Study|Adverse Event|23|||
105517506|NCT00333866|363903491|FG001|Overall Study|Adverse Event|37|||
105517507|NCT00333866|363903492|FG002|Overall Study|Adverse Event|38|||
105517508|NCT00333866|363903493|FG003|Overall Study|Adverse Event|47|||
105517509|NCT00333866|363903490|FG000|Overall Study|Other|3|||
105517510|NCT00333866|363903491|FG001|Overall Study|Other|2|||
105517511|NCT00333866|363903492|FG002|Overall Study|Other|2|||
105517512|NCT00333866|363903493|FG003|Overall Study|Other|2|||
105517513|NCT00333866|363903490|FG000|Overall Study|Lack of Efficacy|8|||
105517514|NCT00333866|363903491|FG001|Overall Study|Lack of Efficacy|6|||
105517515|NCT00333866|363903492|FG002|Overall Study|Lack of Efficacy|3|||
105517516|NCT00333866|363903493|FG003|Overall Study|Lack of Efficacy|5|||
105517517|NCT00333866|363903490|FG000|Overall Study|Lost to Follow-up|1|||
105517518|NCT00333866|363903491|FG001|Overall Study|Lost to Follow-up|2|||
105517519|NCT00333866|363903492|FG002|Overall Study|Lost to Follow-up|2|||
105517520|NCT00333866|363903493|FG003|Overall Study|Lost to Follow-up|2|||
105517521|NCT00333866|363903490|FG000|Overall Study|Withdrawal by Subject|8|||
105517522|NCT00333866|363903491|FG001|Overall Study|Withdrawal by Subject|14|||
105517523|NCT00333866|363903492|FG002|Overall Study|Withdrawal by Subject|4|||
105517524|NCT00333866|363903493|FG003|Overall Study|Withdrawal by Subject|9|||
105517525|NCT00333866|363903490|FG000|Overall Study|Randomized but not Treated|5|||
105517526|NCT00333866|363903491|FG001|Overall Study|Randomized but not Treated|3|||
105517527|NCT00333866|363903492|FG002|Overall Study|Randomized but not Treated|2|||
105517528|NCT00333866|363903493|FG003|Overall Study|Randomized but not Treated|1|||
105517529|NCT02710045|363903494|FG000|Overall Study|Death|1|||
105517530|NCT02710045|363903495|FG001|Overall Study|Death|2|||
105517531|NCT02710045|363903496|FG002|Overall Study|Death|0|||
105517532|NCT02710045|363903494|FG000|Overall Study|Withdrawal by Subject|6|||
105517533|NCT02710045|363903495|FG001|Overall Study|Withdrawal by Subject|6|||
105517534|NCT02710045|363903496|FG002|Overall Study|Withdrawal by Subject|2|||
105517535|NCT02710045|363903494|FG000|Overall Study|Protocol Violation|1|||
105517536|NCT02710045|363903495|FG001|Overall Study|Protocol Violation|2|||
105517537|NCT02710045|363903496|FG002|Overall Study|Protocol Violation|3|||
105517538|NCT02710045|363903494|FG000|Overall Study|Lost to Follow-up|3|||
105517539|NCT02710045|363903495|FG001|Overall Study|Lost to Follow-up|6|||
105517540|NCT02710045|363903496|FG002|Overall Study|Lost to Follow-up|7|||
105517541|NCT02710045|363903494|FG000|Overall Study|Physician Decision|0|||
105517542|NCT02710045|363903495|FG001|Overall Study|Physician Decision|0|||
105517543|NCT02710045|363903496|FG002|Overall Study|Physician Decision|1|||
105517544|NCT02710045|363903494|FG000|Overall Study|Poor Attendance|0|||
105517545|NCT02710045|363903495|FG001|Overall Study|Poor Attendance|1|||
105517546|NCT02710045|363903496|FG002|Overall Study|Poor Attendance|0|||
105517547|NCT00143403|363903497|FG000|Overall Study|Adverse Event|3|||
105517548|NCT00143403|363903498|FG001|Overall Study|Adverse Event|8|||
105517549|NCT00143403|363903497|FG000|Overall Study|Death|1|||
105517550|NCT00143403|363903498|FG001|Overall Study|Death|0|||
105517551|NCT00143403|363903497|FG000|Overall Study|Withdrawal by Subject|3|||
105517552|NCT00143403|363903498|FG001|Overall Study|Withdrawal by Subject|12|||
105517553|NCT00143403|363903497|FG000|Overall Study|Relapse|15|||
105517554|NCT00143403|363903498|FG001|Overall Study|Relapse|7|||
105517555|NCT00143403|363903497|FG000|Overall Study|Protocol Violation|2|||
105517556|NCT00143403|363903498|FG001|Overall Study|Protocol Violation|2|||
105517557|NCT00143403|363903497|FG000|Overall Study|specified by site|4|||
105517558|NCT00143403|363903498|FG001|Overall Study|specified by site|9|||
105517559|NCT00143403|363903497|FG000|Overall Study|Randomized Not Treated|7|||
105517560|NCT00143403|363903498|FG001|Overall Study|Randomized Not Treated|8|||
105517561|NCT02956486|363903499|FG000|Core Phase|Adverse Event|51|||
105517562|NCT02956486|363903500|FG001|Core Phase|Adverse Event|88|||
105517563|NCT02956486|363903501|FG002|Core Phase|Adverse Event|0|||
105517564|NCT02956486|363903499|FG000|Core Phase|Lost to Follow-up|8|||
105517565|NCT02956486|363903500|FG001|Core Phase|Lost to Follow-up|6|||
105517566|NCT02956486|363903501|FG002|Core Phase|Lost to Follow-up|0|||
105517567|NCT02956486|363903499|FG000|Core Phase|Inadequate therapeutic effect|4|||
105517568|NCT02956486|363903500|FG001|Core Phase|Inadequate therapeutic effect|5|||
105517569|NCT02956486|363903501|FG002|Core Phase|Inadequate therapeutic effect|0|||
105517570|NCT02956486|363903499|FG000|Core Phase|Withdrawal by Subject|101|||
105517571|NCT02956486|363903500|FG001|Core Phase|Withdrawal by Subject|104|||
105517572|NCT02956486|363903501|FG002|Core Phase|Withdrawal by Subject|0|||
105517573|NCT02956486|363903499|FG000|Core Phase|Study terminated by sponsor|888|||
105517574|NCT02956486|363903500|FG001|Core Phase|Study terminated by sponsor|848|||
105517575|NCT02956486|363903501|FG002|Core Phase|Study terminated by sponsor|0|||
105517576|NCT02956486|363903499|FG000|Core Phase|Other|27|||
105517577|NCT02956486|363903500|FG001|Core Phase|Other|18|||
105517578|NCT02956486|363903501|FG002|Core Phase|Other|0|||
105517579|NCT02956486|363903499|FG000|Core Phase|Not treated|0|||
105517580|NCT02956486|363903500|FG001|Core Phase|Not treated|3|||
105517581|NCT02956486|363903501|FG002|Core Phase|Not treated|0|||
105517582|NCT02956486|363903499|FG000|Extension Phase|Adverse Event|0|||
105517583|NCT02956486|363903500|FG001|Extension Phase|Adverse Event|0|||
105517584|NCT02956486|363903501|FG002|Extension Phase|Adverse Event|2|||
105517585|NCT02956486|363903499|FG000|Extension Phase|Study terminated by sponsor|0|||
105517586|NCT02956486|363903500|FG001|Extension Phase|Study terminated by sponsor|0|||
105517587|NCT02956486|363903501|FG002|Extension Phase|Study terminated by sponsor|16|||
105517588|NCT02956486|363903499|FG000|Extension Phase|Not Treated|0|||
105517589|NCT02956486|363903500|FG001|Extension Phase|Not Treated|0|||
105517590|NCT02956486|363903501|FG002|Extension Phase|Not Treated|1|||
105517591|NCT00495170|363903502|FG000|Overall Study|Lost to Follow-up|9|||
105517592|NCT00495170|363903502|FG000|Overall Study|Withdrawal by Subject|3|||
105517593|NCT00495170|363903502|FG000|Overall Study|Inappropriate staging|8|||
105517594|NCT03557151|363903506|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
105517595|NCT03557151|363903507|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
105517596|NCT03557151|363903506|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
105517597|NCT03557151|363903507|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
105517598|NCT03557151|363903506|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
105517599|NCT03557151|363903507|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
105517600|NCT02810392|363903508|FG000|Overall Study|Subject too ill to continue|1|||
105517601|NCT02810392|363903509|FG001|Overall Study|Subject too ill to continue|0|||
105517602|NCT02810392|363903508|FG000|Overall Study|COVID 19 research restrictions|0|||
105517603|NCT02810392|363903509|FG001|Overall Study|COVID 19 research restrictions|1|||
105517604|NCT04903626|363903510|FG000|Overall Study|Lost to Follow-up|6|||
105517605|NCT04903626|363903510|FG000|Overall Study|Withdrawal by Subject|1|||
105517606|NCT04903626|363903510|FG000|Overall Study|Other, Not Specified|1|||
105517607|NCT02056340|363903514|FG000|Overall Study|Lost to Follow-up|5|||
105517608|NCT02056340|363903515|FG001|Overall Study|Lost to Follow-up|5|||
105517609|NCT02056340|363903514|FG000|Overall Study|Withdrawal by Subject|2|||
105517610|NCT02056340|363903515|FG001|Overall Study|Withdrawal by Subject|6|||
105517611|NCT01214629|363903517|FG000|Overall Study|Progressive Disease|1|||
105517612|NCT01214629|363903518|FG001|Overall Study|Progressive Disease|1|||
105517613|NCT01214629|363903519|FG002|Overall Study|Progressive Disease|0|||
105517614|NCT01214629|363903520|FG003|Overall Study|Progressive Disease|1|||
105517615|NCT01214629|363903521|FG004|Overall Study|Progressive Disease|2|||
105517616|NCT01214629|363903522|FG005|Overall Study|Progressive Disease|3|||
105517617|NCT01214629|363903523|FG006|Overall Study|Progressive Disease|1|||
105517618|NCT01214629|363903524|FG007|Overall Study|Progressive Disease|1|||
105517619|NCT01214629|363903525|FG008|Overall Study|Progressive Disease|1|||
105517620|NCT01214629|363903526|FG009|Overall Study|Progressive Disease|5|||
105517621|NCT01214629|363903527|FG010|Overall Study|Progressive Disease|1|||
105517622|NCT01214629|363903517|FG000|Overall Study|Adverse Event|0|||
105517623|NCT01214629|363903518|FG001|Overall Study|Adverse Event|0|||
105517624|NCT01214629|363903519|FG002|Overall Study|Adverse Event|0|||
105517625|NCT01214629|363903520|FG003|Overall Study|Adverse Event|1|||
105517626|NCT01214629|363903521|FG004|Overall Study|Adverse Event|0|||
105517627|NCT01214629|363903522|FG005|Overall Study|Adverse Event|1|||
105517628|NCT01214629|363903523|FG006|Overall Study|Adverse Event|0|||
105517629|NCT01214629|363903524|FG007|Overall Study|Adverse Event|0|||
105517630|NCT01214629|363903525|FG008|Overall Study|Adverse Event|0|||
105517631|NCT01214629|363903526|FG009|Overall Study|Adverse Event|1|||
105517632|NCT01214629|363903527|FG010|Overall Study|Adverse Event|0|||
105517633|NCT01214629|363903517|FG000|Overall Study|Physician Decision|0|||
105517634|NCT01214629|363903518|FG001|Overall Study|Physician Decision|0|||
105517635|NCT01214629|363903519|FG002|Overall Study|Physician Decision|0|||
105517636|NCT01214629|363903520|FG003|Overall Study|Physician Decision|0|||
105517637|NCT01214629|363903521|FG004|Overall Study|Physician Decision|0|||
105517638|NCT01214629|363903522|FG005|Overall Study|Physician Decision|0|||
105517639|NCT01214629|363903523|FG006|Overall Study|Physician Decision|0|||
105517640|NCT01214629|363903524|FG007|Overall Study|Physician Decision|0|||
105517641|NCT01214629|363903525|FG008|Overall Study|Physician Decision|0|||
105517642|NCT01214629|363903526|FG009|Overall Study|Physician Decision|0|||
105517643|NCT01214629|363903527|FG010|Overall Study|Physician Decision|1|||
105517644|NCT01214629|363903517|FG000|Overall Study|Withdrawal by Subject|0|||
105517645|NCT01214629|363903518|FG001|Overall Study|Withdrawal by Subject|0|||
105517646|NCT01214629|363903519|FG002|Overall Study|Withdrawal by Subject|0|||
105517647|NCT01214629|363903520|FG003|Overall Study|Withdrawal by Subject|0|||
105517648|NCT01214629|363903521|FG004|Overall Study|Withdrawal by Subject|0|||
105517649|NCT01214629|363903522|FG005|Overall Study|Withdrawal by Subject|0|||
105517650|NCT01214629|363903523|FG006|Overall Study|Withdrawal by Subject|0|||
105517651|NCT01214629|363903524|FG007|Overall Study|Withdrawal by Subject|0|||
105517652|NCT01214629|363903525|FG008|Overall Study|Withdrawal by Subject|0|||
105517653|NCT01214629|363903526|FG009|Overall Study|Withdrawal by Subject|1|||
105517654|NCT01214629|363903527|FG010|Overall Study|Withdrawal by Subject|0|||
105517655|NCT02107482|363903529|FG000|Overall Study|inconveinence|2|||
105517656|NCT02107482|363903529|FG000|Overall Study|Lost to Follow-up|1|||
105517657|NCT02107482|363903529|FG000|Overall Study|Lack of Efficacy|1|||
105517658|NCT03473808|363903530|FG000|Overall Study|Withdrawal by Subject|1|||
105517659|NCT04059094|363903535|FG000|Overall Study|Adverse Event|0|||
105517660|NCT04059094|363903536|FG001|Overall Study|Adverse Event|0|||
105517661|NCT04059094|363903537|FG002|Overall Study|Adverse Event|0|||
105517662|NCT04059094|363903538|FG003|Overall Study|Adverse Event|0|||
105517663|NCT04059094|363903539|FG004|Overall Study|Adverse Event|1|||
105517664|NCT04059094|363903535|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
105517665|NCT04059094|363903536|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
105517666|NCT04059094|363903537|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
105517667|NCT04059094|363903538|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
105517668|NCT04059094|363903539|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
105517669|NCT03715764|363903540|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
105517670|NCT03715764|363903541|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
105517671|NCT03715764|363903540|FG000|3 Month Follow-up|Lost to Follow-up|2|||
105517672|NCT03715764|363903541|FG001|3 Month Follow-up|Lost to Follow-up|2|||
105517673|NCT03715764|363903540|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
105517674|NCT03715764|363903541|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
105517675|NCT03715764|363903540|FG000|6 Month Follow-up|Lost to Follow-up|3|||
105517676|NCT03715764|363903541|FG001|6 Month Follow-up|Lost to Follow-up|0|||
105517677|NCT03715764|363903540|FG000|12 Month Follow-up|Lost to Follow-up|2|||
105517678|NCT03715764|363903541|FG001|12 Month Follow-up|Lost to Follow-up|3|||
105517679|NCT03715764|363903540|FG000|12 Month Follow-up|Pregnancy|0|||
105517680|NCT03715764|363903541|FG001|12 Month Follow-up|Pregnancy|1|||
105517681|NCT03715764|363903540|FG000|12 Month Follow-up|Surgery|2|||
105517682|NCT03715764|363903541|FG001|12 Month Follow-up|Surgery|0|||
105517683|NCT03715764|363903540|FG000|12 Month Follow-up|Wrong address|1|||
105517684|NCT03715764|363903541|FG001|12 Month Follow-up|Wrong address|0|||
105517685|NCT03715764|363903540|FG000|12 Month Follow-up|No symptoms|1|||
105517686|NCT03715764|363903541|FG001|12 Month Follow-up|No symptoms|0|||
105517687|NCT03715764|363903540|FG000|12 Month Follow-up|Changed primary care centre|0|||
105517688|NCT03715764|363903541|FG001|12 Month Follow-up|Changed primary care centre|1|||
105517689|NCT01472081|363903544|FG000|Overall Study|Continuing treatment at time of analysis|1|||
105517690|NCT01472081|363903545|FG001|Overall Study|Continuing treatment at time of analysis|4|||
105517691|NCT01472081|363903546|FG002|Overall Study|Continuing treatment at time of analysis|1|||
105517692|NCT01472081|363903547|FG003|Overall Study|Continuing treatment at time of analysis|8|||
105517693|NCT01472081|363903548|FG004|Overall Study|Continuing treatment at time of analysis|9|||
105517694|NCT01472081|363903549|FG005|Overall Study|Continuing treatment at time of analysis|0|||
105517695|NCT01472081|363903544|FG000|Overall Study|Disease Progression|4|||
105517696|NCT01472081|363903545|FG001|Overall Study|Disease Progression|10|||
105517697|NCT01472081|363903546|FG002|Overall Study|Disease Progression|12|||
105517698|NCT01472081|363903547|FG003|Overall Study|Disease Progression|31|||
105517699|NCT01472081|363903548|FG004|Overall Study|Disease Progression|22|||
105517700|NCT01472081|363903549|FG005|Overall Study|Disease Progression|3|||
105517701|NCT01472081|363903544|FG000|Overall Study|Study drug toxicity|2|||
105517702|NCT01472081|363903545|FG001|Overall Study|Study drug toxicity|9|||
105517703|NCT01472081|363903546|FG002|Overall Study|Study drug toxicity|4|||
105517704|NCT01472081|363903547|FG003|Overall Study|Study drug toxicity|6|||
105517705|NCT01472081|363903548|FG004|Overall Study|Study drug toxicity|13|||
105517706|NCT01472081|363903549|FG005|Overall Study|Study drug toxicity|2|||
105517707|NCT01472081|363903544|FG000|Overall Study|Death|0|||
105517708|NCT01472081|363903545|FG001|Overall Study|Death|0|||
105517709|NCT01472081|363903546|FG002|Overall Study|Death|0|||
105517710|NCT01472081|363903547|FG003|Overall Study|Death|0|||
105517711|NCT01472081|363903548|FG004|Overall Study|Death|1|||
105517712|NCT01472081|363903549|FG005|Overall Study|Death|0|||
105517713|NCT01472081|363903544|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
105517714|NCT01472081|363903545|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
105517715|NCT01472081|363903546|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
105592223|NCT01178762|364169335|FG000|Overall Study|Lost to Follow-up|15|||
105517716|NCT01472081|363903547|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
105517717|NCT01472081|363903548|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
105517718|NCT01472081|363903549|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
105517719|NCT01472081|363903544|FG000|Overall Study|Withdrawal by Subject|0|||
105517720|NCT01472081|363903545|FG001|Overall Study|Withdrawal by Subject|0|||
105517721|NCT01472081|363903546|FG002|Overall Study|Withdrawal by Subject|0|||
105517722|NCT01472081|363903547|FG003|Overall Study|Withdrawal by Subject|0|||
105517723|NCT01472081|363903548|FG004|Overall Study|Withdrawal by Subject|0|||
105517724|NCT01472081|363903549|FG005|Overall Study|Withdrawal by Subject|1|||
105517725|NCT01472081|363903544|FG000|Overall Study|Poor/non-compliance|0|||
105517726|NCT01472081|363903545|FG001|Overall Study|Poor/non-compliance|0|||
105517727|NCT01472081|363903546|FG002|Overall Study|Poor/non-compliance|1|||
105517728|NCT01472081|363903547|FG003|Overall Study|Poor/non-compliance|0|||
105517729|NCT01472081|363903548|FG004|Overall Study|Poor/non-compliance|1|||
105517730|NCT01472081|363903549|FG005|Overall Study|Poor/non-compliance|0|||
105517731|NCT01472081|363903544|FG000|Overall Study|No longer meets study criteria|0|||
105517732|NCT01472081|363903545|FG001|Overall Study|No longer meets study criteria|0|||
105517733|NCT01472081|363903546|FG002|Overall Study|No longer meets study criteria|1|||
105517734|NCT01472081|363903547|FG003|Overall Study|No longer meets study criteria|0|||
105517735|NCT01472081|363903548|FG004|Overall Study|No longer meets study criteria|0|||
105517736|NCT01472081|363903549|FG005|Overall Study|No longer meets study criteria|0|||
105517737|NCT01472081|363903544|FG000|Overall Study|Subject request to discontinue treatment|0|||
105517738|NCT01472081|363903545|FG001|Overall Study|Subject request to discontinue treatment|3|||
105517739|NCT01472081|363903546|FG002|Overall Study|Subject request to discontinue treatment|1|||
105517740|NCT01472081|363903547|FG003|Overall Study|Subject request to discontinue treatment|1|||
105517741|NCT01472081|363903548|FG004|Overall Study|Subject request to discontinue treatment|0|||
105517742|NCT01472081|363903549|FG005|Overall Study|Subject request to discontinue treatment|0|||
105517743|NCT02289079|363903550|FG000|Overall Study|Physician Decision|2|||
105517744|NCT02289079|363903551|FG001|Overall Study|Physician Decision|0|||
105517745|NCT02289079|363903550|FG000|Overall Study|Lost to Follow-up|0|||
105517746|NCT02289079|363903551|FG001|Overall Study|Lost to Follow-up|1|||
105517747|NCT00513474|363903552|FG000|Overall Study|Death|6|||
105517748|NCT00513474|363903553|FG001|Overall Study|Death|9|||
105517749|NCT00513474|363903552|FG000|Overall Study|Participant Withdrew Consent|1|||
105517750|NCT00513474|363903553|FG001|Overall Study|Participant Withdrew Consent|0|||
105517751|NCT00531232|363905210|FG000|Overall Study|Investigator decision|0|||
105517752|NCT00531232|363905211|FG001|Overall Study|Investigator decision|0|||
105517753|NCT00531232|363905212|FG002|Overall Study|Investigator decision|4|||
105517754|NCT00531232|363905210|FG000|Overall Study|Participants refused further treatment|0|||
105517755|NCT00531232|363905211|FG001|Overall Study|Participants refused further treatment|1|||
105517756|NCT00531232|363905212|FG002|Overall Study|Participants refused further treatment|2|||
105517757|NCT00531232|363905210|FG000|Overall Study|Adverse events (AEs)|1|||
105517758|NCT00531232|363905211|FG001|Overall Study|Adverse events (AEs)|2|||
105517759|NCT00531232|363905212|FG002|Overall Study|Adverse events (AEs)|2|||
105517760|NCT00531232|363905210|FG000|Overall Study|Treatment failure|1|||
105517761|NCT00531232|363905211|FG001|Overall Study|Treatment failure|3|||
105517762|NCT00531232|363905212|FG002|Overall Study|Treatment failure|7|||
105517763|NCT00531232|363905210|FG000|Overall Study|Disease recurrence|0|||
105517764|NCT00531232|363905211|FG001|Overall Study|Disease recurrence|0|||
105517765|NCT00531232|363905212|FG002|Overall Study|Disease recurrence|1|||
105517766|NCT00531232|363905210|FG000|Overall Study|Deceased|2|||
105517767|NCT00531232|363905211|FG001|Overall Study|Deceased|2|||
105517768|NCT00531232|363905212|FG002|Overall Study|Deceased|2|||
105517769|NCT00531232|363905210|FG000|Overall Study|Withdrawal by Subject|0|||
105517770|NCT00531232|363905211|FG001|Overall Study|Withdrawal by Subject|1|||
105517771|NCT00531232|363905212|FG002|Overall Study|Withdrawal by Subject|2|||
105517772|NCT00531232|363905210|FG000|Overall Study|Other|0|||
105517773|NCT00531232|363905211|FG001|Overall Study|Other|0|||
105517774|NCT00531232|363905212|FG002|Overall Study|Other|5|||
105517775|NCT02762266|363905213|FG000|Overall Study|Physician Decision|2|||
105517776|NCT02762266|363905214|FG001|Overall Study|Physician Decision|0|||
105517777|NCT00463346|363905220|FG000|Overall Study|Withdrawal by Subject|3|||
105517778|NCT00463346|363905221|FG001|Overall Study|Withdrawal by Subject|3|||
105517779|NCT03641651|363905223|FG000|Overall Study|organizational issues at one study site|1|||
105517780|NCT03010254|363905224|FG000|Overall Study|Adverse Event|0|||
105517781|NCT03010254|363905225|FG001|Overall Study|Adverse Event|1|||
105517782|NCT03010254|363905224|FG000|Overall Study|Lost to Follow-up|4|||
105517783|NCT03010254|363905225|FG001|Overall Study|Lost to Follow-up|0|||
105517784|NCT03010254|363905224|FG000|Overall Study|Withdrawal by Subject|1|||
105517785|NCT03010254|363905225|FG001|Overall Study|Withdrawal by Subject|1|||
105517786|NCT03010254|363905224|FG000|Overall Study|Other|2|||
105517787|NCT03010254|363905225|FG001|Overall Study|Other|3|||
105517788|NCT00951665|363905226|FG000|Phase 1b|Adverse Event|2|||
105517789|NCT00951665|363905227|FG001|Phase 1b|Adverse Event|1|||
105517790|NCT00951665|363905228|FG002|Phase 1b|Adverse Event|0|||
105517791|NCT00951665|363905229|FG003|Phase 1b|Adverse Event|1|||
105517792|NCT00951665|363905230|FG004|Phase 1b|Adverse Event|0|||
105517793|NCT00951665|363905231|FG005|Phase 1b|Adverse Event|0|||
105517794|NCT00951665|363905226|FG000|Phase 1b|Death|1|||
105517795|NCT00951665|363905227|FG001|Phase 1b|Death|0|||
105517796|NCT00951665|363905228|FG002|Phase 1b|Death|2|||
105517797|NCT00951665|363905229|FG003|Phase 1b|Death|0|||
105517798|NCT00951665|363905230|FG004|Phase 1b|Death|0|||
105517799|NCT00951665|363905231|FG005|Phase 1b|Death|0|||
105517800|NCT00951665|363905226|FG000|Phase 1b|Physician Decision|4|||
105517801|NCT00951665|363905227|FG001|Phase 1b|Physician Decision|0|||
105517802|NCT00951665|363905228|FG002|Phase 1b|Physician Decision|1|||
105517803|NCT00951665|363905229|FG003|Phase 1b|Physician Decision|0|||
105517804|NCT00951665|363905230|FG004|Phase 1b|Physician Decision|0|||
105517805|NCT00951665|363905231|FG005|Phase 1b|Physician Decision|0|||
105517806|NCT00951665|363905226|FG000|Phase 1b|Withdrawal by Subject|0|||
105517807|NCT00951665|363905227|FG001|Phase 1b|Withdrawal by Subject|1|||
105517808|NCT00951665|363905228|FG002|Phase 1b|Withdrawal by Subject|0|||
105517809|NCT00951665|363905229|FG003|Phase 1b|Withdrawal by Subject|0|||
105517810|NCT00951665|363905230|FG004|Phase 1b|Withdrawal by Subject|0|||
105517811|NCT00951665|363905231|FG005|Phase 1b|Withdrawal by Subject|0|||
105517812|NCT00951665|363905226|FG000|Phase 1b|Disease Progression|13|||
105517813|NCT00951665|363905227|FG001|Phase 1b|Disease Progression|2|||
105517814|NCT00951665|363905228|FG002|Phase 1b|Disease Progression|14|||
105517815|NCT00951665|363905229|FG003|Phase 1b|Disease Progression|0|||
105517816|NCT00951665|363905230|FG004|Phase 1b|Disease Progression|0|||
105517817|NCT00951665|363905231|FG005|Phase 1b|Disease Progression|0|||
105517818|NCT00951665|363905226|FG000|Phase 1b|Protocol Violation|2|||
105517819|NCT00951665|363905227|FG001|Phase 1b|Protocol Violation|0|||
105517820|NCT00951665|363905228|FG002|Phase 1b|Protocol Violation|0|||
105517821|NCT00951665|363905229|FG003|Phase 1b|Protocol Violation|0|||
105517822|NCT00951665|363905230|FG004|Phase 1b|Protocol Violation|0|||
105517823|NCT00951665|363905231|FG005|Phase 1b|Protocol Violation|0|||
105517824|NCT00951665|363905226|FG000|Phase 2a|Adverse Event|0|||
105517825|NCT00951665|363905227|FG001|Phase 2a|Adverse Event|0|||
105517826|NCT00951665|363905228|FG002|Phase 2a|Adverse Event|0|||
105517827|NCT00951665|363905229|FG003|Phase 2a|Adverse Event|0|||
105517828|NCT00951665|363905230|FG004|Phase 2a|Adverse Event|2|||
105517829|NCT00951665|363905231|FG005|Phase 2a|Adverse Event|0|||
105517830|NCT00951665|363905226|FG000|Phase 2a|Death|0|||
105517831|NCT00951665|363905227|FG001|Phase 2a|Death|0|||
105517832|NCT00951665|363905228|FG002|Phase 2a|Death|0|||
105517833|NCT00951665|363905229|FG003|Phase 2a|Death|0|||
105517834|NCT00951665|363905230|FG004|Phase 2a|Death|1|||
105517835|NCT00951665|363905231|FG005|Phase 2a|Death|1|||
105517836|NCT00951665|363905226|FG000|Phase 2a|Lost to Follow-up|0|||
105517837|NCT00951665|363905227|FG001|Phase 2a|Lost to Follow-up|0|||
105517838|NCT00951665|363905228|FG002|Phase 2a|Lost to Follow-up|0|||
105517839|NCT00951665|363905229|FG003|Phase 2a|Lost to Follow-up|0|||
105517840|NCT00951665|363905230|FG004|Phase 2a|Lost to Follow-up|1|||
105517841|NCT00951665|363905231|FG005|Phase 2a|Lost to Follow-up|0|||
105517842|NCT00951665|363905226|FG000|Phase 2a|Physician Decision|0|||
105517843|NCT00951665|363905227|FG001|Phase 2a|Physician Decision|0|||
105517844|NCT00951665|363905228|FG002|Phase 2a|Physician Decision|0|||
105517845|NCT00951665|363905229|FG003|Phase 2a|Physician Decision|0|||
105517846|NCT00951665|363905230|FG004|Phase 2a|Physician Decision|0|||
105517847|NCT00951665|363905231|FG005|Phase 2a|Physician Decision|1|||
105517848|NCT00951665|363905226|FG000|Phase 2a|Withdrawal by Subject|0|||
105517849|NCT00951665|363905227|FG001|Phase 2a|Withdrawal by Subject|0|||
105517850|NCT00951665|363905228|FG002|Phase 2a|Withdrawal by Subject|0|||
105517851|NCT00951665|363905229|FG003|Phase 2a|Withdrawal by Subject|0|||
105517852|NCT00951665|363905230|FG004|Phase 2a|Withdrawal by Subject|2|||
105517853|NCT00951665|363905231|FG005|Phase 2a|Withdrawal by Subject|0|||
105517854|NCT00951665|363905226|FG000|Phase 2a|Disease Progression|0|||
105517855|NCT00951665|363905227|FG001|Phase 2a|Disease Progression|0|||
105517856|NCT00951665|363905228|FG002|Phase 2a|Disease Progression|0|||
105517857|NCT00951665|363905229|FG003|Phase 2a|Disease Progression|0|||
105517858|NCT00951665|363905230|FG004|Phase 2a|Disease Progression|6|||
105517859|NCT00951665|363905231|FG005|Phase 2a|Disease Progression|5|||
105517860|NCT04317066|363905232|FG000|Overall Study|Sponsor decision|5|||
105517861|NCT04317066|363905232|FG000|Overall Study|Death|2|||
105517862|NCT00488345|363905242|FG000|Overall Study|Adverse Event|0|||
105517863|NCT00488345|363905243|FG001|Overall Study|Adverse Event|1|||
105517864|NCT00488345|363905244|FG002|Overall Study|Adverse Event|1|||
105517865|NCT00488345|363905242|FG000|Overall Study|Unable to administer antibiotics at home|0|||
105517866|NCT00488345|363905243|FG001|Overall Study|Unable to administer antibiotics at home|1|||
105517867|NCT00488345|363905244|FG002|Overall Study|Unable to administer antibiotics at home|0|||
105517868|NCT00488345|363905242|FG000|Overall Study|Institutional Review Board review|0|||
105517869|NCT00488345|363905243|FG001|Overall Study|Institutional Review Board review|0|||
105517870|NCT00488345|363905244|FG002|Overall Study|Institutional Review Board review|1|||
105517871|NCT00488345|363905242|FG000|Overall Study|Surgical team recommendation|0|||
105517872|NCT00488345|363905243|FG001|Overall Study|Surgical team recommendation|1|||
105517873|NCT00488345|363905244|FG002|Overall Study|Surgical team recommendation|0|||
105592224|NCT02377362|364169336|FG000|Part A Second Treatment|Protocol Violation|0|||
105592225|NCT02377362|364169337|FG001|Part A Second Treatment|Protocol Violation|0|||
105592226|NCT02377362|364169338|FG002|Part A Second Treatment|Protocol Violation|0|||
105592227|NCT02377362|364169339|FG003|Part A Second Treatment|Protocol Violation|0|||
105592228|NCT02377362|364169340|FG004|Part A Second Treatment|Protocol Violation|1|||
105592229|NCT02377362|364169341|FG005|Part A Second Treatment|Protocol Violation|0|||
105592230|NCT02377362|364169342|FG006|Part A Second Treatment|Protocol Violation|0|||
105592231|NCT02377362|364169343|FG007|Part A Second Treatment|Protocol Violation|0|||
105592232|NCT02377362|364169344|FG008|Part A Second Treatment|Protocol Violation|0|||
105592233|NCT02377362|364169345|FG009|Part A Second Treatment|Protocol Violation|0|||
105592234|NCT02377362|364169346|FG010|Part A Second Treatment|Protocol Violation|0|||
105592235|NCT02377362|364169347|FG011|Part A Second Treatment|Protocol Violation|0|||
105592236|NCT02377362|364169348|FG012|Part A Second Treatment|Protocol Violation|0|||
105592237|NCT02377362|364169336|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
105592238|NCT02377362|364169337|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
105592239|NCT02377362|364169338|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
105592240|NCT02377362|364169339|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
105592241|NCT02377362|364169340|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
105592242|NCT02377362|364169341|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
105592243|NCT02377362|364169342|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
105592244|NCT02377362|364169343|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
105592245|NCT02377362|364169344|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
105592246|NCT02377362|364169345|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
105592247|NCT02377362|364169346|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
105592248|NCT02377362|364169347|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
105592249|NCT02377362|364169348|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
105592250|NCT02377362|364169336|FG000|Part B Overall|Protocol Violation|0|||
105592251|NCT02377362|364169337|FG001|Part B Overall|Protocol Violation|0|||
105592252|NCT02377362|364169338|FG002|Part B Overall|Protocol Violation|0|||
105592253|NCT02377362|364169339|FG003|Part B Overall|Protocol Violation|0|||
105592254|NCT02377362|364169340|FG004|Part B Overall|Protocol Violation|0|||
105592255|NCT02377362|364169341|FG005|Part B Overall|Protocol Violation|0|||
105592256|NCT02377362|364169342|FG006|Part B Overall|Protocol Violation|0|||
105592257|NCT02377362|364169343|FG007|Part B Overall|Protocol Violation|0|||
105517874|NCT00488345|363905242|FG000|Overall Study|Parent/legal guardian request|0|||
105517875|NCT00488345|363905243|FG001|Overall Study|Parent/legal guardian request|1|||
105517876|NCT00488345|363905244|FG002|Overall Study|Parent/legal guardian request|1|||
105517877|NCT00696696|363905248|FG000|Overall Study|Adverse Event|5|||
105517878|NCT00696696|363905248|FG000|Overall Study|Withdrawal by Subject|8|||
105517879|NCT00696696|363905248|FG000|Overall Study|Physician Decision|2|||
105517880|NCT00696696|363905248|FG000|Overall Study|Death|3|||
105517881|NCT03055260|363905249|FG000|Overall Study|Withdrawal by Subject|1|||
105517882|NCT03055260|363905250|FG001|Overall Study|Withdrawal by Subject|0|||
105517883|NCT02642614|363905251|FG000|Overall Study|Adverse Event|1|||
105517884|NCT02642614|363905252|FG001|Overall Study|Adverse Event|1|||
105517885|NCT02642614|363905253|FG002|Overall Study|Adverse Event|2|||
105517886|NCT02642614|363905254|FG003|Overall Study|Adverse Event|2|||
105517887|NCT02642614|363905251|FG000|Overall Study|Lost to Follow-up|1|||
105517888|NCT02642614|363905252|FG001|Overall Study|Lost to Follow-up|0|||
105517889|NCT02642614|363905253|FG002|Overall Study|Lost to Follow-up|0|||
105517890|NCT02642614|363905254|FG003|Overall Study|Lost to Follow-up|0|||
105517891|NCT02642614|363905251|FG000|Overall Study|Withdrawal by Subject|1|||
105517892|NCT02642614|363905252|FG001|Overall Study|Withdrawal by Subject|1|||
105517893|NCT02642614|363905253|FG002|Overall Study|Withdrawal by Subject|0|||
105517894|NCT02642614|363905254|FG003|Overall Study|Withdrawal by Subject|0|||
105517895|NCT02279173|363905255|FG000|Overall Study|Protocol-specified Criteria|67|||
105517896|NCT02279173|363905255|FG000|Overall Study|Withdrawal by Subject|20|||
105517897|NCT02279173|363905255|FG000|Overall Study|Decision by Sponsor|4|||
105517898|NCT02279173|363905255|FG000|Overall Study|Lost to Follow-up|3|||
105517899|NCT01164956|363905256|FG000|Overall Study|Side Effects|1|||
105517900|NCT01164956|363905257|FG001|Overall Study|Side Effects|0|||
105592258|NCT02377362|364169344|FG008|Part B Overall|Protocol Violation|0|||
105592259|NCT02377362|364169345|FG009|Part B Overall|Protocol Violation|1|||
105592260|NCT02377362|364169346|FG010|Part B Overall|Protocol Violation|0|||
105592261|NCT02377362|364169347|FG011|Part B Overall|Protocol Violation|0|||
105592262|NCT02377362|364169348|FG012|Part B Overall|Protocol Violation|0|||
105592263|NCT02377362|364169336|FG000|Part B Overall|Adverse Event|0|||
105592264|NCT02377362|364169337|FG001|Part B Overall|Adverse Event|0|||
105592265|NCT02377362|364169338|FG002|Part B Overall|Adverse Event|0|||
105517901|NCT01164956|363905258|FG002|Overall Study|Side Effects|1|||
105517902|NCT00967798|363905259|FG000|Overall Study|Withdrawal by Subject|5|||
105517903|NCT00967798|363905260|FG001|Overall Study|Withdrawal by Subject|2|||
105517904|NCT00967798|363905259|FG000|Overall Study|Lost to Follow-up|4|||
105517905|NCT00967798|363905260|FG001|Overall Study|Lost to Follow-up|1|||
105517906|NCT01287897|363905263|FG000|Overall Study|Adverse Event|5|||
105517907|NCT01287897|363905264|FG001|Overall Study|Adverse Event|3|||
105517908|NCT01287897|363905265|FG002|Overall Study|Adverse Event|6|||
105517909|NCT01287897|363905266|FG003|Overall Study|Adverse Event|4|||
105517910|NCT01287897|363905263|FG000|Overall Study|Lack of Efficacy|2|||
105517911|NCT01287897|363905264|FG001|Overall Study|Lack of Efficacy|0|||
105517912|NCT01287897|363905265|FG002|Overall Study|Lack of Efficacy|0|||
105517913|NCT01287897|363905266|FG003|Overall Study|Lack of Efficacy|0|||
105517914|NCT01287897|363905263|FG000|Overall Study|Protocol Violation|1|||
105517915|NCT01287897|363905264|FG001|Overall Study|Protocol Violation|1|||
105517916|NCT01287897|363905265|FG002|Overall Study|Protocol Violation|0|||
105517917|NCT01287897|363905266|FG003|Overall Study|Protocol Violation|1|||
105517918|NCT01287897|363905263|FG000|Overall Study|Lost to Follow-up|0|||
105517919|NCT01287897|363905264|FG001|Overall Study|Lost to Follow-up|0|||
105517920|NCT01287897|363905265|FG002|Overall Study|Lost to Follow-up|2|||
105517921|NCT01287897|363905266|FG003|Overall Study|Lost to Follow-up|0|||
105517922|NCT01287897|363905263|FG000|Overall Study|Withdrawal by Subject|1|||
105517923|NCT01287897|363905264|FG001|Overall Study|Withdrawal by Subject|5|||
105517924|NCT01287897|363905265|FG002|Overall Study|Withdrawal by Subject|3|||
105517925|NCT01287897|363905266|FG003|Overall Study|Withdrawal by Subject|2|||
105517926|NCT01287897|363905263|FG000|Overall Study|Not consented properly|0|||
105517927|NCT01287897|363905264|FG001|Overall Study|Not consented properly|1|||
105517928|NCT01287897|363905265|FG002|Overall Study|Not consented properly|0|||
105517929|NCT01287897|363905266|FG003|Overall Study|Not consented properly|0|||
105517930|NCT01287897|363905263|FG000|Overall Study|Not meeting entrance criteria|1|||
105517931|NCT01287897|363905264|FG001|Overall Study|Not meeting entrance criteria|1|||
105517932|NCT01287897|363905265|FG002|Overall Study|Not meeting entrance criteria|0|||
105517933|NCT01287897|363905266|FG003|Overall Study|Not meeting entrance criteria|0|||
105517934|NCT01287897|363905263|FG000|Overall Study|Other|1|||
105517935|NCT01287897|363905264|FG001|Overall Study|Other|0|||
105517936|NCT01287897|363905265|FG002|Overall Study|Other|1|||
105517937|NCT01287897|363905266|FG003|Overall Study|Other|0|||
105517938|NCT00249444|363905269|FG000|Overall Study|Lost to Follow-up|2|||
105517939|NCT00249444|363905270|FG001|Overall Study|Lost to Follow-up|2|||
105517940|NCT00249444|363905269|FG000|Overall Study|non-compliant|9|||
105517941|NCT00249444|363905270|FG001|Overall Study|non-compliant|11|||
105517942|NCT00249444|363905269|FG000|Overall Study|Adverse Event|1|||
105517943|NCT00249444|363905270|FG001|Overall Study|Adverse Event|1|||
105517944|NCT00249444|363905269|FG000|Overall Study|life event|0|||
105517945|NCT00249444|363905270|FG001|Overall Study|life event|1|||
105517946|NCT01499667|363905271|FG000|Overall Study|administrative problems|4|||
105517947|NCT01499667|363905272|FG001|Overall Study|administrative problems|5|||
105517948|NCT01499667|363905273|FG002|Overall Study|administrative problems|5|||
105517949|NCT01499667|363905271|FG000|Overall Study|Protocol Violation|1|||
105517950|NCT01499667|363905272|FG001|Overall Study|Protocol Violation|3|||
105517951|NCT01499667|363905273|FG002|Overall Study|Protocol Violation|2|||
105517952|NCT01499667|363905271|FG000|Overall Study|Adverse Event|0|||
105517953|NCT01499667|363905272|FG001|Overall Study|Adverse Event|2|||
105517954|NCT01499667|363905273|FG002|Overall Study|Adverse Event|2|||
105517955|NCT01499667|363905271|FG000|Overall Study|Withdrawal by Subject|2|||
105517956|NCT01499667|363905272|FG001|Overall Study|Withdrawal by Subject|1|||
105517957|NCT01499667|363905273|FG002|Overall Study|Withdrawal by Subject|1|||
105517958|NCT01499667|363905271|FG000|Overall Study|Lack of Efficacy|2|||
105517959|NCT01499667|363905272|FG001|Overall Study|Lack of Efficacy|0|||
105517960|NCT01499667|363905273|FG002|Overall Study|Lack of Efficacy|0|||
105517961|NCT02673489|363905274|FG000|Treatment Period|Lost to Follow-up|3|||
105517962|NCT02673489|363905275|FG001|Treatment Period|Lost to Follow-up|0|||
105517963|NCT02673489|363905274|FG000|Treatment Period|Participant request to discontinue|1|||
105517964|NCT02673489|363905275|FG001|Treatment Period|Participant request to discontinue|1|||
105517965|NCT02673489|363905274|FG000|Treatment Period|Participant moved to another province|1|||
105517966|NCT02673489|363905275|FG001|Treatment Period|Participant moved to another province|0|||
105517967|NCT02673489|363905274|FG000|Treatment Period|Participant was incarcerated|0|||
105517968|NCT02673489|363905275|FG001|Treatment Period|Participant was incarcerated|1|||
105517969|NCT02673489|363905274|FG000|Treatment Period|Adverse Event|0|||
105517970|NCT02673489|363905275|FG001|Treatment Period|Adverse Event|1|||
105517971|NCT02673489|363905274|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
105517972|NCT02673489|363905275|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
105517973|NCT02673489|363905274|FG000|Follow Up Period|Unable to return for follow-up|0|||
105592266|NCT02377362|364169339|FG003|Part B Overall|Adverse Event|0|||
105517974|NCT02673489|363905275|FG001|Follow Up Period|Unable to return for follow-up|1|||
105517975|NCT02335489|363905276|FG000|Overall Study|Sponsor terminated study|4|||
105517976|NCT02335489|363905276|FG000|Overall Study|Lost to Follow-up|1|||
105517977|NCT02335489|363905276|FG000|Overall Study|Withdrawal by Subject|2|||
105517978|NCT02335489|363905276|FG000|Overall Study|Physician Decision|2|||
105517979|NCT02335489|363905276|FG000|Overall Study|Lack of Efficacy|1|||
105517980|NCT04483011|363905282|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
105517981|NCT04483011|363905283|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
105517982|NCT01853046|363905284|FG000|Overall Study|Withdrawal by Subject|1|||
105517983|NCT01853046|363905285|FG001|Overall Study|Withdrawal by Subject|1|||
105517984|NCT01853046|363905284|FG000|Overall Study|Adverse Event|4|||
105517985|NCT01853046|363905285|FG001|Overall Study|Adverse Event|2|||
105517986|NCT01853046|363905284|FG000|Overall Study|Disease progression|13|||
105517987|NCT01853046|363905285|FG001|Overall Study|Disease progression|3|||
105517988|NCT03635957|363905286|FG000|Run-In Period|Lost to Follow-up|1|||
105517989|NCT03635957|363905286|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
105517990|NCT00350636|363905287|FG000|Overall Study|Adverse Event|19|||
105517991|NCT00350636|363905288|FG001|Overall Study|Adverse Event|13|||
105517992|NCT00350636|363905287|FG000|Overall Study|Protocol Violation|1|||
105517993|NCT00350636|363905288|FG001|Overall Study|Protocol Violation|3|||
105517994|NCT00350636|363905287|FG000|Overall Study|Withdrawal by Subject|13|||
105517995|NCT00350636|363905288|FG001|Overall Study|Withdrawal by Subject|17|||
105517996|NCT00350636|363905287|FG000|Overall Study|Lost to Follow-up|9|||
105517997|NCT00350636|363905288|FG001|Overall Study|Lost to Follow-up|8|||
105517998|NCT00350636|363905287|FG000|Overall Study|Physician Decision|0|||
105517999|NCT00350636|363905288|FG001|Overall Study|Physician Decision|2|||
105518000|NCT00350636|363905287|FG000|Overall Study|Other|1|||
105518001|NCT00350636|363905288|FG001|Overall Study|Other|2|||
105518002|NCT01710033|363905289|FG000|Stage 2|Adverse Event|0|||
105518003|NCT01710033|363905290|FG001|Stage 2|Adverse Event|0|||
105518004|NCT01710033|363905291|FG002|Stage 2|Adverse Event|0|||
105518005|NCT01710033|363905292|FG003|Stage 2|Adverse Event|0|||
105518006|NCT01710033|363905293|FG004|Stage 2|Adverse Event|1|||
105518007|NCT02514447|363905294|FG000|Overall Study|Withdrawal by Subject|3|||
105518008|NCT02514447|363905295|FG001|Overall Study|Withdrawal by Subject|1|||
105518009|NCT02514447|363905296|FG002|Overall Study|Withdrawal by Subject|1|||
105518010|NCT02514447|363905297|FG003|Overall Study|Withdrawal by Subject|0|||
105518011|NCT02514447|363905298|FG004|Overall Study|Withdrawal by Subject|0|||
105518012|NCT02514447|363905299|FG005|Overall Study|Withdrawal by Subject|0|||
105518013|NCT02514447|363905300|FG006|Overall Study|Withdrawal by Subject|0|||
105518014|NCT02514447|363905301|FG007|Overall Study|Withdrawal by Subject|1|||
105518015|NCT02514447|363905302|FG008|Overall Study|Withdrawal by Subject|1|||
105518016|NCT02514447|363905294|FG000|Overall Study|Death|24|||
105518017|NCT02514447|363905295|FG001|Overall Study|Death|28|||
105518018|NCT02514447|363905296|FG002|Overall Study|Death|29|||
105518019|NCT02514447|363905297|FG003|Overall Study|Death|0|||
105518020|NCT02514447|363905298|FG004|Overall Study|Death|3|||
105518021|NCT02514447|363905299|FG005|Overall Study|Death|4|||
105518022|NCT02514447|363905300|FG006|Overall Study|Death|8|||
105518023|NCT02514447|363905301|FG007|Overall Study|Death|6|||
105518024|NCT02514447|363905302|FG008|Overall Study|Death|5|||
105518025|NCT02514447|363905294|FG000|Overall Study|Lost to Follow-up|1|||
105518026|NCT02514447|363905295|FG001|Overall Study|Lost to Follow-up|0|||
105518027|NCT02514447|363905296|FG002|Overall Study|Lost to Follow-up|0|||
105518028|NCT02514447|363905297|FG003|Overall Study|Lost to Follow-up|0|||
105518029|NCT02514447|363905298|FG004|Overall Study|Lost to Follow-up|0|||
105518030|NCT02514447|363905299|FG005|Overall Study|Lost to Follow-up|0|||
105518031|NCT02514447|363905300|FG006|Overall Study|Lost to Follow-up|0|||
105518032|NCT02514447|363905301|FG007|Overall Study|Lost to Follow-up|0|||
105518033|NCT02514447|363905302|FG008|Overall Study|Lost to Follow-up|1|||
105518034|NCT02514447|363905294|FG000|Overall Study|Sponsor Termination of Study|0|||
105518035|NCT02514447|363905295|FG001|Overall Study|Sponsor Termination of Study|1|||
105518036|NCT02514447|363905296|FG002|Overall Study|Sponsor Termination of Study|1|||
105518037|NCT02514447|363905297|FG003|Overall Study|Sponsor Termination of Study|0|||
105518038|NCT02514447|363905298|FG004|Overall Study|Sponsor Termination of Study|0|||
105518039|NCT02514447|363905299|FG005|Overall Study|Sponsor Termination of Study|0|||
105518040|NCT02514447|363905300|FG006|Overall Study|Sponsor Termination of Study|0|||
105518041|NCT02514447|363905301|FG007|Overall Study|Sponsor Termination of Study|0|||
105518042|NCT02514447|363905302|FG008|Overall Study|Sponsor Termination of Study|0|||
105518043|NCT02514447|363905294|FG000|Overall Study|Study completion per Investigator|1|||
105518044|NCT02514447|363905295|FG001|Overall Study|Study completion per Investigator|0|||
105518045|NCT02514447|363905296|FG002|Overall Study|Study completion per Investigator|1|||
105518046|NCT02514447|363905297|FG003|Overall Study|Study completion per Investigator|2|||
105518047|NCT02514447|363905298|FG004|Overall Study|Study completion per Investigator|0|||
105518048|NCT02514447|363905299|FG005|Overall Study|Study completion per Investigator|0|||
105518049|NCT02514447|363905300|FG006|Overall Study|Study completion per Investigator|0|||
105518050|NCT02514447|363905301|FG007|Overall Study|Study completion per Investigator|0|||
105518051|NCT02514447|363905302|FG008|Overall Study|Study completion per Investigator|1|||
105518052|NCT02877082|363905303|FG000|Overall Study|Trial was closed early|5|||
105518053|NCT03480750|363905304|FG000|Overall Study|Withdrawal by Subject|0|||
105518054|NCT03480750|363905305|FG001|Overall Study|Withdrawal by Subject|1|||
105518055|NCT03480750|363905306|FG002|Overall Study|Withdrawal by Subject|0|||
105518056|NCT03480750|363905307|FG003|Overall Study|Withdrawal by Subject|0|||
105518057|NCT03480750|363905308|FG004|Overall Study|Withdrawal by Subject|0|||
105518058|NCT03480750|363905309|FG005|Overall Study|Withdrawal by Subject|0|||
105592267|NCT02377362|364169340|FG004|Part B Overall|Adverse Event|0|||
105592268|NCT02377362|364169341|FG005|Part B Overall|Adverse Event|0|||
105518059|NCT03480750|363905304|FG000|Overall Study|The interruption in Trientine shippment|0|||
105518060|NCT03480750|363905305|FG001|Overall Study|The interruption in Trientine shippment|0|||
105518061|NCT03480750|363905306|FG002|Overall Study|The interruption in Trientine shippment|0|||
105518062|NCT03480750|363905307|FG003|Overall Study|The interruption in Trientine shippment|0|||
105518063|NCT03480750|363905308|FG004|Overall Study|The interruption in Trientine shippment|0|||
105518064|NCT03480750|363905309|FG005|Overall Study|The interruption in Trientine shippment|1|||
105518065|NCT01103284|363905314|FG000|Overall Study|Death|2|||
105518066|NCT01103284|363905315|FG001|Overall Study|Death|0|||
105518067|NCT01103284|363905314|FG000|Overall Study|Lost to Follow-up|9|||
105518068|NCT01103284|363905315|FG001|Overall Study|Lost to Follow-up|10|||
105518069|NCT01103284|363905314|FG000|Overall Study|Pregnancy|3|||
105518070|NCT01103284|363905315|FG001|Overall Study|Pregnancy|1|||
105518071|NCT01103284|363905314|FG000|Overall Study|Protocol Violation|12|||
105518072|NCT01103284|363905315|FG001|Overall Study|Protocol Violation|5|||
105518073|NCT01103284|363905314|FG000|Overall Study|Adverse Event|0|||
105518074|NCT01103284|363905315|FG001|Overall Study|Adverse Event|5|||
105518075|NCT01103284|363905314|FG000|Overall Study|Withdrawal by Subject|14|||
105518076|NCT01103284|363905315|FG001|Overall Study|Withdrawal by Subject|18|||
105518077|NCT01103284|363905314|FG000|Overall Study|Dermal Hypersensitivity|0|||
105518078|NCT01103284|363905315|FG001|Overall Study|Dermal Hypersensitivity|1|||
105518079|NCT01103284|363905314|FG000|Overall Study|Termination by the Sponsor|0|||
105518080|NCT01103284|363905315|FG001|Overall Study|Termination by the Sponsor|1|||
105518081|NCT01103284|363905314|FG000|Overall Study|Not described|2|||
105518082|NCT01103284|363905315|FG001|Overall Study|Not described|1|||
105518083|NCT01103284|363905314|FG000|Overall Study|Missing CRF entries for study completion|0|||
105518084|NCT01103284|363905315|FG001|Overall Study|Missing CRF entries for study completion|2|||
105518085|NCT04532099|363905316|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
105518086|NCT04532099|363905317|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
105518087|NCT04532099|363905318|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
105518088|NCT01870583|363905319|FG000|Overall Study|Protocol Violation|0|||
105518089|NCT01870583|363905320|FG001|Overall Study|Protocol Violation|5|||
105518090|NCT01870583|363905321|FG002|Overall Study|Protocol Violation|3|||
105518091|NCT01870583|363905319|FG000|Overall Study|Lost to Follow-up|11|||
105518092|NCT01870583|363905320|FG001|Overall Study|Lost to Follow-up|13|||
105518093|NCT01870583|363905321|FG002|Overall Study|Lost to Follow-up|5|||
105518094|NCT01998633|363905324|FG000|Overall Study|Death|1|||
105518095|NCT02611778|363905325|FG000|Overall Study|Withdrawal by Subject|2|||
105518096|NCT02611778|363905326|FG001|Overall Study|Withdrawal by Subject|8|||
105518097|NCT02611778|363905325|FG000|Overall Study|Adverse Event|1|||
105518098|NCT02611778|363905326|FG001|Overall Study|Adverse Event|2|||
105518099|NCT02611778|363905325|FG000|Overall Study|Death|2|||
105518100|NCT02611778|363905326|FG001|Overall Study|Death|1|||
105518101|NCT02611778|363905325|FG000|Overall Study|Protocol Violation|1|||
105518102|NCT02611778|363905326|FG001|Overall Study|Protocol Violation|0|||
105518103|NCT02611778|363905325|FG000|Overall Study|Lost to Follow-up|3|||
105518104|NCT02611778|363905326|FG001|Overall Study|Lost to Follow-up|1|||
105518105|NCT02611778|363905325|FG000|Overall Study|Need for alternative treatment|1|||
105518106|NCT02611778|363905326|FG001|Overall Study|Need for alternative treatment|0|||
105518107|NCT02611778|363905325|FG000|Overall Study|Other Reason|2|||
105518108|NCT02611778|363905326|FG001|Overall Study|Other Reason|1|||
105518109|NCT00810407|363905327|FG000|Overall Study|Protocol Violation|3|||
105518110|NCT00810407|363905327|FG000|Overall Study|No Visit After First Day of Treatment|3|||
105518111|NCT02369341|363905328|FG000|Overall Study|Migrated/moved from study area|1|||
105518112|NCT02369341|363905329|FG001|Overall Study|Migrated/moved from study area|0|||
105518113|NCT02278263|363905330|FG000|Overall Study|Protocol Violation|7|||
105518114|NCT02278263|363905331|FG001|Overall Study|Protocol Violation|0|||
105518115|NCT02278263|363905332|FG002|Overall Study|Protocol Violation|9|||
105518116|NCT02426892|363905337|FG000|Overall Study|Adverse Event|2|||
105518117|NCT02426892|363905337|FG000|Overall Study|Lack of Efficacy|17|||
105518118|NCT02426892|363905337|FG000|Overall Study|Withdrawal by Subject|1|||
105518119|NCT01359449|363905338|FG000|Overall Study|Lost to Follow-up|1|||
105518120|NCT01359449|363905339|FG001|Overall Study|Lost to Follow-up|0|||
105518121|NCT01359449|363905338|FG000|Overall Study|Protocol Violation|0|||
105518122|NCT01359449|363905339|FG001|Overall Study|Protocol Violation|2|||
105518123|NCT01359449|363905338|FG000|Overall Study|Withdrawal by Subject|3|||
105518124|NCT01359449|363905339|FG001|Overall Study|Withdrawal by Subject|2|||
105518125|NCT02574247|363905342|FG000|Overall Study|Withdrawal by Subject|1|||
105518126|NCT02574247|363905343|FG001|Overall Study|Withdrawal by Subject|0|||
105518127|NCT02574247|363905344|FG002|Overall Study|Withdrawal by Subject|0|||
105518128|NCT02574247|363905342|FG000|Overall Study|Did not meet inclusion criteria|4|||
105518129|NCT02574247|363905343|FG001|Overall Study|Did not meet inclusion criteria|3|||
105518130|NCT02574247|363905344|FG002|Overall Study|Did not meet inclusion criteria|5|||
105518131|NCT03325075|363905347|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
105518132|NCT03325075|363905348|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
105518133|NCT03325075|363905349|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
105518134|NCT03325075|363905350|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
105592269|NCT02377362|364169342|FG006|Part B Overall|Adverse Event|1|||
105518135|NCT03325075|363905347|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
105518136|NCT03325075|363905348|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
105518137|NCT03325075|363905349|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
105518138|NCT03325075|363905350|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
105518139|NCT03325075|363905347|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
105518140|NCT03325075|363905348|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
105518141|NCT03325075|363905349|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
105518142|NCT03325075|363905350|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
105518143|NCT00748033|363905351|FG000|Overall Study|Adverse Event|0|||
105518144|NCT00748033|363905352|FG001|Overall Study|Adverse Event|1|||
105518145|NCT02763189|363905353|FG000|Overall Study|Device failure|0|||
105518146|NCT02763189|363905354|FG001|Overall Study|Device failure|2|||
105518147|NCT03406104|363905362|FG000|Overall Study|Lost to Follow-up|2|||
105518148|NCT03406104|363905362|FG000|Overall Study|Withdrawal by Subject|2|||
105518149|NCT03406104|363905362|FG000|Overall Study|due to Covid patient did not want to travel|1|||
105518150|NCT03406104|363905362|FG000|Overall Study|Death|2|||
105518151|NCT01338493|363905363|FG000|Enrolled|Withdrawal by Subject|1|||
105518152|NCT01338493|363905363|FG000|Enrolled|Patient not implanted|4|||
105518153|NCT01338493|363905363|FG000|Discharge|Death|1|||
105518154|NCT01338493|363905363|FG000|Discharge|Missed visit|1|||
105518155|NCT01338493|363905363|FG000|6 Months Follow up|Lost to Follow-up|11|||
105518156|NCT01338493|363905363|FG000|6 Months Follow up|Missed visit|8|||
105518157|NCT01338493|363905363|FG000|12 Months Follow up|Lost to Follow-up|9|||
105518158|NCT00656474|363905364|FG000|Overall Study|Other Reason|1|||
105518159|NCT01614067|363905365|FG000|Overall Study|Pregnancy|1|||
105518160|NCT01614067|363905366|FG001|Overall Study|Pregnancy|0|||
105518161|NCT01614067|363905365|FG000|Overall Study|Physician Decision|6|||
105518162|NCT01614067|363905366|FG001|Overall Study|Physician Decision|5|||
105518163|NCT01614067|363905365|FG000|Overall Study|Withdrawal by Subject|0|||
105518164|NCT01614067|363905366|FG001|Overall Study|Withdrawal by Subject|1|||
105518165|NCT01614067|363905365|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
105518166|NCT01614067|363905366|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
105518167|NCT02998840|363905367|FG000|Overall Study|Lost to Follow-up|1|||
105518168|NCT02998840|363905368|FG001|Overall Study|Lost to Follow-up|1|||
105518169|NCT02998840|363905369|FG002|Overall Study|Lost to Follow-up|2|||
105518170|NCT02998840|363905370|FG003|Overall Study|Lost to Follow-up|3|||
105518171|NCT02998840|363905367|FG000|Overall Study|Withdrawal by Subject|1|||
105518172|NCT02998840|363905368|FG001|Overall Study|Withdrawal by Subject|1|||
105518173|NCT02998840|363905369|FG002|Overall Study|Withdrawal by Subject|0|||
105518174|NCT02998840|363905370|FG003|Overall Study|Withdrawal by Subject|1|||
105518175|NCT02998840|363905367|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
105518176|NCT02998840|363905368|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
105518177|NCT02998840|363905369|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
105518178|NCT02998840|363905370|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
105518179|NCT00982488|363907171|FG000|Overall Study|Administrative reason by sponsor|81|||
105518180|NCT00982488|363907172|FG001|Overall Study|Administrative reason by sponsor|3|||
105518181|NCT00982488|363907173|FG002|Overall Study|Administrative reason by sponsor|11|||
105518182|NCT00982488|363907174|FG003|Overall Study|Administrative reason by sponsor|0|||
105518183|NCT00982488|363907175|FG004|Overall Study|Administrative reason by sponsor|0|||
105518184|NCT00982488|363907171|FG000|Overall Study|Adverse event unrelated to study drug|5|||
105518185|NCT00982488|363907172|FG001|Overall Study|Adverse event unrelated to study drug|1|||
105518186|NCT00982488|363907173|FG002|Overall Study|Adverse event unrelated to study drug|0|||
105518187|NCT00982488|363907174|FG003|Overall Study|Adverse event unrelated to study drug|0|||
105518188|NCT00982488|363907175|FG004|Overall Study|Adverse event unrelated to study drug|0|||
105518189|NCT00982488|363907171|FG000|Overall Study|Death|11|||
105518190|NCT00982488|363907172|FG001|Overall Study|Death|0|||
105518191|NCT00982488|363907173|FG002|Overall Study|Death|2|||
105518192|NCT00982488|363907174|FG003|Overall Study|Death|0|||
105518193|NCT00982488|363907175|FG004|Overall Study|Death|0|||
105518194|NCT00982488|363907171|FG000|Overall Study|Disease progression|30|||
105518195|NCT00982488|363907172|FG001|Overall Study|Disease progression|5|||
105518196|NCT00982488|363907173|FG002|Overall Study|Disease progression|10|||
105592270|NCT02377362|364169343|FG007|Part B Overall|Adverse Event|1|||
105592271|NCT02377362|364169344|FG008|Part B Overall|Adverse Event|0|||
105592272|NCT02377362|364169345|FG009|Part B Overall|Adverse Event|0|||
105518197|NCT00982488|363907174|FG003|Overall Study|Disease progression|1|||
105518198|NCT00982488|363907175|FG004|Overall Study|Disease progression|1|||
105518199|NCT00982488|363907171|FG000|Overall Study|Lost to Follow-up|1|||
105518200|NCT00982488|363907172|FG001|Overall Study|Lost to Follow-up|0|||
105518201|NCT00982488|363907173|FG002|Overall Study|Lost to Follow-up|0|||
105518202|NCT00982488|363907174|FG003|Overall Study|Lost to Follow-up|0|||
105518203|NCT00982488|363907175|FG004|Overall Study|Lost to Follow-up|0|||
105518204|NCT00982488|363907171|FG000|Overall Study|Maximum clinical benefit|1|||
105592273|NCT02377362|364169346|FG010|Part B Overall|Adverse Event|0|||
105592274|NCT02377362|364169347|FG011|Part B Overall|Adverse Event|0|||
105592275|NCT02377362|364169348|FG012|Part B Overall|Adverse Event|0|||
105592276|NCT02377362|364169336|FG000|Part B Overall|Withdrawal by Subject|0|||
105592277|NCT02377362|364169337|FG001|Part B Overall|Withdrawal by Subject|0|||
105592278|NCT02377362|364169338|FG002|Part B Overall|Withdrawal by Subject|0|||
105592279|NCT02377362|364169339|FG003|Part B Overall|Withdrawal by Subject|0|||
105592280|NCT02377362|364169340|FG004|Part B Overall|Withdrawal by Subject|0|||
105592281|NCT02377362|364169341|FG005|Part B Overall|Withdrawal by Subject|0|||
105592282|NCT02377362|364169342|FG006|Part B Overall|Withdrawal by Subject|1|||
105592283|NCT02377362|364169343|FG007|Part B Overall|Withdrawal by Subject|0|||
105592284|NCT02377362|364169344|FG008|Part B Overall|Withdrawal by Subject|0|||
105592285|NCT02377362|364169345|FG009|Part B Overall|Withdrawal by Subject|0|||
105592286|NCT02377362|364169346|FG010|Part B Overall|Withdrawal by Subject|0|||
105592287|NCT02377362|364169347|FG011|Part B Overall|Withdrawal by Subject|1|||
105592288|NCT02377362|364169348|FG012|Part B Overall|Withdrawal by Subject|0|||
105592289|NCT00094809|364169349|FG000|Overall Study|Protocol deviation|2|||
105592290|NCT00094809|364169350|FG001|Overall Study|Protocol deviation|2|||
105592291|NCT00094809|364169349|FG000|Overall Study|Noncompliance|1|||
105592292|NCT00094809|364169350|FG001|Overall Study|Noncompliance|0|||
105518205|NCT00982488|363907172|FG001|Overall Study|Maximum clinical benefit|1|||
105518206|NCT00982488|363907173|FG002|Overall Study|Maximum clinical benefit|1|||
105518207|NCT00982488|363907174|FG003|Overall Study|Maximum clinical benefit|0|||
105518208|NCT00982488|363907175|FG004|Overall Study|Maximum clinical benefit|0|||
105518209|NCT00982488|363907171|FG000|Overall Study|Other|15|||
105518210|NCT00982488|363907172|FG001|Overall Study|Other|1|||
105518211|NCT00982488|363907173|FG002|Overall Study|Other|3|||
105518212|NCT00982488|363907174|FG003|Overall Study|Other|1|||
105518213|NCT00982488|363907175|FG004|Overall Study|Other|0|||
105518214|NCT00982488|363907171|FG000|Overall Study|Poor compliance/noncompliance|0|||
105518215|NCT00982488|363907172|FG001|Overall Study|Poor compliance/noncompliance|1|||
105518216|NCT00982488|363907173|FG002|Overall Study|Poor compliance/noncompliance|0|||
105518217|NCT00982488|363907174|FG003|Overall Study|Poor compliance/noncompliance|0|||
105518218|NCT00982488|363907175|FG004|Overall Study|Poor compliance/noncompliance|0|||
105518219|NCT00982488|363907171|FG000|Overall Study|Stem cell transplant|2|||
105518220|NCT00982488|363907172|FG001|Overall Study|Stem cell transplant|0|||
105518221|NCT00982488|363907173|FG002|Overall Study|Stem cell transplant|0|||
105518222|NCT00982488|363907174|FG003|Overall Study|Stem cell transplant|1|||
105518223|NCT00982488|363907175|FG004|Overall Study|Stem cell transplant|0|||
105518224|NCT00982488|363907171|FG000|Overall Study|Study drug toxicity|34|||
105518225|NCT00982488|363907172|FG001|Overall Study|Study drug toxicity|1|||
105518226|NCT00982488|363907173|FG002|Overall Study|Study drug toxicity|6|||
105518227|NCT00982488|363907174|FG003|Overall Study|Study drug toxicity|0|||
105518228|NCT00982488|363907175|FG004|Overall Study|Study drug toxicity|0|||
105518229|NCT00982488|363907171|FG000|Overall Study|Withdrawal by Subject|5|||
105518230|NCT00982488|363907172|FG001|Overall Study|Withdrawal by Subject|1|||
105518231|NCT00982488|363907173|FG002|Overall Study|Withdrawal by Subject|1|||
105518232|NCT00982488|363907174|FG003|Overall Study|Withdrawal by Subject|0|||
105518233|NCT00982488|363907175|FG004|Overall Study|Withdrawal by Subject|0|||
105518234|NCT00001596|363907179|FG000|Overall Study|Death|1|||
105518235|NCT00001596|363907180|FG001|Overall Study|Death|0|||
105518236|NCT00001596|363907179|FG000|Overall Study|Withdrawal by Subject|3|||
105518237|NCT00001596|363907180|FG001|Overall Study|Withdrawal by Subject|1|||
105518238|NCT00001596|363907179|FG000|Overall Study|Study Termination|12|||
105518239|NCT00001596|363907180|FG001|Overall Study|Study Termination|9|||
105518240|NCT00001596|363907179|FG000|Overall Study|Adverse Event|1|||
105518241|NCT00001596|363907180|FG001|Overall Study|Adverse Event|0|||
105518242|NCT01572909|363907181|FG000|Overall Study|Adverse Event|7|||
105518243|NCT01572909|363907182|FG001|Overall Study|Adverse Event|2|||
105592293|NCT00094809|364169349|FG000|Overall Study|Adverse Event|3|||
105592294|NCT00094809|364169350|FG001|Overall Study|Adverse Event|1|||
105592295|NCT00094809|364169349|FG000|Overall Study|Withdrawal by Subject|8|||
105592296|NCT00094809|364169350|FG001|Overall Study|Withdrawal by Subject|9|||
105518244|NCT01572909|363907181|FG000|Overall Study|Death|3|||
105518245|NCT01572909|363907182|FG001|Overall Study|Death|1|||
105518246|NCT01572909|363907181|FG000|Overall Study|Lost to Follow-up|8|||
105518247|NCT01572909|363907182|FG001|Overall Study|Lost to Follow-up|7|||
105518248|NCT01572909|363907181|FG000|Overall Study|Physician Decision|1|||
105592297|NCT00094809|364169349|FG000|Overall Study|Disease progression|3|||
105592298|NCT00094809|364169350|FG001|Overall Study|Disease progression|3|||
105592299|NCT00094809|364169349|FG000|Overall Study|Physician Decision|3|||
105592300|NCT00094809|364169350|FG001|Overall Study|Physician Decision|5|||
105518249|NCT01572909|363907182|FG001|Overall Study|Physician Decision|1|||
105518250|NCT01572909|363907181|FG000|Overall Study|Technical Issues|1|||
105518251|NCT01572909|363907182|FG001|Overall Study|Technical Issues|0|||
105518252|NCT01572909|363907181|FG000|Overall Study|Withdrawal by Subject|12|||
105518253|NCT01572909|363907182|FG001|Overall Study|Withdrawal by Subject|11|||
105518254|NCT01572909|363907181|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
105518255|NCT01572909|363907182|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
105518256|NCT00613938|363907187|FG000|Overall Study|Withdrawal by Subject|2|||
105518257|NCT00613938|363907188|FG001|Overall Study|Withdrawal by Subject|4|||
105518258|NCT00613938|363907189|FG002|Overall Study|Withdrawal by Subject|9|||
105518259|NCT00613938|363907190|FG003|Overall Study|Withdrawal by Subject|9|||
105518260|NCT00613938|363907187|FG000|Overall Study|Adverse Event|1|||
105518261|NCT00613938|363907188|FG001|Overall Study|Adverse Event|4|||
105592301|NCT00094809|364169349|FG000|Overall Study|Lost to Follow-up|6|||
105518262|NCT00613938|363907189|FG002|Overall Study|Adverse Event|8|||
105518263|NCT00613938|363907190|FG003|Overall Study|Adverse Event|5|||
105518264|NCT00613938|363907187|FG000|Overall Study|Lack of Efficacy|16|||
105518265|NCT00613938|363907188|FG001|Overall Study|Lack of Efficacy|18|||
105518266|NCT00613938|363907189|FG002|Overall Study|Lack of Efficacy|5|||
105518267|NCT00613938|363907190|FG003|Overall Study|Lack of Efficacy|9|||
105518268|NCT00613938|363907187|FG000|Overall Study|Other|1|||
105518269|NCT00613938|363907188|FG001|Overall Study|Other|2|||
105518270|NCT00613938|363907189|FG002|Overall Study|Other|1|||
105518271|NCT00613938|363907190|FG003|Overall Study|Other|3|||
105518272|NCT04779489|363907191|FG000|Overall Study|Physician Decision|1|||
105518273|NCT02636868|363907192|FG000|Overall Study|Death|0|||
105518274|NCT02636868|363907193|FG001|Overall Study|Death|1|||
105518275|NCT02636868|363907194|FG002|Overall Study|Death|2|||
105518276|NCT03745937|363907195|FG000|Overall Study|Withdrawal by Subject|0|||
105518277|NCT03745937|363907196|FG001|Overall Study|Withdrawal by Subject|0|||
105518278|NCT03745937|363907197|FG002|Overall Study|Withdrawal by Subject|0|||
105518279|NCT03745937|363907198|FG003|Overall Study|Withdrawal by Subject|1|||
105518280|NCT03745937|363907195|FG000|Overall Study|Not-specifed|0|||
105518281|NCT03745937|363907196|FG001|Overall Study|Not-specifed|1|||
105518282|NCT03745937|363907197|FG002|Overall Study|Not-specifed|0|||
105518283|NCT03745937|363907198|FG003|Overall Study|Not-specifed|1|||
105518284|NCT02723084|363907199|FG000|Overall Study|Withdrawal by Subject|1|||
105518285|NCT02723084|363907200|FG001|Overall Study|Withdrawal by Subject|1|||
105518286|NCT02723084|363907199|FG000|Overall Study|Lost to Follow-up|3|||
105518287|NCT02723084|363907200|FG001|Overall Study|Lost to Follow-up|0|||
105518288|NCT00501293|363907201|FG000|Optimization Period|Enrolled in error|1|||
105592302|NCT00094809|364169350|FG001|Overall Study|Lost to Follow-up|6|||
105592303|NCT00094809|364169349|FG000|Overall Study|Death|19|||
105592304|NCT00094809|364169350|FG001|Overall Study|Death|25|||
105592305|NCT00094809|364169349|FG000|Overall Study|Protocol-specified criteria|1|||
105592306|NCT00094809|364169350|FG001|Overall Study|Protocol-specified criteria|1|||
105592307|NCT00094809|364169349|FG000|Overall Study|Other|2|||
105592308|NCT00094809|364169350|FG001|Overall Study|Other|4|||
105592309|NCT00094809|364169349|FG000|Overall Study|Informed consent signed after treatment|1|||
105592310|NCT00094809|364169350|FG001|Overall Study|Informed consent signed after treatment|0|||
105592311|NCT00094809|364169349|FG000|Overall Study|Study drug not received|2|||
105592312|NCT00094809|364169350|FG001|Overall Study|Study drug not received|8|||
105592313|NCT00094809|364169349|FG000|Overall Study|Other|1|||
105518289|NCT00501293|363907202|FG001|Optimization Period|Enrolled in error|0|||
105518290|NCT00501293|363907201|FG000|Maintenance Period|Withdrawal by Subject|14|||
105518291|NCT00501293|363907202|FG001|Maintenance Period|Withdrawal by Subject|13|||
105518292|NCT00501293|363907201|FG000|Maintenance Period|Lost to Follow-up|12|||
105518293|NCT00501293|363907202|FG001|Maintenance Period|Lost to Follow-up|7|||
105518294|NCT00501293|363907201|FG000|Maintenance Period|Adverse Event|6|||
105518295|NCT00501293|363907202|FG001|Maintenance Period|Adverse Event|6|||
105518296|NCT00501293|363907201|FG000|Maintenance Period|Protocol Violation|2|||
105518297|NCT00501293|363907202|FG001|Maintenance Period|Protocol Violation|1|||
105518298|NCT00501293|363907201|FG000|Maintenance Period|Lack of Efficacy|4|||
105518299|NCT00501293|363907202|FG001|Maintenance Period|Lack of Efficacy|1|||
105592314|NCT00094809|364169350|FG001|Overall Study|Other|1|||
105592315|NCT04889664|364169351|FG000|Screen|Lost to Follow-up|1|||
105592316|NCT04889664|364169351|FG000|Screen|Failed to meet screening criteria|1|||
105592317|NCT04889664|364169351|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
105518300|NCT00501293|363907201|FG000|Maintenance Period|Noncompliant with study medication|5|||
105518301|NCT00501293|363907202|FG001|Maintenance Period|Noncompliant with study medication|0|||
105518302|NCT00501293|363907201|FG000|Maintenance Period|Went into rehabilitation|1|||
105518303|NCT00501293|363907202|FG001|Maintenance Period|Went into rehabilitation|0|||
105592318|NCT02155829|364169352|FG000|Overall Study|Adverse Event|1|||
105518304|NCT00501293|363907201|FG000|Maintenance Period|Would not wear patch|1|||
105518305|NCT00501293|363907202|FG001|Maintenance Period|Would not wear patch|0|||
105518306|NCT00501293|363907201|FG000|Maintenance Period|Application site reaction|1|||
105592319|NCT02155829|364169353|FG001|Overall Study|Adverse Event|0|||
105518307|NCT00501293|363907202|FG001|Maintenance Period|Application site reaction|0|||
105518308|NCT00127712|363907204|FG000|Overall Study|Adverse Event|3|||
105518309|NCT00127712|363907205|FG001|Overall Study|Adverse Event|0|||
105518310|NCT00127712|363907204|FG000|Overall Study|Lack of GI access to continue|2|||
105518311|NCT00127712|363907205|FG001|Overall Study|Lack of GI access to continue|0|||
105518312|NCT01529346|363907206|FG000|Overall Study|Lost to Follow-up|2|||
105592320|NCT02155829|364169352|FG000|Overall Study|Withdrawal by Subject|3|||
105518313|NCT01529346|363907207|FG001|Overall Study|Lost to Follow-up|0|||
105518314|NCT01529346|363907208|FG002|Overall Study|Lost to Follow-up|1|||
105518315|NCT01529346|363907209|FG003|Overall Study|Lost to Follow-up|0|||
105518316|NCT01529346|363907210|FG004|Overall Study|Lost to Follow-up|0|||
105518317|NCT01529346|363907206|FG000|Overall Study|Other|0|||
105518318|NCT01529346|363907207|FG001|Overall Study|Other|1|||
105518319|NCT01529346|363907208|FG002|Overall Study|Other|1|||
105518320|NCT01529346|363907209|FG003|Overall Study|Other|0|||
105518321|NCT01529346|363907210|FG004|Overall Study|Other|0|||
105518322|NCT02259582|363907211|FG000|Overall Study|Physician Decision|0|||
105518323|NCT02259582|363907212|FG001|Overall Study|Physician Decision|1|||
105518324|NCT02259582|363907213|FG002|Overall Study|Physician Decision|0|||
105518325|NCT02259582|363907211|FG000|Overall Study|Death|0|||
105518326|NCT02259582|363907212|FG001|Overall Study|Death|0|||
105518327|NCT02259582|363907213|FG002|Overall Study|Death|1|||
105518328|NCT02259582|363907211|FG000|Overall Study|Adverse Event|1|||
105518329|NCT02259582|363907212|FG001|Overall Study|Adverse Event|0|||
105518330|NCT02259582|363907213|FG002|Overall Study|Adverse Event|1|||
105518331|NCT02259582|363907211|FG000|Overall Study|Withdrawal by Subject|0|||
105518332|NCT02259582|363907212|FG001|Overall Study|Withdrawal by Subject|0|||
105518333|NCT02259582|363907213|FG002|Overall Study|Withdrawal by Subject|1|||
105518334|NCT02259582|363907211|FG000|Overall Study|Disease progression|14|||
105518335|NCT02259582|363907212|FG001|Overall Study|Disease progression|15|||
105518336|NCT02259582|363907213|FG002|Overall Study|Disease progression|17|||
105518337|NCT02259582|363907211|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
105518338|NCT02259582|363907212|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
105518339|NCT02259582|363907213|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
105518340|NCT00503308|363907214|FG000|Overall Study|Protocol Violation|2|||
105518341|NCT00503308|363907215|FG001|Overall Study|Protocol Violation|1|||
105518342|NCT01172847|363907222|FG000|Overall Study|Withdrawal by Subject|3|||
105518343|NCT01770379|363907228|FG000|Overall Study|Technical issues|1|||
105518344|NCT01770379|363907229|FG001|Overall Study|Technical issues|0|||
105518345|NCT01770379|363907230|FG002|Overall Study|Technical issues|0|||
105518346|NCT01770379|363907228|FG000|Overall Study|Withdrawal by Subject|7|||
105518347|NCT01770379|363907229|FG001|Overall Study|Withdrawal by Subject|10|||
105518348|NCT01770379|363907230|FG002|Overall Study|Withdrawal by Subject|7|||
105518349|NCT01770379|363907228|FG000|Overall Study|study terminated by sponsor|22|||
105518350|NCT01770379|363907229|FG001|Overall Study|study terminated by sponsor|23|||
105518351|NCT01770379|363907230|FG002|Overall Study|study terminated by sponsor|22|||
105518352|NCT01770379|363907228|FG000|Overall Study|Protocol Violation|0|||
105518353|NCT01770379|363907229|FG001|Overall Study|Protocol Violation|1|||
105518354|NCT01770379|363907230|FG002|Overall Study|Protocol Violation|1|||
105518355|NCT01770379|363907228|FG000|Overall Study|Physician Decision|0|||
105518356|NCT01770379|363907229|FG001|Overall Study|Physician Decision|1|||
105518357|NCT01770379|363907230|FG002|Overall Study|Physician Decision|2|||
105518358|NCT01770379|363907228|FG000|Overall Study|Lost to Follow-up|0|||
105518359|NCT01770379|363907229|FG001|Overall Study|Lost to Follow-up|0|||
105518360|NCT01770379|363907230|FG002|Overall Study|Lost to Follow-up|2|||
105518361|NCT01770379|363907228|FG000|Overall Study|Lack of Efficacy|8|||
105518362|NCT01770379|363907229|FG001|Overall Study|Lack of Efficacy|6|||
105518363|NCT01770379|363907230|FG002|Overall Study|Lack of Efficacy|6|||
105518364|NCT01770379|363907228|FG000|Overall Study|Adverse Event|1|||
105518365|NCT01770379|363907229|FG001|Overall Study|Adverse Event|3|||
105518366|NCT01770379|363907230|FG002|Overall Study|Adverse Event|2|||
105518367|NCT00311623|363907231|FG000|Overall Study|Physician Decision|0|||
105518368|NCT00311623|363907232|FG001|Overall Study|Physician Decision|0|||
105518369|NCT00311623|363907233|FG002|Overall Study|Physician Decision|2|||
105518370|NCT03108027|363907239|FG000|Period 1|Subject/Guardian Decision|0|||
105518371|NCT03108027|363907240|FG001|Period 1|Subject/Guardian Decision|0|||
105518372|NCT03108027|363907241|FG002|Period 1|Subject/Guardian Decision|0|||
105518373|NCT03108027|363907242|FG003|Period 1|Subject/Guardian Decision|2|||
105518374|NCT03108027|363907243|FG004|Period 1|Subject/Guardian Decision|0|||
105518375|NCT03108027|363907244|FG005|Period 1|Subject/Guardian Decision|0|||
105518376|NCT03108027|363907239|FG000|Period 3|Adverse Event|0|||
105518377|NCT03108027|363907240|FG001|Period 3|Adverse Event|1|||
105518378|NCT03108027|363907241|FG002|Period 3|Adverse Event|0|||
105518379|NCT03108027|363907242|FG003|Period 3|Adverse Event|0|||
105518380|NCT03108027|363907243|FG004|Period 3|Adverse Event|0|||
105518381|NCT03108027|363907244|FG005|Period 3|Adverse Event|0|||
105518382|NCT03178773|363907245|FG000|Overall Study|Death|0|||
105518383|NCT03178773|363907246|FG001|Overall Study|Death|1|||
105518384|NCT03178773|363907245|FG000|Overall Study|Lost to Follow-up|29|||
105518385|NCT03178773|363907246|FG001|Overall Study|Lost to Follow-up|25|||
105518386|NCT03178773|363907245|FG000|Overall Study|Withdrawal by Subject|10|||
105518387|NCT03178773|363907246|FG001|Overall Study|Withdrawal by Subject|14|||
105518388|NCT00483379|363907247|FG000|Treatment Period|Adverse Event|1|||
105518389|NCT00483379|363907248|FG001|Treatment Period|Adverse Event|0|||
105518390|NCT00483379|363907247|FG000|Treatment Period|Withdrawal by Subject|1|||
105518391|NCT00483379|363907248|FG001|Treatment Period|Withdrawal by Subject|0|||
105518392|NCT02064166|363907249|FG000|Overall Study|Adverse Event|1|||
105518393|NCT02064166|363907250|FG001|Overall Study|Adverse Event|0|||
105518394|NCT01119131|363907257|FG000|Overall Study|Adverse Event|1|||
105518395|NCT01119131|363907258|FG001|Overall Study|Adverse Event|1|||
105518396|NCT01119131|363907259|FG002|Overall Study|Adverse Event|1|||
105518397|NCT01119131|363907257|FG000|Overall Study|Non-Compliance|1|||
105518398|NCT01119131|363907258|FG001|Overall Study|Non-Compliance|0|||
105518399|NCT01119131|363907259|FG002|Overall Study|Non-Compliance|4|||
105518400|NCT01119131|363907257|FG000|Overall Study|Physician Decision|0|||
105518401|NCT01119131|363907258|FG001|Overall Study|Physician Decision|0|||
105518402|NCT01119131|363907259|FG002|Overall Study|Physician Decision|1|||
105518403|NCT00909389|363907260|FG000|Overall Study|Adverse Event|6|||
105518404|NCT00909389|363907260|FG000|Overall Study|Death|4|||
105518405|NCT00909389|363907260|FG000|Overall Study|Poor Compliance|16|||
105518406|NCT00909389|363907260|FG000|Overall Study|Lost to Follow-up|4|||
105518407|NCT00909389|363907260|FG000|Overall Study|No Information|103|||
105518408|NCT04285879|363907261|FG000|Overall Study|Lost to Follow-up|1|||
105518409|NCT04285879|363907262|FG001|Overall Study|Lost to Follow-up|8|||
105518410|NCT04285879|363907261|FG000|Overall Study|medical/surgical exclusion|16|||
105518411|NCT04285879|363907262|FG001|Overall Study|medical/surgical exclusion|0|||
105518412|NCT02669433|363907265|FG000|Overall Study|Protocol Violation|0|||
105518413|NCT02669433|363907266|FG001|Overall Study|Protocol Violation|4|||
105518414|NCT02669433|363907267|FG002|Overall Study|Protocol Violation|1|||
105518415|NCT02669433|363907265|FG000|Overall Study|Disease Progression|1|||
105518416|NCT02669433|363907266|FG001|Overall Study|Disease Progression|0|||
105518417|NCT02669433|363907267|FG002|Overall Study|Disease Progression|0|||
105518418|NCT02669433|363907265|FG000|Overall Study|Physician Decision|1|||
105518419|NCT02669433|363907266|FG001|Overall Study|Physician Decision|1|||
105518420|NCT02669433|363907267|FG002|Overall Study|Physician Decision|0|||
105518421|NCT02669433|363907265|FG000|Overall Study|Adverse Event|6|||
105518422|NCT02669433|363907266|FG001|Overall Study|Adverse Event|7|||
105518423|NCT02669433|363907267|FG002|Overall Study|Adverse Event|10|||
105518424|NCT02669433|363907265|FG000|Overall Study|Sponsor Termination|1|||
105518425|NCT02669433|363907266|FG001|Overall Study|Sponsor Termination|0|||
105518426|NCT02669433|363907267|FG002|Overall Study|Sponsor Termination|1|||
105518427|NCT02669433|363907265|FG000|Overall Study|Withdrawal by Subject|5|||
105518428|NCT02669433|363907266|FG001|Overall Study|Withdrawal by Subject|1|||
105518429|NCT02669433|363907267|FG002|Overall Study|Withdrawal by Subject|0|||
105518430|NCT02669433|363907265|FG000|Overall Study|Withdrawal by Caregiver|1|||
105518431|NCT02669433|363907266|FG001|Overall Study|Withdrawal by Caregiver|0|||
105518432|NCT02669433|363907267|FG002|Overall Study|Withdrawal by Caregiver|2|||
105518433|NCT02669433|363907265|FG000|Overall Study|Death|0|||
105518434|NCT02669433|363907266|FG001|Overall Study|Death|1|||
105518435|NCT02669433|363907267|FG002|Overall Study|Death|1|||
105518436|NCT01721330|363907268|FG000|Overall Study|Withdrawal by Subject|0|||
105518437|NCT01721330|363907269|FG001|Overall Study|Withdrawal by Subject|1|||
105518438|NCT03358290|363907270|FG000|Overall Study|Study discontinued by Sponsor|0|||
105518439|NCT03358290|363907271|FG001|Overall Study|Study discontinued by Sponsor|1|||
105518440|NCT03358290|363907272|FG002|Overall Study|Study discontinued by Sponsor|1|||
105518441|NCT03358290|363907273|FG003|Overall Study|Study discontinued by Sponsor|0|||
105518442|NCT03358290|363907274|FG004|Overall Study|Study discontinued by Sponsor|0|||
105518443|NCT03358290|363907270|FG000|Overall Study|Adverse Event|0|||
105518444|NCT03358290|363907271|FG001|Overall Study|Adverse Event|0|||
105518445|NCT03358290|363907272|FG002|Overall Study|Adverse Event|1|||
105518446|NCT03358290|363907273|FG003|Overall Study|Adverse Event|2|||
105518447|NCT03358290|363907274|FG004|Overall Study|Adverse Event|0|||
105518448|NCT03358290|363907270|FG000|Overall Study|Withdrawal by Subject|0|||
105518449|NCT03358290|363907271|FG001|Overall Study|Withdrawal by Subject|0|||
105518450|NCT03358290|363907272|FG002|Overall Study|Withdrawal by Subject|0|||
105518451|NCT03358290|363907273|FG003|Overall Study|Withdrawal by Subject|0|||
105518452|NCT03358290|363907274|FG004|Overall Study|Withdrawal by Subject|1|||
105518453|NCT00416078|363907277|FG000|Overall Study|Death|3|||
105518454|NCT00416078|363907278|FG001|Overall Study|Death|4|||
105518455|NCT00416078|363907277|FG000|Overall Study|Withdrawal by Subject|3|||
105518456|NCT00416078|363907278|FG001|Overall Study|Withdrawal by Subject|2|||
105518457|NCT00416078|363907277|FG000|Overall Study|Physician Decision|1|||
105518458|NCT00416078|363907278|FG001|Overall Study|Physician Decision|0|||
105518459|NCT00416078|363907277|FG000|Overall Study|Lost to Follow-up|4|||
105518460|NCT00416078|363907278|FG001|Overall Study|Lost to Follow-up|2|||
105518461|NCT01106898|363907280|FG000|Overall Study|Adverse Event|6|||
105518462|NCT00818662|363907281|FG000|Overall Study|Adverse Event|5|||
105518463|NCT00818662|363907282|FG001|Overall Study|Adverse Event|14|||
105518464|NCT00818662|363907283|FG002|Overall Study|Adverse Event|4|||
105518465|NCT00818662|363907284|FG003|Overall Study|Adverse Event|3|||
105518466|NCT00818662|363907281|FG000|Overall Study|Withdrawal by Subject|5|||
105518467|NCT00818662|363907282|FG001|Overall Study|Withdrawal by Subject|4|||
105518468|NCT00818662|363907283|FG002|Overall Study|Withdrawal by Subject|2|||
105518469|NCT00818662|363907284|FG003|Overall Study|Withdrawal by Subject|2|||
105518470|NCT00818662|363907281|FG000|Overall Study|Death|1|||
105518471|NCT00818662|363907282|FG001|Overall Study|Death|3|||
105518472|NCT00818662|363907283|FG002|Overall Study|Death|0|||
105518473|NCT00818662|363907284|FG003|Overall Study|Death|0|||
105518474|NCT00818662|363907281|FG000|Overall Study|Physician Decision|1|||
105518475|NCT00818662|363907282|FG001|Overall Study|Physician Decision|0|||
105518476|NCT00818662|363907283|FG002|Overall Study|Physician Decision|0|||
105518477|NCT00818662|363907284|FG003|Overall Study|Physician Decision|0|||
105518478|NCT00818662|363907281|FG000|Overall Study|Lost to Follow-up|0|||
105518479|NCT00818662|363907282|FG001|Overall Study|Lost to Follow-up|0|||
105518480|NCT00818662|363907283|FG002|Overall Study|Lost to Follow-up|0|||
105518481|NCT00818662|363907284|FG003|Overall Study|Lost to Follow-up|1|||
105518482|NCT00818662|363907281|FG000|Overall Study|Unwilling or Unable to Participate|4|||
105518483|NCT00818662|363907282|FG001|Overall Study|Unwilling or Unable to Participate|6|||
105518484|NCT00818662|363907283|FG002|Overall Study|Unwilling or Unable to Participate|2|||
105518485|NCT00818662|363907284|FG003|Overall Study|Unwilling or Unable to Participate|4|||
105518486|NCT00818662|363907281|FG000|Overall Study|Protocol Violation|1|||
105518487|NCT00818662|363907282|FG001|Overall Study|Protocol Violation|1|||
105518488|NCT00818662|363907283|FG002|Overall Study|Protocol Violation|0|||
105518489|NCT00818662|363907284|FG003|Overall Study|Protocol Violation|0|||
105518490|NCT00818662|363907281|FG000|Overall Study|Requires a Prohibited Medication|1|||
105518491|NCT00818662|363907282|FG001|Overall Study|Requires a Prohibited Medication|0|||
105518492|NCT00818662|363907283|FG002|Overall Study|Requires a Prohibited Medication|0|||
105518493|NCT00818662|363907284|FG003|Overall Study|Requires a Prohibited Medication|0|||
105518494|NCT00818662|363907281|FG000|Overall Study|Safety Risk|1|||
105518495|NCT00818662|363907282|FG001|Overall Study|Safety Risk|1|||
105518496|NCT00818662|363907283|FG002|Overall Study|Safety Risk|0|||
105518497|NCT00818662|363907284|FG003|Overall Study|Safety Risk|1|||
105518498|NCT00818662|363907281|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
105518499|NCT00818662|363907282|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
105518500|NCT00818662|363907283|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
105518501|NCT00818662|363907284|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
105518502|NCT00818662|363907281|FG000|Overall Study|Participant's health declined|0|||
105518503|NCT00818662|363907282|FG001|Overall Study|Participant's health declined|0|||
105518504|NCT00818662|363907283|FG002|Overall Study|Participant's health declined|0|||
105518505|NCT00818662|363907284|FG003|Overall Study|Participant's health declined|1|||
105518506|NCT00818662|363907281|FG000|Overall Study|Caregiver to pursue other treatment|0|||
105518507|NCT00818662|363907282|FG001|Overall Study|Caregiver to pursue other treatment|1|||
105518508|NCT00818662|363907283|FG002|Overall Study|Caregiver to pursue other treatment|0|||
105518509|NCT00818662|363907284|FG003|Overall Study|Caregiver to pursue other treatment|0|||
105518510|NCT00818662|363907281|FG000|Overall Study|Moving out of state|0|||
105518511|NCT00818662|363907282|FG001|Overall Study|Moving out of state|0|||
105518512|NCT00818662|363907283|FG002|Overall Study|Moving out of state|0|||
105518513|NCT00818662|363907284|FG003|Overall Study|Moving out of state|1|||
105518514|NCT00818662|363907281|FG000|Overall Study|Declined move to another study site|1|||
105518515|NCT00818662|363907282|FG001|Overall Study|Declined move to another study site|0|||
105518516|NCT00818662|363907283|FG002|Overall Study|Declined move to another study site|0|||
105518517|NCT00818662|363907284|FG003|Overall Study|Declined move to another study site|0|||
105518518|NCT00818662|363907281|FG000|Overall Study|Change in living situation|0|||
105518519|NCT00818662|363907282|FG001|Overall Study|Change in living situation|0|||
105518520|NCT00818662|363907283|FG002|Overall Study|Change in living situation|0|||
105518521|NCT00818662|363907284|FG003|Overall Study|Change in living situation|1|||
105518522|NCT00818662|363907281|FG000|Overall Study|Study partner decision|0|||
105518523|NCT00818662|363907282|FG001|Overall Study|Study partner decision|0|||
105518524|NCT00818662|363907283|FG002|Overall Study|Study partner decision|0|||
105518525|NCT00818662|363907284|FG003|Overall Study|Study partner decision|1|||
105518526|NCT00818662|363907281|FG000|Overall Study|Admitted to long term nursing care|0|||
105518527|NCT00818662|363907282|FG001|Overall Study|Admitted to long term nursing care|1|||
105518528|NCT00818662|363907283|FG002|Overall Study|Admitted to long term nursing care|0|||
105518529|NCT00818662|363907284|FG003|Overall Study|Admitted to long term nursing care|0|||
105518530|NCT03021265|363907285|FG000|Overall Study|Adverse Event|29|||
105518531|NCT03021265|363907285|FG000|Overall Study|Lack of Efficacy|3|||
105518532|NCT03021265|363907285|FG000|Overall Study|Improved|17|||
105518533|NCT03021265|363907285|FG000|Overall Study|Lost to Follow-up|67|||
105518534|NCT03021265|363907285|FG000|Overall Study|No reason given|2|||
105518535|NCT03021265|363907285|FG000|Overall Study|No visit since the first visit|4|||
105518536|NCT01722071|363907286|FG000|Overall Study|Protocol Violation|1|||
105518537|NCT01722071|363907287|FG001|Overall Study|Protocol Violation|0|||
105518538|NCT00642941|363907288|FG000|Overall Study|Physician Decision|3|||
105518539|NCT00642941|363907289|FG001|Overall Study|Physician Decision|1|||
105518540|NCT00642941|363907290|FG002|Overall Study|Physician Decision|0|||
105518541|NCT00642941|363907291|FG003|Overall Study|Physician Decision|0|||
105518542|NCT00642941|363907292|FG004|Overall Study|Physician Decision|0|||
105518543|NCT00642941|363907293|FG005|Overall Study|Physician Decision|0|||
105518544|NCT00642941|363907294|FG006|Overall Study|Physician Decision|1|||
105518545|NCT00642941|363907295|FG007|Overall Study|Physician Decision|0|||
105518546|NCT00642941|363907296|FG008|Overall Study|Physician Decision|0|||
105518547|NCT00642941|363907297|FG009|Overall Study|Physician Decision|1|||
105518548|NCT00642941|363907298|FG010|Overall Study|Physician Decision|0|||
105518549|NCT00642941|363907299|FG011|Overall Study|Physician Decision|1|||
105518550|NCT00642941|363907288|FG000|Overall Study|Death|4|||
105518551|NCT00642941|363907289|FG001|Overall Study|Death|0|||
105518552|NCT00642941|363907290|FG002|Overall Study|Death|1|||
105518553|NCT00642941|363907291|FG003|Overall Study|Death|1|||
105518554|NCT00642941|363907292|FG004|Overall Study|Death|2|||
105518555|NCT00642941|363907293|FG005|Overall Study|Death|1|||
105518556|NCT00642941|363907294|FG006|Overall Study|Death|0|||
105518557|NCT00642941|363907295|FG007|Overall Study|Death|0|||
105518558|NCT00642941|363907296|FG008|Overall Study|Death|0|||
105518559|NCT00642941|363907297|FG009|Overall Study|Death|0|||
105518560|NCT00642941|363907298|FG010|Overall Study|Death|0|||
105518561|NCT00642941|363907299|FG011|Overall Study|Death|1|||
105518562|NCT00642941|363907288|FG000|Overall Study|Study closed by Sponsor|0|||
105518563|NCT00642941|363907289|FG001|Overall Study|Study closed by Sponsor|1|||
105518564|NCT00642941|363907290|FG002|Overall Study|Study closed by Sponsor|0|||
105518565|NCT00642941|363907291|FG003|Overall Study|Study closed by Sponsor|0|||
105518566|NCT00642941|363907292|FG004|Overall Study|Study closed by Sponsor|0|||
105518567|NCT00642941|363907293|FG005|Overall Study|Study closed by Sponsor|0|||
105518568|NCT00642941|363907294|FG006|Overall Study|Study closed by Sponsor|0|||
105518569|NCT00642941|363907295|FG007|Overall Study|Study closed by Sponsor|0|||
105518570|NCT00642941|363907296|FG008|Overall Study|Study closed by Sponsor|0|||
105518571|NCT00642941|363907297|FG009|Overall Study|Study closed by Sponsor|0|||
105518572|NCT00642941|363907298|FG010|Overall Study|Study closed by Sponsor|0|||
105518573|NCT00642941|363907299|FG011|Overall Study|Study closed by Sponsor|0|||
105518574|NCT00642941|363907288|FG000|Overall Study|Withdrawal by Subject|1|||
105518575|NCT00642941|363907289|FG001|Overall Study|Withdrawal by Subject|0|||
105518576|NCT00642941|363907290|FG002|Overall Study|Withdrawal by Subject|0|||
105518577|NCT00642941|363907291|FG003|Overall Study|Withdrawal by Subject|2|||
105518578|NCT00642941|363907292|FG004|Overall Study|Withdrawal by Subject|0|||
105518579|NCT00642941|363907293|FG005|Overall Study|Withdrawal by Subject|0|||
105518580|NCT00642941|363907294|FG006|Overall Study|Withdrawal by Subject|2|||
105518581|NCT00642941|363907295|FG007|Overall Study|Withdrawal by Subject|0|||
105518582|NCT00642941|363907296|FG008|Overall Study|Withdrawal by Subject|1|||
105518583|NCT00642941|363907297|FG009|Overall Study|Withdrawal by Subject|0|||
105518584|NCT00642941|363907298|FG010|Overall Study|Withdrawal by Subject|0|||
105518585|NCT00642941|363907299|FG011|Overall Study|Withdrawal by Subject|1|||
105518586|NCT00642941|363907288|FG000|Overall Study|Protocol Violation|0|||
105518587|NCT00642941|363907289|FG001|Overall Study|Protocol Violation|0|||
105518588|NCT00642941|363907290|FG002|Overall Study|Protocol Violation|0|||
105518589|NCT00642941|363907291|FG003|Overall Study|Protocol Violation|0|||
105518590|NCT00642941|363907292|FG004|Overall Study|Protocol Violation|0|||
105518591|NCT00642941|363907293|FG005|Overall Study|Protocol Violation|0|||
105518592|NCT00642941|363907294|FG006|Overall Study|Protocol Violation|1|||
105518593|NCT00642941|363907295|FG007|Overall Study|Protocol Violation|0|||
105518594|NCT00642941|363907296|FG008|Overall Study|Protocol Violation|0|||
105518595|NCT00642941|363907297|FG009|Overall Study|Protocol Violation|0|||
105518596|NCT00642941|363907298|FG010|Overall Study|Protocol Violation|0|||
105518597|NCT00642941|363907299|FG011|Overall Study|Protocol Violation|0|||
105518598|NCT00642941|363907288|FG000|Overall Study|Adverse Event|1|||
105518599|NCT00642941|363907289|FG001|Overall Study|Adverse Event|1|||
105518600|NCT00642941|363907290|FG002|Overall Study|Adverse Event|0|||
105518601|NCT00642941|363907291|FG003|Overall Study|Adverse Event|0|||
105518602|NCT00642941|363907292|FG004|Overall Study|Adverse Event|0|||
105518603|NCT00642941|363907293|FG005|Overall Study|Adverse Event|0|||
105518604|NCT00642941|363907294|FG006|Overall Study|Adverse Event|1|||
105518605|NCT00642941|363907295|FG007|Overall Study|Adverse Event|1|||
105518606|NCT00642941|363907296|FG008|Overall Study|Adverse Event|0|||
105518607|NCT00642941|363907297|FG009|Overall Study|Adverse Event|1|||
105518608|NCT00642941|363907298|FG010|Overall Study|Adverse Event|0|||
105518609|NCT00642941|363907299|FG011|Overall Study|Adverse Event|0|||
105518610|NCT00642941|363907288|FG000|Overall Study|Other|1|||
105518611|NCT00642941|363907289|FG001|Overall Study|Other|1|||
105518612|NCT00642941|363907290|FG002|Overall Study|Other|1|||
105518613|NCT00642941|363907291|FG003|Overall Study|Other|1|||
105518614|NCT00642941|363907292|FG004|Overall Study|Other|0|||
105518615|NCT00642941|363907293|FG005|Overall Study|Other|1|||
105518616|NCT00642941|363907294|FG006|Overall Study|Other|0|||
105518617|NCT00642941|363907295|FG007|Overall Study|Other|1|||
105518618|NCT00642941|363907296|FG008|Overall Study|Other|0|||
105518619|NCT00642941|363907297|FG009|Overall Study|Other|0|||
105518620|NCT00642941|363907298|FG010|Overall Study|Other|0|||
105518621|NCT00642941|363907299|FG011|Overall Study|Other|1|||
105518622|NCT00642941|363907288|FG000|Overall Study|Disease progression|60|||
105518623|NCT00642941|363907289|FG001|Overall Study|Disease progression|50|||
105518624|NCT00642941|363907290|FG002|Overall Study|Disease progression|5|||
105518625|NCT00642941|363907291|FG003|Overall Study|Disease progression|36|||
105518626|NCT00642941|363907292|FG004|Overall Study|Disease progression|23|||
105518627|NCT00642941|363907293|FG005|Overall Study|Disease progression|39|||
105518628|NCT00642941|363907294|FG006|Overall Study|Disease progression|18|||
105518629|NCT00642941|363907295|FG007|Overall Study|Disease progression|12|||
105518630|NCT00642941|363907296|FG008|Overall Study|Disease progression|10|||
105518631|NCT00642941|363907297|FG009|Overall Study|Disease progression|7|||
105518632|NCT00642941|363907298|FG010|Overall Study|Disease progression|12|||
105518633|NCT00642941|363907299|FG011|Overall Study|Disease progression|7|||
105518634|NCT01846611|363907301|FG000|Overall Study|Lost to Follow-up|4|||
105518635|NCT01846611|363907302|FG001|Overall Study|Lost to Follow-up|6|||
105518636|NCT01846611|363907301|FG000|Overall Study|Withdrawal by Subject|15|||
105518637|NCT01846611|363907302|FG001|Overall Study|Withdrawal by Subject|19|||
105518638|NCT01846611|363907301|FG000|Overall Study|Other|19|||
105518639|NCT01846611|363907302|FG001|Overall Study|Other|18|||
105518640|NCT00541034|363907303|FG000|Overall Study|Non-Compliance|3|||
105518641|NCT02062879|363907306|FG000|Overall Study|Withdrawal by Subject|4|||
105518642|NCT02062879|363907307|FG001|Overall Study|Withdrawal by Subject|1|||
105518643|NCT02484729|363907308|FG000|Overall Study|Failure of IntelliCap Error|0|||
105518644|NCT02484729|363907309|FG001|Overall Study|Failure of IntelliCap Error|0|||
105518645|NCT02484729|363907310|FG002|Overall Study|Failure of IntelliCap Error|0|||
105518646|NCT02484729|363907311|FG003|Overall Study|Failure of IntelliCap Error|0|||
105518647|NCT02484729|363907312|FG004|Overall Study|Failure of IntelliCap Error|0|||
105518648|NCT02484729|363907313|FG005|Overall Study|Failure of IntelliCap Error|0|||
105518649|NCT02484729|363907314|FG006|Overall Study|Failure of IntelliCap Error|0|||
105518650|NCT02484729|363907315|FG007|Overall Study|Failure of IntelliCap Error|0|||
105518651|NCT02484729|363907316|FG008|Overall Study|Failure of IntelliCap Error|0|||
105518652|NCT02484729|363907317|FG009|Overall Study|Failure of IntelliCap Error|1|||
105518653|NCT03061331|363907318|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
105518654|NCT03061331|363907319|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
105518655|NCT00511667|363907320|FG000|Overall Study|Adverse Event|1|||
105518656|NCT00511667|363907321|FG001|Overall Study|Adverse Event|0|||
105518657|NCT00511667|363907320|FG000|Overall Study|Protocol Violation|1|||
105518658|NCT00511667|363907321|FG001|Overall Study|Protocol Violation|1|||
105518659|NCT00511667|363907320|FG000|Overall Study|Withdrawal by Subject|2|||
105518660|NCT00511667|363907321|FG001|Overall Study|Withdrawal by Subject|0|||
105518661|NCT00511667|363907320|FG000|Overall Study|Site terminated|6|||
105518662|NCT00511667|363907321|FG001|Overall Study|Site terminated|1|||
105518663|NCT00511667|363907320|FG000|Overall Study|Other|2|||
105518664|NCT00511667|363907321|FG001|Overall Study|Other|1|||
105518665|NCT03045081|363908877|FG000|Overall Study|Withdrawal by Subject|6|||
105518666|NCT03045081|363908878|FG001|Overall Study|Withdrawal by Subject|11|||
105518667|NCT02699554|363908879|FG000|Overall Study|Lost to Follow-up|9|||
105518668|NCT02057198|363908884|FG000|Overall Study|Death|0|||
105518669|NCT02057198|363908885|FG001|Overall Study|Death|0|||
105518670|NCT02057198|363908886|FG002|Overall Study|Death|1|||
105518671|NCT02057198|363908884|FG000|Overall Study|Discharged early; lost to followup|0|||
105518672|NCT02057198|363908885|FG001|Overall Study|Discharged early; lost to followup|1|||
105518673|NCT02057198|363908886|FG002|Overall Study|Discharged early; lost to followup|0|||
105518674|NCT01163279|363908890|FG000|Overall Study|Withdrawal by Subject|2|||
105518675|NCT01163279|363908891|FG001|Overall Study|Withdrawal by Subject|0|||
105518676|NCT00453921|363908892|FG000|Overall Study|Withdrawal by Subject|1|||
105518677|NCT00453921|363908893|FG001|Overall Study|Withdrawal by Subject|1|||
105518678|NCT00453921|363908894|FG002|Overall Study|Withdrawal by Subject|1|||
105518679|NCT00453921|363908895|FG003|Overall Study|Withdrawal by Subject|1|||
105518680|NCT00453921|363908892|FG000|Overall Study|Lost to Follow-up|0|||
105518681|NCT00453921|363908893|FG001|Overall Study|Lost to Follow-up|0|||
105518682|NCT00453921|363908894|FG002|Overall Study|Lost to Follow-up|1|||
105518683|NCT00453921|363908895|FG003|Overall Study|Lost to Follow-up|0|||
105518684|NCT00174915|363908896|FG000|Overall Study|Lost to Follow-up|19|||
105518685|NCT00174915|363908897|FG001|Overall Study|Lost to Follow-up|17|||
105518686|NCT00174915|363908898|FG002|Overall Study|Lost to Follow-up|9|||
105518687|NCT00174915|363908899|FG003|Overall Study|Lost to Follow-up|17|||
105518688|NCT00174915|363908900|FG004|Overall Study|Lost to Follow-up|10|||
105518689|NCT00174915|363908896|FG000|Overall Study|Adverse Event|18|||
105518690|NCT00174915|363908897|FG001|Overall Study|Adverse Event|16|||
105518691|NCT00174915|363908898|FG002|Overall Study|Adverse Event|11|||
105518692|NCT00174915|363908899|FG003|Overall Study|Adverse Event|18|||
105518693|NCT00174915|363908900|FG004|Overall Study|Adverse Event|5|||
105518694|NCT00174915|363908896|FG000|Overall Study|Personal Reason(s)|16|||
105518695|NCT00174915|363908897|FG001|Overall Study|Personal Reason(s)|16|||
105518696|NCT00174915|363908898|FG002|Overall Study|Personal Reason(s)|9|||
105518697|NCT00174915|363908899|FG003|Overall Study|Personal Reason(s)|9|||
105518698|NCT00174915|363908900|FG004|Overall Study|Personal Reason(s)|9|||
105518699|NCT00174915|363908896|FG000|Overall Study|Other|15|||
105518700|NCT00174915|363908897|FG001|Overall Study|Other|8|||
105518701|NCT00174915|363908898|FG002|Overall Study|Other|6|||
105518702|NCT00174915|363908899|FG003|Overall Study|Other|5|||
105518703|NCT00174915|363908900|FG004|Overall Study|Other|3|||
105518704|NCT00174915|363908896|FG000|Overall Study|Gout Flare|13|||
105518705|NCT00174915|363908897|FG001|Overall Study|Gout Flare|6|||
105518706|NCT00174915|363908898|FG002|Overall Study|Gout Flare|8|||
105518707|NCT00174915|363908899|FG003|Overall Study|Gout Flare|1|||
105518708|NCT00174915|363908900|FG004|Overall Study|Gout Flare|0|||
105518709|NCT00174915|363908896|FG000|Overall Study|Protocol Violation|6|||
105518710|NCT00174915|363908897|FG001|Overall Study|Protocol Violation|3|||
105518711|NCT00174915|363908898|FG002|Overall Study|Protocol Violation|3|||
105518712|NCT00174915|363908899|FG003|Overall Study|Protocol Violation|6|||
105518713|NCT00174915|363908900|FG004|Overall Study|Protocol Violation|3|||
105518714|NCT00174915|363908896|FG000|Overall Study|Therapeutic Failure|6|||
105518715|NCT00174915|363908897|FG001|Overall Study|Therapeutic Failure|3|||
105518716|NCT00174915|363908898|FG002|Overall Study|Therapeutic Failure|2|||
105518717|NCT00174915|363908899|FG003|Overall Study|Therapeutic Failure|1|||
105518718|NCT00174915|363908900|FG004|Overall Study|Therapeutic Failure|3|||
105518719|NCT03060447|363908905|FG000|Overall Study|Withdrawal by Subject|2|||
105518720|NCT03060447|363908906|FG001|Overall Study|Withdrawal by Subject|0|||
105518721|NCT02232425|363908907|FG000|Overall Study|Lost to Follow-up|6|||
105518722|NCT02232425|363908908|FG001|Overall Study|Lost to Follow-up|2|||
105518723|NCT02232425|363908907|FG000|Overall Study|Adverse Event|2|||
105518724|NCT02232425|363908908|FG001|Overall Study|Adverse Event|0|||
105518725|NCT02232425|363908907|FG000|Overall Study|Withdrawal by Subject|5|||
105518726|NCT02232425|363908908|FG001|Overall Study|Withdrawal by Subject|6|||
105518727|NCT02232425|363908907|FG000|Overall Study|Lack of Efficacy|1|||
105518728|NCT02232425|363908908|FG001|Overall Study|Lack of Efficacy|0|||
105518729|NCT00460031|363908909|FG000|Overall Study|Adverse Event|5|||
105518730|NCT00460031|363908909|FG000|Overall Study|Withdrawal by Subject|5|||
105518731|NCT00460031|363908909|FG000|Overall Study|Death|1|||
105518732|NCT04741074|363908916|FG000|Overall Study|Withdrawal by Subject|1|||
105518733|NCT04741074|363908917|FG001|Overall Study|Withdrawal by Subject|1|||
105518734|NCT04741074|363908916|FG000|Overall Study|Study terminated prematurely|1|||
105518735|NCT04741074|363908917|FG001|Overall Study|Study terminated prematurely|0|||
105518736|NCT02432846|363908918|FG000|Overall Study (4 Arms/Strata)|Death|3|||
105518737|NCT02432846|363908919|FG001|Overall Study (4 Arms/Strata)|Death|2|||
105518738|NCT02432846|363908920|FG002|Overall Study (4 Arms/Strata)|Death|4|||
105518739|NCT02432846|363908921|FG003|Overall Study (4 Arms/Strata)|Death|3|||
105518740|NCT02432846|363908922|FG004|Overall Study (4 Arms/Strata)|Death|0|||
105518741|NCT02432846|363908923|FG005|Overall Study (4 Arms/Strata)|Death|0|||
105518742|NCT02432846|363908918|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
105518743|NCT02432846|363908919|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
105518744|NCT02432846|363908920|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
105518745|NCT02432846|363908921|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
105518746|NCT02432846|363908922|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
105518747|NCT02432846|363908923|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
105518748|NCT02432846|363908918|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
105518749|NCT02432846|363908919|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
105518750|NCT02432846|363908920|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
105518751|NCT02432846|363908921|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
105518752|NCT02432846|363908922|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
105518753|NCT02432846|363908923|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
105518754|NCT02432846|363908918|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
105518755|NCT02432846|363908919|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
105518756|NCT02432846|363908920|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
105518757|NCT02432846|363908921|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
105518758|NCT02432846|363908922|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
105518759|NCT02432846|363908923|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
105518760|NCT02432846|363908918|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
105518761|NCT02432846|363908919|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
105518762|NCT02432846|363908920|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
105518763|NCT02432846|363908921|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
105518764|NCT02432846|363908922|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
105518765|NCT02432846|363908923|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
105518766|NCT02432846|363908918|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
105518767|NCT02432846|363908919|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
105518768|NCT02432846|363908920|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
105518769|NCT02432846|363908921|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
105518770|NCT02432846|363908922|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
105518771|NCT02432846|363908923|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
105518772|NCT02432846|363908918|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
105518773|NCT02432846|363908919|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
105518774|NCT02432846|363908920|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
105518775|NCT02432846|363908921|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
105518776|NCT02432846|363908922|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
105518777|NCT02432846|363908923|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
105518778|NCT02432846|363908918|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
105518779|NCT02432846|363908919|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
105592321|NCT02155829|364169353|FG001|Overall Study|Withdrawal by Subject|3|||
105592322|NCT02155829|364169352|FG000|Overall Study|Protocol Violation|2|||
105592323|NCT02155829|364169353|FG001|Overall Study|Protocol Violation|0|||
105592324|NCT04107805|364169356|FG000|Overall Study|Adverse Event|0|||
105518780|NCT02432846|363908920|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
105518781|NCT02432846|363908921|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
105518782|NCT02432846|363908922|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
105518783|NCT02432846|363908923|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
105518784|NCT02432846|363908918|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
105518785|NCT02432846|363908919|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
105518786|NCT02432846|363908920|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
105518787|NCT02432846|363908921|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
105518788|NCT02432846|363908922|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
105518789|NCT02432846|363908923|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
105518790|NCT02432846|363908918|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
105518791|NCT02432846|363908919|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
105518792|NCT02432846|363908920|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
105518793|NCT02432846|363908921|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
105518794|NCT02432846|363908922|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
105518795|NCT02432846|363908923|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
105518796|NCT02432846|363908918|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
105518797|NCT02432846|363908919|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
105518798|NCT02432846|363908920|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
105518799|NCT02432846|363908921|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
105518800|NCT02432846|363908922|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
105518801|NCT02432846|363908923|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
105518802|NCT02432846|363908918|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
105518803|NCT02432846|363908919|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
105518804|NCT02432846|363908920|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
105518805|NCT02432846|363908921|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
105518806|NCT02432846|363908922|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
105518807|NCT02432846|363908923|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
105518808|NCT02432846|363908918|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
105518809|NCT02432846|363908919|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
105518810|NCT02432846|363908920|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
105518811|NCT02432846|363908921|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
105518812|NCT02432846|363908922|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
105518813|NCT02432846|363908923|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
105518814|NCT02432846|363908918|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
105518815|NCT02432846|363908919|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
105518816|NCT02432846|363908920|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
105518817|NCT02432846|363908921|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
105518818|NCT02432846|363908922|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
105518819|NCT02432846|363908923|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
105518820|NCT00937157|363908927|FG000|Overall Study|Pregnancy|1|||
105518821|NCT00937157|363908927|FG000|Overall Study|Lost to Follow-up|3|||
105518822|NCT00469092|363908928|FG000|Overall Study|Adverse Event|5|||
105518823|NCT00469092|363908929|FG001|Overall Study|Adverse Event|4|||
105518824|NCT00469092|363908928|FG000|Overall Study|Lack of Efficacy|1|||
105518825|NCT00469092|363908929|FG001|Overall Study|Lack of Efficacy|0|||
105518826|NCT00469092|363908928|FG000|Overall Study|Lost to Follow-up|1|||
105518827|NCT00469092|363908929|FG001|Overall Study|Lost to Follow-up|2|||
105518828|NCT00469092|363908928|FG000|Overall Study|Protocol Violation|3|||
105518829|NCT00469092|363908929|FG001|Overall Study|Protocol Violation|3|||
105518830|NCT00469092|363908928|FG000|Overall Study|Withdrawal by Subject|4|||
105518831|NCT00469092|363908929|FG001|Overall Study|Withdrawal by Subject|4|||
105518832|NCT00469092|363908928|FG000|Overall Study|Withdrawal Criteria|3|||
105518833|NCT00469092|363908929|FG001|Overall Study|Withdrawal Criteria|4|||
105518834|NCT00469092|363908928|FG000|Overall Study|Incorrectly Randomised|4|||
105518835|NCT00469092|363908929|FG001|Overall Study|Incorrectly Randomised|3|||
105518836|NCT00469092|363908928|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
105518837|NCT00469092|363908929|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
105518838|NCT00469092|363908928|FG000|Overall Study|Use of lipid lowering drug|1|||
105518839|NCT00469092|363908929|FG001|Overall Study|Use of lipid lowering drug|0|||
105518840|NCT00469092|363908928|FG000|Overall Study|Hypoglycaemic Episodes|1|||
105518841|NCT00469092|363908929|FG001|Overall Study|Hypoglycaemic Episodes|1|||
105518842|NCT00469092|363908928|FG000|Overall Study|Abnormal lab value|1|||
105518843|NCT00469092|363908929|FG001|Overall Study|Abnormal lab value|0|||
105518844|NCT00469092|363908928|FG000|Overall Study|Use of Corticosteroid|1|||
105518845|NCT00469092|363908929|FG001|Overall Study|Use of Corticosteroid|0|||
105518846|NCT00450450|363908930|FG000|Overall Study|Death|1|||
105518847|NCT00450450|363908931|FG001|Overall Study|Death|3|||
105518848|NCT00450450|363908930|FG000|Overall Study|Relapse|2|||
105518849|NCT00450450|363908931|FG001|Overall Study|Relapse|0|||
105518850|NCT00450450|363908930|FG000|Overall Study|Missing Data|2|||
105518851|NCT00450450|363908931|FG001|Overall Study|Missing Data|0|||
105518852|NCT02024867|363908932|FG000|Overall Study|Protocol Violation|3|||
105518853|NCT02024867|363908933|FG001|Overall Study|Protocol Violation|3|||
105518854|NCT02024867|363908932|FG000|Overall Study|Lost to Follow-up|6|||
105518855|NCT02024867|363908933|FG001|Overall Study|Lost to Follow-up|4|||
105518856|NCT01086540|363908934|FG000|Overall Study|Death|3|||
105518857|NCT01086540|363908935|FG001|Overall Study|Death|1|||
105518858|NCT01086540|363908934|FG000|Overall Study|Physician Decision|2|||
105518859|NCT01086540|363908935|FG001|Overall Study|Physician Decision|1|||
105518860|NCT01086540|363908934|FG000|Overall Study|Addition of new therapy for PAH|1|||
105518861|NCT01086540|363908935|FG001|Overall Study|Addition of new therapy for PAH|0|||
105518862|NCT01998737|363908936|FG000|Overall Study|Corrupted database|23|||
105518863|NCT01998737|363908937|FG001|Overall Study|Corrupted database|0|||
105518864|NCT00227305|363908941|FG000|Overall Study|Adverse Event|40|||
105518865|NCT00227305|363908941|FG000|Overall Study|Withdrawal by Subject|42|||
105518866|NCT00227305|363908941|FG000|Overall Study|Lost to Follow-up|33|||
105518867|NCT00227305|363908941|FG000|Overall Study|Study specific discontinuation|13|||
105518868|NCT00227305|363908941|FG000|Overall Study|MOVED OUT OF AREA|3|||
105518869|NCT00227305|363908941|FG000|Overall Study|Lack of Efficacy|7|||
105518870|NCT00227305|363908941|FG000|Overall Study|Physician Decision|3|||
105518871|NCT00227305|363908941|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
105518872|NCT00227305|363908941|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
105518873|NCT00227305|363908941|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
105518874|NCT02118012|363908942|FG000|Overall Study|Adverse Event|0|||
105518875|NCT02118012|363908943|FG001|Overall Study|Adverse Event|1|||
105518876|NCT02118012|363908942|FG000|Overall Study|Physician Decision|0|||
105518877|NCT02118012|363908943|FG001|Overall Study|Physician Decision|1|||
105518878|NCT00268996|363908944|FG000|Overall Study|Adverse Event|11|||
105518879|NCT00268996|363908945|FG001|Overall Study|Adverse Event|7|||
105518880|NCT00268996|363908944|FG000|Overall Study|Lost to Follow-up|3|||
105518881|NCT00268996|363908945|FG001|Overall Study|Lost to Follow-up|1|||
105518882|NCT00268996|363908944|FG000|Overall Study|Withdrawal by Subject|5|||
105518883|NCT00268996|363908945|FG001|Overall Study|Withdrawal by Subject|11|||
105518884|NCT00268996|363908944|FG000|Overall Study|Non-compliance|1|||
105518885|NCT00268996|363908945|FG001|Overall Study|Non-compliance|0|||
105518886|NCT00268996|363908944|FG000|Overall Study|Other|1|||
105518887|NCT00268996|363908945|FG001|Overall Study|Other|1|||
105518888|NCT02733991|363908946|FG000|Overall Study|Adverse Event|1|||
105518889|NCT02733991|363908947|FG001|Overall Study|Adverse Event|0|||
105518890|NCT02733991|363908946|FG000|Overall Study|Withdrawal by Subject|0|||
105518891|NCT02733991|363908947|FG001|Overall Study|Withdrawal by Subject|5|||
105518892|NCT02268864|363908948|FG000|Overall Study|Withdrawal by Subject|2|||
105518893|NCT02268864|363908949|FG001|Overall Study|Withdrawal by Subject|0|||
105518894|NCT02268864|363908950|FG002|Overall Study|Withdrawal by Subject|0|||
105518895|NCT02268864|363908948|FG000|Overall Study|Death|0|||
105518896|NCT02268864|363908949|FG001|Overall Study|Death|1|||
105518897|NCT02268864|363908950|FG002|Overall Study|Death|0|||
105518898|NCT04210310|363908955|FG000|Overall Study|Lost to Follow-up|32|||
105518899|NCT04210310|363908956|FG001|Overall Study|Lost to Follow-up|1|||
105518900|NCT00680745|363908957|FG000|Overall Study|Withdrawal by Subject|8|||
105518901|NCT00680745|363908958|FG001|Overall Study|Withdrawal by Subject|3|||
105518902|NCT00680745|363908959|FG002|Overall Study|Withdrawal by Subject|2|||
105518903|NCT00680745|363908960|FG003|Overall Study|Withdrawal by Subject|8|||
105518904|NCT00680745|363908957|FG000|Overall Study|Lost to Follow-up|0|||
105592325|NCT04107805|364169357|FG001|Overall Study|Adverse Event|0|||
105592326|NCT04107805|364169358|FG002|Overall Study|Adverse Event|0|||
105592327|NCT04107805|364169359|FG003|Overall Study|Adverse Event|1|||
105592328|NCT04107805|364169360|FG004|Overall Study|Adverse Event|0|||
105592329|NCT04107805|364169361|FG005|Overall Study|Adverse Event|1|||
105592330|NCT04107805|364169362|FG006|Overall Study|Adverse Event|0|||
105592331|NCT04107805|364169363|FG007|Overall Study|Adverse Event|0|||
105592332|NCT04107805|364169364|FG008|Overall Study|Adverse Event|1|||
105592333|NCT02750709|364169365|FG000|Treatment Period 1|Adverse Event|0|||
105518905|NCT00680745|363908958|FG001|Overall Study|Lost to Follow-up|1|||
105518906|NCT00680745|363908959|FG002|Overall Study|Lost to Follow-up|1|||
105518907|NCT00680745|363908960|FG003|Overall Study|Lost to Follow-up|0|||
105518908|NCT00680745|363908957|FG000|Overall Study|Death|1|||
105592334|NCT02750709|364169366|FG001|Treatment Period 1|Adverse Event|0|||
105518909|NCT00680745|363908958|FG001|Overall Study|Death|0|||
105518910|NCT00680745|363908959|FG002|Overall Study|Death|1|||
105518911|NCT00680745|363908960|FG003|Overall Study|Death|0|||
105592335|NCT02750709|364169367|FG002|Treatment Period 1|Adverse Event|0|||
105518912|NCT00680745|363908957|FG000|Overall Study|Adverse Event|5|||
105592336|NCT02750709|364169368|FG003|Treatment Period 1|Adverse Event|0|||
105592337|NCT02750709|364169369|FG004|Treatment Period 1|Adverse Event|0|||
105592338|NCT02750709|364169370|FG005|Treatment Period 1|Adverse Event|1|||
105592339|NCT01833832|364169372|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
105592340|NCT01321606|364169373|FG000|Overall Study|Lost to Follow-up|0|||
105592341|NCT01321606|364169374|FG001|Overall Study|Lost to Follow-up|0|||
105592342|NCT01321606|364169375|FG002|Overall Study|Lost to Follow-up|0|||
105592343|NCT01321606|364169376|FG003|Overall Study|Lost to Follow-up|1|||
105592344|NCT03310983|364169377|FG000|Overall Study|Lost to Follow-up|15|||
105592345|NCT03310983|364169378|FG001|Overall Study|Lost to Follow-up|17|||
105592346|NCT04536077|364169379|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
105592347|NCT04536077|364169380|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
105592348|NCT04536077|364169379|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
105592349|NCT04536077|364169380|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
105592350|NCT00906282|364169384|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
105592351|NCT00906282|364169384|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
105592352|NCT00906282|364169384|FG000|Preoperative Chemotherapy|Progressive disease|6|||
105592353|NCT00906282|364169384|FG000|Preoperative Chemotherapy|Toxicity|1|||
105592354|NCT01264718|364169387|FG000|Overall Study|Lost to Follow-up|3|||
105592355|NCT01264718|364169388|FG001|Overall Study|Lost to Follow-up|2|||
105592356|NCT01264718|364169387|FG000|Overall Study|Withdrawal by Subject|9|||
105592357|NCT01264718|364169388|FG001|Overall Study|Withdrawal by Subject|15|||
105592358|NCT01264718|364169387|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
105592359|NCT01264718|364169388|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
105592360|NCT01769391|364169391|FG000|Overall Study|Death|10|||
105592361|NCT01769391|364169392|FG001|Overall Study|Death|1|||
105592362|NCT01769391|364169391|FG000|Overall Study|Adverse Event|0|||
105592363|NCT01769391|364169392|FG001|Overall Study|Adverse Event|3|||
105518913|NCT00680745|363908958|FG001|Overall Study|Adverse Event|3|||
105518914|NCT00680745|363908959|FG002|Overall Study|Adverse Event|3|||
105518915|NCT00680745|363908960|FG003|Overall Study|Adverse Event|3|||
105518916|NCT00680745|363908957|FG000|Overall Study|Poor/Non-compliance|0|||
105518917|NCT00680745|363908958|FG001|Overall Study|Poor/Non-compliance|3|||
105518918|NCT00680745|363908959|FG002|Overall Study|Poor/Non-compliance|0|||
105518919|NCT00680745|363908960|FG003|Overall Study|Poor/Non-compliance|0|||
105518920|NCT00680745|363908957|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
105518921|NCT00680745|363908958|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
105518922|NCT00680745|363908959|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
105518923|NCT00680745|363908960|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
105518924|NCT00680745|363908957|FG000|Overall Study|False Treatment|0|||
105518925|NCT00680745|363908958|FG001|Overall Study|False Treatment|1|||
105518926|NCT00680745|363908959|FG002|Overall Study|False Treatment|3|||
105518927|NCT00680745|363908960|FG003|Overall Study|False Treatment|0|||
105518928|NCT01408914|363908966|FG000|Overall Study|Could not complete tx in protocol period|5|||
105518929|NCT01408914|363908967|FG001|Overall Study|Could not complete tx in protocol period|5|||
105518930|NCT01408914|363908968|FG002|Overall Study|Could not complete tx in protocol period|6|||
105518931|NCT01408914|363908966|FG000|Overall Study|Lost to Follow-up|4|||
105518932|NCT01408914|363908967|FG001|Overall Study|Lost to Follow-up|1|||
105518933|NCT01408914|363908968|FG002|Overall Study|Lost to Follow-up|2|||
105518934|NCT01408914|363908966|FG000|Overall Study|Physician Decision|1|||
105518935|NCT01408914|363908967|FG001|Overall Study|Physician Decision|1|||
105518936|NCT01408914|363908968|FG002|Overall Study|Physician Decision|0|||
105518937|NCT01408914|363908966|FG000|Overall Study|Withdrawal by Subject|1|||
105518938|NCT01408914|363908967|FG001|Overall Study|Withdrawal by Subject|0|||
105518939|NCT01408914|363908968|FG002|Overall Study|Withdrawal by Subject|1|||
105518940|NCT01408914|363908966|FG000|Overall Study|Moved out of study jurisdiction|1|||
105518941|NCT01408914|363908967|FG001|Overall Study|Moved out of study jurisdiction|1|||
105518942|NCT01408914|363908968|FG002|Overall Study|Moved out of study jurisdiction|0|||
105518943|NCT01408914|363908966|FG000|Overall Study|Late exclusion|0|||
105518944|NCT01408914|363908967|FG001|Overall Study|Late exclusion|3|||
105518945|NCT01408914|363908968|FG002|Overall Study|Late exclusion|3|||
105518946|NCT01408914|363908966|FG000|Overall Study|Change in local TB/HIV norms|0|||
105518947|NCT01408914|363908967|FG001|Overall Study|Change in local TB/HIV norms|1|||
105518948|NCT01408914|363908968|FG002|Overall Study|Change in local TB/HIV norms|1|||
105518949|NCT00137423|363908969|FG000|Overall Study|Adverse Event|7|||
105518950|NCT00137423|363908970|FG001|Overall Study|Adverse Event|9|||
105518951|NCT00137423|363908969|FG000|Overall Study|consent withdrawn|1|||
105592364|NCT01769391|364169391|FG000|Overall Study|Progressive Disease|1|||
105592365|NCT01769391|364169392|FG001|Overall Study|Progressive Disease|2|||
105518952|NCT00137423|363908970|FG001|Overall Study|consent withdrawn|1|||
105518953|NCT00137423|363908969|FG000|Overall Study|Lack of Efficacy|31|||
105518954|NCT00137423|363908970|FG001|Overall Study|Lack of Efficacy|33|||
105592366|NCT01769391|364169391|FG000|Overall Study|Withdrawal by Subject|4|||
105518955|NCT00137423|363908969|FG000|Overall Study|Death|0|||
105518956|NCT00137423|363908970|FG001|Overall Study|Death|1|||
105518957|NCT01928329|363908971|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
105518958|NCT01928329|363908972|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
105518959|NCT01928329|363908971|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
105518960|NCT01928329|363908972|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
105518961|NCT01928329|363908971|FG000|Overall Study|Adverse Event|5|||
105518962|NCT01928329|363908972|FG001|Overall Study|Adverse Event|3|||
105518963|NCT01928329|363908971|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
105518964|NCT01928329|363908972|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
105518965|NCT01928329|363908971|FG000|Overall Study|Withdrawal by Subject|1|||
105518966|NCT01928329|363908972|FG001|Overall Study|Withdrawal by Subject|5|||
105518967|NCT01928329|363908971|FG000|Overall Study|Physician Decision|1|||
105518968|NCT01928329|363908972|FG001|Overall Study|Physician Decision|1|||
105518969|NCT03187262|363908973|FG000|Induction|Lack of Efficacy|2|||
105518970|NCT03187262|363908973|FG000|Induction|Progressive Disease|4|||
105518971|NCT03187262|363908973|FG000|Consolidation|Progressive Disease|5|||
105518972|NCT00278109|363908978|FG000|Overall Study|Adverse Event|3|||
105518973|NCT00278109|363908978|FG000|Overall Study|social circumstances|1|||
105518974|NCT01333059|363908983|FG000|Overall Study|Physician Decision|3|||
105518975|NCT01333059|363908984|FG001|Overall Study|Physician Decision|3|||
105518976|NCT01333059|363908983|FG000|Overall Study|Protocol Violation|3|||
105518977|NCT01333059|363908984|FG001|Overall Study|Protocol Violation|0|||
105518978|NCT01166763|363908985|FG000|Overall Study|Withdrawal by Subject|3|||
105518979|NCT04339296|363908986|FG000|Overall Study|Refuse to participate after allocation|1|||
105518980|NCT04339296|363908987|FG001|Overall Study|Refuse to participate after allocation|1|||
105518981|NCT04339296|363908986|FG000|Overall Study|Withdrew after completion of baseline|2|||
105518982|NCT04339296|363908987|FG001|Overall Study|Withdrew after completion of baseline|1|||
105518983|NCT04339296|363908986|FG000|Overall Study|Lost to Follow-up|0|||
105518984|NCT04339296|363908987|FG001|Overall Study|Lost to Follow-up|4|||
105518985|NCT04339296|363908986|FG000|Overall Study|Discontinued intervention|5|||
105518986|NCT04339296|363908987|FG001|Overall Study|Discontinued intervention|3|||
105518987|NCT01994629|363908991|FG000|Overall Study|Withdrawal by Subject|1|||
105518988|NCT01994629|363908992|FG001|Overall Study|Withdrawal by Subject|0|||
105518989|NCT01994629|363908991|FG000|Overall Study|Lost to Follow-up|0|||
105518990|NCT01994629|363908992|FG001|Overall Study|Lost to Follow-up|3|||
105518991|NCT01187043|363908993|FG000|Overall Study|Adverse Event|0|||
105518992|NCT01187043|363908994|FG001|Overall Study|Adverse Event|0|||
105518993|NCT01187043|363908995|FG002|Overall Study|Adverse Event|0|||
105518994|NCT01187043|363908996|FG003|Overall Study|Adverse Event|0|||
105518995|NCT01187043|363908997|FG004|Overall Study|Adverse Event|1|||
105518996|NCT01187043|363908993|FG000|Overall Study|Unable to make scheduled visits|1|||
105518997|NCT01187043|363908994|FG001|Overall Study|Unable to make scheduled visits|0|||
105518998|NCT01187043|363908995|FG002|Overall Study|Unable to make scheduled visits|4|||
105518999|NCT01187043|363908996|FG003|Overall Study|Unable to make scheduled visits|0|||
105519000|NCT01187043|363908997|FG004|Overall Study|Unable to make scheduled visits|1|||
105519001|NCT00453544|363909008|FG000|Overall Study|Withdrawal by Subject|1|||
105519002|NCT00453544|363909009|FG001|Overall Study|Withdrawal by Subject|0|||
105519003|NCT00453544|363909010|FG002|Overall Study|Withdrawal by Subject|0|||
105519004|NCT00453544|363909011|FG003|Overall Study|Withdrawal by Subject|0|||
105519005|NCT00453544|363909008|FG000|Overall Study|Primary outcome measure not completed|1|||
105519006|NCT00453544|363909009|FG001|Overall Study|Primary outcome measure not completed|1|||
105519007|NCT00453544|363909010|FG002|Overall Study|Primary outcome measure not completed|0|||
105519008|NCT00453544|363909011|FG003|Overall Study|Primary outcome measure not completed|1|||
105519009|NCT02457910|363909012|FG000|Overall Study|Withdrawal by Subject|0|||
105519010|NCT02457910|363909013|FG001|Overall Study|Withdrawal by Subject|0|||
105519011|NCT02457910|363909014|FG002|Overall Study|Withdrawal by Subject|0|||
105519012|NCT02457910|363909015|FG003|Overall Study|Withdrawal by Subject|0|||
105519013|NCT02457910|363909016|FG004|Overall Study|Withdrawal by Subject|0|||
105519014|NCT02457910|363909017|FG005|Overall Study|Withdrawal by Subject|1|||
105519015|NCT02457910|363909012|FG000|Overall Study|Adverse Event|0|||
105519016|NCT02457910|363909013|FG001|Overall Study|Adverse Event|2|||
105519017|NCT02457910|363909014|FG002|Overall Study|Adverse Event|1|||
105519018|NCT02457910|363909015|FG003|Overall Study|Adverse Event|1|||
105519019|NCT02457910|363909016|FG004|Overall Study|Adverse Event|1|||
105519020|NCT02457910|363909017|FG005|Overall Study|Adverse Event|3|||
105519021|NCT02457910|363909012|FG000|Overall Study|Disease progression|3|||
105519022|NCT02457910|363909013|FG001|Overall Study|Disease progression|3|||
105519023|NCT02457910|363909014|FG002|Overall Study|Disease progression|1|||
105519024|NCT02457910|363909015|FG003|Overall Study|Disease progression|1|||
105519025|NCT02457910|363909016|FG004|Overall Study|Disease progression|4|||
105519026|NCT02457910|363909017|FG005|Overall Study|Disease progression|6|||
105519027|NCT02457910|363909012|FG000|Overall Study|Other complicating illness|0|||
105519028|NCT02457910|363909013|FG001|Overall Study|Other complicating illness|0|||
105519029|NCT02457910|363909014|FG002|Overall Study|Other complicating illness|0|||
105519030|NCT02457910|363909015|FG003|Overall Study|Other complicating illness|0|||
105519031|NCT02457910|363909016|FG004|Overall Study|Other complicating illness|0|||
105519032|NCT02457910|363909017|FG005|Overall Study|Other complicating illness|1|||
105519033|NCT02457910|363909012|FG000|Overall Study|Death|0|||
105519034|NCT02457910|363909013|FG001|Overall Study|Death|0|||
105519035|NCT02457910|363909014|FG002|Overall Study|Death|1|||
105519036|NCT02457910|363909015|FG003|Overall Study|Death|0|||
105519037|NCT02457910|363909016|FG004|Overall Study|Death|0|||
105519038|NCT02457910|363909017|FG005|Overall Study|Death|0|||
105519039|NCT00619801|363909020|FG000|Overall Study|Lack of Efficacy|0|||
105519040|NCT00619801|363909021|FG001|Overall Study|Lack of Efficacy|1|||
105519041|NCT00619801|363909020|FG000|Overall Study|Withdrawal by Subject|1|||
105519042|NCT00619801|363909021|FG001|Overall Study|Withdrawal by Subject|1|||
105519043|NCT00619801|363909020|FG000|Overall Study|Loss of efficacy|0|||
105519044|NCT00619801|363909021|FG001|Overall Study|Loss of efficacy|1|||
105519045|NCT03721276|363909022|FG000|Overall Study|Lost to Follow-up|5|||
105519046|NCT03721276|363909023|FG001|Overall Study|Lost to Follow-up|3|||
105519047|NCT03721276|363909022|FG000|Overall Study|Adverse Event|0|||
105519048|NCT03721276|363909023|FG001|Overall Study|Adverse Event|1|||
105519049|NCT00450333|363909024|FG000|Overall Study|Study terminated|47|||
105519050|NCT00450333|363909025|FG001|Overall Study|Study terminated|54|||
105519051|NCT00450333|363909026|FG002|Overall Study|Study terminated|16|||
105519052|NCT00450333|363909027|FG003|Overall Study|Study terminated|21|||
105519053|NCT00450333|363909024|FG000|Overall Study|Adverse Event|1|||
105519054|NCT00450333|363909025|FG001|Overall Study|Adverse Event|7|||
105519055|NCT00450333|363909026|FG002|Overall Study|Adverse Event|2|||
105519056|NCT00450333|363909027|FG003|Overall Study|Adverse Event|2|||
105519057|NCT00450333|363909024|FG000|Overall Study|Protocol Violation|1|||
105519058|NCT00450333|363909025|FG001|Overall Study|Protocol Violation|0|||
105519059|NCT00450333|363909026|FG002|Overall Study|Protocol Violation|1|||
105519060|NCT00450333|363909027|FG003|Overall Study|Protocol Violation|0|||
105519061|NCT00450333|363909024|FG000|Overall Study|Withdrawal by Subject|1|||
105519062|NCT00450333|363909025|FG001|Overall Study|Withdrawal by Subject|0|||
105519063|NCT00450333|363909026|FG002|Overall Study|Withdrawal by Subject|3|||
105519064|NCT00450333|363909027|FG003|Overall Study|Withdrawal by Subject|0|||
105519065|NCT00450333|363909024|FG000|Overall Study|Kidney transplant|1|||
105519066|NCT00450333|363909025|FG001|Overall Study|Kidney transplant|0|||
105519067|NCT00450333|363909026|FG002|Overall Study|Kidney transplant|1|||
105519068|NCT00450333|363909027|FG003|Overall Study|Kidney transplant|3|||
105519069|NCT00450333|363909024|FG000|Overall Study|Death|3|||
105519070|NCT00450333|363909025|FG001|Overall Study|Death|2|||
105519071|NCT00450333|363909026|FG002|Overall Study|Death|2|||
105519072|NCT00450333|363909027|FG003|Overall Study|Death|2|||
105519073|NCT01980875|363909032|FG000|Overall Study|Withdrew Consent|1|||
105519074|NCT01980875|363909033|FG001|Overall Study|Withdrew Consent|1|||
105519075|NCT01980875|363909034|FG002|Overall Study|Withdrew Consent|1|||
105519076|NCT01980875|363909032|FG000|Overall Study|Study Terminated by Sponsor|7|||
105519077|NCT01980875|363909033|FG001|Overall Study|Study Terminated by Sponsor|24|||
105519078|NCT01980875|363909034|FG002|Overall Study|Study Terminated by Sponsor|22|||
105519079|NCT01980875|363909032|FG000|Overall Study|Lost to Follow-up|0|||
105519080|NCT01980875|363909033|FG001|Overall Study|Lost to Follow-up|0|||
105519081|NCT01980875|363909034|FG002|Overall Study|Lost to Follow-up|1|||
105519082|NCT01189812|363909038|FG000|Overall Study|Withdrawal by Subject|2|||
105519083|NCT01189812|363909039|FG001|Overall Study|Withdrawal by Subject|3|||
105519084|NCT01189812|363909038|FG000|Overall Study|Adverse Event|1|||
105519085|NCT01189812|363909039|FG001|Overall Study|Adverse Event|0|||
105519086|NCT01189812|363909038|FG000|Overall Study|Out of Window|4|||
105519087|NCT01189812|363909039|FG001|Overall Study|Out of Window|3|||
105519088|NCT01189812|363909038|FG000|Overall Study|Moved out of State|1|||
105519089|NCT01189812|363909039|FG001|Overall Study|Moved out of State|2|||
105519090|NCT00423150|363909040|FG000|Overall Study|Adverse Event|11|||
105519091|NCT00423150|363909040|FG000|Overall Study|Progression of disease being studied|69|||
105519092|NCT00423150|363909040|FG000|Overall Study|Withdrawal by Subject|1|||
105519093|NCT00423150|363909040|FG000|Overall Study|Non-compliance with protocol|1|||
105519094|NCT00423150|363909040|FG000|Overall Study|Administrative|4|||
105519095|NCT02951156|363909041|FG000|Overall Study|Death|3|||
105519096|NCT02951156|363909042|FG001|Overall Study|Death|8|||
105519097|NCT02951156|363909043|FG002|Overall Study|Death|5|||
105519098|NCT02951156|363909041|FG000|Overall Study|Progressive disease|1|||
105519099|NCT02951156|363909042|FG001|Overall Study|Progressive disease|0|||
105519100|NCT02951156|363909043|FG002|Overall Study|Progressive disease|1|||
105519101|NCT02951156|363909041|FG000|Overall Study|Withdrawal by Subject|0|||
105519102|NCT02951156|363909042|FG001|Overall Study|Withdrawal by Subject|0|||
105519103|NCT02951156|363909043|FG002|Overall Study|Withdrawal by Subject|1|||
105519104|NCT02951156|363909041|FG000|Overall Study|Study terminated by sponsor|0|||
105519105|NCT02951156|363909042|FG001|Overall Study|Study terminated by sponsor|0|||
105519106|NCT02951156|363909043|FG002|Overall Study|Study terminated by sponsor|1|||
105519107|NCT02951156|363909041|FG000|Overall Study|Other|5|||
105519108|NCT02951156|363909042|FG001|Overall Study|Other|1|||
105519109|NCT02951156|363909043|FG002|Overall Study|Other|2|||
105519110|NCT02081690|363910798|FG000|Overall Study|Death|3|||
105519111|NCT02081690|363910798|FG000|Overall Study|Physician Decision|3|||
105519112|NCT02081690|363910798|FG000|Overall Study|Withdrawal by Subject|1|||
105519113|NCT00397982|363910800|FG000|Overall Study|Withdrawal by Subject|1|||
105519114|NCT00397982|363910800|FG000|Overall Study|Adverse Event|1|||
105519115|NCT00397982|363910800|FG000|Overall Study|noncompliance|1|||
105519116|NCT00397982|363910800|FG000|Overall Study|Unrelated health issues|1|||
105519117|NCT04244786|363910801|FG000|Overall Study|Adverse Event|0|||
105519118|NCT04244786|363910802|FG001|Overall Study|Adverse Event|0|||
105519119|NCT04244786|363910803|FG002|Overall Study|Adverse Event|2|||
105519120|NCT04244786|363910801|FG000|Overall Study|Withdrawal by Subject|0|||
105519121|NCT04244786|363910802|FG001|Overall Study|Withdrawal by Subject|0|||
105519122|NCT04244786|363910803|FG002|Overall Study|Withdrawal by Subject|5|||
105519123|NCT00623727|363910809|FG000|Double Blind (DB)|Adverse Event|1|||
105519124|NCT00623727|363910810|FG001|Double Blind (DB)|Adverse Event|3|||
105519125|NCT00623727|363910809|FG000|Double Blind (DB)|Physician Decision|0|||
105519126|NCT00623727|363910810|FG001|Double Blind (DB)|Physician Decision|1|||
105519127|NCT00623727|363910809|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
105519128|NCT00623727|363910810|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
105519129|NCT00623727|363910809|FG000|Double Blind (DB)|Lack of Efficacy|2|||
105519130|NCT00623727|363910810|FG001|Double Blind (DB)|Lack of Efficacy|2|||
105519131|NCT00623727|363910809|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
105519132|NCT00623727|363910810|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
105519133|NCT00623727|363910809|FG000|Double Blind (DB)|Lost to Follow-up|1|||
105519134|NCT00623727|363910810|FG001|Double Blind (DB)|Lost to Follow-up|1|||
105519135|NCT00623727|363910809|FG000|Double Blind (DB)|Protocol Violation|2|||
105519136|NCT00623727|363910810|FG001|Double Blind (DB)|Protocol Violation|2|||
105519137|NCT00623727|363910809|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
105519138|NCT00623727|363910810|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
105519139|NCT00623727|363910809|FG000|Open Label Follow-up|Study termination|0|||
105519140|NCT00623727|363910810|FG001|Open Label Follow-up|Study termination|6|||
105519141|NCT00623727|363910809|FG000|Open Label Follow-up|Participant convenience|0|||
105519142|NCT00623727|363910810|FG001|Open Label Follow-up|Participant convenience|1|||
105519143|NCT03220217|363910811|FG000|Overall Study|Withdrawal by Subject|0|||
105519144|NCT03220217|363910812|FG001|Overall Study|Withdrawal by Subject|1|||
105519145|NCT03220217|363910813|FG002|Overall Study|Withdrawal by Subject|0|||
105519146|NCT03220217|363910811|FG000|Overall Study|Subject Missed Procedure|0|||
105519147|NCT03220217|363910812|FG001|Overall Study|Subject Missed Procedure|0|||
105519148|NCT03220217|363910813|FG002|Overall Study|Subject Missed Procedure|1|||
105519149|NCT02734810|363910815|FG000|Overall Study|Adverse Event|1|||
105519150|NCT02734810|363910816|FG001|Overall Study|Adverse Event|0|||
105519151|NCT02734810|363910815|FG000|Overall Study|Lack of Efficacy|1|||
105519152|NCT02734810|363910816|FG001|Overall Study|Lack of Efficacy|0|||
105519153|NCT00903617|363910822|FG000|Overall Study|Adverse Event|0|||
105519154|NCT00903617|363910823|FG001|Overall Study|Adverse Event|1|||
105519155|NCT00903617|363910824|FG002|Overall Study|Adverse Event|1|||
105519156|NCT00903617|363910825|FG003|Overall Study|Adverse Event|0|||
105519157|NCT00903617|363910822|FG000|Overall Study|Protocol-defined stopping criteria|0|||
105519158|NCT00903617|363910823|FG001|Overall Study|Protocol-defined stopping criteria|2|||
105519159|NCT00903617|363910824|FG002|Overall Study|Protocol-defined stopping criteria|0|||
105519160|NCT00903617|363910825|FG003|Overall Study|Protocol-defined stopping criteria|0|||
105519161|NCT00903617|363910822|FG000|Overall Study|Lost to Follow-up|2|||
105519162|NCT00903617|363910823|FG001|Overall Study|Lost to Follow-up|0|||
105519163|NCT00903617|363910824|FG002|Overall Study|Lost to Follow-up|1|||
105519164|NCT00903617|363910825|FG003|Overall Study|Lost to Follow-up|1|||
105519165|NCT00903617|363910822|FG000|Overall Study|Withdrawal by Subject|1|||
105519166|NCT00903617|363910823|FG001|Overall Study|Withdrawal by Subject|2|||
105519167|NCT00903617|363910824|FG002|Overall Study|Withdrawal by Subject|3|||
105519168|NCT00903617|363910825|FG003|Overall Study|Withdrawal by Subject|0|||
105519169|NCT01706003|363910826|FG000|Overall Study|Withdrawal by Subject|2|||
105519170|NCT01706003|363910827|FG001|Overall Study|Withdrawal by Subject|0|||
105519171|NCT01706003|363910826|FG000|Overall Study|Not scheduled|3|||
105519172|NCT01706003|363910827|FG001|Overall Study|Not scheduled|0|||
105519173|NCT01706003|363910826|FG000|Overall Study|Lost to Follow-up|6|||
105592367|NCT01769391|364169392|FG001|Overall Study|Withdrawal by Subject|3|||
105519174|NCT01706003|363910827|FG001|Overall Study|Lost to Follow-up|4|||
105519175|NCT00407563|363910828|FG000|Overall Study|Patient continues on treatment|1|||
105519176|NCT02507505|363910829|FG000|Overall Study|Withdrawal by Subject|13|||
105519177|NCT02507505|363910830|FG001|Overall Study|Withdrawal by Subject|11|||
105519178|NCT02507505|363910829|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
105519179|NCT02507505|363910830|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
105519180|NCT02507505|363910829|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
105519181|NCT02507505|363910830|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
105519182|NCT02507505|363910829|FG000|Overall Study|Death before receipt of anesthesia|0|||
105519183|NCT02507505|363910830|FG001|Overall Study|Death before receipt of anesthesia|1|||
105519184|NCT00254540|363910831|FG000|Overall Study|Adverse Event|6|||
105519185|NCT00254540|363910832|FG001|Overall Study|Adverse Event|7|||
105519186|NCT00254540|363910831|FG000|Overall Study|Lack of Efficacy|13|||
105519187|NCT00254540|363910832|FG001|Overall Study|Lack of Efficacy|13|||
105519188|NCT00254540|363910831|FG000|Overall Study|Death|0|||
105519189|NCT00254540|363910832|FG001|Overall Study|Death|1|||
105519190|NCT00254540|363910831|FG000|Overall Study|Laboratory Test Abnormality|0|||
105519191|NCT00254540|363910832|FG001|Overall Study|Laboratory Test Abnormality|1|||
105519192|NCT00225251|363910833|FG000|Overall Study|Withdrawal by Subject|1|||
105519193|NCT00225251|363910834|FG001|Overall Study|Withdrawal by Subject|1|||
105519194|NCT00082355|363910841|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
105519195|NCT00082355|363910841|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
105519196|NCT00082355|363910841|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
105519197|NCT00759863|363910843|FG000|Overall Study|Death, moved, or lost contact|20|||
105519198|NCT00759863|363910844|FG001|Overall Study|Death, moved, or lost contact|18|||
105519199|NCT00936910|363910848|FG000|Overall Study|Lack of Efficacy|3|||
105519200|NCT00412854|363910849|FG000|Overall Study|Withdrawn due to adverse events|1|||
105519201|NCT00412854|363910850|FG001|Overall Study|Withdrawn due to adverse events|5|||
105519202|NCT00412854|363910849|FG000|Overall Study|Withdrawn for other reasons|13|||
105519203|NCT00412854|363910850|FG001|Overall Study|Withdrawn for other reasons|11|||
105519204|NCT01485640|363910853|FG000|Overall Study|Adverse Event|10|||
105519205|NCT01485640|363910853|FG000|Overall Study|Lack of Efficacy|2|||
105519206|NCT01485640|363910853|FG000|Overall Study|Protocol Violation|1|||
105519207|NCT01485640|363910853|FG000|Overall Study|Withdrawal by Subject|14|||
105519208|NCT01485640|363910853|FG000|Overall Study|Terminated by Sponsor|95|||
105519209|NCT02101775|363910856|FG000|Overall Study|Adverse Event|4|||
105519210|NCT02101775|363910857|FG001|Overall Study|Adverse Event|0|||
105519211|NCT02101775|363910858|FG002|Overall Study|Adverse Event|0|||
105519212|NCT02101775|363910856|FG000|Overall Study|Admission to Hospital|0|||
105519213|NCT02101775|363910857|FG001|Overall Study|Admission to Hospital|1|||
105519214|NCT02101775|363910858|FG002|Overall Study|Admission to Hospital|0|||
105519215|NCT00730912|363910859|FG000|Overall Study|Discontinued|0|||
105519216|NCT00730912|363910860|FG001|Overall Study|Discontinued|0|||
105519217|NCT00730912|363910861|FG002|Overall Study|Discontinued|1|||
105519218|NCT00840294|363910862|FG000|Overall Study|Withdrawal by Subject|2|||
105519219|NCT00840294|363910863|FG001|Overall Study|Withdrawal by Subject|1|||
105519220|NCT00840294|363910862|FG000|Overall Study|Protocol Violation|1|||
105519221|NCT00840294|363910863|FG001|Overall Study|Protocol Violation|3|||
105519222|NCT00840294|363910862|FG000|Overall Study|Illness|0|||
105519223|NCT00840294|363910863|FG001|Overall Study|Illness|1|||
105519224|NCT00383149|363910864|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
105519225|NCT00383149|363910864|FG000|Overall Study|Death|2|||
105519226|NCT00383149|363910864|FG000|Overall Study|Disease Progression|38|||
105519227|NCT00383149|363910864|FG000|Overall Study|Lost to Follow-up|1|||
105519228|NCT00383149|363910864|FG000|Overall Study|Other|1|||
105519229|NCT00383149|363910864|FG000|Overall Study|Study Drug Toxicity|4|||
105519230|NCT00383149|363910864|FG000|Overall Study|Request to Discontinue Treatment|4|||
105519231|NCT00383149|363910864|FG000|Overall Study|Participant Withdrew Consent|1|||
105519232|NCT02196558|363910867|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
105519233|NCT02196558|363910868|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
105519234|NCT02196558|363910869|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
105519235|NCT02196558|363910867|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
105519236|NCT02196558|363910868|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
105519237|NCT02196558|363910869|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
105519238|NCT02196558|363910867|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
105519239|NCT02196558|363910868|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
105519240|NCT02196558|363910869|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
105519241|NCT02196558|363910867|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
105519242|NCT02196558|363910868|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
105519243|NCT02196558|363910869|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
105519244|NCT02196558|363910867|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
105519245|NCT02196558|363910868|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
105519246|NCT02196558|363910869|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
105519247|NCT02375113|363910870|FG000|Overall Study|Undisclosed Reason(s).|1|||
105519248|NCT02375113|363910871|FG001|Overall Study|Undisclosed Reason(s).|1|||
105519249|NCT02375113|363910870|FG000|Overall Study|Poor adherence (<70%).|1|||
105519250|NCT02375113|363910871|FG001|Overall Study|Poor adherence (<70%).|0|||
105519251|NCT02375113|363910870|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
105519252|NCT02375113|363910871|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
105519253|NCT00296374|363910878|FG000|Overall Study|Adverse Event|14|||
105519254|NCT00296374|363910879|FG001|Overall Study|Adverse Event|10|||
105519255|NCT00296374|363910880|FG002|Overall Study|Adverse Event|7|||
105519256|NCT00296374|363910878|FG000|Overall Study|Withdrawal by Subject|3|||
105519257|NCT00296374|363910879|FG001|Overall Study|Withdrawal by Subject|5|||
105519258|NCT00296374|363910880|FG002|Overall Study|Withdrawal by Subject|11|||
105519259|NCT00296374|363910878|FG000|Overall Study|Incorrect enrollment|3|||
105519260|NCT00296374|363910879|FG001|Overall Study|Incorrect enrollment|3|||
105519261|NCT00296374|363910880|FG002|Overall Study|Incorrect enrollment|4|||
105519262|NCT00296374|363910878|FG000|Overall Study|Protocol Violation|1|||
105519263|NCT00296374|363910879|FG001|Overall Study|Protocol Violation|2|||
105519264|NCT00296374|363910880|FG002|Overall Study|Protocol Violation|3|||
105519265|NCT00296374|363910878|FG000|Overall Study|Lost to Follow-up|3|||
105519266|NCT00296374|363910879|FG001|Overall Study|Lost to Follow-up|1|||
105519267|NCT00296374|363910880|FG002|Overall Study|Lost to Follow-up|1|||
105519268|NCT00296374|363910878|FG000|Overall Study|Relocated to another state|1|||
105519269|NCT00296374|363910879|FG001|Overall Study|Relocated to another state|0|||
105519270|NCT00296374|363910880|FG002|Overall Study|Relocated to another state|0|||
105519271|NCT00296374|363910878|FG000|Overall Study|Stopped drug before end of study visit|0|||
105519272|NCT00296374|363910879|FG001|Overall Study|Stopped drug before end of study visit|1|||
105519273|NCT00296374|363910880|FG002|Overall Study|Stopped drug before end of study visit|0|||
105519274|NCT00296374|363910878|FG000|Overall Study|Nephrologist introduced ACE|0|||
105519275|NCT00296374|363910879|FG001|Overall Study|Nephrologist introduced ACE|1|||
105519276|NCT00296374|363910880|FG002|Overall Study|Nephrologist introduced ACE|0|||
105519277|NCT00296374|363910878|FG000|Overall Study|Pregnancy|0|||
105519278|NCT00296374|363910879|FG001|Overall Study|Pregnancy|0|||
105519279|NCT00296374|363910880|FG002|Overall Study|Pregnancy|2|||
105519280|NCT00296374|363910878|FG000|Overall Study|Other|0|||
105519281|NCT00296374|363910879|FG001|Overall Study|Other|0|||
105519282|NCT00296374|363910880|FG002|Overall Study|Other|1|||
105519283|NCT01829230|363910890|FG000|Overall Study|Protocol Violation|0|||
105519284|NCT01829230|363910891|FG001|Overall Study|Protocol Violation|2|||
105519285|NCT01829230|363910890|FG000|Overall Study|Withdrawal by Subject|0|||
105519286|NCT01829230|363910891|FG001|Overall Study|Withdrawal by Subject|1|||
105519287|NCT01829230|363910890|FG000|Overall Study|Lost to Follow-up|1|||
105519288|NCT01829230|363910891|FG001|Overall Study|Lost to Follow-up|1|||
105519289|NCT02157298|363910895|FG000|Overall Study|Adverse Event|1|||
105519290|NCT02157298|363910896|FG001|Overall Study|Adverse Event|0|||
105519291|NCT02157298|363910895|FG000|Overall Study|Subject no longer meets study criteria|1|||
105519292|NCT02157298|363910896|FG001|Overall Study|Subject no longer meets study criteria|2|||
105519293|NCT02157298|363910895|FG000|Overall Study|Poor/Non-compliance|1|||
105519294|NCT02157298|363910896|FG001|Overall Study|Poor/Non-compliance|0|||
105519295|NCT02157298|363910895|FG000|Overall Study|Withdrawal by Subject|1|||
105519296|NCT02157298|363910896|FG001|Overall Study|Withdrawal by Subject|0|||
105519297|NCT04387435|363910897|FG000|Overall Study|Physician Decision|1|||
105519298|NCT03855280|363910898|FG000|Treatment Phase|Adverse Event|1|||
105519299|NCT03855280|363910898|FG000|Treatment Phase|Withdrawal by Subject|1|||
105519300|NCT03855280|363910898|FG000|Continuation Phase|Protocol Violation|1|||
105519301|NCT03855280|363910898|FG000|Continuation Phase|Adverse Event|1|||
105519302|NCT03855280|363910898|FG000|Continuation Phase|Sponsor Concluded Study|1|||
105519303|NCT00461682|363910899|FG000|Overall Study|Protocol Violation|1|||
105519304|NCT00883116|363910900|FG000|Overall Study|Adverse event unrelated to study drug|5|||
105519305|NCT00883116|363910901|FG001|Overall Study|Adverse event unrelated to study drug|10|||
105519306|NCT00883116|363910900|FG000|Overall Study|Death|6|||
105519307|NCT00883116|363910901|FG001|Overall Study|Death|2|||
105519308|NCT00883116|363910900|FG000|Overall Study|Disease progression|130|||
105519309|NCT00883116|363910901|FG001|Overall Study|Disease progression|128|||
105519310|NCT00883116|363910900|FG000|Overall Study|Lost to Follow-up|0|||
105519311|NCT00883116|363910901|FG001|Overall Study|Lost to Follow-up|1|||
105519312|NCT00883116|363910900|FG000|Overall Study|Maximum clinical benefit|13|||
105519313|NCT00883116|363910901|FG001|Overall Study|Maximum clinical benefit|46|||
105519314|NCT00883116|363910900|FG000|Overall Study|Not identified|3|||
105519315|NCT00883116|363910901|FG001|Overall Study|Not identified|6|||
105519316|NCT00883116|363910900|FG000|Overall Study|Study drug toxicity|36|||
105519317|NCT00883116|363910901|FG001|Overall Study|Study drug toxicity|16|||
105519318|NCT00883116|363910900|FG000|Overall Study|Withdrawal by Subject|14|||
105519319|NCT00883116|363910901|FG001|Overall Study|Withdrawal by Subject|8|||
105519320|NCT00883116|363910900|FG000|Overall Study|No longer meets study criteria|2|||
105519321|NCT00883116|363910901|FG001|Overall Study|No longer meets study criteria|2|||
105519322|NCT01361464|363910903|FG000|Overall Study|Death|1|||
105519323|NCT01361464|363910903|FG000|Overall Study|Withdrawal by Subject|2|||
105592368|NCT01769391|364169391|FG000|Overall Study|Investigator Decision|2|||
105519324|NCT04128267|363910912|FG000|Overall Study|Withdrawal by Subject|6|||
105519325|NCT04128267|363910912|FG000|Overall Study|Death|2|||
105519326|NCT04128267|363910912|FG000|Overall Study|Disease progression|1|||
105519327|NCT04128267|363910912|FG000|Overall Study|Participant had other medical issues|4|||
105519328|NCT04128267|363910912|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
105519329|NCT01698801|363910913|FG000|Treatment Phase|Adverse Event|4|||
105519330|NCT01698801|363910913|FG000|Treatment Phase|Protocol Violation|1|||
105519331|NCT01698801|363910913|FG000|Treatment Phase|Other|4|||
105519332|NCT01698801|363910913|FG000|Treatment Phase|Withdrawal by Subject|1|||
105519333|NCT01698801|363910913|FG000|Treatment Phase|Disease progression|1|||
105519334|NCT01698801|363910913|FG000|Follow Up Phase|Withdrawal by Subject|1|||
105519335|NCT01698801|363910913|FG000|Follow Up Phase|Death|4|||
105519336|NCT01505868|363910914|FG000|Overall Study|Withdrawal by Subject|1|||
105519337|NCT01505868|363910915|FG001|Overall Study|Withdrawal by Subject|0|||
105519338|NCT01505868|363910916|FG002|Overall Study|Withdrawal by Subject|0|||
105519339|NCT01505868|363910917|FG003|Overall Study|Withdrawal by Subject|0|||
105519340|NCT01505868|363910918|FG004|Overall Study|Withdrawal by Subject|0|||
105519341|NCT00553150|363910921|FG000|Overall Study|Withdrawal by Subject|0|||
105519342|NCT00553150|363910922|FG001|Overall Study|Withdrawal by Subject|0|||
105519343|NCT00553150|363910923|FG002|Overall Study|Withdrawal by Subject|0|||
105519344|NCT00553150|363910924|FG003|Overall Study|Withdrawal by Subject|2|||
105519345|NCT00553150|363910921|FG000|Overall Study|Protocol Violation|0|||
105519346|NCT00553150|363910922|FG001|Overall Study|Protocol Violation|0|||
105519347|NCT00553150|363910923|FG002|Overall Study|Protocol Violation|0|||
105519348|NCT00553150|363910924|FG003|Overall Study|Protocol Violation|1|||
105519349|NCT00553150|363910921|FG000|Overall Study|Ineligible|0|||
105519350|NCT00553150|363910922|FG001|Overall Study|Ineligible|0|||
105519351|NCT00553150|363910923|FG002|Overall Study|Ineligible|0|||
105519352|NCT00553150|363910924|FG003|Overall Study|Ineligible|1|||
105519353|NCT03338855|363910925|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
105519354|NCT03338855|363910926|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
105519355|NCT00665847|363910927|FG000|Overall Study|Adverse Event|8|||
105519356|NCT00665847|363910927|FG000|Overall Study|Withdrawal by Subject|2|||
105519357|NCT00665847|363910927|FG000|Overall Study|Subject non-compliant|8|||
105519358|NCT00665847|363910927|FG000|Overall Study|Subject reached a virologic endpoint|4|||
105519359|NCT00665847|363910927|FG000|Overall Study|Resistance to TMC125|1|||
105519360|NCT00665847|363910927|FG000|Overall Study|Subject ineligible to continue the trial|1|||
105519361|NCT00665847|363910927|FG000|Overall Study|Switch to Commercial Medication|1|||
105519362|NCT00195676|363910928|FG000|Period O - Open-label Treatment|Adverse Event|82|||
105519363|NCT00195676|363910928|FG000|Period O - Open-label Treatment|Death|6|||
105519364|NCT00195676|363910928|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
105519365|NCT00195676|363910928|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
105519366|NCT00195676|363910928|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
105519367|NCT00195676|363910928|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
105519368|NCT00195676|363910928|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
105519369|NCT00195676|363910928|FG000|Period O - Open-label Treatment|Other reasons|68|||
105519370|NCT00195676|363910928|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
105519371|NCT00195676|363910928|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
105519372|NCT00195676|363910928|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
105519373|NCT00195676|363910928|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
105519374|NCT00195676|363910928|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
105519375|NCT00195676|363910928|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
105519376|NCT00195676|363910928|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
105519377|NCT00195676|363910928|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
105519378|NCT00195676|363910928|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
105519379|NCT00195676|363910928|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
105519380|NCT00195676|363910928|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
105519381|NCT00195676|363910928|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
105519382|NCT00195676|363910928|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
105519383|NCT00616655|363910929|FG000|Overall Study|Adverse Event|10|||
105519384|NCT00616655|363910930|FG001|Overall Study|Adverse Event|7|||
105519385|NCT00616655|363910931|FG002|Overall Study|Adverse Event|12|||
105519386|NCT00616655|363910929|FG000|Overall Study|Lack of Efficacy|5|||
105519387|NCT00616655|363910930|FG001|Overall Study|Lack of Efficacy|5|||
105519388|NCT00616655|363910931|FG002|Overall Study|Lack of Efficacy|5|||
105519389|NCT00616655|363910929|FG000|Overall Study|Lost to Follow-up|3|||
105519390|NCT00616655|363910930|FG001|Overall Study|Lost to Follow-up|12|||
105519391|NCT00616655|363910931|FG002|Overall Study|Lost to Follow-up|10|||
105519392|NCT00616655|363910929|FG000|Overall Study|Protocol Violation|2|||
105519393|NCT00616655|363910930|FG001|Overall Study|Protocol Violation|4|||
105519394|NCT00616655|363910931|FG002|Overall Study|Protocol Violation|3|||
105519395|NCT00616655|363910929|FG000|Overall Study|Withdrawal by Subject|9|||
105519396|NCT00616655|363910930|FG001|Overall Study|Withdrawal by Subject|7|||
105519397|NCT00616655|363910931|FG002|Overall Study|Withdrawal by Subject|11|||
105519398|NCT00616655|363910929|FG000|Overall Study|Does not meet in/ex criteria|0|||
105519399|NCT00616655|363910930|FG001|Overall Study|Does not meet in/ex criteria|0|||
105519400|NCT00616655|363910931|FG002|Overall Study|Does not meet in/ex criteria|2|||
105519401|NCT00616655|363910929|FG000|Overall Study|Other|6|||
105519402|NCT00616655|363910930|FG001|Overall Study|Other|6|||
105519403|NCT00616655|363910931|FG002|Overall Study|Other|5|||
105519404|NCT03605303|363910936|FG000|Period 1|Study Terminated|2|||
105519405|NCT03605303|363910937|FG001|Period 1|Study Terminated|1|||
105519406|NCT00309842|363910940|FG000|Overall Study|Lost to Follow-up|1|||
105519407|NCT01026792|363910941|FG000|Overall Study|Protocol Violation|1|||
105519408|NCT03204305|363910942|FG000|Overall Study|Lost to Follow-up|6|||
105519409|NCT03204305|363910943|FG001|Overall Study|Lost to Follow-up|4|||
105519410|NCT03204305|363910944|FG002|Overall Study|Lost to Follow-up|0|||
105519411|NCT03204305|363910945|FG003|Overall Study|Lost to Follow-up|0|||
105519412|NCT03204305|363910942|FG000|Overall Study|Physician Decision|1|||
105519413|NCT03204305|363910943|FG001|Overall Study|Physician Decision|0|||
105519414|NCT03204305|363910944|FG002|Overall Study|Physician Decision|0|||
105519415|NCT03204305|363910945|FG003|Overall Study|Physician Decision|0|||
105519416|NCT03204305|363910942|FG000|Overall Study|failure to place arterial line|2|||
105519417|NCT03204305|363910943|FG001|Overall Study|failure to place arterial line|1|||
105519418|NCT03204305|363910944|FG002|Overall Study|failure to place arterial line|0|||
105519419|NCT03204305|363910945|FG003|Overall Study|failure to place arterial line|0|||
105519420|NCT03204305|363910942|FG000|Overall Study|Withdrawal by Subject|2|||
105519421|NCT03204305|363910943|FG001|Overall Study|Withdrawal by Subject|0|||
105519422|NCT03204305|363910944|FG002|Overall Study|Withdrawal by Subject|0|||
105519423|NCT03204305|363910945|FG003|Overall Study|Withdrawal by Subject|0|||
105519424|NCT00455429|363910946|FG000|Overall Study|Study Terminated by Sponsor|0|||
105519425|NCT00455429|363910947|FG001|Overall Study|Study Terminated by Sponsor|0|||
105519426|NCT00455429|363910948|FG002|Overall Study|Study Terminated by Sponsor|0|||
105519427|NCT00455429|363910949|FG003|Overall Study|Study Terminated by Sponsor|3|||
105519428|NCT00455429|363910946|FG000|Overall Study|Lost to Follow-up|1|||
105519429|NCT00455429|363910947|FG001|Overall Study|Lost to Follow-up|0|||
105519430|NCT00455429|363910948|FG002|Overall Study|Lost to Follow-up|0|||
105519431|NCT00455429|363910949|FG003|Overall Study|Lost to Follow-up|3|||
105519432|NCT00455429|363910946|FG000|Overall Study|Withdrawal by Subject|0|||
105519433|NCT00455429|363910947|FG001|Overall Study|Withdrawal by Subject|1|||
105519434|NCT00455429|363910948|FG002|Overall Study|Withdrawal by Subject|1|||
105519435|NCT00455429|363910949|FG003|Overall Study|Withdrawal by Subject|0|||
105519436|NCT00455429|363910946|FG000|Overall Study|Lack of Efficacy|0|||
105519437|NCT00455429|363910947|FG001|Overall Study|Lack of Efficacy|1|||
105519438|NCT00455429|363910948|FG002|Overall Study|Lack of Efficacy|0|||
105519439|NCT00455429|363910949|FG003|Overall Study|Lack of Efficacy|1|||
105519440|NCT00455429|363910946|FG000|Overall Study|Adverse Event|0|||
105519441|NCT00455429|363910947|FG001|Overall Study|Adverse Event|1|||
105519442|NCT00455429|363910948|FG002|Overall Study|Adverse Event|0|||
105519443|NCT00455429|363910949|FG003|Overall Study|Adverse Event|3|||
105519444|NCT00455429|363910946|FG000|Overall Study|Randomly assigned but not treated|0|||
105519445|NCT00455429|363910947|FG001|Overall Study|Randomly assigned but not treated|0|||
105519446|NCT00455429|363910948|FG002|Overall Study|Randomly assigned but not treated|0|||
105519447|NCT00455429|363910949|FG003|Overall Study|Randomly assigned but not treated|2|||
105519448|NCT00455429|363910946|FG000|Overall Study|Personal Reason|1|||
105519449|NCT00455429|363910947|FG001|Overall Study|Personal Reason|0|||
105519450|NCT00455429|363910948|FG002|Overall Study|Personal Reason|0|||
105519451|NCT00455429|363910949|FG003|Overall Study|Personal Reason|0|||
105519452|NCT00455429|363910946|FG000|Overall Study|Non-compliance|0|||
105519453|NCT00455429|363910947|FG001|Overall Study|Non-compliance|0|||
105519454|NCT00455429|363910948|FG002|Overall Study|Non-compliance|0|||
105519455|NCT00455429|363910949|FG003|Overall Study|Non-compliance|1|||
105519456|NCT00455429|363910946|FG000|Overall Study|Other|0|||
105519457|NCT00455429|363910947|FG001|Overall Study|Other|2|||
105519458|NCT00455429|363910948|FG002|Overall Study|Other|0|||
105519459|NCT00455429|363910949|FG003|Overall Study|Other|1|||
105519460|NCT01165554|363910950|FG000|Overall Study|Withdrawal by Subject|23|||
105519461|NCT01765153|363910951|FG000|Training Phase 1|Format of intervention differed|1|||
105519462|NCT01765153|363910952|FG001|Training Phase 1|Format of intervention differed|0|||
105519463|NCT01765153|363910951|FG000|Training Phase 1|Poor participation in intervention|0|||
105519464|NCT01765153|363910952|FG001|Training Phase 1|Poor participation in intervention|1|||
105519465|NCT01765153|363910951|FG000|Rest Phase 1|Withdrawal by Subject|0|||
105519466|NCT01765153|363910952|FG001|Rest Phase 1|Withdrawal by Subject|1|||
105519467|NCT01765153|363910951|FG000|Training Phase 2|Withdrawal by Subject|0|||
105519468|NCT01765153|363910952|FG001|Training Phase 2|Withdrawal by Subject|1|||
105519469|NCT01765153|363910951|FG000|Rest Phase 2|Lost to Follow-up|2|||
105519470|NCT01765153|363910952|FG001|Rest Phase 2|Lost to Follow-up|1|||
105519471|NCT00592839|363912324|FG000|Overall Study|Withdrawal by Subject|1|||
105519472|NCT00592839|363912325|FG001|Overall Study|Withdrawal by Subject|1|||
105519473|NCT00592839|363912326|FG002|Overall Study|Withdrawal by Subject|3|||
105519474|NCT00592839|363912324|FG000|Overall Study|Protocol Violation|1|||
105592369|NCT01769391|364169392|FG001|Overall Study|Investigator Decision|0|||
105592370|NCT03386929|364169393|FG000|Overall Study|Death|0|||
105519475|NCT00592839|363912325|FG001|Overall Study|Protocol Violation|1|||
105519476|NCT00592839|363912326|FG002|Overall Study|Protocol Violation|2|||
105519477|NCT00592839|363912324|FG000|Overall Study|Adverse Event|0|||
105519478|NCT00592839|363912325|FG001|Overall Study|Adverse Event|1|||
105519479|NCT00592839|363912326|FG002|Overall Study|Adverse Event|0|||
105519480|NCT00592839|363912324|FG000|Overall Study|Lost to Follow-up|0|||
105519481|NCT00592839|363912325|FG001|Overall Study|Lost to Follow-up|1|||
105519482|NCT00592839|363912326|FG002|Overall Study|Lost to Follow-up|1|||
105519483|NCT01313767|363912327|FG000|Overall Study|Adverse Event|1|||
105519484|NCT01313767|363912328|FG001|Overall Study|Adverse Event|0|||
105592371|NCT03386929|364169394|FG001|Overall Study|Death|0|||
105592372|NCT03386929|364169395|FG002|Overall Study|Death|1|||
105592373|NCT03386929|364169393|FG000|Overall Study|Withdrawal by Subject|0|||
105592374|NCT03386929|364169394|FG001|Overall Study|Withdrawal by Subject|1|||
105592375|NCT03386929|364169395|FG002|Overall Study|Withdrawal by Subject|0|||
105592376|NCT03386929|364169393|FG000|Overall Study|Physician Decision|0|||
105592377|NCT03386929|364169394|FG001|Overall Study|Physician Decision|0|||
105592378|NCT03386929|364169395|FG002|Overall Study|Physician Decision|1|||
105592379|NCT03386929|364169393|FG000|Overall Study|Progression|4|||
105592380|NCT03386929|364169394|FG001|Overall Study|Progression|4|||
105592381|NCT03386929|364169395|FG002|Overall Study|Progression|0|||
105592382|NCT03386929|364169393|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
105592383|NCT03386929|364169394|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
105592384|NCT03386929|364169395|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
105592385|NCT03386929|364169393|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
105592386|NCT03386929|364169394|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
105592387|NCT03386929|364169395|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
105592388|NCT00208767|364169405|FG000|Overall Study|Adverse Event|9|||
105592389|NCT00208767|364169406|FG001|Overall Study|Adverse Event|1|||
105592390|NCT00208767|364169405|FG000|Overall Study|Withdrawal by Subject|14|||
105592391|NCT00208767|364169406|FG001|Overall Study|Withdrawal by Subject|3|||
105592392|NCT00208767|364169405|FG000|Overall Study|Death|1|||
105592393|NCT00208767|364169406|FG001|Overall Study|Death|0|||
105592394|NCT00208767|364169405|FG000|Overall Study|Lost to Follow-up|3|||
105592395|NCT00208767|364169406|FG001|Overall Study|Lost to Follow-up|3|||
105592396|NCT03418324|364169408|FG000|Overall Study|Death|0|||
105592397|NCT03418324|364169409|FG001|Overall Study|Death|1|||
105592398|NCT03418324|364169408|FG000|Overall Study|Physician Decision|1|||
105592399|NCT03418324|364169409|FG001|Overall Study|Physician Decision|1|||
105592400|NCT01196429|364169410|FG000|Overall Study|Ineligible - inadequate pathology|1|||
105592401|NCT01196429|364169411|FG001|Overall Study|Ineligible - inadequate pathology|0|||
105592402|NCT01196429|364169410|FG000|Overall Study|Ineligible - wrong cell type|1|||
105592403|NCT01196429|364169411|FG001|Overall Study|Ineligible - wrong cell type|0|||
105592404|NCT01196429|364169410|FG000|Overall Study|Refused - Never Treated|1|||
105592405|NCT01196429|364169411|FG001|Overall Study|Refused - Never Treated|0|||
105519485|NCT01313767|363912327|FG000|Overall Study|Lost to Follow-up|1|||
105519486|NCT01313767|363912328|FG001|Overall Study|Lost to Follow-up|0|||
105519487|NCT01313767|363912327|FG000|Overall Study|Withdrawal by Subject|2|||
105519488|NCT01313767|363912328|FG001|Overall Study|Withdrawal by Subject|1|||
105519489|NCT01313767|363912327|FG000|Overall Study|Protocol Violation|3|||
105519490|NCT01313767|363912328|FG001|Overall Study|Protocol Violation|1|||
105519491|NCT03020407|363912331|FG000|Overall Study|Withdrawal by Subject|2|||
105519492|NCT03020407|363912332|FG001|Overall Study|Withdrawal by Subject|1|||
105519493|NCT03020407|363912331|FG000|Overall Study|Lost to Follow-up|2|||
105519494|NCT03020407|363912332|FG001|Overall Study|Lost to Follow-up|3|||
105519495|NCT03020407|363912331|FG000|Overall Study|Protocol Violation|0|||
105519496|NCT03020407|363912332|FG001|Overall Study|Protocol Violation|1|||
105519497|NCT02355691|363912333|FG000|Overall Study|Loss of Research Personnel|7|||
105519498|NCT02355691|363912334|FG001|Overall Study|Loss of Research Personnel|9|||
105519499|NCT01042236|363912337|FG000|Treatment Period 1|Adverse Event|0|||
105519500|NCT01042236|363912338|FG001|Treatment Period 1|Adverse Event|1|||
105519501|NCT01042236|363912339|FG002|Treatment Period 1|Adverse Event|0|||
105519502|NCT01042236|363912340|FG003|Treatment Period 1|Adverse Event|0|||
105519503|NCT01042236|363912341|FG004|Treatment Period 1|Adverse Event|1|||
105519504|NCT01042236|363912342|FG005|Treatment Period 1|Adverse Event|0|||
105519505|NCT01042236|363912337|FG000|Treatment Period 3|Adverse Event|0|||
105519506|NCT01042236|363912338|FG001|Treatment Period 3|Adverse Event|0|||
105519507|NCT01042236|363912339|FG002|Treatment Period 3|Adverse Event|0|||
105592406|NCT03121950|364169412|FG000|Overall Study|Withdrawal by Subject|11|||
105592407|NCT03121950|364169413|FG001|Overall Study|Withdrawal by Subject|2|||
105592408|NCT01212757|364169414|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
105519508|NCT01042236|363912340|FG003|Treatment Period 3|Adverse Event|1|||
105519509|NCT01042236|363912341|FG004|Treatment Period 3|Adverse Event|0|||
105519510|NCT01042236|363912342|FG005|Treatment Period 3|Adverse Event|0|||
105519511|NCT01042236|363912337|FG000|Treatment Period 3|Protocol Violation|0|||
105592409|NCT01212757|364169415|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
105592410|NCT01212757|364169416|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
105592411|NCT01212757|364169417|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105592412|NCT01212757|364169418|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105592413|NCT01212757|364169419|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105592414|NCT01212757|364169420|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105592415|NCT01212757|364169421|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105592416|NCT01212757|364169422|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105592417|NCT01212757|364169414|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
105592418|NCT01212757|364169415|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
105592419|NCT01212757|364169416|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
105592420|NCT01212757|364169417|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105592421|NCT01212757|364169418|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105592422|NCT01212757|364169419|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105592423|NCT01212757|364169420|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105592424|NCT01212757|364169421|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105592425|NCT01212757|364169422|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105592426|NCT01212757|364169414|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
105592427|NCT01212757|364169415|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
105592428|NCT01212757|364169416|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
105592429|NCT01212757|364169417|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105592430|NCT01212757|364169418|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105592431|NCT01212757|364169419|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105592432|NCT01212757|364169420|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105592433|NCT01212757|364169421|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105592434|NCT01212757|364169422|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105592435|NCT01212757|364169414|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
105592436|NCT01212757|364169415|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105592437|NCT01212757|364169416|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
105592438|NCT01212757|364169417|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105592439|NCT01212757|364169418|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105592440|NCT01212757|364169419|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105592441|NCT01212757|364169420|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105592442|NCT01212757|364169421|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105592443|NCT01212757|364169422|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105592444|NCT01212757|364169414|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
105592445|NCT01212757|364169415|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
105592446|NCT01212757|364169416|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
105592447|NCT01212757|364169417|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105592448|NCT01212757|364169418|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105592449|NCT01212757|364169419|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105592450|NCT01212757|364169420|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105592451|NCT01212757|364169421|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105592452|NCT01212757|364169422|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105592453|NCT01212757|364169414|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105592454|NCT01212757|364169415|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
105592455|NCT01212757|364169416|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
105592456|NCT01212757|364169417|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105592457|NCT01212757|364169418|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105592458|NCT01212757|364169419|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105592459|NCT01212757|364169420|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105592460|NCT01212757|364169421|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105592461|NCT01212757|364169422|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105592462|NCT01212757|364169414|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
105592463|NCT01212757|364169415|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
105592464|NCT01212757|364169416|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105592465|NCT01212757|364169417|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105592466|NCT01212757|364169418|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105592467|NCT01212757|364169419|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105592468|NCT01212757|364169420|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105592469|NCT01212757|364169421|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105592470|NCT01212757|364169422|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105592471|NCT01212757|364169414|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
105592472|NCT01212757|364169415|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
105592473|NCT01212757|364169416|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
105519512|NCT01042236|363912338|FG001|Treatment Period 3|Protocol Violation|0|||
105519513|NCT01042236|363912339|FG002|Treatment Period 3|Protocol Violation|0|||
105519514|NCT01042236|363912340|FG003|Treatment Period 3|Protocol Violation|1|||
105519515|NCT01042236|363912341|FG004|Treatment Period 3|Protocol Violation|0|||
105519516|NCT01042236|363912342|FG005|Treatment Period 3|Protocol Violation|0|||
105519517|NCT03232281|363912343|FG000|Overall Study|Adverse Event|1|||
105519518|NCT03232281|363912344|FG001|Overall Study|Adverse Event|1|||
105519519|NCT03232281|363912343|FG000|Overall Study|Withdrawal by Subject|5|||
105519520|NCT03232281|363912344|FG001|Overall Study|Withdrawal by Subject|4|||
105519521|NCT03232281|363912343|FG000|Overall Study|Protocol Deviation|1|||
105519522|NCT03232281|363912344|FG001|Overall Study|Protocol Deviation|1|||
105519523|NCT00462761|363912348|FG000|Overall Study|Adverse Event|6|||
105519524|NCT00462761|363912348|FG000|Overall Study|Withdrawal by Subject|9|||
105519525|NCT00462761|363912348|FG000|Overall Study|Physician Decision|5|||
105519526|NCT00462761|363912348|FG000|Overall Study|Disease progression|43|||
105519527|NCT00462761|363912348|FG000|Overall Study|Death|12|||
105519528|NCT00462761|363912348|FG000|Overall Study|Other|1|||
105519529|NCT01132482|363912351|FG000|Overall Study|Adverse Event|1|||
105519530|NCT01132482|363912352|FG001|Overall Study|Adverse Event|0|||
105519531|NCT01955161|363912353|FG000|Overall Study|Withdrawal before treatment|2|||
105519532|NCT01955161|363912354|FG001|Overall Study|Withdrawal before treatment|0|||
105519533|NCT01955161|363912355|FG002|Overall Study|Withdrawal before treatment|1|||
105519534|NCT01955161|363912353|FG000|Overall Study|Adverse Event|10|||
105519535|NCT01955161|363912354|FG001|Overall Study|Adverse Event|14|||
105519536|NCT01955161|363912355|FG002|Overall Study|Adverse Event|15|||
105519537|NCT01955161|363912353|FG000|Overall Study|Death|1|||
105519538|NCT01955161|363912354|FG001|Overall Study|Death|1|||
105519539|NCT01955161|363912355|FG002|Overall Study|Death|3|||
105519540|NCT01955161|363912353|FG000|Overall Study|Withdrawal by Subject|9|||
105519541|NCT01955161|363912354|FG001|Overall Study|Withdrawal by Subject|8|||
105519542|NCT01955161|363912355|FG002|Overall Study|Withdrawal by Subject|12|||
105519543|NCT01955161|363912353|FG000|Overall Study|Protocol Violation|2|||
105519544|NCT01955161|363912354|FG001|Overall Study|Protocol Violation|0|||
105519545|NCT01955161|363912355|FG002|Overall Study|Protocol Violation|0|||
105519546|NCT01955161|363912353|FG000|Overall Study|Other reason: physician decision|0|||
105519547|NCT01955161|363912354|FG001|Overall Study|Other reason: physician decision|1|||
105519548|NCT01955161|363912355|FG002|Overall Study|Other reason: physician decision|1|||
105519549|NCT01955161|363912353|FG000|Overall Study|Other reason: disallowed medication|1|||
105519550|NCT01955161|363912354|FG001|Overall Study|Other reason: disallowed medication|0|||
105519551|NCT01955161|363912355|FG002|Overall Study|Other reason: disallowed medication|1|||
105519552|NCT01955161|363912353|FG000|Overall Study|Other reason: caregiver unavailable|1|||
105519553|NCT01955161|363912354|FG001|Overall Study|Other reason: caregiver unavailable|0|||
105519554|NCT01955161|363912355|FG002|Overall Study|Other reason: caregiver unavailable|0|||
105519555|NCT01955161|363912353|FG000|Overall Study|Other reason: moved to nursing home|0|||
105519556|NCT01955161|363912354|FG001|Overall Study|Other reason: moved to nursing home|1|||
105519557|NCT01955161|363912355|FG002|Overall Study|Other reason: moved to nursing home|0|||
105519558|NCT01955161|363912353|FG000|Overall Study|Other reason: insufficient compliance|0|||
105519559|NCT01955161|363912354|FG001|Overall Study|Other reason: insufficient compliance|0|||
105519560|NCT01955161|363912355|FG002|Overall Study|Other reason: insufficient compliance|1|||
105519561|NCT01955161|363912353|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
105519562|NCT01955161|363912354|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
105519563|NCT01955161|363912355|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
105519564|NCT01955161|363912353|FG000|Overall Study|Other reason: patient's will|0|||
105519565|NCT01955161|363912354|FG001|Overall Study|Other reason: patient's will|0|||
105519566|NCT01955161|363912355|FG002|Overall Study|Other reason: patient's will|1|||
105519567|NCT03683758|363912356|FG000|Overall Study|Non-study commitment conflict|1|||
105519568|NCT03683758|363912357|FG001|Overall Study|Non-study commitment conflict|3|||
105519569|NCT03683758|363912356|FG000|Overall Study|Illness preventing participation|1|||
105519570|NCT03683758|363912357|FG001|Overall Study|Illness preventing participation|0|||
105519571|NCT03683758|363912356|FG000|Overall Study|Adverse Event|1|||
105519572|NCT03683758|363912357|FG001|Overall Study|Adverse Event|0|||
105519573|NCT03720470|363912360|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
105519574|NCT03720470|363912361|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
105519575|NCT03720470|363912362|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
105519576|NCT03720470|363912363|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
105519577|NCT03720470|363912364|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
105592474|NCT01212757|364169417|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
105519578|NCT03720470|363912365|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
105519579|NCT03720470|363912360|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
105519580|NCT03720470|363912361|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
105519581|NCT03720470|363912362|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
105519582|NCT03720470|363912363|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
105519583|NCT03720470|363912364|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
105519584|NCT03720470|363912365|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
105519585|NCT03720470|363912360|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
105519586|NCT03720470|363912361|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
105519587|NCT03720470|363912362|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
105519588|NCT03720470|363912363|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
105519589|NCT03720470|363912364|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
105519590|NCT03720470|363912365|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
105519591|NCT03720470|363912360|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
105519592|NCT03720470|363912361|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
105519593|NCT03720470|363912362|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
105519594|NCT03720470|363912363|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
105519595|NCT03720470|363912364|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
105519596|NCT03720470|363912365|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
105519597|NCT03720470|363912360|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
105519598|NCT03720470|363912361|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
105519599|NCT03720470|363912362|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
105519600|NCT03720470|363912363|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
105519601|NCT03720470|363912364|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
105519602|NCT03720470|363912365|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
105519603|NCT03720470|363912360|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
105519604|NCT03720470|363912361|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
105519605|NCT03720470|363912362|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
105519606|NCT03720470|363912363|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
105519607|NCT03720470|363912364|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
105519608|NCT03720470|363912365|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
105519609|NCT03720470|363912360|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
105519610|NCT03720470|363912361|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
105519611|NCT03720470|363912362|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
105519612|NCT03720470|363912363|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
105519613|NCT03720470|363912364|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
105519614|NCT03720470|363912365|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
105519615|NCT03720470|363912360|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
105519616|NCT03720470|363912361|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
105519617|NCT03720470|363912362|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
105519618|NCT03720470|363912363|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
105519619|NCT03720470|363912364|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
105519620|NCT03720470|363912365|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
105519621|NCT03720470|363912360|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
105519622|NCT03720470|363912361|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
105519623|NCT03720470|363912362|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
105519624|NCT03720470|363912363|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
105519625|NCT03720470|363912364|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
105519626|NCT03720470|363912365|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
105519627|NCT03720470|363912360|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
105519628|NCT03720470|363912361|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
105519629|NCT03720470|363912362|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
105519630|NCT03720470|363912363|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
105519631|NCT03720470|363912364|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
105519632|NCT03720470|363912365|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
105519633|NCT03720470|363912360|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
105519634|NCT03720470|363912361|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
105519635|NCT03720470|363912362|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
105519636|NCT03720470|363912363|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
105519637|NCT03720470|363912364|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
105519638|NCT03720470|363912365|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
105519639|NCT03720470|363912360|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
105519640|NCT03720470|363912361|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
105519641|NCT03720470|363912362|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
105519642|NCT03720470|363912363|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
105519643|NCT03720470|363912364|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
105519644|NCT03720470|363912365|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
105519645|NCT03720470|363912360|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
105519646|NCT03720470|363912361|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
105592475|NCT01212757|364169418|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
105592476|NCT01212757|364169419|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
105592477|NCT01212757|364169420|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
105592478|NCT01212757|364169421|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
105592479|NCT01212757|364169422|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
105592480|NCT01212757|364169414|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
105592481|NCT01212757|364169415|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
105592482|NCT01212757|364169416|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
105592483|NCT01212757|364169417|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
105592484|NCT01212757|364169418|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
105592485|NCT01212757|364169419|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
105592486|NCT01212757|364169420|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
105592487|NCT01212757|364169421|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
105592488|NCT01212757|364169422|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
105592489|NCT01212757|364169414|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
105592490|NCT01212757|364169415|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
105592491|NCT01212757|364169416|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
105592492|NCT01212757|364169417|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
105592493|NCT01212757|364169418|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
105592494|NCT01212757|364169419|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
105592495|NCT01212757|364169420|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
105592496|NCT01212757|364169421|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
105592497|NCT01212757|364169422|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
105592498|NCT01212757|364169414|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
105592499|NCT01212757|364169415|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
105592500|NCT01212757|364169416|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
105592501|NCT01212757|364169417|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
105592502|NCT01212757|364169418|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
105592503|NCT01212757|364169419|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
105592504|NCT01212757|364169420|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
105592505|NCT01212757|364169421|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
105592506|NCT01212757|364169422|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
105592507|NCT01212757|364169414|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
105592508|NCT01212757|364169415|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
105592509|NCT01212757|364169416|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
105592510|NCT01212757|364169417|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
105592511|NCT01212757|364169418|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
105592512|NCT01212757|364169419|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
105592513|NCT01212757|364169420|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
105592514|NCT01212757|364169421|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
105592515|NCT01212757|364169422|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
105592516|NCT01212757|364169414|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
105592517|NCT01212757|364169415|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
105592518|NCT01212757|364169416|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
105592519|NCT01212757|364169417|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
105592520|NCT01212757|364169418|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
105592521|NCT01212757|364169419|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
105592522|NCT01212757|364169420|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
105592523|NCT01212757|364169421|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
105592524|NCT01212757|364169422|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
105592525|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
105592526|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
105592527|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
105592528|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
105592529|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
105592530|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
105592531|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
105592532|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
105592533|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
105592534|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
105592535|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
105592536|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
105592537|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
105592538|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
105592539|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
105592540|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
105592541|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
105592542|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
105592543|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
105519647|NCT03720470|363912362|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
105519648|NCT03720470|363912363|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
105519649|NCT03720470|363912364|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
105519650|NCT03720470|363912365|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
105519651|NCT03720470|363912360|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
105519652|NCT03720470|363912361|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
105519653|NCT03720470|363912362|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
105519654|NCT03720470|363912363|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
105519655|NCT03720470|363912364|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
105519656|NCT03720470|363912365|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
105519657|NCT03720470|363912360|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
105519658|NCT03720470|363912361|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
105519659|NCT03720470|363912362|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
105519660|NCT03720470|363912363|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
105519661|NCT03720470|363912364|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
105519662|NCT03720470|363912365|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
105519663|NCT03720470|363912360|FG000|Treatment Period: Final 4 Weeks|Other|0|||
105519664|NCT03720470|363912361|FG001|Treatment Period: Final 4 Weeks|Other|1|||
105519665|NCT03720470|363912362|FG002|Treatment Period: Final 4 Weeks|Other|0|||
105519666|NCT03720470|363912363|FG003|Treatment Period: Final 4 Weeks|Other|2|||
105519667|NCT03720470|363912364|FG004|Treatment Period: Final 4 Weeks|Other|1|||
105519668|NCT03720470|363912365|FG005|Treatment Period: Final 4 Weeks|Other|0|||
105519669|NCT02411292|363912367|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
105519670|NCT02411292|363912367|FG000|Overall Study|Death|2|||
105519671|NCT02411292|363912367|FG000|Overall Study|Lost to Follow-up|3|||
105519672|NCT01394523|363912372|FG000|Overall Study|Unable to place block|1|||
105519673|NCT01394523|363912373|FG001|Overall Study|Unable to place block|0|||
105519674|NCT01394523|363912374|FG002|Overall Study|Unable to place block|0|||
105519675|NCT03226392|363912376|FG000|Overall Study|Protocol Deviation|1|||
105519676|NCT03226392|363912377|FG001|Overall Study|Protocol Deviation|0|||
105519677|NCT03226392|363912376|FG000|Overall Study|Physician Decision|1|||
105519678|NCT03226392|363912377|FG001|Overall Study|Physician Decision|0|||
105519679|NCT03226392|363912376|FG000|Overall Study|Lost to Follow-up|1|||
105519680|NCT03226392|363912377|FG001|Overall Study|Lost to Follow-up|0|||
105519681|NCT03226392|363912376|FG000|Overall Study|Adverse Event|1|||
105519682|NCT03226392|363912377|FG001|Overall Study|Adverse Event|0|||
105519683|NCT03226392|363912376|FG000|Overall Study|Technical Problems|0|||
105519684|NCT03226392|363912377|FG001|Overall Study|Technical Problems|2|||
105519685|NCT03226392|363912376|FG000|Overall Study|Subject/Guardian Decision|7|||
105519686|NCT03226392|363912377|FG001|Overall Study|Subject/Guardian Decision|6|||
105519687|NCT02357901|363912378|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
105519688|NCT02357901|363912379|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
105519689|NCT02357901|363912380|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
105519690|NCT02357901|363912381|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
105519691|NCT02357901|363912378|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
105519692|NCT02357901|363912379|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
105519693|NCT02357901|363912380|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
105519694|NCT02357901|363912381|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
105519695|NCT02357901|363912378|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
105519696|NCT02357901|363912379|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
105519697|NCT02357901|363912380|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
105519698|NCT02357901|363912381|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
105519699|NCT02357901|363912378|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
105519700|NCT02357901|363912379|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
105519701|NCT02357901|363912380|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
105519702|NCT02357901|363912381|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
105519703|NCT02357901|363912378|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
105519704|NCT02357901|363912379|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
105519705|NCT02357901|363912380|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
105519706|NCT02357901|363912381|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
105519707|NCT02357901|363912378|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
105519708|NCT02357901|363912379|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
105519709|NCT02357901|363912380|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
105519710|NCT02357901|363912381|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
105592544|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
105519711|NCT02357901|363912378|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
105519712|NCT02357901|363912379|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
105519713|NCT02357901|363912380|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
105519714|NCT02357901|363912381|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
105519715|NCT02357901|363912378|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
105519716|NCT02357901|363912379|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
105519717|NCT02357901|363912380|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
105519718|NCT02357901|363912381|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
105519719|NCT02357901|363912378|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
105519720|NCT02357901|363912379|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
105519721|NCT02357901|363912380|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
105519722|NCT02357901|363912381|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
105519723|NCT02357901|363912378|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
105519724|NCT02357901|363912379|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
105519725|NCT02357901|363912380|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
105519726|NCT02357901|363912381|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
105519727|NCT02357901|363912378|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
105519728|NCT02357901|363912379|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
105519729|NCT02357901|363912380|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
105519730|NCT02357901|363912381|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
105519731|NCT02769247|363912382|FG000|Overall Study|Withdrawal by Subject|1|||
105519732|NCT02769247|363912383|FG001|Overall Study|Withdrawal by Subject|0|||
105519733|NCT02769247|363912384|FG002|Overall Study|Withdrawal by Subject|0|||
105519734|NCT02769247|363912385|FG003|Overall Study|Withdrawal by Subject|1|||
105519735|NCT02769247|363912382|FG000|Overall Study|Protocol Violation|0|||
105519736|NCT02769247|363912383|FG001|Overall Study|Protocol Violation|0|||
105519737|NCT02769247|363912384|FG002|Overall Study|Protocol Violation|1|||
105519738|NCT02769247|363912385|FG003|Overall Study|Protocol Violation|0|||
105519739|NCT02769247|363912382|FG000|Overall Study|Physician Decision|1|||
105519740|NCT02769247|363912383|FG001|Overall Study|Physician Decision|0|||
105519741|NCT02769247|363912384|FG002|Overall Study|Physician Decision|0|||
105519742|NCT02769247|363912385|FG003|Overall Study|Physician Decision|0|||
105519743|NCT00413192|363912386|FG000|Overall Study|Disease progression|26|||
105519744|NCT00413192|363912387|FG001|Overall Study|Disease progression|31|||
105519745|NCT00413192|363912388|FG002|Overall Study|Disease progression|16|||
105519746|NCT00413192|363912389|FG003|Overall Study|Disease progression|25|||
105519747|NCT00413192|363912386|FG000|Overall Study|Toxicity|3|||
105519748|NCT00413192|363912387|FG001|Overall Study|Toxicity|2|||
105519749|NCT00413192|363912388|FG002|Overall Study|Toxicity|2|||
105519750|NCT00413192|363912389|FG003|Overall Study|Toxicity|2|||
105519751|NCT00413192|363912386|FG000|Overall Study|Withdrawal by Subject|3|||
105519752|NCT00413192|363912387|FG001|Overall Study|Withdrawal by Subject|5|||
105519753|NCT00413192|363912388|FG002|Overall Study|Withdrawal by Subject|0|||
105519754|NCT00413192|363912389|FG003|Overall Study|Withdrawal by Subject|1|||
105519755|NCT00413192|363912386|FG000|Overall Study|Intercurrent illness|0|||
105519756|NCT00413192|363912387|FG001|Overall Study|Intercurrent illness|0|||
105519757|NCT00413192|363912388|FG002|Overall Study|Intercurrent illness|0|||
105519758|NCT00413192|363912389|FG003|Overall Study|Intercurrent illness|1|||
105519759|NCT00413192|363912386|FG000|Overall Study|Intercurrent death|0|||
105519760|NCT00413192|363912387|FG001|Overall Study|Intercurrent death|1|||
105519761|NCT00413192|363912388|FG002|Overall Study|Intercurrent death|0|||
105519762|NCT00413192|363912389|FG003|Overall Study|Intercurrent death|0|||
105592545|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
105592546|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
105592547|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
105592548|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
105519763|NCT00413192|363912386|FG000|Overall Study|Other|5|||
105519764|NCT00413192|363912387|FG001|Overall Study|Other|1|||
105519765|NCT00413192|363912388|FG002|Overall Study|Other|1|||
105519766|NCT00413192|363912389|FG003|Overall Study|Other|2|||
105519767|NCT00413192|363912386|FG000|Overall Study|Not treated|0|||
105592549|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
105592550|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
105592551|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
105519768|NCT00413192|363912387|FG001|Overall Study|Not treated|0|||
105519769|NCT00413192|363912388|FG002|Overall Study|Not treated|0|||
105519770|NCT00413192|363912389|FG003|Overall Study|Not treated|1|||
105519771|NCT02436356|363912390|FG000|Overall Study|Excluded by MRI Screening|0|||
105519772|NCT02436356|363912391|FG001|Overall Study|Excluded by MRI Screening|0|||
105519773|NCT02436356|363912392|FG002|Overall Study|Excluded by MRI Screening|2|||
105519774|NCT02436356|363912390|FG000|Overall Study|Lost to Follow-up|0|||
105519775|NCT02436356|363912391|FG001|Overall Study|Lost to Follow-up|1|||
105519776|NCT02436356|363912392|FG002|Overall Study|Lost to Follow-up|0|||
105519777|NCT02436356|363912390|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
105592552|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105592553|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
105592554|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
105592555|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105592556|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105592557|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105592558|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105592559|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
105592560|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
105592561|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
105592562|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
105592563|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
105592564|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
105592565|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
105592566|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
105592567|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
105592568|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
105592569|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
105592570|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
105592571|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
105592572|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
105592573|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
105592574|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
105592575|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
105592576|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
105592577|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
105592578|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
105519778|NCT02436356|363912391|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
105519779|NCT02436356|363912392|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
105519780|NCT02436356|363912390|FG000|Overall Study|Excluded due to other medical conditions|3|||
105519781|NCT02436356|363912391|FG001|Overall Study|Excluded due to other medical conditions|0|||
105519782|NCT02436356|363912392|FG002|Overall Study|Excluded due to other medical conditions|0|||
105519783|NCT02436356|363912390|FG000|Overall Study|Withdrawal by Subject|1|||
105519784|NCT02436356|363912391|FG001|Overall Study|Withdrawal by Subject|0|||
105519785|NCT02436356|363912392|FG002|Overall Study|Withdrawal by Subject|0|||
105519786|NCT02968563|363912397|FG000|Overall Study|Adverse Event|0|||
105519787|NCT02968563|363912398|FG001|Overall Study|Adverse Event|6|||
105519788|NCT02968563|363912397|FG000|Overall Study|Death|1|||
105519789|NCT02968563|363912398|FG001|Overall Study|Death|1|||
105519790|NCT02968563|363912397|FG000|Overall Study|Lost to Follow-up|0|||
105519791|NCT02968563|363912398|FG001|Overall Study|Lost to Follow-up|1|||
105519792|NCT03992781|363912399|FG000|Overall Study|Lost to Follow-up|5|||
105519793|NCT03992781|363912399|FG000|Overall Study|Adverse Event|1|||
105519794|NCT03992781|363912399|FG000|Overall Study|Lack of Efficacy|5|||
105519795|NCT03287804|363912400|FG000|Overall Study|Death|1|||
105519796|NCT03287804|363912400|FG000|Overall Study|Physician Decision|2|||
105519797|NCT03287804|363912400|FG000|Overall Study|Progressive disease|8|||
105519798|NCT01275833|363912402|FG000|Overall Study|Study terminated|1|||
105519799|NCT01275833|363912403|FG001|Overall Study|Study terminated|1|||
105519800|NCT02914769|363912410|FG000|Overall Study|Protocol Violation|3|||
105519801|NCT02914769|363912411|FG001|Overall Study|Protocol Violation|2|||
105519802|NCT02914769|363912410|FG000|Overall Study|Withdrawal by Subject|0|||
105519803|NCT02914769|363912411|FG001|Overall Study|Withdrawal by Subject|1|||
105519804|NCT00742001|363912412|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
105519805|NCT00742001|363912413|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
105519806|NCT00742001|363912414|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
105519807|NCT00003492|363912422|FG000|Overall Study|Not evaluable|6|||
105519808|NCT04256785|363912426|FG000|Overall Study|Adverse Event|8|||
105519809|NCT04256785|363912427|FG001|Overall Study|Adverse Event|6|||
105519810|NCT04256785|363912426|FG000|Overall Study|Lack of Efficacy|3|||
105519811|NCT04256785|363912427|FG001|Overall Study|Lack of Efficacy|4|||
105519812|NCT04256785|363912426|FG000|Overall Study|Lost to Follow-up|7|||
105519813|NCT04256785|363912427|FG001|Overall Study|Lost to Follow-up|7|||
105519814|NCT04256785|363912426|FG000|Overall Study|Protocol Violation|1|||
105519815|NCT04256785|363912427|FG001|Overall Study|Protocol Violation|0|||
105519816|NCT04256785|363912426|FG000|Overall Study|Withdrawal by Subject|4|||
105592579|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
105519817|NCT04256785|363912427|FG001|Overall Study|Withdrawal by Subject|1|||
105519818|NCT04256785|363912426|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
105519819|NCT04256785|363912427|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
105519820|NCT01558752|363912428|FG000|Overall Study|Physician Decision|2|||
105519821|NCT01558752|363912429|FG001|Overall Study|Physician Decision|0|||
105519822|NCT01170091|363912432|FG000|Overall Study|Missing efficacy evaluation|3|||
105519823|NCT01170091|363912432|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
105519824|NCT00969150|363912437|FG000|Overall Study|Adverse Event|4|||
105519825|NCT00969150|363912438|FG001|Overall Study|Adverse Event|14|||
105519826|NCT00969150|363912437|FG000|Overall Study|Lack of Efficacy|1|||
105519827|NCT00969150|363912438|FG001|Overall Study|Lack of Efficacy|1|||
105519828|NCT00969150|363912437|FG000|Overall Study|Protocol Violation|9|||
105519829|NCT00969150|363912438|FG001|Overall Study|Protocol Violation|12|||
105519830|NCT00969150|363912437|FG000|Overall Study|Withdrawal by Subject|13|||
105519831|NCT00969150|363912438|FG001|Overall Study|Withdrawal by Subject|9|||
105519832|NCT00969150|363912437|FG000|Overall Study|Lost to Follow-up|5|||
105519833|NCT00969150|363912438|FG001|Overall Study|Lost to Follow-up|4|||
105519834|NCT00969150|363912437|FG000|Overall Study|Other reasons|1|||
105519835|NCT00969150|363912438|FG001|Overall Study|Other reasons|0|||
105519836|NCT00391274|363912445|FG000|Overall Study|Death Due to Study Disease|55|||
105519837|NCT00391274|363912446|FG001|Overall Study|Death Due to Study Disease|45|||
105519838|NCT00391274|363912445|FG000|Overall Study|Lost to Follow-up|0|||
105519839|NCT00391274|363912446|FG001|Overall Study|Lost to Follow-up|3|||
105519840|NCT00391274|363912445|FG000|Overall Study|Physician Decision|4|||
105519841|NCT00391274|363912446|FG001|Overall Study|Physician Decision|2|||
105519842|NCT00391274|363912445|FG000|Overall Study|Withdrawal by Subject|0|||
105519843|NCT00391274|363912446|FG001|Overall Study|Withdrawal by Subject|3|||
105519844|NCT00391274|363912445|FG000|Overall Study|Death Due to Adverse Event|1|||
105519845|NCT00391274|363912446|FG001|Overall Study|Death Due to Adverse Event|3|||
105519846|NCT00391274|363912445|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
105519847|NCT00391274|363912446|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
105519848|NCT00391274|363912445|FG000|Overall Study|Death Not Study Related|0|||
105519849|NCT00391274|363912446|FG001|Overall Study|Death Not Study Related|1|||
105519850|NCT04501666|363912447|FG000|Overall Study|Physician Decision|0|||
105519851|NCT04501666|363912448|FG001|Overall Study|Physician Decision|1|||
105519852|NCT04501666|363912447|FG000|Overall Study|Adverse Event|12|||
105519853|NCT04501666|363912448|FG001|Overall Study|Adverse Event|4|||
105519854|NCT04501666|363912447|FG000|Overall Study|Subject's request|10|||
105519855|NCT04501666|363912448|FG001|Overall Study|Subject's request|6|||
105519856|NCT04501666|363912447|FG000|Overall Study|Protocol Deviation|2|||
105519857|NCT04501666|363912448|FG001|Overall Study|Protocol Deviation|1|||
105519858|NCT04501666|363912447|FG000|Overall Study|Other-- site permanently closing|0|||
105519859|NCT04501666|363912448|FG001|Overall Study|Other-- site permanently closing|1|||
105519860|NCT00894322|363912449|FG000|Overall Study|Withdrawal by Subject|1|||
105519861|NCT00894322|363912450|FG001|Overall Study|Withdrawal by Subject|0|||
105519862|NCT00894322|363912451|FG002|Overall Study|Withdrawal by Subject|0|||
105519863|NCT01686633|363912452|FG000|Overall Study|Lack of Efficacy|33|||
105519864|NCT01686633|363912453|FG001|Overall Study|Lack of Efficacy|13|||
105519865|NCT01686633|363912454|FG002|Overall Study|Lack of Efficacy|11|||
105519866|NCT01686633|363912452|FG000|Overall Study|Withdrawal by Subject|8|||
105519867|NCT01686633|363912453|FG001|Overall Study|Withdrawal by Subject|8|||
105519868|NCT01686633|363912454|FG002|Overall Study|Withdrawal by Subject|5|||
105519869|NCT01686633|363912452|FG000|Overall Study|Physician Decision|3|||
105519870|NCT01686633|363912453|FG001|Overall Study|Physician Decision|4|||
105519871|NCT01686633|363912454|FG002|Overall Study|Physician Decision|4|||
105519872|NCT01686633|363912452|FG000|Overall Study|Adverse Event|4|||
105519873|NCT01686633|363912453|FG001|Overall Study|Adverse Event|3|||
105519874|NCT01686633|363912454|FG002|Overall Study|Adverse Event|3|||
105519875|NCT01686633|363912452|FG000|Overall Study|Protocol Violation|2|||
105519876|NCT01686633|363912453|FG001|Overall Study|Protocol Violation|3|||
105519877|NCT01686633|363912454|FG002|Overall Study|Protocol Violation|0|||
105519878|NCT01686633|363912452|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
105519879|NCT01686633|363912453|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
105519880|NCT01686633|363912454|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
105519881|NCT01686633|363912452|FG000|Overall Study|Lost to Follow-up|0|||
105519882|NCT01686633|363912453|FG001|Overall Study|Lost to Follow-up|1|||
105519883|NCT01686633|363912454|FG002|Overall Study|Lost to Follow-up|1|||
105519884|NCT00056407|363912456|FG000|Overall Study|Adverse Event|282|||
105519885|NCT00056407|363912457|FG001|Overall Study|Adverse Event|364|||
105519886|NCT00056407|363912456|FG000|Overall Study|Withdrawal by Subject|377|||
105519887|NCT00056407|363912457|FG001|Overall Study|Withdrawal by Subject|361|||
105519888|NCT00056407|363912456|FG000|Overall Study|Lost to Follow-up|123|||
105519889|NCT00056407|363912457|FG001|Overall Study|Lost to Follow-up|113|||
105519890|NCT00056407|363912456|FG000|Overall Study|Protocol Violation|104|||
105519891|NCT00056407|363912457|FG001|Overall Study|Protocol Violation|95|||
105519892|NCT00056407|363912456|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
105519893|NCT00056407|363912457|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
105519894|NCT00056407|363912456|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
105519895|NCT00056407|363912457|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
105519896|NCT00056407|363912456|FG000|Overall Study|Missing|25|||
105519897|NCT00056407|363912457|FG001|Overall Study|Missing|34|||
105519898|NCT04782856|363914485|FG000|Overall Study|Withdrawal by Subject|0|||
105519899|NCT04782856|363914486|FG001|Overall Study|Withdrawal by Subject|1|||
105519900|NCT01912287|363914487|FG000|Overall Study|Ineligible|1|||
105519901|NCT01912287|363914488|FG001|Overall Study|Ineligible|0|||
105519902|NCT01912287|363914489|FG002|Overall Study|Ineligible|1|||
105519903|NCT01912287|363914487|FG000|Overall Study|No-show|0|||
105519904|NCT01912287|363914488|FG001|Overall Study|No-show|0|||
105519905|NCT01912287|363914489|FG002|Overall Study|No-show|1|||
105519906|NCT01912287|363914487|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
105519907|NCT01912287|363914488|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
105519908|NCT01912287|363914489|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
105519909|NCT01912287|363914487|FG000|Overall Study|Felt treatment no longer needed|0|||
105519910|NCT01912287|363914488|FG001|Overall Study|Felt treatment no longer needed|1|||
105519911|NCT01912287|363914489|FG002|Overall Study|Felt treatment no longer needed|0|||
105519912|NCT01912287|363914487|FG000|Overall Study|Life circumstances|4|||
105519913|NCT01912287|363914488|FG001|Overall Study|Life circumstances|2|||
105519914|NCT01912287|363914489|FG002|Overall Study|Life circumstances|0|||
105519915|NCT01912287|363914487|FG000|Overall Study|Lost Interest|1|||
105519916|NCT01912287|363914488|FG001|Overall Study|Lost Interest|0|||
105519917|NCT01912287|363914489|FG002|Overall Study|Lost Interest|0|||
105519918|NCT01912287|363914487|FG000|Overall Study|Uknown reason - subject drop out|5|||
105519919|NCT01912287|363914488|FG001|Overall Study|Uknown reason - subject drop out|7|||
105519920|NCT01912287|363914489|FG002|Overall Study|Uknown reason - subject drop out|3|||
105519921|NCT01912287|363914487|FG000|Overall Study|Missed Assesment|1|||
105519922|NCT01912287|363914488|FG001|Overall Study|Missed Assesment|1|||
105519923|NCT01912287|363914489|FG002|Overall Study|Missed Assesment|1|||
105519924|NCT01912287|363914487|FG000|Overall Study|Scheduling/change in availability|17|||
105519925|NCT01912287|363914488|FG001|Overall Study|Scheduling/change in availability|10|||
105519926|NCT01912287|363914489|FG002|Overall Study|Scheduling/change in availability|8|||
105519927|NCT00695396|363914490|FG000|Overall Study|Study Closed Prematurely|5|||
105519928|NCT00695396|363914491|FG001|Overall Study|Study Closed Prematurely|6|||
105519929|NCT00695396|363914492|FG002|Overall Study|Study Closed Prematurely|8|||
105519930|NCT00695396|363914490|FG000|Overall Study|Withdrawal by Subject|2|||
105519931|NCT00695396|363914491|FG001|Overall Study|Withdrawal by Subject|2|||
105519932|NCT00695396|363914492|FG002|Overall Study|Withdrawal by Subject|0|||
105519933|NCT01050257|363914496|FG000|Overall Study|Adverse Event|4|||
105519934|NCT01050257|363914497|FG001|Overall Study|Adverse Event|4|||
105519935|NCT01050257|363914498|FG002|Overall Study|Adverse Event|2|||
105519936|NCT01050257|363914496|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
105519937|NCT01050257|363914497|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
105519938|NCT01050257|363914498|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
105519939|NCT01050257|363914496|FG000|Overall Study|Withdrawal by Subject|0|||
105519940|NCT01050257|363914497|FG001|Overall Study|Withdrawal by Subject|3|||
105519941|NCT01050257|363914498|FG002|Overall Study|Withdrawal by Subject|0|||
105519942|NCT01050257|363914496|FG000|Overall Study|No reason specified|0|||
105519943|NCT01050257|363914497|FG001|Overall Study|No reason specified|0|||
105519944|NCT01050257|363914498|FG002|Overall Study|No reason specified|2|||
105519945|NCT01050257|363914496|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
105519946|NCT01050257|363914497|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
105519947|NCT01050257|363914498|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
105519948|NCT01050257|363914496|FG000|Overall Study|Violation criteria|0|||
105519949|NCT01050257|363914497|FG001|Overall Study|Violation criteria|1|||
105519950|NCT01050257|363914498|FG002|Overall Study|Violation criteria|0|||
105519951|NCT01050257|363914496|FG000|Overall Study|Failure to return|0|||
105519952|NCT01050257|363914497|FG001|Overall Study|Failure to return|2|||
105519953|NCT01050257|363914498|FG002|Overall Study|Failure to return|0|||
105519954|NCT01050257|363914496|FG000|Overall Study|Death|0|||
105519955|NCT01050257|363914497|FG001|Overall Study|Death|0|||
105519956|NCT01050257|363914498|FG002|Overall Study|Death|1|||
105519957|NCT00171223|363914499|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
105519958|NCT00171223|363914500|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
105519959|NCT00171223|363914501|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
105519960|NCT00171223|363914499|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
105519961|NCT00171223|363914500|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
105519962|NCT00171223|363914501|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
105519963|NCT00171223|363914499|FG000|Overall Study|Abnormal Procedure|1|||
105519964|NCT00171223|363914500|FG001|Overall Study|Abnormal Procedure|0|||
105519965|NCT00171223|363914501|FG002|Overall Study|Abnormal Procedure|0|||
105519966|NCT00171223|363914499|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
105519967|NCT00171223|363914500|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
105519968|NCT00171223|363914501|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
105519969|NCT00171223|363914499|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
105519970|NCT00171223|363914500|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
105519971|NCT00171223|363914501|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
105519972|NCT00171223|363914499|FG000|Overall Study|Protocol Violation|2|||
105519973|NCT00171223|363914500|FG001|Overall Study|Protocol Violation|2|||
105519974|NCT00171223|363914501|FG002|Overall Study|Protocol Violation|3|||
105519975|NCT00171223|363914499|FG000|Overall Study|Participant Withdrew Consent|12|||
105519976|NCT00171223|363914500|FG001|Overall Study|Participant Withdrew Consent|21|||
105519977|NCT00171223|363914501|FG002|Overall Study|Participant Withdrew Consent|15|||
105519978|NCT00171223|363914499|FG000|Overall Study|Lost to Follow-up|5|||
105519979|NCT00171223|363914500|FG001|Overall Study|Lost to Follow-up|2|||
105519980|NCT00171223|363914501|FG002|Overall Study|Lost to Follow-up|3|||
105519981|NCT00171223|363914499|FG000|Overall Study|Administrative Problems|4|||
105519982|NCT00171223|363914500|FG001|Overall Study|Administrative Problems|7|||
105519983|NCT00171223|363914501|FG002|Overall Study|Administrative Problems|6|||
105519984|NCT00171223|363914499|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
105519985|NCT00171223|363914500|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
105519986|NCT00171223|363914501|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
105519987|NCT00171223|363914499|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
105519988|NCT00171223|363914500|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
105519989|NCT00171223|363914501|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
105519990|NCT02488681|363914502|FG000|Overall Study|Implant unsuccessful|7|||
105519991|NCT02604212|363914503|FG000|Overall Study|Study Terminated by Sponsor|2|||
105519992|NCT02604212|363914504|FG001|Overall Study|Study Terminated by Sponsor|1|||
105519993|NCT02604212|363914505|FG002|Overall Study|Study Terminated by Sponsor|3|||
105519994|NCT02604212|363914506|FG003|Overall Study|Study Terminated by Sponsor|3|||
105519995|NCT02604212|363914503|FG000|Overall Study|Withdrawal by Subject|0|||
105519996|NCT02604212|363914504|FG001|Overall Study|Withdrawal by Subject|0|||
105519997|NCT02604212|363914505|FG002|Overall Study|Withdrawal by Subject|1|||
105519998|NCT02604212|363914506|FG003|Overall Study|Withdrawal by Subject|0|||
105519999|NCT00451321|363914507|FG000|Overall Study|Lost to Follow-up|3|||
105520000|NCT00451321|363914508|FG001|Overall Study|Lost to Follow-up|3|||
105520001|NCT00451321|363914509|FG002|Overall Study|Lost to Follow-up|1|||
105520002|NCT00451321|363914510|FG003|Overall Study|Lost to Follow-up|3|||
105520003|NCT00451321|363914511|FG004|Overall Study|Lost to Follow-up|0|||
105520004|NCT00451321|363914512|FG005|Overall Study|Lost to Follow-up|1|||
105520005|NCT00451321|363914513|FG006|Overall Study|Lost to Follow-up|0|||
105520006|NCT00451321|363914514|FG007|Overall Study|Lost to Follow-up|0|||
105520007|NCT00451321|363914507|FG000|Overall Study|Withdrawal by Subject|3|||
105520008|NCT00451321|363914508|FG001|Overall Study|Withdrawal by Subject|1|||
105520009|NCT00451321|363914509|FG002|Overall Study|Withdrawal by Subject|0|||
105520010|NCT00451321|363914510|FG003|Overall Study|Withdrawal by Subject|4|||
105520011|NCT00451321|363914511|FG004|Overall Study|Withdrawal by Subject|0|||
105520012|NCT00451321|363914512|FG005|Overall Study|Withdrawal by Subject|0|||
105520013|NCT00451321|363914513|FG006|Overall Study|Withdrawal by Subject|0|||
105520014|NCT00451321|363914514|FG007|Overall Study|Withdrawal by Subject|0|||
105520015|NCT00451321|363914507|FG000|Overall Study|Study closed/terminated|1|||
105520016|NCT00451321|363914508|FG001|Overall Study|Study closed/terminated|1|||
105520017|NCT00451321|363914509|FG002|Overall Study|Study closed/terminated|17|||
105520018|NCT00451321|363914510|FG003|Overall Study|Study closed/terminated|5|||
105520019|NCT00451321|363914511|FG004|Overall Study|Study closed/terminated|7|||
105520020|NCT00451321|363914512|FG005|Overall Study|Study closed/terminated|7|||
105520021|NCT00451321|363914513|FG006|Overall Study|Study closed/terminated|5|||
105520022|NCT00451321|363914514|FG007|Overall Study|Study closed/terminated|3|||
105520023|NCT00451321|363914507|FG000|Overall Study|Sponsor decision to amend protocol|0|||
105520024|NCT00451321|363914508|FG001|Overall Study|Sponsor decision to amend protocol|0|||
105520025|NCT00451321|363914509|FG002|Overall Study|Sponsor decision to amend protocol|0|||
105520026|NCT00451321|363914510|FG003|Overall Study|Sponsor decision to amend protocol|0|||
105520027|NCT00451321|363914511|FG004|Overall Study|Sponsor decision to amend protocol|0|||
105520028|NCT00451321|363914512|FG005|Overall Study|Sponsor decision to amend protocol|1|||
105520029|NCT00451321|363914513|FG006|Overall Study|Sponsor decision to amend protocol|1|||
105520030|NCT00451321|363914514|FG007|Overall Study|Sponsor decision to amend protocol|3|||
105520031|NCT00597766|363914519|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
105520032|NCT00597766|363914520|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
105520033|NCT00597766|363914521|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
105520034|NCT00597766|363914519|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
105520035|NCT00597766|363914520|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
105520036|NCT00597766|363914521|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
105520037|NCT03311659|363914523|FG000|Overall Study|Protocol Violation|1|||
105520038|NCT01909479|363914524|FG000|From Baseline to Week 26|Adverse Event|3|||
105520039|NCT01909479|363914525|FG001|From Baseline to Week 26|Adverse Event|2|||
105520040|NCT01909479|363914524|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
105520041|NCT01909479|363914525|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
105520042|NCT01909479|363914524|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
105520043|NCT01909479|363914525|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
105520044|NCT01909479|363914524|FG000|26 - 52 Weeks|Adverse Event|0|||
105520045|NCT01909479|363914525|FG001|26 - 52 Weeks|Adverse Event|1|||
105520046|NCT01909479|363914524|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
105520047|NCT01909479|363914525|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
105520048|NCT01909479|363914524|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
105520049|NCT01909479|363914525|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
105520050|NCT01909479|363914524|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
105520051|NCT01909479|363914525|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
105520052|NCT01909479|363914524|FG000|52 Weeks to End of Study|Adverse Event|2|||
105520053|NCT01909479|363914525|FG001|52 Weeks to End of Study|Adverse Event|1|||
105520054|NCT01909479|363914524|FG000|52 Weeks to End of Study|Death|0|||
105520055|NCT01909479|363914525|FG001|52 Weeks to End of Study|Death|1|||
105520056|NCT01909479|363914524|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
105520057|NCT01909479|363914525|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
105520058|NCT01909479|363914524|FG000|52 Weeks to End of Study|Protocol Violation|1|||
105520059|NCT01909479|363914525|FG001|52 Weeks to End of Study|Protocol Violation|0|||
105520060|NCT01909479|363914524|FG000|52 Weeks to End of Study|Progressive disease|1|||
105520061|NCT01909479|363914525|FG001|52 Weeks to End of Study|Progressive disease|1|||
105520062|NCT01909479|363914524|FG000|52 Weeks to End of Study|Personal reasons|2|||
105520063|NCT01909479|363914525|FG001|52 Weeks to End of Study|Personal reasons|1|||
105520064|NCT01909479|363914524|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
105520065|NCT01909479|363914525|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
105520066|NCT01909479|363914524|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
105520067|NCT01909479|363914525|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
105520068|NCT01909479|363914524|FG000|52 Weeks to End of Study|Lack of contact|1|||
105520069|NCT01909479|363914525|FG001|52 Weeks to End of Study|Lack of contact|0|||
105520070|NCT01909479|363914524|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
105520071|NCT01909479|363914525|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
105520072|NCT01909479|363914524|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
105520073|NCT01909479|363914525|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
105520074|NCT04446377|363914526|FG000|Overall Study|Withdrawal by Subject|6|||
105520075|NCT04446377|363914527|FG001|Overall Study|Withdrawal by Subject|1|||
105520076|NCT04446377|363914526|FG000|Overall Study|Physician Decision|1|||
105520077|NCT04446377|363914527|FG001|Overall Study|Physician Decision|1|||
105520078|NCT04446377|363914526|FG000|Overall Study|Lost to Follow-up|0|||
105520079|NCT04446377|363914527|FG001|Overall Study|Lost to Follow-up|2|||
105520080|NCT04446377|363914526|FG000|Overall Study|Not eligible|0|||
105520081|NCT04446377|363914527|FG001|Overall Study|Not eligible|1|||
105520082|NCT00271609|363914530|FG000|Overall Study|Adverse Event|11|||
105520083|NCT00271609|363914531|FG001|Overall Study|Adverse Event|3|||
105520084|NCT00271609|363914530|FG000|Overall Study|Withdrawal by Subject|2|||
105520085|NCT00271609|363914531|FG001|Overall Study|Withdrawal by Subject|0|||
105520086|NCT03051607|363914532|FG000|Overall Study|Adverse Event|66|||
105520087|NCT03447990|363914533|FG000|Overall Study|Withdrawal by Subject|0|||
105520088|NCT03447990|363914534|FG001|Overall Study|Withdrawal by Subject|0|||
105520089|NCT03447990|363914535|FG002|Overall Study|Withdrawal by Subject|0|||
105520090|NCT03447990|363914536|FG003|Overall Study|Withdrawal by Subject|0|||
105520091|NCT03447990|363914537|FG004|Overall Study|Withdrawal by Subject|0|||
105520092|NCT03447990|363914538|FG005|Overall Study|Withdrawal by Subject|0|||
105520093|NCT03447990|363914539|FG006|Overall Study|Withdrawal by Subject|1|||
105520094|NCT02738450|363914540|FG000|Overall Study|Withdrawal by Subject|0|||
105520095|NCT02738450|363914541|FG001|Overall Study|Withdrawal by Subject|2|||
105520096|NCT02738450|363914542|FG002|Overall Study|Withdrawal by Subject|0|||
105520097|NCT03559257|363914543|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
105520098|NCT03559257|363914544|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
105520099|NCT03559257|363914543|FG000|Double Blind Treatment Period|Protocol Violation|1|||
105520100|NCT03559257|363914544|FG001|Double Blind Treatment Period|Protocol Violation|4|||
105520101|NCT03559257|363914543|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
105520102|NCT03559257|363914544|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
105520103|NCT03559257|363914543|FG000|Double Blind Treatment Period|Adverse Event|0|||
105520104|NCT03559257|363914544|FG001|Double Blind Treatment Period|Adverse Event|1|||
105520105|NCT03559257|363914543|FG000|Double Blind Treatment Period|Screen Failure|0|||
105520106|NCT03559257|363914544|FG001|Double Blind Treatment Period|Screen Failure|1|||
105520107|NCT03559257|363914543|FG000|Open-label Treatment Period|Adverse Event|1|||
105592580|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
105592581|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
105592582|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
105592583|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
105592584|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
105592585|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
105520108|NCT03559257|363914544|FG001|Open-label Treatment Period|Adverse Event|4|||
105520109|NCT03559257|363914543|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
105592586|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
105520110|NCT03559257|363914544|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
105520111|NCT03559257|363914543|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
105520112|NCT03559257|363914544|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
105520113|NCT03559257|363914543|FG000|Open-label Treatment Period|Protocol Violation|2|||
105520114|NCT03559257|363914544|FG001|Open-label Treatment Period|Protocol Violation|0|||
105520115|NCT03559257|363914543|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
105520116|NCT03559257|363914544|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
105520117|NCT03559257|363914543|FG000|Open-label Treatment Period|Physician Decision|0|||
105520118|NCT03559257|363914544|FG001|Open-label Treatment Period|Physician Decision|1|||
105520119|NCT03761147|363914545|FG000|Overall Study|Withdrawal by Subject|6|||
105520120|NCT03761147|363914546|FG001|Overall Study|Withdrawal by Subject|1|||
105520121|NCT03761147|363914545|FG000|Overall Study|Adverse Event|1|||
105520122|NCT03761147|363914546|FG001|Overall Study|Adverse Event|3|||
105520123|NCT03630120|363914547|FG000|Overall Study|Disease progression|0|||
105520124|NCT03630120|363914548|FG001|Overall Study|Disease progression|1|||
105520125|NCT03630120|363914549|FG002|Overall Study|Disease progression|1|||
105520126|NCT03630120|363914550|FG003|Overall Study|Disease progression|1|||
105520127|NCT01519960|363914551|FG000|Overall Study|Withdrawal from the study|26|||
105520128|NCT01519960|363914552|FG001|Overall Study|Withdrawal from the study|22|||
105520129|NCT01519960|363914553|FG002|Overall Study|Withdrawal from the study|5|||
105520130|NCT04351087|363914561|FG000|Overall Study|Lost to Follow-up|7|||
105520131|NCT04351087|363914562|FG001|Overall Study|Lost to Follow-up|3|||
105520132|NCT04351087|363914561|FG000|Overall Study|Withdrawal by Subject|3|||
105520133|NCT04351087|363914562|FG001|Overall Study|Withdrawal by Subject|4|||
105520134|NCT04351087|363914561|FG000|Overall Study|Lack of Efficacy|3|||
105520135|NCT04351087|363914562|FG001|Overall Study|Lack of Efficacy|2|||
105520136|NCT01603459|363914563|FG000|Overall Study|Adverse Event|5|||
105520137|NCT01603459|363914563|FG000|Overall Study|Withdrawal by Subject|5|||
105520138|NCT01603459|363914563|FG000|Overall Study|Lost to Follow-up|3|||
105520139|NCT01603459|363914563|FG000|Overall Study|Predefined discontinuation criteria|3|||
105520140|NCT01603459|363914563|FG000|Overall Study|Non-compliance|1|||
105520141|NCT01603459|363914563|FG000|Overall Study|Administrative reason|1|||
105520142|NCT00399360|363914564|FG000|Overall Study|Lost to Follow-up|2|||
105520143|NCT00399360|363914565|FG001|Overall Study|Lost to Follow-up|1|||
105520144|NCT00399360|363914566|FG002|Overall Study|Lost to Follow-up|2|||
105520145|NCT00399360|363914567|FG003|Overall Study|Lost to Follow-up|4|||
105520146|NCT00399360|363914564|FG000|Overall Study|Adverse Event|0|||
105520147|NCT00399360|363914565|FG001|Overall Study|Adverse Event|0|||
105520148|NCT00399360|363914566|FG002|Overall Study|Adverse Event|1|||
105520149|NCT00399360|363914567|FG003|Overall Study|Adverse Event|0|||
105520150|NCT00399360|363914564|FG000|Overall Study|Withdrawal by Subject|0|||
105520151|NCT00399360|363914565|FG001|Overall Study|Withdrawal by Subject|2|||
105520152|NCT00399360|363914566|FG002|Overall Study|Withdrawal by Subject|0|||
105520153|NCT00399360|363914567|FG003|Overall Study|Withdrawal by Subject|2|||
105520154|NCT00535223|363914569|FG000|Overall Study|Withdrawal by Subject|4|||
105520155|NCT00535223|363914570|FG001|Overall Study|Withdrawal by Subject|1|||
105520156|NCT02335099|363914571|FG000|Treatment|Withdrawal by Subject|1|||
105520157|NCT02335099|363914572|FG001|Treatment|Withdrawal by Subject|3|||
105520158|NCT02335099|363914571|FG000|Treatment|Lost to Follow-up|2|||
105520159|NCT02335099|363914572|FG001|Treatment|Lost to Follow-up|0|||
105520160|NCT02335099|363914571|FG000|Treatment|Death|1|||
105520161|NCT02335099|363914572|FG001|Treatment|Death|0|||
105520162|NCT02335099|363914571|FG000|Treatment|Adverse Event|1|||
105520163|NCT02335099|363914572|FG001|Treatment|Adverse Event|2|||
105520164|NCT02335099|363914571|FG000|Follow-up|Death|0|||
105520165|NCT02335099|363914572|FG001|Follow-up|Death|1|||
105520166|NCT03519347|363914573|FG000|Interventional Crossover Period 1|Death|0|||
105520167|NCT03519347|363914574|FG001|Interventional Crossover Period 1|Death|0|||
105520168|NCT03519347|363914575|FG002|Interventional Crossover Period 1|Death|0|||
105520169|NCT03519347|363914576|FG003|Interventional Crossover Period 1|Death|1|||
105520170|NCT05517382|363914577|FG000|Overall Study|Lost to Follow-up|0|||
105520171|NCT05517382|363914578|FG001|Overall Study|Lost to Follow-up|1|||
105520172|NCT01641692|363914581|FG000|Treatment Period 1|Adverse Event|1|||
105520173|NCT01641692|363914582|FG001|Treatment Period 1|Adverse Event|0|||
105520174|NCT01641692|363914583|FG002|Treatment Period 1|Adverse Event|0|||
105520175|NCT01641692|363914584|FG003|Treatment Period 1|Adverse Event|0|||
105520176|NCT01641692|363914585|FG004|Treatment Period 1|Adverse Event|0|||
105520177|NCT01641692|363914586|FG005|Treatment Period 1|Adverse Event|0|||
105520178|NCT01641692|363914587|FG006|Treatment Period 1|Adverse Event|0|||
105520179|NCT01641692|363914588|FG007|Treatment Period 1|Adverse Event|0|||
105520180|NCT01641692|363914581|FG000|Treatment Period 1|Lack of Efficacy|0|||
105520181|NCT01641692|363914582|FG001|Treatment Period 1|Lack of Efficacy|0|||
105520182|NCT01641692|363914583|FG002|Treatment Period 1|Lack of Efficacy|0|||
105520183|NCT01641692|363914584|FG003|Treatment Period 1|Lack of Efficacy|0|||
105520184|NCT01641692|363914585|FG004|Treatment Period 1|Lack of Efficacy|0|||
105520185|NCT01641692|363914586|FG005|Treatment Period 1|Lack of Efficacy|0|||
105520186|NCT01641692|363914587|FG006|Treatment Period 1|Lack of Efficacy|0|||
105520187|NCT01641692|363914588|FG007|Treatment Period 1|Lack of Efficacy|1|||
105520188|NCT01641692|363914581|FG000|Treatment Period 1|Protocol Violation|1|||
105520189|NCT01641692|363914582|FG001|Treatment Period 1|Protocol Violation|0|||
105520190|NCT01641692|363914583|FG002|Treatment Period 1|Protocol Violation|0|||
105520191|NCT01641692|363914584|FG003|Treatment Period 1|Protocol Violation|0|||
105520192|NCT01641692|363914585|FG004|Treatment Period 1|Protocol Violation|2|||
105520193|NCT01641692|363914586|FG005|Treatment Period 1|Protocol Violation|0|||
105520194|NCT01641692|363914587|FG006|Treatment Period 1|Protocol Violation|0|||
105520195|NCT01641692|363914588|FG007|Treatment Period 1|Protocol Violation|0|||
105520196|NCT01641692|363914581|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
105520197|NCT01641692|363914582|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
105520198|NCT01641692|363914583|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
105520199|NCT01641692|363914584|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
105520200|NCT01641692|363914585|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
105520201|NCT01641692|363914586|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
105520202|NCT01641692|363914587|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
105520203|NCT01641692|363914588|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
105520204|NCT01641692|363914581|FG000|Treatment Period 1|Lost to Follow-up|0|||
105520205|NCT01641692|363914582|FG001|Treatment Period 1|Lost to Follow-up|0|||
105520206|NCT01641692|363914583|FG002|Treatment Period 1|Lost to Follow-up|1|||
105520207|NCT01641692|363914584|FG003|Treatment Period 1|Lost to Follow-up|0|||
105520208|NCT01641692|363914585|FG004|Treatment Period 1|Lost to Follow-up|0|||
105520209|NCT01641692|363914586|FG005|Treatment Period 1|Lost to Follow-up|0|||
105520210|NCT01641692|363914587|FG006|Treatment Period 1|Lost to Follow-up|0|||
105520211|NCT01641692|363914588|FG007|Treatment Period 1|Lost to Follow-up|0|||
105520212|NCT01641692|363914581|FG000|Treatment Period 1|Physician Decision|0|||
105520213|NCT01641692|363914582|FG001|Treatment Period 1|Physician Decision|0|||
105520214|NCT01641692|363914583|FG002|Treatment Period 1|Physician Decision|0|||
105520215|NCT01641692|363914584|FG003|Treatment Period 1|Physician Decision|0|||
105520216|NCT01641692|363914585|FG004|Treatment Period 1|Physician Decision|1|||
105520217|NCT01641692|363914586|FG005|Treatment Period 1|Physician Decision|0|||
105520218|NCT01641692|363914587|FG006|Treatment Period 1|Physician Decision|0|||
105520219|NCT01641692|363914588|FG007|Treatment Period 1|Physician Decision|0|||
105520220|NCT01641692|363914581|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105520221|NCT01641692|363914582|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105520222|NCT01641692|363914583|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105520223|NCT01641692|363914584|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105520224|NCT01641692|363914585|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105520225|NCT01641692|363914586|FG005|Treatment Period 1|Withdrawal by Subject|2|||
105520226|NCT01641692|363914587|FG006|Treatment Period 1|Withdrawal by Subject|0|||
105520227|NCT01641692|363914588|FG007|Treatment Period 1|Withdrawal by Subject|1|||
105520228|NCT01641692|363914581|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
105520229|NCT01641692|363914582|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
105520230|NCT01641692|363914583|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
105520231|NCT01641692|363914584|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
105520232|NCT01641692|363914585|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
105520233|NCT01641692|363914586|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
105520234|NCT01641692|363914587|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
105520235|NCT01641692|363914588|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
105520236|NCT01641692|363914581|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
105520237|NCT01641692|363914582|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
105520238|NCT01641692|363914583|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
105520239|NCT01641692|363914584|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
105520240|NCT01641692|363914585|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
105520241|NCT01641692|363914586|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
105520242|NCT01641692|363914587|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
105520243|NCT01641692|363914588|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
105520244|NCT01641692|363914581|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
105520245|NCT01641692|363914582|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
105520246|NCT01641692|363914583|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
105520247|NCT01641692|363914584|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
105520248|NCT01641692|363914585|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
105520249|NCT01641692|363914586|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
105520250|NCT01641692|363914587|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
105520251|NCT01641692|363914588|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
105520252|NCT01641692|363914581|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
105520253|NCT01641692|363914582|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
105520254|NCT01641692|363914583|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
105520255|NCT01641692|363914584|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
105520256|NCT01641692|363914585|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
105520257|NCT01641692|363914586|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
105520258|NCT01641692|363914587|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
105520259|NCT01641692|363914588|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
105520260|NCT01641692|363914581|FG000|Treatment Period 2|Lack of Efficacy|1|||
105520261|NCT01641692|363914582|FG001|Treatment Period 2|Lack of Efficacy|0|||
105520262|NCT01641692|363914583|FG002|Treatment Period 2|Lack of Efficacy|0|||
105520263|NCT01641692|363914584|FG003|Treatment Period 2|Lack of Efficacy|0|||
105520264|NCT01641692|363914585|FG004|Treatment Period 2|Lack of Efficacy|0|||
105520265|NCT01641692|363914586|FG005|Treatment Period 2|Lack of Efficacy|0|||
105520266|NCT01641692|363914587|FG006|Treatment Period 2|Lack of Efficacy|0|||
105520267|NCT01641692|363914588|FG007|Treatment Period 2|Lack of Efficacy|0|||
105520268|NCT01641692|363914581|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
105520269|NCT01641692|363914582|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105520270|NCT01641692|363914583|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105520271|NCT01641692|363914584|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105520272|NCT01641692|363914585|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105520273|NCT01641692|363914586|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105520274|NCT01641692|363914587|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105520275|NCT01641692|363914588|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105520276|NCT01641692|363914581|FG000|Treatment Period 2|Lost to Follow-up|0|||
105520277|NCT01641692|363914582|FG001|Treatment Period 2|Lost to Follow-up|0|||
105520278|NCT01641692|363914583|FG002|Treatment Period 2|Lost to Follow-up|0|||
105520279|NCT01641692|363914584|FG003|Treatment Period 2|Lost to Follow-up|0|||
105520280|NCT01641692|363914585|FG004|Treatment Period 2|Lost to Follow-up|0|||
105520281|NCT01641692|363914586|FG005|Treatment Period 2|Lost to Follow-up|1|||
105520282|NCT01641692|363914587|FG006|Treatment Period 2|Lost to Follow-up|0|||
105520283|NCT01641692|363914588|FG007|Treatment Period 2|Lost to Follow-up|0|||
105520284|NCT01641692|363914581|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105520285|NCT01641692|363914582|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105520286|NCT01641692|363914583|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105520287|NCT01641692|363914584|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105520288|NCT01641692|363914585|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105520289|NCT01641692|363914586|FG005|Treatment Period 2|Withdrawal by Subject|1|||
105520290|NCT01641692|363914587|FG006|Treatment Period 2|Withdrawal by Subject|0|||
105520291|NCT01641692|363914588|FG007|Treatment Period 2|Withdrawal by Subject|1|||
105520292|NCT01641692|363914581|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
105520293|NCT01641692|363914582|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
105520294|NCT01641692|363914583|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
105520295|NCT01641692|363914584|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
105520296|NCT01641692|363914585|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
105520297|NCT01641692|363914586|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
105520298|NCT01641692|363914587|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
105520299|NCT01641692|363914588|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
105520300|NCT01641692|363914581|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
105520301|NCT01641692|363914582|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
105520302|NCT01641692|363914583|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
105520303|NCT01641692|363914584|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
105520304|NCT01641692|363914585|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
105520305|NCT01641692|363914586|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
105520306|NCT01641692|363914587|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
105520307|NCT01641692|363914588|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
105520308|NCT01641692|363914581|FG000|Treatment Period 3|Adverse Event|0|||
105520309|NCT01641692|363914582|FG001|Treatment Period 3|Adverse Event|0|||
105520310|NCT01641692|363914583|FG002|Treatment Period 3|Adverse Event|0|||
105520311|NCT01641692|363914584|FG003|Treatment Period 3|Adverse Event|0|||
105520312|NCT01641692|363914585|FG004|Treatment Period 3|Adverse Event|0|||
105520313|NCT01641692|363914586|FG005|Treatment Period 3|Adverse Event|0|||
105520314|NCT01641692|363914587|FG006|Treatment Period 3|Adverse Event|1|||
105520315|NCT01641692|363914588|FG007|Treatment Period 3|Adverse Event|0|||
105520316|NCT01641692|363914581|FG000|Treatment Period 3|Protocol Violation|0|||
105520317|NCT01641692|363914582|FG001|Treatment Period 3|Protocol Violation|0|||
105520318|NCT01641692|363914583|FG002|Treatment Period 3|Protocol Violation|1|||
105520319|NCT01641692|363914584|FG003|Treatment Period 3|Protocol Violation|0|||
105520320|NCT01641692|363914585|FG004|Treatment Period 3|Protocol Violation|0|||
105520321|NCT01641692|363914586|FG005|Treatment Period 3|Protocol Violation|0|||
105520322|NCT01641692|363914587|FG006|Treatment Period 3|Protocol Violation|0|||
105520323|NCT01641692|363914588|FG007|Treatment Period 3|Protocol Violation|0|||
105520324|NCT01641692|363914581|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105520325|NCT01641692|363914582|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105520326|NCT01641692|363914583|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105520327|NCT01641692|363914584|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105520328|NCT01641692|363914585|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105520329|NCT01641692|363914586|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105520330|NCT01641692|363914587|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
105520331|NCT01641692|363914588|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105520332|NCT01641692|363914581|FG000|Treatment Period 3|Lost to Follow-up|0|||
105520333|NCT01641692|363914582|FG001|Treatment Period 3|Lost to Follow-up|1|||
105520334|NCT01641692|363914583|FG002|Treatment Period 3|Lost to Follow-up|0|||
105520335|NCT01641692|363914584|FG003|Treatment Period 3|Lost to Follow-up|0|||
105520336|NCT01641692|363914585|FG004|Treatment Period 3|Lost to Follow-up|0|||
105520337|NCT01641692|363914586|FG005|Treatment Period 3|Lost to Follow-up|0|||
105520338|NCT01641692|363914587|FG006|Treatment Period 3|Lost to Follow-up|0|||
105592587|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
105592588|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
105592589|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
105592590|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
105592591|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
105592592|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
105592593|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
105592594|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
105592595|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
105592596|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
105592597|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105592598|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
105592599|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
105592600|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105520339|NCT01641692|363914588|FG007|Treatment Period 3|Lost to Follow-up|0|||
105520340|NCT01641692|363914581|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
105520341|NCT01641692|363914582|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
105520342|NCT01641692|363914583|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
105520343|NCT01641692|363914584|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
105520344|NCT01641692|363914585|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
105520345|NCT01641692|363914586|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
105520346|NCT01641692|363914587|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
105520347|NCT01641692|363914588|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
105520348|NCT01641692|363914581|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
105520349|NCT01641692|363914582|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
105520350|NCT01641692|363914583|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
105520351|NCT01641692|363914584|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
105520352|NCT01641692|363914585|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
105520353|NCT01641692|363914586|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
105520354|NCT01641692|363914587|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
105520355|NCT01641692|363914588|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
105520356|NCT01412021|363914593|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
105520357|NCT01412021|363914593|FG000|Overall Study|Treatment Prior to Approval|3|||
105520358|NCT01412021|363914593|FG000|Overall Study|Transferred to Other Hospital|9|||
105520359|NCT01166178|363914604|FG000|Overall Study|Withdrawal by Subject|1|||
105520360|NCT01166178|363914605|FG001|Overall Study|Withdrawal by Subject|0|||
105520361|NCT01166178|363914604|FG000|Overall Study|Study was terminated|20|||
105520362|NCT01166178|363914605|FG001|Overall Study|Study was terminated|8|||
105520363|NCT00484939|363914608|FG000|Overall Study|Death|9|||
105520364|NCT00484939|363914609|FG001|Overall Study|Death|13|||
105520365|NCT00484939|363914608|FG000|Overall Study|Adverse Event|22|||
105520366|NCT00484939|363914609|FG001|Overall Study|Adverse Event|12|||
105520367|NCT00484939|363914608|FG000|Overall Study|Patient Withdrew Consent|19|||
105520368|NCT00484939|363914609|FG001|Overall Study|Patient Withdrew Consent|10|||
105520369|NCT00484939|363914608|FG000|Overall Study|Protocol Violation|3|||
105520370|NCT00484939|363914609|FG001|Overall Study|Protocol Violation|3|||
105520371|NCT00484939|363914608|FG000|Overall Study|Lost to Follow-up|0|||
105520372|NCT00484939|363914609|FG001|Overall Study|Lost to Follow-up|3|||
105520373|NCT00484939|363914608|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
105520374|NCT00484939|363914609|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
105520375|NCT00484939|363914608|FG000|Overall Study|Disease progression|67|||
105520376|NCT00484939|363914609|FG001|Overall Study|Disease progression|88|||
105592601|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105592602|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105592603|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105592604|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
105592605|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
105592606|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
105592607|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
105520377|NCT00484939|363914608|FG000|Overall Study|Screen Failure|2|||
105520378|NCT00484939|363914609|FG001|Overall Study|Screen Failure|2|||
105520379|NCT00484939|363914608|FG000|Overall Study|Reason Not Specified|11|||
105520380|NCT00484939|363914609|FG001|Overall Study|Reason Not Specified|6|||
105520381|NCT04948450|363914610|FG000|Overall Study|Return home|1|||
105520382|NCT04948450|363914611|FG001|Overall Study|Return home|3|||
105520383|NCT02677987|363914612|FG000|Overall Study|Withdrawal by Subject|3|||
105520384|NCT02677987|363914613|FG001|Overall Study|Withdrawal by Subject|0|||
105520385|NCT02677987|363914612|FG000|Overall Study|Lost to Follow-up|1|||
105520386|NCT02677987|363914613|FG001|Overall Study|Lost to Follow-up|0|||
105520387|NCT00101907|363914617|FG000|Overall Study|Adverse Event|1|||
105520388|NCT00101907|363914618|FG001|Overall Study|Adverse Event|0|||
105520389|NCT00101907|363914619|FG002|Overall Study|Adverse Event|0|||
105520390|NCT00101907|363914620|FG003|Overall Study|Adverse Event|0|||
105520391|NCT00101907|363914621|FG004|Overall Study|Adverse Event|0|||
105520392|NCT00101907|363914622|FG005|Overall Study|Adverse Event|0|||
105520393|NCT00101907|363914617|FG000|Overall Study|Death|0|||
105520394|NCT00101907|363914618|FG001|Overall Study|Death|1|||
105520395|NCT00101907|363914619|FG002|Overall Study|Death|0|||
105520396|NCT00101907|363914620|FG003|Overall Study|Death|0|||
105520397|NCT00101907|363914621|FG004|Overall Study|Death|3|||
105520398|NCT00101907|363914622|FG005|Overall Study|Death|0|||
105520399|NCT00101907|363914617|FG000|Overall Study|Physician Decision|0|||
105520400|NCT00101907|363914618|FG001|Overall Study|Physician Decision|0|||
105520401|NCT00101907|363914619|FG002|Overall Study|Physician Decision|0|||
105520402|NCT00101907|363914620|FG003|Overall Study|Physician Decision|1|||
105520403|NCT00101907|363914621|FG004|Overall Study|Physician Decision|1|||
105520404|NCT00101907|363914622|FG005|Overall Study|Physician Decision|0|||
105520405|NCT00101907|363914617|FG000|Overall Study|Withdrawal by Subject|1|||
105520406|NCT00101907|363914618|FG001|Overall Study|Withdrawal by Subject|0|||
105520407|NCT00101907|363914619|FG002|Overall Study|Withdrawal by Subject|1|||
105520408|NCT00101907|363914620|FG003|Overall Study|Withdrawal by Subject|0|||
105520409|NCT00101907|363914621|FG004|Overall Study|Withdrawal by Subject|1|||
105520410|NCT00101907|363914622|FG005|Overall Study|Withdrawal by Subject|0|||
105520411|NCT00673179|363914625|FG000|Overall Study|Toxicity/Complications|3|||
105520412|NCT00673179|363914626|FG001|Overall Study|Toxicity/Complications|0|||
105520413|NCT00651755|363914627|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
105520414|NCT00651755|363914628|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
105520415|NCT00651755|363914627|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
105520416|NCT00651755|363914628|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
105520417|NCT00624052|363914629|FG000|Overall Study|Adverse Event|7|||
105520418|NCT00624052|363914630|FG001|Overall Study|Adverse Event|6|||
105520419|NCT00624052|363914631|FG002|Overall Study|Adverse Event|0|||
105520420|NCT00624052|363914632|FG003|Overall Study|Adverse Event|3|||
105520421|NCT00624052|363914629|FG000|Overall Study|Lack of Efficacy|1|||
105520422|NCT00624052|363914630|FG001|Overall Study|Lack of Efficacy|1|||
105520423|NCT00624052|363914631|FG002|Overall Study|Lack of Efficacy|0|||
105520424|NCT00624052|363914632|FG003|Overall Study|Lack of Efficacy|0|||
105520425|NCT00624052|363914629|FG000|Overall Study|Lost to Follow-up|2|||
105520426|NCT00624052|363914630|FG001|Overall Study|Lost to Follow-up|3|||
105520427|NCT00624052|363914631|FG002|Overall Study|Lost to Follow-up|1|||
105520428|NCT00624052|363914632|FG003|Overall Study|Lost to Follow-up|0|||
105520429|NCT00624052|363914629|FG000|Overall Study|Non compliant with the protocol|2|||
105520430|NCT00624052|363914630|FG001|Overall Study|Non compliant with the protocol|1|||
105520431|NCT00624052|363914631|FG002|Overall Study|Non compliant with the protocol|1|||
105520432|NCT00624052|363914632|FG003|Overall Study|Non compliant with the protocol|1|||
105520433|NCT00624052|363914629|FG000|Overall Study|Consent withdrawn|3|||
105520434|NCT00624052|363914630|FG001|Overall Study|Consent withdrawn|1|||
105520435|NCT00624052|363914631|FG002|Overall Study|Consent withdrawn|1|||
105520436|NCT00624052|363914632|FG003|Overall Study|Consent withdrawn|0|||
105520437|NCT00624052|363914629|FG000|Overall Study|Changed job/ran out if meds|0|||
105520438|NCT00624052|363914630|FG001|Overall Study|Changed job/ran out if meds|2|||
105520439|NCT00624052|363914631|FG002|Overall Study|Changed job/ran out if meds|0|||
105520440|NCT00624052|363914632|FG003|Overall Study|Changed job/ran out if meds|0|||
105520441|NCT02587065|363914635|FG000|Overall Study|Adverse Event|14|||
105520442|NCT02587065|363914635|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
105520443|NCT02587065|363914635|FG000|Overall Study|Non-adherence to the Protocol|3|||
105520444|NCT02587065|363914635|FG000|Overall Study|Discontinuation of Study Medication|2|||
105520445|NCT02587065|363914635|FG000|Overall Study|Reason not Specified|3|||
105520446|NCT01559012|363914638|FG000|Overall Study|Withdrawal by Subject|0|||
105520447|NCT01559012|363914639|FG001|Overall Study|Withdrawal by Subject|1|||
105520448|NCT04814433|363914643|FG000|Overall Study|Survey not returned|4|||
105520449|NCT04814433|363914644|FG001|Overall Study|Survey not returned|8|||
105520450|NCT04814433|363914645|FG002|Overall Study|Survey not returned|4|||
105520451|NCT04814433|363914646|FG003|Overall Study|Survey not returned|5|||
105520452|NCT04837131|363914647|FG000|Overall Study|Death|1|||
105520453|NCT04837131|363914647|FG000|Overall Study|Withdrawal by Subject|1|||
105520454|NCT04837131|363914647|FG000|Overall Study|Adverse Event|1|||
105520455|NCT04837131|363914647|FG000|Overall Study|Protocol Violation|1|||
105520456|NCT02496533|363914648|FG000|Overall Study|Lack of data on outcome|3|||
105520457|NCT02496533|363914649|FG001|Overall Study|Lack of data on outcome|0|||
105520458|NCT02496533|363914648|FG000|Overall Study|Patient did not complete all measures|0|||
105520459|NCT02496533|363914649|FG001|Overall Study|Patient did not complete all measures|4|||
105520460|NCT02496533|363914648|FG000|Overall Study|Late for radiologic testing|0|||
105520461|NCT02496533|363914649|FG001|Overall Study|Late for radiologic testing|2|||
105520462|NCT03482791|363914651|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
105520463|NCT03482791|363914652|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
105520464|NCT04219891|363914653|FG000|Overall Study|Lost to Follow-up|3|||
105520465|NCT04219891|363914653|FG000|Overall Study|Withdrawal by Subject|2|||
105520466|NCT00670800|363916569|FG000|Overall Study|2 controls were insulin resistant|0|||
105520467|NCT00670800|363916570|FG001|Overall Study|2 controls were insulin resistant|2|||
105520468|NCT01853826|363916571|FG000|Overall Study|Patients who switched to commercial drug|11|||
105520469|NCT01853826|363916571|FG000|Overall Study|Patient refused to continue medication|21|||
105520470|NCT01853826|363916571|FG000|Overall Study|Lost to Follow-up|2|||
105520471|NCT01853826|363916571|FG000|Overall Study|Non-compliant with protocol|4|||
105520472|NCT01853826|363916571|FG000|Overall Study|Other adverse events (AE)|62|||
105520473|NCT01853826|363916571|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
105520474|NCT01853826|363916571|FG000|Overall Study|Progressive disease|342|||
105520475|NCT01853826|363916571|FG000|Overall Study|Other than listed|13|||
105520476|NCT01853826|363916571|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
105520477|NCT03204981|363916572|FG000|Overall Study|Physician Decision|2|||
105520478|NCT03204981|363916572|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
105520479|NCT03025542|363916573|FG000|Overall Study|Adverse Event|0|||
105520480|NCT03025542|363916574|FG001|Overall Study|Adverse Event|2|||
105520481|NCT03025542|363916573|FG000|Overall Study|Lost to Follow-up|1|||
105520482|NCT03025542|363916574|FG001|Overall Study|Lost to Follow-up|0|||
105520483|NCT03025542|363916573|FG000|Overall Study|Withdrawal by Subject|1|||
105520484|NCT03025542|363916574|FG001|Overall Study|Withdrawal by Subject|0|||
105520485|NCT05024058|363916575|FG000|Treatment|Study terminated by sponsor|5|||
105520486|NCT05024058|363916576|FG001|Treatment|Study terminated by sponsor|6|||
105520487|NCT05024058|363916577|FG002|Treatment|Study terminated by sponsor|4|||
105520488|NCT05024058|363916578|FG003|Treatment|Study terminated by sponsor|2|||
105520489|NCT05024058|363916579|FG004|Treatment|Study terminated by sponsor|3|||
105520490|NCT05024058|363916580|FG005|Treatment|Study terminated by sponsor|3|||
105520491|NCT05024058|363916581|FG006|Treatment|Study terminated by sponsor|1|||
105520492|NCT05024058|363916582|FG007|Treatment|Study terminated by sponsor|3|||
105520493|NCT05024058|363916583|FG008|Treatment|Study terminated by sponsor|6|||
105520494|NCT05024058|363916584|FG009|Treatment|Study terminated by sponsor|6|||
105520495|NCT05024058|363916575|FG000|Follow-up|Withdrawal by Subject|1|||
105520496|NCT05024058|363916576|FG001|Follow-up|Withdrawal by Subject|0|||
105520497|NCT05024058|363916577|FG002|Follow-up|Withdrawal by Subject|1|||
105520498|NCT05024058|363916578|FG003|Follow-up|Withdrawal by Subject|0|||
105520499|NCT05024058|363916579|FG004|Follow-up|Withdrawal by Subject|0|||
105520500|NCT05024058|363916580|FG005|Follow-up|Withdrawal by Subject|0|||
105520501|NCT05024058|363916581|FG006|Follow-up|Withdrawal by Subject|0|||
105520502|NCT05024058|363916582|FG007|Follow-up|Withdrawal by Subject|1|||
105520503|NCT05024058|363916583|FG008|Follow-up|Withdrawal by Subject|0|||
105520504|NCT05024058|363916584|FG009|Follow-up|Withdrawal by Subject|1|||
105520505|NCT01104636|363916586|FG000|Overall Study|Lack of Efficacy|43|||
105520506|NCT01104636|363916586|FG000|Overall Study|Lost to Follow-up|24|||
105520507|NCT01104636|363916586|FG000|Overall Study|Withdrawal by Subject|4|||
105520508|NCT01104636|363916586|FG000|Overall Study|Other|43|||
105520509|NCT01104636|363916586|FG000|Overall Study|Study terminated by sponsor|1|||
105520510|NCT01104636|363916586|FG000|Overall Study|Pregnancy|2|||
105520511|NCT01104636|363916586|FG000|Overall Study|Adverse Event|40|||
105520512|NCT01104636|363916586|FG000|Overall Study|Ongoing|21|||
105520513|NCT00380978|363916588|FG000|Overall Study|Refused allocated intervention|0|||
105520514|NCT00380978|363916589|FG001|Overall Study|Refused allocated intervention|6|||
105520515|NCT00380978|363916588|FG000|Overall Study|Wrong study envelope|0|||
105520516|NCT00380978|363916589|FG001|Overall Study|Wrong study envelope|2|||
105520517|NCT00380978|363916588|FG000|Overall Study|Allocation prior to analgesia request|1|||
105520518|NCT00380978|363916589|FG001|Overall Study|Allocation prior to analgesia request|2|||
105520519|NCT00380978|363916588|FG000|Overall Study|Parous patient|1|||
105520520|NCT00380978|363916589|FG001|Overall Study|Parous patient|0|||
105520521|NCT02750592|363916591|FG000|Overall Study|Adverse Event|3|||
105520522|NCT02750592|363916591|FG000|Overall Study|Lack of Efficacy|2|||
105592608|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
105520523|NCT01372501|363916597|FG000|Overall Study|Adverse Event|4|||
105520524|NCT01372501|363916597|FG000|Overall Study|Device migration|1|||
105520525|NCT01541969|363916598|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
105520526|NCT01541969|363916599|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
105520527|NCT01541969|363916598|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
105520528|NCT01541969|363916599|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
105520529|NCT01541969|363916598|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
105520530|NCT01541969|363916599|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
105520531|NCT01541969|363916598|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
105520532|NCT01541969|363916599|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
105592609|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
105520533|NCT01541969|363916598|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
105520534|NCT01541969|363916599|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
105520535|NCT01541969|363916598|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
105520536|NCT01541969|363916599|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
105520537|NCT01541969|363916598|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
105520538|NCT01541969|363916599|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
105520539|NCT01541969|363916598|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
105520540|NCT01541969|363916599|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
105520541|NCT01541969|363916598|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
105520542|NCT01541969|363916599|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
105520543|NCT01541969|363916598|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
105520544|NCT01541969|363916599|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
105520545|NCT02522286|363916600|FG000|Overall Study|Withdrawal by Subject|3|||
105520546|NCT02522286|363916601|FG001|Overall Study|Withdrawal by Subject|0|||
105520547|NCT02522286|363916602|FG002|Overall Study|Withdrawal by Subject|0|||
105520548|NCT02522286|363916603|FG003|Overall Study|Withdrawal by Subject|3|||
105520549|NCT01466348|363916604|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
105520550|NCT01466348|363916605|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
105520551|NCT03970733|363916606|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
105520552|NCT03970733|363916607|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
105520553|NCT03970733|363916608|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
105520554|NCT03970733|363916609|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
105520555|NCT03970733|363916610|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
105520556|NCT03970733|363916606|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
105520557|NCT03970733|363916607|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
105520558|NCT03970733|363916608|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
105520559|NCT03970733|363916609|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
105520560|NCT03970733|363916610|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
105520561|NCT03970733|363916606|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
105520562|NCT03970733|363916607|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
105520563|NCT03970733|363916608|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
105520564|NCT03970733|363916609|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
105520565|NCT03970733|363916610|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
105520566|NCT03970733|363916606|FG000|Main Study Phase (18 Months)|Other|1|||
105520567|NCT03970733|363916607|FG001|Main Study Phase (18 Months)|Other|1|||
105520568|NCT03970733|363916608|FG002|Main Study Phase (18 Months)|Other|0|||
105520569|NCT03970733|363916609|FG003|Main Study Phase (18 Months)|Other|0|||
105520570|NCT03970733|363916610|FG004|Main Study Phase (18 Months)|Other|0|||
105520571|NCT03970733|363916606|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
105520572|NCT03970733|363916607|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
105520573|NCT03970733|363916608|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
105520574|NCT03970733|363916609|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
105520575|NCT03970733|363916610|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
105520576|NCT02189473|363916614|FG000|Overall Study|Death|22|||
105520577|NCT02189473|363916615|FG001|Overall Study|Death|23|||
105520578|NCT02189473|363916614|FG000|Overall Study|Lost to Follow-up|1|||
105520579|NCT02189473|363916615|FG001|Overall Study|Lost to Follow-up|2|||
105520580|NCT04608500|363916618|FG000|Overall Study|Adverse Event|2|||
105520581|NCT04608500|363916619|FG001|Overall Study|Adverse Event|0|||
105520582|NCT04608500|363916618|FG000|Overall Study|Lost to Follow-up|15|||
105520583|NCT04608500|363916619|FG001|Overall Study|Lost to Follow-up|9|||
105520584|NCT04608500|363916618|FG000|Overall Study|Participant request|11|||
105520585|NCT04608500|363916619|FG001|Overall Study|Participant request|7|||
105520586|NCT04608500|363916618|FG000|Overall Study|Protocol Violation|1|||
105520587|NCT04608500|363916619|FG001|Overall Study|Protocol Violation|0|||
105520588|NCT04608500|363916618|FG000|Overall Study|Other|6|||
105520589|NCT04608500|363916619|FG001|Overall Study|Other|2|||
105520590|NCT00665353|363916626|FG000|Study Step 1|Adverse Event|1|||
105520591|NCT00665353|363916626|FG000|Study Step 1|Withdrawal by Subject|2|||
105520592|NCT00665353|363916626|FG000|Study Step 2|Lost to Follow-up|2|||
105520593|NCT00665353|363916626|FG000|Study Step 2|Lack of Efficacy|12|||
105520594|NCT00573755|363916627|FG000|Overall Study|Still receiving treatment|1|||
105520595|NCT00573755|363916628|FG001|Overall Study|Still receiving treatment|0|||
105520596|NCT01030523|363916629|FG000|Initial Study (5 Years)|Death|1|||
105520597|NCT01030523|363916630|FG001|Initial Study (5 Years)|Death|0|||
105520598|NCT01030523|363916629|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
105520599|NCT01030523|363916630|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
105520600|NCT01030523|363916629|FG000|Initial Study (5 Years)|Implant failure|1|||
105520601|NCT01030523|363916630|FG001|Initial Study (5 Years)|Implant failure|0|||
105520602|NCT01030523|363916629|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
105520603|NCT01030523|363916630|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
105520604|NCT01030523|363916629|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
105592610|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
105592611|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
105592612|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
105592613|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
105592614|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
105592615|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
105592616|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
105592617|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
105592618|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
105592619|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
105592620|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
105592621|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
105592622|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
105592623|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
105592624|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
105592625|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
105592626|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
105592627|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
105592628|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
105592629|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
105592630|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
105592631|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
105592632|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
105592633|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
105592634|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
105592635|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
105592636|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
105592637|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
105592638|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
105592639|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
105592640|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
105592641|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
105592642|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
105592643|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
105592644|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
105592645|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
105592646|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
105592647|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
105592648|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
105592649|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
105592650|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
105592651|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
105592652|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
105592653|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
105592654|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
105592655|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
105592656|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
105592657|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
105592658|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
105592659|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
105592660|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105592661|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
105592662|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
105592663|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105592664|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105592665|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105592666|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105592667|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
105592668|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
105592669|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
105592670|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
105592671|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
105592672|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
105592673|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
105592674|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
105592675|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
105592676|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
105592677|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
105592678|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
105592679|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
105592680|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
105592681|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
105592682|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
105592683|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
105592684|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
105592685|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
105592686|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
105592687|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105592688|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
105592689|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
105592690|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105592691|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105592692|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105592693|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105592694|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
105592695|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
105592696|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
105592697|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
105592698|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
105592699|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
105592700|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
105592701|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
105592702|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
105592703|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
105592704|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
105592705|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
105592706|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
105520605|NCT01030523|363916630|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
105520606|NCT01030523|363916629|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
105520607|NCT01030523|363916630|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
105520608|NCT03724812|363916631|FG000|Overall Study|Missed Visit|1|||
105520609|NCT03724812|363916631|FG000|Overall Study|Death|2|||
105520610|NCT03724812|363916631|FG000|Overall Study|Withdrawal by Subject|1|||
105520611|NCT01465022|363916632|FG000|Overall Study|Lost to Follow-up|15|||
105520612|NCT01465022|363916633|FG001|Overall Study|Lost to Follow-up|14|||
105520613|NCT01465022|363916634|FG002|Overall Study|Lost to Follow-up|0|||
105520614|NCT01465022|363916632|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
105520615|NCT01465022|363916633|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
105520616|NCT01465022|363916634|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
105520617|NCT01465022|363916632|FG000|Overall Study|Not Randomized|0|||
105520618|NCT01465022|363916633|FG001|Overall Study|Not Randomized|0|||
105520619|NCT01465022|363916634|FG002|Overall Study|Not Randomized|70|||
105520620|NCT04475588|363916635|FG000|Overall Study|Adverse Event|2|||
105520621|NCT04475588|363916636|FG001|Overall Study|Adverse Event|0|||
105520622|NCT01528072|363916649|FG000|Overall Study|Withdrawal by Subject|5|||
105520623|NCT01528072|363916649|FG000|Overall Study|Physician Decision|1|||
105520624|NCT01528072|363916649|FG000|Overall Study|Determined not eligible by AEAC|1|||
105520625|NCT01528072|363916649|FG000|Overall Study|Missed Visit|2|||
105520626|NCT01528072|363916649|FG000|Overall Study|Lost to Follow-up|5|||
105520627|NCT01528072|363916649|FG000|Overall Study|Explanted|2|||
105520628|NCT01528072|363916649|FG000|Overall Study|Site Closure|4|||
105520629|NCT01528072|363916649|FG000|Overall Study|Death|2|||
105520630|NCT01528072|363916649|FG000|Overall Study|Early Termination of Study|52|||
105520631|NCT02529137|363916655|FG000|Overall Study|Discontinuation for different reasons|8|||
105520632|NCT02389998|363916656|FG000|Overall Study|car accident|1|||
105520633|NCT02389998|363916657|FG001|Overall Study|car accident|0|||
105520634|NCT03045887|363916658|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
105520635|NCT03045887|363916659|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
105592707|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
105592708|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
105592709|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
105520636|NCT03045887|363916660|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
105520637|NCT03045887|363916661|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
105520638|NCT03045887|363916662|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
105520639|NCT03045887|363916663|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
105520640|NCT03045887|363916664|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
105592710|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
105592711|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
105592712|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
105520641|NCT03045887|363916665|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
105592713|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
105592714|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
105592715|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
105592716|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
105592717|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
105592718|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
105592719|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
105592720|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
105592721|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
105592722|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
105592723|NCT01212757|364169414|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
105592724|NCT01212757|364169415|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
105592725|NCT01212757|364169416|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
105520642|NCT03045887|363916666|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
105520643|NCT03045887|363916667|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
105520644|NCT03045887|363916658|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
105520645|NCT03045887|363916659|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
105520646|NCT03045887|363916660|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
105520647|NCT03045887|363916661|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
105520648|NCT03045887|363916662|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
105520649|NCT03045887|363916663|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
105520650|NCT03045887|363916664|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
105520651|NCT03045887|363916665|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
105520652|NCT03045887|363916666|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
105520653|NCT03045887|363916667|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
105520654|NCT03045887|363916658|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
105520655|NCT03045887|363916659|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
105520656|NCT03045887|363916660|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
105520657|NCT03045887|363916661|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
105520658|NCT03045887|363916662|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
105520659|NCT03045887|363916663|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
105520660|NCT03045887|363916664|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
105520661|NCT03045887|363916665|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
105520662|NCT03045887|363916666|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
105520663|NCT03045887|363916667|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
105520664|NCT03045887|363916658|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
105520665|NCT03045887|363916659|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
105520666|NCT03045887|363916660|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
105520667|NCT03045887|363916661|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
105520668|NCT03045887|363916662|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
105520669|NCT03045887|363916663|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
105520670|NCT03045887|363916664|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
105520671|NCT03045887|363916665|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
105520672|NCT03045887|363916666|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
105520673|NCT03045887|363916667|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
105520674|NCT03045887|363916658|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105520675|NCT03045887|363916659|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105520676|NCT03045887|363916660|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105520677|NCT03045887|363916661|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
105520678|NCT03045887|363916662|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105520679|NCT03045887|363916663|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105520680|NCT03045887|363916664|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105520681|NCT03045887|363916665|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105520682|NCT03045887|363916666|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105520683|NCT03045887|363916667|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105520684|NCT02132767|363916669|FG000|Overall Study|Death|3|||
105520685|NCT02132767|363916670|FG001|Overall Study|Death|2|||
105520686|NCT02132767|363916669|FG000|Overall Study|Withdrawal by Subject|10|||
105520687|NCT02132767|363916670|FG001|Overall Study|Withdrawal by Subject|9|||
105520688|NCT02132767|363916669|FG000|Overall Study|Lost to Follow-up|4|||
105520689|NCT02132767|363916670|FG001|Overall Study|Lost to Follow-up|4|||
105592726|NCT01212757|364169417|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
105592727|NCT01212757|364169418|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
105520690|NCT00778700|363916671|FG000|Overall Study|Adverse Event|6|||
105520691|NCT00778700|363916672|FG001|Overall Study|Adverse Event|1|||
105520692|NCT00778700|363916673|FG002|Overall Study|Adverse Event|3|||
105520693|NCT00778700|363916674|FG003|Overall Study|Adverse Event|5|||
105520694|NCT00778700|363916671|FG000|Overall Study|Protocol Violation|1|||
105520695|NCT00778700|363916672|FG001|Overall Study|Protocol Violation|1|||
105592728|NCT01212757|364169419|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
105592729|NCT01212757|364169420|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
105592730|NCT01212757|364169421|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
105592731|NCT01212757|364169422|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
105592732|NCT05052983|364169423|FG000|Overall Study|Lack of Efficacy|3|||
105592733|NCT05052983|364169424|FG001|Overall Study|Lack of Efficacy|12|||
105592734|NCT05052983|364169423|FG000|Overall Study|Adverse Event|1|||
105592735|NCT05052983|364169424|FG001|Overall Study|Adverse Event|0|||
105592736|NCT03425643|364169425|FG000|Overall Study|Withdrawal by Subject|10|||
105592737|NCT03425643|364169426|FG001|Overall Study|Withdrawal by Subject|12|||
105592738|NCT03425643|364169425|FG000|Overall Study|Lost to Follow-up|2|||
105592739|NCT03425643|364169426|FG001|Overall Study|Lost to Follow-up|0|||
105592740|NCT03425643|364169425|FG000|Overall Study|Death|109|||
105592741|NCT03425643|364169426|FG001|Overall Study|Death|141|||
105592742|NCT03425643|364169425|FG000|Overall Study|Ongoing in study|276|||
105520696|NCT00778700|363916673|FG002|Overall Study|Protocol Violation|0|||
105592743|NCT03425643|364169426|FG001|Overall Study|Ongoing in study|247|||
105592744|NCT03141788|364169427|FG000|Overall Study|Lost to Follow-up|1|||
105592745|NCT03141788|364169427|FG000|Overall Study|Protocol Violation|3|||
105592746|NCT03141788|364169427|FG000|Overall Study|Withdrawal by Subject|4|||
105592747|NCT05526911|364170756|FG000|Overall Study|Adverse Event|2|||
105592748|NCT00172185|364170758|FG000|Overall Study|Adverse Event|0|||
105592749|NCT00172185|364170759|FG001|Overall Study|Adverse Event|1|||
105592750|NCT00172185|364170760|FG002|Overall Study|Adverse Event|3|||
105592751|NCT00172185|364170761|FG003|Overall Study|Adverse Event|4|||
105592752|NCT00172185|364170758|FG000|Overall Study|Physician Decision|0|||
105592753|NCT00172185|364170759|FG001|Overall Study|Physician Decision|0|||
105592754|NCT00172185|364170760|FG002|Overall Study|Physician Decision|1|||
105592755|NCT00172185|364170761|FG003|Overall Study|Physician Decision|0|||
105592756|NCT00172185|364170758|FG000|Overall Study|SPONSOR Decision|0|||
105592757|NCT00172185|364170759|FG001|Overall Study|SPONSOR Decision|1|||
105592758|NCT00172185|364170760|FG002|Overall Study|SPONSOR Decision|0|||
105592759|NCT00172185|364170761|FG003|Overall Study|SPONSOR Decision|0|||
105592760|NCT00172185|364170758|FG000|Overall Study|Withdrawal by Subject|0|||
105592761|NCT00172185|364170759|FG001|Overall Study|Withdrawal by Subject|0|||
105592762|NCT00172185|364170760|FG002|Overall Study|Withdrawal by Subject|1|||
105592763|NCT00172185|364170761|FG003|Overall Study|Withdrawal by Subject|0|||
105592764|NCT04057196|364170762|FG000|Overall Study|Withdrawal by Subject|3|||
105592765|NCT04057196|364170762|FG000|Overall Study|Death|3|||
105592766|NCT03068468|364170763|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
105592767|NCT03068468|364170764|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
105592768|NCT03068468|364170765|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
105520697|NCT00778700|363916674|FG003|Overall Study|Protocol Violation|0|||
105520698|NCT00778700|363916671|FG000|Overall Study|Subject Withdrew Consent|6|||
105520699|NCT00778700|363916672|FG001|Overall Study|Subject Withdrew Consent|4|||
105520700|NCT00778700|363916673|FG002|Overall Study|Subject Withdrew Consent|1|||
105520701|NCT00778700|363916674|FG003|Overall Study|Subject Withdrew Consent|4|||
105520702|NCT00778700|363916671|FG000|Overall Study|Lost to Follow-up|3|||
105520703|NCT00778700|363916672|FG001|Overall Study|Lost to Follow-up|1|||
105520704|NCT00778700|363916673|FG002|Overall Study|Lost to Follow-up|0|||
105520705|NCT00778700|363916674|FG003|Overall Study|Lost to Follow-up|1|||
105520706|NCT00778700|363916671|FG000|Overall Study|Reason not Specified|2|||
105520707|NCT00778700|363916672|FG001|Overall Study|Reason not Specified|0|||
105520708|NCT00778700|363916673|FG002|Overall Study|Reason not Specified|1|||
105520709|NCT00778700|363916674|FG003|Overall Study|Reason not Specified|3|||
105520710|NCT00778700|363916671|FG000|Overall Study|Other|0|||
105520711|NCT00778700|363916672|FG001|Overall Study|Other|0|||
105520712|NCT00778700|363916673|FG002|Overall Study|Other|1|||
105520713|NCT00778700|363916674|FG003|Overall Study|Other|0|||
105520714|NCT04267133|363916678|FG000|Overall Study|Withdrawal by Subject|1|||
105520715|NCT04267133|363916678|FG000|Overall Study|Adverse Event|4|||
105520716|NCT00491387|363916679|FG000|Overall Study|study terminated|20|||
105520717|NCT02150954|363916680|FG000|Overall Study|Protocol Violation|1|||
105520718|NCT02150954|363916681|FG001|Overall Study|Protocol Violation|0|||
105520719|NCT03318315|363916682|FG000|Overall Study|Lost to Follow-up|3|||
105520720|NCT03318315|363916683|FG001|Overall Study|Lost to Follow-up|2|||
105520721|NCT03318315|363916684|FG002|Overall Study|Lost to Follow-up|1|||
105520722|NCT03318315|363916682|FG000|Overall Study|Protocol Violation|1|||
105520723|NCT03318315|363916683|FG001|Overall Study|Protocol Violation|1|||
105520724|NCT03318315|363916684|FG002|Overall Study|Protocol Violation|1|||
105520725|NCT03318315|363916682|FG000|Overall Study|Withdrawal by Subject|0|||
105520726|NCT03318315|363916683|FG001|Overall Study|Withdrawal by Subject|0|||
105592769|NCT03068468|364170766|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
105592770|NCT03068468|364170763|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
105592771|NCT03068468|364170764|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
105592772|NCT03068468|364170765|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
105592773|NCT03068468|364170766|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
105520727|NCT03318315|363916684|FG002|Overall Study|Withdrawal by Subject|2|||
105520728|NCT02631850|363916685|FG000|Treatment Period|Lost to Follow-up|0|||
105520729|NCT02631850|363916686|FG001|Treatment Period|Lost to Follow-up|1|||
105520730|NCT02631850|363916687|FG002|Treatment Period|Lost to Follow-up|0|||
105520731|NCT02631850|363916688|FG003|Treatment Period|Lost to Follow-up|0|||
105520732|NCT02631850|363916685|FG000|Treatment Period|Protocol Violation|1|||
105520733|NCT02631850|363916686|FG001|Treatment Period|Protocol Violation|0|||
105520734|NCT02631850|363916687|FG002|Treatment Period|Protocol Violation|0|||
105520735|NCT02631850|363916688|FG003|Treatment Period|Protocol Violation|0|||
105520736|NCT02631850|363916685|FG000|Treatment Period|Withdrawal by Subject|0|||
105520737|NCT02631850|363916686|FG001|Treatment Period|Withdrawal by Subject|5|||
105520738|NCT02631850|363916687|FG002|Treatment Period|Withdrawal by Subject|2|||
105520739|NCT02631850|363916688|FG003|Treatment Period|Withdrawal by Subject|2|||
105520740|NCT02631850|363916685|FG000|Treatment Period|Adverse Event|1|||
105520741|NCT02631850|363916686|FG001|Treatment Period|Adverse Event|0|||
105520742|NCT02631850|363916687|FG002|Treatment Period|Adverse Event|2|||
105520743|NCT02631850|363916688|FG003|Treatment Period|Adverse Event|3|||
105520744|NCT02631850|363916685|FG000|Treatment Period|Family medical issue|1|||
105520745|NCT02631850|363916686|FG001|Treatment Period|Family medical issue|0|||
105520746|NCT02631850|363916687|FG002|Treatment Period|Family medical issue|0|||
105520747|NCT02631850|363916688|FG003|Treatment Period|Family medical issue|0|||
105520748|NCT02631850|363916685|FG000|6 Month Follow up|Lost to Follow-up|5|||
105520749|NCT02631850|363916686|FG001|6 Month Follow up|Lost to Follow-up|8|||
105520750|NCT02631850|363916687|FG002|6 Month Follow up|Lost to Follow-up|3|||
105520751|NCT02631850|363916688|FG003|6 Month Follow up|Lost to Follow-up|5|||
105520752|NCT02631850|363916685|FG000|6 Month Follow up|Withdrawal by Subject|1|||
105520753|NCT02631850|363916686|FG001|6 Month Follow up|Withdrawal by Subject|0|||
105520754|NCT02631850|363916687|FG002|6 Month Follow up|Withdrawal by Subject|0|||
105520755|NCT02631850|363916688|FG003|6 Month Follow up|Withdrawal by Subject|2|||
105520756|NCT02631850|363916685|FG000|6 Month Follow up|Adverse Event|1|||
105520757|NCT02631850|363916686|FG001|6 Month Follow up|Adverse Event|4|||
105520758|NCT02631850|363916687|FG002|6 Month Follow up|Adverse Event|1|||
105520759|NCT02631850|363916688|FG003|6 Month Follow up|Adverse Event|3|||
105520760|NCT02631850|363916685|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
105520761|NCT02631850|363916686|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
105520762|NCT02631850|363916687|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
105520763|NCT02631850|363916688|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
105520764|NCT01996826|363916697|FG000|Overall Study|Lost to Follow-up|6|||
105520765|NCT01996826|363916698|FG001|Overall Study|Lost to Follow-up|2|||
105520766|NCT01996826|363916697|FG000|Overall Study|Physician Decision|1|||
105520767|NCT01996826|363916698|FG001|Overall Study|Physician Decision|1|||
105520768|NCT00326950|363916699|FG000|Overall Study|Progressive Disease|1|||
105520769|NCT01454570|363916700|FG000|Overall Study|Withdrawal by Subject|2|||
105520770|NCT01454570|363916700|FG000|Overall Study|Screen Failure|7|||
105520771|NCT00003901|363916701|FG000|Overall Study|Adverse Event|1|||
105520772|NCT00003901|363916701|FG000|Overall Study|Withdrawal by Subject|1|||
105520773|NCT00003901|363916701|FG000|Overall Study|Ineligible|6|||
105520774|NCT00003901|363916701|FG000|Overall Study|CT Scan not within protocol requirement|2|||
105520775|NCT00003901|363916701|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
105520776|NCT00003901|363916701|FG000|Overall Study|Medical problems|6|||
105520777|NCT02141997|363916705|FG000|Overall Study|Adverse Event|0|||
105520778|NCT02141997|363916706|FG001|Overall Study|Adverse Event|2|||
105520779|NCT02141997|363916707|FG002|Overall Study|Adverse Event|0|||
105520780|NCT02141997|363916708|FG003|Overall Study|Adverse Event|1|||
105520781|NCT02141997|363916705|FG000|Overall Study|Participant noncompliance|1|||
105520782|NCT02141997|363916706|FG001|Overall Study|Participant noncompliance|0|||
105520783|NCT02141997|363916707|FG002|Overall Study|Participant noncompliance|0|||
105520784|NCT02141997|363916708|FG003|Overall Study|Participant noncompliance|0|||
105520785|NCT02141997|363916705|FG000|Overall Study|Withdrew consent|1|||
105520786|NCT02141997|363916706|FG001|Overall Study|Withdrew consent|0|||
105520787|NCT02141997|363916707|FG002|Overall Study|Withdrew consent|3|||
105520788|NCT02141997|363916708|FG003|Overall Study|Withdrew consent|0|||
105520789|NCT02141997|363916705|FG000|Overall Study|Other|1|||
105520790|NCT02141997|363916706|FG001|Overall Study|Other|4|||
105520791|NCT02141997|363916707|FG002|Overall Study|Other|0|||
105520792|NCT02141997|363916708|FG003|Overall Study|Other|0|||
105520793|NCT04105998|363916710|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
105520794|NCT04105998|363916711|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
105520795|NCT02738151|363916712|FG000|Overall Study|Randomized but not treated|4|||
105592774|NCT03068468|364170763|FG000|Placebo-Controlled Period|Adverse Event|16|||
105592775|NCT03068468|364170764|FG001|Placebo-Controlled Period|Adverse Event|21|||
105520796|NCT02738151|363916713|FG001|Overall Study|Randomized but not treated|1|||
105520797|NCT02738151|363916712|FG000|Overall Study|Adverse Event|4|||
105520798|NCT02738151|363916713|FG001|Overall Study|Adverse Event|5|||
105520799|NCT02738151|363916712|FG000|Overall Study|Hypoglycemia|0|||
105520800|NCT02738151|363916713|FG001|Overall Study|Hypoglycemia|1|||
105520801|NCT02738151|363916712|FG000|Overall Study|Poor Compliance to Protocol|4|||
105520802|NCT02738151|363916713|FG001|Overall Study|Poor Compliance to Protocol|3|||
105520803|NCT02738151|363916712|FG000|Overall Study|Other than specified above|11|||
105520804|NCT02738151|363916713|FG001|Overall Study|Other than specified above|21|||
105520805|NCT02921776|363916723|FG000|Overall Study|patient deterioration, fatigue|2|||
105520806|NCT02921776|363916724|FG001|Overall Study|patient deterioration, fatigue|6|||
105520807|NCT02921776|363916725|FG002|Overall Study|patient deterioration, fatigue|0|||
105520808|NCT02921776|363916726|FG003|Overall Study|patient deterioration, fatigue|0|||
105520809|NCT02921776|363916727|FG004|Overall Study|patient deterioration, fatigue|0|||
105520810|NCT02921776|363916728|FG005|Overall Study|patient deterioration, fatigue|0|||
105520811|NCT02921776|363916729|FG006|Overall Study|patient deterioration, fatigue|0|||
105520812|NCT02921776|363916730|FG007|Overall Study|patient deterioration, fatigue|0|||
105520813|NCT02921776|363916723|FG000|Overall Study|Withdrawal by Subject|0|||
105520814|NCT02921776|363916724|FG001|Overall Study|Withdrawal by Subject|2|||
105520815|NCT02921776|363916725|FG002|Overall Study|Withdrawal by Subject|0|||
105520816|NCT02921776|363916726|FG003|Overall Study|Withdrawal by Subject|1|||
105520817|NCT02921776|363916727|FG004|Overall Study|Withdrawal by Subject|1|||
105520818|NCT02921776|363916728|FG005|Overall Study|Withdrawal by Subject|0|||
105520819|NCT02921776|363916729|FG006|Overall Study|Withdrawal by Subject|8|||
105520820|NCT02921776|363916730|FG007|Overall Study|Withdrawal by Subject|1|||
105520821|NCT02921776|363916723|FG000|Overall Study|Death|0|||
105520822|NCT02921776|363916724|FG001|Overall Study|Death|0|||
105520823|NCT02921776|363916725|FG002|Overall Study|Death|0|||
105520824|NCT02921776|363916726|FG003|Overall Study|Death|2|||
105520825|NCT02921776|363916727|FG004|Overall Study|Death|0|||
105520826|NCT02921776|363916728|FG005|Overall Study|Death|0|||
105520827|NCT02921776|363916729|FG006|Overall Study|Death|0|||
105520828|NCT02921776|363916730|FG007|Overall Study|Death|0|||
105520829|NCT02921776|363916723|FG000|Overall Study|extubation or early discharge|0|||
105520830|NCT02921776|363916724|FG001|Overall Study|extubation or early discharge|0|||
105520831|NCT02921776|363916725|FG002|Overall Study|extubation or early discharge|0|||
105520832|NCT02921776|363916726|FG003|Overall Study|extubation or early discharge|5|||
105520833|NCT02921776|363916727|FG004|Overall Study|extubation or early discharge|5|||
105520834|NCT02921776|363916728|FG005|Overall Study|extubation or early discharge|0|||
105520835|NCT02921776|363916729|FG006|Overall Study|extubation or early discharge|0|||
105520836|NCT02921776|363916730|FG007|Overall Study|extubation or early discharge|0|||
105520837|NCT02921776|363916723|FG000|Overall Study|Lost to Follow-up|0|||
105520838|NCT02921776|363916724|FG001|Overall Study|Lost to Follow-up|0|||
105520839|NCT02921776|363916725|FG002|Overall Study|Lost to Follow-up|0|||
105520840|NCT02921776|363916726|FG003|Overall Study|Lost to Follow-up|0|||
105520841|NCT02921776|363916727|FG004|Overall Study|Lost to Follow-up|0|||
105520842|NCT02921776|363916728|FG005|Overall Study|Lost to Follow-up|2|||
105520843|NCT02921776|363916729|FG006|Overall Study|Lost to Follow-up|3|||
105520844|NCT02921776|363916730|FG007|Overall Study|Lost to Follow-up|6|||
105520845|NCT01581307|363916738|FG000|Overall Study|Withdrawal by Subject|1|||
105520846|NCT01894581|363916739|FG000|Overall Study|Withdrawal by Subject|2|||
105520847|NCT01894581|363916740|FG001|Overall Study|Withdrawal by Subject|3|||
105520848|NCT01894581|363916739|FG000|Overall Study|Screen Failure|3|||
105520849|NCT01894581|363916740|FG001|Overall Study|Screen Failure|4|||
105520850|NCT01252940|363916744|FG000|Main Study Phase|Randomized but not treated|4|||
105520851|NCT01252940|363916745|FG001|Main Study Phase|Randomized but not treated|2|||
105520852|NCT01252940|363916744|FG000|Main Study Phase|Adverse Event|3|||
105520853|NCT01252940|363916745|FG001|Main Study Phase|Adverse Event|1|||
105520854|NCT01252940|363916744|FG000|Main Study Phase|Lack of Efficacy|1|||
105520855|NCT01252940|363916745|FG001|Main Study Phase|Lack of Efficacy|0|||
105520856|NCT01252940|363916744|FG000|Main Study Phase|Lost to Follow-up|6|||
105520857|NCT01252940|363916745|FG001|Main Study Phase|Lost to Follow-up|1|||
105520858|NCT01252940|363916744|FG000|Main Study Phase|Physician Decision|1|||
105520859|NCT01252940|363916745|FG001|Main Study Phase|Physician Decision|0|||
105520860|NCT01252940|363916744|FG000|Main Study Phase|Protocol Violation|4|||
105520861|NCT01252940|363916745|FG001|Main Study Phase|Protocol Violation|2|||
105520862|NCT01252940|363916744|FG000|Main Study Phase|Withdrawal by Subject|6|||
105520863|NCT01252940|363916745|FG001|Main Study Phase|Withdrawal by Subject|5|||
105520864|NCT01252940|363916744|FG000|Main Study Phase|Subject Non-compliance|1|||
105520865|NCT01252940|363916745|FG001|Main Study Phase|Subject Non-compliance|1|||
105520866|NCT01252940|363916744|FG000|Extension Phase|Adverse Event|2|||
105520867|NCT01252940|363916745|FG001|Extension Phase|Adverse Event|1|||
105520868|NCT01252940|363916744|FG000|Extension Phase|Lack of Efficacy|1|||
105520869|NCT01252940|363916745|FG001|Extension Phase|Lack of Efficacy|0|||
105520870|NCT01252940|363916744|FG000|Extension Phase|Lost to Follow-up|5|||
105520871|NCT01252940|363916745|FG001|Extension Phase|Lost to Follow-up|0|||
105520872|NCT01252940|363916744|FG000|Extension Phase|Physician Decision|0|||
105520873|NCT01252940|363916745|FG001|Extension Phase|Physician Decision|1|||
105520874|NCT01252940|363916744|FG000|Extension Phase|Subject Non-compliance|1|||
105520875|NCT01252940|363916745|FG001|Extension Phase|Subject Non-compliance|0|||
105520876|NCT01252940|363916744|FG000|Extension Phase|Withdrawal by Subject|1|||
105520877|NCT01252940|363916745|FG001|Extension Phase|Withdrawal by Subject|1|||
105520878|NCT01344161|363916747|FG000|Overall Study|Lost to Follow-up|4|||
105520879|NCT01344161|363916748|FG001|Overall Study|Lost to Follow-up|1|||
105520880|NCT01344161|363916747|FG000|Overall Study|Pregnancy|0|||
105520881|NCT01344161|363916748|FG001|Overall Study|Pregnancy|1|||
105520882|NCT01344161|363916747|FG000|Overall Study|Protocol Violation|1|||
105520883|NCT01344161|363916748|FG001|Overall Study|Protocol Violation|1|||
105520884|NCT04690751|363916749|FG000|Overall Study|Protocol Violation|0|||
105520885|NCT04690751|363916750|FG001|Overall Study|Protocol Violation|1|||
105520886|NCT04690751|363916751|FG002|Overall Study|Protocol Violation|0|||
105520887|NCT04690751|363916752|FG003|Overall Study|Protocol Violation|1|||
105520888|NCT04690751|363916753|FG004|Overall Study|Protocol Violation|2|||
105520889|NCT04690751|363916754|FG005|Overall Study|Protocol Violation|0|||
105520890|NCT04690751|363916749|FG000|Overall Study|Adverse Event|0|||
105520891|NCT04690751|363916750|FG001|Overall Study|Adverse Event|0|||
105520892|NCT04690751|363916751|FG002|Overall Study|Adverse Event|1|||
105520893|NCT04690751|363916752|FG003|Overall Study|Adverse Event|0|||
105520894|NCT04690751|363916753|FG004|Overall Study|Adverse Event|0|||
105520895|NCT04690751|363916754|FG005|Overall Study|Adverse Event|0|||
105520896|NCT04690751|363916749|FG000|Overall Study|Positive urine drug screen test|0|||
105520897|NCT04690751|363916750|FG001|Overall Study|Positive urine drug screen test|0|||
105520898|NCT04690751|363916751|FG002|Overall Study|Positive urine drug screen test|0|||
105520899|NCT04690751|363916752|FG003|Overall Study|Positive urine drug screen test|0|||
105520900|NCT04690751|363916753|FG004|Overall Study|Positive urine drug screen test|1|||
105520901|NCT04690751|363916754|FG005|Overall Study|Positive urine drug screen test|0|||
105520902|NCT04364620|363916756|FG000|Overall Study|Disease Progression|20|||
105520903|NCT04364620|363916756|FG000|Overall Study|Adverse Event|5|||
105520904|NCT04364620|363916756|FG000|Overall Study|Physician Decision|4|||
105520905|NCT04364620|363916756|FG000|Overall Study|Death|3|||
105520906|NCT04364620|363916756|FG000|Overall Study|Other|2|||
105520907|NCT04364620|363916756|FG000|Overall Study|Withdrawal by Subject|1|||
105520908|NCT01881230|363918240|FG000|Overall Study|Death|2|||
105520909|NCT01881230|363918241|FG001|Overall Study|Death|0|||
105520910|NCT01881230|363918242|FG002|Overall Study|Death|1|||
105520911|NCT01881230|363918240|FG000|Overall Study|Adverse Event|9|||
105520912|NCT01881230|363918241|FG001|Overall Study|Adverse Event|13|||
105520913|NCT01881230|363918242|FG002|Overall Study|Adverse Event|12|||
105520914|NCT01881230|363918240|FG000|Overall Study|Progressive Disease|31|||
105520915|NCT01881230|363918241|FG001|Overall Study|Progressive Disease|35|||
105520916|NCT01881230|363918242|FG002|Overall Study|Progressive Disease|36|||
105520917|NCT01881230|363918240|FG000|Overall Study|Symptomatic Deterioration|3|||
105520918|NCT01881230|363918241|FG001|Overall Study|Symptomatic Deterioration|3|||
105520919|NCT01881230|363918242|FG002|Overall Study|Symptomatic Deterioration|1|||
105520920|NCT01881230|363918240|FG000|Overall Study|Withdrawal by Subject|6|||
105520921|NCT01881230|363918241|FG001|Overall Study|Withdrawal by Subject|4|||
105520922|NCT01881230|363918242|FG002|Overall Study|Withdrawal by Subject|6|||
105520923|NCT01881230|363918240|FG000|Overall Study|Physician Decision|4|||
105520924|NCT01881230|363918241|FG001|Overall Study|Physician Decision|3|||
105520925|NCT01881230|363918242|FG002|Overall Study|Physician Decision|6|||
105520926|NCT01881230|363918240|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105520927|NCT01881230|363918241|FG001|Overall Study|Non-Compliance with Study Drug|2|||
105520928|NCT01881230|363918242|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105520929|NCT01881230|363918240|FG000|Overall Study|Given Commercially Available Drug|0|||
105520930|NCT01881230|363918241|FG001|Overall Study|Given Commercially Available Drug|0|||
105520931|NCT01881230|363918242|FG002|Overall Study|Given Commercially Available Drug|2|||
105520932|NCT01881230|363918240|FG000|Overall Study|Protocol Violation|1|||
105520933|NCT01881230|363918241|FG001|Overall Study|Protocol Violation|1|||
105520934|NCT01881230|363918242|FG002|Overall Study|Protocol Violation|0|||
105520935|NCT01881230|363918240|FG000|Overall Study|Miscellaneous|3|||
105520936|NCT01881230|363918241|FG001|Overall Study|Miscellaneous|3|||
105520937|NCT01881230|363918242|FG002|Overall Study|Miscellaneous|0|||
105520938|NCT01881230|363918240|FG000|Overall Study|Untreated: Other|0|||
105520939|NCT01881230|363918241|FG001|Overall Study|Untreated: Other|0|||
105592776|NCT03068468|364170765|FG002|Placebo-Controlled Period|Adverse Event|0|||
105592777|NCT03068468|364170766|FG003|Placebo-Controlled Period|Adverse Event|0|||
105592778|NCT03068468|364170763|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
105520940|NCT01881230|363918242|FG002|Overall Study|Untreated: Other|1|||
105520941|NCT01881230|363918240|FG000|Overall Study|Untreated: Death|0|||
105520942|NCT01881230|363918241|FG001|Overall Study|Untreated: Death|0|||
105520943|NCT01881230|363918242|FG002|Overall Study|Untreated: Death|1|||
105520944|NCT01881230|363918240|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
105520945|NCT01881230|363918241|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
105520946|NCT01881230|363918242|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
105520947|NCT00914810|363918245|FG000|Overall Study|Withdrawal by Subject|1|||
105520948|NCT00914810|363918246|FG001|Overall Study|Withdrawal by Subject|0|||
105520949|NCT00914810|363918245|FG000|Overall Study|Relocated out of state|1|||
105520950|NCT00914810|363918246|FG001|Overall Study|Relocated out of state|0|||
105592779|NCT03068468|364170764|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
105520951|NCT00914810|363918245|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
105520952|NCT00914810|363918246|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
105520953|NCT02520011|363918247|FG000|Overall Study|Adverse Event|0|||
105520954|NCT02520011|363918248|FG001|Overall Study|Adverse Event|1|||
105520955|NCT02520011|363918249|FG002|Overall Study|Adverse Event|2|||
105520956|NCT02520011|363918247|FG000|Overall Study|Death|0|||
105520957|NCT02520011|363918248|FG001|Overall Study|Death|8|||
105520958|NCT02520011|363918249|FG002|Overall Study|Death|1|||
105520959|NCT02520011|363918247|FG000|Overall Study|Lack of Efficacy|4|||
105520960|NCT02520011|363918248|FG001|Overall Study|Lack of Efficacy|26|||
105520961|NCT02520011|363918249|FG002|Overall Study|Lack of Efficacy|4|||
105520962|NCT02520011|363918247|FG000|Overall Study|Physician Decision|0|||
105520963|NCT02520011|363918248|FG001|Overall Study|Physician Decision|2|||
105520964|NCT02520011|363918249|FG002|Overall Study|Physician Decision|0|||
105520965|NCT02520011|363918247|FG000|Overall Study|Withdrawal by Subject|1|||
105520966|NCT02520011|363918248|FG001|Overall Study|Withdrawal by Subject|3|||
105520967|NCT02520011|363918249|FG002|Overall Study|Withdrawal by Subject|0|||
105520968|NCT02520011|363918247|FG000|Overall Study|Protocol Deviation|0|||
105520969|NCT02520011|363918248|FG001|Overall Study|Protocol Deviation|1|||
105520970|NCT02520011|363918249|FG002|Overall Study|Protocol Deviation|0|||
105520971|NCT02520011|363918247|FG000|Overall Study|Patient went to hospice|0|||
105520972|NCT02520011|363918248|FG001|Overall Study|Patient went to hospice|1|||
105520973|NCT02520011|363918249|FG002|Overall Study|Patient went to hospice|0|||
105520974|NCT02520011|363918247|FG000|Overall Study|Progressive disease following response|0|||
105520975|NCT02520011|363918248|FG001|Overall Study|Progressive disease following response|4|||
105520976|NCT02520011|363918249|FG002|Overall Study|Progressive disease following response|2|||
105520977|NCT02632552|363918250|FG000|Overall Study|Lost to Follow-up|14|||
105520978|NCT02632552|363918251|FG001|Overall Study|Lost to Follow-up|8|||
105520979|NCT02632552|363918250|FG000|Overall Study|Withdrawal by Subject|2|||
105520980|NCT02632552|363918251|FG001|Overall Study|Withdrawal by Subject|0|||
105520981|NCT02632552|363918250|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
105520982|NCT02632552|363918251|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
105520983|NCT02063854|363918259|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
105520984|NCT02063854|363918260|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
105520985|NCT02063854|363918261|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
105520986|NCT02063854|363918262|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
105520987|NCT02063854|363918263|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
105520988|NCT02063854|363918264|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
105520989|NCT02063854|363918265|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
105520990|NCT02063854|363918259|FG000|Overall Study|Major Protocol Deviation|0|||
105520991|NCT02063854|363918260|FG001|Overall Study|Major Protocol Deviation|0|||
105520992|NCT02063854|363918261|FG002|Overall Study|Major Protocol Deviation|3|||
105520993|NCT02063854|363918262|FG003|Overall Study|Major Protocol Deviation|0|||
105520994|NCT02063854|363918263|FG004|Overall Study|Major Protocol Deviation|0|||
105520995|NCT02063854|363918264|FG005|Overall Study|Major Protocol Deviation|0|||
105520996|NCT02063854|363918265|FG006|Overall Study|Major Protocol Deviation|0|||
105520997|NCT02063854|363918259|FG000|Overall Study|Voluntary Withdrawal|2|||
105520998|NCT02063854|363918260|FG001|Overall Study|Voluntary Withdrawal|0|||
105520999|NCT02063854|363918261|FG002|Overall Study|Voluntary Withdrawal|8|||
105521000|NCT02063854|363918262|FG003|Overall Study|Voluntary Withdrawal|1|||
105521001|NCT02063854|363918263|FG004|Overall Study|Voluntary Withdrawal|3|||
105521002|NCT02063854|363918264|FG005|Overall Study|Voluntary Withdrawal|6|||
105521003|NCT02063854|363918265|FG006|Overall Study|Voluntary Withdrawal|1|||
105521004|NCT02063854|363918259|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
105521005|NCT02063854|363918260|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
105521006|NCT02063854|363918261|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
105521007|NCT02063854|363918262|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
105521008|NCT02063854|363918263|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
105521009|NCT02063854|363918264|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
105521010|NCT02063854|363918265|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
105521011|NCT02063854|363918259|FG000|Overall Study|Reason Not Specified|1|||
105521012|NCT02063854|363918260|FG001|Overall Study|Reason Not Specified|0|||
105521013|NCT02063854|363918261|FG002|Overall Study|Reason Not Specified|0|||
105521014|NCT02063854|363918262|FG003|Overall Study|Reason Not Specified|0|||
105521015|NCT02063854|363918263|FG004|Overall Study|Reason Not Specified|0|||
105521016|NCT02063854|363918264|FG005|Overall Study|Reason Not Specified|0|||
105521017|NCT02063854|363918265|FG006|Overall Study|Reason Not Specified|0|||
105521018|NCT02063854|363918259|FG000|Overall Study|Did Not Receive Study Drug|0|||
105521019|NCT02063854|363918260|FG001|Overall Study|Did Not Receive Study Drug|0|||
105521020|NCT02063854|363918261|FG002|Overall Study|Did Not Receive Study Drug|0|||
105521021|NCT02063854|363918262|FG003|Overall Study|Did Not Receive Study Drug|0|||
105521022|NCT02063854|363918263|FG004|Overall Study|Did Not Receive Study Drug|0|||
105521023|NCT02063854|363918264|FG005|Overall Study|Did Not Receive Study Drug|1|||
105521024|NCT02063854|363918265|FG006|Overall Study|Did Not Receive Study Drug|0|||
105521025|NCT01462084|363918266|FG000|Overall Study|Withdrawal by Subject|1|||
105521026|NCT01462084|363918267|FG001|Overall Study|Withdrawal by Subject|0|||
105521027|NCT01462084|363918266|FG000|Overall Study|Protocol Violation|1|||
105521028|NCT01462084|363918267|FG001|Overall Study|Protocol Violation|1|||
105521029|NCT03538158|363918268|FG000|Overall Study|Lost to Follow-up|13|||
105521030|NCT03538158|363918269|FG001|Overall Study|Lost to Follow-up|7|||
105521031|NCT03538158|363918268|FG000|Overall Study|Withdrawal by Subject|2|||
105521032|NCT03538158|363918269|FG001|Overall Study|Withdrawal by Subject|1|||
105521033|NCT05089682|363918270|FG000|Overall Study|Withdrawal by Subject|2|||
105521034|NCT00518323|363918271|FG000|Overall Study|Lack of Efficacy|14|||
105521035|NCT00518323|363918272|FG001|Overall Study|Lack of Efficacy|2|||
105521036|NCT00518323|363918273|FG002|Overall Study|Lack of Efficacy|4|||
105521037|NCT00518323|363918274|FG003|Overall Study|Lack of Efficacy|20|||
105521038|NCT00518323|363918271|FG000|Overall Study|Withdrawal by Subject|1|||
105521039|NCT00518323|363918272|FG001|Overall Study|Withdrawal by Subject|2|||
105521040|NCT00518323|363918273|FG002|Overall Study|Withdrawal by Subject|4|||
105521041|NCT00518323|363918274|FG003|Overall Study|Withdrawal by Subject|2|||
105521042|NCT00518323|363918271|FG000|Overall Study|Lost to Follow-up|0|||
105521043|NCT00518323|363918272|FG001|Overall Study|Lost to Follow-up|2|||
105521044|NCT00518323|363918273|FG002|Overall Study|Lost to Follow-up|1|||
105521045|NCT00518323|363918274|FG003|Overall Study|Lost to Follow-up|3|||
105521046|NCT00518323|363918271|FG000|Overall Study|Adverse Event|1|||
105521047|NCT00518323|363918272|FG001|Overall Study|Adverse Event|1|||
105521048|NCT00518323|363918273|FG002|Overall Study|Adverse Event|1|||
105521049|NCT00518323|363918274|FG003|Overall Study|Adverse Event|0|||
105521050|NCT00518323|363918271|FG000|Overall Study|Prohibited medication and others|3|||
105521051|NCT00518323|363918272|FG001|Overall Study|Prohibited medication and others|1|||
105521052|NCT00518323|363918273|FG002|Overall Study|Prohibited medication and others|1|||
105521053|NCT00518323|363918274|FG003|Overall Study|Prohibited medication and others|0|||
105521054|NCT02255981|363918275|FG000|Overall Study|Lost to Follow-up|3|||
105521055|NCT02255981|363918275|FG000|Overall Study|Withdrawal by Subject|1|||
105521056|NCT02580357|363918277|FG000|Overall Study|Lost to Follow-up|2|||
105521057|NCT02580357|363918278|FG001|Overall Study|Lost to Follow-up|0|||
105521058|NCT02580357|363918279|FG002|Overall Study|Lost to Follow-up|0|||
105521059|NCT02580357|363918277|FG000|Overall Study|Protocol Violation|1|||
105521060|NCT02580357|363918278|FG001|Overall Study|Protocol Violation|0|||
105521061|NCT02580357|363918279|FG002|Overall Study|Protocol Violation|0|||
105521062|NCT01679002|363918280|FG000|Overall Study|Adverse Event|1|||
105521063|NCT01679002|363918281|FG001|Overall Study|Adverse Event|1|||
105521064|NCT01679002|363918282|FG002|Overall Study|Adverse Event|0|||
105521065|NCT00613015|363918285|FG000|Overall Study|Lost to Follow-up|0|||
105521066|NCT00613015|363918286|FG001|Overall Study|Lost to Follow-up|1|||
105521067|NCT00613015|363918287|FG002|Overall Study|Lost to Follow-up|3|||
105521068|NCT00613015|363918288|FG003|Overall Study|Lost to Follow-up|3|||
105521069|NCT00613015|363918289|FG004|Overall Study|Lost to Follow-up|2|||
105521070|NCT00613015|363918290|FG005|Overall Study|Lost to Follow-up|3|||
105521071|NCT01179477|363918293|FG000|Overall Study|Death|542|||
105521072|NCT01179477|363918293|FG000|Overall Study|Unsuccessful implant|80|||
105521073|NCT01179477|363918293|FG000|Overall Study|Non-death withdrawal|438|||
105521074|NCT01179477|363918293|FG000|Overall Study|Did not complete final visit|27|||
105521075|NCT04053023|363918294|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
105521076|NCT04053023|363918295|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
105521077|NCT03341533|363918298|FG000|Overall Study|Withdrawal by Subject|1|||
105521078|NCT03341533|363918299|FG001|Overall Study|Withdrawal by Subject|1|||
105521079|NCT03341533|363918298|FG000|Overall Study|Not eligible after randomization|2|||
105521080|NCT03341533|363918299|FG001|Overall Study|Not eligible after randomization|1|||
105521081|NCT05778786|363918311|FG000|Period 1|COVID-19 Related|3|||
105521082|NCT05778786|363918312|FG001|Period 1|COVID-19 Related|3|||
105521083|NCT05778786|363918311|FG000|Period 1|Withdrew Consent during Study|1|||
105521084|NCT05778786|363918312|FG001|Period 1|Withdrew Consent during Study|0|||
105521085|NCT05778786|363918311|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
105521086|NCT05778786|363918312|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
105521087|NCT05778786|363918311|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
105521088|NCT05778786|363918312|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
105521089|NCT01848756|363918313|FG000|Overall Study|Adverse Event|1|||
105521090|NCT01848756|363918313|FG000|Overall Study|Withdrawal by Subject|1|||
105521091|NCT01848756|363918313|FG000|Overall Study|Enrolled in Error|1|||
105521092|NCT01173718|363918314|FG000|Overall Study|Death|17|||
105521093|NCT01173718|363918314|FG000|Overall Study|Abandonment of study graft|27|||
105521094|NCT02075658|363918315|FG000|Overall Study|Physician Decision|2|||
105521095|NCT02075658|363918316|FG001|Overall Study|Physician Decision|2|||
105521096|NCT01286012|363918317|FG000|Overall Study|Adverse Event|3|||
105521097|NCT01286012|363918318|FG001|Overall Study|Adverse Event|3|||
105521098|NCT01286012|363918317|FG000|Overall Study|Death|2|||
105521099|NCT01286012|363918318|FG001|Overall Study|Death|3|||
105521100|NCT01286012|363918317|FG000|Overall Study|Protocol Violation|1|||
105521101|NCT01286012|363918318|FG001|Overall Study|Protocol Violation|1|||
105521102|NCT01286012|363918317|FG000|Overall Study|Withdrawal by Subject|4|||
105521103|NCT01286012|363918318|FG001|Overall Study|Withdrawal by Subject|4|||
105521104|NCT01286012|363918317|FG000|Overall Study|Physician Decision|2|||
105521105|NCT01286012|363918318|FG001|Overall Study|Physician Decision|0|||
105521106|NCT01286012|363918317|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
105521107|NCT01286012|363918318|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
105521108|NCT01367158|363918319|FG000|Overall Study|Withdrew consent|0|||
105521109|NCT01367158|363918320|FG001|Overall Study|Withdrew consent|2|||
105521110|NCT01367158|363918321|FG002|Overall Study|Withdrew consent|1|||
105521111|NCT01367158|363918322|FG003|Overall Study|Withdrew consent|0|||
105521112|NCT01367158|363918323|FG004|Overall Study|Withdrew consent|2|||
105521113|NCT01367158|363918324|FG005|Overall Study|Withdrew consent|0|||
105521114|NCT01367158|363918325|FG006|Overall Study|Withdrew consent|0|||
105521115|NCT01367158|363918326|FG007|Overall Study|Withdrew consent|1|||
105521116|NCT01367158|363918327|FG008|Overall Study|Withdrew consent|0|||
105521117|NCT01367158|363918328|FG009|Overall Study|Withdrew consent|0|||
105521118|NCT01367158|363918329|FG010|Overall Study|Withdrew consent|0|||
105521119|NCT01367158|363918319|FG000|Overall Study|Lost to Follow-up|0|||
105521120|NCT01367158|363918320|FG001|Overall Study|Lost to Follow-up|0|||
105521121|NCT01367158|363918321|FG002|Overall Study|Lost to Follow-up|0|||
105521122|NCT01367158|363918322|FG003|Overall Study|Lost to Follow-up|1|||
105521123|NCT01367158|363918323|FG004|Overall Study|Lost to Follow-up|0|||
105521124|NCT01367158|363918324|FG005|Overall Study|Lost to Follow-up|2|||
105521125|NCT01367158|363918325|FG006|Overall Study|Lost to Follow-up|0|||
105521126|NCT01367158|363918326|FG007|Overall Study|Lost to Follow-up|1|||
105521127|NCT01367158|363918327|FG008|Overall Study|Lost to Follow-up|0|||
105521128|NCT01367158|363918328|FG009|Overall Study|Lost to Follow-up|0|||
105521129|NCT01367158|363918329|FG010|Overall Study|Lost to Follow-up|1|||
105521130|NCT01367158|363918319|FG000|Overall Study|Protocol Violation|0|||
105521131|NCT01367158|363918320|FG001|Overall Study|Protocol Violation|1|||
105521132|NCT01367158|363918321|FG002|Overall Study|Protocol Violation|0|||
105521133|NCT01367158|363918322|FG003|Overall Study|Protocol Violation|0|||
105521134|NCT01367158|363918323|FG004|Overall Study|Protocol Violation|0|||
105521135|NCT01367158|363918324|FG005|Overall Study|Protocol Violation|0|||
105521136|NCT01367158|363918325|FG006|Overall Study|Protocol Violation|0|||
105521137|NCT01367158|363918326|FG007|Overall Study|Protocol Violation|0|||
105521138|NCT01367158|363918327|FG008|Overall Study|Protocol Violation|0|||
105521139|NCT01367158|363918328|FG009|Overall Study|Protocol Violation|0|||
105521140|NCT01367158|363918329|FG010|Overall Study|Protocol Violation|0|||
105521141|NCT02113956|363918332|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
105521142|NCT02113956|363918333|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
105521143|NCT02113956|363918332|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
105521144|NCT02113956|363918333|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
105521145|NCT02113956|363918332|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
105521146|NCT02113956|363918333|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
105521147|NCT01498458|363918334|FG000|Overall Study|Adverse Event|4|||
105521148|NCT01498458|363918334|FG000|Overall Study|Physician Decision|3|||
105521149|NCT02406651|363918335|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
105521150|NCT02226003|363918337|FG000|Overall Study|Lost to Follow-up|2|||
105521151|NCT02226003|363918338|FG001|Overall Study|Lost to Follow-up|1|||
105521152|NCT02226003|363918339|FG002|Overall Study|Lost to Follow-up|3|||
105521153|NCT02226003|363918337|FG000|Overall Study|Withdrawal by Subject|0|||
105521154|NCT02226003|363918338|FG001|Overall Study|Withdrawal by Subject|0|||
105521155|NCT02226003|363918339|FG002|Overall Study|Withdrawal by Subject|3|||
105521156|NCT02446990|363918349|FG000|Overall Study|Death|485|||
105521157|NCT02446990|363918350|FG001|Overall Study|Death|458|||
105521158|NCT02446990|363918349|FG000|Overall Study|Lost to Follow-up|3|||
105521159|NCT02446990|363918350|FG001|Overall Study|Lost to Follow-up|1|||
105521160|NCT02446990|363918349|FG000|Overall Study|Physician Decision|1|||
105521161|NCT02446990|363918350|FG001|Overall Study|Physician Decision|0|||
105521162|NCT02446990|363918349|FG000|Overall Study|Withdrawal by Subject|231|||
105521163|NCT02446990|363918350|FG001|Overall Study|Withdrawal by Subject|199|||
105521164|NCT01064401|363918354|FG000|Overall Study|Adverse Event|47|||
105521165|NCT01064401|363918355|FG001|Overall Study|Adverse Event|56|||
105521166|NCT01064401|363918354|FG000|Overall Study|Lack of Efficacy|46|||
105521167|NCT01064401|363918355|FG001|Overall Study|Lack of Efficacy|23|||
105521168|NCT01064401|363918354|FG000|Overall Study|Lost to Follow-up|12|||
105521169|NCT01064401|363918355|FG001|Overall Study|Lost to Follow-up|9|||
105521170|NCT01064401|363918354|FG000|Overall Study|Consent Withdrawn|98|||
105521171|NCT01064401|363918355|FG001|Overall Study|Consent Withdrawn|80|||
105521172|NCT01064401|363918354|FG000|Overall Study|Investigator Decision|4|||
105521173|NCT01064401|363918355|FG001|Overall Study|Investigator Decision|6|||
105521174|NCT01064401|363918354|FG000|Overall Study|Death|4|||
105521175|NCT01064401|363918355|FG001|Overall Study|Death|0|||
105521176|NCT01064401|363918354|FG000|Overall Study|Pregnancy|4|||
105521177|NCT01064401|363918355|FG001|Overall Study|Pregnancy|7|||
105521178|NCT01064401|363918354|FG000|Overall Study|Noncompliance|7|||
105521179|NCT01064401|363918355|FG001|Overall Study|Noncompliance|8|||
105521180|NCT01064401|363918354|FG000|Overall Study|Site Closure|4|||
105521181|NCT01064401|363918355|FG001|Overall Study|Site Closure|5|||
105521182|NCT01064401|363918354|FG000|Overall Study|Other|2|||
105521183|NCT01064401|363918355|FG001|Overall Study|Other|1|||
105521184|NCT03158051|363918356|FG000|Overall Study|Lost to Follow-up|41|||
105521185|NCT03158051|363918357|FG001|Overall Study|Lost to Follow-up|47|||
105521186|NCT03158051|363918356|FG000|Overall Study|Physician Decision|6|||
105521187|NCT03158051|363918357|FG001|Overall Study|Physician Decision|7|||
105521188|NCT03158051|363918356|FG000|Overall Study|Withdrawal by Subject|24|||
105521189|NCT03158051|363918357|FG001|Overall Study|Withdrawal by Subject|15|||
105521190|NCT03158051|363918356|FG000|Overall Study|Death|0|||
105521191|NCT03158051|363918357|FG001|Overall Study|Death|1|||
105521192|NCT00323115|363918358|FG000|Vaccine Administration|Adverse Event|1|||
105521193|NCT00323115|363918358|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
105521194|NCT02005250|363918361|FG000|Overall Study|Lost to Follow-up|15|||
105521195|NCT02005250|363918362|FG001|Overall Study|Lost to Follow-up|5|||
105521196|NCT02588833|363918364|FG000|Part 1|Withdrawal by Subject|1|||
105521197|NCT02588833|363918365|FG001|Part 1|Withdrawal by Subject|0|||
105521198|NCT02588833|363918364|FG000|Part 2A|Physician Decision|0|||
105521199|NCT02588833|363918365|FG001|Part 2A|Physician Decision|1|||
105521200|NCT02588833|363918364|FG000|Part 2A|Withdrawal by Subject|0|||
105521201|NCT02588833|363918365|FG001|Part 2A|Withdrawal by Subject|1|||
105521202|NCT02588833|363918364|FG000|Part 2B|Adverse Event|0|||
105521203|NCT02588833|363918365|FG001|Part 2B|Adverse Event|1|||
105521204|NCT02588833|363918364|FG000|Part 2C|Adverse Event|0|||
105521205|NCT02588833|363918365|FG001|Part 2C|Adverse Event|1|||
105521206|NCT02588833|363918364|FG000|Part 2C|Withdrawal by Subject|0|||
105521207|NCT02588833|363918365|FG001|Part 2C|Withdrawal by Subject|1|||
105521208|NCT02588833|363918364|FG000|Part 3 (Safety Follow-up)|Other|0|||
105521209|NCT02588833|363918365|FG001|Part 3 (Safety Follow-up)|Other|2|||
105521210|NCT03649711|363918366|FG000|Overall Study|Adverse Event|0|||
105521211|NCT03649711|363918367|FG001|Overall Study|Adverse Event|1|||
105521212|NCT03649711|363918368|FG002|Overall Study|Adverse Event|0|||
105521213|NCT03649711|363918366|FG000|Overall Study|Kidney Transplant|1|||
105521214|NCT03649711|363918367|FG001|Overall Study|Kidney Transplant|0|||
105521215|NCT03649711|363918368|FG002|Overall Study|Kidney Transplant|0|||
105521216|NCT04007094|363918369|FG000|Overall Study|Lost to Follow-up|1|||
105521217|NCT04007094|363918370|FG001|Overall Study|Lost to Follow-up|1|||
105521218|NCT02946047|363918375|FG000|Overall Study|Adverse Event|1|||
105521219|NCT02946047|363918376|FG001|Overall Study|Adverse Event|0|||
105521220|NCT02946047|363918377|FG002|Overall Study|Adverse Event|0|||
105521221|NCT02946047|363918378|FG003|Overall Study|Adverse Event|0|||
105521222|NCT04350788|363918379|FG000|Overall Study|Lost to Follow-up|6|||
105521223|NCT04350788|363918380|FG001|Overall Study|Lost to Follow-up|2|||
105521224|NCT04350788|363918379|FG000|Overall Study|Withdrawal by Subject|2|||
105521225|NCT04350788|363918380|FG001|Overall Study|Withdrawal by Subject|4|||
105521226|NCT04350788|363918379|FG000|Overall Study|Protocol Violation|4|||
105521227|NCT04350788|363918380|FG001|Overall Study|Protocol Violation|0|||
105521228|NCT03615105|363918381|FG000|Overall Study|Protocol Violation|1|||
105521229|NCT03615105|363918382|FG001|Overall Study|Protocol Violation|0|||
105521230|NCT03615105|363918383|FG002|Overall Study|Protocol Violation|0|||
105521231|NCT03615105|363918381|FG000|Overall Study|Death|0|||
105521232|NCT03615105|363918382|FG001|Overall Study|Death|2|||
105521233|NCT03615105|363918383|FG002|Overall Study|Death|0|||
105521234|NCT00378209|363918389|FG000|Overall Study|Progressive disease|11|||
105521235|NCT00378209|363918389|FG000|Overall Study|Adverse Event|3|||
105521236|NCT00378209|363918389|FG000|Overall Study|Initiation of non-protocol therapy|3|||
105521237|NCT00378209|363918389|FG000|Overall Study|Physician Decision|3|||
105521238|NCT00378209|363918389|FG000|Overall Study|Death|1|||
105521239|NCT00378209|363918389|FG000|Overall Study|Treatment delay|1|||
105521240|NCT03313804|363918390|FG000|Treatment|Death|5|||
105521241|NCT03313804|363918390|FG000|Treatment|still on treatment|2|||
105521242|NCT03313804|363918390|FG000|Follow Up|still on follow up|3|||
105521243|NCT01502423|363918391|FG000|Overall Study|Withdrawal by Subject|0|||
105521244|NCT01502423|363918392|FG001|Overall Study|Withdrawal by Subject|1|||
105521245|NCT00415909|363920375|FG000|Overall Study|Withdrawal by Subject|2|||
105521246|NCT00415909|363920375|FG000|Overall Study|Death|1|||
105521247|NCT00312494|363920376|FG000|Overall Study|Randomized; not treated with study drug|9|||
105521248|NCT00312494|363920377|FG001|Overall Study|Randomized; not treated with study drug|10|||
105521249|NCT00312494|363920378|FG002|Overall Study|Randomized; not treated with study drug|5|||
105521250|NCT00312494|363920376|FG000|Overall Study|Adverse Event|33|||
105521251|NCT00312494|363920377|FG001|Overall Study|Adverse Event|15|||
105521252|NCT00312494|363920378|FG002|Overall Study|Adverse Event|11|||
105521253|NCT00312494|363920376|FG000|Overall Study|Lack of Efficacy|4|||
105521254|NCT00312494|363920377|FG001|Overall Study|Lack of Efficacy|6|||
105521255|NCT00312494|363920378|FG002|Overall Study|Lack of Efficacy|8|||
105521256|NCT00312494|363920376|FG000|Overall Study|Laboratory abnormality|1|||
105521257|NCT00312494|363920377|FG001|Overall Study|Laboratory abnormality|0|||
105521258|NCT00312494|363920378|FG002|Overall Study|Laboratory abnormality|0|||
105521259|NCT00312494|363920376|FG000|Overall Study|Lost to Follow-up|8|||
105521260|NCT00312494|363920377|FG001|Overall Study|Lost to Follow-up|8|||
105521261|NCT00312494|363920378|FG002|Overall Study|Lost to Follow-up|8|||
105521262|NCT00312494|363920376|FG000|Overall Study|Withdrawal by Subject|6|||
105521263|NCT00312494|363920377|FG001|Overall Study|Withdrawal by Subject|9|||
105521264|NCT00312494|363920378|FG002|Overall Study|Withdrawal by Subject|10|||
105521265|NCT00312494|363920376|FG000|Overall Study|Other|10|||
105521266|NCT00312494|363920377|FG001|Overall Study|Other|10|||
105521267|NCT00312494|363920378|FG002|Overall Study|Other|1|||
105521268|NCT00702403|363920379|FG000|From Consent to Engraftment|Progressive leukemia|6|||
105521269|NCT00702403|363920379|FG000|From Consent to Engraftment|Critically ill|2|||
105521270|NCT00702403|363920379|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
105521271|NCT00702403|363920379|FG000|From Consent to Engraftment|Myocardial infarction|1|||
105521272|NCT00702403|363920379|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
105521273|NCT00702403|363920379|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
105521274|NCT00702403|363920379|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
105521275|NCT00702403|363920379|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
105521276|NCT00702403|363920379|FG000|From Engraftment to Study Completion|Non-compliance|2|||
105521277|NCT00702403|363920379|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
105521278|NCT00702403|363920379|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
105521279|NCT00702403|363920379|FG000|From Engraftment to Study Completion|Suicide|1|||
105521280|NCT00702403|363920379|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
105521281|NCT00702403|363920379|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
105521282|NCT00702403|363920379|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
105521283|NCT00858442|363920380|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
105521284|NCT00858442|363920381|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
105521285|NCT02016625|363920384|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
105521286|NCT02016625|363920385|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
105521287|NCT02016625|363920384|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
105521288|NCT02016625|363920385|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
105521289|NCT02016625|363920384|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
105521290|NCT02016625|363920385|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
105521291|NCT01729754|363920386|FG000|Part 1|Adverse Event|2|||
105521292|NCT01729754|363920387|FG001|Part 1|Adverse Event|0|||
105521293|NCT01729754|363920388|FG002|Part 1|Adverse Event|0|||
105521294|NCT01729754|363920389|FG003|Part 1|Adverse Event|1|||
105521295|NCT01729754|363920390|FG004|Part 1|Adverse Event|0|||
105521296|NCT01729754|363920391|FG005|Part 1|Adverse Event|0|||
105521297|NCT01729754|363920392|FG006|Part 1|Adverse Event|2|||
105521298|NCT01729754|363920393|FG007|Part 1|Adverse Event|0|||
105521299|NCT01729754|363920394|FG008|Part 1|Adverse Event|0|||
105521300|NCT01729754|363920395|FG009|Part 1|Adverse Event|5|||
105521301|NCT01729754|363920386|FG000|Part 1|Lack of Efficacy|1|||
105521302|NCT01729754|363920387|FG001|Part 1|Lack of Efficacy|0|||
105521303|NCT01729754|363920388|FG002|Part 1|Lack of Efficacy|0|||
105521304|NCT01729754|363920389|FG003|Part 1|Lack of Efficacy|0|||
105521305|NCT01729754|363920390|FG004|Part 1|Lack of Efficacy|0|||
105521306|NCT01729754|363920391|FG005|Part 1|Lack of Efficacy|0|||
105521307|NCT01729754|363920392|FG006|Part 1|Lack of Efficacy|2|||
105521308|NCT01729754|363920393|FG007|Part 1|Lack of Efficacy|0|||
105521309|NCT01729754|363920394|FG008|Part 1|Lack of Efficacy|0|||
105521310|NCT01729754|363920395|FG009|Part 1|Lack of Efficacy|0|||
105521311|NCT01729754|363920386|FG000|Part 1|Lost to Follow-up|1|||
105521312|NCT01729754|363920387|FG001|Part 1|Lost to Follow-up|0|||
105521313|NCT01729754|363920388|FG002|Part 1|Lost to Follow-up|0|||
105521314|NCT01729754|363920389|FG003|Part 1|Lost to Follow-up|2|||
105521315|NCT01729754|363920390|FG004|Part 1|Lost to Follow-up|0|||
105521316|NCT01729754|363920391|FG005|Part 1|Lost to Follow-up|0|||
105521317|NCT01729754|363920392|FG006|Part 1|Lost to Follow-up|3|||
105521318|NCT01729754|363920393|FG007|Part 1|Lost to Follow-up|0|||
105521319|NCT01729754|363920394|FG008|Part 1|Lost to Follow-up|0|||
105521320|NCT01729754|363920395|FG009|Part 1|Lost to Follow-up|3|||
105521321|NCT01729754|363920386|FG000|Part 1|Non-compliance with Study Drug|1|||
105521322|NCT01729754|363920387|FG001|Part 1|Non-compliance with Study Drug|0|||
105521323|NCT01729754|363920388|FG002|Part 1|Non-compliance with Study Drug|0|||
105521324|NCT01729754|363920389|FG003|Part 1|Non-compliance with Study Drug|0|||
105521325|NCT01729754|363920390|FG004|Part 1|Non-compliance with Study Drug|0|||
105521326|NCT01729754|363920391|FG005|Part 1|Non-compliance with Study Drug|0|||
105521327|NCT01729754|363920392|FG006|Part 1|Non-compliance with Study Drug|0|||
105521328|NCT01729754|363920393|FG007|Part 1|Non-compliance with Study Drug|0|||
105521329|NCT01729754|363920394|FG008|Part 1|Non-compliance with Study Drug|0|||
105521330|NCT01729754|363920395|FG009|Part 1|Non-compliance with Study Drug|0|||
105521331|NCT01729754|363920386|FG000|Part 1|Physician Decision|0|||
105521332|NCT01729754|363920387|FG001|Part 1|Physician Decision|0|||
105521333|NCT01729754|363920388|FG002|Part 1|Physician Decision|0|||
105521334|NCT01729754|363920389|FG003|Part 1|Physician Decision|0|||
105521335|NCT01729754|363920390|FG004|Part 1|Physician Decision|0|||
105521336|NCT01729754|363920391|FG005|Part 1|Physician Decision|0|||
105521337|NCT01729754|363920392|FG006|Part 1|Physician Decision|0|||
105521338|NCT01729754|363920393|FG007|Part 1|Physician Decision|0|||
105521339|NCT01729754|363920394|FG008|Part 1|Physician Decision|0|||
105521340|NCT01729754|363920395|FG009|Part 1|Physician Decision|4|||
105521341|NCT01729754|363920386|FG000|Part 1|Pregnancy|0|||
105521342|NCT01729754|363920387|FG001|Part 1|Pregnancy|0|||
105521343|NCT01729754|363920388|FG002|Part 1|Pregnancy|0|||
105521344|NCT01729754|363920389|FG003|Part 1|Pregnancy|1|||
105521345|NCT01729754|363920390|FG004|Part 1|Pregnancy|0|||
105521346|NCT01729754|363920391|FG005|Part 1|Pregnancy|0|||
105521347|NCT01729754|363920392|FG006|Part 1|Pregnancy|0|||
105521348|NCT01729754|363920393|FG007|Part 1|Pregnancy|0|||
105521349|NCT01729754|363920394|FG008|Part 1|Pregnancy|0|||
105521350|NCT01729754|363920395|FG009|Part 1|Pregnancy|1|||
105521351|NCT01729754|363920386|FG000|Part 1|Progressive Disease|0|||
105521352|NCT01729754|363920387|FG001|Part 1|Progressive Disease|0|||
105521353|NCT01729754|363920388|FG002|Part 1|Progressive Disease|0|||
105521354|NCT01729754|363920389|FG003|Part 1|Progressive Disease|0|||
105521355|NCT01729754|363920390|FG004|Part 1|Progressive Disease|0|||
105521356|NCT01729754|363920391|FG005|Part 1|Progressive Disease|0|||
105521357|NCT01729754|363920392|FG006|Part 1|Progressive Disease|0|||
105521358|NCT01729754|363920393|FG007|Part 1|Progressive Disease|0|||
105521359|NCT01729754|363920394|FG008|Part 1|Progressive Disease|0|||
105521360|NCT01729754|363920395|FG009|Part 1|Progressive Disease|1|||
105521361|NCT01729754|363920386|FG000|Part 1|Protocol Violation|2|||
105521362|NCT01729754|363920387|FG001|Part 1|Protocol Violation|0|||
105521363|NCT01729754|363920388|FG002|Part 1|Protocol Violation|0|||
105521364|NCT01729754|363920389|FG003|Part 1|Protocol Violation|1|||
105521365|NCT01729754|363920390|FG004|Part 1|Protocol Violation|0|||
105521366|NCT01729754|363920391|FG005|Part 1|Protocol Violation|0|||
105521367|NCT01729754|363920392|FG006|Part 1|Protocol Violation|1|||
105521368|NCT01729754|363920393|FG007|Part 1|Protocol Violation|0|||
105521369|NCT01729754|363920394|FG008|Part 1|Protocol Violation|0|||
105521370|NCT01729754|363920395|FG009|Part 1|Protocol Violation|0|||
105521371|NCT01729754|363920386|FG000|Part 1|Withdrawal by Subject|5|||
105521372|NCT01729754|363920387|FG001|Part 1|Withdrawal by Subject|0|||
105521373|NCT01729754|363920388|FG002|Part 1|Withdrawal by Subject|0|||
105521374|NCT01729754|363920389|FG003|Part 1|Withdrawal by Subject|7|||
105521375|NCT01729754|363920390|FG004|Part 1|Withdrawal by Subject|0|||
105521376|NCT01729754|363920391|FG005|Part 1|Withdrawal by Subject|0|||
105521377|NCT01729754|363920392|FG006|Part 1|Withdrawal by Subject|5|||
105521378|NCT01729754|363920393|FG007|Part 1|Withdrawal by Subject|0|||
105521379|NCT01729754|363920394|FG008|Part 1|Withdrawal by Subject|0|||
105521380|NCT01729754|363920395|FG009|Part 1|Withdrawal by Subject|6|||
105521381|NCT01729754|363920386|FG000|Part 1|Other Protocol Specified Criteria|2|||
105521382|NCT01729754|363920387|FG001|Part 1|Other Protocol Specified Criteria|0|||
105521383|NCT01729754|363920388|FG002|Part 1|Other Protocol Specified Criteria|0|||
105521384|NCT01729754|363920389|FG003|Part 1|Other Protocol Specified Criteria|0|||
105521385|NCT01729754|363920390|FG004|Part 1|Other Protocol Specified Criteria|0|||
105521386|NCT01729754|363920391|FG005|Part 1|Other Protocol Specified Criteria|0|||
105521387|NCT01729754|363920392|FG006|Part 1|Other Protocol Specified Criteria|1|||
105521388|NCT01729754|363920393|FG007|Part 1|Other Protocol Specified Criteria|0|||
105521389|NCT01729754|363920394|FG008|Part 1|Other Protocol Specified Criteria|0|||
105521390|NCT01729754|363920395|FG009|Part 1|Other Protocol Specified Criteria|4|||
105521391|NCT01729754|363920386|FG000|Part 2|Adverse Event|2|||
105521392|NCT01729754|363920387|FG001|Part 2|Adverse Event|0|||
105521393|NCT01729754|363920388|FG002|Part 2|Adverse Event|0|||
105521394|NCT01729754|363920389|FG003|Part 2|Adverse Event|0|||
105592780|NCT03068468|364170765|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
105592781|NCT03068468|364170766|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
105521395|NCT01729754|363920390|FG004|Part 2|Adverse Event|0|||
105521396|NCT01729754|363920391|FG005|Part 2|Adverse Event|0|||
105521397|NCT01729754|363920392|FG006|Part 2|Adverse Event|0|||
105521398|NCT01729754|363920393|FG007|Part 2|Adverse Event|0|||
105521399|NCT01729754|363920394|FG008|Part 2|Adverse Event|1|||
105521400|NCT01729754|363920395|FG009|Part 2|Adverse Event|2|||
105521401|NCT01729754|363920386|FG000|Part 2|Lack of Efficacy|0|||
105592782|NCT03068468|364170763|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
105521402|NCT01729754|363920387|FG001|Part 2|Lack of Efficacy|0|||
105521403|NCT01729754|363920388|FG002|Part 2|Lack of Efficacy|0|||
105592783|NCT03068468|364170764|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
105521404|NCT01729754|363920389|FG003|Part 2|Lack of Efficacy|0|||
105521405|NCT01729754|363920390|FG004|Part 2|Lack of Efficacy|0|||
105521406|NCT01729754|363920391|FG005|Part 2|Lack of Efficacy|0|||
105521407|NCT01729754|363920392|FG006|Part 2|Lack of Efficacy|0|||
105521408|NCT01729754|363920393|FG007|Part 2|Lack of Efficacy|0|||
105521409|NCT01729754|363920394|FG008|Part 2|Lack of Efficacy|2|||
105521410|NCT01729754|363920395|FG009|Part 2|Lack of Efficacy|2|||
105521411|NCT01729754|363920386|FG000|Part 2|Lost to Follow-up|0|||
105521412|NCT01729754|363920387|FG001|Part 2|Lost to Follow-up|0|||
105521413|NCT01729754|363920388|FG002|Part 2|Lost to Follow-up|0|||
105521414|NCT01729754|363920389|FG003|Part 2|Lost to Follow-up|2|||
105521415|NCT01729754|363920390|FG004|Part 2|Lost to Follow-up|0|||
105521416|NCT01729754|363920391|FG005|Part 2|Lost to Follow-up|0|||
105521417|NCT01729754|363920392|FG006|Part 2|Lost to Follow-up|0|||
105521418|NCT01729754|363920393|FG007|Part 2|Lost to Follow-up|1|||
105521419|NCT01729754|363920394|FG008|Part 2|Lost to Follow-up|0|||
105521420|NCT01729754|363920395|FG009|Part 2|Lost to Follow-up|2|||
105521421|NCT01729754|363920386|FG000|Part 2|Non-Compliance with Study Drug|0|||
105521422|NCT01729754|363920387|FG001|Part 2|Non-Compliance with Study Drug|0|||
105521423|NCT01729754|363920388|FG002|Part 2|Non-Compliance with Study Drug|0|||
105521424|NCT01729754|363920389|FG003|Part 2|Non-Compliance with Study Drug|0|||
105521425|NCT01729754|363920390|FG004|Part 2|Non-Compliance with Study Drug|0|||
105521426|NCT01729754|363920391|FG005|Part 2|Non-Compliance with Study Drug|0|||
105521427|NCT01729754|363920392|FG006|Part 2|Non-Compliance with Study Drug|0|||
105521428|NCT01729754|363920393|FG007|Part 2|Non-Compliance with Study Drug|0|||
105521429|NCT01729754|363920394|FG008|Part 2|Non-Compliance with Study Drug|0|||
105521430|NCT01729754|363920395|FG009|Part 2|Non-Compliance with Study Drug|1|||
105521431|NCT01729754|363920386|FG000|Part 2|Pregnancy|0|||
105521432|NCT01729754|363920387|FG001|Part 2|Pregnancy|0|||
105521433|NCT01729754|363920388|FG002|Part 2|Pregnancy|0|||
105521434|NCT01729754|363920389|FG003|Part 2|Pregnancy|1|||
105521435|NCT01729754|363920390|FG004|Part 2|Pregnancy|0|||
105521436|NCT01729754|363920391|FG005|Part 2|Pregnancy|0|||
105521437|NCT01729754|363920392|FG006|Part 2|Pregnancy|0|||
105521438|NCT01729754|363920393|FG007|Part 2|Pregnancy|0|||
105521439|NCT01729754|363920394|FG008|Part 2|Pregnancy|0|||
105521440|NCT01729754|363920395|FG009|Part 2|Pregnancy|1|||
105521441|NCT01729754|363920386|FG000|Part 2|Withdrawal by Subject|3|||
105521442|NCT01729754|363920387|FG001|Part 2|Withdrawal by Subject|0|||
105521443|NCT01729754|363920388|FG002|Part 2|Withdrawal by Subject|0|||
105521444|NCT01729754|363920389|FG003|Part 2|Withdrawal by Subject|2|||
105521445|NCT01729754|363920390|FG004|Part 2|Withdrawal by Subject|0|||
105521446|NCT01729754|363920391|FG005|Part 2|Withdrawal by Subject|0|||
105521447|NCT01729754|363920392|FG006|Part 2|Withdrawal by Subject|0|||
105521448|NCT01729754|363920393|FG007|Part 2|Withdrawal by Subject|1|||
105521449|NCT01729754|363920394|FG008|Part 2|Withdrawal by Subject|1|||
105521450|NCT01729754|363920395|FG009|Part 2|Withdrawal by Subject|4|||
105521451|NCT01729754|363920386|FG000|Part 2|Other Protocol Specified Criteria|1|||
105521452|NCT01729754|363920387|FG001|Part 2|Other Protocol Specified Criteria|0|||
105521453|NCT01729754|363920388|FG002|Part 2|Other Protocol Specified Criteria|0|||
105521454|NCT01729754|363920389|FG003|Part 2|Other Protocol Specified Criteria|0|||
105521455|NCT01729754|363920390|FG004|Part 2|Other Protocol Specified Criteria|0|||
105521456|NCT01729754|363920391|FG005|Part 2|Other Protocol Specified Criteria|0|||
105521457|NCT01729754|363920392|FG006|Part 2|Other Protocol Specified Criteria|0|||
105521458|NCT01729754|363920393|FG007|Part 2|Other Protocol Specified Criteria|1|||
105521459|NCT01729754|363920394|FG008|Part 2|Other Protocol Specified Criteria|0|||
105521460|NCT01729754|363920395|FG009|Part 2|Other Protocol Specified Criteria|0|||
105521461|NCT01729754|363920386|FG000|Part 3|Adverse Event|0|||
105521462|NCT01729754|363920387|FG001|Part 3|Adverse Event|0|||
105521463|NCT01729754|363920388|FG002|Part 3|Adverse Event|1|||
105521464|NCT01729754|363920389|FG003|Part 3|Adverse Event|0|||
105521465|NCT01729754|363920390|FG004|Part 3|Adverse Event|0|||
105521466|NCT01729754|363920391|FG005|Part 3|Adverse Event|5|||
105521467|NCT01729754|363920392|FG006|Part 3|Adverse Event|0|||
105521468|NCT01729754|363920393|FG007|Part 3|Adverse Event|0|||
105521469|NCT01729754|363920394|FG008|Part 3|Adverse Event|0|||
105521470|NCT01729754|363920395|FG009|Part 3|Adverse Event|3|||
105521471|NCT01729754|363920386|FG000|Part 3|Death|0|||
105521472|NCT01729754|363920387|FG001|Part 3|Death|0|||
105521473|NCT01729754|363920388|FG002|Part 3|Death|0|||
105521474|NCT01729754|363920389|FG003|Part 3|Death|0|||
105521475|NCT01729754|363920390|FG004|Part 3|Death|0|||
105521476|NCT01729754|363920391|FG005|Part 3|Death|2|||
105521477|NCT01729754|363920392|FG006|Part 3|Death|0|||
105521478|NCT01729754|363920393|FG007|Part 3|Death|0|||
105521479|NCT01729754|363920394|FG008|Part 3|Death|0|||
105521480|NCT01729754|363920395|FG009|Part 3|Death|0|||
105521481|NCT01729754|363920386|FG000|Part 3|Lack of Efficacy|0|||
105521482|NCT01729754|363920387|FG001|Part 3|Lack of Efficacy|0|||
105521483|NCT01729754|363920388|FG002|Part 3|Lack of Efficacy|0|||
105521484|NCT01729754|363920389|FG003|Part 3|Lack of Efficacy|0|||
105521485|NCT01729754|363920390|FG004|Part 3|Lack of Efficacy|2|||
105521486|NCT01729754|363920391|FG005|Part 3|Lack of Efficacy|0|||
105521487|NCT01729754|363920392|FG006|Part 3|Lack of Efficacy|0|||
105521488|NCT01729754|363920393|FG007|Part 3|Lack of Efficacy|0|||
105521489|NCT01729754|363920394|FG008|Part 3|Lack of Efficacy|0|||
105521490|NCT01729754|363920395|FG009|Part 3|Lack of Efficacy|4|||
105521491|NCT01729754|363920386|FG000|Part 3|Lost to Follow-up|0|||
105521492|NCT01729754|363920387|FG001|Part 3|Lost to Follow-up|1|||
105521493|NCT01729754|363920388|FG002|Part 3|Lost to Follow-up|2|||
105521494|NCT01729754|363920389|FG003|Part 3|Lost to Follow-up|0|||
105521495|NCT01729754|363920390|FG004|Part 3|Lost to Follow-up|0|||
105521496|NCT01729754|363920391|FG005|Part 3|Lost to Follow-up|3|||
105521497|NCT01729754|363920392|FG006|Part 3|Lost to Follow-up|0|||
105521498|NCT01729754|363920393|FG007|Part 3|Lost to Follow-up|0|||
105521499|NCT01729754|363920394|FG008|Part 3|Lost to Follow-up|1|||
105521500|NCT01729754|363920395|FG009|Part 3|Lost to Follow-up|0|||
105521501|NCT01729754|363920386|FG000|Part 3|Physician Decision|0|||
105521502|NCT01729754|363920387|FG001|Part 3|Physician Decision|0|||
105521503|NCT01729754|363920388|FG002|Part 3|Physician Decision|1|||
105521504|NCT01729754|363920389|FG003|Part 3|Physician Decision|0|||
105521505|NCT01729754|363920390|FG004|Part 3|Physician Decision|0|||
105521506|NCT01729754|363920391|FG005|Part 3|Physician Decision|0|||
105521507|NCT01729754|363920392|FG006|Part 3|Physician Decision|0|||
105521508|NCT01729754|363920393|FG007|Part 3|Physician Decision|0|||
105521509|NCT01729754|363920394|FG008|Part 3|Physician Decision|0|||
105521510|NCT01729754|363920395|FG009|Part 3|Physician Decision|0|||
105521511|NCT01729754|363920386|FG000|Part 3|Withdrawal by Subject|0|||
105521512|NCT01729754|363920387|FG001|Part 3|Withdrawal by Subject|4|||
105521513|NCT01729754|363920388|FG002|Part 3|Withdrawal by Subject|1|||
105521514|NCT01729754|363920389|FG003|Part 3|Withdrawal by Subject|0|||
105521515|NCT01729754|363920390|FG004|Part 3|Withdrawal by Subject|2|||
105521516|NCT01729754|363920391|FG005|Part 3|Withdrawal by Subject|1|||
105521517|NCT01729754|363920392|FG006|Part 3|Withdrawal by Subject|0|||
105521518|NCT01729754|363920393|FG007|Part 3|Withdrawal by Subject|2|||
105521519|NCT01729754|363920394|FG008|Part 3|Withdrawal by Subject|0|||
105521520|NCT01729754|363920395|FG009|Part 3|Withdrawal by Subject|0|||
105521521|NCT01729754|363920386|FG000|Part 3|Other Protocol Specified Criteria|0|||
105521522|NCT01729754|363920387|FG001|Part 3|Other Protocol Specified Criteria|0|||
105521523|NCT01729754|363920388|FG002|Part 3|Other Protocol Specified Criteria|0|||
105521524|NCT01729754|363920389|FG003|Part 3|Other Protocol Specified Criteria|0|||
105521525|NCT01729754|363920390|FG004|Part 3|Other Protocol Specified Criteria|0|||
105521526|NCT01729754|363920391|FG005|Part 3|Other Protocol Specified Criteria|2|||
105521527|NCT01729754|363920392|FG006|Part 3|Other Protocol Specified Criteria|0|||
105521528|NCT01729754|363920393|FG007|Part 3|Other Protocol Specified Criteria|1|||
105521529|NCT01729754|363920394|FG008|Part 3|Other Protocol Specified Criteria|0|||
105521530|NCT01729754|363920395|FG009|Part 3|Other Protocol Specified Criteria|0|||
105521531|NCT00773292|363920396|FG000|Treatment 48 Weeks|Adverse Event|1|||
105521532|NCT00773292|363920396|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
105521533|NCT01851720|363920397|FG000|Overall Study|Lost to Follow-up|0|||
105521534|NCT01851720|363920398|FG001|Overall Study|Lost to Follow-up|1|||
105521535|NCT02419742|363920401|FG000|Overall Study|Adverse Event|2|||
105521536|NCT02419742|363920402|FG001|Overall Study|Adverse Event|0|||
105521537|NCT02419742|363920401|FG000|Overall Study|Disease Progression|0|||
105521538|NCT02419742|363920402|FG001|Overall Study|Disease Progression|1|||
105521539|NCT02419742|363920401|FG000|Overall Study|Withdrew Consent|2|||
105521540|NCT02419742|363920402|FG001|Overall Study|Withdrew Consent|1|||
105521541|NCT02419742|363920401|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
105521542|NCT02419742|363920402|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
105521543|NCT02672423|363920403|FG000|Period 1|Adverse Event|0|||
105521544|NCT02672423|363920404|FG001|Period 1|Adverse Event|0|||
105521545|NCT02672423|363920405|FG002|Period 1|Adverse Event|0|||
105521546|NCT02672423|363920406|FG003|Period 1|Adverse Event|0|||
105521547|NCT02672423|363920407|FG004|Period 1|Adverse Event|1|||
105521548|NCT02672423|363920408|FG005|Period 1|Adverse Event|0|||
105521549|NCT02672423|363920409|FG006|Period 1|Adverse Event|0|||
105521550|NCT02672423|363920410|FG007|Period 1|Adverse Event|0|||
105521551|NCT02672423|363920411|FG008|Period 1|Adverse Event|0|||
105521552|NCT02672423|363920412|FG009|Period 1|Adverse Event|0|||
105521553|NCT02672423|363920403|FG000|Period 2|Withdrawal by Subject|0|||
105521554|NCT02672423|363920404|FG001|Period 2|Withdrawal by Subject|0|||
105521555|NCT02672423|363920405|FG002|Period 2|Withdrawal by Subject|1|||
105521556|NCT02672423|363920406|FG003|Period 2|Withdrawal by Subject|0|||
105521557|NCT02672423|363920407|FG004|Period 2|Withdrawal by Subject|0|||
105521558|NCT02672423|363920408|FG005|Period 2|Withdrawal by Subject|0|||
105521559|NCT02672423|363920409|FG006|Period 2|Withdrawal by Subject|0|||
105521560|NCT02672423|363920410|FG007|Period 2|Withdrawal by Subject|0|||
105521561|NCT02672423|363920411|FG008|Period 2|Withdrawal by Subject|0|||
105521562|NCT02672423|363920412|FG009|Period 2|Withdrawal by Subject|0|||
105521563|NCT02672423|363920403|FG000|Period 3|Withdrawal by Subject|0|||
105521564|NCT02672423|363920404|FG001|Period 3|Withdrawal by Subject|0|||
105521565|NCT02672423|363920405|FG002|Period 3|Withdrawal by Subject|0|||
105521566|NCT02672423|363920406|FG003|Period 3|Withdrawal by Subject|0|||
105521567|NCT02672423|363920407|FG004|Period 3|Withdrawal by Subject|0|||
105521568|NCT02672423|363920408|FG005|Period 3|Withdrawal by Subject|0|||
105521569|NCT02672423|363920409|FG006|Period 3|Withdrawal by Subject|0|||
105521570|NCT02672423|363920410|FG007|Period 3|Withdrawal by Subject|1|||
105521571|NCT02672423|363920411|FG008|Period 3|Withdrawal by Subject|0|||
105521572|NCT02672423|363920412|FG009|Period 3|Withdrawal by Subject|0|||
105521573|NCT02672423|363920403|FG000|Period 3|Physician Decision|0|||
105521574|NCT02672423|363920404|FG001|Period 3|Physician Decision|0|||
105521575|NCT02672423|363920405|FG002|Period 3|Physician Decision|0|||
105521576|NCT02672423|363920406|FG003|Period 3|Physician Decision|0|||
105521577|NCT02672423|363920407|FG004|Period 3|Physician Decision|0|||
105521578|NCT02672423|363920408|FG005|Period 3|Physician Decision|1|||
105521579|NCT02672423|363920409|FG006|Period 3|Physician Decision|0|||
105521580|NCT02672423|363920410|FG007|Period 3|Physician Decision|0|||
105521581|NCT02672423|363920411|FG008|Period 3|Physician Decision|0|||
105521582|NCT02672423|363920412|FG009|Period 3|Physician Decision|0|||
105521583|NCT01046682|363920414|FG000|Overall Study|Adverse Event|2|||
105521584|NCT01046682|363920415|FG001|Overall Study|Adverse Event|0|||
105521585|NCT02864251|363920419|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
105521586|NCT02864251|363920420|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
105521587|NCT02864251|363920421|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
105521588|NCT02864251|363920419|FG000|Pre-Treatment|Withdrawal by Participant|0|||
105521589|NCT02864251|363920420|FG001|Pre-Treatment|Withdrawal by Participant|0|||
105521590|NCT02864251|363920421|FG002|Pre-Treatment|Withdrawal by Participant|4|||
105521591|NCT02864251|363920419|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
105521592|NCT02864251|363920420|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
105521593|NCT02864251|363920421|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
105521594|NCT02864251|363920419|FG000|Pre-Treatment|Other Reasons|0|||
105521595|NCT02864251|363920420|FG001|Pre-Treatment|Other Reasons|1|||
105521596|NCT02864251|363920421|FG002|Pre-Treatment|Other Reasons|1|||
105521597|NCT02864251|363920419|FG000|Treatment|Disease Progression|109|||
105521598|NCT02864251|363920420|FG001|Treatment|Disease Progression|52|||
105521599|NCT02864251|363920421|FG002|Treatment|Disease Progression|101|||
105521600|NCT02864251|363920419|FG000|Treatment|Study Drug Toxicity|9|||
105521601|NCT02864251|363920420|FG001|Treatment|Study Drug Toxicity|4|||
105521602|NCT02864251|363920421|FG002|Treatment|Study Drug Toxicity|10|||
105521603|NCT02864251|363920419|FG000|Treatment|Death|0|||
105521604|NCT02864251|363920420|FG001|Treatment|Death|2|||
105521605|NCT02864251|363920421|FG002|Treatment|Death|3|||
105521606|NCT02864251|363920419|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
105521607|NCT02864251|363920420|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
105521608|NCT02864251|363920421|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
105521609|NCT02864251|363920419|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
105521610|NCT02864251|363920420|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
105521611|NCT02864251|363920421|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
105521612|NCT02864251|363920419|FG000|Treatment|Withdrawal by Participant|8|||
105521613|NCT02864251|363920420|FG001|Treatment|Withdrawal by Participant|5|||
105521614|NCT02864251|363920421|FG002|Treatment|Withdrawal by Participant|13|||
105521615|NCT02864251|363920419|FG000|Treatment|Maximum Clinical Benefit|1|||
105521616|NCT02864251|363920420|FG001|Treatment|Maximum Clinical Benefit|0|||
105521617|NCT02864251|363920421|FG002|Treatment|Maximum Clinical Benefit|1|||
105521618|NCT02864251|363920419|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
105521619|NCT02864251|363920420|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
105521620|NCT02864251|363920421|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
105521621|NCT02864251|363920419|FG000|Treatment|Other Reasons|1|||
105521622|NCT02864251|363920420|FG001|Treatment|Other Reasons|1|||
105521623|NCT02864251|363920421|FG002|Treatment|Other Reasons|4|||
105521624|NCT02864251|363920419|FG000|Treatment|Administrative Reason by Sponsor|1|||
105521625|NCT02864251|363920420|FG001|Treatment|Administrative Reason by Sponsor|0|||
105521626|NCT02864251|363920421|FG002|Treatment|Administrative Reason by Sponsor|0|||
105521627|NCT01514760|363920422|FG000|Overall Study|Lost to Follow-up|2|||
105521628|NCT02092662|363920423|FG000|Overall Study|Lost to Follow-up|13|||
105521629|NCT02092662|363920424|FG001|Overall Study|Lost to Follow-up|0|||
105521630|NCT00772707|363920425|FG000|Overall Study|Withdrawn|3|||
105521631|NCT00885755|363920429|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
105521632|NCT00885755|363920430|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
105521633|NCT00885755|363920431|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
105521634|NCT00885755|363920429|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
105521635|NCT00885755|363920430|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
105521636|NCT00885755|363920431|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
105521637|NCT00885755|363920429|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
105521638|NCT00885755|363920430|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
105521639|NCT00885755|363920431|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
105521640|NCT00885755|363920429|FG000|Part I: Trastuzumab+Taxane|Death|0|||
105521641|NCT00885755|363920430|FG001|Part I: Trastuzumab+Taxane|Death|0|||
105521642|NCT00885755|363920431|FG002|Part I: Trastuzumab+Taxane|Death|1|||
105521643|NCT00885755|363920429|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
105521644|NCT00885755|363920430|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
105521645|NCT00885755|363920431|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
105521646|NCT01266460|363920432|FG000|Overall Study|Adverse Event|3|||
105521647|NCT01266460|363920432|FG000|Overall Study|Withdrawal by Subject|5|||
105521648|NCT01266460|363920432|FG000|Overall Study|Disease Progression|18|||
105521649|NCT01266460|363920432|FG000|Overall Study|Not otherwise specified|8|||
105521650|NCT01132547|363920433|FG000|Overall Study|Withdrawal by Subject|3|||
105521651|NCT01132547|363920434|FG001|Overall Study|Withdrawal by Subject|1|||
105521652|NCT01132547|363920433|FG000|Overall Study|Death|1|||
105521653|NCT01132547|363920434|FG001|Overall Study|Death|0|||
105521654|NCT02617511|363920436|FG000|Overall Study|Withdrawal by Subject|1|||
105521655|NCT02617511|363920437|FG001|Overall Study|Withdrawal by Subject|0|||
105521656|NCT00720057|363920439|FG000|Overall Study|Lost to Follow-up|0|||
105521657|NCT00720057|363920440|FG001|Overall Study|Lost to Follow-up|2|||
105521658|NCT00720057|363920439|FG000|Overall Study|Protocol Violation|1|||
105521659|NCT00720057|363920440|FG001|Overall Study|Protocol Violation|0|||
105521660|NCT00720057|363920439|FG000|Overall Study|Withdrawal by Subject|0|||
105521661|NCT00720057|363920440|FG001|Overall Study|Withdrawal by Subject|1|||
105521662|NCT03165110|363920446|FG000|Overall Study|Anroid phone software incompatibility|1|||
105521663|NCT00071760|363920451|FG000|Overall Study|Adverse Event|2|||
105521664|NCT00071760|363920452|FG001|Overall Study|Adverse Event|1|||
105521665|NCT00071760|363920451|FG000|Overall Study|Lost to Follow-up|0|||
105521666|NCT00071760|363920452|FG001|Overall Study|Lost to Follow-up|3|||
105521667|NCT00071760|363920451|FG000|Overall Study|Protocol Violation|1|||
105521668|NCT00071760|363920452|FG001|Overall Study|Protocol Violation|0|||
105521669|NCT00071760|363920451|FG000|Overall Study|Withdrawal by Subject|0|||
105521670|NCT00071760|363920452|FG001|Overall Study|Withdrawal by Subject|1|||
105521671|NCT00071760|363920451|FG000|Overall Study|Insufficient Viral Load Response|1|||
105521672|NCT00071760|363920452|FG001|Overall Study|Insufficient Viral Load Response|1|||
105521673|NCT00071760|363920451|FG000|Overall Study|Lack of availability of RTV|1|||
105521674|NCT00071760|363920452|FG001|Overall Study|Lack of availability of RTV|0|||
105521675|NCT00071760|363920451|FG000|Overall Study|Physician Decision|2|||
105521676|NCT00071760|363920452|FG001|Overall Study|Physician Decision|1|||
105521677|NCT00071760|363920451|FG000|Overall Study|Relocation|0|||
105521678|NCT00071760|363920452|FG001|Overall Study|Relocation|1|||
105521679|NCT04120974|363920453|FG000|Overall Study|Death|1|||
105521680|NCT04120974|363920453|FG000|Overall Study|Physician Decision|1|||
105521681|NCT04120974|363920453|FG000|Overall Study|Lost to Follow-up|6|||
105521682|NCT03338062|363920454|FG000|Overall Study|Alternative Therapy|1|||
105521683|NCT03338062|363920455|FG001|Overall Study|Alternative Therapy|0|||
105521684|NCT03424265|363920459|FG000|Overall Study|screening failure|1|||
105521685|NCT03424265|363920460|FG001|Overall Study|screening failure|0|||
105521686|NCT03424265|363920459|FG000|Overall Study|Withdrawal by Subject|0|||
105521687|NCT03424265|363920460|FG001|Overall Study|Withdrawal by Subject|2|||
105521688|NCT01265849|363920461|FG000|Overall Study|Randomized//Treatment not initiated|1|||
105521689|NCT01265849|363920462|FG001|Overall Study|Randomized//Treatment not initiated|4|||
105521690|NCT01265849|363920463|FG002|Overall Study|Randomized//Treatment not initiated|0|||
105521691|NCT01265849|363920461|FG000|Overall Study|Physician Decision|1|||
105521692|NCT01265849|363920462|FG001|Overall Study|Physician Decision|2|||
105521693|NCT01265849|363920463|FG002|Overall Study|Physician Decision|0|||
105521694|NCT01265849|363920461|FG000|Overall Study|Lost to Follow-up|18|||
105521695|NCT01265849|363920462|FG001|Overall Study|Lost to Follow-up|15|||
105521696|NCT01265849|363920463|FG002|Overall Study|Lost to Follow-up|5|||
105521697|NCT01265849|363920461|FG000|Overall Study|Not otherwise specified|1|||
105521698|NCT01265849|363920462|FG001|Overall Study|Not otherwise specified|6|||
105521699|NCT01265849|363920463|FG002|Overall Study|Not otherwise specified|1|||
105521700|NCT01265849|363920461|FG000|Overall Study|Withdrawal by Subject|25|||
105521701|NCT01265849|363920462|FG001|Overall Study|Withdrawal by Subject|34|||
105521702|NCT01265849|363920463|FG002|Overall Study|Withdrawal by Subject|13|||
105521703|NCT00362115|363920464|FG000|Overall Study|Adverse Event|0|||
105521704|NCT00362115|363920465|FG001|Overall Study|Adverse Event|1|||
105521705|NCT00362115|363920466|FG002|Overall Study|Adverse Event|1|||
105521706|NCT00362115|363920467|FG003|Overall Study|Adverse Event|1|||
105521707|NCT00362115|363920468|FG004|Overall Study|Adverse Event|2|||
105521708|NCT00362115|363920469|FG005|Overall Study|Adverse Event|2|||
105521709|NCT00362115|363920470|FG006|Overall Study|Adverse Event|1|||
105521710|NCT00362115|363920464|FG000|Overall Study|Protocol Violation|0|||
105521711|NCT00362115|363920465|FG001|Overall Study|Protocol Violation|0|||
105521712|NCT00362115|363920466|FG002|Overall Study|Protocol Violation|0|||
105521713|NCT00362115|363920467|FG003|Overall Study|Protocol Violation|0|||
105521714|NCT00362115|363920468|FG004|Overall Study|Protocol Violation|0|||
105521715|NCT00362115|363920469|FG005|Overall Study|Protocol Violation|1|||
105521716|NCT00362115|363920470|FG006|Overall Study|Protocol Violation|0|||
105521717|NCT00362115|363920464|FG000|Overall Study|Lost to Follow-up|0|||
105521718|NCT00362115|363920465|FG001|Overall Study|Lost to Follow-up|1|||
105521719|NCT00362115|363920466|FG002|Overall Study|Lost to Follow-up|0|||
105521720|NCT00362115|363920467|FG003|Overall Study|Lost to Follow-up|0|||
105521721|NCT00362115|363920468|FG004|Overall Study|Lost to Follow-up|2|||
105521722|NCT00362115|363920469|FG005|Overall Study|Lost to Follow-up|0|||
105521723|NCT00362115|363920470|FG006|Overall Study|Lost to Follow-up|1|||
105521724|NCT00362115|363920464|FG000|Overall Study|Withdrawal by Subject|1|||
105521725|NCT00362115|363920465|FG001|Overall Study|Withdrawal by Subject|3|||
105521726|NCT00362115|363920466|FG002|Overall Study|Withdrawal by Subject|1|||
105521727|NCT00362115|363920467|FG003|Overall Study|Withdrawal by Subject|0|||
105521728|NCT00362115|363920468|FG004|Overall Study|Withdrawal by Subject|1|||
105521729|NCT00362115|363920469|FG005|Overall Study|Withdrawal by Subject|3|||
105521730|NCT00362115|363920470|FG006|Overall Study|Withdrawal by Subject|4|||
105521731|NCT00362115|363920464|FG000|Overall Study|Lack of Efficacy|1|||
105521732|NCT00362115|363920465|FG001|Overall Study|Lack of Efficacy|0|||
105521733|NCT00362115|363920466|FG002|Overall Study|Lack of Efficacy|5|||
105521734|NCT00362115|363920467|FG003|Overall Study|Lack of Efficacy|2|||
105521735|NCT00362115|363920468|FG004|Overall Study|Lack of Efficacy|2|||
105521736|NCT00362115|363920469|FG005|Overall Study|Lack of Efficacy|0|||
105521737|NCT00362115|363920470|FG006|Overall Study|Lack of Efficacy|3|||
105521738|NCT00362115|363920464|FG000|Overall Study|Physician Decision|0|||
105521739|NCT00362115|363920465|FG001|Overall Study|Physician Decision|0|||
105521740|NCT00362115|363920466|FG002|Overall Study|Physician Decision|0|||
105521741|NCT00362115|363920467|FG003|Overall Study|Physician Decision|0|||
105521742|NCT00362115|363920468|FG004|Overall Study|Physician Decision|0|||
105521743|NCT00362115|363920469|FG005|Overall Study|Physician Decision|0|||
105521744|NCT00362115|363920470|FG006|Overall Study|Physician Decision|3|||
105521745|NCT00362115|363920464|FG000|Overall Study|Other|0|||
105521746|NCT00362115|363920465|FG001|Overall Study|Other|1|||
105521747|NCT00362115|363920466|FG002|Overall Study|Other|0|||
105521748|NCT00362115|363920467|FG003|Overall Study|Other|1|||
105521749|NCT00362115|363920468|FG004|Overall Study|Other|0|||
105521750|NCT00362115|363920469|FG005|Overall Study|Other|1|||
105521751|NCT00362115|363920470|FG006|Overall Study|Other|0|||
105521752|NCT03194321|363920475|FG000|Overall Study|Withdrawal by Subject|1|||
105521753|NCT03194321|363920475|FG000|Overall Study|Lost to Follow-up|1|||
105521754|NCT03194321|363920475|FG000|Overall Study|Travel for Follow-up|1|||
105521755|NCT02188589|363920476|FG000|Overall Study|Withdrawal by Subject|5|||
105521756|NCT00975481|363920486|FG000|Second Intervention Period|Adverse Event|2|||
105521757|NCT00975481|363920487|FG001|Second Intervention Period|Adverse Event|1|||
105521758|NCT00975481|363920488|FG002|Second Intervention Period|Adverse Event|0|||
105521759|NCT00975481|363920489|FG003|Second Intervention Period|Adverse Event|0|||
105521760|NCT00975481|363920490|FG004|Second Intervention Period|Adverse Event|0|||
105521761|NCT00975481|363920491|FG005|Second Intervention Period|Adverse Event|0|||
105521762|NCT00975481|363920486|FG000|Second Intervention Period|Withdrawal by Subject|0|||
105521763|NCT00975481|363920487|FG001|Second Intervention Period|Withdrawal by Subject|0|||
105521764|NCT00975481|363920488|FG002|Second Intervention Period|Withdrawal by Subject|1|||
105521765|NCT00975481|363920489|FG003|Second Intervention Period|Withdrawal by Subject|0|||
105521766|NCT00975481|363920490|FG004|Second Intervention Period|Withdrawal by Subject|0|||
105521767|NCT00975481|363920491|FG005|Second Intervention Period|Withdrawal by Subject|0|||
105521768|NCT00975481|363920486|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
105521769|NCT00975481|363920487|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
105521770|NCT00975481|363920488|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
105521771|NCT00975481|363920489|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
105521772|NCT00975481|363920490|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
105521773|NCT00975481|363920491|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
105521774|NCT00975481|363920486|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
105521775|NCT00975481|363920487|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
105521776|NCT00975481|363920488|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
105521777|NCT00975481|363920489|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
105521778|NCT00975481|363920490|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
105521779|NCT00975481|363920491|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
105521780|NCT00643682|363920492|FG000|Overall Study|did not keep appointment|522|||
105521781|NCT00643682|363920493|FG001|Overall Study|did not keep appointment|509|||
105521782|NCT01408030|363920495|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
105521783|NCT01408030|363920496|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
105521784|NCT01408030|363920497|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
105521785|NCT01408030|363920498|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
105521786|NCT01408030|363920495|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
105521787|NCT01408030|363920496|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
105521788|NCT01408030|363920497|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
105521789|NCT01408030|363920498|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
105521790|NCT01408030|363920495|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
105521791|NCT01408030|363920496|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
105521792|NCT01408030|363920497|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
105521793|NCT01408030|363920498|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
105521794|NCT01408030|363920495|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
105521795|NCT01408030|363920496|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
105521796|NCT01408030|363920497|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
105521797|NCT01408030|363920498|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
105521798|NCT01408030|363920495|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
105521799|NCT01408030|363920496|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
105521800|NCT01408030|363920497|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
105521801|NCT01408030|363920498|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
105521802|NCT01408030|363920495|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
105521803|NCT01408030|363920496|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
105521804|NCT01408030|363920497|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
105521805|NCT01408030|363920498|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
105521806|NCT01408030|363920495|FG000|Observation Phase (Off Drug)|Other|1|||
105521807|NCT01408030|363920496|FG001|Observation Phase (Off Drug)|Other|1|||
105521808|NCT01408030|363920497|FG002|Observation Phase (Off Drug)|Other|1|||
105521809|NCT01408030|363920498|FG003|Observation Phase (Off Drug)|Other|1|||
105521810|NCT03755414|363920501|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
105521811|NCT03755414|363920502|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
105521812|NCT03755414|363920503|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
105521813|NCT03755414|363920501|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
105521814|NCT03755414|363920502|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
105521815|NCT03755414|363920503|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
105521816|NCT03755414|363920501|FG000|Overall Study|Non-compliance|0|||
105521817|NCT03755414|363920502|FG001|Overall Study|Non-compliance|1|||
105521818|NCT03755414|363920503|FG002|Overall Study|Non-compliance|0|||
105521819|NCT02153112|363920504|FG000|Overall Study|Adverse Event|0|||
105521820|NCT02153112|363920505|FG001|Overall Study|Adverse Event|0|||
105521821|NCT02153112|363920506|FG002|Overall Study|Adverse Event|1|||
105521822|NCT02153112|363920507|FG003|Overall Study|Adverse Event|0|||
105521823|NCT02153112|363920508|FG004|Overall Study|Adverse Event|0|||
105521824|NCT02153112|363920509|FG005|Overall Study|Adverse Event|0|||
105521825|NCT02153112|363920510|FG006|Overall Study|Adverse Event|0|||
105521826|NCT02153112|363920511|FG007|Overall Study|Adverse Event|0|||
105521827|NCT02153112|363920512|FG008|Overall Study|Adverse Event|0|||
105521828|NCT02153112|363920513|FG009|Overall Study|Adverse Event|0|||
105521829|NCT02153112|363920504|FG000|Overall Study|Lost to Follow-up|1|||
105521830|NCT02153112|363920505|FG001|Overall Study|Lost to Follow-up|1|||
105521831|NCT02153112|363920506|FG002|Overall Study|Lost to Follow-up|0|||
105521832|NCT02153112|363920507|FG003|Overall Study|Lost to Follow-up|0|||
105521833|NCT02153112|363920508|FG004|Overall Study|Lost to Follow-up|2|||
105521834|NCT02153112|363920509|FG005|Overall Study|Lost to Follow-up|1|||
105521835|NCT02153112|363920510|FG006|Overall Study|Lost to Follow-up|1|||
105521836|NCT02153112|363920511|FG007|Overall Study|Lost to Follow-up|0|||
105521837|NCT02153112|363920512|FG008|Overall Study|Lost to Follow-up|1|||
105521838|NCT02153112|363920513|FG009|Overall Study|Lost to Follow-up|1|||
105521839|NCT02153112|363920504|FG000|Overall Study|Withdrawal by Subject|3|||
105521840|NCT02153112|363920505|FG001|Overall Study|Withdrawal by Subject|1|||
105521841|NCT02153112|363920506|FG002|Overall Study|Withdrawal by Subject|2|||
105521842|NCT02153112|363920507|FG003|Overall Study|Withdrawal by Subject|2|||
105521843|NCT02153112|363920508|FG004|Overall Study|Withdrawal by Subject|1|||
105521844|NCT02153112|363920509|FG005|Overall Study|Withdrawal by Subject|1|||
105521845|NCT02153112|363920510|FG006|Overall Study|Withdrawal by Subject|7|||
105521846|NCT02153112|363920511|FG007|Overall Study|Withdrawal by Subject|2|||
105521847|NCT02153112|363920512|FG008|Overall Study|Withdrawal by Subject|13|||
105521848|NCT02153112|363920513|FG009|Overall Study|Withdrawal by Subject|12|||
105521849|NCT02153112|363920504|FG000|Overall Study|Reason not Specified|0|||
105521850|NCT02153112|363920505|FG001|Overall Study|Reason not Specified|0|||
105521851|NCT02153112|363920506|FG002|Overall Study|Reason not Specified|0|||
105521852|NCT02153112|363920507|FG003|Overall Study|Reason not Specified|0|||
105521853|NCT02153112|363920508|FG004|Overall Study|Reason not Specified|0|||
105521854|NCT02153112|363920509|FG005|Overall Study|Reason not Specified|0|||
105521855|NCT02153112|363920510|FG006|Overall Study|Reason not Specified|0|||
105521856|NCT02153112|363920511|FG007|Overall Study|Reason not Specified|0|||
105521857|NCT02153112|363920512|FG008|Overall Study|Reason not Specified|1|||
105521858|NCT02153112|363920513|FG009|Overall Study|Reason not Specified|1|||
105521859|NCT00561080|363920514|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
105521860|NCT00561080|363920515|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
105521861|NCT00561080|363920516|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
105521862|NCT00561080|363920514|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
105521863|NCT00561080|363920515|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
105521864|NCT00561080|363920516|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
105521865|NCT00561080|363920514|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
105521866|NCT00561080|363920515|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
105521867|NCT00561080|363920516|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
105521868|NCT00561080|363920514|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
105521869|NCT00561080|363920515|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
105521870|NCT00561080|363920516|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
105521871|NCT00561080|363920514|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
105521872|NCT00561080|363920515|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
105521873|NCT00561080|363920516|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
105521874|NCT00561080|363920514|FG000|Vaccination Period (up to Month 4)|Other|0|||
105521875|NCT00561080|363920515|FG001|Vaccination Period (up to Month 4)|Other|2|||
105521876|NCT00561080|363920516|FG002|Vaccination Period (up to Month 4)|Other|1|||
105521877|NCT00561080|363920514|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
105521878|NCT00561080|363920515|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
105521879|NCT00561080|363920516|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
105521880|NCT00561080|363920514|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
105521881|NCT00561080|363920515|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
105521882|NCT00561080|363920516|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
105521883|NCT00561080|363920514|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
105521884|NCT00561080|363920515|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
105521885|NCT00561080|363920516|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
105521886|NCT00561080|363920514|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
105521887|NCT00561080|363920515|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
105521888|NCT00561080|363920516|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
105521889|NCT02154581|363920524|FG000|Overall Study|Lost to Follow-up|7|||
105521890|NCT02154581|363920525|FG001|Overall Study|Lost to Follow-up|8|||
105521891|NCT00741039|363920526|FG000|Overall Study|Patient non-compliance|2|||
105521892|NCT00741039|363920527|FG001|Overall Study|Patient non-compliance|0|||
105521893|NCT01288287|363920528|FG000|Overall Study|Lost to Follow-up|8|||
105521894|NCT01288287|363920528|FG000|Overall Study|Withdrawal by Subject|4|||
105521895|NCT01288287|363920528|FG000|Overall Study|Lack of Efficacy|13|||
105521896|NCT01288287|363920528|FG000|Overall Study|Other Reason|13|||
105521897|NCT01288287|363920528|FG000|Overall Study|Unknown Reason|1|||
105521898|NCT01288287|363920528|FG000|Overall Study|Unknown Status|7|||
105521899|NCT02225743|363920529|FG000|Overall Study|Withdrawal by Subject|18|||
105521900|NCT00445965|363920531|FG000|Overall Study|Adverse Event|2|||
105521901|NCT00445965|363920531|FG000|Overall Study|Physician Decision|1|||
105521902|NCT00445965|363920531|FG000|Overall Study|Enrolled but not treated|1|||
105521903|NCT00445965|363920531|FG000|Overall Study|Removed due to progressive disease|29|||
105521904|NCT00679263|363920532|FG000|Visit 2/Dose 1|Adverse Event|1|||
105521905|NCT00679263|363920533|FG001|Visit 2/Dose 1|Adverse Event|0|||
105521906|NCT00679263|363920534|FG002|Visit 2/Dose 1|Adverse Event|0|||
105521907|NCT00679263|363920532|FG000|Visit 2/Dose 1|subject not compliance|1|||
105521908|NCT00679263|363920533|FG001|Visit 2/Dose 1|subject not compliance|1|||
105521909|NCT00679263|363920534|FG002|Visit 2/Dose 1|subject not compliance|0|||
105521910|NCT02642432|363920537|FG000|Overall Study|Adverse Event|2|||
105521911|NCT02642432|363920537|FG000|Overall Study|Withdrew Consent|1|||
105521912|NCT02642432|363920537|FG000|Overall Study|Lost to Follow-up|2|||
105521913|NCT02642432|363920537|FG000|Overall Study|Other|3|||
105521914|NCT00733746|363920538|FG000|Overall Study|Ineligible|5|||
105521915|NCT02295995|363920539|FG000|Overall Study|Lost to Follow-up|5|||
105521916|NCT02295995|363920540|FG001|Overall Study|Lost to Follow-up|1|||
105521917|NCT02447081|363920541|FG000|Overall Study|Death|161|||
105521918|NCT02447081|363920541|FG000|Overall Study|Lost to Follow-up|36|||
105521919|NCT02447081|363920541|FG000|Overall Study|Visit not completed|17|||
105521920|NCT02447081|363920541|FG000|Overall Study|unsuccessful implant procedure|10|||
105521921|NCT02867709|363920544|FG000|Treatment Period|Adverse Event|1|||
105521922|NCT02867709|363920545|FG001|Treatment Period|Adverse Event|1|||
105521923|NCT02867709|363920546|FG002|Treatment Period|Adverse Event|2|||
105521924|NCT02867709|363920544|FG000|Treatment Period|Withdrawal of Consent|7|||
105521925|NCT02867709|363920545|FG001|Treatment Period|Withdrawal of Consent|9|||
105521926|NCT02867709|363920546|FG002|Treatment Period|Withdrawal of Consent|8|||
105521927|NCT02867709|363920544|FG000|Treatment Period|Lost to Follow-up|17|||
105521928|NCT02867709|363920545|FG001|Treatment Period|Lost to Follow-up|20|||
105521929|NCT02867709|363920546|FG002|Treatment Period|Lost to Follow-up|20|||
105521930|NCT02867709|363920544|FG000|Treatment Period|Lack of Qualifying Event|42|||
105521931|NCT02867709|363920545|FG001|Treatment Period|Lack of Qualifying Event|55|||
105521932|NCT02867709|363920546|FG002|Treatment Period|Lack of Qualifying Event|42|||
105521933|NCT02867709|363920544|FG000|Treatment Period|Protocol Violation|3|||
105521934|NCT02867709|363920545|FG001|Treatment Period|Protocol Violation|2|||
105521935|NCT02867709|363920546|FG002|Treatment Period|Protocol Violation|3|||
105521936|NCT02867709|363920544|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
105521937|NCT02867709|363920545|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
105521938|NCT02867709|363920546|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
105521939|NCT02867709|363920544|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
105521940|NCT02867709|363920545|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
105521941|NCT02867709|363920546|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
105521942|NCT02867709|363920544|FG000|Safety Follow-up Period|Pregnancy|0|||
105521943|NCT02867709|363920545|FG001|Safety Follow-up Period|Pregnancy|1|||
105521944|NCT02867709|363920546|FG002|Safety Follow-up Period|Pregnancy|0|||
105521945|NCT02867709|363920544|FG000|Safety Follow-up Period|Protocol Violation|0|||
105521946|NCT02867709|363920545|FG001|Safety Follow-up Period|Protocol Violation|1|||
105521947|NCT02867709|363920546|FG002|Safety Follow-up Period|Protocol Violation|1|||
105521948|NCT03245008|363920547|FG000|Overall Study|Adverse Event|15|||
105521949|NCT03245008|363920548|FG001|Overall Study|Adverse Event|18|||
105521950|NCT03245008|363920549|FG002|Overall Study|Adverse Event|15|||
105521951|NCT03245008|363920550|FG003|Overall Study|Adverse Event|0|||
105521952|NCT03245008|363920551|FG004|Overall Study|Adverse Event|1|||
105521953|NCT03245008|363920547|FG000|Overall Study|Lack of Efficacy|0|||
105521954|NCT03245008|363920548|FG001|Overall Study|Lack of Efficacy|1|||
105521955|NCT03245008|363920549|FG002|Overall Study|Lack of Efficacy|0|||
105521956|NCT03245008|363920550|FG003|Overall Study|Lack of Efficacy|0|||
105521957|NCT03245008|363920551|FG004|Overall Study|Lack of Efficacy|0|||
105521958|NCT03245008|363920547|FG000|Overall Study|Lost to Follow-up|4|||
105521959|NCT03245008|363920548|FG001|Overall Study|Lost to Follow-up|1|||
105521960|NCT03245008|363920549|FG002|Overall Study|Lost to Follow-up|0|||
105521961|NCT03245008|363920550|FG003|Overall Study|Lost to Follow-up|0|||
105521962|NCT03245008|363920551|FG004|Overall Study|Lost to Follow-up|1|||
105521963|NCT03245008|363920547|FG000|Overall Study|Physician Decision|1|||
105521964|NCT03245008|363920548|FG001|Overall Study|Physician Decision|3|||
105521965|NCT03245008|363920549|FG002|Overall Study|Physician Decision|4|||
105521966|NCT03245008|363920550|FG003|Overall Study|Physician Decision|0|||
105521967|NCT03245008|363920551|FG004|Overall Study|Physician Decision|0|||
105521968|NCT03245008|363920547|FG000|Overall Study|Protocol Violation|0|||
105521969|NCT03245008|363920548|FG001|Overall Study|Protocol Violation|1|||
105521970|NCT03245008|363920549|FG002|Overall Study|Protocol Violation|0|||
105521971|NCT03245008|363920550|FG003|Overall Study|Protocol Violation|0|||
105521972|NCT03245008|363920551|FG004|Overall Study|Protocol Violation|0|||
105521973|NCT03245008|363920547|FG000|Overall Study|Withdrawal by Subject|20|||
105521974|NCT03245008|363920548|FG001|Overall Study|Withdrawal by Subject|19|||
105521975|NCT03245008|363920549|FG002|Overall Study|Withdrawal by Subject|11|||
105521976|NCT03245008|363920550|FG003|Overall Study|Withdrawal by Subject|0|||
105521977|NCT03245008|363920551|FG004|Overall Study|Withdrawal by Subject|0|||
105521978|NCT03245008|363920547|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
105521979|NCT03245008|363920548|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
105521980|NCT03245008|363920549|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
105521981|NCT03245008|363920550|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
105521982|NCT03245008|363920551|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
105521983|NCT03245008|363920547|FG000|Overall Study|Failure to meet randomization criteria|0|||
105521984|NCT03245008|363920548|FG001|Overall Study|Failure to meet randomization criteria|1|||
105521985|NCT03245008|363920549|FG002|Overall Study|Failure to meet randomization criteria|0|||
105521986|NCT03245008|363920550|FG003|Overall Study|Failure to meet randomization criteria|1|||
105521987|NCT03245008|363920551|FG004|Overall Study|Failure to meet randomization criteria|0|||
105521988|NCT01786629|363921762|FG000|Overall Study|Lack of Efficacy|0|||
105521989|NCT01786629|363921763|FG001|Overall Study|Lack of Efficacy|4|||
105521990|NCT01786629|363921762|FG000|Overall Study|Adverse Event|0|||
105521991|NCT01786629|363921763|FG001|Overall Study|Adverse Event|1|||
105521992|NCT02926924|363921766|FG000|Overall Study|withdrawal - reason unknown|0|||
105521993|NCT02926924|363921767|FG001|Overall Study|withdrawal - reason unknown|1|||
105521994|NCT00939809|363921771|FG000|Overall Study|Adverse Event|2|||
105521995|NCT00939809|363921771|FG000|Overall Study|Death|1|||
105521996|NCT04568590|363921773|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
105521997|NCT00202644|363921774|FG000|Overall Study|Adverse Event|12|||
105521998|NCT00202644|363921775|FG001|Overall Study|Adverse Event|13|||
105521999|NCT00202644|363921774|FG000|Overall Study|Withdrawal by Subject|8|||
105522000|NCT00202644|363921775|FG001|Overall Study|Withdrawal by Subject|6|||
105522001|NCT00202644|363921774|FG000|Overall Study|Lack of Efficacy|6|||
105522002|NCT00202644|363921775|FG001|Overall Study|Lack of Efficacy|6|||
105522003|NCT00202644|363921774|FG000|Overall Study|Lost to Follow-up|0|||
105522004|NCT00202644|363921775|FG001|Overall Study|Lost to Follow-up|1|||
105522005|NCT00202644|363921774|FG000|Overall Study|Other|9|||
105522006|NCT00202644|363921775|FG001|Overall Study|Other|1|||
105522007|NCT02784821|363921776|FG000|Overall Study|Death|0|||
105522008|NCT02784821|363921777|FG001|Overall Study|Death|5|||
105522009|NCT02784821|363921778|FG002|Overall Study|Death|4|||
105522010|NCT02784821|363921779|FG003|Overall Study|Death|5|||
105522011|NCT01277523|363921780|FG000|Overall Study|Adverse Event|1|||
105522012|NCT01277523|363921781|FG001|Overall Study|Adverse Event|0|||
105522013|NCT01277523|363921782|FG002|Overall Study|Adverse Event|0|||
105522014|NCT01277523|363921780|FG000|Overall Study|Protocol Violation|2|||
105522015|NCT01277523|363921781|FG001|Overall Study|Protocol Violation|0|||
105522016|NCT01277523|363921782|FG002|Overall Study|Protocol Violation|0|||
105522017|NCT01277523|363921780|FG000|Overall Study|Other Reason not Defined|0|||
105522018|NCT01277523|363921781|FG001|Overall Study|Other Reason not Defined|1|||
105522019|NCT01277523|363921782|FG002|Overall Study|Other Reason not Defined|0|||
105522020|NCT02385266|363921783|FG000|Overall Study|Withdrawal by Subject|1|||
105522021|NCT02385266|363921784|FG001|Overall Study|Withdrawal by Subject|3|||
105522022|NCT01327300|363921789|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
105522023|NCT01327300|363921790|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
105522024|NCT03020823|363921791|FG000|Overall Study|Physician Decision|4|||
105522025|NCT03020823|363921791|FG000|Overall Study|Lack of Efficacy|4|||
105522026|NCT03020823|363921791|FG000|Overall Study|Adverse Event|2|||
105522027|NCT03739112|363921792|FG000|Overall Study|Adverse Event|2|||
105522028|NCT03739112|363921793|FG001|Overall Study|Adverse Event|2|||
105522029|NCT03739112|363921792|FG000|Overall Study|Withdrawal by Subject|38|||
105522030|NCT03739112|363921793|FG001|Overall Study|Withdrawal by Subject|19|||
105522031|NCT03739112|363921792|FG000|Overall Study|Lost to Follow-up|31|||
105522032|NCT03739112|363921793|FG001|Overall Study|Lost to Follow-up|33|||
105522033|NCT03739112|363921792|FG000|Overall Study|Protocol Deviation|12|||
105522034|NCT03739112|363921793|FG001|Overall Study|Protocol Deviation|9|||
105522035|NCT03739112|363921792|FG000|Overall Study|Physician Decision|1|||
105522036|NCT03739112|363921793|FG001|Overall Study|Physician Decision|0|||
105522037|NCT03739112|363921792|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
105522038|NCT03739112|363921793|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
105522039|NCT03739112|363921792|FG000|Overall Study|Site went on hold|65|||
105522040|NCT03739112|363921793|FG001|Overall Study|Site went on hold|67|||
105522041|NCT03739112|363921792|FG000|Overall Study|Other than specified|8|||
105522042|NCT03739112|363921793|FG001|Overall Study|Other than specified|5|||
105522043|NCT03739112|363921792|FG000|Overall Study|Randomized but not vaccinated|31|||
105522044|NCT03739112|363921793|FG001|Overall Study|Randomized but not vaccinated|25|||
105522045|NCT01816893|363921794|FG000|Washout Period|Withdrawal by Subject|2|||
105522046|NCT01816893|363921795|FG001|Washout Period|Withdrawal by Subject|0|||
105522047|NCT02082210|363921797|FG000|Overall Study|Death|0|||
105522048|NCT02082210|363921798|FG001|Overall Study|Death|0|||
105522049|NCT02082210|363921799|FG002|Overall Study|Death|1|||
105522050|NCT02082210|363921800|FG003|Overall Study|Death|1|||
105522051|NCT02082210|363921801|FG004|Overall Study|Death|1|||
105522052|NCT02082210|363921802|FG005|Overall Study|Death|0|||
105522053|NCT02082210|363921797|FG000|Overall Study|Withdrawal by Subject|0|||
105522054|NCT02082210|363921798|FG001|Overall Study|Withdrawal by Subject|0|||
105522055|NCT02082210|363921799|FG002|Overall Study|Withdrawal by Subject|0|||
105522056|NCT02082210|363921800|FG003|Overall Study|Withdrawal by Subject|1|||
105522057|NCT02082210|363921801|FG004|Overall Study|Withdrawal by Subject|2|||
105522058|NCT02082210|363921802|FG005|Overall Study|Withdrawal by Subject|2|||
105522059|NCT02082210|363921797|FG000|Overall Study|Clinical Progression|0|||
105522060|NCT02082210|363921798|FG001|Overall Study|Clinical Progression|0|||
105522061|NCT02082210|363921799|FG002|Overall Study|Clinical Progression|0|||
105522062|NCT02082210|363921800|FG003|Overall Study|Clinical Progression|1|||
105522063|NCT02082210|363921801|FG004|Overall Study|Clinical Progression|0|||
105522064|NCT02082210|363921802|FG005|Overall Study|Clinical Progression|0|||
105522065|NCT02082210|363921797|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
105522066|NCT02082210|363921798|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
105522067|NCT02082210|363921799|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
105522068|NCT02082210|363921800|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
105522069|NCT02082210|363921801|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
105522070|NCT02082210|363921802|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
105522071|NCT02082210|363921797|FG000|Overall Study|Physician Decision|0|||
105522072|NCT02082210|363921798|FG001|Overall Study|Physician Decision|0|||
105522073|NCT02082210|363921799|FG002|Overall Study|Physician Decision|1|||
105522074|NCT02082210|363921800|FG003|Overall Study|Physician Decision|1|||
105522075|NCT02082210|363921801|FG004|Overall Study|Physician Decision|0|||
105522076|NCT02082210|363921802|FG005|Overall Study|Physician Decision|0|||
105522077|NCT03388138|363921803|FG000|Overall Study|Protocol Violation|1|||
105522078|NCT03388138|363921804|FG001|Overall Study|Protocol Violation|0|||
105522079|NCT01859494|363921807|FG000|Overall Study|Adverse Event|1|||
105522080|NCT01063764|363921808|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
105522081|NCT01063764|363921808|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
105522082|NCT01063764|363921808|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
105522083|NCT01063764|363921808|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
105522084|NCT01063764|363921808|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
105522085|NCT01063764|363921808|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
105522086|NCT01063764|363921808|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
105522087|NCT00697515|363921809|FG000|Dose Optimization Period|Adverse Event|4|||
105522088|NCT00697515|363921810|FG001|Dose Optimization Period|Adverse Event|0|||
105522089|NCT00697515|363921809|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
105522090|NCT00697515|363921810|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
105522091|NCT00697515|363921809|FG000|Dose Optimization Period|Lost to Follow-up|2|||
105522092|NCT00697515|363921810|FG001|Dose Optimization Period|Lost to Follow-up|0|||
105522093|NCT00697515|363921809|FG000|Dose Optimization Period|sponsor request|2|||
105522094|NCT00697515|363921810|FG001|Dose Optimization Period|sponsor request|0|||
105522095|NCT00697515|363921809|FG000|Dose Optimization Period|called to active duty|1|||
105522096|NCT00697515|363921810|FG001|Dose Optimization Period|called to active duty|0|||
105522097|NCT00697515|363921809|FG000|Dose Optimization Period|elevated QTc|1|||
105522098|NCT00697515|363921810|FG001|Dose Optimization Period|elevated QTc|0|||
105522099|NCT00697515|363921809|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
105522100|NCT00697515|363921810|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
105592784|NCT03068468|364170765|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105592785|NCT03068468|364170766|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105522101|NCT00697515|363921809|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
105592786|NCT03068468|364170763|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
105522102|NCT00697515|363921810|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
105522103|NCT00697515|363921809|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
105522104|NCT00697515|363921810|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
105522105|NCT00697515|363921809|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
105522106|NCT00697515|363921810|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
105522107|NCT02436759|363921811|FG000|Overall Study|Adverse Event|3|||
105522108|NCT02436759|363921812|FG001|Overall Study|Adverse Event|0|||
105522109|NCT02436759|363921811|FG000|Overall Study|Protocol Violation|1|||
105522110|NCT02436759|363921812|FG001|Overall Study|Protocol Violation|0|||
105522111|NCT02436759|363921811|FG000|Overall Study|Withdrawal by Subject|0|||
105522112|NCT02436759|363921812|FG001|Overall Study|Withdrawal by Subject|1|||
105522113|NCT01124604|363921819|FG000|Overall Study|Adverse Event|10|||
105522114|NCT01124604|363921820|FG001|Overall Study|Adverse Event|1|||
105522115|NCT01124604|363921819|FG000|Overall Study|Lack of Efficacy|1|||
105522116|NCT01124604|363921820|FG001|Overall Study|Lack of Efficacy|0|||
105522117|NCT01124604|363921819|FG000|Overall Study|Withdrawal by Subject|4|||
105522118|NCT01124604|363921820|FG001|Overall Study|Withdrawal by Subject|0|||
105522119|NCT01124604|363921819|FG000|Overall Study|Disease Progression|0|||
105522120|NCT01124604|363921820|FG001|Overall Study|Disease Progression|1|||
105522121|NCT00507442|363921821|FG000|Overall Study|Adverse Event|8|||
105522122|NCT00507442|363921822|FG001|Overall Study|Adverse Event|11|||
105522123|NCT00507442|363921823|FG002|Overall Study|Adverse Event|4|||
105522124|NCT00507442|363921824|FG003|Overall Study|Adverse Event|1|||
105522125|NCT00507442|363921821|FG000|Overall Study|Protocol Violation|0|||
105522126|NCT00507442|363921822|FG001|Overall Study|Protocol Violation|1|||
105522127|NCT00507442|363921823|FG002|Overall Study|Protocol Violation|0|||
105522128|NCT00507442|363921824|FG003|Overall Study|Protocol Violation|0|||
105522129|NCT00507442|363921821|FG000|Overall Study|Lost to Follow-up|0|||
105522130|NCT00507442|363921822|FG001|Overall Study|Lost to Follow-up|0|||
105522131|NCT00507442|363921823|FG002|Overall Study|Lost to Follow-up|1|||
105522132|NCT00507442|363921824|FG003|Overall Study|Lost to Follow-up|0|||
105522133|NCT00507442|363921821|FG000|Overall Study|Physician Decision|0|||
105522134|NCT00507442|363921822|FG001|Overall Study|Physician Decision|2|||
105522135|NCT00507442|363921823|FG002|Overall Study|Physician Decision|4|||
105522136|NCT00507442|363921824|FG003|Overall Study|Physician Decision|1|||
105522137|NCT00507442|363921821|FG000|Overall Study|Progressive Disease|2|||
105522138|NCT00507442|363921822|FG001|Overall Study|Progressive Disease|4|||
105522139|NCT00507442|363921823|FG002|Overall Study|Progressive Disease|2|||
105522140|NCT00507442|363921824|FG003|Overall Study|Progressive Disease|0|||
105522141|NCT00507442|363921821|FG000|Overall Study|Withdrawal by Subject|4|||
105522142|NCT00507442|363921822|FG001|Overall Study|Withdrawal by Subject|4|||
105522143|NCT00507442|363921823|FG002|Overall Study|Withdrawal by Subject|2|||
105522144|NCT00507442|363921824|FG003|Overall Study|Withdrawal by Subject|1|||
105522145|NCT00507442|363921821|FG000|Overall Study|Other|2|||
105522146|NCT00507442|363921822|FG001|Overall Study|Other|5|||
105522147|NCT00507442|363921823|FG002|Overall Study|Other|2|||
105522148|NCT00507442|363921824|FG003|Overall Study|Other|2|||
105522149|NCT00536107|363921829|FG000|Overall Study|Death|5|||
105522150|NCT00536107|363921830|FG001|Overall Study|Death|1|||
105522151|NCT00536107|363921829|FG000|Overall Study|Incorrect enrolment|1|||
105522152|NCT00536107|363921830|FG001|Overall Study|Incorrect enrolment|0|||
105522153|NCT00536107|363921829|FG000|Overall Study|Withdrawal by Subject|0|||
105522154|NCT00536107|363921830|FG001|Overall Study|Withdrawal by Subject|1|||
105522155|NCT00536107|363921829|FG000|Overall Study|Study Termination|2|||
105522156|NCT00536107|363921830|FG001|Overall Study|Study Termination|4|||
105522157|NCT02420691|363921831|FG000|Overall Study|Adverse Event|3|||
105522158|NCT02420691|363921831|FG000|Overall Study|Withdrawal by Subject|3|||
105522159|NCT00857220|363921833|FG000|Overall Study|Adverse Event|35|||
105522160|NCT00857220|363921833|FG000|Overall Study|Death|1|||
105522161|NCT00857220|363921833|FG000|Overall Study|Lack of Efficacy|11|||
105522162|NCT00857220|363921833|FG000|Overall Study|Lost to Follow-up|30|||
105522163|NCT00857220|363921833|FG000|Overall Study|Physician Decision|4|||
105522164|NCT00857220|363921833|FG000|Overall Study|Protocol Violation|16|||
105522165|NCT00857220|363921833|FG000|Overall Study|Withdrawal by Subject|67|||
105522166|NCT00857220|363921833|FG000|Overall Study|Clinical Hold|6|||
105522167|NCT00857220|363921833|FG000|Overall Study|Site Closed|5|||
105522168|NCT00857220|363921833|FG000|Overall Study|Miscellaneous|8|||
105522169|NCT02612428|363921834|FG000|VTL-308|Death|14|||
105522170|NCT02612428|363921835|FG001|VTL-308|Death|16|||
105522171|NCT02612428|363921834|FG000|VTL-308|Withdrawal by Subject|0|||
105522172|NCT02612428|363921835|FG001|VTL-308|Withdrawal by Subject|1|||
105522173|NCT02612428|363921834|FG000|VTL-308E|Death|9|||
105522174|NCT02612428|363921835|FG001|VTL-308E|Death|7|||
105522175|NCT02612428|363921834|FG000|VTL-308E|Lost to Follow-up|2|||
105522176|NCT02612428|363921835|FG001|VTL-308E|Lost to Follow-up|0|||
105522177|NCT02337907|363921838|FG000|Overall Study|Other than listed|1|||
105522178|NCT02337907|363921839|FG001|Overall Study|Other than listed|0|||
105522179|NCT02337907|363921840|FG002|Overall Study|Other than listed|0|||
105522180|NCT02337907|363921841|FG003|Overall Study|Other than listed|1|||
105522181|NCT02337907|363921842|FG004|Overall Study|Other than listed|1|||
105522182|NCT02337907|363921843|FG005|Overall Study|Other than listed|0|||
105522183|NCT02337907|363921838|FG000|Overall Study|Withdrawal by Subject|2|||
105522184|NCT02337907|363921839|FG001|Overall Study|Withdrawal by Subject|3|||
105522185|NCT02337907|363921840|FG002|Overall Study|Withdrawal by Subject|0|||
105522186|NCT02337907|363921841|FG003|Overall Study|Withdrawal by Subject|2|||
105522187|NCT02337907|363921842|FG004|Overall Study|Withdrawal by Subject|5|||
105522188|NCT02337907|363921843|FG005|Overall Study|Withdrawal by Subject|0|||
105522189|NCT02337907|363921838|FG000|Overall Study|Lost to Follow-up|0|||
105522190|NCT02337907|363921839|FG001|Overall Study|Lost to Follow-up|0|||
105522191|NCT02337907|363921840|FG002|Overall Study|Lost to Follow-up|0|||
105522192|NCT02337907|363921841|FG003|Overall Study|Lost to Follow-up|0|||
105522193|NCT02337907|363921842|FG004|Overall Study|Lost to Follow-up|0|||
105522194|NCT02337907|363921843|FG005|Overall Study|Lost to Follow-up|1|||
105522195|NCT02337907|363921838|FG000|Overall Study|Adverse Event|1|||
105522196|NCT02337907|363921839|FG001|Overall Study|Adverse Event|1|||
105522197|NCT02337907|363921840|FG002|Overall Study|Adverse Event|1|||
105522198|NCT02337907|363921841|FG003|Overall Study|Adverse Event|1|||
105522199|NCT02337907|363921842|FG004|Overall Study|Adverse Event|4|||
105522200|NCT02337907|363921843|FG005|Overall Study|Adverse Event|0|||
105522201|NCT01592344|363921848|FG000|Overall Study|Adverse Event|1|||
105522202|NCT01592344|363921849|FG001|Overall Study|Adverse Event|1|||
105522203|NCT01592344|363921848|FG000|Overall Study|Lack of Efficacy|1|||
105522204|NCT01592344|363921849|FG001|Overall Study|Lack of Efficacy|0|||
105522205|NCT01592344|363921848|FG000|Overall Study|not available at primary outcome visit|2|||
105522206|NCT01592344|363921849|FG001|Overall Study|not available at primary outcome visit|4|||
105522207|NCT00751348|363921851|FG000|Overall Study|Withdrawal by Subject|5|||
105522208|NCT00751348|363921852|FG001|Overall Study|Withdrawal by Subject|2|||
105522209|NCT00751348|363921851|FG000|Overall Study|Migration from study area|1|||
105522210|NCT00751348|363921852|FG001|Overall Study|Migration from study area|0|||
105522211|NCT02726074|363921853|FG000|Overall Study|Withdrawal by Subject|4|||
105522212|NCT02726074|363921853|FG000|Overall Study|Adverse Event|14|||
105522213|NCT02726074|363921853|FG000|Overall Study|Protocol Violation|3|||
105522214|NCT02726074|363921853|FG000|Overall Study|Lost to Follow-up|2|||
105522215|NCT02726074|363921853|FG000|Overall Study|Others|3|||
105522216|NCT00878709|363921857|FG000|Overall Study|Withdrawal by Subject|197|||
105522217|NCT00878709|363921858|FG001|Overall Study|Withdrawal by Subject|120|||
105522218|NCT00878709|363921857|FG000|Overall Study|Lost to Follow-up|35|||
105522219|NCT00878709|363921858|FG001|Overall Study|Lost to Follow-up|33|||
105522220|NCT00878709|363921857|FG000|Overall Study|Other Reasons|93|||
105522221|NCT00878709|363921858|FG001|Overall Study|Other Reasons|84|||
105522222|NCT01712854|363921859|FG000|Overall Study|Physician Decision|1|||
105522223|NCT00768300|363921867|FG000|Overall Study|Randomized but not treated|1|||
105522224|NCT00768300|363921868|FG001|Overall Study|Randomized but not treated|1|||
105522225|NCT00768300|363921867|FG000|Overall Study|Adverse Event|10|||
105522226|NCT00768300|363921868|FG001|Overall Study|Adverse Event|2|||
105522227|NCT00768300|363921867|FG000|Overall Study|Protocol Violation|6|||
105522228|NCT00768300|363921868|FG001|Overall Study|Protocol Violation|1|||
105522229|NCT00768300|363921867|FG000|Overall Study|Withdrawal by Subject|13|||
105522230|NCT00768300|363921868|FG001|Overall Study|Withdrawal by Subject|7|||
105522231|NCT00768300|363921867|FG000|Overall Study|Physician Decision|2|||
105522232|NCT00768300|363921868|FG001|Overall Study|Physician Decision|3|||
105522233|NCT00768300|363921867|FG000|Overall Study|Study discontinued by Sponsor|271|||
105522234|NCT00768300|363921868|FG001|Overall Study|Study discontinued by Sponsor|140|||
105522235|NCT00768300|363921867|FG000|Overall Study|Death|21|||
105522236|NCT00768300|363921868|FG001|Overall Study|Death|5|||
105522237|NCT00768300|363921867|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
105522238|NCT00768300|363921868|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
105522239|NCT00768300|363921867|FG000|Overall Study|Screen failure following randomization|1|||
105522240|NCT00768300|363921868|FG001|Overall Study|Screen failure following randomization|0|||
105522241|NCT00768300|363921867|FG000|Overall Study|Received lung transplant|1|||
105522242|NCT00768300|363921868|FG001|Overall Study|Received lung transplant|1|||
105522243|NCT00768300|363921867|FG000|Overall Study|Lost to Follow-up|0|||
105522244|NCT00768300|363921868|FG001|Overall Study|Lost to Follow-up|1|||
105522245|NCT00768300|363921867|FG000|Overall Study|Began prohibited concomitant medication|0|||
105522246|NCT00768300|363921868|FG001|Overall Study|Began prohibited concomitant medication|1|||
105522247|NCT00768300|363921867|FG000|Overall Study|Treated but never dosed with Study drug|1|||
105522248|NCT00768300|363921868|FG001|Overall Study|Treated but never dosed with Study drug|0|||
105522249|NCT00768300|363921867|FG000|Overall Study|Missing data|1|||
105522250|NCT00768300|363921868|FG001|Overall Study|Missing data|0|||
105522251|NCT01374087|363921873|FG000|Overall Study|Adverse Event|1|||
105522252|NCT01374087|363921874|FG001|Overall Study|Adverse Event|0|||
105522253|NCT01374087|363921873|FG000|Overall Study|Disease progression|2|||
105522254|NCT01374087|363921874|FG001|Overall Study|Disease progression|2|||
105522255|NCT01374087|363921873|FG000|Overall Study|Study discontinued|13|||
105522256|NCT01374087|363921874|FG001|Overall Study|Study discontinued|13|||
105522257|NCT01474876|363921880|FG000|Overall Study|Adverse Event|11|||
105522258|NCT01474876|363921881|FG001|Overall Study|Adverse Event|5|||
105522259|NCT01474876|363921882|FG002|Overall Study|Adverse Event|0|||
105522260|NCT01474876|363921880|FG000|Overall Study|Serious Adverse Event|2|||
105522261|NCT01474876|363921881|FG001|Overall Study|Serious Adverse Event|3|||
105522262|NCT01474876|363921882|FG002|Overall Study|Serious Adverse Event|0|||
105522263|NCT01474876|363921880|FG000|Overall Study|Lost to Follow-up|5|||
105522264|NCT01474876|363921881|FG001|Overall Study|Lost to Follow-up|4|||
105522265|NCT01474876|363921882|FG002|Overall Study|Lost to Follow-up|0|||
105522266|NCT01474876|363921880|FG000|Overall Study|Investigator's decision|28|||
105522267|NCT01474876|363921881|FG001|Overall Study|Investigator's decision|6|||
105522268|NCT01474876|363921882|FG002|Overall Study|Investigator's decision|0|||
105522269|NCT01474876|363921880|FG000|Overall Study|Patient's request|19|||
105522270|NCT01474876|363921881|FG001|Overall Study|Patient's request|5|||
105522271|NCT01474876|363921882|FG002|Overall Study|Patient's request|0|||
105522272|NCT01474876|363921880|FG000|Overall Study|Investigator's decision and pt request|1|||
105522273|NCT01474876|363921881|FG001|Overall Study|Investigator's decision and pt request|0|||
105522274|NCT01474876|363921882|FG002|Overall Study|Investigator's decision and pt request|0|||
105522275|NCT00853723|363921883|FG000|Overall Study|Adverse Event|3|||
105522276|NCT00853723|363921884|FG001|Overall Study|Adverse Event|4|||
105522277|NCT00853723|363921885|FG002|Overall Study|Adverse Event|1|||
105522278|NCT00853723|363921883|FG000|Overall Study|Withdrawal by Subject|2|||
105522279|NCT00853723|363921884|FG001|Overall Study|Withdrawal by Subject|1|||
105522280|NCT00853723|363921885|FG002|Overall Study|Withdrawal by Subject|0|||
105522281|NCT00853723|363921883|FG000|Overall Study|Protocol Violation|1|||
105522282|NCT00853723|363921884|FG001|Overall Study|Protocol Violation|2|||
105522283|NCT00853723|363921885|FG002|Overall Study|Protocol Violation|1|||
105522284|NCT01531387|363921886|FG000|Overall Study|Early termination of study|11|||
105522285|NCT01531387|363921887|FG001|Overall Study|Early termination of study|11|||
105522286|NCT01464346|363921891|FG000|Overall Study|Withdrawal by Subject|0|||
105522287|NCT01464346|363921892|FG001|Overall Study|Withdrawal by Subject|0|||
105522288|NCT01464346|363921893|FG002|Overall Study|Withdrawal by Subject|1|||
105522289|NCT03999892|363921894|FG000|Overall Study|Lost to Follow-up|1|||
105522290|NCT01921179|363923688|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
105522291|NCT01921179|363923689|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
105522292|NCT01921179|363923688|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
105522293|NCT01921179|363923689|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
105522294|NCT03873987|363923692|FG000|Overall Study|Adverse Event|1|||
105522295|NCT03873987|363923693|FG001|Overall Study|Adverse Event|0|||
105522296|NCT03873987|363923692|FG000|Overall Study|staff was unable to start a new IV line|1|||
105522297|NCT03873987|363923693|FG001|Overall Study|staff was unable to start a new IV line|0|||
105522298|NCT03873987|363923692|FG000|Overall Study|Lost to Follow-up|0|||
105522299|NCT03873987|363923693|FG001|Overall Study|Lost to Follow-up|1|||
105522300|NCT01023581|363923696|FG000|Overall Study|Adverse Event|4|||
105522301|NCT01023581|363923697|FG001|Overall Study|Adverse Event|4|||
105522302|NCT01023581|363923698|FG002|Overall Study|Adverse Event|7|||
105522303|NCT01023581|363923699|FG003|Overall Study|Adverse Event|3|||
105522304|NCT01023581|363923700|FG004|Overall Study|Adverse Event|2|||
105522305|NCT01023581|363923701|FG005|Overall Study|Adverse Event|5|||
105522306|NCT01023581|363923702|FG006|Overall Study|Adverse Event|11|||
105522307|NCT01023581|363923696|FG000|Overall Study|Major protocol deviation|2|||
105522308|NCT01023581|363923697|FG001|Overall Study|Major protocol deviation|0|||
105522309|NCT01023581|363923698|FG002|Overall Study|Major protocol deviation|3|||
105522310|NCT01023581|363923699|FG003|Overall Study|Major protocol deviation|0|||
105522311|NCT01023581|363923700|FG004|Overall Study|Major protocol deviation|0|||
105522312|NCT01023581|363923701|FG005|Overall Study|Major protocol deviation|0|||
105522313|NCT01023581|363923702|FG006|Overall Study|Major protocol deviation|0|||
105522314|NCT01023581|363923696|FG000|Overall Study|Lost to Follow-up|4|||
105522315|NCT01023581|363923697|FG001|Overall Study|Lost to Follow-up|8|||
105522316|NCT01023581|363923698|FG002|Overall Study|Lost to Follow-up|7|||
105522317|NCT01023581|363923699|FG003|Overall Study|Lost to Follow-up|2|||
105522318|NCT01023581|363923700|FG004|Overall Study|Lost to Follow-up|5|||
105522319|NCT01023581|363923701|FG005|Overall Study|Lost to Follow-up|2|||
105522320|NCT01023581|363923702|FG006|Overall Study|Lost to Follow-up|2|||
105522321|NCT01023581|363923696|FG000|Overall Study|Withdrawal by Subject|13|||
105522322|NCT01023581|363923697|FG001|Overall Study|Withdrawal by Subject|8|||
105522323|NCT01023581|363923698|FG002|Overall Study|Withdrawal by Subject|16|||
105522324|NCT01023581|363923699|FG003|Overall Study|Withdrawal by Subject|10|||
105522325|NCT01023581|363923700|FG004|Overall Study|Withdrawal by Subject|6|||
105522326|NCT01023581|363923701|FG005|Overall Study|Withdrawal by Subject|8|||
105522327|NCT01023581|363923702|FG006|Overall Study|Withdrawal by Subject|5|||
105522328|NCT01023581|363923696|FG000|Overall Study|Pregnancy|0|||
105592787|NCT03068468|364170764|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
105522329|NCT01023581|363923697|FG001|Overall Study|Pregnancy|0|||
105522330|NCT01023581|363923698|FG002|Overall Study|Pregnancy|0|||
105522331|NCT01023581|363923699|FG003|Overall Study|Pregnancy|2|||
105522332|NCT01023581|363923700|FG004|Overall Study|Pregnancy|0|||
105522333|NCT01023581|363923701|FG005|Overall Study|Pregnancy|1|||
105522334|NCT01023581|363923702|FG006|Overall Study|Pregnancy|0|||
105522335|NCT01023581|363923696|FG000|Overall Study|Lack of Efficacy|9|||
105522336|NCT01023581|363923697|FG001|Overall Study|Lack of Efficacy|3|||
105522337|NCT01023581|363923698|FG002|Overall Study|Lack of Efficacy|6|||
105522338|NCT01023581|363923699|FG003|Overall Study|Lack of Efficacy|2|||
105522339|NCT01023581|363923700|FG004|Overall Study|Lack of Efficacy|1|||
105522340|NCT01023581|363923701|FG005|Overall Study|Lack of Efficacy|2|||
105522341|NCT01023581|363923702|FG006|Overall Study|Lack of Efficacy|1|||
105522342|NCT01023581|363923696|FG000|Overall Study|Physician Decision|2|||
105522343|NCT01023581|363923697|FG001|Overall Study|Physician Decision|0|||
105522344|NCT01023581|363923698|FG002|Overall Study|Physician Decision|2|||
105522345|NCT01023581|363923699|FG003|Overall Study|Physician Decision|1|||
105522346|NCT01023581|363923700|FG004|Overall Study|Physician Decision|1|||
105522347|NCT01023581|363923701|FG005|Overall Study|Physician Decision|1|||
105522348|NCT01023581|363923702|FG006|Overall Study|Physician Decision|1|||
105522349|NCT01023581|363923696|FG000|Overall Study|Other|1|||
105522350|NCT01023581|363923697|FG001|Overall Study|Other|0|||
105522351|NCT01023581|363923698|FG002|Overall Study|Other|1|||
105522352|NCT01023581|363923699|FG003|Overall Study|Other|0|||
105522353|NCT01023581|363923700|FG004|Overall Study|Other|1|||
105522354|NCT01023581|363923701|FG005|Overall Study|Other|0|||
105522355|NCT01023581|363923702|FG006|Overall Study|Other|0|||
105522356|NCT01231581|363923703|FG000|Overall Study|Lost to Follow-up|2|||
105522357|NCT01231581|363923704|FG001|Overall Study|Lost to Follow-up|2|||
105522358|NCT01231581|363923703|FG000|Overall Study|Withdrawal by Subject|6|||
105522359|NCT01231581|363923704|FG001|Overall Study|Withdrawal by Subject|9|||
105522360|NCT01231581|363923703|FG000|Overall Study|Study Closed/Terminated|6|||
105522361|NCT01231581|363923704|FG001|Overall Study|Study Closed/Terminated|5|||
105522362|NCT01231581|363923703|FG000|Overall Study|Death|65|||
105522363|NCT01231581|363923704|FG001|Overall Study|Death|64|||
105522364|NCT01231581|363923703|FG000|Overall Study|Ongoing|1|||
105522365|NCT01231581|363923704|FG001|Overall Study|Ongoing|0|||
105522366|NCT01957462|363923707|FG000|Test Period 1|Withdrawal by Subject|1|||
105522367|NCT01957462|363923708|FG001|Test Period 1|Withdrawal by Subject|0|||
105522368|NCT01957462|363923707|FG000|Test Period 1|Adverse Event|1|||
105522369|NCT01957462|363923708|FG001|Test Period 1|Adverse Event|0|||
105522370|NCT03616912|363923709|FG000|Overall Study|Adverse Event|17|||
105522371|NCT03616912|363923710|FG001|Overall Study|Adverse Event|21|||
105522372|NCT03616912|363923711|FG002|Overall Study|Adverse Event|9|||
105522373|NCT03616912|363923712|FG003|Overall Study|Adverse Event|0|||
105522374|NCT03616912|363923713|FG004|Overall Study|Adverse Event|0|||
105522375|NCT03616912|363923714|FG005|Overall Study|Adverse Event|0|||
105522376|NCT03616912|363923709|FG000|Overall Study|Death|1|||
105522377|NCT03616912|363923710|FG001|Overall Study|Death|1|||
105522378|NCT03616912|363923711|FG002|Overall Study|Death|0|||
105522379|NCT03616912|363923712|FG003|Overall Study|Death|0|||
105522380|NCT03616912|363923713|FG004|Overall Study|Death|0|||
105522381|NCT03616912|363923714|FG005|Overall Study|Death|0|||
105522382|NCT03616912|363923709|FG000|Overall Study|Lack of Efficacy|13|||
105522383|NCT03616912|363923710|FG001|Overall Study|Lack of Efficacy|6|||
105522384|NCT03616912|363923711|FG002|Overall Study|Lack of Efficacy|8|||
105522385|NCT03616912|363923712|FG003|Overall Study|Lack of Efficacy|4|||
105522386|NCT03616912|363923713|FG004|Overall Study|Lack of Efficacy|5|||
105522387|NCT03616912|363923714|FG005|Overall Study|Lack of Efficacy|1|||
105522388|NCT03616912|363923709|FG000|Overall Study|Lost to Follow-up|1|||
105522389|NCT03616912|363923710|FG001|Overall Study|Lost to Follow-up|2|||
105522390|NCT03616912|363923711|FG002|Overall Study|Lost to Follow-up|3|||
105522391|NCT03616912|363923712|FG003|Overall Study|Lost to Follow-up|0|||
105522392|NCT03616912|363923713|FG004|Overall Study|Lost to Follow-up|0|||
105522393|NCT03616912|363923714|FG005|Overall Study|Lost to Follow-up|0|||
105522394|NCT03616912|363923709|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
105522395|NCT03616912|363923710|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
105522396|NCT03616912|363923711|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
105522397|NCT03616912|363923712|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
105522398|NCT03616912|363923713|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
105522399|NCT03616912|363923714|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
105522400|NCT03616912|363923709|FG000|Overall Study|Withdrawal by Subject|12|||
105522401|NCT03616912|363923710|FG001|Overall Study|Withdrawal by Subject|12|||
105522402|NCT03616912|363923711|FG002|Overall Study|Withdrawal by Subject|15|||
105522403|NCT03616912|363923712|FG003|Overall Study|Withdrawal by Subject|2|||
105522404|NCT03616912|363923713|FG004|Overall Study|Withdrawal by Subject|0|||
105522405|NCT03616912|363923714|FG005|Overall Study|Withdrawal by Subject|2|||
105522406|NCT03616912|363923709|FG000|Overall Study|Study Terminated by Sponsor|0|||
105522407|NCT03616912|363923710|FG001|Overall Study|Study Terminated by Sponsor|0|||
105522408|NCT03616912|363923711|FG002|Overall Study|Study Terminated by Sponsor|0|||
105522409|NCT03616912|363923712|FG003|Overall Study|Study Terminated by Sponsor|10|||
105522410|NCT03616912|363923713|FG004|Overall Study|Study Terminated by Sponsor|9|||
105522411|NCT03616912|363923714|FG005|Overall Study|Study Terminated by Sponsor|11|||
105522412|NCT03616912|363923709|FG000|Overall Study|Protocol Deviation|1|||
105522413|NCT03616912|363923710|FG001|Overall Study|Protocol Deviation|1|||
105522414|NCT03616912|363923711|FG002|Overall Study|Protocol Deviation|0|||
105522415|NCT03616912|363923712|FG003|Overall Study|Protocol Deviation|0|||
105522416|NCT03616912|363923713|FG004|Overall Study|Protocol Deviation|0|||
105522417|NCT03616912|363923714|FG005|Overall Study|Protocol Deviation|0|||
105522418|NCT03616912|363923709|FG000|Overall Study|Pregnancy|1|||
105522419|NCT03616912|363923710|FG001|Overall Study|Pregnancy|0|||
105522420|NCT03616912|363923711|FG002|Overall Study|Pregnancy|4|||
105522421|NCT03616912|363923712|FG003|Overall Study|Pregnancy|0|||
105522422|NCT03616912|363923713|FG004|Overall Study|Pregnancy|0|||
105522423|NCT03616912|363923714|FG005|Overall Study|Pregnancy|0|||
105522424|NCT03616912|363923709|FG000|Overall Study|Protocol Violation|1|||
105522425|NCT03616912|363923710|FG001|Overall Study|Protocol Violation|0|||
105522426|NCT03616912|363923711|FG002|Overall Study|Protocol Violation|2|||
105522427|NCT03616912|363923712|FG003|Overall Study|Protocol Violation|0|||
105522428|NCT03616912|363923713|FG004|Overall Study|Protocol Violation|0|||
105522429|NCT03616912|363923714|FG005|Overall Study|Protocol Violation|0|||
105522430|NCT03616912|363923709|FG000|Overall Study|Physician Decision|2|||
105522431|NCT03616912|363923710|FG001|Overall Study|Physician Decision|0|||
105522432|NCT03616912|363923711|FG002|Overall Study|Physician Decision|0|||
105522433|NCT03616912|363923712|FG003|Overall Study|Physician Decision|0|||
105522434|NCT03616912|363923713|FG004|Overall Study|Physician Decision|1|||
105522435|NCT03616912|363923714|FG005|Overall Study|Physician Decision|0|||
105522436|NCT03616912|363923709|FG000|Overall Study|Randomized But Never Treated|0|||
105522437|NCT03616912|363923710|FG001|Overall Study|Randomized But Never Treated|2|||
105522438|NCT03616912|363923711|FG002|Overall Study|Randomized But Never Treated|0|||
105522439|NCT03616912|363923712|FG003|Overall Study|Randomized But Never Treated|0|||
105522440|NCT03616912|363923713|FG004|Overall Study|Randomized But Never Treated|0|||
105522441|NCT03616912|363923714|FG005|Overall Study|Randomized But Never Treated|0|||
105522442|NCT01290666|363923715|FG000|Overall Study|Lost to Follow-up|11|||
105522443|NCT01290666|363923715|FG000|Overall Study|Withdrawal by Subject|23|||
105522444|NCT01290666|363923715|FG000|Overall Study|Early Termination of Study|4|||
105522445|NCT01652664|363923716|FG000|Overall Study|Treatment Failure|5|||
105522446|NCT01652664|363923717|FG001|Overall Study|Treatment Failure|1|||
105522447|NCT01652664|363923716|FG000|Overall Study|Inadequate IOP control|1|||
105522448|NCT01652664|363923717|FG001|Overall Study|Inadequate IOP control|0|||
105522449|NCT00076011|363923718|FG000|Overall Study|Death|1|||
105522450|NCT00076011|363923718|FG000|Overall Study|Adverse Event|10|||
105522451|NCT00076011|363923718|FG000|Overall Study|Lack of Efficacy|25|||
105522452|NCT00076011|363923718|FG000|Overall Study|Withdrawal by Subject|1|||
105522453|NCT00076011|363923718|FG000|Overall Study|Study terminated by sponsor|3|||
105522454|NCT00076011|363923718|FG000|Overall Study|Other|11|||
105522455|NCT00076011|363923718|FG000|Overall Study|Ongoing|1|||
105522456|NCT03164928|363923730|FG000|Overall Study|Lost to Follow-up|1|||
105522457|NCT03164928|363923731|FG001|Overall Study|Lost to Follow-up|0|||
105522458|NCT02211131|363923733|FG000|Overall Study|Death|26|||
105522459|NCT02211131|363923734|FG001|Overall Study|Death|16|||
105522460|NCT02211131|363923733|FG000|Overall Study|Lost to Follow-up|4|||
105522461|NCT02211131|363923734|FG001|Overall Study|Lost to Follow-up|3|||
105522462|NCT02211131|363923733|FG000|Overall Study|Decision by Sponsor|1|||
105522463|NCT02211131|363923734|FG001|Overall Study|Decision by Sponsor|1|||
105522464|NCT02211131|363923733|FG000|Overall Study|Withdrawal by Subject|3|||
105522465|NCT02211131|363923734|FG001|Overall Study|Withdrawal by Subject|8|||
105522466|NCT00454987|363923735|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
105522467|NCT00454987|363923736|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
105522468|NCT00454987|363923737|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
105522469|NCT00454987|363923735|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
105522470|NCT00454987|363923736|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
105522471|NCT00454987|363923737|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
105522472|NCT00454987|363923735|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
105522473|NCT00454987|363923736|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
105522474|NCT00454987|363923737|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
105522475|NCT01476696|363923738|FG000|Overall Study|Sponsor decision|2|||
105522476|NCT01476696|363923739|FG001|Overall Study|Sponsor decision|1|||
105522477|NCT01476696|363923740|FG002|Overall Study|Sponsor decision|0|||
105522478|NCT01476696|363923738|FG000|Overall Study|Withdrawal by Subject|1|||
105522479|NCT01476696|363923739|FG001|Overall Study|Withdrawal by Subject|0|||
105522480|NCT01476696|363923740|FG002|Overall Study|Withdrawal by Subject|0|||
105522481|NCT03054870|363923743|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
105522482|NCT03054870|363923743|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
105522483|NCT02009046|363923744|FG000|Overall Study|Lost to Follow-up|256|||
105522484|NCT02009046|363923745|FG001|Overall Study|Lost to Follow-up|206|||
105522485|NCT00728130|363923747|FG000|Overall Study|Withdrawal by Subject|1|||
105522486|NCT00728130|363923747|FG000|Overall Study|Paperwork not completed in time|1|||
105522487|NCT00728130|363923747|FG000|Overall Study|Physician Decision|1|||
105522488|NCT05075850|363923754|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
105522489|NCT03089606|363923755|FG000|Overall Study|Progression after Cycle 1|1|||
105592788|NCT03068468|364170765|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
105522490|NCT01826487|363923758|FG000|Overall Study|Adverse Event|1|||
105522491|NCT01826487|363923759|FG001|Overall Study|Adverse Event|1|||
105522492|NCT01826487|363923758|FG000|Overall Study|Lost to Follow-up|1|||
105522493|NCT01826487|363923759|FG001|Overall Study|Lost to Follow-up|0|||
105522494|NCT01826487|363923758|FG000|Overall Study|Withdrawal by Subject|1|||
105522495|NCT01826487|363923759|FG001|Overall Study|Withdrawal by Subject|3|||
105522496|NCT01826487|363923758|FG000|Overall Study|Protocol Violation|1|||
105522497|NCT01826487|363923759|FG001|Overall Study|Protocol Violation|1|||
105522498|NCT01092182|363923761|FG000|Overall Study|Death|0|||
105522499|NCT01092182|363923762|FG001|Overall Study|Death|5|||
105522500|NCT01092182|363923763|FG002|Overall Study|Death|3|||
105522501|NCT01092182|363923761|FG000|Overall Study|participant safety|1|||
105522502|NCT01092182|363923762|FG001|Overall Study|participant safety|2|||
105522503|NCT01092182|363923763|FG002|Overall Study|participant safety|0|||
105522504|NCT01092182|363923761|FG000|Overall Study|Physician Decision|0|||
105522505|NCT01092182|363923762|FG001|Overall Study|Physician Decision|6|||
105522506|NCT01092182|363923763|FG002|Overall Study|Physician Decision|0|||
105522507|NCT01092182|363923761|FG000|Overall Study|Did not meet criteria|0|||
105522508|NCT01092182|363923762|FG001|Overall Study|Did not meet criteria|0|||
105522509|NCT01092182|363923763|FG002|Overall Study|Did not meet criteria|25|||
105522510|NCT01092182|363923761|FG000|Overall Study|Non-compliance|0|||
105522511|NCT01092182|363923762|FG001|Overall Study|Non-compliance|3|||
105522512|NCT01092182|363923763|FG002|Overall Study|Non-compliance|0|||
105522513|NCT01092182|363923761|FG000|Overall Study|Participant refused follow-up|0|||
105522514|NCT01092182|363923762|FG001|Overall Study|Participant refused follow-up|2|||
105522515|NCT01092182|363923763|FG002|Overall Study|Participant refused follow-up|0|||
105522516|NCT02081079|363923764|FG000|Overall Study|Lack of Efficacy|3|||
105522517|NCT02081079|363923765|FG001|Overall Study|Lack of Efficacy|2|||
105522518|NCT02081079|363923764|FG000|Overall Study|Lost to Follow-up|1|||
105522519|NCT02081079|363923765|FG001|Overall Study|Lost to Follow-up|0|||
105522520|NCT00322842|363923766|FG000|Overall Study|Withdrawal by Subject|0|||
105522521|NCT00322842|363923767|FG001|Overall Study|Withdrawal by Subject|1|||
105522522|NCT00322842|363923766|FG000|Overall Study|Lost to Follow-up|0|||
105522523|NCT00322842|363923767|FG001|Overall Study|Lost to Follow-up|1|||
105522524|NCT00322842|363923766|FG000|Overall Study|Refused transplant|1|||
105522525|NCT00322842|363923767|FG001|Overall Study|Refused transplant|0|||
105522526|NCT00322842|363923766|FG000|Overall Study|Death|1|||
105522527|NCT00322842|363923767|FG001|Overall Study|Death|0|||
105522528|NCT02515045|363923770|FG000|Overall Study|Adverse Event|0|||
105522529|NCT02515045|363923771|FG001|Overall Study|Adverse Event|3|||
105522530|NCT02515045|363923772|FG002|Overall Study|Adverse Event|3|||
105522531|NCT02515045|363923770|FG000|Overall Study|Lost to Follow-up|0|||
105522532|NCT02515045|363923771|FG001|Overall Study|Lost to Follow-up|1|||
105522533|NCT02515045|363923772|FG002|Overall Study|Lost to Follow-up|1|||
105522534|NCT02068222|363923773|FG000|Overall Study|Lost to Follow-up|1|||
105522535|NCT03082599|363923774|FG000|Overall Study|Lost to Follow-up|1|||
105522536|NCT03082599|363923775|FG001|Overall Study|Lost to Follow-up|0|||
105522537|NCT00238121|363923776|FG000|Overall Study|Withdrawal by Subject|1|||
105522538|NCT00238121|363923777|FG001|Overall Study|Withdrawal by Subject|1|||
105522539|NCT00238121|363923776|FG000|Overall Study|Adverse Event|2|||
105522540|NCT00238121|363923777|FG001|Overall Study|Adverse Event|1|||
105522541|NCT03255382|363923778|FG000|Overall Study|Adverse Event|3|||
105522542|NCT03255382|363923779|FG001|Overall Study|Adverse Event|0|||
105522543|NCT03255382|363923778|FG000|Overall Study|Lost to Follow-up|2|||
105522544|NCT03255382|363923779|FG001|Overall Study|Lost to Follow-up|0|||
105522545|NCT03255382|363923778|FG000|Overall Study|Withdrawal by Subject|2|||
105522546|NCT03255382|363923779|FG001|Overall Study|Withdrawal by Subject|0|||
105522547|NCT03255382|363923778|FG000|Overall Study|Other|6|||
105522548|NCT03255382|363923779|FG001|Overall Study|Other|0|||
105522549|NCT02221284|363923784|FG000|Overall Study|Case Report Forms Uncollected|56|||
105522550|NCT02221284|363923784|FG000|Overall Study|Protocol Deviation|5|||
105522551|NCT03011307|363923790|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
105522552|NCT03011307|363923791|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
105522553|NCT03011307|363923790|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
105522554|NCT03011307|363923791|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
105522555|NCT03011307|363923790|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
105522556|NCT03011307|363923791|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
105522557|NCT01782664|363923792|FG000|Overall Study|Adverse Event|2|||
105522558|NCT01782664|363923793|FG001|Overall Study|Adverse Event|2|||
105522559|NCT01782664|363923794|FG002|Overall Study|Adverse Event|2|||
105522560|NCT01782664|363923795|FG003|Overall Study|Adverse Event|2|||
105522561|NCT01782664|363923796|FG004|Overall Study|Adverse Event|0|||
105522562|NCT01782664|363923797|FG005|Overall Study|Adverse Event|0|||
105522563|NCT01782664|363923792|FG000|Overall Study|Lack of Efficacy|2|||
105522564|NCT01782664|363923793|FG001|Overall Study|Lack of Efficacy|0|||
105522565|NCT01782664|363923794|FG002|Overall Study|Lack of Efficacy|2|||
105522566|NCT01782664|363923795|FG003|Overall Study|Lack of Efficacy|2|||
105522567|NCT01782664|363923796|FG004|Overall Study|Lack of Efficacy|0|||
105522568|NCT01782664|363923797|FG005|Overall Study|Lack of Efficacy|0|||
105522569|NCT01782664|363923792|FG000|Overall Study|Protocol Violation|0|||
105522570|NCT01782664|363923793|FG001|Overall Study|Protocol Violation|1|||
105522571|NCT01782664|363923794|FG002|Overall Study|Protocol Violation|0|||
105522572|NCT01782664|363923795|FG003|Overall Study|Protocol Violation|1|||
105522573|NCT01782664|363923796|FG004|Overall Study|Protocol Violation|0|||
105522574|NCT01782664|363923797|FG005|Overall Study|Protocol Violation|0|||
105522575|NCT01782664|363923792|FG000|Overall Study|Withdrawal by Subject|2|||
105522576|NCT01782664|363923793|FG001|Overall Study|Withdrawal by Subject|2|||
105522577|NCT01782664|363923794|FG002|Overall Study|Withdrawal by Subject|0|||
105522578|NCT01782664|363923795|FG003|Overall Study|Withdrawal by Subject|0|||
105522579|NCT01782664|363923796|FG004|Overall Study|Withdrawal by Subject|0|||
105522580|NCT01782664|363923797|FG005|Overall Study|Withdrawal by Subject|0|||
105522581|NCT00281684|363923799|FG000|Overall Study|Lost to Follow-up|0|||
105522582|NCT00281684|363923800|FG001|Overall Study|Lost to Follow-up|0|||
105522583|NCT00281684|363923801|FG002|Overall Study|Lost to Follow-up|1|||
105522584|NCT00281684|363923802|FG003|Overall Study|Lost to Follow-up|0|||
105522585|NCT00281684|363923799|FG000|Overall Study|Withdrawal by Subject|1|||
105522586|NCT00281684|363923800|FG001|Overall Study|Withdrawal by Subject|0|||
105522587|NCT00281684|363923801|FG002|Overall Study|Withdrawal by Subject|0|||
105522588|NCT00281684|363923802|FG003|Overall Study|Withdrawal by Subject|0|||
105522589|NCT00698581|363923805|FG000|Overall Study|Lack of Efficacy|23|||
105522590|NCT00698581|363923806|FG001|Overall Study|Lack of Efficacy|11|||
105522591|NCT00698581|363923805|FG000|Overall Study|Withdrawal by Subject|6|||
105522592|NCT00698581|363923806|FG001|Overall Study|Withdrawal by Subject|0|||
105522593|NCT00698581|363923805|FG000|Overall Study|Other reason|9|||
105522594|NCT00698581|363923806|FG001|Overall Study|Other reason|1|||
105522595|NCT00698581|363923805|FG000|Overall Study|SAE, non-fatal|1|||
105522596|NCT00698581|363923806|FG001|Overall Study|SAE, non-fatal|0|||
105522597|NCT00698581|363923805|FG000|Overall Study|AE, non-serious non-fatal|4|||
105522598|NCT00698581|363923806|FG001|Overall Study|AE, non-serious non-fatal|0|||
105522599|NCT00698581|363923805|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
105522600|NCT00698581|363923806|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
105522601|NCT00698581|363923805|FG000|Overall Study|AE of unknown type|1|||
105522602|NCT00698581|363923806|FG001|Overall Study|AE of unknown type|0|||
105522603|NCT01082965|363923807|FG000|Overall Study|Protocol Violation|0|||
105522604|NCT01082965|363923808|FG001|Overall Study|Protocol Violation|1|||
105522605|NCT01082965|363923807|FG000|Overall Study|Other|1|||
105522606|NCT01082965|363923808|FG001|Overall Study|Other|1|||
105522607|NCT00529542|363923809|FG000|Overall Study|Withdrawal by Subject|1|||
105522608|NCT00529542|363923810|FG001|Overall Study|Withdrawal by Subject|0|||
105522609|NCT00529542|363923809|FG000|Overall Study|Lost to Follow-up|0|||
105522610|NCT00529542|363923810|FG001|Overall Study|Lost to Follow-up|1|||
105522611|NCT00946712|363923811|FG000|Overall Study|Adverse Event|118|||
105522612|NCT00946712|363923812|FG001|Overall Study|Adverse Event|124|||
105522613|NCT00946712|363923811|FG000|Overall Study|Disease progression|308|||
105522614|NCT00946712|363923812|FG001|Overall Study|Disease progression|404|||
105522615|NCT00946712|363923811|FG000|Overall Study|Death|21|||
105522616|NCT00946712|363923812|FG001|Overall Study|Death|22|||
105522617|NCT00946712|363923811|FG000|Overall Study|No treatment given|25|||
105522618|NCT00946712|363923812|FG001|Overall Study|No treatment given|29|||
105522619|NCT00946712|363923811|FG000|Overall Study|Other reasons|61|||
105522620|NCT00946712|363923812|FG001|Overall Study|Other reasons|73|||
105522621|NCT00946712|363923811|FG000|Overall Study|On Treatment|0|||
105522622|NCT00946712|363923812|FG001|Overall Study|On Treatment|4|||
105522623|NCT00946712|363923811|FG000|Overall Study|Ineligible|14|||
105522624|NCT00946712|363923812|FG001|Overall Study|Ineligible|6|||
105522625|NCT01523886|363923813|FG000|Overall Study|surgery cancelled|0|||
105522626|NCT01523886|363923814|FG001|Overall Study|surgery cancelled|1|||
105522627|NCT03839212|363923818|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
105522628|NCT00718328|363923824|FG000|Overall Study|Lost to Follow-up|1|||
105522629|NCT00718328|363923825|FG001|Overall Study|Lost to Follow-up|0|||
105522630|NCT00663052|363923828|FG000|Overall Study|Adverse Event|6|||
105522631|NCT00663052|363923829|FG001|Overall Study|Adverse Event|3|||
105522632|NCT00663052|363923828|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
105522633|NCT00663052|363923829|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
105522634|NCT00663052|363923828|FG000|Overall Study|Protocol Violation|1|||
105522635|NCT00663052|363923829|FG001|Overall Study|Protocol Violation|0|||
105522636|NCT00663052|363923828|FG000|Overall Study|Withdrawal by Subject|2|||
105522637|NCT00663052|363923829|FG001|Overall Study|Withdrawal by Subject|5|||
105522638|NCT00663052|363923828|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
105522639|NCT00663052|363923829|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
105522640|NCT00663052|363923828|FG000|Overall Study|Other|0|||
105522641|NCT00663052|363923829|FG001|Overall Study|Other|1|||
105522642|NCT00567892|363923830|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
105522643|NCT00567892|363923831|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
105522644|NCT00567892|363923832|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
105522645|NCT00567892|363923833|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
105522646|NCT00567892|363923830|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
105522647|NCT00567892|363923831|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
105522648|NCT00567892|363923832|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
105522649|NCT00567892|363923833|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
105522650|NCT01852942|363926321|FG000|Overall Study|Physician Decision|1|||
105522651|NCT01852942|363926322|FG001|Overall Study|Physician Decision|0|||
105522652|NCT01852942|363926321|FG000|Overall Study|Death|1|||
105522653|NCT01852942|363926322|FG001|Overall Study|Death|1|||
105522654|NCT01852942|363926321|FG000|Overall Study|Withdrawal by Subject|2|||
105522655|NCT01852942|363926322|FG001|Overall Study|Withdrawal by Subject|3|||
105522656|NCT01852942|363926321|FG000|Overall Study|Lost to Follow-up|1|||
105522657|NCT01852942|363926322|FG001|Overall Study|Lost to Follow-up|2|||
105522658|NCT00887354|363926330|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
105522659|NCT00887354|363926331|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
105522660|NCT00887354|363926330|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
105522661|NCT00887354|363926331|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
105522662|NCT00887354|363926330|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
105522663|NCT00887354|363926331|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
105522664|NCT00887354|363926330|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
105522665|NCT00887354|363926331|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
105522666|NCT00887354|363926330|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
105522667|NCT00887354|363926331|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
105522668|NCT00887354|363926330|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
105522669|NCT00887354|363926331|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
105522670|NCT00887354|363926330|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
105522671|NCT00887354|363926331|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
105522672|NCT00887354|363926330|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
105522673|NCT00887354|363926331|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
105522674|NCT00887354|363926330|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
105522675|NCT00887354|363926331|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
105522676|NCT00887354|363926330|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
105522677|NCT00887354|363926331|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
105522678|NCT00887354|363926330|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
105522679|NCT00887354|363926331|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
105522680|NCT00887354|363926330|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
105522681|NCT00887354|363926331|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
105522682|NCT00887354|363926330|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
105522683|NCT00887354|363926331|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
105522684|NCT00887354|363926330|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
105522685|NCT00887354|363926331|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
105522686|NCT00887354|363926330|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
105522687|NCT00887354|363926331|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
105522688|NCT02981342|363926333|FG000|Overall Study|Adverse Event|0|||
105522689|NCT02981342|363926334|FG001|Overall Study|Adverse Event|0|||
105522690|NCT02981342|363926335|FG002|Overall Study|Adverse Event|0|||
105522691|NCT02981342|363926336|FG003|Overall Study|Adverse Event|1|||
105522692|NCT02981342|363926333|FG000|Overall Study|Death|0|||
105522693|NCT02981342|363926334|FG001|Overall Study|Death|9|||
105522694|NCT02981342|363926335|FG002|Overall Study|Death|9|||
105522695|NCT02981342|363926336|FG003|Overall Study|Death|4|||
105522696|NCT02981342|363926333|FG000|Overall Study|Withdrawal by Subject|0|||
105522697|NCT02981342|363926334|FG001|Overall Study|Withdrawal by Subject|0|||
105522698|NCT02981342|363926335|FG002|Overall Study|Withdrawal by Subject|3|||
105522699|NCT02981342|363926336|FG003|Overall Study|Withdrawal by Subject|1|||
105522700|NCT02981342|363926333|FG000|Overall Study|Study closed by sponsor|0|||
105522701|NCT02981342|363926334|FG001|Overall Study|Study closed by sponsor|0|||
105522702|NCT02981342|363926335|FG002|Overall Study|Study closed by sponsor|1|||
105522703|NCT02981342|363926336|FG003|Overall Study|Study closed by sponsor|1|||
105522704|NCT02981342|363926333|FG000|Overall Study|Randomized, Never Treated|0|||
105522705|NCT02981342|363926334|FG001|Overall Study|Randomized, Never Treated|1|||
105522706|NCT02981342|363926335|FG002|Overall Study|Randomized, Never Treated|0|||
105522707|NCT02981342|363926336|FG003|Overall Study|Randomized, Never Treated|7|||
105522708|NCT02981342|363926333|FG000|Overall Study|Lost to Follow-up|0|||
105522709|NCT02981342|363926334|FG001|Overall Study|Lost to Follow-up|1|||
105522710|NCT02981342|363926335|FG002|Overall Study|Lost to Follow-up|0|||
105522711|NCT02981342|363926336|FG003|Overall Study|Lost to Follow-up|0|||
105522712|NCT01365507|363926337|FG000|Overall Study|Withdrawal Criteria|8|||
105522713|NCT01365507|363926338|FG001|Overall Study|Withdrawal Criteria|5|||
105522714|NCT01365507|363926337|FG000|Overall Study|Unclassified|1|||
105522715|NCT01365507|363926338|FG001|Overall Study|Unclassified|4|||
105522716|NCT00192504|363926343|FG000|Overall Study|Lost to Follow-up|1|||
105522717|NCT00192504|363926344|FG001|Overall Study|Lost to Follow-up|0|||
105522718|NCT00192504|363926345|FG002|Overall Study|Lost to Follow-up|0|||
105522719|NCT00192504|363926346|FG003|Overall Study|Lost to Follow-up|0|||
105522720|NCT00192504|363926343|FG000|Overall Study|Dosing window missed|0|||
105522721|NCT00192504|363926344|FG001|Overall Study|Dosing window missed|0|||
105522722|NCT00192504|363926345|FG002|Overall Study|Dosing window missed|1|||
105522723|NCT00192504|363926346|FG003|Overall Study|Dosing window missed|0|||
105522724|NCT00605813|363926347|FG000|Overall Study|Protocol Violation|25|||
105522725|NCT03989440|363926348|FG000|Overall Study|COVID-19 travel restrictions|0|||
105522726|NCT03989440|363926349|FG001|Overall Study|COVID-19 travel restrictions|0|||
105522727|NCT03989440|363926350|FG002|Overall Study|COVID-19 travel restrictions|1|||
105522728|NCT03989440|363926351|FG003|Overall Study|COVID-19 travel restrictions|0|||
105522729|NCT03989440|363926352|FG004|Overall Study|COVID-19 travel restrictions|0|||
105522730|NCT03989440|363926353|FG005|Overall Study|COVID-19 travel restrictions|0|||
105522731|NCT03989440|363926348|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
105522732|NCT03989440|363926349|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
105522733|NCT03989440|363926350|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
105522734|NCT03989440|363926351|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
105522735|NCT03989440|363926352|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
105522736|NCT03989440|363926353|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
105522737|NCT03265249|363926354|FG000|Overall Study|Withdrawal by Subject|0|||
105522738|NCT03265249|363926355|FG001|Overall Study|Withdrawal by Subject|1|||
105522739|NCT01614990|363926356|FG000|Overall Study|Protocol Violation|1|||
105522740|NCT01614990|363926357|FG001|Overall Study|Protocol Violation|1|||
105522741|NCT02794103|363926358|FG000|Overall Study|Loss to follow up due to high sedation|3|||
105522742|NCT01139450|363926359|FG000|Overall Study|Withdrawal by Subject|7|||
105522743|NCT01139450|363926360|FG001|Overall Study|Withdrawal by Subject|10|||
105522744|NCT01139450|363926361|FG002|Overall Study|Withdrawal by Subject|13|||
105522745|NCT01139450|363926359|FG000|Overall Study|Lack of Efficacy|3|||
105522746|NCT01139450|363926360|FG001|Overall Study|Lack of Efficacy|1|||
105522747|NCT01139450|363926361|FG002|Overall Study|Lack of Efficacy|8|||
105522748|NCT01139450|363926359|FG000|Overall Study|Protocol Violation|6|||
105522749|NCT01139450|363926360|FG001|Overall Study|Protocol Violation|5|||
105522750|NCT01139450|363926361|FG002|Overall Study|Protocol Violation|2|||
105522751|NCT01139450|363926359|FG000|Overall Study|Lost to Follow-up|9|||
105522752|NCT01139450|363926360|FG001|Overall Study|Lost to Follow-up|7|||
105522753|NCT01139450|363926361|FG002|Overall Study|Lost to Follow-up|11|||
105522754|NCT01139450|363926359|FG000|Overall Study|Administrative|0|||
105522755|NCT01139450|363926360|FG001|Overall Study|Administrative|0|||
105522756|NCT01139450|363926361|FG002|Overall Study|Administrative|1|||
105522757|NCT01139450|363926359|FG000|Overall Study|Adverse Event|2|||
105522758|NCT01139450|363926360|FG001|Overall Study|Adverse Event|2|||
105522759|NCT01139450|363926361|FG002|Overall Study|Adverse Event|3|||
105522760|NCT05333900|363926362|FG000|Overall Study|Protocol Violation|0|||
105522761|NCT05333900|363926363|FG001|Overall Study|Protocol Violation|1|||
105522762|NCT05333900|363926362|FG000|Overall Study|Withdrawal by Subject|0|||
105522763|NCT05333900|363926363|FG001|Overall Study|Withdrawal by Subject|1|||
105522764|NCT05333900|363926362|FG000|Overall Study|COVID-19 Pandemic|1|||
105522765|NCT05333900|363926363|FG001|Overall Study|COVID-19 Pandemic|1|||
105522766|NCT00542919|363926364|FG000|Overall Study|Adverse Event|1|||
105522767|NCT00542919|363926365|FG001|Overall Study|Adverse Event|5|||
105522768|NCT00542919|363926366|FG002|Overall Study|Adverse Event|1|||
105522769|NCT00542919|363926364|FG000|Overall Study|Withdrawal by Subject|1|||
105522770|NCT00542919|363926365|FG001|Overall Study|Withdrawal by Subject|0|||
105522771|NCT00542919|363926366|FG002|Overall Study|Withdrawal by Subject|3|||
105522772|NCT00542919|363926364|FG000|Overall Study|Physician Decision|2|||
105522773|NCT00542919|363926365|FG001|Overall Study|Physician Decision|2|||
105522774|NCT00542919|363926366|FG002|Overall Study|Physician Decision|1|||
105522775|NCT00542919|363926364|FG000|Overall Study|Sponsor Decision|1|||
105522776|NCT00542919|363926365|FG001|Overall Study|Sponsor Decision|0|||
105522777|NCT00542919|363926366|FG002|Overall Study|Sponsor Decision|0|||
105522778|NCT00542919|363926364|FG000|Overall Study|Lost to Follow-up|2|||
105522779|NCT00542919|363926365|FG001|Overall Study|Lost to Follow-up|0|||
105522780|NCT00542919|363926366|FG002|Overall Study|Lost to Follow-up|1|||
105522781|NCT00112502|363926372|FG000|Overall Study|Withdrawal by Subject|0|||
105522782|NCT00112502|363926373|FG001|Overall Study|Withdrawal by Subject|1|||
105522783|NCT00112502|363926374|FG002|Overall Study|Withdrawal by Subject|1|||
105522784|NCT00112502|363926375|FG003|Overall Study|Withdrawal by Subject|4|||
105522785|NCT00112502|363926376|FG004|Overall Study|Withdrawal by Subject|2|||
105522786|NCT00112502|363926377|FG005|Overall Study|Withdrawal by Subject|5|||
105522787|NCT00112502|363926378|FG006|Overall Study|Withdrawal by Subject|3|||
105522788|NCT00112502|363926379|FG007|Overall Study|Withdrawal by Subject|7|||
105522789|NCT02747420|363926380|FG000|Overall Study|Lost to Follow-up|4|||
105522790|NCT02747420|363926381|FG001|Overall Study|Lost to Follow-up|2|||
105522791|NCT02747420|363926380|FG000|Overall Study|Withdrawal by Subject|3|||
105522792|NCT02747420|363926381|FG001|Overall Study|Withdrawal by Subject|2|||
105522793|NCT02255500|363926382|FG000|Overall Study|Withdrawal by Subject|1|||
105522794|NCT02255500|363926383|FG001|Overall Study|Withdrawal by Subject|0|||
105522795|NCT05129488|363926384|FG000|Overall Study|Protocol Violation|3|||
105522796|NCT00265343|363926385|FG000|Overall Study|Adverse Event|10|||
105522797|NCT00265343|363926386|FG001|Overall Study|Adverse Event|7|||
105522798|NCT00265343|363926385|FG000|Overall Study|Withdrawal by Subject|3|||
105522799|NCT00265343|363926386|FG001|Overall Study|Withdrawal by Subject|9|||
105522800|NCT00265343|363926385|FG000|Overall Study|Other|8|||
105522801|NCT00265343|363926386|FG001|Overall Study|Other|3|||
105522802|NCT02608268|363926387|FG000|Overall Study|Adverse Event|0|||
105522803|NCT02608268|363926388|FG001|Overall Study|Adverse Event|0|||
105522804|NCT02608268|363926389|FG002|Overall Study|Adverse Event|1|||
105522805|NCT02608268|363926390|FG003|Overall Study|Adverse Event|0|||
105522806|NCT02608268|363926391|FG004|Overall Study|Adverse Event|0|||
105522807|NCT02608268|363926392|FG005|Overall Study|Adverse Event|0|||
105522808|NCT02608268|363926393|FG006|Overall Study|Adverse Event|0|||
105522809|NCT02608268|363926394|FG007|Overall Study|Adverse Event|0|||
105522810|NCT02608268|363926395|FG008|Overall Study|Adverse Event|0|||
105522811|NCT02608268|363926396|FG009|Overall Study|Adverse Event|0|||
105522812|NCT02608268|363926397|FG010|Overall Study|Adverse Event|0|||
105522813|NCT02608268|363926398|FG011|Overall Study|Adverse Event|0|||
105522814|NCT02608268|363926399|FG012|Overall Study|Adverse Event|2|||
105522815|NCT02608268|363926400|FG013|Overall Study|Adverse Event|0|||
105522816|NCT02608268|363926401|FG014|Overall Study|Adverse Event|0|||
105522817|NCT02608268|363926402|FG015|Overall Study|Adverse Event|0|||
105522818|NCT02608268|363926403|FG016|Overall Study|Adverse Event|0|||
105522819|NCT02608268|363926404|FG017|Overall Study|Adverse Event|0|||
105522820|NCT02608268|363926405|FG018|Overall Study|Adverse Event|0|||
105522821|NCT02608268|363926406|FG019|Overall Study|Adverse Event|0|||
105522822|NCT02608268|363926407|FG020|Overall Study|Adverse Event|1|||
105522823|NCT02608268|363926408|FG021|Overall Study|Adverse Event|1|||
105522824|NCT02608268|363926409|FG022|Overall Study|Adverse Event|0|||
105522825|NCT02608268|363926410|FG023|Overall Study|Adverse Event|0|||
105522826|NCT02608268|363926411|FG024|Overall Study|Adverse Event|1|||
105522827|NCT02608268|363926412|FG025|Overall Study|Adverse Event|0|||
105522828|NCT02608268|363926413|FG026|Overall Study|Adverse Event|0|||
105522829|NCT02608268|363926414|FG027|Overall Study|Adverse Event|0|||
105522830|NCT02608268|363926415|FG028|Overall Study|Adverse Event|1|||
105522831|NCT02608268|363926416|FG029|Overall Study|Adverse Event|0|||
105522832|NCT02608268|363926387|FG000|Overall Study|Death|1|||
105522833|NCT02608268|363926388|FG001|Overall Study|Death|0|||
105522834|NCT02608268|363926389|FG002|Overall Study|Death|0|||
105522835|NCT02608268|363926390|FG003|Overall Study|Death|0|||
105522836|NCT02608268|363926391|FG004|Overall Study|Death|0|||
105522837|NCT02608268|363926392|FG005|Overall Study|Death|0|||
105522838|NCT02608268|363926393|FG006|Overall Study|Death|0|||
105522839|NCT02608268|363926394|FG007|Overall Study|Death|0|||
105522840|NCT02608268|363926395|FG008|Overall Study|Death|1|||
105522841|NCT02608268|363926396|FG009|Overall Study|Death|1|||
105522842|NCT02608268|363926397|FG010|Overall Study|Death|0|||
105522843|NCT02608268|363926398|FG011|Overall Study|Death|0|||
105522844|NCT02608268|363926399|FG012|Overall Study|Death|0|||
105522845|NCT02608268|363926400|FG013|Overall Study|Death|0|||
105522846|NCT02608268|363926401|FG014|Overall Study|Death|0|||
105522847|NCT02608268|363926402|FG015|Overall Study|Death|1|||
105522848|NCT02608268|363926403|FG016|Overall Study|Death|0|||
105522849|NCT02608268|363926404|FG017|Overall Study|Death|1|||
105522850|NCT02608268|363926405|FG018|Overall Study|Death|0|||
105522851|NCT02608268|363926406|FG019|Overall Study|Death|1|||
105522852|NCT02608268|363926407|FG020|Overall Study|Death|1|||
105522853|NCT02608268|363926408|FG021|Overall Study|Death|0|||
105522854|NCT02608268|363926409|FG022|Overall Study|Death|0|||
105522855|NCT02608268|363926410|FG023|Overall Study|Death|0|||
105522856|NCT02608268|363926411|FG024|Overall Study|Death|1|||
105522857|NCT02608268|363926412|FG025|Overall Study|Death|2|||
105522858|NCT02608268|363926413|FG026|Overall Study|Death|0|||
105522859|NCT02608268|363926414|FG027|Overall Study|Death|1|||
105522860|NCT02608268|363926415|FG028|Overall Study|Death|4|||
105522861|NCT02608268|363926416|FG029|Overall Study|Death|0|||
105522862|NCT02608268|363926387|FG000|Overall Study|Physician Decision|0|||
105522863|NCT02608268|363926388|FG001|Overall Study|Physician Decision|0|||
105522864|NCT02608268|363926389|FG002|Overall Study|Physician Decision|0|||
105522865|NCT02608268|363926390|FG003|Overall Study|Physician Decision|0|||
105522866|NCT02608268|363926391|FG004|Overall Study|Physician Decision|0|||
105522867|NCT02608268|363926392|FG005|Overall Study|Physician Decision|0|||
105522868|NCT02608268|363926393|FG006|Overall Study|Physician Decision|0|||
105522869|NCT02608268|363926394|FG007|Overall Study|Physician Decision|0|||
105522870|NCT02608268|363926395|FG008|Overall Study|Physician Decision|0|||
105522871|NCT02608268|363926396|FG009|Overall Study|Physician Decision|0|||
105522872|NCT02608268|363926397|FG010|Overall Study|Physician Decision|1|||
105522873|NCT02608268|363926398|FG011|Overall Study|Physician Decision|0|||
105522874|NCT02608268|363926399|FG012|Overall Study|Physician Decision|0|||
105522875|NCT02608268|363926400|FG013|Overall Study|Physician Decision|1|||
105522876|NCT02608268|363926401|FG014|Overall Study|Physician Decision|0|||
105522877|NCT02608268|363926402|FG015|Overall Study|Physician Decision|0|||
105522878|NCT02608268|363926403|FG016|Overall Study|Physician Decision|0|||
105522879|NCT02608268|363926404|FG017|Overall Study|Physician Decision|0|||
105522880|NCT02608268|363926405|FG018|Overall Study|Physician Decision|0|||
105522881|NCT02608268|363926406|FG019|Overall Study|Physician Decision|0|||
105522882|NCT02608268|363926407|FG020|Overall Study|Physician Decision|0|||
105522883|NCT02608268|363926408|FG021|Overall Study|Physician Decision|0|||
105522884|NCT02608268|363926409|FG022|Overall Study|Physician Decision|1|||
105522885|NCT02608268|363926410|FG023|Overall Study|Physician Decision|1|||
105522886|NCT02608268|363926411|FG024|Overall Study|Physician Decision|1|||
105522887|NCT02608268|363926412|FG025|Overall Study|Physician Decision|0|||
105522888|NCT02608268|363926413|FG026|Overall Study|Physician Decision|0|||
105522889|NCT02608268|363926414|FG027|Overall Study|Physician Decision|2|||
105522890|NCT02608268|363926415|FG028|Overall Study|Physician Decision|1|||
105522891|NCT02608268|363926416|FG029|Overall Study|Physician Decision|1|||
105522892|NCT02608268|363926387|FG000|Overall Study|Progressive disease|12|||
105522893|NCT02608268|363926388|FG001|Overall Study|Progressive disease|8|||
105522894|NCT02608268|363926389|FG002|Overall Study|Progressive disease|13|||
105522895|NCT02608268|363926390|FG003|Overall Study|Progressive disease|5|||
105522896|NCT02608268|363926391|FG004|Overall Study|Progressive disease|2|||
105522897|NCT02608268|363926392|FG005|Overall Study|Progressive disease|4|||
105522898|NCT02608268|363926393|FG006|Overall Study|Progressive disease|6|||
105522899|NCT02608268|363926394|FG007|Overall Study|Progressive disease|2|||
105522900|NCT02608268|363926395|FG008|Overall Study|Progressive disease|5|||
105522901|NCT02608268|363926396|FG009|Overall Study|Progressive disease|6|||
105522902|NCT02608268|363926397|FG010|Overall Study|Progressive disease|5|||
105522903|NCT02608268|363926398|FG011|Overall Study|Progressive disease|5|||
105522904|NCT02608268|363926399|FG012|Overall Study|Progressive disease|4|||
105522905|NCT02608268|363926400|FG013|Overall Study|Progressive disease|11|||
105522906|NCT02608268|363926401|FG014|Overall Study|Progressive disease|6|||
105522907|NCT02608268|363926402|FG015|Overall Study|Progressive disease|3|||
105522908|NCT02608268|363926403|FG016|Overall Study|Progressive disease|5|||
105522909|NCT02608268|363926404|FG017|Overall Study|Progressive disease|5|||
105522910|NCT02608268|363926405|FG018|Overall Study|Progressive disease|5|||
105522911|NCT02608268|363926406|FG019|Overall Study|Progressive disease|2|||
105522912|NCT02608268|363926407|FG020|Overall Study|Progressive disease|10|||
105522913|NCT02608268|363926408|FG021|Overall Study|Progressive disease|4|||
105522914|NCT02608268|363926409|FG022|Overall Study|Progressive disease|5|||
105522915|NCT02608268|363926410|FG023|Overall Study|Progressive disease|5|||
105522916|NCT02608268|363926411|FG024|Overall Study|Progressive disease|3|||
105522917|NCT02608268|363926412|FG025|Overall Study|Progressive disease|11|||
105522918|NCT02608268|363926413|FG026|Overall Study|Progressive disease|16|||
105522919|NCT02608268|363926414|FG027|Overall Study|Progressive disease|11|||
105522920|NCT02608268|363926415|FG028|Overall Study|Progressive disease|10|||
105522921|NCT02608268|363926416|FG029|Overall Study|Progressive disease|15|||
105522922|NCT02608268|363926387|FG000|Overall Study|Subject/guardian decision|1|||
105522923|NCT02608268|363926388|FG001|Overall Study|Subject/guardian decision|1|||
105522924|NCT02608268|363926389|FG002|Overall Study|Subject/guardian decision|2|||
105522925|NCT02608268|363926390|FG003|Overall Study|Subject/guardian decision|0|||
105522926|NCT02608268|363926391|FG004|Overall Study|Subject/guardian decision|0|||
105522927|NCT02608268|363926392|FG005|Overall Study|Subject/guardian decision|0|||
105522928|NCT02608268|363926393|FG006|Overall Study|Subject/guardian decision|0|||
105522929|NCT02608268|363926394|FG007|Overall Study|Subject/guardian decision|0|||
105522930|NCT02608268|363926395|FG008|Overall Study|Subject/guardian decision|2|||
105522931|NCT02608268|363926396|FG009|Overall Study|Subject/guardian decision|2|||
105522932|NCT02608268|363926397|FG010|Overall Study|Subject/guardian decision|0|||
105522933|NCT02608268|363926398|FG011|Overall Study|Subject/guardian decision|1|||
105522934|NCT02608268|363926399|FG012|Overall Study|Subject/guardian decision|0|||
105522935|NCT02608268|363926400|FG013|Overall Study|Subject/guardian decision|1|||
105522936|NCT02608268|363926401|FG014|Overall Study|Subject/guardian decision|0|||
105522937|NCT02608268|363926402|FG015|Overall Study|Subject/guardian decision|1|||
105522938|NCT02608268|363926403|FG016|Overall Study|Subject/guardian decision|0|||
105522939|NCT02608268|363926404|FG017|Overall Study|Subject/guardian decision|0|||
105522940|NCT02608268|363926405|FG018|Overall Study|Subject/guardian decision|1|||
105522941|NCT02608268|363926406|FG019|Overall Study|Subject/guardian decision|0|||
105522942|NCT02608268|363926407|FG020|Overall Study|Subject/guardian decision|0|||
105522943|NCT02608268|363926408|FG021|Overall Study|Subject/guardian decision|0|||
105522944|NCT02608268|363926409|FG022|Overall Study|Subject/guardian decision|1|||
105522945|NCT02608268|363926410|FG023|Overall Study|Subject/guardian decision|0|||
105522946|NCT02608268|363926411|FG024|Overall Study|Subject/guardian decision|0|||
105522947|NCT02608268|363926412|FG025|Overall Study|Subject/guardian decision|1|||
105522948|NCT02608268|363926413|FG026|Overall Study|Subject/guardian decision|1|||
105522949|NCT02608268|363926414|FG027|Overall Study|Subject/guardian decision|1|||
105522950|NCT02608268|363926415|FG028|Overall Study|Subject/guardian decision|1|||
105522951|NCT02608268|363926416|FG029|Overall Study|Subject/guardian decision|0|||
105522952|NCT04865354|363926417|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
105522953|NCT04865354|363926418|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
105522954|NCT04865354|363926417|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
105522955|NCT04865354|363926418|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
105522956|NCT04865354|363926417|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
105522957|NCT04865354|363926418|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
105522958|NCT01012622|363926423|FG000|Overall Study|Withdrawal by Subject|6|||
105522959|NCT01012622|363926423|FG000|Overall Study|Lost to Follow-up|5|||
105522960|NCT01012622|363926423|FG000|Overall Study|Adverse Event|7|||
105522961|NCT01012622|363926423|FG000|Overall Study|non-compliance with the drug|9|||
105522962|NCT01012622|363926423|FG000|Overall Study|Other|1|||
105522963|NCT01012622|363926423|FG000|Overall Study|screening failure|1|||
105522964|NCT01012622|363926423|FG000|Overall Study|withdrawal of consent by a parent|2|||
105522965|NCT00706641|363926424|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
105522966|NCT00706641|363926424|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
105522967|NCT00706641|363926424|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
105522968|NCT02535741|363926425|FG000|Overall Study|Adverse Event|3|||
105522969|NCT02535741|363926425|FG000|Overall Study|Withdrawal by Subject|9|||
105522970|NCT02535741|363926425|FG000|Overall Study|Lost to Follow-up|10|||
105522971|NCT02535741|363926425|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
105522972|NCT02535741|363926425|FG000|Overall Study|Missing data|6|||
105522973|NCT00798369|363926426|FG000|Overall Study|Subject withdrew consent|0|||
105522974|NCT00798369|363926427|FG001|Overall Study|Subject withdrew consent|0|||
105522975|NCT00798369|363926428|FG002|Overall Study|Subject withdrew consent|1|||
105522976|NCT00798369|363926429|FG003|Overall Study|Subject withdrew consent|1|||
105522977|NCT00798369|363926430|FG004|Overall Study|Subject withdrew consent|0|||
105522978|NCT00798369|363926431|FG005|Overall Study|Subject withdrew consent|2|||
105522979|NCT00798369|363926426|FG000|Overall Study|Lost to Follow-up|1|||
105522980|NCT00798369|363926427|FG001|Overall Study|Lost to Follow-up|1|||
105522981|NCT00798369|363926428|FG002|Overall Study|Lost to Follow-up|1|||
105522982|NCT00798369|363926429|FG003|Overall Study|Lost to Follow-up|0|||
105522983|NCT00798369|363926430|FG004|Overall Study|Lost to Follow-up|1|||
105522984|NCT00798369|363926431|FG005|Overall Study|Lost to Follow-up|0|||
105522985|NCT00798369|363926426|FG000|Overall Study|Adminstrative problems|0|||
105522986|NCT00798369|363926427|FG001|Overall Study|Adminstrative problems|0|||
105522987|NCT00798369|363926428|FG002|Overall Study|Adminstrative problems|0|||
105522988|NCT00798369|363926429|FG003|Overall Study|Adminstrative problems|0|||
105522989|NCT00798369|363926430|FG004|Overall Study|Adminstrative problems|0|||
105522990|NCT00798369|363926431|FG005|Overall Study|Adminstrative problems|1|||
105522991|NCT04307446|363926434|FG000|Overall Study|Lost to Follow-up|2|||
105522992|NCT04307446|363926435|FG001|Overall Study|Lost to Follow-up|0|||
105522993|NCT01480076|363926438|FG000|Overall Study|Run-in Failure|52|||
105522994|NCT01480076|363926438|FG000|Overall Study|Adverse Event|39|||
105522995|NCT01480076|363926438|FG000|Overall Study|Death|2|||
105522996|NCT01480076|363926438|FG000|Overall Study|Disease Progression|5|||
105522997|NCT01480076|363926438|FG000|Overall Study|Non-compliance With Study Protocol|15|||
105522998|NCT01480076|363926438|FG000|Overall Study|Withdrawal by Subject|105|||
105522999|NCT01480076|363926438|FG000|Overall Study|Lost to Follow-up|7|||
105523000|NCT01480076|363926438|FG000|Overall Study|Investigator Decision|13|||
105523001|NCT01480076|363926438|FG000|Overall Study|Other|52|||
105523002|NCT02503332|363926439|FG000|Overall Study|Adverse Event|17|||
105523003|NCT02503332|363926440|FG001|Overall Study|Adverse Event|5|||
105523004|NCT02503332|363926441|FG002|Overall Study|Adverse Event|3|||
105523005|NCT02503332|363926442|FG003|Overall Study|Adverse Event|1|||
105523006|NCT02503332|363926439|FG000|Overall Study|Investigator's Decision|5|||
105523007|NCT02503332|363926440|FG001|Overall Study|Investigator's Decision|1|||
105523008|NCT02503332|363926441|FG002|Overall Study|Investigator's Decision|0|||
105523009|NCT02503332|363926442|FG003|Overall Study|Investigator's Decision|0|||
105523010|NCT02503332|363926439|FG000|Overall Study|Sponsor's Decision|1|||
105523011|NCT02503332|363926440|FG001|Overall Study|Sponsor's Decision|0|||
105523012|NCT02503332|363926441|FG002|Overall Study|Sponsor's Decision|0|||
105523013|NCT02503332|363926442|FG003|Overall Study|Sponsor's Decision|1|||
105523014|NCT02503332|363926439|FG000|Overall Study|Subject Request|6|||
105523015|NCT02503332|363926440|FG001|Overall Study|Subject Request|5|||
105523016|NCT02503332|363926441|FG002|Overall Study|Subject Request|2|||
105523017|NCT02503332|363926442|FG003|Overall Study|Subject Request|1|||
105523018|NCT02503332|363926439|FG000|Overall Study|Death|0|||
105523019|NCT02503332|363926440|FG001|Overall Study|Death|2|||
105523020|NCT02503332|363926441|FG002|Overall Study|Death|2|||
105523021|NCT02503332|363926442|FG003|Overall Study|Death|0|||
105523022|NCT02503332|363926439|FG000|Overall Study|Other|5|||
105523023|NCT02503332|363926440|FG001|Overall Study|Other|6|||
105523024|NCT02503332|363926441|FG002|Overall Study|Other|1|||
105523025|NCT02503332|363926442|FG003|Overall Study|Other|1|||
105523026|NCT00371254|363926445|FG000|Overall Study|Disease progression|13|||
105523027|NCT00371254|363926446|FG001|Overall Study|Disease progression|13|||
105523028|NCT00371254|363926445|FG000|Overall Study|Study drug toxicity|3|||
105523029|NCT00371254|363926446|FG001|Overall Study|Study drug toxicity|5|||
105523030|NCT00371254|363926445|FG000|Overall Study|Subject request|5|||
105523031|NCT00371254|363926446|FG001|Overall Study|Subject request|0|||
105523032|NCT00371254|363926445|FG000|Overall Study|Investigator Decision|2|||
105523033|NCT00371254|363926446|FG001|Overall Study|Investigator Decision|0|||
105523034|NCT00371254|363926445|FG000|Overall Study|Adverse event unrelated to study drug|0|||
105523035|NCT00371254|363926446|FG001|Overall Study|Adverse event unrelated to study drug|1|||
105523036|NCT00371254|363926445|FG000|Overall Study|Lost to Follow-up|0|||
105523037|NCT00371254|363926446|FG001|Overall Study|Lost to Follow-up|1|||
105523038|NCT00371254|363926445|FG000|Overall Study|Withdrawal by Subject|0|||
105523039|NCT00371254|363926446|FG001|Overall Study|Withdrawal by Subject|1|||
105523040|NCT03329690|363926449|FG000|Overall Study|Progressive disease per RECIST|85|||
105523041|NCT03329690|363926450|FG001|Overall Study|Progressive disease per RECIST|44|||
105523042|NCT03329690|363926451|FG002|Overall Study|Progressive disease per RECIST|6|||
105523043|NCT03329690|363926452|FG003|Overall Study|Progressive disease per RECIST|16|||
105523044|NCT03329690|363926453|FG004|Overall Study|Progressive disease per RECIST|20|||
105523045|NCT03329690|363926449|FG000|Overall Study|Clinical progression|7|||
105523046|NCT03329690|363926450|FG001|Overall Study|Clinical progression|4|||
105523047|NCT03329690|363926451|FG002|Overall Study|Clinical progression|1|||
105523048|NCT03329690|363926452|FG003|Overall Study|Clinical progression|1|||
105523049|NCT03329690|363926453|FG004|Overall Study|Clinical progression|1|||
105523050|NCT03329690|363926449|FG000|Overall Study|Adverse Event|22|||
105523051|NCT03329690|363926450|FG001|Overall Study|Adverse Event|4|||
105523052|NCT03329690|363926451|FG002|Overall Study|Adverse Event|0|||
105523053|NCT03329690|363926452|FG003|Overall Study|Adverse Event|1|||
105523054|NCT03329690|363926453|FG004|Overall Study|Adverse Event|2|||
105523055|NCT03329690|363926449|FG000|Overall Study|Death|2|||
105523056|NCT03329690|363926450|FG001|Overall Study|Death|0|||
105523057|NCT03329690|363926451|FG002|Overall Study|Death|0|||
105523058|NCT03329690|363926452|FG003|Overall Study|Death|1|||
105523059|NCT03329690|363926453|FG004|Overall Study|Death|0|||
105523060|NCT03329690|363926449|FG000|Overall Study|Withdrawal by Subject|2|||
105523061|NCT03329690|363926450|FG001|Overall Study|Withdrawal by Subject|3|||
105523062|NCT03329690|363926451|FG002|Overall Study|Withdrawal by Subject|0|||
105523063|NCT03329690|363926452|FG003|Overall Study|Withdrawal by Subject|1|||
105523064|NCT03329690|363926453|FG004|Overall Study|Withdrawal by Subject|0|||
105523065|NCT03329690|363926449|FG000|Overall Study|Physician Decision|1|||
105523066|NCT03329690|363926450|FG001|Overall Study|Physician Decision|0|||
105523067|NCT03329690|363926451|FG002|Overall Study|Physician Decision|0|||
105523068|NCT03329690|363926452|FG003|Overall Study|Physician Decision|0|||
105523069|NCT03329690|363926453|FG004|Overall Study|Physician Decision|1|||
105523070|NCT03329690|363926449|FG000|Overall Study|Miscellaneous|6|||
105523071|NCT03329690|363926450|FG001|Overall Study|Miscellaneous|0|||
105523072|NCT03329690|363926451|FG002|Overall Study|Miscellaneous|0|||
105523073|NCT03329690|363926452|FG003|Overall Study|Miscellaneous|0|||
105523074|NCT03329690|363926453|FG004|Overall Study|Miscellaneous|0|||
105523075|NCT03329690|363926449|FG000|Overall Study|Did not receive treatment|1|||
105523076|NCT03329690|363926450|FG001|Overall Study|Did not receive treatment|0|||
105523077|NCT03329690|363926451|FG002|Overall Study|Did not receive treatment|0|||
105523078|NCT03329690|363926452|FG003|Overall Study|Did not receive treatment|1|||
105523079|NCT03329690|363926453|FG004|Overall Study|Did not receive treatment|0|||
105523080|NCT01852812|363926454|FG000|Overall Study|Adverse Event|0|||
105523081|NCT01852812|363926455|FG001|Overall Study|Adverse Event|0|||
105523082|NCT01852812|363926456|FG002|Overall Study|Adverse Event|1|||
105523083|NCT01852812|363926454|FG000|Overall Study|Non-compliance With Study Drug|0|||
105523084|NCT01852812|363926455|FG001|Overall Study|Non-compliance With Study Drug|1|||
105523085|NCT01852812|363926456|FG002|Overall Study|Non-compliance With Study Drug|0|||
105523086|NCT00949325|363926472|FG000|Overall Study|Adverse Event|0|||
105523087|NCT00949325|363926473|FG001|Overall Study|Adverse Event|2|||
105523088|NCT00949325|363926474|FG002|Overall Study|Adverse Event|0|||
105523089|NCT00791518|363926475|FG000|Overall Study|Protocol Violation|93|||
105523090|NCT01892501|363926476|FG000|Overall Study|Protocol Violation|2|||
105523091|NCT01892501|363926476|FG000|Overall Study|Puncture not carried out|9|||
105523092|NCT01892501|363926476|FG000|Overall Study|Radiological monitoring not carried out|5|||
105523093|NCT01892501|363926476|FG000|Overall Study|Non-contributory histological result|12|||
105523094|NCT02319031|363926477|FG000|Treatment Period|Death|1|||
105523095|NCT02319031|363926478|FG001|Treatment Period|Death|0|||
105523096|NCT01176266|363926479|FG000|Overall Study|Death|6|||
105523097|NCT01176266|363926479|FG000|Overall Study|Withdrawal by Subject|3|||
105523098|NCT01154218|363926480|FG000|Third Intervention Period|Adverse Event|0|||
105523099|NCT01154218|363926481|FG001|Third Intervention Period|Adverse Event|1|||
105523100|NCT01154218|363926482|FG002|Third Intervention Period|Adverse Event|0|||
105523101|NCT01154218|363926483|FG003|Third Intervention Period|Adverse Event|0|||
105523102|NCT01154218|363926480|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
105523103|NCT01154218|363926481|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
105523104|NCT01154218|363926482|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
105523105|NCT01154218|363926483|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
105523106|NCT01154218|363926480|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
105523107|NCT01154218|363926481|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
105523108|NCT01154218|363926482|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
105523109|NCT01154218|363926483|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
105523110|NCT00335972|363926484|FG000|Overall Study|not given treatments|0|||
105523111|NCT00335972|363926485|FG001|Overall Study|not given treatments|3|||
105523112|NCT01524692|363926488|FG000|Overall Study|Withdrawal by Subject|3|||
105523113|NCT02039674|363926491|FG000|Overall Study|Adverse Event|0|||
105523114|NCT02039674|363926492|FG001|Overall Study|Adverse Event|0|||
105523115|NCT02039674|363926493|FG002|Overall Study|Adverse Event|0|||
105523116|NCT02039674|363926494|FG003|Overall Study|Adverse Event|1|||
105523117|NCT02039674|363926495|FG004|Overall Study|Adverse Event|0|||
105523118|NCT02039674|363926496|FG005|Overall Study|Adverse Event|0|||
105523119|NCT02039674|363926497|FG006|Overall Study|Adverse Event|0|||
105523120|NCT02039674|363926498|FG007|Overall Study|Adverse Event|0|||
105523121|NCT02039674|363926499|FG008|Overall Study|Adverse Event|2|||
105523122|NCT02039674|363926500|FG009|Overall Study|Adverse Event|1|||
105523123|NCT02039674|363926501|FG010|Overall Study|Adverse Event|0|||
105523124|NCT02039674|363926502|FG011|Overall Study|Adverse Event|2|||
105523125|NCT02039674|363926503|FG012|Overall Study|Adverse Event|3|||
105523126|NCT02039674|363926504|FG013|Overall Study|Adverse Event|1|||
105523127|NCT02039674|363926491|FG000|Overall Study|Death|2|||
105523128|NCT02039674|363926492|FG001|Overall Study|Death|0|||
105523129|NCT02039674|363926493|FG002|Overall Study|Death|2|||
105523130|NCT02039674|363926494|FG003|Overall Study|Death|3|||
105523131|NCT02039674|363926495|FG004|Overall Study|Death|0|||
105523132|NCT02039674|363926496|FG005|Overall Study|Death|0|||
105523133|NCT02039674|363926497|FG006|Overall Study|Death|1|||
105523134|NCT02039674|363926498|FG007|Overall Study|Death|0|||
105523135|NCT02039674|363926499|FG008|Overall Study|Death|2|||
105523136|NCT02039674|363926500|FG009|Overall Study|Death|0|||
105523137|NCT02039674|363926501|FG010|Overall Study|Death|1|||
105523138|NCT02039674|363926502|FG011|Overall Study|Death|3|||
105523139|NCT02039674|363926503|FG012|Overall Study|Death|2|||
105523140|NCT02039674|363926504|FG013|Overall Study|Death|8|||
105523141|NCT02039674|363926491|FG000|Overall Study|Excluded Medication|1|||
105523142|NCT02039674|363926492|FG001|Overall Study|Excluded Medication|1|||
105523143|NCT02039674|363926493|FG002|Overall Study|Excluded Medication|0|||
105523144|NCT02039674|363926494|FG003|Overall Study|Excluded Medication|1|||
105523145|NCT02039674|363926495|FG004|Overall Study|Excluded Medication|0|||
105523146|NCT02039674|363926496|FG005|Overall Study|Excluded Medication|1|||
105523147|NCT02039674|363926497|FG006|Overall Study|Excluded Medication|0|||
105523148|NCT02039674|363926498|FG007|Overall Study|Excluded Medication|0|||
105523149|NCT02039674|363926499|FG008|Overall Study|Excluded Medication|2|||
105523150|NCT02039674|363926500|FG009|Overall Study|Excluded Medication|3|||
105523151|NCT02039674|363926501|FG010|Overall Study|Excluded Medication|5|||
105523152|NCT02039674|363926502|FG011|Overall Study|Excluded Medication|6|||
105523153|NCT02039674|363926503|FG012|Overall Study|Excluded Medication|8|||
105523154|NCT02039674|363926504|FG013|Overall Study|Excluded Medication|3|||
105523155|NCT02039674|363926491|FG000|Overall Study|Lost to Follow-up|0|||
105523156|NCT02039674|363926492|FG001|Overall Study|Lost to Follow-up|0|||
105523157|NCT02039674|363926493|FG002|Overall Study|Lost to Follow-up|0|||
105523158|NCT02039674|363926494|FG003|Overall Study|Lost to Follow-up|0|||
105523159|NCT02039674|363926495|FG004|Overall Study|Lost to Follow-up|1|||
105523160|NCT02039674|363926496|FG005|Overall Study|Lost to Follow-up|1|||
105523161|NCT02039674|363926497|FG006|Overall Study|Lost to Follow-up|0|||
105523162|NCT02039674|363926498|FG007|Overall Study|Lost to Follow-up|0|||
105523163|NCT02039674|363926499|FG008|Overall Study|Lost to Follow-up|0|||
105523164|NCT02039674|363926500|FG009|Overall Study|Lost to Follow-up|0|||
105523165|NCT02039674|363926501|FG010|Overall Study|Lost to Follow-up|0|||
105523166|NCT02039674|363926502|FG011|Overall Study|Lost to Follow-up|2|||
105523167|NCT02039674|363926503|FG012|Overall Study|Lost to Follow-up|2|||
105523168|NCT02039674|363926504|FG013|Overall Study|Lost to Follow-up|1|||
105523169|NCT02039674|363926491|FG000|Overall Study|Physician Decision|0|||
105523170|NCT02039674|363926492|FG001|Overall Study|Physician Decision|0|||
105523171|NCT02039674|363926493|FG002|Overall Study|Physician Decision|0|||
105523172|NCT02039674|363926494|FG003|Overall Study|Physician Decision|0|||
105523173|NCT02039674|363926495|FG004|Overall Study|Physician Decision|0|||
105523174|NCT02039674|363926496|FG005|Overall Study|Physician Decision|0|||
105523175|NCT02039674|363926497|FG006|Overall Study|Physician Decision|0|||
105523176|NCT02039674|363926498|FG007|Overall Study|Physician Decision|0|||
105523177|NCT02039674|363926499|FG008|Overall Study|Physician Decision|0|||
105523178|NCT02039674|363926500|FG009|Overall Study|Physician Decision|0|||
105523179|NCT02039674|363926501|FG010|Overall Study|Physician Decision|0|||
105523180|NCT02039674|363926502|FG011|Overall Study|Physician Decision|1|||
105523181|NCT02039674|363926503|FG012|Overall Study|Physician Decision|1|||
105523182|NCT02039674|363926504|FG013|Overall Study|Physician Decision|0|||
105523183|NCT02039674|363926491|FG000|Overall Study|Progressive Disease|8|||
105523184|NCT02039674|363926492|FG001|Overall Study|Progressive Disease|8|||
105523185|NCT02039674|363926493|FG002|Overall Study|Progressive Disease|6|||
105523186|NCT02039674|363926494|FG003|Overall Study|Progressive Disease|7|||
105523187|NCT02039674|363926495|FG004|Overall Study|Progressive Disease|9|||
105523188|NCT02039674|363926496|FG005|Overall Study|Progressive Disease|10|||
105523189|NCT02039674|363926497|FG006|Overall Study|Progressive Disease|1|||
105523190|NCT02039674|363926498|FG007|Overall Study|Progressive Disease|3|||
105523191|NCT02039674|363926499|FG008|Overall Study|Progressive Disease|6|||
105523192|NCT02039674|363926500|FG009|Overall Study|Progressive Disease|4|||
105523193|NCT02039674|363926501|FG010|Overall Study|Progressive Disease|0|||
105523194|NCT02039674|363926502|FG011|Overall Study|Progressive Disease|34|||
105523195|NCT02039674|363926503|FG012|Overall Study|Progressive Disease|34|||
105523196|NCT02039674|363926504|FG013|Overall Study|Progressive Disease|18|||
105523197|NCT02039674|363926491|FG000|Overall Study|Withdrawal by Subject|1|||
105523198|NCT02039674|363926492|FG001|Overall Study|Withdrawal by Subject|2|||
105523199|NCT02039674|363926493|FG002|Overall Study|Withdrawal by Subject|3|||
105523200|NCT02039674|363926494|FG003|Overall Study|Withdrawal by Subject|0|||
105523201|NCT02039674|363926495|FG004|Overall Study|Withdrawal by Subject|1|||
105523202|NCT02039674|363926496|FG005|Overall Study|Withdrawal by Subject|0|||
105523203|NCT02039674|363926497|FG006|Overall Study|Withdrawal by Subject|0|||
105523204|NCT02039674|363926498|FG007|Overall Study|Withdrawal by Subject|0|||
105523205|NCT02039674|363926499|FG008|Overall Study|Withdrawal by Subject|0|||
105523206|NCT02039674|363926500|FG009|Overall Study|Withdrawal by Subject|1|||
105523207|NCT02039674|363926501|FG010|Overall Study|Withdrawal by Subject|1|||
105523208|NCT02039674|363926502|FG011|Overall Study|Withdrawal by Subject|4|||
105523209|NCT02039674|363926503|FG012|Overall Study|Withdrawal by Subject|6|||
105523210|NCT02039674|363926504|FG013|Overall Study|Withdrawal by Subject|2|||
105523211|NCT02039674|363926491|FG000|Overall Study|Clinical Progression|0|||
105523212|NCT02039674|363926492|FG001|Overall Study|Clinical Progression|0|||
105523213|NCT02039674|363926493|FG002|Overall Study|Clinical Progression|0|||
105523214|NCT02039674|363926494|FG003|Overall Study|Clinical Progression|0|||
105523215|NCT02039674|363926495|FG004|Overall Study|Clinical Progression|0|||
105523216|NCT02039674|363926496|FG005|Overall Study|Clinical Progression|0|||
105523217|NCT02039674|363926497|FG006|Overall Study|Clinical Progression|1|||
105523218|NCT02039674|363926498|FG007|Overall Study|Clinical Progression|0|||
105523219|NCT02039674|363926499|FG008|Overall Study|Clinical Progression|0|||
105523220|NCT02039674|363926500|FG009|Overall Study|Clinical Progression|0|||
105523221|NCT02039674|363926501|FG010|Overall Study|Clinical Progression|0|||
105523222|NCT02039674|363926502|FG011|Overall Study|Clinical Progression|0|||
105523223|NCT02039674|363926503|FG012|Overall Study|Clinical Progression|1|||
105523224|NCT02039674|363926504|FG013|Overall Study|Clinical Progression|0|||
105523225|NCT02039674|363926491|FG000|Overall Study|Sponsor Decision|1|||
105523226|NCT02039674|363926492|FG001|Overall Study|Sponsor Decision|1|||
105523227|NCT02039674|363926493|FG002|Overall Study|Sponsor Decision|1|||
105523228|NCT02039674|363926494|FG003|Overall Study|Sponsor Decision|1|||
105523229|NCT02039674|363926495|FG004|Overall Study|Sponsor Decision|1|||
105523230|NCT02039674|363926496|FG005|Overall Study|Sponsor Decision|0|||
105523231|NCT02039674|363926497|FG006|Overall Study|Sponsor Decision|0|||
105523232|NCT02039674|363926498|FG007|Overall Study|Sponsor Decision|0|||
105523233|NCT02039674|363926499|FG008|Overall Study|Sponsor Decision|0|||
105523234|NCT02039674|363926500|FG009|Overall Study|Sponsor Decision|3|||
105523235|NCT02039674|363926501|FG010|Overall Study|Sponsor Decision|0|||
105523236|NCT02039674|363926502|FG011|Overall Study|Sponsor Decision|8|||
105523237|NCT02039674|363926503|FG012|Overall Study|Sponsor Decision|5|||
105523238|NCT02039674|363926504|FG013|Overall Study|Sponsor Decision|0|||
105523239|NCT02039674|363926491|FG000|Overall Study|Other|0|||
105523240|NCT02039674|363926492|FG001|Overall Study|Other|0|||
105523241|NCT02039674|363926493|FG002|Overall Study|Other|0|||
105523242|NCT02039674|363926494|FG003|Overall Study|Other|0|||
105523243|NCT02039674|363926495|FG004|Overall Study|Other|0|||
105523244|NCT02039674|363926496|FG005|Overall Study|Other|0|||
105523245|NCT02039674|363926497|FG006|Overall Study|Other|0|||
105523246|NCT02039674|363926498|FG007|Overall Study|Other|0|||
105523247|NCT02039674|363926499|FG008|Overall Study|Other|0|||
105523248|NCT02039674|363926500|FG009|Overall Study|Other|0|||
105523249|NCT02039674|363926501|FG010|Overall Study|Other|0|||
105523250|NCT02039674|363926502|FG011|Overall Study|Other|0|||
105523251|NCT02039674|363926503|FG012|Overall Study|Other|1|||
105523252|NCT02039674|363926504|FG013|Overall Study|Other|0|||
105523253|NCT01387347|363926505|FG000|Overall Study|Lost to Follow-up|2|||
105523254|NCT01387347|363926506|FG001|Overall Study|Lost to Follow-up|1|||
105523255|NCT00075582|363926507|FG000|Overall Study|Adverse Event|3|||
105523256|NCT00075582|363926508|FG001|Overall Study|Adverse Event|1|||
105523257|NCT00075582|363926507|FG000|Overall Study|Lack of Efficacy|4|||
105523258|NCT00075582|363926508|FG001|Overall Study|Lack of Efficacy|8|||
105523259|NCT00075582|363926507|FG000|Overall Study|Physician Decision|5|||
105523260|NCT00075582|363926508|FG001|Overall Study|Physician Decision|8|||
105523261|NCT00075582|363926507|FG000|Overall Study|Withdrawal by Subject|2|||
105523262|NCT00075582|363926508|FG001|Overall Study|Withdrawal by Subject|2|||
105523263|NCT00075582|363926507|FG000|Overall Study|Ineligible for study|36|||
105523264|NCT00075582|363926508|FG001|Overall Study|Ineligible for study|16|||
105523265|NCT00323492|363926510|FG000|Study Phase 1|Adverse Event|2|||
105523266|NCT00323492|363926511|FG001|Study Phase 1|Adverse Event|0|||
105523267|NCT00323492|363926512|FG002|Study Phase 1|Adverse Event|0|||
105523268|NCT00323492|363926510|FG000|Study Phase 2|Adverse Event|1|||
105523269|NCT00323492|363926511|FG001|Study Phase 2|Adverse Event|0|||
105523270|NCT00323492|363926512|FG002|Study Phase 2|Adverse Event|0|||
105523271|NCT00323492|363926510|FG000|Study Phase 2|Physician Decision|1|||
105523272|NCT00323492|363926511|FG001|Study Phase 2|Physician Decision|0|||
105523273|NCT00323492|363926512|FG002|Study Phase 2|Physician Decision|0|||
105523274|NCT00323492|363926510|FG000|Study Phase 2|Lost to Follow-up|1|||
105523275|NCT00323492|363926511|FG001|Study Phase 2|Lost to Follow-up|0|||
105523276|NCT00323492|363926512|FG002|Study Phase 2|Lost to Follow-up|0|||
105523277|NCT00323492|363926510|FG000|Study Phase 2|Withdrawal by Subject|0|||
105523278|NCT00323492|363926511|FG001|Study Phase 2|Withdrawal by Subject|1|||
105523279|NCT00323492|363926512|FG002|Study Phase 2|Withdrawal by Subject|0|||
105523280|NCT00323492|363926510|FG000|Study Phase 2|Noncompliance with study schedule|0|||
105523281|NCT00323492|363926511|FG001|Study Phase 2|Noncompliance with study schedule|0|||
105523282|NCT00323492|363926512|FG002|Study Phase 2|Noncompliance with study schedule|1|||
105523283|NCT00323492|363926510|FG000|Study Phase 2|Protocol Violation|1|||
105523284|NCT00323492|363926511|FG001|Study Phase 2|Protocol Violation|0|||
105523285|NCT00323492|363926512|FG002|Study Phase 2|Protocol Violation|0|||
105523286|NCT01675128|363926513|FG000|Overall Study|Disease progression on study|1|||
105523287|NCT01675128|363926514|FG001|Overall Study|Disease progression on study|1|||
105523288|NCT01675128|363926515|FG002|Overall Study|Disease progression on study|1|||
105523289|NCT01675128|363926513|FG000|Overall Study|Refused further treatment|1|||
105523290|NCT01675128|363926514|FG001|Overall Study|Refused further treatment|0|||
105523291|NCT01675128|363926515|FG002|Overall Study|Refused further treatment|0|||
105523292|NCT01675128|363926513|FG000|Overall Study|Pulmonary complication; off study|0|||
105523293|NCT01675128|363926514|FG001|Overall Study|Pulmonary complication; off study|1|||
105523294|NCT01675128|363926515|FG002|Overall Study|Pulmonary complication; off study|0|||
105523295|NCT00994240|363926516|FG000|Overall Study|Lost to Follow-up|3|||
105523296|NCT00994240|363926517|FG001|Overall Study|Lost to Follow-up|2|||
105523297|NCT00994240|363926516|FG000|Overall Study|Withdrawal by Subject|1|||
105523298|NCT00994240|363926517|FG001|Overall Study|Withdrawal by Subject|0|||
105523299|NCT00994240|363926516|FG000|Overall Study|study termination|2|||
105523300|NCT00994240|363926517|FG001|Overall Study|study termination|3|||
105523301|NCT01239368|363928378|FG000|Overall Study|Principal investigator discretion|1|||
105523302|NCT01239368|363928379|FG001|Overall Study|Principal investigator discretion|0|||
105523303|NCT01239368|363928380|FG002|Overall Study|Principal investigator discretion|0|||
105523304|NCT01239368|363928381|FG003|Overall Study|Principal investigator discretion|0|||
105523305|NCT01239368|363928382|FG004|Overall Study|Principal investigator discretion|1|||
105523306|NCT01239368|363928383|FG005|Overall Study|Principal investigator discretion|2|||
105523307|NCT01239368|363928384|FG006|Overall Study|Principal investigator discretion|0|||
105523308|NCT01239368|363928385|FG007|Overall Study|Principal investigator discretion|0|||
105523309|NCT01239368|363928386|FG008|Overall Study|Principal investigator discretion|0|||
105523310|NCT01239368|363928387|FG009|Overall Study|Principal investigator discretion|1|||
105523311|NCT01239368|363928378|FG000|Overall Study|Disease progression on study|1|||
105523312|NCT01239368|363928379|FG001|Overall Study|Disease progression on study|1|||
105523313|NCT01239368|363928380|FG002|Overall Study|Disease progression on study|1|||
105523314|NCT01239368|363928381|FG003|Overall Study|Disease progression on study|1|||
105523315|NCT01239368|363928382|FG004|Overall Study|Disease progression on study|4|||
105523316|NCT01239368|363928383|FG005|Overall Study|Disease progression on study|2|||
105523317|NCT01239368|363928384|FG006|Overall Study|Disease progression on study|5|||
105523318|NCT01239368|363928385|FG007|Overall Study|Disease progression on study|0|||
105523319|NCT01239368|363928386|FG008|Overall Study|Disease progression on study|0|||
105523320|NCT01239368|363928387|FG009|Overall Study|Disease progression on study|2|||
105523321|NCT01239368|363928378|FG000|Overall Study|Refused further treatment|0|||
105523322|NCT01239368|363928379|FG001|Overall Study|Refused further treatment|0|||
105523323|NCT01239368|363928380|FG002|Overall Study|Refused further treatment|0|||
105523324|NCT01239368|363928381|FG003|Overall Study|Refused further treatment|0|||
105523325|NCT01239368|363928382|FG004|Overall Study|Refused further treatment|0|||
105523326|NCT01239368|363928383|FG005|Overall Study|Refused further treatment|0|||
105523327|NCT01239368|363928384|FG006|Overall Study|Refused further treatment|0|||
105523328|NCT01239368|363928385|FG007|Overall Study|Refused further treatment|0|||
105523329|NCT01239368|363928386|FG008|Overall Study|Refused further treatment|0|||
105523330|NCT01239368|363928387|FG009|Overall Study|Refused further treatment|1|||
105523331|NCT01239368|363928378|FG000|Overall Study|Death|0|||
105523332|NCT01239368|363928379|FG001|Overall Study|Death|0|||
105523333|NCT01239368|363928380|FG002|Overall Study|Death|0|||
105523334|NCT01239368|363928381|FG003|Overall Study|Death|0|||
105523335|NCT01239368|363928382|FG004|Overall Study|Death|0|||
105523336|NCT01239368|363928383|FG005|Overall Study|Death|0|||
105523337|NCT01239368|363928384|FG006|Overall Study|Death|1|||
105523338|NCT01239368|363928385|FG007|Overall Study|Death|0|||
105523339|NCT01239368|363928386|FG008|Overall Study|Death|0|||
105523340|NCT01239368|363928387|FG009|Overall Study|Death|0|||
105523341|NCT01536379|363928389|FG000|Overall Study|Adverse Event|1|||
105523342|NCT01536379|363928390|FG001|Overall Study|Adverse Event|2|||
105523343|NCT01536379|363928389|FG000|Overall Study|Withdrawal by Subject|1|||
105523344|NCT01536379|363928390|FG001|Overall Study|Withdrawal by Subject|1|||
105523345|NCT02268409|363928394|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
105523346|NCT02268409|363928394|FG000|Overall Study|Death|1|||
105523347|NCT02268409|363928394|FG000|Overall Study|Lost to Follow-up|1|||
105523348|NCT02268409|363928394|FG000|Overall Study|Protocol Violation|3|||
105523349|NCT02268409|363928394|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
105523350|NCT02268409|363928394|FG000|Overall Study|Withdrawal by Subject|5|||
105523351|NCT02155738|363928397|FG000|Overall Study|Missing critical information|1|||
105523352|NCT02155738|363928398|FG001|Overall Study|Missing critical information|0|||
105523353|NCT02155738|363928399|FG002|Overall Study|Missing critical information|0|||
105523354|NCT02155738|363928400|FG003|Overall Study|Missing critical information|1|||
105523355|NCT01190254|363928403|FG000|Overall Study|Adverse Event|3|||
105523356|NCT01190254|363928404|FG001|Overall Study|Adverse Event|6|||
105523357|NCT01190254|363928405|FG002|Overall Study|Adverse Event|8|||
105523358|NCT01190254|363928403|FG000|Overall Study|Lack of Efficacy|7|||
105523359|NCT01190254|363928404|FG001|Overall Study|Lack of Efficacy|4|||
105523360|NCT01190254|363928405|FG002|Overall Study|Lack of Efficacy|5|||
105523361|NCT01190254|363928403|FG000|Overall Study|Lost to Follow-up|4|||
105523362|NCT01190254|363928404|FG001|Overall Study|Lost to Follow-up|2|||
105523363|NCT01190254|363928405|FG002|Overall Study|Lost to Follow-up|0|||
105523364|NCT01190254|363928403|FG000|Overall Study|Withdrawal by Subject|4|||
105523365|NCT01190254|363928404|FG001|Overall Study|Withdrawal by Subject|5|||
105523366|NCT01190254|363928405|FG002|Overall Study|Withdrawal by Subject|7|||
105523367|NCT01190254|363928403|FG000|Overall Study|Protocol Violation|2|||
105523368|NCT01190254|363928404|FG001|Overall Study|Protocol Violation|0|||
105523369|NCT01190254|363928405|FG002|Overall Study|Protocol Violation|2|||
105523370|NCT01190254|363928403|FG000|Overall Study|Did not meet protocol eligibility|1|||
105523371|NCT01190254|363928404|FG001|Overall Study|Did not meet protocol eligibility|0|||
105523372|NCT01190254|363928405|FG002|Overall Study|Did not meet protocol eligibility|0|||
105523373|NCT00489853|363928406|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
105523374|NCT00489853|363928407|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
105523375|NCT00489853|363928408|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
105523376|NCT00489853|363928406|FG000|Wash-out Period 1|Adverse Event|0|||
105523377|NCT00489853|363928407|FG001|Wash-out Period 1|Adverse Event|1|||
105523378|NCT00489853|363928408|FG002|Wash-out Period 1|Adverse Event|1|||
105523379|NCT00489853|363928406|FG000|Wash-out Period 1|Protocol Violation|0|||
105523380|NCT00489853|363928407|FG001|Wash-out Period 1|Protocol Violation|1|||
105523381|NCT00489853|363928408|FG002|Wash-out Period 1|Protocol Violation|1|||
105523382|NCT00489853|363928406|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
105523383|NCT00489853|363928407|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
105523384|NCT00489853|363928408|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
105523385|NCT00489853|363928406|FG000|Wash-out Period 2|Adverse Event|1|||
105523386|NCT00489853|363928407|FG001|Wash-out Period 2|Adverse Event|1|||
105523387|NCT00489853|363928408|FG002|Wash-out Period 2|Adverse Event|0|||
105523388|NCT00489853|363928406|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
105523389|NCT00489853|363928407|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
105523390|NCT00489853|363928408|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
105523391|NCT00489853|363928406|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
105523392|NCT00489853|363928407|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
105523393|NCT00489853|363928408|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
105523394|NCT02356783|363928409|FG000|Overall Study|Lost to Follow-up|1|||
105523395|NCT02356783|363928410|FG001|Overall Study|Lost to Follow-up|3|||
105523396|NCT02603809|363928411|FG000|Overall Study|Withdrawal by Subject|4|||
105523397|NCT02603809|363928412|FG001|Overall Study|Withdrawal by Subject|1|||
105523398|NCT02603809|363928413|FG002|Overall Study|Withdrawal by Subject|2|||
105523399|NCT02603809|363928414|FG003|Overall Study|Withdrawal by Subject|3|||
105523400|NCT02603809|363928415|FG004|Overall Study|Withdrawal by Subject|3|||
105523401|NCT02603809|363928416|FG005|Overall Study|Withdrawal by Subject|4|||
105523402|NCT02603809|363928411|FG000|Overall Study|Lost to Follow-up|2|||
105523403|NCT02603809|363928412|FG001|Overall Study|Lost to Follow-up|3|||
105523404|NCT02603809|363928413|FG002|Overall Study|Lost to Follow-up|1|||
105523405|NCT02603809|363928414|FG003|Overall Study|Lost to Follow-up|4|||
105523406|NCT02603809|363928415|FG004|Overall Study|Lost to Follow-up|2|||
105523407|NCT02603809|363928416|FG005|Overall Study|Lost to Follow-up|2|||
105523408|NCT02603809|363928411|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
105523409|NCT02603809|363928412|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
105523410|NCT02603809|363928413|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
105523411|NCT02603809|363928414|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
105523412|NCT02603809|363928415|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
105523413|NCT02603809|363928416|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
105523414|NCT02603809|363928411|FG000|Overall Study|Physician Decision|0|||
105523415|NCT02603809|363928412|FG001|Overall Study|Physician Decision|0|||
105523416|NCT02603809|363928413|FG002|Overall Study|Physician Decision|0|||
105523417|NCT02603809|363928414|FG003|Overall Study|Physician Decision|1|||
105523418|NCT02603809|363928415|FG004|Overall Study|Physician Decision|2|||
105523419|NCT02603809|363928416|FG005|Overall Study|Physician Decision|1|||
105523420|NCT02603809|363928411|FG000|Overall Study|Adverse Event|3|||
105523421|NCT02603809|363928412|FG001|Overall Study|Adverse Event|0|||
105523422|NCT02603809|363928413|FG002|Overall Study|Adverse Event|2|||
105523423|NCT02603809|363928414|FG003|Overall Study|Adverse Event|2|||
105523424|NCT02603809|363928415|FG004|Overall Study|Adverse Event|1|||
105523425|NCT02603809|363928416|FG005|Overall Study|Adverse Event|1|||
105523426|NCT02603809|363928411|FG000|Overall Study|Lack of Efficacy|0|||
105523427|NCT02603809|363928412|FG001|Overall Study|Lack of Efficacy|1|||
105523428|NCT02603809|363928413|FG002|Overall Study|Lack of Efficacy|0|||
105523429|NCT02603809|363928414|FG003|Overall Study|Lack of Efficacy|0|||
105523430|NCT02603809|363928415|FG004|Overall Study|Lack of Efficacy|0|||
105523431|NCT02603809|363928416|FG005|Overall Study|Lack of Efficacy|1|||
105523432|NCT04146545|363928418|FG000|Overall Study|deemed ineligible after randomization|1|||
105523433|NCT04146545|363928419|FG001|Overall Study|deemed ineligible after randomization|0|||
105523434|NCT00156533|363928420|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
105523435|NCT00156533|363928421|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
105523436|NCT00156533|363928422|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
105523437|NCT00156533|363928423|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
105523438|NCT00156533|363928420|FG000|Overall Study|Withdrawal by Subject|1|||
105523439|NCT00156533|363928421|FG001|Overall Study|Withdrawal by Subject|0|||
105523440|NCT00156533|363928422|FG002|Overall Study|Withdrawal by Subject|0|||
105523441|NCT00156533|363928423|FG003|Overall Study|Withdrawal by Subject|1|||
105523442|NCT00156533|363928420|FG000|Overall Study|Failed Screening|1|||
105523443|NCT00156533|363928421|FG001|Overall Study|Failed Screening|0|||
105523444|NCT00156533|363928422|FG002|Overall Study|Failed Screening|1|||
105523445|NCT00156533|363928423|FG003|Overall Study|Failed Screening|1|||
105523446|NCT04729127|363928426|FG000|Overall Study|Suspended/Terminated EI Services|4|||
105523447|NCT04729127|363928427|FG001|Overall Study|Suspended/Terminated EI Services|0|||
105523448|NCT04729127|363928428|FG002|Overall Study|Suspended/Terminated EI Services|4|||
105523449|NCT04729127|363928429|FG003|Overall Study|Suspended/Terminated EI Services|6|||
105523450|NCT04729127|363928430|FG004|Overall Study|Suspended/Terminated EI Services|0|||
105523451|NCT04729127|363928431|FG005|Overall Study|Suspended/Terminated EI Services|6|||
105523452|NCT04729127|363928432|FG006|Overall Study|Suspended/Terminated EI Services|2|||
105523453|NCT04729127|363928433|FG007|Overall Study|Suspended/Terminated EI Services|0|||
105523454|NCT04729127|363928434|FG008|Overall Study|Suspended/Terminated EI Services|2|||
105523455|NCT04729127|363928426|FG000|Overall Study|Withdrawal by Subject|1|||
105523456|NCT04729127|363928427|FG001|Overall Study|Withdrawal by Subject|0|||
105523457|NCT04729127|363928428|FG002|Overall Study|Withdrawal by Subject|1|||
105523458|NCT04729127|363928429|FG003|Overall Study|Withdrawal by Subject|0|||
105523459|NCT04729127|363928430|FG004|Overall Study|Withdrawal by Subject|0|||
105523460|NCT04729127|363928431|FG005|Overall Study|Withdrawal by Subject|0|||
105523461|NCT04729127|363928432|FG006|Overall Study|Withdrawal by Subject|0|||
105523462|NCT04729127|363928433|FG007|Overall Study|Withdrawal by Subject|0|||
105523463|NCT04729127|363928434|FG008|Overall Study|Withdrawal by Subject|0|||
105523464|NCT04729127|363928426|FG000|Overall Study|Switched Agency/Setting|1|||
105523465|NCT04729127|363928427|FG001|Overall Study|Switched Agency/Setting|0|||
105523466|NCT04729127|363928428|FG002|Overall Study|Switched Agency/Setting|1|||
105523467|NCT04729127|363928429|FG003|Overall Study|Switched Agency/Setting|1|||
105523468|NCT04729127|363928430|FG004|Overall Study|Switched Agency/Setting|0|||
105523469|NCT04729127|363928431|FG005|Overall Study|Switched Agency/Setting|1|||
105523470|NCT04729127|363928432|FG006|Overall Study|Switched Agency/Setting|1|||
105523471|NCT04729127|363928433|FG007|Overall Study|Switched Agency/Setting|0|||
105523472|NCT04729127|363928434|FG008|Overall Study|Switched Agency/Setting|1|||
105523473|NCT01727141|363928435|FG000|Overall Study|Physician Decision|0|||
105523474|NCT01727141|363928436|FG001|Overall Study|Physician Decision|1|||
105592789|NCT03068468|364170766|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
105592790|NCT03068468|364170763|FG000|Placebo-Controlled Period|Death|0|||
105523475|NCT01727141|363928437|FG002|Overall Study|Physician Decision|0|||
105523476|NCT01727141|363928438|FG003|Overall Study|Physician Decision|2|||
105523477|NCT01727141|363928435|FG000|Overall Study|Lost to Follow-up|0|||
105523478|NCT01727141|363928436|FG001|Overall Study|Lost to Follow-up|2|||
105523479|NCT01727141|363928437|FG002|Overall Study|Lost to Follow-up|0|||
105523480|NCT01727141|363928438|FG003|Overall Study|Lost to Follow-up|0|||
105523481|NCT01727141|363928435|FG000|Overall Study|Death|0|||
105523482|NCT01727141|363928436|FG001|Overall Study|Death|1|||
105523483|NCT01727141|363928437|FG002|Overall Study|Death|1|||
105523484|NCT01727141|363928438|FG003|Overall Study|Death|1|||
105523485|NCT01727141|363928435|FG000|Overall Study|Protocol deviation|1|||
105523486|NCT01727141|363928436|FG001|Overall Study|Protocol deviation|1|||
105523487|NCT01727141|363928437|FG002|Overall Study|Protocol deviation|0|||
105523488|NCT01727141|363928438|FG003|Overall Study|Protocol deviation|1|||
105523489|NCT01727141|363928435|FG000|Overall Study|Withdrawal by Subject|4|||
105523490|NCT01727141|363928436|FG001|Overall Study|Withdrawal by Subject|4|||
105523491|NCT01727141|363928437|FG002|Overall Study|Withdrawal by Subject|2|||
105523492|NCT01727141|363928438|FG003|Overall Study|Withdrawal by Subject|11|||
105523493|NCT02603432|363928439|FG000|Overall Study|Adverse Event|1|||
105523494|NCT02603432|363928440|FG001|Overall Study|Adverse Event|0|||
105523495|NCT02603432|363928439|FG000|Overall Study|Death|221|||
105523496|NCT02603432|363928440|FG001|Overall Study|Death|242|||
105523497|NCT02603432|363928439|FG000|Overall Study|Lost to Follow-up|3|||
105523498|NCT02603432|363928440|FG001|Overall Study|Lost to Follow-up|9|||
105523499|NCT02603432|363928439|FG000|Overall Study|Progressive Disease|7|||
105523500|NCT02603432|363928440|FG001|Overall Study|Progressive Disease|5|||
105523501|NCT02603432|363928439|FG000|Overall Study|Withdrawal by Subject|12|||
105523502|NCT02603432|363928440|FG001|Overall Study|Withdrawal by Subject|18|||
105523503|NCT02603432|363928439|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
105523504|NCT02603432|363928440|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
105523505|NCT02603432|363928439|FG000|Overall Study|Study terminated by sponsor|74|||
105523506|NCT02603432|363928440|FG001|Overall Study|Study terminated by sponsor|75|||
105523507|NCT02603432|363928439|FG000|Overall Study|Other|13|||
105523508|NCT02603432|363928440|FG001|Overall Study|Other|0|||
105523509|NCT04765358|363928443|FG000|Overall Study|Withdrawal by Subject|1|||
105523510|NCT02731729|363928444|FG000|Overall Study|Death|2|||
105523511|NCT02731729|363928445|FG001|Overall Study|Death|2|||
105523512|NCT02731729|363928444|FG000|Overall Study|Study terminated by Sponsor|6|||
105523513|NCT02731729|363928445|FG001|Overall Study|Study terminated by Sponsor|6|||
105523514|NCT02731729|363928444|FG000|Overall Study|Withdrawal by Subject|1|||
105523515|NCT02731729|363928445|FG001|Overall Study|Withdrawal by Subject|0|||
105523516|NCT00159588|363928446|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
105523517|NCT00159588|363928447|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
105523518|NCT00159588|363928448|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
105523519|NCT00952341|363928453|FG000|Cycle 1|Adverse Event|4|||
105523520|NCT00952341|363928454|FG001|Cycle 1|Adverse Event|1|||
105523521|NCT00952341|363928453|FG000|Cycle 1|Withdrawal by Subject|3|||
105523522|NCT00952341|363928454|FG001|Cycle 1|Withdrawal by Subject|8|||
105523523|NCT00952341|363928453|FG000|Cycle 1|Protocol Violation|2|||
105523524|NCT00952341|363928454|FG001|Cycle 1|Protocol Violation|1|||
105523525|NCT00952341|363928453|FG000|Cycle 1|Lost to Follow-up|11|||
105523526|NCT00952341|363928454|FG001|Cycle 1|Lost to Follow-up|2|||
105523527|NCT00952341|363928453|FG000|Cycle 1|Physician Decision|0|||
105523528|NCT00952341|363928454|FG001|Cycle 1|Physician Decision|1|||
105523529|NCT00952341|363928453|FG000|Cycle 2|Withdrawal by Subject|1|||
105523530|NCT00952341|363928454|FG001|Cycle 2|Withdrawal by Subject|1|||
105523531|NCT00952341|363928453|FG000|Cycle 2|Protocol Violation|1|||
105523532|NCT00952341|363928454|FG001|Cycle 2|Protocol Violation|0|||
105523533|NCT00952341|363928453|FG000|Cycle 2|Lost to Follow-up|6|||
105523534|NCT00952341|363928454|FG001|Cycle 2|Lost to Follow-up|9|||
105523535|NCT00952341|363928453|FG000|Cycle 2|Physician Decision|1|||
105523536|NCT00952341|363928454|FG001|Cycle 2|Physician Decision|1|||
105523537|NCT00952341|363928453|FG000|Cycle 2|Progressive Disease|0|||
105523538|NCT00952341|363928454|FG001|Cycle 2|Progressive Disease|1|||
105523539|NCT00456521|363928455|FG000|Overall Study|Adverse Event|150|||
105523540|NCT00456521|363928456|FG001|Overall Study|Adverse Event|25|||
105523541|NCT00456521|363928455|FG000|Overall Study|Withdrawal by Subject|43|||
105523542|NCT00456521|363928456|FG001|Overall Study|Withdrawal by Subject|24|||
105523543|NCT00456521|363928455|FG000|Overall Study|Lost to Follow-up|22|||
105523544|NCT00456521|363928456|FG001|Overall Study|Lost to Follow-up|17|||
105523545|NCT00456521|363928455|FG000|Overall Study|Lack of Efficacy|3|||
105523546|NCT00456521|363928456|FG001|Overall Study|Lack of Efficacy|6|||
105523547|NCT00456521|363928455|FG000|Overall Study|Protocol Violation|4|||
105523548|NCT00456521|363928456|FG001|Overall Study|Protocol Violation|0|||
105523549|NCT00456521|363928455|FG000|Overall Study|Pregnancy|1|||
105523550|NCT00456521|363928456|FG001|Overall Study|Pregnancy|1|||
105523551|NCT00456521|363928455|FG000|Overall Study|Drug non-compliance, moved, other|26|||
105523552|NCT00456521|363928456|FG001|Overall Study|Drug non-compliance, moved, other|11|||
105523553|NCT01316276|363928457|FG000|Overall Study|Death|1|||
105523554|NCT01316276|363928457|FG000|Overall Study|Adverse Event|19|||
105523555|NCT01316276|363928457|FG000|Overall Study|Withdrawal of consent|24|||
105523556|NCT01316276|363928457|FG000|Overall Study|Lost to Follow-up|1|||
105523557|NCT01316276|363928457|FG000|Overall Study|Other|22|||
105523558|NCT00605475|363928458|FG000|Overall Study|Abnormal Laboratory Values|0|||
105523559|NCT00605475|363928459|FG001|Overall Study|Abnormal Laboratory Values|0|||
105523560|NCT00605475|363928460|FG002|Overall Study|Abnormal Laboratory Values|0|||
105523561|NCT00605475|363928461|FG003|Overall Study|Abnormal Laboratory Values|0|||
105523562|NCT00605475|363928462|FG004|Overall Study|Abnormal Laboratory Values|0|||
105523563|NCT00605475|363928463|FG005|Overall Study|Abnormal Laboratory Values|0|||
105523564|NCT00605475|363928464|FG006|Overall Study|Abnormal Laboratory Values|0|||
105523565|NCT00605475|363928465|FG007|Overall Study|Abnormal Laboratory Values|0|||
105523566|NCT00605475|363928466|FG008|Overall Study|Abnormal Laboratory Values|1|||
105523567|NCT00605475|363928467|FG009|Overall Study|Abnormal Laboratory Values|0|||
105523568|NCT00605475|363928458|FG000|Overall Study|Administrative problems|0|||
105523569|NCT00605475|363928459|FG001|Overall Study|Administrative problems|0|||
105523570|NCT00605475|363928460|FG002|Overall Study|Administrative problems|0|||
105523571|NCT00605475|363928461|FG003|Overall Study|Administrative problems|0|||
105523572|NCT00605475|363928462|FG004|Overall Study|Administrative problems|0|||
105523573|NCT00605475|363928463|FG005|Overall Study|Administrative problems|0|||
105523574|NCT00605475|363928464|FG006|Overall Study|Administrative problems|1|||
105523575|NCT00605475|363928465|FG007|Overall Study|Administrative problems|0|||
105523576|NCT00605475|363928466|FG008|Overall Study|Administrative problems|0|||
105523577|NCT00605475|363928467|FG009|Overall Study|Administrative problems|0|||
105523578|NCT00605475|363928458|FG000|Overall Study|Lost to Follow-up|0|||
105523579|NCT00605475|363928459|FG001|Overall Study|Lost to Follow-up|0|||
105523580|NCT00605475|363928460|FG002|Overall Study|Lost to Follow-up|0|||
105523581|NCT00605475|363928461|FG003|Overall Study|Lost to Follow-up|0|||
105523582|NCT00605475|363928462|FG004|Overall Study|Lost to Follow-up|0|||
105523583|NCT00605475|363928463|FG005|Overall Study|Lost to Follow-up|0|||
105523584|NCT00605475|363928464|FG006|Overall Study|Lost to Follow-up|0|||
105523585|NCT00605475|363928465|FG007|Overall Study|Lost to Follow-up|0|||
105523586|NCT00605475|363928466|FG008|Overall Study|Lost to Follow-up|1|||
105523587|NCT00605475|363928467|FG009|Overall Study|Lost to Follow-up|1|||
105523588|NCT00605475|363928458|FG000|Overall Study|Protocol Violation|0|||
105523589|NCT00605475|363928459|FG001|Overall Study|Protocol Violation|0|||
105523590|NCT00605475|363928460|FG002|Overall Study|Protocol Violation|0|||
105523591|NCT00605475|363928461|FG003|Overall Study|Protocol Violation|0|||
105523592|NCT00605475|363928462|FG004|Overall Study|Protocol Violation|1|||
105523593|NCT00605475|363928463|FG005|Overall Study|Protocol Violation|0|||
105523594|NCT00605475|363928464|FG006|Overall Study|Protocol Violation|0|||
105523595|NCT00605475|363928465|FG007|Overall Study|Protocol Violation|0|||
105523596|NCT00605475|363928466|FG008|Overall Study|Protocol Violation|0|||
105523597|NCT00605475|363928467|FG009|Overall Study|Protocol Violation|0|||
105523598|NCT00605475|363928458|FG000|Overall Study|Withdrawal by Subject|0|||
105523599|NCT00605475|363928459|FG001|Overall Study|Withdrawal by Subject|0|||
105523600|NCT00605475|363928460|FG002|Overall Study|Withdrawal by Subject|0|||
105523601|NCT00605475|363928461|FG003|Overall Study|Withdrawal by Subject|0|||
105523602|NCT00605475|363928462|FG004|Overall Study|Withdrawal by Subject|0|||
105523603|NCT00605475|363928463|FG005|Overall Study|Withdrawal by Subject|2|||
105523604|NCT00605475|363928464|FG006|Overall Study|Withdrawal by Subject|0|||
105523605|NCT00605475|363928465|FG007|Overall Study|Withdrawal by Subject|0|||
105523606|NCT00605475|363928466|FG008|Overall Study|Withdrawal by Subject|0|||
105523607|NCT00605475|363928467|FG009|Overall Study|Withdrawal by Subject|1|||
105523608|NCT00297037|363928470|FG000|Overall Study|Withdrawal by Subject|2|||
105523609|NCT00297037|363928471|FG001|Overall Study|Withdrawal by Subject|0|||
105523610|NCT05352815|363928472|FG000|Overall Study|Withdrawal by Subject|28|||
105523611|NCT05352815|363928473|FG001|Overall Study|Withdrawal by Subject|24|||
105523612|NCT05352815|363928472|FG000|Overall Study|Lost to Follow-up|4|||
105523613|NCT05352815|363928473|FG001|Overall Study|Lost to Follow-up|7|||
105523614|NCT05352815|363928472|FG000|Overall Study|Death|2|||
105523615|NCT05352815|363928473|FG001|Overall Study|Death|3|||
105523616|NCT05352815|363928472|FG000|Overall Study|Site closure|1|||
105523617|NCT05352815|363928473|FG001|Overall Study|Site closure|0|||
105523618|NCT00464568|363928477|FG000|Overall Study|Adverse Event|2|||
105523619|NCT00930579|363928484|FG000|Overall Study|Withdrawal by Subject|1|||
105523620|NCT00930579|363928484|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
105523621|NCT04356963|363928491|FG000|First Session|Withdrawal by Subject|1|||
105523622|NCT04356963|363928491|FG000|Second Session|Withdrawal by Subject|3|||
105523623|NCT04356963|363928491|FG000|Second Session|Lost to Follow-up|1|||
105523624|NCT04356963|363928491|FG000|Third Session|Lost to Follow-up|6|||
105523625|NCT04356963|363928491|FG000|Third Session|Withdrawal by Subject|1|||
105523626|NCT02410954|363928497|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
105523627|NCT02410954|363928498|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
105523628|NCT02410954|363928497|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
105523629|NCT02410954|363928498|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
105523630|NCT00304356|363928505|FG000|Nitazoxanide|Physician Decision|5|||
105523631|NCT00304356|363928505|FG000|Nitazoxanide|Physician Decision|1|||
105523632|NCT00304356|363928505|FG000|Nitazoxanide|number is 0|1|||
105523633|NCT00304356|363928505|FG000|Nitazoxanide|Physician Decision|1|||
105523634|NCT00304356|363928505|FG000|Nitazoxanide|Physician Decision|1|||
105523635|NCT00304356|363928505|FG000|Nitazoxanide|Physician Decision|1|||
105523636|NCT02140567|363928506|FG000|Overall Study|Problems with recording equipment|6|||
105523637|NCT02385084|363928512|FG000|Period 2|Protocol Violation|0|||
105523638|NCT02385084|363928513|FG001|Period 2|Protocol Violation|0|||
105523639|NCT02385084|363928514|FG002|Period 2|Protocol Violation|1|||
105523640|NCT02385084|363928515|FG003|Period 2|Protocol Violation|0|||
105523641|NCT02385084|363928516|FG004|Period 2|Protocol Violation|0|||
105523642|NCT02385084|363928517|FG005|Period 2|Protocol Violation|0|||
105523643|NCT00744627|363928523|FG000|Overall Study|Adverse Event|6|||
105523644|NCT00744627|363928524|FG001|Overall Study|Adverse Event|9|||
105523645|NCT00744627|363928523|FG000|Overall Study|Lack of Efficacy|7|||
105523646|NCT00744627|363928524|FG001|Overall Study|Lack of Efficacy|3|||
105523647|NCT00744627|363928523|FG000|Overall Study|Noncompliance|0|||
105523648|NCT00744627|363928524|FG001|Overall Study|Noncompliance|1|||
105523649|NCT00744627|363928523|FG000|Overall Study|Protocol Deviations|0|||
105523650|NCT00744627|363928524|FG001|Overall Study|Protocol Deviations|2|||
105523651|NCT00744627|363928523|FG000|Overall Study|Voluntary Withdrawal|9|||
105523652|NCT00744627|363928524|FG001|Overall Study|Voluntary Withdrawal|6|||
105523653|NCT00744627|363928523|FG000|Overall Study|Lost to Follow-up|2|||
105523654|NCT00744627|363928524|FG001|Overall Study|Lost to Follow-up|1|||
105523655|NCT00744627|363928523|FG000|Overall Study|Other|1|||
105523656|NCT00744627|363928524|FG001|Overall Study|Other|0|||
105523657|NCT04251221|363928525|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
105523658|NCT04251221|363928526|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
105523659|NCT01466387|363928530|FG000|Overall Study|Adverse Event|0|||
105523660|NCT01466387|363928531|FG001|Overall Study|Adverse Event|0|||
105523661|NCT01466387|363928532|FG002|Overall Study|Adverse Event|1|||
105523662|NCT01466387|363928533|FG003|Overall Study|Adverse Event|1|||
105523663|NCT01466387|363928534|FG004|Overall Study|Adverse Event|0|||
105523664|NCT01466387|363928535|FG005|Overall Study|Adverse Event|0|||
105523665|NCT01466387|363928530|FG000|Overall Study|Lost to Follow-up|0|||
105523666|NCT01466387|363928531|FG001|Overall Study|Lost to Follow-up|0|||
105523667|NCT01466387|363928532|FG002|Overall Study|Lost to Follow-up|0|||
105523668|NCT01466387|363928533|FG003|Overall Study|Lost to Follow-up|0|||
105523669|NCT01466387|363928534|FG004|Overall Study|Lost to Follow-up|0|||
105523670|NCT01466387|363928535|FG005|Overall Study|Lost to Follow-up|1|||
105523671|NCT01466387|363928530|FG000|Overall Study|Protocol Violation|1|||
105523672|NCT01466387|363928531|FG001|Overall Study|Protocol Violation|0|||
105523673|NCT01466387|363928532|FG002|Overall Study|Protocol Violation|0|||
105523674|NCT01466387|363928533|FG003|Overall Study|Protocol Violation|1|||
105523675|NCT01466387|363928534|FG004|Overall Study|Protocol Violation|0|||
105523676|NCT01466387|363928535|FG005|Overall Study|Protocol Violation|0|||
105523677|NCT00832585|363928537|FG000|Overall Study|Withdrawal by Subject|1|||
105523678|NCT00832585|363928537|FG000|Overall Study|Lost to Follow-up|1|||
105523679|NCT03526458|363928540|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
105523680|NCT03526458|363928541|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
105523681|NCT03526458|363928540|FG000|Overall Study|Stone passed, surgery cancelled|2|||
105523682|NCT03526458|363928541|FG001|Overall Study|Stone passed, surgery cancelled|1|||
105523683|NCT03526458|363928540|FG000|Overall Study|Withdrawal by Subject|1|||
105523684|NCT03526458|363928541|FG001|Overall Study|Withdrawal by Subject|0|||
105523685|NCT03526458|363928540|FG000|Overall Study|Physician Decision|2|||
105523686|NCT03526458|363928541|FG001|Overall Study|Physician Decision|1|||
105523687|NCT03526458|363928540|FG000|Overall Study|Lack of equipment|1|||
105523688|NCT03526458|363928541|FG001|Overall Study|Lack of equipment|1|||
105523689|NCT00271947|363928542|FG000|Overall Study|Lost to Follow-up|1|||
105523690|NCT04404855|363928543|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
105523691|NCT04404855|363928544|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
105523692|NCT01522365|363928545|FG000|Overall Study|Withdrawal by Subject|1|||
105523693|NCT01522365|363928546|FG001|Overall Study|Withdrawal by Subject|1|||
105523694|NCT01522365|363928545|FG000|Overall Study|Lost to Follow-up|1|||
105523695|NCT01522365|363928546|FG001|Overall Study|Lost to Follow-up|1|||
105523696|NCT03760146|363928551|FG000|Overall Study|Adverse Event|11|||
105523697|NCT03760146|363928552|FG001|Overall Study|Adverse Event|8|||
105523698|NCT03760146|363928553|FG002|Overall Study|Adverse Event|0|||
105523699|NCT03760146|363928554|FG003|Overall Study|Adverse Event|0|||
105523700|NCT03760146|363928555|FG004|Overall Study|Adverse Event|0|||
105523701|NCT03760146|363928556|FG005|Overall Study|Adverse Event|0|||
105523702|NCT03760146|363928551|FG000|Overall Study|Death|1|||
105523703|NCT03760146|363928552|FG001|Overall Study|Death|0|||
105523704|NCT03760146|363928553|FG002|Overall Study|Death|0|||
105523705|NCT03760146|363928554|FG003|Overall Study|Death|0|||
105523706|NCT03760146|363928555|FG004|Overall Study|Death|0|||
105523707|NCT03760146|363928556|FG005|Overall Study|Death|0|||
105523708|NCT03760146|363928551|FG000|Overall Study|Lost to Follow-up|41|||
105523709|NCT03760146|363928552|FG001|Overall Study|Lost to Follow-up|28|||
105523710|NCT03760146|363928553|FG002|Overall Study|Lost to Follow-up|9|||
105523711|NCT03760146|363928554|FG003|Overall Study|Lost to Follow-up|2|||
105523712|NCT03760146|363928555|FG004|Overall Study|Lost to Follow-up|14|||
105523713|NCT03760146|363928556|FG005|Overall Study|Lost to Follow-up|8|||
105523714|NCT03760146|363928551|FG000|Overall Study|No longer met eligibility criteria|3|||
105523715|NCT03760146|363928552|FG001|Overall Study|No longer met eligibility criteria|9|||
105523716|NCT03760146|363928553|FG002|Overall Study|No longer met eligibility criteria|0|||
105523717|NCT03760146|363928554|FG003|Overall Study|No longer met eligibility criteria|0|||
105523718|NCT03760146|363928555|FG004|Overall Study|No longer met eligibility criteria|1|||
105523719|NCT03760146|363928556|FG005|Overall Study|No longer met eligibility criteria|0|||
105523720|NCT03760146|363928551|FG000|Overall Study|Protocol Violation|21|||
105523721|NCT03760146|363928552|FG001|Overall Study|Protocol Violation|13|||
105523722|NCT03760146|363928553|FG002|Overall Study|Protocol Violation|1|||
105523723|NCT03760146|363928554|FG003|Overall Study|Protocol Violation|0|||
105523724|NCT03760146|363928555|FG004|Overall Study|Protocol Violation|1|||
105523725|NCT03760146|363928556|FG005|Overall Study|Protocol Violation|0|||
105523726|NCT03760146|363928551|FG000|Overall Study|Withdrawal by Subject|19|||
105523727|NCT03760146|363928552|FG001|Overall Study|Withdrawal by Subject|20|||
105523728|NCT03760146|363928553|FG002|Overall Study|Withdrawal by Subject|1|||
105523729|NCT03760146|363928554|FG003|Overall Study|Withdrawal by Subject|0|||
105523730|NCT03760146|363928555|FG004|Overall Study|Withdrawal by Subject|1|||
105523731|NCT03760146|363928556|FG005|Overall Study|Withdrawal by Subject|0|||
105523732|NCT00449644|363928557|FG000|Overall Study|Adverse Event|0|||
105523733|NCT00449644|363928558|FG001|Overall Study|Adverse Event|0|||
105523734|NCT00449644|363928559|FG002|Overall Study|Adverse Event|3|||
105523735|NCT00449644|363928560|FG003|Overall Study|Adverse Event|5|||
105523736|NCT00449644|363928557|FG000|Overall Study|Death|1|||
105523737|NCT00449644|363928558|FG001|Overall Study|Death|0|||
105523738|NCT00449644|363928559|FG002|Overall Study|Death|6|||
105523739|NCT00449644|363928560|FG003|Overall Study|Death|1|||
105523740|NCT00449644|363928557|FG000|Overall Study|Lost to Follow-up|1|||
105523741|NCT00449644|363928558|FG001|Overall Study|Lost to Follow-up|1|||
105523742|NCT00449644|363928559|FG002|Overall Study|Lost to Follow-up|5|||
105523743|NCT00449644|363928560|FG003|Overall Study|Lost to Follow-up|3|||
105523744|NCT00449644|363928557|FG000|Overall Study|Pregnancy|0|||
105523745|NCT00449644|363928558|FG001|Overall Study|Pregnancy|0|||
105523746|NCT00449644|363928559|FG002|Overall Study|Pregnancy|3|||
105523747|NCT00449644|363928560|FG003|Overall Study|Pregnancy|2|||
105523748|NCT00449644|363928557|FG000|Overall Study|Protocol Violation|4|||
105523749|NCT00449644|363928558|FG001|Overall Study|Protocol Violation|4|||
105523750|NCT00449644|363928559|FG002|Overall Study|Protocol Violation|3|||
105523751|NCT00449644|363928560|FG003|Overall Study|Protocol Violation|7|||
105523752|NCT00449644|363928557|FG000|Overall Study|Withdrawal by Subject|3|||
105523753|NCT00449644|363928558|FG001|Overall Study|Withdrawal by Subject|4|||
105523754|NCT00449644|363928559|FG002|Overall Study|Withdrawal by Subject|6|||
105523755|NCT00449644|363928560|FG003|Overall Study|Withdrawal by Subject|7|||
105523756|NCT00449644|363928557|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
105523757|NCT00449644|363928558|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
105523758|NCT00449644|363928559|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
105523759|NCT00449644|363928560|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
105523760|NCT00449644|363928557|FG000|Overall Study|Other|1|||
105523761|NCT00449644|363928558|FG001|Overall Study|Other|4|||
105523762|NCT00449644|363928559|FG002|Overall Study|Other|1|||
105523763|NCT00449644|363928560|FG003|Overall Study|Other|0|||
105523764|NCT00449644|363928557|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
105523765|NCT00449644|363928558|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
105523766|NCT00449644|363928559|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
105523767|NCT00449644|363928560|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
105523768|NCT02291055|363928563|FG000|Overall Study|Death|2|||
105523769|NCT02291055|363928564|FG001|Overall Study|Death|2|||
105523770|NCT02291055|363928565|FG002|Overall Study|Death|5|||
105523771|NCT02291055|363928566|FG003|Overall Study|Death|8|||
105523772|NCT02291055|363928567|FG004|Overall Study|Death|12|||
105523773|NCT02291055|363928563|FG000|Overall Study|Lost to Follow-up|0|||
105523774|NCT02291055|363928564|FG001|Overall Study|Lost to Follow-up|0|||
105523775|NCT02291055|363928565|FG002|Overall Study|Lost to Follow-up|0|||
105523776|NCT02291055|363928566|FG003|Overall Study|Lost to Follow-up|1|||
105523777|NCT02291055|363928567|FG004|Overall Study|Lost to Follow-up|2|||
105523778|NCT02291055|363928563|FG000|Overall Study|Withdrawal by Subject|3|||
105523779|NCT02291055|363928564|FG001|Overall Study|Withdrawal by Subject|1|||
105523780|NCT02291055|363928565|FG002|Overall Study|Withdrawal by Subject|1|||
105523781|NCT02291055|363928566|FG003|Overall Study|Withdrawal by Subject|5|||
105523782|NCT02291055|363928567|FG004|Overall Study|Withdrawal by Subject|10|||
105523783|NCT02291055|363928563|FG000|Overall Study|Progressive Disease|0|||
105523784|NCT02291055|363928564|FG001|Overall Study|Progressive Disease|0|||
105523785|NCT02291055|363928565|FG002|Overall Study|Progressive Disease|1|||
105523786|NCT02291055|363928566|FG003|Overall Study|Progressive Disease|4|||
105523787|NCT02291055|363928567|FG004|Overall Study|Progressive Disease|2|||
105523788|NCT02291055|363928563|FG000|Overall Study|Study Terminated by Sponsor|0|||
105523789|NCT02291055|363928564|FG001|Overall Study|Study Terminated by Sponsor|0|||
105523790|NCT02291055|363928565|FG002|Overall Study|Study Terminated by Sponsor|0|||
105523791|NCT02291055|363928566|FG003|Overall Study|Study Terminated by Sponsor|5|||
105523792|NCT02291055|363928567|FG004|Overall Study|Study Terminated by Sponsor|1|||
105523793|NCT02291055|363928563|FG000|Overall Study|Other|0|||
105523794|NCT02291055|363928564|FG001|Overall Study|Other|2|||
105523795|NCT02291055|363928565|FG002|Overall Study|Other|1|||
105523796|NCT02291055|363928566|FG003|Overall Study|Other|4|||
105523797|NCT02291055|363928567|FG004|Overall Study|Other|0|||
105523798|NCT02910167|363928571|FG000|Overall Study|Adverse Event|1|||
105523799|NCT02910167|363928571|FG000|Overall Study|Lost to Follow-up|18|||
105523800|NCT02680639|363928572|FG000|Screening Period|Screen Failure|7|||
105523801|NCT02680639|363928573|FG001|Screening Period|Screen Failure|0|||
105523802|NCT02680639|363928574|FG002|Screening Period|Screen Failure|0|||
105523803|NCT04059146|363928575|FG000|Overall Study|Withdrawal by Subject|0|||
105523804|NCT04059146|363928576|FG001|Overall Study|Withdrawal by Subject|1|||
105523805|NCT03662542|363930279|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
105523806|NCT03662542|363930280|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
105523807|NCT03662542|363930281|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
105523808|NCT03662542|363930282|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
105523809|NCT03662542|363930283|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
105523810|NCT03662542|363930284|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
105523811|NCT03662542|363930285|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
105523812|NCT03662542|363930286|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
105523813|NCT03662542|363930287|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
105523814|NCT03662542|363930279|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
105523815|NCT03662542|363930280|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
105523816|NCT03662542|363930281|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
105523817|NCT03662542|363930282|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
105523818|NCT03662542|363930283|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
105523819|NCT03662542|363930284|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
105523820|NCT03662542|363930285|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
105523821|NCT03662542|363930286|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
105523822|NCT03662542|363930287|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
105523823|NCT03662542|363930279|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
105523824|NCT03662542|363930280|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
105523825|NCT03662542|363930281|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
105523826|NCT03662542|363930282|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
105523827|NCT03662542|363930283|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
105523828|NCT03662542|363930284|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
105523829|NCT03662542|363930285|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
105523830|NCT03662542|363930286|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
105523831|NCT03662542|363930287|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
105523832|NCT03662542|363930279|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
105523833|NCT03662542|363930280|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
105523834|NCT03662542|363930281|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
105523835|NCT03662542|363930282|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
105523836|NCT03662542|363930283|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
105523837|NCT03662542|363930284|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
105523838|NCT03662542|363930285|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
105523839|NCT03662542|363930286|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
105523840|NCT03662542|363930287|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
105523841|NCT03662542|363930279|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
105523842|NCT03662542|363930280|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
105523843|NCT03662542|363930281|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
105523844|NCT03662542|363930282|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
105523845|NCT03662542|363930283|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
105523846|NCT03662542|363930284|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
105523847|NCT03662542|363930285|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
105523848|NCT03662542|363930286|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
105523849|NCT03662542|363930287|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
105523850|NCT03662542|363930279|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
105523851|NCT03662542|363930280|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
105523852|NCT03662542|363930281|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
105523853|NCT03662542|363930282|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
105523854|NCT03662542|363930283|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
105523855|NCT03662542|363930284|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
105523856|NCT03662542|363930285|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
105523857|NCT03662542|363930286|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
105523858|NCT03662542|363930287|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
105523859|NCT03662542|363930279|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
105523860|NCT03662542|363930280|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
105523861|NCT03662542|363930281|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
105523862|NCT03662542|363930282|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
105523863|NCT03662542|363930283|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
105523864|NCT03662542|363930284|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
105523865|NCT03662542|363930285|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
105523866|NCT03662542|363930286|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
105523867|NCT03662542|363930287|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
105523868|NCT03662542|363930279|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
105523869|NCT03662542|363930280|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
105523870|NCT03662542|363930281|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
105523871|NCT03662542|363930282|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
105523872|NCT03662542|363930283|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
105523873|NCT03662542|363930284|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
105523874|NCT03662542|363930285|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
105523875|NCT03662542|363930286|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
105523876|NCT03662542|363930287|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
105523877|NCT03662542|363930279|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
105523878|NCT03662542|363930280|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
105523879|NCT03662542|363930281|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
105523880|NCT03662542|363930282|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
105523881|NCT03662542|363930283|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
105523882|NCT03662542|363930284|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
105523883|NCT03662542|363930285|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
105523884|NCT03662542|363930286|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
105523885|NCT03662542|363930287|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
105523886|NCT03662542|363930279|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
105523887|NCT03662542|363930280|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
105523888|NCT03662542|363930281|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
105523889|NCT03662542|363930282|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
105523890|NCT03662542|363930283|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
105523891|NCT03662542|363930284|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
105523892|NCT03662542|363930285|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
105523893|NCT03662542|363930286|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
105523894|NCT03662542|363930287|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
105523895|NCT03662542|363930279|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
105523896|NCT03662542|363930280|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
105523897|NCT03662542|363930281|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
105523898|NCT03662542|363930282|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
105523899|NCT03662542|363930283|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
105523900|NCT03662542|363930284|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
105523901|NCT03662542|363930285|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
105523902|NCT03662542|363930286|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
105523903|NCT03662542|363930287|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
105523904|NCT03662542|363930279|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
105523905|NCT03662542|363930280|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
105523906|NCT03662542|363930281|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
105523907|NCT03662542|363930282|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
105523908|NCT03662542|363930283|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
105523909|NCT03662542|363930284|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
105523910|NCT03662542|363930285|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
105523911|NCT03662542|363930286|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
105523912|NCT03662542|363930287|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
105523913|NCT03662542|363930279|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
105523914|NCT03662542|363930280|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
105523915|NCT03662542|363930281|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
105523916|NCT03662542|363930282|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
105523917|NCT03662542|363930283|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
105523918|NCT03662542|363930284|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
105523919|NCT03662542|363930285|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
105523920|NCT03662542|363930286|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
105523921|NCT03662542|363930287|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
105523922|NCT00588822|363930288|FG000|Overall Study|progression of disease|8|||
105523923|NCT00004888|363930289|FG000|Overall Study|Adverse Event|5|||
105523924|NCT00004888|363930290|FG001|Overall Study|Adverse Event|10|||
105523925|NCT00004888|363930289|FG000|Overall Study|Withdrawal by Subject|0|||
105523926|NCT00004888|363930290|FG001|Overall Study|Withdrawal by Subject|3|||
105523927|NCT00004888|363930289|FG000|Overall Study|Physician Decision|1|||
105523928|NCT00004888|363930290|FG001|Overall Study|Physician Decision|1|||
105523929|NCT00004888|363930289|FG000|Overall Study|Progressive Disease|4|||
105523930|NCT00004888|363930290|FG001|Overall Study|Progressive Disease|9|||
105523931|NCT00004888|363930289|FG000|Overall Study|Death without progressive disease|0|||
105523932|NCT00004888|363930290|FG001|Overall Study|Death without progressive disease|1|||
105523933|NCT00004888|363930289|FG000|Overall Study|Toxic death|1|||
105523934|NCT00004888|363930290|FG001|Overall Study|Toxic death|0|||
105523935|NCT02174848|363930295|FG000|Overall Study|Adverse Event|2|||
105523936|NCT02174848|363930296|FG001|Overall Study|Adverse Event|1|||
105523937|NCT02174848|363930295|FG000|Overall Study|Withdrawal by Subject|3|||
105523938|NCT02174848|363930296|FG001|Overall Study|Withdrawal by Subject|3|||
105523939|NCT02174848|363930295|FG000|Overall Study|Lost to Follow-up|0|||
105523940|NCT02174848|363930296|FG001|Overall Study|Lost to Follow-up|1|||
105523941|NCT02174848|363930295|FG000|Overall Study|Worsening of disease|1|||
105523942|NCT02174848|363930296|FG001|Overall Study|Worsening of disease|1|||
105523943|NCT02174848|363930295|FG000|Overall Study|Unable to comply with study requirements|1|||
105523944|NCT02174848|363930296|FG001|Overall Study|Unable to comply with study requirements|0|||
105523945|NCT03239470|363930303|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
105523946|NCT03239470|363930304|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
105523947|NCT00922766|363930305|FG000|Overall Study|Death|3|||
105523948|NCT00922766|363930305|FG000|Overall Study|Withdrawal by Subject|2|||
105523949|NCT00922766|363930305|FG000|Overall Study|Other|1|||
105523950|NCT00922766|363930305|FG000|Overall Study|Adverse Event|1|||
105523951|NCT04014075|363930306|FG000|Overall Study|Progressive Disease|53|||
105523952|NCT04014075|363930306|FG000|Overall Study|Adverse Event|15|||
105523953|NCT04014075|363930306|FG000|Overall Study|Clinical Progression|4|||
105523954|NCT04014075|363930306|FG000|Overall Study|Death|2|||
105523955|NCT04014075|363930306|FG000|Overall Study|Withdrawal by Subject|2|||
105523956|NCT04014075|363930306|FG000|Overall Study|Miscellaneous|2|||
105523957|NCT04014075|363930306|FG000|Overall Study|Physician Decision|1|||
105523958|NCT02622828|363930307|FG000|Overall Study|participant withdrew|3|||
105523959|NCT00666757|363930308|FG000|Overall Study|Lost to Follow-up|39|||
105523960|NCT00666757|363930309|FG001|Overall Study|Lost to Follow-up|35|||
105523961|NCT00666757|363930308|FG000|Overall Study|Protocol Violation|23|||
105523962|NCT00666757|363930309|FG001|Overall Study|Protocol Violation|24|||
105523963|NCT00666757|363930308|FG000|Overall Study|Adverse Event|22|||
105523964|NCT00666757|363930309|FG001|Overall Study|Adverse Event|12|||
105523965|NCT00666757|363930308|FG000|Overall Study|Withdrawal by Subject|13|||
105523966|NCT00666757|363930309|FG001|Overall Study|Withdrawal by Subject|17|||
105523967|NCT00666757|363930308|FG000|Overall Study|Lack of Efficacy|3|||
105523968|NCT00666757|363930309|FG001|Overall Study|Lack of Efficacy|6|||
105523969|NCT00666757|363930308|FG000|Overall Study|Physician Decision|0|||
105523970|NCT00666757|363930309|FG001|Overall Study|Physician Decision|2|||
105523971|NCT00666757|363930308|FG000|Overall Study|Sponsor decision|0|||
105523972|NCT00666757|363930309|FG001|Overall Study|Sponsor decision|1|||
105523973|NCT02510794|363930310|FG000|Overall Study|Adverse Event|0|||
105523974|NCT02510794|363930311|FG001|Overall Study|Adverse Event|1|||
105523975|NCT02510794|363930312|FG002|Overall Study|Adverse Event|0|||
105523976|NCT02510794|363930313|FG003|Overall Study|Adverse Event|0|||
105523977|NCT02510794|363930310|FG000|Overall Study|Death|1|||
105523978|NCT02510794|363930311|FG001|Overall Study|Death|2|||
105523979|NCT02510794|363930312|FG002|Overall Study|Death|1|||
105523980|NCT02510794|363930313|FG003|Overall Study|Death|1|||
105523981|NCT02510794|363930310|FG000|Overall Study|Lack of Efficacy|3|||
105523982|NCT02510794|363930311|FG001|Overall Study|Lack of Efficacy|1|||
105523983|NCT02510794|363930312|FG002|Overall Study|Lack of Efficacy|1|||
105523984|NCT02510794|363930313|FG003|Overall Study|Lack of Efficacy|0|||
105523985|NCT02510794|363930310|FG000|Overall Study|Participant moved out of the area|0|||
105523986|NCT02510794|363930311|FG001|Overall Study|Participant moved out of the area|0|||
105523987|NCT02510794|363930312|FG002|Overall Study|Participant moved out of the area|0|||
105523988|NCT02510794|363930313|FG003|Overall Study|Participant moved out of the area|1|||
105523989|NCT02510794|363930310|FG000|Overall Study|Physician Decision|3|||
105523990|NCT02510794|363930311|FG001|Overall Study|Physician Decision|0|||
105523991|NCT02510794|363930312|FG002|Overall Study|Physician Decision|0|||
105523992|NCT02510794|363930313|FG003|Overall Study|Physician Decision|0|||
105523993|NCT02510794|363930310|FG000|Overall Study|Protocol Violation|0|||
105523994|NCT02510794|363930311|FG001|Overall Study|Protocol Violation|0|||
105523995|NCT02510794|363930312|FG002|Overall Study|Protocol Violation|1|||
105523996|NCT02510794|363930313|FG003|Overall Study|Protocol Violation|0|||
105523997|NCT02510794|363930310|FG000|Overall Study|Withdrawal by Subject|1|||
105523998|NCT02510794|363930311|FG001|Overall Study|Withdrawal by Subject|2|||
105523999|NCT02510794|363930312|FG002|Overall Study|Withdrawal by Subject|4|||
105524000|NCT02510794|363930313|FG003|Overall Study|Withdrawal by Subject|3|||
105524001|NCT01649375|363930314|FG000|Up to Week 16|Adverse Event|2|||
105524002|NCT01649375|363930315|FG001|Up to Week 16|Adverse Event|5|||
105524003|NCT01649375|363930316|FG002|Up to Week 16|Adverse Event|4|||
105524004|NCT01649375|363930317|FG003|Up to Week 16|Adverse Event|0|||
105524005|NCT01649375|363930318|FG004|Up to Week 16|Adverse Event|0|||
105524006|NCT01649375|363930314|FG000|Up to Week 16|Lack of Efficacy|0|||
105524007|NCT01649375|363930315|FG001|Up to Week 16|Lack of Efficacy|0|||
105524008|NCT01649375|363930316|FG002|Up to Week 16|Lack of Efficacy|1|||
105524009|NCT01649375|363930317|FG003|Up to Week 16|Lack of Efficacy|0|||
105524010|NCT01649375|363930318|FG004|Up to Week 16|Lack of Efficacy|0|||
105524011|NCT01649375|363930314|FG000|Up to Week 16|Physician Decision|0|||
105524012|NCT01649375|363930315|FG001|Up to Week 16|Physician Decision|0|||
105524013|NCT01649375|363930316|FG002|Up to Week 16|Physician Decision|1|||
105524014|NCT01649375|363930317|FG003|Up to Week 16|Physician Decision|0|||
105524015|NCT01649375|363930318|FG004|Up to Week 16|Physician Decision|0|||
105524016|NCT01649375|363930314|FG000|Up to Week 16|Withdrawal by Subject|2|||
105524017|NCT01649375|363930315|FG001|Up to Week 16|Withdrawal by Subject|1|||
105524018|NCT01649375|363930316|FG002|Up to Week 16|Withdrawal by Subject|2|||
105524019|NCT01649375|363930317|FG003|Up to Week 16|Withdrawal by Subject|0|||
105524020|NCT01649375|363930318|FG004|Up to Week 16|Withdrawal by Subject|0|||
105524021|NCT01649375|363930314|FG000|Up to Week 16|Death|1|||
105524022|NCT01649375|363930315|FG001|Up to Week 16|Death|0|||
105524023|NCT01649375|363930316|FG002|Up to Week 16|Death|0|||
105524024|NCT01649375|363930317|FG003|Up to Week 16|Death|0|||
105524025|NCT01649375|363930318|FG004|Up to Week 16|Death|0|||
105524026|NCT01649375|363930314|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
105524027|NCT01649375|363930315|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
105524028|NCT01649375|363930316|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
105524029|NCT01649375|363930317|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
105524030|NCT01649375|363930318|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
105524031|NCT01649375|363930314|FG000|Week 16 up to Week 260|Non-compliance|0|||
105524032|NCT01649375|363930315|FG001|Week 16 up to Week 260|Non-compliance|1|||
105524033|NCT01649375|363930316|FG002|Week 16 up to Week 260|Non-compliance|0|||
105524034|NCT01649375|363930317|FG003|Week 16 up to Week 260|Non-compliance|1|||
105524035|NCT01649375|363930318|FG004|Week 16 up to Week 260|Non-compliance|0|||
105524036|NCT01649375|363930314|FG000|Week 16 up to Week 260|Physician Decision|0|||
105524037|NCT01649375|363930315|FG001|Week 16 up to Week 260|Physician Decision|2|||
105524038|NCT01649375|363930316|FG002|Week 16 up to Week 260|Physician Decision|0|||
105524039|NCT01649375|363930317|FG003|Week 16 up to Week 260|Physician Decision|0|||
105524040|NCT01649375|363930318|FG004|Week 16 up to Week 260|Physician Decision|0|||
105524041|NCT01649375|363930314|FG000|Week 16 up to Week 260|Technical issues|0|||
105524042|NCT01649375|363930315|FG001|Week 16 up to Week 260|Technical issues|1|||
105524043|NCT01649375|363930316|FG002|Week 16 up to Week 260|Technical issues|0|||
105524044|NCT01649375|363930317|FG003|Week 16 up to Week 260|Technical issues|1|||
105524045|NCT01649375|363930318|FG004|Week 16 up to Week 260|Technical issues|0|||
105524046|NCT01649375|363930314|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
105524047|NCT01649375|363930315|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
105524048|NCT01649375|363930316|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
105524049|NCT01649375|363930317|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
105524050|NCT01649375|363930318|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
105524051|NCT01649375|363930314|FG000|Week 16 up to Week 260|Death|1|||
105524052|NCT01649375|363930315|FG001|Week 16 up to Week 260|Death|1|||
105524053|NCT01649375|363930316|FG002|Week 16 up to Week 260|Death|0|||
105524054|NCT01649375|363930317|FG003|Week 16 up to Week 260|Death|0|||
105524055|NCT01649375|363930318|FG004|Week 16 up to Week 260|Death|0|||
105524056|NCT01649375|363930314|FG000|Week 16 up to Week 260|Adverse Event|5|||
105524057|NCT01649375|363930315|FG001|Week 16 up to Week 260|Adverse Event|2|||
105524058|NCT01649375|363930316|FG002|Week 16 up to Week 260|Adverse Event|0|||
105524059|NCT01649375|363930317|FG003|Week 16 up to Week 260|Adverse Event|3|||
105524060|NCT01649375|363930318|FG004|Week 16 up to Week 260|Adverse Event|2|||
105524061|NCT01856790|363930321|FG000|Closed Loop Control|Withdrawal by Subject|2|||
105524062|NCT01856790|363930321|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
105524063|NCT02584504|363930322|FG000|Double-blind Treatment|Participant withdrew consent|0|||
105524064|NCT02584504|363930323|FG001|Double-blind Treatment|Participant withdrew consent|0|||
105524065|NCT02584504|363930324|FG002|Double-blind Treatment|Participant withdrew consent|1|||
105524066|NCT02584504|363930322|FG000|Double-blind Treatment|Adverse Event|0|||
105524067|NCT02584504|363930323|FG001|Double-blind Treatment|Adverse Event|1|||
105524068|NCT02584504|363930324|FG002|Double-blind Treatment|Adverse Event|0|||
105524069|NCT02584504|363930322|FG000|Double-blind Treatment|Family Matter|0|||
105524070|NCT02584504|363930323|FG001|Double-blind Treatment|Family Matter|1|||
105524071|NCT02584504|363930324|FG002|Double-blind Treatment|Family Matter|0|||
105524072|NCT02584504|363930322|FG000|Open-label Treatment|Participant withdrew consent|0|||
105524073|NCT02584504|363930323|FG001|Open-label Treatment|Participant withdrew consent|0|||
105524074|NCT02584504|363930324|FG002|Open-label Treatment|Participant withdrew consent|4|||
105524075|NCT02584504|363930322|FG000|Open-label Treatment|Adverse Event|2|||
105524076|NCT02584504|363930323|FG001|Open-label Treatment|Adverse Event|2|||
105524077|NCT02584504|363930324|FG002|Open-label Treatment|Adverse Event|3|||
105524078|NCT02584504|363930322|FG000|Open-label Treatment|Physician Decision|0|||
105524079|NCT02584504|363930323|FG001|Open-label Treatment|Physician Decision|1|||
105524080|NCT02584504|363930324|FG002|Open-label Treatment|Physician Decision|0|||
105524081|NCT02584504|363930322|FG000|Open-label Treatment|Entered but not treated|0|||
105524082|NCT02584504|363930323|FG001|Open-label Treatment|Entered but not treated|1|||
105524083|NCT02584504|363930324|FG002|Open-label Treatment|Entered but not treated|1|||
105524084|NCT04091646|363930325|FG000|Overall Study|Adverse Event|2|||
105524085|NCT04091646|363930326|FG001|Overall Study|Adverse Event|1|||
105524086|NCT04091646|363930325|FG000|Overall Study|Lost to Follow-up|6|||
105524087|NCT04091646|363930326|FG001|Overall Study|Lost to Follow-up|2|||
105524088|NCT04091646|363930325|FG000|Overall Study|Protocol Violation|0|||
105524089|NCT04091646|363930326|FG001|Overall Study|Protocol Violation|1|||
105524090|NCT04091646|363930325|FG000|Overall Study|Withdrawal by Subject|4|||
105524091|NCT04091646|363930326|FG001|Overall Study|Withdrawal by Subject|1|||
105524092|NCT04091646|363930325|FG000|Overall Study|Participant Incarcerated|1|||
105524093|NCT04091646|363930326|FG001|Overall Study|Participant Incarcerated|0|||
105524094|NCT03102918|363930328|FG000|Overall Study|Protocol Violation|1|||
105524095|NCT03102918|363930329|FG001|Overall Study|Protocol Violation|0|||
105524096|NCT01762943|363930330|FG000|Overall Study|Physician Decision|1|||
105524097|NCT01762943|363930331|FG001|Overall Study|Physician Decision|1|||
105524098|NCT01762943|363930330|FG000|Overall Study|Protocol Violation|1|||
105524099|NCT01762943|363930331|FG001|Overall Study|Protocol Violation|0|||
105524100|NCT01762943|363930330|FG000|Overall Study|Withdrawal by Subject|2|||
105524101|NCT01762943|363930331|FG001|Overall Study|Withdrawal by Subject|1|||
105524102|NCT00539838|363930332|FG000|Overall Study|Fail to return|2|||
105524103|NCT00539838|363930333|FG001|Overall Study|Fail to return|0|||
105524104|NCT00539838|363930334|FG002|Overall Study|Fail to return|0|||
105524105|NCT00539838|363930332|FG000|Overall Study|Withdrawal by Subject|0|||
105524106|NCT00539838|363930333|FG001|Overall Study|Withdrawal by Subject|4|||
105524107|NCT00539838|363930334|FG002|Overall Study|Withdrawal by Subject|0|||
105524108|NCT00539838|363930332|FG000|Overall Study|Death|0|||
105524109|NCT00539838|363930333|FG001|Overall Study|Death|2|||
105524110|NCT00539838|363930334|FG002|Overall Study|Death|0|||
105524111|NCT00539838|363930332|FG000|Overall Study|Did not cooperate|1|||
105524112|NCT00539838|363930333|FG001|Overall Study|Did not cooperate|0|||
105524113|NCT00539838|363930334|FG002|Overall Study|Did not cooperate|1|||
105524114|NCT00539838|363930332|FG000|Overall Study|Administrative|4|||
105524115|NCT00539838|363930333|FG001|Overall Study|Administrative|0|||
105524116|NCT00539838|363930334|FG002|Overall Study|Administrative|8|||
105524117|NCT03090100|363930338|FG000|Overall Study|Adverse Event|9|||
105524118|NCT03090100|363930339|FG001|Overall Study|Adverse Event|11|||
105524119|NCT03090100|363930338|FG000|Overall Study|Pregnancy|1|||
105524120|NCT03090100|363930339|FG001|Overall Study|Pregnancy|1|||
105524121|NCT03090100|363930338|FG000|Overall Study|Lack of Efficacy|2|||
105524122|NCT03090100|363930339|FG001|Overall Study|Lack of Efficacy|7|||
105524123|NCT03090100|363930338|FG000|Overall Study|Lost to Follow-up|2|||
105524124|NCT03090100|363930339|FG001|Overall Study|Lost to Follow-up|2|||
105524125|NCT03090100|363930338|FG000|Overall Study|Withdrawal by Subject|7|||
105524126|NCT03090100|363930339|FG001|Overall Study|Withdrawal by Subject|19|||
105524127|NCT03090100|363930338|FG000|Overall Study|Protocol Violation|2|||
105524128|NCT03090100|363930339|FG001|Overall Study|Protocol Violation|6|||
105524129|NCT03090100|363930338|FG000|Overall Study|Non-compliance|2|||
105524130|NCT03090100|363930339|FG001|Overall Study|Non-compliance|0|||
105524131|NCT03090100|363930338|FG000|Overall Study|Other|2|||
105524132|NCT03090100|363930339|FG001|Overall Study|Other|2|||
105524133|NCT02066467|363930340|FG000|Overall Study|Did not undergo implant procedure|24|||
105524134|NCT02066467|363930340|FG000|Overall Study|Attempted to implant withoput success|43|||
105524135|NCT02066467|363930340|FG000|Overall Study|Consent ineligible|1|||
105524136|NCT02066467|363930340|FG000|Overall Study|Death|54|||
105524137|NCT02066467|363930340|FG000|Overall Study|Lost to Follow-up|51|||
105524138|NCT02066467|363930340|FG000|Overall Study|Adverse Event|20|||
105524139|NCT02066467|363930340|FG000|Overall Study|Withdrawal by Subject|16|||
105524140|NCT02066467|363930340|FG000|Overall Study|Physician Decision|2|||
105524141|NCT02066467|363930340|FG000|Overall Study|Not defined|4|||
105524142|NCT02596854|363930345|FG000|Overall Study|Withdrawn|8|||
105524143|NCT00581776|363930348|FG000|Overall Study|Disease progression or no response|3|||
105524144|NCT00405587|363930351|FG000|Overall Study|Death|0|||
105524145|NCT00405587|363930352|FG001|Overall Study|Death|0|||
105524146|NCT00405587|363930353|FG002|Overall Study|Death|0|||
105524147|NCT00405587|363930354|FG003|Overall Study|Death|1|||
105524148|NCT00405587|363930351|FG000|Overall Study|Disease Progression|22|||
105524149|NCT00405587|363930352|FG001|Overall Study|Disease Progression|23|||
105524150|NCT00405587|363930353|FG002|Overall Study|Disease Progression|21|||
105524151|NCT00405587|363930354|FG003|Overall Study|Disease Progression|17|||
105524152|NCT00405587|363930351|FG000|Overall Study|Physician Decision|3|||
105524153|NCT00405587|363930352|FG001|Overall Study|Physician Decision|2|||
105524154|NCT00405587|363930353|FG002|Overall Study|Physician Decision|0|||
105524155|NCT00405587|363930354|FG003|Overall Study|Physician Decision|0|||
105524156|NCT00405587|363930351|FG000|Overall Study|Adverse Event|1|||
105524157|NCT00405587|363930352|FG001|Overall Study|Adverse Event|0|||
105524158|NCT00405587|363930353|FG002|Overall Study|Adverse Event|0|||
105524159|NCT00405587|363930354|FG003|Overall Study|Adverse Event|0|||
105524160|NCT00405587|363930351|FG000|Overall Study|Lost to Follow-up|0|||
105524161|NCT00405587|363930352|FG001|Overall Study|Lost to Follow-up|1|||
105524162|NCT00405587|363930353|FG002|Overall Study|Lost to Follow-up|1|||
105524163|NCT00405587|363930354|FG003|Overall Study|Lost to Follow-up|0|||
105524164|NCT00405587|363930351|FG000|Overall Study|Radiation induced necrosis|0|||
105524165|NCT00405587|363930352|FG001|Overall Study|Radiation induced necrosis|1|||
105524166|NCT00405587|363930353|FG002|Overall Study|Radiation induced necrosis|0|||
105524167|NCT00405587|363930354|FG003|Overall Study|Radiation induced necrosis|0|||
105524168|NCT00405587|363930351|FG000|Overall Study|Withdrawal by Subject|0|||
105524169|NCT00405587|363930352|FG001|Overall Study|Withdrawal by Subject|0|||
105524170|NCT00405587|363930353|FG002|Overall Study|Withdrawal by Subject|0|||
105524171|NCT00405587|363930354|FG003|Overall Study|Withdrawal by Subject|2|||
105524172|NCT00405587|363930351|FG000|Overall Study|Participant not dosed|0|||
105524173|NCT00405587|363930352|FG001|Overall Study|Participant not dosed|1|||
105524174|NCT00405587|363930353|FG002|Overall Study|Participant not dosed|0|||
105524175|NCT00405587|363930354|FG003|Overall Study|Participant not dosed|0|||
105524176|NCT02250443|363930372|FG000|Overall Study|Administrative problems|7|||
105524177|NCT02250443|363930372|FG000|Overall Study|Adverse Event|3|||
105524178|NCT02136576|363930379|FG000|Overall Study|Lost to Follow-up|2|||
105524179|NCT02136576|363930380|FG001|Overall Study|Lost to Follow-up|0|||
105524180|NCT02136576|363930381|FG002|Overall Study|Lost to Follow-up|0|||
105524181|NCT02197806|363930383|FG000|Overall Study|Adverse Event|0|||
105524182|NCT02197806|363930384|FG001|Overall Study|Adverse Event|1|||
105524183|NCT02197806|363930385|FG002|Overall Study|Adverse Event|0|||
105524184|NCT02197806|363930386|FG003|Overall Study|Adverse Event|1|||
105524185|NCT00537381|363930387|FG000|Overall Study|Adverse Event|13|||
105524186|NCT00537381|363930388|FG001|Overall Study|Adverse Event|9|||
105524187|NCT00537381|363930387|FG000|Overall Study|Death|3|||
105524188|NCT00537381|363930388|FG001|Overall Study|Death|3|||
105524189|NCT00537381|363930387|FG000|Overall Study|Withdrawal by Subject|5|||
105524190|NCT00537381|363930388|FG001|Overall Study|Withdrawal by Subject|14|||
105524191|NCT00537381|363930387|FG000|Overall Study|Physician Decision|7|||
105524192|NCT00537381|363930388|FG001|Overall Study|Physician Decision|6|||
105524193|NCT00537381|363930387|FG000|Overall Study|Disease Progression|9|||
105524194|NCT00537381|363930388|FG001|Overall Study|Disease Progression|18|||
105524195|NCT00537381|363930387|FG000|Overall Study|Sponsor decision|14|||
105524196|NCT00537381|363930388|FG001|Overall Study|Sponsor decision|9|||
105524197|NCT00537381|363930387|FG000|Overall Study|Other|5|||
105524198|NCT00537381|363930388|FG001|Overall Study|Other|3|||
105524199|NCT02590939|363930389|FG000|Overall Study|Withdrawal by Subject|3|||
105524200|NCT02590939|363930390|FG001|Overall Study|Withdrawal by Subject|1|||
105524201|NCT02590939|363930389|FG000|Overall Study|Failed the nociceptive test|2|||
105524202|NCT02590939|363930390|FG001|Overall Study|Failed the nociceptive test|1|||
105524203|NCT00108160|363930395|FG000|Overall Study|Lost to Follow-up|25|||
105524204|NCT00108160|363930396|FG001|Overall Study|Lost to Follow-up|12|||
105524205|NCT00108160|363930395|FG000|Overall Study|Death|1|||
105524206|NCT00108160|363930396|FG001|Overall Study|Death|2|||
105524207|NCT00108160|363930395|FG000|Overall Study|Withdrawal by Subject|4|||
105524208|NCT00108160|363930396|FG001|Overall Study|Withdrawal by Subject|2|||
105524209|NCT00108160|363930395|FG000|Overall Study|Protocol Violation|9|||
105524210|NCT00108160|363930396|FG001|Overall Study|Protocol Violation|5|||
105524211|NCT00923559|363930399|FG000|Overall Study|Lost to Follow-up|2|||
105524212|NCT00923559|363930400|FG001|Overall Study|Lost to Follow-up|3|||
105524213|NCT01774786|363930402|FG000|Overall Study|Death|300|||
105524214|NCT01774786|363930403|FG001|Overall Study|Death|319|||
105524215|NCT01774786|363930402|FG000|Overall Study|Lost to Follow-up|6|||
105524216|NCT01774786|363930403|FG001|Overall Study|Lost to Follow-up|7|||
105524217|NCT01774786|363930402|FG000|Overall Study|Withdrawal by Subject|18|||
105524218|NCT01774786|363930403|FG001|Overall Study|Withdrawal by Subject|14|||
105524219|NCT01774786|363930402|FG000|Overall Study|Physician Decision|2|||
105524220|NCT01774786|363930403|FG001|Overall Study|Physician Decision|0|||
105524221|NCT01774786|363930402|FG000|Overall Study|Non-compliance|0|||
105524222|NCT01774786|363930403|FG001|Overall Study|Non-compliance|1|||
105524223|NCT01774786|363930402|FG000|Overall Study|Reason Not Specified|2|||
105524224|NCT01774786|363930403|FG001|Overall Study|Reason Not Specified|5|||
105524225|NCT02268812|363930404|FG000|Overall Study|Adverse Event|8|||
105524226|NCT02268812|363930405|FG001|Overall Study|Adverse Event|26|||
105524227|NCT02268812|363930406|FG002|Overall Study|Adverse Event|7|||
105524228|NCT02268812|363930407|FG003|Overall Study|Adverse Event|10|||
105524229|NCT02268812|363930404|FG000|Overall Study|Protocol deviation|0|||
105524230|NCT02268812|363930405|FG001|Overall Study|Protocol deviation|0|||
105524231|NCT02268812|363930406|FG002|Overall Study|Protocol deviation|1|||
105524232|NCT02268812|363930407|FG003|Overall Study|Protocol deviation|0|||
105524233|NCT02268812|363930404|FG000|Overall Study|Withdrawal by Subject|0|||
105524234|NCT02268812|363930405|FG001|Overall Study|Withdrawal by Subject|1|||
105524235|NCT02268812|363930406|FG002|Overall Study|Withdrawal by Subject|0|||
105524236|NCT02268812|363930407|FG003|Overall Study|Withdrawal by Subject|0|||
105524237|NCT02268812|363930404|FG000|Overall Study|Physician Decision|3|||
105524238|NCT02268812|363930405|FG001|Overall Study|Physician Decision|1|||
105524239|NCT02268812|363930406|FG002|Overall Study|Physician Decision|0|||
105524240|NCT02268812|363930407|FG003|Overall Study|Physician Decision|1|||
105524241|NCT02268812|363930404|FG000|Overall Study|Other|5|||
105524242|NCT02268812|363930405|FG001|Overall Study|Other|4|||
105524243|NCT02268812|363930406|FG002|Overall Study|Other|1|||
105524244|NCT02268812|363930407|FG003|Overall Study|Other|3|||
105524245|NCT05045144|363930408|FG000|Overall Study|Lost to Follow-up|3|||
105524246|NCT05045144|363930409|FG001|Overall Study|Lost to Follow-up|2|||
105524247|NCT05045144|363930410|FG002|Overall Study|Lost to Follow-up|3|||
105524248|NCT05045144|363930411|FG003|Overall Study|Lost to Follow-up|5|||
105524249|NCT05045144|363930412|FG004|Overall Study|Lost to Follow-up|13|||
105524250|NCT05045144|363930408|FG000|Overall Study|Withdrawal by Subject|0|||
105524251|NCT05045144|363930409|FG001|Overall Study|Withdrawal by Subject|1|||
105524252|NCT05045144|363930410|FG002|Overall Study|Withdrawal by Subject|0|||
105524253|NCT05045144|363930411|FG003|Overall Study|Withdrawal by Subject|0|||
105524254|NCT05045144|363930412|FG004|Overall Study|Withdrawal by Subject|0|||
105524255|NCT05045144|363930408|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105524256|NCT05045144|363930409|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105524257|NCT05045144|363930410|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105524258|NCT05045144|363930411|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105524259|NCT05045144|363930412|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105524260|NCT00768144|363930413|FG000|Overall Study|Adverse Event|13|||
105524261|NCT00768144|363930413|FG000|Overall Study|Progressive Disease|21|||
105524262|NCT00768144|363930413|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
105524263|NCT00768144|363930413|FG000|Overall Study|Pt Withdrew Consent|1|||
105524264|NCT03886220|363930414|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
105524265|NCT03886220|363930415|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
105524266|NCT03886220|363930414|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
105524267|NCT03886220|363930415|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105524268|NCT03886220|363930414|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
105524269|NCT03886220|363930415|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
105524270|NCT01319877|363930419|FG000|Overall Study|Lost to Follow-up|100|||
105524271|NCT01319877|363930420|FG001|Overall Study|Lost to Follow-up|37|||
105524272|NCT01319877|363930419|FG000|Overall Study|Physician Decision|2|||
105524273|NCT01319877|363930420|FG001|Overall Study|Physician Decision|0|||
105524274|NCT01319877|363930419|FG000|Overall Study|Disease Progression|2|||
105524275|NCT01319877|363930420|FG001|Overall Study|Disease Progression|2|||
105524276|NCT01319877|363930419|FG000|Overall Study|Withdrawal by Subject|0|||
105524277|NCT01319877|363930420|FG001|Overall Study|Withdrawal by Subject|1|||
105524278|NCT01319877|363930419|FG000|Overall Study|Reason Not Specified|4|||
105524279|NCT01319877|363930420|FG001|Overall Study|Reason Not Specified|5|||
105524280|NCT02347189|363930421|FG000|Overall Study|No implant attempted of study device|9|||
105524281|NCT02347189|363930421|FG000|Overall Study|No primary outcome data available|2|||
105524282|NCT00735878|363930423|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
105524283|NCT00735878|363930424|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
105524284|NCT00735878|363930425|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
105524285|NCT03320564|363930426|FG000|Overall Study|Protocol Violation|1|||
105524286|NCT00788827|363930427|FG000|Overall Study|Lack of Efficacy|2|||
105524287|NCT03745144|363930431|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
105524288|NCT03745144|363930432|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
105524289|NCT03745144|363930433|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
105524290|NCT03745144|363930431|FG000|Period 1|Other|0|||
105524291|NCT03745144|363930432|FG001|Period 1|Other|0|||
105524292|NCT03745144|363930433|FG002|Period 1|Other|1|||
105524293|NCT03642717|363930434|FG000|Overall Study|Lost to Follow-up|2|||
105524294|NCT03642717|363930434|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
105524295|NCT03642717|363930434|FG000|Overall Study|Taken study drug prior to contract date|3|||
105524296|NCT00642668|363930439|FG000|Overall Study|Lost to Follow-up|1|||
105524297|NCT00642668|363930439|FG000|Overall Study|Adverse Event|2|||
105524298|NCT00642668|363930439|FG000|Overall Study|Death|2|||
105524299|NCT00642668|363930439|FG000|Overall Study|Insufficient Therapeutic Response|1|||
105524300|NCT00642668|363930439|FG000|Overall Study|Failure to Return|1|||
105524301|NCT00642668|363930439|FG000|Overall Study|Dialysis Initiation|5|||
105524302|NCT00642668|363930439|FG000|Overall Study|Blood Transfusion|2|||
105524303|NCT01177540|363930440|FG000|Overall Study|Adverse Event|1|||
105524304|NCT01177540|363930441|FG001|Overall Study|Adverse Event|0|||
105524305|NCT00302458|363930442|FG000|Overall Study|Lost to Follow-up|1|||
105524306|NCT00302458|363930442|FG000|Overall Study|Ineligible after screening|1|||
105524307|NCT00302458|363930442|FG000|Overall Study|Withdrawal by Subject|1|||
105524308|NCT04248933|363930444|FG000|Overall Study|Lost to Follow-up|9|||
105524309|NCT04248933|363930444|FG000|Overall Study|Withdrawal by Subject|2|||
105524310|NCT02658890|363932927|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524311|NCT02658890|363932928|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524312|NCT02658890|363932929|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524313|NCT02658890|363932930|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524314|NCT02658890|363932931|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524315|NCT02658890|363932932|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524316|NCT02658890|363932933|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524317|NCT02658890|363932934|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524318|NCT02658890|363932935|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
105524319|NCT02658890|363932936|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524320|NCT02658890|363932937|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524321|NCT02658890|363932938|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524322|NCT02658890|363932939|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524323|NCT02658890|363932940|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524324|NCT02658890|363932941|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524325|NCT02658890|363932942|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524326|NCT02658890|363932943|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524327|NCT02658890|363932944|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524328|NCT02658890|363932945|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524329|NCT02658890|363932946|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524330|NCT02658890|363932947|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524331|NCT02658890|363932948|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524332|NCT02658890|363932949|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524333|NCT02658890|363932950|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524334|NCT02658890|363932951|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524335|NCT02658890|363932952|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524336|NCT02658890|363932953|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524337|NCT02658890|363932927|FG000|Treatment Phase|Adverse Event|0|||
105524338|NCT02658890|363932928|FG001|Treatment Phase|Adverse Event|1|||
105524339|NCT02658890|363932929|FG002|Treatment Phase|Adverse Event|2|||
105524340|NCT02658890|363932930|FG003|Treatment Phase|Adverse Event|2|||
105524341|NCT02658890|363932931|FG004|Treatment Phase|Adverse Event|1|||
105524342|NCT02658890|363932932|FG005|Treatment Phase|Adverse Event|0|||
105524343|NCT02658890|363932933|FG006|Treatment Phase|Adverse Event|0|||
105524344|NCT02658890|363932934|FG007|Treatment Phase|Adverse Event|2|||
105524345|NCT02658890|363932935|FG008|Treatment Phase|Adverse Event|1|||
105524346|NCT02658890|363932936|FG009|Treatment Phase|Adverse Event|2|||
105524347|NCT02658890|363932937|FG010|Treatment Phase|Adverse Event|3|||
105524348|NCT02658890|363932938|FG011|Treatment Phase|Adverse Event|0|||
105524349|NCT02658890|363932939|FG012|Treatment Phase|Adverse Event|1|||
105524350|NCT02658890|363932940|FG013|Treatment Phase|Adverse Event|4|||
105524351|NCT02658890|363932941|FG014|Treatment Phase|Adverse Event|0|||
105524352|NCT02658890|363932942|FG015|Treatment Phase|Adverse Event|0|||
105524353|NCT02658890|363932943|FG016|Treatment Phase|Adverse Event|0|||
105524354|NCT02658890|363932944|FG017|Treatment Phase|Adverse Event|0|||
105524355|NCT02658890|363932945|FG018|Treatment Phase|Adverse Event|5|||
105524356|NCT02658890|363932946|FG019|Treatment Phase|Adverse Event|1|||
105524357|NCT02658890|363932947|FG020|Treatment Phase|Adverse Event|3|||
105524358|NCT02658890|363932948|FG021|Treatment Phase|Adverse Event|0|||
105524359|NCT02658890|363932949|FG022|Treatment Phase|Adverse Event|5|||
105524360|NCT02658890|363932950|FG023|Treatment Phase|Adverse Event|0|||
105524361|NCT02658890|363932951|FG024|Treatment Phase|Adverse Event|0|||
105524362|NCT02658890|363932952|FG025|Treatment Phase|Adverse Event|2|||
105524363|NCT02658890|363932953|FG026|Treatment Phase|Adverse Event|1|||
105524364|NCT02658890|363932927|FG000|Treatment Phase|Death|0|||
105524365|NCT02658890|363932928|FG001|Treatment Phase|Death|0|||
105524366|NCT02658890|363932929|FG002|Treatment Phase|Death|0|||
105524367|NCT02658890|363932930|FG003|Treatment Phase|Death|0|||
105524368|NCT02658890|363932931|FG004|Treatment Phase|Death|0|||
105524369|NCT02658890|363932932|FG005|Treatment Phase|Death|0|||
105524370|NCT02658890|363932933|FG006|Treatment Phase|Death|0|||
105524371|NCT02658890|363932934|FG007|Treatment Phase|Death|0|||
105524372|NCT02658890|363932935|FG008|Treatment Phase|Death|0|||
105524373|NCT02658890|363932936|FG009|Treatment Phase|Death|0|||
105524374|NCT02658890|363932937|FG010|Treatment Phase|Death|0|||
105524375|NCT02658890|363932938|FG011|Treatment Phase|Death|0|||
105524376|NCT02658890|363932939|FG012|Treatment Phase|Death|0|||
105524377|NCT02658890|363932940|FG013|Treatment Phase|Death|0|||
105524378|NCT02658890|363932941|FG014|Treatment Phase|Death|0|||
105524379|NCT02658890|363932942|FG015|Treatment Phase|Death|0|||
105524380|NCT02658890|363932943|FG016|Treatment Phase|Death|0|||
105524381|NCT02658890|363932944|FG017|Treatment Phase|Death|0|||
105524382|NCT02658890|363932945|FG018|Treatment Phase|Death|1|||
105524383|NCT02658890|363932946|FG019|Treatment Phase|Death|0|||
105524384|NCT02658890|363932947|FG020|Treatment Phase|Death|0|||
105524385|NCT02658890|363932948|FG021|Treatment Phase|Death|0|||
105524386|NCT02658890|363932949|FG022|Treatment Phase|Death|0|||
105524387|NCT02658890|363932950|FG023|Treatment Phase|Death|0|||
105524388|NCT02658890|363932951|FG024|Treatment Phase|Death|0|||
105524389|NCT02658890|363932952|FG025|Treatment Phase|Death|0|||
105592791|NCT03068468|364170764|FG001|Placebo-Controlled Period|Death|1|||
105592792|NCT03068468|364170765|FG002|Placebo-Controlled Period|Death|0|||
105524390|NCT02658890|363932953|FG026|Treatment Phase|Death|0|||
105524391|NCT02658890|363932927|FG000|Treatment Phase|Lost to Follow-up|0|||
105524392|NCT02658890|363932928|FG001|Treatment Phase|Lost to Follow-up|0|||
105524393|NCT02658890|363932929|FG002|Treatment Phase|Lost to Follow-up|0|||
105524394|NCT02658890|363932930|FG003|Treatment Phase|Lost to Follow-up|0|||
105524395|NCT02658890|363932931|FG004|Treatment Phase|Lost to Follow-up|0|||
105524396|NCT02658890|363932932|FG005|Treatment Phase|Lost to Follow-up|0|||
105524397|NCT02658890|363932933|FG006|Treatment Phase|Lost to Follow-up|1|||
105524398|NCT02658890|363932934|FG007|Treatment Phase|Lost to Follow-up|0|||
105524399|NCT02658890|363932935|FG008|Treatment Phase|Lost to Follow-up|0|||
105524400|NCT02658890|363932936|FG009|Treatment Phase|Lost to Follow-up|0|||
105524401|NCT02658890|363932937|FG010|Treatment Phase|Lost to Follow-up|0|||
105524402|NCT02658890|363932938|FG011|Treatment Phase|Lost to Follow-up|0|||
105524403|NCT02658890|363932939|FG012|Treatment Phase|Lost to Follow-up|0|||
105524404|NCT02658890|363932940|FG013|Treatment Phase|Lost to Follow-up|0|||
105524405|NCT02658890|363932941|FG014|Treatment Phase|Lost to Follow-up|0|||
105524406|NCT02658890|363932942|FG015|Treatment Phase|Lost to Follow-up|0|||
105524407|NCT02658890|363932943|FG016|Treatment Phase|Lost to Follow-up|0|||
105524408|NCT02658890|363932944|FG017|Treatment Phase|Lost to Follow-up|0|||
105524409|NCT02658890|363932945|FG018|Treatment Phase|Lost to Follow-up|0|||
105524410|NCT02658890|363932946|FG019|Treatment Phase|Lost to Follow-up|0|||
105524411|NCT02658890|363932947|FG020|Treatment Phase|Lost to Follow-up|0|||
105524412|NCT02658890|363932948|FG021|Treatment Phase|Lost to Follow-up|0|||
105524413|NCT02658890|363932949|FG022|Treatment Phase|Lost to Follow-up|0|||
105524414|NCT02658890|363932950|FG023|Treatment Phase|Lost to Follow-up|0|||
105524415|NCT02658890|363932951|FG024|Treatment Phase|Lost to Follow-up|0|||
105524416|NCT02658890|363932952|FG025|Treatment Phase|Lost to Follow-up|0|||
105524417|NCT02658890|363932953|FG026|Treatment Phase|Lost to Follow-up|0|||
105524418|NCT02658890|363932927|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
105524419|NCT02658890|363932928|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
105524420|NCT02658890|363932929|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
105524421|NCT02658890|363932930|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
105524422|NCT02658890|363932931|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
105524423|NCT02658890|363932932|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
105524424|NCT02658890|363932933|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
105524425|NCT02658890|363932934|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
105524426|NCT02658890|363932935|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
105524427|NCT02658890|363932936|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
105524428|NCT02658890|363932937|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
105524429|NCT02658890|363932938|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
105524430|NCT02658890|363932939|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
105524431|NCT02658890|363932940|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
105524432|NCT02658890|363932941|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
105524433|NCT02658890|363932942|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
105524434|NCT02658890|363932943|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
105524435|NCT02658890|363932944|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
105524436|NCT02658890|363932945|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
105524437|NCT02658890|363932946|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
105524438|NCT02658890|363932947|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
105524439|NCT02658890|363932948|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
105524440|NCT02658890|363932949|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
105524441|NCT02658890|363932950|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
105524442|NCT02658890|363932951|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
105524443|NCT02658890|363932952|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
105524444|NCT02658890|363932953|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
105524445|NCT02658890|363932927|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
105524446|NCT02658890|363932928|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
105524447|NCT02658890|363932929|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
105524448|NCT02658890|363932930|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
105524449|NCT02658890|363932931|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
105524450|NCT02658890|363932932|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
105524451|NCT02658890|363932933|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
105524452|NCT02658890|363932934|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
105524453|NCT02658890|363932935|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
105524454|NCT02658890|363932936|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
105524455|NCT02658890|363932937|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
105524456|NCT02658890|363932938|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
105524457|NCT02658890|363932939|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
105524458|NCT02658890|363932940|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
105524459|NCT02658890|363932941|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
105524460|NCT02658890|363932942|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
105524461|NCT02658890|363932943|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
105524462|NCT02658890|363932944|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
105524463|NCT02658890|363932945|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
105524464|NCT02658890|363932946|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
105524465|NCT02658890|363932947|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
105524466|NCT02658890|363932948|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
105524467|NCT02658890|363932949|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
105524468|NCT02658890|363932950|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
105524469|NCT02658890|363932951|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
105524470|NCT02658890|363932952|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
105524471|NCT02658890|363932953|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
105524472|NCT02658890|363932927|FG000|Treatment Phase|Other Reasons|0|||
105524473|NCT02658890|363932928|FG001|Treatment Phase|Other Reasons|0|||
105524474|NCT02658890|363932929|FG002|Treatment Phase|Other Reasons|0|||
105524475|NCT02658890|363932930|FG003|Treatment Phase|Other Reasons|0|||
105524476|NCT02658890|363932931|FG004|Treatment Phase|Other Reasons|0|||
105524477|NCT02658890|363932932|FG005|Treatment Phase|Other Reasons|0|||
105524478|NCT02658890|363932933|FG006|Treatment Phase|Other Reasons|1|||
105524479|NCT02658890|363932934|FG007|Treatment Phase|Other Reasons|0|||
105524480|NCT02658890|363932935|FG008|Treatment Phase|Other Reasons|1|||
105524481|NCT02658890|363932936|FG009|Treatment Phase|Other Reasons|0|||
105524482|NCT02658890|363932937|FG010|Treatment Phase|Other Reasons|0|||
105524483|NCT02658890|363932938|FG011|Treatment Phase|Other Reasons|0|||
105524484|NCT02658890|363932939|FG012|Treatment Phase|Other Reasons|0|||
105524485|NCT02658890|363932940|FG013|Treatment Phase|Other Reasons|2|||
105524486|NCT02658890|363932941|FG014|Treatment Phase|Other Reasons|0|||
105524487|NCT02658890|363932942|FG015|Treatment Phase|Other Reasons|0|||
105524488|NCT02658890|363932943|FG016|Treatment Phase|Other Reasons|0|||
105524489|NCT02658890|363932944|FG017|Treatment Phase|Other Reasons|0|||
105524490|NCT02658890|363932945|FG018|Treatment Phase|Other Reasons|1|||
105524491|NCT02658890|363932946|FG019|Treatment Phase|Other Reasons|0|||
105524492|NCT02658890|363932947|FG020|Treatment Phase|Other Reasons|0|||
105524493|NCT02658890|363932948|FG021|Treatment Phase|Other Reasons|0|||
105524494|NCT02658890|363932949|FG022|Treatment Phase|Other Reasons|0|||
105524495|NCT02658890|363932950|FG023|Treatment Phase|Other Reasons|0|||
105524496|NCT02658890|363932951|FG024|Treatment Phase|Other Reasons|1|||
105524497|NCT02658890|363932952|FG025|Treatment Phase|Other Reasons|0|||
105524498|NCT02658890|363932953|FG026|Treatment Phase|Other Reasons|1|||
105524499|NCT02658890|363932927|FG000|Treatment Phase|Progressive Disease|6|||
105524500|NCT02658890|363932928|FG001|Treatment Phase|Progressive Disease|7|||
105524501|NCT02658890|363932929|FG002|Treatment Phase|Progressive Disease|6|||
105524502|NCT02658890|363932930|FG003|Treatment Phase|Progressive Disease|12|||
105524503|NCT02658890|363932931|FG004|Treatment Phase|Progressive Disease|6|||
105524504|NCT02658890|363932932|FG005|Treatment Phase|Progressive Disease|18|||
105524505|NCT02658890|363932933|FG006|Treatment Phase|Progressive Disease|12|||
105524506|NCT02658890|363932934|FG007|Treatment Phase|Progressive Disease|19|||
105524507|NCT02658890|363932935|FG008|Treatment Phase|Progressive Disease|26|||
105524508|NCT02658890|363932936|FG009|Treatment Phase|Progressive Disease|8|||
105524509|NCT02658890|363932937|FG010|Treatment Phase|Progressive Disease|7|||
105524510|NCT02658890|363932938|FG011|Treatment Phase|Progressive Disease|9|||
105524511|NCT02658890|363932939|FG012|Treatment Phase|Progressive Disease|8|||
105524512|NCT02658890|363932940|FG013|Treatment Phase|Progressive Disease|29|||
105524513|NCT02658890|363932941|FG014|Treatment Phase|Progressive Disease|6|||
105524514|NCT02658890|363932942|FG015|Treatment Phase|Progressive Disease|2|||
105524515|NCT02658890|363932943|FG016|Treatment Phase|Progressive Disease|32|||
105524516|NCT02658890|363932944|FG017|Treatment Phase|Progressive Disease|14|||
105524517|NCT02658890|363932945|FG018|Treatment Phase|Progressive Disease|40|||
105524518|NCT02658890|363932946|FG019|Treatment Phase|Progressive Disease|32|||
105524519|NCT02658890|363932947|FG020|Treatment Phase|Progressive Disease|19|||
105524520|NCT02658890|363932948|FG021|Treatment Phase|Progressive Disease|30|||
105524521|NCT02658890|363932949|FG022|Treatment Phase|Progressive Disease|15|||
105524522|NCT02658890|363932950|FG023|Treatment Phase|Progressive Disease|0|||
105524523|NCT02658890|363932951|FG024|Treatment Phase|Progressive Disease|0|||
105524524|NCT02658890|363932952|FG025|Treatment Phase|Progressive Disease|14|||
105524525|NCT02658890|363932953|FG026|Treatment Phase|Progressive Disease|11|||
105524526|NCT02658890|363932927|FG000|Treatment Phase|Study Drug Toxicity|0|||
105524527|NCT02658890|363932928|FG001|Treatment Phase|Study Drug Toxicity|0|||
105524528|NCT02658890|363932929|FG002|Treatment Phase|Study Drug Toxicity|2|||
105524529|NCT02658890|363932930|FG003|Treatment Phase|Study Drug Toxicity|0|||
105524530|NCT02658890|363932931|FG004|Treatment Phase|Study Drug Toxicity|0|||
105524531|NCT02658890|363932932|FG005|Treatment Phase|Study Drug Toxicity|0|||
105524532|NCT02658890|363932933|FG006|Treatment Phase|Study Drug Toxicity|0|||
105524533|NCT02658890|363932934|FG007|Treatment Phase|Study Drug Toxicity|0|||
105524534|NCT02658890|363932935|FG008|Treatment Phase|Study Drug Toxicity|3|||
105524535|NCT02658890|363932936|FG009|Treatment Phase|Study Drug Toxicity|0|||
105524536|NCT02658890|363932937|FG010|Treatment Phase|Study Drug Toxicity|1|||
105524537|NCT02658890|363932938|FG011|Treatment Phase|Study Drug Toxicity|1|||
105524538|NCT02658890|363932939|FG012|Treatment Phase|Study Drug Toxicity|2|||
105524539|NCT02658890|363932940|FG013|Treatment Phase|Study Drug Toxicity|9|||
105524540|NCT02658890|363932941|FG014|Treatment Phase|Study Drug Toxicity|0|||
105524541|NCT02658890|363932942|FG015|Treatment Phase|Study Drug Toxicity|1|||
105524542|NCT02658890|363932943|FG016|Treatment Phase|Study Drug Toxicity|1|||
105524543|NCT02658890|363932944|FG017|Treatment Phase|Study Drug Toxicity|0|||
105524544|NCT02658890|363932945|FG018|Treatment Phase|Study Drug Toxicity|8|||
105524545|NCT02658890|363932946|FG019|Treatment Phase|Study Drug Toxicity|3|||
105524546|NCT02658890|363932947|FG020|Treatment Phase|Study Drug Toxicity|2|||
105524547|NCT02658890|363932948|FG021|Treatment Phase|Study Drug Toxicity|0|||
105524548|NCT02658890|363932949|FG022|Treatment Phase|Study Drug Toxicity|8|||
105524549|NCT02658890|363932950|FG023|Treatment Phase|Study Drug Toxicity|0|||
105524550|NCT02658890|363932951|FG024|Treatment Phase|Study Drug Toxicity|0|||
105524551|NCT02658890|363932952|FG025|Treatment Phase|Study Drug Toxicity|2|||
105524552|NCT02658890|363932953|FG026|Treatment Phase|Study Drug Toxicity|0|||
105524553|NCT02658890|363932927|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524554|NCT02658890|363932928|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524555|NCT02658890|363932929|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524556|NCT02658890|363932930|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
105524557|NCT02658890|363932931|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524558|NCT02658890|363932932|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524559|NCT02658890|363932933|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524560|NCT02658890|363932934|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524561|NCT02658890|363932935|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524562|NCT02658890|363932936|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
105524563|NCT02658890|363932937|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524564|NCT02658890|363932938|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524565|NCT02658890|363932939|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524566|NCT02658890|363932940|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524567|NCT02658890|363932941|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524568|NCT02658890|363932942|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524569|NCT02658890|363932943|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524570|NCT02658890|363932944|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524571|NCT02658890|363932945|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
105524572|NCT02658890|363932946|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524573|NCT02658890|363932947|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524574|NCT02658890|363932948|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524575|NCT02658890|363932949|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
105524576|NCT02658890|363932950|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524577|NCT02658890|363932951|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524578|NCT02658890|363932952|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524579|NCT02658890|363932953|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105524580|NCT02658890|363932927|FG000|Treatment Phase|Withdrawal by Subject|0|||
105524581|NCT02658890|363932928|FG001|Treatment Phase|Withdrawal by Subject|1|||
105524582|NCT02658890|363932929|FG002|Treatment Phase|Withdrawal by Subject|0|||
105524583|NCT02658890|363932930|FG003|Treatment Phase|Withdrawal by Subject|0|||
105524584|NCT02658890|363932931|FG004|Treatment Phase|Withdrawal by Subject|0|||
105524585|NCT02658890|363932932|FG005|Treatment Phase|Withdrawal by Subject|0|||
105524586|NCT02658890|363932933|FG006|Treatment Phase|Withdrawal by Subject|1|||
105524587|NCT02658890|363932934|FG007|Treatment Phase|Withdrawal by Subject|0|||
105524588|NCT02658890|363932935|FG008|Treatment Phase|Withdrawal by Subject|0|||
105524589|NCT02658890|363932936|FG009|Treatment Phase|Withdrawal by Subject|1|||
105524590|NCT02658890|363932937|FG010|Treatment Phase|Withdrawal by Subject|0|||
105524591|NCT02658890|363932938|FG011|Treatment Phase|Withdrawal by Subject|0|||
105524592|NCT02658890|363932939|FG012|Treatment Phase|Withdrawal by Subject|1|||
105524593|NCT02658890|363932940|FG013|Treatment Phase|Withdrawal by Subject|3|||
105524594|NCT02658890|363932941|FG014|Treatment Phase|Withdrawal by Subject|0|||
105524595|NCT02658890|363932942|FG015|Treatment Phase|Withdrawal by Subject|0|||
105524596|NCT02658890|363932943|FG016|Treatment Phase|Withdrawal by Subject|1|||
105524597|NCT02658890|363932944|FG017|Treatment Phase|Withdrawal by Subject|0|||
105524598|NCT02658890|363932945|FG018|Treatment Phase|Withdrawal by Subject|4|||
105592793|NCT03068468|364170766|FG003|Placebo-Controlled Period|Death|0|||
105524599|NCT02658890|363932946|FG019|Treatment Phase|Withdrawal by Subject|3|||
105524600|NCT02658890|363932947|FG020|Treatment Phase|Withdrawal by Subject|0|||
105524601|NCT02658890|363932948|FG021|Treatment Phase|Withdrawal by Subject|4|||
105524602|NCT02658890|363932949|FG022|Treatment Phase|Withdrawal by Subject|1|||
105524603|NCT02658890|363932950|FG023|Treatment Phase|Withdrawal by Subject|1|||
105592794|NCT03068468|364170763|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
105524604|NCT02658890|363932951|FG024|Treatment Phase|Withdrawal by Subject|0|||
105524605|NCT02658890|363932952|FG025|Treatment Phase|Withdrawal by Subject|0|||
105524606|NCT02658890|363932953|FG026|Treatment Phase|Withdrawal by Subject|0|||
105524607|NCT04461015|363932954|FG000|Overall Study|IV access lost during the study|0|||
105524608|NCT04461015|363932955|FG001|Overall Study|IV access lost during the study|1|||
105524609|NCT04461015|363932954|FG000|Overall Study|Withdrawal by Subject|0|||
105524610|NCT04461015|363932955|FG001|Overall Study|Withdrawal by Subject|1|||
105524611|NCT02532647|363932962|FG000|Overall Study|Did not receive trial medication|1|||
105524612|NCT02532647|363932963|FG001|Overall Study|Did not receive trial medication|0|||
105524613|NCT02532647|363932964|FG002|Overall Study|Did not receive trial medication|1|||
105524614|NCT02939560|363932965|FG000|Overall Study|Withdrawal by Subject|2|||
105524615|NCT02939560|363932965|FG000|Overall Study|Protocol Violation|1|||
105524616|NCT03340025|363932966|FG000|Overall Study|Lost to Follow-up|2|||
105524617|NCT03340025|363932967|FG001|Overall Study|Lost to Follow-up|2|||
105524618|NCT03897179|363932971|FG000|Overall Study|Withdrawal by Subject|1|||
105524619|NCT00704535|363932972|FG000|Overall Study|Adverse Event|2|||
105524620|NCT00704535|363932972|FG000|Overall Study|Death|2|||
105524621|NCT00704535|363932972|FG000|Overall Study|Lost to Follow-up|8|||
105524622|NCT00704535|363932972|FG000|Overall Study|Protocol Violation|10|||
105524623|NCT00704535|363932972|FG000|Overall Study|Completed status not on Case Report Form|124|||
105524624|NCT01413360|363932973|FG000|Overall Study|Lost to Follow-up|2|||
105524625|NCT01413360|363932973|FG000|Overall Study|Adverse Event|1|||
105524626|NCT02120950|363932974|FG000|Overall Study|Adverse Event|5|||
105524627|NCT02120950|363932975|FG001|Overall Study|Adverse Event|4|||
105524628|NCT02120950|363932976|FG002|Overall Study|Adverse Event|3|||
105524629|NCT02120950|363932974|FG000|Overall Study|Death|3|||
105524630|NCT02120950|363932975|FG001|Overall Study|Death|0|||
105524631|NCT02120950|363932976|FG002|Overall Study|Death|1|||
105524632|NCT02120950|363932974|FG000|Overall Study|Withdrawal by Subject|6|||
105524633|NCT02120950|363932975|FG001|Overall Study|Withdrawal by Subject|3|||
105524634|NCT02120950|363932976|FG002|Overall Study|Withdrawal by Subject|2|||
105524635|NCT02120950|363932974|FG000|Overall Study|Protocol Violation|1|||
105524636|NCT02120950|363932975|FG001|Overall Study|Protocol Violation|1|||
105524637|NCT02120950|363932976|FG002|Overall Study|Protocol Violation|7|||
105524638|NCT02120950|363932974|FG000|Overall Study|Other reasons|5|||
105524639|NCT02120950|363932975|FG001|Overall Study|Other reasons|4|||
105524640|NCT02120950|363932976|FG002|Overall Study|Other reasons|1|||
105524641|NCT02120950|363932974|FG000|Overall Study|Lost to Follow-up|0|||
105524642|NCT02120950|363932975|FG001|Overall Study|Lost to Follow-up|2|||
105524643|NCT02120950|363932976|FG002|Overall Study|Lost to Follow-up|1|||
105524644|NCT02424383|363932977|FG000|Overall Study|Withdrawal by Subject|32|||
105524645|NCT02424383|363932977|FG000|Overall Study|Death|170|||
105524646|NCT02424383|363932977|FG000|Overall Study|Sponsor's decision|3|||
105524647|NCT02424383|363932977|FG000|Overall Study|Investigator's decision|44|||
105524648|NCT02424383|363932977|FG000|Overall Study|Lost to Follow-up|81|||
105524649|NCT02424383|363932977|FG000|Overall Study|Other|7|||
105524650|NCT02424383|363932977|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
105524651|NCT01589445|363932981|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
105524652|NCT01589445|363932981|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
105524653|NCT01589445|363932981|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
105524654|NCT01589445|363932981|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
105524655|NCT01589445|363932981|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
105524656|NCT01589445|363932981|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
105524657|NCT01589445|363932981|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
105524658|NCT01589445|363932981|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
105524659|NCT01589445|363932981|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
105524660|NCT01589445|363932981|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
105524661|NCT00325754|363932982|FG000|Overall Study|Adverse Event|4|||
105524662|NCT00325754|363932983|FG001|Overall Study|Adverse Event|1|||
105524663|NCT02246673|363932987|FG000|Overall Study|Sponsor Decision|1|||
105524664|NCT02246673|363932988|FG001|Overall Study|Sponsor Decision|0|||
105524665|NCT02246673|363932989|FG002|Overall Study|Sponsor Decision|0|||
105524666|NCT02246673|363932990|FG003|Overall Study|Sponsor Decision|0|||
105592795|NCT03068468|364170764|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
105524667|NCT02246673|363932991|FG004|Overall Study|Sponsor Decision|0|||
105524668|NCT02246673|363932987|FG000|Overall Study|Withdrawal by Subject|0|||
105524669|NCT02246673|363932988|FG001|Overall Study|Withdrawal by Subject|0|||
105524670|NCT02246673|363932989|FG002|Overall Study|Withdrawal by Subject|0|||
105524671|NCT02246673|363932990|FG003|Overall Study|Withdrawal by Subject|0|||
105524672|NCT02246673|363932991|FG004|Overall Study|Withdrawal by Subject|1|||
105524673|NCT02246673|363932987|FG000|Overall Study|Lost to Follow-up|0|||
105524674|NCT02246673|363932988|FG001|Overall Study|Lost to Follow-up|0|||
105524675|NCT02246673|363932989|FG002|Overall Study|Lost to Follow-up|0|||
105524676|NCT02246673|363932990|FG003|Overall Study|Lost to Follow-up|1|||
105524677|NCT02246673|363932991|FG004|Overall Study|Lost to Follow-up|0|||
105524678|NCT02246673|363932987|FG000|Overall Study|Protocol Violation|0|||
105524679|NCT02246673|363932988|FG001|Overall Study|Protocol Violation|0|||
105524680|NCT02246673|363932989|FG002|Overall Study|Protocol Violation|0|||
105524681|NCT02246673|363932990|FG003|Overall Study|Protocol Violation|1|||
105524682|NCT02246673|363932991|FG004|Overall Study|Protocol Violation|0|||
105524683|NCT01928862|363932995|FG000|Overall Study|Lost to Follow-up|1|||
105524684|NCT01928862|363932996|FG001|Overall Study|Lost to Follow-up|0|||
105524685|NCT01928862|363932997|FG002|Overall Study|Lost to Follow-up|0|||
105524686|NCT01928862|363932998|FG003|Overall Study|Lost to Follow-up|0|||
105524687|NCT01928862|363932999|FG004|Overall Study|Lost to Follow-up|1|||
105524688|NCT02625090|363933000|FG000|Overall Study|Participant wants to be pregnant|2|||
105524689|NCT02625090|363933000|FG000|Overall Study|For the Promoter|1|||
105524690|NCT02625090|363933000|FG000|Overall Study|Sponsor's Decision|9|||
105524691|NCT02625090|363933000|FG000|Overall Study|Somnolence|1|||
105524692|NCT02625090|363933000|FG000|Overall Study|Study terminated by Sponsor|7|||
105524693|NCT02625090|363933000|FG000|Overall Study|Negative Benefit/Risk|1|||
105524694|NCT02625090|363933000|FG000|Overall Study|Protocol Deviation|2|||
105524695|NCT02625090|363933000|FG000|Overall Study|Lack of Efficacy|16|||
105524696|NCT02625090|363933000|FG000|Overall Study|Adverse Event|3|||
105524697|NCT04649164|363933001|FG000|Overall Study|Withdrawal by Subject|1|||
105524698|NCT04649164|363933002|FG001|Overall Study|Withdrawal by Subject|1|||
105524699|NCT04649164|363933003|FG002|Overall Study|Withdrawal by Subject|2|||
105524700|NCT04649164|363933001|FG000|Overall Study|Participant's care recipient expired|0|||
105524701|NCT04649164|363933002|FG001|Overall Study|Participant's care recipient expired|0|||
105524702|NCT04649164|363933003|FG002|Overall Study|Participant's care recipient expired|2|||
105524703|NCT01549964|363933004|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
105524704|NCT01549964|363933005|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
105524705|NCT01549964|363933006|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
105524706|NCT01549964|363933007|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
105524707|NCT01549964|363933004|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
105524708|NCT01549964|363933005|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
105524709|NCT01549964|363933006|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
105524710|NCT01549964|363933007|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
105524711|NCT01549964|363933004|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
105524712|NCT01549964|363933005|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
105524713|NCT01549964|363933006|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
105524714|NCT01549964|363933007|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
105524715|NCT01549964|363933004|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
105524716|NCT01549964|363933005|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
105524717|NCT01549964|363933006|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
105524718|NCT01549964|363933007|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
105524719|NCT01549964|363933004|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
105524720|NCT01549964|363933005|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
105524721|NCT01549964|363933006|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
105524722|NCT01549964|363933007|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
105524723|NCT01549964|363933004|FG000|24-Week Treatment Period|Other|1|||
105524724|NCT01549964|363933005|FG001|24-Week Treatment Period|Other|0|||
105524725|NCT01549964|363933006|FG002|24-Week Treatment Period|Other|1|||
105524726|NCT01549964|363933007|FG003|24-Week Treatment Period|Other|0|||
105524727|NCT01549964|363933004|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
105524728|NCT01549964|363933005|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
105524729|NCT01549964|363933006|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
105524730|NCT01549964|363933007|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
105524731|NCT01549964|363933004|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
105524732|NCT01549964|363933005|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
105524733|NCT01549964|363933006|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
105524734|NCT01549964|363933007|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
105524735|NCT01549964|363933004|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
105524736|NCT01549964|363933005|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
105524737|NCT01549964|363933006|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
105524738|NCT01549964|363933007|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
105524739|NCT01549964|363933004|FG000|80-Week Extension Period|Pregnancy|0|||
105524740|NCT01549964|363933005|FG001|80-Week Extension Period|Pregnancy|0|||
105524741|NCT01549964|363933006|FG002|80-Week Extension Period|Pregnancy|1|||
105524742|NCT01549964|363933007|FG003|80-Week Extension Period|Pregnancy|0|||
105524743|NCT01549964|363933004|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
105524744|NCT01549964|363933005|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
105524745|NCT01549964|363933006|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
105524746|NCT01549964|363933007|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
105524747|NCT01549964|363933004|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
105524748|NCT01549964|363933005|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
105524749|NCT01549964|363933006|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
105524750|NCT01549964|363933007|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
105524751|NCT01549964|363933004|FG000|80-Week Extension Period|Lost to Follow-up|1|||
105524752|NCT01549964|363933005|FG001|80-Week Extension Period|Lost to Follow-up|0|||
105524753|NCT01549964|363933006|FG002|80-Week Extension Period|Lost to Follow-up|2|||
105524754|NCT01549964|363933007|FG003|80-Week Extension Period|Lost to Follow-up|1|||
105524755|NCT01549964|363933004|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
105524756|NCT01549964|363933005|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
105524757|NCT01549964|363933006|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
105524758|NCT01549964|363933007|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
105524759|NCT02290821|363933010|FG000|Overall Study|Withdrawal by Subject|1|||
105524760|NCT02290821|363933011|FG001|Overall Study|Withdrawal by Subject|1|||
105524761|NCT02290821|363933010|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
105524762|NCT02290821|363933011|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
105524763|NCT02290821|363933010|FG000|Overall Study|Lost to Follow-up|3|||
105524764|NCT02290821|363933011|FG001|Overall Study|Lost to Follow-up|2|||
105524765|NCT02439320|363933014|FG000|Overall Study|Adverse Event|0|||
105524766|NCT02439320|363933015|FG001|Overall Study|Adverse Event|2|||
105524767|NCT02439320|363933016|FG002|Overall Study|Adverse Event|0|||
105524768|NCT02439320|363933014|FG000|Overall Study|Lost to Follow-up|37|||
105524769|NCT02439320|363933015|FG001|Overall Study|Lost to Follow-up|34|||
105524770|NCT02439320|363933016|FG002|Overall Study|Lost to Follow-up|42|||
105524771|NCT02439320|363933014|FG000|Overall Study|Death|0|||
105524772|NCT02439320|363933015|FG001|Overall Study|Death|1|||
105524773|NCT02439320|363933016|FG002|Overall Study|Death|0|||
105524774|NCT02439320|363933014|FG000|Overall Study|Noncompliance with Protocol|10|||
105524775|NCT02439320|363933015|FG001|Overall Study|Noncompliance with Protocol|11|||
105524776|NCT02439320|363933016|FG002|Overall Study|Noncompliance with Protocol|7|||
105524777|NCT02439320|363933014|FG000|Overall Study|Pregnancy|0|||
105524778|NCT02439320|363933015|FG001|Overall Study|Pregnancy|1|||
105524779|NCT02439320|363933016|FG002|Overall Study|Pregnancy|1|||
105524780|NCT02439320|363933014|FG000|Overall Study|Withdrawal by Subject|12|||
105524781|NCT02439320|363933015|FG001|Overall Study|Withdrawal by Subject|16|||
105524782|NCT02439320|363933016|FG002|Overall Study|Withdrawal by Subject|14|||
105524783|NCT02439320|363933014|FG000|Overall Study|Physician Decision|2|||
105524784|NCT02439320|363933015|FG001|Overall Study|Physician Decision|1|||
105524785|NCT02439320|363933016|FG002|Overall Study|Physician Decision|0|||
105524786|NCT02439320|363933014|FG000|Overall Study|Sponsor Request|0|||
105524787|NCT02439320|363933015|FG001|Overall Study|Sponsor Request|2|||
105524788|NCT02439320|363933016|FG002|Overall Study|Sponsor Request|1|||
105524789|NCT02439320|363933014|FG000|Overall Study|Randomization Failure|35|||
105524790|NCT02439320|363933015|FG001|Overall Study|Randomization Failure|46|||
105524791|NCT02439320|363933016|FG002|Overall Study|Randomization Failure|34|||
105524792|NCT02972632|363933017|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
105524793|NCT02972632|363933017|FG000|Overall Study|Lost to Follow-up|4|||
105524794|NCT02972632|363933017|FG000|Overall Study|Voluntary Withdrawal|10|||
105524795|NCT02418468|363933018|FG000|Overall Study|Adverse Event|1|||
105524796|NCT02418468|363933019|FG001|Overall Study|Adverse Event|0|||
105524797|NCT02418468|363933018|FG000|Overall Study|Withdrawal of informed consent|1|||
105524798|NCT02418468|363933019|FG001|Overall Study|Withdrawal of informed consent|1|||
105524799|NCT00481195|363933020|FG000|Overall Study|Adverse Event|16|||
105524800|NCT00481195|363933021|FG001|Overall Study|Adverse Event|11|||
105524801|NCT00481195|363933020|FG000|Overall Study|Lack of Efficacy|1|||
105524802|NCT00481195|363933021|FG001|Overall Study|Lack of Efficacy|3|||
105524803|NCT00481195|363933020|FG000|Overall Study|Lost to Follow-up|4|||
105524804|NCT00481195|363933021|FG001|Overall Study|Lost to Follow-up|6|||
105524805|NCT00481195|363933020|FG000|Overall Study|Physician Decision|3|||
105524806|NCT00481195|363933021|FG001|Overall Study|Physician Decision|1|||
105524807|NCT00481195|363933020|FG000|Overall Study|Protocol Violation|10|||
105524808|NCT00481195|363933021|FG001|Overall Study|Protocol Violation|7|||
105524809|NCT00481195|363933020|FG000|Overall Study|Withdrawal by Subject|3|||
105524810|NCT00481195|363933021|FG001|Overall Study|Withdrawal by Subject|9|||
105524811|NCT00481195|363933020|FG000|Overall Study|Miscellaneous|2|||
105524812|NCT00481195|363933021|FG001|Overall Study|Miscellaneous|2|||
105524813|NCT01488097|363933022|FG000|Overall Study|Lost to Follow-up|1|||
105524814|NCT00909779|363933023|FG000|Overall Study|Adverse Event|53|||
105524815|NCT00909779|363933024|FG001|Overall Study|Adverse Event|55|||
105524816|NCT00909779|363933023|FG000|Overall Study|Lack of Efficacy|7|||
105524817|NCT00909779|363933024|FG001|Overall Study|Lack of Efficacy|4|||
105524818|NCT00909779|363933023|FG000|Overall Study|Lost to Follow-up|19|||
105524819|NCT00909779|363933024|FG001|Overall Study|Lost to Follow-up|15|||
105524820|NCT00909779|363933023|FG000|Overall Study|Physician Decision|8|||
105524821|NCT00909779|363933024|FG001|Overall Study|Physician Decision|2|||
105524822|NCT00909779|363933023|FG000|Overall Study|Protocol Violation|2|||
105524823|NCT00909779|363933024|FG001|Overall Study|Protocol Violation|5|||
105524824|NCT00909779|363933023|FG000|Overall Study|Withdrawal by Subject|116|||
105524825|NCT00909779|363933024|FG001|Overall Study|Withdrawal by Subject|80|||
105524826|NCT00909779|363933023|FG000|Overall Study|Site Ceasing Operation|2|||
105524827|NCT00909779|363933024|FG001|Overall Study|Site Ceasing Operation|2|||
105524828|NCT00909779|363933023|FG000|Overall Study|Medical Monitor Decision|1|||
105524829|NCT00909779|363933024|FG001|Overall Study|Medical Monitor Decision|0|||
105524830|NCT00909779|363933023|FG000|Overall Study|Noncompliance|1|||
105524831|NCT00909779|363933024|FG001|Overall Study|Noncompliance|1|||
105524832|NCT00909779|363933023|FG000|Overall Study|Randomized in error|1|||
105524833|NCT00909779|363933024|FG001|Overall Study|Randomized in error|1|||
105524834|NCT02016482|363933027|FG000|Period A|Adverse Event|3|||
105524835|NCT02016482|363933028|FG001|Period A|Adverse Event|5|||
105524836|NCT02016482|363933027|FG000|Period A|Withdrawal by Subject|3|||
105524837|NCT02016482|363933028|FG001|Period A|Withdrawal by Subject|4|||
105524838|NCT02016482|363933027|FG000|Period A|Lost to Follow-up|3|||
105524839|NCT02016482|363933028|FG001|Period A|Lost to Follow-up|3|||
105524840|NCT02016482|363933027|FG000|Period A|Lack of Efficacy|2|||
105524841|NCT02016482|363933028|FG001|Period A|Lack of Efficacy|1|||
105524842|NCT02016482|363933027|FG000|Period A|Other|3|||
105524843|NCT02016482|363933028|FG001|Period A|Other|0|||
105524844|NCT02016482|363933027|FG000|Period A|Protocol Violation|0|||
105524845|NCT02016482|363933028|FG001|Period A|Protocol Violation|1|||
105524846|NCT02016482|363933027|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
105524847|NCT02016482|363933028|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
105524848|NCT02016482|363933027|FG000|Period B|Withdrawal by Subject|1|||
105524849|NCT02016482|363933028|FG001|Period B|Withdrawal by Subject|1|||
105524850|NCT02016482|363933027|FG000|Period B|Lost to Follow-up|2|||
105524851|NCT02016482|363933028|FG001|Period B|Lost to Follow-up|0|||
105524852|NCT02016482|363933027|FG000|Period B|Lack of Efficacy|6|||
105524853|NCT02016482|363933028|FG001|Period B|Lack of Efficacy|4|||
105524854|NCT02016482|363933027|FG000|Period B|Other|4|||
105524855|NCT02016482|363933028|FG001|Period B|Other|0|||
105524856|NCT02016482|363933027|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
105524857|NCT02016482|363933028|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
105524858|NCT02738333|363933029|FG000|Overall Study|Death|1|||
105524859|NCT02738333|363933030|FG001|Overall Study|Death|0|||
105524860|NCT02738333|363933031|FG002|Overall Study|Death|0|||
105524861|NCT02738333|363933029|FG000|Overall Study|Lost to Follow-up|1|||
105524862|NCT02738333|363933030|FG001|Overall Study|Lost to Follow-up|0|||
105524863|NCT02738333|363933031|FG002|Overall Study|Lost to Follow-up|0|||
105524864|NCT02205333|363933041|FG000|Overall Study|Death|5|||
105524865|NCT02205333|363933042|FG001|Overall Study|Death|6|||
105524866|NCT02205333|363933043|FG002|Overall Study|Death|2|||
105524867|NCT02205333|363933044|FG003|Overall Study|Death|6|||
105524868|NCT02205333|363933045|FG004|Overall Study|Death|5|||
105524869|NCT02205333|363933046|FG005|Overall Study|Death|3|||
105524870|NCT02205333|363933047|FG006|Overall Study|Death|3|||
105524871|NCT02205333|363933048|FG007|Overall Study|Death|2|||
105524872|NCT02205333|363933049|FG008|Overall Study|Death|0|||
105524873|NCT02205333|363933041|FG000|Overall Study|Withdrawal by Subject|1|||
105524874|NCT02205333|363933042|FG001|Overall Study|Withdrawal by Subject|0|||
105524875|NCT02205333|363933043|FG002|Overall Study|Withdrawal by Subject|0|||
105524876|NCT02205333|363933044|FG003|Overall Study|Withdrawal by Subject|1|||
105524877|NCT02205333|363933045|FG004|Overall Study|Withdrawal by Subject|0|||
105524878|NCT02205333|363933046|FG005|Overall Study|Withdrawal by Subject|0|||
105524879|NCT02205333|363933047|FG006|Overall Study|Withdrawal by Subject|2|||
105524880|NCT02205333|363933048|FG007|Overall Study|Withdrawal by Subject|0|||
105524881|NCT02205333|363933049|FG008|Overall Study|Withdrawal by Subject|0|||
105524882|NCT01324388|363933050|FG000|Part 1 of Study|Adverse Event|2|||
105524883|NCT01324388|363933051|FG001|Part 1 of Study|Adverse Event|0|||
105524884|NCT01324388|363933052|FG002|Part 1 of Study|Adverse Event|0|||
105524885|NCT01324388|363933053|FG003|Part 1 of Study|Adverse Event|0|||
105524886|NCT01324388|363933050|FG000|Part 1 of Study|Protocol Violation|1|||
105524887|NCT01324388|363933051|FG001|Part 1 of Study|Protocol Violation|2|||
105524888|NCT01324388|363933052|FG002|Part 1 of Study|Protocol Violation|0|||
105524889|NCT01324388|363933053|FG003|Part 1 of Study|Protocol Violation|0|||
105524890|NCT01324388|363933050|FG000|Part 1 of Study|Physician Decision|1|||
105524891|NCT01324388|363933051|FG001|Part 1 of Study|Physician Decision|0|||
105524892|NCT01324388|363933052|FG002|Part 1 of Study|Physician Decision|0|||
105524893|NCT01324388|363933053|FG003|Part 1 of Study|Physician Decision|0|||
105524894|NCT01324388|363933050|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
105524895|NCT01324388|363933051|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
105524896|NCT01324388|363933052|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
105524897|NCT01324388|363933053|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
105524898|NCT01324388|363933050|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
105524899|NCT01324388|363933051|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
105524900|NCT01324388|363933052|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
105524901|NCT01324388|363933053|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
105524902|NCT02073279|363933057|FG000|Double-blind Period|Adverse Event|1|||
105524903|NCT02073279|363933058|FG001|Double-blind Period|Adverse Event|1|||
105524904|NCT02073279|363933057|FG000|Double-blind Period|Switched to another treatment|1|||
105524905|NCT02073279|363933058|FG001|Double-blind Period|Switched to another treatment|2|||
105524906|NCT02073279|363933057|FG000|Double-blind Period|Protocol Violation|0|||
105524907|NCT02073279|363933058|FG001|Double-blind Period|Protocol Violation|1|||
105524908|NCT02073279|363933057|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
105524909|NCT02073279|363933058|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
105524910|NCT02073279|363933057|FG000|Double-blind Period|Withdrawal by Subject|2|||
105524911|NCT02073279|363933058|FG001|Double-blind Period|Withdrawal by Subject|2|||
105524912|NCT02073279|363933057|FG000|Open-label Extension Period|Adverse Event|1|||
105524913|NCT02073279|363933058|FG001|Open-label Extension Period|Adverse Event|0|||
105524914|NCT02073279|363933057|FG000|Open-label Extension Period|Lack of Efficacy|1|||
105524915|NCT02073279|363933058|FG001|Open-label Extension Period|Lack of Efficacy|0|||
105524916|NCT02073279|363933057|FG000|Open-label Extension Period|Lost to Follow-up|0|||
105524917|NCT02073279|363933058|FG001|Open-label Extension Period|Lost to Follow-up|4|||
105524918|NCT02073279|363933057|FG000|Open-label Extension Period|Switched to another treatment|1|||
105524919|NCT02073279|363933058|FG001|Open-label Extension Period|Switched to another treatment|4|||
105524920|NCT02073279|363933057|FG000|Open-label Extension Period|Protocol Violation|0|||
105524921|NCT02073279|363933058|FG001|Open-label Extension Period|Protocol Violation|1|||
105524922|NCT02073279|363933057|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
105524923|NCT02073279|363933058|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
105524924|NCT02073279|363933057|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
105524925|NCT02073279|363933058|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
105524926|NCT01085097|363933059|FG000|Overall Study|Adverse Event|0|||
105524927|NCT01085097|363933060|FG001|Overall Study|Adverse Event|0|||
105524928|NCT01085097|363933061|FG002|Overall Study|Adverse Event|2|||
105524929|NCT01085097|363933059|FG000|Overall Study|Treatment failure|2|||
105524930|NCT01085097|363933060|FG001|Overall Study|Treatment failure|0|||
105524931|NCT01085097|363933061|FG002|Overall Study|Treatment failure|0|||
105524932|NCT00973479|363933064|FG000|Overall Study|Lost to Follow-up|0|||
105524933|NCT00973479|363933065|FG001|Overall Study|Lost to Follow-up|3|||
105524934|NCT00973479|363933064|FG000|Overall Study|Death|2|||
105524935|NCT00973479|363933065|FG001|Overall Study|Death|2|||
105524936|NCT00973479|363933064|FG000|Overall Study|Withdrawal by Subject|15|||
105524937|NCT00973479|363933065|FG001|Overall Study|Withdrawal by Subject|16|||
105524938|NCT00973479|363933064|FG000|Overall Study|Lack of Efficacy|5|||
105524939|NCT00973479|363933065|FG001|Overall Study|Lack of Efficacy|7|||
105524940|NCT00973479|363933064|FG000|Overall Study|Adverse Event|12|||
105524941|NCT00973479|363933065|FG001|Overall Study|Adverse Event|32|||
105524942|NCT00973479|363933064|FG000|Overall Study|Protocol Violation|2|||
105524943|NCT00973479|363933065|FG001|Overall Study|Protocol Violation|2|||
105524944|NCT00973479|363933064|FG000|Overall Study|Other|1|||
105524945|NCT00973479|363933065|FG001|Overall Study|Other|7|||
105524946|NCT00129129|363933066|FG000|Primary Phase|Adverse Event|2|||
105524947|NCT00129129|363933067|FG001|Primary Phase|Adverse Event|1|||
105524948|NCT00129129|363933068|FG002|Primary Phase|Adverse Event|0|||
105524949|NCT00129129|363933069|FG003|Primary Phase|Adverse Event|0|||
105524950|NCT00129129|363933070|FG004|Primary Phase|Adverse Event|0|||
105524951|NCT00129129|363933066|FG000|Primary Phase|Withdrawal by Subject|12|||
105524952|NCT00129129|363933067|FG001|Primary Phase|Withdrawal by Subject|10|||
105524953|NCT00129129|363933068|FG002|Primary Phase|Withdrawal by Subject|0|||
105524954|NCT00129129|363933069|FG003|Primary Phase|Withdrawal by Subject|0|||
105524955|NCT00129129|363933070|FG004|Primary Phase|Withdrawal by Subject|0|||
105524956|NCT00129129|363933066|FG000|Primary Phase|Migration from study area|1|||
105524957|NCT00129129|363933067|FG001|Primary Phase|Migration from study area|3|||
105524958|NCT00129129|363933068|FG002|Primary Phase|Migration from study area|0|||
105524959|NCT00129129|363933069|FG003|Primary Phase|Migration from study area|0|||
105524960|NCT00129129|363933070|FG004|Primary Phase|Migration from study area|0|||
105524961|NCT00129129|363933066|FG000|Primary Phase|Lost to Follow-up|8|||
105524962|NCT00129129|363933067|FG001|Primary Phase|Lost to Follow-up|6|||
105524963|NCT00129129|363933068|FG002|Primary Phase|Lost to Follow-up|0|||
105524964|NCT00129129|363933069|FG003|Primary Phase|Lost to Follow-up|0|||
105524965|NCT00129129|363933070|FG004|Primary Phase|Lost to Follow-up|0|||
105524966|NCT00129129|363933066|FG000|Primary Phase|Other|2|||
105524967|NCT00129129|363933067|FG001|Primary Phase|Other|5|||
105524968|NCT00129129|363933068|FG002|Primary Phase|Other|0|||
105524969|NCT00129129|363933069|FG003|Primary Phase|Other|0|||
105524970|NCT00129129|363933070|FG004|Primary Phase|Other|0|||
105524971|NCT00129129|363933066|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
105524972|NCT00129129|363933067|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
105524973|NCT00129129|363933068|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
105524974|NCT00129129|363933069|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
105524975|NCT00129129|363933070|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
105524976|NCT00129129|363933066|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
105524977|NCT00129129|363933067|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
105524978|NCT00129129|363933068|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
105524979|NCT00129129|363933069|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
105524980|NCT00129129|363933070|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
105524981|NCT00129129|363933066|FG000|Fourth Dose Phase|Migration from study area|0|||
105524982|NCT00129129|363933067|FG001|Fourth Dose Phase|Migration from study area|0|||
105524983|NCT00129129|363933068|FG002|Fourth Dose Phase|Migration from study area|0|||
105524984|NCT00129129|363933069|FG003|Fourth Dose Phase|Migration from study area|0|||
105524985|NCT00129129|363933070|FG004|Fourth Dose Phase|Migration from study area|2|||
105524986|NCT00129129|363933066|FG000|Fourth Dose Phase|Other|0|||
105524987|NCT00129129|363933067|FG001|Fourth Dose Phase|Other|0|||
105524988|NCT00129129|363933068|FG002|Fourth Dose Phase|Other|0|||
105524989|NCT00129129|363933069|FG003|Fourth Dose Phase|Other|1|||
105524990|NCT00129129|363933070|FG004|Fourth Dose Phase|Other|1|||
105524991|NCT00129129|363933066|FG000|Fourth Dose Phase|Protocol Violation|0|||
105524992|NCT00129129|363933067|FG001|Fourth Dose Phase|Protocol Violation|0|||
105524993|NCT00129129|363933068|FG002|Fourth Dose Phase|Protocol Violation|0|||
105524994|NCT00129129|363933069|FG003|Fourth Dose Phase|Protocol Violation|1|||
105524995|NCT00129129|363933070|FG004|Fourth Dose Phase|Protocol Violation|0|||
105524996|NCT02802592|363933072|FG000|Overall Study|Study terminated due to loss of funding|4|||
105524997|NCT04007523|363933073|FG000|Overall Study|Withdrawal by Subject|0|||
105524998|NCT04007523|363933074|FG001|Overall Study|Withdrawal by Subject|1|||
105524999|NCT04007523|363933075|FG002|Overall Study|Withdrawal by Subject|1|||
105525000|NCT04007523|363933076|FG003|Overall Study|Withdrawal by Subject|0|||
105525001|NCT04007523|363933073|FG000|Overall Study|ICU Transfer|0|||
105525002|NCT04007523|363933074|FG001|Overall Study|ICU Transfer|1|||
105525003|NCT04007523|363933075|FG002|Overall Study|ICU Transfer|0|||
105525004|NCT04007523|363933076|FG003|Overall Study|ICU Transfer|0|||
105525005|NCT04007523|363933073|FG000|Overall Study|COVID hospital closure|0|||
105525006|NCT04007523|363933074|FG001|Overall Study|COVID hospital closure|0|||
105525007|NCT04007523|363933075|FG002|Overall Study|COVID hospital closure|1|||
105525008|NCT04007523|363933076|FG003|Overall Study|COVID hospital closure|2|||
105525009|NCT04007523|363933073|FG000|Overall Study|Surgery cancelled|0|||
105525010|NCT04007523|363933074|FG001|Overall Study|Surgery cancelled|0|||
105525011|NCT04007523|363933075|FG002|Overall Study|Surgery cancelled|1|||
105525012|NCT04007523|363933076|FG003|Overall Study|Surgery cancelled|1|||
105525013|NCT02882854|363933077|FG000|Overall Study|Lost to Follow-up|1|||
105525014|NCT02882854|363933078|FG001|Overall Study|Lost to Follow-up|2|||
105525015|NCT02882854|363933077|FG000|Overall Study|Physician Decision|0|||
105525016|NCT02882854|363933078|FG001|Overall Study|Physician Decision|1|||
105525017|NCT01358357|363933081|FG000|Open Label Phase|Adverse Event|0|||
105525018|NCT01358357|363933082|FG001|Open Label Phase|Adverse Event|0|||
105525019|NCT01358357|363933083|FG002|Open Label Phase|Adverse Event|59|||
105525020|NCT01358357|363933081|FG000|Open Label Phase|Lack of Efficacy|0|||
105525021|NCT01358357|363933082|FG001|Open Label Phase|Lack of Efficacy|0|||
105525022|NCT01358357|363933083|FG002|Open Label Phase|Lack of Efficacy|107|||
105525023|NCT01358357|363933081|FG000|Open Label Phase|Lost to Follow-up|0|||
105525024|NCT01358357|363933082|FG001|Open Label Phase|Lost to Follow-up|0|||
105525025|NCT01358357|363933083|FG002|Open Label Phase|Lost to Follow-up|76|||
105525026|NCT01358357|363933081|FG000|Open Label Phase|Protocol Violation|0|||
105525027|NCT01358357|363933082|FG001|Open Label Phase|Protocol Violation|0|||
105525028|NCT01358357|363933083|FG002|Open Label Phase|Protocol Violation|45|||
105525029|NCT01358357|363933081|FG000|Open Label Phase|Withdrawal by Subject|0|||
105525030|NCT01358357|363933082|FG001|Open Label Phase|Withdrawal by Subject|0|||
105525031|NCT01358357|363933083|FG002|Open Label Phase|Withdrawal by Subject|112|||
105525032|NCT01358357|363933081|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
105525033|NCT01358357|363933082|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
105525034|NCT01358357|363933083|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
105525035|NCT01358357|363933081|FG000|Open Label Phase|Terminated at study completion|0|||
105525036|NCT01358357|363933082|FG001|Open Label Phase|Terminated at study completion|0|||
105525037|NCT01358357|363933083|FG002|Open Label Phase|Terminated at study completion|5|||
105525038|NCT01358357|363933081|FG000|Open Label Phase|Mood episode|0|||
105525039|NCT01358357|363933082|FG001|Open Label Phase|Mood episode|0|||
105525040|NCT01358357|363933083|FG002|Open Label Phase|Mood episode|42|||
105525041|NCT01358357|363933081|FG000|Double-Blind Phase|Adverse Event|8|||
105525042|NCT01358357|363933082|FG001|Double-Blind Phase|Adverse Event|5|||
105525043|NCT01358357|363933083|FG002|Double-Blind Phase|Adverse Event|0|||
105525044|NCT01358357|363933081|FG000|Double-Blind Phase|Lost to Follow-up|5|||
105525045|NCT01358357|363933082|FG001|Double-Blind Phase|Lost to Follow-up|7|||
105525046|NCT01358357|363933083|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105525047|NCT01358357|363933081|FG000|Double-Blind Phase|Protocol Violation|1|||
105525048|NCT01358357|363933082|FG001|Double-Blind Phase|Protocol Violation|11|||
105525049|NCT01358357|363933083|FG002|Double-Blind Phase|Protocol Violation|0|||
105525050|NCT01358357|363933081|FG000|Double-Blind Phase|Protocol Violation|16|||
105525051|NCT01358357|363933082|FG001|Double-Blind Phase|Protocol Violation|12|||
105525052|NCT01358357|363933083|FG002|Double-Blind Phase|Protocol Violation|0|||
105525053|NCT01358357|363933081|FG000|Double-Blind Phase|Terminated at study completion|2|||
105592796|NCT03068468|364170765|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
105525054|NCT01358357|363933082|FG001|Double-Blind Phase|Terminated at study completion|0|||
105525055|NCT01358357|363933083|FG002|Double-Blind Phase|Terminated at study completion|0|||
105525056|NCT01358357|363933081|FG000|Double-Blind Phase|Recurrence of mood event|48|||
105525057|NCT01358357|363933082|FG001|Double-Blind Phase|Recurrence of mood event|64|||
105525058|NCT01358357|363933083|FG002|Double-Blind Phase|Recurrence of mood event|0|||
105525059|NCT01358357|363933081|FG000|Double-Blind Phase|Administrative|0|||
105525060|NCT01358357|363933082|FG001|Double-Blind Phase|Administrative|1|||
105525061|NCT01358357|363933083|FG002|Double-Blind Phase|Administrative|0|||
105525062|NCT02268786|363933085|FG000|Overall Study|No Euploid Embryos available|42|||
105525063|NCT02268786|363933086|FG001|Overall Study|No Euploid Embryos available|0|||
105525064|NCT02268786|363933085|FG000|Overall Study|Withdrawal by Subject|7|||
105525065|NCT02268786|363933086|FG001|Overall Study|Withdrawal by Subject|14|||
105525066|NCT02268786|363933085|FG000|Overall Study|Thaw Failure|6|||
105525067|NCT02268786|363933086|FG001|Overall Study|Thaw Failure|4|||
105525068|NCT02268786|363933085|FG000|Overall Study|Protocol Violation|1|||
105525069|NCT02268786|363933086|FG001|Overall Study|Protocol Violation|0|||
105525070|NCT01150123|363933087|FG000|Overall Study|Withdrawal by Subject|1|||
105525071|NCT01150123|363933088|FG001|Overall Study|Withdrawal by Subject|1|||
105525072|NCT01150123|363933089|FG002|Overall Study|Withdrawal by Subject|2|||
105525073|NCT01150123|363933090|FG003|Overall Study|Withdrawal by Subject|1|||
105525074|NCT01150123|363933091|FG004|Overall Study|Withdrawal by Subject|1|||
105525075|NCT01150123|363933092|FG005|Overall Study|Withdrawal by Subject|1|||
105525076|NCT01150123|363933093|FG006|Overall Study|Withdrawal by Subject|0|||
105525077|NCT01150123|363933094|FG007|Overall Study|Withdrawal by Subject|3|||
105525078|NCT01150123|363933095|FG008|Overall Study|Withdrawal by Subject|2|||
105525079|NCT01150123|363933096|FG009|Overall Study|Withdrawal by Subject|0|||
105525080|NCT01150123|363933097|FG010|Overall Study|Withdrawal by Subject|1|||
105525081|NCT01150123|363933098|FG011|Overall Study|Withdrawal by Subject|0|||
105525082|NCT01150123|363933099|FG012|Overall Study|Withdrawal by Subject|1|||
105525083|NCT01150123|363933100|FG013|Overall Study|Withdrawal by Subject|0|||
105525084|NCT01150123|363933101|FG014|Overall Study|Withdrawal by Subject|0|||
105525085|NCT01150123|363933102|FG015|Overall Study|Withdrawal by Subject|1|||
105525086|NCT01150123|363933103|FG016|Overall Study|Withdrawal by Subject|0|||
105525087|NCT01150123|363933104|FG017|Overall Study|Withdrawal by Subject|1|||
105525088|NCT01150123|363933087|FG000|Overall Study|Lost to Follow-up|2|||
105525089|NCT01150123|363933088|FG001|Overall Study|Lost to Follow-up|1|||
105525090|NCT01150123|363933089|FG002|Overall Study|Lost to Follow-up|2|||
105525091|NCT01150123|363933090|FG003|Overall Study|Lost to Follow-up|2|||
105525092|NCT01150123|363933091|FG004|Overall Study|Lost to Follow-up|2|||
105525093|NCT01150123|363933092|FG005|Overall Study|Lost to Follow-up|5|||
105525094|NCT01150123|363933093|FG006|Overall Study|Lost to Follow-up|0|||
105525095|NCT01150123|363933094|FG007|Overall Study|Lost to Follow-up|0|||
105525096|NCT01150123|363933095|FG008|Overall Study|Lost to Follow-up|3|||
105525097|NCT01150123|363933096|FG009|Overall Study|Lost to Follow-up|1|||
105525098|NCT01150123|363933097|FG010|Overall Study|Lost to Follow-up|1|||
105525099|NCT01150123|363933098|FG011|Overall Study|Lost to Follow-up|1|||
105525100|NCT01150123|363933099|FG012|Overall Study|Lost to Follow-up|2|||
105525101|NCT01150123|363933100|FG013|Overall Study|Lost to Follow-up|0|||
105525102|NCT01150123|363933101|FG014|Overall Study|Lost to Follow-up|0|||
105525103|NCT01150123|363933102|FG015|Overall Study|Lost to Follow-up|0|||
105525104|NCT01150123|363933103|FG016|Overall Study|Lost to Follow-up|0|||
105525105|NCT01150123|363933104|FG017|Overall Study|Lost to Follow-up|0|||
105525106|NCT02171260|363933109|FG000|Overall Study|Death|0|||
105525107|NCT02171260|363933110|FG001|Overall Study|Death|0|||
105525108|NCT02171260|363933111|FG002|Overall Study|Death|0|||
105525109|NCT02171260|363933112|FG003|Overall Study|Death|1|||
105525110|NCT02171260|363933109|FG000|Overall Study|Physician Decision|1|||
105525111|NCT02171260|363933110|FG001|Overall Study|Physician Decision|0|||
105525112|NCT02171260|363933111|FG002|Overall Study|Physician Decision|1|||
105525113|NCT02171260|363933112|FG003|Overall Study|Physician Decision|0|||
105525114|NCT02171260|363933109|FG000|Overall Study|Withdrawal by Subject|1|||
105525115|NCT02171260|363933110|FG001|Overall Study|Withdrawal by Subject|0|||
105525116|NCT02171260|363933111|FG002|Overall Study|Withdrawal by Subject|0|||
105525117|NCT02171260|363933112|FG003|Overall Study|Withdrawal by Subject|0|||
105525118|NCT02171260|363933109|FG000|Overall Study|Evidence of progressive disease|4|||
105525119|NCT02171260|363933110|FG001|Overall Study|Evidence of progressive disease|6|||
105525120|NCT02171260|363933111|FG002|Overall Study|Evidence of progressive disease|4|||
105525121|NCT02171260|363933112|FG003|Overall Study|Evidence of progressive disease|4|||
105525122|NCT01062555|363933117|FG000|Phase 1|Death|10|||
105525123|NCT01062555|363933118|FG001|Phase 1|Death|17|||
105525124|NCT01062555|363933119|FG002|Phase 1|Death|0|||
105525125|NCT01062555|363933120|FG003|Phase 1|Death|0|||
105525126|NCT01062555|363933117|FG000|Phase 1|Graft Failure|12|||
105525127|NCT01062555|363933118|FG001|Phase 1|Graft Failure|8|||
105525128|NCT01062555|363933119|FG002|Phase 1|Graft Failure|0|||
105525129|NCT01062555|363933120|FG003|Phase 1|Graft Failure|0|||
105525130|NCT01062555|363933117|FG000|Phase 1|Withdrawal by Subject|1|||
105592797|NCT03068468|364170766|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
105525131|NCT01062555|363933118|FG001|Phase 1|Withdrawal by Subject|1|||
105525132|NCT01062555|363933119|FG002|Phase 1|Withdrawal by Subject|0|||
105525133|NCT01062555|363933120|FG003|Phase 1|Withdrawal by Subject|0|||
105525134|NCT01062555|363933117|FG000|Phase 2|Death|0|||
105525135|NCT01062555|363933118|FG001|Phase 2|Death|0|||
105525136|NCT01062555|363933119|FG002|Phase 2|Death|8|||
105525137|NCT01062555|363933120|FG003|Phase 2|Death|3|||
105525138|NCT01062555|363933117|FG000|Phase 2|Graft failure|0|||
105525139|NCT01062555|363933118|FG001|Phase 2|Graft failure|0|||
105525140|NCT01062555|363933119|FG002|Phase 2|Graft failure|7|||
105525141|NCT01062555|363933120|FG003|Phase 2|Graft failure|4|||
105525142|NCT01062555|363933117|FG000|Phase 2|Withdrawal by Subject|0|||
105525143|NCT01062555|363933118|FG001|Phase 2|Withdrawal by Subject|0|||
105525144|NCT01062555|363933119|FG002|Phase 2|Withdrawal by Subject|0|||
105525145|NCT01062555|363933120|FG003|Phase 2|Withdrawal by Subject|7|||
105525146|NCT01062555|363933117|FG000|Phase 2|Protocol Violation|0|||
105525147|NCT01062555|363933118|FG001|Phase 2|Protocol Violation|0|||
105525148|NCT01062555|363933119|FG002|Phase 2|Protocol Violation|0|||
105525149|NCT01062555|363933120|FG003|Phase 2|Protocol Violation|3|||
105525150|NCT01062555|363933117|FG000|Phase 2|Physician Decision|0|||
105525151|NCT01062555|363933118|FG001|Phase 2|Physician Decision|0|||
105525152|NCT01062555|363933119|FG002|Phase 2|Physician Decision|0|||
105525153|NCT01062555|363933120|FG003|Phase 2|Physician Decision|17|||
105525154|NCT02486042|363933121|FG000|Overall Study|Physician Decision|1|||
105525155|NCT02486042|363933122|FG001|Overall Study|Physician Decision|7|||
105525156|NCT02486042|363933121|FG000|Overall Study|Hospital transfer|2|||
105525157|NCT02486042|363933122|FG001|Overall Study|Hospital transfer|2|||
105525158|NCT02486042|363933121|FG000|Overall Study|Withdrawal by Subject|0|||
105525159|NCT02486042|363933122|FG001|Overall Study|Withdrawal by Subject|2|||
105525160|NCT00066066|363934679|FG000|Overall Study|Lost to Follow-up|6|||
105525161|NCT00066066|363934680|FG001|Overall Study|Lost to Follow-up|4|||
105525162|NCT00066066|363934681|FG002|Overall Study|Lost to Follow-up|7|||
105525163|NCT00066066|363934682|FG003|Overall Study|Lost to Follow-up|4|||
105525164|NCT00066066|363934683|FG004|Overall Study|Lost to Follow-up|3|||
105525165|NCT00066066|363934684|FG005|Overall Study|Lost to Follow-up|5|||
105525166|NCT01254227|363934691|FG000|Overall Study|Withdrawal by Subject|6|||
105525167|NCT01254227|363934691|FG000|Overall Study|Lost to Follow-up|6|||
105525168|NCT01254227|363934691|FG000|Overall Study|Adverse Event|5|||
105525169|NCT01254227|363934691|FG000|Overall Study|Abnormal test procedure result|5|||
105525170|NCT01254227|363934691|FG000|Overall Study|Administrative problems|2|||
105525171|NCT01254227|363934691|FG000|Overall Study|Death|1|||
105525172|NCT01254227|363934691|FG000|Overall Study|Protocol deviation|1|||
105525173|NCT05123222|363934692|FG000|Overall Study|Lost to Follow-up|2|||
105525174|NCT05123222|363934693|FG001|Overall Study|Lost to Follow-up|0|||
105525175|NCT05123222|363934694|FG002|Overall Study|Lost to Follow-up|0|||
105525176|NCT05123222|363934695|FG003|Overall Study|Lost to Follow-up|0|||
105525177|NCT05123222|363934692|FG000|Overall Study|Protocol Violation|0|||
105525178|NCT05123222|363934693|FG001|Overall Study|Protocol Violation|0|||
105525179|NCT05123222|363934694|FG002|Overall Study|Protocol Violation|1|||
105525180|NCT05123222|363934695|FG003|Overall Study|Protocol Violation|0|||
105525181|NCT01217060|363934696|FG000|Overall Study|Withdrawal by Subject|1|||
105525182|NCT02579265|363934697|FG000|Overall Study|Weaned off earlier than 28 days|44|||
105525183|NCT02579265|363934698|FG001|Overall Study|Weaned off earlier than 28 days|43|||
105525184|NCT02579265|363934697|FG000|Overall Study|Adverse Event|2|||
105525185|NCT02579265|363934698|FG001|Overall Study|Adverse Event|0|||
105525186|NCT02579265|363934697|FG000|Overall Study|Any other reason not specified|0|||
105525187|NCT02579265|363934698|FG001|Overall Study|Any other reason not specified|2|||
105525188|NCT02579265|363934697|FG000|Overall Study|Withdrawal by Subject|2|||
105525189|NCT02579265|363934698|FG001|Overall Study|Withdrawal by Subject|0|||
105525190|NCT02579265|363934697|FG000|Overall Study|Physician Decision|1|||
105525191|NCT02579265|363934698|FG001|Overall Study|Physician Decision|0|||
105525192|NCT02579265|363934697|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
105525193|NCT02579265|363934698|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
105525194|NCT04254978|363934704|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
105525195|NCT04254978|363934704|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
105525196|NCT04254978|363934704|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
105525197|NCT04254978|363934704|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
105525198|NCT04254978|363934704|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
105525199|NCT04254978|363934704|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
105525200|NCT00644969|363934705|FG000|Treatment Phase|Randomized, not treated|1|||
105525201|NCT00644969|363934706|FG001|Treatment Phase|Randomized, not treated|0|||
105525202|NCT00644969|363934705|FG000|Treatment Phase|Adverse Event|3|||
105525203|NCT00644969|363934706|FG001|Treatment Phase|Adverse Event|0|||
105525204|NCT00644969|363934705|FG000|Treatment Phase|Withdrawal by Subject|4|||
105525205|NCT00644969|363934706|FG001|Treatment Phase|Withdrawal by Subject|0|||
105525206|NCT00644969|363934705|FG000|Treatment Phase|Lost to Follow-up|2|||
105525207|NCT00644969|363934706|FG001|Treatment Phase|Lost to Follow-up|2|||
105525208|NCT00644969|363934705|FG000|Treatment Phase|Other|4|||
105525209|NCT00644969|363934706|FG001|Treatment Phase|Other|1|||
105525210|NCT00644969|363934705|FG000|Post Treatment Phase|Death|1|||
105525211|NCT00644969|363934706|FG001|Post Treatment Phase|Death|0|||
105525212|NCT00644969|363934705|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
105525213|NCT00644969|363934706|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
105525214|NCT00644969|363934705|FG000|Post Treatment Phase|Lost to Follow-up|4|||
105525215|NCT00644969|363934706|FG001|Post Treatment Phase|Lost to Follow-up|1|||
105525216|NCT00644969|363934705|FG000|Post Treatment Phase|Other|1|||
105525217|NCT00644969|363934706|FG001|Post Treatment Phase|Other|0|||
105525218|NCT02515942|363934707|FG000|Overall Study|Adverse Event|5|||
105525219|NCT02515942|363934708|FG001|Overall Study|Adverse Event|0|||
105525220|NCT02515942|363934709|FG002|Overall Study|Adverse Event|0|||
105525221|NCT02515942|363934707|FG000|Overall Study|Death|0|||
105525222|NCT02515942|363934708|FG001|Overall Study|Death|0|||
105525223|NCT02515942|363934709|FG002|Overall Study|Death|1|||
105525224|NCT02515942|363934707|FG000|Overall Study|Lack of Efficacy|0|||
105525225|NCT02515942|363934708|FG001|Overall Study|Lack of Efficacy|0|||
105525226|NCT02515942|363934709|FG002|Overall Study|Lack of Efficacy|1|||
105525227|NCT02515942|363934707|FG000|Overall Study|Lost to Follow-up|2|||
105525228|NCT02515942|363934708|FG001|Overall Study|Lost to Follow-up|0|||
105525229|NCT02515942|363934709|FG002|Overall Study|Lost to Follow-up|0|||
105525230|NCT02515942|363934707|FG000|Overall Study|Withdrawal by Subject|0|||
105525231|NCT02515942|363934708|FG001|Overall Study|Withdrawal by Subject|3|||
105525232|NCT02515942|363934709|FG002|Overall Study|Withdrawal by Subject|2|||
105525233|NCT03257631|363934710|FG000|Overall Study|Death|1|||
105525234|NCT03257631|363934711|FG001|Overall Study|Death|0|||
105525235|NCT03257631|363934712|FG002|Overall Study|Death|1|||
105525236|NCT03257631|363934713|FG003|Overall Study|Death|1|||
105525237|NCT03257631|363934710|FG000|Overall Study|Progressive Disease|10|||
105525238|NCT03257631|363934711|FG001|Overall Study|Progressive Disease|9|||
105525239|NCT03257631|363934712|FG002|Overall Study|Progressive Disease|17|||
105525240|NCT03257631|363934713|FG003|Overall Study|Progressive Disease|8|||
105525241|NCT03257631|363934710|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105525242|NCT03257631|363934711|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105525243|NCT03257631|363934712|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
105525244|NCT03257631|363934713|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
105525245|NCT03257631|363934710|FG000|Overall Study|Adverse Event|0|||
105525246|NCT03257631|363934711|FG001|Overall Study|Adverse Event|0|||
105525247|NCT03257631|363934712|FG002|Overall Study|Adverse Event|2|||
105525248|NCT03257631|363934713|FG003|Overall Study|Adverse Event|0|||
105525249|NCT00277212|363934714|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
105525250|NCT00277212|363934715|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
105525251|NCT00277212|363934716|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
105525252|NCT00277212|363934714|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
105525253|NCT00277212|363934715|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
105525254|NCT00277212|363934716|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
105525255|NCT00277212|363934714|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
105525256|NCT00277212|363934715|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
105525257|NCT00277212|363934716|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
105525258|NCT00277212|363934714|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
105525259|NCT00277212|363934715|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
105525260|NCT00277212|363934716|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
105525261|NCT00277212|363934714|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
105525262|NCT00277212|363934715|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
105525263|NCT00277212|363934716|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
105525264|NCT00277212|363934714|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
105525265|NCT00277212|363934715|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
105525266|NCT00277212|363934716|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
105525267|NCT00277212|363934714|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
105525268|NCT00277212|363934715|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
105525269|NCT00277212|363934716|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
105525270|NCT00277212|363934714|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
105592798|NCT03068468|364170763|FG000|Open-Label Extension Period|Adverse Event|0|||
105592799|NCT03068468|364170764|FG001|Open-Label Extension Period|Adverse Event|0|||
105592800|NCT03068468|364170765|FG002|Open-Label Extension Period|Adverse Event|13|||
105592801|NCT03068468|364170766|FG003|Open-Label Extension Period|Adverse Event|17|||
105592802|NCT03068468|364170763|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
105592803|NCT03068468|364170764|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
105592804|NCT03068468|364170765|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
105525271|NCT00277212|363934715|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
105592805|NCT03068468|364170766|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
105592806|NCT03068468|364170763|FG000|Open-Label Extension Period|Death|0|||
105592807|NCT03068468|364170764|FG001|Open-Label Extension Period|Death|0|||
105592808|NCT03068468|364170765|FG002|Open-Label Extension Period|Death|0|||
105525272|NCT00277212|363934716|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
105525273|NCT00277212|363934714|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
105525274|NCT00277212|363934715|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
105525275|NCT00277212|363934716|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
105592809|NCT03068468|364170766|FG003|Open-Label Extension Period|Death|1|||
105525276|NCT00277212|363934714|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
105525277|NCT00277212|363934715|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
105525278|NCT00277212|363934716|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
105525279|NCT00277212|363934714|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
105525280|NCT00277212|363934715|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
105525281|NCT00277212|363934716|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
105525282|NCT00277212|363934714|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
105525283|NCT00277212|363934715|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
105525284|NCT00277212|363934716|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
105525285|NCT00277212|363934714|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
105525286|NCT00277212|363934715|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
105525287|NCT00277212|363934716|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
105525288|NCT00277212|363934714|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
105525289|NCT00277212|363934715|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
105525290|NCT00277212|363934716|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
105525291|NCT00277212|363934714|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
105525292|NCT00277212|363934715|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
105525293|NCT00277212|363934716|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
105525294|NCT00277212|363934714|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
105525295|NCT00277212|363934715|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
105525296|NCT00277212|363934716|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
105525297|NCT00277212|363934714|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
105525298|NCT00277212|363934715|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
105525299|NCT00277212|363934716|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
105525300|NCT00277212|363934714|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
105525301|NCT00277212|363934715|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
105525302|NCT00277212|363934716|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
105525303|NCT00902564|363934717|FG000|Overall Study|Withdrawal by Subject|2|||
105525304|NCT05620576|363934718|FG000|Overall Study|Adverse Event|1|||
105525305|NCT05620576|363934719|FG001|Overall Study|Adverse Event|1|||
105525306|NCT05620576|363934718|FG000|Overall Study|Lost to Follow-up|3|||
105525307|NCT05620576|363934719|FG001|Overall Study|Lost to Follow-up|1|||
105525308|NCT05620576|363934718|FG000|Overall Study|Physician Decision|0|||
105525309|NCT05620576|363934719|FG001|Overall Study|Physician Decision|1|||
105525310|NCT05620576|363934718|FG000|Overall Study|Protocol Deviation|1|||
105525311|NCT05620576|363934719|FG001|Overall Study|Protocol Deviation|1|||
105525312|NCT05620576|363934718|FG000|Overall Study|Withdrawal by Subject|2|||
105525313|NCT05620576|363934719|FG001|Overall Study|Withdrawal by Subject|3|||
105525314|NCT03336216|363934725|FG000|Randomization|Not reported|2|||
105525315|NCT03336216|363934726|FG001|Randomization|Not reported|0|||
105525316|NCT03336216|363934727|FG002|Randomization|Not reported|1|||
105525317|NCT03336216|363934728|FG003|Randomization|Not reported|0|||
105525318|NCT03336216|363934725|FG000|Randomization|Other reasons|1|||
105525319|NCT03336216|363934726|FG001|Randomization|Other reasons|1|||
105525320|NCT03336216|363934727|FG002|Randomization|Other reasons|1|||
105525321|NCT03336216|363934728|FG003|Randomization|Other reasons|0|||
105525322|NCT03336216|363934725|FG000|Randomization|Participant no longer meets study criteria|0|||
105525323|NCT03336216|363934726|FG001|Randomization|Participant no longer meets study criteria|2|||
105525324|NCT03336216|363934727|FG002|Randomization|Participant no longer meets study criteria|4|||
105525325|NCT03336216|363934728|FG003|Randomization|Participant no longer meets study criteria|1|||
105525326|NCT03336216|363934725|FG000|Randomization|Lost to Follow-up|1|||
105525327|NCT03336216|363934726|FG001|Randomization|Lost to Follow-up|0|||
105525328|NCT03336216|363934727|FG002|Randomization|Lost to Follow-up|0|||
105525329|NCT03336216|363934728|FG003|Randomization|Lost to Follow-up|0|||
105525330|NCT03336216|363934725|FG000|Randomization|Participant withdrew consent|9|||
105525331|NCT03336216|363934726|FG001|Randomization|Participant withdrew consent|1|||
105525332|NCT03336216|363934727|FG002|Randomization|Participant withdrew consent|0|||
105525333|NCT03336216|363934728|FG003|Randomization|Participant withdrew consent|0|||
105525334|NCT03336216|363934725|FG000|Randomization|Adverse Event|1|||
105525335|NCT03336216|363934726|FG001|Randomization|Adverse Event|1|||
105525336|NCT03336216|363934727|FG002|Randomization|Adverse Event|0|||
105525337|NCT03336216|363934728|FG003|Randomization|Adverse Event|0|||
105525338|NCT03336216|363934725|FG000|Treatment|Adverse Event|2|||
105525339|NCT03336216|363934726|FG001|Treatment|Adverse Event|3|||
105525340|NCT03336216|363934727|FG002|Treatment|Adverse Event|4|||
105525341|NCT03336216|363934728|FG003|Treatment|Adverse Event|4|||
105525342|NCT03336216|363934725|FG000|Treatment|Participant request to discontinue treatment|2|||
105525343|NCT03336216|363934726|FG001|Treatment|Participant request to discontinue treatment|1|||
105525344|NCT03336216|363934727|FG002|Treatment|Participant request to discontinue treatment|2|||
105525345|NCT03336216|363934728|FG003|Treatment|Participant request to discontinue treatment|2|||
105525346|NCT03336216|363934725|FG000|Treatment|Participant withdrew consent|7|||
105525347|NCT03336216|363934726|FG001|Treatment|Participant withdrew consent|2|||
105525348|NCT03336216|363934727|FG002|Treatment|Participant withdrew consent|3|||
105525349|NCT03336216|363934728|FG003|Treatment|Participant withdrew consent|2|||
105525350|NCT03336216|363934725|FG000|Treatment|Death|2|||
105525351|NCT03336216|363934726|FG001|Treatment|Death|3|||
105525352|NCT03336216|363934727|FG002|Treatment|Death|3|||
105525353|NCT03336216|363934728|FG003|Treatment|Death|4|||
105525354|NCT03336216|363934725|FG000|Treatment|Participant no longer meets study criteria|0|||
105525355|NCT03336216|363934726|FG001|Treatment|Participant no longer meets study criteria|1|||
105525356|NCT03336216|363934727|FG002|Treatment|Participant no longer meets study criteria|0|||
105525357|NCT03336216|363934728|FG003|Treatment|Participant no longer meets study criteria|0|||
105525358|NCT03336216|363934725|FG000|Treatment|Other reasons|2|||
105525359|NCT03336216|363934726|FG001|Treatment|Other reasons|0|||
105525360|NCT03336216|363934727|FG002|Treatment|Other reasons|0|||
105525361|NCT03336216|363934728|FG003|Treatment|Other reasons|3|||
105525362|NCT03336216|363934725|FG000|Treatment|Disease progression|23|||
105525363|NCT03336216|363934726|FG001|Treatment|Disease progression|34|||
105525364|NCT03336216|363934727|FG002|Treatment|Disease progression|33|||
105525365|NCT03336216|363934728|FG003|Treatment|Disease progression|26|||
105525366|NCT03336216|363934725|FG000|Treatment|Study drug toxicity|0|||
105525367|NCT03336216|363934726|FG001|Treatment|Study drug toxicity|3|||
105525368|NCT03336216|363934727|FG002|Treatment|Study drug toxicity|2|||
105525369|NCT03336216|363934728|FG003|Treatment|Study drug toxicity|0|||
105525370|NCT03336216|363934725|FG000|Treatment|Adverse Event unrelated to study drug|1|||
105525371|NCT03336216|363934726|FG001|Treatment|Adverse Event unrelated to study drug|1|||
105525372|NCT03336216|363934727|FG002|Treatment|Adverse Event unrelated to study drug|1|||
105525373|NCT03336216|363934728|FG003|Treatment|Adverse Event unrelated to study drug|0|||
105525374|NCT03336216|363934725|FG000|Treatment|Disease Recurrence|1|||
105525375|NCT03336216|363934726|FG001|Treatment|Disease Recurrence|0|||
105525376|NCT03336216|363934727|FG002|Treatment|Disease Recurrence|0|||
105525377|NCT03336216|363934728|FG003|Treatment|Disease Recurrence|0|||
105525378|NCT02474199|363934729|FG000|Overall Study|Lost to Follow-up|1|||
105525379|NCT02474199|363934730|FG001|Overall Study|Lost to Follow-up|0|||
105525380|NCT02474199|363934731|FG002|Overall Study|Lost to Follow-up|0|||
105525381|NCT02474199|363934732|FG003|Overall Study|Lost to Follow-up|0|||
105525382|NCT02474199|363934729|FG000|Overall Study|Withdrawal by Subject|1|||
105525383|NCT02474199|363934730|FG001|Overall Study|Withdrawal by Subject|2|||
105525384|NCT02474199|363934731|FG002|Overall Study|Withdrawal by Subject|0|||
105525385|NCT02474199|363934732|FG003|Overall Study|Withdrawal by Subject|1|||
105525386|NCT02474199|363934729|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
105525387|NCT02474199|363934730|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
105525388|NCT02474199|363934731|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
105525389|NCT02474199|363934732|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
105525390|NCT02474199|363934729|FG000|Overall Study|Did not meet eligibility criteria|0|||
105525391|NCT02474199|363934730|FG001|Overall Study|Did not meet eligibility criteria|0|||
105525392|NCT02474199|363934731|FG002|Overall Study|Did not meet eligibility criteria|2|||
105525393|NCT02474199|363934732|FG003|Overall Study|Did not meet eligibility criteria|2|||
105525394|NCT01660711|363934733|FG000|Overall Study|Adverse Event|7|||
105525395|NCT01660711|363934733|FG000|Overall Study|Withdrawal by Subject|1|||
105525396|NCT03253848|363934734|FG000|Overall Study|Adverse Event|7|||
105525397|NCT03253848|363934734|FG000|Overall Study|Death|5|||
105525398|NCT03253848|363934734|FG000|Overall Study|initiation of other treatments|3|||
105525399|NCT03253848|363934734|FG000|Overall Study|Other complicating disease|1|||
105525400|NCT03253848|363934734|FG000|Overall Study|Withdrawal by Subject|1|||
105525401|NCT03253848|363934734|FG000|Overall Study|Declining health|1|||
105525402|NCT04214288|363934737|FG000|Overall Study|Ongoing in the study|41|||
105525403|NCT04214288|363934738|FG001|Overall Study|Ongoing in the study|51|||
105525404|NCT04214288|363934739|FG002|Overall Study|Ongoing in the study|12|||
105525405|NCT04214288|363934740|FG003|Overall Study|Ongoing in the study|39|||
105525406|NCT04214288|363934737|FG000|Overall Study|Adverse Event|1|||
105525407|NCT04214288|363934738|FG001|Overall Study|Adverse Event|0|||
105525408|NCT04214288|363934739|FG002|Overall Study|Adverse Event|0|||
105525409|NCT04214288|363934740|FG003|Overall Study|Adverse Event|0|||
105525410|NCT04214288|363934737|FG000|Overall Study|Death|22|||
105525411|NCT04214288|363934738|FG001|Overall Study|Death|13|||
105525412|NCT04214288|363934739|FG002|Overall Study|Death|7|||
105525413|NCT04214288|363934740|FG003|Overall Study|Death|19|||
105525414|NCT04214288|363934737|FG000|Overall Study|Lost to Follow-up|1|||
105525415|NCT04214288|363934738|FG001|Overall Study|Lost to Follow-up|2|||
105525416|NCT04214288|363934739|FG002|Overall Study|Lost to Follow-up|1|||
105525417|NCT04214288|363934740|FG003|Overall Study|Lost to Follow-up|0|||
105525418|NCT04214288|363934737|FG000|Overall Study|Other|1|||
105525419|NCT04214288|363934738|FG001|Overall Study|Other|2|||
105525420|NCT04214288|363934739|FG002|Overall Study|Other|0|||
105525421|NCT04214288|363934740|FG003|Overall Study|Other|6|||
105525422|NCT04214288|363934737|FG000|Overall Study|Protocol Violation|0|||
105525423|NCT04214288|363934738|FG001|Overall Study|Protocol Violation|1|||
105525424|NCT04214288|363934739|FG002|Overall Study|Protocol Violation|0|||
105525425|NCT04214288|363934740|FG003|Overall Study|Protocol Violation|0|||
105525426|NCT04214288|363934737|FG000|Overall Study|Withdrawal by Subject|8|||
105525427|NCT04214288|363934738|FG001|Overall Study|Withdrawal by Subject|4|||
105525428|NCT04214288|363934739|FG002|Overall Study|Withdrawal by Subject|0|||
105525429|NCT04214288|363934740|FG003|Overall Study|Withdrawal by Subject|9|||
105525430|NCT00278954|363934741|FG000|Overall Study|Adverse Event|3|||
105525431|NCT00278954|363934741|FG000|Overall Study|Lost to Follow-up|1|||
105525432|NCT00278954|363934741|FG000|Overall Study|Withdrawal by Subject|1|||
105525433|NCT05071183|363934744|FG000|Overall Study|Death|1|||
105525434|NCT05071183|363934745|FG001|Overall Study|Death|2|||
105525435|NCT05071183|363934746|FG002|Overall Study|Death|0|||
105525436|NCT05071183|363934744|FG000|Overall Study|Other Reasons|1|||
105525437|NCT05071183|363934745|FG001|Overall Study|Other Reasons|3|||
105525438|NCT05071183|363934746|FG002|Overall Study|Other Reasons|2|||
105525439|NCT02046148|363934747|FG000|Overall Study|Lost to Follow-up|1|||
105525440|NCT02046148|363934748|FG001|Overall Study|Lost to Follow-up|1|||
105525441|NCT02046148|363934747|FG000|Overall Study|Withdrawal by Subject|0|||
105525442|NCT02046148|363934748|FG001|Overall Study|Withdrawal by Subject|2|||
105525443|NCT03412084|363934761|FG000|Overall Study|Withdrawal by Subject|2|||
105525444|NCT03412084|363934762|FG001|Overall Study|Withdrawal by Subject|0|||
105525445|NCT03412084|363934761|FG000|Overall Study|Participant moved|1|||
105525446|NCT03412084|363934762|FG001|Overall Study|Participant moved|0|||
105525447|NCT03412084|363934761|FG000|Overall Study|Lost to Follow-up|1|||
105525448|NCT03412084|363934762|FG001|Overall Study|Lost to Follow-up|1|||
105525449|NCT01478321|363934767|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
105525450|NCT01478321|363934767|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
105525451|NCT01478321|363934767|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
105525452|NCT01478321|363934767|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
105525453|NCT01478321|363934767|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
105525454|NCT01478321|363934767|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
105525455|NCT01478321|363934767|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
105525456|NCT01478321|363934767|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
105525457|NCT00634088|363934768|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
105525458|NCT00634088|363934769|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
105525459|NCT00634088|363934770|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
105525460|NCT00634088|363934771|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
105525461|NCT00634088|363934768|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
105525462|NCT00634088|363934769|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
105525463|NCT00634088|363934770|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
105525464|NCT00634088|363934771|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
105525465|NCT00634088|363934768|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
105525466|NCT00634088|363934769|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
105525467|NCT00634088|363934770|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
105525468|NCT00634088|363934771|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
105525469|NCT00634088|363934768|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
105525470|NCT00634088|363934769|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
105525471|NCT00634088|363934770|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
105525472|NCT00634088|363934771|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
105525473|NCT00634088|363934768|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
105525474|NCT00634088|363934769|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
105525475|NCT00634088|363934770|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
105525476|NCT00634088|363934771|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
105525477|NCT00634088|363934768|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
105525478|NCT00634088|363934769|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
105525479|NCT00634088|363934770|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
105525480|NCT00634088|363934771|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
105525481|NCT04064294|363934772|FG000|Overall Study|Adverse Event|1|||
105525482|NCT04064294|363934773|FG001|Overall Study|Adverse Event|0|||
105525483|NCT04064294|363934774|FG002|Overall Study|Adverse Event|0|||
105525484|NCT03450707|363934775|FG000|Overall Study|Outside enrollment window|4|||
105525485|NCT03450707|363934776|FG001|Overall Study|Outside enrollment window|1|||
105525486|NCT03450707|363934775|FG000|Overall Study|Death|1|||
105525487|NCT03450707|363934776|FG001|Overall Study|Death|0|||
105592810|NCT03068468|364170763|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
105525488|NCT03450707|363934775|FG000|Overall Study|Indication for thiamine|1|||
105525489|NCT03450707|363934776|FG001|Overall Study|Indication for thiamine|1|||
105525490|NCT03450707|363934775|FG000|Overall Study|Evidence of traumatic brain injury|1|||
105525491|NCT03450707|363934776|FG001|Overall Study|Evidence of traumatic brain injury|0|||
105525492|NCT03450707|363934775|FG000|Overall Study|Following commands|0|||
105525493|NCT03450707|363934776|FG001|Overall Study|Following commands|3|||
105525494|NCT03450707|363934775|FG000|Overall Study|Lactate < 3.5|0|||
105525495|NCT03450707|363934776|FG001|Overall Study|Lactate < 3.5|2|||
105525496|NCT03450707|363934775|FG000|Overall Study|Rearrest with ECMO|0|||
105525497|NCT03450707|363934776|FG001|Overall Study|Rearrest with ECMO|1|||
105525498|NCT03450707|363934775|FG000|Overall Study|Indication for thiamine + head CT results|0|||
105525499|NCT03450707|363934776|FG001|Overall Study|Indication for thiamine + head CT results|1|||
105525500|NCT03450707|363934775|FG000|Overall Study|Family/patient goals of care|0|||
105525501|NCT03450707|363934776|FG001|Overall Study|Family/patient goals of care|1|||
105525502|NCT03343483|363934777|FG000|Overall Study|Death|0|||
105525503|NCT03343483|363934778|FG001|Overall Study|Death|3|||
105525504|NCT03343483|363934777|FG000|Overall Study|Lost to Follow-up|9|||
105525505|NCT03343483|363934778|FG001|Overall Study|Lost to Follow-up|13|||
105525506|NCT03343483|363934777|FG000|Overall Study|Withdrawal by Subject|8|||
105525507|NCT03343483|363934778|FG001|Overall Study|Withdrawal by Subject|17|||
105525508|NCT01505608|363934779|FG000|Phase I|Lack of Efficacy|0|||
105525509|NCT01505608|363934780|FG001|Phase I|Lack of Efficacy|4|||
105525510|NCT01505608|363934779|FG000|Phase I|Adverse Event|0|||
105525511|NCT01505608|363934780|FG001|Phase I|Adverse Event|1|||
105525512|NCT01505608|363934779|FG000|Phase I|Withdrawal by Subject|0|||
105525513|NCT01505608|363934780|FG001|Phase I|Withdrawal by Subject|1|||
105525514|NCT01505608|363934779|FG000|Phase II|Lack of Efficacy|2|||
105525515|NCT01505608|363934780|FG001|Phase II|Lack of Efficacy|1|||
105525516|NCT01505608|363934779|FG000|Phase II|Protocol Violation|0|||
105525517|NCT01505608|363934780|FG001|Phase II|Protocol Violation|1|||
105525518|NCT01520363|363934789|FG000|Overall Study|Withdrawal by Subject|2|||
105525519|NCT01520363|363934790|FG001|Overall Study|Withdrawal by Subject|0|||
105525520|NCT01251380|363934793|FG000|Overall Study|Other (Not otherwise specified)|12|||
105525521|NCT01251380|363934793|FG000|Overall Study|Withdrawal by Subject|6|||
105525522|NCT01251380|363934793|FG000|Overall Study|Lack of Efficacy|1|||
105525523|NCT01251380|363934793|FG000|Overall Study|Adverse Event|1|||
105525524|NCT01251380|363934793|FG000|Overall Study|Lost to Follow-up|2|||
105525525|NCT03792672|363934794|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
105525526|NCT03792672|363934795|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
105525527|NCT03792672|363934796|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
105525528|NCT03792672|363934797|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
105525529|NCT03792672|363934798|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
105525530|NCT03792672|363934799|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
105525531|NCT03792672|363934794|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
105525532|NCT03792672|363934795|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
105525533|NCT03792672|363934796|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
105525534|NCT03792672|363934797|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
105525535|NCT03792672|363934798|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
105525536|NCT03792672|363934799|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
105525537|NCT03792672|363934794|FG000|Treatment Period 4 (2 Days)|Other|1|||
105525538|NCT03792672|363934795|FG001|Treatment Period 4 (2 Days)|Other|0|||
105525539|NCT03792672|363934796|FG002|Treatment Period 4 (2 Days)|Other|0|||
105525540|NCT03792672|363934797|FG003|Treatment Period 4 (2 Days)|Other|0|||
105525541|NCT03792672|363934798|FG004|Treatment Period 4 (2 Days)|Other|0|||
105525542|NCT03792672|363934799|FG005|Treatment Period 4 (2 Days)|Other|0|||
105525543|NCT01498952|363934807|FG000|Overall Study|Death|2|||
105525544|NCT01498952|363934808|FG001|Overall Study|Death|2|||
105525545|NCT01498952|363934809|FG002|Overall Study|Death|0|||
105525546|NCT01498952|363934810|FG003|Overall Study|Death|0|||
105525547|NCT01498952|363934811|FG004|Overall Study|Death|0|||
105525548|NCT00579826|363934814|FG000|Overall Study|Withdrawal by Subject|5|||
105525549|NCT00579826|363934815|FG001|Overall Study|Withdrawal by Subject|3|||
105525550|NCT02968979|363934818|FG000|Overall Study|Protocol Violation|7|||
105525551|NCT02968979|363934818|FG000|Overall Study|Withdrawal by Subject|1|||
105525552|NCT01471379|363934819|FG000|Overall Study|Adverse Event|1|||
105525553|NCT01471379|363934820|FG001|Overall Study|Adverse Event|0|||
105525554|NCT01471379|363934821|FG002|Overall Study|Adverse Event|0|||
105525555|NCT01471379|363934819|FG000|Overall Study|Study terminated|0|||
105525556|NCT01471379|363934820|FG001|Overall Study|Study terminated|1|||
105525557|NCT01471379|363934821|FG002|Overall Study|Study terminated|0|||
105525558|NCT00352846|363934824|FG000|Overall Study|Disease progression|0|||
105525559|NCT00352846|363934825|FG001|Overall Study|Disease progression|2|||
105525560|NCT00352846|363934824|FG000|Overall Study|Withdrawal by Subject|3|||
105525561|NCT00352846|363934825|FG001|Overall Study|Withdrawal by Subject|8|||
105525562|NCT00352846|363934824|FG000|Overall Study|Ineligible|3|||
105525563|NCT00352846|363934825|FG001|Overall Study|Ineligible|2|||
105525564|NCT00352846|363934824|FG000|Overall Study|Non-compliance|2|||
105525565|NCT00352846|363934825|FG001|Overall Study|Non-compliance|0|||
105525566|NCT00352846|363934824|FG000|Overall Study|Death|0|||
105525567|NCT00352846|363934825|FG001|Overall Study|Death|1|||
105525568|NCT00729183|363934826|FG000|Overall Study|Adverse Event|11|||
105525569|NCT00729183|363934827|FG001|Overall Study|Adverse Event|5|||
105525570|NCT00729183|363934826|FG000|Overall Study|Lack of Efficacy|0|||
105525571|NCT00729183|363934827|FG001|Overall Study|Lack of Efficacy|1|||
105525572|NCT00729183|363934826|FG000|Overall Study|Lost to Follow-up|3|||
105525573|NCT00729183|363934827|FG001|Overall Study|Lost to Follow-up|1|||
105525574|NCT00729183|363934826|FG000|Overall Study|Physician Decision|1|||
105525575|NCT00729183|363934827|FG001|Overall Study|Physician Decision|1|||
105525576|NCT00729183|363934826|FG000|Overall Study|Protocol Violation|1|||
105525577|NCT00729183|363934827|FG001|Overall Study|Protocol Violation|0|||
105525578|NCT00729183|363934826|FG000|Overall Study|Withdrawal by Subject|9|||
105525579|NCT00729183|363934827|FG001|Overall Study|Withdrawal by Subject|7|||
105525580|NCT02466555|363934828|FG000|Overall Study|Lost to Follow-up|2|||
105525581|NCT01527682|363934835|FG000|Overall Study|Protocol Violation|8|||
105525582|NCT01120756|363934836|FG000|Overall Study|Withdrawal by Subject|1|||
105525583|NCT01120756|363934837|FG001|Overall Study|Withdrawal by Subject|1|||
105525584|NCT00896337|363934838|FG000|Overall Study|Death|7|||
105525585|NCT00896337|363934838|FG000|Overall Study|Withdrawal by Subject|7|||
105525586|NCT00896337|363934838|FG000|Overall Study|Lost to Follow-up|11|||
105525587|NCT04668950|363934839|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
105525588|NCT04668950|363934840|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
105525589|NCT04668950|363934839|FG000|Overall Study|Could not confirm started study medication|15|||
105525590|NCT04668950|363934840|FG001|Overall Study|Could not confirm started study medication|15|||
105525591|NCT04668950|363934839|FG000|Overall Study|Could not confirm baseline status|6|||
105525592|NCT04668950|363934840|FG001|Overall Study|Could not confirm baseline status|2|||
105525593|NCT04668950|363934839|FG000|Overall Study|Drop out and did not start medication|15|||
105525594|NCT04668950|363934840|FG001|Overall Study|Drop out and did not start medication|17|||
105525595|NCT04668950|363934839|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
105525596|NCT04668950|363934840|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
105525597|NCT04668950|363934839|FG000|Overall Study|Other|2|||
105525598|NCT04668950|363934840|FG001|Overall Study|Other|4|||
105525599|NCT00747435|363934844|FG000|Overall Study|Lost to Follow-up|2|||
105525600|NCT00747435|363934844|FG000|Overall Study|Withdrawal by Subject|3|||
105525601|NCT00747435|363934844|FG000|Overall Study|Still undergoing follow up|1|||
105525602|NCT00006478|363936106|FG000|Overall Study|Vaccine could not be produced|1|||
105525603|NCT00006478|363936106|FG000|Overall Study|Physician Decision|6|||
105525604|NCT03161483|363936107|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
105525605|NCT03161483|363936108|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
105525606|NCT03161483|363936109|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
105525607|NCT03161483|363936110|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
105525608|NCT03161483|363936107|FG000|Treatment Period|Death|1|||
105525609|NCT03161483|363936108|FG001|Treatment Period|Death|0|||
105525610|NCT03161483|363936109|FG002|Treatment Period|Death|0|||
105525611|NCT03161483|363936110|FG003|Treatment Period|Death|0|||
105525612|NCT03161483|363936107|FG000|Treatment Period|Adverse Event|5|||
105525613|NCT03161483|363936108|FG001|Treatment Period|Adverse Event|2|||
105525614|NCT03161483|363936109|FG002|Treatment Period|Adverse Event|1|||
105525615|NCT03161483|363936110|FG003|Treatment Period|Adverse Event|11|||
105525616|NCT03161483|363936107|FG000|Treatment Period|Pregnancy|1|||
105525617|NCT03161483|363936108|FG001|Treatment Period|Pregnancy|0|||
105525618|NCT03161483|363936109|FG002|Treatment Period|Pregnancy|0|||
105525619|NCT03161483|363936110|FG003|Treatment Period|Pregnancy|0|||
105525620|NCT03161483|363936107|FG000|Treatment Period|Lack of Efficacy|0|||
105525621|NCT03161483|363936108|FG001|Treatment Period|Lack of Efficacy|0|||
105525622|NCT03161483|363936109|FG002|Treatment Period|Lack of Efficacy|0|||
105525623|NCT03161483|363936110|FG003|Treatment Period|Lack of Efficacy|1|||
105525624|NCT03161483|363936107|FG000|Treatment Period|Withdrawal by Subject|2|||
105525625|NCT03161483|363936108|FG001|Treatment Period|Withdrawal by Subject|5|||
105525626|NCT03161483|363936109|FG002|Treatment Period|Withdrawal by Subject|2|||
105525627|NCT03161483|363936110|FG003|Treatment Period|Withdrawal by Subject|6|||
105525628|NCT03161483|363936107|FG000|Treatment Period|Lost to Follow-up|0|||
105525629|NCT03161483|363936108|FG001|Treatment Period|Lost to Follow-up|0|||
105525630|NCT03161483|363936109|FG002|Treatment Period|Lost to Follow-up|0|||
105525631|NCT03161483|363936110|FG003|Treatment Period|Lost to Follow-up|1|||
105525632|NCT03161483|363936107|FG000|Treatment Period|Protocol Violation|0|||
105525633|NCT03161483|363936108|FG001|Treatment Period|Protocol Violation|0|||
105525634|NCT03161483|363936109|FG002|Treatment Period|Protocol Violation|0|||
105525635|NCT03161483|363936110|FG003|Treatment Period|Protocol Violation|1|||
105525636|NCT03161483|363936107|FG000|Treatment Period|Other reasons|1|||
105525637|NCT03161483|363936108|FG001|Treatment Period|Other reasons|1|||
105525638|NCT03161483|363936109|FG002|Treatment Period|Other reasons|0|||
105525639|NCT03161483|363936110|FG003|Treatment Period|Other reasons|0|||
105525640|NCT03261947|363936112|FG000|Overall Study|Death|10|||
105525641|NCT03261947|363936113|FG001|Overall Study|Death|13|||
105525642|NCT03261947|363936114|FG002|Overall Study|Death|17|||
105525643|NCT03261947|363936115|FG003|Overall Study|Death|12|||
105525644|NCT03261947|363936116|FG004|Overall Study|Death|8|||
105525645|NCT03261947|363936112|FG000|Overall Study|Lost to Follow-up|0|||
105525646|NCT03261947|363936113|FG001|Overall Study|Lost to Follow-up|0|||
105525647|NCT03261947|363936114|FG002|Overall Study|Lost to Follow-up|2|||
105525648|NCT03261947|363936115|FG003|Overall Study|Lost to Follow-up|1|||
105525649|NCT03261947|363936116|FG004|Overall Study|Lost to Follow-up|0|||
105525650|NCT03261947|363936112|FG000|Overall Study|Withdrawal by Subject|0|||
105525651|NCT03261947|363936113|FG001|Overall Study|Withdrawal by Subject|0|||
105525652|NCT03261947|363936114|FG002|Overall Study|Withdrawal by Subject|3|||
105525653|NCT03261947|363936115|FG003|Overall Study|Withdrawal by Subject|0|||
105525654|NCT03261947|363936116|FG004|Overall Study|Withdrawal by Subject|1|||
105525655|NCT03261947|363936112|FG000|Overall Study|Site Terminated by Sponsor|0|||
105525656|NCT03261947|363936113|FG001|Overall Study|Site Terminated by Sponsor|0|||
105525657|NCT03261947|363936114|FG002|Overall Study|Site Terminated by Sponsor|4|||
105525658|NCT03261947|363936115|FG003|Overall Study|Site Terminated by Sponsor|7|||
105525659|NCT03261947|363936116|FG004|Overall Study|Site Terminated by Sponsor|5|||
105525660|NCT03261947|363936112|FG000|Overall Study|Reason not Specified|2|||
105525661|NCT03261947|363936113|FG001|Overall Study|Reason not Specified|0|||
105525662|NCT03261947|363936114|FG002|Overall Study|Reason not Specified|4|||
105525663|NCT03261947|363936115|FG003|Overall Study|Reason not Specified|1|||
105525664|NCT03261947|363936116|FG004|Overall Study|Reason not Specified|3|||
105525665|NCT00228917|363936117|FG000|Overall Study|Migrated/moved from study area|0|||
105525666|NCT00228917|363936118|FG001|Overall Study|Migrated/moved from study area|0|||
105525667|NCT00228917|363936119|FG002|Overall Study|Migrated/moved from study area|0|||
105525668|NCT00228917|363936120|FG003|Overall Study|Migrated/moved from study area|0|||
105525669|NCT00228917|363936121|FG004|Overall Study|Migrated/moved from study area|0|||
105525670|NCT00228917|363936122|FG005|Overall Study|Migrated/moved from study area|2|||
105525671|NCT00228917|363936123|FG006|Overall Study|Migrated/moved from study area|0|||
105525672|NCT00228917|363936124|FG007|Overall Study|Migrated/moved from study area|0|||
105525673|NCT00409617|363936125|FG000|Overall Study|Adverse Event|57|||
105525674|NCT00409617|363936125|FG000|Overall Study|Lack of Efficacy|54|||
105525675|NCT00409617|363936125|FG000|Overall Study|Lost to Follow-up|2|||
105525676|NCT00409617|363936125|FG000|Overall Study|Protocol Violation|24|||
105525677|NCT00409617|363936125|FG000|Overall Study|Withdrawal by Subject|8|||
105525678|NCT00409617|363936125|FG000|Overall Study|Administrative reasons|1|||
105525679|NCT00409617|363936125|FG000|Overall Study|Not described|14|||
105525680|NCT02063737|363936127|FG000|Overall Study|Lost to Follow-up|11|||
105525681|NCT02063737|363936128|FG001|Overall Study|Lost to Follow-up|4|||
105525682|NCT00149747|363936129|FG000|Overall Study|Death|1|||
105525683|NCT00149747|363936130|FG001|Overall Study|Death|0|||
105525684|NCT00149747|363936129|FG000|Overall Study|Withdrawal by Subject|3|||
105525685|NCT00149747|363936130|FG001|Overall Study|Withdrawal by Subject|3|||
105525686|NCT03373383|363936131|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
105525687|NCT03373383|363936132|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
105525688|NCT03373383|363936133|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
105525689|NCT03373383|363936134|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
105525690|NCT03373383|363936135|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
105525691|NCT03373383|363936131|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
105525692|NCT03373383|363936132|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
105525693|NCT03373383|363936133|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
105525694|NCT03373383|363936134|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
105525695|NCT03373383|363936135|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
105525696|NCT03373383|363936131|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
105525697|NCT03373383|363936132|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
105525698|NCT03373383|363936133|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
105525699|NCT03373383|363936134|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
105525700|NCT03373383|363936135|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
105525701|NCT03373383|363936131|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
105525702|NCT03373383|363936132|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
105525703|NCT03373383|363936133|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
105525704|NCT03373383|363936134|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
105525705|NCT03373383|363936135|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
105525706|NCT03373383|363936131|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
105525707|NCT03373383|363936132|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
105525708|NCT03373383|363936133|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
105525709|NCT03373383|363936134|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
105525710|NCT03373383|363936135|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
105525711|NCT03373383|363936131|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
105525712|NCT03373383|363936132|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
105525713|NCT03373383|363936133|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
105525714|NCT03373383|363936134|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
105525715|NCT03373383|363936135|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
105525716|NCT03373383|363936131|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
105525717|NCT03373383|363936132|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
105525718|NCT03373383|363936133|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
105525719|NCT03373383|363936134|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
105525720|NCT03373383|363936135|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
105525721|NCT03373383|363936131|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
105525722|NCT03373383|363936132|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
105525723|NCT03373383|363936133|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
105525724|NCT03373383|363936134|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
105525725|NCT03373383|363936135|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
105525726|NCT03373383|363936131|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
105525727|NCT03373383|363936132|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
105525728|NCT03373383|363936133|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
105525729|NCT03373383|363936134|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
105525730|NCT03373383|363936135|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
105525731|NCT02871739|363936137|FG000|Overall Study|Lost to Follow-up|3|||
105525732|NCT02871739|363936138|FG001|Overall Study|Lost to Follow-up|2|||
105525733|NCT02871739|363936139|FG002|Overall Study|Lost to Follow-up|0|||
105525734|NCT02871739|363936140|FG003|Overall Study|Lost to Follow-up|2|||
105525735|NCT03316885|363936141|FG000|Overall Study|Adverse Event|1|||
105525736|NCT03316885|363936141|FG000|Overall Study|Death|10|||
105525737|NCT03316885|363936141|FG000|Overall Study|Lost to Follow-up|4|||
105525738|NCT03316885|363936141|FG000|Overall Study|Withdrawal by Subject|9|||
105525739|NCT03316885|363936141|FG000|Overall Study|COVID related|8|||
105525740|NCT00978068|363936148|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
105525741|NCT00978068|363936149|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
105525742|NCT00978068|363936148|FG000|Overall Study|Death|1|||
105525743|NCT00978068|363936149|FG001|Overall Study|Death|2|||
105525744|NCT00978068|363936148|FG000|Overall Study|Lost to Follow-up|1|||
105525745|NCT00978068|363936149|FG001|Overall Study|Lost to Follow-up|2|||
105525746|NCT00978068|363936148|FG000|Overall Study|Physician Decision|0|||
105525747|NCT00978068|363936149|FG001|Overall Study|Physician Decision|1|||
105525748|NCT00978068|363936148|FG000|Overall Study|Unable to Comply with Study|0|||
105525749|NCT00978068|363936149|FG001|Overall Study|Unable to Comply with Study|2|||
105525750|NCT03560531|363936150|FG000|Overall Study|Death|4|||
105525751|NCT03560531|363936151|FG001|Overall Study|Death|1|||
105525752|NCT03560531|363936152|FG002|Overall Study|Death|1|||
105525753|NCT03560531|363936153|FG003|Overall Study|Death|2|||
105525754|NCT03560531|363936154|FG004|Overall Study|Death|6|||
105525755|NCT03560531|363936155|FG005|Overall Study|Death|1|||
105525756|NCT03560531|363936156|FG006|Overall Study|Death|4|||
105525757|NCT03560531|363936157|FG007|Overall Study|Death|8|||
105525758|NCT03560531|363936158|FG008|Overall Study|Death|1|||
105525759|NCT03560531|363936159|FG009|Overall Study|Death|3|||
105525760|NCT03560531|363936160|FG010|Overall Study|Death|2|||
105525761|NCT03560531|363936161|FG011|Overall Study|Death|0|||
105525762|NCT03560531|363936162|FG012|Overall Study|Death|4|||
105525763|NCT03560531|363936163|FG013|Overall Study|Death|1|||
105525764|NCT03560531|363936150|FG000|Overall Study|Lost to Follow-up|1|||
105525765|NCT03560531|363936151|FG001|Overall Study|Lost to Follow-up|1|||
105525766|NCT03560531|363936152|FG002|Overall Study|Lost to Follow-up|0|||
105525767|NCT03560531|363936153|FG003|Overall Study|Lost to Follow-up|0|||
105525768|NCT03560531|363936154|FG004|Overall Study|Lost to Follow-up|0|||
105525769|NCT03560531|363936155|FG005|Overall Study|Lost to Follow-up|0|||
105525770|NCT03560531|363936156|FG006|Overall Study|Lost to Follow-up|1|||
105525771|NCT03560531|363936157|FG007|Overall Study|Lost to Follow-up|0|||
105525772|NCT03560531|363936158|FG008|Overall Study|Lost to Follow-up|0|||
105525773|NCT03560531|363936159|FG009|Overall Study|Lost to Follow-up|0|||
105525774|NCT03560531|363936160|FG010|Overall Study|Lost to Follow-up|0|||
105525775|NCT03560531|363936161|FG011|Overall Study|Lost to Follow-up|0|||
105525776|NCT03560531|363936162|FG012|Overall Study|Lost to Follow-up|0|||
105525777|NCT03560531|363936163|FG013|Overall Study|Lost to Follow-up|0|||
105525778|NCT03560531|363936150|FG000|Overall Study|Withdrawal by Subject|1|||
105525779|NCT03560531|363936151|FG001|Overall Study|Withdrawal by Subject|0|||
105525780|NCT03560531|363936152|FG002|Overall Study|Withdrawal by Subject|0|||
105525781|NCT03560531|363936153|FG003|Overall Study|Withdrawal by Subject|0|||
105525782|NCT03560531|363936154|FG004|Overall Study|Withdrawal by Subject|0|||
105525783|NCT03560531|363936155|FG005|Overall Study|Withdrawal by Subject|0|||
105525784|NCT03560531|363936156|FG006|Overall Study|Withdrawal by Subject|0|||
105525785|NCT03560531|363936157|FG007|Overall Study|Withdrawal by Subject|3|||
105525786|NCT03560531|363936158|FG008|Overall Study|Withdrawal by Subject|2|||
105525787|NCT03560531|363936159|FG009|Overall Study|Withdrawal by Subject|0|||
105592811|NCT03068468|364170764|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
105525788|NCT03560531|363936160|FG010|Overall Study|Withdrawal by Subject|0|||
105525789|NCT03560531|363936161|FG011|Overall Study|Withdrawal by Subject|0|||
105525790|NCT03560531|363936162|FG012|Overall Study|Withdrawal by Subject|2|||
105525791|NCT03560531|363936163|FG013|Overall Study|Withdrawal by Subject|0|||
105525792|NCT03560531|363936150|FG000|Overall Study|Study end per-protocol|1|||
105525793|NCT03560531|363936151|FG001|Overall Study|Study end per-protocol|1|||
105525794|NCT03560531|363936152|FG002|Overall Study|Study end per-protocol|2|||
105525795|NCT03560531|363936153|FG003|Overall Study|Study end per-protocol|0|||
105525796|NCT03560531|363936154|FG004|Overall Study|Study end per-protocol|1|||
105525797|NCT03560531|363936155|FG005|Overall Study|Study end per-protocol|0|||
105525798|NCT03560531|363936156|FG006|Overall Study|Study end per-protocol|0|||
105525799|NCT03560531|363936157|FG007|Overall Study|Study end per-protocol|0|||
105525800|NCT03560531|363936158|FG008|Overall Study|Study end per-protocol|0|||
105525801|NCT03560531|363936159|FG009|Overall Study|Study end per-protocol|0|||
105525802|NCT03560531|363936160|FG010|Overall Study|Study end per-protocol|0|||
105525803|NCT03560531|363936161|FG011|Overall Study|Study end per-protocol|0|||
105525804|NCT03560531|363936162|FG012|Overall Study|Study end per-protocol|0|||
105525805|NCT03560531|363936163|FG013|Overall Study|Study end per-protocol|0|||
105525806|NCT03560531|363936150|FG000|Overall Study|Early study termination by sponsor|9|||
105525807|NCT03560531|363936151|FG001|Overall Study|Early study termination by sponsor|0|||
105525808|NCT03560531|363936152|FG002|Overall Study|Early study termination by sponsor|0|||
105525809|NCT03560531|363936153|FG003|Overall Study|Early study termination by sponsor|4|||
105525810|NCT03560531|363936154|FG004|Overall Study|Early study termination by sponsor|8|||
105525811|NCT03560531|363936155|FG005|Overall Study|Early study termination by sponsor|2|||
105525812|NCT03560531|363936156|FG006|Overall Study|Early study termination by sponsor|5|||
105525813|NCT03560531|363936157|FG007|Overall Study|Early study termination by sponsor|64|||
105525814|NCT03560531|363936158|FG008|Overall Study|Early study termination by sponsor|7|||
105525815|NCT03560531|363936159|FG009|Overall Study|Early study termination by sponsor|2|||
105525816|NCT03560531|363936160|FG010|Overall Study|Early study termination by sponsor|16|||
105525817|NCT03560531|363936161|FG011|Overall Study|Early study termination by sponsor|2|||
105525818|NCT03560531|363936162|FG012|Overall Study|Early study termination by sponsor|6|||
105525819|NCT03560531|363936163|FG013|Overall Study|Early study termination by sponsor|2|||
105525820|NCT01165138|363936164|FG000|Overall Study|Adverse Event|0|||
105525821|NCT01165138|363936165|FG001|Overall Study|Adverse Event|1|||
105525822|NCT01165138|363936166|FG002|Overall Study|Adverse Event|0|||
105525823|NCT01165138|363936167|FG003|Overall Study|Adverse Event|2|||
105525824|NCT01165138|363936164|FG000|Overall Study|Lack of Efficacy|0|||
105525825|NCT01165138|363936165|FG001|Overall Study|Lack of Efficacy|32|||
105525826|NCT01165138|363936166|FG002|Overall Study|Lack of Efficacy|6|||
105525827|NCT01165138|363936167|FG003|Overall Study|Lack of Efficacy|7|||
105525828|NCT01165138|363936164|FG000|Overall Study|Protocol Violation|0|||
105525829|NCT01165138|363936165|FG001|Overall Study|Protocol Violation|7|||
105525830|NCT01165138|363936166|FG002|Overall Study|Protocol Violation|0|||
105525831|NCT01165138|363936167|FG003|Overall Study|Protocol Violation|2|||
105525832|NCT01165138|363936164|FG000|Overall Study|Lost to Follow-up|0|||
105525833|NCT01165138|363936165|FG001|Overall Study|Lost to Follow-up|0|||
105525834|NCT01165138|363936166|FG002|Overall Study|Lost to Follow-up|1|||
105525835|NCT01165138|363936167|FG003|Overall Study|Lost to Follow-up|2|||
105525836|NCT01165138|363936164|FG000|Overall Study|Physician Decision|0|||
105525837|NCT01165138|363936165|FG001|Overall Study|Physician Decision|6|||
105525838|NCT01165138|363936166|FG002|Overall Study|Physician Decision|7|||
105525839|NCT01165138|363936167|FG003|Overall Study|Physician Decision|6|||
105525840|NCT01165138|363936164|FG000|Overall Study|Withdrawal by Subject|0|||
105525841|NCT01165138|363936165|FG001|Overall Study|Withdrawal by Subject|6|||
105525842|NCT01165138|363936166|FG002|Overall Study|Withdrawal by Subject|6|||
105525843|NCT01165138|363936167|FG003|Overall Study|Withdrawal by Subject|3|||
105525844|NCT04964128|363936168|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
105525845|NCT04964128|363936168|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
105525846|NCT02120794|363936169|FG000|Overall Study|Withdrawal by Subject|43|||
105525847|NCT02120794|363936169|FG000|Overall Study|Adverse Event|10|||
105525848|NCT02120794|363936169|FG000|Overall Study|Physician Decision|4|||
105525849|NCT02120794|363936169|FG000|Overall Study|Due to insurance coverage|1|||
105525850|NCT01148511|363936171|FG000|Exposed to Study Drug|Protocol Violation|2|||
105525851|NCT01148511|363936172|FG001|Exposed to Study Drug|Protocol Violation|0|||
105525852|NCT01148511|363936173|FG002|Exposed to Study Drug|Protocol Violation|0|||
105525853|NCT01148511|363936171|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
105525854|NCT01148511|363936172|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
105525855|NCT01148511|363936173|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
105525856|NCT01148511|363936171|FG000|Randomized|Adverse Event|0|||
105525857|NCT01148511|363936172|FG001|Randomized|Adverse Event|1|||
105525858|NCT01148511|363936173|FG002|Randomized|Adverse Event|0|||
105525859|NCT01148511|363936171|FG000|Randomized|Protocol Violation|0|||
105525860|NCT01148511|363936172|FG001|Randomized|Protocol Violation|2|||
105525861|NCT01148511|363936173|FG002|Randomized|Protocol Violation|1|||
105438923|NCT03100058|363613384|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105438924|NCT03100058|363613372|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105438925|NCT03100058|363613373|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
105438926|NCT03100058|363613374|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105438927|NCT03100058|363613375|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105438928|NCT03100058|363613376|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105438929|NCT03100058|363613377|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105438930|NCT03100058|363613378|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105438931|NCT03100058|363613379|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105525862|NCT01148511|363936171|FG000|Randomized|Lost to Follow-up|0|||
105525863|NCT01148511|363936172|FG001|Randomized|Lost to Follow-up|1|||
105525864|NCT01148511|363936173|FG002|Randomized|Lost to Follow-up|1|||
105525865|NCT01148511|363936171|FG000|Randomized|Consent withdrawal|0|||
105525866|NCT01148511|363936172|FG001|Randomized|Consent withdrawal|5|||
105525867|NCT01148511|363936173|FG002|Randomized|Consent withdrawal|3|||
105525868|NCT01148511|363936171|FG000|Randomized|Other|0|||
105525869|NCT01148511|363936172|FG001|Randomized|Other|1|||
105525870|NCT01148511|363936173|FG002|Randomized|Other|1|||
105438932|NCT03100058|363613380|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105438933|NCT03100058|363613381|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105438934|NCT03100058|363613382|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105438935|NCT03100058|363613383|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105438936|NCT03100058|363613384|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105438937|NCT03100058|363613372|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
105438938|NCT03100058|363613373|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105438939|NCT03100058|363613374|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105438940|NCT03100058|363613375|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105438941|NCT03100058|363613376|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105438942|NCT03100058|363613377|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105438943|NCT03100058|363613378|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105438944|NCT03100058|363613379|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105438945|NCT03100058|363613380|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105438946|NCT03100058|363613381|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105438947|NCT03100058|363613382|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105438948|NCT03100058|363613383|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105438949|NCT03100058|363613384|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105438950|NCT03100058|363613372|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105438951|NCT03100058|363613373|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105438952|NCT03100058|363613374|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105438953|NCT03100058|363613375|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105438954|NCT03100058|363613376|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105438955|NCT03100058|363613377|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105438956|NCT03100058|363613378|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
105438957|NCT03100058|363613379|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105438958|NCT03100058|363613380|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105438959|NCT03100058|363613381|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105438960|NCT03100058|363613382|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105438961|NCT03100058|363613383|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105438962|NCT03100058|363613384|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105438963|NCT03100058|363613372|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105438964|NCT03100058|363613373|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105438965|NCT03100058|363613374|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105438966|NCT03100058|363613375|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105438967|NCT03100058|363613376|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105438968|NCT03100058|363613377|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105438969|NCT03100058|363613378|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105438970|NCT03100058|363613379|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105438971|NCT03100058|363613380|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105438972|NCT03100058|363613381|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105438973|NCT03100058|363613382|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
105438974|NCT03100058|363613383|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
105438975|NCT03100058|363613384|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
105438976|NCT03100058|363613372|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105438977|NCT03100058|363613373|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105438978|NCT03100058|363613374|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105438979|NCT03100058|363613375|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105438980|NCT03100058|363613376|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105438981|NCT03100058|363613377|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105438982|NCT03100058|363613378|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105438983|NCT03100058|363613379|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105438984|NCT03100058|363613380|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105438985|NCT03100058|363613381|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105438986|NCT03100058|363613382|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
105438987|NCT03100058|363613383|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
105438988|NCT03100058|363613384|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105438989|NCT03100058|363613372|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105438990|NCT03100058|363613373|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105438991|NCT03100058|363613374|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105438992|NCT03100058|363613375|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105438993|NCT03100058|363613376|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105438994|NCT03100058|363613377|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105438995|NCT03100058|363613378|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105438996|NCT03100058|363613379|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105525871|NCT01200797|363936176|FG000|Overall Study|symptomatic deterioration|2|||
105525872|NCT01200797|363936176|FG000|Overall Study|Adverse Event|4|||
105525873|NCT01200797|363936176|FG000|Overall Study|Disease Progression|13|||
105525874|NCT03608774|363936177|FG000|Overall Study|Lost to Follow-up|5|||
105525875|NCT03608774|363936178|FG001|Overall Study|Lost to Follow-up|5|||
105525876|NCT03608774|363936177|FG000|Overall Study|Withdrawal by Subject|1|||
105525877|NCT03608774|363936178|FG001|Overall Study|Withdrawal by Subject|0|||
105525878|NCT03608774|363936177|FG000|Overall Study|Protocol Violation|1|||
105525879|NCT03608774|363936178|FG001|Overall Study|Protocol Violation|0|||
105525880|NCT03608774|363936177|FG000|Overall Study|Not eligible at enrollment|0|||
105525881|NCT03608774|363936178|FG001|Overall Study|Not eligible at enrollment|1|||
105525882|NCT03608774|363936177|FG000|Overall Study|Health related event|0|||
105525883|NCT03608774|363936178|FG001|Overall Study|Health related event|1|||
105525884|NCT01586819|363936179|FG000|Overall Study|Withdrawal by Subject|1|||
105525885|NCT01586819|363936180|FG001|Overall Study|Withdrawal by Subject|0|||
105525886|NCT01359254|363936181|FG000|Overall Study|Death|1|||
105525887|NCT01359254|363936182|FG001|Overall Study|Death|0|||
105525888|NCT03979638|363936186|FG000|Period 1|Physician Decision|1|||
105525889|NCT03979638|363936187|FG001|Period 1|Physician Decision|1|||
105525890|NCT03979638|363936186|FG000|Period 1|Withdrawal by Subject|4|||
105525891|NCT03979638|363936187|FG001|Period 1|Withdrawal by Subject|3|||
105525892|NCT03979638|363936186|FG000|Period 1|Study terminated by Sponsor|1|||
105525893|NCT03979638|363936187|FG001|Period 1|Study terminated by Sponsor|3|||
105525894|NCT03979638|363936186|FG000|Period 1|Protocol Violation|1|||
105525895|NCT03979638|363936187|FG001|Period 1|Protocol Violation|0|||
105525896|NCT03979638|363936186|FG000|Period 2|Study terminated by Sponsor|1|||
105525897|NCT03979638|363936187|FG001|Period 2|Study terminated by Sponsor|1|||
105525898|NCT00578942|363936191|FG000|Overall Study|Lost to Follow-up|1|||
105525899|NCT00600938|363936194|FG000|Core Study|Abnormal test procedure result(s)|3|||
105525900|NCT00600938|363936195|FG001|Core Study|Abnormal test procedure result(s)|2|||
105525901|NCT00600938|363936196|FG002|Core Study|Abnormal test procedure result(s)|0|||
105525902|NCT00600938|363936197|FG003|Core Study|Abnormal test procedure result(s)|0|||
105525903|NCT00600938|363936194|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
105525904|NCT00600938|363936195|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
105525905|NCT00600938|363936196|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
105525906|NCT00600938|363936197|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
105525907|NCT00600938|363936194|FG000|Core Study|Patient withdrew consent|7|||
105525908|NCT00600938|363936195|FG001|Core Study|Patient withdrew consent|12|||
105525909|NCT00600938|363936196|FG002|Core Study|Patient withdrew consent|0|||
105525910|NCT00600938|363936197|FG003|Core Study|Patient withdrew consent|0|||
105525911|NCT00600938|363936194|FG000|Core Study|Lost to Follow-up|3|||
105525912|NCT00600938|363936195|FG001|Core Study|Lost to Follow-up|2|||
105525913|NCT00600938|363936196|FG002|Core Study|Lost to Follow-up|0|||
105525914|NCT00600938|363936197|FG003|Core Study|Lost to Follow-up|0|||
105525915|NCT00600938|363936194|FG000|Core Study|Death|1|||
105525916|NCT00600938|363936195|FG001|Core Study|Death|1|||
105525917|NCT00600938|363936196|FG002|Core Study|Death|0|||
105525918|NCT00600938|363936197|FG003|Core Study|Death|0|||
105525919|NCT00600938|363936194|FG000|Core Study|Protocol Violation|1|||
105525920|NCT00600938|363936195|FG001|Core Study|Protocol Violation|2|||
105525921|NCT00600938|363936196|FG002|Core Study|Protocol Violation|0|||
105525922|NCT00600938|363936197|FG003|Core Study|Protocol Violation|0|||
105525923|NCT00600938|363936194|FG000|Extension Study|Adverse Event|1|||
105525924|NCT00600938|363936195|FG001|Extension Study|Adverse Event|0|||
105525925|NCT00600938|363936196|FG002|Extension Study|Adverse Event|2|||
105525926|NCT00600938|363936197|FG003|Extension Study|Adverse Event|0|||
105525927|NCT00600938|363936194|FG000|Extension Study|Abnormal test procedure results|0|||
105525928|NCT00600938|363936195|FG001|Extension Study|Abnormal test procedure results|1|||
105525929|NCT00600938|363936196|FG002|Extension Study|Abnormal test procedure results|1|||
105525930|NCT00600938|363936197|FG003|Extension Study|Abnormal test procedure results|1|||
105525931|NCT00600938|363936194|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
105525932|NCT00600938|363936195|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
105525933|NCT00600938|363936196|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
105525934|NCT00600938|363936197|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
105525935|NCT00600938|363936194|FG000|Extension Study|Withdrawal by Subject|2|||
105525936|NCT00600938|363936195|FG001|Extension Study|Withdrawal by Subject|2|||
105525937|NCT00600938|363936196|FG002|Extension Study|Withdrawal by Subject|3|||
105525938|NCT00600938|363936197|FG003|Extension Study|Withdrawal by Subject|0|||
105525939|NCT00600938|363936194|FG000|Extension Study|Lost to Follow-up|1|||
105525940|NCT00600938|363936195|FG001|Extension Study|Lost to Follow-up|1|||
105525941|NCT00600938|363936196|FG002|Extension Study|Lost to Follow-up|2|||
105525942|NCT00600938|363936197|FG003|Extension Study|Lost to Follow-up|0|||
105525943|NCT00600938|363936194|FG000|Extension Study|Death|1|||
105525944|NCT00600938|363936195|FG001|Extension Study|Death|0|||
105525945|NCT00600938|363936196|FG002|Extension Study|Death|0|||
105525946|NCT00600938|363936197|FG003|Extension Study|Death|0|||
105525947|NCT01124643|363936200|FG000|Overall Study|Death|1|||
105525948|NCT04220411|363936201|FG000|Overall Study|Adverse Event|0|||
105525949|NCT04220411|363936202|FG001|Overall Study|Adverse Event|0|||
105525950|NCT04220411|363936203|FG002|Overall Study|Adverse Event|0|||
105525951|NCT04220411|363936204|FG003|Overall Study|Adverse Event|1|||
105525952|NCT02028988|363936205|FG000|Overall Study|Withdrawal by Subject|2|||
105525953|NCT01063595|363936206|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
105525954|NCT01063595|363936207|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
105525955|NCT01063595|363936206|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
105525956|NCT01063595|363936207|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
105525957|NCT01063595|363936206|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
105525958|NCT01063595|363936207|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
105525959|NCT01063595|363936206|FG000|First Intervention|Adverse Event|1|||
105525960|NCT01063595|363936207|FG001|First Intervention|Adverse Event|4|||
105525961|NCT01063595|363936206|FG000|First Intervention|Withdrawal by Subject|1|||
105525962|NCT01063595|363936207|FG001|First Intervention|Withdrawal by Subject|0|||
105525963|NCT01063595|363936206|FG000|First Intervention|Reason not Specified|0|||
105525964|NCT01063595|363936207|FG001|First Intervention|Reason not Specified|1|||
105525965|NCT02678676|363936208|FG000|Overall Study|Death|619|||
105525966|NCT02678676|363936209|FG001|Overall Study|Death|649|||
105592812|NCT03068468|364170765|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
105592813|NCT03068468|364170766|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
105592814|NCT03068468|364170763|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
105592815|NCT03068468|364170764|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
105592816|NCT03068468|364170765|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
105592817|NCT03068468|364170766|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
105592818|NCT03068468|364170763|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
105592819|NCT03068468|364170764|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
105592820|NCT03068468|364170765|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
105592821|NCT03068468|364170766|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
105592822|NCT03068468|364170763|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
105592823|NCT03068468|364170764|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
105592824|NCT03068468|364170765|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
105592825|NCT03068468|364170766|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
105592826|NCT03068468|364170763|FG000|Open-Label Extension Period|Reason not Specified|0|||
105592827|NCT03068468|364170764|FG001|Open-Label Extension Period|Reason not Specified|0|||
105525967|NCT02678676|363936208|FG000|Overall Study|Withdrawal by Subject|13|||
105525968|NCT02678676|363936209|FG001|Overall Study|Withdrawal by Subject|5|||
105525969|NCT02678676|363936208|FG000|Overall Study|Lost to Follow-up|171|||
105525970|NCT02678676|363936209|FG001|Overall Study|Lost to Follow-up|151|||
105525971|NCT02678676|363936208|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
105525972|NCT02678676|363936209|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
105525973|NCT01623596|363936210|FG000|Overall Study|Abnormal laboratory values|2|||
105525974|NCT01623596|363936211|FG001|Overall Study|Abnormal laboratory values|0|||
105525975|NCT01623596|363936210|FG000|Overall Study|Administrative problems|9|||
105525976|NCT01623596|363936211|FG001|Overall Study|Administrative problems|13|||
105525977|NCT01623596|363936210|FG000|Overall Study|Adverse Event|20|||
105525978|NCT01623596|363936211|FG001|Overall Study|Adverse Event|29|||
105525979|NCT01623596|363936210|FG000|Overall Study|Death|0|||
105525980|NCT01623596|363936211|FG001|Overall Study|Death|2|||
105525981|NCT01623596|363936210|FG000|Overall Study|Lost to Follow-up|12|||
105525982|NCT01623596|363936211|FG001|Overall Study|Lost to Follow-up|16|||
105525983|NCT01623596|363936210|FG000|Overall Study|Withdrawal by Subject|13|||
105525984|NCT01623596|363936211|FG001|Overall Study|Withdrawal by Subject|31|||
105525985|NCT01623596|363936210|FG000|Overall Study|Patient no longer requires study drug|1|||
105525986|NCT01623596|363936211|FG001|Overall Study|Patient no longer requires study drug|0|||
105525987|NCT01623596|363936210|FG000|Overall Study|Protocol Violation|0|||
105525988|NCT01623596|363936211|FG001|Overall Study|Protocol Violation|6|||
105525989|NCT01623596|363936210|FG000|Overall Study|Lack of Efficacy|5|||
105525990|NCT01623596|363936211|FG001|Overall Study|Lack of Efficacy|3|||
105525991|NCT01400516|363936222|FG000|Primary Trial|Withdrawal by Subject|0|||
105525992|NCT01400516|363936223|FG001|Primary Trial|Withdrawal by Subject|2|||
105525993|NCT02865915|363936226|FG000|Overall Study|Pregnancy|1|||
105525994|NCT02865915|363936227|FG001|Overall Study|Pregnancy|0|||
105525995|NCT02865915|363936226|FG000|Overall Study|Withdrawal by Subject|1|||
105525996|NCT02865915|363936227|FG001|Overall Study|Withdrawal by Subject|1|||
105525997|NCT02865915|363936226|FG000|Overall Study|Adverse Event|0|||
105525998|NCT02865915|363936227|FG001|Overall Study|Adverse Event|4|||
105525999|NCT02865915|363936226|FG000|Overall Study|Lost to Follow-up|0|||
105526000|NCT02865915|363936227|FG001|Overall Study|Lost to Follow-up|1|||
105526001|NCT02865915|363936226|FG000|Overall Study|Protocol Violation|0|||
105526002|NCT02865915|363936227|FG001|Overall Study|Protocol Violation|1|||
105526003|NCT02865915|363936226|FG000|Overall Study|Study terminated by sponsor|23|||
105526004|NCT02865915|363936227|FG001|Overall Study|Study terminated by sponsor|18|||
105526005|NCT02865915|363936226|FG000|Overall Study|Dosing group discontinued|0|||
105526006|NCT02865915|363936227|FG001|Overall Study|Dosing group discontinued|5|||
105526007|NCT03913091|363936231|FG000|Overall Study|Lost to Follow-up|18|||
105526008|NCT03913091|363936232|FG001|Overall Study|Lost to Follow-up|11|||
105526009|NCT03913091|363936231|FG000|Overall Study|Required additional meds/surgery|1|||
105526010|NCT03913091|363936232|FG001|Overall Study|Required additional meds/surgery|2|||
105526011|NCT03913091|363936231|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
105526012|NCT03913091|363936232|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
105526013|NCT00082433|363936233|FG000|Overall Study|Adverse Event|12|||
105526014|NCT00082433|363936234|FG001|Overall Study|Adverse Event|17|||
105526015|NCT00082433|363936233|FG000|Overall Study|Death|8|||
105526016|NCT00082433|363936234|FG001|Overall Study|Death|18|||
105526017|NCT00082433|363936233|FG000|Overall Study|Disease Progression/Relapse|270|||
105526018|NCT00082433|363936234|FG001|Overall Study|Disease Progression/Relapse|388|||
105526019|NCT00082433|363936233|FG000|Overall Study|Physician Decision|50|||
105526020|NCT00082433|363936234|FG001|Overall Study|Physician Decision|61|||
105526021|NCT00082433|363936233|FG000|Overall Study|Lost to Follow-up|1|||
105526022|NCT00082433|363936234|FG001|Overall Study|Lost to Follow-up|2|||
105526023|NCT00082433|363936233|FG000|Overall Study|Study Drug Toxicity|179|||
105526024|NCT00082433|363936234|FG001|Overall Study|Study Drug Toxicity|66|||
105526025|NCT00082433|363936233|FG000|Overall Study|Withdrawal by Subject|55|||
105526026|NCT00082433|363936234|FG001|Overall Study|Withdrawal by Subject|30|||
105526027|NCT00082433|363936233|FG000|Overall Study|Still On Treatment|2|||
105526028|NCT00082433|363936234|FG001|Overall Study|Still On Treatment|1|||
105526029|NCT00082433|363936233|FG000|Overall Study|Not Treated|12|||
105526030|NCT00082433|363936234|FG001|Overall Study|Not Treated|11|||
105526031|NCT00082433|363936233|FG000|Overall Study|Ineligible|2|||
105526032|NCT00082433|363936234|FG001|Overall Study|Ineligible|1|||
105526033|NCT00082433|363936233|FG000|Overall Study|Noncompliance|2|||
105526034|NCT00082433|363936234|FG001|Overall Study|Noncompliance|1|||
105526035|NCT00082433|363936233|FG000|Overall Study|New primary cancer|1|||
105526036|NCT00082433|363936234|FG001|Overall Study|New primary cancer|0|||
105526037|NCT00082433|363936233|FG000|Overall Study|Impending surgery|0|||
105526038|NCT00082433|363936234|FG001|Overall Study|Impending surgery|1|||
105526039|NCT01380184|363936238|FG000|Part 1 (19 Days)|Adverse Event|1|||
105526040|NCT01380184|363936238|FG000|Part 2|Adverse Event|5|||
105526041|NCT01380184|363936238|FG000|Part 2|Disease Progression|8|||
105526042|NCT01380184|363936238|FG000|Part 2|Lost to Follow-up|1|||
105526043|NCT04327986|363936239|FG000|Overall Study|Physician Decision|2|||
105526044|NCT04327986|363936240|FG001|Overall Study|Physician Decision|0|||
105526045|NCT04327986|363936241|FG002|Overall Study|Physician Decision|0|||
105526046|NCT04327986|363936239|FG000|Overall Study|Death|1|||
105526047|NCT04327986|363936240|FG001|Overall Study|Death|0|||
105526048|NCT04327986|363936241|FG002|Overall Study|Death|0|||
105526049|NCT03406858|363937608|FG000|Overall Study|Failure to receive treatment drug.|1|||
105526050|NCT03406858|363937608|FG000|Overall Study|ineligible|1|||
105526051|NCT05664490|363937612|FG000|Overall Study|Withdrawal by Subject|0|||
105526052|NCT05664490|363937613|FG001|Overall Study|Withdrawal by Subject|1|||
105526053|NCT05664490|363937612|FG000|Overall Study|Lost to Follow-up|14|||
105526054|NCT05664490|363937613|FG001|Overall Study|Lost to Follow-up|22|||
105526055|NCT02053753|363937614|FG000|Overall Study|Withdrawal by Subject|2|||
105526056|NCT02053753|363937615|FG001|Overall Study|Withdrawal by Subject|4|||
105526057|NCT02053753|363937614|FG000|Overall Study|Decision by Sponsor|1|||
105526058|NCT02053753|363937615|FG001|Overall Study|Decision by Sponsor|1|||
105526059|NCT02053753|363937614|FG000|Overall Study|Lost to Follow-up|4|||
105526060|NCT02053753|363937615|FG001|Overall Study|Lost to Follow-up|3|||
105526061|NCT01203072|363937616|FG000|Overall Study|Adverse Event|5|||
105526062|NCT01203072|363937617|FG001|Overall Study|Adverse Event|3|||
105526063|NCT01203072|363937618|FG002|Overall Study|Adverse Event|2|||
105526064|NCT01203072|363937619|FG003|Overall Study|Adverse Event|4|||
105526065|NCT01203072|363937620|FG004|Overall Study|Adverse Event|2|||
105526066|NCT01203072|363937616|FG000|Overall Study|Lack of Efficacy|1|||
105526067|NCT01203072|363937617|FG001|Overall Study|Lack of Efficacy|0|||
105526068|NCT01203072|363937618|FG002|Overall Study|Lack of Efficacy|0|||
105526069|NCT01203072|363937619|FG003|Overall Study|Lack of Efficacy|0|||
105526070|NCT01203072|363937620|FG004|Overall Study|Lack of Efficacy|0|||
105526071|NCT01203072|363937616|FG000|Overall Study|Lost to Follow-up|0|||
105526072|NCT01203072|363937617|FG001|Overall Study|Lost to Follow-up|1|||
105526073|NCT01203072|363937618|FG002|Overall Study|Lost to Follow-up|0|||
105526074|NCT01203072|363937619|FG003|Overall Study|Lost to Follow-up|0|||
105526075|NCT01203072|363937620|FG004|Overall Study|Lost to Follow-up|0|||
105526076|NCT01203072|363937616|FG000|Overall Study|Protocol Violation|2|||
105526077|NCT01203072|363937617|FG001|Overall Study|Protocol Violation|0|||
105526078|NCT01203072|363937618|FG002|Overall Study|Protocol Violation|0|||
105526079|NCT01203072|363937619|FG003|Overall Study|Protocol Violation|0|||
105526080|NCT01203072|363937620|FG004|Overall Study|Protocol Violation|1|||
105526081|NCT01203072|363937616|FG000|Overall Study|Withdrawal by Subject|2|||
105526082|NCT01203072|363937617|FG001|Overall Study|Withdrawal by Subject|2|||
105526083|NCT01203072|363937618|FG002|Overall Study|Withdrawal by Subject|1|||
105526084|NCT01203072|363937619|FG003|Overall Study|Withdrawal by Subject|2|||
105526085|NCT01203072|363937620|FG004|Overall Study|Withdrawal by Subject|3|||
105526086|NCT01577758|363937621|FG000|Dose Escalation Phase|Adverse Event|0|||
105526087|NCT01577758|363937622|FG001|Dose Escalation Phase|Adverse Event|0|||
105526088|NCT01577758|363937623|FG002|Dose Escalation Phase|Adverse Event|0|||
105526089|NCT01577758|363937624|FG003|Dose Escalation Phase|Adverse Event|0|||
105526090|NCT01577758|363937625|FG004|Dose Escalation Phase|Adverse Event|0|||
105526091|NCT01577758|363937626|FG005|Dose Escalation Phase|Adverse Event|2|||
105526092|NCT01577758|363937627|FG006|Dose Escalation Phase|Adverse Event|1|||
105526093|NCT01577758|363937628|FG007|Dose Escalation Phase|Adverse Event|0|||
105526094|NCT01577758|363937621|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
105526095|NCT01577758|363937622|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
105526096|NCT01577758|363937623|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
105526097|NCT01577758|363937624|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
105526098|NCT01577758|363937625|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
105526099|NCT01577758|363937626|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
105526100|NCT01577758|363937627|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
105526101|NCT01577758|363937628|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
105526102|NCT01577758|363937621|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
105526103|NCT01577758|363937622|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
105526104|NCT01577758|363937623|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
105526105|NCT01577758|363937624|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
105526106|NCT01577758|363937625|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
105526107|NCT01577758|363937626|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
105526108|NCT01577758|363937627|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
105526109|NCT01577758|363937628|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
105526110|NCT01577758|363937621|FG000|Dose Escalation Phase|Progression Disease|2|||
105526111|NCT01577758|363937622|FG001|Dose Escalation Phase|Progression Disease|2|||
105526112|NCT01577758|363937623|FG002|Dose Escalation Phase|Progression Disease|1|||
105526113|NCT01577758|363937624|FG003|Dose Escalation Phase|Progression Disease|2|||
105526114|NCT01577758|363937625|FG004|Dose Escalation Phase|Progression Disease|5|||
105526115|NCT01577758|363937626|FG005|Dose Escalation Phase|Progression Disease|0|||
105526116|NCT01577758|363937627|FG006|Dose Escalation Phase|Progression Disease|0|||
105526117|NCT01577758|363937628|FG007|Dose Escalation Phase|Progression Disease|0|||
105526118|NCT01577758|363937621|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
105526119|NCT01577758|363937622|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
105526120|NCT01577758|363937623|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
105526121|NCT01577758|363937624|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
105526122|NCT01577758|363937625|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
105526123|NCT01577758|363937626|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
105526124|NCT01577758|363937627|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
105526125|NCT01577758|363937628|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
105526126|NCT01577758|363937621|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
105526127|NCT01577758|363937622|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
105526128|NCT01577758|363937623|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
105526129|NCT01577758|363937624|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
105526130|NCT01577758|363937625|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
105526131|NCT01577758|363937626|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
105526132|NCT01577758|363937627|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
105526133|NCT01577758|363937628|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
105526134|NCT01577758|363937621|FG000|mCRC Expansion Phase|Progression Disease|0|||
105526135|NCT01577758|363937622|FG001|mCRC Expansion Phase|Progression Disease|0|||
105526136|NCT01577758|363937623|FG002|mCRC Expansion Phase|Progression Disease|0|||
105526137|NCT01577758|363937624|FG003|mCRC Expansion Phase|Progression Disease|0|||
105526138|NCT01577758|363937625|FG004|mCRC Expansion Phase|Progression Disease|0|||
105526139|NCT01577758|363937626|FG005|mCRC Expansion Phase|Progression Disease|0|||
105526140|NCT01577758|363937627|FG006|mCRC Expansion Phase|Progression Disease|0|||
105526141|NCT01577758|363937628|FG007|mCRC Expansion Phase|Progression Disease|19|||
105526142|NCT03925324|363937632|FG000|Overall Study|Death|1|||
105526143|NCT03925324|363937633|FG001|Overall Study|Death|1|||
105526144|NCT02689258|363937637|FG000|Overall Study|Subject Non-Compliance|0|||
105526145|NCT02689258|363937638|FG001|Overall Study|Subject Non-Compliance|1|||
105526146|NCT02689258|363937639|FG002|Overall Study|Subject Non-Compliance|0|||
105526147|NCT02689258|363937640|FG003|Overall Study|Subject Non-Compliance|0|||
105526148|NCT02689258|363937641|FG004|Overall Study|Subject Non-Compliance|0|||
105526149|NCT02689258|363937642|FG005|Overall Study|Subject Non-Compliance|0|||
105526150|NCT02689258|363937643|FG006|Overall Study|Subject Non-Compliance|0|||
105526151|NCT02689258|363937644|FG007|Overall Study|Subject Non-Compliance|0|||
105526152|NCT02689258|363937645|FG008|Overall Study|Subject Non-Compliance|0|||
105526153|NCT02689258|363937646|FG009|Overall Study|Subject Non-Compliance|0|||
105526154|NCT02689258|363937647|FG010|Overall Study|Subject Non-Compliance|0|||
105526155|NCT02689258|363937648|FG011|Overall Study|Subject Non-Compliance|0|||
105526156|NCT02689258|363937637|FG000|Overall Study|Subject Refusal to Continue|0|||
105526157|NCT02689258|363937638|FG001|Overall Study|Subject Refusal to Continue|1|||
105526158|NCT02689258|363937639|FG002|Overall Study|Subject Refusal to Continue|0|||
105526159|NCT02689258|363937640|FG003|Overall Study|Subject Refusal to Continue|0|||
105526160|NCT02689258|363937641|FG004|Overall Study|Subject Refusal to Continue|0|||
105526161|NCT02689258|363937642|FG005|Overall Study|Subject Refusal to Continue|0|||
105526162|NCT02689258|363937643|FG006|Overall Study|Subject Refusal to Continue|0|||
105526163|NCT02689258|363937644|FG007|Overall Study|Subject Refusal to Continue|0|||
105526164|NCT02689258|363937645|FG008|Overall Study|Subject Refusal to Continue|1|||
105526165|NCT02689258|363937646|FG009|Overall Study|Subject Refusal to Continue|0|||
105526166|NCT02689258|363937647|FG010|Overall Study|Subject Refusal to Continue|0|||
105526167|NCT02689258|363937648|FG011|Overall Study|Subject Refusal to Continue|1|||
105526168|NCT02689258|363937637|FG000|Overall Study|Other|0|||
105526169|NCT02689258|363937638|FG001|Overall Study|Other|2|||
105526170|NCT02689258|363937639|FG002|Overall Study|Other|0|||
105526171|NCT02689258|363937640|FG003|Overall Study|Other|0|||
105526172|NCT02689258|363937641|FG004|Overall Study|Other|1|||
105526173|NCT02689258|363937642|FG005|Overall Study|Other|0|||
105526174|NCT02689258|363937643|FG006|Overall Study|Other|0|||
105526175|NCT02689258|363937644|FG007|Overall Study|Other|0|||
105526176|NCT02689258|363937645|FG008|Overall Study|Other|1|||
105526177|NCT02689258|363937646|FG009|Overall Study|Other|0|||
105526178|NCT02689258|363937647|FG010|Overall Study|Other|0|||
105526179|NCT02689258|363937648|FG011|Overall Study|Other|0|||
105526180|NCT02159521|363937649|FG000|Overall Study|Enrolled but not treated|3|||
105526181|NCT02159521|363937649|FG000|Overall Study|Withdrawal by Subject|7|||
105526182|NCT02159521|363937649|FG000|Overall Study|Lost to Follow-up|6|||
105526183|NCT02159521|363937649|FG000|Overall Study|Death|1|||
105526184|NCT02159521|363937649|FG000|Overall Study|Other than specified|1|||
105526185|NCT04372602|363937658|FG000|Overall Study|Withdrawal by Subject|1|||
105526186|NCT04372602|363937659|FG001|Overall Study|Withdrawal by Subject|1|||
105526187|NCT04372602|363937658|FG000|Overall Study|Adverse Event|0|||
105526188|NCT04372602|363937659|FG001|Overall Study|Adverse Event|1|||
105526189|NCT04372602|363937658|FG000|Overall Study|Transitioned to comfort care|0|||
105526190|NCT04372602|363937659|FG001|Overall Study|Transitioned to comfort care|1|||
105526191|NCT00775437|363937660|FG000|Overall Study|Loss of efficacy|2|||
105526192|NCT00775437|363937660|FG000|Overall Study|Withdrawal by Subject|3|||
105526193|NCT00775437|363937660|FG000|Overall Study|Lost to Follow-up|1|||
105526194|NCT03131440|363937661|FG000|Overall Study|Withdrawal by Subject|1|||
105526195|NCT03131440|363937662|FG001|Overall Study|Withdrawal by Subject|3|||
105526196|NCT03131440|363937663|FG002|Overall Study|Withdrawal by Subject|0|||
105526197|NCT03131440|363937664|FG003|Overall Study|Withdrawal by Subject|0|||
105526198|NCT03131440|363937665|FG004|Overall Study|Withdrawal by Subject|1|||
105526199|NCT03131440|363937666|FG005|Overall Study|Withdrawal by Subject|0|||
105526200|NCT03131440|363937667|FG006|Overall Study|Withdrawal by Subject|0|||
105526201|NCT03131440|363937668|FG007|Overall Study|Withdrawal by Subject|1|||
105526202|NCT03131440|363937669|FG008|Overall Study|Withdrawal by Subject|1|||
105526203|NCT03131440|363937670|FG009|Overall Study|Withdrawal by Subject|1|||
105526204|NCT03131440|363937671|FG010|Overall Study|Withdrawal by Subject|0|||
105526205|NCT03131440|363937672|FG011|Overall Study|Withdrawal by Subject|1|||
105526206|NCT03131440|363937673|FG012|Overall Study|Withdrawal by Subject|1|||
105526207|NCT03131440|363937674|FG013|Overall Study|Withdrawal by Subject|0|||
105526208|NCT03131440|363937675|FG014|Overall Study|Withdrawal by Subject|1|||
105526209|NCT03131440|363937676|FG015|Overall Study|Withdrawal by Subject|0|||
105526210|NCT03131440|363937677|FG016|Overall Study|Withdrawal by Subject|0|||
105526211|NCT03131440|363937678|FG017|Overall Study|Withdrawal by Subject|0|||
105526212|NCT03131440|363937679|FG018|Overall Study|Withdrawal by Subject|1|||
105526213|NCT03131440|363937680|FG019|Overall Study|Withdrawal by Subject|0|||
105526214|NCT03131440|363937681|FG020|Overall Study|Withdrawal by Subject|1|||
105526215|NCT03131440|363937682|FG021|Overall Study|Withdrawal by Subject|1|||
105526216|NCT03131440|363937683|FG022|Overall Study|Withdrawal by Subject|1|||
105526217|NCT03131440|363937684|FG023|Overall Study|Withdrawal by Subject|0|||
105526218|NCT03131440|363937685|FG024|Overall Study|Withdrawal by Subject|0|||
105526219|NCT03131440|363937686|FG025|Overall Study|Withdrawal by Subject|0|||
105526220|NCT03131440|363937687|FG026|Overall Study|Withdrawal by Subject|0|||
105526221|NCT03131440|363937688|FG027|Overall Study|Withdrawal by Subject|0|||
105526222|NCT03131440|363937689|FG028|Overall Study|Withdrawal by Subject|0|||
105526223|NCT03131440|363937690|FG029|Overall Study|Withdrawal by Subject|0|||
105526224|NCT03131440|363937691|FG030|Overall Study|Withdrawal by Subject|1|||
105526225|NCT03131440|363937692|FG031|Overall Study|Withdrawal by Subject|0|||
105526226|NCT03131440|363937661|FG000|Overall Study|Lost to Follow-up|0|||
105526227|NCT03131440|363937662|FG001|Overall Study|Lost to Follow-up|0|||
105526228|NCT03131440|363937663|FG002|Overall Study|Lost to Follow-up|0|||
105526229|NCT03131440|363937664|FG003|Overall Study|Lost to Follow-up|0|||
105526230|NCT03131440|363937665|FG004|Overall Study|Lost to Follow-up|0|||
105526231|NCT03131440|363937666|FG005|Overall Study|Lost to Follow-up|1|||
105526232|NCT03131440|363937667|FG006|Overall Study|Lost to Follow-up|0|||
105526233|NCT03131440|363937668|FG007|Overall Study|Lost to Follow-up|0|||
105592828|NCT03068468|364170765|FG002|Open-Label Extension Period|Reason not Specified|1|||
105592829|NCT03068468|364170766|FG003|Open-Label Extension Period|Reason not Specified|4|||
105592830|NCT03181958|364170772|FG000|Overall Study|Lost to Follow-up|17|||
105592831|NCT03181958|364170773|FG001|Overall Study|Lost to Follow-up|21|||
105592832|NCT03181958|364170774|FG002|Overall Study|Lost to Follow-up|15|||
105592833|NCT02030028|364170775|FG000|Overall Study|Withdrawal by Subject|4|||
105592834|NCT02030028|364170775|FG000|Overall Study|lack of transportation|1|||
105592835|NCT05355116|364170776|FG000|Overall Study|Withdrawal by Subject|2|||
105592836|NCT00149630|364170777|FG000|Overall Study|Incarceration|2|||
105592837|NCT00149630|364170778|FG001|Overall Study|Incarceration|0|||
105592838|NCT00149630|364170777|FG000|Overall Study|Treatment Programs|4|||
105592839|NCT00149630|364170778|FG001|Overall Study|Treatment Programs|5|||
105592840|NCT00149630|364170777|FG000|Overall Study|Adverse Event|2|||
105592841|NCT00149630|364170778|FG001|Overall Study|Adverse Event|0|||
105592842|NCT00567879|364170781|FG000|Overall Study|Adverse Event|2|||
105592843|NCT00567879|364170782|FG001|Overall Study|Adverse Event|0|||
105592844|NCT00567879|364170783|FG002|Overall Study|Adverse Event|1|||
105592845|NCT00567879|364170784|FG003|Overall Study|Adverse Event|0|||
105592846|NCT00567879|364170785|FG004|Overall Study|Adverse Event|1|||
105592847|NCT00567879|364170786|FG005|Overall Study|Adverse Event|0|||
105592848|NCT00567879|364170781|FG000|Overall Study|Abnormal test procedure(s)|0|||
105592849|NCT00567879|364170782|FG001|Overall Study|Abnormal test procedure(s)|0|||
105592850|NCT00567879|364170783|FG002|Overall Study|Abnormal test procedure(s)|1|||
105592851|NCT00567879|364170784|FG003|Overall Study|Abnormal test procedure(s)|0|||
105592852|NCT00567879|364170785|FG004|Overall Study|Abnormal test procedure(s)|0|||
105592853|NCT00567879|364170786|FG005|Overall Study|Abnormal test procedure(s)|0|||
105592854|NCT00567879|364170781|FG000|Overall Study|Withdrawal by Subject|0|||
105592855|NCT00567879|364170782|FG001|Overall Study|Withdrawal by Subject|0|||
105592856|NCT00567879|364170783|FG002|Overall Study|Withdrawal by Subject|3|||
105592857|NCT00567879|364170784|FG003|Overall Study|Withdrawal by Subject|1|||
105592858|NCT00567879|364170785|FG004|Overall Study|Withdrawal by Subject|0|||
105592859|NCT00567879|364170786|FG005|Overall Study|Withdrawal by Subject|0|||
105592860|NCT00567879|364170781|FG000|Overall Study|New cancer therapy|0|||
105592861|NCT00567879|364170782|FG001|Overall Study|New cancer therapy|0|||
105592862|NCT00567879|364170783|FG002|Overall Study|New cancer therapy|1|||
105592863|NCT00567879|364170784|FG003|Overall Study|New cancer therapy|0|||
105592864|NCT00567879|364170785|FG004|Overall Study|New cancer therapy|0|||
105592865|NCT00567879|364170786|FG005|Overall Study|New cancer therapy|0|||
105592866|NCT00567879|364170781|FG000|Overall Study|Disease progression|5|||
105592867|NCT00567879|364170782|FG001|Overall Study|Disease progression|7|||
105592868|NCT00567879|364170783|FG002|Overall Study|Disease progression|15|||
105592869|NCT00567879|364170784|FG003|Overall Study|Disease progression|5|||
105592870|NCT00567879|364170785|FG004|Overall Study|Disease progression|11|||
105592871|NCT00567879|364170786|FG005|Overall Study|Disease progression|3|||
105592872|NCT05298111|364170789|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
105592873|NCT05298111|364170790|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
105592874|NCT03518112|364170793|FG000|Overall Study|Withdrawal by Subject|1|||
105592875|NCT02987543|364170794|FG000|Overall Study|Ongoing study at data cut off|49|||
105592876|NCT02987543|364170795|FG001|Overall Study|Ongoing study at data cut off|21|||
105592877|NCT02987543|364170796|FG002|Overall Study|Ongoing study at data cut off|19|||
105592878|NCT02987543|364170797|FG003|Overall Study|Ongoing study at data cut off|12|||
105592879|NCT02987543|364170794|FG000|Overall Study|Death|88|||
105592880|NCT02987543|364170795|FG001|Overall Study|Death|54|||
105526234|NCT03131440|363937669|FG008|Overall Study|Lost to Follow-up|0|||
105526235|NCT03131440|363937670|FG009|Overall Study|Lost to Follow-up|0|||
105526236|NCT03131440|363937671|FG010|Overall Study|Lost to Follow-up|0|||
105526237|NCT03131440|363937672|FG011|Overall Study|Lost to Follow-up|0|||
105526238|NCT03131440|363937673|FG012|Overall Study|Lost to Follow-up|0|||
105526239|NCT03131440|363937674|FG013|Overall Study|Lost to Follow-up|0|||
105526240|NCT03131440|363937675|FG014|Overall Study|Lost to Follow-up|0|||
105526241|NCT03131440|363937676|FG015|Overall Study|Lost to Follow-up|0|||
105526242|NCT03131440|363937677|FG016|Overall Study|Lost to Follow-up|0|||
105526243|NCT03131440|363937678|FG017|Overall Study|Lost to Follow-up|0|||
105526244|NCT03131440|363937679|FG018|Overall Study|Lost to Follow-up|0|||
105526245|NCT03131440|363937680|FG019|Overall Study|Lost to Follow-up|2|||
105592881|NCT02987543|364170796|FG002|Overall Study|Death|67|||
105592882|NCT02987543|364170797|FG003|Overall Study|Death|28|||
105592883|NCT02987543|364170794|FG000|Overall Study|Lost to Follow-up|3|||
105592884|NCT02987543|364170795|FG001|Overall Study|Lost to Follow-up|0|||
105592885|NCT02987543|364170796|FG002|Overall Study|Lost to Follow-up|1|||
105592886|NCT02987543|364170797|FG003|Overall Study|Lost to Follow-up|0|||
105592887|NCT02987543|364170794|FG000|Overall Study|Screen failure|0|||
105592888|NCT02987543|364170795|FG001|Overall Study|Screen failure|0|||
105592889|NCT02987543|364170796|FG002|Overall Study|Screen failure|0|||
105592890|NCT02987543|364170797|FG003|Overall Study|Screen failure|1|||
105592891|NCT02987543|364170794|FG000|Overall Study|Withdrawal by Subject|21|||
105526246|NCT03131440|363937681|FG020|Overall Study|Lost to Follow-up|1|||
105526247|NCT03131440|363937682|FG021|Overall Study|Lost to Follow-up|0|||
105526248|NCT03131440|363937683|FG022|Overall Study|Lost to Follow-up|1|||
105526249|NCT03131440|363937684|FG023|Overall Study|Lost to Follow-up|0|||
105526250|NCT03131440|363937685|FG024|Overall Study|Lost to Follow-up|1|||
105526251|NCT03131440|363937686|FG025|Overall Study|Lost to Follow-up|0|||
105526252|NCT03131440|363937687|FG026|Overall Study|Lost to Follow-up|0|||
105526253|NCT03131440|363937688|FG027|Overall Study|Lost to Follow-up|2|||
105526254|NCT03131440|363937689|FG028|Overall Study|Lost to Follow-up|0|||
105526255|NCT03131440|363937690|FG029|Overall Study|Lost to Follow-up|2|||
105526256|NCT03131440|363937691|FG030|Overall Study|Lost to Follow-up|0|||
105526257|NCT03131440|363937692|FG031|Overall Study|Lost to Follow-up|0|||
105526258|NCT03131440|363937661|FG000|Overall Study|Death|0|||
105526259|NCT03131440|363937662|FG001|Overall Study|Death|0|||
105526260|NCT03131440|363937663|FG002|Overall Study|Death|0|||
105526261|NCT03131440|363937664|FG003|Overall Study|Death|0|||
105526262|NCT03131440|363937665|FG004|Overall Study|Death|0|||
105526263|NCT03131440|363937666|FG005|Overall Study|Death|0|||
105526264|NCT03131440|363937667|FG006|Overall Study|Death|0|||
105526265|NCT03131440|363937668|FG007|Overall Study|Death|0|||
105526266|NCT03131440|363937669|FG008|Overall Study|Death|0|||
105526267|NCT03131440|363937670|FG009|Overall Study|Death|0|||
105526268|NCT03131440|363937671|FG010|Overall Study|Death|0|||
105526269|NCT03131440|363937672|FG011|Overall Study|Death|0|||
105526270|NCT03131440|363937673|FG012|Overall Study|Death|0|||
105526271|NCT03131440|363937674|FG013|Overall Study|Death|0|||
105526272|NCT03131440|363937675|FG014|Overall Study|Death|0|||
105526273|NCT03131440|363937676|FG015|Overall Study|Death|0|||
105526274|NCT03131440|363937677|FG016|Overall Study|Death|0|||
105526275|NCT03131440|363937678|FG017|Overall Study|Death|0|||
105526276|NCT03131440|363937679|FG018|Overall Study|Death|0|||
105526277|NCT03131440|363937680|FG019|Overall Study|Death|0|||
105526278|NCT03131440|363937681|FG020|Overall Study|Death|0|||
105526279|NCT03131440|363937682|FG021|Overall Study|Death|0|||
105526280|NCT03131440|363937683|FG022|Overall Study|Death|0|||
105526281|NCT03131440|363937684|FG023|Overall Study|Death|0|||
105526282|NCT03131440|363937685|FG024|Overall Study|Death|0|||
105526283|NCT03131440|363937686|FG025|Overall Study|Death|1|||
105526284|NCT03131440|363937687|FG026|Overall Study|Death|0|||
105526285|NCT03131440|363937688|FG027|Overall Study|Death|0|||
105526286|NCT03131440|363937689|FG028|Overall Study|Death|0|||
105526287|NCT03131440|363937690|FG029|Overall Study|Death|0|||
105526288|NCT03131440|363937691|FG030|Overall Study|Death|0|||
105526289|NCT03131440|363937692|FG031|Overall Study|Death|0|||
105526290|NCT01405963|363937693|FG000|Overall Study|Moved Away|2|||
105526291|NCT01405963|363937694|FG001|Overall Study|Moved Away|0|||
105526292|NCT01405963|363937693|FG000|Overall Study|Adverse Event|0|||
105526293|NCT01405963|363937694|FG001|Overall Study|Adverse Event|1|||
105526294|NCT01405963|363937693|FG000|Overall Study|Lost to Follow-up|0|||
105526295|NCT01405963|363937694|FG001|Overall Study|Lost to Follow-up|1|||
105526296|NCT04180020|363937703|FG000|Overall Study|missed visit|18|||
105526297|NCT04180020|363937704|FG001|Overall Study|missed visit|16|||
105526298|NCT04180020|363937703|FG000|Overall Study|Death|2|||
105526299|NCT04180020|363937704|FG001|Overall Study|Death|3|||
105526300|NCT04180020|363937703|FG000|Overall Study|Withdrawal by Subject|1|||
105526301|NCT04180020|363937704|FG001|Overall Study|Withdrawal by Subject|5|||
105526302|NCT04180020|363937703|FG000|Overall Study|incarcerated|1|||
105526303|NCT04180020|363937704|FG001|Overall Study|incarcerated|1|||
105526304|NCT04180020|363937703|FG000|Overall Study|Physician Decision|0|||
105526305|NCT04180020|363937704|FG001|Overall Study|Physician Decision|2|||
105526306|NCT03190889|363937709|FG000|Overall Study|Lost to Follow-up|7|||
105526307|NCT03190889|363937710|FG001|Overall Study|Lost to Follow-up|7|||
105526308|NCT03190889|363937711|FG002|Overall Study|Lost to Follow-up|3|||
105526309|NCT03190889|363937709|FG000|Overall Study|Withdrawal by Subject|1|||
105526310|NCT03190889|363937710|FG001|Overall Study|Withdrawal by Subject|1|||
105526311|NCT03190889|363937711|FG002|Overall Study|Withdrawal by Subject|2|||
105526312|NCT03190889|363937709|FG000|Overall Study|Did not complete protocol|4|||
105526313|NCT03190889|363937710|FG001|Overall Study|Did not complete protocol|9|||
105592892|NCT02987543|364170795|FG001|Overall Study|Withdrawal by Subject|7|||
105526314|NCT03190889|363937711|FG002|Overall Study|Did not complete protocol|0|||
105526315|NCT03190889|363937709|FG000|Overall Study|COVID-19|1|||
105526316|NCT03190889|363937710|FG001|Overall Study|COVID-19|0|||
105526317|NCT03190889|363937711|FG002|Overall Study|COVID-19|2|||
105526318|NCT01709695|363937713|FG000|Overall Study|Withdrawal by Subject|1|||
105526319|NCT01709695|363937714|FG001|Overall Study|Withdrawal by Subject|1|||
105526320|NCT01228747|363937715|FG000|Overall Study|Adverse Event|8|||
105526321|NCT01228747|363937716|FG001|Overall Study|Adverse Event|4|||
105526322|NCT01228747|363937715|FG000|Overall Study|Lack of Efficacy|40|||
105526323|NCT01228747|363937716|FG001|Overall Study|Lack of Efficacy|27|||
105526324|NCT01228747|363937715|FG000|Overall Study|Protocol Violation|6|||
105526325|NCT01228747|363937716|FG001|Overall Study|Protocol Violation|5|||
105526326|NCT01228747|363937715|FG000|Overall Study|Lost to Follow-up|4|||
105526327|NCT01228747|363937716|FG001|Overall Study|Lost to Follow-up|3|||
105526328|NCT01228747|363937715|FG000|Overall Study|Withdrawal by Subject|5|||
105526329|NCT01228747|363937716|FG001|Overall Study|Withdrawal by Subject|1|||
105526330|NCT01228747|363937715|FG000|Overall Study|Other Reason|2|||
105526331|NCT01228747|363937716|FG001|Overall Study|Other Reason|5|||
105526332|NCT02036502|363937717|FG000|Part 1:Dose Determination/Escalation|Death|3|||
105526333|NCT02036502|363937718|FG001|Part 1:Dose Determination/Escalation|Death|2|||
105526334|NCT02036502|363937719|FG002|Part 1:Dose Determination/Escalation|Death|0|||
105526335|NCT02036502|363937720|FG003|Part 1:Dose Determination/Escalation|Death|0|||
105526336|NCT02036502|363937721|FG004|Part 1:Dose Determination/Escalation|Death|0|||
105526337|NCT02036502|363937722|FG005|Part 1:Dose Determination/Escalation|Death|0|||
105526338|NCT02036502|363937723|FG006|Part 1:Dose Determination/Escalation|Death|0|||
105526339|NCT02036502|363937724|FG007|Part 1:Dose Determination/Escalation|Death|0|||
105526340|NCT02036502|363937717|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
105526341|NCT02036502|363937718|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
105526342|NCT02036502|363937719|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
105526343|NCT02036502|363937720|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
105526344|NCT02036502|363937721|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
105526345|NCT02036502|363937722|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
105526346|NCT02036502|363937723|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
105526347|NCT02036502|363937724|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
105526348|NCT02036502|363937717|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
105526349|NCT02036502|363937718|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
105526350|NCT02036502|363937719|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
105526351|NCT02036502|363937720|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
105526352|NCT02036502|363937721|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
105526353|NCT02036502|363937722|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
105526354|NCT02036502|363937723|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
105526355|NCT02036502|363937724|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
105526356|NCT02036502|363937717|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
105526357|NCT02036502|363937718|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
105526358|NCT02036502|363937719|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
105526359|NCT02036502|363937720|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
105526360|NCT02036502|363937721|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
105526361|NCT02036502|363937722|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
105526362|NCT02036502|363937723|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
105526363|NCT02036502|363937724|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
105526364|NCT02036502|363937717|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
105526365|NCT02036502|363937718|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
105526366|NCT02036502|363937719|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
105526367|NCT02036502|363937720|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
105526368|NCT02036502|363937721|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
105526369|NCT02036502|363937722|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
105526370|NCT02036502|363937723|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
105526371|NCT02036502|363937724|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
105526372|NCT02036502|363937717|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
105526373|NCT02036502|363937718|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
105526374|NCT02036502|363937719|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
105526375|NCT02036502|363937720|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
105526376|NCT02036502|363937721|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
105526377|NCT02036502|363937722|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
105526378|NCT02036502|363937723|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
105526379|NCT02036502|363937724|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
105526380|NCT02036502|363937717|FG000|Part 2:Dose Confirmation|Death|0|||
105526381|NCT02036502|363937718|FG001|Part 2:Dose Confirmation|Death|0|||
105526382|NCT02036502|363937719|FG002|Part 2:Dose Confirmation|Death|1|||
105526383|NCT02036502|363937720|FG003|Part 2:Dose Confirmation|Death|0|||
105526384|NCT02036502|363937721|FG004|Part 2:Dose Confirmation|Death|0|||
105526385|NCT02036502|363937722|FG005|Part 2:Dose Confirmation|Death|0|||
105526386|NCT02036502|363937723|FG006|Part 2:Dose Confirmation|Death|0|||
105526387|NCT02036502|363937724|FG007|Part 2:Dose Confirmation|Death|0|||
105526388|NCT02036502|363937717|FG000|Part 2:Dose Confirmation|Not treated|0|||
105526389|NCT02036502|363937718|FG001|Part 2:Dose Confirmation|Not treated|0|||
105526390|NCT02036502|363937719|FG002|Part 2:Dose Confirmation|Not treated|0|||
105526391|NCT02036502|363937720|FG003|Part 2:Dose Confirmation|Not treated|1|||
105526392|NCT02036502|363937721|FG004|Part 2:Dose Confirmation|Not treated|0|||
105526393|NCT02036502|363937722|FG005|Part 2:Dose Confirmation|Not treated|0|||
105526394|NCT02036502|363937723|FG006|Part 2:Dose Confirmation|Not treated|0|||
105592893|NCT02987543|364170796|FG002|Overall Study|Withdrawal by Subject|7|||
105592894|NCT02987543|364170797|FG003|Overall Study|Withdrawal by Subject|6|||
105526395|NCT02036502|363937724|FG007|Part 2:Dose Confirmation|Not treated|0|||
105526396|NCT02036502|363937717|FG000|Part 3:Dose Expansion|Adverse Event|0|||
105526397|NCT02036502|363937718|FG001|Part 3:Dose Expansion|Adverse Event|0|||
105526398|NCT02036502|363937719|FG002|Part 3:Dose Expansion|Adverse Event|0|||
105592895|NCT02987543|364170794|FG000|Overall Study|Study terminated by sponsor|1|||
105592896|NCT02987543|364170795|FG001|Overall Study|Study terminated by sponsor|0|||
105592897|NCT02987543|364170796|FG002|Overall Study|Study terminated by sponsor|0|||
105592898|NCT02987543|364170797|FG003|Overall Study|Study terminated by sponsor|0|||
105592899|NCT02987543|364170794|FG000|Overall Study|Investigator decision|0|||
105592900|NCT02987543|364170795|FG001|Overall Study|Investigator decision|1|||
105592901|NCT02987543|364170796|FG002|Overall Study|Investigator decision|0|||
105592902|NCT02987543|364170797|FG003|Overall Study|Investigator decision|0|||
105592903|NCT02987543|364170794|FG000|Overall Study|Disease progression|0|||
105592904|NCT02987543|364170795|FG001|Overall Study|Disease progression|0|||
105592905|NCT02987543|364170796|FG002|Overall Study|Disease progression|0|||
105592906|NCT02987543|364170797|FG003|Overall Study|Disease progression|1|||
105592907|NCT00109967|364170798|FG000|Overall Study|Cancel Prior to Treatment|2|||
105592908|NCT00109967|364170799|FG001|Overall Study|Cancel Prior to Treatment|0|||
105592909|NCT00109967|364170798|FG000|Overall Study|Adverse Event|12|||
105592910|NCT00109967|364170799|FG001|Overall Study|Adverse Event|1|||
105592911|NCT00109967|364170798|FG000|Overall Study|Withdrawal by Subject|5|||
105592912|NCT00109967|364170799|FG001|Overall Study|Withdrawal by Subject|0|||
105592913|NCT00109967|364170798|FG000|Overall Study|Physician Decision|1|||
105592914|NCT00109967|364170799|FG001|Overall Study|Physician Decision|3|||
105592915|NCT00109967|364170798|FG000|Overall Study|Death|0|||
105592916|NCT00109967|364170799|FG001|Overall Study|Death|2|||
105592917|NCT03439124|364170800|FG000|Overall Study|Adverse Event|2|||
105592918|NCT03439124|364170801|FG001|Overall Study|Adverse Event|0|||
105592919|NCT03439124|364170800|FG000|Overall Study|Lost to Follow-up|1|||
105592920|NCT03439124|364170801|FG001|Overall Study|Lost to Follow-up|0|||
105592921|NCT03439124|364170800|FG000|Overall Study|Other reasons|1|||
105592922|NCT03439124|364170801|FG001|Overall Study|Other reasons|0|||
105592923|NCT00686517|364170802|FG000|Treatment|Serious Adverse Event|1|||
105592924|NCT00686517|364170803|FG001|Treatment|Serious Adverse Event|2|||
105592925|NCT00686517|364170804|FG002|Treatment|Serious Adverse Event|1|||
105592926|NCT00686517|364170802|FG000|Treatment|Adverse Event|2|||
105592927|NCT00686517|364170803|FG001|Treatment|Adverse Event|0|||
105592928|NCT00686517|364170804|FG002|Treatment|Adverse Event|0|||
105592929|NCT00686517|364170802|FG000|Treatment|Poor Protocol Compliance|1|||
105592930|NCT00686517|364170803|FG001|Treatment|Poor Protocol Compliance|0|||
105592931|NCT00686517|364170804|FG002|Treatment|Poor Protocol Compliance|0|||
105592932|NCT00686517|364170802|FG000|Treatment|Protocol Violation|2|||
105592933|NCT00686517|364170803|FG001|Treatment|Protocol Violation|1|||
105592934|NCT00686517|364170804|FG002|Treatment|Protocol Violation|0|||
105592935|NCT01131494|364170807|FG000|Overall Study|Withdrawal by Subject|2|||
105592936|NCT01585038|364170809|FG000|Overall Study|Adverse Event|2|||
105592937|NCT01585038|364170810|FG001|Overall Study|Adverse Event|2|||
105592938|NCT01191086|364170819|FG000|Overall Study|Adverse Event|20|||
105592939|NCT01191086|364170819|FG000|Overall Study|Lack of Efficacy|10|||
105592940|NCT01191086|364170819|FG000|Overall Study|Lost to Follow-up|4|||
105592941|NCT01191086|364170819|FG000|Overall Study|Physician Decision|2|||
105592942|NCT01191086|364170819|FG000|Overall Study|Withdrawal by Subject|24|||
105526399|NCT02036502|363937720|FG003|Part 3:Dose Expansion|Adverse Event|0|||
105526400|NCT02036502|363937721|FG004|Part 3:Dose Expansion|Adverse Event|0|||
105526401|NCT02036502|363937722|FG005|Part 3:Dose Expansion|Adverse Event|4|||
105526402|NCT02036502|363937723|FG006|Part 3:Dose Expansion|Adverse Event|0|||
105526403|NCT02036502|363937724|FG007|Part 3:Dose Expansion|Adverse Event|2|||
105526404|NCT02036502|363937717|FG000|Part 3:Dose Expansion|Death|0|||
105526405|NCT02036502|363937718|FG001|Part 3:Dose Expansion|Death|0|||
105526406|NCT02036502|363937719|FG002|Part 3:Dose Expansion|Death|0|||
105526407|NCT02036502|363937720|FG003|Part 3:Dose Expansion|Death|0|||
105526408|NCT02036502|363937721|FG004|Part 3:Dose Expansion|Death|0|||
105526409|NCT02036502|363937722|FG005|Part 3:Dose Expansion|Death|24|||
105526410|NCT02036502|363937723|FG006|Part 3:Dose Expansion|Death|0|||
105526411|NCT02036502|363937724|FG007|Part 3:Dose Expansion|Death|3|||
105526412|NCT02036502|363937717|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
105526413|NCT02036502|363937718|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
105526414|NCT02036502|363937719|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
105592943|NCT01191086|364170819|FG000|Overall Study|Discontinuation criterion met|1|||
105592944|NCT01191086|364170819|FG000|Overall Study|Other|1|||
105592945|NCT00290732|364170822|FG000|Overall Study|Inability to instill drug intraductally.|0|||
105592946|NCT00290732|364170823|FG001|Overall Study|Inability to instill drug intraductally.|1|||
105592947|NCT00290732|364170824|FG002|Overall Study|Inability to instill drug intraductally.|1|||
105592948|NCT00290732|364170825|FG003|Overall Study|Inability to instill drug intraductally.|0|||
105592949|NCT00290732|364170826|FG004|Overall Study|Inability to instill drug intraductally.|0|||
105592950|NCT01370694|364170828|FG000|Overall Study|Switched to rituximab|4|||
105592951|NCT01370694|364170828|FG000|Overall Study|Progressive disease|2|||
105592952|NCT02393716|364170829|FG000|Overall Study|Death|29|||
105592953|NCT02393716|364170829|FG000|Overall Study|Withdrawal by Subject|8|||
105526415|NCT02036502|363937720|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
105526416|NCT02036502|363937721|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
105592954|NCT02393716|364170829|FG000|Overall Study|Device Explanted|8|||
105592955|NCT02393716|364170829|FG000|Overall Study|Missed visit|16|||
105592956|NCT02046616|364170830|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
105592957|NCT02046616|364170830|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
105592958|NCT02046616|364170830|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
105592959|NCT02046616|364170830|FG000|24-Week Treatment Period|Physician Decision|3|||
105592960|NCT02046616|364170830|FG000|24-Week Treatment Period|Other|1|||
105592961|NCT02046616|364170830|FG000|8-Week FU Period|Lost to Follow-up|1|||
105592962|NCT02595398|364170831|FG000|Overall Study|Non-compliance|1|||
105592963|NCT02595398|364170832|FG001|Overall Study|Non-compliance|0|||
105592964|NCT02595398|364170831|FG000|Overall Study|Withdrawal by Subject|2|||
105592965|NCT02595398|364170832|FG001|Overall Study|Withdrawal by Subject|1|||
105592966|NCT02595398|364170831|FG000|Overall Study|Lost to Follow-up|1|||
105592967|NCT02595398|364170832|FG001|Overall Study|Lost to Follow-up|0|||
105592968|NCT02736799|364170833|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
105592969|NCT02736799|364170834|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
105592970|NCT02736799|364170835|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
105592971|NCT02736799|364170836|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
105592972|NCT01156116|364170838|FG000|Overall Study|Withdrawal by Subject|3|||
105592973|NCT01156116|364170839|FG001|Overall Study|Withdrawal by Subject|1|||
105592974|NCT01156116|364170838|FG000|Overall Study|CPAP intolerance|2|||
105592975|NCT01156116|364170839|FG001|Overall Study|CPAP intolerance|0|||
105592976|NCT01193153|364170840|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
105592977|NCT01193153|364170841|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
105592978|NCT01193153|364170840|FG000|Open-label Lead in Period|Pregnancy|1|||
105592979|NCT01193153|364170841|FG001|Open-label Lead in Period|Pregnancy|0|||
105592980|NCT01193153|364170840|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
105592981|NCT01193153|364170841|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
105592982|NCT01193153|364170840|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
105592983|NCT01193153|364170841|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
105592984|NCT01193153|364170840|FG000|Open-label Lead in Period|Other|14|||
105592985|NCT01193153|364170841|FG001|Open-label Lead in Period|Other|0|||
105592986|NCT01193153|364170840|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
105592987|NCT01193153|364170841|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
105592988|NCT01193153|364170840|FG000|Open-label Lead in Period|Adverse Event|41|||
105592989|NCT01193153|364170841|FG001|Open-label Lead in Period|Adverse Event|0|||
105592990|NCT01193153|364170840|FG000|Open-label Lead in Period|Death|1|||
105592991|NCT01193153|364170841|FG001|Open-label Lead in Period|Death|0|||
105592992|NCT01193153|364170840|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
105592993|NCT01193153|364170841|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
105592994|NCT01193153|364170840|FG000|Open-label Stabilization Period|Adverse Event|9|||
105592995|NCT01193153|364170841|FG001|Open-label Stabilization Period|Adverse Event|0|||
105592996|NCT01193153|364170840|FG000|Open-label Stabilization Period|Death|2|||
105592997|NCT01193153|364170841|FG001|Open-label Stabilization Period|Death|0|||
105592998|NCT01193153|364170840|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
105592999|NCT01193153|364170841|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
105593000|NCT01193153|364170840|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
105593001|NCT01193153|364170841|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
105593002|NCT01193153|364170840|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
105593003|NCT01193153|364170841|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
105593004|NCT01193153|364170840|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
105593005|NCT01193153|364170841|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
105593006|NCT01193153|364170840|FG000|Open-label Stabilization Period|Other|8|||
105593007|NCT01193153|364170841|FG001|Open-label Stabilization Period|Other|0|||
105593008|NCT01193153|364170840|FG000|Double Blind Relapse Prevention Period|Other|2|||
105593009|NCT01193153|364170841|FG001|Double Blind Relapse Prevention Period|Other|3|||
105593010|NCT01193153|364170840|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
105593011|NCT01193153|364170841|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
105593012|NCT01193153|364170840|FG000|Double Blind Relapse Prevention Period|Death|2|||
105593013|NCT01193153|364170841|FG001|Double Blind Relapse Prevention Period|Death|0|||
105593014|NCT01193153|364170840|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
105593015|NCT01193153|364170841|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
105593016|NCT01193153|364170840|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
105593017|NCT01193153|364170841|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
105593018|NCT01193153|364170840|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
105593019|NCT01193153|364170841|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
105593020|NCT01193153|364170840|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
105593021|NCT01193153|364170841|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
105593022|NCT01193153|364170840|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
105593023|NCT01193153|364170841|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
105593024|NCT01648140|364170842|FG000|Overall Study|Physician Decision|1|||
105593025|NCT01648140|364170843|FG001|Overall Study|Physician Decision|0|||
105593026|NCT01648140|364170844|FG002|Overall Study|Physician Decision|0|||
105593027|NCT01648140|364170845|FG003|Overall Study|Physician Decision|0|||
105526417|NCT02036502|363937722|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
105526418|NCT02036502|363937723|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
105526419|NCT02036502|363937724|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
105526420|NCT02036502|363937717|FG000|Part 3:Dose Expansion|Physician Decision|0|||
105526421|NCT02036502|363937718|FG001|Part 3:Dose Expansion|Physician Decision|0|||
105526422|NCT02036502|363937719|FG002|Part 3:Dose Expansion|Physician Decision|0|||
105526423|NCT02036502|363937720|FG003|Part 3:Dose Expansion|Physician Decision|0|||
105526424|NCT02036502|363937721|FG004|Part 3:Dose Expansion|Physician Decision|0|||
105526425|NCT02036502|363937722|FG005|Part 3:Dose Expansion|Physician Decision|1|||
105526426|NCT02036502|363937723|FG006|Part 3:Dose Expansion|Physician Decision|0|||
105526427|NCT02036502|363937724|FG007|Part 3:Dose Expansion|Physician Decision|0|||
105526428|NCT02036502|363937717|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
105526429|NCT02036502|363937718|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
105526430|NCT02036502|363937719|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
105526431|NCT02036502|363937720|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
105526432|NCT02036502|363937721|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
105526433|NCT02036502|363937722|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
105526434|NCT02036502|363937723|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
105526435|NCT02036502|363937724|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
105526436|NCT02036502|363937717|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
105526437|NCT02036502|363937718|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
105526438|NCT02036502|363937719|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
105526439|NCT02036502|363937720|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
105526440|NCT02036502|363937721|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
105526441|NCT02036502|363937722|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
105526442|NCT02036502|363937723|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
105526443|NCT02036502|363937724|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
105526444|NCT02036502|363937717|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
105526445|NCT02036502|363937718|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
105526446|NCT02036502|363937719|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
105526447|NCT02036502|363937720|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
105526448|NCT02036502|363937721|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
105526449|NCT02036502|363937722|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
105526450|NCT02036502|363937723|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
105526451|NCT02036502|363937724|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
105526452|NCT02036502|363937717|FG000|Part 3:Dose Expansion|Not Treated|0|||
105526453|NCT02036502|363937718|FG001|Part 3:Dose Expansion|Not Treated|0|||
105526454|NCT02036502|363937719|FG002|Part 3:Dose Expansion|Not Treated|0|||
105526455|NCT02036502|363937720|FG003|Part 3:Dose Expansion|Not Treated|0|||
105526456|NCT02036502|363937721|FG004|Part 3:Dose Expansion|Not Treated|0|||
105526457|NCT02036502|363937722|FG005|Part 3:Dose Expansion|Not Treated|2|||
105526458|NCT02036502|363937723|FG006|Part 3:Dose Expansion|Not Treated|0|||
105526459|NCT02036502|363937724|FG007|Part 3:Dose Expansion|Not Treated|0|||
105526460|NCT03065244|363937731|FG000|Overall Study|Lost to Follow-up|1|||
105526461|NCT03065244|363937732|FG001|Overall Study|Lost to Follow-up|1|||
105526462|NCT03065244|363937731|FG000|Overall Study|Diagnosed with a different disease|1|||
105526463|NCT03065244|363937732|FG001|Overall Study|Diagnosed with a different disease|1|||
105526464|NCT03065244|363937731|FG000|Overall Study|Protocol Violation|0|||
105526465|NCT03065244|363937732|FG001|Overall Study|Protocol Violation|1|||
105526466|NCT03065244|363937731|FG000|Overall Study|Withdrawal by Subject|1|||
105526467|NCT03065244|363937732|FG001|Overall Study|Withdrawal by Subject|1|||
105526468|NCT03717480|363937733|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
105526469|NCT03774433|363937736|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
105593028|NCT01648140|364170842|FG000|Overall Study|Lack of Efficacy|4|||
105526470|NCT01708174|363937737|FG000|Treatment Period|Withdrawal by Subject|1|||
105526471|NCT01708174|363937738|FG001|Treatment Period|Withdrawal by Subject|0|||
105526472|NCT01708174|363937739|FG002|Treatment Period|Withdrawal by Subject|0|||
105526473|NCT01708174|363937737|FG000|Treatment Period|Progressive disease|0|||
105526474|NCT01708174|363937738|FG001|Treatment Period|Progressive disease|1|||
105526475|NCT01708174|363937739|FG002|Treatment Period|Progressive disease|0|||
105526476|NCT01708174|363937737|FG000|Treatment Period|Death|0|||
105526477|NCT01708174|363937738|FG001|Treatment Period|Death|0|||
105526478|NCT01708174|363937739|FG002|Treatment Period|Death|1|||
105526479|NCT01708174|363937737|FG000|Treatment Period|Adverse Event|0|||
105526480|NCT01708174|363937738|FG001|Treatment Period|Adverse Event|1|||
105526481|NCT01708174|363937739|FG002|Treatment Period|Adverse Event|0|||
105526482|NCT01951157|363937740|FG000|Overall Study|Progressive Disease|12|||
105526483|NCT01951157|363937741|FG001|Overall Study|Progressive Disease|13|||
105593029|NCT01648140|364170843|FG001|Overall Study|Lack of Efficacy|7|||
105593030|NCT01648140|364170844|FG002|Overall Study|Lack of Efficacy|1|||
105593031|NCT01648140|364170845|FG003|Overall Study|Lack of Efficacy|0|||
105593032|NCT01648140|364170842|FG000|Overall Study|Adverse Event|3|||
105593033|NCT01648140|364170843|FG001|Overall Study|Adverse Event|1|||
105593034|NCT01648140|364170844|FG002|Overall Study|Adverse Event|2|||
105593035|NCT01648140|364170845|FG003|Overall Study|Adverse Event|0|||
105593036|NCT01648140|364170842|FG000|Overall Study|Withdrawal by Subject|2|||
105593037|NCT01648140|364170843|FG001|Overall Study|Withdrawal by Subject|3|||
105593038|NCT01648140|364170844|FG002|Overall Study|Withdrawal by Subject|3|||
105593039|NCT01648140|364170845|FG003|Overall Study|Withdrawal by Subject|2|||
105593040|NCT01648140|364170842|FG000|Overall Study|Lost to Follow-up|2|||
105593041|NCT01648140|364170843|FG001|Overall Study|Lost to Follow-up|1|||
105593042|NCT01648140|364170844|FG002|Overall Study|Lost to Follow-up|2|||
105593043|NCT01648140|364170845|FG003|Overall Study|Lost to Follow-up|0|||
105593044|NCT00542386|364170846|FG000|Overall Study|Adverse Event|1|||
105593045|NCT00542386|364170847|FG001|Overall Study|Adverse Event|7|||
105593046|NCT00542386|364170848|FG002|Overall Study|Adverse Event|7|||
105593047|NCT00542386|364170849|FG003|Overall Study|Adverse Event|8|||
105593048|NCT00542386|364170850|FG004|Overall Study|Adverse Event|13|||
105593049|NCT00542386|364170851|FG005|Overall Study|Adverse Event|4|||
105593050|NCT00542386|364170846|FG000|Overall Study|Death|0|||
105526484|NCT01951157|363937742|FG002|Overall Study|Progressive Disease|10|||
105526485|NCT01951157|363937740|FG000|Overall Study|Treatment-unrelated AE|1|||
105526486|NCT01951157|363937741|FG001|Overall Study|Treatment-unrelated AE|0|||
105526487|NCT01951157|363937742|FG002|Overall Study|Treatment-unrelated AE|3|||
105526488|NCT01951157|363937740|FG000|Overall Study|Study Termination|0|||
105526489|NCT01951157|363937741|FG001|Overall Study|Study Termination|0|||
105526490|NCT01951157|363937742|FG002|Overall Study|Study Termination|1|||
105526491|NCT01951157|363937740|FG000|Overall Study|Physician Decision|5|||
105526492|NCT01951157|363937741|FG001|Overall Study|Physician Decision|3|||
105526493|NCT01951157|363937742|FG002|Overall Study|Physician Decision|2|||
105526494|NCT01951157|363937740|FG000|Overall Study|Non-treatmentrelated death|2|||
105526495|NCT01951157|363937741|FG001|Overall Study|Non-treatmentrelated death|2|||
105526496|NCT01951157|363937742|FG002|Overall Study|Non-treatmentrelated death|2|||
105526497|NCT01951157|363937740|FG000|Overall Study|No treated|0|||
105526498|NCT01951157|363937741|FG001|Overall Study|No treated|1|||
105438997|NCT03100058|363613380|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105438998|NCT03100058|363613381|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
105438999|NCT03100058|363613382|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
105526499|NCT01951157|363937742|FG002|Overall Study|No treated|0|||
105526500|NCT01951157|363937740|FG000|Overall Study|Treatment-related AE|2|||
105526501|NCT01951157|363937741|FG001|Overall Study|Treatment-related AE|0|||
105526502|NCT01951157|363937742|FG002|Overall Study|Treatment-related AE|4|||
105439000|NCT03100058|363613383|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105439001|NCT03100058|363613384|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
105439002|NCT03100058|363613372|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105439003|NCT03100058|363613373|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105439004|NCT03100058|363613374|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105439005|NCT03100058|363613375|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105439006|NCT03100058|363613376|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105439007|NCT03100058|363613377|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105439008|NCT03100058|363613378|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105439009|NCT03100058|363613379|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105439010|NCT03100058|363613380|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105439011|NCT03100058|363613381|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105439012|NCT03100058|363613382|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
105439013|NCT03100058|363613383|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105593051|NCT00542386|364170847|FG001|Overall Study|Death|0|||
105593052|NCT00542386|364170848|FG002|Overall Study|Death|1|||
105593053|NCT00542386|364170849|FG003|Overall Study|Death|2|||
105593054|NCT00542386|364170850|FG004|Overall Study|Death|1|||
105593055|NCT00542386|364170851|FG005|Overall Study|Death|2|||
105439014|NCT03100058|363613384|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105439015|NCT03100058|363613372|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105593056|NCT00542386|364170846|FG000|Overall Study|Lack of Efficacy|32|||
105593057|NCT00542386|364170847|FG001|Overall Study|Lack of Efficacy|12|||
105439016|NCT03100058|363613373|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105439017|NCT03100058|363613374|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105526503|NCT01951157|363937740|FG000|Overall Study|Consent withdrawn by subject|0|||
105526504|NCT01951157|363937741|FG001|Overall Study|Consent withdrawn by subject|1|||
105593058|NCT00542386|364170848|FG002|Overall Study|Lack of Efficacy|10|||
105593059|NCT00542386|364170849|FG003|Overall Study|Lack of Efficacy|13|||
105593060|NCT00542386|364170850|FG004|Overall Study|Lack of Efficacy|7|||
105593061|NCT00542386|364170851|FG005|Overall Study|Lack of Efficacy|31|||
105593062|NCT00542386|364170846|FG000|Overall Study|Physician Decision|1|||
105593063|NCT00542386|364170847|FG001|Overall Study|Physician Decision|0|||
105439018|NCT03100058|363613375|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105439019|NCT03100058|363613376|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105439020|NCT03100058|363613377|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105439021|NCT03100058|363613378|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105439022|NCT03100058|363613379|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105439023|NCT03100058|363613380|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105439024|NCT03100058|363613381|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105439025|NCT03100058|363613382|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105439026|NCT03100058|363613383|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105439027|NCT03100058|363613384|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
105439028|NCT03100058|363613372|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105526505|NCT01951157|363937742|FG002|Overall Study|Consent withdrawn by subject|3|||
105526506|NCT01951157|363937740|FG000|Overall Study|Treatment-related death|0|||
105526507|NCT01951157|363937741|FG001|Overall Study|Treatment-related death|2|||
105526508|NCT01951157|363937742|FG002|Overall Study|Treatment-related death|0|||
105526509|NCT00329407|363937743|FG000|Overall Study|Withdrawal by Subject|1|||
105526510|NCT00851799|363937751|FG000|Overall Study|Death|1|||
105526511|NCT00851799|363937752|FG001|Overall Study|Death|0|||
105526512|NCT00851799|363937753|FG002|Overall Study|Death|1|||
105526513|NCT00851799|363937751|FG000|Overall Study|Lost to Follow-up|5|||
105526514|NCT00851799|363937752|FG001|Overall Study|Lost to Follow-up|3|||
105439029|NCT03100058|363613373|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105439030|NCT03100058|363613374|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105439031|NCT03100058|363613375|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105439032|NCT03100058|363613376|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105439033|NCT03100058|363613377|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105439034|NCT03100058|363613378|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105439035|NCT03100058|363613379|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105439036|NCT03100058|363613380|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105439037|NCT03100058|363613381|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
105439038|NCT03100058|363613382|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105439039|NCT03100058|363613383|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105439040|NCT03100058|363613384|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105439041|NCT03671304|363613385|FG000|Overall Study|study terminated|7|||
105439042|NCT02718716|363613386|FG000|Overall Study|Lack of Efficacy|1|||
105439043|NCT02718716|363613387|FG001|Overall Study|Lack of Efficacy|0|||
105439044|NCT02718716|363613388|FG002|Overall Study|Lack of Efficacy|0|||
105439045|NCT02718716|363613389|FG003|Overall Study|Lack of Efficacy|0|||
105439046|NCT02718716|363613390|FG004|Overall Study|Lack of Efficacy|0|||
105439047|NCT00395850|363613392|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
105439048|NCT00395850|363613393|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
105439049|NCT00395850|363613394|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
105439050|NCT00395850|363613395|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
105439051|NCT00395850|363613392|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
105439052|NCT00395850|363613393|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
105439053|NCT00395850|363613394|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
105439054|NCT00395850|363613395|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
105439055|NCT00395850|363613392|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
105439056|NCT00395850|363613393|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
105439057|NCT00395850|363613394|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
105439058|NCT00395850|363613395|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
105439059|NCT00395850|363613392|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
105439060|NCT00395850|363613393|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
105439061|NCT00395850|363613394|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
105439062|NCT00395850|363613395|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
105439063|NCT00395850|363613392|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
105439064|NCT00395850|363613393|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
105439065|NCT00395850|363613394|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
105439066|NCT00395850|363613395|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
105439067|NCT00395850|363613392|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
105439068|NCT00395850|363613393|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
105439069|NCT00395850|363613394|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
105439070|NCT00395850|363613395|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
105439071|NCT00395850|363613392|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
105526515|NCT00851799|363937753|FG002|Overall Study|Lost to Follow-up|10|||
105593064|NCT00542386|364170848|FG002|Overall Study|Physician Decision|0|||
105439072|NCT00395850|363613393|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
105526516|NCT00851799|363937751|FG000|Overall Study|Not able to get to clinic|8|||
105526517|NCT00851799|363937752|FG001|Overall Study|Not able to get to clinic|5|||
105526518|NCT00851799|363937753|FG002|Overall Study|Not able to get to clinic|9|||
105526519|NCT00851799|363937751|FG000|Overall Study|Not willing to adhere to requirements|1|||
105526520|NCT00851799|363937752|FG001|Overall Study|Not willing to adhere to requirements|2|||
105526521|NCT00851799|363937753|FG002|Overall Study|Not willing to adhere to requirements|2|||
105526522|NCT00851799|363937751|FG000|Overall Study|Withdrew consent prior study completion|1|||
105526523|NCT00851799|363937752|FG001|Overall Study|Withdrew consent prior study completion|2|||
105526524|NCT00851799|363937753|FG002|Overall Study|Withdrew consent prior study completion|1|||
105526525|NCT00851799|363937751|FG000|Overall Study|Severe Debilitation|0|||
105526526|NCT00851799|363937752|FG001|Overall Study|Severe Debilitation|1|||
105526527|NCT00851799|363937753|FG002|Overall Study|Severe Debilitation|0|||
105526528|NCT00851799|363937751|FG000|Overall Study|Completed protocol due to pregnancy|0|||
105526529|NCT00851799|363937752|FG001|Overall Study|Completed protocol due to pregnancy|0|||
105439073|NCT00395850|363613394|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
105439074|NCT00395850|363613395|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
105526530|NCT00851799|363937753|FG002|Overall Study|Completed protocol due to pregnancy|1|||
105526531|NCT04056195|363937754|FG000|Overall Study|Adverse Event|1|||
105526532|NCT04056195|363937755|FG001|Overall Study|Adverse Event|0|||
105526533|NCT04056195|363937756|FG002|Overall Study|Adverse Event|0|||
105526534|NCT04056195|363937754|FG000|Overall Study|Withdrawal by Subject|0|||
105526535|NCT04056195|363937755|FG001|Overall Study|Withdrawal by Subject|1|||
105526536|NCT04056195|363937756|FG002|Overall Study|Withdrawal by Subject|1|||
105526537|NCT04056195|363937754|FG000|Overall Study|Physician Decision|1|||
105526538|NCT04056195|363937755|FG001|Overall Study|Physician Decision|1|||
105526539|NCT04056195|363937756|FG002|Overall Study|Physician Decision|1|||
105526540|NCT00026793|363937760|FG000|Overall Study|Death on study due to underlying disease|4|||
105526541|NCT00026793|363937760|FG000|Overall Study|Physician Decision|2|||
105526542|NCT00026793|363937760|FG000|Overall Study|Off study|2|||
105526543|NCT01342510|363937761|FG000|Overall Study|Protocol Violation|12|||
105526544|NCT01342510|363937762|FG001|Overall Study|Protocol Violation|6|||
105526545|NCT01342510|363937763|FG002|Overall Study|Protocol Violation|13|||
105526546|NCT01342510|363937764|FG003|Overall Study|Protocol Violation|11|||
105526547|NCT01449526|363937765|FG000|Overall Study|Lost to Follow-up|1|||
105526548|NCT01449526|363937766|FG001|Overall Study|Lost to Follow-up|2|||
105526549|NCT01449526|363937765|FG000|Overall Study|Withdrawal by Subject|1|||
105526550|NCT01449526|363937766|FG001|Overall Study|Withdrawal by Subject|1|||
105526551|NCT01449526|363937765|FG000|Overall Study|Symptoms/complaints|0|||
105526552|NCT01449526|363937766|FG001|Overall Study|Symptoms/complaints|1|||
105526553|NCT01449526|363937765|FG000|Overall Study|Lack of Motivation|0|||
105526554|NCT01449526|363937766|FG001|Overall Study|Lack of Motivation|1|||
105526555|NCT01449526|363937765|FG000|Overall Study|Cannot maintain visits|0|||
105526556|NCT01449526|363937766|FG001|Overall Study|Cannot maintain visits|1|||
105526557|NCT03323658|363937768|FG000|Overall Study|Adverse Event|0|||
105526558|NCT03323658|363937769|FG001|Overall Study|Adverse Event|1|||
105526559|NCT03323658|363937770|FG002|Overall Study|Adverse Event|0|||
105526560|NCT00549562|363937771|FG000|Overall Study|Adverse Event|1|||
105526561|NCT00549562|363937771|FG000|Overall Study|Lack of Efficacy|1|||
105526562|NCT02276612|363937772|FG000|Overall Study|Death|1|||
105526563|NCT02276612|363937773|FG001|Overall Study|Death|0|||
105526564|NCT02276612|363937772|FG000|Overall Study|Pregnancy|1|||
105526565|NCT02276612|363937773|FG001|Overall Study|Pregnancy|0|||
105439075|NCT01844778|363613396|FG000|Overall Study|Protocol deviation|0|||
105439076|NCT01844778|363613397|FG001|Overall Study|Protocol deviation|1|||
105439077|NCT01844778|363613398|FG002|Overall Study|Protocol deviation|2|||
105439078|NCT01844778|363613396|FG000|Overall Study|Withdrawal by Subject|2|||
105439079|NCT01844778|363613397|FG001|Overall Study|Withdrawal by Subject|0|||
105439080|NCT01844778|363613398|FG002|Overall Study|Withdrawal by Subject|0|||
105439081|NCT01844778|363613396|FG000|Overall Study|Adverse Event|0|||
105439082|NCT01844778|363613397|FG001|Overall Study|Adverse Event|2|||
105439083|NCT01844778|363613398|FG002|Overall Study|Adverse Event|2|||
105439084|NCT02409719|363613399|FG000|Overall Study|Lost to Follow-up|3|||
105439085|NCT02409719|363613400|FG001|Overall Study|Lost to Follow-up|3|||
105439086|NCT00588094|363613401|FG000|Overall Study|Adverse Event|3|||
105526566|NCT02276612|363937772|FG000|Overall Study|Withdrew Consent|1|||
105526567|NCT02276612|363937773|FG001|Overall Study|Withdrew Consent|0|||
105526568|NCT02276612|363937772|FG000|Overall Study|Lost to Follow-up|1|||
105526569|NCT02276612|363937773|FG001|Overall Study|Lost to Follow-up|0|||
105526570|NCT04709575|363938918|FG000|Overall Study|Withdrawal by Subject|6|||
105526571|NCT04709575|363938919|FG001|Overall Study|Withdrawal by Subject|2|||
105526572|NCT04709575|363938918|FG000|Overall Study|Lost to Follow-up|2|||
105526573|NCT04709575|363938919|FG001|Overall Study|Lost to Follow-up|2|||
105439087|NCT00588094|363613401|FG000|Overall Study|Progression of Disease|2|||
105439088|NCT02951429|363613406|FG000|Overall Study|Adverse Event|3|||
105439089|NCT02951429|363613407|FG001|Overall Study|Adverse Event|7|||
105439090|NCT02951429|363613406|FG000|Overall Study|Death|28|||
105593065|NCT00542386|364170849|FG003|Overall Study|Physician Decision|1|||
105593066|NCT00542386|364170850|FG004|Overall Study|Physician Decision|0|||
105593067|NCT00542386|364170851|FG005|Overall Study|Physician Decision|0|||
105593068|NCT00542386|364170846|FG000|Overall Study|Protocol Violation|0|||
105593069|NCT00542386|364170847|FG001|Overall Study|Protocol Violation|0|||
105593070|NCT00542386|364170848|FG002|Overall Study|Protocol Violation|1|||
105593071|NCT00542386|364170849|FG003|Overall Study|Protocol Violation|0|||
105593072|NCT00542386|364170850|FG004|Overall Study|Protocol Violation|0|||
105593073|NCT00542386|364170851|FG005|Overall Study|Protocol Violation|4|||
105593074|NCT00542386|364170846|FG000|Overall Study|Withdrawal by Subject|5|||
105593075|NCT00542386|364170847|FG001|Overall Study|Withdrawal by Subject|8|||
105593076|NCT00542386|364170848|FG002|Overall Study|Withdrawal by Subject|10|||
105593077|NCT00542386|364170849|FG003|Overall Study|Withdrawal by Subject|11|||
105593078|NCT00542386|364170850|FG004|Overall Study|Withdrawal by Subject|15|||
105593079|NCT00542386|364170851|FG005|Overall Study|Withdrawal by Subject|7|||
105593080|NCT00542386|364170846|FG000|Overall Study|Other Reasons|4|||
105593081|NCT00542386|364170847|FG001|Overall Study|Other Reasons|1|||
105593082|NCT00542386|364170848|FG002|Overall Study|Other Reasons|4|||
105593083|NCT00542386|364170849|FG003|Overall Study|Other Reasons|3|||
105593084|NCT00542386|364170850|FG004|Overall Study|Other Reasons|4|||
105593085|NCT00542386|364170851|FG005|Overall Study|Other Reasons|2|||
105593086|NCT02503202|364170852|FG000|Base Study: Up to Month 6|Death|1|||
105593087|NCT02503202|364170853|FG001|Base Study: Up to Month 6|Death|1|||
105593088|NCT02503202|364170854|FG002|Base Study: Up to Month 6|Death|0|||
105593089|NCT02503202|364170855|FG003|Base Study: Up to Month 6|Death|0|||
105593090|NCT02503202|364170856|FG004|Base Study: Up to Month 6|Death|0|||
105593091|NCT02503202|364170852|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
105593092|NCT02503202|364170853|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
105593093|NCT02503202|364170854|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
105593094|NCT02503202|364170855|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
105593095|NCT02503202|364170856|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
105593096|NCT02503202|364170852|FG000|Base Study: Up to Month 6|Physician Decision|0|||
105593097|NCT02503202|364170853|FG001|Base Study: Up to Month 6|Physician Decision|0|||
105593098|NCT02503202|364170854|FG002|Base Study: Up to Month 6|Physician Decision|0|||
105593099|NCT02503202|364170855|FG003|Base Study: Up to Month 6|Physician Decision|0|||
105593100|NCT02503202|364170856|FG004|Base Study: Up to Month 6|Physician Decision|1|||
105593101|NCT02503202|364170852|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
105593102|NCT02503202|364170853|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
105593103|NCT02503202|364170854|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
105593104|NCT02503202|364170855|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
105593105|NCT02503202|364170856|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
105593106|NCT02503202|364170852|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
105593107|NCT02503202|364170853|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
105593108|NCT02503202|364170854|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
105593109|NCT02503202|364170855|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
105593110|NCT02503202|364170856|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
105593111|NCT02503202|364170852|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
105593112|NCT02503202|364170853|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
105593113|NCT02503202|364170854|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
105593114|NCT02503202|364170855|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
105593115|NCT02503202|364170856|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
105439091|NCT02951429|363613407|FG001|Overall Study|Death|36|||
105439092|NCT02951429|363613406|FG000|Overall Study|Lack of Efficacy|0|||
105439093|NCT02951429|363613407|FG001|Overall Study|Lack of Efficacy|1|||
105439094|NCT02951429|363613406|FG000|Overall Study|Lost to Follow-up|0|||
105439095|NCT02951429|363613407|FG001|Overall Study|Lost to Follow-up|1|||
105439096|NCT02951429|363613406|FG000|Overall Study|Lung Transplantation|9|||
105439097|NCT02951429|363613407|FG001|Overall Study|Lung Transplantation|6|||
105439098|NCT02951429|363613406|FG000|Overall Study|Other|1|||
105439099|NCT02951429|363613407|FG001|Overall Study|Other|3|||
105439100|NCT02951429|363613406|FG000|Overall Study|Progressive Disease|1|||
105439101|NCT02951429|363613407|FG001|Overall Study|Progressive Disease|1|||
105439102|NCT02951429|363613406|FG000|Overall Study|Withdrawal by Subject|7|||
105439103|NCT02951429|363613407|FG001|Overall Study|Withdrawal by Subject|11|||
105439104|NCT02951429|363613406|FG000|Overall Study|Participant ongoing in the study|23|||
105439105|NCT02951429|363613407|FG001|Overall Study|Participant ongoing in the study|17|||
105439106|NCT01894022|363613411|FG000|Overall Study|Death|1|||
105439107|NCT01894022|363613412|FG001|Overall Study|Death|0|||
105439108|NCT01894022|363613411|FG000|Overall Study|Adverse Event, non-fatal|1|||
105439109|NCT01894022|363613412|FG001|Overall Study|Adverse Event, non-fatal|0|||
105439110|NCT01894022|363613411|FG000|Overall Study|Study Closed/terminated|7|||
105439111|NCT01894022|363613412|FG001|Overall Study|Study Closed/terminated|10|||
105439112|NCT00391625|363613414|FG000|Month 14|Withdrawal by Subject|1|||
105439113|NCT00391625|363613414|FG000|Month 50|Physician Decision|1|||
105439114|NCT00767819|363613415|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
105593116|NCT02503202|364170852|FG000|Extension: Month 6 to 24|Death|1|||
105526574|NCT04709575|363938918|FG000|Overall Study|Adverse Event|1|||
105526575|NCT04709575|363938919|FG001|Overall Study|Adverse Event|0|||
105526576|NCT04709575|363938918|FG000|Overall Study|Protocol Violation|1|||
105526577|NCT04709575|363938919|FG001|Overall Study|Protocol Violation|1|||
105526578|NCT03299842|363938924|FG000|Overall Study|Caregiver withdrew consent|2|||
105526579|NCT03299842|363938924|FG000|Overall Study|Child would not keep the watch on|3|||
105526580|NCT00136084|363938929|FG000|Overall Study|Death|12|||
105526581|NCT00136084|363938930|FG001|Overall Study|Death|5|||
105526582|NCT00136084|363938929|FG000|Overall Study|Unacceptable toxicity|8|||
105526583|NCT00136084|363938930|FG001|Overall Study|Unacceptable toxicity|11|||
105526584|NCT00136084|363938929|FG000|Overall Study|Relapse|20|||
105526585|NCT00136084|363938930|FG001|Overall Study|Relapse|23|||
105526586|NCT00136084|363938929|FG000|Overall Study|Lost to Follow-up|2|||
105526587|NCT00136084|363938930|FG001|Overall Study|Lost to Follow-up|0|||
105526588|NCT00136084|363938929|FG000|Overall Study|No Response|1|||
105526589|NCT00136084|363938930|FG001|Overall Study|No Response|2|||
105439115|NCT00767819|363613416|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
105439116|NCT00767819|363613417|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105439117|NCT00767819|363613415|FG000|Overall Study|Withdrawal by Subject|1|||
105439118|NCT00767819|363613416|FG001|Overall Study|Withdrawal by Subject|1|||
105439119|NCT00767819|363613417|FG002|Overall Study|Withdrawal by Subject|0|||
105439120|NCT00767819|363613415|FG000|Overall Study|Administrative problems|0|||
105439121|NCT00767819|363613416|FG001|Overall Study|Administrative problems|1|||
105439122|NCT00767819|363613417|FG002|Overall Study|Administrative problems|0|||
105439123|NCT00767819|363613415|FG000|Overall Study|Death|2|||
105439124|NCT00767819|363613416|FG001|Overall Study|Death|3|||
105439125|NCT00767819|363613417|FG002|Overall Study|Death|0|||
105439126|NCT00767819|363613415|FG000|Overall Study|Adverse Event|2|||
105439127|NCT00767819|363613416|FG001|Overall Study|Adverse Event|0|||
105439128|NCT00767819|363613417|FG002|Overall Study|Adverse Event|0|||
105439129|NCT00767819|363613415|FG000|Overall Study|Abnormal lab values|1|||
105439130|NCT00767819|363613416|FG001|Overall Study|Abnormal lab values|0|||
105439131|NCT00767819|363613417|FG002|Overall Study|Abnormal lab values|0|||
105439132|NCT00767819|363613415|FG000|Overall Study|Lost to Follow-up|1|||
105439133|NCT00767819|363613416|FG001|Overall Study|Lost to Follow-up|0|||
105439134|NCT00767819|363613417|FG002|Overall Study|Lost to Follow-up|0|||
105439135|NCT05392803|363613422|FG000|Overall Study|Lost to Follow-up|0|||
105439136|NCT05392803|363613423|FG001|Overall Study|Lost to Follow-up|2|||
105439137|NCT04294147|363613424|FG000|Overall Study|Protocol Violation|2|||
105439138|NCT04294147|363613425|FG001|Overall Study|Protocol Violation|0|||
105439139|NCT00699335|363613435|FG000|Overall Study|Combination of multiple reasons|176|||
105439140|NCT00699335|363613435|FG000|Overall Study|Missing data|52|||
105439141|NCT00915551|363613436|FG000|Overall Study|Withdrawal by Subject|0|||
105439142|NCT00915551|363613437|FG001|Overall Study|Withdrawal by Subject|1|||
105439143|NCT01371734|363613438|FG000|Overall Study|Other|2|||
105439144|NCT01371734|363613439|FG001|Overall Study|Other|1|||
105439145|NCT01371734|363613440|FG002|Overall Study|Other|2|||
105439146|NCT01371734|363613438|FG000|Overall Study|Withdrawal by Subject|3|||
105439147|NCT01371734|363613439|FG001|Overall Study|Withdrawal by Subject|4|||
105439148|NCT01371734|363613440|FG002|Overall Study|Withdrawal by Subject|9|||
105439149|NCT01371734|363613438|FG000|Overall Study|Lost to Follow-up|5|||
105439150|NCT01371734|363613439|FG001|Overall Study|Lost to Follow-up|3|||
105439151|NCT01371734|363613440|FG002|Overall Study|Lost to Follow-up|1|||
105439152|NCT01371734|363613438|FG000|Overall Study|Protocol Violation|3|||
105439153|NCT01371734|363613439|FG001|Overall Study|Protocol Violation|1|||
105439154|NCT01371734|363613440|FG002|Overall Study|Protocol Violation|2|||
105439155|NCT01371734|363613438|FG000|Overall Study|Adverse Event|8|||
105439156|NCT01371734|363613439|FG001|Overall Study|Adverse Event|8|||
105439157|NCT01371734|363613440|FG002|Overall Study|Adverse Event|3|||
105439158|NCT01371734|363613438|FG000|Overall Study|Lack of Efficacy|2|||
105439159|NCT01371734|363613439|FG001|Overall Study|Lack of Efficacy|2|||
105439160|NCT01371734|363613440|FG002|Overall Study|Lack of Efficacy|0|||
105439161|NCT01743040|363613441|FG000|Overall Study|Death|1|||
105439162|NCT01743040|363613441|FG000|Overall Study|Lost to Follow-up|66|||
105439163|NCT01743040|363613441|FG000|Overall Study|Physician Decision|40|||
105439164|NCT01743040|363613441|FG000|Overall Study|Protocol Violation|1|||
105439165|NCT01743040|363613441|FG000|Overall Study|Withdrawal by Subject|121|||
105439166|NCT01620944|363613443|FG000|Overall Study|Early termination of Study|2|||
105439167|NCT01620944|363613444|FG001|Overall Study|Early termination of Study|1|||
105439168|NCT01123707|363613445|FG000|Overall Study|Lost to Follow-up|3|||
105439169|NCT01123707|363613446|FG001|Overall Study|Lost to Follow-up|1|||
105439170|NCT01123707|363613447|FG002|Overall Study|Lost to Follow-up|3|||
105439171|NCT01123707|363613448|FG003|Overall Study|Lost to Follow-up|2|||
105439172|NCT01123707|363613445|FG000|Overall Study|Adverse Event|5|||
105439173|NCT01123707|363613446|FG001|Overall Study|Adverse Event|7|||
105439174|NCT01123707|363613447|FG002|Overall Study|Adverse Event|5|||
105439175|NCT01123707|363613448|FG003|Overall Study|Adverse Event|3|||
105439176|NCT01123707|363613445|FG000|Overall Study|Sponsor Discontinued Study|30|||
105439177|NCT01123707|363613446|FG001|Overall Study|Sponsor Discontinued Study|24|||
105439178|NCT01123707|363613447|FG002|Overall Study|Sponsor Discontinued Study|25|||
105439179|NCT01123707|363613448|FG003|Overall Study|Sponsor Discontinued Study|40|||
105439180|NCT01123707|363613445|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
105439181|NCT01123707|363613446|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
105439182|NCT01123707|363613447|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
105439183|NCT01123707|363613448|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
105439184|NCT01123707|363613445|FG000|Overall Study|Investigator Withdrew Participant|0|||
105439185|NCT01123707|363613446|FG001|Overall Study|Investigator Withdrew Participant|1|||
105439186|NCT01123707|363613447|FG002|Overall Study|Investigator Withdrew Participant|1|||
105439187|NCT01123707|363613448|FG003|Overall Study|Investigator Withdrew Participant|1|||
105439188|NCT01123707|363613445|FG000|Overall Study|Subject Withdrew Consent|4|||
105439189|NCT01123707|363613446|FG001|Overall Study|Subject Withdrew Consent|5|||
105439190|NCT01123707|363613447|FG002|Overall Study|Subject Withdrew Consent|1|||
105439191|NCT01123707|363613448|FG003|Overall Study|Subject Withdrew Consent|2|||
105439192|NCT01123707|363613445|FG000|Overall Study|Lack of Efficacy|1|||
105439193|NCT01123707|363613446|FG001|Overall Study|Lack of Efficacy|2|||
105439194|NCT01123707|363613447|FG002|Overall Study|Lack of Efficacy|1|||
105439195|NCT01123707|363613448|FG003|Overall Study|Lack of Efficacy|0|||
105439196|NCT01123707|363613445|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
105439197|NCT01123707|363613446|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
105439198|NCT01123707|363613447|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
105439199|NCT01123707|363613448|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
105439200|NCT01959243|363613449|FG000|Overall Study|Investigator Decision|3|||
105439201|NCT01959243|363613450|FG001|Overall Study|Investigator Decision|0|||
105439202|NCT01959243|363613449|FG000|Overall Study|Adverse Event|5|||
105439203|NCT01959243|363613450|FG001|Overall Study|Adverse Event|2|||
105439204|NCT01959243|363613449|FG000|Overall Study|Administrative reasons|2|||
105439205|NCT01959243|363613450|FG001|Overall Study|Administrative reasons|1|||
105439206|NCT01959243|363613449|FG000|Overall Study|Lost to Follow-up|3|||
105439207|NCT01959243|363613450|FG001|Overall Study|Lost to Follow-up|1|||
105439208|NCT02554981|363613453|FG000|Overall Study|Adverse Event|1|||
105439209|NCT02554981|363613453|FG000|Overall Study|Administrative Reasons|1|||
105439210|NCT02554981|363613453|FG000|Overall Study|Other Miscellaneous Reasons|3|||
105439211|NCT00428844|363613454|FG000|Completed Study Drug Treatment|Adverse Event|2|||
105439212|NCT00428844|363613455|FG001|Completed Study Drug Treatment|Adverse Event|4|||
105439213|NCT00428844|363613456|FG002|Completed Study Drug Treatment|Adverse Event|4|||
105439214|NCT00428844|363613454|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
105439215|NCT00428844|363613455|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
105439216|NCT00428844|363613456|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
105439217|NCT00428844|363613454|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
105439218|NCT00428844|363613455|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
105439219|NCT00428844|363613456|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
105526590|NCT00136084|363938929|FG000|Overall Study|Withdrawal by Subject|5|||
105526591|NCT00136084|363938930|FG001|Overall Study|Withdrawal by Subject|1|||
105526592|NCT01275066|363938933|FG000|Overall Study|Withdrawal by Subject|0|||
105526593|NCT01275066|363938934|FG001|Overall Study|Withdrawal by Subject|0|||
105526594|NCT01275066|363938935|FG002|Overall Study|Withdrawal by Subject|1|||
105526595|NCT01275066|363938933|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
105526596|NCT01275066|363938934|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
105526597|NCT01275066|363938935|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
105526598|NCT03509675|363938937|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
105526599|NCT03509675|363938938|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
105526600|NCT03509675|363938937|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
105526601|NCT03509675|363938938|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
105526602|NCT03509675|363938937|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
105526603|NCT03509675|363938938|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
105439220|NCT00428844|363613454|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
105439221|NCT00428844|363613455|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
105439222|NCT00428844|363613456|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
105439223|NCT00428844|363613454|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
105439224|NCT00428844|363613455|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
105439225|NCT00428844|363613456|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
105439226|NCT00428844|363613454|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
105439227|NCT00428844|363613455|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
105439228|NCT00428844|363613456|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
105439229|NCT00428844|363613454|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
105439230|NCT00428844|363613455|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
105439231|NCT00428844|363613456|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
105439232|NCT00428844|363613454|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
105526604|NCT03509675|363938937|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
105526605|NCT03509675|363938938|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
105593117|NCT02503202|364170853|FG001|Extension: Month 6 to 24|Death|0|||
105526606|NCT02780804|363938941|FG000|Overall Study|Death|1|||
105439233|NCT00428844|363613455|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
105439234|NCT00428844|363613456|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
105593118|NCT02503202|364170854|FG002|Extension: Month 6 to 24|Death|0|||
105439235|NCT00428844|363613454|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
105439236|NCT00428844|363613455|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
105526607|NCT02780804|363938942|FG001|Overall Study|Death|0|||
105526608|NCT02780804|363938943|FG002|Overall Study|Death|0|||
105526609|NCT02780804|363938941|FG000|Overall Study|Lack of Efficacy|5|||
105526610|NCT02780804|363938942|FG001|Overall Study|Lack of Efficacy|8|||
105526611|NCT02780804|363938943|FG002|Overall Study|Lack of Efficacy|4|||
105526612|NCT02780804|363938941|FG000|Overall Study|Physician Decision|0|||
105526613|NCT02780804|363938942|FG001|Overall Study|Physician Decision|0|||
105526614|NCT02780804|363938943|FG002|Overall Study|Physician Decision|2|||
105526615|NCT02780804|363938941|FG000|Overall Study|Withdrawal by Subject|0|||
105593119|NCT02503202|364170855|FG003|Extension: Month 6 to 24|Death|0|||
105526616|NCT02780804|363938942|FG001|Overall Study|Withdrawal by Subject|1|||
105526617|NCT02780804|363938943|FG002|Overall Study|Withdrawal by Subject|0|||
105526618|NCT01723163|363938944|FG000|Treatment Phase|Withdrawal by Subject|14|||
105526619|NCT01723163|363938945|FG001|Treatment Phase|Withdrawal by Subject|6|||
105526620|NCT01723163|363938944|FG000|Treatment Phase|Withdrawal by PI|5|||
105526621|NCT01723163|363938945|FG001|Treatment Phase|Withdrawal by PI|1|||
105526622|NCT01723163|363938944|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
105526623|NCT01723163|363938945|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
105526624|NCT01723163|363938944|FG000|3-Month Follow-up|Unable to Contact|12|||
105526625|NCT01723163|363938945|FG001|3-Month Follow-up|Unable to Contact|19|||
105526626|NCT01723163|363938944|FG000|6-Month Follow-up|Death|1|||
105526627|NCT01723163|363938945|FG001|6-Month Follow-up|Death|0|||
105526628|NCT01723163|363938944|FG000|6-Month Follow-up|Unable to Contact|17|||
105526629|NCT01723163|363938945|FG001|6-Month Follow-up|Unable to Contact|15|||
105526630|NCT01723163|363938944|FG000|12-Month Follow-up|Death|1|||
105526631|NCT01723163|363938945|FG001|12-Month Follow-up|Death|0|||
105526632|NCT01723163|363938944|FG000|12-Month Follow-up|Unable to Contact|23|||
105526633|NCT01723163|363938945|FG001|12-Month Follow-up|Unable to Contact|28|||
105526634|NCT01859507|363938948|FG000|Overall Study|left the country|4|||
105526635|NCT02342704|363938951|FG000|Overall Study|Physician Decision|0|||
105526636|NCT02342704|363938952|FG001|Overall Study|Physician Decision|3|||
105526637|NCT02342704|363938951|FG000|Overall Study|Sponsor Termination|49|||
105526638|NCT02342704|363938952|FG001|Overall Study|Sponsor Termination|43|||
105526639|NCT02342704|363938951|FG000|Overall Study|Other|0|||
105526640|NCT02342704|363938952|FG001|Overall Study|Other|1|||
105526641|NCT02342704|363938951|FG000|Overall Study|Withdrawal by Subject|1|||
105526642|NCT02342704|363938952|FG001|Overall Study|Withdrawal by Subject|0|||
105526643|NCT02342704|363938951|FG000|Overall Study|Lost to Follow-up|2|||
105526644|NCT02342704|363938952|FG001|Overall Study|Lost to Follow-up|1|||
105526645|NCT02342704|363938951|FG000|Overall Study|Adverse Event|1|||
105526646|NCT02342704|363938952|FG001|Overall Study|Adverse Event|3|||
105526647|NCT02506816|363938957|FG000|Overall Study|Adverse Event|3|||
105526648|NCT02759120|363938965|FG000|Overall Study|Death|34|||
105526649|NCT02759120|363938966|FG001|Overall Study|Death|36|||
105526650|NCT02759120|363938965|FG000|Overall Study|Lost to Follow-up|4|||
105526651|NCT02759120|363938966|FG001|Overall Study|Lost to Follow-up|7|||
105526652|NCT02759120|363938965|FG000|Overall Study|Physician Decision|3|||
105526653|NCT02759120|363938966|FG001|Overall Study|Physician Decision|0|||
105526654|NCT02759120|363938965|FG000|Overall Study|Withdrawal by Subject|28|||
105526655|NCT02759120|363938966|FG001|Overall Study|Withdrawal by Subject|15|||
105526656|NCT02759120|363938965|FG000|Overall Study|Moved out of area|3|||
105526657|NCT02759120|363938966|FG001|Overall Study|Moved out of area|4|||
105526658|NCT02759120|363938965|FG000|Overall Study|Lung transplant|3|||
105526659|NCT02759120|363938966|FG001|Overall Study|Lung transplant|5|||
105526660|NCT02759120|363938965|FG000|Overall Study|Other reason not completed|10|||
105526661|NCT02759120|363938966|FG001|Overall Study|Other reason not completed|12|||
105526662|NCT01817725|363938967|FG000|Overall Study|Withdrawal by Subject|1|||
105526663|NCT02286193|363938970|FG000|Overall Study|Referred: CRS unable to make contact|62|||
105526664|NCT02286193|363938970|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
105526665|NCT02286193|363938970|FG000|Overall Study|Referred: Declined service|38|||
105526666|NCT01232296|363938971|FG000|Overall Study|Adverse Event|24|||
105439237|NCT00428844|363613456|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
105439238|NCT03208088|363613462|FG000|Period 2|Withdrawal by Subject|0|||
105439239|NCT03208088|363613463|FG001|Period 2|Withdrawal by Subject|0|||
105439240|NCT03208088|363613464|FG002|Period 2|Withdrawal by Subject|0|||
105439241|NCT03208088|363613465|FG003|Period 2|Withdrawal by Subject|0|||
105439242|NCT03208088|363613466|FG004|Period 2|Withdrawal by Subject|0|||
105439243|NCT03208088|363613467|FG005|Period 2|Withdrawal by Subject|0|||
105439244|NCT03208088|363613468|FG006|Period 2|Withdrawal by Subject|0|||
105439245|NCT03208088|363613469|FG007|Period 2|Withdrawal by Subject|0|||
105439246|NCT03208088|363613470|FG008|Period 2|Withdrawal by Subject|1|||
105439247|NCT03208088|363613471|FG009|Period 2|Withdrawal by Subject|0|||
105439248|NCT03208088|363613462|FG000|Period 3|Unsatisfactory Test Article|0|||
105526667|NCT01232296|363938972|FG001|Overall Study|Adverse Event|12|||
105439249|NCT03208088|363613463|FG001|Period 3|Unsatisfactory Test Article|0|||
105439250|NCT03208088|363613464|FG002|Period 3|Unsatisfactory Test Article|0|||
105439251|NCT03208088|363613465|FG003|Period 3|Unsatisfactory Test Article|1|||
105439252|NCT03208088|363613466|FG004|Period 3|Unsatisfactory Test Article|0|||
105439253|NCT03208088|363613467|FG005|Period 3|Unsatisfactory Test Article|0|||
105439254|NCT03208088|363613468|FG006|Period 3|Unsatisfactory Test Article|0|||
105439255|NCT03208088|363613469|FG007|Period 3|Unsatisfactory Test Article|0|||
105439256|NCT03208088|363613470|FG008|Period 3|Unsatisfactory Test Article|0|||
105439257|NCT03208088|363613471|FG009|Period 3|Unsatisfactory Test Article|0|||
105439258|NCT03208088|363613462|FG000|Period 4|Unsatisfactory Test Article|0|||
105439259|NCT03208088|363613463|FG001|Period 4|Unsatisfactory Test Article|0|||
105439260|NCT03208088|363613464|FG002|Period 4|Unsatisfactory Test Article|0|||
105439261|NCT03208088|363613465|FG003|Period 4|Unsatisfactory Test Article|1|||
105439262|NCT03208088|363613466|FG004|Period 4|Unsatisfactory Test Article|0|||
105439263|NCT03208088|363613467|FG005|Period 4|Unsatisfactory Test Article|0|||
105439264|NCT03208088|363613468|FG006|Period 4|Unsatisfactory Test Article|0|||
105439265|NCT03208088|363613469|FG007|Period 4|Unsatisfactory Test Article|0|||
105439266|NCT03208088|363613470|FG008|Period 4|Unsatisfactory Test Article|0|||
105439267|NCT03208088|363613471|FG009|Period 4|Unsatisfactory Test Article|0|||
105439268|NCT01068158|363613474|FG000|Overall Study|Withdrawal by Subject|1|||
105439269|NCT01068158|363613475|FG001|Overall Study|Withdrawal by Subject|2|||
105439270|NCT01068158|363613474|FG000|Overall Study|Lost to Follow-up|7|||
105439271|NCT01068158|363613475|FG001|Overall Study|Lost to Follow-up|0|||
105439272|NCT01068158|363613474|FG000|Overall Study|Protocol Violation|0|||
105439273|NCT01068158|363613475|FG001|Overall Study|Protocol Violation|2|||
105439274|NCT00991406|363613476|FG000|Overall Study|One participant did not respond to FES.|1|||
105439275|NCT00986362|363613477|FG000|Overall Study|Death|2|||
105439276|NCT00986362|363613478|FG001|Overall Study|Death|0|||
105439277|NCT00986362|363613477|FG000|Overall Study|Lost to Follow-up|0|||
105439278|NCT00986362|363613478|FG001|Overall Study|Lost to Follow-up|1|||
105439279|NCT01300572|363613479|FG000|Overall Study|HAMA + post dosimetry|1|||
105439280|NCT00384332|363613480|FG000|Overall Study|Lost to Follow-up|4|||
105439281|NCT00384332|363613481|FG001|Overall Study|Lost to Follow-up|0|||
105439282|NCT03597061|363613482|FG000|Overall Study|Lost to Follow-up|1|||
105439283|NCT03597061|363613483|FG001|Overall Study|Lost to Follow-up|0|||
105439284|NCT03597061|363613482|FG000|Overall Study|Protocol Violation|0|||
105439285|NCT03597061|363613483|FG001|Overall Study|Protocol Violation|1|||
105439286|NCT02006979|363613484|FG000|Overall Study|Withdrawal by Subject|1|||
105439287|NCT02006979|363613485|FG001|Overall Study|Withdrawal by Subject|1|||
105439288|NCT02006979|363613484|FG000|Overall Study|Protocol Violation|0|||
105593120|NCT02503202|364170856|FG004|Extension: Month 6 to 24|Death|0|||
105593121|NCT02503202|364170852|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
105593122|NCT02503202|364170853|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
105439289|NCT02006979|363613485|FG001|Overall Study|Protocol Violation|1|||
105439290|NCT00375518|363613486|FG000|Overall Study|Withdrawal by Subject|2|||
105439291|NCT00375518|363613487|FG001|Overall Study|Withdrawal by Subject|10|||
105439292|NCT00375518|363613486|FG000|Overall Study|Patient Not Treated|6|||
105439293|NCT00375518|363613487|FG001|Overall Study|Patient Not Treated|6|||
105439294|NCT00375518|363613486|FG000|Overall Study|Death|0|||
105439295|NCT00375518|363613487|FG001|Overall Study|Death|1|||
105439296|NCT03170193|363613488|FG000|Overall Study|Withdrawal by Subject|0|||
105439297|NCT03170193|363613489|FG001|Overall Study|Withdrawal by Subject|0|||
105439298|NCT03170193|363613490|FG002|Overall Study|Withdrawal by Subject|0|||
105526668|NCT01232296|363938971|FG000|Overall Study|Physician Decision|1|||
105593123|NCT02503202|364170854|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
105593124|NCT02503202|364170855|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
105593125|NCT02503202|364170856|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
105593126|NCT02503202|364170852|FG000|Extension: Month 6 to 24|Physician Decision|1|||
105593127|NCT02503202|364170853|FG001|Extension: Month 6 to 24|Physician Decision|0|||
105593128|NCT02503202|364170854|FG002|Extension: Month 6 to 24|Physician Decision|1|||
105593129|NCT02503202|364170855|FG003|Extension: Month 6 to 24|Physician Decision|3|||
105593130|NCT02503202|364170856|FG004|Extension: Month 6 to 24|Physician Decision|0|||
105593131|NCT02503202|364170852|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
105593132|NCT02503202|364170853|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
105593133|NCT02503202|364170854|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
105593134|NCT02503202|364170855|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
105593135|NCT02503202|364170856|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
105593136|NCT00906035|364170859|FG000|Overall Study|Withdrawal by Subject|2|||
105593137|NCT00906035|364170860|FG001|Overall Study|Withdrawal by Subject|3|||
105593138|NCT00906035|364170861|FG002|Overall Study|Withdrawal by Subject|0|||
105593139|NCT03058991|364170862|FG000|Overall Study|Lost to Follow-up|17|||
105593140|NCT03058991|364170863|FG001|Overall Study|Lost to Follow-up|12|||
105593141|NCT03058991|364170864|FG002|Overall Study|Lost to Follow-up|12|||
105593142|NCT03058991|364170862|FG000|Overall Study|Withdrawal by Subject|1|||
105593143|NCT03058991|364170863|FG001|Overall Study|Withdrawal by Subject|0|||
105593144|NCT03058991|364170864|FG002|Overall Study|Withdrawal by Subject|0|||
105593145|NCT00130637|364170865|FG000|Overall Study|Adverse Event|2|||
105593146|NCT00130637|364170865|FG000|Overall Study|Withdrawal by Subject|1|||
105593147|NCT03621761|364170866|FG000|Overall Study|Lost to Follow-up|1|||
105593148|NCT03621761|364170867|FG001|Overall Study|Lost to Follow-up|1|||
105593149|NCT03621761|364170868|FG002|Overall Study|Lost to Follow-up|2|||
105593150|NCT03621761|364170866|FG000|Overall Study|Withdrawal by Subject|2|||
105593151|NCT03621761|364170867|FG001|Overall Study|Withdrawal by Subject|1|||
105593152|NCT03621761|364170868|FG002|Overall Study|Withdrawal by Subject|1|||
105593153|NCT03621761|364170866|FG000|Overall Study|Became Ineligible|0|||
105593154|NCT03621761|364170867|FG001|Overall Study|Became Ineligible|2|||
105593155|NCT03621761|364170868|FG002|Overall Study|Became Ineligible|0|||
105593156|NCT01050569|364170870|FG000|Overall Study|Lost to Follow-up|20|||
105593157|NCT01050569|364170871|FG001|Overall Study|Lost to Follow-up|14|||
105593158|NCT01050569|364170872|FG002|Overall Study|Lost to Follow-up|16|||
105593159|NCT01050569|364170870|FG000|Overall Study|Withdrawal by Subject|9|||
105593160|NCT01050569|364170871|FG001|Overall Study|Withdrawal by Subject|3|||
105593161|NCT01050569|364170872|FG002|Overall Study|Withdrawal by Subject|11|||
105593162|NCT01050569|364170870|FG000|Overall Study|Lack of Efficacy|5|||
105593163|NCT01050569|364170871|FG001|Overall Study|Lack of Efficacy|4|||
105593164|NCT01050569|364170872|FG002|Overall Study|Lack of Efficacy|3|||
105593165|NCT01050569|364170870|FG000|Overall Study|Adverse Event|1|||
105593166|NCT01050569|364170871|FG001|Overall Study|Adverse Event|0|||
105593167|NCT01050569|364170872|FG002|Overall Study|Adverse Event|0|||
105593168|NCT01050569|364170870|FG000|Overall Study|Physician Decision|3|||
105593169|NCT01050569|364170871|FG001|Overall Study|Physician Decision|3|||
105593170|NCT01050569|364170872|FG002|Overall Study|Physician Decision|3|||
105593171|NCT03939819|364170873|FG000|Overall Study|Death|2|||
105593172|NCT03939819|364170874|FG001|Overall Study|Death|0|||
105593173|NCT01959412|364170875|FG000|Overall Study|Protocol deviation|1|||
105593174|NCT01959412|364170876|FG001|Overall Study|Protocol deviation|1|||
105593175|NCT01959412|364170877|FG002|Overall Study|Protocol deviation|0|||
105593176|NCT01959412|364170878|FG003|Overall Study|Protocol deviation|1|||
105593177|NCT01959412|364170879|FG004|Overall Study|Protocol deviation|3|||
105593178|NCT01959412|364170880|FG005|Overall Study|Protocol deviation|0|||
105593179|NCT01959412|364170875|FG000|Overall Study|Adverse Event|0|||
105593180|NCT01959412|364170876|FG001|Overall Study|Adverse Event|0|||
105593181|NCT01959412|364170877|FG002|Overall Study|Adverse Event|0|||
105593182|NCT01959412|364170878|FG003|Overall Study|Adverse Event|1|||
105593183|NCT01959412|364170879|FG004|Overall Study|Adverse Event|0|||
105593184|NCT01959412|364170880|FG005|Overall Study|Adverse Event|0|||
105593185|NCT01186848|364170881|FG000|Overall Study|Lost to Follow-up|4|||
105593186|NCT01186848|364170881|FG000|Overall Study|Withdrawal by Subject|2|||
105593187|NCT01186848|364170881|FG000|Overall Study|Adverse Event|2|||
105593188|NCT00079183|364170901|FG000|Overall Study|Withdrawal by Subject|4|||
105593189|NCT00079183|364170901|FG000|Overall Study|Study medication non-compliance|2|||
105593190|NCT00079183|364170901|FG000|Overall Study|Specimen collection non-compliance|1|||
105593191|NCT01194258|364170902|FG000|Titration Period|Withdrawal by Subject|6|||
105593192|NCT01194258|364170903|FG001|Titration Period|Withdrawal by Subject|0|||
105593193|NCT01194258|364170904|FG002|Titration Period|Withdrawal by Subject|0|||
105593194|NCT01194258|364170905|FG003|Titration Period|Withdrawal by Subject|0|||
105593195|NCT01194258|364170906|FG004|Titration Period|Withdrawal by Subject|0|||
105593196|NCT01194258|364170902|FG000|Titration Period|Lost to Follow-up|2|||
105593197|NCT01194258|364170903|FG001|Titration Period|Lost to Follow-up|0|||
105593198|NCT01194258|364170904|FG002|Titration Period|Lost to Follow-up|0|||
105593199|NCT01194258|364170905|FG003|Titration Period|Lost to Follow-up|0|||
105439299|NCT03170193|363613491|FG003|Overall Study|Withdrawal by Subject|1|||
105439300|NCT03170193|363613492|FG004|Overall Study|Withdrawal by Subject|0|||
105439301|NCT03170193|363613493|FG005|Overall Study|Withdrawal by Subject|0|||
105439302|NCT03170193|363613494|FG006|Overall Study|Withdrawal by Subject|0|||
105439303|NCT03170193|363613488|FG000|Overall Study|Lost to Follow-up|1|||
105439304|NCT03170193|363613489|FG001|Overall Study|Lost to Follow-up|1|||
105439305|NCT03170193|363613490|FG002|Overall Study|Lost to Follow-up|0|||
105439306|NCT03170193|363613491|FG003|Overall Study|Lost to Follow-up|0|||
105439307|NCT03170193|363613492|FG004|Overall Study|Lost to Follow-up|0|||
105439308|NCT03170193|363613493|FG005|Overall Study|Lost to Follow-up|0|||
105439309|NCT03170193|363613494|FG006|Overall Study|Lost to Follow-up|0|||
105439310|NCT02596945|363613495|FG000|Overall Study|No documentation of study drug dosing|3|||
105439311|NCT02596945|363613495|FG000|Overall Study|Other|32|||
105439312|NCT02596945|363613495|FG000|Overall Study|Change to hemodialysis|15|||
105439313|NCT02596945|363613495|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
105439314|NCT02596945|363613495|FG000|Overall Study|Withdrawal by Subject|1|||
105439315|NCT02596945|363613495|FG000|Overall Study|Missing|1|||
105439316|NCT00411632|363613496|FG000|Overall Study|Death|1|||
105439317|NCT00238238|363613498|FG000|Overall Study|Withdrawal by Subject|0|||
105439318|NCT00238238|363613499|FG001|Overall Study|Withdrawal by Subject|3|||
105439319|NCT00238238|363613500|FG002|Overall Study|Withdrawal by Subject|0|||
105439320|NCT02560012|363613501|FG000|Overall Study|Study Terminated|2|||
105439321|NCT01108523|363613502|FG000|Overall Study|Protocol Violation|4|||
105439322|NCT03052816|363613504|FG000|Overall Study|Withdrawal by Subject|1|||
105439323|NCT03052816|363613505|FG001|Overall Study|Withdrawal by Subject|0|||
105439324|NCT03052816|363613504|FG000|Overall Study|Desired opioids|2|||
105439325|NCT03052816|363613505|FG001|Overall Study|Desired opioids|0|||
105439326|NCT02218008|363613506|FG000|Stage 1 (S1)|Adverse Event|6|||
105439327|NCT02218008|363613507|FG001|Stage 1 (S1)|Adverse Event|5|||
105439328|NCT02218008|363613508|FG002|Stage 1 (S1)|Adverse Event|11|||
105439329|NCT02218008|363613509|FG003|Stage 1 (S1)|Adverse Event|0|||
105439330|NCT02218008|363613510|FG004|Stage 1 (S1)|Adverse Event|0|||
105439331|NCT02218008|363613511|FG005|Stage 1 (S1)|Adverse Event|0|||
105439332|NCT02218008|363613506|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
105439333|NCT02218008|363613507|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
105439334|NCT02218008|363613508|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
105439335|NCT02218008|363613509|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
105439336|NCT02218008|363613510|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
105439337|NCT02218008|363613511|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
105439338|NCT02218008|363613506|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
105439339|NCT02218008|363613507|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
105439340|NCT02218008|363613508|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
105439341|NCT02218008|363613509|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
105439342|NCT02218008|363613510|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
105439343|NCT02218008|363613511|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
105439344|NCT02218008|363613506|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
105439345|NCT02218008|363613507|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
105439346|NCT02218008|363613508|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
105439347|NCT02218008|363613509|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
105439348|NCT02218008|363613510|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
105439349|NCT02218008|363613511|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
105439350|NCT02218008|363613506|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
105439351|NCT02218008|363613507|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
105439352|NCT02218008|363613508|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
105439353|NCT02218008|363613509|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
105439354|NCT02218008|363613510|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
105439355|NCT02218008|363613511|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
105439356|NCT02218008|363613506|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
105439357|NCT02218008|363613507|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
105439358|NCT02218008|363613508|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
105439359|NCT02218008|363613509|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
105439360|NCT02218008|363613510|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
105439361|NCT02218008|363613511|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
105439362|NCT02218008|363613506|FG000|Stage 1 (S1)|Pregnancy|0|||
105439363|NCT02218008|363613507|FG001|Stage 1 (S1)|Pregnancy|0|||
105439364|NCT02218008|363613508|FG002|Stage 1 (S1)|Pregnancy|1|||
105439365|NCT02218008|363613509|FG003|Stage 1 (S1)|Pregnancy|0|||
105439366|NCT02218008|363613510|FG004|Stage 1 (S1)|Pregnancy|0|||
105439367|NCT02218008|363613511|FG005|Stage 1 (S1)|Pregnancy|0|||
105439368|NCT02218008|363613506|FG000|Stage 1 (S1)|Protocol Violation|0|||
105439369|NCT02218008|363613507|FG001|Stage 1 (S1)|Protocol Violation|0|||
105439370|NCT02218008|363613508|FG002|Stage 1 (S1)|Protocol Violation|1|||
105439371|NCT02218008|363613509|FG003|Stage 1 (S1)|Protocol Violation|0|||
105439372|NCT02218008|363613510|FG004|Stage 1 (S1)|Protocol Violation|0|||
105439373|NCT02218008|363613511|FG005|Stage 1 (S1)|Protocol Violation|0|||
105439374|NCT02218008|363613506|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
105439375|NCT02218008|363613507|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
105439376|NCT02218008|363613508|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
105593200|NCT01194258|364170906|FG004|Titration Period|Lost to Follow-up|0|||
105593201|NCT01194258|364170902|FG000|Titration Period|Titration failure|3|||
105593202|NCT01194258|364170903|FG001|Titration Period|Titration failure|0|||
105593203|NCT01194258|364170904|FG002|Titration Period|Titration failure|0|||
105593204|NCT01194258|364170905|FG003|Titration Period|Titration failure|0|||
105593205|NCT01194258|364170906|FG004|Titration Period|Titration failure|0|||
105593206|NCT01194258|364170902|FG000|Period 1 (12 Weeks)|Death|0|||
105593207|NCT01194258|364170903|FG001|Period 1 (12 Weeks)|Death|0|||
105593208|NCT01194258|364170904|FG002|Period 1 (12 Weeks)|Death|0|||
105593209|NCT01194258|364170905|FG003|Period 1 (12 Weeks)|Death|0|||
105593210|NCT01194258|364170906|FG004|Period 1 (12 Weeks)|Death|1|||
105593211|NCT01194258|364170902|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
105593212|NCT01194258|364170903|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
105593213|NCT01194258|364170904|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
105593214|NCT01194258|364170905|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
105593215|NCT01194258|364170906|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
105593216|NCT01194258|364170902|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
105593217|NCT01194258|364170903|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
105593218|NCT01194258|364170904|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
105593219|NCT01194258|364170905|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
105593220|NCT01194258|364170906|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
105593221|NCT01194258|364170902|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105593222|NCT01194258|364170903|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
105593223|NCT01194258|364170904|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
105593224|NCT01194258|364170905|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105593225|NCT01194258|364170906|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105593226|NCT00436644|364170907|FG000|Overall Study|Adverse Event|2|||
105593227|NCT00436644|364170907|FG000|Overall Study|Death|1|||
105593228|NCT00597519|364170908|FG000|Overall Study|Death|1|||
105593229|NCT04246762|364170909|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
105593230|NCT03247543|364170910|FG000|Overall Study|Adverse Event|3|||
105593231|NCT03247543|364170911|FG001|Overall Study|Adverse Event|6|||
105593232|NCT03247543|364170912|FG002|Overall Study|Adverse Event|4|||
105593233|NCT03247543|364170910|FG000|Overall Study|Lost to Follow-up|10|||
105593234|NCT03247543|364170911|FG001|Overall Study|Lost to Follow-up|7|||
105593235|NCT03247543|364170912|FG002|Overall Study|Lost to Follow-up|8|||
105593236|NCT03247543|364170910|FG000|Overall Study|Consent withdrawn by caregiver|2|||
105593237|NCT03247543|364170911|FG001|Overall Study|Consent withdrawn by caregiver|2|||
105593238|NCT03247543|364170912|FG002|Overall Study|Consent withdrawn by caregiver|9|||
105439377|NCT02218008|363613509|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
105439378|NCT02218008|363613510|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
105439379|NCT02218008|363613511|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
105439380|NCT02218008|363613506|FG000|Stage 2 (S2)|Adverse Event|0|||
105439381|NCT02218008|363613507|FG001|Stage 2 (S2)|Adverse Event|0|||
105439382|NCT02218008|363613508|FG002|Stage 2 (S2)|Adverse Event|0|||
105439383|NCT02218008|363613509|FG003|Stage 2 (S2)|Adverse Event|2|||
105439384|NCT02218008|363613510|FG004|Stage 2 (S2)|Adverse Event|3|||
105439385|NCT02218008|363613511|FG005|Stage 2 (S2)|Adverse Event|3|||
105439386|NCT02218008|363613506|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
105439387|NCT02218008|363613507|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
105439388|NCT02218008|363613508|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
105439389|NCT02218008|363613509|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
105439390|NCT02218008|363613510|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
105439391|NCT02218008|363613511|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
105439392|NCT02218008|363613506|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
105439393|NCT02218008|363613507|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
105439394|NCT02218008|363613508|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
105439395|NCT02218008|363613509|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
105439396|NCT02218008|363613510|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
105593239|NCT03247543|364170910|FG000|Overall Study|Withdrawal by Subject|0|||
105593240|NCT03247543|364170911|FG001|Overall Study|Withdrawal by Subject|0|||
105593241|NCT03247543|364170912|FG002|Overall Study|Withdrawal by Subject|1|||
105593242|NCT03247543|364170910|FG000|Overall Study|Failure to Follow study procedures|1|||
105593243|NCT03247543|364170911|FG001|Overall Study|Failure to Follow study procedures|3|||
105593244|NCT03247543|364170912|FG002|Overall Study|Failure to Follow study procedures|1|||
105593245|NCT03247543|364170910|FG000|Overall Study|Lack of Efficacy|1|||
105593246|NCT03247543|364170911|FG001|Overall Study|Lack of Efficacy|0|||
105593247|NCT03247543|364170912|FG002|Overall Study|Lack of Efficacy|0|||
105439397|NCT02218008|363613511|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
105439398|NCT02218008|363613506|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
105439399|NCT02218008|363613507|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
105439400|NCT02218008|363613508|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
105593248|NCT03247543|364170910|FG000|Overall Study|Non-compliance with study visits|0|||
105439401|NCT02218008|363613509|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
105593249|NCT03247543|364170911|FG001|Overall Study|Non-compliance with study visits|1|||
105593250|NCT03247543|364170912|FG002|Overall Study|Non-compliance with study visits|0|||
105593251|NCT03586544|364170917|FG000|First Intervention|Adverse Event|0|||
105439402|NCT02218008|363613510|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
105439403|NCT02218008|363613511|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
105439404|NCT02218008|363613506|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
105439405|NCT02218008|363613507|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
105439406|NCT02218008|363613508|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
105439407|NCT02218008|363613509|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
105439408|NCT02218008|363613510|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
105439409|NCT02218008|363613511|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
105439410|NCT00400569|363613518|FG000|Overall Study|Death|1|||
105439411|NCT01811186|363613519|FG000|Overall Study|Adverse Event|54|||
105439412|NCT01811186|363613520|FG001|Overall Study|Adverse Event|38|||
105439413|NCT01811186|363613519|FG000|Overall Study|Protocol Violation|5|||
105439414|NCT01811186|363613520|FG001|Overall Study|Protocol Violation|6|||
105439415|NCT01811186|363613519|FG000|Overall Study|Withdrawal by Subject|5|||
105439416|NCT01811186|363613520|FG001|Overall Study|Withdrawal by Subject|10|||
105439417|NCT01811186|363613519|FG000|Overall Study|Lack of Efficacy|3|||
105439418|NCT01811186|363613520|FG001|Overall Study|Lack of Efficacy|6|||
105439419|NCT01811186|363613519|FG000|Overall Study|Lost to Follow-up|4|||
105439420|NCT01811186|363613520|FG001|Overall Study|Lost to Follow-up|2|||
105439421|NCT00620113|363613525|FG000|Overall Study|Adverse Event|3|||
105439422|NCT00620113|363613526|FG001|Overall Study|Adverse Event|2|||
105439423|NCT00620113|363613527|FG002|Overall Study|Adverse Event|2|||
105439424|NCT00620113|363613528|FG003|Overall Study|Adverse Event|1|||
105439425|NCT00620113|363613525|FG000|Overall Study|Lack of Efficacy|2|||
105439426|NCT00620113|363613526|FG001|Overall Study|Lack of Efficacy|3|||
105439427|NCT00620113|363613527|FG002|Overall Study|Lack of Efficacy|0|||
105439428|NCT00620113|363613528|FG003|Overall Study|Lack of Efficacy|2|||
105439429|NCT00620113|363613525|FG000|Overall Study|Physician Decision|1|||
105439430|NCT00620113|363613526|FG001|Overall Study|Physician Decision|0|||
105439431|NCT00620113|363613527|FG002|Overall Study|Physician Decision|0|||
105439432|NCT00620113|363613528|FG003|Overall Study|Physician Decision|2|||
105439433|NCT00620113|363613525|FG000|Overall Study|Protocol Violation|2|||
105439434|NCT00620113|363613526|FG001|Overall Study|Protocol Violation|1|||
105439435|NCT00620113|363613527|FG002|Overall Study|Protocol Violation|0|||
105439436|NCT00620113|363613528|FG003|Overall Study|Protocol Violation|0|||
105439437|NCT00620113|363613525|FG000|Overall Study|Withdrawal by Subject|5|||
105439438|NCT00620113|363613526|FG001|Overall Study|Withdrawal by Subject|1|||
105439439|NCT00620113|363613527|FG002|Overall Study|Withdrawal by Subject|3|||
105439440|NCT00620113|363613528|FG003|Overall Study|Withdrawal by Subject|5|||
105439441|NCT01769196|363614935|FG000|Overall Study|Adverse Event|24|||
105439442|NCT01769196|363614936|FG001|Overall Study|Adverse Event|20|||
105439443|NCT01769196|363614935|FG000|Overall Study|Death|21|||
105439444|NCT01769196|363614936|FG001|Overall Study|Death|26|||
105439445|NCT01769196|363614935|FG000|Overall Study|Investigator Discretion|7|||
105439446|NCT01769196|363614936|FG001|Overall Study|Investigator Discretion|3|||
105439447|NCT01769196|363614935|FG000|Overall Study|Lack of Efficacy|3|||
105439448|NCT01769196|363614936|FG001|Overall Study|Lack of Efficacy|2|||
105439449|NCT01769196|363614935|FG000|Overall Study|Progressive disease|11|||
105439450|NCT01769196|363614936|FG001|Overall Study|Progressive disease|6|||
105439451|NCT01769196|363614935|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
105439452|NCT01769196|363614936|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
105439453|NCT01769196|363614935|FG000|Overall Study|Protocol Violation|0|||
105439454|NCT01769196|363614936|FG001|Overall Study|Protocol Violation|3|||
105439455|NCT01769196|363614935|FG000|Overall Study|Study terminated by sponsor|160|||
105439456|NCT01769196|363614936|FG001|Overall Study|Study terminated by sponsor|161|||
105439457|NCT01769196|363614935|FG000|Overall Study|Participant never dosed with study drug|1|||
105439458|NCT01769196|363614936|FG001|Overall Study|Participant never dosed with study drug|0|||
105439459|NCT01769196|363614935|FG000|Overall Study|Withdrew consent|36|||
105439460|NCT01769196|363614936|FG001|Overall Study|Withdrew consent|40|||
105439461|NCT00742417|363614937|FG000|Randomized|Withdrawal by legal representative|0|||
105439462|NCT00742417|363614938|FG001|Randomized|Withdrawal by legal representative|1|||
105439463|NCT00742417|363614937|FG000|Randomized|Withdrawal by Subject|1|||
105439464|NCT00742417|363614938|FG001|Randomized|Withdrawal by Subject|0|||
105439465|NCT00742417|363614937|FG000|Randomized|Physician Decision|1|||
105439466|NCT00742417|363614938|FG001|Randomized|Physician Decision|0|||
105439467|NCT00742417|363614937|FG000|Intensive Period|Withdrawal by Subject|1|||
105439468|NCT00742417|363614938|FG001|Intensive Period|Withdrawal by Subject|1|||
105439469|NCT00742417|363614937|FG000|Intensive Period|Adverse Event|2|||
105439470|NCT00742417|363614938|FG001|Intensive Period|Adverse Event|0|||
105439471|NCT03499314|363614939|FG000|Overall Study|Time Commitment|1|||
105439472|NCT03499314|363614940|FG001|Overall Study|Time Commitment|2|||
105439473|NCT03499314|363614939|FG000|Overall Study|Medical issue unrelated to research study|1|||
105439474|NCT03499314|363614940|FG001|Overall Study|Medical issue unrelated to research study|1|||
105439475|NCT02291419|363614943|FG000|Overall Study|Early study termination|1|||
105439476|NCT02291419|363614944|FG001|Overall Study|Early study termination|5|||
105439477|NCT00965575|363614948|FG000|Overall Study|subject unwillingness to swallow study c|1|||
105439478|NCT00965575|363614949|FG001|Overall Study|subject unwillingness to swallow study c|0|||
105439479|NCT03679624|363614952|FG000|Overall Study|Adverse Event|1|||
105439480|NCT03679624|363614953|FG001|Overall Study|Adverse Event|0|||
105439481|NCT00767806|363614954|FG000|Overall Study|Adverse Event|30|||
105439482|NCT00767806|363614955|FG001|Overall Study|Adverse Event|11|||
105439483|NCT00767806|363614954|FG000|Overall Study|Withdrawal by Subject|8|||
105439484|NCT00767806|363614955|FG001|Overall Study|Withdrawal by Subject|13|||
105439485|NCT00767806|363614954|FG000|Overall Study|Protocol Violation|6|||
105439486|NCT00767806|363614955|FG001|Overall Study|Protocol Violation|5|||
105439487|NCT00767806|363614954|FG000|Overall Study|Lack of Efficacy|1|||
105439488|NCT00767806|363614955|FG001|Overall Study|Lack of Efficacy|9|||
105439489|NCT00767806|363614954|FG000|Overall Study|Physician Decision|4|||
105439490|NCT00767806|363614955|FG001|Overall Study|Physician Decision|3|||
105439491|NCT00767806|363614954|FG000|Overall Study|Lost to Follow-up|1|||
105439492|NCT00767806|363614955|FG001|Overall Study|Lost to Follow-up|4|||
105439493|NCT00767806|363614954|FG000|Overall Study|Entry Criteria Not Met|1|||
105439494|NCT00767806|363614955|FG001|Overall Study|Entry Criteria Not Met|1|||
105439495|NCT00767806|363614954|FG000|Overall Study|Sponsor Decision|0|||
105439496|NCT00767806|363614955|FG001|Overall Study|Sponsor Decision|1|||
105439497|NCT00539305|363614958|FG000|Overall Study|Adverse Event|1|||
105439498|NCT00539305|363614959|FG001|Overall Study|Adverse Event|0|||
105439499|NCT00539305|363614958|FG000|Overall Study|Substance Use|0|||
105439500|NCT00539305|363614959|FG001|Overall Study|Substance Use|1|||
105439501|NCT00539305|363614958|FG000|Overall Study|Withdrawal by Subject|0|||
105439502|NCT00539305|363614959|FG001|Overall Study|Withdrawal by Subject|1|||
105439503|NCT01363908|363614962|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
105439504|NCT01363908|363614963|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
105439505|NCT01363908|363614962|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
105439506|NCT01363908|363614963|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
105439507|NCT01363908|363614962|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
105439508|NCT01363908|363614963|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
105439509|NCT01363908|363614962|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
105439510|NCT01363908|363614963|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
105439511|NCT03282097|363614967|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
105439512|NCT03282097|363614968|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
105439513|NCT03282097|363614967|FG000|Intervention Visit Complete|Patient Death|13|||
105439514|NCT03282097|363614968|FG001|Intervention Visit Complete|Patient Death|15|||
105439515|NCT03282097|363614967|FG000|Intervention Visit Complete|Caregiver Death|0|||
105439516|NCT03282097|363614968|FG001|Intervention Visit Complete|Caregiver Death|3|||
105439517|NCT03282097|363614967|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
105439518|NCT03282097|363614968|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
105439519|NCT03282097|363614967|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
105439520|NCT03282097|363614968|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
105439521|NCT03282097|363614967|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
105439522|NCT03282097|363614968|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
105439523|NCT03282097|363614967|FG000|Primary Outcome Data Collection Complete|Missing|2|||
105439524|NCT03282097|363614968|FG001|Primary Outcome Data Collection Complete|Missing|3|||
105439525|NCT03282097|363614967|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
105439526|NCT03282097|363614968|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
105439527|NCT03282097|363614967|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
105439528|NCT03282097|363614968|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
105439529|NCT03282097|363614967|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
105439530|NCT03282097|363614968|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
105439531|NCT00183625|363614969|FG000|Overall Study|Withdrawal by Subject|18|||
105439532|NCT00183625|363614970|FG001|Overall Study|Withdrawal by Subject|18|||
105439533|NCT00183625|363614971|FG002|Overall Study|Withdrawal by Subject|19|||
105439534|NCT00183625|363614972|FG003|Overall Study|Withdrawal by Subject|14|||
105439535|NCT03250182|363614973|FG000|Overall Study|Withdrawal by Subject|1|||
105439536|NCT04752358|363614985|FG000|Overall Study|Death|2|||
105439537|NCT04752358|363614986|FG001|Overall Study|Death|1|||
105439538|NCT00296140|363614990|FG000|Overall Study|Lost to Follow-up|1|||
105439539|NCT00296140|363614991|FG001|Overall Study|Lost to Follow-up|0|||
105593252|NCT03586544|364170918|FG001|First Intervention|Adverse Event|1|||
105593253|NCT03586544|364170917|FG000|Second Intervention|Withdrawal by Subject|0|||
105593254|NCT03586544|364170918|FG001|Second Intervention|Withdrawal by Subject|1|||
105439540|NCT00296140|363614990|FG000|Overall Study|Withdrawal by Subject|1|||
105439541|NCT00296140|363614991|FG001|Overall Study|Withdrawal by Subject|0|||
105439542|NCT00296140|363614990|FG000|Overall Study|Discharge to Nursing Home|1|||
105439543|NCT00296140|363614991|FG001|Overall Study|Discharge to Nursing Home|0|||
105439544|NCT04369950|363614998|FG000|Overall Study|Protocol Violation|2|||
105439545|NCT04369950|363614999|FG001|Overall Study|Protocol Violation|2|||
105439546|NCT00596830|363615000|FG000|Overall Study|Death|258|||
105439547|NCT00596830|363615001|FG001|Overall Study|Death|247|||
105439548|NCT00596830|363615000|FG000|Overall Study|Lost to Follow-up|7|||
105439549|NCT00596830|363615001|FG001|Overall Study|Lost to Follow-up|11|||
105439550|NCT00596830|363615000|FG000|Overall Study|Withdrawal by Subject|22|||
105593255|NCT00741988|364170919|FG000|Overall Study|Adverse Event|2|||
105439551|NCT00596830|363615001|FG001|Overall Study|Withdrawal by Subject|12|||
105439552|NCT00596830|363615000|FG000|Overall Study|Study terminated by sponsor|51|||
105439553|NCT00596830|363615001|FG001|Overall Study|Study terminated by sponsor|62|||
105439554|NCT00596830|363615000|FG000|Overall Study|Follow-up was discontinued|1|||
105439555|NCT00596830|363615001|FG001|Overall Study|Follow-up was discontinued|0|||
105439556|NCT00596830|363615000|FG000|Overall Study|Randomized but not treated|3|||
105439557|NCT00596830|363615001|FG001|Overall Study|Randomized but not treated|7|||
105439558|NCT00646399|363615005|FG000|Overall Study|Death|63|||
105439559|NCT00646399|363615006|FG001|Overall Study|Death|53|||
105439560|NCT00646399|363615005|FG000|Overall Study|Withdrawal by Subject|9|||
105439561|NCT00646399|363615006|FG001|Overall Study|Withdrawal by Subject|10|||
105439562|NCT00646399|363615005|FG000|Overall Study|Other Reason|11|||
105439563|NCT00646399|363615006|FG001|Overall Study|Other Reason|11|||
105439564|NCT05198843|363615007|FG000|Overall Study|Lack of Efficacy|1|||
105439565|NCT03068754|363615008|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
105439566|NCT03068754|363615009|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
105439567|NCT03068754|363615010|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
105439568|NCT03068754|363615011|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
105439569|NCT03068754|363615008|FG000|Randomized Treatment Period (RTP)|Death|2|||
105439570|NCT03068754|363615009|FG001|Randomized Treatment Period (RTP)|Death|2|||
105526669|NCT01232296|363938972|FG001|Overall Study|Physician Decision|1|||
105526670|NCT01232296|363938971|FG000|Overall Study|Progressive disease|43|||
105526671|NCT01232296|363938972|FG001|Overall Study|Progressive disease|61|||
105526672|NCT01232296|363938971|FG000|Overall Study|Study terminated by sponsor|0|||
105526673|NCT01232296|363938972|FG001|Overall Study|Study terminated by sponsor|1|||
105526674|NCT01232296|363938971|FG000|Overall Study|Technical problems|3|||
105526675|NCT01232296|363938972|FG001|Overall Study|Technical problems|0|||
105526676|NCT01232296|363938971|FG000|Overall Study|Subject/guardian decision|10|||
105526677|NCT01232296|363938972|FG001|Overall Study|Subject/guardian decision|2|||
105526678|NCT01232296|363938971|FG000|Overall Study|Death|1|||
105526679|NCT01232296|363938972|FG001|Overall Study|Death|6|||
105526680|NCT00337103|363938976|FG000|Overall Study|Progressive Disease|414|||
105526681|NCT00337103|363938977|FG001|Overall Study|Progressive Disease|410|||
105526682|NCT00337103|363938976|FG000|Overall Study|Adverse Event|45|||
105526683|NCT00337103|363938977|FG001|Overall Study|Adverse Event|59|||
105526684|NCT00337103|363938976|FG000|Overall Study|Subject Choice|34|||
105526685|NCT00337103|363938977|FG001|Overall Study|Subject Choice|27|||
105526686|NCT00337103|363938976|FG000|Overall Study|Clinical Progression|27|||
105526687|NCT00337103|363938977|FG001|Overall Study|Clinical Progression|24|||
105526688|NCT00337103|363938976|FG000|Overall Study|Physician Decision|15|||
105526689|NCT00337103|363938977|FG001|Overall Study|Physician Decision|14|||
105526690|NCT00337103|363938976|FG000|Overall Study|Withdrawal by Subject|8|||
105526691|NCT00337103|363938977|FG001|Overall Study|Withdrawal by Subject|5|||
105526692|NCT00337103|363938976|FG000|Overall Study|Other|5|||
105526693|NCT00337103|363938977|FG001|Overall Study|Other|6|||
105526694|NCT00337103|363938976|FG000|Overall Study|Entry Criteria Not Met|4|||
105526695|NCT00337103|363938977|FG001|Overall Study|Entry Criteria Not Met|1|||
105526696|NCT00337103|363938976|FG000|Overall Study|Lost to Follow-up|1|||
105526697|NCT00337103|363938977|FG001|Overall Study|Lost to Follow-up|2|||
105526698|NCT00337103|363938976|FG000|Overall Study|Death|1|||
105526699|NCT00337103|363938977|FG001|Overall Study|Death|0|||
105526700|NCT01289847|363938980|FG000|Overall Study|Patient could not comply with visits|1|||
105526701|NCT04327999|363938981|FG000|Overall Study|Protocol Violation|1|||
105526702|NCT02404350|363938987|FG000|Overall Study|Adverse Event|2|||
105526703|NCT02404350|363938988|FG001|Overall Study|Adverse Event|2|||
105526704|NCT02404350|363938989|FG002|Overall Study|Adverse Event|3|||
105526705|NCT02404350|363938990|FG003|Overall Study|Adverse Event|9|||
105526706|NCT02404350|363938987|FG000|Overall Study|Lack of Efficacy|3|||
105526707|NCT02404350|363938988|FG001|Overall Study|Lack of Efficacy|1|||
105526708|NCT02404350|363938989|FG002|Overall Study|Lack of Efficacy|0|||
105526709|NCT02404350|363938990|FG003|Overall Study|Lack of Efficacy|3|||
105526710|NCT02404350|363938987|FG000|Overall Study|Lost to Follow-up|2|||
105526711|NCT02404350|363938988|FG001|Overall Study|Lost to Follow-up|0|||
105526712|NCT02404350|363938989|FG002|Overall Study|Lost to Follow-up|0|||
105526713|NCT02404350|363938990|FG003|Overall Study|Lost to Follow-up|1|||
105526714|NCT02404350|363938987|FG000|Overall Study|Physician Decision|1|||
105526715|NCT02404350|363938988|FG001|Overall Study|Physician Decision|0|||
105526716|NCT02404350|363938989|FG002|Overall Study|Physician Decision|0|||
105526717|NCT02404350|363938990|FG003|Overall Study|Physician Decision|2|||
105526718|NCT02404350|363938987|FG000|Overall Study|Pregnancy|0|||
105526719|NCT02404350|363938988|FG001|Overall Study|Pregnancy|0|||
105526720|NCT02404350|363938989|FG002|Overall Study|Pregnancy|0|||
105526721|NCT02404350|363938990|FG003|Overall Study|Pregnancy|1|||
105526722|NCT02404350|363938987|FG000|Overall Study|Withdrawal by Subject|7|||
105526723|NCT02404350|363938988|FG001|Overall Study|Withdrawal by Subject|3|||
105526724|NCT02404350|363938989|FG002|Overall Study|Withdrawal by Subject|3|||
105526725|NCT02404350|363938990|FG003|Overall Study|Withdrawal by Subject|19|||
105526726|NCT02404350|363938987|FG000|Overall Study|Due to Non-compliance with treatment|0|||
105526727|NCT02404350|363938988|FG001|Overall Study|Due to Non-compliance with treatment|0|||
105526728|NCT02404350|363938989|FG002|Overall Study|Due to Non-compliance with treatment|0|||
105526729|NCT02404350|363938990|FG003|Overall Study|Due to Non-compliance with treatment|1|||
105526730|NCT02404350|363938987|FG000|Overall Study|Due to Technical problems|0|||
105526731|NCT02404350|363938988|FG001|Overall Study|Due to Technical problems|0|||
105526732|NCT02404350|363938989|FG002|Overall Study|Due to Technical problems|0|||
105526733|NCT02404350|363938990|FG003|Overall Study|Due to Technical problems|1|||
105526734|NCT00805766|363938992|FG000|Screening Period|Adverse Event|1|||
105526735|NCT00805766|363938992|FG000|Screening Period|Lack of Efficacy|2|||
105526736|NCT00805766|363938992|FG000|Screening Period|Pregnancy|1|||
105526737|NCT00805766|363938992|FG000|Screening Period|Responder|2|||
105526738|NCT00805766|363938992|FG000|Increased Dose Period|Adverse Event|4|||
105526739|NCT00805766|363938992|FG000|Increased Dose Period|Lack of Efficacy|7|||
105526740|NCT00805766|363938992|FG000|Increased Dose Period|Pregnancy|1|||
105526741|NCT00805766|363938992|FG000|Increased Dose Period|Withdrawal by Subject|1|||
105526742|NCT00600756|363938993|FG000|Analysis After 6 Months|Adverse Event|43|||
105526743|NCT00600756|363938994|FG001|Analysis After 6 Months|Adverse Event|33|||
105526744|NCT00600756|363938993|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
105526745|NCT00600756|363938994|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
105526746|NCT00600756|363938993|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
105526747|NCT00600756|363938994|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
105526748|NCT00600756|363938993|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
105526749|NCT00600756|363938994|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
105526750|NCT00600756|363938993|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
105526751|NCT00600756|363938994|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
105526752|NCT00600756|363938993|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
105526753|NCT00600756|363938994|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
105526754|NCT00600756|363938993|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
105526755|NCT00600756|363938994|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
105526756|NCT00600756|363938993|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
105526757|NCT00600756|363938994|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
105526758|NCT00600756|363938993|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
105526759|NCT00600756|363938994|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
105526760|NCT00600756|363938993|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
105526761|NCT00600756|363938994|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
105526762|NCT00600756|363938993|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
105526763|NCT00600756|363938994|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
105526764|NCT00600756|363938993|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
105526765|NCT00600756|363938994|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
105526766|NCT00600756|363938993|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
105526767|NCT00600756|363938994|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
105526768|NCT00600756|363938993|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
105526769|NCT00600756|363938994|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
105526770|NCT01256593|363938995|FG000|Overall Study|Protocol Violation|26|||
105526771|NCT01256593|363938995|FG000|Overall Study|No Drug Administration Information|2|||
105526772|NCT01256593|363938995|FG000|Overall Study|No Visit After Treatment|186|||
105526773|NCT04414553|363938996|FG000|Overall Study|Lost to Follow-up|20|||
105526774|NCT04753164|363938999|FG000|Overall Study|Adverse Event|0|||
105526775|NCT04753164|363939000|FG001|Overall Study|Adverse Event|2|||
105526776|NCT04753164|363938999|FG000|Overall Study|Withdrawal by Subject|9|||
105526777|NCT04753164|363939000|FG001|Overall Study|Withdrawal by Subject|7|||
105526778|NCT04753164|363938999|FG000|Overall Study|Lost to Follow-up|6|||
105526779|NCT04753164|363939000|FG001|Overall Study|Lost to Follow-up|6|||
105526780|NCT04753164|363938999|FG000|Overall Study|Other|12|||
105526781|NCT04753164|363939000|FG001|Overall Study|Other|5|||
105526782|NCT00694369|363939002|FG000|Overall Study|Adverse Event|0|||
105526783|NCT00694369|363939003|FG001|Overall Study|Adverse Event|1|||
105526784|NCT00694369|363939004|FG002|Overall Study|Adverse Event|0|||
105526785|NCT00694369|363939005|FG003|Overall Study|Adverse Event|1|||
105526786|NCT00694369|363939006|FG004|Overall Study|Adverse Event|3|||
105526787|NCT00694369|363939002|FG000|Overall Study|Lost to Follow-up|0|||
105526788|NCT00694369|363939003|FG001|Overall Study|Lost to Follow-up|0|||
105526789|NCT00694369|363939004|FG002|Overall Study|Lost to Follow-up|1|||
105526790|NCT00694369|363939005|FG003|Overall Study|Lost to Follow-up|1|||
105526791|NCT00694369|363939006|FG004|Overall Study|Lost to Follow-up|0|||
105526792|NCT00694369|363939002|FG000|Overall Study|Physician Decision|0|||
105526793|NCT00694369|363939003|FG001|Overall Study|Physician Decision|0|||
105526794|NCT00694369|363939004|FG002|Overall Study|Physician Decision|0|||
105526795|NCT00694369|363939005|FG003|Overall Study|Physician Decision|0|||
105526796|NCT00694369|363939006|FG004|Overall Study|Physician Decision|1|||
105526797|NCT00694369|363939002|FG000|Overall Study|Protocol Violation|0|||
105526798|NCT00694369|363939003|FG001|Overall Study|Protocol Violation|1|||
105526799|NCT00694369|363939004|FG002|Overall Study|Protocol Violation|0|||
105593256|NCT00741988|364170920|FG001|Overall Study|Adverse Event|4|||
105593257|NCT00741988|364170919|FG000|Overall Study|Lack of Efficacy|2|||
105593258|NCT00741988|364170920|FG001|Overall Study|Lack of Efficacy|0|||
105593259|NCT01645111|364172673|FG000|Overall Study|Did not require Clevidipine|15|||
105593260|NCT04048135|364172674|FG000|Overall Study|Withdrawal by Subject|1|||
105593261|NCT04048135|364172675|FG001|Overall Study|Withdrawal by Subject|1|||
105593262|NCT04048135|364172676|FG002|Overall Study|Withdrawal by Subject|1|||
105593263|NCT04048135|364172677|FG003|Overall Study|Withdrawal by Subject|2|||
105593264|NCT04048135|364172678|FG004|Overall Study|Withdrawal by Subject|0|||
105593265|NCT04048135|364172679|FG005|Overall Study|Withdrawal by Subject|0|||
105593266|NCT04048135|364172680|FG006|Overall Study|Withdrawal by Subject|1|||
105593267|NCT04048135|364172681|FG007|Overall Study|Withdrawal by Subject|1|||
105593268|NCT04048135|364172674|FG000|Overall Study|Adverse Event|0|||
105593269|NCT04048135|364172675|FG001|Overall Study|Adverse Event|0|||
105593270|NCT04048135|364172676|FG002|Overall Study|Adverse Event|0|||
105593271|NCT04048135|364172677|FG003|Overall Study|Adverse Event|1|||
105593272|NCT04048135|364172678|FG004|Overall Study|Adverse Event|1|||
105593273|NCT04048135|364172679|FG005|Overall Study|Adverse Event|0|||
105593274|NCT04048135|364172680|FG006|Overall Study|Adverse Event|0|||
105593275|NCT04048135|364172681|FG007|Overall Study|Adverse Event|0|||
105593276|NCT04048135|364172674|FG000|Overall Study|Protocol Violation|0|||
105593277|NCT04048135|364172675|FG001|Overall Study|Protocol Violation|0|||
105593278|NCT04048135|364172676|FG002|Overall Study|Protocol Violation|0|||
105593279|NCT04048135|364172677|FG003|Overall Study|Protocol Violation|0|||
105593280|NCT04048135|364172678|FG004|Overall Study|Protocol Violation|0|||
105593281|NCT04048135|364172679|FG005|Overall Study|Protocol Violation|1|||
105593282|NCT04048135|364172680|FG006|Overall Study|Protocol Violation|0|||
105593283|NCT04048135|364172681|FG007|Overall Study|Protocol Violation|0|||
105593284|NCT01677936|364172682|FG000|Overall Study|Lost to Follow-up|4|||
105593285|NCT01677936|364172683|FG001|Overall Study|Lost to Follow-up|1|||
105593286|NCT01677936|364172682|FG000|Overall Study|Protocol Violation|3|||
105593287|NCT01677936|364172683|FG001|Overall Study|Protocol Violation|0|||
105593288|NCT01677936|364172682|FG000|Overall Study|Adverse Event|1|||
105593289|NCT01677936|364172683|FG001|Overall Study|Adverse Event|0|||
105593290|NCT01677936|364172682|FG000|Overall Study|Lost to Follow-up|1|||
105593291|NCT01677936|364172683|FG001|Overall Study|Lost to Follow-up|0|||
105593292|NCT01677936|364172682|FG000|Overall Study|Protocol Violation|0|||
105593293|NCT01677936|364172683|FG001|Overall Study|Protocol Violation|4|||
105593294|NCT03140176|364172687|FG000|Overall Study|Reason missing|23|||
105593295|NCT03140176|364172687|FG000|Overall Study|Death|33|||
105593296|NCT03140176|364172687|FG000|Overall Study|Disease progression|1|||
105593297|NCT03140176|364172687|FG000|Overall Study|Physician Decision|1|||
105593298|NCT03140176|364172687|FG000|Overall Study|Withdrawal by Subject|1|||
105593299|NCT03140176|364172687|FG000|Overall Study|Lost to Follow-up|15|||
105593300|NCT01091454|364172688|FG000|Overall Study|Ineligible|1|||
105593301|NCT03784963|364172689|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
105593302|NCT03784963|364172690|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
105593303|NCT03784963|364172691|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
105593304|NCT03784963|364172692|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
105593305|NCT03179787|364172693|FG000|Overall Study|Lost to Follow-up|15|||
105593306|NCT03179787|364172693|FG000|Overall Study|Case report failures|2|||
105593307|NCT03179787|364172693|FG000|Overall Study|Treatment not administered|1|||
105593308|NCT00157014|364172694|FG000|Overall Study|Death|4|||
105593309|NCT00157014|364172695|FG001|Overall Study|Death|2|||
105593310|NCT00157014|364172696|FG002|Overall Study|Death|1|||
105593311|NCT00157014|364172697|FG003|Overall Study|Death|1|||
105593312|NCT00157014|364172694|FG000|Overall Study|Physician Decision|0|||
105593313|NCT00157014|364172695|FG001|Overall Study|Physician Decision|1|||
105593314|NCT00157014|364172696|FG002|Overall Study|Physician Decision|0|||
105593315|NCT00157014|364172697|FG003|Overall Study|Physician Decision|0|||
105593316|NCT00157014|364172694|FG000|Overall Study|Medications withdrawn on family request|0|||
105593317|NCT00157014|364172695|FG001|Overall Study|Medications withdrawn on family request|1|||
105593318|NCT00157014|364172696|FG002|Overall Study|Medications withdrawn on family request|0|||
105593319|NCT00157014|364172697|FG003|Overall Study|Medications withdrawn on family request|0|||
105593320|NCT00157014|364172694|FG000|Overall Study|Patient withdrawn by investigator|1|||
105593321|NCT00157014|364172695|FG001|Overall Study|Patient withdrawn by investigator|0|||
105593322|NCT00157014|364172696|FG002|Overall Study|Patient withdrawn by investigator|0|||
105593323|NCT00157014|364172697|FG003|Overall Study|Patient withdrawn by investigator|0|||
105593324|NCT00157014|364172694|FG000|Overall Study|Patient unable to return in nursing home|1|||
105593325|NCT00157014|364172695|FG001|Overall Study|Patient unable to return in nursing home|0|||
105593326|NCT00157014|364172696|FG002|Overall Study|Patient unable to return in nursing home|0|||
105593327|NCT00157014|364172697|FG003|Overall Study|Patient unable to return in nursing home|0|||
105593328|NCT00157014|364172694|FG000|Overall Study|Patient would not receive transplant|0|||
105593329|NCT00157014|364172695|FG001|Overall Study|Patient would not receive transplant|1|||
105526800|NCT00694369|363939005|FG003|Overall Study|Protocol Violation|0|||
105526801|NCT00694369|363939006|FG004|Overall Study|Protocol Violation|0|||
105526802|NCT00694369|363939002|FG000|Overall Study|Withdrawal by Subject|1|||
105526803|NCT00694369|363939003|FG001|Overall Study|Withdrawal by Subject|1|||
105526804|NCT00694369|363939004|FG002|Overall Study|Withdrawal by Subject|1|||
105526805|NCT00694369|363939005|FG003|Overall Study|Withdrawal by Subject|1|||
105526806|NCT00694369|363939006|FG004|Overall Study|Withdrawal by Subject|2|||
105526807|NCT03818516|363939007|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
105526808|NCT02907359|363939014|FG000|Overall Study|Death|234|||
105526809|NCT02907359|363939015|FG001|Overall Study|Death|117|||
105526810|NCT02907359|363939014|FG000|Overall Study|Withdrawal by Subject|6|||
105526811|NCT02907359|363939015|FG001|Overall Study|Withdrawal by Subject|11|||
105526812|NCT02907359|363939014|FG000|Overall Study|Lost to Follow-up|1|||
105526813|NCT02907359|363939015|FG001|Overall Study|Lost to Follow-up|0|||
105526814|NCT00746941|363939016|FG000|Overall Study|Death|2|||
105526815|NCT00746941|363939017|FG001|Overall Study|Death|0|||
105526816|NCT00746941|363939018|FG002|Overall Study|Death|0|||
105526817|NCT00746941|363939019|FG003|Overall Study|Death|6|||
105526818|NCT00746941|363939016|FG000|Overall Study|Physician Decision|0|||
105526819|NCT00746941|363939017|FG001|Overall Study|Physician Decision|0|||
105526820|NCT00746941|363939018|FG002|Overall Study|Physician Decision|2|||
105526821|NCT00746941|363939019|FG003|Overall Study|Physician Decision|0|||
105526822|NCT00746941|363939016|FG000|Overall Study|Withdrawal by Subject|3|||
105526823|NCT00746941|363939017|FG001|Overall Study|Withdrawal by Subject|0|||
105526824|NCT00746941|363939018|FG002|Overall Study|Withdrawal by Subject|0|||
105526825|NCT00746941|363939019|FG003|Overall Study|Withdrawal by Subject|2|||
105526826|NCT00746941|363939016|FG000|Overall Study|Other, reason not provided|2|||
105526827|NCT00746941|363939017|FG001|Overall Study|Other, reason not provided|4|||
105526828|NCT00746941|363939018|FG002|Overall Study|Other, reason not provided|0|||
105526829|NCT00746941|363939019|FG003|Overall Study|Other, reason not provided|4|||
105526830|NCT00746941|363939016|FG000|Overall Study|Adverse Event|0|||
105526831|NCT00746941|363939017|FG001|Overall Study|Adverse Event|0|||
105526832|NCT00746941|363939018|FG002|Overall Study|Adverse Event|0|||
105526833|NCT00746941|363939019|FG003|Overall Study|Adverse Event|1|||
105526834|NCT01498640|363939022|FG000|Overall Study|Lost to Follow-up|1|||
105526835|NCT01498640|363939022|FG000|Overall Study|Death|1|||
105526836|NCT01498640|363939022|FG000|Overall Study|Other|3|||
105526837|NCT04371380|363939023|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
105526838|NCT04371380|363939024|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
105526839|NCT04371380|363939025|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
105526840|NCT06049043|363939026|FG000|Overall Study|Lost to Follow-up|11|||
105526841|NCT06049043|363939027|FG001|Overall Study|Lost to Follow-up|9|||
105526842|NCT01070316|363939037|FG000|Extension Phase|Lack of Efficacy|3|||
105526843|NCT01070316|363939037|FG000|Extension Phase|Withdrawal by Subject|1|||
105526844|NCT00748215|363939040|FG000|Overall Study|Withdrawal by Subject|7|||
105526845|NCT00748215|363939041|FG001|Overall Study|Withdrawal by Subject|7|||
105526846|NCT00748215|363939040|FG000|Overall Study|Treatment change|2|||
105526847|NCT00748215|363939041|FG001|Overall Study|Treatment change|1|||
105526848|NCT00748215|363939040|FG000|Overall Study|Change in patient condition|0|||
105526849|NCT00748215|363939041|FG001|Overall Study|Change in patient condition|3|||
105526850|NCT00748215|363939040|FG000|Overall Study|Non-compliant|0|||
105526851|NCT00748215|363939041|FG001|Overall Study|Non-compliant|2|||
105526852|NCT00748215|363939040|FG000|Overall Study|Adverse Event|0|||
105526853|NCT00748215|363939041|FG001|Overall Study|Adverse Event|5|||
105526854|NCT00962104|363939042|FG000|Overall Study|Adverse Event|10|||
105526855|NCT00962104|363939043|FG001|Overall Study|Adverse Event|3|||
105526856|NCT00962104|363939042|FG000|Overall Study|Entry Criteria Not Met|1|||
105526857|NCT00962104|363939043|FG001|Overall Study|Entry Criteria Not Met|2|||
105526858|NCT00962104|363939042|FG000|Overall Study|Lack of Efficacy|0|||
105526859|NCT00962104|363939043|FG001|Overall Study|Lack of Efficacy|1|||
105526860|NCT00962104|363939042|FG000|Overall Study|Lost to Follow-up|10|||
105526861|NCT00962104|363939043|FG001|Overall Study|Lost to Follow-up|4|||
105526862|NCT00962104|363939042|FG000|Overall Study|Physician Decision|1|||
105526863|NCT00962104|363939043|FG001|Overall Study|Physician Decision|0|||
105526864|NCT00962104|363939042|FG000|Overall Study|Protocol Violation|6|||
105526865|NCT00962104|363939043|FG001|Overall Study|Protocol Violation|8|||
105526866|NCT00962104|363939042|FG000|Overall Study|Sponsor Decision|0|||
105526867|NCT00962104|363939043|FG001|Overall Study|Sponsor Decision|1|||
105526868|NCT00962104|363939042|FG000|Overall Study|Withdrawal by Subject|10|||
105526869|NCT00962104|363939043|FG001|Overall Study|Withdrawal by Subject|6|||
105526870|NCT00962104|363939042|FG000|Overall Study|Other|2|||
105526871|NCT00962104|363939043|FG001|Overall Study|Other|0|||
105526872|NCT03200899|363939044|FG000|Overall Study|Lost to Follow-up|10|||
105526873|NCT03200899|363939045|FG001|Overall Study|Lost to Follow-up|23|||
105593330|NCT00157014|364172696|FG002|Overall Study|Patient would not receive transplant|0|||
105526874|NCT03274986|363939046|FG000|Overall Study|Withdrawal by Subject|0|||
105526875|NCT03274986|363939047|FG001|Overall Study|Withdrawal by Subject|1|||
105526876|NCT03274986|363939046|FG000|Overall Study|Lost to Follow-up|0|||
105526877|NCT03274986|363939047|FG001|Overall Study|Lost to Follow-up|1|||
105439571|NCT03068754|363615010|FG002|Randomized Treatment Period (RTP)|Death|0|||
105439572|NCT03068754|363615011|FG003|Randomized Treatment Period (RTP)|Death|0|||
105439573|NCT03068754|363615008|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
105439574|NCT03068754|363615009|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
105439575|NCT03068754|363615010|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
105439576|NCT03068754|363615011|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
105439577|NCT03068754|363615008|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
105439578|NCT03068754|363615009|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
105439579|NCT03068754|363615010|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
105439580|NCT03068754|363615011|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
105439581|NCT03068754|363615008|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
105439582|NCT03068754|363615009|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
105439583|NCT03068754|363615010|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
105439584|NCT03068754|363615011|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
105439585|NCT03068754|363615008|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
105439586|NCT03068754|363615009|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
105439587|NCT03068754|363615010|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
105439588|NCT03068754|363615011|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
105439589|NCT03068754|363615008|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
105439590|NCT03068754|363615009|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
105439591|NCT03068754|363615010|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
105439592|NCT03068754|363615011|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
105439593|NCT03068754|363615008|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
105439594|NCT03068754|363615009|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
105439595|NCT03068754|363615010|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
105439596|NCT03068754|363615011|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
105439597|NCT03068754|363615008|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
105439598|NCT03068754|363615009|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
105439599|NCT03068754|363615010|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
105439600|NCT03068754|363615011|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
105439601|NCT03068754|363615008|FG000|Open Label Extension Period (OLE)|Death|0|||
105439602|NCT03068754|363615009|FG001|Open Label Extension Period (OLE)|Death|0|||
105439603|NCT03068754|363615010|FG002|Open Label Extension Period (OLE)|Death|0|||
105439604|NCT03068754|363615011|FG003|Open Label Extension Period (OLE)|Death|1|||
105439605|NCT03068754|363615008|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
105439606|NCT03068754|363615009|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
105439607|NCT03068754|363615010|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
105439608|NCT03068754|363615011|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
105439609|NCT03068754|363615008|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
105439610|NCT03068754|363615009|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
105439611|NCT03068754|363615010|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
105439612|NCT03068754|363615011|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
105439613|NCT03068754|363615008|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
105439614|NCT03068754|363615009|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
105439615|NCT03068754|363615010|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
105439616|NCT03068754|363615011|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
105439617|NCT03068754|363615008|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
105439618|NCT03068754|363615009|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
105439619|NCT03068754|363615010|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
105439620|NCT03068754|363615011|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
105439621|NCT00098306|363615015|FG000|Double Blind|Randomized, not treated|9|||
105439622|NCT00098306|363615016|FG001|Double Blind|Randomized, not treated|5|||
105439623|NCT00098306|363615017|FG002|Double Blind|Randomized, not treated|2|||
105439624|NCT00098306|363615018|FG003|Double Blind|Randomized, not treated|0|||
105439625|NCT00098306|363615019|FG004|Double Blind|Randomized, not treated|0|||
105439626|NCT00098306|363615020|FG005|Double Blind|Randomized, not treated|0|||
105439627|NCT00098306|363615021|FG006|Double Blind|Randomized, not treated|0|||
105439628|NCT00098306|363615015|FG000|Double Blind|Ongoing at cut-off date|151|||
105439629|NCT00098306|363615016|FG001|Double Blind|Ongoing at cut-off date|166|||
105439630|NCT00098306|363615017|FG002|Double Blind|Ongoing at cut-off date|72|||
105439631|NCT00098306|363615018|FG003|Double Blind|Ongoing at cut-off date|0|||
105439632|NCT00098306|363615019|FG004|Double Blind|Ongoing at cut-off date|0|||
105439633|NCT00098306|363615020|FG005|Double Blind|Ongoing at cut-off date|0|||
105439634|NCT00098306|363615021|FG006|Double Blind|Ongoing at cut-off date|0|||
105439635|NCT00098306|363615015|FG000|Double Blind|Adverse Event|11|||
105439636|NCT00098306|363615016|FG001|Double Blind|Adverse Event|10|||
105439637|NCT00098306|363615017|FG002|Double Blind|Adverse Event|6|||
105439638|NCT00098306|363615018|FG003|Double Blind|Adverse Event|0|||
105439639|NCT00098306|363615019|FG004|Double Blind|Adverse Event|0|||
105439640|NCT00098306|363615020|FG005|Double Blind|Adverse Event|0|||
105526878|NCT01132495|363939048|FG000|Overall Study|Various reasons|40|||
105526879|NCT01132495|363939049|FG001|Overall Study|Various reasons|38|||
105526880|NCT01132495|363939050|FG002|Overall Study|Various reasons|20|||
105526881|NCT01132495|363939051|FG003|Overall Study|Various reasons|12|||
105526882|NCT04536727|363939052|FG000|Overall Study|Lost to Follow-up|1|||
105526883|NCT04536727|363939053|FG001|Overall Study|Lost to Follow-up|1|||
105526884|NCT04536727|363939052|FG000|Overall Study|Death|0|||
105526885|NCT04536727|363939053|FG001|Overall Study|Death|1|||
105526886|NCT00699972|363940982|FG000|Overall Study|Adverse Event|7|||
105526887|NCT00699972|363940983|FG001|Overall Study|Adverse Event|9|||
105526888|NCT00699972|363940984|FG002|Overall Study|Adverse Event|24|||
105526889|NCT00699972|363940982|FG000|Overall Study|Lost to Follow-up|0|||
105526890|NCT00699972|363940983|FG001|Overall Study|Lost to Follow-up|2|||
105526891|NCT00699972|363940984|FG002|Overall Study|Lost to Follow-up|0|||
105526892|NCT00699972|363940982|FG000|Overall Study|Withdrawal by Subject|3|||
105526893|NCT00699972|363940983|FG001|Overall Study|Withdrawal by Subject|7|||
105526894|NCT00699972|363940984|FG002|Overall Study|Withdrawal by Subject|4|||
105526895|NCT00699972|363940982|FG000|Overall Study|Lack of Efficacy|2|||
105526896|NCT00699972|363940983|FG001|Overall Study|Lack of Efficacy|0|||
105526897|NCT00699972|363940984|FG002|Overall Study|Lack of Efficacy|2|||
105526898|NCT00699972|363940982|FG000|Overall Study|Administrative/Other|3|||
105526899|NCT00699972|363940983|FG001|Overall Study|Administrative/Other|1|||
105526900|NCT00699972|363940984|FG002|Overall Study|Administrative/Other|4|||
105526901|NCT00699972|363940982|FG000|Overall Study|Randomized, Not Treated|1|||
105526902|NCT00699972|363940983|FG001|Overall Study|Randomized, Not Treated|0|||
105526903|NCT00699972|363940984|FG002|Overall Study|Randomized, Not Treated|1|||
105526904|NCT01852292|363940985|FG000|Overall Study|Untreated - did not receive study drug|3|||
105526905|NCT01852292|363940986|FG001|Overall Study|Untreated - did not receive study drug|1|||
105526906|NCT01852292|363940985|FG000|Overall Study|Death|9|||
105526907|NCT01852292|363940986|FG001|Overall Study|Death|8|||
105526908|NCT01852292|363940985|FG000|Overall Study|Patient/guardian decision|8|||
105526909|NCT01852292|363940986|FG001|Overall Study|Patient/guardian decision|4|||
105526910|NCT01852292|363940985|FG000|Overall Study|Adverse Event|8|||
105526911|NCT01852292|363940986|FG001|Overall Study|Adverse Event|11|||
105526912|NCT01852292|363940985|FG000|Overall Study|Physician Decision|6|||
105526913|NCT01852292|363940986|FG001|Overall Study|Physician Decision|2|||
105526914|NCT01852292|363940985|FG000|Overall Study|Protocol Violation|2|||
105526915|NCT01852292|363940986|FG001|Overall Study|Protocol Violation|0|||
105526916|NCT01852292|363940985|FG000|Overall Study|Non-compliance with study treatment|1|||
105439641|NCT00098306|363615021|FG006|Double Blind|Adverse Event|0|||
105439642|NCT00098306|363615015|FG000|Double Blind|Lack of Efficacy|43|||
105439643|NCT00098306|363615016|FG001|Double Blind|Lack of Efficacy|34|||
105439644|NCT00098306|363615017|FG002|Double Blind|Lack of Efficacy|17|||
105439645|NCT00098306|363615018|FG003|Double Blind|Lack of Efficacy|0|||
105439646|NCT00098306|363615019|FG004|Double Blind|Lack of Efficacy|0|||
105439647|NCT00098306|363615020|FG005|Double Blind|Lack of Efficacy|0|||
105439648|NCT00098306|363615021|FG006|Double Blind|Lack of Efficacy|0|||
105439649|NCT00098306|363615015|FG000|Double Blind|Death|1|||
105439650|NCT00098306|363615016|FG001|Double Blind|Death|4|||
105439651|NCT00098306|363615017|FG002|Double Blind|Death|1|||
105439652|NCT00098306|363615018|FG003|Double Blind|Death|0|||
105439653|NCT00098306|363615019|FG004|Double Blind|Death|0|||
105439654|NCT00098306|363615020|FG005|Double Blind|Death|0|||
105439655|NCT00098306|363615021|FG006|Double Blind|Death|0|||
105439656|NCT00098306|363615015|FG000|Double Blind|Participant defaulted|19|||
105439657|NCT00098306|363615016|FG001|Double Blind|Participant defaulted|18|||
105439658|NCT00098306|363615017|FG002|Double Blind|Participant defaulted|11|||
105439659|NCT00098306|363615018|FG003|Double Blind|Participant defaulted|0|||
105439660|NCT00098306|363615019|FG004|Double Blind|Participant defaulted|0|||
105439661|NCT00098306|363615020|FG005|Double Blind|Participant defaulted|0|||
105439662|NCT00098306|363615021|FG006|Double Blind|Participant defaulted|0|||
105439663|NCT00098306|363615015|FG000|Double Blind|Un-specified|7|||
105439664|NCT00098306|363615016|FG001|Double Blind|Un-specified|3|||
105439665|NCT00098306|363615017|FG002|Double Blind|Un-specified|11|||
105439666|NCT00098306|363615018|FG003|Double Blind|Un-specified|0|||
105439667|NCT00098306|363615019|FG004|Double Blind|Un-specified|0|||
105439668|NCT00098306|363615020|FG005|Double Blind|Un-specified|0|||
105439669|NCT00098306|363615021|FG006|Double Blind|Un-specified|0|||
105439670|NCT00098306|363615015|FG000|Open Label|Lack of Efficacy|0|||
105439671|NCT00098306|363615016|FG001|Open Label|Lack of Efficacy|0|||
105439672|NCT00098306|363615017|FG002|Open Label|Lack of Efficacy|0|||
105439673|NCT00098306|363615018|FG003|Open Label|Lack of Efficacy|13|||
105526917|NCT01852292|363940986|FG001|Overall Study|Non-compliance with study treatment|0|||
105526918|NCT01852292|363940985|FG000|Overall Study|Study terminated by Sponsor|0|||
105526919|NCT01852292|363940986|FG001|Overall Study|Study terminated by Sponsor|1|||
105526920|NCT01852292|363940985|FG000|Overall Study|Progressive disease|42|||
105526921|NCT01852292|363940986|FG001|Overall Study|Progressive disease|52|||
105526922|NCT02558790|363940987|FG000|Overall Study|Lost to Follow-up|2|||
105526923|NCT02558790|363940987|FG000|Overall Study|Physician Decision|1|||
105526924|NCT02558790|363940987|FG000|Overall Study|Withdrawal by Subject|1|||
105526925|NCT02558790|363940987|FG000|Overall Study|Screen Fail|3|||
105526926|NCT00838201|363940988|FG000|Overall Study|Investigator decision, or other reasons|2|||
105526927|NCT00838201|363940989|FG001|Overall Study|Investigator decision, or other reasons|3|||
105526928|NCT00838201|363940988|FG000|Overall Study|Noncompliance|0|||
105526929|NCT00838201|363940989|FG001|Overall Study|Noncompliance|1|||
105526930|NCT00838201|363940988|FG000|Overall Study|Administrative decision|1|||
105526931|NCT00838201|363940989|FG001|Overall Study|Administrative decision|2|||
105526932|NCT00838201|363940988|FG000|Overall Study|Disease progression|3|||
105526933|NCT00838201|363940989|FG001|Overall Study|Disease progression|3|||
105526934|NCT00838201|363940988|FG000|Overall Study|Consent withdrawn|16|||
105526935|NCT00838201|363940989|FG001|Overall Study|Consent withdrawn|19|||
105526936|NCT00838201|363940988|FG000|Overall Study|Lost to Follow-up|4|||
105526937|NCT00838201|363940989|FG001|Overall Study|Lost to Follow-up|3|||
105526938|NCT00838201|363940988|FG000|Overall Study|Adverse Event|5|||
105526939|NCT00838201|363940989|FG001|Overall Study|Adverse Event|9|||
105526940|NCT00838201|363940988|FG000|Overall Study|Death|11|||
105526941|NCT00838201|363940989|FG001|Overall Study|Death|13|||
105526942|NCT05083442|363940990|FG000|Overall Study|Lost to Follow-up|1|||
105526943|NCT05083442|363940991|FG001|Overall Study|Lost to Follow-up|0|||
105526944|NCT05083442|363940990|FG000|Overall Study|Lack of Efficacy|0|||
105526945|NCT05083442|363940991|FG001|Overall Study|Lack of Efficacy|1|||
105526946|NCT05083442|363940990|FG000|Overall Study|Withdrawal by Subject|1|||
105526947|NCT05083442|363940991|FG001|Overall Study|Withdrawal by Subject|3|||
105526948|NCT05083442|363940990|FG000|Overall Study|scheduling difficulties|1|||
105526949|NCT05083442|363940991|FG001|Overall Study|scheduling difficulties|2|||
105526950|NCT03711162|363940992|FG000|Overall Study|Adverse Event|5|||
105526951|NCT03711162|363940993|FG001|Overall Study|Adverse Event|2|||
105526952|NCT03711162|363940994|FG002|Overall Study|Adverse Event|4|||
105526953|NCT03711162|363940992|FG000|Overall Study|Death|11|||
105526954|NCT03711162|363940993|FG001|Overall Study|Death|7|||
105526955|NCT03711162|363940994|FG002|Overall Study|Death|8|||
105593331|NCT00157014|364172697|FG003|Overall Study|Patient would not receive transplant|0|||
105593332|NCT00157014|364172694|FG000|Overall Study|Withdrawal by Subject|1|||
105593333|NCT00157014|364172695|FG001|Overall Study|Withdrawal by Subject|0|||
105593334|NCT00157014|364172696|FG002|Overall Study|Withdrawal by Subject|0|||
105593335|NCT00157014|364172697|FG003|Overall Study|Withdrawal by Subject|0|||
105526956|NCT03711162|363940992|FG000|Overall Study|Lost to Follow-up|1|||
105526957|NCT03711162|363940993|FG001|Overall Study|Lost to Follow-up|0|||
105526958|NCT03711162|363940994|FG002|Overall Study|Lost to Follow-up|1|||
105526959|NCT03711162|363940992|FG000|Overall Study|Study Terminated by Sponsor|139|||
105526960|NCT03711162|363940993|FG001|Overall Study|Study Terminated by Sponsor|152|||
105526961|NCT03711162|363940994|FG002|Overall Study|Study Terminated by Sponsor|146|||
105526962|NCT03711162|363940992|FG000|Overall Study|Withdrawal by Subject|17|||
105526963|NCT03711162|363940993|FG001|Overall Study|Withdrawal by Subject|10|||
105526964|NCT03711162|363940994|FG002|Overall Study|Withdrawal by Subject|10|||
105526965|NCT03711162|363940992|FG000|Overall Study|Miscellaneous|1|||
105526966|NCT03711162|363940993|FG001|Overall Study|Miscellaneous|2|||
105526967|NCT03711162|363940994|FG002|Overall Study|Miscellaneous|2|||
105526968|NCT03711162|363940992|FG000|Overall Study|Not Treated|1|||
105526969|NCT03711162|363940993|FG001|Overall Study|Not Treated|0|||
105526970|NCT03711162|363940994|FG002|Overall Study|Not Treated|1|||
105526971|NCT03711162|363940992|FG000|Overall Study|Physician Decision|0|||
105526972|NCT03711162|363940993|FG001|Overall Study|Physician Decision|2|||
105526973|NCT03711162|363940994|FG002|Overall Study|Physician Decision|0|||
105526974|NCT03711162|363940992|FG000|Overall Study|Lack of Efficacy|0|||
105526975|NCT03711162|363940993|FG001|Overall Study|Lack of Efficacy|0|||
105526976|NCT03711162|363940994|FG002|Overall Study|Lack of Efficacy|2|||
105526977|NCT03711162|363940992|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
105526978|NCT03711162|363940993|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
105526979|NCT03711162|363940994|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
105526980|NCT03034954|363940995|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
105526981|NCT03034954|363940996|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
105526982|NCT05228470|363940997|FG000|Overall Study|Death|6|||
105526983|NCT05228470|363940998|FG001|Overall Study|Death|11|||
105526984|NCT05228470|363940997|FG000|Overall Study|Withdrawal by Subject|1|||
105526985|NCT05228470|363940998|FG001|Overall Study|Withdrawal by Subject|8|||
105526986|NCT05228470|363940997|FG000|Overall Study|Ongoing|1|||
105526987|NCT05228470|363940998|FG001|Overall Study|Ongoing|11|||
105526988|NCT00588445|363941001|FG000|Overall Study|Protocol Violation|1|||
105526989|NCT00588445|363941001|FG000|Overall Study|Withdrawal by Subject|3|||
105526990|NCT00588445|363941001|FG000|Overall Study|Disease Progression|1|||
105526991|NCT00588445|363941001|FG000|Overall Study|Not Treated|10|||
105526992|NCT03240133|363941002|FG000|Overall Study|Withdrawal by Subject|0|||
105526993|NCT03240133|363941003|FG001|Overall Study|Withdrawal by Subject|1|||
105526994|NCT03240133|363941004|FG002|Overall Study|Withdrawal by Subject|0|||
105526995|NCT03240133|363941002|FG000|Overall Study|Adverse Event|1|||
105526996|NCT03240133|363941003|FG001|Overall Study|Adverse Event|1|||
105526997|NCT03240133|363941004|FG002|Overall Study|Adverse Event|0|||
105526998|NCT03240133|363941002|FG000|Overall Study|Rash|1|||
105526999|NCT03240133|363941003|FG001|Overall Study|Rash|0|||
105527000|NCT03240133|363941004|FG002|Overall Study|Rash|0|||
105527001|NCT03240133|363941002|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
105527002|NCT03240133|363941003|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
105527003|NCT03240133|363941004|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
105527004|NCT03240133|363941002|FG000|Overall Study|Intercurrent illness.|0|||
105527005|NCT03240133|363941003|FG001|Overall Study|Intercurrent illness.|1|||
105527006|NCT03240133|363941004|FG002|Overall Study|Intercurrent illness.|0|||
105527007|NCT03240133|363941002|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
105527008|NCT03240133|363941003|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
105527009|NCT03240133|363941004|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
105527010|NCT00997503|363941005|FG000|Overall Study|Death|53|||
105593336|NCT01362491|364172698|FG000|Overall Study|Ineligible|1|||
105593337|NCT01362491|364172699|FG001|Overall Study|Ineligible|0|||
105593338|NCT01362491|364172700|FG002|Overall Study|Ineligible|0|||
105593339|NCT04867902|364172701|FG000|Overall Study|Lost to Follow-up|1|||
105593340|NCT04867902|364172701|FG000|Overall Study|Withdrawal by Subject|2|||
105593341|NCT04867902|364172701|FG000|Overall Study|Protocol Violation|1|||
105527011|NCT00997503|363941005|FG000|Overall Study|Withdrawal by Subject|76|||
105527012|NCT00997503|363941005|FG000|Overall Study|Lost to Follow-up|33|||
105527013|NCT00997503|363941005|FG000|Overall Study|Adverse Event|3|||
105527014|NCT00997503|363941005|FG000|Overall Study|Physician Decision|10|||
105527015|NCT00997503|363941005|FG000|Overall Study|Missed 12-month follow-up|85|||
105527016|NCT00997503|363941005|FG000|Overall Study|Other reason|13|||
105527017|NCT00116831|363941006|FG000|Overall Study|Adverse Event|14|||
105527018|NCT00116831|363941007|FG001|Overall Study|Adverse Event|16|||
105527019|NCT00116831|363941006|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
105593342|NCT01185522|364172702|FG000|Overall Study|Lack of Efficacy|28|||
105527020|NCT00116831|363941007|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
105527021|NCT00116831|363941006|FG000|Overall Study|Lost to Follow-up|8|||
105527022|NCT00116831|363941007|FG001|Overall Study|Lost to Follow-up|6|||
105527023|NCT00116831|363941006|FG000|Overall Study|Protocol Violation|3|||
105527024|NCT00116831|363941007|FG001|Overall Study|Protocol Violation|6|||
105527025|NCT00116831|363941006|FG000|Overall Study|Hypoglycaemic events|1|||
105527026|NCT00116831|363941007|FG001|Overall Study|Hypoglycaemic events|0|||
105527027|NCT00116831|363941006|FG000|Overall Study|Low haemoglobin on screening|1|||
105527028|NCT00116831|363941007|FG001|Overall Study|Low haemoglobin on screening|0|||
105527029|NCT00116831|363941006|FG000|Overall Study|Withdrawn investigational product|1|||
105527030|NCT00116831|363941007|FG001|Overall Study|Withdrawn investigational product|0|||
105527031|NCT00116831|363941006|FG000|Overall Study|Withdrawal by Subject|32|||
105527032|NCT00116831|363941007|FG001|Overall Study|Withdrawal by Subject|32|||
105527033|NCT00116831|363941006|FG000|Overall Study|Insufficient therapeutic effect|0|||
105527034|NCT00116831|363941007|FG001|Overall Study|Insufficient therapeutic effect|1|||
105527035|NCT00116831|363941006|FG000|Overall Study|Missing data for participant|1|||
105527036|NCT00116831|363941007|FG001|Overall Study|Missing data for participant|0|||
105527037|NCT00283439|363941008|FG000|Overall Study|Adverse Event|0|||
105527038|NCT00283439|363941009|FG001|Overall Study|Adverse Event|0|||
105527039|NCT00283439|363941010|FG002|Overall Study|Adverse Event|0|||
105527040|NCT00283439|363941011|FG003|Overall Study|Adverse Event|1|||
105527041|NCT00283439|363941008|FG000|Overall Study|Death|0|||
105527042|NCT00283439|363941009|FG001|Overall Study|Death|0|||
105527043|NCT00283439|363941010|FG002|Overall Study|Death|1|||
105527044|NCT00283439|363941011|FG003|Overall Study|Death|0|||
105527045|NCT00283439|363941008|FG000|Overall Study|Disease progression|0|||
105527046|NCT00283439|363941009|FG001|Overall Study|Disease progression|1|||
105527047|NCT00283439|363941010|FG002|Overall Study|Disease progression|0|||
105527048|NCT00283439|363941011|FG003|Overall Study|Disease progression|0|||
105527049|NCT00283439|363941008|FG000|Overall Study|Requirement for alternative therapy|1|||
105527050|NCT00283439|363941009|FG001|Overall Study|Requirement for alternative therapy|2|||
105527051|NCT00283439|363941010|FG002|Overall Study|Requirement for alternative therapy|5|||
105527052|NCT00283439|363941011|FG003|Overall Study|Requirement for alternative therapy|2|||
105527053|NCT00283439|363941008|FG000|Overall Study|Stem cell transplant|6|||
105527054|NCT00283439|363941009|FG001|Overall Study|Stem cell transplant|6|||
105527055|NCT00283439|363941010|FG002|Overall Study|Stem cell transplant|4|||
105527056|NCT00283439|363941011|FG003|Overall Study|Stem cell transplant|3|||
105527057|NCT00283439|363941008|FG000|Overall Study|Treatment discontinued|0|||
105527058|NCT00283439|363941009|FG001|Overall Study|Treatment discontinued|2|||
105527059|NCT00283439|363941010|FG002|Overall Study|Treatment discontinued|1|||
105527060|NCT00283439|363941011|FG003|Overall Study|Treatment discontinued|3|||
105439674|NCT00098306|363615019|FG004|Open Label|Lack of Efficacy|0|||
105527061|NCT00283439|363941008|FG000|Overall Study|Other|1|||
105527062|NCT00283439|363941009|FG001|Overall Study|Other|0|||
105527063|NCT00283439|363941010|FG002|Overall Study|Other|0|||
105527064|NCT00283439|363941011|FG003|Overall Study|Other|0|||
105527065|NCT00218296|363941014|FG000|Overall Study|Lost to Follow-up|9|||
105527066|NCT00218296|363941015|FG001|Overall Study|Lost to Follow-up|7|||
105527067|NCT00218296|363941014|FG000|Overall Study|Withdrawal by Subject|36|||
105527068|NCT00218296|363941015|FG001|Overall Study|Withdrawal by Subject|47|||
105527069|NCT00218296|363941014|FG000|Overall Study|Randomized but did not enter treatment|66|||
105527070|NCT00218296|363941015|FG001|Overall Study|Randomized but did not enter treatment|67|||
105527071|NCT04164901|363941019|FG000|Overall Study|Withdrawal by Subject|4|||
105527072|NCT04164901|363941020|FG001|Overall Study|Withdrawal by Subject|4|||
105527073|NCT01990495|363941037|FG000|Overall Study|Physician Decision|5|||
105527074|NCT01990495|363941038|FG001|Overall Study|Physician Decision|4|||
105527075|NCT01752855|363941042|FG000|Overall Study|Adverse Event|1|||
105527076|NCT01752855|363941043|FG001|Overall Study|Adverse Event|0|||
105527077|NCT01752855|363941042|FG000|Overall Study|Withdrew Consent|0|||
105527078|NCT01752855|363941043|FG001|Overall Study|Withdrew Consent|2|||
105527079|NCT01752855|363941042|FG000|Overall Study|Lack of Efficacy|0|||
105527080|NCT01752855|363941043|FG001|Overall Study|Lack of Efficacy|2|||
105593343|NCT01185522|364172702|FG000|Overall Study|Lost to Follow-up|19|||
105439675|NCT00098306|363615020|FG005|Open Label|Lack of Efficacy|0|||
105439676|NCT00098306|363615021|FG006|Open Label|Lack of Efficacy|0|||
105439677|NCT00098306|363615015|FG000|Open Label|Adverse Event|0|||
105439678|NCT00098306|363615016|FG001|Open Label|Adverse Event|0|||
105439679|NCT00098306|363615017|FG002|Open Label|Adverse Event|0|||
105439680|NCT00098306|363615018|FG003|Open Label|Adverse Event|2|||
105439681|NCT00098306|363615019|FG004|Open Label|Adverse Event|0|||
105439682|NCT00098306|363615020|FG005|Open Label|Adverse Event|0|||
105439683|NCT00098306|363615021|FG006|Open Label|Adverse Event|0|||
105439684|NCT00098306|363615015|FG000|Open Label|Death|0|||
105439685|NCT00098306|363615016|FG001|Open Label|Death|0|||
105439686|NCT00098306|363615017|FG002|Open Label|Death|0|||
105439687|NCT00098306|363615018|FG003|Open Label|Death|4|||
105439688|NCT00098306|363615019|FG004|Open Label|Death|0|||
105439689|NCT00098306|363615020|FG005|Open Label|Death|0|||
105439690|NCT00098306|363615021|FG006|Open Label|Death|0|||
105593344|NCT01185522|364172702|FG000|Overall Study|Withdrawal by Subject|10|||
105593345|NCT01185522|364172702|FG000|Overall Study|Poor tolerance|39|||
105593346|NCT01185522|364172702|FG000|Overall Study|Other reasons|12|||
105593347|NCT00771667|364172703|FG000|Induction Phase|Adverse Event|5|||
105593348|NCT00771667|364172704|FG001|Induction Phase|Adverse Event|2|||
105593349|NCT00771667|364172705|FG002|Induction Phase|Adverse Event|4|||
105593350|NCT00771667|364172706|FG003|Induction Phase|Adverse Event|1|||
105593351|NCT00771667|364172707|FG004|Induction Phase|Adverse Event|0|||
105593352|NCT00771667|364172708|FG005|Induction Phase|Adverse Event|0|||
105593353|NCT00771667|364172709|FG006|Induction Phase|Adverse Event|0|||
105593354|NCT00771667|364172710|FG007|Induction Phase|Adverse Event|0|||
105593355|NCT00771667|364172711|FG008|Induction Phase|Adverse Event|0|||
105593356|NCT00771667|364172712|FG009|Induction Phase|Adverse Event|0|||
105593357|NCT00771667|364172703|FG000|Induction Phase|Lack of Efficacy|9|||
105593358|NCT00771667|364172704|FG001|Induction Phase|Lack of Efficacy|2|||
105593359|NCT00771667|364172705|FG002|Induction Phase|Lack of Efficacy|4|||
105593360|NCT00771667|364172706|FG003|Induction Phase|Lack of Efficacy|3|||
105593361|NCT00771667|364172707|FG004|Induction Phase|Lack of Efficacy|0|||
105593362|NCT00771667|364172708|FG005|Induction Phase|Lack of Efficacy|0|||
105593363|NCT00771667|364172709|FG006|Induction Phase|Lack of Efficacy|0|||
105593364|NCT00771667|364172710|FG007|Induction Phase|Lack of Efficacy|0|||
105593365|NCT00771667|364172711|FG008|Induction Phase|Lack of Efficacy|0|||
105593366|NCT00771667|364172712|FG009|Induction Phase|Lack of Efficacy|0|||
105593367|NCT00771667|364172703|FG000|Induction Phase|Lost to Follow-up|1|||
105593368|NCT00771667|364172704|FG001|Induction Phase|Lost to Follow-up|0|||
105593369|NCT00771667|364172705|FG002|Induction Phase|Lost to Follow-up|1|||
105593370|NCT00771667|364172706|FG003|Induction Phase|Lost to Follow-up|0|||
105593371|NCT00771667|364172707|FG004|Induction Phase|Lost to Follow-up|0|||
105593372|NCT00771667|364172708|FG005|Induction Phase|Lost to Follow-up|0|||
105593373|NCT00771667|364172709|FG006|Induction Phase|Lost to Follow-up|0|||
105593374|NCT00771667|364172710|FG007|Induction Phase|Lost to Follow-up|0|||
105593375|NCT00771667|364172711|FG008|Induction Phase|Lost to Follow-up|0|||
105593376|NCT00771667|364172712|FG009|Induction Phase|Lost to Follow-up|0|||
105593377|NCT00771667|364172703|FG000|Induction Phase|Other|4|||
105593378|NCT00771667|364172704|FG001|Induction Phase|Other|6|||
105593379|NCT00771667|364172705|FG002|Induction Phase|Other|3|||
105593380|NCT00771667|364172706|FG003|Induction Phase|Other|4|||
105593381|NCT00771667|364172707|FG004|Induction Phase|Other|0|||
105593382|NCT00771667|364172708|FG005|Induction Phase|Other|0|||
105593383|NCT00771667|364172709|FG006|Induction Phase|Other|0|||
105593384|NCT00771667|364172710|FG007|Induction Phase|Other|0|||
105593385|NCT00771667|364172711|FG008|Induction Phase|Other|0|||
105593386|NCT00771667|364172712|FG009|Induction Phase|Other|0|||
105593387|NCT00771667|364172703|FG000|Maintenance Phase|Adverse Event|0|||
105593388|NCT00771667|364172704|FG001|Maintenance Phase|Adverse Event|0|||
105593389|NCT00771667|364172705|FG002|Maintenance Phase|Adverse Event|0|||
105593390|NCT00771667|364172706|FG003|Maintenance Phase|Adverse Event|0|||
105593391|NCT00771667|364172707|FG004|Maintenance Phase|Adverse Event|1|||
105593392|NCT00771667|364172708|FG005|Maintenance Phase|Adverse Event|3|||
105593393|NCT00771667|364172709|FG006|Maintenance Phase|Adverse Event|5|||
105593394|NCT00771667|364172710|FG007|Maintenance Phase|Adverse Event|1|||
105593395|NCT00771667|364172711|FG008|Maintenance Phase|Adverse Event|8|||
105593396|NCT00771667|364172712|FG009|Maintenance Phase|Adverse Event|7|||
105593397|NCT00771667|364172703|FG000|Maintenance Phase|Lack of Efficacy|0|||
105593398|NCT00771667|364172704|FG001|Maintenance Phase|Lack of Efficacy|0|||
105593399|NCT00771667|364172705|FG002|Maintenance Phase|Lack of Efficacy|0|||
105593400|NCT00771667|364172706|FG003|Maintenance Phase|Lack of Efficacy|0|||
105593401|NCT00771667|364172707|FG004|Maintenance Phase|Lack of Efficacy|1|||
105593402|NCT00771667|364172708|FG005|Maintenance Phase|Lack of Efficacy|3|||
105593403|NCT00771667|364172709|FG006|Maintenance Phase|Lack of Efficacy|3|||
105593404|NCT00771667|364172710|FG007|Maintenance Phase|Lack of Efficacy|2|||
105593405|NCT00771667|364172711|FG008|Maintenance Phase|Lack of Efficacy|11|||
105593406|NCT00771667|364172712|FG009|Maintenance Phase|Lack of Efficacy|7|||
105593407|NCT00771667|364172703|FG000|Maintenance Phase|Other|0|||
105593408|NCT00771667|364172704|FG001|Maintenance Phase|Other|0|||
105593409|NCT00771667|364172705|FG002|Maintenance Phase|Other|0|||
105593410|NCT00771667|364172706|FG003|Maintenance Phase|Other|0|||
105593411|NCT00771667|364172707|FG004|Maintenance Phase|Other|0|||
105593412|NCT00771667|364172708|FG005|Maintenance Phase|Other|1|||
105593413|NCT00771667|364172709|FG006|Maintenance Phase|Other|2|||
105593414|NCT00771667|364172710|FG007|Maintenance Phase|Other|2|||
105593415|NCT00771667|364172711|FG008|Maintenance Phase|Other|3|||
105593416|NCT00771667|364172712|FG009|Maintenance Phase|Other|3|||
105593417|NCT00357396|364172715|FG000|Overall Study|Adverse Event|1|||
105593418|NCT00357396|364172716|FG001|Overall Study|Adverse Event|0|||
105593419|NCT04379713|364172720|FG000|Overall Study|Adverse Event|2|||
105593420|NCT04379713|364172721|FG001|Overall Study|Adverse Event|0|||
105593421|NCT04379713|364172720|FG000|Overall Study|Physician Decision|2|||
105593422|NCT04379713|364172721|FG001|Overall Study|Physician Decision|1|||
105593423|NCT04379713|364172720|FG000|Overall Study|Protocol Violation|11|||
105593424|NCT04379713|364172721|FG001|Overall Study|Protocol Violation|6|||
105527081|NCT03168464|363941046|FG000|Overall Study|Death|9|||
105527082|NCT03168464|363941046|FG000|Overall Study|Progression of disease|6|||
105527083|NCT00235872|363941059|FG000|Overall Study|Adverse Event|34|||
105527084|NCT00235872|363941059|FG000|Overall Study|Death|1|||
105527085|NCT00235872|363941059|FG000|Overall Study|Lost to Follow-up|1|||
105527086|NCT00235872|363941059|FG000|Overall Study|Withdrawal by Subject|50|||
105527087|NCT00235872|363941059|FG000|Overall Study|Administrative reason|61|||
105527088|NCT01446965|363941065|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
105527089|NCT01446965|363941066|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
105527090|NCT01446965|363941065|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
105527091|NCT01446965|363941066|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
105527092|NCT02023151|363941067|FG000|Overall Study|Lost to Follow-up|4|||
105527093|NCT02932904|363941073|FG000|Overall Study|Reason not Specified|1|||
105527094|NCT02932904|363941074|FG001|Overall Study|Reason not Specified|0|||
105527095|NCT02932904|363941075|FG002|Overall Study|Reason not Specified|2|||
105527096|NCT02932904|363941076|FG003|Overall Study|Reason not Specified|2|||
105527097|NCT02932904|363941073|FG000|Overall Study|Noncompliance with Study Drug|2|||
105527098|NCT02932904|363941074|FG001|Overall Study|Noncompliance with Study Drug|3|||
105527099|NCT02932904|363941075|FG002|Overall Study|Noncompliance with Study Drug|3|||
105527100|NCT02932904|363941076|FG003|Overall Study|Noncompliance with Study Drug|4|||
105527101|NCT02932904|363941073|FG000|Overall Study|Pregnancy|0|||
105527102|NCT02932904|363941074|FG001|Overall Study|Pregnancy|1|||
105527103|NCT02932904|363941075|FG002|Overall Study|Pregnancy|1|||
105527104|NCT02932904|363941076|FG003|Overall Study|Pregnancy|0|||
105527105|NCT02932904|363941073|FG000|Overall Study|Study Termination|0|||
105527106|NCT02932904|363941074|FG001|Overall Study|Study Termination|1|||
105527107|NCT02932904|363941075|FG002|Overall Study|Study Termination|0|||
105527108|NCT02932904|363941076|FG003|Overall Study|Study Termination|0|||
105527109|NCT02932904|363941073|FG000|Overall Study|Voluntary Withdrawal|2|||
105527110|NCT02932904|363941074|FG001|Overall Study|Voluntary Withdrawal|1|||
105527111|NCT02932904|363941075|FG002|Overall Study|Voluntary Withdrawal|4|||
105527112|NCT02932904|363941076|FG003|Overall Study|Voluntary Withdrawal|2|||
105527113|NCT02932904|363941073|FG000|Overall Study|Lost to Follow-up|5|||
105527114|NCT02932904|363941074|FG001|Overall Study|Lost to Follow-up|3|||
105527115|NCT02932904|363941075|FG002|Overall Study|Lost to Follow-up|6|||
105527116|NCT02932904|363941076|FG003|Overall Study|Lost to Follow-up|0|||
105527117|NCT02932904|363941073|FG000|Overall Study|Significant Protocol Deviation|2|||
105527118|NCT02932904|363941074|FG001|Overall Study|Significant Protocol Deviation|3|||
105593425|NCT04379713|364172720|FG000|Overall Study|No longer met eligibility criteria|14|||
105593426|NCT04379713|364172721|FG001|Overall Study|No longer met eligibility criteria|11|||
105593427|NCT04379713|364172720|FG000|Overall Study|Withdrawal by parent/guardian|36|||
105593428|NCT04379713|364172721|FG001|Overall Study|Withdrawal by parent/guardian|15|||
105593429|NCT04379713|364172720|FG000|Overall Study|Lost to Follow-up|31|||
105593430|NCT04379713|364172721|FG001|Overall Study|Lost to Follow-up|21|||
105593431|NCT02148133|364172722|FG000|Overall Study|Investigator discretion|1|||
105593432|NCT02148133|364172722|FG000|Overall Study|Lack of Efficacy|1|||
105593433|NCT02148133|364172722|FG000|Overall Study|Protocol deviation|1|||
105593434|NCT02148133|364172722|FG000|Overall Study|Protocol-defined stopping criteria|2|||
105593435|NCT03808883|364172723|FG000|Overall Study|Withdrawal by Subject|2|||
105593436|NCT03808883|364172724|FG001|Overall Study|Withdrawal by Subject|0|||
105593437|NCT03808883|364172723|FG000|Overall Study|Did not complete pre test or post test survey|4|||
105593438|NCT03808883|364172724|FG001|Overall Study|Did not complete pre test or post test survey|3|||
105593439|NCT00509769|364172734|FG000|Overall Study|Progressive disease|77|||
105593440|NCT00509769|364172734|FG000|Overall Study|Adverse Event|4|||
105593441|NCT00509769|364172734|FG000|Overall Study|Patient's decision|1|||
105593442|NCT00509769|364172734|FG000|Overall Study|Physician Decision|8|||
105593443|NCT00509769|364172734|FG000|Overall Study|Use of prohibited therapies during study|1|||
105593444|NCT04567888|364172735|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
105593445|NCT04567888|364172736|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
105593446|NCT04567888|364172735|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
105593447|NCT04567888|364172736|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
105593448|NCT04567888|364172735|FG000|Overall Study|Reported Unusual Birth Year|2|||
105593449|NCT04567888|364172736|FG001|Overall Study|Reported Unusual Birth Year|3|||
105593450|NCT04567888|364172735|FG000|Overall Study|Duplicate Responses|0|||
105593451|NCT04567888|364172736|FG001|Overall Study|Duplicate Responses|1|||
105593452|NCT00414648|364172737|FG000|Overall Study|Adverse Event|5|||
105593453|NCT00414648|364172738|FG001|Overall Study|Adverse Event|5|||
105593454|NCT00414648|364172737|FG000|Overall Study|Death|0|||
105593455|NCT00414648|364172738|FG001|Overall Study|Death|1|||
105593456|NCT00414648|364172737|FG000|Overall Study|Lack of Efficacy|0|||
105593457|NCT00414648|364172738|FG001|Overall Study|Lack of Efficacy|2|||
105593458|NCT00414648|364172737|FG000|Overall Study|Withdrawal by Subject|0|||
105593459|NCT00414648|364172738|FG001|Overall Study|Withdrawal by Subject|1|||
105593460|NCT02371746|364172739|FG000|Overall Study|Consent withdrawn|0|||
105593461|NCT02371746|364172740|FG001|Overall Study|Consent withdrawn|0|||
105593462|NCT02371746|364172741|FG002|Overall Study|Consent withdrawn|0|||
105593463|NCT02371746|364172742|FG003|Overall Study|Consent withdrawn|0|||
105593464|NCT02371746|364172743|FG004|Overall Study|Consent withdrawn|0|||
105593465|NCT02371746|364172744|FG005|Overall Study|Consent withdrawn|0|||
105593466|NCT02371746|364172745|FG006|Overall Study|Consent withdrawn|1|||
105593467|NCT02613364|364172751|FG000|Overall Study|Other|19|||
105593468|NCT02613364|364172752|FG001|Overall Study|Other|29|||
105593469|NCT02613364|364172753|FG002|Overall Study|Other|17|||
105593470|NCT02613364|364172751|FG000|Overall Study|Too time consuming|21|||
105593471|NCT02613364|364172752|FG001|Overall Study|Too time consuming|26|||
105439691|NCT00098306|363615015|FG000|Open Label|Participant defaulted|0|||
105439692|NCT00098306|363615016|FG001|Open Label|Participant defaulted|0|||
105439693|NCT00098306|363615017|FG002|Open Label|Participant defaulted|0|||
105439694|NCT00098306|363615018|FG003|Open Label|Participant defaulted|24|||
105439695|NCT00098306|363615019|FG004|Open Label|Participant defaulted|0|||
105439696|NCT00098306|363615020|FG005|Open Label|Participant defaulted|0|||
105439697|NCT00098306|363615021|FG006|Open Label|Participant defaulted|0|||
105439698|NCT00098306|363615015|FG000|Open Label|Un-specified|0|||
105439699|NCT00098306|363615016|FG001|Open Label|Un-specified|0|||
105439700|NCT00098306|363615017|FG002|Open Label|Un-specified|0|||
105439701|NCT00098306|363615018|FG003|Open Label|Un-specified|15|||
105439702|NCT00098306|363615019|FG004|Open Label|Un-specified|0|||
105439703|NCT00098306|363615020|FG005|Open Label|Un-specified|0|||
105439704|NCT00098306|363615021|FG006|Open Label|Un-specified|0|||
105439705|NCT00098306|363615015|FG000|Open Label|Ongoing at cut-off date|0|||
105439706|NCT00098306|363615016|FG001|Open Label|Ongoing at cut-off date|0|||
105439707|NCT00098306|363615017|FG002|Open Label|Ongoing at cut-off date|0|||
105439708|NCT00098306|363615018|FG003|Open Label|Ongoing at cut-off date|269|||
105439709|NCT00098306|363615019|FG004|Open Label|Ongoing at cut-off date|62|||
105593472|NCT02613364|364172753|FG002|Overall Study|Too time consuming|26|||
105593473|NCT02613364|364172751|FG000|Overall Study|Withdrawal by Subject|13|||
105593474|NCT02613364|364172752|FG001|Overall Study|Withdrawal by Subject|18|||
105593475|NCT02613364|364172753|FG002|Overall Study|Withdrawal by Subject|17|||
105593476|NCT02613364|364172751|FG000|Overall Study|Medical|12|||
105593477|NCT02613364|364172752|FG001|Overall Study|Medical|13|||
105593478|NCT02613364|364172753|FG002|Overall Study|Medical|9|||
105439710|NCT00098306|363615020|FG005|Open Label|Ongoing at cut-off date|0|||
105439711|NCT00098306|363615021|FG006|Open Label|Ongoing at cut-off date|0|||
105439712|NCT00098306|363615015|FG000|Observational Phase|Death|0|||
105439713|NCT00098306|363615016|FG001|Observational Phase|Death|0|||
105439714|NCT00098306|363615017|FG002|Observational Phase|Death|0|||
105593479|NCT02613364|364172751|FG000|Overall Study|Disliked Study Procedure|1|||
105593480|NCT02613364|364172752|FG001|Overall Study|Disliked Study Procedure|1|||
105593481|NCT02613364|364172753|FG002|Overall Study|Disliked Study Procedure|4|||
105593482|NCT02613364|364172751|FG000|Overall Study|Disliked Intervention|0|||
105593483|NCT02613364|364172752|FG001|Overall Study|Disliked Intervention|3|||
105593484|NCT02613364|364172753|FG002|Overall Study|Disliked Intervention|3|||
105593485|NCT01235949|364172754|FG000|Primary Phase|Migrated/moved from study area|1|||
105593486|NCT01235949|364172755|FG001|Primary Phase|Migrated/moved from study area|1|||
105593487|NCT01235949|364172756|FG002|Primary Phase|Migrated/moved from study area|0|||
105593488|NCT01235949|364172757|FG003|Primary Phase|Migrated/moved from study area|0|||
105593489|NCT01235949|364172758|FG004|Primary Phase|Migrated/moved from study area|1|||
105593490|NCT01235949|364172759|FG005|Primary Phase|Migrated/moved from study area|2|||
105593491|NCT01235949|364172760|FG006|Primary Phase|Migrated/moved from study area|0|||
105593492|NCT01235949|364172761|FG007|Primary Phase|Migrated/moved from study area|0|||
105593493|NCT01235949|364172762|FG008|Primary Phase|Migrated/moved from study area|0|||
105593494|NCT01235949|364172763|FG009|Primary Phase|Migrated/moved from study area|0|||
105593495|NCT01235949|364172764|FG010|Primary Phase|Migrated/moved from study area|0|||
105593496|NCT01235949|364172765|FG011|Primary Phase|Migrated/moved from study area|0|||
105593497|NCT01235949|364172766|FG012|Primary Phase|Migrated/moved from study area|0|||
105593498|NCT01235949|364172767|FG013|Primary Phase|Migrated/moved from study area|0|||
105593499|NCT01235949|364172768|FG014|Primary Phase|Migrated/moved from study area|0|||
105593500|NCT01235949|364172769|FG015|Primary Phase|Migrated/moved from study area|0|||
105593501|NCT01235949|364172770|FG016|Primary Phase|Migrated/moved from study area|0|||
105593502|NCT01235949|364172771|FG017|Primary Phase|Migrated/moved from study area|0|||
105593503|NCT01235949|364172754|FG000|Primary Phase|Adverse Event|0|||
105593504|NCT01235949|364172755|FG001|Primary Phase|Adverse Event|0|||
105593505|NCT01235949|364172756|FG002|Primary Phase|Adverse Event|0|||
105593506|NCT01235949|364172757|FG003|Primary Phase|Adverse Event|1|||
105593507|NCT01235949|364172758|FG004|Primary Phase|Adverse Event|0|||
105593508|NCT01235949|364172759|FG005|Primary Phase|Adverse Event|0|||
105593509|NCT01235949|364172760|FG006|Primary Phase|Adverse Event|0|||
105593510|NCT01235949|364172761|FG007|Primary Phase|Adverse Event|0|||
105593511|NCT01235949|364172762|FG008|Primary Phase|Adverse Event|0|||
105593512|NCT01235949|364172763|FG009|Primary Phase|Adverse Event|0|||
105593513|NCT01235949|364172764|FG010|Primary Phase|Adverse Event|0|||
105593514|NCT01235949|364172765|FG011|Primary Phase|Adverse Event|0|||
105593515|NCT01235949|364172766|FG012|Primary Phase|Adverse Event|0|||
105593516|NCT01235949|364172767|FG013|Primary Phase|Adverse Event|0|||
105593517|NCT01235949|364172768|FG014|Primary Phase|Adverse Event|0|||
105593518|NCT01235949|364172769|FG015|Primary Phase|Adverse Event|0|||
105593519|NCT01235949|364172770|FG016|Primary Phase|Adverse Event|0|||
105593520|NCT01235949|364172771|FG017|Primary Phase|Adverse Event|0|||
105593521|NCT01235949|364172754|FG000|Primary Phase|Withdrawal by Subject|3|||
105593522|NCT01235949|364172755|FG001|Primary Phase|Withdrawal by Subject|2|||
105593523|NCT01235949|364172756|FG002|Primary Phase|Withdrawal by Subject|2|||
105593524|NCT01235949|364172757|FG003|Primary Phase|Withdrawal by Subject|0|||
105593525|NCT01235949|364172758|FG004|Primary Phase|Withdrawal by Subject|0|||
105593526|NCT01235949|364172759|FG005|Primary Phase|Withdrawal by Subject|3|||
105593527|NCT01235949|364172760|FG006|Primary Phase|Withdrawal by Subject|0|||
105593528|NCT01235949|364172761|FG007|Primary Phase|Withdrawal by Subject|0|||
105593529|NCT01235949|364172762|FG008|Primary Phase|Withdrawal by Subject|0|||
105593530|NCT01235949|364172763|FG009|Primary Phase|Withdrawal by Subject|0|||
105593531|NCT01235949|364172764|FG010|Primary Phase|Withdrawal by Subject|0|||
105593532|NCT01235949|364172765|FG011|Primary Phase|Withdrawal by Subject|0|||
105593533|NCT01235949|364172766|FG012|Primary Phase|Withdrawal by Subject|0|||
105593534|NCT01235949|364172767|FG013|Primary Phase|Withdrawal by Subject|0|||
105593535|NCT01235949|364172768|FG014|Primary Phase|Withdrawal by Subject|0|||
105593536|NCT01235949|364172769|FG015|Primary Phase|Withdrawal by Subject|0|||
105593537|NCT01235949|364172770|FG016|Primary Phase|Withdrawal by Subject|0|||
105593538|NCT01235949|364172771|FG017|Primary Phase|Withdrawal by Subject|0|||
105593539|NCT01235949|364172754|FG000|Primary Phase|Lost to Follow-up|0|||
105593540|NCT01235949|364172755|FG001|Primary Phase|Lost to Follow-up|0|||
105593541|NCT01235949|364172756|FG002|Primary Phase|Lost to Follow-up|1|||
105593542|NCT01235949|364172757|FG003|Primary Phase|Lost to Follow-up|1|||
105593543|NCT01235949|364172758|FG004|Primary Phase|Lost to Follow-up|0|||
105593544|NCT01235949|364172759|FG005|Primary Phase|Lost to Follow-up|2|||
105593545|NCT01235949|364172760|FG006|Primary Phase|Lost to Follow-up|0|||
105593546|NCT01235949|364172761|FG007|Primary Phase|Lost to Follow-up|0|||
105593547|NCT01235949|364172762|FG008|Primary Phase|Lost to Follow-up|0|||
105593548|NCT01235949|364172763|FG009|Primary Phase|Lost to Follow-up|0|||
105593549|NCT01235949|364172764|FG010|Primary Phase|Lost to Follow-up|0|||
105593550|NCT01235949|364172765|FG011|Primary Phase|Lost to Follow-up|0|||
105593551|NCT01235949|364172766|FG012|Primary Phase|Lost to Follow-up|0|||
105593552|NCT01235949|364172767|FG013|Primary Phase|Lost to Follow-up|0|||
105593553|NCT01235949|364172768|FG014|Primary Phase|Lost to Follow-up|0|||
105593554|NCT01235949|364172769|FG015|Primary Phase|Lost to Follow-up|0|||
105439715|NCT00098306|363615018|FG003|Observational Phase|Death|0|||
105439716|NCT00098306|363615019|FG004|Observational Phase|Death|0|||
105439717|NCT00098306|363615020|FG005|Observational Phase|Death|5|||
105439718|NCT00098306|363615021|FG006|Observational Phase|Death|4|||
105439719|NCT00098306|363615015|FG000|Observational Phase|Participant defaulted|0|||
105439720|NCT00098306|363615016|FG001|Observational Phase|Participant defaulted|0|||
105439721|NCT00098306|363615017|FG002|Observational Phase|Participant defaulted|0|||
105439722|NCT00098306|363615018|FG003|Observational Phase|Participant defaulted|0|||
105439723|NCT00098306|363615019|FG004|Observational Phase|Participant defaulted|0|||
105439724|NCT00098306|363615020|FG005|Observational Phase|Participant defaulted|34|||
105439725|NCT00098306|363615021|FG006|Observational Phase|Participant defaulted|18|||
105439726|NCT00098306|363615015|FG000|Observational Phase|Un-specified|0|||
105439727|NCT00098306|363615016|FG001|Observational Phase|Un-specified|0|||
105439728|NCT00098306|363615017|FG002|Observational Phase|Un-specified|0|||
105439729|NCT00098306|363615018|FG003|Observational Phase|Un-specified|0|||
105439730|NCT00098306|363615019|FG004|Observational Phase|Un-specified|0|||
105439731|NCT00098306|363615020|FG005|Observational Phase|Un-specified|7|||
105439732|NCT00098306|363615021|FG006|Observational Phase|Un-specified|4|||
105439733|NCT02106403|363615022|FG000|Follow-Up Visit 3|Other Reason|0|||
105439734|NCT02106403|363615023|FG001|Follow-Up Visit 3|Other Reason|0|||
105439735|NCT02106403|363615024|FG002|Follow-Up Visit 3|Other Reason|0|||
105439736|NCT02106403|363615025|FG003|Follow-Up Visit 3|Other Reason|0|||
105439737|NCT02106403|363615026|FG004|Follow-Up Visit 3|Other Reason|0|||
105439738|NCT02106403|363615027|FG005|Follow-Up Visit 3|Other Reason|1|||
105439739|NCT01069705|363615028|FG000|Overall Study|Adverse Event|1|||
105439740|NCT01069705|363615028|FG000|Overall Study|Withdrawal by Subject|2|||
105439741|NCT00923845|363615029|FG000|Induction Therapy|Poor performance status|0|||
105439742|NCT00923845|363615030|FG001|Induction Therapy|Poor performance status|2|||
105439743|NCT01628965|363615037|FG000|Overall Study|Adverse Event|30|||
105439744|NCT01628965|363615037|FG000|Overall Study|Lack of Efficacy|7|||
105439745|NCT01628965|363615037|FG000|Overall Study|Withdrawal by Subject|3|||
105439746|NCT01628965|363615037|FG000|Overall Study|Lost to Follow-up|1|||
105439747|NCT01628965|363615037|FG000|Overall Study|Discontinuation criteria|8|||
105439748|NCT00148941|363615038|FG000|Overall Study|Lost to Follow-up|17|||
105439749|NCT00148941|363615039|FG001|Overall Study|Lost to Follow-up|24|||
105439750|NCT00148941|363615040|FG002|Overall Study|Lost to Follow-up|18|||
105439751|NCT00148941|363615041|FG003|Overall Study|Lost to Follow-up|22|||
105439752|NCT00148941|363615038|FG000|Overall Study|Withdrawal by Subject|1|||
105439753|NCT00148941|363615039|FG001|Overall Study|Withdrawal by Subject|0|||
105439754|NCT00148941|363615040|FG002|Overall Study|Withdrawal by Subject|1|||
105439755|NCT00148941|363615041|FG003|Overall Study|Withdrawal by Subject|0|||
105439756|NCT00148941|363615038|FG000|Overall Study|Other|0|||
105439757|NCT00148941|363615039|FG001|Overall Study|Other|0|||
105439758|NCT00148941|363615040|FG002|Overall Study|Other|1|||
105439759|NCT00148941|363615041|FG003|Overall Study|Other|2|||
105439760|NCT01339897|363615042|FG000|Overall Study|Adverse Event|1|||
105439761|NCT01339897|363615043|FG001|Overall Study|Adverse Event|0|||
105439762|NCT01339897|363615044|FG002|Overall Study|Adverse Event|0|||
105439763|NCT01339897|363615045|FG003|Overall Study|Adverse Event|1|||
105439764|NCT02461745|363615057|FG000|Overall Study|Lack of Efficacy|9|||
105439765|NCT02461745|363615058|FG001|Overall Study|Lack of Efficacy|1|||
105439766|NCT02461745|363615057|FG000|Overall Study|Lost to Follow-up|2|||
105439767|NCT02461745|363615058|FG001|Overall Study|Lost to Follow-up|2|||
105439768|NCT02461745|363615057|FG000|Overall Study|Withdrawal by Subject|3|||
105527119|NCT02932904|363941075|FG002|Overall Study|Significant Protocol Deviation|6|||
105527120|NCT02932904|363941076|FG003|Overall Study|Significant Protocol Deviation|1|||
105527121|NCT02932904|363941073|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
105527122|NCT02932904|363941074|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
105527123|NCT02932904|363941075|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
105527124|NCT02932904|363941076|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
105527125|NCT02932904|363941073|FG000|Overall Study|Randomized But Not Treated|1|||
105527126|NCT02932904|363941074|FG001|Overall Study|Randomized But Not Treated|1|||
105527127|NCT02932904|363941075|FG002|Overall Study|Randomized But Not Treated|0|||
105527128|NCT02932904|363941076|FG003|Overall Study|Randomized But Not Treated|2|||
105439769|NCT02461745|363615058|FG001|Overall Study|Withdrawal by Subject|1|||
105439770|NCT00211887|363615061|FG000|Overall Study|Adverse Event|8|||
105439771|NCT00211887|363615062|FG001|Overall Study|Adverse Event|4|||
105439772|NCT00211887|363615063|FG002|Overall Study|Adverse Event|6|||
105439773|NCT00211887|363615061|FG000|Overall Study|Death|1|||
105439774|NCT00211887|363615062|FG001|Overall Study|Death|1|||
105439775|NCT00211887|363615063|FG002|Overall Study|Death|1|||
105439776|NCT00211887|363615061|FG000|Overall Study|Lost to Follow-up|28|||
105439777|NCT00211887|363615062|FG001|Overall Study|Lost to Follow-up|13|||
105439778|NCT00211887|363615063|FG002|Overall Study|Lost to Follow-up|9|||
105439779|NCT00211887|363615061|FG000|Overall Study|Non-medical reason|31|||
105439780|NCT00211887|363615062|FG001|Overall Study|Non-medical reason|14|||
105439781|NCT00211887|363615063|FG002|Overall Study|Non-medical reason|8|||
105439782|NCT00211887|363615061|FG000|Overall Study|Other medical reason|15|||
105439783|NCT00211887|363615062|FG001|Overall Study|Other medical reason|11|||
105593555|NCT01235949|364172770|FG016|Primary Phase|Lost to Follow-up|0|||
105593556|NCT01235949|364172771|FG017|Primary Phase|Lost to Follow-up|0|||
105593557|NCT01235949|364172754|FG000|Booster Phase|Migrated/moved from study area|0|||
105593558|NCT01235949|364172755|FG001|Booster Phase|Migrated/moved from study area|0|||
105593559|NCT01235949|364172756|FG002|Booster Phase|Migrated/moved from study area|0|||
105593560|NCT01235949|364172757|FG003|Booster Phase|Migrated/moved from study area|0|||
105593561|NCT01235949|364172758|FG004|Booster Phase|Migrated/moved from study area|0|||
105593562|NCT01235949|364172759|FG005|Booster Phase|Migrated/moved from study area|0|||
105593563|NCT01235949|364172760|FG006|Booster Phase|Migrated/moved from study area|0|||
105593564|NCT01235949|364172761|FG007|Booster Phase|Migrated/moved from study area|0|||
105593565|NCT01235949|364172762|FG008|Booster Phase|Migrated/moved from study area|0|||
105593566|NCT01235949|364172763|FG009|Booster Phase|Migrated/moved from study area|0|||
105593567|NCT01235949|364172764|FG010|Booster Phase|Migrated/moved from study area|0|||
105593568|NCT01235949|364172765|FG011|Booster Phase|Migrated/moved from study area|1|||
105593569|NCT01235949|364172766|FG012|Booster Phase|Migrated/moved from study area|1|||
105593570|NCT01235949|364172767|FG013|Booster Phase|Migrated/moved from study area|0|||
105593571|NCT01235949|364172768|FG014|Booster Phase|Migrated/moved from study area|0|||
105593572|NCT01235949|364172769|FG015|Booster Phase|Migrated/moved from study area|0|||
105593573|NCT01235949|364172770|FG016|Booster Phase|Migrated/moved from study area|0|||
105593574|NCT01235949|364172771|FG017|Booster Phase|Migrated/moved from study area|1|||
105593575|NCT01235949|364172754|FG000|Booster Phase|Adverse Event|0|||
105593576|NCT01235949|364172755|FG001|Booster Phase|Adverse Event|0|||
105593577|NCT01235949|364172756|FG002|Booster Phase|Adverse Event|0|||
105593578|NCT01235949|364172757|FG003|Booster Phase|Adverse Event|0|||
105593579|NCT01235949|364172758|FG004|Booster Phase|Adverse Event|0|||
105593580|NCT01235949|364172759|FG005|Booster Phase|Adverse Event|0|||
105593581|NCT01235949|364172760|FG006|Booster Phase|Adverse Event|0|||
105593582|NCT01235949|364172761|FG007|Booster Phase|Adverse Event|0|||
105593583|NCT01235949|364172762|FG008|Booster Phase|Adverse Event|0|||
105593584|NCT01235949|364172763|FG009|Booster Phase|Adverse Event|0|||
105593585|NCT01235949|364172764|FG010|Booster Phase|Adverse Event|0|||
105593586|NCT01235949|364172765|FG011|Booster Phase|Adverse Event|0|||
105593587|NCT01235949|364172766|FG012|Booster Phase|Adverse Event|0|||
105593588|NCT01235949|364172767|FG013|Booster Phase|Adverse Event|0|||
105593589|NCT01235949|364172768|FG014|Booster Phase|Adverse Event|0|||
105593590|NCT01235949|364172769|FG015|Booster Phase|Adverse Event|1|||
105593591|NCT01235949|364172770|FG016|Booster Phase|Adverse Event|0|||
105593592|NCT01235949|364172771|FG017|Booster Phase|Adverse Event|0|||
105593593|NCT01235949|364172754|FG000|Booster Phase|Withdrawal by Subject|0|||
105593594|NCT01235949|364172755|FG001|Booster Phase|Withdrawal by Subject|0|||
105593595|NCT01235949|364172756|FG002|Booster Phase|Withdrawal by Subject|0|||
105593596|NCT01235949|364172757|FG003|Booster Phase|Withdrawal by Subject|0|||
105593597|NCT01235949|364172758|FG004|Booster Phase|Withdrawal by Subject|0|||
105593598|NCT01235949|364172759|FG005|Booster Phase|Withdrawal by Subject|0|||
105593599|NCT01235949|364172760|FG006|Booster Phase|Withdrawal by Subject|0|||
105593600|NCT01235949|364172761|FG007|Booster Phase|Withdrawal by Subject|1|||
105527129|NCT01293240|363941079|FG000|Overall Study|Noncompliance|2|||
105527130|NCT04238728|363941085|FG000|Overall Study|Withdrawal by Subject|1|||
105527131|NCT04238728|363941085|FG000|Overall Study|Lost to Follow-up|2|||
105527132|NCT01364428|363941094|FG000|Overall Study|Adverse Event|1|||
105527133|NCT01364428|363941095|FG001|Overall Study|Adverse Event|2|||
105527134|NCT01364428|363941094|FG000|Overall Study|Protocol Violation|2|||
105527135|NCT01364428|363941095|FG001|Overall Study|Protocol Violation|0|||
105527136|NCT01364428|363941094|FG000|Overall Study|Withdrawal Criteria|14|||
105527137|NCT01364428|363941095|FG001|Overall Study|Withdrawal Criteria|10|||
105527138|NCT01364428|363941094|FG000|Overall Study|Other|3|||
105527139|NCT01364428|363941095|FG001|Overall Study|Other|3|||
105527140|NCT01987427|363941096|FG000|Overall Study|Adverse Event|4|||
105527141|NCT01987427|363941097|FG001|Overall Study|Adverse Event|2|||
105527142|NCT01987427|363941098|FG002|Overall Study|Adverse Event|8|||
105527143|NCT01987427|363941096|FG000|Overall Study|Lost to Follow-up|6|||
105593601|NCT01235949|364172762|FG008|Booster Phase|Withdrawal by Subject|1|||
105593602|NCT01235949|364172763|FG009|Booster Phase|Withdrawal by Subject|0|||
105593603|NCT01235949|364172764|FG010|Booster Phase|Withdrawal by Subject|1|||
105593604|NCT01235949|364172765|FG011|Booster Phase|Withdrawal by Subject|1|||
105593605|NCT01235949|364172766|FG012|Booster Phase|Withdrawal by Subject|2|||
105527144|NCT01987427|363941097|FG001|Overall Study|Lost to Follow-up|6|||
105527145|NCT01987427|363941098|FG002|Overall Study|Lost to Follow-up|9|||
105593606|NCT01235949|364172767|FG013|Booster Phase|Withdrawal by Subject|0|||
105593607|NCT01235949|364172768|FG014|Booster Phase|Withdrawal by Subject|2|||
105593608|NCT01235949|364172769|FG015|Booster Phase|Withdrawal by Subject|0|||
105593609|NCT01235949|364172770|FG016|Booster Phase|Withdrawal by Subject|0|||
105593610|NCT01235949|364172771|FG017|Booster Phase|Withdrawal by Subject|0|||
105527146|NCT01987427|363941096|FG000|Overall Study|Withdrawal by Subject|2|||
105527147|NCT01987427|363941097|FG001|Overall Study|Withdrawal by Subject|1|||
105527148|NCT01987427|363941098|FG002|Overall Study|Withdrawal by Subject|3|||
105527149|NCT01987427|363941096|FG000|Overall Study|Lack of Efficacy|1|||
105527150|NCT01987427|363941097|FG001|Overall Study|Lack of Efficacy|0|||
105527151|NCT01987427|363941098|FG002|Overall Study|Lack of Efficacy|0|||
105527152|NCT01987427|363941096|FG000|Overall Study|Other|1|||
105527153|NCT01987427|363941097|FG001|Overall Study|Other|1|||
105527154|NCT01987427|363941098|FG002|Overall Study|Other|0|||
105527155|NCT01073865|363941099|FG000|Overall Study|Reasons other than below|19|||
105527156|NCT01073865|363941100|FG001|Overall Study|Reasons other than below|31|||
105527157|NCT01073865|363941099|FG000|Overall Study|Lost to Follow-up|1|||
105527158|NCT01073865|363941100|FG001|Overall Study|Lost to Follow-up|1|||
105527159|NCT01073865|363941099|FG000|Overall Study|Death|3|||
105527160|NCT01073865|363941100|FG001|Overall Study|Death|2|||
105527161|NCT01073865|363941099|FG000|Overall Study|Withdrawal by Subject|5|||
105527162|NCT01073865|363941100|FG001|Overall Study|Withdrawal by Subject|5|||
105527163|NCT00743652|363941101|FG000|Overall Study|Parent/Legal Guardian Request|3|||
105527164|NCT00743652|363941102|FG001|Overall Study|Parent/Legal Guardian Request|2|||
105527165|NCT00743652|363941103|FG002|Overall Study|Parent/Legal Guardian Request|2|||
105527166|NCT00743652|363941104|FG003|Overall Study|Parent/Legal Guardian Request|2|||
105527167|NCT00743652|363941105|FG004|Overall Study|Parent/Legal Guardian Request|0|||
105527168|NCT00743652|363941101|FG000|Overall Study|Adverse Event|3|||
105527169|NCT00743652|363941102|FG001|Overall Study|Adverse Event|0|||
105527170|NCT00743652|363941103|FG002|Overall Study|Adverse Event|0|||
105527171|NCT00743652|363941104|FG003|Overall Study|Adverse Event|0|||
105527172|NCT00743652|363941105|FG004|Overall Study|Adverse Event|0|||
105527173|NCT00743652|363941101|FG000|Overall Study|Death|2|||
105527174|NCT00743652|363941102|FG001|Overall Study|Death|0|||
105527175|NCT00743652|363941103|FG002|Overall Study|Death|0|||
105527176|NCT00743652|363941104|FG003|Overall Study|Death|0|||
105527177|NCT00743652|363941105|FG004|Overall Study|Death|0|||
105527178|NCT00743652|363941101|FG000|Overall Study|Investigator Request|0|||
105527179|NCT00743652|363941102|FG001|Overall Study|Investigator Request|0|||
105527180|NCT00743652|363941103|FG002|Overall Study|Investigator Request|0|||
105527181|NCT00743652|363941104|FG003|Overall Study|Investigator Request|2|||
105527182|NCT00743652|363941105|FG004|Overall Study|Investigator Request|0|||
105527183|NCT00743652|363941101|FG000|Overall Study|Other|1|||
105527184|NCT00743652|363941102|FG001|Overall Study|Other|1|||
105527185|NCT00743652|363941103|FG002|Overall Study|Other|0|||
105527186|NCT00743652|363941104|FG003|Overall Study|Other|0|||
105527187|NCT00743652|363941105|FG004|Overall Study|Other|0|||
105527188|NCT00743652|363941101|FG000|Overall Study|Lost to Follow-up|1|||
105527189|NCT00743652|363941102|FG001|Overall Study|Lost to Follow-up|0|||
105527190|NCT00743652|363941103|FG002|Overall Study|Lost to Follow-up|0|||
105527191|NCT00743652|363941104|FG003|Overall Study|Lost to Follow-up|0|||
105527192|NCT00743652|363941105|FG004|Overall Study|Lost to Follow-up|0|||
105527193|NCT00907374|363941109|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
105527194|NCT00907374|363941110|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
105527195|NCT00439556|363941111|FG000|Overall Study|Patient was taken off study for non-comp|0|||
105527196|NCT00439556|363941112|FG001|Overall Study|Patient was taken off study for non-comp|1|||
105527197|NCT00439556|363941113|FG002|Overall Study|Patient was taken off study for non-comp|0|||
105527198|NCT01183975|363941114|FG000|Overall Study|Lost to Follow-up|73|||
105527199|NCT00405548|363941115|FG000|Overall Study|Cognitive Memory problems on study day|1|||
105527200|NCT00405548|363941116|FG001|Overall Study|Cognitive Memory problems on study day|0|||
105527201|NCT00405548|363941115|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
105527202|NCT00405548|363941116|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
105527203|NCT00405548|363941115|FG000|Overall Study|Unable to self-administer shots|1|||
105527204|NCT00405548|363941116|FG001|Overall Study|Unable to self-administer shots|0|||
105527205|NCT00405548|363941115|FG000|Overall Study|Venous access failed during study day|1|||
105527206|NCT00405548|363941116|FG001|Overall Study|Venous access failed during study day|0|||
105527207|NCT00405548|363941115|FG000|Overall Study|Withdrawal by Subject|1|||
105527208|NCT00405548|363941116|FG001|Overall Study|Withdrawal by Subject|0|||
105527209|NCT03554291|363941117|FG000|Overall Study|Death|2|||
105593611|NCT01235949|364172754|FG000|Booster Phase|Lost to Follow-up|0|||
105527210|NCT03554291|363941118|FG001|Overall Study|Death|1|||
105527211|NCT03554291|363941117|FG000|Overall Study|Lost to Follow-up|1|||
105527212|NCT03554291|363941118|FG001|Overall Study|Lost to Follow-up|0|||
105527213|NCT03554291|363941117|FG000|Overall Study|Withdrawal by Subject|1|||
105527214|NCT03554291|363941118|FG001|Overall Study|Withdrawal by Subject|0|||
105527215|NCT03554291|363941117|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
105527216|NCT03554291|363941118|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
105527217|NCT02741700|363941122|FG000|Overall Study|Lost to Follow-up|17|||
105527218|NCT02741700|363941123|FG001|Overall Study|Lost to Follow-up|8|||
105527219|NCT02741700|363941122|FG000|Overall Study|Withdrawal by Subject|2|||
105527220|NCT02741700|363941123|FG001|Overall Study|Withdrawal by Subject|5|||
105527221|NCT02741700|363941122|FG000|Overall Study|Physician Decision|3|||
105527222|NCT02741700|363941123|FG001|Overall Study|Physician Decision|0|||
105527223|NCT02741700|363941122|FG000|Overall Study|Moved out of State|0|||
105527224|NCT02741700|363941123|FG001|Overall Study|Moved out of State|1|||
105527225|NCT02741700|363941122|FG000|Overall Study|Death|4|||
105527226|NCT02741700|363941123|FG001|Overall Study|Death|5|||
105527227|NCT04809220|363941124|FG000|Overall Study|Adverse Event|4|||
105527228|NCT04809220|363941125|FG001|Overall Study|Adverse Event|0|||
105527229|NCT04809220|363941124|FG000|Overall Study|Death|1|||
105527230|NCT04809220|363941125|FG001|Overall Study|Death|0|||
105527231|NCT04809220|363941124|FG000|Overall Study|Lost to Follow-up|3|||
105527232|NCT04809220|363941125|FG001|Overall Study|Lost to Follow-up|0|||
105527233|NCT04809220|363941124|FG000|Overall Study|Physician Decision|0|||
105527234|NCT04809220|363941125|FG001|Overall Study|Physician Decision|1|||
105527235|NCT04809220|363941124|FG000|Overall Study|Withdrawal by Subject|9|||
105527236|NCT04809220|363941125|FG001|Overall Study|Withdrawal by Subject|5|||
105527237|NCT04809220|363941124|FG000|Overall Study|Due to long-term overseas business trips|1|||
105527238|NCT04809220|363941125|FG001|Overall Study|Due to long-term overseas business trips|0|||
105527239|NCT01644175|363941126|FG000|Overall Study|Randomized But Not Treated|0|||
105527240|NCT01644175|363941127|FG001|Overall Study|Randomized But Not Treated|2|||
105527241|NCT01644175|363941126|FG000|Overall Study|Adverse Event|8|||
105527242|NCT01644175|363941127|FG001|Overall Study|Adverse Event|13|||
105527243|NCT01644175|363941126|FG000|Overall Study|Death|1|||
105527244|NCT01644175|363941127|FG001|Overall Study|Death|2|||
105527245|NCT01644175|363941126|FG000|Overall Study|Poor compliance to protocol|9|||
105527246|NCT01644175|363941127|FG001|Overall Study|Poor compliance to protocol|10|||
105527247|NCT01644175|363941126|FG000|Overall Study|Physician Decision|1|||
105527248|NCT01644175|363941127|FG001|Overall Study|Physician Decision|2|||
105527249|NCT01644175|363941126|FG000|Overall Study|Participant Moved|1|||
105527250|NCT01644175|363941127|FG001|Overall Study|Participant Moved|2|||
105527251|NCT01644175|363941126|FG000|Overall Study|Consent withdrawn by participant|3|||
105527252|NCT01644175|363941127|FG001|Overall Study|Consent withdrawn by participant|4|||
105527253|NCT01644175|363941126|FG000|Overall Study|Related to Autoinjector Administration|2|||
105527254|NCT01644175|363941127|FG001|Overall Study|Related to Autoinjector Administration|1|||
105527255|NCT01644175|363941126|FG000|Overall Study|Last visit outside protocol visit window|4|||
105527256|NCT01644175|363941127|FG001|Overall Study|Last visit outside protocol visit window|11|||
105527257|NCT01644175|363941126|FG000|Overall Study|Selection criteria finally not met|0|||
105527258|NCT01644175|363941127|FG001|Overall Study|Selection criteria finally not met|1|||
105527259|NCT01644175|363941126|FG000|Overall Study|Site closure|2|||
105527260|NCT01644175|363941127|FG001|Overall Study|Site closure|2|||
105527261|NCT01644175|363941126|FG000|Overall Study|Lost to Follow-up|1|||
105527262|NCT01644175|363941127|FG001|Overall Study|Lost to Follow-up|0|||
105527263|NCT01644175|363941126|FG000|Overall Study|Other than specified above|0|||
105527264|NCT01644175|363941127|FG001|Overall Study|Other than specified above|3|||
105527265|NCT02818777|363941140|FG000|Overall Study|Adverse Event|3|||
105527266|NCT01418937|363941141|FG000|Overall Study|Lost to Follow-up|5|||
105527267|NCT01418937|363941141|FG000|Overall Study|Protocol Violation|1|||
105527268|NCT01418937|363941141|FG000|Overall Study|Pregnancy|1|||
105527269|NCT01418937|363941141|FG000|Overall Study|Withdrawal by Subject|1|||
105527270|NCT00856908|363941147|FG000|Overall Study|Lost to Follow-up|1|||
105527271|NCT00856908|363941148|FG001|Overall Study|Lost to Follow-up|0|||
105527272|NCT00451035|363941155|FG000|Overall Study|Disease progression|11|||
105527273|NCT00451035|363941155|FG000|Overall Study|Death|3|||
105527274|NCT00451035|363941155|FG000|Overall Study|New anti-neoplastic therapy|3|||
105527275|NCT01324349|363941156|FG000|Overall Study|Death|1|||
105527276|NCT01324349|363941157|FG001|Overall Study|Death|1|||
105527277|NCT01324349|363941156|FG000|Overall Study|Withdrawal by Subject|0|||
105527278|NCT01324349|363941157|FG001|Overall Study|Withdrawal by Subject|1|||
105527279|NCT01712256|363941158|FG000|Overall Study|Lost to Follow-up|1|||
105527280|NCT02013167|363941161|FG000|Overall Study|Withdrawal by Subject|15|||
105527281|NCT02013167|363941162|FG001|Overall Study|Withdrawal by Subject|14|||
105527282|NCT02013167|363941161|FG000|Overall Study|Sponsor Decision|1|||
105527283|NCT02013167|363941162|FG001|Overall Study|Sponsor Decision|3|||
105527284|NCT02013167|363941161|FG000|Overall Study|Lost to Follow-up|0|||
105527285|NCT02013167|363941162|FG001|Overall Study|Lost to Follow-up|1|||
105527286|NCT02013167|363941161|FG000|Overall Study|Death|85|||
105527287|NCT02013167|363941162|FG001|Overall Study|Death|160|||
105527288|NCT00842348|363941163|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
105527289|NCT00842348|363941164|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
105527290|NCT00842348|363941163|FG000|Study 729|Disease progression/death|19|||
105527291|NCT00842348|363941164|FG001|Study 729|Disease progression/death|30|||
105527292|NCT00842348|363941163|FG000|Study 729|Adverse Event|1|||
105527293|NCT00842348|363941164|FG001|Study 729|Adverse Event|1|||
105527294|NCT00842348|363941163|FG000|Study 729|Protocol Violation|1|||
105527295|NCT00842348|363941164|FG001|Study 729|Protocol Violation|1|||
105527296|NCT00842348|363941163|FG000|Study 729|Withdrawal by Subject|2|||
105527297|NCT00842348|363941164|FG001|Study 729|Withdrawal by Subject|4|||
105527298|NCT00842348|363941163|FG000|Study 729|Due to Sponsor stopping the study|1|||
105527299|NCT00842348|363941164|FG001|Study 729|Due to Sponsor stopping the study|1|||
105527300|NCT00842348|363941163|FG000|Study 729|Due to non-availability of IP|0|||
105527301|NCT00842348|363941164|FG001|Study 729|Due to non-availability of IP|1|||
105527302|NCT00842348|363941163|FG000|Study 729|Sponsor's decision|1|||
105527303|NCT00842348|363941164|FG001|Study 729|Sponsor's decision|0|||
105527304|NCT00842348|363941163|FG000|Study 729|Surgical resection|1|||
105527305|NCT00842348|363941164|FG001|Study 729|Surgical resection|0|||
105527306|NCT00603746|363941165|FG000|Overall Study|Adverse Event|2|||
105527307|NCT00603746|363941166|FG001|Overall Study|Adverse Event|3|||
105527308|NCT00603746|363941167|FG002|Overall Study|Adverse Event|0|||
105527309|NCT00603746|363941168|FG003|Overall Study|Adverse Event|1|||
105527310|NCT00603746|363941169|FG004|Overall Study|Adverse Event|0|||
105527311|NCT00603746|363941170|FG005|Overall Study|Adverse Event|4|||
105527312|NCT00603746|363941165|FG000|Overall Study|Lack of Efficacy|34|||
105527313|NCT00603746|363941166|FG001|Overall Study|Lack of Efficacy|11|||
105527314|NCT00603746|363941167|FG002|Overall Study|Lack of Efficacy|6|||
105527315|NCT00603746|363941168|FG003|Overall Study|Lack of Efficacy|11|||
105527316|NCT00603746|363941169|FG004|Overall Study|Lack of Efficacy|12|||
105527317|NCT00603746|363941170|FG005|Overall Study|Lack of Efficacy|8|||
105527318|NCT00603746|363941165|FG000|Overall Study|Protocol Violation|0|||
105527319|NCT00603746|363941166|FG001|Overall Study|Protocol Violation|3|||
105527320|NCT00603746|363941167|FG002|Overall Study|Protocol Violation|1|||
105527321|NCT00603746|363941168|FG003|Overall Study|Protocol Violation|0|||
105527322|NCT00603746|363941169|FG004|Overall Study|Protocol Violation|1|||
105527323|NCT00603746|363941170|FG005|Overall Study|Protocol Violation|0|||
105527324|NCT00603746|363941165|FG000|Overall Study|Lost to Follow-up|0|||
105527325|NCT00603746|363941166|FG001|Overall Study|Lost to Follow-up|1|||
105527326|NCT00603746|363941167|FG002|Overall Study|Lost to Follow-up|1|||
105527327|NCT00603746|363941168|FG003|Overall Study|Lost to Follow-up|0|||
105527328|NCT00603746|363941169|FG004|Overall Study|Lost to Follow-up|0|||
105527329|NCT00603746|363941170|FG005|Overall Study|Lost to Follow-up|0|||
105527330|NCT00603746|363941165|FG000|Overall Study|Physician Decision|1|||
105527331|NCT00603746|363941166|FG001|Overall Study|Physician Decision|0|||
105527332|NCT00603746|363941167|FG002|Overall Study|Physician Decision|0|||
105527333|NCT00603746|363941168|FG003|Overall Study|Physician Decision|0|||
105527334|NCT00603746|363941169|FG004|Overall Study|Physician Decision|1|||
105527335|NCT00603746|363941170|FG005|Overall Study|Physician Decision|0|||
105527336|NCT00603746|363941165|FG000|Overall Study|Withdrawal by Subject|1|||
105527337|NCT00603746|363941166|FG001|Overall Study|Withdrawal by Subject|0|||
105527338|NCT00603746|363941167|FG002|Overall Study|Withdrawal by Subject|0|||
105527339|NCT00603746|363941168|FG003|Overall Study|Withdrawal by Subject|1|||
105527340|NCT00603746|363941169|FG004|Overall Study|Withdrawal by Subject|3|||
105527341|NCT00603746|363941170|FG005|Overall Study|Withdrawal by Subject|1|||
105527342|NCT01113879|363941173|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
105527343|NCT01113879|363941174|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
105527344|NCT04151290|363941183|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
105527345|NCT01914666|363942892|FG000|Treatment Period|Lack of Efficacy|0|||
105527346|NCT01914666|363942893|FG001|Treatment Period|Lack of Efficacy|0|||
105527347|NCT01914666|363942894|FG002|Treatment Period|Lack of Efficacy|2|||
105527348|NCT01914666|363942892|FG000|Treatment Period|Adverse Event|10|||
105527349|NCT01914666|363942893|FG001|Treatment Period|Adverse Event|4|||
105527350|NCT01914666|363942894|FG002|Treatment Period|Adverse Event|2|||
105527351|NCT01914666|363942892|FG000|Treatment Period|Withdrawal by Subject|3|||
105527352|NCT01914666|363942893|FG001|Treatment Period|Withdrawal by Subject|2|||
105527353|NCT01914666|363942894|FG002|Treatment Period|Withdrawal by Subject|2|||
105527354|NCT01914666|363942892|FG000|Treatment Period|Physician Decision|0|||
105527355|NCT01914666|363942893|FG001|Treatment Period|Physician Decision|0|||
105527356|NCT01914666|363942894|FG002|Treatment Period|Physician Decision|2|||
105527357|NCT02388737|363942895|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
105527358|NCT02388737|363942896|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
105527359|NCT02388737|363942897|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
105527360|NCT02388737|363942895|FG000|Overall Study|Major Protocol Deviation|18|||
105527361|NCT02388737|363942896|FG001|Overall Study|Major Protocol Deviation|25|||
105527362|NCT02388737|363942897|FG002|Overall Study|Major Protocol Deviation|22|||
105527363|NCT02388737|363942895|FG000|Overall Study|Lost to Follow-up|5|||
105527364|NCT02388737|363942896|FG001|Overall Study|Lost to Follow-up|1|||
105527365|NCT02388737|363942897|FG002|Overall Study|Lost to Follow-up|4|||
105527366|NCT02388737|363942895|FG000|Overall Study|Voluntary Withdrawal|10|||
105527367|NCT02388737|363942896|FG001|Overall Study|Voluntary Withdrawal|18|||
105527368|NCT02388737|363942897|FG002|Overall Study|Voluntary Withdrawal|17|||
105527369|NCT02388737|363942895|FG000|Overall Study|Lack of Efficacy|3|||
105527370|NCT02388737|363942896|FG001|Overall Study|Lack of Efficacy|0|||
105527371|NCT02388737|363942897|FG002|Overall Study|Lack of Efficacy|3|||
105527372|NCT02388737|363942895|FG000|Overall Study|Reason Not Specified|5|||
105527373|NCT02388737|363942896|FG001|Overall Study|Reason Not Specified|5|||
105527374|NCT02388737|363942897|FG002|Overall Study|Reason Not Specified|4|||
105527375|NCT01176292|363942910|FG000|Overall Study|Lost to Follow-up|2|||
105527376|NCT01176292|363942911|FG001|Overall Study|Lost to Follow-up|4|||
105527377|NCT01176292|363942910|FG000|Overall Study|Adverse Event|1|||
105527378|NCT01176292|363942911|FG001|Overall Study|Adverse Event|1|||
105527379|NCT01176292|363942910|FG000|Overall Study|Physician Decision|0|||
105527380|NCT01176292|363942911|FG001|Overall Study|Physician Decision|2|||
105527381|NCT01176292|363942910|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
105527382|NCT01176292|363942911|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
105527383|NCT02945410|363942912|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
105527384|NCT02945410|363942913|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
105527385|NCT02945410|363942914|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
105527386|NCT02945410|363942915|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
105527387|NCT02945410|363942916|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
105527388|NCT02945410|363942917|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
105527389|NCT02945410|363942912|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
105527390|NCT02945410|363942913|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
105527391|NCT02945410|363942914|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
105527392|NCT02945410|363942915|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
105527393|NCT02945410|363942916|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
105527394|NCT02945410|363942917|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
105527395|NCT02945410|363942912|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
105527396|NCT02945410|363942913|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
105527397|NCT02945410|363942914|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
105527398|NCT02945410|363942915|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
105527399|NCT02945410|363942916|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
105527400|NCT02945410|363942917|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
105527401|NCT02476968|363942920|FG000|Overall Study|Other|0|||
105527402|NCT02476968|363942921|FG001|Overall Study|Other|2|||
105527403|NCT02476968|363942922|FG002|Overall Study|Other|0|||
105527404|NCT02476968|363942920|FG000|Overall Study|Lost to Follow-up|10|||
105527405|NCT02476968|363942921|FG001|Overall Study|Lost to Follow-up|0|||
105527406|NCT02476968|363942922|FG002|Overall Study|Lost to Follow-up|1|||
105527407|NCT02476968|363942920|FG000|Overall Study|Death|48|||
105527408|NCT02476968|363942921|FG001|Overall Study|Death|8|||
105527409|NCT02476968|363942922|FG002|Overall Study|Death|1|||
105527410|NCT02476968|363942920|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105527411|NCT02476968|363942921|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105527412|NCT02476968|363942922|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
105527413|NCT02476968|363942920|FG000|Overall Study|Patient decision|37|||
105527414|NCT02476968|363942921|FG001|Overall Study|Patient decision|8|||
105527415|NCT02476968|363942922|FG002|Overall Study|Patient decision|0|||
105527416|NCT03848845|363942923|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
105527417|NCT03848845|363942924|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
105527418|NCT03848845|363942925|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
105527419|NCT03848845|363942926|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
105527420|NCT03848845|363942923|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
105527421|NCT03848845|363942924|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
105593612|NCT01235949|364172755|FG001|Booster Phase|Lost to Follow-up|0|||
105593613|NCT01235949|364172756|FG002|Booster Phase|Lost to Follow-up|0|||
105527422|NCT03848845|363942925|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
105527423|NCT03848845|363942926|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
105527424|NCT03848845|363942923|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
105527425|NCT03848845|363942924|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
105527426|NCT03848845|363942925|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
105527427|NCT03848845|363942926|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
105593614|NCT01235949|364172757|FG003|Booster Phase|Lost to Follow-up|0|||
105593615|NCT01235949|364172758|FG004|Booster Phase|Lost to Follow-up|0|||
105527428|NCT03848845|363942923|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
105527429|NCT03848845|363942924|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
105527430|NCT03848845|363942925|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
105527431|NCT03848845|363942926|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
105527432|NCT02256891|363942929|FG000|Overall Study|Death|0|||
105527433|NCT02256891|363942930|FG001|Overall Study|Death|2|||
105527434|NCT02256891|363942929|FG000|Overall Study|Lost to Follow-up|0|||
105527435|NCT02256891|363942930|FG001|Overall Study|Lost to Follow-up|3|||
105593616|NCT01235949|364172759|FG005|Booster Phase|Lost to Follow-up|0|||
105527436|NCT02256891|363942929|FG000|Overall Study|Physician Decision|7|||
105527437|NCT02256891|363942930|FG001|Overall Study|Physician Decision|3|||
105527438|NCT02256891|363942929|FG000|Overall Study|Screen Fail|5|||
105527439|NCT02256891|363942930|FG001|Overall Study|Screen Fail|4|||
105527440|NCT02256891|363942929|FG000|Overall Study|Equipment Malfunction|0|||
105527441|NCT02256891|363942930|FG001|Overall Study|Equipment Malfunction|1|||
105527442|NCT02852265|363942935|FG000|3-month Follow-up|Lost to Follow-up|1|||
105527443|NCT02852265|363942936|FG001|3-month Follow-up|Lost to Follow-up|1|||
105527444|NCT01354496|363942953|FG000|Period 1|Adverse Event|0|||
105527445|NCT01354496|363942954|FG001|Period 1|Adverse Event|0|||
105527446|NCT01354496|363942955|FG002|Period 1|Adverse Event|1|||
105527447|NCT01354496|363942956|FG003|Period 1|Adverse Event|0|||
105527448|NCT01354496|363942957|FG004|Period 1|Adverse Event|0|||
105527449|NCT01354496|363942958|FG005|Period 1|Adverse Event|0|||
105527450|NCT01354496|363942953|FG000|Period 1|Physician Decision|0|||
105527451|NCT01354496|363942954|FG001|Period 1|Physician Decision|0|||
105527452|NCT01354496|363942955|FG002|Period 1|Physician Decision|1|||
105527453|NCT01354496|363942956|FG003|Period 1|Physician Decision|0|||
105527454|NCT01354496|363942957|FG004|Period 1|Physician Decision|0|||
105527455|NCT01354496|363942958|FG005|Period 1|Physician Decision|0|||
105527456|NCT01354496|363942953|FG000|Period 2|Adverse Event|0|||
105527457|NCT01354496|363942954|FG001|Period 2|Adverse Event|0|||
105527458|NCT01354496|363942955|FG002|Period 2|Adverse Event|0|||
105527459|NCT01354496|363942956|FG003|Period 2|Adverse Event|1|||
105527460|NCT01354496|363942957|FG004|Period 2|Adverse Event|0|||
105527461|NCT01354496|363942958|FG005|Period 2|Adverse Event|0|||
105527462|NCT01354496|363942953|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
105527463|NCT01354496|363942954|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
105527464|NCT01354496|363942955|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
105527465|NCT01354496|363942956|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
105527466|NCT01354496|363942957|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
105527467|NCT01354496|363942958|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
105527468|NCT03216850|363942959|FG000|Overall Study|Pre-analytical error|6|||
105527469|NCT01894152|363942960|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
105527470|NCT00811577|363942961|FG000|Overall Study|Lost to Follow-up|7|||
105527471|NCT00811577|363942962|FG001|Overall Study|Lost to Follow-up|1|||
105527472|NCT00811577|363942961|FG000|Overall Study|Withdrawal by Subject|3|||
105527473|NCT00811577|363942962|FG001|Overall Study|Withdrawal by Subject|0|||
105527474|NCT01068509|363942963|FG000|Overall Study|Death|0|||
105527475|NCT01068509|363942964|FG001|Overall Study|Death|0|||
105527476|NCT01068509|363942965|FG002|Overall Study|Death|1|||
105527477|NCT01068509|363942963|FG000|Overall Study|Disease Progression|5|||
105527478|NCT01068509|363942964|FG001|Overall Study|Disease Progression|20|||
105527479|NCT01068509|363942965|FG002|Overall Study|Disease Progression|18|||
105527480|NCT01068509|363942963|FG000|Overall Study|Lost to Follow-up|1|||
105527481|NCT01068509|363942964|FG001|Overall Study|Lost to Follow-up|0|||
105527482|NCT01068509|363942965|FG002|Overall Study|Lost to Follow-up|0|||
105527483|NCT01068509|363942963|FG000|Overall Study|Withdrew Consent|0|||
105527484|NCT01068509|363942964|FG001|Overall Study|Withdrew Consent|1|||
105527485|NCT01068509|363942965|FG002|Overall Study|Withdrew Consent|2|||
105527486|NCT01068509|363942963|FG000|Overall Study|Reason Not Specified|0|||
105527487|NCT01068509|363942964|FG001|Overall Study|Reason Not Specified|1|||
105527488|NCT01068509|363942965|FG002|Overall Study|Reason Not Specified|0|||
105527489|NCT03465878|363942982|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
105527490|NCT03465878|363942983|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
105527491|NCT03465878|363942984|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
105527492|NCT03465878|363942985|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
105527493|NCT03465878|363942982|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
105527494|NCT03465878|363942983|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
105527495|NCT03465878|363942984|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
105593617|NCT01235949|364172760|FG006|Booster Phase|Lost to Follow-up|0|||
105593618|NCT01235949|364172761|FG007|Booster Phase|Lost to Follow-up|0|||
105527496|NCT03465878|363942985|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
105527497|NCT03465878|363942982|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
105527498|NCT03465878|363942983|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
105527499|NCT03465878|363942984|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
105593619|NCT01235949|364172762|FG008|Booster Phase|Lost to Follow-up|1|||
105527500|NCT03465878|363942985|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
105527501|NCT01524627|363942986|FG000|Overall Study|Physician Decision|0|||
105527502|NCT01524627|363942987|FG001|Overall Study|Physician Decision|1|||
105527503|NCT01524627|363942986|FG000|Overall Study|Lost to Follow-up|1|||
105527504|NCT01524627|363942987|FG001|Overall Study|Lost to Follow-up|1|||
105527505|NCT00969553|363942988|FG000|Overall Study|Progressive disease (PD)|2|||
105527506|NCT00969553|363942989|FG001|Overall Study|Progressive disease (PD)|2|||
105527507|NCT00969553|363942990|FG002|Overall Study|Progressive disease (PD)|6|||
105593620|NCT01235949|364172763|FG009|Booster Phase|Lost to Follow-up|1|||
105593621|NCT01235949|364172764|FG010|Booster Phase|Lost to Follow-up|1|||
105527508|NCT00969553|363942991|FG003|Overall Study|Progressive disease (PD)|9|||
105527509|NCT00969553|363942992|FG004|Overall Study|Progressive disease (PD)|2|||
105527510|NCT00969553|363942993|FG005|Overall Study|Progressive disease (PD)|4|||
105527511|NCT00969553|363942994|FG006|Overall Study|Progressive disease (PD)|2|||
105527512|NCT00969553|363942995|FG007|Overall Study|Progressive disease (PD)|12|||
105527513|NCT00969553|363942996|FG008|Overall Study|Progressive disease (PD)|3|||
105527514|NCT00969553|363942988|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
105527515|NCT00969553|363942989|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
105527516|NCT00969553|363942990|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
105527517|NCT00969553|363942991|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
105527518|NCT00969553|363942992|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
105527519|NCT00969553|363942993|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
105527520|NCT00969553|363942994|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
105527521|NCT00969553|363942995|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
105527522|NCT00969553|363942996|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
105527523|NCT00969553|363942988|FG000|Overall Study|Other Adverse Event|0|||
105527524|NCT00969553|363942989|FG001|Overall Study|Other Adverse Event|0|||
105527525|NCT00969553|363942990|FG002|Overall Study|Other Adverse Event|0|||
105527526|NCT00969553|363942991|FG003|Overall Study|Other Adverse Event|1|||
105527527|NCT00969553|363942992|FG004|Overall Study|Other Adverse Event|0|||
105527528|NCT00969553|363942993|FG005|Overall Study|Other Adverse Event|0|||
105527529|NCT00969553|363942994|FG006|Overall Study|Other Adverse Event|1|||
105527530|NCT00969553|363942995|FG007|Overall Study|Other Adverse Event|0|||
105527531|NCT00969553|363942996|FG008|Overall Study|Other Adverse Event|0|||
105527532|NCT00969553|363942988|FG000|Overall Study|Refused cont. medication|1|||
105527533|NCT00969553|363942989|FG001|Overall Study|Refused cont. medication|1|||
105527534|NCT00969553|363942990|FG002|Overall Study|Refused cont. medication|0|||
105527535|NCT00969553|363942991|FG003|Overall Study|Refused cont. medication|2|||
105527536|NCT00969553|363942992|FG004|Overall Study|Refused cont. medication|0|||
105527537|NCT00969553|363942993|FG005|Overall Study|Refused cont. medication|0|||
105527538|NCT00969553|363942994|FG006|Overall Study|Refused cont. medication|0|||
105527539|NCT00969553|363942995|FG007|Overall Study|Refused cont. medication|1|||
105527540|NCT00969553|363942996|FG008|Overall Study|Refused cont. medication|0|||
105527541|NCT00969553|363942988|FG000|Overall Study|Not specified above|0|||
105527542|NCT00969553|363942989|FG001|Overall Study|Not specified above|0|||
105527543|NCT00969553|363942990|FG002|Overall Study|Not specified above|0|||
105527544|NCT00969553|363942991|FG003|Overall Study|Not specified above|4|||
105527545|NCT00969553|363942992|FG004|Overall Study|Not specified above|0|||
105527546|NCT00969553|363942993|FG005|Overall Study|Not specified above|0|||
105527547|NCT00969553|363942994|FG006|Overall Study|Not specified above|1|||
105527548|NCT00969553|363942995|FG007|Overall Study|Not specified above|1|||
105527549|NCT00969553|363942996|FG008|Overall Study|Not specified above|0|||
105527550|NCT02141074|363942998|FG000|Pre-prophylaxis|Adverse Event|3|||
105527551|NCT02141074|363942999|FG001|Pre-prophylaxis|Adverse Event|0|||
105527552|NCT02141074|363942998|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
105527553|NCT02141074|363942999|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
105527554|NCT02141074|363942998|FG000|Prophylaxis|Adverse Event|0|||
105527555|NCT02141074|363942999|FG001|Prophylaxis|Adverse Event|4|||
105527556|NCT02141074|363942998|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
105527557|NCT02141074|363942999|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
105527558|NCT02141074|363942998|FG000|Prophylaxis|Withdrawal by Subject|0|||
105527559|NCT02141074|363942999|FG001|Prophylaxis|Withdrawal by Subject|1|||
105527560|NCT01077804|363943000|FG000|Overall Study|Unreachable|102|||
105527561|NCT01077804|363943000|FG000|Overall Study|Refused to continue|79|||
105527562|NCT01077804|363943000|FG000|Overall Study|Other|18|||
105527563|NCT02357147|363943001|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
105527564|NCT02357147|363943002|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
105527565|NCT02357147|363943001|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
105527566|NCT02357147|363943002|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
105527567|NCT02357147|363943001|FG000|Combination Treatment Phase|Investigator Discretion|1|||
105527568|NCT02357147|363943002|FG001|Combination Treatment Phase|Investigator Discretion|1|||
105527569|NCT02357147|363943001|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
105527570|NCT02357147|363943002|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
105527571|NCT02357147|363943001|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
105527572|NCT02357147|363943002|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
105527573|NCT02357147|363943001|FG000|Combination Treatment Phase|Adverse Event|12|||
105527574|NCT02357147|363943002|FG001|Combination Treatment Phase|Adverse Event|4|||
105527575|NCT02357147|363943001|FG000|Combination Treatment Phase|Death|1|||
105527576|NCT02357147|363943002|FG001|Combination Treatment Phase|Death|1|||
105527577|NCT02357147|363943001|FG000|Combination Treatment Phase|Sponsor Decision|0|||
105527578|NCT02357147|363943002|FG001|Combination Treatment Phase|Sponsor Decision|12|||
105527579|NCT02357147|363943001|FG000|Combination Treatment Phase|Other|1|||
105527580|NCT02357147|363943002|FG001|Combination Treatment Phase|Other|0|||
105527581|NCT02357147|363943001|FG000|Combination Treatment Phase|Not treated|0|||
105527582|NCT02357147|363943002|FG001|Combination Treatment Phase|Not treated|2|||
105527583|NCT02357147|363943001|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
105527584|NCT02357147|363943002|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
105527585|NCT02357147|363943001|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
105527586|NCT02357147|363943002|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
105527587|NCT02357147|363943001|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
105527588|NCT02357147|363943002|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
105527589|NCT02357147|363943001|FG000|Maintenance Treatment Phase|Adverse Event|0|||
105527590|NCT02357147|363943002|FG001|Maintenance Treatment Phase|Adverse Event|3|||
105527591|NCT02357147|363943001|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
105527592|NCT02357147|363943002|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
105527593|NCT02357147|363943001|FG000|Maintenance Treatment Phase|Not Treated|1|||
105527594|NCT02357147|363943002|FG001|Maintenance Treatment Phase|Not Treated|0|||
105527595|NCT00256698|363943003|FG000|Overall Study|Withdrawal by Subject|7|||
105527596|NCT00256698|363943004|FG001|Overall Study|Withdrawal by Subject|7|||
105527597|NCT00256698|363943003|FG000|Overall Study|Adverse Event|13|||
105527598|NCT00256698|363943004|FG001|Overall Study|Adverse Event|6|||
105527599|NCT00256698|363943003|FG000|Overall Study|Protocol Violation|6|||
105527600|NCT00256698|363943004|FG001|Overall Study|Protocol Violation|5|||
105527601|NCT00256698|363943003|FG000|Overall Study|Lost to Follow-up|1|||
105527602|NCT00256698|363943004|FG001|Overall Study|Lost to Follow-up|3|||
105527603|NCT00256698|363943003|FG000|Overall Study|disease progression|97|||
105527604|NCT00256698|363943004|FG001|Overall Study|disease progression|105|||
105527605|NCT00256698|363943003|FG000|Overall Study|still ongoing at data cut-off|41|||
105527606|NCT00256698|363943004|FG001|Overall Study|still ongoing at data cut-off|46|||
105527607|NCT00256698|363943003|FG000|Overall Study|withdrawn due to osteoporosis|1|||
105527608|NCT00256698|363943004|FG001|Overall Study|withdrawn due to osteoporosis|0|||
105527609|NCT00256698|363943003|FG000|Overall Study|Prematurely Discontinued|1|||
105527610|NCT00256698|363943004|FG001|Overall Study|Prematurely Discontinued|0|||
105527611|NCT02620046|363943006|FG000|Overall Study|Adverse Event|22|||
105527612|NCT02620046|363943007|FG001|Overall Study|Adverse Event|42|||
105527613|NCT02620046|363943006|FG000|Overall Study|Lost to Follow-up|4|||
105527614|NCT02620046|363943007|FG001|Overall Study|Lost to Follow-up|10|||
105527615|NCT02620046|363943006|FG000|Overall Study|Withdrawal by Subject|36|||
105527616|NCT02620046|363943007|FG001|Overall Study|Withdrawal by Subject|66|||
105527617|NCT02620046|363943006|FG000|Overall Study|Site Termination|3|||
105527618|NCT02620046|363943007|FG001|Overall Study|Site Termination|3|||
105527619|NCT02620046|363943006|FG000|Overall Study|Pregnancy|3|||
105527620|NCT02620046|363943007|FG001|Overall Study|Pregnancy|7|||
105527621|NCT02620046|363943006|FG000|Overall Study|Lack of Efficacy|81|||
105527622|NCT02620046|363943007|FG001|Overall Study|Lack of Efficacy|146|||
105527623|NCT02620046|363943006|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
105527624|NCT02620046|363943007|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
105527625|NCT02620046|363943006|FG000|Overall Study|Reason Not Specified|13|||
105527626|NCT02620046|363943007|FG001|Overall Study|Reason Not Specified|21|||
105527627|NCT02620046|363943006|FG000|Overall Study|Significant Protocol Deviation|0|||
105527628|NCT02620046|363943007|FG001|Overall Study|Significant Protocol Deviation|1|||
105527629|NCT00560950|363943010|FG000|Overall Study|Lost to Follow-up|1|||
105527630|NCT00560950|363943011|FG001|Overall Study|Lost to Follow-up|0|||
105527631|NCT01064648|363943012|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
105527632|NCT01064648|363943013|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
105527633|NCT01064648|363943014|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
105527634|NCT01064648|363943015|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
105527635|NCT01064648|363943012|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
105527636|NCT01064648|363943013|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
105527637|NCT01064648|363943014|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
105527638|NCT01064648|363943015|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
105527639|NCT01064648|363943012|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
105527640|NCT01064648|363943013|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
105527641|NCT01064648|363943014|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
105527642|NCT01064648|363943015|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
105527643|NCT01064648|363943012|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
105527644|NCT01064648|363943013|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
105527645|NCT01064648|363943014|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
105527646|NCT01064648|363943015|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
105527647|NCT01064648|363943012|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
105527648|NCT01064648|363943013|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
105527649|NCT01064648|363943014|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
105527650|NCT01064648|363943015|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
105527651|NCT01064648|363943012|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
105527652|NCT01064648|363943013|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
105527653|NCT01064648|363943014|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
105527654|NCT01064648|363943015|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
105527655|NCT01064648|363943012|FG000|Phase II|Adverse Event|0|||
105527656|NCT01064648|363943013|FG001|Phase II|Adverse Event|0|||
105527657|NCT01064648|363943014|FG002|Phase II|Adverse Event|15|||
105527658|NCT01064648|363943015|FG003|Phase II|Adverse Event|8|||
105527659|NCT01064648|363943012|FG000|Phase II|Death|0|||
105527660|NCT01064648|363943013|FG001|Phase II|Death|0|||
105527661|NCT01064648|363943014|FG002|Phase II|Death|4|||
105527662|NCT01064648|363943015|FG003|Phase II|Death|5|||
105527663|NCT01064648|363943012|FG000|Phase II|Withdrawal by Subject|0|||
105527664|NCT01064648|363943013|FG001|Phase II|Withdrawal by Subject|0|||
105527665|NCT01064648|363943014|FG002|Phase II|Withdrawal by Subject|2|||
105527666|NCT01064648|363943015|FG003|Phase II|Withdrawal by Subject|5|||
105527667|NCT01064648|363943012|FG000|Phase II|Progression|0|||
105527668|NCT01064648|363943013|FG001|Phase II|Progression|0|||
105527669|NCT01064648|363943014|FG002|Phase II|Progression|21|||
105527670|NCT01064648|363943015|FG003|Phase II|Progression|27|||
105527671|NCT01064648|363943012|FG000|Phase II|Non-protocol specified|0|||
105527672|NCT01064648|363943013|FG001|Phase II|Non-protocol specified|0|||
105527673|NCT01064648|363943014|FG002|Phase II|Non-protocol specified|5|||
105527674|NCT01064648|363943015|FG003|Phase II|Non-protocol specified|3|||
105527675|NCT01064648|363943012|FG000|Phase II|Under Review|0|||
105527676|NCT01064648|363943013|FG001|Phase II|Under Review|0|||
105527677|NCT01064648|363943014|FG002|Phase II|Under Review|2|||
105527678|NCT01064648|363943015|FG003|Phase II|Under Review|0|||
105527679|NCT06023394|363943016|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
105527680|NCT06023394|363943017|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
105527681|NCT06023394|363943016|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
105527682|NCT06023394|363943017|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
105527683|NCT06023394|363943016|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
105527684|NCT06023394|363943017|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
105527685|NCT06023394|363943016|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
105527686|NCT06023394|363943017|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
105527687|NCT02283788|363943018|FG000|Overall Study|Adverse Event|1|||
105527688|NCT02283788|363943019|FG001|Overall Study|Adverse Event|3|||
105527689|NCT02283788|363943020|FG002|Overall Study|Adverse Event|5|||
105527690|NCT02283788|363943021|FG003|Overall Study|Adverse Event|1|||
105527691|NCT02283788|363943018|FG000|Overall Study|Withdrawal by Subject|0|||
105527692|NCT02283788|363943019|FG001|Overall Study|Withdrawal by Subject|1|||
105527693|NCT02283788|363943020|FG002|Overall Study|Withdrawal by Subject|0|||
105527694|NCT02283788|363943021|FG003|Overall Study|Withdrawal by Subject|1|||
105593622|NCT01235949|364172765|FG011|Booster Phase|Lost to Follow-up|1|||
105593623|NCT01235949|364172766|FG012|Booster Phase|Lost to Follow-up|0|||
105593624|NCT01235949|364172767|FG013|Booster Phase|Lost to Follow-up|0|||
105593625|NCT01235949|364172768|FG014|Booster Phase|Lost to Follow-up|0|||
105593626|NCT01235949|364172769|FG015|Booster Phase|Lost to Follow-up|0|||
105593627|NCT01235949|364172770|FG016|Booster Phase|Lost to Follow-up|0|||
105593628|NCT01235949|364172771|FG017|Booster Phase|Lost to Follow-up|1|||
105593629|NCT00754936|364172772|FG000|Overall Study|Lost to Follow-up|3|||
105593630|NCT00754936|364172772|FG000|Overall Study|Physician Decision|1|||
105593631|NCT00754936|364172772|FG000|Overall Study|Withdrawal by Subject|2|||
105593632|NCT00754936|364172772|FG000|Overall Study|Side Effects|3|||
105593633|NCT00754936|364172772|FG000|Overall Study|Inter-current medical events|3|||
105593634|NCT00619645|364172773|FG000|Overall Study|Adverse Event|1|||
105593635|NCT04364269|364172775|FG000|Overall Study|Adverse Event|1|||
105593636|NCT04364269|364172776|FG001|Overall Study|Adverse Event|0|||
105593637|NCT04364269|364172777|FG002|Overall Study|Adverse Event|0|||
105593638|NCT04364269|364172775|FG000|Overall Study|Withdrawal by Subject|0|||
105593639|NCT04364269|364172776|FG001|Overall Study|Withdrawal by Subject|1|||
105593640|NCT04364269|364172777|FG002|Overall Study|Withdrawal by Subject|0|||
105593641|NCT04173572|364172778|FG000|Overall Study|Withdrawal by Subject|1|||
105593642|NCT04173572|364172779|FG001|Overall Study|Withdrawal by Subject|5|||
105593643|NCT04173572|364172778|FG000|Overall Study|Lost to Follow-up|3|||
105593644|NCT04173572|364172779|FG001|Overall Study|Lost to Follow-up|1|||
105593645|NCT00371566|364172780|FG000|Treatment Phase|Withdrawal by Subject|0|||
105593646|NCT00371566|364172781|FG001|Treatment Phase|Withdrawal by Subject|1|||
105593647|NCT00371566|364172780|FG000|Treatment Phase|Adverse Event|0|||
105593648|NCT00371566|364172781|FG001|Treatment Phase|Adverse Event|1|||
105593649|NCT00371566|364172780|FG000|Treatment Phase|Protocol Violation|0|||
105593650|NCT00371566|364172781|FG001|Treatment Phase|Protocol Violation|1|||
105593651|NCT00371566|364172780|FG000|Chemoradiation Phase|Physician Decision|2|||
105593652|NCT00371566|364172781|FG001|Chemoradiation Phase|Physician Decision|0|||
105593653|NCT00371566|364172780|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
105593654|NCT00371566|364172781|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
105593655|NCT00371566|364172780|FG000|Chemoradiation Phase|Non compliant|0|||
105593656|NCT00371566|364172781|FG001|Chemoradiation Phase|Non compliant|1|||
105593657|NCT00371566|364172780|FG000|Chemoradiation Phase|Progressive Disease|1|||
105527695|NCT00403273|363944648|FG000|Overall Study|Lost to Follow-up|3|||
105527696|NCT00403273|363944649|FG001|Overall Study|Lost to Follow-up|2|||
105527697|NCT00403273|363944648|FG000|Overall Study|Physician Decision|0|||
105527698|NCT00403273|363944649|FG001|Overall Study|Physician Decision|1|||
105527699|NCT00403273|363944648|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
105527700|NCT00403273|363944649|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
105527701|NCT03252522|363944654|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
105527702|NCT03252522|363944655|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
105527703|NCT03252522|363944656|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
105527704|NCT03252522|363944654|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
105527705|NCT03252522|363944655|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
105527706|NCT03252522|363944656|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
105527707|NCT03252522|363944654|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
105527708|NCT03252522|363944655|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
105527709|NCT03252522|363944656|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
105527710|NCT03252522|363944654|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
105527711|NCT03252522|363944655|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
105527712|NCT03252522|363944656|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
105527713|NCT03252522|363944654|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
105527714|NCT03252522|363944655|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
105527715|NCT03252522|363944656|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
105527716|NCT03252522|363944654|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
105527717|NCT03252522|363944655|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
105527718|NCT03252522|363944656|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
105527719|NCT03252522|363944654|FG000|Phase 2: Open Label|Adverse Event|0|||
105527720|NCT03252522|363944655|FG001|Phase 2: Open Label|Adverse Event|0|||
105527721|NCT03252522|363944656|FG002|Phase 2: Open Label|Adverse Event|2|||
105527722|NCT03252522|363944654|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
105527723|NCT03252522|363944655|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
105527724|NCT03252522|363944656|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
105527725|NCT03026257|363944657|FG000|Overall Study|Adverse Event|3|||
105527726|NCT03026257|363944658|FG001|Overall Study|Adverse Event|0|||
105527727|NCT03026257|363944659|FG002|Overall Study|Adverse Event|0|||
105527728|NCT03026257|363944660|FG003|Overall Study|Adverse Event|0|||
105527729|NCT03026257|363944661|FG004|Overall Study|Adverse Event|0|||
105527730|NCT03026257|363944662|FG005|Overall Study|Adverse Event|0|||
105527731|NCT03026257|363944657|FG000|Overall Study|Lost to Follow-up|1|||
105527732|NCT03026257|363944658|FG001|Overall Study|Lost to Follow-up|0|||
105527733|NCT03026257|363944659|FG002|Overall Study|Lost to Follow-up|0|||
105527734|NCT03026257|363944660|FG003|Overall Study|Lost to Follow-up|0|||
105527735|NCT03026257|363944661|FG004|Overall Study|Lost to Follow-up|0|||
105527736|NCT03026257|363944662|FG005|Overall Study|Lost to Follow-up|0|||
105527737|NCT03026257|363944657|FG000|Overall Study|Protocol Violation|1|||
105527738|NCT03026257|363944658|FG001|Overall Study|Protocol Violation|0|||
105527739|NCT03026257|363944659|FG002|Overall Study|Protocol Violation|0|||
105527740|NCT03026257|363944660|FG003|Overall Study|Protocol Violation|1|||
105527741|NCT03026257|363944661|FG004|Overall Study|Protocol Violation|1|||
105527742|NCT03026257|363944662|FG005|Overall Study|Protocol Violation|0|||
105527743|NCT03026257|363944657|FG000|Overall Study|Withdrawal by Subject|1|||
105527744|NCT03026257|363944658|FG001|Overall Study|Withdrawal by Subject|1|||
105527745|NCT03026257|363944659|FG002|Overall Study|Withdrawal by Subject|0|||
105527746|NCT03026257|363944660|FG003|Overall Study|Withdrawal by Subject|0|||
105527747|NCT03026257|363944661|FG004|Overall Study|Withdrawal by Subject|0|||
105527748|NCT03026257|363944662|FG005|Overall Study|Withdrawal by Subject|0|||
105527749|NCT02181556|363944663|FG000|Overall Study|Withdrawal by Subject|1|||
105527750|NCT04380857|363944664|FG000|Overall Study|Lost to Follow-up|3|||
105527751|NCT04380857|363944665|FG001|Overall Study|Lost to Follow-up|3|||
105527752|NCT00394212|363944668|FG000|Overall Study|Lost to Follow-up|3|||
105527753|NCT00394212|363944669|FG001|Overall Study|Lost to Follow-up|0|||
105527754|NCT00394212|363944668|FG000|Overall Study|Withdrawal by Subject|4|||
105527755|NCT00394212|363944669|FG001|Overall Study|Withdrawal by Subject|1|||
105527756|NCT03569371|363944671|FG000|Overall Study|Lack of Efficacy|1|||
105527757|NCT03569371|363944671|FG000|Overall Study|Lost to Follow-up|1|||
105527758|NCT03569371|363944671|FG000|Overall Study|Adverse Event|1|||
105527759|NCT02404311|363944673|FG000|Part A: Month 0-18|Death|2|||
105527760|NCT02404311|363944674|FG001|Part A: Month 0-18|Death|0|||
105527761|NCT02404311|363944675|FG002|Part A: Month 0-18|Death|0|||
105527762|NCT02404311|363944676|FG003|Part A: Month 0-18|Death|0|||
105527763|NCT02404311|363944677|FG004|Part A: Month 0-18|Death|0|||
105527764|NCT02404311|363944673|FG000|Part A: Month 0-18|Physician Decision|1|||
105527765|NCT02404311|363944674|FG001|Part A: Month 0-18|Physician Decision|0|||
105527766|NCT02404311|363944675|FG002|Part A: Month 0-18|Physician Decision|0|||
105527767|NCT02404311|363944676|FG003|Part A: Month 0-18|Physician Decision|0|||
105527768|NCT02404311|363944677|FG004|Part A: Month 0-18|Physician Decision|0|||
105527769|NCT02404311|363944673|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
105527770|NCT02404311|363944674|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
105527771|NCT02404311|363944675|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
105527772|NCT02404311|363944676|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
105527773|NCT02404311|363944677|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
105527774|NCT02404311|363944673|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
105527775|NCT02404311|363944674|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
105527776|NCT02404311|363944675|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
105527777|NCT02404311|363944676|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
105527778|NCT02404311|363944677|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
105527779|NCT02404311|363944673|FG000|Part A: Month 0-18|HIV Infection|6|||
105527780|NCT02404311|363944674|FG001|Part A: Month 0-18|HIV Infection|2|||
105527781|NCT02404311|363944675|FG002|Part A: Month 0-18|HIV Infection|0|||
105527782|NCT02404311|363944676|FG003|Part A: Month 0-18|HIV Infection|0|||
105527783|NCT02404311|363944677|FG004|Part A: Month 0-18|HIV Infection|0|||
105527784|NCT02404311|363944673|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
105527785|NCT02404311|363944674|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
105527786|NCT02404311|363944675|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
105527787|NCT02404311|363944676|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
105527788|NCT02404311|363944677|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
105527789|NCT01539226|363944679|FG000|Overall Study|Withdrawal by Subject|24|||
105527790|NCT01539226|363944680|FG001|Overall Study|Withdrawal by Subject|54|||
105527791|NCT01539226|363944679|FG000|Overall Study|Lost to Follow-up|20|||
105527792|NCT01539226|363944680|FG001|Overall Study|Lost to Follow-up|54|||
105527793|NCT01539226|363944679|FG000|Overall Study|Death|1|||
105527794|NCT01539226|363944680|FG001|Overall Study|Death|2|||
105527795|NCT01539226|363944679|FG000|Overall Study|Adverse Event|2|||
105527796|NCT01539226|363944680|FG001|Overall Study|Adverse Event|0|||
105527797|NCT01539226|363944679|FG000|Overall Study|Pregnancy|13|||
105527798|NCT01539226|363944680|FG001|Overall Study|Pregnancy|29|||
105527799|NCT01539226|363944679|FG000|Overall Study|inappropriate enrollment|0|||
105527800|NCT01539226|363944680|FG001|Overall Study|inappropriate enrollment|1|||
105527801|NCT01539226|363944679|FG000|Overall Study|Multiple Reasons|3|||
105527802|NCT01539226|363944680|FG001|Overall Study|Multiple Reasons|1|||
105527803|NCT01539226|363944679|FG000|Overall Study|not HIV seroconversion-related|93|||
105527804|NCT01539226|363944680|FG001|Overall Study|not HIV seroconversion-related|176|||
105527805|NCT01539226|363944679|FG000|Overall Study|HIV seroconversion-related|55|||
105527806|NCT01539226|363944680|FG001|Overall Study|HIV seroconversion-related|80|||
105527807|NCT01539226|363944679|FG000|Overall Study|Non-compliance|6|||
105527808|NCT01539226|363944680|FG001|Overall Study|Non-compliance|8|||
105527809|NCT01714310|363944684|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
105527810|NCT01714310|363944685|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
105527811|NCT01714310|363944686|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
105527812|NCT01714310|363944684|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
105527813|NCT01714310|363944685|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
105527814|NCT01714310|363944686|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
105527815|NCT01714310|363944684|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
105527816|NCT01714310|363944685|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
105527817|NCT01714310|363944686|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
105527818|NCT01714310|363944684|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
105527819|NCT01714310|363944685|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
105527820|NCT01714310|363944686|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
105527821|NCT01641367|363944694|FG000|Cohorts|Death|18|||
105527822|NCT01641367|363944695|FG001|Cohorts|Death|1|||
105527823|NCT01641367|363944696|FG002|Cohorts|Death|2|||
105527824|NCT01641367|363944697|FG003|Cohorts|Death|0|||
105527825|NCT01641367|363944698|FG004|Cohorts|Death|1|||
105527826|NCT01641367|363944699|FG005|Cohorts|Death|1|||
105527827|NCT01641367|363944700|FG006|Cohorts|Death|0|||
105527828|NCT01641367|363944701|FG007|Cohorts|Death|0|||
105527829|NCT01641367|363944694|FG000|Cohorts|Lost to Follow-up|16|||
105527830|NCT01641367|363944695|FG001|Cohorts|Lost to Follow-up|0|||
105527831|NCT01641367|363944696|FG002|Cohorts|Lost to Follow-up|2|||
105527832|NCT01641367|363944697|FG003|Cohorts|Lost to Follow-up|0|||
105527833|NCT01641367|363944698|FG004|Cohorts|Lost to Follow-up|2|||
105527834|NCT01641367|363944699|FG005|Cohorts|Lost to Follow-up|0|||
105527835|NCT01641367|363944700|FG006|Cohorts|Lost to Follow-up|0|||
105527836|NCT01641367|363944701|FG007|Cohorts|Lost to Follow-up|0|||
105527837|NCT01641367|363944694|FG000|Randomized Adherence Intervention|Death|0|||
105527838|NCT01641367|363944695|FG001|Randomized Adherence Intervention|Death|0|||
105527839|NCT01641367|363944696|FG002|Randomized Adherence Intervention|Death|0|||
105527840|NCT01641367|363944697|FG003|Randomized Adherence Intervention|Death|0|||
105527841|NCT01641367|363944698|FG004|Randomized Adherence Intervention|Death|0|||
105527842|NCT01641367|363944699|FG005|Randomized Adherence Intervention|Death|0|||
105527843|NCT01641367|363944700|FG006|Randomized Adherence Intervention|Death|11|||
105527844|NCT01641367|363944701|FG007|Randomized Adherence Intervention|Death|12|||
105527845|NCT01641367|363944694|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
105527846|NCT01641367|363944695|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
105527847|NCT01641367|363944696|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
105527848|NCT01641367|363944697|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
105527849|NCT01641367|363944698|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
105527850|NCT01641367|363944699|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
105527851|NCT01641367|363944700|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
105527852|NCT01641367|363944701|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
105527853|NCT00654381|363944704|FG000|1st Stage|Adverse Event|3|||
105527854|NCT00654381|363944705|FG001|1st Stage|Adverse Event|3|||
105527855|NCT00654381|363944706|FG002|1st Stage|Adverse Event|3|||
105527856|NCT00654381|363944707|FG003|1st Stage|Adverse Event|3|||
105527857|NCT00654381|363944708|FG004|1st Stage|Adverse Event|2|||
105527858|NCT00654381|363944709|FG005|1st Stage|Adverse Event|1|||
105527859|NCT00654381|363944704|FG000|1st Stage|Withdrawal by Subject|0|||
105527860|NCT00654381|363944705|FG001|1st Stage|Withdrawal by Subject|0|||
105527861|NCT00654381|363944706|FG002|1st Stage|Withdrawal by Subject|0|||
105527862|NCT00654381|363944707|FG003|1st Stage|Withdrawal by Subject|1|||
105527863|NCT00654381|363944708|FG004|1st Stage|Withdrawal by Subject|0|||
105527864|NCT00654381|363944709|FG005|1st Stage|Withdrawal by Subject|1|||
105527865|NCT00654381|363944704|FG000|1st Stage|Investigator's decision|0|||
105527866|NCT00654381|363944705|FG001|1st Stage|Investigator's decision|0|||
105527867|NCT00654381|363944706|FG002|1st Stage|Investigator's decision|0|||
105527868|NCT00654381|363944707|FG003|1st Stage|Investigator's decision|1|||
105527869|NCT00654381|363944708|FG004|1st Stage|Investigator's decision|0|||
105527870|NCT00654381|363944709|FG005|1st Stage|Investigator's decision|0|||
105527871|NCT00654381|363944704|FG000|2nd Stage|Adverse Event|2|||
105527872|NCT00654381|363944705|FG001|2nd Stage|Adverse Event|0|||
105527873|NCT00654381|363944706|FG002|2nd Stage|Adverse Event|2|||
105527874|NCT00654381|363944707|FG003|2nd Stage|Adverse Event|3|||
105527875|NCT00654381|363944708|FG004|2nd Stage|Adverse Event|7|||
105527876|NCT00654381|363944709|FG005|2nd Stage|Adverse Event|2|||
105527877|NCT00654381|363944704|FG000|2nd Stage|Withdrawal by Subject|0|||
105527878|NCT00654381|363944705|FG001|2nd Stage|Withdrawal by Subject|0|||
105527879|NCT00654381|363944706|FG002|2nd Stage|Withdrawal by Subject|0|||
105527880|NCT00654381|363944707|FG003|2nd Stage|Withdrawal by Subject|0|||
105527881|NCT00654381|363944708|FG004|2nd Stage|Withdrawal by Subject|1|||
105527882|NCT00654381|363944709|FG005|2nd Stage|Withdrawal by Subject|1|||
105527883|NCT00654381|363944704|FG000|2nd Stage|Investigator's decision|0|||
105527884|NCT00654381|363944705|FG001|2nd Stage|Investigator's decision|0|||
105527885|NCT00654381|363944706|FG002|2nd Stage|Investigator's decision|1|||
105527886|NCT00654381|363944707|FG003|2nd Stage|Investigator's decision|1|||
105527887|NCT00654381|363944708|FG004|2nd Stage|Investigator's decision|0|||
105527888|NCT00654381|363944709|FG005|2nd Stage|Investigator's decision|0|||
105527889|NCT00654381|363944704|FG000|Extension Stage|Adverse Event|1|||
105527890|NCT00654381|363944705|FG001|Extension Stage|Adverse Event|2|||
105527891|NCT00654381|363944706|FG002|Extension Stage|Adverse Event|9|||
105527892|NCT00654381|363944707|FG003|Extension Stage|Adverse Event|7|||
105527893|NCT00654381|363944708|FG004|Extension Stage|Adverse Event|1|||
105527894|NCT00654381|363944709|FG005|Extension Stage|Adverse Event|1|||
105527895|NCT00654381|363944704|FG000|Extension Stage|Protocol Violation|0|||
105527896|NCT00654381|363944705|FG001|Extension Stage|Protocol Violation|0|||
105527897|NCT00654381|363944706|FG002|Extension Stage|Protocol Violation|0|||
105527898|NCT00654381|363944707|FG003|Extension Stage|Protocol Violation|1|||
105527899|NCT00654381|363944708|FG004|Extension Stage|Protocol Violation|0|||
105527900|NCT00654381|363944709|FG005|Extension Stage|Protocol Violation|0|||
105593658|NCT00371566|364172781|FG001|Chemoradiation Phase|Progressive Disease|1|||
105593659|NCT00371566|364172780|FG000|Chemoradiation Phase|Death|2|||
105593660|NCT00371566|364172781|FG001|Chemoradiation Phase|Death|0|||
105593661|NCT00371566|364172780|FG000|Follow Up Phase|Death|0|||
105593662|NCT00371566|364172781|FG001|Follow Up Phase|Death|5|||
105593663|NCT00371566|364172780|FG000|Follow Up Phase|Disease progression|1|||
105527901|NCT00654381|363944704|FG000|Extension Stage|Lack of Efficacy|0|||
105527902|NCT00654381|363944705|FG001|Extension Stage|Lack of Efficacy|0|||
105527903|NCT00654381|363944706|FG002|Extension Stage|Lack of Efficacy|1|||
105527904|NCT00654381|363944707|FG003|Extension Stage|Lack of Efficacy|0|||
105527905|NCT00654381|363944708|FG004|Extension Stage|Lack of Efficacy|0|||
105527906|NCT00654381|363944709|FG005|Extension Stage|Lack of Efficacy|0|||
105527907|NCT00654381|363944704|FG000|Extension Stage|Withdrawal by Subject|0|||
105593664|NCT00371566|364172781|FG001|Follow Up Phase|Disease progression|0|||
105593665|NCT00371566|364172780|FG000|Follow Up Phase|Withdrawal by Subject|0|||
105527908|NCT00654381|363944705|FG001|Extension Stage|Withdrawal by Subject|0|||
105527909|NCT00654381|363944706|FG002|Extension Stage|Withdrawal by Subject|1|||
105527910|NCT00654381|363944707|FG003|Extension Stage|Withdrawal by Subject|1|||
105527911|NCT00654381|363944708|FG004|Extension Stage|Withdrawal by Subject|1|||
105527912|NCT00654381|363944709|FG005|Extension Stage|Withdrawal by Subject|1|||
105527913|NCT00654381|363944704|FG000|Extension Stage|Closure of the trial site|0|||
105527914|NCT00654381|363944705|FG001|Extension Stage|Closure of the trial site|0|||
105527915|NCT00654381|363944706|FG002|Extension Stage|Closure of the trial site|0|||
105527916|NCT00654381|363944707|FG003|Extension Stage|Closure of the trial site|0|||
105527917|NCT00654381|363944708|FG004|Extension Stage|Closure of the trial site|1|||
105527918|NCT00654381|363944709|FG005|Extension Stage|Closure of the trial site|1|||
105527919|NCT03100825|363944710|FG000|Overall Study|Participant/Guardian Decision|7|||
105527920|NCT03100825|363944710|FG000|Overall Study|Physician Decision|1|||
105527921|NCT02586493|363944716|FG000|Overall Study|Adverse Event|4|||
105527922|NCT02586493|363944716|FG000|Overall Study|Protocol Violation|6|||
105527923|NCT02586493|363944716|FG000|Overall Study|Lost to Follow-up|1|||
105527924|NCT02586493|363944716|FG000|Overall Study|Withdrawal by Subject|1|||
105527925|NCT01675882|363944717|FG000|Overall Study|Adverse Event|0|||
105527926|NCT01675882|363944718|FG001|Overall Study|Adverse Event|2|||
105527927|NCT01675882|363944719|FG002|Overall Study|Adverse Event|1|||
105527928|NCT01675882|363944720|FG003|Overall Study|Adverse Event|0|||
105527929|NCT01675882|363944717|FG000|Overall Study|Participant unwilling to continue|2|||
105527930|NCT01675882|363944718|FG001|Overall Study|Participant unwilling to continue|4|||
105527931|NCT01675882|363944719|FG002|Overall Study|Participant unwilling to continue|2|||
105527932|NCT01675882|363944720|FG003|Overall Study|Participant unwilling to continue|1|||
105527933|NCT01675882|363944717|FG000|Overall Study|Lost to Follow-up|0|||
105527934|NCT01675882|363944718|FG001|Overall Study|Lost to Follow-up|1|||
105527935|NCT01675882|363944719|FG002|Overall Study|Lost to Follow-up|0|||
105527936|NCT01675882|363944720|FG003|Overall Study|Lost to Follow-up|0|||
105527937|NCT01675882|363944717|FG000|Overall Study|Non-compliance|0|||
105527938|NCT01675882|363944718|FG001|Overall Study|Non-compliance|0|||
105527939|NCT01675882|363944719|FG002|Overall Study|Non-compliance|0|||
105527940|NCT01675882|363944720|FG003|Overall Study|Non-compliance|1|||
105527941|NCT00735371|363944722|FG000|Overall Study|Adverse Event|3|||
105527942|NCT00735371|363944723|FG001|Overall Study|Adverse Event|3|||
105527943|NCT00735371|363944724|FG002|Overall Study|Adverse Event|4|||
105527944|NCT00735371|363944725|FG003|Overall Study|Adverse Event|1|||
105527945|NCT00735371|363944722|FG000|Overall Study|Protocol Violation|2|||
105527946|NCT00735371|363944723|FG001|Overall Study|Protocol Violation|2|||
105527947|NCT00735371|363944724|FG002|Overall Study|Protocol Violation|0|||
105527948|NCT00735371|363944725|FG003|Overall Study|Protocol Violation|3|||
105527949|NCT00735371|363944722|FG000|Overall Study|Withdrawal by Subject|0|||
105527950|NCT00735371|363944723|FG001|Overall Study|Withdrawal by Subject|2|||
105527951|NCT00735371|363944724|FG002|Overall Study|Withdrawal by Subject|2|||
105527952|NCT00735371|363944725|FG003|Overall Study|Withdrawal by Subject|0|||
105527953|NCT00735371|363944722|FG000|Overall Study|Lost to Follow-up|1|||
105527954|NCT00735371|363944723|FG001|Overall Study|Lost to Follow-up|1|||
105527955|NCT00735371|363944724|FG002|Overall Study|Lost to Follow-up|3|||
105527956|NCT00735371|363944725|FG003|Overall Study|Lost to Follow-up|1|||
105527957|NCT00735371|363944722|FG000|Overall Study|Lack of Efficacy|4|||
105527958|NCT00735371|363944723|FG001|Overall Study|Lack of Efficacy|2|||
105527959|NCT00735371|363944724|FG002|Overall Study|Lack of Efficacy|0|||
105527960|NCT00735371|363944725|FG003|Overall Study|Lack of Efficacy|4|||
105527961|NCT00735371|363944722|FG000|Overall Study|Sponsor Decision|3|||
105527962|NCT00735371|363944723|FG001|Overall Study|Sponsor Decision|1|||
105527963|NCT00735371|363944724|FG002|Overall Study|Sponsor Decision|0|||
105527964|NCT00735371|363944725|FG003|Overall Study|Sponsor Decision|1|||
105527965|NCT00735371|363944722|FG000|Overall Study|Protocol Violation|0|||
105527966|NCT00735371|363944723|FG001|Overall Study|Protocol Violation|1|||
105527967|NCT00735371|363944724|FG002|Overall Study|Protocol Violation|2|||
105527968|NCT00735371|363944725|FG003|Overall Study|Protocol Violation|0|||
105527969|NCT00735371|363944722|FG000|Overall Study|Prior Vyvanse Exposure|1|||
105527970|NCT00735371|363944723|FG001|Overall Study|Prior Vyvanse Exposure|1|||
105527971|NCT00735371|363944724|FG002|Overall Study|Prior Vyvanse Exposure|0|||
105527972|NCT00735371|363944725|FG003|Overall Study|Prior Vyvanse Exposure|0|||
105527973|NCT00735371|363944722|FG000|Overall Study|Exclusion criteria|1|||
105527974|NCT00735371|363944723|FG001|Overall Study|Exclusion criteria|0|||
105527975|NCT00735371|363944724|FG002|Overall Study|Exclusion criteria|0|||
105527976|NCT00735371|363944725|FG003|Overall Study|Exclusion criteria|0|||
105527977|NCT00994448|363944726|FG000|Overall Study|Adverse Event|1|||
105527978|NCT00994448|363944727|FG001|Overall Study|Adverse Event|0|||
105527979|NCT00994448|363944726|FG000|Overall Study|Lost to Follow-up|5|||
105527980|NCT00994448|363944727|FG001|Overall Study|Lost to Follow-up|1|||
105527981|NCT00994448|363944726|FG000|Overall Study|Withdrawal by Subject|1|||
105527982|NCT00994448|363944727|FG001|Overall Study|Withdrawal by Subject|1|||
105527983|NCT00994448|363944726|FG000|Overall Study|Physician Decision|1|||
105527984|NCT00994448|363944727|FG001|Overall Study|Physician Decision|0|||
105527985|NCT00097721|363944732|FG000|Overall Study|Adverse Event|8|||
105527986|NCT00097721|363944733|FG001|Overall Study|Adverse Event|1|||
105527987|NCT00097721|363944732|FG000|Overall Study|Withdrawal by Subject|6|||
105527988|NCT00097721|363944733|FG001|Overall Study|Withdrawal by Subject|1|||
105527989|NCT00097721|363944732|FG000|Overall Study|Progressive Disease|55|||
105527990|NCT00097721|363944733|FG001|Overall Study|Progressive Disease|27|||
105527991|NCT00097721|363944732|FG000|Overall Study|Physician Decision|1|||
105527992|NCT00097721|363944733|FG001|Overall Study|Physician Decision|3|||
105527993|NCT00097721|363944732|FG000|Overall Study|Reason not given|1|||
105527994|NCT00097721|363944733|FG001|Overall Study|Reason not given|1|||
105527995|NCT00449956|363944734|FG000|Overall Study|Adverse Event|7|||
105527996|NCT00449956|363944735|FG001|Overall Study|Adverse Event|1|||
105527997|NCT00449956|363944736|FG002|Overall Study|Adverse Event|6|||
105527998|NCT00449956|363944734|FG000|Overall Study|Lack of Efficacy|0|||
105527999|NCT00449956|363944735|FG001|Overall Study|Lack of Efficacy|0|||
105528000|NCT00449956|363944736|FG002|Overall Study|Lack of Efficacy|1|||
105528001|NCT00449956|363944734|FG000|Overall Study|Protocol Violation|1|||
105528002|NCT00449956|363944735|FG001|Overall Study|Protocol Violation|1|||
105528003|NCT00449956|363944736|FG002|Overall Study|Protocol Violation|1|||
105528004|NCT00449956|363944734|FG000|Overall Study|Withdrawal by Subject|0|||
105528005|NCT00449956|363944735|FG001|Overall Study|Withdrawal by Subject|1|||
105528006|NCT00449956|363944736|FG002|Overall Study|Withdrawal by Subject|0|||
105528007|NCT00449956|363944734|FG000|Overall Study|Physician Decision|2|||
105528008|NCT00449956|363944735|FG001|Overall Study|Physician Decision|1|||
105528009|NCT00449956|363944736|FG002|Overall Study|Physician Decision|1|||
105528010|NCT00404352|363944741|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
105528011|NCT00404352|363944742|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
105528012|NCT00404352|363944743|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
105528013|NCT00404352|363944744|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
105528014|NCT00404352|363944745|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
105528015|NCT00404352|363944746|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
105528016|NCT00404352|363944747|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
105528017|NCT00404352|363944748|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
105528018|NCT00404352|363944749|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
105528019|NCT00404352|363944741|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
105528020|NCT00404352|363944742|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
105528021|NCT00404352|363944743|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
105528022|NCT00404352|363944744|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
105528023|NCT00404352|363944745|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
105528024|NCT00404352|363944746|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
105528025|NCT00404352|363944747|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
105528026|NCT00404352|363944748|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
105528027|NCT00404352|363944749|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
105528028|NCT00404352|363944741|FG000|Double Blind (up to 24 Month)|Death|0|||
105528029|NCT00404352|363944742|FG001|Double Blind (up to 24 Month)|Death|0|||
105528030|NCT00404352|363944743|FG002|Double Blind (up to 24 Month)|Death|1|||
105528031|NCT00404352|363944744|FG003|Double Blind (up to 24 Month)|Death|0|||
105528032|NCT00404352|363944745|FG004|Double Blind (up to 24 Month)|Death|0|||
105528033|NCT00404352|363944746|FG005|Double Blind (up to 24 Month)|Death|0|||
105528034|NCT00404352|363944747|FG006|Double Blind (up to 24 Month)|Death|0|||
105528035|NCT00404352|363944748|FG007|Double Blind (up to 24 Month)|Death|0|||
105528036|NCT00404352|363944749|FG008|Double Blind (up to 24 Month)|Death|0|||
105528037|NCT00404352|363944741|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
105528038|NCT00404352|363944742|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
105528039|NCT00404352|363944743|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
105528040|NCT00404352|363944744|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
105528041|NCT00404352|363944745|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
105528042|NCT00404352|363944746|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
105528043|NCT00404352|363944747|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
105528044|NCT00404352|363944748|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
105528045|NCT00404352|363944749|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
105528046|NCT00404352|363944741|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
105528047|NCT00404352|363944742|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
105528048|NCT00404352|363944743|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
105528049|NCT00404352|363944744|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
105528050|NCT00404352|363944745|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
105528051|NCT00404352|363944746|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
105528052|NCT00404352|363944747|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
105528053|NCT00404352|363944748|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
105528054|NCT00404352|363944749|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
105528055|NCT00404352|363944741|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
105528056|NCT00404352|363944742|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
105528057|NCT00404352|363944743|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
105528058|NCT00404352|363944744|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
105528059|NCT00404352|363944745|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
105528060|NCT00404352|363944746|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
105528061|NCT00404352|363944747|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
105528062|NCT00404352|363944748|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
105528063|NCT00404352|363944749|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
105528064|NCT00404352|363944741|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
105528065|NCT00404352|363944742|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
105528066|NCT00404352|363944743|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
105528067|NCT00404352|363944744|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
105528068|NCT00404352|363944745|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
105528069|NCT00404352|363944746|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
105528070|NCT00404352|363944747|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
105528071|NCT00404352|363944748|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
105528072|NCT00404352|363944749|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
105528073|NCT00404352|363944741|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
105528074|NCT00404352|363944742|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
105528075|NCT00404352|363944743|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
105528076|NCT00404352|363944744|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
105528077|NCT00404352|363944745|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
105528078|NCT00404352|363944746|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
105528079|NCT00404352|363944747|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
105528080|NCT00404352|363944748|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
105528081|NCT00404352|363944749|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
105528082|NCT00404352|363944741|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
105528083|NCT00404352|363944742|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
105528084|NCT00404352|363944743|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
105528085|NCT00404352|363944744|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
105528086|NCT00404352|363944745|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
105528087|NCT00404352|363944746|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
105528088|NCT00404352|363944747|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
105528089|NCT00404352|363944748|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
105528090|NCT00404352|363944749|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
105528091|NCT00404352|363944741|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
105528092|NCT00404352|363944742|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
105528093|NCT00404352|363944743|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
105528094|NCT00404352|363944744|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
105528095|NCT00404352|363944745|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
105528096|NCT00404352|363944746|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
105528097|NCT00404352|363944747|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
105528098|NCT00404352|363944748|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
105528099|NCT00404352|363944749|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
105528100|NCT00404352|363944741|FG000|Double Blind (up to 24 Month)|Other|0|||
105528101|NCT00404352|363944742|FG001|Double Blind (up to 24 Month)|Other|1|||
105528102|NCT00404352|363944743|FG002|Double Blind (up to 24 Month)|Other|0|||
105528103|NCT00404352|363944744|FG003|Double Blind (up to 24 Month)|Other|0|||
105528104|NCT00404352|363944745|FG004|Double Blind (up to 24 Month)|Other|0|||
105528105|NCT00404352|363944746|FG005|Double Blind (up to 24 Month)|Other|0|||
105528106|NCT00404352|363944747|FG006|Double Blind (up to 24 Month)|Other|0|||
105528107|NCT00404352|363944748|FG007|Double Blind (up to 24 Month)|Other|0|||
105528108|NCT00404352|363944749|FG008|Double Blind (up to 24 Month)|Other|0|||
105528109|NCT00404352|363944741|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
105528110|NCT00404352|363944742|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
105528111|NCT00404352|363944743|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
105528112|NCT00404352|363944744|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
105528113|NCT00404352|363944745|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
105528114|NCT00404352|363944746|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
105528115|NCT00404352|363944747|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
105528116|NCT00404352|363944748|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
105528117|NCT00404352|363944749|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
105528118|NCT00404352|363944741|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
105528119|NCT00404352|363944742|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
105528120|NCT00404352|363944743|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
105528121|NCT00404352|363944744|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
105528122|NCT00404352|363944745|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
105528123|NCT00404352|363944746|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
105528124|NCT00404352|363944747|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
105528125|NCT00404352|363944748|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
105528126|NCT00404352|363944749|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
105528127|NCT00404352|363944741|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
105528128|NCT00404352|363944742|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
105528129|NCT00404352|363944743|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
105528130|NCT00404352|363944744|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
105528131|NCT00404352|363944745|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
105528132|NCT00404352|363944746|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
105528133|NCT00404352|363944747|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
105528134|NCT00404352|363944748|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
105528135|NCT00404352|363944749|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
105528136|NCT00404352|363944741|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
105528137|NCT00404352|363944742|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
105528138|NCT00404352|363944743|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
105593666|NCT00371566|364172781|FG001|Follow Up Phase|Withdrawal by Subject|1|||
105528139|NCT00404352|363944744|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
105528140|NCT00404352|363944745|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
105528141|NCT00404352|363944746|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
105528142|NCT00404352|363944747|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
105528143|NCT00404352|363944748|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
105528144|NCT00404352|363944749|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
105528145|NCT00404352|363944741|FG000|Open Label (up to 24 Month)|Disease progression|0|||
105528146|NCT00404352|363944742|FG001|Open Label (up to 24 Month)|Disease progression|0|||
105528147|NCT00404352|363944743|FG002|Open Label (up to 24 Month)|Disease progression|0|||
105528148|NCT00404352|363944744|FG003|Open Label (up to 24 Month)|Disease progression|1|||
105528149|NCT00404352|363944745|FG004|Open Label (up to 24 Month)|Disease progression|0|||
105528150|NCT00404352|363944746|FG005|Open Label (up to 24 Month)|Disease progression|0|||
105528151|NCT00404352|363944747|FG006|Open Label (up to 24 Month)|Disease progression|0|||
105528152|NCT00404352|363944748|FG007|Open Label (up to 24 Month)|Disease progression|0|||
105528153|NCT00404352|363944749|FG008|Open Label (up to 24 Month)|Disease progression|0|||
105528154|NCT00404352|363944741|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
105528155|NCT00404352|363944742|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
105528156|NCT00404352|363944743|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
105528157|NCT00404352|363944744|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
105528158|NCT00404352|363944745|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
105528159|NCT00404352|363944746|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
105528160|NCT00404352|363944747|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
105528161|NCT00404352|363944748|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
105528162|NCT00404352|363944749|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
105528163|NCT00404352|363944741|FG000|Open Label Extension (up to 36 Months)|Other|0|||
105528164|NCT00404352|363944742|FG001|Open Label Extension (up to 36 Months)|Other|0|||
105528165|NCT00404352|363944743|FG002|Open Label Extension (up to 36 Months)|Other|0|||
105528166|NCT00404352|363944744|FG003|Open Label Extension (up to 36 Months)|Other|0|||
105528167|NCT00404352|363944745|FG004|Open Label Extension (up to 36 Months)|Other|0|||
105528168|NCT00404352|363944746|FG005|Open Label Extension (up to 36 Months)|Other|0|||
105528169|NCT00404352|363944747|FG006|Open Label Extension (up to 36 Months)|Other|0|||
105528170|NCT00404352|363944748|FG007|Open Label Extension (up to 36 Months)|Other|0|||
105528171|NCT00404352|363944749|FG008|Open Label Extension (up to 36 Months)|Other|2|||
105528172|NCT03746522|363944750|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
105528173|NCT03746522|363944751|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
105528174|NCT03746522|363944752|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
105528175|NCT03746522|363944750|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
105528176|NCT03746522|363944751|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
105528177|NCT03746522|363944752|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
105528178|NCT03746522|363944750|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
105528179|NCT03746522|363944751|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
105528180|NCT03746522|363944752|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
105528181|NCT03746522|363944750|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
105528182|NCT03746522|363944751|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
105528183|NCT03746522|363944752|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
105528184|NCT03746522|363944750|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
105528185|NCT03746522|363944751|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
105528186|NCT03746522|363944752|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
105528187|NCT01479621|363944753|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
105528188|NCT01479621|363944754|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
105528189|NCT01479621|363944755|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
105528190|NCT01479621|363944756|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
105528191|NCT01479621|363944757|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
105528192|NCT01479621|363944758|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
105528193|NCT01479621|363944759|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
105528194|NCT01479621|363944753|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
105528195|NCT01479621|363944754|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
105528196|NCT01479621|363944755|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
105528197|NCT01479621|363944756|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
105528198|NCT01479621|363944757|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
105528199|NCT01479621|363944758|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
105528200|NCT01479621|363944759|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
105528201|NCT01479621|363944753|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
105528202|NCT01479621|363944754|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
105528203|NCT01479621|363944755|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
105593667|NCT00371566|364172780|FG000|Follow Up Phase|Physician Decision|1|||
105528204|NCT01479621|363944756|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
105528205|NCT01479621|363944757|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
105528206|NCT01479621|363944758|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
105528207|NCT01479621|363944759|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
105528208|NCT01479621|363944753|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
105528209|NCT01479621|363944754|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
105528210|NCT01479621|363944755|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
105528211|NCT01479621|363944756|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
105528212|NCT01479621|363944757|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
105528213|NCT01479621|363944758|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
105528214|NCT01479621|363944759|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
105528215|NCT01479621|363944753|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
105528216|NCT01479621|363944754|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
105528217|NCT01479621|363944755|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
105528218|NCT01479621|363944756|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
105528219|NCT01479621|363944757|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
105528220|NCT01479621|363944758|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
105528221|NCT01479621|363944759|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
105528222|NCT01479621|363944753|FG000|Treatment Period|Adverse Event|0|||
105528223|NCT01479621|363944754|FG001|Treatment Period|Adverse Event|0|||
105528224|NCT01479621|363944755|FG002|Treatment Period|Adverse Event|0|||
105528225|NCT01479621|363944756|FG003|Treatment Period|Adverse Event|0|||
105528226|NCT01479621|363944757|FG004|Treatment Period|Adverse Event|1|||
105528227|NCT01479621|363944758|FG005|Treatment Period|Adverse Event|2|||
105528228|NCT01479621|363944759|FG006|Treatment Period|Adverse Event|2|||
105528229|NCT01479621|363944753|FG000|Treatment Period|Withdrawal by Subject|0|||
105528230|NCT01479621|363944754|FG001|Treatment Period|Withdrawal by Subject|4|||
105528231|NCT01479621|363944755|FG002|Treatment Period|Withdrawal by Subject|2|||
105528232|NCT01479621|363944756|FG003|Treatment Period|Withdrawal by Subject|2|||
105528233|NCT01479621|363944757|FG004|Treatment Period|Withdrawal by Subject|5|||
105528234|NCT01479621|363944758|FG005|Treatment Period|Withdrawal by Subject|5|||
105528235|NCT01479621|363944759|FG006|Treatment Period|Withdrawal by Subject|1|||
105528236|NCT01479621|363944753|FG000|Treatment Period|Physician Decision|0|||
105528237|NCT01479621|363944754|FG001|Treatment Period|Physician Decision|0|||
105528238|NCT01479621|363944755|FG002|Treatment Period|Physician Decision|0|||
105528239|NCT01479621|363944756|FG003|Treatment Period|Physician Decision|0|||
105528240|NCT01479621|363944757|FG004|Treatment Period|Physician Decision|1|||
105528241|NCT01479621|363944758|FG005|Treatment Period|Physician Decision|1|||
105528242|NCT01479621|363944759|FG006|Treatment Period|Physician Decision|0|||
105528243|NCT01479621|363944753|FG000|Treatment Period|Non-compliance to study drug|0|||
105528244|NCT01479621|363944754|FG001|Treatment Period|Non-compliance to study drug|1|||
105528245|NCT01479621|363944755|FG002|Treatment Period|Non-compliance to study drug|0|||
105528246|NCT01479621|363944756|FG003|Treatment Period|Non-compliance to study drug|0|||
105528247|NCT01479621|363944757|FG004|Treatment Period|Non-compliance to study drug|0|||
105528248|NCT01479621|363944758|FG005|Treatment Period|Non-compliance to study drug|0|||
105528249|NCT01479621|363944759|FG006|Treatment Period|Non-compliance to study drug|1|||
105528250|NCT01479621|363944753|FG000|Treatment Period|Protocol Violation|0|||
105528251|NCT01479621|363944754|FG001|Treatment Period|Protocol Violation|9|||
105528252|NCT01479621|363944755|FG002|Treatment Period|Protocol Violation|6|||
105528253|NCT01479621|363944756|FG003|Treatment Period|Protocol Violation|5|||
105528254|NCT01479621|363944757|FG004|Treatment Period|Protocol Violation|2|||
105528255|NCT01479621|363944758|FG005|Treatment Period|Protocol Violation|10|||
105528256|NCT01479621|363944759|FG006|Treatment Period|Protocol Violation|6|||
105528257|NCT01479621|363944753|FG000|Treatment Period|Pregnancy|0|||
105528258|NCT01479621|363944754|FG001|Treatment Period|Pregnancy|0|||
105528259|NCT01479621|363944755|FG002|Treatment Period|Pregnancy|2|||
105528260|NCT01479621|363944756|FG003|Treatment Period|Pregnancy|0|||
105528261|NCT01479621|363944757|FG004|Treatment Period|Pregnancy|0|||
105528262|NCT01479621|363944758|FG005|Treatment Period|Pregnancy|0|||
105528263|NCT01479621|363944759|FG006|Treatment Period|Pregnancy|0|||
105528264|NCT01479621|363944753|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
105528265|NCT01479621|363944754|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
105528266|NCT01479621|363944755|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
105528267|NCT01479621|363944756|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
105528268|NCT01479621|363944757|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
105528269|NCT01479621|363944758|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
105528270|NCT01479621|363944759|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
105528271|NCT01479621|363944753|FG000|Treatment Period|Lost to Follow-up|0|||
105528272|NCT01479621|363944754|FG001|Treatment Period|Lost to Follow-up|0|||
105528273|NCT01479621|363944755|FG002|Treatment Period|Lost to Follow-up|1|||
105528274|NCT01479621|363944756|FG003|Treatment Period|Lost to Follow-up|0|||
105528275|NCT01479621|363944757|FG004|Treatment Period|Lost to Follow-up|2|||
105528276|NCT01479621|363944758|FG005|Treatment Period|Lost to Follow-up|2|||
105528277|NCT01479621|363944759|FG006|Treatment Period|Lost to Follow-up|1|||
105528278|NCT01479621|363944753|FG000|Treatment Period|Met stopping criteria|0|||
105528279|NCT01479621|363944754|FG001|Treatment Period|Met stopping criteria|8|||
105528280|NCT01479621|363944755|FG002|Treatment Period|Met stopping criteria|7|||
105528281|NCT01479621|363944756|FG003|Treatment Period|Met stopping criteria|4|||
105528282|NCT01479621|363944757|FG004|Treatment Period|Met stopping criteria|9|||
105528283|NCT01479621|363944758|FG005|Treatment Period|Met stopping criteria|20|||
105528284|NCT01479621|363944759|FG006|Treatment Period|Met stopping criteria|6|||
105528285|NCT00453999|363944767|FG000|Overall Study|Adverse Event|1|||
105528286|NCT00453999|363944768|FG001|Overall Study|Adverse Event|2|||
105528287|NCT00453999|363944769|FG002|Overall Study|Adverse Event|1|||
105528288|NCT00453999|363944767|FG000|Overall Study|Lost to Follow-up|0|||
105528289|NCT00453999|363944768|FG001|Overall Study|Lost to Follow-up|1|||
105528290|NCT00453999|363944769|FG002|Overall Study|Lost to Follow-up|1|||
105528291|NCT00453999|363944767|FG000|Overall Study|Withdrawal by Subject|2|||
105528292|NCT00453999|363944768|FG001|Overall Study|Withdrawal by Subject|1|||
105528293|NCT00453999|363944769|FG002|Overall Study|Withdrawal by Subject|1|||
105528294|NCT00453999|363944767|FG000|Overall Study|Subject Request|2|||
105528295|NCT00453999|363944768|FG001|Overall Study|Subject Request|1|||
105528296|NCT00453999|363944769|FG002|Overall Study|Subject Request|0|||
105528297|NCT01907828|363944772|FG000|Overall Study|Exclusion criteria not met|0|||
105528298|NCT01907828|363944773|FG001|Overall Study|Exclusion criteria not met|1|||
105528299|NCT01907828|363944772|FG000|Overall Study|Withdrawal by Subject|3|||
105528300|NCT01907828|363944773|FG001|Overall Study|Withdrawal by Subject|4|||
105528301|NCT01907828|363944772|FG000|Overall Study|Lost to Follow-up|3|||
105528302|NCT01907828|363944773|FG001|Overall Study|Lost to Follow-up|0|||
105528303|NCT01907828|363944772|FG000|Overall Study|Participant refused 24-month follow-up|1|||
105528304|NCT01907828|363944773|FG001|Overall Study|Participant refused 24-month follow-up|0|||
105528305|NCT01907828|363944772|FG000|Overall Study|Participant met exclusion criteria|0|||
105528306|NCT01907828|363944773|FG001|Overall Study|Participant met exclusion criteria|1|||
105528307|NCT02547129|363944774|FG000|Overall Study|Difficulty with ongoing infection|1|||
105528308|NCT02547129|363944775|FG001|Overall Study|Difficulty with ongoing infection|0|||
105528309|NCT00794196|363944777|FG000|Overall Study|Lost to Follow-up|5|||
105528310|NCT00794196|363944778|FG001|Overall Study|Lost to Follow-up|23|||
105528311|NCT00696137|363944779|FG000|Overall Study|Withdrawal by Subject|2|||
105528312|NCT00850395|363944780|FG000|Overall Study|Death|1|||
105593668|NCT00371566|364172781|FG001|Follow Up Phase|Physician Decision|1|||
105593669|NCT00371566|364172780|FG000|Follow Up Phase|Lost to Follow-up|1|||
105593670|NCT00371566|364172781|FG001|Follow Up Phase|Lost to Follow-up|0|||
105593671|NCT00972504|364172782|FG000|Overall Study|Adverse Event|2|||
105593672|NCT00972504|364172782|FG000|Overall Study|Investigator discretion|1|||
105593673|NCT02954848|364172783|FG000|Overall Study|Randomized but Not Treated|0|||
105593674|NCT02954848|364172784|FG001|Overall Study|Randomized but Not Treated|1|||
105528313|NCT00850395|363944780|FG000|Overall Study|Adverse Event|1|||
105528314|NCT00850395|363944780|FG000|Overall Study|Insufficient clinical response|3|||
105528315|NCT00850395|363944780|FG000|Overall Study|Other|5|||
105528316|NCT00500292|363944781|FG000|Overall Study|Adverse Event|3|||
105528317|NCT00500292|363944782|FG001|Overall Study|Adverse Event|6|||
105528318|NCT00500292|363944783|FG002|Overall Study|Adverse Event|4|||
105528319|NCT00500292|363944781|FG000|Overall Study|Condition under investigation worsened|21|||
105528320|NCT00500292|363944782|FG001|Overall Study|Condition under investigation worsened|23|||
105528321|NCT00500292|363944783|FG002|Overall Study|Condition under investigation worsened|19|||
105528322|NCT00500292|363944781|FG000|Overall Study|Withdrawal by Subject|0|||
105528323|NCT00500292|363944782|FG001|Overall Study|Withdrawal by Subject|1|||
105528324|NCT00500292|363944783|FG002|Overall Study|Withdrawal by Subject|0|||
105528325|NCT00500292|363944781|FG000|Overall Study|Other|1|||
105528326|NCT00500292|363944782|FG001|Overall Study|Other|1|||
105528327|NCT00500292|363944783|FG002|Overall Study|Other|4|||
105528328|NCT04011410|363944786|FG000|Overall Study|Withdrawal by Subject|1|||
105528329|NCT04258605|363944787|FG000|Overall Study|Death|1|||
105528330|NCT04258605|363944788|FG001|Overall Study|Death|0|||
105528331|NCT04258605|363944787|FG000|Overall Study|Early study termination|21|||
105528332|NCT04258605|363944788|FG001|Overall Study|Early study termination|2|||
105528333|NCT00589108|363946383|FG000|Overall Study|Lost to Follow-up|1|||
105528334|NCT00589108|363946384|FG001|Overall Study|Lost to Follow-up|1|||
105528335|NCT00589108|363946385|FG002|Overall Study|Lost to Follow-up|1|||
105528336|NCT00589108|363946383|FG000|Overall Study|Death|3|||
105528337|NCT00589108|363946384|FG001|Overall Study|Death|3|||
105528338|NCT00589108|363946385|FG002|Overall Study|Death|4|||
105528339|NCT03256552|363946386|FG000|Overall Study|Protocol Violation|1|||
105593675|NCT02954848|364172783|FG000|Overall Study|Adverse Event|2|||
105593676|NCT02954848|364172784|FG001|Overall Study|Adverse Event|3|||
105528340|NCT03256552|363946386|FG000|Overall Study|Physician Decision|1|||
105528341|NCT03256552|363946386|FG000|Overall Study|Adverse Event|1|||
105528342|NCT03256552|363946386|FG000|Overall Study|Withdrawal by Subject|2|||
105528343|NCT01888497|363946390|FG000|Washout Period 1|Withdrawal by Subject|0|||
105528344|NCT01888497|363946391|FG001|Washout Period 1|Withdrawal by Subject|0|||
105528345|NCT01888497|363946392|FG002|Washout Period 1|Withdrawal by Subject|1|||
105528346|NCT01888497|363946393|FG003|Washout Period 1|Withdrawal by Subject|1|||
105528347|NCT01888497|363946390|FG000|Washout Period 2|Adverse Event|0|||
105528348|NCT01888497|363946391|FG001|Washout Period 2|Adverse Event|0|||
105528349|NCT01888497|363946392|FG002|Washout Period 2|Adverse Event|0|||
105528350|NCT01888497|363946393|FG003|Washout Period 2|Adverse Event|1|||
105528351|NCT01888497|363946390|FG000|Washout Period 2|Withdrawal by Subject|0|||
105528352|NCT01888497|363946391|FG001|Washout Period 2|Withdrawal by Subject|0|||
105528353|NCT01888497|363946392|FG002|Washout Period 2|Withdrawal by Subject|0|||
105528354|NCT01888497|363946393|FG003|Washout Period 2|Withdrawal by Subject|1|||
105528355|NCT04152447|363946394|FG000|Overall Study|Lost to Follow-up|1|||
105528356|NCT04152447|363946395|FG001|Overall Study|Lost to Follow-up|0|||
105528357|NCT04152447|363946394|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
105528358|NCT04152447|363946395|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
105528359|NCT04152447|363946394|FG000|Overall Study|Withdrawal by Subject|0|||
105528360|NCT04152447|363946395|FG001|Overall Study|Withdrawal by Subject|1|||
105528361|NCT04152447|363946394|FG000|Overall Study|Found ineligible after enrolling|1|||
105528362|NCT04152447|363946395|FG001|Overall Study|Found ineligible after enrolling|1|||
105528363|NCT04152447|363946394|FG000|Overall Study|Did not receive VR headset in time.|0|||
105528364|NCT04152447|363946395|FG001|Overall Study|Did not receive VR headset in time.|2|||
105528365|NCT04013191|363946396|FG000|Overall Study|Adverse Event|1|||
105528366|NCT04013191|363946397|FG001|Overall Study|Adverse Event|0|||
105528367|NCT02449239|363946398|FG000|Induction Phase|Lack of Efficacy|64|||
105528368|NCT02449239|363946398|FG000|Induction Phase|Adverse Event|1|||
105528369|NCT02449239|363946398|FG000|Induction Phase|Lost to Follow-up|1|||
105528370|NCT02449239|363946398|FG000|Induction Phase|Protocol Violation|1|||
105528371|NCT02449239|363946398|FG000|Induction Phase|Physician Decision|1|||
105528372|NCT02449239|363946398|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
105528373|NCT02449239|363946398|FG000|Induction Phase|Withdrawal by Subject|1|||
105528374|NCT02449239|363946398|FG000|Maintenance Month 3|Lack of Efficacy|14|||
105528375|NCT02449239|363946398|FG000|Maintenance Month 6|Lack of Efficacy|10|||
105528376|NCT02449239|363946398|FG000|Maintenance Month 6|Adverse Event|2|||
105528377|NCT02449239|363946398|FG000|Maintenance Month 6|Physician Decision|1|||
105528378|NCT02449239|363946398|FG000|Maintenance Month 9|Lack of Efficacy|2|||
105528379|NCT02449239|363946398|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
105528380|NCT02449239|363946398|FG000|Maintenance Month 12|Lack of Efficacy|5|||
105528381|NCT02449239|363946398|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
105528382|NCT02449239|363946398|FG000|Maintenance Month 12|Subject moved from area|1|||
105528383|NCT02449239|363946398|FG000|Maintenance Month 15|Lack of Efficacy|1|||
105528384|NCT02449239|363946398|FG000|Maintenance Month 21|Lack of Efficacy|1|||
105528385|NCT02449239|363946398|FG000|Maintenance Month 21|Sponsor decision|1|||
105528386|NCT01236755|363946402|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
105528387|NCT01236755|363946402|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
105528388|NCT01236755|363946402|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
105528389|NCT01236755|363946402|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
105528390|NCT01344369|363946405|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
105528391|NCT01344369|363946406|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
105528392|NCT01344369|363946405|FG000|Washout of 28 Days|Physician Decision|0|||
105528393|NCT01344369|363946406|FG001|Washout of 28 Days|Physician Decision|1|||
105528394|NCT01344369|363946405|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
105528395|NCT01344369|363946406|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
105528396|NCT00110812|363946407|FG000|Main Study|Death|0|||
105528397|NCT00110812|363946408|FG001|Main Study|Death|0|||
105528398|NCT00110812|363946409|FG002|Main Study|Death|2|||
105528399|NCT00110812|363946407|FG000|Main Study|Withdrawal by Subject|0|||
105528400|NCT00110812|363946408|FG001|Main Study|Withdrawal by Subject|0|||
105528401|NCT00110812|363946409|FG002|Main Study|Withdrawal by Subject|1|||
105528402|NCT00110812|363946407|FG000|Main Study|Lost to Follow-up|8|||
105528403|NCT00110812|363946408|FG001|Main Study|Lost to Follow-up|11|||
105528404|NCT00110812|363946409|FG002|Main Study|Lost to Follow-up|10|||
105528405|NCT00110812|363946407|FG000|Extended Follow-up|Death|1|||
105528406|NCT00110812|363946408|FG001|Extended Follow-up|Death|0|||
105593677|NCT02954848|364172783|FG000|Overall Study|Withdrawal by Participant|0|||
105593678|NCT02954848|364172784|FG001|Overall Study|Withdrawal by Participant|1|||
105528407|NCT00110812|363946409|FG002|Extended Follow-up|Death|3|||
105528408|NCT00110812|363946407|FG000|Extended Follow-up|Withdrawal by Subject|0|||
105528409|NCT00110812|363946408|FG001|Extended Follow-up|Withdrawal by Subject|1|||
105528410|NCT00110812|363946409|FG002|Extended Follow-up|Withdrawal by Subject|0|||
105528411|NCT00110812|363946407|FG000|Extended Follow-up|Lost to Follow-up|1|||
105528412|NCT00110812|363946408|FG001|Extended Follow-up|Lost to Follow-up|3|||
105528413|NCT00110812|363946409|FG002|Extended Follow-up|Lost to Follow-up|1|||
105593679|NCT00835380|364172789|FG000|Overall Study|Withdrawal by Subject|2|||
105593680|NCT02914522|364172790|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
105528414|NCT00380393|363946410|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
105528415|NCT00380393|363946411|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
105528416|NCT00380393|363946410|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
105528417|NCT00380393|363946411|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
105528418|NCT00380393|363946410|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
105528419|NCT00380393|363946411|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
105528420|NCT00380393|363946410|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
105528421|NCT00380393|363946411|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
105528422|NCT00380393|363946410|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
105528423|NCT00380393|363946411|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
105528424|NCT00380393|363946410|FG000|Month 14|Withdrawal by Subject|9|||
105528425|NCT00380393|363946411|FG001|Month 14|Withdrawal by Subject|7|||
105528426|NCT00380393|363946410|FG000|Month 14|Death|1|||
105528427|NCT00380393|363946411|FG001|Month 14|Death|0|||
105528428|NCT00380393|363946410|FG000|Month 14|Lost to Follow-up|0|||
105528429|NCT00380393|363946411|FG001|Month 14|Lost to Follow-up|1|||
105528430|NCT00380393|363946410|FG000|Month 14|Migrated/moved from study area|39|||
105528431|NCT00380393|363946411|FG001|Month 14|Migrated/moved from study area|42|||
105528432|NCT00380393|363946410|FG000|Month 14|Protocol Violation|2|||
105528433|NCT00380393|363946411|FG001|Month 14|Protocol Violation|0|||
105528434|NCT00380393|363946410|FG000|Month 14|Others|6|||
105528435|NCT00380393|363946411|FG001|Month 14|Others|6|||
105528436|NCT04200248|363946412|FG000|Overall Study|Personal reasons|0|||
105528437|NCT04200248|363946413|FG001|Overall Study|Personal reasons|0|||
105528438|NCT04200248|363946414|FG002|Overall Study|Personal reasons|1|||
105528439|NCT04200248|363946412|FG000|Overall Study|Discontinued prior to treatment|3|||
105528440|NCT04200248|363946413|FG001|Overall Study|Discontinued prior to treatment|3|||
105528441|NCT04200248|363946414|FG002|Overall Study|Discontinued prior to treatment|2|||
105528442|NCT01454726|363946417|FG000|Overall Study|Withdrawal by Subject|0|||
105528443|NCT01454726|363946418|FG001|Overall Study|Withdrawal by Subject|1|||
105528444|NCT04476030|363946419|FG000|Overall Study|Withdrawal by Subject|20|||
105528445|NCT04476030|363946420|FG001|Overall Study|Withdrawal by Subject|16|||
105528446|NCT04476030|363946419|FG000|Overall Study|Adverse Event|10|||
105528447|NCT04476030|363946420|FG001|Overall Study|Adverse Event|11|||
105528448|NCT04476030|363946419|FG000|Overall Study|Lost to Follow-up|7|||
105528449|NCT04476030|363946420|FG001|Overall Study|Lost to Follow-up|4|||
105528450|NCT04476030|363946419|FG000|Overall Study|Physician Decision|1|||
105528451|NCT04476030|363946420|FG001|Overall Study|Physician Decision|1|||
105528452|NCT04476030|363946419|FG000|Overall Study|Protocol Deviation|2|||
105528453|NCT04476030|363946420|FG001|Overall Study|Protocol Deviation|0|||
105528454|NCT04476030|363946419|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
105528455|NCT04476030|363946420|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
105528456|NCT04476030|363946419|FG000|Overall Study|Randomized but not Dosed|2|||
105528457|NCT04476030|363946420|FG001|Overall Study|Randomized but not Dosed|8|||
105528458|NCT02347527|363946421|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
105528459|NCT02347527|363946422|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
105528460|NCT02347527|363946423|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
105528461|NCT02347527|363946424|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
105528462|NCT02347527|363946421|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
105528463|NCT02347527|363946422|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
105528464|NCT02347527|363946423|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
105528465|NCT02347527|363946424|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
105528466|NCT02347527|363946421|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
105528467|NCT02347527|363946422|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
105528468|NCT02347527|363946423|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
105528469|NCT02347527|363946424|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
105528470|NCT02347527|363946421|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
105528471|NCT02347527|363946422|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
105528472|NCT02347527|363946423|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
105528473|NCT02347527|363946424|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
105528474|NCT02347527|363946421|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
105528475|NCT02347527|363946422|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
105528476|NCT02347527|363946423|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
105528477|NCT02347527|363946424|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
105528478|NCT00934544|363946427|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
105528479|NCT00934544|363946428|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
105528480|NCT00934544|363946429|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
105528481|NCT00934544|363946427|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
105528482|NCT00934544|363946428|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
105528483|NCT00934544|363946429|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
105528484|NCT00934544|363946427|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
105528485|NCT00934544|363946428|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
105528486|NCT00934544|363946429|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
105528487|NCT00934544|363946427|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
105528488|NCT00934544|363946428|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
105528489|NCT00934544|363946429|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
105528490|NCT00934544|363946427|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
105528491|NCT00934544|363946428|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
105528492|NCT00934544|363946429|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
105528493|NCT00934544|363946427|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
105528494|NCT00934544|363946428|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
105528495|NCT00934544|363946429|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
105528496|NCT00934544|363946427|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
105528497|NCT00934544|363946428|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
105528498|NCT00934544|363946429|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
105528499|NCT00934544|363946427|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
105528500|NCT00934544|363946428|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
105528501|NCT00934544|363946429|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
105528502|NCT00934544|363946427|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
105528503|NCT00934544|363946428|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
105528504|NCT00934544|363946429|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
105528505|NCT00934544|363946427|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
105528506|NCT00934544|363946428|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
105528507|NCT00934544|363946429|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
105528508|NCT00934544|363946427|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
105528509|NCT00934544|363946428|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
105528510|NCT00934544|363946429|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
105528511|NCT00934544|363946427|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
105528512|NCT00934544|363946428|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
105528513|NCT00934544|363946429|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
105528514|NCT00934544|363946427|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
105528515|NCT00934544|363946428|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
105528516|NCT00934544|363946429|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
105528517|NCT00934544|363946427|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
105528518|NCT00934544|363946428|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
105528519|NCT00934544|363946429|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
105528520|NCT00934544|363946427|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
105528521|NCT00934544|363946428|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
105528522|NCT00934544|363946429|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
105528523|NCT00934544|363946427|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
105528524|NCT00934544|363946428|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
105528525|NCT00934544|363946429|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
105528526|NCT00302003|363946430|FG000|Overall Study|Lack of Efficacy|62|||
105528527|NCT00302003|363946430|FG000|Overall Study|Lost to Follow-up|1|||
105528528|NCT00302003|363946430|FG000|Overall Study|Physician Decision|2|||
105528529|NCT00302003|363946430|FG000|Overall Study|Withdrawal by Subject|5|||
105528530|NCT00302003|363946430|FG000|Overall Study|Ineligible|9|||
105528531|NCT00302003|363946430|FG000|Overall Study|Protocol Violation|1|||
105528532|NCT01218516|363946431|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
105528533|NCT01218516|363946432|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
105528534|NCT01218516|363946433|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
105528535|NCT01218516|363946434|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
105528536|NCT01218516|363946431|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
105528537|NCT01218516|363946432|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
105528538|NCT01218516|363946433|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
105528539|NCT01218516|363946434|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
105528540|NCT01218516|363946431|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
105528541|NCT01218516|363946432|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
105528542|NCT01218516|363946433|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
105528543|NCT01218516|363946434|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
105528544|NCT01218516|363946431|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
105528545|NCT01218516|363946432|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
105528546|NCT01218516|363946433|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
105528547|NCT01218516|363946434|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
105528548|NCT01218516|363946431|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
105528549|NCT01218516|363946432|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
105528550|NCT01218516|363946433|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
105528551|NCT01218516|363946434|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
105528552|NCT01218516|363946431|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
105528553|NCT01218516|363946432|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
105528554|NCT01218516|363946433|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
105528555|NCT01218516|363946434|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
105528556|NCT01218516|363946431|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
105528557|NCT01218516|363946432|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
105528558|NCT01218516|363946433|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
105528559|NCT01218516|363946434|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
105528560|NCT01218516|363946431|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
105528561|NCT01218516|363946432|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
105528562|NCT01218516|363946433|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
105528563|NCT01218516|363946434|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
105528564|NCT01218516|363946431|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
105528565|NCT01218516|363946432|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
105528566|NCT01218516|363946433|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
105528567|NCT01218516|363946434|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
105528568|NCT01218516|363946431|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
105528569|NCT01218516|363946432|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
105528570|NCT01218516|363946433|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
105528571|NCT01218516|363946434|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
105528572|NCT01218516|363946431|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
105528573|NCT01218516|363946432|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
105528574|NCT01218516|363946433|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
105528575|NCT01218516|363946434|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
105528576|NCT01218516|363946431|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
105528577|NCT01218516|363946432|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
105528578|NCT01218516|363946433|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
105528579|NCT01218516|363946434|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
105528580|NCT02042924|363946435|FG000|Overall Study|Early Death|1|||
105528581|NCT04033003|363946436|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
105528582|NCT04033003|363946437|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
105528583|NCT04033003|363946436|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
105528584|NCT04033003|363946437|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
105528585|NCT04033003|363946436|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
105528586|NCT04033003|363946437|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
105528587|NCT04033003|363946436|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
105528588|NCT04033003|363946437|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
105528589|NCT04033003|363946436|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
105528590|NCT04033003|363946437|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
105528591|NCT04033003|363946436|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
105528592|NCT04033003|363946437|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
105528593|NCT04033003|363946436|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
105528594|NCT04033003|363946437|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
105528595|NCT04033003|363946436|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
105528596|NCT04033003|363946437|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
105528597|NCT04033003|363946436|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
105528598|NCT04033003|363946437|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
105528599|NCT04033003|363946436|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
105528600|NCT04033003|363946437|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
105528601|NCT04033003|363946436|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
105528602|NCT04033003|363946437|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
105528603|NCT04033003|363946436|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
105528604|NCT04033003|363946437|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
105528605|NCT04033003|363946436|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
105528606|NCT04033003|363946437|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
105528607|NCT00240071|363946438|FG000|Overall Study|Withdrawal by Subject|3|||
105528608|NCT01344447|363946439|FG000|Overall Study|Adverse Event|1|||
105528609|NCT01344447|363946439|FG000|Overall Study|Protocol Violation|1|||
105528610|NCT01344447|363946439|FG000|Overall Study|Withdrawal by Subject|1|||
105528611|NCT01344447|363946439|FG000|Overall Study|The contrast was not seen|1|||
105528612|NCT01344447|363946439|FG000|Overall Study|Physician Decision|1|||
105528613|NCT01344447|363946439|FG000|Overall Study|MRA unsuccessful|1|||
105528614|NCT01344447|363946439|FG000|Overall Study|Bolus tracking failed|1|||
105528615|NCT01344447|363946439|FG000|Overall Study|Error of power injector|1|||
105528616|NCT00430092|363946441|FG000|Overall Study|Adverse Event|0|||
105528617|NCT00430092|363946442|FG001|Overall Study|Adverse Event|0|||
105528618|NCT00430092|363946443|FG002|Overall Study|Adverse Event|1|||
105528619|NCT00430092|363946441|FG000|Overall Study|Lack of Efficacy|5|||
105528620|NCT00430092|363946442|FG001|Overall Study|Lack of Efficacy|2|||
105528621|NCT00430092|363946443|FG002|Overall Study|Lack of Efficacy|54|||
105528622|NCT00430092|363946441|FG000|Overall Study|Lost to Follow-up|1|||
105528623|NCT00430092|363946442|FG001|Overall Study|Lost to Follow-up|0|||
105528624|NCT00430092|363946443|FG002|Overall Study|Lost to Follow-up|0|||
105528625|NCT00430092|363946441|FG000|Overall Study|Protocol Violation|0|||
105528626|NCT00430092|363946442|FG001|Overall Study|Protocol Violation|1|||
105528627|NCT00430092|363946443|FG002|Overall Study|Protocol Violation|1|||
105528628|NCT00430092|363946441|FG000|Overall Study|Withdrawal by Subject|0|||
105528629|NCT00430092|363946442|FG001|Overall Study|Withdrawal by Subject|1|||
105528630|NCT00430092|363946443|FG002|Overall Study|Withdrawal by Subject|1|||
105528631|NCT02884089|363946451|FG000|Period 1|Dosing error|2|||
105528632|NCT02884089|363946452|FG001|Period 1|Dosing error|2|||
105528633|NCT02884089|363946453|FG002|Period 1|Dosing error|0|||
105528634|NCT02884089|363946454|FG003|Period 1|Dosing error|0|||
105528635|NCT02884089|363946451|FG000|Washout Period 1|Lost to Follow-up|0|||
105528636|NCT02884089|363946452|FG001|Washout Period 1|Lost to Follow-up|1|||
105528637|NCT02884089|363946453|FG002|Washout Period 1|Lost to Follow-up|0|||
105528638|NCT02884089|363946454|FG003|Washout Period 1|Lost to Follow-up|1|||
105528639|NCT02884089|363946451|FG000|Washout Period 1|Withdrawal by Subject|0|||
105528640|NCT02884089|363946452|FG001|Washout Period 1|Withdrawal by Subject|1|||
105528641|NCT02884089|363946453|FG002|Washout Period 1|Withdrawal by Subject|0|||
105528642|NCT02884089|363946454|FG003|Washout Period 1|Withdrawal by Subject|0|||
105528643|NCT02884089|363946451|FG000|Period 2|Adverse Event|1|||
105528644|NCT02884089|363946452|FG001|Period 2|Adverse Event|0|||
105528645|NCT02884089|363946453|FG002|Period 2|Adverse Event|0|||
105528646|NCT02884089|363946454|FG003|Period 2|Adverse Event|0|||
105528647|NCT02884089|363946451|FG000|Period 3|Withdrawal by Subject|0|||
105528648|NCT02884089|363946452|FG001|Period 3|Withdrawal by Subject|0|||
105528649|NCT02884089|363946453|FG002|Period 3|Withdrawal by Subject|1|||
105528650|NCT02884089|363946454|FG003|Period 3|Withdrawal by Subject|0|||
105528651|NCT02884089|363946451|FG000|Washout Period 3|Withdrawal by Subject|0|||
105528652|NCT02884089|363946452|FG001|Washout Period 3|Withdrawal by Subject|0|||
105528653|NCT02884089|363946453|FG002|Washout Period 3|Withdrawal by Subject|1|||
105528654|NCT02884089|363946454|FG003|Washout Period 3|Withdrawal by Subject|0|||
105528655|NCT02884089|363946451|FG000|Washout Period 3|Lost to Follow-up|0|||
105528656|NCT02884089|363946452|FG001|Washout Period 3|Lost to Follow-up|0|||
105528657|NCT02884089|363946453|FG002|Washout Period 3|Lost to Follow-up|0|||
105528658|NCT02884089|363946454|FG003|Washout Period 3|Lost to Follow-up|1|||
105528659|NCT02884089|363946451|FG000|Period 4|Withdrawal by Subject|0|||
105528660|NCT02884089|363946452|FG001|Period 4|Withdrawal by Subject|1|||
105528661|NCT02884089|363946453|FG002|Period 4|Withdrawal by Subject|0|||
105528662|NCT02884089|363946454|FG003|Period 4|Withdrawal by Subject|0|||
105528663|NCT02884089|363946451|FG000|Period 4|Lost to Follow-up|1|||
105528664|NCT02884089|363946452|FG001|Period 4|Lost to Follow-up|0|||
105528665|NCT02884089|363946453|FG002|Period 4|Lost to Follow-up|0|||
105528666|NCT02884089|363946454|FG003|Period 4|Lost to Follow-up|0|||
105528667|NCT02884089|363946451|FG000|Follow-up Visit|Withdrawal by Subject|1|||
105528668|NCT02884089|363946452|FG001|Follow-up Visit|Withdrawal by Subject|0|||
105528669|NCT02884089|363946453|FG002|Follow-up Visit|Withdrawal by Subject|0|||
105528670|NCT02884089|363946454|FG003|Follow-up Visit|Withdrawal by Subject|1|||
105528671|NCT02487394|363946455|FG000|Phase 1|Withdrawal by Subject|0|||
105528672|NCT02487394|363946456|FG001|Phase 1|Withdrawal by Subject|1|||
105528673|NCT00594464|363946471|FG000|Overall Study|Withdrawal by Subject|1|||
105528674|NCT00594464|363946471|FG000|Overall Study|Delay in operation|2|||
105528675|NCT02350309|363946475|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
105528676|NCT02350309|363946476|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
105528677|NCT02350309|363946477|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
105528678|NCT02350309|363946478|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
105528679|NCT02350309|363946479|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
105528680|NCT02350309|363946480|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
105528681|NCT02350309|363946475|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
105528682|NCT02350309|363946476|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
105528683|NCT02350309|363946477|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
105528684|NCT02350309|363946478|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
105528685|NCT02350309|363946479|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
105528686|NCT02350309|363946480|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
105528687|NCT00058825|363946483|FG000|Overall Study|Relapse|9|||
105528688|NCT00058825|363946483|FG000|Overall Study|Progressive Disease|5|||
105528689|NCT00058825|363946483|FG000|Overall Study|Graft Failure|5|||
105528690|NCT00058825|363946483|FG000|Overall Study|Death|3|||
105528691|NCT01640366|363946484|FG000|Overall Study|Withdrawal by Subject|1|||
105528692|NCT01640366|363946484|FG000|Overall Study|Protocol Violation|16|||
105528693|NCT01640366|363946484|FG000|Overall Study|Lost to Follow-up|5|||
105528694|NCT02739269|363946485|FG000|Overall Study|Protocol Violation|5|||
105528695|NCT02739269|363946486|FG001|Overall Study|Protocol Violation|0|||
105528696|NCT02739269|363946485|FG000|Overall Study|Cycle cancellation|2|||
105528697|NCT02739269|363946486|FG001|Overall Study|Cycle cancellation|2|||
105528698|NCT02739269|363946485|FG000|Overall Study|Withdrawal by Subject|0|||
105528699|NCT02739269|363946486|FG001|Overall Study|Withdrawal by Subject|2|||
105528700|NCT02357940|363946488|FG000|Overall Study|Adverse Event|0|||
105528701|NCT02357940|363946489|FG001|Overall Study|Adverse Event|1|||
105528702|NCT02357940|363946488|FG000|Overall Study|Investigator's judgement|0|||
105528703|NCT02357940|363946489|FG001|Overall Study|Investigator's judgement|1|||
105528704|NCT02641379|363946492|FG000|Overall Study|Exclusion criterion during screening|1|||
105528705|NCT02641379|363946493|FG001|Overall Study|Exclusion criterion during screening|0|||
105528706|NCT02641379|363946494|FG002|Overall Study|Exclusion criterion during screening|0|||
105528707|NCT02641379|363946495|FG003|Overall Study|Exclusion criterion during screening|1|||
105528708|NCT02641379|363946496|FG004|Overall Study|Exclusion criterion during screening|2|||
105528709|NCT02641379|363946497|FG005|Overall Study|Exclusion criterion during screening|0|||
105528710|NCT02641379|363946498|FG006|Overall Study|Exclusion criterion during screening|0|||
105528711|NCT02641379|363946499|FG007|Overall Study|Exclusion criterion during screening|0|||
105528712|NCT02641379|363946500|FG008|Overall Study|Exclusion criterion during screening|0|||
105528713|NCT02641379|363946501|FG009|Overall Study|Exclusion criterion during screening|0|||
105528714|NCT02641379|363946502|FG010|Overall Study|Exclusion criterion during screening|0|||
105528715|NCT02641379|363946492|FG000|Overall Study|Withdrawal of informed consent|0|||
105528716|NCT02641379|363946493|FG001|Overall Study|Withdrawal of informed consent|1|||
105528717|NCT02641379|363946494|FG002|Overall Study|Withdrawal of informed consent|0|||
105528718|NCT02641379|363946495|FG003|Overall Study|Withdrawal of informed consent|0|||
105528719|NCT02641379|363946496|FG004|Overall Study|Withdrawal of informed consent|0|||
105528720|NCT02641379|363946497|FG005|Overall Study|Withdrawal of informed consent|0|||
105528721|NCT02641379|363946498|FG006|Overall Study|Withdrawal of informed consent|0|||
105528722|NCT02641379|363946499|FG007|Overall Study|Withdrawal of informed consent|1|||
105528723|NCT02641379|363946500|FG008|Overall Study|Withdrawal of informed consent|0|||
105528724|NCT02641379|363946501|FG009|Overall Study|Withdrawal of informed consent|0|||
105528725|NCT02641379|363946502|FG010|Overall Study|Withdrawal of informed consent|0|||
105528726|NCT02641379|363946492|FG000|Overall Study|Adverse Event|7|||
105528727|NCT02641379|363946493|FG001|Overall Study|Adverse Event|8|||
105528728|NCT02641379|363946494|FG002|Overall Study|Adverse Event|2|||
105528729|NCT02641379|363946495|FG003|Overall Study|Adverse Event|2|||
105528730|NCT02641379|363946496|FG004|Overall Study|Adverse Event|5|||
105528731|NCT02641379|363946497|FG005|Overall Study|Adverse Event|1|||
105528732|NCT02641379|363946498|FG006|Overall Study|Adverse Event|5|||
105528733|NCT02641379|363946499|FG007|Overall Study|Adverse Event|0|||
105528734|NCT02641379|363946500|FG008|Overall Study|Adverse Event|1|||
105528735|NCT02641379|363946501|FG009|Overall Study|Adverse Event|1|||
105528736|NCT02641379|363946502|FG010|Overall Study|Adverse Event|5|||
105528737|NCT02641379|363946492|FG000|Overall Study|Lack of Efficacy|0|||
105528738|NCT02641379|363946493|FG001|Overall Study|Lack of Efficacy|0|||
105528739|NCT02641379|363946494|FG002|Overall Study|Lack of Efficacy|2|||
105528740|NCT02641379|363946495|FG003|Overall Study|Lack of Efficacy|0|||
105528741|NCT02641379|363946496|FG004|Overall Study|Lack of Efficacy|0|||
105528742|NCT02641379|363946497|FG005|Overall Study|Lack of Efficacy|2|||
105528743|NCT02641379|363946498|FG006|Overall Study|Lack of Efficacy|0|||
105528744|NCT02641379|363946499|FG007|Overall Study|Lack of Efficacy|5|||
105528745|NCT02641379|363946500|FG008|Overall Study|Lack of Efficacy|0|||
105528746|NCT02641379|363946501|FG009|Overall Study|Lack of Efficacy|0|||
105528747|NCT02641379|363946502|FG010|Overall Study|Lack of Efficacy|0|||
105528748|NCT02641379|363946492|FG000|Overall Study|Participant unable to attend study visit|4|||
105528749|NCT02641379|363946493|FG001|Overall Study|Participant unable to attend study visit|10|||
105528750|NCT02641379|363946494|FG002|Overall Study|Participant unable to attend study visit|1|||
105528751|NCT02641379|363946495|FG003|Overall Study|Participant unable to attend study visit|2|||
105528752|NCT02641379|363946496|FG004|Overall Study|Participant unable to attend study visit|5|||
105528753|NCT02641379|363946497|FG005|Overall Study|Participant unable to attend study visit|1|||
105528754|NCT02641379|363946498|FG006|Overall Study|Participant unable to attend study visit|1|||
105528755|NCT02641379|363946499|FG007|Overall Study|Participant unable to attend study visit|1|||
105528756|NCT02641379|363946500|FG008|Overall Study|Participant unable to attend study visit|0|||
105528757|NCT02641379|363946501|FG009|Overall Study|Participant unable to attend study visit|2|||
105528758|NCT02641379|363946502|FG010|Overall Study|Participant unable to attend study visit|0|||
105528759|NCT02641379|363946492|FG000|Overall Study|Participant's compliance|0|||
105528760|NCT02641379|363946493|FG001|Overall Study|Participant's compliance|1|||
105528761|NCT02641379|363946494|FG002|Overall Study|Participant's compliance|0|||
105528762|NCT02641379|363946495|FG003|Overall Study|Participant's compliance|1|||
105528763|NCT02641379|363946496|FG004|Overall Study|Participant's compliance|0|||
105528764|NCT02641379|363946497|FG005|Overall Study|Participant's compliance|2|||
105528765|NCT02641379|363946498|FG006|Overall Study|Participant's compliance|0|||
105528766|NCT02641379|363946499|FG007|Overall Study|Participant's compliance|0|||
105528767|NCT02641379|363946500|FG008|Overall Study|Participant's compliance|1|||
105528768|NCT02641379|363946501|FG009|Overall Study|Participant's compliance|1|||
105528769|NCT02641379|363946502|FG010|Overall Study|Participant's compliance|1|||
105528770|NCT02641379|363946492|FG000|Overall Study|Participant cannot be reached|4|||
105528771|NCT02641379|363946493|FG001|Overall Study|Participant cannot be reached|4|||
105528772|NCT02641379|363946494|FG002|Overall Study|Participant cannot be reached|0|||
105528773|NCT02641379|363946495|FG003|Overall Study|Participant cannot be reached|8|||
105528774|NCT02641379|363946496|FG004|Overall Study|Participant cannot be reached|2|||
105528775|NCT02641379|363946497|FG005|Overall Study|Participant cannot be reached|1|||
105528776|NCT02641379|363946498|FG006|Overall Study|Participant cannot be reached|0|||
105528777|NCT02641379|363946499|FG007|Overall Study|Participant cannot be reached|1|||
105528778|NCT02641379|363946500|FG008|Overall Study|Participant cannot be reached|0|||
105528779|NCT02641379|363946501|FG009|Overall Study|Participant cannot be reached|2|||
105528780|NCT02641379|363946502|FG010|Overall Study|Participant cannot be reached|1|||
105528781|NCT02641379|363946492|FG000|Overall Study|PCR positive at Week 24|15|||
105528782|NCT02641379|363946493|FG001|Overall Study|PCR positive at Week 24|21|||
105528783|NCT02641379|363946494|FG002|Overall Study|PCR positive at Week 24|62|||
105528784|NCT02641379|363946495|FG003|Overall Study|PCR positive at Week 24|0|||
105528785|NCT02641379|363946496|FG004|Overall Study|PCR positive at Week 24|0|||
105528786|NCT02641379|363946497|FG005|Overall Study|PCR positive at Week 24|6|||
105528787|NCT02641379|363946498|FG006|Overall Study|PCR positive at Week 24|3|||
105528788|NCT02641379|363946499|FG007|Overall Study|PCR positive at Week 24|8|||
105528789|NCT02641379|363946500|FG008|Overall Study|PCR positive at Week 24|0|||
105528790|NCT02641379|363946501|FG009|Overall Study|PCR positive at Week 24|1|||
105528791|NCT02641379|363946502|FG010|Overall Study|PCR positive at Week 24|0|||
105528792|NCT02641379|363946492|FG000|Overall Study|PCR positive at follow up 2|1|||
105528793|NCT02641379|363946493|FG001|Overall Study|PCR positive at follow up 2|0|||
105528794|NCT02641379|363946494|FG002|Overall Study|PCR positive at follow up 2|0|||
105528795|NCT02641379|363946495|FG003|Overall Study|PCR positive at follow up 2|0|||
105528796|NCT02641379|363946496|FG004|Overall Study|PCR positive at follow up 2|0|||
105528797|NCT02641379|363946497|FG005|Overall Study|PCR positive at follow up 2|0|||
105528798|NCT02641379|363946498|FG006|Overall Study|PCR positive at follow up 2|0|||
105528799|NCT02641379|363946499|FG007|Overall Study|PCR positive at follow up 2|0|||
105528800|NCT02641379|363946500|FG008|Overall Study|PCR positive at follow up 2|0|||
105528801|NCT02641379|363946501|FG009|Overall Study|PCR positive at follow up 2|0|||
105528802|NCT02641379|363946502|FG010|Overall Study|PCR positive at follow up 2|0|||
105528803|NCT02641379|363946492|FG000|Overall Study|Participant showed relapse|1|||
105528804|NCT02641379|363946493|FG001|Overall Study|Participant showed relapse|0|||
105528805|NCT02641379|363946494|FG002|Overall Study|Participant showed relapse|0|||
105528806|NCT02641379|363946495|FG003|Overall Study|Participant showed relapse|0|||
105528807|NCT02641379|363946496|FG004|Overall Study|Participant showed relapse|0|||
105528808|NCT02641379|363946497|FG005|Overall Study|Participant showed relapse|0|||
105528809|NCT02641379|363946498|FG006|Overall Study|Participant showed relapse|1|||
105528810|NCT02641379|363946499|FG007|Overall Study|Participant showed relapse|0|||
105528811|NCT02641379|363946500|FG008|Overall Study|Participant showed relapse|0|||
105528812|NCT02641379|363946501|FG009|Overall Study|Participant showed relapse|0|||
105528813|NCT02641379|363946502|FG010|Overall Study|Participant showed relapse|0|||
105528814|NCT02641379|363946492|FG000|Overall Study|Participant stopped study/treatment|1|||
105528815|NCT02641379|363946493|FG001|Overall Study|Participant stopped study/treatment|3|||
105528816|NCT02641379|363946494|FG002|Overall Study|Participant stopped study/treatment|1|||
105528817|NCT02641379|363946495|FG003|Overall Study|Participant stopped study/treatment|0|||
105528818|NCT02641379|363946496|FG004|Overall Study|Participant stopped study/treatment|0|||
105528819|NCT02641379|363946497|FG005|Overall Study|Participant stopped study/treatment|1|||
105528820|NCT02641379|363946498|FG006|Overall Study|Participant stopped study/treatment|2|||
105528821|NCT02641379|363946499|FG007|Overall Study|Participant stopped study/treatment|0|||
105528822|NCT02641379|363946500|FG008|Overall Study|Participant stopped study/treatment|1|||
105528823|NCT02641379|363946501|FG009|Overall Study|Participant stopped study/treatment|0|||
105528824|NCT02641379|363946502|FG010|Overall Study|Participant stopped study/treatment|0|||
105528825|NCT02641379|363946492|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
105528826|NCT02641379|363946493|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
105528827|NCT02641379|363946494|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
105528828|NCT02641379|363946495|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
105528829|NCT02641379|363946496|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
105528830|NCT02641379|363946497|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
105528831|NCT02641379|363946498|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
105528832|NCT02641379|363946499|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
105528833|NCT02641379|363946500|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
105528834|NCT02641379|363946501|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
105528835|NCT02641379|363946502|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
105528836|NCT02641379|363946492|FG000|Overall Study|Financial problems|0|||
105528837|NCT02641379|363946493|FG001|Overall Study|Financial problems|1|||
105528838|NCT02641379|363946494|FG002|Overall Study|Financial problems|0|||
105528839|NCT02641379|363946495|FG003|Overall Study|Financial problems|0|||
105528840|NCT02641379|363946496|FG004|Overall Study|Financial problems|0|||
105528841|NCT02641379|363946497|FG005|Overall Study|Financial problems|0|||
105528842|NCT02641379|363946498|FG006|Overall Study|Financial problems|0|||
105528843|NCT02641379|363946499|FG007|Overall Study|Financial problems|0|||
105528844|NCT02641379|363946500|FG008|Overall Study|Financial problems|0|||
105528845|NCT02641379|363946501|FG009|Overall Study|Financial problems|0|||
105528846|NCT02641379|363946502|FG010|Overall Study|Financial problems|0|||
105528847|NCT02641379|363946492|FG000|Overall Study|PCR positive at Week 68|0|||
105528848|NCT02641379|363946493|FG001|Overall Study|PCR positive at Week 68|1|||
105528849|NCT02641379|363946494|FG002|Overall Study|PCR positive at Week 68|0|||
105528850|NCT02641379|363946495|FG003|Overall Study|PCR positive at Week 68|0|||
105528851|NCT02641379|363946496|FG004|Overall Study|PCR positive at Week 68|0|||
105528852|NCT02641379|363946497|FG005|Overall Study|PCR positive at Week 68|0|||
105528853|NCT02641379|363946498|FG006|Overall Study|PCR positive at Week 68|0|||
105528854|NCT02641379|363946499|FG007|Overall Study|PCR positive at Week 68|0|||
105528855|NCT02641379|363946500|FG008|Overall Study|PCR positive at Week 68|0|||
105528856|NCT02641379|363946501|FG009|Overall Study|PCR positive at Week 68|0|||
105528857|NCT02641379|363946502|FG010|Overall Study|PCR positive at Week 68|0|||
105528858|NCT02641379|363946492|FG000|Overall Study|PCR positive at Week 48|0|||
105528859|NCT02641379|363946493|FG001|Overall Study|PCR positive at Week 48|1|||
105528860|NCT02641379|363946494|FG002|Overall Study|PCR positive at Week 48|0|||
105528861|NCT02641379|363946495|FG003|Overall Study|PCR positive at Week 48|0|||
105528862|NCT02641379|363946496|FG004|Overall Study|PCR positive at Week 48|0|||
105528863|NCT02641379|363946497|FG005|Overall Study|PCR positive at Week 48|0|||
105528864|NCT02641379|363946498|FG006|Overall Study|PCR positive at Week 48|0|||
105528865|NCT02641379|363946499|FG007|Overall Study|PCR positive at Week 48|0|||
105528866|NCT02641379|363946500|FG008|Overall Study|PCR positive at Week 48|0|||
105528867|NCT02641379|363946501|FG009|Overall Study|PCR positive at Week 48|0|||
105528868|NCT02641379|363946502|FG010|Overall Study|PCR positive at Week 48|0|||
105528869|NCT02641379|363946492|FG000|Overall Study|PCR not performed at Week 12|0|||
105528870|NCT02641379|363946493|FG001|Overall Study|PCR not performed at Week 12|0|||
105528871|NCT02641379|363946494|FG002|Overall Study|PCR not performed at Week 12|1|||
105528872|NCT02641379|363946495|FG003|Overall Study|PCR not performed at Week 12|0|||
105528873|NCT02641379|363946496|FG004|Overall Study|PCR not performed at Week 12|0|||
105528874|NCT02641379|363946497|FG005|Overall Study|PCR not performed at Week 12|0|||
105528875|NCT02641379|363946498|FG006|Overall Study|PCR not performed at Week 12|0|||
105528876|NCT02641379|363946499|FG007|Overall Study|PCR not performed at Week 12|0|||
105528877|NCT02641379|363946500|FG008|Overall Study|PCR not performed at Week 12|0|||
105528878|NCT02641379|363946501|FG009|Overall Study|PCR not performed at Week 12|0|||
105528879|NCT02641379|363946502|FG010|Overall Study|PCR not performed at Week 12|0|||
105528880|NCT02641379|363946492|FG000|Overall Study|No PCR at baseline|0|||
105528881|NCT02641379|363946493|FG001|Overall Study|No PCR at baseline|0|||
105528882|NCT02641379|363946494|FG002|Overall Study|No PCR at baseline|1|||
105528883|NCT02641379|363946495|FG003|Overall Study|No PCR at baseline|0|||
105528884|NCT02641379|363946496|FG004|Overall Study|No PCR at baseline|0|||
105528885|NCT02641379|363946497|FG005|Overall Study|No PCR at baseline|0|||
105528886|NCT02641379|363946498|FG006|Overall Study|No PCR at baseline|0|||
105528887|NCT02641379|363946499|FG007|Overall Study|No PCR at baseline|0|||
105528888|NCT02641379|363946500|FG008|Overall Study|No PCR at baseline|0|||
105528889|NCT02641379|363946501|FG009|Overall Study|No PCR at baseline|0|||
105528890|NCT02641379|363946502|FG010|Overall Study|No PCR at baseline|0|||
105528891|NCT02641379|363946492|FG000|Overall Study|PCR positive at Week 28|0|||
105528892|NCT02641379|363946493|FG001|Overall Study|PCR positive at Week 28|0|||
105528893|NCT02641379|363946494|FG002|Overall Study|PCR positive at Week 28|1|||
105528894|NCT02641379|363946495|FG003|Overall Study|PCR positive at Week 28|0|||
105528895|NCT02641379|363946496|FG004|Overall Study|PCR positive at Week 28|0|||
105528896|NCT02641379|363946497|FG005|Overall Study|PCR positive at Week 28|0|||
105528897|NCT02641379|363946498|FG006|Overall Study|PCR positive at Week 28|0|||
105528898|NCT02641379|363946499|FG007|Overall Study|PCR positive at Week 28|0|||
105528899|NCT02641379|363946500|FG008|Overall Study|PCR positive at Week 28|0|||
105528900|NCT02641379|363946501|FG009|Overall Study|PCR positive at Week 28|0|||
105528901|NCT02641379|363946502|FG010|Overall Study|PCR positive at Week 28|0|||
105528902|NCT02641379|363946492|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
105528903|NCT02641379|363946493|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
105528904|NCT02641379|363946494|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
105528905|NCT02641379|363946495|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
105528906|NCT02641379|363946496|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
105528907|NCT02641379|363946497|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
105528908|NCT02641379|363946498|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
105528909|NCT02641379|363946499|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
105528910|NCT02641379|363946500|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
105528911|NCT02641379|363946501|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
105528912|NCT02641379|363946502|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
105528913|NCT02641379|363946492|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
105528914|NCT02641379|363946493|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
105528915|NCT02641379|363946494|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
105528916|NCT02641379|363946495|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
105528917|NCT02641379|363946496|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
105528918|NCT02641379|363946497|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
105528919|NCT02641379|363946498|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
105528920|NCT02641379|363946499|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
105528921|NCT02641379|363946500|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
105528922|NCT02641379|363946501|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
105528923|NCT02641379|363946502|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
105528924|NCT02641379|363946492|FG000|Overall Study|Baseline viral load unavailable|0|||
105528925|NCT02641379|363946493|FG001|Overall Study|Baseline viral load unavailable|0|||
105528926|NCT02641379|363946494|FG002|Overall Study|Baseline viral load unavailable|0|||
105528927|NCT02641379|363946495|FG003|Overall Study|Baseline viral load unavailable|1|||
105528928|NCT02641379|363946496|FG004|Overall Study|Baseline viral load unavailable|0|||
105528929|NCT02641379|363946497|FG005|Overall Study|Baseline viral load unavailable|0|||
105528930|NCT02641379|363946498|FG006|Overall Study|Baseline viral load unavailable|0|||
105528931|NCT02641379|363946499|FG007|Overall Study|Baseline viral load unavailable|0|||
105528932|NCT02641379|363946500|FG008|Overall Study|Baseline viral load unavailable|0|||
105528933|NCT02641379|363946501|FG009|Overall Study|Baseline viral load unavailable|0|||
105528934|NCT02641379|363946502|FG010|Overall Study|Baseline viral load unavailable|0|||
105528935|NCT02641379|363946492|FG000|Overall Study|Blood could not be drawn|0|||
105528936|NCT02641379|363946493|FG001|Overall Study|Blood could not be drawn|0|||
105528937|NCT02641379|363946494|FG002|Overall Study|Blood could not be drawn|0|||
105528938|NCT02641379|363946495|FG003|Overall Study|Blood could not be drawn|0|||
105528939|NCT02641379|363946496|FG004|Overall Study|Blood could not be drawn|1|||
105528940|NCT02641379|363946497|FG005|Overall Study|Blood could not be drawn|0|||
105528941|NCT02641379|363946498|FG006|Overall Study|Blood could not be drawn|0|||
105528942|NCT02641379|363946499|FG007|Overall Study|Blood could not be drawn|0|||
105528943|NCT02641379|363946500|FG008|Overall Study|Blood could not be drawn|0|||
105528944|NCT02641379|363946501|FG009|Overall Study|Blood could not be drawn|0|||
105528945|NCT02641379|363946502|FG010|Overall Study|Blood could not be drawn|0|||
105528946|NCT02641379|363946492|FG000|Overall Study|Protocol Violation|0|||
105528947|NCT02641379|363946493|FG001|Overall Study|Protocol Violation|0|||
105528948|NCT02641379|363946494|FG002|Overall Study|Protocol Violation|0|||
105528949|NCT02641379|363946495|FG003|Overall Study|Protocol Violation|0|||
105528950|NCT02641379|363946496|FG004|Overall Study|Protocol Violation|2|||
105528951|NCT02641379|363946497|FG005|Overall Study|Protocol Violation|0|||
105528952|NCT02641379|363946498|FG006|Overall Study|Protocol Violation|0|||
105528953|NCT02641379|363946499|FG007|Overall Study|Protocol Violation|0|||
105528954|NCT02641379|363946500|FG008|Overall Study|Protocol Violation|1|||
105528955|NCT02641379|363946501|FG009|Overall Study|Protocol Violation|0|||
105528956|NCT02641379|363946502|FG010|Overall Study|Protocol Violation|0|||
105528957|NCT02641379|363946492|FG000|Overall Study|Participation in sili rescue study|0|||
105528958|NCT02641379|363946493|FG001|Overall Study|Participation in sili rescue study|0|||
105528959|NCT02641379|363946494|FG002|Overall Study|Participation in sili rescue study|0|||
105528960|NCT02641379|363946495|FG003|Overall Study|Participation in sili rescue study|0|||
105528961|NCT02641379|363946496|FG004|Overall Study|Participation in sili rescue study|0|||
105528962|NCT02641379|363946497|FG005|Overall Study|Participation in sili rescue study|1|||
105528963|NCT02641379|363946498|FG006|Overall Study|Participation in sili rescue study|0|||
105528964|NCT02641379|363946499|FG007|Overall Study|Participation in sili rescue study|0|||
105528965|NCT02641379|363946500|FG008|Overall Study|Participation in sili rescue study|0|||
105528966|NCT02641379|363946501|FG009|Overall Study|Participation in sili rescue study|0|||
105528967|NCT02641379|363946502|FG010|Overall Study|Participation in sili rescue study|0|||
105528968|NCT02641379|363946492|FG000|Overall Study|Lost to Follow-up|0|||
105528969|NCT02641379|363946493|FG001|Overall Study|Lost to Follow-up|0|||
105528970|NCT02641379|363946494|FG002|Overall Study|Lost to Follow-up|0|||
105528971|NCT02641379|363946495|FG003|Overall Study|Lost to Follow-up|0|||
105528972|NCT02641379|363946496|FG004|Overall Study|Lost to Follow-up|0|||
105528973|NCT02641379|363946497|FG005|Overall Study|Lost to Follow-up|0|||
105528974|NCT02641379|363946498|FG006|Overall Study|Lost to Follow-up|0|||
105528975|NCT02641379|363946499|FG007|Overall Study|Lost to Follow-up|0|||
105528976|NCT02641379|363946500|FG008|Overall Study|Lost to Follow-up|1|||
105528977|NCT02641379|363946501|FG009|Overall Study|Lost to Follow-up|0|||
105528978|NCT02641379|363946502|FG010|Overall Study|Lost to Follow-up|0|||
105528979|NCT02641379|363946492|FG000|Overall Study|Source data not found|0|||
105528980|NCT02641379|363946493|FG001|Overall Study|Source data not found|0|||
105528981|NCT02641379|363946494|FG002|Overall Study|Source data not found|0|||
105528982|NCT02641379|363946495|FG003|Overall Study|Source data not found|0|||
105528983|NCT02641379|363946496|FG004|Overall Study|Source data not found|0|||
105593681|NCT02914522|364172791|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
105593682|NCT02914522|364172792|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
105593683|NCT02914522|364172793|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
105593684|NCT02914522|364172794|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
105593685|NCT02914522|364172795|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
105593686|NCT02914522|364172796|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
105593687|NCT02914522|364172797|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
105593688|NCT02914522|364172798|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
105593689|NCT02914522|364172799|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
105593690|NCT02914522|364172800|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
105593691|NCT02914522|364172790|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
105593692|NCT02914522|364172791|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
105593693|NCT02914522|364172792|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
105593694|NCT02914522|364172793|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
105593695|NCT02914522|364172794|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
105593696|NCT02914522|364172795|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
105593697|NCT02914522|364172796|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
105593698|NCT02914522|364172797|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
105593699|NCT02914522|364172798|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
105593700|NCT02914522|364172799|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
105593701|NCT02914522|364172800|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
105593702|NCT02914522|364172790|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
105593703|NCT02914522|364172791|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
105593704|NCT02914522|364172792|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
105593705|NCT02914522|364172793|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
105593706|NCT02914522|364172794|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
105593707|NCT02914522|364172795|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
105593708|NCT02914522|364172796|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
105593709|NCT02914522|364172797|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
105593710|NCT02914522|364172798|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
105593711|NCT02914522|364172799|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
105593712|NCT02914522|364172800|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
105593713|NCT02914522|364172790|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
105593714|NCT02914522|364172791|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
105593715|NCT02914522|364172792|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
105593716|NCT02914522|364172793|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
105593717|NCT02914522|364172794|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
105593718|NCT02914522|364172795|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
105593719|NCT02914522|364172796|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
105528984|NCT02641379|363946497|FG005|Overall Study|Source data not found|1|||
105528985|NCT02641379|363946498|FG006|Overall Study|Source data not found|0|||
105528986|NCT02641379|363946499|FG007|Overall Study|Source data not found|0|||
105528987|NCT02641379|363946500|FG008|Overall Study|Source data not found|0|||
105528988|NCT02641379|363946501|FG009|Overall Study|Source data not found|0|||
105528989|NCT02641379|363946502|FG010|Overall Study|Source data not found|0|||
105528990|NCT02641379|363946492|FG000|Overall Study|Participant showed weight reduction|0|||
105528991|NCT02641379|363946493|FG001|Overall Study|Participant showed weight reduction|0|||
105528992|NCT02641379|363946494|FG002|Overall Study|Participant showed weight reduction|0|||
105528993|NCT02641379|363946495|FG003|Overall Study|Participant showed weight reduction|0|||
105528994|NCT02641379|363946496|FG004|Overall Study|Participant showed weight reduction|0|||
105528995|NCT02641379|363946497|FG005|Overall Study|Participant showed weight reduction|0|||
105528996|NCT02641379|363946498|FG006|Overall Study|Participant showed weight reduction|0|||
105528997|NCT02641379|363946499|FG007|Overall Study|Participant showed weight reduction|1|||
105528998|NCT02641379|363946500|FG008|Overall Study|Participant showed weight reduction|0|||
105528999|NCT02641379|363946501|FG009|Overall Study|Participant showed weight reduction|0|||
105529000|NCT02641379|363946502|FG010|Overall Study|Participant showed weight reduction|0|||
105529001|NCT02641379|363946492|FG000|Overall Study|Non-response Week 12|0|||
105529002|NCT02641379|363946493|FG001|Overall Study|Non-response Week 12|0|||
105529003|NCT02641379|363946494|FG002|Overall Study|Non-response Week 12|0|||
105529004|NCT02641379|363946495|FG003|Overall Study|Non-response Week 12|0|||
105529005|NCT02641379|363946496|FG004|Overall Study|Non-response Week 12|0|||
105529006|NCT02641379|363946497|FG005|Overall Study|Non-response Week 12|0|||
105529007|NCT02641379|363946498|FG006|Overall Study|Non-response Week 12|0|||
105529008|NCT02641379|363946499|FG007|Overall Study|Non-response Week 12|1|||
105529009|NCT02641379|363946500|FG008|Overall Study|Non-response Week 12|0|||
105529010|NCT02641379|363946501|FG009|Overall Study|Non-response Week 12|0|||
105529011|NCT02641379|363946502|FG010|Overall Study|Non-response Week 12|0|||
105593720|NCT02914522|364172797|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
105593721|NCT02914522|364172798|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
105593722|NCT02914522|364172799|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
105529012|NCT02641379|363946492|FG000|Overall Study|No 2 Log drop at Week 12|0|||
105529013|NCT02641379|363946493|FG001|Overall Study|No 2 Log drop at Week 12|0|||
105529014|NCT02641379|363946494|FG002|Overall Study|No 2 Log drop at Week 12|0|||
105529015|NCT02641379|363946495|FG003|Overall Study|No 2 Log drop at Week 12|0|||
105529016|NCT02641379|363946496|FG004|Overall Study|No 2 Log drop at Week 12|0|||
105529017|NCT02641379|363946497|FG005|Overall Study|No 2 Log drop at Week 12|0|||
105529018|NCT02641379|363946498|FG006|Overall Study|No 2 Log drop at Week 12|0|||
105529019|NCT02641379|363946499|FG007|Overall Study|No 2 Log drop at Week 12|0|||
105529020|NCT02641379|363946500|FG008|Overall Study|No 2 Log drop at Week 12|0|||
105529021|NCT02641379|363946501|FG009|Overall Study|No 2 Log drop at Week 12|0|||
105529022|NCT02641379|363946502|FG010|Overall Study|No 2 Log drop at Week 12|1|||
105529023|NCT02641379|363946492|FG000|Overall Study|Negative PCR result|0|||
105529024|NCT02641379|363946493|FG001|Overall Study|Negative PCR result|0|||
105529025|NCT02641379|363946494|FG002|Overall Study|Negative PCR result|0|||
105529026|NCT02641379|363946495|FG003|Overall Study|Negative PCR result|0|||
105529027|NCT02641379|363946496|FG004|Overall Study|Negative PCR result|0|||
105529028|NCT02641379|363946497|FG005|Overall Study|Negative PCR result|0|||
105529029|NCT02641379|363946498|FG006|Overall Study|Negative PCR result|0|||
105529030|NCT02641379|363946499|FG007|Overall Study|Negative PCR result|0|||
105529031|NCT02641379|363946500|FG008|Overall Study|Negative PCR result|0|||
105529032|NCT02641379|363946501|FG009|Overall Study|Negative PCR result|1|||
105529033|NCT02641379|363946502|FG010|Overall Study|Negative PCR result|0|||
105529034|NCT02641379|363946492|FG000|Overall Study|Participant's PCR high|0|||
105529035|NCT02641379|363946493|FG001|Overall Study|Participant's PCR high|0|||
105529036|NCT02641379|363946494|FG002|Overall Study|Participant's PCR high|0|||
105529037|NCT02641379|363946495|FG003|Overall Study|Participant's PCR high|0|||
105529038|NCT02641379|363946496|FG004|Overall Study|Participant's PCR high|0|||
105529039|NCT02641379|363946497|FG005|Overall Study|Participant's PCR high|0|||
105529040|NCT02641379|363946498|FG006|Overall Study|Participant's PCR high|0|||
105529041|NCT02641379|363946499|FG007|Overall Study|Participant's PCR high|1|||
105529042|NCT02641379|363946500|FG008|Overall Study|Participant's PCR high|0|||
105529043|NCT02641379|363946501|FG009|Overall Study|Participant's PCR high|0|||
105529044|NCT02641379|363946502|FG010|Overall Study|Participant's PCR high|0|||
105439784|NCT00211887|363615063|FG002|Overall Study|Other medical reason|7|||
105439785|NCT00211887|363615061|FG000|Overall Study|Side effects|19|||
105439786|NCT00211887|363615062|FG001|Overall Study|Side effects|13|||
105439787|NCT00211887|363615063|FG002|Overall Study|Side effects|5|||
105439788|NCT02353728|363615068|FG000|Overall Study|Subject non-compliance|1|||
105439789|NCT00659230|363615069|FG000|Overall Study|Lost to Follow-up|2|||
105439790|NCT00659230|363615070|FG001|Overall Study|Lost to Follow-up|5|||
105439791|NCT00659230|363615069|FG000|Overall Study|Lost source documentation|5|||
105439792|NCT00659230|363615070|FG001|Overall Study|Lost source documentation|4|||
105439793|NCT00659230|363615069|FG000|Overall Study|Did not return post-randomization|2|||
105439794|NCT00659230|363615070|FG001|Overall Study|Did not return post-randomization|3|||
105439795|NCT02147288|363615071|FG000|Overall Study|post-operative hematoma|1|||
105439796|NCT02147288|363615072|FG001|Overall Study|post-operative hematoma|1|||
105439797|NCT02147288|363615073|FG002|Overall Study|post-operative hematoma|0|||
105439798|NCT02147288|363615074|FG003|Overall Study|post-operative hematoma|0|||
105439799|NCT02147288|363615075|FG004|Overall Study|post-operative hematoma|0|||
105439800|NCT02147288|363615076|FG005|Overall Study|post-operative hematoma|0|||
105439801|NCT02147288|363615077|FG006|Overall Study|post-operative hematoma|0|||
105439802|NCT02147288|363615078|FG007|Overall Study|post-operative hematoma|0|||
105439803|NCT02147288|363615079|FG008|Overall Study|post-operative hematoma|0|||
105529045|NCT02641379|363946492|FG000|Overall Study|Participant treated after Week 24|0|||
105529046|NCT02641379|363946493|FG001|Overall Study|Participant treated after Week 24|0|||
105529047|NCT02641379|363946494|FG002|Overall Study|Participant treated after Week 24|0|||
105529048|NCT02641379|363946495|FG003|Overall Study|Participant treated after Week 24|0|||
105529049|NCT02641379|363946496|FG004|Overall Study|Participant treated after Week 24|0|||
105529050|NCT02641379|363946497|FG005|Overall Study|Participant treated after Week 24|0|||
105529051|NCT02641379|363946498|FG006|Overall Study|Participant treated after Week 24|0|||
105529052|NCT02641379|363946499|FG007|Overall Study|Participant treated after Week 24|0|||
105529053|NCT02641379|363946500|FG008|Overall Study|Participant treated after Week 24|1|||
105529054|NCT02641379|363946501|FG009|Overall Study|Participant treated after Week 24|0|||
105529055|NCT02641379|363946502|FG010|Overall Study|Participant treated after Week 24|0|||
105529056|NCT02641379|363946492|FG000|Overall Study|Missing PCR result at Week 8|0|||
105529057|NCT02641379|363946493|FG001|Overall Study|Missing PCR result at Week 8|0|||
105529058|NCT02641379|363946494|FG002|Overall Study|Missing PCR result at Week 8|0|||
105529059|NCT02641379|363946495|FG003|Overall Study|Missing PCR result at Week 8|0|||
105529060|NCT02641379|363946496|FG004|Overall Study|Missing PCR result at Week 8|0|||
105529061|NCT02641379|363946497|FG005|Overall Study|Missing PCR result at Week 8|0|||
105529062|NCT02641379|363946498|FG006|Overall Study|Missing PCR result at Week 8|0|||
105529063|NCT02641379|363946499|FG007|Overall Study|Missing PCR result at Week 8|0|||
105529064|NCT02641379|363946500|FG008|Overall Study|Missing PCR result at Week 8|0|||
105529065|NCT02641379|363946501|FG009|Overall Study|Missing PCR result at Week 8|1|||
105529066|NCT02641379|363946502|FG010|Overall Study|Missing PCR result at Week 8|0|||
105529067|NCT02641379|363946492|FG000|Overall Study|PCR positive|0|||
105529068|NCT02641379|363946493|FG001|Overall Study|PCR positive|0|||
105529069|NCT02641379|363946494|FG002|Overall Study|PCR positive|0|||
105529070|NCT02641379|363946495|FG003|Overall Study|PCR positive|0|||
105529071|NCT02641379|363946496|FG004|Overall Study|PCR positive|0|||
105529072|NCT02641379|363946497|FG005|Overall Study|PCR positive|0|||
105529073|NCT02641379|363946498|FG006|Overall Study|PCR positive|1|||
105529074|NCT02641379|363946499|FG007|Overall Study|PCR positive|0|||
105529075|NCT02641379|363946500|FG008|Overall Study|PCR positive|0|||
105529076|NCT02641379|363946501|FG009|Overall Study|PCR positive|0|||
105529077|NCT02641379|363946502|FG010|Overall Study|PCR positive|0|||
105529078|NCT00291668|363946503|FG000|Overall Study|Lack of Efficacy|1|||
105529079|NCT00291668|363946504|FG001|Overall Study|Lack of Efficacy|0|||
105529080|NCT00291668|363946505|FG002|Overall Study|Lack of Efficacy|0|||
105529081|NCT00291668|363946503|FG000|Overall Study|SAE, non-fatal|1|||
105529082|NCT00291668|363946504|FG001|Overall Study|SAE, non-fatal|1|||
105529083|NCT00291668|363946505|FG002|Overall Study|SAE, non-fatal|1|||
105529084|NCT00291668|363946503|FG000|Overall Study|AE, non-serious non-fatal|1|||
105529085|NCT00291668|363946504|FG001|Overall Study|AE, non-serious non-fatal|0|||
105529086|NCT00291668|363946505|FG002|Overall Study|AE, non-serious non-fatal|0|||
105529087|NCT00291668|363946503|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
105529088|NCT00291668|363946504|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
105529089|NCT00291668|363946505|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
105529090|NCT00313612|363946506|FG000|Overall Study|Patient never received treatment|0|||
105529091|NCT00313612|363946507|FG001|Overall Study|Patient never received treatment|1|||
105529092|NCT02281552|363946510|FG000|Overall Study|Medication error|1|||
105529093|NCT02281552|363946511|FG001|Overall Study|Medication error|0|||
105529094|NCT02281552|363946510|FG000|Overall Study|Insufficient clinical response|0|||
105529095|NCT02281552|363946511|FG001|Overall Study|Insufficient clinical response|1|||
105529096|NCT02281552|363946510|FG000|Overall Study|Adverse Event|3|||
105529097|NCT02281552|363946511|FG001|Overall Study|Adverse Event|9|||
105529098|NCT00615056|363946512|FG000|Overall Study|Death|31|||
105529099|NCT00615056|363946513|FG001|Overall Study|Death|31|||
105529100|NCT00615056|363946514|FG002|Overall Study|Death|21|||
105529101|NCT00615056|363946515|FG003|Overall Study|Death|23|||
105529102|NCT00615056|363946512|FG000|Overall Study|Lost to Follow-up|1|||
105529103|NCT00615056|363946513|FG001|Overall Study|Lost to Follow-up|2|||
105529104|NCT00615056|363946514|FG002|Overall Study|Lost to Follow-up|4|||
105529105|NCT00615056|363946515|FG003|Overall Study|Lost to Follow-up|5|||
105529106|NCT00615056|363946512|FG000|Overall Study|Other|13|||
105529107|NCT00615056|363946513|FG001|Overall Study|Other|15|||
105529108|NCT00615056|363946514|FG002|Overall Study|Other|10|||
105529109|NCT00615056|363946515|FG003|Overall Study|Other|7|||
105529110|NCT00615056|363946512|FG000|Overall Study|Objective progression or relapse|0|||
105529111|NCT00615056|363946513|FG001|Overall Study|Objective progression or relapse|2|||
105529112|NCT00615056|363946514|FG002|Overall Study|Objective progression or relapse|0|||
105529113|NCT00615056|363946515|FG003|Overall Study|Objective progression or relapse|0|||
105529114|NCT00615056|363946512|FG000|Overall Study|Withdrawal by Subject|0|||
105529115|NCT00615056|363946513|FG001|Overall Study|Withdrawal by Subject|1|||
105529116|NCT00615056|363946514|FG002|Overall Study|Withdrawal by Subject|1|||
105529117|NCT00615056|363946515|FG003|Overall Study|Withdrawal by Subject|0|||
105529118|NCT00615056|363946512|FG000|Overall Study|Discontinued by Sponsor|1|||
105529119|NCT00615056|363946513|FG001|Overall Study|Discontinued by Sponsor|0|||
105529120|NCT00615056|363946514|FG002|Overall Study|Discontinued by Sponsor|0|||
105529121|NCT00615056|363946515|FG003|Overall Study|Discontinued by Sponsor|0|||
105529122|NCT00615056|363946512|FG000|Overall Study|Randomized but not treated|3|||
105529123|NCT00615056|363946513|FG001|Overall Study|Randomized but not treated|0|||
105529124|NCT00615056|363946514|FG002|Overall Study|Randomized but not treated|0|||
105529125|NCT00615056|363946515|FG003|Overall Study|Randomized but not treated|0|||
105529126|NCT00717769|363946516|FG000|Overall Study|Adverse Event|9|||
105529127|NCT00717769|363946517|FG001|Overall Study|Adverse Event|6|||
105529128|NCT00717769|363946518|FG002|Overall Study|Adverse Event|1|||
105529129|NCT00717769|363946516|FG000|Overall Study|Lack of compliance|0|||
105529130|NCT00717769|363946517|FG001|Overall Study|Lack of compliance|2|||
105529131|NCT00717769|363946518|FG002|Overall Study|Lack of compliance|0|||
105529132|NCT00717769|363946516|FG000|Overall Study|Lost to Follow-up|3|||
105529133|NCT00717769|363946517|FG001|Overall Study|Lost to Follow-up|4|||
105529134|NCT00717769|363946518|FG002|Overall Study|Lost to Follow-up|0|||
105529135|NCT00717769|363946516|FG000|Overall Study|Lack of Efficacy|1|||
105529136|NCT00717769|363946517|FG001|Overall Study|Lack of Efficacy|2|||
105529137|NCT00717769|363946518|FG002|Overall Study|Lack of Efficacy|0|||
105529138|NCT00717769|363946516|FG000|Overall Study|Protocol Violation|0|||
105529139|NCT00717769|363946517|FG001|Overall Study|Protocol Violation|2|||
105529140|NCT00717769|363946518|FG002|Overall Study|Protocol Violation|0|||
105529141|NCT00717769|363946516|FG000|Overall Study|Sponsor decision|1|||
105529142|NCT00717769|363946517|FG001|Overall Study|Sponsor decision|0|||
105529143|NCT00717769|363946518|FG002|Overall Study|Sponsor decision|10|||
105529144|NCT00717769|363946516|FG000|Overall Study|Withdrew consent|2|||
105529145|NCT00717769|363946517|FG001|Overall Study|Withdrew consent|2|||
105529146|NCT00717769|363946518|FG002|Overall Study|Withdrew consent|0|||
105593723|NCT02914522|364172800|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
105593724|NCT02914522|364172790|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
105593725|NCT02914522|364172791|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
105593726|NCT02914522|364172792|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
105593727|NCT02914522|364172793|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
105593728|NCT02914522|364172794|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
105593729|NCT02914522|364172795|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
105593730|NCT02914522|364172796|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
105593731|NCT02914522|364172797|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
105593732|NCT02914522|364172798|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
105593733|NCT02914522|364172799|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
105593734|NCT02914522|364172800|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
105593735|NCT02914522|364172790|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
105593736|NCT02914522|364172791|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
105593737|NCT02914522|364172792|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
105593738|NCT02914522|364172793|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
105593739|NCT02914522|364172794|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
105593740|NCT02914522|364172795|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
105593741|NCT02914522|364172796|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
105593742|NCT02914522|364172797|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
105593743|NCT02914522|364172798|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
105593744|NCT02914522|364172799|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
105593745|NCT02914522|364172800|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
105593746|NCT02914522|364172790|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
105593747|NCT02914522|364172791|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
105593748|NCT02914522|364172792|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
105593749|NCT02914522|364172793|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
105593750|NCT02914522|364172794|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
105593751|NCT02914522|364172795|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
105593752|NCT02914522|364172796|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
105593753|NCT02914522|364172797|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
105593754|NCT02914522|364172798|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
105593755|NCT02914522|364172799|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
105593756|NCT02914522|364172800|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
105593757|NCT02914522|364172790|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
105593758|NCT02914522|364172791|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
105593759|NCT02914522|364172792|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
105593760|NCT02914522|364172793|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
105593761|NCT02914522|364172794|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
105593762|NCT02914522|364172795|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
105593763|NCT02914522|364172796|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
105593764|NCT02914522|364172797|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
105593765|NCT02914522|364172798|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
105593766|NCT02914522|364172799|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
105593767|NCT02914522|364172800|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
105593768|NCT02914522|364172790|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
105593769|NCT02914522|364172791|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
105593770|NCT02914522|364172792|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
105593771|NCT02914522|364172793|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
105593772|NCT02914522|364172794|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
105593773|NCT02914522|364172795|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
105593774|NCT02914522|364172796|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
105593775|NCT02914522|364172797|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
105593776|NCT02914522|364172798|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
105593777|NCT02914522|364172799|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
105593778|NCT02914522|364172800|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
105593779|NCT02914522|364172790|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
105593780|NCT02914522|364172791|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
105593781|NCT02914522|364172792|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
105593782|NCT02914522|364172793|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
105593783|NCT02914522|364172794|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
105593784|NCT02914522|364172795|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
105593785|NCT02914522|364172796|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
105593786|NCT02914522|364172797|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
105529147|NCT02196324|363946520|FG000|Overall Study|Withdrawal by Subject|8|||
105529148|NCT02196324|363946521|FG001|Overall Study|Withdrawal by Subject|4|||
105529149|NCT02196324|363946520|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
105529150|NCT02196324|363946521|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
105529151|NCT02196324|363946520|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
105529152|NCT02196324|363946521|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
105529153|NCT02196324|363946520|FG000|Overall Study|Other|1|||
105529154|NCT02196324|363946521|FG001|Overall Study|Other|0|||
105529155|NCT00692770|363946524|FG000|Overall Study|Protocol Violation|2|||
105529156|NCT00692770|363946525|FG001|Overall Study|Protocol Violation|7|||
105529157|NCT00692770|363946524|FG000|Overall Study|Withdrawal by Subject|97|||
105529158|NCT00692770|363946525|FG001|Overall Study|Withdrawal by Subject|36|||
105529159|NCT00692770|363946524|FG000|Overall Study|Adverse Event|136|||
105529160|NCT00692770|363946525|FG001|Overall Study|Adverse Event|41|||
105529161|NCT00692770|363946524|FG000|Overall Study|Death|10|||
105529162|NCT00692770|363946525|FG001|Overall Study|Death|5|||
105529163|NCT00692770|363946524|FG000|Overall Study|Lost to Follow-up|7|||
105529164|NCT00692770|363946525|FG001|Overall Study|Lost to Follow-up|3|||
105529165|NCT00692770|363946524|FG000|Overall Study|Non-compliant with study medication|11|||
105529166|NCT00692770|363946525|FG001|Overall Study|Non-compliant with study medication|5|||
105529167|NCT00692770|363946524|FG000|Overall Study|Progression by clinical judgment|2|||
105529168|NCT00692770|363946525|FG001|Overall Study|Progression by clinical judgment|3|||
105529169|NCT00692770|363946524|FG000|Overall Study|Physician decision not protocol driven|10|||
105529170|NCT00692770|363946525|FG001|Overall Study|Physician decision not protocol driven|14|||
105529171|NCT00692770|363946524|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
105529172|NCT00692770|363946525|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
105529173|NCT00692770|363946524|FG000|Overall Study|Protocol driven decision point|3|||
105529174|NCT00692770|363946525|FG001|Overall Study|Protocol driven decision point|7|||
105529175|NCT00692770|363946524|FG000|Overall Study|Completed all planned assessments|79|||
105529176|NCT00692770|363946525|FG001|Overall Study|Completed all planned assessments|101|||
105529177|NCT00692770|363946524|FG000|Overall Study|Radiological and clinical progression|8|||
105529178|NCT00692770|363946525|FG001|Overall Study|Radiological and clinical progression|8|||
105529179|NCT00692770|363946524|FG000|Overall Study|Clinical endpoint reached|16|||
105529180|NCT00692770|363946525|FG001|Overall Study|Clinical endpoint reached|43|||
105529181|NCT00692770|363946524|FG000|Overall Study|Study terminated by sponsor|2|||
105529182|NCT00692770|363946525|FG001|Overall Study|Study terminated by sponsor|2|||
105529183|NCT00692770|363946524|FG000|Overall Study|Randomized but not treated|3|||
105529184|NCT00692770|363946525|FG001|Overall Study|Randomized but not treated|4|||
105529185|NCT04248816|363946527|FG000|Overall Study|Ineligible post-randomization|7|||
105529186|NCT04248816|363946528|FG001|Overall Study|Ineligible post-randomization|21|||
105529187|NCT04248816|363946529|FG002|Overall Study|Ineligible post-randomization|25|||
105529188|NCT03350503|363946530|FG000|Overall Study|Adverse Event|5|||
105529189|NCT03350503|363946530|FG000|Overall Study|Withdrawal by Subject|5|||
105529190|NCT03350503|363946530|FG000|Overall Study|Continuation impossible due to move|4|||
105529191|NCT03350503|363946530|FG000|Overall Study|Physician Decision|3|||
105529192|NCT00655564|363946538|FG000|Overall Study|Adverse Event|1|||
105529193|NCT00655564|363946538|FG000|Overall Study|Lost to Follow-up|1|||
105529194|NCT00655564|363946538|FG000|Overall Study|Desired Alternate Therapy|1|||
105529195|NCT00344773|363946539|FG000|Overall Study|Adverse Event|2|||
105529196|NCT00344773|363946539|FG000|Overall Study|Objective Disease Progression|16|||
105529197|NCT00344773|363946539|FG000|Overall Study|Withdrawal by Subject|1|||
105529198|NCT00344773|363946539|FG000|Overall Study|Not Eligible for the study|2|||
105529199|NCT00660348|363946540|FG000|Overall Study|Withdrawal by Subject|1|||
105529200|NCT00660348|363946541|FG001|Overall Study|Withdrawal by Subject|0|||
105529201|NCT02849548|363946542|FG000|Overall Study|Lost to Follow-up|1|||
105529202|NCT02849548|363946543|FG001|Overall Study|Lost to Follow-up|2|||
105529203|NCT02849548|363946542|FG000|Overall Study|Protocol Violation|1|||
105529204|NCT02849548|363946543|FG001|Overall Study|Protocol Violation|0|||
105529205|NCT04804813|363946545|FG000|Overall Study|Protocol Violation|2|||
105529206|NCT04804813|363946546|FG001|Overall Study|Protocol Violation|0|||
105529207|NCT04804813|363946545|FG000|Overall Study|Withdrawal by Subject|1|||
105529208|NCT04804813|363946546|FG001|Overall Study|Withdrawal by Subject|0|||
105529209|NCT00502697|363947748|FG000|Overall Study|Withdrawal by Subject|3|||
105529210|NCT00502697|363947749|FG001|Overall Study|Withdrawal by Subject|1|||
105529211|NCT00502697|363947748|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
105529212|NCT00502697|363947749|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
105529213|NCT00502697|363947748|FG000|Overall Study|found not to meet eligibility criteria|3|||
105529214|NCT00502697|363947749|FG001|Overall Study|found not to meet eligibility criteria|4|||
105529215|NCT00502697|363947748|FG000|Overall Study|did not meet assignment criteria|4|||
105529216|NCT00502697|363947749|FG001|Overall Study|did not meet assignment criteria|2|||
105529217|NCT01545817|363947750|FG000|Pazopanib|Disease progression|51|||
105529218|NCT01545817|363947751|FG001|Pazopanib|Disease progression|0|||
105529219|NCT01545817|363947750|FG000|Pazopanib|Adverse Event|19|||
105529220|NCT01545817|363947751|FG001|Pazopanib|Adverse Event|0|||
105529221|NCT01545817|363947750|FG000|Pazopanib|Other reason|4|||
105529222|NCT01545817|363947751|FG001|Pazopanib|Other reason|0|||
105529223|NCT01545817|363947750|FG000|Everolimus|Other reason|0|||
105529224|NCT01545817|363947751|FG001|Everolimus|Other reason|7|||
105529225|NCT01545817|363947750|FG000|Everolimus|Disease progression|0|||
105529226|NCT01545817|363947751|FG001|Everolimus|Disease progression|25|||
105529227|NCT01545817|363947750|FG000|Everolimus|Adverse Event|0|||
105529228|NCT01545817|363947751|FG001|Everolimus|Adverse Event|6|||
105529229|NCT02586012|363947752|FG000|Overall Study|Withdrawal by Subject|1|||
105529230|NCT02586012|363947753|FG001|Overall Study|Withdrawal by Subject|1|||
105529231|NCT02586012|363947754|FG002|Overall Study|Withdrawal by Subject|0|||
105529232|NCT02586012|363947755|FG003|Overall Study|Withdrawal by Subject|1|||
105529233|NCT02586012|363947756|FG004|Overall Study|Withdrawal by Subject|0|||
105529234|NCT02586012|363947757|FG005|Overall Study|Withdrawal by Subject|2|||
105529235|NCT02586012|363947752|FG000|Overall Study|Protocol Violation|0|||
105529236|NCT02586012|363947753|FG001|Overall Study|Protocol Violation|0|||
105529237|NCT02586012|363947754|FG002|Overall Study|Protocol Violation|0|||
105529238|NCT02586012|363947755|FG003|Overall Study|Protocol Violation|0|||
105529239|NCT02586012|363947756|FG004|Overall Study|Protocol Violation|0|||
105529240|NCT02586012|363947757|FG005|Overall Study|Protocol Violation|1|||
105529241|NCT02586012|363947752|FG000|Overall Study|study terminated|0|||
105529242|NCT02586012|363947753|FG001|Overall Study|study terminated|2|||
105529243|NCT02586012|363947754|FG002|Overall Study|study terminated|1|||
105529244|NCT02586012|363947755|FG003|Overall Study|study terminated|1|||
105529245|NCT02586012|363947756|FG004|Overall Study|study terminated|1|||
105529246|NCT02586012|363947757|FG005|Overall Study|study terminated|0|||
105529247|NCT00427635|363947758|FG000|Treatment Phase|Withdrawal by Subject|1|||
105529248|NCT00427635|363947759|FG001|Treatment Phase|Withdrawal by Subject|0|||
105529249|NCT00427635|363947758|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
105529250|NCT00427635|363947759|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
105529251|NCT03277846|363947760|FG000|Overall Study|Inpatient stay too brief|12|||
105529252|NCT03277846|363947761|FG001|Overall Study|Inpatient stay too brief|11|||
105529253|NCT03240575|363947762|FG000|Overall Study|Adverse Event|0|||
105529254|NCT03240575|363947763|FG001|Overall Study|Adverse Event|2|||
105529255|NCT03240575|363947764|FG002|Overall Study|Adverse Event|0|||
105529256|NCT03240575|363947765|FG003|Overall Study|Adverse Event|1|||
105529257|NCT03240575|363947762|FG000|Overall Study|Withdrawal by Subject|2|||
105529258|NCT03240575|363947763|FG001|Overall Study|Withdrawal by Subject|11|||
105529259|NCT03240575|363947764|FG002|Overall Study|Withdrawal by Subject|0|||
105529260|NCT03240575|363947765|FG003|Overall Study|Withdrawal by Subject|1|||
105529261|NCT03240575|363947762|FG000|Overall Study|Other|0|||
105529262|NCT03240575|363947763|FG001|Overall Study|Other|1|||
105529263|NCT03240575|363947764|FG002|Overall Study|Other|0|||
105529264|NCT03240575|363947765|FG003|Overall Study|Other|0|||
105529265|NCT02365636|363947766|FG000|Overall Study|Adverse Event|3|||
105529266|NCT02365636|363947767|FG001|Overall Study|Adverse Event|3|||
105529267|NCT02365636|363947768|FG002|Overall Study|Adverse Event|2|||
105529268|NCT02365636|363947766|FG000|Overall Study|Protocol Violation|1|||
105529269|NCT02365636|363947767|FG001|Overall Study|Protocol Violation|4|||
105529270|NCT02365636|363947768|FG002|Overall Study|Protocol Violation|0|||
105529271|NCT02365636|363947766|FG000|Overall Study|Lost to Follow-up|0|||
105529272|NCT02365636|363947767|FG001|Overall Study|Lost to Follow-up|0|||
105529273|NCT02365636|363947768|FG002|Overall Study|Lost to Follow-up|1|||
105529274|NCT02365636|363947766|FG000|Overall Study|Other|2|||
105529275|NCT02365636|363947767|FG001|Overall Study|Other|0|||
105529276|NCT02365636|363947768|FG002|Overall Study|Other|0|||
105529277|NCT01454934|363947772|FG000|Overall Study|Clinical progression|28|||
105529278|NCT01454934|363947773|FG001|Overall Study|Clinical progression|25|||
105529279|NCT01454934|363947772|FG000|Overall Study|Other|6|||
105529280|NCT01454934|363947773|FG001|Overall Study|Other|17|||
105529281|NCT01454934|363947772|FG000|Overall Study|Adverse Event|28|||
105529282|NCT01454934|363947773|FG001|Overall Study|Adverse Event|24|||
105529283|NCT01454934|363947772|FG000|Overall Study|Withdrawn consent|2|||
105529284|NCT01454934|363947773|FG001|Overall Study|Withdrawn consent|5|||
105529285|NCT01454934|363947772|FG000|Overall Study|Withdrawal by Subject|11|||
105529286|NCT01454934|363947773|FG001|Overall Study|Withdrawal by Subject|15|||
105529287|NCT01454934|363947772|FG000|Overall Study|Disease progression|194|||
105529288|NCT01454934|363947773|FG001|Overall Study|Disease progression|181|||
105529289|NCT01454934|363947772|FG000|Overall Study|Lost to Follow-up|0|||
105529290|NCT01454934|363947773|FG001|Overall Study|Lost to Follow-up|1|||
105529291|NCT01454934|363947772|FG000|Overall Study|Not treated|1|||
105529292|NCT01454934|363947773|FG001|Overall Study|Not treated|2|||
105529293|NCT02118428|363947776|FG000|Overall Study|Physician Decision|0|||
105529294|NCT02118428|363947777|FG001|Overall Study|Physician Decision|1|||
105529295|NCT02118428|363947778|FG002|Overall Study|Physician Decision|0|||
105529296|NCT02118428|363947776|FG000|Overall Study|Withdrawal by Subject|2|||
105529297|NCT02118428|363947777|FG001|Overall Study|Withdrawal by Subject|2|||
105529298|NCT02118428|363947778|FG002|Overall Study|Withdrawal by Subject|0|||
105529299|NCT02118428|363947776|FG000|Overall Study|Death|7|||
105529300|NCT02118428|363947777|FG001|Overall Study|Death|5|||
105529301|NCT02118428|363947778|FG002|Overall Study|Death|0|||
105529302|NCT02118428|363947776|FG000|Overall Study|Lost to Follow-up|3|||
105529303|NCT02118428|363947777|FG001|Overall Study|Lost to Follow-up|1|||
105529304|NCT02118428|363947778|FG002|Overall Study|Lost to Follow-up|0|||
105529305|NCT02118428|363947776|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
105529306|NCT02118428|363947777|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
105529307|NCT02118428|363947778|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
105529308|NCT01067352|363947790|FG000|Overall Study|Withdrawal by Subject|1|||
105529309|NCT01067352|363947791|FG001|Overall Study|Withdrawal by Subject|2|||
105529310|NCT01067352|363947792|FG002|Overall Study|Withdrawal by Subject|1|||
105529311|NCT01067352|363947790|FG000|Overall Study|Physician Decision|0|||
105529312|NCT01067352|363947791|FG001|Overall Study|Physician Decision|1|||
105529313|NCT01067352|363947792|FG002|Overall Study|Physician Decision|0|||
105529314|NCT00436748|363947799|FG000|Overall Study|Ineligibility Determined|1|||
105529315|NCT00436748|363947800|FG001|Overall Study|Ineligibility Determined|1|||
105529316|NCT00436748|363947799|FG000|Overall Study|Adverse Event|0|||
105529317|NCT00436748|363947800|FG001|Overall Study|Adverse Event|2|||
105529318|NCT00436748|363947799|FG000|Overall Study|Consent Withdrawn|1|||
105529319|NCT00436748|363947800|FG001|Overall Study|Consent Withdrawn|4|||
105529320|NCT00436748|363947799|FG000|Overall Study|Administrative Decision|1|||
105529321|NCT00436748|363947800|FG001|Overall Study|Administrative Decision|0|||
105529322|NCT00436748|363947799|FG000|Overall Study|Lost to Follow-up|0|||
105529323|NCT00436748|363947800|FG001|Overall Study|Lost to Follow-up|1|||
105529324|NCT00436748|363947799|FG000|Overall Study|Protocol-specified Criteria|5|||
105529325|NCT00436748|363947800|FG001|Overall Study|Protocol-specified Criteria|4|||
105529326|NCT00436748|363947799|FG000|Overall Study|Other|3|||
105529327|NCT00436748|363947800|FG001|Overall Study|Other|0|||
105529328|NCT00850200|363947802|FG000|Overall Study|Physician Decision|2|||
105529329|NCT00850200|363947802|FG000|Overall Study|Did not recieve treatment|2|||
105529330|NCT00850200|363947802|FG000|Overall Study|Withdrawal by Subject|1|||
105529331|NCT00423891|363947803|FG000|Enrolled|Withdrawal by Subject|0|||
105529332|NCT00423891|363947804|FG001|Enrolled|Withdrawal by Subject|0|||
105529333|NCT00423891|363947805|FG002|Enrolled|Withdrawal by Subject|1|||
105529334|NCT00423891|363947803|FG000|Enrolled|Lost to Follow-up|0|||
105529335|NCT00423891|363947804|FG001|Enrolled|Lost to Follow-up|0|||
105529336|NCT00423891|363947805|FG002|Enrolled|Lost to Follow-up|1|||
105529337|NCT00423891|363947803|FG000|Enrolled|No longer met criteria|11|||
105529338|NCT00423891|363947804|FG001|Enrolled|No longer met criteria|2|||
105529339|NCT00423891|363947805|FG002|Enrolled|No longer met criteria|1|||
105529340|NCT00423891|363947803|FG000|Treatment|Withdrawal by Subject|1|||
105529341|NCT00423891|363947804|FG001|Treatment|Withdrawal by Subject|0|||
105529342|NCT00423891|363947805|FG002|Treatment|Withdrawal by Subject|0|||
105529343|NCT00423891|363947803|FG000|Treatment|Lost to Follow-up|1|||
105529344|NCT00423891|363947804|FG001|Treatment|Lost to Follow-up|0|||
105529345|NCT00423891|363947805|FG002|Treatment|Lost to Follow-up|0|||
105529346|NCT00423891|363947803|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
105529347|NCT00423891|363947804|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
105529348|NCT00423891|363947805|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
105529349|NCT00423891|363947803|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
105529350|NCT00423891|363947804|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
105529351|NCT00423891|363947805|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
105529352|NCT02308735|363947806|FG000|Overall Study|Physician Decision|2|||
105529353|NCT02308735|363947807|FG001|Overall Study|Physician Decision|0|||
105529354|NCT02308735|363947808|FG002|Overall Study|Physician Decision|0|||
105529355|NCT02308735|363947809|FG003|Overall Study|Physician Decision|2|||
105529356|NCT03013543|363947810|FG000|Overall Study|Withdrawal by Subject|0|||
105529357|NCT03013543|363947811|FG001|Overall Study|Withdrawal by Subject|2|||
105529358|NCT03013543|363947812|FG002|Overall Study|Withdrawal by Subject|0|||
105529359|NCT03013543|363947813|FG003|Overall Study|Withdrawal by Subject|5|||
105529360|NCT03013543|363947814|FG004|Overall Study|Withdrawal by Subject|6|||
105529361|NCT03013543|363947815|FG005|Overall Study|Withdrawal by Subject|2|||
105529362|NCT03013543|363947816|FG006|Overall Study|Withdrawal by Subject|3|||
105529363|NCT03013543|363947817|FG007|Overall Study|Withdrawal by Subject|1|||
105529364|NCT03013543|363947818|FG008|Overall Study|Withdrawal by Subject|0|||
105529365|NCT03013543|363947819|FG009|Overall Study|Withdrawal by Subject|4|||
105529366|NCT03013543|363947810|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
105529367|NCT03013543|363947811|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
105529368|NCT03013543|363947812|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
105529369|NCT03013543|363947813|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
105529370|NCT03013543|363947814|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
105529371|NCT03013543|363947815|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
105529372|NCT03013543|363947816|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
105529373|NCT03013543|363947817|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
105529374|NCT03013543|363947818|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
105529375|NCT03013543|363947819|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
105529376|NCT03013543|363947810|FG000|Overall Study|Other|0|||
105529377|NCT03013543|363947811|FG001|Overall Study|Other|0|||
105529378|NCT03013543|363947812|FG002|Overall Study|Other|2|||
105529379|NCT03013543|363947813|FG003|Overall Study|Other|0|||
105529380|NCT03013543|363947814|FG004|Overall Study|Other|2|||
105529381|NCT03013543|363947815|FG005|Overall Study|Other|0|||
105529382|NCT03013543|363947816|FG006|Overall Study|Other|0|||
105529383|NCT03013543|363947817|FG007|Overall Study|Other|0|||
105529384|NCT03013543|363947818|FG008|Overall Study|Other|1|||
105529385|NCT03013543|363947819|FG009|Overall Study|Other|0|||
105529386|NCT03013543|363947810|FG000|Overall Study|Adverse Event|0|||
105529387|NCT03013543|363947811|FG001|Overall Study|Adverse Event|0|||
105529388|NCT03013543|363947812|FG002|Overall Study|Adverse Event|0|||
105529389|NCT03013543|363947813|FG003|Overall Study|Adverse Event|3|||
105529390|NCT03013543|363947814|FG004|Overall Study|Adverse Event|2|||
105529391|NCT03013543|363947815|FG005|Overall Study|Adverse Event|1|||
105529392|NCT03013543|363947816|FG006|Overall Study|Adverse Event|3|||
105529393|NCT03013543|363947817|FG007|Overall Study|Adverse Event|8|||
105529394|NCT03013543|363947818|FG008|Overall Study|Adverse Event|0|||
105529395|NCT03013543|363947819|FG009|Overall Study|Adverse Event|2|||
105529396|NCT03013543|363947810|FG000|Overall Study|Death|0|||
105529397|NCT03013543|363947811|FG001|Overall Study|Death|0|||
105529398|NCT03013543|363947812|FG002|Overall Study|Death|0|||
105529399|NCT03013543|363947813|FG003|Overall Study|Death|1|||
105529400|NCT03013543|363947814|FG004|Overall Study|Death|0|||
105529401|NCT03013543|363947815|FG005|Overall Study|Death|0|||
105529402|NCT03013543|363947816|FG006|Overall Study|Death|0|||
105529403|NCT03013543|363947817|FG007|Overall Study|Death|0|||
105529404|NCT03013543|363947818|FG008|Overall Study|Death|0|||
105529405|NCT03013543|363947819|FG009|Overall Study|Death|0|||
105529406|NCT03013543|363947810|FG000|Overall Study|Lack of Efficacy|0|||
105529407|NCT03013543|363947811|FG001|Overall Study|Lack of Efficacy|0|||
105529408|NCT03013543|363947812|FG002|Overall Study|Lack of Efficacy|0|||
105529409|NCT03013543|363947813|FG003|Overall Study|Lack of Efficacy|1|||
105529410|NCT03013543|363947814|FG004|Overall Study|Lack of Efficacy|0|||
105529411|NCT03013543|363947815|FG005|Overall Study|Lack of Efficacy|0|||
105529412|NCT03013543|363947816|FG006|Overall Study|Lack of Efficacy|0|||
105529413|NCT03013543|363947817|FG007|Overall Study|Lack of Efficacy|0|||
105529414|NCT03013543|363947818|FG008|Overall Study|Lack of Efficacy|0|||
105529415|NCT03013543|363947819|FG009|Overall Study|Lack of Efficacy|0|||
105529416|NCT03013543|363947810|FG000|Overall Study|Lost to Follow-up|0|||
105529417|NCT03013543|363947811|FG001|Overall Study|Lost to Follow-up|0|||
105529418|NCT03013543|363947812|FG002|Overall Study|Lost to Follow-up|0|||
105529419|NCT03013543|363947813|FG003|Overall Study|Lost to Follow-up|1|||
105529420|NCT03013543|363947814|FG004|Overall Study|Lost to Follow-up|0|||
105529421|NCT03013543|363947815|FG005|Overall Study|Lost to Follow-up|0|||
105529422|NCT03013543|363947816|FG006|Overall Study|Lost to Follow-up|1|||
105529423|NCT03013543|363947817|FG007|Overall Study|Lost to Follow-up|0|||
105529424|NCT03013543|363947818|FG008|Overall Study|Lost to Follow-up|0|||
105529425|NCT03013543|363947819|FG009|Overall Study|Lost to Follow-up|2|||
105529426|NCT03013543|363947810|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105529427|NCT03013543|363947811|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105529428|NCT03013543|363947812|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105529429|NCT03013543|363947813|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105529430|NCT03013543|363947814|FG004|Overall Study|Non-Compliance With Study Drug|0|||
105529431|NCT03013543|363947815|FG005|Overall Study|Non-Compliance With Study Drug|0|||
105529432|NCT03013543|363947816|FG006|Overall Study|Non-Compliance With Study Drug|0|||
105529433|NCT03013543|363947817|FG007|Overall Study|Non-Compliance With Study Drug|0|||
105529434|NCT03013543|363947818|FG008|Overall Study|Non-Compliance With Study Drug|1|||
105529435|NCT03013543|363947819|FG009|Overall Study|Non-Compliance With Study Drug|0|||
105529436|NCT03013543|363947810|FG000|Overall Study|Physician Decision|0|||
105529437|NCT03013543|363947811|FG001|Overall Study|Physician Decision|0|||
105529438|NCT03013543|363947812|FG002|Overall Study|Physician Decision|0|||
105529439|NCT03013543|363947813|FG003|Overall Study|Physician Decision|0|||
105529440|NCT03013543|363947814|FG004|Overall Study|Physician Decision|1|||
105529441|NCT03013543|363947815|FG005|Overall Study|Physician Decision|0|||
105529442|NCT03013543|363947816|FG006|Overall Study|Physician Decision|0|||
105529443|NCT03013543|363947817|FG007|Overall Study|Physician Decision|0|||
105529444|NCT03013543|363947818|FG008|Overall Study|Physician Decision|0|||
105529445|NCT03013543|363947819|FG009|Overall Study|Physician Decision|0|||
105529446|NCT03013543|363947810|FG000|Overall Study|Protocol Violation|0|||
105529447|NCT03013543|363947811|FG001|Overall Study|Protocol Violation|0|||
105529448|NCT03013543|363947812|FG002|Overall Study|Protocol Violation|0|||
105529449|NCT03013543|363947813|FG003|Overall Study|Protocol Violation|0|||
105529450|NCT03013543|363947814|FG004|Overall Study|Protocol Violation|0|||
105529451|NCT03013543|363947815|FG005|Overall Study|Protocol Violation|0|||
105529452|NCT03013543|363947816|FG006|Overall Study|Protocol Violation|0|||
105529453|NCT03013543|363947817|FG007|Overall Study|Protocol Violation|0|||
105529454|NCT03013543|363947818|FG008|Overall Study|Protocol Violation|0|||
105529455|NCT03013543|363947819|FG009|Overall Study|Protocol Violation|1|||
105529456|NCT00606892|363947820|FG000|First Intervention|Protocol Violation|1|||
105529457|NCT00606892|363947821|FG001|First Intervention|Protocol Violation|4|||
105529458|NCT01417481|363947822|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
105529459|NCT01417481|363947823|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
105529460|NCT01554618|363947834|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
105529461|NCT01554618|363947835|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
105529462|NCT01554618|363947834|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
105529463|NCT01554618|363947835|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
105593787|NCT02914522|364172798|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
105593788|NCT02914522|364172799|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
105593789|NCT02914522|364172800|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
105593790|NCT02914522|364172790|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
105593791|NCT02914522|364172791|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
105593792|NCT02914522|364172792|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
105593793|NCT02914522|364172793|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
105593794|NCT02914522|364172794|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
105593795|NCT02914522|364172795|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
105593796|NCT02914522|364172796|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
105593797|NCT02914522|364172797|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
105593798|NCT02914522|364172798|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
105593799|NCT02914522|364172799|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
105593800|NCT02914522|364172800|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
105593801|NCT02914522|364172790|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
105593802|NCT02914522|364172791|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
105593803|NCT02914522|364172792|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
105593804|NCT02914522|364172793|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
105529464|NCT01554618|363947834|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
105529465|NCT01554618|363947835|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
105529466|NCT01554618|363947834|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
105529467|NCT01554618|363947835|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
105529468|NCT01554618|363947834|FG000|Open-Label Extension Period|Physician Decision|0|||
105529469|NCT01554618|363947835|FG001|Open-Label Extension Period|Physician Decision|1|||
105529470|NCT01554618|363947834|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
105529471|NCT01554618|363947835|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
105529472|NCT03742141|363947836|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
105529473|NCT02376166|363947838|FG000|Overall Study|Adverse Event|1|||
105529474|NCT02376166|363947838|FG000|Overall Study|Discontinued metformin early|2|||
105529475|NCT00838565|363947841|FG000|Overall Study|Withdrawal by Subject|0|||
105529476|NCT00838565|363947842|FG001|Overall Study|Withdrawal by Subject|0|||
105529477|NCT00838565|363947843|FG002|Overall Study|Withdrawal by Subject|1|||
105529478|NCT00838565|363947844|FG003|Overall Study|Withdrawal by Subject|0|||
105529479|NCT00838565|363947845|FG004|Overall Study|Withdrawal by Subject|0|||
105529480|NCT00838565|363947846|FG005|Overall Study|Withdrawal by Subject|2|||
105529481|NCT00838565|363947841|FG000|Overall Study|Other|0|||
105529482|NCT00838565|363947842|FG001|Overall Study|Other|2|||
105529483|NCT00838565|363947843|FG002|Overall Study|Other|0|||
105529484|NCT00838565|363947844|FG003|Overall Study|Other|0|||
105529485|NCT00838565|363947845|FG004|Overall Study|Other|0|||
105529486|NCT00838565|363947846|FG005|Overall Study|Other|0|||
105529487|NCT00838565|363947841|FG000|Overall Study|Randomized but not Treated|0|||
105529488|NCT00838565|363947842|FG001|Overall Study|Randomized but not Treated|1|||
105529489|NCT00838565|363947843|FG002|Overall Study|Randomized but not Treated|0|||
105529490|NCT00838565|363947844|FG003|Overall Study|Randomized but not Treated|0|||
105529491|NCT00838565|363947845|FG004|Overall Study|Randomized but not Treated|0|||
105529492|NCT00838565|363947846|FG005|Overall Study|Randomized but not Treated|0|||
105529493|NCT02275481|363947847|FG000|Overall Study|Death|2|||
105529494|NCT02275481|363947848|FG001|Overall Study|Death|1|||
105529495|NCT02275481|363947847|FG000|Overall Study|Lost to Follow-up|2|||
105529496|NCT02275481|363947848|FG001|Overall Study|Lost to Follow-up|0|||
105529497|NCT02275481|363947847|FG000|Overall Study|Withdrawal by Subject|3|||
105529498|NCT02275481|363947848|FG001|Overall Study|Withdrawal by Subject|0|||
105529499|NCT02275481|363947847|FG000|Overall Study|all other reasons combined|2|||
105529500|NCT02275481|363947848|FG001|Overall Study|all other reasons combined|1|||
105529501|NCT02275481|363947847|FG000|Overall Study|Physician Decision|0|||
105529502|NCT02275481|363947848|FG001|Overall Study|Physician Decision|1|||
105529503|NCT01393405|363947849|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
105529504|NCT01393405|363947850|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
105529505|NCT01393405|363947851|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
105529506|NCT01393405|363947849|FG000|Induction Period (week1-16)|Adverse Event|16|||
105529507|NCT01393405|363947850|FG001|Induction Period (week1-16)|Adverse Event|0|||
105529508|NCT01393405|363947851|FG002|Induction Period (week1-16)|Adverse Event|0|||
105529509|NCT01393405|363947849|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
105529510|NCT01393405|363947850|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
105529511|NCT01393405|363947851|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
105529512|NCT01393405|363947849|FG000|Maintenance Period Week|Lack of Efficacy|0|||
105593805|NCT02914522|364172794|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
105529513|NCT01393405|363947850|FG001|Maintenance Period Week|Lack of Efficacy|22|||
105529514|NCT01393405|363947851|FG002|Maintenance Period Week|Lack of Efficacy|22|||
105529515|NCT01393405|363947849|FG000|Maintenance Period Week|Adverse Event|0|||
105529516|NCT01393405|363947850|FG001|Maintenance Period Week|Adverse Event|5|||
105529517|NCT01393405|363947851|FG002|Maintenance Period Week|Adverse Event|2|||
105529518|NCT01393405|363947849|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
105529519|NCT01393405|363947850|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
105529520|NCT01393405|363947851|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
105529521|NCT01393405|363947849|FG000|Maintenance Period Week|Lost to Follow-up|0|||
105529522|NCT01393405|363947850|FG001|Maintenance Period Week|Lost to Follow-up|1|||
105529523|NCT01393405|363947851|FG002|Maintenance Period Week|Lost to Follow-up|0|||
105529524|NCT00244712|363947860|FG000|Overall Study|Adverse Event|20|||
105529525|NCT00244712|363947861|FG001|Overall Study|Adverse Event|21|||
105529526|NCT00244712|363947860|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
105529527|NCT00244712|363947861|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
105529528|NCT00244712|363947860|FG000|Overall Study|Lack of Compliance|10|||
105529529|NCT00244712|363947861|FG001|Overall Study|Lack of Compliance|11|||
105529530|NCT00244712|363947860|FG000|Overall Study|Lost to Follow-up|45|||
105529531|NCT00244712|363947861|FG001|Overall Study|Lost to Follow-up|52|||
105529532|NCT00244712|363947860|FG000|Overall Study|Withdrawal by Subject|13|||
105529533|NCT00244712|363947861|FG001|Overall Study|Withdrawal by Subject|23|||
105529534|NCT00244712|363947860|FG000|Overall Study|Protocol Violation, disease progression|13|||
105529535|NCT00244712|363947861|FG001|Overall Study|Protocol Violation, disease progression|11|||
105529536|NCT01806896|363947864|FG000|Overall Study|Adverse Event|2|||
105529537|NCT01806896|363947865|FG001|Overall Study|Adverse Event|0|||
105529538|NCT01806896|363947864|FG000|Overall Study|Other|1|||
105529539|NCT01806896|363947865|FG001|Overall Study|Other|0|||
105529540|NCT05627518|363947866|FG000|Treatment Period 1|Adverse Event|0|||
105529541|NCT05627518|363947867|FG001|Treatment Period 1|Adverse Event|0|||
105529542|NCT05627518|363947868|FG002|Treatment Period 1|Adverse Event|1|||
105529543|NCT05627518|363947869|FG003|Treatment Period 1|Adverse Event|0|||
105529544|NCT05627518|363947870|FG004|Treatment Period 1|Adverse Event|0|||
105529545|NCT05627518|363947871|FG005|Treatment Period 1|Adverse Event|0|||
105529546|NCT05627518|363947872|FG006|Treatment Period 1|Adverse Event|0|||
105529547|NCT05627518|363947873|FG007|Treatment Period 1|Adverse Event|1|||
105529548|NCT05627518|363947866|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105529549|NCT05627518|363947867|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105529550|NCT05627518|363947868|FG002|Treatment Period 1|Withdrawal by Subject|1|||
105529551|NCT05627518|363947869|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105529552|NCT05627518|363947870|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105529553|NCT05627518|363947871|FG005|Treatment Period 1|Withdrawal by Subject|1|||
105529554|NCT05627518|363947872|FG006|Treatment Period 1|Withdrawal by Subject|0|||
105529555|NCT05627518|363947873|FG007|Treatment Period 1|Withdrawal by Subject|0|||
105529556|NCT05627518|363947866|FG000|Treatment Period 1|Protocol Violation|0|||
105529557|NCT05627518|363947867|FG001|Treatment Period 1|Protocol Violation|0|||
105529558|NCT05627518|363947868|FG002|Treatment Period 1|Protocol Violation|0|||
105529559|NCT05627518|363947869|FG003|Treatment Period 1|Protocol Violation|0|||
105529560|NCT05627518|363947870|FG004|Treatment Period 1|Protocol Violation|0|||
105529561|NCT05627518|363947871|FG005|Treatment Period 1|Protocol Violation|0|||
105529562|NCT05627518|363947872|FG006|Treatment Period 1|Protocol Violation|6|||
105529563|NCT05627518|363947873|FG007|Treatment Period 1|Protocol Violation|6|||
105529564|NCT05627518|363947866|FG000|Treatment Period 2|Adverse Event|1|||
105529565|NCT05627518|363947867|FG001|Treatment Period 2|Adverse Event|0|||
105529566|NCT05627518|363947868|FG002|Treatment Period 2|Adverse Event|0|||
105529567|NCT05627518|363947869|FG003|Treatment Period 2|Adverse Event|0|||
105529568|NCT05627518|363947870|FG004|Treatment Period 2|Adverse Event|0|||
105529569|NCT05627518|363947871|FG005|Treatment Period 2|Adverse Event|0|||
105529570|NCT05627518|363947872|FG006|Treatment Period 2|Adverse Event|0|||
105529571|NCT05627518|363947873|FG007|Treatment Period 2|Adverse Event|0|||
105529572|NCT05627518|363947866|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105529573|NCT05627518|363947867|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105529574|NCT05627518|363947868|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105529575|NCT05627518|363947869|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105529576|NCT05627518|363947870|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105529577|NCT05627518|363947871|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105529578|NCT05627518|363947872|FG006|Treatment Period 2|Withdrawal by Subject|0|||
105529579|NCT05627518|363947873|FG007|Treatment Period 2|Withdrawal by Subject|0|||
105529580|NCT00316199|363947876|FG000|Overall Study|Adverse Event|2|||
105529581|NCT00316199|363947876|FG000|Overall Study|Death|8|||
105529582|NCT00316199|363947876|FG000|Overall Study|Lost to Follow-up|2|||
105529583|NCT00590954|363947877|FG000|Overall Study|Inevaluable|2|||
105529584|NCT02777125|363947878|FG000|Overall Study|Consent form violation|14|||
105529585|NCT02777125|363947879|FG001|Overall Study|Consent form violation|12|||
105529586|NCT02777125|363947878|FG000|Overall Study|Assent form violation|21|||
105529587|NCT02777125|363947879|FG001|Overall Study|Assent form violation|23|||
105529588|NCT02777125|363947878|FG000|Overall Study|Protocol Violation|8|||
105529589|NCT02777125|363947879|FG001|Overall Study|Protocol Violation|12|||
105529590|NCT02917031|363947880|FG000|Overall Study|Reason not specified|7|||
105529591|NCT02917031|363947881|FG001|Overall Study|Reason not specified|5|||
105529592|NCT02917031|363947882|FG002|Overall Study|Reason not specified|6|||
105529593|NCT02917031|363947880|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
105529594|NCT02917031|363947881|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
105529595|NCT02917031|363947882|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
105529596|NCT02917031|363947880|FG000|Overall Study|Withdrawal by Subject|3|||
105529597|NCT02917031|363947881|FG001|Overall Study|Withdrawal by Subject|3|||
105529598|NCT02917031|363947882|FG002|Overall Study|Withdrawal by Subject|0|||
105529599|NCT02917031|363947880|FG000|Overall Study|Physician Decision|1|||
105529600|NCT02917031|363947881|FG001|Overall Study|Physician Decision|0|||
105529601|NCT02917031|363947882|FG002|Overall Study|Physician Decision|0|||
105529602|NCT02917031|363947880|FG000|Overall Study|Adverse Event|4|||
105529603|NCT02917031|363947881|FG001|Overall Study|Adverse Event|1|||
105529604|NCT02917031|363947882|FG002|Overall Study|Adverse Event|5|||
105529605|NCT02917031|363947880|FG000|Overall Study|Death|2|||
105529606|NCT02917031|363947881|FG001|Overall Study|Death|3|||
105529607|NCT02917031|363947882|FG002|Overall Study|Death|4|||
105529608|NCT03003520|363949723|FG000|Overall Study|Adverse Event|9|||
105529609|NCT03003520|363949724|FG001|Overall Study|Adverse Event|0|||
105529610|NCT03003520|363949723|FG000|Overall Study|Death|1|||
105529611|NCT03003520|363949724|FG001|Overall Study|Death|0|||
105529612|NCT03003520|363949723|FG000|Overall Study|Other reasons|4|||
105529613|NCT03003520|363949724|FG001|Overall Study|Other reasons|0|||
105529614|NCT03003520|363949723|FG000|Overall Study|Withdrawal by Subject|6|||
105529615|NCT03003520|363949724|FG001|Overall Study|Withdrawal by Subject|0|||
105529616|NCT03003520|363949723|FG000|Overall Study|Progressive disease|9|||
105529617|NCT03003520|363949724|FG001|Overall Study|Progressive disease|1|||
105529618|NCT01332149|363949725|FG000|Overall Study|Adverse Event|11|||
105529619|NCT01332149|363949726|FG001|Overall Study|Adverse Event|9|||
105529620|NCT01332149|363949725|FG000|Overall Study|Other unspecified|5|||
105529621|NCT01332149|363949726|FG001|Overall Study|Other unspecified|7|||
105529622|NCT01332149|363949725|FG000|Overall Study|Protocol Violation|1|||
105529623|NCT01332149|363949726|FG001|Overall Study|Protocol Violation|3|||
105529624|NCT01332149|363949725|FG000|Overall Study|Withdrawal by Subject|4|||
105529625|NCT01332149|363949726|FG001|Overall Study|Withdrawal by Subject|5|||
105529626|NCT01332149|363949725|FG000|Overall Study|Lost to Follow-up|1|||
105529627|NCT01332149|363949726|FG001|Overall Study|Lost to Follow-up|1|||
105529628|NCT01332149|363949725|FG000|Overall Study|Insufficient clinical response|4|||
105529629|NCT01332149|363949726|FG001|Overall Study|Insufficient clinical response|7|||
105529630|NCT01332149|363949725|FG000|Overall Study|Did not meet entrance criteria|3|||
105529631|NCT01332149|363949726|FG001|Overall Study|Did not meet entrance criteria|4|||
105529632|NCT01332149|363949725|FG000|Overall Study|Randomized but not treated|1|||
105529633|NCT01332149|363949726|FG001|Overall Study|Randomized but not treated|2|||
105529634|NCT01816139|363949732|FG000|Overall Study|Adverse Event|6|||
105529635|NCT01816139|363949733|FG001|Overall Study|Adverse Event|8|||
105529636|NCT01816139|363949732|FG000|Overall Study|Lack of Efficacy|1|||
105529637|NCT01816139|363949733|FG001|Overall Study|Lack of Efficacy|2|||
105529638|NCT01816139|363949732|FG000|Overall Study|Lost to Follow-up|5|||
105529639|NCT01816139|363949733|FG001|Overall Study|Lost to Follow-up|3|||
105529640|NCT01816139|363949732|FG000|Overall Study|Withdrew Consent|6|||
105529641|NCT01816139|363949733|FG001|Overall Study|Withdrew Consent|4|||
105529642|NCT01816139|363949732|FG000|Overall Study|Protocol Violation|6|||
105529643|NCT01816139|363949733|FG001|Overall Study|Protocol Violation|3|||
105529644|NCT01816139|363949732|FG000|Overall Study|Reason not Specified|4|||
105529645|NCT01816139|363949733|FG001|Overall Study|Reason not Specified|2|||
105529646|NCT01940120|363949736|FG000|Overall Study|Death|40|||
105529647|NCT01940120|363949736|FG000|Overall Study|Withdrawal by Subject|8|||
105529648|NCT02554656|363949737|FG000|Overall Study|Protocol Violation|3|||
105529649|NCT03325166|363949743|FG000|Overall Study|Adverse Event|1|||
105529650|NCT01782313|363949744|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
105529651|NCT01782313|363949744|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
105529652|NCT01782313|363949744|FG000|Treated Cycle 3|Progressive Disease|21|||
105529653|NCT01782313|363949744|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
105529654|NCT01782313|363949744|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
105529655|NCT01782313|363949744|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
105529656|NCT01782313|363949744|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
105529657|NCT01782313|363949744|FG000|Survival Follow up|Lost to Follow-up|1|||
105529658|NCT00418691|363949747|FG000|Overall Study|Lost to Follow-up|1|||
105529659|NCT00418691|363949748|FG001|Overall Study|Lost to Follow-up|2|||
105593806|NCT02914522|364172795|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
105529660|NCT00418691|363949749|FG002|Overall Study|Lost to Follow-up|3|||
105529661|NCT00418691|363949747|FG000|Overall Study|Started new medication voiding entry|0|||
105529662|NCT00418691|363949748|FG001|Overall Study|Started new medication voiding entry|0|||
105529663|NCT00418691|363949749|FG002|Overall Study|Started new medication voiding entry|1|||
105529664|NCT00418691|363949747|FG000|Overall Study|Progressive Disease|1|||
105529665|NCT00418691|363949748|FG001|Overall Study|Progressive Disease|0|||
105529666|NCT00418691|363949749|FG002|Overall Study|Progressive Disease|1|||
105529667|NCT01802775|363949750|FG000|Overall Study|Death|0|||
105529668|NCT01802775|363949751|FG001|Overall Study|Death|3|||
105529669|NCT01802775|363949750|FG000|Overall Study|Reason not provided|0|||
105529670|NCT01802775|363949751|FG001|Overall Study|Reason not provided|1|||
105529671|NCT01802775|363949750|FG000|Overall Study|Physician Decision|1|||
105529672|NCT01802775|363949751|FG001|Overall Study|Physician Decision|0|||
105529673|NCT01802775|363949750|FG000|Overall Study|Adverse Event|1|||
105529674|NCT01802775|363949751|FG001|Overall Study|Adverse Event|1|||
105529675|NCT01802775|363949750|FG000|Overall Study|Withdrawal by Subject|3|||
105529676|NCT01802775|363949751|FG001|Overall Study|Withdrawal by Subject|5|||
105529677|NCT01802775|363949750|FG000|Overall Study|Lost to Follow-up|1|||
105529678|NCT01802775|363949751|FG001|Overall Study|Lost to Follow-up|2|||
105529679|NCT00782210|363949754|FG000|Overall Study|Adverse Event|21|||
105529680|NCT00782210|363949755|FG001|Overall Study|Adverse Event|17|||
105529681|NCT00782210|363949756|FG002|Overall Study|Adverse Event|16|||
105529682|NCT00782210|363949754|FG000|Overall Study|Lost to Follow-up|2|||
105529683|NCT00782210|363949755|FG001|Overall Study|Lost to Follow-up|1|||
105529684|NCT00782210|363949756|FG002|Overall Study|Lost to Follow-up|2|||
105529685|NCT00782210|363949754|FG000|Overall Study|Withdrawal by Subject|11|||
105529686|NCT00782210|363949755|FG001|Overall Study|Withdrawal by Subject|8|||
105529687|NCT00782210|363949756|FG002|Overall Study|Withdrawal by Subject|11|||
105529688|NCT00782210|363949754|FG000|Overall Study|Non compliance with protocol|0|||
105529689|NCT00782210|363949755|FG001|Overall Study|Non compliance with protocol|3|||
105529690|NCT00782210|363949756|FG002|Overall Study|Non compliance with protocol|2|||
105529691|NCT00782210|363949754|FG000|Overall Study|Lack of Efficacy|13|||
105529692|NCT00782210|363949755|FG001|Overall Study|Lack of Efficacy|4|||
105529693|NCT00782210|363949756|FG002|Overall Study|Lack of Efficacy|1|||
105529694|NCT00782210|363949754|FG000|Overall Study|Other reason not described above|3|||
105529695|NCT00782210|363949755|FG001|Overall Study|Other reason not described above|2|||
105529696|NCT00782210|363949756|FG002|Overall Study|Other reason not described above|3|||
105529697|NCT01604343|363949763|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
105529698|NCT01604343|363949764|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
105529699|NCT01604343|363949765|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
105529700|NCT01604343|363949766|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
105529701|NCT01604343|363949767|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
105529702|NCT01604343|363949763|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
105529703|NCT01604343|363949764|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
105529704|NCT01604343|363949765|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
105529705|NCT01604343|363949766|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
105529706|NCT01604343|363949767|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
105529707|NCT01604343|363949763|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
105529708|NCT01604343|363949764|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
105529709|NCT01604343|363949765|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
105529710|NCT01604343|363949766|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
105529711|NCT01604343|363949767|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
105529712|NCT01604343|363949763|FG000|Prior to W52 Administration(Through W52)|Death|5|||
105529713|NCT01604343|363949764|FG001|Prior to W52 Administration(Through W52)|Death|0|||
105529714|NCT01604343|363949765|FG002|Prior to W52 Administration(Through W52)|Death|2|||
105529715|NCT01604343|363949766|FG003|Prior to W52 Administration(Through W52)|Death|0|||
105529716|NCT01604343|363949767|FG004|Prior to W52 Administration(Through W52)|Death|4|||
105529717|NCT01604343|363949763|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
105529718|NCT01604343|363949764|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
105529719|NCT01604343|363949765|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
105529720|NCT01604343|363949766|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
105529721|NCT01604343|363949767|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
105529722|NCT01604343|363949763|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
105529723|NCT01604343|363949764|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
105529724|NCT01604343|363949765|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
105529725|NCT01604343|363949766|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
105529726|NCT01604343|363949767|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
105529727|NCT01604343|363949763|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
105529728|NCT01604343|363949764|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
105529729|NCT01604343|363949765|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
105529730|NCT01604343|363949766|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
105529731|NCT01604343|363949767|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
105529732|NCT01604343|363949763|FG000|Prior to W52 Administration(Through W52)|Other|15|||
105529733|NCT01604343|363949764|FG001|Prior to W52 Administration(Through W52)|Other|0|||
105529734|NCT01604343|363949765|FG002|Prior to W52 Administration(Through W52)|Other|10|||
105529735|NCT01604343|363949766|FG003|Prior to W52 Administration(Through W52)|Other|0|||
105529736|NCT01604343|363949767|FG004|Prior to W52 Administration(Through W52)|Other|6|||
105529737|NCT01604343|363949763|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
105529738|NCT01604343|363949764|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
105529739|NCT01604343|363949765|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
105529740|NCT01604343|363949766|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
105529741|NCT01604343|363949767|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
105529742|NCT01604343|363949763|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
105529743|NCT01604343|363949764|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
105529744|NCT01604343|363949765|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
105529745|NCT01604343|363949766|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
105529746|NCT01604343|363949767|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
105529747|NCT01604343|363949763|FG000|Week 52 to Week 104|Adverse Event|0|||
105529748|NCT01604343|363949764|FG001|Week 52 to Week 104|Adverse Event|12|||
105529749|NCT01604343|363949765|FG002|Week 52 to Week 104|Adverse Event|26|||
105529750|NCT01604343|363949766|FG003|Week 52 to Week 104|Adverse Event|21|||
105529751|NCT01604343|363949767|FG004|Week 52 to Week 104|Adverse Event|27|||
105529752|NCT01604343|363949763|FG000|Week 52 to Week 104|Death|0|||
105529753|NCT01604343|363949764|FG001|Week 52 to Week 104|Death|4|||
105529754|NCT01604343|363949765|FG002|Week 52 to Week 104|Death|2|||
105529755|NCT01604343|363949766|FG003|Week 52 to Week 104|Death|5|||
105529756|NCT01604343|363949767|FG004|Week 52 to Week 104|Death|0|||
105529757|NCT01604343|363949763|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
105529758|NCT01604343|363949764|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
105529759|NCT01604343|363949765|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
105529760|NCT01604343|363949766|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
105529761|NCT01604343|363949767|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
105529762|NCT01604343|363949763|FG000|Week 52 to Week 104|Physician Decision|0|||
105529763|NCT01604343|363949764|FG001|Week 52 to Week 104|Physician Decision|1|||
105529764|NCT01604343|363949765|FG002|Week 52 to Week 104|Physician Decision|0|||
105529765|NCT01604343|363949766|FG003|Week 52 to Week 104|Physician Decision|0|||
105529766|NCT01604343|363949767|FG004|Week 52 to Week 104|Physician Decision|2|||
105529767|NCT01604343|363949763|FG000|Week 52 to Week 104|Pregnancy|0|||
105529768|NCT01604343|363949764|FG001|Week 52 to Week 104|Pregnancy|0|||
105529769|NCT01604343|363949765|FG002|Week 52 to Week 104|Pregnancy|1|||
105529770|NCT01604343|363949766|FG003|Week 52 to Week 104|Pregnancy|2|||
105529771|NCT01604343|363949767|FG004|Week 52 to Week 104|Pregnancy|1|||
105529772|NCT01604343|363949763|FG000|Week 52 to Week 104|Other|0|||
105529773|NCT01604343|363949764|FG001|Week 52 to Week 104|Other|11|||
105529774|NCT01604343|363949765|FG002|Week 52 to Week 104|Other|11|||
105529775|NCT01604343|363949766|FG003|Week 52 to Week 104|Other|6|||
105529776|NCT01604343|363949767|FG004|Week 52 to Week 104|Other|3|||
105529777|NCT01604343|363949763|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
105529778|NCT01604343|363949764|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
105529779|NCT01604343|363949765|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
105529780|NCT01604343|363949766|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
105529781|NCT01604343|363949767|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
105529782|NCT01604343|363949763|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
105529783|NCT01604343|363949764|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
105529784|NCT01604343|363949765|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
105529785|NCT01604343|363949766|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
105529786|NCT01604343|363949767|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
105529787|NCT01604343|363949763|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
105529788|NCT01604343|363949764|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
105529789|NCT01604343|363949765|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
105529790|NCT01604343|363949766|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
105529791|NCT01604343|363949767|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
105529792|NCT00048542|363949768|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
105529793|NCT00048542|363949769|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
105529794|NCT00048542|363949770|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
105529795|NCT00048542|363949771|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
105529796|NCT00048542|363949772|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
105529797|NCT00048542|363949773|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
105529798|NCT00048542|363949774|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
105529799|NCT00048542|363949775|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
105529800|NCT00048542|363949768|FG000|Double-Blind Phase|Protocol Violation|0|||
105529801|NCT00048542|363949769|FG001|Double-Blind Phase|Protocol Violation|0|||
105529802|NCT00048542|363949770|FG002|Double-Blind Phase|Protocol Violation|1|||
105529803|NCT00048542|363949771|FG003|Double-Blind Phase|Protocol Violation|0|||
105529804|NCT00048542|363949772|FG004|Double-Blind Phase|Protocol Violation|0|||
105529805|NCT00048542|363949773|FG005|Double-Blind Phase|Protocol Violation|0|||
105529806|NCT00048542|363949774|FG006|Double-Blind Phase|Protocol Violation|0|||
105529807|NCT00048542|363949775|FG007|Double-Blind Phase|Protocol Violation|0|||
105529808|NCT00048542|363949768|FG000|Double-Blind Phase|Sponsor request or decision|2|||
105529809|NCT00048542|363949769|FG001|Double-Blind Phase|Sponsor request or decision|0|||
105529810|NCT00048542|363949770|FG002|Double-Blind Phase|Sponsor request or decision|0|||
105529811|NCT00048542|363949771|FG003|Double-Blind Phase|Sponsor request or decision|0|||
105529812|NCT00048542|363949772|FG004|Double-Blind Phase|Sponsor request or decision|0|||
105529813|NCT00048542|363949773|FG005|Double-Blind Phase|Sponsor request or decision|0|||
105529814|NCT00048542|363949774|FG006|Double-Blind Phase|Sponsor request or decision|0|||
105529815|NCT00048542|363949775|FG007|Double-Blind Phase|Sponsor request or decision|0|||
105529816|NCT00048542|363949768|FG000|Double-Blind Phase|Randomized in error|1|||
105529817|NCT00048542|363949769|FG001|Double-Blind Phase|Randomized in error|0|||
105529818|NCT00048542|363949770|FG002|Double-Blind Phase|Randomized in error|0|||
105529819|NCT00048542|363949771|FG003|Double-Blind Phase|Randomized in error|0|||
105529820|NCT00048542|363949772|FG004|Double-Blind Phase|Randomized in error|0|||
105529821|NCT00048542|363949773|FG005|Double-Blind Phase|Randomized in error|0|||
105529822|NCT00048542|363949774|FG006|Double-Blind Phase|Randomized in error|0|||
105529823|NCT00048542|363949775|FG007|Double-Blind Phase|Randomized in error|0|||
105529824|NCT00048542|363949768|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
105529825|NCT00048542|363949769|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
105529826|NCT00048542|363949770|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
105529827|NCT00048542|363949771|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
105529828|NCT00048542|363949772|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
105529829|NCT00048542|363949773|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
105529830|NCT00048542|363949774|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
105529831|NCT00048542|363949775|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
105529832|NCT00048542|363949768|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
105529833|NCT00048542|363949769|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
105529834|NCT00048542|363949770|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
105529835|NCT00048542|363949771|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
105529836|NCT00048542|363949772|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
105529837|NCT00048542|363949773|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
105529838|NCT00048542|363949774|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
105529839|NCT00048542|363949775|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
105529840|NCT00048542|363949768|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
105529841|NCT00048542|363949769|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
105529842|NCT00048542|363949770|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
105529843|NCT00048542|363949771|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
105529844|NCT00048542|363949772|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
105529845|NCT00048542|363949773|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
105529846|NCT00048542|363949774|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
105529847|NCT00048542|363949775|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
105529848|NCT00048542|363949768|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
105529849|NCT00048542|363949769|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
105529850|NCT00048542|363949770|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
105529851|NCT00048542|363949771|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
105529852|NCT00048542|363949772|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
105529853|NCT00048542|363949773|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
105529854|NCT00048542|363949774|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
105529855|NCT00048542|363949775|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
105529856|NCT00048542|363949768|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
105529857|NCT00048542|363949769|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
105529858|NCT00048542|363949770|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
105529859|NCT00048542|363949771|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
105529860|NCT00048542|363949772|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
105529861|NCT00048542|363949773|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
105529862|NCT00048542|363949774|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
105529863|NCT00048542|363949775|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
105529864|NCT00048542|363949768|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
105529865|NCT00048542|363949769|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
105529866|NCT00048542|363949770|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
105529867|NCT00048542|363949771|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
105529868|NCT00048542|363949772|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
105529869|NCT00048542|363949773|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
105529870|NCT00048542|363949774|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
105529871|NCT00048542|363949775|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
105529872|NCT00048542|363949768|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
105529873|NCT00048542|363949769|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
105529874|NCT00048542|363949770|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
105529875|NCT00048542|363949771|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
105529876|NCT00048542|363949772|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
105529877|NCT00048542|363949773|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
105529878|NCT00048542|363949774|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
105529879|NCT00048542|363949775|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
105529880|NCT00048542|363949768|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
105529881|NCT00048542|363949769|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
105529882|NCT00048542|363949770|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
105529883|NCT00048542|363949771|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
105529884|NCT00048542|363949772|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
105529885|NCT00048542|363949773|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
105529886|NCT00048542|363949774|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
105529887|NCT00048542|363949775|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
105529888|NCT00048542|363949768|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
105529889|NCT00048542|363949769|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
105529890|NCT00048542|363949770|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
105529891|NCT00048542|363949771|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
105529892|NCT00048542|363949772|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
105529893|NCT00048542|363949773|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
105529894|NCT00048542|363949774|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
105529895|NCT00048542|363949775|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
105529896|NCT00048542|363949768|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
105529897|NCT00048542|363949769|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
105529898|NCT00048542|363949770|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
105529899|NCT00048542|363949771|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
105529900|NCT00048542|363949772|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
105529901|NCT00048542|363949773|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
105529902|NCT00048542|363949774|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
105529903|NCT00048542|363949775|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
105529904|NCT00048542|363949768|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
105529905|NCT00048542|363949769|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
105529906|NCT00048542|363949770|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
105529907|NCT00048542|363949771|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
105529908|NCT00048542|363949772|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
105529909|NCT00048542|363949773|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
105529910|NCT00048542|363949774|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
105529911|NCT00048542|363949775|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
105529912|NCT02775344|363949776|FG000|Overall Study|No ovarian cyst identified|3|||
105529913|NCT02775344|363949777|FG001|Overall Study|No ovarian cyst identified|2|||
105529914|NCT02018458|363949778|FG000|Overall Study|Death|4|||
105529915|NCT04098458|363949802|FG000|Overall Study|Death|1|||
105529916|NCT04098458|363949802|FG000|Overall Study|did not meet study inclusion criteria|3|||
105529917|NCT04033159|363949803|FG000|Washout Period|Physician Decision|0|||
105529918|NCT04033159|363949804|FG001|Washout Period|Physician Decision|1|||
105529919|NCT04033159|363949805|FG002|Washout Period|Physician Decision|0|||
105529920|NCT04033159|363949803|FG000|Washout Period|Study terminated by Sponsor|0|||
105529921|NCT04033159|363949804|FG001|Washout Period|Study terminated by Sponsor|7|||
105529922|NCT04033159|363949805|FG002|Washout Period|Study terminated by Sponsor|0|||
105529923|NCT04033159|363949803|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
105529924|NCT04033159|363949804|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
105529925|NCT04033159|363949805|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
105529926|NCT00314574|363949808|FG000|Overall Study|Death|3|||
105529927|NCT00314574|363949809|FG001|Overall Study|Death|0|||
105593807|NCT02914522|364172796|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
105593808|NCT02914522|364172797|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
105593809|NCT02914522|364172798|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
105593810|NCT02914522|364172799|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
105593811|NCT02914522|364172800|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
105593812|NCT02914522|364172790|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
105593813|NCT02914522|364172791|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
105593814|NCT02914522|364172792|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
105593815|NCT02914522|364172793|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
105593816|NCT02914522|364172794|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
105593817|NCT02914522|364172795|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
105593818|NCT02914522|364172796|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
105593819|NCT02914522|364172797|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
105593820|NCT02914522|364172798|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
105593821|NCT02914522|364172799|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
105529928|NCT00314574|363949808|FG000|Overall Study|Adverse Event|11|||
105529929|NCT00314574|363949809|FG001|Overall Study|Adverse Event|16|||
105529930|NCT00314574|363949808|FG000|Overall Study|Lost to Follow-up|19|||
105529931|NCT00314574|363949809|FG001|Overall Study|Lost to Follow-up|25|||
105529932|NCT00314574|363949808|FG000|Overall Study|Withdrawal by Subject|33|||
105529933|NCT00314574|363949809|FG001|Overall Study|Withdrawal by Subject|22|||
105529934|NCT00314574|363949808|FG000|Overall Study|Physician Decision|22|||
105529935|NCT00314574|363949809|FG001|Overall Study|Physician Decision|15|||
105529936|NCT00314574|363949808|FG000|Overall Study|Pregnancy|6|||
105529937|NCT00314574|363949809|FG001|Overall Study|Pregnancy|4|||
105529938|NCT00314574|363949808|FG000|Overall Study|Data unknown at database lock|0|||
105529939|NCT00314574|363949809|FG001|Overall Study|Data unknown at database lock|1|||
105529940|NCT00006489|363949810|FG000|Overall Study|Adverse Event|3|||
105529941|NCT00006489|363949811|FG001|Overall Study|Adverse Event|2|||
105529942|NCT00006489|363949812|FG002|Overall Study|Adverse Event|4|||
105529943|NCT00006489|363949813|FG003|Overall Study|Adverse Event|3|||
105529944|NCT00006489|363949810|FG000|Overall Study|Withdrawal by Subject|10|||
105529945|NCT00006489|363949811|FG001|Overall Study|Withdrawal by Subject|9|||
105529946|NCT00006489|363949812|FG002|Overall Study|Withdrawal by Subject|9|||
105529947|NCT00006489|363949813|FG003|Overall Study|Withdrawal by Subject|6|||
105529948|NCT00006489|363949810|FG000|Overall Study|Scheduling Conflict|0|||
105529949|NCT00006489|363949811|FG001|Overall Study|Scheduling Conflict|3|||
105529950|NCT00006489|363949812|FG002|Overall Study|Scheduling Conflict|2|||
105529951|NCT00006489|363949813|FG003|Overall Study|Scheduling Conflict|1|||
105529952|NCT00006489|363949810|FG000|Overall Study|Death|0|||
105529953|NCT00006489|363949811|FG001|Overall Study|Death|0|||
105529954|NCT00006489|363949812|FG002|Overall Study|Death|0|||
105529955|NCT00006489|363949813|FG003|Overall Study|Death|1|||
105529956|NCT02086110|363949814|FG000|Overall Study|Withdrawal by Subject|1|||
105529957|NCT02086110|363949815|FG001|Overall Study|Withdrawal by Subject|1|||
105529958|NCT00116558|363949821|FG000|Overall Study|Death|11|||
105529959|NCT00116558|363949822|FG001|Overall Study|Death|5|||
105529960|NCT00116558|363949823|FG002|Overall Study|Death|3|||
105529961|NCT00116558|363949821|FG000|Overall Study|Withdrawal by Subject|17|||
105529962|NCT00116558|363949822|FG001|Overall Study|Withdrawal by Subject|3|||
105593822|NCT02914522|364172800|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
105593823|NCT02914522|364172790|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
105593824|NCT02914522|364172791|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
105593825|NCT02914522|364172792|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
105593826|NCT02914522|364172793|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
105593827|NCT02914522|364172794|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
105593828|NCT02914522|364172795|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
105593829|NCT02914522|364172796|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
105593830|NCT02914522|364172797|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
105593831|NCT02914522|364172798|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
105593832|NCT02914522|364172799|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
105593833|NCT02914522|364172800|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
105593834|NCT02914522|364172790|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
105593835|NCT02914522|364172791|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
105593836|NCT02914522|364172792|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
105593837|NCT02914522|364172793|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
105593838|NCT02914522|364172794|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
105593839|NCT02914522|364172795|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
105593840|NCT02914522|364172796|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
105593841|NCT02914522|364172797|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
105593842|NCT02914522|364172798|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
105593843|NCT02914522|364172799|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
105593844|NCT02914522|364172800|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
105593845|NCT02914522|364172790|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
105593846|NCT02914522|364172791|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
105593847|NCT02914522|364172792|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
105529963|NCT00116558|363949823|FG002|Overall Study|Withdrawal by Subject|12|||
105529964|NCT00116558|363949821|FG000|Overall Study|disease progression|3|||
105529965|NCT00116558|363949822|FG001|Overall Study|disease progression|7|||
105529966|NCT00116558|363949823|FG002|Overall Study|disease progression|18|||
105529967|NCT02272413|363949825|FG000|Randomized Through Treatment Start|Not treated|3|||
105529968|NCT02272413|363949826|FG001|Randomized Through Treatment Start|Not treated|5|||
105529969|NCT02272413|363949825|FG000|Pre-switch Period|Adverse Event|38|||
105529970|NCT02272413|363949826|FG001|Pre-switch Period|Adverse Event|37|||
105529971|NCT02272413|363949825|FG000|Pre-switch Period|Death|26|||
105529972|NCT02272413|363949826|FG001|Pre-switch Period|Death|26|||
105529973|NCT02272413|363949825|FG000|Pre-switch Period|Withdrawal by Subject|27|||
105529974|NCT02272413|363949826|FG001|Pre-switch Period|Withdrawal by Subject|15|||
105529975|NCT02272413|363949825|FG000|Pre-switch Period|Physician Decision|6|||
105529976|NCT02272413|363949826|FG001|Pre-switch Period|Physician Decision|18|||
105529977|NCT02272413|363949825|FG000|Pre-switch Period|Progressive disease|185|||
105529978|NCT02272413|363949826|FG001|Pre-switch Period|Progressive disease|173|||
105529979|NCT02272413|363949825|FG000|Pre-switch Period|Lost to Follow-up|0|||
105529980|NCT02272413|363949826|FG001|Pre-switch Period|Lost to Follow-up|2|||
105529981|NCT02272413|363949825|FG000|Pre-switch Period|Protocol Violation|1|||
105529982|NCT02272413|363949826|FG001|Pre-switch Period|Protocol Violation|0|||
105529983|NCT02272413|363949825|FG000|Pre-switch Period|Other than listed|10|||
105529984|NCT02272413|363949826|FG001|Pre-switch Period|Other than listed|11|||
105529985|NCT02272413|363949825|FG000|Post-switch Period|Adverse Event|4|||
105529986|NCT02272413|363949826|FG001|Post-switch Period|Adverse Event|4|||
105529987|NCT02272413|363949825|FG000|Post-switch Period|Death|3|||
105529988|NCT02272413|363949826|FG001|Post-switch Period|Death|2|||
105529989|NCT02272413|363949825|FG000|Post-switch Period|Withdrawal by Subject|1|||
105529990|NCT02272413|363949826|FG001|Post-switch Period|Withdrawal by Subject|2|||
105529991|NCT02272413|363949825|FG000|Post-switch Period|Physician Decision|1|||
105529992|NCT02272413|363949826|FG001|Post-switch Period|Physician Decision|1|||
105529993|NCT02272413|363949825|FG000|Post-switch Period|Progressive disease|21|||
105529994|NCT02272413|363949826|FG001|Post-switch Period|Progressive disease|21|||
105529995|NCT02272413|363949825|FG000|Post-switch Period|Study terminated by sponsor|8|||
105529996|NCT02272413|363949826|FG001|Post-switch Period|Study terminated by sponsor|11|||
105529997|NCT02272413|363949825|FG000|Post-switch Period|Other than listed|4|||
105529998|NCT02272413|363949826|FG001|Post-switch Period|Other than listed|5|||
105529999|NCT02027844|363949827|FG000|Overall Study|Withdrawal by Subject|3|||
105530000|NCT02027844|363949828|FG001|Overall Study|Withdrawal by Subject|2|||
105530001|NCT02027844|363949829|FG002|Overall Study|Withdrawal by Subject|1|||
105530002|NCT02027844|363949827|FG000|Overall Study|Lost to Follow-up|0|||
105530003|NCT02027844|363949828|FG001|Overall Study|Lost to Follow-up|2|||
105530004|NCT02027844|363949829|FG002|Overall Study|Lost to Follow-up|1|||
105530005|NCT02027844|363949827|FG000|Overall Study|Protocol Violation|0|||
105530006|NCT02027844|363949828|FG001|Overall Study|Protocol Violation|2|||
105530007|NCT02027844|363949829|FG002|Overall Study|Protocol Violation|0|||
105530008|NCT02027844|363949827|FG000|Overall Study|Incomlete data|2|||
105530009|NCT02027844|363949828|FG001|Overall Study|Incomlete data|0|||
105530010|NCT02027844|363949829|FG002|Overall Study|Incomlete data|0|||
105530011|NCT02126969|363949830|FG000|Overall Study|Withdrawal by Subject|1|||
105530012|NCT02126969|363949831|FG001|Overall Study|Withdrawal by Subject|2|||
105530013|NCT01533246|363949832|FG000|Overall Study|Adverse Event|1|||
105530014|NCT01533246|363949832|FG000|Overall Study|Withdrawal by Subject|1|||
105530015|NCT00354172|363949833|FG000|Overall Study|Did not receive transplant|1|||
105530016|NCT00414661|363949834|FG000|Overall Study|Death|2|||
105530017|NCT00414661|363949835|FG001|Overall Study|Death|5|||
105530018|NCT00414661|363949836|FG002|Overall Study|Death|0|||
105530019|NCT00414661|363949837|FG003|Overall Study|Death|0|||
105530020|NCT00414661|363949834|FG000|Overall Study|Lost to Follow-up|1|||
105530021|NCT00414661|363949835|FG001|Overall Study|Lost to Follow-up|4|||
105530022|NCT00414661|363949836|FG002|Overall Study|Lost to Follow-up|0|||
105530023|NCT00414661|363949837|FG003|Overall Study|Lost to Follow-up|1|||
105530024|NCT00414661|363949834|FG000|Overall Study|Withdrawal by Subject|5|||
105530025|NCT00414661|363949835|FG001|Overall Study|Withdrawal by Subject|2|||
105593848|NCT02914522|364172793|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
105593849|NCT02914522|364172794|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
105593850|NCT02914522|364172795|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
105593851|NCT02914522|364172796|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
105593852|NCT02914522|364172797|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
105593853|NCT02914522|364172798|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
105593854|NCT02914522|364172799|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
105593855|NCT02914522|364172800|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
105593856|NCT00988637|364172802|FG000|Overall Study|Lost to Follow-up|2|||
105530026|NCT00414661|363949836|FG002|Overall Study|Withdrawal by Subject|2|||
105530027|NCT00414661|363949837|FG003|Overall Study|Withdrawal by Subject|2|||
105530028|NCT00414661|363949834|FG000|Overall Study|Other|6|||
105530029|NCT00414661|363949835|FG001|Overall Study|Other|3|||
105530030|NCT00414661|363949836|FG002|Overall Study|Other|0|||
105530031|NCT00414661|363949837|FG003|Overall Study|Other|0|||
105530032|NCT01143090|363949838|FG000|Overall Study|Lack of Efficacy|2|||
105530033|NCT01143090|363949838|FG000|Overall Study|Adverse Event|17|||
105530034|NCT01143090|363949838|FG000|Overall Study|Lost to Follow-up|9|||
105530035|NCT01143090|363949838|FG000|Overall Study|Protocol Violation|2|||
105530036|NCT01143090|363949838|FG000|Overall Study|Withdrawal by Subject|18|||
105530037|NCT01143090|363949838|FG000|Overall Study|Non-compliance with study drug|1|||
105530038|NCT01143090|363949838|FG000|Overall Study|Failure to meet eligibility criteria|1|||
105530039|NCT01143090|363949838|FG000|Overall Study|Administrative|1|||
105530040|NCT03491150|363949839|FG000|Overall Study|Adverse Event|1|||
105530041|NCT03491150|363949840|FG001|Overall Study|Adverse Event|0|||
105530042|NCT03491150|363949839|FG000|Overall Study|Study Terminated by Sponsor|74|||
105530043|NCT03491150|363949840|FG001|Overall Study|Study Terminated by Sponsor|70|||
105530044|NCT03491150|363949839|FG000|Overall Study|Other|0|||
105530045|NCT03491150|363949840|FG001|Overall Study|Other|1|||
105530046|NCT03491150|363949839|FG000|Overall Study|Withdrawal by Subject|1|||
105530047|NCT03491150|363949840|FG001|Overall Study|Withdrawal by Subject|2|||
105530048|NCT01988571|363949843|FG000|Overall Study|Death|3|||
105530049|NCT01988571|363949844|FG001|Overall Study|Death|1|||
105530050|NCT01988571|363949843|FG000|Overall Study|Physician Decision|2|||
105530051|NCT01988571|363949844|FG001|Overall Study|Physician Decision|1|||
105530052|NCT01988571|363949843|FG000|Overall Study|Lost to Follow-up|3|||
105530053|NCT01988571|363949844|FG001|Overall Study|Lost to Follow-up|0|||
105530054|NCT01988571|363949843|FG000|Overall Study|Withdrawal by Subject|31|||
105530055|NCT01988571|363949844|FG001|Overall Study|Withdrawal by Subject|33|||
105530056|NCT00937547|363949845|FG000|Overall Study|misdiagnosis|1|||
105530057|NCT00937547|363949846|FG001|Overall Study|misdiagnosis|6|||
105530058|NCT00937547|363949847|FG002|Overall Study|misdiagnosis|7|||
105530059|NCT00486265|363949857|FG000|Overall Study|Adverse Event|1|||
105530060|NCT00486265|363949857|FG000|Overall Study|Lack of Efficacy|8|||
105530061|NCT01452412|363949858|FG000|Overall Study|Withdrawal by Subject|15|||
105530062|NCT01452412|363949859|FG001|Overall Study|Withdrawal by Subject|11|||
105530063|NCT01452412|363949858|FG000|Overall Study|Adverse Event|4|||
105530064|NCT01452412|363949859|FG001|Overall Study|Adverse Event|3|||
105530065|NCT01452412|363949858|FG000|Overall Study|Lost to Follow-up|5|||
105530066|NCT01452412|363949859|FG001|Overall Study|Lost to Follow-up|3|||
105530067|NCT01452412|363949858|FG000|Overall Study|Death|1|||
105530068|NCT01452412|363949859|FG001|Overall Study|Death|0|||
105530069|NCT01452412|363949858|FG000|Overall Study|Initiated dialysis|1|||
105530070|NCT01452412|363949859|FG001|Overall Study|Initiated dialysis|0|||
105530071|NCT01452412|363949858|FG000|Overall Study|Other|2|||
105530072|NCT01452412|363949859|FG001|Overall Study|Other|0|||
105530073|NCT00855309|363949863|FG000|Overall Study|patient never recieved drug|1|||
105530074|NCT00855309|363949864|FG001|Overall Study|patient never recieved drug|0|||
105530075|NCT00829296|363949865|FG000|Overall Study|Adverse Event|5|||
105530076|NCT00829296|363949866|FG001|Overall Study|Adverse Event|4|||
105530077|NCT03029624|363949867|FG000|Overall Study|Adverse Event|1|||
105530078|NCT03029624|363949867|FG000|Overall Study|Withdrawal by Subject|1|||
105530079|NCT03029624|363949867|FG000|Overall Study|Lack of Efficacy|1|||
105530080|NCT03029624|363949867|FG000|Overall Study|MRI need|2|||
105530081|NCT04116710|363949870|FG000|Overall Study|Death|4|||
105530082|NCT04116710|363949871|FG001|Overall Study|Death|6|||
105530083|NCT04116710|363949872|FG002|Overall Study|Death|3|||
105530084|NCT04116710|363949873|FG003|Overall Study|Death|1|||
105530085|NCT04116710|363949870|FG000|Overall Study|Withdrawal by Subject|0|||
105530086|NCT04116710|363949871|FG001|Overall Study|Withdrawal by Subject|0|||
105530087|NCT04116710|363949872|FG002|Overall Study|Withdrawal by Subject|0|||
105530088|NCT04116710|363949873|FG003|Overall Study|Withdrawal by Subject|1|||
105530089|NCT00582933|363949874|FG000|Overall Study|Physician Decision|3|||
105593857|NCT00988637|364172803|FG001|Overall Study|Lost to Follow-up|1|||
105593858|NCT00988637|364172802|FG000|Overall Study|Withdrawal by Subject|1|||
105593859|NCT00988637|364172803|FG001|Overall Study|Withdrawal by Subject|1|||
105593860|NCT00988637|364172802|FG000|Overall Study|non-compliance with study drug|0|||
105593861|NCT00988637|364172803|FG001|Overall Study|non-compliance with study drug|1|||
105593862|NCT01161498|364172804|FG000|Overall Study|Disease Progression|0|||
105593863|NCT01161498|364172805|FG001|Overall Study|Disease Progression|1|||
105593864|NCT05484726|364172813|FG000|Overall Study|Protocol Violation|3|||
105593865|NCT05484726|364172814|FG001|Overall Study|Protocol Violation|3|||
105593866|NCT05484726|364172813|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
105530090|NCT02129803|363949875|FG000|Overall Study|Protocol Violation|4|||
105530091|NCT02129803|363949876|FG001|Overall Study|Protocol Violation|0|||
105530092|NCT02129803|363949875|FG000|Overall Study|Physician Decision|0|||
105530093|NCT02129803|363949876|FG001|Overall Study|Physician Decision|1|||
105530094|NCT02129803|363949875|FG000|Overall Study|Difficulty sleeping|1|||
105530095|NCT02129803|363949876|FG001|Overall Study|Difficulty sleeping|0|||
105530096|NCT02129803|363949875|FG000|Overall Study|Morning headache|0|||
105530097|NCT02129803|363949876|FG001|Overall Study|Morning headache|1|||
105530098|NCT02129803|363949875|FG000|Overall Study|Withdrawal by Subject|1|||
105530099|NCT02129803|363949876|FG001|Overall Study|Withdrawal by Subject|1|||
105530100|NCT03837899|363949877|FG000|Overall Study|Death|6|||
105530101|NCT03837899|363949878|FG001|Overall Study|Death|8|||
105530102|NCT03837899|363949879|FG002|Overall Study|Death|3|||
105530103|NCT03837899|363949880|FG003|Overall Study|Death|7|||
105530104|NCT03837899|363949881|FG004|Overall Study|Death|8|||
105530105|NCT03837899|363949882|FG005|Overall Study|Death|7|||
105530106|NCT03837899|363949877|FG000|Overall Study|Moved to post-trial access program|0|||
105530107|NCT03837899|363949878|FG001|Overall Study|Moved to post-trial access program|1|||
105530108|NCT03837899|363949879|FG002|Overall Study|Moved to post-trial access program|0|||
105530109|NCT03837899|363949880|FG003|Overall Study|Moved to post-trial access program|0|||
105530110|NCT03837899|363949881|FG004|Overall Study|Moved to post-trial access program|0|||
105530111|NCT03837899|363949882|FG005|Overall Study|Moved to post-trial access program|0|||
105530112|NCT03837899|363949877|FG000|Overall Study|Other|0|||
105530113|NCT03837899|363949878|FG001|Overall Study|Other|0|||
105530114|NCT03837899|363949879|FG002|Overall Study|Other|0|||
105530115|NCT03837899|363949880|FG003|Overall Study|Other|0|||
105530116|NCT03837899|363949881|FG004|Overall Study|Other|0|||
105530117|NCT03837899|363949882|FG005|Overall Study|Other|2|||
105530118|NCT03837899|363949877|FG000|Overall Study|Lost to Follow-up|0|||
105530119|NCT03837899|363949878|FG001|Overall Study|Lost to Follow-up|1|||
105530120|NCT03837899|363949879|FG002|Overall Study|Lost to Follow-up|0|||
105530121|NCT03837899|363949880|FG003|Overall Study|Lost to Follow-up|0|||
105530122|NCT03837899|363949881|FG004|Overall Study|Lost to Follow-up|0|||
105530123|NCT03837899|363949882|FG005|Overall Study|Lost to Follow-up|0|||
105530124|NCT03837899|363949877|FG000|Overall Study|Withdrawal by Subject|0|||
105530125|NCT03837899|363949878|FG001|Overall Study|Withdrawal by Subject|0|||
105530126|NCT03837899|363949879|FG002|Overall Study|Withdrawal by Subject|0|||
105530127|NCT03837899|363949880|FG003|Overall Study|Withdrawal by Subject|1|||
105530128|NCT03837899|363949881|FG004|Overall Study|Withdrawal by Subject|0|||
105530129|NCT03837899|363949882|FG005|Overall Study|Withdrawal by Subject|0|||
105530130|NCT03837899|363949877|FG000|Overall Study|Study specific discontinuation criteria|0|||
105530131|NCT03837899|363949878|FG001|Overall Study|Study specific discontinuation criteria|1|||
105530132|NCT03837899|363949879|FG002|Overall Study|Study specific discontinuation criteria|0|||
105530133|NCT03837899|363949880|FG003|Overall Study|Study specific discontinuation criteria|0|||
105530134|NCT03837899|363949881|FG004|Overall Study|Study specific discontinuation criteria|3|||
105530135|NCT03837899|363949882|FG005|Overall Study|Study specific discontinuation criteria|1|||
105530136|NCT02703636|363949883|FG000|Overall Study|Adverse Event|14|||
105530137|NCT02703636|363949883|FG000|Overall Study|Study stopped by sponsor|1|||
105530138|NCT02703636|363949883|FG000|Overall Study|Withdrawal by Subject|1|||
105530139|NCT01494610|363949884|FG000|Period 1|Withdrawal by Subject|1|||
105530140|NCT01494610|363949885|FG001|Period 1|Withdrawal by Subject|1|||
105530141|NCT01494610|363949884|FG000|Period 3|Adverse Event|1|||
105530142|NCT01494610|363949885|FG001|Period 3|Adverse Event|0|||
105530143|NCT01494610|363949884|FG000|Period 3|Withdrawal by Subject|1|||
105530144|NCT01494610|363949885|FG001|Period 3|Withdrawal by Subject|0|||
105530145|NCT01494610|363949884|FG000|Period 4|Protocol Violation|1|||
105530146|NCT01494610|363949885|FG001|Period 4|Protocol Violation|0|||
105530147|NCT01465464|363949886|FG000|Overall Study|Adverse Event|96|||
105530148|NCT01465464|363949887|FG001|Overall Study|Adverse Event|49|||
105530149|NCT01465464|363949886|FG000|Overall Study|Lack of Efficacy|139|||
105530150|NCT01465464|363949887|FG001|Overall Study|Lack of Efficacy|190|||
105530151|NCT01465464|363949886|FG000|Overall Study|Physician Decision|13|||
105530152|NCT01465464|363949887|FG001|Overall Study|Physician Decision|5|||
105530153|NCT01465464|363949886|FG000|Overall Study|Protocol Violation|1|||
105530154|NCT01465464|363949887|FG001|Overall Study|Protocol Violation|1|||
105530155|NCT01465464|363949886|FG000|Overall Study|Withdrawal by Subject|46|||
105530156|NCT01465464|363949887|FG001|Overall Study|Withdrawal by Subject|30|||
105530157|NCT01465464|363949886|FG000|Overall Study|Other|9|||
105530158|NCT01465464|363949887|FG001|Overall Study|Other|3|||
105530159|NCT01465464|363949886|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
105530160|NCT01465464|363949887|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
105530161|NCT00547703|363949890|FG000|Overall Study|Lost to Follow-up|1|||
105530162|NCT00547703|363949891|FG001|Overall Study|Lost to Follow-up|0|||
105530163|NCT00785486|363949892|FG000|Midazolam Alone|Withdrawal by Subject|1|||
105530164|NCT01537783|363949902|FG000|Overall Study|Lost to Follow-up|11|||
105530165|NCT01537783|363949903|FG001|Overall Study|Lost to Follow-up|2|||
105530166|NCT04399161|363949904|FG000|Overall Study|Withdrawal by Subject|1|||
105530167|NCT04399161|363949905|FG001|Overall Study|Withdrawal by Subject|0|||
105530168|NCT04399161|363949906|FG002|Overall Study|Withdrawal by Subject|2|||
105530169|NCT04399161|363949904|FG000|Overall Study|Protocol Violation|1|||
105530170|NCT04399161|363949905|FG001|Overall Study|Protocol Violation|2|||
105530171|NCT04399161|363949906|FG002|Overall Study|Protocol Violation|0|||
105530172|NCT02722928|363949909|FG000|Overall Study|Standard CT was not as required per prot|5|||
105530173|NCT02722928|363949910|FG001|Overall Study|Standard CT was not as required per prot|13|||
105530174|NCT02722928|363949909|FG000|Overall Study|Required Intraoperative MRI|5|||
105530175|NCT02722928|363949910|FG001|Overall Study|Required Intraoperative MRI|7|||
105530176|NCT01116232|363949911|FG000|Overall Study|Progressive diease|4|||
105530177|NCT01434290|363949913|FG000|Overall Study|Protocol Violation|6|||
105530178|NCT01434290|363949914|FG001|Overall Study|Protocol Violation|3|||
105530179|NCT01434290|363949913|FG000|Overall Study|No protocol treatment|2|||
105530180|NCT01434290|363949914|FG001|Overall Study|No protocol treatment|4|||
105530181|NCT02970968|363951554|FG000|Overall Study|Withdrawal by Subject|3|||
105530182|NCT02970968|363951555|FG001|Overall Study|Withdrawal by Subject|3|||
105530183|NCT02970968|363951554|FG000|Overall Study|Adverse Event|1|||
105530184|NCT02970968|363951555|FG001|Overall Study|Adverse Event|2|||
105530185|NCT02970968|363951554|FG000|Overall Study|Lost to Follow-up|1|||
105530186|NCT02970968|363951555|FG001|Overall Study|Lost to Follow-up|1|||
105530187|NCT02970968|363951554|FG000|Overall Study|Non-Compliance|0|||
105530188|NCT02970968|363951555|FG001|Overall Study|Non-Compliance|1|||
105530189|NCT03264404|363951556|FG000|Overall Study|Death|2|||
105530190|NCT03264404|363951556|FG000|Overall Study|Physician Decision|1|||
105530191|NCT03264404|363951556|FG000|Overall Study|Disease Progression|28|||
105530192|NCT03264404|363951556|FG000|Overall Study|Adverse Event|1|||
105530193|NCT03264404|363951556|FG000|Overall Study|Off study prior to treatment|2|||
105530194|NCT03036566|363951559|FG000|Overall Study|Lost to Follow-up|3|||
105530195|NCT01933048|363951563|FG000|Overall Study|Lost to Follow-up|15|||
105530196|NCT01933048|363951564|FG001|Overall Study|Lost to Follow-up|18|||
105530197|NCT01933048|363951563|FG000|Overall Study|personal reasons|1|||
105530198|NCT01933048|363951564|FG001|Overall Study|personal reasons|1|||
105530199|NCT01933048|363951563|FG000|Overall Study|Protocol Violation|7|||
105530200|NCT01933048|363951564|FG001|Overall Study|Protocol Violation|8|||
105530201|NCT01933048|363951563|FG000|Overall Study|Physician Decision|1|||
105530202|NCT01933048|363951564|FG001|Overall Study|Physician Decision|0|||
105530203|NCT01933048|363951563|FG000|Overall Study|unknown reasons|1|||
105530204|NCT01933048|363951564|FG001|Overall Study|unknown reasons|1|||
105530205|NCT01632891|363951565|FG000|Overall Study|Lost to Follow-up|0|||
105530206|NCT01632891|363951566|FG001|Overall Study|Lost to Follow-up|1|||
105530207|NCT01632891|363951565|FG000|Overall Study|Withdrawal by Subject|1|||
105530208|NCT01632891|363951566|FG001|Overall Study|Withdrawal by Subject|0|||
105530209|NCT00333229|363951567|FG000|Overall Study|Lack of Efficacy|0|||
105530210|NCT00333229|363951568|FG001|Overall Study|Lack of Efficacy|1|||
105530211|NCT00348556|363951569|FG000|Overall Study|Adverse Event|1|||
105530212|NCT01466270|363951571|FG000|Overall Study|Withdrawal by Subject|4|||
105530213|NCT01466270|363951572|FG001|Overall Study|Withdrawal by Subject|1|||
105530214|NCT01466270|363951571|FG000|Overall Study|Physician Decision|1|||
105530215|NCT01466270|363951572|FG001|Overall Study|Physician Decision|0|||
105530216|NCT01466270|363951571|FG000|Overall Study|Lost to Follow-up|1|||
105530217|NCT01466270|363951572|FG001|Overall Study|Lost to Follow-up|3|||
105530218|NCT01466270|363951571|FG000|Overall Study|Progression|1|||
105530219|NCT01466270|363951572|FG001|Overall Study|Progression|0|||
105530220|NCT01466270|363951571|FG000|Overall Study|Toxicity|4|||
105530221|NCT01466270|363951572|FG001|Overall Study|Toxicity|1|||
105530222|NCT01466270|363951571|FG000|Overall Study|Multiple|1|||
105530223|NCT01466270|363951572|FG001|Overall Study|Multiple|1|||
105530224|NCT01944059|363951573|FG000|Overall Study|Lost to Follow-up|1|||
105530225|NCT01944059|363951573|FG000|Overall Study|Physician Decision|3|||
105530226|NCT01944059|363951573|FG000|Overall Study|Withdrawal by Subject|1|||
105530227|NCT01944059|363951573|FG000|Overall Study|Adverse Event|2|||
105530228|NCT02821962|363951574|FG000|Overall Study|Lost to Follow-up|2|||
105530229|NCT02821962|363951575|FG001|Overall Study|Lost to Follow-up|0|||
105530230|NCT04206293|363951590|FG000|Overall Study|Consent withdrawal|1|||
105530231|NCT00463060|363951594|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
105530232|NCT00463060|363951594|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
105530233|NCT01631474|363951596|FG000|Overall Study|Lost to Follow-up|8|||
105530234|NCT01631474|363951597|FG001|Overall Study|Lost to Follow-up|5|||
105530235|NCT01631474|363951598|FG002|Overall Study|Lost to Follow-up|7|||
105530236|NCT01631474|363951599|FG003|Overall Study|Lost to Follow-up|5|||
105530237|NCT01631474|363951600|FG004|Overall Study|Lost to Follow-up|5|||
105530238|NCT01631474|363951596|FG000|Overall Study|Withdrawal by Subject|4|||
105530239|NCT01631474|363951597|FG001|Overall Study|Withdrawal by Subject|4|||
105530240|NCT01631474|363951598|FG002|Overall Study|Withdrawal by Subject|2|||
105530241|NCT01631474|363951599|FG003|Overall Study|Withdrawal by Subject|6|||
105530242|NCT01631474|363951600|FG004|Overall Study|Withdrawal by Subject|5|||
105530243|NCT01631474|363951596|FG000|Overall Study|Lack of Efficacy|2|||
105530244|NCT01631474|363951597|FG001|Overall Study|Lack of Efficacy|2|||
105530245|NCT01631474|363951598|FG002|Overall Study|Lack of Efficacy|0|||
105530246|NCT01631474|363951599|FG003|Overall Study|Lack of Efficacy|0|||
105530247|NCT01631474|363951600|FG004|Overall Study|Lack of Efficacy|2|||
105530248|NCT01631474|363951596|FG000|Overall Study|Noncompliance with Study Drug|0|||
105530249|NCT01631474|363951597|FG001|Overall Study|Noncompliance with Study Drug|0|||
105530250|NCT01631474|363951598|FG002|Overall Study|Noncompliance with Study Drug|0|||
105530251|NCT01631474|363951599|FG003|Overall Study|Noncompliance with Study Drug|0|||
105530252|NCT01631474|363951600|FG004|Overall Study|Noncompliance with Study Drug|1|||
105530253|NCT01631474|363951596|FG000|Overall Study|Adverse Event|0|||
105530254|NCT01631474|363951597|FG001|Overall Study|Adverse Event|1|||
105530255|NCT01631474|363951598|FG002|Overall Study|Adverse Event|0|||
105530256|NCT01631474|363951599|FG003|Overall Study|Adverse Event|0|||
105530257|NCT01631474|363951600|FG004|Overall Study|Adverse Event|0|||
105530258|NCT01869192|363951607|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
105530259|NCT01869192|363951608|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
105593867|NCT05484726|364172814|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
105593868|NCT05484726|364172813|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
105593869|NCT05484726|364172814|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
105593870|NCT05484726|364172813|FG000|Overall Study|continued need of mechanical ventilation|2|||
105593871|NCT05484726|364172814|FG001|Overall Study|continued need of mechanical ventilation|3|||
105593872|NCT05484726|364172813|FG000|Overall Study|Withdrawal by Subject|2|||
105593873|NCT05484726|364172814|FG001|Overall Study|Withdrawal by Subject|3|||
105593874|NCT05484726|364172813|FG000|Overall Study|IVH (G III & IV)|2|||
105593875|NCT05484726|364172814|FG001|Overall Study|IVH (G III & IV)|1|||
105593876|NCT05484726|364172813|FG000|Overall Study|NEC (stage II & III)|2|||
105593877|NCT05484726|364172814|FG001|Overall Study|NEC (stage II & III)|3|||
105593878|NCT00823979|364172817|FG000|Overall Study|Lack of Efficacy|13|||
105593879|NCT00823979|364172818|FG001|Overall Study|Lack of Efficacy|16|||
105593880|NCT00823979|364172819|FG002|Overall Study|Lack of Efficacy|9|||
105593881|NCT00823979|364172817|FG000|Overall Study|Lost to Follow-up|2|||
105593882|NCT00823979|364172818|FG001|Overall Study|Lost to Follow-up|1|||
105593883|NCT00823979|364172819|FG002|Overall Study|Lost to Follow-up|0|||
105593884|NCT00823979|364172817|FG000|Overall Study|Withdrawal by Subject|2|||
105593885|NCT00823979|364172818|FG001|Overall Study|Withdrawal by Subject|3|||
105593886|NCT00823979|364172819|FG002|Overall Study|Withdrawal by Subject|2|||
105593887|NCT00823979|364172817|FG000|Overall Study|Protocol Violation|1|||
105593888|NCT00823979|364172818|FG001|Overall Study|Protocol Violation|1|||
105593889|NCT00823979|364172819|FG002|Overall Study|Protocol Violation|0|||
105593890|NCT00823979|364172817|FG000|Overall Study|Pregnancy|0|||
105593891|NCT00823979|364172818|FG001|Overall Study|Pregnancy|1|||
105593892|NCT00823979|364172819|FG002|Overall Study|Pregnancy|0|||
105593893|NCT00823979|364172817|FG000|Overall Study|Adverse Event|0|||
105593894|NCT00823979|364172818|FG001|Overall Study|Adverse Event|2|||
105593895|NCT00823979|364172819|FG002|Overall Study|Adverse Event|4|||
105593896|NCT00823979|364172817|FG000|Overall Study|Other|2|||
105593897|NCT00823979|364172818|FG001|Overall Study|Other|0|||
105593898|NCT00823979|364172819|FG002|Overall Study|Other|1|||
105593899|NCT00823979|364172817|FG000|Overall Study|Randomized but not Treated|4|||
105593900|NCT00823979|364172818|FG001|Overall Study|Randomized but not Treated|3|||
105593901|NCT00823979|364172819|FG002|Overall Study|Randomized but not Treated|1|||
105593902|NCT00823979|364172817|FG000|Overall Study|Study Terminated by Sponsor|5|||
105593903|NCT00823979|364172818|FG001|Overall Study|Study Terminated by Sponsor|5|||
105593904|NCT00823979|364172819|FG002|Overall Study|Study Terminated by Sponsor|7|||
105593905|NCT02770248|364172821|FG000|Overall Study|Adverse Event|0|||
105593906|NCT02770248|364172822|FG001|Overall Study|Adverse Event|1|||
105593907|NCT02770248|364172821|FG000|Overall Study|Randomized in error, prior to treatment|0|||
105593908|NCT02770248|364172822|FG001|Overall Study|Randomized in error, prior to treatment|1|||
105593909|NCT01768676|364172823|FG000|Overall Study|Adverse Event|3|||
105593910|NCT01768676|364172824|FG001|Overall Study|Adverse Event|3|||
105593911|NCT01768676|364172823|FG000|Overall Study|Lost to Follow-up|13|||
105593912|NCT01768676|364172824|FG001|Overall Study|Lost to Follow-up|16|||
105593913|NCT01768676|364172823|FG000|Overall Study|Protocol Violation|1|||
105593914|NCT01768676|364172824|FG001|Overall Study|Protocol Violation|1|||
105593915|NCT01768676|364172823|FG000|Overall Study|Physician Decision|4|||
105593916|NCT01768676|364172824|FG001|Overall Study|Physician Decision|1|||
105593917|NCT01768676|364172823|FG000|Overall Study|Withdrawal by Subject|3|||
105593918|NCT01768676|364172824|FG001|Overall Study|Withdrawal by Subject|10|||
105593919|NCT04133363|364172825|FG000|Overall Study|Lost to Follow-up|2|||
105593920|NCT04133363|364172826|FG001|Overall Study|Lost to Follow-up|1|||
105593921|NCT04133363|364172827|FG002|Overall Study|Lost to Follow-up|4|||
105593922|NCT03227757|364174867|FG000|Overall Study|Death|25|||
105593923|NCT03227757|364174867|FG000|Overall Study|Withdrawal|10|||
105593924|NCT03227757|364174867|FG000|Overall Study|Missed visits|1|||
105593925|NCT03227757|364174867|FG000|Overall Study|Lost to Follow-up|2|||
105593926|NCT02738840|364174868|FG000|Overall Study|MRI Scan not Performed|5|||
105593927|NCT02738840|364174868|FG000|Overall Study|Lost to Follow-up|1|||
105593928|NCT02738840|364174868|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
105593929|NCT02738840|364174868|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
105593930|NCT01311648|364174871|FG000|Main Study|Protocol Violation|0|||
105593931|NCT01311648|364174872|FG001|Main Study|Protocol Violation|1|||
105593932|NCT01311648|364174871|FG000|Main Study|Adverse Event|0|||
105593933|NCT01311648|364174872|FG001|Main Study|Adverse Event|1|||
105593934|NCT01311648|364174871|FG000|Main Study|Inhibitor management|0|||
105593935|NCT01311648|364174872|FG001|Main Study|Inhibitor management|17|||
105593936|NCT01311648|364174871|FG000|Main Study|Withdrawal by Subject|0|||
105593937|NCT01311648|364174872|FG001|Main Study|Withdrawal by Subject|2|||
105593938|NCT01311648|364174871|FG000|Extension Study|Physician Decision|0|||
105593939|NCT01311648|364174872|FG001|Extension Study|Physician Decision|1|||
105593940|NCT01311648|364174871|FG000|Extension Study|ITI therapy with marketed product|0|||
105593941|NCT01311648|364174872|FG001|Extension Study|ITI therapy with marketed product|1|||
105593942|NCT01311648|364174871|FG000|Extension Study|Incorrect visit planning|0|||
105593943|NCT01311648|364174872|FG001|Extension Study|Incorrect visit planning|1|||
105593944|NCT01311648|364174871|FG000|Extension Study|Family's decision|0|||
105593945|NCT01311648|364174872|FG001|Extension Study|Family's decision|1|||
105593946|NCT01311648|364174871|FG000|Extension Study|Failure of ITI therapy|0|||
105593947|NCT01311648|364174872|FG001|Extension Study|Failure of ITI therapy|3|||
105593948|NCT01311648|364174871|FG000|Extension Study|Long travel|0|||
105593949|NCT01311648|364174872|FG001|Extension Study|Long travel|1|||
105593950|NCT01311648|364174871|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
105593951|NCT01311648|364174872|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
105593952|NCT01311648|364174871|FG000|Extension Study|Withdrawal by Subject|0|||
105593953|NCT01311648|364174872|FG001|Extension Study|Withdrawal by Subject|1|||
105593954|NCT01311648|364174871|FG000|Extension Study|Inhibitor management|0|||
105593955|NCT01311648|364174872|FG001|Extension Study|Inhibitor management|2|||
105593956|NCT03837028|364174877|FG000|Overall Study|Lost to Follow-up|4|||
105593957|NCT03837028|364174878|FG001|Overall Study|Lost to Follow-up|0|||
105593958|NCT03837028|364174879|FG002|Overall Study|Lost to Follow-up|2|||
105593959|NCT03837028|364174880|FG003|Overall Study|Lost to Follow-up|0|||
105593960|NCT03837028|364174877|FG000|Overall Study|Withdrawal by Subject|12|||
105593961|NCT03837028|364174878|FG001|Overall Study|Withdrawal by Subject|11|||
105593962|NCT03837028|364174879|FG002|Overall Study|Withdrawal by Subject|11|||
105593963|NCT03837028|364174880|FG003|Overall Study|Withdrawal by Subject|7|||
105593964|NCT02974634|364174881|FG000|Overall Study|Advanced disease|12|||
105593965|NCT02974634|364174882|FG001|Overall Study|Advanced disease|3|||
105593966|NCT02974634|364174881|FG000|Overall Study|Noncompliance|3|||
105530260|NCT01869192|363951607|FG000|Postoperative Chemotherapy|Physician Decision|0|||
105530261|NCT01869192|363951608|FG001|Postoperative Chemotherapy|Physician Decision|2|||
105530262|NCT01800916|363951609|FG000|Test Period 1 (1 Week)|Convex product user|0|||
105530263|NCT01800916|363951610|FG001|Test Period 1 (1 Week)|Convex product user|0|||
105530264|NCT01800916|363951611|FG002|Test Period 1 (1 Week)|Convex product user|0|||
105530265|NCT01800916|363951612|FG003|Test Period 1 (1 Week)|Convex product user|1|||
105530266|NCT01800916|363951613|FG004|Test Period 1 (1 Week)|Convex product user|0|||
105530267|NCT01800916|363951614|FG005|Test Period 1 (1 Week)|Convex product user|0|||
105530268|NCT01800916|363951615|FG006|Test Period 1 (1 Week)|Convex product user|0|||
105530269|NCT01800916|363951616|FG007|Test Period 1 (1 Week)|Convex product user|0|||
105530270|NCT01800916|363951617|FG008|Test Period 1 (1 Week)|Convex product user|0|||
105530271|NCT01800916|363951609|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
105530272|NCT01800916|363951610|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
105530273|NCT01800916|363951611|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
105530274|NCT01800916|363951612|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
105530275|NCT01800916|363951613|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
105530276|NCT01800916|363951614|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
105530277|NCT01800916|363951615|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
105530278|NCT01800916|363951616|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
105530279|NCT01800916|363951617|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
105530280|NCT00004412|363951619|FG000|Randomized Period|Moved to Crossover Period|3|||
105530281|NCT00004412|363951620|FG001|Randomized Period|Moved to Crossover Period|0|||
105530282|NCT00004412|363951621|FG002|Randomized Period|Moved to Crossover Period|0|||
105530283|NCT00727714|363951627|FG000|Overall Study|Lost to Follow-up|2|||
105530284|NCT01234467|363951633|FG000|Overall Study|Adverse Event|3|||
105530285|NCT01234467|363951633|FG000|Overall Study|Death|2|||
105530286|NCT01234467|363951633|FG000|Overall Study|Withdrawal by Subject|2|||
105530287|NCT01234467|363951633|FG000|Overall Study|Disease Progression|2|||
105530288|NCT01234467|363951633|FG000|Overall Study|Clinical deterioration|1|||
105530289|NCT01234467|363951633|FG000|Overall Study|Physician Decision|1|||
105530290|NCT01234467|363951633|FG000|Overall Study|Other complicating disease (stroke)|1|||
105530291|NCT01461096|363951637|FG000|Overall Study|Death|3|||
105530292|NCT01461096|363951638|FG001|Overall Study|Death|6|||
105530293|NCT01461096|363951637|FG000|Overall Study|Severe debilitation, unable to continue|1|||
105530294|NCT01461096|363951638|FG001|Overall Study|Severe debilitation, unable to continue|1|||
105530295|NCT01461096|363951637|FG000|Overall Study|Subj not able to get to clinic|15|||
105530296|NCT01461096|363951638|FG001|Overall Study|Subj not able to get to clinic|13|||
105530297|NCT01461096|363951637|FG000|Overall Study|Site is closing|27|||
105593967|NCT02974634|364174882|FG001|Overall Study|Noncompliance|7|||
105593968|NCT02974634|364174881|FG000|Overall Study|intervention technology related issues|5|||
105530298|NCT01461096|363951638|FG001|Overall Study|Site is closing|30|||
105530299|NCT01461096|363951637|FG000|Overall Study|Withdrawal by Subject|5|||
105593969|NCT02974634|364174882|FG001|Overall Study|intervention technology related issues|0|||
105593970|NCT02974634|364174881|FG000|Overall Study|Death|8|||
105530300|NCT01461096|363951638|FG001|Overall Study|Withdrawal by Subject|3|||
105530301|NCT01461096|363951637|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
105530302|NCT01461096|363951638|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
105530303|NCT01461096|363951637|FG000|Overall Study|Lost to Follow-up|8|||
105530304|NCT01461096|363951638|FG001|Overall Study|Lost to Follow-up|4|||
105593971|NCT02974634|364174882|FG001|Overall Study|Death|11|||
105593972|NCT01249092|364174884|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
105593973|NCT01249092|364174884|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
105593974|NCT01546155|364174885|FG000|Overall Study|could not tolerate long scan duration|3|||
105530305|NCT04889625|363951640|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
105530306|NCT04889625|363951641|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
105530307|NCT04889625|363951640|FG000|Period 1|Subject out of window|0|||
105530308|NCT04889625|363951641|FG001|Period 1|Subject out of window|1|||
105530309|NCT04889625|363951640|FG000|Period 1|Wrong add power dispensed|0|||
105530310|NCT04889625|363951641|FG001|Period 1|Wrong add power dispensed|1|||
105530311|NCT04889625|363951640|FG000|Period 1|Discontinued due to fitting guide error|1|||
105530312|NCT04889625|363951641|FG001|Period 1|Discontinued due to fitting guide error|1|||
105530313|NCT04889625|363951640|FG000|Period 2|Test article no longer available|1|||
105530314|NCT04889625|363951641|FG001|Period 2|Test article no longer available|0|||
105530315|NCT04889625|363951640|FG000|Period 2|Incorrect lens dispensed|1|||
105530316|NCT04889625|363951641|FG001|Period 2|Incorrect lens dispensed|0|||
105530317|NCT04889625|363951640|FG000|Period 2|Wrong add power dispensed|0|||
105530318|NCT04889625|363951641|FG001|Period 2|Wrong add power dispensed|1|||
105530319|NCT03144180|363951642|FG000|Overall Study|STAT Delivery|1|||
105530320|NCT03144180|363951643|FG001|Overall Study|STAT Delivery|1|||
105530321|NCT03144180|363951642|FG000|Overall Study|Provider forgot to fill out forms|1|||
105530322|NCT03144180|363951643|FG001|Overall Study|Provider forgot to fill out forms|3|||
105530323|NCT03144180|363951642|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
105530324|NCT03144180|363951643|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
105530325|NCT03144180|363951642|FG000|Overall Study|Scrub tech removed tube cap|0|||
105530326|NCT03144180|363951643|FG001|Overall Study|Scrub tech removed tube cap|1|||
105530327|NCT01639040|363951646|FG000|Overall Study|Adverse Event|1|||
105530328|NCT01639040|363951647|FG001|Overall Study|Adverse Event|0|||
105530329|NCT02346136|363951652|FG000|Overall Study|Withdrawal by Subject|7|||
105530330|NCT02346136|363951653|FG001|Overall Study|Withdrawal by Subject|5|||
105530331|NCT02346136|363951652|FG000|Overall Study|Death|1|||
105530332|NCT02346136|363951653|FG001|Overall Study|Death|0|||
105530333|NCT02346136|363951652|FG000|Overall Study|Study termination|14|||
105530334|NCT02346136|363951653|FG001|Overall Study|Study termination|18|||
105530335|NCT00323414|363951660|FG000|Overall Study|Withdrawal by Subject|0|||
105530336|NCT00323414|363951661|FG001|Overall Study|Withdrawal by Subject|1|||
105530337|NCT02659020|363951662|FG000|Overall Study|Adverse Event|0|||
105530338|NCT02659020|363951663|FG001|Overall Study|Adverse Event|0|||
105530339|NCT02659020|363951664|FG002|Overall Study|Adverse Event|0|||
105530340|NCT02659020|363951665|FG003|Overall Study|Adverse Event|2|||
105530341|NCT02659020|363951666|FG004|Overall Study|Adverse Event|0|||
105530342|NCT02659020|363951667|FG005|Overall Study|Adverse Event|0|||
105530343|NCT02659020|363951668|FG006|Overall Study|Adverse Event|2|||
105530344|NCT02659020|363951662|FG000|Overall Study|Lost to Follow-up|1|||
105530345|NCT02659020|363951663|FG001|Overall Study|Lost to Follow-up|2|||
105530346|NCT02659020|363951664|FG002|Overall Study|Lost to Follow-up|1|||
105530347|NCT02659020|363951665|FG003|Overall Study|Lost to Follow-up|6|||
105530348|NCT02659020|363951666|FG004|Overall Study|Lost to Follow-up|1|||
105530349|NCT02659020|363951667|FG005|Overall Study|Lost to Follow-up|5|||
105530350|NCT02659020|363951668|FG006|Overall Study|Lost to Follow-up|0|||
105530351|NCT02659020|363951662|FG000|Overall Study|Physician Decision|0|||
105530352|NCT02659020|363951663|FG001|Overall Study|Physician Decision|0|||
105530353|NCT02659020|363951664|FG002|Overall Study|Physician Decision|0|||
105530354|NCT02659020|363951665|FG003|Overall Study|Physician Decision|1|||
105530355|NCT02659020|363951666|FG004|Overall Study|Physician Decision|1|||
105530356|NCT02659020|363951667|FG005|Overall Study|Physician Decision|0|||
105530357|NCT02659020|363951668|FG006|Overall Study|Physician Decision|1|||
105530358|NCT02659020|363951662|FG000|Overall Study|Withdrawal by Subject|2|||
105530359|NCT02659020|363951663|FG001|Overall Study|Withdrawal by Subject|1|||
105530360|NCT02659020|363951664|FG002|Overall Study|Withdrawal by Subject|0|||
105530361|NCT02659020|363951665|FG003|Overall Study|Withdrawal by Subject|3|||
105530362|NCT02659020|363951666|FG004|Overall Study|Withdrawal by Subject|3|||
105530363|NCT02659020|363951667|FG005|Overall Study|Withdrawal by Subject|6|||
105530364|NCT02659020|363951668|FG006|Overall Study|Withdrawal by Subject|3|||
105530365|NCT02659020|363951662|FG000|Overall Study|Progressive Disease|0|||
105530366|NCT02659020|363951663|FG001|Overall Study|Progressive Disease|0|||
105530367|NCT02659020|363951664|FG002|Overall Study|Progressive Disease|0|||
105530368|NCT02659020|363951665|FG003|Overall Study|Progressive Disease|4|||
105530369|NCT02659020|363951666|FG004|Overall Study|Progressive Disease|1|||
105530370|NCT02659020|363951667|FG005|Overall Study|Progressive Disease|0|||
105530371|NCT02659020|363951668|FG006|Overall Study|Progressive Disease|2|||
105530372|NCT04382911|363951669|FG000|Overall Study|unable to be imaged prior to surgery|2|||
105530373|NCT01077960|363951672|FG000|Overall Study|Adverse Event|6|||
105530374|NCT01077960|363951672|FG000|Overall Study|Protocol Violation|3|||
105530375|NCT01077960|363951672|FG000|Overall Study|Lost to Follow-up|5|||
105530376|NCT01077960|363951672|FG000|Overall Study|Subject decision|1|||
105530377|NCT01077960|363951672|FG000|Overall Study|Reason unspecified|1|||
105530378|NCT00974571|363951673|FG000|Overall Study|Adverse Event|31|||
105530379|NCT00974571|363951674|FG001|Overall Study|Adverse Event|4|||
105530380|NCT00974571|363951675|FG002|Overall Study|Adverse Event|27|||
105530381|NCT00974571|363951673|FG000|Overall Study|Lack of Efficacy|3|||
105530382|NCT00974571|363951674|FG001|Overall Study|Lack of Efficacy|2|||
105530383|NCT00974571|363951675|FG002|Overall Study|Lack of Efficacy|9|||
105530384|NCT00974571|363951673|FG000|Overall Study|Lost to Follow-up|2|||
105530385|NCT00974571|363951674|FG001|Overall Study|Lost to Follow-up|1|||
105530386|NCT00974571|363951675|FG002|Overall Study|Lost to Follow-up|2|||
105530387|NCT00974571|363951673|FG000|Overall Study|Protocol Violation|13|||
105530388|NCT00974571|363951674|FG001|Overall Study|Protocol Violation|4|||
105530389|NCT00974571|363951675|FG002|Overall Study|Protocol Violation|18|||
105530390|NCT00974571|363951673|FG000|Overall Study|Withdrawal by Subject|14|||
105530391|NCT00974571|363951674|FG001|Overall Study|Withdrawal by Subject|5|||
105530392|NCT00974571|363951675|FG002|Overall Study|Withdrawal by Subject|16|||
105530393|NCT00974571|363951673|FG000|Overall Study|Patient Moved|1|||
105530394|NCT00974571|363951674|FG001|Overall Study|Patient Moved|0|||
105530395|NCT00974571|363951675|FG002|Overall Study|Patient Moved|1|||
105530396|NCT00974571|363951673|FG000|Overall Study|Other|4|||
105530397|NCT00974571|363951674|FG001|Overall Study|Other|0|||
105530398|NCT00974571|363951675|FG002|Overall Study|Other|10|||
105530399|NCT01371656|363951676|FG000|Overall Study|Death|7|||
105530400|NCT01371656|363951677|FG001|Overall Study|Death|4|||
105530401|NCT01371656|363951676|FG000|Overall Study|Physician Decision|46|||
105530402|NCT01371656|363951677|FG001|Overall Study|Physician Decision|7|||
105530403|NCT01371656|363951676|FG000|Overall Study|Withdrawal by Subject|7|||
105530404|NCT01371656|363951677|FG001|Overall Study|Withdrawal by Subject|0|||
105530405|NCT01371656|363951676|FG000|Overall Study|Ineligible|4|||
105530406|NCT01371656|363951677|FG001|Overall Study|Ineligible|3|||
105530407|NCT04334460|363951686|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
105530408|NCT04334460|363951687|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
105530409|NCT04334460|363951686|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
105530410|NCT04334460|363951687|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
105530411|NCT02385799|363951688|FG000|Overall Study|Lost to Follow-up|1|||
105530412|NCT02385799|363951689|FG001|Overall Study|Lost to Follow-up|2|||
105530413|NCT02385799|363951688|FG000|Overall Study|Adverse Event|4|||
105530414|NCT02385799|363951689|FG001|Overall Study|Adverse Event|2|||
105530415|NCT02385799|363951688|FG000|Overall Study|Withdrawal by Subject|0|||
105530416|NCT02385799|363951689|FG001|Overall Study|Withdrawal by Subject|4|||
105530417|NCT02130765|363951692|FG000|Overall Study|Did not receive treatment|4|||
105530418|NCT02130765|363951693|FG001|Overall Study|Did not receive treatment|0|||
105530419|NCT02130765|363951694|FG002|Overall Study|Did not receive treatment|0|||
105530420|NCT02130765|363951695|FG003|Overall Study|Did not receive treatment|0|||
105530421|NCT00376168|363951697|FG000|Overall Study|Adverse Event|1|||
105530422|NCT00376168|363951698|FG001|Overall Study|Adverse Event|1|||
105530423|NCT00376168|363951697|FG000|Overall Study|Pregnancy|1|||
105530424|NCT00376168|363951698|FG001|Overall Study|Pregnancy|0|||
105530425|NCT00477672|363951699|FG000|Overall Study|Adverse Event|3|||
105530426|NCT00477672|363951700|FG001|Overall Study|Adverse Event|5|||
105530427|NCT00477672|363951701|FG002|Overall Study|Adverse Event|6|||
105530428|NCT00477672|363951699|FG000|Overall Study|Death|0|||
105530429|NCT00477672|363951700|FG001|Overall Study|Death|1|||
105530430|NCT00477672|363951701|FG002|Overall Study|Death|0|||
105530431|NCT00477672|363951699|FG000|Overall Study|Disease progression|0|||
105530432|NCT00477672|363951700|FG001|Overall Study|Disease progression|1|||
105530433|NCT00477672|363951701|FG002|Overall Study|Disease progression|0|||
105530434|NCT00477672|363951699|FG000|Overall Study|Physician Decision|1|||
105530435|NCT00477672|363951700|FG001|Overall Study|Physician Decision|0|||
105530436|NCT00477672|363951701|FG002|Overall Study|Physician Decision|0|||
105530437|NCT00477672|363951699|FG000|Overall Study|Protocol noncompliance|0|||
105530438|NCT00477672|363951700|FG001|Overall Study|Protocol noncompliance|2|||
105530439|NCT00477672|363951701|FG002|Overall Study|Protocol noncompliance|0|||
105530440|NCT00477672|363951699|FG000|Overall Study|Consent withdrawn|2|||
105530441|NCT00477672|363951700|FG001|Overall Study|Consent withdrawn|5|||
105530442|NCT00477672|363951701|FG002|Overall Study|Consent withdrawn|10|||
105530443|NCT00477672|363951699|FG000|Overall Study|Discretion of Sponsor|1|||
105530444|NCT00477672|363951700|FG001|Overall Study|Discretion of Sponsor|2|||
105530445|NCT00477672|363951701|FG002|Overall Study|Discretion of Sponsor|0|||
105530446|NCT03571516|363951702|FG000|Overall Study|Severe diarrhea|1|||
105530447|NCT03571516|363951703|FG001|Overall Study|Severe diarrhea|0|||
105530448|NCT03571516|363951702|FG000|Overall Study|Withdrawal by Subject|0|||
105530449|NCT03571516|363951703|FG001|Overall Study|Withdrawal by Subject|1|||
105530450|NCT02442778|363951704|FG000|Overall Study|Adverse Event|2|||
105530451|NCT02442778|363951705|FG001|Overall Study|Adverse Event|6|||
105530452|NCT02442778|363951706|FG002|Overall Study|Adverse Event|6|||
105530453|NCT02442778|363951704|FG000|Overall Study|Death|0|||
105530454|NCT02442778|363951705|FG001|Overall Study|Death|2|||
105530455|NCT02442778|363951706|FG002|Overall Study|Death|0|||
105530456|NCT02442778|363951704|FG000|Overall Study|Lack of Efficacy|1|||
105530457|NCT02442778|363951705|FG001|Overall Study|Lack of Efficacy|0|||
105530458|NCT02442778|363951706|FG002|Overall Study|Lack of Efficacy|0|||
105530459|NCT02442778|363951704|FG000|Overall Study|Lost to Follow-up|1|||
105530460|NCT02442778|363951705|FG001|Overall Study|Lost to Follow-up|1|||
105530461|NCT02442778|363951706|FG002|Overall Study|Lost to Follow-up|1|||
105530462|NCT02442778|363951704|FG000|Overall Study|Non-compliance with study drug|2|||
105530463|NCT02442778|363951705|FG001|Overall Study|Non-compliance with study drug|0|||
105530464|NCT02442778|363951706|FG002|Overall Study|Non-compliance with study drug|1|||
105530465|NCT02442778|363951704|FG000|Overall Study|Physician Decision|1|||
105530466|NCT02442778|363951705|FG001|Overall Study|Physician Decision|1|||
105530467|NCT02442778|363951706|FG002|Overall Study|Physician Decision|1|||
105530468|NCT02442778|363951704|FG000|Overall Study|Protocol Deviation|3|||
105530469|NCT02442778|363951705|FG001|Overall Study|Protocol Deviation|0|||
105530470|NCT02442778|363951706|FG002|Overall Study|Protocol Deviation|1|||
105530471|NCT02442778|363951704|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
105530472|NCT02442778|363951705|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
105530473|NCT02442778|363951706|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
105530474|NCT02442778|363951704|FG000|Overall Study|Withdrawal by Subject|4|||
105530475|NCT02442778|363951705|FG001|Overall Study|Withdrawal by Subject|4|||
105530476|NCT02442778|363951706|FG002|Overall Study|Withdrawal by Subject|3|||
105530477|NCT02442778|363951704|FG000|Overall Study|Reason not specified|1|||
105530478|NCT02442778|363951705|FG001|Overall Study|Reason not specified|4|||
105530479|NCT02442778|363951706|FG002|Overall Study|Reason not specified|0|||
105530480|NCT01557400|363951707|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
105530481|NCT01557400|363951707|FG000|Overall Study|Adverse Event|3|||
105530482|NCT01557400|363951707|FG000|Overall Study|Lost to Follow-up|5|||
105530483|NCT01557400|363951707|FG000|Overall Study|Withdrawal by Subject|9|||
105530484|NCT04019041|363951710|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
105530485|NCT04019041|363951711|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
105530486|NCT04019041|363951712|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
105530487|NCT04019041|363951713|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
105530488|NCT04019041|363951714|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
105530489|NCT04019041|363951715|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
105530490|NCT04019041|363951710|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
105530491|NCT04019041|363951711|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
105530492|NCT04019041|363951712|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
105530493|NCT04019041|363951713|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
105530494|NCT04019041|363951714|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
105530495|NCT04019041|363951715|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
105530496|NCT04019041|363951710|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
105530497|NCT04019041|363951711|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
105530498|NCT04019041|363951712|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
105530499|NCT04019041|363951713|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
105530500|NCT04019041|363951714|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
105530501|NCT04019041|363951715|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
105530502|NCT04019041|363951710|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
105530503|NCT04019041|363951711|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
105530504|NCT04019041|363951712|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
105530505|NCT04019041|363951713|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
105530506|NCT04019041|363951714|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
105530507|NCT04019041|363951715|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
105530508|NCT04019041|363951710|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
105530509|NCT04019041|363951711|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
105530510|NCT04019041|363951712|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
105530511|NCT04019041|363951713|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
105530512|NCT04019041|363951714|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
105530513|NCT04019041|363951715|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
105530514|NCT04019041|363951710|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
105530515|NCT04019041|363951711|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
105530516|NCT04019041|363951712|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
105530517|NCT04019041|363951713|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
105530518|NCT04019041|363951714|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
105530519|NCT04019041|363951715|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
105530520|NCT04019041|363951710|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
105530521|NCT04019041|363951711|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
105530522|NCT04019041|363951712|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
105530523|NCT04019041|363951713|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
105530524|NCT04019041|363951714|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
105593975|NCT00486759|364174889|FG000|Treatment|Adverse event/intercurrent illness|86|||
105530525|NCT04019041|363951715|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
105530526|NCT04019041|363951710|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
105530527|NCT04019041|363951711|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
105530528|NCT04019041|363951712|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
105530529|NCT04019041|363951713|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
105530530|NCT04019041|363951714|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
105530531|NCT04019041|363951715|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
105530532|NCT04019041|363951710|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
105530533|NCT04019041|363951711|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
105530534|NCT04019041|363951712|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
105530535|NCT04019041|363951713|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
105530536|NCT04019041|363951714|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
105530537|NCT04019041|363951715|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
105530538|NCT04365699|363951716|FG000|Overall Study|Death|2|||
105530539|NCT04365699|363951717|FG001|Overall Study|Death|5|||
105530540|NCT04365699|363951718|FG002|Overall Study|Death|15|||
105530541|NCT02540954|363951719|FG000|Overall Study|Physician Decision|3|||
105530542|NCT02540954|363951720|FG001|Overall Study|Physician Decision|1|||
105530543|NCT02540954|363951719|FG000|Overall Study|Withdrawal by Subject|6|||
105530544|NCT02540954|363951720|FG001|Overall Study|Withdrawal by Subject|5|||
105530545|NCT02540954|363951719|FG000|Overall Study|Lost to Follow-up|1|||
105530546|NCT02540954|363951720|FG001|Overall Study|Lost to Follow-up|1|||
105530547|NCT02540954|363951719|FG000|Overall Study|Adverse Event|4|||
105530548|NCT02540954|363951720|FG001|Overall Study|Adverse Event|2|||
105530549|NCT02540954|363951719|FG000|Overall Study|Death|0|||
105530550|NCT02540954|363951720|FG001|Overall Study|Death|3|||
105530551|NCT02540954|363951719|FG000|Overall Study|Treatment failure|1|||
105530552|NCT02540954|363951720|FG001|Overall Study|Treatment failure|0|||
105530553|NCT02540954|363951719|FG000|Overall Study|Other reason|4|||
105530554|NCT02540954|363951720|FG001|Overall Study|Other reason|2|||
105530555|NCT01393743|363951721|FG000|Core Study|Adverse Event|5|||
105530556|NCT01393743|363951722|FG001|Core Study|Adverse Event|9|||
105530557|NCT01393743|363951723|FG002|Core Study|Adverse Event|0|||
105530558|NCT01393743|363951721|FG000|Core Study|Lost to Follow-up|1|||
105530559|NCT01393743|363951722|FG001|Core Study|Lost to Follow-up|1|||
105530560|NCT01393743|363951723|FG002|Core Study|Lost to Follow-up|0|||
105530561|NCT01393743|363951721|FG000|Core Study|Participant's Choice|2|||
105530562|NCT01393743|363951722|FG001|Core Study|Participant's Choice|3|||
105530563|NCT01393743|363951723|FG002|Core Study|Participant's Choice|0|||
105530564|NCT01393743|363951721|FG000|Core Study|Inadequate therapeutic effect|2|||
105530565|NCT01393743|363951722|FG001|Core Study|Inadequate therapeutic effect|0|||
105530566|NCT01393743|363951723|FG002|Core Study|Inadequate therapeutic effect|0|||
105530567|NCT01393743|363951721|FG000|Extension Phase|Adverse Event|0|||
105530568|NCT01393743|363951722|FG001|Extension Phase|Adverse Event|0|||
105530569|NCT01393743|363951723|FG002|Extension Phase|Adverse Event|12|||
105530570|NCT01393743|363951721|FG000|Extension Phase|Lost to Follow-up|0|||
105530571|NCT01393743|363951722|FG001|Extension Phase|Lost to Follow-up|0|||
105530572|NCT01393743|363951723|FG002|Extension Phase|Lost to Follow-up|2|||
105530573|NCT01393743|363951721|FG000|Extension Phase|Participant choice|0|||
105530574|NCT01393743|363951722|FG001|Extension Phase|Participant choice|0|||
105530575|NCT01393743|363951723|FG002|Extension Phase|Participant choice|16|||
105530576|NCT01393743|363951721|FG000|Extension Phase|Inadequate therapeutic effect|0|||
105530577|NCT01393743|363951722|FG001|Extension Phase|Inadequate therapeutic effect|0|||
105530578|NCT01393743|363951723|FG002|Extension Phase|Inadequate therapeutic effect|7|||
105530579|NCT01393743|363951721|FG000|Extension Phase|Withdrawal by Subject|0|||
105530580|NCT01393743|363951722|FG001|Extension Phase|Withdrawal by Subject|0|||
105530581|NCT01393743|363951723|FG002|Extension Phase|Withdrawal by Subject|8|||
105530582|NCT01393743|363951721|FG000|Extension Phase|Pregnancy|0|||
105530583|NCT01393743|363951722|FG001|Extension Phase|Pregnancy|0|||
105530584|NCT01393743|363951723|FG002|Extension Phase|Pregnancy|1|||
105530585|NCT01393743|363951721|FG000|Extension Phase|Other|0|||
105530586|NCT01393743|363951722|FG001|Extension Phase|Other|0|||
105530587|NCT01393743|363951723|FG002|Extension Phase|Other|14|||
105530588|NCT00213148|363951724|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
105530589|NCT00213148|363951725|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
105530590|NCT00213148|363951726|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
105530591|NCT00213148|363951727|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
105530592|NCT00213148|363951728|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
105530593|NCT00213148|363951724|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
105530594|NCT00213148|363951725|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
105530595|NCT00213148|363951726|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
105530596|NCT00213148|363951727|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
105530597|NCT00213148|363951728|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
105530598|NCT00213148|363951724|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
105530599|NCT00213148|363951725|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
105530600|NCT00213148|363951726|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
105530601|NCT00213148|363951727|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
105530602|NCT00213148|363951728|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
105530603|NCT00213148|363951724|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
105530604|NCT00213148|363951725|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
105530605|NCT00213148|363951726|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
105530606|NCT00213148|363951727|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
105530607|NCT00213148|363951728|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
105530608|NCT00213148|363951724|FG000|Cycle 1 (1 Month)|Other|3|||
105530609|NCT00213148|363951725|FG001|Cycle 1 (1 Month)|Other|0|||
105530610|NCT00213148|363951726|FG002|Cycle 1 (1 Month)|Other|2|||
105530611|NCT00213148|363951727|FG003|Cycle 1 (1 Month)|Other|2|||
105530612|NCT00213148|363951728|FG004|Cycle 1 (1 Month)|Other|7|||
105530613|NCT00213148|363951724|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
105530614|NCT00213148|363951725|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
105530615|NCT00213148|363951726|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
105530616|NCT00213148|363951727|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
105530617|NCT00213148|363951728|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
105530618|NCT00213148|363951724|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
105530619|NCT00213148|363951725|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
105530620|NCT00213148|363951726|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
105530621|NCT00213148|363951727|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
105530622|NCT00213148|363951728|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
105530623|NCT00213148|363951724|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
105530624|NCT00213148|363951725|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
105530625|NCT00213148|363951726|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
105530626|NCT00213148|363951727|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
105530627|NCT00213148|363951728|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
105530628|NCT00213148|363951724|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
105530629|NCT00213148|363951725|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
105530630|NCT00213148|363951726|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
105530631|NCT00213148|363951727|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
105530632|NCT00213148|363951728|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
105530633|NCT00213148|363951724|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
105530634|NCT00213148|363951725|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
105530635|NCT00213148|363951726|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
105530636|NCT00213148|363951727|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
105530637|NCT00213148|363951728|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
105530638|NCT00213148|363951724|FG000|Cycle 2 (1 Month)|Other|2|||
105530639|NCT00213148|363951725|FG001|Cycle 2 (1 Month)|Other|1|||
105530640|NCT00213148|363951726|FG002|Cycle 2 (1 Month)|Other|2|||
105530641|NCT00213148|363951727|FG003|Cycle 2 (1 Month)|Other|8|||
105530642|NCT00213148|363951728|FG004|Cycle 2 (1 Month)|Other|7|||
105530643|NCT00213148|363951724|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
105530644|NCT00213148|363951725|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
105530645|NCT00213148|363951726|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
105530646|NCT00213148|363951727|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
105530647|NCT00213148|363951728|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
105530648|NCT00213148|363951724|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
105530649|NCT00213148|363951725|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
105530650|NCT00213148|363951726|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
105530651|NCT00213148|363951727|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
105530652|NCT00213148|363951728|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
105530653|NCT00213148|363951724|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
105530654|NCT00213148|363951725|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
105530655|NCT00213148|363951726|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
105530656|NCT00213148|363951727|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
105530657|NCT00213148|363951728|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
105530658|NCT00213148|363951724|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
105530659|NCT00213148|363951725|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
105530660|NCT00213148|363951726|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
105530661|NCT00213148|363951727|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
105530662|NCT00213148|363951728|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
105530663|NCT00213148|363951724|FG000|Cycle 3 (1 Month)|Other|0|||
105530664|NCT00213148|363951725|FG001|Cycle 3 (1 Month)|Other|0|||
105530665|NCT00213148|363951726|FG002|Cycle 3 (1 Month)|Other|1|||
105530666|NCT00213148|363951727|FG003|Cycle 3 (1 Month)|Other|1|||
105530667|NCT00213148|363951728|FG004|Cycle 3 (1 Month)|Other|0|||
105530668|NCT02321462|363951731|FG000|Overall Study|Withdrawal by Subject|5|||
105593976|NCT00486759|364174890|FG001|Treatment|Adverse event/intercurrent illness|39|||
105530669|NCT02321462|363951732|FG001|Overall Study|Withdrawal by Subject|2|||
105530670|NCT02321462|363951731|FG000|Overall Study|Subject withdrawn before any treatment|1|||
105530671|NCT02321462|363951732|FG001|Overall Study|Subject withdrawn before any treatment|1|||
105530672|NCT00558103|363951733|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
105530673|NCT00558103|363951734|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
105530674|NCT00558103|363951735|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
105530675|NCT00558103|363951736|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
105530676|NCT00558103|363951737|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
105530677|NCT00558103|363951738|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
105530678|NCT00558103|363951733|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
105530679|NCT00558103|363951734|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
105530680|NCT00558103|363951735|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
105530681|NCT00558103|363951736|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
105530682|NCT00558103|363951737|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
105530683|NCT00558103|363951738|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
105530684|NCT00558103|363951733|FG000|Randomized Treatment Phase|Disease Progression|1|||
105530685|NCT00558103|363951734|FG001|Randomized Treatment Phase|Disease Progression|0|||
105530686|NCT00558103|363951735|FG002|Randomized Treatment Phase|Disease Progression|1|||
105530687|NCT00558103|363951736|FG003|Randomized Treatment Phase|Disease Progression|0|||
105530688|NCT00558103|363951737|FG004|Randomized Treatment Phase|Disease Progression|0|||
105530689|NCT00558103|363951738|FG005|Randomized Treatment Phase|Disease Progression|0|||
105530690|NCT00558103|363951733|FG000|Randomized Treatment Phase|Adverse Event|0|||
105530691|NCT00558103|363951734|FG001|Randomized Treatment Phase|Adverse Event|0|||
105530692|NCT00558103|363951735|FG002|Randomized Treatment Phase|Adverse Event|0|||
105530693|NCT00558103|363951736|FG003|Randomized Treatment Phase|Adverse Event|1|||
105530694|NCT00558103|363951737|FG004|Randomized Treatment Phase|Adverse Event|1|||
105530695|NCT00558103|363951738|FG005|Randomized Treatment Phase|Adverse Event|0|||
105530696|NCT00558103|363951733|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
105530697|NCT00558103|363951734|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
105530698|NCT00558103|363951735|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
105530699|NCT00558103|363951736|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
105530700|NCT00558103|363951737|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
105530701|NCT00558103|363951738|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
105530702|NCT00558103|363951733|FG000|Monotherapy Extension Phase|Disease Progression|0|||
105530703|NCT00558103|363951734|FG001|Monotherapy Extension Phase|Disease Progression|0|||
105530704|NCT00558103|363951735|FG002|Monotherapy Extension Phase|Disease Progression|0|||
105530705|NCT00558103|363951736|FG003|Monotherapy Extension Phase|Disease Progression|0|||
105530706|NCT00558103|363951737|FG004|Monotherapy Extension Phase|Disease Progression|0|||
105593977|NCT00486759|364174889|FG000|Treatment|Insufficient therapeutic response|37|||
105593978|NCT00486759|364174890|FG001|Treatment|Insufficient therapeutic response|39|||
105593979|NCT00486759|364174889|FG000|Treatment|Death|17|||
105593980|NCT00486759|364174890|FG001|Treatment|Death|10|||
105593981|NCT00486759|364174889|FG000|Treatment|Withdrew consent|15|||
105593982|NCT00486759|364174890|FG001|Treatment|Withdrew consent|12|||
105593983|NCT00486759|364174889|FG000|Treatment|Administrative/reason not specified|17|||
105593984|NCT00486759|364174890|FG001|Treatment|Administrative/reason not specified|21|||
105593985|NCT00486759|364174889|FG000|Treatment|Refused treatment|10|||
105593986|NCT00486759|364174890|FG001|Treatment|Refused treatment|7|||
105593987|NCT00486759|364174889|FG000|Treatment|Violation of selection criteria at entry|3|||
105593988|NCT00486759|364174890|FG001|Treatment|Violation of selection criteria at entry|3|||
105593989|NCT00486759|364174889|FG000|Treatment|Other protocol violation|1|||
105593990|NCT00486759|364174890|FG001|Treatment|Other protocol violation|5|||
105593991|NCT00486759|364174889|FG000|Treatment|Failure to return|1|||
105593992|NCT00486759|364174890|FG001|Treatment|Failure to return|1|||
105593993|NCT00486759|364174889|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
105593994|NCT00486759|364174890|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
105593995|NCT00486759|364174889|FG000|Safety Follow-up|Death|40|||
105593996|NCT00486759|364174890|FG001|Safety Follow-up|Death|29|||
105593997|NCT00486759|364174889|FG000|Safety Follow-up|Withdrew consent|32|||
105593998|NCT00486759|364174890|FG001|Safety Follow-up|Withdrew consent|23|||
105593999|NCT00486759|364174889|FG000|Safety Follow-up|Failure to return|9|||
105594000|NCT00486759|364174890|FG001|Safety Follow-up|Failure to return|6|||
105594001|NCT00486759|364174889|FG000|Safety Follow-up|Administrative/not specified|8|||
105594002|NCT00486759|364174890|FG001|Safety Follow-up|Administrative/not specified|6|||
105594003|NCT00486759|364174889|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
105594004|NCT00486759|364174890|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
105594005|NCT00486759|364174889|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
105594006|NCT00486759|364174890|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
105594007|NCT01025843|364174891|FG000|Washout 4|Withdrawal by Subject|0|||
105594008|NCT01025843|364174892|FG001|Washout 4|Withdrawal by Subject|0|||
105594009|NCT01025843|364174893|FG002|Washout 4|Withdrawal by Subject|1|||
105594010|NCT01025843|364174894|FG003|Washout 4|Withdrawal by Subject|1|||
105594011|NCT01025843|364174895|FG004|Washout 4|Withdrawal by Subject|0|||
105594012|NCT01025843|364174896|FG005|Washout 4|Withdrawal by Subject|0|||
105594013|NCT01025843|364174897|FG006|Washout 4|Withdrawal by Subject|0|||
105594014|NCT01025843|364174898|FG007|Washout 4|Withdrawal by Subject|0|||
105594015|NCT01025843|364174899|FG008|Washout 4|Withdrawal by Subject|0|||
105530707|NCT00558103|363951738|FG005|Monotherapy Extension Phase|Disease Progression|8|||
105594016|NCT01025843|364174900|FG009|Washout 4|Withdrawal by Subject|0|||
105530708|NCT00834912|363951740|FG000|Treatment Period 1|Adverse Event|0|||
105530709|NCT00834912|363951741|FG001|Treatment Period 1|Adverse Event|1|||
105530710|NCT00834912|363951742|FG002|Treatment Period 1|Adverse Event|0|||
105530711|NCT00834912|363951743|FG003|Treatment Period 1|Adverse Event|1|||
105530712|NCT00834912|363951744|FG004|Treatment Period 1|Adverse Event|0|||
105530713|NCT00834912|363951745|FG005|Treatment Period 1|Adverse Event|0|||
105530714|NCT00834912|363951740|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105530715|NCT00834912|363951741|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105530716|NCT00834912|363951742|FG002|Treatment Period 2|Withdrawal by Subject|1|||
105530717|NCT00834912|363951743|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105530718|NCT00834912|363951744|FG004|Treatment Period 2|Withdrawal by Subject|1|||
105530719|NCT00834912|363951745|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105530720|NCT00262067|363951746|FG000|Overall Study|Death|190|||
105530721|NCT00262067|363951747|FG001|Overall Study|Death|89|||
105530722|NCT00262067|363951748|FG002|Overall Study|Death|186|||
105530723|NCT00262067|363951749|FG003|Overall Study|Death|99|||
105530724|NCT00262067|363951746|FG000|Overall Study|Lost to Follow-up|5|||
105530725|NCT00262067|363951747|FG001|Overall Study|Lost to Follow-up|4|||
105530726|NCT00262067|363951748|FG002|Overall Study|Lost to Follow-up|7|||
105530727|NCT00262067|363951749|FG003|Overall Study|Lost to Follow-up|5|||
105530728|NCT00262067|363951746|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
105530729|NCT00262067|363951747|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
105530730|NCT00262067|363951748|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
105530731|NCT00262067|363951749|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
105530732|NCT00262067|363951746|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
105530733|NCT00262067|363951747|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
105530734|NCT00262067|363951748|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
105530735|NCT00262067|363951749|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
105530736|NCT00989833|363951751|FG000|Overall Study|Lost to Follow-up|0|||
105530737|NCT00989833|363951752|FG001|Overall Study|Lost to Follow-up|1|||
105530738|NCT00989833|363951753|FG002|Overall Study|Lost to Follow-up|0|||
105530739|NCT00989833|363951751|FG000|Overall Study|Protocol Violation|1|||
105530740|NCT00989833|363951752|FG001|Overall Study|Protocol Violation|2|||
105530741|NCT00989833|363951753|FG002|Overall Study|Protocol Violation|1|||
105530742|NCT00989833|363951751|FG000|Overall Study|Withdrawal by Subject|0|||
105530743|NCT00989833|363951752|FG001|Overall Study|Withdrawal by Subject|0|||
105530744|NCT00989833|363951753|FG002|Overall Study|Withdrawal by Subject|1|||
105530745|NCT00989833|363951751|FG000|Overall Study|Incorrectly randomized|1|||
105530746|NCT00989833|363951752|FG001|Overall Study|Incorrectly randomized|0|||
105530747|NCT00989833|363951753|FG002|Overall Study|Incorrectly randomized|0|||
105530748|NCT01920932|363953426|FG000|Overall Study|Death|1|||
105530749|NCT01920932|363953426|FG000|Overall Study|Withdrawal of consent|1|||
105530750|NCT01572038|363953427|FG000|Overall Study|Death|648|||
105530751|NCT01572038|363953427|FG000|Overall Study|Withdrawal by Subject|204|||
105530752|NCT01572038|363953427|FG000|Overall Study|Lost to Follow-up|81|||
105530753|NCT01572038|363953427|FG000|Overall Study|Physician Decision|20|||
105530754|NCT01572038|363953427|FG000|Overall Study|Patient Decision|14|||
105530755|NCT01572038|363953427|FG000|Overall Study|Progressive Disease|8|||
105530756|NCT01572038|363953427|FG000|Overall Study|Site Closed Before Completing Form|6|||
105530757|NCT01572038|363953427|FG000|Overall Study|Enrolled into Another Trial|3|||
105530758|NCT01572038|363953427|FG000|Overall Study|Participated in Another Trial|3|||
105530759|NCT01572038|363953427|FG000|Overall Study|Termination by Sponsor|2|||
105530760|NCT01572038|363953427|FG000|Overall Study|Patient Deterioration|1|||
105530761|NCT01572038|363953427|FG000|Overall Study|Sponsor Decision|1|||
105530762|NCT01904604|363953434|FG000|Overall Study|Withdrew before receiving dosing|0|||
105530763|NCT01904604|363953435|FG001|Overall Study|Withdrew before receiving dosing|1|||
105530764|NCT01904604|363953436|FG002|Overall Study|Withdrew before receiving dosing|0|||
105530765|NCT01904604|363953434|FG000|Overall Study|Non-compliance|1|||
105530766|NCT01904604|363953435|FG001|Overall Study|Non-compliance|0|||
105530767|NCT01904604|363953436|FG002|Overall Study|Non-compliance|0|||
105530768|NCT01904604|363953434|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
105530769|NCT01904604|363953435|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
105530770|NCT01904604|363953436|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
105530771|NCT01904604|363953434|FG000|Overall Study|Patch site reactions|1|||
105530772|NCT01904604|363953435|FG001|Overall Study|Patch site reactions|1|||
105530773|NCT01904604|363953436|FG002|Overall Study|Patch site reactions|0|||
105530774|NCT01904604|363953434|FG000|Overall Study|Increased syncope|0|||
105530775|NCT01904604|363953435|FG001|Overall Study|Increased syncope|1|||
105530776|NCT01904604|363953436|FG002|Overall Study|Increased syncope|0|||
105530777|NCT01904604|363953434|FG000|Overall Study|Unrelated illness|0|||
105530778|NCT01904604|363953435|FG001|Overall Study|Unrelated illness|1|||
105530779|NCT01904604|363953436|FG002|Overall Study|Unrelated illness|0|||
105530780|NCT01904604|363953434|FG000|Overall Study|Passed Week 52 OFC|1|||
105530781|NCT01904604|363953435|FG001|Overall Study|Passed Week 52 OFC|0|||
105530782|NCT01904604|363953436|FG002|Overall Study|Passed Week 52 OFC|0|||
105530783|NCT01904604|363953434|FG000|Overall Study|Withdrawal by Subject|1|||
105530784|NCT01904604|363953435|FG001|Overall Study|Withdrawal by Subject|2|||
105530785|NCT01904604|363953436|FG002|Overall Study|Withdrawal by Subject|0|||
105530786|NCT01904604|363953434|FG000|Overall Study|Participant Relocated|1|||
105530787|NCT01904604|363953435|FG001|Overall Study|Participant Relocated|1|||
105530788|NCT01904604|363953436|FG002|Overall Study|Participant Relocated|1|||
105530789|NCT01904604|363953434|FG000|Overall Study|Lost to Follow-up|0|||
105530790|NCT01904604|363953435|FG001|Overall Study|Lost to Follow-up|0|||
105530791|NCT01904604|363953436|FG002|Overall Study|Lost to Follow-up|1|||
105530792|NCT01945489|363953439|FG000|Cycle 1|Adverse Event|2|||
105530793|NCT01945489|363953440|FG001|Cycle 1|Adverse Event|0|||
105530794|NCT01945489|363953439|FG000|Cycle 1|Lost to Follow-up|4|||
105530795|NCT01945489|363953440|FG001|Cycle 1|Lost to Follow-up|0|||
105530796|NCT01945489|363953439|FG000|Cycle 1|Personal Reasons|4|||
105530797|NCT01945489|363953440|FG001|Cycle 1|Personal Reasons|2|||
105530798|NCT01945489|363953439|FG000|Cycle 1|Protocol Violation|0|||
105530799|NCT01945489|363953440|FG001|Cycle 1|Protocol Violation|1|||
105530800|NCT01945489|363953439|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
105530801|NCT01945489|363953440|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
105530802|NCT01945489|363953439|FG000|Cycle 2|Adverse Event|1|||
105530803|NCT01945489|363953440|FG001|Cycle 2|Adverse Event|0|||
105530804|NCT01945489|363953439|FG000|Cycle 2|Lost to Follow-up|0|||
105530805|NCT01945489|363953440|FG001|Cycle 2|Lost to Follow-up|1|||
105530806|NCT00749463|363953443|FG000|Overall Study|Adverse Event|0|||
105530807|NCT00749463|363953444|FG001|Overall Study|Adverse Event|4|||
105530808|NCT00749463|363953445|FG002|Overall Study|Adverse Event|1|||
105530809|NCT00749463|363953443|FG000|Overall Study|Withdrawal by Subject|1|||
105530810|NCT00749463|363953444|FG001|Overall Study|Withdrawal by Subject|0|||
105530811|NCT00749463|363953445|FG002|Overall Study|Withdrawal by Subject|0|||
105594017|NCT02577523|364174905|FG000|Overall Study|Adverse Event|1|||
105594018|NCT02577523|364174906|FG001|Overall Study|Adverse Event|1|||
105594019|NCT02577523|364174905|FG000|Overall Study|Lack of Efficacy|1|||
105594020|NCT02577523|364174906|FG001|Overall Study|Lack of Efficacy|1|||
105594021|NCT02577523|364174905|FG000|Overall Study|Withdrawal by Subject|1|||
105594022|NCT02577523|364174906|FG001|Overall Study|Withdrawal by Subject|0|||
105594023|NCT04860258|364174907|FG000|Overall Study|Withdrawal by Subject|0|||
105594024|NCT04860258|364174908|FG001|Overall Study|Withdrawal by Subject|0|||
105594025|NCT04860258|364174909|FG002|Overall Study|Withdrawal by Subject|4|||
105594026|NCT04860258|364174910|FG003|Overall Study|Withdrawal by Subject|1|||
105594027|NCT04860258|364174911|FG004|Overall Study|Withdrawal by Subject|4|||
105594028|NCT04860258|364174912|FG005|Overall Study|Withdrawal by Subject|1|||
105594029|NCT04860258|364174913|FG006|Overall Study|Withdrawal by Subject|0|||
105594030|NCT02810080|364174914|FG000|Overall Study|Adverse Event|3|||
105594031|NCT02810080|364174915|FG001|Overall Study|Adverse Event|0|||
105594032|NCT02810080|364174914|FG000|Overall Study|Death|0|||
105594033|NCT02810080|364174915|FG001|Overall Study|Death|2|||
105594034|NCT02810080|364174914|FG000|Overall Study|Physician Decision|4|||
105594035|NCT02810080|364174915|FG001|Overall Study|Physician Decision|0|||
105594036|NCT02810080|364174914|FG000|Overall Study|Withdrawal by Subject|0|||
105594037|NCT02810080|364174915|FG001|Overall Study|Withdrawal by Subject|2|||
105594038|NCT01616654|364174916|FG000|Overall Study|Lack of Efficacy|1|||
105594039|NCT01616654|364174917|FG001|Overall Study|Lack of Efficacy|0|||
105594040|NCT01616654|364174918|FG002|Overall Study|Lack of Efficacy|0|||
105594041|NCT01616654|364174919|FG003|Overall Study|Lack of Efficacy|0|||
105594042|NCT01616654|364174920|FG004|Overall Study|Lack of Efficacy|1|||
105594043|NCT01616654|364174916|FG000|Overall Study|Adverse Event|0|||
105594044|NCT01616654|364174917|FG001|Overall Study|Adverse Event|1|||
105594045|NCT01616654|364174918|FG002|Overall Study|Adverse Event|2|||
105594046|NCT01616654|364174919|FG003|Overall Study|Adverse Event|1|||
105594047|NCT01616654|364174920|FG004|Overall Study|Adverse Event|0|||
105530812|NCT00697346|363953453|FG000|Overall Study|Adverse Event|4|||
105530813|NCT00697346|363953454|FG001|Overall Study|Adverse Event|5|||
105530814|NCT00697346|363953455|FG002|Overall Study|Adverse Event|0|||
105530815|NCT00697346|363953453|FG000|Overall Study|Progressive Disease|19|||
105530816|NCT00697346|363953454|FG001|Overall Study|Progressive Disease|18|||
105594048|NCT01616654|364174916|FG000|Overall Study|Withdrawal by Subject|2|||
105594049|NCT01616654|364174917|FG001|Overall Study|Withdrawal by Subject|2|||
105594050|NCT01616654|364174918|FG002|Overall Study|Withdrawal by Subject|3|||
105530817|NCT00697346|363953455|FG002|Overall Study|Progressive Disease|0|||
105594051|NCT01616654|364174919|FG003|Overall Study|Withdrawal by Subject|1|||
105594052|NCT01616654|364174920|FG004|Overall Study|Withdrawal by Subject|5|||
105594053|NCT01616654|364174916|FG000|Overall Study|Protocol Violation|0|||
105594054|NCT01616654|364174917|FG001|Overall Study|Protocol Violation|5|||
105594055|NCT01616654|364174918|FG002|Overall Study|Protocol Violation|2|||
105594056|NCT01616654|364174919|FG003|Overall Study|Protocol Violation|4|||
105594057|NCT01616654|364174920|FG004|Overall Study|Protocol Violation|4|||
105594058|NCT01616654|364174916|FG000|Overall Study|Lost to Follow-up|1|||
105594059|NCT01616654|364174917|FG001|Overall Study|Lost to Follow-up|0|||
105594060|NCT01616654|364174918|FG002|Overall Study|Lost to Follow-up|3|||
105594061|NCT01616654|364174919|FG003|Overall Study|Lost to Follow-up|2|||
105594062|NCT01616654|364174920|FG004|Overall Study|Lost to Follow-up|1|||
105594063|NCT01616654|364174916|FG000|Overall Study|Pregnancy|1|||
105594064|NCT01616654|364174917|FG001|Overall Study|Pregnancy|0|||
105594065|NCT01616654|364174918|FG002|Overall Study|Pregnancy|0|||
105594066|NCT01616654|364174919|FG003|Overall Study|Pregnancy|0|||
105594067|NCT01616654|364174920|FG004|Overall Study|Pregnancy|1|||
105594068|NCT03923491|364174924|FG000|Overall Study|Lost to Follow-up|5|||
105594069|NCT03923491|364174925|FG001|Overall Study|Lost to Follow-up|8|||
105594070|NCT03923491|364174924|FG000|Overall Study|Withdrawal by Subject|4|||
105530818|NCT00697346|363953453|FG000|Overall Study|Symptomatic Deterioration|0|||
105530819|NCT00697346|363953454|FG001|Overall Study|Symptomatic Deterioration|1|||
105530820|NCT00697346|363953455|FG002|Overall Study|Symptomatic Deterioration|0|||
105530821|NCT00697346|363953453|FG000|Overall Study|Withdrawal by Subject|2|||
105530822|NCT00697346|363953454|FG001|Overall Study|Withdrawal by Subject|2|||
105530823|NCT00697346|363953455|FG002|Overall Study|Withdrawal by Subject|0|||
105530824|NCT00697346|363953453|FG000|Overall Study|Reason not Specified|3|||
105530825|NCT00697346|363953454|FG001|Overall Study|Reason not Specified|0|||
105530826|NCT00697346|363953455|FG002|Overall Study|Reason not Specified|1|||
105530827|NCT02643251|363953456|FG000|Overall Study|Adverse Event|3|||
105530828|NCT02643251|363953457|FG001|Overall Study|Adverse Event|1|||
105530829|NCT02643251|363953456|FG000|Overall Study|Withdrawal by Subject|2|||
105530830|NCT02643251|363953457|FG001|Overall Study|Withdrawal by Subject|0|||
105530831|NCT02643251|363953456|FG000|Overall Study|Lost to Follow-up|4|||
105530832|NCT02643251|363953457|FG001|Overall Study|Lost to Follow-up|1|||
105530833|NCT02643251|363953456|FG000|Overall Study|Protocol Violation|1|||
105530834|NCT02643251|363953457|FG001|Overall Study|Protocol Violation|0|||
105530835|NCT02643251|363953456|FG000|Overall Study|PI Decision to terminate patient|1|||
105530836|NCT02643251|363953457|FG001|Overall Study|PI Decision to terminate patient|0|||
105530837|NCT04171414|363953458|FG000|Overall Study|Death|1|||
105530838|NCT04171414|363953458|FG000|Overall Study|Withdrawal by Subject|1|||
105530839|NCT00706966|363953459|FG000|Overall Study|Adverse Event|1|||
105530840|NCT02624284|363953460|FG000|Overall Study|Withdrawal by Subject|3|||
105530841|NCT02624284|363953461|FG001|Overall Study|Withdrawal by Subject|6|||
105530842|NCT02624284|363953462|FG002|Overall Study|Withdrawal by Subject|3|||
105530843|NCT02624284|363953460|FG000|Overall Study|Protocol Violation|9|||
105530844|NCT02624284|363953461|FG001|Overall Study|Protocol Violation|10|||
105530845|NCT02624284|363953462|FG002|Overall Study|Protocol Violation|7|||
105530846|NCT02624284|363953460|FG000|Overall Study|Revealed exclusionary condition|2|||
105530847|NCT02624284|363953461|FG001|Overall Study|Revealed exclusionary condition|2|||
105530848|NCT02624284|363953462|FG002|Overall Study|Revealed exclusionary condition|0|||
105530849|NCT02624284|363953460|FG000|Overall Study|Adverse Event|0|||
105530850|NCT02624284|363953461|FG001|Overall Study|Adverse Event|0|||
105530851|NCT02624284|363953462|FG002|Overall Study|Adverse Event|1|||
105530852|NCT01610791|363953463|FG000|Overall Study|Lost to Follow-up|7|||
105530853|NCT01610791|363953463|FG000|Overall Study|Adverse Event|6|||
105530854|NCT01610791|363953463|FG000|Overall Study|Physician Decision|1|||
105530855|NCT01610791|363953463|FG000|Overall Study|Adverse event and Investigator decision|1|||
105530856|NCT01610791|363953463|FG000|Overall Study|Death|1|||
105530857|NCT01610791|363953463|FG000|Overall Study|Not determined|5|||
105530858|NCT02711800|363953464|FG000|Overall Study|Lost to Follow-up|1|||
105530859|NCT02711800|363953464|FG000|Overall Study|Withdrawal by Subject|1|||
105594071|NCT03923491|364174925|FG001|Overall Study|Withdrawal by Subject|6|||
105594072|NCT02174562|364174928|FG000|Overall Study|Withdrawal by Subject|7|||
105530860|NCT05923229|363953469|FG000|Overall Study|Withdrawal by Subject|3|||
105530861|NCT05923229|363953470|FG001|Overall Study|Withdrawal by Subject|0|||
105530862|NCT05923229|363953469|FG000|Overall Study|Health related|2|||
105530863|NCT05923229|363953470|FG001|Overall Study|Health related|1|||
105530864|NCT05040152|363953471|FG000|Overall Study|Withdrawal by Subject|5|||
105530865|NCT05040152|363953472|FG001|Overall Study|Withdrawal by Subject|0|||
105530866|NCT05040152|363953471|FG000|Overall Study|Lost to Follow-up|0|||
105530867|NCT05040152|363953472|FG001|Overall Study|Lost to Follow-up|2|||
105530868|NCT00578175|363953475|FG000|Overall Study|Adverse Event|0|||
105530869|NCT00578175|363953476|FG001|Overall Study|Adverse Event|1|||
105530870|NCT00578175|363953477|FG002|Overall Study|Adverse Event|1|||
105530871|NCT00578175|363953475|FG000|Overall Study|Other reasons|70|||
105594073|NCT02174562|364174929|FG001|Overall Study|Withdrawal by Subject|2|||
105594074|NCT02174562|364174928|FG000|Overall Study|Death|2|||
105594075|NCT02174562|364174929|FG001|Overall Study|Death|0|||
105594076|NCT02174562|364174928|FG000|Overall Study|Lost to Follow-up|0|||
105594077|NCT02174562|364174929|FG001|Overall Study|Lost to Follow-up|3|||
105530872|NCT00578175|363953476|FG001|Overall Study|Other reasons|42|||
105530873|NCT00578175|363953477|FG002|Overall Study|Other reasons|23|||
105530874|NCT00357370|363953481|FG000|Cohort 2|Lack of Efficacy|0|||
105530875|NCT00357370|363953482|FG001|Cohort 2|Lack of Efficacy|2|||
105530876|NCT00357370|363953483|FG002|Cohort 2|Lack of Efficacy|1|||
105530877|NCT00357370|363953481|FG000|Cohort 2|Adverse Event|1|||
105530878|NCT00357370|363953482|FG001|Cohort 2|Adverse Event|1|||
105530879|NCT00357370|363953483|FG002|Cohort 2|Adverse Event|1|||
105530880|NCT00357370|363953481|FG000|Cohort 2|Lost to Follow-up|0|||
105530881|NCT00357370|363953482|FG001|Cohort 2|Lost to Follow-up|1|||
105530882|NCT00357370|363953483|FG002|Cohort 2|Lost to Follow-up|0|||
105530883|NCT00357370|363953481|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
105530884|NCT00357370|363953482|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
105530885|NCT00357370|363953483|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
105530886|NCT00357370|363953481|FG000|Cohort 2|Withdrawal by Subject|0|||
105530887|NCT00357370|363953482|FG001|Cohort 2|Withdrawal by Subject|2|||
105530888|NCT00357370|363953483|FG002|Cohort 2|Withdrawal by Subject|0|||
105530889|NCT01828034|363953484|FG000|Overall Study|Withdrawal by Subject|0|||
105530890|NCT01828034|363953485|FG001|Overall Study|Withdrawal by Subject|0|||
105530891|NCT01828034|363953486|FG002|Overall Study|Withdrawal by Subject|0|||
105530892|NCT01828034|363953487|FG003|Overall Study|Withdrawal by Subject|1|||
105530893|NCT02871375|363953488|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
105530894|NCT02871375|363953489|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
105530895|NCT00499603|363953490|FG000|Overall Study|Adverse Event|0|||
105530896|NCT00499603|363953491|FG001|Overall Study|Adverse Event|1|||
105530897|NCT00325234|363953496|FG000|Overall Study|Adverse Event|10|||
105530898|NCT00325234|363953497|FG001|Overall Study|Adverse Event|7|||
105530899|NCT00325234|363953496|FG000|Overall Study|Death due to Study Disease|1|||
105530900|NCT00325234|363953497|FG001|Overall Study|Death due to Study Disease|0|||
105530901|NCT00325234|363953496|FG000|Overall Study|Entry Criteria Not Met|1|||
105530902|NCT00325234|363953497|FG001|Overall Study|Entry Criteria Not Met|2|||
105530903|NCT00325234|363953496|FG000|Overall Study|Subject Decision|6|||
105530904|NCT00325234|363953497|FG001|Overall Study|Subject Decision|8|||
105530905|NCT00325234|363953496|FG000|Overall Study|Physician Decision|17|||
105530906|NCT00325234|363953497|FG001|Overall Study|Physician Decision|12|||
105530907|NCT00325234|363953496|FG000|Overall Study|Progressive Disease|34|||
105530908|NCT00325234|363953497|FG001|Overall Study|Progressive Disease|37|||
105530909|NCT02287896|363953498|FG000|Second Injection Visit|Withdrawal by Subject|0|||
105530910|NCT02287896|363953499|FG001|Second Injection Visit|Withdrawal by Subject|1|||
105530911|NCT00559962|363953500|FG000|Overall Study|Adverse Event|1|||
105530912|NCT00559962|363953501|FG001|Overall Study|Adverse Event|7|||
105530913|NCT00559962|363953502|FG002|Overall Study|Adverse Event|8|||
105530914|NCT00559962|363953503|FG003|Overall Study|Adverse Event|5|||
105530915|NCT00559962|363953504|FG004|Overall Study|Adverse Event|11|||
105530916|NCT00559962|363953505|FG005|Overall Study|Adverse Event|4|||
105530917|NCT00559962|363953506|FG006|Overall Study|Adverse Event|4|||
105530918|NCT00559962|363953507|FG007|Overall Study|Adverse Event|2|||
105530919|NCT00559962|363953500|FG000|Overall Study|Lost to Follow-up|0|||
105530920|NCT00559962|363953501|FG001|Overall Study|Lost to Follow-up|1|||
105530921|NCT00559962|363953502|FG002|Overall Study|Lost to Follow-up|0|||
105530922|NCT00559962|363953503|FG003|Overall Study|Lost to Follow-up|0|||
105530923|NCT00559962|363953504|FG004|Overall Study|Lost to Follow-up|0|||
105530924|NCT00559962|363953505|FG005|Overall Study|Lost to Follow-up|0|||
105530925|NCT00559962|363953506|FG006|Overall Study|Lost to Follow-up|0|||
105530926|NCT00559962|363953507|FG007|Overall Study|Lost to Follow-up|0|||
105530927|NCT00559962|363953500|FG000|Overall Study|Withdrawal by Subject|1|||
105530928|NCT00559962|363953501|FG001|Overall Study|Withdrawal by Subject|1|||
105530929|NCT00559962|363953502|FG002|Overall Study|Withdrawal by Subject|2|||
105530930|NCT00559962|363953503|FG003|Overall Study|Withdrawal by Subject|0|||
105530931|NCT00559962|363953504|FG004|Overall Study|Withdrawal by Subject|3|||
105530932|NCT00559962|363953505|FG005|Overall Study|Withdrawal by Subject|1|||
105530933|NCT00559962|363953506|FG006|Overall Study|Withdrawal by Subject|0|||
105530934|NCT00559962|363953507|FG007|Overall Study|Withdrawal by Subject|2|||
105530935|NCT00559962|363953500|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
105530936|NCT00559962|363953501|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
105530937|NCT00559962|363953502|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
105530938|NCT00559962|363953503|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
105530939|NCT00559962|363953504|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
105530940|NCT00559962|363953505|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
105530941|NCT00559962|363953506|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
105530942|NCT00559962|363953507|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
105530943|NCT04370691|363953508|FG000|Overall Study|Pending visit|48|||
105530944|NCT04370691|363953508|FG000|Overall Study|Have Not Reached Lower Window|15|||
105530945|NCT04370691|363953508|FG000|Overall Study|Termination|14|||
105530946|NCT04370691|363953508|FG000|Overall Study|Missed or Overdue|10|||
105530947|NCT03690388|363953509|FG000|Overall Study|Adverse Event|8|||
105530948|NCT03690388|363953510|FG001|Overall Study|Adverse Event|1|||
105530949|NCT03690388|363953509|FG000|Overall Study|Radiographic Progression|14|||
105530950|NCT03690388|363953510|FG001|Overall Study|Radiographic Progression|29|||
105530951|NCT03690388|363953509|FG000|Overall Study|Clinical deterioration|10|||
105530952|NCT03690388|363953510|FG001|Overall Study|Clinical deterioration|6|||
105530953|NCT03690388|363953509|FG000|Overall Study|Withdrawal by Subject|2|||
105530954|NCT03690388|363953510|FG001|Overall Study|Withdrawal by Subject|0|||
105530955|NCT03690388|363953509|FG000|Overall Study|Lack of Efficacy|1|||
105530956|NCT03690388|363953510|FG001|Overall Study|Lack of Efficacy|0|||
105530957|NCT03690388|363953509|FG000|Overall Study|Lost to Follow-up|1|||
105530958|NCT03690388|363953510|FG001|Overall Study|Lost to Follow-up|0|||
105530959|NCT04225923|363953511|FG000|Overall Study|Protocol Violation|1|||
105530960|NCT04225923|363953512|FG001|Overall Study|Protocol Violation|0|||
105530961|NCT04225923|363953513|FG002|Overall Study|Protocol Violation|1|||
105530962|NCT04225923|363953511|FG000|Overall Study|Withdrawal by Subject|4|||
105530963|NCT04225923|363953512|FG001|Overall Study|Withdrawal by Subject|1|||
105530964|NCT04225923|363953513|FG002|Overall Study|Withdrawal by Subject|3|||
105530965|NCT04225923|363953511|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
105530966|NCT04225923|363953512|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
105530967|NCT04225923|363953513|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
105530968|NCT01526889|363953514|FG000|Treatment Period|Adverse Event|2|||
105530969|NCT01526889|363953515|FG001|Treatment Period|Adverse Event|0|||
105530970|NCT01526889|363953514|FG000|Treatment Extension Period|Administrative problems|1|||
105530971|NCT01526889|363953515|FG001|Treatment Extension Period|Administrative problems|0|||
105530972|NCT02098109|363953524|FG000|Overall Study|Protocol Violation|3|||
105530973|NCT02098109|363953525|FG001|Overall Study|Protocol Violation|0|||
105530974|NCT01455012|363953529|FG000|Overall Study|Adverse Event|0|||
105530975|NCT01455012|363953530|FG001|Overall Study|Adverse Event|2|||
105530976|NCT01455012|363953529|FG000|Overall Study|Lack of Efficacy|6|||
105530977|NCT01455012|363953530|FG001|Overall Study|Lack of Efficacy|1|||
105530978|NCT01455012|363953529|FG000|Overall Study|Withdrawal by Subject|3|||
105530979|NCT01455012|363953530|FG001|Overall Study|Withdrawal by Subject|1|||
105530980|NCT01455012|363953529|FG000|Overall Study|Unknown reason|2|||
105530981|NCT01455012|363953530|FG001|Overall Study|Unknown reason|0|||
105530982|NCT00677807|363953535|FG000|Overall Study|Adverse Event|4|||
105530983|NCT00677807|363953536|FG001|Overall Study|Adverse Event|1|||
105530984|NCT00677807|363953537|FG002|Overall Study|Adverse Event|6|||
105530985|NCT00677807|363953535|FG000|Overall Study|Lack of Efficacy|0|||
105530986|NCT00677807|363953536|FG001|Overall Study|Lack of Efficacy|0|||
105530987|NCT00677807|363953537|FG002|Overall Study|Lack of Efficacy|2|||
105530988|NCT00677807|363953535|FG000|Overall Study|Participant no longer needs study drug|0|||
105530989|NCT00677807|363953536|FG001|Overall Study|Participant no longer needs study drug|0|||
105530990|NCT00677807|363953537|FG002|Overall Study|Participant no longer needs study drug|1|||
105530991|NCT00677807|363953535|FG000|Overall Study|Withdrawal by Subject|10|||
105530992|NCT00677807|363953536|FG001|Overall Study|Withdrawal by Subject|3|||
105530993|NCT00677807|363953537|FG002|Overall Study|Withdrawal by Subject|6|||
105530994|NCT00677807|363953535|FG000|Overall Study|Lost to Follow-up|2|||
105530995|NCT00677807|363953536|FG001|Overall Study|Lost to Follow-up|2|||
105530996|NCT00677807|363953537|FG002|Overall Study|Lost to Follow-up|2|||
105530997|NCT00677807|363953535|FG000|Overall Study|Administrative problems|1|||
105530998|NCT00677807|363953536|FG001|Overall Study|Administrative problems|1|||
105530999|NCT00677807|363953537|FG002|Overall Study|Administrative problems|2|||
105531000|NCT00677807|363953535|FG000|Overall Study|Death|0|||
105531001|NCT00677807|363953536|FG001|Overall Study|Death|1|||
105531002|NCT00677807|363953537|FG002|Overall Study|Death|1|||
105531003|NCT00677807|363953535|FG000|Overall Study|Protocol Deviation|1|||
105531004|NCT00677807|363953536|FG001|Overall Study|Protocol Deviation|3|||
105531005|NCT00677807|363953537|FG002|Overall Study|Protocol Deviation|0|||
105531006|NCT03400033|363953538|FG000|Overall Study|Withdrawal by Subject|1|||
105531007|NCT03400033|363953539|FG001|Overall Study|Withdrawal by Subject|2|||
105531008|NCT01399593|363953543|FG000|Overall Study|Physician Decision|1|||
105531009|NCT01399593|363953544|FG001|Overall Study|Physician Decision|0|||
105531010|NCT01399593|363953543|FG000|Overall Study|Adverse Event|1|||
105531011|NCT01399593|363953544|FG001|Overall Study|Adverse Event|0|||
105531012|NCT01399593|363953543|FG000|Overall Study|Death|1|||
105531013|NCT01399593|363953544|FG001|Overall Study|Death|1|||
105531014|NCT01399593|363953543|FG000|Overall Study|Transplantectomy|0|||
105531015|NCT01399593|363953544|FG001|Overall Study|Transplantectomy|1|||
105531016|NCT00500370|363953557|FG000|Overall Study|Adverse Event|9|||
105531017|NCT00500370|363953558|FG001|Overall Study|Adverse Event|3|||
105531018|NCT00500370|363953557|FG000|Overall Study|Lost to Follow-up|10|||
105531019|NCT00500370|363953558|FG001|Overall Study|Lost to Follow-up|10|||
105531020|NCT00500370|363953557|FG000|Overall Study|Protocol Violation|2|||
105531021|NCT00500370|363953558|FG001|Overall Study|Protocol Violation|4|||
105531022|NCT00500370|363953557|FG000|Overall Study|Sponsor Decision|2|||
105531023|NCT00500370|363953558|FG001|Overall Study|Sponsor Decision|0|||
105531024|NCT00500370|363953557|FG000|Overall Study|Subject Decision|10|||
105531025|NCT00500370|363953558|FG001|Overall Study|Subject Decision|17|||
105531026|NCT02434770|363953565|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
105531027|NCT02434770|363953566|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
105531028|NCT02434770|363953567|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
105531029|NCT02434770|363953565|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
105531030|NCT02434770|363953566|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
105531031|NCT02434770|363953567|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
105531032|NCT02434770|363953565|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
105531033|NCT02434770|363953566|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
105531034|NCT02434770|363953567|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
105531035|NCT02434770|363953565|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
105531036|NCT02434770|363953566|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
105531037|NCT02434770|363953567|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
105531038|NCT02434770|363953565|FG000|Week 1 to Week 18|Death|1|||
105531039|NCT02434770|363953566|FG001|Week 1 to Week 18|Death|0|||
105531040|NCT02434770|363953567|FG002|Week 1 to Week 18|Death|0|||
105531041|NCT02434770|363953565|FG000|Week 18 to Week|Lost to Follow-up|2|||
105531042|NCT02434770|363953566|FG001|Week 18 to Week|Lost to Follow-up|2|||
105531043|NCT02434770|363953567|FG002|Week 18 to Week|Lost to Follow-up|1|||
105531044|NCT02434770|363953565|FG000|Week 18 to Week|Withdrawal by Subject|0|||
105531045|NCT02434770|363953566|FG001|Week 18 to Week|Withdrawal by Subject|0|||
105531046|NCT02434770|363953567|FG002|Week 18 to Week|Withdrawal by Subject|2|||
105531047|NCT02434770|363953565|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
105531048|NCT02434770|363953566|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
105531049|NCT02434770|363953567|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
105531050|NCT00245765|363953568|FG000|Overall Study|Adverse Event|1|||
105531051|NCT00245765|363953569|FG001|Overall Study|Adverse Event|1|||
105531052|NCT00245765|363953570|FG002|Overall Study|Adverse Event|0|||
105531053|NCT00245765|363953568|FG000|Overall Study|Lack of Efficacy|14|||
105531054|NCT00245765|363953569|FG001|Overall Study|Lack of Efficacy|7|||
105531055|NCT00245765|363953570|FG002|Overall Study|Lack of Efficacy|0|||
105531056|NCT00245765|363953568|FG000|Overall Study|Lost to Follow-up|1|||
105531057|NCT00245765|363953569|FG001|Overall Study|Lost to Follow-up|2|||
105531058|NCT00245765|363953570|FG002|Overall Study|Lost to Follow-up|0|||
105531059|NCT00245765|363953568|FG000|Overall Study|Withdrawal by Subject|1|||
105531060|NCT00245765|363953569|FG001|Overall Study|Withdrawal by Subject|0|||
105531061|NCT00245765|363953570|FG002|Overall Study|Withdrawal by Subject|3|||
105531062|NCT00245765|363953568|FG000|Overall Study|Other reason|2|||
105531063|NCT00245765|363953569|FG001|Overall Study|Other reason|0|||
105531064|NCT00245765|363953570|FG002|Overall Study|Other reason|1|||
105531065|NCT00245765|363953568|FG000|Overall Study|Other|13|||
105531066|NCT00245765|363953569|FG001|Overall Study|Other|4|||
105531067|NCT00245765|363953570|FG002|Overall Study|Other|4|||
105531068|NCT01574352|363953571|FG000|Overall Study|Withdrawal by Subject|6|||
105531069|NCT01574352|363953572|FG001|Overall Study|Withdrawal by Subject|13|||
105531070|NCT01574352|363953571|FG000|Overall Study|Injury in non-camp related sport|1|||
105531071|NCT01574352|363953572|FG001|Overall Study|Injury in non-camp related sport|0|||
105531072|NCT01282424|363953576|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
105531073|NCT01282424|363953576|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
105531074|NCT01282424|363953576|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
105531075|NCT01282424|363953576|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
105531076|NCT01282424|363953576|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
105531077|NCT01282424|363953576|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
105531078|NCT01282424|363953576|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
105531079|NCT01282424|363953576|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
105531080|NCT00714259|363953577|FG000|Overall Study|Death|2|||
105531081|NCT00528528|363953578|FG000|Overall Study|Lost to Follow-up|0|||
105531082|NCT00528528|363953579|FG001|Overall Study|Lost to Follow-up|0|||
105531083|NCT00528528|363953580|FG002|Overall Study|Lost to Follow-up|1|||
105531084|NCT00528528|363953581|FG003|Overall Study|Lost to Follow-up|1|||
105531085|NCT00528528|363953578|FG000|Overall Study|Ineligible to continue the trial|0|||
105531086|NCT00528528|363953579|FG001|Overall Study|Ineligible to continue the trial|0|||
105531087|NCT00528528|363953580|FG002|Overall Study|Ineligible to continue the trial|0|||
105531088|NCT00528528|363953581|FG003|Overall Study|Ineligible to continue the trial|1|||
105531089|NCT00528528|363953578|FG000|Overall Study|Other|0|||
105531090|NCT00528528|363953579|FG001|Overall Study|Other|1|||
105531091|NCT00528528|363953580|FG002|Overall Study|Other|0|||
105531092|NCT00528528|363953581|FG003|Overall Study|Other|0|||
105531093|NCT00528528|363953578|FG000|Overall Study|Withdrawal by Subject|3|||
105531094|NCT00528528|363953579|FG001|Overall Study|Withdrawal by Subject|2|||
105531095|NCT00528528|363953580|FG002|Overall Study|Withdrawal by Subject|1|||
105531096|NCT00528528|363953581|FG003|Overall Study|Withdrawal by Subject|1|||
105531097|NCT00528528|363953578|FG000|Overall Study|Ongoing participant|0|||
105531098|NCT00528528|363953579|FG001|Overall Study|Ongoing participant|0|||
105531099|NCT00528528|363953580|FG002|Overall Study|Ongoing participant|1|||
105594078|NCT00864682|364174935|FG000|Overall Study|Protocol Violation|2|||
105594079|NCT00864682|364174936|FG001|Overall Study|Protocol Violation|1|||
105594080|NCT00864682|364174937|FG002|Overall Study|Protocol Violation|2|||
105594081|NCT00246012|364174938|FG000|Overall Study|Adverse Event|0|||
105594082|NCT00246012|364174939|FG001|Overall Study|Adverse Event|0|||
105594083|NCT00246012|364174940|FG002|Overall Study|Adverse Event|0|||
105594084|NCT00246012|364174941|FG003|Overall Study|Adverse Event|0|||
105594085|NCT00246012|364174942|FG004|Overall Study|Adverse Event|0|||
105594086|NCT00246012|364174943|FG005|Overall Study|Adverse Event|1|||
105594087|NCT00246012|364174944|FG006|Overall Study|Adverse Event|0|||
105594088|NCT00246012|364174945|FG007|Overall Study|Adverse Event|0|||
105594089|NCT00246012|364174946|FG008|Overall Study|Adverse Event|2|||
105594090|NCT00246012|364174938|FG000|Overall Study|Withdrawal by Subject|0|||
105594091|NCT00246012|364174939|FG001|Overall Study|Withdrawal by Subject|0|||
105594092|NCT00246012|364174940|FG002|Overall Study|Withdrawal by Subject|0|||
105594093|NCT00246012|364174941|FG003|Overall Study|Withdrawal by Subject|0|||
105594094|NCT00246012|364174942|FG004|Overall Study|Withdrawal by Subject|0|||
105594095|NCT00246012|364174943|FG005|Overall Study|Withdrawal by Subject|1|||
105594096|NCT00246012|364174944|FG006|Overall Study|Withdrawal by Subject|0|||
105594097|NCT00246012|364174945|FG007|Overall Study|Withdrawal by Subject|0|||
105594098|NCT00246012|364174946|FG008|Overall Study|Withdrawal by Subject|0|||
105594099|NCT00246012|364174938|FG000|Overall Study|Disease progression|3|||
105594100|NCT00246012|364174939|FG001|Overall Study|Disease progression|1|||
105594101|NCT00246012|364174940|FG002|Overall Study|Disease progression|2|||
105594102|NCT00246012|364174941|FG003|Overall Study|Disease progression|3|||
105594103|NCT00246012|364174942|FG004|Overall Study|Disease progression|3|||
105594104|NCT00246012|364174943|FG005|Overall Study|Disease progression|25|||
105594105|NCT00246012|364174944|FG006|Overall Study|Disease progression|30|||
105594106|NCT00246012|364174945|FG007|Overall Study|Disease progression|27|||
105594107|NCT00246012|364174946|FG008|Overall Study|Disease progression|26|||
105594108|NCT00246012|364174938|FG000|Overall Study|Other|0|||
105594109|NCT00246012|364174939|FG001|Overall Study|Other|0|||
105594110|NCT00246012|364174940|FG002|Overall Study|Other|0|||
105594111|NCT00246012|364174941|FG003|Overall Study|Other|0|||
105594112|NCT00246012|364174942|FG004|Overall Study|Other|0|||
105594113|NCT00246012|364174943|FG005|Overall Study|Other|0|||
105594114|NCT00246012|364174944|FG006|Overall Study|Other|0|||
105594115|NCT00246012|364174945|FG007|Overall Study|Other|1|||
105594116|NCT00246012|364174946|FG008|Overall Study|Other|0|||
105594117|NCT00246012|364174938|FG000|Overall Study|Randomly assigned but not treated|0|||
105594118|NCT00246012|364174939|FG001|Overall Study|Randomly assigned but not treated|0|||
105594119|NCT00246012|364174940|FG002|Overall Study|Randomly assigned but not treated|0|||
105531100|NCT00528528|363953581|FG003|Overall Study|Ongoing participant|0|||
105531101|NCT02741115|363953582|FG000|Overall Study|Adverse Event|1|||
105531102|NCT02741115|363953583|FG001|Overall Study|Adverse Event|0|||
105531103|NCT02741115|363953582|FG000|Overall Study|Lost to Follow-up|7|||
105531104|NCT02741115|363953583|FG001|Overall Study|Lost to Follow-up|4|||
105531105|NCT02741115|363953582|FG000|Overall Study|Withdrawal by Subject|4|||
105531106|NCT02741115|363953583|FG001|Overall Study|Withdrawal by Subject|2|||
105531107|NCT00445328|363953584|FG000|Overall Study|Death|0|||
105531108|NCT00445328|363953585|FG001|Overall Study|Death|1|||
105531109|NCT00445328|363953584|FG000|Overall Study|Adverse Event|0|||
105531110|NCT00445328|363953585|FG001|Overall Study|Adverse Event|3|||
105531111|NCT00445328|363953584|FG000|Overall Study|Other|0|||
105531112|NCT00445328|363953585|FG001|Overall Study|Other|2|||
105531113|NCT00445328|363953584|FG000|Overall Study|Withdrawal by Subject|2|||
105531114|NCT00445328|363953585|FG001|Overall Study|Withdrawal by Subject|0|||
105531115|NCT00445328|363953584|FG000|Overall Study|Protocol Violation|1|||
105531116|NCT00445328|363953585|FG001|Overall Study|Protocol Violation|0|||
105531117|NCT00574405|363955329|FG000|Overall Study|Withdrawal by Subject|3|||
105531118|NCT00574405|363955330|FG001|Overall Study|Withdrawal by Subject|2|||
105531119|NCT03568942|363955333|FG000|Overall Study|Family emergency|1|||
105531120|NCT03568942|363955333|FG000|Overall Study|Lost to Follow-up|1|||
105594120|NCT00246012|364174941|FG003|Overall Study|Randomly assigned but not treated|0|||
105594121|NCT00246012|364174942|FG004|Overall Study|Randomly assigned but not treated|0|||
105594122|NCT00246012|364174943|FG005|Overall Study|Randomly assigned but not treated|1|||
105594123|NCT00246012|364174944|FG006|Overall Study|Randomly assigned but not treated|1|||
105531121|NCT00358527|363955335|FG000|Overall Study|Adverse Event|4|||
105531122|NCT00358527|363955336|FG001|Overall Study|Adverse Event|0|||
105531123|NCT00358527|363955335|FG000|Overall Study|Withdrawal by Subject|1|||
105531124|NCT00358527|363955336|FG001|Overall Study|Withdrawal by Subject|1|||
105594124|NCT00246012|364174945|FG007|Overall Study|Randomly assigned but not treated|0|||
105594125|NCT00246012|364174946|FG008|Overall Study|Randomly assigned but not treated|0|||
105594126|NCT00608907|364174949|FG000|Overall Study|Adverse Event|6|||
105594127|NCT00608907|364174950|FG001|Overall Study|Adverse Event|0|||
105594128|NCT00608907|364174951|FG002|Overall Study|Adverse Event|1|||
105594129|NCT00608907|364174949|FG000|Overall Study|Death|1|||
105594130|NCT00608907|364174950|FG001|Overall Study|Death|0|||
105531125|NCT00358527|363955335|FG000|Overall Study|Non-compliance with protocol|6|||
105531126|NCT00358527|363955336|FG001|Overall Study|Non-compliance with protocol|1|||
105531127|NCT00358527|363955335|FG000|Overall Study|Administrative|2|||
105531128|NCT00358527|363955336|FG001|Overall Study|Administrative|1|||
105531129|NCT04144166|363955339|FG000|Overall Study|Discharged before study start|1|||
105531130|NCT04144166|363955339|FG000|Overall Study|Pregnancy|1|||
105531131|NCT04144166|363955339|FG000|Overall Study|Nail polish could not be removed from finger|1|||
105531132|NCT03643562|363955343|FG000|Overall Study|Adverse Event|1|||
105531133|NCT03643562|363955344|FG001|Overall Study|Adverse Event|0|||
105531134|NCT03643562|363955343|FG000|Overall Study|Lack of Efficacy|0|||
105531135|NCT03643562|363955344|FG001|Overall Study|Lack of Efficacy|1|||
105531136|NCT03643562|363955343|FG000|Overall Study|Physician Decision|0|||
105531137|NCT03643562|363955344|FG001|Overall Study|Physician Decision|1|||
105531138|NCT03643562|363955343|FG000|Overall Study|Study Terminated by Sponsor|2|||
105531139|NCT03643562|363955344|FG001|Overall Study|Study Terminated by Sponsor|10|||
105531140|NCT03643562|363955343|FG000|Overall Study|Withdrawal by Subject|2|||
105531141|NCT03643562|363955344|FG001|Overall Study|Withdrawal by Subject|2|||
105531142|NCT03643562|363955343|FG000|Overall Study|Other than specified|3|||
105531143|NCT03643562|363955344|FG001|Overall Study|Other than specified|2|||
105531144|NCT01982253|363955345|FG000|Overall Study|Withdrawal by Subject|1|||
105531145|NCT01982253|363955346|FG001|Overall Study|Withdrawal by Subject|0|||
105531146|NCT01982253|363955347|FG002|Overall Study|Withdrawal by Subject|0|||
105531147|NCT01982253|363955345|FG000|Overall Study|Study terminated by sponsor|1|||
105531148|NCT01982253|363955346|FG001|Overall Study|Study terminated by sponsor|4|||
105531149|NCT01982253|363955347|FG002|Overall Study|Study terminated by sponsor|4|||
105531150|NCT04145895|363955348|FG000|Overall Study|Physician Decision|2|||
105531151|NCT04145895|363955349|FG001|Overall Study|Physician Decision|0|||
105531152|NCT04145895|363955348|FG000|Overall Study|Withdrawal by Subject|0|||
105531153|NCT04145895|363955349|FG001|Overall Study|Withdrawal by Subject|2|||
105531154|NCT00326612|363955350|FG000|Overall Study|They did not have a seizure requiring tx|129|||
105531155|NCT00326612|363955351|FG001|Overall Study|They did not have a seizure requiring tx|137|||
105531156|NCT00419562|363955352|FG000|Overall Study|Lost to Follow-up|12|||
105531157|NCT00419562|363955353|FG001|Overall Study|Lost to Follow-up|13|||
105531158|NCT00419562|363955352|FG000|Overall Study|Withdrawal by Subject|20|||
105531159|NCT00419562|363955353|FG001|Overall Study|Withdrawal by Subject|18|||
105531160|NCT00419562|363955352|FG000|Overall Study|Participant Institutionalized|1|||
105531161|NCT00419562|363955353|FG001|Overall Study|Participant Institutionalized|0|||
105531162|NCT00913744|363955356|FG000|Overall Study|Adverse Event|2|||
105531163|NCT00913744|363955357|FG001|Overall Study|Adverse Event|0|||
105531164|NCT00913744|363955356|FG000|Overall Study|Withdrawal by Subject|2|||
105531165|NCT00913744|363955357|FG001|Overall Study|Withdrawal by Subject|1|||
105531166|NCT00913744|363955356|FG000|Overall Study|Death|1|||
105531167|NCT00913744|363955357|FG001|Overall Study|Death|0|||
105531168|NCT00805935|363955358|FG000|Overall Study|Stimulation Failure|1|||
105531169|NCT00805935|363955359|FG001|Overall Study|Stimulation Failure|5|||
105531170|NCT00805935|363955360|FG002|Overall Study|Stimulation Failure|2|||
105531171|NCT00805935|363955361|FG003|Overall Study|Stimulation Failure|2|||
105531172|NCT00805935|363955358|FG000|Overall Study|Cycle cancelled|0|||
105531173|NCT00805935|363955359|FG001|Overall Study|Cycle cancelled|0|||
105531174|NCT00805935|363955360|FG002|Overall Study|Cycle cancelled|2|||
105531175|NCT00805935|363955361|FG003|Overall Study|Cycle cancelled|0|||
105531176|NCT00805935|363955358|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
105531177|NCT00805935|363955359|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
105531178|NCT00805935|363955360|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
105531179|NCT00805935|363955361|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
105531180|NCT00805935|363955358|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
105531181|NCT00805935|363955359|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
105531182|NCT00805935|363955360|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
105531183|NCT00805935|363955361|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
105531184|NCT00805935|363955358|FG000|Overall Study|Lost to Follow-up|1|||
105531185|NCT00805935|363955359|FG001|Overall Study|Lost to Follow-up|0|||
105531186|NCT00805935|363955360|FG002|Overall Study|Lost to Follow-up|0|||
105531187|NCT00805935|363955361|FG003|Overall Study|Lost to Follow-up|0|||
105531188|NCT00805935|363955358|FG000|Overall Study|No positive serum pregnancy|8|||
105531189|NCT00805935|363955359|FG001|Overall Study|No positive serum pregnancy|7|||
105531190|NCT00805935|363955360|FG002|Overall Study|No positive serum pregnancy|6|||
105531191|NCT00805935|363955361|FG003|Overall Study|No positive serum pregnancy|5|||
105531192|NCT00805935|363955358|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
105531193|NCT00805935|363955359|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
105531194|NCT00805935|363955360|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
105531195|NCT00805935|363955361|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
105531196|NCT00805935|363955358|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
105531197|NCT00805935|363955359|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
105531198|NCT00805935|363955360|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
105531199|NCT00805935|363955361|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
105531200|NCT00805935|363955358|FG000|Overall Study|Biochemical pregnancy|0|||
105531201|NCT00805935|363955359|FG001|Overall Study|Biochemical pregnancy|1|||
105531202|NCT00805935|363955360|FG002|Overall Study|Biochemical pregnancy|0|||
105531203|NCT00805935|363955361|FG003|Overall Study|Biochemical pregnancy|0|||
105531204|NCT00805935|363955358|FG000|Overall Study|Chemical pregnancy|0|||
105531205|NCT00805935|363955359|FG001|Overall Study|Chemical pregnancy|5|||
105531206|NCT00805935|363955360|FG002|Overall Study|Chemical pregnancy|3|||
105531207|NCT00805935|363955361|FG003|Overall Study|Chemical pregnancy|2|||
105531208|NCT00805935|363955358|FG000|Overall Study|Ectopic pregnancy|0|||
105531209|NCT00805935|363955359|FG001|Overall Study|Ectopic pregnancy|0|||
105531210|NCT00805935|363955360|FG002|Overall Study|Ectopic pregnancy|1|||
105531211|NCT00805935|363955361|FG003|Overall Study|Ectopic pregnancy|0|||
105531212|NCT00805935|363955358|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
105531213|NCT00805935|363955359|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
105531214|NCT00805935|363955360|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
105531215|NCT00805935|363955361|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
105531216|NCT01886833|363955364|FG000|Overall Study|IgA not available from both periods|204|||
105531217|NCT01921829|363955372|FG000|Overall Study|Withdrawal by Subject|0|||
105531218|NCT01921829|363955373|FG001|Overall Study|Withdrawal by Subject|1|||
105531219|NCT02223767|363955374|FG000|Overall Study|Withdrawal by Subject|4|||
105531220|NCT02223767|363955375|FG001|Overall Study|Withdrawal by Subject|4|||
105531221|NCT00640510|363955376|FG000|Overall Study|Lack of Efficacy|0|||
105531222|NCT00640510|363955377|FG001|Overall Study|Lack of Efficacy|1|||
105531223|NCT00640510|363955376|FG000|Overall Study|Protocol Violation|1|||
105531224|NCT00640510|363955377|FG001|Overall Study|Protocol Violation|0|||
105531225|NCT00640510|363955376|FG000|Overall Study|Physician Decision|0|||
105531226|NCT00640510|363955377|FG001|Overall Study|Physician Decision|1|||
105531227|NCT01467076|363955389|FG000|Overall Study|Lost to Follow-up|1|||
105531228|NCT01467076|363955390|FG001|Overall Study|Lost to Follow-up|0|||
105531229|NCT01467076|363955391|FG002|Overall Study|Lost to Follow-up|0|||
105531230|NCT04960228|363955393|FG000|Overall Study|Withdrawal by Subject|216|||
105531231|NCT04960228|363955394|FG001|Overall Study|Withdrawal by Subject|35|||
105531232|NCT04960228|363955393|FG000|Overall Study|Failed attention check|69|||
105531233|NCT04960228|363955394|FG001|Overall Study|Failed attention check|148|||
105531234|NCT04960228|363955393|FG000|Overall Study|Flagged for response quality by Dynata|3|||
105594131|NCT00608907|364174951|FG002|Overall Study|Death|0|||
105594132|NCT00608907|364174949|FG000|Overall Study|Withdrawal by Subject|4|||
105594133|NCT00608907|364174950|FG001|Overall Study|Withdrawal by Subject|0|||
105594134|NCT00608907|364174951|FG002|Overall Study|Withdrawal by Subject|0|||
105594135|NCT00608907|364174949|FG000|Overall Study|Progressive Disease|1|||
105594136|NCT00608907|364174950|FG001|Overall Study|Progressive Disease|0|||
105594137|NCT00608907|364174951|FG002|Overall Study|Progressive Disease|0|||
105594138|NCT01689519|364174954|FG000|Intent to Treat|Death|157|||
105594139|NCT01689519|364174955|FG001|Intent to Treat|Death|167|||
105594140|NCT01689519|364174954|FG000|Intent to Treat|Lost to Follow-up|4|||
105594141|NCT01689519|364174955|FG001|Intent to Treat|Lost to Follow-up|8|||
105594142|NCT01689519|364174954|FG000|Intent to Treat|Other|2|||
105594143|NCT01689519|364174955|FG001|Intent to Treat|Other|4|||
105594144|NCT01689519|364174954|FG000|Intent to Treat|Physician Decision|4|||
105594145|NCT01689519|364174955|FG001|Intent to Treat|Physician Decision|1|||
105594146|NCT01689519|364174954|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
105594147|NCT01689519|364174955|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
105594148|NCT01689519|364174954|FG000|Intent to Treat|Withdrawal by Subject|21|||
105594149|NCT01689519|364174955|FG001|Intent to Treat|Withdrawal by Subject|20|||
105594150|NCT01689519|364174954|FG000|Safety Population|Death|158|||
105594151|NCT01689519|364174955|FG001|Safety Population|Death|165|||
105594152|NCT01689519|364174954|FG000|Safety Population|Lost to Follow-up|4|||
105594153|NCT01689519|364174955|FG001|Safety Population|Lost to Follow-up|8|||
105594154|NCT01689519|364174954|FG000|Safety Population|Other|2|||
105594155|NCT01689519|364174955|FG001|Safety Population|Other|4|||
105594156|NCT01689519|364174954|FG000|Safety Population|Physician Decision|4|||
105594157|NCT01689519|364174955|FG001|Safety Population|Physician Decision|1|||
105594158|NCT01689519|364174954|FG000|Safety Population|Study Terminated By Sponsor|60|||
105594159|NCT01689519|364174955|FG001|Safety Population|Study Terminated By Sponsor|47|||
105594160|NCT01689519|364174954|FG000|Safety Population|Withdrawal by Subject|20|||
105594161|NCT01689519|364174955|FG001|Safety Population|Withdrawal by Subject|20|||
105594162|NCT00559949|364174957|FG000|Overall Study|Progressive Disease during cycle 1|1|||
105594163|NCT00559949|364174957|FG000|Overall Study|Adverse Event|1|||
105594164|NCT00559949|364174957|FG000|Overall Study|Withdrawal by Subject|4|||
105594165|NCT00559949|364174957|FG000|Overall Study|No disease evaluation per protocol|1|||
105594166|NCT01183780|364174958|FG000|Overall Study|Withdrawal by Subject|25|||
105531235|NCT04960228|363955394|FG001|Overall Study|Flagged for response quality by Dynata|3|||
105531236|NCT01585766|363955395|FG000|Overall Study|Withdrawal by Subject|0|||
105531237|NCT01585766|363955396|FG001|Overall Study|Withdrawal by Subject|1|||
105531238|NCT01585766|363955397|FG002|Overall Study|Withdrawal by Subject|1|||
105594167|NCT01183780|364174959|FG001|Overall Study|Withdrawal by Subject|14|||
105594168|NCT01183780|364174958|FG000|Overall Study|Lost to Follow-up|6|||
105594169|NCT01183780|364174959|FG001|Overall Study|Lost to Follow-up|11|||
105531239|NCT01585766|363955398|FG003|Overall Study|Withdrawal by Subject|0|||
105531240|NCT01585766|363955399|FG004|Overall Study|Withdrawal by Subject|0|||
105531241|NCT01585766|363955400|FG005|Overall Study|Withdrawal by Subject|0|||
105531242|NCT01585766|363955395|FG000|Overall Study|Death|0|||
105531243|NCT01585766|363955396|FG001|Overall Study|Death|1|||
105531244|NCT01585766|363955397|FG002|Overall Study|Death|0|||
105531245|NCT01585766|363955398|FG003|Overall Study|Death|0|||
105531246|NCT01585766|363955399|FG004|Overall Study|Death|0|||
105531247|NCT01585766|363955400|FG005|Overall Study|Death|0|||
105531248|NCT01585766|363955395|FG000|Overall Study|Physician Decision|0|||
105531249|NCT01585766|363955396|FG001|Overall Study|Physician Decision|0|||
105531250|NCT01585766|363955397|FG002|Overall Study|Physician Decision|1|||
105531251|NCT01585766|363955398|FG003|Overall Study|Physician Decision|0|||
105531252|NCT01585766|363955399|FG004|Overall Study|Physician Decision|0|||
105531253|NCT01585766|363955400|FG005|Overall Study|Physician Decision|0|||
105531254|NCT04049760|363955403|FG000|Overall Study|Withdrawal by Subject|1|||
105531255|NCT00393939|363955404|FG000|Overall Study|Protocol Violation|1|||
105531256|NCT00393939|363955405|FG001|Overall Study|Protocol Violation|1|||
105531257|NCT00393939|363955404|FG000|Overall Study|Lost to Follow-up|2|||
105531258|NCT00393939|363955405|FG001|Overall Study|Lost to Follow-up|4|||
105531259|NCT00393939|363955404|FG000|Overall Study|Death|10|||
105531260|NCT00393939|363955405|FG001|Overall Study|Death|4|||
105531261|NCT00393939|363955404|FG000|Overall Study|Sponsor|5|||
105531262|NCT00393939|363955405|FG001|Overall Study|Sponsor|13|||
105531263|NCT00393939|363955404|FG000|Overall Study|Objective progression or relapse|239|||
105531264|NCT00393939|363955405|FG001|Overall Study|Objective progression or relapse|223|||
105531265|NCT00393939|363955404|FG000|Overall Study|Withdrawal by Subject|2|||
105531266|NCT00393939|363955405|FG001|Overall Study|Withdrawal by Subject|7|||
105531267|NCT00393939|363955404|FG000|Overall Study|Other|37|||
105531268|NCT00393939|363955405|FG001|Overall Study|Other|45|||
105531269|NCT02214121|363955412|FG000|Part A|Patient decision|2|||
105531270|NCT02214121|363955413|FG001|Part A|Patient decision|0|||
105531271|NCT02214121|363955414|FG002|Part A|Patient decision|0|||
105531272|NCT02214121|363955412|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
105531273|NCT02214121|363955413|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
105531274|NCT02214121|363955414|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
105531275|NCT02214121|363955412|FG000|Part A|Other|1|||
105531276|NCT02214121|363955413|FG001|Part A|Other|0|||
105531277|NCT02214121|363955414|FG002|Part A|Other|0|||
105531278|NCT02214121|363955412|FG000|Part B|Patient decision|0|||
105531279|NCT02214121|363955413|FG001|Part B|Patient decision|1|||
105531280|NCT02214121|363955414|FG002|Part B|Patient decision|0|||
105531281|NCT02214121|363955412|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
105531282|NCT02214121|363955413|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
105531283|NCT02214121|363955414|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
105531284|NCT02214121|363955412|FG000|Part B|Lost to Follow-up|0|||
105531285|NCT02214121|363955413|FG001|Part B|Lost to Follow-up|0|||
105531286|NCT02214121|363955414|FG002|Part B|Lost to Follow-up|1|||
105531287|NCT02375672|363955415|FG000|Overall Study|remain on follow up|20|||
105531288|NCT01256710|363955416|FG000|Overall Study|Death|449|||
105531289|NCT01256710|363955416|FG000|Overall Study|System Explant|67|||
105531290|NCT01256710|363955416|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
105531291|NCT01256710|363955416|FG000|Overall Study|Lost to Follow-up|67|||
105531292|NCT01256710|363955416|FG000|Overall Study|Withdrawal by Subject|29|||
105531293|NCT01256710|363955416|FG000|Overall Study|Physician Decision|9|||
105531294|NCT01256710|363955416|FG000|Overall Study|Subject Noncompliance|2|||
105531295|NCT01256710|363955416|FG000|Overall Study|Study Terminated by Sponsor|273|||
105531296|NCT02244580|363955421|FG000|Overall Study|No cancer tissues available|241|||
105531297|NCT01736696|363955422|FG000|Overall Study|Withdrawal by Subject|0|||
105531298|NCT01736696|363955423|FG001|Overall Study|Withdrawal by Subject|0|||
105531299|NCT01736696|363955424|FG002|Overall Study|Withdrawal by Subject|1|||
105531300|NCT01736696|363955425|FG003|Overall Study|Withdrawal by Subject|0|||
105531301|NCT01736696|363955426|FG004|Overall Study|Withdrawal by Subject|0|||
105531302|NCT01736696|363955427|FG005|Overall Study|Withdrawal by Subject|0|||
105531303|NCT01736696|363955428|FG006|Overall Study|Withdrawal by Subject|0|||
105531304|NCT02114879|363955429|FG000|Overall Study|Withdrawal by Subject|9|||
105531305|NCT02114879|363955430|FG001|Overall Study|Withdrawal by Subject|5|||
105531306|NCT02114879|363955429|FG000|Overall Study|Death|6|||
105531307|NCT02114879|363955430|FG001|Overall Study|Death|11|||
105531308|NCT02114879|363955429|FG000|Overall Study|Lost to Follow-up|4|||
105531309|NCT02114879|363955430|FG001|Overall Study|Lost to Follow-up|6|||
105531310|NCT02114879|363955429|FG000|Overall Study|Physician Decision|0|||
105531311|NCT02114879|363955430|FG001|Overall Study|Physician Decision|2|||
105531312|NCT04552587|363955434|FG000|Overall Study|Lost to Follow-up|4|||
105531313|NCT00480779|363955435|FG000|Overall Study|Other|2|||
105531314|NCT00480779|363955436|FG001|Overall Study|Other|0|||
105531315|NCT00480779|363955435|FG000|Overall Study|Job and Health-related|0|||
105531316|NCT00480779|363955436|FG001|Overall Study|Job and Health-related|3|||
105531317|NCT04907032|363955438|FG000|Overall Study|Withdrawal by Subject|7|||
105531318|NCT04907032|363955439|FG001|Overall Study|Withdrawal by Subject|1|||
105531319|NCT01838642|363955440|FG000|Overall Study|Died on study|1|||
105531320|NCT02519712|363955443|FG000|Overall Study|Disease Relapse|1|||
105531321|NCT02519712|363955443|FG000|Overall Study|Disease Progression|1|||
105531322|NCT02519712|363955443|FG000|Overall Study|Accruals are donors|2|||
105531323|NCT00613509|363955444|FG000|Cycle 1|Adverse Event|2|||
105531324|NCT00613509|363955445|FG001|Cycle 1|Adverse Event|1|||
105531325|NCT00613509|363955444|FG000|Cycle 1|Disease Progression|2|||
105531326|NCT00613509|363955445|FG001|Cycle 1|Disease Progression|6|||
105531327|NCT00613509|363955444|FG000|Cycle 1|Unacceptable Toxicity|1|||
105531328|NCT00613509|363955445|FG001|Cycle 1|Unacceptable Toxicity|0|||
105531329|NCT00613509|363955444|FG000|Cycle 1|Other administrative reason|0|||
105531330|NCT00613509|363955445|FG001|Cycle 1|Other administrative reason|1|||
105531331|NCT01215227|363955446|FG000|Overall Study|Adverse Event|11|||
105531332|NCT01215227|363955447|FG001|Overall Study|Adverse Event|11|||
105594170|NCT00158054|364174963|FG000|Overall Study|Refused to continue|3|||
105594171|NCT00158054|364174964|FG001|Overall Study|Refused to continue|0|||
105594172|NCT00158054|364174963|FG000|Overall Study|Unavailable for follow up|7|||
105594173|NCT00158054|364174964|FG001|Overall Study|Unavailable for follow up|3|||
105594174|NCT00855465|364174965|FG000|Treatment Period|Adverse Event|4|||
105594175|NCT00855465|364174966|FG001|Treatment Period|Adverse Event|2|||
105594176|NCT00855465|364174965|FG000|Treatment Period|Death|2|||
105594177|NCT00855465|364174966|FG001|Treatment Period|Death|2|||
105594178|NCT00855465|364174965|FG000|Treatment Period|Lack of Efficacy|2|||
105594179|NCT00855465|364174966|FG001|Treatment Period|Lack of Efficacy|1|||
105594180|NCT00855465|364174965|FG000|Treatment Period|Non-compliance|1|||
105594181|NCT00855465|364174966|FG001|Treatment Period|Non-compliance|0|||
105594182|NCT00855465|364174965|FG000|Treatment Period|Protocol Violation|2|||
105594183|NCT00855465|364174966|FG001|Treatment Period|Protocol Violation|0|||
105594184|NCT00855465|364174965|FG000|Treatment Period|Withdrawal by Subject|2|||
105594185|NCT00855465|364174966|FG001|Treatment Period|Withdrawal by Subject|0|||
105594186|NCT00855465|364174965|FG000|Treatment Period|Not treated|1|||
105594187|NCT00855465|364174966|FG001|Treatment Period|Not treated|0|||
105594188|NCT00855465|364174965|FG000|Follow-up Period (FUP)|Adverse Event|0|||
105594189|NCT00855465|364174966|FG001|Follow-up Period (FUP)|Adverse Event|1|||
105594190|NCT00855465|364174965|FG000|Follow-up Period (FUP)|Death|0|||
105594191|NCT00855465|364174966|FG001|Follow-up Period (FUP)|Death|1|||
105594192|NCT00855465|364174965|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
105594193|NCT00855465|364174966|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
105594194|NCT00855465|364174965|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
105594195|NCT00855465|364174966|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
105594196|NCT00855465|364174965|FG000|Follow-up Period (FUP)|Missing|1|||
105594197|NCT00855465|364174966|FG001|Follow-up Period (FUP)|Missing|0|||
105594198|NCT00770965|364174967|FG000|Safety Set|Withdrawal by Subject|0|||
105594199|NCT00770965|364174968|FG001|Safety Set|Withdrawal by Subject|0|||
105594200|NCT00770965|364174969|FG002|Safety Set|Withdrawal by Subject|0|||
105594201|NCT00770965|364174970|FG003|Safety Set|Withdrawal by Subject|1|||
105594202|NCT00770965|364174967|FG000|Safety Set|Protocol deviation|0|||
105594203|NCT00770965|364174968|FG001|Safety Set|Protocol deviation|0|||
105594204|NCT00770965|364174969|FG002|Safety Set|Protocol deviation|1|||
105594205|NCT00770965|364174970|FG003|Safety Set|Protocol deviation|0|||
105594206|NCT00770965|364174967|FG000|Excluded Set|Administrative problems|14|||
105594207|NCT00770965|364174968|FG001|Excluded Set|Administrative problems|12|||
105594208|NCT00770965|364174969|FG002|Excluded Set|Administrative problems|12|||
105594209|NCT00770965|364174970|FG003|Excluded Set|Administrative problems|10|||
105594210|NCT00770965|364174967|FG000|Excluded Set|Withdrawal by Subject|1|||
105594211|NCT00770965|364174968|FG001|Excluded Set|Withdrawal by Subject|1|||
105594212|NCT00770965|364174969|FG002|Excluded Set|Withdrawal by Subject|2|||
105594213|NCT00770965|364174970|FG003|Excluded Set|Withdrawal by Subject|3|||
105594214|NCT00612586|364174971|FG000|Overall Study|Adverse Event|6|||
105594215|NCT00612586|364174972|FG001|Overall Study|Adverse Event|2|||
105594216|NCT00612586|364174971|FG000|Overall Study|Death|1|||
105594217|NCT00612586|364174972|FG001|Overall Study|Death|0|||
105594218|NCT00612586|364174971|FG000|Overall Study|Entry Criteria Not Met|0|||
105594219|NCT00612586|364174972|FG001|Overall Study|Entry Criteria Not Met|2|||
105594220|NCT00612586|364174971|FG000|Overall Study|Withdrawal by Subject|7|||
105594221|NCT00612586|364174972|FG001|Overall Study|Withdrawal by Subject|9|||
105594222|NCT00612586|364174971|FG000|Overall Study|Physician Decision|1|||
105594223|NCT00612586|364174972|FG001|Overall Study|Physician Decision|2|||
105594224|NCT00612586|364174971|FG000|Overall Study|Sponsor Decision|1|||
105594225|NCT00612586|364174972|FG001|Overall Study|Sponsor Decision|1|||
105594226|NCT00612586|364174971|FG000|Overall Study|Progressive Disease|26|||
105594227|NCT00612586|364174972|FG001|Overall Study|Progressive Disease|24|||
105594228|NCT00612586|364174971|FG000|Overall Study|Randomized and Not Treated|1|||
105594229|NCT00612586|364174972|FG001|Overall Study|Randomized and Not Treated|1|||
105594230|NCT03743246|364174973|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
105594231|NCT03743246|364174974|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
105531333|NCT01215227|363955448|FG002|Overall Study|Adverse Event|4|||
105531334|NCT01215227|363955449|FG003|Overall Study|Adverse Event|8|||
105531335|NCT01215227|363955450|FG004|Overall Study|Adverse Event|7|||
105594232|NCT03743246|364174975|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
105594233|NCT03743246|364174976|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
105531336|NCT01215227|363955451|FG005|Overall Study|Adverse Event|6|||
105531337|NCT01215227|363955446|FG000|Overall Study|Treatment Failure|8|||
105531338|NCT01215227|363955447|FG001|Overall Study|Treatment Failure|4|||
105531339|NCT01215227|363955448|FG002|Overall Study|Treatment Failure|1|||
105531340|NCT01215227|363955449|FG003|Overall Study|Treatment Failure|5|||
105531341|NCT01215227|363955450|FG004|Overall Study|Treatment Failure|1|||
105531342|NCT01215227|363955451|FG005|Overall Study|Treatment Failure|1|||
105531343|NCT01215227|363955446|FG000|Overall Study|Lost to Follow-up|1|||
105531344|NCT01215227|363955447|FG001|Overall Study|Lost to Follow-up|4|||
105531345|NCT01215227|363955448|FG002|Overall Study|Lost to Follow-up|1|||
105531346|NCT01215227|363955449|FG003|Overall Study|Lost to Follow-up|1|||
105531347|NCT01215227|363955450|FG004|Overall Study|Lost to Follow-up|1|||
105531348|NCT01215227|363955451|FG005|Overall Study|Lost to Follow-up|2|||
105531349|NCT01215227|363955446|FG000|Overall Study|Subject Withdrew Consent|16|||
105531350|NCT01215227|363955447|FG001|Overall Study|Subject Withdrew Consent|20|||
105531351|NCT01215227|363955448|FG002|Overall Study|Subject Withdrew Consent|7|||
105531352|NCT01215227|363955449|FG003|Overall Study|Subject Withdrew Consent|10|||
105531353|NCT01215227|363955450|FG004|Overall Study|Subject Withdrew Consent|11|||
105531354|NCT01215227|363955451|FG005|Overall Study|Subject Withdrew Consent|8|||
105531355|NCT01215227|363955446|FG000|Overall Study|Non-Compliance With Protocol|2|||
105531356|NCT01215227|363955447|FG001|Overall Study|Non-Compliance With Protocol|6|||
105531357|NCT01215227|363955448|FG002|Overall Study|Non-Compliance With Protocol|1|||
105531358|NCT01215227|363955449|FG003|Overall Study|Non-Compliance With Protocol|0|||
105531359|NCT01215227|363955450|FG004|Overall Study|Non-Compliance With Protocol|0|||
105531360|NCT01215227|363955451|FG005|Overall Study|Non-Compliance With Protocol|0|||
105531361|NCT01215227|363955446|FG000|Overall Study|Administrative|83|||
105531362|NCT01215227|363955447|FG001|Overall Study|Administrative|73|||
105531363|NCT01215227|363955448|FG002|Overall Study|Administrative|42|||
105531364|NCT01215227|363955449|FG003|Overall Study|Administrative|24|||
105531365|NCT01215227|363955450|FG004|Overall Study|Administrative|28|||
105531366|NCT01215227|363955451|FG005|Overall Study|Administrative|40|||
105531367|NCT01215227|363955446|FG000|Overall Study|Missing Status|0|||
105531368|NCT01215227|363955447|FG001|Overall Study|Missing Status|1|||
105531369|NCT01215227|363955448|FG002|Overall Study|Missing Status|0|||
105531370|NCT01215227|363955449|FG003|Overall Study|Missing Status|0|||
105531371|NCT01215227|363955450|FG004|Overall Study|Missing Status|0|||
105531372|NCT01215227|363955451|FG005|Overall Study|Missing Status|0|||
105531373|NCT01215227|363955446|FG000|Overall Study|Randomized but not treated|0|||
105531374|NCT01215227|363955447|FG001|Overall Study|Randomized but not treated|0|||
105531375|NCT01215227|363955448|FG002|Overall Study|Randomized but not treated|1|||
105531376|NCT01215227|363955449|FG003|Overall Study|Randomized but not treated|1|||
105531377|NCT01215227|363955450|FG004|Overall Study|Randomized but not treated|0|||
105594234|NCT03743246|364174973|FG000|Pre-Treatment Period|Death|0|||
105594235|NCT03743246|364174974|FG001|Pre-Treatment Period|Death|1|||
105594236|NCT03743246|364174975|FG002|Pre-Treatment Period|Death|0|||
105594237|NCT03743246|364174976|FG003|Pre-Treatment Period|Death|1|||
105594238|NCT03743246|364174973|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
105594239|NCT03743246|364174974|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
105594240|NCT03743246|364174975|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
105594241|NCT03743246|364174976|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
105594242|NCT03743246|364174973|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
105594243|NCT03743246|364174974|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
105594244|NCT03743246|364174975|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
105594245|NCT03743246|364174976|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
105594246|NCT03743246|364174973|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
105531378|NCT01215227|363955451|FG005|Overall Study|Randomized but not treated|1|||
105531379|NCT01398956|363955461|FG000|Overall Study|Withdrawal by Subject|4|||
105531380|NCT01398956|363955461|FG000|Overall Study|AE, non-serious non-fatal|4|||
105531381|NCT01398956|363955461|FG000|Overall Study|Withdrawal Criteria No.3|1|||
105531382|NCT01398956|363955461|FG000|Overall Study|Subject moved a long distance|1|||
105531383|NCT01339390|363955462|FG000|Overall Study|Death|32|||
105531384|NCT01339390|363955463|FG001|Overall Study|Death|29|||
105531385|NCT01339390|363955462|FG000|Overall Study|Lost to Follow-up|125|||
105594247|NCT03743246|364174974|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
105531386|NCT01339390|363955463|FG001|Overall Study|Lost to Follow-up|127|||
105531387|NCT01224639|363955470|FG000|Overall Study|Withdrawal by Subject|0|||
105531388|NCT01224639|363955471|FG001|Overall Study|Withdrawal by Subject|0|||
105531389|NCT01224639|363955472|FG002|Overall Study|Withdrawal by Subject|0|||
105531390|NCT01224639|363955473|FG003|Overall Study|Withdrawal by Subject|0|||
105531391|NCT01224639|363955474|FG004|Overall Study|Withdrawal by Subject|2|||
105531392|NCT01224639|363955475|FG005|Overall Study|Withdrawal by Subject|0|||
105531393|NCT01224639|363955476|FG006|Overall Study|Withdrawal by Subject|1|||
105531394|NCT01224639|363955477|FG007|Overall Study|Withdrawal by Subject|1|||
105531395|NCT01224639|363955470|FG000|Overall Study|Adverse Event|0|||
105531396|NCT01224639|363955471|FG001|Overall Study|Adverse Event|0|||
105531397|NCT01224639|363955472|FG002|Overall Study|Adverse Event|0|||
105531398|NCT01224639|363955473|FG003|Overall Study|Adverse Event|0|||
105531399|NCT01224639|363955474|FG004|Overall Study|Adverse Event|0|||
105531400|NCT01224639|363955475|FG005|Overall Study|Adverse Event|0|||
105531401|NCT01224639|363955476|FG006|Overall Study|Adverse Event|0|||
105531402|NCT01224639|363955477|FG007|Overall Study|Adverse Event|1|||
105531403|NCT04656132|363955478|FG000|Overall Study|Lost to Follow-up|4|||
105531404|NCT04656132|363955478|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
105531405|NCT03925727|363955484|FG000|Overall Study|Adverse Event|4|||
105531406|NCT03925727|363955485|FG001|Overall Study|Adverse Event|0|||
105531407|NCT03925727|363955486|FG002|Overall Study|Adverse Event|3|||
105531408|NCT03925727|363955484|FG000|Overall Study|Protocol Violation|1|||
105531409|NCT03925727|363955485|FG001|Overall Study|Protocol Violation|2|||
105531410|NCT03925727|363955486|FG002|Overall Study|Protocol Violation|2|||
105531411|NCT03925727|363955484|FG000|Overall Study|Withdrawal by Subject|3|||
105531412|NCT03925727|363955485|FG001|Overall Study|Withdrawal by Subject|2|||
105531413|NCT03925727|363955486|FG002|Overall Study|Withdrawal by Subject|4|||
105531414|NCT03925727|363955484|FG000|Overall Study|Administrative Reasons|3|||
105531415|NCT03925727|363955485|FG001|Overall Study|Administrative Reasons|1|||
105531416|NCT03925727|363955486|FG002|Overall Study|Administrative Reasons|2|||
105531417|NCT03925727|363955484|FG000|Overall Study|Randomized in error or Disqualified|8|||
105531418|NCT03925727|363955485|FG001|Overall Study|Randomized in error or Disqualified|1|||
105531419|NCT03925727|363955486|FG002|Overall Study|Randomized in error or Disqualified|7|||
105531420|NCT00314366|363955487|FG000|Overall Study|not treated due to patient medical condi|1|||
105531421|NCT00314366|363955488|FG001|Overall Study|not treated due to patient medical condi|0|||
105531422|NCT03945981|363955489|FG000|Overall Study|Lost to Follow-up|12|||
105531423|NCT03945981|363955489|FG000|Overall Study|Physician Decision|4|||
105531424|NCT03945981|363955489|FG000|Overall Study|Withdrawal by Subject|6|||
105531425|NCT03945981|363955489|FG000|Overall Study|Protocol Violation|1|||
105531426|NCT01336738|363956679|FG000|Overall Study|Adverse Event|0|||
105531427|NCT01336738|363956680|FG001|Overall Study|Adverse Event|3|||
105531428|NCT01336738|363956681|FG002|Overall Study|Adverse Event|2|||
105531429|NCT01336738|363956682|FG003|Overall Study|Adverse Event|1|||
105531430|NCT01336738|363956683|FG004|Overall Study|Adverse Event|3|||
105531431|NCT01336738|363956679|FG000|Overall Study|Lost to Follow-up|2|||
105531432|NCT01336738|363956680|FG001|Overall Study|Lost to Follow-up|1|||
105531433|NCT01336738|363956681|FG002|Overall Study|Lost to Follow-up|2|||
105531434|NCT01336738|363956682|FG003|Overall Study|Lost to Follow-up|2|||
105531435|NCT01336738|363956683|FG004|Overall Study|Lost to Follow-up|2|||
105531436|NCT01336738|363956679|FG000|Overall Study|Did not meet entrance criteria|0|||
105531437|NCT01336738|363956680|FG001|Overall Study|Did not meet entrance criteria|1|||
105531438|NCT01336738|363956681|FG002|Overall Study|Did not meet entrance criteria|0|||
105531439|NCT01336738|363956682|FG003|Overall Study|Did not meet entrance criteria|0|||
105531440|NCT01336738|363956683|FG004|Overall Study|Did not meet entrance criteria|0|||
105531441|NCT01336738|363956679|FG000|Overall Study|Protocol Violation|0|||
105531442|NCT01336738|363956680|FG001|Overall Study|Protocol Violation|1|||
105531443|NCT01336738|363956681|FG002|Overall Study|Protocol Violation|0|||
105531444|NCT01336738|363956682|FG003|Overall Study|Protocol Violation|0|||
105531445|NCT01336738|363956683|FG004|Overall Study|Protocol Violation|0|||
105531446|NCT01336738|363956679|FG000|Overall Study|Withdrawal by Subject|2|||
105531447|NCT01336738|363956680|FG001|Overall Study|Withdrawal by Subject|0|||
105531448|NCT01336738|363956681|FG002|Overall Study|Withdrawal by Subject|2|||
105531449|NCT01336738|363956682|FG003|Overall Study|Withdrawal by Subject|1|||
105531450|NCT01336738|363956683|FG004|Overall Study|Withdrawal by Subject|1|||
105531451|NCT01336738|363956679|FG000|Overall Study|Other|3|||
105531452|NCT01336738|363956680|FG001|Overall Study|Other|3|||
105531453|NCT01336738|363956681|FG002|Overall Study|Other|2|||
105531454|NCT01336738|363956682|FG003|Overall Study|Other|3|||
105531455|NCT01336738|363956683|FG004|Overall Study|Other|4|||
105531456|NCT02565381|363956684|FG000|Overall Study|Lost to Follow-up|1|||
105531457|NCT02565381|363956685|FG001|Overall Study|Lost to Follow-up|0|||
105531458|NCT02565381|363956686|FG002|Overall Study|Lost to Follow-up|1|||
105531459|NCT00978731|363956689|FG000|Overall Study|Death|4|||
105531460|NCT00978731|363956690|FG001|Overall Study|Death|1|||
105531461|NCT00978731|363956691|FG002|Overall Study|Death|1|||
105531462|NCT00978731|363956692|FG003|Overall Study|Death|0|||
105531463|NCT00978731|363956689|FG000|Overall Study|Lost to Follow-up|0|||
105531464|NCT00978731|363956690|FG001|Overall Study|Lost to Follow-up|0|||
105531465|NCT00978731|363956691|FG002|Overall Study|Lost to Follow-up|0|||
105531466|NCT00978731|363956692|FG003|Overall Study|Lost to Follow-up|1|||
105531467|NCT00978731|363956689|FG000|Overall Study|Adverse Event|5|||
105531468|NCT00978731|363956690|FG001|Overall Study|Adverse Event|2|||
105531469|NCT00978731|363956691|FG002|Overall Study|Adverse Event|0|||
105531470|NCT00978731|363956692|FG003|Overall Study|Adverse Event|0|||
105531471|NCT00978731|363956689|FG000|Overall Study|Participant's request|1|||
105531472|NCT00978731|363956690|FG001|Overall Study|Participant's request|0|||
105531473|NCT00978731|363956691|FG002|Overall Study|Participant's request|0|||
105531474|NCT00978731|363956692|FG003|Overall Study|Participant's request|0|||
105531475|NCT00978731|363956689|FG000|Overall Study|Administrative reason|3|||
105531476|NCT00978731|363956690|FG001|Overall Study|Administrative reason|3|||
105531477|NCT00978731|363956691|FG002|Overall Study|Administrative reason|1|||
105531478|NCT00978731|363956692|FG003|Overall Study|Administrative reason|0|||
105531479|NCT00978731|363956689|FG000|Overall Study|Deterioration without progression|0|||
105531480|NCT00978731|363956690|FG001|Overall Study|Deterioration without progression|1|||
105531481|NCT00978731|363956691|FG002|Overall Study|Deterioration without progression|0|||
105531482|NCT00978731|363956692|FG003|Overall Study|Deterioration without progression|0|||
105531483|NCT00978731|363956689|FG000|Overall Study|Disease progression/relapse|5|||
105531484|NCT00978731|363956690|FG001|Overall Study|Disease progression/relapse|4|||
105531485|NCT00978731|363956691|FG002|Overall Study|Disease progression/relapse|2|||
105531486|NCT00978731|363956692|FG003|Overall Study|Disease progression/relapse|2|||
105531487|NCT00978731|363956689|FG000|Overall Study|Study closure|3|||
105531488|NCT00978731|363956690|FG001|Overall Study|Study closure|4|||
105531489|NCT00978731|363956691|FG002|Overall Study|Study closure|1|||
105531490|NCT00978731|363956692|FG003|Overall Study|Study closure|1|||
105531491|NCT00978731|363956689|FG000|Overall Study|No response|1|||
105531492|NCT00978731|363956690|FG001|Overall Study|No response|0|||
105531493|NCT00978731|363956691|FG002|Overall Study|No response|0|||
105531494|NCT00978731|363956692|FG003|Overall Study|No response|0|||
105531495|NCT00071812|363956693|FG000|24-Week Double-Blind Period|Adverse Event|2|||
105531496|NCT00071812|363956694|FG001|24-Week Double-Blind Period|Adverse Event|3|||
105531497|NCT00071812|363956695|FG002|24-Week Double-Blind Period|Adverse Event|4|||
105531498|NCT00071812|363956696|FG003|24-Week Double-Blind Period|Adverse Event|4|||
105531499|NCT00071812|363956693|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
105531500|NCT00071812|363956694|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
105531501|NCT00071812|363956695|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
105531502|NCT00071812|363956696|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
105531503|NCT00071812|363956693|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
105531504|NCT00071812|363956694|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
105531505|NCT00071812|363956695|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
105531506|NCT00071812|363956696|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
105531507|NCT00071812|363956693|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
105531508|NCT00071812|363956694|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
105531509|NCT00071812|363956695|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
105531510|NCT00071812|363956696|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
105531511|NCT00071812|363956693|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
105531512|NCT00071812|363956694|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
105531513|NCT00071812|363956695|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
105531514|NCT00071812|363956696|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
105531515|NCT00071812|363956693|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
105531516|NCT00071812|363956694|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
105531517|NCT00071812|363956695|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
105531518|NCT00071812|363956696|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
105531519|NCT00071812|363956693|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
105531520|NCT00071812|363956694|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
105531521|NCT00071812|363956695|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
105531522|NCT00071812|363956696|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
105531523|NCT00071812|363956693|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
105531524|NCT00071812|363956694|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
105531525|NCT00071812|363956695|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
105531526|NCT00071812|363956696|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
105531527|NCT00071812|363956693|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
105531528|NCT00071812|363956694|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
105531529|NCT00071812|363956695|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
105531530|NCT00071812|363956696|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
105531531|NCT00071812|363956693|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
105531532|NCT00071812|363956694|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
105531533|NCT00071812|363956695|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
105531534|NCT00071812|363956696|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
105531535|NCT01896895|363956697|FG000|Double-blind MP|Physician Decision|0|||
105531536|NCT01896895|363956698|FG001|Double-blind MP|Physician Decision|0|||
105531537|NCT01896895|363956699|FG002|Double-blind MP|Physician Decision|1|||
105531538|NCT01896895|363956700|FG003|Double-blind MP|Physician Decision|0|||
105531539|NCT01896895|363956697|FG000|Double-blind MP|Withdrawal by Subject|0|||
105531540|NCT01896895|363956698|FG001|Double-blind MP|Withdrawal by Subject|2|||
105531541|NCT01896895|363956699|FG002|Double-blind MP|Withdrawal by Subject|1|||
105594248|NCT03743246|364174975|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
105531542|NCT01896895|363956700|FG003|Double-blind MP|Withdrawal by Subject|0|||
105531543|NCT01896895|363956697|FG000|Double-blind MP|Lost to Follow-up|1|||
105531544|NCT01896895|363956698|FG001|Double-blind MP|Lost to Follow-up|0|||
105594249|NCT03743246|364174976|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
105594250|NCT03743246|364174973|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
105594251|NCT03743246|364174974|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
105594252|NCT03743246|364174975|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
105594253|NCT03743246|364174976|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
105594254|NCT03743246|364174973|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
105594255|NCT03743246|364174974|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
105594256|NCT03743246|364174975|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
105594257|NCT03743246|364174976|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
105594258|NCT03743246|364174973|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
105531545|NCT01896895|363956699|FG002|Double-blind MP|Lost to Follow-up|1|||
105531546|NCT01896895|363956700|FG003|Double-blind MP|Lost to Follow-up|0|||
105531547|NCT01433263|363956703|FG000|Overall Study|Adverse Event|3|||
105531548|NCT01433263|363956704|FG001|Overall Study|Adverse Event|1|||
105531549|NCT01433263|363956703|FG000|Overall Study|Death|5|||
105531550|NCT01433263|363956704|FG001|Overall Study|Death|3|||
105531551|NCT01433263|363956703|FG000|Overall Study|Lost to Follow-up|0|||
105531552|NCT01433263|363956704|FG001|Overall Study|Lost to Follow-up|1|||
105531553|NCT01433263|363956703|FG000|Overall Study|Protocol Deviation|1|||
105531554|NCT01433263|363956704|FG001|Overall Study|Protocol Deviation|0|||
105531555|NCT01433263|363956703|FG000|Overall Study|Withdrawal by Subject|10|||
105531556|NCT01433263|363956704|FG001|Overall Study|Withdrawal by Subject|7|||
105531557|NCT01589822|363956705|FG000|Overall Study|Withdrawal by Subject|1|||
105531558|NCT01589822|363956706|FG001|Overall Study|Withdrawal by Subject|2|||
105531559|NCT01589822|363956707|FG002|Overall Study|Withdrawal by Subject|0|||
105531560|NCT01589822|363956705|FG000|Overall Study|Death|1|||
105531561|NCT01589822|363956706|FG001|Overall Study|Death|0|||
105531562|NCT01589822|363956707|FG002|Overall Study|Death|0|||
105531563|NCT01589822|363956705|FG000|Overall Study|Missed 90 day visit|2|||
105531564|NCT01589822|363956706|FG001|Overall Study|Missed 90 day visit|1|||
105531565|NCT01589822|363956707|FG002|Overall Study|Missed 90 day visit|1|||
105531566|NCT05168475|363956708|FG000|Period 1|Protocol Violation|1|||
105531567|NCT05168475|363956708|FG000|Period 1|IMP shortage|2|||
105531568|NCT05168475|363956708|FG000|Period 1|Not randomised|2|||
105531569|NCT05168475|363956708|FG000|Period 2|IMP shortage|1|||
105531570|NCT01140477|363956709|FG000|Overall Study|Lost to Follow-up|4|||
105531571|NCT01140477|363956710|FG001|Overall Study|Lost to Follow-up|0|||
105531572|NCT01140477|363956709|FG000|Overall Study|Withdrawal by Subject|1|||
105531573|NCT01140477|363956710|FG001|Overall Study|Withdrawal by Subject|4|||
105531574|NCT01140477|363956709|FG000|Overall Study|Surgical complication preventing implant|2|||
105531575|NCT01140477|363956710|FG001|Overall Study|Surgical complication preventing implant|0|||
105531576|NCT01140477|363956709|FG000|Overall Study|Death|1|||
105531577|NCT01140477|363956710|FG001|Overall Study|Death|1|||
105531578|NCT01140477|363956709|FG000|Overall Study|Subject explanted|0|||
105531579|NCT01140477|363956710|FG001|Overall Study|Subject explanted|1|||
105531580|NCT01302964|363956718|FG000|Overall Study|Adverse Event|1|||
105531581|NCT01302964|363956719|FG001|Overall Study|Adverse Event|0|||
105594259|NCT03743246|364174974|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
105594260|NCT03743246|364174975|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
105594261|NCT03743246|364174976|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
105594262|NCT03743246|364174973|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
105594263|NCT03743246|364174974|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
105594264|NCT03743246|364174975|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
105594265|NCT03743246|364174976|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
105594266|NCT00949975|364174978|FG000|Overall Study|Voluntary discontinuation|6|||
105594267|NCT00949975|364174979|FG001|Overall Study|Voluntary discontinuation|5|||
105594268|NCT00949975|364174980|FG002|Overall Study|Voluntary discontinuation|3|||
105594269|NCT00949975|364174981|FG003|Overall Study|Voluntary discontinuation|6|||
105594270|NCT00949975|364174978|FG000|Overall Study|Adverse Event|11|||
105531582|NCT00145509|363956720|FG000|Overall Study|Adverse Event|10|||
105531583|NCT00145509|363956721|FG001|Overall Study|Adverse Event|3|||
105531584|NCT00145509|363956720|FG000|Overall Study|Lack of Efficacy|3|||
105531585|NCT00145509|363956721|FG001|Overall Study|Lack of Efficacy|1|||
105531586|NCT00145509|363956720|FG000|Overall Study|Lost to Follow-up|5|||
105531587|NCT00145509|363956721|FG001|Overall Study|Lost to Follow-up|9|||
105531588|NCT00145509|363956720|FG000|Overall Study|Withdrew Consent|2|||
105531589|NCT00145509|363956721|FG001|Overall Study|Withdrew Consent|7|||
105531590|NCT00145509|363956720|FG000|Overall Study|Reason not provided|2|||
105531591|NCT00145509|363956721|FG001|Overall Study|Reason not provided|1|||
105531592|NCT01359592|363956722|FG000|Initial Registration|Adverse Event|1|||
105531593|NCT01359592|363956723|FG001|Initial Registration|Adverse Event|0|||
105531594|NCT01359592|363956724|FG002|Initial Registration|Adverse Event|0|||
105531595|NCT01359592|363956725|FG003|Initial Registration|Adverse Event|0|||
105531596|NCT01359592|363956722|FG000|Initial Registration|Death|1|||
105531597|NCT01359592|363956723|FG001|Initial Registration|Death|0|||
105531598|NCT01359592|363956724|FG002|Initial Registration|Death|0|||
105531599|NCT01359592|363956725|FG003|Initial Registration|Death|0|||
105531600|NCT01359592|363956722|FG000|Initial Registration|Other reason not protocol specified|1|||
105531601|NCT01359592|363956723|FG001|Initial Registration|Other reason not protocol specified|0|||
105531602|NCT01359592|363956724|FG002|Initial Registration|Other reason not protocol specified|0|||
105531603|NCT01359592|363956725|FG003|Initial Registration|Other reason not protocol specified|0|||
105531604|NCT01359592|363956722|FG000|Initial Registration|Ineligible|26|||
105531605|NCT01359592|363956723|FG001|Initial Registration|Ineligible|0|||
105531606|NCT01359592|363956724|FG002|Initial Registration|Ineligible|0|||
105531607|NCT01359592|363956725|FG003|Initial Registration|Ineligible|0|||
105531608|NCT01359592|363956722|FG000|PET-Directed Therapy|Adverse Event|0|||
105531609|NCT01359592|363956723|FG001|PET-Directed Therapy|Adverse Event|0|||
105531610|NCT01359592|363956724|FG002|PET-Directed Therapy|Adverse Event|1|||
105531611|NCT01359592|363956725|FG003|PET-Directed Therapy|Adverse Event|0|||
105531612|NCT01359592|363956722|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
105531613|NCT01359592|363956723|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
105531614|NCT01359592|363956724|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
105531615|NCT01359592|363956725|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
105531616|NCT01359592|363956722|FG000|PET-Directed Therapy|Ineligible|0|||
105531617|NCT01359592|363956723|FG001|PET-Directed Therapy|Ineligible|0|||
105531618|NCT01359592|363956724|FG002|PET-Directed Therapy|Ineligible|24|||
105531619|NCT01359592|363956725|FG003|PET-Directed Therapy|Ineligible|0|||
105531620|NCT02919670|363956727|FG000|Overall Study|Only 17 participants met compliance|43|||
105531621|NCT02919670|363956728|FG001|Overall Study|Only 17 participants met compliance|39|||
105531622|NCT00910715|363956731|FG000|Overall Study|Lost to Follow-up|22|||
105531623|NCT00910715|363956732|FG001|Overall Study|Lost to Follow-up|26|||
105531624|NCT00910715|363956733|FG002|Overall Study|Lost to Follow-up|0|||
105531625|NCT01096784|363956736|FG000|Overall Study|Withdrawal by Subject|2|||
105531626|NCT01096784|363956737|FG001|Overall Study|Withdrawal by Subject|1|||
105531627|NCT01096784|363956736|FG000|Overall Study|Adverse Event|11|||
105531628|NCT01096784|363956737|FG001|Overall Study|Adverse Event|9|||
105531629|NCT01096784|363956736|FG000|Overall Study|Protocol Deviation|2|||
105531630|NCT01096784|363956737|FG001|Overall Study|Protocol Deviation|2|||
105531631|NCT01096784|363956736|FG000|Overall Study|Administrative Decision|0|||
105531632|NCT01096784|363956737|FG001|Overall Study|Administrative Decision|1|||
105531633|NCT01096784|363956736|FG000|Overall Study|Other Unspecified|0|||
105531634|NCT01096784|363956737|FG001|Overall Study|Other Unspecified|1|||
105531635|NCT03064126|363956749|FG000|Overall Study|Death|40|||
105531636|NCT03064126|363956750|FG001|Overall Study|Death|16|||
105531637|NCT03064126|363956751|FG002|Overall Study|Death|4|||
105531638|NCT03064126|363956752|FG003|Overall Study|Death|2|||
105531639|NCT03064126|363956749|FG000|Overall Study|Withdrawal by Subject|17|||
105531640|NCT03064126|363956750|FG001|Overall Study|Withdrawal by Subject|9|||
105531641|NCT03064126|363956751|FG002|Overall Study|Withdrawal by Subject|0|||
105531642|NCT03064126|363956752|FG003|Overall Study|Withdrawal by Subject|2|||
105531643|NCT03064126|363956749|FG000|Overall Study|Lost to Follow-up|7|||
105531644|NCT03064126|363956750|FG001|Overall Study|Lost to Follow-up|3|||
105531645|NCT03064126|363956751|FG002|Overall Study|Lost to Follow-up|0|||
105531646|NCT03064126|363956752|FG003|Overall Study|Lost to Follow-up|0|||
105531647|NCT03064126|363956749|FG000|Overall Study|Adverse Event|2|||
105531648|NCT03064126|363956750|FG001|Overall Study|Adverse Event|0|||
105531649|NCT03064126|363956751|FG002|Overall Study|Adverse Event|0|||
105531650|NCT03064126|363956752|FG003|Overall Study|Adverse Event|0|||
105531651|NCT03064126|363956749|FG000|Overall Study|Physician Decision|3|||
105531652|NCT03064126|363956750|FG001|Overall Study|Physician Decision|0|||
105531653|NCT03064126|363956751|FG002|Overall Study|Physician Decision|0|||
105531654|NCT03064126|363956752|FG003|Overall Study|Physician Decision|0|||
105531655|NCT03064126|363956749|FG000|Overall Study|Other reason for early termination|3|||
105531656|NCT03064126|363956750|FG001|Overall Study|Other reason for early termination|2|||
105531657|NCT03064126|363956751|FG002|Overall Study|Other reason for early termination|0|||
105531658|NCT03064126|363956752|FG003|Overall Study|Other reason for early termination|0|||
105531659|NCT03064126|363956749|FG000|Overall Study|Missed Visit|3|||
105531660|NCT03064126|363956750|FG001|Overall Study|Missed Visit|1|||
105531661|NCT03064126|363956751|FG002|Overall Study|Missed Visit|0|||
105531662|NCT03064126|363956752|FG003|Overall Study|Missed Visit|0|||
105531663|NCT02465528|363956753|FG000|Overall Study|Progressive disease|0|||
105531664|NCT02465528|363956754|FG001|Overall Study|Progressive disease|2|||
105531665|NCT02465528|363956755|FG002|Overall Study|Progressive disease|9|||
105531666|NCT02465528|363956756|FG003|Overall Study|Progressive disease|4|||
105531667|NCT02465528|363956753|FG000|Overall Study|Study terminated by sponsor|1|||
105531668|NCT02465528|363956754|FG001|Overall Study|Study terminated by sponsor|2|||
105531669|NCT02465528|363956755|FG002|Overall Study|Study terminated by sponsor|0|||
105531670|NCT02465528|363956756|FG003|Overall Study|Study terminated by sponsor|0|||
105531671|NCT02465528|363956753|FG000|Overall Study|Withdrawal by Subject|0|||
105531672|NCT02465528|363956754|FG001|Overall Study|Withdrawal by Subject|0|||
105594271|NCT00949975|364174979|FG001|Overall Study|Adverse Event|11|||
105531673|NCT02465528|363956755|FG002|Overall Study|Withdrawal by Subject|2|||
105531674|NCT02465528|363956756|FG003|Overall Study|Withdrawal by Subject|0|||
105531675|NCT02465528|363956753|FG000|Overall Study|Adverse Event|0|||
105531676|NCT02465528|363956754|FG001|Overall Study|Adverse Event|0|||
105531677|NCT02465528|363956755|FG002|Overall Study|Adverse Event|0|||
105531678|NCT02465528|363956756|FG003|Overall Study|Adverse Event|1|||
105531679|NCT02465528|363956753|FG000|Overall Study|Physician Decision|0|||
105531680|NCT02465528|363956754|FG001|Overall Study|Physician Decision|0|||
105531681|NCT02465528|363956755|FG002|Overall Study|Physician Decision|1|||
105531682|NCT02465528|363956756|FG003|Overall Study|Physician Decision|0|||
105531683|NCT03752619|363956757|FG000|Overall Study|Lost to Follow-up|2|||
105531684|NCT03752619|363956758|FG001|Overall Study|Lost to Follow-up|1|||
105531685|NCT03752619|363956757|FG000|Overall Study|Withdrawal by Subject|1|||
105531686|NCT03752619|363956758|FG001|Overall Study|Withdrawal by Subject|1|||
105531687|NCT03752619|363956757|FG000|Overall Study|Adverse Event|0|||
105531688|NCT03752619|363956758|FG001|Overall Study|Adverse Event|1|||
105531689|NCT03907683|363956759|FG000|Overall Study|Pregnancy|1|||
105531690|NCT03907683|363956759|FG000|Overall Study|Withdrawal by Subject|1|||
105531691|NCT02704364|363956763|FG000|Overall Study|Adverse Event|1|||
105531692|NCT02704364|363956764|FG001|Overall Study|Adverse Event|1|||
105531693|NCT02704364|363956765|FG002|Overall Study|Adverse Event|0|||
105531694|NCT02704364|363956763|FG000|Overall Study|Noncompliance with study drug|1|||
105531695|NCT02704364|363956764|FG001|Overall Study|Noncompliance with study drug|1|||
105531696|NCT02704364|363956765|FG002|Overall Study|Noncompliance with study drug|0|||
105531697|NCT02704364|363956763|FG000|Overall Study|Other|0|||
105531698|NCT02704364|363956764|FG001|Overall Study|Other|1|||
105531699|NCT02704364|363956765|FG002|Overall Study|Other|1|||
105531700|NCT00846742|363956766|FG000|Overall Study|Withdrawal by Subject|1|||
105531701|NCT06034496|363956774|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
105531702|NCT06034496|363956775|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
105531703|NCT06034496|363956774|FG000|Overall Study|Withdrawal by Subject|5|||
105531704|NCT06034496|363956775|FG001|Overall Study|Withdrawal by Subject|4|||
105531705|NCT00006916|363956781|FG000|Overall Study|Device not inserted|4|||
105531706|NCT00006916|363956781|FG000|Overall Study|Complication of device insertion|1|||
105531707|NCT03044197|363956788|FG000|Overall Study|Withdrawal by Subject|3|||
105531708|NCT03044197|363956789|FG001|Overall Study|Withdrawal by Subject|1|||
105531709|NCT03829046|363956790|FG000|Overall Study|Withdrawal by Subject|1|||
105531710|NCT03829046|363956791|FG001|Overall Study|Withdrawal by Subject|0|||
105531711|NCT02469610|363956796|FG000|Overall Study|Death|1|||
105531712|NCT02469610|363956797|FG001|Overall Study|Death|0|||
105531713|NCT02469610|363956796|FG000|Overall Study|Lost to Follow-up|1|||
105531714|NCT02469610|363956797|FG001|Overall Study|Lost to Follow-up|0|||
105531715|NCT02469610|363956796|FG000|Overall Study|exclusion criteria|2|||
105531716|NCT02469610|363956797|FG001|Overall Study|exclusion criteria|1|||
105531717|NCT02448875|363956798|FG000|Overall Study|Adverse Event|2|||
105531718|NCT02448875|363956799|FG001|Overall Study|Adverse Event|1|||
105531719|NCT02448875|363956800|FG002|Overall Study|Adverse Event|0|||
105531720|NCT02448875|363956798|FG000|Overall Study|Lost to Follow-up|1|||
105531721|NCT02448875|363956799|FG001|Overall Study|Lost to Follow-up|0|||
105531722|NCT02448875|363956800|FG002|Overall Study|Lost to Follow-up|0|||
105531723|NCT02448875|363956798|FG000|Overall Study|Investigator Decision|3|||
105531724|NCT02448875|363956799|FG001|Overall Study|Investigator Decision|0|||
105531725|NCT02448875|363956800|FG002|Overall Study|Investigator Decision|1|||
105531726|NCT02448875|363956798|FG000|Overall Study|Withdrawal by Subject|1|||
105531727|NCT02448875|363956799|FG001|Overall Study|Withdrawal by Subject|0|||
105531728|NCT02448875|363956800|FG002|Overall Study|Withdrawal by Subject|0|||
105531729|NCT02908529|363956802|FG000|Overall Study|Lost to Follow-up|0|||
105531730|NCT02908529|363956803|FG001|Overall Study|Lost to Follow-up|2|||
105531731|NCT00689481|363956806|FG000|Overall Study|Adverse Event|7|||
105531732|NCT00689481|363956807|FG001|Overall Study|Adverse Event|1|||
105531733|NCT00689481|363956806|FG000|Overall Study|Lost to Follow-up|4|||
105531734|NCT00689481|363956807|FG001|Overall Study|Lost to Follow-up|3|||
105531735|NCT00689481|363956806|FG000|Overall Study|Lack of Efficacy|4|||
105531736|NCT00689481|363956807|FG001|Overall Study|Lack of Efficacy|3|||
105531737|NCT00689481|363956806|FG000|Overall Study|Non-compliance with study treatment|1|||
105531738|NCT00689481|363956807|FG001|Overall Study|Non-compliance with study treatment|1|||
105531739|NCT00689481|363956806|FG000|Overall Study|Withdrawal by Subject|8|||
105531740|NCT00689481|363956807|FG001|Overall Study|Withdrawal by Subject|4|||
105531741|NCT00689481|363956806|FG000|Overall Study|Excluded medication started during study|0|||
105531742|NCT00689481|363956807|FG001|Overall Study|Excluded medication started during study|1|||
105531743|NCT00689481|363956806|FG000|Overall Study|Subject early term, left on vacation|0|||
105531744|NCT00689481|363956807|FG001|Overall Study|Subject early term, left on vacation|1|||
105531745|NCT03551210|363956810|FG000|Overall Study|Adverse Event|5|||
105531746|NCT03551210|363956811|FG001|Overall Study|Adverse Event|6|||
105531747|NCT03551210|363956810|FG000|Overall Study|Withdrawal by Subject|1|||
105531748|NCT03551210|363956811|FG001|Overall Study|Withdrawal by Subject|7|||
105531749|NCT03551210|363956810|FG000|Overall Study|Needed in other antibiotic treatment|2|||
105531750|NCT03551210|363956811|FG001|Overall Study|Needed in other antibiotic treatment|5|||
105531751|NCT03551210|363956810|FG000|Overall Study|Lost to Follow-up|1|||
105531752|NCT03551210|363956811|FG001|Overall Study|Lost to Follow-up|1|||
105531753|NCT03551210|363956810|FG000|Overall Study|Absence of visit 4 and 5|1|||
105531754|NCT03551210|363956811|FG001|Overall Study|Absence of visit 4 and 5|0|||
105531755|NCT03551210|363956810|FG000|Overall Study|No drug for dispensing|0|||
105531756|NCT03551210|363956811|FG001|Overall Study|No drug for dispensing|1|||
105531757|NCT02239536|363956812|FG000|Overall Study|Non-neoplastic polyp|23|||
105531758|NCT02239536|363956813|FG001|Overall Study|Non-neoplastic polyp|17|||
105531759|NCT04074317|363956814|FG000|Third Period|Withdrawal by Subject|0|||
105531760|NCT04074317|363956815|FG001|Third Period|Withdrawal by Subject|0|||
105531761|NCT04074317|363956816|FG002|Third Period|Withdrawal by Subject|0|||
105531762|NCT04074317|363956817|FG003|Third Period|Withdrawal by Subject|1|||
105531763|NCT04074317|363956818|FG004|Third Period|Withdrawal by Subject|0|||
105531764|NCT04074317|363956819|FG005|Third Period|Withdrawal by Subject|0|||
105531923|NCT04615949|363960392|FG000|Overall Study|Withdrawal by Subject|2|||
105531924|NCT04615949|363960393|FG001|Overall Study|Withdrawal by Subject|4|||
105531925|NCT04615949|363960392|FG000|Overall Study|Lost to Follow-up|2|||
105531926|NCT04615949|363960393|FG001|Overall Study|Lost to Follow-up|2|||
105531927|NCT04615949|363960392|FG000|Overall Study|Death|0|||
105531928|NCT04615949|363960393|FG001|Overall Study|Death|2|||
105531929|NCT05458856|363960394|FG000|Overall Study|Withdrawal by Subject|5|||
105531930|NCT05458856|363960394|FG000|Overall Study|Death|4|||
105531931|NCT05458856|363960394|FG000|Overall Study|Protocol Deviation|3|||
105531932|NCT05458856|363960394|FG000|Overall Study|Physician Decision|1|||
105594272|NCT00949975|364174980|FG002|Overall Study|Adverse Event|10|||
105531965|NCT05308901|363960409|FG000|Overall Study|Death|6|||
105594273|NCT00949975|364174981|FG003|Overall Study|Adverse Event|10|||
105594274|NCT00949975|364174978|FG000|Overall Study|Safety reason|0|||
105594275|NCT00949975|364174979|FG001|Overall Study|Safety reason|1|||
105594276|NCT00949975|364174980|FG002|Overall Study|Safety reason|0|||
105594277|NCT00949975|364174981|FG003|Overall Study|Safety reason|0|||
105594278|NCT00949975|364174978|FG000|Overall Study|Study-specific criteria|0|||
105594279|NCT00949975|364174979|FG001|Overall Study|Study-specific criteria|1|||
105594280|NCT00949975|364174980|FG002|Overall Study|Study-specific criteria|1|||
105594281|NCT00949975|364174981|FG003|Overall Study|Study-specific criteria|0|||
105594282|NCT00949975|364174978|FG000|Overall Study|Incorrect enrolment|5|||
105594283|NCT00949975|364174979|FG001|Overall Study|Incorrect enrolment|10|||
105594284|NCT00949975|364174980|FG002|Overall Study|Incorrect enrolment|4|||
105594285|NCT00949975|364174981|FG003|Overall Study|Incorrect enrolment|7|||
105594286|NCT00949975|364174978|FG000|Overall Study|Severe non-compliance|3|||
105594287|NCT00949975|364174979|FG001|Overall Study|Severe non-compliance|1|||
105594288|NCT00949975|364174980|FG002|Overall Study|Severe non-compliance|0|||
105594289|NCT00949975|364174981|FG003|Overall Study|Severe non-compliance|2|||
105594290|NCT00949975|364174978|FG000|Overall Study|Lost to Follow-up|1|||
105532035|NCT04904185|363960441|FG000|Overall Study|Expansion failure|1|||
105532036|NCT04904185|363960442|FG001|Overall Study|Expansion failure|0|||
105532037|NCT04904185|363960441|FG000|Overall Study|Late response on prior treatment|1|||
105532038|NCT04904185|363960442|FG001|Overall Study|Late response on prior treatment|0|||
105532053|NCT03761628|363960460|FG000|Overall Study|Withdrawal by Subject|3|||
105532054|NCT03761628|363960460|FG000|Overall Study|Physician Decision|1|||
105532055|NCT03761628|363960460|FG000|Overall Study|Pregnancy|1|||
105532056|NCT03761628|363960460|FG000|Overall Study|Lost to Follow-up|1|||
105594291|NCT00949975|364174979|FG001|Overall Study|Lost to Follow-up|0|||
105594292|NCT00949975|364174980|FG002|Overall Study|Lost to Follow-up|1|||
105594293|NCT00949975|364174981|FG003|Overall Study|Lost to Follow-up|3|||
105594294|NCT00949975|364174978|FG000|Overall Study|Other|1|||
105594295|NCT00949975|364174979|FG001|Overall Study|Other|0|||
105594296|NCT00949975|364174980|FG002|Overall Study|Other|0|||
105594297|NCT00949975|364174981|FG003|Overall Study|Other|0|||
105594298|NCT02873754|364174982|FG000|Overall Study|Lost to Follow-up|5|||
105594299|NCT02873754|364174982|FG000|Overall Study|Couldn't complete study procedures|1|||
105594300|NCT00410124|364174995|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
105594301|NCT00410124|364174996|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
105594302|NCT00410124|364174995|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
105594303|NCT00410124|364174996|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
105594304|NCT00410124|364174995|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
105594305|NCT00410124|364174996|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
105594306|NCT00410124|364174995|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
105594307|NCT00410124|364174996|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
105594308|NCT00410124|364174995|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
105594309|NCT00410124|364174996|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
105594310|NCT00410124|364174995|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
105594311|NCT00410124|364174996|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
105594312|NCT00410124|364174995|FG000|Core Phase Double Blind (15 Months)|Death|7|||
105594313|NCT00410124|364174996|FG001|Core Phase Double Blind (15 Months)|Death|4|||
105532265|NCT05288556|363960489|FG000|Overall Study|Protocol Violation|1|||
105532266|NCT05288556|363960489|FG000|Overall Study|Withdrawal by Subject|1|||
105532312|NCT04656652|363960511|FG000|Overall Study|Lost to Follow-up|2|||
105532313|NCT04656652|363960512|FG001|Overall Study|Lost to Follow-up|2|||
105532314|NCT04656652|363960511|FG000|Overall Study|Death|213|||
105532315|NCT04656652|363960512|FG001|Overall Study|Death|212|||
105532316|NCT04656652|363960511|FG000|Overall Study|Other|1|||
105532317|NCT04656652|363960512|FG001|Overall Study|Other|0|||
105532318|NCT04656652|363960511|FG000|Overall Study|Withdrawal by Subject|15|||
105532319|NCT04656652|363960512|FG001|Overall Study|Withdrawal by Subject|29|||
105532394|NCT03400332|363960526|FG000|Pre-Treatment|Other reasons|0|||
105532395|NCT03400332|363960527|FG001|Pre-Treatment|Other reasons|0|||
105532396|NCT03400332|363960528|FG002|Pre-Treatment|Other reasons|0|||
105532397|NCT03400332|363960529|FG003|Pre-Treatment|Other reasons|0|||
105532398|NCT03400332|363960530|FG004|Pre-Treatment|Other reasons|0|||
105532399|NCT03400332|363960531|FG005|Pre-Treatment|Other reasons|0|||
105532400|NCT03400332|363960532|FG006|Pre-Treatment|Other reasons|0|||
105532401|NCT03400332|363960533|FG007|Pre-Treatment|Other reasons|0|||
105532402|NCT03400332|363960534|FG008|Pre-Treatment|Other reasons|1|||
105532403|NCT03400332|363960526|FG000|Pre-Treatment|No longer met study criteria|0|||
105532404|NCT03400332|363960527|FG001|Pre-Treatment|No longer met study criteria|0|||
105532405|NCT03400332|363960528|FG002|Pre-Treatment|No longer met study criteria|0|||
105532406|NCT03400332|363960529|FG003|Pre-Treatment|No longer met study criteria|0|||
105532407|NCT03400332|363960530|FG004|Pre-Treatment|No longer met study criteria|0|||
105532408|NCT03400332|363960531|FG005|Pre-Treatment|No longer met study criteria|0|||
105532409|NCT03400332|363960532|FG006|Pre-Treatment|No longer met study criteria|0|||
105532410|NCT03400332|363960533|FG007|Pre-Treatment|No longer met study criteria|0|||
105532411|NCT03400332|363960534|FG008|Pre-Treatment|No longer met study criteria|1|||
105532412|NCT03400332|363960526|FG000|Pre-Treatment|Withdrawal by Subject|0|||
105532413|NCT03400332|363960527|FG001|Pre-Treatment|Withdrawal by Subject|0|||
105532414|NCT03400332|363960528|FG002|Pre-Treatment|Withdrawal by Subject|0|||
105532415|NCT03400332|363960529|FG003|Pre-Treatment|Withdrawal by Subject|0|||
105532416|NCT03400332|363960530|FG004|Pre-Treatment|Withdrawal by Subject|0|||
105532417|NCT03400332|363960531|FG005|Pre-Treatment|Withdrawal by Subject|0|||
105532418|NCT03400332|363960532|FG006|Pre-Treatment|Withdrawal by Subject|0|||
105532419|NCT03400332|363960533|FG007|Pre-Treatment|Withdrawal by Subject|0|||
105532420|NCT03400332|363960534|FG008|Pre-Treatment|Withdrawal by Subject|1|||
105532421|NCT03400332|363960526|FG000|Treatment|Participant withdrew consent|2|||
105532422|NCT03400332|363960527|FG001|Treatment|Participant withdrew consent|2|||
105532423|NCT03400332|363960528|FG002|Treatment|Participant withdrew consent|0|||
105532424|NCT03400332|363960529|FG003|Treatment|Participant withdrew consent|0|||
105532425|NCT03400332|363960530|FG004|Treatment|Participant withdrew consent|3|||
105532426|NCT03400332|363960531|FG005|Treatment|Participant withdrew consent|3|||
105532427|NCT03400332|363960532|FG006|Treatment|Participant withdrew consent|1|||
105532428|NCT03400332|363960533|FG007|Treatment|Participant withdrew consent|1|||
105532429|NCT03400332|363960534|FG008|Treatment|Participant withdrew consent|1|||
105532430|NCT03400332|363960526|FG000|Treatment|Other reasons|0|||
105532431|NCT03400332|363960527|FG001|Treatment|Other reasons|1|||
105532432|NCT03400332|363960528|FG002|Treatment|Other reasons|1|||
105532433|NCT03400332|363960529|FG003|Treatment|Other reasons|0|||
105532434|NCT03400332|363960530|FG004|Treatment|Other reasons|3|||
105532435|NCT03400332|363960531|FG005|Treatment|Other reasons|1|||
105532436|NCT03400332|363960532|FG006|Treatment|Other reasons|2|||
105532437|NCT03400332|363960533|FG007|Treatment|Other reasons|0|||
105532438|NCT03400332|363960534|FG008|Treatment|Other reasons|1|||
105532439|NCT03400332|363960526|FG000|Treatment|Lost to Follow-up|0|||
105532440|NCT03400332|363960527|FG001|Treatment|Lost to Follow-up|1|||
105532441|NCT03400332|363960528|FG002|Treatment|Lost to Follow-up|0|||
105532442|NCT03400332|363960529|FG003|Treatment|Lost to Follow-up|0|||
105532443|NCT03400332|363960530|FG004|Treatment|Lost to Follow-up|0|||
105532444|NCT03400332|363960531|FG005|Treatment|Lost to Follow-up|0|||
105532445|NCT03400332|363960532|FG006|Treatment|Lost to Follow-up|0|||
105594314|NCT00410124|364174995|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
105594315|NCT00410124|364174996|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
105532446|NCT03400332|363960533|FG007|Treatment|Lost to Follow-up|0|||
105532447|NCT03400332|363960534|FG008|Treatment|Lost to Follow-up|0|||
105532448|NCT03400332|363960526|FG000|Treatment|Death|3|||
105532449|NCT03400332|363960527|FG001|Treatment|Death|1|||
105532450|NCT03400332|363960528|FG002|Treatment|Death|2|||
105532451|NCT03400332|363960529|FG003|Treatment|Death|3|||
105532452|NCT03400332|363960530|FG004|Treatment|Death|6|||
105532453|NCT03400332|363960531|FG005|Treatment|Death|2|||
105532454|NCT03400332|363960532|FG006|Treatment|Death|1|||
105532455|NCT03400332|363960533|FG007|Treatment|Death|3|||
105532456|NCT03400332|363960534|FG008|Treatment|Death|6|||
105532500|NCT02975934|363960549|FG000|Treatment Phase|Never initiated study drug|0|||
105532501|NCT02975934|363960550|FG001|Treatment Phase|Never initiated study drug|5|||
105532502|NCT02975934|363960551|FG002|Treatment Phase|Never initiated study drug|0|||
105594316|NCT00410124|364174995|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
105532511|NCT02075840|363960560|FG000|Overall Study|Withdrawal by Subject|13|||
105532512|NCT02075840|363960561|FG001|Overall Study|Withdrawal by Subject|22|||
105532513|NCT02075840|363960560|FG000|Overall Study|Reason not specified|1|||
105532514|NCT02075840|363960561|FG001|Overall Study|Reason not specified|0|||
105532515|NCT02075840|363960560|FG000|Overall Study|Adverse Event|0|||
105532516|NCT02075840|363960561|FG001|Overall Study|Adverse Event|2|||
105532517|NCT02075840|363960560|FG000|Overall Study|Death|35|||
105532518|NCT02075840|363960561|FG001|Overall Study|Death|40|||
105532519|NCT02075840|363960560|FG000|Overall Study|Lost to Follow-up|3|||
105532520|NCT02075840|363960561|FG001|Overall Study|Lost to Follow-up|2|||
105532521|NCT02075840|363960560|FG000|Overall Study|Physician Decision|1|||
105532522|NCT02075840|363960561|FG001|Overall Study|Physician Decision|3|||
105532523|NCT02075840|363960560|FG000|Overall Study|Ongoing at CCOD|99|||
105532524|NCT02075840|363960561|FG001|Overall Study|Ongoing at CCOD|82|||
105594317|NCT00410124|364174996|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
105594318|NCT00410124|364174995|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
105594319|NCT00410124|364174996|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
105594320|NCT00410124|364174995|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
105532644|NCT03795610|363960569|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
105532645|NCT03795610|363960569|FG000|Overall Study|Withdrawal by Subject|1|||
105532646|NCT03795610|363960569|FG000|Overall Study|Screen Failure (Unknown)|1|||
105594321|NCT00410124|364174996|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
105594322|NCT00410124|364174995|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
105594323|NCT00410124|364174996|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
105594324|NCT00410124|364174995|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
105594325|NCT00410124|364174996|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
105594326|NCT00410124|364174995|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
105594327|NCT00410124|364174996|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
105594328|NCT00410124|364174995|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
105594329|NCT00410124|364174996|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
105594330|NCT00410124|364174995|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
105594331|NCT00410124|364174996|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
105594332|NCT00716144|364174997|FG000|Overall Study|Withdrawal by Subject|4|||
105594333|NCT00716144|364174998|FG001|Overall Study|Withdrawal by Subject|2|||
105594334|NCT00716144|364174999|FG002|Overall Study|Withdrawal by Subject|6|||
105594335|NCT00716144|364175000|FG003|Overall Study|Withdrawal by Subject|6|||
105594336|NCT00716144|364174997|FG000|Overall Study|Lost to Follow-up|2|||
105594337|NCT00716144|364174998|FG001|Overall Study|Lost to Follow-up|2|||
105594338|NCT00716144|364174999|FG002|Overall Study|Lost to Follow-up|1|||
105594339|NCT00716144|364175000|FG003|Overall Study|Lost to Follow-up|2|||
105594340|NCT00716144|364174997|FG000|Overall Study|Adverse Event|0|||
105594341|NCT00716144|364174998|FG001|Overall Study|Adverse Event|0|||
105594342|NCT00716144|364174999|FG002|Overall Study|Adverse Event|0|||
105594343|NCT00716144|364175000|FG003|Overall Study|Adverse Event|2|||
105594344|NCT00716144|364174997|FG000|Overall Study|Non-compliance|1|||
105594345|NCT00716144|364174998|FG001|Overall Study|Non-compliance|0|||
105594346|NCT00716144|364174999|FG002|Overall Study|Non-compliance|0|||
105594347|NCT00716144|364175000|FG003|Overall Study|Non-compliance|0|||
105594348|NCT00716144|364174997|FG000|Overall Study|Protocol Violation|2|||
105594349|NCT00716144|364174998|FG001|Overall Study|Protocol Violation|0|||
105594350|NCT00716144|364174999|FG002|Overall Study|Protocol Violation|1|||
105594351|NCT00716144|364175000|FG003|Overall Study|Protocol Violation|0|||
105594352|NCT00716144|364174997|FG000|Overall Study|Physician Decision|0|||
105594353|NCT00716144|364174998|FG001|Overall Study|Physician Decision|1|||
105594354|NCT00716144|364174999|FG002|Overall Study|Physician Decision|2|||
105594355|NCT00716144|364175000|FG003|Overall Study|Physician Decision|2|||
105594356|NCT00716144|364174997|FG000|Overall Study|Intercurrent illness|0|||
105594357|NCT00716144|364174998|FG001|Overall Study|Intercurrent illness|0|||
105594358|NCT00716144|364174999|FG002|Overall Study|Intercurrent illness|1|||
105594359|NCT00716144|364175000|FG003|Overall Study|Intercurrent illness|0|||
105594360|NCT00716144|364174997|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
105594361|NCT00716144|364174998|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
105594362|NCT00716144|364174999|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
105594363|NCT00716144|364175000|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
105594364|NCT00716144|364174997|FG000|Overall Study|Adverse event: left foot pain|0|||
105594365|NCT00716144|364174998|FG001|Overall Study|Adverse event: left foot pain|1|||
105594366|NCT00716144|364174999|FG002|Overall Study|Adverse event: left foot pain|0|||
105594367|NCT00716144|364175000|FG003|Overall Study|Adverse event: left foot pain|0|||
105594368|NCT00716144|364174997|FG000|Overall Study|Clinical Depression|0|||
105594369|NCT00716144|364174998|FG001|Overall Study|Clinical Depression|1|||
105594370|NCT00716144|364174999|FG002|Overall Study|Clinical Depression|0|||
105594371|NCT00716144|364175000|FG003|Overall Study|Clinical Depression|0|||
105594372|NCT00909363|364175001|FG000|Overall Study|Withdrawal by Subject|1|||
105594373|NCT00909363|364175002|FG001|Overall Study|Withdrawal by Subject|0|||
105594374|NCT00909363|364175003|FG002|Overall Study|Withdrawal by Subject|0|||
105594375|NCT00909363|364175001|FG000|Overall Study|Lack of Efficacy|1|||
105594376|NCT00909363|364175002|FG001|Overall Study|Lack of Efficacy|0|||
105594377|NCT00909363|364175003|FG002|Overall Study|Lack of Efficacy|0|||
105594378|NCT05641311|364175004|FG000|Dosing Period 1|Adverse Event|1|||
105594379|NCT05641311|364175005|FG001|Dosing Period 1|Adverse Event|0|||
105594380|NCT00082810|364175007|FG000|Overall Study|Adverse Event|3|||
105594381|NCT00082810|364175007|FG000|Overall Study|Progressive disease|24|||
105594382|NCT00082810|364175007|FG000|Overall Study|Withdrawal by Subject|4|||
105594383|NCT02950558|364175008|FG000|Overall Study|Lost to Follow-up|2|||
105594384|NCT02950558|364175009|FG001|Overall Study|Lost to Follow-up|0|||
105594385|NCT02059980|364175014|FG000|Overall Study|Lost to Follow-up|2|||
105594386|NCT02059980|364175015|FG001|Overall Study|Lost to Follow-up|1|||
105594387|NCT02341625|364175016|FG000|Overall Study|Disease Progression|2|||
105594388|NCT02341625|364175017|FG001|Overall Study|Disease Progression|2|||
105594389|NCT02341625|364175018|FG002|Overall Study|Disease Progression|3|||
105594390|NCT02341625|364175019|FG003|Overall Study|Disease Progression|6|||
105594391|NCT02341625|364175020|FG004|Overall Study|Disease Progression|7|||
105594392|NCT02341625|364175021|FG005|Overall Study|Disease Progression|7|||
105594393|NCT02341625|364175022|FG006|Overall Study|Disease Progression|28|||
105594394|NCT02341625|364175023|FG007|Overall Study|Disease Progression|5|||
105594395|NCT02341625|364175024|FG008|Overall Study|Disease Progression|4|||
105594396|NCT02341625|364175025|FG009|Overall Study|Disease Progression|19|||
105594397|NCT02341625|364175016|FG000|Overall Study|Study Drug Toxicity|0|||
105594398|NCT02341625|364175017|FG001|Overall Study|Study Drug Toxicity|0|||
105594399|NCT02341625|364175018|FG002|Overall Study|Study Drug Toxicity|0|||
105594400|NCT02341625|364175019|FG003|Overall Study|Study Drug Toxicity|1|||
105594401|NCT02341625|364175020|FG004|Overall Study|Study Drug Toxicity|0|||
105594402|NCT02341625|364175021|FG005|Overall Study|Study Drug Toxicity|3|||
105594403|NCT02341625|364175022|FG006|Overall Study|Study Drug Toxicity|10|||
105594404|NCT02341625|364175023|FG007|Overall Study|Study Drug Toxicity|0|||
105594405|NCT02341625|364175024|FG008|Overall Study|Study Drug Toxicity|0|||
105594406|NCT02341625|364175025|FG009|Overall Study|Study Drug Toxicity|3|||
105594407|NCT02341625|364175016|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
105594408|NCT02341625|364175017|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
105594409|NCT02341625|364175018|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
105594410|NCT02341625|364175019|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
105594411|NCT02341625|364175020|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
105594412|NCT02341625|364175021|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
105594413|NCT02341625|364175022|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
105594414|NCT02341625|364175023|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
105594415|NCT02341625|364175024|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
105594416|NCT02341625|364175025|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
105594417|NCT02341625|364175016|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
105594418|NCT02341625|364175017|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
105594419|NCT02341625|364175018|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
105594420|NCT02341625|364175019|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
105594421|NCT02341625|364175020|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
105594422|NCT02341625|364175021|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
105594423|NCT02341625|364175022|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
105594424|NCT02341625|364175023|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
105594425|NCT02341625|364175024|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
105594426|NCT02341625|364175025|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
105594427|NCT02341625|364175016|FG000|Overall Study|Participant Withdrew Consent|0|||
105594428|NCT02341625|364175017|FG001|Overall Study|Participant Withdrew Consent|0|||
105594429|NCT02341625|364175018|FG002|Overall Study|Participant Withdrew Consent|0|||
105594430|NCT02341625|364175019|FG003|Overall Study|Participant Withdrew Consent|1|||
105594431|NCT02341625|364175020|FG004|Overall Study|Participant Withdrew Consent|0|||
105594432|NCT02341625|364175021|FG005|Overall Study|Participant Withdrew Consent|0|||
105594433|NCT02341625|364175022|FG006|Overall Study|Participant Withdrew Consent|0|||
105594434|NCT02341625|364175023|FG007|Overall Study|Participant Withdrew Consent|0|||
105594435|NCT02341625|364175024|FG008|Overall Study|Participant Withdrew Consent|0|||
105594436|NCT02341625|364175025|FG009|Overall Study|Participant Withdrew Consent|0|||
105594437|NCT02341625|364175016|FG000|Overall Study|Completed Treatment as per Protocol|0|||
105594438|NCT02341625|364175017|FG001|Overall Study|Completed Treatment as per Protocol|0|||
105594439|NCT02341625|364175018|FG002|Overall Study|Completed Treatment as per Protocol|0|||
105594440|NCT02341625|364175019|FG003|Overall Study|Completed Treatment as per Protocol|0|||
105594441|NCT02341625|364175020|FG004|Overall Study|Completed Treatment as per Protocol|0|||
105532833|NCT03909165|363960605|FG000|Overall Study|Physician Decision|0|||
105532834|NCT03909165|363960606|FG001|Overall Study|Physician Decision|1|||
105532835|NCT03909165|363960607|FG002|Overall Study|Physician Decision|0|||
105532836|NCT03909165|363960608|FG003|Overall Study|Physician Decision|0|||
105532837|NCT03909165|363960609|FG004|Overall Study|Physician Decision|0|||
105532838|NCT03909165|363960605|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105532839|NCT03909165|363960606|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105532840|NCT03909165|363960607|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105532841|NCT03909165|363960608|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105532842|NCT03909165|363960609|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
105532843|NCT03909165|363960605|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
105532844|NCT03909165|363960606|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
105532845|NCT03909165|363960607|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
105532846|NCT03909165|363960608|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
105532847|NCT03909165|363960609|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
105532848|NCT03909165|363960605|FG000|Overall Study|Previous Drug Exposure|0|||
105532849|NCT03909165|363960606|FG001|Overall Study|Previous Drug Exposure|0|||
105532850|NCT03909165|363960607|FG002|Overall Study|Previous Drug Exposure|1|||
105532851|NCT03909165|363960608|FG003|Overall Study|Previous Drug Exposure|0|||
105532852|NCT03909165|363960609|FG004|Overall Study|Previous Drug Exposure|0|||
105532853|NCT03909165|363960605|FG000|Overall Study|Early Discharge|1|||
105532854|NCT03909165|363960606|FG001|Overall Study|Early Discharge|0|||
105532855|NCT03909165|363960607|FG002|Overall Study|Early Discharge|0|||
105532856|NCT03909165|363960608|FG003|Overall Study|Early Discharge|0|||
105532857|NCT03909165|363960609|FG004|Overall Study|Early Discharge|0|||
105532882|NCT04627064|363960614|FG000|Overall Study|Progressive disease|8|||
105532883|NCT04627064|363960615|FG001|Overall Study|Progressive disease|0|||
105532884|NCT04627064|363960614|FG000|Overall Study|Withdrawal by Subject|2|||
105532885|NCT04627064|363960615|FG001|Overall Study|Withdrawal by Subject|0|||
105532886|NCT04627064|363960614|FG000|Overall Study|Physician Decision|1|||
105532887|NCT04627064|363960615|FG001|Overall Study|Physician Decision|0|||
105594442|NCT02341625|364175021|FG005|Overall Study|Completed Treatment as per Protocol|0|||
105594443|NCT02341625|364175022|FG006|Overall Study|Completed Treatment as per Protocol|0|||
105594444|NCT02341625|364175023|FG007|Overall Study|Completed Treatment as per Protocol|0|||
105594445|NCT02341625|364175024|FG008|Overall Study|Completed Treatment as per Protocol|0|||
105594446|NCT02341625|364175025|FG009|Overall Study|Completed Treatment as per Protocol|1|||
105594447|NCT02341625|364175016|FG000|Overall Study|Other Reasons|0|||
105594448|NCT02341625|364175017|FG001|Overall Study|Other Reasons|0|||
105594449|NCT02341625|364175018|FG002|Overall Study|Other Reasons|0|||
105533449|NCT03762083|363960636|FG000|Overall Study|Withdrawal by Subject|2|||
105533450|NCT03762083|363960636|FG000|Overall Study|Physician Decision|1|||
105594450|NCT02341625|364175019|FG003|Overall Study|Other Reasons|0|||
105594451|NCT02341625|364175020|FG004|Overall Study|Other Reasons|1|||
105533710|NCT01403974|363960704|FG000|Overall Study|Progressive disease according to RECIST|3|||
105533711|NCT01403974|363960705|FG001|Overall Study|Progressive disease according to RECIST|3|||
105533712|NCT01403974|363960706|FG002|Overall Study|Progressive disease according to RECIST|2|||
105533713|NCT01403974|363960707|FG003|Overall Study|Progressive disease according to RECIST|3|||
105533714|NCT01403974|363960708|FG004|Overall Study|Progressive disease according to RECIST|3|||
105533715|NCT01403974|363960709|FG005|Overall Study|Progressive disease according to RECIST|2|||
105533716|NCT01403974|363960710|FG006|Overall Study|Progressive disease according to RECIST|3|||
105533717|NCT01403974|363960711|FG007|Overall Study|Progressive disease according to RECIST|2|||
105533718|NCT01403974|363960712|FG008|Overall Study|Progressive disease according to RECIST|6|||
105533719|NCT01403974|363960713|FG009|Overall Study|Progressive disease according to RECIST|2|||
105533720|NCT01403974|363960714|FG010|Overall Study|Progressive disease according to RECIST|3|||
105533721|NCT01403974|363960715|FG011|Overall Study|Progressive disease according to RECIST|2|||
105533722|NCT01403974|363960716|FG012|Overall Study|Progressive disease according to RECIST|2|||
105533723|NCT01403974|363960717|FG013|Overall Study|Progressive disease according to RECIST|3|||
105533724|NCT01403974|363960718|FG014|Overall Study|Progressive disease according to RECIST|1|||
105533725|NCT01403974|363960719|FG015|Overall Study|Progressive disease according to RECIST|8|||
105533726|NCT01403974|363960704|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
105533727|NCT01403974|363960705|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
105533728|NCT01403974|363960706|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
105533729|NCT01403974|363960707|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
105533730|NCT01403974|363960708|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
105533731|NCT01403974|363960709|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
105533732|NCT01403974|363960710|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
105533733|NCT01403974|363960711|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
105533734|NCT01403974|363960712|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
105533735|NCT01403974|363960713|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
105533736|NCT01403974|363960714|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
105533737|NCT01403974|363960715|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
105533738|NCT01403974|363960716|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
105533739|NCT01403974|363960717|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
105533740|NCT01403974|363960718|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
105533741|NCT01403974|363960719|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
105533742|NCT01403974|363960704|FG000|Overall Study|Refused to continue study medication|0|||
105533743|NCT01403974|363960705|FG001|Overall Study|Refused to continue study medication|0|||
105533744|NCT01403974|363960706|FG002|Overall Study|Refused to continue study medication|0|||
105533745|NCT01403974|363960707|FG003|Overall Study|Refused to continue study medication|0|||
105594452|NCT02341625|364175021|FG005|Overall Study|Other Reasons|0|||
105594453|NCT02341625|364175022|FG006|Overall Study|Other Reasons|5|||
105533746|NCT01403974|363960708|FG004|Overall Study|Refused to continue study medication|0|||
105533747|NCT01403974|363960709|FG005|Overall Study|Refused to continue study medication|1|||
105533748|NCT01403974|363960710|FG006|Overall Study|Refused to continue study medication|0|||
105533749|NCT01403974|363960711|FG007|Overall Study|Refused to continue study medication|0|||
105533750|NCT01403974|363960712|FG008|Overall Study|Refused to continue study medication|1|||
105533751|NCT01403974|363960713|FG009|Overall Study|Refused to continue study medication|0|||
105533752|NCT01403974|363960714|FG010|Overall Study|Refused to continue study medication|1|||
105533753|NCT01403974|363960715|FG011|Overall Study|Refused to continue study medication|0|||
105533754|NCT01403974|363960716|FG012|Overall Study|Refused to continue study medication|0|||
105533755|NCT01403974|363960717|FG013|Overall Study|Refused to continue study medication|0|||
105533756|NCT01403974|363960718|FG014|Overall Study|Refused to continue study medication|0|||
105533757|NCT01403974|363960719|FG015|Overall Study|Refused to continue study medication|4|||
105533758|NCT01403974|363960704|FG000|Overall Study|Adverse Event|0|||
105533759|NCT01403974|363960705|FG001|Overall Study|Adverse Event|0|||
105533760|NCT01403974|363960706|FG002|Overall Study|Adverse Event|1|||
105533761|NCT01403974|363960707|FG003|Overall Study|Adverse Event|0|||
105533762|NCT01403974|363960708|FG004|Overall Study|Adverse Event|0|||
105533763|NCT01403974|363960709|FG005|Overall Study|Adverse Event|0|||
105533764|NCT01403974|363960710|FG006|Overall Study|Adverse Event|0|||
105533765|NCT01403974|363960711|FG007|Overall Study|Adverse Event|1|||
105533766|NCT01403974|363960712|FG008|Overall Study|Adverse Event|0|||
105533767|NCT01403974|363960713|FG009|Overall Study|Adverse Event|0|||
105533768|NCT01403974|363960714|FG010|Overall Study|Adverse Event|0|||
105533769|NCT01403974|363960715|FG011|Overall Study|Adverse Event|0|||
105533770|NCT01403974|363960716|FG012|Overall Study|Adverse Event|1|||
105533771|NCT01403974|363960717|FG013|Overall Study|Adverse Event|0|||
105533772|NCT01403974|363960718|FG014|Overall Study|Adverse Event|0|||
105533773|NCT01403974|363960719|FG015|Overall Study|Adverse Event|0|||
105533774|NCT01403974|363960704|FG000|Overall Study|Other than specified|0|||
105533775|NCT01403974|363960705|FG001|Overall Study|Other than specified|0|||
105533776|NCT01403974|363960706|FG002|Overall Study|Other than specified|0|||
105533777|NCT01403974|363960707|FG003|Overall Study|Other than specified|0|||
105533778|NCT01403974|363960708|FG004|Overall Study|Other than specified|0|||
105533779|NCT01403974|363960709|FG005|Overall Study|Other than specified|0|||
105533780|NCT01403974|363960710|FG006|Overall Study|Other than specified|0|||
105533781|NCT01403974|363960711|FG007|Overall Study|Other than specified|0|||
105533782|NCT01403974|363960712|FG008|Overall Study|Other than specified|0|||
105533783|NCT01403974|363960713|FG009|Overall Study|Other than specified|1|||
105533784|NCT01403974|363960714|FG010|Overall Study|Other than specified|0|||
105533785|NCT01403974|363960715|FG011|Overall Study|Other than specified|1|||
105533786|NCT01403974|363960716|FG012|Overall Study|Other than specified|0|||
105533787|NCT01403974|363960717|FG013|Overall Study|Other than specified|0|||
105533788|NCT01403974|363960718|FG014|Overall Study|Other than specified|0|||
105533789|NCT01403974|363960719|FG015|Overall Study|Other than specified|0|||
105594454|NCT02341625|364175023|FG007|Overall Study|Other Reasons|0|||
105594455|NCT02341625|364175024|FG008|Overall Study|Other Reasons|0|||
105594456|NCT02341625|364175025|FG009|Overall Study|Other Reasons|2|||
105594457|NCT02341625|364175016|FG000|Overall Study|Not Reported|0|||
105594458|NCT02341625|364175017|FG001|Overall Study|Not Reported|0|||
105594459|NCT02341625|364175018|FG002|Overall Study|Not Reported|0|||
105594460|NCT02341625|364175019|FG003|Overall Study|Not Reported|0|||
105594461|NCT02341625|364175020|FG004|Overall Study|Not Reported|0|||
105594462|NCT02341625|364175021|FG005|Overall Study|Not Reported|0|||
105594463|NCT02341625|364175022|FG006|Overall Study|Not Reported|0|||
105594464|NCT02341625|364175023|FG007|Overall Study|Not Reported|0|||
105594465|NCT02341625|364175024|FG008|Overall Study|Not Reported|0|||
105594466|NCT02341625|364175025|FG009|Overall Study|Not Reported|3|||
105594467|NCT00367055|364175026|FG000|Overall Study|Adverse Event|6|||
105594468|NCT00367055|364175027|FG001|Overall Study|Adverse Event|3|||
105594469|NCT00367055|364175026|FG000|Overall Study|Patient's Willing|3|||
105594470|NCT00367055|364175027|FG001|Overall Study|Patient's Willing|2|||
105594471|NCT00367055|364175026|FG000|Overall Study|Lack of Efficacy|1|||
105594472|NCT00367055|364175027|FG001|Overall Study|Lack of Efficacy|2|||
105594473|NCT00367055|364175026|FG000|Overall Study|Lost to Follow-up|1|||
105594474|NCT00367055|364175027|FG001|Overall Study|Lost to Follow-up|1|||
105594475|NCT00367055|364175026|FG000|Overall Study|Protocol Violation|0|||
105594476|NCT00367055|364175027|FG001|Overall Study|Protocol Violation|1|||
105594477|NCT00367055|364175026|FG000|Overall Study|Stopping Criterion Met|0|||
105594478|NCT00367055|364175027|FG001|Overall Study|Stopping Criterion Met|1|||
105594479|NCT00367055|364175026|FG000|Overall Study|Participant Living too Far from Hospital|0|||
105594480|NCT00367055|364175027|FG001|Overall Study|Participant Living too Far from Hospital|1|||
105594481|NCT03523091|364175035|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
105594482|NCT03523091|364175036|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
105594483|NCT03523091|364175035|FG000|Overall Study|Withdrawal by Subject|0|||
105594484|NCT03523091|364175036|FG001|Overall Study|Withdrawal by Subject|3|||
105594485|NCT03523091|364175035|FG000|Overall Study|Increase Botox dose|0|||
105594486|NCT03523091|364175036|FG001|Overall Study|Increase Botox dose|1|||
105594487|NCT05019729|364175037|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
105594488|NCT05019729|364175038|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
105594489|NCT05019729|364175039|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
105594490|NCT05019729|364175040|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
105594491|NCT05019729|364175041|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
105594492|NCT05019729|364175042|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
105594493|NCT01697319|364175046|FG000|Primary Phase|Withdrawal by Subject|1|||
105594494|NCT01697319|364175046|FG000|Extension Phase|Terminated by Sponsor|15|||
105594495|NCT04222959|364175048|FG000|Overall Study|Lost to Follow-up|76|||
105594496|NCT04222959|364175049|FG001|Overall Study|Lost to Follow-up|28|||
105594497|NCT00387465|364175050|FG000|Overall Study|Withdrawal by Subject|0|||
105534031|NCT02681302|363962745|FG000|Overall Study|Withdrawal by Subject|1|||
105534032|NCT02681302|363962746|FG001|Overall Study|Withdrawal by Subject|1|||
105534033|NCT02681302|363962747|FG002|Overall Study|Withdrawal by Subject|0|||
105534034|NCT02681302|363962748|FG003|Overall Study|Withdrawal by Subject|0|||
105534035|NCT02681302|363962749|FG004|Overall Study|Withdrawal by Subject|1|||
105534036|NCT02681302|363962750|FG005|Overall Study|Withdrawal by Subject|0|||
105534037|NCT02681302|363962745|FG000|Overall Study|Screen Failure|2|||
105534038|NCT02681302|363962746|FG001|Overall Study|Screen Failure|4|||
105534039|NCT02681302|363962747|FG002|Overall Study|Screen Failure|2|||
105534040|NCT02681302|363962748|FG003|Overall Study|Screen Failure|0|||
105534041|NCT02681302|363962749|FG004|Overall Study|Screen Failure|1|||
105534042|NCT02681302|363962750|FG005|Overall Study|Screen Failure|1|||
105534043|NCT02681302|363962745|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
105534044|NCT02681302|363962746|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
105534045|NCT02681302|363962747|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
105534046|NCT02681302|363962748|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
105534047|NCT02681302|363962749|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
105534048|NCT02681302|363962750|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
105594498|NCT00387465|364175051|FG001|Overall Study|Withdrawal by Subject|1|||
105594499|NCT00387465|364175052|FG002|Overall Study|Withdrawal by Subject|0|||
105594500|NCT03545984|364175053|FG000|Overall Study|CSF cases not present during rotation|11|||
105594501|NCT03545984|364175054|FG001|Overall Study|CSF cases not present during rotation|9|||
105594502|NCT03768206|364175055|FG000|Overall Study|Lost to Follow-up|2|||
105594503|NCT03768206|364175056|FG001|Overall Study|Lost to Follow-up|1|||
105594504|NCT03768206|364175055|FG000|Overall Study|Withdrawal by Subject|0|||
105594505|NCT03768206|364175056|FG001|Overall Study|Withdrawal by Subject|1|||
105594506|NCT01390402|364175057|FG000|Overall Study|Death|1|||
105594507|NCT01390402|364175057|FG000|Overall Study|Disease Progression|4|||
105594508|NCT02812966|364175058|FG000|Overall Study|Death|1|||
105594509|NCT02812966|364175059|FG001|Overall Study|Death|0|||
105594510|NCT00849147|364175063|FG000|Overall Study|Withdrawal by Subject|1|||
105594511|NCT00849147|364175063|FG000|Overall Study|Protocol Violation|2|||
105594512|NCT00849147|364175063|FG000|Overall Study|Disease Relapse/Progression|2|||
105594513|NCT01331824|364176554|FG000|Overall Study|Adverse Event|2|||
105594514|NCT01331824|364176554|FG000|Overall Study|Death|1|||
105594515|NCT01331824|364176554|FG000|Overall Study|Disease Progression|9|||
105594516|NCT01331824|364176554|FG000|Overall Study|Withdrawal by Subject|1|||
105594517|NCT00646451|364176555|FG000|Overall Study|Adverse Event|3|||
105594518|NCT00646451|364176556|FG001|Overall Study|Adverse Event|0|||
105594519|NCT00646451|364176555|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
105594520|NCT00646451|364176556|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
105594521|NCT00377455|364176559|FG000|Overall Study|Withdrawal by Subject|1|||
105594522|NCT01063036|364176565|FG000|Participants Treated With Study Drug|Adverse Event|1|||
105594523|NCT01063036|364176565|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
105594524|NCT01063036|364176565|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
105594525|NCT01063036|364176565|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
105594526|NCT01063036|364176565|FG000|Participants Treated With Study Drug|Pregnancy|1|||
105594527|NCT01063036|364176565|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
105594528|NCT01063036|364176565|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
105594529|NCT01063036|364176565|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
105594530|NCT00918957|364176566|FG000|Overall Study|Adverse Event|2|||
105594531|NCT00918957|364176567|FG001|Overall Study|Adverse Event|0|||
105594532|NCT00918957|364176566|FG000|Overall Study|Withdrawal by Subject|1|||
105594533|NCT00918957|364176567|FG001|Overall Study|Withdrawal by Subject|0|||
105594534|NCT00487578|364176568|FG000|Overall Study|Adverse Event|1|||
105594535|NCT00487578|364176569|FG001|Overall Study|Adverse Event|2|||
105594536|NCT00487578|364176568|FG000|Overall Study|Lack of Efficacy|0|||
105594537|NCT00487578|364176569|FG001|Overall Study|Lack of Efficacy|1|||
105594538|NCT00487578|364176568|FG000|Overall Study|Lost to Follow-up|0|||
105594539|NCT00487578|364176569|FG001|Overall Study|Lost to Follow-up|1|||
105594540|NCT01499134|364176570|FG000|Overall Study|Withdrawal by Subject|0|||
105594541|NCT01499134|364176571|FG001|Overall Study|Withdrawal by Subject|1|||
105594542|NCT00708032|364176572|FG000|Overall Study|Adverse Event|0|||
105594543|NCT00708032|364176573|FG001|Overall Study|Adverse Event|2|||
105594544|NCT00708032|364176572|FG000|Overall Study|Lost to Follow-up|1|||
105594545|NCT00708032|364176573|FG001|Overall Study|Lost to Follow-up|2|||
105594546|NCT00708032|364176572|FG000|Overall Study|Pregnancy|0|||
105594547|NCT00708032|364176573|FG001|Overall Study|Pregnancy|1|||
105594548|NCT00708032|364176572|FG000|Overall Study|Poor vision|0|||
105594549|NCT00708032|364176573|FG001|Overall Study|Poor vision|6|||
105594550|NCT00708032|364176572|FG000|Overall Study|Visit out of range at month 12|4|||
105594551|NCT00708032|364176573|FG001|Overall Study|Visit out of range at month 12|1|||
105594552|NCT00708032|364176572|FG000|Overall Study|Did not meet protocol criteria|1|||
105594553|NCT00708032|364176573|FG001|Overall Study|Did not meet protocol criteria|2|||
105594554|NCT00708032|364176572|FG000|Overall Study|Protocol Violation|4|||
105594555|NCT00708032|364176573|FG001|Overall Study|Protocol Violation|1|||
105594556|NCT00708032|364176572|FG000|Overall Study|Withdrawal by Subject|0|||
105594557|NCT00708032|364176573|FG001|Overall Study|Withdrawal by Subject|1|||
105594558|NCT02385669|364176583|FG000|Overall Study|Adverse Event|2|||
105594559|NCT02477670|364176584|FG000|Stage 1|Adverse Event|2|||
105594560|NCT02477670|364176585|FG001|Stage 1|Adverse Event|7|||
105594561|NCT02477670|364176586|FG002|Stage 1|Adverse Event|0|||
105594562|NCT02477670|364176587|FG003|Stage 1|Adverse Event|0|||
105594563|NCT02477670|364176588|FG004|Stage 1|Adverse Event|0|||
105594564|NCT02477670|364176589|FG005|Stage 1|Adverse Event|0|||
105594565|NCT02477670|364176590|FG006|Stage 1|Adverse Event|0|||
105594566|NCT02477670|364176584|FG000|Stage 1|Lost to Follow-up|0|||
105594567|NCT02477670|364176585|FG001|Stage 1|Lost to Follow-up|2|||
105594568|NCT02477670|364176586|FG002|Stage 1|Lost to Follow-up|0|||
105594569|NCT02477670|364176587|FG003|Stage 1|Lost to Follow-up|0|||
105594570|NCT02477670|364176588|FG004|Stage 1|Lost to Follow-up|0|||
105594571|NCT02477670|364176589|FG005|Stage 1|Lost to Follow-up|0|||
105594572|NCT02477670|364176590|FG006|Stage 1|Lost to Follow-up|0|||
105594573|NCT02477670|364176584|FG000|Stage 1|Withdrawal by Subject|1|||
105594574|NCT02477670|364176585|FG001|Stage 1|Withdrawal by Subject|2|||
105594575|NCT02477670|364176586|FG002|Stage 1|Withdrawal by Subject|0|||
105594576|NCT02477670|364176587|FG003|Stage 1|Withdrawal by Subject|0|||
105594577|NCT02477670|364176588|FG004|Stage 1|Withdrawal by Subject|0|||
105594578|NCT02477670|364176589|FG005|Stage 1|Withdrawal by Subject|0|||
105594579|NCT02477670|364176590|FG006|Stage 1|Withdrawal by Subject|0|||
105594580|NCT02477670|364176584|FG000|Stage 1|Non-compliance with Study Drug|1|||
105594581|NCT02477670|364176585|FG001|Stage 1|Non-compliance with Study Drug|2|||
105594582|NCT02477670|364176586|FG002|Stage 1|Non-compliance with Study Drug|0|||
105594583|NCT02477670|364176587|FG003|Stage 1|Non-compliance with Study Drug|0|||
105594584|NCT02477670|364176588|FG004|Stage 1|Non-compliance with Study Drug|0|||
105594585|NCT02477670|364176589|FG005|Stage 1|Non-compliance with Study Drug|0|||
105594586|NCT02477670|364176590|FG006|Stage 1|Non-compliance with Study Drug|0|||
105594587|NCT02477670|364176584|FG000|Stage 2|Adverse Event|0|||
105594588|NCT02477670|364176585|FG001|Stage 2|Adverse Event|0|||
105594589|NCT02477670|364176586|FG002|Stage 2|Adverse Event|1|||
105594590|NCT02477670|364176587|FG003|Stage 2|Adverse Event|0|||
105594591|NCT02477670|364176588|FG004|Stage 2|Adverse Event|0|||
105594592|NCT02477670|364176589|FG005|Stage 2|Adverse Event|0|||
105594593|NCT02477670|364176590|FG006|Stage 2|Adverse Event|0|||
105594594|NCT02477670|364176584|FG000|Stage 2|Antipsychotic Medication Changed|0|||
105594595|NCT02477670|364176585|FG001|Stage 2|Antipsychotic Medication Changed|0|||
105594596|NCT02477670|364176586|FG002|Stage 2|Antipsychotic Medication Changed|1|||
105594597|NCT02477670|364176587|FG003|Stage 2|Antipsychotic Medication Changed|0|||
105594598|NCT02477670|364176588|FG004|Stage 2|Antipsychotic Medication Changed|0|||
105594599|NCT02477670|364176589|FG005|Stage 2|Antipsychotic Medication Changed|0|||
105594600|NCT02477670|364176590|FG006|Stage 2|Antipsychotic Medication Changed|0|||
105594601|NCT02477670|364176584|FG000|Stage 2|Withdrawal by Subject|0|||
105594602|NCT02477670|364176585|FG001|Stage 2|Withdrawal by Subject|0|||
105594603|NCT02477670|364176586|FG002|Stage 2|Withdrawal by Subject|0|||
105594604|NCT02477670|364176587|FG003|Stage 2|Withdrawal by Subject|1|||
105594605|NCT02477670|364176588|FG004|Stage 2|Withdrawal by Subject|0|||
105594606|NCT02477670|364176589|FG005|Stage 2|Withdrawal by Subject|0|||
105594607|NCT02477670|364176590|FG006|Stage 2|Withdrawal by Subject|0|||
105594608|NCT01281813|364176591|FG000|Overall Study|Adverse Event|0|||
105594609|NCT01281813|364176592|FG001|Overall Study|Adverse Event|0|||
105594610|NCT01281813|364176593|FG002|Overall Study|Adverse Event|10|||
105594611|NCT01281813|364176591|FG000|Overall Study|Lost to Follow-up|0|||
105594612|NCT01281813|364176592|FG001|Overall Study|Lost to Follow-up|0|||
105594613|NCT01281813|364176593|FG002|Overall Study|Lost to Follow-up|31|||
105594614|NCT01281813|364176591|FG000|Overall Study|Withdrawal by Subject|0|||
105594615|NCT01281813|364176592|FG001|Overall Study|Withdrawal by Subject|0|||
105594616|NCT01281813|364176593|FG002|Overall Study|Withdrawal by Subject|13|||
105594617|NCT01281813|364176591|FG000|Overall Study|Subject Non-Compliant|0|||
105594618|NCT01281813|364176592|FG001|Overall Study|Subject Non-Compliant|0|||
105594619|NCT01281813|364176593|FG002|Overall Study|Subject Non-Compliant|6|||
105594620|NCT01281813|364176591|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
105594621|NCT01281813|364176592|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
105594622|NCT01281813|364176593|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
105594623|NCT01281813|364176591|FG000|Overall Study|Sponsor's Decision|4|||
105594624|NCT01281813|364176592|FG001|Overall Study|Sponsor's Decision|3|||
105594625|NCT01281813|364176593|FG002|Overall Study|Sponsor's Decision|7|||
105594626|NCT01281813|364176591|FG000|Overall Study|Switched to Commercially Available Medication|0|||
105594627|NCT01281813|364176592|FG001|Overall Study|Switched to Commercially Available Medication|0|||
105594628|NCT01281813|364176593|FG002|Overall Study|Switched to Commercially Available Medication|26|||
105594629|NCT01281813|364176591|FG000|Overall Study|Other|0|||
105594630|NCT01281813|364176592|FG001|Overall Study|Other|1|||
105594631|NCT01281813|364176593|FG002|Overall Study|Other|39|||
105594632|NCT03546907|364176594|FG000|Overall Study|Lack of Efficacy|1|||
105594633|NCT03546907|364176595|FG001|Overall Study|Lack of Efficacy|1|||
105594634|NCT03546907|364176594|FG000|Overall Study|Withdrawal by Subject|8|||
105594635|NCT03546907|364176595|FG001|Overall Study|Withdrawal by Subject|9|||
105594636|NCT03546907|364176594|FG000|Overall Study|Adverse events (AEs)|7|||
105594637|NCT03546907|364176595|FG001|Overall Study|Adverse events (AEs)|10|||
105594638|NCT03546907|364176594|FG000|Overall Study|Other-unspecified|1|||
105594639|NCT03546907|364176595|FG001|Overall Study|Other-unspecified|1|||
105594640|NCT00970307|364176596|FG000|Overall Study|Serious Adverse Event|1|||
105594641|NCT00970307|364176597|FG001|Overall Study|Serious Adverse Event|0|||
105594642|NCT00970307|364176598|FG002|Overall Study|Serious Adverse Event|0|||
105594643|NCT00970307|364176596|FG000|Overall Study|Withdrawal by Subject|2|||
105594644|NCT00970307|364176597|FG001|Overall Study|Withdrawal by Subject|3|||
105594645|NCT00970307|364176598|FG002|Overall Study|Withdrawal by Subject|2|||
105594646|NCT02937831|364176605|FG000|Overall Study|Protocol Violation|4|||
105594647|NCT05257798|364176606|FG000|Follow-up Phase|Lost to Follow-up|1|||
105594648|NCT05257798|364176607|FG001|Follow-up Phase|Lost to Follow-up|0|||
105594649|NCT04033432|364176608|FG000|Overall Study|Progressive Disease|8|||
105594650|NCT04033432|364176608|FG000|Overall Study|Adverse Event|4|||
105594651|NCT04033432|364176608|FG000|Overall Study|Death|1|||
105594652|NCT01064817|364176609|FG000|Study Completion|Physician Decision|1|||
105594653|NCT01064817|364176610|FG001|Study Completion|Physician Decision|0|||
105594654|NCT01064817|364176609|FG000|Study Completion|Withdrawal by Subject|1|||
105594655|NCT01064817|364176610|FG001|Study Completion|Withdrawal by Subject|0|||
105594656|NCT01066923|364176613|FG000|Overall Study|Withdrawal by Subject|3|||
105594657|NCT01066923|364176614|FG001|Overall Study|Withdrawal by Subject|3|||
105594658|NCT01066923|364176615|FG002|Overall Study|Withdrawal by Subject|8|||
105594659|NCT01066923|364176616|FG003|Overall Study|Withdrawal by Subject|8|||
105594660|NCT02192606|364176620|FG000|Overall Study|surgery type was changed|1|||
105594661|NCT02192606|364176621|FG001|Overall Study|surgery type was changed|1|||
105594662|NCT02192606|364176620|FG000|Overall Study|Physician Decision|1|||
105594663|NCT02192606|364176621|FG001|Overall Study|Physician Decision|2|||
105594664|NCT02192606|364176620|FG000|Overall Study|3D equipment rep unable to join|0|||
105594665|NCT02192606|364176621|FG001|Overall Study|3D equipment rep unable to join|1|||
105594666|NCT00738699|364176622|FG000|Overall Study|Withdrawal by Subject|5|||
105594667|NCT00738699|364176623|FG001|Overall Study|Withdrawal by Subject|0|||
105594668|NCT00738699|364176622|FG000|Overall Study|Lost to Follow-up|1|||
105594669|NCT00738699|364176623|FG001|Overall Study|Lost to Follow-up|0|||
105594670|NCT00738699|364176622|FG000|Overall Study|Death|144|||
105594671|NCT00738699|364176623|FG001|Overall Study|Death|68|||
105594672|NCT00738699|364176622|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
105594673|NCT00738699|364176623|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
105594674|NCT00738699|364176622|FG000|Overall Study|Other|2|||
105594675|NCT00738699|364176623|FG001|Overall Study|Other|0|||
105594676|NCT01171625|364176624|FG000|Overall Study|On-Protocol|67|||
105594677|NCT01171625|364176624|FG000|Overall Study|Death|38|||
105594678|NCT01171625|364176624|FG000|Overall Study|Withdrawal by Subject|31|||
105594679|NCT01171625|364176624|FG000|Overall Study|Explanted|10|||
105594680|NCT01171625|364176624|FG000|Overall Study|Lost to Follow-up|5|||
105594681|NCT01171625|364176624|FG000|Overall Study|Patient received valve-in-valve|3|||
105594682|NCT01171625|364176624|FG000|Overall Study|Other|1|||
105594683|NCT01171625|364176624|FG000|Overall Study|Consented but did not receive device|25|||
105594684|NCT00419094|364176625|FG000|Overall Study|Adverse Event|3|||
105594685|NCT00419094|364176626|FG001|Overall Study|Adverse Event|7|||
105594686|NCT00419094|364176625|FG000|Overall Study|Lack of Efficacy|1|||
105594687|NCT00419094|364176626|FG001|Overall Study|Lack of Efficacy|0|||
105594688|NCT00419094|364176625|FG000|Overall Study|Lost to Follow-up|0|||
105594689|NCT00419094|364176626|FG001|Overall Study|Lost to Follow-up|2|||
105594690|NCT00419094|364176625|FG000|Overall Study|Protocol Violation|1|||
105594691|NCT00419094|364176626|FG001|Overall Study|Protocol Violation|14|||
105594692|NCT00419094|364176625|FG000|Overall Study|Withdrawal of consent|1|||
105594693|NCT00419094|364176626|FG001|Overall Study|Withdrawal of consent|5|||
105594694|NCT00419094|364176625|FG000|Overall Study|Other: Error determining exit criteria|1|||
105594695|NCT00419094|364176626|FG001|Overall Study|Other: Error determining exit criteria|0|||
105594696|NCT00419094|364176625|FG000|Overall Study|Other: Patient non-compliant|0|||
105594697|NCT00419094|364176626|FG001|Overall Study|Other: Patient non-compliant|1|||
105594698|NCT00419094|364176625|FG000|Overall Study|Other: No contact for extended period|0|||
105594699|NCT00419094|364176626|FG001|Overall Study|Other: No contact for extended period|1|||
105594700|NCT00486330|364176631|FG000|Overall Study|Adverse Event|2|||
105594701|NCT01290224|364176632|FG000|Overall Study|Adverse Event|1|||
105594702|NCT01290224|364176632|FG000|Overall Study|Refused Further Treatment|4|||
105594703|NCT00853827|364176633|FG000|Single Blind Period (1 Week)|Other|4|||
105594704|NCT00853827|364176634|FG001|Single Blind Period (1 Week)|Other|0|||
105594705|NCT00853827|364176633|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
105594706|NCT00853827|364176634|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
105594707|NCT00853827|364176633|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
105594708|NCT00853827|364176634|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
105594709|NCT00853827|364176633|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
105594710|NCT00853827|364176634|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
105534208|NCT03706690|363962770|FG000|Overall Study|Withdrawal by Subject|8|||
105534209|NCT03706690|363962771|FG001|Overall Study|Withdrawal by Subject|8|||
105534210|NCT03706690|363962770|FG000|Overall Study|Death|143|||
105534211|NCT03706690|363962771|FG001|Overall Study|Death|75|||
105534212|NCT03706690|363962770|FG000|Overall Study|Ongoing at DCO|121|||
105534213|NCT03706690|363962771|FG001|Overall Study|Ongoing at DCO|52|||
105594711|NCT00853827|364176633|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
105594712|NCT00853827|364176634|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
105594713|NCT00853827|364176633|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
105594714|NCT00853827|364176634|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
105594715|NCT00853827|364176633|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
105594716|NCT00853827|364176634|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
105594717|NCT00853827|364176633|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
105594718|NCT00853827|364176634|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
105594719|NCT00853827|364176633|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
105594720|NCT00853827|364176634|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
105594721|NCT00853827|364176633|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
105594722|NCT00853827|364176634|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
105594723|NCT00853827|364176633|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
105594724|NCT00853827|364176634|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
105594725|NCT00853827|364176633|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
105594726|NCT00853827|364176634|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
105594727|NCT00853827|364176633|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
105594728|NCT00853827|364176634|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
105594729|NCT00853827|364176633|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
105594730|NCT00853827|364176634|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
105594731|NCT00853827|364176633|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
105594732|NCT00853827|364176634|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
105594733|NCT00853827|364176633|FG000|Double Blind Period (103 Weeks)|Death|1|||
105594734|NCT00853827|364176634|FG001|Double Blind Period (103 Weeks)|Death|6|||
105594735|NCT00771849|364176635|FG000|Overall Study|Lost to Follow-up|1|||
105594736|NCT00771849|364176636|FG001|Overall Study|Lost to Follow-up|2|||
105594737|NCT00771849|364176635|FG000|Overall Study|Withdrawal by Subject|1|||
105594738|NCT00771849|364176636|FG001|Overall Study|Withdrawal by Subject|1|||
105594739|NCT00771849|364176635|FG000|Overall Study|Not vaccinated|0|||
105594740|NCT00771849|364176636|FG001|Overall Study|Not vaccinated|1|||
105594741|NCT03987451|364176645|FG000|Overall Study|Lost to Follow-up|1|||
105594742|NCT03987451|364176646|FG001|Overall Study|Lost to Follow-up|0|||
105594743|NCT03987451|364176645|FG000|Overall Study|Withdrawal by Subject|1|||
105594744|NCT03987451|364176646|FG001|Overall Study|Withdrawal by Subject|1|||
105594745|NCT02194933|364176647|FG000|Overall Study|Lost to Follow-up|1|||
105594746|NCT02194933|364176648|FG001|Overall Study|Lost to Follow-up|2|||
105594747|NCT02194933|364176647|FG000|Overall Study|Participant met withdrawal criteria|1|||
105594748|NCT02194933|364176648|FG001|Overall Study|Participant met withdrawal criteria|3|||
105594749|NCT02194933|364176647|FG000|Overall Study|Withdrawal by Subject|0|||
105594750|NCT02194933|364176648|FG001|Overall Study|Withdrawal by Subject|2|||
105594751|NCT02194933|364176647|FG000|Overall Study|Lack of Efficacy|1|||
105594752|NCT02194933|364176648|FG001|Overall Study|Lack of Efficacy|2|||
105594753|NCT02045836|364176649|FG000|Overall Study|Adverse Event|4|||
105594754|NCT02045836|364176650|FG001|Overall Study|Adverse Event|4|||
105594755|NCT02045836|364176649|FG000|Overall Study|Withdrawal by Subject|1|||
105594756|NCT02045836|364176650|FG001|Overall Study|Withdrawal by Subject|1|||
105594757|NCT02045836|364176649|FG000|Overall Study|Lost to Follow-up|4|||
105594758|NCT02045836|364176650|FG001|Overall Study|Lost to Follow-up|7|||
105594759|NCT02045836|364176649|FG000|Overall Study|Migrated from study area|0|||
105594760|NCT02045836|364176650|FG001|Overall Study|Migrated from study area|2|||
105594761|NCT03920215|364176651|FG000|Overall Study|Lost to Follow-up|1|||
105594762|NCT03920215|364176652|FG001|Overall Study|Lost to Follow-up|2|||
105594763|NCT03920215|364176653|FG002|Overall Study|Lost to Follow-up|0|||
105594764|NCT03920215|364176654|FG003|Overall Study|Lost to Follow-up|0|||
105594765|NCT03920215|364176651|FG000|Overall Study|Death|0|||
105594766|NCT03920215|364176652|FG001|Overall Study|Death|0|||
105594767|NCT03920215|364176653|FG002|Overall Study|Death|0|||
105594768|NCT03920215|364176654|FG003|Overall Study|Death|1|||
105594769|NCT00756730|364176655|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
105594770|NCT00756730|364176656|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
105594771|NCT00756730|364176655|FG000|Overall Study|persistent low-level viremmia|0|||
105594772|NCT00756730|364176656|FG001|Overall Study|persistent low-level viremmia|1|||
105594773|NCT00177216|364176657|FG000|Overall Study|Withdrawal by Subject|6|||
105594774|NCT00177216|364176658|FG001|Overall Study|Withdrawal by Subject|3|||
105594775|NCT00177216|364176659|FG002|Overall Study|Withdrawal by Subject|1|||
105594776|NCT01081145|364176660|FG000|Open-Label Phase|Lack of Efficacy|56|||
105594777|NCT01081145|364176661|FG001|Open-Label Phase|Lack of Efficacy|0|||
105594778|NCT01081145|364176660|FG000|Open-Label Phase|Response criteria not met|46|||
105594779|NCT01081145|364176661|FG001|Open-Label Phase|Response criteria not met|0|||
105594780|NCT01081145|364176660|FG000|Open-Label Phase|Adverse Event|42|||
105594781|NCT01081145|364176661|FG001|Open-Label Phase|Adverse Event|0|||
105594782|NCT01081145|364176660|FG000|Open-Label Phase|Withdrawal by Subject|41|||
105594783|NCT01081145|364176661|FG001|Open-Label Phase|Withdrawal by Subject|0|||
105594784|NCT01081145|364176660|FG000|Open-Label Phase|Other|12|||
105594785|NCT01081145|364176661|FG001|Open-Label Phase|Other|0|||
105594786|NCT01081145|364176660|FG000|Open-Label Phase|Lost to Follow-up|11|||
105594787|NCT01081145|364176661|FG001|Open-Label Phase|Lost to Follow-up|0|||
105594788|NCT01081145|364176660|FG000|Open-Label Phase|Protocol Violation|4|||
105594789|NCT01081145|364176661|FG001|Open-Label Phase|Protocol Violation|0|||
105594790|NCT01081145|364176660|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
105594791|NCT01081145|364176661|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
105594792|NCT01081145|364176660|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
105594793|NCT01081145|364176661|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
105594794|NCT01081145|364176660|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
105594795|NCT01081145|364176661|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
105594796|NCT01081145|364176660|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
105594797|NCT01081145|364176661|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
105594798|NCT01081145|364176660|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
105594799|NCT01081145|364176661|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
105594800|NCT01081145|364176660|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
105594801|NCT01081145|364176661|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
105594802|NCT01081145|364176660|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
105534340|NCT05569954|363962826|FG000|Overall Study|Lost to Follow-up|3|||
105534341|NCT05569954|363962827|FG001|Overall Study|Lost to Follow-up|4|||
105534342|NCT05569954|363962826|FG000|Overall Study|Protocol Violation|1|||
105534343|NCT05569954|363962827|FG001|Overall Study|Protocol Violation|2|||
105534344|NCT05569954|363962826|FG000|Overall Study|Withdrawal by Subject|4|||
105534345|NCT05569954|363962827|FG001|Overall Study|Withdrawal by Subject|2|||
105594803|NCT01081145|364176661|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
105594804|NCT00038103|364176671|FG000|Overall Study|Adverse Event|5|||
105594805|NCT00038103|364176672|FG001|Overall Study|Adverse Event|6|||
105594806|NCT00038103|364176671|FG000|Overall Study|Lack of Efficacy|48|||
105594807|NCT00038103|364176672|FG001|Overall Study|Lack of Efficacy|41|||
105594808|NCT00038103|364176671|FG000|Overall Study|Withdrawal by Subject|0|||
105594809|NCT00038103|364176672|FG001|Overall Study|Withdrawal by Subject|3|||
105594810|NCT00038103|364176671|FG000|Overall Study|Lost to Follow-up|0|||
105594811|NCT00038103|364176672|FG001|Overall Study|Lost to Follow-up|3|||
105594812|NCT00038103|364176671|FG000|Overall Study|Protocol Violation|0|||
105594813|NCT00038103|364176672|FG001|Overall Study|Protocol Violation|2|||
105534604|NCT02254278|363962848|FG000|Overall Study|Protocol Violation|1|||
105534605|NCT02254278|363962849|FG001|Overall Study|Protocol Violation|1|||
105534608|NCT04579679|363962864|FG000|Overall Study|New Antitumor Therapy|6|||
105534609|NCT04579679|363962865|FG001|Overall Study|New Antitumor Therapy|4|||
105534610|NCT04579679|363962866|FG002|Overall Study|New Antitumor Therapy|7|||
105534611|NCT04579679|363962867|FG003|Overall Study|New Antitumor Therapy|0|||
105534612|NCT04579679|363962864|FG000|Overall Study|Withdrawal of Consent|1|||
105534613|NCT04579679|363962865|FG001|Overall Study|Withdrawal of Consent|1|||
105534614|NCT04579679|363962866|FG002|Overall Study|Withdrawal of Consent|2|||
105534615|NCT04579679|363962867|FG003|Overall Study|Withdrawal of Consent|4|||
105534616|NCT04579679|363962864|FG000|Overall Study|Death|2|||
105534617|NCT04579679|363962865|FG001|Overall Study|Death|2|||
105534618|NCT04579679|363962866|FG002|Overall Study|Death|2|||
105534619|NCT04579679|363962867|FG003|Overall Study|Death|0|||
105534620|NCT04579679|363962864|FG000|Overall Study|Adverse Event|0|||
105534621|NCT04579679|363962865|FG001|Overall Study|Adverse Event|4|||
105534622|NCT04579679|363962866|FG002|Overall Study|Adverse Event|0|||
105534623|NCT04579679|363962867|FG003|Overall Study|Adverse Event|0|||
105534624|NCT04579679|363962864|FG000|Overall Study|Disease Progression|9|||
105534625|NCT04579679|363962865|FG001|Overall Study|Disease Progression|13|||
105534626|NCT04579679|363962866|FG002|Overall Study|Disease Progression|7|||
105534627|NCT04579679|363962867|FG003|Overall Study|Disease Progression|0|||
105534628|NCT04579679|363962864|FG000|Overall Study|Physician Decision|0|||
105534629|NCT04579679|363962865|FG001|Overall Study|Physician Decision|0|||
105534630|NCT04579679|363962866|FG002|Overall Study|Physician Decision|1|||
105534631|NCT04579679|363962867|FG003|Overall Study|Physician Decision|0|||
105534632|NCT04579679|363962864|FG000|Overall Study|Study Terminated by Sponsor|2|||
105534633|NCT04579679|363962865|FG001|Overall Study|Study Terminated by Sponsor|7|||
105534634|NCT04579679|363962866|FG002|Overall Study|Study Terminated by Sponsor|1|||
105534635|NCT04579679|363962867|FG003|Overall Study|Study Terminated by Sponsor|0|||
105534636|NCT03316872|363962870|FG000|Overall Study|Death|1|||
105534639|NCT03655236|363962880|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
105534640|NCT03655236|363962881|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
105534641|NCT03655236|363962882|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
105534642|NCT03655236|363962880|FG000|Subject Disposition in Part 1 Period|Death|1|||
105534643|NCT03655236|363962881|FG001|Subject Disposition in Part 1 Period|Death|0|||
105534644|NCT03655236|363962882|FG002|Subject Disposition in Part 1 Period|Death|0|||
105534645|NCT03655236|363962880|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
105534646|NCT03655236|363962881|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
105534647|NCT03655236|363962882|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
105534648|NCT03655236|363962880|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
105534649|NCT03655236|363962881|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
105534650|NCT03655236|363962882|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
105534651|NCT03655236|363962880|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
105534652|NCT03655236|363962881|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
105534653|NCT03655236|363962882|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
105534654|NCT03655236|363962880|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
105534655|NCT03655236|363962881|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
105534656|NCT03655236|363962882|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
105534657|NCT03655236|363962880|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
105534658|NCT03655236|363962881|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
105534659|NCT03655236|363962882|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
105534660|NCT03655236|363962880|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
105534661|NCT03655236|363962881|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
105534662|NCT03655236|363962882|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
105534663|NCT03655236|363962880|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
105534664|NCT03655236|363962881|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
105534665|NCT03655236|363962882|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
105534666|NCT03655236|363962880|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
105534667|NCT03655236|363962881|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
105534668|NCT03655236|363962882|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
105534669|NCT03655236|363962880|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
105534670|NCT03655236|363962881|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
105534671|NCT03655236|363962882|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
105534672|NCT03655236|363962880|FG000|Subject Disposition in Part 1 Period|Other|0|||
105534673|NCT03655236|363962881|FG001|Subject Disposition in Part 1 Period|Other|2|||
105534674|NCT03655236|363962882|FG002|Subject Disposition in Part 1 Period|Other|2|||
105534675|NCT03655236|363962880|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
105534676|NCT03655236|363962881|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
105534677|NCT03655236|363962882|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
105534678|NCT03655236|363962880|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
105534679|NCT03655236|363962881|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
105534680|NCT03655236|363962882|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
105534681|NCT03655236|363962880|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
105534682|NCT03655236|363962881|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
105534683|NCT03655236|363962882|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
105534684|NCT03655236|363962880|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
105534685|NCT03655236|363962881|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
105534686|NCT03655236|363962882|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
105534687|NCT03655236|363962880|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
105534688|NCT03655236|363962881|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
105534689|NCT03655236|363962882|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
105534690|NCT03655236|363962880|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
105534691|NCT03655236|363962881|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
105534692|NCT03655236|363962882|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
105534693|NCT03655236|363962880|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
105534694|NCT03655236|363962881|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
105534695|NCT03655236|363962882|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
105534696|NCT03655236|363962880|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
105534697|NCT03655236|363962881|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
105534698|NCT03655236|363962882|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
105534699|NCT03655236|363962880|FG000|Subject Disposition in Part 2 Period|Other|1|||
105534700|NCT03655236|363962881|FG001|Subject Disposition in Part 2 Period|Other|0|||
105534701|NCT03655236|363962882|FG002|Subject Disposition in Part 2 Period|Other|0|||
105594814|NCT00038103|364176671|FG000|Overall Study|Sponsor Decision|0|||
105594815|NCT00038103|364176672|FG001|Overall Study|Sponsor Decision|1|||
105594816|NCT00038103|364176671|FG000|Overall Study|Randomized/never treated|2|||
105594817|NCT00038103|364176672|FG001|Overall Study|Randomized/never treated|0|||
105594818|NCT01123083|364176673|FG000|Overall Study|Investigator recommendation|1|||
105594819|NCT01123083|364176674|FG001|Overall Study|Investigator recommendation|1|||
105594820|NCT01123083|364176673|FG000|Overall Study|Administrative reasons|0|||
105594821|NCT01123083|364176674|FG001|Overall Study|Administrative reasons|4|||
105594822|NCT01123083|364176673|FG000|Overall Study|Lost to Follow-up|2|||
105594823|NCT01123083|364176674|FG001|Overall Study|Lost to Follow-up|6|||
105594824|NCT01123083|364176673|FG000|Overall Study|Adverse Event|1|||
105594825|NCT01123083|364176674|FG001|Overall Study|Adverse Event|0|||
105594826|NCT01123083|364176673|FG000|Overall Study|Withdrew for another reason not covered|0|||
105594827|NCT01123083|364176674|FG001|Overall Study|Withdrew for another reason not covered|1|||
105594828|NCT01123083|364176673|FG000|Overall Study|Participant/legal representative request|7|||
105594829|NCT01123083|364176674|FG001|Overall Study|Participant/legal representative request|3|||
105594830|NCT00290706|364176675|FG000|Overall Study|Withdrawal by Subject|2|||
105594831|NCT00290706|364176676|FG001|Overall Study|Withdrawal by Subject|0|||
105594832|NCT00290706|364176677|FG002|Overall Study|Withdrawal by Subject|0|||
105594833|NCT00290706|364176678|FG003|Overall Study|Withdrawal by Subject|0|||
105594834|NCT00290706|364176675|FG000|Overall Study|Progressive Disease|3|||
105594835|NCT00290706|364176676|FG001|Overall Study|Progressive Disease|5|||
105594836|NCT00290706|364176677|FG002|Overall Study|Progressive Disease|4|||
105594837|NCT00290706|364176678|FG003|Overall Study|Progressive Disease|10|||
105594838|NCT00290706|364176675|FG000|Overall Study|Adverse Event|0|||
105594839|NCT00290706|364176676|FG001|Overall Study|Adverse Event|1|||
105594840|NCT00290706|364176677|FG002|Overall Study|Adverse Event|2|||
105594841|NCT00290706|364176678|FG003|Overall Study|Adverse Event|0|||
105594842|NCT00290706|364176675|FG000|Overall Study|Receive auto transplant or radiation|0|||
105594843|NCT00290706|364176676|FG001|Overall Study|Receive auto transplant or radiation|0|||
105594844|NCT00290706|364176677|FG002|Overall Study|Receive auto transplant or radiation|0|||
105594845|NCT00290706|364176678|FG003|Overall Study|Receive auto transplant or radiation|1|||
105594846|NCT00290706|364176675|FG000|Overall Study|Physician Decision|0|||
105594847|NCT00290706|364176676|FG001|Overall Study|Physician Decision|0|||
105594848|NCT00290706|364176677|FG002|Overall Study|Physician Decision|0|||
105594849|NCT00290706|364176678|FG003|Overall Study|Physician Decision|1|||
105594850|NCT01751724|364176679|FG000|Overall Study|extubated bef.start assigned treatment|1|||
105594851|NCT01751724|364176680|FG001|Overall Study|extubated bef.start assigned treatment|0|||
105594852|NCT01751724|364176679|FG000|Overall Study|withdrawn by parent|0|||
105594853|NCT01751724|364176680|FG001|Overall Study|withdrawn by parent|2|||
105594854|NCT01144468|364178000|FG000|Overall Study|Lost to Follow-up|4|||
105594855|NCT01144468|364178001|FG001|Overall Study|Lost to Follow-up|7|||
105594856|NCT01144468|364178000|FG000|Overall Study|Adverse Event|3|||
105594857|NCT01144468|364178001|FG001|Overall Study|Adverse Event|2|||
105594858|NCT01144468|364178000|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
105594859|NCT01144468|364178001|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
105594860|NCT02960659|364178002|FG000|Overall Study|Withdrawal by Subject|1|||
105594861|NCT02960659|364178003|FG001|Overall Study|Withdrawal by Subject|0|||
105594862|NCT02960659|364178002|FG000|Overall Study|Poor compliance|0|||
105594863|NCT02960659|364178003|FG001|Overall Study|Poor compliance|1|||
105594864|NCT04199728|364178004|FG000|Overall Study|Adverse Event|1|||
105594865|NCT04199728|364178005|FG001|Overall Study|Adverse Event|0|||
105594866|NCT04199728|364178004|FG000|Overall Study|Withdrawal by Subject|8|||
105594867|NCT04199728|364178005|FG001|Overall Study|Withdrawal by Subject|3|||
105594868|NCT04199728|364178004|FG000|Overall Study|Screen fail after consent|0|||
105594869|NCT04199728|364178005|FG001|Overall Study|Screen fail after consent|1|||
105594870|NCT04199728|364178004|FG000|Overall Study|Early withdraw criteria met|0|||
105594871|NCT04199728|364178005|FG001|Overall Study|Early withdraw criteria met|1|||
105594872|NCT04199728|364178004|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
105594873|NCT04199728|364178005|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
105594874|NCT01875250|364178006|FG000|Overall Study|Adverse Event|2|||
105594875|NCT01875250|364178007|FG001|Overall Study|Adverse Event|0|||
105594876|NCT03712930|364178008|FG000|Overall Study|Death|7|||
105594877|NCT03712930|364178008|FG000|Overall Study|Physician Decision|1|||
105594878|NCT03712930|364178008|FG000|Overall Study|Study Terminated by Sponsor|3|||
105594879|NCT03712930|364178008|FG000|Overall Study|Progressive Disease|2|||
105594880|NCT02001623|364178009|FG000|Overall Study|Disease Progression|2|||
105594881|NCT02001623|364178010|FG001|Overall Study|Disease Progression|2|||
105594882|NCT02001623|364178011|FG002|Overall Study|Disease Progression|3|||
105594883|NCT02001623|364178012|FG003|Overall Study|Disease Progression|2|||
105594884|NCT02001623|364178013|FG004|Overall Study|Disease Progression|3|||
105594885|NCT02001623|364178014|FG005|Overall Study|Disease Progression|2|||
105594886|NCT02001623|364178015|FG006|Overall Study|Disease Progression|3|||
105594887|NCT02001623|364178016|FG007|Overall Study|Disease Progression|3|||
105594888|NCT02001623|364178017|FG008|Overall Study|Disease Progression|7|||
105594889|NCT02001623|364178018|FG009|Overall Study|Disease Progression|40|||
105594890|NCT02001623|364178019|FG010|Overall Study|Disease Progression|5|||
105594891|NCT02001623|364178020|FG011|Overall Study|Disease Progression|9|||
105594892|NCT02001623|364178021|FG012|Overall Study|Disease Progression|9|||
105594893|NCT02001623|364178022|FG013|Overall Study|Disease Progression|20|||
105594894|NCT02001623|364178023|FG014|Overall Study|Disease Progression|9|||
105594895|NCT02001623|364178009|FG000|Overall Study|Physician Decision|0|||
105594896|NCT02001623|364178010|FG001|Overall Study|Physician Decision|0|||
105594897|NCT02001623|364178011|FG002|Overall Study|Physician Decision|0|||
105594898|NCT02001623|364178012|FG003|Overall Study|Physician Decision|0|||
105594899|NCT02001623|364178013|FG004|Overall Study|Physician Decision|0|||
105594900|NCT02001623|364178014|FG005|Overall Study|Physician Decision|0|||
105594901|NCT02001623|364178015|FG006|Overall Study|Physician Decision|0|||
105534930|NCT03912233|363964909|FG000|Overall Study|Adverse Event|1|||
105534931|NCT03912233|363964910|FG001|Overall Study|Adverse Event|0|||
105534932|NCT03912233|363964911|FG002|Overall Study|Adverse Event|0|||
105534933|NCT03912233|363964912|FG003|Overall Study|Adverse Event|0|||
105534934|NCT03912233|363964913|FG004|Overall Study|Adverse Event|0|||
105534935|NCT03912233|363964914|FG005|Overall Study|Adverse Event|0|||
105534936|NCT03912233|363964909|FG000|Overall Study|Physician Decision|1|||
105534937|NCT03912233|363964910|FG001|Overall Study|Physician Decision|0|||
105534938|NCT03912233|363964911|FG002|Overall Study|Physician Decision|0|||
105534939|NCT03912233|363964912|FG003|Overall Study|Physician Decision|0|||
105534940|NCT03912233|363964913|FG004|Overall Study|Physician Decision|0|||
105534941|NCT03912233|363964914|FG005|Overall Study|Physician Decision|0|||
105534942|NCT03912233|363964909|FG000|Overall Study|Other|0|||
105534943|NCT03912233|363964910|FG001|Overall Study|Other|0|||
105534944|NCT03912233|363964911|FG002|Overall Study|Other|0|||
105534945|NCT03912233|363964912|FG003|Overall Study|Other|0|||
105534946|NCT03912233|363964913|FG004|Overall Study|Other|7|||
105534947|NCT03912233|363964914|FG005|Overall Study|Other|12|||
105534948|NCT00326911|363964915|FG000|Overall Study|Hospitalization prior to treatment|0|||
105534949|NCT00326911|363964916|FG001|Overall Study|Hospitalization prior to treatment|1|||
105534950|NCT00326911|363964915|FG000|Overall Study|Physician decision prior to treatment|1|||
105534951|NCT00326911|363964916|FG001|Overall Study|Physician decision prior to treatment|0|||
105534952|NCT00326911|363964915|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
105534953|NCT00326911|363964916|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
105534954|NCT02583256|363964917|FG000|Overall Study|Withdrawal by Subject|0|||
105534955|NCT02583256|363964918|FG001|Overall Study|Withdrawal by Subject|1|||
105534956|NCT02583256|363964919|FG002|Overall Study|Withdrawal by Subject|1|||
105534957|NCT02583256|363964920|FG003|Overall Study|Withdrawal by Subject|0|||
105534958|NCT02583256|363964917|FG000|Overall Study|Lost to Follow-up|1|||
105534959|NCT02583256|363964918|FG001|Overall Study|Lost to Follow-up|1|||
105534960|NCT02583256|363964919|FG002|Overall Study|Lost to Follow-up|0|||
105534961|NCT02583256|363964920|FG003|Overall Study|Lost to Follow-up|1|||
105534962|NCT02583256|363964917|FG000|Overall Study|Administrative/Other|2|||
105534963|NCT02583256|363964918|FG001|Overall Study|Administrative/Other|0|||
105534964|NCT02583256|363964919|FG002|Overall Study|Administrative/Other|1|||
105534965|NCT02583256|363964920|FG003|Overall Study|Administrative/Other|2|||
105534966|NCT00654628|363964929|FG000|6-week Active Treatment Period|Adverse Event|9|||
105534967|NCT00654628|363964929|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
105534968|NCT00654628|363964929|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
105534969|NCT00654628|363964929|FG000|6-week Active Treatment Period|Out of window period|1|||
105534970|NCT00654628|363964929|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
105534971|NCT00654628|363964929|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
105534972|NCT04537806|363964933|FG000|Overall Study|Randomized but not treated|1|||
105534973|NCT04537806|363964934|FG001|Overall Study|Randomized but not treated|0|||
105534974|NCT04537806|363964933|FG000|Overall Study|Adverse Event|1|||
105534975|NCT04537806|363964934|FG001|Overall Study|Adverse Event|1|||
105534976|NCT03019627|363964937|FG000|Overall Study|Adverse Event|8|||
105534977|NCT03019627|363964938|FG001|Overall Study|Adverse Event|0|||
105534978|NCT03019627|363964937|FG000|Overall Study|Unrelated to adverse event|1|||
105534979|NCT03019627|363964938|FG001|Overall Study|Unrelated to adverse event|3|||
105534980|NCT03019627|363964937|FG000|Overall Study|Lost to Follow-up|2|||
105534981|NCT03019627|363964938|FG001|Overall Study|Lost to Follow-up|1|||
105534982|NCT03019627|363964937|FG000|Overall Study|not compliance|2|||
105534983|NCT03019627|363964938|FG001|Overall Study|not compliance|2|||
105534984|NCT03019627|363964937|FG000|Overall Study|Other|2|||
105534985|NCT03019627|363964938|FG001|Overall Study|Other|2|||
105534986|NCT03364049|363964939|FG000|Overall Study|Death|6|||
105534987|NCT03364049|363964940|FG001|Overall Study|Death|4|||
105534988|NCT03364049|363964941|FG002|Overall Study|Death|5|||
105534989|NCT03364049|363964942|FG003|Overall Study|Death|14|||
105534990|NCT03364049|363964939|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
105534991|NCT03364049|363964940|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
105594902|NCT02001623|364178016|FG007|Overall Study|Physician Decision|0|||
105594903|NCT02001623|364178017|FG008|Overall Study|Physician Decision|3|||
105594904|NCT02001623|364178018|FG009|Overall Study|Physician Decision|2|||
105534992|NCT03364049|363964941|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
105534993|NCT03364049|363964942|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
105594905|NCT02001623|364178019|FG010|Overall Study|Physician Decision|3|||
105594906|NCT02001623|364178020|FG011|Overall Study|Physician Decision|3|||
105534994|NCT03364049|363964939|FG000|Overall Study|Withdrawal by Subject|0|||
105594907|NCT02001623|364178021|FG012|Overall Study|Physician Decision|1|||
105534995|NCT03364049|363964940|FG001|Overall Study|Withdrawal by Subject|1|||
105534996|NCT03364049|363964941|FG002|Overall Study|Withdrawal by Subject|1|||
105594908|NCT02001623|364178022|FG013|Overall Study|Physician Decision|2|||
105534997|NCT03364049|363964942|FG003|Overall Study|Withdrawal by Subject|1|||
105534998|NCT00953329|363964943|FG000|Overall Study|Lack of Efficacy|1|||
105534999|NCT00519649|363964944|FG000|Overall Study|Withdrawal by Subject|1|||
105535000|NCT02953821|363964945|FG000|Overall Study|Adverse Event|0|||
105535001|NCT02953821|363964946|FG001|Overall Study|Adverse Event|4|||
105535002|NCT02953821|363964945|FG000|Overall Study|Death|1|||
105535003|NCT02953821|363964946|FG001|Overall Study|Death|0|||
105535004|NCT02953821|363964945|FG000|Overall Study|Progressive Disease|5|||
105535005|NCT02953821|363964946|FG001|Overall Study|Progressive Disease|1|||
105535006|NCT02953821|363964945|FG000|Overall Study|Lost to Follow-up|2|||
105535007|NCT02953821|363964946|FG001|Overall Study|Lost to Follow-up|0|||
105535008|NCT02953821|363964945|FG000|Overall Study|Physician Decision|1|||
105535009|NCT02953821|363964946|FG001|Overall Study|Physician Decision|1|||
105535010|NCT02953821|363964945|FG000|Overall Study|Withdrawal by Subject|3|||
105535011|NCT02953821|363964946|FG001|Overall Study|Withdrawal by Subject|3|||
105535012|NCT02953821|363964945|FG000|Overall Study|Change of address|0|||
105535013|NCT02953821|363964946|FG001|Overall Study|Change of address|1|||
105535014|NCT02953821|363964945|FG000|Overall Study|Lack of Efficacy|1|||
105535015|NCT02953821|363964946|FG001|Overall Study|Lack of Efficacy|0|||
105535016|NCT02953821|363964945|FG000|Overall Study|Out of state for indeterminate time|0|||
105535017|NCT02953821|363964946|FG001|Overall Study|Out of state for indeterminate time|1|||
105535018|NCT02953821|363964945|FG000|Overall Study|No improvement|0|||
105535019|NCT02953821|363964946|FG001|Overall Study|No improvement|1|||
105535020|NCT02953821|363964945|FG000|Overall Study|Refused follow-up visit|2|||
105535021|NCT02953821|363964946|FG001|Overall Study|Refused follow-up visit|1|||
105535022|NCT00826267|363964947|FG000|Overall Study|Other Adverse Event|1|||
105535023|NCT00826267|363964948|FG001|Overall Study|Other Adverse Event|0|||
105535024|NCT00826267|363964949|FG002|Overall Study|Other Adverse Event|0|||
105535025|NCT01470469|363964950|FG000|Overall Study|Withdrawal by Subject|4|||
105535026|NCT01470469|363964951|FG001|Overall Study|Withdrawal by Subject|6|||
105535027|NCT01470469|363964950|FG000|Overall Study|Lack of Efficacy|1|||
105535028|NCT01470469|363964951|FG001|Overall Study|Lack of Efficacy|7|||
105535029|NCT01470469|363964950|FG000|Overall Study|Adverse Event|0|||
105535030|NCT01470469|363964951|FG001|Overall Study|Adverse Event|7|||
105535031|NCT01470469|363964950|FG000|Overall Study|Lost to Follow-up|2|||
105535032|NCT01470469|363964951|FG001|Overall Study|Lost to Follow-up|2|||
105535033|NCT01470469|363964950|FG000|Overall Study|Protocol Violation|1|||
105535034|NCT01470469|363964951|FG001|Overall Study|Protocol Violation|1|||
105535035|NCT01470469|363964950|FG000|Overall Study|Other|2|||
105535036|NCT01470469|363964951|FG001|Overall Study|Other|1|||
105535037|NCT02579616|363964952|FG000|Overall Study|Participants did not receive treatment|3|||
105535038|NCT01350128|363964957|FG000|Overall Study|Withdrawal by Subject|3|||
105535039|NCT01350128|363964957|FG000|Overall Study|Protocol discontinuation criteria|8|||
105535040|NCT01350128|363964957|FG000|Overall Study|Physician Decision|1|||
105535041|NCT01350128|363964957|FG000|Overall Study|Lost to Follow-up|2|||
105535066|NCT01428193|363964960|FG000|Overall Study|Physician Decision|1|||
105535067|NCT01428193|363964960|FG000|Overall Study|Elevated screening liver enzymes|1|||
105535068|NCT03277261|363964965|FG000|Overall Study|Adverse Event|17|||
105535069|NCT03277261|363964966|FG001|Overall Study|Adverse Event|1|||
105535070|NCT03277261|363964965|FG000|Overall Study|Participant Withdrawal of Consent|6|||
105535071|NCT03277261|363964966|FG001|Overall Study|Participant Withdrawal of Consent|15|||
105535072|NCT03277261|363964965|FG000|Overall Study|Investigator / Sponsor Decision|4|||
105535073|NCT03277261|363964966|FG001|Overall Study|Investigator / Sponsor Decision|2|||
105535074|NCT03277261|363964965|FG000|Overall Study|Pregnancy|2|||
105535075|NCT03277261|363964966|FG001|Overall Study|Pregnancy|0|||
105535076|NCT03277261|363964965|FG000|Overall Study|Lost to Follow-up|2|||
105535077|NCT03277261|363964966|FG001|Overall Study|Lost to Follow-up|2|||
105535078|NCT03277261|363964965|FG000|Overall Study|Lack of Efficacy|2|||
105535079|NCT03277261|363964966|FG001|Overall Study|Lack of Efficacy|2|||
105535080|NCT03277261|363964965|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
105535081|NCT03277261|363964966|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
105535082|NCT01252290|363964967|FG000|Overall Study|Withdrawal by Subject|1|||
105535083|NCT00378014|363964968|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
105535084|NCT00378014|363964969|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
105535085|NCT00378014|363964968|FG000|Core (Randomization to Month 11)|Graft loss|1|||
105535086|NCT00378014|363964969|FG001|Core (Randomization to Month 11)|Graft loss|2|||
105535087|NCT00378014|363964968|FG000|Core (Randomization to Month 11)|Death|5|||
105535088|NCT00378014|363964969|FG001|Core (Randomization to Month 11)|Death|3|||
105535089|NCT00378014|363964968|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
105535090|NCT00378014|363964969|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
105535091|NCT00378014|363964968|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
105535092|NCT00378014|363964969|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
105535093|NCT00378014|363964968|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
105535094|NCT00378014|363964969|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
105535095|NCT00378014|363964968|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
105535096|NCT00378014|363964969|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
105535097|NCT00378014|363964968|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
105535098|NCT00378014|363964969|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
105535099|NCT00378014|363964968|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
105535100|NCT00378014|363964969|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
105535101|NCT00378014|363964968|FG000|Extension (Month 12 to Month 59)|Death|1|||
105535102|NCT00378014|363964969|FG001|Extension (Month 12 to Month 59)|Death|2|||
105535103|NCT00378014|363964968|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
105535104|NCT00378014|363964969|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
105535105|NCT00378014|363964968|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
105535106|NCT00378014|363964969|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
105535107|NCT00378014|363964968|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
105535108|NCT00378014|363964969|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
105535109|NCT00378014|363964968|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
105535110|NCT00378014|363964969|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
105535111|NCT00099437|363964972|FG000|Overall Study|Lost to Follow-up|30|||
105535112|NCT00099437|363964973|FG001|Overall Study|Lost to Follow-up|33|||
105535113|NCT00099437|363964972|FG000|Overall Study|Death|293|||
105535114|NCT00099437|363964973|FG001|Overall Study|Death|261|||
105535115|NCT00099437|363964972|FG000|Overall Study|Withdrawal by Subject|6|||
105535116|NCT00099437|363964973|FG001|Overall Study|Withdrawal by Subject|10|||
105535117|NCT00099437|363964972|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
105535118|NCT00099437|363964973|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
105535119|NCT03047135|363964976|FG000|Overall Study|Still being treated|3|||
105535120|NCT02552316|363964979|FG000|Overall Study|Withdrawal by Subject|1|||
105535121|NCT02552316|363964979|FG000|Overall Study|Withdrawal due to non-compliance|1|||
105535122|NCT01120210|363964980|FG000|MAIN INFUSION|Adverse Event|1|||
105535123|NCT01120210|363964981|FG001|MAIN INFUSION|Adverse Event|0|||
105535124|NCT01120210|363964980|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
105535125|NCT01120210|363964981|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
105535126|NCT02043015|363964984|FG000|Overall Study|Lost to Follow-up|4|||
105535127|NCT02043015|363964984|FG000|Overall Study|Withdrawal by Subject|4|||
105535128|NCT02043015|363964984|FG000|Overall Study|Removed once target enrollment reached|15|||
105535129|NCT02043015|363964984|FG000|Overall Study|Participant moved away from study city|4|||
105535130|NCT02043015|363964984|FG000|Overall Study|Incarceration|1|||
105535131|NCT02457598|363964986|FG000|Overall Study|Progressive Disease|2|||
105535132|NCT02457598|363964987|FG001|Overall Study|Progressive Disease|2|||
105535133|NCT02457598|363964988|FG002|Overall Study|Progressive Disease|1|||
105535134|NCT02457598|363964989|FG003|Overall Study|Progressive Disease|11|||
105535135|NCT02457598|363964990|FG004|Overall Study|Progressive Disease|7|||
105535136|NCT02457598|363964991|FG005|Overall Study|Progressive Disease|3|||
105535137|NCT02457598|363964992|FG006|Overall Study|Progressive Disease|2|||
105535138|NCT02457598|363964993|FG007|Overall Study|Progressive Disease|1|||
105535139|NCT02457598|363964994|FG008|Overall Study|Progressive Disease|1|||
105535140|NCT02457598|363964995|FG009|Overall Study|Progressive Disease|2|||
105535141|NCT02457598|363964996|FG010|Overall Study|Progressive Disease|45|||
105535142|NCT02457598|363964997|FG011|Overall Study|Progressive Disease|6|||
105594909|NCT02001623|364178023|FG014|Overall Study|Physician Decision|1|||
105535143|NCT02457598|363964998|FG012|Overall Study|Progressive Disease|2|||
105594910|NCT02001623|364178009|FG000|Overall Study|Death|0|||
105594911|NCT02001623|364178010|FG001|Overall Study|Death|1|||
105535144|NCT02457598|363964999|FG013|Overall Study|Progressive Disease|2|||
105594912|NCT02001623|364178011|FG002|Overall Study|Death|0|||
105594913|NCT02001623|364178012|FG003|Overall Study|Death|0|||
105594914|NCT02001623|364178013|FG004|Overall Study|Death|0|||
105594915|NCT02001623|364178014|FG005|Overall Study|Death|0|||
105594916|NCT02001623|364178015|FG006|Overall Study|Death|0|||
105594917|NCT02001623|364178016|FG007|Overall Study|Death|0|||
105594918|NCT02001623|364178017|FG008|Overall Study|Death|0|||
105594919|NCT02001623|364178018|FG009|Overall Study|Death|0|||
105594920|NCT02001623|364178019|FG010|Overall Study|Death|0|||
105594921|NCT02001623|364178020|FG011|Overall Study|Death|0|||
105594922|NCT02001623|364178021|FG012|Overall Study|Death|0|||
105594923|NCT02001623|364178022|FG013|Overall Study|Death|0|||
105594924|NCT02001623|364178023|FG014|Overall Study|Death|0|||
105594925|NCT02001623|364178009|FG000|Overall Study|Adverse Event|0|||
105594926|NCT02001623|364178010|FG001|Overall Study|Adverse Event|0|||
105594927|NCT02001623|364178011|FG002|Overall Study|Adverse Event|0|||
105594928|NCT02001623|364178012|FG003|Overall Study|Adverse Event|0|||
105594929|NCT02001623|364178013|FG004|Overall Study|Adverse Event|0|||
105594930|NCT02001623|364178014|FG005|Overall Study|Adverse Event|1|||
105594931|NCT02001623|364178015|FG006|Overall Study|Adverse Event|0|||
105594932|NCT02001623|364178016|FG007|Overall Study|Adverse Event|3|||
105594933|NCT02001623|364178017|FG008|Overall Study|Adverse Event|4|||
105594934|NCT02001623|364178018|FG009|Overall Study|Adverse Event|6|||
105594935|NCT02001623|364178019|FG010|Overall Study|Adverse Event|4|||
105594936|NCT02001623|364178020|FG011|Overall Study|Adverse Event|0|||
105594937|NCT02001623|364178021|FG012|Overall Study|Adverse Event|3|||
105594938|NCT02001623|364178022|FG013|Overall Study|Adverse Event|5|||
105594939|NCT02001623|364178023|FG014|Overall Study|Adverse Event|6|||
105594940|NCT02001623|364178009|FG000|Overall Study|Other - Miscellaneous|0|||
105594941|NCT02001623|364178010|FG001|Overall Study|Other - Miscellaneous|0|||
105594942|NCT02001623|364178011|FG002|Overall Study|Other - Miscellaneous|0|||
105594943|NCT02001623|364178012|FG003|Overall Study|Other - Miscellaneous|0|||
105594944|NCT02001623|364178013|FG004|Overall Study|Other - Miscellaneous|0|||
105594945|NCT02001623|364178014|FG005|Overall Study|Other - Miscellaneous|0|||
105594946|NCT02001623|364178015|FG006|Overall Study|Other - Miscellaneous|0|||
105594947|NCT02001623|364178016|FG007|Overall Study|Other - Miscellaneous|0|||
105594948|NCT02001623|364178017|FG008|Overall Study|Other - Miscellaneous|0|||
105594949|NCT02001623|364178018|FG009|Overall Study|Other - Miscellaneous|1|||
105594950|NCT02001623|364178019|FG010|Overall Study|Other - Miscellaneous|0|||
105594951|NCT02001623|364178020|FG011|Overall Study|Other - Miscellaneous|0|||
105594952|NCT02001623|364178021|FG012|Overall Study|Other - Miscellaneous|0|||
105594953|NCT02001623|364178022|FG013|Overall Study|Other - Miscellaneous|1|||
105594954|NCT02001623|364178023|FG014|Overall Study|Other - Miscellaneous|0|||
105594955|NCT02001623|364178009|FG000|Overall Study|Withdrawal by Subject|1|||
105594956|NCT02001623|364178010|FG001|Overall Study|Withdrawal by Subject|0|||
105594957|NCT02001623|364178011|FG002|Overall Study|Withdrawal by Subject|0|||
105594958|NCT02001623|364178012|FG003|Overall Study|Withdrawal by Subject|0|||
105594959|NCT02001623|364178013|FG004|Overall Study|Withdrawal by Subject|0|||
105535145|NCT02457598|363965000|FG014|Overall Study|Progressive Disease|10|||
105535146|NCT02457598|363965001|FG015|Overall Study|Progressive Disease|1|||
105535147|NCT02457598|363965002|FG016|Overall Study|Progressive Disease|1|||
105535148|NCT02457598|363964986|FG000|Overall Study|Investigator's Discretion|0|||
105535149|NCT02457598|363964987|FG001|Overall Study|Investigator's Discretion|2|||
105535150|NCT02457598|363964988|FG002|Overall Study|Investigator's Discretion|2|||
105535151|NCT02457598|363964989|FG003|Overall Study|Investigator's Discretion|2|||
105535152|NCT02457598|363964990|FG004|Overall Study|Investigator's Discretion|0|||
105535153|NCT02457598|363964991|FG005|Overall Study|Investigator's Discretion|0|||
105535154|NCT02457598|363964992|FG006|Overall Study|Investigator's Discretion|0|||
105535155|NCT02457598|363964993|FG007|Overall Study|Investigator's Discretion|1|||
105535156|NCT02457598|363964994|FG008|Overall Study|Investigator's Discretion|2|||
105535157|NCT02457598|363964995|FG009|Overall Study|Investigator's Discretion|0|||
105535158|NCT02457598|363964996|FG010|Overall Study|Investigator's Discretion|10|||
105535159|NCT02457598|363964997|FG011|Overall Study|Investigator's Discretion|2|||
105594960|NCT02001623|364178014|FG005|Overall Study|Withdrawal by Subject|0|||
105594961|NCT02001623|364178015|FG006|Overall Study|Withdrawal by Subject|0|||
105594962|NCT02001623|364178016|FG007|Overall Study|Withdrawal by Subject|0|||
105594963|NCT02001623|364178017|FG008|Overall Study|Withdrawal by Subject|1|||
105594964|NCT02001623|364178018|FG009|Overall Study|Withdrawal by Subject|3|||
105594965|NCT02001623|364178019|FG010|Overall Study|Withdrawal by Subject|2|||
105594966|NCT02001623|364178020|FG011|Overall Study|Withdrawal by Subject|2|||
105594967|NCT02001623|364178021|FG012|Overall Study|Withdrawal by Subject|1|||
105594968|NCT02001623|364178022|FG013|Overall Study|Withdrawal by Subject|5|||
105594969|NCT02001623|364178023|FG014|Overall Study|Withdrawal by Subject|2|||
105594970|NCT02001623|364178009|FG000|Overall Study|Lost to Follow-up|0|||
105594971|NCT02001623|364178010|FG001|Overall Study|Lost to Follow-up|0|||
105535160|NCT02457598|363964998|FG012|Overall Study|Investigator's Discretion|2|||
105535161|NCT02457598|363964999|FG013|Overall Study|Investigator's Discretion|1|||
105535162|NCT02457598|363965000|FG014|Overall Study|Investigator's Discretion|5|||
105535163|NCT02457598|363965001|FG015|Overall Study|Investigator's Discretion|0|||
105535164|NCT02457598|363965002|FG016|Overall Study|Investigator's Discretion|0|||
105535165|NCT02457598|363964986|FG000|Overall Study|Study Terminated by Sponsor|0|||
105535166|NCT02457598|363964987|FG001|Overall Study|Study Terminated by Sponsor|1|||
105535167|NCT02457598|363964988|FG002|Overall Study|Study Terminated by Sponsor|0|||
105535168|NCT02457598|363964989|FG003|Overall Study|Study Terminated by Sponsor|4|||
105535169|NCT02457598|363964990|FG004|Overall Study|Study Terminated by Sponsor|1|||
105535170|NCT02457598|363964991|FG005|Overall Study|Study Terminated by Sponsor|0|||
105535171|NCT02457598|363964992|FG006|Overall Study|Study Terminated by Sponsor|1|||
105535172|NCT02457598|363964993|FG007|Overall Study|Study Terminated by Sponsor|0|||
105535173|NCT02457598|363964994|FG008|Overall Study|Study Terminated by Sponsor|0|||
105535174|NCT02457598|363964995|FG009|Overall Study|Study Terminated by Sponsor|0|||
105535175|NCT02457598|363964996|FG010|Overall Study|Study Terminated by Sponsor|4|||
105535176|NCT02457598|363964997|FG011|Overall Study|Study Terminated by Sponsor|0|||
105535177|NCT02457598|363964998|FG012|Overall Study|Study Terminated by Sponsor|1|||
105535178|NCT02457598|363964999|FG013|Overall Study|Study Terminated by Sponsor|0|||
105535179|NCT02457598|363965000|FG014|Overall Study|Study Terminated by Sponsor|8|||
105535180|NCT02457598|363965001|FG015|Overall Study|Study Terminated by Sponsor|1|||
105535181|NCT02457598|363965002|FG016|Overall Study|Study Terminated by Sponsor|0|||
105535182|NCT02457598|363964986|FG000|Overall Study|Adverse Event|0|||
105535183|NCT02457598|363964987|FG001|Overall Study|Adverse Event|1|||
105535184|NCT02457598|363964988|FG002|Overall Study|Adverse Event|1|||
105535185|NCT02457598|363964989|FG003|Overall Study|Adverse Event|4|||
105535186|NCT02457598|363964990|FG004|Overall Study|Adverse Event|1|||
105535187|NCT02457598|363964991|FG005|Overall Study|Adverse Event|0|||
105535188|NCT02457598|363964992|FG006|Overall Study|Adverse Event|0|||
105535189|NCT02457598|363964993|FG007|Overall Study|Adverse Event|1|||
105535190|NCT02457598|363964994|FG008|Overall Study|Adverse Event|0|||
105535191|NCT02457598|363964995|FG009|Overall Study|Adverse Event|1|||
105535192|NCT02457598|363964996|FG010|Overall Study|Adverse Event|6|||
105535193|NCT02457598|363964997|FG011|Overall Study|Adverse Event|0|||
105535194|NCT02457598|363964998|FG012|Overall Study|Adverse Event|0|||
105535195|NCT02457598|363964999|FG013|Overall Study|Adverse Event|1|||
105535196|NCT02457598|363965000|FG014|Overall Study|Adverse Event|2|||
105535197|NCT02457598|363965001|FG015|Overall Study|Adverse Event|0|||
105535198|NCT02457598|363965002|FG016|Overall Study|Adverse Event|0|||
105535199|NCT02457598|363964986|FG000|Overall Study|Death|0|||
105535200|NCT02457598|363964987|FG001|Overall Study|Death|0|||
105535201|NCT02457598|363964988|FG002|Overall Study|Death|0|||
105535202|NCT02457598|363964989|FG003|Overall Study|Death|3|||
105535203|NCT02457598|363964990|FG004|Overall Study|Death|0|||
105535204|NCT02457598|363964991|FG005|Overall Study|Death|1|||
105535205|NCT02457598|363964992|FG006|Overall Study|Death|0|||
105535206|NCT02457598|363964993|FG007|Overall Study|Death|0|||
105535207|NCT02457598|363964994|FG008|Overall Study|Death|0|||
105535208|NCT02457598|363964995|FG009|Overall Study|Death|0|||
105535209|NCT02457598|363964996|FG010|Overall Study|Death|3|||
105535210|NCT02457598|363964997|FG011|Overall Study|Death|0|||
105535211|NCT02457598|363964998|FG012|Overall Study|Death|0|||
105535212|NCT02457598|363964999|FG013|Overall Study|Death|1|||
105535213|NCT02457598|363965000|FG014|Overall Study|Death|2|||
105535214|NCT02457598|363965001|FG015|Overall Study|Death|0|||
105535215|NCT02457598|363965002|FG016|Overall Study|Death|1|||
105535216|NCT02457598|363964986|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
105535217|NCT02457598|363964987|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
105535218|NCT02457598|363964988|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
105535219|NCT02457598|363964989|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
105535220|NCT02457598|363964990|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
105535221|NCT02457598|363964991|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
105535222|NCT02457598|363964992|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
105535223|NCT02457598|363964993|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
105535224|NCT02457598|363964994|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
105535225|NCT02457598|363964995|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
105535226|NCT02457598|363964996|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
105535227|NCT02457598|363964997|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
105535228|NCT02457598|363964998|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
105535229|NCT02457598|363964999|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
105535230|NCT02457598|363965000|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
105535231|NCT02457598|363965001|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
105535232|NCT02457598|363965002|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
105535233|NCT02457598|363964986|FG000|Overall Study|Withdrew Consent|0|||
105535234|NCT02457598|363964987|FG001|Overall Study|Withdrew Consent|0|||
105535235|NCT02457598|363964988|FG002|Overall Study|Withdrew Consent|0|||
105535236|NCT02457598|363964989|FG003|Overall Study|Withdrew Consent|0|||
105535237|NCT02457598|363964990|FG004|Overall Study|Withdrew Consent|0|||
105535238|NCT02457598|363964991|FG005|Overall Study|Withdrew Consent|0|||
105535239|NCT02457598|363964992|FG006|Overall Study|Withdrew Consent|0|||
105535240|NCT02457598|363964993|FG007|Overall Study|Withdrew Consent|2|||
105535241|NCT02457598|363964994|FG008|Overall Study|Withdrew Consent|0|||
105535242|NCT02457598|363964995|FG009|Overall Study|Withdrew Consent|0|||
105535243|NCT02457598|363964996|FG010|Overall Study|Withdrew Consent|3|||
105535244|NCT02457598|363964997|FG011|Overall Study|Withdrew Consent|0|||
105535245|NCT02457598|363964998|FG012|Overall Study|Withdrew Consent|0|||
105535246|NCT02457598|363964999|FG013|Overall Study|Withdrew Consent|1|||
105535247|NCT02457598|363965000|FG014|Overall Study|Withdrew Consent|0|||
105535248|NCT02457598|363965001|FG015|Overall Study|Withdrew Consent|0|||
105535249|NCT02457598|363965002|FG016|Overall Study|Withdrew Consent|0|||
105535250|NCT02457598|363964986|FG000|Overall Study|Unacceptable Toxicity|0|||
105535251|NCT02457598|363964987|FG001|Overall Study|Unacceptable Toxicity|0|||
105535252|NCT02457598|363964988|FG002|Overall Study|Unacceptable Toxicity|0|||
105535253|NCT02457598|363964989|FG003|Overall Study|Unacceptable Toxicity|0|||
105535254|NCT02457598|363964990|FG004|Overall Study|Unacceptable Toxicity|0|||
105535255|NCT02457598|363964991|FG005|Overall Study|Unacceptable Toxicity|0|||
105535256|NCT02457598|363964992|FG006|Overall Study|Unacceptable Toxicity|0|||
105535257|NCT02457598|363964993|FG007|Overall Study|Unacceptable Toxicity|0|||
105535258|NCT02457598|363964994|FG008|Overall Study|Unacceptable Toxicity|0|||
105535259|NCT02457598|363964995|FG009|Overall Study|Unacceptable Toxicity|0|||
105535260|NCT02457598|363964996|FG010|Overall Study|Unacceptable Toxicity|1|||
105535261|NCT02457598|363964997|FG011|Overall Study|Unacceptable Toxicity|0|||
105535262|NCT02457598|363964998|FG012|Overall Study|Unacceptable Toxicity|1|||
105535263|NCT02457598|363964999|FG013|Overall Study|Unacceptable Toxicity|1|||
105535264|NCT02457598|363965000|FG014|Overall Study|Unacceptable Toxicity|1|||
105535265|NCT02457598|363965001|FG015|Overall Study|Unacceptable Toxicity|0|||
105535266|NCT02457598|363965002|FG016|Overall Study|Unacceptable Toxicity|0|||
105535267|NCT02457598|363964986|FG000|Overall Study|Intercurrent Illness|0|||
105535268|NCT02457598|363964987|FG001|Overall Study|Intercurrent Illness|0|||
105535269|NCT02457598|363964988|FG002|Overall Study|Intercurrent Illness|0|||
105535270|NCT02457598|363964989|FG003|Overall Study|Intercurrent Illness|0|||
105535271|NCT02457598|363964990|FG004|Overall Study|Intercurrent Illness|0|||
105535272|NCT02457598|363964991|FG005|Overall Study|Intercurrent Illness|0|||
105535273|NCT02457598|363964992|FG006|Overall Study|Intercurrent Illness|0|||
105535274|NCT02457598|363964993|FG007|Overall Study|Intercurrent Illness|0|||
105535275|NCT02457598|363964994|FG008|Overall Study|Intercurrent Illness|0|||
105535276|NCT02457598|363964995|FG009|Overall Study|Intercurrent Illness|0|||
105535277|NCT02457598|363964996|FG010|Overall Study|Intercurrent Illness|1|||
105535278|NCT02457598|363964997|FG011|Overall Study|Intercurrent Illness|0|||
105535279|NCT02457598|363964998|FG012|Overall Study|Intercurrent Illness|0|||
105535280|NCT02457598|363964999|FG013|Overall Study|Intercurrent Illness|0|||
105535281|NCT02457598|363965000|FG014|Overall Study|Intercurrent Illness|0|||
105535282|NCT02457598|363965001|FG015|Overall Study|Intercurrent Illness|0|||
105535283|NCT02457598|363965002|FG016|Overall Study|Intercurrent Illness|0|||
105535284|NCT02457598|363964986|FG000|Overall Study|Protocol Violation|0|||
105535285|NCT02457598|363964987|FG001|Overall Study|Protocol Violation|0|||
105535286|NCT02457598|363964988|FG002|Overall Study|Protocol Violation|0|||
105535287|NCT02457598|363964989|FG003|Overall Study|Protocol Violation|0|||
105535288|NCT02457598|363964990|FG004|Overall Study|Protocol Violation|0|||
105535289|NCT02457598|363964991|FG005|Overall Study|Protocol Violation|0|||
105535290|NCT02457598|363964992|FG006|Overall Study|Protocol Violation|0|||
105535291|NCT02457598|363964993|FG007|Overall Study|Protocol Violation|0|||
105535292|NCT02457598|363964994|FG008|Overall Study|Protocol Violation|0|||
105535293|NCT02457598|363964995|FG009|Overall Study|Protocol Violation|0|||
105535294|NCT02457598|363964996|FG010|Overall Study|Protocol Violation|1|||
105535295|NCT02457598|363964997|FG011|Overall Study|Protocol Violation|0|||
105535296|NCT02457598|363964998|FG012|Overall Study|Protocol Violation|0|||
105535297|NCT02457598|363964999|FG013|Overall Study|Protocol Violation|0|||
105535298|NCT02457598|363965000|FG014|Overall Study|Protocol Violation|0|||
105535299|NCT02457598|363965001|FG015|Overall Study|Protocol Violation|0|||
105594972|NCT02001623|364178011|FG002|Overall Study|Lost to Follow-up|0|||
105594973|NCT02001623|364178012|FG003|Overall Study|Lost to Follow-up|0|||
105535300|NCT02457598|363965002|FG016|Overall Study|Protocol Violation|0|||
105535301|NCT00637195|363965003|FG000|Overall Study|Lost to Follow-up|1|||
105535302|NCT00637195|363965004|FG001|Overall Study|Lost to Follow-up|0|||
105535303|NCT00637195|363965003|FG000|Overall Study|Other|2|||
105535304|NCT00637195|363965004|FG001|Overall Study|Other|0|||
105535305|NCT00637195|363965003|FG000|Overall Study|Withdrawal by Subject|0|||
105535306|NCT00637195|363965004|FG001|Overall Study|Withdrawal by Subject|1|||
105535307|NCT00006184|363965008|FG000|Overall Study|Death|1|||
105535308|NCT00006184|363965009|FG001|Overall Study|Death|0|||
105535309|NCT01110915|363965014|FG000|Overall Study|Death|2|||
105535310|NCT01110915|363965015|FG001|Overall Study|Death|1|||
105535311|NCT01110915|363965014|FG000|Overall Study|Lost to Follow-up|1|||
105535312|NCT01110915|363965015|FG001|Overall Study|Lost to Follow-up|0|||
105535313|NCT01110915|363965014|FG000|Overall Study|Withdrawal by Subject|7|||
105535314|NCT01110915|363965015|FG001|Overall Study|Withdrawal by Subject|1|||
105535315|NCT02948842|363965017|FG000|Overall Study|Withdrawal by Subject|4|||
105594974|NCT02001623|364178013|FG004|Overall Study|Lost to Follow-up|0|||
105594975|NCT02001623|364178014|FG005|Overall Study|Lost to Follow-up|0|||
105594976|NCT02001623|364178015|FG006|Overall Study|Lost to Follow-up|0|||
105594977|NCT02001623|364178016|FG007|Overall Study|Lost to Follow-up|0|||
105594978|NCT02001623|364178017|FG008|Overall Study|Lost to Follow-up|0|||
105594979|NCT02001623|364178018|FG009|Overall Study|Lost to Follow-up|1|||
105594980|NCT02001623|364178019|FG010|Overall Study|Lost to Follow-up|0|||
105594981|NCT02001623|364178020|FG011|Overall Study|Lost to Follow-up|0|||
105594982|NCT02001623|364178021|FG012|Overall Study|Lost to Follow-up|0|||
105594983|NCT02001623|364178022|FG013|Overall Study|Lost to Follow-up|0|||
105594984|NCT02001623|364178023|FG014|Overall Study|Lost to Follow-up|0|||
105594985|NCT02001623|364178009|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
105594986|NCT02001623|364178010|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
105594987|NCT02001623|364178011|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
105594988|NCT02001623|364178012|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
105594989|NCT02001623|364178013|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
105594990|NCT02001623|364178014|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
105594991|NCT02001623|364178015|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
105594992|NCT02001623|364178016|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
105594993|NCT02001623|364178017|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
105594994|NCT02001623|364178018|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
105594995|NCT02001623|364178019|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
105594996|NCT02001623|364178020|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
105594997|NCT02001623|364178021|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
105594998|NCT02001623|364178022|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
105594999|NCT02001623|364178023|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
105595000|NCT02001623|364178009|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
105595001|NCT02001623|364178010|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
105595002|NCT02001623|364178011|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
105595003|NCT02001623|364178012|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
105595004|NCT02001623|364178013|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
105595005|NCT02001623|364178014|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
105595006|NCT02001623|364178015|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
105595007|NCT02001623|364178016|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
105595008|NCT02001623|364178017|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
105595009|NCT02001623|364178018|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
105595010|NCT02001623|364178019|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
105595011|NCT02001623|364178020|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
105595012|NCT02001623|364178021|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
105595013|NCT02001623|364178022|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
105595014|NCT02001623|364178023|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
105595015|NCT02962674|364178024|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
105595016|NCT02715258|364178029|FG000|Overall Study|Withdrawal by Subject|6|||
105595017|NCT02715258|364178030|FG001|Overall Study|Withdrawal by Subject|1|||
105595018|NCT02715258|364178029|FG000|Overall Study|Lost to Follow-up|7|||
105595019|NCT02715258|364178030|FG001|Overall Study|Lost to Follow-up|1|||
105595020|NCT02715258|364178029|FG000|Overall Study|Terminated by Sponsor|0|||
105595021|NCT02715258|364178030|FG001|Overall Study|Terminated by Sponsor|1|||
105595022|NCT02715258|364178029|FG000|Overall Study|Death|0|||
105595023|NCT02715258|364178030|FG001|Overall Study|Death|1|||
105595024|NCT02715258|364178029|FG000|Overall Study|Subject non-compliant|1|||
105595025|NCT02715258|364178030|FG001|Overall Study|Subject non-compliant|1|||
105595026|NCT02715258|364178029|FG000|Overall Study|GCP violation|2|||
105595027|NCT02715258|364178030|FG001|Overall Study|GCP violation|1|||
105595028|NCT03265210|364178032|FG000|Overall Study|Withdrawal by Subject|7|||
105595029|NCT03265210|364178033|FG001|Overall Study|Withdrawal by Subject|9|||
105595030|NCT03265210|364178032|FG000|Overall Study|Lost to Follow-up|2|||
105595031|NCT03265210|364178033|FG001|Overall Study|Lost to Follow-up|0|||
105595032|NCT03265210|364178032|FG000|Overall Study|Physician Decision|2|||
105595033|NCT03265210|364178033|FG001|Overall Study|Physician Decision|0|||
105595034|NCT03265210|364178032|FG000|Overall Study|Adverse Event|1|||
105595035|NCT03265210|364178033|FG001|Overall Study|Adverse Event|0|||
105595036|NCT01227278|364178036|FG000|Overall Study|Withdrawal by Subject|4|||
105595037|NCT01227278|364178037|FG001|Overall Study|Withdrawal by Subject|4|||
105595038|NCT01227278|364178036|FG000|Overall Study|Death|0|||
105595039|NCT01227278|364178037|FG001|Overall Study|Death|2|||
105595040|NCT01227278|364178036|FG000|Overall Study|Other|1|||
105595041|NCT01227278|364178037|FG001|Overall Study|Other|2|||
105595042|NCT02320123|364178038|FG000|Overall Study|Lost to Follow-up|4|||
105595043|NCT02320123|364178039|FG001|Overall Study|Lost to Follow-up|6|||
105595044|NCT02320123|364178038|FG000|Overall Study|Death|6|||
105595045|NCT02320123|364178039|FG001|Overall Study|Death|5|||
105595046|NCT00941655|364178044|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
105595047|NCT00941655|364178045|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
105595048|NCT00941655|364178044|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
105535316|NCT02143843|363965020|FG000|Overall Study|Adverse Event|8|||
105535317|NCT02143843|363965020|FG000|Overall Study|Lack of Efficacy|2|||
105535318|NCT02143843|363965020|FG000|Overall Study|Withdrawal by Subject|2|||
105535319|NCT01822132|363965021|FG000|Overall Study|Lost to Follow-up|4|||
105535320|NCT01822132|363965022|FG001|Overall Study|Lost to Follow-up|2|||
105535321|NCT04847674|363965024|FG000|Overall Study|Withdrawal by Subject|0|||
105535322|NCT04847674|363965025|FG001|Overall Study|Withdrawal by Subject|1|||
105535323|NCT04847674|363965026|FG002|Overall Study|Withdrawal by Subject|0|||
105535324|NCT04847674|363965024|FG000|Overall Study|Lost to Follow-up|0|||
105535325|NCT04847674|363965025|FG001|Overall Study|Lost to Follow-up|0|||
105535326|NCT04847674|363965026|FG002|Overall Study|Lost to Follow-up|2|||
105535327|NCT04847674|363965024|FG000|Overall Study|Other than specified|21|||
105535328|NCT04847674|363965025|FG001|Overall Study|Other than specified|20|||
105535329|NCT04847674|363965026|FG002|Overall Study|Other than specified|20|||
105535330|NCT02563028|363965027|FG000|Overall Study|Lack of equipment|1|||
105535331|NCT02563028|363965027|FG000|Overall Study|Unable to elicit VEP post induction|1|||
105535332|NCT00378703|363965028|FG000|Overall Study|Disease progression|59|||
105535333|NCT00378703|363965029|FG001|Overall Study|Disease progression|43|||
105535334|NCT00378703|363965030|FG002|Overall Study|Disease progression|48|||
105535335|NCT00378703|363965031|FG003|Overall Study|Disease progression|49|||
105535336|NCT00378703|363965028|FG000|Overall Study|Adverse Event|11|||
105535337|NCT00378703|363965029|FG001|Overall Study|Adverse Event|17|||
105535338|NCT00378703|363965030|FG002|Overall Study|Adverse Event|20|||
105535339|NCT00378703|363965031|FG003|Overall Study|Adverse Event|18|||
105535340|NCT00378703|363965028|FG000|Overall Study|Death|2|||
105535341|NCT00378703|363965029|FG001|Overall Study|Death|2|||
105535342|NCT00378703|363965030|FG002|Overall Study|Death|4|||
105535343|NCT00378703|363965031|FG003|Overall Study|Death|3|||
105535344|NCT00378703|363965028|FG000|Overall Study|Withdrawal by Subject|4|||
105535345|NCT00378703|363965029|FG001|Overall Study|Withdrawal by Subject|8|||
105535346|NCT00378703|363965030|FG002|Overall Study|Withdrawal by Subject|5|||
105535347|NCT00378703|363965031|FG003|Overall Study|Withdrawal by Subject|7|||
105535348|NCT00378703|363965028|FG000|Overall Study|Physician Decision|1|||
105535349|NCT00378703|363965029|FG001|Overall Study|Physician Decision|4|||
105535350|NCT00378703|363965030|FG002|Overall Study|Physician Decision|1|||
105535351|NCT00378703|363965031|FG003|Overall Study|Physician Decision|0|||
105535352|NCT00378703|363965028|FG000|Overall Study|Alternative therapy|4|||
105535353|NCT00378703|363965029|FG001|Overall Study|Alternative therapy|2|||
105535354|NCT00378703|363965030|FG002|Overall Study|Alternative therapy|0|||
105535355|NCT00378703|363965031|FG003|Overall Study|Alternative therapy|0|||
105535356|NCT00378703|363965028|FG000|Overall Study|Other complicated disease|0|||
105535357|NCT00378703|363965029|FG001|Overall Study|Other complicated disease|2|||
105535358|NCT00378703|363965030|FG002|Overall Study|Other complicated disease|2|||
105535359|NCT00378703|363965031|FG003|Overall Study|Other complicated disease|0|||
105535360|NCT00378703|363965028|FG000|Overall Study|Symptomatic deterioration|0|||
105535361|NCT00378703|363965029|FG001|Overall Study|Symptomatic deterioration|1|||
105535362|NCT00378703|363965030|FG002|Overall Study|Symptomatic deterioration|0|||
105535363|NCT00378703|363965031|FG003|Overall Study|Symptomatic deterioration|2|||
105535364|NCT00378703|363965028|FG000|Overall Study|Surgery|1|||
105535365|NCT00378703|363965029|FG001|Overall Study|Surgery|0|||
105535366|NCT00378703|363965030|FG002|Overall Study|Surgery|0|||
105535367|NCT00378703|363965031|FG003|Overall Study|Surgery|1|||
105535368|NCT00378703|363965028|FG000|Overall Study|Joint decision of physician and patient|1|||
105535369|NCT00378703|363965029|FG001|Overall Study|Joint decision of physician and patient|0|||
105535370|NCT00378703|363965030|FG002|Overall Study|Joint decision of physician and patient|0|||
105535371|NCT00378703|363965031|FG003|Overall Study|Joint decision of physician and patient|0|||
105535372|NCT00378703|363965028|FG000|Overall Study|Adverse events and progressive disease|0|||
105535373|NCT00378703|363965029|FG001|Overall Study|Adverse events and progressive disease|0|||
105535374|NCT00378703|363965030|FG002|Overall Study|Adverse events and progressive disease|0|||
105535375|NCT00378703|363965031|FG003|Overall Study|Adverse events and progressive disease|1|||
105535376|NCT00378703|363965028|FG000|Overall Study|Relocation|0|||
105595049|NCT00941655|364178045|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
105535377|NCT00378703|363965029|FG001|Overall Study|Relocation|0|||
105595050|NCT00941655|364178044|FG000|Overall Study|progressed while on chemo|0|||
105595051|NCT00941655|364178045|FG001|Overall Study|progressed while on chemo|2|||
105535378|NCT00378703|363965030|FG002|Overall Study|Relocation|1|||
105535379|NCT00378703|363965031|FG003|Overall Study|Relocation|0|||
105535380|NCT00378703|363965028|FG000|Overall Study|Ineligible|4|||
105535381|NCT00378703|363965029|FG001|Overall Study|Ineligible|7|||
105535382|NCT00378703|363965030|FG002|Overall Study|Ineligible|7|||
105535383|NCT00378703|363965031|FG003|Overall Study|Ineligible|7|||
105535384|NCT00378703|363965028|FG000|Overall Study|Never started treatment|1|||
105535385|NCT00378703|363965029|FG001|Overall Study|Never started treatment|4|||
105535386|NCT00378703|363965030|FG002|Overall Study|Never started treatment|0|||
105535387|NCT00378703|363965031|FG003|Overall Study|Never started treatment|0|||
105535388|NCT00378703|363965028|FG000|Overall Study|Other|1|||
105535389|NCT00378703|363965029|FG001|Overall Study|Other|1|||
105535390|NCT00378703|363965030|FG002|Overall Study|Other|2|||
105595052|NCT00941655|364178044|FG000|Overall Study|refused further treatment|0|||
105595053|NCT00941655|364178045|FG001|Overall Study|refused further treatment|1|||
105595054|NCT00941655|364178044|FG000|Overall Study|withdrew consent|0|||
105595055|NCT00941655|364178045|FG001|Overall Study|withdrew consent|1|||
105595056|NCT00941655|364178044|FG000|Overall Study|non-compliant|0|||
105595057|NCT00941655|364178045|FG001|Overall Study|non-compliant|1|||
105595058|NCT01458210|364178053|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
105595059|NCT01458210|364178053|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
105595060|NCT01458210|364178053|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
105595061|NCT01458210|364178053|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
105595062|NCT00753012|364178060|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
105595063|NCT00753012|364178061|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
105595064|NCT00753012|364178060|FG000|Overall Study|Adverse Event|2|||
105595065|NCT00753012|364178061|FG001|Overall Study|Adverse Event|0|||
105595066|NCT00753012|364178060|FG000|Overall Study|Withdrawal by Subject|0|||
105595067|NCT00753012|364178061|FG001|Overall Study|Withdrawal by Subject|1|||
105595068|NCT00753012|364178060|FG000|Overall Study|Lost to Follow-up|4|||
105595069|NCT00753012|364178061|FG001|Overall Study|Lost to Follow-up|0|||
105595070|NCT00753012|364178060|FG000|Overall Study|Confounded endpoint data|1|||
105595071|NCT00753012|364178061|FG001|Overall Study|Confounded endpoint data|0|||
105595072|NCT00957658|364178062|FG000|Overall Study|Death|1|||
105595073|NCT00957658|364178062|FG000|Overall Study|Lost to Follow-up|4|||
105595074|NCT00957658|364178062|FG000|Overall Study|Withdrawal by Subject|12|||
105595075|NCT00957658|364178062|FG000|Overall Study|Revision|1|||
105595076|NCT00957658|364178062|FG000|Overall Study|Incomplete 2 yr data|28|||
105595077|NCT00957658|364178062|FG000|Overall Study|Site termination|10|||
105595078|NCT00957658|364178062|FG000|Overall Study|unwilling/unable to return|2|||
105595079|NCT00957658|364178062|FG000|Overall Study|surgery cancelled|2|||
105595080|NCT00957658|364178062|FG000|Overall Study|Protocol Violation|5|||
105595081|NCT00344019|364178064|FG000|Overall Study|did not meet final inclusion criteria|0|||
105595082|NCT00344019|364178065|FG001|Overall Study|did not meet final inclusion criteria|0|||
105595083|NCT00344019|364178066|FG002|Overall Study|did not meet final inclusion criteria|74|||
105595084|NCT01565928|364178069|FG000|Overall Study|Adverse Event|3|||
105595085|NCT01565928|364178069|FG000|Overall Study|Other|3|||
105595086|NCT01565928|364178069|FG000|Overall Study|Progressive Disease|13|||
105595087|NCT01565928|364178069|FG000|Overall Study|Withdrawal by Subject|1|||
105595088|NCT01565928|364178069|FG000|Overall Study|Death|2|||
105595089|NCT01988233|364178071|FG000|Overall Study|Lost to Follow-up|64|||
105595090|NCT01988233|364178072|FG001|Overall Study|Lost to Follow-up|51|||
105595091|NCT03781336|364178077|FG000|Overall Study|Withdrawal by Subject|2|||
105595092|NCT03781336|364178078|FG001|Overall Study|Withdrawal by Subject|2|||
105595093|NCT00319436|364178079|FG000|Overall Study|Withdrawal by Subject|6|||
105595094|NCT00319436|364178080|FG001|Overall Study|Withdrawal by Subject|7|||
105595095|NCT00790790|364178081|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
105595096|NCT00790790|364178082|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
105595097|NCT00790790|364178083|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
105595098|NCT00790790|364178081|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
105595099|NCT00790790|364178082|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
105595100|NCT00790790|364178083|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
105595101|NCT00790790|364178081|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
105595102|NCT00790790|364178082|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
105595103|NCT00790790|364178083|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
105595104|NCT00790790|364178081|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
105595105|NCT00790790|364178082|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
105595106|NCT00790790|364178083|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
105595107|NCT00790790|364178081|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
105595108|NCT00790790|364178082|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
105595109|NCT00790790|364178083|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
105595110|NCT00940992|364178091|FG000|Overall Study|Adverse Event|2|||
105595111|NCT00940992|364178092|FG001|Overall Study|Adverse Event|0|||
105595112|NCT00940992|364178093|FG002|Overall Study|Adverse Event|1|||
105595113|NCT00940992|364178091|FG000|Overall Study|subject request|2|||
105595114|NCT00940992|364178092|FG001|Overall Study|subject request|1|||
105595115|NCT00940992|364178093|FG002|Overall Study|subject request|0|||
105595116|NCT00940992|364178091|FG000|Overall Study|Lost to Follow-up|0|||
105595117|NCT00940992|364178092|FG001|Overall Study|Lost to Follow-up|1|||
105595118|NCT00940992|364178093|FG002|Overall Study|Lost to Follow-up|1|||
105595119|NCT02517307|364178094|FG000|Overall Study|Withdrawal by Subject|1|||
105595120|NCT02517307|364178095|FG001|Overall Study|Withdrawal by Subject|0|||
105595121|NCT02517307|364178096|FG002|Overall Study|Withdrawal by Subject|1|||
105595122|NCT02517307|364178097|FG003|Overall Study|Withdrawal by Subject|0|||
105595123|NCT02517307|364178094|FG000|Overall Study|Protocol Violation|0|||
105595124|NCT02517307|364178095|FG001|Overall Study|Protocol Violation|0|||
105595125|NCT02517307|364178096|FG002|Overall Study|Protocol Violation|1|||
105595126|NCT02517307|364178097|FG003|Overall Study|Protocol Violation|1|||
105595127|NCT03612804|364178098|FG000|Overall Study|Death|0|||
105535391|NCT00378703|363965031|FG003|Overall Study|Other|3|||
105535392|NCT05402995|363965032|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
105535393|NCT05402995|363965033|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
105535394|NCT05402995|363965034|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
105535395|NCT05402995|363965035|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
105535396|NCT02705820|363965036|FG000|Overall Study|Death|2|||
105535397|NCT02705820|363965036|FG000|Overall Study|Disease Progression|34|||
105535398|NCT02705820|363965036|FG000|Overall Study|Clinical Deterioration|3|||
105535399|NCT03181542|363965037|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
105535400|NCT03181542|363965038|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
105535401|NCT01009099|363965039|FG000|Overall Study|Lost to Follow-up|1|||
105535402|NCT01009099|363965040|FG001|Overall Study|Lost to Follow-up|0|||
105535403|NCT01009099|363965039|FG000|Overall Study|Physician Decision|3|||
105535404|NCT01009099|363965040|FG001|Overall Study|Physician Decision|2|||
105535405|NCT01009099|363965039|FG000|Overall Study|Withdrawal by Subject|1|||
105535406|NCT01009099|363965040|FG001|Overall Study|Withdrawal by Subject|1|||
105535407|NCT01009099|363965039|FG000|Overall Study|Death|0|||
105535408|NCT01009099|363965040|FG001|Overall Study|Death|1|||
105535409|NCT02702401|363965041|FG000|Overall Study|Death|242|||
105535410|NCT02702401|363965042|FG001|Overall Study|Death|125|||
105535411|NCT02702401|363965041|FG000|Overall Study|Withdrawal by Subject|15|||
105535412|NCT02702401|363965042|FG001|Overall Study|Withdrawal by Subject|5|||
105535413|NCT02702401|363965041|FG000|Overall Study|Sponsor Decision|19|||
105535414|NCT02702401|363965042|FG001|Overall Study|Sponsor Decision|3|||
105535415|NCT02702401|363965041|FG000|Overall Study|Physician Decision|1|||
105535416|NCT02702401|363965042|FG001|Overall Study|Physician Decision|2|||
105535417|NCT02702401|363965041|FG000|Overall Study|Lost to Follow-up|1|||
105535418|NCT02702401|363965042|FG001|Overall Study|Lost to Follow-up|0|||
105535419|NCT01527292|363965045|FG000|Overall Study|Physician Decision|0|||
105535420|NCT01527292|363965046|FG001|Overall Study|Physician Decision|3|||
105535421|NCT01482767|363965047|FG000|Overall Study|Death|1|||
105535422|NCT01482767|363965048|FG001|Overall Study|Death|1|||
105535423|NCT01482767|363965047|FG000|Overall Study|Withdrawal by Subject|7|||
105535424|NCT01482767|363965048|FG001|Overall Study|Withdrawal by Subject|5|||
105535425|NCT01482767|363965047|FG000|Overall Study|Lost to Follow-up|12|||
105535426|NCT01482767|363965048|FG001|Overall Study|Lost to Follow-up|6|||
105535427|NCT01482767|363965047|FG000|Overall Study|Adverse Event|0|||
105535428|NCT01482767|363965048|FG001|Overall Study|Adverse Event|3|||
105535429|NCT01482767|363965047|FG000|Overall Study|Site closure|22|||
105535430|NCT01482767|363965048|FG001|Overall Study|Site closure|14|||
105535431|NCT01482767|363965047|FG000|Overall Study|Non-adherence to study requirements|4|||
105535432|NCT01482767|363965048|FG001|Overall Study|Non-adherence to study requirements|7|||
105535433|NCT01482767|363965047|FG000|Overall Study|Alternate HCV treatment|7|||
105535434|NCT01482767|363965048|FG001|Overall Study|Alternate HCV treatment|8|||
105535435|NCT01482767|363965047|FG000|Overall Study|Ineligible|0|||
105535436|NCT01482767|363965048|FG001|Overall Study|Ineligible|5|||
105535437|NCT01482767|363965047|FG000|Overall Study|Nurse error|1|||
105535438|NCT01482767|363965048|FG001|Overall Study|Nurse error|0|||
105535439|NCT02457325|363965049|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
105535440|NCT02457325|363965050|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
105535441|NCT01541930|363965051|FG000|Overall Study|Withdrawal by Subject|1|||
105535442|NCT01574703|363965052|FG000|Overall Study|Adverse Event|0|||
105535443|NCT01574703|363965053|FG001|Overall Study|Adverse Event|2|||
105535444|NCT01574703|363965054|FG002|Overall Study|Adverse Event|1|||
105535445|NCT01574703|363965055|FG003|Overall Study|Adverse Event|1|||
105535446|NCT01574703|363965052|FG000|Overall Study|Protocol Violation|0|||
105535447|NCT01574703|363965053|FG001|Overall Study|Protocol Violation|0|||
105535448|NCT01574703|363965054|FG002|Overall Study|Protocol Violation|0|||
105535449|NCT01574703|363965055|FG003|Overall Study|Protocol Violation|1|||
105535450|NCT01574703|363965052|FG000|Overall Study|Unspecified Reason|27|||
105535451|NCT01574703|363965053|FG001|Overall Study|Unspecified Reason|15|||
105535452|NCT01574703|363965054|FG002|Overall Study|Unspecified Reason|20|||
105535453|NCT01574703|363965055|FG003|Overall Study|Unspecified Reason|16|||
105535454|NCT01574703|363965052|FG000|Overall Study|Withdrawal by Subject|53|||
105535455|NCT01574703|363965053|FG001|Overall Study|Withdrawal by Subject|52|||
105535456|NCT01574703|363965054|FG002|Overall Study|Withdrawal by Subject|36|||
105535457|NCT01574703|363965055|FG003|Overall Study|Withdrawal by Subject|61|||
105535458|NCT01574703|363965052|FG000|Overall Study|Met Withdrawal Criteria|0|||
105535459|NCT01574703|363965053|FG001|Overall Study|Met Withdrawal Criteria|1|||
105535460|NCT01574703|363965054|FG002|Overall Study|Met Withdrawal Criteria|1|||
105535461|NCT01574703|363965055|FG003|Overall Study|Met Withdrawal Criteria|0|||
105535462|NCT01574703|363965052|FG000|Overall Study|Lost to Follow-up|43|||
105535463|NCT01574703|363965053|FG001|Overall Study|Lost to Follow-up|41|||
105535464|NCT01574703|363965054|FG002|Overall Study|Lost to Follow-up|46|||
105535465|NCT01574703|363965055|FG003|Overall Study|Lost to Follow-up|35|||
105535466|NCT01574703|363965052|FG000|Overall Study|Death|2|||
105535467|NCT01574703|363965053|FG001|Overall Study|Death|1|||
105535468|NCT01574703|363965054|FG002|Overall Study|Death|1|||
105535469|NCT01574703|363965055|FG003|Overall Study|Death|0|||
105535470|NCT01524770|363965056|FG000|First Intervention|Withdrawal by Subject|1|||
105535471|NCT01524770|363965057|FG001|First Intervention|Withdrawal by Subject|0|||
105535472|NCT01524770|363965056|FG000|First Intervention|Adverse Event|1|||
105535473|NCT01524770|363965057|FG001|First Intervention|Adverse Event|1|||
105535474|NCT01524770|363965056|FG000|First Intervention|Protocol Violation|1|||
105535475|NCT01524770|363965057|FG001|First Intervention|Protocol Violation|0|||
105535476|NCT01552772|363965058|FG000|Overall Study|Lost to Follow-up|2|||
105535477|NCT01552772|363965058|FG000|Overall Study|Adverse Event|1|||
105535478|NCT01552772|363965058|FG000|Overall Study|Protocol Deviation|1|||
105535479|NCT03013491|363965064|FG000|Main Study|Death|2|||
105535480|NCT03013491|363965065|FG001|Main Study|Death|2|||
105535481|NCT03013491|363965066|FG002|Main Study|Death|5|||
105535482|NCT03013491|363965067|FG003|Main Study|Death|3|||
105535483|NCT03013491|363965068|FG004|Main Study|Death|9|||
105535484|NCT03013491|363965069|FG005|Main Study|Death|12|||
105535485|NCT03013491|363965070|FG006|Main Study|Death|3|||
105535486|NCT03013491|363965071|FG007|Main Study|Death|5|||
105535487|NCT03013491|363965072|FG008|Main Study|Death|1|||
105535488|NCT03013491|363965073|FG009|Main Study|Death|2|||
105535489|NCT03013491|363965074|FG010|Main Study|Death|4|||
105535490|NCT03013491|363965075|FG011|Main Study|Death|1|||
105535491|NCT03013491|363965076|FG012|Main Study|Death|1|||
105535492|NCT03013491|363965077|FG013|Main Study|Death|4|||
105535493|NCT03013491|363965078|FG014|Main Study|Death|0|||
105535494|NCT03013491|363965079|FG015|Main Study|Death|3|||
105535495|NCT03013491|363965080|FG016|Main Study|Death|5|||
105535496|NCT03013491|363965081|FG017|Main Study|Death|1|||
105535497|NCT03013491|363965082|FG018|Main Study|Death|47|||
105535498|NCT03013491|363965064|FG000|Main Study|Lost to Follow-up|0|||
105535499|NCT03013491|363965065|FG001|Main Study|Lost to Follow-up|0|||
105535500|NCT03013491|363965066|FG002|Main Study|Lost to Follow-up|1|||
105535501|NCT03013491|363965067|FG003|Main Study|Lost to Follow-up|0|||
105535502|NCT03013491|363965068|FG004|Main Study|Lost to Follow-up|1|||
105535503|NCT03013491|363965069|FG005|Main Study|Lost to Follow-up|0|||
105535504|NCT03013491|363965070|FG006|Main Study|Lost to Follow-up|0|||
105595128|NCT03612804|364178099|FG001|Overall Study|Death|7|||
105595129|NCT03612804|364178100|FG002|Overall Study|Death|0|||
105595130|NCT03612804|364178101|FG003|Overall Study|Death|8|||
105595131|NCT03612804|364178098|FG000|Overall Study|Medication copay coverage issues|0|||
105595132|NCT03612804|364178099|FG001|Overall Study|Medication copay coverage issues|0|||
105595133|NCT03612804|364178100|FG002|Overall Study|Medication copay coverage issues|0|||
105595134|NCT03612804|364178101|FG003|Overall Study|Medication copay coverage issues|17|||
105595135|NCT03612804|364178098|FG000|Overall Study|Not current smoker at time of screening|0|||
105595136|NCT03612804|364178099|FG001|Overall Study|Not current smoker at time of screening|1|||
105595137|NCT03612804|364178100|FG002|Overall Study|Not current smoker at time of screening|0|||
105595138|NCT03612804|364178101|FG003|Overall Study|Not current smoker at time of screening|3|||
105595139|NCT03612804|364178098|FG000|Overall Study|Non-veteran status|0|||
105595140|NCT03612804|364178099|FG001|Overall Study|Non-veteran status|1|||
105595141|NCT03612804|364178100|FG002|Overall Study|Non-veteran status|0|||
105595142|NCT03612804|364178101|FG003|Overall Study|Non-veteran status|0|||
105595143|NCT03612804|364178098|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
105595144|NCT03612804|364178099|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
105595145|NCT03612804|364178100|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
105595146|NCT03612804|364178101|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
105595147|NCT03612804|364178098|FG000|Overall Study|Provider retired from VA|0|||
105595148|NCT03612804|364178099|FG001|Overall Study|Provider retired from VA|0|||
105595149|NCT03612804|364178100|FG002|Overall Study|Provider retired from VA|2|||
105595150|NCT03612804|364178101|FG003|Overall Study|Provider retired from VA|0|||
105595151|NCT03612804|364178098|FG000|Overall Study|Withdrawal by Subject|0|||
105595152|NCT03612804|364178099|FG001|Overall Study|Withdrawal by Subject|0|||
105595153|NCT03612804|364178100|FG002|Overall Study|Withdrawal by Subject|7|||
105595154|NCT03612804|364178101|FG003|Overall Study|Withdrawal by Subject|0|||
105595155|NCT03612804|364178098|FG000|Overall Study|Provider involved with study activities|1|||
105535505|NCT03013491|363965071|FG007|Main Study|Lost to Follow-up|0|||
105535506|NCT03013491|363965072|FG008|Main Study|Lost to Follow-up|0|||
105535507|NCT03013491|363965073|FG009|Main Study|Lost to Follow-up|0|||
105535508|NCT03013491|363965074|FG010|Main Study|Lost to Follow-up|0|||
105535509|NCT03013491|363965075|FG011|Main Study|Lost to Follow-up|0|||
105535510|NCT03013491|363965076|FG012|Main Study|Lost to Follow-up|0|||
105535511|NCT03013491|363965077|FG013|Main Study|Lost to Follow-up|0|||
105535512|NCT03013491|363965078|FG014|Main Study|Lost to Follow-up|0|||
105535513|NCT03013491|363965079|FG015|Main Study|Lost to Follow-up|0|||
105535514|NCT03013491|363965080|FG016|Main Study|Lost to Follow-up|0|||
105535515|NCT03013491|363965081|FG017|Main Study|Lost to Follow-up|0|||
105535516|NCT03013491|363965082|FG018|Main Study|Lost to Follow-up|3|||
105535517|NCT03013491|363965064|FG000|Main Study|Termination of the study by Sponsor|0|||
105535518|NCT03013491|363965065|FG001|Main Study|Termination of the study by Sponsor|0|||
105535519|NCT03013491|363965066|FG002|Main Study|Termination of the study by Sponsor|2|||
105535520|NCT03013491|363965067|FG003|Main Study|Termination of the study by Sponsor|0|||
105535521|NCT03013491|363965068|FG004|Main Study|Termination of the study by Sponsor|1|||
105535522|NCT03013491|363965069|FG005|Main Study|Termination of the study by Sponsor|2|||
105535523|NCT03013491|363965070|FG006|Main Study|Termination of the study by Sponsor|0|||
105535524|NCT03013491|363965071|FG007|Main Study|Termination of the study by Sponsor|0|||
105535525|NCT03013491|363965072|FG008|Main Study|Termination of the study by Sponsor|1|||
105535526|NCT03013491|363965073|FG009|Main Study|Termination of the study by Sponsor|1|||
105535527|NCT03013491|363965074|FG010|Main Study|Termination of the study by Sponsor|1|||
105535528|NCT03013491|363965075|FG011|Main Study|Termination of the study by Sponsor|2|||
105535529|NCT03013491|363965076|FG012|Main Study|Termination of the study by Sponsor|0|||
105535530|NCT03013491|363965077|FG013|Main Study|Termination of the study by Sponsor|0|||
105535531|NCT03013491|363965078|FG014|Main Study|Termination of the study by Sponsor|0|||
105535532|NCT03013491|363965079|FG015|Main Study|Termination of the study by Sponsor|0|||
105535533|NCT03013491|363965080|FG016|Main Study|Termination of the study by Sponsor|0|||
105535534|NCT03013491|363965081|FG017|Main Study|Termination of the study by Sponsor|1|||
105535535|NCT03013491|363965082|FG018|Main Study|Termination of the study by Sponsor|13|||
105535536|NCT03013491|363965064|FG000|Main Study|Withdrawal by Subject|0|||
105535537|NCT03013491|363965065|FG001|Main Study|Withdrawal by Subject|0|||
105535538|NCT03013491|363965066|FG002|Main Study|Withdrawal by Subject|0|||
105535539|NCT03013491|363965067|FG003|Main Study|Withdrawal by Subject|4|||
105535540|NCT03013491|363965068|FG004|Main Study|Withdrawal by Subject|2|||
105535541|NCT03013491|363965069|FG005|Main Study|Withdrawal by Subject|1|||
105535542|NCT03013491|363965070|FG006|Main Study|Withdrawal by Subject|0|||
105535543|NCT03013491|363965071|FG007|Main Study|Withdrawal by Subject|0|||
105535544|NCT03013491|363965072|FG008|Main Study|Withdrawal by Subject|0|||
105535545|NCT03013491|363965073|FG009|Main Study|Withdrawal by Subject|0|||
105535546|NCT03013491|363965074|FG010|Main Study|Withdrawal by Subject|1|||
105535547|NCT03013491|363965075|FG011|Main Study|Withdrawal by Subject|2|||
105535548|NCT03013491|363965076|FG012|Main Study|Withdrawal by Subject|0|||
105535549|NCT03013491|363965077|FG013|Main Study|Withdrawal by Subject|2|||
105535550|NCT03013491|363965078|FG014|Main Study|Withdrawal by Subject|0|||
105535551|NCT03013491|363965079|FG015|Main Study|Withdrawal by Subject|0|||
105535552|NCT03013491|363965080|FG016|Main Study|Withdrawal by Subject|0|||
105535553|NCT03013491|363965081|FG017|Main Study|Withdrawal by Subject|0|||
105535554|NCT03013491|363965082|FG018|Main Study|Withdrawal by Subject|18|||
105535555|NCT03013491|363965064|FG000|Main Study|Disease progression|0|||
105535556|NCT03013491|363965065|FG001|Main Study|Disease progression|0|||
105535557|NCT03013491|363965066|FG002|Main Study|Disease progression|0|||
105535558|NCT03013491|363965067|FG003|Main Study|Disease progression|1|||
105535559|NCT03013491|363965068|FG004|Main Study|Disease progression|0|||
105535560|NCT03013491|363965069|FG005|Main Study|Disease progression|0|||
105535561|NCT03013491|363965070|FG006|Main Study|Disease progression|0|||
105535562|NCT03013491|363965071|FG007|Main Study|Disease progression|0|||
105535563|NCT03013491|363965072|FG008|Main Study|Disease progression|1|||
105535564|NCT03013491|363965073|FG009|Main Study|Disease progression|0|||
105535565|NCT03013491|363965074|FG010|Main Study|Disease progression|1|||
105535566|NCT03013491|363965075|FG011|Main Study|Disease progression|0|||
105535567|NCT03013491|363965076|FG012|Main Study|Disease progression|0|||
105535568|NCT03013491|363965077|FG013|Main Study|Disease progression|0|||
105535569|NCT03013491|363965078|FG014|Main Study|Disease progression|0|||
105535570|NCT03013491|363965079|FG015|Main Study|Disease progression|0|||
105535571|NCT03013491|363965080|FG016|Main Study|Disease progression|0|||
105535572|NCT03013491|363965081|FG017|Main Study|Disease progression|0|||
105535573|NCT03013491|363965082|FG018|Main Study|Disease progression|4|||
105535574|NCT03013491|363965064|FG000|Main Study|Symptomatic deterioration|0|||
105535575|NCT03013491|363965065|FG001|Main Study|Symptomatic deterioration|0|||
105535576|NCT03013491|363965066|FG002|Main Study|Symptomatic deterioration|0|||
105535577|NCT03013491|363965067|FG003|Main Study|Symptomatic deterioration|0|||
105535578|NCT03013491|363965068|FG004|Main Study|Symptomatic deterioration|0|||
105535579|NCT03013491|363965069|FG005|Main Study|Symptomatic deterioration|1|||
105535580|NCT03013491|363965070|FG006|Main Study|Symptomatic deterioration|0|||
105535581|NCT03013491|363965071|FG007|Main Study|Symptomatic deterioration|0|||
105535582|NCT03013491|363965072|FG008|Main Study|Symptomatic deterioration|0|||
105535583|NCT03013491|363965073|FG009|Main Study|Symptomatic deterioration|0|||
105535584|NCT03013491|363965074|FG010|Main Study|Symptomatic deterioration|0|||
105535585|NCT03013491|363965075|FG011|Main Study|Symptomatic deterioration|0|||
105535586|NCT03013491|363965076|FG012|Main Study|Symptomatic deterioration|0|||
105535587|NCT03013491|363965077|FG013|Main Study|Symptomatic deterioration|0|||
105535588|NCT03013491|363965078|FG014|Main Study|Symptomatic deterioration|0|||
105535589|NCT03013491|363965079|FG015|Main Study|Symptomatic deterioration|0|||
105535590|NCT03013491|363965080|FG016|Main Study|Symptomatic deterioration|0|||
105535591|NCT03013491|363965081|FG017|Main Study|Symptomatic deterioration|0|||
105535592|NCT03013491|363965082|FG018|Main Study|Symptomatic deterioration|0|||
105535593|NCT03013491|363965064|FG000|Main Study|Protocol version 8.0 approval|0|||
105535594|NCT03013491|363965065|FG001|Main Study|Protocol version 8.0 approval|0|||
105535595|NCT03013491|363965066|FG002|Main Study|Protocol version 8.0 approval|0|||
105535596|NCT03013491|363965067|FG003|Main Study|Protocol version 8.0 approval|0|||
105535597|NCT03013491|363965068|FG004|Main Study|Protocol version 8.0 approval|0|||
105535598|NCT03013491|363965069|FG005|Main Study|Protocol version 8.0 approval|0|||
105535599|NCT03013491|363965070|FG006|Main Study|Protocol version 8.0 approval|0|||
105535600|NCT03013491|363965071|FG007|Main Study|Protocol version 8.0 approval|0|||
105535601|NCT03013491|363965072|FG008|Main Study|Protocol version 8.0 approval|0|||
105535602|NCT03013491|363965073|FG009|Main Study|Protocol version 8.0 approval|0|||
105535603|NCT03013491|363965074|FG010|Main Study|Protocol version 8.0 approval|1|||
105535604|NCT03013491|363965075|FG011|Main Study|Protocol version 8.0 approval|0|||
105535605|NCT03013491|363965076|FG012|Main Study|Protocol version 8.0 approval|0|||
105535606|NCT03013491|363965077|FG013|Main Study|Protocol version 8.0 approval|0|||
105535607|NCT03013491|363965078|FG014|Main Study|Protocol version 8.0 approval|0|||
105535608|NCT03013491|363965079|FG015|Main Study|Protocol version 8.0 approval|0|||
105535609|NCT03013491|363965080|FG016|Main Study|Protocol version 8.0 approval|0|||
105535610|NCT03013491|363965081|FG017|Main Study|Protocol version 8.0 approval|0|||
105535611|NCT03013491|363965082|FG018|Main Study|Protocol version 8.0 approval|0|||
105535612|NCT03013491|363965064|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
105535613|NCT03013491|363965065|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
105535614|NCT03013491|363965066|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
105535615|NCT03013491|363965067|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
105535616|NCT03013491|363965068|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
105535617|NCT03013491|363965069|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
105535618|NCT03013491|363965070|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
105535619|NCT03013491|363965071|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
105535620|NCT03013491|363965072|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
105535621|NCT03013491|363965073|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
105535622|NCT03013491|363965074|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
105535623|NCT03013491|363965075|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
105535624|NCT03013491|363965076|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
105535625|NCT03013491|363965077|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
105535626|NCT03013491|363965078|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
105535627|NCT03013491|363965079|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
105535628|NCT03013491|363965080|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
105535629|NCT03013491|363965081|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
105535630|NCT03013491|363965082|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
105535631|NCT03013491|363965064|FG000|Main Study|Start of new anticancer therapy|0|||
105535632|NCT03013491|363965065|FG001|Main Study|Start of new anticancer therapy|0|||
105535633|NCT03013491|363965066|FG002|Main Study|Start of new anticancer therapy|0|||
105535634|NCT03013491|363965067|FG003|Main Study|Start of new anticancer therapy|0|||
105535635|NCT03013491|363965068|FG004|Main Study|Start of new anticancer therapy|0|||
105535636|NCT03013491|363965069|FG005|Main Study|Start of new anticancer therapy|0|||
105535637|NCT03013491|363965070|FG006|Main Study|Start of new anticancer therapy|0|||
105535638|NCT03013491|363965071|FG007|Main Study|Start of new anticancer therapy|0|||
105535639|NCT03013491|363965072|FG008|Main Study|Start of new anticancer therapy|0|||
105535640|NCT03013491|363965073|FG009|Main Study|Start of new anticancer therapy|0|||
105535641|NCT03013491|363965074|FG010|Main Study|Start of new anticancer therapy|0|||
105535642|NCT03013491|363965075|FG011|Main Study|Start of new anticancer therapy|0|||
105535643|NCT03013491|363965076|FG012|Main Study|Start of new anticancer therapy|0|||
105535644|NCT03013491|363965077|FG013|Main Study|Start of new anticancer therapy|0|||
105535645|NCT03013491|363965078|FG014|Main Study|Start of new anticancer therapy|0|||
105535646|NCT03013491|363965079|FG015|Main Study|Start of new anticancer therapy|0|||
105535647|NCT03013491|363965080|FG016|Main Study|Start of new anticancer therapy|0|||
105535648|NCT03013491|363965081|FG017|Main Study|Start of new anticancer therapy|0|||
105535649|NCT03013491|363965082|FG018|Main Study|Start of new anticancer therapy|2|||
105535650|NCT03013491|363965064|FG000|Long-term Extension|Disease progression|0|||
105535651|NCT03013491|363965065|FG001|Long-term Extension|Disease progression|0|||
105535652|NCT03013491|363965066|FG002|Long-term Extension|Disease progression|0|||
105535653|NCT03013491|363965067|FG003|Long-term Extension|Disease progression|1|||
105535654|NCT03013491|363965068|FG004|Long-term Extension|Disease progression|0|||
105535655|NCT03013491|363965069|FG005|Long-term Extension|Disease progression|0|||
105535656|NCT03013491|363965070|FG006|Long-term Extension|Disease progression|0|||
105535657|NCT03013491|363965071|FG007|Long-term Extension|Disease progression|0|||
105535658|NCT03013491|363965072|FG008|Long-term Extension|Disease progression|0|||
105535659|NCT03013491|363965073|FG009|Long-term Extension|Disease progression|0|||
105535660|NCT03013491|363965074|FG010|Long-term Extension|Disease progression|0|||
105535661|NCT03013491|363965075|FG011|Long-term Extension|Disease progression|0|||
105535662|NCT03013491|363965076|FG012|Long-term Extension|Disease progression|0|||
105535663|NCT03013491|363965077|FG013|Long-term Extension|Disease progression|0|||
105535664|NCT03013491|363965078|FG014|Long-term Extension|Disease progression|0|||
105535665|NCT03013491|363965079|FG015|Long-term Extension|Disease progression|0|||
105535666|NCT03013491|363965080|FG016|Long-term Extension|Disease progression|0|||
105535667|NCT03013491|363965081|FG017|Long-term Extension|Disease progression|0|||
105535668|NCT03013491|363965082|FG018|Long-term Extension|Disease progression|1|||
105535669|NCT03013491|363965064|FG000|Long-term Extension|Withdrawal by Subject|0|||
105535670|NCT03013491|363965065|FG001|Long-term Extension|Withdrawal by Subject|0|||
105535671|NCT03013491|363965066|FG002|Long-term Extension|Withdrawal by Subject|0|||
105535672|NCT03013491|363965067|FG003|Long-term Extension|Withdrawal by Subject|0|||
105535673|NCT03013491|363965068|FG004|Long-term Extension|Withdrawal by Subject|0|||
105535674|NCT03013491|363965069|FG005|Long-term Extension|Withdrawal by Subject|0|||
105535675|NCT03013491|363965070|FG006|Long-term Extension|Withdrawal by Subject|0|||
105535676|NCT03013491|363965071|FG007|Long-term Extension|Withdrawal by Subject|1|||
105535677|NCT03013491|363965072|FG008|Long-term Extension|Withdrawal by Subject|0|||
105535678|NCT03013491|363965073|FG009|Long-term Extension|Withdrawal by Subject|0|||
105535679|NCT03013491|363965074|FG010|Long-term Extension|Withdrawal by Subject|0|||
105535680|NCT03013491|363965075|FG011|Long-term Extension|Withdrawal by Subject|0|||
105535681|NCT03013491|363965076|FG012|Long-term Extension|Withdrawal by Subject|0|||
105535682|NCT03013491|363965077|FG013|Long-term Extension|Withdrawal by Subject|0|||
105535683|NCT03013491|363965078|FG014|Long-term Extension|Withdrawal by Subject|0|||
105535684|NCT03013491|363965079|FG015|Long-term Extension|Withdrawal by Subject|0|||
105535685|NCT03013491|363965080|FG016|Long-term Extension|Withdrawal by Subject|0|||
105535686|NCT03013491|363965081|FG017|Long-term Extension|Withdrawal by Subject|0|||
105535687|NCT03013491|363965082|FG018|Long-term Extension|Withdrawal by Subject|0|||
105535688|NCT03013491|363965064|FG000|Long-term Extension|Adverse Event|0|||
105535689|NCT03013491|363965065|FG001|Long-term Extension|Adverse Event|0|||
105535690|NCT03013491|363965066|FG002|Long-term Extension|Adverse Event|0|||
105535691|NCT03013491|363965067|FG003|Long-term Extension|Adverse Event|0|||
105595156|NCT03612804|364178099|FG001|Overall Study|Provider involved with study activities|0|||
105595157|NCT03612804|364178100|FG002|Overall Study|Provider involved with study activities|0|||
105595158|NCT03612804|364178101|FG003|Overall Study|Provider involved with study activities|0|||
105595159|NCT00256243|364178102|FG000|Overall Study|Lost to Follow-up|2|||
105535692|NCT03013491|363965068|FG004|Long-term Extension|Adverse Event|0|||
105535693|NCT03013491|363965069|FG005|Long-term Extension|Adverse Event|0|||
105535694|NCT03013491|363965070|FG006|Long-term Extension|Adverse Event|0|||
105535695|NCT03013491|363965071|FG007|Long-term Extension|Adverse Event|0|||
105535696|NCT03013491|363965072|FG008|Long-term Extension|Adverse Event|0|||
105535697|NCT03013491|363965073|FG009|Long-term Extension|Adverse Event|0|||
105535698|NCT03013491|363965074|FG010|Long-term Extension|Adverse Event|0|||
105535699|NCT03013491|363965075|FG011|Long-term Extension|Adverse Event|0|||
105535700|NCT03013491|363965076|FG012|Long-term Extension|Adverse Event|0|||
105535701|NCT03013491|363965077|FG013|Long-term Extension|Adverse Event|0|||
105535702|NCT03013491|363965078|FG014|Long-term Extension|Adverse Event|0|||
105535703|NCT03013491|363965079|FG015|Long-term Extension|Adverse Event|0|||
105535704|NCT03013491|363965080|FG016|Long-term Extension|Adverse Event|0|||
105535705|NCT03013491|363965081|FG017|Long-term Extension|Adverse Event|0|||
105535706|NCT03013491|363965082|FG018|Long-term Extension|Adverse Event|1|||
105535707|NCT03013491|363965064|FG000|Long-term Extension|Death|0|||
105535708|NCT03013491|363965065|FG001|Long-term Extension|Death|0|||
105535709|NCT03013491|363965066|FG002|Long-term Extension|Death|0|||
105535710|NCT03013491|363965067|FG003|Long-term Extension|Death|0|||
105535711|NCT03013491|363965068|FG004|Long-term Extension|Death|0|||
105535712|NCT03013491|363965069|FG005|Long-term Extension|Death|0|||
105535713|NCT03013491|363965070|FG006|Long-term Extension|Death|0|||
105535714|NCT03013491|363965071|FG007|Long-term Extension|Death|0|||
105535715|NCT03013491|363965072|FG008|Long-term Extension|Death|0|||
105535716|NCT03013491|363965073|FG009|Long-term Extension|Death|0|||
105535717|NCT03013491|363965074|FG010|Long-term Extension|Death|0|||
105535718|NCT03013491|363965075|FG011|Long-term Extension|Death|0|||
105535719|NCT03013491|363965076|FG012|Long-term Extension|Death|0|||
105535720|NCT03013491|363965077|FG013|Long-term Extension|Death|0|||
105535721|NCT03013491|363965078|FG014|Long-term Extension|Death|0|||
105535722|NCT03013491|363965079|FG015|Long-term Extension|Death|0|||
105535723|NCT03013491|363965080|FG016|Long-term Extension|Death|0|||
105535724|NCT03013491|363965081|FG017|Long-term Extension|Death|0|||
105535725|NCT03013491|363965082|FG018|Long-term Extension|Death|1|||
105535726|NCT04745689|363965083|FG000|Overall Study|Death|9|||
105535727|NCT04745689|363965084|FG001|Overall Study|Death|6|||
105535728|NCT04745689|363965083|FG000|Overall Study|Lost to Follow-up|1|||
105535729|NCT04745689|363965084|FG001|Overall Study|Lost to Follow-up|0|||
105535730|NCT04745689|363965083|FG000|Overall Study|Withdrawal by Subject|2|||
105535731|NCT04745689|363965084|FG001|Overall Study|Withdrawal by Subject|0|||
105535732|NCT04745689|363965083|FG000|Overall Study|Study terminated by sponsor|10|||
105535733|NCT04745689|363965084|FG001|Overall Study|Study terminated by sponsor|3|||
105535734|NCT03548584|363966766|FG000|Overall Study|Lost to Follow-up|0|||
105535735|NCT03548584|363966767|FG001|Overall Study|Lost to Follow-up|0|||
105535736|NCT03548584|363966768|FG002|Overall Study|Lost to Follow-up|1|||
105535737|NCT03548584|363966766|FG000|Overall Study|Adverse Event|1|||
105535738|NCT03548584|363966767|FG001|Overall Study|Adverse Event|11|||
105535739|NCT03548584|363966768|FG002|Overall Study|Adverse Event|5|||
105535740|NCT03548584|363966766|FG000|Overall Study|Site Terminated by Sponsor|1|||
105535741|NCT03548584|363966767|FG001|Overall Study|Site Terminated by Sponsor|3|||
105535742|NCT03548584|363966768|FG002|Overall Study|Site Terminated by Sponsor|2|||
105535743|NCT03548584|363966766|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
105535744|NCT03548584|363966767|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
105535745|NCT03548584|363966768|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
105535746|NCT03548584|363966766|FG000|Overall Study|Lack of Efficacy|0|||
105535747|NCT03548584|363966767|FG001|Overall Study|Lack of Efficacy|1|||
105535748|NCT03548584|363966768|FG002|Overall Study|Lack of Efficacy|0|||
105535749|NCT03548584|363966766|FG000|Overall Study|Non-compliance with Study Drug|0|||
105535750|NCT03548584|363966767|FG001|Overall Study|Non-compliance with Study Drug|1|||
105535751|NCT03548584|363966768|FG002|Overall Study|Non-compliance with Study Drug|0|||
105535752|NCT03548584|363966766|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
105535753|NCT03548584|363966767|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
105535754|NCT03548584|363966768|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
105535755|NCT04524403|363966773|FG000|Overall Study|Withdrawal by Subject|10|||
105535756|NCT04524403|363966774|FG001|Overall Study|Withdrawal by Subject|3|||
105535757|NCT04524403|363966775|FG002|Overall Study|Withdrawal by Subject|8|||
105535758|NCT04524403|363966773|FG000|Overall Study|Lost to Follow-up|3|||
105535759|NCT04524403|363966774|FG001|Overall Study|Lost to Follow-up|4|||
105535760|NCT04524403|363966775|FG002|Overall Study|Lost to Follow-up|3|||
105535761|NCT04524403|363966773|FG000|Overall Study|Adverse Event|3|||
105595160|NCT00256243|364178102|FG000|Overall Study|Death|7|||
105595161|NCT00256243|364178102|FG000|Overall Study|Not treated|1|||
105595162|NCT02685488|364178106|FG000|Overall Study|Withdrawal by Subject|0|||
105595163|NCT02685488|364178107|FG001|Overall Study|Withdrawal by Subject|1|||
105535762|NCT04524403|363966774|FG001|Overall Study|Adverse Event|1|||
105535763|NCT04524403|363966775|FG002|Overall Study|Adverse Event|4|||
105535764|NCT04524403|363966773|FG000|Overall Study|Non-compliant with study drug|1|||
105535765|NCT04524403|363966774|FG001|Overall Study|Non-compliant with study drug|2|||
105535766|NCT04524403|363966775|FG002|Overall Study|Non-compliant with study drug|3|||
105535767|NCT04524403|363966773|FG000|Overall Study|Moved|0|||
105535768|NCT04524403|363966774|FG001|Overall Study|Moved|1|||
105535769|NCT04524403|363966775|FG002|Overall Study|Moved|0|||
105535770|NCT01083433|363966780|FG000|Overall Study|Lost to Follow-up|2|||
105535771|NCT01083433|363966781|FG001|Overall Study|Lost to Follow-up|1|||
105535772|NCT01083433|363966782|FG002|Overall Study|Lost to Follow-up|1|||
105595164|NCT00324038|364178112|FG000|Overall Study|Adverse Event|38|||
105595165|NCT00324038|364178113|FG001|Overall Study|Adverse Event|23|||
105535773|NCT01083433|363966780|FG000|Overall Study|Withdrawal by Subject|0|||
105535774|NCT01083433|363966781|FG001|Overall Study|Withdrawal by Subject|5|||
105535775|NCT01083433|363966782|FG002|Overall Study|Withdrawal by Subject|3|||
105535776|NCT01083433|363966780|FG000|Overall Study|Pregnancy|0|||
105535777|NCT01083433|363966781|FG001|Overall Study|Pregnancy|0|||
105535778|NCT01083433|363966782|FG002|Overall Study|Pregnancy|1|||
105535779|NCT03370341|363966783|FG000|Overall Study|Lost to Follow-up|0|||
105535780|NCT03370341|363966784|FG001|Overall Study|Lost to Follow-up|1|||
105535781|NCT01581593|363966787|FG000|Overall Study|Withdrawal by Subject|1|||
105535782|NCT01101841|363966788|FG000|Overall Study|Adverse Event|15|||
105535783|NCT01101841|363966789|FG001|Overall Study|Adverse Event|15|||
105535784|NCT01101841|363966788|FG000|Overall Study|Lost to Follow-up|9|||
105535785|NCT01101841|363966789|FG001|Overall Study|Lost to Follow-up|3|||
105535786|NCT01101841|363966788|FG000|Overall Study|Withdrawal by Subject|21|||
105535787|NCT01101841|363966789|FG001|Overall Study|Withdrawal by Subject|40|||
105535788|NCT01101841|363966788|FG000|Overall Study|Protocol Violation|1|||
105535789|NCT01101841|363966789|FG001|Overall Study|Protocol Violation|1|||
105535790|NCT01101841|363966788|FG000|Overall Study|Physician Decision|0|||
105535791|NCT01101841|363966789|FG001|Overall Study|Physician Decision|2|||
105535792|NCT01101841|363966788|FG000|Overall Study|Lack of Efficacy|0|||
105535793|NCT01101841|363966789|FG001|Overall Study|Lack of Efficacy|2|||
105535794|NCT01101841|363966788|FG000|Overall Study|Other|0|||
105535795|NCT01101841|363966789|FG001|Overall Study|Other|1|||
105535796|NCT01101841|363966788|FG000|Overall Study|Suicidality Tracking Scale|3|||
105535797|NCT01101841|363966789|FG001|Overall Study|Suicidality Tracking Scale|1|||
105535798|NCT01101841|363966788|FG000|Overall Study|Eligibility Criteria|1|||
105535799|NCT01101841|363966789|FG001|Overall Study|Eligibility Criteria|2|||
105535800|NCT01707004|363966792|FG000|Overall Study|Physician Decision|3|||
105535801|NCT00653224|363966795|FG000|Overall Study|Adverse Event|2|||
105535802|NCT00653224|363966796|FG001|Overall Study|Adverse Event|1|||
105535803|NCT00653224|363966795|FG000|Overall Study|Lack of Efficacy|1|||
105535804|NCT00653224|363966796|FG001|Overall Study|Lack of Efficacy|2|||
105535805|NCT00653224|363966795|FG000|Overall Study|Loss of efficacy|1|||
105535806|NCT00653224|363966796|FG001|Overall Study|Loss of efficacy|0|||
105535807|NCT00653224|363966795|FG000|Overall Study|Lost to Follow-up|1|||
105535808|NCT00653224|363966796|FG001|Overall Study|Lost to Follow-up|0|||
105535809|NCT00653224|363966795|FG000|Overall Study|Other|2|||
105535810|NCT00653224|363966796|FG001|Overall Study|Other|4|||
105535811|NCT04982029|363966797|FG000|Overall Study|Lost to Follow-up|2|||
105535812|NCT04982029|363966798|FG001|Overall Study|Lost to Follow-up|3|||
105535813|NCT05084053|363966799|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
105535814|NCT05084053|363966800|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
105535815|NCT05084053|363966801|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
105535816|NCT05084053|363966802|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
105535817|NCT05084053|363966799|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
105535818|NCT05084053|363966800|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
105535819|NCT05084053|363966801|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
105535820|NCT05084053|363966802|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
105535821|NCT05084053|363966799|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
105535822|NCT05084053|363966800|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
105535823|NCT05084053|363966801|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
105535824|NCT05084053|363966802|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
105535825|NCT00679341|363966803|FG000|Overall Study|Disease progression|42|||
105535826|NCT00679341|363966804|FG001|Overall Study|Disease progression|36|||
105535827|NCT00679341|363966803|FG000|Overall Study|Adverse Event|5|||
105535828|NCT00679341|363966804|FG001|Overall Study|Adverse Event|6|||
105535829|NCT00679341|363966803|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
105535830|NCT00679341|363966804|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
105535831|NCT00679341|363966803|FG000|Overall Study|Death|1|||
105535832|NCT00679341|363966804|FG001|Overall Study|Death|1|||
105535833|NCT00679341|363966803|FG000|Overall Study|Other|1|||
105535834|NCT00679341|363966804|FG001|Overall Study|Other|0|||
105535835|NCT00679341|363966803|FG000|Overall Study|Physician Decision|1|||
105535836|NCT00679341|363966804|FG001|Overall Study|Physician Decision|0|||
105535837|NCT00679341|363966803|FG000|Overall Study|Not treated|0|||
105535838|NCT00679341|363966804|FG001|Overall Study|Not treated|2|||
105535839|NCT00679341|363966803|FG000|Overall Study|Physician/patient decision to withdraw|0|||
105535840|NCT00679341|363966804|FG001|Overall Study|Physician/patient decision to withdraw|6|||
105535841|NCT01207778|363966805|FG000|Overall Study|Lost to Follow-up|0|||
105535842|NCT01207778|363966806|FG001|Overall Study|Lost to Follow-up|3|||
105535843|NCT01207778|363966807|FG002|Overall Study|Lost to Follow-up|3|||
105535844|NCT00646204|363966808|FG000|Overall Study|Adverse Event|3|||
105535845|NCT00646204|363966809|FG001|Overall Study|Adverse Event|0|||
105535846|NCT00646204|363966808|FG000|Overall Study|Withdrawal by Subject|1|||
105535847|NCT00646204|363966809|FG001|Overall Study|Withdrawal by Subject|0|||
105535848|NCT04709237|363966812|FG000|Overall Study|Lost to Follow-up|1|||
105535849|NCT04709237|363966813|FG001|Overall Study|Lost to Follow-up|0|||
105535850|NCT04709237|363966814|FG002|Overall Study|Lost to Follow-up|0|||
105535851|NCT01440322|363966818|FG000|Overall Study|Discomfort|2|||
105535852|NCT01440322|363966819|FG001|Overall Study|Discomfort|0|||
105535853|NCT01440322|363966818|FG000|Overall Study|Biomicroscopy|1|||
105535854|NCT01440322|363966819|FG001|Overall Study|Biomicroscopy|0|||
105535855|NCT01440322|363966818|FG000|Overall Study|Symptoms and Problems|1|||
105535856|NCT01440322|363966819|FG001|Overall Study|Symptoms and Problems|0|||
105535857|NCT01440322|363966818|FG000|Overall Study|Unacceptable Subjective Vision|1|||
105535858|NCT01440322|363966819|FG001|Overall Study|Unacceptable Subjective Vision|0|||
105535859|NCT01440322|363966818|FG000|Overall Study|Other Product Related|1|||
105535860|NCT01440322|363966819|FG001|Overall Study|Other Product Related|0|||
105535861|NCT01440322|363966818|FG000|Overall Study|Unrelated Medical Problem|0|||
105535862|NCT01440322|363966819|FG001|Overall Study|Unrelated Medical Problem|1|||
105535863|NCT01440322|363966818|FG000|Overall Study|Other Non-Product Related|1|||
105535864|NCT01440322|363966819|FG001|Overall Study|Other Non-Product Related|0|||
105535865|NCT01956110|363966825|FG000|Overall Study|Protocol Violation|25|||
105535866|NCT01956110|363966826|FG001|Overall Study|Protocol Violation|11|||
105535867|NCT01956110|363966825|FG000|Overall Study|Adverse Event|9|||
105535868|NCT01956110|363966826|FG001|Overall Study|Adverse Event|10|||
105535869|NCT01956110|363966825|FG000|Overall Study|Personal reasons|1|||
105535870|NCT01956110|363966826|FG001|Overall Study|Personal reasons|1|||
105535871|NCT02412631|363966828|FG000|Overall Study|Adverse Event|1|||
105535872|NCT02412631|363966829|FG001|Overall Study|Adverse Event|2|||
105535873|NCT02412631|363966828|FG000|Overall Study|Lost to Follow-up|5|||
105535874|NCT02412631|363966829|FG001|Overall Study|Lost to Follow-up|9|||
105535875|NCT02412631|363966828|FG000|Overall Study|Withdrawal by Subject|9|||
105535876|NCT02412631|363966829|FG001|Overall Study|Withdrawal by Subject|3|||
105535877|NCT02412631|363966828|FG000|Overall Study|Early stop by FDA|5|||
105535878|NCT02412631|363966829|FG001|Overall Study|Early stop by FDA|2|||
105535879|NCT02412631|363966828|FG000|Overall Study|Unspecified reason|6|||
105535880|NCT02412631|363966829|FG001|Overall Study|Unspecified reason|8|||
105535881|NCT00770120|363966830|FG000|Overall Study|Progression|31|||
105535882|NCT00770120|363966830|FG000|Overall Study|Adverse Event|11|||
105535883|NCT00770120|363966830|FG000|Overall Study|Not Protocol Specified|11|||
105535884|NCT00770120|363966830|FG000|Overall Study|Death|3|||
105535885|NCT00770120|363966830|FG000|Overall Study|Withdrawal by Subject|2|||
105535886|NCT00770120|363966830|FG000|Overall Study|Ineligible|1|||
105535887|NCT00770120|363966830|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
105535888|NCT00770120|363966830|FG000|Overall Study|Reason under Review|1|||
105535889|NCT02488629|363966831|FG000|Overall Study|Lack of Efficacy|3|||
105535890|NCT02488629|363966832|FG001|Overall Study|Lack of Efficacy|1|||
105535891|NCT02488629|363966833|FG002|Overall Study|Lack of Efficacy|0|||
105535892|NCT02488629|363966834|FG003|Overall Study|Lack of Efficacy|0|||
105535893|NCT02488629|363966831|FG000|Overall Study|Withdrawal by Subject|0|||
105535894|NCT02488629|363966832|FG001|Overall Study|Withdrawal by Subject|1|||
105535895|NCT02488629|363966833|FG002|Overall Study|Withdrawal by Subject|0|||
105535896|NCT02488629|363966834|FG003|Overall Study|Withdrawal by Subject|0|||
105535897|NCT00958776|363966835|FG000|Overall Study|Adverse Event|0|||
105535898|NCT00958776|363966836|FG001|Overall Study|Adverse Event|1|||
105535899|NCT00958776|363966835|FG000|Overall Study|Physician Decision|1|||
105535900|NCT00958776|363966836|FG001|Overall Study|Physician Decision|0|||
105535901|NCT00958776|363966835|FG000|Overall Study|Lost to Follow-up|2|||
105535902|NCT00958776|363966836|FG001|Overall Study|Lost to Follow-up|6|||
105535903|NCT00958776|363966835|FG000|Overall Study|Withdrawal by Subject|7|||
105535904|NCT00958776|363966836|FG001|Overall Study|Withdrawal by Subject|16|||
105535905|NCT00958776|363966835|FG000|Overall Study|Protocol Violation|1|||
105535906|NCT00958776|363966836|FG001|Overall Study|Protocol Violation|1|||
105535907|NCT00958776|363966835|FG000|Overall Study|Death|2|||
105535908|NCT00958776|363966836|FG001|Overall Study|Death|1|||
105535909|NCT00958776|363966835|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
105535910|NCT00958776|363966836|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
105535911|NCT00958776|363966835|FG000|Overall Study|Missing|1|||
105535912|NCT00958776|363966836|FG001|Overall Study|Missing|1|||
105535913|NCT00480636|363966837|FG000|Overall Study|Death|12|||
105535914|NCT00480636|363966837|FG000|Overall Study|Lost to Follow-up|4|||
105535915|NCT00480636|363966837|FG000|Overall Study|Other|2|||
105535916|NCT00480636|363966837|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
105535917|NCT05179421|363966839|FG000|First Infusion Day|Adverse Event|1|||
105535918|NCT05179421|363966840|FG001|First Infusion Day|Adverse Event|0|||
105535919|NCT01857063|363966841|FG000|Period 1 (7 Days)|Adverse Event|0|||
105535920|NCT01857063|363966842|FG001|Period 1 (7 Days)|Adverse Event|1|||
105535921|NCT01857063|363966841|FG000|Period 1 (7 Days)|Physician Decision|1|||
105535922|NCT01857063|363966842|FG001|Period 1 (7 Days)|Physician Decision|0|||
105535923|NCT01857063|363966841|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
105535924|NCT01857063|363966842|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
105535925|NCT01857063|363966841|FG000|Period 2 (7 Days)|Adverse Event|2|||
105535926|NCT01857063|363966842|FG001|Period 2 (7 Days)|Adverse Event|1|||
105535927|NCT01857063|363966841|FG000|Period 2 (7 Days)|Physician Decision|1|||
105535928|NCT01857063|363966842|FG001|Period 2 (7 Days)|Physician Decision|1|||
105535929|NCT01857063|363966841|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
105535930|NCT01857063|363966842|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
105535931|NCT04958109|363966843|FG000|Overall Study|Withdrawal by Subject|0|||
105535932|NCT04958109|363966844|FG001|Overall Study|Withdrawal by Subject|1|||
105535933|NCT04958109|363966843|FG000|Overall Study|Lost to Follow-up|0|||
105535934|NCT04958109|363966844|FG001|Overall Study|Lost to Follow-up|1|||
105535935|NCT04115358|363966845|FG000|Overall Study|exfoliation|0|||
105535936|NCT04115358|363966846|FG001|Overall Study|exfoliation|0|||
105535937|NCT04115358|363966847|FG002|Overall Study|exfoliation|1|||
105535938|NCT01205165|363966848|FG000|Overall Study|Lost to Follow-up|2|||
105535939|NCT02346240|363966852|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535940|NCT02346240|363966853|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
105535941|NCT02346240|363966854|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
105535942|NCT02346240|363966855|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
105535943|NCT02346240|363966856|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535944|NCT02346240|363966857|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535945|NCT02346240|363966858|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535946|NCT02346240|363966859|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535947|NCT02346240|363966860|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535948|NCT02346240|363966861|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535949|NCT02346240|363966862|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535950|NCT02346240|363966863|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535951|NCT02346240|363966864|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535952|NCT02346240|363966865|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535953|NCT02346240|363966866|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535954|NCT02346240|363966867|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535955|NCT02346240|363966868|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535956|NCT02346240|363966869|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535957|NCT02346240|363966870|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535958|NCT02346240|363966871|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535959|NCT02346240|363966872|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535960|NCT02346240|363966873|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535961|NCT02346240|363966874|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535962|NCT02346240|363966875|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
105535963|NCT02346240|363966852|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535964|NCT02346240|363966853|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
105535965|NCT02346240|363966854|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535966|NCT02346240|363966855|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535967|NCT02346240|363966856|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535968|NCT02346240|363966857|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535969|NCT02346240|363966858|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535970|NCT02346240|363966859|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535971|NCT02346240|363966860|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535972|NCT02346240|363966861|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535973|NCT02346240|363966862|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535974|NCT02346240|363966863|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535975|NCT02346240|363966864|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535976|NCT02346240|363966865|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535977|NCT02346240|363966866|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535978|NCT02346240|363966867|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535979|NCT02346240|363966868|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535980|NCT02346240|363966869|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535981|NCT02346240|363966870|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535982|NCT02346240|363966871|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535983|NCT02346240|363966872|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535984|NCT02346240|363966873|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535985|NCT02346240|363966874|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535986|NCT02346240|363966875|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
105535987|NCT02346240|363966852|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105535988|NCT02346240|363966853|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
105535989|NCT02346240|363966854|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105535990|NCT02346240|363966855|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105535991|NCT02346240|363966856|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105535992|NCT02346240|363966857|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105535993|NCT02346240|363966858|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105535994|NCT02346240|363966859|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105535995|NCT02346240|363966860|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105535996|NCT02346240|363966861|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105535997|NCT02346240|363966862|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105535998|NCT02346240|363966863|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105535999|NCT02346240|363966864|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105536000|NCT02346240|363966865|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105536001|NCT02346240|363966866|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105595166|NCT00324038|364178112|FG000|Overall Study|Lack of Efficacy|5|||
105536002|NCT02346240|363966867|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105536003|NCT02346240|363966868|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105536004|NCT02346240|363966869|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105536005|NCT02346240|363966870|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105536006|NCT02346240|363966871|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105536007|NCT02346240|363966872|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105536008|NCT02346240|363966873|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105536009|NCT02346240|363966874|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105536010|NCT02346240|363966875|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
105536011|NCT02346240|363966852|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
105536012|NCT02346240|363966853|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
105536013|NCT02346240|363966854|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
105536014|NCT02346240|363966855|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
105536015|NCT02346240|363966856|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536016|NCT02346240|363966857|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536017|NCT02346240|363966858|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536018|NCT02346240|363966859|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536019|NCT02346240|363966860|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536020|NCT02346240|363966861|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536021|NCT02346240|363966862|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536022|NCT02346240|363966863|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536023|NCT02346240|363966864|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536024|NCT02346240|363966865|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536025|NCT02346240|363966866|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536026|NCT02346240|363966867|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536027|NCT02346240|363966868|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536028|NCT02346240|363966869|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536029|NCT02346240|363966870|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536030|NCT02346240|363966871|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536031|NCT02346240|363966872|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536032|NCT02346240|363966873|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536033|NCT02346240|363966874|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536034|NCT02346240|363966875|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
105536035|NCT02346240|363966852|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
105536036|NCT02346240|363966853|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
105536037|NCT02346240|363966854|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
105536038|NCT02346240|363966855|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
105536039|NCT02346240|363966856|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536040|NCT02346240|363966857|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536041|NCT02346240|363966858|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536042|NCT02346240|363966859|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536043|NCT02346240|363966860|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536044|NCT02346240|363966861|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536045|NCT02346240|363966862|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536046|NCT02346240|363966863|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536047|NCT02346240|363966864|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536048|NCT02346240|363966865|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536049|NCT02346240|363966866|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536050|NCT02346240|363966867|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536051|NCT02346240|363966868|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536052|NCT02346240|363966869|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536053|NCT02346240|363966870|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536054|NCT02346240|363966871|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536055|NCT02346240|363966872|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536056|NCT02346240|363966873|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536057|NCT02346240|363966874|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536058|NCT02346240|363966875|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
105536059|NCT02346240|363966852|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536060|NCT02346240|363966853|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
105536061|NCT02346240|363966854|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536062|NCT02346240|363966855|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
105536063|NCT02346240|363966856|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536064|NCT02346240|363966857|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536065|NCT02346240|363966858|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105595167|NCT00324038|364178113|FG001|Overall Study|Lack of Efficacy|13|||
105595168|NCT00324038|364178112|FG000|Overall Study|Lost to Follow-up|0|||
105595169|NCT00324038|364178113|FG001|Overall Study|Lost to Follow-up|2|||
105595170|NCT00324038|364178112|FG000|Overall Study|Other|6|||
105595171|NCT00324038|364178113|FG001|Overall Study|Other|13|||
105595172|NCT03008915|364178114|FG000|Treatment 1|Withdrawal by Subject|0|||
105595173|NCT03008915|364178115|FG001|Treatment 1|Withdrawal by Subject|1|||
105595174|NCT00605033|364178121|FG000|Overall Study|Adverse Event|2|||
105595175|NCT00605033|364178122|FG001|Overall Study|Adverse Event|2|||
105595176|NCT00605033|364178121|FG000|Overall Study|Lost to Follow-up|1|||
105595177|NCT00605033|364178122|FG001|Overall Study|Lost to Follow-up|1|||
105536066|NCT02346240|363966859|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536067|NCT02346240|363966860|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536068|NCT02346240|363966861|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536069|NCT02346240|363966862|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536070|NCT02346240|363966863|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536071|NCT02346240|363966864|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536072|NCT02346240|363966865|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536073|NCT02346240|363966866|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536074|NCT02346240|363966867|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536075|NCT02346240|363966868|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536076|NCT02346240|363966869|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536077|NCT02346240|363966870|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536078|NCT02346240|363966871|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536079|NCT02346240|363966872|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536080|NCT02346240|363966873|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105536081|NCT02346240|363966874|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105595178|NCT00605033|364178121|FG000|Overall Study|Withdrawal by Subject|3|||
105595179|NCT00605033|364178122|FG001|Overall Study|Withdrawal by Subject|4|||
105595180|NCT00605033|364178121|FG000|Overall Study|Protocol Violation|1|||
105595181|NCT00605033|364178122|FG001|Overall Study|Protocol Violation|1|||
105595182|NCT03395353|364178123|FG000|Overall Study|Adverse Event|20|||
105595183|NCT03395353|364178123|FG000|Overall Study|Protocol Violation|1|||
105595184|NCT03395353|364178123|FG000|Overall Study|Lack of Efficacy|3|||
105595185|NCT03395353|364178123|FG000|Overall Study|Withdrawal by Subject|24|||
105595186|NCT03395353|364178123|FG000|Overall Study|Discontinued visit|1|||
105595187|NCT03395353|364178123|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
105595188|NCT03395353|364178123|FG000|Overall Study|Physician Decision|4|||
105595189|NCT03395353|364178123|FG000|Overall Study|Early termination of overall study|33|||
105595190|NCT01070888|364180106|FG000|First Intervention (14 Days)|Adverse Event|0|||
105595191|NCT01070888|364180107|FG001|First Intervention (14 Days)|Adverse Event|1|||
105595192|NCT01070888|364180106|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
105595193|NCT01070888|364180107|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
105595194|NCT01070888|364180106|FG000|Washout (14 Days)|Physician Decision|1|||
105595195|NCT01070888|364180107|FG001|Washout (14 Days)|Physician Decision|0|||
105595196|NCT02263508|364180108|FG000|Overall Study|Withdrawal by Subject|1|||
105595197|NCT02263508|364180109|FG001|Overall Study|Withdrawal by Subject|23|||
105595198|NCT02263508|364180110|FG002|Overall Study|Withdrawal by Subject|17|||
105595199|NCT02263508|364180108|FG000|Overall Study|Sponsor Decision|12|||
105595200|NCT02263508|364180109|FG001|Overall Study|Sponsor Decision|165|||
105595201|NCT02263508|364180110|FG002|Overall Study|Sponsor Decision|182|||
105595202|NCT02263508|364180108|FG000|Overall Study|Lost to Follow-up|2|||
105595203|NCT02263508|364180109|FG001|Overall Study|Lost to Follow-up|7|||
105595204|NCT02263508|364180110|FG002|Overall Study|Lost to Follow-up|7|||
105595205|NCT02263508|364180108|FG000|Overall Study|Death|6|||
105595206|NCT02263508|364180109|FG001|Overall Study|Death|151|||
105595207|NCT02263508|364180110|FG002|Overall Study|Death|140|||
105595208|NCT00028769|364180111|FG000|Overall Study|Adverse Event|2|||
105595209|NCT00028769|364180111|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
105595210|NCT00028769|364180111|FG000|Overall Study|Progression or Death|31|||
105595211|NCT00028769|364180111|FG000|Overall Study|Other - Not Protocol Specified|1|||
105595212|NCT00028769|364180111|FG000|Overall Study|Ineligible|5|||
105595213|NCT00028769|364180111|FG000|Overall Study|Not Analyzable|1|||
105595214|NCT01134562|364180112|FG000|Overall Study|Adverse Event|0|||
105595215|NCT01134562|364180113|FG001|Overall Study|Adverse Event|1|||
105595216|NCT01134562|364180114|FG002|Overall Study|Adverse Event|0|||
105595217|NCT01134562|364180115|FG003|Overall Study|Adverse Event|0|||
105595218|NCT01134562|364180116|FG004|Overall Study|Adverse Event|0|||
105595219|NCT02496702|364180117|FG000|Overall Study|Lost to Follow-up|8|||
105536082|NCT02346240|363966875|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
105595220|NCT02496702|364180118|FG001|Overall Study|Lost to Follow-up|6|||
105595221|NCT02496702|364180117|FG000|Overall Study|Only partially tested|0|||
105595222|NCT02496702|364180118|FG001|Overall Study|Only partially tested|2|||
105595223|NCT02525796|364180123|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
105595224|NCT02525796|364180124|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
105595225|NCT02525796|364180125|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
105595226|NCT02525796|364180123|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
105595227|NCT02525796|364180124|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
105595228|NCT02525796|364180125|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
105595229|NCT02525796|364180123|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
105595230|NCT02525796|364180124|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
105595231|NCT02525796|364180125|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
105595232|NCT02525796|364180123|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
105595233|NCT02525796|364180124|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
105595234|NCT02525796|364180125|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
105595235|NCT02525796|364180123|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
105595236|NCT02525796|364180124|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
105595237|NCT02525796|364180125|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
105595238|NCT02488980|364180126|FG000|Overall Study|Protocol Violation|2|||
105595239|NCT02488980|364180127|FG001|Overall Study|Protocol Violation|2|||
105595240|NCT02488980|364180128|FG002|Overall Study|Protocol Violation|2|||
105595241|NCT00391846|364180129|FG000|Overall Study|Adverse Event|4|||
105595242|NCT00391846|364180130|FG001|Overall Study|Adverse Event|1|||
105595243|NCT00391846|364180129|FG000|Overall Study|Did not meet the required elig. crit|2|||
105595244|NCT00391846|364180130|FG001|Overall Study|Did not meet the required elig. crit|2|||
105595245|NCT00391846|364180129|FG000|Overall Study|Withdrawal by Subject|2|||
105595246|NCT00391846|364180130|FG001|Overall Study|Withdrawal by Subject|3|||
105595247|NCT00391846|364180129|FG000|Overall Study|Developed study specific DC criteria|0|||
105595248|NCT00391846|364180130|FG001|Overall Study|Developed study specific DC criteria|1|||
105595249|NCT00150176|364180131|FG000|Overall Study|Adverse Event|16|||
105595250|NCT00150176|364180132|FG001|Overall Study|Adverse Event|53|||
105595251|NCT00150176|364180131|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
105595252|NCT00150176|364180132|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
105595253|NCT00150176|364180131|FG000|Overall Study|Withdrawal by Subject|19|||
105595254|NCT00150176|364180132|FG001|Overall Study|Withdrawal by Subject|12|||
105595255|NCT00150176|364180131|FG000|Overall Study|Lost to Follow-up|3|||
105595256|NCT00150176|364180132|FG001|Overall Study|Lost to Follow-up|3|||
105595257|NCT00150176|364180131|FG000|Overall Study|OTHER|11|||
105595258|NCT00150176|364180132|FG001|Overall Study|OTHER|13|||
105595259|NCT00423098|364180133|FG000|Overall Study|Adverse Event|1|||
105595260|NCT00423098|364180134|FG001|Overall Study|Adverse Event|2|||
105595261|NCT00423098|364180133|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105595262|NCT00423098|364180134|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105595263|NCT00423098|364180133|FG000|Overall Study|Administrative problems|0|||
105595264|NCT00423098|364180134|FG001|Overall Study|Administrative problems|1|||
105595265|NCT00423098|364180133|FG000|Overall Study|Death|2|||
105595266|NCT00423098|364180134|FG001|Overall Study|Death|0|||
105595267|NCT04035668|364180135|FG000|Overall Study|Adverse Event|3|||
105595268|NCT04035668|364180136|FG001|Overall Study|Adverse Event|4|||
105595269|NCT04035668|364180137|FG002|Overall Study|Adverse Event|2|||
105595270|NCT04035668|364180135|FG000|Overall Study|Lost to Follow-up|0|||
105595271|NCT04035668|364180136|FG001|Overall Study|Lost to Follow-up|1|||
105595272|NCT04035668|364180137|FG002|Overall Study|Lost to Follow-up|0|||
105595273|NCT04035668|364180135|FG000|Overall Study|Physician Decision|2|||
105595274|NCT04035668|364180136|FG001|Overall Study|Physician Decision|1|||
105595275|NCT04035668|364180137|FG002|Overall Study|Physician Decision|1|||
105595276|NCT04035668|364180135|FG000|Overall Study|Subject Decision|2|||
105595277|NCT04035668|364180136|FG001|Overall Study|Subject Decision|2|||
105595278|NCT04035668|364180137|FG002|Overall Study|Subject Decision|0|||
105595279|NCT04480827|364180139|FG000|Overall Study|Adverse Event|0|||
105595280|NCT04480827|364180140|FG001|Overall Study|Adverse Event|0|||
105595281|NCT04480827|364180141|FG002|Overall Study|Adverse Event|0|||
105595282|NCT04480827|364180142|FG003|Overall Study|Adverse Event|0|||
105595283|NCT04480827|364180143|FG004|Overall Study|Adverse Event|0|||
105595284|NCT04480827|364180144|FG005|Overall Study|Adverse Event|1|||
105595285|NCT04480827|364180145|FG006|Overall Study|Adverse Event|0|||
105595286|NCT00465816|364180146|FG000|Overall Study|Lost to Follow-up|0|||
105595287|NCT00465816|364180147|FG001|Overall Study|Lost to Follow-up|0|||
105595288|NCT00465816|364180148|FG002|Overall Study|Lost to Follow-up|2|||
105595289|NCT02983617|364180152|FG000|Overall Study|Adverse Event|0|||
105595290|NCT02983617|364180153|FG001|Overall Study|Adverse Event|7|||
105595291|NCT02983617|364180152|FG000|Overall Study|Death|0|||
105595292|NCT02983617|364180153|FG001|Overall Study|Death|1|||
105595293|NCT02983617|364180152|FG000|Overall Study|Investigator's Discretion|0|||
105595294|NCT02983617|364180153|FG001|Overall Study|Investigator's Discretion|1|||
105595295|NCT02027558|364180156|FG000|Overall Study|Death|0|||
105595296|NCT02027558|364180157|FG001|Overall Study|Death|1|||
105595297|NCT02027558|364180156|FG000|Overall Study|Withdrawal by Subject|2|||
105595298|NCT02027558|364180157|FG001|Overall Study|Withdrawal by Subject|0|||
105595299|NCT02027558|364180156|FG000|Overall Study|Lost to Follow-up|4|||
105595300|NCT02027558|364180157|FG001|Overall Study|Lost to Follow-up|1|||
105536083|NCT02346240|363966852|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536084|NCT02346240|363966853|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536085|NCT02346240|363966854|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
105536086|NCT02346240|363966855|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536087|NCT02346240|363966856|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536088|NCT02346240|363966857|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536089|NCT02346240|363966858|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536090|NCT02346240|363966859|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536091|NCT02346240|363966860|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536092|NCT02346240|363966861|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536093|NCT02346240|363966862|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536094|NCT02346240|363966863|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536095|NCT02346240|363966864|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536096|NCT02346240|363966865|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536097|NCT02346240|363966866|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536098|NCT02346240|363966867|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536099|NCT02346240|363966868|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536100|NCT02346240|363966869|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536101|NCT02346240|363966870|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536102|NCT02346240|363966871|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536103|NCT02346240|363966872|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536104|NCT02346240|363966873|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536105|NCT02346240|363966874|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536106|NCT02346240|363966875|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
105536107|NCT02346240|363966852|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536108|NCT02346240|363966853|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536109|NCT02346240|363966854|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536110|NCT02346240|363966855|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536111|NCT02346240|363966856|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536112|NCT02346240|363966857|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536113|NCT02346240|363966858|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536114|NCT02346240|363966859|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
105536115|NCT02346240|363966860|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
105536116|NCT02346240|363966861|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536117|NCT02346240|363966862|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536118|NCT02346240|363966863|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536119|NCT02346240|363966864|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536120|NCT02346240|363966865|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
105536121|NCT02346240|363966866|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
105536122|NCT02346240|363966867|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
105536123|NCT02346240|363966868|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
105536124|NCT02346240|363966869|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536125|NCT02346240|363966870|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536126|NCT02346240|363966871|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536127|NCT02346240|363966872|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536128|NCT02346240|363966873|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536129|NCT02346240|363966874|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536130|NCT02346240|363966875|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105536131|NCT02346240|363966852|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536132|NCT02346240|363966853|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536133|NCT02346240|363966854|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536134|NCT02346240|363966855|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536135|NCT02346240|363966856|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536136|NCT02346240|363966857|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536137|NCT02346240|363966858|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536138|NCT02346240|363966859|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536139|NCT02346240|363966860|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536140|NCT02346240|363966861|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536141|NCT02346240|363966862|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536142|NCT02346240|363966863|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536143|NCT02346240|363966864|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536144|NCT02346240|363966865|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
105536145|NCT02346240|363966866|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536146|NCT02346240|363966867|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
105595301|NCT02027558|364180156|FG000|Overall Study|Refused assessment|3|||
105595302|NCT02027558|364180157|FG001|Overall Study|Refused assessment|0|||
105595303|NCT03720210|364180162|FG000|Overall Study|Lost to Follow-up|1|||
105595304|NCT00516386|364180163|FG000|Overall Study|not interested in the study|4|||
105595305|NCT00516386|364180163|FG000|Overall Study|Lost to Follow-up|2|||
105595306|NCT00703911|364180164|FG000|Overall Study|Death|1|||
105595307|NCT00703911|364180164|FG000|Overall Study|Physician Decision|6|||
105595308|NCT00703911|364180164|FG000|Overall Study|Lost to Follow-up|1|||
105595309|NCT00703911|364180164|FG000|Overall Study|Withdrawal by Subject|2|||
105595310|NCT02139046|364180165|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
105595311|NCT02139046|364180166|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
105595312|NCT02139046|364180167|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
105595313|NCT02139046|364180168|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
105595314|NCT02139046|364180169|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
105595315|NCT02139046|364180165|FG000|Overall Study|Major Protocol Deviation|9|||
105595316|NCT02139046|364180166|FG001|Overall Study|Major Protocol Deviation|10|||
105595317|NCT02139046|364180167|FG002|Overall Study|Major Protocol Deviation|16|||
105595318|NCT02139046|364180168|FG003|Overall Study|Major Protocol Deviation|12|||
105595319|NCT02139046|364180169|FG004|Overall Study|Major Protocol Deviation|6|||
105595320|NCT02139046|364180165|FG000|Overall Study|Lost to Follow-up|13|||
105595321|NCT02139046|364180166|FG001|Overall Study|Lost to Follow-up|16|||
105595322|NCT02139046|364180167|FG002|Overall Study|Lost to Follow-up|16|||
105595323|NCT02139046|364180168|FG003|Overall Study|Lost to Follow-up|18|||
105595324|NCT02139046|364180169|FG004|Overall Study|Lost to Follow-up|13|||
105595325|NCT02139046|364180165|FG000|Overall Study|Voluntary Withdrawal|20|||
105595326|NCT02139046|364180166|FG001|Overall Study|Voluntary Withdrawal|8|||
105595327|NCT02139046|364180167|FG002|Overall Study|Voluntary Withdrawal|10|||
105595328|NCT02139046|364180168|FG003|Overall Study|Voluntary Withdrawal|15|||
105595329|NCT02139046|364180169|FG004|Overall Study|Voluntary Withdrawal|16|||
105595330|NCT02139046|364180165|FG000|Overall Study|Lack of Efficacy|0|||
105595331|NCT02139046|364180166|FG001|Overall Study|Lack of Efficacy|1|||
105595332|NCT02139046|364180167|FG002|Overall Study|Lack of Efficacy|2|||
105595333|NCT02139046|364180168|FG003|Overall Study|Lack of Efficacy|1|||
105595334|NCT02139046|364180169|FG004|Overall Study|Lack of Efficacy|2|||
105595335|NCT02139046|364180165|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
105595336|NCT02139046|364180166|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
105595337|NCT02139046|364180167|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
105595338|NCT02139046|364180168|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
105595339|NCT02139046|364180169|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
105595340|NCT02139046|364180165|FG000|Overall Study|Other Miscellaneous Reasons|10|||
105595341|NCT02139046|364180166|FG001|Overall Study|Other Miscellaneous Reasons|9|||
105595342|NCT02139046|364180167|FG002|Overall Study|Other Miscellaneous Reasons|4|||
105595343|NCT02139046|364180168|FG003|Overall Study|Other Miscellaneous Reasons|9|||
105536147|NCT02346240|363966868|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536148|NCT02346240|363966869|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536149|NCT02346240|363966870|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536150|NCT02346240|363966871|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536151|NCT02346240|363966872|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536152|NCT02346240|363966873|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536153|NCT02346240|363966874|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536154|NCT02346240|363966875|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105536155|NCT02346240|363966852|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536156|NCT02346240|363966853|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536157|NCT02346240|363966854|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536158|NCT02346240|363966855|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536159|NCT02346240|363966856|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536160|NCT02346240|363966857|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536161|NCT02346240|363966858|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536162|NCT02346240|363966859|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536163|NCT02346240|363966860|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105595344|NCT02139046|364180169|FG004|Overall Study|Other Miscellaneous Reasons|12|||
105595345|NCT00393848|364180170|FG000|Overall Study|Surgical schedule|0|||
105595346|NCT00393848|364180171|FG001|Overall Study|Surgical schedule|0|||
105595347|NCT00393848|364180172|FG002|Overall Study|Surgical schedule|0|||
105595348|NCT00393848|364180173|FG003|Overall Study|Surgical schedule|1|||
105595349|NCT00393848|364180170|FG000|Overall Study|Personal reasons|0|||
105595350|NCT00393848|364180171|FG001|Overall Study|Personal reasons|0|||
105595351|NCT00393848|364180172|FG002|Overall Study|Personal reasons|2|||
105595352|NCT00393848|364180173|FG003|Overall Study|Personal reasons|0|||
105536164|NCT02346240|363966861|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536165|NCT02346240|363966862|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536166|NCT02346240|363966863|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536167|NCT02346240|363966864|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536168|NCT02346240|363966865|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536169|NCT02346240|363966866|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
105536170|NCT02346240|363966867|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536171|NCT02346240|363966868|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536172|NCT02346240|363966869|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536173|NCT02346240|363966870|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536174|NCT02346240|363966871|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536175|NCT02346240|363966872|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536176|NCT02346240|363966873|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536177|NCT02346240|363966874|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536178|NCT02346240|363966875|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105536179|NCT02346240|363966852|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105536180|NCT02346240|363966853|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105536181|NCT02346240|363966854|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105536182|NCT02346240|363966855|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105536183|NCT02346240|363966856|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105536184|NCT02346240|363966857|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105536185|NCT02346240|363966858|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105536186|NCT02346240|363966859|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105536187|NCT02346240|363966860|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105536188|NCT02346240|363966861|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105536189|NCT02346240|363966862|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105536190|NCT02346240|363966863|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
105536191|NCT02346240|363966864|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105536192|NCT02346240|363966865|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
105536193|NCT02346240|363966866|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
105536194|NCT02346240|363966867|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
105536195|NCT02346240|363966868|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105536196|NCT02346240|363966869|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105536197|NCT02346240|363966870|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105536198|NCT02346240|363966871|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105536199|NCT02346240|363966872|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105536200|NCT02346240|363966873|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105536201|NCT02346240|363966874|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105536202|NCT02346240|363966875|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105536203|NCT02346240|363966852|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536204|NCT02346240|363966853|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536205|NCT02346240|363966854|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536206|NCT02346240|363966855|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536207|NCT02346240|363966856|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536208|NCT02346240|363966857|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536209|NCT02346240|363966858|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536210|NCT02346240|363966859|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536211|NCT02346240|363966860|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536212|NCT02346240|363966861|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536213|NCT02346240|363966862|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536214|NCT02346240|363966863|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536215|NCT02346240|363966864|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536216|NCT02346240|363966865|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
105536217|NCT02346240|363966866|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
105536218|NCT02346240|363966867|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
105536219|NCT02346240|363966868|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
105536220|NCT02346240|363966869|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105595353|NCT00549848|364180177|FG000|Overall Study|Death|1|||
105536221|NCT02346240|363966870|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105595354|NCT00549848|364180178|FG001|Overall Study|Death|4|||
105595355|NCT00549848|364180179|FG002|Overall Study|Death|13|||
105595356|NCT00549848|364180177|FG000|Overall Study|Physician Decision|0|||
105595357|NCT00549848|364180178|FG001|Overall Study|Physician Decision|0|||
105536222|NCT02346240|363966871|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536223|NCT02346240|363966872|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536224|NCT02346240|363966873|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536225|NCT02346240|363966874|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536226|NCT02346240|363966875|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105536227|NCT02346240|363966852|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536228|NCT02346240|363966853|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536229|NCT02346240|363966854|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536230|NCT02346240|363966855|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536231|NCT02346240|363966856|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536232|NCT02346240|363966857|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536233|NCT02346240|363966858|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
105536234|NCT02346240|363966859|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536235|NCT02346240|363966860|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536236|NCT02346240|363966861|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536237|NCT02346240|363966862|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536238|NCT02346240|363966863|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536239|NCT02346240|363966864|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536240|NCT02346240|363966865|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536241|NCT02346240|363966866|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536242|NCT02346240|363966867|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536243|NCT02346240|363966868|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536244|NCT02346240|363966869|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536245|NCT02346240|363966870|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536246|NCT02346240|363966871|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536247|NCT02346240|363966872|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536248|NCT02346240|363966873|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536249|NCT02346240|363966874|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536250|NCT02346240|363966875|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
105536251|NCT02346240|363966852|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536252|NCT02346240|363966853|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536253|NCT02346240|363966854|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536254|NCT02346240|363966855|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536255|NCT02346240|363966856|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536256|NCT02346240|363966857|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536257|NCT02346240|363966858|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536258|NCT02346240|363966859|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536259|NCT02346240|363966860|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
105536260|NCT02346240|363966861|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536261|NCT02346240|363966862|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536262|NCT02346240|363966863|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
105536263|NCT02346240|363966864|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536264|NCT02346240|363966865|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
105536265|NCT02346240|363966866|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
105536266|NCT02346240|363966867|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536267|NCT02346240|363966868|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536268|NCT02346240|363966869|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536269|NCT02346240|363966870|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536270|NCT02346240|363966871|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536271|NCT02346240|363966872|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536272|NCT02346240|363966873|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536273|NCT02346240|363966874|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536274|NCT02346240|363966875|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
105536275|NCT02346240|363966852|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536276|NCT02346240|363966853|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536277|NCT02346240|363966854|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536278|NCT02346240|363966855|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536279|NCT02346240|363966856|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536280|NCT02346240|363966857|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536281|NCT02346240|363966858|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536282|NCT02346240|363966859|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536283|NCT02346240|363966860|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536284|NCT02346240|363966861|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
105536285|NCT02346240|363966862|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536286|NCT02346240|363966863|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536287|NCT02346240|363966864|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536288|NCT02346240|363966865|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536289|NCT02346240|363966866|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536290|NCT02346240|363966867|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536291|NCT02346240|363966868|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536292|NCT02346240|363966869|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536293|NCT02346240|363966870|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536294|NCT02346240|363966871|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536295|NCT02346240|363966872|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536296|NCT02346240|363966873|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536297|NCT02346240|363966874|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536298|NCT02346240|363966875|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
105536299|NCT02346240|363966852|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536300|NCT02346240|363966853|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536301|NCT02346240|363966854|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536302|NCT02346240|363966855|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536303|NCT02346240|363966856|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536304|NCT02346240|363966857|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536305|NCT02346240|363966858|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536306|NCT02346240|363966859|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536307|NCT02346240|363966860|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536308|NCT02346240|363966861|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536309|NCT02346240|363966862|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
105536310|NCT02346240|363966863|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536311|NCT02346240|363966864|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536312|NCT02346240|363966865|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536313|NCT02346240|363966866|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536314|NCT02346240|363966867|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536315|NCT02346240|363966868|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536316|NCT02346240|363966869|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536317|NCT02346240|363966870|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536318|NCT02346240|363966871|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536319|NCT02346240|363966872|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536320|NCT02346240|363966873|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536321|NCT02346240|363966874|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536322|NCT02346240|363966875|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
105536323|NCT02346240|363966852|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536324|NCT02346240|363966853|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536325|NCT02346240|363966854|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536326|NCT02346240|363966855|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536327|NCT02346240|363966856|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536328|NCT02346240|363966857|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536329|NCT02346240|363966858|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105595358|NCT00549848|364180179|FG002|Overall Study|Physician Decision|4|||
105595359|NCT00549848|364180177|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
105595360|NCT00549848|364180178|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
105595361|NCT00549848|364180179|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
105595362|NCT00549848|364180177|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
105595363|NCT00549848|364180178|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
105595364|NCT00549848|364180179|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
105595365|NCT00549848|364180177|FG000|Overall Study|Participant/Family Withdraw|2|||
105595366|NCT00549848|364180178|FG001|Overall Study|Participant/Family Withdraw|3|||
105595367|NCT00549848|364180179|FG002|Overall Study|Participant/Family Withdraw|5|||
105595368|NCT00549848|364180177|FG000|Overall Study|Second Malignancy|1|||
105536330|NCT02346240|363966859|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536331|NCT02346240|363966860|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536332|NCT02346240|363966861|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536333|NCT02346240|363966862|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536334|NCT02346240|363966863|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536335|NCT02346240|363966864|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536336|NCT02346240|363966865|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536337|NCT02346240|363966866|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
105536338|NCT02346240|363966867|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536339|NCT02346240|363966868|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536340|NCT02346240|363966869|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536341|NCT02346240|363966870|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536342|NCT02346240|363966871|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536343|NCT02346240|363966872|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536344|NCT02346240|363966873|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536345|NCT02346240|363966874|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536346|NCT02346240|363966875|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
105536347|NCT02346240|363966852|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536348|NCT02346240|363966853|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536349|NCT02346240|363966854|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536350|NCT02346240|363966855|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536351|NCT02346240|363966856|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105595369|NCT00549848|364180178|FG001|Overall Study|Second Malignancy|0|||
105595370|NCT00549848|364180179|FG002|Overall Study|Second Malignancy|0|||
105595371|NCT00549848|364180177|FG000|Overall Study|Transplant|3|||
105595372|NCT00549848|364180178|FG001|Overall Study|Transplant|3|||
105595373|NCT00549848|364180179|FG002|Overall Study|Transplant|18|||
105595374|NCT00549848|364180177|FG000|Overall Study|Unacceptable Toxicity|1|||
105595375|NCT00549848|364180178|FG001|Overall Study|Unacceptable Toxicity|6|||
105595376|NCT00549848|364180179|FG002|Overall Study|Unacceptable Toxicity|6|||
105595377|NCT01456936|364180182|FG000|Overall Study|Other reason|41|||
105595378|NCT01456936|364180183|FG001|Overall Study|Other reason|30|||
105595379|NCT01456936|364180184|FG002|Overall Study|Other reason|36|||
105595380|NCT01456936|364180185|FG003|Overall Study|Other reason|33|||
105595381|NCT01456936|364180182|FG000|Overall Study|No longer meets eligibility criteria|4|||
105595382|NCT01456936|364180183|FG001|Overall Study|No longer meets eligibility criteria|8|||
105595383|NCT01456936|364180184|FG002|Overall Study|No longer meets eligibility criteria|6|||
105595384|NCT01456936|364180185|FG003|Overall Study|No longer meets eligibility criteria|5|||
105595385|NCT01456936|364180182|FG000|Overall Study|Protocol Violation|4|||
105595386|NCT01456936|364180183|FG001|Overall Study|Protocol Violation|2|||
105595387|NCT01456936|364180184|FG002|Overall Study|Protocol Violation|5|||
105595388|NCT01456936|364180185|FG003|Overall Study|Protocol Violation|5|||
105595389|NCT01456936|364180182|FG000|Overall Study|Pregnancy|1|||
105595390|NCT01456936|364180183|FG001|Overall Study|Pregnancy|0|||
105595391|NCT01456936|364180184|FG002|Overall Study|Pregnancy|0|||
105595392|NCT01456936|364180185|FG003|Overall Study|Pregnancy|1|||
105595393|NCT01456936|364180182|FG000|Overall Study|Insufficient clinical response|4|||
105595394|NCT01456936|364180183|FG001|Overall Study|Insufficient clinical response|4|||
105595395|NCT01456936|364180184|FG002|Overall Study|Insufficient clinical response|14|||
105595396|NCT01456936|364180185|FG003|Overall Study|Insufficient clinical response|13|||
105595397|NCT01456936|364180182|FG000|Overall Study|No longer willing to participate|195|||
105595398|NCT01456936|364180183|FG001|Overall Study|No longer willing to participate|218|||
105595399|NCT01456936|364180184|FG002|Overall Study|No longer willing to participate|224|||
105595400|NCT01456936|364180185|FG003|Overall Study|No longer willing to participate|248|||
105595401|NCT01456936|364180182|FG000|Overall Study|Lost to Follow-up|135|||
105595402|NCT01456936|364180183|FG001|Overall Study|Lost to Follow-up|126|||
105595403|NCT01456936|364180184|FG002|Overall Study|Lost to Follow-up|144|||
105595404|NCT01456936|364180185|FG003|Overall Study|Lost to Follow-up|127|||
105595405|NCT01456936|364180182|FG000|Overall Study|Medication error|0|||
105595406|NCT01456936|364180183|FG001|Overall Study|Medication error|1|||
105595407|NCT01456936|364180184|FG002|Overall Study|Medication error|0|||
105595408|NCT01456936|364180185|FG003|Overall Study|Medication error|1|||
105595409|NCT01456936|364180182|FG000|Overall Study|Adverse event (study drug)|25|||
105595410|NCT01456936|364180183|FG001|Overall Study|Adverse event (study drug)|21|||
105595411|NCT01456936|364180184|FG002|Overall Study|Adverse event (study drug)|26|||
105536352|NCT02346240|363966857|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536353|NCT02346240|363966858|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536354|NCT02346240|363966859|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536355|NCT02346240|363966860|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536356|NCT02346240|363966861|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536357|NCT02346240|363966862|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536358|NCT02346240|363966863|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536359|NCT02346240|363966864|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536360|NCT02346240|363966865|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536361|NCT02346240|363966866|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
105536362|NCT02346240|363966867|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536363|NCT02346240|363966868|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536364|NCT02346240|363966869|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536365|NCT02346240|363966870|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536366|NCT02346240|363966871|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536367|NCT02346240|363966872|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536368|NCT02346240|363966873|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536369|NCT02346240|363966874|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536370|NCT02346240|363966875|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
105536371|NCT02346240|363966852|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536372|NCT02346240|363966853|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536373|NCT02346240|363966854|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536374|NCT02346240|363966855|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536375|NCT02346240|363966856|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536376|NCT02346240|363966857|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536377|NCT02346240|363966858|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536378|NCT02346240|363966859|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536379|NCT02346240|363966860|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536380|NCT02346240|363966861|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536381|NCT02346240|363966862|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536382|NCT02346240|363966863|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536383|NCT02346240|363966864|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536384|NCT02346240|363966865|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536385|NCT02346240|363966866|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
105536386|NCT02346240|363966867|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536387|NCT02346240|363966868|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536388|NCT02346240|363966869|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536389|NCT02346240|363966870|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536390|NCT02346240|363966871|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536391|NCT02346240|363966872|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536392|NCT02346240|363966873|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536393|NCT02346240|363966874|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536394|NCT02346240|363966875|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
105536395|NCT02346240|363966852|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536396|NCT02346240|363966853|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536397|NCT02346240|363966854|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536398|NCT02346240|363966855|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536399|NCT02346240|363966856|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536400|NCT02346240|363966857|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536401|NCT02346240|363966858|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536402|NCT02346240|363966859|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536403|NCT02346240|363966860|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536404|NCT02346240|363966861|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536405|NCT02346240|363966862|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105595412|NCT01456936|364180185|FG003|Overall Study|Adverse event (study drug)|17|||
105595413|NCT01456936|364180182|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
105595414|NCT01456936|364180183|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
105595415|NCT01456936|364180184|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
105536406|NCT02346240|363966863|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536407|NCT02346240|363966864|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536408|NCT02346240|363966865|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536409|NCT02346240|363966866|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536410|NCT02346240|363966867|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536411|NCT02346240|363966868|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
105536412|NCT02346240|363966869|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
105536413|NCT02346240|363966870|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
105536414|NCT02346240|363966871|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
105536415|NCT02346240|363966872|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
105536416|NCT02346240|363966873|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
105536417|NCT02346240|363966874|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
105536418|NCT02346240|363966875|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
105536419|NCT02346240|363966852|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536420|NCT02346240|363966853|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536421|NCT02346240|363966854|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536422|NCT02346240|363966855|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536423|NCT02346240|363966856|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536424|NCT02346240|363966857|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536425|NCT02346240|363966858|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536426|NCT02346240|363966859|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536427|NCT02346240|363966860|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536428|NCT02346240|363966861|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536429|NCT02346240|363966862|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536430|NCT02346240|363966863|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536431|NCT02346240|363966864|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536432|NCT02346240|363966865|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536433|NCT02346240|363966866|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536434|NCT02346240|363966867|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536435|NCT02346240|363966868|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536436|NCT02346240|363966869|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536437|NCT02346240|363966870|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
105536438|NCT02346240|363966871|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
105536439|NCT02346240|363966872|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536440|NCT02346240|363966873|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
105536441|NCT02346240|363966874|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536442|NCT02346240|363966875|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
105536443|NCT02346240|363966852|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536444|NCT02346240|363966853|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536445|NCT02346240|363966854|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536446|NCT02346240|363966855|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536447|NCT02346240|363966856|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536448|NCT02346240|363966857|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536449|NCT02346240|363966858|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536450|NCT02346240|363966859|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536451|NCT02346240|363966860|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536452|NCT02346240|363966861|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536453|NCT02346240|363966862|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536454|NCT02346240|363966863|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536455|NCT02346240|363966864|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536456|NCT02346240|363966865|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536457|NCT02346240|363966866|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536458|NCT02346240|363966867|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536459|NCT02346240|363966868|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536460|NCT02346240|363966869|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536461|NCT02346240|363966870|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
105536462|NCT02346240|363966871|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536463|NCT02346240|363966872|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536464|NCT02346240|363966873|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
105536465|NCT02346240|363966874|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536466|NCT02346240|363966875|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105536467|NCT02346240|363966852|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536468|NCT02346240|363966853|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536469|NCT02346240|363966854|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536470|NCT02346240|363966855|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536471|NCT02346240|363966856|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536472|NCT02346240|363966857|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536473|NCT02346240|363966858|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536474|NCT02346240|363966859|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536475|NCT02346240|363966860|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536476|NCT02346240|363966861|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536477|NCT02346240|363966862|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536478|NCT02346240|363966863|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536479|NCT02346240|363966864|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536480|NCT02346240|363966865|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536481|NCT02346240|363966866|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536482|NCT02346240|363966867|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536483|NCT02346240|363966868|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536484|NCT02346240|363966869|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536485|NCT02346240|363966870|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536486|NCT02346240|363966871|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536487|NCT02346240|363966872|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536488|NCT02346240|363966873|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
105536489|NCT02346240|363966874|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536490|NCT02346240|363966875|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
105536491|NCT02346240|363966852|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536492|NCT02346240|363966853|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536493|NCT02346240|363966854|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536494|NCT02346240|363966855|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536495|NCT02346240|363966856|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536496|NCT02346240|363966857|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536497|NCT02346240|363966858|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536498|NCT02346240|363966859|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536499|NCT02346240|363966860|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536500|NCT02346240|363966861|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536501|NCT02346240|363966862|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536502|NCT02346240|363966863|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536503|NCT02346240|363966864|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536504|NCT02346240|363966865|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536505|NCT02346240|363966866|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536506|NCT02346240|363966867|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536507|NCT02346240|363966868|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536508|NCT02346240|363966869|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
105536509|NCT02346240|363966870|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
105536510|NCT02346240|363966871|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
105536511|NCT02346240|363966872|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105536512|NCT02346240|363966873|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
105536513|NCT02346240|363966874|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
105536514|NCT02346240|363966875|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
105536515|NCT02346240|363966852|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536516|NCT02346240|363966853|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536517|NCT02346240|363966854|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536518|NCT02346240|363966855|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536519|NCT02346240|363966856|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536520|NCT02346240|363966857|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536521|NCT02346240|363966858|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536522|NCT02346240|363966859|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536523|NCT02346240|363966860|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536524|NCT02346240|363966861|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536525|NCT02346240|363966862|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536526|NCT02346240|363966863|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536527|NCT02346240|363966864|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536528|NCT02346240|363966865|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536529|NCT02346240|363966866|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536530|NCT02346240|363966867|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536531|NCT02346240|363966868|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536532|NCT02346240|363966869|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536533|NCT02346240|363966870|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
105536534|NCT02346240|363966871|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
105536535|NCT02346240|363966872|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105536536|NCT02346240|363966873|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
105536537|NCT02346240|363966874|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
105536538|NCT02346240|363966875|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
105536539|NCT02346240|363966852|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536540|NCT02346240|363966853|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536541|NCT02346240|363966854|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536542|NCT02346240|363966855|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536543|NCT02346240|363966856|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536544|NCT02346240|363966857|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536545|NCT02346240|363966858|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536546|NCT02346240|363966859|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536547|NCT02346240|363966860|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536548|NCT02346240|363966861|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536549|NCT02346240|363966862|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536550|NCT02346240|363966863|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536551|NCT02346240|363966864|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536552|NCT02346240|363966865|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536553|NCT02346240|363966866|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536554|NCT02346240|363966867|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536555|NCT02346240|363966868|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536556|NCT02346240|363966869|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536557|NCT02346240|363966870|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
105536558|NCT02346240|363966871|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536559|NCT02346240|363966872|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
105536560|NCT02346240|363966873|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
105536561|NCT02346240|363966874|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
105536562|NCT02346240|363966875|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
105536563|NCT02346240|363966852|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536564|NCT02346240|363966853|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536565|NCT02346240|363966854|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536566|NCT02346240|363966855|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536567|NCT02346240|363966856|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536568|NCT02346240|363966857|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536569|NCT02346240|363966858|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536570|NCT02346240|363966859|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536571|NCT02346240|363966860|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536572|NCT02346240|363966861|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536573|NCT02346240|363966862|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536574|NCT02346240|363966863|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536575|NCT02346240|363966864|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536576|NCT02346240|363966865|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536577|NCT02346240|363966866|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536578|NCT02346240|363966867|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536579|NCT02346240|363966868|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536580|NCT02346240|363966869|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536581|NCT02346240|363966870|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
105536582|NCT02346240|363966871|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536583|NCT02346240|363966872|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536584|NCT02346240|363966873|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536585|NCT02346240|363966874|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536586|NCT02346240|363966875|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
105536587|NCT03306264|363966876|FG000|Overall Study|Death|33|||
105536588|NCT03306264|363966877|FG001|Overall Study|Death|25|||
105536589|NCT03306264|363966878|FG002|Overall Study|Death|34|||
105536590|NCT03306264|363966879|FG003|Overall Study|Death|34|||
105536591|NCT03306264|363966876|FG000|Overall Study|Complete Consent Withdrawal|4|||
105536592|NCT03306264|363966877|FG001|Overall Study|Complete Consent Withdrawal|4|||
105536593|NCT03306264|363966878|FG002|Overall Study|Complete Consent Withdrawal|1|||
105536594|NCT03306264|363966879|FG003|Overall Study|Complete Consent Withdrawal|8|||
105536595|NCT03306264|363966876|FG000|Overall Study|Lost to Follow-up|1|||
105536596|NCT03306264|363966877|FG001|Overall Study|Lost to Follow-up|0|||
105536597|NCT03306264|363966878|FG002|Overall Study|Lost to Follow-up|1|||
105536598|NCT03306264|363966879|FG003|Overall Study|Lost to Follow-up|0|||
105536599|NCT03306264|363966876|FG000|Overall Study|Rollover to ASTX727-06|10|||
105536600|NCT03306264|363966877|FG001|Overall Study|Rollover to ASTX727-06|18|||
105536601|NCT03306264|363966878|FG002|Overall Study|Rollover to ASTX727-06|4|||
105536602|NCT03306264|363966879|FG003|Overall Study|Rollover to ASTX727-06|2|||
105536603|NCT03306264|363966876|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
105536604|NCT03306264|363966877|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
105536605|NCT03306264|363966878|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
105536606|NCT03306264|363966879|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
105536607|NCT01849588|363966880|FG000|Overall Study|Lack of Efficacy|3|||
105536608|NCT00458484|363966885|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
105536609|NCT00458484|363966886|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
105536610|NCT00458484|363966887|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
105536611|NCT00458484|363966888|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
105536612|NCT00458484|363966889|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
105536613|NCT00458484|363966890|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
105536614|NCT00458484|363966891|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
105536615|NCT02253810|363966893|FG000|Overall Study|Withdrawal by Subject|2|||
105536616|NCT02253810|363966894|FG001|Overall Study|Withdrawal by Subject|1|||
105536617|NCT02253810|363966893|FG000|Overall Study|Unknown concomitant procedure|3|||
105536618|NCT02253810|363966894|FG001|Overall Study|Unknown concomitant procedure|2|||
105536619|NCT00854581|363966895|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
105536620|NCT00854581|363966895|FG000|Induction (Up to Day 21)|Death|1|||
105536621|NCT00854581|363966895|FG000|Induction (Up to Day 21)|Physician Decision|1|||
105536622|NCT00854581|363966895|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
105536623|NCT00806546|363966901|FG000|Overall Study|Enrolled, not treated|35|||
105536624|NCT00806546|363966901|FG000|Overall Study|Lost to Follow-up|32|||
105536625|NCT00806546|363966901|FG000|Overall Study|Adverse Event|74|||
105536626|NCT00806546|363966901|FG000|Overall Study|Withdrawal by Subject|75|||
105536627|NCT00806546|363966901|FG000|Overall Study|Protocol Violation|49|||
105536628|NCT00806546|363966901|FG000|Overall Study|Various|42|||
105536629|NCT03385239|363966909|FG000|Overall Study|Voluntary Withdrawal|2|||
105536630|NCT03385239|363966910|FG001|Overall Study|Voluntary Withdrawal|3|||
105536631|NCT03385239|363966911|FG002|Overall Study|Voluntary Withdrawal|2|||
105536632|NCT03385239|363966912|FG003|Overall Study|Voluntary Withdrawal|3|||
105536633|NCT03385239|363966913|FG004|Overall Study|Voluntary Withdrawal|0|||
105536634|NCT03385239|363966909|FG000|Overall Study|Adverse Event|0|||
105536635|NCT03385239|363966910|FG001|Overall Study|Adverse Event|0|||
105536636|NCT03385239|363966911|FG002|Overall Study|Adverse Event|1|||
105536637|NCT03385239|363966912|FG003|Overall Study|Adverse Event|0|||
105536638|NCT03385239|363966913|FG004|Overall Study|Adverse Event|0|||
105536639|NCT03385239|363966909|FG000|Overall Study|Other|0|||
105536640|NCT03385239|363966910|FG001|Overall Study|Other|0|||
105536641|NCT03385239|363966911|FG002|Overall Study|Other|0|||
105536642|NCT03385239|363966912|FG003|Overall Study|Other|1|||
105536643|NCT03385239|363966913|FG004|Overall Study|Other|0|||
105536644|NCT00308711|363966914|FG000|Overall Study|Withdrawal by Subject|1|||
105536645|NCT00308711|363966915|FG001|Overall Study|Withdrawal by Subject|0|||
105536646|NCT00308711|363966916|FG002|Overall Study|Withdrawal by Subject|1|||
105536647|NCT00308711|363966914|FG000|Overall Study|Protocol Violation|0|||
105536648|NCT00308711|363966915|FG001|Overall Study|Protocol Violation|1|||
105536649|NCT00308711|363966916|FG002|Overall Study|Protocol Violation|1|||
105536650|NCT00308711|363966914|FG000|Overall Study|Lost to Follow-up|0|||
105536651|NCT00308711|363966915|FG001|Overall Study|Lost to Follow-up|1|||
105536652|NCT00308711|363966916|FG002|Overall Study|Lost to Follow-up|0|||
105536653|NCT00308711|363966914|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
105536654|NCT00308711|363966915|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
105536655|NCT00308711|363966916|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
105536656|NCT00308711|363966914|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
105536657|NCT00308711|363966915|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
105536658|NCT00308711|363966916|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
105536659|NCT00096044|363966917|FG000|Overall Study|Withdrawal by Subject|9|||
105536660|NCT00096044|363966917|FG000|Overall Study|Adverse Event|21|||
105536661|NCT00096044|363966917|FG000|Overall Study|Disease Progression|4|||
105536662|NCT03149237|363966918|FG000|Overall Study|Withdrawal by Subject|4|||
105536663|NCT03149237|363966919|FG001|Overall Study|Withdrawal by Subject|5|||
105536664|NCT02167256|363966920|FG000|Overall Study|Adverse Event|13|||
105536665|NCT02167256|363966921|FG001|Overall Study|Adverse Event|6|||
105536666|NCT02167256|363966920|FG000|Overall Study|Withdrawal by Subject|4|||
105536667|NCT02167256|363966921|FG001|Overall Study|Withdrawal by Subject|4|||
105536668|NCT02167256|363966920|FG000|Overall Study|non-compliance|3|||
105536669|NCT02167256|363966921|FG001|Overall Study|non-compliance|0|||
105536670|NCT02167256|363966920|FG000|Overall Study|Study partner unable to participate|1|||
105536671|NCT02167256|363966921|FG001|Overall Study|Study partner unable to participate|0|||
105536672|NCT03139916|363966922|FG000|Overall Study|Withdrawal by Subject|2|||
105536673|NCT03139916|363966922|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
105536674|NCT01957475|363966923|FG000|Test Period 1|Withdrawal by Subject|1|||
105536675|NCT01957475|363966924|FG001|Test Period 1|Withdrawal by Subject|0|||
105536676|NCT01957475|363966923|FG000|Test Period 1|Other|1|||
105536677|NCT01957475|363966924|FG001|Test Period 1|Other|0|||
105536678|NCT01957475|363966923|FG000|Test Period 1|Lack of Efficacy|0|||
105536679|NCT01957475|363966924|FG001|Test Period 1|Lack of Efficacy|1|||
105536680|NCT01957475|363966923|FG000|Test Period 2|Adverse Event|1|||
105536681|NCT01957475|363966924|FG001|Test Period 2|Adverse Event|0|||
105536682|NCT04587193|363966925|FG000|Overall Study|Screen failure after consent|3|||
105536683|NCT04587193|363966926|FG001|Overall Study|Screen failure after consent|0|||
105536684|NCT04587193|363966925|FG000|Overall Study|Device broke during study|3|||
105536685|NCT04587193|363966926|FG001|Overall Study|Device broke during study|2|||
105536686|NCT04740034|363966927|FG000|Overall Study|Death|0|||
105536687|NCT04740034|363966928|FG001|Overall Study|Death|1|||
105536688|NCT04740034|363966929|FG002|Overall Study|Death|2|||
105536689|NCT04740034|363966930|FG003|Overall Study|Death|3|||
105536690|NCT04740034|363966931|FG004|Overall Study|Death|4|||
105536691|NCT04740034|363966932|FG005|Overall Study|Death|4|||
105536692|NCT04740034|363966933|FG006|Overall Study|Death|2|||
105536693|NCT04740034|363966934|FG007|Overall Study|Death|2|||
105536694|NCT04740034|363966935|FG008|Overall Study|Death|2|||
105536695|NCT04740034|363966936|FG009|Overall Study|Death|4|||
105536696|NCT04740034|363966937|FG010|Overall Study|Death|0|||
105536697|NCT04740034|363966927|FG000|Overall Study|Lost to Follow-up|0|||
105536698|NCT04740034|363966928|FG001|Overall Study|Lost to Follow-up|0|||
105536699|NCT04740034|363966929|FG002|Overall Study|Lost to Follow-up|0|||
105536700|NCT04740034|363966930|FG003|Overall Study|Lost to Follow-up|1|||
105536701|NCT04740034|363966931|FG004|Overall Study|Lost to Follow-up|2|||
105536702|NCT04740034|363966932|FG005|Overall Study|Lost to Follow-up|2|||
105536703|NCT04740034|363966933|FG006|Overall Study|Lost to Follow-up|0|||
105536704|NCT04740034|363966934|FG007|Overall Study|Lost to Follow-up|0|||
105536705|NCT04740034|363966935|FG008|Overall Study|Lost to Follow-up|0|||
105536706|NCT04740034|363966936|FG009|Overall Study|Lost to Follow-up|1|||
105536707|NCT04740034|363966937|FG010|Overall Study|Lost to Follow-up|0|||
105536708|NCT04740034|363966927|FG000|Overall Study|Withdrawal by Subject|1|||
105536709|NCT04740034|363966928|FG001|Overall Study|Withdrawal by Subject|0|||
105536710|NCT04740034|363966929|FG002|Overall Study|Withdrawal by Subject|0|||
105536711|NCT04740034|363966930|FG003|Overall Study|Withdrawal by Subject|0|||
105536712|NCT04740034|363966931|FG004|Overall Study|Withdrawal by Subject|0|||
105536713|NCT04740034|363966932|FG005|Overall Study|Withdrawal by Subject|0|||
105536714|NCT04740034|363966933|FG006|Overall Study|Withdrawal by Subject|0|||
105536715|NCT04740034|363966934|FG007|Overall Study|Withdrawal by Subject|1|||
105536716|NCT04740034|363966935|FG008|Overall Study|Withdrawal by Subject|0|||
105536717|NCT04740034|363966936|FG009|Overall Study|Withdrawal by Subject|1|||
105536718|NCT04740034|363966937|FG010|Overall Study|Withdrawal by Subject|0|||
105536719|NCT04740034|363966927|FG000|Overall Study|Decision by sponsor|0|||
105536720|NCT04740034|363966928|FG001|Overall Study|Decision by sponsor|0|||
105536721|NCT04740034|363966929|FG002|Overall Study|Decision by sponsor|1|||
105536722|NCT04740034|363966930|FG003|Overall Study|Decision by sponsor|0|||
105536723|NCT04740034|363966931|FG004|Overall Study|Decision by sponsor|0|||
105536724|NCT04740034|363966932|FG005|Overall Study|Decision by sponsor|0|||
105536725|NCT04740034|363966933|FG006|Overall Study|Decision by sponsor|1|||
105536726|NCT04740034|363966934|FG007|Overall Study|Decision by sponsor|2|||
105536727|NCT04740034|363966935|FG008|Overall Study|Decision by sponsor|1|||
105536728|NCT04740034|363966936|FG009|Overall Study|Decision by sponsor|1|||
105536729|NCT04740034|363966937|FG010|Overall Study|Decision by sponsor|2|||
105536730|NCT00533949|363968887|FG000|Overall Study|Protocol Violation|12|||
105536731|NCT00533949|363968888|FG001|Overall Study|Protocol Violation|12|||
105536732|NCT00533949|363968889|FG002|Overall Study|Protocol Violation|9|||
105536733|NCT00533949|363968890|FG003|Overall Study|Protocol Violation|9|||
105536734|NCT00533949|363968887|FG000|Overall Study|Withdrawal by Subject|3|||
105536735|NCT00533949|363968888|FG001|Overall Study|Withdrawal by Subject|2|||
105536736|NCT00533949|363968889|FG002|Overall Study|Withdrawal by Subject|1|||
105536737|NCT00533949|363968890|FG003|Overall Study|Withdrawal by Subject|1|||
105536738|NCT00727194|363968891|FG000|Screening Period|Low QMG scores|0|||
105536739|NCT00727194|363968892|FG001|Screening Period|Low QMG scores|0|||
105536740|NCT00727194|363968893|FG002|Screening Period|Low QMG scores|6|||
105536741|NCT00727194|363968891|FG000|Screening Period|Lacked AChR antibodies|0|||
105536742|NCT00727194|363968892|FG001|Screening Period|Lacked AChR antibodies|0|||
105536743|NCT00727194|363968893|FG002|Screening Period|Lacked AChR antibodies|5|||
105536744|NCT00727194|363968891|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
105536745|NCT00727194|363968892|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
105536746|NCT00727194|363968893|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
105536747|NCT00727194|363968891|FG000|Screening Period|Severe infections|0|||
105536748|NCT00727194|363968892|FG001|Screening Period|Severe infections|0|||
105536749|NCT00727194|363968893|FG002|Screening Period|Severe infections|2|||
105536750|NCT00727194|363968891|FG000|Screening Period|History of thymoma|0|||
105536751|NCT00727194|363968892|FG001|Screening Period|History of thymoma|0|||
105536752|NCT00727194|363968893|FG002|Screening Period|History of thymoma|1|||
105536753|NCT00727194|363968891|FG000|Treatment Period 2|Lack of Efficacy|0|||
105536754|NCT00727194|363968892|FG001|Treatment Period 2|Lack of Efficacy|1|||
105536755|NCT00727194|363968893|FG002|Treatment Period 2|Lack of Efficacy|0|||
105536756|NCT02472756|363968899|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
105536757|NCT02472756|363968899|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
105536758|NCT02472756|363968899|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
105536759|NCT02472756|363968899|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
105536760|NCT02472756|363968899|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
105536761|NCT01700179|363968901|FG000|Overall Study|Physician Decision|2|||
105536762|NCT00667342|363968902|FG000|Overall Study|Protocol Violation|1|||
105536763|NCT00667342|363968903|FG001|Overall Study|Protocol Violation|0|||
105536764|NCT00667342|363968904|FG002|Overall Study|Protocol Violation|0|||
105536765|NCT00667342|363968902|FG000|Overall Study|Withdrawal by Subject|1|||
105536766|NCT00667342|363968903|FG001|Overall Study|Withdrawal by Subject|0|||
105536767|NCT00667342|363968904|FG002|Overall Study|Withdrawal by Subject|0|||
105536768|NCT00667342|363968902|FG000|Overall Study|Physician Decision|3|||
105536769|NCT00667342|363968903|FG001|Overall Study|Physician Decision|0|||
105536770|NCT00667342|363968904|FG002|Overall Study|Physician Decision|0|||
105536771|NCT00667342|363968902|FG000|Overall Study|Relapse or tumor progression|9|||
105536772|NCT00667342|363968903|FG001|Overall Study|Relapse or tumor progression|0|||
105536773|NCT00667342|363968904|FG002|Overall Study|Relapse or tumor progression|7|||
105536774|NCT00667342|363968902|FG000|Overall Study|Adverse Event|0|||
105536775|NCT00667342|363968903|FG001|Overall Study|Adverse Event|0|||
105536776|NCT00667342|363968904|FG002|Overall Study|Adverse Event|1|||
105536777|NCT00667342|363968902|FG000|Overall Study|Ineligible|0|||
105536778|NCT00667342|363968903|FG001|Overall Study|Ineligible|0|||
105536779|NCT00667342|363968904|FG002|Overall Study|Ineligible|1|||
105536780|NCT00293384|363968910|FG000|Overall Study|Non-compliance|2|||
105536781|NCT00293384|363968910|FG000|Overall Study|Missed dosage/study drug|1|||
105536782|NCT00293384|363968910|FG000|Overall Study|Ineligible|2|||
105536783|NCT00773175|363968911|FG000|Overall Study|Adverse Event|2|||
105536784|NCT00773175|363968912|FG001|Overall Study|Adverse Event|0|||
105536785|NCT00773175|363968911|FG000|Overall Study|Consent Withdrawn|0|||
105536786|NCT00773175|363968912|FG001|Overall Study|Consent Withdrawn|2|||
105536787|NCT02789176|363968914|FG000|Overall Study|Death|0|||
105536788|NCT02789176|363968915|FG001|Overall Study|Death|0|||
105536789|NCT02789176|363968916|FG002|Overall Study|Death|3|||
105536790|NCT02789176|363968917|FG003|Overall Study|Death|0|||
105536791|NCT02789176|363968914|FG000|Overall Study|Withdrawal by Subject|0|||
105536792|NCT02789176|363968915|FG001|Overall Study|Withdrawal by Subject|0|||
105536793|NCT02789176|363968916|FG002|Overall Study|Withdrawal by Subject|1|||
105536794|NCT02789176|363968917|FG003|Overall Study|Withdrawal by Subject|0|||
105536795|NCT02789176|363968914|FG000|Overall Study|Lost to Follow-up|8|||
105536796|NCT02789176|363968915|FG001|Overall Study|Lost to Follow-up|2|||
105536797|NCT02789176|363968916|FG002|Overall Study|Lost to Follow-up|6|||
105536798|NCT02789176|363968917|FG003|Overall Study|Lost to Follow-up|1|||
105536799|NCT00192075|363968918|FG000|Overall Study|Disease Progression|23|||
105536800|NCT00192075|363968919|FG001|Overall Study|Disease Progression|6|||
105536801|NCT00192075|363968918|FG000|Overall Study|Adverse Event|1|||
105536802|NCT00192075|363968919|FG001|Overall Study|Adverse Event|3|||
105536803|NCT00192075|363968918|FG000|Overall Study|Death|0|||
105536804|NCT00192075|363968919|FG001|Overall Study|Death|1|||
105536805|NCT00192075|363968918|FG000|Overall Study|Lack of Efficacy|0|||
105536806|NCT00192075|363968919|FG001|Overall Study|Lack of Efficacy|0|||
105536807|NCT00192075|363968918|FG000|Overall Study|Physician Decision|3|||
105536808|NCT00192075|363968919|FG001|Overall Study|Physician Decision|0|||
105536809|NCT00192075|363968918|FG000|Overall Study|Withdrawal by Subject|5|||
105536810|NCT00192075|363968919|FG001|Overall Study|Withdrawal by Subject|5|||
105536811|NCT00192075|363968918|FG000|Overall Study|Patient Non-Compliance|0|||
105536812|NCT00192075|363968919|FG001|Overall Study|Patient Non-Compliance|1|||
105536813|NCT00192075|363968918|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
105536814|NCT00192075|363968919|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
105536815|NCT00192075|363968918|FG000|Overall Study|Other|5|||
105536816|NCT00192075|363968919|FG001|Overall Study|Other|2|||
105536817|NCT00779675|363968920|FG000|Treatment Period|Adverse Event|87|||
105536818|NCT00779675|363968920|FG000|Treatment Period|Treatment Failure|80|||
105536819|NCT00779675|363968920|FG000|Treatment Period|Transferred to Another Study|38|||
105536820|NCT00779675|363968920|FG000|Treatment Period|Lost to Follow-up|23|||
105595416|NCT01456936|364180185|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
105595417|NCT01456936|364180182|FG000|Overall Study|Death|0|||
105536821|NCT00779675|363968920|FG000|Treatment Period|Withdrawal by Subject|46|||
105536822|NCT00779675|363968920|FG000|Treatment Period|Protocol Violation|54|||
105536823|NCT00779675|363968920|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
105536824|NCT00779675|363968920|FG000|Treatment Period|Administrative|3|||
105536825|NCT00779675|363968920|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
105536826|NCT00779675|363968920|FG000|Extended Treatment Period|Protocol Violation|13|||
105536827|NCT00779675|363968920|FG000|Extended Treatment Period|Adverse Event|6|||
105536828|NCT00779675|363968920|FG000|Extended Treatment Period|Treatment Failure|11|||
105536829|NCT00779675|363968920|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
105536830|NCT00779675|363968920|FG000|Extended Treatment Period|Lost to Follow-up|6|||
105536831|NCT00749775|363968923|FG000|Overall Study|Protocol Violation|24|||
105536832|NCT00749775|363968923|FG000|Overall Study|Lost to Follow-up|36|||
105536833|NCT00749775|363968923|FG000|Overall Study|No visit after first day of treatment|44|||
105536834|NCT00749775|363968923|FG000|Overall Study|No drug administration|3|||
105536835|NCT04300296|363968924|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
105536836|NCT04300296|363968925|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
105536837|NCT04300296|363968926|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
105536838|NCT04300296|363968927|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
105536839|NCT04300296|363968928|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
105536840|NCT04300296|363968929|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
105536841|NCT04300296|363968924|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
105536842|NCT04300296|363968925|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
105536843|NCT04300296|363968926|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
105536844|NCT04300296|363968927|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
105536845|NCT04300296|363968928|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
105536846|NCT04300296|363968929|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
105536847|NCT04300296|363968924|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
105536848|NCT04300296|363968925|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
105536849|NCT04300296|363968926|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
105536850|NCT04300296|363968927|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
105536851|NCT04300296|363968928|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
105536852|NCT04300296|363968929|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
105536853|NCT04300296|363968924|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
105536854|NCT04300296|363968925|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
105536855|NCT04300296|363968926|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
105536856|NCT04300296|363968927|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
105536857|NCT04300296|363968928|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
105536858|NCT04300296|363968929|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
105536859|NCT04300296|363968924|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
105536860|NCT04300296|363968925|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
105536861|NCT04300296|363968926|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
105536862|NCT04300296|363968927|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
105536863|NCT04300296|363968928|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
105536864|NCT04300296|363968929|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
105536865|NCT04300296|363968924|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
105536866|NCT04300296|363968925|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
105536867|NCT04300296|363968926|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
105536868|NCT04300296|363968927|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
105536869|NCT04300296|363968928|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
105536870|NCT04300296|363968929|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
105536871|NCT04300296|363968924|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
105536872|NCT04300296|363968925|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
105536873|NCT04300296|363968926|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
105536874|NCT04300296|363968927|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
105536875|NCT04300296|363968928|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
105536876|NCT04300296|363968929|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
105536877|NCT01633944|363968930|FG000|Open-label Titration Phase|Adverse Event|109|||
105536878|NCT01633944|363968931|FG001|Open-label Titration Phase|Adverse Event|0|||
105536879|NCT01633944|363968932|FG002|Open-label Titration Phase|Adverse Event|0|||
105536880|NCT01633944|363968930|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
105536881|NCT01633944|363968931|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
105536882|NCT01633944|363968932|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
105536883|NCT01633944|363968930|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
105536884|NCT01633944|363968931|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
105536885|NCT01633944|363968932|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
105536886|NCT01633944|363968930|FG000|Open-label Titration Phase|Protocol Violation|24|||
105536887|NCT01633944|363968931|FG001|Open-label Titration Phase|Protocol Violation|0|||
105536888|NCT01633944|363968932|FG002|Open-label Titration Phase|Protocol Violation|0|||
105536889|NCT01633944|363968930|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
105536890|NCT01633944|363968931|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
105536891|NCT01633944|363968932|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
105536892|NCT01633944|363968930|FG000|Open-label Titration Phase|Other|68|||
105536893|NCT01633944|363968931|FG001|Open-label Titration Phase|Other|0|||
105536894|NCT01633944|363968932|FG002|Open-label Titration Phase|Other|0|||
105595418|NCT01456936|364180183|FG001|Overall Study|Death|3|||
105595419|NCT01456936|364180184|FG002|Overall Study|Death|1|||
105595420|NCT01456936|364180185|FG003|Overall Study|Death|3|||
105595421|NCT01456936|364180182|FG000|Overall Study|Randomized but not treated|21|||
105536895|NCT01633944|363968930|FG000|Double-blind Treatment Phase|Adverse Event|0|||
105536896|NCT01633944|363968931|FG001|Double-blind Treatment Phase|Adverse Event|13|||
105536897|NCT01633944|363968932|FG002|Double-blind Treatment Phase|Adverse Event|7|||
105536898|NCT01633944|363968930|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
105536899|NCT01633944|363968931|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
105536900|NCT01633944|363968932|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
105536901|NCT01633944|363968930|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105536902|NCT01633944|363968931|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
105536903|NCT01633944|363968932|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
105536904|NCT01633944|363968930|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
105536905|NCT01633944|363968931|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
105536906|NCT01633944|363968932|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
105536907|NCT01633944|363968930|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
105536908|NCT01633944|363968931|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
105536909|NCT01633944|363968932|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
105536910|NCT01633944|363968930|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
105536911|NCT01633944|363968931|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
105536912|NCT01633944|363968932|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
105536913|NCT01633944|363968930|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
105536914|NCT01633944|363968931|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
105536915|NCT01633944|363968932|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
105536916|NCT01633944|363968930|FG000|Double-blind Treatment Phase|Other|0|||
105536917|NCT01633944|363968931|FG001|Double-blind Treatment Phase|Other|7|||
105536918|NCT01633944|363968932|FG002|Double-blind Treatment Phase|Other|0|||
105536919|NCT01400841|363968933|FG000|Initial Study Phase (6 Months)|Death|1|||
105536920|NCT01400841|363968933|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
105536921|NCT00701129|363968934|FG000|Overall Study|Death|2|||
105536922|NCT00279708|363968935|FG000|Overall Study|Withdrawal by Subject|2|||
105536923|NCT00279708|363968936|FG001|Overall Study|Withdrawal by Subject|3|||
105536924|NCT00279708|363968935|FG000|Overall Study|Adverse Event|1|||
105536925|NCT00279708|363968936|FG001|Overall Study|Adverse Event|1|||
105536926|NCT02177266|363968939|FG000|Overall Study|Adverse Event|0|||
105536927|NCT02177266|363968940|FG001|Overall Study|Adverse Event|1|||
105536928|NCT02177266|363968939|FG000|Overall Study|Withdrawal by Subject|1|||
105536929|NCT02177266|363968940|FG001|Overall Study|Withdrawal by Subject|0|||
105536930|NCT00546715|363968941|FG000|Overall Study|Withdrawal by Subject|0|||
105536931|NCT00546715|363968942|FG001|Overall Study|Withdrawal by Subject|1|||
105536932|NCT00546715|363968943|FG002|Overall Study|Withdrawal by Subject|0|||
105536933|NCT00546715|363968944|FG003|Overall Study|Withdrawal by Subject|0|||
105536934|NCT02148003|363968948|FG000|Overall Study|Failed inclusion criteria|1|||
105536935|NCT02148003|363968949|FG001|Overall Study|Failed inclusion criteria|0|||
105536936|NCT02148003|363968948|FG000|Overall Study|Met exclusion criteria|0|||
105536937|NCT02148003|363968949|FG001|Overall Study|Met exclusion criteria|1|||
105536938|NCT02148003|363968948|FG000|Overall Study|Withdrawal by Subject|0|||
105536939|NCT02148003|363968949|FG001|Overall Study|Withdrawal by Subject|1|||
105536940|NCT01018264|363968954|FG000|Overall Study|Withdrawal by Subject|1|||
105536941|NCT01018264|363968955|FG001|Overall Study|Withdrawal by Subject|0|||
105536942|NCT01018264|363968954|FG000|Overall Study|Lost to Follow-up|0|||
105536943|NCT01018264|363968955|FG001|Overall Study|Lost to Follow-up|1|||
105536944|NCT03670810|363968958|FG000|Main Study|Adverse Event|37|||
105536945|NCT03670810|363968959|FG001|Main Study|Adverse Event|38|||
105536946|NCT03670810|363968960|FG002|Main Study|Adverse Event|3|||
105536947|NCT03670810|363968961|FG003|Main Study|Adverse Event|4|||
105536948|NCT03670810|363968962|FG004|Main Study|Adverse Event|4|||
105536949|NCT03670810|363968963|FG005|Main Study|Adverse Event|5|||
105536950|NCT03670810|363968964|FG006|Main Study|Adverse Event|0|||
105536951|NCT03670810|363968965|FG007|Main Study|Adverse Event|0|||
105536952|NCT03670810|363968966|FG008|Main Study|Adverse Event|0|||
105536953|NCT03670810|363968958|FG000|Main Study|Lack of Efficacy|8|||
105536954|NCT03670810|363968959|FG001|Main Study|Lack of Efficacy|9|||
105536955|NCT03670810|363968960|FG002|Main Study|Lack of Efficacy|3|||
105536956|NCT03670810|363968961|FG003|Main Study|Lack of Efficacy|4|||
105536957|NCT03670810|363968962|FG004|Main Study|Lack of Efficacy|0|||
105536958|NCT03670810|363968963|FG005|Main Study|Lack of Efficacy|0|||
105536959|NCT03670810|363968964|FG006|Main Study|Lack of Efficacy|0|||
105536960|NCT03670810|363968965|FG007|Main Study|Lack of Efficacy|0|||
105536961|NCT03670810|363968966|FG008|Main Study|Lack of Efficacy|0|||
105536962|NCT03670810|363968958|FG000|Main Study|Lost to Follow-up|9|||
105536963|NCT03670810|363968959|FG001|Main Study|Lost to Follow-up|7|||
105536964|NCT03670810|363968960|FG002|Main Study|Lost to Follow-up|4|||
105536965|NCT03670810|363968961|FG003|Main Study|Lost to Follow-up|6|||
105536966|NCT03670810|363968962|FG004|Main Study|Lost to Follow-up|1|||
105536967|NCT03670810|363968963|FG005|Main Study|Lost to Follow-up|0|||
105536968|NCT03670810|363968964|FG006|Main Study|Lost to Follow-up|0|||
105536969|NCT03670810|363968965|FG007|Main Study|Lost to Follow-up|0|||
105536970|NCT03670810|363968966|FG008|Main Study|Lost to Follow-up|0|||
105536971|NCT03670810|363968958|FG000|Main Study|Non-compliance with Study Drug|0|||
105536972|NCT03670810|363968959|FG001|Main Study|Non-compliance with Study Drug|2|||
105536973|NCT03670810|363968960|FG002|Main Study|Non-compliance with Study Drug|3|||
105536974|NCT03670810|363968961|FG003|Main Study|Non-compliance with Study Drug|0|||
105536975|NCT03670810|363968962|FG004|Main Study|Non-compliance with Study Drug|0|||
105536976|NCT03670810|363968963|FG005|Main Study|Non-compliance with Study Drug|0|||
105536977|NCT03670810|363968964|FG006|Main Study|Non-compliance with Study Drug|0|||
105536978|NCT03670810|363968965|FG007|Main Study|Non-compliance with Study Drug|1|||
105536979|NCT03670810|363968966|FG008|Main Study|Non-compliance with Study Drug|0|||
105536980|NCT03670810|363968958|FG000|Main Study|Physician Decision|3|||
105536981|NCT03670810|363968959|FG001|Main Study|Physician Decision|0|||
105536982|NCT03670810|363968960|FG002|Main Study|Physician Decision|1|||
105536983|NCT03670810|363968961|FG003|Main Study|Physician Decision|0|||
105536984|NCT03670810|363968962|FG004|Main Study|Physician Decision|0|||
105536985|NCT03670810|363968963|FG005|Main Study|Physician Decision|0|||
105536986|NCT03670810|363968964|FG006|Main Study|Physician Decision|1|||
105536987|NCT03670810|363968965|FG007|Main Study|Physician Decision|1|||
105536988|NCT03670810|363968966|FG008|Main Study|Physician Decision|0|||
105536989|NCT03670810|363968958|FG000|Main Study|Pregnancy|1|||
105536990|NCT03670810|363968959|FG001|Main Study|Pregnancy|2|||
105536991|NCT03670810|363968960|FG002|Main Study|Pregnancy|0|||
105536992|NCT03670810|363968961|FG003|Main Study|Pregnancy|0|||
105536993|NCT03670810|363968962|FG004|Main Study|Pregnancy|0|||
105536994|NCT03670810|363968963|FG005|Main Study|Pregnancy|0|||
105536995|NCT03670810|363968964|FG006|Main Study|Pregnancy|0|||
105536996|NCT03670810|363968965|FG007|Main Study|Pregnancy|0|||
105536997|NCT03670810|363968966|FG008|Main Study|Pregnancy|0|||
105536998|NCT03670810|363968958|FG000|Main Study|Protocol Deviation|2|||
105536999|NCT03670810|363968959|FG001|Main Study|Protocol Deviation|12|||
105537000|NCT03670810|363968960|FG002|Main Study|Protocol Deviation|8|||
105537001|NCT03670810|363968961|FG003|Main Study|Protocol Deviation|4|||
105537002|NCT03670810|363968962|FG004|Main Study|Protocol Deviation|0|||
105537003|NCT03670810|363968963|FG005|Main Study|Protocol Deviation|0|||
105537004|NCT03670810|363968964|FG006|Main Study|Protocol Deviation|0|||
105537005|NCT03670810|363968965|FG007|Main Study|Protocol Deviation|0|||
105537006|NCT03670810|363968966|FG008|Main Study|Protocol Deviation|0|||
105537007|NCT03670810|363968958|FG000|Main Study|Withdrawal by Subject|21|||
105537008|NCT03670810|363968959|FG001|Main Study|Withdrawal by Subject|21|||
105537009|NCT03670810|363968960|FG002|Main Study|Withdrawal by Subject|8|||
105537010|NCT03670810|363968961|FG003|Main Study|Withdrawal by Subject|9|||
105537011|NCT03670810|363968962|FG004|Main Study|Withdrawal by Subject|5|||
105537012|NCT03670810|363968963|FG005|Main Study|Withdrawal by Subject|2|||
105537013|NCT03670810|363968964|FG006|Main Study|Withdrawal by Subject|1|||
105537014|NCT03670810|363968965|FG007|Main Study|Withdrawal by Subject|1|||
105537015|NCT03670810|363968966|FG008|Main Study|Withdrawal by Subject|0|||
105537016|NCT03670810|363968958|FG000|Main Study|Participant did not want to take the three other treatments|1|||
105537017|NCT03670810|363968959|FG001|Main Study|Participant did not want to take the three other treatments|0|||
105537018|NCT03670810|363968960|FG002|Main Study|Participant did not want to take the three other treatments|0|||
105537019|NCT03670810|363968961|FG003|Main Study|Participant did not want to take the three other treatments|0|||
105537020|NCT03670810|363968962|FG004|Main Study|Participant did not want to take the three other treatments|0|||
105537021|NCT03670810|363968963|FG005|Main Study|Participant did not want to take the three other treatments|0|||
105537022|NCT03670810|363968964|FG006|Main Study|Participant did not want to take the three other treatments|0|||
105537023|NCT03670810|363968965|FG007|Main Study|Participant did not want to take the three other treatments|0|||
105537024|NCT03670810|363968966|FG008|Main Study|Participant did not want to take the three other treatments|0|||
105537025|NCT03670810|363968958|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
105537026|NCT03670810|363968959|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
105537027|NCT03670810|363968960|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
105537028|NCT03670810|363968961|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
105537029|NCT03670810|363968962|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
105537030|NCT03670810|363968963|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
105537031|NCT03670810|363968964|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
105537032|NCT03670810|363968965|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
105537033|NCT03670810|363968966|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
105537034|NCT03670810|363968958|FG000|Main Study|Travel and Coronavirus issues|0|||
105537035|NCT03670810|363968959|FG001|Main Study|Travel and Coronavirus issues|0|||
105537036|NCT03670810|363968960|FG002|Main Study|Travel and Coronavirus issues|0|||
105537037|NCT03670810|363968961|FG003|Main Study|Travel and Coronavirus issues|1|||
105537038|NCT03670810|363968962|FG004|Main Study|Travel and Coronavirus issues|0|||
105537039|NCT03670810|363968963|FG005|Main Study|Travel and Coronavirus issues|0|||
105537040|NCT03670810|363968964|FG006|Main Study|Travel and Coronavirus issues|0|||
105537041|NCT03670810|363968965|FG007|Main Study|Travel and Coronavirus issues|0|||
105537042|NCT03670810|363968966|FG008|Main Study|Travel and Coronavirus issues|0|||
105537043|NCT03670810|363968958|FG000|Open Label Extension|Protocol Deviation|0|||
105537044|NCT03670810|363968959|FG001|Open Label Extension|Protocol Deviation|0|||
105537045|NCT03670810|363968960|FG002|Open Label Extension|Protocol Deviation|0|||
105537046|NCT03670810|363968961|FG003|Open Label Extension|Protocol Deviation|0|||
105537047|NCT03670810|363968962|FG004|Open Label Extension|Protocol Deviation|0|||
105537048|NCT03670810|363968963|FG005|Open Label Extension|Protocol Deviation|0|||
105537049|NCT03670810|363968964|FG006|Open Label Extension|Protocol Deviation|0|||
105537050|NCT03670810|363968965|FG007|Open Label Extension|Protocol Deviation|0|||
105537051|NCT03670810|363968966|FG008|Open Label Extension|Protocol Deviation|5|||
105537052|NCT03670810|363968958|FG000|Open Label Extension|Death|0|||
105537053|NCT03670810|363968959|FG001|Open Label Extension|Death|0|||
105537054|NCT03670810|363968960|FG002|Open Label Extension|Death|0|||
105537055|NCT03670810|363968961|FG003|Open Label Extension|Death|0|||
105537056|NCT03670810|363968962|FG004|Open Label Extension|Death|0|||
105537057|NCT03670810|363968963|FG005|Open Label Extension|Death|0|||
105537058|NCT03670810|363968964|FG006|Open Label Extension|Death|0|||
105537059|NCT03670810|363968965|FG007|Open Label Extension|Death|0|||
105537060|NCT03670810|363968966|FG008|Open Label Extension|Death|1|||
105537061|NCT03670810|363968958|FG000|Open Label Extension|COVID-19|0|||
105537062|NCT03670810|363968959|FG001|Open Label Extension|COVID-19|0|||
105537063|NCT03670810|363968960|FG002|Open Label Extension|COVID-19|0|||
105537064|NCT03670810|363968961|FG003|Open Label Extension|COVID-19|0|||
105537065|NCT03670810|363968962|FG004|Open Label Extension|COVID-19|0|||
105537066|NCT03670810|363968963|FG005|Open Label Extension|COVID-19|0|||
105537067|NCT03670810|363968964|FG006|Open Label Extension|COVID-19|0|||
105537068|NCT03670810|363968965|FG007|Open Label Extension|COVID-19|0|||
105537069|NCT03670810|363968966|FG008|Open Label Extension|COVID-19|1|||
105537070|NCT03670810|363968958|FG000|Open Label Extension|Lack of Efficacy|0|||
105537071|NCT03670810|363968959|FG001|Open Label Extension|Lack of Efficacy|0|||
105537072|NCT03670810|363968960|FG002|Open Label Extension|Lack of Efficacy|0|||
105537073|NCT03670810|363968961|FG003|Open Label Extension|Lack of Efficacy|0|||
105537074|NCT03670810|363968962|FG004|Open Label Extension|Lack of Efficacy|0|||
105537075|NCT03670810|363968963|FG005|Open Label Extension|Lack of Efficacy|0|||
105537076|NCT03670810|363968964|FG006|Open Label Extension|Lack of Efficacy|0|||
105537077|NCT03670810|363968965|FG007|Open Label Extension|Lack of Efficacy|0|||
105537078|NCT03670810|363968966|FG008|Open Label Extension|Lack of Efficacy|39|||
105537079|NCT03670810|363968958|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
105537080|NCT03670810|363968959|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
105537081|NCT03670810|363968960|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
105537082|NCT03670810|363968961|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
105537083|NCT03670810|363968962|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
105537084|NCT03670810|363968963|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
105537085|NCT03670810|363968964|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
105537086|NCT03670810|363968965|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
105537087|NCT03670810|363968966|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
105537088|NCT03670810|363968958|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
105537089|NCT03670810|363968959|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
105537090|NCT03670810|363968960|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
105537091|NCT03670810|363968961|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
105537092|NCT03670810|363968962|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
105537093|NCT03670810|363968963|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
105537094|NCT03670810|363968964|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
105537095|NCT03670810|363968965|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
105537096|NCT03670810|363968966|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
105537097|NCT03670810|363968958|FG000|Open Label Extension|Withdrawal by Subject|0|||
105537098|NCT03670810|363968959|FG001|Open Label Extension|Withdrawal by Subject|0|||
105537099|NCT03670810|363968960|FG002|Open Label Extension|Withdrawal by Subject|0|||
105537100|NCT03670810|363968961|FG003|Open Label Extension|Withdrawal by Subject|0|||
105537101|NCT03670810|363968962|FG004|Open Label Extension|Withdrawal by Subject|0|||
105537102|NCT03670810|363968963|FG005|Open Label Extension|Withdrawal by Subject|0|||
105537103|NCT03670810|363968964|FG006|Open Label Extension|Withdrawal by Subject|0|||
105537104|NCT03670810|363968965|FG007|Open Label Extension|Withdrawal by Subject|0|||
105537105|NCT03670810|363968966|FG008|Open Label Extension|Withdrawal by Subject|46|||
105595422|NCT01456936|364180183|FG001|Overall Study|Randomized but not treated|28|||
105595423|NCT01456936|364180184|FG002|Overall Study|Randomized but not treated|16|||
105595424|NCT01456936|364180185|FG003|Overall Study|Randomized but not treated|21|||
105595425|NCT03691428|364180187|FG000|Overall Study|Withdrawal by Subject|6|||
105595426|NCT03691428|364180188|FG001|Overall Study|Withdrawal by Subject|8|||
105595427|NCT03184558|364180189|FG000|Overall Study|Withdrawal by Subject|2|||
105595428|NCT03184558|364180189|FG000|Overall Study|Death|16|||
105595429|NCT03184558|364180189|FG000|Overall Study|Lost to Follow-up|2|||
105595430|NCT03184558|364180189|FG000|Overall Study|Other|9|||
105537106|NCT03670810|363968958|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
105537107|NCT03670810|363968959|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
105537108|NCT03670810|363968960|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
105537109|NCT03670810|363968961|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
105537110|NCT03670810|363968962|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
105537111|NCT03670810|363968963|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
105537112|NCT03670810|363968964|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
105537113|NCT03670810|363968965|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
105537114|NCT03670810|363968966|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
105537115|NCT03670810|363968958|FG000|Open Label Extension|Physician Decision|0|||
105537116|NCT03670810|363968959|FG001|Open Label Extension|Physician Decision|0|||
105537117|NCT03670810|363968960|FG002|Open Label Extension|Physician Decision|0|||
105537118|NCT03670810|363968961|FG003|Open Label Extension|Physician Decision|0|||
105537119|NCT03670810|363968962|FG004|Open Label Extension|Physician Decision|0|||
105537120|NCT03670810|363968963|FG005|Open Label Extension|Physician Decision|0|||
105537121|NCT03670810|363968964|FG006|Open Label Extension|Physician Decision|0|||
105537122|NCT03670810|363968965|FG007|Open Label Extension|Physician Decision|0|||
105537123|NCT03670810|363968966|FG008|Open Label Extension|Physician Decision|2|||
105537124|NCT03670810|363968958|FG000|Open Label Extension|Non-compliance with study drug|0|||
105537125|NCT03670810|363968959|FG001|Open Label Extension|Non-compliance with study drug|0|||
105537126|NCT03670810|363968960|FG002|Open Label Extension|Non-compliance with study drug|0|||
105537127|NCT03670810|363968961|FG003|Open Label Extension|Non-compliance with study drug|0|||
105537128|NCT03670810|363968962|FG004|Open Label Extension|Non-compliance with study drug|0|||
105537129|NCT03670810|363968963|FG005|Open Label Extension|Non-compliance with study drug|0|||
105537130|NCT03670810|363968964|FG006|Open Label Extension|Non-compliance with study drug|0|||
105537131|NCT03670810|363968965|FG007|Open Label Extension|Non-compliance with study drug|0|||
105537132|NCT03670810|363968966|FG008|Open Label Extension|Non-compliance with study drug|5|||
105537133|NCT03670810|363968958|FG000|Open Label Extension|Pregnancy|0|||
105537134|NCT03670810|363968959|FG001|Open Label Extension|Pregnancy|0|||
105537135|NCT03670810|363968960|FG002|Open Label Extension|Pregnancy|0|||
105537136|NCT03670810|363968961|FG003|Open Label Extension|Pregnancy|0|||
105537137|NCT03670810|363968962|FG004|Open Label Extension|Pregnancy|0|||
105537138|NCT03670810|363968963|FG005|Open Label Extension|Pregnancy|0|||
105537139|NCT03670810|363968964|FG006|Open Label Extension|Pregnancy|0|||
105537140|NCT03670810|363968965|FG007|Open Label Extension|Pregnancy|0|||
105537141|NCT03670810|363968966|FG008|Open Label Extension|Pregnancy|3|||
105537142|NCT03670810|363968958|FG000|Open Label Extension|Adverse Event|0|||
105537143|NCT03670810|363968959|FG001|Open Label Extension|Adverse Event|0|||
105537144|NCT03670810|363968960|FG002|Open Label Extension|Adverse Event|0|||
105537145|NCT03670810|363968961|FG003|Open Label Extension|Adverse Event|0|||
105537146|NCT03670810|363968962|FG004|Open Label Extension|Adverse Event|0|||
105537147|NCT03670810|363968963|FG005|Open Label Extension|Adverse Event|0|||
105537148|NCT03670810|363968964|FG006|Open Label Extension|Adverse Event|0|||
105537149|NCT03670810|363968965|FG007|Open Label Extension|Adverse Event|0|||
105537150|NCT03670810|363968966|FG008|Open Label Extension|Adverse Event|24|||
105537151|NCT03670810|363968958|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
105537152|NCT03670810|363968959|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
105537153|NCT03670810|363968960|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
105537154|NCT03670810|363968961|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
105537155|NCT03670810|363968962|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
105537156|NCT03670810|363968963|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
105537157|NCT03670810|363968964|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
105537158|NCT03670810|363968965|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
105537159|NCT03670810|363968966|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
105537160|NCT03670810|363968958|FG000|Open Label Extension|Lost to Follow-up|0|||
105537161|NCT03670810|363968959|FG001|Open Label Extension|Lost to Follow-up|0|||
105537162|NCT03670810|363968960|FG002|Open Label Extension|Lost to Follow-up|0|||
105537163|NCT03670810|363968961|FG003|Open Label Extension|Lost to Follow-up|0|||
105537164|NCT03670810|363968962|FG004|Open Label Extension|Lost to Follow-up|0|||
105537165|NCT03670810|363968963|FG005|Open Label Extension|Lost to Follow-up|0|||
105537166|NCT03670810|363968964|FG006|Open Label Extension|Lost to Follow-up|0|||
105537167|NCT03670810|363968965|FG007|Open Label Extension|Lost to Follow-up|0|||
105537168|NCT03670810|363968966|FG008|Open Label Extension|Lost to Follow-up|23|||
105537169|NCT00482391|363968967|FG000|Overall Study|Withdrawal by Subject|1|||
105537170|NCT00482391|363968967|FG000|Overall Study|Adverse Event|1|||
105537171|NCT00482391|363968967|FG000|Overall Study|Death|1|||
105537172|NCT00086580|363968973|FG000|Treatment Period|Disease progression|9|||
105537173|NCT00086580|363968974|FG001|Treatment Period|Disease progression|8|||
105595431|NCT02957539|364180190|FG000|Baseline to Week 16|Lost to Follow-up|8|||
105595432|NCT02957539|364180191|FG001|Baseline to Week 16|Lost to Follow-up|10|||
105537174|NCT00086580|363968973|FG000|Treatment Period|Unable to comply with protocol|3|||
105537175|NCT00086580|363968974|FG001|Treatment Period|Unable to comply with protocol|1|||
105537176|NCT00086580|363968973|FG000|Treatment Period|Withdrawal by Subject|7|||
105537177|NCT00086580|363968974|FG001|Treatment Period|Withdrawal by Subject|8|||
105537178|NCT00086580|363968973|FG000|Treatment Period|Physician Decision|13|||
105537179|NCT00086580|363968974|FG001|Treatment Period|Physician Decision|7|||
105537180|NCT00086580|363968973|FG000|Treatment Period|AE - not treatment related|7|||
105537181|NCT00086580|363968974|FG001|Treatment Period|AE - not treatment related|7|||
105537182|NCT00086580|363968973|FG000|Treatment Period|Toxicity - treatment related|15|||
105537183|NCT00086580|363968974|FG001|Treatment Period|Toxicity - treatment related|15|||
105537184|NCT00086580|363968973|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
105537185|NCT00086580|363968974|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
105537186|NCT00086580|363968973|FG000|Treatment Period|Death|5|||
105537187|NCT00086580|363968974|FG001|Treatment Period|Death|7|||
105537188|NCT00086580|363968973|FG000|Treatment Period|Other|5|||
105537189|NCT00086580|363968974|FG001|Treatment Period|Other|3|||
105537190|NCT00086580|363968973|FG000|Follow-up Period|Disease progression|72|||
105537191|NCT00086580|363968974|FG001|Follow-up Period|Disease progression|99|||
105537192|NCT00086580|363968973|FG000|Follow-up Period|Unable to comply with protocol|5|||
105537193|NCT00086580|363968974|FG001|Follow-up Period|Unable to comply with protocol|0|||
105537194|NCT00086580|363968973|FG000|Follow-up Period|Withdrawal by Subject|6|||
105537195|NCT00086580|363968974|FG001|Follow-up Period|Withdrawal by Subject|6|||
105537196|NCT00086580|363968973|FG000|Follow-up Period|Physician Decision|0|||
105537197|NCT00086580|363968974|FG001|Follow-up Period|Physician Decision|1|||
105537198|NCT00086580|363968973|FG000|Follow-up Period|AE - not related|1|||
105537199|NCT00086580|363968974|FG001|Follow-up Period|AE - not related|0|||
105537200|NCT00086580|363968973|FG000|Follow-up Period|Death|13|||
105537201|NCT00086580|363968974|FG001|Follow-up Period|Death|7|||
105537202|NCT00086580|363968973|FG000|Follow-up Period|Other|7|||
105537203|NCT00086580|363968974|FG001|Follow-up Period|Other|6|||
105537204|NCT00086580|363968973|FG000|Observation Period|Unable to comply with protocol|1|||
105537205|NCT00086580|363968974|FG001|Observation Period|Unable to comply with protocol|1|||
105537206|NCT00086580|363968973|FG000|Observation Period|Withdrawal by Subject|4|||
105537207|NCT00086580|363968974|FG001|Observation Period|Withdrawal by Subject|2|||
105537208|NCT00086580|363968973|FG000|Observation Period|Death|33|||
105537209|NCT00086580|363968974|FG001|Observation Period|Death|55|||
105537210|NCT00086580|363968973|FG000|Observation Period|Other|8|||
105537211|NCT00086580|363968974|FG001|Observation Period|Other|7|||
105537212|NCT00261716|363968975|FG000|Overall Study|Withdrawal by Subject|6|||
105537213|NCT00261716|363968976|FG001|Overall Study|Withdrawal by Subject|8|||
105537214|NCT00261716|363968975|FG000|Overall Study|Lost to Follow-up|0|||
105537215|NCT00261716|363968976|FG001|Overall Study|Lost to Follow-up|2|||
105537216|NCT04439240|363968977|FG000|Overall Study|Ineligible|2|||
105537217|NCT04439240|363968977|FG000|Overall Study|Never started treatment|2|||
105537218|NCT04439240|363968977|FG000|Overall Study|Adverse Event|12|||
105537219|NCT04439240|363968977|FG000|Overall Study|Death|2|||
105537220|NCT04439240|363968977|FG000|Overall Study|Disease progression|25|||
105537221|NCT04439240|363968977|FG000|Overall Study|Other diseases|2|||
105537222|NCT04439240|363968977|FG000|Overall Study|Withdrawal by Subject|3|||
105537223|NCT04439240|363968977|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
105537224|NCT04439240|363968977|FG000|Overall Study|Symptomatic decline|1|||
105537225|NCT04439240|363968977|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
105537226|NCT04439240|363968977|FG000|Overall Study|Clinical progression|1|||
105537227|NCT02644967|363968978|FG000|Overall Study|Death|26|||
105537228|NCT02644967|363968978|FG000|Overall Study|Physician Decision|1|||
105537229|NCT02644967|363968978|FG000|Overall Study|Withdrawal by Subject|2|||
105537230|NCT02644967|363968978|FG000|Overall Study|Protocol Violation|1|||
105537231|NCT02644967|363968978|FG000|Overall Study|Progressive Disease|1|||
105537232|NCT02644967|363968978|FG000|Overall Study|Study Terminated by Sponsor|4|||
105537233|NCT02075320|363968983|FG000|Overall Study|Withdrawal by Subject|2|||
105537234|NCT02388997|363968984|FG000|Overall Study|Adverse Event|1|||
105537235|NCT02388997|363968985|FG001|Overall Study|Adverse Event|2|||
105537236|NCT02388997|363968984|FG000|Overall Study|Withdrawal by Subject|2|||
105537237|NCT02388997|363968985|FG001|Overall Study|Withdrawal by Subject|1|||
105537238|NCT02388997|363968984|FG000|Overall Study|Lung function exclusion criteria|0|||
105537239|NCT02388997|363968985|FG001|Overall Study|Lung function exclusion criteria|2|||
105537240|NCT02388997|363968984|FG000|Overall Study|Tested positive for virus during run-in|0|||
105537241|NCT02388997|363968985|FG001|Overall Study|Tested positive for virus during run-in|1|||
105537242|NCT03075644|363968991|FG000|Overall Study|Withdrawal by Subject|1|||
105537243|NCT03075644|363968992|FG001|Overall Study|Withdrawal by Subject|1|||
105537244|NCT03025828|363968996|FG000|Overall Study|Lost to Follow-up|1|||
105537245|NCT00207142|363968997|FG000|Induction Phase|Adverse Event|9|||
105537246|NCT00207142|363968998|FG001|Induction Phase|Adverse Event|0|||
105537247|NCT00207142|363968999|FG002|Induction Phase|Adverse Event|0|||
105537248|NCT00207142|363969000|FG003|Induction Phase|Adverse Event|0|||
105537249|NCT00207142|363968997|FG000|Induction Phase|Death|1|||
105537250|NCT00207142|363968998|FG001|Induction Phase|Death|0|||
105537251|NCT00207142|363968999|FG002|Induction Phase|Death|0|||
105537252|NCT00207142|363969000|FG003|Induction Phase|Death|0|||
105537253|NCT00207142|363968997|FG000|Induction Phase|Lack of Efficacy|1|||
105537254|NCT00207142|363968998|FG001|Induction Phase|Lack of Efficacy|0|||
105537255|NCT00207142|363968999|FG002|Induction Phase|Lack of Efficacy|0|||
105537256|NCT00207142|363969000|FG003|Induction Phase|Lack of Efficacy|0|||
105537257|NCT00207142|363968997|FG000|Induction Phase|Lost to Follow-up|5|||
105537258|NCT00207142|363968998|FG001|Induction Phase|Lost to Follow-up|0|||
105537259|NCT00207142|363968999|FG002|Induction Phase|Lost to Follow-up|0|||
105537260|NCT00207142|363969000|FG003|Induction Phase|Lost to Follow-up|0|||
105537261|NCT00207142|363968997|FG000|Induction Phase|Physician Decision|2|||
105537262|NCT00207142|363968998|FG001|Induction Phase|Physician Decision|0|||
105537263|NCT00207142|363968999|FG002|Induction Phase|Physician Decision|0|||
105537264|NCT00207142|363969000|FG003|Induction Phase|Physician Decision|0|||
105537265|NCT00207142|363968997|FG000|Induction Phase|Poor/noncompliance|2|||
105537266|NCT00207142|363968998|FG001|Induction Phase|Poor/noncompliance|0|||
105537267|NCT00207142|363968999|FG002|Induction Phase|Poor/noncompliance|0|||
105537268|NCT00207142|363969000|FG003|Induction Phase|Poor/noncompliance|0|||
105537269|NCT00207142|363968997|FG000|Induction Phase|Pregnancy|1|||
105537270|NCT00207142|363968998|FG001|Induction Phase|Pregnancy|0|||
105537271|NCT00207142|363968999|FG002|Induction Phase|Pregnancy|0|||
105537272|NCT00207142|363969000|FG003|Induction Phase|Pregnancy|0|||
105537273|NCT00207142|363968997|FG000|Induction Phase|Subject no longer meets study criteria|3|||
105537274|NCT00207142|363968998|FG001|Induction Phase|Subject no longer meets study criteria|0|||
105537275|NCT00207142|363968999|FG002|Induction Phase|Subject no longer meets study criteria|0|||
105537276|NCT00207142|363969000|FG003|Induction Phase|Subject no longer meets study criteria|0|||
105537277|NCT00207142|363968997|FG000|Induction Phase|Withdrawal by Subject|4|||
105537278|NCT00207142|363968998|FG001|Induction Phase|Withdrawal by Subject|0|||
105537279|NCT00207142|363968999|FG002|Induction Phase|Withdrawal by Subject|0|||
105537280|NCT00207142|363969000|FG003|Induction Phase|Withdrawal by Subject|0|||
105537281|NCT00207142|363968997|FG000|Induction Phase|Incarceration|1|||
105537282|NCT00207142|363968998|FG001|Induction Phase|Incarceration|0|||
105537283|NCT00207142|363968999|FG002|Induction Phase|Incarceration|0|||
105537284|NCT00207142|363969000|FG003|Induction Phase|Incarceration|0|||
105537285|NCT00207142|363968997|FG000|Induction Phase|Missing lab data|1|||
105537286|NCT00207142|363968998|FG001|Induction Phase|Missing lab data|0|||
105537287|NCT00207142|363968999|FG002|Induction Phase|Missing lab data|0|||
105537288|NCT00207142|363969000|FG003|Induction Phase|Missing lab data|0|||
105537289|NCT00207142|363968997|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
105537290|NCT00207142|363968998|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
105537291|NCT00207142|363968999|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
105537292|NCT00207142|363969000|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
105537293|NCT00207142|363968997|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
105537294|NCT00207142|363968998|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
105537295|NCT00207142|363968999|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
105537296|NCT00207142|363969000|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
105537297|NCT00207142|363968997|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
105537298|NCT00207142|363968998|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
105537299|NCT00207142|363968999|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
105537300|NCT00207142|363969000|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
105537301|NCT00207142|363968997|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
105537302|NCT00207142|363968998|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
105537303|NCT00207142|363968999|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
105537304|NCT00207142|363969000|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
105537305|NCT00207142|363968997|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
105537306|NCT00207142|363968998|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
105537307|NCT00207142|363968999|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
105537308|NCT00207142|363969000|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
105537309|NCT00207142|363968997|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
105537310|NCT00207142|363968998|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
105537311|NCT00207142|363968999|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
105537312|NCT00207142|363969000|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
105537313|NCT00207142|363968997|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
105537314|NCT00207142|363968998|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
105537315|NCT00207142|363968999|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
105537316|NCT00207142|363969000|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
105537317|NCT00207142|363968997|FG000|Maintenance Phase/Rescue Phase|Death|0|||
105595433|NCT02957539|364180192|FG002|Baseline to Week 16|Lost to Follow-up|16|||
105595434|NCT02957539|364180190|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
105537318|NCT00207142|363968998|FG001|Maintenance Phase/Rescue Phase|Death|0|||
105537319|NCT00207142|363968999|FG002|Maintenance Phase/Rescue Phase|Death|0|||
105537320|NCT00207142|363969000|FG003|Maintenance Phase/Rescue Phase|Death|1|||
105595435|NCT02957539|364180191|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
105537321|NCT00207142|363968997|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
105537322|NCT00207142|363968998|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
105537323|NCT00207142|363968999|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
105537324|NCT00207142|363969000|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
105537325|NCT01020019|363969001|FG000|Overall Study|Lost to Follow-up|21|||
105537326|NCT01020019|363969002|FG001|Overall Study|Lost to Follow-up|18|||
105537327|NCT01020019|363969001|FG000|Overall Study|Adverse Event|1|||
105537328|NCT01020019|363969002|FG001|Overall Study|Adverse Event|5|||
105537329|NCT01020019|363969001|FG000|Overall Study|not interested in treatment|4|||
105537330|NCT01020019|363969002|FG001|Overall Study|not interested in treatment|4|||
105537331|NCT01020019|363969001|FG000|Overall Study|moving|0|||
105537332|NCT01020019|363969002|FG001|Overall Study|moving|2|||
105537333|NCT05091528|363969003|FG000|Overall Study|Study Termination by Sponsor|0|||
105537334|NCT05091528|363969004|FG001|Overall Study|Study Termination by Sponsor|1|||
105537335|NCT05091528|363969005|FG002|Overall Study|Study Termination by Sponsor|0|||
105537336|NCT05091528|363969006|FG003|Overall Study|Study Termination by Sponsor|1|||
105537337|NCT01192152|363969009|FG000|Period 1|left prematurely (while on treatment B)|0|||
105537338|NCT01192152|363969010|FG001|Period 1|left prematurely (while on treatment B)|1|||
105537339|NCT01192152|363969009|FG000|Period 3|family emergency|1|||
105537340|NCT01192152|363969010|FG001|Period 3|family emergency|0|||
105537341|NCT00715793|363969011|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
105537342|NCT00715793|363969012|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
105537343|NCT00715793|363969011|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
105537344|NCT00715793|363969012|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
105537345|NCT01559311|363969013|FG000|Overall Study|Protocol Violation|0|||
105537346|NCT01559311|363969014|FG001|Overall Study|Protocol Violation|0|||
105537347|NCT01559311|363969015|FG002|Overall Study|Protocol Violation|2|||
105537348|NCT01559311|363969013|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
105537349|NCT01559311|363969014|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
105537350|NCT01559311|363969015|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
105537351|NCT01559311|363969013|FG000|Overall Study|Withdrawal by Subject|2|||
105537352|NCT01559311|363969014|FG001|Overall Study|Withdrawal by Subject|1|||
105537353|NCT01559311|363969015|FG002|Overall Study|Withdrawal by Subject|0|||
105537354|NCT01559311|363969013|FG000|Overall Study|Death|0|||
105537355|NCT01559311|363969014|FG001|Overall Study|Death|2|||
105537356|NCT01559311|363969015|FG002|Overall Study|Death|3|||
105537357|NCT01559311|363969013|FG000|Overall Study|Lost to Follow-up|0|||
105537358|NCT01559311|363969014|FG001|Overall Study|Lost to Follow-up|3|||
105537359|NCT01559311|363969015|FG002|Overall Study|Lost to Follow-up|2|||
105537360|NCT01559311|363969013|FG000|Overall Study|Adverse Event|0|||
105537361|NCT01559311|363969014|FG001|Overall Study|Adverse Event|0|||
105537362|NCT01559311|363969015|FG002|Overall Study|Adverse Event|1|||
105537363|NCT00094653|363969016|FG000|Overall Study|Death|306|||
105537364|NCT00094653|363969017|FG001|Overall Study|Death|100|||
105537365|NCT00094653|363969018|FG002|Overall Study|Death|119|||
105537366|NCT00094653|363969016|FG000|Overall Study|Subject Withdrew Consent|10|||
105537367|NCT00094653|363969017|FG001|Overall Study|Subject Withdrew Consent|2|||
105537368|NCT00094653|363969018|FG002|Overall Study|Subject Withdrew Consent|3|||
105537369|NCT00094653|363969016|FG000|Overall Study|Other|2|||
105537370|NCT00094653|363969017|FG001|Overall Study|Other|2|||
105537371|NCT00094653|363969018|FG002|Overall Study|Other|2|||
105537372|NCT00094653|363969016|FG000|Overall Study|Lost to Follow-up|3|||
105537373|NCT00094653|363969017|FG001|Overall Study|Lost to Follow-up|2|||
105537374|NCT00094653|363969018|FG002|Overall Study|Lost to Follow-up|1|||
105537375|NCT00094653|363969016|FG000|Overall Study|Protocol Violation|0|||
105537376|NCT00094653|363969017|FG001|Overall Study|Protocol Violation|0|||
105537377|NCT00094653|363969018|FG002|Overall Study|Protocol Violation|1|||
105537378|NCT03120013|363969019|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
105537379|NCT03120013|363969020|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
105537380|NCT01541826|363969021|FG000|Overall Study|Lost to Follow-up|2|||
105537381|NCT01541826|363969022|FG001|Overall Study|Lost to Follow-up|3|||
105537382|NCT01541826|363969023|FG002|Overall Study|Lost to Follow-up|0|||
105537383|NCT01541826|363969021|FG000|Overall Study|Withdrawal by Subject|2|||
105537384|NCT01541826|363969022|FG001|Overall Study|Withdrawal by Subject|0|||
105537385|NCT01541826|363969023|FG002|Overall Study|Withdrawal by Subject|0|||
105537386|NCT02673775|363969024|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
105537387|NCT02673775|363969025|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
105537388|NCT02673775|363969024|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
105537389|NCT02673775|363969025|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
105537390|NCT02673775|363969024|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
105537391|NCT02673775|363969025|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
105537392|NCT02673775|363969024|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
105537393|NCT02673775|363969025|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
105537394|NCT03254134|363969026|FG000|Overall Study|Not eligible patients|599|||
105537395|NCT03254134|363969027|FG001|Overall Study|Not eligible patients|3630|||
105537396|NCT01462357|363969031|FG000|Overall Study|Death|0|||
105537397|NCT01462357|363969032|FG001|Overall Study|Death|0|||
105537398|NCT01462357|363969033|FG002|Overall Study|Death|1|||
105537399|NCT01462357|363969031|FG000|Overall Study|Withdrawal by Subject|3|||
105537400|NCT01462357|363969032|FG001|Overall Study|Withdrawal by Subject|11|||
105537401|NCT01462357|363969033|FG002|Overall Study|Withdrawal by Subject|3|||
105537402|NCT01462357|363969031|FG000|Overall Study|Migrated/moved from study area|2|||
105537403|NCT01462357|363969032|FG001|Overall Study|Migrated/moved from study area|3|||
105537404|NCT01462357|363969033|FG002|Overall Study|Migrated/moved from study area|1|||
105537405|NCT01462357|363969031|FG000|Overall Study|Lost to Follow-up|3|||
105537406|NCT01462357|363969032|FG001|Overall Study|Lost to Follow-up|5|||
105537407|NCT01462357|363969033|FG002|Overall Study|Lost to Follow-up|7|||
105537408|NCT04292730|363969038|FG000|Overall Study|Lost to Follow-up|8|||
105537409|NCT04292730|363969039|FG001|Overall Study|Lost to Follow-up|12|||
105537410|NCT04292730|363969040|FG002|Overall Study|Lost to Follow-up|12|||
105537411|NCT04292730|363969041|FG003|Overall Study|Lost to Follow-up|48|||
105537412|NCT04292730|363969038|FG000|Overall Study|Death|2|||
105537413|NCT04292730|363969039|FG001|Overall Study|Death|2|||
105537414|NCT04292730|363969040|FG002|Overall Study|Death|4|||
105537415|NCT04292730|363969041|FG003|Overall Study|Death|12|||
105537416|NCT04292730|363969038|FG000|Overall Study|Withdrew Consent|2|||
105537417|NCT04292730|363969039|FG001|Overall Study|Withdrew Consent|2|||
105537418|NCT04292730|363969040|FG002|Overall Study|Withdrew Consent|5|||
105537419|NCT04292730|363969041|FG003|Overall Study|Withdrew Consent|6|||
105537420|NCT04292730|363969038|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105537421|NCT04292730|363969039|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105537422|NCT04292730|363969040|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105537423|NCT04292730|363969041|FG003|Overall Study|Non-Compliance with Study Drug|0|||
105537424|NCT04292730|363969038|FG000|Overall Study|Protocol Violation|0|||
105537425|NCT04292730|363969039|FG001|Overall Study|Protocol Violation|0|||
105537426|NCT04292730|363969040|FG002|Overall Study|Protocol Violation|1|||
105537427|NCT04292730|363969041|FG003|Overall Study|Protocol Violation|0|||
105537428|NCT04292730|363969038|FG000|Overall Study|Randomized but not Treated|8|||
105537429|NCT04292730|363969039|FG001|Overall Study|Randomized but not Treated|4|||
105537430|NCT04292730|363969040|FG002|Overall Study|Randomized but not Treated|0|||
105537431|NCT04292730|363969041|FG003|Overall Study|Randomized but not Treated|14|||
105537432|NCT02188485|363969042|FG000|Overall Study|Withdrawal by Subject|2|||
105537433|NCT02188485|363969043|FG001|Overall Study|Withdrawal by Subject|1|||
105537434|NCT02188485|363969042|FG000|Overall Study|PI withdrew, lack of capacity|0|||
105537435|NCT02188485|363969043|FG001|Overall Study|PI withdrew, lack of capacity|2|||
105537436|NCT02501096|363969045|FG000|Overall Study|Lost to Follow-up|0|||
105537437|NCT02501096|363969046|FG001|Overall Study|Lost to Follow-up|0|||
105537438|NCT02501096|363969047|FG002|Overall Study|Lost to Follow-up|0|||
105537439|NCT02501096|363969048|FG003|Overall Study|Lost to Follow-up|0|||
105537440|NCT02501096|363969049|FG004|Overall Study|Lost to Follow-up|1|||
105537441|NCT02501096|363969050|FG005|Overall Study|Lost to Follow-up|1|||
105537442|NCT02501096|363969051|FG006|Overall Study|Lost to Follow-up|3|||
105537443|NCT02501096|363969052|FG007|Overall Study|Lost to Follow-up|0|||
105537444|NCT02501096|363969053|FG008|Overall Study|Lost to Follow-up|0|||
105537445|NCT02501096|363969045|FG000|Overall Study|Withdrawal by Subject|1|||
105537446|NCT02501096|363969046|FG001|Overall Study|Withdrawal by Subject|0|||
105537447|NCT02501096|363969047|FG002|Overall Study|Withdrawal by Subject|7|||
105537448|NCT02501096|363969048|FG003|Overall Study|Withdrawal by Subject|13|||
105537449|NCT02501096|363969049|FG004|Overall Study|Withdrawal by Subject|2|||
105537450|NCT02501096|363969050|FG005|Overall Study|Withdrawal by Subject|2|||
105537451|NCT02501096|363969051|FG006|Overall Study|Withdrawal by Subject|2|||
105537452|NCT02501096|363969052|FG007|Overall Study|Withdrawal by Subject|3|||
105537453|NCT02501096|363969053|FG008|Overall Study|Withdrawal by Subject|0|||
105537454|NCT02501096|363969045|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
105537455|NCT02501096|363969046|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
105537456|NCT02501096|363969047|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
105537457|NCT02501096|363969048|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
105537458|NCT02501096|363969049|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
105537459|NCT02501096|363969050|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
105537460|NCT02501096|363969051|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
105537461|NCT02501096|363969052|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
105537462|NCT02501096|363969053|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
105537463|NCT02501096|363969045|FG000|Overall Study|Death|1|||
105537464|NCT02501096|363969046|FG001|Overall Study|Death|1|||
105537465|NCT02501096|363969047|FG002|Overall Study|Death|88|||
105537466|NCT02501096|363969048|FG003|Overall Study|Death|74|||
105537467|NCT02501096|363969049|FG004|Overall Study|Death|15|||
105537468|NCT02501096|363969050|FG005|Overall Study|Death|16|||
105537469|NCT02501096|363969051|FG006|Overall Study|Death|15|||
105537470|NCT02501096|363969052|FG007|Overall Study|Death|16|||
105537471|NCT02501096|363969053|FG008|Overall Study|Death|1|||
105537472|NCT02751983|363969055|FG000|Treatment|Stopped ACT, but Remained in study|2|||
105537473|NCT02751983|363969056|FG001|Treatment|Stopped ACT, but Remained in study|0|||
105537474|NCT02751983|363969055|FG000|Treatment|Discharged prior to beginning ACT|2|||
105537475|NCT02751983|363969056|FG001|Treatment|Discharged prior to beginning ACT|0|||
105537476|NCT02751983|363969055|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
105537477|NCT02751983|363969056|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
105537478|NCT02751983|363969055|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
105537479|NCT02751983|363969056|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
105537480|NCT02751983|363969055|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
105537481|NCT02751983|363969056|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
105537482|NCT01420081|363969059|FG000|Overall Study|Death|1|||
105537483|NCT01420081|363969060|FG001|Overall Study|Death|0|||
105537484|NCT01420081|363969061|FG002|Overall Study|Death|8|||
105537485|NCT01420081|363969062|FG003|Overall Study|Death|0|||
105537486|NCT01420081|363969063|FG004|Overall Study|Death|7|||
105537487|NCT01420081|363969064|FG005|Overall Study|Death|12|||
105537488|NCT01420081|363969065|FG006|Overall Study|Death|0|||
105537489|NCT01420081|363969066|FG007|Overall Study|Death|1|||
105537490|NCT01420081|363969067|FG008|Overall Study|Death|1|||
105537491|NCT01420081|363969059|FG000|Overall Study|Lost to Follow-up|0|||
105537492|NCT01420081|363969060|FG001|Overall Study|Lost to Follow-up|0|||
105537493|NCT01420081|363969061|FG002|Overall Study|Lost to Follow-up|0|||
105537494|NCT01420081|363969062|FG003|Overall Study|Lost to Follow-up|0|||
105537495|NCT01420081|363969063|FG004|Overall Study|Lost to Follow-up|1|||
105537496|NCT01420081|363969064|FG005|Overall Study|Lost to Follow-up|1|||
105537497|NCT01420081|363969065|FG006|Overall Study|Lost to Follow-up|0|||
105537498|NCT01420081|363969066|FG007|Overall Study|Lost to Follow-up|0|||
105537499|NCT01420081|363969067|FG008|Overall Study|Lost to Follow-up|0|||
105537500|NCT01420081|363969059|FG000|Overall Study|Study Terminated by Sponsor|2|||
105537501|NCT01420081|363969060|FG001|Overall Study|Study Terminated by Sponsor|1|||
105537502|NCT01420081|363969061|FG002|Overall Study|Study Terminated by Sponsor|1|||
105537503|NCT01420081|363969062|FG003|Overall Study|Study Terminated by Sponsor|3|||
105537504|NCT01420081|363969063|FG004|Overall Study|Study Terminated by Sponsor|11|||
105537505|NCT01420081|363969064|FG005|Overall Study|Study Terminated by Sponsor|7|||
105537506|NCT01420081|363969065|FG006|Overall Study|Study Terminated by Sponsor|3|||
105537507|NCT01420081|363969066|FG007|Overall Study|Study Terminated by Sponsor|2|||
105537508|NCT01420081|363969067|FG008|Overall Study|Study Terminated by Sponsor|2|||
105537509|NCT01420081|363969059|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
105537510|NCT01420081|363969060|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
105537511|NCT01420081|363969061|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
105537512|NCT01420081|363969062|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
105537513|NCT01420081|363969063|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
105537514|NCT01420081|363969064|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
105537515|NCT01420081|363969065|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
105537516|NCT01420081|363969066|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
105537517|NCT01420081|363969067|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
105537518|NCT01420081|363969059|FG000|Overall Study|Other Reasons|0|||
105537519|NCT01420081|363969060|FG001|Overall Study|Other Reasons|0|||
105537520|NCT01420081|363969061|FG002|Overall Study|Other Reasons|1|||
105537521|NCT01420081|363969062|FG003|Overall Study|Other Reasons|0|||
105537522|NCT01420081|363969063|FG004|Overall Study|Other Reasons|0|||
105537523|NCT01420081|363969064|FG005|Overall Study|Other Reasons|0|||
105537524|NCT01420081|363969065|FG006|Overall Study|Other Reasons|0|||
105537525|NCT01420081|363969066|FG007|Overall Study|Other Reasons|0|||
105537526|NCT01420081|363969067|FG008|Overall Study|Other Reasons|0|||
105537527|NCT00414388|363969068|FG000|Overall Study|Adverse Event|1|||
105537528|NCT03591575|363969070|FG000|Overall Study|Adverse Event|2|||
105595436|NCT02957539|364180192|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
105537529|NCT03591575|363969071|FG001|Overall Study|Adverse Event|0|||
105537530|NCT03591575|363969070|FG000|Overall Study|Withdrawal by Subject|4|||
105537531|NCT03591575|363969071|FG001|Overall Study|Withdrawal by Subject|1|||
105537532|NCT00025883|363969072|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
105537533|NCT00025883|363969072|FG000|Overall Study|no baseline data|1|||
105537534|NCT00025883|363969072|FG000|Overall Study|Death|1|||
105537535|NCT00025883|363969072|FG000|Overall Study|Adverse Event|1|||
105537536|NCT00025883|363969072|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
105537537|NCT00813358|363969075|FG000|Overall Study|Death|32|||
105537538|NCT00813358|363969075|FG000|Overall Study|Lost to Follow-up|12|||
105537539|NCT00813358|363969075|FG000|Overall Study|other endpoints|5|||
105537540|NCT00813358|363969075|FG000|Overall Study|Withdrawal by Subject|20|||
105537541|NCT01723228|363969076|FG000|Overall Study|Adverse Event|2|||
105537542|NCT01723228|363969077|FG001|Overall Study|Adverse Event|6|||
105537543|NCT01723228|363969076|FG000|Overall Study|Withdrawal by Subject|2|||
105537544|NCT01723228|363969077|FG001|Overall Study|Withdrawal by Subject|1|||
105537545|NCT01723228|363969076|FG000|Overall Study|Protocol Violation|0|||
105537546|NCT01723228|363969077|FG001|Overall Study|Protocol Violation|2|||
105537547|NCT01723228|363969076|FG000|Overall Study|Lost to Follow-up|2|||
105537548|NCT01723228|363969077|FG001|Overall Study|Lost to Follow-up|1|||
105537549|NCT01723228|363969076|FG000|Overall Study|Other|2|||
105537550|NCT01723228|363969077|FG001|Overall Study|Other|1|||
105537551|NCT00218543|363969078|FG000|Overall Study|Lost to Follow-up|8|||
105537552|NCT00218543|363969078|FG000|Overall Study|relocated|1|||
105537553|NCT00218543|363969078|FG000|Overall Study|Withdrawal by Subject|1|||
105537554|NCT00218543|363969078|FG000|Overall Study|Physician Decision|3|||
105537555|NCT00218543|363969078|FG000|Overall Study|Adverse Event|2|||
105537556|NCT00004031|363969079|FG000|Overall Study|Adverse Event|5|||
105537557|NCT00004031|363969080|FG001|Overall Study|Adverse Event|0|||
105537558|NCT00004031|363969079|FG000|Overall Study|Refusal unrelated to adverse events|2|||
105537559|NCT00004031|363969080|FG001|Overall Study|Refusal unrelated to adverse events|11|||
105537560|NCT00004031|363969079|FG000|Overall Study|Progression/relapse|9|||
105537561|NCT00004031|363969080|FG001|Overall Study|Progression/relapse|4|||
105537562|NCT00004031|363969079|FG000|Overall Study|Death|3|||
105537563|NCT00004031|363969080|FG001|Overall Study|Death|1|||
105537564|NCT00004031|363969079|FG000|Overall Study|Other- not protocol specified|3|||
105537565|NCT00004031|363969080|FG001|Overall Study|Other- not protocol specified|3|||
105537566|NCT00004031|363969079|FG000|Overall Study|Reason under review|3|||
105537567|NCT00004031|363969080|FG001|Overall Study|Reason under review|2|||
105537568|NCT01864291|363969081|FG000|Overall Study|need for revision surgery|2|||
105537569|NCT01282216|363969082|FG000|Overall Study|Graft failure|0|||
105537570|NCT01282216|363969083|FG001|Overall Study|Graft failure|0|||
105537571|NCT01282216|363969084|FG002|Overall Study|Graft failure|3|||
105537572|NCT01282216|363969085|FG003|Overall Study|Graft failure|2|||
105537573|NCT01282216|363969082|FG000|Overall Study|Physician Decision|0|||
105537574|NCT01282216|363969083|FG001|Overall Study|Physician Decision|0|||
105537575|NCT01282216|363969084|FG002|Overall Study|Physician Decision|11|||
105537576|NCT01282216|363969085|FG003|Overall Study|Physician Decision|0|||
105537577|NCT01282216|363969082|FG000|Overall Study|Relapse|0|||
105537578|NCT01282216|363969083|FG001|Overall Study|Relapse|0|||
105537579|NCT01282216|363969084|FG002|Overall Study|Relapse|17|||
105537580|NCT01282216|363969085|FG003|Overall Study|Relapse|6|||
105537581|NCT01282216|363969082|FG000|Overall Study|Death|0|||
105537582|NCT01282216|363969083|FG001|Overall Study|Death|0|||
105537583|NCT01282216|363969084|FG002|Overall Study|Death|2|||
105537584|NCT01282216|363969085|FG003|Overall Study|Death|0|||
105537585|NCT01451424|363969086|FG000|Overall Study|Withdrawal by Subject|1|||
105537586|NCT01451424|363969087|FG001|Overall Study|Withdrawal by Subject|1|||
105537587|NCT01451424|363969088|FG002|Overall Study|Withdrawal by Subject|0|||
105537588|NCT01451424|363969089|FG003|Overall Study|Withdrawal by Subject|2|||
105537589|NCT01451424|363969086|FG000|Overall Study|Lost to Follow-up|0|||
105537590|NCT01451424|363969087|FG001|Overall Study|Lost to Follow-up|1|||
105537591|NCT01451424|363969088|FG002|Overall Study|Lost to Follow-up|0|||
105537592|NCT01451424|363969089|FG003|Overall Study|Lost to Follow-up|1|||
105537593|NCT01451424|363969086|FG000|Overall Study|Physician Decision|0|||
105537594|NCT01451424|363969087|FG001|Overall Study|Physician Decision|0|||
105537595|NCT01451424|363969088|FG002|Overall Study|Physician Decision|1|||
105537596|NCT01451424|363969089|FG003|Overall Study|Physician Decision|1|||
105537597|NCT01451424|363969086|FG000|Overall Study|Adverse Event|0|||
105537598|NCT01451424|363969087|FG001|Overall Study|Adverse Event|0|||
105537599|NCT01451424|363969088|FG002|Overall Study|Adverse Event|0|||
105537600|NCT01451424|363969089|FG003|Overall Study|Adverse Event|1|||
105537601|NCT04346615|363970653|FG000|Overall Study|Lost to Follow-up|0|||
105537602|NCT04346615|363970654|FG001|Overall Study|Lost to Follow-up|2|||
105537603|NCT04346615|363970653|FG000|Overall Study|Withdrawal by Subject|1|||
105537604|NCT04346615|363970654|FG001|Overall Study|Withdrawal by Subject|0|||
105537605|NCT04346615|363970653|FG000|Overall Study|Death|5|||
105537606|NCT04346615|363970654|FG001|Overall Study|Death|1|||
105537607|NCT04346615|363970653|FG000|Overall Study|Other|0|||
105537608|NCT04346615|363970654|FG001|Overall Study|Other|2|||
105537609|NCT04346615|363970653|FG000|Overall Study|Randomized not treated|1|||
105537610|NCT04346615|363970654|FG001|Overall Study|Randomized not treated|0|||
105537611|NCT01513317|363970655|FG000|Overall Study|Withdrawal by Subject|15|||
105537612|NCT01513317|363970656|FG001|Overall Study|Withdrawal by Subject|4|||
105537613|NCT01513317|363970655|FG000|Overall Study|Death|1|||
105537614|NCT01513317|363970656|FG001|Overall Study|Death|1|||
105537615|NCT01513317|363970655|FG000|Overall Study|Study terminated by sponsor|18|||
105537616|NCT01513317|363970656|FG001|Overall Study|Study terminated by sponsor|18|||
105537617|NCT01513317|363970655|FG000|Overall Study|Other|0|||
105537618|NCT01513317|363970656|FG001|Overall Study|Other|1|||
105537619|NCT04108130|363970657|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
105537620|NCT04108130|363970658|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
105537621|NCT04108130|363970657|FG000|Overall Study|Consent Withdrawn|9|||
105537622|NCT04108130|363970658|FG001|Overall Study|Consent Withdrawn|6|||
105537623|NCT04108130|363970657|FG000|Overall Study|Surgery Cancelled|4|||
105537624|NCT04108130|363970658|FG001|Overall Study|Surgery Cancelled|4|||
105537625|NCT04108130|363970657|FG000|Overall Study|Found Ineligible for Study|4|||
105537626|NCT04108130|363970658|FG001|Overall Study|Found Ineligible for Study|3|||
105537627|NCT04108130|363970657|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
105537628|NCT04108130|363970658|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
105537629|NCT04108130|363970657|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
105537630|NCT04108130|363970658|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
105537631|NCT02097134|363970661|FG000|Overall Study|Physician Decision|4|||
105537632|NCT02097134|363970661|FG000|Overall Study|Non-Protocol Therapy|1|||
105537633|NCT02097134|363970661|FG000|Overall Study|Progressive Disease|3|||
105537634|NCT02097134|363970661|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
105537635|NCT00634647|363970662|FG000|Overall Study|death on study|3|||
105537636|NCT00634647|363970662|FG000|Overall Study|refused further treatment|3|||
105537637|NCT00634647|363970662|FG000|Overall Study|declined to participate before treatment|1|||
105537638|NCT00298896|363970666|FG000|Overall Study|Death|3|||
105537639|NCT00298896|363970666|FG000|Overall Study|Physician Decision|2|||
105537640|NCT00298896|363970666|FG000|Overall Study|Intercurrent Illness|1|||
105537641|NCT00298896|363970666|FG000|Overall Study|Disease Progression|41|||
105537642|NCT00298896|363970666|FG000|Overall Study|Withdrawal by Subject|2|||
105537643|NCT00298896|363970666|FG000|Overall Study|Assigned to treatment in error|1|||
105537644|NCT02649972|363970669|FG000|Overall Study|Not treated|1|||
105537645|NCT03285646|363970670|FG000|Overall Study|Adverse Event|1|||
105537646|NCT03285646|363970671|FG001|Overall Study|Adverse Event|0|||
105537647|NCT03285646|363970670|FG000|Overall Study|Withdrawal by Subject|10|||
105537648|NCT03285646|363970671|FG001|Overall Study|Withdrawal by Subject|2|||
105537649|NCT03285646|363970670|FG000|Overall Study|Lost to Follow-up|2|||
105537650|NCT03285646|363970671|FG001|Overall Study|Lost to Follow-up|1|||
105537651|NCT03285646|363970670|FG000|Overall Study|Investigator/Sponsor Decision|0|||
105537652|NCT03285646|363970671|FG001|Overall Study|Investigator/Sponsor Decision|1|||
105537653|NCT00503841|363970672|FG000|Overall Study|All screen failures|44|||
105537654|NCT01344057|363970673|FG000|Overall Study|Premature Withdrawal|1|||
105537655|NCT00306592|363970674|FG000|Overall Study|Adverse Event|8|||
105537656|NCT00306592|363970675|FG001|Overall Study|Adverse Event|15|||
105537657|NCT00306592|363970674|FG000|Overall Study|Lost to Follow-up|1|||
105537658|NCT00306592|363970675|FG001|Overall Study|Lost to Follow-up|0|||
105537659|NCT00306592|363970674|FG000|Overall Study|Noncompliance|0|||
105537660|NCT00306592|363970675|FG001|Overall Study|Noncompliance|2|||
105537661|NCT00306592|363970674|FG000|Overall Study|Persistent Antibodies|6|||
105537662|NCT00306592|363970675|FG001|Overall Study|Persistent Antibodies|3|||
105537663|NCT00306592|363970674|FG000|Overall Study|Voluntary|10|||
105537664|NCT00306592|363970675|FG001|Overall Study|Voluntary|6|||
105537665|NCT00306592|363970674|FG000|Overall Study|Other|5|||
105537666|NCT00306592|363970675|FG001|Overall Study|Other|10|||
105537667|NCT00306592|363970674|FG000|Overall Study|Other|1|||
105537668|NCT00306592|363970675|FG001|Overall Study|Other|2|||
105537669|NCT00306592|363970674|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
105537670|NCT00306592|363970675|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
105537671|NCT01481116|363970676|FG000|Overall Study|Adverse Event|26|||
105537672|NCT01481116|363970677|FG001|Overall Study|Adverse Event|26|||
105537673|NCT01481116|363970678|FG002|Overall Study|Adverse Event|42|||
105537674|NCT01481116|363970676|FG000|Overall Study|Major Protocol Deviation|3|||
105537675|NCT01481116|363970677|FG001|Overall Study|Major Protocol Deviation|7|||
105537676|NCT01481116|363970678|FG002|Overall Study|Major Protocol Deviation|1|||
105537677|NCT01481116|363970676|FG000|Overall Study|Lost to Follow-up|8|||
105537678|NCT01481116|363970677|FG001|Overall Study|Lost to Follow-up|12|||
105537679|NCT01481116|363970678|FG002|Overall Study|Lost to Follow-up|11|||
105537680|NCT01481116|363970676|FG000|Overall Study|Withdrawal by Subject|37|||
105537681|NCT01481116|363970677|FG001|Overall Study|Withdrawal by Subject|33|||
105537682|NCT01481116|363970678|FG002|Overall Study|Withdrawal by Subject|37|||
105537683|NCT01481116|363970676|FG000|Overall Study|Study Termination|730|||
105537684|NCT01481116|363970677|FG001|Overall Study|Study Termination|729|||
105537685|NCT01481116|363970678|FG002|Overall Study|Study Termination|713|||
105537686|NCT01481116|363970676|FG000|Overall Study|Pregnancy|0|||
105537687|NCT01481116|363970677|FG001|Overall Study|Pregnancy|0|||
105537688|NCT01481116|363970678|FG002|Overall Study|Pregnancy|1|||
105537689|NCT01481116|363970676|FG000|Overall Study|Lack of Efficacy|3|||
105537690|NCT01481116|363970677|FG001|Overall Study|Lack of Efficacy|3|||
105537691|NCT01481116|363970678|FG002|Overall Study|Lack of Efficacy|1|||
105537692|NCT01481116|363970676|FG000|Overall Study|Contraindications|1|||
105537693|NCT01481116|363970677|FG001|Overall Study|Contraindications|1|||
105537694|NCT01481116|363970678|FG002|Overall Study|Contraindications|0|||
105537695|NCT01481116|363970676|FG000|Overall Study|Other|1|||
105537696|NCT01481116|363970677|FG001|Overall Study|Other|1|||
105537697|NCT01481116|363970678|FG002|Overall Study|Other|0|||
105537698|NCT01481116|363970676|FG000|Overall Study|Participant Started Taking Glipizide|1|||
105537699|NCT01481116|363970677|FG001|Overall Study|Participant Started Taking Glipizide|0|||
105537700|NCT01481116|363970678|FG002|Overall Study|Participant Started Taking Glipizide|0|||
105537701|NCT01481116|363970676|FG000|Overall Study|Participant Moved Out of Area|2|||
105537702|NCT01481116|363970677|FG001|Overall Study|Participant Moved Out of Area|0|||
105537703|NCT01481116|363970678|FG002|Overall Study|Participant Moved Out of Area|1|||
105537704|NCT01481116|363970676|FG000|Overall Study|Participant Moved Out of Country|1|||
105537705|NCT01481116|363970677|FG001|Overall Study|Participant Moved Out of Country|0|||
105537706|NCT01481116|363970678|FG002|Overall Study|Participant Moved Out of Country|1|||
105537707|NCT01481116|363970676|FG000|Overall Study|Investigator Decision|3|||
105537708|NCT01481116|363970677|FG001|Overall Study|Investigator Decision|2|||
105537709|NCT01481116|363970678|FG002|Overall Study|Investigator Decision|1|||
105537710|NCT01481116|363970676|FG000|Overall Study|Sponsor Decision|0|||
105537711|NCT01481116|363970677|FG001|Overall Study|Sponsor Decision|1|||
105537712|NCT01481116|363970678|FG002|Overall Study|Sponsor Decision|3|||
105537713|NCT01481116|363970676|FG000|Overall Study|Non-Compliant With Study Drug|0|||
105537714|NCT01481116|363970677|FG001|Overall Study|Non-Compliant With Study Drug|1|||
105537715|NCT01481116|363970678|FG002|Overall Study|Non-Compliant With Study Drug|1|||
105537716|NCT01481116|363970676|FG000|Overall Study|Investigator's Discretion|2|||
105537717|NCT01481116|363970677|FG001|Overall Study|Investigator's Discretion|0|||
105537718|NCT01481116|363970678|FG002|Overall Study|Investigator's Discretion|0|||
105537719|NCT01481116|363970676|FG000|Overall Study|Death|2|||
105537720|NCT01481116|363970677|FG001|Overall Study|Death|1|||
105537721|NCT01481116|363970678|FG002|Overall Study|Death|0|||
105537722|NCT01481116|363970676|FG000|Overall Study|Hypoglycemic Event|4|||
105537723|NCT01481116|363970677|FG001|Overall Study|Hypoglycemic Event|0|||
105537724|NCT01481116|363970678|FG002|Overall Study|Hypoglycemic Event|0|||
105537725|NCT03592641|363970679|FG000|Overall Study|Withdrawal by Subject|1|||
105537726|NCT00436280|363970680|FG000|Period 1: Induction|Adverse Event|8|||
105537727|NCT00436280|363970680|FG000|Period 1: Induction|Progressive Disease|12|||
105537728|NCT00436280|363970680|FG000|Period 1: Induction|Stable Disease|6|||
105537729|NCT00436280|363970680|FG000|Period 1: Induction|Withdrawal by Subject|1|||
105537730|NCT00436280|363970680|FG000|Period 1: Induction|Death|1|||
105537731|NCT00436280|363970680|FG000|Period 2: Consolidation|Adverse Event|1|||
105537732|NCT00436280|363970680|FG000|Period 2: Consolidation|Progressive Disease|10|||
105537733|NCT00436280|363970680|FG000|Period 2: Consolidation|Stable Disease|1|||
105537734|NCT00436280|363970680|FG000|Period 2: Consolidation|Physician Decision|2|||
105537735|NCT00436280|363970680|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
105537736|NCT00436280|363970680|FG000|Period 2: Consolidation|Death|1|||
105537737|NCT00436280|363970680|FG000|Period 3: Maintenance|Adverse Event|6|||
105537738|NCT00436280|363970680|FG000|Period 3: Maintenance|Progressive Disease|12|||
105537739|NCT01049919|363970683|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
105537740|NCT01049919|363970684|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
105537741|NCT01049919|363970683|FG000|Overall Study|Withdrawal by Subject|5|||
105537742|NCT01049919|363970684|FG001|Overall Study|Withdrawal by Subject|0|||
105537743|NCT01049919|363970683|FG000|Overall Study|Lost to Follow-up|6|||
105537744|NCT01049919|363970684|FG001|Overall Study|Lost to Follow-up|1|||
105537745|NCT01049919|363970683|FG000|Overall Study|Physician Decision|2|||
105537746|NCT01049919|363970684|FG001|Overall Study|Physician Decision|0|||
105537747|NCT01049919|363970683|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
105537748|NCT01049919|363970684|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
105537749|NCT01049919|363970683|FG000|Overall Study|Early study termination by sponsor.|2|||
105537750|NCT01049919|363970684|FG001|Overall Study|Early study termination by sponsor.|0|||
105537751|NCT02103478|363970685|FG000|Overall Study|Adverse Event|0|||
105537752|NCT02103478|363970686|FG001|Overall Study|Adverse Event|0|||
105537753|NCT02103478|363970687|FG002|Overall Study|Adverse Event|1|||
105537754|NCT02103478|363970688|FG003|Overall Study|Adverse Event|1|||
105537755|NCT02103478|363970689|FG004|Overall Study|Adverse Event|2|||
105537756|NCT02103478|363970690|FG005|Overall Study|Adverse Event|1|||
105537757|NCT02103478|363970691|FG006|Overall Study|Adverse Event|0|||
105537758|NCT02103478|363970692|FG007|Overall Study|Adverse Event|0|||
105537759|NCT02103478|363970693|FG008|Overall Study|Adverse Event|0|||
105537760|NCT02103478|363970685|FG000|Overall Study|Death|2|||
105537761|NCT02103478|363970686|FG001|Overall Study|Death|2|||
105537762|NCT02103478|363970687|FG002|Overall Study|Death|1|||
105537763|NCT02103478|363970688|FG003|Overall Study|Death|1|||
105537764|NCT02103478|363970689|FG004|Overall Study|Death|5|||
105537765|NCT02103478|363970690|FG005|Overall Study|Death|15|||
105537766|NCT02103478|363970691|FG006|Overall Study|Death|14|||
105537767|NCT02103478|363970692|FG007|Overall Study|Death|10|||
105537768|NCT02103478|363970693|FG008|Overall Study|Death|11|||
105537769|NCT02103478|363970685|FG000|Overall Study|Progressive Disease|2|||
105537770|NCT02103478|363970686|FG001|Overall Study|Progressive Disease|1|||
105537771|NCT02103478|363970687|FG002|Overall Study|Progressive Disease|2|||
105537772|NCT02103478|363970688|FG003|Overall Study|Progressive Disease|0|||
105537773|NCT02103478|363970689|FG004|Overall Study|Progressive Disease|9|||
105537774|NCT02103478|363970690|FG005|Overall Study|Progressive Disease|1|||
105537775|NCT02103478|363970691|FG006|Overall Study|Progressive Disease|2|||
105537776|NCT02103478|363970692|FG007|Overall Study|Progressive Disease|0|||
105537777|NCT02103478|363970693|FG008|Overall Study|Progressive Disease|1|||
105537778|NCT02103478|363970685|FG000|Overall Study|Withdrawal by Subject|2|||
105537779|NCT02103478|363970686|FG001|Overall Study|Withdrawal by Subject|0|||
105537780|NCT02103478|363970687|FG002|Overall Study|Withdrawal by Subject|0|||
105537781|NCT02103478|363970688|FG003|Overall Study|Withdrawal by Subject|4|||
105537782|NCT02103478|363970689|FG004|Overall Study|Withdrawal by Subject|0|||
105537783|NCT02103478|363970690|FG005|Overall Study|Withdrawal by Subject|0|||
105537784|NCT02103478|363970691|FG006|Overall Study|Withdrawal by Subject|1|||
105537785|NCT02103478|363970692|FG007|Overall Study|Withdrawal by Subject|1|||
105537786|NCT02103478|363970693|FG008|Overall Study|Withdrawal by Subject|0|||
105537787|NCT02103478|363970685|FG000|Overall Study|Lost to Follow-up|0|||
105537788|NCT02103478|363970686|FG001|Overall Study|Lost to Follow-up|0|||
105537789|NCT02103478|363970687|FG002|Overall Study|Lost to Follow-up|0|||
105537790|NCT02103478|363970688|FG003|Overall Study|Lost to Follow-up|0|||
105537791|NCT02103478|363970689|FG004|Overall Study|Lost to Follow-up|0|||
105537792|NCT02103478|363970690|FG005|Overall Study|Lost to Follow-up|0|||
105537793|NCT02103478|363970691|FG006|Overall Study|Lost to Follow-up|0|||
105537794|NCT02103478|363970692|FG007|Overall Study|Lost to Follow-up|1|||
105537795|NCT02103478|363970693|FG008|Overall Study|Lost to Follow-up|0|||
105537796|NCT02103478|363970685|FG000|Overall Study|Other|1|||
105537797|NCT02103478|363970686|FG001|Overall Study|Other|3|||
105537798|NCT02103478|363970687|FG002|Overall Study|Other|2|||
105537799|NCT02103478|363970688|FG003|Overall Study|Other|0|||
105537800|NCT02103478|363970689|FG004|Overall Study|Other|3|||
105537801|NCT02103478|363970690|FG005|Overall Study|Other|8|||
105537802|NCT02103478|363970691|FG006|Overall Study|Other|8|||
105537803|NCT02103478|363970692|FG007|Overall Study|Other|4|||
105537804|NCT02103478|363970693|FG008|Overall Study|Other|2|||
105537805|NCT03603964|363970694|FG000|Overall Study|Death|9|||
105537806|NCT03603964|363970694|FG000|Overall Study|Withdrawal by participant|7|||
105537807|NCT03603964|363970694|FG000|Overall Study|Study terminated by Sponsor|19|||
105537808|NCT03219333|363970695|FG000|Overall Study|Withdrawal by Subject|9|||
105537809|NCT03219333|363970696|FG001|Overall Study|Withdrawal by Subject|4|||
105537810|NCT03219333|363970695|FG000|Overall Study|Lost to Follow-up|1|||
105537811|NCT03219333|363970696|FG001|Overall Study|Lost to Follow-up|1|||
105537812|NCT03219333|363970695|FG000|Overall Study|Death|104|||
105537813|NCT03219333|363970696|FG001|Overall Study|Death|72|||
105537814|NCT03219333|363970695|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
105537815|NCT03219333|363970696|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
105537816|NCT03219333|363970695|FG000|Overall Study|Other|2|||
105537817|NCT03219333|363970696|FG001|Overall Study|Other|2|||
105537818|NCT00723606|363970697|FG000|Overall Study|Adverse Event|2|||
105537819|NCT00723606|363970698|FG001|Overall Study|Adverse Event|5|||
105537820|NCT00723606|363970697|FG000|Overall Study|Other|2|||
105537821|NCT00723606|363970698|FG001|Overall Study|Other|0|||
105537822|NCT00723606|363970697|FG000|Overall Study|Withdrawal by Subject|0|||
105537823|NCT00723606|363970698|FG001|Overall Study|Withdrawal by Subject|2|||
105537824|NCT01126541|363970699|FG000|Overall Study|Adverse Event|0|||
105537825|NCT01126541|363970700|FG001|Overall Study|Adverse Event|2|||
105537826|NCT01126541|363970701|FG002|Overall Study|Adverse Event|4|||
105537827|NCT01126541|363970699|FG000|Overall Study|Death|0|||
105537828|NCT01126541|363970700|FG001|Overall Study|Death|1|||
105537829|NCT01126541|363970701|FG002|Overall Study|Death|0|||
105537830|NCT01126541|363970699|FG000|Overall Study|Lack of Efficacy|6|||
105537831|NCT01126541|363970700|FG001|Overall Study|Lack of Efficacy|1|||
105537832|NCT01126541|363970701|FG002|Overall Study|Lack of Efficacy|11|||
105537833|NCT01126541|363970699|FG000|Overall Study|Lost to Follow-up|1|||
105537834|NCT01126541|363970700|FG001|Overall Study|Lost to Follow-up|2|||
105537835|NCT01126541|363970701|FG002|Overall Study|Lost to Follow-up|2|||
105537836|NCT01126541|363970699|FG000|Overall Study|Withdrawal by Subject|2|||
105537837|NCT01126541|363970700|FG001|Overall Study|Withdrawal by Subject|5|||
105537838|NCT01126541|363970701|FG002|Overall Study|Withdrawal by Subject|6|||
105537839|NCT01126541|363970699|FG000|Overall Study|Protocol Violation|0|||
105537840|NCT01126541|363970700|FG001|Overall Study|Protocol Violation|0|||
105537841|NCT01126541|363970701|FG002|Overall Study|Protocol Violation|1|||
105537842|NCT01126541|363970699|FG000|Overall Study|Administrative reason or other|1|||
105537843|NCT01126541|363970700|FG001|Overall Study|Administrative reason or other|1|||
105537844|NCT01126541|363970701|FG002|Overall Study|Administrative reason or other|2|||
105537845|NCT00226941|363970702|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
105537846|NCT00226941|363970703|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
105537847|NCT00226941|363970704|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
105537848|NCT00226941|363970705|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
105537849|NCT00226941|363970702|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
105537850|NCT00226941|363970703|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
105537851|NCT00226941|363970704|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
105537852|NCT00226941|363970705|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
105537853|NCT01513291|363970706|FG000|Treatment Period|Adverse Event|8|||
105537854|NCT01513291|363970707|FG001|Treatment Period|Adverse Event|4|||
105537855|NCT01513291|363970708|FG002|Treatment Period|Adverse Event|0|||
105537856|NCT01513291|363970709|FG003|Treatment Period|Adverse Event|0|||
105537857|NCT01513291|363970710|FG004|Treatment Period|Adverse Event|0|||
105537858|NCT01513291|363970706|FG000|Treatment Period|Lack of Efficacy|3|||
105537859|NCT01513291|363970707|FG001|Treatment Period|Lack of Efficacy|0|||
105537860|NCT01513291|363970708|FG002|Treatment Period|Lack of Efficacy|0|||
105537861|NCT01513291|363970709|FG003|Treatment Period|Lack of Efficacy|0|||
105537862|NCT01513291|363970710|FG004|Treatment Period|Lack of Efficacy|0|||
105537863|NCT01513291|363970706|FG000|Treatment Period|Lost to Follow-up|2|||
105537864|NCT01513291|363970707|FG001|Treatment Period|Lost to Follow-up|3|||
105537865|NCT01513291|363970708|FG002|Treatment Period|Lost to Follow-up|0|||
105537866|NCT01513291|363970709|FG003|Treatment Period|Lost to Follow-up|0|||
105537867|NCT01513291|363970710|FG004|Treatment Period|Lost to Follow-up|0|||
105537868|NCT01513291|363970706|FG000|Treatment Period|Physician Decision|1|||
105537869|NCT01513291|363970707|FG001|Treatment Period|Physician Decision|0|||
105537870|NCT01513291|363970708|FG002|Treatment Period|Physician Decision|0|||
105537871|NCT01513291|363970709|FG003|Treatment Period|Physician Decision|0|||
105537872|NCT01513291|363970710|FG004|Treatment Period|Physician Decision|0|||
105537873|NCT01513291|363970706|FG000|Treatment Period|Protocol Violation|1|||
105537874|NCT01513291|363970707|FG001|Treatment Period|Protocol Violation|2|||
105537875|NCT01513291|363970708|FG002|Treatment Period|Protocol Violation|0|||
105537876|NCT01513291|363970709|FG003|Treatment Period|Protocol Violation|0|||
105537877|NCT01513291|363970710|FG004|Treatment Period|Protocol Violation|0|||
105537878|NCT01513291|363970706|FG000|Treatment Period|Withdrawal by Subject|8|||
105537879|NCT01513291|363970707|FG001|Treatment Period|Withdrawal by Subject|5|||
105537880|NCT01513291|363970708|FG002|Treatment Period|Withdrawal by Subject|0|||
105537881|NCT01513291|363970709|FG003|Treatment Period|Withdrawal by Subject|0|||
105537882|NCT01513291|363970710|FG004|Treatment Period|Withdrawal by Subject|0|||
105537883|NCT01513291|363970706|FG000|Treatment Period|Randomized not treated|0|||
105537884|NCT01513291|363970707|FG001|Treatment Period|Randomized not treated|2|||
105537885|NCT01513291|363970708|FG002|Treatment Period|Randomized not treated|0|||
105537886|NCT01513291|363970709|FG003|Treatment Period|Randomized not treated|0|||
105537887|NCT01513291|363970710|FG004|Treatment Period|Randomized not treated|0|||
105537888|NCT01513291|363970706|FG000|Run-out Period|Lost to Follow-up|0|||
105537889|NCT01513291|363970707|FG001|Run-out Period|Lost to Follow-up|0|||
105537890|NCT01513291|363970708|FG002|Run-out Period|Lost to Follow-up|0|||
105537891|NCT01513291|363970709|FG003|Run-out Period|Lost to Follow-up|1|||
105537892|NCT01513291|363970710|FG004|Run-out Period|Lost to Follow-up|0|||
105537893|NCT01513291|363970706|FG000|Run-out Period|Withdrawal by Subject|0|||
105537894|NCT01513291|363970707|FG001|Run-out Period|Withdrawal by Subject|0|||
105537895|NCT01513291|363970708|FG002|Run-out Period|Withdrawal by Subject|0|||
105537896|NCT01513291|363970709|FG003|Run-out Period|Withdrawal by Subject|1|||
105537897|NCT01513291|363970710|FG004|Run-out Period|Withdrawal by Subject|0|||
105537898|NCT01358981|363970711|FG000|Period 1|Withdrawal by Subject|0|||
105537899|NCT01358981|363970712|FG001|Period 1|Withdrawal by Subject|0|||
105537900|NCT01358981|363970713|FG002|Period 1|Withdrawal by Subject|0|||
105537901|NCT01358981|363970714|FG003|Period 1|Withdrawal by Subject|1|||
105537902|NCT01358981|363970715|FG004|Period 1|Withdrawal by Subject|0|||
105537903|NCT01358981|363970716|FG005|Period 1|Withdrawal by Subject|0|||
105537904|NCT01358981|363970717|FG006|Period 1|Withdrawal by Subject|0|||
105537905|NCT02247349|363970723|FG000|Overall Study|Disease Progression|7|||
105537906|NCT02247349|363970724|FG001|Overall Study|Disease Progression|4|||
105537907|NCT02247349|363970725|FG002|Overall Study|Disease Progression|26|||
105537908|NCT02247349|363970726|FG003|Overall Study|Disease Progression|31|||
105537909|NCT02247349|363970727|FG004|Overall Study|Disease Progression|16|||
105537910|NCT02247349|363970728|FG005|Overall Study|Disease Progression|6|||
105537911|NCT02247349|363970723|FG000|Overall Study|Study drug toxicity|0|||
105537912|NCT02247349|363970724|FG001|Overall Study|Study drug toxicity|1|||
105537913|NCT02247349|363970725|FG002|Overall Study|Study drug toxicity|1|||
105537914|NCT02247349|363970726|FG003|Overall Study|Study drug toxicity|1|||
105537915|NCT02247349|363970727|FG004|Overall Study|Study drug toxicity|2|||
105537916|NCT02247349|363970728|FG005|Overall Study|Study drug toxicity|2|||
105537917|NCT02247349|363970723|FG000|Overall Study|Death|0|||
105537918|NCT02247349|363970724|FG001|Overall Study|Death|0|||
105537919|NCT02247349|363970725|FG002|Overall Study|Death|0|||
105537920|NCT02247349|363970726|FG003|Overall Study|Death|1|||
105537921|NCT02247349|363970727|FG004|Overall Study|Death|0|||
105537922|NCT02247349|363970728|FG005|Overall Study|Death|0|||
105537923|NCT02247349|363970723|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
105537924|NCT02247349|363970724|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
105537925|NCT02247349|363970725|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
105537926|NCT02247349|363970726|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
105537927|NCT02247349|363970727|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
105537928|NCT02247349|363970728|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
105537929|NCT02247349|363970723|FG000|Overall Study|Participant request to discontinue study treatment|0|||
105537930|NCT02247349|363970724|FG001|Overall Study|Participant request to discontinue study treatment|0|||
105537931|NCT02247349|363970725|FG002|Overall Study|Participant request to discontinue study treatment|1|||
105537932|NCT02247349|363970726|FG003|Overall Study|Participant request to discontinue study treatment|2|||
105537933|NCT02247349|363970727|FG004|Overall Study|Participant request to discontinue study treatment|1|||
105537934|NCT02247349|363970728|FG005|Overall Study|Participant request to discontinue study treatment|0|||
105537935|NCT02247349|363970723|FG000|Overall Study|Withdrawal by Subject|0|||
105537936|NCT02247349|363970724|FG001|Overall Study|Withdrawal by Subject|1|||
105537937|NCT02247349|363970725|FG002|Overall Study|Withdrawal by Subject|0|||
105537938|NCT02247349|363970726|FG003|Overall Study|Withdrawal by Subject|0|||
105537939|NCT02247349|363970727|FG004|Overall Study|Withdrawal by Subject|0|||
105537940|NCT02247349|363970728|FG005|Overall Study|Withdrawal by Subject|0|||
105537941|NCT02247349|363970723|FG000|Overall Study|Administrative reason by sponsor|0|||
105537942|NCT02247349|363970724|FG001|Overall Study|Administrative reason by sponsor|0|||
105537943|NCT02247349|363970725|FG002|Overall Study|Administrative reason by sponsor|0|||
105537944|NCT02247349|363970726|FG003|Overall Study|Administrative reason by sponsor|0|||
105537945|NCT02247349|363970727|FG004|Overall Study|Administrative reason by sponsor|1|||
105537946|NCT02247349|363970728|FG005|Overall Study|Administrative reason by sponsor|0|||
105537947|NCT02247349|363970723|FG000|Overall Study|Other reasons|0|||
105537948|NCT02247349|363970724|FG001|Overall Study|Other reasons|0|||
105537949|NCT02247349|363970725|FG002|Overall Study|Other reasons|1|||
105537950|NCT02247349|363970726|FG003|Overall Study|Other reasons|0|||
105537951|NCT02247349|363970727|FG004|Overall Study|Other reasons|0|||
105537952|NCT02247349|363970728|FG005|Overall Study|Other reasons|0|||
105537953|NCT03773757|363970731|FG000|Overall Study|Withdrawal by Subject|2|||
105537954|NCT03773757|363970732|FG001|Overall Study|Withdrawal by Subject|4|||
105537955|NCT01502644|363970733|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
105537956|NCT01502644|363970734|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
105537957|NCT01502644|363970735|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
105537958|NCT01502644|363970736|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
105537959|NCT01502644|363970733|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
105537960|NCT01502644|363970734|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
105537961|NCT01502644|363970735|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
105537962|NCT01502644|363970736|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
105537963|NCT01502644|363970733|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
105537964|NCT01502644|363970734|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
105537965|NCT01502644|363970735|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
105537966|NCT01502644|363970736|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
105537967|NCT01502644|363970733|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
105537968|NCT01502644|363970734|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
105537969|NCT01502644|363970735|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
105537970|NCT01502644|363970736|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
105537971|NCT01502644|363970733|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
105537972|NCT01502644|363970734|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
105537973|NCT01502644|363970735|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
105537974|NCT01502644|363970736|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
105537975|NCT01147653|363970737|FG000|Year 2|Withdrawal by Subject|2|||
105537976|NCT01147653|363970738|FG001|Year 2|Withdrawal by Subject|3|||
105537977|NCT00353366|363970741|FG000|Overall Study|Adverse Event|8|||
105537978|NCT00353366|363970741|FG000|Overall Study|Protocol Violation|12|||
105537979|NCT00353366|363970741|FG000|Overall Study|Withdrawal by Subject|12|||
105537980|NCT00353366|363970741|FG000|Overall Study|Lost to Follow-up|92|||
105537981|NCT00353366|363970741|FG000|Overall Study|Other|19|||
105537982|NCT01109316|363970742|FG000|Study Period 1|Adverse Event|0|||
105537983|NCT01109316|363970743|FG001|Study Period 1|Adverse Event|0|||
105537984|NCT01109316|363970744|FG002|Study Period 1|Adverse Event|1|||
105537985|NCT01109316|363970745|FG003|Study Period 1|Adverse Event|0|||
105537986|NCT01109316|363970746|FG004|Study Period 1|Adverse Event|0|||
105537987|NCT01109316|363970747|FG005|Study Period 1|Adverse Event|0|||
105537988|NCT01109316|363970742|FG000|Study Period 1|Lost to Follow-up|0|||
105537989|NCT01109316|363970743|FG001|Study Period 1|Lost to Follow-up|0|||
105537990|NCT01109316|363970744|FG002|Study Period 1|Lost to Follow-up|1|||
105537991|NCT01109316|363970745|FG003|Study Period 1|Lost to Follow-up|1|||
105537992|NCT01109316|363970746|FG004|Study Period 1|Lost to Follow-up|0|||
105537993|NCT01109316|363970747|FG005|Study Period 1|Lost to Follow-up|0|||
105537994|NCT01109316|363970742|FG000|Study Period 1|Withdrawal by Subject|0|||
105537995|NCT01109316|363970743|FG001|Study Period 1|Withdrawal by Subject|0|||
105537996|NCT01109316|363970744|FG002|Study Period 1|Withdrawal by Subject|1|||
105537997|NCT01109316|363970745|FG003|Study Period 1|Withdrawal by Subject|0|||
105537998|NCT01109316|363970746|FG004|Study Period 1|Withdrawal by Subject|2|||
105537999|NCT01109316|363970747|FG005|Study Period 1|Withdrawal by Subject|0|||
105538000|NCT01109316|363970742|FG000|Study Period 1|Sponsor Decision|0|||
105538001|NCT01109316|363970743|FG001|Study Period 1|Sponsor Decision|0|||
105538002|NCT01109316|363970744|FG002|Study Period 1|Sponsor Decision|0|||
105538003|NCT01109316|363970745|FG003|Study Period 1|Sponsor Decision|0|||
105538004|NCT01109316|363970746|FG004|Study Period 1|Sponsor Decision|0|||
105538005|NCT01109316|363970747|FG005|Study Period 1|Sponsor Decision|2|||
105538006|NCT01109316|363970742|FG000|Study Period 2|Entry Criteria Not Met|0|||
105538007|NCT01109316|363970743|FG001|Study Period 2|Entry Criteria Not Met|1|||
105538008|NCT01109316|363970744|FG002|Study Period 2|Entry Criteria Not Met|0|||
105538009|NCT01109316|363970745|FG003|Study Period 2|Entry Criteria Not Met|0|||
105538010|NCT01109316|363970746|FG004|Study Period 2|Entry Criteria Not Met|0|||
105538011|NCT01109316|363970747|FG005|Study Period 2|Entry Criteria Not Met|0|||
105538012|NCT01109316|363970742|FG000|Study Period 2|Physician Decision|0|||
105538013|NCT01109316|363970743|FG001|Study Period 2|Physician Decision|0|||
105538014|NCT01109316|363970744|FG002|Study Period 2|Physician Decision|0|||
105538015|NCT01109316|363970745|FG003|Study Period 2|Physician Decision|1|||
105538016|NCT01109316|363970746|FG004|Study Period 2|Physician Decision|0|||
105538017|NCT01109316|363970747|FG005|Study Period 2|Physician Decision|0|||
105538018|NCT01109316|363970742|FG000|Study Period 2|Protocol Violation|1|||
105538019|NCT01109316|363970743|FG001|Study Period 2|Protocol Violation|0|||
105538020|NCT01109316|363970744|FG002|Study Period 2|Protocol Violation|0|||
105538021|NCT01109316|363970745|FG003|Study Period 2|Protocol Violation|0|||
105538022|NCT01109316|363970746|FG004|Study Period 2|Protocol Violation|0|||
105538023|NCT01109316|363970747|FG005|Study Period 2|Protocol Violation|0|||
105538024|NCT01109316|363970742|FG000|Study Period 2|Withdrawal by Subject|0|||
105538025|NCT01109316|363970743|FG001|Study Period 2|Withdrawal by Subject|0|||
105538026|NCT01109316|363970744|FG002|Study Period 2|Withdrawal by Subject|1|||
105538027|NCT01109316|363970745|FG003|Study Period 2|Withdrawal by Subject|0|||
105538028|NCT01109316|363970746|FG004|Study Period 2|Withdrawal by Subject|0|||
105538029|NCT01109316|363970747|FG005|Study Period 2|Withdrawal by Subject|1|||
105538030|NCT01109316|363970742|FG000|Study Period 3|Lost to Follow-up|0|||
105538031|NCT01109316|363970743|FG001|Study Period 3|Lost to Follow-up|0|||
105538032|NCT01109316|363970744|FG002|Study Period 3|Lost to Follow-up|0|||
105538033|NCT01109316|363970745|FG003|Study Period 3|Lost to Follow-up|0|||
105538034|NCT01109316|363970746|FG004|Study Period 3|Lost to Follow-up|1|||
105538035|NCT01109316|363970747|FG005|Study Period 3|Lost to Follow-up|0|||
105538036|NCT01109316|363970742|FG000|Study Period 3|Withdrawal by Subject|1|||
105538037|NCT01109316|363970743|FG001|Study Period 3|Withdrawal by Subject|0|||
105538038|NCT01109316|363970744|FG002|Study Period 3|Withdrawal by Subject|0|||
105538039|NCT01109316|363970745|FG003|Study Period 3|Withdrawal by Subject|0|||
105538040|NCT01109316|363970746|FG004|Study Period 3|Withdrawal by Subject|1|||
105538041|NCT01109316|363970747|FG005|Study Period 3|Withdrawal by Subject|0|||
105538042|NCT00259857|363970748|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
105538043|NCT00259857|363970749|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
105538044|NCT00259857|363970748|FG000|24 Months Treatment|Lost to Follow-up|0|||
105538045|NCT00259857|363970749|FG001|24 Months Treatment|Lost to Follow-up|3|||
105538046|NCT02161718|363970754|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
105538047|NCT02161718|363970755|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
105538048|NCT02161718|363970756|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
105538049|NCT02161718|363970754|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
105538050|NCT02161718|363970755|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
105538051|NCT02161718|363970756|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
105538052|NCT02161718|363970754|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
105538053|NCT02161718|363970755|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
105538054|NCT02161718|363970756|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
105538055|NCT02161718|363970754|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
105538056|NCT02161718|363970755|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
105538057|NCT02161718|363970756|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
105538058|NCT02161718|363970754|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
105538059|NCT02161718|363970755|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
105538060|NCT02161718|363970756|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
105538061|NCT02161718|363970754|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
105538062|NCT02161718|363970755|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
105538063|NCT02161718|363970756|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
105538064|NCT02161718|363970754|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
105538065|NCT02161718|363970755|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
105538066|NCT02161718|363970756|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
105538067|NCT02161718|363970754|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
105538068|NCT02161718|363970755|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
105538069|NCT02161718|363970756|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
105538070|NCT02161718|363970754|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
105538071|NCT02161718|363970755|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
105538072|NCT02161718|363970756|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
105538073|NCT02161718|363970754|FG000|Post- Randomization Period|Lost to Follow-up|0|||
105538074|NCT02161718|363970755|FG001|Post- Randomization Period|Lost to Follow-up|9|||
105538075|NCT02161718|363970756|FG002|Post- Randomization Period|Lost to Follow-up|15|||
105595437|NCT02957539|364180190|FG000|Week 16 to 32|Withdrawal by Subject|3|||
105538076|NCT02161718|363970754|FG000|Post- Randomization Period|Adverse Event|0|||
105538077|NCT02161718|363970755|FG001|Post- Randomization Period|Adverse Event|9|||
105538078|NCT02161718|363970756|FG002|Post- Randomization Period|Adverse Event|10|||
105538079|NCT02161718|363970754|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
105538080|NCT02161718|363970755|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
105538081|NCT02161718|363970756|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
105538082|NCT02161718|363970754|FG000|Post- Randomization Period|Physician Decision|0|||
105538083|NCT02161718|363970755|FG001|Post- Randomization Period|Physician Decision|2|||
105538084|NCT02161718|363970756|FG002|Post- Randomization Period|Physician Decision|4|||
105538085|NCT02161718|363970754|FG000|Post- Randomization Period|Protocol Violation|0|||
105538086|NCT02161718|363970755|FG001|Post- Randomization Period|Protocol Violation|2|||
105538087|NCT02161718|363970756|FG002|Post- Randomization Period|Protocol Violation|3|||
105538088|NCT02161718|363970754|FG000|Post- Randomization Period|Lack of Efficacy|0|||
105538089|NCT02161718|363970755|FG001|Post- Randomization Period|Lack of Efficacy|0|||
105538090|NCT02161718|363970756|FG002|Post- Randomization Period|Lack of Efficacy|1|||
105538091|NCT02161718|363970754|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
105538092|NCT02161718|363970755|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
105538093|NCT02161718|363970756|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
105538094|NCT02161718|363970754|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
105538095|NCT02161718|363970755|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
105538096|NCT02161718|363970756|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
105538097|NCT02161718|363970754|FG000|Post- Randomization Period|Relocation|0|||
105538098|NCT02161718|363970755|FG001|Post- Randomization Period|Relocation|3|||
105538099|NCT02161718|363970756|FG002|Post- Randomization Period|Relocation|0|||
105538100|NCT01573624|363970757|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
105538101|NCT01573624|363970758|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
105538102|NCT01573624|363970759|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
105538103|NCT01573624|363970760|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
105538104|NCT01573624|363970761|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
105538105|NCT01573624|363970762|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
105538106|NCT01573624|363970763|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
105538107|NCT01573624|363970757|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
105538108|NCT01573624|363970758|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
105538109|NCT01573624|363970759|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
105538110|NCT01573624|363970760|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
105538111|NCT01573624|363970761|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
105538112|NCT01573624|363970762|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
105538113|NCT01573624|363970763|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
105538114|NCT01573624|363970757|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
105538115|NCT01573624|363970758|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
105538116|NCT01573624|363970759|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
105538117|NCT01573624|363970760|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
105538118|NCT01573624|363970761|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
105538119|NCT01573624|363970762|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
105538120|NCT01573624|363970763|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
105538121|NCT01573624|363970757|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
105538122|NCT01573624|363970758|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105538123|NCT01573624|363970759|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
105538124|NCT01573624|363970760|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105538125|NCT01573624|363970761|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105538126|NCT01573624|363970762|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
105538127|NCT01573624|363970763|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105538128|NCT01573624|363970757|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
105538129|NCT01573624|363970758|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
105538130|NCT01573624|363970759|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
105538131|NCT01573624|363970760|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
105538132|NCT01573624|363970761|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
105538133|NCT01573624|363970762|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
105538134|NCT01573624|363970763|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
105538135|NCT01573624|363970757|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
105595438|NCT02957539|364180191|FG001|Week 16 to 32|Withdrawal by Subject|3|||
105595439|NCT02957539|364180192|FG002|Week 16 to 32|Withdrawal by Subject|1|||
105595440|NCT02957539|364180190|FG000|Week 16 to 32|Lost to Follow-up|8|||
105595441|NCT02957539|364180191|FG001|Week 16 to 32|Lost to Follow-up|7|||
105595442|NCT02957539|364180192|FG002|Week 16 to 32|Lost to Follow-up|5|||
105538136|NCT01573624|363970758|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
105538137|NCT01573624|363970759|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
105538138|NCT01573624|363970760|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
105538139|NCT01573624|363970761|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
105538140|NCT01573624|363970762|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
105538141|NCT01573624|363970763|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
105538142|NCT01573624|363970757|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
105538143|NCT01573624|363970758|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
105538144|NCT01573624|363970759|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
105538145|NCT01573624|363970760|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
105538146|NCT01573624|363970761|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
105538147|NCT01573624|363970762|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
105538148|NCT01573624|363970763|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
105538149|NCT01573624|363970757|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
105538150|NCT01573624|363970758|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
105538151|NCT01573624|363970759|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
105538152|NCT01573624|363970760|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
105538153|NCT01573624|363970761|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
105538154|NCT01573624|363970762|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
105538155|NCT01573624|363970763|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
105538156|NCT01573624|363970757|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
105538157|NCT01573624|363970758|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
105538158|NCT01573624|363970759|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
105538159|NCT01573624|363970760|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
105538160|NCT01573624|363970761|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
105538161|NCT01573624|363970762|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
105538162|NCT01573624|363970763|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
105538163|NCT01573624|363970757|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
105538164|NCT01573624|363970758|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
105538165|NCT01573624|363970759|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
105538166|NCT01573624|363970760|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
105538167|NCT01573624|363970761|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
105538168|NCT01573624|363970762|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
105538169|NCT01573624|363970763|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
105538170|NCT01573624|363970757|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
105538171|NCT01573624|363970758|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
105538172|NCT01573624|363970759|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
105538173|NCT01573624|363970760|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
105538174|NCT01573624|363970761|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
105538175|NCT01573624|363970762|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
105538176|NCT01573624|363970763|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
105538177|NCT01573624|363970757|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
105538178|NCT01573624|363970758|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
105538179|NCT01573624|363970759|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
105538180|NCT01573624|363970760|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
105538181|NCT01573624|363970761|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
105538182|NCT01573624|363970762|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
105538183|NCT01573624|363970763|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
105538184|NCT01573624|363970757|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
105538185|NCT01573624|363970758|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
105538186|NCT01573624|363970759|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
105538187|NCT01573624|363970760|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
105538188|NCT01573624|363970761|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
105538189|NCT01573624|363970762|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
105538190|NCT01573624|363970763|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
105538191|NCT01573624|363970757|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
105538192|NCT01573624|363970758|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
105538193|NCT01573624|363970759|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
105538194|NCT01573624|363970760|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
105538195|NCT01573624|363970761|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
105538196|NCT01573624|363970762|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
105538197|NCT01573624|363970763|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
105538198|NCT01573624|363970757|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
105538199|NCT01573624|363970758|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
105538200|NCT01573624|363970759|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
105538201|NCT01573624|363970760|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
105538202|NCT01573624|363970761|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
105538203|NCT01573624|363970762|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
105538204|NCT01573624|363970763|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
105538205|NCT01573624|363970757|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
105538206|NCT01573624|363970758|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
105538207|NCT01573624|363970759|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
105538208|NCT01573624|363970760|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
105538209|NCT01573624|363970761|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
105538210|NCT01573624|363970762|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
105538211|NCT01573624|363970763|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
105538212|NCT01573624|363970757|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
105538213|NCT01573624|363970758|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
105538214|NCT01573624|363970759|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
105538215|NCT01573624|363970760|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
105538216|NCT01573624|363970761|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
105538217|NCT01573624|363970762|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
105538218|NCT01573624|363970763|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
105538219|NCT01573624|363970757|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
105538220|NCT01573624|363970758|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
105538221|NCT01573624|363970759|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
105538222|NCT01573624|363970760|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
105538223|NCT01573624|363970761|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
105538224|NCT01573624|363970762|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
105538225|NCT01573624|363970763|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
105538226|NCT01573624|363970757|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
105538227|NCT01573624|363970758|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
105538228|NCT01573624|363970759|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
105538229|NCT01573624|363970760|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
105538230|NCT01573624|363970761|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
105538231|NCT01573624|363970762|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
105538232|NCT01573624|363970763|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
105538233|NCT01573624|363970757|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
105538234|NCT01573624|363970758|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
105538235|NCT01573624|363970759|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
105538236|NCT01573624|363970760|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
105538237|NCT01573624|363970761|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
105538238|NCT01573624|363970762|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
105538239|NCT01573624|363970763|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
105538240|NCT01573624|363970757|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
105538241|NCT01573624|363970758|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
105538242|NCT01573624|363970759|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
105538243|NCT01573624|363970760|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
105538244|NCT01573624|363970761|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
105538245|NCT01573624|363970762|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
105538246|NCT01573624|363970763|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
105538247|NCT01573624|363970757|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
105538248|NCT01573624|363970758|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
105538249|NCT01573624|363970759|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
105538250|NCT01573624|363970760|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
105538251|NCT01573624|363970761|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
105538252|NCT01573624|363970762|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
105538253|NCT01573624|363970763|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
105538254|NCT01573624|363970757|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
105538255|NCT01573624|363970758|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105538256|NCT01573624|363970759|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105538257|NCT01573624|363970760|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105538258|NCT01573624|363970761|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
105538259|NCT01573624|363970762|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
105538260|NCT01573624|363970763|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
105538261|NCT01573624|363970757|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
105538262|NCT01573624|363970758|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
105538263|NCT01573624|363970759|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
105538264|NCT01573624|363970760|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
105538265|NCT01573624|363970761|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
105538266|NCT01573624|363970762|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
105538267|NCT01573624|363970763|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
105538268|NCT01573624|363970757|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
105538269|NCT01573624|363970758|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
105538270|NCT01573624|363970759|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
105538271|NCT01573624|363970760|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
105538272|NCT01573624|363970761|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
105538273|NCT01573624|363970762|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
105538274|NCT01573624|363970763|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
105538275|NCT01573624|363970757|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
105538276|NCT01573624|363970758|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
105538277|NCT01573624|363970759|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
105538278|NCT01573624|363970760|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
105538279|NCT01573624|363970761|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
105538280|NCT01573624|363970762|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
105538281|NCT01573624|363970763|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
105538282|NCT01573624|363970757|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
105538283|NCT01573624|363970758|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
105538284|NCT01573624|363970759|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
105538285|NCT01573624|363970760|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
105538286|NCT01573624|363970761|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
105538287|NCT01573624|363970762|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
105538288|NCT01573624|363970763|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
105538289|NCT04187196|363970766|FG000|Overall Study|Screen Failure|2|||
105538290|NCT04187196|363970767|FG001|Overall Study|Screen Failure|0|||
105538291|NCT03467425|363970770|FG000|Overall Study|Adverse Event|9|||
105538292|NCT03467425|363970771|FG001|Overall Study|Adverse Event|9|||
105538293|NCT03467425|363970770|FG000|Overall Study|Lack of Efficacy|3|||
105538294|NCT03467425|363970771|FG001|Overall Study|Lack of Efficacy|1|||
105538295|NCT03467425|363970770|FG000|Overall Study|Protocol Violation|0|||
105538296|NCT03467425|363970771|FG001|Overall Study|Protocol Violation|1|||
105538297|NCT03467425|363970770|FG000|Overall Study|Lost to Follow-up|18|||
105538298|NCT03467425|363970771|FG001|Overall Study|Lost to Follow-up|25|||
105538299|NCT03467425|363970770|FG000|Overall Study|Physician Decision|2|||
105538300|NCT03467425|363970771|FG001|Overall Study|Physician Decision|1|||
105538301|NCT03467425|363970770|FG000|Overall Study|Withdrawal by Subject|15|||
105538302|NCT03467425|363970771|FG001|Overall Study|Withdrawal by Subject|17|||
105538303|NCT02318693|363970772|FG000|Overall Study|Protocol Violation|0|||
105538304|NCT02318693|363970773|FG001|Overall Study|Protocol Violation|1|||
105538305|NCT03878134|363970774|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
105538306|NCT03851016|363970775|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
105538307|NCT03851016|363970776|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
105538308|NCT03080961|363970777|FG000|Overall Study|Withdrawal by Subject|3|||
105538309|NCT00586469|363970778|FG000|Overall Study|Adverse Event|0|||
105538310|NCT00586469|363970779|FG001|Overall Study|Adverse Event|1|||
105538311|NCT04497987|363970780|FG000|Overall Study|Adverse Event|1|||
105538312|NCT04497987|363970781|FG001|Overall Study|Adverse Event|0|||
105538313|NCT04497987|363970780|FG000|Overall Study|Death|21|||
105538314|NCT04497987|363970781|FG001|Overall Study|Death|13|||
105538315|NCT04497987|363970780|FG000|Overall Study|Lost to Follow-up|19|||
105538316|NCT04497987|363970781|FG001|Overall Study|Lost to Follow-up|17|||
105538317|NCT04497987|363970780|FG000|Overall Study|Other - as reported by the investigator|22|||
105538318|NCT04497987|363970781|FG001|Overall Study|Other - as reported by the investigator|16|||
105538319|NCT04497987|363970780|FG000|Overall Study|Physician Decision|1|||
105538320|NCT04497987|363970781|FG001|Overall Study|Physician Decision|0|||
105538321|NCT04497987|363970780|FG000|Overall Study|Withdrawal by Subject|35|||
105538322|NCT04497987|363970781|FG001|Overall Study|Withdrawal by Subject|21|||
105538323|NCT00512096|363970782|FG000|Overall Study|Adverse Event|2|||
105538324|NCT00512096|363970782|FG000|Overall Study|Withdrawal by Subject|2|||
105538325|NCT00512096|363970782|FG000|Overall Study|Lack of Efficacy|3|||
105595443|NCT02957539|364180190|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
105595444|NCT02957539|364180191|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
105595445|NCT02957539|364180192|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
105595446|NCT02957539|364180190|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
105595447|NCT02957539|364180191|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
105595448|NCT02957539|364180192|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
105595449|NCT01119950|364180193|FG000|Overall Study|Adverse Event|25|||
105595450|NCT01119950|364180193|FG000|Overall Study|Withdrawal by Subject|9|||
105595451|NCT01119950|364180193|FG000|Overall Study|Protocol Violation|5|||
105595452|NCT01119950|364180193|FG000|Overall Study|Lost to Follow-up|4|||
105595453|NCT01119950|364180193|FG000|Overall Study|Administrative|2|||
105595454|NCT01119950|364180193|FG000|Overall Study|Abnormal lab value|1|||
105595455|NCT01119950|364180193|FG000|Overall Study|Death|1|||
105595456|NCT00217672|364180198|FG000|Allocation|Ineligible|2|||
105595457|NCT00217672|364180199|FG001|Allocation|Ineligible|0|||
105595458|NCT00217672|364180198|FG000|Treatment|disease progression|33|||
105595459|NCT00217672|364180199|FG001|Treatment|disease progression|4|||
105595460|NCT00217672|364180198|FG000|Treatment|Adverse Event|18|||
105595461|NCT00217672|364180199|FG001|Treatment|Adverse Event|2|||
105595462|NCT00217672|364180198|FG000|Treatment|reqd treatment not permitted by protocol|6|||
105595463|NCT00217672|364180199|FG001|Treatment|reqd treatment not permitted by protocol|0|||
105595464|NCT00217672|364180198|FG000|Treatment|Physician Decision|6|||
105595465|NCT00217672|364180199|FG001|Treatment|Physician Decision|0|||
105595466|NCT00217672|364180198|FG000|Treatment|insurance issues|1|||
105595467|NCT00217672|364180199|FG001|Treatment|insurance issues|1|||
105595468|NCT00217672|364180198|FG000|Treatment|Death|2|||
105595469|NCT00217672|364180199|FG001|Treatment|Death|0|||
105595470|NCT00217672|364180198|FG000|Treatment|secondary malignancy|1|||
105595471|NCT00217672|364180199|FG001|Treatment|secondary malignancy|0|||
105595472|NCT00217672|364180198|FG000|Follow-up|Withdrawal by Subject|4|||
105595473|NCT00217672|364180199|FG001|Follow-up|Withdrawal by Subject|0|||
105595474|NCT00217672|364180198|FG000|Follow-up|Lost to Follow-up|1|||
105595475|NCT00217672|364180199|FG001|Follow-up|Lost to Follow-up|0|||
105595476|NCT01591616|364180200|FG000|Overall Study|Withdrawal by Subject|1|||
105595477|NCT01713530|364180201|FG000|Overall Study|Adverse Event|0|||
105595478|NCT01713530|364180202|FG001|Overall Study|Adverse Event|5|||
105595479|NCT01713530|364180201|FG000|Overall Study|Withdrawal criteria|21|||
105595480|NCT01713530|364180202|FG001|Overall Study|Withdrawal criteria|12|||
105595481|NCT01713530|364180201|FG000|Overall Study|Unclassified|4|||
105595482|NCT01713530|364180202|FG001|Overall Study|Unclassified|2|||
105595483|NCT00758602|364180203|FG000|Overall Study|Adverse Event|11|||
105595484|NCT00758602|364180204|FG001|Overall Study|Adverse Event|10|||
105595485|NCT00758602|364180203|FG000|Overall Study|Lost to Follow-up|4|||
105595486|NCT00758602|364180204|FG001|Overall Study|Lost to Follow-up|3|||
105595487|NCT00758602|364180203|FG000|Overall Study|Withdrawal by Subject|1|||
105595488|NCT00758602|364180204|FG001|Overall Study|Withdrawal by Subject|3|||
105595489|NCT00758602|364180203|FG000|Overall Study|Protocol Violation|0|||
105595490|NCT00758602|364180204|FG001|Overall Study|Protocol Violation|2|||
105595491|NCT00758602|364180203|FG000|Overall Study|Death|0|||
105595492|NCT00758602|364180204|FG001|Overall Study|Death|1|||
105595493|NCT00758602|364180203|FG000|Overall Study|Reason not specified|3|||
105595494|NCT00758602|364180204|FG001|Overall Study|Reason not specified|3|||
105595495|NCT00762606|364180206|FG000|Overall Study|Lost to Follow-up|18|||
105595496|NCT00762606|364180207|FG001|Overall Study|Lost to Follow-up|13|||
105595497|NCT01194154|364180210|FG000|Overall Study|Adverse Event|12|||
105595498|NCT01194154|364180211|FG001|Overall Study|Adverse Event|7|||
105595499|NCT01194154|364180210|FG000|Overall Study|Lost to Follow-up|2|||
105595500|NCT01194154|364180211|FG001|Overall Study|Lost to Follow-up|3|||
105595501|NCT01194154|364180210|FG000|Overall Study|Protocol Violation|0|||
105595502|NCT01194154|364180211|FG001|Overall Study|Protocol Violation|1|||
105595503|NCT01194154|364180210|FG000|Overall Study|Withdrawal by Subject|5|||
105595504|NCT01194154|364180211|FG001|Overall Study|Withdrawal by Subject|6|||
105595505|NCT01194154|364180210|FG000|Overall Study|Blood pressure increase|5|||
105595506|NCT01194154|364180211|FG001|Overall Study|Blood pressure increase|3|||
105595507|NCT01194154|364180210|FG000|Overall Study|Hemoglobin decrease|0|||
105595508|NCT01194154|364180211|FG001|Overall Study|Hemoglobin decrease|1|||
105595509|NCT01194154|364180210|FG000|Overall Study|Hemoglobin increase|12|||
105595510|NCT01194154|364180211|FG001|Overall Study|Hemoglobin increase|3|||
105595511|NCT01194154|364180210|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
105595512|NCT01194154|364180211|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
105595513|NCT01194154|364180210|FG000|Overall Study|Treatment with prohibited medication|4|||
105595514|NCT01194154|364180211|FG001|Overall Study|Treatment with prohibited medication|5|||
105595515|NCT01194154|364180210|FG000|Overall Study|Other|4|||
105595516|NCT01194154|364180211|FG001|Overall Study|Other|0|||
105595517|NCT01194154|364180210|FG000|Overall Study|Did not receive study medication|2|||
105595518|NCT01194154|364180211|FG001|Overall Study|Did not receive study medication|4|||
105595519|NCT00842257|364180212|FG000|Overall Study|Adverse Event|1|||
105595520|NCT01069341|364180217|FG000|Overall Study|Lost to Follow-up|1|||
105595521|NCT00922207|364180218|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
105595522|NCT00922207|364180219|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
105595523|NCT00922207|364180220|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
105595524|NCT00922207|364180218|FG000|Overall Study|Insufficient Therapeutic Response|0|||
105595525|NCT00922207|364180219|FG001|Overall Study|Insufficient Therapeutic Response|0|||
105595526|NCT00922207|364180220|FG002|Overall Study|Insufficient Therapeutic Response|1|||
105595527|NCT00922207|364180218|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
105595528|NCT00922207|364180219|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
105595529|NCT00922207|364180220|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
105595530|NCT00922207|364180218|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
105595531|NCT00922207|364180219|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
105595532|NCT00922207|364180220|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
105595533|NCT00922207|364180218|FG000|Overall Study|Withdrew Consent|2|||
105595534|NCT00922207|364180219|FG001|Overall Study|Withdrew Consent|5|||
105595535|NCT00922207|364180220|FG002|Overall Study|Withdrew Consent|2|||
105595536|NCT00922207|364180218|FG000|Overall Study|Abnormality of Laboratory Test|0|||
105595537|NCT00922207|364180219|FG001|Overall Study|Abnormality of Laboratory Test|1|||
105595538|NCT00922207|364180220|FG002|Overall Study|Abnormality of Laboratory Test|1|||
105595539|NCT01802632|364180221|FG000|Overall Study|Death|28|||
105595540|NCT01802632|364180222|FG001|Overall Study|Death|1|||
105595541|NCT01802632|364180223|FG002|Overall Study|Death|38|||
105595542|NCT01802632|364180224|FG003|Overall Study|Death|0|||
105595543|NCT01802632|364180225|FG004|Overall Study|Death|2|||
105595544|NCT01802632|364180226|FG005|Overall Study|Death|0|||
105595545|NCT01802632|364180221|FG000|Overall Study|Withdrawal by Subject|4|||
105595546|NCT01802632|364180222|FG001|Overall Study|Withdrawal by Subject|2|||
105595547|NCT01802632|364180223|FG002|Overall Study|Withdrawal by Subject|7|||
105595548|NCT01802632|364180224|FG003|Overall Study|Withdrawal by Subject|3|||
105595549|NCT01802632|364180225|FG004|Overall Study|Withdrawal by Subject|0|||
105595550|NCT01802632|364180226|FG005|Overall Study|Withdrawal by Subject|1|||
105595551|NCT01802632|364180221|FG000|Overall Study|Objective Disease Progression|1|||
105595552|NCT01802632|364180222|FG001|Overall Study|Objective Disease Progression|12|||
105595553|NCT01802632|364180223|FG002|Overall Study|Objective Disease Progression|104|||
105595554|NCT01802632|364180224|FG003|Overall Study|Objective Disease Progression|6|||
105595555|NCT01802632|364180225|FG004|Overall Study|Objective Disease Progression|4|||
105595556|NCT01802632|364180226|FG005|Overall Study|Objective Disease Progression|4|||
105595557|NCT01802632|364180221|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
105595558|NCT01802632|364180222|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
105595559|NCT01802632|364180223|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
105595560|NCT01802632|364180224|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
105595561|NCT01802632|364180225|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
105595562|NCT01802632|364180226|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
105595563|NCT01802632|364180221|FG000|Overall Study|Other (not specified)|0|||
105595564|NCT01802632|364180222|FG001|Overall Study|Other (not specified)|0|||
105595565|NCT01802632|364180223|FG002|Overall Study|Other (not specified)|7|||
105595566|NCT01802632|364180224|FG003|Overall Study|Other (not specified)|1|||
105595567|NCT01802632|364180225|FG004|Overall Study|Other (not specified)|0|||
105595568|NCT01802632|364180226|FG005|Overall Study|Other (not specified)|1|||
105595569|NCT02880241|364180227|FG000|Overall Study|Lack of Efficacy|1|||
105595570|NCT02880241|364180228|FG001|Overall Study|Lack of Efficacy|0|||
105595571|NCT02880241|364180229|FG002|Overall Study|Lack of Efficacy|0|||
105595572|NCT02880241|364180230|FG003|Overall Study|Lack of Efficacy|0|||
105595573|NCT02880241|364180231|FG004|Overall Study|Lack of Efficacy|0|||
105595574|NCT02880241|364180232|FG005|Overall Study|Lack of Efficacy|0|||
105595575|NCT02705586|364180233|FG000|Overall Study|Health Issues|2|||
105595576|NCT02705586|364180233|FG000|Overall Study|Transportation Difficulties|5|||
105595577|NCT02705586|364180233|FG000|Overall Study|Vacation/Planned Absence|1|||
105595578|NCT02000817|364180237|FG000|Overall Study|Withdrawal by Subject|2|||
105595579|NCT02000817|364180238|FG001|Overall Study|Withdrawal by Subject|0|||
105595580|NCT02000817|364180239|FG002|Overall Study|Withdrawal by Subject|0|||
105595581|NCT02000817|364180240|FG003|Overall Study|Withdrawal by Subject|0|||
105595582|NCT02000817|364180237|FG000|Overall Study|Adverse Event|0|||
105595583|NCT02000817|364180238|FG001|Overall Study|Adverse Event|1|||
105595584|NCT02000817|364180239|FG002|Overall Study|Adverse Event|0|||
105595585|NCT02000817|364180240|FG003|Overall Study|Adverse Event|0|||
105595586|NCT02000817|364180237|FG000|Overall Study|Lost to Follow-up|0|||
105595587|NCT02000817|364180238|FG001|Overall Study|Lost to Follow-up|0|||
105595588|NCT02000817|364180239|FG002|Overall Study|Lost to Follow-up|1|||
105595589|NCT02000817|364180240|FG003|Overall Study|Lost to Follow-up|0|||
105595590|NCT05686421|364180245|FG000|Overall Study|Screen failure|22|||
105595591|NCT05686421|364180246|FG001|Overall Study|Screen failure|0|||
105595592|NCT05686421|364180247|FG002|Overall Study|Screen failure|0|||
105595593|NCT05686421|364180248|FG003|Overall Study|Screen failure|0|||
105595594|NCT02459899|364180251|FG000|Overall Study|Adverse Event|1|||
105595595|NCT02459899|364180252|FG001|Overall Study|Adverse Event|1|||
105595596|NCT02459899|364180253|FG002|Overall Study|Adverse Event|0|||
105595597|NCT02459899|364180254|FG003|Overall Study|Adverse Event|0|||
105595598|NCT02459899|364180251|FG000|Overall Study|Lost to Follow-up|1|||
105595599|NCT02459899|364180252|FG001|Overall Study|Lost to Follow-up|2|||
105595600|NCT02459899|364180253|FG002|Overall Study|Lost to Follow-up|0|||
105595601|NCT02459899|364180254|FG003|Overall Study|Lost to Follow-up|1|||
105595602|NCT02459899|364180251|FG000|Overall Study|Non-compliance with the treatment|0|||
105595603|NCT02459899|364180252|FG001|Overall Study|Non-compliance with the treatment|0|||
105595604|NCT02459899|364180253|FG002|Overall Study|Non-compliance with the treatment|0|||
105595605|NCT02459899|364180254|FG003|Overall Study|Non-compliance with the treatment|1|||
105595606|NCT02459899|364180251|FG000|Overall Study|Withdrawal by Subject|1|||
105595607|NCT02459899|364180252|FG001|Overall Study|Withdrawal by Subject|3|||
105595608|NCT02459899|364180253|FG002|Overall Study|Withdrawal by Subject|0|||
105595609|NCT02459899|364180254|FG003|Overall Study|Withdrawal by Subject|0|||
105595610|NCT02739035|364180257|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
105595611|NCT02739035|364180258|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
105595612|NCT02739035|364180257|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
105595613|NCT02739035|364180258|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
105595614|NCT02739035|364180257|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
105595615|NCT02739035|364180258|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
105595616|NCT02739035|364180257|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
105595617|NCT02739035|364180258|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
105595618|NCT03210402|364180259|FG000|Overall Study|Withdrawal by Subject|0|||
105595619|NCT03210402|364180260|FG001|Overall Study|Withdrawal by Subject|1|||
105595620|NCT02248480|364180275|FG000|Overall Study|Lack of Efficacy|4|||
105595621|NCT02248480|364180276|FG001|Overall Study|Lack of Efficacy|6|||
105595622|NCT02248480|364180275|FG000|Overall Study|Adverse Event|11|||
105595623|NCT02248480|364180276|FG001|Overall Study|Adverse Event|2|||
105595624|NCT02248480|364180275|FG000|Overall Study|Withdrawal by Subject|2|||
105595625|NCT02248480|364180276|FG001|Overall Study|Withdrawal by Subject|4|||
105595626|NCT02248480|364180275|FG000|Overall Study|Entry Criteria Not Met|0|||
105595627|NCT02248480|364180276|FG001|Overall Study|Entry Criteria Not Met|1|||
105595628|NCT02248480|364180275|FG000|Overall Study|Other:Physician Decision|0|||
105595629|NCT02248480|364180276|FG001|Overall Study|Other:Physician Decision|1|||
105595630|NCT04493242|364180280|FG000|Overall Study|Death|10|||
105595631|NCT04493242|364180281|FG001|Overall Study|Death|14|||
105595632|NCT04493242|364180282|FG002|Overall Study|Death|16|||
105595633|NCT04493242|364180280|FG000|Overall Study|Lost to Follow-up|1|||
105595634|NCT04493242|364180281|FG001|Overall Study|Lost to Follow-up|1|||
105595635|NCT04493242|364180282|FG002|Overall Study|Lost to Follow-up|0|||
105595636|NCT04493242|364180280|FG000|Overall Study|Withdrawal by Subject|1|||
105595637|NCT04493242|364180281|FG001|Overall Study|Withdrawal by Subject|0|||
105595638|NCT04493242|364180282|FG002|Overall Study|Withdrawal by Subject|0|||
105595639|NCT04493242|364180280|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
105595640|NCT04493242|364180281|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
105595641|NCT04493242|364180282|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
105595642|NCT04493242|364180280|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
105595643|NCT04493242|364180281|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
105595644|NCT04493242|364180282|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
105538326|NCT02696096|363970784|FG000|Overall Study|ruled out at screening|1|||
105538327|NCT02696096|363970784|FG000|Overall Study|did not attend second fMRI|1|||
105538328|NCT03337724|363970789|FG000|Overall Study|Reason not Specified|12|||
105538329|NCT03337724|363970790|FG001|Overall Study|Reason not Specified|21|||
105538330|NCT03337724|363970791|FG002|Overall Study|Reason not Specified|9|||
105538331|NCT03337724|363970792|FG003|Overall Study|Reason not Specified|9|||
105538332|NCT03337724|363970793|FG004|Overall Study|Reason not Specified|29|||
105538333|NCT03337724|363970789|FG000|Overall Study|Withdrawal by Subject|13|||
105538334|NCT03337724|363970790|FG001|Overall Study|Withdrawal by Subject|15|||
105538335|NCT03337724|363970791|FG002|Overall Study|Withdrawal by Subject|4|||
105538336|NCT03337724|363970792|FG003|Overall Study|Withdrawal by Subject|15|||
105538337|NCT03337724|363970793|FG004|Overall Study|Withdrawal by Subject|6|||
105538338|NCT03337724|363970789|FG000|Overall Study|Protocol Deviation|0|||
105538339|NCT03337724|363970790|FG001|Overall Study|Protocol Deviation|1|||
105538340|NCT03337724|363970791|FG002|Overall Study|Protocol Deviation|1|||
105538341|NCT03337724|363970792|FG003|Overall Study|Protocol Deviation|1|||
105538342|NCT03337724|363970793|FG004|Overall Study|Protocol Deviation|0|||
105538343|NCT03337724|363970789|FG000|Overall Study|Adverse Event|1|||
105595645|NCT02466516|364182304|FG000|Overall Study|Adverse Event|1|||
105595646|NCT02466516|364182305|FG001|Overall Study|Adverse Event|1|||
105595647|NCT02466516|364182306|FG002|Overall Study|Adverse Event|0|||
105595648|NCT02466516|364182307|FG003|Overall Study|Adverse Event|0|||
105538344|NCT03337724|363970790|FG001|Overall Study|Adverse Event|1|||
105538345|NCT03337724|363970791|FG002|Overall Study|Adverse Event|0|||
105538346|NCT03337724|363970792|FG003|Overall Study|Adverse Event|1|||
105538347|NCT03337724|363970793|FG004|Overall Study|Adverse Event|0|||
105538348|NCT03337724|363970789|FG000|Overall Study|Death|40|||
105538349|NCT03337724|363970790|FG001|Overall Study|Death|89|||
105538350|NCT03337724|363970791|FG002|Overall Study|Death|43|||
105538351|NCT03337724|363970792|FG003|Overall Study|Death|76|||
105538352|NCT03337724|363970793|FG004|Overall Study|Death|50|||
105538353|NCT03337724|363970789|FG000|Overall Study|Lost to Follow-up|5|||
105538354|NCT03337724|363970790|FG001|Overall Study|Lost to Follow-up|5|||
105538355|NCT03337724|363970791|FG002|Overall Study|Lost to Follow-up|4|||
105538356|NCT03337724|363970792|FG003|Overall Study|Lost to Follow-up|7|||
105538357|NCT03337724|363970793|FG004|Overall Study|Lost to Follow-up|4|||
105538358|NCT03337724|363970789|FG000|Overall Study|Physician Decision|16|||
105538359|NCT03337724|363970790|FG001|Overall Study|Physician Decision|34|||
105538360|NCT03337724|363970791|FG002|Overall Study|Physician Decision|14|||
105538361|NCT03337724|363970792|FG003|Overall Study|Physician Decision|34|||
105538362|NCT03337724|363970793|FG004|Overall Study|Physician Decision|13|||
105538363|NCT03337724|363970789|FG000|Overall Study|Progressive Disease|0|||
105538364|NCT03337724|363970790|FG001|Overall Study|Progressive Disease|2|||
105538365|NCT03337724|363970791|FG002|Overall Study|Progressive Disease|1|||
105538366|NCT03337724|363970792|FG003|Overall Study|Progressive Disease|2|||
105538367|NCT03337724|363970793|FG004|Overall Study|Progressive Disease|0|||
105538368|NCT03337724|363970789|FG000|Overall Study|Symptomatic Deterioration|0|||
105538369|NCT03337724|363970790|FG001|Overall Study|Symptomatic Deterioration|0|||
105538370|NCT03337724|363970791|FG002|Overall Study|Symptomatic Deterioration|0|||
105538371|NCT03337724|363970792|FG003|Overall Study|Symptomatic Deterioration|1|||
105538372|NCT03337724|363970793|FG004|Overall Study|Symptomatic Deterioration|0|||
105538373|NCT06748040|363970794|FG000|Overall Study|Death|3|||
105538374|NCT06748040|363970795|FG001|Overall Study|Death|4|||
105538375|NCT06748040|363970794|FG000|Overall Study|Lost to Follow-up|134|||
105538376|NCT06748040|363970795|FG001|Overall Study|Lost to Follow-up|132|||
105538377|NCT06748040|363970794|FG000|Overall Study|Withdrawal by Subject|3|||
105538378|NCT06748040|363970795|FG001|Overall Study|Withdrawal by Subject|5|||
105538379|NCT00991302|363972107|FG000|Overall Study|Death|0|||
105538380|NCT00991302|363972108|FG001|Overall Study|Death|1|||
105538381|NCT00991302|363972107|FG000|Overall Study|Lost to Follow-up|14|||
105538382|NCT00991302|363972108|FG001|Overall Study|Lost to Follow-up|12|||
105538383|NCT02383758|363972109|FG000|Overall Study|Withdrawal by Subject|0|||
105538384|NCT02383758|363972110|FG001|Overall Study|Withdrawal by Subject|2|||
105538385|NCT00646958|363972115|FG000|Overall Study|Lack of Efficacy|1|||
105538386|NCT00646958|363972116|FG001|Overall Study|Lack of Efficacy|0|||
105538387|NCT00646958|363972117|FG002|Overall Study|Lack of Efficacy|0|||
105538388|NCT00646958|363972115|FG000|Overall Study|Adverse Event|4|||
105538389|NCT00646958|363972116|FG001|Overall Study|Adverse Event|0|||
105538390|NCT00646958|363972117|FG002|Overall Study|Adverse Event|0|||
105538391|NCT00646958|363972115|FG000|Overall Study|Lost to Follow-up|1|||
105538392|NCT00646958|363972116|FG001|Overall Study|Lost to Follow-up|5|||
105538393|NCT00646958|363972117|FG002|Overall Study|Lost to Follow-up|7|||
105538394|NCT00646958|363972115|FG000|Overall Study|Protocol Violation|1|||
105538395|NCT00646958|363972116|FG001|Overall Study|Protocol Violation|1|||
105538396|NCT00646958|363972117|FG002|Overall Study|Protocol Violation|0|||
105538397|NCT00646958|363972115|FG000|Overall Study|Abnormal screening lab tests|1|||
105538398|NCT00646958|363972116|FG001|Overall Study|Abnormal screening lab tests|1|||
105538399|NCT00646958|363972117|FG002|Overall Study|Abnormal screening lab tests|0|||
105538400|NCT00646958|363972115|FG000|Overall Study|Withdrawal by Subject|1|||
105538401|NCT00646958|363972116|FG001|Overall Study|Withdrawal by Subject|2|||
105538402|NCT00646958|363972117|FG002|Overall Study|Withdrawal by Subject|0|||
105538403|NCT00646958|363972115|FG000|Overall Study|Did not receive study drug|2|||
105538404|NCT00646958|363972116|FG001|Overall Study|Did not receive study drug|0|||
105538405|NCT00646958|363972117|FG002|Overall Study|Did not receive study drug|2|||
105538406|NCT03085927|363972119|FG000|Overall Study|Withdrawal by Subject|1|||
105538407|NCT03085927|363972120|FG001|Overall Study|Withdrawal by Subject|4|||
105538408|NCT03085927|363972119|FG000|Overall Study|Lost to Follow-up|3|||
105538409|NCT03085927|363972120|FG001|Overall Study|Lost to Follow-up|1|||
105595649|NCT02466516|364182308|FG004|Overall Study|Adverse Event|0|||
105595650|NCT02466516|364182304|FG000|Overall Study|Withdrew Consent|1|||
105538410|NCT03085927|363972119|FG000|Overall Study|Death|1|||
105538411|NCT03085927|363972120|FG001|Overall Study|Death|0|||
105538412|NCT03085927|363972119|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
105538413|NCT03085927|363972120|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
105595651|NCT02466516|364182305|FG001|Overall Study|Withdrew Consent|0|||
105595652|NCT02466516|364182306|FG002|Overall Study|Withdrew Consent|0|||
105538414|NCT03085927|363972119|FG000|Overall Study|Dyad Became Ineligible|0|||
105538415|NCT03085927|363972120|FG001|Overall Study|Dyad Became Ineligible|1|||
105538416|NCT02573324|363972121|FG000|Overall Study|Withdrawal by Subject|26|||
105538417|NCT02573324|363972122|FG001|Overall Study|Withdrawal by Subject|23|||
105538418|NCT02573324|363972123|FG002|Overall Study|Withdrawal by Subject|3|||
105538419|NCT02573324|363972121|FG000|Overall Study|Lost to Follow-up|4|||
105538420|NCT02573324|363972122|FG001|Overall Study|Lost to Follow-up|5|||
105538421|NCT02573324|363972123|FG002|Overall Study|Lost to Follow-up|0|||
105538422|NCT02573324|363972121|FG000|Overall Study|Study Terminated by Sponsor|107|||
105538423|NCT02573324|363972122|FG001|Overall Study|Study Terminated by Sponsor|89|||
105595653|NCT02466516|364182307|FG003|Overall Study|Withdrew Consent|0|||
105595654|NCT02466516|364182308|FG004|Overall Study|Withdrew Consent|0|||
105595655|NCT02466516|364182304|FG000|Overall Study|Lost to Follow-up|2|||
105595656|NCT02466516|364182305|FG001|Overall Study|Lost to Follow-up|0|||
105595657|NCT02466516|364182306|FG002|Overall Study|Lost to Follow-up|1|||
105595658|NCT02466516|364182307|FG003|Overall Study|Lost to Follow-up|0|||
105595659|NCT02466516|364182308|FG004|Overall Study|Lost to Follow-up|0|||
105595660|NCT01580293|364182316|FG000|Part A_Main Trial|Adverse Event|0|||
105595661|NCT01580293|364182317|FG001|Part A_Main Trial|Adverse Event|2|||
105595662|NCT01580293|364182318|FG002|Part A_Main Trial|Adverse Event|0|||
105595663|NCT01580293|364182316|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
105595664|NCT01580293|364182317|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
105595665|NCT01580293|364182318|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
105595666|NCT01580293|364182316|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
105595667|NCT01580293|364182317|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
105595668|NCT01580293|364182318|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
105595669|NCT01580293|364182316|FG000|Part A_Extension|Adverse Event|0|||
105595670|NCT01580293|364182317|FG001|Part A_Extension|Adverse Event|2|||
105595671|NCT01580293|364182318|FG002|Part A_Extension|Adverse Event|0|||
105595672|NCT01580293|364182316|FG000|Part A_Extension|Withdrawal by Subject|0|||
105595673|NCT01580293|364182317|FG001|Part A_Extension|Withdrawal by Subject|3|||
105595674|NCT01580293|364182318|FG002|Part A_Extension|Withdrawal by Subject|0|||
105595675|NCT01580293|364182316|FG000|Part A_Extension|Lost to Follow-up|0|||
105595676|NCT01580293|364182317|FG001|Part A_Extension|Lost to Follow-up|1|||
105595677|NCT01580293|364182318|FG002|Part A_Extension|Lost to Follow-up|0|||
105595678|NCT01580293|364182316|FG000|Part A_Extension|Other Reason|0|||
105595679|NCT01580293|364182317|FG001|Part A_Extension|Other Reason|1|||
105595680|NCT01580293|364182318|FG002|Part A_Extension|Other Reason|0|||
105595681|NCT01580293|364182316|FG000|Part A_Extension|Completed Japan only|0|||
105595682|NCT01580293|364182317|FG001|Part A_Extension|Completed Japan only|5|||
105595683|NCT01580293|364182318|FG002|Part A_Extension|Completed Japan only|0|||
105595684|NCT01580293|364182316|FG000|Part B|Withdrawal by Subject|0|||
105595685|NCT01580293|364182317|FG001|Part B|Withdrawal by Subject|0|||
105595686|NCT01580293|364182318|FG002|Part B|Withdrawal by Subject|1|||
105595687|NCT01580293|364182316|FG000|Part B|Other reason|0|||
105595688|NCT01580293|364182317|FG001|Part B|Other reason|0|||
105595689|NCT01580293|364182318|FG002|Part B|Other reason|1|||
105595690|NCT00004124|364182323|FG000|Overall Study|Received no protocol therapy|12|||
105595691|NCT00004124|364182324|FG001|Overall Study|Received no protocol therapy|20|||
105595692|NCT00446550|364182325|FG000|Overall Study|Adverse Event|1|||
105595693|NCT00446550|364182326|FG001|Overall Study|Adverse Event|0|||
105595694|NCT02698891|364182329|FG000|Overall Study|Withdrawal by Subject|2|||
105595695|NCT02698891|364182329|FG000|Overall Study|deemed ineligible|1|||
105595696|NCT02698891|364182329|FG000|Overall Study|Adverse Event|9|||
105595697|NCT02082158|364182331|FG000|Overall Study|Withdrawal by Subject|0|||
105595698|NCT02082158|364182332|FG001|Overall Study|Withdrawal by Subject|0|||
105595699|NCT02082158|364182333|FG002|Overall Study|Withdrawal by Subject|0|||
105595700|NCT02082158|364182334|FG003|Overall Study|Withdrawal by Subject|0|||
105595701|NCT02082158|364182335|FG004|Overall Study|Withdrawal by Subject|1|||
105595702|NCT02082158|364182336|FG005|Overall Study|Withdrawal by Subject|0|||
105595703|NCT02082158|364182331|FG000|Overall Study|Failed Fit-testing|8|||
105595704|NCT02082158|364182332|FG001|Overall Study|Failed Fit-testing|8|||
105595705|NCT02082158|364182333|FG002|Overall Study|Failed Fit-testing|14|||
105595706|NCT02082158|364182334|FG003|Overall Study|Failed Fit-testing|4|||
105595707|NCT02082158|364182335|FG004|Overall Study|Failed Fit-testing|3|||
105595708|NCT02082158|364182336|FG005|Overall Study|Failed Fit-testing|7|||
105595709|NCT02057692|364182348|FG000|Overall Study|Adverse Event|1|||
105595710|NCT02057692|364182349|FG001|Overall Study|Adverse Event|0|||
105595711|NCT02057692|364182350|FG002|Overall Study|Adverse Event|0|||
105595712|NCT02057692|364182351|FG003|Overall Study|Adverse Event|0|||
105595713|NCT02057692|364182348|FG000|Overall Study|Lost to Follow-up|0|||
105595714|NCT02057692|364182349|FG001|Overall Study|Lost to Follow-up|0|||
105595715|NCT02057692|364182350|FG002|Overall Study|Lost to Follow-up|0|||
105595716|NCT02057692|364182351|FG003|Overall Study|Lost to Follow-up|1|||
105595717|NCT00943735|364182354|FG000|Overall Study|Adverse Event|12|||
105595718|NCT00943735|364182354|FG000|Overall Study|Withdrawal by Subject|8|||
105595719|NCT00943735|364182354|FG000|Overall Study|Death|1|||
105595720|NCT00943735|364182354|FG000|Overall Study|Other|8|||
105595721|NCT00943735|364182354|FG000|Overall Study|Other|3|||
105595722|NCT01405924|364182355|FG000|Overall Study|Protocol Violation|8|||
105595723|NCT01405924|364182355|FG000|Overall Study|Missing/Incomplete Data|2|||
105595724|NCT01329328|364182356|FG000|Overall Study|Withdrawal by Subject|2|||
105595725|NCT01329328|364182357|FG001|Overall Study|Withdrawal by Subject|4|||
105595726|NCT01329328|364182358|FG002|Overall Study|Withdrawal by Subject|3|||
105595727|NCT01924767|364182359|FG000|Overall Study|Adverse Event|1|||
105595728|NCT01924767|364182360|FG001|Overall Study|Adverse Event|0|||
105595729|NCT01924767|364182361|FG002|Overall Study|Adverse Event|1|||
105595730|NCT01924767|364182362|FG003|Overall Study|Adverse Event|0|||
105595731|NCT01924767|364182363|FG004|Overall Study|Adverse Event|0|||
105538424|NCT02573324|363972123|FG002|Overall Study|Study Terminated by Sponsor|2|||
105538425|NCT02573324|363972121|FG000|Overall Study|Death|182|||
105538426|NCT02573324|363972122|FG001|Overall Study|Death|200|||
105538427|NCT02573324|363972123|FG002|Overall Study|Death|1|||
105538428|NCT02573324|363972121|FG000|Overall Study|Other, Not Specified|20|||
105538429|NCT02573324|363972122|FG001|Overall Study|Other, Not Specified|27|||
105538430|NCT02573324|363972123|FG002|Overall Study|Other, Not Specified|0|||
105538431|NCT02573324|363972121|FG000|Overall Study|Unknown Reason|2|||
105538432|NCT02573324|363972122|FG001|Overall Study|Unknown Reason|0|||
105538433|NCT02573324|363972123|FG002|Overall Study|Unknown Reason|0|||
105538434|NCT00600821|363972124|FG000|Overall Study|Death|45|||
105538435|NCT00600821|363972125|FG001|Overall Study|Death|46|||
105538436|NCT00600821|363972124|FG000|Overall Study|Lost to Follow-up|2|||
105538437|NCT00600821|363972125|FG001|Overall Study|Lost to Follow-up|2|||
105538438|NCT00600821|363972124|FG000|Overall Study|Withdrawal by Subject|1|||
105538439|NCT00600821|363972125|FG001|Overall Study|Withdrawal by Subject|1|||
105538440|NCT00600821|363972124|FG000|Overall Study|Terminated by sponsor|8|||
105538441|NCT00600821|363972125|FG001|Overall Study|Terminated by sponsor|6|||
105538442|NCT00600821|363972124|FG000|Overall Study|Objective progression or relapse|0|||
105538443|NCT00600821|363972125|FG001|Overall Study|Objective progression or relapse|1|||
105538444|NCT00600821|363972124|FG000|Overall Study|Randomized but not treated|0|||
105538445|NCT00600821|363972125|FG001|Overall Study|Randomized but not treated|1|||
105538446|NCT00600821|363972124|FG000|Overall Study|Other|2|||
105538447|NCT00600821|363972125|FG001|Overall Study|Other|3|||
105538448|NCT04269161|363972126|FG000|Overall Study|Change of modality and no longer eligible|3|||
105538449|NCT04269161|363972127|FG001|Overall Study|Change of modality and no longer eligible|3|||
105538450|NCT04269161|363972126|FG000|Overall Study|Required procedure outside of NICU|1|||
105538451|NCT04269161|363972127|FG001|Overall Study|Required procedure outside of NICU|0|||
105538452|NCT04269161|363972126|FG000|Overall Study|Equipment issue|1|||
105538453|NCT04269161|363972127|FG001|Overall Study|Equipment issue|1|||
105538454|NCT02200042|363972128|FG000|Overall Study|Withdrawal by Subject|0|||
105538455|NCT02200042|363972129|FG001|Overall Study|Withdrawal by Subject|1|||
105538456|NCT00110266|363972130|FG000|Overall Study|Adverse Event|27|||
105538457|NCT00110266|363972130|FG000|Overall Study|Abnormal laboratory value|15|||
105538458|NCT00110266|363972130|FG000|Overall Study|Withdrawal by Subject|16|||
105538459|NCT00110266|363972130|FG000|Overall Study|Death|17|||
105538460|NCT00110266|363972130|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105538461|NCT00110266|363972130|FG000|Overall Study|Participant condition no longer requires study drug|1|||
105538462|NCT02896400|363972131|FG000|1 Month Follow-up|Lost to Follow-up|7|||
105538463|NCT02896400|363972132|FG001|1 Month Follow-up|Lost to Follow-up|7|||
105538464|NCT02896400|363972133|FG002|1 Month Follow-up|Lost to Follow-up|5|||
105538465|NCT02896400|363972134|FG003|1 Month Follow-up|Lost to Follow-up|8|||
105538466|NCT02896400|363972135|FG004|1 Month Follow-up|Lost to Follow-up|9|||
105538467|NCT02896400|363972136|FG005|1 Month Follow-up|Lost to Follow-up|6|||
105538468|NCT02896400|363972137|FG006|1 Month Follow-up|Lost to Follow-up|5|||
105538469|NCT02896400|363972138|FG007|1 Month Follow-up|Lost to Follow-up|6|||
105538470|NCT02896400|363972139|FG008|1 Month Follow-up|Lost to Follow-up|4|||
105538471|NCT02896400|363972140|FG009|1 Month Follow-up|Lost to Follow-up|7|||
105538472|NCT02896400|363972141|FG010|1 Month Follow-up|Lost to Follow-up|5|||
105538473|NCT02896400|363972142|FG011|1 Month Follow-up|Lost to Follow-up|5|||
105538474|NCT02896400|363972143|FG012|1 Month Follow-up|Lost to Follow-up|3|||
105538475|NCT02896400|363972144|FG013|1 Month Follow-up|Lost to Follow-up|4|||
105538476|NCT02896400|363972145|FG014|1 Month Follow-up|Lost to Follow-up|1|||
105538477|NCT02896400|363972146|FG015|1 Month Follow-up|Lost to Follow-up|2|||
105538478|NCT02896400|363972131|FG000|1 Month Follow-up|Death|0|||
105538479|NCT02896400|363972132|FG001|1 Month Follow-up|Death|0|||
105538480|NCT02896400|363972133|FG002|1 Month Follow-up|Death|0|||
105538481|NCT02896400|363972134|FG003|1 Month Follow-up|Death|0|||
105538482|NCT02896400|363972135|FG004|1 Month Follow-up|Death|0|||
105538483|NCT02896400|363972136|FG005|1 Month Follow-up|Death|0|||
105538484|NCT02896400|363972137|FG006|1 Month Follow-up|Death|0|||
105538485|NCT02896400|363972138|FG007|1 Month Follow-up|Death|0|||
105538486|NCT02896400|363972139|FG008|1 Month Follow-up|Death|0|||
105538487|NCT02896400|363972140|FG009|1 Month Follow-up|Death|0|||
105538488|NCT02896400|363972141|FG010|1 Month Follow-up|Death|0|||
105538489|NCT02896400|363972142|FG011|1 Month Follow-up|Death|0|||
105538490|NCT02896400|363972143|FG012|1 Month Follow-up|Death|0|||
105538491|NCT02896400|363972144|FG013|1 Month Follow-up|Death|0|||
105538492|NCT02896400|363972145|FG014|1 Month Follow-up|Death|0|||
105538493|NCT02896400|363972146|FG015|1 Month Follow-up|Death|1|||
105538494|NCT02896400|363972131|FG000|3 Month Follow-up|Lost to Follow-up|6|||
105538495|NCT02896400|363972132|FG001|3 Month Follow-up|Lost to Follow-up|3|||
105538496|NCT02896400|363972133|FG002|3 Month Follow-up|Lost to Follow-up|6|||
105538497|NCT02896400|363972134|FG003|3 Month Follow-up|Lost to Follow-up|11|||
105538498|NCT02896400|363972135|FG004|3 Month Follow-up|Lost to Follow-up|12|||
105538499|NCT02896400|363972136|FG005|3 Month Follow-up|Lost to Follow-up|6|||
105538500|NCT02896400|363972137|FG006|3 Month Follow-up|Lost to Follow-up|4|||
105538501|NCT02896400|363972138|FG007|3 Month Follow-up|Lost to Follow-up|3|||
105538502|NCT02896400|363972139|FG008|3 Month Follow-up|Lost to Follow-up|6|||
105538503|NCT02896400|363972140|FG009|3 Month Follow-up|Lost to Follow-up|5|||
105538504|NCT02896400|363972141|FG010|3 Month Follow-up|Lost to Follow-up|6|||
105538505|NCT02896400|363972142|FG011|3 Month Follow-up|Lost to Follow-up|6|||
105538506|NCT02896400|363972143|FG012|3 Month Follow-up|Lost to Follow-up|3|||
105538507|NCT02896400|363972144|FG013|3 Month Follow-up|Lost to Follow-up|5|||
105538508|NCT02896400|363972145|FG014|3 Month Follow-up|Lost to Follow-up|3|||
105538509|NCT02896400|363972146|FG015|3 Month Follow-up|Lost to Follow-up|2|||
105538510|NCT02896400|363972131|FG000|3 Month Follow-up|Death|0|||
105538511|NCT02896400|363972132|FG001|3 Month Follow-up|Death|0|||
105538512|NCT02896400|363972133|FG002|3 Month Follow-up|Death|0|||
105538513|NCT02896400|363972134|FG003|3 Month Follow-up|Death|0|||
105538514|NCT02896400|363972135|FG004|3 Month Follow-up|Death|0|||
105538515|NCT02896400|363972136|FG005|3 Month Follow-up|Death|0|||
105538516|NCT02896400|363972137|FG006|3 Month Follow-up|Death|0|||
105538517|NCT02896400|363972138|FG007|3 Month Follow-up|Death|0|||
105538518|NCT02896400|363972139|FG008|3 Month Follow-up|Death|0|||
105538519|NCT02896400|363972140|FG009|3 Month Follow-up|Death|0|||
105538520|NCT02896400|363972141|FG010|3 Month Follow-up|Death|0|||
105538521|NCT02896400|363972142|FG011|3 Month Follow-up|Death|0|||
105538522|NCT02896400|363972143|FG012|3 Month Follow-up|Death|0|||
105538523|NCT02896400|363972144|FG013|3 Month Follow-up|Death|1|||
105538524|NCT02896400|363972145|FG014|3 Month Follow-up|Death|1|||
105538525|NCT02896400|363972146|FG015|3 Month Follow-up|Death|0|||
105538526|NCT02896400|363972131|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
105538527|NCT02896400|363972132|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
105538528|NCT02896400|363972133|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
105538529|NCT02896400|363972134|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
105538530|NCT02896400|363972135|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
105538531|NCT02896400|363972136|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
105538532|NCT02896400|363972137|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
105538533|NCT02896400|363972138|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
105538534|NCT02896400|363972139|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
105538535|NCT02896400|363972140|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
105538536|NCT02896400|363972141|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
105538537|NCT02896400|363972142|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
105538538|NCT02896400|363972143|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
105538539|NCT02896400|363972144|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
105538540|NCT02896400|363972145|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
105538541|NCT02896400|363972146|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
105538542|NCT02896400|363972131|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
105538543|NCT02896400|363972132|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
105538544|NCT02896400|363972133|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
105538545|NCT02896400|363972134|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
105538546|NCT02896400|363972135|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
105538547|NCT02896400|363972136|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
105538548|NCT02896400|363972137|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
105538549|NCT02896400|363972138|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
105538550|NCT02896400|363972139|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
105538551|NCT02896400|363972140|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
105538552|NCT02896400|363972141|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
105538553|NCT02896400|363972142|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
105538554|NCT02896400|363972143|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
105538555|NCT02896400|363972144|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
105538556|NCT02896400|363972145|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
105538557|NCT02896400|363972146|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
105538558|NCT05723770|363972147|FG000|Overall Study|Lost to Follow-up|4|||
105538559|NCT05723770|363972147|FG000|Overall Study|Withdrawal by Subject|2|||
105538560|NCT02433834|363972148|FG000|Overall Study|Protocol-specified criteria|7|||
105538561|NCT02433834|363972148|FG000|Overall Study|Protocol Violation|3|||
105538562|NCT02433834|363972148|FG000|Overall Study|Lost to Follow-up|6|||
105538563|NCT02433834|363972148|FG000|Overall Study|Withdrawal by Subject|14|||
105538564|NCT02433834|363972148|FG000|Overall Study|Adverse Event|6|||
105538565|NCT02433834|363972148|FG000|Overall Study|Physician Decision|1|||
105538566|NCT00355238|363972153|FG000|Overall Study|Adverse event unrelated to study drug|2|||
105538567|NCT00355238|363972154|FG001|Overall Study|Adverse event unrelated to study drug|2|||
105538568|NCT00355238|363972155|FG002|Overall Study|Adverse event unrelated to study drug|0|||
105538569|NCT00355238|363972156|FG003|Overall Study|Adverse event unrelated to study drug|1|||
105538570|NCT00355238|363972153|FG000|Overall Study|Death|1|||
105595732|NCT00139737|364182368|FG000|Overall Study|Withdrawal by Subject|190|||
105595733|NCT00139737|364182368|FG000|Overall Study|Adverse Event|58|||
105595734|NCT00139737|364182368|FG000|Overall Study|Lack of Efficacy|40|||
105595735|NCT00139737|364182368|FG000|Overall Study|Lost to Follow-up|8|||
105595736|NCT00139737|364182368|FG000|Overall Study|Death|3|||
105595737|NCT00139737|364182368|FG000|Overall Study|Laboratory Abnormality|2|||
105595738|NCT00139737|364182368|FG000|Overall Study|Protocol Violation|18|||
105595739|NCT00139737|364182368|FG000|Overall Study|Withdrew During Screening Phase|8|||
105595740|NCT00139737|364182368|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
105595741|NCT00139737|364182368|FG000|Overall Study|Screened, Not Treated|13|||
105595742|NCT01505881|364182373|FG000|Overall Study|Adverse Event|0|||
105595743|NCT01505881|364182374|FG001|Overall Study|Adverse Event|1|||
105595744|NCT01505881|364182373|FG000|Overall Study|Lost to Follow-up|2|||
105595745|NCT01505881|364182374|FG001|Overall Study|Lost to Follow-up|0|||
105595746|NCT01505881|364182373|FG000|Overall Study|Withdrawal by Subject|2|||
105595747|NCT01505881|364182374|FG001|Overall Study|Withdrawal by Subject|0|||
105595748|NCT01596504|364182375|FG000|Overall Study|Participant's Private Reason|0|||
105595749|NCT01596504|364182376|FG001|Overall Study|Participant's Private Reason|1|||
105595750|NCT01596504|364182377|FG002|Overall Study|Participant's Private Reason|0|||
105595751|NCT01596504|364182375|FG000|Overall Study|Adverse Event|1|||
105595752|NCT01596504|364182376|FG001|Overall Study|Adverse Event|2|||
105595753|NCT01596504|364182377|FG002|Overall Study|Adverse Event|1|||
105595754|NCT01596504|364182375|FG000|Overall Study|Withdrawal by Subject|1|||
105595755|NCT01596504|364182376|FG001|Overall Study|Withdrawal by Subject|0|||
105595756|NCT01596504|364182377|FG002|Overall Study|Withdrawal by Subject|0|||
105595757|NCT01490580|364182378|FG000|Overall Study|Parents withdrew consent|0|||
105595758|NCT01490580|364182379|FG001|Overall Study|Parents withdrew consent|2|||
105595759|NCT02026258|364182380|FG000|Randomized|Did not start treatment|2|||
105595760|NCT02026258|364182381|FG001|Randomized|Did not start treatment|1|||
105595761|NCT02026258|364182380|FG000|Randomized|Change in treatment plan|1|||
105595762|NCT02026258|364182381|FG001|Randomized|Change in treatment plan|0|||
105595763|NCT02026258|364182380|FG000|Randomized|Presence of periodontal disease|1|||
105595764|NCT02026258|364182381|FG001|Randomized|Presence of periodontal disease|1|||
105595765|NCT02026258|364182380|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
105595766|NCT02026258|364182381|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
105595767|NCT02026258|364182380|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
105595768|NCT02026258|364182381|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
105595769|NCT01104415|364182384|FG000|Core Phase|Consent withdrawn by subjects|1|||
105595770|NCT01104415|364182385|FG001|Core Phase|Consent withdrawn by subjects|0|||
105595771|NCT01104415|364182384|FG000|Extension Period|Progressive disease|0|||
105595772|NCT01104415|364182385|FG001|Extension Period|Progressive disease|4|||
105595773|NCT01104415|364182384|FG000|Extension Period|Death|0|||
105595774|NCT01104415|364182385|FG001|Extension Period|Death|1|||
105595775|NCT01104415|364182384|FG000|Extension Period|Physician Decision|0|||
105595776|NCT01104415|364182385|FG001|Extension Period|Physician Decision|1|||
105595777|NCT01104415|364182384|FG000|Extension Period|Transition to Study LX1606.302|0|||
105595778|NCT01104415|364182385|FG001|Extension Period|Transition to Study LX1606.302|4|||
105595779|NCT01104415|364182384|FG000|Extension Period|Heart surgery/feeling miserable|0|||
105595780|NCT01104415|364182385|FG001|Extension Period|Heart surgery/feeling miserable|1|||
105595781|NCT03383146|364182389|FG000|Overall Study|Screen Failure|1|||
105595782|NCT03383146|364182390|FG001|Overall Study|Screen Failure|0|||
105595783|NCT03383146|364182389|FG000|Overall Study|Adverse Event|6|||
105595784|NCT03383146|364182390|FG001|Overall Study|Adverse Event|18|||
105595785|NCT03383146|364182389|FG000|Overall Study|Lack of Efficacy|0|||
105595786|NCT03383146|364182390|FG001|Overall Study|Lack of Efficacy|3|||
105595787|NCT03383146|364182389|FG000|Overall Study|Withdrawal by Subject|20|||
105595788|NCT03383146|364182390|FG001|Overall Study|Withdrawal by Subject|36|||
105595789|NCT03383146|364182389|FG000|Overall Study|Lost to Follow-up|5|||
105595790|NCT03383146|364182390|FG001|Overall Study|Lost to Follow-up|15|||
105595791|NCT03383146|364182389|FG000|Overall Study|Death|0|||
105595792|NCT03383146|364182390|FG001|Overall Study|Death|2|||
105595793|NCT03383146|364182389|FG000|Overall Study|Physician Decision|0|||
105595794|NCT03383146|364182390|FG001|Overall Study|Physician Decision|1|||
105595795|NCT03383146|364182389|FG000|Overall Study|Protocol Deviation|1|||
105595796|NCT03383146|364182390|FG001|Overall Study|Protocol Deviation|8|||
105595797|NCT03383146|364182389|FG000|Overall Study|Study Terminated by the Sponsor|48|||
105595798|NCT03383146|364182390|FG001|Overall Study|Study Terminated by the Sponsor|95|||
105595799|NCT03383146|364182389|FG000|Overall Study|Reason not Specified|4|||
105595800|NCT03383146|364182390|FG001|Overall Study|Reason not Specified|6|||
105595801|NCT03024606|364182391|FG000|Overall Study|Withdrawal by Subject|9|||
105595802|NCT03024606|364182392|FG001|Overall Study|Withdrawal by Subject|10|||
105595803|NCT00639002|364182399|FG000|Overall Study|Death|1|||
105595804|NCT00639002|364182399|FG000|Overall Study|Adverse Event|1|||
105595805|NCT00639002|364182399|FG000|Overall Study|Protocol Violation|1|||
105595806|NCT00639002|364182399|FG000|Overall Study|Disease progression|3|||
105595807|NCT00639002|364182399|FG000|Overall Study|Physician Decision|6|||
105595808|NCT00639002|364182399|FG000|Overall Study|Lack of Efficacy|1|||
105538571|NCT00355238|363972154|FG001|Overall Study|Death|0|||
105538572|NCT00355238|363972155|FG002|Overall Study|Death|0|||
105538573|NCT00355238|363972156|FG003|Overall Study|Death|0|||
105538574|NCT00355238|363972153|FG000|Overall Study|Disease progression|37|||
105538575|NCT00355238|363972154|FG001|Overall Study|Disease progression|36|||
105538576|NCT00355238|363972155|FG002|Overall Study|Disease progression|16|||
105538577|NCT00355238|363972156|FG003|Overall Study|Disease progression|11|||
105538578|NCT00355238|363972153|FG000|Overall Study|Study drug toxicity|11|||
105538579|NCT00355238|363972154|FG001|Overall Study|Study drug toxicity|7|||
105538580|NCT00355238|363972155|FG002|Overall Study|Study drug toxicity|5|||
105538581|NCT00355238|363972156|FG003|Overall Study|Study drug toxicity|2|||
105538582|NCT00355238|363972153|FG000|Overall Study|Participant withdrew consent|3|||
105538583|NCT00355238|363972154|FG001|Overall Study|Participant withdrew consent|1|||
105538584|NCT00355238|363972155|FG002|Overall Study|Participant withdrew consent|0|||
105538585|NCT00355238|363972156|FG003|Overall Study|Participant withdrew consent|0|||
105538586|NCT00355238|363972153|FG000|Overall Study|Participant request to discontinue study treatment|1|||
105538587|NCT00355238|363972154|FG001|Overall Study|Participant request to discontinue study treatment|0|||
105538588|NCT00355238|363972155|FG002|Overall Study|Participant request to discontinue study treatment|1|||
105538589|NCT00355238|363972156|FG003|Overall Study|Participant request to discontinue study treatment|0|||
105538590|NCT00548808|363972157|FG000|Overall Study|Lost to Follow-up|9|||
105538591|NCT00548808|363972158|FG001|Overall Study|Lost to Follow-up|3|||
105538592|NCT00548808|363972157|FG000|Overall Study|Protocol Violation|8|||
105538593|NCT00548808|363972158|FG001|Overall Study|Protocol Violation|8|||
105538594|NCT00548808|363972157|FG000|Overall Study|Withdrawal by Subject|8|||
105538595|NCT00548808|363972158|FG001|Overall Study|Withdrawal by Subject|4|||
105538596|NCT00548808|363972157|FG000|Overall Study|Physician Decision|6|||
105538597|NCT00548808|363972158|FG001|Overall Study|Physician Decision|3|||
105538598|NCT00548808|363972157|FG000|Overall Study|Adverse Event|4|||
105538599|NCT00548808|363972158|FG001|Overall Study|Adverse Event|5|||
105538600|NCT00548808|363972157|FG000|Overall Study|Death|2|||
105538601|NCT00548808|363972158|FG001|Overall Study|Death|0|||
105538602|NCT00548808|363972157|FG000|Overall Study|Entry Criteria Not Met|2|||
105538603|NCT00548808|363972158|FG001|Overall Study|Entry Criteria Not Met|2|||
105538604|NCT00548808|363972157|FG000|Overall Study|Lack of Efficacy|2|||
105538605|NCT00548808|363972158|FG001|Overall Study|Lack of Efficacy|0|||
105538606|NCT00548808|363972157|FG000|Overall Study|Sponsor Decision|1|||
105538607|NCT00548808|363972158|FG001|Overall Study|Sponsor Decision|1|||
105538608|NCT04622254|363972161|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
105538609|NCT04622254|363972162|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
105538610|NCT04622254|363972163|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
105538611|NCT04622254|363972164|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
105538612|NCT04622254|363972165|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
105538613|NCT04622254|363972166|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
105538614|NCT04622254|363972161|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
105538615|NCT04622254|363972162|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
105538616|NCT04622254|363972163|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
105538617|NCT04622254|363972164|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
105538618|NCT04622254|363972165|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
105538619|NCT04622254|363972166|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
105538620|NCT04622254|363972161|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
105538621|NCT04622254|363972162|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
105538622|NCT04622254|363972163|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
105538623|NCT04622254|363972164|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
105538624|NCT04622254|363972165|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
105538625|NCT04622254|363972166|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
105538626|NCT04622254|363972161|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
105538627|NCT04622254|363972162|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
105538628|NCT04622254|363972163|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
105538629|NCT04622254|363972164|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
105538630|NCT04622254|363972165|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
105538631|NCT04622254|363972166|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
105538632|NCT04622254|363972161|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
105538633|NCT04622254|363972162|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
105538634|NCT04622254|363972163|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
105538635|NCT04622254|363972164|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
105538636|NCT04622254|363972165|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
105538637|NCT04622254|363972166|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
105538638|NCT04622254|363972161|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
105538639|NCT04622254|363972162|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
105538640|NCT04622254|363972163|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
105538641|NCT04622254|363972164|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
105538642|NCT04622254|363972165|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
105538643|NCT04622254|363972166|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
105538644|NCT04622254|363972161|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
105538645|NCT04622254|363972162|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
105538646|NCT04622254|363972163|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
105538647|NCT04622254|363972164|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
105538648|NCT04622254|363972165|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
105538649|NCT04622254|363972166|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
105538650|NCT04622254|363972161|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
105538651|NCT04622254|363972162|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
105538652|NCT04622254|363972163|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
105538653|NCT04622254|363972164|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
105538654|NCT04622254|363972165|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
105538655|NCT04622254|363972166|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
105538656|NCT04622254|363972161|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
105538657|NCT04622254|363972162|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
105538658|NCT04622254|363972163|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
105538659|NCT04622254|363972164|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
105538660|NCT04622254|363972165|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
105538661|NCT04622254|363972166|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
105538662|NCT04622254|363972161|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
105538663|NCT04622254|363972162|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
105538664|NCT04622254|363972163|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
105538665|NCT04622254|363972164|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
105538666|NCT04622254|363972165|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
105538667|NCT04622254|363972166|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
105538668|NCT04622254|363972161|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
105538669|NCT04622254|363972162|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
105538670|NCT04622254|363972163|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
105538671|NCT04622254|363972164|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
105538672|NCT04622254|363972165|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
105538673|NCT04622254|363972166|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
105538674|NCT00912405|363972169|FG000|Overall Study|Lost to Follow-up|5|||
105538675|NCT01434823|363972170|FG000|Overall Study|Incomplete data in medical record|4|||
105538676|NCT01434823|363972171|FG001|Overall Study|Incomplete data in medical record|7|||
105538677|NCT02477020|363972175|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
105538678|NCT02477020|363972176|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
105538679|NCT02477020|363972175|FG000|Overall Study|Voluntary Withdrawal|7|||
105538680|NCT02477020|363972176|FG001|Overall Study|Voluntary Withdrawal|16|||
105538681|NCT02477020|363972175|FG000|Overall Study|Reason not Specified|3|||
105538682|NCT02477020|363972176|FG001|Overall Study|Reason not Specified|1|||
105538683|NCT02477020|363972175|FG000|Overall Study|Lack of Efficacy|14|||
105538684|NCT02477020|363972176|FG001|Overall Study|Lack of Efficacy|5|||
105538685|NCT01465802|363972177|FG000|Overall Study|Study terminated by sponsor|1|||
105538686|NCT01465802|363972178|FG001|Overall Study|Study terminated by sponsor|0|||
105538687|NCT01465802|363972179|FG002|Overall Study|Study terminated by sponsor|0|||
105538688|NCT01465802|363972180|FG003|Overall Study|Study terminated by sponsor|1|||
105538689|NCT01465802|363972181|FG004|Overall Study|Study terminated by sponsor|7|||
105538690|NCT01465802|363972177|FG000|Overall Study|Withdrawal by Subject|7|||
105538691|NCT01465802|363972178|FG001|Overall Study|Withdrawal by Subject|7|||
105538692|NCT01465802|363972179|FG002|Overall Study|Withdrawal by Subject|0|||
105538693|NCT01465802|363972180|FG003|Overall Study|Withdrawal by Subject|8|||
105538694|NCT01465802|363972181|FG004|Overall Study|Withdrawal by Subject|1|||
105538695|NCT01465802|363972177|FG000|Overall Study|Lost to Follow-up|1|||
105538696|NCT01465802|363972178|FG001|Overall Study|Lost to Follow-up|1|||
105538697|NCT01465802|363972179|FG002|Overall Study|Lost to Follow-up|0|||
105538698|NCT01465802|363972180|FG003|Overall Study|Lost to Follow-up|0|||
105538699|NCT01465802|363972181|FG004|Overall Study|Lost to Follow-up|0|||
105538700|NCT01465802|363972177|FG000|Overall Study|Reason not specified|9|||
105538701|NCT01465802|363972178|FG001|Overall Study|Reason not specified|4|||
105538702|NCT01465802|363972179|FG002|Overall Study|Reason not specified|0|||
105538703|NCT01465802|363972180|FG003|Overall Study|Reason not specified|10|||
105538704|NCT01465802|363972181|FG004|Overall Study|Reason not specified|2|||
105538705|NCT01465802|363972177|FG000|Overall Study|Death|15|||
105538706|NCT01465802|363972178|FG001|Overall Study|Death|12|||
105538707|NCT01465802|363972179|FG002|Overall Study|Death|0|||
105538708|NCT01465802|363972180|FG003|Overall Study|Death|10|||
105538709|NCT01465802|363972181|FG004|Overall Study|Death|2|||
105538710|NCT01340976|363972182|FG000|Overall Study|Physician Decision|2|||
105538711|NCT01340976|363972183|FG001|Overall Study|Physician Decision|0|||
105538712|NCT01340976|363972184|FG002|Overall Study|Physician Decision|1|||
105538713|NCT01340976|363972185|FG003|Overall Study|Physician Decision|1|||
105538714|NCT01340976|363972186|FG004|Overall Study|Physician Decision|1|||
105538715|NCT01340976|363972187|FG005|Overall Study|Physician Decision|0|||
105595809|NCT00547118|364182408|FG000|Overall Study|Did not qualify prior to starting drug|1|||
105595810|NCT00547118|364182409|FG001|Overall Study|Did not qualify prior to starting drug|1|||
105595811|NCT00547118|364182408|FG000|Overall Study|Study suspended|7|||
105595812|NCT00547118|364182409|FG001|Overall Study|Study suspended|8|||
105595813|NCT03863834|364182410|FG000|Overall Study|Lost to Follow-up|3|||
105595814|NCT01585558|364182412|FG000|Overall Study|Withdrawal by Subject|4|||
105595815|NCT01585558|364182413|FG001|Overall Study|Withdrawal by Subject|5|||
105595816|NCT01585558|364182414|FG002|Overall Study|Withdrawal by Subject|8|||
105595817|NCT01585558|364182412|FG000|Overall Study|Lost to Follow-up|2|||
105595818|NCT01585558|364182413|FG001|Overall Study|Lost to Follow-up|0|||
105595819|NCT01585558|364182414|FG002|Overall Study|Lost to Follow-up|3|||
105595820|NCT01585558|364182412|FG000|Overall Study|Adverse Event|3|||
105595821|NCT01585558|364182413|FG001|Overall Study|Adverse Event|4|||
105595822|NCT01585558|364182414|FG002|Overall Study|Adverse Event|1|||
105595823|NCT01585558|364182412|FG000|Overall Study|Protocol Violation|4|||
105595824|NCT01585558|364182413|FG001|Overall Study|Protocol Violation|3|||
105595825|NCT01585558|364182414|FG002|Overall Study|Protocol Violation|2|||
105595826|NCT01585558|364182412|FG000|Overall Study|Lack of Efficacy|0|||
105538716|NCT01340976|363972182|FG000|Overall Study|Death|0|||
105538717|NCT01340976|363972183|FG001|Overall Study|Death|1|||
105595827|NCT01585558|364182413|FG001|Overall Study|Lack of Efficacy|0|||
105595828|NCT01585558|364182414|FG002|Overall Study|Lack of Efficacy|1|||
105595829|NCT00841035|364182415|FG000|Phase 1 Overall Study|Physician Decision|13|||
105595830|NCT00361283|364182416|FG000|Overall Study|Lost to Follow-up|27|||
105595831|NCT00094575|364182417|FG000|Overall Study|Death|146|||
105595832|NCT00094575|364182418|FG001|Overall Study|Death|146|||
105595833|NCT03603717|364182435|FG000|Overall Study|Lost to Follow-up|20|||
105595834|NCT03603717|364182436|FG001|Overall Study|Lost to Follow-up|20|||
105595835|NCT03603717|364182435|FG000|Overall Study|Withdrawal by Subject|16|||
105595836|NCT03603717|364182436|FG001|Overall Study|Withdrawal by Subject|10|||
105595837|NCT02551055|364182442|FG000|Overall Study|Death|2|||
105595838|NCT02551055|364182443|FG001|Overall Study|Death|4|||
105595839|NCT02551055|364182444|FG002|Overall Study|Death|2|||
105595840|NCT02551055|364182445|FG003|Overall Study|Death|2|||
105595841|NCT02551055|364182446|FG004|Overall Study|Death|2|||
105595842|NCT02551055|364182447|FG005|Overall Study|Death|1|||
105595843|NCT02551055|364182448|FG006|Overall Study|Death|2|||
105595844|NCT02551055|364182449|FG007|Overall Study|Death|0|||
105538718|NCT01340976|363972184|FG002|Overall Study|Death|0|||
105538719|NCT01340976|363972185|FG003|Overall Study|Death|0|||
105538720|NCT01340976|363972186|FG004|Overall Study|Death|0|||
105538721|NCT01340976|363972187|FG005|Overall Study|Death|0|||
105538722|NCT01340976|363972182|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
105538723|NCT01340976|363972183|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
105538724|NCT01340976|363972184|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
105538725|NCT01340976|363972185|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
105538726|NCT01340976|363972186|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
105538727|NCT01340976|363972187|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
105538728|NCT01340976|363972182|FG000|Overall Study|Withdrawal by Subject|0|||
105538729|NCT01340976|363972183|FG001|Overall Study|Withdrawal by Subject|0|||
105538730|NCT01340976|363972184|FG002|Overall Study|Withdrawal by Subject|0|||
105538731|NCT01340976|363972185|FG003|Overall Study|Withdrawal by Subject|1|||
105538732|NCT01340976|363972186|FG004|Overall Study|Withdrawal by Subject|1|||
105538733|NCT01340976|363972187|FG005|Overall Study|Withdrawal by Subject|0|||
105538734|NCT01340976|363972182|FG000|Overall Study|Other anemia treatment|1|||
105538735|NCT01340976|363972183|FG001|Overall Study|Other anemia treatment|0|||
105538736|NCT01340976|363972184|FG002|Overall Study|Other anemia treatment|2|||
105538737|NCT01340976|363972185|FG003|Overall Study|Other anemia treatment|1|||
105538738|NCT01340976|363972186|FG004|Overall Study|Other anemia treatment|0|||
105538739|NCT01340976|363972187|FG005|Overall Study|Other anemia treatment|1|||
105538740|NCT01340976|363972182|FG000|Overall Study|Adverse Event|0|||
105538741|NCT01340976|363972183|FG001|Overall Study|Adverse Event|1|||
105538742|NCT01340976|363972184|FG002|Overall Study|Adverse Event|0|||
105538743|NCT01340976|363972185|FG003|Overall Study|Adverse Event|0|||
105538744|NCT01340976|363972186|FG004|Overall Study|Adverse Event|0|||
105538745|NCT01340976|363972187|FG005|Overall Study|Adverse Event|0|||
105595845|NCT02551055|364182442|FG000|Overall Study|Study Terminated by Sponsor|1|||
105595846|NCT02551055|364182443|FG001|Overall Study|Study Terminated by Sponsor|1|||
105595847|NCT02551055|364182444|FG002|Overall Study|Study Terminated by Sponsor|0|||
105595848|NCT02551055|364182445|FG003|Overall Study|Study Terminated by Sponsor|2|||
105595849|NCT02551055|364182446|FG004|Overall Study|Study Terminated by Sponsor|2|||
105595850|NCT02551055|364182447|FG005|Overall Study|Study Terminated by Sponsor|0|||
105595851|NCT02551055|364182448|FG006|Overall Study|Study Terminated by Sponsor|0|||
105595852|NCT02551055|364182449|FG007|Overall Study|Study Terminated by Sponsor|0|||
105595853|NCT02551055|364182442|FG000|Overall Study|Withdrawal by Subject|1|||
105538746|NCT00796861|363972202|FG000|Overall Study|Withdrawal by Subject|2|||
105538747|NCT00796861|363972202|FG000|Overall Study|Death|2|||
105538748|NCT03852316|363972205|FG000|Overall Study|Protocol Violation|1|||
105538749|NCT03852316|363972205|FG000|Overall Study|Withdrawal by Subject|2|||
105538750|NCT03852316|363972205|FG000|Overall Study|Enrolled but Device not Utilized|1|||
105538751|NCT00529386|363972208|FG000|Overall Study|Lost to Follow-up|1|||
105538752|NCT02939404|363972209|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
105538753|NCT02939404|363972210|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
105538754|NCT02939404|363972209|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
105538755|NCT02939404|363972210|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
105538756|NCT03417141|363972215|FG000|Overall Study|Withdrawal by Subject|1|||
105538757|NCT03417141|363972215|FG000|Overall Study|Protocol Violation|3|||
105538758|NCT02550652|363972216|FG000|Overall Study|Death|1|||
105538759|NCT02550652|363972217|FG001|Overall Study|Death|4|||
105538760|NCT02550652|363972216|FG000|Overall Study|Lack of Efficacy|1|||
105538761|NCT02550652|363972217|FG001|Overall Study|Lack of Efficacy|0|||
105538762|NCT02550652|363972216|FG000|Overall Study|Withdrawal by Subject|4|||
105538763|NCT02550652|363972217|FG001|Overall Study|Withdrawal by Subject|7|||
105538764|NCT02550652|363972216|FG000|Overall Study|Post Trial Access|1|||
105538765|NCT02550652|363972217|FG001|Overall Study|Post Trial Access|0|||
105538766|NCT02550652|363972216|FG000|Overall Study|Lost to Follow-up|1|||
105538767|NCT02550652|363972217|FG001|Overall Study|Lost to Follow-up|3|||
105538768|NCT02550652|363972216|FG000|Overall Study|Physician Decision|0|||
105538769|NCT02550652|363972217|FG001|Overall Study|Physician Decision|2|||
105538770|NCT02550652|363972216|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
105538771|NCT02550652|363972217|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
105538772|NCT03921411|363972219|FG000|Overall Study|Withdrawal by Subject|1|||
105538773|NCT03921411|363972219|FG000|Overall Study|Protocol Deviation|2|||
105538774|NCT03921411|363972219|FG000|Overall Study|Enrolled, but never treated|2|||
105538775|NCT03286140|363972220|FG000|Overall Study|Withdrawal by Subject|10|||
105538776|NCT03286140|363972221|FG001|Overall Study|Withdrawal by Subject|5|||
105538777|NCT03286140|363972220|FG000|Overall Study|Lost to Follow-up|5|||
105538778|NCT03286140|363972221|FG001|Overall Study|Lost to Follow-up|10|||
105538779|NCT03286140|363972220|FG000|Overall Study|Failure to comply|0|||
105538780|NCT03286140|363972221|FG001|Overall Study|Failure to comply|1|||
105538781|NCT01565291|363972222|FG000|Overall Study|Withdrawal by Subject|1|||
105538782|NCT01565291|363972223|FG001|Overall Study|Withdrawal by Subject|0|||
105538783|NCT00515827|363972224|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
105538784|NCT00515827|363972225|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
105538785|NCT00515827|363972224|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
105538786|NCT00515827|363972225|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
105538787|NCT01365273|363972228|FG000|Overall Study|Lost to Follow-up|1|||
105538788|NCT01365273|363972229|FG001|Overall Study|Lost to Follow-up|0|||
105538789|NCT01365273|363972228|FG000|Overall Study|Protocol Violation|0|||
105538790|NCT01365273|363972229|FG001|Overall Study|Protocol Violation|1|||
105538791|NCT01365273|363972228|FG000|Overall Study|Physician Decision|1|||
105538792|NCT01365273|363972229|FG001|Overall Study|Physician Decision|0|||
105538793|NCT02920983|363972233|FG000|Dispense 1|Unacceptable Lens Fit|0|||
105538794|NCT02920983|363972234|FG001|Dispense 1|Unacceptable Lens Fit|0|||
105538795|NCT02920983|363972235|FG002|Dispense 1|Unacceptable Lens Fit|0|||
105538796|NCT02920983|363972236|FG003|Dispense 1|Unacceptable Lens Fit|0|||
105538797|NCT02920983|363972237|FG004|Dispense 1|Unacceptable Lens Fit|1|||
105538798|NCT02920983|363972238|FG005|Dispense 1|Unacceptable Lens Fit|0|||
105538799|NCT02920983|363972233|FG000|Dispense 2|Unscceptable lens fit|1|||
105538800|NCT02920983|363972234|FG001|Dispense 2|Unscceptable lens fit|0|||
105538801|NCT02920983|363972235|FG002|Dispense 2|Unscceptable lens fit|0|||
105538802|NCT02920983|363972236|FG003|Dispense 2|Unscceptable lens fit|0|||
105538803|NCT02920983|363972237|FG004|Dispense 2|Unscceptable lens fit|1|||
105538804|NCT02920983|363972238|FG005|Dispense 2|Unscceptable lens fit|0|||
105538805|NCT02920983|363972233|FG000|Dispense 3|Unacceptable Lens Fit|1|||
105538806|NCT02920983|363972234|FG001|Dispense 3|Unacceptable Lens Fit|1|||
105538807|NCT02920983|363972235|FG002|Dispense 3|Unacceptable Lens Fit|0|||
105538808|NCT02920983|363972236|FG003|Dispense 3|Unacceptable Lens Fit|0|||
105538809|NCT02920983|363972237|FG004|Dispense 3|Unacceptable Lens Fit|1|||
105538810|NCT02920983|363972238|FG005|Dispense 3|Unacceptable Lens Fit|0|||
105538811|NCT01387607|363972241|FG000|Overall Study|Adverse Event|23|||
105538812|NCT01387607|363972242|FG001|Overall Study|Adverse Event|11|||
105538813|NCT01387607|363972241|FG000|Overall Study|Lack of Efficacy|8|||
105538814|NCT01387607|363972242|FG001|Overall Study|Lack of Efficacy|6|||
105538815|NCT01387607|363972241|FG000|Overall Study|Lost to Follow-up|2|||
105538816|NCT01387607|363972242|FG001|Overall Study|Lost to Follow-up|1|||
105538817|NCT01387607|363972241|FG000|Overall Study|No longer meets eligibility criteria|0|||
105538818|NCT01387607|363972242|FG001|Overall Study|No longer meets eligibility criteria|1|||
105538819|NCT01387607|363972241|FG000|Overall Study|Protocol Violation|1|||
105538820|NCT01387607|363972242|FG001|Overall Study|Protocol Violation|5|||
105538821|NCT01387607|363972241|FG000|Overall Study|Withdrawal by Subject|13|||
105538822|NCT01387607|363972242|FG001|Overall Study|Withdrawal by Subject|14|||
105538823|NCT01387607|363972241|FG000|Overall Study|Other|1|||
105538824|NCT01387607|363972242|FG001|Overall Study|Other|1|||
105538825|NCT01387607|363972241|FG000|Overall Study|Randomized, not treated|3|||
105538826|NCT01387607|363972242|FG001|Overall Study|Randomized, not treated|6|||
105538827|NCT02774681|363972244|FG000|Treatment on Study|Progressive Disease|7|||
105538828|NCT02774681|363972244|FG000|Follow-Up for 3 Years|Death|11|||
105538829|NCT02774681|363972244|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
105538830|NCT02707640|363972246|FG000|Overall Study|Adverse Event|4|||
105538831|NCT02707640|363972247|FG001|Overall Study|Adverse Event|2|||
105538832|NCT02707640|363972246|FG000|Overall Study|Death|1|||
105538833|NCT02707640|363972247|FG001|Overall Study|Death|2|||
105538834|NCT02707640|363972246|FG000|Overall Study|Physician Decision|2|||
105538835|NCT02707640|363972247|FG001|Overall Study|Physician Decision|0|||
105538836|NCT02707640|363972246|FG000|Overall Study|Withdrawal by Subject|0|||
105538837|NCT02707640|363972247|FG001|Overall Study|Withdrawal by Subject|1|||
105538838|NCT02707640|363972246|FG000|Overall Study|Participant's Personal Decision|1|||
105538839|NCT02707640|363972247|FG001|Overall Study|Participant's Personal Decision|2|||
105538840|NCT02707640|363972246|FG000|Overall Study|Sponsor Discretion|1|||
105538841|NCT02707640|363972247|FG001|Overall Study|Sponsor Discretion|0|||
105538842|NCT02517905|363972248|FG000|Overall Study|Lost to Follow-up|4|||
105538843|NCT02517905|363972249|FG001|Overall Study|Lost to Follow-up|0|||
105538844|NCT02517905|363972248|FG000|Overall Study|Withdrawal by Subject|4|||
105538845|NCT02517905|363972249|FG001|Overall Study|Withdrawal by Subject|0|||
105538846|NCT02517905|363972248|FG000|Overall Study|Screen failure|2|||
105538847|NCT02517905|363972249|FG001|Overall Study|Screen failure|2|||
105538848|NCT01660412|363972257|FG000|Overall Study|Protocol Violation|0|||
105538849|NCT01660412|363972258|FG001|Overall Study|Protocol Violation|3|||
105538850|NCT01209624|363972260|FG000|Overall Study|Death|2|||
105538851|NCT01209624|363972260|FG000|Overall Study|Adverse Event|13|||
105538852|NCT01209624|363972260|FG000|Overall Study|Lack of Efficacy|17|||
105538853|NCT01209624|363972260|FG000|Overall Study|Lost to Follow-up|290|||
105538854|NCT01209624|363972260|FG000|Overall Study|Other|4|||
105538855|NCT03265119|363972261|FG000|Overall Study|Adverse Event|2|||
105538856|NCT03265119|363972262|FG001|Overall Study|Adverse Event|1|||
105538857|NCT03265119|363972261|FG000|Overall Study|Lack of Efficacy|3|||
105538858|NCT03265119|363972262|FG001|Overall Study|Lack of Efficacy|0|||
105538859|NCT03265119|363972261|FG000|Overall Study|Protocol Violation|1|||
105538860|NCT03265119|363972262|FG001|Overall Study|Protocol Violation|2|||
105538861|NCT03265119|363972261|FG000|Overall Study|Withdrawal by Subject|2|||
105538862|NCT03265119|363972262|FG001|Overall Study|Withdrawal by Subject|4|||
105538863|NCT03265119|363972261|FG000|Overall Study|Lost to Follow-up|1|||
105538864|NCT03265119|363972262|FG001|Overall Study|Lost to Follow-up|0|||
105538865|NCT03265119|363972261|FG000|Overall Study|Lack of Compliance|1|||
105538866|NCT03265119|363972262|FG001|Overall Study|Lack of Compliance|0|||
105538867|NCT03238911|363972264|FG000|Overall Study|Withdrawal by Subject|1|||
105538868|NCT03238911|363972265|FG001|Overall Study|Withdrawal by Subject|2|||
105538869|NCT03238911|363972264|FG000|Overall Study|Lost to Follow-up|2|||
105538870|NCT03238911|363972265|FG001|Overall Study|Lost to Follow-up|1|||
105538871|NCT02564198|363974141|FG000|Overall Study|Withdrawal by Subject|2|||
105538872|NCT02564198|363974142|FG001|Overall Study|Withdrawal by Subject|4|||
105538873|NCT02564198|363974143|FG002|Overall Study|Withdrawal by Subject|0|||
105538874|NCT02564198|363974141|FG000|Overall Study|Adverse Event|0|||
105538875|NCT02564198|363974142|FG001|Overall Study|Adverse Event|1|||
105538876|NCT02564198|363974143|FG002|Overall Study|Adverse Event|0|||
105538877|NCT00938431|363974149|FG000|Overall Study|Adverse Event|5|||
105538878|NCT00938431|363974150|FG001|Overall Study|Adverse Event|8|||
105538879|NCT00938431|363974151|FG002|Overall Study|Adverse Event|6|||
105538880|NCT00938431|363974149|FG000|Overall Study|Lack of Efficacy|0|||
105538881|NCT00938431|363974150|FG001|Overall Study|Lack of Efficacy|1|||
105538882|NCT00938431|363974151|FG002|Overall Study|Lack of Efficacy|0|||
105538883|NCT00938431|363974149|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
105538884|NCT00938431|363974150|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
105538885|NCT00938431|363974151|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
105538886|NCT00938431|363974149|FG000|Overall Study|Dosing compliance issue|0|||
105538887|NCT00938431|363974150|FG001|Overall Study|Dosing compliance issue|0|||
105538888|NCT00938431|363974151|FG002|Overall Study|Dosing compliance issue|1|||
105538889|NCT00938431|363974149|FG000|Overall Study|Reached maximum dose early|0|||
105538890|NCT00938431|363974150|FG001|Overall Study|Reached maximum dose early|0|||
105538891|NCT00938431|363974151|FG002|Overall Study|Reached maximum dose early|1|||
105538892|NCT02984020|363974152|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
105538893|NCT02984020|363974152|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
105538894|NCT02984020|363974152|FG000|Overall Study|Other significant protocol violation|2|||
105538895|NCT02610192|363974162|FG000|Overall Study|Received other treatment|8|||
105538896|NCT02610192|363974162|FG000|Overall Study|Physician Decision|1|||
105538897|NCT04101526|363974166|FG000|Overall Study|Did not complete all sleep diary entries|0|||
105538898|NCT04101526|363974167|FG001|Overall Study|Did not complete all sleep diary entries|1|||
105538899|NCT04127786|363974168|FG000|Primary Series|Adverse Event|1|||
105538900|NCT04127786|363974169|FG001|Primary Series|Adverse Event|0|||
105538901|NCT04127786|363974170|FG002|Primary Series|Adverse Event|0|||
105538902|NCT04127786|363974171|FG003|Primary Series|Adverse Event|1|||
105538903|NCT04127786|363974172|FG004|Primary Series|Adverse Event|0|||
105538904|NCT04127786|363974173|FG005|Primary Series|Adverse Event|1|||
105538905|NCT04127786|363974168|FG000|Primary Series|Protocol Violation|5|||
105538906|NCT04127786|363974169|FG001|Primary Series|Protocol Violation|3|||
105538907|NCT04127786|363974170|FG002|Primary Series|Protocol Violation|4|||
105538908|NCT04127786|363974171|FG003|Primary Series|Protocol Violation|3|||
105538909|NCT04127786|363974172|FG004|Primary Series|Protocol Violation|2|||
105538910|NCT04127786|363974173|FG005|Primary Series|Protocol Violation|0|||
105538911|NCT04127786|363974168|FG000|Primary Series|Withdrawal by Subject|0|||
105538912|NCT04127786|363974169|FG001|Primary Series|Withdrawal by Subject|0|||
105538913|NCT04127786|363974170|FG002|Primary Series|Withdrawal by Subject|0|||
105538914|NCT04127786|363974171|FG003|Primary Series|Withdrawal by Subject|1|||
105538915|NCT04127786|363974172|FG004|Primary Series|Withdrawal by Subject|0|||
105538916|NCT04127786|363974173|FG005|Primary Series|Withdrawal by Subject|0|||
105538917|NCT04127786|363974168|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
105538918|NCT04127786|363974169|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
105538919|NCT04127786|363974170|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
105538920|NCT04127786|363974171|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
105538921|NCT04127786|363974172|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
105538922|NCT04127786|363974173|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
105538923|NCT04127786|363974168|FG000|Booster Phase|Withdrawal by Subject|2|||
105538924|NCT04127786|363974169|FG001|Booster Phase|Withdrawal by Subject|0|||
105538925|NCT04127786|363974170|FG002|Booster Phase|Withdrawal by Subject|0|||
105538926|NCT04127786|363974171|FG003|Booster Phase|Withdrawal by Subject|0|||
105538927|NCT04127786|363974172|FG004|Booster Phase|Withdrawal by Subject|0|||
105538928|NCT04127786|363974173|FG005|Booster Phase|Withdrawal by Subject|0|||
105538929|NCT00596011|363974174|FG000|Overall Study|Withdrawal by Subject|2|||
105538930|NCT00596011|363974175|FG001|Overall Study|Withdrawal by Subject|3|||
105538931|NCT00596011|363974174|FG000|Overall Study|Adverse Event|11|||
105538932|NCT00596011|363974175|FG001|Overall Study|Adverse Event|7|||
105538933|NCT00424372|363974180|FG000|Overall Study|Death|1|||
105538934|NCT00424372|363974180|FG000|Overall Study|Adverse Event|18|||
105538935|NCT00424372|363974180|FG000|Overall Study|Lack of Efficacy|6|||
105538936|NCT00424372|363974180|FG000|Overall Study|Withdrawal by Subject|4|||
105538937|NCT00424372|363974180|FG000|Overall Study|Protocol Violation|1|||
105538938|NCT00424372|363974180|FG000|Overall Study|Health deterioration|1|||
105538939|NCT05044234|363974181|FG000|Overall Study|Lost to Follow-up|2|||
105538940|NCT05044234|363974182|FG001|Overall Study|Lost to Follow-up|1|||
105538941|NCT05044234|363974183|FG002|Overall Study|Lost to Follow-up|1|||
105538942|NCT05044234|363974184|FG003|Overall Study|Lost to Follow-up|2|||
105538943|NCT05044234|363974181|FG000|Overall Study|Withdrawal by Subject|6|||
105538944|NCT05044234|363974182|FG001|Overall Study|Withdrawal by Subject|4|||
105538945|NCT05044234|363974183|FG002|Overall Study|Withdrawal by Subject|5|||
105538946|NCT05044234|363974184|FG003|Overall Study|Withdrawal by Subject|8|||
105538947|NCT05044234|363974181|FG000|Overall Study|Study terminated by Sponsor|21|||
105538948|NCT05044234|363974182|FG001|Overall Study|Study terminated by Sponsor|21|||
105538949|NCT05044234|363974183|FG002|Overall Study|Study terminated by Sponsor|20|||
105538950|NCT05044234|363974184|FG003|Overall Study|Study terminated by Sponsor|14|||
105538951|NCT05044234|363974181|FG000|Overall Study|Other, not specified|0|||
105538952|NCT05044234|363974182|FG001|Overall Study|Other, not specified|0|||
105538953|NCT05044234|363974183|FG002|Overall Study|Other, not specified|1|||
105538954|NCT05044234|363974184|FG003|Overall Study|Other, not specified|2|||
105538955|NCT05044234|363974181|FG000|Overall Study|Delayed data entry|0|||
105538956|NCT05044234|363974182|FG001|Overall Study|Delayed data entry|0|||
105538957|NCT05044234|363974183|FG002|Overall Study|Delayed data entry|0|||
105538958|NCT05044234|363974184|FG003|Overall Study|Delayed data entry|1|||
105538959|NCT02896127|363974185|FG000|COMPLETED WEEK 52|Adverse Event|9|||
105538960|NCT02896127|363974186|FG001|COMPLETED WEEK 52|Adverse Event|2|||
105538961|NCT02896127|363974185|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
105538962|NCT02896127|363974186|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
105538963|NCT02896127|363974185|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
105538964|NCT02896127|363974186|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
105538965|NCT02896127|363974185|FG000|COMPLETED WEEK 52|Physician Decision|1|||
105538966|NCT02896127|363974186|FG001|COMPLETED WEEK 52|Physician Decision|1|||
105538967|NCT02896127|363974185|FG000|COMPLETED WEEK 52|Pregnancy|2|||
105538968|NCT02896127|363974186|FG001|COMPLETED WEEK 52|Pregnancy|0|||
105538969|NCT02896127|363974185|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
105538970|NCT02896127|363974186|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
105538971|NCT02896127|363974185|FG000|COMPLETED WEEK 52|Technical problems|1|||
105538972|NCT02896127|363974186|FG001|COMPLETED WEEK 52|Technical problems|0|||
105538973|NCT02896127|363974185|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
105538974|NCT02896127|363974186|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
105538975|NCT02896127|363974185|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
105538976|NCT02896127|363974186|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
105538977|NCT02896127|363974185|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
105538978|NCT02896127|363974186|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
105538979|NCT02896127|363974185|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
105538980|NCT02896127|363974186|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
105538981|NCT02896127|363974185|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
105538982|NCT02896127|363974186|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
105538983|NCT03354429|363974187|FG000|Overall Study|Withdrawal by Subject|8|||
105538984|NCT03354429|363974188|FG001|Overall Study|Withdrawal by Subject|7|||
105538985|NCT03354429|363974187|FG000|Overall Study|Lost to Follow-up|1|||
105538986|NCT03354429|363974188|FG001|Overall Study|Lost to Follow-up|0|||
105538987|NCT02940691|363974189|FG000|Overall Study|Lost to Follow-up|5|||
105538988|NCT02940691|363974189|FG000|Overall Study|Incarceration|1|||
105538989|NCT02932891|363974190|FG000|Overall Study|Lost to Follow-up|2|||
105538990|NCT02932891|363974190|FG000|Overall Study|HPA Suppress|2|||
105538991|NCT02652624|363974193|FG000|Randomized Phase|Pregnancy|3|||
105538992|NCT02652624|363974194|FG001|Randomized Phase|Pregnancy|1|||
105538993|NCT02652624|363974193|FG000|Randomized Phase|Investigator's Discretion|0|||
105538994|NCT02652624|363974194|FG001|Randomized Phase|Investigator's Discretion|2|||
105538995|NCT02652624|363974193|FG000|Randomized Phase|Death|0|||
105538996|NCT02652624|363974194|FG001|Randomized Phase|Death|1|||
105538997|NCT02652624|363974193|FG000|Randomized Phase|Lost to Follow-up|0|||
105538998|NCT02652624|363974194|FG001|Randomized Phase|Lost to Follow-up|1|||
105538999|NCT02652624|363974193|FG000|Extension Phase|Lost to Follow-up|3|||
105539000|NCT02652624|363974194|FG001|Extension Phase|Lost to Follow-up|1|||
105539001|NCT02652624|363974193|FG000|Extension Phase|Pregnancy|1|||
105539002|NCT02652624|363974194|FG001|Extension Phase|Pregnancy|1|||
105539003|NCT02652624|363974193|FG000|Extension Phase|Adverse Event|0|||
105539004|NCT02652624|363974194|FG001|Extension Phase|Adverse Event|1|||
105539005|NCT02652624|363974193|FG000|Extension Phase|Withdrew Consent|0|||
105539006|NCT02652624|363974194|FG001|Extension Phase|Withdrew Consent|1|||
105539007|NCT03228680|363974196|FG000|Overall Study|Adverse Event|13|||
105539008|NCT03228680|363974197|FG001|Overall Study|Adverse Event|18|||
105539009|NCT03228680|363974196|FG000|Overall Study|Randomization failure|0|||
105539010|NCT03228680|363974197|FG001|Overall Study|Randomization failure|1|||
105539011|NCT03228680|363974196|FG000|Overall Study|Withdrawal by Subject|1|||
105539012|NCT03228680|363974197|FG001|Overall Study|Withdrawal by Subject|0|||
105539013|NCT03228680|363974196|FG000|Overall Study|Other|9|||
105539014|NCT03228680|363974197|FG001|Overall Study|Other|16|||
105539015|NCT02331446|363974198|FG000|Overall Study|Lost to Follow-up|2|||
105539016|NCT02331446|363974199|FG001|Overall Study|Lost to Follow-up|1|||
105539017|NCT02331446|363974200|FG002|Overall Study|Lost to Follow-up|0|||
105539018|NCT02331446|363974201|FG003|Overall Study|Lost to Follow-up|1|||
105539019|NCT02331446|363974198|FG000|Overall Study|Personal Problem|2|||
105539020|NCT02331446|363974199|FG001|Overall Study|Personal Problem|0|||
105539021|NCT02331446|363974200|FG002|Overall Study|Personal Problem|0|||
105539022|NCT02331446|363974201|FG003|Overall Study|Personal Problem|0|||
105539023|NCT02331446|363974198|FG000|Overall Study|Disease|0|||
105539024|NCT02331446|363974199|FG001|Overall Study|Disease|2|||
105539025|NCT02331446|363974200|FG002|Overall Study|Disease|2|||
105539026|NCT02331446|363974201|FG003|Overall Study|Disease|1|||
105539027|NCT02331446|363974198|FG000|Overall Study|Physician Decision|0|||
105539028|NCT02331446|363974199|FG001|Overall Study|Physician Decision|1|||
105539029|NCT02331446|363974200|FG002|Overall Study|Physician Decision|0|||
105539030|NCT02331446|363974201|FG003|Overall Study|Physician Decision|1|||
105539031|NCT02331446|363974198|FG000|Overall Study|Lost before baseline analysis|0|||
105539032|NCT02331446|363974199|FG001|Overall Study|Lost before baseline analysis|1|||
105539033|NCT02331446|363974200|FG002|Overall Study|Lost before baseline analysis|1|||
105539034|NCT02331446|363974201|FG003|Overall Study|Lost before baseline analysis|0|||
105539035|NCT02489981|363974202|FG000|Overall Study|Adverse Event|21|||
105539036|NCT02489981|363974202|FG000|Overall Study|Insufficient effectiveness|16|||
105539037|NCT02489981|363974202|FG000|Overall Study|Improved|31|||
105539038|NCT02489981|363974202|FG000|Overall Study|Lost to Follow-up|31|||
105539039|NCT02489981|363974202|FG000|Overall Study|Other than listed|28|||
105539040|NCT02566759|363974204|FG000|All Parts|Withdrawal by Subject|0|||
105539041|NCT02566759|363974205|FG001|All Parts|Withdrawal by Subject|1|||
105539042|NCT02566759|363974206|FG002|All Parts|Withdrawal by Subject|0|||
105539043|NCT02566759|363974207|FG003|All Parts|Withdrawal by Subject|0|||
105539044|NCT02566759|363974208|FG004|All Parts|Withdrawal by Subject|0|||
105539045|NCT02566759|363974209|FG005|All Parts|Withdrawal by Subject|0|||
105539046|NCT02566759|363974210|FG006|All Parts|Withdrawal by Subject|0|||
105539047|NCT02566759|363974211|FG007|All Parts|Withdrawal by Subject|0|||
105539048|NCT02566759|363974212|FG008|All Parts|Withdrawal by Subject|0|||
105539049|NCT02566759|363974213|FG009|All Parts|Withdrawal by Subject|0|||
105539050|NCT02566759|363974214|FG010|All Parts|Withdrawal by Subject|0|||
105539051|NCT02566759|363974215|FG011|All Parts|Withdrawal by Subject|0|||
105539052|NCT02566759|363974216|FG012|All Parts|Withdrawal by Subject|0|||
105539053|NCT02566759|363974217|FG013|All Parts|Withdrawal by Subject|0|||
105539054|NCT02566759|363974218|FG014|All Parts|Withdrawal by Subject|0|||
105539055|NCT02566759|363974219|FG015|All Parts|Withdrawal by Subject|0|||
105539056|NCT02566759|363974220|FG016|All Parts|Withdrawal by Subject|0|||
105539057|NCT02566759|363974204|FG000|All Parts|Adverse Event|0|||
105539058|NCT02566759|363974205|FG001|All Parts|Adverse Event|0|||
105539059|NCT02566759|363974206|FG002|All Parts|Adverse Event|0|||
105539060|NCT02566759|363974207|FG003|All Parts|Adverse Event|0|||
105539061|NCT02566759|363974208|FG004|All Parts|Adverse Event|0|||
105539062|NCT02566759|363974209|FG005|All Parts|Adverse Event|0|||
105539063|NCT02566759|363974210|FG006|All Parts|Adverse Event|0|||
105539064|NCT02566759|363974211|FG007|All Parts|Adverse Event|0|||
105539065|NCT02566759|363974212|FG008|All Parts|Adverse Event|0|||
105539066|NCT02566759|363974213|FG009|All Parts|Adverse Event|0|||
105539067|NCT02566759|363974214|FG010|All Parts|Adverse Event|0|||
105539068|NCT02566759|363974215|FG011|All Parts|Adverse Event|0|||
105539069|NCT02566759|363974216|FG012|All Parts|Adverse Event|1|||
105539070|NCT02566759|363974217|FG013|All Parts|Adverse Event|3|||
105539071|NCT02566759|363974218|FG014|All Parts|Adverse Event|0|||
105539072|NCT02566759|363974219|FG015|All Parts|Adverse Event|0|||
105539073|NCT02566759|363974220|FG016|All Parts|Adverse Event|0|||
105539074|NCT02566759|363974204|FG000|All Parts|Other|0|||
105539075|NCT02566759|363974205|FG001|All Parts|Other|0|||
105539076|NCT02566759|363974206|FG002|All Parts|Other|0|||
105539077|NCT02566759|363974207|FG003|All Parts|Other|0|||
105539078|NCT02566759|363974208|FG004|All Parts|Other|0|||
105539079|NCT02566759|363974209|FG005|All Parts|Other|0|||
105539080|NCT02566759|363974210|FG006|All Parts|Other|0|||
105539081|NCT02566759|363974211|FG007|All Parts|Other|0|||
105539082|NCT02566759|363974212|FG008|All Parts|Other|0|||
105539083|NCT02566759|363974213|FG009|All Parts|Other|0|||
105539084|NCT02566759|363974214|FG010|All Parts|Other|0|||
105539085|NCT02566759|363974215|FG011|All Parts|Other|0|||
105539086|NCT02566759|363974216|FG012|All Parts|Other|0|||
105539087|NCT02566759|363974217|FG013|All Parts|Other|2|||
105539088|NCT02566759|363974218|FG014|All Parts|Other|0|||
105539089|NCT02566759|363974219|FG015|All Parts|Other|0|||
105539090|NCT02566759|363974220|FG016|All Parts|Other|0|||
105539091|NCT02566759|363974204|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539092|NCT02566759|363974205|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539093|NCT02566759|363974206|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539094|NCT02566759|363974207|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539095|NCT02566759|363974208|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539096|NCT02566759|363974209|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539097|NCT02566759|363974210|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539098|NCT02566759|363974211|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539099|NCT02566759|363974212|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539100|NCT02566759|363974213|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539101|NCT02566759|363974214|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539102|NCT02566759|363974215|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539103|NCT02566759|363974216|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539104|NCT02566759|363974217|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539105|NCT02566759|363974218|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539106|NCT02566759|363974219|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
105539107|NCT02566759|363974220|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
105539108|NCT03160703|363974221|FG000|Overall Study|Withdrawal by Subject|0|||
105539109|NCT03160703|363974222|FG001|Overall Study|Withdrawal by Subject|0|||
105539110|NCT03160703|363974223|FG002|Overall Study|Withdrawal by Subject|0|||
105539111|NCT03160703|363974224|FG003|Overall Study|Withdrawal by Subject|1|||
105539112|NCT03732638|363974225|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
105539113|NCT03732638|363974226|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
105539114|NCT03732638|363974225|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
105539115|NCT03732638|363974226|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
105539116|NCT03732638|363974225|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
105539117|NCT03732638|363974226|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
105539118|NCT03732638|363974225|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
105539119|NCT03732638|363974226|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
105539120|NCT03732638|363974225|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
105539121|NCT03732638|363974226|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
105539122|NCT03732638|363974225|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
105539123|NCT03732638|363974226|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
105539124|NCT03732638|363974225|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
105539125|NCT03732638|363974226|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
105539126|NCT03732638|363974225|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
105539127|NCT03732638|363974226|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
105539128|NCT03732638|363974225|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
105539129|NCT03732638|363974226|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
105539130|NCT03732638|363974225|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
105539131|NCT03732638|363974226|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
105539132|NCT03732638|363974225|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
105539133|NCT03732638|363974226|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
105539134|NCT03732638|363974225|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
105539135|NCT03732638|363974226|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
105539136|NCT03732638|363974225|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
105539137|NCT03732638|363974226|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
105539138|NCT03732638|363974225|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
105539139|NCT03732638|363974226|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
105539140|NCT03732638|363974225|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
105539141|NCT03732638|363974226|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
105539142|NCT03732638|363974225|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
105539143|NCT03732638|363974226|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
105539144|NCT03732638|363974225|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
105539145|NCT03732638|363974226|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
105539146|NCT03732638|363974225|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
105539147|NCT03732638|363974226|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
105539148|NCT03732638|363974225|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
105539149|NCT03732638|363974226|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
105539150|NCT03732638|363974225|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
105539151|NCT03732638|363974226|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
105539152|NCT03732638|363974225|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
105539153|NCT03732638|363974226|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
105539154|NCT03732638|363974225|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
105539155|NCT03732638|363974226|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
105539156|NCT03732638|363974225|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
105539157|NCT03732638|363974226|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
105539158|NCT03732638|363974225|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
105539159|NCT03732638|363974226|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
105539160|NCT04394351|363974227|FG000|Part A (16 Weeks)|Adverse Event|1|||
105539161|NCT04394351|363974228|FG001|Part A (16 Weeks)|Adverse Event|0|||
105539162|NCT04394351|363974229|FG002|Part A (16 Weeks)|Adverse Event|0|||
105539163|NCT04394351|363974230|FG003|Part A (16 Weeks)|Adverse Event|0|||
105539164|NCT04394351|363974231|FG004|Part A (16 Weeks)|Adverse Event|0|||
105539165|NCT04394351|363974232|FG005|Part A (16 Weeks)|Adverse Event|0|||
105539166|NCT04394351|363974233|FG006|Part A (16 Weeks)|Adverse Event|0|||
105539167|NCT04394351|363974234|FG007|Part A (16 Weeks)|Adverse Event|0|||
105539168|NCT04394351|363974227|FG000|Part A (16 Weeks)|Physician Decision|0|||
105539169|NCT04394351|363974228|FG001|Part A (16 Weeks)|Physician Decision|1|||
105539170|NCT04394351|363974229|FG002|Part A (16 Weeks)|Physician Decision|0|||
105539171|NCT04394351|363974230|FG003|Part A (16 Weeks)|Physician Decision|0|||
105539172|NCT04394351|363974231|FG004|Part A (16 Weeks)|Physician Decision|0|||
105539173|NCT04394351|363974232|FG005|Part A (16 Weeks)|Physician Decision|0|||
105539174|NCT04394351|363974233|FG006|Part A (16 Weeks)|Physician Decision|0|||
105539175|NCT04394351|363974234|FG007|Part A (16 Weeks)|Physician Decision|0|||
105539176|NCT04394351|363974227|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
105539177|NCT04394351|363974228|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
105539178|NCT04394351|363974229|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
105539179|NCT04394351|363974230|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
105539180|NCT04394351|363974231|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
105539181|NCT04394351|363974232|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
105539182|NCT04394351|363974233|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
105539183|NCT04394351|363974234|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
105539184|NCT04394351|363974227|FG000|Part B (36 Weeks)|Adverse Event|0|||
105539185|NCT04394351|363974228|FG001|Part B (36 Weeks)|Adverse Event|0|||
105539186|NCT04394351|363974229|FG002|Part B (36 Weeks)|Adverse Event|0|||
105539187|NCT04394351|363974230|FG003|Part B (36 Weeks)|Adverse Event|0|||
105539188|NCT04394351|363974231|FG004|Part B (36 Weeks)|Adverse Event|0|||
105539189|NCT04394351|363974232|FG005|Part B (36 Weeks)|Adverse Event|0|||
105539190|NCT04394351|363974233|FG006|Part B (36 Weeks)|Adverse Event|1|||
105539191|NCT04394351|363974234|FG007|Part B (36 Weeks)|Adverse Event|0|||
105539192|NCT03728582|363974235|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
105539193|NCT03728582|363974236|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
105539194|NCT03728582|363974235|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
105539195|NCT03728582|363974236|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
105539196|NCT02738775|363974237|FG000|Overall Study|Withdrawal by Subject|0|||
105539197|NCT02738775|363974238|FG001|Overall Study|Withdrawal by Subject|1|||
105539198|NCT02738775|363974239|FG002|Overall Study|Withdrawal by Subject|0|||
105539199|NCT02738775|363974240|FG003|Overall Study|Withdrawal by Subject|0|||
105539200|NCT02738775|363974241|FG004|Overall Study|Withdrawal by Subject|0|||
105539201|NCT02738775|363974242|FG005|Overall Study|Withdrawal by Subject|0|||
105539202|NCT02738775|363974237|FG000|Overall Study|Adverse Event|0|||
105539203|NCT02738775|363974238|FG001|Overall Study|Adverse Event|0|||
105539204|NCT02738775|363974239|FG002|Overall Study|Adverse Event|0|||
105539205|NCT02738775|363974240|FG003|Overall Study|Adverse Event|1|||
105539206|NCT02738775|363974241|FG004|Overall Study|Adverse Event|0|||
105539207|NCT02738775|363974242|FG005|Overall Study|Adverse Event|0|||
105539208|NCT02738775|363974237|FG000|Overall Study|Pregnancy|0|||
105539209|NCT02738775|363974238|FG001|Overall Study|Pregnancy|1|||
105539210|NCT02738775|363974239|FG002|Overall Study|Pregnancy|0|||
105539211|NCT02738775|363974240|FG003|Overall Study|Pregnancy|0|||
105539212|NCT02738775|363974241|FG004|Overall Study|Pregnancy|0|||
105539213|NCT02738775|363974242|FG005|Overall Study|Pregnancy|0|||
105539214|NCT02738775|363974237|FG000|Overall Study|Missing|0|||
105539215|NCT02738775|363974238|FG001|Overall Study|Missing|0|||
105539216|NCT02738775|363974239|FG002|Overall Study|Missing|0|||
105539217|NCT02738775|363974240|FG003|Overall Study|Missing|0|||
105539218|NCT02738775|363974241|FG004|Overall Study|Missing|0|||
105539219|NCT02738775|363974242|FG005|Overall Study|Missing|1|||
105539220|NCT01034397|363974243|FG000|Overall Study|Lack of compliance|0|||
105539221|NCT01034397|363974244|FG001|Overall Study|Lack of compliance|1|||
105539222|NCT01034397|363974243|FG000|Overall Study|Lack of Efficacy|3|||
105539223|NCT01034397|363974244|FG001|Overall Study|Lack of Efficacy|0|||
105539224|NCT01034397|363974243|FG000|Overall Study|Adverse Event|4|||
105539225|NCT01034397|363974244|FG001|Overall Study|Adverse Event|0|||
105539226|NCT01034397|363974243|FG000|Overall Study|Other|0|||
105539227|NCT01034397|363974244|FG001|Overall Study|Other|1|||
105539228|NCT01785524|363974245|FG000|Overall Study|Withdrawal by Subject|2|||
105539229|NCT01785524|363974246|FG001|Overall Study|Withdrawal by Subject|2|||
105539230|NCT01060384|363974247|FG000|Overall Study|Withdrawal by Subject|0|||
105539231|NCT01060384|363974248|FG001|Overall Study|Withdrawal by Subject|1|||
105539232|NCT01060384|363974249|FG002|Overall Study|Withdrawal by Subject|0|||
105539233|NCT01060384|363974250|FG003|Overall Study|Withdrawal by Subject|0|||
105539234|NCT01060384|363974251|FG004|Overall Study|Withdrawal by Subject|0|||
105539235|NCT01060384|363974247|FG000|Overall Study|Death|0|||
105539236|NCT01060384|363974248|FG001|Overall Study|Death|0|||
105539237|NCT01060384|363974249|FG002|Overall Study|Death|0|||
105539238|NCT01060384|363974250|FG003|Overall Study|Death|0|||
105539239|NCT01060384|363974251|FG004|Overall Study|Death|1|||
105539240|NCT01060384|363974247|FG000|Overall Study|Intercurrent illness|0|||
105539241|NCT01060384|363974248|FG001|Overall Study|Intercurrent illness|0|||
105539242|NCT01060384|363974249|FG002|Overall Study|Intercurrent illness|0|||
105539243|NCT01060384|363974250|FG003|Overall Study|Intercurrent illness|0|||
105539244|NCT01060384|363974251|FG004|Overall Study|Intercurrent illness|1|||
105539245|NCT00812929|363974253|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
105539246|NCT00812929|363974254|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
105539247|NCT00812929|363974255|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
105539248|NCT00812929|363974256|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
105539249|NCT00812929|363974257|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
105539250|NCT00812929|363974258|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
105539251|NCT00812929|363974259|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
105539252|NCT00812929|363974260|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
105539253|NCT00812929|363974261|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
105539254|NCT00812929|363974262|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
105539255|NCT00812929|363974253|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
105539256|NCT00812929|363974254|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
105539257|NCT00812929|363974255|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
105539258|NCT00812929|363974256|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
105539259|NCT00812929|363974257|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
105539260|NCT00812929|363974258|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
105539261|NCT00812929|363974259|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
105539262|NCT00812929|363974260|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
105539263|NCT00812929|363974261|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
105539264|NCT00812929|363974262|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
105539265|NCT00812929|363974253|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
105539266|NCT00812929|363974254|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
105539267|NCT00812929|363974255|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
105539268|NCT00812929|363974256|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
105539269|NCT00812929|363974257|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
105539270|NCT00812929|363974258|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
105539271|NCT00812929|363974259|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
105539272|NCT00812929|363974260|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
105539273|NCT00812929|363974261|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
105539274|NCT00812929|363974262|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
105539275|NCT04027686|363974263|FG000|Overall Study|Lost to Follow-up|2|||
105539276|NCT04027686|363974264|FG001|Overall Study|Lost to Follow-up|0|||
105539277|NCT04027686|363974263|FG000|Overall Study|Withdrawal by Subject|0|||
105539278|NCT04027686|363974264|FG001|Overall Study|Withdrawal by Subject|1|||
105539279|NCT01263873|363974265|FG000|Overall Study|One provider unable to complete numbers|1|||
105539280|NCT01263873|363974266|FG001|Overall Study|One provider unable to complete numbers|1|||
105539281|NCT04713748|363974267|FG000|Overall Study|Not enough kits allocated|35|||
105539282|NCT00113516|363974268|FG000|Part 1|Adverse Event|6|||
105539283|NCT00113516|363974269|FG001|Part 1|Adverse Event|0|||
105539284|NCT00113516|363974268|FG000|Part 1|Death|3|||
105539285|NCT00113516|363974269|FG001|Part 1|Death|0|||
105539286|NCT00113516|363974268|FG000|Part 1|Other|3|||
105539287|NCT00113516|363974269|FG001|Part 1|Other|0|||
105539288|NCT00113516|363974268|FG000|Part 1|Withdrawal by Subject|2|||
105539289|NCT00113516|363974269|FG001|Part 1|Withdrawal by Subject|0|||
105539290|NCT00113516|363974268|FG000|Part 1|Lack of Efficacy|2|||
105539291|NCT00113516|363974269|FG001|Part 1|Lack of Efficacy|0|||
105539292|NCT00113516|363974268|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
105539293|NCT00113516|363974269|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
105539294|NCT00113516|363974268|FG000|Part 1|Laboratory Abnormality|1|||
105539295|NCT00113516|363974269|FG001|Part 1|Laboratory Abnormality|0|||
105539296|NCT00113516|363974268|FG000|Part 1|Ongoing|1|||
105539297|NCT00113516|363974269|FG001|Part 1|Ongoing|0|||
105539298|NCT00113516|363974268|FG000|Part 1|Missing|65|||
105539299|NCT00113516|363974269|FG001|Part 1|Missing|0|||
105539300|NCT00113516|363974268|FG000|Part 2|Adverse Event|0|||
105539301|NCT00113516|363974269|FG001|Part 2|Adverse Event|16|||
105539302|NCT00113516|363974268|FG000|Part 2|Death|0|||
105539303|NCT00113516|363974269|FG001|Part 2|Death|5|||
105539304|NCT00113516|363974268|FG000|Part 2|Lack of Efficacy|0|||
105539305|NCT00113516|363974269|FG001|Part 2|Lack of Efficacy|37|||
105539306|NCT00113516|363974268|FG000|Part 2|Withdrawal by Subject|0|||
105539307|NCT00113516|363974269|FG001|Part 2|Withdrawal by Subject|3|||
105539308|NCT00113516|363974268|FG000|Part 2|Other|0|||
105539309|NCT00113516|363974269|FG001|Part 2|Other|3|||
105539310|NCT00113516|363974268|FG000|Part 2|Laboratory Abnormality|0|||
105539311|NCT00113516|363974269|FG001|Part 2|Laboratory Abnormality|1|||
105539312|NCT00113516|363974268|FG000|Part 2|Ongoing|0|||
105539313|NCT00113516|363974269|FG001|Part 2|Ongoing|1|||
105539314|NCT00047463|363974270|FG000|Overall Study|Withdrawal by Subject|0|||
105539315|NCT00047463|363974271|FG001|Overall Study|Withdrawal by Subject|3|||
105539316|NCT03217136|363974273|FG000|Overall Study|Lost to Follow-up|2|||
105539317|NCT03217136|363974274|FG001|Overall Study|Lost to Follow-up|1|||
105539318|NCT03217136|363974273|FG000|Overall Study|Site Randomized Participant in Error|0|||
105539319|NCT03217136|363974274|FG001|Overall Study|Site Randomized Participant in Error|1|||
105539320|NCT03217136|363974273|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
105539321|NCT03217136|363974274|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
105539322|NCT03217136|363974273|FG000|Overall Study|Dispensing Error|1|||
105539323|NCT03217136|363974274|FG001|Overall Study|Dispensing Error|0|||
105539324|NCT03217136|363974273|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105539325|NCT03217136|363974274|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105539326|NCT01401530|363974275|FG000|Overall Study|Disease Progression|1|||
105539327|NCT01401530|363974276|FG001|Overall Study|Disease Progression|2|||
105539328|NCT01401530|363974277|FG002|Overall Study|Disease Progression|1|||
105539329|NCT01401530|363974275|FG000|Overall Study|Adverse Event|1|||
105539330|NCT01401530|363974276|FG001|Overall Study|Adverse Event|1|||
105539331|NCT01401530|363974277|FG002|Overall Study|Adverse Event|1|||
105539332|NCT01401530|363974275|FG000|Overall Study|Participant Choice|1|||
105539333|NCT01401530|363974276|FG001|Overall Study|Participant Choice|2|||
105539334|NCT01401530|363974277|FG002|Overall Study|Participant Choice|1|||
105539335|NCT01401530|363974275|FG000|Overall Study|Physician Decision|0|||
105539336|NCT01401530|363974276|FG001|Overall Study|Physician Decision|1|||
105539337|NCT01401530|363974277|FG002|Overall Study|Physician Decision|0|||
105539338|NCT02104557|363974278|FG000|Overall Study|Adverse Event|24|||
105539339|NCT02104557|363974278|FG000|Overall Study|Lost to Follow-up|34|||
105539340|NCT02104557|363974278|FG000|Overall Study|Violated the usage and dosage|14|||
105539341|NCT02104557|363974278|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
105539342|NCT02104557|363974278|FG000|Overall Study|Administered Sayana prior to the contract|1|||
105539343|NCT02104557|363974278|FG000|Overall Study|Other|17|||
105539344|NCT02104557|363974278|FG000|Overall Study|Change to other contraception methods|5|||
105539345|NCT02104557|363974278|FG000|Overall Study|Discontinuation due to no pain|1|||
105539346|NCT02104557|363974278|FG000|Overall Study|Withdrawal consent|2|||
105539347|NCT02104557|363974278|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
105539348|NCT02104557|363974278|FG000|Overall Study|Discontinuation of contraception|9|||
105539349|NCT03192150|363974284|FG000|Overall Study|Adverse Event|14|||
105539350|NCT03192150|363974285|FG001|Overall Study|Adverse Event|12|||
105539351|NCT03192150|363974284|FG000|Overall Study|Lack of Efficacy|23|||
105539352|NCT03192150|363974285|FG001|Overall Study|Lack of Efficacy|30|||
105539353|NCT03192150|363974284|FG000|Overall Study|Lost to Follow-up|1|||
105539354|NCT03192150|363974285|FG001|Overall Study|Lost to Follow-up|1|||
105539355|NCT03192150|363974284|FG000|Overall Study|Withdrawal by Subject|4|||
105539356|NCT03192150|363974285|FG001|Overall Study|Withdrawal by Subject|2|||
105539357|NCT03192150|363974284|FG000|Overall Study|Protocol Violation|5|||
105539358|NCT03192150|363974285|FG001|Overall Study|Protocol Violation|2|||
105539359|NCT03192150|363974284|FG000|Overall Study|Surgery Canceled|6|||
105539360|NCT03192150|363974285|FG001|Overall Study|Surgery Canceled|2|||
105539361|NCT03192150|363974284|FG000|Overall Study|Other-Various Administrative Reasons|2|||
105539362|NCT03192150|363974285|FG001|Overall Study|Other-Various Administrative Reasons|5|||
105539363|NCT02178475|363974286|FG000|Overall Study|Withdrawal by Subject|7|||
105539364|NCT02178475|363974286|FG000|Overall Study|Lost to Follow-up|10|||
105539365|NCT02178475|363974286|FG000|Overall Study|Death|13|||
105539366|NCT02178475|363974286|FG000|Overall Study|Protocol-specified Criteria|99|||
105539367|NCT01430585|363974287|FG000|Overall Study|Death|1|||
105539368|NCT01430585|363974287|FG000|Overall Study|Objective Progression or Relapse|3|||
105539369|NCT01430585|363974287|FG000|Overall Study|Study Terminated by Sponsor|3|||
105539370|NCT01430585|363974287|FG000|Overall Study|Other|7|||
105539371|NCT01448850|363974288|FG000|Overall Study|Death|3|||
105539372|NCT01448850|363974289|FG001|Overall Study|Death|6|||
105539373|NCT01448850|363974288|FG000|Overall Study|Withdrawal by Subject|13|||
105539374|NCT01448850|363974289|FG001|Overall Study|Withdrawal by Subject|21|||
105539375|NCT01448850|363974288|FG000|Overall Study|Lost to Follow-up|3|||
105539376|NCT01448850|363974289|FG001|Overall Study|Lost to Follow-up|1|||
105539377|NCT01448850|363974288|FG000|Overall Study|Other|15|||
105539378|NCT01448850|363974289|FG001|Overall Study|Other|12|||
105539379|NCT00813124|363974298|FG000|Overall Study|Death|2|||
105539380|NCT00813124|363974298|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
105539381|NCT00813124|363974298|FG000|Overall Study|Withdrawal by Subject|1|||
105539382|NCT00280566|363974302|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
105539383|NCT00280566|363974303|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
105539384|NCT00280566|363974304|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
105539385|NCT00280566|363974302|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
105539386|NCT00280566|363974303|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
105539387|NCT00280566|363974304|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
105539388|NCT00280566|363974302|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
105539389|NCT00280566|363974303|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
105539390|NCT00280566|363974304|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
105539391|NCT00280566|363974302|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
105539392|NCT00280566|363974303|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
105539393|NCT00280566|363974304|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
105539394|NCT00280566|363974302|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
105539395|NCT00280566|363974303|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
105539396|NCT00280566|363974304|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
105539397|NCT00280566|363974302|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
105539398|NCT00280566|363974303|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
105539399|NCT00280566|363974304|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
105539400|NCT00280566|363974302|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
105539401|NCT00280566|363974303|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
105539402|NCT00280566|363974304|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
105539403|NCT00280566|363974302|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
105539404|NCT00280566|363974303|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
105539405|NCT00280566|363974304|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
105539406|NCT00280566|363974302|FG000|Period 2 Double Blind|Adverse Event|0|||
105539407|NCT00280566|363974303|FG001|Period 2 Double Blind|Adverse Event|11|||
105539408|NCT00280566|363974304|FG002|Period 2 Double Blind|Adverse Event|15|||
105539409|NCT00280566|363974302|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
105539410|NCT00280566|363974303|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
105539411|NCT00280566|363974304|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
105539412|NCT00280566|363974302|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
105539413|NCT00280566|363974303|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
105539414|NCT00280566|363974304|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
105539415|NCT00280566|363974302|FG000|Period 2 Double Blind|miscellaneous|0|||
105539416|NCT00280566|363974303|FG001|Period 2 Double Blind|miscellaneous|10|||
105539417|NCT00280566|363974304|FG002|Period 2 Double Blind|miscellaneous|5|||
105539418|NCT01412424|363976321|FG000|Core Treatment Period|Treatment Failure|24|||
105539419|NCT01412424|363976321|FG000|Core Treatment Period|Adverse Event|21|||
105539420|NCT01412424|363976321|FG000|Core Treatment Period|Patient Request|5|||
105539421|NCT01412424|363976321|FG000|Core Treatment Period|Lost to Follow-up|2|||
105539422|NCT01412424|363976321|FG000|Core Treatment Period|Sponsor Request|1|||
105539423|NCT01412424|363976321|FG000|Extension Treatment Period|Adverse Event|2|||
105539424|NCT01412424|363976321|FG000|Extension Treatment Period|Treatment Failure|2|||
105539425|NCT01412424|363976321|FG000|Extension Treatment Period|Patient Request|2|||
105539426|NCT02863354|363976328|FG000|Year 1|Lost to Follow-up|1|||
105539427|NCT02863354|363976329|FG001|Year 1|Lost to Follow-up|1|||
105539428|NCT02863354|363976328|FG000|Year 1|Withdrawal by Subject|3|||
105539429|NCT02863354|363976329|FG001|Year 1|Withdrawal by Subject|0|||
105539430|NCT02863354|363976328|FG000|Year 1|Death|0|||
105539431|NCT02863354|363976329|FG001|Year 1|Death|1|||
105539432|NCT02863354|363976328|FG000|Year 2|Lost to Follow-up|2|||
105539433|NCT02863354|363976329|FG001|Year 2|Lost to Follow-up|2|||
105539434|NCT05218499|363976337|FG000|Overall Study|Not treated|1|||
105539435|NCT05218499|363976338|FG001|Overall Study|Not treated|1|||
105539436|NCT05218499|363976339|FG002|Overall Study|Not treated|8|||
105539437|NCT05218499|363976337|FG000|Overall Study|Death|2|||
105539438|NCT05218499|363976338|FG001|Overall Study|Death|0|||
105539439|NCT05218499|363976339|FG002|Overall Study|Death|0|||
105539440|NCT05218499|363976337|FG000|Overall Study|Other than listed|3|||
105539441|NCT05218499|363976338|FG001|Overall Study|Other than listed|7|||
105539442|NCT05218499|363976339|FG002|Overall Study|Other than listed|10|||
105539443|NCT05218499|363976337|FG000|Overall Study|Protocol deviation|5|||
105539444|NCT05218499|363976338|FG001|Overall Study|Protocol deviation|6|||
105539445|NCT05218499|363976339|FG002|Overall Study|Protocol deviation|4|||
105539446|NCT05218499|363976337|FG000|Overall Study|Technical problems|0|||
105539447|NCT05218499|363976338|FG001|Overall Study|Technical problems|1|||
105539448|NCT05218499|363976339|FG002|Overall Study|Technical problems|0|||
105539449|NCT05218499|363976337|FG000|Overall Study|Burden of trial procedures|0|||
105539450|NCT05218499|363976338|FG001|Overall Study|Burden of trial procedures|1|||
105539451|NCT05218499|363976339|FG002|Overall Study|Burden of trial procedures|2|||
105539452|NCT05218499|363976337|FG000|Overall Study|Clinical disease progression|6|||
105539453|NCT05218499|363976338|FG001|Overall Study|Clinical disease progression|6|||
105539454|NCT05218499|363976339|FG002|Overall Study|Clinical disease progression|11|||
105539455|NCT05218499|363976337|FG000|Overall Study|Objective disease progression|44|||
105539456|NCT05218499|363976338|FG001|Overall Study|Objective disease progression|61|||
105539457|NCT05218499|363976339|FG002|Overall Study|Objective disease progression|42|||
105539458|NCT05218499|363976337|FG000|Overall Study|Adverse Event|11|||
105539459|NCT05218499|363976338|FG001|Overall Study|Adverse Event|36|||
105539460|NCT05218499|363976339|FG002|Overall Study|Adverse Event|9|||
105539461|NCT05218499|363976337|FG000|Overall Study|On treatment at time of snapshot|18|||
105539462|NCT05218499|363976338|FG001|Overall Study|On treatment at time of snapshot|29|||
105539463|NCT05218499|363976339|FG002|Overall Study|On treatment at time of snapshot|0|||
105539464|NCT03258593|363976340|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
105539465|NCT03258593|363976341|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
105539466|NCT03258593|363976342|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
105539467|NCT03258593|363976343|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
105539468|NCT03258593|363976340|FG000|Run-In Maintenance Phase|Disease progression|3|||
105539469|NCT03258593|363976341|FG001|Run-In Maintenance Phase|Disease progression|0|||
105539470|NCT03258593|363976342|FG002|Run-In Maintenance Phase|Disease progression|0|||
105539471|NCT03258593|363976343|FG003|Run-In Maintenance Phase|Disease progression|0|||
105539472|NCT03258593|363976340|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
105539473|NCT03258593|363976341|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
105539474|NCT03258593|363976342|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
105539475|NCT03258593|363976343|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
105539476|NCT03258593|363976340|FG000|Expansion Maintenance Phase|Physician Decision|0|||
105539477|NCT03258593|363976341|FG001|Expansion Maintenance Phase|Physician Decision|1|||
105539478|NCT03258593|363976342|FG002|Expansion Maintenance Phase|Physician Decision|0|||
105539479|NCT03258593|363976343|FG003|Expansion Maintenance Phase|Physician Decision|0|||
105539480|NCT06640829|363976344|FG000|Overall Study|Withdrawal by Subject|1|||
105539481|NCT06640829|363976344|FG000|Overall Study|Lost to Follow-up|1|||
105539482|NCT04694131|363976352|FG000|Overall Study|Withdrawal by Subject|7|||
105539483|NCT04694131|363976352|FG000|Overall Study|Screen Failure|1|||
105539484|NCT04694131|363976352|FG000|Overall Study|High stimulation threshold|3|||
105539485|NCT04112810|363976353|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
105539486|NCT02075437|363976356|FG000|Overall Study|Withdrawal by Subject|5|||
105539487|NCT02075437|363976356|FG000|Overall Study|Lost to Follow-up|1|||
105539488|NCT00705575|363976357|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105539489|NCT00705575|363976358|FG001|Overall Study|Abnormal laboratory value(s)|3|||
105539490|NCT00705575|363976357|FG000|Overall Study|Abnormal test procedure result(s)|2|||
105539491|NCT00705575|363976358|FG001|Overall Study|Abnormal test procedure result(s)|12|||
105539492|NCT00705575|363976357|FG000|Overall Study|Adverse Event|11|||
105539493|NCT00705575|363976358|FG001|Overall Study|Adverse Event|15|||
105539494|NCT00705575|363976357|FG000|Overall Study|Lost to Follow-up|3|||
105539495|NCT00705575|363976358|FG001|Overall Study|Lost to Follow-up|4|||
105539496|NCT00705575|363976357|FG000|Overall Study|Protocol Violation|2|||
105539497|NCT00705575|363976358|FG001|Overall Study|Protocol Violation|2|||
105539498|NCT00705575|363976357|FG000|Overall Study|Withdrawal by Subject|5|||
105539499|NCT00705575|363976358|FG001|Overall Study|Withdrawal by Subject|10|||
105539500|NCT01000051|363976361|FG000|Overall Study|Withdrawal by Subject|1|||
105539501|NCT01000051|363976362|FG001|Overall Study|Withdrawal by Subject|1|||
105539502|NCT01000051|363976361|FG000|Overall Study|Disease Progression|1|||
105539503|NCT01000051|363976362|FG001|Overall Study|Disease Progression|0|||
105539504|NCT01000051|363976361|FG000|Overall Study|Serious noncompliance|1|||
105539505|NCT01000051|363976362|FG001|Overall Study|Serious noncompliance|0|||
105539506|NCT00414050|363976365|FG000|Overall Study|Adverse Event|1|||
105539507|NCT00414050|363976366|FG001|Overall Study|Adverse Event|1|||
105539508|NCT00414050|363976367|FG002|Overall Study|Adverse Event|1|||
105539509|NCT00414050|363976368|FG003|Overall Study|Adverse Event|1|||
105539510|NCT00414050|363976365|FG000|Overall Study|Lost to Follow-up|2|||
105539511|NCT00414050|363976366|FG001|Overall Study|Lost to Follow-up|2|||
105539512|NCT00414050|363976367|FG002|Overall Study|Lost to Follow-up|1|||
105539513|NCT00414050|363976368|FG003|Overall Study|Lost to Follow-up|1|||
105539514|NCT00414050|363976365|FG000|Overall Study|Withdrawal by Subject|5|||
105539515|NCT00414050|363976366|FG001|Overall Study|Withdrawal by Subject|3|||
105539516|NCT00414050|363976367|FG002|Overall Study|Withdrawal by Subject|2|||
105539517|NCT00414050|363976368|FG003|Overall Study|Withdrawal by Subject|4|||
105539518|NCT00414050|363976365|FG000|Overall Study|Subject discontinued for other reason|1|||
105539519|NCT00414050|363976366|FG001|Overall Study|Subject discontinued for other reason|2|||
105539520|NCT00414050|363976367|FG002|Overall Study|Subject discontinued for other reason|2|||
105539521|NCT00414050|363976368|FG003|Overall Study|Subject discontinued for other reason|1|||
105539522|NCT00414050|363976365|FG000|Overall Study|Subject Moved|0|||
105539523|NCT00414050|363976366|FG001|Overall Study|Subject Moved|0|||
105539524|NCT00414050|363976367|FG002|Overall Study|Subject Moved|0|||
105539525|NCT00414050|363976368|FG003|Overall Study|Subject Moved|1|||
105539526|NCT01959581|363976369|FG000|Overall Study|Lost to Follow-up|5|||
105539527|NCT03323099|363976371|FG000|Overall Study|Withdrawal by Subject|6|||
105539528|NCT03323099|363976372|FG001|Overall Study|Withdrawal by Subject|12|||
105539529|NCT03323099|363976371|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
105539530|NCT03323099|363976372|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
105539531|NCT00767676|363976373|FG000|Overall Study|Investigator error|54|||
105539532|NCT03495908|363976374|FG000|Overall Study|Withdrawal by Subject|3|||
105539533|NCT03495908|363976375|FG001|Overall Study|Withdrawal by Subject|1|||
105539534|NCT03495908|363976374|FG000|Overall Study|Lost to Follow-up|1|||
105539535|NCT03495908|363976375|FG001|Overall Study|Lost to Follow-up|4|||
105539536|NCT03495908|363976374|FG000|Overall Study|Adverse Event|0|||
105539537|NCT03495908|363976375|FG001|Overall Study|Adverse Event|2|||
105539538|NCT03495908|363976374|FG000|Overall Study|Death|1|||
105539539|NCT03495908|363976375|FG001|Overall Study|Death|0|||
105539540|NCT03495908|363976374|FG000|Overall Study|Physician Decision|5|||
105539541|NCT03495908|363976375|FG001|Overall Study|Physician Decision|4|||
105539542|NCT03495908|363976374|FG000|Overall Study|No documented reason|0|||
105539543|NCT03495908|363976375|FG001|Overall Study|No documented reason|2|||
105539544|NCT03304379|363976376|FG000|Overall Study|Protocol Violation|8|||
105539545|NCT03304379|363976377|FG001|Overall Study|Protocol Violation|10|||
105539546|NCT03304379|363976378|FG002|Overall Study|Protocol Violation|5|||
105539547|NCT03304379|363976379|FG003|Overall Study|Protocol Violation|0|||
105539548|NCT03304379|363976380|FG004|Overall Study|Protocol Violation|2|||
105539549|NCT03304379|363976376|FG000|Overall Study|Adverse Event|4|||
105539550|NCT03304379|363976377|FG001|Overall Study|Adverse Event|20|||
105539551|NCT03304379|363976378|FG002|Overall Study|Adverse Event|17|||
105539552|NCT03304379|363976379|FG003|Overall Study|Adverse Event|1|||
105539553|NCT03304379|363976380|FG004|Overall Study|Adverse Event|0|||
105539554|NCT03304379|363976376|FG000|Overall Study|Lack of Efficacy|17|||
105539555|NCT03304379|363976377|FG001|Overall Study|Lack of Efficacy|16|||
105539556|NCT03304379|363976378|FG002|Overall Study|Lack of Efficacy|20|||
105539557|NCT03304379|363976379|FG003|Overall Study|Lack of Efficacy|0|||
105539558|NCT03304379|363976380|FG004|Overall Study|Lack of Efficacy|0|||
105539559|NCT03304379|363976376|FG000|Overall Study|Physician Decision|6|||
105539560|NCT03304379|363976377|FG001|Overall Study|Physician Decision|10|||
105539561|NCT03304379|363976378|FG002|Overall Study|Physician Decision|6|||
105539562|NCT03304379|363976379|FG003|Overall Study|Physician Decision|9|||
105539563|NCT03304379|363976380|FG004|Overall Study|Physician Decision|10|||
105539564|NCT03304379|363976376|FG000|Overall Study|Withdrawal by Subject|26|||
105539565|NCT03304379|363976377|FG001|Overall Study|Withdrawal by Subject|58|||
105539566|NCT03304379|363976378|FG002|Overall Study|Withdrawal by Subject|66|||
105539567|NCT03304379|363976379|FG003|Overall Study|Withdrawal by Subject|3|||
105539568|NCT03304379|363976380|FG004|Overall Study|Withdrawal by Subject|5|||
105539569|NCT03304379|363976376|FG000|Overall Study|Lost to Follow-up|8|||
105539570|NCT03304379|363976377|FG001|Overall Study|Lost to Follow-up|24|||
105539571|NCT03304379|363976378|FG002|Overall Study|Lost to Follow-up|35|||
105539572|NCT03304379|363976379|FG003|Overall Study|Lost to Follow-up|4|||
105539573|NCT03304379|363976380|FG004|Overall Study|Lost to Follow-up|0|||
105539574|NCT03304379|363976376|FG000|Overall Study|Death|1|||
105539575|NCT03304379|363976377|FG001|Overall Study|Death|2|||
105539576|NCT03304379|363976378|FG002|Overall Study|Death|0|||
105539577|NCT03304379|363976379|FG003|Overall Study|Death|0|||
105539578|NCT03304379|363976380|FG004|Overall Study|Death|0|||
105539579|NCT03304379|363976376|FG000|Overall Study|Other|0|||
105539580|NCT03304379|363976377|FG001|Overall Study|Other|1|||
105539581|NCT03304379|363976378|FG002|Overall Study|Other|0|||
105539582|NCT03304379|363976379|FG003|Overall Study|Other|0|||
105539583|NCT03304379|363976380|FG004|Overall Study|Other|0|||
105539584|NCT00617240|363976381|FG000|Overall Study|Lack of Efficacy|1|||
105539585|NCT00617240|363976382|FG001|Overall Study|Lack of Efficacy|0|||
105539586|NCT04936685|363976383|FG000|Overall Study|Protocol Violation|1|||
105539587|NCT04936685|363976384|FG001|Overall Study|Protocol Violation|0|||
105539588|NCT00670228|363976385|FG000|Overall Study|Adverse Event|1|||
105539589|NCT00670228|363976386|FG001|Overall Study|Adverse Event|0|||
105539590|NCT00670228|363976385|FG000|Overall Study|Death or MACE|0|||
105539591|NCT00670228|363976386|FG001|Overall Study|Death or MACE|1|||
105539592|NCT00670228|363976385|FG000|Overall Study|Not treated|2|||
105539593|NCT00670228|363976386|FG001|Overall Study|Not treated|2|||
105539594|NCT00670228|363976385|FG000|Overall Study|Not meeting the selection criteria|2|||
105539595|NCT00670228|363976386|FG001|Overall Study|Not meeting the selection criteria|0|||
105539596|NCT05013905|363976396|FG000|Overall Study|Adverse Event|1|||
105539597|NCT05013905|363976396|FG000|Overall Study|Lack of Efficacy|1|||
105539598|NCT01856543|363976409|FG000|Overall Study|Treatment discontinued|6|||
105539599|NCT01856543|363976410|FG001|Overall Study|Treatment discontinued|3|||
105539600|NCT01856543|363976409|FG000|Overall Study|Withdrawn before start|7|||
105539601|NCT01856543|363976410|FG001|Overall Study|Withdrawn before start|3|||
105539602|NCT01247090|363976413|FG000|Overall Study|Physician Decision|1|||
105539603|NCT01247090|363976414|FG001|Overall Study|Physician Decision|0|||
105539604|NCT01247090|363976415|FG002|Overall Study|Physician Decision|0|||
105539605|NCT01247090|363976413|FG000|Overall Study|Withdrawal by Subject|0|||
105539606|NCT01247090|363976414|FG001|Overall Study|Withdrawal by Subject|1|||
105539607|NCT01247090|363976415|FG002|Overall Study|Withdrawal by Subject|0|||
105539608|NCT01466192|363976416|FG000|Overall Study|Physician Decision|1|||
105539609|NCT01466192|363976416|FG000|Overall Study|Withdrawal by Subject|3|||
105539610|NCT04568122|363976417|FG000|Overall Study|Lost to Follow-up|48|||
105539611|NCT04568122|363976418|FG001|Overall Study|Lost to Follow-up|44|||
105539612|NCT04568122|363976419|FG002|Overall Study|Lost to Follow-up|4|||
105539613|NCT04568122|363976420|FG003|Overall Study|Lost to Follow-up|0|||
105539614|NCT04568122|363976421|FG004|Overall Study|Lost to Follow-up|0|||
105539615|NCT00437034|363976422|FG000|Overall Study|Adverse Event|1|||
105539616|NCT00437034|363976422|FG000|Overall Study|Disease progression during treatment|5|||
105539617|NCT02460224|363976425|FG000|Overall Study|Adverse Event|0|||
105539618|NCT02460224|363976426|FG001|Overall Study|Adverse Event|0|||
105539619|NCT02460224|363976427|FG002|Overall Study|Adverse Event|0|||
105539620|NCT02460224|363976428|FG003|Overall Study|Adverse Event|0|||
105539621|NCT02460224|363976429|FG004|Overall Study|Adverse Event|0|||
105539622|NCT02460224|363976430|FG005|Overall Study|Adverse Event|0|||
105539623|NCT02460224|363976431|FG006|Overall Study|Adverse Event|1|||
105539624|NCT02460224|363976432|FG007|Overall Study|Adverse Event|0|||
105539625|NCT02460224|363976433|FG008|Overall Study|Adverse Event|0|||
105539626|NCT02460224|363976434|FG009|Overall Study|Adverse Event|0|||
105539627|NCT02460224|363976435|FG010|Overall Study|Adverse Event|0|||
105539628|NCT02460224|363976436|FG011|Overall Study|Adverse Event|0|||
105539629|NCT02460224|363976437|FG012|Overall Study|Adverse Event|1|||
105539630|NCT02460224|363976438|FG013|Overall Study|Adverse Event|0|||
105539631|NCT02460224|363976439|FG014|Overall Study|Adverse Event|0|||
105539632|NCT02460224|363976440|FG015|Overall Study|Adverse Event|0|||
105539633|NCT02460224|363976441|FG016|Overall Study|Adverse Event|1|||
105539634|NCT02460224|363976442|FG017|Overall Study|Adverse Event|0|||
105539635|NCT02460224|363976443|FG018|Overall Study|Adverse Event|1|||
105539636|NCT02460224|363976444|FG019|Overall Study|Adverse Event|0|||
105539637|NCT02460224|363976445|FG020|Overall Study|Adverse Event|1|||
105539638|NCT02460224|363976446|FG021|Overall Study|Adverse Event|1|||
105539639|NCT02460224|363976447|FG022|Overall Study|Adverse Event|1|||
105539640|NCT02460224|363976448|FG023|Overall Study|Adverse Event|0|||
105539641|NCT02460224|363976449|FG024|Overall Study|Adverse Event|0|||
105539642|NCT02460224|363976450|FG025|Overall Study|Adverse Event|0|||
105539643|NCT02460224|363976451|FG026|Overall Study|Adverse Event|11|||
105539644|NCT02460224|363976452|FG027|Overall Study|Adverse Event|1|||
105539645|NCT02460224|363976453|FG028|Overall Study|Adverse Event|6|||
105539646|NCT02460224|363976425|FG000|Overall Study|Death|0|||
105539647|NCT02460224|363976426|FG001|Overall Study|Death|0|||
105539648|NCT02460224|363976427|FG002|Overall Study|Death|0|||
105539649|NCT02460224|363976428|FG003|Overall Study|Death|0|||
105539650|NCT02460224|363976429|FG004|Overall Study|Death|0|||
105539651|NCT02460224|363976430|FG005|Overall Study|Death|2|||
105539652|NCT02460224|363976431|FG006|Overall Study|Death|1|||
105539653|NCT02460224|363976432|FG007|Overall Study|Death|0|||
105539654|NCT02460224|363976433|FG008|Overall Study|Death|0|||
105539655|NCT02460224|363976434|FG009|Overall Study|Death|1|||
105539656|NCT02460224|363976435|FG010|Overall Study|Death|0|||
105539657|NCT02460224|363976436|FG011|Overall Study|Death|0|||
105539658|NCT02460224|363976437|FG012|Overall Study|Death|0|||
105539659|NCT02460224|363976438|FG013|Overall Study|Death|1|||
105539660|NCT02460224|363976439|FG014|Overall Study|Death|0|||
105539661|NCT02460224|363976440|FG015|Overall Study|Death|0|||
105539662|NCT02460224|363976441|FG016|Overall Study|Death|2|||
105539663|NCT02460224|363976442|FG017|Overall Study|Death|1|||
105539664|NCT02460224|363976443|FG018|Overall Study|Death|0|||
105539665|NCT02460224|363976444|FG019|Overall Study|Death|2|||
105539666|NCT02460224|363976445|FG020|Overall Study|Death|0|||
105539667|NCT02460224|363976446|FG021|Overall Study|Death|0|||
105539668|NCT02460224|363976447|FG022|Overall Study|Death|0|||
105539669|NCT02460224|363976448|FG023|Overall Study|Death|0|||
105539670|NCT02460224|363976449|FG024|Overall Study|Death|1|||
105539671|NCT02460224|363976450|FG025|Overall Study|Death|1|||
105539672|NCT02460224|363976451|FG026|Overall Study|Death|5|||
105539673|NCT02460224|363976452|FG027|Overall Study|Death|0|||
105539674|NCT02460224|363976453|FG028|Overall Study|Death|1|||
105539675|NCT02460224|363976425|FG000|Overall Study|Lost to Follow-up|0|||
105539676|NCT02460224|363976426|FG001|Overall Study|Lost to Follow-up|0|||
105539677|NCT02460224|363976427|FG002|Overall Study|Lost to Follow-up|0|||
105539678|NCT02460224|363976428|FG003|Overall Study|Lost to Follow-up|0|||
105539679|NCT02460224|363976429|FG004|Overall Study|Lost to Follow-up|0|||
105539680|NCT02460224|363976430|FG005|Overall Study|Lost to Follow-up|0|||
105539681|NCT02460224|363976431|FG006|Overall Study|Lost to Follow-up|0|||
105539682|NCT02460224|363976432|FG007|Overall Study|Lost to Follow-up|0|||
105539683|NCT02460224|363976433|FG008|Overall Study|Lost to Follow-up|0|||
105539684|NCT02460224|363976434|FG009|Overall Study|Lost to Follow-up|0|||
105539685|NCT02460224|363976435|FG010|Overall Study|Lost to Follow-up|0|||
105539686|NCT02460224|363976436|FG011|Overall Study|Lost to Follow-up|0|||
105539687|NCT02460224|363976437|FG012|Overall Study|Lost to Follow-up|0|||
105539688|NCT02460224|363976438|FG013|Overall Study|Lost to Follow-up|0|||
105539689|NCT02460224|363976439|FG014|Overall Study|Lost to Follow-up|0|||
105539690|NCT02460224|363976440|FG015|Overall Study|Lost to Follow-up|0|||
105539691|NCT02460224|363976441|FG016|Overall Study|Lost to Follow-up|0|||
105539692|NCT02460224|363976442|FG017|Overall Study|Lost to Follow-up|0|||
105539693|NCT02460224|363976443|FG018|Overall Study|Lost to Follow-up|0|||
105539694|NCT02460224|363976444|FG019|Overall Study|Lost to Follow-up|0|||
105539695|NCT02460224|363976445|FG020|Overall Study|Lost to Follow-up|0|||
105539696|NCT02460224|363976446|FG021|Overall Study|Lost to Follow-up|0|||
105539697|NCT02460224|363976447|FG022|Overall Study|Lost to Follow-up|1|||
105539698|NCT02460224|363976448|FG023|Overall Study|Lost to Follow-up|0|||
105539699|NCT02460224|363976449|FG024|Overall Study|Lost to Follow-up|0|||
105539700|NCT02460224|363976450|FG025|Overall Study|Lost to Follow-up|0|||
105539701|NCT02460224|363976451|FG026|Overall Study|Lost to Follow-up|0|||
105539702|NCT02460224|363976452|FG027|Overall Study|Lost to Follow-up|0|||
105539703|NCT02460224|363976453|FG028|Overall Study|Lost to Follow-up|0|||
105539704|NCT02460224|363976425|FG000|Overall Study|Physician Decision|0|||
105539705|NCT02460224|363976426|FG001|Overall Study|Physician Decision|1|||
105539706|NCT02460224|363976427|FG002|Overall Study|Physician Decision|0|||
105539707|NCT02460224|363976428|FG003|Overall Study|Physician Decision|0|||
105539708|NCT02460224|363976429|FG004|Overall Study|Physician Decision|1|||
105539709|NCT02460224|363976430|FG005|Overall Study|Physician Decision|0|||
105539710|NCT02460224|363976431|FG006|Overall Study|Physician Decision|0|||
105539711|NCT02460224|363976432|FG007|Overall Study|Physician Decision|1|||
105539712|NCT02460224|363976433|FG008|Overall Study|Physician Decision|0|||
105539713|NCT02460224|363976434|FG009|Overall Study|Physician Decision|0|||
105539714|NCT02460224|363976435|FG010|Overall Study|Physician Decision|0|||
105539715|NCT02460224|363976436|FG011|Overall Study|Physician Decision|1|||
105539716|NCT02460224|363976437|FG012|Overall Study|Physician Decision|0|||
105539717|NCT02460224|363976438|FG013|Overall Study|Physician Decision|1|||
105539718|NCT02460224|363976439|FG014|Overall Study|Physician Decision|0|||
105539719|NCT02460224|363976440|FG015|Overall Study|Physician Decision|0|||
105539720|NCT02460224|363976441|FG016|Overall Study|Physician Decision|2|||
105539721|NCT02460224|363976442|FG017|Overall Study|Physician Decision|1|||
105539722|NCT02460224|363976443|FG018|Overall Study|Physician Decision|1|||
105539723|NCT02460224|363976444|FG019|Overall Study|Physician Decision|2|||
105539724|NCT02460224|363976445|FG020|Overall Study|Physician Decision|1|||
105539725|NCT02460224|363976446|FG021|Overall Study|Physician Decision|1|||
105539726|NCT02460224|363976447|FG022|Overall Study|Physician Decision|0|||
105539727|NCT02460224|363976448|FG023|Overall Study|Physician Decision|0|||
105539728|NCT02460224|363976449|FG024|Overall Study|Physician Decision|1|||
105539729|NCT02460224|363976450|FG025|Overall Study|Physician Decision|0|||
105539730|NCT02460224|363976451|FG026|Overall Study|Physician Decision|14|||
105539731|NCT02460224|363976452|FG027|Overall Study|Physician Decision|1|||
105539732|NCT02460224|363976453|FG028|Overall Study|Physician Decision|6|||
105539733|NCT02460224|363976425|FG000|Overall Study|Progressive disease|15|||
105539734|NCT02460224|363976426|FG001|Overall Study|Progressive disease|11|||
105539735|NCT02460224|363976427|FG002|Overall Study|Progressive disease|5|||
105539736|NCT02460224|363976428|FG003|Overall Study|Progressive disease|6|||
105539737|NCT02460224|363976429|FG004|Overall Study|Progressive disease|3|||
105539738|NCT02460224|363976430|FG005|Overall Study|Progressive disease|26|||
105539739|NCT02460224|363976431|FG006|Overall Study|Progressive disease|28|||
105539740|NCT02460224|363976432|FG007|Overall Study|Progressive disease|4|||
105539741|NCT02460224|363976433|FG008|Overall Study|Progressive disease|5|||
105539742|NCT02460224|363976434|FG009|Overall Study|Progressive disease|9|||
105539743|NCT02460224|363976435|FG010|Overall Study|Progressive disease|5|||
105539744|NCT02460224|363976436|FG011|Overall Study|Progressive disease|4|||
105539745|NCT02460224|363976437|FG012|Overall Study|Progressive disease|5|||
105539746|NCT02460224|363976438|FG013|Overall Study|Progressive disease|4|||
105539747|NCT02460224|363976439|FG014|Overall Study|Progressive disease|5|||
105539748|NCT02460224|363976440|FG015|Overall Study|Progressive disease|5|||
105539749|NCT02460224|363976441|FG016|Overall Study|Progressive disease|15|||
105539750|NCT02460224|363976442|FG017|Overall Study|Progressive disease|3|||
105539751|NCT02460224|363976443|FG018|Overall Study|Progressive disease|8|||
105539752|NCT02460224|363976444|FG019|Overall Study|Progressive disease|3|||
105539753|NCT02460224|363976445|FG020|Overall Study|Progressive disease|4|||
105539754|NCT02460224|363976446|FG021|Overall Study|Progressive disease|9|||
105539755|NCT02460224|363976447|FG022|Overall Study|Progressive disease|4|||
105539756|NCT02460224|363976448|FG023|Overall Study|Progressive disease|11|||
105539757|NCT02460224|363976449|FG024|Overall Study|Progressive disease|4|||
105539758|NCT02460224|363976450|FG025|Overall Study|Progressive disease|5|||
105539759|NCT02460224|363976451|FG026|Overall Study|Progressive disease|85|||
105539760|NCT02460224|363976452|FG027|Overall Study|Progressive disease|17|||
105539761|NCT02460224|363976453|FG028|Overall Study|Progressive disease|77|||
105539762|NCT02460224|363976425|FG000|Overall Study|Subject/guardian decision|2|||
105539763|NCT02460224|363976426|FG001|Overall Study|Subject/guardian decision|0|||
105539764|NCT02460224|363976427|FG002|Overall Study|Subject/guardian decision|1|||
105539765|NCT02460224|363976428|FG003|Overall Study|Subject/guardian decision|0|||
105539766|NCT02460224|363976429|FG004|Overall Study|Subject/guardian decision|2|||
105539767|NCT02460224|363976430|FG005|Overall Study|Subject/guardian decision|2|||
105539768|NCT02460224|363976431|FG006|Overall Study|Subject/guardian decision|0|||
105539769|NCT02460224|363976432|FG007|Overall Study|Subject/guardian decision|0|||
105539770|NCT02460224|363976433|FG008|Overall Study|Subject/guardian decision|1|||
105539771|NCT02460224|363976434|FG009|Overall Study|Subject/guardian decision|1|||
105539772|NCT02460224|363976435|FG010|Overall Study|Subject/guardian decision|0|||
105539773|NCT02460224|363976436|FG011|Overall Study|Subject/guardian decision|1|||
105539774|NCT02460224|363976437|FG012|Overall Study|Subject/guardian decision|0|||
105539775|NCT02460224|363976438|FG013|Overall Study|Subject/guardian decision|0|||
105539776|NCT02460224|363976439|FG014|Overall Study|Subject/guardian decision|0|||
105539777|NCT02460224|363976440|FG015|Overall Study|Subject/guardian decision|1|||
105539778|NCT02460224|363976441|FG016|Overall Study|Subject/guardian decision|0|||
105539779|NCT02460224|363976442|FG017|Overall Study|Subject/guardian decision|1|||
105539780|NCT02460224|363976443|FG018|Overall Study|Subject/guardian decision|2|||
105539781|NCT02460224|363976444|FG019|Overall Study|Subject/guardian decision|0|||
105539782|NCT02460224|363976445|FG020|Overall Study|Subject/guardian decision|0|||
105539783|NCT02460224|363976446|FG021|Overall Study|Subject/guardian decision|1|||
105539784|NCT02460224|363976447|FG022|Overall Study|Subject/guardian decision|0|||
105539785|NCT02460224|363976448|FG023|Overall Study|Subject/guardian decision|0|||
105539786|NCT02460224|363976449|FG024|Overall Study|Subject/guardian decision|0|||
105539787|NCT02460224|363976450|FG025|Overall Study|Subject/guardian decision|0|||
105539788|NCT02460224|363976451|FG026|Overall Study|Subject/guardian decision|6|||
105539789|NCT02460224|363976452|FG027|Overall Study|Subject/guardian decision|2|||
105539790|NCT02460224|363976453|FG028|Overall Study|Subject/guardian decision|3|||
105539791|NCT01227512|363976457|FG000|Overall Study|Physician Decision|6|||
105539792|NCT01227512|363976458|FG001|Overall Study|Physician Decision|6|||
105539793|NCT01227512|363976457|FG000|Overall Study|Adverse Event|4|||
105539794|NCT01227512|363976458|FG001|Overall Study|Adverse Event|3|||
105539795|NCT01227512|363976457|FG000|Overall Study|Withdrawal by Subject|3|||
105539796|NCT01227512|363976458|FG001|Overall Study|Withdrawal by Subject|0|||
105539797|NCT01227512|363976457|FG000|Overall Study|Participant met withdrawal criteria|0|||
105539798|NCT01227512|363976458|FG001|Overall Study|Participant met withdrawal criteria|1|||
105539799|NCT04055116|363976465|FG000|First Intervention|Physician Decision|2|||
105539800|NCT04055116|363976466|FG001|First Intervention|Physician Decision|7|||
105539801|NCT02553421|363976471|FG000|Overall Study|Lost to Follow-up|21|||
105539802|NCT02553421|363976472|FG001|Overall Study|Lost to Follow-up|1|||
105539803|NCT02553421|363976471|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
105539804|NCT02553421|363976472|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
105539805|NCT02553421|363976471|FG000|Overall Study|Improper Device Placement|3|||
105539806|NCT02553421|363976472|FG001|Overall Study|Improper Device Placement|0|||
105539807|NCT02047604|363976473|FG000|Overall Study|Withdrawal by Subject|0|||
105539808|NCT02047604|363976474|FG001|Overall Study|Withdrawal by Subject|0|||
105539809|NCT02047604|363976475|FG002|Overall Study|Withdrawal by Subject|0|||
105539810|NCT02047604|363976476|FG003|Overall Study|Withdrawal by Subject|0|||
105539811|NCT02047604|363976477|FG004|Overall Study|Withdrawal by Subject|1|||
105539812|NCT02047604|363976478|FG005|Overall Study|Withdrawal by Subject|1|||
105539813|NCT03861273|363976479|FG000|Screening Phase (3 Weeks)|Other|1|||
105539814|NCT03861273|363976479|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
105539815|NCT03861273|363976479|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
105539816|NCT03861273|363976479|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
105539817|NCT03861273|363976479|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
105539818|NCT03333486|363976480|FG000|Overall Study|Withdrawal by Subject|1|||
105539819|NCT03333486|363976480|FG000|Overall Study|Lost to Follow-up|1|||
105539820|NCT04197713|363976483|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
105539821|NCT04197713|363976484|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
105539822|NCT01755416|363976485|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
105539823|NCT01755416|363976486|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
105539824|NCT01065454|363976487|FG000|Treatment|Adverse Event|7|||
105539825|NCT01065454|363976488|FG001|Treatment|Adverse Event|4|||
105539826|NCT01065454|363976489|FG002|Treatment|Adverse Event|3|||
105539827|NCT01065454|363976490|FG003|Treatment|Adverse Event|6|||
105539828|NCT01065454|363976487|FG000|Treatment|Death|1|||
105539829|NCT01065454|363976488|FG001|Treatment|Death|0|||
105539830|NCT01065454|363976489|FG002|Treatment|Death|0|||
105539831|NCT01065454|363976490|FG003|Treatment|Death|0|||
105539832|NCT01065454|363976487|FG000|Treatment|Non-compliance|1|||
105539833|NCT01065454|363976488|FG001|Treatment|Non-compliance|0|||
105539834|NCT01065454|363976489|FG002|Treatment|Non-compliance|0|||
105539835|NCT01065454|363976490|FG003|Treatment|Non-compliance|1|||
105539836|NCT01065454|363976487|FG000|Treatment|Protocol Decision|0|||
105539837|NCT01065454|363976488|FG001|Treatment|Protocol Decision|0|||
105539838|NCT01065454|363976489|FG002|Treatment|Protocol Decision|3|||
105539839|NCT01065454|363976490|FG003|Treatment|Protocol Decision|2|||
105539840|NCT01065454|363976487|FG000|Treatment|Protocol Violation|1|||
105539841|NCT01065454|363976488|FG001|Treatment|Protocol Violation|0|||
105539842|NCT01065454|363976489|FG002|Treatment|Protocol Violation|1|||
105539843|NCT01065454|363976490|FG003|Treatment|Protocol Violation|0|||
105539844|NCT01065454|363976487|FG000|Treatment|Withdrawal by Subject|3|||
105539845|NCT01065454|363976488|FG001|Treatment|Withdrawal by Subject|1|||
105539846|NCT01065454|363976489|FG002|Treatment|Withdrawal by Subject|2|||
105539847|NCT01065454|363976490|FG003|Treatment|Withdrawal by Subject|3|||
105539848|NCT01065454|363976487|FG000|Follow up|Adverse Event|1|||
105539849|NCT01065454|363976488|FG001|Follow up|Adverse Event|0|||
105539850|NCT01065454|363976489|FG002|Follow up|Adverse Event|0|||
105539851|NCT01065454|363976490|FG003|Follow up|Adverse Event|1|||
105539852|NCT01065454|363976487|FG000|Follow up|Death|0|||
105539853|NCT01065454|363976488|FG001|Follow up|Death|1|||
105539854|NCT01065454|363976489|FG002|Follow up|Death|1|||
105539855|NCT01065454|363976490|FG003|Follow up|Death|0|||
105539856|NCT01065454|363976487|FG000|Follow up|Lost to Follow-up|0|||
105539857|NCT01065454|363976488|FG001|Follow up|Lost to Follow-up|0|||
105539858|NCT01065454|363976489|FG002|Follow up|Lost to Follow-up|0|||
105539859|NCT01065454|363976490|FG003|Follow up|Lost to Follow-up|1|||
105539860|NCT01065454|363976487|FG000|Follow up|Progressive disease|0|||
105539861|NCT01065454|363976488|FG001|Follow up|Progressive disease|0|||
105539862|NCT01065454|363976489|FG002|Follow up|Progressive disease|0|||
105539863|NCT01065454|363976490|FG003|Follow up|Progressive disease|1|||
105539864|NCT01065454|363976487|FG000|Follow up|Withdrawal by Subject|1|||
105539865|NCT01065454|363976488|FG001|Follow up|Withdrawal by Subject|1|||
105539866|NCT01065454|363976489|FG002|Follow up|Withdrawal by Subject|1|||
105539867|NCT01065454|363976490|FG003|Follow up|Withdrawal by Subject|0|||
105539868|NCT01065454|363976487|FG000|Follow up|study ongoing|37|||
105539869|NCT01065454|363976488|FG001|Follow up|study ongoing|22|||
105539870|NCT01065454|363976489|FG002|Follow up|study ongoing|15|||
105539871|NCT01065454|363976490|FG003|Follow up|study ongoing|41|||
105539872|NCT03042312|363978020|FG000|Overall Study|Administrative Reason|1|||
105539873|NCT03042312|363978021|FG001|Overall Study|Administrative Reason|1|||
105539874|NCT03042312|363978020|FG000|Overall Study|Adverse Event|0|||
105539875|NCT03042312|363978021|FG001|Overall Study|Adverse Event|1|||
105539876|NCT03042312|363978020|FG000|Overall Study|Lost to Follow-up|1|||
105539877|NCT03042312|363978021|FG001|Overall Study|Lost to Follow-up|3|||
105539878|NCT03042312|363978020|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
105539879|NCT03042312|363978021|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
105539880|NCT03042312|363978020|FG000|Overall Study|Withdrawal by Subject|4|||
105539881|NCT03042312|363978021|FG001|Overall Study|Withdrawal by Subject|5|||
105539882|NCT02349711|363978022|FG000|Overall Study|Withdrawal by Subject|2|||
105539883|NCT02349711|363978023|FG001|Overall Study|Withdrawal by Subject|1|||
105539884|NCT02349711|363978022|FG000|Overall Study|Lost to Follow-up|1|||
105539885|NCT02349711|363978023|FG001|Overall Study|Lost to Follow-up|1|||
105539886|NCT00194012|363978024|FG000|Randomized Phase|Lack of Efficacy|8|||
105539887|NCT00194012|363978025|FG001|Randomized Phase|Lack of Efficacy|18|||
105539888|NCT00194012|363978024|FG000|Randomized Phase|Study nonadherence|2|||
105539889|NCT00194012|363978025|FG001|Randomized Phase|Study nonadherence|1|||
105539890|NCT00194012|363978024|FG000|Randomized Phase|Withdrawal by Subject|3|||
105539891|NCT00194012|363978025|FG001|Randomized Phase|Withdrawal by Subject|3|||
105539892|NCT00194012|363978024|FG000|Randomized Phase|Adverse Event|2|||
105539893|NCT00194012|363978025|FG001|Randomized Phase|Adverse Event|1|||
105539894|NCT00194012|363978024|FG000|Randomized Phase|Participant reported having a rash|1|||
105539895|NCT00194012|363978025|FG001|Randomized Phase|Participant reported having a rash|0|||
105539896|NCT00194012|363978024|FG000|Randomized Phase|Emesis and enuresis|0|||
105539897|NCT00194012|363978025|FG001|Randomized Phase|Emesis and enuresis|1|||
105539898|NCT00194012|363978024|FG000|Randomized Phase|Oral/nasal twitching|0|||
105595854|NCT02551055|364182443|FG001|Overall Study|Withdrawal by Subject|1|||
105539899|NCT00194012|363978025|FG001|Randomized Phase|Oral/nasal twitching|1|||
105539900|NCT00194012|363978024|FG000|Open Label Extension (OLE)|Weight Gain|1|||
105539901|NCT00194012|363978025|FG001|Open Label Extension (OLE)|Weight Gain|0|||
105539902|NCT00194012|363978024|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
105539903|NCT00194012|363978025|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
105539904|NCT00194012|363978024|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
105539905|NCT00194012|363978025|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
105539906|NCT00194012|363978024|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
105539907|NCT00194012|363978025|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
105595855|NCT02551055|364182444|FG002|Overall Study|Withdrawal by Subject|0|||
105595856|NCT02551055|364182445|FG003|Overall Study|Withdrawal by Subject|1|||
105595857|NCT02551055|364182446|FG004|Overall Study|Withdrawal by Subject|2|||
105539908|NCT01105533|363978031|FG000|Overall Study|Death|0|||
105539909|NCT01105533|363978032|FG001|Overall Study|Death|0|||
105539910|NCT01105533|363978033|FG002|Overall Study|Death|0|||
105539911|NCT01105533|363978034|FG003|Overall Study|Death|0|||
105539912|NCT01105533|363978035|FG004|Overall Study|Death|1|||
105539913|NCT01105533|363978036|FG005|Overall Study|Death|0|||
105539914|NCT01105533|363978037|FG006|Overall Study|Death|0|||
105539915|NCT01105533|363978038|FG007|Overall Study|Death|0|||
105539916|NCT01105533|363978039|FG008|Overall Study|Death|0|||
105539917|NCT01105533|363978031|FG000|Overall Study|Lack of Efficacy|1|||
105539918|NCT01105533|363978032|FG001|Overall Study|Lack of Efficacy|1|||
105539919|NCT01105533|363978033|FG002|Overall Study|Lack of Efficacy|3|||
105539920|NCT01105533|363978034|FG003|Overall Study|Lack of Efficacy|3|||
105539921|NCT01105533|363978035|FG004|Overall Study|Lack of Efficacy|4|||
105539922|NCT01105533|363978036|FG005|Overall Study|Lack of Efficacy|5|||
105539923|NCT01105533|363978037|FG006|Overall Study|Lack of Efficacy|3|||
105539924|NCT01105533|363978038|FG007|Overall Study|Lack of Efficacy|2|||
105539925|NCT01105533|363978039|FG008|Overall Study|Lack of Efficacy|9|||
105539926|NCT01105533|363978031|FG000|Overall Study|Adverse Event|0|||
105539927|NCT01105533|363978032|FG001|Overall Study|Adverse Event|0|||
105539928|NCT01105533|363978033|FG002|Overall Study|Adverse Event|0|||
105539929|NCT01105533|363978034|FG003|Overall Study|Adverse Event|0|||
105539930|NCT01105533|363978035|FG004|Overall Study|Adverse Event|1|||
105539931|NCT01105533|363978036|FG005|Overall Study|Adverse Event|2|||
105539932|NCT01105533|363978037|FG006|Overall Study|Adverse Event|2|||
105539933|NCT01105533|363978038|FG007|Overall Study|Adverse Event|0|||
105539934|NCT01105533|363978039|FG008|Overall Study|Adverse Event|1|||
105539935|NCT01105533|363978031|FG000|Overall Study|Other|0|||
105539936|NCT01105533|363978032|FG001|Overall Study|Other|0|||
105539937|NCT01105533|363978033|FG002|Overall Study|Other|0|||
105539938|NCT01105533|363978034|FG003|Overall Study|Other|0|||
105539939|NCT01105533|363978035|FG004|Overall Study|Other|1|||
105539940|NCT01105533|363978036|FG005|Overall Study|Other|0|||
105539941|NCT01105533|363978037|FG006|Overall Study|Other|3|||
105539942|NCT01105533|363978038|FG007|Overall Study|Other|1|||
105539943|NCT01105533|363978039|FG008|Overall Study|Other|2|||
105539944|NCT01105533|363978031|FG000|Overall Study|Physician Decision|0|||
105539945|NCT01105533|363978032|FG001|Overall Study|Physician Decision|0|||
105539946|NCT01105533|363978033|FG002|Overall Study|Physician Decision|0|||
105539947|NCT01105533|363978034|FG003|Overall Study|Physician Decision|0|||
105539948|NCT01105533|363978035|FG004|Overall Study|Physician Decision|0|||
105539949|NCT01105533|363978036|FG005|Overall Study|Physician Decision|0|||
105539950|NCT01105533|363978037|FG006|Overall Study|Physician Decision|0|||
105539951|NCT01105533|363978038|FG007|Overall Study|Physician Decision|1|||
105539952|NCT01105533|363978039|FG008|Overall Study|Physician Decision|0|||
105539953|NCT02096835|363978040|FG000|Overall Study|Withdrawal by Subject|1|||
105539954|NCT02096835|363978041|FG001|Overall Study|Withdrawal by Subject|0|||
105539955|NCT02096835|363978042|FG002|Overall Study|Withdrawal by Subject|0|||
105539956|NCT02096835|363978040|FG000|Overall Study|converted to open procedures|1|||
105539957|NCT02096835|363978041|FG001|Overall Study|converted to open procedures|0|||
105539958|NCT02096835|363978042|FG002|Overall Study|converted to open procedures|0|||
105539959|NCT02096835|363978040|FG000|Overall Study|Lost to Follow-up|1|||
105539960|NCT02096835|363978041|FG001|Overall Study|Lost to Follow-up|0|||
105539961|NCT02096835|363978042|FG002|Overall Study|Lost to Follow-up|1|||
105539962|NCT04260191|363978043|FG000|Overall Study|Decision by Sponsor|0|||
105539963|NCT04260191|363978044|FG001|Overall Study|Decision by Sponsor|1|||
105539964|NCT04260191|363978045|FG002|Overall Study|Decision by Sponsor|0|||
105539965|NCT04260191|363978043|FG000|Overall Study|Withdrawal by Subject|1|||
105539966|NCT04260191|363978044|FG001|Overall Study|Withdrawal by Subject|0|||
105539967|NCT04260191|363978045|FG002|Overall Study|Withdrawal by Subject|3|||
105539968|NCT04260191|363978043|FG000|Overall Study|Death|4|||
105539969|NCT04260191|363978044|FG001|Overall Study|Death|3|||
105539970|NCT04260191|363978045|FG002|Overall Study|Death|2|||
105539971|NCT01677195|363978046|FG000|Overall Study|Lost to Follow-up|14|||
105539972|NCT01677195|363978047|FG001|Overall Study|Lost to Follow-up|22|||
105539973|NCT01677195|363978048|FG002|Overall Study|Lost to Follow-up|22|||
105539974|NCT01677195|363978046|FG000|Overall Study|Withdrawal by Subject|1|||
105595858|NCT02551055|364182447|FG005|Overall Study|Withdrawal by Subject|0|||
105539975|NCT01677195|363978047|FG001|Overall Study|Withdrawal by Subject|0|||
105539976|NCT01677195|363978048|FG002|Overall Study|Withdrawal by Subject|1|||
105539977|NCT01677195|363978046|FG000|Overall Study|Adverse Event|6|||
105539978|NCT01677195|363978047|FG001|Overall Study|Adverse Event|4|||
105539979|NCT01677195|363978048|FG002|Overall Study|Adverse Event|1|||
105539980|NCT01677195|363978046|FG000|Overall Study|Physician Decision|1|||
105539981|NCT01677195|363978047|FG001|Overall Study|Physician Decision|2|||
105539982|NCT01677195|363978048|FG002|Overall Study|Physician Decision|2|||
105539983|NCT01677195|363978046|FG000|Overall Study|Pregnancy|0|||
105539984|NCT01677195|363978047|FG001|Overall Study|Pregnancy|1|||
105539985|NCT01677195|363978048|FG002|Overall Study|Pregnancy|0|||
105539986|NCT01677195|363978046|FG000|Overall Study|Protocol Violation|7|||
105539987|NCT01677195|363978047|FG001|Overall Study|Protocol Violation|3|||
105539988|NCT01677195|363978048|FG002|Overall Study|Protocol Violation|4|||
105539989|NCT01643473|363978049|FG000|Overall Study|Lost to Follow-up|1|||
105539990|NCT01643473|363978050|FG001|Overall Study|Lost to Follow-up|0|||
105595859|NCT02551055|364182448|FG006|Overall Study|Withdrawal by Subject|0|||
105539991|NCT01312909|363978051|FG000|Overall Study|Randomized but not treated|1|||
105539992|NCT01312909|363978052|FG001|Overall Study|Randomized but not treated|3|||
105539993|NCT01312909|363978053|FG002|Overall Study|Randomized but not treated|1|||
105539994|NCT01312909|363978051|FG000|Overall Study|Adverse Event|1|||
105539995|NCT01312909|363978052|FG001|Overall Study|Adverse Event|0|||
105539996|NCT01312909|363978053|FG002|Overall Study|Adverse Event|3|||
105539997|NCT01312909|363978051|FG000|Overall Study|Protocol Violation|2|||
105539998|NCT01312909|363978052|FG001|Overall Study|Protocol Violation|0|||
105539999|NCT01312909|363978053|FG002|Overall Study|Protocol Violation|2|||
105540000|NCT01312909|363978051|FG000|Overall Study|Other|9|||
105540001|NCT01312909|363978052|FG001|Overall Study|Other|6|||
105540002|NCT01312909|363978053|FG002|Overall Study|Other|11|||
105540003|NCT01312909|363978051|FG000|Overall Study|Withdrawal by Subject|8|||
105540004|NCT01312909|363978052|FG001|Overall Study|Withdrawal by Subject|10|||
105540005|NCT01312909|363978053|FG002|Overall Study|Withdrawal by Subject|7|||
105540006|NCT01312909|363978051|FG000|Overall Study|Lost to Follow-up|21|||
105540007|NCT01312909|363978052|FG001|Overall Study|Lost to Follow-up|17|||
105540008|NCT01312909|363978053|FG002|Overall Study|Lost to Follow-up|20|||
105540009|NCT01312909|363978051|FG000|Overall Study|Insufficient clinical response|0|||
105540010|NCT01312909|363978052|FG001|Overall Study|Insufficient clinical response|0|||
105540011|NCT01312909|363978053|FG002|Overall Study|Insufficient clinical response|1|||
105540012|NCT01312909|363978051|FG000|Overall Study|Entrance criteria not met|0|||
105540013|NCT01312909|363978052|FG001|Overall Study|Entrance criteria not met|0|||
105540014|NCT01312909|363978053|FG002|Overall Study|Entrance criteria not met|2|||
105540015|NCT00659646|363978056|FG000|Overall Study|Protocol Violation|12|||
105540016|NCT00659646|363978057|FG001|Overall Study|Protocol Violation|8|||
105540017|NCT00659646|363978056|FG000|Overall Study|Adverse Event|1|||
105540018|NCT00659646|363978057|FG001|Overall Study|Adverse Event|0|||
105540019|NCT00659646|363978056|FG000|Overall Study|Lost to Follow-up|1|||
105540020|NCT00659646|363978057|FG001|Overall Study|Lost to Follow-up|0|||
105540021|NCT00659646|363978056|FG000|Overall Study|protocol noncompliance after randomized|1|||
105540022|NCT00659646|363978057|FG001|Overall Study|protocol noncompliance after randomized|0|||
105540023|NCT01774903|363978059|FG000|Overall Study|Adverse Event|7|||
105540024|NCT01774903|363978059|FG000|Overall Study|Withdrawal by Subject|2|||
105540025|NCT01774903|363978059|FG000|Overall Study|Lack of Efficacy|1|||
105540026|NCT01774903|363978059|FG000|Overall Study|Ineligible to continue the trial|1|||
105540027|NCT01023659|363978060|FG000|Overall Study|Lost to Follow-up|73|||
105540028|NCT01023659|363978061|FG001|Overall Study|Lost to Follow-up|228|||
105540029|NCT01023659|363978062|FG002|Overall Study|Lost to Follow-up|99|||
105540030|NCT00451282|363978063|FG000|Overall Study|Lost to Follow-up|6|||
105540031|NCT00451282|363978064|FG001|Overall Study|Lost to Follow-up|5|||
105540032|NCT01797536|363978065|FG000|Overall Study|Adverse Event|0|||
105540033|NCT01797536|363978066|FG001|Overall Study|Adverse Event|1|||
105540034|NCT01797536|363978067|FG002|Overall Study|Adverse Event|0|||
105540035|NCT01797536|363978068|FG003|Overall Study|Adverse Event|0|||
105540036|NCT00501540|363978069|FG000|Overall Study|Death|5|||
105540037|NCT00098839|363978070|FG000|Overall Study|Adverse Event|5|||
105540038|NCT00098839|363978071|FG001|Overall Study|Adverse Event|2|||
105540039|NCT00098839|363978070|FG000|Overall Study|Death|1|||
105540040|NCT00098839|363978071|FG001|Overall Study|Death|2|||
105540041|NCT00098839|363978070|FG000|Overall Study|Physician Decision|4|||
105540042|NCT00098839|363978071|FG001|Overall Study|Physician Decision|14|||
105540043|NCT00098839|363978070|FG000|Overall Study|Withdrawal by Subject|1|||
105540044|NCT00098839|363978071|FG001|Overall Study|Withdrawal by Subject|0|||
105540045|NCT00098839|363978070|FG000|Overall Study|Refusal of further protocol therapy|3|||
105540046|NCT00098839|363978071|FG001|Overall Study|Refusal of further protocol therapy|1|||
105540047|NCT00098839|363978070|FG000|Overall Study|Relapse|6|||
105540048|NCT00098839|363978071|FG001|Overall Study|Relapse|3|||
105540049|NCT00098839|363978070|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
105540050|NCT00098839|363978071|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
105540051|NCT00098839|363978070|FG000|Overall Study|Ineligible|2|||
105540052|NCT00098839|363978071|FG001|Overall Study|Ineligible|0|||
105540053|NCT04879745|363978073|FG000|Overall Study|Lost to Follow-up|4|||
105540054|NCT04879745|363978074|FG001|Overall Study|Lost to Follow-up|1|||
105595860|NCT02551055|364182449|FG007|Overall Study|Withdrawal by Subject|0|||
105595861|NCT02551055|364182442|FG000|Overall Study|Reason not specified|0|||
105595862|NCT02551055|364182443|FG001|Overall Study|Reason not specified|0|||
105595863|NCT02551055|364182444|FG002|Overall Study|Reason not specified|0|||
105540055|NCT02167035|363978075|FG000|Overall Study|Adverse Event|2|||
105540056|NCT02167035|363978076|FG001|Overall Study|Adverse Event|2|||
105540057|NCT02167035|363978075|FG000|Overall Study|Lost to Follow-up|3|||
105540058|NCT02167035|363978076|FG001|Overall Study|Lost to Follow-up|3|||
105540059|NCT02167035|363978075|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
105540060|NCT02167035|363978076|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
105540061|NCT01565993|363978077|FG000|Overall Study|Physician Decision|0|||
105540062|NCT01565993|363978078|FG001|Overall Study|Physician Decision|3|||
105540063|NCT03348904|363978079|FG000|Overall Study|Administrative reason by the sponsor|0|||
105540064|NCT03348904|363978080|FG001|Overall Study|Administrative reason by the sponsor|1|||
105540065|NCT03348904|363978081|FG002|Overall Study|Administrative reason by the sponsor|0|||
105540066|NCT01532687|363978082|FG000|Overall Study|Death|2|||
105540067|NCT01532687|363978083|FG001|Overall Study|Death|0|||
105540068|NCT01532687|363978082|FG000|Overall Study|Adverse Event|6|||
105540069|NCT01532687|363978083|FG001|Overall Study|Adverse Event|1|||
105540070|NCT01532687|363978082|FG000|Overall Study|Withdrawal by Subject|1|||
105540071|NCT01532687|363978083|FG001|Overall Study|Withdrawal by Subject|0|||
105540072|NCT01532687|363978082|FG000|Overall Study|Physician Decision|2|||
105540073|NCT01532687|363978083|FG001|Overall Study|Physician Decision|1|||
105540074|NCT01532687|363978082|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
105540075|NCT01532687|363978083|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
105540076|NCT00807092|363978084|FG000|Overall Study|Adverse Event|0|||
105540077|NCT00807092|363978085|FG001|Overall Study|Adverse Event|1|||
105540078|NCT00807092|363978084|FG000|Overall Study|Protocol Violation|0|||
105540079|NCT00807092|363978085|FG001|Overall Study|Protocol Violation|2|||
105540080|NCT00807092|363978084|FG000|Overall Study|Withdrawal by Subject|1|||
105540081|NCT00807092|363978085|FG001|Overall Study|Withdrawal by Subject|0|||
105540082|NCT00807092|363978084|FG000|Overall Study|CGMS data collection failed|0|||
105540083|NCT00807092|363978085|FG001|Overall Study|CGMS data collection failed|1|||
105540084|NCT04354831|363978092|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
105540085|NCT04354831|363978093|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
105540086|NCT00211081|363978096|FG000|Overall Study|Withdrawal by Subject|2|||
105540087|NCT01332305|363978097|FG000|Overall Study|Adverse Event|1|||
105540088|NCT01332305|363978098|FG001|Overall Study|Adverse Event|4|||
105540089|NCT01332305|363978099|FG002|Overall Study|Adverse Event|6|||
105540090|NCT01332305|363978100|FG003|Overall Study|Adverse Event|3|||
105540091|NCT01332305|363978101|FG004|Overall Study|Adverse Event|5|||
105540092|NCT01332305|363978097|FG000|Overall Study|Withdrawal by Subject|6|||
105540093|NCT01332305|363978098|FG001|Overall Study|Withdrawal by Subject|5|||
105540094|NCT01332305|363978099|FG002|Overall Study|Withdrawal by Subject|4|||
105540095|NCT01332305|363978100|FG003|Overall Study|Withdrawal by Subject|1|||
105540096|NCT01332305|363978101|FG004|Overall Study|Withdrawal by Subject|0|||
105540097|NCT01332305|363978097|FG000|Overall Study|Lost to Follow-up|0|||
105540098|NCT01332305|363978098|FG001|Overall Study|Lost to Follow-up|2|||
105540099|NCT01332305|363978099|FG002|Overall Study|Lost to Follow-up|3|||
105540100|NCT01332305|363978100|FG003|Overall Study|Lost to Follow-up|2|||
105540101|NCT01332305|363978101|FG004|Overall Study|Lost to Follow-up|3|||
105540102|NCT01332305|363978097|FG000|Overall Study|Protocol Violation|1|||
105540103|NCT01332305|363978098|FG001|Overall Study|Protocol Violation|2|||
105540104|NCT01332305|363978099|FG002|Overall Study|Protocol Violation|1|||
105540105|NCT01332305|363978100|FG003|Overall Study|Protocol Violation|0|||
105540106|NCT01332305|363978101|FG004|Overall Study|Protocol Violation|3|||
105540107|NCT01332305|363978097|FG000|Overall Study|Withdrawal by Sponsor|1|||
105540108|NCT01332305|363978098|FG001|Overall Study|Withdrawal by Sponsor|0|||
105540109|NCT01332305|363978099|FG002|Overall Study|Withdrawal by Sponsor|0|||
105540110|NCT01332305|363978100|FG003|Overall Study|Withdrawal by Sponsor|1|||
105540111|NCT01332305|363978101|FG004|Overall Study|Withdrawal by Sponsor|1|||
105540112|NCT01332305|363978097|FG000|Overall Study|Treatment Failure|1|||
105540113|NCT01332305|363978098|FG001|Overall Study|Treatment Failure|1|||
105540114|NCT01332305|363978099|FG002|Overall Study|Treatment Failure|0|||
105540115|NCT01332305|363978100|FG003|Overall Study|Treatment Failure|0|||
105540116|NCT01332305|363978101|FG004|Overall Study|Treatment Failure|0|||
105540117|NCT01332305|363978097|FG000|Overall Study|Physician Decision|0|||
105540118|NCT01332305|363978098|FG001|Overall Study|Physician Decision|0|||
105540119|NCT01332305|363978099|FG002|Overall Study|Physician Decision|0|||
105540120|NCT01332305|363978100|FG003|Overall Study|Physician Decision|1|||
105540121|NCT01332305|363978101|FG004|Overall Study|Physician Decision|0|||
105540122|NCT00642304|363978106|FG000|Overall Study|Adverse Event|1|||
105540123|NCT00642304|363978106|FG000|Overall Study|Death|1|||
105540124|NCT00642304|363978106|FG000|Overall Study|Blood transfusion|2|||
105540125|NCT00642304|363978106|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
105540126|NCT00642304|363978106|FG000|Overall Study|Transplantation|1|||
105540127|NCT02047110|363978123|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
105540128|NCT02047110|363978124|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
105540129|NCT02047110|363978125|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
105540130|NCT02047110|363978126|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
105540131|NCT02047110|363978123|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
105540132|NCT02047110|363978124|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
105540133|NCT02047110|363978125|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
105540134|NCT02047110|363978126|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
105540135|NCT02047110|363978123|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
105540136|NCT02047110|363978124|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
105540137|NCT02047110|363978125|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
105540138|NCT02047110|363978126|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
105540139|NCT02047110|363978123|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
105540140|NCT02047110|363978124|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
105540141|NCT02047110|363978125|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
105540142|NCT02047110|363978126|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
105540143|NCT02047110|363978123|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
105540144|NCT02047110|363978124|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
105540145|NCT02047110|363978125|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
105540146|NCT02047110|363978126|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
105540147|NCT02047110|363978123|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
105540148|NCT02047110|363978124|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
105540149|NCT02047110|363978125|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
105540150|NCT02047110|363978126|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
105540151|NCT02047110|363978123|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
105540152|NCT02047110|363978124|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
105540153|NCT02047110|363978125|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
105540154|NCT02047110|363978126|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
105540155|NCT02047110|363978123|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
105540156|NCT02047110|363978124|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
105540157|NCT02047110|363978125|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
105540158|NCT02047110|363978126|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
105540159|NCT02047110|363978123|FG000|Escape Treatment Period|Adverse Event|1|||
105540160|NCT02047110|363978124|FG001|Escape Treatment Period|Adverse Event|2|||
105540161|NCT02047110|363978125|FG002|Escape Treatment Period|Adverse Event|2|||
105540162|NCT02047110|363978126|FG003|Escape Treatment Period|Adverse Event|0|||
105540163|NCT02047110|363978123|FG000|Escape Treatment Period|Other than specified|1|||
105540164|NCT02047110|363978124|FG001|Escape Treatment Period|Other than specified|2|||
105540165|NCT02047110|363978125|FG002|Escape Treatment Period|Other than specified|0|||
105540166|NCT02047110|363978126|FG003|Escape Treatment Period|Other than specified|1|||
105540167|NCT02047110|363978123|FG000|OLE Treatment Period|Other than specified|0|||
105540168|NCT02047110|363978124|FG001|OLE Treatment Period|Other than specified|0|||
105540169|NCT02047110|363978125|FG002|OLE Treatment Period|Other than specified|1|||
105540170|NCT02047110|363978126|FG003|OLE Treatment Period|Other than specified|0|||
105540171|NCT00673452|363978127|FG000|Acute Double-Blind Phase|Adverse Event|41|||
105540172|NCT00673452|363978128|FG001|Acute Double-Blind Phase|Adverse Event|24|||
105540173|NCT00673452|363978127|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
105540174|NCT00673452|363978128|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
105540175|NCT00673452|363978127|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
105540176|NCT00673452|363978128|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
105540177|NCT00673452|363978127|FG000|Acute Double-Blind Phase|Physician Decision|0|||
105540178|NCT00673452|363978128|FG001|Acute Double-Blind Phase|Physician Decision|6|||
105540179|NCT00673452|363978127|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
105540180|NCT00673452|363978128|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
105540181|NCT00673452|363978127|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
105540182|NCT00673452|363978128|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
105540183|NCT00673452|363978127|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
105540184|NCT00673452|363978128|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
105540185|NCT00673452|363978127|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
105540186|NCT00673452|363978128|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
105540187|NCT00673452|363978127|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
105540188|NCT00673452|363978128|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
105540189|NCT00673452|363978127|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
105540190|NCT00673452|363978128|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
105540191|NCT00673452|363978127|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
105540192|NCT00673452|363978128|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
105540193|NCT00673452|363978127|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
105540194|NCT00673452|363978128|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
105540195|NCT00673452|363978127|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
105540196|NCT00673452|363978128|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
105540197|NCT00673452|363978127|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
105540198|NCT00673452|363978128|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
105595864|NCT02551055|364182445|FG003|Overall Study|Reason not specified|0|||
105540199|NCT00673452|363978127|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
105540200|NCT00673452|363978128|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
105540201|NCT00720876|363978131|FG000|Overall Study|found to be ineligible after starting tx|2|||
105540202|NCT00079274|363978137|FG000|Overall Study|Withdrawal by Subject|111|||
105540203|NCT00079274|363978138|FG001|Overall Study|Withdrawal by Subject|10|||
105540204|NCT00079274|363978139|FG002|Overall Study|Withdrawal by Subject|12|||
105540205|NCT00079274|363978140|FG003|Overall Study|Withdrawal by Subject|163|||
105540206|NCT00079274|363978141|FG004|Overall Study|Withdrawal by Subject|7|||
105540207|NCT00079274|363978142|FG005|Overall Study|Withdrawal by Subject|8|||
105595865|NCT02551055|364182446|FG004|Overall Study|Reason not specified|1|||
105540208|NCT00079274|363978143|FG006|Overall Study|Withdrawal by Subject|0|||
105540209|NCT00079274|363978137|FG000|Overall Study|Adverse Event|130|||
105540210|NCT00079274|363978138|FG001|Overall Study|Adverse Event|8|||
105540211|NCT00079274|363978139|FG002|Overall Study|Adverse Event|8|||
105540212|NCT00079274|363978140|FG003|Overall Study|Adverse Event|184|||
105540213|NCT00079274|363978141|FG004|Overall Study|Adverse Event|7|||
105540214|NCT00079274|363978142|FG005|Overall Study|Adverse Event|8|||
105540215|NCT00079274|363978143|FG006|Overall Study|Adverse Event|0|||
105540216|NCT00079274|363978137|FG000|Overall Study|Recurrence|21|||
105540217|NCT00079274|363978138|FG001|Overall Study|Recurrence|0|||
105540218|NCT00079274|363978139|FG002|Overall Study|Recurrence|1|||
105540219|NCT00079274|363978140|FG003|Overall Study|Recurrence|15|||
105540220|NCT00079274|363978141|FG004|Overall Study|Recurrence|0|||
105540221|NCT00079274|363978142|FG005|Overall Study|Recurrence|2|||
105540222|NCT00079274|363978143|FG006|Overall Study|Recurrence|0|||
105540223|NCT00079274|363978137|FG000|Overall Study|Alternate Treatment|6|||
105540224|NCT00079274|363978138|FG001|Overall Study|Alternate Treatment|1|||
105540225|NCT00079274|363978139|FG002|Overall Study|Alternate Treatment|0|||
105540226|NCT00079274|363978140|FG003|Overall Study|Alternate Treatment|3|||
105540227|NCT00079274|363978141|FG004|Overall Study|Alternate Treatment|0|||
105540228|NCT00079274|363978142|FG005|Overall Study|Alternate Treatment|0|||
105540229|NCT00079274|363978143|FG006|Overall Study|Alternate Treatment|0|||
105540230|NCT00079274|363978137|FG000|Overall Study|Other Medical Problems|6|||
105540231|NCT00079274|363978138|FG001|Overall Study|Other Medical Problems|1|||
105540232|NCT00079274|363978139|FG002|Overall Study|Other Medical Problems|0|||
105540233|NCT00079274|363978140|FG003|Overall Study|Other Medical Problems|7|||
105540234|NCT00079274|363978141|FG004|Overall Study|Other Medical Problems|0|||
105540235|NCT00079274|363978142|FG005|Overall Study|Other Medical Problems|0|||
105540236|NCT00079274|363978143|FG006|Overall Study|Other Medical Problems|0|||
105540237|NCT00079274|363978137|FG000|Overall Study|Death|4|||
105540238|NCT00079274|363978138|FG001|Overall Study|Death|0|||
105540239|NCT00079274|363978139|FG002|Overall Study|Death|1|||
105540240|NCT00079274|363978140|FG003|Overall Study|Death|15|||
105540241|NCT00079274|363978141|FG004|Overall Study|Death|0|||
105540242|NCT00079274|363978142|FG005|Overall Study|Death|0|||
105540243|NCT00079274|363978143|FG006|Overall Study|Death|0|||
105540244|NCT00079274|363978137|FG000|Overall Study|Cytogenetic resistance|0|||
105540245|NCT00079274|363978138|FG001|Overall Study|Cytogenetic resistance|0|||
105540246|NCT00079274|363978139|FG002|Overall Study|Cytogenetic resistance|0|||
105540247|NCT00079274|363978140|FG003|Overall Study|Cytogenetic resistance|2|||
105540248|NCT00079274|363978141|FG004|Overall Study|Cytogenetic resistance|0|||
105540249|NCT00079274|363978142|FG005|Overall Study|Cytogenetic resistance|0|||
105540250|NCT00079274|363978143|FG006|Overall Study|Cytogenetic resistance|0|||
105540251|NCT00079274|363978137|FG000|Overall Study|Other|43|||
105540252|NCT00079274|363978138|FG001|Overall Study|Other|7|||
105540253|NCT00079274|363978139|FG002|Overall Study|Other|5|||
105595866|NCT02551055|364182447|FG005|Overall Study|Reason not specified|0|||
105540254|NCT00079274|363978140|FG003|Overall Study|Other|55|||
105540255|NCT00079274|363978141|FG004|Overall Study|Other|1|||
105540256|NCT00079274|363978142|FG005|Overall Study|Other|2|||
105540257|NCT00079274|363978143|FG006|Overall Study|Other|0|||
105540258|NCT01611259|363978147|FG000|Overall Study|Physician Decision|1|||
105540259|NCT01611259|363978147|FG000|Overall Study|Lack of Efficacy|2|||
105540260|NCT01611259|363978147|FG000|Overall Study|Adverse Event|4|||
105540261|NCT01611259|363978147|FG000|Overall Study|Withdrawal by Subject|7|||
105540262|NCT03969212|363978150|FG000|Overall Study|Adverse Event|1|||
105540263|NCT03969212|363978151|FG001|Overall Study|Adverse Event|0|||
105540264|NCT03969212|363978152|FG002|Overall Study|Adverse Event|0|||
105540265|NCT03969212|363978153|FG003|Overall Study|Adverse Event|0|||
105595867|NCT02551055|364182448|FG006|Overall Study|Reason not specified|1|||
105540266|NCT03969212|363978150|FG000|Overall Study|Lost to Follow-up|2|||
105540267|NCT03969212|363978151|FG001|Overall Study|Lost to Follow-up|2|||
105540268|NCT03969212|363978152|FG002|Overall Study|Lost to Follow-up|2|||
105540269|NCT03969212|363978153|FG003|Overall Study|Lost to Follow-up|2|||
105540270|NCT03969212|363978150|FG000|Overall Study|Protocol Violation|0|||
105540271|NCT03969212|363978151|FG001|Overall Study|Protocol Violation|0|||
105540272|NCT03969212|363978152|FG002|Overall Study|Protocol Violation|0|||
105540273|NCT03969212|363978153|FG003|Overall Study|Protocol Violation|1|||
105540274|NCT03969212|363978150|FG000|Overall Study|Withdrawal by Subject|7|||
105540275|NCT03969212|363978151|FG001|Overall Study|Withdrawal by Subject|13|||
105540276|NCT03969212|363978152|FG002|Overall Study|Withdrawal by Subject|5|||
105540277|NCT03969212|363978153|FG003|Overall Study|Withdrawal by Subject|11|||
105540278|NCT03969212|363978150|FG000|Overall Study|Physician Decision|0|||
105540279|NCT03969212|363978151|FG001|Overall Study|Physician Decision|0|||
105540280|NCT03969212|363978152|FG002|Overall Study|Physician Decision|1|||
105540281|NCT03969212|363978153|FG003|Overall Study|Physician Decision|0|||
105540282|NCT03969212|363978150|FG000|Overall Study|Reason not Specified|22|||
105540283|NCT03969212|363978151|FG001|Overall Study|Reason not Specified|23|||
105540284|NCT03969212|363978152|FG002|Overall Study|Reason not Specified|28|||
105595868|NCT02551055|364182449|FG007|Overall Study|Reason not specified|0|||
105540285|NCT03969212|363978153|FG003|Overall Study|Reason not Specified|26|||
105540286|NCT00684424|363978156|FG000|Overall Study|Adverse Event|1|||
105540287|NCT00684424|363978156|FG000|Overall Study|Lost to Follow-up|2|||
105540288|NCT00684424|363978156|FG000|Overall Study|Other|2|||
105540289|NCT00057746|363978157|FG000|Overall Study|Withdrawal by Subject|0|||
105540290|NCT00057746|363978158|FG001|Overall Study|Withdrawal by Subject|0|||
105540291|NCT00057746|363978159|FG002|Overall Study|Withdrawal by Subject|1|||
105540292|NCT01302392|363978162|FG000|Overall Study|Lost to Follow-up|1|||
105540293|NCT01302392|363978163|FG001|Overall Study|Lost to Follow-up|0|||
105540294|NCT01302392|363978162|FG000|Overall Study|Withdrawal by Subject|6|||
105540295|NCT01302392|363978163|FG001|Overall Study|Withdrawal by Subject|1|||
105540296|NCT05857527|363978164|FG000|Overall Study|Withdrawal by Subject|0|||
105540297|NCT05857527|363978165|FG001|Overall Study|Withdrawal by Subject|1|||
105540298|NCT01469065|363978172|FG000|Overall Study|Lack of Efficacy|0|||
105540299|NCT01469065|363978173|FG001|Overall Study|Lack of Efficacy|0|||
105540300|NCT01469065|363978174|FG002|Overall Study|Lack of Efficacy|0|||
105540301|NCT01469065|363978175|FG003|Overall Study|Lack of Efficacy|0|||
105540302|NCT01469065|363978176|FG004|Overall Study|Lack of Efficacy|1|||
105540303|NCT01469065|363978172|FG000|Overall Study|Other|0|||
105540304|NCT01469065|363978173|FG001|Overall Study|Other|1|||
105540305|NCT01469065|363978174|FG002|Overall Study|Other|0|||
105540306|NCT01469065|363978175|FG003|Overall Study|Other|0|||
105540307|NCT01469065|363978176|FG004|Overall Study|Other|0|||
105540308|NCT04542070|363978179|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
105540309|NCT04542070|363978180|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
105540310|NCT04542070|363978181|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
105540311|NCT04542070|363978182|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
105540312|NCT04542070|363978179|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
105540313|NCT04542070|363978180|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
105540314|NCT04542070|363978181|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
105540315|NCT04542070|363978182|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
105540316|NCT04542070|363978179|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
105540317|NCT04542070|363978180|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
105540318|NCT04542070|363978181|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
105540319|NCT04542070|363978182|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
105540320|NCT04542070|363978179|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
105540321|NCT04542070|363978180|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
105540322|NCT04542070|363978181|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
105540323|NCT04542070|363978182|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
105540324|NCT04542070|363978179|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
105540325|NCT04542070|363978180|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
105540326|NCT04542070|363978181|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
105540327|NCT04542070|363978182|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
105540328|NCT04542070|363978179|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
105540329|NCT04542070|363978180|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
105540330|NCT04542070|363978181|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
105540331|NCT04542070|363978182|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
105540332|NCT04542070|363978179|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
105540333|NCT04542070|363978180|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
105540334|NCT04542070|363978181|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
105540335|NCT04542070|363978182|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
105540336|NCT04542070|363978179|FG000|Maintenance + Extension Period|Adverse Event|10|||
105540337|NCT04542070|363978180|FG001|Maintenance + Extension Period|Adverse Event|2|||
105540338|NCT04542070|363978181|FG002|Maintenance + Extension Period|Adverse Event|0|||
105540339|NCT04542070|363978182|FG003|Maintenance + Extension Period|Adverse Event|0|||
105540340|NCT04542070|363978179|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
105540341|NCT04542070|363978180|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
105540342|NCT04542070|363978181|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
105540343|NCT04542070|363978182|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
105540344|NCT04542070|363978179|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
105540345|NCT04542070|363978180|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
105540346|NCT04542070|363978181|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
105540347|NCT04542070|363978182|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
105540348|NCT04542070|363978179|FG000|Maintenance + Extension Period|Physician Decision|1|||
105540349|NCT04542070|363978180|FG001|Maintenance + Extension Period|Physician Decision|1|||
105540350|NCT04542070|363978181|FG002|Maintenance + Extension Period|Physician Decision|0|||
105540351|NCT04542070|363978182|FG003|Maintenance + Extension Period|Physician Decision|0|||
105540352|NCT04542070|363978179|FG000|Maintenance + Extension Period|Protocol Violation|2|||
105540353|NCT04542070|363978180|FG001|Maintenance + Extension Period|Protocol Violation|5|||
105540354|NCT04542070|363978181|FG002|Maintenance + Extension Period|Protocol Violation|0|||
105540355|NCT04542070|363978182|FG003|Maintenance + Extension Period|Protocol Violation|0|||
105540356|NCT04542070|363978179|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
105540357|NCT04542070|363978180|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
105540358|NCT04542070|363978181|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
105540359|NCT04542070|363978182|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
105540360|NCT04542070|363978179|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
105540361|NCT04542070|363978180|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
105540362|NCT04542070|363978181|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
105540363|NCT04542070|363978182|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
105540364|NCT04542070|363978179|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
105540365|NCT04542070|363978180|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
105540366|NCT04542070|363978181|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
105540367|NCT04542070|363978182|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
105540368|NCT04542070|363978179|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
105540369|NCT04542070|363978180|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
105540370|NCT04542070|363978181|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
105540371|NCT04542070|363978182|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
105540372|NCT04542070|363978179|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
105540373|NCT04542070|363978180|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
105540374|NCT04542070|363978181|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
105540375|NCT04542070|363978182|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
105540376|NCT04542070|363978179|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
105540377|NCT04542070|363978180|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
105540378|NCT04542070|363978181|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
105540379|NCT04542070|363978182|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
105540380|NCT04542070|363978179|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
105540381|NCT04542070|363978180|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
105540382|NCT04542070|363978181|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
105540383|NCT04542070|363978182|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
105540384|NCT03511560|363978183|FG000|Overall Study|Death|0|||
105540385|NCT03511560|363978184|FG001|Overall Study|Death|1|||
105540386|NCT03511560|363978183|FG000|Overall Study|Adverse Event|0|||
105540387|NCT03511560|363978184|FG001|Overall Study|Adverse Event|2|||
105540388|NCT03511560|363978183|FG000|Overall Study|Transplant cancelled|0|||
105540389|NCT03511560|363978184|FG001|Overall Study|Transplant cancelled|1|||
105540390|NCT03511560|363978183|FG000|Overall Study|Patient switched to another drug|1|||
105540391|NCT03511560|363978184|FG001|Overall Study|Patient switched to another drug|0|||
105540392|NCT03049813|363978185|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
105540393|NCT03049813|363978186|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
105540394|NCT03049813|363978187|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
105540395|NCT03049813|363978188|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
105540396|NCT03049813|363978185|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
105540397|NCT03049813|363978186|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
105540398|NCT03049813|363978187|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
105540399|NCT03049813|363978188|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
105540400|NCT03049813|363978185|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
105540401|NCT03049813|363978186|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
105540402|NCT03049813|363978187|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
105540403|NCT03049813|363978188|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
105540404|NCT03049813|363978185|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
105540405|NCT03049813|363978186|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
105540406|NCT03049813|363978187|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
105540407|NCT03049813|363978188|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
105540408|NCT00550836|363978189|FG000|Overall Study|Withdrawal by Subject|3|||
105540409|NCT00550836|363978190|FG001|Overall Study|Withdrawal by Subject|9|||
105540410|NCT02127307|363978195|FG000|Overall Study|Protocol Violation|36|||
105540411|NCT02127307|363978195|FG000|Overall Study|Lost to Follow-up|2|||
105540412|NCT02127307|363978195|FG000|Overall Study|Death|101|||
105595869|NCT00430300|364182450|FG000|Overall Study|Adverse Event|0|||
105595870|NCT00430300|364182451|FG001|Overall Study|Adverse Event|2|||
105595871|NCT00430300|364182452|FG002|Overall Study|Adverse Event|1|||
105595872|NCT00430300|364182453|FG003|Overall Study|Adverse Event|1|||
105595873|NCT00430300|364182450|FG000|Overall Study|Withdrawal by Subject|1|||
105540413|NCT02127307|363978195|FG000|Overall Study|Other than specified above|169|||
105540414|NCT00235989|363978202|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
105540415|NCT00235989|363978203|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
105595874|NCT00430300|364182451|FG001|Overall Study|Withdrawal by Subject|0|||
105595875|NCT00430300|364182452|FG002|Overall Study|Withdrawal by Subject|5|||
105540416|NCT00235989|363978204|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
105540417|NCT00235989|363978205|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
105540418|NCT00235989|363978206|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
105540419|NCT00235989|363978207|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
105540420|NCT00235989|363978202|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
105540421|NCT00235989|363978203|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
105540422|NCT00235989|363978204|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
105540423|NCT00235989|363978205|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
105540424|NCT00235989|363978206|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
105540425|NCT00235989|363978207|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
105540426|NCT00235989|363978202|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
105540427|NCT00235989|363978203|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
105540428|NCT00235989|363978204|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
105540429|NCT00235989|363978205|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
105540430|NCT00235989|363978206|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
105540431|NCT00235989|363978207|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
105540432|NCT00235989|363978202|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
105540433|NCT00235989|363978203|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
105540434|NCT00235989|363978204|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
105540435|NCT00235989|363978205|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
105540436|NCT00235989|363978206|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
105540437|NCT00235989|363978207|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
105540438|NCT00235989|363978202|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
105540439|NCT00235989|363978203|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
105540440|NCT00235989|363978204|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
105540441|NCT00235989|363978205|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
105540442|NCT00235989|363978206|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
105540443|NCT00235989|363978207|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
105540444|NCT02742103|363980392|FG000|Overall Study|Protocol Violation|1|||
105540445|NCT02742103|363980393|FG001|Overall Study|Protocol Violation|0|||
105540446|NCT02742103|363980392|FG000|Overall Study|Death|2|||
105540447|NCT02742103|363980393|FG001|Overall Study|Death|2|||
105540448|NCT02742103|363980392|FG000|Overall Study|Adverse Event|1|||
105540449|NCT02742103|363980393|FG001|Overall Study|Adverse Event|0|||
105540450|NCT02742103|363980392|FG000|Overall Study|Moved to another town|0|||
105540451|NCT02742103|363980393|FG001|Overall Study|Moved to another town|1|||
105540452|NCT02742103|363980392|FG000|Overall Study|Withdrawal by Subject|5|||
105540453|NCT02742103|363980393|FG001|Overall Study|Withdrawal by Subject|2|||
105540454|NCT01709318|363980394|FG000|Overall Study|Adverse Event|3|||
105540455|NCT01709318|363980395|FG001|Overall Study|Adverse Event|4|||
105540456|NCT01709318|363980396|FG002|Overall Study|Adverse Event|2|||
105540457|NCT01709318|363980397|FG003|Overall Study|Adverse Event|2|||
105540458|NCT01709318|363980398|FG004|Overall Study|Adverse Event|0|||
105540459|NCT01709318|363980399|FG005|Overall Study|Adverse Event|1|||
105540460|NCT01709318|363980400|FG006|Overall Study|Adverse Event|2|||
105540461|NCT01709318|363980394|FG000|Overall Study|Lost to Follow-up|2|||
105540462|NCT01709318|363980395|FG001|Overall Study|Lost to Follow-up|0|||
105540463|NCT01709318|363980396|FG002|Overall Study|Lost to Follow-up|0|||
105540464|NCT01709318|363980397|FG003|Overall Study|Lost to Follow-up|0|||
105540465|NCT01709318|363980398|FG004|Overall Study|Lost to Follow-up|1|||
105540466|NCT01709318|363980399|FG005|Overall Study|Lost to Follow-up|1|||
105540467|NCT01709318|363980400|FG006|Overall Study|Lost to Follow-up|1|||
105540468|NCT01709318|363980394|FG000|Overall Study|Non-compliance with Study Drug|0|||
105540469|NCT01709318|363980395|FG001|Overall Study|Non-compliance with Study Drug|2|||
105540470|NCT01709318|363980396|FG002|Overall Study|Non-compliance with Study Drug|1|||
105540471|NCT01709318|363980397|FG003|Overall Study|Non-compliance with Study Drug|1|||
105540472|NCT01709318|363980398|FG004|Overall Study|Non-compliance with Study Drug|0|||
105540473|NCT01709318|363980399|FG005|Overall Study|Non-compliance with Study Drug|0|||
105540474|NCT01709318|363980400|FG006|Overall Study|Non-compliance with Study Drug|2|||
105540475|NCT01709318|363980394|FG000|Overall Study|Physician Decision|0|||
105540476|NCT01709318|363980395|FG001|Overall Study|Physician Decision|0|||
105540477|NCT01709318|363980396|FG002|Overall Study|Physician Decision|0|||
105540478|NCT01709318|363980397|FG003|Overall Study|Physician Decision|0|||
105540479|NCT01709318|363980398|FG004|Overall Study|Physician Decision|0|||
105540480|NCT01709318|363980399|FG005|Overall Study|Physician Decision|0|||
105540481|NCT01709318|363980400|FG006|Overall Study|Physician Decision|1|||
105540482|NCT01709318|363980394|FG000|Overall Study|Pregnancy|0|||
105540483|NCT01709318|363980395|FG001|Overall Study|Pregnancy|0|||
105540484|NCT01709318|363980396|FG002|Overall Study|Pregnancy|0|||
105540485|NCT01709318|363980397|FG003|Overall Study|Pregnancy|0|||
105595876|NCT00430300|364182453|FG003|Overall Study|Withdrawal by Subject|0|||
105540486|NCT01709318|363980398|FG004|Overall Study|Pregnancy|1|||
105540487|NCT01709318|363980399|FG005|Overall Study|Pregnancy|0|||
105540488|NCT01709318|363980400|FG006|Overall Study|Pregnancy|0|||
105540489|NCT01709318|363980394|FG000|Overall Study|Protocol Violation|0|||
105540490|NCT01709318|363980395|FG001|Overall Study|Protocol Violation|0|||
105540491|NCT01709318|363980396|FG002|Overall Study|Protocol Violation|0|||
105540492|NCT01709318|363980397|FG003|Overall Study|Protocol Violation|0|||
105540493|NCT01709318|363980398|FG004|Overall Study|Protocol Violation|2|||
105540494|NCT01709318|363980399|FG005|Overall Study|Protocol Violation|0|||
105540495|NCT01709318|363980400|FG006|Overall Study|Protocol Violation|1|||
105540496|NCT01709318|363980394|FG000|Overall Study|Technical Problems|1|||
105540497|NCT01709318|363980395|FG001|Overall Study|Technical Problems|0|||
105540498|NCT01709318|363980396|FG002|Overall Study|Technical Problems|0|||
105540499|NCT01709318|363980397|FG003|Overall Study|Technical Problems|0|||
105540500|NCT01709318|363980398|FG004|Overall Study|Technical Problems|0|||
105540501|NCT01709318|363980399|FG005|Overall Study|Technical Problems|0|||
105540502|NCT01709318|363980400|FG006|Overall Study|Technical Problems|0|||
105540503|NCT01709318|363980394|FG000|Overall Study|Withdrawal by Subject|3|||
105540504|NCT01709318|363980395|FG001|Overall Study|Withdrawal by Subject|0|||
105540505|NCT01709318|363980396|FG002|Overall Study|Withdrawal by Subject|3|||
105540506|NCT01709318|363980397|FG003|Overall Study|Withdrawal by Subject|3|||
105540507|NCT01709318|363980398|FG004|Overall Study|Withdrawal by Subject|0|||
105540508|NCT01709318|363980399|FG005|Overall Study|Withdrawal by Subject|2|||
105540509|NCT01709318|363980400|FG006|Overall Study|Withdrawal by Subject|4|||
105540510|NCT01709318|363980394|FG000|Overall Study|Other Protocol Specified Criteria|0|||
105540511|NCT01709318|363980395|FG001|Overall Study|Other Protocol Specified Criteria|1|||
105540512|NCT01709318|363980396|FG002|Overall Study|Other Protocol Specified Criteria|0|||
105540513|NCT01709318|363980397|FG003|Overall Study|Other Protocol Specified Criteria|0|||
105540514|NCT01709318|363980398|FG004|Overall Study|Other Protocol Specified Criteria|0|||
105540515|NCT01709318|363980399|FG005|Overall Study|Other Protocol Specified Criteria|0|||
105540516|NCT01709318|363980400|FG006|Overall Study|Other Protocol Specified Criteria|0|||
105540517|NCT03143829|363980405|FG000|Overall Study|Withdrawal by Subject|2|||
105540518|NCT03143829|363980406|FG001|Overall Study|Withdrawal by Subject|5|||
105540519|NCT03143829|363980405|FG000|Overall Study|Lost to Follow-up|0|||
105540520|NCT03143829|363980406|FG001|Overall Study|Lost to Follow-up|2|||
105540521|NCT03143829|363980405|FG000|Overall Study|Death|1|||
105540522|NCT03143829|363980406|FG001|Overall Study|Death|1|||
105540523|NCT03143829|363980405|FG000|Overall Study|changed treatment, no longer eligible|2|||
105540524|NCT03143829|363980406|FG001|Overall Study|changed treatment, no longer eligible|2|||
105540525|NCT00672477|363980409|FG000|Overall Study|Adverse Event|10|||
105540526|NCT00672477|363980410|FG001|Overall Study|Adverse Event|7|||
105540527|NCT00672477|363980409|FG000|Overall Study|Death|7|||
105540528|NCT00672477|363980410|FG001|Overall Study|Death|11|||
105540529|NCT00672477|363980409|FG000|Overall Study|Physician Decision|2|||
105540530|NCT00672477|363980410|FG001|Overall Study|Physician Decision|0|||
105540531|NCT00672477|363980409|FG000|Overall Study|Protocol Violation|1|||
105540532|NCT00672477|363980410|FG001|Overall Study|Protocol Violation|1|||
105540533|NCT00672477|363980409|FG000|Overall Study|Withdrawal by Subject|5|||
105540534|NCT00672477|363980410|FG001|Overall Study|Withdrawal by Subject|3|||
105540535|NCT00672477|363980409|FG000|Overall Study|Lack of Efficacy|1|||
105540536|NCT00672477|363980410|FG001|Overall Study|Lack of Efficacy|1|||
105540537|NCT00672477|363980409|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
105540538|NCT00672477|363980410|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
105540539|NCT02391948|363980411|FG000|6-month Assessment|Death|0|||
105540540|NCT02391948|363980412|FG001|6-month Assessment|Death|0|||
105540541|NCT02391948|363980413|FG002|6-month Assessment|Death|0|||
105540542|NCT02391948|363980414|FG003|6-month Assessment|Death|0|||
105540543|NCT02391948|363980415|FG004|6-month Assessment|Death|1|||
105540544|NCT02391948|363980411|FG000|6-month Assessment|Withdrawal by Subject|0|||
105540545|NCT02391948|363980412|FG001|6-month Assessment|Withdrawal by Subject|0|||
105540546|NCT02391948|363980413|FG002|6-month Assessment|Withdrawal by Subject|1|||
105540547|NCT02391948|363980414|FG003|6-month Assessment|Withdrawal by Subject|2|||
105540548|NCT02391948|363980415|FG004|6-month Assessment|Withdrawal by Subject|0|||
105540549|NCT02391948|363980411|FG000|6-month Assessment|Lost to Follow-up|4|||
105540550|NCT02391948|363980412|FG001|6-month Assessment|Lost to Follow-up|5|||
105540551|NCT02391948|363980413|FG002|6-month Assessment|Lost to Follow-up|2|||
105540552|NCT02391948|363980414|FG003|6-month Assessment|Lost to Follow-up|3|||
105540553|NCT02391948|363980415|FG004|6-month Assessment|Lost to Follow-up|1|||
105540554|NCT02391948|363980411|FG000|6-month Assessment|Medical issue/illness|1|||
105540555|NCT02391948|363980412|FG001|6-month Assessment|Medical issue/illness|1|||
105540556|NCT02391948|363980413|FG002|6-month Assessment|Medical issue/illness|0|||
105540557|NCT02391948|363980414|FG003|6-month Assessment|Medical issue/illness|0|||
105540558|NCT02391948|363980415|FG004|6-month Assessment|Medical issue/illness|0|||
105540559|NCT02391948|363980411|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
105540560|NCT02391948|363980412|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
105540561|NCT02391948|363980413|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
105540562|NCT02391948|363980414|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
105540563|NCT02391948|363980415|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
105540564|NCT02391948|363980411|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
105540565|NCT02391948|363980412|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
105540566|NCT02391948|363980413|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
105540567|NCT02391948|363980414|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
105540568|NCT02391948|363980415|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
105540569|NCT02391948|363980411|FG000|12-month Assessment|Death|0|||
105540570|NCT02391948|363980412|FG001|12-month Assessment|Death|0|||
105540571|NCT02391948|363980413|FG002|12-month Assessment|Death|0|||
105540572|NCT02391948|363980414|FG003|12-month Assessment|Death|1|||
105540573|NCT02391948|363980415|FG004|12-month Assessment|Death|0|||
105540574|NCT02391948|363980411|FG000|12-month Assessment|Withdrawal by Subject|1|||
105540575|NCT02391948|363980412|FG001|12-month Assessment|Withdrawal by Subject|0|||
105540576|NCT02391948|363980413|FG002|12-month Assessment|Withdrawal by Subject|0|||
105540577|NCT02391948|363980414|FG003|12-month Assessment|Withdrawal by Subject|1|||
105540578|NCT02391948|363980415|FG004|12-month Assessment|Withdrawal by Subject|0|||
105540579|NCT02391948|363980411|FG000|12-month Assessment|Lost to Follow-up|5|||
105540580|NCT02391948|363980412|FG001|12-month Assessment|Lost to Follow-up|4|||
105540581|NCT02391948|363980413|FG002|12-month Assessment|Lost to Follow-up|4|||
105540582|NCT02391948|363980414|FG003|12-month Assessment|Lost to Follow-up|4|||
105540583|NCT02391948|363980415|FG004|12-month Assessment|Lost to Follow-up|5|||
105540584|NCT02391948|363980411|FG000|12-month Assessment|Medical issue/illness|0|||
105540585|NCT02391948|363980412|FG001|12-month Assessment|Medical issue/illness|1|||
105540586|NCT02391948|363980413|FG002|12-month Assessment|Medical issue/illness|0|||
105540587|NCT02391948|363980414|FG003|12-month Assessment|Medical issue/illness|1|||
105540588|NCT02391948|363980415|FG004|12-month Assessment|Medical issue/illness|0|||
105540589|NCT02391948|363980411|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
105540590|NCT02391948|363980412|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
105540591|NCT02391948|363980413|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
105540592|NCT02391948|363980414|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
105540593|NCT02391948|363980415|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
105540594|NCT02391948|363980411|FG000|18-month Assessment|Death|0|||
105540595|NCT02391948|363980412|FG001|18-month Assessment|Death|0|||
105540596|NCT02391948|363980413|FG002|18-month Assessment|Death|0|||
105540597|NCT02391948|363980414|FG003|18-month Assessment|Death|1|||
105540598|NCT02391948|363980415|FG004|18-month Assessment|Death|1|||
105540599|NCT02391948|363980411|FG000|18-month Assessment|Withdrawal by Subject|1|||
105540600|NCT02391948|363980412|FG001|18-month Assessment|Withdrawal by Subject|0|||
105540601|NCT02391948|363980413|FG002|18-month Assessment|Withdrawal by Subject|0|||
105540602|NCT02391948|363980414|FG003|18-month Assessment|Withdrawal by Subject|1|||
105540603|NCT02391948|363980415|FG004|18-month Assessment|Withdrawal by Subject|0|||
105540604|NCT02391948|363980411|FG000|18-month Assessment|Lost to Follow-up|2|||
105540605|NCT02391948|363980412|FG001|18-month Assessment|Lost to Follow-up|6|||
105540606|NCT02391948|363980413|FG002|18-month Assessment|Lost to Follow-up|2|||
105540607|NCT02391948|363980414|FG003|18-month Assessment|Lost to Follow-up|2|||
105540608|NCT02391948|363980415|FG004|18-month Assessment|Lost to Follow-up|3|||
105540609|NCT02391948|363980411|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
105540610|NCT02391948|363980412|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
105540611|NCT02391948|363980413|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
105540612|NCT02391948|363980414|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
105540613|NCT02391948|363980415|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
105540614|NCT02391948|363980411|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
105540615|NCT02391948|363980412|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
105540616|NCT02391948|363980413|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
105540617|NCT02391948|363980414|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
105540618|NCT02391948|363980415|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
105540619|NCT02391948|363980411|FG000|24-month Assessment|Death|0|||
105540620|NCT02391948|363980412|FG001|24-month Assessment|Death|0|||
105540621|NCT02391948|363980413|FG002|24-month Assessment|Death|0|||
105540622|NCT02391948|363980414|FG003|24-month Assessment|Death|0|||
105540623|NCT02391948|363980415|FG004|24-month Assessment|Death|1|||
105540624|NCT02391948|363980411|FG000|24-month Assessment|Withdrawal by Subject|1|||
105540625|NCT02391948|363980412|FG001|24-month Assessment|Withdrawal by Subject|1|||
105540626|NCT02391948|363980413|FG002|24-month Assessment|Withdrawal by Subject|0|||
105540627|NCT02391948|363980414|FG003|24-month Assessment|Withdrawal by Subject|0|||
105540628|NCT02391948|363980415|FG004|24-month Assessment|Withdrawal by Subject|1|||
105540629|NCT02391948|363980411|FG000|24-month Assessment|Lost to Follow-up|5|||
105540630|NCT02391948|363980412|FG001|24-month Assessment|Lost to Follow-up|4|||
105540631|NCT02391948|363980413|FG002|24-month Assessment|Lost to Follow-up|0|||
105540632|NCT02391948|363980414|FG003|24-month Assessment|Lost to Follow-up|0|||
105540633|NCT02391948|363980415|FG004|24-month Assessment|Lost to Follow-up|0|||
105540634|NCT02391948|363980411|FG000|24-month Assessment|Medical issue/illness|0|||
105540635|NCT02391948|363980412|FG001|24-month Assessment|Medical issue/illness|0|||
105540636|NCT02391948|363980413|FG002|24-month Assessment|Medical issue/illness|1|||
105540637|NCT02391948|363980414|FG003|24-month Assessment|Medical issue/illness|0|||
105540638|NCT02391948|363980415|FG004|24-month Assessment|Medical issue/illness|0|||
105540639|NCT02391948|363980411|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
105540640|NCT02391948|363980412|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
105540641|NCT02391948|363980413|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
105540642|NCT02391948|363980414|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
105540643|NCT02391948|363980415|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
105540644|NCT00023673|363980416|FG000|Overall Study|Ineligible / no protocol treatment|0|||
105540645|NCT00023673|363980417|FG001|Overall Study|Ineligible / no protocol treatment|0|||
105540646|NCT00023673|363980418|FG002|Overall Study|Ineligible / no protocol treatment|0|||
105540647|NCT00023673|363980419|FG003|Overall Study|Ineligible / no protocol treatment|1|||
105540648|NCT00023673|363980416|FG000|Overall Study|Patient withdrew consent|0|||
105540649|NCT00023673|363980417|FG001|Overall Study|Patient withdrew consent|0|||
105540650|NCT00023673|363980418|FG002|Overall Study|Patient withdrew consent|0|||
105540651|NCT00023673|363980419|FG003|Overall Study|Patient withdrew consent|1|||
105540652|NCT02453594|363980420|FG000|Overall Study|Protocol Violation|0|||
105540653|NCT02453594|363980421|FG001|Overall Study|Protocol Violation|0|||
105540654|NCT02453594|363980422|FG002|Overall Study|Protocol Violation|1|||
105540655|NCT02453594|363980420|FG000|Overall Study|Cohort Was Closed|17|||
105540656|NCT02453594|363980421|FG001|Overall Study|Cohort Was Closed|21|||
105540657|NCT02453594|363980422|FG002|Overall Study|Cohort Was Closed|14|||
105540658|NCT02453594|363980420|FG000|Overall Study|Death|20|||
105540659|NCT02453594|363980421|FG001|Overall Study|Death|24|||
105540660|NCT02453594|363980422|FG002|Overall Study|Death|16|||
105540661|NCT02453594|363980420|FG000|Overall Study|Lost to Follow-up|6|||
105540662|NCT02453594|363980421|FG001|Overall Study|Lost to Follow-up|14|||
105540663|NCT02453594|363980422|FG002|Overall Study|Lost to Follow-up|2|||
105540664|NCT02453594|363980420|FG000|Overall Study|Physician Decision|2|||
105540665|NCT02453594|363980421|FG001|Overall Study|Physician Decision|4|||
105540666|NCT02453594|363980422|FG002|Overall Study|Physician Decision|0|||
105540667|NCT02453594|363980420|FG000|Overall Study|Site Terminated by Sponsor|1|||
105540668|NCT02453594|363980421|FG001|Overall Study|Site Terminated by Sponsor|0|||
105540669|NCT02453594|363980422|FG002|Overall Study|Site Terminated by Sponsor|1|||
105540670|NCT02453594|363980420|FG000|Overall Study|Transitioned to Extension Study|16|||
105540671|NCT02453594|363980421|FG001|Overall Study|Transitioned to Extension Study|9|||
105540672|NCT02453594|363980422|FG002|Overall Study|Transitioned to Extension Study|16|||
105540673|NCT02453594|363980420|FG000|Overall Study|Withdrawal by Subject|7|||
105540674|NCT02453594|363980421|FG001|Overall Study|Withdrawal by Subject|9|||
105540675|NCT02453594|363980422|FG002|Overall Study|Withdrawal by Subject|11|||
105540676|NCT01257204|363980437|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
105540677|NCT01257204|363980438|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
105540678|NCT01257204|363980439|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
105540679|NCT01257204|363980437|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
105540680|NCT01257204|363980438|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
105540681|NCT01257204|363980439|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
105540682|NCT01257204|363980437|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
105540683|NCT01257204|363980438|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
105540684|NCT01257204|363980439|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
105540685|NCT01257204|363980437|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
105540686|NCT01257204|363980438|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
105540687|NCT01257204|363980439|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
105540688|NCT01257204|363980437|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
105540689|NCT01257204|363980438|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
105540690|NCT01257204|363980439|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
105540691|NCT01257204|363980437|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
105540692|NCT01257204|363980438|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
105540693|NCT01257204|363980439|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
105540694|NCT01257204|363980437|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
105540695|NCT01257204|363980438|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
105540696|NCT01257204|363980439|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
105540697|NCT01257204|363980437|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
105540698|NCT01257204|363980438|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
105595877|NCT00430300|364182450|FG000|Overall Study|Laboratory abnormality|1|||
105540699|NCT01257204|363980439|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
105540700|NCT01257204|363980437|FG000|Follow-up Period (up to Week 48)|Other|0|||
105540701|NCT01257204|363980438|FG001|Follow-up Period (up to Week 48)|Other|0|||
105540702|NCT01257204|363980439|FG002|Follow-up Period (up to Week 48)|Other|5|||
105595878|NCT00430300|364182451|FG001|Overall Study|Laboratory abnormality|0|||
105540703|NCT03394391|363980441|FG000|Overall Study|Lost to Follow-up|1|||
105540704|NCT03394391|363980442|FG001|Overall Study|Lost to Follow-up|2|||
105540705|NCT00120042|363980447|FG000|Overall Study|all completed protocl|0|||
105540706|NCT00120042|363980448|FG001|Overall Study|all completed protocl|0|||
105540707|NCT00120042|363980449|FG002|Overall Study|all completed protocl|0|||
105540708|NCT04532112|363980450|FG000|Overall Study|Adverse Event|3|||
105540709|NCT04532112|363980451|FG001|Overall Study|Adverse Event|0|||
105540710|NCT02809976|363980454|FG000|Overall Study|Lost to Follow-up|1|||
105540711|NCT02809976|363980454|FG000|Overall Study|Withdrawal by Subject|1|||
105540712|NCT02732847|363980455|FG000|Overall Study|some filled early|42|||
105540713|NCT02732847|363980456|FG001|Overall Study|some filled early|42|||
105540714|NCT04574362|363980457|FG000|Overall Study|Other|0|||
105540715|NCT04574362|363980458|FG001|Overall Study|Other|5|||
105540716|NCT04574362|363980457|FG000|Overall Study|COVID-19|0|||
105540717|NCT04574362|363980458|FG001|Overall Study|COVID-19|1|||
105540718|NCT04574362|363980457|FG000|Overall Study|Adverse Event|1|||
105540719|NCT04574362|363980458|FG001|Overall Study|Adverse Event|1|||
105540720|NCT04574362|363980457|FG000|Overall Study|Withdrawal by Subject|2|||
105540721|NCT04574362|363980458|FG001|Overall Study|Withdrawal by Subject|4|||
105540722|NCT04574362|363980457|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
105540723|NCT04574362|363980458|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
105540724|NCT04574362|363980457|FG000|Overall Study|Participant refused to come to the hospital|1|||
105540725|NCT04574362|363980458|FG001|Overall Study|Participant refused to come to the hospital|0|||
105540726|NCT04574362|363980457|FG000|Overall Study|Participant refused the visit|1|||
105540727|NCT04574362|363980458|FG001|Overall Study|Participant refused the visit|0|||
105540728|NCT04574362|363980457|FG000|Overall Study|Participant quit early because of business trip|1|||
105540729|NCT04574362|363980458|FG001|Overall Study|Participant quit early because of business trip|0|||
105540730|NCT01859715|363980461|FG000|Overall Study|No 2nd VAS|16|||
105540731|NCT01859715|363980462|FG001|Overall Study|No 2nd VAS|8|||
105540732|NCT01859715|363980463|FG002|Overall Study|No 2nd VAS|23|||
105540733|NCT03795922|363980466|FG000|Overall Study|Adverse Event|2|||
105540734|NCT03795922|363980467|FG001|Overall Study|Adverse Event|1|||
105540735|NCT03795922|363980466|FG000|Overall Study|Withdrawal by Subject|5|||
105540736|NCT03795922|363980467|FG001|Overall Study|Withdrawal by Subject|13|||
105540737|NCT03795922|363980466|FG000|Overall Study|Lost to Follow-up|2|||
105540738|NCT03795922|363980467|FG001|Overall Study|Lost to Follow-up|3|||
105540739|NCT03795922|363980466|FG000|Overall Study|Pregnancy|0|||
105540740|NCT03795922|363980467|FG001|Overall Study|Pregnancy|1|||
105540741|NCT03795922|363980466|FG000|Overall Study|Physician Decision|1|||
105540742|NCT03795922|363980467|FG001|Overall Study|Physician Decision|2|||
105540743|NCT03795922|363980466|FG000|Overall Study|Protocol Violation|0|||
105540744|NCT03795922|363980467|FG001|Overall Study|Protocol Violation|1|||
105540745|NCT03795922|363980466|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
105540746|NCT03795922|363980467|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
105540747|NCT03056690|363980468|FG000|Overall Study|Adverse Event|3|||
105540748|NCT03056690|363980469|FG001|Overall Study|Adverse Event|2|||
105540749|NCT03056690|363980468|FG000|Overall Study|Lack of Efficacy|1|||
105540750|NCT03056690|363980469|FG001|Overall Study|Lack of Efficacy|2|||
105540751|NCT03056690|363980468|FG000|Overall Study|Lost to Follow-up|3|||
105540752|NCT03056690|363980469|FG001|Overall Study|Lost to Follow-up|2|||
105540753|NCT03056690|363980468|FG000|Overall Study|Protocol Violation|2|||
105540754|NCT03056690|363980469|FG001|Overall Study|Protocol Violation|2|||
105540755|NCT03056690|363980468|FG000|Overall Study|Withdrawal by Subject|3|||
105540756|NCT03056690|363980469|FG001|Overall Study|Withdrawal by Subject|6|||
105540757|NCT03056690|363980468|FG000|Overall Study|Non-compliance with Study Drug|1|||
105540758|NCT03056690|363980469|FG001|Overall Study|Non-compliance with Study Drug|0|||
105540759|NCT03056690|363980468|FG000|Overall Study|Miscellaneous|1|||
105540760|NCT03056690|363980469|FG001|Overall Study|Miscellaneous|2|||
105540761|NCT02052739|363980470|FG000|Overall Study|Withdrew due to Adverse Event|3|||
105540762|NCT02052739|363980471|FG001|Overall Study|Withdrew due to Adverse Event|0|||
105540763|NCT02052739|363980470|FG000|Overall Study|Participant Died|2|||
105540764|NCT02052739|363980471|FG001|Overall Study|Participant Died|1|||
105540765|NCT02985736|363980476|FG000|Overall Study|Lost to Follow-up|3|||
105540766|NCT00382733|363980477|FG000|Overall Study|Withdrawal by Subject|0|||
105540767|NCT00382733|363980478|FG001|Overall Study|Withdrawal by Subject|1|||
105540768|NCT00382733|363980479|FG002|Overall Study|Withdrawal by Subject|0|||
105540769|NCT00382733|363980480|FG003|Overall Study|Withdrawal by Subject|0|||
105540770|NCT00382733|363980481|FG004|Overall Study|Withdrawal by Subject|0|||
105540771|NCT00179413|363980482|FG000|Overall Study|Adverse Event|38|||
105540772|NCT00179413|363980483|FG001|Overall Study|Adverse Event|20|||
105540773|NCT00179413|363980482|FG000|Overall Study|Withdrawal by Subject|87|||
105540774|NCT00179413|363980483|FG001|Overall Study|Withdrawal by Subject|95|||
105540775|NCT01813019|363980485|FG000|Overall Study|Adverse Event|0|||
105540776|NCT01813019|363980486|FG001|Overall Study|Adverse Event|3|||
105540777|NCT01813019|363980485|FG000|Overall Study|Withdrawal by Subject|3|||
105540778|NCT01813019|363980486|FG001|Overall Study|Withdrawal by Subject|2|||
105540779|NCT01813019|363980485|FG000|Overall Study|administrative problems|2|||
105540780|NCT01813019|363980486|FG001|Overall Study|administrative problems|0|||
105540781|NCT01813019|363980485|FG000|Overall Study|Protocol Deviation|2|||
105540782|NCT01813019|363980486|FG001|Overall Study|Protocol Deviation|1|||
105540783|NCT00439140|363980488|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
105540784|NCT00439140|363980489|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
105540785|NCT00439140|363980490|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
105540786|NCT00439140|363980488|FG000|Treatment Cycle 1|Personal reasons|0|||
105540787|NCT00439140|363980489|FG001|Treatment Cycle 1|Personal reasons|2|||
105540788|NCT00439140|363980490|FG002|Treatment Cycle 1|Personal reasons|0|||
105540789|NCT00439140|363980488|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
105540790|NCT00439140|363980489|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
105540791|NCT00439140|363980490|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
105540792|NCT00439140|363980488|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
105540793|NCT00439140|363980489|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
105540794|NCT00439140|363980490|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
105540795|NCT00439140|363980488|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
105540796|NCT00439140|363980489|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
105540797|NCT00439140|363980490|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
105540798|NCT01723904|363980491|FG000|Overall Study|Noncompliant|3|||
105540799|NCT01723904|363980491|FG000|Overall Study|Adverse Event|5|||
105540800|NCT01723904|363980491|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
105540801|NCT01458171|363980494|FG000|Overall Study|Adverse Event|1|||
105540802|NCT01193556|363980495|FG000|Overall Study|Study termination|26|||
105540803|NCT01193556|363980496|FG001|Overall Study|Study termination|25|||
105540804|NCT03169153|363980497|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
105540805|NCT03169153|363980498|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
105540806|NCT03169153|363980497|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
105540807|NCT03169153|363980498|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
105540808|NCT03169153|363980497|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
105540809|NCT03169153|363980498|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
105540810|NCT03169153|363980497|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
105540811|NCT03169153|363980498|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
105540812|NCT02617589|363980499|FG000|Randomization|Request to Discontinue Study Treatment|1|||
105540813|NCT02617589|363980500|FG001|Randomization|Request to Discontinue Study Treatment|3|||
105540814|NCT02617589|363980499|FG000|Randomization|Participant Withdrew Consent|1|||
105540815|NCT02617589|363980500|FG001|Randomization|Participant Withdrew Consent|2|||
105540816|NCT02617589|363980499|FG000|Treatment|Other Reasons|3|||
105540817|NCT02617589|363980500|FG001|Treatment|Other Reasons|3|||
105540818|NCT02617589|363980499|FG000|Treatment|Poor/Non Compliance|1|||
105540819|NCT02617589|363980500|FG001|Treatment|Poor/Non Compliance|1|||
105540820|NCT02617589|363980499|FG000|Treatment|Maximum Clinical Benefit|0|||
105540821|NCT02617589|363980500|FG001|Treatment|Maximum Clinical Benefit|2|||
105540822|NCT02617589|363980499|FG000|Treatment|Participant Withdrew Consent|2|||
105540823|NCT02617589|363980500|FG001|Treatment|Participant Withdrew Consent|6|||
105540824|NCT02617589|363980499|FG000|Treatment|Participant Request to Discontinue|12|||
105540825|NCT02617589|363980500|FG001|Treatment|Participant Request to Discontinue|21|||
105540826|NCT02617589|363980499|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
105540827|NCT02617589|363980500|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
105540828|NCT02617589|363980499|FG000|Treatment|Death|1|||
105540829|NCT02617589|363980500|FG001|Treatment|Death|1|||
105540830|NCT02617589|363980499|FG000|Treatment|Study Drug Toxicity|27|||
105540831|NCT02617589|363980500|FG001|Treatment|Study Drug Toxicity|20|||
105540832|NCT02617589|363980499|FG000|Treatment|Disease Progression|216|||
105540833|NCT02617589|363980500|FG001|Treatment|Disease Progression|136|||
105540834|NCT01696032|363980501|FG000|Overall Study|Withdrawal by Subject|0|||
105540835|NCT01696032|363980502|FG001|Overall Study|Withdrawal by Subject|0|||
105540836|NCT01696032|363980503|FG002|Overall Study|Withdrawal by Subject|1|||
105540837|NCT01696032|363980504|FG003|Overall Study|Withdrawal by Subject|2|||
105540838|NCT01696032|363980501|FG000|Overall Study|Death|14|||
105540839|NCT01696032|363980502|FG001|Overall Study|Death|4|||
105540840|NCT01696032|363980503|FG002|Overall Study|Death|43|||
105540841|NCT01696032|363980504|FG003|Overall Study|Death|18|||
105540842|NCT01696032|363980501|FG000|Overall Study|Lost to Follow-up|0|||
105540843|NCT01696032|363980502|FG001|Overall Study|Lost to Follow-up|1|||
105540844|NCT01696032|363980503|FG002|Overall Study|Lost to Follow-up|0|||
105540845|NCT01696032|363980504|FG003|Overall Study|Lost to Follow-up|0|||
105540846|NCT01696032|363980501|FG000|Overall Study|Database lock|0|||
105540847|NCT01696032|363980502|FG001|Overall Study|Database lock|1|||
105540848|NCT01696032|363980503|FG002|Overall Study|Database lock|7|||
105540849|NCT01696032|363980504|FG003|Overall Study|Database lock|2|||
105540850|NCT00578565|363980507|FG000|Overall Study|Adverse Event|3|||
105540851|NCT01752933|363980508|FG000|Treatment|Disease Progression|3|||
105540852|NCT01752933|363980509|FG001|Treatment|Disease Progression|29|||
105540853|NCT01752933|363980508|FG000|Treatment|Withdrawal by Subject|0|||
105540854|NCT01752933|363980509|FG001|Treatment|Withdrawal by Subject|5|||
105540855|NCT01752933|363980508|FG000|Treatment|Adverse Event|1|||
105540856|NCT01752933|363980509|FG001|Treatment|Adverse Event|4|||
105540857|NCT01752933|363980508|FG000|Treatment|Physician Decision|0|||
105540858|NCT01752933|363980509|FG001|Treatment|Physician Decision|3|||
105540859|NCT01752933|363980508|FG000|Treatment|Death|0|||
105540860|NCT01752933|363980509|FG001|Treatment|Death|2|||
105540861|NCT01752933|363980508|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
105540862|NCT01752933|363980509|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
105540863|NCT01752933|363980508|FG000|Treatment|Patient noncompliant|0|||
105540864|NCT01752933|363980509|FG001|Treatment|Patient noncompliant|1|||
105540865|NCT01752933|363980508|FG000|Treatment|Patient unable to travel to appointments|0|||
105540866|NCT01752933|363980509|FG001|Treatment|Patient unable to travel to appointments|1|||
105540867|NCT01752933|363980508|FG000|Overall Study and Follow-up|Death|4|||
105540868|NCT01752933|363980509|FG001|Overall Study and Follow-up|Death|34|||
105540869|NCT01752933|363980508|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
105540870|NCT01752933|363980509|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
105540871|NCT01752933|363980508|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
105540872|NCT01752933|363980509|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
105540873|NCT01752933|363980508|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
105540874|NCT01752933|363980509|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
105540875|NCT02203591|363980513|FG000|Overall Study|Did not meet treatment day baseline|147|||
105540876|NCT02203591|363980514|FG001|Overall Study|Did not meet treatment day baseline|141|||
105540877|NCT02203591|363980515|FG002|Overall Study|Did not meet treatment day baseline|150|||
105540878|NCT02203591|363980516|FG003|Overall Study|Did not meet treatment day baseline|45|||
105540879|NCT02203591|363980517|FG004|Overall Study|Did not meet treatment day baseline|33|||
105540880|NCT02203591|363980518|FG005|Overall Study|Did not meet treatment day baseline|35|||
105540881|NCT02203591|363980519|FG006|Overall Study|Did not meet treatment day baseline|29|||
105540882|NCT02203591|363980520|FG007|Overall Study|Did not meet treatment day baseline|12|||
105540883|NCT02203591|363980513|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
105540884|NCT02203591|363980514|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
105540885|NCT02203591|363980515|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
105540886|NCT02203591|363980516|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
105540887|NCT02203591|363980517|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
105540888|NCT02203591|363980518|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
105540889|NCT02203591|363980519|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
105540890|NCT02203591|363980520|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
105540891|NCT04154631|363980521|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
105540892|NCT04154631|363980522|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
105540893|NCT02138214|363980523|FG000|Overall Study|Withdrawal by Subject|0|||
105540894|NCT02138214|363980524|FG001|Overall Study|Withdrawal by Subject|1|||
105540895|NCT02138214|363980525|FG002|Overall Study|Withdrawal by Subject|0|||
105540896|NCT02138214|363980523|FG000|Overall Study|Lost to Follow-up|0|||
105540897|NCT02138214|363980524|FG001|Overall Study|Lost to Follow-up|2|||
105540898|NCT02138214|363980525|FG002|Overall Study|Lost to Follow-up|4|||
105540899|NCT02138214|363980523|FG000|Overall Study|Screen Failure|0|||
105540900|NCT02138214|363980524|FG001|Overall Study|Screen Failure|1|||
105540901|NCT02138214|363980525|FG002|Overall Study|Screen Failure|0|||
105540902|NCT02185768|363980526|FG000|Overall Study|Patients were not treated|2|||
105540903|NCT03027466|363980527|FG000|Overall Study|Opting out of the app|1869|||
105540904|NCT03027466|363980528|FG001|Overall Study|Opting out of the app|1819|||
105540905|NCT03027466|363980529|FG002|Overall Study|Opting out of the app|1743|||
105540906|NCT03027466|363980530|FG003|Overall Study|Opting out of the app|1821|||
105540907|NCT01706250|363980531|FG000|Overall Study|Lost to Follow-up|2|||
105540908|NCT04666259|363980542|FG000|Treatment Phase|Physician Decision|9|||
105540909|NCT04666259|363980543|FG001|Treatment Phase|Physician Decision|3|||
105540910|NCT04666259|363980544|FG002|Treatment Phase|Physician Decision|3|||
105540911|NCT04666259|363980542|FG000|Treatment Phase|Adverse Event|3|||
105540912|NCT04666259|363980543|FG001|Treatment Phase|Adverse Event|1|||
105540913|NCT04666259|363980544|FG002|Treatment Phase|Adverse Event|0|||
105540914|NCT04666259|363980542|FG000|Treatment Phase|Subject decision|1|||
105540915|NCT04666259|363980543|FG001|Treatment Phase|Subject decision|2|||
105540916|NCT04666259|363980544|FG002|Treatment Phase|Subject decision|0|||
105540917|NCT04666259|363980542|FG000|Treatment Phase|Progressive disease|0|||
105540918|NCT04666259|363980543|FG001|Treatment Phase|Progressive disease|1|||
105540919|NCT04666259|363980544|FG002|Treatment Phase|Progressive disease|0|||
105540920|NCT04666259|363980542|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
105540921|NCT04666259|363980543|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
105540922|NCT04666259|363980544|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
105540923|NCT04666259|363980542|FG000|Safety Follow-up Phase|Physician Decision|2|||
105540924|NCT04666259|363980543|FG001|Safety Follow-up Phase|Physician Decision|0|||
105540925|NCT04666259|363980544|FG002|Safety Follow-up Phase|Physician Decision|0|||
105540926|NCT04666259|363980542|FG000|Safety Follow-up Phase|Subject decision|1|||
105540927|NCT04666259|363980543|FG001|Safety Follow-up Phase|Subject decision|0|||
105540928|NCT04666259|363980544|FG002|Safety Follow-up Phase|Subject decision|0|||
105540929|NCT04666259|363980542|FG000|Safety Follow-up Phase|Death|0|||
105540930|NCT04666259|363980543|FG001|Safety Follow-up Phase|Death|1|||
105540931|NCT04666259|363980544|FG002|Safety Follow-up Phase|Death|0|||
105540932|NCT01079234|363980545|FG000|Main: Week 0 to 26|Adverse Event|5|||
105540933|NCT01079234|363980546|FG001|Main: Week 0 to 26|Adverse Event|4|||
105540934|NCT01079234|363980547|FG002|Main: Week 0 to 26|Adverse Event|1|||
105540935|NCT01079234|363980548|FG003|Main: Week 0 to 26|Adverse Event|0|||
105540936|NCT01079234|363980545|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
105540937|NCT01079234|363980546|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
105540938|NCT01079234|363980547|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
105540939|NCT01079234|363980548|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
105540940|NCT01079234|363980545|FG000|Main: Week 0 to 26|Protocol Violation|6|||
105540941|NCT01079234|363980546|FG001|Main: Week 0 to 26|Protocol Violation|2|||
105540942|NCT01079234|363980547|FG002|Main: Week 0 to 26|Protocol Violation|4|||
105540943|NCT01079234|363980548|FG003|Main: Week 0 to 26|Protocol Violation|0|||
105540944|NCT01079234|363980545|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
105540945|NCT01079234|363980546|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
105540946|NCT01079234|363980547|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
105540947|NCT01079234|363980548|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
105540948|NCT01079234|363980545|FG000|Main: Week 0 to 26|Unclassified|7|||
105540949|NCT01079234|363980546|FG001|Main: Week 0 to 26|Unclassified|13|||
105540950|NCT01079234|363980547|FG002|Main: Week 0 to 26|Unclassified|4|||
105540951|NCT01079234|363980548|FG003|Main: Week 0 to 26|Unclassified|0|||
105540952|NCT01079234|363980545|FG000|Extension: Week 27 to 52|Adverse Event|0|||
105540953|NCT01079234|363980546|FG001|Extension: Week 27 to 52|Adverse Event|0|||
105540954|NCT01079234|363980547|FG002|Extension: Week 27 to 52|Adverse Event|1|||
105540955|NCT01079234|363980548|FG003|Extension: Week 27 to 52|Adverse Event|0|||
105540956|NCT01079234|363980545|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
105540957|NCT01079234|363980546|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
105540958|NCT01079234|363980547|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
105540959|NCT01079234|363980548|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
105540960|NCT01079234|363980545|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
105540961|NCT01079234|363980546|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
105540962|NCT01079234|363980547|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
105540963|NCT01079234|363980548|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
105540964|NCT01079234|363980545|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
105540965|NCT01079234|363980546|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
105540966|NCT01079234|363980547|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
105540967|NCT01079234|363980548|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
105540968|NCT01079234|363980545|FG000|Extension: Week 27 to 52|Unclassified|0|||
105540969|NCT01079234|363980546|FG001|Extension: Week 27 to 52|Unclassified|0|||
105540970|NCT01079234|363980547|FG002|Extension: Week 27 to 52|Unclassified|4|||
105540971|NCT01079234|363980548|FG003|Extension: Week 27 to 52|Unclassified|7|||
105540972|NCT04545515|363980549|FG000|Overall Study|Adverse Event|1|||
105540973|NCT04545515|363980549|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
105540974|NCT04545515|363980549|FG000|Overall Study|Commercial drug is available for participant|7|||
105540975|NCT01069289|363980550|FG000|Overall Study|Withdrawal by Subject|15|||
105540976|NCT01069289|363980551|FG001|Overall Study|Withdrawal by Subject|26|||
105540977|NCT01069289|363980550|FG000|Overall Study|Adverse Event|21|||
105540978|NCT01069289|363980551|FG001|Overall Study|Adverse Event|28|||
105540979|NCT01069289|363980550|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
105540980|NCT01069289|363980551|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105540981|NCT01069289|363980550|FG000|Overall Study|Severe non-compliance to protocol|3|||
105540982|NCT01069289|363980551|FG001|Overall Study|Severe non-compliance to protocol|2|||
105540983|NCT01069289|363980550|FG000|Overall Study|Due to deteriorating health condition|1|||
105540984|NCT01069289|363980551|FG001|Overall Study|Due to deteriorating health condition|0|||
105540985|NCT04035486|363980561|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
105540986|NCT04035486|363980562|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
105540987|NCT04035486|363980563|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
105540988|NCT04035486|363980564|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
105540989|NCT04035486|363980561|FG000|Overall Study|Death|6|||
105540990|NCT04035486|363980562|FG001|Overall Study|Death|3|||
105540991|NCT04035486|363980563|FG002|Overall Study|Death|70|||
105540992|NCT04035486|363980564|FG003|Overall Study|Death|77|||
105540993|NCT04035486|363980561|FG000|Overall Study|Screen Failure|0|||
105540994|NCT04035486|363980562|FG001|Overall Study|Screen Failure|0|||
105540995|NCT04035486|363980563|FG002|Overall Study|Screen Failure|1|||
105540996|NCT04035486|363980564|FG003|Overall Study|Screen Failure|1|||
105540997|NCT04035486|363980561|FG000|Overall Study|Withdrawal by Subject|1|||
105540998|NCT04035486|363980562|FG001|Overall Study|Withdrawal by Subject|1|||
105540999|NCT04035486|363980563|FG002|Overall Study|Withdrawal by Subject|11|||
105541000|NCT04035486|363980564|FG003|Overall Study|Withdrawal by Subject|9|||
105541001|NCT01976845|363980565|FG000|Overall Study|Physician Decision|8|||
105541002|NCT01976845|363980566|FG001|Overall Study|Physician Decision|8|||
105541003|NCT01976845|363980567|FG002|Overall Study|Physician Decision|3|||
105541004|NCT00774995|363980570|FG000|Overall Study|Protocol Violation|0|||
105541005|NCT00774995|363980571|FG001|Overall Study|Protocol Violation|0|||
105541006|NCT00774995|363980572|FG002|Overall Study|Protocol Violation|1|||
105541007|NCT00774995|363980573|FG003|Overall Study|Protocol Violation|0|||
105541008|NCT03568461|363980577|FG000|Overall Study|Death|7|||
105541009|NCT03568461|363980577|FG000|Overall Study|Physician Decision|5|||
105541010|NCT03568461|363980577|FG000|Overall Study|Subject decision|5|||
105541011|NCT03568461|363980577|FG000|Overall Study|Lost to Follow-up|1|||
105541012|NCT01818336|363981985|FG000|Overall Study|Declined retest visit|0|||
105541013|NCT01818336|363981986|FG001|Overall Study|Declined retest visit|11|||
105541014|NCT01818336|363981985|FG000|Overall Study|Lost to Follow-up|0|||
105541015|NCT01818336|363981986|FG001|Overall Study|Lost to Follow-up|1|||
105541016|NCT00612066|363981991|FG000|Overall Study|Adverse Event|1|||
105541017|NCT00844545|363981992|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
105541018|NCT00844545|363981992|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
105541019|NCT00844545|363981992|FG000|Extension Treatment Period|Adverse Event|2|||
105541020|NCT00844545|363981992|FG000|Post Treatment Period|Withdrawal by Subject|1|||
105541021|NCT01743092|363981993|FG000|Overall Study|Lost to Follow-up|14|||
105541022|NCT01743092|363981994|FG001|Overall Study|Lost to Follow-up|15|||
105541023|NCT01794949|363981998|FG000|Overall Study|Lost to Follow-up|1|||
105541024|NCT01794949|363981999|FG001|Overall Study|Lost to Follow-up|0|||
105541025|NCT00087568|363982000|FG000|Overall Study|Adverse Event|4|||
105541026|NCT00087568|363982001|FG001|Overall Study|Adverse Event|0|||
105541027|NCT00087568|363982000|FG000|Overall Study|Withdrawal by Subject|1|||
105541028|NCT00087568|363982001|FG001|Overall Study|Withdrawal by Subject|1|||
105541029|NCT00087568|363982000|FG000|Overall Study|Lost to Follow-up|1|||
105541030|NCT00087568|363982001|FG001|Overall Study|Lost to Follow-up|0|||
105541031|NCT00087568|363982000|FG000|Overall Study|Lack of Efficacy|24|||
105541032|NCT00087568|363982001|FG001|Overall Study|Lack of Efficacy|1|||
105541033|NCT02984995|363982002|FG000|Overall Study|Required stem cell transplant|13|||
105541034|NCT02984995|363982003|FG001|Overall Study|Required stem cell transplant|2|||
105541035|NCT02984995|363982002|FG000|Overall Study|Progressive disease|11|||
105541036|NCT02984995|363982003|FG001|Overall Study|Progressive disease|1|||
105541037|NCT02984995|363982002|FG000|Overall Study|Adverse Event|1|||
105541038|NCT02984995|363982003|FG001|Overall Study|Adverse Event|0|||
105541039|NCT02370888|363982004|FG000|Overall Study|disease progression|2|||
105541040|NCT02370888|363982004|FG000|Overall Study|did not meet chimerism criteria|6|||
105541041|NCT01600040|363982005|FG000|Overall Study|Withdrawal by Subject|1|||
105541042|NCT00812812|363982008|FG000|Overall Study|Adverse Event|2|||
105541043|NCT00812812|363982009|FG001|Overall Study|Adverse Event|1|||
105541044|NCT00812812|363982008|FG000|Overall Study|Lack of Efficacy|1|||
105541045|NCT00812812|363982009|FG001|Overall Study|Lack of Efficacy|0|||
105541046|NCT00812812|363982008|FG000|Overall Study|Lost to Follow-up|0|||
105541047|NCT00812812|363982009|FG001|Overall Study|Lost to Follow-up|1|||
105541048|NCT00812812|363982008|FG000|Overall Study|Withdrawal by Subject|0|||
105541049|NCT00812812|363982009|FG001|Overall Study|Withdrawal by Subject|2|||
105541050|NCT03755765|363982010|FG000|Overall Study|Withdrawal by Subject|2|||
105541051|NCT03755765|363982011|FG001|Overall Study|Withdrawal by Subject|4|||
105541052|NCT03755765|363982012|FG002|Overall Study|Withdrawal by Subject|4|||
105541053|NCT00111228|363982013|FG000|Overall Study|Withdrawal by Subject|5|||
105541054|NCT00111228|363982014|FG001|Overall Study|Withdrawal by Subject|1|||
105541055|NCT00111228|363982015|FG002|Overall Study|Withdrawal by Subject|0|||
105541056|NCT00678691|363982016|FG000|Overall Study|Adverse Event|6|||
105541057|NCT00678691|363982017|FG001|Overall Study|Adverse Event|4|||
105541058|NCT00779766|363982018|FG000|Month 24|Serious Adverse Event|2|||
105541059|NCT00779766|363982019|FG001|Month 24|Serious Adverse Event|3|||
105541060|NCT00779766|363982018|FG000|Month 24|Adverse Event|3|||
105541061|NCT00779766|363982019|FG001|Month 24|Adverse Event|3|||
105541062|NCT00779766|363982018|FG000|Month 24|Protocol Violation|3|||
105541063|NCT00779766|363982019|FG001|Month 24|Protocol Violation|1|||
105541064|NCT00779766|363982018|FG000|Month 24|Withdrawal by Subject|159|||
105541065|NCT00779766|363982019|FG001|Month 24|Withdrawal by Subject|127|||
105541066|NCT00779766|363982018|FG000|Month 24|Migrated/moved from study area|138|||
105541067|NCT00779766|363982019|FG001|Month 24|Migrated/moved from study area|162|||
105541068|NCT00779766|363982018|FG000|Month 24|Lost to Follow-up|9|||
105541069|NCT00779766|363982019|FG001|Month 24|Lost to Follow-up|9|||
105541070|NCT00779766|363982018|FG000|Month 24|Other|18|||
105541071|NCT00779766|363982019|FG001|Month 24|Other|27|||
105541072|NCT00779766|363982018|FG000|Month 48|Withdrawal by Subject|68|||
105541073|NCT00779766|363982019|FG001|Month 48|Withdrawal by Subject|63|||
105541074|NCT00779766|363982018|FG000|Month 48|Migrated/moved from study area|76|||
105541075|NCT00779766|363982019|FG001|Month 48|Migrated/moved from study area|75|||
105541076|NCT00779766|363982018|FG000|Month 48|Lost to Follow-up|29|||
105541077|NCT00779766|363982019|FG001|Month 48|Lost to Follow-up|30|||
105541078|NCT00779766|363982018|FG000|Month 48|Other|1|||
105541079|NCT00779766|363982019|FG001|Month 48|Other|0|||
105541080|NCT00779766|363982018|FG000|Month 72|Withdrawal by Subject|55|||
105541081|NCT00779766|363982019|FG001|Month 72|Withdrawal by Subject|71|||
105541082|NCT00779766|363982018|FG000|Month 72|Migrated/moved from study area|124|||
105541083|NCT00779766|363982019|FG001|Month 72|Migrated/moved from study area|109|||
105541084|NCT00779766|363982018|FG000|Month 72|Lost to Follow-up|6|||
105541085|NCT00779766|363982019|FG001|Month 72|Lost to Follow-up|8|||
105541086|NCT00779766|363982018|FG000|Month 72|Other|0|||
105541087|NCT00779766|363982019|FG001|Month 72|Other|1|||
105541088|NCT04304001|363982020|FG000|Overall Study|Lost to Follow-up|13|||
105541089|NCT04304001|363982021|FG001|Overall Study|Lost to Follow-up|9|||
105541090|NCT02606136|363982029|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
105541091|NCT02606136|363982029|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
105541092|NCT02606136|363982029|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
105541093|NCT02606136|363982029|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
105541094|NCT03296696|363982030|FG000|Overall Study|Started Other Antitumor Therapy|1|||
105541095|NCT03296696|363982031|FG001|Overall Study|Started Other Antitumor Therapy|2|||
105541096|NCT03296696|363982032|FG002|Overall Study|Started Other Antitumor Therapy|1|||
105541097|NCT03296696|363982033|FG003|Overall Study|Started Other Antitumor Therapy|2|||
105541098|NCT03296696|363982034|FG004|Overall Study|Started Other Antitumor Therapy|1|||
105541099|NCT03296696|363982035|FG005|Overall Study|Started Other Antitumor Therapy|1|||
105541100|NCT03296696|363982036|FG006|Overall Study|Started Other Antitumor Therapy|2|||
105541101|NCT03296696|363982037|FG007|Overall Study|Started Other Antitumor Therapy|3|||
105541102|NCT03296696|363982038|FG008|Overall Study|Started Other Antitumor Therapy|1|||
105541103|NCT03296696|363982039|FG009|Overall Study|Started Other Antitumor Therapy|0|||
105541104|NCT03296696|363982030|FG000|Overall Study|Death|0|||
105541105|NCT03296696|363982031|FG001|Overall Study|Death|1|||
105541106|NCT03296696|363982032|FG002|Overall Study|Death|1|||
105541107|NCT03296696|363982033|FG003|Overall Study|Death|2|||
105541108|NCT03296696|363982034|FG004|Overall Study|Death|2|||
105541109|NCT03296696|363982035|FG005|Overall Study|Death|3|||
105541110|NCT03296696|363982036|FG006|Overall Study|Death|1|||
105541111|NCT03296696|363982037|FG007|Overall Study|Death|2|||
105541112|NCT03296696|363982038|FG008|Overall Study|Death|0|||
105541113|NCT03296696|363982039|FG009|Overall Study|Death|0|||
105541114|NCT03296696|363982030|FG000|Overall Study|Withdrawal by Subject|0|||
105541115|NCT03296696|363982031|FG001|Overall Study|Withdrawal by Subject|0|||
105541116|NCT03296696|363982032|FG002|Overall Study|Withdrawal by Subject|1|||
105541117|NCT03296696|363982033|FG003|Overall Study|Withdrawal by Subject|0|||
105541118|NCT03296696|363982034|FG004|Overall Study|Withdrawal by Subject|1|||
105541119|NCT03296696|363982035|FG005|Overall Study|Withdrawal by Subject|0|||
105541120|NCT03296696|363982036|FG006|Overall Study|Withdrawal by Subject|0|||
105541121|NCT03296696|363982037|FG007|Overall Study|Withdrawal by Subject|0|||
105541122|NCT03296696|363982038|FG008|Overall Study|Withdrawal by Subject|0|||
105541123|NCT03296696|363982039|FG009|Overall Study|Withdrawal by Subject|1|||
105541124|NCT04456699|363982043|FG000|Overall Study|Death|48|||
105541125|NCT04456699|363982044|FG001|Overall Study|Death|50|||
105541126|NCT04456699|363982045|FG002|Overall Study|Death|52|||
105541127|NCT04456699|363982043|FG000|Overall Study|Physician Decision|0|||
105541128|NCT04456699|363982044|FG001|Overall Study|Physician Decision|0|||
105541129|NCT04456699|363982045|FG002|Overall Study|Physician Decision|2|||
105541130|NCT04456699|363982043|FG000|Overall Study|Sponsor Decision|55|||
105541131|NCT04456699|363982044|FG001|Overall Study|Sponsor Decision|61|||
105541132|NCT04456699|363982045|FG002|Overall Study|Sponsor Decision|50|||
105541133|NCT04456699|363982043|FG000|Overall Study|Withdrawal by Subject|8|||
105541134|NCT04456699|363982044|FG001|Overall Study|Withdrawal by Subject|4|||
105541135|NCT04456699|363982045|FG002|Overall Study|Withdrawal by Subject|5|||
105541136|NCT05074433|363982046|FG000|Overall Study|Adverse Event|0|||
105541137|NCT05074433|363982047|FG001|Overall Study|Adverse Event|2|||
105541138|NCT05074433|363982048|FG002|Overall Study|Adverse Event|0|||
105541139|NCT05074433|363982049|FG003|Overall Study|Adverse Event|1|||
105541140|NCT05074433|363982046|FG000|Overall Study|Sponsor Request|0|||
105541141|NCT05074433|363982047|FG001|Overall Study|Sponsor Request|1|||
105541142|NCT05074433|363982048|FG002|Overall Study|Sponsor Request|1|||
105541143|NCT05074433|363982049|FG003|Overall Study|Sponsor Request|0|||
105541144|NCT05074433|363982046|FG000|Overall Study|Death|1|||
105541145|NCT05074433|363982047|FG001|Overall Study|Death|0|||
105541146|NCT05074433|363982048|FG002|Overall Study|Death|0|||
105541147|NCT05074433|363982049|FG003|Overall Study|Death|0|||
105541148|NCT05074433|363982046|FG000|Overall Study|Lost to Follow-up|0|||
105541149|NCT05074433|363982047|FG001|Overall Study|Lost to Follow-up|0|||
105541150|NCT05074433|363982048|FG002|Overall Study|Lost to Follow-up|2|||
105541151|NCT05074433|363982049|FG003|Overall Study|Lost to Follow-up|0|||
105541152|NCT05074433|363982046|FG000|Overall Study|Subject Decision|8|||
105541153|NCT05074433|363982047|FG001|Overall Study|Subject Decision|6|||
105541154|NCT05074433|363982048|FG002|Overall Study|Subject Decision|4|||
105541155|NCT05074433|363982049|FG003|Overall Study|Subject Decision|5|||
105541156|NCT04278417|363982060|FG000|Overall Study|Withdrawal by Subject|20|||
105541157|NCT04278417|363982061|FG001|Overall Study|Withdrawal by Subject|20|||
105541158|NCT04278417|363982060|FG000|Overall Study|Progressive disease|0|||
105541159|NCT04278417|363982061|FG001|Overall Study|Progressive disease|2|||
105541160|NCT04278417|363982060|FG000|Overall Study|Physician Decision|4|||
105541161|NCT04278417|363982061|FG001|Overall Study|Physician Decision|6|||
105541162|NCT04278417|363982060|FG000|Overall Study|Lost to Follow-up|11|||
105541163|NCT04278417|363982061|FG001|Overall Study|Lost to Follow-up|13|||
105541164|NCT04278417|363982060|FG000|Overall Study|Death|8|||
105541165|NCT04278417|363982061|FG001|Overall Study|Death|9|||
105541166|NCT04278417|363982060|FG000|Overall Study|Adverse Event|3|||
105541167|NCT04278417|363982061|FG001|Overall Study|Adverse Event|5|||
105541168|NCT03299192|363982062|FG000|Overall Study|Fell before classes started|1|||
105541169|NCT03299192|363982063|FG001|Overall Study|Fell before classes started|0|||
105541170|NCT03299192|363982064|FG002|Overall Study|Fell before classes started|0|||
105541171|NCT03299192|363982062|FG000|Overall Study|Other|0|||
105541172|NCT03299192|363982063|FG001|Overall Study|Other|2|||
105541173|NCT03299192|363982064|FG002|Overall Study|Other|1|||
105541174|NCT00205712|363982067|FG000|Overall Study|Lost to Follow-up|0|||
105541175|NCT00205712|363982068|FG001|Overall Study|Lost to Follow-up|1|||
105541176|NCT01334866|363982078|FG000|Overall Study|Withdrawal by Subject|10|||
105541177|NCT01334866|363982078|FG000|Overall Study|Lost to Follow-up|3|||
105541178|NCT01334866|363982078|FG000|Overall Study|Physician Decision|3|||
105541179|NCT01334866|363982078|FG000|Overall Study|medically necessary prior to procedure|2|||
105541180|NCT01334866|363982078|FG000|Overall Study|medically necessary post-procedure|1|||
105541181|NCT00983580|363982079|FG000|Overall Study|Cancel Prior to treatment|1|||
105541182|NCT00983580|363982080|FG001|Overall Study|Cancel Prior to treatment|3|||
105541183|NCT00983580|363982079|FG000|Overall Study|Protocol Violation|1|||
105541184|NCT00983580|363982080|FG001|Overall Study|Protocol Violation|1|||
105541185|NCT00983580|363982079|FG000|Overall Study|Ineligible|3|||
105541186|NCT00983580|363982080|FG001|Overall Study|Ineligible|0|||
105541187|NCT01603875|363982081|FG000|Overall Study|Preexisting rabies antibody|3|||
105541188|NCT01603875|363982082|FG001|Overall Study|Preexisting rabies antibody|4|||
105541189|NCT01603875|363982083|FG002|Overall Study|Preexisting rabies antibody|3|||
105541190|NCT01603875|363982081|FG000|Overall Study|Lost to Follow-up|4|||
105541191|NCT01603875|363982082|FG001|Overall Study|Lost to Follow-up|3|||
105541192|NCT01603875|363982083|FG002|Overall Study|Lost to Follow-up|6|||
105541193|NCT01603875|363982081|FG000|Overall Study|Protocol Violation|0|||
105541194|NCT01603875|363982082|FG001|Overall Study|Protocol Violation|1|||
105541195|NCT01603875|363982083|FG002|Overall Study|Protocol Violation|0|||
105541196|NCT01071512|363982084|FG000|Overall Study|Adverse Event|1|||
105541197|NCT01071512|363982084|FG000|Overall Study|Development of antibodies to drug|2|||
105541198|NCT01071512|363982084|FG000|Overall Study|positive anti-JC virus antibody test|2|||
105541199|NCT00799617|363982091|FG000|Main Testosterone Trial|Randomized in error|1|||
105541200|NCT00799617|363982092|FG001|Main Testosterone Trial|Randomized in error|1|||
105541201|NCT00799617|363982091|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
105541202|NCT00799617|363982092|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
105541203|NCT00799617|363982091|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
105541204|NCT00799617|363982092|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
105541205|NCT00799617|363982091|FG000|Sexual Funtion Trial|No Baseline Data|4|||
105541206|NCT00799617|363982092|FG001|Sexual Funtion Trial|No Baseline Data|7|||
105541207|NCT00799617|363982091|FG000|Physical Function Trial|Lost to Follow-up|6|||
105541208|NCT00799617|363982092|FG001|Physical Function Trial|Lost to Follow-up|11|||
105541209|NCT00799617|363982091|FG000|Vitality Trial|Lost to Follow-up|7|||
105541210|NCT00799617|363982092|FG001|Vitality Trial|Lost to Follow-up|22|||
105541211|NCT00799617|363982091|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
105541212|NCT00799617|363982092|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
105541213|NCT00799617|363982091|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
105541214|NCT00799617|363982092|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
105541215|NCT00799617|363982091|FG000|Bone Trial|Month 12 scan not available|6|||
105541216|NCT00799617|363982092|FG001|Bone Trial|Month 12 scan not available|16|||
105541217|NCT00799617|363982091|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
105541218|NCT00799617|363982092|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
105541219|NCT00799617|363982091|FG000|Anemia Trial|Withdrawal by Subject|3|||
105541220|NCT00799617|363982092|FG001|Anemia Trial|Withdrawal by Subject|3|||
105541221|NCT01337297|363982093|FG000|Overall Study|They entered to single anodal tDCS|4|||
105541222|NCT01337297|363982094|FG001|Overall Study|They entered to single anodal tDCS|3|||
105541223|NCT01337297|363982093|FG000|Overall Study|Lost to Follow-up|1|||
105541224|NCT01337297|363982094|FG001|Overall Study|Lost to Follow-up|3|||
105541225|NCT02296112|363982095|FG000|Overall Study|Disease progression|7|||
105541226|NCT02296112|363982095|FG000|Overall Study|Toxicity|1|||
105541227|NCT02296112|363982095|FG000|Overall Study|Began an alternate therapy|1|||
105541228|NCT02442830|363982096|FG000|Overall Study|Technical Failure|0|||
105541229|NCT02442830|363982097|FG001|Overall Study|Technical Failure|1|||
105541230|NCT00183872|363982098|FG000|Overall Study|Death|3|||
105541231|NCT00183872|363982098|FG000|Overall Study|Adverse Event|9|||
105541232|NCT00183872|363982098|FG000|Overall Study|Withdrawal by Subject|2|||
105541233|NCT00183872|363982098|FG000|Overall Study|Drug delayed more than 28 days|2|||
105541234|NCT01720069|363982099|FG000|Overall Study|Could not use e-diary correctly|0|||
105541235|NCT01720069|363982100|FG001|Overall Study|Could not use e-diary correctly|1|||
105541236|NCT01720069|363982101|FG002|Overall Study|Could not use e-diary correctly|1|||
105541237|NCT01720069|363982099|FG000|Overall Study|Randomised without baseline values|0|||
105541238|NCT01720069|363982100|FG001|Overall Study|Randomised without baseline values|0|||
105541239|NCT01720069|363982101|FG002|Overall Study|Randomised without baseline values|1|||
105541240|NCT01720069|363982099|FG000|Overall Study|Adverse Event|0|||
105541241|NCT01720069|363982100|FG001|Overall Study|Adverse Event|0|||
105541242|NCT01720069|363982101|FG002|Overall Study|Adverse Event|1|||
105541243|NCT01720069|363982099|FG000|Overall Study|Lack of Efficacy|0|||
105541244|NCT01720069|363982100|FG001|Overall Study|Lack of Efficacy|4|||
105541245|NCT01720069|363982101|FG002|Overall Study|Lack of Efficacy|0|||
105541246|NCT01720069|363982099|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
105541247|NCT01720069|363982100|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
105541248|NCT01720069|363982101|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
105541249|NCT01720069|363982099|FG000|Overall Study|Withdrawal by Subject|0|||
105541250|NCT01720069|363982100|FG001|Overall Study|Withdrawal by Subject|2|||
105541251|NCT01720069|363982101|FG002|Overall Study|Withdrawal by Subject|1|||
105541252|NCT01720069|363982099|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
105541253|NCT01720069|363982100|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
105541254|NCT01720069|363982101|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
105541255|NCT01720069|363982099|FG000|Overall Study|Non-compliance on using e-diary|0|||
105541256|NCT01720069|363982100|FG001|Overall Study|Non-compliance on using e-diary|0|||
105541257|NCT01720069|363982101|FG002|Overall Study|Non-compliance on using e-diary|1|||
105541258|NCT01720069|363982099|FG000|Overall Study|Lost to Follow-up|0|||
105541259|NCT01720069|363982100|FG001|Overall Study|Lost to Follow-up|0|||
105541260|NCT01720069|363982101|FG002|Overall Study|Lost to Follow-up|1|||
105541261|NCT00508742|363982102|FG000|Period 1: Infant Series|Adverse Event|5|||
105541262|NCT00508742|363982103|FG001|Period 1: Infant Series|Adverse Event|4|||
105541263|NCT00508742|363982102|FG000|Period 1: Infant Series|Protocol Violation|1|||
105541264|NCT00508742|363982103|FG001|Period 1: Infant Series|Protocol Violation|0|||
105541265|NCT00508742|363982102|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
105541266|NCT00508742|363982103|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
105541267|NCT00508742|363982102|FG000|Period 1: Infant Series|Physician Decision|1|||
105541268|NCT00508742|363982103|FG001|Period 1: Infant Series|Physician Decision|0|||
105541269|NCT00508742|363982102|FG000|Period 1: Infant Series|Other|4|||
105541270|NCT00508742|363982103|FG001|Period 1: Infant Series|Other|1|||
105541271|NCT00508742|363982102|FG000|Period 2: After Infant Series|Adverse Event|2|||
105541272|NCT00508742|363982103|FG001|Period 2: After Infant Series|Adverse Event|6|||
105541273|NCT00508742|363982102|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
105541274|NCT00508742|363982103|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
105541275|NCT00508742|363982102|FG000|Period 2: After Infant Series|Protocol Violation|1|||
105541276|NCT00508742|363982103|FG001|Period 2: After Infant Series|Protocol Violation|0|||
105541277|NCT00508742|363982102|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
105541278|NCT00508742|363982103|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
105541279|NCT00508742|363982102|FG000|Period 2: After Infant Series|Failed to Return|1|||
105541280|NCT00508742|363982103|FG001|Period 2: After Infant Series|Failed to Return|0|||
105541281|NCT00508742|363982102|FG000|Period 2: After Infant Series|Other|2|||
105541282|NCT00508742|363982103|FG001|Period 2: After Infant Series|Other|1|||
105541283|NCT00508742|363982102|FG000|Period 3: Toddler Dose|Adverse Event|1|||
105541284|NCT00508742|363982103|FG001|Period 3: Toddler Dose|Adverse Event|0|||
105541285|NCT00508742|363982102|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
105541286|NCT00508742|363982103|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
105541287|NCT00508742|363982102|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
105541288|NCT00508742|363982103|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
105541289|NCT00508742|363982102|FG000|Period 3: Toddler Dose|Other|5|||
105541290|NCT00508742|363982103|FG001|Period 3: Toddler Dose|Other|4|||
105541291|NCT00595582|363982109|FG000|Overall Study|Pilot study that PI terminated|2|||
105541292|NCT00595582|363982109|FG000|Overall Study|Lost to Follow-up|1|||
105541293|NCT00595582|363982109|FG000|Overall Study|Adverse Event|2|||
105541294|NCT00595582|363982109|FG000|Overall Study|Physician Decision|5|||
105541295|NCT01978184|363982110|FG000|Overall Study|Progressive disease|5|||
105541296|NCT01978184|363982111|FG001|Overall Study|Progressive disease|5|||
105541297|NCT01978184|363982110|FG000|Overall Study|Other than PDA|2|||
105541298|NCT01978184|363982111|FG001|Overall Study|Other than PDA|2|||
105541299|NCT01978184|363982110|FG000|Overall Study|Physician Decision|0|||
105541300|NCT01978184|363982111|FG001|Overall Study|Physician Decision|3|||
105541301|NCT01978184|363982110|FG000|Overall Study|Noncompliance|1|||
105541302|NCT01978184|363982111|FG001|Overall Study|Noncompliance|2|||
105541303|NCT01978184|363982110|FG000|Overall Study|Death|1|||
105541304|NCT01978184|363982111|FG001|Overall Study|Death|0|||
105541305|NCT01978184|363982110|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
105541306|NCT01978184|363982111|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
105541307|NCT01898793|363982112|FG000|Overall Study|Death|2|||
105541308|NCT01898793|363982113|FG001|Overall Study|Death|1|||
105541309|NCT01898793|363982114|FG002|Overall Study|Death|4|||
105541310|NCT01898793|363982115|FG003|Overall Study|Death|0|||
105541311|NCT01898793|363982116|FG004|Overall Study|Death|0|||
105541312|NCT01898793|363982117|FG005|Overall Study|Death|0|||
105541313|NCT01898793|363982118|FG006|Overall Study|Death|0|||
105541314|NCT00298038|363982121|FG000|Overall Study|Lost to Follow-up|0|||
105541315|NCT00298038|363982122|FG001|Overall Study|Lost to Follow-up|1|||
105541316|NCT00298038|363982121|FG000|Overall Study|Liver Transplant|0|||
105541317|NCT00298038|363982122|FG001|Overall Study|Liver Transplant|1|||
105541318|NCT00298038|363982121|FG000|Overall Study|Protocol Violation|1|||
105541319|NCT00298038|363982122|FG001|Overall Study|Protocol Violation|3|||
105541320|NCT00298038|363982121|FG000|Overall Study|Death|6|||
105541321|NCT00298038|363982122|FG001|Overall Study|Death|3|||
105541322|NCT00298038|363982121|FG000|Overall Study|Withdrawal by Subject|6|||
105541323|NCT00298038|363982122|FG001|Overall Study|Withdrawal by Subject|9|||
105541324|NCT00298038|363982121|FG000|Overall Study|Adverse Event|8|||
105541325|NCT00298038|363982122|FG001|Overall Study|Adverse Event|7|||
105541326|NCT00298038|363982121|FG000|Overall Study|Breakthrough overt HE episode|28|||
105541327|NCT00298038|363982122|FG001|Overall Study|Breakthrough overt HE episode|69|||
105541328|NCT00298038|363982121|FG000|Overall Study|Noncompliance|1|||
105541329|NCT00298038|363982122|FG001|Overall Study|Noncompliance|0|||
105541330|NCT00298038|363982121|FG000|Overall Study|Cocaine Abuse|1|||
105541331|NCT00298038|363982122|FG001|Overall Study|Cocaine Abuse|0|||
105541332|NCT00298038|363982121|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
105541333|NCT00298038|363982122|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
105541334|NCT00441337|363982127|FG000|Overall Study|Disease Progression|6|||
105541335|NCT00441337|363982128|FG001|Overall Study|Disease Progression|6|||
105541336|NCT00441337|363982129|FG002|Overall Study|Disease Progression|4|||
105541337|NCT00441337|363982130|FG003|Overall Study|Disease Progression|18|||
105541338|NCT00441337|363982127|FG000|Overall Study|Lost to Follow-up|0|||
105541339|NCT00441337|363982128|FG001|Overall Study|Lost to Follow-up|0|||
105541340|NCT00441337|363982129|FG002|Overall Study|Lost to Follow-up|0|||
105541341|NCT00441337|363982130|FG003|Overall Study|Lost to Follow-up|1|||
105541342|NCT00441337|363982127|FG000|Overall Study|Sponsor Decision|0|||
105541343|NCT00441337|363982128|FG001|Overall Study|Sponsor Decision|0|||
105541344|NCT00441337|363982129|FG002|Overall Study|Sponsor Decision|1|||
105541345|NCT00441337|363982130|FG003|Overall Study|Sponsor Decision|2|||
105541346|NCT00441337|363982127|FG000|Overall Study|Did not meet inclusion criteria|0|||
105541347|NCT00441337|363982128|FG001|Overall Study|Did not meet inclusion criteria|0|||
105541348|NCT00441337|363982129|FG002|Overall Study|Did not meet inclusion criteria|1|||
105541349|NCT00441337|363982130|FG003|Overall Study|Did not meet inclusion criteria|0|||
105541350|NCT03570892|363982131|FG000|Overall Study|Death|51|||
105541351|NCT03570892|363982132|FG001|Overall Study|Death|45|||
105541352|NCT03570892|363982131|FG000|Overall Study|Subject decision|5|||
105541353|NCT03570892|363982132|FG001|Overall Study|Subject decision|3|||
105541354|NCT03570892|363982131|FG000|Overall Study|Protocol Violation|1|||
105541355|NCT03570892|363982132|FG001|Overall Study|Protocol Violation|4|||
105541356|NCT03570892|363982131|FG000|Overall Study|Physician Decision|0|||
105541357|NCT03570892|363982132|FG001|Overall Study|Physician Decision|2|||
105541358|NCT03964454|363982133|FG000|Overall Study|Lost to Follow-up|13|||
105541359|NCT03964454|363982134|FG001|Overall Study|Lost to Follow-up|7|||
105541360|NCT03964454|363982133|FG000|Overall Study|Withdrawal by Subject|4|||
105541361|NCT03964454|363982134|FG001|Overall Study|Withdrawal by Subject|11|||
105541362|NCT05350449|363982138|FG000|Overall Study|Withdrawal by Subject|4|||
105541363|NCT05350449|363982139|FG001|Overall Study|Withdrawal by Subject|8|||
105541364|NCT00827372|363983453|FG000|Overall Study|Adverse Event|5|||
105541365|NCT00827372|363983453|FG000|Overall Study|Lack of Efficacy|3|||
105541366|NCT02086591|363983460|FG000|Overall Study|Adverse Event|1|||
105541367|NCT02086591|363983460|FG000|Overall Study|Withdrawal by Subject|1|||
105541368|NCT02086591|363983460|FG000|Overall Study|protocol terminated|3|||
105541369|NCT01602315|363983461|FG000|Overall Study|Protocol Violation|0|||
105541370|NCT01602315|363983462|FG001|Overall Study|Protocol Violation|0|||
105541371|NCT01602315|363983463|FG002|Overall Study|Protocol Violation|0|||
105541372|NCT01602315|363983464|FG003|Overall Study|Protocol Violation|0|||
105541373|NCT01602315|363983465|FG004|Overall Study|Protocol Violation|0|||
105541374|NCT01602315|363983466|FG005|Overall Study|Protocol Violation|1|||
105541375|NCT01602315|363983467|FG006|Overall Study|Protocol Violation|0|||
105541376|NCT01602315|363983461|FG000|Overall Study|Physician Decision|2|||
105541377|NCT01602315|363983462|FG001|Overall Study|Physician Decision|0|||
105541378|NCT01602315|363983463|FG002|Overall Study|Physician Decision|0|||
105541379|NCT01602315|363983464|FG003|Overall Study|Physician Decision|0|||
105541380|NCT01602315|363983465|FG004|Overall Study|Physician Decision|2|||
105541381|NCT01602315|363983466|FG005|Overall Study|Physician Decision|1|||
105541382|NCT01602315|363983467|FG006|Overall Study|Physician Decision|1|||
105541383|NCT01602315|363983461|FG000|Overall Study|Disease progression|6|||
105541384|NCT01602315|363983462|FG001|Overall Study|Disease progression|3|||
105541385|NCT01602315|363983463|FG002|Overall Study|Disease progression|10|||
105541386|NCT01602315|363983464|FG003|Overall Study|Disease progression|1|||
105541387|NCT01602315|363983465|FG004|Overall Study|Disease progression|41|||
105541388|NCT01602315|363983466|FG005|Overall Study|Disease progression|12|||
105541389|NCT01602315|363983467|FG006|Overall Study|Disease progression|15|||
105541390|NCT01602315|363983461|FG000|Overall Study|Death|1|||
105541391|NCT01602315|363983462|FG001|Overall Study|Death|1|||
105541392|NCT01602315|363983463|FG002|Overall Study|Death|1|||
105541393|NCT01602315|363983464|FG003|Overall Study|Death|1|||
105541394|NCT01602315|363983465|FG004|Overall Study|Death|7|||
105541395|NCT01602315|363983466|FG005|Overall Study|Death|2|||
105541396|NCT01602315|363983467|FG006|Overall Study|Death|2|||
105541397|NCT01602315|363983461|FG000|Overall Study|Withdrawal by Subject|2|||
105541398|NCT01602315|363983462|FG001|Overall Study|Withdrawal by Subject|0|||
105541399|NCT01602315|363983463|FG002|Overall Study|Withdrawal by Subject|2|||
105541400|NCT01602315|363983464|FG003|Overall Study|Withdrawal by Subject|0|||
105541401|NCT01602315|363983465|FG004|Overall Study|Withdrawal by Subject|6|||
105541402|NCT01602315|363983466|FG005|Overall Study|Withdrawal by Subject|0|||
105541403|NCT01602315|363983467|FG006|Overall Study|Withdrawal by Subject|1|||
105541404|NCT01602315|363983461|FG000|Overall Study|Adverse Event|5|||
105541405|NCT01602315|363983462|FG001|Overall Study|Adverse Event|1|||
105541406|NCT01602315|363983463|FG002|Overall Study|Adverse Event|5|||
105541407|NCT01602315|363983464|FG003|Overall Study|Adverse Event|4|||
105541408|NCT01602315|363983465|FG004|Overall Study|Adverse Event|15|||
105541409|NCT01602315|363983466|FG005|Overall Study|Adverse Event|3|||
105541410|NCT01602315|363983467|FG006|Overall Study|Adverse Event|9|||
105541411|NCT01602315|363983461|FG000|Overall Study|Subject/guardian decision|0|||
105541412|NCT01602315|363983462|FG001|Overall Study|Subject/guardian decision|0|||
105541413|NCT01602315|363983463|FG002|Overall Study|Subject/guardian decision|0|||
105541414|NCT01602315|363983464|FG003|Overall Study|Subject/guardian decision|0|||
105541415|NCT01602315|363983465|FG004|Overall Study|Subject/guardian decision|0|||
105541416|NCT01602315|363983466|FG005|Overall Study|Subject/guardian decision|0|||
105541417|NCT01602315|363983467|FG006|Overall Study|Subject/guardian decision|1|||
105541418|NCT01602315|363983461|FG000|Overall Study|Cross-over patients to combo treatment|0|||
105541419|NCT01602315|363983462|FG001|Overall Study|Cross-over patients to combo treatment|0|||
105541420|NCT01602315|363983463|FG002|Overall Study|Cross-over patients to combo treatment|0|||
105541421|NCT01602315|363983464|FG003|Overall Study|Cross-over patients to combo treatment|0|||
105541422|NCT01602315|363983465|FG004|Overall Study|Cross-over patients to combo treatment|0|||
105541423|NCT01602315|363983466|FG005|Overall Study|Cross-over patients to combo treatment|16|||
105541424|NCT01602315|363983467|FG006|Overall Study|Cross-over patients to combo treatment|0|||
105541425|NCT02212730|363983470|FG000|Overall Study|Tumor not of the required cell histology|1|||
105541426|NCT02212730|363983471|FG001|Overall Study|Tumor not of the required cell histology|0|||
105541427|NCT02212730|363983470|FG000|Overall Study|Withdrawal by Subject|1|||
105541428|NCT02212730|363983471|FG001|Overall Study|Withdrawal by Subject|0|||
105541429|NCT02212730|363983470|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
105541430|NCT02212730|363983471|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
105541431|NCT01777997|363983474|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
105541432|NCT01777997|363983474|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
105541433|NCT01777997|363983474|FG000|Weeks 48 to 72/96 on ART|Death|1|||
105541434|NCT01777997|363983474|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
105541435|NCT02660359|363983475|FG000|Overall Study|Protocol Deviation|0|||
105541436|NCT02660359|363983476|FG001|Overall Study|Protocol Deviation|0|||
105541437|NCT02660359|363983477|FG002|Overall Study|Protocol Deviation|1|||
105541438|NCT02660359|363983475|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
105541439|NCT02660359|363983476|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
105541440|NCT02660359|363983477|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
105541441|NCT02660359|363983475|FG000|Overall Study|Lack of Efficacy|1|||
105541442|NCT02660359|363983476|FG001|Overall Study|Lack of Efficacy|1|||
105541443|NCT02660359|363983477|FG002|Overall Study|Lack of Efficacy|1|||
105541444|NCT02660359|363983475|FG000|Overall Study|Adverse Event|0|||
105541445|NCT02660359|363983476|FG001|Overall Study|Adverse Event|1|||
105541446|NCT02660359|363983477|FG002|Overall Study|Adverse Event|0|||
105541447|NCT02660359|363983475|FG000|Overall Study|Other|2|||
105541448|NCT02660359|363983476|FG001|Overall Study|Other|1|||
105541449|NCT02660359|363983477|FG002|Overall Study|Other|3|||
105541450|NCT02660359|363983475|FG000|Overall Study|Withdrawal by Subject|7|||
105541451|NCT02660359|363983476|FG001|Overall Study|Withdrawal by Subject|5|||
105541452|NCT02660359|363983477|FG002|Overall Study|Withdrawal by Subject|8|||
105541453|NCT02660359|363983475|FG000|Overall Study|Lost to Follow-up|3|||
105541454|NCT02660359|363983476|FG001|Overall Study|Lost to Follow-up|3|||
105541455|NCT02660359|363983477|FG002|Overall Study|Lost to Follow-up|0|||
105541456|NCT00723801|363983478|FG000|Overall Study|Lost to Follow-up|1|||
105541457|NCT00723801|363983479|FG001|Overall Study|Lost to Follow-up|2|||
105541458|NCT00723801|363983478|FG000|Overall Study|Protocol Violation|2|||
105541459|NCT00723801|363983479|FG001|Overall Study|Protocol Violation|1|||
105541460|NCT01824303|363983480|FG000|Randomized Study|Withdrawal by Subject|1|||
105541461|NCT01824303|363983481|FG001|Randomized Study|Withdrawal by Subject|1|||
105541462|NCT01824303|363983480|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
105541463|NCT01824303|363983481|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
105541464|NCT02039427|363983482|FG000|Overall Study|Duration of surgery > 3h|1|||
105541465|NCT02039427|363983483|FG001|Overall Study|Duration of surgery > 3h|1|||
105541466|NCT02039427|363983484|FG002|Overall Study|Duration of surgery > 3h|0|||
105541467|NCT02039427|363983485|FG003|Overall Study|Duration of surgery > 3h|0|||
105541468|NCT02039427|363983482|FG000|Overall Study|Withdrawal on concent|0|||
105541469|NCT02039427|363983483|FG001|Overall Study|Withdrawal on concent|0|||
105541470|NCT02039427|363983484|FG002|Overall Study|Withdrawal on concent|0|||
105541471|NCT02039427|363983485|FG003|Overall Study|Withdrawal on concent|1|||
105541472|NCT02039427|363983482|FG000|Overall Study|Cancellation of surgery|0|||
105541473|NCT02039427|363983483|FG001|Overall Study|Cancellation of surgery|0|||
105541474|NCT02039427|363983484|FG002|Overall Study|Cancellation of surgery|1|||
105541475|NCT02039427|363983485|FG003|Overall Study|Cancellation of surgery|0|||
105541476|NCT02039427|363983482|FG000|Overall Study|Loss of follow - up|1|||
105541477|NCT02039427|363983483|FG001|Overall Study|Loss of follow - up|0|||
105541478|NCT02039427|363983484|FG002|Overall Study|Loss of follow - up|2|||
105541479|NCT02039427|363983485|FG003|Overall Study|Loss of follow - up|4|||
105541480|NCT02039427|363983482|FG000|Overall Study|Steroid Use|1|||
105541481|NCT02039427|363983483|FG001|Overall Study|Steroid Use|0|||
105541482|NCT02039427|363983484|FG002|Overall Study|Steroid Use|0|||
105541483|NCT02039427|363983485|FG003|Overall Study|Steroid Use|0|||
105541484|NCT01274637|363983487|FG000|Overall Study|Withdrawal by Subject|0|||
105541485|NCT01274637|363983488|FG001|Overall Study|Withdrawal by Subject|1|||
105541486|NCT01274637|363983487|FG000|Overall Study|Lost to Follow-up|0|||
105541487|NCT01274637|363983488|FG001|Overall Study|Lost to Follow-up|1|||
105541488|NCT01490060|363983489|FG000|Cycle 1|Change of Treatment|0|||
105541489|NCT01490060|363983490|FG001|Cycle 1|Change of Treatment|1|||
105541490|NCT01490060|363983491|FG002|Cycle 1|Change of Treatment|1|||
105541491|NCT01490060|363983492|FG003|Cycle 1|Change of Treatment|1|||
105541492|NCT01490060|363983489|FG000|Cycle 1|Insurance Denied|0|||
105541493|NCT01490060|363983490|FG001|Cycle 1|Insurance Denied|0|||
105541494|NCT01490060|363983491|FG002|Cycle 1|Insurance Denied|2|||
105541495|NCT01490060|363983492|FG003|Cycle 1|Insurance Denied|0|||
105541496|NCT01490060|363983489|FG000|Cycle 1|Withdrawal by Subject|0|||
105541497|NCT01490060|363983490|FG001|Cycle 1|Withdrawal by Subject|0|||
105541498|NCT01490060|363983491|FG002|Cycle 1|Withdrawal by Subject|0|||
105541499|NCT01490060|363983492|FG003|Cycle 1|Withdrawal by Subject|1|||
105541500|NCT01490060|363983489|FG000|Cycle 1|Treatment at Another Facility|0|||
105541501|NCT01490060|363983490|FG001|Cycle 1|Treatment at Another Facility|0|||
105541502|NCT01490060|363983491|FG002|Cycle 1|Treatment at Another Facility|0|||
105541503|NCT01490060|363983492|FG003|Cycle 1|Treatment at Another Facility|1|||
105541504|NCT01490060|363983489|FG000|Cycle 2|Change of Treatment|1|||
105541505|NCT01490060|363983490|FG001|Cycle 2|Change of Treatment|1|||
105541506|NCT01490060|363983491|FG002|Cycle 2|Change of Treatment|0|||
105541507|NCT01490060|363983492|FG003|Cycle 2|Change of Treatment|0|||
105541508|NCT01490060|363983489|FG000|Cycle 2|Non-Compliance|0|||
105541509|NCT01490060|363983490|FG001|Cycle 2|Non-Compliance|0|||
105541510|NCT01490060|363983491|FG002|Cycle 2|Non-Compliance|1|||
105541511|NCT01490060|363983492|FG003|Cycle 2|Non-Compliance|0|||
105541512|NCT01490060|363983489|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
105541513|NCT01490060|363983490|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
105541514|NCT01490060|363983491|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
105541515|NCT01490060|363983492|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
105541516|NCT02664038|363983493|FG000|13 Week|Lost to Follow-up|7|||
105541517|NCT02664038|363983494|FG001|13 Week|Lost to Follow-up|14|||
105541518|NCT02664038|363983493|FG000|13 Week|Withdrawal by Subject|1|||
105541519|NCT02664038|363983494|FG001|13 Week|Withdrawal by Subject|0|||
105541520|NCT02664038|363983493|FG000|26 Week|Lost to Follow-up|5|||
105541521|NCT02664038|363983494|FG001|26 Week|Lost to Follow-up|4|||
105541522|NCT02357576|363983495|FG000|Treatment Period|Withdrawal by Subject|0|||
105541523|NCT02357576|363983496|FG001|Treatment Period|Withdrawal by Subject|1|||
105541524|NCT02357576|363983495|FG000|Treatment Period|Physician Decision|0|||
105541525|NCT02357576|363983496|FG001|Treatment Period|Physician Decision|1|||
105541526|NCT02357576|363983495|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
105541527|NCT02357576|363983496|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
105541528|NCT02357576|363983495|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
105541529|NCT02357576|363983496|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
105541530|NCT02357576|363983495|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
105541531|NCT02357576|363983496|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
105541532|NCT02357576|363983495|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
105541533|NCT02357576|363983496|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
105541534|NCT01416805|363983502|FG000|Overall Study|Lost to Follow-up|4|||
105541535|NCT01416805|363983503|FG001|Overall Study|Lost to Follow-up|4|||
105541536|NCT00622635|363983504|FG000|Treatment Period 1|Adverse Event|0|||
105541537|NCT00622635|363983505|FG001|Treatment Period 1|Adverse Event|0|||
105541538|NCT00622635|363983506|FG002|Treatment Period 1|Adverse Event|1|||
105541539|NCT00622635|363983507|FG003|Treatment Period 1|Adverse Event|0|||
105541540|NCT00622635|363983508|FG004|Treatment Period 1|Adverse Event|0|||
105541541|NCT00622635|363983509|FG005|Treatment Period 1|Adverse Event|0|||
105541542|NCT00622635|363983504|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105541543|NCT00622635|363983505|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105541544|NCT00622635|363983506|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105541545|NCT00622635|363983507|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105541546|NCT00622635|363983508|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105541547|NCT00622635|363983509|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105541548|NCT00622635|363983504|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
105541549|NCT00622635|363983505|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
105541550|NCT00622635|363983506|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
105541551|NCT00622635|363983507|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
105541552|NCT00622635|363983508|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
105541553|NCT00622635|363983509|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
105541554|NCT00622635|363983504|FG000|Treatment Period 2|Adverse Event|1|||
105541555|NCT00622635|363983505|FG001|Treatment Period 2|Adverse Event|0|||
105541556|NCT00622635|363983506|FG002|Treatment Period 2|Adverse Event|0|||
105541557|NCT00622635|363983507|FG003|Treatment Period 2|Adverse Event|0|||
105541558|NCT00622635|363983508|FG004|Treatment Period 2|Adverse Event|0|||
105541559|NCT00622635|363983509|FG005|Treatment Period 2|Adverse Event|0|||
105541560|NCT00622635|363983504|FG000|Treatment Period 3|Adverse Event|0|||
105541561|NCT00622635|363983505|FG001|Treatment Period 3|Adverse Event|0|||
105541562|NCT00622635|363983506|FG002|Treatment Period 3|Adverse Event|0|||
105541563|NCT00622635|363983507|FG003|Treatment Period 3|Adverse Event|2|||
105541564|NCT00622635|363983508|FG004|Treatment Period 3|Adverse Event|0|||
105541565|NCT00622635|363983509|FG005|Treatment Period 3|Adverse Event|0|||
105541566|NCT00622635|363983504|FG000|Treatment Period 3|Withdrawal by Subject|0|||
105541567|NCT00622635|363983505|FG001|Treatment Period 3|Withdrawal by Subject|0|||
105541568|NCT00622635|363983506|FG002|Treatment Period 3|Withdrawal by Subject|0|||
105541569|NCT00622635|363983507|FG003|Treatment Period 3|Withdrawal by Subject|1|||
105541570|NCT00622635|363983508|FG004|Treatment Period 3|Withdrawal by Subject|0|||
105541571|NCT00622635|363983509|FG005|Treatment Period 3|Withdrawal by Subject|0|||
105541572|NCT02486406|363983519|FG000|Overall Study|Withdrew consent|1|||
105541573|NCT02486406|363983520|FG001|Overall Study|Withdrew consent|0|||
105541574|NCT02486406|363983521|FG002|Overall Study|Withdrew consent|0|||
105541575|NCT02486406|363983522|FG003|Overall Study|Withdrew consent|1|||
105541576|NCT02486406|363983519|FG000|Overall Study|Lost to Follow-up|1|||
105541577|NCT02486406|363983520|FG001|Overall Study|Lost to Follow-up|3|||
105541578|NCT02486406|363983521|FG002|Overall Study|Lost to Follow-up|1|||
105541579|NCT02486406|363983522|FG003|Overall Study|Lost to Follow-up|3|||
105541580|NCT02486406|363983519|FG000|Overall Study|Other, not specified|0|||
105541581|NCT02486406|363983520|FG001|Overall Study|Other, not specified|0|||
105541582|NCT02486406|363983521|FG002|Overall Study|Other, not specified|1|||
105541583|NCT02486406|363983522|FG003|Overall Study|Other, not specified|0|||
105541584|NCT03062891|363983523|FG000|Overall Study|Withdrawal by Subject|2|||
105541585|NCT03062891|363983524|FG001|Overall Study|Withdrawal by Subject|0|||
105541586|NCT03062891|363983523|FG000|Overall Study|Lost to Follow-up|50|||
105541587|NCT03062891|363983524|FG001|Overall Study|Lost to Follow-up|38|||
105541588|NCT03509948|363983528|FG000|Overall Study|Protocol Violation|0|||
105541589|NCT03509948|363983529|FG001|Overall Study|Protocol Violation|1|||
105541590|NCT01418209|363983531|FG000|Overall Study|Withdrawal by Subject|1|||
105541591|NCT01418209|363983532|FG001|Overall Study|Withdrawal by Subject|0|||
105541592|NCT01418209|363983533|FG002|Overall Study|Withdrawal by Subject|1|||
105541593|NCT01418209|363983531|FG000|Overall Study|Did not provide hot flash diary data|1|||
105541594|NCT01418209|363983532|FG001|Overall Study|Did not provide hot flash diary data|3|||
105541595|NCT01418209|363983533|FG002|Overall Study|Did not provide hot flash diary data|3|||
105541596|NCT00101101|363983534|FG000|Overall Study|never received vaccine|20|||
105541597|NCT01848990|363983541|FG000|Overall Study|Adverse Event|6|||
105541598|NCT01848990|363983542|FG001|Overall Study|Adverse Event|2|||
105541599|NCT01848990|363983543|FG002|Overall Study|Adverse Event|0|||
105541600|NCT01848990|363983541|FG000|Overall Study|Lost to Follow-up|6|||
105541601|NCT01848990|363983542|FG001|Overall Study|Lost to Follow-up|2|||
105541602|NCT01848990|363983543|FG002|Overall Study|Lost to Follow-up|2|||
105541603|NCT01848990|363983541|FG000|Overall Study|Protocol Violation|1|||
105541604|NCT01848990|363983542|FG001|Overall Study|Protocol Violation|1|||
105541605|NCT01848990|363983543|FG002|Overall Study|Protocol Violation|0|||
105541606|NCT01848990|363983541|FG000|Overall Study|Withdrawal by Subject|29|||
105541607|NCT01848990|363983542|FG001|Overall Study|Withdrawal by Subject|10|||
105541608|NCT01848990|363983543|FG002|Overall Study|Withdrawal by Subject|11|||
105541609|NCT01848990|363983541|FG000|Overall Study|Physician Decision|1|||
105541610|NCT01848990|363983542|FG001|Overall Study|Physician Decision|1|||
105541611|NCT01848990|363983543|FG002|Overall Study|Physician Decision|0|||
105541612|NCT01848990|363983541|FG000|Overall Study|Non Compliance|1|||
105541613|NCT01848990|363983542|FG001|Overall Study|Non Compliance|0|||
105541614|NCT01848990|363983543|FG002|Overall Study|Non Compliance|0|||
105541615|NCT01848990|363983541|FG000|Overall Study|Death|1|||
105541616|NCT01848990|363983542|FG001|Overall Study|Death|0|||
105541617|NCT01848990|363983543|FG002|Overall Study|Death|1|||
105541618|NCT01848990|363983541|FG000|Overall Study|Other|1|||
105541619|NCT01848990|363983542|FG001|Overall Study|Other|4|||
105541620|NCT01848990|363983543|FG002|Overall Study|Other|2|||
105541621|NCT00360334|363983549|FG000|Overall Study|Adverse Event|7|||
105541622|NCT00360334|363983550|FG001|Overall Study|Adverse Event|4|||
105541623|NCT00360334|363983549|FG000|Overall Study|Protocol Violation|1|||
105541624|NCT00360334|363983550|FG001|Overall Study|Protocol Violation|1|||
105541625|NCT00360334|363983549|FG000|Overall Study|Physician Decision|2|||
105541626|NCT00360334|363983550|FG001|Overall Study|Physician Decision|3|||
105541627|NCT00360334|363983549|FG000|Overall Study|Lack of Efficacy|0|||
105541628|NCT00360334|363983550|FG001|Overall Study|Lack of Efficacy|1|||
105541629|NCT00360334|363983549|FG000|Overall Study|Entry criterion not met|1|||
105541630|NCT00360334|363983550|FG001|Overall Study|Entry criterion not met|2|||
105541631|NCT00360334|363983549|FG000|Overall Study|Subject decision|8|||
105541632|NCT00360334|363983550|FG001|Overall Study|Subject decision|2|||
105541633|NCT00700011|363983551|FG000|Overall Study|Death|0|||
105541634|NCT00700011|363983552|FG001|Overall Study|Death|1|||
105541635|NCT00678561|363983553|FG000|Overall Study|Adverse Event|0|||
105541636|NCT00678561|363983554|FG001|Overall Study|Adverse Event|1|||
105541637|NCT00678561|363983555|FG002|Overall Study|Adverse Event|1|||
105541638|NCT00678561|363983556|FG003|Overall Study|Adverse Event|0|||
105541639|NCT00678561|363983557|FG004|Overall Study|Adverse Event|1|||
105541640|NCT00678561|363983558|FG005|Overall Study|Adverse Event|0|||
105541641|NCT00678561|363983559|FG006|Overall Study|Adverse Event|0|||
105541642|NCT00678561|363983560|FG007|Overall Study|Adverse Event|0|||
105541643|NCT00678561|363983553|FG000|Overall Study|Protocol Violation|0|||
105541644|NCT00678561|363983554|FG001|Overall Study|Protocol Violation|0|||
105541645|NCT00678561|363983555|FG002|Overall Study|Protocol Violation|0|||
105541646|NCT00678561|363983556|FG003|Overall Study|Protocol Violation|0|||
105541647|NCT00678561|363983557|FG004|Overall Study|Protocol Violation|1|||
105541648|NCT00678561|363983558|FG005|Overall Study|Protocol Violation|1|||
105541649|NCT00678561|363983559|FG006|Overall Study|Protocol Violation|0|||
105541650|NCT00678561|363983560|FG007|Overall Study|Protocol Violation|0|||
105541651|NCT00678561|363983553|FG000|Overall Study|Withdrawal by Subject|0|||
105541652|NCT00678561|363983554|FG001|Overall Study|Withdrawal by Subject|0|||
105541653|NCT00678561|363983555|FG002|Overall Study|Withdrawal by Subject|0|||
105541654|NCT00678561|363983556|FG003|Overall Study|Withdrawal by Subject|0|||
105541655|NCT00678561|363983557|FG004|Overall Study|Withdrawal by Subject|0|||
105541656|NCT00678561|363983558|FG005|Overall Study|Withdrawal by Subject|0|||
105541657|NCT00678561|363983559|FG006|Overall Study|Withdrawal by Subject|0|||
105541658|NCT00678561|363983560|FG007|Overall Study|Withdrawal by Subject|1|||
105541659|NCT00853658|363983563|FG000|Overall Study|Death|713|||
105541660|NCT00853658|363983564|FG001|Overall Study|Death|768|||
105541661|NCT00853658|363983565|FG002|Overall Study|Death|753|||
105541662|NCT00853658|363983563|FG000|Overall Study|Lost to Follow-up|11|||
105541663|NCT00853658|363983564|FG001|Overall Study|Lost to Follow-up|6|||
105541664|NCT00853658|363983565|FG002|Overall Study|Lost to Follow-up|11|||
105541665|NCT00853658|363983563|FG000|Overall Study|H.A. Request|26|||
105541666|NCT00853658|363983564|FG001|Overall Study|H.A. Request|23|||
105541667|NCT00853658|363983565|FG002|Overall Study|H.A. Request|19|||
105541668|NCT00853658|363983563|FG000|Overall Study|IRB request|0|||
105541669|NCT00853658|363983564|FG001|Overall Study|IRB request|0|||
105541670|NCT00853658|363983565|FG002|Overall Study|IRB request|2|||
105541671|NCT00853658|363983563|FG000|Overall Study|Vital Status known (alive) at study end|2|||
105541672|NCT00853658|363983564|FG001|Overall Study|Vital Status known (alive) at study end|3|||
105541673|NCT00853658|363983565|FG002|Overall Study|Vital Status known (alive) at study end|3|||
105541674|NCT00853658|363983563|FG000|Overall Study|Vital Status unknown at study end|1|||
105541675|NCT00853658|363983564|FG001|Overall Study|Vital Status unknown at study end|1|||
105541676|NCT00853658|363983565|FG002|Overall Study|Vital Status unknown at study end|0|||
105541677|NCT00853658|363983563|FG000|Overall Study|Vital Status at study end N/A|8|||
105541678|NCT00853658|363983564|FG001|Overall Study|Vital Status at study end N/A|10|||
105541679|NCT00853658|363983565|FG002|Overall Study|Vital Status at study end N/A|10|||
105541680|NCT00853658|363983563|FG000|Overall Study|Patient's request|21|||
105541681|NCT00853658|363983564|FG001|Overall Study|Patient's request|17|||
105541682|NCT00853658|363983565|FG002|Overall Study|Patient's request|11|||
105541683|NCT00853658|363983563|FG000|Overall Study|Missing study completion information|5|||
105541684|NCT00853658|363983564|FG001|Overall Study|Missing study completion information|4|||
105541685|NCT00853658|363983565|FG002|Overall Study|Missing study completion information|6|||
105541686|NCT02797262|363983566|FG000|Overall Study|Withdrawal by Subject|5|||
105541687|NCT02797262|363983567|FG001|Overall Study|Withdrawal by Subject|1|||
105541688|NCT02797262|363983566|FG000|Overall Study|Lost to Follow-up|10|||
105541689|NCT02797262|363983567|FG001|Overall Study|Lost to Follow-up|7|||
105541690|NCT02797262|363983566|FG000|Overall Study|Death|1|||
105541691|NCT02797262|363983567|FG001|Overall Study|Death|2|||
105541692|NCT02797262|363983566|FG000|Overall Study|Adverse Event|1|||
105541693|NCT02797262|363983567|FG001|Overall Study|Adverse Event|0|||
105541694|NCT02797262|363983566|FG000|Overall Study|COVID-19|2|||
105541695|NCT02797262|363983567|FG001|Overall Study|COVID-19|1|||
105541696|NCT02797262|363983566|FG000|Overall Study|Out-of-country|1|||
105541697|NCT02797262|363983567|FG001|Overall Study|Out-of-country|0|||
105541698|NCT03146650|363983569|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
105595879|NCT00430300|364182452|FG002|Overall Study|Laboratory abnormality|0|||
105595880|NCT00430300|364182453|FG003|Overall Study|Laboratory abnormality|0|||
105595881|NCT00430300|364182450|FG000|Overall Study|Other|0|||
105541699|NCT03146650|363983569|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
105541700|NCT03146650|363983569|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
105541701|NCT03146650|363983569|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
105541702|NCT03146650|363983569|FG000|2 Year Follow-up|Death|11|||
105541703|NCT03146650|363983569|FG000|2 Year Follow-up|Still in follow-up|7|||
105595882|NCT00430300|364182451|FG001|Overall Study|Other|0|||
105541704|NCT03146650|363983569|FG000|2 Year Follow-up|Lost to Follow-up|1|||
105541705|NCT01306617|363983575|FG000|Overall Study|Adverse Event|1|||
105541706|NCT01306617|363983576|FG001|Overall Study|Adverse Event|0|||
105541707|NCT01306617|363983577|FG002|Overall Study|Adverse Event|0|||
105541708|NCT01306617|363983575|FG000|Overall Study|Virologic Failure|0|||
105541709|NCT01306617|363983576|FG001|Overall Study|Virologic Failure|0|||
105541710|NCT01306617|363983577|FG002|Overall Study|Virologic Failure|5|||
105541711|NCT01306617|363983575|FG000|Overall Study|Non-compliance|0|||
105541712|NCT01306617|363983576|FG001|Overall Study|Non-compliance|1|||
105541713|NCT01306617|363983577|FG002|Overall Study|Non-compliance|0|||
105541714|NCT00983814|363983578|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
105541715|NCT00983814|363983579|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
105541716|NCT00983814|363983580|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
105541717|NCT00983814|363983578|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
105541718|NCT00983814|363983579|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
105541719|NCT00983814|363983580|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
105541720|NCT00983814|363983578|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
105541721|NCT00983814|363983579|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
105541722|NCT00983814|363983580|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
105541723|NCT00983814|363983578|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
105541724|NCT00983814|363983579|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
105541725|NCT00983814|363983580|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
105541726|NCT00983814|363983578|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
105541727|NCT00983814|363983579|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
105541728|NCT00983814|363983580|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
105541729|NCT00773097|363983581|FG000|Overall Study|Withdrawal by Subject|1|||
105541730|NCT00773097|363983581|FG000|Overall Study|Physician Decision|6|||
105541731|NCT01114516|363983584|FG000|Overall Study|Lost to Follow-up|2|||
105541732|NCT01114516|363983585|FG001|Overall Study|Lost to Follow-up|1|||
105541733|NCT01994395|363983586|FG000|Overall Study|Withdrawal by Subject|1|||
105541734|NCT01994395|363983587|FG001|Overall Study|Withdrawal by Subject|2|||
105541735|NCT03403634|363983598|FG000|Overall Study|Disease progression|3|||
105541736|NCT03403634|363983598|FG000|Overall Study|Did not meet eligibility criteria|4|||
105541737|NCT00961259|363985633|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
105541738|NCT00961259|363985634|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
105541739|NCT00961259|363985635|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
105541740|NCT02944578|363985636|FG000|Overall Study|Physician Decision|1|||
105541741|NCT02944578|363985637|FG001|Overall Study|Physician Decision|0|||
105541742|NCT02691455|363985638|FG000|Overall Study|Withdrawal by Subject|1|||
105541743|NCT02691455|363985639|FG001|Overall Study|Withdrawal by Subject|2|||
105541744|NCT02691455|363985638|FG000|Overall Study|Lost to Follow-up|15|||
105541745|NCT02691455|363985639|FG001|Overall Study|Lost to Follow-up|15|||
105541746|NCT00577122|363985640|FG000|Overall Study|Adverse Event|0|||
105541747|NCT00577122|363985641|FG001|Overall Study|Adverse Event|2|||
105541748|NCT00577122|363985640|FG000|Overall Study|Progression, relapse during active trt|6|||
105541749|NCT00577122|363985641|FG001|Overall Study|Progression, relapse during active trt|8|||
105541750|NCT00577122|363985640|FG000|Overall Study|Prog, refract disease during active trt|8|||
105541751|NCT00577122|363985641|FG001|Overall Study|Prog, refract disease during active trt|5|||
105541752|NCT00577122|363985640|FG000|Overall Study|Alternative Therapy|0|||
105541753|NCT00577122|363985641|FG001|Overall Study|Alternative Therapy|1|||
105541754|NCT00633984|363985644|FG000|Overall Study|Lost to Follow-up|0|||
105541755|NCT00633984|363985645|FG001|Overall Study|Lost to Follow-up|6|||
105541756|NCT00633984|363985644|FG000|Overall Study|Withdrawal by Subject|8|||
105541757|NCT00633984|363985645|FG001|Overall Study|Withdrawal by Subject|7|||
105541758|NCT00633984|363985644|FG000|Overall Study|Hospitalized|1|||
105541759|NCT00633984|363985645|FG001|Overall Study|Hospitalized|0|||
105541760|NCT02840877|363985646|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
105541761|NCT02840877|363985646|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
105541762|NCT02840877|363985646|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
105541763|NCT02840877|363985646|FG000|Baseline to 12 Weeks|Death|1|||
105541764|NCT02840877|363985646|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
105541765|NCT02840877|363985646|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
105541766|NCT02840877|363985646|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
105541767|NCT02840877|363985646|FG000|12 Weeks to 6 Months|Treatment failure|1|||
105541768|NCT02840877|363985646|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
105541769|NCT02840877|363985646|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
105541770|NCT02840877|363985646|FG000|12 Weeks to 6 Months|Death|1|||
105541771|NCT02840877|363985646|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
105541772|NCT02840877|363985646|FG000|6 Months to 18 Months|Treatment failure|7|||
105541773|NCT02840877|363985646|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
105541774|NCT02840877|363985646|FG000|6 Months to 18 Months|Moved/transferred out|6|||
105541775|NCT02840877|363985646|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
105541776|NCT02840877|363985646|FG000|6 Months to 18 Months|Death|4|||
105541777|NCT02840877|363985646|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
105541778|NCT02840877|363985646|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
105541779|NCT02840877|363985646|FG000|6 Months to 18 Months|Still in study.|14|||
105541780|NCT04086472|363985649|FG000|Overall Study|Lost to Follow-up|1|||
105541781|NCT04086472|363985650|FG001|Overall Study|Lost to Follow-up|0|||
105541782|NCT04086472|363985651|FG002|Overall Study|Lost to Follow-up|0|||
105541783|NCT04086472|363985652|FG003|Overall Study|Lost to Follow-up|0|||
105541784|NCT04086472|363985653|FG004|Overall Study|Lost to Follow-up|1|||
105541785|NCT04086472|363985649|FG000|Overall Study|Physician Decision|0|||
105541786|NCT04086472|363985650|FG001|Overall Study|Physician Decision|1|||
105541787|NCT04086472|363985651|FG002|Overall Study|Physician Decision|1|||
105541788|NCT04086472|363985652|FG003|Overall Study|Physician Decision|0|||
105541789|NCT04086472|363985653|FG004|Overall Study|Physician Decision|0|||
105541790|NCT04086472|363985649|FG000|Overall Study|Withdrawal by Subject|1|||
105541791|NCT04086472|363985650|FG001|Overall Study|Withdrawal by Subject|1|||
105541792|NCT04086472|363985651|FG002|Overall Study|Withdrawal by Subject|1|||
105541793|NCT04086472|363985652|FG003|Overall Study|Withdrawal by Subject|0|||
105541794|NCT04086472|363985653|FG004|Overall Study|Withdrawal by Subject|0|||
105541795|NCT04086472|363985649|FG000|Overall Study|Various reasons|2|||
105541796|NCT04086472|363985650|FG001|Overall Study|Various reasons|0|||
105541797|NCT04086472|363985651|FG002|Overall Study|Various reasons|0|||
105541798|NCT04086472|363985652|FG003|Overall Study|Various reasons|3|||
105541799|NCT04086472|363985653|FG004|Overall Study|Various reasons|1|||
105541800|NCT00048724|363985659|FG000|Overall Study|Adverse Event|53|||
105541801|NCT00048724|363985660|FG001|Overall Study|Adverse Event|12|||
105541802|NCT00048724|363985659|FG000|Overall Study|Withdrawal by Subject|34|||
105541803|NCT00048724|363985660|FG001|Overall Study|Withdrawal by Subject|54|||
105541804|NCT00048724|363985659|FG000|Overall Study|Lost to Follow-up|5|||
105541805|NCT00048724|363985660|FG001|Overall Study|Lost to Follow-up|5|||
105541806|NCT00048724|363985659|FG000|Overall Study|Protocol-defined Clinical Event|17|||
105541807|NCT00048724|363985660|FG001|Overall Study|Protocol-defined Clinical Event|32|||
105541808|NCT00048724|363985659|FG000|Overall Study|Noncompliance With Protocol|4|||
105541809|NCT00048724|363985660|FG001|Overall Study|Noncompliance With Protocol|12|||
105541810|NCT00048724|363985659|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
105541811|NCT00048724|363985660|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
105541812|NCT00048724|363985659|FG000|Overall Study|Administrative|1|||
105541813|NCT00048724|363985660|FG001|Overall Study|Administrative|1|||
105541814|NCT04317586|363985661|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
105541815|NCT04317586|363985661|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
105541816|NCT01276327|363985664|FG000|Overall Study|Adverse Event|1|||
105541817|NCT01276327|363985665|FG001|Overall Study|Adverse Event|3|||
105541818|NCT01276327|363985664|FG000|Overall Study|Withdrawal by Subject|1|||
105541819|NCT01276327|363985665|FG001|Overall Study|Withdrawal by Subject|0|||
105541820|NCT02992899|363985672|FG000|Overall Study|Withdrawal by Subject|1|||
105541821|NCT02992899|363985673|FG001|Overall Study|Withdrawal by Subject|0|||
105541822|NCT02992899|363985672|FG000|Overall Study|Lost to Follow-up|1|||
105541823|NCT02992899|363985673|FG001|Overall Study|Lost to Follow-up|3|||
105541824|NCT01831089|363985674|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
105541825|NCT01831089|363985675|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
105541826|NCT01831089|363985676|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
105541827|NCT01831089|363985677|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
105541828|NCT01831089|363985678|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
105541829|NCT01831089|363985679|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
105541830|NCT01831089|363985674|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
105541831|NCT01831089|363985675|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
105541832|NCT01831089|363985676|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
105541833|NCT01831089|363985677|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
105541834|NCT01831089|363985678|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
105541835|NCT01831089|363985679|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
105541836|NCT01831089|363985674|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
105541837|NCT01831089|363985675|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
105541838|NCT01831089|363985676|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
105541839|NCT01831089|363985677|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
105541840|NCT01831089|363985678|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
105541841|NCT01831089|363985679|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
105541842|NCT01831089|363985674|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
105541843|NCT01831089|363985675|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
105541844|NCT01831089|363985676|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
105541845|NCT01831089|363985677|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
105541846|NCT01831089|363985678|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
105541847|NCT01831089|363985679|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
105541848|NCT01831089|363985674|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
105541849|NCT01831089|363985675|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
105541850|NCT01831089|363985676|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
105541851|NCT01831089|363985677|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
105541852|NCT01831089|363985678|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
105541853|NCT01831089|363985679|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
105541854|NCT01831089|363985674|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
105541855|NCT01831089|363985675|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
105541856|NCT01831089|363985676|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
105541857|NCT01831089|363985677|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
105541858|NCT01831089|363985678|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
105541859|NCT01831089|363985679|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
105541860|NCT01831089|363985674|FG000|Cohort III: Dose Level 3|Global end of study|0|||
105541861|NCT01831089|363985675|FG001|Cohort III: Dose Level 3|Global end of study|0|||
105541862|NCT01831089|363985676|FG002|Cohort III: Dose Level 3|Global end of study|1|||
105541863|NCT01831089|363985677|FG003|Cohort III: Dose Level 3|Global end of study|0|||
105541864|NCT01831089|363985678|FG004|Cohort III: Dose Level 3|Global end of study|0|||
105541865|NCT01831089|363985679|FG005|Cohort III: Dose Level 3|Global end of study|0|||
105541866|NCT01831089|363985674|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
105541867|NCT01831089|363985675|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
105541868|NCT01831089|363985676|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
105541869|NCT01831089|363985677|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
105541870|NCT01831089|363985678|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
105541871|NCT01831089|363985679|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
105541872|NCT01831089|363985674|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
105541873|NCT01831089|363985675|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
105541874|NCT01831089|363985676|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
105541875|NCT01831089|363985677|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
105541876|NCT01831089|363985678|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
105541877|NCT01831089|363985679|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
105541878|NCT01831089|363985674|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
105541879|NCT01831089|363985675|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
105541880|NCT01831089|363985676|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
105541881|NCT01831089|363985677|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
105541882|NCT01831089|363985678|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
105541883|NCT01831089|363985679|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
105541884|NCT01831089|363985674|FG000|Cohort V: Dose Level 5|Death|0|||
105541885|NCT01831089|363985675|FG001|Cohort V: Dose Level 5|Death|0|||
105541886|NCT01831089|363985676|FG002|Cohort V: Dose Level 5|Death|0|||
105541887|NCT01831089|363985677|FG003|Cohort V: Dose Level 5|Death|0|||
105541888|NCT01831089|363985678|FG004|Cohort V: Dose Level 5|Death|1|||
105541889|NCT01831089|363985679|FG005|Cohort V: Dose Level 5|Death|0|||
105541890|NCT01831089|363985674|FG000|Cohort V: Dose Level 5|Global end of study|0|||
105541891|NCT01831089|363985675|FG001|Cohort V: Dose Level 5|Global end of study|0|||
105541892|NCT01831089|363985676|FG002|Cohort V: Dose Level 5|Global end of study|0|||
105541893|NCT01831089|363985677|FG003|Cohort V: Dose Level 5|Global end of study|0|||
105541894|NCT01831089|363985678|FG004|Cohort V: Dose Level 5|Global end of study|2|||
105541895|NCT01831089|363985679|FG005|Cohort V: Dose Level 5|Global end of study|0|||
105541896|NCT01831089|363985674|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
105541897|NCT01831089|363985675|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
105541898|NCT01831089|363985676|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
105541899|NCT01831089|363985677|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
105541900|NCT01831089|363985678|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
105541901|NCT01831089|363985679|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
105541902|NCT01831089|363985674|FG000|Cohort B: Arm B|Progressive disease|0|||
105541903|NCT01831089|363985675|FG001|Cohort B: Arm B|Progressive disease|0|||
105541904|NCT01831089|363985676|FG002|Cohort B: Arm B|Progressive disease|0|||
105541905|NCT01831089|363985677|FG003|Cohort B: Arm B|Progressive disease|0|||
105541906|NCT01831089|363985678|FG004|Cohort B: Arm B|Progressive disease|0|||
105541907|NCT01831089|363985679|FG005|Cohort B: Arm B|Progressive disease|8|||
105541908|NCT01831089|363985674|FG000|Cohort B: Arm B|Physician Decision|0|||
105541909|NCT01831089|363985675|FG001|Cohort B: Arm B|Physician Decision|0|||
105541910|NCT01831089|363985676|FG002|Cohort B: Arm B|Physician Decision|0|||
105541911|NCT01831089|363985677|FG003|Cohort B: Arm B|Physician Decision|0|||
105541912|NCT01831089|363985678|FG004|Cohort B: Arm B|Physician Decision|0|||
105541913|NCT01831089|363985679|FG005|Cohort B: Arm B|Physician Decision|2|||
105541914|NCT01831089|363985674|FG000|Cohort B: Arm B|Never treated|0|||
105541915|NCT01831089|363985675|FG001|Cohort B: Arm B|Never treated|0|||
105541916|NCT01831089|363985676|FG002|Cohort B: Arm B|Never treated|0|||
105541917|NCT01831089|363985677|FG003|Cohort B: Arm B|Never treated|0|||
105541918|NCT01831089|363985678|FG004|Cohort B: Arm B|Never treated|0|||
105541919|NCT01831089|363985679|FG005|Cohort B: Arm B|Never treated|2|||
105541920|NCT01831089|363985674|FG000|Cohort B: Arm B|Adverse Event|0|||
105541921|NCT01831089|363985675|FG001|Cohort B: Arm B|Adverse Event|0|||
105541922|NCT01831089|363985676|FG002|Cohort B: Arm B|Adverse Event|0|||
105541923|NCT01831089|363985677|FG003|Cohort B: Arm B|Adverse Event|0|||
105541924|NCT01831089|363985678|FG004|Cohort B: Arm B|Adverse Event|0|||
105541925|NCT01831089|363985679|FG005|Cohort B: Arm B|Adverse Event|1|||
105541926|NCT01831089|363985674|FG000|Cohort B: Arm B|Global end of study|0|||
105541927|NCT01831089|363985675|FG001|Cohort B: Arm B|Global end of study|0|||
105541928|NCT01831089|363985676|FG002|Cohort B: Arm B|Global end of study|0|||
105541929|NCT01831089|363985677|FG003|Cohort B: Arm B|Global end of study|0|||
105541930|NCT01831089|363985678|FG004|Cohort B: Arm B|Global end of study|0|||
105541931|NCT01831089|363985679|FG005|Cohort B: Arm B|Global end of study|1|||
105541932|NCT02443298|363985680|FG000|Overall Study|Adverse Event|3|||
105541933|NCT02443298|363985681|FG001|Overall Study|Adverse Event|3|||
105541934|NCT02443298|363985680|FG000|Overall Study|Withdrawal by Subject|1|||
105541935|NCT02443298|363985681|FG001|Overall Study|Withdrawal by Subject|2|||
105541936|NCT03698773|363985682|FG000|Overall Study|Lost to Follow-up|2|||
105541937|NCT03698773|363985683|FG001|Overall Study|Lost to Follow-up|1|||
105541938|NCT00908960|363985684|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
105541939|NCT00908960|363985685|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
105541940|NCT00908960|363985686|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
105541941|NCT02822794|363985687|FG000|Overall Study|Withdrew Consent|1|||
105541942|NCT02822794|363985688|FG001|Overall Study|Withdrew Consent|0|||
105541943|NCT01599650|363985689|FG000|Overall Study|Administrative issue|1|||
105541944|NCT01599650|363985690|FG001|Overall Study|Administrative issue|0|||
105541945|NCT01599650|363985691|FG002|Overall Study|Administrative issue|1|||
105541946|NCT01599650|363985689|FG000|Overall Study|Physician Decision|2|||
105541947|NCT01599650|363985690|FG001|Overall Study|Physician Decision|0|||
105541948|NCT01599650|363985691|FG002|Overall Study|Physician Decision|7|||
105541949|NCT01599650|363985689|FG000|Overall Study|Protocol Violation|0|||
105541950|NCT01599650|363985690|FG001|Overall Study|Protocol Violation|3|||
105541951|NCT01599650|363985691|FG002|Overall Study|Protocol Violation|0|||
105541952|NCT01599650|363985689|FG000|Overall Study|Death|2|||
105541953|NCT01599650|363985690|FG001|Overall Study|Death|1|||
105541954|NCT01599650|363985691|FG002|Overall Study|Death|2|||
105541955|NCT01599650|363985689|FG000|Overall Study|Lost to Follow-up|3|||
105541956|NCT01599650|363985690|FG001|Overall Study|Lost to Follow-up|3|||
105541957|NCT01599650|363985691|FG002|Overall Study|Lost to Follow-up|3|||
105541958|NCT01599650|363985689|FG000|Overall Study|Withdrawal by Subject|11|||
105541959|NCT01599650|363985690|FG001|Overall Study|Withdrawal by Subject|11|||
105541960|NCT01599650|363985691|FG002|Overall Study|Withdrawal by Subject|10|||
105541961|NCT01599650|363985689|FG000|Overall Study|Adverse Event|3|||
105541962|NCT01599650|363985690|FG001|Overall Study|Adverse Event|8|||
105541963|NCT01599650|363985691|FG002|Overall Study|Adverse Event|4|||
105541964|NCT01748994|363985692|FG000|Overall Study|Lost to Follow-up|8|||
105541965|NCT01748994|363985693|FG001|Overall Study|Lost to Follow-up|6|||
105541966|NCT01767116|363985694|FG000|Overall Study|Lost to Follow-up|2|||
105541967|NCT01767116|363985695|FG001|Overall Study|Lost to Follow-up|2|||
105541968|NCT02520531|363985700|FG000|Overall Study|Revision of study device components|2|||
105541969|NCT02520531|363985701|FG001|Overall Study|Revision of study device components|2|||
105541970|NCT02520531|363985700|FG000|Overall Study|Death|1|||
105541971|NCT02520531|363985701|FG001|Overall Study|Death|2|||
105541972|NCT02520531|363985700|FG000|Overall Study|Lost to Follow-up|1|||
105541973|NCT02520531|363985701|FG001|Overall Study|Lost to Follow-up|1|||
105541974|NCT02520531|363985700|FG000|Overall Study|Meet exclusion criterion|0|||
105541975|NCT02520531|363985701|FG001|Overall Study|Meet exclusion criterion|1|||
105541976|NCT02520531|363985700|FG000|Overall Study|Withdrawal by Subject|1|||
105541977|NCT02520531|363985701|FG001|Overall Study|Withdrawal by Subject|0|||
105541978|NCT02520531|363985700|FG000|Overall Study|Not study device|1|||
105541979|NCT02520531|363985701|FG001|Overall Study|Not study device|0|||
105541980|NCT02141516|363985702|FG000|Overall Study|Adverse Event|0|||
105541981|NCT02141516|363985703|FG001|Overall Study|Adverse Event|1|||
105541982|NCT02141516|363985704|FG002|Overall Study|Adverse Event|0|||
105541983|NCT02141516|363985702|FG000|Overall Study|Lost to Follow-up|0|||
105541984|NCT02141516|363985703|FG001|Overall Study|Lost to Follow-up|1|||
105541985|NCT02141516|363985704|FG002|Overall Study|Lost to Follow-up|0|||
105541986|NCT02141516|363985702|FG000|Overall Study|Other|0|||
105541987|NCT02141516|363985703|FG001|Overall Study|Other|3|||
105541988|NCT02141516|363985704|FG002|Overall Study|Other|0|||
105541989|NCT02041429|363985707|FG000|Overall Study|Progressive Disease|2|||
105541990|NCT02041429|363985708|FG001|Overall Study|Progressive Disease|2|||
105541991|NCT02041429|363985709|FG002|Overall Study|Progressive Disease|3|||
105541992|NCT02041429|363985710|FG003|Overall Study|Progressive Disease|2|||
105541993|NCT02041429|363985707|FG000|Overall Study|Toxicity|0|||
105541994|NCT02041429|363985708|FG001|Overall Study|Toxicity|1|||
105541995|NCT02041429|363985709|FG002|Overall Study|Toxicity|4|||
105595883|NCT00430300|364182452|FG002|Overall Study|Other|0|||
105595884|NCT00430300|364182453|FG003|Overall Study|Other|1|||
105541996|NCT02041429|363985710|FG003|Overall Study|Toxicity|2|||
105541997|NCT02041429|363985707|FG000|Overall Study|Withdrawal by Subject|0|||
105541998|NCT02041429|363985708|FG001|Overall Study|Withdrawal by Subject|1|||
105541999|NCT02041429|363985709|FG002|Overall Study|Withdrawal by Subject|0|||
105542000|NCT02041429|363985710|FG003|Overall Study|Withdrawal by Subject|0|||
105542001|NCT02041429|363985707|FG000|Overall Study|On Maintenance Therapy|1|||
105542002|NCT02041429|363985708|FG001|Overall Study|On Maintenance Therapy|0|||
105595885|NCT02754479|364182454|FG000|Overall Study|Lost to Follow-up|1|||
105542003|NCT02041429|363985709|FG002|Overall Study|On Maintenance Therapy|0|||
105542004|NCT02041429|363985710|FG003|Overall Study|On Maintenance Therapy|2|||
105542005|NCT03251924|363985713|FG000|Overall Study|Disease Progression|6|||
105542006|NCT03251924|363985714|FG001|Overall Study|Disease Progression|6|||
105542007|NCT03251924|363985715|FG002|Overall Study|Disease Progression|7|||
105542008|NCT03251924|363985716|FG003|Overall Study|Disease Progression|8|||
105542009|NCT03251924|363985717|FG004|Overall Study|Disease Progression|8|||
105542010|NCT03251924|363985718|FG005|Overall Study|Disease Progression|7|||
105542011|NCT03251924|363985719|FG006|Overall Study|Disease Progression|6|||
105542012|NCT03251924|363985720|FG007|Overall Study|Disease Progression|10|||
105542013|NCT03251924|363985721|FG008|Overall Study|Disease Progression|6|||
105542014|NCT03251924|363985713|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
105542015|NCT03251924|363985714|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
105542016|NCT03251924|363985715|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
105542017|NCT03251924|363985716|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
105542018|NCT03251924|363985717|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
105542019|NCT03251924|363985718|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
105542020|NCT03251924|363985719|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
105542021|NCT03251924|363985720|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
105542022|NCT03251924|363985721|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
105542023|NCT03251924|363985713|FG000|Overall Study|Death|0|||
105542024|NCT03251924|363985714|FG001|Overall Study|Death|1|||
105542025|NCT03251924|363985715|FG002|Overall Study|Death|0|||
105542026|NCT03251924|363985716|FG003|Overall Study|Death|1|||
105542027|NCT03251924|363985717|FG004|Overall Study|Death|1|||
105542028|NCT03251924|363985718|FG005|Overall Study|Death|1|||
105542029|NCT03251924|363985719|FG006|Overall Study|Death|0|||
105542030|NCT03251924|363985720|FG007|Overall Study|Death|0|||
105542031|NCT03251924|363985721|FG008|Overall Study|Death|0|||
105542032|NCT03251924|363985713|FG000|Overall Study|Study Drug Toxicity|0|||
105542033|NCT03251924|363985714|FG001|Overall Study|Study Drug Toxicity|0|||
105542034|NCT03251924|363985715|FG002|Overall Study|Study Drug Toxicity|0|||
105542035|NCT03251924|363985716|FG003|Overall Study|Study Drug Toxicity|1|||
105542036|NCT03251924|363985717|FG004|Overall Study|Study Drug Toxicity|0|||
105542037|NCT03251924|363985718|FG005|Overall Study|Study Drug Toxicity|0|||
105542038|NCT03251924|363985719|FG006|Overall Study|Study Drug Toxicity|0|||
105542039|NCT03251924|363985720|FG007|Overall Study|Study Drug Toxicity|0|||
105542040|NCT03251924|363985721|FG008|Overall Study|Study Drug Toxicity|1|||
105542041|NCT03251924|363985713|FG000|Overall Study|Other Reasons|0|||
105542042|NCT03251924|363985714|FG001|Overall Study|Other Reasons|0|||
105542043|NCT03251924|363985715|FG002|Overall Study|Other Reasons|0|||
105542044|NCT03251924|363985716|FG003|Overall Study|Other Reasons|0|||
105542045|NCT03251924|363985717|FG004|Overall Study|Other Reasons|0|||
105542046|NCT03251924|363985718|FG005|Overall Study|Other Reasons|0|||
105542047|NCT03251924|363985719|FG006|Overall Study|Other Reasons|0|||
105542048|NCT03251924|363985720|FG007|Overall Study|Other Reasons|0|||
105542049|NCT03251924|363985721|FG008|Overall Study|Other Reasons|1|||
105542050|NCT03251924|363985713|FG000|Overall Study|Participant request to discontinue study treatment|0|||
105542051|NCT03251924|363985714|FG001|Overall Study|Participant request to discontinue study treatment|0|||
105542052|NCT03251924|363985715|FG002|Overall Study|Participant request to discontinue study treatment|0|||
105542053|NCT03251924|363985716|FG003|Overall Study|Participant request to discontinue study treatment|0|||
105542054|NCT03251924|363985717|FG004|Overall Study|Participant request to discontinue study treatment|0|||
105542055|NCT03251924|363985718|FG005|Overall Study|Participant request to discontinue study treatment|0|||
105542056|NCT03251924|363985719|FG006|Overall Study|Participant request to discontinue study treatment|0|||
105542057|NCT03251924|363985720|FG007|Overall Study|Participant request to discontinue study treatment|1|||
105542058|NCT03251924|363985721|FG008|Overall Study|Participant request to discontinue study treatment|0|||
105542059|NCT00153101|363985725|FG000|Overall Study|Lost to Follow-up|14|||
105542060|NCT00153101|363985726|FG001|Overall Study|Lost to Follow-up|14|||
105542061|NCT00153101|363985727|FG002|Overall Study|Lost to Follow-up|12|||
105542062|NCT00153101|363985728|FG003|Overall Study|Lost to Follow-up|5|||
105542063|NCT00153101|363985729|FG004|Overall Study|Lost to Follow-up|5|||
105542064|NCT00153101|363985725|FG000|Overall Study|Withdrawal by Subject|3|||
105542065|NCT00153101|363985726|FG001|Overall Study|Withdrawal by Subject|4|||
105542066|NCT00153101|363985727|FG002|Overall Study|Withdrawal by Subject|3|||
105542067|NCT00153101|363985728|FG003|Overall Study|Withdrawal by Subject|3|||
105542068|NCT00153101|363985729|FG004|Overall Study|Withdrawal by Subject|5|||
105542069|NCT02610140|363985730|FG000|Randomization and Treatment Period|Radiological progression|23|||
105542070|NCT02610140|363985731|FG001|Randomization and Treatment Period|Radiological progression|15|||
105542071|NCT02610140|363985730|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
105542072|NCT02610140|363985731|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
105542073|NCT02610140|363985730|FG000|Randomization and Treatment Period|Protocol Violation|1|||
105542074|NCT02610140|363985731|FG001|Randomization and Treatment Period|Protocol Violation|0|||
105542075|NCT02610140|363985730|FG000|Randomization and Treatment Period|Physician Decision|0|||
105542076|NCT02610140|363985731|FG001|Randomization and Treatment Period|Physician Decision|1|||
105542077|NCT02610140|363985730|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
105542078|NCT02610140|363985731|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
105542079|NCT02610140|363985730|FG000|Randomization and Treatment Period|Death|7|||
105542080|NCT02610140|363985731|FG001|Randomization and Treatment Period|Death|1|||
105542081|NCT02610140|363985730|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
105542082|NCT02610140|363985731|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
105542083|NCT02610140|363985730|FG000|Randomization and Treatment Period|Adverse Event|44|||
105542084|NCT02610140|363985731|FG001|Randomization and Treatment Period|Adverse Event|13|||
105542085|NCT02610140|363985730|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
105542086|NCT02610140|363985731|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
105542087|NCT02610140|363985730|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
105542088|NCT02610140|363985731|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
105542089|NCT02610140|363985730|FG000|Randomization and Treatment Period|Not treated|3|||
105542090|NCT02610140|363985731|FG001|Randomization and Treatment Period|Not treated|10|||
105542091|NCT02610140|363985730|FG000|Safety Follow-up|Other|0|||
105542092|NCT02610140|363985731|FG001|Safety Follow-up|Other|2|||
105542093|NCT02610140|363985730|FG000|Safety Follow-up|Lost to Follow-up|1|||
105542094|NCT02610140|363985731|FG001|Safety Follow-up|Lost to Follow-up|0|||
105542095|NCT02610140|363985730|FG000|Safety Follow-up|No follow-up|5|||
105542096|NCT02610140|363985731|FG001|Safety Follow-up|No follow-up|3|||
105542097|NCT02610140|363985730|FG000|Safety Follow-up|Death|12|||
105542098|NCT02610140|363985731|FG001|Safety Follow-up|Death|2|||
105542099|NCT02610140|363985730|FG000|Safety Follow-up|Deterioration of general conditions|15|||
105542100|NCT02610140|363985731|FG001|Safety Follow-up|Deterioration of general conditions|5|||
105542101|NCT02610140|363985730|FG000|Safety Follow-up|Withdrawal by Subject|12|||
105542102|NCT02610140|363985731|FG001|Safety Follow-up|Withdrawal by Subject|12|||
105542103|NCT02610140|363985730|FG000|Active Follow-up|Progressive disease - radiological|30|||
105542104|NCT02610140|363985731|FG001|Active Follow-up|Progressive disease - radiological|22|||
105542105|NCT02610140|363985730|FG000|Active Follow-up|Death|8|||
105542106|NCT02610140|363985731|FG001|Active Follow-up|Death|1|||
105542107|NCT02610140|363985730|FG000|Active Follow-up|Withdrawal by Subject|4|||
105542108|NCT02610140|363985731|FG001|Active Follow-up|Withdrawal by Subject|0|||
105542109|NCT02610140|363985730|FG000|Active Follow-up|Progressive disease - clinical|1|||
105542110|NCT02610140|363985731|FG001|Active Follow-up|Progressive disease - clinical|2|||
105542111|NCT02610140|363985730|FG000|Active Follow-up|Deterioration of general conditions|1|||
105542112|NCT02610140|363985731|FG001|Active Follow-up|Deterioration of general conditions|0|||
105542113|NCT02610140|363985730|FG000|Active Follow-up|Ongoing but not completed|4|||
105542114|NCT02610140|363985731|FG001|Active Follow-up|Ongoing but not completed|1|||
105542115|NCT02610140|363985730|FG000|Long-term Follow-up|Death|86|||
105542116|NCT02610140|363985731|FG001|Long-term Follow-up|Death|44|||
105542117|NCT02610140|363985730|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
105542118|NCT02610140|363985731|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
105542119|NCT02610140|363985730|FG000|Long-term Follow-up|Lost to Follow-up|1|||
105542120|NCT02610140|363985731|FG001|Long-term Follow-up|Lost to Follow-up|2|||
105542121|NCT02610140|363985730|FG000|Long-term Follow-up|Ongoing but not completed|30|||
105542122|NCT02610140|363985731|FG001|Long-term Follow-up|Ongoing but not completed|17|||
105542123|NCT00887341|363985732|FG000|Overall Study|Refused treatment|1|||
105542124|NCT00887341|363985733|FG001|Overall Study|Refused treatment|0|||
105542125|NCT00887341|363985732|FG000|Overall Study|Withdrawal by Subject|1|||
105542126|NCT00887341|363985733|FG001|Overall Study|Withdrawal by Subject|1|||
105542127|NCT00887341|363985732|FG000|Overall Study|Adverse Event|0|||
105542128|NCT00887341|363985733|FG001|Overall Study|Adverse Event|1|||
105542129|NCT00887341|363985732|FG000|Overall Study|Lost to Follow-up|0|||
105542130|NCT00887341|363985733|FG001|Overall Study|Lost to Follow-up|1|||
105542131|NCT01591681|363985736|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
105542132|NCT01591681|363985736|FG000|Overall Study|Failed to use system during run-in|1|||
105542133|NCT01649856|363985739|FG000|Overall Study|Withdrawal by Subject|14|||
105542134|NCT01649856|363985740|FG001|Overall Study|Withdrawal by Subject|14|||
105542135|NCT01649856|363985739|FG000|Overall Study|Protocol Violation|4|||
105542136|NCT01649856|363985740|FG001|Overall Study|Protocol Violation|4|||
105542137|NCT01649856|363985739|FG000|Overall Study|Treatment Failure|1|||
105542138|NCT01649856|363985740|FG001|Overall Study|Treatment Failure|1|||
105542139|NCT01649856|363985739|FG000|Overall Study|Death|69|||
105542140|NCT01649856|363985740|FG001|Overall Study|Death|34|||
105542141|NCT01649856|363985739|FG000|Overall Study|Stable or Progressed Disease|5|||
105542142|NCT01649856|363985740|FG001|Overall Study|Stable or Progressed Disease|3|||
105542143|NCT01649856|363985739|FG000|Overall Study|Lost to Follow-up|20|||
105542144|NCT01649856|363985740|FG001|Overall Study|Lost to Follow-up|16|||
105542145|NCT01649856|363985739|FG000|Overall Study|Lack of Compliance|6|||
105542146|NCT01649856|363985740|FG001|Overall Study|Lack of Compliance|1|||
105542147|NCT01649856|363985739|FG000|Overall Study|Other|20|||
105542148|NCT01649856|363985740|FG001|Overall Study|Other|5|||
105542149|NCT00179647|363985741|FG000|Overall Study|Adverse Event|294|||
105542150|NCT00179647|363985741|FG000|Overall Study|Lack of Efficacy|478|||
105542151|NCT00179647|363985741|FG000|Overall Study|Withdrawal by Subject|83|||
105542152|NCT00179647|363985741|FG000|Overall Study|Lost to Follow-up|4|||
105542153|NCT00179647|363985741|FG000|Overall Study|Death|94|||
105542154|NCT00179647|363985741|FG000|Overall Study|Other|960|||
105542155|NCT00281840|363985742|FG000|Overall Study|Adverse Event|12|||
105542156|NCT00281840|363985742|FG000|Overall Study|Physician Decision|6|||
105542157|NCT00281840|363985742|FG000|Overall Study|Withdrawal by Subject|3|||
105542158|NCT00281840|363985742|FG000|Overall Study|Disease Progression|2|||
105542159|NCT00281840|363985742|FG000|Overall Study|exceed maximum delay in treatment|1|||
105542160|NCT00281840|363985742|FG000|Overall Study|Complicating Disease|1|||
105542161|NCT01440946|363985743|FG000|Overall Study|Lost to Follow-up|1|||
105542162|NCT01440946|363985744|FG001|Overall Study|Lost to Follow-up|1|||
105542163|NCT01440946|363985743|FG000|Overall Study|Physician Decision|1|||
105542164|NCT01440946|363985744|FG001|Overall Study|Physician Decision|0|||
105542165|NCT01826825|363985745|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
105542166|NCT01826825|363985746|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
105542167|NCT01858194|363985747|FG000|Overall Study|Total Artificial Heart Implant|0|||
105542168|NCT01858194|363985748|FG001|Overall Study|Total Artificial Heart Implant|1|||
105542169|NCT01858194|363985747|FG000|Overall Study|Lost to Follow-up|0|||
105542170|NCT01858194|363985748|FG001|Overall Study|Lost to Follow-up|1|||
105542171|NCT01312961|363985754|FG000|Overall Study|Adverse Event|3|||
105542172|NCT01312961|363985755|FG001|Overall Study|Adverse Event|3|||
105542173|NCT01312961|363985754|FG000|Overall Study|Lack of Efficacy|11|||
105542174|NCT01312961|363985755|FG001|Overall Study|Lack of Efficacy|1|||
105542175|NCT01312961|363985754|FG000|Overall Study|Poor compliance to protocol|1|||
105542176|NCT01312961|363985755|FG001|Overall Study|Poor compliance to protocol|0|||
105542177|NCT01312961|363985754|FG000|Overall Study|Other than specified above|2|||
105542178|NCT01312961|363985755|FG001|Overall Study|Other than specified above|3|||
105542179|NCT03221257|363985756|FG000|Overall Study|Lost to Follow-up|0|||
105542180|NCT03221257|363985757|FG001|Overall Study|Lost to Follow-up|1|||
105542181|NCT03221257|363985756|FG000|Overall Study|Withdrawal by Subject|1|||
105542182|NCT03221257|363985757|FG001|Overall Study|Withdrawal by Subject|1|||
105542183|NCT02207829|363985758|FG000|Overall Study|Adverse Event|10|||
105542184|NCT02207829|363985759|FG001|Overall Study|Adverse Event|9|||
105542185|NCT02207829|363985758|FG000|Overall Study|Lack of Efficacy|7|||
105542186|NCT02207829|363985759|FG001|Overall Study|Lack of Efficacy|5|||
105542187|NCT02207829|363985758|FG000|Overall Study|Lost to Follow-up|2|||
105542188|NCT02207829|363985759|FG001|Overall Study|Lost to Follow-up|2|||
105542189|NCT02207829|363985758|FG000|Overall Study|Protocol deviation|5|||
105542190|NCT02207829|363985759|FG001|Overall Study|Protocol deviation|4|||
105542191|NCT02207829|363985758|FG000|Overall Study|Withdrew consent|18|||
105542192|NCT02207829|363985759|FG001|Overall Study|Withdrew consent|14|||
105542193|NCT00958880|363985762|FG000|Overall Study|Lost to Follow-up|2|||
105542194|NCT00958880|363985763|FG001|Overall Study|Lost to Follow-up|2|||
105542195|NCT01971346|363985764|FG000|Overall Study|Protocol Violation|3|||
105542196|NCT01971346|363985764|FG000|Overall Study|Lost to Follow-up|2|||
105542197|NCT01971346|363985764|FG000|Overall Study|Withdrawal by Subject|2|||
105542198|NCT01971346|363985764|FG000|Overall Study|Physician Decision|1|||
105542199|NCT01712984|363985765|FG000|Overall Study|Adverse Event|0|||
105542200|NCT01712984|363985766|FG001|Overall Study|Adverse Event|0|||
105542201|NCT01712984|363985767|FG002|Overall Study|Adverse Event|1|||
105542202|NCT01712984|363985765|FG000|Overall Study|Protocol Violation|2|||
105542203|NCT01712984|363985766|FG001|Overall Study|Protocol Violation|0|||
105542204|NCT01712984|363985767|FG002|Overall Study|Protocol Violation|1|||
105542205|NCT01712984|363985765|FG000|Overall Study|Lost to Follow-up|8|||
105542206|NCT01712984|363985766|FG001|Overall Study|Lost to Follow-up|10|||
105542207|NCT01712984|363985767|FG002|Overall Study|Lost to Follow-up|1|||
105542208|NCT01712984|363985765|FG000|Overall Study|Withdrawal by Subject|6|||
105542209|NCT01712984|363985766|FG001|Overall Study|Withdrawal by Subject|6|||
105542210|NCT01712984|363985767|FG002|Overall Study|Withdrawal by Subject|7|||
105542211|NCT01652716|363985768|FG000|Overall Study|Loss of glucose control|1|||
105542212|NCT01652716|363985769|FG001|Overall Study|Loss of glucose control|0|||
105542213|NCT01652716|363985768|FG000|Overall Study|Administrative|0|||
105542214|NCT01652716|363985769|FG001|Overall Study|Administrative|2|||
105542215|NCT01652716|363985768|FG000|Overall Study|Investigator decision|1|||
105542216|NCT01652716|363985769|FG001|Overall Study|Investigator decision|4|||
105542217|NCT01652716|363985768|FG000|Overall Study|Lost to Follow-up|12|||
105542218|NCT01652716|363985769|FG001|Overall Study|Lost to Follow-up|11|||
105542219|NCT01652716|363985768|FG000|Overall Study|Protocol Violation|2|||
105542220|NCT01652716|363985769|FG001|Overall Study|Protocol Violation|1|||
105542221|NCT01652716|363985768|FG000|Overall Study|Adverse Event|7|||
105542222|NCT01652716|363985769|FG001|Overall Study|Adverse Event|10|||
105542223|NCT01652716|363985768|FG000|Overall Study|Withdrawal by Subject|33|||
105542224|NCT01652716|363985769|FG001|Overall Study|Withdrawal by Subject|18|||
105542225|NCT02316717|363985770|FG000|Overall Study|Adverse Event|2|||
105542226|NCT02316717|363985771|FG001|Overall Study|Adverse Event|2|||
105542227|NCT02316717|363985772|FG002|Overall Study|Adverse Event|0|||
105542228|NCT02316717|363985770|FG000|Overall Study|Lost to Follow-up|1|||
105542229|NCT02316717|363985771|FG001|Overall Study|Lost to Follow-up|2|||
105542230|NCT02316717|363985772|FG002|Overall Study|Lost to Follow-up|1|||
105542231|NCT02316717|363985770|FG000|Overall Study|Non compliance|3|||
105542232|NCT02316717|363985771|FG001|Overall Study|Non compliance|1|||
105542233|NCT02316717|363985772|FG002|Overall Study|Non compliance|0|||
105542234|NCT02316717|363985770|FG000|Overall Study|Protocol Violation|2|||
105542235|NCT02316717|363985771|FG001|Overall Study|Protocol Violation|0|||
105542236|NCT02316717|363985772|FG002|Overall Study|Protocol Violation|0|||
105542237|NCT02316717|363985770|FG000|Overall Study|Withdrawal by Subject|2|||
105542238|NCT02316717|363985771|FG001|Overall Study|Withdrawal by Subject|1|||
105542239|NCT02316717|363985772|FG002|Overall Study|Withdrawal by Subject|1|||
105542240|NCT02316717|363985770|FG000|Overall Study|Death|0|||
105542241|NCT02316717|363985771|FG001|Overall Study|Death|0|||
105542242|NCT02316717|363985772|FG002|Overall Study|Death|1|||
105542243|NCT02316717|363985770|FG000|Overall Study|Physician Decision|0|||
105542244|NCT02316717|363985771|FG001|Overall Study|Physician Decision|1|||
105542245|NCT02316717|363985772|FG002|Overall Study|Physician Decision|0|||
105542246|NCT02316717|363985770|FG000|Overall Study|TBC|1|||
105542247|NCT02316717|363985771|FG001|Overall Study|TBC|0|||
105542248|NCT02316717|363985772|FG002|Overall Study|TBC|0|||
105542249|NCT04122443|363985773|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
105542250|NCT04122443|363985774|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
105542251|NCT04122443|363985775|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
105542252|NCT04122443|363985773|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
105542253|NCT04122443|363985774|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
105542254|NCT04122443|363985775|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
105542255|NCT01916304|363985776|FG000|Overall Study|Screening failure|17|||
105542256|NCT01600586|363985777|FG000|Overall Study|Physician Decision|3|||
105542257|NCT01600586|363985778|FG001|Overall Study|Physician Decision|3|||
105542258|NCT02447991|363985782|FG000|Overall Study|Withdrawn by subject - no data|0|||
105542259|NCT02447991|363985783|FG001|Overall Study|Withdrawn by subject - no data|2|||
105542260|NCT02447991|363985782|FG000|Overall Study|Withdrawn by Subject - with data|4|||
105542261|NCT02447991|363985783|FG001|Overall Study|Withdrawn by Subject - with data|4|||
105542262|NCT02447991|363985782|FG000|Overall Study|Lost to Follow-up - no data|3|||
105542263|NCT02447991|363985783|FG001|Overall Study|Lost to Follow-up - no data|6|||
105542264|NCT02447991|363985782|FG000|Overall Study|Lost to follow-up - with data|0|||
105542265|NCT02447991|363985783|FG001|Overall Study|Lost to follow-up - with data|3|||
105542266|NCT02447991|363985782|FG000|Overall Study|End of study - no treatment results|3|||
105542267|NCT02447991|363985783|FG001|Overall Study|End of study - no treatment results|6|||
105542268|NCT02447991|363985782|FG000|Overall Study|End of study - partial treatment results|0|||
105542269|NCT02447991|363985783|FG001|Overall Study|End of study - partial treatment results|9|||
105542270|NCT02788175|363985784|FG000|Overall Study|Protocol Violation|3|||
105542271|NCT02788175|363985784|FG000|Overall Study|Withdrawal by Subject|4|||
105542272|NCT02788175|363985784|FG000|Overall Study|Ineligible prior to study agent|6|||
105542273|NCT00162136|363985785|FG000|Overall Study|Adverse Event|1|||
105542274|NCT00162136|363985785|FG000|Overall Study|Death|1|||
105542275|NCT00162136|363985785|FG000|Overall Study|Disease Progression/Relapse|23|||
105542276|NCT00162136|363985785|FG000|Overall Study|Investigator Request|5|||
105542277|NCT00162136|363985785|FG000|Overall Study|Study Drug Toxicity|4|||
105542278|NCT00162136|363985785|FG000|Overall Study|Withdrawal by Subject|1|||
105542279|NCT03930745|363985786|FG000|Overall Study|Lost to Follow-up|10|||
105542280|NCT03930745|363985787|FG001|Overall Study|Lost to Follow-up|5|||
105542281|NCT03930745|363985786|FG000|Overall Study|Withdrawal by Subject|1|||
105542282|NCT03930745|363985787|FG001|Overall Study|Withdrawal by Subject|2|||
105542283|NCT03930745|363985786|FG000|Overall Study|Protocol Violation|2|||
105542284|NCT03930745|363985787|FG001|Overall Study|Protocol Violation|2|||
105542285|NCT03930745|363985786|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
105542286|NCT03930745|363985787|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
105542287|NCT03930745|363985786|FG000|Overall Study|Adverse Event|0|||
105542288|NCT03930745|363985787|FG001|Overall Study|Adverse Event|1|||
105542289|NCT03930745|363985786|FG000|Overall Study|Pregnancy|0|||
105542290|NCT03930745|363985787|FG001|Overall Study|Pregnancy|1|||
105542291|NCT00818441|363985788|FG000|Overall Study|Death|69|||
105542292|NCT00818441|363985789|FG001|Overall Study|Death|26|||
105542293|NCT00818441|363985788|FG000|Overall Study|Other|5|||
105542294|NCT00818441|363985789|FG001|Overall Study|Other|0|||
105542295|NCT00818441|363985788|FG000|Overall Study|Lost to Follow-up|2|||
105542296|NCT00818441|363985789|FG001|Overall Study|Lost to Follow-up|1|||
105542297|NCT00818441|363985788|FG000|Overall Study|Withdrawal by Subject|2|||
105542298|NCT00818441|363985789|FG001|Overall Study|Withdrawal by Subject|0|||
105542299|NCT00818441|363985788|FG000|Overall Study|Adverse Event|0|||
105542300|NCT00818441|363985789|FG001|Overall Study|Adverse Event|1|||
105542301|NCT00818441|363985788|FG000|Overall Study|Study terminated by sponsor|11|||
105542302|NCT00818441|363985789|FG001|Overall Study|Study terminated by sponsor|2|||
105542303|NCT00560833|363985802|FG000|Overall Study|Adverse Event|16|||
105542304|NCT00560833|363985803|FG001|Overall Study|Adverse Event|10|||
105542305|NCT00560833|363985804|FG002|Overall Study|Adverse Event|25|||
105542306|NCT00560833|363985805|FG003|Overall Study|Adverse Event|23|||
105542307|NCT00560833|363985806|FG004|Overall Study|Adverse Event|35|||
105542308|NCT00560833|363985802|FG000|Overall Study|Lost to Follow-up|0|||
105542309|NCT00560833|363985803|FG001|Overall Study|Lost to Follow-up|0|||
105542310|NCT00560833|363985804|FG002|Overall Study|Lost to Follow-up|1|||
105542311|NCT00560833|363985805|FG003|Overall Study|Lost to Follow-up|0|||
105542312|NCT00560833|363985806|FG004|Overall Study|Lost to Follow-up|0|||
105542313|NCT00560833|363985802|FG000|Overall Study|Lack of Efficacy|22|||
105542314|NCT00560833|363985803|FG001|Overall Study|Lack of Efficacy|9|||
105542315|NCT00560833|363985804|FG002|Overall Study|Lack of Efficacy|6|||
105542316|NCT00560833|363985805|FG003|Overall Study|Lack of Efficacy|4|||
105542317|NCT00560833|363985806|FG004|Overall Study|Lack of Efficacy|4|||
105542318|NCT00560833|363985802|FG000|Overall Study|Participant uncooperative|5|||
105542319|NCT00560833|363985803|FG001|Overall Study|Participant uncooperative|5|||
105542320|NCT00560833|363985804|FG002|Overall Study|Participant uncooperative|4|||
105542321|NCT00560833|363985805|FG003|Overall Study|Participant uncooperative|4|||
105542322|NCT00560833|363985806|FG004|Overall Study|Participant uncooperative|2|||
105542323|NCT00560833|363985802|FG000|Overall Study|Other|1|||
105542324|NCT00560833|363985803|FG001|Overall Study|Other|1|||
105542325|NCT00560833|363985804|FG002|Overall Study|Other|3|||
105542326|NCT00560833|363985805|FG003|Overall Study|Other|0|||
105542327|NCT00560833|363985806|FG004|Overall Study|Other|0|||
105542328|NCT00560833|363985802|FG000|Overall Study|Never received drug|0|||
105542329|NCT00560833|363985803|FG001|Overall Study|Never received drug|1|||
105542330|NCT00560833|363985804|FG002|Overall Study|Never received drug|0|||
105542331|NCT00560833|363985805|FG003|Overall Study|Never received drug|0|||
105542332|NCT00560833|363985806|FG004|Overall Study|Never received drug|1|||
105542333|NCT00829621|363985807|FG000|Overall Study|Death|1|||
105542334|NCT00829621|363985808|FG001|Overall Study|Death|0|||
105542335|NCT00829621|363985807|FG000|Overall Study|Lost to Follow-up|3|||
105542336|NCT00829621|363985808|FG001|Overall Study|Lost to Follow-up|4|||
105542337|NCT02770391|363985809|FG000|Overall Study|Lost to Follow-up|2|||
105542338|NCT02770391|363985809|FG000|Overall Study|Withdrawal by Subject|1|||
105542339|NCT02770391|363985809|FG000|Overall Study|Surgery delayed unevaluable|2|||
105542340|NCT02770391|363985809|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
105542341|NCT00612313|363985815|FG000|Overall Study|Withdrawal by Subject|6|||
105542342|NCT00612313|363985816|FG001|Overall Study|Withdrawal by Subject|9|||
105542343|NCT00612313|363985815|FG000|Overall Study|Lost to Follow-up|11|||
105542344|NCT00612313|363985816|FG001|Overall Study|Lost to Follow-up|4|||
105542345|NCT04258839|363987759|FG000|Overall Study|Adverse Event|2|||
105542346|NCT04258839|363987760|FG001|Overall Study|Adverse Event|4|||
105542347|NCT04258839|363987759|FG000|Overall Study|Lack of Efficacy|0|||
105542348|NCT04258839|363987760|FG001|Overall Study|Lack of Efficacy|2|||
105542349|NCT04258839|363987759|FG000|Overall Study|Lost to Follow-up|2|||
105542350|NCT04258839|363987760|FG001|Overall Study|Lost to Follow-up|0|||
105542351|NCT04258839|363987759|FG000|Overall Study|Withdrawal by Subject|1|||
105542352|NCT04258839|363987760|FG001|Overall Study|Withdrawal by Subject|2|||
105542353|NCT04258839|363987759|FG000|Overall Study|Withdrawal by Caregiver|5|||
105542354|NCT04258839|363987760|FG001|Overall Study|Withdrawal by Caregiver|6|||
105542355|NCT04258839|363987759|FG000|Overall Study|Reason not Specified|0|||
105542356|NCT04258839|363987760|FG001|Overall Study|Reason not Specified|1|||
105542357|NCT02564471|363987761|FG000|Overall Study|Adverse Event|1|||
105542358|NCT02564471|363987762|FG001|Overall Study|Adverse Event|0|||
105542359|NCT02564471|363987763|FG002|Overall Study|Adverse Event|0|||
105542360|NCT02564471|363987764|FG003|Overall Study|Adverse Event|0|||
105542361|NCT02564471|363987761|FG000|Overall Study|Withdrawal by Subject|2|||
105542362|NCT02564471|363987762|FG001|Overall Study|Withdrawal by Subject|1|||
105542363|NCT02564471|363987763|FG002|Overall Study|Withdrawal by Subject|3|||
105542364|NCT02564471|363987764|FG003|Overall Study|Withdrawal by Subject|0|||
105542365|NCT02564471|363987761|FG000|Overall Study|Lost to Follow-up|0|||
105542366|NCT02564471|363987762|FG001|Overall Study|Lost to Follow-up|2|||
105542367|NCT02564471|363987763|FG002|Overall Study|Lost to Follow-up|0|||
105542368|NCT02564471|363987764|FG003|Overall Study|Lost to Follow-up|0|||
105595886|NCT01121549|364182457|FG000|Overall Study|Adverse Event|10|||
105542369|NCT03738865|363987769|FG000|Overall Study|Withdrawal by Subject|3|||
105542370|NCT03738865|363987770|FG001|Overall Study|Withdrawal by Subject|3|||
105542371|NCT03738865|363987769|FG000|Overall Study|Adverse Event|2|||
105542372|NCT03738865|363987770|FG001|Overall Study|Adverse Event|0|||
105542373|NCT03738865|363987769|FG000|Overall Study|Physician Decision|0|||
105542374|NCT03738865|363987770|FG001|Overall Study|Physician Decision|1|||
105542375|NCT01529645|363987771|FG000|Overall Study|Lost to Follow-up|0|||
105542376|NCT01529645|363987772|FG001|Overall Study|Lost to Follow-up|1|||
105542377|NCT01529645|363987773|FG002|Overall Study|Lost to Follow-up|1|||
105542378|NCT01529645|363987774|FG003|Overall Study|Lost to Follow-up|1|||
105542379|NCT01529645|363987775|FG004|Overall Study|Lost to Follow-up|1|||
105542380|NCT01529645|363987776|FG005|Overall Study|Lost to Follow-up|0|||
105542381|NCT01529645|363987777|FG006|Overall Study|Lost to Follow-up|2|||
105542382|NCT01529645|363987778|FG007|Overall Study|Lost to Follow-up|0|||
105542383|NCT01529645|363987779|FG008|Overall Study|Lost to Follow-up|1|||
105542384|NCT01529645|363987780|FG009|Overall Study|Lost to Follow-up|0|||
105542385|NCT01529645|363987771|FG000|Overall Study|SAE - Premature contractions|0|||
105542386|NCT01529645|363987772|FG001|Overall Study|SAE - Premature contractions|0|||
105542387|NCT01529645|363987773|FG002|Overall Study|SAE - Premature contractions|1|||
105542388|NCT01529645|363987774|FG003|Overall Study|SAE - Premature contractions|0|||
105542389|NCT01529645|363987775|FG004|Overall Study|SAE - Premature contractions|0|||
105542390|NCT01529645|363987776|FG005|Overall Study|SAE - Premature contractions|0|||
105542391|NCT01529645|363987777|FG006|Overall Study|SAE - Premature contractions|0|||
105542392|NCT01529645|363987778|FG007|Overall Study|SAE - Premature contractions|0|||
105542393|NCT01529645|363987779|FG008|Overall Study|SAE - Premature contractions|0|||
105542394|NCT01529645|363987780|FG009|Overall Study|SAE - Premature contractions|0|||
105542395|NCT01529645|363987771|FG000|Overall Study|Withdrawal by Subject|2|||
105542396|NCT01529645|363987772|FG001|Overall Study|Withdrawal by Subject|0|||
105542397|NCT01529645|363987773|FG002|Overall Study|Withdrawal by Subject|0|||
105542398|NCT01529645|363987774|FG003|Overall Study|Withdrawal by Subject|1|||
105542399|NCT01529645|363987775|FG004|Overall Study|Withdrawal by Subject|1|||
105542400|NCT01529645|363987776|FG005|Overall Study|Withdrawal by Subject|1|||
105542401|NCT01529645|363987777|FG006|Overall Study|Withdrawal by Subject|0|||
105542402|NCT01529645|363987778|FG007|Overall Study|Withdrawal by Subject|0|||
105542403|NCT01529645|363987779|FG008|Overall Study|Withdrawal by Subject|0|||
105542404|NCT01529645|363987780|FG009|Overall Study|Withdrawal by Subject|0|||
105542405|NCT03455855|363987781|FG000|Overall Study|Lost to Follow-up|4|||
105542406|NCT03455855|363987782|FG001|Overall Study|Lost to Follow-up|2|||
105542407|NCT00587587|363987783|FG000|Overall Study|Lost to Follow-up|6|||
105542408|NCT00587587|363987784|FG001|Overall Study|Lost to Follow-up|1|||
105542409|NCT02880371|363987787|FG000|Phase 1b|Lost to Follow-up|1|||
105542410|NCT02880371|363987788|FG001|Phase 1b|Lost to Follow-up|0|||
105542411|NCT02880371|363987789|FG002|Phase 1b|Lost to Follow-up|0|||
105542412|NCT02880371|363987790|FG003|Phase 1b|Lost to Follow-up|0|||
105542413|NCT02880371|363987791|FG004|Phase 1b|Lost to Follow-up|0|||
105542414|NCT02880371|363987792|FG005|Phase 1b|Lost to Follow-up|0|||
105542415|NCT02880371|363987793|FG006|Phase 1b|Lost to Follow-up|0|||
105542416|NCT02880371|363987794|FG007|Phase 1b|Lost to Follow-up|0|||
105542417|NCT02880371|363987787|FG000|Phase 1b|Participants terminated by Sponsor|1|||
105542418|NCT02880371|363987788|FG001|Phase 1b|Participants terminated by Sponsor|0|||
105542419|NCT02880371|363987789|FG002|Phase 1b|Participants terminated by Sponsor|0|||
105542420|NCT02880371|363987790|FG003|Phase 1b|Participants terminated by Sponsor|0|||
105542421|NCT02880371|363987791|FG004|Phase 1b|Participants terminated by Sponsor|0|||
105542422|NCT02880371|363987792|FG005|Phase 1b|Participants terminated by Sponsor|0|||
105542423|NCT02880371|363987793|FG006|Phase 1b|Participants terminated by Sponsor|0|||
105542424|NCT02880371|363987794|FG007|Phase 1b|Participants terminated by Sponsor|0|||
105542425|NCT02880371|363987787|FG000|Phase 1b|Withdrawal by Subject|0|||
105542426|NCT02880371|363987788|FG001|Phase 1b|Withdrawal by Subject|0|||
105542427|NCT02880371|363987789|FG002|Phase 1b|Withdrawal by Subject|1|||
105542428|NCT02880371|363987790|FG003|Phase 1b|Withdrawal by Subject|0|||
105542429|NCT02880371|363987791|FG004|Phase 1b|Withdrawal by Subject|0|||
105542430|NCT02880371|363987792|FG005|Phase 1b|Withdrawal by Subject|0|||
105542431|NCT02880371|363987793|FG006|Phase 1b|Withdrawal by Subject|0|||
105542432|NCT02880371|363987794|FG007|Phase 1b|Withdrawal by Subject|0|||
105542433|NCT02880371|363987787|FG000|Phase 1b|Death|4|||
105542434|NCT02880371|363987788|FG001|Phase 1b|Death|6|||
105542435|NCT02880371|363987789|FG002|Phase 1b|Death|5|||
105542436|NCT02880371|363987790|FG003|Phase 1b|Death|1|||
105542437|NCT02880371|363987791|FG004|Phase 1b|Death|0|||
105542438|NCT02880371|363987792|FG005|Phase 1b|Death|0|||
105542439|NCT02880371|363987793|FG006|Phase 1b|Death|0|||
105542440|NCT02880371|363987794|FG007|Phase 1b|Death|0|||
105542441|NCT02880371|363987787|FG000|Phase 1b|Enrolled but not Treated|0|||
105542442|NCT02880371|363987788|FG001|Phase 1b|Enrolled but not Treated|1|||
105542443|NCT02880371|363987789|FG002|Phase 1b|Enrolled but not Treated|0|||
105542444|NCT02880371|363987790|FG003|Phase 1b|Enrolled but not Treated|0|||
105542445|NCT02880371|363987791|FG004|Phase 1b|Enrolled but not Treated|0|||
105542446|NCT02880371|363987792|FG005|Phase 1b|Enrolled but not Treated|0|||
105542447|NCT02880371|363987793|FG006|Phase 1b|Enrolled but not Treated|0|||
105542448|NCT02880371|363987794|FG007|Phase 1b|Enrolled but not Treated|0|||
105542449|NCT02880371|363987787|FG000|Phase 2|Enrolled but not Treated|0|||
105542450|NCT02880371|363987788|FG001|Phase 2|Enrolled but not Treated|0|||
105542451|NCT02880371|363987789|FG002|Phase 2|Enrolled but not Treated|0|||
105542452|NCT02880371|363987790|FG003|Phase 2|Enrolled but not Treated|0|||
105542453|NCT02880371|363987791|FG004|Phase 2|Enrolled but not Treated|0|||
105542454|NCT02880371|363987792|FG005|Phase 2|Enrolled but not Treated|1|||
105542455|NCT02880371|363987793|FG006|Phase 2|Enrolled but not Treated|1|||
105542456|NCT02880371|363987794|FG007|Phase 2|Enrolled but not Treated|0|||
105542457|NCT02880371|363987787|FG000|Phase 2|Other|0|||
105542458|NCT02880371|363987788|FG001|Phase 2|Other|0|||
105542459|NCT02880371|363987789|FG002|Phase 2|Other|0|||
105542460|NCT02880371|363987790|FG003|Phase 2|Other|0|||
105542461|NCT02880371|363987791|FG004|Phase 2|Other|0|||
105542462|NCT02880371|363987792|FG005|Phase 2|Other|1|||
105542463|NCT02880371|363987793|FG006|Phase 2|Other|2|||
105542464|NCT02880371|363987794|FG007|Phase 2|Other|1|||
105542465|NCT02880371|363987787|FG000|Phase 2|Participants terminated by Sponsor|0|||
105542466|NCT02880371|363987788|FG001|Phase 2|Participants terminated by Sponsor|0|||
105542467|NCT02880371|363987789|FG002|Phase 2|Participants terminated by Sponsor|0|||
105542468|NCT02880371|363987790|FG003|Phase 2|Participants terminated by Sponsor|0|||
105542469|NCT02880371|363987791|FG004|Phase 2|Participants terminated by Sponsor|1|||
105542470|NCT02880371|363987792|FG005|Phase 2|Participants terminated by Sponsor|6|||
105542471|NCT02880371|363987793|FG006|Phase 2|Participants terminated by Sponsor|1|||
105542472|NCT02880371|363987794|FG007|Phase 2|Participants terminated by Sponsor|5|||
105542473|NCT02880371|363987787|FG000|Phase 2|Death|0|||
105542474|NCT02880371|363987788|FG001|Phase 2|Death|0|||
105542475|NCT02880371|363987789|FG002|Phase 2|Death|0|||
105542476|NCT02880371|363987790|FG003|Phase 2|Death|0|||
105542477|NCT02880371|363987791|FG004|Phase 2|Death|1|||
105542478|NCT02880371|363987792|FG005|Phase 2|Death|10|||
105542479|NCT02880371|363987793|FG006|Phase 2|Death|20|||
105542480|NCT02880371|363987794|FG007|Phase 2|Death|5|||
105542481|NCT02880371|363987787|FG000|Phase 2|Lost to Follow-up|0|||
105542482|NCT02880371|363987788|FG001|Phase 2|Lost to Follow-up|0|||
105542483|NCT02880371|363987789|FG002|Phase 2|Lost to Follow-up|0|||
105542484|NCT02880371|363987790|FG003|Phase 2|Lost to Follow-up|0|||
105542485|NCT02880371|363987791|FG004|Phase 2|Lost to Follow-up|0|||
105542486|NCT02880371|363987792|FG005|Phase 2|Lost to Follow-up|0|||
105542487|NCT02880371|363987793|FG006|Phase 2|Lost to Follow-up|3|||
105542488|NCT02880371|363987794|FG007|Phase 2|Lost to Follow-up|0|||
105542489|NCT02880371|363987787|FG000|Phase 2|Withdrawal by Subject|0|||
105542490|NCT02880371|363987788|FG001|Phase 2|Withdrawal by Subject|0|||
105542491|NCT02880371|363987789|FG002|Phase 2|Withdrawal by Subject|0|||
105542492|NCT02880371|363987790|FG003|Phase 2|Withdrawal by Subject|0|||
105542493|NCT02880371|363987791|FG004|Phase 2|Withdrawal by Subject|0|||
105542494|NCT02880371|363987792|FG005|Phase 2|Withdrawal by Subject|1|||
105542495|NCT02880371|363987793|FG006|Phase 2|Withdrawal by Subject|1|||
105542496|NCT02880371|363987794|FG007|Phase 2|Withdrawal by Subject|0|||
105542497|NCT02880371|363987787|FG000|Phase 2|End of Study page not completed by error|0|||
105542498|NCT02880371|363987788|FG001|Phase 2|End of Study page not completed by error|0|||
105542499|NCT02880371|363987789|FG002|Phase 2|End of Study page not completed by error|0|||
105542500|NCT02880371|363987790|FG003|Phase 2|End of Study page not completed by error|0|||
105542501|NCT02880371|363987791|FG004|Phase 2|End of Study page not completed by error|0|||
105542502|NCT02880371|363987792|FG005|Phase 2|End of Study page not completed by error|1|||
105542503|NCT02880371|363987793|FG006|Phase 2|End of Study page not completed by error|0|||
105542504|NCT02880371|363987794|FG007|Phase 2|End of Study page not completed by error|0|||
105542505|NCT01694706|363987799|FG000|Overall Study|Adverse Event|0|||
105542506|NCT01694706|363987800|FG001|Overall Study|Adverse Event|1|||
105542507|NCT01694706|363987801|FG002|Overall Study|Adverse Event|0|||
105542508|NCT01694706|363987799|FG000|Overall Study|other reason not defined above|1|||
105542509|NCT01694706|363987800|FG001|Overall Study|other reason not defined above|0|||
105542510|NCT01694706|363987801|FG002|Overall Study|other reason not defined above|0|||
105542511|NCT01923181|363987804|FG000|Overall Study|Protocol Violation|2|||
105542512|NCT01923181|363987805|FG001|Overall Study|Protocol Violation|2|||
105542513|NCT01923181|363987806|FG002|Overall Study|Protocol Violation|0|||
105542514|NCT01923181|363987807|FG003|Overall Study|Protocol Violation|2|||
105542515|NCT01923181|363987808|FG004|Overall Study|Protocol Violation|2|||
105542516|NCT01923181|363987809|FG005|Overall Study|Protocol Violation|1|||
105542517|NCT01923181|363987810|FG006|Overall Study|Protocol Violation|1|||
105542518|NCT01923181|363987811|FG007|Overall Study|Protocol Violation|2|||
105542519|NCT01923181|363987812|FG008|Overall Study|Protocol Violation|1|||
105542520|NCT01923181|363987804|FG000|Overall Study|Withdrawal by Subject|0|||
105542521|NCT01923181|363987805|FG001|Overall Study|Withdrawal by Subject|1|||
105542522|NCT01923181|363987806|FG002|Overall Study|Withdrawal by Subject|0|||
105542523|NCT01923181|363987807|FG003|Overall Study|Withdrawal by Subject|1|||
105542524|NCT01923181|363987808|FG004|Overall Study|Withdrawal by Subject|4|||
105542525|NCT01923181|363987809|FG005|Overall Study|Withdrawal by Subject|2|||
105542526|NCT01923181|363987810|FG006|Overall Study|Withdrawal by Subject|4|||
105542527|NCT01923181|363987811|FG007|Overall Study|Withdrawal by Subject|3|||
105542528|NCT01923181|363987812|FG008|Overall Study|Withdrawal by Subject|1|||
105542529|NCT01923181|363987804|FG000|Overall Study|Other|1|||
105542530|NCT01923181|363987805|FG001|Overall Study|Other|0|||
105542531|NCT01923181|363987806|FG002|Overall Study|Other|0|||
105542532|NCT01923181|363987807|FG003|Overall Study|Other|1|||
105542533|NCT01923181|363987808|FG004|Overall Study|Other|0|||
105542534|NCT01923181|363987809|FG005|Overall Study|Other|0|||
105542535|NCT01923181|363987810|FG006|Overall Study|Other|0|||
105542536|NCT01923181|363987811|FG007|Overall Study|Other|0|||
105542537|NCT01923181|363987812|FG008|Overall Study|Other|0|||
105542538|NCT01923181|363987804|FG000|Overall Study|Lost to Follow-up|0|||
105542539|NCT01923181|363987805|FG001|Overall Study|Lost to Follow-up|3|||
105542540|NCT01923181|363987806|FG002|Overall Study|Lost to Follow-up|2|||
105542541|NCT01923181|363987807|FG003|Overall Study|Lost to Follow-up|1|||
105542542|NCT01923181|363987808|FG004|Overall Study|Lost to Follow-up|2|||
105542543|NCT01923181|363987809|FG005|Overall Study|Lost to Follow-up|1|||
105542544|NCT01923181|363987810|FG006|Overall Study|Lost to Follow-up|3|||
105542545|NCT01923181|363987811|FG007|Overall Study|Lost to Follow-up|3|||
105542546|NCT01923181|363987812|FG008|Overall Study|Lost to Follow-up|1|||
105542547|NCT02082522|363987816|FG000|Overall Study|Sponsor termination|5|||
105542548|NCT02082522|363987817|FG001|Overall Study|Sponsor termination|3|||
105542549|NCT02082522|363987816|FG000|Overall Study|Withdrawal by Subject|2|||
105542550|NCT02082522|363987817|FG001|Overall Study|Withdrawal by Subject|4|||
105542551|NCT02082522|363987816|FG000|Overall Study|Death|1|||
105542552|NCT02082522|363987817|FG001|Overall Study|Death|0|||
105542553|NCT02082522|363987816|FG000|Overall Study|Lost to Follow-up|1|||
105542554|NCT02082522|363987817|FG001|Overall Study|Lost to Follow-up|0|||
105542555|NCT02082522|363987816|FG000|Overall Study|Physician Decision|3|||
105542556|NCT02082522|363987817|FG001|Overall Study|Physician Decision|1|||
105542557|NCT02082522|363987816|FG000|Overall Study|Disease progression|2|||
105542558|NCT02082522|363987817|FG001|Overall Study|Disease progression|2|||
105542559|NCT02082522|363987816|FG000|Overall Study|Chemotherapy change|1|||
105542560|NCT02082522|363987817|FG001|Overall Study|Chemotherapy change|3|||
105542561|NCT00440271|363987818|FG000|Overall Study|Protocol Violation|1|||
105542562|NCT00440271|363987819|FG001|Overall Study|Protocol Violation|1|||
105542563|NCT00440271|363987818|FG000|Overall Study|Adverse Event|0|||
105542564|NCT00440271|363987819|FG001|Overall Study|Adverse Event|1|||
105542565|NCT00440271|363987818|FG000|Overall Study|Lost to Follow-up|1|||
105542566|NCT00440271|363987819|FG001|Overall Study|Lost to Follow-up|0|||
105542567|NCT00440271|363987818|FG000|Overall Study|Withdrawal by Subject|0|||
105542568|NCT00440271|363987819|FG001|Overall Study|Withdrawal by Subject|2|||
105542569|NCT00440271|363987818|FG000|Overall Study|Lack of Efficacy|0|||
105542570|NCT00440271|363987819|FG001|Overall Study|Lack of Efficacy|1|||
105542571|NCT00440271|363987818|FG000|Overall Study|Due to closure of trial|8|||
105542572|NCT00440271|363987819|FG001|Overall Study|Due to closure of trial|10|||
105542573|NCT00440271|363987818|FG000|Overall Study|Other|2|||
105542574|NCT00440271|363987819|FG001|Overall Study|Other|0|||
105542575|NCT00456092|363987820|FG000|Extension Phase|Grade 2 or Greater AE|2|||
105542576|NCT00456092|363987821|FG001|Extension Phase|Grade 2 or Greater AE|2|||
105542577|NCT00456092|363987822|FG002|Extension Phase|Grade 2 or Greater AE|0|||
105542578|NCT00456092|363987823|FG003|Extension Phase|Grade 2 or Greater AE|0|||
105542579|NCT00456092|363987824|FG004|Extension Phase|Grade 2 or Greater AE|2|||
105542580|NCT00456092|363987820|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
105542581|NCT00456092|363987821|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
105542582|NCT00456092|363987822|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
105542583|NCT00456092|363987823|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
105542584|NCT00456092|363987824|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
105542585|NCT00456092|363987820|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
105542586|NCT00456092|363987821|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
105542587|NCT00456092|363987822|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
105542588|NCT00456092|363987823|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
105542589|NCT00456092|363987824|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
105542590|NCT00456092|363987820|FG000|Extension Phase|Withdrew Consent|2|||
105542591|NCT00456092|363987821|FG001|Extension Phase|Withdrew Consent|0|||
105542592|NCT00456092|363987822|FG002|Extension Phase|Withdrew Consent|0|||
105542593|NCT00456092|363987823|FG003|Extension Phase|Withdrew Consent|0|||
105542594|NCT00456092|363987824|FG004|Extension Phase|Withdrew Consent|0|||
105542595|NCT00456092|363987820|FG000|Extension Phase|Lost to Follow-up|1|||
105542596|NCT00456092|363987821|FG001|Extension Phase|Lost to Follow-up|1|||
105542597|NCT00456092|363987822|FG002|Extension Phase|Lost to Follow-up|0|||
105542598|NCT00456092|363987823|FG003|Extension Phase|Lost to Follow-up|0|||
105542599|NCT00456092|363987824|FG004|Extension Phase|Lost to Follow-up|1|||
105542600|NCT00456092|363987820|FG000|Extension Phase|Other|2|||
105542601|NCT00456092|363987821|FG001|Extension Phase|Other|0|||
105542602|NCT00456092|363987822|FG002|Extension Phase|Other|0|||
105542603|NCT00456092|363987823|FG003|Extension Phase|Other|1|||
105542604|NCT00456092|363987824|FG004|Extension Phase|Other|1|||
105542605|NCT00456092|363987820|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
105542606|NCT00456092|363987821|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
105542607|NCT00456092|363987822|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
105542608|NCT00456092|363987823|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
105542609|NCT00456092|363987824|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
105542610|NCT00456092|363987820|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
105542611|NCT00456092|363987821|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
105542612|NCT00456092|363987822|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
105542613|NCT00456092|363987823|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
105542614|NCT00456092|363987824|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
105542615|NCT00456092|363987820|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
105595887|NCT01121549|364182457|FG000|Overall Study|Lack of Efficacy|11|||
105542616|NCT00456092|363987821|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
105542617|NCT00456092|363987822|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
105542618|NCT00456092|363987823|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
105542619|NCT00456092|363987824|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
105542620|NCT00456092|363987820|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
105542621|NCT00456092|363987821|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
105542622|NCT00456092|363987822|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
105542623|NCT00456092|363987823|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
105542624|NCT00456092|363987824|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
105542625|NCT00456092|363987820|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
105542626|NCT00456092|363987821|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
105542627|NCT00456092|363987822|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
105542628|NCT00456092|363987823|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
105542629|NCT00456092|363987824|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
105542630|NCT00456092|363987820|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
105542631|NCT00456092|363987821|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
105542632|NCT00456092|363987822|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
105542633|NCT00456092|363987823|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
105542634|NCT00456092|363987824|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
105542635|NCT00456092|363987820|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
105542636|NCT00456092|363987821|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
105542637|NCT00456092|363987822|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
105542638|NCT00456092|363987823|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
105542639|NCT00456092|363987824|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
105542640|NCT00456092|363987820|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
105542641|NCT00456092|363987821|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
105542642|NCT00456092|363987822|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
105542643|NCT00456092|363987823|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
105542644|NCT00456092|363987824|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
105542645|NCT00456092|363987820|FG000|Treatment Phase (12 Weeks)|Other|1|||
105542646|NCT00456092|363987821|FG001|Treatment Phase (12 Weeks)|Other|0|||
105542647|NCT00456092|363987822|FG002|Treatment Phase (12 Weeks)|Other|1|||
105542648|NCT00456092|363987823|FG003|Treatment Phase (12 Weeks)|Other|0|||
105542649|NCT00456092|363987824|FG004|Treatment Phase (12 Weeks)|Other|0|||
105542650|NCT01863446|363987825|FG000|Overall Study|Withdrawal by Subject|1|||
105542651|NCT01863446|363987826|FG001|Overall Study|Withdrawal by Subject|0|||
105542652|NCT01863446|363987827|FG002|Overall Study|Withdrawal by Subject|1|||
105542653|NCT01863446|363987828|FG003|Overall Study|Withdrawal by Subject|2|||
105542654|NCT01863446|363987825|FG000|Overall Study|Physician Decision|0|||
105542655|NCT01863446|363987826|FG001|Overall Study|Physician Decision|0|||
105542656|NCT01863446|363987827|FG002|Overall Study|Physician Decision|1|||
105542657|NCT01863446|363987828|FG003|Overall Study|Physician Decision|0|||
105542658|NCT02252081|363987829|FG000|Overall Study|Withdrawal by Subject|2|||
105542659|NCT02252081|363987830|FG001|Overall Study|Withdrawal by Subject|1|||
105542660|NCT02252081|363987829|FG000|Overall Study|Adverse Event|4|||
105542661|NCT02252081|363987830|FG001|Overall Study|Adverse Event|1|||
105542662|NCT02252081|363987829|FG000|Overall Study|non compliance & others|0|||
105542663|NCT02252081|363987830|FG001|Overall Study|non compliance & others|2|||
105542664|NCT03586869|363987835|FG000|Overall Study|Progressive Disease|3|||
105542665|NCT04116229|363987836|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
105542666|NCT04116229|363987837|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
105542667|NCT04116229|363987836|FG000|Overall Study|Scheduling not possible.|0|||
105542668|NCT04116229|363987837|FG001|Overall Study|Scheduling not possible.|1|||
105542669|NCT00403455|363987838|FG000|Overall Study|Withdrawal by Subject|1|||
105542670|NCT00833924|363987843|FG000|Overall Study|Death|21|||
105542671|NCT00833924|363987843|FG000|Overall Study|Conversion|2|||
105542672|NCT00833924|363987843|FG000|Overall Study|Lost to Follow-up|2|||
105542673|NCT00833924|363987843|FG000|Overall Study|Withdrawal by Subject|13|||
105542674|NCT00833924|363987843|FG000|Overall Study|In study follow-up|71|||
105542675|NCT03235024|363987844|FG000|Overall Study|Adverse Event|2|||
105542676|NCT03235024|363987845|FG001|Overall Study|Adverse Event|2|||
105542677|NCT03235024|363987844|FG000|Overall Study|Death|1|||
105542678|NCT03235024|363987845|FG001|Overall Study|Death|0|||
105542679|NCT03235024|363987844|FG000|Overall Study|Lost to Follow-up|2|||
105542680|NCT03235024|363987845|FG001|Overall Study|Lost to Follow-up|5|||
105542681|NCT03235024|363987844|FG000|Overall Study|Protocol Violation|1|||
105542682|NCT03235024|363987845|FG001|Overall Study|Protocol Violation|0|||
105542683|NCT03235024|363987844|FG000|Overall Study|Withdrawal by Subject|0|||
105542684|NCT03235024|363987845|FG001|Overall Study|Withdrawal by Subject|3|||
105542685|NCT01158924|363987847|FG000|Overall Study|Withdrawal by Subject|1|||
105542686|NCT01158924|363987848|FG001|Overall Study|Withdrawal by Subject|2|||
105542687|NCT01158924|363987847|FG000|Overall Study|Lost to Follow-up|0|||
105542688|NCT01158924|363987848|FG001|Overall Study|Lost to Follow-up|1|||
105542689|NCT00699699|363987849|FG000|Overall Study|Adverse Event|36|||
105542690|NCT00699699|363987849|FG000|Overall Study|Individual different reasons|21|||
105542691|NCT02170727|363987855|FG000|Overall Study|Lost to Follow-up|1|||
105542692|NCT02170727|363987856|FG001|Overall Study|Lost to Follow-up|0|||
105542693|NCT02170727|363987855|FG000|Overall Study|Withdrawal by Subject|2|||
105542694|NCT02170727|363987856|FG001|Overall Study|Withdrawal by Subject|0|||
105542695|NCT01243944|363987857|FG000|Overall Study|Adverse Event|15|||
105542696|NCT01243944|363987858|FG001|Overall Study|Adverse Event|13|||
105542697|NCT01243944|363987857|FG000|Overall Study|Lost to Follow-up|2|||
105542698|NCT01243944|363987858|FG001|Overall Study|Lost to Follow-up|1|||
105542699|NCT01243944|363987857|FG000|Overall Study|Physician Decision|2|||
105542700|NCT01243944|363987858|FG001|Overall Study|Physician Decision|7|||
105542701|NCT01243944|363987857|FG000|Overall Study|Disease progression|12|||
105542702|NCT01243944|363987858|FG001|Overall Study|Disease progression|11|||
105542703|NCT01243944|363987857|FG000|Overall Study|Protocol deviation|1|||
105542704|NCT01243944|363987858|FG001|Overall Study|Protocol deviation|1|||
105542705|NCT01243944|363987857|FG000|Overall Study|Participant decision|10|||
105542706|NCT01243944|363987858|FG001|Overall Study|Participant decision|15|||
105542707|NCT01243944|363987857|FG000|Overall Study|Death|2|||
105542708|NCT01243944|363987858|FG001|Overall Study|Death|3|||
105542709|NCT01243944|363987857|FG000|Overall Study|Non-compliance with study treatment|1|||
105542710|NCT01243944|363987858|FG001|Overall Study|Non-compliance with study treatment|0|||
105542711|NCT01525082|363987867|FG000|Overall Study|Death|1|||
105542712|NCT02480621|363987868|FG000|Randomization|Withdrawal by Subject|1|||
105542713|NCT02480621|363987869|FG001|Randomization|Withdrawal by Subject|0|||
105542714|NCT02480621|363987868|FG000|Randomization|Surgeon did not give intervention|0|||
105542715|NCT02480621|363987869|FG001|Randomization|Surgeon did not give intervention|1|||
105542716|NCT02480621|363987868|FG000|Follow Up|Lost to Follow-up|4|||
105542717|NCT02480621|363987869|FG001|Follow Up|Lost to Follow-up|2|||
105542718|NCT04632940|363987873|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
105542719|NCT04632940|363987874|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
105542720|NCT04632940|363987873|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
105542721|NCT04632940|363987874|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
105542722|NCT04632940|363987873|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
105542723|NCT04632940|363987874|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
105542724|NCT04632940|363987873|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
105542725|NCT04632940|363987874|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
105542726|NCT04632940|363987873|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
105542727|NCT04632940|363987874|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
105542728|NCT04632940|363987873|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
105542729|NCT04632940|363987874|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
105542730|NCT04632940|363987873|FG000|OLE Period (52 Weeks)|Other than specified|0|||
105542731|NCT04632940|363987874|FG001|OLE Period (52 Weeks)|Other than specified|1|||
105542732|NCT04632940|363987873|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
105542733|NCT04632940|363987874|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
105542734|NCT02410811|363987875|FG000|Overall Study|Withdrawal by Subject|0|||
105542735|NCT02410811|363987876|FG001|Overall Study|Withdrawal by Subject|0|||
105542736|NCT02410811|363987877|FG002|Overall Study|Withdrawal by Subject|1|||
105542737|NCT02410811|363987878|FG003|Overall Study|Withdrawal by Subject|0|||
105542738|NCT02799082|363987885|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
105542739|NCT02799082|363987886|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
105542740|NCT02799082|363987885|FG000|Overall Study|Protocol Violation|0|||
105542741|NCT02799082|363987886|FG001|Overall Study|Protocol Violation|1|||
105542742|NCT03783923|363987887|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
105542743|NCT03783923|363987888|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
105542744|NCT03783923|363987887|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
105542745|NCT03783923|363987888|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
105542746|NCT03783923|363987887|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
105542747|NCT03783923|363987888|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
105542748|NCT03783923|363987887|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
105542749|NCT03783923|363987888|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
105542750|NCT03783923|363987887|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
105542751|NCT03783923|363987888|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
105542752|NCT01592708|363987889|FG000|Overall Study|Protocol Violation|3|||
105542753|NCT01592708|363987890|FG001|Overall Study|Protocol Violation|0|||
105542754|NCT01687166|363987906|FG000|Overall Study|Attempt subject|2|||
105542755|NCT01687166|363987907|FG001|Overall Study|Attempt subject|3|||
105542756|NCT01687166|363987908|FG002|Overall Study|Attempt subject|2|||
105542757|NCT01687166|363987909|FG003|Overall Study|Attempt subject|0|||
105542758|NCT01687166|363987906|FG000|Overall Study|Did not meet eligibility criteria|4|||
105542759|NCT01687166|363987907|FG001|Overall Study|Did not meet eligibility criteria|6|||
105542760|NCT01687166|363987908|FG002|Overall Study|Did not meet eligibility criteria|1|||
105542761|NCT01687166|363987909|FG003|Overall Study|Did not meet eligibility criteria|1|||
105542762|NCT01687166|363987906|FG000|Overall Study|Adverse Event|2|||
105542763|NCT01687166|363987907|FG001|Overall Study|Adverse Event|1|||
105542764|NCT01687166|363987908|FG002|Overall Study|Adverse Event|0|||
105542765|NCT01687166|363987909|FG003|Overall Study|Adverse Event|0|||
105542766|NCT01687166|363987906|FG000|Overall Study|Physician Decision|3|||
105542767|NCT01687166|363987907|FG001|Overall Study|Physician Decision|2|||
105542768|NCT01687166|363987908|FG002|Overall Study|Physician Decision|1|||
105542769|NCT01687166|363987909|FG003|Overall Study|Physician Decision|0|||
105542770|NCT01687166|363987906|FG000|Overall Study|Withdrawal by Subject|11|||
105542771|NCT01687166|363987907|FG001|Overall Study|Withdrawal by Subject|4|||
105542772|NCT01687166|363987908|FG002|Overall Study|Withdrawal by Subject|3|||
105542773|NCT01687166|363987909|FG003|Overall Study|Withdrawal by Subject|0|||
105542774|NCT01687166|363987906|FG000|Overall Study|Lost to Follow-up|2|||
105542775|NCT01687166|363987907|FG001|Overall Study|Lost to Follow-up|5|||
105542776|NCT01687166|363987908|FG002|Overall Study|Lost to Follow-up|1|||
105595888|NCT01121549|364182457|FG000|Overall Study|Lost to Follow-up|12|||
105595889|NCT01121549|364182457|FG000|Overall Study|Did not meet entrance criteria|9|||
105595890|NCT01121549|364182457|FG000|Overall Study|Study terminated by sponsor|197|||
105595891|NCT01121549|364182457|FG000|Overall Study|Pregnancy|1|||
105595892|NCT01121549|364182457|FG000|Overall Study|Protocol Violation|33|||
105595893|NCT01121549|364182457|FG000|Overall Study|Withdrawal by Subject|16|||
105595894|NCT01121549|364182457|FG000|Overall Study|Other|58|||
105595895|NCT02041104|364182458|FG000|Overall Study|Lost to Follow-up|1|||
105595896|NCT02041104|364182459|FG001|Overall Study|Lost to Follow-up|4|||
105595897|NCT02041104|364182458|FG000|Overall Study|discomfort during OGTT|0|||
105595898|NCT02041104|364182459|FG001|Overall Study|discomfort during OGTT|3|||
105595899|NCT01063517|364182460|FG000|Overall Study|Consent withdrawal|1|||
105595900|NCT01063517|364182461|FG001|Overall Study|Consent withdrawal|0|||
105595901|NCT01063517|364182460|FG000|Overall Study|Study reached data cut-off|19|||
105595902|NCT01063517|364182461|FG001|Overall Study|Study reached data cut-off|7|||
105595903|NCT01063517|364182460|FG000|Overall Study|Lost to Follow-up|4|||
105595904|NCT01063517|364182461|FG001|Overall Study|Lost to Follow-up|3|||
105542777|NCT01687166|363987909|FG003|Overall Study|Lost to Follow-up|0|||
105542778|NCT01687166|363987906|FG000|Overall Study|Equipment/Device Availability|0|||
105542779|NCT01687166|363987907|FG001|Overall Study|Equipment/Device Availability|1|||
105542780|NCT01687166|363987908|FG002|Overall Study|Equipment/Device Availability|0|||
105542781|NCT01687166|363987909|FG003|Overall Study|Equipment/Device Availability|0|||
105542782|NCT01687166|363987906|FG000|Overall Study|Death|1|||
105542783|NCT01687166|363987907|FG001|Overall Study|Death|1|||
105542784|NCT01687166|363987908|FG002|Overall Study|Death|0|||
105542785|NCT01687166|363987909|FG003|Overall Study|Death|0|||
105542786|NCT01687166|363987906|FG000|Overall Study|Protocol Violation|1|||
105542787|NCT01687166|363987907|FG001|Overall Study|Protocol Violation|1|||
105542788|NCT01687166|363987908|FG002|Overall Study|Protocol Violation|1|||
105542789|NCT01687166|363987909|FG003|Overall Study|Protocol Violation|0|||
105542790|NCT01687166|363987906|FG000|Overall Study|Subject moved out of state|0|||
105542791|NCT01687166|363987907|FG001|Overall Study|Subject moved out of state|1|||
105542792|NCT01687166|363987908|FG002|Overall Study|Subject moved out of state|0|||
105542793|NCT01687166|363987909|FG003|Overall Study|Subject moved out of state|0|||
105542794|NCT01687166|363987906|FG000|Overall Study|Patient unable to be compliant|1|||
105542795|NCT01687166|363987907|FG001|Overall Study|Patient unable to be compliant|0|||
105542796|NCT01687166|363987908|FG002|Overall Study|Patient unable to be compliant|0|||
105542797|NCT01687166|363987909|FG003|Overall Study|Patient unable to be compliant|0|||
105542798|NCT01687166|363987906|FG000|Overall Study|Physician choice to use different device|1|||
105542799|NCT01687166|363987907|FG001|Overall Study|Physician choice to use different device|2|||
105542800|NCT01687166|363987908|FG002|Overall Study|Physician choice to use different device|4|||
105542801|NCT01687166|363987909|FG003|Overall Study|Physician choice to use different device|0|||
105542802|NCT01687166|363987906|FG000|Overall Study|Insurance|0|||
105542803|NCT01687166|363987907|FG001|Overall Study|Insurance|0|||
105542804|NCT01687166|363987908|FG002|Overall Study|Insurance|1|||
105542805|NCT01687166|363987909|FG003|Overall Study|Insurance|1|||
105542806|NCT01800903|363987910|FG000|Second Test Period|unable to catheterise|1|||
105542807|NCT01800903|363987911|FG001|Second Test Period|unable to catheterise|0|||
105542808|NCT01800903|363987912|FG002|Second Test Period|unable to catheterise|0|||
105595905|NCT01063517|364182460|FG000|Overall Study|Withdrawal by Subject|1|||
105595906|NCT01063517|364182461|FG001|Overall Study|Withdrawal by Subject|2|||
105595907|NCT01063517|364182460|FG000|Overall Study|Death|33|||
105595908|NCT01063517|364182461|FG001|Overall Study|Death|48|||
105595909|NCT00617201|364182464|FG000|Overall Study|Lost to Follow-up|9|||
105542809|NCT01800903|363987913|FG003|Second Test Period|unable to catheterise|0|||
105542810|NCT01800903|363987914|FG004|Second Test Period|unable to catheterise|0|||
105542811|NCT01800903|363987915|FG005|Second Test Period|unable to catheterise|0|||
105542812|NCT01516879|363987916|FG000|Overall Study|Withdrawal by Subject|9|||
105542813|NCT01516879|363987917|FG001|Overall Study|Withdrawal by Subject|11|||
105542814|NCT01516879|363987916|FG000|Overall Study|Death|0|||
105542815|NCT01516879|363987917|FG001|Overall Study|Death|2|||
105542816|NCT01516879|363987916|FG000|Overall Study|Lost to Follow-up|2|||
105542817|NCT01516879|363987917|FG001|Overall Study|Lost to Follow-up|11|||
105542818|NCT01516879|363987916|FG000|Overall Study|Other|5|||
105542819|NCT01516879|363987917|FG001|Overall Study|Other|10|||
105595910|NCT00617201|364182465|FG001|Overall Study|Lost to Follow-up|13|||
105542820|NCT01072201|363987918|FG000|Overall Study|Lost to Follow-up|0|||
105542821|NCT01072201|363987919|FG001|Overall Study|Lost to Follow-up|1|||
105542822|NCT00931307|363987921|FG000|Overall Study|Lack of Efficacy|12|||
105542823|NCT00931307|363987921|FG000|Overall Study|Biomicroscopy|1|||
105542824|NCT04666441|363987924|FG000|Overall Study|Lost to Follow-up|1|||
105542825|NCT04666441|363987925|FG001|Overall Study|Lost to Follow-up|4|||
105542826|NCT04666441|363987926|FG002|Overall Study|Lost to Follow-up|1|||
105542827|NCT04666441|363987927|FG003|Overall Study|Lost to Follow-up|3|||
105542828|NCT04666441|363987928|FG004|Overall Study|Lost to Follow-up|0|||
105542829|NCT04666441|363987929|FG005|Overall Study|Lost to Follow-up|2|||
105542830|NCT04666441|363987930|FG006|Overall Study|Lost to Follow-up|2|||
105542831|NCT04666441|363987931|FG007|Overall Study|Lost to Follow-up|2|||
105542832|NCT04666441|363987924|FG000|Overall Study|Subject Decision|1|||
105542833|NCT04666441|363987925|FG001|Overall Study|Subject Decision|1|||
105542834|NCT04666441|363987926|FG002|Overall Study|Subject Decision|3|||
105542835|NCT04666441|363987927|FG003|Overall Study|Subject Decision|1|||
105542836|NCT04666441|363987928|FG004|Overall Study|Subject Decision|0|||
105542837|NCT04666441|363987929|FG005|Overall Study|Subject Decision|1|||
105542838|NCT04666441|363987930|FG006|Overall Study|Subject Decision|3|||
105542839|NCT04666441|363987931|FG007|Overall Study|Subject Decision|2|||
105542840|NCT01328002|363987933|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
105542841|NCT01328002|363987934|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
105542842|NCT01328002|363987933|FG000|Open-Label Period|Adverse Event|8|||
105542843|NCT01328002|363987934|FG001|Open-Label Period|Adverse Event|0|||
105542844|NCT01328002|363987933|FG000|Open-Label Period|Lack of Efficacy|3|||
105542845|NCT01328002|363987934|FG001|Open-Label Period|Lack of Efficacy|0|||
105542846|NCT01328002|363987933|FG000|Open-Label Period|Protocol Violation|2|||
105542847|NCT01328002|363987934|FG001|Open-Label Period|Protocol Violation|0|||
105542848|NCT01328002|363987933|FG000|Open-Label Period|Withdrawal by Subject|9|||
105542849|NCT01328002|363987934|FG001|Open-Label Period|Withdrawal by Subject|0|||
105542850|NCT01328002|363987933|FG000|Open-Label Period|Lost to Follow-up|6|||
105542851|NCT01328002|363987934|FG001|Open-Label Period|Lost to Follow-up|0|||
105542852|NCT01328002|363987933|FG000|Open-Label Period|Other Reason|2|||
105542853|NCT01328002|363987934|FG001|Open-Label Period|Other Reason|0|||
105542854|NCT01328002|363987933|FG000|Double-Blind Period|Adverse Event|1|||
105542855|NCT01328002|363987934|FG001|Double-Blind Period|Adverse Event|0|||
105542856|NCT01328002|363987933|FG000|Double-Blind Period|Lack of Efficacy|1|||
105542857|NCT01328002|363987934|FG001|Double-Blind Period|Lack of Efficacy|0|||
105542858|NCT01208233|363987937|FG000|Overall Study|Adverse Event|0|||
105542859|NCT01208233|363987938|FG001|Overall Study|Adverse Event|1|||
105542860|NCT01208233|363987939|FG002|Overall Study|Adverse Event|2|||
105542861|NCT01208233|363987940|FG003|Overall Study|Adverse Event|0|||
105542862|NCT01208233|363987941|FG004|Overall Study|Adverse Event|3|||
105542863|NCT01208233|363987942|FG005|Overall Study|Adverse Event|5|||
105542864|NCT01208233|363987937|FG000|Overall Study|Death|0|||
105542865|NCT01208233|363987938|FG001|Overall Study|Death|0|||
105542866|NCT01208233|363987939|FG002|Overall Study|Death|0|||
105542867|NCT01208233|363987940|FG003|Overall Study|Death|0|||
105542868|NCT01208233|363987941|FG004|Overall Study|Death|3|||
105542869|NCT01208233|363987942|FG005|Overall Study|Death|5|||
105542870|NCT01208233|363987937|FG000|Overall Study|Did not meet entrance criteria|2|||
105595911|NCT00546871|364182466|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
105595912|NCT00546871|364182467|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
105595913|NCT00546871|364182466|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
105595914|NCT00546871|364182467|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
105542871|NCT01208233|363987938|FG001|Overall Study|Did not meet entrance criteria|1|||
105542872|NCT01208233|363987939|FG002|Overall Study|Did not meet entrance criteria|1|||
105542873|NCT01208233|363987940|FG003|Overall Study|Did not meet entrance criteria|0|||
105542874|NCT01208233|363987941|FG004|Overall Study|Did not meet entrance criteria|1|||
105542875|NCT01208233|363987942|FG005|Overall Study|Did not meet entrance criteria|0|||
105542876|NCT01208233|363987937|FG000|Overall Study|Medication error without adverse event|0|||
105542877|NCT01208233|363987938|FG001|Overall Study|Medication error without adverse event|0|||
105542878|NCT01208233|363987939|FG002|Overall Study|Medication error without adverse event|0|||
105542879|NCT01208233|363987940|FG003|Overall Study|Medication error without adverse event|0|||
105542880|NCT01208233|363987941|FG004|Overall Study|Medication error without adverse event|0|||
105542881|NCT01208233|363987942|FG005|Overall Study|Medication error without adverse event|1|||
105542882|NCT01208233|363987937|FG000|Overall Study|Study terminated by sponsor|0|||
105542883|NCT01208233|363987938|FG001|Overall Study|Study terminated by sponsor|0|||
105542884|NCT01208233|363987939|FG002|Overall Study|Study terminated by sponsor|0|||
105542885|NCT01208233|363987940|FG003|Overall Study|Study terminated by sponsor|0|||
105542886|NCT01208233|363987941|FG004|Overall Study|Study terminated by sponsor|10|||
105542887|NCT01208233|363987942|FG005|Overall Study|Study terminated by sponsor|7|||
105542888|NCT01208233|363987937|FG000|Overall Study|Protocol Violation|0|||
105542889|NCT01208233|363987938|FG001|Overall Study|Protocol Violation|0|||
105542890|NCT01208233|363987939|FG002|Overall Study|Protocol Violation|0|||
105542891|NCT01208233|363987940|FG003|Overall Study|Protocol Violation|0|||
105542892|NCT01208233|363987941|FG004|Overall Study|Protocol Violation|3|||
105542893|NCT01208233|363987942|FG005|Overall Study|Protocol Violation|0|||
105542894|NCT01208233|363987937|FG000|Overall Study|Other|2|||
105542895|NCT01208233|363987938|FG001|Overall Study|Other|1|||
105542896|NCT01208233|363987939|FG002|Overall Study|Other|0|||
105542897|NCT01208233|363987940|FG003|Overall Study|Other|0|||
105542898|NCT01208233|363987941|FG004|Overall Study|Other|0|||
105542899|NCT01208233|363987942|FG005|Overall Study|Other|1|||
105542900|NCT01208233|363987937|FG000|Overall Study|Withdrawal by Subject|1|||
105542901|NCT01208233|363987938|FG001|Overall Study|Withdrawal by Subject|0|||
105542902|NCT01208233|363987939|FG002|Overall Study|Withdrawal by Subject|1|||
105542903|NCT01208233|363987940|FG003|Overall Study|Withdrawal by Subject|1|||
105542904|NCT01208233|363987941|FG004|Overall Study|Withdrawal by Subject|4|||
105542905|NCT01208233|363987942|FG005|Overall Study|Withdrawal by Subject|2|||
105542906|NCT02556710|363990061|FG000|Overall Study|Surgical treatment|3|||
105542907|NCT02556710|363990062|FG001|Overall Study|Surgical treatment|0|||
105542908|NCT02556710|363990061|FG000|Overall Study|Required proscribed pain medication|2|||
105542909|NCT02556710|363990062|FG001|Overall Study|Required proscribed pain medication|1|||
105542910|NCT02556710|363990061|FG000|Overall Study|Lack of Efficacy|1|||
105542911|NCT02556710|363990062|FG001|Overall Study|Lack of Efficacy|0|||
105542912|NCT02556710|363990061|FG000|Overall Study|Worsening osteoarthritis|1|||
105542913|NCT02556710|363990062|FG001|Overall Study|Worsening osteoarthritis|0|||
105542914|NCT02556710|363990061|FG000|Overall Study|Moved out of state|1|||
105542915|NCT02556710|363990062|FG001|Overall Study|Moved out of state|0|||
105542916|NCT02556710|363990061|FG000|Overall Study|Missing reason|3|||
105542917|NCT02556710|363990062|FG001|Overall Study|Missing reason|1|||
105542918|NCT02556710|363990061|FG000|Overall Study|Pain as lack of efficacy|0|||
105542919|NCT02556710|363990062|FG001|Overall Study|Pain as lack of efficacy|4|||
105542920|NCT02139644|363990063|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
105542921|NCT02139644|363990064|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105542922|NCT02139644|363990065|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105542923|NCT02139644|363990066|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105542924|NCT02139644|363990067|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105542925|NCT02139644|363990068|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105542926|NCT02139644|363990063|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
105542927|NCT02139644|363990064|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105542928|NCT02139644|363990065|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105542929|NCT02139644|363990066|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105542930|NCT02139644|363990067|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105542931|NCT02139644|363990068|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105542932|NCT02139644|363990063|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
105542933|NCT02139644|363990064|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105542934|NCT02139644|363990065|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105542935|NCT02139644|363990066|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105542936|NCT02139644|363990067|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105542937|NCT02139644|363990068|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105542938|NCT02139644|363990063|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
105542939|NCT02139644|363990064|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105542940|NCT02139644|363990065|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105542941|NCT02139644|363990066|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105542942|NCT02139644|363990067|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105542943|NCT02139644|363990068|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105542944|NCT02139644|363990063|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
105542945|NCT02139644|363990064|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105542946|NCT02139644|363990065|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105542947|NCT02139644|363990066|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105542948|NCT02139644|363990067|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105542949|NCT02139644|363990068|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105542950|NCT02139644|363990063|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
105542951|NCT02139644|363990064|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
105542952|NCT02139644|363990065|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
105542953|NCT02139644|363990066|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
105542954|NCT02139644|363990067|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
105542955|NCT02139644|363990068|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
105542956|NCT02139644|363990063|FG000|Run-In Period (Pre-assignment)|Other|6|||
105542957|NCT02139644|363990064|FG001|Run-In Period (Pre-assignment)|Other|0|||
105542958|NCT02139644|363990065|FG002|Run-In Period (Pre-assignment)|Other|0|||
105542959|NCT02139644|363990066|FG003|Run-In Period (Pre-assignment)|Other|0|||
105542960|NCT02139644|363990067|FG004|Run-In Period (Pre-assignment)|Other|0|||
105542961|NCT02139644|363990068|FG005|Run-In Period (Pre-assignment)|Other|0|||
105542962|NCT02139644|363990063|FG000|Treatment Period|Adverse Event|0|||
105542963|NCT02139644|363990064|FG001|Treatment Period|Adverse Event|0|||
105542964|NCT02139644|363990065|FG002|Treatment Period|Adverse Event|3|||
105542965|NCT02139644|363990066|FG003|Treatment Period|Adverse Event|2|||
105542966|NCT02139644|363990067|FG004|Treatment Period|Adverse Event|1|||
105542967|NCT02139644|363990068|FG005|Treatment Period|Adverse Event|6|||
105542968|NCT02139644|363990063|FG000|Treatment Period|Withdrawal by Subject|0|||
105542969|NCT02139644|363990064|FG001|Treatment Period|Withdrawal by Subject|0|||
105542970|NCT02139644|363990065|FG002|Treatment Period|Withdrawal by Subject|2|||
105542971|NCT02139644|363990066|FG003|Treatment Period|Withdrawal by Subject|2|||
105542972|NCT02139644|363990067|FG004|Treatment Period|Withdrawal by Subject|3|||
105542973|NCT02139644|363990068|FG005|Treatment Period|Withdrawal by Subject|2|||
105542974|NCT02139644|363990063|FG000|Treatment Period|Non-compliance|0|||
105542975|NCT02139644|363990064|FG001|Treatment Period|Non-compliance|0|||
105542976|NCT02139644|363990065|FG002|Treatment Period|Non-compliance|0|||
105542977|NCT02139644|363990066|FG003|Treatment Period|Non-compliance|1|||
105542978|NCT02139644|363990067|FG004|Treatment Period|Non-compliance|0|||
105542979|NCT02139644|363990068|FG005|Treatment Period|Non-compliance|0|||
105542980|NCT02139644|363990063|FG000|Treatment Period|Protocol Violation|0|||
105542981|NCT02139644|363990064|FG001|Treatment Period|Protocol Violation|0|||
105542982|NCT02139644|363990065|FG002|Treatment Period|Protocol Violation|0|||
105542983|NCT02139644|363990066|FG003|Treatment Period|Protocol Violation|1|||
105542984|NCT02139644|363990067|FG004|Treatment Period|Protocol Violation|1|||
105542985|NCT02139644|363990068|FG005|Treatment Period|Protocol Violation|1|||
105542986|NCT02139644|363990063|FG000|Treatment Period|Disease progression|0|||
105542987|NCT02139644|363990064|FG001|Treatment Period|Disease progression|0|||
105542988|NCT02139644|363990065|FG002|Treatment Period|Disease progression|0|||
105542989|NCT02139644|363990066|FG003|Treatment Period|Disease progression|1|||
105542990|NCT02139644|363990067|FG004|Treatment Period|Disease progression|1|||
105542991|NCT02139644|363990068|FG005|Treatment Period|Disease progression|2|||
105542992|NCT02139644|363990063|FG000|Treatment Period|Lost to Follow-up|0|||
105542993|NCT02139644|363990064|FG001|Treatment Period|Lost to Follow-up|0|||
105542994|NCT02139644|363990065|FG002|Treatment Period|Lost to Follow-up|1|||
105542995|NCT02139644|363990066|FG003|Treatment Period|Lost to Follow-up|1|||
105542996|NCT02139644|363990067|FG004|Treatment Period|Lost to Follow-up|1|||
105542997|NCT02139644|363990068|FG005|Treatment Period|Lost to Follow-up|1|||
105542998|NCT02139644|363990063|FG000|Treatment Period|Lack of Efficacy|0|||
105542999|NCT02139644|363990064|FG001|Treatment Period|Lack of Efficacy|0|||
105543000|NCT02139644|363990065|FG002|Treatment Period|Lack of Efficacy|1|||
105543001|NCT02139644|363990066|FG003|Treatment Period|Lack of Efficacy|0|||
105543002|NCT02139644|363990067|FG004|Treatment Period|Lack of Efficacy|1|||
105543003|NCT02139644|363990068|FG005|Treatment Period|Lack of Efficacy|4|||
105543004|NCT02139644|363990063|FG000|Treatment Period|Other|0|||
105543005|NCT02139644|363990064|FG001|Treatment Period|Other|3|||
105543006|NCT02139644|363990065|FG002|Treatment Period|Other|1|||
105543007|NCT02139644|363990066|FG003|Treatment Period|Other|1|||
105543008|NCT02139644|363990067|FG004|Treatment Period|Other|0|||
105543009|NCT02139644|363990068|FG005|Treatment Period|Other|1|||
105543010|NCT01607905|363990069|FG000|Overall Study|Withdrawal by participant|7|||
105543011|NCT01607905|363990070|FG001|Overall Study|Withdrawal by participant|2|||
105543012|NCT01607905|363990071|FG002|Overall Study|Withdrawal by participant|4|||
105543013|NCT01607905|363990072|FG003|Overall Study|Withdrawal by participant|6|||
105543014|NCT01607905|363990073|FG004|Overall Study|Withdrawal by participant|0|||
105543015|NCT01607905|363990074|FG005|Overall Study|Withdrawal by participant|4|||
105543016|NCT01607905|363990075|FG006|Overall Study|Withdrawal by participant|12|||
105543017|NCT01607905|363990069|FG000|Overall Study|Incidence or severity of AEs|5|||
105543018|NCT01607905|363990070|FG001|Overall Study|Incidence or severity of AEs|1|||
105543019|NCT01607905|363990071|FG002|Overall Study|Incidence or severity of AEs|1|||
105543020|NCT01607905|363990072|FG003|Overall Study|Incidence or severity of AEs|3|||
105543021|NCT01607905|363990073|FG004|Overall Study|Incidence or severity of AEs|0|||
105543022|NCT01607905|363990074|FG005|Overall Study|Incidence or severity of AEs|2|||
105543023|NCT01607905|363990075|FG006|Overall Study|Incidence or severity of AEs|8|||
105543024|NCT01607905|363990069|FG000|Overall Study|Disease progression|44|||
105543025|NCT01607905|363990070|FG001|Overall Study|Disease progression|16|||
105543026|NCT01607905|363990071|FG002|Overall Study|Disease progression|15|||
105543027|NCT01607905|363990072|FG003|Overall Study|Disease progression|11|||
105543028|NCT01607905|363990073|FG004|Overall Study|Disease progression|6|||
105543029|NCT01607905|363990074|FG005|Overall Study|Disease progression|7|||
105543030|NCT01607905|363990075|FG006|Overall Study|Disease progression|21|||
105543031|NCT01607905|363990069|FG000|Overall Study|Non-compliance with study procedures|0|||
105543032|NCT01607905|363990070|FG001|Overall Study|Non-compliance with study procedures|0|||
105543033|NCT01607905|363990071|FG002|Overall Study|Non-compliance with study procedures|0|||
105543034|NCT01607905|363990072|FG003|Overall Study|Non-compliance with study procedures|0|||
105543035|NCT01607905|363990073|FG004|Overall Study|Non-compliance with study procedures|0|||
105543036|NCT01607905|363990074|FG005|Overall Study|Non-compliance with study procedures|0|||
105543037|NCT01607905|363990075|FG006|Overall Study|Non-compliance with study procedures|1|||
105543038|NCT01607905|363990069|FG000|Overall Study|Death|1|||
105543039|NCT01607905|363990070|FG001|Overall Study|Death|1|||
105543040|NCT01607905|363990071|FG002|Overall Study|Death|1|||
105543041|NCT01607905|363990072|FG003|Overall Study|Death|1|||
105543042|NCT01607905|363990073|FG004|Overall Study|Death|0|||
105543043|NCT01607905|363990074|FG005|Overall Study|Death|0|||
105543044|NCT01607905|363990075|FG006|Overall Study|Death|3|||
105543045|NCT01607905|363990069|FG000|Overall Study|Other treatments become available|1|||
105543046|NCT01607905|363990070|FG001|Overall Study|Other treatments become available|0|||
105543047|NCT01607905|363990071|FG002|Overall Study|Other treatments become available|0|||
105543048|NCT01607905|363990072|FG003|Overall Study|Other treatments become available|0|||
105543049|NCT01607905|363990073|FG004|Overall Study|Other treatments become available|0|||
105543050|NCT01607905|363990074|FG005|Overall Study|Other treatments become available|0|||
105543051|NCT01607905|363990075|FG006|Overall Study|Other treatments become available|1|||
105543052|NCT01607905|363990069|FG000|Overall Study|Investigator discretion|0|||
105543053|NCT01607905|363990070|FG001|Overall Study|Investigator discretion|0|||
105543054|NCT01607905|363990071|FG002|Overall Study|Investigator discretion|0|||
105543055|NCT01607905|363990072|FG003|Overall Study|Investigator discretion|0|||
105543056|NCT01607905|363990073|FG004|Overall Study|Investigator discretion|0|||
105543057|NCT01607905|363990074|FG005|Overall Study|Investigator discretion|1|||
105543058|NCT01607905|363990075|FG006|Overall Study|Investigator discretion|0|||
105543059|NCT01607905|363990069|FG000|Overall Study|Other|1|||
105543060|NCT01607905|363990070|FG001|Overall Study|Other|0|||
105543061|NCT01607905|363990071|FG002|Overall Study|Other|0|||
105543062|NCT01607905|363990072|FG003|Overall Study|Other|0|||
105543063|NCT01607905|363990073|FG004|Overall Study|Other|0|||
105543064|NCT01607905|363990074|FG005|Overall Study|Other|0|||
105543065|NCT01607905|363990075|FG006|Overall Study|Other|1|||
105543066|NCT01607905|363990069|FG000|Overall Study|Randomized but not treated|1|||
105543067|NCT01607905|363990070|FG001|Overall Study|Randomized but not treated|0|||
105543068|NCT01607905|363990071|FG002|Overall Study|Randomized but not treated|0|||
105543069|NCT01607905|363990072|FG003|Overall Study|Randomized but not treated|0|||
105543070|NCT01607905|363990073|FG004|Overall Study|Randomized but not treated|1|||
105543071|NCT01607905|363990074|FG005|Overall Study|Randomized but not treated|1|||
105543072|NCT01607905|363990075|FG006|Overall Study|Randomized but not treated|0|||
105543073|NCT01310413|363990076|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
105543074|NCT01310413|363990077|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
105543075|NCT01310413|363990078|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
105543076|NCT01310413|363990079|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
105543077|NCT01310413|363990080|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
105543078|NCT01310413|363990081|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
105543079|NCT01310413|363990082|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
105543080|NCT01310413|363990076|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
105543081|NCT01310413|363990077|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
105543082|NCT01310413|363990078|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
105543083|NCT01310413|363990079|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
105543084|NCT01310413|363990080|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
105543085|NCT01310413|363990081|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
105543086|NCT01310413|363990082|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
105543087|NCT01310413|363990076|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
105543088|NCT01310413|363990077|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
105543089|NCT01310413|363990078|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
105543090|NCT01310413|363990079|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
105543091|NCT01310413|363990080|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
105543092|NCT01310413|363990081|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
105543093|NCT01310413|363990082|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
105543094|NCT01310413|363990076|FG000|Day 0 to Day 385|Other|1|||
105543095|NCT01310413|363990077|FG001|Day 0 to Day 385|Other|0|||
105543096|NCT01310413|363990078|FG002|Day 0 to Day 385|Other|3|||
105543097|NCT01310413|363990079|FG003|Day 0 to Day 385|Other|0|||
105543098|NCT01310413|363990080|FG004|Day 0 to Day 385|Other|0|||
105543099|NCT01310413|363990081|FG005|Day 0 to Day 385|Other|0|||
105543100|NCT01310413|363990082|FG006|Day 0 to Day 385|Other|0|||
105543101|NCT01310413|363990076|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
105543102|NCT01310413|363990077|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
105543103|NCT01310413|363990078|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
105543104|NCT01310413|363990079|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
105543105|NCT01310413|363990080|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
105543106|NCT01310413|363990081|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
105543107|NCT01310413|363990082|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
105543108|NCT01310413|363990076|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
105543109|NCT01310413|363990077|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
105543110|NCT01310413|363990078|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
105543111|NCT01310413|363990079|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
105543112|NCT01310413|363990080|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
105543113|NCT01310413|363990081|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
105543114|NCT01310413|363990082|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
105543115|NCT00941733|363990083|FG000|Overall Study|Death|24|||
105543116|NCT00941733|363990084|FG001|Overall Study|Death|10|||
105543117|NCT00941733|363990083|FG000|Overall Study|Withdrawal by Subject|14|||
105543118|NCT00941733|363990084|FG001|Overall Study|Withdrawal by Subject|6|||
105543119|NCT00941733|363990083|FG000|Overall Study|Adverse Event|20|||
105543120|NCT00941733|363990084|FG001|Overall Study|Adverse Event|4|||
105543121|NCT00941733|363990083|FG000|Overall Study|Lost to Follow-up|1|||
105543122|NCT00941733|363990084|FG001|Overall Study|Lost to Follow-up|2|||
105543123|NCT00941733|363990083|FG000|Overall Study|Protocol Violation|15|||
105543124|NCT00941733|363990084|FG001|Overall Study|Protocol Violation|6|||
105543125|NCT00975975|363990086|FG000|Overall Study|Death|6|||
105543126|NCT01324024|363990087|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
105543127|NCT01324024|363990088|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
105543128|NCT03614793|363990093|FG000|Overall Study|Lost to Follow-up|1|||
105543129|NCT03614793|363990094|FG001|Overall Study|Lost to Follow-up|2|||
105543130|NCT03614793|363990093|FG000|Overall Study|Lack of Efficacy|0|||
105543131|NCT03614793|363990094|FG001|Overall Study|Lack of Efficacy|5|||
105543132|NCT03614793|363990093|FG000|Overall Study|Withdrawal by Subject|0|||
105543133|NCT03614793|363990094|FG001|Overall Study|Withdrawal by Subject|1|||
105543134|NCT03614793|363990093|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
105543135|NCT03614793|363990094|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
105543136|NCT01168999|363990097|FG000|Overall Study|Lost to Follow-up|2|||
105543137|NCT01168999|363990098|FG001|Overall Study|Lost to Follow-up|1|||
105543138|NCT01168999|363990099|FG002|Overall Study|Lost to Follow-up|0|||
105543139|NCT01168999|363990100|FG003|Overall Study|Lost to Follow-up|0|||
105543140|NCT00563797|363990101|FG000|Overall Study|Lost to Follow-up|7|||
105543141|NCT00563797|363990102|FG001|Overall Study|Lost to Follow-up|2|||
105543142|NCT02461589|363990105|FG000|Overall Study|Withdrawal by Subject|5|||
105543143|NCT02461589|363990106|FG001|Overall Study|Withdrawal by Subject|1|||
105543144|NCT02461589|363990107|FG002|Overall Study|Withdrawal by Subject|3|||
105543145|NCT02461589|363990108|FG003|Overall Study|Withdrawal by Subject|2|||
105543146|NCT02461589|363990109|FG004|Overall Study|Withdrawal by Subject|1|||
105543147|NCT02461589|363990110|FG005|Overall Study|Withdrawal by Subject|2|||
105543148|NCT02461589|363990111|FG006|Overall Study|Withdrawal by Subject|1|||
105543149|NCT02461589|363990112|FG007|Overall Study|Withdrawal by Subject|3|||
105543150|NCT02461589|363990113|FG008|Overall Study|Withdrawal by Subject|3|||
105543151|NCT02461589|363990114|FG009|Overall Study|Withdrawal by Subject|1|||
105543152|NCT02461589|363990105|FG000|Overall Study|Lost to Follow-up|0|||
105543153|NCT02461589|363990106|FG001|Overall Study|Lost to Follow-up|0|||
105543154|NCT02461589|363990107|FG002|Overall Study|Lost to Follow-up|2|||
105543155|NCT02461589|363990108|FG003|Overall Study|Lost to Follow-up|3|||
105543156|NCT02461589|363990109|FG004|Overall Study|Lost to Follow-up|1|||
105543157|NCT02461589|363990110|FG005|Overall Study|Lost to Follow-up|1|||
105543158|NCT02461589|363990111|FG006|Overall Study|Lost to Follow-up|3|||
105543159|NCT02461589|363990112|FG007|Overall Study|Lost to Follow-up|1|||
105543160|NCT02461589|363990113|FG008|Overall Study|Lost to Follow-up|3|||
105543161|NCT02461589|363990114|FG009|Overall Study|Lost to Follow-up|1|||
105543162|NCT02461589|363990105|FG000|Overall Study|Death|0|||
105543163|NCT02461589|363990106|FG001|Overall Study|Death|0|||
105543164|NCT02461589|363990107|FG002|Overall Study|Death|0|||
105543165|NCT02461589|363990108|FG003|Overall Study|Death|0|||
105543166|NCT02461589|363990109|FG004|Overall Study|Death|0|||
105543167|NCT02461589|363990110|FG005|Overall Study|Death|0|||
105543168|NCT02461589|363990111|FG006|Overall Study|Death|0|||
105543169|NCT02461589|363990112|FG007|Overall Study|Death|1|||
105543170|NCT02461589|363990113|FG008|Overall Study|Death|0|||
105543171|NCT02461589|363990114|FG009|Overall Study|Death|0|||
105543172|NCT02461589|363990105|FG000|Overall Study|Unclassified|0|||
105543173|NCT02461589|363990106|FG001|Overall Study|Unclassified|0|||
105543174|NCT02461589|363990107|FG002|Overall Study|Unclassified|0|||
105543175|NCT02461589|363990108|FG003|Overall Study|Unclassified|0|||
105543176|NCT02461589|363990109|FG004|Overall Study|Unclassified|0|||
105543177|NCT02461589|363990110|FG005|Overall Study|Unclassified|0|||
105543178|NCT02461589|363990111|FG006|Overall Study|Unclassified|1|||
105543179|NCT02461589|363990112|FG007|Overall Study|Unclassified|0|||
105543180|NCT02461589|363990113|FG008|Overall Study|Unclassified|0|||
105543181|NCT02461589|363990114|FG009|Overall Study|Unclassified|2|||
105543182|NCT02461589|363990105|FG000|Overall Study|Missing follow-up information|1|||
105543183|NCT02461589|363990106|FG001|Overall Study|Missing follow-up information|1|||
105543184|NCT02461589|363990107|FG002|Overall Study|Missing follow-up information|0|||
105543185|NCT02461589|363990108|FG003|Overall Study|Missing follow-up information|0|||
105543186|NCT02461589|363990109|FG004|Overall Study|Missing follow-up information|0|||
105543187|NCT02461589|363990110|FG005|Overall Study|Missing follow-up information|0|||
105543188|NCT02461589|363990111|FG006|Overall Study|Missing follow-up information|1|||
105543189|NCT02461589|363990112|FG007|Overall Study|Missing follow-up information|0|||
105543190|NCT02461589|363990113|FG008|Overall Study|Missing follow-up information|0|||
105543191|NCT02461589|363990114|FG009|Overall Study|Missing follow-up information|0|||
105543192|NCT02461589|363990105|FG000|Overall Study|Withdrawal from trial before exposure|0|||
105543193|NCT02461589|363990106|FG001|Overall Study|Withdrawal from trial before exposure|0|||
105543194|NCT02461589|363990107|FG002|Overall Study|Withdrawal from trial before exposure|0|||
105543195|NCT02461589|363990108|FG003|Overall Study|Withdrawal from trial before exposure|0|||
105543196|NCT02461589|363990109|FG004|Overall Study|Withdrawal from trial before exposure|0|||
105543197|NCT02461589|363990110|FG005|Overall Study|Withdrawal from trial before exposure|0|||
105543198|NCT02461589|363990111|FG006|Overall Study|Withdrawal from trial before exposure|0|||
105543199|NCT02461589|363990112|FG007|Overall Study|Withdrawal from trial before exposure|0|||
105543200|NCT02461589|363990113|FG008|Overall Study|Withdrawal from trial before exposure|0|||
105543201|NCT02461589|363990114|FG009|Overall Study|Withdrawal from trial before exposure|1|||
105543202|NCT04067141|363990115|FG000|First Intervention|Withdrawal by Subject|0|||
105543203|NCT04067141|363990116|FG001|First Intervention|Withdrawal by Subject|1|||
105543204|NCT04067141|363990115|FG000|Second Intervention|Adverse Event|0|||
105543205|NCT04067141|363990116|FG001|Second Intervention|Adverse Event|2|||
105543206|NCT01557946|363990117|FG000|Overall Study|Adverse Event|3|||
105543207|NCT01557946|363990118|FG001|Overall Study|Adverse Event|0|||
105543208|NCT01038921|363990119|FG000|Overall Study|Withdrawal by Subject|1|||
105543209|NCT01038921|363990120|FG001|Overall Study|Withdrawal by Subject|0|||
105543210|NCT01038921|363990119|FG000|Overall Study|Physician Decision|1|||
105543211|NCT01038921|363990120|FG001|Overall Study|Physician Decision|0|||
105543212|NCT04327934|363990121|FG000|Overall Study|Did not qualify|7|||
105543213|NCT04327934|363990122|FG001|Overall Study|Did not qualify|4|||
105543214|NCT04327934|363990121|FG000|Overall Study|Physician Decision|0|||
105543215|NCT04327934|363990122|FG001|Overall Study|Physician Decision|1|||
105543216|NCT00840970|363990123|FG000|Overall Study|Adverse Event|0|||
105543217|NCT00840970|363990124|FG001|Overall Study|Adverse Event|0|||
105543218|NCT00840970|363990125|FG002|Overall Study|Adverse Event|1|||
105543219|NCT01877421|363990126|FG000|Phase 2|Lost to Follow-up|0|||
105543220|NCT01877421|363990127|FG001|Phase 2|Lost to Follow-up|0|||
105543221|NCT01877421|363990128|FG002|Phase 2|Lost to Follow-up|0|||
105543222|NCT01877421|363990129|FG003|Phase 2|Lost to Follow-up|0|||
105543223|NCT01877421|363990130|FG004|Phase 2|Lost to Follow-up|0|||
105543224|NCT01877421|363990131|FG005|Phase 2|Lost to Follow-up|0|||
105543225|NCT01877421|363990132|FG006|Phase 2|Lost to Follow-up|1|||
105543226|NCT01877421|363990133|FG007|Phase 2|Lost to Follow-up|0|||
105543227|NCT01877421|363990134|FG008|Phase 2|Lost to Follow-up|0|||
105543228|NCT01877421|363990135|FG009|Phase 2|Lost to Follow-up|0|||
105543229|NCT01877421|363990136|FG010|Phase 2|Lost to Follow-up|0|||
105543230|NCT01877421|363990137|FG011|Phase 2|Lost to Follow-up|0|||
105543231|NCT01877421|363990138|FG012|Phase 2|Lost to Follow-up|0|||
105543232|NCT01877421|363990139|FG013|Phase 2|Lost to Follow-up|0|||
105543233|NCT01877421|363990140|FG014|Phase 2|Lost to Follow-up|0|||
105543234|NCT01877421|363990141|FG015|Phase 2|Lost to Follow-up|0|||
105543235|NCT01877421|363990142|FG016|Phase 2|Lost to Follow-up|0|||
105543236|NCT01877421|363990143|FG017|Phase 2|Lost to Follow-up|0|||
105543237|NCT01877421|363990126|FG000|Phase 2|Withdrawal by Subject|0|||
105543238|NCT01877421|363990127|FG001|Phase 2|Withdrawal by Subject|0|||
105543239|NCT01877421|363990128|FG002|Phase 2|Withdrawal by Subject|0|||
105543240|NCT01877421|363990129|FG003|Phase 2|Withdrawal by Subject|0|||
105543241|NCT01877421|363990130|FG004|Phase 2|Withdrawal by Subject|0|||
105543242|NCT01877421|363990131|FG005|Phase 2|Withdrawal by Subject|0|||
105543243|NCT01877421|363990132|FG006|Phase 2|Withdrawal by Subject|0|||
105543244|NCT01877421|363990133|FG007|Phase 2|Withdrawal by Subject|0|||
105543245|NCT01877421|363990134|FG008|Phase 2|Withdrawal by Subject|1|||
105543246|NCT01877421|363990135|FG009|Phase 2|Withdrawal by Subject|0|||
105543247|NCT01877421|363990136|FG010|Phase 2|Withdrawal by Subject|1|||
105543248|NCT01877421|363990137|FG011|Phase 2|Withdrawal by Subject|0|||
105543249|NCT01877421|363990138|FG012|Phase 2|Withdrawal by Subject|1|||
105543250|NCT01877421|363990139|FG013|Phase 2|Withdrawal by Subject|0|||
105543251|NCT01877421|363990140|FG014|Phase 2|Withdrawal by Subject|0|||
105543252|NCT01877421|363990141|FG015|Phase 2|Withdrawal by Subject|1|||
105543253|NCT01877421|363990142|FG016|Phase 2|Withdrawal by Subject|0|||
105543254|NCT01877421|363990143|FG017|Phase 2|Withdrawal by Subject|0|||
105543255|NCT01877421|363990126|FG000|Phase 2|Protocol Violation|0|||
105543256|NCT01877421|363990127|FG001|Phase 2|Protocol Violation|0|||
105543257|NCT01877421|363990128|FG002|Phase 2|Protocol Violation|0|||
105543258|NCT01877421|363990129|FG003|Phase 2|Protocol Violation|0|||
105543259|NCT01877421|363990130|FG004|Phase 2|Protocol Violation|0|||
105543260|NCT01877421|363990131|FG005|Phase 2|Protocol Violation|0|||
105543261|NCT01877421|363990132|FG006|Phase 2|Protocol Violation|0|||
105543262|NCT01877421|363990133|FG007|Phase 2|Protocol Violation|0|||
105543263|NCT01877421|363990134|FG008|Phase 2|Protocol Violation|0|||
105543264|NCT01877421|363990135|FG009|Phase 2|Protocol Violation|0|||
105543265|NCT01877421|363990136|FG010|Phase 2|Protocol Violation|1|||
105543266|NCT01877421|363990137|FG011|Phase 2|Protocol Violation|0|||
105543267|NCT01877421|363990138|FG012|Phase 2|Protocol Violation|0|||
105543268|NCT01877421|363990139|FG013|Phase 2|Protocol Violation|0|||
105543269|NCT01877421|363990140|FG014|Phase 2|Protocol Violation|0|||
105543270|NCT01877421|363990141|FG015|Phase 2|Protocol Violation|0|||
105543271|NCT01877421|363990142|FG016|Phase 2|Protocol Violation|0|||
105595915|NCT00546871|364182466|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
105595916|NCT00546871|364182467|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
105595917|NCT00546871|364182466|FG000|Study Extension Period|Protocol Violation|1|||
105595918|NCT00546871|364182467|FG001|Study Extension Period|Protocol Violation|0|||
105595919|NCT00546871|364182466|FG000|Study Extension Period|Withdrawal by Subject|0|||
105595920|NCT00546871|364182467|FG001|Study Extension Period|Withdrawal by Subject|1|||
105543272|NCT01877421|363990143|FG017|Phase 2|Protocol Violation|0|||
105543273|NCT01047683|363990144|FG000|Overall Study|Adverse Event|3|||
105543274|NCT01047683|363990145|FG001|Overall Study|Adverse Event|1|||
105543275|NCT01047683|363990146|FG002|Overall Study|Adverse Event|0|||
105543276|NCT01047683|363990144|FG000|Overall Study|Withdrew Consent|1|||
105543277|NCT01047683|363990145|FG001|Overall Study|Withdrew Consent|4|||
105543278|NCT01047683|363990146|FG002|Overall Study|Withdrew Consent|2|||
105543279|NCT01047683|363990144|FG000|Overall Study|Lost to Follow-up|0|||
105543280|NCT01047683|363990145|FG001|Overall Study|Lost to Follow-up|1|||
105543281|NCT01047683|363990146|FG002|Overall Study|Lost to Follow-up|0|||
105543282|NCT01047683|363990144|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
105543283|NCT01047683|363990145|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
105543284|NCT01047683|363990146|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
105543285|NCT02399085|363990158|FG000|Overall Study|Adverse Event|16|||
105543286|NCT02399085|363990158|FG000|Overall Study|Death|2|||
105543287|NCT02399085|363990158|FG000|Overall Study|Withdrawal by Subject|8|||
105543288|NCT02399085|363990158|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
105543289|NCT02399085|363990158|FG000|Overall Study|Physician Decision|5|||
105543290|NCT01485861|363990159|FG000|Phase Ib|Death|1|||
105543291|NCT01485861|363990160|FG001|Phase Ib|Death|0|||
105543292|NCT01485861|363990161|FG002|Phase Ib|Death|0|||
105543293|NCT01485861|363990162|FG003|Phase Ib|Death|0|||
105543294|NCT01485861|363990163|FG004|Phase Ib|Death|0|||
105543295|NCT01485861|363990164|FG005|Phase Ib|Death|0|||
105543296|NCT01485861|363990159|FG000|Phase Ib|Physician Decision|1|||
105543297|NCT01485861|363990160|FG001|Phase Ib|Physician Decision|1|||
105543298|NCT01485861|363990161|FG002|Phase Ib|Physician Decision|0|||
105543299|NCT01485861|363990162|FG003|Phase Ib|Physician Decision|0|||
105543300|NCT01485861|363990163|FG004|Phase Ib|Physician Decision|0|||
105543301|NCT01485861|363990164|FG005|Phase Ib|Physician Decision|0|||
105543302|NCT01485861|363990159|FG000|Phase Ib|Adverse Event|0|||
105543303|NCT01485861|363990160|FG001|Phase Ib|Adverse Event|4|||
105543304|NCT01485861|363990161|FG002|Phase Ib|Adverse Event|0|||
105543305|NCT01485861|363990162|FG003|Phase Ib|Adverse Event|0|||
105543306|NCT01485861|363990163|FG004|Phase Ib|Adverse Event|0|||
105543307|NCT01485861|363990164|FG005|Phase Ib|Adverse Event|0|||
105543308|NCT01485861|363990159|FG000|Phase Ib|Progression of disease|5|||
105543309|NCT01485861|363990160|FG001|Phase Ib|Progression of disease|0|||
105543310|NCT01485861|363990161|FG002|Phase Ib|Progression of disease|0|||
105543311|NCT01485861|363990162|FG003|Phase Ib|Progression of disease|0|||
105543312|NCT01485861|363990163|FG004|Phase Ib|Progression of disease|0|||
105543313|NCT01485861|363990164|FG005|Phase Ib|Progression of disease|0|||
105543314|NCT01485861|363990159|FG000|Phase Ib|Other|3|||
105543315|NCT01485861|363990160|FG001|Phase Ib|Other|0|||
105543316|NCT01485861|363990161|FG002|Phase Ib|Other|0|||
105543317|NCT01485861|363990162|FG003|Phase Ib|Other|0|||
105543318|NCT01485861|363990163|FG004|Phase Ib|Other|0|||
105543319|NCT01485861|363990164|FG005|Phase Ib|Other|0|||
105543320|NCT01485861|363990159|FG000|Phase Ib|Withdrawal by Subject|4|||
105543321|NCT01485861|363990160|FG001|Phase Ib|Withdrawal by Subject|1|||
105543322|NCT01485861|363990161|FG002|Phase Ib|Withdrawal by Subject|0|||
105543323|NCT01485861|363990162|FG003|Phase Ib|Withdrawal by Subject|0|||
105543324|NCT01485861|363990163|FG004|Phase Ib|Withdrawal by Subject|0|||
105543325|NCT01485861|363990164|FG005|Phase Ib|Withdrawal by Subject|0|||
105543326|NCT01485861|363990159|FG000|Phase II|Death|0|||
105543327|NCT01485861|363990160|FG001|Phase II|Death|0|||
105543328|NCT01485861|363990161|FG002|Phase II|Death|67|||
105543329|NCT01485861|363990162|FG003|Phase II|Death|71|||
105543330|NCT01485861|363990163|FG004|Phase II|Death|68|||
105543331|NCT01485861|363990164|FG005|Phase II|Death|0|||
105543332|NCT01485861|363990159|FG000|Phase II|Progression of Disease|0|||
105543333|NCT01485861|363990160|FG001|Phase II|Progression of Disease|0|||
105543334|NCT01485861|363990161|FG002|Phase II|Progression of Disease|1|||
105595921|NCT01350804|364182468|FG000|Core Study|Withdrawal by Subject|11|||
105543335|NCT01485861|363990162|FG003|Phase II|Progression of Disease|0|||
105543336|NCT01485861|363990163|FG004|Phase II|Progression of Disease|0|||
105543337|NCT01485861|363990164|FG005|Phase II|Progression of Disease|0|||
105543338|NCT01485861|363990159|FG000|Phase II|Other|0|||
105543339|NCT01485861|363990160|FG001|Phase II|Other|0|||
105543340|NCT01485861|363990161|FG002|Phase II|Other|0|||
105543341|NCT01485861|363990162|FG003|Phase II|Other|1|||
105543342|NCT01485861|363990163|FG004|Phase II|Other|0|||
105543343|NCT01485861|363990164|FG005|Phase II|Other|0|||
105543344|NCT01485861|363990159|FG000|Phase II|Withdrawal by Subject|0|||
105543345|NCT01485861|363990160|FG001|Phase II|Withdrawal by Subject|0|||
105543346|NCT01485861|363990161|FG002|Phase II|Withdrawal by Subject|6|||
105543347|NCT01485861|363990162|FG003|Phase II|Withdrawal by Subject|3|||
105543348|NCT01485861|363990163|FG004|Phase II|Withdrawal by Subject|4|||
105543349|NCT01485861|363990164|FG005|Phase II|Withdrawal by Subject|0|||
105543350|NCT01485861|363990159|FG000|Phase II|Lost to Follow-up|0|||
105543351|NCT01485861|363990160|FG001|Phase II|Lost to Follow-up|0|||
105543352|NCT01485861|363990161|FG002|Phase II|Lost to Follow-up|2|||
105543353|NCT01485861|363990162|FG003|Phase II|Lost to Follow-up|3|||
105543354|NCT01485861|363990163|FG004|Phase II|Lost to Follow-up|5|||
105543355|NCT01485861|363990164|FG005|Phase II|Lost to Follow-up|0|||
105543356|NCT01485861|363990159|FG000|Phase II|Study Ended|0|||
105543357|NCT01485861|363990160|FG001|Phase II|Study Ended|0|||
105543358|NCT01485861|363990161|FG002|Phase II|Study Ended|7|||
105543359|NCT01485861|363990162|FG003|Phase II|Study Ended|8|||
105543360|NCT01485861|363990163|FG004|Phase II|Study Ended|6|||
105543361|NCT01485861|363990164|FG005|Phase II|Study Ended|0|||
105543362|NCT01485861|363990159|FG000|Safety Phase|Death|0|||
105543363|NCT01485861|363990160|FG001|Safety Phase|Death|0|||
105543364|NCT01485861|363990161|FG002|Safety Phase|Death|0|||
105543365|NCT01485861|363990162|FG003|Safety Phase|Death|0|||
105543366|NCT01485861|363990163|FG004|Safety Phase|Death|0|||
105543367|NCT01485861|363990164|FG005|Safety Phase|Death|2|||
105543368|NCT01485861|363990159|FG000|Safety Phase|Adverse Event|0|||
105543369|NCT01485861|363990160|FG001|Safety Phase|Adverse Event|0|||
105543370|NCT01485861|363990161|FG002|Safety Phase|Adverse Event|0|||
105543371|NCT01485861|363990162|FG003|Safety Phase|Adverse Event|0|||
105543372|NCT01485861|363990163|FG004|Safety Phase|Adverse Event|0|||
105543373|NCT01485861|363990164|FG005|Safety Phase|Adverse Event|1|||
105543374|NCT01485861|363990159|FG000|Safety Phase|Other|0|||
105543375|NCT01485861|363990160|FG001|Safety Phase|Other|0|||
105543376|NCT01485861|363990161|FG002|Safety Phase|Other|0|||
105543377|NCT01485861|363990162|FG003|Safety Phase|Other|0|||
105543378|NCT01485861|363990163|FG004|Safety Phase|Other|0|||
105543379|NCT01485861|363990164|FG005|Safety Phase|Other|5|||
105543380|NCT01485861|363990159|FG000|Safety Phase|Progression of Disease|0|||
105543381|NCT01485861|363990160|FG001|Safety Phase|Progression of Disease|0|||
105543382|NCT01485861|363990161|FG002|Safety Phase|Progression of Disease|0|||
105543383|NCT01485861|363990162|FG003|Safety Phase|Progression of Disease|0|||
105543384|NCT01485861|363990163|FG004|Safety Phase|Progression of Disease|0|||
105543385|NCT01485861|363990164|FG005|Safety Phase|Progression of Disease|9|||
105543386|NCT01485861|363990159|FG000|Safety Phase|Withdrawal by Subject|0|||
105543387|NCT01485861|363990160|FG001|Safety Phase|Withdrawal by Subject|0|||
105543388|NCT01485861|363990161|FG002|Safety Phase|Withdrawal by Subject|0|||
105543389|NCT01485861|363990162|FG003|Safety Phase|Withdrawal by Subject|0|||
105543390|NCT01485861|363990163|FG004|Safety Phase|Withdrawal by Subject|0|||
105543391|NCT01485861|363990164|FG005|Safety Phase|Withdrawal by Subject|6|||
105543392|NCT01485861|363990159|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
105543393|NCT01485861|363990160|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
105543394|NCT01485861|363990161|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
105543395|NCT01485861|363990162|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
105543396|NCT01485861|363990163|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
105543397|NCT01485861|363990164|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
105543398|NCT00724451|363990168|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
105543399|NCT00724451|363990168|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
105543400|NCT00724451|363990168|FG000|Overall Study|Not Eligible for Treatment|431|||
105543401|NCT00724451|363990168|FG000|Overall Study|Participant Refused Treatment|89|||
105543402|NCT00724451|363990168|FG000|Overall Study|Never Started Treatment|89|||
105543403|NCT00724451|363990168|FG000|Overall Study|Unknown; No Data Sources Available|9|||
105543404|NCT00724451|363990168|FG000|Overall Study|Physician Decision|116|||
105543405|NCT00724451|363990168|FG000|Overall Study|Withdrawal by Subject|45|||
105543406|NCT00724451|363990168|FG000|Overall Study|Investigator + Participant Decision|13|||
105543407|NCT01632800|363990169|FG000|Overall Study|Subject did not fit in apparatus|1|||
105543408|NCT01260922|363990170|FG000|First Intervention|Withdrawal by Subject|0|||
105543409|NCT01260922|363990171|FG001|First Intervention|Withdrawal by Subject|1|||
105543410|NCT01260922|363990170|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
105543411|NCT01260922|363990171|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
105543412|NCT01260922|363990170|FG000|Second Intervention|Emesis|0|||
105543413|NCT01260922|363990171|FG001|Second Intervention|Emesis|2|||
105543414|NCT03732248|363990172|FG000|Overall Study|Withdrawal by Subject|1|||
105543415|NCT03732248|363990173|FG001|Overall Study|Withdrawal by Subject|0|||
105543416|NCT02266381|363990174|FG000|Overall Study|Physician Decision|3|||
105543417|NCT02266381|363990175|FG001|Overall Study|Physician Decision|5|||
105543418|NCT02266381|363990176|FG002|Overall Study|Physician Decision|4|||
105543419|NCT01459796|363990177|FG000|Overall Study|Non compliance with protocol|2|||
105543420|NCT01459796|363990178|FG001|Overall Study|Non compliance with protocol|4|||
105543421|NCT01459796|363990177|FG000|Overall Study|Adverse Event|5|||
105543422|NCT01459796|363990178|FG001|Overall Study|Adverse Event|5|||
105595922|NCT01350804|364182469|FG001|Core Study|Withdrawal by Subject|17|||
105543423|NCT01459796|363990177|FG000|Overall Study|Withdrawal by Subject|6|||
105543424|NCT01459796|363990178|FG001|Overall Study|Withdrawal by Subject|3|||
105543425|NCT01459796|363990177|FG000|Overall Study|Lost to Follow-up|5|||
105543426|NCT01459796|363990178|FG001|Overall Study|Lost to Follow-up|4|||
105543427|NCT01459796|363990177|FG000|Overall Study|Reason unspecified|1|||
105543428|NCT01459796|363990178|FG001|Overall Study|Reason unspecified|2|||
105543429|NCT01459796|363990177|FG000|Overall Study|Decision by the sponsor|75|||
105543430|NCT01459796|363990178|FG001|Overall Study|Decision by the sponsor|108|||
105543431|NCT00733824|363990179|FG000|Phase I|Withdrawal by Subject|1|||
105543432|NCT00733824|363990180|FG001|Phase I|Withdrawal by Subject|0|||
105543433|NCT00733824|363990181|FG002|Phase I|Withdrawal by Subject|0|||
105543434|NCT00733824|363990182|FG003|Phase I|Withdrawal by Subject|0|||
105543435|NCT00733824|363990183|FG004|Phase I|Withdrawal by Subject|0|||
105543436|NCT02802345|363990184|FG000|Overall Study|Not Treated|0|||
105543437|NCT02802345|363990185|FG001|Overall Study|Not Treated|1|||
105543438|NCT02802345|363990184|FG000|Overall Study|Adverse Event|28|||
105543439|NCT02802345|363990185|FG001|Overall Study|Adverse Event|20|||
105543440|NCT02802345|363990184|FG000|Overall Study|Withdrawal by Subject|3|||
105543441|NCT02802345|363990185|FG001|Overall Study|Withdrawal by Subject|3|||
105543442|NCT02802345|363990184|FG000|Overall Study|Protocol Violation|0|||
105543443|NCT02802345|363990185|FG001|Overall Study|Protocol Violation|1|||
105543444|NCT02802345|363990184|FG000|Overall Study|Other than listed|1|||
105543445|NCT02802345|363990185|FG001|Overall Study|Other than listed|5|||
105543446|NCT03433456|363990186|FG000|Overall Study|Death|1|||
105543447|NCT03433456|363990187|FG001|Overall Study|Death|1|||
105543448|NCT03433456|363990186|FG000|Overall Study|Lost to Follow-up|14|||
105543449|NCT03433456|363990187|FG001|Overall Study|Lost to Follow-up|11|||
105543450|NCT03433456|363990186|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
105543451|NCT03433456|363990187|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
105543452|NCT01669343|363990197|FG000|Part A: All Patients|Withdrawal by Subject|7|||
105543453|NCT01669343|363990197|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
105543454|NCT01669343|363990197|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
105543455|NCT01669343|363990197|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
105543456|NCT01669343|363990197|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
105543457|NCT00835406|363990202|FG000|Period: First Intervention|Adverse Event|0|||
105543458|NCT00835406|363990203|FG001|Period: First Intervention|Adverse Event|1|||
105543459|NCT00835406|363990202|FG000|Period: First Intervention|Withdrawal by Subject|2|||
105543460|NCT00835406|363990203|FG001|Period: First Intervention|Withdrawal by Subject|0|||
105543461|NCT00835406|363990202|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
105543462|NCT00835406|363990203|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
105543463|NCT03791398|363990208|FG000|Overall Study|Progression of Disease Under Study|2|||
105543464|NCT03791398|363990209|FG001|Overall Study|Progression of Disease Under Study|0|||
105543465|NCT03791398|363990210|FG002|Overall Study|Progression of Disease Under Study|0|||
105543466|NCT02158039|363990211|FG000|Overall Study|Withdrawal by Subject|1|||
105543467|NCT02158039|363990211|FG000|Overall Study|Screen Failure|9|||
105543468|NCT02755831|363990217|FG000|Overall Study|Lost to Follow-up|3|||
105543469|NCT02755831|363990218|FG001|Overall Study|Lost to Follow-up|3|||
105543470|NCT00298831|363990219|FG000|Overall Study|Adverse Event|1|||
105543471|NCT00298831|363990219|FG000|Overall Study|Lost to Follow-up|3|||
105543472|NCT00298831|363990219|FG000|Overall Study|Withdrawal by Subject|1|||
105543473|NCT00298831|363990219|FG000|Overall Study|Participants did not receive treatment|27|||
105543474|NCT02052466|363990220|FG000|Overall Study|Withdrawal by Subject|1|||
105543475|NCT02052466|363990220|FG000|Overall Study|Acromial fracture|1|||
105543476|NCT04382612|363990225|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
105543477|NCT03149328|363990226|FG000|Overall Study|Withdrawal by Subject|30|||
105543478|NCT03149328|363990227|FG001|Overall Study|Withdrawal by Subject|26|||
105543479|NCT03149328|363990226|FG000|Overall Study|Changed Dialysis Modality|18|||
105543480|NCT03149328|363990227|FG001|Overall Study|Changed Dialysis Modality|1|||
105543481|NCT03149328|363990226|FG000|Overall Study|Transplant|9|||
105543482|NCT03149328|363990227|FG001|Overall Study|Transplant|1|||
105543483|NCT03149328|363990226|FG000|Overall Study|Lost to Follow-up|25|||
105543484|NCT03149328|363990227|FG001|Overall Study|Lost to Follow-up|16|||
105543485|NCT03149328|363990226|FG000|Overall Study|Left Study Site|1|||
105543486|NCT03149328|363990227|FG001|Overall Study|Left Study Site|2|||
105543487|NCT03149328|363990226|FG000|Overall Study|Language Barrier|1|||
105543488|NCT03149328|363990227|FG001|Overall Study|Language Barrier|0|||
105543489|NCT00691210|363990228|FG000|Overall Study|Progression of Disease|0|||
105543490|NCT00691210|363990229|FG001|Overall Study|Progression of Disease|0|||
105543491|NCT00691210|363990230|FG002|Overall Study|Progression of Disease|0|||
105543492|NCT00691210|363990231|FG003|Overall Study|Progression of Disease|2|||
105543493|NCT00691210|363990232|FG004|Overall Study|Progression of Disease|0|||
105543494|NCT00691210|363990233|FG005|Overall Study|Progression of Disease|0|||
105543495|NCT00691210|363990234|FG006|Overall Study|Progression of Disease|0|||
105543496|NCT00691210|363990235|FG007|Overall Study|Progression of Disease|0|||
105543497|NCT00691210|363990228|FG000|Overall Study|Lack of Efficacy|0|||
105543498|NCT00691210|363990229|FG001|Overall Study|Lack of Efficacy|0|||
105543499|NCT00691210|363990230|FG002|Overall Study|Lack of Efficacy|0|||
105543500|NCT00691210|363990231|FG003|Overall Study|Lack of Efficacy|1|||
105543501|NCT00691210|363990232|FG004|Overall Study|Lack of Efficacy|0|||
105543502|NCT00691210|363990233|FG005|Overall Study|Lack of Efficacy|1|||
105543503|NCT00691210|363990234|FG006|Overall Study|Lack of Efficacy|0|||
105543504|NCT00691210|363990235|FG007|Overall Study|Lack of Efficacy|0|||
105543505|NCT04028388|363990238|FG000|Overall Study|Evaluations missing|3|||
105543506|NCT04028388|363990239|FG001|Overall Study|Evaluations missing|6|||
105543507|NCT04028388|363990238|FG000|Overall Study|Not started|2|||
105543508|NCT04028388|363990239|FG001|Overall Study|Not started|0|||
105543509|NCT04369469|363990246|FG000|Overall Study|Lost to Follow-up|2|||
105543510|NCT04369469|363990247|FG001|Overall Study|Lost to Follow-up|4|||
105543511|NCT04369469|363990246|FG000|Overall Study|Physician Decision|2|||
105543512|NCT04369469|363990247|FG001|Overall Study|Physician Decision|1|||
105543513|NCT04369469|363990246|FG000|Overall Study|Withdrawal by Subject|2|||
105543514|NCT04369469|363990247|FG001|Overall Study|Withdrawal by Subject|3|||
105543515|NCT04369469|363990246|FG000|Overall Study|Adverse Event|1|||
105543516|NCT04369469|363990247|FG001|Overall Study|Adverse Event|0|||
105543517|NCT04369469|363990246|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
105543518|NCT04369469|363990247|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
105543519|NCT04369469|363990246|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
105543520|NCT04369469|363990247|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
105543521|NCT04369469|363990246|FG000|Overall Study|Unable to Provide Consent|0|||
105543522|NCT04369469|363990247|FG001|Overall Study|Unable to Provide Consent|1|||
105543523|NCT00555438|363990248|FG000|10 Days Post-operative|Death|4|||
105543524|NCT00555438|363990248|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
105543525|NCT00061048|363990249|FG000|Overall Study|Adverse Event|2|||
105543526|NCT00061048|363990249|FG000|Overall Study|disease progression|20|||
105543527|NCT03099382|363990250|FG000|Overall Study|Protocol Violation|2|||
105543528|NCT03099382|363990251|FG001|Overall Study|Protocol Violation|3|||
105543529|NCT01940705|363990258|FG000|Overall Study|Lost to Follow-up|1|||
105543530|NCT01940705|363990259|FG001|Overall Study|Lost to Follow-up|3|||
105543531|NCT01940705|363990260|FG002|Overall Study|Lost to Follow-up|2|||
105543532|NCT01940705|363990261|FG003|Overall Study|Lost to Follow-up|2|||
105543533|NCT01940705|363990258|FG000|Overall Study|Withdrawal by Subject|2|||
105543534|NCT01940705|363990259|FG001|Overall Study|Withdrawal by Subject|2|||
105543535|NCT01940705|363990260|FG002|Overall Study|Withdrawal by Subject|3|||
105543536|NCT01940705|363990261|FG003|Overall Study|Withdrawal by Subject|2|||
105543537|NCT01940705|363990258|FG000|Overall Study|Intervention not given|0|||
105543538|NCT01940705|363990259|FG001|Overall Study|Intervention not given|3|||
105543539|NCT01940705|363990260|FG002|Overall Study|Intervention not given|3|||
105543540|NCT01940705|363990261|FG003|Overall Study|Intervention not given|0|||
105543541|NCT01940705|363990258|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
105543542|NCT01940705|363990259|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
105543543|NCT01940705|363990260|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
105543544|NCT01940705|363990261|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
105543545|NCT03779841|363990262|FG000|Randomized Population|Did Not Receive Treatment|3|||
105543546|NCT03779841|363990263|FG001|Randomized Population|Did Not Receive Treatment|1|||
105543547|NCT03779841|363990264|FG002|Randomized Population|Did Not Receive Treatment|0|||
105543548|NCT03779841|363990262|FG000|Treated (Safety) Population|Adverse Event|1|||
105543549|NCT03779841|363990263|FG001|Treated (Safety) Population|Adverse Event|1|||
105543550|NCT03779841|363990264|FG002|Treated (Safety) Population|Adverse Event|0|||
105543551|NCT03779841|363990262|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
105543552|NCT03779841|363990263|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
105543553|NCT03779841|363990264|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
105543554|NCT03779841|363990262|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
105543555|NCT03779841|363990263|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
105543556|NCT03779841|363990264|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
105543557|NCT03779841|363990262|FG000|Treated (Safety) Population|Death|1|||
105543558|NCT03779841|363990263|FG001|Treated (Safety) Population|Death|0|||
105543559|NCT03779841|363990264|FG002|Treated (Safety) Population|Death|2|||
105543560|NCT01632579|363990265|FG000|Washout Period|Adverse Event|1|||
105543561|NCT01632579|363990266|FG001|Washout Period|Adverse Event|0|||
105543562|NCT01632579|363990267|FG002|Washout Period|Adverse Event|0|||
105543563|NCT01632579|363990268|FG003|Washout Period|Adverse Event|0|||
105543564|NCT01632579|363990269|FG004|Washout Period|Adverse Event|0|||
105543565|NCT01632579|363990270|FG005|Washout Period|Adverse Event|0|||
105543566|NCT01632579|363990271|FG006|Washout Period|Adverse Event|0|||
105543567|NCT01632579|363990272|FG007|Washout Period|Adverse Event|0|||
105543568|NCT01632579|363990273|FG008|Washout Period|Adverse Event|0|||
105543569|NCT01632579|363990265|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
105543570|NCT01632579|363990266|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
105543571|NCT01632579|363990267|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
105543572|NCT01632579|363990268|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
105543573|NCT01632579|363990269|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
105543574|NCT01632579|363990270|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
105543575|NCT01632579|363990271|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
105543576|NCT01632579|363990272|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
105543577|NCT01632579|363990273|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
105543578|NCT00459134|363990274|FG000|Overall Study|Physician Decision|1|||
105543579|NCT00459134|363990275|FG001|Overall Study|Physician Decision|1|||
105543580|NCT00459134|363990274|FG000|Overall Study|Withdrawal by Subject|8|||
105543581|NCT00459134|363990275|FG001|Overall Study|Withdrawal by Subject|7|||
105543582|NCT00459134|363990274|FG000|Overall Study|Lost to Follow-up|6|||
105543583|NCT00459134|363990275|FG001|Overall Study|Lost to Follow-up|7|||
105543584|NCT00459134|363990274|FG000|Overall Study|Surgery|1|||
105543585|NCT00459134|363990275|FG001|Overall Study|Surgery|2|||
105543586|NCT00459134|363990274|FG000|Overall Study|Toxicity|4|||
105543587|NCT00459134|363990275|FG001|Overall Study|Toxicity|5|||
105543588|NCT00459134|363990274|FG000|Overall Study|Progression|1|||
105543589|NCT00459134|363990275|FG001|Overall Study|Progression|0|||
105543590|NCT00459134|363990274|FG000|Overall Study|Multiple Reasons|2|||
105543591|NCT00459134|363990275|FG001|Overall Study|Multiple Reasons|3|||
105543592|NCT04095858|363990276|FG000|Overall Study|Death|1|||
105543593|NCT04095858|363990277|FG001|Overall Study|Death|0|||
105543594|NCT04095858|363990276|FG000|Overall Study|Study terminated by Sponsor|2|||
105543595|NCT04095858|363990277|FG001|Overall Study|Study terminated by Sponsor|4|||
105543596|NCT00836875|363990280|FG000|Overall Study|Death|3|||
105543597|NCT00836875|363990281|FG001|Overall Study|Death|2|||
105543598|NCT00836875|363990280|FG000|Overall Study|Withdrawal by Subject|0|||
105543599|NCT00836875|363990281|FG001|Overall Study|Withdrawal by Subject|1|||
105543600|NCT03246529|363990284|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
105543601|NCT03246529|363990285|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
105543602|NCT03246529|363990286|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
105543603|NCT03246529|363990284|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
105543604|NCT03246529|363990285|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
105543605|NCT03246529|363990286|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
105543606|NCT03246529|363990284|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
105543607|NCT03246529|363990285|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
105543608|NCT03246529|363990286|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
105543609|NCT03246529|363990284|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
105543610|NCT03246529|363990285|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
105543611|NCT03246529|363990286|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
105543612|NCT03246529|363990284|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
105543613|NCT03246529|363990285|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
105543614|NCT03246529|363990286|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
105543615|NCT03246529|363990284|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
105543616|NCT03246529|363990285|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
105543617|NCT03246529|363990286|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
105543618|NCT03246529|363990284|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
105543619|NCT03246529|363990285|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
105543620|NCT03246529|363990286|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
105543621|NCT03246529|363990284|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
105543622|NCT03246529|363990285|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
105543623|NCT03246529|363990286|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
105543624|NCT03246529|363990284|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
105543625|NCT03246529|363990285|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
105543626|NCT03246529|363990286|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
105543627|NCT01850004|363990290|FG000|Overall Study|Poor/Non-compliance|1|||
105543628|NCT01850004|363990290|FG000|Overall Study|Participant Withdrew Consent|9|||
105543629|NCT01850004|363990290|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
105543630|NCT01850004|363990290|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
105543631|NCT01850004|363990290|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
105543632|NCT01850004|363990290|FG000|Overall Study|Other Reasons|2|||
105543633|NCT01850004|363990290|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
105543634|NCT01850004|363990290|FG000|Overall Study|Maximum Clinical Benefit|4|||
105543635|NCT00428610|363990291|FG000|Overall Study|Death Due to Adverse Event|3|||
105543636|NCT00428610|363990292|FG001|Overall Study|Death Due to Adverse Event|0|||
105543637|NCT00428610|363990293|FG002|Overall Study|Death Due to Adverse Event|5|||
105543638|NCT00428610|363990291|FG000|Overall Study|Death Due to Progressive Disease|0|||
105543639|NCT00428610|363990292|FG001|Overall Study|Death Due to Progressive Disease|0|||
105543640|NCT00428610|363990293|FG002|Overall Study|Death Due to Progressive Disease|2|||
105543641|NCT00428610|363990291|FG000|Overall Study|Adverse Event|2|||
105543642|NCT00428610|363990292|FG001|Overall Study|Adverse Event|3|||
105543643|NCT00428610|363990293|FG002|Overall Study|Adverse Event|2|||
105543644|NCT00428610|363990291|FG000|Overall Study|Investigator Decision|2|||
105543645|NCT00428610|363990292|FG001|Overall Study|Investigator Decision|1|||
105543646|NCT00428610|363990293|FG002|Overall Study|Investigator Decision|1|||
105543647|NCT00428610|363990291|FG000|Overall Study|Progressive Disease|42|||
105543648|NCT00428610|363990292|FG001|Overall Study|Progressive Disease|14|||
105543649|NCT00428610|363990293|FG002|Overall Study|Progressive Disease|22|||
105543650|NCT00428610|363990291|FG000|Overall Study|Withdrawal by Subject|4|||
105543651|NCT00428610|363990292|FG001|Overall Study|Withdrawal by Subject|0|||
105543652|NCT00428610|363990293|FG002|Overall Study|Withdrawal by Subject|0|||
105543653|NCT02293005|363992375|FG000|Overall Study|Adverse Event|2|||
105543654|NCT02293005|363992375|FG000|Overall Study|Death|4|||
105543655|NCT02293005|363992375|FG000|Overall Study|Lost to Follow-up|1|||
105543656|NCT02293005|363992375|FG000|Overall Study|Withdrawal by Subject|2|||
105543657|NCT02293005|363992375|FG000|Overall Study|Progression|17|||
105543658|NCT03328897|363992379|FG000|Randomized-treatment Epoch|Adverse Event|4|||
105543659|NCT03328897|363992380|FG001|Randomized-treatment Epoch|Adverse Event|1|||
105543660|NCT03328897|363992381|FG002|Randomized-treatment Epoch|Adverse Event|1|||
105543661|NCT03328897|363992379|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
105543662|NCT03328897|363992380|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
105543663|NCT03328897|363992381|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
105543664|NCT03328897|363992379|FG000|Randomized-treatment Epoch|Pregnancy|3|||
105543665|NCT03328897|363992380|FG001|Randomized-treatment Epoch|Pregnancy|0|||
105543666|NCT03328897|363992381|FG002|Randomized-treatment Epoch|Pregnancy|0|||
105543667|NCT03328897|363992379|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
105543668|NCT03328897|363992380|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
105543669|NCT03328897|363992381|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
105595923|NCT01350804|364182470|FG002|Core Study|Withdrawal by Subject|16|||
105595924|NCT01350804|364182471|FG003|Core Study|Withdrawal by Subject|7|||
105595925|NCT01350804|364182468|FG000|Core Study|Study terminated by Sponsor|0|||
105595926|NCT01350804|364182469|FG001|Core Study|Study terminated by Sponsor|0|||
105595927|NCT01350804|364182470|FG002|Core Study|Study terminated by Sponsor|0|||
105595928|NCT01350804|364182471|FG003|Core Study|Study terminated by Sponsor|2|||
105595929|NCT01350804|364182468|FG000|Core Study|Protocol deviation|1|||
105595930|NCT01350804|364182469|FG001|Core Study|Protocol deviation|0|||
105595931|NCT01350804|364182470|FG002|Core Study|Protocol deviation|1|||
105595932|NCT01350804|364182471|FG003|Core Study|Protocol deviation|0|||
105595933|NCT01350804|364182468|FG000|Core Study|Physician Decision|1|||
105595934|NCT01350804|364182469|FG001|Core Study|Physician Decision|0|||
105595935|NCT01350804|364182470|FG002|Core Study|Physician Decision|1|||
105595936|NCT01350804|364182471|FG003|Core Study|Physician Decision|3|||
105595937|NCT01350804|364182468|FG000|Core Study|Lost to Follow-up|3|||
105595938|NCT01350804|364182469|FG001|Core Study|Lost to Follow-up|0|||
105595939|NCT01350804|364182470|FG002|Core Study|Lost to Follow-up|2|||
105595940|NCT01350804|364182471|FG003|Core Study|Lost to Follow-up|1|||
105595941|NCT01350804|364182468|FG000|Core Study|Lack of Efficacy|16|||
105595942|NCT01350804|364182469|FG001|Core Study|Lack of Efficacy|19|||
105595943|NCT01350804|364182470|FG002|Core Study|Lack of Efficacy|18|||
105595944|NCT01350804|364182471|FG003|Core Study|Lack of Efficacy|5|||
105595945|NCT01350804|364182468|FG000|Core Study|Death|1|||
105595946|NCT01350804|364182469|FG001|Core Study|Death|1|||
105595947|NCT01350804|364182470|FG002|Core Study|Death|1|||
105595948|NCT01350804|364182471|FG003|Core Study|Death|0|||
105595949|NCT01350804|364182468|FG000|Core Study|Adverse Event|8|||
105595950|NCT01350804|364182469|FG001|Core Study|Adverse Event|10|||
105595951|NCT01350804|364182470|FG002|Core Study|Adverse Event|8|||
105595952|NCT01350804|364182471|FG003|Core Study|Adverse Event|8|||
105543670|NCT03328897|363992379|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
105543671|NCT03328897|363992380|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
105543672|NCT03328897|363992381|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
105543673|NCT03328897|363992379|FG000|Follow-up Epoch|Adverse Event|4|||
105543674|NCT03328897|363992380|FG001|Follow-up Epoch|Adverse Event|0|||
105543675|NCT03328897|363992381|FG002|Follow-up Epoch|Adverse Event|1|||
105543676|NCT03328897|363992379|FG000|Follow-up Epoch|Lack of Efficacy|1|||
105543677|NCT03328897|363992380|FG001|Follow-up Epoch|Lack of Efficacy|1|||
105543678|NCT03328897|363992381|FG002|Follow-up Epoch|Lack of Efficacy|1|||
105543679|NCT03328897|363992379|FG000|Follow-up Epoch|Lost to Follow-up|0|||
105543680|NCT03328897|363992380|FG001|Follow-up Epoch|Lost to Follow-up|1|||
105543681|NCT03328897|363992381|FG002|Follow-up Epoch|Lost to Follow-up|0|||
105543682|NCT03328897|363992379|FG000|Follow-up Epoch|Pregnancy|1|||
105543683|NCT03328897|363992380|FG001|Follow-up Epoch|Pregnancy|0|||
105543684|NCT03328897|363992381|FG002|Follow-up Epoch|Pregnancy|0|||
105543685|NCT03328897|363992379|FG000|Follow-up Epoch|Patient/guardian decision|2|||
105543686|NCT03328897|363992380|FG001|Follow-up Epoch|Patient/guardian decision|1|||
105543687|NCT03328897|363992381|FG002|Follow-up Epoch|Patient/guardian decision|0|||
105595953|NCT01350804|364182468|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
105595954|NCT01350804|364182469|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
105543688|NCT02805257|363992385|FG000|Overall Study|Lost to Follow-up|7|||
105543689|NCT02805257|363992386|FG001|Overall Study|Lost to Follow-up|6|||
105543690|NCT02805257|363992385|FG000|Overall Study|Death|0|||
105595955|NCT01350804|364182470|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
105595956|NCT01350804|364182471|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
105595957|NCT01350804|364182468|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
105543691|NCT02805257|363992386|FG001|Overall Study|Death|1|||
105543692|NCT03892889|363992390|FG000|Overall Study|Adverse Event|17|||
105543693|NCT03892889|363992390|FG000|Overall Study|Lack of Efficacy|1|||
105543694|NCT03892889|363992390|FG000|Overall Study|Lost to Follow-up|46|||
105543695|NCT03892889|363992390|FG000|Overall Study|Non-compliance with study drug|22|||
105543696|NCT03892889|363992390|FG000|Overall Study|Pregnancy|1|||
105543697|NCT03892889|363992390|FG000|Overall Study|Protocol Deviation|3|||
105543698|NCT03892889|363992390|FG000|Overall Study|Withdrawal by Subject|50|||
105543699|NCT03892889|363992390|FG000|Overall Study|Withdrawal by Caregiver|1|||
105543700|NCT03892889|363992390|FG000|Overall Study|Study Terminated by Sponsor|50|||
105543701|NCT03892889|363992390|FG000|Overall Study|Physician Decision|8|||
105543702|NCT03892889|363992390|FG000|Overall Study|Reason not Specified|5|||
105543703|NCT00630877|363992391|FG000|Overall Study|Adverse Event|11|||
105543704|NCT00630877|363992392|FG001|Overall Study|Adverse Event|8|||
105543705|NCT00630877|363992393|FG002|Overall Study|Adverse Event|7|||
105543706|NCT00630877|363992391|FG000|Overall Study|Withdrawal by Subject|3|||
105543707|NCT00630877|363992392|FG001|Overall Study|Withdrawal by Subject|4|||
105543708|NCT00630877|363992393|FG002|Overall Study|Withdrawal by Subject|0|||
105543709|NCT00630877|363992391|FG000|Overall Study|Lost to Follow-up|2|||
105543710|NCT00630877|363992392|FG001|Overall Study|Lost to Follow-up|0|||
105543711|NCT00630877|363992393|FG002|Overall Study|Lost to Follow-up|0|||
105543712|NCT00630877|363992391|FG000|Overall Study|Noncompliance|2|||
105543713|NCT00630877|363992392|FG001|Overall Study|Noncompliance|3|||
105543714|NCT00630877|363992393|FG002|Overall Study|Noncompliance|1|||
105543715|NCT00630877|363992391|FG000|Overall Study|Protocol violation|1|||
105543716|NCT00630877|363992392|FG001|Overall Study|Protocol violation|0|||
105543717|NCT00630877|363992393|FG002|Overall Study|Protocol violation|1|||
105543718|NCT00630877|363992391|FG000|Overall Study|Personal reasons|0|||
105543719|NCT00630877|363992392|FG001|Overall Study|Personal reasons|0|||
105543720|NCT00630877|363992393|FG002|Overall Study|Personal reasons|1|||
105543721|NCT02080091|363992394|FG000|Overall Study|Study Terminated|22|||
105543722|NCT02080091|363992394|FG000|Overall Study|Death|1|||
105543723|NCT02080091|363992394|FG000|Overall Study|Withdrawal by Subject|1|||
105543724|NCT02080091|363992394|FG000|Overall Study|Other|1|||
105543725|NCT01913041|363992395|FG000|Overall Study|Protocol Violation|35|||
105543726|NCT01913041|363992395|FG000|Overall Study|Withdrawal by Subject|3|||
105543727|NCT01913041|363992395|FG000|Overall Study|Physician Decision|1|||
105543728|NCT01610700|363992396|FG000|Overall Study|Adverse Event|3|||
105543729|NCT01610700|363992397|FG001|Overall Study|Adverse Event|1|||
105543730|NCT01610700|363992396|FG000|Overall Study|Withdrawal by Subject|0|||
105543731|NCT01610700|363992397|FG001|Overall Study|Withdrawal by Subject|1|||
105543732|NCT01610700|363992396|FG000|Overall Study|subject took one dose of street cannabis|0|||
105543733|NCT01610700|363992397|FG001|Overall Study|subject took one dose of street cannabis|1|||
105543734|NCT02866682|363992400|FG000|Overall Study|Death|0|||
105543735|NCT02866682|363992401|FG001|Overall Study|Death|1|||
105543736|NCT02866682|363992400|FG000|Overall Study|Lost to Follow-up|0|||
105543737|NCT02866682|363992401|FG001|Overall Study|Lost to Follow-up|4|||
105543738|NCT02866682|363992400|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
105543739|NCT02866682|363992401|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
105543740|NCT02866682|363992400|FG000|Overall Study|Other|0|||
105543741|NCT02866682|363992401|FG001|Overall Study|Other|1|||
105543742|NCT00201006|363992402|FG000|Overall Study|Withdrawal by Subject|7|||
105543743|NCT00201006|363992403|FG001|Overall Study|Withdrawal by Subject|2|||
105543744|NCT00201006|363992404|FG002|Overall Study|Withdrawal by Subject|3|||
105543745|NCT00201006|363992402|FG000|Overall Study|Adverse Event|1|||
105543746|NCT00201006|363992403|FG001|Overall Study|Adverse Event|0|||
105543747|NCT00201006|363992404|FG002|Overall Study|Adverse Event|1|||
105543748|NCT01750268|363992405|FG000|Overall Study|Lost to Follow-up|0|||
105543749|NCT01750268|363992406|FG001|Overall Study|Lost to Follow-up|2|||
105543750|NCT01750268|363992405|FG000|Overall Study|Physician Decision|0|||
105543751|NCT01750268|363992406|FG001|Overall Study|Physician Decision|3|||
105543752|NCT01750268|363992405|FG000|Overall Study|Withdrawal by Subject|2|||
105543753|NCT01750268|363992406|FG001|Overall Study|Withdrawal by Subject|0|||
105543754|NCT02886572|363992409|FG000|Overall Study|Death|8|||
105543755|NCT02621606|363992413|FG000|Overall Study|Withdrawal by Subject|0|||
105543756|NCT02621606|363992414|FG001|Overall Study|Withdrawal by Subject|1|||
105543757|NCT02621606|363992415|FG002|Overall Study|Withdrawal by Subject|0|||
105543758|NCT01175824|363992416|FG000|Overall Study|Adverse Event|2|||
105543759|NCT01175824|363992417|FG001|Overall Study|Adverse Event|1|||
105543760|NCT01175824|363992416|FG000|Overall Study|Lack of Efficacy|2|||
105543761|NCT01175824|363992417|FG001|Overall Study|Lack of Efficacy|0|||
105543762|NCT01175824|363992416|FG000|Overall Study|Lost to Follow-up|0|||
105595958|NCT01350804|364182469|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
105543763|NCT01175824|363992417|FG001|Overall Study|Lost to Follow-up|1|||
105543764|NCT01175824|363992416|FG000|Overall Study|Physician Decision|0|||
105543765|NCT01175824|363992417|FG001|Overall Study|Physician Decision|4|||
105543766|NCT01175824|363992416|FG000|Overall Study|Protocol Violation|2|||
105543767|NCT01175824|363992417|FG001|Overall Study|Protocol Violation|5|||
105543768|NCT01175824|363992416|FG000|Overall Study|Withdrawal by Subject|3|||
105543769|NCT01175824|363992417|FG001|Overall Study|Withdrawal by Subject|7|||
105543770|NCT01175824|363992416|FG000|Overall Study|Sponsor Decision|1|||
105543771|NCT01175824|363992417|FG001|Overall Study|Sponsor Decision|0|||
105543772|NCT01175824|363992416|FG000|Overall Study|Entry Criteria Not Met|6|||
105543773|NCT01175824|363992417|FG001|Overall Study|Entry Criteria Not Met|4|||
105543774|NCT00982319|363992423|FG000|Overall Study|Surgery date change|1|||
105543775|NCT00982319|363992424|FG001|Overall Study|Surgery date change|0|||
105543776|NCT00982319|363992423|FG000|Overall Study|Preop values out of acceptable range|1|||
105543777|NCT00982319|363992424|FG001|Overall Study|Preop values out of acceptable range|1|||
105543778|NCT00982319|363992423|FG000|Overall Study|Pregnancy|0|||
105543779|NCT00982319|363992424|FG001|Overall Study|Pregnancy|1|||
105543780|NCT01252251|363992425|FG000|Overall Study|Withdrawal by Subject|1|||
105543781|NCT02057757|363992426|FG000|Overall Study|Withdrawal by Subject|3|||
105543782|NCT02057757|363992427|FG001|Overall Study|Withdrawal by Subject|5|||
105543783|NCT02057757|363992426|FG000|Overall Study|Death|2|||
105543784|NCT02057757|363992427|FG001|Overall Study|Death|0|||
105543785|NCT02057757|363992426|FG000|Overall Study|Lost to Follow-up|8|||
105543786|NCT02057757|363992427|FG001|Overall Study|Lost to Follow-up|3|||
105543787|NCT02057757|363992426|FG000|Overall Study|Non-compliance|1|||
105543788|NCT02057757|363992427|FG001|Overall Study|Non-compliance|0|||
105543789|NCT00009737|363992428|FG000|Overall Study|Adverse Event|112|||
105543790|NCT00009737|363992429|FG001|Overall Study|Adverse Event|75|||
105543791|NCT00009737|363992428|FG000|Overall Study|Death|4|||
105543792|NCT00009737|363992429|FG001|Overall Study|Death|6|||
105543793|NCT00009737|363992428|FG000|Overall Study|Lack of Efficacy|17|||
105543794|NCT00009737|363992429|FG001|Overall Study|Lack of Efficacy|15|||
105543795|NCT00009737|363992428|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
105543796|NCT00009737|363992429|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
105543797|NCT00009737|363992428|FG000|Overall Study|Other Protocol Violation|1|||
105543798|NCT00009737|363992429|FG001|Overall Study|Other Protocol Violation|0|||
105543799|NCT00009737|363992428|FG000|Overall Study|Refused Treatment|15|||
105543800|NCT00009737|363992429|FG001|Overall Study|Refused Treatment|16|||
105543801|NCT00009737|363992428|FG000|Overall Study|Lost to Follow-up|1|||
105543802|NCT00009737|363992429|FG001|Overall Study|Lost to Follow-up|1|||
105543803|NCT00009737|363992428|FG000|Overall Study|Administrative/Other Reasons|7|||
105543804|NCT00009737|363992429|FG001|Overall Study|Administrative/Other Reasons|1|||
105543805|NCT02956629|363992431|FG000|Overall Study|Adverse Event|0|||
105543806|NCT02956629|363992432|FG001|Overall Study|Adverse Event|0|||
105543807|NCT02956629|363992433|FG002|Overall Study|Adverse Event|1|||
105543808|NCT02956629|363992434|FG003|Overall Study|Adverse Event|0|||
105543809|NCT02956629|363992435|FG004|Overall Study|Adverse Event|0|||
105543810|NCT02956629|363992436|FG005|Overall Study|Adverse Event|0|||
105543811|NCT02956629|363992431|FG000|Overall Study|Lost to Follow-up|2|||
105543812|NCT02956629|363992432|FG001|Overall Study|Lost to Follow-up|5|||
105543813|NCT02956629|363992433|FG002|Overall Study|Lost to Follow-up|3|||
105543814|NCT02956629|363992434|FG003|Overall Study|Lost to Follow-up|1|||
105543815|NCT02956629|363992435|FG004|Overall Study|Lost to Follow-up|0|||
105543816|NCT02956629|363992436|FG005|Overall Study|Lost to Follow-up|1|||
105543817|NCT02956629|363992431|FG000|Overall Study|Withdrawal by Subject|3|||
105543818|NCT02956629|363992432|FG001|Overall Study|Withdrawal by Subject|1|||
105543819|NCT02956629|363992433|FG002|Overall Study|Withdrawal by Subject|0|||
105543820|NCT02956629|363992434|FG003|Overall Study|Withdrawal by Subject|0|||
105543821|NCT02956629|363992435|FG004|Overall Study|Withdrawal by Subject|0|||
105543822|NCT02956629|363992436|FG005|Overall Study|Withdrawal by Subject|0|||
105543823|NCT04808609|363992437|FG000|Overall Study|Lost to Follow-up|0|||
105543824|NCT04808609|363992438|FG001|Overall Study|Lost to Follow-up|2|||
105543825|NCT04808609|363992437|FG000|Overall Study|Administrative Withdrawal|0|||
105543826|NCT04808609|363992438|FG001|Overall Study|Administrative Withdrawal|1|||
105543827|NCT01993719|363992439|FG000|First Drug Administration|Not treated|1|||
105543828|NCT01993719|363992440|FG001|First Drug Administration|Not treated|0|||
105543829|NCT01993719|363992441|FG002|First Drug Administration|Not treated|0|||
105543830|NCT01993719|363992442|FG003|First Drug Administration|Not treated|0|||
105543831|NCT01993719|363992443|FG004|First Drug Administration|Not treated|0|||
105543832|NCT04382326|363992447|FG000|Overall Study|Adverse Event, not serious|1|||
105543833|NCT04382326|363992448|FG001|Overall Study|Adverse Event, not serious|2|||
105543834|NCT04382326|363992447|FG000|Overall Study|Other|1|||
105543835|NCT04382326|363992448|FG001|Overall Study|Other|0|||
105543836|NCT04382326|363992447|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
105543837|NCT04382326|363992448|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
105543838|NCT04382326|363992447|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
105543839|NCT04382326|363992448|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
105543840|NCT04382326|363992447|FG000|Overall Study|Protocol Violation|29|||
105543841|NCT04382326|363992448|FG001|Overall Study|Protocol Violation|23|||
105543842|NCT04382326|363992447|FG000|Overall Study|Physician Decision|0|||
105543843|NCT04382326|363992448|FG001|Overall Study|Physician Decision|1|||
105543844|NCT04382326|363992447|FG000|Overall Study|Lost to Follow-up|48|||
105543845|NCT04382326|363992448|FG001|Overall Study|Lost to Follow-up|63|||
105543846|NCT04382326|363992447|FG000|Overall Study|Adverse Event, non-fatal|1|||
105543847|NCT04382326|363992448|FG001|Overall Study|Adverse Event, non-fatal|1|||
105543848|NCT01709227|363992458|FG000|Overall Study|Physician Decision|1|||
105543849|NCT01709227|363992459|FG001|Overall Study|Physician Decision|0|||
105543850|NCT01709227|363992458|FG000|Overall Study|Pleural Peritoneal communication|0|||
105543851|NCT01709227|363992459|FG001|Overall Study|Pleural Peritoneal communication|9|||
105543852|NCT01978119|363992460|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
105543853|NCT01978119|363992461|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
105543854|NCT01978119|363992460|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
105543855|NCT01978119|363992461|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
105543856|NCT01978119|363992460|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105543857|NCT01978119|363992461|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
105543858|NCT03669081|363992462|FG000|Overall Study|Data could not be validated|1|||
105543859|NCT03669081|363992463|FG001|Overall Study|Data could not be validated|1|||
105543860|NCT02352493|363992464|FG000|Overall Study|Pregnancy|0|||
105543861|NCT02352493|363992465|FG001|Overall Study|Pregnancy|0|||
105543862|NCT02352493|363992466|FG002|Overall Study|Pregnancy|0|||
105543863|NCT02352493|363992467|FG003|Overall Study|Pregnancy|0|||
105543864|NCT02352493|363992468|FG004|Overall Study|Pregnancy|0|||
105543865|NCT02352493|363992469|FG005|Overall Study|Pregnancy|0|||
105543866|NCT02352493|363992470|FG006|Overall Study|Pregnancy|1|||
105543867|NCT02352493|363992471|FG007|Overall Study|Pregnancy|0|||
105543868|NCT02352493|363992472|FG008|Overall Study|Pregnancy|1|||
105543869|NCT02352493|363992473|FG009|Overall Study|Pregnancy|0|||
105543870|NCT02352493|363992474|FG010|Overall Study|Pregnancy|0|||
105543871|NCT02352493|363992475|FG011|Overall Study|Pregnancy|0|||
105543872|NCT02352493|363992476|FG012|Overall Study|Pregnancy|0|||
105543873|NCT02352493|363992477|FG013|Overall Study|Pregnancy|0|||
105543874|NCT02352493|363992478|FG014|Overall Study|Pregnancy|0|||
105543875|NCT02352493|363992479|FG015|Overall Study|Pregnancy|0|||
105543876|NCT02352493|363992480|FG016|Overall Study|Pregnancy|0|||
105543877|NCT02352493|363992481|FG017|Overall Study|Pregnancy|0|||
105543878|NCT02352493|363992464|FG000|Overall Study|Withdrawal by Subject|0|||
105543879|NCT02352493|363992465|FG001|Overall Study|Withdrawal by Subject|0|||
105543880|NCT02352493|363992466|FG002|Overall Study|Withdrawal by Subject|0|||
105543881|NCT02352493|363992467|FG003|Overall Study|Withdrawal by Subject|0|||
105543882|NCT02352493|363992468|FG004|Overall Study|Withdrawal by Subject|0|||
105543883|NCT02352493|363992469|FG005|Overall Study|Withdrawal by Subject|0|||
105543884|NCT02352493|363992470|FG006|Overall Study|Withdrawal by Subject|0|||
105543885|NCT02352493|363992471|FG007|Overall Study|Withdrawal by Subject|0|||
105543886|NCT02352493|363992472|FG008|Overall Study|Withdrawal by Subject|1|||
105543887|NCT02352493|363992473|FG009|Overall Study|Withdrawal by Subject|0|||
105543888|NCT02352493|363992474|FG010|Overall Study|Withdrawal by Subject|0|||
105543889|NCT02352493|363992475|FG011|Overall Study|Withdrawal by Subject|0|||
105543890|NCT02352493|363992476|FG012|Overall Study|Withdrawal by Subject|0|||
105543891|NCT02352493|363992477|FG013|Overall Study|Withdrawal by Subject|0|||
105543892|NCT02352493|363992478|FG014|Overall Study|Withdrawal by Subject|1|||
105543893|NCT02352493|363992479|FG015|Overall Study|Withdrawal by Subject|0|||
105543894|NCT02352493|363992480|FG016|Overall Study|Withdrawal by Subject|0|||
105543895|NCT02352493|363992481|FG017|Overall Study|Withdrawal by Subject|0|||
105543896|NCT02352493|363992464|FG000|Overall Study|Lost to Follow-up|0|||
105543897|NCT02352493|363992465|FG001|Overall Study|Lost to Follow-up|0|||
105543898|NCT02352493|363992466|FG002|Overall Study|Lost to Follow-up|0|||
105543899|NCT02352493|363992467|FG003|Overall Study|Lost to Follow-up|0|||
105543900|NCT02352493|363992468|FG004|Overall Study|Lost to Follow-up|0|||
105543901|NCT02352493|363992469|FG005|Overall Study|Lost to Follow-up|0|||
105543902|NCT02352493|363992470|FG006|Overall Study|Lost to Follow-up|0|||
105543903|NCT02352493|363992471|FG007|Overall Study|Lost to Follow-up|0|||
105543904|NCT02352493|363992472|FG008|Overall Study|Lost to Follow-up|0|||
105543905|NCT02352493|363992473|FG009|Overall Study|Lost to Follow-up|1|||
105543906|NCT02352493|363992474|FG010|Overall Study|Lost to Follow-up|0|||
105543907|NCT02352493|363992475|FG011|Overall Study|Lost to Follow-up|0|||
105543908|NCT02352493|363992476|FG012|Overall Study|Lost to Follow-up|1|||
105543909|NCT02352493|363992477|FG013|Overall Study|Lost to Follow-up|2|||
105543910|NCT02352493|363992478|FG014|Overall Study|Lost to Follow-up|0|||
105543911|NCT02352493|363992479|FG015|Overall Study|Lost to Follow-up|0|||
105543912|NCT02352493|363992480|FG016|Overall Study|Lost to Follow-up|0|||
105543913|NCT02352493|363992481|FG017|Overall Study|Lost to Follow-up|0|||
105543914|NCT03295201|363992483|FG000|Overall Study|Lost to Follow-up|1|||
105543915|NCT03295201|363992484|FG001|Overall Study|Lost to Follow-up|1|||
105543916|NCT03295201|363992483|FG000|Overall Study|Hospital admission|0|||
105543917|NCT03295201|363992484|FG001|Overall Study|Hospital admission|1|||
105543918|NCT00389324|363992485|FG000|Run-In Phase|Adverse Event|1|||
105543919|NCT00389324|363992485|FG000|Run-In Phase|Lost to Follow-up|1|||
105543920|NCT00389324|363992485|FG000|Run-In Phase|Withdrawal by Subject|1|||
105543921|NCT00389324|363992485|FG000|Subcutaneous Phase|Adverse Event|2|||
105543922|NCT00389324|363992485|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
105543923|NCT00389324|363992485|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
105543924|NCT00389324|363992485|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
105543925|NCT02317575|363992486|FG000|Period 1|Difficulty with venous cannulation|0|||
105543926|NCT02317575|363992487|FG001|Period 1|Difficulty with venous cannulation|1|||
105543927|NCT02317575|363992488|FG002|Period 1|Difficulty with venous cannulation|0|||
105543928|NCT02317575|363992489|FG003|Period 1|Difficulty with venous cannulation|0|||
105543929|NCT02317575|363992490|FG004|Period 1|Difficulty with venous cannulation|0|||
105543930|NCT02317575|363992486|FG000|Period 1|Withdrawal by Subject|1|||
105543931|NCT02317575|363992487|FG001|Period 1|Withdrawal by Subject|0|||
105543932|NCT02317575|363992488|FG002|Period 1|Withdrawal by Subject|0|||
105543933|NCT02317575|363992489|FG003|Period 1|Withdrawal by Subject|0|||
105543934|NCT02317575|363992490|FG004|Period 1|Withdrawal by Subject|0|||
105543935|NCT02223390|363992491|FG000|Overall Study|Lost to Follow-up|9|||
105543936|NCT02223390|363992492|FG001|Overall Study|Lost to Follow-up|4|||
105543937|NCT00572572|363992493|FG000|Overall Study|Withdrawal by Subject|3|||
105543938|NCT00572572|363992494|FG001|Overall Study|Withdrawal by Subject|6|||
105543939|NCT02114892|363992500|FG000|Overall Study|Lost to Follow-up|1|||
105543940|NCT02114892|363992501|FG001|Overall Study|Lost to Follow-up|2|||
105543941|NCT02013765|363992502|FG000|Overall Study|Trial was terminated by sponsor|1|||
105543942|NCT00659269|363992503|FG000|Overall Study|Physician Decision|1|||
105543943|NCT00659269|363992504|FG001|Overall Study|Physician Decision|1|||
105543944|NCT01158222|363992505|FG000|Overall Study|Not eligible for intermediate phase|17|||
105543945|NCT04096560|363992508|FG000|Overall Study|Reason not Specified|1|||
105543946|NCT04096560|363992509|FG001|Overall Study|Reason not Specified|0|||
105543947|NCT04096560|363992510|FG002|Overall Study|Reason not Specified|0|||
105543948|NCT04096560|363992511|FG003|Overall Study|Reason not Specified|0|||
105543949|NCT04096560|363992512|FG004|Overall Study|Reason not Specified|1|||
105543950|NCT04096560|363992513|FG005|Overall Study|Reason not Specified|1|||
105543951|NCT04096560|363992514|FG006|Overall Study|Reason not Specified|1|||
105543952|NCT04096560|363992515|FG007|Overall Study|Reason not Specified|0|||
105543953|NCT04096560|363992508|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
105543954|NCT04096560|363992509|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
105543955|NCT04096560|363992510|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
105543956|NCT04096560|363992511|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
105543957|NCT04096560|363992512|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
105543958|NCT04096560|363992513|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
105543959|NCT04096560|363992514|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
105543960|NCT04096560|363992515|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
105543961|NCT04096560|363992508|FG000|Overall Study|Study Terminated by Sponsor|0|||
105543962|NCT04096560|363992509|FG001|Overall Study|Study Terminated by Sponsor|0|||
105543963|NCT04096560|363992510|FG002|Overall Study|Study Terminated by Sponsor|0|||
105543964|NCT04096560|363992511|FG003|Overall Study|Study Terminated by Sponsor|5|||
105543965|NCT04096560|363992512|FG004|Overall Study|Study Terminated by Sponsor|6|||
105543966|NCT04096560|363992513|FG005|Overall Study|Study Terminated by Sponsor|4|||
105543967|NCT04096560|363992514|FG006|Overall Study|Study Terminated by Sponsor|6|||
105543968|NCT04096560|363992515|FG007|Overall Study|Study Terminated by Sponsor|1|||
105543969|NCT04096560|363992508|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
105543970|NCT04096560|363992509|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
105543971|NCT04096560|363992510|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
105543972|NCT04096560|363992511|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
105543973|NCT04096560|363992512|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
105543974|NCT04096560|363992513|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
105543975|NCT04096560|363992514|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
105543976|NCT04096560|363992515|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
105543977|NCT04796610|363992518|FG000|Overall Study|Withdrawal by Subject|1|||
105543978|NCT04796610|363992519|FG001|Overall Study|Withdrawal by Subject|0|||
105543979|NCT04796610|363992520|FG002|Overall Study|Withdrawal by Subject|0|||
105543980|NCT04796610|363992521|FG003|Overall Study|Withdrawal by Subject|0|||
105543981|NCT04796610|363992518|FG000|Overall Study|Lost to Follow-up|2|||
105543982|NCT04796610|363992519|FG001|Overall Study|Lost to Follow-up|0|||
105543983|NCT04796610|363992520|FG002|Overall Study|Lost to Follow-up|1|||
105543984|NCT04796610|363992521|FG003|Overall Study|Lost to Follow-up|1|||
105543985|NCT02059148|363992522|FG000|Treatment 1|Protocol Violation|0|||
105543986|NCT02059148|363992523|FG001|Treatment 1|Protocol Violation|0|||
105543987|NCT02059148|363992524|FG002|Treatment 1|Protocol Violation|0|||
105543988|NCT02059148|363992525|FG003|Treatment 1|Protocol Violation|0|||
105543989|NCT02059148|363992526|FG004|Treatment 1|Protocol Violation|0|||
105543990|NCT02059148|363992527|FG005|Treatment 1|Protocol Violation|1|||
105543991|NCT00022516|363992531|FG000|Overall Study|Adverse Event|0|||
105543992|NCT00022516|363992532|FG001|Overall Study|Adverse Event|59|||
105543993|NCT00022516|363992531|FG000|Overall Study|Lack of Efficacy|0|||
105543994|NCT00022516|363992532|FG001|Overall Study|Lack of Efficacy|27|||
105543995|NCT00022516|363992531|FG000|Overall Study|Physician Decision|0|||
105543996|NCT00022516|363992532|FG001|Overall Study|Physician Decision|1|||
105543997|NCT00022516|363992531|FG000|Overall Study|Protocol Violation|1|||
105543998|NCT00022516|363992532|FG001|Overall Study|Protocol Violation|3|||
105543999|NCT00022516|363992531|FG000|Overall Study|Withdrawal by Subject|2|||
105544000|NCT00022516|363992532|FG001|Overall Study|Withdrawal by Subject|113|||
105544001|NCT00022516|363992531|FG000|Overall Study|Incomplete documentation|0|||
105544002|NCT00022516|363992532|FG001|Overall Study|Incomplete documentation|27|||
105544003|NCT01785602|363992536|FG000|Overall Study|Withdrawal by Subject|2|||
105544004|NCT01785602|363992537|FG001|Overall Study|Withdrawal by Subject|0|||
105544005|NCT01785602|363992536|FG000|Overall Study|Lost to Follow-up|1|||
105544006|NCT01785602|363992537|FG001|Overall Study|Lost to Follow-up|1|||
105544007|NCT01785602|363992536|FG000|Overall Study|Adverse Event|3|||
105544008|NCT01785602|363992537|FG001|Overall Study|Adverse Event|5|||
105544009|NCT01785602|363992536|FG000|Overall Study|Administrative problems|7|||
105544010|NCT01785602|363992537|FG001|Overall Study|Administrative problems|3|||
105544011|NCT03135522|363992544|FG000|Overall Study|Adverse Event|1|||
105544012|NCT03135522|363992545|FG001|Overall Study|Adverse Event|0|||
105544013|NCT02752048|363992548|FG000|Overall Study|Withdrawal by Subject|0|||
105544014|NCT02752048|363992549|FG001|Overall Study|Withdrawal by Subject|0|||
105544015|NCT02752048|363992550|FG002|Overall Study|Withdrawal by Subject|3|||
105544016|NCT01431508|363992553|FG000|Overall Study|Lack of Efficacy|1|||
105544017|NCT01431508|363992553|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
105544018|NCT02758236|363992556|FG000|Overall Study|Investigator discretion|43|||
105544019|NCT05789875|363992557|FG000|Overall Study|Lost to Follow-up|6|||
105544020|NCT00499369|363992558|FG000|Overall Study|Adverse Event|2|||
105544021|NCT00499369|363992559|FG001|Overall Study|Adverse Event|2|||
105544022|NCT00499369|363992560|FG002|Overall Study|Adverse Event|3|||
105544023|NCT00499369|363992561|FG003|Overall Study|Adverse Event|1|||
105544024|NCT00499369|363992562|FG004|Overall Study|Adverse Event|2|||
105544025|NCT00499369|363992558|FG000|Overall Study|Withdrawal by Subject|0|||
105544026|NCT00499369|363992559|FG001|Overall Study|Withdrawal by Subject|1|||
105544027|NCT00499369|363992560|FG002|Overall Study|Withdrawal by Subject|1|||
105544028|NCT00499369|363992561|FG003|Overall Study|Withdrawal by Subject|0|||
105544029|NCT00499369|363992562|FG004|Overall Study|Withdrawal by Subject|0|||
105544030|NCT00499369|363992558|FG000|Overall Study|Progression|10|||
105544031|NCT00499369|363992559|FG001|Overall Study|Progression|12|||
105544032|NCT00499369|363992560|FG002|Overall Study|Progression|9|||
105544033|NCT00499369|363992561|FG003|Overall Study|Progression|6|||
105544034|NCT00499369|363992562|FG004|Overall Study|Progression|10|||
105544035|NCT00499369|363992558|FG000|Overall Study|Death|0|||
105544036|NCT00499369|363992559|FG001|Overall Study|Death|1|||
105544037|NCT00499369|363992560|FG002|Overall Study|Death|0|||
105544038|NCT00499369|363992561|FG003|Overall Study|Death|0|||
105544039|NCT00499369|363992562|FG004|Overall Study|Death|0|||
105544040|NCT00499369|363992558|FG000|Overall Study|Not protocol specified|2|||
105544041|NCT00499369|363992559|FG001|Overall Study|Not protocol specified|0|||
105544042|NCT00499369|363992560|FG002|Overall Study|Not protocol specified|3|||
105544043|NCT00499369|363992561|FG003|Overall Study|Not protocol specified|1|||
105544044|NCT00499369|363992562|FG004|Overall Study|Not protocol specified|0|||
105544045|NCT00499369|363992558|FG000|Overall Study|Ineligible|2|||
105544046|NCT00499369|363992559|FG001|Overall Study|Ineligible|2|||
105544047|NCT00499369|363992560|FG002|Overall Study|Ineligible|1|||
105544048|NCT00499369|363992561|FG003|Overall Study|Ineligible|1|||
105544049|NCT00499369|363992562|FG004|Overall Study|Ineligible|0|||
105544050|NCT01663636|363992563|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
105544051|NCT01663636|363992564|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
105544052|NCT03285477|363992570|FG000|Treatment and Response Assessment Period|Death|1|||
105544053|NCT03285477|363992571|FG001|Treatment and Response Assessment Period|Death|0|||
105544054|NCT03285477|363992570|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
105544055|NCT03285477|363992571|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
105544056|NCT03285477|363992570|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
105544057|NCT03285477|363992571|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
105544058|NCT03285477|363992570|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
105544059|NCT03285477|363992571|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
105544060|NCT03285477|363992570|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
105544061|NCT03285477|363992571|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
105544062|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
105544063|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
105544064|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
105544065|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
105544066|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
105544067|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
105544068|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
105544069|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
105544070|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
105544071|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
105544072|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
105544073|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
105544074|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
105544075|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
105544076|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
105544077|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
105544078|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
105544079|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
105544080|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
105544081|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
105544082|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
105544083|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
105544084|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
105544085|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
105544086|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
105544087|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
105544088|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
105544089|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
105544090|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
105544091|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
105544092|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
105544093|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
105544094|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
105544095|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
105544096|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
105544097|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
105544098|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
105544099|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
105544100|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
105544101|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
105544102|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
105544103|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
105544104|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
105544105|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
105544106|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
105544107|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
105544108|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
105544109|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
105544110|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
105544111|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
105544112|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
105544113|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
105544114|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
105544115|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
105544116|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
105544117|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
105544118|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
105544119|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
105544120|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
105544121|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
105544122|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
105544123|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
105544124|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
105544125|NCT01884350|363992572|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
105544126|NCT01884350|363992573|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
105544127|NCT01884350|363992574|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
105544128|NCT01438541|363992575|FG000|Overall Study|Physician Decision|1|||
105544129|NCT01438541|363992575|FG000|Overall Study|Withdrawal by Subject|1|||
105595959|NCT01350804|364182470|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
105595960|NCT01350804|364182471|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
105544130|NCT01438541|363992575|FG000|Overall Study|discharge from the hospital|5|||
105544131|NCT01968434|363992576|FG000|Overall Study|Lost to Follow-up|3|||
105544132|NCT01968434|363992577|FG001|Overall Study|Lost to Follow-up|6|||
105544133|NCT02091167|363992579|FG000|Overall Study|Lost to Follow-up|0|||
105544134|NCT02091167|363992580|FG001|Overall Study|Lost to Follow-up|2|||
105544135|NCT02199691|363992582|FG000|Overall Study|Protocol Violation|3|||
105544136|NCT02199691|363992583|FG001|Overall Study|Protocol Violation|3|||
105544137|NCT02199691|363992584|FG002|Overall Study|Protocol Violation|6|||
105544138|NCT02199691|363992585|FG003|Overall Study|Protocol Violation|7|||
105544139|NCT02199691|363992582|FG000|Overall Study|Withdrawal by Subject|5|||
105544140|NCT02199691|363992583|FG001|Overall Study|Withdrawal by Subject|3|||
105544141|NCT02199691|363992584|FG002|Overall Study|Withdrawal by Subject|12|||
105544142|NCT02199691|363992585|FG003|Overall Study|Withdrawal by Subject|13|||
105544143|NCT02199691|363992582|FG000|Overall Study|Lost to Follow-up|2|||
105544144|NCT02199691|363992583|FG001|Overall Study|Lost to Follow-up|1|||
105544145|NCT02199691|363992584|FG002|Overall Study|Lost to Follow-up|9|||
105544146|NCT02199691|363992585|FG003|Overall Study|Lost to Follow-up|10|||
105544147|NCT02766608|363994014|FG000|Overall Study|Adverse Event|27|||
105544148|NCT02766608|363994015|FG001|Overall Study|Adverse Event|22|||
105544149|NCT02766608|363994016|FG002|Overall Study|Adverse Event|17|||
105544150|NCT02766608|363994017|FG003|Overall Study|Adverse Event|13|||
105544151|NCT02766608|363994018|FG004|Overall Study|Adverse Event|12|||
105544152|NCT02766608|363994014|FG000|Overall Study|Withdrawal by Subject|21|||
105544153|NCT02766608|363994015|FG001|Overall Study|Withdrawal by Subject|20|||
105544154|NCT02766608|363994016|FG002|Overall Study|Withdrawal by Subject|24|||
105544155|NCT02766608|363994017|FG003|Overall Study|Withdrawal by Subject|13|||
105544156|NCT02766608|363994018|FG004|Overall Study|Withdrawal by Subject|10|||
105544157|NCT02766608|363994014|FG000|Overall Study|Lack of Efficacy|16|||
105544158|NCT02766608|363994015|FG001|Overall Study|Lack of Efficacy|15|||
105544159|NCT02766608|363994016|FG002|Overall Study|Lack of Efficacy|32|||
105544160|NCT02766608|363994017|FG003|Overall Study|Lack of Efficacy|8|||
105544161|NCT02766608|363994018|FG004|Overall Study|Lack of Efficacy|2|||
105544162|NCT02766608|363994014|FG000|Overall Study|Lost to Follow-up|6|||
105544163|NCT02766608|363994015|FG001|Overall Study|Lost to Follow-up|3|||
105544164|NCT02766608|363994016|FG002|Overall Study|Lost to Follow-up|5|||
105544165|NCT02766608|363994017|FG003|Overall Study|Lost to Follow-up|2|||
105544166|NCT02766608|363994018|FG004|Overall Study|Lost to Follow-up|2|||
105544167|NCT02766608|363994014|FG000|Overall Study|Physician Decision|3|||
105544168|NCT02766608|363994015|FG001|Overall Study|Physician Decision|2|||
105544169|NCT02766608|363994016|FG002|Overall Study|Physician Decision|3|||
105544170|NCT02766608|363994017|FG003|Overall Study|Physician Decision|1|||
105544171|NCT02766608|363994018|FG004|Overall Study|Physician Decision|2|||
105544172|NCT02766608|363994014|FG000|Overall Study|Protocol disc criteria|3|||
105544173|NCT02766608|363994015|FG001|Overall Study|Protocol disc criteria|3|||
105544174|NCT02766608|363994016|FG002|Overall Study|Protocol disc criteria|4|||
105544175|NCT02766608|363994017|FG003|Overall Study|Protocol disc criteria|0|||
105544176|NCT02766608|363994018|FG004|Overall Study|Protocol disc criteria|0|||
105544177|NCT02766608|363994014|FG000|Overall Study|Protocol Violation|0|||
105544178|NCT02766608|363994015|FG001|Overall Study|Protocol Violation|4|||
105544179|NCT02766608|363994016|FG002|Overall Study|Protocol Violation|4|||
105544180|NCT02766608|363994017|FG003|Overall Study|Protocol Violation|0|||
105544181|NCT02766608|363994018|FG004|Overall Study|Protocol Violation|1|||
105544182|NCT02766608|363994014|FG000|Overall Study|Administrative Reasons|3|||
105544183|NCT02766608|363994015|FG001|Overall Study|Administrative Reasons|1|||
105544184|NCT02766608|363994016|FG002|Overall Study|Administrative Reasons|1|||
105544185|NCT02766608|363994017|FG003|Overall Study|Administrative Reasons|0|||
105544186|NCT02766608|363994018|FG004|Overall Study|Administrative Reasons|0|||
105544187|NCT01519518|363994020|FG000|Overall Study|Consent not available|7|||
105544188|NCT01519518|363994021|FG001|Overall Study|Consent not available|10|||
105544189|NCT01043874|363994026|FG000|Overall Study|Adverse Event|3|||
105544190|NCT01043874|363994026|FG000|Overall Study|Withdrawal by Subject|1|||
105544191|NCT01043874|363994026|FG000|Overall Study|Lack of Efficacy|1|||
105544192|NCT01043874|363994026|FG000|Overall Study|Administrative Problems|1|||
105544193|NCT01265953|363994032|FG000|Overall Study|Non compliance|5|||
105544194|NCT01265953|363994033|FG001|Overall Study|Non compliance|3|||
105595961|NCT01350804|364182468|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
105544195|NCT00182689|363994034|FG000|Overall Study|Adverse Event|8|||
105544196|NCT00182689|363994035|FG001|Overall Study|Adverse Event|11|||
105544197|NCT00182689|363994034|FG000|Overall Study|Withdrawal by Subject|2|||
105544198|NCT00182689|363994035|FG001|Overall Study|Withdrawal by Subject|2|||
105544199|NCT00182689|363994034|FG000|Overall Study|Progression|27|||
105544200|NCT00182689|363994035|FG001|Overall Study|Progression|29|||
105595962|NCT01350804|364182469|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
105544201|NCT00182689|363994034|FG000|Overall Study|Death|1|||
105544202|NCT00182689|363994035|FG001|Overall Study|Death|0|||
105544203|NCT00182689|363994034|FG000|Overall Study|not protocol specified|0|||
105544204|NCT00182689|363994035|FG001|Overall Study|not protocol specified|3|||
105544205|NCT00182689|363994034|FG000|Overall Study|Ineligible|1|||
105544206|NCT00182689|363994035|FG001|Overall Study|Ineligible|4|||
105544207|NCT00182689|363994034|FG000|Overall Study|Never received treatment|1|||
105544208|NCT00182689|363994035|FG001|Overall Study|Never received treatment|0|||
105544209|NCT03422003|363994036|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
105544210|NCT03422003|363994037|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
105544211|NCT03422003|363994036|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
105544212|NCT03422003|363994037|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
105544213|NCT01337089|363994038|FG000|Overall Study|Adverse Event|237|||
105544214|NCT01337089|363994038|FG000|Overall Study|Withdrawal by Subject|129|||
105544215|NCT01337089|363994038|FG000|Overall Study|Withdrawal by Investigator|33|||
105544216|NCT01337089|363994038|FG000|Overall Study|Met Withdrawal Criteria|3|||
105544217|NCT01337089|363994038|FG000|Overall Study|Lost to Follow-up|2|||
105544218|NCT01640301|363994039|FG000|Overall Study|Death|0|||
105544219|NCT01640301|363994040|FG001|Overall Study|Death|8|||
105544220|NCT02348489|363994043|FG000|Overall Study|Death|336|||
105544221|NCT02348489|363994044|FG001|Overall Study|Death|335|||
105544222|NCT02348489|363994043|FG000|Overall Study|Withdrawal by Subject|14|||
105544223|NCT02348489|363994044|FG001|Overall Study|Withdrawal by Subject|27|||
105544224|NCT02348489|363994043|FG000|Overall Study|Lost to Follow-up|3|||
105544225|NCT02348489|363994044|FG001|Overall Study|Lost to Follow-up|5|||
105544226|NCT01639001|363994045|FG000|Overall Study|Refused further follow-up|9|||
105544227|NCT01639001|363994046|FG001|Overall Study|Refused further follow-up|12|||
105544228|NCT01639001|363994045|FG000|Overall Study|Lost to Follow-up|3|||
105544229|NCT01639001|363994046|FG001|Overall Study|Lost to Follow-up|0|||
105544230|NCT01639001|363994045|FG000|Overall Study|Death|62|||
105544231|NCT01639001|363994046|FG001|Overall Study|Death|61|||
105544232|NCT01639001|363994045|FG000|Overall Study|Randomized but not treated|0|||
105544233|NCT01639001|363994046|FG001|Overall Study|Randomized but not treated|2|||
105544234|NCT01639001|363994045|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
105544235|NCT01639001|363994046|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
105544236|NCT01040871|363994048|FG000|Overall Study|Adverse Event|6|||
105544237|NCT01040871|363994049|FG001|Overall Study|Adverse Event|2|||
105544238|NCT01040871|363994048|FG000|Overall Study|Withdrawal by Subject|2|||
105544239|NCT01040871|363994049|FG001|Overall Study|Withdrawal by Subject|0|||
105544240|NCT01040871|363994048|FG000|Overall Study|Death|1|||
105544241|NCT01040871|363994049|FG001|Overall Study|Death|3|||
105544242|NCT01040871|363994048|FG000|Overall Study|Lack of Efficacy|1|||
105544243|NCT01040871|363994049|FG001|Overall Study|Lack of Efficacy|1|||
105544244|NCT01040871|363994048|FG000|Overall Study|drug supply issue|1|||
105544245|NCT01040871|363994049|FG001|Overall Study|drug supply issue|0|||
105544246|NCT01040871|363994048|FG000|Overall Study|Randomized and Not Treated|2|||
105544247|NCT01040871|363994049|FG001|Overall Study|Randomized and Not Treated|1|||
105544248|NCT01969838|363994050|FG000|Double-blind Phase|Adverse Event|10|||
105544249|NCT01969838|363994051|FG001|Double-blind Phase|Adverse Event|4|||
105544250|NCT01969838|363994052|FG002|Double-blind Phase|Adverse Event|0|||
105544251|NCT01969838|363994053|FG003|Double-blind Phase|Adverse Event|0|||
105544252|NCT01969838|363994050|FG000|Double-blind Phase|Death|5|||
105544253|NCT01969838|363994051|FG001|Double-blind Phase|Death|2|||
105544254|NCT01969838|363994052|FG002|Double-blind Phase|Death|0|||
105544255|NCT01969838|363994053|FG003|Double-blind Phase|Death|0|||
105544256|NCT01969838|363994050|FG000|Double-blind Phase|Physician Decision|5|||
105544257|NCT01969838|363994051|FG001|Double-blind Phase|Physician Decision|1|||
105544258|NCT01969838|363994052|FG002|Double-blind Phase|Physician Decision|0|||
105544259|NCT01969838|363994053|FG003|Double-blind Phase|Physician Decision|0|||
105544260|NCT01969838|363994050|FG000|Double-blind Phase|Subject Decision|4|||
105544261|NCT01969838|363994051|FG001|Double-blind Phase|Subject Decision|2|||
105544262|NCT01969838|363994052|FG002|Double-blind Phase|Subject Decision|0|||
105544263|NCT01969838|363994053|FG003|Double-blind Phase|Subject Decision|0|||
105544264|NCT01969838|363994050|FG000|Double-blind Phase|Disease Progression|2|||
105544265|NCT01969838|363994051|FG001|Double-blind Phase|Disease Progression|0|||
105544266|NCT01969838|363994052|FG002|Double-blind Phase|Disease Progression|0|||
105544267|NCT01969838|363994053|FG003|Double-blind Phase|Disease Progression|0|||
105544268|NCT01969838|363994050|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
105595963|NCT01350804|364182470|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
105544269|NCT01969838|363994051|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
105544270|NCT01969838|363994052|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
105544271|NCT01969838|363994053|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
105544272|NCT01969838|363994050|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
105544273|NCT01969838|363994051|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
105544274|NCT01969838|363994052|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
105544275|NCT01969838|363994053|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
105544276|NCT01969838|363994050|FG000|Open-label Phase|Adverse Event|0|||
105544277|NCT01969838|363994051|FG001|Open-label Phase|Adverse Event|0|||
105544278|NCT01969838|363994052|FG002|Open-label Phase|Adverse Event|37|||
105544279|NCT01969838|363994053|FG003|Open-label Phase|Adverse Event|49|||
105544280|NCT01969838|363994050|FG000|Open-label Phase|Disease Progression|0|||
105544281|NCT01969838|363994051|FG001|Open-label Phase|Disease Progression|0|||
105544282|NCT01969838|363994052|FG002|Open-label Phase|Disease Progression|26|||
105544283|NCT01969838|363994053|FG003|Open-label Phase|Disease Progression|27|||
105544284|NCT01969838|363994050|FG000|Open-label Phase|Lack of Efficacy|0|||
105544285|NCT01969838|363994051|FG001|Open-label Phase|Lack of Efficacy|0|||
105544286|NCT01969838|363994052|FG002|Open-label Phase|Lack of Efficacy|17|||
105544287|NCT01969838|363994053|FG003|Open-label Phase|Lack of Efficacy|19|||
105544288|NCT01969838|363994050|FG000|Open-label Phase|Subject Decision|0|||
105544289|NCT01969838|363994051|FG001|Open-label Phase|Subject Decision|0|||
105544290|NCT01969838|363994052|FG002|Open-label Phase|Subject Decision|14|||
105544291|NCT01969838|363994053|FG003|Open-label Phase|Subject Decision|15|||
105544292|NCT01969838|363994050|FG000|Open-label Phase|Death|0|||
105544293|NCT01969838|363994051|FG001|Open-label Phase|Death|0|||
105544294|NCT01969838|363994052|FG002|Open-label Phase|Death|13|||
105544295|NCT01969838|363994053|FG003|Open-label Phase|Death|11|||
105544296|NCT01969838|363994050|FG000|Open-label Phase|Physician Decision|0|||
105544297|NCT01969838|363994051|FG001|Open-label Phase|Physician Decision|0|||
105544298|NCT01969838|363994052|FG002|Open-label Phase|Physician Decision|9|||
105544299|NCT01969838|363994053|FG003|Open-label Phase|Physician Decision|14|||
105544300|NCT01969838|363994050|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
105544301|NCT01969838|363994051|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
105544302|NCT01969838|363994052|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
105544303|NCT01969838|363994053|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
105544304|NCT00408993|363994054|FG000|Overall Study|Adverse Event|15|||
105544305|NCT00408993|363994055|FG001|Overall Study|Adverse Event|4|||
105544306|NCT00408993|363994054|FG000|Overall Study|Protocol Violation|1|||
105544307|NCT00408993|363994055|FG001|Overall Study|Protocol Violation|6|||
105544308|NCT00408993|363994054|FG000|Overall Study|Lack of Efficacy|1|||
105544309|NCT00408993|363994055|FG001|Overall Study|Lack of Efficacy|4|||
105544310|NCT00408993|363994054|FG000|Overall Study|Withdrawal by Subject|2|||
105544311|NCT00408993|363994055|FG001|Overall Study|Withdrawal by Subject|3|||
105544312|NCT04820673|363994058|FG000|Overall Study|Adverse Event|6|||
105544313|NCT04820673|363994058|FG000|Overall Study|Due to Lack of Effectiveness|1|||
105544314|NCT04820673|363994058|FG000|Overall Study|Pregnancy|1|||
105544315|NCT04820673|363994058|FG000|Overall Study|Voluntary Withdrawal|20|||
105544316|NCT04820673|363994058|FG000|Overall Study|Lost to Follow-up|10|||
105544317|NCT01933334|363994062|FG000|Overall Study|Adverse Event|5|||
105544318|NCT01933334|363994063|FG001|Overall Study|Adverse Event|1|||
105544319|NCT01933334|363994062|FG000|Overall Study|Withdrawal by Subject|0|||
105544320|NCT01933334|363994063|FG001|Overall Study|Withdrawal by Subject|1|||
105544321|NCT00767000|363994064|FG000|54-week Study|Adverse Event|4|||
105544322|NCT00767000|363994065|FG001|54-week Study|Adverse Event|6|||
105544323|NCT00767000|363994066|FG002|54-week Study|Adverse Event|6|||
105544324|NCT00767000|363994067|FG003|54-week Study|Adverse Event|8|||
105544325|NCT00767000|363994068|FG004|54-week Study|Adverse Event|4|||
105544326|NCT00767000|363994064|FG000|54-week Study|Creaninine/creatinine clearance|2|||
105544327|NCT00767000|363994065|FG001|54-week Study|Creaninine/creatinine clearance|1|||
105544328|NCT00767000|363994066|FG002|54-week Study|Creaninine/creatinine clearance|2|||
105544329|NCT00767000|363994067|FG003|54-week Study|Creaninine/creatinine clearance|2|||
105544330|NCT00767000|363994068|FG004|54-week Study|Creaninine/creatinine clearance|4|||
105544331|NCT00767000|363994064|FG000|54-week Study|Hyperglycemia|0|||
105544332|NCT00767000|363994065|FG001|54-week Study|Hyperglycemia|0|||
105544333|NCT00767000|363994066|FG002|54-week Study|Hyperglycemia|1|||
105544334|NCT00767000|363994067|FG003|54-week Study|Hyperglycemia|0|||
105544335|NCT00767000|363994068|FG004|54-week Study|Hyperglycemia|1|||
105544336|NCT00767000|363994064|FG000|54-week Study|Hypoglycemia|0|||
105544337|NCT00767000|363994065|FG001|54-week Study|Hypoglycemia|1|||
105544338|NCT00767000|363994066|FG002|54-week Study|Hypoglycemia|0|||
105544339|NCT00767000|363994067|FG003|54-week Study|Hypoglycemia|0|||
105544340|NCT00767000|363994068|FG004|54-week Study|Hypoglycemia|0|||
105544341|NCT00767000|363994064|FG000|54-week Study|Interruption of study medication|0|||
105544342|NCT00767000|363994065|FG001|54-week Study|Interruption of study medication|0|||
105544343|NCT00767000|363994066|FG002|54-week Study|Interruption of study medication|1|||
105544344|NCT00767000|363994067|FG003|54-week Study|Interruption of study medication|0|||
105544345|NCT00767000|363994068|FG004|54-week Study|Interruption of study medication|0|||
105544346|NCT00767000|363994064|FG000|54-week Study|Lack of Efficacy|2|||
105544347|NCT00767000|363994065|FG001|54-week Study|Lack of Efficacy|0|||
105544348|NCT00767000|363994066|FG002|54-week Study|Lack of Efficacy|1|||
105544349|NCT00767000|363994067|FG003|54-week Study|Lack of Efficacy|0|||
105544350|NCT00767000|363994068|FG004|54-week Study|Lack of Efficacy|5|||
105544351|NCT00767000|363994064|FG000|54-week Study|Lost to Follow-up|4|||
105544352|NCT00767000|363994065|FG001|54-week Study|Lost to Follow-up|0|||
105544353|NCT00767000|363994066|FG002|54-week Study|Lost to Follow-up|1|||
105544354|NCT00767000|363994067|FG003|54-week Study|Lost to Follow-up|4|||
105544355|NCT00767000|363994068|FG004|54-week Study|Lost to Follow-up|2|||
105595964|NCT01350804|364182471|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
105544356|NCT00767000|363994064|FG000|54-week Study|Physician Decision|4|||
105544357|NCT00767000|363994065|FG001|54-week Study|Physician Decision|0|||
105544358|NCT00767000|363994066|FG002|54-week Study|Physician Decision|1|||
105544359|NCT00767000|363994067|FG003|54-week Study|Physician Decision|1|||
105544360|NCT00767000|363994068|FG004|54-week Study|Physician Decision|1|||
105544361|NCT00767000|363994064|FG000|54-week Study|Progressive disease|0|||
105544362|NCT00767000|363994065|FG001|54-week Study|Progressive disease|0|||
105544363|NCT00767000|363994066|FG002|54-week Study|Progressive disease|1|||
105544364|NCT00767000|363994067|FG003|54-week Study|Progressive disease|0|||
105544365|NCT00767000|363994068|FG004|54-week Study|Progressive disease|0|||
105544366|NCT00767000|363994064|FG000|54-week Study|Protocol Violation|0|||
105544367|NCT00767000|363994065|FG001|54-week Study|Protocol Violation|0|||
105544368|NCT00767000|363994066|FG002|54-week Study|Protocol Violation|1|||
105544369|NCT00767000|363994067|FG003|54-week Study|Protocol Violation|2|||
105544370|NCT00767000|363994068|FG004|54-week Study|Protocol Violation|0|||
105544371|NCT00767000|363994064|FG000|54-week Study|Withdrawal by Subject|2|||
105544372|NCT00767000|363994065|FG001|54-week Study|Withdrawal by Subject|3|||
105544373|NCT00767000|363994066|FG002|54-week Study|Withdrawal by Subject|5|||
105544374|NCT00767000|363994067|FG003|54-week Study|Withdrawal by Subject|11|||
105544375|NCT00767000|363994068|FG004|54-week Study|Withdrawal by Subject|13|||
105544376|NCT00767000|363994064|FG000|54-week Study|Study terminated by sponsor|90|||
105544377|NCT00767000|363994065|FG001|54-week Study|Study terminated by sponsor|102|||
105544378|NCT00767000|363994066|FG002|54-week Study|Study terminated by sponsor|89|||
105544379|NCT00767000|363994067|FG003|54-week Study|Study terminated by sponsor|196|||
105544380|NCT00767000|363994068|FG004|54-week Study|Study terminated by sponsor|194|||
105544381|NCT00767000|363994064|FG000|54-week Study|Reason not reported|0|||
105544382|NCT00767000|363994065|FG001|54-week Study|Reason not reported|0|||
105544383|NCT00767000|363994066|FG002|54-week Study|Reason not reported|0|||
105544384|NCT00767000|363994067|FG003|54-week Study|Reason not reported|1|||
105544385|NCT00767000|363994068|FG004|54-week Study|Reason not reported|0|||
105544386|NCT00767000|363994064|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
105544387|NCT00767000|363994065|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
105544388|NCT00767000|363994066|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
105544389|NCT00767000|363994067|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
105544390|NCT00767000|363994068|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
105544391|NCT00466193|363994069|FG000|Overall Study|Adverse Event|0|||
105544392|NCT00466193|363994070|FG001|Overall Study|Adverse Event|1|||
105544393|NCT00466193|363994069|FG000|Overall Study|Lost to Follow-up|2|||
105544394|NCT00466193|363994070|FG001|Overall Study|Lost to Follow-up|4|||
105544395|NCT00466193|363994069|FG000|Overall Study|Physician Decision|1|||
105544396|NCT00466193|363994070|FG001|Overall Study|Physician Decision|0|||
105544397|NCT00466193|363994069|FG000|Overall Study|Protocol Violation|1|||
105544398|NCT00466193|363994070|FG001|Overall Study|Protocol Violation|1|||
105544399|NCT00466193|363994069|FG000|Overall Study|Withdrawal by Subject|7|||
105544400|NCT00466193|363994070|FG001|Overall Study|Withdrawal by Subject|2|||
105544401|NCT00466193|363994069|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
105544402|NCT00466193|363994070|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
105544403|NCT01375049|363994071|FG000|Overall Study|Adverse Event|2|||
105544404|NCT01375049|363994071|FG000|Overall Study|Lost to Follow-up|1|||
105544405|NCT01375049|363994071|FG000|Overall Study|Withdrawal by Subject|2|||
105544406|NCT01375049|363994071|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
105544407|NCT01175382|363994072|FG000|Overall Study|Lost to Follow-up|4|||
105544408|NCT01175382|363994073|FG001|Overall Study|Lost to Follow-up|3|||
105544409|NCT01175382|363994074|FG002|Overall Study|Lost to Follow-up|1|||
105544410|NCT01175382|363994072|FG000|Overall Study|Physician Decision|0|||
105544411|NCT01175382|363994073|FG001|Overall Study|Physician Decision|1|||
105595965|NCT01350804|364182468|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
105595966|NCT01350804|364182469|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
105595967|NCT01350804|364182470|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
105595968|NCT01350804|364182471|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
105544412|NCT01175382|363994074|FG002|Overall Study|Physician Decision|0|||
105544413|NCT01175382|363994072|FG000|Overall Study|Withdrawal by Subject|0|||
105544414|NCT01175382|363994073|FG001|Overall Study|Withdrawal by Subject|0|||
105544415|NCT01175382|363994074|FG002|Overall Study|Withdrawal by Subject|1|||
105544416|NCT01175382|363994072|FG000|Overall Study|No longer having problem|1|||
105544417|NCT01175382|363994073|FG001|Overall Study|No longer having problem|0|||
105544418|NCT01175382|363994074|FG002|Overall Study|No longer having problem|1|||
105544419|NCT01175382|363994072|FG000|Overall Study|Unable/unwilling to attend visits|3|||
105544420|NCT01175382|363994073|FG001|Overall Study|Unable/unwilling to attend visits|1|||
105544421|NCT01175382|363994074|FG002|Overall Study|Unable/unwilling to attend visits|2|||
105544422|NCT01175382|363994072|FG000|Overall Study|Unwilling to follow protocol|0|||
105544423|NCT01175382|363994073|FG001|Overall Study|Unwilling to follow protocol|1|||
105544424|NCT01175382|363994074|FG002|Overall Study|Unwilling to follow protocol|0|||
105544425|NCT01175382|363994072|FG000|Overall Study|Unable to tolerate study meds|0|||
105595969|NCT01350804|364182468|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
105544426|NCT01175382|363994073|FG001|Overall Study|Unable to tolerate study meds|1|||
105544427|NCT01175382|363994074|FG002|Overall Study|Unable to tolerate study meds|1|||
105544428|NCT03766646|363994083|FG000|Overall Study|Withdrawal by Subject|1|||
105544429|NCT03766646|363994084|FG001|Overall Study|Withdrawal by Subject|0|||
105544430|NCT03766646|363994083|FG000|Overall Study|Protocol Violation|0|||
105544431|NCT03766646|363994084|FG001|Overall Study|Protocol Violation|3|||
105544432|NCT02530619|363994085|FG000|Registered for Study|Withdrawal by Subject|2|||
105544433|NCT02530619|363994085|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
105544434|NCT02530619|363994085|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
105544435|NCT02530619|363994085|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
105544436|NCT02530619|363994085|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
105544437|NCT02530619|363994085|FG000|Follow-up Period (6 Months)|Death|4|||
105544438|NCT02530619|363994085|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
105544439|NCT02530619|363994085|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
105544440|NCT01958918|363994092|FG000|Overall Study|Death|1|||
105544441|NCT01958918|363994093|FG001|Overall Study|Death|3|||
105544442|NCT01958918|363994092|FG000|Overall Study|Lost to Follow-up|4|||
105544443|NCT01958918|363994093|FG001|Overall Study|Lost to Follow-up|7|||
105544444|NCT01958918|363994092|FG000|Overall Study|Withdrawal by Subject|13|||
105544445|NCT01958918|363994093|FG001|Overall Study|Withdrawal by Subject|8|||
105544446|NCT01958918|363994092|FG000|Overall Study|Lack of Efficacy|13|||
105544447|NCT01958918|363994093|FG001|Overall Study|Lack of Efficacy|10|||
105544448|NCT01958918|363994092|FG000|Overall Study|Adverse Event|12|||
105544449|NCT01958918|363994093|FG001|Overall Study|Adverse Event|12|||
105544450|NCT01958918|363994092|FG000|Overall Study|administrative problems|0|||
105544451|NCT01958918|363994093|FG001|Overall Study|administrative problems|2|||
105544452|NCT01925183|363994094|FG000|Overall Study|Adverse Event|1|||
105544453|NCT01925183|363994095|FG001|Overall Study|Adverse Event|0|||
105544454|NCT00718042|363994100|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
105544455|NCT00718042|363994101|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
105544456|NCT00718042|363994102|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
105544457|NCT00718042|363994103|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
105544458|NCT00718042|363994104|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
105544459|NCT00718042|363994105|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
105544460|NCT00718042|363994100|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
105544461|NCT00718042|363994101|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
105544462|NCT00718042|363994102|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
105544463|NCT00718042|363994103|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
105544464|NCT00718042|363994104|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
105544465|NCT00718042|363994105|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
105544466|NCT00718042|363994100|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
105544467|NCT00718042|363994101|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
105544468|NCT00718042|363994102|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
105544469|NCT00718042|363994103|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
105544470|NCT00718042|363994104|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
105544471|NCT00718042|363994105|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
105544472|NCT00718042|363994100|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
105544473|NCT00718042|363994101|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
105544474|NCT00718042|363994102|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
105544475|NCT00718042|363994103|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
105544476|NCT00718042|363994104|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
105544477|NCT00718042|363994105|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
105544478|NCT00718042|363994100|FG000|Donor Follow-up|Lost to Follow-up|13|||
105544479|NCT00718042|363994101|FG001|Donor Follow-up|Lost to Follow-up|0|||
105544480|NCT00718042|363994102|FG002|Donor Follow-up|Lost to Follow-up|0|||
105544481|NCT00718042|363994103|FG003|Donor Follow-up|Lost to Follow-up|0|||
105544482|NCT00718042|363994104|FG004|Donor Follow-up|Lost to Follow-up|19|||
105544483|NCT00718042|363994105|FG005|Donor Follow-up|Lost to Follow-up|0|||
105544484|NCT01430130|363994106|FG000|Overall Study|Lost to Follow-up|1|||
105544485|NCT01430130|363994106|FG000|Overall Study|Infection on Control Side of Incision|1|||
105544486|NCT03525834|363994107|FG000|Overall Study|Progressive disease|1|||
105544487|NCT03095417|363994108|FG000|Overall Study|missed|1|||
105544488|NCT03095417|363994109|FG001|Overall Study|missed|2|||
105544489|NCT03095417|363994110|FG002|Overall Study|missed|0|||
105544490|NCT03095417|363994111|FG003|Overall Study|missed|1|||
105544491|NCT03095417|363994108|FG000|Overall Study|Lost to Follow-up|2|||
105544492|NCT03095417|363994109|FG001|Overall Study|Lost to Follow-up|2|||
105544493|NCT03095417|363994110|FG002|Overall Study|Lost to Follow-up|1|||
105544494|NCT03095417|363994111|FG003|Overall Study|Lost to Follow-up|0|||
105544495|NCT03095417|363994108|FG000|Overall Study|refusal|0|||
105544496|NCT03095417|363994109|FG001|Overall Study|refusal|1|||
105544497|NCT03095417|363994110|FG002|Overall Study|refusal|0|||
105544498|NCT03095417|363994111|FG003|Overall Study|refusal|1|||
105544499|NCT03095417|363994108|FG000|Overall Study|Withdrawal by Subject|8|||
105544500|NCT03095417|363994109|FG001|Overall Study|Withdrawal by Subject|2|||
105544501|NCT03095417|363994110|FG002|Overall Study|Withdrawal by Subject|5|||
105544502|NCT03095417|363994111|FG003|Overall Study|Withdrawal by Subject|4|||
105544503|NCT03095417|363994108|FG000|Overall Study|Physician Decision|1|||
105544504|NCT03095417|363994109|FG001|Overall Study|Physician Decision|2|||
105544505|NCT03095417|363994110|FG002|Overall Study|Physician Decision|2|||
105544506|NCT03095417|363994111|FG003|Overall Study|Physician Decision|2|||
105544507|NCT03095417|363994108|FG000|Overall Study|Death|1|||
105544508|NCT03095417|363994109|FG001|Overall Study|Death|2|||
105544509|NCT03095417|363994110|FG002|Overall Study|Death|1|||
105544510|NCT03095417|363994111|FG003|Overall Study|Death|3|||
105544511|NCT02660944|363994112|FG000|Overall Study|Adverse Event|3|||
105544512|NCT02660944|363994113|FG001|Overall Study|Adverse Event|4|||
105544513|NCT02660944|363994112|FG000|Overall Study|Physician Decision|3|||
105544514|NCT02660944|363994113|FG001|Overall Study|Physician Decision|1|||
105544515|NCT02660944|363994112|FG000|Overall Study|Withdrawal by Subject|5|||
105544516|NCT02660944|363994113|FG001|Overall Study|Withdrawal by Subject|3|||
105544517|NCT02660944|363994112|FG000|Overall Study|Lost to Follow-up|4|||
105544518|NCT02660944|363994113|FG001|Overall Study|Lost to Follow-up|1|||
105544519|NCT02660944|363994112|FG000|Overall Study|Subject schedule|0|||
105544520|NCT02660944|363994113|FG001|Overall Study|Subject schedule|1|||
105544521|NCT02660944|363994112|FG000|Overall Study|Exclusion criteria met|2|||
105544522|NCT02660944|363994113|FG001|Overall Study|Exclusion criteria met|0|||
105544523|NCT04776148|363994114|FG000|Overall Study|Death|172|||
105544524|NCT04776148|363994115|FG001|Overall Study|Death|188|||
105544525|NCT04776148|363994114|FG000|Overall Study|Lost to Follow-up|0|||
105544526|NCT04776148|363994115|FG001|Overall Study|Lost to Follow-up|1|||
105544527|NCT04776148|363994114|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105544528|NCT04776148|363994115|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
105544529|NCT04776148|363994114|FG000|Overall Study|Withdrawal by Subject|2|||
105544530|NCT04776148|363994115|FG001|Overall Study|Withdrawal by Subject|4|||
105544531|NCT04776148|363994114|FG000|Overall Study|Ongoing in Study|67|||
105544532|NCT04776148|363994115|FG001|Overall Study|Ongoing in Study|45|||
105544533|NCT00096941|363994129|FG000|Overall Study|disease progression|3|||
105544534|NCT00701051|363994130|FG000|Screening|Failed Screening|40|||
105544535|NCT00701051|363994131|FG001|Screening|Failed Screening|0|||
105544536|NCT00701051|363994132|FG002|Screening|Failed Screening|0|||
105544537|NCT00701051|363994130|FG000|Screening|Time conflicts|19|||
105544538|NCT00701051|363994131|FG001|Screening|Time conflicts|0|||
105544539|NCT00701051|363994132|FG002|Screening|Time conflicts|0|||
105544540|NCT00701051|363994130|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
105544541|NCT00701051|363994131|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
105544542|NCT00701051|363994132|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
105544543|NCT01410110|363994133|FG000|Overall Study|Withdrawal by Subject|4|||
105544544|NCT01410110|363994134|FG001|Overall Study|Withdrawal by Subject|2|||
105544545|NCT02778204|363994141|FG000|Overall Study|Adverse Event|1|||
105544546|NCT02778204|363994142|FG001|Overall Study|Adverse Event|0|||
105544547|NCT02778204|363994143|FG002|Overall Study|Adverse Event|0|||
105544548|NCT02778204|363994144|FG003|Overall Study|Adverse Event|0|||
105544549|NCT02778204|363994141|FG000|Overall Study|Withdrawal by Subject|0|||
105544550|NCT02778204|363994142|FG001|Overall Study|Withdrawal by Subject|0|||
105544551|NCT02778204|363994143|FG002|Overall Study|Withdrawal by Subject|1|||
105544552|NCT02778204|363994144|FG003|Overall Study|Withdrawal by Subject|2|||
105544553|NCT02778204|363994141|FG000|Overall Study|Lost to Follow-up|1|||
105544554|NCT02778204|363994142|FG001|Overall Study|Lost to Follow-up|0|||
105544555|NCT02778204|363994143|FG002|Overall Study|Lost to Follow-up|2|||
105544556|NCT02778204|363994144|FG003|Overall Study|Lost to Follow-up|1|||
105544557|NCT02778204|363994141|FG000|Overall Study|Protocol Violation|0|||
105544558|NCT02778204|363994142|FG001|Overall Study|Protocol Violation|0|||
105544559|NCT02778204|363994143|FG002|Overall Study|Protocol Violation|1|||
105595970|NCT01350804|364182469|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
105544560|NCT02778204|363994144|FG003|Overall Study|Protocol Violation|0|||
105544561|NCT02778204|363994141|FG000|Overall Study|Eligibility Violation|0|||
105595971|NCT01350804|364182470|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
105595972|NCT01350804|364182471|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
105595973|NCT01350804|364182468|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
105544562|NCT02778204|363994142|FG001|Overall Study|Eligibility Violation|0|||
105544563|NCT02778204|363994143|FG002|Overall Study|Eligibility Violation|0|||
105544564|NCT02778204|363994144|FG003|Overall Study|Eligibility Violation|1|||
105595974|NCT01350804|364182469|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
105544565|NCT03191903|363994145|FG000|Overall Study|Withdrawal by Subject|6|||
105544566|NCT03191903|363994146|FG001|Overall Study|Withdrawal by Subject|5|||
105544567|NCT03191903|363994147|FG002|Overall Study|Withdrawal by Subject|4|||
105544568|NCT03191903|363994145|FG000|Overall Study|Adverse Event|1|||
105544569|NCT03191903|363994146|FG001|Overall Study|Adverse Event|0|||
105544570|NCT03191903|363994147|FG002|Overall Study|Adverse Event|0|||
105544571|NCT00813761|363994148|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
105544572|NCT00813761|363994149|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
105544573|NCT00813761|363994150|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
105544574|NCT00813761|363994151|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
105544575|NCT00813761|363994148|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
105544576|NCT00813761|363994149|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
105544577|NCT00813761|363994150|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
105544578|NCT00813761|363994151|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
105544579|NCT00813761|363994148|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
105544580|NCT00813761|363994149|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
105544581|NCT00813761|363994150|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
105544582|NCT00813761|363994151|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
105544583|NCT00813761|363994148|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
105544584|NCT00813761|363994149|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
105544585|NCT00813761|363994150|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
105544586|NCT00813761|363994151|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
105544587|NCT00813761|363994148|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
105544588|NCT00813761|363994149|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
105544589|NCT00813761|363994150|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
105544590|NCT00813761|363994151|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
105544591|NCT00813761|363994148|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
105544592|NCT00813761|363994149|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
105544593|NCT00813761|363994150|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
105544594|NCT00813761|363994151|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
105544595|NCT00813761|363994148|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
105544596|NCT00813761|363994149|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
105544597|NCT00813761|363994150|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
105544598|NCT00813761|363994151|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
105544599|NCT00813761|363994148|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
105544600|NCT00813761|363994149|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
105544601|NCT00813761|363994150|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
105544602|NCT00813761|363994151|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
105544603|NCT00813761|363994148|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
105544604|NCT00813761|363994149|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
105544605|NCT00813761|363994150|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
105544606|NCT00813761|363994151|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
105544607|NCT00813761|363994148|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
105544608|NCT00813761|363994149|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
105544609|NCT00813761|363994150|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
105544610|NCT00813761|363994151|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
105544611|NCT00813761|363994148|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
105544612|NCT00813761|363994149|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
105544613|NCT00813761|363994150|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
105544614|NCT00813761|363994151|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
105544615|NCT00813761|363994148|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
105544616|NCT00813761|363994149|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
105544617|NCT00813761|363994150|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
105544618|NCT00813761|363994151|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
105544619|NCT05204134|363994152|FG000|Overall Study|Withdrawal by Subject|3|||
105544620|NCT05204134|363994152|FG000|Overall Study|Physician Decision|1|||
105544621|NCT00766415|363994154|FG000|Overall Study|Withdrawal by Subject|0|||
105544622|NCT00766415|363994155|FG001|Overall Study|Withdrawal by Subject|1|||
105544623|NCT00129259|363994157|FG000|Overall Study|Lost to Follow-up|1|||
105544624|NCT00129259|363994158|FG001|Overall Study|Lost to Follow-up|1|||
105544625|NCT00129259|363994157|FG000|Overall Study|Withdrawal by Subject|2|||
105544626|NCT00129259|363994158|FG001|Overall Study|Withdrawal by Subject|1|||
105544627|NCT00129259|363994157|FG000|Overall Study|Only available minimal phone assessments|0|||
105544628|NCT00129259|363994158|FG001|Overall Study|Only available minimal phone assessments|1|||
105544629|NCT02120924|363994159|FG000|Overall Study|Lack of Efficacy|1|||
105544630|NCT02120924|363994160|FG001|Overall Study|Lack of Efficacy|2|||
105544631|NCT02120924|363994161|FG002|Overall Study|Lack of Efficacy|3|||
105544632|NCT02120924|363994159|FG000|Overall Study|Adverse Event|0|||
105544633|NCT02120924|363994160|FG001|Overall Study|Adverse Event|1|||
105544634|NCT02120924|363994161|FG002|Overall Study|Adverse Event|3|||
105544635|NCT02120924|363994159|FG000|Overall Study|Withdrawal by Subject|16|||
105544636|NCT02120924|363994160|FG001|Overall Study|Withdrawal by Subject|20|||
105544637|NCT02120924|363994161|FG002|Overall Study|Withdrawal by Subject|8|||
105544638|NCT02120924|363994159|FG000|Overall Study|Lost to Follow-up|14|||
105544639|NCT02120924|363994160|FG001|Overall Study|Lost to Follow-up|14|||
105544640|NCT02120924|363994161|FG002|Overall Study|Lost to Follow-up|11|||
105544641|NCT02120924|363994159|FG000|Overall Study|Pregnancy|2|||
105544642|NCT02120924|363994160|FG001|Overall Study|Pregnancy|0|||
105544643|NCT02120924|363994161|FG002|Overall Study|Pregnancy|0|||
105544644|NCT02120924|363994159|FG000|Overall Study|Protocol Violation|3|||
105544645|NCT02120924|363994160|FG001|Overall Study|Protocol Violation|7|||
105544646|NCT02120924|363994161|FG002|Overall Study|Protocol Violation|2|||
105544647|NCT02120924|363994159|FG000|Overall Study|Physician Decision|0|||
105544648|NCT02120924|363994160|FG001|Overall Study|Physician Decision|1|||
105544649|NCT02120924|363994161|FG002|Overall Study|Physician Decision|1|||
105544650|NCT02120924|363994159|FG000|Overall Study|Death|1|||
105544651|NCT02120924|363994160|FG001|Overall Study|Death|0|||
105544652|NCT02120924|363994161|FG002|Overall Study|Death|0|||
105544653|NCT02120924|363994159|FG000|Overall Study|Compliance with IP|5|||
105544654|NCT02120924|363994160|FG001|Overall Study|Compliance with IP|1|||
105544655|NCT02120924|363994161|FG002|Overall Study|Compliance with IP|1|||
105544656|NCT02602288|363996062|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
105544657|NCT02602288|363996063|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
105544658|NCT02602288|363996062|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
105544659|NCT02602288|363996063|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
105544660|NCT02602288|363996062|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
105544661|NCT02602288|363996063|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
105544662|NCT02602288|363996062|FG000|12 Month Follow-up|Lost to Follow-up|0|||
105544663|NCT02602288|363996063|FG001|12 Month Follow-up|Lost to Follow-up|4|||
105544664|NCT02602288|363996062|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
105544665|NCT02602288|363996063|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
105544666|NCT02066298|363996064|FG000|Overall Study|Lost to Follow-up|3|||
105544667|NCT02066298|363996065|FG001|Overall Study|Lost to Follow-up|2|||
105544668|NCT02066298|363996066|FG002|Overall Study|Lost to Follow-up|3|||
105544669|NCT02066298|363996067|FG003|Overall Study|Lost to Follow-up|2|||
105544670|NCT02066298|363996068|FG004|Overall Study|Lost to Follow-up|3|||
105544671|NCT02066298|363996069|FG005|Overall Study|Lost to Follow-up|4|||
105544672|NCT02066298|363996064|FG000|Overall Study|Withdrawal by Subject|6|||
105544673|NCT02066298|363996065|FG001|Overall Study|Withdrawal by Subject|6|||
105544674|NCT02066298|363996066|FG002|Overall Study|Withdrawal by Subject|6|||
105544675|NCT02066298|363996067|FG003|Overall Study|Withdrawal by Subject|4|||
105544676|NCT02066298|363996068|FG004|Overall Study|Withdrawal by Subject|5|||
105544677|NCT02066298|363996069|FG005|Overall Study|Withdrawal by Subject|8|||
105544678|NCT02066298|363996064|FG000|Overall Study|Physician Decision|0|||
105544679|NCT02066298|363996065|FG001|Overall Study|Physician Decision|0|||
105544680|NCT02066298|363996066|FG002|Overall Study|Physician Decision|1|||
105544681|NCT02066298|363996067|FG003|Overall Study|Physician Decision|0|||
105544682|NCT02066298|363996068|FG004|Overall Study|Physician Decision|1|||
105544683|NCT02066298|363996069|FG005|Overall Study|Physician Decision|0|||
105544684|NCT02033889|363996071|FG000|Overall Study|Adverse Event|3|||
105544685|NCT02033889|363996072|FG001|Overall Study|Adverse Event|1|||
105544686|NCT02033889|363996073|FG002|Overall Study|Adverse Event|3|||
105544687|NCT02033889|363996071|FG000|Overall Study|Death|3|||
105544688|NCT02033889|363996072|FG001|Overall Study|Death|1|||
105544689|NCT02033889|363996073|FG002|Overall Study|Death|2|||
105544690|NCT02033889|363996071|FG000|Overall Study|Excluded Medication|1|||
105544691|NCT02033889|363996072|FG001|Overall Study|Excluded Medication|1|||
105544692|NCT02033889|363996073|FG002|Overall Study|Excluded Medication|0|||
105544693|NCT02033889|363996071|FG000|Overall Study|Lost to Follow-up|8|||
105544694|NCT02033889|363996072|FG001|Overall Study|Lost to Follow-up|5|||
105544695|NCT02033889|363996073|FG002|Overall Study|Lost to Follow-up|6|||
105544696|NCT02033889|363996071|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105544697|NCT02033889|363996072|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105544698|NCT02033889|363996073|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105544699|NCT02033889|363996071|FG000|Overall Study|Physician Decision|0|||
105544700|NCT02033889|363996072|FG001|Overall Study|Physician Decision|1|||
105544701|NCT02033889|363996073|FG002|Overall Study|Physician Decision|1|||
105544702|NCT02033889|363996071|FG000|Overall Study|Participant moved|0|||
105544703|NCT02033889|363996072|FG001|Overall Study|Participant moved|1|||
105544704|NCT02033889|363996073|FG002|Overall Study|Participant moved|0|||
105544705|NCT02033889|363996071|FG000|Overall Study|Withdrawal by Subject|18|||
105544706|NCT02033889|363996072|FG001|Overall Study|Withdrawal by Subject|10|||
105544707|NCT02033889|363996073|FG002|Overall Study|Withdrawal by Subject|13|||
105544708|NCT02343458|363996074|FG000|Overall Study|Adverse Event|15|||
105544709|NCT02343458|363996075|FG001|Overall Study|Adverse Event|14|||
105544710|NCT02343458|363996076|FG002|Overall Study|Adverse Event|15|||
105544711|NCT02343458|363996077|FG003|Overall Study|Adverse Event|3|||
105544712|NCT02343458|363996074|FG000|Overall Study|Lack of Efficacy|3|||
105544713|NCT02343458|363996075|FG001|Overall Study|Lack of Efficacy|8|||
105544714|NCT02343458|363996076|FG002|Overall Study|Lack of Efficacy|4|||
105544715|NCT02343458|363996077|FG003|Overall Study|Lack of Efficacy|8|||
105544716|NCT02343458|363996074|FG000|Overall Study|Withdrawal by Subject|18|||
105544717|NCT02343458|363996075|FG001|Overall Study|Withdrawal by Subject|17|||
105544718|NCT02343458|363996076|FG002|Overall Study|Withdrawal by Subject|23|||
105544719|NCT02343458|363996077|FG003|Overall Study|Withdrawal by Subject|14|||
105544720|NCT02343458|363996074|FG000|Overall Study|Physician Decision|1|||
105544721|NCT02343458|363996075|FG001|Overall Study|Physician Decision|4|||
105544722|NCT02343458|363996076|FG002|Overall Study|Physician Decision|2|||
105544723|NCT02343458|363996077|FG003|Overall Study|Physician Decision|2|||
105544724|NCT02343458|363996074|FG000|Overall Study|Lost to Follow-up|5|||
105544725|NCT02343458|363996075|FG001|Overall Study|Lost to Follow-up|5|||
105544726|NCT02343458|363996076|FG002|Overall Study|Lost to Follow-up|3|||
105544727|NCT02343458|363996077|FG003|Overall Study|Lost to Follow-up|1|||
105544728|NCT02343458|363996074|FG000|Overall Study|Protocol Violation|2|||
105544729|NCT02343458|363996075|FG001|Overall Study|Protocol Violation|5|||
105544730|NCT02343458|363996076|FG002|Overall Study|Protocol Violation|2|||
105544731|NCT02343458|363996077|FG003|Overall Study|Protocol Violation|2|||
105544732|NCT02343458|363996074|FG000|Overall Study|Protocol Specified Criteria|17|||
105544733|NCT02343458|363996075|FG001|Overall Study|Protocol Specified Criteria|13|||
105544734|NCT02343458|363996076|FG002|Overall Study|Protocol Specified Criteria|14|||
105544735|NCT02343458|363996077|FG003|Overall Study|Protocol Specified Criteria|8|||
105544736|NCT03019536|363996078|FG000|Overall Study|Withdrawal by Subject|1|||
105544737|NCT03019536|363996079|FG001|Overall Study|Withdrawal by Subject|1|||
105544738|NCT03019536|363996080|FG002|Overall Study|Withdrawal by Subject|0|||
105544739|NCT03019536|363996078|FG000|Overall Study|Adverse Event|0|||
105544740|NCT03019536|363996079|FG001|Overall Study|Adverse Event|0|||
105544741|NCT03019536|363996080|FG002|Overall Study|Adverse Event|2|||
105544742|NCT03859323|363996081|FG000|Overall Study|Lost to Follow-up|0|||
105544743|NCT03859323|363996082|FG001|Overall Study|Lost to Follow-up|0|||
105544744|NCT03859323|363996083|FG002|Overall Study|Lost to Follow-up|0|||
105544745|NCT03859323|363996084|FG003|Overall Study|Lost to Follow-up|0|||
105544746|NCT03859323|363996085|FG004|Overall Study|Lost to Follow-up|0|||
105544747|NCT03859323|363996086|FG005|Overall Study|Lost to Follow-up|0|||
105544748|NCT03859323|363996087|FG006|Overall Study|Lost to Follow-up|1|||
105544749|NCT03859323|363996088|FG007|Overall Study|Lost to Follow-up|0|||
105544750|NCT03859323|363996089|FG008|Overall Study|Lost to Follow-up|0|||
105544751|NCT03859323|363996090|FG009|Overall Study|Lost to Follow-up|0|||
105544752|NCT03859323|363996091|FG010|Overall Study|Lost to Follow-up|0|||
105544753|NCT03859323|363996092|FG011|Overall Study|Lost to Follow-up|0|||
105544754|NCT03859323|363996093|FG012|Overall Study|Lost to Follow-up|0|||
105544755|NCT03859323|363996081|FG000|Overall Study|Withdrawal by Subject|0|||
105544756|NCT03859323|363996082|FG001|Overall Study|Withdrawal by Subject|0|||
105544757|NCT03859323|363996083|FG002|Overall Study|Withdrawal by Subject|1|||
105544758|NCT03859323|363996084|FG003|Overall Study|Withdrawal by Subject|0|||
105544759|NCT03859323|363996085|FG004|Overall Study|Withdrawal by Subject|0|||
105544760|NCT03859323|363996086|FG005|Overall Study|Withdrawal by Subject|1|||
105544761|NCT03859323|363996087|FG006|Overall Study|Withdrawal by Subject|0|||
105544762|NCT03859323|363996088|FG007|Overall Study|Withdrawal by Subject|0|||
105544763|NCT03859323|363996089|FG008|Overall Study|Withdrawal by Subject|0|||
105544764|NCT03859323|363996090|FG009|Overall Study|Withdrawal by Subject|1|||
105544765|NCT03859323|363996091|FG010|Overall Study|Withdrawal by Subject|1|||
105544766|NCT03859323|363996092|FG011|Overall Study|Withdrawal by Subject|2|||
105544767|NCT03859323|363996093|FG012|Overall Study|Withdrawal by Subject|1|||
105544768|NCT03859323|363996081|FG000|Overall Study|Pregnancy|0|||
105544769|NCT03859323|363996082|FG001|Overall Study|Pregnancy|0|||
105544770|NCT03859323|363996083|FG002|Overall Study|Pregnancy|0|||
105544771|NCT03859323|363996084|FG003|Overall Study|Pregnancy|0|||
105544772|NCT03859323|363996085|FG004|Overall Study|Pregnancy|0|||
105544773|NCT03859323|363996086|FG005|Overall Study|Pregnancy|0|||
105544774|NCT03859323|363996087|FG006|Overall Study|Pregnancy|0|||
105544775|NCT03859323|363996088|FG007|Overall Study|Pregnancy|0|||
105544776|NCT03859323|363996089|FG008|Overall Study|Pregnancy|0|||
105544777|NCT03859323|363996090|FG009|Overall Study|Pregnancy|1|||
105544778|NCT03859323|363996091|FG010|Overall Study|Pregnancy|0|||
105544779|NCT03859323|363996092|FG011|Overall Study|Pregnancy|0|||
105544780|NCT03859323|363996093|FG012|Overall Study|Pregnancy|0|||
105544781|NCT02648698|363996096|FG000|Overall Study|Protocol Violation|1|||
105544782|NCT02648698|363996097|FG001|Overall Study|Protocol Violation|5|||
105544783|NCT03087591|363996103|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
105544784|NCT03087591|363996103|FG000|Overall Study|Withdrawal by Subject|1|||
105544785|NCT02032901|363996104|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
105544786|NCT02032901|363996105|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
105544787|NCT02032901|363996104|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
105544788|NCT02032901|363996105|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
105544789|NCT02019719|363996106|FG000|Overall Study|Adverse Event|1|||
105544790|NCT02019719|363996107|FG001|Overall Study|Adverse Event|0|||
105544791|NCT02019719|363996108|FG002|Overall Study|Adverse Event|0|||
105544792|NCT02019719|363996109|FG003|Overall Study|Adverse Event|1|||
105544793|NCT02019719|363996110|FG004|Overall Study|Adverse Event|1|||
105544794|NCT02019719|363996106|FG000|Overall Study|Protocol Violation|1|||
105544795|NCT02019719|363996107|FG001|Overall Study|Protocol Violation|1|||
105544796|NCT02019719|363996108|FG002|Overall Study|Protocol Violation|0|||
105544797|NCT02019719|363996109|FG003|Overall Study|Protocol Violation|0|||
105544798|NCT02019719|363996110|FG004|Overall Study|Protocol Violation|0|||
105544799|NCT02019719|363996106|FG000|Overall Study|Protocol defined stopping criteria|2|||
105544800|NCT02019719|363996107|FG001|Overall Study|Protocol defined stopping criteria|0|||
105544801|NCT02019719|363996108|FG002|Overall Study|Protocol defined stopping criteria|0|||
105544802|NCT02019719|363996109|FG003|Overall Study|Protocol defined stopping criteria|1|||
105544803|NCT02019719|363996110|FG004|Overall Study|Protocol defined stopping criteria|1|||
105544804|NCT02019719|363996106|FG000|Overall Study|Physician Decision|2|||
105544805|NCT02019719|363996107|FG001|Overall Study|Physician Decision|0|||
105544806|NCT02019719|363996108|FG002|Overall Study|Physician Decision|0|||
105544807|NCT02019719|363996109|FG003|Overall Study|Physician Decision|0|||
105544808|NCT02019719|363996110|FG004|Overall Study|Physician Decision|0|||
105544809|NCT03003676|363996111|FG000|Overall Study|Lack of Efficacy|5|||
105544810|NCT03003676|363996112|FG001|Overall Study|Lack of Efficacy|7|||
105544811|NCT03003676|363996111|FG000|Overall Study|Withdrawal by Subject|0|||
105544812|NCT03003676|363996112|FG001|Overall Study|Withdrawal by Subject|1|||
105544813|NCT03003676|363996111|FG000|Overall Study|Hepatitis B infection|1|||
105544814|NCT03003676|363996112|FG001|Overall Study|Hepatitis B infection|0|||
105544815|NCT01931839|363996127|FG000|Overall Study|Death|0|||
105544816|NCT01931839|363996128|FG001|Overall Study|Death|1|||
105544817|NCT01931839|363996129|FG002|Overall Study|Death|2|||
105544818|NCT01931839|363996130|FG003|Overall Study|Death|0|||
105544819|NCT01931839|363996131|FG004|Overall Study|Death|0|||
105544820|NCT01931839|363996132|FG005|Overall Study|Death|0|||
105544821|NCT01931839|363996133|FG006|Overall Study|Death|0|||
105544822|NCT01931839|363996127|FG000|Overall Study|Physician Decision|1|||
105544823|NCT01931839|363996128|FG001|Overall Study|Physician Decision|0|||
105544824|NCT01931839|363996129|FG002|Overall Study|Physician Decision|1|||
105544825|NCT01931839|363996130|FG003|Overall Study|Physician Decision|0|||
105544826|NCT01931839|363996131|FG004|Overall Study|Physician Decision|0|||
105544827|NCT01931839|363996132|FG005|Overall Study|Physician Decision|0|||
105544828|NCT01931839|363996133|FG006|Overall Study|Physician Decision|1|||
105544829|NCT01931839|363996127|FG000|Overall Study|Withdrawal of consent|0|||
105544830|NCT01931839|363996128|FG001|Overall Study|Withdrawal of consent|0|||
105544831|NCT01931839|363996129|FG002|Overall Study|Withdrawal of consent|0|||
105544832|NCT01931839|363996130|FG003|Overall Study|Withdrawal of consent|0|||
105544833|NCT01931839|363996131|FG004|Overall Study|Withdrawal of consent|1|||
105544834|NCT01931839|363996132|FG005|Overall Study|Withdrawal of consent|0|||
105544835|NCT01931839|363996133|FG006|Overall Study|Withdrawal of consent|0|||
105544836|NCT01931839|363996127|FG000|Overall Study|Adverse Event|9|||
105544837|NCT01931839|363996128|FG001|Overall Study|Adverse Event|4|||
105544838|NCT01931839|363996129|FG002|Overall Study|Adverse Event|1|||
105544839|NCT01931839|363996130|FG003|Overall Study|Adverse Event|3|||
105544840|NCT01931839|363996131|FG004|Overall Study|Adverse Event|0|||
105544841|NCT01931839|363996132|FG005|Overall Study|Adverse Event|0|||
105544842|NCT01931839|363996133|FG006|Overall Study|Adverse Event|1|||
105544843|NCT01931839|363996127|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
105544844|NCT01931839|363996128|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
105544845|NCT01931839|363996129|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
105544846|NCT01931839|363996130|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
105544847|NCT01931839|363996131|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
105544848|NCT01931839|363996132|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
105544849|NCT01931839|363996133|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
105544850|NCT01931839|363996127|FG000|Overall Study|Other non-compliance|15|||
105544851|NCT01931839|363996128|FG001|Overall Study|Other non-compliance|9|||
105544852|NCT01931839|363996129|FG002|Overall Study|Other non-compliance|12|||
105544853|NCT01931839|363996130|FG003|Overall Study|Other non-compliance|3|||
105544854|NCT01931839|363996131|FG004|Overall Study|Other non-compliance|0|||
105544855|NCT01931839|363996132|FG005|Overall Study|Other non-compliance|3|||
105544856|NCT01931839|363996133|FG006|Overall Study|Other non-compliance|0|||
105544857|NCT01931839|363996127|FG000|Overall Study|Lost to Follow-up|1|||
105544858|NCT01931839|363996128|FG001|Overall Study|Lost to Follow-up|2|||
105544859|NCT01931839|363996129|FG002|Overall Study|Lost to Follow-up|4|||
105544860|NCT01931839|363996130|FG003|Overall Study|Lost to Follow-up|5|||
105544861|NCT01931839|363996131|FG004|Overall Study|Lost to Follow-up|0|||
105544862|NCT01931839|363996132|FG005|Overall Study|Lost to Follow-up|0|||
105544863|NCT01931839|363996133|FG006|Overall Study|Lost to Follow-up|0|||
105544864|NCT01931839|363996127|FG000|Overall Study|Other|4|||
105544865|NCT01931839|363996128|FG001|Overall Study|Other|2|||
105544866|NCT01931839|363996129|FG002|Overall Study|Other|6|||
105544867|NCT01931839|363996130|FG003|Overall Study|Other|0|||
105544868|NCT01931839|363996131|FG004|Overall Study|Other|0|||
105544869|NCT01931839|363996132|FG005|Overall Study|Other|0|||
105544870|NCT01931839|363996133|FG006|Overall Study|Other|0|||
105544871|NCT01762761|363996135|FG000|Overall Study|Adverse Event|15|||
105544872|NCT01762761|363996136|FG001|Overall Study|Adverse Event|17|||
105544873|NCT01762761|363996135|FG000|Overall Study|Lack of Efficacy|9|||
105544874|NCT01762761|363996136|FG001|Overall Study|Lack of Efficacy|25|||
105544875|NCT01762761|363996135|FG000|Overall Study|Protocol Violation|1|||
105544876|NCT01762761|363996136|FG001|Overall Study|Protocol Violation|1|||
105544877|NCT01762761|363996135|FG000|Overall Study|Study closed/terminated|0|||
105544878|NCT01762761|363996136|FG001|Overall Study|Study closed/terminated|2|||
105544879|NCT01762761|363996135|FG000|Overall Study|Lost to Follow-up|3|||
105544880|NCT01762761|363996136|FG001|Overall Study|Lost to Follow-up|6|||
105544881|NCT01762761|363996135|FG000|Overall Study|Physician Decision|4|||
105544882|NCT01762761|363996136|FG001|Overall Study|Physician Decision|6|||
105544883|NCT01762761|363996135|FG000|Overall Study|Withdrawal by Subject|7|||
105544884|NCT01762761|363996136|FG001|Overall Study|Withdrawal by Subject|8|||
105544885|NCT01465334|363996141|FG000|Overall Study|Disease Progression|1|||
105544886|NCT01465334|363996142|FG001|Overall Study|Disease Progression|0|||
105544887|NCT01465334|363996141|FG000|Overall Study|Adverse Event|1|||
105544888|NCT01465334|363996142|FG001|Overall Study|Adverse Event|0|||
105544889|NCT01465334|363996141|FG000|Overall Study|Richter's transformation|0|||
105544890|NCT01465334|363996142|FG001|Overall Study|Richter's transformation|3|||
105544891|NCT01465334|363996141|FG000|Overall Study|Refractory Disease|0|||
105544892|NCT01465334|363996142|FG001|Overall Study|Refractory Disease|3|||
105544893|NCT00575588|363996144|FG000|Overall Study|Adverse Event|11|||
105544894|NCT00575588|363996145|FG001|Overall Study|Adverse Event|13|||
105544895|NCT00575588|363996144|FG000|Overall Study|Withdrawal by Subject|27|||
105544896|NCT00575588|363996145|FG001|Overall Study|Withdrawal by Subject|31|||
105544897|NCT00575588|363996144|FG000|Overall Study|Lost to Follow-up|1|||
105544898|NCT00575588|363996145|FG001|Overall Study|Lost to Follow-up|3|||
105544899|NCT00575588|363996144|FG000|Overall Study|Death|4|||
105544900|NCT00575588|363996145|FG001|Overall Study|Death|2|||
105544901|NCT00575588|363996144|FG000|Overall Study|Incorrect enrollment|8|||
105544902|NCT00575588|363996145|FG001|Overall Study|Incorrect enrollment|4|||
105544903|NCT00575588|363996144|FG000|Overall Study|Study specific discontinuation criteria|203|||
105544904|NCT00575588|363996145|FG001|Overall Study|Study specific discontinuation criteria|218|||
105544905|NCT00575588|363996144|FG000|Overall Study|Severe non-compliance to protocol|5|||
105544906|NCT00575588|363996145|FG001|Overall Study|Severe non-compliance to protocol|7|||
105544907|NCT00575588|363996144|FG000|Overall Study|Safety reasons|2|||
105544908|NCT00575588|363996145|FG001|Overall Study|Safety reasons|1|||
105544909|NCT00575588|363996144|FG000|Overall Study|Elevated triglyceride|1|||
105544910|NCT00575588|363996145|FG001|Overall Study|Elevated triglyceride|0|||
105544911|NCT00575588|363996144|FG000|Overall Study|Patient moved|1|||
105544912|NCT00575588|363996145|FG001|Overall Study|Patient moved|3|||
105544913|NCT00575588|363996144|FG000|Overall Study|Impossible to determine HbA1c|0|||
105544914|NCT00575588|363996145|FG001|Overall Study|Impossible to determine HbA1c|1|||
105544915|NCT00377676|363996146|FG000|Overall Study|Adverse Event|498|||
105544916|NCT00377676|363996147|FG001|Overall Study|Adverse Event|107|||
105544917|NCT00377676|363996146|FG000|Overall Study|Protocol Violation|33|||
105544918|NCT00377676|363996147|FG001|Overall Study|Protocol Violation|27|||
105544919|NCT00377676|363996146|FG000|Overall Study|Death|5|||
105544920|NCT00377676|363996147|FG001|Overall Study|Death|2|||
105544921|NCT00377676|363996146|FG000|Overall Study|Withdrawal by Subject|187|||
105544922|NCT00377676|363996147|FG001|Overall Study|Withdrawal by Subject|72|||
105544923|NCT00377676|363996146|FG000|Overall Study|Lost to Follow-up|120|||
105544924|NCT00377676|363996147|FG001|Overall Study|Lost to Follow-up|56|||
105544925|NCT00377676|363996146|FG000|Overall Study|Other|118|||
105544926|NCT00377676|363996147|FG001|Overall Study|Other|58|||
105544927|NCT00614939|363996149|FG000|Overall Study|Withdrawal by Subject|10|||
105544928|NCT00614939|363996150|FG001|Overall Study|Withdrawal by Subject|17|||
105544929|NCT00614939|363996149|FG000|Overall Study|Study specific discontinuation criteris|13|||
105544930|NCT00614939|363996150|FG001|Overall Study|Study specific discontinuation criteris|16|||
105544931|NCT00614939|363996149|FG000|Overall Study|Adverse Event|2|||
105544932|NCT00614939|363996150|FG001|Overall Study|Adverse Event|5|||
105544933|NCT00614939|363996149|FG000|Overall Study|Incorrect enrollment|1|||
105544934|NCT00614939|363996150|FG001|Overall Study|Incorrect enrollment|2|||
105544935|NCT00614939|363996149|FG000|Overall Study|Death|4|||
105544936|NCT00614939|363996150|FG001|Overall Study|Death|3|||
105544937|NCT00614939|363996149|FG000|Overall Study|Poor/non-compliance|4|||
105544938|NCT00614939|363996150|FG001|Overall Study|Poor/non-compliance|0|||
105544939|NCT00614939|363996149|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
105544940|NCT00614939|363996150|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
105544941|NCT00504829|363996151|FG000|Overall Study|Protocol Violation|6|||
105544942|NCT00504829|363996152|FG001|Overall Study|Protocol Violation|4|||
105544943|NCT00504829|363996153|FG002|Overall Study|Protocol Violation|10|||
105544944|NCT00462384|363996154|FG000|Overall Study|Adverse Event|2|||
105544945|NCT00462384|363996154|FG000|Overall Study|Death|2|||
105544946|NCT00462384|363996154|FG000|Overall Study|Withdrawal by Subject|1|||
105544947|NCT00462384|363996154|FG000|Overall Study|Other|4|||
105544948|NCT02571452|363996155|FG000|Overall Study Treatment|Protocol Violation|0|||
105544949|NCT02571452|363996156|FG001|Overall Study Treatment|Protocol Violation|1|||
105544950|NCT02571452|363996155|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
105544951|NCT02571452|363996156|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
105544952|NCT02571452|363996155|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
105544953|NCT02571452|363996156|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
105544954|NCT01751568|363996157|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
105544955|NCT01751568|363996158|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
105544956|NCT01751568|363996159|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
105544957|NCT03586999|363996160|FG000|Overall Study|Lack of Efficacy|2|||
105544958|NCT02464969|363996161|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
105544959|NCT02464969|363996162|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
105544960|NCT02464969|363996161|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
105544961|NCT02464969|363996162|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
105544962|NCT02464969|363996161|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
105544963|NCT02464969|363996162|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
105544964|NCT02464969|363996161|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
105544965|NCT02464969|363996162|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
105544966|NCT02464969|363996161|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
105544967|NCT02464969|363996162|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
105544968|NCT02464969|363996161|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
105544969|NCT02464969|363996162|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
105544970|NCT02464969|363996161|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
105544971|NCT02464969|363996162|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
105544972|NCT02464969|363996161|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
105544973|NCT02464969|363996162|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
105544974|NCT02464969|363996161|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
105544975|NCT02464969|363996162|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
105544976|NCT02464969|363996161|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
105544977|NCT02464969|363996162|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
105544978|NCT02464969|363996161|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
105544979|NCT02464969|363996162|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
105544980|NCT00534352|363996163|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
105544981|NCT00534352|363996163|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
105544982|NCT00534352|363996163|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
105544983|NCT00534352|363996163|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
105544984|NCT00534352|363996163|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
105544985|NCT00534352|363996163|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
105544986|NCT01986829|363996169|FG000|Overall Study|Death|1|||
105544987|NCT02504866|363996170|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
105544988|NCT02504866|363996171|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
105544989|NCT02504866|363996172|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
105544990|NCT05101252|363996175|FG000|Overall Study|Unsatisfactory Test Article|1|||
105544991|NCT05101252|363996176|FG001|Overall Study|Unsatisfactory Test Article|0|||
105544992|NCT05101252|363996175|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
105544993|NCT05101252|363996176|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
105544994|NCT05101252|363996175|FG000|Overall Study|Withdrew Consent during study|0|||
105544995|NCT05101252|363996176|FG001|Overall Study|Withdrew Consent during study|1|||
105544996|NCT05101252|363996175|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
105544997|NCT05101252|363996176|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
105544998|NCT02401672|363996177|FG000|Overall Study|Withdrawal by Subject|1|||
105544999|NCT02401672|363996178|FG001|Overall Study|Withdrawal by Subject|3|||
105545000|NCT01731171|363996185|FG000|Overall Study|Withdrawal by Subject|4|||
105545001|NCT01731171|363996186|FG001|Overall Study|Withdrawal by Subject|1|||
105545002|NCT01731171|363996185|FG000|Overall Study|Lost to Follow-up|3|||
105545003|NCT01731171|363996186|FG001|Overall Study|Lost to Follow-up|2|||
105545004|NCT01731171|363996185|FG000|Overall Study|Moved out of Area|0|||
105545005|NCT01731171|363996186|FG001|Overall Study|Moved out of Area|2|||
105545006|NCT01731171|363996185|FG000|Overall Study|Terminated for Lack of Adherence|0|||
105545007|NCT01731171|363996186|FG001|Overall Study|Terminated for Lack of Adherence|1|||
105545008|NCT01731171|363996185|FG000|Overall Study|Terminated for Safety Reasons|0|||
105545009|NCT01731171|363996186|FG001|Overall Study|Terminated for Safety Reasons|1|||
105545010|NCT03653429|363996189|FG000|Overall Study|Physician Decision|4|||
105545011|NCT03653429|363996190|FG001|Overall Study|Physician Decision|10|||
105545012|NCT00403546|363996195|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
105545013|NCT00403546|363996196|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
105545014|NCT00403546|363996197|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
105545015|NCT00403546|363996195|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
105545016|NCT00403546|363996196|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
105545017|NCT00403546|363996197|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
105545018|NCT00403546|363996195|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
105545019|NCT00403546|363996196|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
105545020|NCT00403546|363996197|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
105545021|NCT00403546|363996195|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
105545022|NCT00403546|363996196|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
105545023|NCT00403546|363996197|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
105545024|NCT00403546|363996195|FG000|Screening Phase|Screening Failure|22|||
105545025|NCT00403546|363996196|FG001|Screening Phase|Screening Failure|0|||
105545026|NCT00403546|363996197|FG002|Screening Phase|Screening Failure|0|||
105545027|NCT00403546|363996195|FG000|Screening Phase|Adverse Event|1|||
105545028|NCT00403546|363996196|FG001|Screening Phase|Adverse Event|0|||
105545029|NCT00403546|363996197|FG002|Screening Phase|Adverse Event|0|||
105545030|NCT00403546|363996195|FG000|Screening Phase|Terminated Prior to Randomization|5|||
105545031|NCT00403546|363996196|FG001|Screening Phase|Terminated Prior to Randomization|0|||
105545032|NCT00403546|363996197|FG002|Screening Phase|Terminated Prior to Randomization|0|||
105545033|NCT00403546|363996195|FG000|Randomized Trial|Early Terminations|0|||
105545034|NCT00403546|363996196|FG001|Randomized Trial|Early Terminations|17|||
105545035|NCT00403546|363996197|FG002|Randomized Trial|Early Terminations|16|||
105545036|NCT00437489|363996198|FG000|Overall Study|Study terminated by sponsor|23|||
105545037|NCT00437489|363996199|FG001|Overall Study|Study terminated by sponsor|21|||
105545038|NCT00437489|363996198|FG000|Overall Study|Lost to Follow-up|0|||
105545039|NCT00437489|363996199|FG001|Overall Study|Lost to Follow-up|1|||
105545040|NCT03893448|363996207|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
105545041|NCT03893448|363996208|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
105545042|NCT03893448|363996207|FG000|Overall Study|Physician Decision|8|||
105545043|NCT03893448|363996208|FG001|Overall Study|Physician Decision|14|||
105595975|NCT01350804|364182470|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
105595976|NCT01350804|364182471|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
105595977|NCT03183518|364182472|FG000|Overall Study|Other (Not specified)|2|||
105595978|NCT03183518|364182472|FG000|Overall Study|Other (Withdrawal of consent)|1|||
105595979|NCT02106442|364182475|FG000|Overall Study|Case Report Forms Uncollected|7|||
105595980|NCT02106442|364182475|FG000|Overall Study|Protocol Deviation|30|||
105595981|NCT04722003|364184085|FG000|Overall Study|Lost to Follow-up|2|||
105595982|NCT04722003|364184086|FG001|Overall Study|Lost to Follow-up|0|||
105595983|NCT04722003|364184085|FG000|Overall Study|Physician Decision|1|||
105595984|NCT04722003|364184086|FG001|Overall Study|Physician Decision|0|||
105595985|NCT00364286|364184087|FG000|Overall Study|Withdrawal by Subject|1|||
105545044|NCT03893448|363996207|FG000|Overall Study|Lost to Follow-up|34|||
105545045|NCT03893448|363996208|FG001|Overall Study|Lost to Follow-up|27|||
105545046|NCT03893448|363996207|FG000|Overall Study|Death|1|||
105545047|NCT03893448|363996208|FG001|Overall Study|Death|0|||
105545048|NCT04177108|363996211|FG000|Overall Study|Withdrawal by Subject|4|||
105545049|NCT04177108|363996212|FG001|Overall Study|Withdrawal by Subject|8|||
105545050|NCT04177108|363996213|FG002|Overall Study|Withdrawal by Subject|9|||
105545051|NCT04177108|363996214|FG003|Overall Study|Withdrawal by Subject|11|||
105545052|NCT04177108|363996215|FG004|Overall Study|Withdrawal by Subject|13|||
105545053|NCT04177108|363996211|FG000|Overall Study|Physician Decision|23|||
105545054|NCT04177108|363996212|FG001|Overall Study|Physician Decision|15|||
105545055|NCT04177108|363996213|FG002|Overall Study|Physician Decision|18|||
105545056|NCT04177108|363996214|FG003|Overall Study|Physician Decision|29|||
105545057|NCT04177108|363996215|FG004|Overall Study|Physician Decision|23|||
105545058|NCT04177108|363996211|FG000|Overall Study|Reason Not Specified|0|||
105545059|NCT04177108|363996212|FG001|Overall Study|Reason Not Specified|1|||
105545060|NCT04177108|363996213|FG002|Overall Study|Reason Not Specified|0|||
105545061|NCT04177108|363996214|FG003|Overall Study|Reason Not Specified|0|||
105545062|NCT04177108|363996215|FG004|Overall Study|Reason Not Specified|2|||
105545063|NCT04177108|363996211|FG000|Overall Study|Lost to Follow-up|0|||
105545064|NCT04177108|363996212|FG001|Overall Study|Lost to Follow-up|0|||
105545065|NCT04177108|363996213|FG002|Overall Study|Lost to Follow-up|1|||
105545066|NCT04177108|363996214|FG003|Overall Study|Lost to Follow-up|1|||
105545067|NCT04177108|363996215|FG004|Overall Study|Lost to Follow-up|1|||
105545068|NCT04177108|363996211|FG000|Overall Study|Death|16|||
105545069|NCT04177108|363996212|FG001|Overall Study|Death|19|||
105545070|NCT04177108|363996213|FG002|Overall Study|Death|13|||
105545071|NCT04177108|363996214|FG003|Overall Study|Death|17|||
105545072|NCT04177108|363996215|FG004|Overall Study|Death|18|||
105545073|NCT03855189|363996216|FG000|Overall Study|Adverse Event|5|||
105545074|NCT03855189|363996217|FG001|Overall Study|Adverse Event|2|||
105595986|NCT00364286|364184087|FG000|Overall Study|Adverse Event|2|||
105595987|NCT00768664|364184088|FG000|Overall Study|Death|57|||
105595988|NCT00768664|364184088|FG000|Overall Study|Lost to Follow-up|2|||
105595989|NCT00768664|364184088|FG000|Overall Study|Other|9|||
105545075|NCT03855189|363996218|FG002|Overall Study|Adverse Event|4|||
105545076|NCT03855189|363996216|FG000|Overall Study|Treatment Failure|1|||
105595990|NCT00768664|364184088|FG000|Overall Study|Participant refused|1|||
105595991|NCT01400776|364184089|FG000|Overall Study|Adverse Event|7|||
105595992|NCT01400776|364184090|FG001|Overall Study|Adverse Event|2|||
105595993|NCT01400776|364184091|FG002|Overall Study|Adverse Event|9|||
105595994|NCT01400776|364184092|FG003|Overall Study|Adverse Event|2|||
105595995|NCT01400776|364184089|FG000|Overall Study|Lost to Follow-up|1|||
105595996|NCT01400776|364184090|FG001|Overall Study|Lost to Follow-up|0|||
105595997|NCT01400776|364184091|FG002|Overall Study|Lost to Follow-up|4|||
105545077|NCT03855189|363996217|FG001|Overall Study|Treatment Failure|1|||
105545078|NCT03855189|363996218|FG002|Overall Study|Treatment Failure|2|||
105545079|NCT03855189|363996216|FG000|Overall Study|Noncompliance with Protocol|0|||
105545080|NCT03855189|363996217|FG001|Overall Study|Noncompliance with Protocol|1|||
105545081|NCT03855189|363996218|FG002|Overall Study|Noncompliance with Protocol|0|||
105545082|NCT03855189|363996216|FG000|Overall Study|Did Not Return|4|||
105545083|NCT03855189|363996217|FG001|Overall Study|Did Not Return|3|||
105545084|NCT03855189|363996218|FG002|Overall Study|Did Not Return|0|||
105545085|NCT03864900|363996219|FG000|Overall Study|Withdrawal by Subject|1|||
105545086|NCT03864900|363996220|FG001|Overall Study|Withdrawal by Subject|1|||
105545087|NCT03864900|363996219|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
105545088|NCT03864900|363996220|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
105545089|NCT01827904|363996221|FG000|Main Study|Withdrawal by Subject|1|||
105545090|NCT01827904|363996222|FG001|Main Study|Withdrawal by Subject|0|||
105545091|NCT01827904|363996223|FG002|Main Study|Withdrawal by Subject|0|||
105545092|NCT01827904|363996221|FG000|Main Study|Adverse Event|1|||
105545093|NCT01827904|363996222|FG001|Main Study|Adverse Event|0|||
105545094|NCT01827904|363996223|FG002|Main Study|Adverse Event|0|||
105545095|NCT01827904|363996221|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
105545096|NCT01827904|363996222|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
105545097|NCT01827904|363996223|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
105545098|NCT01827904|363996221|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
105545099|NCT01827904|363996222|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
105545100|NCT01827904|363996223|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
105545101|NCT01827904|363996221|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
105545102|NCT01827904|363996222|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
105545103|NCT01827904|363996223|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
105545104|NCT01827904|363996221|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
105545105|NCT01827904|363996222|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
105545106|NCT01827904|363996223|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
105545107|NCT01827904|363996221|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
105545108|NCT01827904|363996222|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
105545109|NCT01827904|363996223|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
105545110|NCT01827904|363996221|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
105545111|NCT01827904|363996222|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
105545112|NCT01827904|363996223|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
105545113|NCT01827904|363996221|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
105545114|NCT01827904|363996222|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
105545115|NCT01827904|363996223|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
105545116|NCT01827904|363996221|FG000|Long-term Annual Follow-up|Physician Decision|1|||
105545117|NCT01827904|363996222|FG001|Long-term Annual Follow-up|Physician Decision|0|||
105545118|NCT01827904|363996223|FG002|Long-term Annual Follow-up|Physician Decision|0|||
105545119|NCT01827904|363996221|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
105545120|NCT01827904|363996222|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
105545121|NCT01827904|363996223|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
105545122|NCT01827904|363996221|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
105545123|NCT01827904|363996222|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
105545124|NCT01827904|363996223|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
105545125|NCT01866709|363996224|FG000|Overall Study|Adverse Event|1|||
105545126|NCT01866709|363996225|FG001|Overall Study|Adverse Event|0|||
105545127|NCT01975389|363996226|FG000|Overall Study|Adverse Event|10|||
105545128|NCT01975389|363996227|FG001|Overall Study|Adverse Event|6|||
105545129|NCT01975389|363996226|FG000|Overall Study|Death|61|||
105545130|NCT01975389|363996227|FG001|Overall Study|Death|54|||
105545131|NCT01975389|363996226|FG000|Overall Study|Lost to Follow-up|81|||
105545132|NCT01975389|363996227|FG001|Overall Study|Lost to Follow-up|86|||
105545133|NCT01975389|363996226|FG000|Overall Study|Withdrawal by Subject|90|||
105545134|NCT01975389|363996227|FG001|Overall Study|Withdrawal by Subject|76|||
105545135|NCT01975389|363996226|FG000|Overall Study|Other|6|||
105545136|NCT01975389|363996227|FG001|Overall Study|Other|9|||
105545137|NCT01975389|363996226|FG000|Overall Study|Randomized, not treated|4|||
105545138|NCT01975389|363996227|FG001|Overall Study|Randomized, not treated|5|||
105545139|NCT02460198|363996228|FG000|Overall Study|Adverse Event|1|||
105545140|NCT02460198|363996229|FG001|Overall Study|Adverse Event|3|||
105545141|NCT02460198|363996228|FG000|Overall Study|Death|36|||
105545142|NCT02460198|363996229|FG001|Overall Study|Death|28|||
105545143|NCT02460198|363996228|FG000|Overall Study|Lost to Follow-up|1|||
105595998|NCT01400776|364184092|FG003|Overall Study|Lost to Follow-up|1|||
105595999|NCT01400776|364184089|FG000|Overall Study|Withdrew Consent|4|||
105596000|NCT01400776|364184090|FG001|Overall Study|Withdrew Consent|2|||
105596001|NCT01400776|364184091|FG002|Overall Study|Withdrew Consent|6|||
105596002|NCT01400776|364184092|FG003|Overall Study|Withdrew Consent|1|||
105545144|NCT02460198|363996229|FG001|Overall Study|Lost to Follow-up|1|||
105545145|NCT02460198|363996228|FG000|Overall Study|Transferred to Extension Study|15|||
105545146|NCT02460198|363996229|FG001|Overall Study|Transferred to Extension Study|15|||
105545147|NCT02460198|363996228|FG000|Overall Study|Withdrawal by Subject|2|||
105545148|NCT02460198|363996229|FG001|Overall Study|Withdrawal by Subject|4|||
105545149|NCT02460198|363996228|FG000|Overall Study|Site Terminated By Sponsor|0|||
105545150|NCT02460198|363996229|FG001|Overall Study|Site Terminated By Sponsor|1|||
105545151|NCT02460198|363996228|FG000|Overall Study|Did Not Continue on Extension Study|6|||
105545152|NCT02460198|363996229|FG001|Overall Study|Did Not Continue on Extension Study|11|||
105545153|NCT00965848|363996230|FG000|Overall Study|Protocol Violation|3|||
105545154|NCT00965848|363996231|FG001|Overall Study|Protocol Violation|0|||
105545155|NCT00965848|363996232|FG002|Overall Study|Protocol Violation|1|||
105545156|NCT00965848|363996230|FG000|Overall Study|Death|11|||
105545157|NCT00965848|363996231|FG001|Overall Study|Death|1|||
105545158|NCT00965848|363996232|FG002|Overall Study|Death|5|||
105545159|NCT00965848|363996230|FG000|Overall Study|Lost to Follow-up|0|||
105545160|NCT00965848|363996231|FG001|Overall Study|Lost to Follow-up|0|||
105545161|NCT00965848|363996232|FG002|Overall Study|Lost to Follow-up|1|||
105545162|NCT00965848|363996230|FG000|Overall Study|Withdrawal by Subject|1|||
105545163|NCT00965848|363996231|FG001|Overall Study|Withdrawal by Subject|0|||
105545164|NCT00965848|363996232|FG002|Overall Study|Withdrawal by Subject|0|||
105545165|NCT00965848|363996230|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
105545166|NCT00965848|363996231|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
105545167|NCT00965848|363996232|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
105545168|NCT00965848|363996230|FG000|Overall Study|Not Clinically Evaluable|7|||
105545169|NCT00965848|363996231|FG001|Overall Study|Not Clinically Evaluable|1|||
105545170|NCT00965848|363996232|FG002|Overall Study|Not Clinically Evaluable|1|||
105545171|NCT00965848|363996230|FG000|Overall Study|Other|5|||
105545172|NCT00965848|363996231|FG001|Overall Study|Other|0|||
105545173|NCT00965848|363996232|FG002|Overall Study|Other|1|||
105545174|NCT00927927|363996238|FG000|Overall Study|Withdrawal by Subject|0|||
105545175|NCT00927927|363996239|FG001|Overall Study|Withdrawal by Subject|0|||
105545176|NCT00927927|363996240|FG002|Overall Study|Withdrawal by Subject|0|||
105545177|NCT00927927|363996241|FG003|Overall Study|Withdrawal by Subject|0|||
105545178|NCT00927927|363996242|FG004|Overall Study|Withdrawal by Subject|0|||
105545179|NCT00927927|363996243|FG005|Overall Study|Withdrawal by Subject|0|||
105545180|NCT00927927|363996244|FG006|Overall Study|Withdrawal by Subject|0|||
105545181|NCT00927927|363996245|FG007|Overall Study|Withdrawal by Subject|2|||
105545182|NCT00927927|363996246|FG008|Overall Study|Withdrawal by Subject|0|||
105545183|NCT00927927|363996247|FG009|Overall Study|Withdrawal by Subject|0|||
105545184|NCT00927927|363996248|FG010|Overall Study|Withdrawal by Subject|0|||
105545185|NCT00927927|363996249|FG011|Overall Study|Withdrawal by Subject|2|||
105545186|NCT00927927|363996250|FG012|Overall Study|Withdrawal by Subject|0|||
105545187|NCT00927927|363996251|FG013|Overall Study|Withdrawal by Subject|0|||
105545188|NCT00927927|363996252|FG014|Overall Study|Withdrawal by Subject|0|||
105545189|NCT01312467|363996253|FG000|Overall Study|Adverse Event|4|||
105545190|NCT01312467|363996253|FG000|Overall Study|Lost to Follow-up|1|||
105545191|NCT01312467|363996253|FG000|Overall Study|Withdrawal by Subject|2|||
105545192|NCT01312467|363996253|FG000|Overall Study|Deported to country of origin|1|||
105545193|NCT01312467|363996253|FG000|Overall Study|Another medical condition|1|||
105545194|NCT01312467|363996253|FG000|Overall Study|Ineligible|4|||
105545195|NCT04452344|363996254|FG000|Overall Study|Withdrawal by Subject|3|||
105545196|NCT04452344|363996255|FG001|Overall Study|Withdrawal by Subject|6|||
105545197|NCT04452344|363996254|FG000|Overall Study|Adverse Event|1|||
105545198|NCT04452344|363996255|FG001|Overall Study|Adverse Event|2|||
105545199|NCT04452344|363996254|FG000|Overall Study|Lost to Follow-up|2|||
105545200|NCT04452344|363996255|FG001|Overall Study|Lost to Follow-up|2|||
105545201|NCT04452344|363996254|FG000|Overall Study|No Post-Op Visit|6|||
105545202|NCT04452344|363996255|FG001|Overall Study|No Post-Op Visit|7|||
105545203|NCT03823651|363996259|FG000|Overall Study|Death|5|||
105545204|NCT03823651|363996260|FG001|Overall Study|Death|0|||
105545205|NCT03823651|363996259|FG000|Overall Study|Physician Decision|1|||
105545206|NCT03823651|363996260|FG001|Overall Study|Physician Decision|0|||
105545207|NCT03823651|363996259|FG000|Overall Study|Caregiver to patient who died|0|||
105545208|NCT03823651|363996260|FG001|Overall Study|Caregiver to patient who died|5|||
105545209|NCT03823651|363996259|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
105545210|NCT03823651|363996260|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
105545211|NCT00608829|363998563|FG000|Overall Study|Death|6|||
105545212|NCT00608829|363998563|FG000|Overall Study|Withdrawal by Subject|4|||
105545213|NCT00608829|363998563|FG000|Overall Study|Subject refuses to follow up or return.|5|||
105545214|NCT00274716|363998568|FG000|Phase A|Other non-reported reason|4|||
105545215|NCT00274716|363998569|FG001|Phase A|Other non-reported reason|2|||
105545216|NCT00274716|363998570|FG002|Phase A|Other non-reported reason|1|||
105545217|NCT00274716|363998571|FG003|Phase A|Other non-reported reason|2|||
105545218|NCT00274716|363998572|FG004|Phase A|Other non-reported reason|0|||
105545219|NCT00274716|363998573|FG005|Phase A|Other non-reported reason|1|||
105545220|NCT00274716|363998568|FG000|Phase A|Participant moved|0|||
105545221|NCT00274716|363998569|FG001|Phase A|Participant moved|0|||
105545222|NCT00274716|363998570|FG002|Phase A|Participant moved|1|||
105545223|NCT00274716|363998571|FG003|Phase A|Participant moved|0|||
105545224|NCT00274716|363998572|FG004|Phase A|Participant moved|0|||
105545225|NCT00274716|363998573|FG005|Phase A|Participant moved|1|||
105545226|NCT00274716|363998568|FG000|Phase A|Site Terminated|0|||
105545227|NCT00274716|363998569|FG001|Phase A|Site Terminated|0|||
105545228|NCT00274716|363998570|FG002|Phase A|Site Terminated|0|||
105545229|NCT00274716|363998571|FG003|Phase A|Site Terminated|1|||
105545230|NCT00274716|363998572|FG004|Phase A|Site Terminated|0|||
105545231|NCT00274716|363998573|FG005|Phase A|Site Terminated|0|||
105545232|NCT00274716|363998568|FG000|Phase A|Protocol Violation|1|||
105545233|NCT00274716|363998569|FG001|Phase A|Protocol Violation|0|||
105545234|NCT00274716|363998570|FG002|Phase A|Protocol Violation|0|||
105545235|NCT00274716|363998571|FG003|Phase A|Protocol Violation|1|||
105545236|NCT00274716|363998572|FG004|Phase A|Protocol Violation|0|||
105545237|NCT00274716|363998573|FG005|Phase A|Protocol Violation|0|||
105545238|NCT00274716|363998568|FG000|Phase A|Met criteria for discontinuation|1|||
105545239|NCT00274716|363998569|FG001|Phase A|Met criteria for discontinuation|1|||
105545240|NCT00274716|363998570|FG002|Phase A|Met criteria for discontinuation|0|||
105545241|NCT00274716|363998571|FG003|Phase A|Met criteria for discontinuation|0|||
105545242|NCT00274716|363998572|FG004|Phase A|Met criteria for discontinuation|0|||
105545243|NCT00274716|363998573|FG005|Phase A|Met criteria for discontinuation|0|||
105545244|NCT00274716|363998568|FG000|Phase A|Withdrawal by Subject|2|||
105545245|NCT00274716|363998569|FG001|Phase A|Withdrawal by Subject|2|||
105545246|NCT00274716|363998570|FG002|Phase A|Withdrawal by Subject|1|||
105545247|NCT00274716|363998571|FG003|Phase A|Withdrawal by Subject|3|||
105545248|NCT00274716|363998572|FG004|Phase A|Withdrawal by Subject|0|||
105545249|NCT00274716|363998573|FG005|Phase A|Withdrawal by Subject|1|||
105545250|NCT00274716|363998568|FG000|Phase A|Adverse Event|2|||
105545251|NCT00274716|363998569|FG001|Phase A|Adverse Event|3|||
105545252|NCT00274716|363998570|FG002|Phase A|Adverse Event|3|||
105545253|NCT00274716|363998571|FG003|Phase A|Adverse Event|0|||
105545254|NCT00274716|363998572|FG004|Phase A|Adverse Event|2|||
105545255|NCT00274716|363998573|FG005|Phase A|Adverse Event|0|||
105545256|NCT00274716|363998568|FG000|Phase A|Completed but did not enter Phase B|1|||
105545257|NCT00274716|363998569|FG001|Phase A|Completed but did not enter Phase B|2|||
105545258|NCT00274716|363998570|FG002|Phase A|Completed but did not enter Phase B|2|||
105545259|NCT00274716|363998571|FG003|Phase A|Completed but did not enter Phase B|2|||
105545260|NCT00274716|363998572|FG004|Phase A|Completed but did not enter Phase B|1|||
105545261|NCT00274716|363998573|FG005|Phase A|Completed but did not enter Phase B|1|||
105545262|NCT00274716|363998568|FG000|Phase B|Adverse Event|0|||
105545263|NCT00274716|363998569|FG001|Phase B|Adverse Event|0|||
105545264|NCT00274716|363998570|FG002|Phase B|Adverse Event|2|||
105545265|NCT00274716|363998571|FG003|Phase B|Adverse Event|0|||
105545266|NCT00274716|363998572|FG004|Phase B|Adverse Event|0|||
105545267|NCT00274716|363998573|FG005|Phase B|Adverse Event|1|||
105545268|NCT00274716|363998568|FG000|Phase B|Protocol Violation|0|||
105545269|NCT00274716|363998569|FG001|Phase B|Protocol Violation|2|||
105545270|NCT00274716|363998570|FG002|Phase B|Protocol Violation|0|||
105545271|NCT00274716|363998571|FG003|Phase B|Protocol Violation|0|||
105545272|NCT00274716|363998572|FG004|Phase B|Protocol Violation|0|||
105545273|NCT00274716|363998573|FG005|Phase B|Protocol Violation|0|||
105545274|NCT00274716|363998568|FG000|Phase B|Withdrawal by Subject|0|||
105545275|NCT00274716|363998569|FG001|Phase B|Withdrawal by Subject|1|||
105545276|NCT00274716|363998570|FG002|Phase B|Withdrawal by Subject|0|||
105545277|NCT00274716|363998571|FG003|Phase B|Withdrawal by Subject|0|||
105545278|NCT00274716|363998572|FG004|Phase B|Withdrawal by Subject|0|||
105545279|NCT00274716|363998573|FG005|Phase B|Withdrawal by Subject|0|||
105545280|NCT00274716|363998568|FG000|Phase B|Participant moved|1|||
105545281|NCT00274716|363998569|FG001|Phase B|Participant moved|0|||
105545282|NCT00274716|363998570|FG002|Phase B|Participant moved|0|||
105545283|NCT00274716|363998571|FG003|Phase B|Participant moved|0|||
105545284|NCT00274716|363998572|FG004|Phase B|Participant moved|0|||
105545285|NCT00274716|363998573|FG005|Phase B|Participant moved|0|||
105545286|NCT00274716|363998568|FG000|Phase B|Other non-reported reason|0|||
105545287|NCT00274716|363998569|FG001|Phase B|Other non-reported reason|0|||
105545288|NCT00274716|363998570|FG002|Phase B|Other non-reported reason|1|||
105545289|NCT00274716|363998571|FG003|Phase B|Other non-reported reason|1|||
105545290|NCT00274716|363998572|FG004|Phase B|Other non-reported reason|0|||
105545291|NCT00274716|363998573|FG005|Phase B|Other non-reported reason|0|||
105545292|NCT00274716|363998568|FG000|Phase B|Lost to Follow-up|0|||
105545293|NCT00274716|363998569|FG001|Phase B|Lost to Follow-up|1|||
105545294|NCT00274716|363998570|FG002|Phase B|Lost to Follow-up|0|||
105545295|NCT00274716|363998571|FG003|Phase B|Lost to Follow-up|0|||
105545296|NCT00274716|363998572|FG004|Phase B|Lost to Follow-up|0|||
105545297|NCT00274716|363998573|FG005|Phase B|Lost to Follow-up|0|||
105545298|NCT04193202|363998574|FG000|Overall Study|Adverse Event|2|||
105545299|NCT04193202|363998575|FG001|Overall Study|Adverse Event|1|||
105545300|NCT04193202|363998574|FG000|Overall Study|Death|0|||
105545301|NCT04193202|363998575|FG001|Overall Study|Death|1|||
105545302|NCT04193202|363998574|FG000|Overall Study|Physician Decision|1|||
105545303|NCT04193202|363998575|FG001|Overall Study|Physician Decision|1|||
105545304|NCT04193202|363998574|FG000|Overall Study|Protocol Violation|2|||
105545305|NCT04193202|363998575|FG001|Overall Study|Protocol Violation|2|||
105545306|NCT04193202|363998574|FG000|Overall Study|Withdrawal by Subject|11|||
105545307|NCT04193202|363998575|FG001|Overall Study|Withdrawal by Subject|5|||
105545308|NCT00982020|363998577|FG000|Overall Study|Adverse Event|19|||
105545309|NCT00982020|363998578|FG001|Overall Study|Adverse Event|15|||
105545310|NCT00982020|363998577|FG000|Overall Study|Withdrawal by Subject|11|||
105545311|NCT00982020|363998578|FG001|Overall Study|Withdrawal by Subject|14|||
105545312|NCT00982020|363998577|FG000|Overall Study|Lost to Follow-up|5|||
105545313|NCT00982020|363998578|FG001|Overall Study|Lost to Follow-up|11|||
105545314|NCT00982020|363998577|FG000|Overall Study|Lack of Efficacy|10|||
105545315|NCT00982020|363998578|FG001|Overall Study|Lack of Efficacy|4|||
105545316|NCT00982020|363998577|FG000|Overall Study|Parent/Caregiver Decision|5|||
105545317|NCT00982020|363998578|FG001|Overall Study|Parent/Caregiver Decision|5|||
105545318|NCT00982020|363998577|FG000|Overall Study|Treatment Non-compliance|3|||
105545319|NCT00982020|363998578|FG001|Overall Study|Treatment Non-compliance|6|||
105545320|NCT00982020|363998577|FG000|Overall Study|Physician Decision|2|||
105545321|NCT00982020|363998578|FG001|Overall Study|Physician Decision|5|||
105545322|NCT00982020|363998577|FG000|Overall Study|Entry Criteria Not Met|2|||
105545323|NCT00982020|363998578|FG001|Overall Study|Entry Criteria Not Met|1|||
105545324|NCT00982020|363998577|FG000|Overall Study|Protocol Violation|0|||
105545325|NCT00982020|363998578|FG001|Overall Study|Protocol Violation|2|||
105545326|NCT00982020|363998577|FG000|Overall Study|Clinical Relapse|0|||
105545327|NCT00982020|363998578|FG001|Overall Study|Clinical Relapse|1|||
105545328|NCT02039505|363998579|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
105545329|NCT02039505|363998580|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
105545330|NCT02039505|363998581|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
105545331|NCT02039505|363998582|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
105545332|NCT02039505|363998583|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
105545333|NCT02039505|363998584|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
105545334|NCT02039505|363998585|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
105545335|NCT02039505|363998579|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
105545336|NCT02039505|363998580|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
105545337|NCT02039505|363998581|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
105545338|NCT02039505|363998582|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
105545339|NCT02039505|363998583|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
105545340|NCT02039505|363998584|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
105545341|NCT02039505|363998585|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
105545342|NCT02039505|363998579|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
105545343|NCT02039505|363998580|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
105545344|NCT02039505|363998581|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
105545345|NCT02039505|363998582|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
105545346|NCT02039505|363998583|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
105545347|NCT02039505|363998584|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
105545348|NCT02039505|363998585|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
105545349|NCT02039505|363998579|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
105545350|NCT02039505|363998580|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
105545351|NCT02039505|363998581|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
105545352|NCT02039505|363998582|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
105545353|NCT02039505|363998583|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
105545354|NCT02039505|363998584|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
105545355|NCT02039505|363998585|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
105545356|NCT02039505|363998579|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
105545357|NCT02039505|363998580|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
105545358|NCT02039505|363998581|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
105545359|NCT02039505|363998582|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
105545360|NCT02039505|363998583|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
105545361|NCT02039505|363998584|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
105545362|NCT02039505|363998585|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
105545363|NCT02039505|363998579|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
105545364|NCT02039505|363998580|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
105545365|NCT02039505|363998581|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
105545366|NCT02039505|363998582|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
105545367|NCT02039505|363998583|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
105545368|NCT02039505|363998584|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
105545369|NCT02039505|363998585|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
105545370|NCT02039505|363998579|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
105545371|NCT02039505|363998580|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
105545372|NCT02039505|363998581|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
105545373|NCT02039505|363998582|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
105545374|NCT02039505|363998583|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
105545375|NCT02039505|363998584|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
105545376|NCT02039505|363998585|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
105545377|NCT02039505|363998579|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
105545378|NCT02039505|363998580|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
105545379|NCT02039505|363998581|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
105545380|NCT02039505|363998582|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
105545381|NCT02039505|363998583|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
105545382|NCT02039505|363998584|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
105545383|NCT02039505|363998585|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
105545384|NCT02039505|363998579|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
105545385|NCT02039505|363998580|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
105545386|NCT02039505|363998581|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
105545387|NCT02039505|363998582|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
105545388|NCT02039505|363998583|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
105545389|NCT02039505|363998584|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
105545390|NCT02039505|363998585|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
105545391|NCT02039505|363998579|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
105545392|NCT02039505|363998580|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
105545393|NCT02039505|363998581|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
105545394|NCT02039505|363998582|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
105545395|NCT02039505|363998583|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
105545396|NCT02039505|363998584|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
105545397|NCT02039505|363998585|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
105545398|NCT02039505|363998579|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
105545399|NCT02039505|363998580|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
105545400|NCT02039505|363998581|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
105545401|NCT02039505|363998582|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
105545402|NCT02039505|363998583|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
105545403|NCT02039505|363998584|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
105545404|NCT02039505|363998585|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
105545405|NCT00262834|363998586|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
105545406|NCT00262834|363998587|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
105545407|NCT00086346|363998590|FG000|Randomization|Did not receive test article|4|||
105545408|NCT00086346|363998591|FG001|Randomization|Did not receive test article|4|||
105545409|NCT00086346|363998590|FG000|Patients Dosed With Test Article|Adverse Event|94|||
105545410|NCT00086346|363998591|FG001|Patients Dosed With Test Article|Adverse Event|11|||
105596003|NCT01400776|364184089|FG000|Overall Study|Protocol Deviation|6|||
105596004|NCT01400776|364184090|FG001|Overall Study|Protocol Deviation|1|||
105545411|NCT00086346|363998590|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
105545412|NCT00086346|363998591|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
105545413|NCT00086346|363998590|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
105545414|NCT00086346|363998591|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
105545415|NCT00086346|363998590|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
105545416|NCT00086346|363998591|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
105545417|NCT00086346|363998590|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
105545418|NCT00086346|363998591|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
105545419|NCT00086346|363998590|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
105545420|NCT00086346|363998591|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
105545421|NCT00353704|363998592|FG000|Overall Study|Protocol Violation|3|||
105545422|NCT00353704|363998593|FG001|Overall Study|Protocol Violation|1|||
105545423|NCT01172938|363998594|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
105545424|NCT01172938|363998595|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
105545425|NCT01172938|363998596|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
105545426|NCT01172938|363998597|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105545427|NCT01172938|363998598|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105545428|NCT01172938|363998599|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105545429|NCT01172938|363998600|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105545430|NCT01172938|363998601|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105545431|NCT01172938|363998602|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105545432|NCT01172938|363998594|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
105545433|NCT01172938|363998595|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
105545434|NCT01172938|363998596|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
105545435|NCT01172938|363998597|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105545436|NCT01172938|363998598|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105545437|NCT01172938|363998599|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105545438|NCT01172938|363998600|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105545439|NCT01172938|363998601|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105545440|NCT01172938|363998602|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105545441|NCT01172938|363998594|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105545442|NCT01172938|363998595|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
105545443|NCT01172938|363998596|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
105545444|NCT01172938|363998597|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105545445|NCT01172938|363998598|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105545446|NCT01172938|363998599|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105545447|NCT01172938|363998600|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105545448|NCT01172938|363998601|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105545449|NCT01172938|363998602|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105545450|NCT01172938|363998594|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
105545451|NCT01172938|363998595|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
105545452|NCT01172938|363998596|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
105545453|NCT01172938|363998597|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105545454|NCT01172938|363998598|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105545455|NCT01172938|363998599|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105545456|NCT01172938|363998600|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105545457|NCT01172938|363998601|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105545458|NCT01172938|363998602|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105545459|NCT01172938|363998594|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
105545460|NCT01172938|363998595|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
105545461|NCT01172938|363998596|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
105545462|NCT01172938|363998597|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
105545463|NCT01172938|363998598|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
105545464|NCT01172938|363998599|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
105545465|NCT01172938|363998600|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
105545466|NCT01172938|363998601|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
105545467|NCT01172938|363998602|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
105545468|NCT01172938|363998594|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
105545469|NCT01172938|363998595|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105545470|NCT01172938|363998596|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105545471|NCT01172938|363998597|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105545472|NCT01172938|363998598|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105545473|NCT01172938|363998599|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105596005|NCT01400776|364184091|FG002|Overall Study|Protocol Deviation|5|||
105545474|NCT01172938|363998600|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105545475|NCT01172938|363998601|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105545476|NCT01172938|363998602|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105545477|NCT01172938|363998594|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
105545478|NCT01172938|363998595|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
105545479|NCT01172938|363998596|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
105545480|NCT01172938|363998597|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
105545481|NCT01172938|363998598|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
105545482|NCT01172938|363998599|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
105545483|NCT01172938|363998600|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
105545484|NCT01172938|363998601|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
105545485|NCT01172938|363998602|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
105545486|NCT01172938|363998594|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
105545487|NCT01172938|363998595|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
105545488|NCT01172938|363998596|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
105545489|NCT01172938|363998597|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
105545490|NCT01172938|363998598|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
105545491|NCT01172938|363998599|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
105545492|NCT01172938|363998600|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
105545493|NCT01172938|363998601|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
105545494|NCT01172938|363998602|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
105545495|NCT01172938|363998594|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
105545496|NCT01172938|363998595|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
105545497|NCT01172938|363998596|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
105545498|NCT01172938|363998597|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
105545499|NCT01172938|363998598|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
105545500|NCT01172938|363998599|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
105545501|NCT01172938|363998600|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
105545502|NCT01172938|363998601|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
105545503|NCT01172938|363998602|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
105545504|NCT01172938|363998594|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
105545505|NCT01172938|363998595|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
105545506|NCT01172938|363998596|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
105545507|NCT01172938|363998597|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
105545508|NCT01172938|363998598|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
105545509|NCT01172938|363998599|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
105545510|NCT01172938|363998600|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
105545511|NCT01172938|363998601|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
105545512|NCT01172938|363998602|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
105545513|NCT01172938|363998594|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
105545514|NCT01172938|363998595|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
105545515|NCT01172938|363998596|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
105545516|NCT01172938|363998597|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
105545517|NCT01172938|363998598|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
105545518|NCT01172938|363998599|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
105545519|NCT01172938|363998600|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
105545520|NCT01172938|363998601|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
105545521|NCT01172938|363998602|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
105545522|NCT01172938|363998594|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
105545523|NCT01172938|363998595|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
105545524|NCT01172938|363998596|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
105545525|NCT01172938|363998597|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
105545526|NCT01172938|363998598|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
105545527|NCT01172938|363998599|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
105545528|NCT01172938|363998600|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
105545529|NCT01172938|363998601|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
105545530|NCT01172938|363998602|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
105545531|NCT01172938|363998594|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
105545532|NCT01172938|363998595|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
105545533|NCT01172938|363998596|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
105545534|NCT01172938|363998597|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
105545535|NCT01172938|363998598|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
105545536|NCT01172938|363998599|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
105545537|NCT01172938|363998600|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
105596006|NCT01400776|364184092|FG003|Overall Study|Protocol Deviation|2|||
105596007|NCT01400776|364184089|FG000|Overall Study|Reason not Specified|3|||
105545538|NCT01172938|363998601|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
105545539|NCT01172938|363998602|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
105545540|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
105545541|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
105545542|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
105545543|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
105545544|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
105545545|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
105545546|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
105545547|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
105545548|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
105545549|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
105545550|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
105545551|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
105545552|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
105545553|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
105545554|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
105545555|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
105545556|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
105545557|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
105545558|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
105545559|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
105545560|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
105545561|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
105545562|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
105545563|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
105545564|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
105545565|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
105545566|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
105545567|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
105545568|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
105545569|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
105545570|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
105545571|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
105545572|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
105545573|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
105545574|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
105545575|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
105545576|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
105545577|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
105545578|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
105545579|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
105545580|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
105545581|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
105596008|NCT01400776|364184090|FG001|Overall Study|Reason not Specified|0|||
105545582|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
105545583|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
105545584|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
105545585|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
105545586|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
105545587|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
105596009|NCT01400776|364184091|FG002|Overall Study|Reason not Specified|4|||
105596010|NCT01400776|364184092|FG003|Overall Study|Reason not Specified|3|||
105545588|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
105545589|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
105545590|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
105545591|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
105545592|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
105545593|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
105545594|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
105545595|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
105596011|NCT01198275|364184093|FG000|Overall Study|Adverse Event|2|||
105596012|NCT01198275|364184094|FG001|Overall Study|Adverse Event|3|||
105596013|NCT01198275|364184093|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
105596014|NCT01198275|364184094|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
105545596|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
105545597|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
105545598|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
105545599|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
105545600|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
105545601|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
105545602|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
105545603|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
105545604|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
105545605|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
105545606|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
105545607|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
105545608|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
105545609|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
105545610|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
105545611|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
105545612|NCT01172938|363998594|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
105545613|NCT01172938|363998595|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
105545614|NCT01172938|363998596|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
105545615|NCT01172938|363998597|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
105545616|NCT01172938|363998598|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
105545617|NCT01172938|363998599|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
105545618|NCT01172938|363998600|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
105545619|NCT01172938|363998601|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
105545620|NCT01172938|363998602|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
105545621|NCT01172938|363998594|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
105545622|NCT01172938|363998595|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
105545623|NCT01172938|363998596|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
105545624|NCT01172938|363998597|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
105545625|NCT01172938|363998598|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
105545626|NCT01172938|363998599|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
105545627|NCT01172938|363998600|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
105545628|NCT01172938|363998601|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
105545629|NCT01172938|363998602|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
105545630|NCT01172938|363998594|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
105545631|NCT01172938|363998595|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
105545632|NCT01172938|363998596|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
105545633|NCT01172938|363998597|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
105545634|NCT01172938|363998598|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
105545635|NCT01172938|363998599|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
105545636|NCT01172938|363998600|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
105545637|NCT01172938|363998601|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
105545638|NCT01172938|363998602|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
105545639|NCT01172938|363998594|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
105545640|NCT01172938|363998595|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
105545641|NCT01172938|363998596|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
105545642|NCT01172938|363998597|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
105545643|NCT01172938|363998598|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
105545644|NCT01172938|363998599|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
105545645|NCT01172938|363998600|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
105545646|NCT01172938|363998601|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
105545647|NCT01172938|363998602|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
105545648|NCT01172938|363998594|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
105545649|NCT01172938|363998595|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
105545650|NCT01172938|363998596|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
105545651|NCT01172938|363998597|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
105596015|NCT00814346|364184101|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
105545652|NCT01172938|363998598|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
105545653|NCT01172938|363998599|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
105545654|NCT01172938|363998600|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
105545655|NCT01172938|363998601|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
105545656|NCT01172938|363998602|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
105545657|NCT01172938|363998594|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
105545658|NCT01172938|363998595|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
105545659|NCT01172938|363998596|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
105545660|NCT01172938|363998597|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
105545661|NCT01172938|363998598|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
105545662|NCT01172938|363998599|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
105545663|NCT01172938|363998600|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
105545664|NCT01172938|363998601|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
105545665|NCT01172938|363998602|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
105545666|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
105545667|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
105545668|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
105545669|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
105545670|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
105545671|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
105545672|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
105545673|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
105545674|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
105545675|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
105545676|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
105545677|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
105545678|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
105545679|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
105545680|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
105545681|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
105545682|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
105545683|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
105545684|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
105545685|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
105545686|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
105545687|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
105545688|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
105545689|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
105545690|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
105545691|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
105545692|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
105545693|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
105545694|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
105545695|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
105545696|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
105545697|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
105545698|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
105545699|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
105545700|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
105545701|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
105545702|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
105545703|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
105545704|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
105545705|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
105545706|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
105545707|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
105545708|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
105545709|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
105545710|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
105545711|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
105545712|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
105545713|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
105545714|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
105545715|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
105545716|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
105545717|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
105545718|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
105545719|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
105545720|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
105545721|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
105545722|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
105545723|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
105545724|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
105545725|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
105545726|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
105545727|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
105545728|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
105545729|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
105545730|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
105545731|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
105545732|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
105545733|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
105545734|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
105545735|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
105545736|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
105545737|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
105545738|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
105545739|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
105545740|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
105545741|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
105545742|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
105545743|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
105545744|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
105545745|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
105545746|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
105545747|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
105545748|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
105545749|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
105545750|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
105545751|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
105545752|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
105596016|NCT00814346|364184102|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
105596017|NCT00814346|364184101|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
105596018|NCT00814346|364184102|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
105596019|NCT00814346|364184101|FG000|Open Phase (17 Months)|Adverse Event|5|||
105596020|NCT00814346|364184102|FG001|Open Phase (17 Months)|Adverse Event|0|||
105596021|NCT00814346|364184101|FG000|Open Phase (17 Months)|Consent|2|||
105596022|NCT00814346|364184102|FG001|Open Phase (17 Months)|Consent|0|||
105596023|NCT00814346|364184101|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
105596024|NCT00814346|364184102|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
105596025|NCT00814346|364184101|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
105596026|NCT00814346|364184102|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
105596027|NCT02613871|364184104|FG000|Overall Study|Death|2|||
105596028|NCT02613871|364184104|FG000|Overall Study|Withdrew Consent|1|||
105596029|NCT01930045|364184105|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
105596030|NCT01930045|364184106|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
105596031|NCT01930045|364184107|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
105596032|NCT01930045|364184108|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
105596033|NCT01930045|364184109|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
105596034|NCT01930045|364184110|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
105596035|NCT01930045|364184105|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
105596036|NCT01930045|364184106|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
105596037|NCT01930045|364184107|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
105596038|NCT01930045|364184108|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
105596039|NCT01930045|364184109|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
105596040|NCT01930045|364184110|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
105596041|NCT01786564|364184111|FG000|Overall Study|Lost to Follow-up|47|||
105596042|NCT01786564|364184111|FG000|Overall Study|Ineligible|17|||
105596043|NCT00494442|364184112|FG000|Overall Study|Death|1|||
105596044|NCT00494442|364184113|FG001|Overall Study|Death|1|||
105596045|NCT00494442|364184112|FG000|Overall Study|Lack of Efficacy|16|||
105596046|NCT00494442|364184113|FG001|Overall Study|Lack of Efficacy|10|||
105596047|NCT00494442|364184112|FG000|Overall Study|Adverse Event|0|||
105596048|NCT00494442|364184113|FG001|Overall Study|Adverse Event|2|||
105596049|NCT00494442|364184112|FG000|Overall Study|Physician Decision|0|||
105596050|NCT00494442|364184113|FG001|Overall Study|Physician Decision|1|||
105596051|NCT00494442|364184112|FG000|Overall Study|Non-compliance|0|||
105596052|NCT00494442|364184113|FG001|Overall Study|Non-compliance|1|||
105596053|NCT00494442|364184112|FG000|Overall Study|Intercurrent illness|0|||
105545753|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
105545754|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
105545755|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
105545756|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
105596054|NCT00494442|364184113|FG001|Overall Study|Intercurrent illness|1|||
105545757|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
105545758|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
105545759|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
105545760|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
105545761|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
105545762|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
105545763|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
105545764|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
105545765|NCT01172938|363998594|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
105545766|NCT01172938|363998595|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
105545767|NCT01172938|363998596|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
105545768|NCT01172938|363998597|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
105545769|NCT01172938|363998598|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
105545770|NCT01172938|363998599|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
105545771|NCT01172938|363998600|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
105545772|NCT01172938|363998601|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
105545773|NCT01172938|363998602|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
105545774|NCT05282004|363998603|FG000|Overall Study|Adverse Event|2|||
105545775|NCT01992536|363998610|FG000|Overall Study|Administrative Reason|0|||
105545776|NCT01992536|363998611|FG001|Overall Study|Administrative Reason|0|||
105545777|NCT01992536|363998612|FG002|Overall Study|Administrative Reason|0|||
105545778|NCT01992536|363998613|FG003|Overall Study|Administrative Reason|0|||
105545779|NCT01992536|363998614|FG004|Overall Study|Administrative Reason|0|||
105545780|NCT01992536|363998615|FG005|Overall Study|Administrative Reason|0|||
105545781|NCT01992536|363998616|FG006|Overall Study|Administrative Reason|7|||
105545782|NCT01992536|363998617|FG007|Overall Study|Administrative Reason|0|||
105545783|NCT01992536|363998618|FG008|Overall Study|Administrative Reason|0|||
105545784|NCT01992536|363998619|FG009|Overall Study|Administrative Reason|0|||
105545785|NCT01992536|363998610|FG000|Overall Study|Lost to Follow-up|4|||
105545786|NCT01992536|363998611|FG001|Overall Study|Lost to Follow-up|2|||
105545787|NCT01992536|363998612|FG002|Overall Study|Lost to Follow-up|1|||
105545788|NCT01992536|363998613|FG003|Overall Study|Lost to Follow-up|0|||
105545789|NCT01992536|363998614|FG004|Overall Study|Lost to Follow-up|0|||
105545790|NCT01992536|363998615|FG005|Overall Study|Lost to Follow-up|1|||
105545791|NCT01992536|363998616|FG006|Overall Study|Lost to Follow-up|0|||
105545792|NCT01992536|363998617|FG007|Overall Study|Lost to Follow-up|0|||
105545793|NCT01992536|363998618|FG008|Overall Study|Lost to Follow-up|1|||
105545794|NCT01992536|363998619|FG009|Overall Study|Lost to Follow-up|1|||
105545795|NCT01992536|363998610|FG000|Overall Study|Withdrawal by Subject|0|||
105545796|NCT01992536|363998611|FG001|Overall Study|Withdrawal by Subject|1|||
105545797|NCT01992536|363998612|FG002|Overall Study|Withdrawal by Subject|0|||
105545798|NCT01992536|363998613|FG003|Overall Study|Withdrawal by Subject|2|||
105545799|NCT01992536|363998614|FG004|Overall Study|Withdrawal by Subject|0|||
105545800|NCT01992536|363998615|FG005|Overall Study|Withdrawal by Subject|0|||
105545801|NCT01992536|363998616|FG006|Overall Study|Withdrawal by Subject|0|||
105545802|NCT01992536|363998617|FG007|Overall Study|Withdrawal by Subject|0|||
105545803|NCT01992536|363998618|FG008|Overall Study|Withdrawal by Subject|0|||
105545804|NCT01992536|363998619|FG009|Overall Study|Withdrawal by Subject|0|||
105545805|NCT03224468|363998620|FG000|Overall Study|Did not obtain MM card|53|||
105545806|NCT03224468|363998621|FG001|Overall Study|Did not obtain MM card|0|||
105545807|NCT03224468|363998620|FG000|Overall Study|Lost to Follow-up|4|||
105545808|NCT03224468|363998621|FG001|Overall Study|Lost to Follow-up|11|||
105545809|NCT03224468|363998620|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
105545810|NCT03224468|363998621|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
105545811|NCT00889421|363998626|FG000|Overall Study|Lack of Efficacy|3|||
105545812|NCT00795600|363998627|FG000|Overall Study|Adverse Event|1|||
105545813|NCT00795600|363998628|FG001|Overall Study|Adverse Event|1|||
105545814|NCT00795600|363998627|FG000|Overall Study|Protocol Violation|1|||
105545815|NCT00795600|363998628|FG001|Overall Study|Protocol Violation|2|||
105545816|NCT00795600|363998627|FG000|Overall Study|Withdrawal by Subject|1|||
105545817|NCT00795600|363998628|FG001|Overall Study|Withdrawal by Subject|0|||
105545818|NCT00795600|363998627|FG000|Overall Study|Unclassified|1|||
105545819|NCT00795600|363998628|FG001|Overall Study|Unclassified|1|||
105545820|NCT02806986|363998637|FG000|Treatment Stage 1|Adverse Event|1|||
105545821|NCT02806986|363998637|FG000|Treatment Stage 2|Adverse Event|3|||
105545822|NCT02806986|363998637|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
105545823|NCT04443218|363998638|FG000|Overall Study|Exited study for other reasons|9|||
105545824|NCT04443218|363998638|FG000|Overall Study|Withdrawal by Subject|1|||
105545825|NCT04443218|363998638|FG000|Overall Study|Lost to Follow-up|4|||
105545826|NCT04443218|363998638|FG000|Overall Study|Death|19|||
105545827|NCT00383435|363998639|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
105545828|NCT00383435|363998640|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
105545829|NCT00383435|363998641|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
105545830|NCT00383435|363998642|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
105545831|NCT00383435|363998643|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
105545832|NCT00383435|363998639|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
105545833|NCT00383435|363998640|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
105545834|NCT00383435|363998641|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
105545835|NCT00383435|363998642|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
105545836|NCT00383435|363998643|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
105545837|NCT00383435|363998639|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
105545838|NCT00383435|363998640|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
105545839|NCT00383435|363998641|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
105545840|NCT00383435|363998642|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
105545841|NCT00383435|363998643|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
105545842|NCT00383435|363998639|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
105545843|NCT00383435|363998640|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
105545844|NCT00383435|363998641|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
105545845|NCT00383435|363998642|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
105545846|NCT00383435|363998643|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
105545847|NCT00383435|363998639|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
105545848|NCT00383435|363998640|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
105545849|NCT00383435|363998641|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
105545850|NCT00383435|363998642|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
105545851|NCT00383435|363998643|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
105545852|NCT00383435|363998639|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
105545853|NCT00383435|363998640|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
105545854|NCT00383435|363998641|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
105545855|NCT00383435|363998642|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
105545856|NCT00383435|363998643|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
105545857|NCT00383435|363998639|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
105545858|NCT00383435|363998640|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
105545859|NCT00383435|363998641|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
105545860|NCT00383435|363998642|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
105545861|NCT00383435|363998643|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
105545862|NCT00383435|363998639|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
105545863|NCT00383435|363998640|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
105545864|NCT00383435|363998641|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
105545865|NCT00383435|363998642|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
105545866|NCT00383435|363998643|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
105545867|NCT00383435|363998639|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
105545868|NCT00383435|363998640|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
105545869|NCT00383435|363998641|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
105545870|NCT00383435|363998642|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
105545871|NCT00383435|363998643|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
105545872|NCT00383435|363998639|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
105545873|NCT00383435|363998640|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
105545874|NCT00383435|363998641|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
105545875|NCT00383435|363998642|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
105545876|NCT00383435|363998643|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
105545877|NCT00383435|363998639|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
105545878|NCT00383435|363998640|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
105545879|NCT00383435|363998641|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
105545880|NCT00383435|363998642|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
105545881|NCT00383435|363998643|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
105545882|NCT00383435|363998639|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
105545883|NCT00383435|363998640|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
105545884|NCT00383435|363998641|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
105596055|NCT03804918|364184114|FG000|Overall Study|Participant did not use the app|1|||
105596056|NCT00813904|364184119|FG000|Overall Study|Death|1|||
105596057|NCT00964366|364184120|FG000|Overall Study|Did not qualify at Day 1|1|||
105596058|NCT00964366|364184121|FG001|Overall Study|Did not qualify at Day 1|0|||
105596059|NCT00964366|364184120|FG000|Overall Study|Withdrawal by Subject|0|||
105596060|NCT00964366|364184121|FG001|Overall Study|Withdrawal by Subject|1|||
105596061|NCT04842604|364184122|FG000|Overall Study|Death|1|||
105596062|NCT04842604|364184123|FG001|Overall Study|Death|0|||
105596063|NCT04842604|364184122|FG000|Overall Study|Other|4|||
105596064|NCT04842604|364184123|FG001|Overall Study|Other|4|||
105545885|NCT00383435|363998642|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
105545886|NCT00383435|363998643|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
105545887|NCT00383435|363998639|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
105545888|NCT00383435|363998640|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
105545889|NCT00383435|363998641|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
105545890|NCT00383435|363998642|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
105545891|NCT00383435|363998643|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
105545892|NCT00383435|363998639|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
105545893|NCT00383435|363998640|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
105545894|NCT00383435|363998641|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
105545895|NCT00383435|363998642|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
105545896|NCT00383435|363998643|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
105545897|NCT00383435|363998639|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
105545898|NCT00383435|363998640|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
105545899|NCT00383435|363998641|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
105545900|NCT00383435|363998642|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
105545901|NCT00383435|363998643|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
105545902|NCT00383435|363998639|FG000|26-Week Treatment Safety Extension|Administrative|1|||
105545903|NCT00383435|363998640|FG001|26-Week Treatment Safety Extension|Administrative|1|||
105545904|NCT00383435|363998641|FG002|26-Week Treatment Safety Extension|Administrative|0|||
105545905|NCT00383435|363998642|FG003|26-Week Treatment Safety Extension|Administrative|1|||
105545906|NCT00383435|363998643|FG004|26-Week Treatment Safety Extension|Administrative|0|||
105545907|NCT01255358|363998650|FG000|Overall Study|Adverse Event|2|||
105545908|NCT01255358|363998650|FG000|Overall Study|Protocol Violation|2|||
105545909|NCT04079933|363998651|FG000|Overall Study|Withdrawal by Subject|3|||
105545910|NCT04079933|363998652|FG001|Overall Study|Withdrawal by Subject|4|||
105545911|NCT04079933|363998651|FG000|Overall Study|Lost to Follow-up|0|||
105545912|NCT04079933|363998652|FG001|Overall Study|Lost to Follow-up|1|||
105545913|NCT04788147|363998653|FG000|Overall Study|Screen Failure|3|||
105545914|NCT04788147|363998654|FG001|Overall Study|Screen Failure|10|||
105545915|NCT04788147|363998653|FG000|Overall Study|Incomplete RMRS image session|2|||
105545916|NCT04788147|363998654|FG001|Overall Study|Incomplete RMRS image session|0|||
105545917|NCT03231371|363998656|FG000|Overall Study|Withdrawal by Subject|1|||
105545918|NCT03231371|363998656|FG000|Overall Study|chose or were ineligible to have MRI|12|||
105545919|NCT00345579|363998657|FG000|Overall Study|Adverse Event|9|||
105545920|NCT00345579|363998658|FG001|Overall Study|Adverse Event|6|||
105545921|NCT00345579|363998657|FG000|Overall Study|Protocol Violation|14|||
105545922|NCT00345579|363998658|FG001|Overall Study|Protocol Violation|5|||
105545923|NCT00345579|363998657|FG000|Overall Study|Withdrawal by Subject|50|||
105545924|NCT00345579|363998658|FG001|Overall Study|Withdrawal by Subject|17|||
105545925|NCT00345579|363998657|FG000|Overall Study|Lost to Follow-up|82|||
105545926|NCT00345579|363998658|FG001|Overall Study|Lost to Follow-up|36|||
105545927|NCT00345579|363998657|FG000|Overall Study|Other|9|||
105545928|NCT00345579|363998658|FG001|Overall Study|Other|1|||
105545929|NCT00413413|363998659|FG000|Single-Blind|Adverse Event|0|||
105545930|NCT00413413|363998660|FG001|Single-Blind|Adverse Event|9|||
105545931|NCT00413413|363998661|FG002|Single-Blind|Adverse Event|0|||
105545932|NCT00413413|363998659|FG000|Single-Blind|Lack of Efficacy|0|||
105545933|NCT00413413|363998660|FG001|Single-Blind|Lack of Efficacy|5|||
105545934|NCT00413413|363998661|FG002|Single-Blind|Lack of Efficacy|0|||
105545935|NCT00413413|363998659|FG000|Single-Blind|Subject no longer requires study drug|0|||
105545936|NCT00413413|363998660|FG001|Single-Blind|Subject no longer requires study drug|151|||
105545937|NCT00413413|363998661|FG002|Single-Blind|Subject no longer requires study drug|0|||
105545938|NCT00413413|363998659|FG000|Single-Blind|Protocol Violation|0|||
105545939|NCT00413413|363998660|FG001|Single-Blind|Protocol Violation|16|||
105545940|NCT00413413|363998661|FG002|Single-Blind|Protocol Violation|0|||
105545941|NCT00413413|363998659|FG000|Single-Blind|Withdrawal by Subject|0|||
105545942|NCT00413413|363998660|FG001|Single-Blind|Withdrawal by Subject|27|||
105545943|NCT00413413|363998661|FG002|Single-Blind|Withdrawal by Subject|0|||
105545944|NCT00413413|363998659|FG000|Single-Blind|Lost to Follow-up|0|||
105545945|NCT00413413|363998660|FG001|Single-Blind|Lost to Follow-up|8|||
105545946|NCT00413413|363998661|FG002|Single-Blind|Lost to Follow-up|0|||
105545947|NCT00413413|363998659|FG000|Double-Blind|Adverse Event|6|||
105545948|NCT00413413|363998660|FG001|Double-Blind|Adverse Event|0|||
105545949|NCT00413413|363998661|FG002|Double-Blind|Adverse Event|5|||
105545950|NCT00413413|363998659|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
105545951|NCT00413413|363998660|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
105545952|NCT00413413|363998661|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
105545953|NCT00413413|363998659|FG000|Double-Blind|Protocol deviation|1|||
105545954|NCT00413413|363998660|FG001|Double-Blind|Protocol deviation|2|||
105545955|NCT00413413|363998661|FG002|Double-Blind|Protocol deviation|1|||
105545956|NCT00413413|363998659|FG000|Double-Blind|Subject withdrew consent|4|||
105545957|NCT00413413|363998660|FG001|Double-Blind|Subject withdrew consent|6|||
105545958|NCT00413413|363998661|FG002|Double-Blind|Subject withdrew consent|9|||
105545959|NCT00413413|363998659|FG000|Double-Blind|Lost to Follow-up|3|||
105545960|NCT00413413|363998660|FG001|Double-Blind|Lost to Follow-up|4|||
105545961|NCT00413413|363998661|FG002|Double-Blind|Lost to Follow-up|2|||
105545962|NCT02673697|363998662|FG000|Overall Study|Adverse Event|2|||
105545963|NCT02673697|363998663|FG001|Overall Study|Adverse Event|0|||
105545964|NCT02673697|363998662|FG000|Overall Study|Death|32|||
105545965|NCT02673697|363998663|FG001|Overall Study|Death|24|||
105545966|NCT02673697|363998662|FG000|Overall Study|Lost to Follow-up|5|||
105545967|NCT02673697|363998663|FG001|Overall Study|Lost to Follow-up|2|||
105545968|NCT02673697|363998662|FG000|Overall Study|Physician Decision|2|||
105545969|NCT02673697|363998663|FG001|Overall Study|Physician Decision|1|||
105545970|NCT02673697|363998662|FG000|Overall Study|Withdrawal by Subject|10|||
105545971|NCT02673697|363998663|FG001|Overall Study|Withdrawal by Subject|7|||
105545972|NCT02673697|363998662|FG000|Overall Study|Change subj medical status|1|||
105545973|NCT02673697|363998663|FG001|Overall Study|Change subj medical status|2|||
105545974|NCT02673697|363998662|FG000|Overall Study|Explant|10|||
105545975|NCT02673697|363998663|FG001|Overall Study|Explant|5|||
105545976|NCT02673697|363998662|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
105545977|NCT02673697|363998663|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
105545978|NCT02604589|363998664|FG000|Overall Study|catheter dislodgement|0|||
105545979|NCT02604589|363998665|FG001|Overall Study|catheter dislodgement|0|||
105545980|NCT02604589|363998666|FG002|Overall Study|catheter dislodgement|1|||
105545981|NCT05061446|363998671|FG000|Overall Study|Adverse Event|2|||
105545982|NCT05061446|363998672|FG001|Overall Study|Adverse Event|0|||
105545983|NCT05061446|363998673|FG002|Overall Study|Adverse Event|0|||
105545984|NCT05061446|363998671|FG000|Overall Study|Participant no longer available due to personal reason|0|||
105545985|NCT05061446|363998672|FG001|Overall Study|Participant no longer available due to personal reason|1|||
105545986|NCT05061446|363998673|FG002|Overall Study|Participant no longer available due to personal reason|0|||
105545987|NCT04111497|363998674|FG000|Overall Study|relapse of primary disease|1|||
105545988|NCT04111497|363998674|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
105545989|NCT03880578|363998675|FG000|Overall Study|Withdrawal by Subject|0|||
105545990|NCT03880578|363998676|FG001|Overall Study|Withdrawal by Subject|3|||
105545991|NCT03880578|363998677|FG002|Overall Study|Withdrawal by Subject|1|||
105545992|NCT03880578|363998675|FG000|Overall Study|Death|0|||
105545993|NCT03880578|363998676|FG001|Overall Study|Death|1|||
105545994|NCT03880578|363998677|FG002|Overall Study|Death|0|||
105545995|NCT02056301|363998678|FG000|Overall Study|Protocol Violation|1|||
105545996|NCT02056301|363998679|FG001|Overall Study|Protocol Violation|2|||
105545997|NCT02056301|363998678|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
105545998|NCT02056301|363998679|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
105545999|NCT02056301|363998678|FG000|Overall Study|Withdrawal by Subject|0|||
105546000|NCT02056301|363998679|FG001|Overall Study|Withdrawal by Subject|1|||
105546001|NCT02056301|363998678|FG000|Overall Study|Issues with epidural|0|||
105546002|NCT02056301|363998679|FG001|Overall Study|Issues with epidural|3|||
105546003|NCT02209324|363998680|FG000|Overall Study|Adverse Event|2|||
105546004|NCT02209324|363998680|FG000|Overall Study|Lack of Efficacy|1|||
105546005|NCT02209324|363998680|FG000|Overall Study|Lost to Follow-up|1|||
105546006|NCT02209324|363998680|FG000|Overall Study|Physician Decision|3|||
105546007|NCT02209324|363998680|FG000|Overall Study|Protocol Violation|14|||
105546008|NCT02209324|363998680|FG000|Overall Study|Withdrawal by Subject|8|||
105546009|NCT02209324|363998680|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
105546010|NCT02209324|363998680|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
105546011|NCT02209324|363998680|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
105546012|NCT05799495|363998681|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
105546013|NCT05799495|363998682|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
105546014|NCT05799495|363998683|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
105546015|NCT05799495|363998684|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
105546016|NCT05799495|363998681|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
105546017|NCT05799495|363998682|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
105546018|NCT05799495|363998683|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
105546019|NCT05799495|363998684|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
105546020|NCT05799495|363998681|FG000|Treatment (Up to 5 Days)|Other|0|||
105546021|NCT05799495|363998682|FG001|Treatment (Up to 5 Days)|Other|1|||
105546022|NCT05799495|363998683|FG002|Treatment (Up to 5 Days)|Other|0|||
105546023|NCT05799495|363998684|FG003|Treatment (Up to 5 Days)|Other|0|||
105546024|NCT05799495|363998681|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
105546025|NCT05799495|363998682|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
105546026|NCT05799495|363998683|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
105546027|NCT05799495|363998684|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
105546028|NCT05799495|363998681|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
105546029|NCT05799495|363998682|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
105546030|NCT05799495|363998683|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
105546031|NCT05799495|363998684|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
105546032|NCT05799495|363998681|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
105546033|NCT05799495|363998682|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
105546034|NCT05799495|363998683|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
105546035|NCT05799495|363998684|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
105546036|NCT01198600|363998685|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
105546037|NCT01198600|363998686|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
105546038|NCT01198600|363998687|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
105546039|NCT01198600|363998688|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
105546040|NCT01198600|363998685|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
105546041|NCT01198600|363998686|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
105546042|NCT01198600|363998687|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
105546043|NCT01198600|363998688|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
105546044|NCT01198600|363998685|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
105546045|NCT01198600|363998686|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
105546046|NCT01198600|363998687|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
105546047|NCT01198600|363998688|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
105546048|NCT01198600|363998685|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
105546049|NCT01198600|363998686|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
105546050|NCT01198600|363998687|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
105546051|NCT01198600|363998688|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
105546052|NCT01198600|363998685|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
105546053|NCT01198600|363998686|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
105546054|NCT01198600|363998687|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
105546055|NCT01198600|363998688|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
105546056|NCT01198600|363998685|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
105546057|NCT01198600|363998686|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
105546058|NCT01198600|363998687|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
105546059|NCT01198600|363998688|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
105546060|NCT01198600|363998685|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
105546061|NCT01198600|363998686|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
105546062|NCT01198600|363998687|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
105546063|NCT01198600|363998688|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
105546064|NCT03694548|363998689|FG000|Part A Survey|Protocol Violation|3|||
105546065|NCT03694548|363998690|FG001|Part A Survey|Protocol Violation|3|||
105546066|NCT03694548|363998691|FG002|Part A Survey|Protocol Violation|0|||
105546067|NCT03694548|363998689|FG000|Part B Yoga Program|Protocol Violation|0|||
105546068|NCT03694548|363998690|FG001|Part B Yoga Program|Protocol Violation|0|||
105546069|NCT03694548|363998691|FG002|Part B Yoga Program|Protocol Violation|3|||
105546070|NCT03694548|363998689|FG000|Part B Yoga Program|Did not attend intervention|0|||
105546071|NCT03694548|363998690|FG001|Part B Yoga Program|Did not attend intervention|0|||
105546072|NCT03694548|363998691|FG002|Part B Yoga Program|Did not attend intervention|8|||
105546073|NCT04496258|363998693|FG000|Overall Study|Withdrawal by Subject|2|||
105546074|NCT04496258|363998694|FG001|Overall Study|Withdrawal by Subject|1|||
105546075|NCT00439777|363998695|FG000|Treatment Period|Death|29|||
105546076|NCT00439777|363998696|FG001|Treatment Period|Death|21|||
105546077|NCT00439777|363998695|FG000|Treatment Period|Study terminated by sponsor|125|||
105546078|NCT00439777|363998696|FG001|Treatment Period|Study terminated by sponsor|132|||
105546079|NCT00439777|363998695|FG000|Treatment Period|Site closed by investigator|0|||
105546080|NCT00439777|363998696|FG001|Treatment Period|Site closed by investigator|1|||
105546081|NCT00439777|363998695|FG000|Treatment Period|Did not take study treatment|7|||
105546082|NCT00439777|363998696|FG001|Treatment Period|Did not take study treatment|8|||
105546083|NCT00439777|363998695|FG000|Treatment Period|Adverse Event|111|||
105546084|NCT00439777|363998696|FG001|Treatment Period|Adverse Event|92|||
105546085|NCT00439777|363998695|FG000|Treatment Period|Protocol Violation|23|||
105546086|NCT00439777|363998696|FG001|Treatment Period|Protocol Violation|30|||
105546087|NCT00439777|363998695|FG000|Treatment Period|Withdrawal by Subject|66|||
105546088|NCT00439777|363998696|FG001|Treatment Period|Withdrawal by Subject|118|||
105546089|NCT00439777|363998695|FG000|Treatment Period|Lack of Efficacy|1|||
105546090|NCT00439777|363998696|FG001|Treatment Period|Lack of Efficacy|4|||
105546091|NCT00439777|363998695|FG000|Treatment Period|Lost to Follow-up|8|||
105546092|NCT00439777|363998696|FG001|Treatment Period|Lost to Follow-up|10|||
105546093|NCT00439777|363998695|FG000|Treatment Period|Protocol driven decision point|1|||
105546094|NCT00439777|363998696|FG001|Treatment Period|Protocol driven decision point|3|||
105546095|NCT00439777|363998695|FG000|Treatment Period|Physician Decision|7|||
105546096|NCT00439777|363998696|FG001|Treatment Period|Physician Decision|18|||
105546097|NCT00439777|363998695|FG000|Treatment Period|Clinical endpoint reached|26|||
105546098|NCT00439777|363998696|FG001|Treatment Period|Clinical endpoint reached|13|||
105546099|NCT00439777|363998695|FG000|Treatment Period|Technical problems|3|||
105546100|NCT00439777|363998696|FG001|Treatment Period|Technical problems|1|||
105546101|NCT00439777|363998695|FG000|Treatment Period|Participant convenience|12|||
105546102|NCT00439777|363998696|FG001|Treatment Period|Participant convenience|8|||
105546103|NCT00439777|363998695|FG000|Observational Period|Protocol Violation|0|||
105546104|NCT00439777|363998696|FG001|Observational Period|Protocol Violation|2|||
105546105|NCT00439777|363998695|FG000|Observational Period|Withdrawal by Subject|9|||
105546106|NCT00439777|363998696|FG001|Observational Period|Withdrawal by Subject|5|||
105546107|NCT00439777|363998695|FG000|Observational Period|Lost to Follow-up|1|||
105546108|NCT00439777|363998696|FG001|Observational Period|Lost to Follow-up|11|||
105546109|NCT00439777|363998695|FG000|Observational Period|Death|27|||
105546110|NCT00439777|363998696|FG001|Observational Period|Death|20|||
105546111|NCT00439777|363998695|FG000|Observational Period|Study terminated by sponsor|3|||
105546112|NCT00439777|363998696|FG001|Observational Period|Study terminated by sponsor|1|||
105546113|NCT00439777|363998695|FG000|Observational Period|Protocol driven decision point|0|||
105546114|NCT00439777|363998696|FG001|Observational Period|Protocol driven decision point|1|||
105546115|NCT00439777|363998695|FG000|Observational Period|Lack of Efficacy|1|||
105546116|NCT00439777|363998696|FG001|Observational Period|Lack of Efficacy|0|||
105546117|NCT00439777|363998695|FG000|Observational Period|Technical problems|0|||
105546118|NCT00439777|363998696|FG001|Observational Period|Technical problems|1|||
105546119|NCT00861341|363998699|FG000|Overall Study|Withdrawal by Subject|2|||
105546120|NCT00503685|363998700|FG000|Overall Study|Adverse Event|0|||
105546121|NCT00503685|363998701|FG001|Overall Study|Adverse Event|0|||
105546122|NCT00503685|363998702|FG002|Overall Study|Adverse Event|2|||
105546123|NCT00503685|363998700|FG000|Overall Study|Withdrawal by Subject|0|||
105546124|NCT00503685|363998701|FG001|Overall Study|Withdrawal by Subject|1|||
105546125|NCT00503685|363998702|FG002|Overall Study|Withdrawal by Subject|0|||
105546126|NCT00503685|363998700|FG000|Overall Study|Protocol Violation|0|||
105546127|NCT00503685|363998701|FG001|Overall Study|Protocol Violation|1|||
105546128|NCT00503685|363998702|FG002|Overall Study|Protocol Violation|0|||
105546129|NCT00503685|363998700|FG000|Overall Study|Eligibility Criteria Not Met|0|||
105546130|NCT00503685|363998701|FG001|Overall Study|Eligibility Criteria Not Met|1|||
105546131|NCT00503685|363998702|FG002|Overall Study|Eligibility Criteria Not Met|0|||
105546132|NCT01578551|363998707|FG000|Overall Study|Adverse Event|1|||
105546133|NCT01578551|363998708|FG001|Overall Study|Adverse Event|0|||
105546134|NCT01181895|363998711|FG000|Overall Study|Adverse Event|3|||
105546135|NCT01181895|363998712|FG001|Overall Study|Adverse Event|1|||
105546136|NCT01181895|363998713|FG002|Overall Study|Adverse Event|1|||
105546137|NCT01181895|363998711|FG000|Overall Study|Lack of Efficacy|8|||
105546138|NCT01181895|363998712|FG001|Overall Study|Lack of Efficacy|9|||
105546139|NCT01181895|363998713|FG002|Overall Study|Lack of Efficacy|9|||
105546140|NCT01181895|363998711|FG000|Overall Study|Protocol Violation|2|||
105546141|NCT01181895|363998712|FG001|Overall Study|Protocol Violation|1|||
105546142|NCT01181895|363998713|FG002|Overall Study|Protocol Violation|0|||
105546143|NCT01181895|363998711|FG000|Overall Study|Lost to Follow-up|0|||
105546144|NCT01181895|363998712|FG001|Overall Study|Lost to Follow-up|1|||
105546145|NCT01181895|363998713|FG002|Overall Study|Lost to Follow-up|2|||
105546146|NCT01181895|363998711|FG000|Overall Study|Investigator Discretion|1|||
105546147|NCT01181895|363998712|FG001|Overall Study|Investigator Discretion|2|||
105546148|NCT01181895|363998713|FG002|Overall Study|Investigator Discretion|1|||
105546149|NCT01181895|363998711|FG000|Overall Study|Withdrawal by Subject|3|||
105546150|NCT01181895|363998712|FG001|Overall Study|Withdrawal by Subject|0|||
105546151|NCT01181895|363998713|FG002|Overall Study|Withdrawal by Subject|5|||
105546152|NCT00080223|363998719|FG000|Overall Study|Adverse Event|23|||
105546153|NCT00080223|363998719|FG000|Overall Study|Death|21|||
105546154|NCT00080223|363998719|FG000|Overall Study|Withdrawal by Subject|13|||
105546155|NCT00080223|363998719|FG000|Overall Study|Lung Transplantation|9|||
105546156|NCT00080223|363998719|FG000|Overall Study|Non-compliance With Study Treatment|7|||
105546157|NCT00080223|363998719|FG000|Overall Study|Participant unwilling to continue|2|||
105546158|NCT00080223|363998719|FG000|Overall Study|Physician Decision|1|||
105546159|NCT01609556|363998720|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
105546160|NCT01609556|363998721|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
105546161|NCT01609556|363998722|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
105546162|NCT01609556|363998723|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
105546163|NCT01609556|363998724|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
105546164|NCT01609556|363998725|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
105546165|NCT01609556|363998726|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
105546166|NCT01609556|363998727|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
105546167|NCT01609556|363998728|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
105546168|NCT01609556|363998729|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
105546169|NCT01609556|363998730|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
105546170|NCT01609556|363998731|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
105546171|NCT01609556|363998732|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
105546172|NCT01609556|363998733|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
105546173|NCT01609556|363998734|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
105546174|NCT01609556|363998735|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
105546175|NCT01609556|363998720|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
105546176|NCT01609556|363998721|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
105546177|NCT01609556|363998722|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
105546178|NCT01609556|363998723|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
105546179|NCT01609556|363998724|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
105546180|NCT01609556|363998725|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
105546181|NCT01609556|363998726|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
105546182|NCT01609556|363998727|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
105546183|NCT01609556|363998728|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
105546184|NCT01609556|363998729|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
105546185|NCT01609556|363998730|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
105546186|NCT01609556|363998731|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
105546187|NCT01609556|363998732|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
105546188|NCT01609556|363998733|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
105546189|NCT01609556|363998734|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
105546190|NCT01609556|363998735|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
105546191|NCT01609556|363998720|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
105546192|NCT01609556|363998721|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
105546193|NCT01609556|363998722|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
105546194|NCT01609556|363998723|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
105546195|NCT01609556|363998724|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
105546196|NCT01609556|363998725|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
105546197|NCT01609556|363998726|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
105546198|NCT01609556|363998727|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
105546199|NCT01609556|363998728|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
105546200|NCT01609556|363998729|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
105546201|NCT01609556|363998730|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
105546202|NCT01609556|363998731|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
105546203|NCT01609556|363998732|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
105546204|NCT01609556|363998733|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
105546205|NCT01609556|363998734|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
105546206|NCT01609556|363998735|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
105546207|NCT01609556|363998720|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
105546208|NCT01609556|363998721|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
105546209|NCT01609556|363998722|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
105546210|NCT01609556|363998723|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
105546211|NCT01609556|363998724|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
105546212|NCT01609556|363998725|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
105546213|NCT01609556|363998726|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
105546214|NCT01609556|363998727|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
105546215|NCT01609556|363998728|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
105546216|NCT01609556|363998729|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
105546217|NCT01609556|363998730|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
105546218|NCT01609556|363998731|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
105546219|NCT01609556|363998732|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
105546220|NCT01609556|363998733|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
105546221|NCT01609556|363998734|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
105546222|NCT01609556|363998735|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
105546223|NCT01609556|363998720|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
105546224|NCT01609556|363998721|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
105546225|NCT01609556|363998722|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
105546226|NCT01609556|363998723|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
105546227|NCT01609556|363998724|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
105546228|NCT01609556|363998725|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
105546229|NCT01609556|363998726|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
105546230|NCT01609556|363998727|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
105546231|NCT01609556|363998728|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
105546232|NCT01609556|363998729|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
105546233|NCT01609556|363998730|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
105546234|NCT01609556|363998731|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
105546235|NCT01609556|363998732|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
105546236|NCT01609556|363998733|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
105546237|NCT01609556|363998734|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
105546238|NCT01609556|363998735|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
105546239|NCT01609556|363998720|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
105546240|NCT01609556|363998721|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
105546241|NCT01609556|363998722|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
105546242|NCT01609556|363998723|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
105546243|NCT01609556|363998724|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
105546244|NCT01609556|363998725|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
105546245|NCT01609556|363998726|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
105546246|NCT01609556|363998727|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
105546247|NCT01609556|363998728|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
105546248|NCT01609556|363998729|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
105546249|NCT01609556|363998730|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
105546250|NCT01609556|363998731|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
105546251|NCT01609556|363998732|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
105546252|NCT01609556|363998733|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
105546253|NCT01609556|363998734|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
105546254|NCT01609556|363998735|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
105546255|NCT01609556|363998720|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
105546256|NCT01609556|363998721|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
105546257|NCT01609556|363998722|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
105546258|NCT01609556|363998723|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
105546259|NCT01609556|363998724|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
105546260|NCT01609556|363998725|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
105546261|NCT01609556|363998726|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
105546262|NCT01609556|363998727|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
105546263|NCT01609556|363998728|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
105546264|NCT01609556|363998729|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
105546265|NCT01609556|363998730|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
105546266|NCT01609556|363998731|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
105546267|NCT01609556|363998732|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
105546268|NCT01609556|363998733|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
105546269|NCT01609556|363998734|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
105546270|NCT01609556|363998735|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
105546271|NCT01609556|363998720|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
105546272|NCT01609556|363998721|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
105546273|NCT01609556|363998722|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
105546274|NCT01609556|363998723|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
105546275|NCT01609556|363998724|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
105546276|NCT01609556|363998725|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
105546277|NCT01609556|363998726|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
105546278|NCT01609556|363998727|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
105546279|NCT01609556|363998728|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
105546280|NCT01609556|363998729|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
105546281|NCT01609556|363998730|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
105546282|NCT01609556|363998731|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
105546283|NCT01609556|363998732|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
105546284|NCT01609556|363998733|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
105546285|NCT01609556|363998734|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
105546286|NCT01609556|363998735|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
105546287|NCT01609556|363998720|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
105546288|NCT01609556|363998721|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
105546289|NCT01609556|363998722|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
105546290|NCT01609556|363998723|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
105596065|NCT04842604|364184122|FG000|Overall Study|Randomized but not treated|1|||
105596066|NCT04842604|364184123|FG001|Overall Study|Randomized but not treated|0|||
105596067|NCT01563354|364184124|FG000|Core Phase|Adverse Event|5|||
105596068|NCT01563354|364184125|FG001|Core Phase|Adverse Event|15|||
105596069|NCT01563354|364184126|FG002|Core Phase|Adverse Event|13|||
105546291|NCT01609556|363998724|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
105546292|NCT01609556|363998725|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
105596070|NCT01563354|364184124|FG000|Core Phase|Withdrawal by Subject|1|||
105546293|NCT01609556|363998726|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
105546294|NCT01609556|363998727|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
105546295|NCT01609556|363998728|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
105546296|NCT01609556|363998729|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
105546297|NCT01609556|363998730|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
105546298|NCT01609556|363998731|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
105546299|NCT01609556|363998732|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
105546300|NCT01609556|363998733|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
105546301|NCT01609556|363998734|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
105546302|NCT01609556|363998735|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
105546303|NCT01609556|363998720|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
105546304|NCT01609556|363998721|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
105546305|NCT01609556|363998722|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
105546306|NCT01609556|363998723|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
105546307|NCT01609556|363998724|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
105546308|NCT01609556|363998725|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
105546309|NCT01609556|363998726|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
105546310|NCT01609556|363998727|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
105546311|NCT01609556|363998728|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
105546312|NCT01609556|363998729|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
105546313|NCT01609556|363998730|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
105546314|NCT01609556|363998731|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
105546315|NCT01609556|363998732|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
105546316|NCT01609556|363998733|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
105546317|NCT01609556|363998734|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
105546318|NCT01609556|363998735|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
105546319|NCT01609556|363998720|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
105546320|NCT01609556|363998721|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
105546321|NCT01609556|363998722|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
105546322|NCT01609556|363998723|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
105546323|NCT01609556|363998724|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
105546324|NCT01609556|363998725|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
105546325|NCT01609556|363998726|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
105546326|NCT01609556|363998727|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
105546327|NCT01609556|363998728|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
105546328|NCT01609556|363998729|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
105546329|NCT01609556|363998730|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
105546330|NCT01609556|363998731|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
105546331|NCT01609556|363998732|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
105546332|NCT01609556|363998733|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
105546333|NCT01609556|363998734|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
105546334|NCT01609556|363998735|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
105546335|NCT01609556|363998720|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
105546336|NCT01609556|363998721|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
105546337|NCT01609556|363998722|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
105546338|NCT01609556|363998723|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
105546339|NCT01609556|363998724|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
105546340|NCT01609556|363998725|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
105546341|NCT01609556|363998726|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
105546342|NCT01609556|363998727|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
105546343|NCT01609556|363998728|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
105546344|NCT01609556|363998729|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
105546345|NCT01609556|363998730|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
105546346|NCT01609556|363998731|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
105596071|NCT01563354|364184125|FG001|Core Phase|Withdrawal by Subject|0|||
105596072|NCT01563354|364184126|FG002|Core Phase|Withdrawal by Subject|3|||
105596073|NCT01563354|364184124|FG000|Core Phase|Lost to Follow-up|1|||
105596074|NCT01563354|364184125|FG001|Core Phase|Lost to Follow-up|0|||
105596075|NCT01563354|364184126|FG002|Core Phase|Lost to Follow-up|0|||
105596076|NCT01563354|364184124|FG000|Core Phase|Death|1|||
105596077|NCT01563354|364184125|FG001|Core Phase|Death|5|||
105596078|NCT01563354|364184126|FG002|Core Phase|Death|2|||
105596079|NCT01563354|364184124|FG000|Core Phase|Diseasse progression|18|||
105596080|NCT01563354|364184125|FG001|Core Phase|Diseasse progression|7|||
105596081|NCT01563354|364184126|FG002|Core Phase|Diseasse progression|8|||
105596082|NCT01563354|364184124|FG000|Core Phase|Protocol deviation|2|||
105596083|NCT01563354|364184125|FG001|Core Phase|Protocol deviation|0|||
105546347|NCT01609556|363998732|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
105546348|NCT01609556|363998733|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
105546349|NCT01609556|363998734|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
105546350|NCT01609556|363998735|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
105546351|NCT01609556|363998720|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
105546352|NCT01609556|363998721|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
105546353|NCT01609556|363998722|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
105546354|NCT01609556|363998723|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
105546355|NCT01609556|363998724|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
105546356|NCT01609556|363998725|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
105546357|NCT01609556|363998726|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
105546358|NCT01609556|363998727|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
105546359|NCT01609556|363998728|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
105546360|NCT01609556|363998729|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
105546361|NCT01609556|363998730|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
105546362|NCT01609556|363998731|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
105546363|NCT01609556|363998732|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
105546364|NCT01609556|363998733|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
105546365|NCT01609556|363998734|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
105546366|NCT01609556|363998735|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
105546367|NCT01609556|363998720|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
105546368|NCT01609556|363998721|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
105546369|NCT01609556|363998722|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
105546370|NCT01609556|363998723|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
105546371|NCT01609556|363998724|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
105546372|NCT01609556|363998725|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
105546373|NCT01609556|363998726|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
105546374|NCT01609556|363998727|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
105546375|NCT01609556|363998728|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
105546376|NCT01609556|363998729|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
105546377|NCT01609556|363998730|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
105546378|NCT01609556|363998731|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
105546379|NCT01609556|363998732|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
105546380|NCT01609556|363998733|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
105546381|NCT01609556|363998734|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
105546382|NCT01609556|363998735|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
105546383|NCT01609556|363998720|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
105546384|NCT01609556|363998721|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
105546385|NCT01609556|363998722|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
105546386|NCT01609556|363998723|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
105546387|NCT01609556|363998724|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
105546388|NCT01609556|363998725|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
105546389|NCT01609556|363998726|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
105546390|NCT01609556|363998727|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
105546391|NCT01609556|363998728|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
105546392|NCT01609556|363998729|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
105546393|NCT01609556|363998730|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
105546394|NCT01609556|363998731|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
105546395|NCT01609556|363998732|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
105546396|NCT01609556|363998733|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
105546397|NCT01609556|363998734|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
105546398|NCT01609556|363998735|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
105546399|NCT03483623|363998736|FG000|Overall Study|43 complete sets achieved|1|||
105546400|NCT00898677|363998740|FG000|Overall Study|Adverse Event|0|||
105546401|NCT00898677|363998741|FG001|Overall Study|Adverse Event|0|||
105546402|NCT00898677|363998742|FG002|Overall Study|Adverse Event|1|||
105546403|NCT00898677|363998743|FG003|Overall Study|Adverse Event|0|||
105546404|NCT00898677|363998740|FG000|Overall Study|Lost to Follow-up|0|||
105546405|NCT00898677|363998741|FG001|Overall Study|Lost to Follow-up|0|||
105546406|NCT00898677|363998742|FG002|Overall Study|Lost to Follow-up|2|||
105546407|NCT00898677|363998743|FG003|Overall Study|Lost to Follow-up|0|||
105546408|NCT00898677|363998740|FG000|Overall Study|Protocol Violation|1|||
105546409|NCT00898677|363998741|FG001|Overall Study|Protocol Violation|1|||
105546410|NCT00898677|363998742|FG002|Overall Study|Protocol Violation|2|||
105546411|NCT00898677|363998743|FG003|Overall Study|Protocol Violation|0|||
105546412|NCT00898677|363998740|FG000|Overall Study|Withdrawal by Subject|0|||
105546413|NCT00898677|363998741|FG001|Overall Study|Withdrawal by Subject|0|||
105546414|NCT00898677|363998742|FG002|Overall Study|Withdrawal by Subject|0|||
105546415|NCT00898677|363998743|FG003|Overall Study|Withdrawal by Subject|1|||
105546416|NCT00898677|363998740|FG000|Overall Study|Not Treated: Adverse Event|0|||
105546417|NCT00898677|363998741|FG001|Overall Study|Not Treated: Adverse Event|2|||
105546418|NCT00898677|363998742|FG002|Overall Study|Not Treated: Adverse Event|1|||
105546419|NCT00898677|363998743|FG003|Overall Study|Not Treated: Adverse Event|0|||
105546420|NCT00898677|363998740|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
105546421|NCT00898677|363998741|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
105546422|NCT00898677|363998742|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
105546423|NCT00898677|363998743|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
105546424|NCT00898677|363998740|FG000|Overall Study|Not Treated: Pregnancy|0|||
105546425|NCT00898677|363998741|FG001|Overall Study|Not Treated: Pregnancy|0|||
105546426|NCT00898677|363998742|FG002|Overall Study|Not Treated: Pregnancy|1|||
105546427|NCT00898677|363998743|FG003|Overall Study|Not Treated: Pregnancy|0|||
105546428|NCT00898677|363998740|FG000|Overall Study|Not Treated: Protocol Violation|2|||
105546429|NCT00898677|363998741|FG001|Overall Study|Not Treated: Protocol Violation|0|||
105546430|NCT00898677|363998742|FG002|Overall Study|Not Treated: Protocol Violation|2|||
105546431|NCT00898677|363998743|FG003|Overall Study|Not Treated: Protocol Violation|0|||
105546432|NCT00898677|363998740|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
105546433|NCT00898677|363998741|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
105546434|NCT00898677|363998742|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
105546435|NCT00898677|363998743|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
105546436|NCT00898677|363998740|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
105546437|NCT00898677|363998741|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
105546438|NCT00898677|363998742|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
105546439|NCT00898677|363998743|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
105546440|NCT00898677|363998740|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
105546441|NCT00898677|363998741|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
105546442|NCT00898677|363998742|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
105546443|NCT00898677|363998743|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
105546444|NCT00898677|363998740|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
105546445|NCT00898677|363998741|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
105546446|NCT00898677|363998742|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
105546447|NCT00898677|363998743|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
105546448|NCT00898677|363998740|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
105546449|NCT00898677|363998741|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
105546450|NCT00898677|363998742|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
105546451|NCT00898677|363998743|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
105546452|NCT00898677|363998740|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
105546453|NCT00898677|363998741|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
105546454|NCT00898677|363998742|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
105546455|NCT00898677|363998743|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
105546456|NCT00898677|363998740|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
105546457|NCT00898677|363998741|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
105546458|NCT00898677|363998742|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
105546459|NCT00898677|363998743|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
105546460|NCT00659334|363998744|FG000|Overall Study|Screen Failure|8|||
105546461|NCT00659334|363998745|FG001|Overall Study|Screen Failure|5|||
105546462|NCT00659334|363998746|FG002|Overall Study|Screen Failure|0|||
105546463|NCT00659334|363998747|FG003|Overall Study|Screen Failure|0|||
105546464|NCT00659334|363998748|FG004|Overall Study|Screen Failure|0|||
105546465|NCT00659334|363998749|FG005|Overall Study|Screen Failure|0|||
105546466|NCT00659334|363998750|FG006|Overall Study|Screen Failure|1|||
105546467|NCT03864614|363998753|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
105546468|NCT03864614|363998754|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
105546469|NCT03864614|363998755|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
105546470|NCT03864614|363998756|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
105546471|NCT03864614|363998753|FG000|Overall Study|Withdrawal by Subject|72|||
105546472|NCT03864614|363998754|FG001|Overall Study|Withdrawal by Subject|100|||
105546473|NCT03864614|363998755|FG002|Overall Study|Withdrawal by Subject|1|||
105546474|NCT03864614|363998756|FG003|Overall Study|Withdrawal by Subject|21|||
105546475|NCT03864614|363998753|FG000|Overall Study|Lost to Follow-up|45|||
105546476|NCT03864614|363998754|FG001|Overall Study|Lost to Follow-up|54|||
105546477|NCT03864614|363998755|FG002|Overall Study|Lost to Follow-up|0|||
105546478|NCT03864614|363998756|FG003|Overall Study|Lost to Follow-up|9|||
105596084|NCT01563354|364184126|FG002|Core Phase|Protocol deviation|0|||
105596085|NCT01563354|364184124|FG000|Core Phase|PI decision - did not enter extension|0|||
105546479|NCT03864614|363998753|FG000|Overall Study|Adverse Event|42|||
105546480|NCT03864614|363998754|FG001|Overall Study|Adverse Event|30|||
105546481|NCT03864614|363998755|FG002|Overall Study|Adverse Event|1|||
105546482|NCT03864614|363998756|FG003|Overall Study|Adverse Event|9|||
105546483|NCT03864614|363998753|FG000|Overall Study|Protocol Deviation|6|||
105546484|NCT03864614|363998754|FG001|Overall Study|Protocol Deviation|26|||
105596086|NCT01563354|364184125|FG001|Core Phase|PI decision - did not enter extension|1|||
105596087|NCT01563354|364184126|FG002|Core Phase|PI decision - did not enter extension|0|||
105596088|NCT01563354|364184124|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
105546485|NCT03864614|363998755|FG002|Overall Study|Protocol Deviation|0|||
105546486|NCT03864614|363998756|FG003|Overall Study|Protocol Deviation|1|||
105546487|NCT03864614|363998753|FG000|Overall Study|Physician Decision|7|||
105546488|NCT03864614|363998754|FG001|Overall Study|Physician Decision|10|||
105546489|NCT03864614|363998755|FG002|Overall Study|Physician Decision|1|||
105546490|NCT03864614|363998756|FG003|Overall Study|Physician Decision|5|||
105546491|NCT03864614|363998753|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
105546492|NCT03864614|363998754|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
105546493|NCT03864614|363998755|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
105546494|NCT03864614|363998756|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
105546495|NCT03864614|363998753|FG000|Overall Study|Sponsor Decision|1|||
105546496|NCT03864614|363998754|FG001|Overall Study|Sponsor Decision|2|||
105546497|NCT03864614|363998755|FG002|Overall Study|Sponsor Decision|0|||
105546498|NCT03864614|363998756|FG003|Overall Study|Sponsor Decision|0|||
105546499|NCT03864614|363998753|FG000|Overall Study|Pregnancy|0|||
105546500|NCT03864614|363998754|FG001|Overall Study|Pregnancy|1|||
105546501|NCT03864614|363998755|FG002|Overall Study|Pregnancy|0|||
105546502|NCT03864614|363998756|FG003|Overall Study|Pregnancy|0|||
105546503|NCT03864614|363998753|FG000|Overall Study|Other|7|||
105546504|NCT03864614|363998754|FG001|Overall Study|Other|9|||
105546505|NCT03864614|363998755|FG002|Overall Study|Other|1|||
105546506|NCT03864614|363998756|FG003|Overall Study|Other|4|||
105546507|NCT03864614|363998753|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
105546508|NCT03864614|363998754|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
105546509|NCT03864614|363998755|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
105546510|NCT03864614|363998756|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
105546511|NCT02239510|364000504|FG000|Overall Study|Lost to Follow-up|2|||
105546512|NCT02239510|364000505|FG001|Overall Study|Lost to Follow-up|1|||
105546513|NCT01782131|364000508|FG000|Overall Study|Death|93|||
105546514|NCT01782131|364000509|FG001|Overall Study|Death|96|||
105546515|NCT01782131|364000508|FG000|Overall Study|Lost to Follow-up|1|||
105546516|NCT01782131|364000509|FG001|Overall Study|Lost to Follow-up|3|||
105546517|NCT01782131|364000508|FG000|Overall Study|Withdrawal by Subject|10|||
105546518|NCT01782131|364000509|FG001|Overall Study|Withdrawal by Subject|10|||
105546519|NCT01782131|364000508|FG000|Overall Study|Randomized but not treated|5|||
105546520|NCT01782131|364000509|FG001|Overall Study|Randomized but not treated|5|||
105546521|NCT01782131|364000508|FG000|Overall Study|Reason not provided|0|||
105546522|NCT01782131|364000509|FG001|Overall Study|Reason not provided|1|||
105546523|NCT01627249|364000510|FG000|Overall Study|Death|3|||
105546524|NCT01627249|364000511|FG001|Overall Study|Death|5|||
105546525|NCT01627249|364000512|FG002|Overall Study|Death|3|||
105546526|NCT01627249|364000510|FG000|Overall Study|Withdrawal by Subject|12|||
105546527|NCT01627249|364000511|FG001|Overall Study|Withdrawal by Subject|6|||
105546528|NCT01627249|364000512|FG002|Overall Study|Withdrawal by Subject|9|||
105546529|NCT01627249|364000510|FG000|Overall Study|Missed Visit|1|||
105546530|NCT01627249|364000511|FG001|Overall Study|Missed Visit|1|||
105546531|NCT01627249|364000512|FG002|Overall Study|Missed Visit|0|||
105546532|NCT03564496|364000513|FG000|Overall Study|Withdrawal by Subject|1|||
105546533|NCT03564496|364000514|FG001|Overall Study|Withdrawal by Subject|1|||
105546534|NCT03564496|364000515|FG002|Overall Study|Withdrawal by Subject|0|||
105546535|NCT03564496|364000513|FG000|Overall Study|Screen failure|0|||
105546536|NCT03564496|364000514|FG001|Overall Study|Screen failure|3|||
105546537|NCT03564496|364000515|FG002|Overall Study|Screen failure|0|||
105546538|NCT00966940|364000517|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
105546539|NCT00966940|364000518|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
105546540|NCT00966940|364000517|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
105546541|NCT00966940|364000518|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
105546542|NCT02044510|364000521|FG000|Overall Study|Adverse Event|1|||
105546543|NCT02044510|364000522|FG001|Overall Study|Adverse Event|2|||
105546544|NCT00924950|364000523|FG000|Overall Study|Lost to Follow-up|2|||
105546545|NCT01075321|364000527|FG000|Overall Study|Withdrawal by Subject|0|||
105546546|NCT01075321|364000528|FG001|Overall Study|Withdrawal by Subject|0|||
105546547|NCT01075321|364000529|FG002|Overall Study|Withdrawal by Subject|1|||
105546548|NCT01075321|364000530|FG003|Overall Study|Withdrawal by Subject|1|||
105546549|NCT01075321|364000527|FG000|Overall Study|Protocol Violation|0|||
105546550|NCT01075321|364000528|FG001|Overall Study|Protocol Violation|0|||
105546551|NCT01075321|364000529|FG002|Overall Study|Protocol Violation|1|||
105546552|NCT01075321|364000530|FG003|Overall Study|Protocol Violation|0|||
105546553|NCT01075321|364000527|FG000|Overall Study|Treatment Incomplete due to progression|1|||
105546554|NCT01075321|364000528|FG001|Overall Study|Treatment Incomplete due to progression|0|||
105546555|NCT01075321|364000529|FG002|Overall Study|Treatment Incomplete due to progression|0|||
105546556|NCT01075321|364000530|FG003|Overall Study|Treatment Incomplete due to progression|0|||
105546557|NCT01075321|364000527|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
105546558|NCT01075321|364000528|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
105546559|NCT01075321|364000529|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
105546560|NCT01075321|364000530|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
105546561|NCT02246998|364000531|FG000|Overall Study|Adverse Event|0|||
105546562|NCT02246998|364000532|FG001|Overall Study|Adverse Event|1|||
105546563|NCT02246998|364000533|FG002|Overall Study|Adverse Event|1|||
105546564|NCT02246998|364000534|FG003|Overall Study|Adverse Event|0|||
105546565|NCT02246998|364000531|FG000|Overall Study|Lost to Follow-up|1|||
105546566|NCT02246998|364000532|FG001|Overall Study|Lost to Follow-up|0|||
105546567|NCT02246998|364000533|FG002|Overall Study|Lost to Follow-up|0|||
105546568|NCT02246998|364000534|FG003|Overall Study|Lost to Follow-up|1|||
105546569|NCT02246998|364000531|FG000|Overall Study|Randomized but Never Dosed|1|||
105546570|NCT02246998|364000532|FG001|Overall Study|Randomized but Never Dosed|2|||
105546571|NCT02246998|364000533|FG002|Overall Study|Randomized but Never Dosed|2|||
105546572|NCT02246998|364000534|FG003|Overall Study|Randomized but Never Dosed|1|||
105546573|NCT02473614|364000535|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
105546574|NCT02473614|364000536|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
105546575|NCT02525133|364000537|FG000|Overall Study|Adverse Event|0|||
105546576|NCT02525133|364000538|FG001|Overall Study|Adverse Event|1|||
105546577|NCT02525133|364000537|FG000|Overall Study|Death|0|||
105546578|NCT02525133|364000538|FG001|Overall Study|Death|1|||
105546579|NCT02525133|364000537|FG000|Overall Study|did not meet randomization criteria|1|||
105546580|NCT02525133|364000538|FG001|Overall Study|did not meet randomization criteria|0|||
105546581|NCT02525133|364000537|FG000|Overall Study|Lost to Follow-up|5|||
105546582|NCT02525133|364000538|FG001|Overall Study|Lost to Follow-up|1|||
105546583|NCT02525133|364000537|FG000|Overall Study|randomized not enrolled|3|||
105546584|NCT02525133|364000538|FG001|Overall Study|randomized not enrolled|0|||
105546585|NCT02525133|364000537|FG000|Overall Study|Withdrawal by Subject|1|||
105546586|NCT02525133|364000538|FG001|Overall Study|Withdrawal by Subject|0|||
105546587|NCT01075074|364000539|FG000|Overall Study|Surgeon changed to open incisional case|1|||
105546588|NCT01075074|364000540|FG001|Overall Study|Surgeon changed to open incisional case|2|||
105546589|NCT01075074|364000541|FG002|Overall Study|Surgeon changed to open incisional case|2|||
105546590|NCT01054729|364000543|FG000|Overall Study|Randomized but Not Treated|0|||
105546591|NCT01054729|364000544|FG001|Overall Study|Randomized but Not Treated|1|||
105546592|NCT01054729|364000545|FG002|Overall Study|Randomized but Not Treated|0|||
105546593|NCT01054729|364000546|FG003|Overall Study|Randomized but Not Treated|0|||
105546594|NCT01054729|364000543|FG000|Overall Study|Adverse Event|1|||
105546595|NCT01054729|364000544|FG001|Overall Study|Adverse Event|1|||
105546596|NCT01054729|364000545|FG002|Overall Study|Adverse Event|2|||
105546597|NCT01054729|364000546|FG003|Overall Study|Adverse Event|1|||
105546598|NCT01054729|364000543|FG000|Overall Study|Withdrawal by Subject|1|||
105546599|NCT01054729|364000544|FG001|Overall Study|Withdrawal by Subject|0|||
105546600|NCT01054729|364000545|FG002|Overall Study|Withdrawal by Subject|1|||
105546601|NCT01054729|364000546|FG003|Overall Study|Withdrawal by Subject|0|||
105546602|NCT01054729|364000543|FG000|Overall Study|Lost to Follow-up|0|||
105546603|NCT01054729|364000544|FG001|Overall Study|Lost to Follow-up|1|||
105546604|NCT01054729|364000545|FG002|Overall Study|Lost to Follow-up|0|||
105546605|NCT01054729|364000546|FG003|Overall Study|Lost to Follow-up|0|||
105546606|NCT01054729|364000543|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
105546607|NCT01054729|364000544|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
105546608|NCT01054729|364000545|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
105546609|NCT01054729|364000546|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
105546610|NCT01054729|364000543|FG000|Overall Study|Non-responder|1|||
105546611|NCT01054729|364000544|FG001|Overall Study|Non-responder|0|||
105546612|NCT01054729|364000545|FG002|Overall Study|Non-responder|1|||
105546613|NCT01054729|364000546|FG003|Overall Study|Non-responder|1|||
105546614|NCT01054729|364000543|FG000|Overall Study|PEG/RBV Non-responder|1|||
105546615|NCT01054729|364000544|FG001|Overall Study|PEG/RBV Non-responder|0|||
105546616|NCT01054729|364000545|FG002|Overall Study|PEG/RBV Non-responder|1|||
105546617|NCT01054729|364000546|FG003|Overall Study|PEG/RBV Non-responder|0|||
105546618|NCT01054729|364000543|FG000|Overall Study|Personal/Obligations|0|||
105546619|NCT01054729|364000544|FG001|Overall Study|Personal/Obligations|1|||
105546620|NCT01054729|364000545|FG002|Overall Study|Personal/Obligations|0|||
105546621|NCT01054729|364000546|FG003|Overall Study|Personal/Obligations|0|||
105546622|NCT01054729|364000543|FG000|Overall Study|Subject moved|0|||
105546623|NCT01054729|364000544|FG001|Overall Study|Subject moved|0|||
105546624|NCT01054729|364000545|FG002|Overall Study|Subject moved|1|||
105546625|NCT01054729|364000546|FG003|Overall Study|Subject moved|0|||
105546626|NCT01054729|364000543|FG000|Overall Study|Lack of Efficacy|0|||
105546627|NCT01054729|364000544|FG001|Overall Study|Lack of Efficacy|0|||
105546628|NCT01054729|364000545|FG002|Overall Study|Lack of Efficacy|0|||
105546629|NCT01054729|364000546|FG003|Overall Study|Lack of Efficacy|1|||
105546630|NCT04265755|364000547|FG000|Overall Study|Withdrawal by Subject|39|||
105546631|NCT04265755|364000547|FG000|Overall Study|Decision by sponsor|2|||
105546632|NCT04265755|364000547|FG000|Overall Study|Lost to Follow-up|11|||
105546633|NCT04265755|364000547|FG000|Overall Study|Death|1|||
105546634|NCT04535037|364000548|FG000|Overall Study|Protocol Violation|1|||
105546635|NCT04535037|364000549|FG001|Overall Study|Protocol Violation|0|||
105546636|NCT04535037|364000548|FG000|Overall Study|Withdrawal by Subject|8|||
105546637|NCT04535037|364000549|FG001|Overall Study|Withdrawal by Subject|9|||
105546638|NCT04535037|364000548|FG000|Overall Study|Migrated / moved from the study area|1|||
105546639|NCT04535037|364000549|FG001|Overall Study|Migrated / moved from the study area|4|||
105546640|NCT04535037|364000548|FG000|Overall Study|Other|2|||
105546641|NCT04535037|364000549|FG001|Overall Study|Other|5|||
105546642|NCT02667912|364000560|FG000|Overall Study|Death|3|||
105546643|NCT02667912|364000561|FG001|Overall Study|Death|1|||
105546644|NCT02667912|364000560|FG000|Overall Study|Withdrawal by Subject|1|||
105546645|NCT02667912|364000561|FG001|Overall Study|Withdrawal by Subject|2|||
105546646|NCT02667912|364000560|FG000|Overall Study|Withdrawal by Subject|1|||
105546647|NCT02667912|364000561|FG001|Overall Study|Withdrawal by Subject|0|||
105546648|NCT03321019|364000562|FG000|Overall Study|Withdrawal by Subject|0|||
105546649|NCT03321019|364000563|FG001|Overall Study|Withdrawal by Subject|6|||
105546650|NCT03321019|364000562|FG000|Overall Study|Lost to Follow-up|0|||
105546651|NCT03321019|364000563|FG001|Overall Study|Lost to Follow-up|22|||
105546652|NCT04934670|364000564|FG000|Overall Study|Death|4|||
105546653|NCT04934670|364000565|FG001|Overall Study|Death|0|||
105546654|NCT04934670|364000564|FG000|Overall Study|Lost to Follow-up|1|||
105546655|NCT04934670|364000565|FG001|Overall Study|Lost to Follow-up|4|||
105546656|NCT03067441|364000566|FG000|Overall Study|Withdrawal by Subject|16|||
105546657|NCT03067441|364000567|FG001|Overall Study|Withdrawal by Subject|34|||
105546658|NCT03067441|364000566|FG000|Overall Study|Lost to Follow-up|7|||
105546659|NCT03067441|364000567|FG001|Overall Study|Lost to Follow-up|5|||
105546660|NCT03067441|364000566|FG000|Overall Study|Adverse Event|7|||
105546661|NCT03067441|364000567|FG001|Overall Study|Adverse Event|14|||
105546662|NCT03067441|364000566|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
105546663|NCT03067441|364000567|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
105546664|NCT03067441|364000566|FG000|Overall Study|Physician Decision|1|||
105546665|NCT03067441|364000567|FG001|Overall Study|Physician Decision|3|||
105596089|NCT01563354|364184125|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
105596090|NCT01563354|364184126|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
105596091|NCT01563354|364184124|FG000|Extension Phase|Adverse Event|0|||
105596092|NCT01563354|364184125|FG001|Extension Phase|Adverse Event|3|||
105596093|NCT01563354|364184126|FG002|Extension Phase|Adverse Event|2|||
105596094|NCT01563354|364184124|FG000|Extension Phase|Withdrawal by Subject|0|||
105596095|NCT01563354|364184125|FG001|Extension Phase|Withdrawal by Subject|1|||
105596096|NCT01563354|364184126|FG002|Extension Phase|Withdrawal by Subject|0|||
105596097|NCT01563354|364184124|FG000|Extension Phase|Administration problems|3|||
105596098|NCT01563354|364184125|FG001|Extension Phase|Administration problems|2|||
105596099|NCT01563354|364184126|FG002|Extension Phase|Administration problems|3|||
105596100|NCT01563354|364184124|FG000|Extension Phase|Disease progression|9|||
105596101|NCT01563354|364184125|FG001|Extension Phase|Disease progression|8|||
105596102|NCT01563354|364184126|FG002|Extension Phase|Disease progression|10|||
105596103|NCT01460342|364184127|FG000|Overall Study|Adverse Event|5|||
105596104|NCT01460342|364184128|FG001|Overall Study|Adverse Event|4|||
105596105|NCT01460342|364184127|FG000|Overall Study|Lost to Follow-up|1|||
105596106|NCT01460342|364184128|FG001|Overall Study|Lost to Follow-up|2|||
105596107|NCT01460342|364184127|FG000|Overall Study|Protocol Violation|0|||
105596108|NCT01460342|364184128|FG001|Overall Study|Protocol Violation|1|||
105596109|NCT01460342|364184127|FG000|Overall Study|Withdrawal by Subject|3|||
105596110|NCT01460342|364184128|FG001|Overall Study|Withdrawal by Subject|4|||
105596111|NCT01460342|364184127|FG000|Overall Study|Physician Decision|1|||
105596112|NCT01460342|364184128|FG001|Overall Study|Physician Decision|3|||
105596113|NCT01460342|364184127|FG000|Overall Study|Lack of Efficacy|1|||
105596114|NCT01460342|364184128|FG001|Overall Study|Lack of Efficacy|0|||
105596115|NCT05046132|364184131|FG000|Overall Study|Adverse Event|4|||
105596116|NCT05046132|364184132|FG001|Overall Study|Adverse Event|0|||
105596117|NCT05046132|364184133|FG002|Overall Study|Adverse Event|0|||
105596118|NCT05046132|364184131|FG000|Overall Study|Withdrawal by Subject|3|||
105596119|NCT05046132|364184132|FG001|Overall Study|Withdrawal by Subject|0|||
105596120|NCT05046132|364184133|FG002|Overall Study|Withdrawal by Subject|0|||
105596121|NCT05046132|364184131|FG000|Overall Study|Positive Covid19 Result.|0|||
105596122|NCT05046132|364184132|FG001|Overall Study|Positive Covid19 Result.|1|||
105596123|NCT05046132|364184133|FG002|Overall Study|Positive Covid19 Result.|0|||
105546666|NCT03067441|364000566|FG000|Overall Study|Other|1|||
105596124|NCT01831791|364184134|FG000|Overall Study|Withdrawal by Subject|10|||
105596125|NCT03460756|364184135|FG000|Overall Study|Adverse Event|0|||
105596126|NCT03460756|364184136|FG001|Overall Study|Adverse Event|0|||
105546667|NCT03067441|364000567|FG001|Overall Study|Other|1|||
105546668|NCT04102501|364000577|FG000|Overall Study|Withdrawal by Subject|7|||
105546669|NCT04102501|364000578|FG001|Overall Study|Withdrawal by Subject|9|||
105546670|NCT04102501|364000577|FG000|Overall Study|Adverse Event|1|||
105596127|NCT03460756|364184137|FG002|Overall Study|Adverse Event|0|||
105546671|NCT04102501|364000578|FG001|Overall Study|Adverse Event|3|||
105546672|NCT01427712|364000579|FG000|Overall Study|Transfer to a different hospital|2|||
105546673|NCT01427712|364000579|FG000|Overall Study|Lost to Follow-up|1|||
105546674|NCT01427712|364000579|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
105546675|NCT01427712|364000579|FG000|Overall Study|Failure to visit|1|||
105546676|NCT00968617|364000581|FG000|Overall Study|Study terminated by sponsor|6|||
105546677|NCT04433767|364000582|FG000|Overall Study|Adverse Event|1|||
105546678|NCT00661492|364000588|FG000|Overall Study|Adverse Event|16|||
105546679|NCT00661492|364000589|FG001|Overall Study|Adverse Event|13|||
105546680|NCT00661492|364000588|FG000|Overall Study|Disease Progression|44|||
105546681|NCT00661492|364000589|FG001|Overall Study|Disease Progression|14|||
105546682|NCT00661492|364000588|FG000|Overall Study|Patient Request|6|||
105546683|NCT00661492|364000589|FG001|Overall Study|Patient Request|1|||
105546684|NCT00661492|364000588|FG000|Overall Study|Investigator Request|1|||
105546685|NCT00661492|364000589|FG001|Overall Study|Investigator Request|0|||
105546686|NCT00661492|364000588|FG000|Overall Study|Lost to Follow-up|0|||
105546687|NCT00661492|364000589|FG001|Overall Study|Lost to Follow-up|1|||
105546688|NCT00661492|364000588|FG000|Overall Study|Other|1|||
105546689|NCT00661492|364000589|FG001|Overall Study|Other|0|||
105546690|NCT01024387|364000590|FG000|Overall Study|Radiographic Progression|29|||
105546691|NCT01024387|364000590|FG000|Overall Study|Symptomatic Progression|10|||
105546692|NCT01024387|364000590|FG000|Overall Study|Physician Decision|5|||
105546693|NCT01024387|364000590|FG000|Overall Study|Withdrawal by Subject|5|||
105546694|NCT01024387|364000590|FG000|Overall Study|Death|2|||
105546695|NCT01024387|364000590|FG000|Overall Study|Prolonged Treatment Delay|1|||
105546696|NCT01024387|364000590|FG000|Overall Study|Adverse Event|3|||
105546697|NCT01024387|364000590|FG000|Overall Study|Other|5|||
105546698|NCT01143259|364000591|FG000|Overall Study|Withdrawal by Subject|3|||
105546699|NCT01143259|364000592|FG001|Overall Study|Withdrawal by Subject|2|||
105546700|NCT01143259|364000591|FG000|Overall Study|Protocol Violation|13|||
105546701|NCT01143259|364000592|FG001|Overall Study|Protocol Violation|9|||
105546702|NCT01143259|364000591|FG000|Overall Study|Screen Failure|7|||
105546703|NCT01143259|364000592|FG001|Overall Study|Screen Failure|9|||
105546704|NCT03965052|364000594|FG000|Overall Study|Protocol Violation|1|||
105546705|NCT03965052|364000595|FG001|Overall Study|Protocol Violation|0|||
105546706|NCT03238001|364000602|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
105546707|NCT03238001|364000602|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
105546708|NCT03238001|364000602|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
105546709|NCT03238001|364000602|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
105546710|NCT03238001|364000602|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
105546711|NCT03238001|364000602|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
105546712|NCT03238001|364000602|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
105546713|NCT03238001|364000602|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
105546714|NCT00142909|364000614|FG000|Randomization|Various Reasons|7|||
105546715|NCT00142909|364000615|FG001|Randomization|Various Reasons|10|||
105546716|NCT00142909|364000614|FG000|Medications Begin|Protocol Violation|2|||
105546717|NCT00142909|364000615|FG001|Medications Begin|Protocol Violation|0|||
105546718|NCT00142909|364000614|FG000|Medications Begin|Withdrawal by Subject|5|||
105546719|NCT00142909|364000615|FG001|Medications Begin|Withdrawal by Subject|3|||
105546720|NCT00142909|364000614|FG000|Medications Begin|Withdrawal by Subject|2|||
105546721|NCT00142909|364000615|FG001|Medications Begin|Withdrawal by Subject|0|||
105546722|NCT00766376|364000618|FG000|Overall Study|Withdrawal by Subject|27|||
105546723|NCT01110239|364000619|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
105546724|NCT01110239|364000620|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
105546725|NCT01110239|364000621|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
105596128|NCT03460756|364184138|FG003|Overall Study|Adverse Event|1|||
105596129|NCT03460756|364184135|FG000|Overall Study|Lack of Efficacy|0|||
105546726|NCT01110239|364000622|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
105546727|NCT01110239|364000619|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
105546728|NCT01110239|364000620|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
105546729|NCT01110239|364000621|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
105546730|NCT01110239|364000622|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
105546731|NCT00132769|364000623|FG000|Overall Study|Withdrawal by Subject|1|||
105546732|NCT00132769|364000624|FG001|Overall Study|Withdrawal by Subject|3|||
105546733|NCT00132769|364000623|FG000|Overall Study|Lack of Efficacy|7|||
105546734|NCT00132769|364000624|FG001|Overall Study|Lack of Efficacy|6|||
105546735|NCT00132769|364000623|FG000|Overall Study|Adverse Event|2|||
105546736|NCT00132769|364000624|FG001|Overall Study|Adverse Event|1|||
105546737|NCT00132769|364000623|FG000|Overall Study|Protocol Violation|1|||
105546738|NCT00132769|364000624|FG001|Overall Study|Protocol Violation|1|||
105546739|NCT03832192|364000628|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
105546740|NCT03832192|364000629|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
105546741|NCT00023452|364000630|FG000|Overall Study|Ineligible for Study|163|||
105546742|NCT00023452|364000631|FG001|Overall Study|Ineligible for Study|159|||
105546743|NCT00023452|364000630|FG000|Overall Study|Out of Window|129|||
105546744|NCT00023452|364000631|FG001|Overall Study|Out of Window|69|||
105596130|NCT03460756|364184136|FG001|Overall Study|Lack of Efficacy|0|||
105546745|NCT00023452|364000630|FG000|Overall Study|Death|2|||
105596131|NCT03460756|364184137|FG002|Overall Study|Lack of Efficacy|0|||
105546746|NCT00023452|364000631|FG001|Overall Study|Death|0|||
105546747|NCT00023452|364000630|FG000|Overall Study|Withdrawal by Subject|66|||
105546748|NCT00023452|364000631|FG001|Overall Study|Withdrawal by Subject|54|||
105546749|NCT00023452|364000630|FG000|Overall Study|Adverse Event|139|||
105546750|NCT00023452|364000631|FG001|Overall Study|Adverse Event|196|||
105546751|NCT00023452|364000630|FG000|Overall Study|Lost to Follow-up|293|||
105546752|NCT00023452|364000631|FG001|Overall Study|Lost to Follow-up|60|||
105546753|NCT00023452|364000630|FG000|Overall Study|Physician Decision|49|||
105546754|NCT00023452|364000631|FG001|Overall Study|Physician Decision|21|||
105546755|NCT00023452|364000630|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
105546756|NCT00023452|364000631|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
105546757|NCT00023452|364000630|FG000|Overall Study|Pregnant|53|||
105546758|NCT00023452|364000631|FG001|Overall Study|Pregnant|20|||
105546759|NCT00023452|364000630|FG000|Overall Study|Other|204|||
105546760|NCT00023452|364000631|FG001|Overall Study|Other|69|||
105546761|NCT01802411|364000635|FG000|Overall Study|Death|2|||
105546762|NCT01802411|364000636|FG001|Overall Study|Death|1|||
105546763|NCT01802411|364000635|FG000|Overall Study|Adverse Event|2|||
105546764|NCT01802411|364000636|FG001|Overall Study|Adverse Event|7|||
105546765|NCT01802411|364000635|FG000|Overall Study|Lack of Efficacy|8|||
105546766|NCT01802411|364000636|FG001|Overall Study|Lack of Efficacy|10|||
105546767|NCT01802411|364000635|FG000|Overall Study|Withdrawal by Subject|0|||
105546768|NCT01802411|364000636|FG001|Overall Study|Withdrawal by Subject|2|||
105546769|NCT01802411|364000635|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
105546770|NCT01802411|364000636|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
105546771|NCT01802411|364000635|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
105546772|NCT01802411|364000636|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
105546773|NCT01802411|364000635|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
105546774|NCT01802411|364000636|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
105546775|NCT05070897|364000642|FG000|Overall Study|Protocol Violation|123|||
105546776|NCT05070897|364000643|FG001|Overall Study|Protocol Violation|68|||
105546777|NCT01337245|364000644|FG000|Overall Study|Lost to Follow-up|1|||
105546778|NCT01059617|364000649|FG000|Overall Study|Other|7|||
105546779|NCT01059617|364000650|FG001|Overall Study|Other|1|||
105546780|NCT01059617|364000651|FG002|Overall Study|Other|8|||
105546781|NCT01059617|364000652|FG003|Overall Study|Other|6|||
105546782|NCT00852397|364000653|FG000|Overall Study|Adverse Event|4|||
105546783|NCT00852397|364000654|FG001|Overall Study|Adverse Event|6|||
105546784|NCT00852397|364000655|FG002|Overall Study|Adverse Event|4|||
105546785|NCT00852397|364000653|FG000|Overall Study|Death|0|||
105546786|NCT00852397|364000654|FG001|Overall Study|Death|0|||
105546787|NCT00852397|364000655|FG002|Overall Study|Death|1|||
105546788|NCT00852397|364000653|FG000|Overall Study|Withdrawal by Subject|4|||
105546789|NCT00852397|364000654|FG001|Overall Study|Withdrawal by Subject|1|||
105546790|NCT00852397|364000655|FG002|Overall Study|Withdrawal by Subject|2|||
105546791|NCT00852397|364000653|FG000|Overall Study|Study terminated by sponsor|2|||
105546792|NCT00852397|364000654|FG001|Overall Study|Study terminated by sponsor|1|||
105546793|NCT00852397|364000655|FG002|Overall Study|Study terminated by sponsor|6|||
105546794|NCT00852397|364000653|FG000|Overall Study|Difficulty in study site visit|1|||
105546795|NCT00852397|364000654|FG001|Overall Study|Difficulty in study site visit|0|||
105546796|NCT00852397|364000655|FG002|Overall Study|Difficulty in study site visit|0|||
105546797|NCT00852397|364000653|FG000|Overall Study|Protocol Violation|0|||
105546798|NCT00852397|364000654|FG001|Overall Study|Protocol Violation|0|||
105546799|NCT00852397|364000655|FG002|Overall Study|Protocol Violation|1|||
105546800|NCT02345512|364000656|FG000|Overall Study|Adverse Event|1|||
105546801|NCT02345512|364000656|FG000|Overall Study|Withdrawal by Subject|1|||
105546802|NCT02663817|364000657|FG000|Overall Study|Screen failure|2|||
105546803|NCT03096782|364000659|FG000|Overall Study|Death|1|||
105546804|NCT03096782|364000659|FG000|Overall Study|Participant Relapsed|1|||
105546805|NCT00932893|364000660|FG000|Overall Study|Death|115|||
105546806|NCT00932893|364000661|FG001|Overall Study|Death|24|||
105546807|NCT00932893|364000660|FG000|Overall Study|Lost to Follow-up|8|||
105546808|NCT00932893|364000661|FG001|Overall Study|Lost to Follow-up|0|||
105546809|NCT00932893|364000660|FG000|Overall Study|Withdrawal by Subject|5|||
105546810|NCT00932893|364000661|FG001|Overall Study|Withdrawal by Subject|2|||
105546811|NCT00932893|364000660|FG000|Overall Study|Other|5|||
105546812|NCT00932893|364000661|FG001|Overall Study|Other|144|||
105546813|NCT03136068|364001875|FG000|Overall Study|Lost to Follow-up|1|||
105546814|NCT03136068|364001876|FG001|Overall Study|Lost to Follow-up|1|||
105546815|NCT03136068|364001875|FG000|Overall Study|Protocol Violation|1|||
105546816|NCT03136068|364001876|FG001|Overall Study|Protocol Violation|0|||
105546817|NCT00432380|364001882|FG000|Overall Study|Migrated/moved from study area|3|||
105546818|NCT00432380|364001883|FG001|Overall Study|Migrated/moved from study area|4|||
105546819|NCT00432380|364001884|FG002|Overall Study|Migrated/moved from study area|1|||
105546820|NCT00432380|364001882|FG000|Overall Study|Adverse Event|1|||
105546821|NCT00432380|364001883|FG001|Overall Study|Adverse Event|0|||
105546822|NCT00432380|364001884|FG002|Overall Study|Adverse Event|0|||
105546823|NCT01071395|364001885|FG000|Overall Study|Withdrawal by Subject|2|||
105546824|NCT01071395|364001886|FG001|Overall Study|Withdrawal by Subject|1|||
105546825|NCT01071395|364001885|FG000|Overall Study|Adverse Event|3|||
105546826|NCT01071395|364001886|FG001|Overall Study|Adverse Event|1|||
105546827|NCT01539291|364001887|FG000|Study GS-US-312-0116|Adverse Event|9|||
105546828|NCT01539291|364001888|FG001|Study GS-US-312-0116|Adverse Event|0|||
105546829|NCT01539291|364001889|FG002|Study GS-US-312-0116|Adverse Event|0|||
105546830|NCT01539291|364001890|FG003|Study GS-US-312-0116|Adverse Event|0|||
105546831|NCT01539291|364001887|FG000|Study GS-US-312-0116|Physician Decision|1|||
105546832|NCT01539291|364001888|FG001|Study GS-US-312-0116|Physician Decision|0|||
105546833|NCT01539291|364001889|FG002|Study GS-US-312-0116|Physician Decision|0|||
105546834|NCT01539291|364001890|FG003|Study GS-US-312-0116|Physician Decision|0|||
105546835|NCT01539291|364001887|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
105546836|NCT01539291|364001888|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
105546837|NCT01539291|364001889|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
105546838|NCT01539291|364001890|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
105546839|NCT01539291|364001887|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
105546840|NCT01539291|364001888|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
105546841|NCT01539291|364001889|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
105546842|NCT01539291|364001890|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
105546843|NCT01539291|364001887|FG000|Study GS-US-312-0116|Other|1|||
105546844|NCT01539291|364001888|FG001|Study GS-US-312-0116|Other|0|||
105546845|NCT01539291|364001889|FG002|Study GS-US-312-0116|Other|0|||
105546846|NCT01539291|364001890|FG003|Study GS-US-312-0116|Other|0|||
105546847|NCT01539291|364001887|FG000|Study GS-US-312-0117|Adverse Event|22|||
105546848|NCT01539291|364001888|FG001|Study GS-US-312-0117|Adverse Event|1|||
105546849|NCT01539291|364001889|FG002|Study GS-US-312-0117|Adverse Event|9|||
105546850|NCT01539291|364001890|FG003|Study GS-US-312-0117|Adverse Event|12|||
105546851|NCT01539291|364001887|FG000|Study GS-US-312-0117|Physician Decision|9|||
105546852|NCT01539291|364001888|FG001|Study GS-US-312-0117|Physician Decision|0|||
105546853|NCT01539291|364001889|FG002|Study GS-US-312-0117|Physician Decision|6|||
105546854|NCT01539291|364001890|FG003|Study GS-US-312-0117|Physician Decision|4|||
105546855|NCT01539291|364001887|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
105546856|NCT01539291|364001888|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
105546857|NCT01539291|364001889|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
105546858|NCT01539291|364001890|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
105546859|NCT01539291|364001887|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
105546860|NCT01539291|364001888|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
105546861|NCT01539291|364001889|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
105546862|NCT01539291|364001890|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
105546863|NCT01539291|364001887|FG000|Study GS-US-312-0117|Other|2|||
105546864|NCT01539291|364001888|FG001|Study GS-US-312-0117|Other|1|||
105546865|NCT01539291|364001889|FG002|Study GS-US-312-0117|Other|1|||
105546866|NCT01539291|364001890|FG003|Study GS-US-312-0117|Other|1|||
105546867|NCT01076400|364001891|FG000|Overall Study|Adverse Event|2|||
105546868|NCT01076400|364001892|FG001|Overall Study|Adverse Event|0|||
105546869|NCT01076400|364001893|FG002|Overall Study|Adverse Event|0|||
105546870|NCT01076400|364001891|FG000|Overall Study|Progressive Disease|5|||
105546871|NCT01076400|364001892|FG001|Overall Study|Progressive Disease|0|||
105546872|NCT01076400|364001893|FG002|Overall Study|Progressive Disease|0|||
105546873|NCT01773226|364001894|FG000|Overall Study|Withdrawal by Subject|1|||
105546874|NCT01153633|364001895|FG000|Overall Study|Protocol Violation|1|||
105546875|NCT01153633|364001896|FG001|Overall Study|Protocol Violation|1|||
105546876|NCT01153633|364001895|FG000|Overall Study|Therapeutic failure|3|||
105546877|NCT01153633|364001896|FG001|Overall Study|Therapeutic failure|3|||
105546878|NCT00581945|364001897|FG000|Overall Study|Adverse Event|4|||
105546879|NCT00581945|364001898|FG001|Overall Study|Adverse Event|4|||
105546880|NCT00581945|364001897|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105546881|NCT00581945|364001898|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105546882|NCT00581945|364001897|FG000|Overall Study|Withdrawal by Subject|2|||
105546883|NCT00581945|364001898|FG001|Overall Study|Withdrawal by Subject|6|||
105546884|NCT00581945|364001897|FG000|Overall Study|Death|1|||
105546885|NCT00581945|364001898|FG001|Overall Study|Death|0|||
105546886|NCT02496884|364001899|FG000|Overall Study|Counted twice as enrolled|2|||
105546887|NCT02496884|364001900|FG001|Overall Study|Counted twice as enrolled|0|||
105546888|NCT02496884|364001901|FG002|Overall Study|Counted twice as enrolled|0|||
105546889|NCT02496884|364001902|FG003|Overall Study|Counted twice as enrolled|0|||
105546890|NCT02496884|364001899|FG000|Overall Study|Withdrawal by Subject|0|||
105546891|NCT02496884|364001900|FG001|Overall Study|Withdrawal by Subject|3|||
105546892|NCT02496884|364001901|FG002|Overall Study|Withdrawal by Subject|0|||
105546893|NCT02496884|364001902|FG003|Overall Study|Withdrawal by Subject|0|||
105546894|NCT01163682|364001903|FG000|Overall Study|Lost to Follow-up|6|||
105546895|NCT01163682|364001904|FG001|Overall Study|Lost to Follow-up|9|||
105546896|NCT00359762|364001910|FG000|Period II|Adverse Event|17|||
105546897|NCT00359762|364001911|FG001|Period II|Adverse Event|0|||
105546898|NCT00359762|364001912|FG002|Period II|Adverse Event|0|||
105546899|NCT00359762|364001913|FG003|Period II|Adverse Event|0|||
105546900|NCT00359762|364001914|FG004|Period II|Adverse Event|49|||
105546901|NCT00359762|364001910|FG000|Period II|Protocol Violation|18|||
105546902|NCT00359762|364001911|FG001|Period II|Protocol Violation|0|||
105546903|NCT00359762|364001912|FG002|Period II|Protocol Violation|0|||
105546904|NCT00359762|364001913|FG003|Period II|Protocol Violation|0|||
105546905|NCT00359762|364001914|FG004|Period II|Protocol Violation|11|||
105546906|NCT00359762|364001910|FG000|Period II|Physician Decision|17|||
105546907|NCT00359762|364001911|FG001|Period II|Physician Decision|0|||
105546908|NCT00359762|364001912|FG002|Period II|Physician Decision|0|||
105546909|NCT00359762|364001913|FG003|Period II|Physician Decision|0|||
105546910|NCT00359762|364001914|FG004|Period II|Physician Decision|23|||
105546911|NCT00359762|364001910|FG000|Period II|Death|2|||
105546912|NCT00359762|364001911|FG001|Period II|Death|0|||
105546913|NCT00359762|364001912|FG002|Period II|Death|0|||
105546914|NCT00359762|364001913|FG003|Period II|Death|0|||
105546915|NCT00359762|364001914|FG004|Period II|Death|4|||
105546916|NCT00359762|364001910|FG000|Period II|Lack of Efficacy|11|||
105546917|NCT00359762|364001911|FG001|Period II|Lack of Efficacy|0|||
105546918|NCT00359762|364001912|FG002|Period II|Lack of Efficacy|0|||
105546919|NCT00359762|364001913|FG003|Period II|Lack of Efficacy|0|||
105546920|NCT00359762|364001914|FG004|Period II|Lack of Efficacy|8|||
105546921|NCT00359762|364001910|FG000|Period II|Lost to follow up|5|||
105546922|NCT00359762|364001911|FG001|Period II|Lost to follow up|0|||
105546923|NCT00359762|364001912|FG002|Period II|Lost to follow up|0|||
105546924|NCT00359762|364001913|FG003|Period II|Lost to follow up|0|||
105546925|NCT00359762|364001914|FG004|Period II|Lost to follow up|5|||
105546926|NCT00359762|364001910|FG000|Period II|Entry Criteria Not Met|8|||
105546927|NCT00359762|364001911|FG001|Period II|Entry Criteria Not Met|0|||
105546928|NCT00359762|364001912|FG002|Period II|Entry Criteria Not Met|0|||
105546929|NCT00359762|364001913|FG003|Period II|Entry Criteria Not Met|0|||
105546930|NCT00359762|364001914|FG004|Period II|Entry Criteria Not Met|4|||
105546931|NCT00359762|364001910|FG000|Period II|Subject Decision|50|||
105546932|NCT00359762|364001911|FG001|Period II|Subject Decision|0|||
105546933|NCT00359762|364001912|FG002|Period II|Subject Decision|0|||
105546934|NCT00359762|364001913|FG003|Period II|Subject Decision|0|||
105546935|NCT00359762|364001914|FG004|Period II|Subject Decision|70|||
105546936|NCT00359762|364001910|FG000|Period III|Protocol Violation|0|||
105546937|NCT00359762|364001911|FG001|Period III|Protocol Violation|5|||
105546938|NCT00359762|364001912|FG002|Period III|Protocol Violation|3|||
105546939|NCT00359762|364001913|FG003|Period III|Protocol Violation|8|||
105546940|NCT00359762|364001914|FG004|Period III|Protocol Violation|0|||
105546941|NCT00359762|364001910|FG000|Period III|Adverse Event|0|||
105546942|NCT00359762|364001911|FG001|Period III|Adverse Event|3|||
105546943|NCT00359762|364001912|FG002|Period III|Adverse Event|4|||
105546944|NCT00359762|364001913|FG003|Period III|Adverse Event|10|||
105546945|NCT00359762|364001914|FG004|Period III|Adverse Event|0|||
105546946|NCT00359762|364001910|FG000|Period III|Physician Decision|0|||
105546947|NCT00359762|364001911|FG001|Period III|Physician Decision|5|||
105546948|NCT00359762|364001912|FG002|Period III|Physician Decision|9|||
105546949|NCT00359762|364001913|FG003|Period III|Physician Decision|15|||
105546950|NCT00359762|364001914|FG004|Period III|Physician Decision|0|||
105546951|NCT00359762|364001910|FG000|Period III|Lack of Efficacy|0|||
105546952|NCT00359762|364001911|FG001|Period III|Lack of Efficacy|7|||
105546953|NCT00359762|364001912|FG002|Period III|Lack of Efficacy|5|||
105546954|NCT00359762|364001913|FG003|Period III|Lack of Efficacy|9|||
105546955|NCT00359762|364001914|FG004|Period III|Lack of Efficacy|0|||
105546956|NCT00359762|364001910|FG000|Period III|Lost to follow up|0|||
105546957|NCT00359762|364001911|FG001|Period III|Lost to follow up|1|||
105546958|NCT00359762|364001912|FG002|Period III|Lost to follow up|1|||
105546959|NCT00359762|364001913|FG003|Period III|Lost to follow up|2|||
105546960|NCT00359762|364001914|FG004|Period III|Lost to follow up|0|||
105546961|NCT00359762|364001910|FG000|Period III|Entry Criteria Not Met|0|||
105596132|NCT03460756|364184138|FG003|Overall Study|Lack of Efficacy|2|||
105596133|NCT03460756|364184135|FG000|Overall Study|Lost to Follow-up|0|||
105546962|NCT00359762|364001911|FG001|Period III|Entry Criteria Not Met|1|||
105546963|NCT00359762|364001912|FG002|Period III|Entry Criteria Not Met|0|||
105546964|NCT00359762|364001913|FG003|Period III|Entry Criteria Not Met|1|||
105546965|NCT00359762|364001914|FG004|Period III|Entry Criteria Not Met|0|||
105546966|NCT00359762|364001910|FG000|Period III|Subject Decision|0|||
105546967|NCT00359762|364001911|FG001|Period III|Subject Decision|7|||
105546968|NCT00359762|364001912|FG002|Period III|Subject Decision|8|||
105546969|NCT00359762|364001913|FG003|Period III|Subject Decision|20|||
105546970|NCT00359762|364001914|FG004|Period III|Subject Decision|0|||
105546971|NCT00530023|364001915|FG000|Overall Study|Withdrawal by Subject|0|||
105546972|NCT00530023|364001916|FG001|Overall Study|Withdrawal by Subject|1|||
105546973|NCT00003498|364001919|FG000|Overall Study|Not evaluable.|4|||
105546974|NCT04360824|364001920|FG000|Overall Study|Withdrawal by Subject|2|||
105546975|NCT04360824|364001921|FG001|Overall Study|Withdrawal by Subject|1|||
105546976|NCT04360824|364001920|FG000|Overall Study|Did not receive assigned treatment|1|||
105546977|NCT04360824|364001921|FG001|Overall Study|Did not receive assigned treatment|3|||
105546978|NCT02265705|364001922|FG000|Treatment Period Week 0-24|Adverse Event|3|||
105546979|NCT02265705|364001923|FG001|Treatment Period Week 0-24|Adverse Event|2|||
105546980|NCT02265705|364001924|FG002|Treatment Period Week 0-24|Adverse Event|0|||
105546981|NCT02265705|364001925|FG003|Treatment Period Week 0-24|Adverse Event|0|||
105546982|NCT02265705|364001926|FG004|Treatment Period Week 0-24|Adverse Event|0|||
105546983|NCT02265705|364001927|FG005|Treatment Period Week 0-24|Adverse Event|0|||
105546984|NCT02265705|364001928|FG006|Treatment Period Week 0-24|Adverse Event|0|||
105546985|NCT02265705|364001922|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
105546986|NCT02265705|364001923|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
105546987|NCT02265705|364001924|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
105546988|NCT02265705|364001925|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
105546989|NCT02265705|364001926|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
105546990|NCT02265705|364001927|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
105546991|NCT02265705|364001928|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
105546992|NCT02265705|364001922|FG000|Treatment Period Week 0-24|Physician Decision|1|||
105546993|NCT02265705|364001923|FG001|Treatment Period Week 0-24|Physician Decision|0|||
105546994|NCT02265705|364001924|FG002|Treatment Period Week 0-24|Physician Decision|0|||
105546995|NCT02265705|364001925|FG003|Treatment Period Week 0-24|Physician Decision|0|||
105546996|NCT02265705|364001926|FG004|Treatment Period Week 0-24|Physician Decision|0|||
105546997|NCT02265705|364001927|FG005|Treatment Period Week 0-24|Physician Decision|0|||
105546998|NCT02265705|364001928|FG006|Treatment Period Week 0-24|Physician Decision|0|||
105546999|NCT02265705|364001922|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
105547000|NCT02265705|364001923|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
105547001|NCT02265705|364001924|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
105547002|NCT02265705|364001925|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
105547003|NCT02265705|364001926|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
105547004|NCT02265705|364001927|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
105547005|NCT02265705|364001928|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
105547006|NCT02265705|364001922|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
105547007|NCT02265705|364001923|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
105547008|NCT02265705|364001924|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
105547009|NCT02265705|364001925|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
105547010|NCT02265705|364001926|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
105547011|NCT02265705|364001927|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
105547012|NCT02265705|364001928|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
105547013|NCT02265705|364001922|FG000|Rescue Period|Withdrawal by Subject|0|||
105547014|NCT02265705|364001923|FG001|Rescue Period|Withdrawal by Subject|0|||
105547015|NCT02265705|364001924|FG002|Rescue Period|Withdrawal by Subject|1|||
105547016|NCT02265705|364001925|FG003|Rescue Period|Withdrawal by Subject|0|||
105547017|NCT02265705|364001926|FG004|Rescue Period|Withdrawal by Subject|0|||
105547018|NCT02265705|364001927|FG005|Rescue Period|Withdrawal by Subject|0|||
105547019|NCT02265705|364001928|FG006|Rescue Period|Withdrawal by Subject|0|||
105547020|NCT02265705|364001922|FG000|Rescue Period|Death|0|||
105547021|NCT02265705|364001923|FG001|Rescue Period|Death|0|||
105547022|NCT02265705|364001924|FG002|Rescue Period|Death|1|||
105547023|NCT02265705|364001925|FG003|Rescue Period|Death|0|||
105547024|NCT02265705|364001926|FG004|Rescue Period|Death|0|||
105547025|NCT02265705|364001927|FG005|Rescue Period|Death|0|||
105547026|NCT02265705|364001928|FG006|Rescue Period|Death|0|||
105547027|NCT02265705|364001922|FG000|Rescue Period|Lack of Efficacy|0|||
105547028|NCT02265705|364001923|FG001|Rescue Period|Lack of Efficacy|0|||
105547029|NCT02265705|364001924|FG002|Rescue Period|Lack of Efficacy|1|||
105547030|NCT02265705|364001925|FG003|Rescue Period|Lack of Efficacy|0|||
105547031|NCT02265705|364001926|FG004|Rescue Period|Lack of Efficacy|0|||
105547032|NCT02265705|364001927|FG005|Rescue Period|Lack of Efficacy|0|||
105547033|NCT02265705|364001928|FG006|Rescue Period|Lack of Efficacy|0|||
105547034|NCT02265705|364001922|FG000|Open Label Period|Adverse Event|0|||
105547035|NCT02265705|364001923|FG001|Open Label Period|Adverse Event|0|||
105547036|NCT02265705|364001924|FG002|Open Label Period|Adverse Event|0|||
105547037|NCT02265705|364001925|FG003|Open Label Period|Adverse Event|2|||
105547038|NCT02265705|364001926|FG004|Open Label Period|Adverse Event|2|||
105547039|NCT02265705|364001927|FG005|Open Label Period|Adverse Event|0|||
105547040|NCT02265705|364001928|FG006|Open Label Period|Adverse Event|0|||
105547041|NCT02265705|364001922|FG000|Open Label Period|Physician Decision|0|||
105547042|NCT02265705|364001923|FG001|Open Label Period|Physician Decision|0|||
105547043|NCT02265705|364001924|FG002|Open Label Period|Physician Decision|0|||
105547044|NCT02265705|364001925|FG003|Open Label Period|Physician Decision|0|||
105547045|NCT02265705|364001926|FG004|Open Label Period|Physician Decision|1|||
105547046|NCT02265705|364001927|FG005|Open Label Period|Physician Decision|0|||
105547047|NCT02265705|364001928|FG006|Open Label Period|Physician Decision|0|||
105547048|NCT02265705|364001922|FG000|Open Label Period|Withdrawal by Subject|0|||
105547049|NCT02265705|364001923|FG001|Open Label Period|Withdrawal by Subject|0|||
105547050|NCT02265705|364001924|FG002|Open Label Period|Withdrawal by Subject|0|||
105547051|NCT02265705|364001925|FG003|Open Label Period|Withdrawal by Subject|0|||
105547052|NCT02265705|364001926|FG004|Open Label Period|Withdrawal by Subject|2|||
105547053|NCT02265705|364001927|FG005|Open Label Period|Withdrawal by Subject|0|||
105547054|NCT02265705|364001928|FG006|Open Label Period|Withdrawal by Subject|0|||
105547055|NCT02265705|364001922|FG000|Follow-up Period|Sponsor Decision|0|||
105547056|NCT02265705|364001923|FG001|Follow-up Period|Sponsor Decision|0|||
105547057|NCT02265705|364001924|FG002|Follow-up Period|Sponsor Decision|0|||
105547058|NCT02265705|364001925|FG003|Follow-up Period|Sponsor Decision|0|||
105547059|NCT02265705|364001926|FG004|Follow-up Period|Sponsor Decision|0|||
105547060|NCT02265705|364001927|FG005|Follow-up Period|Sponsor Decision|1|||
105547061|NCT02265705|364001928|FG006|Follow-up Period|Sponsor Decision|6|||
105547062|NCT02265705|364001922|FG000|Follow-up Period|Adverse Event|0|||
105547063|NCT02265705|364001923|FG001|Follow-up Period|Adverse Event|0|||
105547064|NCT02265705|364001924|FG002|Follow-up Period|Adverse Event|0|||
105547065|NCT02265705|364001925|FG003|Follow-up Period|Adverse Event|0|||
105547066|NCT02265705|364001926|FG004|Follow-up Period|Adverse Event|0|||
105547067|NCT02265705|364001927|FG005|Follow-up Period|Adverse Event|0|||
105547068|NCT02265705|364001928|FG006|Follow-up Period|Adverse Event|3|||
105547069|NCT02265705|364001922|FG000|Follow-up Period|Physician Decision|0|||
105547070|NCT02265705|364001923|FG001|Follow-up Period|Physician Decision|0|||
105547071|NCT02265705|364001924|FG002|Follow-up Period|Physician Decision|0|||
105547072|NCT02265705|364001925|FG003|Follow-up Period|Physician Decision|0|||
105547073|NCT02265705|364001926|FG004|Follow-up Period|Physician Decision|0|||
105547074|NCT02265705|364001927|FG005|Follow-up Period|Physician Decision|0|||
105547075|NCT02265705|364001928|FG006|Follow-up Period|Physician Decision|1|||
105547076|NCT02265705|364001922|FG000|Follow-up Period|Withdrawal by Subject|0|||
105547077|NCT02265705|364001923|FG001|Follow-up Period|Withdrawal by Subject|0|||
105547078|NCT02265705|364001924|FG002|Follow-up Period|Withdrawal by Subject|0|||
105547079|NCT02265705|364001925|FG003|Follow-up Period|Withdrawal by Subject|0|||
105547080|NCT02265705|364001926|FG004|Follow-up Period|Withdrawal by Subject|0|||
105547081|NCT02265705|364001927|FG005|Follow-up Period|Withdrawal by Subject|0|||
105547082|NCT02265705|364001928|FG006|Follow-up Period|Withdrawal by Subject|1|||
105547083|NCT00346034|364001931|FG000|Overall Study|Adverse Event|34|||
105547084|NCT00346034|364001931|FG000|Overall Study|Lack of Efficacy|8|||
105547085|NCT00346034|364001931|FG000|Overall Study|Withdrawal by Subject|13|||
105547086|NCT00346034|364001931|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
105547087|NCT00346034|364001931|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
105547088|NCT00583557|364001932|FG000|Overall Study|Withdrawal by Subject|18|||
105547089|NCT00583557|364001932|FG000|Overall Study|Adverse Event|9|||
105547090|NCT00583557|364001932|FG000|Overall Study|Lack of Efficacy|31|||
105547091|NCT00583557|364001932|FG000|Overall Study|Lack of Compliance|5|||
105547092|NCT00583557|364001932|FG000|Overall Study|Other|5|||
105547093|NCT00583557|364001932|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
105547094|NCT02843568|364001933|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
105547095|NCT02843568|364001934|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
105547096|NCT02843568|364001933|FG000|Overall Study|Death|3|||
105547097|NCT02843568|364001934|FG001|Overall Study|Death|3|||
105547098|NCT02843568|364001933|FG000|Overall Study|Withdrawal by Subject|1|||
105547099|NCT02843568|364001934|FG001|Overall Study|Withdrawal by Subject|1|||
105547100|NCT02843568|364001933|FG000|Overall Study|Lost to Follow-up|2|||
105547101|NCT02843568|364001934|FG001|Overall Study|Lost to Follow-up|0|||
105547102|NCT00797667|364001937|FG000|Overall Study|Lack of Efficacy|0|||
105547103|NCT00797667|364001938|FG001|Overall Study|Lack of Efficacy|1|||
105547104|NCT00797667|364001939|FG002|Overall Study|Lack of Efficacy|0|||
105547105|NCT00797667|364001937|FG000|Overall Study|Lost to Follow-up|8|||
105547106|NCT00797667|364001938|FG001|Overall Study|Lost to Follow-up|12|||
105547107|NCT00797667|364001939|FG002|Overall Study|Lost to Follow-up|2|||
105547108|NCT00797667|364001937|FG000|Overall Study|Physician Decision|3|||
105547109|NCT00797667|364001938|FG001|Overall Study|Physician Decision|1|||
105547110|NCT00797667|364001939|FG002|Overall Study|Physician Decision|0|||
105596134|NCT03460756|364184136|FG001|Overall Study|Lost to Follow-up|1|||
105596135|NCT03460756|364184137|FG002|Overall Study|Lost to Follow-up|2|||
105596136|NCT03460756|364184138|FG003|Overall Study|Lost to Follow-up|1|||
105596137|NCT03460756|364184135|FG000|Overall Study|Pregnancy|0|||
105596138|NCT03460756|364184136|FG001|Overall Study|Pregnancy|0|||
105596139|NCT03460756|364184137|FG002|Overall Study|Pregnancy|0|||
105596140|NCT03460756|364184138|FG003|Overall Study|Pregnancy|1|||
105596141|NCT03460756|364184135|FG000|Overall Study|Protocol Violation|0|||
105547111|NCT00797667|364001937|FG000|Overall Study|Pregnancy|2|||
105547112|NCT00797667|364001938|FG001|Overall Study|Pregnancy|0|||
105547113|NCT00797667|364001939|FG002|Overall Study|Pregnancy|0|||
105547114|NCT00797667|364001937|FG000|Overall Study|Protocol Violation|2|||
105547115|NCT00797667|364001938|FG001|Overall Study|Protocol Violation|7|||
105547116|NCT00797667|364001939|FG002|Overall Study|Protocol Violation|0|||
105547117|NCT00797667|364001937|FG000|Overall Study|Study Terminated by Sponsor|217|||
105547118|NCT00797667|364001938|FG001|Overall Study|Study Terminated by Sponsor|216|||
105547119|NCT00797667|364001939|FG002|Overall Study|Study Terminated by Sponsor|115|||
105596142|NCT03460756|364184136|FG001|Overall Study|Protocol Violation|0|||
105596143|NCT03460756|364184137|FG002|Overall Study|Protocol Violation|0|||
105547120|NCT00797667|364001937|FG000|Overall Study|Withdrawal by Subject|9|||
105547121|NCT00797667|364001938|FG001|Overall Study|Withdrawal by Subject|14|||
105547122|NCT00797667|364001939|FG002|Overall Study|Withdrawal by Subject|2|||
105547123|NCT00797667|364001937|FG000|Overall Study|Adverse Event|19|||
105547124|NCT00797667|364001938|FG001|Overall Study|Adverse Event|8|||
105547125|NCT00797667|364001939|FG002|Overall Study|Adverse Event|8|||
105547126|NCT01229436|364001940|FG000|Overall Study|Withdrawal by Subject|2|||
105547127|NCT01229436|364001940|FG000|Overall Study|Lost to Follow-up|3|||
105547128|NCT00781326|364001941|FG000|Phase I|Adverse Event|1|||
105547129|NCT00781326|364001941|FG000|Phase I|Withdrawal by Subject|1|||
105547130|NCT00781326|364001941|FG000|Phase I|Physician Decision|2|||
105547131|NCT01775137|364001942|FG000|Overall Study|Death|1|||
105547132|NCT01775137|364001942|FG000|Overall Study|Protocol deviation|2|||
105547133|NCT01775137|364001942|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105547134|NCT01775137|364001942|FG000|Overall Study|Adverse Event|1|||
105547135|NCT01775137|364001942|FG000|Overall Study|Withdrawal by participants|5|||
105547136|NCT01732835|364001955|FG000|6-month Primary Endpoint|Did not receive device|19|||
105547137|NCT01732835|364001955|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
105547138|NCT01732835|364001955|FG000|6-month Primary Endpoint|Adverse Event|3|||
105547139|NCT01732835|364001955|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
105547140|NCT01732835|364001955|FG000|2-year Extended Follow-up|Adverse Event|3|||
105547141|NCT01732835|364001955|FG000|2-year Extended Follow-up|Death|1|||
105547142|NCT00793910|364001956|FG000|Overall Study|discarded study pills|0|||
105547143|NCT00793910|364001957|FG001|Overall Study|discarded study pills|1|||
105547144|NCT00793910|364001956|FG000|Overall Study|did not pick up medications|1|||
105547145|NCT00793910|364001957|FG001|Overall Study|did not pick up medications|1|||
105547146|NCT00793910|364001956|FG000|Overall Study|ineligible based on entry criteria|2|||
105547147|NCT00793910|364001957|FG001|Overall Study|ineligible based on entry criteria|3|||
105547148|NCT00793910|364001956|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
105547149|NCT00793910|364001957|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
105547150|NCT00793910|364001956|FG000|Overall Study|Withdrawal by Subject|0|||
105547151|NCT00793910|364001957|FG001|Overall Study|Withdrawal by Subject|1|||
105547152|NCT01700946|364001958|FG000|Overall Study|Lost to Follow-up|1|||
105547153|NCT01700946|364001959|FG001|Overall Study|Lost to Follow-up|0|||
105547154|NCT01700946|364001958|FG000|Overall Study|Physician Decision|7|||
105547155|NCT01700946|364001959|FG001|Overall Study|Physician Decision|12|||
105547156|NCT01700946|364001958|FG000|Overall Study|Withdrawal by Subject|0|||
105547157|NCT01700946|364001959|FG001|Overall Study|Withdrawal by Subject|2|||
105547158|NCT01700946|364001958|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
105547159|NCT01700946|364001959|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
105547160|NCT01700946|364001958|FG000|Overall Study|Relapse|2|||
105547161|NCT01700946|364001959|FG001|Overall Study|Relapse|1|||
105547162|NCT01700946|364001958|FG000|Overall Study|Unacceptable toxicity|1|||
105547163|NCT01700946|364001959|FG001|Overall Study|Unacceptable toxicity|0|||
105547164|NCT03321981|364001967|FG000|Overall Study|Progressive Disease (PD)|15|||
105547165|NCT03321981|364001968|FG001|Overall Study|Progressive Disease (PD)|30|||
105547166|NCT03321981|364001969|FG002|Overall Study|Progressive Disease (PD)|47|||
105547167|NCT03321981|364001967|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
105547168|NCT03321981|364001968|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
105547169|NCT03321981|364001969|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
105547170|NCT03321981|364001967|FG000|Overall Study|Adverse Event|0|||
105547171|NCT03321981|364001968|FG001|Overall Study|Adverse Event|0|||
105547172|NCT03321981|364001969|FG002|Overall Study|Adverse Event|2|||
105547173|NCT03321981|364001967|FG000|Overall Study|symptomatic deterioration|0|||
105547174|NCT03321981|364001968|FG001|Overall Study|symptomatic deterioration|1|||
105547175|NCT03321981|364001969|FG002|Overall Study|symptomatic deterioration|1|||
105547176|NCT03321981|364001967|FG000|Overall Study|Lack of compliance|0|||
105547177|NCT03321981|364001968|FG001|Overall Study|Lack of compliance|1|||
105547178|NCT03321981|364001969|FG002|Overall Study|Lack of compliance|0|||
105547179|NCT03321981|364001967|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
105547180|NCT03321981|364001968|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
105547181|NCT03321981|364001969|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
105547182|NCT03321981|364001967|FG000|Overall Study|Death|0|||
105547183|NCT03321981|364001968|FG001|Overall Study|Death|1|||
105547184|NCT03321981|364001969|FG002|Overall Study|Death|0|||
105547185|NCT03321981|364001967|FG000|Overall Study|Subject withdrawal of investigational product|0|||
105547186|NCT03321981|364001968|FG001|Overall Study|Subject withdrawal of investigational product|1|||
105547187|NCT03321981|364001969|FG002|Overall Study|Subject withdrawal of investigational product|0|||
105547188|NCT03321981|364001967|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
105547189|NCT03321981|364001968|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
105596144|NCT03460756|364184138|FG003|Overall Study|Protocol Violation|1|||
105596145|NCT03460756|364184135|FG000|Overall Study|Withdrawal by Subject|0|||
105547190|NCT03321981|364001969|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
105547191|NCT03321981|364001967|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
105547192|NCT03321981|364001968|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
105547193|NCT03321981|364001969|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
105547194|NCT00096135|364001970|FG000|Overall Study|Physician Decision|20|||
105547195|NCT00096135|364001971|FG001|Overall Study|Physician Decision|4|||
105547196|NCT00096135|364001970|FG000|Overall Study|Refusal of further protocol therapy|4|||
105547197|NCT00096135|364001971|FG001|Overall Study|Refusal of further protocol therapy|1|||
105547198|NCT00096135|364001970|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
105547199|NCT00096135|364001971|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
105547200|NCT00096135|364001970|FG000|Overall Study|Other, specify|15|||
105547201|NCT00096135|364001971|FG001|Overall Study|Other, specify|3|||
105547202|NCT00096135|364001970|FG000|Overall Study|Ineligible|2|||
105547203|NCT00096135|364001971|FG001|Overall Study|Ineligible|0|||
105547204|NCT00817089|364001972|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
105547205|NCT00817089|364001973|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
105547206|NCT00817089|364001974|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
105547207|NCT00817089|364001975|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
105547208|NCT00817089|364001972|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
105547209|NCT00817089|364001973|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
105547210|NCT00817089|364001974|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
105547211|NCT00817089|364001975|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
105547212|NCT02543346|364001986|FG000|Second Priming Visit|Withdrawal by Subject|0|||
105547213|NCT02543346|364001987|FG001|Second Priming Visit|Withdrawal by Subject|2|||
105547214|NCT02543346|364001988|FG002|Second Priming Visit|Withdrawal by Subject|2|||
105547215|NCT02543346|364001989|FG003|Second Priming Visit|Withdrawal by Subject|2|||
105547216|NCT02543346|364001986|FG000|Second Priming Visit|Adverse Event|1|||
105547217|NCT02543346|364001987|FG001|Second Priming Visit|Adverse Event|0|||
105547218|NCT02543346|364001988|FG002|Second Priming Visit|Adverse Event|0|||
105547219|NCT02543346|364001989|FG003|Second Priming Visit|Adverse Event|0|||
105547220|NCT04798586|364001990|FG000|Overall Study|Death|2|||
105547221|NCT02371369|364001995|FG000|Part 1|Physician Decision|0|||
105547222|NCT02371369|364001996|FG001|Part 1|Physician Decision|3|||
105547223|NCT02371369|364001995|FG000|Part 1|Adverse Event|8|||
105547224|NCT02371369|364001996|FG001|Part 1|Adverse Event|0|||
105547225|NCT02371369|364001995|FG000|Part 1|Withdrawal by Subject|1|||
105547226|NCT02371369|364001996|FG001|Part 1|Withdrawal by Subject|6|||
105547227|NCT02371369|364001995|FG000|Part 1|Disease progression|0|||
105547228|NCT02371369|364001996|FG001|Part 1|Disease progression|1|||
105547229|NCT02371369|364001995|FG000|Part 1|Protocol Violation|0|||
105547230|NCT02371369|364001996|FG001|Part 1|Protocol Violation|1|||
105596146|NCT03460756|364184136|FG001|Overall Study|Withdrawal by Subject|4|||
105596147|NCT03460756|364184137|FG002|Overall Study|Withdrawal by Subject|7|||
105596148|NCT03460756|364184138|FG003|Overall Study|Withdrawal by Subject|3|||
105596149|NCT02441036|364184141|FG000|Overall Study|No tissue resected|0|||
105596150|NCT02441036|364184142|FG001|Overall Study|No tissue resected|1|||
105596151|NCT02441036|364184143|FG002|Overall Study|No tissue resected|0|||
105596152|NCT02441036|364184144|FG003|Overall Study|No tissue resected|1|||
105596153|NCT02441036|364184145|FG004|Overall Study|No tissue resected|0|||
105596154|NCT00723450|364184149|FG000|Open-Label Phase|Adverse Event|26|||
105596155|NCT00723450|364184150|FG001|Open-Label Phase|Adverse Event|0|||
105596156|NCT00723450|364184151|FG002|Open-Label Phase|Adverse Event|0|||
105596157|NCT00723450|364184149|FG000|Open-Label Phase|Lack of Efficacy|18|||
105596158|NCT00723450|364184150|FG001|Open-Label Phase|Lack of Efficacy|0|||
105596159|NCT00723450|364184151|FG002|Open-Label Phase|Lack of Efficacy|0|||
105596160|NCT00723450|364184149|FG000|Open-Label Phase|Protocol Violation|35|||
105596161|NCT00723450|364184150|FG001|Open-Label Phase|Protocol Violation|0|||
105596162|NCT00723450|364184151|FG002|Open-Label Phase|Protocol Violation|0|||
105596163|NCT00723450|364184149|FG000|Open-Label Phase|Lost to Follow-up|7|||
105596164|NCT00723450|364184150|FG001|Open-Label Phase|Lost to Follow-up|0|||
105596165|NCT00723450|364184151|FG002|Open-Label Phase|Lost to Follow-up|0|||
105596166|NCT00723450|364184149|FG000|Open-Label Phase|Physician Decision|2|||
105596167|NCT00723450|364184150|FG001|Open-Label Phase|Physician Decision|0|||
105547231|NCT02371369|364001995|FG000|Part 2|Adverse Event|6|||
105547232|NCT02371369|364001996|FG001|Part 2|Adverse Event|5|||
105547233|NCT02371369|364001995|FG000|Part 2|Withdrawal by Subject|16|||
105547234|NCT02371369|364001996|FG001|Part 2|Withdrawal by Subject|6|||
105547235|NCT02371369|364001995|FG000|Part 2|Investigator decision|1|||
105547236|NCT02371369|364001996|FG001|Part 2|Investigator decision|2|||
105596168|NCT00723450|364184151|FG002|Open-Label Phase|Physician Decision|0|||
105596169|NCT00723450|364184149|FG000|Open-Label Phase|Withdrawal by Subject|37|||
105596170|NCT00723450|364184150|FG001|Open-Label Phase|Withdrawal by Subject|0|||
105596171|NCT00723450|364184151|FG002|Open-Label Phase|Withdrawal by Subject|0|||
105547237|NCT02371369|364001995|FG000|Part 2|Death|0|||
105547238|NCT02371369|364001996|FG001|Part 2|Death|1|||
105547239|NCT02371369|364001995|FG000|Part 2|Disease progression|1|||
105547240|NCT02371369|364001996|FG001|Part 2|Disease progression|0|||
105547241|NCT02371369|364001995|FG000|Part 2|Subject Noncompliance|1|||
105547242|NCT02371369|364001996|FG001|Part 2|Subject Noncompliance|0|||
105547243|NCT02371369|364001995|FG000|Part 2|Lost to Follow-up|1|||
105547244|NCT02371369|364001996|FG001|Part 2|Lost to Follow-up|1|||
105547245|NCT02371369|364001995|FG000|Part 2|Subject transitioned to commercial supply|6|||
105547246|NCT02371369|364001996|FG001|Part 2|Subject transitioned to commercial supply|4|||
105547247|NCT02371369|364001995|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
105547248|NCT02371369|364001996|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
105547249|NCT02371369|364001995|FG000|Part 2|Surgical resection of tumor|1|||
105547250|NCT02371369|364001996|FG001|Part 2|Surgical resection of tumor|1|||
105547251|NCT02371369|364001995|FG000|Part 2|Other|0|||
105547252|NCT02371369|364001996|FG001|Part 2|Other|1|||
105547253|NCT00803634|364001997|FG000|Overall Study|Withdrew Consent|1|||
105547254|NCT00803634|364001998|FG001|Overall Study|Withdrew Consent|0|||
105547255|NCT00803634|364001997|FG000|Overall Study|Lost to Follow-up|2|||
105547256|NCT00803634|364001998|FG001|Overall Study|Lost to Follow-up|3|||
105547257|NCT00803634|364001997|FG000|Overall Study|Death|3|||
105547258|NCT00803634|364001998|FG001|Overall Study|Death|2|||
105547259|NCT02720484|364002006|FG000|Treatment on Study|Adverse Event|1|||
105547260|NCT02720484|364002006|FG000|Treatment on Study|Withdrawal by Subject|1|||
105547261|NCT02720484|364002006|FG000|Treatment on Study|Progressive Disease|4|||
105547262|NCT02720484|364002006|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
105547263|NCT02720484|364002006|FG000|Follow Up for 2 Years|Death|3|||
105547264|NCT02720484|364002006|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
105547265|NCT03588572|364002007|FG000|Visitation 1|Lack of Efficacy|1|||
105547266|NCT03588572|364002008|FG001|Visitation 1|Lack of Efficacy|1|||
105547267|NCT03588572|364002007|FG000|Visitation 2|Lost to Follow-up|1|||
105547268|NCT03588572|364002008|FG001|Visitation 2|Lost to Follow-up|1|||
105547269|NCT03588572|364002007|FG000|Visitation 2|Lack of Efficacy|0|||
105547270|NCT03588572|364002008|FG001|Visitation 2|Lack of Efficacy|1|||
105547271|NCT03588572|364002007|FG000|Visitation 2|Withdrawal by Subject|1|||
105547272|NCT03588572|364002008|FG001|Visitation 2|Withdrawal by Subject|0|||
105547273|NCT03588572|364002007|FG000|Visitation 3|Lost to Follow-up|1|||
105547274|NCT03588572|364002008|FG001|Visitation 3|Lost to Follow-up|1|||
105547275|NCT03588572|364002007|FG000|Visitation 3|Physician Decision|1|||
105547276|NCT03588572|364002008|FG001|Visitation 3|Physician Decision|1|||
105547277|NCT03588572|364002007|FG000|Visitation 3|Withdrawal by Subject|1|||
105547278|NCT03588572|364002008|FG001|Visitation 3|Withdrawal by Subject|0|||
105547279|NCT01307501|364002011|FG000|Overall Study|Treatment Failure|1|||
105547280|NCT01307501|364002011|FG000|Overall Study|Death|20|||
105547281|NCT01307501|364002011|FG000|Overall Study|Lost to Follow-up|1|||
105547282|NCT01307501|364002011|FG000|Overall Study|Starting Hospice|1|||
105547283|NCT03712917|364002014|FG000|Overall Study|Pregnancy|0|||
105547284|NCT03712917|364002015|FG001|Overall Study|Pregnancy|0|||
105547285|NCT03712917|364002016|FG002|Overall Study|Pregnancy|1|||
105547286|NCT03712917|364002014|FG000|Overall Study|Adverse Event|0|||
105547287|NCT03712917|364002015|FG001|Overall Study|Adverse Event|4|||
105547288|NCT03712917|364002016|FG002|Overall Study|Adverse Event|3|||
105547289|NCT03712917|364002014|FG000|Overall Study|Lost to Follow-up|9|||
105547290|NCT03712917|364002015|FG001|Overall Study|Lost to Follow-up|4|||
105547291|NCT03712917|364002016|FG002|Overall Study|Lost to Follow-up|5|||
105547292|NCT03662750|364002020|FG000|Overall Study|Withdrawal by Subject|1|||
105547293|NCT00116805|364003689|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
105547294|NCT00116805|364003690|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
105547295|NCT00116805|364003689|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
105547296|NCT00116805|364003690|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
105547297|NCT00116805|364003689|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
105547298|NCT00116805|364003690|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
105547299|NCT00116805|364003689|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
105547300|NCT00116805|364003690|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
105547301|NCT00116805|364003689|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
105547302|NCT00116805|364003690|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
105547303|NCT00116805|364003689|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
105547304|NCT00116805|364003690|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
105547305|NCT00116805|364003689|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
105547306|NCT00116805|364003690|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
105547307|NCT00116805|364003689|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
105547308|NCT00116805|364003690|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
105547309|NCT00116805|364003689|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
105547310|NCT00116805|364003690|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
105547311|NCT00116805|364003689|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
105547312|NCT00116805|364003690|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
105547313|NCT00116805|364003689|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
105547314|NCT00116805|364003690|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
105547315|NCT00116805|364003689|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
105547316|NCT00116805|364003690|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
105547317|NCT00116805|364003689|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
105547318|NCT00116805|364003690|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
105547319|NCT00116805|364003689|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
105547320|NCT00116805|364003690|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
105547321|NCT00116805|364003689|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
105547322|NCT00116805|364003690|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
105547323|NCT00116805|364003689|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
105547324|NCT00116805|364003690|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
105547325|NCT00116805|364003689|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
105547326|NCT00116805|364003690|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
105547327|NCT00116805|364003689|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
105547328|NCT00116805|364003690|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
105547329|NCT00116805|364003689|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
105547330|NCT00116805|364003690|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
105547331|NCT00116805|364003689|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
105547332|NCT00116805|364003690|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
105547333|NCT00116805|364003689|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
105547334|NCT00116805|364003690|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
105547335|NCT00116805|364003689|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
105547336|NCT00116805|364003690|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
105547337|NCT00116805|364003689|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
105547338|NCT00116805|364003690|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
105547339|NCT00116805|364003689|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
105547340|NCT00116805|364003690|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
105547341|NCT00116805|364003689|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
105547342|NCT00116805|364003690|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
105547343|NCT00116805|364003689|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
105547344|NCT00116805|364003690|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
105547345|NCT00116805|364003689|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
105547346|NCT00116805|364003690|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
105547347|NCT00116805|364003689|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
105547348|NCT00116805|364003690|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
105547349|NCT00116805|364003689|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
105547350|NCT00116805|364003690|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
105547351|NCT00116805|364003689|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
105547352|NCT00116805|364003690|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
105547353|NCT00116805|364003689|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
105547354|NCT00116805|364003690|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
105547355|NCT00116805|364003689|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
105547356|NCT00116805|364003690|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
105547357|NCT00116805|364003689|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
105547358|NCT00116805|364003690|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
105547359|NCT00116805|364003689|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
105547360|NCT00116805|364003690|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
105547361|NCT00116805|364003689|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
105547362|NCT00116805|364003690|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
105547363|NCT00116805|364003689|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
105547364|NCT00116805|364003690|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
105547365|NCT00116805|364003689|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
105547366|NCT00116805|364003690|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
105547367|NCT00116805|364003689|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
105547368|NCT00116805|364003690|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
105547369|NCT00116805|364003689|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
105547370|NCT00116805|364003690|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
105547371|NCT00116805|364003689|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
105547372|NCT00116805|364003690|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
105547373|NCT00116805|364003689|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
105547374|NCT00116805|364003690|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
105547375|NCT00116805|364003689|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
105547376|NCT00116805|364003690|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
105547377|NCT00116805|364003689|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
105547378|NCT00116805|364003690|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
105547379|NCT00116805|364003689|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
105547380|NCT00116805|364003690|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
105547381|NCT00116805|364003689|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
105547382|NCT00116805|364003690|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
105547383|NCT01760954|364003691|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
105547384|NCT01760954|364003692|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
105547385|NCT01760954|364003693|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
105547386|NCT01760954|364003694|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
105547387|NCT01760954|364003691|FG000|Treatment Period (6 Months)|Adverse Event|5|||
105547388|NCT01760954|364003692|FG001|Treatment Period (6 Months)|Adverse Event|3|||
105547389|NCT01760954|364003693|FG002|Treatment Period (6 Months)|Adverse Event|4|||
105547390|NCT01760954|364003694|FG003|Treatment Period (6 Months)|Adverse Event|10|||
105547391|NCT01760954|364003691|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
105547392|NCT01760954|364003692|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
105547393|NCT01760954|364003693|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
105547394|NCT01760954|364003694|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
105547395|NCT01760954|364003691|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
105547396|NCT01760954|364003692|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
105547397|NCT01760954|364003693|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
105547398|NCT01760954|364003694|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
105547399|NCT01760954|364003691|FG000|Treatment Period (6 Months)|Pregnancy|5|||
105547400|NCT01760954|364003692|FG001|Treatment Period (6 Months)|Pregnancy|0|||
105547401|NCT01760954|364003693|FG002|Treatment Period (6 Months)|Pregnancy|3|||
105547402|NCT01760954|364003694|FG003|Treatment Period (6 Months)|Pregnancy|2|||
105547403|NCT01760954|364003691|FG000|Treatment Period (6 Months)|Non-compliance|1|||
105547404|NCT01760954|364003692|FG001|Treatment Period (6 Months)|Non-compliance|4|||
105547405|NCT01760954|364003693|FG002|Treatment Period (6 Months)|Non-compliance|0|||
105547406|NCT01760954|364003694|FG003|Treatment Period (6 Months)|Non-compliance|3|||
105547407|NCT01760954|364003691|FG000|Treatment Period (6 Months)|Other|0|||
105547408|NCT01760954|364003692|FG001|Treatment Period (6 Months)|Other|3|||
105547409|NCT01760954|364003693|FG002|Treatment Period (6 Months)|Other|3|||
105547410|NCT01760954|364003694|FG003|Treatment Period (6 Months)|Other|1|||
105547411|NCT01760954|364003691|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
105547412|NCT01760954|364003692|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
105547413|NCT01760954|364003693|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
105547414|NCT01760954|364003694|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
105547415|NCT01760954|364003691|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
105547416|NCT01760954|364003692|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
105547417|NCT01760954|364003693|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
105547418|NCT01760954|364003694|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
105547419|NCT01760954|364003691|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
105547420|NCT01760954|364003692|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
105547421|NCT01760954|364003693|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
105547422|NCT01760954|364003694|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
105547423|NCT01760954|364003691|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
105547424|NCT01760954|364003692|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
105547425|NCT01760954|364003693|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
105547426|NCT01760954|364003694|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
105547427|NCT01760954|364003691|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
105547428|NCT01760954|364003692|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
105547429|NCT01760954|364003693|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
105547430|NCT01760954|364003694|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
105547431|NCT01760954|364003691|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
105547432|NCT01760954|364003692|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
105547433|NCT01760954|364003693|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
105596172|NCT00723450|364184149|FG000|Randomized Phase|Adverse Event|0|||
105596173|NCT00723450|364184150|FG001|Randomized Phase|Adverse Event|26|||
105596174|NCT00723450|364184151|FG002|Randomized Phase|Adverse Event|17|||
105596175|NCT00723450|364184149|FG000|Randomized Phase|Lack of Efficacy|0|||
105596176|NCT00723450|364184150|FG001|Randomized Phase|Lack of Efficacy|11|||
105596177|NCT00723450|364184151|FG002|Randomized Phase|Lack of Efficacy|11|||
105596178|NCT00723450|364184149|FG000|Randomized Phase|Protocol Violation|0|||
105596179|NCT00723450|364184150|FG001|Randomized Phase|Protocol Violation|9|||
105547434|NCT01760954|364003694|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
105547435|NCT01760954|364003691|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
105547436|NCT01760954|364003692|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
105547437|NCT01760954|364003693|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
105547438|NCT01760954|364003694|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
105547439|NCT01760954|364003691|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
105547440|NCT01760954|364003692|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
105547441|NCT01760954|364003693|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
105547442|NCT01760954|364003694|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
105547443|NCT02707055|364003695|FG000|Phase 1|Withdrawal by Subject|1|||
105547444|NCT02707055|364003696|FG001|Phase 1|Withdrawal by Subject|2|||
105547445|NCT02707055|364003695|FG000|Phase 1|Physician Decision|0|||
105547446|NCT02707055|364003696|FG001|Phase 1|Physician Decision|1|||
105547447|NCT02707055|364003695|FG000|Phase 2|Adverse Event|1|||
105547448|NCT02707055|364003696|FG001|Phase 2|Adverse Event|2|||
105547449|NCT00796718|364003697|FG000|Overall Study|Adverse Event|2|||
105547450|NCT00796718|364003697|FG000|Overall Study|Exclusion Criteria|1|||
105547451|NCT00796718|364003697|FG000|Overall Study|Lost to Follow-up|5|||
105547452|NCT00796718|364003697|FG000|Overall Study|Withdrawal by Informed Consent|1|||
105547453|NCT03266588|364003698|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
105547454|NCT03266588|364003699|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
105547455|NCT03266588|364003700|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
105547456|NCT03266588|364003698|FG000|Observational Period|Withdrawal by Subject|44|||
105547457|NCT03266588|364003699|FG001|Observational Period|Withdrawal by Subject|22|||
105547458|NCT03266588|364003700|FG002|Observational Period|Withdrawal by Subject|13|||
105547459|NCT03266588|364003698|FG000|Observational Period|Non-compliance|18|||
105547460|NCT03266588|364003699|FG001|Observational Period|Non-compliance|12|||
105547461|NCT03266588|364003700|FG002|Observational Period|Non-compliance|10|||
105547462|NCT03266588|364003698|FG000|Observational Period|Lost to Follow-up|8|||
105547463|NCT03266588|364003699|FG001|Observational Period|Lost to Follow-up|12|||
105547464|NCT03266588|364003700|FG002|Observational Period|Lost to Follow-up|4|||
105547465|NCT03266588|364003698|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
105547466|NCT03266588|364003699|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
105547467|NCT03266588|364003700|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
105547468|NCT03266588|364003698|FG000|Observational Period|Protocol Deviation|1|||
105547469|NCT03266588|364003699|FG001|Observational Period|Protocol Deviation|0|||
105547470|NCT03266588|364003700|FG002|Observational Period|Protocol Deviation|0|||
105547471|NCT03266588|364003698|FG000|Observational Period|Other Reasons|3|||
105547472|NCT03266588|364003699|FG001|Observational Period|Other Reasons|0|||
105547473|NCT03266588|364003700|FG002|Observational Period|Other Reasons|1|||
105547474|NCT03266588|364003698|FG000|Long-term Treatment Period|Adverse Event|33|||
105547475|NCT03266588|364003699|FG001|Long-term Treatment Period|Adverse Event|17|||
105547476|NCT03266588|364003700|FG002|Long-term Treatment Period|Adverse Event|8|||
105547477|NCT03266588|364003698|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
105547478|NCT03266588|364003699|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
105547479|NCT03266588|364003700|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
105547480|NCT03266588|364003698|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
105547481|NCT03266588|364003699|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
105547482|NCT03266588|364003700|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
105547483|NCT03266588|364003698|FG000|Long-term Treatment Period|Non-Compliance|126|||
105547484|NCT03266588|364003699|FG001|Long-term Treatment Period|Non-Compliance|57|||
105547485|NCT03266588|364003700|FG002|Long-term Treatment Period|Non-Compliance|7|||
105547486|NCT03266588|364003698|FG000|Long-term Treatment Period|Pregnancy|11|||
105547487|NCT03266588|364003699|FG001|Long-term Treatment Period|Pregnancy|5|||
105547488|NCT03266588|364003700|FG002|Long-term Treatment Period|Pregnancy|0|||
105547489|NCT03266588|364003698|FG000|Long-term Treatment Period|Protocol Deviation|17|||
105547490|NCT03266588|364003699|FG001|Long-term Treatment Period|Protocol Deviation|10|||
105547491|NCT03266588|364003700|FG002|Long-term Treatment Period|Protocol Deviation|4|||
105547492|NCT03266588|364003698|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
105547493|NCT03266588|364003699|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
105547494|NCT03266588|364003700|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
105547495|NCT03266588|364003698|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
105547496|NCT03266588|364003699|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
105547497|NCT03266588|364003700|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
105547498|NCT03266588|364003698|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
105547499|NCT03266588|364003699|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
105547500|NCT03266588|364003700|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
105547501|NCT03266588|364003698|FG000|Long-term Treatment Period|Other Reasons|5|||
105547502|NCT03266588|364003699|FG001|Long-term Treatment Period|Other Reasons|0|||
105547503|NCT03266588|364003700|FG002|Long-term Treatment Period|Other Reasons|0|||
105547504|NCT03266588|364003698|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
105547505|NCT03266588|364003699|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
105547506|NCT03266588|364003700|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
105547507|NCT02627677|364003701|FG000|Overall Study|Adverse event (not progressive disease)|1|||
105547508|NCT02627677|364003702|FG001|Overall Study|Adverse event (not progressive disease)|4|||
105547509|NCT02627677|364003703|FG002|Overall Study|Adverse event (not progressive disease)|1|||
105547510|NCT02627677|364003701|FG000|Overall Study|Progressive disease|1|||
105547511|NCT02627677|364003702|FG001|Overall Study|Progressive disease|3|||
105547512|NCT02627677|364003703|FG002|Overall Study|Progressive disease|0|||
105547513|NCT02627677|364003701|FG000|Overall Study|Lack of Efficacy|1|||
105547514|NCT02627677|364003702|FG001|Overall Study|Lack of Efficacy|2|||
105547515|NCT02627677|364003703|FG002|Overall Study|Lack of Efficacy|0|||
105547516|NCT02627677|364003701|FG000|Overall Study|Lost to Follow-up|0|||
105547517|NCT02627677|364003702|FG001|Overall Study|Lost to Follow-up|0|||
105547518|NCT02627677|364003703|FG002|Overall Study|Lost to Follow-up|1|||
105547519|NCT02627677|364003701|FG000|Overall Study|Pregnancy|0|||
105547520|NCT02627677|364003702|FG001|Overall Study|Pregnancy|1|||
105547521|NCT02627677|364003703|FG002|Overall Study|Pregnancy|0|||
105547522|NCT02627677|364003701|FG000|Overall Study|Study Terminated by Sponsor|5|||
105547523|NCT02627677|364003702|FG001|Overall Study|Study Terminated by Sponsor|10|||
105547524|NCT02627677|364003703|FG002|Overall Study|Study Terminated by Sponsor|6|||
105547525|NCT02627677|364003701|FG000|Overall Study|Physician Decision|0|||
105547526|NCT02627677|364003702|FG001|Overall Study|Physician Decision|0|||
105547527|NCT02627677|364003703|FG002|Overall Study|Physician Decision|2|||
105547528|NCT02627677|364003701|FG000|Overall Study|Withdrawal by Subject|2|||
105547529|NCT02627677|364003702|FG001|Overall Study|Withdrawal by Subject|1|||
105547530|NCT02627677|364003703|FG002|Overall Study|Withdrawal by Subject|1|||
105547531|NCT02627677|364003701|FG000|Overall Study|Reason not Specified|0|||
105547532|NCT02627677|364003702|FG001|Overall Study|Reason not Specified|0|||
105547533|NCT02627677|364003703|FG002|Overall Study|Reason not Specified|1|||
105547534|NCT02627677|364003701|FG000|Overall Study|Randomized but not Treated|1|||
105547535|NCT02627677|364003702|FG001|Overall Study|Randomized but not Treated|0|||
105547536|NCT02627677|364003703|FG002|Overall Study|Randomized but not Treated|0|||
105547537|NCT02244944|364003704|FG000|Overall Study|Withdrawal by Subject|1|||
105547538|NCT02244944|364003704|FG000|Overall Study|Study Terminated|1|||
105547539|NCT02979535|364003705|FG000|Overall Study|Non compliance with the protocol|78|||
105547540|NCT02979535|364003706|FG001|Overall Study|Non compliance with the protocol|82|||
105547541|NCT02979535|364003705|FG000|Overall Study|Consent withdrawn by participant|11|||
105547542|NCT02979535|364003706|FG001|Overall Study|Consent withdrawn by participant|18|||
105547543|NCT02979535|364003705|FG000|Overall Study|Lost to Follow-up|6|||
105547544|NCT02979535|364003706|FG001|Overall Study|Lost to Follow-up|1|||
105547545|NCT01722331|364003707|FG000|Part 1|Adverse Event|5|||
105547546|NCT01722331|364003708|FG001|Part 1|Adverse Event|0|||
105547547|NCT01722331|364003709|FG002|Part 1|Adverse Event|0|||
105547548|NCT01722331|364003710|FG003|Part 1|Adverse Event|0|||
105547549|NCT01722331|364003711|FG004|Part 1|Adverse Event|0|||
105547550|NCT01722331|364003712|FG005|Part 1|Adverse Event|0|||
105547551|NCT01722331|364003713|FG006|Part 1|Adverse Event|0|||
105547552|NCT01722331|364003707|FG000|Part 1|Lack of Efficacy|0|||
105547553|NCT01722331|364003708|FG001|Part 1|Lack of Efficacy|0|||
105547554|NCT01722331|364003709|FG002|Part 1|Lack of Efficacy|1|||
105547555|NCT01722331|364003710|FG003|Part 1|Lack of Efficacy|0|||
105547556|NCT01722331|364003711|FG004|Part 1|Lack of Efficacy|2|||
105547557|NCT01722331|364003712|FG005|Part 1|Lack of Efficacy|0|||
105547558|NCT01722331|364003713|FG006|Part 1|Lack of Efficacy|0|||
105547559|NCT01722331|364003707|FG000|Part 1|Lost to Follow-up|1|||
105547560|NCT01722331|364003708|FG001|Part 1|Lost to Follow-up|0|||
105547561|NCT01722331|364003709|FG002|Part 1|Lost to Follow-up|2|||
105547562|NCT01722331|364003710|FG003|Part 1|Lost to Follow-up|0|||
105547563|NCT01722331|364003711|FG004|Part 1|Lost to Follow-up|1|||
105547564|NCT01722331|364003712|FG005|Part 1|Lost to Follow-up|0|||
105547565|NCT01722331|364003713|FG006|Part 1|Lost to Follow-up|0|||
105596180|NCT00723450|364184151|FG002|Randomized Phase|Protocol Violation|13|||
105547566|NCT01722331|364003707|FG000|Part 1|Physician Decision|0|||
105547567|NCT01722331|364003708|FG001|Part 1|Physician Decision|0|||
105547568|NCT01722331|364003709|FG002|Part 1|Physician Decision|3|||
105547569|NCT01722331|364003710|FG003|Part 1|Physician Decision|0|||
105547570|NCT01722331|364003711|FG004|Part 1|Physician Decision|1|||
105547571|NCT01722331|364003712|FG005|Part 1|Physician Decision|0|||
105547572|NCT01722331|364003713|FG006|Part 1|Physician Decision|0|||
105547573|NCT01722331|364003707|FG000|Part 1|Pregnancy|1|||
105547574|NCT01722331|364003708|FG001|Part 1|Pregnancy|0|||
105547575|NCT01722331|364003709|FG002|Part 1|Pregnancy|0|||
105547576|NCT01722331|364003710|FG003|Part 1|Pregnancy|0|||
105547577|NCT01722331|364003711|FG004|Part 1|Pregnancy|0|||
105547578|NCT01722331|364003712|FG005|Part 1|Pregnancy|0|||
105547579|NCT01722331|364003713|FG006|Part 1|Pregnancy|0|||
105547580|NCT01722331|364003707|FG000|Part 1|Progressive Disease|0|||
105547581|NCT01722331|364003708|FG001|Part 1|Progressive Disease|0|||
105547582|NCT01722331|364003709|FG002|Part 1|Progressive Disease|0|||
105547583|NCT01722331|364003710|FG003|Part 1|Progressive Disease|0|||
105547584|NCT01722331|364003711|FG004|Part 1|Progressive Disease|1|||
105547585|NCT01722331|364003712|FG005|Part 1|Progressive Disease|0|||
105547586|NCT01722331|364003713|FG006|Part 1|Progressive Disease|0|||
105547587|NCT01722331|364003707|FG000|Part 1|Protocol Violation|1|||
105547588|NCT01722331|364003708|FG001|Part 1|Protocol Violation|0|||
105547589|NCT01722331|364003709|FG002|Part 1|Protocol Violation|0|||
105547590|NCT01722331|364003710|FG003|Part 1|Protocol Violation|0|||
105547591|NCT01722331|364003711|FG004|Part 1|Protocol Violation|1|||
105547592|NCT01722331|364003712|FG005|Part 1|Protocol Violation|0|||
105547593|NCT01722331|364003713|FG006|Part 1|Protocol Violation|0|||
105547594|NCT01722331|364003707|FG000|Part 1|Withdrawal by Subject|2|||
105547595|NCT01722331|364003708|FG001|Part 1|Withdrawal by Subject|0|||
105547596|NCT01722331|364003709|FG002|Part 1|Withdrawal by Subject|3|||
105547597|NCT01722331|364003710|FG003|Part 1|Withdrawal by Subject|0|||
105596181|NCT00723450|364184149|FG000|Randomized Phase|Lost to Follow-up|0|||
105596182|NCT00723450|364184150|FG001|Randomized Phase|Lost to Follow-up|2|||
105596183|NCT00723450|364184151|FG002|Randomized Phase|Lost to Follow-up|3|||
105596184|NCT00723450|364184149|FG000|Randomized Phase|Physician Decision|0|||
105596185|NCT00723450|364184150|FG001|Randomized Phase|Physician Decision|3|||
105596186|NCT00723450|364184151|FG002|Randomized Phase|Physician Decision|1|||
105596187|NCT00723450|364184149|FG000|Randomized Phase|Withdrawal by Subject|0|||
105596188|NCT00723450|364184150|FG001|Randomized Phase|Withdrawal by Subject|14|||
105596189|NCT00723450|364184151|FG002|Randomized Phase|Withdrawal by Subject|22|||
105596190|NCT03192046|364184152|FG000|Overall Study|Withdrawal by Subject|1|||
105596191|NCT03192046|364184153|FG001|Overall Study|Withdrawal by Subject|1|||
105596192|NCT01909336|364184154|FG000|Overall Study|Lost to Follow-up|4|||
105596193|NCT01909336|364184155|FG001|Overall Study|Lost to Follow-up|2|||
105596194|NCT01909336|364184156|FG002|Overall Study|Lost to Follow-up|2|||
105596195|NCT01909336|364184154|FG000|Overall Study|Physician Decision|0|||
105596196|NCT01909336|364184155|FG001|Overall Study|Physician Decision|1|||
105596197|NCT01909336|364184156|FG002|Overall Study|Physician Decision|1|||
105596198|NCT01901276|364184161|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
105596199|NCT01901276|364184162|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
105596200|NCT00878722|364184166|FG000|Overall Study|Progressive disease|3|||
105596201|NCT00878722|364184167|FG001|Overall Study|Progressive disease|3|||
105596202|NCT00878722|364184168|FG002|Overall Study|Progressive disease|3|||
105596203|NCT00878722|364184169|FG003|Overall Study|Progressive disease|7|||
105596204|NCT00878722|364184170|FG004|Overall Study|Progressive disease|7|||
105596205|NCT00878722|364184171|FG005|Overall Study|Progressive disease|1|||
105596206|NCT00878722|364184172|FG006|Overall Study|Progressive disease|4|||
105596207|NCT00878722|364184173|FG007|Overall Study|Progressive disease|3|||
105596208|NCT00878722|364184166|FG000|Overall Study|Death|0|||
105596209|NCT00878722|364184167|FG001|Overall Study|Death|0|||
105596210|NCT00878722|364184168|FG002|Overall Study|Death|0|||
105596211|NCT00878722|364184169|FG003|Overall Study|Death|1|||
105596212|NCT00878722|364184170|FG004|Overall Study|Death|0|||
105596213|NCT00878722|364184171|FG005|Overall Study|Death|1|||
105596214|NCT00878722|364184172|FG006|Overall Study|Death|0|||
105596215|NCT00878722|364184173|FG007|Overall Study|Death|2|||
105596216|NCT00878722|364184166|FG000|Overall Study|Adverse Event|0|||
105596217|NCT00878722|364184167|FG001|Overall Study|Adverse Event|0|||
105596218|NCT00878722|364184168|FG002|Overall Study|Adverse Event|0|||
105596219|NCT00878722|364184169|FG003|Overall Study|Adverse Event|0|||
105596220|NCT00878722|364184170|FG004|Overall Study|Adverse Event|0|||
105596221|NCT00878722|364184171|FG005|Overall Study|Adverse Event|0|||
105596222|NCT00878722|364184172|FG006|Overall Study|Adverse Event|2|||
105596223|NCT00878722|364184173|FG007|Overall Study|Adverse Event|0|||
105547598|NCT01722331|364003711|FG004|Part 1|Withdrawal by Subject|3|||
105547599|NCT01722331|364003712|FG005|Part 1|Withdrawal by Subject|0|||
105547600|NCT01722331|364003713|FG006|Part 1|Withdrawal by Subject|0|||
105596224|NCT00878722|364184166|FG000|Overall Study|Withdrawal by Subject|0|||
105596225|NCT00878722|364184167|FG001|Overall Study|Withdrawal by Subject|0|||
105596226|NCT00878722|364184168|FG002|Overall Study|Withdrawal by Subject|0|||
105596227|NCT00878722|364184169|FG003|Overall Study|Withdrawal by Subject|0|||
105596228|NCT00878722|364184170|FG004|Overall Study|Withdrawal by Subject|0|||
105596229|NCT00878722|364184171|FG005|Overall Study|Withdrawal by Subject|0|||
105596230|NCT00878722|364184172|FG006|Overall Study|Withdrawal by Subject|0|||
105547601|NCT01722331|364003707|FG000|Part 2|Adverse Event|3|||
105547602|NCT01722331|364003708|FG001|Part 2|Adverse Event|0|||
105547603|NCT01722331|364003709|FG002|Part 2|Adverse Event|0|||
105596231|NCT00878722|364184173|FG007|Overall Study|Withdrawal by Subject|2|||
105596232|NCT00878722|364184166|FG000|Overall Study|Relapse|0|||
105596233|NCT00878722|364184167|FG001|Overall Study|Relapse|0|||
105596234|NCT00878722|364184168|FG002|Overall Study|Relapse|0|||
105596235|NCT00878722|364184169|FG003|Overall Study|Relapse|1|||
105547604|NCT01722331|364003710|FG003|Part 2|Adverse Event|0|||
105547605|NCT01722331|364003711|FG004|Part 2|Adverse Event|0|||
105596236|NCT00878722|364184170|FG004|Overall Study|Relapse|0|||
105547606|NCT01722331|364003712|FG005|Part 2|Adverse Event|1|||
105547607|NCT01722331|364003713|FG006|Part 2|Adverse Event|0|||
105596237|NCT00878722|364184171|FG005|Overall Study|Relapse|0|||
105596238|NCT00878722|364184172|FG006|Overall Study|Relapse|0|||
105547608|NCT01722331|364003707|FG000|Part 2|Lack of Efficacy|3|||
105547609|NCT01722331|364003708|FG001|Part 2|Lack of Efficacy|0|||
105547610|NCT01722331|364003709|FG002|Part 2|Lack of Efficacy|11|||
105547611|NCT01722331|364003710|FG003|Part 2|Lack of Efficacy|0|||
105547612|NCT01722331|364003711|FG004|Part 2|Lack of Efficacy|0|||
105547613|NCT01722331|364003712|FG005|Part 2|Lack of Efficacy|3|||
105547614|NCT01722331|364003713|FG006|Part 2|Lack of Efficacy|3|||
105547615|NCT01722331|364003707|FG000|Part 2|Lost to Follow-up|0|||
105547616|NCT01722331|364003708|FG001|Part 2|Lost to Follow-up|0|||
105547617|NCT01722331|364003709|FG002|Part 2|Lost to Follow-up|3|||
105547618|NCT01722331|364003710|FG003|Part 2|Lost to Follow-up|0|||
105547619|NCT01722331|364003711|FG004|Part 2|Lost to Follow-up|0|||
105547620|NCT01722331|364003712|FG005|Part 2|Lost to Follow-up|1|||
105547621|NCT01722331|364003713|FG006|Part 2|Lost to Follow-up|1|||
105547622|NCT01722331|364003707|FG000|Part 2|Non-Compliance with Study Drug|1|||
105547623|NCT01722331|364003708|FG001|Part 2|Non-Compliance with Study Drug|0|||
105547624|NCT01722331|364003709|FG002|Part 2|Non-Compliance with Study Drug|1|||
105547625|NCT01722331|364003710|FG003|Part 2|Non-Compliance with Study Drug|0|||
105547626|NCT01722331|364003711|FG004|Part 2|Non-Compliance with Study Drug|0|||
105547627|NCT01722331|364003712|FG005|Part 2|Non-Compliance with Study Drug|0|||
105547628|NCT01722331|364003713|FG006|Part 2|Non-Compliance with Study Drug|0|||
105547629|NCT01722331|364003707|FG000|Part 2|Physician Decision|0|||
105547630|NCT01722331|364003708|FG001|Part 2|Physician Decision|0|||
105547631|NCT01722331|364003709|FG002|Part 2|Physician Decision|2|||
105547632|NCT01722331|364003710|FG003|Part 2|Physician Decision|0|||
105547633|NCT01722331|364003711|FG004|Part 2|Physician Decision|0|||
105547634|NCT01722331|364003712|FG005|Part 2|Physician Decision|0|||
105547635|NCT01722331|364003713|FG006|Part 2|Physician Decision|0|||
105547636|NCT01722331|364003707|FG000|Part 2|Pregnancy|0|||
105547637|NCT01722331|364003708|FG001|Part 2|Pregnancy|0|||
105547638|NCT01722331|364003709|FG002|Part 2|Pregnancy|0|||
105547639|NCT01722331|364003710|FG003|Part 2|Pregnancy|0|||
105547640|NCT01722331|364003711|FG004|Part 2|Pregnancy|0|||
105547641|NCT01722331|364003712|FG005|Part 2|Pregnancy|1|||
105547642|NCT01722331|364003713|FG006|Part 2|Pregnancy|0|||
105547643|NCT01722331|364003707|FG000|Part 2|Progressive Disease|0|||
105547644|NCT01722331|364003708|FG001|Part 2|Progressive Disease|0|||
105547645|NCT01722331|364003709|FG002|Part 2|Progressive Disease|1|||
105547646|NCT01722331|364003710|FG003|Part 2|Progressive Disease|0|||
105547647|NCT01722331|364003711|FG004|Part 2|Progressive Disease|0|||
105547648|NCT01722331|364003712|FG005|Part 2|Progressive Disease|0|||
105547649|NCT01722331|364003713|FG006|Part 2|Progressive Disease|0|||
105547650|NCT01722331|364003707|FG000|Part 2|Protocol Violation|1|||
105547651|NCT01722331|364003708|FG001|Part 2|Protocol Violation|0|||
105547652|NCT01722331|364003709|FG002|Part 2|Protocol Violation|0|||
105547653|NCT01722331|364003710|FG003|Part 2|Protocol Violation|0|||
105547654|NCT01722331|364003711|FG004|Part 2|Protocol Violation|0|||
105547655|NCT01722331|364003712|FG005|Part 2|Protocol Violation|0|||
105547656|NCT01722331|364003713|FG006|Part 2|Protocol Violation|0|||
105547657|NCT01722331|364003707|FG000|Part 2|Withdrawal by Subject|5|||
105547658|NCT01722331|364003708|FG001|Part 2|Withdrawal by Subject|0|||
105547659|NCT01722331|364003709|FG002|Part 2|Withdrawal by Subject|3|||
105547660|NCT01722331|364003710|FG003|Part 2|Withdrawal by Subject|0|||
105547661|NCT01722331|364003711|FG004|Part 2|Withdrawal by Subject|0|||
105547662|NCT01722331|364003712|FG005|Part 2|Withdrawal by Subject|2|||
105547663|NCT01722331|364003713|FG006|Part 2|Withdrawal by Subject|2|||
105547664|NCT01722331|364003707|FG000|Part 2|Other Protocol Specified Criteria|6|||
105547665|NCT01722331|364003708|FG001|Part 2|Other Protocol Specified Criteria|0|||
105547666|NCT01722331|364003709|FG002|Part 2|Other Protocol Specified Criteria|10|||
105547667|NCT01722331|364003710|FG003|Part 2|Other Protocol Specified Criteria|0|||
105547668|NCT01722331|364003711|FG004|Part 2|Other Protocol Specified Criteria|0|||
105547669|NCT01722331|364003712|FG005|Part 2|Other Protocol Specified Criteria|2|||
105547670|NCT01722331|364003713|FG006|Part 2|Other Protocol Specified Criteria|1|||
105547671|NCT01722331|364003707|FG000|Part 3|Adverse Event|2|||
105547672|NCT01722331|364003708|FG001|Part 3|Adverse Event|2|||
105547673|NCT01722331|364003709|FG002|Part 3|Adverse Event|0|||
105547674|NCT01722331|364003710|FG003|Part 3|Adverse Event|1|||
105547675|NCT01722331|364003711|FG004|Part 3|Adverse Event|0|||
105547676|NCT01722331|364003712|FG005|Part 3|Adverse Event|0|||
105596239|NCT00878722|364184173|FG007|Overall Study|Relapse|0|||
105547677|NCT01722331|364003713|FG006|Part 3|Adverse Event|0|||
105547678|NCT01722331|364003707|FG000|Part 3|Death|1|||
105547679|NCT01722331|364003708|FG001|Part 3|Death|0|||
105547680|NCT01722331|364003709|FG002|Part 3|Death|0|||
105547681|NCT01722331|364003710|FG003|Part 3|Death|0|||
105547682|NCT01722331|364003711|FG004|Part 3|Death|0|||
105596240|NCT00530842|364184176|FG000|Overall Study|Adverse Event|10|||
105547683|NCT01722331|364003712|FG005|Part 3|Death|0|||
105547684|NCT01722331|364003713|FG006|Part 3|Death|0|||
105547685|NCT01722331|364003707|FG000|Part 3|Lack of Efficacy|1|||
105547686|NCT01722331|364003708|FG001|Part 3|Lack of Efficacy|0|||
105547687|NCT01722331|364003709|FG002|Part 3|Lack of Efficacy|0|||
105547688|NCT01722331|364003710|FG003|Part 3|Lack of Efficacy|0|||
105547689|NCT01722331|364003711|FG004|Part 3|Lack of Efficacy|0|||
105547690|NCT01722331|364003712|FG005|Part 3|Lack of Efficacy|0|||
105547691|NCT01722331|364003713|FG006|Part 3|Lack of Efficacy|0|||
105547692|NCT01722331|364003707|FG000|Part 3|Lost to Follow-up|3|||
105547693|NCT01722331|364003708|FG001|Part 3|Lost to Follow-up|4|||
105547694|NCT01722331|364003709|FG002|Part 3|Lost to Follow-up|0|||
105547695|NCT01722331|364003710|FG003|Part 3|Lost to Follow-up|0|||
105547696|NCT01722331|364003711|FG004|Part 3|Lost to Follow-up|0|||
105547697|NCT01722331|364003712|FG005|Part 3|Lost to Follow-up|1|||
105547698|NCT01722331|364003713|FG006|Part 3|Lost to Follow-up|0|||
105547699|NCT01722331|364003707|FG000|Part 3|Non-Compliance with Study Drug|0|||
105547700|NCT01722331|364003708|FG001|Part 3|Non-Compliance with Study Drug|1|||
105547701|NCT01722331|364003709|FG002|Part 3|Non-Compliance with Study Drug|0|||
105547702|NCT01722331|364003710|FG003|Part 3|Non-Compliance with Study Drug|0|||
105547703|NCT01722331|364003711|FG004|Part 3|Non-Compliance with Study Drug|0|||
105547704|NCT01722331|364003712|FG005|Part 3|Non-Compliance with Study Drug|0|||
105547705|NCT01722331|364003713|FG006|Part 3|Non-Compliance with Study Drug|0|||
105547706|NCT01722331|364003707|FG000|Part 3|Physician Decision|1|||
105547707|NCT01722331|364003708|FG001|Part 3|Physician Decision|1|||
105547708|NCT01722331|364003709|FG002|Part 3|Physician Decision|0|||
105547709|NCT01722331|364003710|FG003|Part 3|Physician Decision|0|||
105547710|NCT01722331|364003711|FG004|Part 3|Physician Decision|0|||
105547711|NCT01722331|364003712|FG005|Part 3|Physician Decision|0|||
105547712|NCT01722331|364003713|FG006|Part 3|Physician Decision|1|||
105547713|NCT01722331|364003707|FG000|Part 3|Protocol Violation|2|||
105547714|NCT01722331|364003708|FG001|Part 3|Protocol Violation|1|||
105547715|NCT01722331|364003709|FG002|Part 3|Protocol Violation|0|||
105547716|NCT01722331|364003710|FG003|Part 3|Protocol Violation|0|||
105547717|NCT01722331|364003711|FG004|Part 3|Protocol Violation|0|||
105547718|NCT01722331|364003712|FG005|Part 3|Protocol Violation|0|||
105547719|NCT01722331|364003713|FG006|Part 3|Protocol Violation|0|||
105547720|NCT01722331|364003707|FG000|Part 3|Withdrawal by Subject|4|||
105547721|NCT01722331|364003708|FG001|Part 3|Withdrawal by Subject|7|||
105547722|NCT01722331|364003709|FG002|Part 3|Withdrawal by Subject|0|||
105547723|NCT01722331|364003710|FG003|Part 3|Withdrawal by Subject|0|||
105547724|NCT01722331|364003711|FG004|Part 3|Withdrawal by Subject|0|||
105547725|NCT01722331|364003712|FG005|Part 3|Withdrawal by Subject|2|||
105547726|NCT01722331|364003713|FG006|Part 3|Withdrawal by Subject|1|||
105547727|NCT01722331|364003707|FG000|Part 3|Other Protocol Specified Criteria|1|||
105547728|NCT01722331|364003708|FG001|Part 3|Other Protocol Specified Criteria|1|||
105547729|NCT01722331|364003709|FG002|Part 3|Other Protocol Specified Criteria|0|||
105547730|NCT01722331|364003710|FG003|Part 3|Other Protocol Specified Criteria|0|||
105547731|NCT01722331|364003711|FG004|Part 3|Other Protocol Specified Criteria|0|||
105547732|NCT01722331|364003712|FG005|Part 3|Other Protocol Specified Criteria|0|||
105547733|NCT01722331|364003713|FG006|Part 3|Other Protocol Specified Criteria|0|||
105547734|NCT00512135|364003714|FG000|Overall Study|Not Treated|5|||
105547735|NCT00512135|364003714|FG000|Overall Study|Lack of Efficacy|2|||
105547736|NCT00512135|364003714|FG000|Overall Study|Adverse Event|6|||
105547737|NCT00512135|364003714|FG000|Overall Study|Withdrawal by Subject|22|||
105547738|NCT00512135|364003714|FG000|Overall Study|Lost to Follow-up|27|||
105547739|NCT00512135|364003714|FG000|Overall Study|Other|22|||
105547740|NCT00003457|364003717|FG000|Overall Study|Not evaluable|9|||
105547741|NCT04495374|364003730|FG000|Overall Study|Protocol Violation|2|||
105547742|NCT04495374|364003731|FG001|Overall Study|Protocol Violation|1|||
105547743|NCT02807948|364003732|FG000|Overall Study|Physician Decision|1|||
105547744|NCT02807948|364003733|FG001|Overall Study|Physician Decision|0|||
105547745|NCT01303627|364003735|FG000|Overall Study|the failure while performing URS|0|||
105547746|NCT01303627|364003736|FG001|Overall Study|the failure while performing URS|1|||
105547747|NCT01343082|364003737|FG000|The run-in Period|Not meeting criteria|3|||
105596241|NCT00530842|364184177|FG001|Overall Study|Adverse Event|6|||
105547748|NCT01343082|364003738|FG001|The run-in Period|Not meeting criteria|4|||
105547749|NCT01343082|364003739|FG002|The run-in Period|Not meeting criteria|5|||
105547750|NCT01343082|364003737|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
105547751|NCT01343082|364003738|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
105547752|NCT01343082|364003739|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
105547753|NCT01343082|364003737|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
105596242|NCT00530842|364184176|FG000|Overall Study|Lack of Efficacy|2|||
105596243|NCT00530842|364184177|FG001|Overall Study|Lack of Efficacy|1|||
105596244|NCT00530842|364184176|FG000|Overall Study|Lost to Follow-up|0|||
105596245|NCT00530842|364184177|FG001|Overall Study|Lost to Follow-up|4|||
105547754|NCT01343082|364003738|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
105547755|NCT01343082|364003739|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
105547756|NCT01343082|364003737|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
105547757|NCT01343082|364003738|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
105547758|NCT01343082|364003739|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
105547759|NCT01343082|364003737|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
105547760|NCT01343082|364003738|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
105547761|NCT01343082|364003739|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
105547762|NCT04121962|364003741|FG000|Overall Study|Lost to Follow-up|42|||
105596246|NCT00530842|364184176|FG000|Overall Study|Protocol Violation|3|||
105547763|NCT04121962|364003742|FG001|Overall Study|Lost to Follow-up|39|||
105547764|NCT01575561|364003743|FG000|Overall Study|Adverse Event|9|||
105547765|NCT01575561|364003743|FG000|Overall Study|Lack of Efficacy|8|||
105547766|NCT01575561|364003743|FG000|Overall Study|Lost to Follow-up|6|||
105547767|NCT01575561|364003743|FG000|Overall Study|Protocol Violation|4|||
105547768|NCT01575561|364003743|FG000|Overall Study|Withdrawal by Subject|11|||
105547769|NCT01575561|364003743|FG000|Overall Study|administration|1|||
105547770|NCT02554773|364003744|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
105547771|NCT02554773|364003745|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
105547772|NCT02554773|364003744|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
105547773|NCT02554773|364003745|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
105547774|NCT02554773|364003744|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
105547775|NCT02554773|364003745|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
105547776|NCT02554773|364003744|FG000|Original Dose Regimen (SAS 1)|Death|1|||
105547777|NCT02554773|364003745|FG001|Original Dose Regimen (SAS 1)|Death|0|||
105547778|NCT02554773|364003744|FG000|Original Dose Regimen (SAS 1)|Other|4|||
105547779|NCT02554773|364003745|FG001|Original Dose Regimen (SAS 1)|Other|0|||
105547780|NCT02554773|364003744|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
105547781|NCT02554773|364003745|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
105547782|NCT02554773|364003744|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
105547783|NCT02554773|364003745|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
105547784|NCT02554773|364003744|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
105547785|NCT02554773|364003745|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
105547786|NCT02554773|364003744|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
105547787|NCT02554773|364003745|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
105547788|NCT00097591|364003746|FG000|Overall Study|Withdrawal of consent|342|||
105547789|NCT00097591|364003747|FG001|Overall Study|Withdrawal of consent|323|||
105547790|NCT00097591|364003746|FG000|Overall Study|Less than 6 months on study drug|9|||
105547791|NCT00097591|364003747|FG001|Overall Study|Less than 6 months on study drug|7|||
105547792|NCT00097591|364003746|FG000|Overall Study|Unable to attend termination visit|53|||
105547793|NCT00097591|364003747|FG001|Overall Study|Unable to attend termination visit|51|||
105547794|NCT00097591|364003746|FG000|Overall Study|Lost to follow up|6|||
105547795|NCT00097591|364003747|FG001|Overall Study|Lost to follow up|10|||
105547796|NCT00097591|364003746|FG000|Overall Study|Other|0|||
105547797|NCT00097591|364003747|FG001|Overall Study|Other|3|||
105547798|NCT02031276|364003750|FG000|Period 1 Double-blind IV|Adverse Event|6|||
105547799|NCT02031276|364003751|FG001|Period 1 Double-blind IV|Adverse Event|5|||
105547800|NCT02031276|364003752|FG002|Period 1 Double-blind IV|Adverse Event|1|||
105547801|NCT02031276|364003750|FG000|Period 1 Double-blind IV|Other|0|||
105547802|NCT02031276|364003751|FG001|Period 1 Double-blind IV|Other|1|||
105547803|NCT02031276|364003752|FG002|Period 1 Double-blind IV|Other|0|||
105547804|NCT02031276|364003750|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
105547805|NCT02031276|364003751|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
105547806|NCT02031276|364003752|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
105547807|NCT02031276|364003750|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
105547808|NCT02031276|364003751|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
105547809|NCT02031276|364003752|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
105547810|NCT02031276|364003750|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
105547811|NCT02031276|364003751|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
105547812|NCT02031276|364003752|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
105547813|NCT02031276|364003750|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
105547814|NCT02031276|364003751|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
105547815|NCT02031276|364003752|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
105547816|NCT02031276|364003750|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
105547817|NCT02031276|364003751|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
105547818|NCT02031276|364003752|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
105547819|NCT02031276|364003750|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
105547820|NCT02031276|364003751|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
105547821|NCT02031276|364003752|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
105547822|NCT02031276|364003750|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
105547823|NCT02031276|364003751|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
105547824|NCT02031276|364003752|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
105547825|NCT01148810|364003753|FG000|Overall Study|Adverse Event|0|||
105547826|NCT01148810|364003754|FG001|Overall Study|Adverse Event|2|||
105547827|NCT01148810|364003753|FG000|Overall Study|Lack of Efficacy|0|||
105547828|NCT01148810|364003754|FG001|Overall Study|Lack of Efficacy|1|||
105547829|NCT01148810|364003753|FG000|Overall Study|Withdrawal by Subject|0|||
105547830|NCT01148810|364003754|FG001|Overall Study|Withdrawal by Subject|2|||
105547831|NCT01148810|364003753|FG000|Overall Study|Protocol Violation|1|||
105547832|NCT01148810|364003754|FG001|Overall Study|Protocol Violation|0|||
105547833|NCT00844194|364003758|FG000|Overall Study|Adverse Event|17|||
105547834|NCT00844194|364003759|FG001|Overall Study|Adverse Event|5|||
105547835|NCT00844194|364003758|FG000|Overall Study|Protocol Violation|1|||
105547836|NCT00844194|364003759|FG001|Overall Study|Protocol Violation|1|||
105547837|NCT00844194|364003758|FG000|Overall Study|Lost to Follow-up|1|||
105547838|NCT00844194|364003759|FG001|Overall Study|Lost to Follow-up|1|||
105547839|NCT00844194|364003758|FG000|Overall Study|Withdrawal by Subject|2|||
105547840|NCT00844194|364003759|FG001|Overall Study|Withdrawal by Subject|1|||
105547841|NCT00844194|364003758|FG000|Overall Study|Lack of Efficacy|3|||
105547842|NCT00844194|364003759|FG001|Overall Study|Lack of Efficacy|0|||
105547843|NCT00844194|364003758|FG000|Overall Study|Other reason (not specified)|1|||
105547844|NCT00844194|364003759|FG001|Overall Study|Other reason (not specified)|0|||
105547845|NCT00803023|364003760|FG000|Overall Study|Adverse Event|5|||
105547846|NCT00803023|364003761|FG001|Overall Study|Adverse Event|4|||
105547847|NCT00803023|364003762|FG002|Overall Study|Adverse Event|8|||
105547848|NCT00803023|364003763|FG003|Overall Study|Adverse Event|6|||
105547849|NCT00803023|364003760|FG000|Overall Study|Withdrawal by Subject|0|||
105547850|NCT00803023|364003761|FG001|Overall Study|Withdrawal by Subject|2|||
105547851|NCT00803023|364003762|FG002|Overall Study|Withdrawal by Subject|0|||
105547852|NCT00803023|364003763|FG003|Overall Study|Withdrawal by Subject|0|||
105547853|NCT00803023|364003760|FG000|Overall Study|Lost to Follow-up|0|||
105547854|NCT00803023|364003761|FG001|Overall Study|Lost to Follow-up|1|||
105547855|NCT00803023|364003762|FG002|Overall Study|Lost to Follow-up|2|||
105547856|NCT00803023|364003763|FG003|Overall Study|Lost to Follow-up|1|||
105547857|NCT00803023|364003760|FG000|Overall Study|Lack of Efficacy|0|||
105547858|NCT00803023|364003761|FG001|Overall Study|Lack of Efficacy|1|||
105547859|NCT00803023|364003762|FG002|Overall Study|Lack of Efficacy|1|||
105547860|NCT00803023|364003763|FG003|Overall Study|Lack of Efficacy|1|||
105547861|NCT01542528|364003764|FG000|Overall Study|Lost to Follow-up|2|||
105547862|NCT01542528|364003765|FG001|Overall Study|Lost to Follow-up|1|||
105547863|NCT01542528|364003764|FG000|Overall Study|Physician Decision|1|||
105547864|NCT01542528|364003765|FG001|Overall Study|Physician Decision|0|||
105547865|NCT01542528|364003764|FG000|Overall Study|Withdrawal by Subject|9|||
105547866|NCT01542528|364003765|FG001|Overall Study|Withdrawal by Subject|6|||
105547867|NCT00765245|364003768|FG000|Overall Study|disease progression|3|||
105547868|NCT00765245|364003769|FG001|Overall Study|disease progression|2|||
105547869|NCT00765245|364003768|FG000|Overall Study|Withdrawal by Subject|3|||
105547870|NCT00765245|364003769|FG001|Overall Study|Withdrawal by Subject|0|||
105547871|NCT00765245|364003768|FG000|Overall Study|Adverse Event|5|||
105547872|NCT00765245|364003769|FG001|Overall Study|Adverse Event|0|||
105547873|NCT00765245|364003768|FG000|Overall Study|Physician Decision|1|||
105547874|NCT00765245|364003769|FG001|Overall Study|Physician Decision|0|||
105547875|NCT00765245|364003768|FG000|Overall Study|Death|1|||
105547876|NCT00765245|364003769|FG001|Overall Study|Death|0|||
105547877|NCT02417246|364003772|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
105547878|NCT02417246|364003773|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
105547879|NCT02417246|364003772|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
105547880|NCT02417246|364003773|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
105547881|NCT02417246|364003772|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
105547882|NCT02417246|364003773|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
105547883|NCT02417246|364003772|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
105547884|NCT02417246|364003773|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
105547885|NCT04321460|364003774|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
105547886|NCT04321460|364003775|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
105547887|NCT02162810|364003776|FG000|Overall Study|Protocol Violation|1|||
105547888|NCT02162810|364003777|FG001|Overall Study|Protocol Violation|0|||
105547889|NCT02162810|364003776|FG000|Overall Study|patients did not report compliance|4|||
105547890|NCT02162810|364003777|FG001|Overall Study|patients did not report compliance|1|||
105547891|NCT01308749|364003778|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
105547892|NCT01308749|364003779|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
105547893|NCT01308749|364003778|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
105547894|NCT01308749|364003779|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
105547895|NCT01308749|364003778|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
105596247|NCT00530842|364184177|FG001|Overall Study|Protocol Violation|2|||
105596248|NCT00530842|364184176|FG000|Overall Study|Withdrawal by Subject|4|||
105596249|NCT00530842|364184177|FG001|Overall Study|Withdrawal by Subject|5|||
105596250|NCT00530842|364184176|FG000|Overall Study|Individual different reasons|4|||
105547896|NCT01308749|364003779|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
105547897|NCT04726709|364003780|FG000|Overall Study|Withdrawal by Subject|2|||
105547898|NCT04726709|364003781|FG001|Overall Study|Withdrawal by Subject|2|||
105547899|NCT01921348|364003782|FG000|Overall Study|Withdrawal by Subject|1|||
105547900|NCT01921348|364003783|FG001|Overall Study|Withdrawal by Subject|0|||
105547901|NCT01921348|364003782|FG000|Overall Study|Lost to Follow-up|0|||
105547902|NCT01921348|364003783|FG001|Overall Study|Lost to Follow-up|2|||
105547903|NCT03936244|364003784|FG000|Overall Study|Lost to Follow-up|5|||
105547904|NCT03936244|364003785|FG001|Overall Study|Lost to Follow-up|1|||
105547905|NCT03936244|364003784|FG000|Overall Study|Physician Decision|7|||
105547906|NCT03936244|364003785|FG001|Overall Study|Physician Decision|3|||
105547907|NCT01046110|364003789|FG000|Overall Study|Adverse Event|9|||
105547908|NCT01046110|364003790|FG001|Overall Study|Adverse Event|2|||
105547909|NCT01046110|364003789|FG000|Overall Study|Lack of Efficacy|0|||
105547910|NCT01046110|364003790|FG001|Overall Study|Lack of Efficacy|1|||
105547911|NCT01046110|364003789|FG000|Overall Study|Protocol Violation|7|||
105547912|NCT01046110|364003790|FG001|Overall Study|Protocol Violation|12|||
105547913|NCT01046110|364003789|FG000|Overall Study|Withdrawal Criteria|3|||
105547914|NCT01046110|364003790|FG001|Overall Study|Withdrawal Criteria|5|||
105547915|NCT01046110|364003789|FG000|Overall Study|Unclassified|36|||
105547916|NCT01046110|364003790|FG001|Overall Study|Unclassified|35|||
105547917|NCT01114646|364003791|FG000|Overall Study|Withdrawal by Subject|3|||
105547918|NCT01114646|364003792|FG001|Overall Study|Withdrawal by Subject|2|||
105547919|NCT04479618|364003795|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
105547920|NCT04479618|364003796|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
105547921|NCT04479618|364003797|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
105547922|NCT04479618|364003795|FG000|Overall Study|Lack of Efficacy|1|||
105547923|NCT04479618|364003796|FG001|Overall Study|Lack of Efficacy|0|||
105547924|NCT04479618|364003797|FG002|Overall Study|Lack of Efficacy|0|||
105547925|NCT04479618|364003795|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
105547926|NCT04479618|364003796|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
105547927|NCT04479618|364003797|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
105547928|NCT04479618|364003795|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
105547929|NCT04479618|364003796|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
105547930|NCT04479618|364003797|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
105547931|NCT04479618|364003795|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
105547932|NCT04479618|364003796|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
105547933|NCT04479618|364003797|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
105547934|NCT04479618|364003795|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
105547935|NCT04479618|364003796|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
105547936|NCT04479618|364003797|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
105547937|NCT00304070|364003803|FG000|Overall Study|Death|0|||
105547938|NCT00304070|364003804|FG001|Overall Study|Death|0|||
105547939|NCT00304070|364003805|FG002|Overall Study|Death|3|||
105547940|NCT00304070|364003803|FG000|Overall Study|Lost to Follow-up|0|||
105547941|NCT00304070|364003804|FG001|Overall Study|Lost to Follow-up|0|||
105547942|NCT00304070|364003805|FG002|Overall Study|Lost to Follow-up|1|||
105547943|NCT00304070|364003803|FG000|Overall Study|Physician Decision|0|||
105547944|NCT00304070|364003804|FG001|Overall Study|Physician Decision|0|||
105547945|NCT00304070|364003805|FG002|Overall Study|Physician Decision|3|||
105547946|NCT00304070|364003803|FG000|Overall Study|Withdrawal by Subject|0|||
105547947|NCT00304070|364003804|FG001|Overall Study|Withdrawal by Subject|0|||
105547948|NCT00304070|364003805|FG002|Overall Study|Withdrawal by Subject|1|||
105547949|NCT00304070|364003803|FG000|Overall Study|Progressive Disease|3|||
105547950|NCT00304070|364003804|FG001|Overall Study|Progressive Disease|7|||
105547951|NCT00304070|364003805|FG002|Overall Study|Progressive Disease|4|||
105547952|NCT00941603|364003806|FG000|Overall Study|Adverse Event|10|||
105547953|NCT00941603|364003807|FG001|Overall Study|Adverse Event|15|||
105547954|NCT00941603|364003808|FG002|Overall Study|Adverse Event|5|||
105547955|NCT00941603|364003809|FG003|Overall Study|Adverse Event|1|||
105547956|NCT00941603|364003810|FG004|Overall Study|Adverse Event|4|||
105547957|NCT00941603|364003811|FG005|Overall Study|Adverse Event|0|||
105547958|NCT00941603|364003806|FG000|Overall Study|Lost to Follow-up|0|||
105547959|NCT00941603|364003807|FG001|Overall Study|Lost to Follow-up|0|||
105547960|NCT00941603|364003808|FG002|Overall Study|Lost to Follow-up|0|||
105547961|NCT00941603|364003809|FG003|Overall Study|Lost to Follow-up|1|||
105547962|NCT00941603|364003810|FG004|Overall Study|Lost to Follow-up|0|||
105547963|NCT00941603|364003811|FG005|Overall Study|Lost to Follow-up|2|||
105596251|NCT00530842|364184177|FG001|Overall Study|Individual different reasons|3|||
105547964|NCT00941603|364003806|FG000|Overall Study|Withdrawal by Subject|0|||
105547965|NCT00941603|364003807|FG001|Overall Study|Withdrawal by Subject|0|||
105547966|NCT00941603|364003808|FG002|Overall Study|Withdrawal by Subject|0|||
105547967|NCT00941603|364003809|FG003|Overall Study|Withdrawal by Subject|2|||
105596252|NCT00530842|364184176|FG000|Period 1|Adverse Event|7|||
105596253|NCT00530842|364184177|FG001|Period 1|Adverse Event|3|||
105547968|NCT00941603|364003810|FG004|Overall Study|Withdrawal by Subject|0|||
105547969|NCT00941603|364003811|FG005|Overall Study|Withdrawal by Subject|1|||
105547970|NCT00941603|364003806|FG000|Overall Study|Protocol Violation|0|||
105547971|NCT00941603|364003807|FG001|Overall Study|Protocol Violation|1|||
105547972|NCT00941603|364003808|FG002|Overall Study|Protocol Violation|0|||
105547973|NCT00941603|364003809|FG003|Overall Study|Protocol Violation|0|||
105547974|NCT00941603|364003810|FG004|Overall Study|Protocol Violation|0|||
105547975|NCT00941603|364003811|FG005|Overall Study|Protocol Violation|0|||
105547976|NCT00941603|364003806|FG000|Overall Study|Did not meet protocol eligibility|1|||
105547977|NCT00941603|364003807|FG001|Overall Study|Did not meet protocol eligibility|0|||
105547978|NCT00941603|364003808|FG002|Overall Study|Did not meet protocol eligibility|0|||
105547979|NCT00941603|364003809|FG003|Overall Study|Did not meet protocol eligibility|0|||
105547980|NCT00941603|364003810|FG004|Overall Study|Did not meet protocol eligibility|0|||
105547981|NCT00941603|364003811|FG005|Overall Study|Did not meet protocol eligibility|0|||
105547982|NCT02014116|364003812|FG000|Overall Study|Progressive Disease|3|||
105547983|NCT02014116|364003813|FG001|Overall Study|Progressive Disease|4|||
105547984|NCT02014116|364003814|FG002|Overall Study|Progressive Disease|2|||
105547985|NCT02014116|364003815|FG003|Overall Study|Progressive Disease|6|||
105547986|NCT02014116|364003816|FG004|Overall Study|Progressive Disease|1|||
105547987|NCT02014116|364003817|FG005|Overall Study|Progressive Disease|13|||
105547988|NCT02014116|364003818|FG006|Overall Study|Progressive Disease|1|||
105547989|NCT02014116|364003819|FG007|Overall Study|Progressive Disease|3|||
105547990|NCT02014116|364003820|FG008|Overall Study|Progressive Disease|7|||
105547991|NCT02014116|364003812|FG000|Overall Study|Adverse Event|0|||
105547992|NCT02014116|364003813|FG001|Overall Study|Adverse Event|0|||
105547993|NCT02014116|364003814|FG002|Overall Study|Adverse Event|0|||
105547994|NCT02014116|364003815|FG003|Overall Study|Adverse Event|0|||
105547995|NCT02014116|364003816|FG004|Overall Study|Adverse Event|1|||
105547996|NCT02014116|364003817|FG005|Overall Study|Adverse Event|0|||
105547997|NCT02014116|364003818|FG006|Overall Study|Adverse Event|0|||
105547998|NCT02014116|364003819|FG007|Overall Study|Adverse Event|1|||
105547999|NCT02014116|364003820|FG008|Overall Study|Adverse Event|0|||
105548000|NCT02014116|364003812|FG000|Overall Study|Lost to Follow-up|0|||
105548001|NCT02014116|364003813|FG001|Overall Study|Lost to Follow-up|0|||
105548002|NCT02014116|364003814|FG002|Overall Study|Lost to Follow-up|0|||
105548003|NCT02014116|364003815|FG003|Overall Study|Lost to Follow-up|0|||
105548004|NCT02014116|364003816|FG004|Overall Study|Lost to Follow-up|0|||
105548005|NCT02014116|364003817|FG005|Overall Study|Lost to Follow-up|1|||
105548006|NCT02014116|364003818|FG006|Overall Study|Lost to Follow-up|0|||
105548007|NCT02014116|364003819|FG007|Overall Study|Lost to Follow-up|0|||
105548008|NCT02014116|364003820|FG008|Overall Study|Lost to Follow-up|1|||
105548009|NCT02014116|364003812|FG000|Overall Study|Death|0|||
105548010|NCT02014116|364003813|FG001|Overall Study|Death|0|||
105548011|NCT02014116|364003814|FG002|Overall Study|Death|0|||
105548012|NCT02014116|364003815|FG003|Overall Study|Death|0|||
105548013|NCT02014116|364003816|FG004|Overall Study|Death|0|||
105548014|NCT02014116|364003817|FG005|Overall Study|Death|0|||
105548015|NCT02014116|364003818|FG006|Overall Study|Death|0|||
105548016|NCT02014116|364003819|FG007|Overall Study|Death|1|||
105548017|NCT02014116|364003820|FG008|Overall Study|Death|1|||
105548018|NCT02014116|364003812|FG000|Overall Study|Withdrawal by Subject|0|||
105548019|NCT02014116|364003813|FG001|Overall Study|Withdrawal by Subject|0|||
105548020|NCT02014116|364003814|FG002|Overall Study|Withdrawal by Subject|1|||
105548021|NCT02014116|364003815|FG003|Overall Study|Withdrawal by Subject|1|||
105548022|NCT02014116|364003816|FG004|Overall Study|Withdrawal by Subject|0|||
105548023|NCT02014116|364003817|FG005|Overall Study|Withdrawal by Subject|1|||
105548024|NCT02014116|364003818|FG006|Overall Study|Withdrawal by Subject|0|||
105548025|NCT02014116|364003819|FG007|Overall Study|Withdrawal by Subject|0|||
105548026|NCT02014116|364003820|FG008|Overall Study|Withdrawal by Subject|0|||
105548027|NCT02014116|364003812|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
105548028|NCT02014116|364003813|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
105548029|NCT02014116|364003814|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
105548030|NCT02014116|364003815|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
105548031|NCT02014116|364003816|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
105548032|NCT02014116|364003817|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
105548033|NCT02014116|364003818|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
105548034|NCT02014116|364003819|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
105548035|NCT02014116|364003820|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
105548036|NCT02014116|364003812|FG000|Overall Study|Physician Decision|0|||
105548037|NCT02014116|364003813|FG001|Overall Study|Physician Decision|0|||
105548038|NCT02014116|364003814|FG002|Overall Study|Physician Decision|0|||
105548039|NCT02014116|364003815|FG003|Overall Study|Physician Decision|0|||
105548040|NCT02014116|364003816|FG004|Overall Study|Physician Decision|0|||
105548041|NCT02014116|364003817|FG005|Overall Study|Physician Decision|0|||
105548042|NCT02014116|364003818|FG006|Overall Study|Physician Decision|0|||
105548043|NCT02014116|364003819|FG007|Overall Study|Physician Decision|0|||
105548044|NCT02014116|364003820|FG008|Overall Study|Physician Decision|1|||
105548045|NCT03207750|364003821|FG000|Overall Study|Adverse Event|3|||
105548046|NCT03207750|364003822|FG001|Overall Study|Adverse Event|2|||
105548047|NCT03207750|364003821|FG000|Overall Study|Lost to Follow-up|21|||
105548048|NCT03207750|364003822|FG001|Overall Study|Lost to Follow-up|29|||
105548049|NCT03207750|364003821|FG000|Overall Study|Protocol Violation|0|||
105548050|NCT03207750|364003822|FG001|Overall Study|Protocol Violation|1|||
105548051|NCT03207750|364003821|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
105596254|NCT00530842|364184176|FG000|Period 1|Lack of Efficacy|1|||
105548052|NCT03207750|364003822|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
105548053|NCT03207750|364003821|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
105548054|NCT03207750|364003822|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
105548055|NCT03207750|364003821|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
105548056|NCT03207750|364003822|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
105548057|NCT03207750|364003821|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
105548058|NCT03207750|364003822|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
105548059|NCT03207750|364003821|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
105548060|NCT03207750|364003822|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
105548061|NCT03634579|364003828|FG000|Overall Study|study termination|9|||
105548062|NCT04389840|364003829|FG000|Overall Study|Adverse Event|0|||
105548063|NCT04389840|364003830|FG001|Overall Study|Adverse Event|0|||
105548064|NCT04389840|364003831|FG002|Overall Study|Adverse Event|0|||
105548065|NCT04389840|364003832|FG003|Overall Study|Adverse Event|1|||
105548066|NCT04389840|364003833|FG004|Overall Study|Adverse Event|0|||
105548067|NCT04389840|364003834|FG005|Overall Study|Adverse Event|0|||
105548068|NCT04389840|364003829|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
105548069|NCT04389840|364003830|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
105548070|NCT04389840|364003831|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
105548071|NCT04389840|364003832|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
105548072|NCT04389840|364003833|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
105548073|NCT04389840|364003834|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
105548074|NCT04389840|364003829|FG000|Overall Study|Death|0|||
105548075|NCT04389840|364003830|FG001|Overall Study|Death|1|||
105548076|NCT04389840|364003831|FG002|Overall Study|Death|0|||
105548077|NCT04389840|364003832|FG003|Overall Study|Death|0|||
105548078|NCT04389840|364003833|FG004|Overall Study|Death|0|||
105548079|NCT04389840|364003834|FG005|Overall Study|Death|0|||
105548080|NCT00464542|364005360|FG000|Pre-treatment|Withdrawal by Subject|2|||
105548081|NCT01404312|364005361|FG000|Overall Study|Death|21|||
105548082|NCT01404312|364005362|FG001|Overall Study|Death|27|||
105548083|NCT01404312|364005361|FG000|Overall Study|Withdrawal by Subject|15|||
105548084|NCT01404312|364005362|FG001|Overall Study|Withdrawal by Subject|18|||
105548085|NCT01404312|364005361|FG000|Overall Study|Participant Unable to get to clinic|93|||
105548086|NCT01404312|364005362|FG001|Overall Study|Participant Unable to get to clinic|103|||
105548087|NCT01404312|364005361|FG000|Overall Study|Lost to Follow-up|115|||
105548088|NCT01404312|364005362|FG001|Overall Study|Lost to Follow-up|111|||
105548089|NCT01404312|364005361|FG000|Overall Study|Site closed|22|||
105548090|NCT01404312|364005362|FG001|Overall Study|Site closed|21|||
105548091|NCT01404312|364005361|FG000|Overall Study|Participant not willing to adhere to req|31|||
105548092|NCT01404312|364005362|FG001|Overall Study|Participant not willing to adhere to req|29|||
105548093|NCT01404312|364005361|FG000|Overall Study|Severe debilitation, unable to continue|1|||
105548094|NCT01404312|364005362|FG001|Overall Study|Severe debilitation, unable to continue|2|||
105548095|NCT02055352|364005363|FG000|Overall Study|Adverse Event|0|||
105548096|NCT02055352|364005364|FG001|Overall Study|Adverse Event|1|||
105548097|NCT02055352|364005363|FG000|Overall Study|Non-eligible|0|||
105548098|NCT02055352|364005364|FG001|Overall Study|Non-eligible|1|||
105548099|NCT02055352|364005363|FG000|Overall Study|Poor compliance|1|||
105548100|NCT02055352|364005364|FG001|Overall Study|Poor compliance|1|||
105548101|NCT02055352|364005363|FG000|Overall Study|Death|1|||
105548102|NCT02055352|364005364|FG001|Overall Study|Death|2|||
105548103|NCT02055352|364005363|FG000|Overall Study|Patient decision|1|||
105548104|NCT02055352|364005364|FG001|Overall Study|Patient decision|1|||
105548105|NCT02055352|364005363|FG000|Overall Study|Use of prohibited treatment|0|||
105548106|NCT02055352|364005364|FG001|Overall Study|Use of prohibited treatment|3|||
105548107|NCT02055352|364005363|FG000|Overall Study|AE, study drug would be detrimental|1|||
105548108|NCT02055352|364005364|FG001|Overall Study|AE, study drug would be detrimental|3|||
105548109|NCT02055352|364005363|FG000|Overall Study|Withdrawal of informed consent|1|||
105548110|NCT02055352|364005364|FG001|Overall Study|Withdrawal of informed consent|0|||
105548111|NCT02055352|364005363|FG000|Overall Study|Reason unknown|1|||
105548112|NCT02055352|364005364|FG001|Overall Study|Reason unknown|5|||
105548113|NCT04419493|364005365|FG000|Wash-out After Period 1|Adverse Event|1|||
105548114|NCT04419493|364005366|FG001|Wash-out After Period 1|Adverse Event|2|||
105548115|NCT04419493|364005367|FG002|Wash-out After Period 1|Adverse Event|1|||
105548116|NCT04419493|364005368|FG003|Wash-out After Period 1|Adverse Event|0|||
105548117|NCT00524134|364005369|FG000|Overall Study|Withdrawal by Subject|1|||
105548118|NCT00524134|364005369|FG000|Overall Study|Physician Decision|1|||
105596255|NCT00530842|364184177|FG001|Period 1|Lack of Efficacy|1|||
105596256|NCT00530842|364184176|FG000|Period 1|Protocol Violation|2|||
105596257|NCT00530842|364184177|FG001|Period 1|Protocol Violation|1|||
105596258|NCT00530842|364184176|FG000|Period 1|Withdrawal by Subject|2|||
105596259|NCT00530842|364184177|FG001|Period 1|Withdrawal by Subject|3|||
105548119|NCT03794089|364005370|FG000|Overall Study|Lost to Follow-up|4|||
105596260|NCT00530842|364184176|FG000|Period 1|Individual different reasons|2|||
105548120|NCT03794089|364005371|FG001|Overall Study|Lost to Follow-up|1|||
105548121|NCT03794089|364005370|FG000|Overall Study|Withdrawal by Subject|2|||
105548122|NCT03794089|364005371|FG001|Overall Study|Withdrawal by Subject|0|||
105548123|NCT01045447|364005380|FG000|Overall Study|Adverse Event|0|||
105548124|NCT01045447|364005381|FG001|Overall Study|Adverse Event|1|||
105548125|NCT01045447|364005380|FG000|Overall Study|Lack of Efficacy|3|||
105548126|NCT01045447|364005381|FG001|Overall Study|Lack of Efficacy|1|||
105548127|NCT01045447|364005380|FG000|Overall Study|Protocol Violation|6|||
105548128|NCT01045447|364005381|FG001|Overall Study|Protocol Violation|3|||
105548129|NCT01045447|364005380|FG000|Overall Study|Withdrawal Criteria|10|||
105548130|NCT01045447|364005381|FG001|Overall Study|Withdrawal Criteria|10|||
105548131|NCT01045447|364005380|FG000|Overall Study|Unclassified|17|||
105548132|NCT01045447|364005381|FG001|Overall Study|Unclassified|13|||
105548133|NCT00993447|364005383|FG000|Overall Study|Withdrawal by Subject|23|||
105548134|NCT00993447|364005384|FG001|Overall Study|Withdrawal by Subject|8|||
105548135|NCT00993447|364005383|FG000|Overall Study|Protocol Violation|12|||
105548136|NCT00993447|364005384|FG001|Overall Study|Protocol Violation|8|||
105548137|NCT00993447|364005383|FG000|Overall Study|Lost to Follow-up|1|||
105548138|NCT00993447|364005384|FG001|Overall Study|Lost to Follow-up|3|||
105548139|NCT00993447|364005383|FG000|Overall Study|Adverse Event|1|||
105548140|NCT00993447|364005384|FG001|Overall Study|Adverse Event|0|||
105548141|NCT00129987|364005386|FG000|1st Educational Session|Withdrawal by Subject|141|||
105548142|NCT00129987|364005387|FG001|1st Educational Session|Withdrawal by Subject|109|||
105548143|NCT00129987|364005386|FG000|1 Year|Withdrawal by Subject|32|||
105548144|NCT00129987|364005387|FG001|1 Year|Withdrawal by Subject|21|||
105548145|NCT00970502|364005388|FG000|Overall Study|Withdrawal by Subject|1|||
105548146|NCT01863680|364005389|FG000|Overall Study|Adverse Event|17|||
105548147|NCT01863680|364005389|FG000|Overall Study|Risk of OHSS|17|||
105548148|NCT01863680|364005389|FG000|Overall Study|Spontaneous pregnancy|2|||
105548149|NCT01863680|364005389|FG000|Overall Study|Withdrawal by Subject|1|||
105548150|NCT01863680|364005389|FG000|Overall Study|Did not undergo IVF/ET|14|||
105548151|NCT01863680|364005389|FG000|Overall Study|Other|6|||
105548152|NCT00566228|364005394|FG000|Overall Study|Withdrawal by Subject|1|||
105548153|NCT00566228|364005395|FG001|Overall Study|Withdrawal by Subject|0|||
105548154|NCT00566228|364005394|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
105548155|NCT00566228|364005395|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
105548156|NCT00566228|364005394|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
105548157|NCT00566228|364005395|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
105548158|NCT00566228|364005394|FG000|Overall Study|progressed before infusion could occur|0|||
105548159|NCT00566228|364005395|FG001|Overall Study|progressed before infusion could occur|1|||
105548160|NCT01159938|364005396|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
105548161|NCT01159938|364005397|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
105548162|NCT01159938|364005398|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
105548163|NCT01159938|364005399|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
105548164|NCT01159938|364005400|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
105548165|NCT01073618|364005403|FG000|Overall Study|Death|208|||
105548166|NCT01073618|364005403|FG000|Overall Study|Adverse Event|19|||
105548167|NCT01073618|364005403|FG000|Overall Study|Other|80|||
105548168|NCT02696850|364005404|FG000|Overall Study|Withdrawal by Subject|3|||
105548169|NCT02696850|364005405|FG001|Overall Study|Withdrawal by Subject|3|||
105548170|NCT02696850|364005404|FG000|Overall Study|Lost to Follow-up|8|||
105548171|NCT02696850|364005405|FG001|Overall Study|Lost to Follow-up|5|||
105548172|NCT00673049|364005406|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
105548173|NCT00673049|364005407|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
105548174|NCT00673049|364005408|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
105548175|NCT00673049|364005409|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
105548176|NCT00673049|364005406|FG000|Before Progression on Erlotinib|Death|235|||
105548177|NCT00673049|364005407|FG001|Before Progression on Erlotinib|Death|167|||
105548178|NCT00673049|364005408|FG002|Before Progression on Erlotinib|Death|1|||
105548179|NCT00673049|364005409|FG003|Before Progression on Erlotinib|Death|0|||
105548180|NCT00673049|364005406|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
105548181|NCT00673049|364005407|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
105548182|NCT00673049|364005408|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
105548183|NCT00673049|364005409|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
105548184|NCT00673049|364005406|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
105548185|NCT00673049|364005407|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
105548186|NCT00673049|364005408|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
105548187|NCT00673049|364005409|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
105548188|NCT00673049|364005406|FG000|Before Progression on Erlotinib|Other|1|||
105548189|NCT00673049|364005407|FG001|Before Progression on Erlotinib|Other|2|||
105548190|NCT00673049|364005408|FG002|Before Progression on Erlotinib|Other|0|||
105548191|NCT00673049|364005409|FG003|Before Progression on Erlotinib|Other|0|||
105548192|NCT00673049|364005406|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
105548193|NCT00673049|364005407|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
105548194|NCT00673049|364005408|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
105548195|NCT00673049|364005409|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
105548196|NCT00673049|364005406|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
105548197|NCT00673049|364005407|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
105548198|NCT00673049|364005408|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
105548199|NCT00673049|364005409|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
105548200|NCT00673049|364005406|FG000|After Progression on Erlotinib|Death|0|||
105548201|NCT00673049|364005407|FG001|After Progression on Erlotinib|Death|0|||
105548202|NCT00673049|364005408|FG002|After Progression on Erlotinib|Death|0|||
105548203|NCT00673049|364005409|FG003|After Progression on Erlotinib|Death|71|||
105548204|NCT00673049|364005406|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
105548205|NCT00673049|364005407|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
105548206|NCT00673049|364005408|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
105548207|NCT00673049|364005409|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
105548208|NCT00673049|364005406|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
105548209|NCT00673049|364005407|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
105548210|NCT00673049|364005408|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
105548211|NCT00673049|364005409|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
105548212|NCT00673049|364005406|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
105548213|NCT00673049|364005407|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
105548214|NCT00673049|364005408|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
105548215|NCT00673049|364005409|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
105548216|NCT04837482|364005411|FG000|Period 2|Withdrawal by Subject|0|||
105548217|NCT04837482|364005412|FG001|Period 2|Withdrawal by Subject|1|||
105548218|NCT02416791|364005416|FG000|6 Months|Lost to Follow-up|0|||
105548219|NCT02416791|364005417|FG001|6 Months|Lost to Follow-up|0|||
105548220|NCT02416791|364005418|FG002|6 Months|Lost to Follow-up|1|||
105548221|NCT01054820|364005419|FG000|Overall Study|Withdrawal by Subject|2|||
105548222|NCT01154166|364005420|FG000|Overall Study|Adverse Event|14|||
105548223|NCT01154166|364005421|FG001|Overall Study|Adverse Event|9|||
105548224|NCT01154166|364005420|FG000|Overall Study|Lost to Follow-up|1|||
105548225|NCT01154166|364005421|FG001|Overall Study|Lost to Follow-up|1|||
105548226|NCT01154166|364005420|FG000|Overall Study|Protocol Violation|4|||
105548227|NCT01154166|364005421|FG001|Overall Study|Protocol Violation|1|||
105548228|NCT01154166|364005420|FG000|Overall Study|Withdrawal by Subject|10|||
105548229|NCT01154166|364005421|FG001|Overall Study|Withdrawal by Subject|1|||
105548230|NCT01154166|364005420|FG000|Overall Study|Lack of Efficacy|3|||
105548231|NCT01154166|364005421|FG001|Overall Study|Lack of Efficacy|0|||
105548232|NCT01154166|364005420|FG000|Overall Study|Disease Progression|1|||
105548233|NCT01154166|364005421|FG001|Overall Study|Disease Progression|0|||
105548234|NCT01154166|364005420|FG000|Overall Study|Poor Compliance|1|||
105548235|NCT01154166|364005421|FG001|Overall Study|Poor Compliance|0|||
105548236|NCT02099838|364005422|FG000|Overall Study|Death|1|||
105548237|NCT02099838|364005423|FG001|Overall Study|Death|0|||
105548238|NCT02099838|364005422|FG000|Overall Study|Lost to Follow-up|3|||
105548239|NCT02099838|364005423|FG001|Overall Study|Lost to Follow-up|1|||
105548240|NCT02099838|364005422|FG000|Overall Study|Withdrawal by Subject|0|||
105548241|NCT02099838|364005423|FG001|Overall Study|Withdrawal by Subject|1|||
105548242|NCT02301143|364005424|FG000|Induction Period|Enrolled But Not Treated|1|||
105548243|NCT02301143|364005425|FG001|Induction Period|Enrolled But Not Treated|0|||
105548244|NCT02301143|364005424|FG000|Induction Period|Death|1|||
105548245|NCT02301143|364005425|FG001|Induction Period|Death|0|||
105548246|NCT02301143|364005424|FG000|Induction Period|Adverse Event|22|||
105548247|NCT02301143|364005425|FG001|Induction Period|Adverse Event|0|||
105548248|NCT02301143|364005424|FG000|Induction Period|Progressive Disease|8|||
105548249|NCT02301143|364005425|FG001|Induction Period|Progressive Disease|0|||
105548250|NCT02301143|364005424|FG000|Induction Period|Withdrawal by Subject|3|||
105548251|NCT02301143|364005425|FG001|Induction Period|Withdrawal by Subject|0|||
105548252|NCT02301143|364005424|FG000|Induction Period|Noncompliance with Study Drug|1|||
105548253|NCT02301143|364005425|FG001|Induction Period|Noncompliance with Study Drug|0|||
105548254|NCT02301143|364005424|FG000|Induction Period|Physician Decision|4|||
105548255|NCT02301143|364005425|FG001|Induction Period|Physician Decision|0|||
105548256|NCT02301143|364005424|FG000|Induction Period|Symptomatic Deterioration|2|||
105548257|NCT02301143|364005425|FG001|Induction Period|Symptomatic Deterioration|0|||
105548258|NCT02301143|364005424|FG000|Induction Period|Protocol Violation|2|||
105548259|NCT02301143|364005425|FG001|Induction Period|Protocol Violation|0|||
105548260|NCT02301143|364005424|FG000|Induction Period|Other|1|||
105548261|NCT02301143|364005425|FG001|Induction Period|Other|0|||
105548262|NCT02301143|364005424|FG000|Investigator's Choice|Adverse Event|0|||
105548263|NCT02301143|364005425|FG001|Investigator's Choice|Adverse Event|3|||
105548264|NCT02301143|364005424|FG000|Investigator's Choice|Progressive Disease|0|||
105548265|NCT02301143|364005425|FG001|Investigator's Choice|Progressive Disease|3|||
105548266|NCT02301143|364005424|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
105548267|NCT02301143|364005425|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
105548268|NCT02301143|364005424|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
105548269|NCT02301143|364005425|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
105548270|NCT02301143|364005424|FG000|Investigator's Choice|Other|0|||
105548271|NCT02301143|364005425|FG001|Investigator's Choice|Other|1|||
105548272|NCT02301143|364005424|FG000|Investigator's Choice|Unresectable Surgery|0|||
105548273|NCT02301143|364005425|FG001|Investigator's Choice|Unresectable Surgery|1|||
105548274|NCT01227889|364005426|FG000|Randomized Phase (RP)|Adverse Event|13|||
105548275|NCT01227889|364005427|FG001|Randomized Phase (RP)|Adverse Event|0|||
105548276|NCT01227889|364005426|FG000|Randomized Phase (RP)|Physician Decision|13|||
105548277|NCT01227889|364005427|FG001|Randomized Phase (RP)|Physician Decision|5|||
105548278|NCT01227889|364005426|FG000|Randomized Phase (RP)|Progressive Disease|135|||
105548279|NCT01227889|364005427|FG001|Randomized Phase (RP)|Progressive Disease|52|||
105548280|NCT01227889|364005426|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
105548281|NCT01227889|364005427|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
105548282|NCT01227889|364005426|FG000|Randomized Phase (RP)|Missing|1|||
105548283|NCT01227889|364005427|FG001|Randomized Phase (RP)|Missing|3|||
105548284|NCT01227889|364005426|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
105548285|NCT01227889|364005427|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
105548286|NCT01227889|364005426|FG000|Crossover Phase|Adverse Event|0|||
105548287|NCT01227889|364005427|FG001|Crossover Phase|Adverse Event|1|||
105548288|NCT01227889|364005426|FG000|Crossover Phase|Physician Decision|0|||
105548289|NCT01227889|364005427|FG001|Crossover Phase|Physician Decision|3|||
105548290|NCT01227889|364005426|FG000|Crossover Phase|Progressive Disease|0|||
105548291|NCT01227889|364005427|FG001|Crossover Phase|Progressive Disease|31|||
105548292|NCT01227889|364005426|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
105548293|NCT01227889|364005427|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
105548294|NCT01227889|364005426|FG000|Crossover Phase|Withdrawal by Subject|0|||
105548295|NCT01227889|364005427|FG001|Crossover Phase|Withdrawal by Subject|1|||
105548296|NCT00774787|364005428|FG000|Overall Study|Lost to Follow-up|1|||
105548297|NCT01854554|364005430|FG000|Overall Study|Denial of Insurance Coverage|12|||
105548298|NCT01854554|364005431|FG001|Overall Study|Denial of Insurance Coverage|0|||
105548299|NCT01854554|364005430|FG000|Overall Study|Decided to get treatment locally|1|||
105548300|NCT01854554|364005431|FG001|Overall Study|Decided to get treatment locally|5|||
105548301|NCT01854554|364005430|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
105548302|NCT01854554|364005431|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
105548303|NCT01854554|364005430|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
105548304|NCT01854554|364005431|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
105548305|NCT01854554|364005430|FG000|Overall Study|Progression|0|||
105548306|NCT01854554|364005431|FG001|Overall Study|Progression|1|||
105548307|NCT01854554|364005430|FG000|Overall Study|Lost to Follow-up|0|||
105548308|NCT01854554|364005431|FG001|Overall Study|Lost to Follow-up|1|||
105548309|NCT02819726|364005432|FG000|Part A (All Participants)|Lost to Follow-up|0|||
105548310|NCT02819726|364005433|FG001|Part A (All Participants)|Lost to Follow-up|1|||
105548311|NCT02819726|364005434|FG002|Part A (All Participants)|Lost to Follow-up|0|||
105548312|NCT02819726|364005435|FG003|Part A (All Participants)|Lost to Follow-up|0|||
105548313|NCT02819726|364005432|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
105548314|NCT02819726|364005433|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
105548315|NCT02819726|364005434|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
105548316|NCT02819726|364005435|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
105548317|NCT02819726|364005432|FG000|Part A (All Participants)|Protocol non-compliance|3|||
105548318|NCT02819726|364005433|FG001|Part A (All Participants)|Protocol non-compliance|4|||
105548319|NCT02819726|364005434|FG002|Part A (All Participants)|Protocol non-compliance|5|||
105548320|NCT02819726|364005435|FG003|Part A (All Participants)|Protocol non-compliance|0|||
105548321|NCT02819726|364005432|FG000|Part B (All Participants)|Lost to Follow-up|1|||
105548322|NCT02819726|364005433|FG001|Part B (All Participants)|Lost to Follow-up|1|||
105548323|NCT02819726|364005434|FG002|Part B (All Participants)|Lost to Follow-up|2|||
105548324|NCT02819726|364005435|FG003|Part B (All Participants)|Lost to Follow-up|2|||
105548325|NCT02819726|364005432|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
105548326|NCT02819726|364005433|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
105548327|NCT02819726|364005434|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
105548328|NCT02819726|364005435|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
105548329|NCT02819726|364005432|FG000|Part B (All Participants)|Protocol non-compliance|0|||
105548330|NCT02819726|364005433|FG001|Part B (All Participants)|Protocol non-compliance|0|||
105548331|NCT02819726|364005434|FG002|Part B (All Participants)|Protocol non-compliance|1|||
105548332|NCT02819726|364005435|FG003|Part B (All Participants)|Protocol non-compliance|0|||
105548333|NCT02536508|364005436|FG000|Overall Study|Withdrawal by Subject|18|||
105548334|NCT02536508|364005437|FG001|Overall Study|Withdrawal by Subject|13|||
105548335|NCT02536508|364005438|FG002|Overall Study|Withdrawal by Subject|7|||
105548336|NCT02536508|364005436|FG000|Overall Study|Adverse Event|14|||
105548337|NCT02536508|364005437|FG001|Overall Study|Adverse Event|13|||
105548338|NCT02536508|364005438|FG002|Overall Study|Adverse Event|6|||
105548339|NCT02536508|364005436|FG000|Overall Study|Lost to Follow-up|12|||
105548340|NCT02536508|364005437|FG001|Overall Study|Lost to Follow-up|4|||
105548341|NCT02536508|364005438|FG002|Overall Study|Lost to Follow-up|0|||
105548342|NCT02536508|364005436|FG000|Overall Study|Lack of Efficacy|3|||
105548343|NCT02536508|364005437|FG001|Overall Study|Lack of Efficacy|5|||
105548344|NCT02536508|364005438|FG002|Overall Study|Lack of Efficacy|4|||
105548345|NCT02536508|364005436|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
105548346|NCT02536508|364005437|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
105548347|NCT02536508|364005438|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
105548348|NCT02536508|364005436|FG000|Overall Study|Physician Decision|0|||
105548349|NCT02536508|364005437|FG001|Overall Study|Physician Decision|4|||
105548350|NCT02536508|364005438|FG002|Overall Study|Physician Decision|2|||
105548351|NCT02536508|364005436|FG000|Overall Study|Major Protocol Deviation|2|||
105548352|NCT02536508|364005437|FG001|Overall Study|Major Protocol Deviation|2|||
105548353|NCT02536508|364005438|FG002|Overall Study|Major Protocol Deviation|2|||
105548354|NCT02536508|364005436|FG000|Overall Study|Administrative Reasons|0|||
105548355|NCT02536508|364005437|FG001|Overall Study|Administrative Reasons|1|||
105548356|NCT02536508|364005438|FG002|Overall Study|Administrative Reasons|0|||
105548357|NCT02613481|364005439|FG000|Overall Study|Lost to Follow-up|7|||
105548358|NCT02613481|364005439|FG000|Overall Study|Withdrawal by Subject|2|||
105548359|NCT01033747|364005440|FG000|Overall Study|Adverse Event|9|||
105548360|NCT01033747|364005441|FG001|Overall Study|Adverse Event|4|||
105548361|NCT01033747|364005440|FG000|Overall Study|Abnormal Laboratory Value|1|||
105548362|NCT01033747|364005441|FG001|Overall Study|Abnormal Laboratory Value|0|||
105548363|NCT01033747|364005440|FG000|Overall Study|Abnormal test procedure|0|||
105548364|NCT01033747|364005441|FG001|Overall Study|Abnormal test procedure|1|||
105548365|NCT01033747|364005440|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
105548366|NCT01033747|364005441|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
105548367|NCT01033747|364005440|FG000|Overall Study|Protocol Violation|1|||
105548368|NCT01033747|364005441|FG001|Overall Study|Protocol Violation|0|||
105548369|NCT01033747|364005440|FG000|Overall Study|Withdrawal by Subject|9|||
105548370|NCT01033747|364005441|FG001|Overall Study|Withdrawal by Subject|6|||
105548371|NCT01033747|364005440|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
105548372|NCT01033747|364005441|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
105548373|NCT01033747|364005440|FG000|Overall Study|Stopped at end of Extension 1|2|||
105548374|NCT01033747|364005441|FG001|Overall Study|Stopped at end of Extension 1|0|||
105548375|NCT02647658|364005442|FG000|Overall Study|Consent refusal|15|||
105548376|NCT02647658|364005443|FG001|Overall Study|Consent refusal|24|||
105548377|NCT01181921|364005451|FG000|Overall Study|Lost to Follow-up|1|||
105548378|NCT02682264|364005457|FG000|Overall Study|Withdrawal by Subject|56|||
105548379|NCT02682264|364005458|FG001|Overall Study|Withdrawal by Subject|45|||
105548380|NCT02682264|364005457|FG000|Overall Study|Lost to Follow-up|49|||
105548381|NCT02682264|364005458|FG001|Overall Study|Lost to Follow-up|41|||
105548382|NCT02682264|364005457|FG000|Overall Study|Lack of Efficacy|14|||
105548383|NCT02682264|364005458|FG001|Overall Study|Lack of Efficacy|16|||
105548384|NCT02682264|364005457|FG000|Overall Study|Withdrawal by Parent|6|||
105548385|NCT02682264|364005458|FG001|Overall Study|Withdrawal by Parent|7|||
105548386|NCT02682264|364005457|FG000|Overall Study|Adverse Event|9|||
105548387|NCT02682264|364005458|FG001|Overall Study|Adverse Event|0|||
105548388|NCT02682264|364005457|FG000|Overall Study|Noncompliance with study drug|1|||
105548389|NCT02682264|364005458|FG001|Overall Study|Noncompliance with study drug|4|||
105548390|NCT02682264|364005457|FG000|Overall Study|Pregnancy|1|||
105548391|NCT02682264|364005458|FG001|Overall Study|Pregnancy|2|||
105548392|NCT02682264|364005457|FG000|Overall Study|Recovery|1|||
105548393|NCT02682264|364005458|FG001|Overall Study|Recovery|2|||
105548394|NCT02682264|364005457|FG000|Overall Study|Progressive Disease|1|||
105548395|NCT02682264|364005458|FG001|Overall Study|Progressive Disease|0|||
105548396|NCT02682264|364005457|FG000|Overall Study|Technical Problems|0|||
105548397|NCT02682264|364005458|FG001|Overall Study|Technical Problems|1|||
105548398|NCT02682264|364005457|FG000|Overall Study|Moved abroad and unable to continue|0|||
105548399|NCT02682264|364005458|FG001|Overall Study|Moved abroad and unable to continue|3|||
105548400|NCT02682264|364005457|FG000|Overall Study|Stopped test article application|0|||
105548401|NCT02682264|364005458|FG001|Overall Study|Stopped test article application|1|||
105548402|NCT03713593|364005460|FG000|Overall Study|Participants Ongoing|140|||
105548403|NCT03713593|364005461|FG001|Overall Study|Participants Ongoing|114|||
105548404|NCT03713593|364005460|FG000|Overall Study|Withdrawal by Subject|3|||
105548405|NCT03713593|364005461|FG001|Overall Study|Withdrawal by Subject|6|||
105548406|NCT03713593|364005460|FG000|Overall Study|Death|252|||
105548407|NCT03713593|364005461|FG001|Overall Study|Death|279|||
105548408|NCT05348681|364005463|FG000|Overall Study|Study terminated by Sponsor|8|||
105548409|NCT05348681|364005464|FG001|Overall Study|Study terminated by Sponsor|3|||
105548410|NCT05348681|364005463|FG000|Overall Study|Withdrawal by Subject|1|||
105548411|NCT05348681|364005464|FG001|Overall Study|Withdrawal by Subject|1|||
105548412|NCT05348681|364005463|FG000|Overall Study|Lost to Follow-up|1|||
105548413|NCT05348681|364005464|FG001|Overall Study|Lost to Follow-up|1|||
105548414|NCT05348681|364005463|FG000|Overall Study|Adverse Event|1|||
105548415|NCT05348681|364005464|FG001|Overall Study|Adverse Event|0|||
105548416|NCT05348681|364005463|FG000|Overall Study|Other|2|||
105548417|NCT05348681|364005464|FG001|Overall Study|Other|1|||
105548418|NCT03646513|364005468|FG000|Overall Study|Premature study termination|4|||
105548419|NCT00856583|364005470|FG000|Overall Study|Lack of Efficacy|389|||
105548420|NCT00856583|364005471|FG001|Overall Study|Lack of Efficacy|377|||
105548421|NCT00856583|364005470|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
105548422|NCT00856583|364005471|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
105548423|NCT00856583|364005470|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
105548424|NCT00856583|364005471|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
105548425|NCT00856583|364005470|FG000|Overall Study|Non-compliance|305|||
105548426|NCT00856583|364005471|FG001|Overall Study|Non-compliance|262|||
105548427|NCT00856583|364005470|FG000|Overall Study|Withdrawal by Subject|1092|||
105548428|NCT00856583|364005471|FG001|Overall Study|Withdrawal by Subject|919|||
105548429|NCT00856583|364005470|FG000|Overall Study|Physician Decision|59|||
105548430|NCT00856583|364005471|FG001|Overall Study|Physician Decision|82|||
105548431|NCT00856583|364005470|FG000|Overall Study|Pregnancy|14|||
105548432|NCT00856583|364005471|FG001|Overall Study|Pregnancy|5|||
105548433|NCT00856583|364005470|FG000|Overall Study|Other|92|||
105548434|NCT00856583|364005471|FG001|Overall Study|Other|104|||
105548435|NCT00856583|364005470|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
105548436|NCT00856583|364005471|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
105548437|NCT01944046|364005475|FG000|Randomized to DB|Adverse Event|5|||
105548438|NCT01944046|364005476|FG001|Randomized to DB|Adverse Event|2|||
105548439|NCT01944046|364005475|FG000|Randomized to DB|Clinical Worsening|3|||
105548440|NCT01944046|364005476|FG001|Randomized to DB|Clinical Worsening|2|||
105548441|NCT01944046|364005475|FG000|Randomized to DB|Lost to Follow-up|3|||
105548442|NCT01944046|364005476|FG001|Randomized to DB|Lost to Follow-up|3|||
105548443|NCT01944046|364005475|FG000|Randomized to DB|Withdrawal by Subject|2|||
105548444|NCT01944046|364005476|FG001|Randomized to DB|Withdrawal by Subject|4|||
105548445|NCT01944046|364005475|FG000|Randomized to DB|Physician Decision|1|||
105548446|NCT01944046|364005476|FG001|Randomized to DB|Physician Decision|2|||
105548447|NCT01944046|364005475|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
105548448|NCT01944046|364005476|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
105548449|NCT01944046|364005475|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
105548450|NCT01944046|364005476|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
105548451|NCT01944046|364005475|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
105548452|NCT01944046|364005476|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
105548453|NCT01944046|364005475|FG000|Open Label Eligible and Consented|Adverse Event|6|||
105548454|NCT01944046|364005476|FG001|Open Label Eligible and Consented|Adverse Event|1|||
105548455|NCT01944046|364005475|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
105548456|NCT01944046|364005476|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
105548457|NCT01944046|364005475|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
105548458|NCT01944046|364005476|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
105548459|NCT03105362|364005477|FG000|Overall Study|Withdrawal by Subject|1|||
105548460|NCT03105362|364005477|FG000|Overall Study|Lost to Follow-up|1|||
105548461|NCT00305058|364005478|FG000|Overall Study|Participant too young|1|||
105548462|NCT00305058|364005479|FG001|Overall Study|Participant too young|0|||
105548463|NCT00305058|364005478|FG000|Overall Study|Missing data collection instrument|3|||
105548464|NCT00305058|364005479|FG001|Overall Study|Missing data collection instrument|2|||
105548465|NCT00305058|364005478|FG000|Overall Study|Missing outcome data|3|||
105548466|NCT00305058|364005479|FG001|Overall Study|Missing outcome data|2|||
105548467|NCT01109992|364005480|FG000|Overall Study|Withdrawal by Subject|0|||
105548468|NCT01109992|364005481|FG001|Overall Study|Withdrawal by Subject|1|||
105548469|NCT01109992|364005480|FG000|Overall Study|Movement during rest scan.|0|||
105548470|NCT01109992|364005481|FG001|Overall Study|Movement during rest scan.|1|||
105548471|NCT02338362|364005482|FG000|Overall Study|Withdrawal by Subject|1|||
105548472|NCT02338362|364005483|FG001|Overall Study|Withdrawal by Subject|1|||
105548473|NCT00690755|364005488|FG000|Overall Study|Physician Decision|2|||
105548474|NCT00690755|364005489|FG001|Overall Study|Physician Decision|0|||
105548475|NCT00690755|364005490|FG002|Overall Study|Physician Decision|46|||
105548476|NCT00690755|364005491|FG003|Overall Study|Physician Decision|5|||
105548477|NCT00690755|364005492|FG004|Overall Study|Physician Decision|0|||
105548478|NCT00690755|364005493|FG005|Overall Study|Physician Decision|4|||
105548479|NCT00690755|364005494|FG006|Overall Study|Physician Decision|0|||
105548480|NCT00784043|364005495|FG000|Overall Study|Withdrawal by Subject|8|||
105548481|NCT00784043|364005496|FG001|Overall Study|Withdrawal by Subject|5|||
105548482|NCT00784043|364005495|FG000|Overall Study|Protocol Terminated|23|||
105548483|NCT00784043|364005496|FG001|Overall Study|Protocol Terminated|1|||
105548484|NCT04313634|364005497|FG000|Overall Study|Adverse Event|2|||
105548485|NCT04313634|364005498|FG001|Overall Study|Adverse Event|2|||
105548486|NCT04313634|364005499|FG002|Overall Study|Adverse Event|0|||
105548487|NCT04313634|364005497|FG000|Overall Study|Withdrawal by Subject|1|||
105548488|NCT04313634|364005498|FG001|Overall Study|Withdrawal by Subject|0|||
105548489|NCT04313634|364005499|FG002|Overall Study|Withdrawal by Subject|1|||
105548490|NCT04313634|364005497|FG000|Overall Study|Protocol Violation|0|||
105548491|NCT04313634|364005498|FG001|Overall Study|Protocol Violation|0|||
105548492|NCT04313634|364005499|FG002|Overall Study|Protocol Violation|1|||
105548493|NCT02641080|364005500|FG000|Overall Study|Physician Decision|2|||
105548494|NCT02641080|364005501|FG001|Overall Study|Physician Decision|0|||
105548495|NCT02641080|364005500|FG000|Overall Study|Withdrawal by Subject|0|||
105548496|NCT02641080|364005501|FG001|Overall Study|Withdrawal by Subject|1|||
105548497|NCT02641080|364005500|FG000|Overall Study|Rehab Center denied use of pumps|0|||
105548498|NCT02641080|364005501|FG001|Overall Study|Rehab Center denied use of pumps|3|||
105548499|NCT02641080|364005500|FG000|Overall Study|Lost to Follow-up|0|||
105548500|NCT02641080|364005501|FG001|Overall Study|Lost to Follow-up|3|||
105548501|NCT04558346|364005508|FG000|Overall Study|Withdrawal by Subject|2|||
105548502|NCT04558346|364005509|FG001|Overall Study|Withdrawal by Subject|0|||
105548503|NCT04558346|364005508|FG000|Overall Study|Lost to Follow-up|0|||
105548504|NCT04558346|364005509|FG001|Overall Study|Lost to Follow-up|1|||
105548505|NCT04558346|364005508|FG000|Overall Study|Adverse Event|0|||
105548506|NCT04558346|364005509|FG001|Overall Study|Adverse Event|1|||
105548507|NCT03985423|364007789|FG000|Overall Study|Adverse Event|1|||
105548508|NCT03985423|364007789|FG000|Overall Study|Death|2|||
105548509|NCT03985423|364007789|FG000|Overall Study|Physician Decision|1|||
105548510|NCT03985423|364007789|FG000|Overall Study|Withdrawal by Subject|2|||
105548511|NCT03985423|364007789|FG000|Overall Study|Lack of insurance and citizenship|1|||
105548512|NCT03811912|364007793|FG000|Overall Study|Withdrew Consent|4|||
105548513|NCT03811912|364007794|FG001|Overall Study|Withdrew Consent|2|||
105548514|NCT04401579|364007795|FG000|Overall Study|Death|23|||
105548515|NCT04401579|364007796|FG001|Overall Study|Death|36|||
105548516|NCT04401579|364007795|FG000|Overall Study|Lost to Follow-up|40|||
105548517|NCT04401579|364007796|FG001|Overall Study|Lost to Follow-up|41|||
105548518|NCT04401579|364007795|FG000|Overall Study|Withdrawal by Subject|8|||
105548519|NCT04401579|364007796|FG001|Overall Study|Withdrawal by Subject|16|||
105548520|NCT04401579|364007795|FG000|Overall Study|Physician Decision|1|||
105548521|NCT04401579|364007796|FG001|Overall Study|Physician Decision|2|||
105548522|NCT04401579|364007795|FG000|Overall Study|Became ineligible after enrollment|1|||
105548523|NCT04401579|364007796|FG001|Overall Study|Became ineligible after enrollment|1|||
105548524|NCT04401579|364007795|FG000|Overall Study|Enrolled but treatment not administered|7|||
105548525|NCT04401579|364007796|FG001|Overall Study|Enrolled but treatment not administered|9|||
105548526|NCT04401579|364007795|FG000|Overall Study|Adverse Event|2|||
105548527|NCT04401579|364007796|FG001|Overall Study|Adverse Event|1|||
105548528|NCT04401579|364007795|FG000|Overall Study|Scheduling error|1|||
105548529|NCT04401579|364007796|FG001|Overall Study|Scheduling error|2|||
105548530|NCT04401579|364007795|FG000|Overall Study|Transferred to another hospital|1|||
105548531|NCT04401579|364007796|FG001|Overall Study|Transferred to another hospital|2|||
105548532|NCT01438411|364007797|FG000|Overall Study|Adverse Event|8|||
105548533|NCT01438411|364007797|FG000|Overall Study|Lost to Follow-up|1|||
105548534|NCT01438411|364007797|FG000|Overall Study|Lack of Efficacy|1|||
105548535|NCT01438411|364007797|FG000|Overall Study|Withdrawal by Subject|3|||
105548536|NCT03521635|364007798|FG000|Overall Study|Adverse Event|1|||
105548537|NCT03521635|364007799|FG001|Overall Study|Adverse Event|1|||
105548538|NCT03521635|364007798|FG000|Overall Study|Refused to complete study visit|1|||
105548539|NCT03521635|364007799|FG001|Overall Study|Refused to complete study visit|0|||
105548540|NCT03521635|364007798|FG000|Overall Study|Refused to continue trial medication|2|||
105548541|NCT03521635|364007799|FG001|Overall Study|Refused to continue trial medication|2|||
105548542|NCT03521635|364007798|FG000|Overall Study|Lost to Follow-up|0|||
105548543|NCT03521635|364007799|FG001|Overall Study|Lost to Follow-up|1|||
105548544|NCT03521635|364007798|FG000|Overall Study|Meet exclusion criteria|0|||
105548545|NCT03521635|364007799|FG001|Overall Study|Meet exclusion criteria|1|||
105548546|NCT03521635|364007798|FG000|Overall Study|Patient not taken study medicine|0|||
105548547|NCT03521635|364007799|FG001|Overall Study|Patient not taken study medicine|1|||
105548548|NCT00317772|364007800|FG000|Overall Study|Adverse Event|0|||
105548549|NCT00317772|364007801|FG001|Overall Study|Adverse Event|0|||
105548550|NCT00317772|364007802|FG002|Overall Study|Adverse Event|0|||
105548551|NCT00317772|364007803|FG003|Overall Study|Adverse Event|2|||
105548552|NCT00317772|364007800|FG000|Overall Study|Disease Progression|2|||
105548553|NCT00317772|364007801|FG001|Overall Study|Disease Progression|2|||
105548554|NCT00317772|364007802|FG002|Overall Study|Disease Progression|1|||
105548555|NCT00317772|364007803|FG003|Overall Study|Disease Progression|7|||
105548556|NCT00384085|364007807|FG000|Overall Study|Adverse Event|5|||
105548557|NCT00384085|364007808|FG001|Overall Study|Adverse Event|5|||
105548558|NCT00384085|364007809|FG002|Overall Study|Adverse Event|4|||
105548559|NCT00384085|364007807|FG000|Overall Study|Lack of Efficacy|0|||
105548560|NCT00384085|364007808|FG001|Overall Study|Lack of Efficacy|3|||
105548561|NCT00384085|364007809|FG002|Overall Study|Lack of Efficacy|2|||
105548562|NCT00384085|364007807|FG000|Overall Study|No longer Requires Study Treatment|1|||
105548563|NCT00384085|364007808|FG001|Overall Study|No longer Requires Study Treatment|0|||
105548564|NCT00384085|364007809|FG002|Overall Study|No longer Requires Study Treatment|1|||
105548565|NCT00384085|364007807|FG000|Overall Study|Protocol Violation|2|||
105548566|NCT00384085|364007808|FG001|Overall Study|Protocol Violation|2|||
105548567|NCT00384085|364007809|FG002|Overall Study|Protocol Violation|2|||
105548568|NCT00384085|364007807|FG000|Overall Study|Lost to Follow-up|9|||
105548569|NCT00384085|364007808|FG001|Overall Study|Lost to Follow-up|9|||
105548570|NCT00384085|364007809|FG002|Overall Study|Lost to Follow-up|10|||
105548571|NCT00384085|364007807|FG000|Overall Study|Progressive Disease|0|||
105548572|NCT00384085|364007808|FG001|Overall Study|Progressive Disease|1|||
105548573|NCT00384085|364007809|FG002|Overall Study|Progressive Disease|0|||
105548574|NCT00384085|364007807|FG000|Overall Study|Withdrawal by Subject|14|||
105548575|NCT00384085|364007808|FG001|Overall Study|Withdrawal by Subject|19|||
105548576|NCT00384085|364007809|FG002|Overall Study|Withdrawal by Subject|29|||
105548577|NCT00384085|364007807|FG000|Overall Study|Patient non-compliant|4|||
105548578|NCT00384085|364007808|FG001|Overall Study|Patient non-compliant|4|||
105548579|NCT00384085|364007809|FG002|Overall Study|Patient non-compliant|5|||
105548580|NCT00384085|364007807|FG000|Overall Study|Physician Decision|1|||
105548581|NCT00384085|364007808|FG001|Overall Study|Physician Decision|0|||
105548582|NCT00384085|364007809|FG002|Overall Study|Physician Decision|0|||
105548583|NCT00384085|364007807|FG000|Overall Study|Loss of site personnel|1|||
105548584|NCT00384085|364007808|FG001|Overall Study|Loss of site personnel|0|||
105548585|NCT00384085|364007809|FG002|Overall Study|Loss of site personnel|1|||
105548586|NCT00384085|364007807|FG000|Overall Study|Sponsor decision|1|||
105548587|NCT00384085|364007808|FG001|Overall Study|Sponsor decision|2|||
105548588|NCT00384085|364007809|FG002|Overall Study|Sponsor decision|1|||
105548589|NCT00384085|364007807|FG000|Overall Study|Patient moved|1|||
105548590|NCT00384085|364007808|FG001|Overall Study|Patient moved|0|||
105548591|NCT00384085|364007809|FG002|Overall Study|Patient moved|1|||
105548592|NCT00384085|364007807|FG000|Overall Study|Patient required surgery|0|||
105548593|NCT00384085|364007808|FG001|Overall Study|Patient required surgery|1|||
105548594|NCT00384085|364007809|FG002|Overall Study|Patient required surgery|0|||
105548595|NCT02318329|364007812|FG000|Overall Study|Progressive Disease|2|||
105548596|NCT02318329|364007813|FG001|Overall Study|Progressive Disease|3|||
105548597|NCT02318329|364007814|FG002|Overall Study|Progressive Disease|2|||
105548598|NCT02318329|364007815|FG003|Overall Study|Progressive Disease|3|||
105548599|NCT02318329|364007816|FG004|Overall Study|Progressive Disease|3|||
105548600|NCT02318329|364007817|FG005|Overall Study|Progressive Disease|3|||
105548601|NCT02318329|364007818|FG006|Overall Study|Progressive Disease|1|||
105548602|NCT02318329|364007819|FG007|Overall Study|Progressive Disease|1|||
105548603|NCT02318329|364007820|FG008|Overall Study|Progressive Disease|5|||
105548604|NCT02318329|364007821|FG009|Overall Study|Progressive Disease|39|||
105548605|NCT02318329|364007812|FG000|Overall Study|Death|0|||
105548606|NCT02318329|364007813|FG001|Overall Study|Death|0|||
105548607|NCT02318329|364007814|FG002|Overall Study|Death|0|||
105548608|NCT02318329|364007815|FG003|Overall Study|Death|0|||
105548609|NCT02318329|364007816|FG004|Overall Study|Death|0|||
105548610|NCT02318329|364007817|FG005|Overall Study|Death|0|||
105548611|NCT02318329|364007818|FG006|Overall Study|Death|0|||
105548612|NCT02318329|364007819|FG007|Overall Study|Death|0|||
105548613|NCT02318329|364007820|FG008|Overall Study|Death|0|||
105548614|NCT02318329|364007821|FG009|Overall Study|Death|5|||
105548615|NCT02318329|364007812|FG000|Overall Study|Lost to Follow-up|0|||
105548616|NCT02318329|364007813|FG001|Overall Study|Lost to Follow-up|0|||
105548617|NCT02318329|364007814|FG002|Overall Study|Lost to Follow-up|0|||
105548618|NCT02318329|364007815|FG003|Overall Study|Lost to Follow-up|0|||
105548619|NCT02318329|364007816|FG004|Overall Study|Lost to Follow-up|0|||
105548620|NCT02318329|364007817|FG005|Overall Study|Lost to Follow-up|0|||
105548621|NCT02318329|364007818|FG006|Overall Study|Lost to Follow-up|0|||
105548622|NCT02318329|364007819|FG007|Overall Study|Lost to Follow-up|0|||
105548623|NCT02318329|364007820|FG008|Overall Study|Lost to Follow-up|0|||
105548624|NCT02318329|364007821|FG009|Overall Study|Lost to Follow-up|1|||
105548625|NCT02318329|364007812|FG000|Overall Study|Withdrawal by Subject|0|||
105548626|NCT02318329|364007813|FG001|Overall Study|Withdrawal by Subject|0|||
105548627|NCT02318329|364007814|FG002|Overall Study|Withdrawal by Subject|0|||
105548628|NCT02318329|364007815|FG003|Overall Study|Withdrawal by Subject|0|||
105548629|NCT02318329|364007816|FG004|Overall Study|Withdrawal by Subject|0|||
105548630|NCT02318329|364007817|FG005|Overall Study|Withdrawal by Subject|0|||
105548631|NCT02318329|364007818|FG006|Overall Study|Withdrawal by Subject|0|||
105548632|NCT02318329|364007819|FG007|Overall Study|Withdrawal by Subject|0|||
105548633|NCT02318329|364007820|FG008|Overall Study|Withdrawal by Subject|0|||
105548634|NCT02318329|364007821|FG009|Overall Study|Withdrawal by Subject|6|||
105548635|NCT02318329|364007812|FG000|Overall Study|Other|1|||
105548636|NCT02318329|364007813|FG001|Overall Study|Other|1|||
105548637|NCT02318329|364007814|FG002|Overall Study|Other|1|||
105548638|NCT02318329|364007815|FG003|Overall Study|Other|0|||
105548639|NCT02318329|364007816|FG004|Overall Study|Other|0|||
105548640|NCT02318329|364007817|FG005|Overall Study|Other|0|||
105548641|NCT02318329|364007818|FG006|Overall Study|Other|0|||
105548642|NCT02318329|364007819|FG007|Overall Study|Other|0|||
105548643|NCT02318329|364007820|FG008|Overall Study|Other|1|||
105548644|NCT02318329|364007821|FG009|Overall Study|Other|1|||
105548645|NCT03725982|364007822|FG000|First Intervention|Withdrawal by Subject|0|||
105548646|NCT03725982|364007823|FG001|First Intervention|Withdrawal by Subject|1|||
105548647|NCT03725982|364007822|FG000|First Intervention|Physician Decision|1|||
105548648|NCT03725982|364007823|FG001|First Intervention|Physician Decision|1|||
105548649|NCT00987467|364007827|FG000|Overall Study|Lost to Follow-up|2|||
105548650|NCT02731131|364007830|FG000|Overall Study|Psychiatric Disorder|0|||
105548651|NCT02731131|364007831|FG001|Overall Study|Psychiatric Disorder|1|||
105548652|NCT02731131|364007830|FG000|Overall Study|Refused Therapy|0|||
105548653|NCT02731131|364007831|FG001|Overall Study|Refused Therapy|1|||
105548654|NCT04408469|364007832|FG000|Overall Study|Lost to Follow-up|6|||
105548655|NCT04408469|364007833|FG001|Overall Study|Lost to Follow-up|9|||
105548656|NCT04408469|364007832|FG000|Overall Study|Withdrawal by Subject|6|||
105548657|NCT04408469|364007833|FG001|Overall Study|Withdrawal by Subject|1|||
105548658|NCT04408469|364007832|FG000|Overall Study|Dismissal due to ineligibility|0|||
105548659|NCT04408469|364007833|FG001|Overall Study|Dismissal due to ineligibility|1|||
105548660|NCT02519504|364007836|FG000|Overall Study|Protocol Violation|6|||
105548661|NCT02519504|364007837|FG001|Overall Study|Protocol Violation|5|||
105548662|NCT02519504|364007836|FG000|Overall Study|Ineligible for direct testing|12|||
105548663|NCT02519504|364007837|FG001|Overall Study|Ineligible for direct testing|12|||
105548664|NCT02519504|364007836|FG000|Overall Study|Did not participate in direct testing|95|||
105548665|NCT02519504|364007837|FG001|Overall Study|Did not participate in direct testing|86|||
105548666|NCT02546544|364007838|FG000|Overall Study|Disease Progression|14|||
105548667|NCT02546544|364007838|FG000|Overall Study|Adverse Event|1|||
105548668|NCT02546544|364007838|FG000|Overall Study|Withdrawal by Subject|1|||
105548669|NCT02548962|364007841|FG000|Overall Study|Withdrawal by Subject|1|||
105548670|NCT02548962|364007842|FG001|Overall Study|Withdrawal by Subject|0|||
105548671|NCT01233817|364007843|FG000|Overall Study|Lost to Follow-up|1|||
105548672|NCT01233817|364007843|FG000|Overall Study|Withdrawal by Subject|2|||
105548673|NCT01202773|364007847|FG000|Overall Study|Adverse Event|4|||
105548674|NCT01202773|364007848|FG001|Overall Study|Adverse Event|5|||
105548675|NCT01202773|364007849|FG002|Overall Study|Adverse Event|5|||
105548676|NCT01202773|364007847|FG000|Overall Study|Lack of Efficacy|5|||
105548677|NCT01202773|364007848|FG001|Overall Study|Lack of Efficacy|4|||
105548678|NCT01202773|364007849|FG002|Overall Study|Lack of Efficacy|9|||
105548679|NCT01202773|364007847|FG000|Overall Study|Entry Criteria Not Met|2|||
105548680|NCT01202773|364007848|FG001|Overall Study|Entry Criteria Not Met|0|||
105548681|NCT01202773|364007849|FG002|Overall Study|Entry Criteria Not Met|1|||
105548682|NCT01202773|364007847|FG000|Overall Study|Lost to Follow-up|1|||
105548683|NCT01202773|364007848|FG001|Overall Study|Lost to Follow-up|2|||
105548684|NCT01202773|364007849|FG002|Overall Study|Lost to Follow-up|2|||
105548685|NCT01202773|364007847|FG000|Overall Study|Withdrawal by Subject|13|||
105548686|NCT01202773|364007848|FG001|Overall Study|Withdrawal by Subject|6|||
105548687|NCT01202773|364007849|FG002|Overall Study|Withdrawal by Subject|5|||
105548688|NCT01202773|364007847|FG000|Overall Study|Physician Decision|2|||
105548689|NCT01202773|364007848|FG001|Overall Study|Physician Decision|0|||
105548690|NCT01202773|364007849|FG002|Overall Study|Physician Decision|0|||
105548691|NCT01202773|364007847|FG000|Overall Study|Protocol Violation|11|||
105548692|NCT01202773|364007848|FG001|Overall Study|Protocol Violation|6|||
105548693|NCT01202773|364007849|FG002|Overall Study|Protocol Violation|10|||
105548694|NCT01202773|364007847|FG000|Overall Study|Sponsor Decision|19|||
105548695|NCT01202773|364007848|FG001|Overall Study|Sponsor Decision|20|||
105548696|NCT01202773|364007849|FG002|Overall Study|Sponsor Decision|23|||
105548697|NCT00599326|364007856|FG000|Overall Study|Lost to Follow-up|1|||
105548698|NCT00599326|364007856|FG000|Overall Study|Noncompliant|1|||
105548699|NCT02862106|364007857|FG000|Overall Study|Adverse Event|4|||
105548700|NCT02862106|364007858|FG001|Overall Study|Adverse Event|0|||
105548701|NCT02862106|364007857|FG000|Overall Study|Protocol Violation|16|||
105548702|NCT02862106|364007858|FG001|Overall Study|Protocol Violation|1|||
105548703|NCT02862106|364007857|FG000|Overall Study|Lost to Follow-up|15|||
105548704|NCT02862106|364007858|FG001|Overall Study|Lost to Follow-up|5|||
105548705|NCT02862106|364007857|FG000|Overall Study|Withdrawal by Subject|2|||
105548706|NCT02862106|364007858|FG001|Overall Study|Withdrawal by Subject|0|||
105548707|NCT02862106|364007857|FG000|Overall Study|Subjects moved to other city|1|||
105548708|NCT02862106|364007858|FG001|Overall Study|Subjects moved to other city|0|||
105548709|NCT00320216|364007864|FG000|Overall Study|Adverse Event|0|||
105548710|NCT00320216|364007865|FG001|Overall Study|Adverse Event|6|||
105548711|NCT00320216|364007866|FG002|Overall Study|Adverse Event|0|||
105548712|NCT00320216|364007867|FG003|Overall Study|Adverse Event|2|||
105548713|NCT00320216|364007868|FG004|Overall Study|Adverse Event|2|||
105548714|NCT00320216|364007864|FG000|Overall Study|Lack of Efficacy|6|||
105548715|NCT00320216|364007865|FG001|Overall Study|Lack of Efficacy|2|||
105548716|NCT00320216|364007866|FG002|Overall Study|Lack of Efficacy|1|||
105548717|NCT00320216|364007867|FG003|Overall Study|Lack of Efficacy|0|||
105548718|NCT00320216|364007868|FG004|Overall Study|Lack of Efficacy|1|||
105548719|NCT00320216|364007864|FG000|Overall Study|Lost to Follow-up|3|||
105548720|NCT00320216|364007865|FG001|Overall Study|Lost to Follow-up|0|||
105548721|NCT00320216|364007866|FG002|Overall Study|Lost to Follow-up|0|||
105548722|NCT00320216|364007867|FG003|Overall Study|Lost to Follow-up|0|||
105548723|NCT00320216|364007868|FG004|Overall Study|Lost to Follow-up|0|||
105548724|NCT00320216|364007864|FG000|Overall Study|Other|7|||
105548725|NCT00320216|364007865|FG001|Overall Study|Other|2|||
105548726|NCT00320216|364007866|FG002|Overall Study|Other|5|||
105548727|NCT00320216|364007867|FG003|Overall Study|Other|1|||
105548728|NCT00320216|364007868|FG004|Overall Study|Other|3|||
105548729|NCT03465540|364007872|FG000|Overall Study|Withdrawal by Subject|0|||
105548730|NCT03465540|364007873|FG001|Overall Study|Withdrawal by Subject|0|||
105548731|NCT03465540|364007874|FG002|Overall Study|Withdrawal by Subject|1|||
105548732|NCT03465540|364007875|FG003|Overall Study|Withdrawal by Subject|1|||
105548733|NCT03465540|364007876|FG004|Overall Study|Withdrawal by Subject|1|||
105548734|NCT03465540|364007877|FG005|Overall Study|Withdrawal by Subject|0|||
105548735|NCT03465540|364007872|FG000|Overall Study|Lost to Follow-up|0|||
105548736|NCT03465540|364007873|FG001|Overall Study|Lost to Follow-up|1|||
105548737|NCT03465540|364007874|FG002|Overall Study|Lost to Follow-up|0|||
105548738|NCT03465540|364007875|FG003|Overall Study|Lost to Follow-up|0|||
105548739|NCT03465540|364007876|FG004|Overall Study|Lost to Follow-up|1|||
105548740|NCT03465540|364007877|FG005|Overall Study|Lost to Follow-up|0|||
105548741|NCT03465540|364007872|FG000|Overall Study|Death|1|||
105548742|NCT03465540|364007873|FG001|Overall Study|Death|1|||
105548743|NCT03465540|364007874|FG002|Overall Study|Death|0|||
105548744|NCT03465540|364007875|FG003|Overall Study|Death|2|||
105548745|NCT03465540|364007876|FG004|Overall Study|Death|0|||
105548746|NCT03465540|364007877|FG005|Overall Study|Death|2|||
105548747|NCT03465540|364007872|FG000|Overall Study|Protocol specified criteria|0|||
105548748|NCT03465540|364007873|FG001|Overall Study|Protocol specified criteria|2|||
105548749|NCT03465540|364007874|FG002|Overall Study|Protocol specified criteria|2|||
105548750|NCT03465540|364007875|FG003|Overall Study|Protocol specified criteria|0|||
105548751|NCT03465540|364007876|FG004|Overall Study|Protocol specified criteria|2|||
105548752|NCT03465540|364007877|FG005|Overall Study|Protocol specified criteria|0|||
105548753|NCT01854827|364007878|FG000|Overall Study|Death|1|||
105548754|NCT00736996|364007879|FG000|Overall Study|Lost to Follow-up|1|||
105548755|NCT00736996|364007880|FG001|Overall Study|Lost to Follow-up|9|||
105548756|NCT00736996|364007881|FG002|Overall Study|Lost to Follow-up|2|||
105548757|NCT03264989|364007883|FG000|Overall Study|Lost to Follow-up|1|||
105548758|NCT03264989|364007884|FG001|Overall Study|Lost to Follow-up|0|||
105548759|NCT03264989|364007883|FG000|Overall Study|New Therapy for study Indication|1|||
105548760|NCT03264989|364007884|FG001|Overall Study|New Therapy for study Indication|0|||
105548761|NCT03264989|364007883|FG000|Overall Study|Protocol Violation|0|||
105548762|NCT03264989|364007884|FG001|Overall Study|Protocol Violation|1|||
105548763|NCT03264989|364007883|FG000|Overall Study|Patient decision|13|||
105548764|NCT03264989|364007884|FG001|Overall Study|Patient decision|0|||
105548765|NCT03264989|364007883|FG000|Overall Study|Physician Decision|6|||
105548766|NCT03264989|364007884|FG001|Overall Study|Physician Decision|4|||
105548767|NCT03264989|364007883|FG000|Overall Study|Adverse Event|2|||
105548768|NCT03264989|364007884|FG001|Overall Study|Adverse Event|1|||
105548769|NCT03264989|364007883|FG000|Overall Study|Death|1|||
105548770|NCT03264989|364007884|FG001|Overall Study|Death|1|||
105548771|NCT03264989|364007883|FG000|Overall Study|Pregnancy|2|||
105548772|NCT03264989|364007884|FG001|Overall Study|Pregnancy|0|||
105548773|NCT03264989|364007883|FG000|Overall Study|End of Study|19|||
105548774|NCT03264989|364007884|FG001|Overall Study|End of Study|5|||
105548775|NCT01040130|364007885|FG000|Overall Study|Adverse Event|1|||
105548776|NCT01040130|364007886|FG001|Overall Study|Adverse Event|1|||
105548777|NCT01040130|364007887|FG002|Overall Study|Adverse Event|0|||
105548778|NCT01040130|364007888|FG003|Overall Study|Adverse Event|5|||
105548779|NCT01040130|364007889|FG004|Overall Study|Adverse Event|0|||
105548780|NCT01040130|364007890|FG005|Overall Study|Adverse Event|3|||
105548781|NCT01040130|364007885|FG000|Overall Study|Protocol Violation|0|||
105548782|NCT01040130|364007886|FG001|Overall Study|Protocol Violation|0|||
105548783|NCT01040130|364007887|FG002|Overall Study|Protocol Violation|2|||
105548784|NCT01040130|364007888|FG003|Overall Study|Protocol Violation|0|||
105548785|NCT01040130|364007889|FG004|Overall Study|Protocol Violation|0|||
105548786|NCT01040130|364007890|FG005|Overall Study|Protocol Violation|0|||
105548787|NCT01040130|364007885|FG000|Overall Study|Withdrawal by Subject|0|||
105548788|NCT01040130|364007886|FG001|Overall Study|Withdrawal by Subject|2|||
105548789|NCT01040130|364007887|FG002|Overall Study|Withdrawal by Subject|0|||
105548790|NCT01040130|364007888|FG003|Overall Study|Withdrawal by Subject|0|||
105548791|NCT01040130|364007889|FG004|Overall Study|Withdrawal by Subject|0|||
105548792|NCT01040130|364007890|FG005|Overall Study|Withdrawal by Subject|1|||
105548793|NCT01040130|364007885|FG000|Overall Study|Other reasons not listed above|2|||
105548794|NCT01040130|364007886|FG001|Overall Study|Other reasons not listed above|0|||
105548795|NCT01040130|364007887|FG002|Overall Study|Other reasons not listed above|0|||
105548796|NCT01040130|364007888|FG003|Overall Study|Other reasons not listed above|0|||
105548797|NCT01040130|364007889|FG004|Overall Study|Other reasons not listed above|0|||
105548798|NCT01040130|364007890|FG005|Overall Study|Other reasons not listed above|0|||
105548799|NCT03029208|364007891|FG000|Overall Study|Withdrawal by Subject|2|||
105548800|NCT03029208|364007892|FG001|Overall Study|Withdrawal by Subject|3|||
105548801|NCT03029208|364007891|FG000|Overall Study|Lost to Follow-up|0|||
105596261|NCT00530842|364184177|FG001|Period 1|Individual different reasons|3|||
105596262|NCT00530842|364184176|FG000|Period 2|Adverse Event|3|||
105596263|NCT00530842|364184177|FG001|Period 2|Adverse Event|3|||
105596264|NCT00530842|364184176|FG000|Period 2|Lack of Efficacy|1|||
105596265|NCT00530842|364184177|FG001|Period 2|Lack of Efficacy|0|||
105596266|NCT00530842|364184176|FG000|Period 2|Lost to Follow-up|0|||
105596267|NCT00530842|364184177|FG001|Period 2|Lost to Follow-up|4|||
105596268|NCT00530842|364184176|FG000|Period 2|Protocol Violation|1|||
105596269|NCT00530842|364184177|FG001|Period 2|Protocol Violation|0|||
105596270|NCT00530842|364184176|FG000|Period 2|Withdrawal by Subject|1|||
105596271|NCT00530842|364184177|FG001|Period 2|Withdrawal by Subject|2|||
105596272|NCT00530842|364184176|FG000|Period 2|Individual different reasons|2|||
105596273|NCT00530842|364184177|FG001|Period 2|Individual different reasons|0|||
105596274|NCT04347954|364184178|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
105548802|NCT03029208|364007892|FG001|Overall Study|Lost to Follow-up|1|||
105548803|NCT02334748|364007893|FG000|Overall Study|Adverse Event|1|||
105548804|NCT02334748|364007893|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
105548805|NCT02334748|364007893|FG000|Overall Study|Patient no longer required study drug|2|||
105548806|NCT02334748|364007893|FG000|Overall Study|Lack of Efficacy|4|||
105548807|NCT01046643|364007894|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
105548808|NCT01046643|364007895|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
105548809|NCT01046643|364007896|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
105548810|NCT01046643|364007897|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
105548811|NCT00553267|364007907|FG000|Overall Study|Adverse Event|8|||
105548812|NCT00553267|364007908|FG001|Overall Study|Adverse Event|10|||
105548813|NCT00553267|364007909|FG002|Overall Study|Adverse Event|5|||
105548814|NCT00553267|364007907|FG000|Overall Study|Non compliant with protocol|3|||
105548815|NCT00553267|364007908|FG001|Overall Study|Non compliant with protocol|3|||
105548816|NCT00553267|364007909|FG002|Overall Study|Non compliant with protocol|2|||
105548817|NCT00553267|364007907|FG000|Overall Study|Lost to Follow-up|0|||
105548818|NCT00553267|364007908|FG001|Overall Study|Lost to Follow-up|0|||
105548819|NCT00553267|364007909|FG002|Overall Study|Lost to Follow-up|1|||
105548820|NCT00553267|364007907|FG000|Overall Study|Consent withdrawn|2|||
105548821|NCT00553267|364007908|FG001|Overall Study|Consent withdrawn|3|||
105548822|NCT00553267|364007909|FG002|Overall Study|Consent withdrawn|1|||
105548823|NCT00553267|364007907|FG000|Overall Study|Specified category|1|||
105548824|NCT00553267|364007908|FG001|Overall Study|Specified category|2|||
105548825|NCT00553267|364007909|FG002|Overall Study|Specified category|1|||
105548826|NCT02252211|364007917|FG000|Overall Study|Adverse Event|0|||
105548827|NCT02252211|364007918|FG001|Overall Study|Adverse Event|1|||
105548828|NCT02252211|364007919|FG002|Overall Study|Adverse Event|0|||
105548829|NCT02252211|364007917|FG000|Overall Study|Progressive disease|3|||
105548830|NCT02252211|364007918|FG001|Overall Study|Progressive disease|2|||
105548831|NCT02252211|364007919|FG002|Overall Study|Progressive disease|0|||
105548832|NCT02252211|364007917|FG000|Overall Study|Withdrawal by Subject|1|||
105548833|NCT02252211|364007918|FG001|Overall Study|Withdrawal by Subject|0|||
105548834|NCT02252211|364007919|FG002|Overall Study|Withdrawal by Subject|0|||
105548835|NCT02252211|364007917|FG000|Overall Study|Serious Adverse Event During Screening|1|||
105548836|NCT02252211|364007918|FG001|Overall Study|Serious Adverse Event During Screening|0|||
105548837|NCT02252211|364007919|FG002|Overall Study|Serious Adverse Event During Screening|1|||
105548838|NCT00968669|364007920|FG000|Overall Study|Lost to Follow-up|5|||
105548839|NCT00968669|364007921|FG001|Overall Study|Lost to Follow-up|2|||
105548840|NCT00968669|364007922|FG002|Overall Study|Lost to Follow-up|1|||
105548841|NCT00968669|364007923|FG003|Overall Study|Lost to Follow-up|4|||
105548842|NCT00968669|364007920|FG000|Overall Study|Withdrawal by Subject|9|||
105548843|NCT00968669|364007921|FG001|Overall Study|Withdrawal by Subject|7|||
105548844|NCT00968669|364007922|FG002|Overall Study|Withdrawal by Subject|5|||
105548845|NCT00968669|364007923|FG003|Overall Study|Withdrawal by Subject|3|||
105548846|NCT00968669|364007920|FG000|Overall Study|Pregnancy|0|||
105548847|NCT00968669|364007921|FG001|Overall Study|Pregnancy|0|||
105548848|NCT00968669|364007922|FG002|Overall Study|Pregnancy|2|||
105548849|NCT00968669|364007923|FG003|Overall Study|Pregnancy|0|||
105548850|NCT00968669|364007920|FG000|Overall Study|AE|1|||
105548851|NCT00968669|364007921|FG001|Overall Study|AE|0|||
105596275|NCT04347954|364184179|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
105596276|NCT04347954|364184180|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
105596277|NCT04347954|364184178|FG000|Overall Study|Lost to Follow-up|0|||
105548852|NCT00968669|364007922|FG002|Overall Study|AE|0|||
105548853|NCT00968669|364007923|FG003|Overall Study|AE|0|||
105548854|NCT00968669|364007920|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
105548855|NCT00968669|364007921|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
105548856|NCT00968669|364007922|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
105548857|NCT00968669|364007923|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
105548858|NCT00968669|364007920|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
105548859|NCT00968669|364007921|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
105548860|NCT00968669|364007922|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
105548861|NCT00968669|364007923|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
105548862|NCT00968669|364007920|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
105548863|NCT00968669|364007921|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
105548864|NCT00968669|364007922|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
105548865|NCT00968669|364007923|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
105548866|NCT00968669|364007920|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
105548867|NCT00968669|364007921|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
105548868|NCT00968669|364007922|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
105548869|NCT00968669|364007923|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
105548870|NCT00968669|364007920|FG000|Overall Study|EARLY WITHDRAWAL|0|||
105548871|NCT00968669|364007921|FG001|Overall Study|EARLY WITHDRAWAL|1|||
105548872|NCT00968669|364007922|FG002|Overall Study|EARLY WITHDRAWAL|0|||
105548873|NCT00968669|364007923|FG003|Overall Study|EARLY WITHDRAWAL|0|||
105548874|NCT00968669|364007920|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
105548875|NCT00968669|364007921|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
105548876|NCT00968669|364007922|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
105548877|NCT00968669|364007923|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
105548878|NCT00968669|364007920|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
105548879|NCT00968669|364007921|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
105548880|NCT00968669|364007922|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
105548881|NCT00968669|364007923|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
105548882|NCT00968669|364007920|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
105548883|NCT00968669|364007921|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
105548884|NCT00968669|364007922|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
105548885|NCT00968669|364007923|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
105548886|NCT00968669|364007920|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
105548887|NCT00968669|364007921|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
105548888|NCT00968669|364007922|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
105548889|NCT00968669|364007923|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
105548890|NCT00968669|364007920|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
105548891|NCT00968669|364007921|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
105548892|NCT00968669|364007922|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
105548893|NCT00968669|364007923|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
105548894|NCT00968669|364007920|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
105548895|NCT00968669|364007921|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
105548896|NCT00968669|364007922|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
105548897|NCT00968669|364007923|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
105548898|NCT00968669|364007920|FG000|Overall Study|SPONSOR DECISION|0|||
105548899|NCT00968669|364007921|FG001|Overall Study|SPONSOR DECISION|1|||
105548900|NCT00968669|364007922|FG002|Overall Study|SPONSOR DECISION|0|||
105548901|NCT00968669|364007923|FG003|Overall Study|SPONSOR DECISION|0|||
105548902|NCT00968669|364007920|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
105548903|NCT00968669|364007921|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
105548904|NCT00968669|364007922|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
105548905|NCT00968669|364007923|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
105548906|NCT00968669|364007920|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
105548907|NCT00968669|364007921|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
105548908|NCT00968669|364007922|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
105548909|NCT00968669|364007923|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
105548910|NCT00968669|364007920|FG000|Overall Study|SUBJECT INCARCERATED|0|||
105548911|NCT00968669|364007921|FG001|Overall Study|SUBJECT INCARCERATED|1|||
105548912|NCT00968669|364007922|FG002|Overall Study|SUBJECT INCARCERATED|0|||
105548913|NCT00968669|364007923|FG003|Overall Study|SUBJECT INCARCERATED|0|||
105548914|NCT00968669|364007920|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
105548915|NCT00968669|364007921|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
105548916|NCT00968669|364007922|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
105548917|NCT00968669|364007923|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
105548918|NCT00968669|364007920|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
105548919|NCT00968669|364007921|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
105548920|NCT00968669|364007922|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
105548921|NCT00968669|364007923|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
105548922|NCT00144339|364007924|FG000|Overall Study|Adverse Event|746|||
105548923|NCT00144339|364007925|FG001|Overall Study|Adverse Event|627|||
105548924|NCT00144339|364007924|FG000|Overall Study|Protocol Violation|75|||
105548925|NCT00144339|364007925|FG001|Overall Study|Protocol Violation|48|||
105548926|NCT00144339|364007924|FG000|Overall Study|Withdrawal by Subject|403|||
105548927|NCT00144339|364007925|FG001|Overall Study|Withdrawal by Subject|300|||
105548928|NCT00144339|364007924|FG000|Overall Study|Lost to Follow-up|76|||
105548929|NCT00144339|364007925|FG001|Overall Study|Lost to Follow-up|64|||
105548930|NCT00144339|364007924|FG000|Overall Study|Other|58|||
105548931|NCT00144339|364007925|FG001|Overall Study|Other|60|||
105548932|NCT01272934|364007926|FG000|Overall Study|Adverse Event|0|||
105548933|NCT01272934|364007927|FG001|Overall Study|Adverse Event|1|||
105548934|NCT01272934|364007926|FG000|Overall Study|Abnormal Laboratory Value|0|||
105548935|NCT01272934|364007927|FG001|Overall Study|Abnormal Laboratory Value|1|||
105548936|NCT04287920|364007928|FG000|Overall Study|Lost to Follow-up|1|||
105548937|NCT04287920|364007929|FG001|Overall Study|Lost to Follow-up|1|||
105548938|NCT04287920|364007928|FG000|Overall Study|Withdrawal by Subject|0|||
105548939|NCT04287920|364007929|FG001|Overall Study|Withdrawal by Subject|3|||
105548940|NCT00099983|364007934|FG000|Overall Study|Lost to Follow-up|2|||
105548941|NCT00099983|364007935|FG001|Overall Study|Lost to Follow-up|3|||
105548942|NCT00099983|364007934|FG000|Overall Study|Missing Source Documents|14|||
105548943|NCT00099983|364007935|FG001|Overall Study|Missing Source Documents|15|||
105548944|NCT00099983|364007934|FG000|Overall Study|Withdrawal by Subject|3|||
105548945|NCT00099983|364007935|FG001|Overall Study|Withdrawal by Subject|2|||
105548946|NCT00099983|364007934|FG000|Overall Study|Adverse Event|1|||
105548947|NCT00099983|364007935|FG001|Overall Study|Adverse Event|1|||
105548948|NCT00099983|364007934|FG000|Overall Study|Lack of Efficacy|0|||
105548949|NCT00099983|364007935|FG001|Overall Study|Lack of Efficacy|1|||
105548950|NCT00099983|364007934|FG000|Overall Study|Unable to return for appointments|1|||
105548951|NCT00099983|364007935|FG001|Overall Study|Unable to return for appointments|1|||
105548952|NCT00099983|364007934|FG000|Overall Study|Moved|1|||
105548953|NCT00099983|364007935|FG001|Overall Study|Moved|0|||
105548954|NCT00099983|364007934|FG000|Overall Study|Other psychiatric problem|1|||
105548955|NCT00099983|364007935|FG001|Overall Study|Other psychiatric problem|0|||
105548956|NCT00099983|364007934|FG000|Overall Study|Incarcerated|0|||
105548957|NCT00099983|364007935|FG001|Overall Study|Incarcerated|1|||
105548958|NCT00099983|364007934|FG000|Overall Study|Intolerant of burden of visits|0|||
105548959|NCT00099983|364007935|FG001|Overall Study|Intolerant of burden of visits|1|||
105548960|NCT00099983|364007934|FG000|Overall Study|Other issue|1|||
105548961|NCT00099983|364007935|FG001|Overall Study|Other issue|0|||
105548962|NCT03585244|364007940|FG000|Overall Study|Withdrawal by Subject|15|||
105548963|NCT04307186|364007941|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
105548964|NCT04307186|364007941|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
105548965|NCT04307186|364007941|FG000|Washout 3-14 Days|Progressive disease|1|||
105548966|NCT04307186|364007941|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
105548967|NCT04307186|364007941|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
105548968|NCT03538626|364007943|FG000|Overall Study|Withdrawal by Subject|0|||
105548969|NCT03538626|364007944|FG001|Overall Study|Withdrawal by Subject|1|||
105548970|NCT03538626|364007945|FG002|Overall Study|Withdrawal by Subject|0|||
105548971|NCT03538626|364007946|FG003|Overall Study|Withdrawal by Subject|0|||
105548972|NCT03538626|364007947|FG004|Overall Study|Withdrawal by Subject|0|||
105548973|NCT03538626|364007948|FG005|Overall Study|Withdrawal by Subject|0|||
105548974|NCT03538626|364007949|FG006|Overall Study|Withdrawal by Subject|0|||
105548975|NCT03538626|364007950|FG007|Overall Study|Withdrawal by Subject|0|||
105548976|NCT03538626|364007943|FG000|Overall Study|Lost to Follow-up|0|||
105548977|NCT03538626|364007944|FG001|Overall Study|Lost to Follow-up|0|||
105548978|NCT03538626|364007945|FG002|Overall Study|Lost to Follow-up|0|||
105548979|NCT03538626|364007946|FG003|Overall Study|Lost to Follow-up|0|||
105548980|NCT03538626|364007947|FG004|Overall Study|Lost to Follow-up|0|||
105548981|NCT03538626|364007948|FG005|Overall Study|Lost to Follow-up|0|||
105548982|NCT03538626|364007949|FG006|Overall Study|Lost to Follow-up|1|||
105548983|NCT03538626|364007950|FG007|Overall Study|Lost to Follow-up|0|||
105548984|NCT00288587|364007951|FG000|Overall Study|Death|4|||
105548985|NCT00288587|364007952|FG001|Overall Study|Death|4|||
105596278|NCT04347954|364184179|FG001|Overall Study|Lost to Follow-up|1|||
105596279|NCT04347954|364184180|FG002|Overall Study|Lost to Follow-up|0|||
105596280|NCT02534350|364184181|FG000|Overall Study|Randomized But Not Treated|1|||
105596281|NCT02534350|364184182|FG001|Overall Study|Randomized But Not Treated|0|||
105596282|NCT02534350|364184181|FG000|Overall Study|Protocol Violation|1|||
105596283|NCT02534350|364184182|FG001|Overall Study|Protocol Violation|0|||
105548986|NCT00288587|364007951|FG000|Overall Study|Transplant|0|||
105596284|NCT02534350|364184181|FG000|Overall Study|Withdrew Consent|2|||
105596285|NCT02534350|364184182|FG001|Overall Study|Withdrew Consent|0|||
105596286|NCT03478696|364184186|FG000|Overall Study|Adverse Event|1|||
105596287|NCT03478696|364184187|FG001|Overall Study|Adverse Event|5|||
105548987|NCT00288587|364007952|FG001|Overall Study|Transplant|3|||
105548988|NCT00288587|364007951|FG000|Overall Study|Adverse Event|0|||
105548989|NCT00288587|364007952|FG001|Overall Study|Adverse Event|1|||
105548990|NCT00288587|364007951|FG000|Overall Study|Physician Decision|0|||
105548991|NCT00288587|364007952|FG001|Overall Study|Physician Decision|2|||
105548992|NCT00288587|364007951|FG000|Overall Study|Severe Aortic Stenosis|1|||
105548993|NCT00288587|364007952|FG001|Overall Study|Severe Aortic Stenosis|0|||
105548994|NCT01434602|364007958|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
105596288|NCT03478696|364184186|FG000|Overall Study|Lost to Follow-up|1|||
105596289|NCT03478696|364184187|FG001|Overall Study|Lost to Follow-up|0|||
105596290|NCT03478696|364184186|FG000|Overall Study|Physician Decision|6|||
105548995|NCT01434602|364007959|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
105548996|NCT01434602|364007960|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
105548997|NCT01434602|364007961|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
105548998|NCT01434602|364007962|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
105548999|NCT01434602|364007958|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
105549000|NCT01434602|364007959|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
105549001|NCT01434602|364007960|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
105549002|NCT01434602|364007961|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
105549003|NCT01434602|364007962|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
105549004|NCT01434602|364007958|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
105549005|NCT01434602|364007959|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
105549006|NCT01434602|364007960|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
105549007|NCT01434602|364007961|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
105549008|NCT01434602|364007962|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
105549009|NCT01434602|364007958|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
105549010|NCT01434602|364007959|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
105596291|NCT03478696|364184187|FG001|Overall Study|Physician Decision|3|||
105596292|NCT03478696|364184186|FG000|Overall Study|Withdrawal by Subject|9|||
105596293|NCT03478696|364184187|FG001|Overall Study|Withdrawal by Subject|4|||
105596294|NCT03299816|364184188|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
105596295|NCT03299816|364184189|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
105596296|NCT03299816|364184188|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
105596297|NCT03299816|364184189|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
105596298|NCT03299816|364184188|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
105596299|NCT03299816|364184189|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
105596300|NCT00367991|364184190|FG000|Overall Study|Withdrawal by Subject|1|||
105596301|NCT00367991|364184191|FG001|Overall Study|Withdrawal by Subject|1|||
105596302|NCT00367991|364184190|FG000|Overall Study|Adverse Event|1|||
105596303|NCT00367991|364184191|FG001|Overall Study|Adverse Event|1|||
105596304|NCT01968226|364184207|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
105596305|NCT04707313|364184208|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
105596306|NCT04707313|364184209|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
105596307|NCT04707313|364184210|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
105596308|NCT04707313|364184211|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
105596309|NCT04707313|364184212|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
105596310|NCT04707313|364184213|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
105596311|NCT04707313|364184214|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
105596312|NCT04707313|364184215|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
105596313|NCT04707313|364184216|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
105596314|NCT04707313|364184217|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
105596315|NCT04707313|364184218|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
105596316|NCT04707313|364184219|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
105596317|NCT04707313|364184220|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
105596318|NCT04707313|364184208|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
105596319|NCT04707313|364184209|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
105596320|NCT04707313|364184210|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
105596321|NCT04707313|364184211|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
105596322|NCT04707313|364184212|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
105596323|NCT04707313|364184213|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
105596324|NCT04707313|364184214|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
105596325|NCT04707313|364184215|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
105596326|NCT04707313|364184216|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
105596327|NCT04707313|364184217|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
105596328|NCT04707313|364184218|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
105596329|NCT04707313|364184219|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
105596330|NCT04707313|364184220|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
105596331|NCT04707313|364184208|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
105596332|NCT04707313|364184209|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
105596333|NCT04707313|364184210|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
105596334|NCT04707313|364184211|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
105596335|NCT04707313|364184212|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
105596336|NCT04707313|364184213|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
105549011|NCT01434602|364007960|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
105549012|NCT01434602|364007961|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
105549013|NCT01434602|364007962|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
105549014|NCT01434602|364007958|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
105549015|NCT01434602|364007959|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
105549016|NCT01434602|364007960|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
105549017|NCT01434602|364007961|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
105549018|NCT01434602|364007962|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
105549019|NCT01434602|364007958|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
105549020|NCT01434602|364007959|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
105549021|NCT01434602|364007960|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
105549022|NCT01434602|364007961|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
105549023|NCT01434602|364007962|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
105549024|NCT01434602|364007958|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
105549025|NCT01434602|364007959|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
105549026|NCT01434602|364007960|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
105549027|NCT01434602|364007961|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
105549028|NCT01434602|364007962|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
105549029|NCT01434602|364007958|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
105549030|NCT01434602|364007959|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
105549031|NCT01434602|364007960|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
105549032|NCT01434602|364007961|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
105549033|NCT01434602|364007962|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
105549034|NCT01434602|364007958|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
105549035|NCT01434602|364007959|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
105549036|NCT01434602|364007960|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
105549037|NCT01434602|364007961|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
105549038|NCT01434602|364007962|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
105549039|NCT01434602|364007958|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
105549040|NCT01434602|364007959|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
105549041|NCT01434602|364007960|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
105549042|NCT01434602|364007961|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
105549043|NCT01434602|364007962|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
105549044|NCT05077267|364007963|FG000|Treatment Period|Lost to Follow-up|0|||
105549045|NCT05077267|364007964|FG001|Treatment Period|Lost to Follow-up|1|||
105549046|NCT05077267|364007965|FG002|Treatment Period|Lost to Follow-up|0|||
105549047|NCT05077267|364007963|FG000|Treatment Period|Withdrawal by Subject|0|||
105549048|NCT05077267|364007964|FG001|Treatment Period|Withdrawal by Subject|1|||
105549049|NCT05077267|364007965|FG002|Treatment Period|Withdrawal by Subject|0|||
105549050|NCT05077267|364007963|FG000|Follow-up Period|Lost to Follow-up|0|||
105549051|NCT05077267|364007964|FG001|Follow-up Period|Lost to Follow-up|5|||
105549052|NCT05077267|364007965|FG002|Follow-up Period|Lost to Follow-up|7|||
105549053|NCT05077267|364007963|FG000|Follow-up Period|Withdrawal by Subject|0|||
105549054|NCT05077267|364007964|FG001|Follow-up Period|Withdrawal by Subject|2|||
105549055|NCT05077267|364007965|FG002|Follow-up Period|Withdrawal by Subject|5|||
105549056|NCT05077267|364007963|FG000|Follow-up Period|Study terminated by sponsor|0|||
105549057|NCT05077267|364007964|FG001|Follow-up Period|Study terminated by sponsor|27|||
105549058|NCT05077267|364007965|FG002|Follow-up Period|Study terminated by sponsor|23|||
105549059|NCT05077267|364007963|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
105549060|NCT05077267|364007964|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
105549061|NCT05077267|364007965|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
105549062|NCT05077267|364007963|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
105549063|NCT05077267|364007964|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
105549064|NCT05077267|364007965|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
105549065|NCT01136291|364007966|FG000|Overall Study|Lost to Follow-up|1|||
105596337|NCT04707313|364184214|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
105549066|NCT01136291|364007967|FG001|Overall Study|Lost to Follow-up|1|||
105549067|NCT02308033|364007970|FG000|Overall Study|Normal Gram stain at Baseline|13|||
105549068|NCT02308033|364007971|FG001|Overall Study|Normal Gram stain at Baseline|10|||
105549069|NCT02308033|364007970|FG000|Overall Study|Positive for STD at Baseline|7|||
105549070|NCT02308033|364007971|FG001|Overall Study|Positive for STD at Baseline|4|||
105549071|NCT02308033|364007970|FG000|Overall Study|Lost to Follow-up|6|||
105549072|NCT02308033|364007971|FG001|Overall Study|Lost to Follow-up|5|||
105549073|NCT00759109|364007972|FG000|Overall Study|Adverse Event|17|||
105549074|NCT00759109|364007973|FG001|Overall Study|Adverse Event|12|||
105549075|NCT00759109|364007972|FG000|Overall Study|Inability to comply|1|||
105549076|NCT00759109|364007973|FG001|Overall Study|Inability to comply|1|||
105549077|NCT00759109|364007972|FG000|Overall Study|Withdrawal by Subject|9|||
105549078|NCT00759109|364007973|FG001|Overall Study|Withdrawal by Subject|5|||
105549079|NCT00759109|364007972|FG000|Overall Study|Death|4|||
105549080|NCT00759109|364007973|FG001|Overall Study|Death|3|||
105549081|NCT00759109|364007972|FG000|Overall Study|Lost to Follow-up|4|||
105549082|NCT00759109|364007973|FG001|Overall Study|Lost to Follow-up|6|||
105549083|NCT00759109|364007972|FG000|Overall Study|Started new therapy|2|||
105549084|NCT00759109|364007973|FG001|Overall Study|Started new therapy|6|||
105549085|NCT00759109|364007972|FG000|Overall Study|HCV RNA negative|1|||
105549086|NCT00759109|364007973|FG001|Overall Study|HCV RNA negative|0|||
105549087|NCT00759109|364007972|FG000|Overall Study|Participant moved to a different city|0|||
105549088|NCT00759109|364007973|FG001|Overall Study|Participant moved to a different city|1|||
105549089|NCT00759109|364007972|FG000|Overall Study|Participant had a liver transplant|0|||
105549090|NCT00759109|364007973|FG001|Overall Study|Participant had a liver transplant|1|||
105549091|NCT00759109|364007972|FG000|Overall Study|Lost during study|1|||
105549092|NCT00759109|364007973|FG001|Overall Study|Lost during study|0|||
105549093|NCT03165045|364007974|FG000|Visit 1|No registration after visit 1|9|||
105549094|NCT03165045|364007974|FG000|Visit 1|No treatment documented|10|||
105549095|NCT03165045|364007974|FG000|Visit 1|No visit 1|10|||
105549096|NCT03165045|364007974|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
105549097|NCT03165045|364007974|FG000|Visit 2|No available total CCQ score at all|29|||
105549098|NCT03165045|364007974|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
105549099|NCT03351049|364007975|FG000|Overall Study|Withdrawal|26|||
105549100|NCT03351049|364007976|FG001|Overall Study|Withdrawal|22|||
105549101|NCT00718718|364007977|FG000|Prior to Week 12|Adverse Event|0|||
105549102|NCT00718718|364007978|FG001|Prior to Week 12|Adverse Event|0|||
105549103|NCT00718718|364007979|FG002|Prior to Week 12|Adverse Event|0|||
105549104|NCT00718718|364007980|FG003|Prior to Week 12|Adverse Event|0|||
105549105|NCT00718718|364007981|FG004|Prior to Week 12|Adverse Event|0|||
105549106|NCT00718718|364007982|FG005|Prior to Week 12|Adverse Event|0|||
105549107|NCT00718718|364007983|FG006|Prior to Week 12|Adverse Event|0|||
105549108|NCT00718718|364007984|FG007|Prior to Week 12|Adverse Event|1|||
105549109|NCT00718718|364007985|FG008|Prior to Week 12|Adverse Event|1|||
105549110|NCT00718718|364007986|FG009|Prior to Week 12|Adverse Event|0|||
105549111|NCT00718718|364007977|FG000|Prior to Week 12|Withdrawal by Subject|0|||
105549112|NCT00718718|364007978|FG001|Prior to Week 12|Withdrawal by Subject|0|||
105549113|NCT00718718|364007979|FG002|Prior to Week 12|Withdrawal by Subject|0|||
105549114|NCT00718718|364007980|FG003|Prior to Week 12|Withdrawal by Subject|0|||
105549115|NCT00718718|364007981|FG004|Prior to Week 12|Withdrawal by Subject|3|||
105549116|NCT00718718|364007982|FG005|Prior to Week 12|Withdrawal by Subject|0|||
105549117|NCT00718718|364007983|FG006|Prior to Week 12|Withdrawal by Subject|1|||
105549118|NCT00718718|364007984|FG007|Prior to Week 12|Withdrawal by Subject|1|||
105549119|NCT00718718|364007985|FG008|Prior to Week 12|Withdrawal by Subject|1|||
105549120|NCT00718718|364007986|FG009|Prior to Week 12|Withdrawal by Subject|0|||
105549121|NCT00718718|364007977|FG000|Prior to Week 12|Other|1|||
105549122|NCT00718718|364007978|FG001|Prior to Week 12|Other|0|||
105549123|NCT00718718|364007979|FG002|Prior to Week 12|Other|1|||
105549124|NCT00718718|364007980|FG003|Prior to Week 12|Other|0|||
105549125|NCT00718718|364007981|FG004|Prior to Week 12|Other|0|||
105549126|NCT00718718|364007982|FG005|Prior to Week 12|Other|0|||
105549127|NCT00718718|364007983|FG006|Prior to Week 12|Other|0|||
105549128|NCT00718718|364007984|FG007|Prior to Week 12|Other|0|||
105549129|NCT00718718|364007985|FG008|Prior to Week 12|Other|0|||
105549130|NCT00718718|364007986|FG009|Prior to Week 12|Other|0|||
105549131|NCT00718718|364007977|FG000|Week 12 to End of Study|Adverse Event|0|||
105549132|NCT00718718|364007978|FG001|Week 12 to End of Study|Adverse Event|0|||
105549133|NCT00718718|364007979|FG002|Week 12 to End of Study|Adverse Event|0|||
105549134|NCT00718718|364007980|FG003|Week 12 to End of Study|Adverse Event|0|||
105549135|NCT00718718|364007981|FG004|Week 12 to End of Study|Adverse Event|0|||
105549136|NCT00718718|364007982|FG005|Week 12 to End of Study|Adverse Event|0|||
105549137|NCT00718718|364007983|FG006|Week 12 to End of Study|Adverse Event|0|||
105549138|NCT00718718|364007984|FG007|Week 12 to End of Study|Adverse Event|1|||
105549139|NCT00718718|364007985|FG008|Week 12 to End of Study|Adverse Event|0|||
105549140|NCT00718718|364007986|FG009|Week 12 to End of Study|Adverse Event|0|||
105549141|NCT00718718|364007977|FG000|Week 12 to End of Study|Death|0|||
105549142|NCT00718718|364007978|FG001|Week 12 to End of Study|Death|0|||
105549143|NCT00718718|364007979|FG002|Week 12 to End of Study|Death|0|||
105549144|NCT00718718|364007980|FG003|Week 12 to End of Study|Death|0|||
105549145|NCT00718718|364007981|FG004|Week 12 to End of Study|Death|0|||
105549146|NCT00718718|364007982|FG005|Week 12 to End of Study|Death|1|||
105549147|NCT00718718|364007983|FG006|Week 12 to End of Study|Death|0|||
105549148|NCT00718718|364007984|FG007|Week 12 to End of Study|Death|0|||
105549149|NCT00718718|364007985|FG008|Week 12 to End of Study|Death|0|||
105549150|NCT00718718|364007986|FG009|Week 12 to End of Study|Death|0|||
105549151|NCT00718718|364007977|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
105549152|NCT00718718|364007978|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
105549153|NCT00718718|364007979|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
105549154|NCT00718718|364007980|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
105549155|NCT00718718|364007981|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
105549156|NCT00718718|364007982|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
105549157|NCT00718718|364007983|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
105549158|NCT00718718|364007984|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
105549159|NCT00718718|364007985|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
105549160|NCT00718718|364007986|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
105549161|NCT00718718|364007977|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
105549162|NCT00718718|364007978|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
105549163|NCT00718718|364007979|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
105549164|NCT00718718|364007980|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
105549165|NCT00718718|364007981|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
105549166|NCT00718718|364007982|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
105549167|NCT00718718|364007983|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
105549168|NCT00718718|364007984|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
105549169|NCT00718718|364007985|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
105549170|NCT00718718|364007986|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
105549171|NCT00718718|364007977|FG000|Week 12 to End of Study|Other|0|||
105549172|NCT00718718|364007978|FG001|Week 12 to End of Study|Other|1|||
105549173|NCT00718718|364007979|FG002|Week 12 to End of Study|Other|0|||
105549174|NCT00718718|364007980|FG003|Week 12 to End of Study|Other|1|||
105549175|NCT00718718|364007981|FG004|Week 12 to End of Study|Other|0|||
105549176|NCT00718718|364007982|FG005|Week 12 to End of Study|Other|0|||
105549177|NCT00718718|364007983|FG006|Week 12 to End of Study|Other|1|||
105549178|NCT00718718|364007984|FG007|Week 12 to End of Study|Other|0|||
105549179|NCT00718718|364007985|FG008|Week 12 to End of Study|Other|0|||
105549180|NCT00718718|364007986|FG009|Week 12 to End of Study|Other|0|||
105549181|NCT01617629|364007989|FG000|Overall Study|Death|2|||
105549182|NCT01617629|364007989|FG000|Overall Study|Investigator's Clinical Judgement|1|||
105549183|NCT01617629|364007989|FG000|Overall Study|Reason Not Specified|1|||
105549184|NCT01617629|364007989|FG000|Overall Study|Participant Withdrew Consent|2|||
105549185|NCT01660906|364007990|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
105549186|NCT03478891|364007997|FG000|Overall Study|Enrolled, but product never administered|0|||
105549187|NCT03478891|364007998|FG001|Overall Study|Enrolled, but product never administered|0|||
105549188|NCT03478891|364007999|FG002|Overall Study|Enrolled, but product never administered|1|||
105549189|NCT03478891|364007997|FG000|Overall Study|Moved from area|0|||
105549190|NCT03478891|364007998|FG001|Overall Study|Moved from area|0|||
105549191|NCT03478891|364007999|FG002|Overall Study|Moved from area|1|||
105549192|NCT03478891|364007997|FG000|Overall Study|Lost to Follow-up|1|||
105549193|NCT03478891|364007998|FG001|Overall Study|Lost to Follow-up|0|||
105549194|NCT03478891|364007999|FG002|Overall Study|Lost to Follow-up|1|||
105549195|NCT00809757|364008003|FG000|Overall Study|Adverse Event|2|||
105549196|NCT00809757|364008004|FG001|Overall Study|Adverse Event|3|||
105549197|NCT00809757|364008005|FG002|Overall Study|Adverse Event|3|||
105549198|NCT00809757|364008003|FG000|Overall Study|Lost to Follow-up|0|||
105549199|NCT00809757|364008004|FG001|Overall Study|Lost to Follow-up|0|||
105549200|NCT00809757|364008005|FG002|Overall Study|Lost to Follow-up|1|||
105549201|NCT00809757|364008003|FG000|Overall Study|Protocol Violation|1|||
105549202|NCT00809757|364008004|FG001|Overall Study|Protocol Violation|1|||
105549203|NCT00809757|364008005|FG002|Overall Study|Protocol Violation|1|||
105549204|NCT00809757|364008003|FG000|Overall Study|Withdrawal by Subject|2|||
105549205|NCT00809757|364008004|FG001|Overall Study|Withdrawal by Subject|1|||
105549206|NCT00809757|364008005|FG002|Overall Study|Withdrawal by Subject|3|||
105549207|NCT00809757|364008003|FG000|Overall Study|Subject Uncooperative|1|||
105549208|NCT00809757|364008004|FG001|Overall Study|Subject Uncooperative|0|||
105549209|NCT00809757|364008005|FG002|Overall Study|Subject Uncooperative|2|||
105549210|NCT00809757|364008003|FG000|Overall Study|Noncompliance with Medication|0|||
105549211|NCT00809757|364008004|FG001|Overall Study|Noncompliance with Medication|0|||
105549212|NCT00809757|364008005|FG002|Overall Study|Noncompliance with Medication|1|||
105549213|NCT00253864|364008006|FG000|Overall Study|Lost to Follow-up|5|||
105549214|NCT00253864|364008007|FG001|Overall Study|Lost to Follow-up|8|||
105549215|NCT04368429|364009771|FG000|Overall Study|Adverse Event|1|||
105549216|NCT04368429|364009772|FG001|Overall Study|Adverse Event|0|||
105549217|NCT00618514|364009775|FG000|Overall Study|Lost to Follow-up|11|||
105549218|NCT00618514|364009776|FG001|Overall Study|Lost to Follow-up|12|||
105549219|NCT00618514|364009777|FG002|Overall Study|Lost to Follow-up|4|||
105549220|NCT03320070|364009780|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
105549221|NCT03320070|364009781|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
105549222|NCT03320070|364009780|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
105549223|NCT03320070|364009781|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
105549224|NCT03320070|364009780|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
105549225|NCT03320070|364009781|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
105549226|NCT03320070|364009780|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
105549227|NCT03320070|364009781|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
105549228|NCT03320070|364009780|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
105549229|NCT03320070|364009781|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
105549230|NCT03320070|364009780|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
105549231|NCT03320070|364009781|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
105549232|NCT04579757|364009785|FG000|Overall Study|Adverse Event|0|||
105549233|NCT04579757|364009786|FG001|Overall Study|Adverse Event|0|||
105549234|NCT04579757|364009787|FG002|Overall Study|Adverse Event|0|||
105549235|NCT04579757|364009788|FG003|Overall Study|Adverse Event|2|||
105549236|NCT04579757|364009789|FG004|Overall Study|Adverse Event|1|||
105549237|NCT04579757|364009790|FG005|Overall Study|Adverse Event|1|||
105549238|NCT04579757|364009791|FG006|Overall Study|Adverse Event|0|||
105549239|NCT04579757|364009792|FG007|Overall Study|Adverse Event|0|||
105549240|NCT04579757|364009793|FG008|Overall Study|Adverse Event|0|||
105549241|NCT04579757|364009785|FG000|Overall Study|Death|4|||
105549242|NCT04579757|364009786|FG001|Overall Study|Death|1|||
105549243|NCT04579757|364009787|FG002|Overall Study|Death|14|||
105549244|NCT04579757|364009788|FG003|Overall Study|Death|3|||
105549245|NCT04579757|364009789|FG004|Overall Study|Death|2|||
105549246|NCT04579757|364009790|FG005|Overall Study|Death|7|||
105549247|NCT04579757|364009791|FG006|Overall Study|Death|0|||
105549248|NCT04579757|364009792|FG007|Overall Study|Death|1|||
105549249|NCT04579757|364009793|FG008|Overall Study|Death|3|||
105549250|NCT04579757|364009785|FG000|Overall Study|Physician Decision|0|||
105549251|NCT04579757|364009786|FG001|Overall Study|Physician Decision|0|||
105549252|NCT04579757|364009787|FG002|Overall Study|Physician Decision|0|||
105549253|NCT04579757|364009788|FG003|Overall Study|Physician Decision|2|||
105549254|NCT04579757|364009789|FG004|Overall Study|Physician Decision|1|||
105549255|NCT04579757|364009790|FG005|Overall Study|Physician Decision|1|||
105549256|NCT04579757|364009791|FG006|Overall Study|Physician Decision|1|||
105549257|NCT04579757|364009792|FG007|Overall Study|Physician Decision|0|||
105549258|NCT04579757|364009793|FG008|Overall Study|Physician Decision|0|||
105549259|NCT04579757|364009785|FG000|Overall Study|Study Terminated By Sponsor|0|||
105549260|NCT04579757|364009786|FG001|Overall Study|Study Terminated By Sponsor|0|||
105549261|NCT04579757|364009787|FG002|Overall Study|Study Terminated By Sponsor|0|||
105549262|NCT04579757|364009788|FG003|Overall Study|Study Terminated By Sponsor|0|||
105549263|NCT04579757|364009789|FG004|Overall Study|Study Terminated By Sponsor|2|||
105549264|NCT04579757|364009790|FG005|Overall Study|Study Terminated By Sponsor|0|||
105549265|NCT04579757|364009791|FG006|Overall Study|Study Terminated By Sponsor|0|||
105549266|NCT04579757|364009792|FG007|Overall Study|Study Terminated By Sponsor|2|||
105549267|NCT04579757|364009793|FG008|Overall Study|Study Terminated By Sponsor|0|||
105549268|NCT04579757|364009785|FG000|Overall Study|Withdrawal by Subject|1|||
105549269|NCT04579757|364009786|FG001|Overall Study|Withdrawal by Subject|1|||
105549270|NCT04579757|364009787|FG002|Overall Study|Withdrawal by Subject|0|||
105549271|NCT04579757|364009788|FG003|Overall Study|Withdrawal by Subject|0|||
105549272|NCT04579757|364009789|FG004|Overall Study|Withdrawal by Subject|2|||
105549273|NCT04579757|364009790|FG005|Overall Study|Withdrawal by Subject|1|||
105549274|NCT04579757|364009791|FG006|Overall Study|Withdrawal by Subject|0|||
105549275|NCT04579757|364009792|FG007|Overall Study|Withdrawal by Subject|3|||
105549276|NCT04579757|364009793|FG008|Overall Study|Withdrawal by Subject|0|||
105549277|NCT04579757|364009785|FG000|Overall Study|Radiological or Clinical PD|1|||
105549278|NCT04579757|364009786|FG001|Overall Study|Radiological or Clinical PD|4|||
105549279|NCT04579757|364009787|FG002|Overall Study|Radiological or Clinical PD|1|||
105549280|NCT04579757|364009788|FG003|Overall Study|Radiological or Clinical PD|3|||
105549281|NCT04579757|364009789|FG004|Overall Study|Radiological or Clinical PD|9|||
105549282|NCT04579757|364009790|FG005|Overall Study|Radiological or Clinical PD|4|||
105549283|NCT04579757|364009791|FG006|Overall Study|Radiological or Clinical PD|2|||
105549284|NCT04579757|364009792|FG007|Overall Study|Radiological or Clinical PD|2|||
105549285|NCT04579757|364009793|FG008|Overall Study|Radiological or Clinical PD|0|||
105549286|NCT04579757|364009785|FG000|Overall Study|Start of New Therapy|0|||
105549287|NCT04579757|364009786|FG001|Overall Study|Start of New Therapy|0|||
105549288|NCT04579757|364009787|FG002|Overall Study|Start of New Therapy|0|||
105549289|NCT04579757|364009788|FG003|Overall Study|Start of New Therapy|0|||
105549290|NCT04579757|364009789|FG004|Overall Study|Start of New Therapy|2|||
105549291|NCT04579757|364009790|FG005|Overall Study|Start of New Therapy|1|||
105549292|NCT04579757|364009791|FG006|Overall Study|Start of New Therapy|0|||
105549293|NCT04579757|364009792|FG007|Overall Study|Start of New Therapy|0|||
105549294|NCT04579757|364009793|FG008|Overall Study|Start of New Therapy|0|||
105549295|NCT00071487|364009794|FG000|52-Week Double-Blind Period|Adverse Event|5|||
105549296|NCT00071487|364009795|FG001|52-Week Double-Blind Period|Adverse Event|8|||
105549297|NCT00071487|364009796|FG002|52-Week Double-Blind Period|Adverse Event|4|||
105549298|NCT00071487|364009797|FG003|52-Week Double-Blind Period|Adverse Event|8|||
105549299|NCT00071487|364009794|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
105549300|NCT00071487|364009795|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
105549301|NCT00071487|364009796|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
105549302|NCT00071487|364009797|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
105549303|NCT00071487|364009794|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
105549304|NCT00071487|364009795|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
105549305|NCT00071487|364009796|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
105549306|NCT00071487|364009797|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
105549307|NCT00071487|364009794|FG000|52-Week Double-Blind Period|Physician Decision|1|||
105549308|NCT00071487|364009795|FG001|52-Week Double-Blind Period|Physician Decision|0|||
105549309|NCT00071487|364009796|FG002|52-Week Double-Blind Period|Physician Decision|0|||
105549310|NCT00071487|364009797|FG003|52-Week Double-Blind Period|Physician Decision|0|||
105549311|NCT00071487|364009794|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
105549312|NCT00071487|364009795|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
105549313|NCT00071487|364009796|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
105549314|NCT00071487|364009797|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
105549315|NCT00071487|364009794|FG000|52-Week Double-Blind Period|Pregnancy|0|||
105549316|NCT00071487|364009795|FG001|52-Week Double-Blind Period|Pregnancy|1|||
105549317|NCT00071487|364009796|FG002|52-Week Double-Blind Period|Pregnancy|0|||
105549318|NCT00071487|364009797|FG003|52-Week Double-Blind Period|Pregnancy|0|||
105549319|NCT00071487|364009794|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
105549320|NCT00071487|364009795|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
105549321|NCT00071487|364009796|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
105549322|NCT00071487|364009797|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
105549323|NCT00071487|364009794|FG000|52-Week Double-Blind Period|Death|0|||
105549324|NCT00071487|364009795|FG001|52-Week Double-Blind Period|Death|1|||
105549325|NCT00071487|364009796|FG002|52-Week Double-Blind Period|Death|0|||
105549326|NCT00071487|364009797|FG003|52-Week Double-Blind Period|Death|0|||
105549327|NCT00071487|364009794|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
105549328|NCT00071487|364009795|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
105549329|NCT00071487|364009796|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
105549330|NCT00071487|364009797|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
105549331|NCT00071487|364009794|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
105549332|NCT00071487|364009795|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
105549333|NCT00071487|364009796|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
105549334|NCT00071487|364009797|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
105549335|NCT00071487|364009794|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
105549336|NCT00071487|364009795|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
105549337|NCT00071487|364009796|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
105549338|NCT00071487|364009797|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
105549339|NCT00071487|364009794|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
105549340|NCT00071487|364009795|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
105549341|NCT00071487|364009796|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
105549342|NCT00071487|364009797|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
105549343|NCT00071487|364009794|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
105549344|NCT00071487|364009795|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
105549345|NCT00071487|364009796|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
105549346|NCT00071487|364009797|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
105549347|NCT00071487|364009794|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
105549348|NCT00071487|364009795|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
105549349|NCT00071487|364009796|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
105549350|NCT00071487|364009797|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
105549351|NCT00071487|364009794|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
105549352|NCT00071487|364009795|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
105549353|NCT00071487|364009796|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
105549354|NCT00071487|364009797|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
105549355|NCT01055639|364009807|FG000|Overall Study|Adverse Event|0|||
105549356|NCT01055639|364009808|FG001|Overall Study|Adverse Event|1|||
105549357|NCT01055639|364009807|FG000|Overall Study|Lack of Efficacy|0|||
105549358|NCT01055639|364009808|FG001|Overall Study|Lack of Efficacy|1|||
105549359|NCT01055639|364009807|FG000|Overall Study|Lost to Follow-up|8|||
105549360|NCT01055639|364009808|FG001|Overall Study|Lost to Follow-up|11|||
105549361|NCT01055639|364009807|FG000|Overall Study|Protocol Violation|5|||
105549362|NCT01055639|364009808|FG001|Overall Study|Protocol Violation|5|||
105549363|NCT01055639|364009807|FG000|Overall Study|Withdrawal by Subject|8|||
105549364|NCT01055639|364009808|FG001|Overall Study|Withdrawal by Subject|11|||
105549365|NCT00562159|364009809|FG000|Overall Study|Adverse Event|11|||
105549366|NCT00562159|364009810|FG001|Overall Study|Adverse Event|8|||
105549367|NCT00562159|364009809|FG000|Overall Study|Lost to Follow-up|5|||
105549368|NCT00562159|364009810|FG001|Overall Study|Lost to Follow-up|4|||
105549369|NCT00562159|364009809|FG000|Overall Study|Withdrawal by Subject|9|||
105549370|NCT00562159|364009810|FG001|Overall Study|Withdrawal by Subject|8|||
105549371|NCT00562159|364009809|FG000|Overall Study|Protocol Violation|12|||
105549372|NCT00562159|364009810|FG001|Overall Study|Protocol Violation|12|||
105549373|NCT00562159|364009809|FG000|Overall Study|Did not meet protocol eligibility|1|||
105549374|NCT00562159|364009810|FG001|Overall Study|Did not meet protocol eligibility|1|||
105549375|NCT00406029|364009813|FG000|Overall Study|Adverse Event|12|||
105549376|NCT00406029|364009814|FG001|Overall Study|Adverse Event|2|||
105549377|NCT00406029|364009815|FG002|Overall Study|Adverse Event|5|||
105549378|NCT00406029|364009816|FG003|Overall Study|Adverse Event|10|||
105549379|NCT00406029|364009817|FG004|Overall Study|Adverse Event|7|||
105549380|NCT00406029|364009813|FG000|Overall Study|Withdrawal by Subject|3|||
105549381|NCT00406029|364009814|FG001|Overall Study|Withdrawal by Subject|4|||
105549382|NCT00406029|364009815|FG002|Overall Study|Withdrawal by Subject|2|||
105549383|NCT00406029|364009816|FG003|Overall Study|Withdrawal by Subject|2|||
105549384|NCT00406029|364009817|FG004|Overall Study|Withdrawal by Subject|0|||
105549385|NCT00406029|364009813|FG000|Overall Study|Protocol Violation|1|||
105549386|NCT00406029|364009814|FG001|Overall Study|Protocol Violation|2|||
105549387|NCT00406029|364009815|FG002|Overall Study|Protocol Violation|0|||
105549388|NCT00406029|364009816|FG003|Overall Study|Protocol Violation|2|||
105549389|NCT00406029|364009817|FG004|Overall Study|Protocol Violation|0|||
105549390|NCT00406029|364009813|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
105549391|NCT00406029|364009814|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
105549392|NCT00406029|364009815|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
105549393|NCT00406029|364009816|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
105549394|NCT00406029|364009817|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
105549395|NCT00406029|364009813|FG000|Overall Study|Randomized in Error|0|||
105549396|NCT00406029|364009814|FG001|Overall Study|Randomized in Error|0|||
105549397|NCT00406029|364009815|FG002|Overall Study|Randomized in Error|2|||
105549398|NCT00406029|364009816|FG003|Overall Study|Randomized in Error|3|||
105549399|NCT00406029|364009817|FG004|Overall Study|Randomized in Error|1|||
105549400|NCT01197950|364009819|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
105549401|NCT01197950|364009820|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
105549402|NCT01197950|364009821|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
105549403|NCT04831736|364009824|FG000|Overall Study|Withdrawal by Subject|0|||
105549404|NCT04831736|364009825|FG001|Overall Study|Withdrawal by Subject|1|||
105549405|NCT02553330|364009826|FG000|Overall Study|Study Terminated by Sponsor|2|||
105549406|NCT02553330|364009827|FG001|Overall Study|Study Terminated by Sponsor|13|||
105549407|NCT02553330|364009828|FG002|Overall Study|Study Terminated by Sponsor|12|||
105549408|NCT02553330|364009826|FG000|Overall Study|Withdrawal by Subject|3|||
105549409|NCT02553330|364009827|FG001|Overall Study|Withdrawal by Subject|19|||
105549410|NCT02553330|364009828|FG002|Overall Study|Withdrawal by Subject|21|||
105549411|NCT02553330|364009826|FG000|Overall Study|Other|0|||
105549412|NCT02553330|364009827|FG001|Overall Study|Other|1|||
105549413|NCT02553330|364009828|FG002|Overall Study|Other|0|||
105549414|NCT02553330|364009826|FG000|Overall Study|Non compliance to study treatment|0|||
105549415|NCT02553330|364009827|FG001|Overall Study|Non compliance to study treatment|1|||
105549416|NCT02553330|364009828|FG002|Overall Study|Non compliance to study treatment|0|||
105549417|NCT02553330|364009826|FG000|Overall Study|Adverse Event|0|||
105549418|NCT02553330|364009827|FG001|Overall Study|Adverse Event|1|||
105549419|NCT02553330|364009828|FG002|Overall Study|Adverse Event|0|||
105549420|NCT02553330|364009826|FG000|Overall Study|Lost to Follow-up|0|||
105549421|NCT02553330|364009827|FG001|Overall Study|Lost to Follow-up|4|||
105549422|NCT02553330|364009828|FG002|Overall Study|Lost to Follow-up|4|||
105549423|NCT01666002|364009834|FG000|Overall Study|Lost to Follow-up|5|||
105549424|NCT01666002|364009835|FG001|Overall Study|Lost to Follow-up|0|||
105549425|NCT02159482|364009836|FG000|Overall Study|Withdrawal by Subject|2|||
105549426|NCT02159482|364009836|FG000|Overall Study|Physician Decision|3|||
105549427|NCT00726752|364009837|FG000|Overall Study|Lack of Efficacy|6|||
105549428|NCT01248884|364009838|FG000|Overall Study|Withdrawal by Subject|1|||
105549429|NCT01248884|364009839|FG001|Overall Study|Withdrawal by Subject|3|||
105549430|NCT01248884|364009840|FG002|Overall Study|Withdrawal by Subject|1|||
105549431|NCT01248884|364009838|FG000|Overall Study|Adverse Event|1|||
105549432|NCT01248884|364009839|FG001|Overall Study|Adverse Event|0|||
105549433|NCT01248884|364009840|FG002|Overall Study|Adverse Event|0|||
105549434|NCT02511431|364009841|FG000|Treatment|Lost to Follow-up|0|||
105549435|NCT02511431|364009842|FG001|Treatment|Lost to Follow-up|0|||
105549436|NCT02511431|364009843|FG002|Treatment|Lost to Follow-up|1|||
105549437|NCT02511431|364009844|FG003|Treatment|Lost to Follow-up|0|||
105549438|NCT02511431|364009845|FG004|Treatment|Lost to Follow-up|0|||
105549439|NCT02511431|364009846|FG005|Treatment|Lost to Follow-up|1|||
105549440|NCT04827212|364009849|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
105549441|NCT04827212|364009850|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
105549442|NCT04827212|364009849|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
105549443|NCT04827212|364009850|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
105549444|NCT03058679|364009851|FG000|Baseline to Week 6|Lost to Follow-up|3|||
105549445|NCT03058679|364009852|FG001|Baseline to Week 6|Lost to Follow-up|2|||
105549446|NCT03058679|364009851|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
105549447|NCT03058679|364009852|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
105549448|NCT03058679|364009851|FG000|Baseline to Week 6|Adverse Event|6|||
105549449|NCT03058679|364009852|FG001|Baseline to Week 6|Adverse Event|6|||
105549450|NCT03058679|364009851|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
105549451|NCT03058679|364009852|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
105549452|NCT03058679|364009851|FG000|Baseline to Week 6|Difficulty following the diet|0|||
105549453|NCT03058679|364009852|FG001|Baseline to Week 6|Difficulty following the diet|2|||
105549454|NCT03058679|364009851|FG000|Baseline to Week 6|Physician Decision|1|||
105549455|NCT03058679|364009852|FG001|Baseline to Week 6|Physician Decision|0|||
105549456|NCT03058679|364009851|FG000|Week 6 to Week 12|Change in medication|5|||
105549457|NCT03058679|364009852|FG001|Week 6 to Week 12|Change in medication|7|||
105549458|NCT03058679|364009851|FG000|Week 6 to Week 12|Adverse Event|4|||
105549459|NCT03058679|364009852|FG001|Week 6 to Week 12|Adverse Event|3|||
105549460|NCT03058679|364009851|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
105549461|NCT03058679|364009852|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
105549462|NCT03058679|364009851|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
105549463|NCT03058679|364009852|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
105549464|NCT03434119|364009855|FG000|Overall Study|Randomized but not treated|1|||
105549465|NCT03434119|364009856|FG001|Overall Study|Randomized but not treated|0|||
105549466|NCT03434119|364009855|FG000|Overall Study|Adverse Event|1|||
105549467|NCT03434119|364009856|FG001|Overall Study|Adverse Event|0|||
105549468|NCT03434119|364009855|FG000|Overall Study|Poor Compliance to Protocol|0|||
105549469|NCT03434119|364009856|FG001|Overall Study|Poor Compliance to Protocol|1|||
105549470|NCT03434119|364009855|FG000|Overall Study|Study Terminated by Sponsor|91|||
105549471|NCT03434119|364009856|FG001|Overall Study|Study Terminated by Sponsor|102|||
105549472|NCT03434119|364009855|FG000|Overall Study|Withdrawal by Subject|7|||
105549473|NCT03434119|364009856|FG001|Overall Study|Withdrawal by Subject|5|||
105549474|NCT03434119|364009855|FG000|Overall Study|Other than specified|7|||
105549475|NCT03434119|364009856|FG001|Overall Study|Other than specified|5|||
105549476|NCT00779246|364009857|FG000|Overall Study|Missing sufficient data for analysis|33|||
105549477|NCT00779246|364009858|FG001|Overall Study|Missing sufficient data for analysis|53|||
105549478|NCT03579459|364009859|FG000|Overall Study|Adverse Event|7|||
105549479|NCT03579459|364009860|FG001|Overall Study|Adverse Event|6|||
105549480|NCT03579459|364009861|FG002|Overall Study|Adverse Event|2|||
105549481|NCT03579459|364009862|FG003|Overall Study|Adverse Event|6|||
105549482|NCT03579459|364009859|FG000|Overall Study|Death|1|||
105549483|NCT03579459|364009860|FG001|Overall Study|Death|0|||
105549484|NCT03579459|364009861|FG002|Overall Study|Death|1|||
105549485|NCT03579459|364009862|FG003|Overall Study|Death|2|||
105549486|NCT03579459|364009859|FG000|Overall Study|Lost to Follow-up|6|||
105549487|NCT03579459|364009860|FG001|Overall Study|Lost to Follow-up|2|||
105549488|NCT03579459|364009861|FG002|Overall Study|Lost to Follow-up|4|||
105549489|NCT03579459|364009862|FG003|Overall Study|Lost to Follow-up|1|||
105549490|NCT03579459|364009859|FG000|Overall Study|Physician Decision|0|||
105549491|NCT03579459|364009860|FG001|Overall Study|Physician Decision|1|||
105549492|NCT03579459|364009861|FG002|Overall Study|Physician Decision|0|||
105549493|NCT03579459|364009862|FG003|Overall Study|Physician Decision|1|||
105549494|NCT03579459|364009859|FG000|Overall Study|Protocol Violation|1|||
105549495|NCT03579459|364009860|FG001|Overall Study|Protocol Violation|2|||
105549496|NCT03579459|364009861|FG002|Overall Study|Protocol Violation|3|||
105549497|NCT03579459|364009862|FG003|Overall Study|Protocol Violation|5|||
105549498|NCT03579459|364009859|FG000|Overall Study|Withdrawal by Subject|12|||
105549499|NCT03579459|364009860|FG001|Overall Study|Withdrawal by Subject|8|||
105549500|NCT03579459|364009861|FG002|Overall Study|Withdrawal by Subject|11|||
105549501|NCT03579459|364009862|FG003|Overall Study|Withdrawal by Subject|8|||
105549502|NCT03579459|364009859|FG000|Overall Study|Medication error without associated adverse event|2|||
105549503|NCT03579459|364009860|FG001|Overall Study|Medication error without associated adverse event|1|||
105549504|NCT03579459|364009861|FG002|Overall Study|Medication error without associated adverse event|1|||
105549505|NCT03579459|364009862|FG003|Overall Study|Medication error without associated adverse event|0|||
105549506|NCT03579459|364009859|FG000|Overall Study|Other|0|||
105549507|NCT03579459|364009860|FG001|Overall Study|Other|1|||
105549508|NCT03579459|364009861|FG002|Overall Study|Other|1|||
105549509|NCT03579459|364009862|FG003|Overall Study|Other|0|||
105549510|NCT03579459|364009859|FG000|Overall Study|Randomized not vaccinated|0|||
105549511|NCT03579459|364009860|FG001|Overall Study|Randomized not vaccinated|2|||
105549512|NCT03579459|364009861|FG002|Overall Study|Randomized not vaccinated|0|||
105549513|NCT03579459|364009862|FG003|Overall Study|Randomized not vaccinated|1|||
105549514|NCT04000165|364009863|FG000|Overall Study|Physician Decision|1|||
105549515|NCT04000165|364009863|FG000|Overall Study|Withdrawal by Subject|1|||
105549516|NCT01519206|364009864|FG000|Overall Study|Lost to Follow-up|3|||
105549517|NCT01519206|364009864|FG000|Overall Study|Missed Visit|2|||
105549518|NCT01753193|364009866|FG000|Overall Study|Withdrawal by Subject|23|||
105549519|NCT01753193|364009866|FG000|Overall Study|Lost to Follow-up|6|||
105549520|NCT01753193|364009866|FG000|Overall Study|Death|1|||
105549521|NCT01753193|364009866|FG000|Overall Study|Other|16|||
105549522|NCT01131312|364009867|FG000|Overall Study|Lost to Follow-up|425|||
105549523|NCT01131312|364009868|FG001|Overall Study|Lost to Follow-up|229|||
105549524|NCT01131312|364009869|FG002|Overall Study|Lost to Follow-up|351|||
105549525|NCT01380327|364009870|FG000|Overall Study|Lost to Follow-up|0|||
105549526|NCT01380327|364009871|FG001|Overall Study|Lost to Follow-up|1|||
105549527|NCT01380327|364009872|FG002|Overall Study|Lost to Follow-up|1|||
105549528|NCT01380327|364009870|FG000|Overall Study|Protocol Violation|3|||
105549529|NCT01380327|364009871|FG001|Overall Study|Protocol Violation|2|||
105549530|NCT01380327|364009872|FG002|Overall Study|Protocol Violation|3|||
105549531|NCT01380327|364009870|FG000|Overall Study|Withdrawal by Subject|0|||
105549532|NCT01380327|364009871|FG001|Overall Study|Withdrawal by Subject|0|||
105549533|NCT01380327|364009872|FG002|Overall Study|Withdrawal by Subject|1|||
105549534|NCT01380327|364009870|FG000|Overall Study|Housing situation precluded ability to k|0|||
105549535|NCT01380327|364009871|FG001|Overall Study|Housing situation precluded ability to k|0|||
105549536|NCT01380327|364009872|FG002|Overall Study|Housing situation precluded ability to k|1|||
105549537|NCT01380327|364009870|FG000|Overall Study|Questionable onset of epilepsy|0|||
105549538|NCT01380327|364009871|FG001|Overall Study|Questionable onset of epilepsy|0|||
105549539|NCT01380327|364009872|FG002|Overall Study|Questionable onset of epilepsy|1|||
105549540|NCT03447769|364009873|FG000|Overall Study|Progressive disease|138|||
105549541|NCT03447769|364009874|FG001|Overall Study|Progressive disease|148|||
105549542|NCT03447769|364009873|FG000|Overall Study|Study terminated by Sponsor|60|||
105549543|NCT03447769|364009874|FG001|Overall Study|Study terminated by Sponsor|44|||
105549544|NCT03447769|364009873|FG000|Overall Study|Adverse Event|34|||
105549545|NCT03447769|364009874|FG001|Overall Study|Adverse Event|31|||
105549546|NCT03447769|364009873|FG000|Overall Study|Patient decision|27|||
105549547|NCT03447769|364009874|FG001|Overall Study|Patient decision|27|||
105549548|NCT03447769|364009873|FG000|Overall Study|Protocol deviation|4|||
105549549|NCT03447769|364009874|FG001|Overall Study|Protocol deviation|6|||
105549550|NCT03447769|364009873|FG000|Overall Study|Death|2|||
105549551|NCT03447769|364009874|FG001|Overall Study|Death|7|||
105549552|NCT03447769|364009873|FG000|Overall Study|Technical problems|1|||
105549553|NCT03447769|364009874|FG001|Overall Study|Technical problems|0|||
105549554|NCT03447769|364009873|FG000|Overall Study|Lost to Follow-up|0|||
105549555|NCT03447769|364009874|FG001|Overall Study|Lost to Follow-up|1|||
105549556|NCT03447769|364009873|FG000|Overall Study|Physician Decision|13|||
105549557|NCT03447769|364009874|FG001|Overall Study|Physician Decision|5|||
105549558|NCT03625570|364009875|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
105549559|NCT03625570|364009876|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
105549560|NCT03625570|364009875|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
105549561|NCT03625570|364009876|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
105549562|NCT03625570|364009875|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
105549563|NCT03625570|364009876|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
105549564|NCT01343056|364009877|FG000|Overall Study|Lost to Follow-up|7|||
105549565|NCT01343056|364009878|FG001|Overall Study|Lost to Follow-up|5|||
105549566|NCT01343056|364009879|FG002|Overall Study|Lost to Follow-up|3|||
105549567|NCT01343056|364009880|FG003|Overall Study|Lost to Follow-up|9|||
105549568|NCT00499889|364009884|FG000|Overall Study|Infection prior to treatment|1|||
105549569|NCT01660763|364009888|FG000|Overall Study|Lack of Efficacy|45|||
105549570|NCT01660763|364009889|FG001|Overall Study|Lack of Efficacy|50|||
105549571|NCT01660763|364009888|FG000|Overall Study|Adverse Event|22|||
105549572|NCT01660763|364009889|FG001|Overall Study|Adverse Event|7|||
105549573|NCT01660763|364009888|FG000|Overall Study|Protocol Violation|1|||
105549574|NCT01660763|364009889|FG001|Overall Study|Protocol Violation|0|||
105549575|NCT01660763|364009888|FG000|Overall Study|Withdrawal by Subject|4|||
105549576|NCT01660763|364009889|FG001|Overall Study|Withdrawal by Subject|0|||
105549577|NCT01660763|364009888|FG000|Overall Study|Patient ready for early discharge|28|||
105549578|NCT01660763|364009889|FG001|Overall Study|Patient ready for early discharge|4|||
105549579|NCT01870843|364009890|FG000|Overall Study|Adverse Event|10|||
105549580|NCT01870843|364009890|FG000|Overall Study|Lost to Follow-up|24|||
105549581|NCT01870843|364009890|FG000|Overall Study|Death|1|||
105549582|NCT01870843|364009890|FG000|Overall Study|Withdrawal by Subject|18|||
105549583|NCT00345397|364009891|FG000|Overall Study|Death|1|||
105549584|NCT01910519|364009894|FG000|Overall Study|Withdrawal by Subject|2|||
105549585|NCT01910519|364009895|FG001|Overall Study|Withdrawal by Subject|0|||
105549586|NCT01910519|364009894|FG000|Overall Study|Adverse Event|2|||
105549587|NCT01910519|364009895|FG001|Overall Study|Adverse Event|0|||
105549588|NCT04266028|364009896|FG000|Overall Study|Adverse Event|0|||
105549589|NCT04266028|364009897|FG001|Overall Study|Adverse Event|0|||
105549590|NCT04266028|364009898|FG002|Overall Study|Adverse Event|1|||
105549591|NCT04266028|364009899|FG003|Overall Study|Adverse Event|0|||
105549592|NCT04266028|364009900|FG004|Overall Study|Adverse Event|1|||
105549593|NCT04266028|364009901|FG005|Overall Study|Adverse Event|0|||
105549594|NCT04266028|364009902|FG006|Overall Study|Adverse Event|2|||
105549595|NCT04266028|364009903|FG007|Overall Study|Adverse Event|0|||
105549596|NCT04266028|364009896|FG000|Overall Study|temporary halt of the study|0|||
105549597|NCT04266028|364009897|FG001|Overall Study|temporary halt of the study|0|||
105549598|NCT04266028|364009898|FG002|Overall Study|temporary halt of the study|0|||
105549599|NCT04266028|364009899|FG003|Overall Study|temporary halt of the study|0|||
105549600|NCT04266028|364009900|FG004|Overall Study|temporary halt of the study|0|||
105549601|NCT04266028|364009901|FG005|Overall Study|temporary halt of the study|0|||
105549602|NCT04266028|364009902|FG006|Overall Study|temporary halt of the study|2|||
105549603|NCT04266028|364009903|FG007|Overall Study|temporary halt of the study|1|||
105549604|NCT04266028|364009896|FG000|Overall Study|Onset of birch pollen season|0|||
105549605|NCT04266028|364009897|FG001|Overall Study|Onset of birch pollen season|0|||
105549606|NCT04266028|364009898|FG002|Overall Study|Onset of birch pollen season|0|||
105549607|NCT04266028|364009899|FG003|Overall Study|Onset of birch pollen season|0|||
105549608|NCT04266028|364009900|FG004|Overall Study|Onset of birch pollen season|1|||
105549609|NCT04266028|364009901|FG005|Overall Study|Onset of birch pollen season|0|||
105549610|NCT04266028|364009902|FG006|Overall Study|Onset of birch pollen season|0|||
105549611|NCT04266028|364009903|FG007|Overall Study|Onset of birch pollen season|0|||
105549612|NCT04964089|364009904|FG000|Overall Study|Adverse Event|8|||
105549613|NCT04964089|364009905|FG001|Overall Study|Adverse Event|6|||
105549614|NCT04964089|364009904|FG000|Overall Study|Non-compliance with study schedule|1|||
105549615|NCT04964089|364009905|FG001|Overall Study|Non-compliance with study schedule|0|||
105549616|NCT04964089|364009904|FG000|Overall Study|Withdrawal by Subject|6|||
105549617|NCT04964089|364009905|FG001|Overall Study|Withdrawal by Subject|5|||
105549618|NCT04964089|364009904|FG000|Overall Study|Lost to Follow-up|1|||
105549619|NCT04964089|364009905|FG001|Overall Study|Lost to Follow-up|1|||
105549620|NCT04964089|364009904|FG000|Overall Study|Progressive disease|4|||
105549621|NCT04964089|364009905|FG001|Overall Study|Progressive disease|0|||
105549622|NCT04964089|364009904|FG000|Overall Study|Physician Decision|1|||
105549623|NCT04964089|364009905|FG001|Overall Study|Physician Decision|0|||
105549624|NCT04964089|364009904|FG000|Overall Study|Participant did not want to continue study treatment|1|||
105549625|NCT04964089|364009905|FG001|Overall Study|Participant did not want to continue study treatment|0|||
105549626|NCT04964089|364009904|FG000|Overall Study|Participant moved to different state|1|||
105549627|NCT04964089|364009905|FG001|Overall Study|Participant moved to different state|0|||
105549628|NCT04964089|364009904|FG000|Overall Study|Participant decided to discontinue|0|||
105549629|NCT04964089|364009905|FG001|Overall Study|Participant decided to discontinue|1|||
105549630|NCT03021187|364009906|FG000|Overall Study|Death|0|||
105549631|NCT03021187|364009907|FG001|Overall Study|Death|0|||
105549632|NCT03021187|364009908|FG002|Overall Study|Death|3|||
105549633|NCT03021187|364009909|FG003|Overall Study|Death|0|||
105549634|NCT03021187|364009906|FG000|Overall Study|Withdrawal by Subject|0|||
105549635|NCT03021187|364009907|FG001|Overall Study|Withdrawal by Subject|6|||
105549636|NCT03021187|364009908|FG002|Overall Study|Withdrawal by Subject|2|||
105549637|NCT03021187|364009909|FG003|Overall Study|Withdrawal by Subject|5|||
105549638|NCT03021187|364009906|FG000|Overall Study|Lost to Follow-up|10|||
105549639|NCT03021187|364009907|FG001|Overall Study|Lost to Follow-up|3|||
105549640|NCT03021187|364009908|FG002|Overall Study|Lost to Follow-up|1|||
105549641|NCT03021187|364009909|FG003|Overall Study|Lost to Follow-up|4|||
105549642|NCT01462344|364009910|FG000|Overall Study|Withdrawal by Subject|245|||
105549643|NCT01462344|364009911|FG001|Overall Study|Withdrawal by Subject|226|||
105549644|NCT01462344|364009910|FG000|Overall Study|Adverse Event|24|||
105549645|NCT01462344|364009911|FG001|Overall Study|Adverse Event|23|||
105549646|NCT01462344|364009910|FG000|Overall Study|Asthma Exacerbation|34|||
105549647|NCT01462344|364009911|FG001|Overall Study|Asthma Exacerbation|35|||
105549648|NCT01462344|364009910|FG000|Overall Study|Lack of Efficacy|5|||
105549649|NCT01462344|364009911|FG001|Overall Study|Lack of Efficacy|6|||
105596338|NCT04707313|364184215|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
105549650|NCT01462344|364009910|FG000|Overall Study|Protocol Violation|68|||
105549651|NCT01462344|364009911|FG001|Overall Study|Protocol Violation|53|||
105549652|NCT01462344|364009910|FG000|Overall Study|Lost to Follow-up|7|||
105549653|NCT01462344|364009911|FG001|Overall Study|Lost to Follow-up|7|||
105549654|NCT00724971|364009912|FG000|Overall Study|Adverse Event|5|||
105549655|NCT00724971|364009912|FG000|Overall Study|Withdrawal by Subject|1|||
105549656|NCT01344460|364009915|FG000|Overall Study|Withdrawal by Subject|1|||
105549657|NCT01344460|364009915|FG000|Overall Study|Lost to Follow-up|2|||
105549658|NCT01003249|364009916|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
105549659|NCT01003249|364009917|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
105549660|NCT01003249|364009916|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
105549661|NCT01003249|364009917|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
105549662|NCT01003249|364009916|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
105549663|NCT01003249|364009917|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
105549664|NCT01003249|364009916|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
105549665|NCT01003249|364009917|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
105549666|NCT01962974|364009918|FG000|Overall Study|Study termination|7|||
105549667|NCT02838017|364009919|FG000|Overall Study|Lost to Follow-up|14|||
105549668|NCT02838017|364009920|FG001|Overall Study|Lost to Follow-up|11|||
105549669|NCT01692197|364009921|FG000|Overall Study|Failed Screening|3|||
105549670|NCT03283670|364009933|FG000|Placebo Gas|Withdrawal by Subject|2|||
105549671|NCT03283670|364009933|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
105549672|NCT03283670|364009933|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
105549673|NCT02276482|364009936|FG000|Overall Study|Adverse Event|1|||
105549674|NCT02276482|364009937|FG001|Overall Study|Adverse Event|0|||
105549675|NCT02276482|364009936|FG000|Overall Study|Withdrawal by Subject|1|||
105549676|NCT02276482|364009937|FG001|Overall Study|Withdrawal by Subject|0|||
105549677|NCT02276482|364009936|FG000|Overall Study|Gram-negative infection|1|||
105549678|NCT02276482|364009937|FG001|Overall Study|Gram-negative infection|0|||
105549679|NCT02276482|364009936|FG000|Overall Study|Reason not specified|0|||
105549680|NCT02276482|364009937|FG001|Overall Study|Reason not specified|1|||
105549681|NCT02863991|364009938|FG000|Overall Study|Death|0|||
105549682|NCT02863991|364009939|FG001|Overall Study|Death|3|||
105549683|NCT02863991|364009938|FG000|Overall Study|Lack of Efficacy|0|||
105549684|NCT02863991|364009939|FG001|Overall Study|Lack of Efficacy|1|||
105549685|NCT02863991|364009938|FG000|Overall Study|Study Terminated|2|||
105549686|NCT02863991|364009939|FG001|Overall Study|Study Terminated|8|||
105549687|NCT00364858|364009940|FG000|Overall Study|Adverse Event|1|||
105549688|NCT00364858|364009941|FG001|Overall Study|Adverse Event|5|||
105549689|NCT00364858|364009940|FG000|Overall Study|Withdrawal by Subject|1|||
105549690|NCT00364858|364009941|FG001|Overall Study|Withdrawal by Subject|1|||
105549691|NCT00364858|364009940|FG000|Overall Study|Pregnancy|1|||
105549692|NCT00364858|364009941|FG001|Overall Study|Pregnancy|1|||
105549693|NCT00364858|364009940|FG000|Overall Study|Clinical failure|2|||
105549694|NCT00364858|364009941|FG001|Overall Study|Clinical failure|13|||
105549695|NCT00364858|364009940|FG000|Overall Study|Discontinuation at baseline|1|||
105549696|NCT00364858|364009941|FG001|Overall Study|Discontinuation at baseline|0|||
105549697|NCT00364858|364009940|FG000|Overall Study|Non-compliant|1|||
105549698|NCT00364858|364009941|FG001|Overall Study|Non-compliant|0|||
105549699|NCT00364858|364009940|FG000|Overall Study|Return to Q2 regimen|0|||
105549700|NCT00364858|364009941|FG001|Overall Study|Return to Q2 regimen|1|||
105549701|NCT00364858|364009940|FG000|Overall Study|Clinical baseline issue|0|||
105549702|NCT00364858|364009941|FG001|Overall Study|Clinical baseline issue|1|||
105549703|NCT00627705|364009942|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
105549704|NCT00627705|364009943|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
105549705|NCT00627705|364009942|FG000|Overall Study|Adverse Event|1|||
105549706|NCT00627705|364009943|FG001|Overall Study|Adverse Event|0|||
105549707|NCT00627705|364009942|FG000|Overall Study|Withdrawal by Subject|0|||
105549708|NCT00627705|364009943|FG001|Overall Study|Withdrawal by Subject|2|||
105549709|NCT00627705|364009942|FG000|Overall Study|Lost to Follow-up|0|||
105549710|NCT00627705|364009943|FG001|Overall Study|Lost to Follow-up|1|||
105549711|NCT02730819|364009944|FG000|Overall Study|Lost to Follow-up|9|||
105549712|NCT02473952|364011662|FG000|Overall Study|Adverse Event|2|||
105549713|NCT02473952|364011663|FG001|Overall Study|Adverse Event|2|||
105549714|NCT02473952|364011662|FG000|Overall Study|Withdrawal by Subject|0|||
105549715|NCT02473952|364011663|FG001|Overall Study|Withdrawal by Subject|6|||
105549716|NCT00823719|364011664|FG000|Overall Study|Adverse Event|1|||
105549717|NCT00823719|364011665|FG001|Overall Study|Adverse Event|2|||
105549718|NCT00823719|364011664|FG000|Overall Study|Physician Decision|1|||
105549719|NCT00823719|364011665|FG001|Overall Study|Physician Decision|4|||
105549720|NCT00823719|364011664|FG000|Overall Study|Withdrawal by Subject|0|||
105549721|NCT00823719|364011665|FG001|Overall Study|Withdrawal by Subject|1|||
105549722|NCT00823719|364011664|FG000|Overall Study|Disease Progression|4|||
105549723|NCT00823719|364011665|FG001|Overall Study|Disease Progression|4|||
105549724|NCT01286779|364011668|FG000|Overall Study|Withdrawal by Subject|9|||
105549725|NCT01286779|364011668|FG000|Overall Study|Protocol Violation|5|||
105549726|NCT01286779|364011668|FG000|Overall Study|Physician Decision|2|||
105549727|NCT01286779|364011668|FG000|Overall Study|Participant had scheduled surgery|1|||
105549728|NCT01286779|364011668|FG000|Overall Study|Participant moved to another country|1|||
105549729|NCT01286779|364011668|FG000|Overall Study|Discontinued by sponsor|1|||
105549730|NCT01205685|364011669|FG000|Overall Study|Disease Progression|10|||
105549731|NCT01205685|364011669|FG000|Overall Study|Withdrawal by Subject|1|||
105549732|NCT03349710|364011670|FG000|Treatment Period|Death|0|||
105549733|NCT03349710|364011671|FG001|Treatment Period|Death|0|||
105549734|NCT03349710|364011672|FG002|Treatment Period|Death|1|||
105549735|NCT03349710|364011673|FG003|Treatment Period|Death|0|||
105549736|NCT03349710|364011670|FG000|Treatment Period|Disease Progression|0|||
105549737|NCT03349710|364011671|FG001|Treatment Period|Disease Progression|2|||
105549738|NCT03349710|364011672|FG002|Treatment Period|Disease Progression|0|||
105549739|NCT03349710|364011673|FG003|Treatment Period|Disease Progression|1|||
105549740|NCT03349710|364011670|FG000|Treatment Period|Study Drug Toxicity|1|||
105549741|NCT03349710|364011671|FG001|Treatment Period|Study Drug Toxicity|0|||
105549742|NCT03349710|364011672|FG002|Treatment Period|Study Drug Toxicity|1|||
105549743|NCT03349710|364011673|FG003|Treatment Period|Study Drug Toxicity|1|||
105549744|NCT03349710|364011670|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
105549745|NCT03349710|364011671|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
105549746|NCT03349710|364011672|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
105549747|NCT03349710|364011673|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
105549748|NCT03349710|364011670|FG000|Treatment Period|admin reason by sponsor|0|||
105549749|NCT03349710|364011671|FG001|Treatment Period|admin reason by sponsor|7|||
105549750|NCT03349710|364011672|FG002|Treatment Period|admin reason by sponsor|0|||
105549751|NCT03349710|364011673|FG003|Treatment Period|admin reason by sponsor|19|||
105549752|NCT03349710|364011670|FG000|Treatment Period|Other Reason|2|||
105549753|NCT03349710|364011671|FG001|Treatment Period|Other Reason|0|||
105549754|NCT03349710|364011672|FG002|Treatment Period|Other Reason|2|||
105549755|NCT03349710|364011673|FG003|Treatment Period|Other Reason|1|||
105549756|NCT03349710|364011670|FG000|Treatment Period|completed|6|||
105549757|NCT03349710|364011671|FG001|Treatment Period|completed|0|||
105549758|NCT03349710|364011672|FG002|Treatment Period|completed|18|||
105549759|NCT03349710|364011673|FG003|Treatment Period|completed|1|||
105549760|NCT03349710|364011670|FG000|Treatment Period|participant request to discontinue|0|||
105549761|NCT03349710|364011671|FG001|Treatment Period|participant request to discontinue|0|||
105549762|NCT03349710|364011672|FG002|Treatment Period|participant request to discontinue|4|||
105549763|NCT03349710|364011673|FG003|Treatment Period|participant request to discontinue|0|||
105549764|NCT03349710|364011670|FG000|Treatment Period|participant withdrew consent|1|||
105549765|NCT03349710|364011671|FG001|Treatment Period|participant withdrew consent|0|||
105549766|NCT03349710|364011672|FG002|Treatment Period|participant withdrew consent|0|||
105549767|NCT03349710|364011673|FG003|Treatment Period|participant withdrew consent|0|||
105549768|NCT01343368|364011674|FG000|Overall Study|Death|1|||
105549769|NCT01343368|364011675|FG001|Overall Study|Death|0|||
105549770|NCT01343368|364011674|FG000|Overall Study|Lost to Follow-up|1|||
105549771|NCT01343368|364011675|FG001|Overall Study|Lost to Follow-up|0|||
105549772|NCT00563784|364011676|FG000|Overall Study|Withdrawal by Subject|2|||
105549773|NCT00563784|364011676|FG000|Overall Study|Screen Failures|20|||
105549774|NCT02528214|364011677|FG000|Overall Study|Protocol Violation|0|||
105549775|NCT02528214|364011678|FG001|Overall Study|Protocol Violation|1|||
105549776|NCT02528214|364011677|FG000|Overall Study|Adverse Event|0|||
105549777|NCT02528214|364011678|FG001|Overall Study|Adverse Event|1|||
105549778|NCT02528214|364011677|FG000|Overall Study|Other than specified above|0|||
105549779|NCT02528214|364011678|FG001|Overall Study|Other than specified above|1|||
105549780|NCT02079805|364011682|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
105549781|NCT02079805|364011683|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
105549782|NCT02079805|364011682|FG000|Overall Study|Voluntary Withdrawal|0|||
105549783|NCT02079805|364011683|FG001|Overall Study|Voluntary Withdrawal|1|||
105549784|NCT02347761|364011684|FG000|All Collected|Death|1|||
105549785|NCT02347761|364011685|FG001|All Collected|Death|0|||
105549786|NCT02347761|364011686|FG002|All Collected|Death|0|||
105596339|NCT04707313|364184216|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
105596340|NCT04707313|364184217|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
105596341|NCT04707313|364184218|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
105596342|NCT04707313|364184219|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
105596343|NCT04707313|364184220|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
105596344|NCT04707313|364184208|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
105596345|NCT04707313|364184209|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
105596346|NCT04707313|364184210|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
105596347|NCT04707313|364184211|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
105596348|NCT04707313|364184212|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
105596349|NCT04707313|364184213|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
105596350|NCT04707313|364184214|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
105596351|NCT04707313|364184215|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
105596352|NCT04707313|364184216|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
105596353|NCT04707313|364184217|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
105596354|NCT04707313|364184218|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
105596355|NCT04707313|364184219|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
105596356|NCT04707313|364184220|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
105596357|NCT04707313|364184208|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
105596358|NCT04707313|364184209|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
105596359|NCT04707313|364184210|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
105596360|NCT04707313|364184211|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
105596361|NCT04707313|364184212|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
105596362|NCT04707313|364184213|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
105596363|NCT04707313|364184214|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
105596364|NCT04707313|364184215|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
105596365|NCT04707313|364184216|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
105596366|NCT04707313|364184217|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
105596367|NCT04707313|364184218|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
105596368|NCT04707313|364184219|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
105596369|NCT04707313|364184220|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
105596370|NCT04707313|364184208|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
105596371|NCT04707313|364184209|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
105596372|NCT04707313|364184210|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
105596373|NCT04707313|364184211|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
105596374|NCT04707313|364184212|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
105596375|NCT04707313|364184213|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
105596376|NCT04707313|364184214|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
105596377|NCT04707313|364184215|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
105596378|NCT04707313|364184216|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
105596379|NCT04707313|364184217|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
105596380|NCT04707313|364184218|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
105596381|NCT04707313|364184219|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
105596382|NCT04707313|364184220|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
105596383|NCT04707313|364184208|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
105596384|NCT04707313|364184209|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
105596385|NCT04707313|364184210|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
105596386|NCT04707313|364184211|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
105596387|NCT04707313|364184212|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
105596388|NCT04707313|364184213|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
105596389|NCT04707313|364184214|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
105596390|NCT04707313|364184215|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
105596391|NCT04707313|364184216|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
105596392|NCT04707313|364184217|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
105596393|NCT04707313|364184218|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
105596394|NCT04707313|364184219|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
105596395|NCT04707313|364184220|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
105596396|NCT04707313|364184208|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
105596397|NCT04707313|364184209|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
105596398|NCT04707313|364184210|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
105596399|NCT04707313|364184211|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
105596400|NCT04707313|364184212|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
105596401|NCT04707313|364184213|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
105596402|NCT04707313|364184214|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
105596403|NCT04707313|364184215|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
105596404|NCT04707313|364184216|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
105549787|NCT02347761|364011684|FG000|All Collected|Lost to Follow-up|3|||
105549788|NCT02347761|364011685|FG001|All Collected|Lost to Follow-up|2|||
105549789|NCT02347761|364011686|FG002|All Collected|Lost to Follow-up|3|||
105549790|NCT02347761|364011684|FG000|All Collected|Withdrawal by Subject|11|||
105549791|NCT02347761|364011685|FG001|All Collected|Withdrawal by Subject|11|||
105549792|NCT02347761|364011686|FG002|All Collected|Withdrawal by Subject|22|||
105549793|NCT02347761|364011684|FG000|All Collected|invetigator disretion|2|||
105549794|NCT02347761|364011685|FG001|All Collected|invetigator disretion|0|||
105549795|NCT02347761|364011686|FG002|All Collected|invetigator disretion|0|||
105549796|NCT02347761|364011684|FG000|All Collected|instillation site pain|0|||
105549797|NCT02347761|364011685|FG001|All Collected|instillation site pain|0|||
105549798|NCT02347761|364011686|FG002|All Collected|instillation site pain|1|||
105549799|NCT02347761|364011684|FG000|All Collected|exacerbation of COPD|0|||
105549800|NCT02347761|364011685|FG001|All Collected|exacerbation of COPD|0|||
105549801|NCT02347761|364011686|FG002|All Collected|exacerbation of COPD|1|||
105549802|NCT02347761|364011684|FG000|All Collected|moved/travel|0|||
105549803|NCT02347761|364011685|FG001|All Collected|moved/travel|1|||
105549804|NCT02347761|364011686|FG002|All Collected|moved/travel|0|||
105549805|NCT02347761|364011684|FG000|On Study Treatment|Lack of Efficacy|2|||
105549806|NCT02347761|364011685|FG001|On Study Treatment|Lack of Efficacy|3|||
105549807|NCT02347761|364011686|FG002|On Study Treatment|Lack of Efficacy|4|||
105549808|NCT02347761|364011684|FG000|On Study Treatment|non-compliance with study medication|0|||
105549809|NCT02347761|364011685|FG001|On Study Treatment|non-compliance with study medication|0|||
105549810|NCT02347761|364011686|FG002|On Study Treatment|non-compliance with study medication|2|||
105549811|NCT02347761|364011684|FG000|On Study Treatment|Withdrawal by Subject|7|||
105549812|NCT02347761|364011685|FG001|On Study Treatment|Withdrawal by Subject|3|||
105549813|NCT02347761|364011686|FG002|On Study Treatment|Withdrawal by Subject|5|||
105549814|NCT02347761|364011684|FG000|On Study Treatment|move/travel|2|||
105549815|NCT02347761|364011685|FG001|On Study Treatment|move/travel|6|||
105549816|NCT02347761|364011686|FG002|On Study Treatment|move/travel|5|||
105549817|NCT02347761|364011684|FG000|On Study Treatment|dissastisfaction with device|2|||
105549818|NCT02347761|364011685|FG001|On Study Treatment|dissastisfaction with device|1|||
105549819|NCT02347761|364011686|FG002|On Study Treatment|dissastisfaction with device|4|||
105549820|NCT02347761|364011684|FG000|On Study Treatment|Lost to Follow-up|2|||
105549821|NCT02347761|364011685|FG001|On Study Treatment|Lost to Follow-up|1|||
105549822|NCT02347761|364011686|FG002|On Study Treatment|Lost to Follow-up|1|||
105549823|NCT02347761|364011684|FG000|On Study Treatment|investigator discretion|2|||
105549824|NCT02347761|364011685|FG001|On Study Treatment|investigator discretion|0|||
105549825|NCT02347761|364011686|FG002|On Study Treatment|investigator discretion|0|||
105549826|NCT02347761|364011684|FG000|On Study Treatment|durg not working|0|||
105549827|NCT02347761|364011685|FG001|On Study Treatment|durg not working|1|||
105549828|NCT02347761|364011686|FG002|On Study Treatment|durg not working|1|||
105549829|NCT02347761|364011684|FG000|On Study Treatment|Adverse Event|10|||
105549830|NCT02347761|364011685|FG001|On Study Treatment|Adverse Event|8|||
105549831|NCT02347761|364011686|FG002|On Study Treatment|Adverse Event|20|||
105549832|NCT02864082|364011687|FG000|Overall Study|Adverse Event|1|||
105549833|NCT02864082|364011688|FG001|Overall Study|Adverse Event|1|||
105549834|NCT02864082|364011687|FG000|Overall Study|Lost to Follow-up|0|||
105549835|NCT02864082|364011688|FG001|Overall Study|Lost to Follow-up|1|||
105549836|NCT02864082|364011687|FG000|Overall Study|Withdrawal by Subject|2|||
105549837|NCT02864082|364011688|FG001|Overall Study|Withdrawal by Subject|2|||
105549838|NCT00782340|364011694|FG000|Open Label Titration|Adverse Event|12|||
105549839|NCT00782340|364011695|FG001|Open Label Titration|Adverse Event|0|||
105549840|NCT00782340|364011696|FG002|Open Label Titration|Adverse Event|0|||
105549841|NCT00782340|364011694|FG000|Open Label Titration|Treatment failure|50|||
105549842|NCT00782340|364011695|FG001|Open Label Titration|Treatment failure|0|||
105549843|NCT00782340|364011696|FG002|Open Label Titration|Treatment failure|0|||
105549844|NCT00782340|364011694|FG000|Open Label Titration|Protocol Violation|5|||
105549845|NCT00782340|364011695|FG001|Open Label Titration|Protocol Violation|0|||
105549846|NCT00782340|364011696|FG002|Open Label Titration|Protocol Violation|0|||
105549847|NCT00782340|364011694|FG000|Open Label Titration|Withdrawal by Subject|5|||
105549848|NCT00782340|364011695|FG001|Open Label Titration|Withdrawal by Subject|0|||
105549849|NCT00782340|364011696|FG002|Open Label Titration|Withdrawal by Subject|0|||
105549850|NCT00782340|364011694|FG000|Open Label Titration|Enrollment capped|16|||
105549851|NCT00782340|364011695|FG001|Open Label Titration|Enrollment capped|0|||
105549852|NCT00782340|364011696|FG002|Open Label Titration|Enrollment capped|0|||
105549853|NCT00782340|364011694|FG000|Open Label Titration|Did not meet responder criteria|2|||
105549854|NCT00782340|364011695|FG001|Open Label Titration|Did not meet responder criteria|0|||
105549855|NCT00782340|364011696|FG002|Open Label Titration|Did not meet responder criteria|0|||
105549856|NCT00782340|364011694|FG000|Open Label Titration|Lost to Follow-up|5|||
105549857|NCT00782340|364011695|FG001|Open Label Titration|Lost to Follow-up|0|||
105549858|NCT00782340|364011696|FG002|Open Label Titration|Lost to Follow-up|0|||
105549859|NCT00782340|364011694|FG000|Open Label Titration|Randomized in error|6|||
105549860|NCT00782340|364011695|FG001|Open Label Titration|Randomized in error|0|||
105549861|NCT00782340|364011696|FG002|Open Label Titration|Randomized in error|0|||
105549862|NCT02493361|364011697|FG000|Overall Study|Withdrawal by Subject|3|||
105549863|NCT02219932|364011699|FG000|Overall Study|Other|5|||
105549864|NCT02219932|364011700|FG001|Overall Study|Other|11|||
105549865|NCT02219932|364011699|FG000|Overall Study|Death|1|||
105549866|NCT02219932|364011700|FG001|Overall Study|Death|1|||
105549867|NCT02219932|364011699|FG000|Overall Study|Investigator Decision|0|||
105549868|NCT02219932|364011700|FG001|Overall Study|Investigator Decision|1|||
105549869|NCT02219932|364011699|FG000|Overall Study|Consent Withdrawn|11|||
105549870|NCT02219932|364011700|FG001|Overall Study|Consent Withdrawn|7|||
105549871|NCT02219932|364011699|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
105549872|NCT02219932|364011700|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
105549873|NCT02219932|364011699|FG000|Overall Study|Protocol Violation|10|||
105549874|NCT02219932|364011700|FG001|Overall Study|Protocol Violation|6|||
105549875|NCT02219932|364011699|FG000|Overall Study|Pregnancy|1|||
105549876|NCT02219932|364011700|FG001|Overall Study|Pregnancy|0|||
105549877|NCT02219932|364011699|FG000|Overall Study|Lost to Follow-up|4|||
105549878|NCT02219932|364011700|FG001|Overall Study|Lost to Follow-up|2|||
105549879|NCT02219932|364011699|FG000|Overall Study|Adverse Event|23|||
105549880|NCT02219932|364011700|FG001|Overall Study|Adverse Event|21|||
105549881|NCT00093145|364011701|FG000|Overall Study|Unacceptable Toxicity Only|2|||
105549882|NCT00093145|364011701|FG000|Overall Study|Physician Decision|5|||
105549883|NCT00093145|364011701|FG000|Overall Study|Withdrawal by Subject|9|||
105549884|NCT00093145|364011701|FG000|Overall Study|Other|1|||
105549885|NCT01175668|364011702|FG000|Overall Study|Withdrawal by Subject|2|||
105549886|NCT01175668|364011703|FG001|Overall Study|Withdrawal by Subject|0|||
105549887|NCT01568047|364011709|FG000|Overall Study|Ineligibility|1|||
105549888|NCT01568047|364011710|FG001|Overall Study|Ineligibility|0|||
105549889|NCT01568047|364011711|FG002|Overall Study|Ineligibility|0|||
105549890|NCT01568047|364011712|FG003|Overall Study|Ineligibility|0|||
105549891|NCT01568047|364011709|FG000|Overall Study|Withdrawal by Subject|0|||
105549892|NCT01568047|364011710|FG001|Overall Study|Withdrawal by Subject|1|||
105549893|NCT01568047|364011711|FG002|Overall Study|Withdrawal by Subject|0|||
105549894|NCT01568047|364011712|FG003|Overall Study|Withdrawal by Subject|0|||
105549895|NCT01568047|364011709|FG000|Overall Study|Adverse Event|0|||
105549896|NCT01568047|364011710|FG001|Overall Study|Adverse Event|0|||
105549897|NCT01568047|364011711|FG002|Overall Study|Adverse Event|1|||
105549898|NCT01568047|364011712|FG003|Overall Study|Adverse Event|1|||
105549899|NCT02328326|364011715|FG000|Overall Study|Withdrawal by Subject|10|||
105549900|NCT02328326|364011716|FG001|Overall Study|Withdrawal by Subject|3|||
105549901|NCT02328326|364011715|FG000|Overall Study|Death|2|||
105549902|NCT02328326|364011716|FG001|Overall Study|Death|1|||
105549903|NCT02328326|364011715|FG000|Overall Study|Lost to Follow-up|10|||
105549904|NCT02328326|364011716|FG001|Overall Study|Lost to Follow-up|4|||
105549905|NCT02937545|364011720|FG000|Overall Study|Withdrawal by Subject|1|||
105549906|NCT02937545|364011721|FG001|Overall Study|Withdrawal by Subject|2|||
105549907|NCT02937545|364011722|FG002|Overall Study|Withdrawal by Subject|6|||
105549908|NCT02937545|364011723|FG003|Overall Study|Withdrawal by Subject|7|||
105549909|NCT02937545|364011720|FG000|Overall Study|Lost to Follow-up|1|||
105549910|NCT02937545|364011721|FG001|Overall Study|Lost to Follow-up|0|||
105549911|NCT02937545|364011722|FG002|Overall Study|Lost to Follow-up|0|||
105549912|NCT02937545|364011723|FG003|Overall Study|Lost to Follow-up|0|||
105549913|NCT01985126|364011724|FG000|Overall Study|Death|15|||
105549914|NCT01985126|364011725|FG001|Overall Study|Death|69|||
105549915|NCT01985126|364011724|FG000|Overall Study|Lost to Follow-up|0|||
105549916|NCT01985126|364011725|FG001|Overall Study|Lost to Follow-up|8|||
105549917|NCT01985126|364011724|FG000|Overall Study|Study Terminated By Sponsor|1|||
105549918|NCT01985126|364011725|FG001|Overall Study|Study Terminated By Sponsor|22|||
105549919|NCT01985126|364011724|FG000|Overall Study|Withdrawal by Subject|2|||
105549920|NCT01985126|364011725|FG001|Overall Study|Withdrawal by Subject|7|||
105549921|NCT06281548|364011728|FG000|Overall Study|Lost to Follow-up|3|||
105549922|NCT01618838|364011729|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
105549923|NCT01764945|364011731|FG000|Overall Study|Adverse Event|0|||
105549924|NCT01764945|364011732|FG001|Overall Study|Adverse Event|1|||
105549925|NCT01764945|364011733|FG002|Overall Study|Adverse Event|0|||
105549926|NCT01764945|364011734|FG003|Overall Study|Adverse Event|0|||
105549927|NCT01764945|364011735|FG004|Overall Study|Adverse Event|0|||
105549928|NCT01764945|364011736|FG005|Overall Study|Adverse Event|0|||
105549929|NCT01764945|364011737|FG006|Overall Study|Adverse Event|1|||
105549930|NCT01764945|364011738|FG007|Overall Study|Adverse Event|0|||
105549931|NCT02911948|364011740|FG000|Overall Study|Protocol Violation|0|||
105549932|NCT02911948|364011741|FG001|Overall Study|Protocol Violation|1|||
105549933|NCT02911948|364011740|FG000|Overall Study|Withdrawal by Subject|0|||
105549934|NCT02911948|364011741|FG001|Overall Study|Withdrawal by Subject|2|||
105549935|NCT02911948|364011740|FG000|Overall Study|Lack of Efficacy|0|||
105549936|NCT02911948|364011741|FG001|Overall Study|Lack of Efficacy|1|||
105549937|NCT02911948|364011740|FG000|Overall Study|Unclassified|0|||
105549938|NCT02911948|364011741|FG001|Overall Study|Unclassified|3|||
105549939|NCT00586105|364011744|FG000|Overall Study|Adverse Event|4|||
105549940|NCT00586105|364011744|FG000|Overall Study|Death|2|||
105549941|NCT00586105|364011744|FG000|Overall Study|Protocol Violation|1|||
105549942|NCT00586105|364011744|FG000|Overall Study|Withdrawal by Subject|3|||
105549943|NCT00586105|364011744|FG000|Overall Study|Disease progression|19|||
105549944|NCT00586105|364011744|FG000|Overall Study|Switched to commercial drug|9|||
105549945|NCT00586105|364011744|FG000|Overall Study|Reason not reported|1|||
105549946|NCT03835533|364011747|FG000|Overall Study|Death|5|||
105549947|NCT03835533|364011748|FG001|Overall Study|Death|10|||
105549948|NCT03835533|364011749|FG002|Overall Study|Death|9|||
105549949|NCT03835533|364011747|FG000|Overall Study|Withdrawal by Subject|2|||
105549950|NCT03835533|364011748|FG001|Overall Study|Withdrawal by Subject|2|||
105549951|NCT03835533|364011749|FG002|Overall Study|Withdrawal by Subject|2|||
105549952|NCT03835533|364011747|FG000|Overall Study|Lost to Follow-up|1|||
105549953|NCT03835533|364011748|FG001|Overall Study|Lost to Follow-up|0|||
105549954|NCT03835533|364011749|FG002|Overall Study|Lost to Follow-up|0|||
105549955|NCT03867734|364011752|FG000|Overall Study|Lost to Follow-up|2|||
105549956|NCT00380068|364011759|FG000|Overall Study|Adverse Event|40|||
105549957|NCT00380068|364011759|FG000|Overall Study|Withdrawal by Subject|10|||
105549958|NCT00380068|364011759|FG000|Overall Study|Not compliant|6|||
105549959|NCT00380068|364011759|FG000|Overall Study|Lost to Follow-up|1|||
105549960|NCT00380068|364011759|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
105549961|NCT00380068|364011759|FG000|Overall Study|Lung transplant|3|||
105549962|NCT00380068|364011759|FG000|Overall Study|Physician Decision|2|||
105549963|NCT00380068|364011759|FG000|Overall Study|Partipant moved away|1|||
105549964|NCT00380068|364011759|FG000|Overall Study|Lack of Efficacy|5|||
105549965|NCT01682837|364011760|FG000|Baseline|Withdrawal by Subject|5|||
105549966|NCT03738150|364011761|FG000|Base Study|Withdrawal by Subject|1|||
105549967|NCT03738150|364011761|FG000|Extension Study|Withdrawal by Subject|1|||
105549968|NCT01898195|364011762|FG000|Smoking Abstinence|Did not have good measurements|35|||
105549969|NCT01898195|364011763|FG001|Smoking Abstinence|Did not have good measurements|38|||
105549970|NCT01898195|364011764|FG002|Smoking Abstinence|Did not have good measurements|36|||
105549971|NCT02663128|364011765|FG000|Period 2|Physician Decision|0|||
105549972|NCT02663128|364011766|FG001|Period 2|Physician Decision|0|||
105549973|NCT02663128|364011767|FG002|Period 2|Physician Decision|0|||
105549974|NCT02663128|364011768|FG003|Period 2|Physician Decision|0|||
105549975|NCT02663128|364011769|FG004|Period 2|Physician Decision|1|||
105549976|NCT02663128|364011770|FG005|Period 2|Physician Decision|0|||
105549977|NCT01358526|364011771|FG000|Open-label Titration Period|Adverse Event|95|||
105549978|NCT01358526|364011772|FG001|Open-label Titration Period|Adverse Event|0|||
105549979|NCT01358526|364011773|FG002|Open-label Titration Period|Adverse Event|0|||
105549980|NCT01358526|364011771|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
105549981|NCT01358526|364011772|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
105549982|NCT01358526|364011773|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
105549983|NCT01358526|364011771|FG000|Open-label Titration Period|Lost to Follow-up|25|||
105549984|NCT01358526|364011772|FG001|Open-label Titration Period|Lost to Follow-up|0|||
105549985|NCT01358526|364011773|FG002|Open-label Titration Period|Lost to Follow-up|0|||
105549986|NCT01358526|364011771|FG000|Open-label Titration Period|Lack of Efficacy|107|||
105549987|NCT01358526|364011772|FG001|Open-label Titration Period|Lack of Efficacy|0|||
105549988|NCT01358526|364011773|FG002|Open-label Titration Period|Lack of Efficacy|0|||
105549989|NCT01358526|364011771|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
105549990|NCT01358526|364011772|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
105549991|NCT01358526|364011773|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
105549992|NCT01358526|364011771|FG000|Open-label Titration Period|Administrative|8|||
105549993|NCT01358526|364011772|FG001|Open-label Titration Period|Administrative|0|||
105549994|NCT01358526|364011773|FG002|Open-label Titration Period|Administrative|0|||
105549995|NCT01358526|364011771|FG000|Open-label Titration Period|Did not qualify|178|||
105596405|NCT04707313|364184217|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
105549996|NCT01358526|364011772|FG001|Open-label Titration Period|Did not qualify|0|||
105549997|NCT01358526|364011773|FG002|Open-label Titration Period|Did not qualify|0|||
105549998|NCT01358526|364011771|FG000|Double-blind Phase|Adverse Event|0|||
105549999|NCT01358526|364011772|FG001|Double-blind Phase|Adverse Event|24|||
105550000|NCT01358526|364011773|FG002|Double-blind Phase|Adverse Event|23|||
105550001|NCT01358526|364011771|FG000|Double-blind Phase|Withdrawal by Subject|0|||
105550002|NCT01358526|364011772|FG001|Double-blind Phase|Withdrawal by Subject|10|||
105596406|NCT04707313|364184218|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
105550003|NCT01358526|364011773|FG002|Double-blind Phase|Withdrawal by Subject|8|||
105550004|NCT01358526|364011771|FG000|Double-blind Phase|Lost to Follow-up|0|||
105550005|NCT01358526|364011772|FG001|Double-blind Phase|Lost to Follow-up|4|||
105550006|NCT01358526|364011773|FG002|Double-blind Phase|Lost to Follow-up|1|||
105550007|NCT01358526|364011771|FG000|Double-blind Phase|Lack of Efficacy|0|||
105550008|NCT01358526|364011772|FG001|Double-blind Phase|Lack of Efficacy|31|||
105550009|NCT01358526|364011773|FG002|Double-blind Phase|Lack of Efficacy|73|||
105550010|NCT01358526|364011771|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
105550011|NCT01358526|364011772|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
105550012|NCT01358526|364011773|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
105550013|NCT01358526|364011771|FG000|Double-blind Phase|Administrative|0|||
105550014|NCT01358526|364011772|FG001|Double-blind Phase|Administrative|6|||
105550015|NCT01358526|364011773|FG002|Double-blind Phase|Administrative|10|||
105550016|NCT03086447|364011774|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
105550017|NCT03086447|364011775|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
105550018|NCT03086447|364011774|FG000|Overall Study|Lost Lens|2|||
105550019|NCT03086447|364011775|FG001|Overall Study|Lost Lens|5|||
105550020|NCT03086447|364011774|FG000|Overall Study|Product quality complaint|0|||
105550021|NCT03086447|364011775|FG001|Overall Study|Product quality complaint|1|||
105550022|NCT03086447|364011774|FG000|Overall Study|Lens Damage|1|||
105550023|NCT03086447|364011775|FG001|Overall Study|Lens Damage|6|||
105550024|NCT03086447|364011774|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
105550025|NCT03086447|364011775|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
105550026|NCT03086447|364011774|FG000|Overall Study|Test Article No Longer Available|1|||
105550027|NCT03086447|364011775|FG001|Overall Study|Test Article No Longer Available|0|||
105550028|NCT03086447|364011774|FG000|Overall Study|Protocol Violation|2|||
105550029|NCT03086447|364011775|FG001|Overall Study|Protocol Violation|4|||
105550030|NCT03086447|364011774|FG000|Overall Study|Lost to Follow-up|0|||
105550031|NCT03086447|364011775|FG001|Overall Study|Lost to Follow-up|1|||
105550032|NCT03086447|364011774|FG000|Overall Study|Adverse Event|3|||
105550033|NCT03086447|364011775|FG001|Overall Study|Adverse Event|0|||
105550034|NCT03086447|364011774|FG000|Overall Study|Lens Discomfort|2|||
105550035|NCT03086447|364011775|FG001|Overall Study|Lens Discomfort|1|||
105550036|NCT02132611|364011780|FG000|Overall Study|Death|2|||
105550037|NCT00363766|364011781|FG000|Overall Study|Progressive Disease|15|||
105550038|NCT00363766|364011782|FG001|Overall Study|Progressive Disease|9|||
105550039|NCT00363766|364011781|FG000|Overall Study|Adverse Event|10|||
105550040|NCT00363766|364011782|FG001|Overall Study|Adverse Event|2|||
105550041|NCT00363766|364011781|FG000|Overall Study|Disease Related Death|1|||
105550042|NCT00363766|364011782|FG001|Overall Study|Disease Related Death|3|||
105550043|NCT00363766|364011781|FG000|Overall Study|Not Disease Related Death|3|||
105550044|NCT00363766|364011782|FG001|Overall Study|Not Disease Related Death|4|||
105550045|NCT00363766|364011781|FG000|Overall Study|Withdrawal by Subject|2|||
105550046|NCT00363766|364011782|FG001|Overall Study|Withdrawal by Subject|0|||
105550047|NCT00363766|364011781|FG000|Overall Study|Physician Decision|1|||
105550048|NCT00363766|364011782|FG001|Overall Study|Physician Decision|2|||
105550049|NCT00558285|364011784|FG000|Overall Study|Adverse Event|1|||
105550050|NCT00558285|364011785|FG001|Overall Study|Adverse Event|1|||
105550051|NCT00558285|364011786|FG002|Overall Study|Adverse Event|4|||
105550052|NCT00558285|364011787|FG003|Overall Study|Adverse Event|1|||
105550053|NCT00558285|364011788|FG004|Overall Study|Adverse Event|2|||
105550054|NCT00558285|364011784|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105550055|NCT00558285|364011785|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105550056|NCT00558285|364011786|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105550057|NCT00558285|364011787|FG003|Overall Study|Abnormal test procedure result(s)|0|||
105550058|NCT00558285|364011788|FG004|Overall Study|Abnormal test procedure result(s)|0|||
105550059|NCT00558285|364011784|FG000|Overall Study|Subject withdrew consent|2|||
105550060|NCT00558285|364011785|FG001|Overall Study|Subject withdrew consent|0|||
105550061|NCT00558285|364011786|FG002|Overall Study|Subject withdrew consent|1|||
105550062|NCT00558285|364011787|FG003|Overall Study|Subject withdrew consent|1|||
105550063|NCT00558285|364011788|FG004|Overall Study|Subject withdrew consent|1|||
105550064|NCT00558285|364011784|FG000|Overall Study|Lost to Follow-up|1|||
105550065|NCT00558285|364011785|FG001|Overall Study|Lost to Follow-up|1|||
105550066|NCT00558285|364011786|FG002|Overall Study|Lost to Follow-up|0|||
105550067|NCT00558285|364011787|FG003|Overall Study|Lost to Follow-up|0|||
105550068|NCT00558285|364011788|FG004|Overall Study|Lost to Follow-up|0|||
105550069|NCT00558285|364011784|FG000|Overall Study|Administrative problems|0|||
105550070|NCT00558285|364011785|FG001|Overall Study|Administrative problems|0|||
105550071|NCT00558285|364011786|FG002|Overall Study|Administrative problems|0|||
105550072|NCT00558285|364011787|FG003|Overall Study|Administrative problems|1|||
105550073|NCT00558285|364011788|FG004|Overall Study|Administrative problems|1|||
105550074|NCT00558285|364011784|FG000|Overall Study|Protocol deviation|1|||
105550075|NCT00558285|364011785|FG001|Overall Study|Protocol deviation|1|||
105550076|NCT00558285|364011786|FG002|Overall Study|Protocol deviation|0|||
105550077|NCT00558285|364011787|FG003|Overall Study|Protocol deviation|1|||
105550078|NCT00558285|364011788|FG004|Overall Study|Protocol deviation|0|||
105550079|NCT00110617|364011792|FG000|Overall Study|Adverse Event|2|||
105550080|NCT00110617|364011793|FG001|Overall Study|Adverse Event|4|||
105550081|NCT00110617|364011792|FG000|Overall Study|Abnormal Laboratory Value|4|||
105550082|NCT00110617|364011793|FG001|Overall Study|Abnormal Laboratory Value|2|||
105550083|NCT00110617|364011792|FG000|Overall Study|Lack of Efficacy|1|||
105550084|NCT00110617|364011793|FG001|Overall Study|Lack of Efficacy|0|||
105550085|NCT00110617|364011792|FG000|Overall Study|Patient no longer requires study drug|1|||
105550086|NCT00110617|364011793|FG001|Overall Study|Patient no longer requires study drug|0|||
105550087|NCT00110617|364011792|FG000|Overall Study|Protocol Violation|5|||
105550088|NCT00110617|364011793|FG001|Overall Study|Protocol Violation|0|||
105550089|NCT00110617|364011792|FG000|Overall Study|Withdrawal by Subject|10|||
105550090|NCT00110617|364011793|FG001|Overall Study|Withdrawal by Subject|4|||
105550091|NCT00110617|364011792|FG000|Overall Study|Lost to Follow-up|9|||
105550092|NCT00110617|364011793|FG001|Overall Study|Lost to Follow-up|1|||
105550093|NCT00110617|364011792|FG000|Overall Study|Administrative problems|6|||
105550094|NCT00110617|364011793|FG001|Overall Study|Administrative problems|5|||
105550095|NCT00110617|364011792|FG000|Overall Study|Death|1|||
105550096|NCT00110617|364011793|FG001|Overall Study|Death|1|||
105550097|NCT00110617|364011792|FG000|Overall Study|Did not receive study drug|0|||
105550098|NCT00110617|364011793|FG001|Overall Study|Did not receive study drug|12|||
105550099|NCT01781572|364011794|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
105550100|NCT01781572|364011795|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
105550101|NCT01781572|364011796|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
105550102|NCT01781572|364011794|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
105550103|NCT01781572|364011795|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
105550104|NCT01781572|364011796|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
105550105|NCT01781572|364011794|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
105550106|NCT01781572|364011795|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
105550107|NCT01781572|364011796|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
105550108|NCT01781572|364011794|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
105550109|NCT01781572|364011795|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
105550110|NCT01781572|364011796|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
105550111|NCT01781572|364011794|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
105550112|NCT01781572|364011795|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
105550113|NCT01781572|364011796|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
105550114|NCT01781572|364011794|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
105550115|NCT01781572|364011795|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
105550116|NCT01781572|364011796|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
105550117|NCT01781572|364011794|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
105550118|NCT01781572|364011795|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
105550119|NCT01781572|364011796|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
105550120|NCT01781572|364011794|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
105550121|NCT01781572|364011795|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
105550122|NCT01781572|364011796|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
105550123|NCT01781572|364011794|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
105550124|NCT01781572|364011795|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
105550125|NCT01781572|364011796|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
105550126|NCT01781572|364011794|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
105550127|NCT01781572|364011795|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
105550128|NCT01781572|364011796|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
105550129|NCT01781572|364011794|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
105550130|NCT01781572|364011795|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
105550131|NCT01781572|364011796|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
105550132|NCT01781572|364011794|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
105550133|NCT01781572|364011795|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
105550134|NCT01781572|364011796|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
105550135|NCT01781572|364011794|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
105550136|NCT01781572|364011795|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
105550137|NCT01781572|364011796|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
105550138|NCT01781572|364011794|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
105550139|NCT01781572|364011795|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
105550140|NCT01781572|364011796|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
105550141|NCT01781572|364011794|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
105550142|NCT01781572|364011795|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
105550143|NCT01781572|364011796|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
105550144|NCT01781572|364011794|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
105550145|NCT01781572|364011795|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
105550146|NCT01781572|364011796|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
105550147|NCT01781572|364011794|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
105550148|NCT01781572|364011795|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
105550149|NCT01781572|364011796|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
105550150|NCT01781572|364011794|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
105550151|NCT01781572|364011795|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
105550152|NCT01781572|364011796|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
105550153|NCT02010060|364011800|FG000|Overall Study|Lost to Follow-up|1|||
105550154|NCT02010060|364011801|FG001|Overall Study|Lost to Follow-up|2|||
105550155|NCT02010060|364011802|FG002|Overall Study|Lost to Follow-up|2|||
105550156|NCT02010060|364011800|FG000|Overall Study|Injury|0|||
105550157|NCT02010060|364011801|FG001|Overall Study|Injury|1|||
105550158|NCT02010060|364011802|FG002|Overall Study|Injury|0|||
105550159|NCT00660010|364011803|FG000|Overall Study|Withdrawal by Subject|2|||
105550160|NCT00660010|364011803|FG000|Overall Study|Lost to Follow-up|3|||
105550161|NCT00660010|364011803|FG000|Overall Study|Adverse Event|1|||
105550162|NCT00660010|364011803|FG000|Overall Study|Noncompliance with visit schedule|3|||
105596407|NCT04707313|364184219|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
105596408|NCT04707313|364184220|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
105596409|NCT04707313|364184208|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
105596410|NCT04707313|364184209|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
105596411|NCT04707313|364184210|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
105596412|NCT04707313|364184211|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
105596413|NCT04707313|364184212|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
105596414|NCT04707313|364184213|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
105596415|NCT04707313|364184214|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
105596416|NCT04707313|364184215|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
105596417|NCT04707313|364184216|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
105596418|NCT04707313|364184217|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
105596419|NCT04707313|364184218|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
105596420|NCT04707313|364184219|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
105596421|NCT04707313|364184220|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
105596422|NCT04707313|364184208|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
105596423|NCT04707313|364184209|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
105596424|NCT04707313|364184210|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
105596425|NCT04707313|364184211|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
105596426|NCT04707313|364184212|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
105596427|NCT04707313|364184213|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
105596428|NCT04707313|364184214|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
105596429|NCT04707313|364184215|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
105596430|NCT04707313|364184216|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
105596431|NCT04707313|364184217|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
105596432|NCT04707313|364184218|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
105596433|NCT04707313|364184219|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
105596434|NCT04707313|364184220|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
105596435|NCT04707313|364184208|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
105596436|NCT04707313|364184209|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
105596437|NCT04707313|364184210|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
105596438|NCT04707313|364184211|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
105596439|NCT04707313|364184212|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
105596440|NCT04707313|364184213|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
105596441|NCT04707313|364184214|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
105596442|NCT04707313|364184215|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
105596443|NCT04707313|364184216|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
105596444|NCT04707313|364184217|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
105596445|NCT04707313|364184218|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
105596446|NCT04707313|364184219|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
105596447|NCT04707313|364184220|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
105596448|NCT04707313|364184208|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
105596449|NCT04707313|364184209|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
105596450|NCT04707313|364184210|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
105596451|NCT04707313|364184211|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
105596452|NCT04707313|364184212|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
105596453|NCT04707313|364184213|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
105596454|NCT04707313|364184214|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
105596455|NCT04707313|364184215|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
105596456|NCT04707313|364184216|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
105596457|NCT04707313|364184217|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
105596458|NCT04707313|364184218|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
105596459|NCT04707313|364184219|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
105596460|NCT04707313|364184220|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
105596461|NCT04707313|364184208|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
105596462|NCT04707313|364184209|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
105596463|NCT04707313|364184210|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
105596464|NCT04707313|364184211|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
105596465|NCT04707313|364184212|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
105596466|NCT04707313|364184213|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
105596467|NCT04707313|364184214|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
105596468|NCT04707313|364184215|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
105596469|NCT04707313|364184216|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
105596470|NCT04707313|364184217|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
105596471|NCT04707313|364184218|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
105596472|NCT04707313|364184219|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
105596473|NCT04707313|364184220|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
105596474|NCT04707313|364184208|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
105596475|NCT04707313|364184209|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
105596476|NCT04707313|364184210|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
105596477|NCT04707313|364184211|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
105596478|NCT04707313|364184212|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
105596479|NCT04707313|364184213|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
105596480|NCT04707313|364184214|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
105596481|NCT04707313|364184215|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
105596482|NCT04707313|364184216|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
105596483|NCT04707313|364184217|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
105596484|NCT04707313|364184218|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
105596485|NCT04707313|364184219|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
105596486|NCT04707313|364184220|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
105596487|NCT00919763|364184221|FG000|Overall Study|Adverse Event|7|||
105596488|NCT00919763|364184222|FG001|Overall Study|Adverse Event|1|||
105596489|NCT00919763|364184221|FG000|Overall Study|Lost to Follow-up|1|||
105596490|NCT00919763|364184222|FG001|Overall Study|Lost to Follow-up|0|||
105596491|NCT00919763|364184221|FG000|Overall Study|Protocol Violation|1|||
105596492|NCT00919763|364184222|FG001|Overall Study|Protocol Violation|1|||
105596493|NCT00919763|364184221|FG000|Overall Study|Withdrawal by Subject|3|||
105596494|NCT00919763|364184222|FG001|Overall Study|Withdrawal by Subject|1|||
105596495|NCT00919763|364184221|FG000|Overall Study|Non-compliance|0|||
105596496|NCT00919763|364184222|FG001|Overall Study|Non-compliance|1|||
105596497|NCT01713946|364184232|FG000|Overall Study|Death|0|||
105596498|NCT01713946|364184233|FG001|Overall Study|Death|2|||
105596499|NCT01713946|364184234|FG002|Overall Study|Death|2|||
105596500|NCT01713946|364184232|FG000|Overall Study|Adverse Event|19|||
105596501|NCT01713946|364184233|FG001|Overall Study|Adverse Event|14|||
105596502|NCT01713946|364184234|FG002|Overall Study|Adverse Event|13|||
105596503|NCT01713946|364184232|FG000|Overall Study|Withdrawal by Subject|12|||
105596504|NCT01713946|364184233|FG001|Overall Study|Withdrawal by Subject|12|||
105596505|NCT01713946|364184234|FG002|Overall Study|Withdrawal by Subject|8|||
105596506|NCT01713946|364184232|FG000|Overall Study|Lack of Efficacy|8|||
105596507|NCT01713946|364184233|FG001|Overall Study|Lack of Efficacy|8|||
105596508|NCT01713946|364184234|FG002|Overall Study|Lack of Efficacy|14|||
105596509|NCT01713946|364184232|FG000|Overall Study|Protocol Violation|2|||
105596510|NCT01713946|364184233|FG001|Overall Study|Protocol Violation|4|||
105596511|NCT01713946|364184234|FG002|Overall Study|Protocol Violation|1|||
105596512|NCT01713946|364184232|FG000|Overall Study|Lost to Follow-up|0|||
105596513|NCT01713946|364184233|FG001|Overall Study|Lost to Follow-up|0|||
105596514|NCT01713946|364184234|FG002|Overall Study|Lost to Follow-up|1|||
105596515|NCT01713946|364184232|FG000|Overall Study|Administrative problems|1|||
105596516|NCT01713946|364184233|FG001|Overall Study|Administrative problems|0|||
105596517|NCT01713946|364184234|FG002|Overall Study|Administrative problems|0|||
105596518|NCT01713946|364184232|FG000|Overall Study|Did not continue in Ext|0|||
105596519|NCT01713946|364184233|FG001|Overall Study|Did not continue in Ext|3|||
105596520|NCT01713946|364184234|FG002|Overall Study|Did not continue in Ext|0|||
105596521|NCT01713946|364184232|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
105596522|NCT01713946|364184233|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
105596523|NCT01713946|364184234|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
105596524|NCT01713946|364184232|FG000|Overall Study|Patients never switched to everolimus|0|||
105596525|NCT01713946|364184233|FG001|Overall Study|Patients never switched to everolimus|0|||
105596526|NCT01713946|364184234|FG002|Overall Study|Patients never switched to everolimus|5|||
105596527|NCT02299336|364184235|FG000|Overall Study|Withdrawal by Subject|11|||
105596528|NCT02299336|364184235|FG000|Overall Study|Adverse Event|1|||
105596529|NCT02299336|364184235|FG000|Overall Study|Death|1|||
105596530|NCT02299336|364184235|FG000|Overall Study|Lost to Follow-up|1|||
105596531|NCT00482729|364186034|FG000|Overall Study|Adverse Event|29|||
105596532|NCT00482729|364186035|FG001|Overall Study|Adverse Event|33|||
105596533|NCT00482729|364186034|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
105596534|NCT00482729|364186035|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
105596535|NCT00482729|364186034|FG000|Overall Study|Hyperglycemia Criteria|7|||
105596536|NCT00482729|364186035|FG001|Overall Study|Hyperglycemia Criteria|5|||
105596537|NCT00482729|364186034|FG000|Overall Study|Lack of Efficacy|4|||
105596538|NCT00482729|364186035|FG001|Overall Study|Lack of Efficacy|16|||
105596539|NCT00482729|364186034|FG000|Overall Study|Lost to Follow-up|86|||
105596540|NCT00482729|364186035|FG001|Overall Study|Lost to Follow-up|66|||
105596541|NCT00482729|364186034|FG000|Overall Study|Physician Decision|10|||
105596542|NCT00482729|364186035|FG001|Overall Study|Physician Decision|7|||
105596543|NCT00482729|364186034|FG000|Overall Study|Pregnancy|4|||
105596544|NCT00482729|364186035|FG001|Overall Study|Pregnancy|2|||
105596545|NCT00482729|364186034|FG000|Overall Study|Protocol Violation|10|||
105596546|NCT00482729|364186035|FG001|Overall Study|Protocol Violation|18|||
105596547|NCT00482729|364186034|FG000|Overall Study|Withdrawal by Subject|67|||
105596548|NCT00482729|364186035|FG001|Overall Study|Withdrawal by Subject|69|||
105596549|NCT01062126|364186039|FG000|Overall Study|Death|209|||
105596550|NCT01062126|364186039|FG000|Overall Study|All Withdrawals|324|||
105596551|NCT00661778|364186049|FG000|Overall Study|Disease Progression|23|||
105596552|NCT00661778|364186049|FG000|Overall Study|Adverse Event|18|||
105596553|NCT00661778|364186049|FG000|Overall Study|Reason not Specified|6|||
105596554|NCT00661778|364186049|FG000|Overall Study|Protocol Violation|2|||
105596555|NCT00661778|364186049|FG000|Overall Study|Withdrawal of Consent|1|||
105596556|NCT00628862|364186050|FG000|Overall Study|Adverse Event|6|||
105596557|NCT00628862|364186051|FG001|Overall Study|Adverse Event|8|||
105596558|NCT00628862|364186052|FG002|Overall Study|Adverse Event|10|||
105596559|NCT00628862|364186050|FG000|Overall Study|Withdrawal by Subject|4|||
105596560|NCT00628862|364186051|FG001|Overall Study|Withdrawal by Subject|6|||
105596561|NCT00628862|364186052|FG002|Overall Study|Withdrawal by Subject|11|||
105596562|NCT00628862|364186050|FG000|Overall Study|Lost to Follow-up|0|||
105596563|NCT00628862|364186051|FG001|Overall Study|Lost to Follow-up|2|||
105596564|NCT00628862|364186052|FG002|Overall Study|Lost to Follow-up|1|||
105596565|NCT00628862|364186050|FG000|Overall Study|Protocol Violation|1|||
105596566|NCT00628862|364186051|FG001|Overall Study|Protocol Violation|0|||
105596567|NCT00628862|364186052|FG002|Overall Study|Protocol Violation|0|||
105596568|NCT00628862|364186050|FG000|Overall Study|COPD Exacerbation|0|||
105596569|NCT00628862|364186051|FG001|Overall Study|COPD Exacerbation|1|||
105596570|NCT00628862|364186052|FG002|Overall Study|COPD Exacerbation|0|||
105596571|NCT02814643|364186053|FG000|Overall Study|Lost to Follow-up|0|||
105596572|NCT02814643|364186054|FG001|Overall Study|Lost to Follow-up|1|||
105596573|NCT02814643|364186053|FG000|Overall Study|Withdrawal by Subject|1|||
105596574|NCT02814643|364186054|FG001|Overall Study|Withdrawal by Subject|2|||
105596575|NCT02631148|364186057|FG000|Overall Study|8 were ineligible|8|||
105596576|NCT02631148|364186058|FG001|Overall Study|8 were ineligible|0|||
105596577|NCT02631148|364186057|FG000|Overall Study|Withdrawal by Subject|1|||
105596578|NCT02631148|364186058|FG001|Overall Study|Withdrawal by Subject|0|||
105596579|NCT02631148|364186057|FG000|Overall Study|PAH not available to study participant|1|||
105596580|NCT02631148|364186058|FG001|Overall Study|PAH not available to study participant|0|||
105596581|NCT00726999|364186063|FG000|Overall Study|Physician Decision|0|||
105596582|NCT00726999|364186064|FG001|Overall Study|Physician Decision|1|||
105596583|NCT00726999|364186063|FG000|Overall Study|Withdrawal by Subject|2|||
105596584|NCT00726999|364186064|FG001|Overall Study|Withdrawal by Subject|0|||
105596585|NCT00726999|364186063|FG000|Overall Study|Protocol Violation|1|||
105596586|NCT00726999|364186064|FG001|Overall Study|Protocol Violation|0|||
105596587|NCT00807144|364186067|FG000|Overall Study|Lost to Follow-up|0|||
105596588|NCT00807144|364186068|FG001|Overall Study|Lost to Follow-up|1|||
105596589|NCT01337635|364186069|FG000|Overall Study|Lost to Follow-up|0|||
105596590|NCT01337635|364186070|FG001|Overall Study|Lost to Follow-up|1|||
105596591|NCT04956575|364186071|FG000|Overall Study|Death|1|||
105596592|NCT04956575|364186072|FG001|Overall Study|Death|0|||
105596593|NCT04956575|364186073|FG002|Overall Study|Death|0|||
105596594|NCT04956575|364186074|FG003|Overall Study|Death|0|||
105596595|NCT04956575|364186075|FG004|Overall Study|Death|0|||
105596596|NCT04956575|364186076|FG005|Overall Study|Death|0|||
105596597|NCT04956575|364186077|FG006|Overall Study|Death|0|||
105596598|NCT04956575|364186078|FG007|Overall Study|Death|1|||
105596599|NCT04956575|364186079|FG008|Overall Study|Death|0|||
105596600|NCT04956575|364186080|FG009|Overall Study|Death|1|||
105596601|NCT04956575|364186081|FG010|Overall Study|Death|0|||
105596602|NCT04956575|364186082|FG011|Overall Study|Death|0|||
105596603|NCT04956575|364186071|FG000|Overall Study|Lost to Follow-up|3|||
105596604|NCT04956575|364186072|FG001|Overall Study|Lost to Follow-up|4|||
105596605|NCT04956575|364186073|FG002|Overall Study|Lost to Follow-up|2|||
105596606|NCT04956575|364186074|FG003|Overall Study|Lost to Follow-up|3|||
105596607|NCT04956575|364186075|FG004|Overall Study|Lost to Follow-up|1|||
105596608|NCT04956575|364186076|FG005|Overall Study|Lost to Follow-up|10|||
105596609|NCT04956575|364186077|FG006|Overall Study|Lost to Follow-up|11|||
105596610|NCT04956575|364186078|FG007|Overall Study|Lost to Follow-up|7|||
105596611|NCT04956575|364186079|FG008|Overall Study|Lost to Follow-up|4|||
105596612|NCT04956575|364186080|FG009|Overall Study|Lost to Follow-up|2|||
105596613|NCT04956575|364186081|FG010|Overall Study|Lost to Follow-up|3|||
105596614|NCT04956575|364186082|FG011|Overall Study|Lost to Follow-up|8|||
105596615|NCT04956575|364186071|FG000|Overall Study|Withdrawal by Subject|1|||
105596616|NCT04956575|364186072|FG001|Overall Study|Withdrawal by Subject|2|||
105596617|NCT04956575|364186073|FG002|Overall Study|Withdrawal by Subject|1|||
105596618|NCT04956575|364186074|FG003|Overall Study|Withdrawal by Subject|4|||
105596619|NCT04956575|364186075|FG004|Overall Study|Withdrawal by Subject|2|||
105596620|NCT04956575|364186076|FG005|Overall Study|Withdrawal by Subject|8|||
105596621|NCT04956575|364186077|FG006|Overall Study|Withdrawal by Subject|5|||
105596622|NCT04956575|364186078|FG007|Overall Study|Withdrawal by Subject|1|||
105596623|NCT04956575|364186079|FG008|Overall Study|Withdrawal by Subject|1|||
105596624|NCT04956575|364186080|FG009|Overall Study|Withdrawal by Subject|0|||
105596625|NCT04956575|364186081|FG010|Overall Study|Withdrawal by Subject|3|||
105596626|NCT04956575|364186082|FG011|Overall Study|Withdrawal by Subject|1|||
105596627|NCT00854906|364186083|FG000|Overall Study|One person had no ocular history|1|||
105596628|NCT05136443|364186085|FG000|Overall Study|Lost to Follow-up|2|||
105596629|NCT05136443|364186085|FG000|Overall Study|Adverse Event|2|||
105596630|NCT00507689|364186096|FG000|Pre-Randomization Period|Adverse Event|1|||
105596631|NCT00507689|364186097|FG001|Pre-Randomization Period|Adverse Event|0|||
105596632|NCT00507689|364186096|FG000|Pre-Randomization Period|Physician Decision|1|||
105596633|NCT00507689|364186097|FG001|Pre-Randomization Period|Physician Decision|0|||
105596634|NCT00507689|364186096|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
105596635|NCT00507689|364186097|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
105596636|NCT00507689|364186096|FG000|Randomized Period|Adverse Event|1|||
105596637|NCT00507689|364186097|FG001|Randomized Period|Adverse Event|1|||
105596638|NCT00507689|364186096|FG000|Randomized Period|Withdrawal by Subject|0|||
105596639|NCT00507689|364186097|FG001|Randomized Period|Withdrawal by Subject|1|||
105596640|NCT01241292|364186098|FG000|Overall Study|Administrative Reason by Sponsor|1|||
105596641|NCT01241292|364186099|FG001|Overall Study|Administrative Reason by Sponsor|0|||
105596642|NCT01241292|364186098|FG000|Overall Study|Disease Progression|2|||
105596643|NCT01241292|364186099|FG001|Overall Study|Disease Progression|0|||
105596644|NCT01241292|364186098|FG000|Overall Study|Study Drug Toxicity|0|||
105596645|NCT01241292|364186099|FG001|Overall Study|Study Drug Toxicity|1|||
105596646|NCT01241292|364186098|FG000|Overall Study|Participant Discontinued Treatment|0|||
105596647|NCT01241292|364186099|FG001|Overall Study|Participant Discontinued Treatment|2|||
105596648|NCT03034915|364186100|FG000|Overall Study|Adverse Event|29|||
105596649|NCT03034915|364186101|FG001|Overall Study|Adverse Event|32|||
105596650|NCT03034915|364186102|FG002|Overall Study|Adverse Event|22|||
105596651|NCT03034915|364186100|FG000|Overall Study|Lost to Follow-up|5|||
105596652|NCT03034915|364186101|FG001|Overall Study|Lost to Follow-up|13|||
105596653|NCT03034915|364186102|FG002|Overall Study|Lost to Follow-up|3|||
105596654|NCT03034915|364186100|FG000|Overall Study|Withdrawal by Subject|29|||
105596655|NCT03034915|364186101|FG001|Overall Study|Withdrawal by Subject|46|||
105596656|NCT03034915|364186102|FG002|Overall Study|Withdrawal by Subject|41|||
105596657|NCT03034915|364186100|FG000|Overall Study|Protocol Deviation|2|||
105596658|NCT03034915|364186101|FG001|Overall Study|Protocol Deviation|14|||
105596659|NCT03034915|364186102|FG002|Overall Study|Protocol Deviation|7|||
105596660|NCT03034915|364186100|FG000|Overall Study|Lack of Efficacy|8|||
105596661|NCT03034915|364186101|FG001|Overall Study|Lack of Efficacy|16|||
105596662|NCT03034915|364186102|FG002|Overall Study|Lack of Efficacy|18|||
105596663|NCT03034915|364186100|FG000|Overall Study|Site closed|2|||
105596664|NCT03034915|364186101|FG001|Overall Study|Site closed|2|||
105596665|NCT03034915|364186102|FG002|Overall Study|Site closed|4|||
105596666|NCT03034915|364186100|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
105596667|NCT03034915|364186101|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
105596668|NCT03034915|364186102|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
105596669|NCT03034915|364186100|FG000|Overall Study|Physician Decision|1|||
105596670|NCT03034915|364186101|FG001|Overall Study|Physician Decision|5|||
105596671|NCT03034915|364186102|FG002|Overall Study|Physician Decision|2|||
105596672|NCT03861767|364186103|FG000|Overall Study|Withdrawal by Subject|2|||
105596673|NCT03861767|364186104|FG001|Overall Study|Withdrawal by Subject|1|||
105596674|NCT03861767|364186105|FG002|Overall Study|Withdrawal by Subject|0|||
105596675|NCT03861767|364186106|FG003|Overall Study|Withdrawal by Subject|5|||
105596676|NCT03861767|364186107|FG004|Overall Study|Withdrawal by Subject|2|||
105596677|NCT03861767|364186108|FG005|Overall Study|Withdrawal by Subject|1|||
105596678|NCT03861767|364186109|FG006|Overall Study|Withdrawal by Subject|3|||
105596679|NCT03861767|364186110|FG007|Overall Study|Withdrawal by Subject|1|||
105596680|NCT03861767|364186111|FG008|Overall Study|Withdrawal by Subject|0|||
105596681|NCT03861767|364186112|FG009|Overall Study|Withdrawal by Subject|5|||
105596682|NCT00346333|364186113|FG000|Overall Study|Death|1|||
105596683|NCT00346333|364186114|FG001|Overall Study|Death|0|||
105596684|NCT00346333|364186113|FG000|Overall Study|unwilling or unable to continue|4|||
105596685|NCT00346333|364186114|FG001|Overall Study|unwilling or unable to continue|8|||
105596686|NCT00424762|364186115|FG000|Overall Study|Withdrawal by Subject|18|||
105596687|NCT00424762|364186116|FG001|Overall Study|Withdrawal by Subject|19|||
105596688|NCT00424762|364186115|FG000|Overall Study|Lost to Follow-up|2|||
105596689|NCT00424762|364186116|FG001|Overall Study|Lost to Follow-up|3|||
105596690|NCT02506257|364186117|FG000|Overall Study|Adverse Event|0|||
105596691|NCT02506257|364186118|FG001|Overall Study|Adverse Event|2|||
105596692|NCT02506257|364186119|FG002|Overall Study|Adverse Event|3|||
105596693|NCT02506257|364186120|FG003|Overall Study|Adverse Event|0|||
105596694|NCT02506257|364186117|FG000|Overall Study|Protocol Violation|0|||
105596695|NCT02506257|364186118|FG001|Overall Study|Protocol Violation|0|||
105596696|NCT02506257|364186119|FG002|Overall Study|Protocol Violation|1|||
105596697|NCT02506257|364186120|FG003|Overall Study|Protocol Violation|0|||
105596698|NCT01157182|364186124|FG000|Washout of 28 Days|Adverse Event|2|||
105596699|NCT01157182|364186125|FG001|Washout of 28 Days|Adverse Event|0|||
105596700|NCT00880048|364186131|FG000|Overall Study|Adverse Event|2|||
105596701|NCT00880048|364186132|FG001|Overall Study|Adverse Event|3|||
105596702|NCT00880048|364186133|FG002|Overall Study|Adverse Event|5|||
105596703|NCT00880048|364186131|FG000|Overall Study|Lack of Efficacy|1|||
105596704|NCT00880048|364186132|FG001|Overall Study|Lack of Efficacy|2|||
105596705|NCT00880048|364186133|FG002|Overall Study|Lack of Efficacy|2|||
105596706|NCT00880048|364186131|FG000|Overall Study|Protocol Violation|4|||
105596707|NCT00880048|364186132|FG001|Overall Study|Protocol Violation|6|||
105596708|NCT00880048|364186133|FG002|Overall Study|Protocol Violation|5|||
105596709|NCT00880048|364186131|FG000|Overall Study|Lost to Follow-up|6|||
105596710|NCT00880048|364186132|FG001|Overall Study|Lost to Follow-up|6|||
105596711|NCT00880048|364186133|FG002|Overall Study|Lost to Follow-up|5|||
105596712|NCT00880048|364186131|FG000|Overall Study|Physician Decision|1|||
105596713|NCT00880048|364186132|FG001|Overall Study|Physician Decision|1|||
105596714|NCT00880048|364186133|FG002|Overall Study|Physician Decision|7|||
105596715|NCT00880048|364186131|FG000|Overall Study|Withdrawal by Subject|5|||
105596716|NCT00880048|364186132|FG001|Overall Study|Withdrawal by Subject|8|||
105596717|NCT00880048|364186133|FG002|Overall Study|Withdrawal by Subject|5|||
105596718|NCT00880048|364186131|FG000|Overall Study|Study closed/terminated|9|||
105596719|NCT00880048|364186132|FG001|Overall Study|Study closed/terminated|7|||
105596720|NCT00880048|364186133|FG002|Overall Study|Study closed/terminated|6|||
105596721|NCT05001945|364186136|FG000|Overall Study|Adverse Event|0|||
105596722|NCT05001945|364186137|FG001|Overall Study|Adverse Event|0|||
105596723|NCT05001945|364186138|FG002|Overall Study|Adverse Event|0|||
105596724|NCT05001945|364186139|FG003|Overall Study|Adverse Event|1|||
105596725|NCT05001945|364186140|FG004|Overall Study|Adverse Event|0|||
105596726|NCT05001945|364186141|FG005|Overall Study|Adverse Event|0|||
105596727|NCT05001945|364186142|FG006|Overall Study|Adverse Event|0|||
105596728|NCT05001945|364186143|FG007|Overall Study|Adverse Event|0|||
105596729|NCT05001945|364186136|FG000|Overall Study|Lost to Follow-up|0|||
105596730|NCT05001945|364186137|FG001|Overall Study|Lost to Follow-up|1|||
105596731|NCT05001945|364186138|FG002|Overall Study|Lost to Follow-up|1|||
105596732|NCT05001945|364186139|FG003|Overall Study|Lost to Follow-up|2|||
105596733|NCT05001945|364186140|FG004|Overall Study|Lost to Follow-up|0|||
105596734|NCT05001945|364186141|FG005|Overall Study|Lost to Follow-up|1|||
105596735|NCT05001945|364186142|FG006|Overall Study|Lost to Follow-up|0|||
105596736|NCT05001945|364186143|FG007|Overall Study|Lost to Follow-up|0|||
105596737|NCT05001945|364186136|FG000|Overall Study|Protocol Violation|1|||
105596738|NCT05001945|364186137|FG001|Overall Study|Protocol Violation|0|||
105596739|NCT05001945|364186138|FG002|Overall Study|Protocol Violation|1|||
105596740|NCT05001945|364186139|FG003|Overall Study|Protocol Violation|1|||
105596741|NCT05001945|364186140|FG004|Overall Study|Protocol Violation|0|||
105596742|NCT05001945|364186141|FG005|Overall Study|Protocol Violation|1|||
105596743|NCT05001945|364186142|FG006|Overall Study|Protocol Violation|0|||
105596744|NCT05001945|364186143|FG007|Overall Study|Protocol Violation|0|||
105596745|NCT05001945|364186136|FG000|Overall Study|Withdrawal by Subject|0|||
105596746|NCT05001945|364186137|FG001|Overall Study|Withdrawal by Subject|0|||
105596747|NCT05001945|364186138|FG002|Overall Study|Withdrawal by Subject|0|||
105596748|NCT05001945|364186139|FG003|Overall Study|Withdrawal by Subject|1|||
105596749|NCT05001945|364186140|FG004|Overall Study|Withdrawal by Subject|1|||
105596750|NCT05001945|364186141|FG005|Overall Study|Withdrawal by Subject|1|||
105596751|NCT05001945|364186142|FG006|Overall Study|Withdrawal by Subject|0|||
105596752|NCT05001945|364186143|FG007|Overall Study|Withdrawal by Subject|1|||
105596753|NCT05001945|364186136|FG000|Overall Study|Not specified by Investigator|0|||
105596754|NCT05001945|364186137|FG001|Overall Study|Not specified by Investigator|3|||
105596755|NCT05001945|364186138|FG002|Overall Study|Not specified by Investigator|0|||
105596756|NCT05001945|364186139|FG003|Overall Study|Not specified by Investigator|0|||
105596757|NCT05001945|364186140|FG004|Overall Study|Not specified by Investigator|1|||
105596758|NCT05001945|364186141|FG005|Overall Study|Not specified by Investigator|0|||
105596759|NCT05001945|364186142|FG006|Overall Study|Not specified by Investigator|0|||
105596760|NCT05001945|364186143|FG007|Overall Study|Not specified by Investigator|0|||
105596761|NCT05382104|364186146|FG000|Period 2 (2 Days)|Adverse Event|0|||
105596762|NCT05382104|364186147|FG001|Period 2 (2 Days)|Adverse Event|1|||
105596763|NCT05382104|364186148|FG002|Period 2 (2 Days)|Adverse Event|0|||
105596764|NCT05382104|364186149|FG003|Period 2 (2 Days)|Adverse Event|0|||
105596765|NCT05382104|364186150|FG004|Period 2 (2 Days)|Adverse Event|0|||
105596766|NCT05382104|364186151|FG005|Period 2 (2 Days)|Adverse Event|0|||
105596767|NCT02547922|364186154|FG000|Overall Study|Withdrawal by Subject|9|||
105596768|NCT02547922|364186155|FG001|Overall Study|Withdrawal by Subject|6|||
105596769|NCT02547922|364186156|FG002|Overall Study|Withdrawal by Subject|10|||
105596770|NCT02547922|364186154|FG000|Overall Study|Adverse Event|3|||
105596771|NCT02547922|364186155|FG001|Overall Study|Adverse Event|1|||
105596772|NCT02547922|364186156|FG002|Overall Study|Adverse Event|2|||
105596773|NCT02547922|364186154|FG000|Overall Study|Lost to Follow-up|1|||
105596774|NCT02547922|364186155|FG001|Overall Study|Lost to Follow-up|0|||
105596775|NCT02547922|364186156|FG002|Overall Study|Lost to Follow-up|0|||
105596776|NCT02547922|364186154|FG000|Overall Study|Lack of Efficacy|5|||
105596777|NCT02547922|364186155|FG001|Overall Study|Lack of Efficacy|7|||
105596778|NCT02547922|364186156|FG002|Overall Study|Lack of Efficacy|4|||
105596779|NCT02547922|364186154|FG000|Overall Study|Death|1|||
105596780|NCT02547922|364186155|FG001|Overall Study|Death|0|||
105596781|NCT02547922|364186156|FG002|Overall Study|Death|0|||
105596782|NCT02547922|364186154|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
105596783|NCT02547922|364186155|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
105596784|NCT02547922|364186156|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
105596785|NCT02547922|364186154|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
105596786|NCT02547922|364186155|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
105596787|NCT02547922|364186156|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
105596788|NCT02547922|364186154|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
105596789|NCT02547922|364186155|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
105596790|NCT02547922|364186156|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
105596791|NCT02547922|364186154|FG000|Overall Study|Physician Decision|2|||
105596792|NCT02547922|364186155|FG001|Overall Study|Physician Decision|1|||
105596793|NCT02547922|364186156|FG002|Overall Study|Physician Decision|2|||
105596794|NCT02547922|364186154|FG000|Overall Study|Patients did not receive IP|1|||
105596795|NCT02547922|364186155|FG001|Overall Study|Patients did not receive IP|1|||
105596796|NCT02547922|364186156|FG002|Overall Study|Patients did not receive IP|0|||
105596797|NCT03194958|364186157|FG000|Overall Study|Death|0|||
105596798|NCT03194958|364186158|FG001|Overall Study|Death|1|||
105596799|NCT03194958|364186159|FG002|Overall Study|Death|1|||
105596800|NCT03194958|364186160|FG003|Overall Study|Death|1|||
105596801|NCT03194958|364186157|FG000|Overall Study|Withdrawal by Subject|24|||
105596802|NCT03194958|364186158|FG001|Overall Study|Withdrawal by Subject|27|||
105596803|NCT03194958|364186159|FG002|Overall Study|Withdrawal by Subject|7|||
105596804|NCT03194958|364186160|FG003|Overall Study|Withdrawal by Subject|22|||
105596805|NCT03194958|364186157|FG000|Overall Study|Lost to Follow-up|168|||
105596806|NCT03194958|364186158|FG001|Overall Study|Lost to Follow-up|196|||
105596807|NCT03194958|364186159|FG002|Overall Study|Lost to Follow-up|174|||
105596808|NCT03194958|364186160|FG003|Overall Study|Lost to Follow-up|186|||
105596809|NCT02807493|364186162|FG000|Overall Study|Adverse Event|5|||
105596810|NCT02807493|364186163|FG001|Overall Study|Adverse Event|2|||
105596811|NCT02807493|364186162|FG000|Overall Study|Lost to Follow-up|6|||
105596812|NCT02807493|364186163|FG001|Overall Study|Lost to Follow-up|0|||
105596813|NCT02807493|364186162|FG000|Overall Study|Physician Decision|4|||
105596814|NCT02807493|364186163|FG001|Overall Study|Physician Decision|1|||
105596815|NCT02807493|364186162|FG000|Overall Study|Protocol Violation|7|||
105596816|NCT02807493|364186163|FG001|Overall Study|Protocol Violation|0|||
105596817|NCT02807493|364186162|FG000|Overall Study|Withdrawal by Subject|17|||
105596818|NCT02807493|364186163|FG001|Overall Study|Withdrawal by Subject|10|||
105596819|NCT02807493|364186162|FG000|Overall Study|Other withdrawal|17|||
105596820|NCT02807493|364186163|FG001|Overall Study|Other withdrawal|0|||
105596821|NCT02807493|364186162|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
105596822|NCT02807493|364186163|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
105596823|NCT00102063|364186164|FG000|Overall Study|Lack of Efficacy|5|||
105596824|NCT00102063|364186165|FG001|Overall Study|Lack of Efficacy|1|||
105596825|NCT00102063|364186166|FG002|Overall Study|Lack of Efficacy|1|||
105596826|NCT00102063|364186164|FG000|Overall Study|Adverse Event|7|||
105596827|NCT00102063|364186165|FG001|Overall Study|Adverse Event|4|||
105596828|NCT00102063|364186166|FG002|Overall Study|Adverse Event|2|||
105596829|NCT00102063|364186164|FG000|Overall Study|Withdrawal by Subject|4|||
105596830|NCT00102063|364186165|FG001|Overall Study|Withdrawal by Subject|12|||
105596831|NCT00102063|364186166|FG002|Overall Study|Withdrawal by Subject|5|||
105596832|NCT00102063|364186164|FG000|Overall Study|Lost to Follow-up|0|||
105596833|NCT00102063|364186165|FG001|Overall Study|Lost to Follow-up|0|||
105596834|NCT00102063|364186166|FG002|Overall Study|Lost to Follow-up|1|||
105596835|NCT00102063|364186164|FG000|Overall Study|Protocol Violation|0|||
105596836|NCT00102063|364186165|FG001|Overall Study|Protocol Violation|1|||
105596837|NCT00102063|364186166|FG002|Overall Study|Protocol Violation|1|||
105596838|NCT01179334|364186167|FG000|Treatment Period|Adverse Event|1|||
105596839|NCT01179334|364186168|FG001|Treatment Period|Adverse Event|0|||
105596840|NCT01179334|364186167|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
105596841|NCT01179334|364186168|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
105596842|NCT01179334|364186167|FG000|Long-term Extension (LTE) Period|Death|3|||
105596843|NCT01179334|364186168|FG001|Long-term Extension (LTE) Period|Death|0|||
105596844|NCT01179334|364186167|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
105596845|NCT01179334|364186168|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
105596846|NCT05190419|364186169|FG000|Overall Study|Lack of Efficacy|8|||
105596847|NCT05190419|364186170|FG001|Overall Study|Lack of Efficacy|0|||
105596848|NCT05190419|364186171|FG002|Overall Study|Lack of Efficacy|1|||
105596849|NCT05190419|364186172|FG003|Overall Study|Lack of Efficacy|0|||
105596850|NCT05190419|364186169|FG000|Overall Study|Withdrawal by Subject|7|||
105596851|NCT05190419|364186170|FG001|Overall Study|Withdrawal by Subject|1|||
105596852|NCT05190419|364186171|FG002|Overall Study|Withdrawal by Subject|2|||
105596853|NCT05190419|364186172|FG003|Overall Study|Withdrawal by Subject|2|||
105596854|NCT05190419|364186169|FG000|Overall Study|Adverse Event|2|||
105596855|NCT05190419|364186170|FG001|Overall Study|Adverse Event|10|||
105596856|NCT05190419|364186171|FG002|Overall Study|Adverse Event|11|||
105596857|NCT05190419|364186172|FG003|Overall Study|Adverse Event|21|||
105596858|NCT05190419|364186169|FG000|Overall Study|Lost to Follow-up|1|||
105596859|NCT05190419|364186170|FG001|Overall Study|Lost to Follow-up|2|||
105596860|NCT05190419|364186171|FG002|Overall Study|Lost to Follow-up|3|||
105596861|NCT05190419|364186172|FG003|Overall Study|Lost to Follow-up|1|||
105596862|NCT05190419|364186169|FG000|Overall Study|Other|1|||
105596863|NCT05190419|364186170|FG001|Overall Study|Other|1|||
105596864|NCT05190419|364186171|FG002|Overall Study|Other|0|||
105596865|NCT05190419|364186172|FG003|Overall Study|Other|3|||
105596866|NCT01909778|364186173|FG000|Overall Study|failed screening|1|||
105596867|NCT00539292|364186176|FG000|Overall Study|Physician Decision|1|||
105596868|NCT00539292|364186177|FG001|Overall Study|Physician Decision|0|||
105596869|NCT02020616|364186178|FG000|Overall Study|Adverse Event|0|||
105596870|NCT02020616|364186179|FG001|Overall Study|Adverse Event|0|||
105596871|NCT02020616|364186180|FG002|Overall Study|Adverse Event|0|||
105596872|NCT02020616|364186181|FG003|Overall Study|Adverse Event|0|||
105596873|NCT02020616|364186182|FG004|Overall Study|Adverse Event|0|||
105596874|NCT02020616|364186183|FG005|Overall Study|Adverse Event|1|||
105596875|NCT02020616|364186184|FG006|Overall Study|Adverse Event|1|||
105596876|NCT02020616|364186178|FG000|Overall Study|Physician Decision|0|||
105596877|NCT02020616|364186179|FG001|Overall Study|Physician Decision|0|||
105596878|NCT02020616|364186180|FG002|Overall Study|Physician Decision|0|||
105596879|NCT02020616|364186181|FG003|Overall Study|Physician Decision|0|||
105596880|NCT02020616|364186182|FG004|Overall Study|Physician Decision|0|||
105596881|NCT02020616|364186183|FG005|Overall Study|Physician Decision|1|||
105596882|NCT02020616|364186184|FG006|Overall Study|Physician Decision|2|||
105596883|NCT02020616|364186178|FG000|Overall Study|Withdrawal by Subject|0|||
105596884|NCT02020616|364186179|FG001|Overall Study|Withdrawal by Subject|0|||
105596885|NCT02020616|364186180|FG002|Overall Study|Withdrawal by Subject|1|||
105596886|NCT02020616|364186181|FG003|Overall Study|Withdrawal by Subject|0|||
105596887|NCT02020616|364186182|FG004|Overall Study|Withdrawal by Subject|0|||
105596888|NCT02020616|364186183|FG005|Overall Study|Withdrawal by Subject|1|||
105596889|NCT02020616|364186184|FG006|Overall Study|Withdrawal by Subject|1|||
105596890|NCT02020616|364186178|FG000|Overall Study|Lost to Follow-up|0|||
105596891|NCT02020616|364186179|FG001|Overall Study|Lost to Follow-up|1|||
105596892|NCT02020616|364186180|FG002|Overall Study|Lost to Follow-up|0|||
105596893|NCT02020616|364186181|FG003|Overall Study|Lost to Follow-up|1|||
105596894|NCT02020616|364186182|FG004|Overall Study|Lost to Follow-up|1|||
105596895|NCT02020616|364186183|FG005|Overall Study|Lost to Follow-up|1|||
105596896|NCT02020616|364186184|FG006|Overall Study|Lost to Follow-up|0|||
105596897|NCT02020616|364186178|FG000|Overall Study|Early Termination Criteria Met|0|||
105596898|NCT02020616|364186179|FG001|Overall Study|Early Termination Criteria Met|0|||
105596899|NCT02020616|364186180|FG002|Overall Study|Early Termination Criteria Met|1|||
105596900|NCT02020616|364186181|FG003|Overall Study|Early Termination Criteria Met|0|||
105596901|NCT02020616|364186182|FG004|Overall Study|Early Termination Criteria Met|0|||
105596902|NCT02020616|364186183|FG005|Overall Study|Early Termination Criteria Met|1|||
105596903|NCT02020616|364186184|FG006|Overall Study|Early Termination Criteria Met|0|||
105596904|NCT02020616|364186178|FG000|Overall Study|Randomized in Error|0|||
105596905|NCT02020616|364186179|FG001|Overall Study|Randomized in Error|0|||
105596906|NCT02020616|364186180|FG002|Overall Study|Randomized in Error|0|||
105596907|NCT02020616|364186181|FG003|Overall Study|Randomized in Error|1|||
105596908|NCT02020616|364186182|FG004|Overall Study|Randomized in Error|0|||
105596909|NCT02020616|364186183|FG005|Overall Study|Randomized in Error|0|||
105596910|NCT02020616|364186184|FG006|Overall Study|Randomized in Error|0|||
105596911|NCT02020616|364186178|FG000|Overall Study|Lack of Efficacy|0|||
105596912|NCT02020616|364186179|FG001|Overall Study|Lack of Efficacy|0|||
105596913|NCT02020616|364186180|FG002|Overall Study|Lack of Efficacy|0|||
105596914|NCT02020616|364186181|FG003|Overall Study|Lack of Efficacy|0|||
105596915|NCT02020616|364186182|FG004|Overall Study|Lack of Efficacy|1|||
105596916|NCT02020616|364186183|FG005|Overall Study|Lack of Efficacy|0|||
105596917|NCT02020616|364186184|FG006|Overall Study|Lack of Efficacy|0|||
105596918|NCT02621424|364186187|FG000|Overall Study|Withdrawal by Subject|1|||
105596919|NCT02621424|364186188|FG001|Overall Study|Withdrawal by Subject|2|||
105596920|NCT00732381|364186197|FG000|Overall Study|Adverse Event|1|||
105596921|NCT00732381|364186198|FG001|Overall Study|Adverse Event|0|||
105596922|NCT00732381|364186197|FG000|Overall Study|Treatment Failure|1|||
105596923|NCT00732381|364186198|FG001|Overall Study|Treatment Failure|1|||
105596924|NCT00457691|364186200|FG000|Overall Study|Adverse Event|4|||
105596925|NCT00457691|364186201|FG001|Overall Study|Adverse Event|1|||
105596926|NCT00457691|364186200|FG000|Overall Study|Death|163|||
105596927|NCT00457691|364186201|FG001|Overall Study|Death|148|||
105596928|NCT00457691|364186200|FG000|Overall Study|Protocol Violation|1|||
105596929|NCT00457691|364186201|FG001|Overall Study|Protocol Violation|3|||
105596930|NCT00457691|364186200|FG000|Overall Study|Lost to Follow-up|23|||
105596931|NCT00457691|364186201|FG001|Overall Study|Lost to Follow-up|14|||
105596932|NCT00457691|364186200|FG000|Overall Study|Study terminated by Sponsor|1|||
105596933|NCT00457691|364186201|FG001|Overall Study|Study terminated by Sponsor|1|||
105596934|NCT00457691|364186200|FG000|Overall Study|Subject refused (reason other than AE)|14|||
105596935|NCT00457691|364186201|FG001|Overall Study|Subject refused (reason other than AE)|19|||
105596936|NCT00457691|364186200|FG000|Overall Study|Disease progression, study terminated|180|||
105596937|NCT00457691|364186201|FG001|Overall Study|Disease progression, study terminated|196|||
105596938|NCT00711958|364187409|FG000|Overall Study|Withdrawal by Subject|6|||
105596939|NCT00711958|364187410|FG001|Overall Study|Withdrawal by Subject|8|||
105596940|NCT00711958|364187409|FG000|Overall Study|Lack of Efficacy|3|||
105596941|NCT00711958|364187410|FG001|Overall Study|Lack of Efficacy|1|||
105596942|NCT00711958|364187409|FG000|Overall Study|Clinical deterioration|1|||
105596943|NCT00711958|364187410|FG001|Overall Study|Clinical deterioration|0|||
105596944|NCT00711958|364187409|FG000|Overall Study|Adverse Event|9|||
105596945|NCT00711958|364187410|FG001|Overall Study|Adverse Event|7|||
105596946|NCT00711958|364187409|FG000|Overall Study|Protocol Violation|1|||
105596947|NCT00711958|364187410|FG001|Overall Study|Protocol Violation|0|||
105596948|NCT00711958|364187409|FG000|Overall Study|Lost to Follow-up|2|||
105596949|NCT00711958|364187410|FG001|Overall Study|Lost to Follow-up|2|||
105596950|NCT00711958|364187409|FG000|Overall Study|Death|10|||
105596951|NCT00711958|364187410|FG001|Overall Study|Death|5|||
105596952|NCT00711958|364187409|FG000|Overall Study|Progression of disease|1|||
105596953|NCT00711958|364187410|FG001|Overall Study|Progression of disease|0|||
105596954|NCT02015546|364187411|FG000|Overall Study|Withdrawal by Subject|1|||
105596955|NCT02015546|364187412|FG001|Overall Study|Withdrawal by Subject|1|||
105596956|NCT02015546|364187413|FG002|Overall Study|Withdrawal by Subject|1|||
105596957|NCT02015546|364187411|FG000|Overall Study|Screem Failure|2|||
105596958|NCT02015546|364187412|FG001|Overall Study|Screem Failure|1|||
105596959|NCT02015546|364187413|FG002|Overall Study|Screem Failure|3|||
105596960|NCT02694978|364187414|FG000|Overall Study|Adverse Event|10|||
105596961|NCT02694978|364187415|FG001|Overall Study|Adverse Event|9|||
105596962|NCT02694978|364187414|FG000|Overall Study|Withdrawal by Subject|22|||
105596963|NCT02694978|364187415|FG001|Overall Study|Withdrawal by Subject|19|||
105596964|NCT02694978|364187414|FG000|Overall Study|Lost to Follow-up|14|||
105596965|NCT02694978|364187415|FG001|Overall Study|Lost to Follow-up|17|||
105596966|NCT02694978|364187414|FG000|Overall Study|Death|4|||
105596967|NCT02694978|364187415|FG001|Overall Study|Death|1|||
105596968|NCT02694978|364187414|FG000|Overall Study|Other-Decision of Participant|6|||
105596969|NCT02694978|364187415|FG001|Overall Study|Other-Decision of Participant|1|||
105596970|NCT02694978|364187414|FG000|Overall Study|Other-Investigator's decision|1|||
105596971|NCT02694978|364187415|FG001|Overall Study|Other-Investigator's decision|0|||
105596972|NCT02694978|364187414|FG000|Overall Study|Other-Unable to be reached|0|||
105596973|NCT02694978|364187415|FG001|Overall Study|Other-Unable to be reached|1|||
105596974|NCT02694978|364187414|FG000|Overall Study|Other-Protocol noncompliant|2|||
105596975|NCT02694978|364187415|FG001|Overall Study|Other-Protocol noncompliant|1|||
105596976|NCT02694978|364187414|FG000|Overall Study|Other-Personal reasons|3|||
105596977|NCT02694978|364187415|FG001|Overall Study|Other-Personal reasons|3|||
105596978|NCT02694978|364187414|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
105596979|NCT02694978|364187415|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
105596980|NCT01376089|364187416|FG000|Overall Study|Patient received no contrast media|3|||
105596981|NCT01376089|364187417|FG001|Overall Study|Patient received no contrast media|4|||
105596982|NCT02224924|364187418|FG000|Overall Study|Withdrawal by Subject|7|||
105596983|NCT02224924|364187419|FG001|Overall Study|Withdrawal by Subject|6|||
105596984|NCT02224924|364187418|FG000|Overall Study|Biopsy cancelled|20|||
105596985|NCT02224924|364187419|FG001|Overall Study|Biopsy cancelled|14|||
105596986|NCT02224924|364187418|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
105596987|NCT02224924|364187419|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
105596988|NCT02224924|364187418|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
105596989|NCT02224924|364187419|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
105596990|NCT03020745|364187420|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
105596991|NCT03020745|364187421|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
105596992|NCT03020745|364187422|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
105596993|NCT03020745|364187423|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
105596994|NCT03020745|364187424|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
105596995|NCT03020745|364187425|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
105596996|NCT03020745|364187426|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
105596997|NCT03020745|364187427|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
105596998|NCT03020745|364187428|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
105596999|NCT03020745|364187429|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
105597000|NCT03020745|364187420|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
105597001|NCT03020745|364187421|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
105597002|NCT03020745|364187422|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
105597003|NCT03020745|364187423|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
105597004|NCT03020745|364187424|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
105597005|NCT03020745|364187425|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
105597006|NCT03020745|364187426|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
105597007|NCT03020745|364187427|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
105597008|NCT03020745|364187428|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
105597009|NCT03020745|364187429|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
105597010|NCT03020745|364187420|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
105597011|NCT03020745|364187421|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
105597012|NCT03020745|364187422|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
105597013|NCT03020745|364187423|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
105597014|NCT03020745|364187424|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
105597015|NCT03020745|364187425|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
105597016|NCT03020745|364187426|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
105597017|NCT03020745|364187427|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
105597018|NCT03020745|364187428|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
105597019|NCT03020745|364187429|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
105597020|NCT03020745|364187420|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
105597021|NCT03020745|364187421|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
105597022|NCT03020745|364187422|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
105597023|NCT03020745|364187423|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
105597024|NCT03020745|364187424|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
105597025|NCT03020745|364187425|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
105597026|NCT03020745|364187426|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
105597027|NCT03020745|364187427|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
105597028|NCT03020745|364187428|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
105597029|NCT03020745|364187429|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
105597030|NCT00831415|364187435|FG000|Overall Study|Adverse Event|14|||
105597031|NCT00831415|364187435|FG000|Overall Study|Failed to return|3|||
105597032|NCT00831415|364187435|FG000|Overall Study|Physician Decision|6|||
105597033|NCT00831415|364187435|FG000|Overall Study|Lost to Follow-up|9|||
105597034|NCT00831415|364187435|FG000|Overall Study|Protocol Violation|3|||
105597035|NCT00831415|364187435|FG000|Overall Study|Withdrawal by Subject|35|||
105597036|NCT00831415|364187435|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
105597037|NCT00831415|364187435|FG000|Overall Study|Death|1|||
105597038|NCT01145885|364187436|FG000|Overall Study|Progressive Disease|7|||
105597039|NCT01391130|364187438|FG000|Overall Study|Withdrawal by Subject|3|||
105597040|NCT01391130|364187439|FG001|Overall Study|Withdrawal by Subject|2|||
105597041|NCT01391130|364187438|FG000|Overall Study|Physician Decision|2|||
105597042|NCT01391130|364187439|FG001|Overall Study|Physician Decision|3|||
105597043|NCT01391130|364187438|FG000|Overall Study|Did not Receive Drug|1|||
105597044|NCT01391130|364187439|FG001|Overall Study|Did not Receive Drug|1|||
105597045|NCT03257813|364187440|FG000|Overall Study|Protocol Violation|6|||
105597046|NCT03257813|364187441|FG001|Overall Study|Protocol Violation|3|||
105597047|NCT03520413|364187446|FG000|Overall Study|Lost to Follow-up|1|||
105597048|NCT03520413|364187447|FG001|Overall Study|Lost to Follow-up|1|||
105597049|NCT03520413|364187446|FG000|Overall Study|Withdrawal by Subject|1|||
105597050|NCT03520413|364187447|FG001|Overall Study|Withdrawal by Subject|2|||
105597051|NCT03520413|364187446|FG000|Overall Study|Death|0|||
105597052|NCT03520413|364187447|FG001|Overall Study|Death|1|||
105597053|NCT03520413|364187446|FG000|Overall Study|Physician Decision|3|||
105597054|NCT03520413|364187447|FG001|Overall Study|Physician Decision|3|||
105597055|NCT03520413|364187446|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
105597056|NCT03520413|364187447|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
105597057|NCT02808338|364187450|FG000|Screening|Screen Failure|10|||
105597058|NCT02808338|364187450|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
105597059|NCT02808338|364187450|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
105597060|NCT00891930|364187451|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
105597061|NCT00891930|364187451|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
105597062|NCT00891930|364187451|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
105597063|NCT00891930|364187451|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
105597064|NCT00891930|364187451|FG000|Part 2 Panitumumab + AMG479|Death|30|||
105597065|NCT00057837|364187455|FG000|Overall Study|Progression/relapse|12|||
105597066|NCT00057837|364187456|FG001|Overall Study|Progression/relapse|14|||
105597067|NCT00057837|364187455|FG000|Overall Study|Adverse Event|2|||
105597068|NCT00057837|364187456|FG001|Overall Study|Adverse Event|12|||
105597069|NCT00057837|364187455|FG000|Overall Study|Death|5|||
105597070|NCT00057837|364187456|FG001|Overall Study|Death|4|||
105597071|NCT00057837|364187455|FG000|Overall Study|Withdrawal by Subject|5|||
105597072|NCT00057837|364187456|FG001|Overall Study|Withdrawal by Subject|3|||
105597073|NCT00057837|364187455|FG000|Overall Study|Alternative therapy|0|||
105597074|NCT00057837|364187456|FG001|Overall Study|Alternative therapy|1|||
105597075|NCT00057837|364187455|FG000|Overall Study|Other complicating disease|2|||
105597076|NCT00057837|364187456|FG001|Overall Study|Other complicating disease|1|||
105597077|NCT00057837|364187455|FG000|Overall Study|Physician Decision|1|||
105597078|NCT00057837|364187456|FG001|Overall Study|Physician Decision|0|||
105597079|NCT00057837|364187455|FG000|Overall Study|Ineligible|3|||
105597080|NCT00057837|364187456|FG001|Overall Study|Ineligible|3|||
105597081|NCT00057837|364187455|FG000|Overall Study|Never started treatment|1|||
105597082|NCT00057837|364187456|FG001|Overall Study|Never started treatment|1|||
105597083|NCT02537522|364187459|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
105597084|NCT02537522|364187460|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
105597085|NCT02537522|364187461|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
105597086|NCT02537522|364187462|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
105597087|NCT02537522|364187459|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
105597088|NCT02537522|364187460|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
105597089|NCT02537522|364187461|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
105597090|NCT02537522|364187462|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
105597091|NCT02537522|364187459|FG000|Phase I - Contralateral|incorrect randomization|0|||
105597092|NCT02537522|364187460|FG001|Phase I - Contralateral|incorrect randomization|1|||
105597093|NCT02537522|364187461|FG002|Phase I - Contralateral|incorrect randomization|0|||
105597094|NCT02537522|364187462|FG003|Phase I - Contralateral|incorrect randomization|0|||
105597095|NCT02537522|364187459|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
105597096|NCT02537522|364187460|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
105597097|NCT02537522|364187461|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
105597098|NCT02537522|364187462|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
105597099|NCT02537522|364187459|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
105597100|NCT02537522|364187460|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
105597101|NCT02537522|364187461|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
105597102|NCT02537522|364187462|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
105597103|NCT02570711|364187463|FG000|Overall Study|Death|1|||
105597104|NCT02570711|364187464|FG001|Overall Study|Death|0|||
105597105|NCT02570711|364187463|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
105597106|NCT02570711|364187464|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
105597107|NCT01490086|364187465|FG000|Overall Study|Consent withdrawn|4|||
105597108|NCT01490086|364187466|FG001|Overall Study|Consent withdrawn|4|||
105597109|NCT01490086|364187467|FG002|Overall Study|Consent withdrawn|3|||
105597110|NCT01490086|364187468|FG003|Overall Study|Consent withdrawn|0|||
105597111|NCT01490086|364187469|FG004|Overall Study|Consent withdrawn|1|||
105597112|NCT01490086|364187465|FG000|Overall Study|Non-compliance|0|||
105597113|NCT01490086|364187466|FG001|Overall Study|Non-compliance|1|||
105597114|NCT01490086|364187467|FG002|Overall Study|Non-compliance|0|||
105597115|NCT01490086|364187468|FG003|Overall Study|Non-compliance|0|||
105597116|NCT01490086|364187469|FG004|Overall Study|Non-compliance|0|||
105597117|NCT01490086|364187465|FG000|Overall Study|Abnormal laboratory findings|1|||
105597118|NCT01490086|364187466|FG001|Overall Study|Abnormal laboratory findings|0|||
105597119|NCT01490086|364187467|FG002|Overall Study|Abnormal laboratory findings|0|||
105597120|NCT01490086|364187468|FG003|Overall Study|Abnormal laboratory findings|0|||
105597121|NCT01490086|364187469|FG004|Overall Study|Abnormal laboratory findings|0|||
105597122|NCT01490086|364187465|FG000|Overall Study|Lost to Follow-up|0|||
105597123|NCT01490086|364187466|FG001|Overall Study|Lost to Follow-up|0|||
105597124|NCT01490086|364187467|FG002|Overall Study|Lost to Follow-up|0|||
105597125|NCT01490086|364187468|FG003|Overall Study|Lost to Follow-up|0|||
105597126|NCT01490086|364187469|FG004|Overall Study|Lost to Follow-up|1|||
105597127|NCT01490086|364187465|FG000|Overall Study|Physician Decision|3|||
105597128|NCT01490086|364187466|FG001|Overall Study|Physician Decision|4|||
105597129|NCT01490086|364187467|FG002|Overall Study|Physician Decision|2|||
105597130|NCT01490086|364187468|FG003|Overall Study|Physician Decision|3|||
105597131|NCT01490086|364187469|FG004|Overall Study|Physician Decision|1|||
105597132|NCT01490086|364187465|FG000|Overall Study|Adverse Event|0|||
105597133|NCT01490086|364187466|FG001|Overall Study|Adverse Event|0|||
105597134|NCT01490086|364187467|FG002|Overall Study|Adverse Event|1|||
105597135|NCT01490086|364187468|FG003|Overall Study|Adverse Event|2|||
105597136|NCT01490086|364187469|FG004|Overall Study|Adverse Event|0|||
105597137|NCT01490086|364187465|FG000|Overall Study|Lack of Efficacy|0|||
105597138|NCT01490086|364187466|FG001|Overall Study|Lack of Efficacy|3|||
105597139|NCT01490086|364187467|FG002|Overall Study|Lack of Efficacy|1|||
105597140|NCT01490086|364187468|FG003|Overall Study|Lack of Efficacy|0|||
105597141|NCT01490086|364187469|FG004|Overall Study|Lack of Efficacy|8|||
105597142|NCT01490086|364187465|FG000|Overall Study|Worsening of symptoms|0|||
105597143|NCT01490086|364187466|FG001|Overall Study|Worsening of symptoms|1|||
105597144|NCT01490086|364187467|FG002|Overall Study|Worsening of symptoms|0|||
105597145|NCT01490086|364187468|FG003|Overall Study|Worsening of symptoms|1|||
105597146|NCT01490086|364187469|FG004|Overall Study|Worsening of symptoms|0|||
105597147|NCT01490086|364187465|FG000|Overall Study|Subject uncontrollable and abusive|0|||
105597148|NCT01490086|364187466|FG001|Overall Study|Subject uncontrollable and abusive|1|||
105597149|NCT01490086|364187467|FG002|Overall Study|Subject uncontrollable and abusive|0|||
105597150|NCT01490086|364187468|FG003|Overall Study|Subject uncontrollable and abusive|0|||
105597151|NCT01490086|364187469|FG004|Overall Study|Subject uncontrollable and abusive|0|||
105597152|NCT01490086|364187465|FG000|Overall Study|Subject left hospital|0|||
105597153|NCT01490086|364187466|FG001|Overall Study|Subject left hospital|1|||
105597154|NCT01490086|364187467|FG002|Overall Study|Subject left hospital|0|||
105597155|NCT01490086|364187468|FG003|Overall Study|Subject left hospital|1|||
105597156|NCT01490086|364187469|FG004|Overall Study|Subject left hospital|0|||
105597157|NCT02798835|364187470|FG000|Overall Study|Protocol Violation|0|||
105597158|NCT02798835|364187471|FG001|Overall Study|Protocol Violation|0|||
105597159|NCT02798835|364187472|FG002|Overall Study|Protocol Violation|3|||
105597160|NCT02423291|364187484|FG000|Overall Study|Lack of Efficacy|14|||
105597161|NCT02423291|364187484|FG000|Overall Study|Adverse Event|1|||
105597162|NCT02200770|364187485|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
105597163|NCT02200770|364187486|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
105597164|NCT02200770|364187485|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
105597165|NCT02200770|364187486|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
105597166|NCT02200770|364187485|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
105597167|NCT02200770|364187486|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
105597168|NCT02200770|364187485|FG000|Randomized-controlled Period (RCP)|Other|1|||
105597169|NCT02200770|364187486|FG001|Randomized-controlled Period (RCP)|Other|2|||
105597170|NCT02200770|364187485|FG000|Open-label Period (OLP)|Adverse Event|1|||
105597171|NCT02200770|364187486|FG001|Open-label Period (OLP)|Adverse Event|2|||
105597172|NCT02200770|364187485|FG000|Open-label Period (OLP)|Death|1|||
105597173|NCT02200770|364187486|FG001|Open-label Period (OLP)|Death|2|||
105597174|NCT02200770|364187485|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
105597175|NCT02200770|364187486|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
105597176|NCT02200770|364187485|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
105597177|NCT02200770|364187486|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
105597178|NCT02200770|364187485|FG000|Open-label Period (OLP)|Other|6|||
105597179|NCT02200770|364187486|FG001|Open-label Period (OLP)|Other|15|||
105597180|NCT02471755|364187488|FG000|Overall Study|Withdrawal by Subject|1|||
105597181|NCT02471755|364187489|FG001|Overall Study|Withdrawal by Subject|0|||
105597182|NCT02471755|364187488|FG000|Overall Study|Lost to Follow-up|0|||
105597183|NCT02471755|364187489|FG001|Overall Study|Lost to Follow-up|1|||
105597184|NCT04740164|364187491|FG000|Overall Study|Lack of Efficacy|4|||
105597185|NCT04740164|364187492|FG001|Overall Study|Lack of Efficacy|0|||
105597186|NCT04740164|364187491|FG000|Overall Study|Physician Decision|3|||
105597187|NCT04740164|364187492|FG001|Overall Study|Physician Decision|3|||
105597188|NCT01152190|364187493|FG000|Overall Study|Adverse Event|2|||
105597189|NCT01152190|364187494|FG001|Overall Study|Adverse Event|4|||
105597190|NCT01152190|364187493|FG000|Overall Study|Death|1|||
105597191|NCT01152190|364187494|FG001|Overall Study|Death|0|||
105597192|NCT01152190|364187493|FG000|Overall Study|Protocol Violation|1|||
105597193|NCT01152190|364187494|FG001|Overall Study|Protocol Violation|1|||
105597194|NCT01152190|364187493|FG000|Overall Study|Withdrawal by Subject|1|||
105597195|NCT01152190|364187494|FG001|Overall Study|Withdrawal by Subject|3|||
105597196|NCT00258895|364187495|FG000|Overall Study|Lost to Follow-up|3|||
105597197|NCT00258895|364187496|FG001|Overall Study|Lost to Follow-up|1|||
105597198|NCT00258895|364187495|FG000|Overall Study|Protocol Violation|6|||
105597199|NCT00258895|364187496|FG001|Overall Study|Protocol Violation|2|||
105597200|NCT00258895|364187495|FG000|Overall Study|Withdrawal by Subject|1|||
105597201|NCT00258895|364187496|FG001|Overall Study|Withdrawal by Subject|0|||
105597202|NCT00834834|364187497|FG000|Overall Study|Withdrawal by Subject|4|||
105597203|NCT00834834|364187498|FG001|Overall Study|Withdrawal by Subject|3|||
105597204|NCT00305695|364187505|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
105597205|NCT00305695|364187506|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
105597206|NCT00305695|364187505|FG000|Overall Study|Did not have baseline scan|1|||
105597207|NCT00305695|364187506|FG001|Overall Study|Did not have baseline scan|1|||
105597208|NCT02031471|364187507|FG000|24 Week Treatment Period|Adverse Event|6|||
105597209|NCT02031471|364187507|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
105597210|NCT02031471|364187507|FG000|24 Week Treatment Period|Protocol Violation|1|||
105597211|NCT02031471|364187507|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
105597212|NCT02031471|364187507|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
105597213|NCT02031471|364187507|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
105597214|NCT02031471|364187507|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
105597215|NCT03070483|364187508|FG000|Overall Study|Lost to Follow-up|2|||
105597216|NCT02994654|364187512|FG000|Overall Study|Lost to Follow-up|1|||
105597217|NCT00837616|364187513|FG000|Overall Study|Withdrawal by Subject|0|||
105597218|NCT00837616|364187514|FG001|Overall Study|Withdrawal by Subject|1|||
105597219|NCT00961636|364187517|FG000|Overall Study|Adverse Event|35|||
105597220|NCT00961636|364187518|FG001|Overall Study|Adverse Event|54|||
105597221|NCT00961636|364187519|FG002|Overall Study|Adverse Event|13|||
105597222|NCT00961636|364187517|FG000|Overall Study|Flushing Symptoms|29|||
105597223|NCT00961636|364187518|FG001|Overall Study|Flushing Symptoms|46|||
105597224|NCT00961636|364187519|FG002|Overall Study|Flushing Symptoms|3|||
105597225|NCT00961636|364187517|FG000|Overall Study|Lost to Follow-up|2|||
105597226|NCT00961636|364187518|FG001|Overall Study|Lost to Follow-up|3|||
105597227|NCT00961636|364187519|FG002|Overall Study|Lost to Follow-up|1|||
105597228|NCT00961636|364187517|FG000|Overall Study|Physician Decision|3|||
105597229|NCT00961636|364187518|FG001|Overall Study|Physician Decision|1|||
105597230|NCT00961636|364187519|FG002|Overall Study|Physician Decision|1|||
105597231|NCT00961636|364187517|FG000|Overall Study|Protocol Violation|9|||
105597232|NCT00961636|364187518|FG001|Overall Study|Protocol Violation|5|||
105597233|NCT00961636|364187519|FG002|Overall Study|Protocol Violation|1|||
105597234|NCT00961636|364187517|FG000|Overall Study|Withdrawal by Subject|29|||
105597235|NCT00961636|364187518|FG001|Overall Study|Withdrawal by Subject|22|||
105597236|NCT00961636|364187519|FG002|Overall Study|Withdrawal by Subject|13|||
105597237|NCT02999477|364187522|FG000|Overall Study|found ineligible after first dose|0|||
105597238|NCT02999477|364187523|FG001|Overall Study|found ineligible after first dose|1|||
105597239|NCT02999477|364187522|FG000|Overall Study|Withdrawal by Subject|1|||
105597240|NCT02999477|364187523|FG001|Overall Study|Withdrawal by Subject|1|||
105597241|NCT00573833|364187524|FG000|Overall Study|Not Treated|2|||
105597242|NCT01049503|364189882|FG000|Overall Study|Lost to Follow-up|11|||
105597243|NCT01049503|364189883|FG001|Overall Study|Lost to Follow-up|12|||
105597244|NCT01049503|364189884|FG002|Overall Study|Lost to Follow-up|24|||
105597245|NCT01049503|364189885|FG003|Overall Study|Lost to Follow-up|26|||
105597246|NCT01049503|364189886|FG004|Overall Study|Lost to Follow-up|27|||
105597247|NCT01049503|364189887|FG005|Overall Study|Lost to Follow-up|8|||
105597248|NCT00726596|364189888|FG000|Overall Study|Adverse Event|2|||
105597249|NCT00726596|364189889|FG001|Overall Study|Adverse Event|1|||
105597250|NCT00726596|364189888|FG000|Overall Study|Withdrawal by Subject|3|||
105597251|NCT00726596|364189889|FG001|Overall Study|Withdrawal by Subject|3|||
105597252|NCT04424641|364189894|FG000|Overall Study|Death|1|||
105597253|NCT04424641|364189895|FG001|Overall Study|Death|2|||
105597254|NCT04424641|364189896|FG002|Overall Study|Death|3|||
105597255|NCT04424641|364189897|FG003|Overall Study|Death|0|||
105597256|NCT04424641|364189898|FG004|Overall Study|Death|3|||
105597257|NCT04424641|364189899|FG005|Overall Study|Death|0|||
105597258|NCT04424641|364189900|FG006|Overall Study|Death|1|||
105597259|NCT04424641|364189901|FG007|Overall Study|Death|2|||
105597260|NCT04424641|364189894|FG000|Overall Study|Sponsor decision|0|||
105597261|NCT04424641|364189895|FG001|Overall Study|Sponsor decision|2|||
105597262|NCT04424641|364189896|FG002|Overall Study|Sponsor decision|3|||
105597263|NCT04424641|364189897|FG003|Overall Study|Sponsor decision|7|||
105597264|NCT04424641|364189898|FG004|Overall Study|Sponsor decision|2|||
105597265|NCT04424641|364189899|FG005|Overall Study|Sponsor decision|2|||
105597266|NCT04424641|364189900|FG006|Overall Study|Sponsor decision|3|||
105597267|NCT04424641|364189901|FG007|Overall Study|Sponsor decision|4|||
105597268|NCT04424641|364189894|FG000|Overall Study|Withdrawal by Subject|0|||
105597269|NCT04424641|364189895|FG001|Overall Study|Withdrawal by Subject|0|||
105597270|NCT04424641|364189896|FG002|Overall Study|Withdrawal by Subject|0|||
105597271|NCT04424641|364189897|FG003|Overall Study|Withdrawal by Subject|0|||
105597272|NCT04424641|364189898|FG004|Overall Study|Withdrawal by Subject|1|||
105597273|NCT04424641|364189899|FG005|Overall Study|Withdrawal by Subject|0|||
105597274|NCT04424641|364189900|FG006|Overall Study|Withdrawal by Subject|0|||
105597275|NCT04424641|364189901|FG007|Overall Study|Withdrawal by Subject|0|||
105597276|NCT04424641|364189894|FG000|Overall Study|Other|0|||
105597277|NCT04424641|364189895|FG001|Overall Study|Other|0|||
105597278|NCT04424641|364189896|FG002|Overall Study|Other|1|||
105597279|NCT04424641|364189897|FG003|Overall Study|Other|0|||
105597280|NCT04424641|364189898|FG004|Overall Study|Other|0|||
105597281|NCT04424641|364189899|FG005|Overall Study|Other|0|||
105597282|NCT04424641|364189900|FG006|Overall Study|Other|0|||
105597283|NCT04424641|364189901|FG007|Overall Study|Other|0|||
105597284|NCT01426269|364189908|FG000|Period 1: 12 Weeks|Adverse Event|5|||
105597285|NCT01426269|364189909|FG001|Period 1: 12 Weeks|Adverse Event|0|||
105597286|NCT01426269|364189910|FG002|Period 1: 12 Weeks|Adverse Event|0|||
105597287|NCT01426269|364189908|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
105597288|NCT01426269|364189909|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
105597289|NCT01426269|364189910|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
105597290|NCT01426269|364189908|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
105597291|NCT01426269|364189909|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
105597292|NCT01426269|364189910|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
105597293|NCT01426269|364189908|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
105597294|NCT01426269|364189909|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
105597295|NCT01426269|364189910|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
105597296|NCT01426269|364189908|FG000|Period 1: 12 Weeks|Pregnancy|1|||
105597297|NCT01426269|364189909|FG001|Period 1: 12 Weeks|Pregnancy|0|||
105597298|NCT01426269|364189910|FG002|Period 1: 12 Weeks|Pregnancy|0|||
105597299|NCT01426269|364189908|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
105597300|NCT01426269|364189909|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
105597301|NCT01426269|364189910|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
105597302|NCT01426269|364189908|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
105597303|NCT01426269|364189909|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
105597304|NCT01426269|364189910|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
105597305|NCT01426269|364189908|FG000|Period 2: 40 Weeks|Adverse Event|0|||
105597306|NCT01426269|364189909|FG001|Period 2: 40 Weeks|Adverse Event|1|||
105597307|NCT01426269|364189910|FG002|Period 2: 40 Weeks|Adverse Event|2|||
105597308|NCT01426269|364189908|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
105597309|NCT01426269|364189909|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
105597310|NCT01426269|364189910|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
105597311|NCT01426269|364189908|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
105597312|NCT01426269|364189909|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
105597313|NCT01426269|364189910|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
105597314|NCT01426269|364189908|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
105597315|NCT01426269|364189909|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
105597316|NCT01426269|364189910|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
105597317|NCT01426269|364189908|FG000|Period 2: 40 Weeks|Site closed|0|||
105597318|NCT01426269|364189909|FG001|Period 2: 40 Weeks|Site closed|6|||
105597319|NCT01426269|364189910|FG002|Period 2: 40 Weeks|Site closed|5|||
105597320|NCT01426269|364189908|FG000|Period 2: 40 Weeks|Relapsed|0|||
105597321|NCT01426269|364189909|FG001|Period 2: 40 Weeks|Relapsed|9|||
105597322|NCT01426269|364189910|FG002|Period 2: 40 Weeks|Relapsed|18|||
105597323|NCT03262935|364189911|FG000|Overall Study|Withdrawal by Subject|6|||
105597324|NCT03262935|364189912|FG001|Overall Study|Withdrawal by Subject|7|||
105597325|NCT03262935|364189911|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
105597326|NCT03262935|364189912|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
105597327|NCT03262935|364189911|FG000|Overall Study|Death|181|||
105597328|NCT03262935|364189912|FG001|Overall Study|Death|94|||
105597329|NCT03262935|364189911|FG000|Overall Study|Lost to Follow-up|9|||
105597330|NCT03262935|364189912|FG001|Overall Study|Lost to Follow-up|4|||
105597331|NCT03262935|364189911|FG000|Overall Study|Other reason|5|||
105597332|NCT03262935|364189912|FG001|Overall Study|Other reason|0|||
105597333|NCT01811706|364189913|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
105597334|NCT01811706|364189914|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
105597335|NCT02296424|364189915|FG000|Part 1|New therapy for study indication|0|||
105597336|NCT02296424|364189916|FG001|Part 1|New therapy for study indication|1|||
105597337|NCT02296424|364189917|FG002|Part 1|New therapy for study indication|0|||
105597338|NCT02296424|364189918|FG003|Part 1|New therapy for study indication|0|||
105597339|NCT02296424|364189915|FG000|Part 1|Protocol Violation|0|||
105597340|NCT02296424|364189916|FG001|Part 1|Protocol Violation|1|||
105597341|NCT02296424|364189917|FG002|Part 1|Protocol Violation|0|||
105597342|NCT02296424|364189918|FG003|Part 1|Protocol Violation|0|||
105597343|NCT02296424|364189915|FG000|Part 1|Withdrawal by Subject|0|||
105597344|NCT02296424|364189916|FG001|Part 1|Withdrawal by Subject|2|||
105597345|NCT02296424|364189917|FG002|Part 1|Withdrawal by Subject|0|||
105597346|NCT02296424|364189918|FG003|Part 1|Withdrawal by Subject|0|||
105597347|NCT02296424|364189915|FG000|Part 1|Study terminated by sponsor|0|||
105597348|NCT02296424|364189916|FG001|Part 1|Study terminated by sponsor|1|||
105597349|NCT02296424|364189917|FG002|Part 1|Study terminated by sponsor|0|||
105597350|NCT02296424|364189918|FG003|Part 1|Study terminated by sponsor|0|||
105597351|NCT02296424|364189915|FG000|Part 1|Adverse Event|2|||
105597352|NCT02296424|364189916|FG001|Part 1|Adverse Event|11|||
105597353|NCT02296424|364189917|FG002|Part 1|Adverse Event|0|||
105597354|NCT02296424|364189918|FG003|Part 1|Adverse Event|0|||
105597355|NCT02296424|364189915|FG000|Part 1|Lack of Efficacy|5|||
105597356|NCT02296424|364189916|FG001|Part 1|Lack of Efficacy|17|||
105597357|NCT02296424|364189917|FG002|Part 1|Lack of Efficacy|0|||
105597358|NCT02296424|364189918|FG003|Part 1|Lack of Efficacy|0|||
105597359|NCT02296424|364189915|FG000|Part 1|16 directly started part II|16|||
105597360|NCT02296424|364189916|FG001|Part 1|16 directly started part II|0|||
105597361|NCT02296424|364189917|FG002|Part 1|16 directly started part II|0|||
105597362|NCT02296424|364189918|FG003|Part 1|16 directly started part II|0|||
105597363|NCT02296424|364189915|FG000|Part 2|Lack of Efficacy|0|||
105597364|NCT02296424|364189916|FG001|Part 2|Lack of Efficacy|0|||
105597365|NCT02296424|364189917|FG002|Part 2|Lack of Efficacy|1|||
105597366|NCT02296424|364189918|FG003|Part 2|Lack of Efficacy|0|||
105597367|NCT02296424|364189915|FG000|Part 2|Adverse Event|0|||
105597368|NCT02296424|364189916|FG001|Part 2|Adverse Event|0|||
105597369|NCT02296424|364189917|FG002|Part 2|Adverse Event|1|||
105597370|NCT02296424|364189918|FG003|Part 2|Adverse Event|0|||
105597371|NCT02296424|364189915|FG000|Part 2|Lost to Follow-up|0|||
105597372|NCT02296424|364189916|FG001|Part 2|Lost to Follow-up|0|||
105597373|NCT02296424|364189917|FG002|Part 2|Lost to Follow-up|1|||
105597374|NCT02296424|364189918|FG003|Part 2|Lost to Follow-up|0|||
105597375|NCT00743444|364189919|FG000|First Intervention|Catheter placement problems|0|||
105597376|NCT00743444|364189920|FG001|First Intervention|Catheter placement problems|1|||
105597377|NCT00743444|364189919|FG000|Washout Period|Adverse Event|0|||
105597378|NCT00743444|364189920|FG001|Washout Period|Adverse Event|1|||
105597379|NCT01307267|364189923|FG000|Overall Study|Death|4|||
105597380|NCT01307267|364189924|FG001|Overall Study|Death|3|||
105597381|NCT01307267|364189925|FG002|Overall Study|Death|5|||
105597382|NCT01307267|364189926|FG003|Overall Study|Death|3|||
105597383|NCT01307267|364189927|FG004|Overall Study|Death|1|||
105597384|NCT01307267|364189928|FG005|Overall Study|Death|26|||
105597385|NCT01307267|364189929|FG006|Overall Study|Death|2|||
105597386|NCT01307267|364189930|FG007|Overall Study|Death|2|||
105597387|NCT01307267|364189931|FG008|Overall Study|Death|21|||
105597388|NCT01307267|364189932|FG009|Overall Study|Death|2|||
105597389|NCT01307267|364189933|FG010|Overall Study|Death|3|||
105597390|NCT01307267|364189934|FG011|Overall Study|Death|9|||
105597391|NCT01307267|364189935|FG012|Overall Study|Death|0|||
105597392|NCT01307267|364189936|FG013|Overall Study|Death|0|||
105597393|NCT01307267|364189937|FG014|Overall Study|Death|0|||
105597394|NCT01307267|364189938|FG015|Overall Study|Death|0|||
105597395|NCT01307267|364189939|FG016|Overall Study|Death|1|||
105597396|NCT01307267|364189940|FG017|Overall Study|Death|1|||
105597397|NCT01307267|364189941|FG018|Overall Study|Death|2|||
105597398|NCT01307267|364189942|FG019|Overall Study|Death|8|||
105597399|NCT01307267|364189943|FG020|Overall Study|Death|1|||
105597400|NCT01307267|364189944|FG021|Overall Study|Death|2|||
105597401|NCT01307267|364189945|FG022|Overall Study|Death|2|||
105597402|NCT01307267|364189923|FG000|Overall Study|Lost to Follow-up|0|||
105597403|NCT01307267|364189924|FG001|Overall Study|Lost to Follow-up|0|||
105597404|NCT01307267|364189925|FG002|Overall Study|Lost to Follow-up|0|||
105597405|NCT01307267|364189926|FG003|Overall Study|Lost to Follow-up|0|||
105597406|NCT01307267|364189927|FG004|Overall Study|Lost to Follow-up|0|||
105597407|NCT01307267|364189928|FG005|Overall Study|Lost to Follow-up|7|||
105597408|NCT01307267|364189929|FG006|Overall Study|Lost to Follow-up|0|||
105597409|NCT01307267|364189930|FG007|Overall Study|Lost to Follow-up|0|||
105597410|NCT01307267|364189931|FG008|Overall Study|Lost to Follow-up|1|||
105597411|NCT01307267|364189932|FG009|Overall Study|Lost to Follow-up|2|||
105597412|NCT01307267|364189933|FG010|Overall Study|Lost to Follow-up|1|||
105597413|NCT01307267|364189934|FG011|Overall Study|Lost to Follow-up|0|||
105597414|NCT01307267|364189935|FG012|Overall Study|Lost to Follow-up|0|||
105597415|NCT01307267|364189936|FG013|Overall Study|Lost to Follow-up|0|||
105597416|NCT01307267|364189937|FG014|Overall Study|Lost to Follow-up|0|||
105597417|NCT01307267|364189938|FG015|Overall Study|Lost to Follow-up|0|||
105597418|NCT01307267|364189939|FG016|Overall Study|Lost to Follow-up|0|||
105597419|NCT01307267|364189940|FG017|Overall Study|Lost to Follow-up|0|||
105597420|NCT01307267|364189941|FG018|Overall Study|Lost to Follow-up|0|||
105597421|NCT01307267|364189942|FG019|Overall Study|Lost to Follow-up|2|||
105597422|NCT01307267|364189943|FG020|Overall Study|Lost to Follow-up|0|||
105597423|NCT01307267|364189944|FG021|Overall Study|Lost to Follow-up|0|||
105597424|NCT01307267|364189945|FG022|Overall Study|Lost to Follow-up|0|||
105597425|NCT01307267|364189923|FG000|Overall Study|Withdrawal by Subject|0|||
105597426|NCT01307267|364189924|FG001|Overall Study|Withdrawal by Subject|0|||
105597427|NCT01307267|364189925|FG002|Overall Study|Withdrawal by Subject|0|||
105597428|NCT01307267|364189926|FG003|Overall Study|Withdrawal by Subject|0|||
105597429|NCT01307267|364189927|FG004|Overall Study|Withdrawal by Subject|0|||
105597430|NCT01307267|364189928|FG005|Overall Study|Withdrawal by Subject|1|||
105597431|NCT01307267|364189929|FG006|Overall Study|Withdrawal by Subject|0|||
105597432|NCT01307267|364189930|FG007|Overall Study|Withdrawal by Subject|1|||
105597433|NCT01307267|364189931|FG008|Overall Study|Withdrawal by Subject|5|||
105597434|NCT01307267|364189932|FG009|Overall Study|Withdrawal by Subject|1|||
105597435|NCT01307267|364189933|FG010|Overall Study|Withdrawal by Subject|1|||
105597436|NCT01307267|364189934|FG011|Overall Study|Withdrawal by Subject|1|||
105597437|NCT01307267|364189935|FG012|Overall Study|Withdrawal by Subject|0|||
105597438|NCT01307267|364189936|FG013|Overall Study|Withdrawal by Subject|0|||
105597439|NCT01307267|364189937|FG014|Overall Study|Withdrawal by Subject|0|||
105597440|NCT01307267|364189938|FG015|Overall Study|Withdrawal by Subject|0|||
105597441|NCT01307267|364189939|FG016|Overall Study|Withdrawal by Subject|0|||
105597442|NCT01307267|364189940|FG017|Overall Study|Withdrawal by Subject|0|||
105597443|NCT01307267|364189941|FG018|Overall Study|Withdrawal by Subject|0|||
105597444|NCT01307267|364189942|FG019|Overall Study|Withdrawal by Subject|3|||
105597445|NCT01307267|364189943|FG020|Overall Study|Withdrawal by Subject|0|||
105597446|NCT01307267|364189944|FG021|Overall Study|Withdrawal by Subject|0|||
105597447|NCT01307267|364189945|FG022|Overall Study|Withdrawal by Subject|0|||
105597448|NCT01307267|364189923|FG000|Overall Study|Other|0|||
105597449|NCT01307267|364189924|FG001|Overall Study|Other|0|||
105597450|NCT01307267|364189925|FG002|Overall Study|Other|0|||
105597451|NCT01307267|364189926|FG003|Overall Study|Other|0|||
105597452|NCT01307267|364189927|FG004|Overall Study|Other|0|||
105597453|NCT01307267|364189928|FG005|Overall Study|Other|7|||
105597454|NCT01307267|364189929|FG006|Overall Study|Other|0|||
105597455|NCT01307267|364189930|FG007|Overall Study|Other|1|||
105597456|NCT01307267|364189931|FG008|Overall Study|Other|3|||
105597457|NCT01307267|364189932|FG009|Overall Study|Other|0|||
105597458|NCT01307267|364189933|FG010|Overall Study|Other|1|||
105597459|NCT01307267|364189934|FG011|Overall Study|Other|1|||
105597460|NCT01307267|364189935|FG012|Overall Study|Other|1|||
105597461|NCT01307267|364189936|FG013|Overall Study|Other|0|||
105597462|NCT01307267|364189937|FG014|Overall Study|Other|2|||
105597463|NCT01307267|364189938|FG015|Overall Study|Other|1|||
105597464|NCT01307267|364189939|FG016|Overall Study|Other|0|||
105597465|NCT01307267|364189940|FG017|Overall Study|Other|0|||
105597466|NCT01307267|364189941|FG018|Overall Study|Other|0|||
105597467|NCT01307267|364189942|FG019|Overall Study|Other|19|||
105597468|NCT01307267|364189943|FG020|Overall Study|Other|2|||
105597469|NCT01307267|364189944|FG021|Overall Study|Other|3|||
105597470|NCT01307267|364189945|FG022|Overall Study|Other|2|||
105597471|NCT05174013|364189946|FG000|Overall Study|Lost to Follow-up|0|||
105597472|NCT05174013|364189947|FG001|Overall Study|Lost to Follow-up|0|||
105597473|NCT05174013|364189948|FG002|Overall Study|Lost to Follow-up|0|||
105597474|NCT05174013|364189949|FG003|Overall Study|Lost to Follow-up|1|||
105597475|NCT05174013|364189950|FG004|Overall Study|Lost to Follow-up|0|||
105597476|NCT05174013|364189951|FG005|Overall Study|Lost to Follow-up|0|||
105597477|NCT05174013|364189946|FG000|Overall Study|Withdrawal by Subject|0|||
105597478|NCT05174013|364189947|FG001|Overall Study|Withdrawal by Subject|0|||
105597479|NCT05174013|364189948|FG002|Overall Study|Withdrawal by Subject|1|||
105597480|NCT05174013|364189949|FG003|Overall Study|Withdrawal by Subject|0|||
105597481|NCT05174013|364189950|FG004|Overall Study|Withdrawal by Subject|0|||
105597482|NCT05174013|364189951|FG005|Overall Study|Withdrawal by Subject|0|||
105597483|NCT03593876|364189954|FG000|Overall Study|Withdrawal by Subject|1|||
105597484|NCT03593876|364189954|FG000|Overall Study|Discharged home before intervention completion|2|||
105597485|NCT02034916|364189955|FG000|Overall Study|Death|39|||
105597486|NCT02034916|364189956|FG001|Overall Study|Death|28|||
105597487|NCT02034916|364189955|FG000|Overall Study|Withdrawal by Subject|2|||
105597488|NCT02034916|364189956|FG001|Overall Study|Withdrawal by Subject|1|||
105597489|NCT02034916|364189955|FG000|Overall Study|Lost to Follow-up|4|||
105597490|NCT02034916|364189956|FG001|Overall Study|Lost to Follow-up|1|||
105597491|NCT02034916|364189955|FG000|Overall Study|Study terminated by sponsor|4|||
105597492|NCT02034916|364189956|FG001|Overall Study|Study terminated by sponsor|5|||
105597493|NCT03287622|364189957|FG000|Overall Study|Withdrawal by Subject|1|||
105597494|NCT03287622|364189958|FG001|Overall Study|Withdrawal by Subject|0|||
105597495|NCT03287622|364189957|FG000|Overall Study|Lost to Follow-up|27|||
105597496|NCT03287622|364189958|FG001|Overall Study|Lost to Follow-up|15|||
105597497|NCT03287622|364189957|FG000|Overall Study|No prescripion after surgery|28|||
105597498|NCT03287622|364189958|FG001|Overall Study|No prescripion after surgery|31|||
105597499|NCT03287622|364189957|FG000|Overall Study|prolonged Length of stay|2|||
105597500|NCT03287622|364189958|FG001|Overall Study|prolonged Length of stay|0|||
105597501|NCT03287622|364189957|FG000|Overall Study|surgery related|0|||
105597502|NCT03287622|364189958|FG001|Overall Study|surgery related|2|||
105597503|NCT03959241|364189962|FG000|Overall Study|Withdrawal by Subject|7|||
105597504|NCT03959241|364189963|FG001|Overall Study|Withdrawal by Subject|8|||
105597505|NCT03959241|364189962|FG000|Overall Study|Lost to Follow-up|1|||
105597506|NCT03959241|364189963|FG001|Overall Study|Lost to Follow-up|0|||
105597507|NCT03959241|364189962|FG000|Overall Study|Move to Hospice Care|1|||
105597508|NCT03959241|364189963|FG001|Overall Study|Move to Hospice Care|0|||
105597509|NCT03959241|364189962|FG000|Overall Study|Screen Failure|1|||
105597510|NCT03959241|364189963|FG001|Overall Study|Screen Failure|0|||
105597511|NCT03959241|364189962|FG000|Overall Study|Disease Relapse|0|||
105597512|NCT03959241|364189963|FG001|Overall Study|Disease Relapse|1|||
105597513|NCT03959241|364189962|FG000|Overall Study|Off Study|1|||
105597514|NCT03959241|364189963|FG001|Overall Study|Off Study|0|||
105597515|NCT01087762|364189964|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
105597516|NCT01087762|364189965|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
105597517|NCT01087762|364189966|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
105597518|NCT01087762|364189967|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
105597519|NCT01087762|364189968|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
105597520|NCT01087762|364189964|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
105597521|NCT01087762|364189965|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
105597522|NCT01087762|364189966|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
105597523|NCT01087762|364189967|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
105597524|NCT01087762|364189968|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
105597525|NCT01087762|364189964|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
105597526|NCT01087762|364189965|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
105597527|NCT01087762|364189966|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
105597528|NCT01087762|364189967|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
105597529|NCT01087762|364189968|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
105597530|NCT01087762|364189964|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
105597531|NCT01087762|364189965|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
105597532|NCT01087762|364189966|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
105597533|NCT01087762|364189967|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
105597534|NCT01087762|364189968|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
105597535|NCT01087762|364189964|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
105597536|NCT01087762|364189965|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
105597537|NCT01087762|364189966|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
105597538|NCT01087762|364189967|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
105597539|NCT01087762|364189968|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
105597540|NCT01087762|364189964|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
105597541|NCT01087762|364189965|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
105597542|NCT01087762|364189966|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
105597543|NCT01087762|364189967|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
105597544|NCT01087762|364189968|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
105597545|NCT01087762|364189964|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
105597546|NCT01087762|364189965|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
105597547|NCT01087762|364189966|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
105597548|NCT01087762|364189967|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
105597549|NCT01087762|364189968|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
105597550|NCT01087762|364189964|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
105597551|NCT01087762|364189965|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
105597552|NCT01087762|364189966|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
105597553|NCT01087762|364189967|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
105597554|NCT01087762|364189968|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
105597555|NCT01087762|364189964|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
105597556|NCT01087762|364189965|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
105597557|NCT01087762|364189966|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
105597558|NCT01087762|364189967|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
105597559|NCT01087762|364189968|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
105597560|NCT01087762|364189964|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
105597561|NCT01087762|364189965|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
105597562|NCT01087762|364189966|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
105597563|NCT01087762|364189967|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
105597564|NCT01087762|364189968|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
105597565|NCT01087762|364189964|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
105597566|NCT01087762|364189965|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
105597567|NCT01087762|364189966|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
105597568|NCT01087762|364189967|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
105597569|NCT01087762|364189968|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
105597570|NCT01087762|364189964|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
105597571|NCT01087762|364189965|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
105597572|NCT01087762|364189966|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
105597573|NCT01087762|364189967|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
105597574|NCT01087762|364189968|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
105597575|NCT01087762|364189964|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
105597576|NCT01087762|364189965|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
105597577|NCT01087762|364189966|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
105597578|NCT01087762|364189967|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
105597579|NCT01087762|364189968|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
105597580|NCT02527148|364189976|FG000|Overall Study|Did not receive study intervention|1|||
105597581|NCT02527148|364189977|FG001|Overall Study|Did not receive study intervention|0|||
105597582|NCT03061474|364189978|FG000|Overall Study|Adverse Event|2|||
105597583|NCT03061474|364189979|FG001|Overall Study|Adverse Event|0|||
105597584|NCT03061474|364189978|FG000|Overall Study|Safety Risk|0|||
105597585|NCT03061474|364189979|FG001|Overall Study|Safety Risk|1|||
105597586|NCT03061474|364189978|FG000|Overall Study|Participant unwilling or unable to participate|0|||
105597587|NCT03061474|364189979|FG001|Overall Study|Participant unwilling or unable to participate|2|||
105597588|NCT03061474|364189978|FG000|Overall Study|Lost to Follow-up|0|||
105597589|NCT03061474|364189979|FG001|Overall Study|Lost to Follow-up|1|||
105597590|NCT01147341|364189980|FG000|Double Blind Period|Lack of Efficacy|1|||
105597591|NCT01147341|364189981|FG001|Double Blind Period|Lack of Efficacy|1|||
105597592|NCT01147341|364189980|FG000|Double Blind Period|Withdrawal by Subject|0|||
105597593|NCT01147341|364189981|FG001|Double Blind Period|Withdrawal by Subject|1|||
105597594|NCT01147341|364189980|FG000|Open Label Period|Lack of Efficacy|3|||
105597595|NCT01147341|364189981|FG001|Open Label Period|Lack of Efficacy|0|||
105597596|NCT01147341|364189980|FG000|Open Label Period|Subject moved|1|||
105597597|NCT01147341|364189981|FG001|Open Label Period|Subject moved|0|||
105597598|NCT02888080|364189982|FG000|Overall Study|Subject / Guardian decision|1|||
105597599|NCT02888080|364189983|FG001|Overall Study|Subject / Guardian decision|3|||
105597600|NCT02888080|364189982|FG000|Overall Study|New Therapy for study indication|1|||
105597601|NCT02888080|364189983|FG001|Overall Study|New Therapy for study indication|0|||
105597602|NCT02888080|364189982|FG000|Overall Study|Lack of Efficacy|0|||
105597603|NCT02888080|364189983|FG001|Overall Study|Lack of Efficacy|1|||
105597604|NCT02888080|364189982|FG000|Overall Study|Adverse Event|0|||
105597605|NCT02888080|364189983|FG001|Overall Study|Adverse Event|1|||
105597606|NCT00395018|364189984|FG000|On-Treatment|Death|4|||
105597607|NCT00395018|364189984|FG000|On-Treatment|Other Reason|2|||
105597608|NCT00395018|364189984|FG000|On-Treatment|Poor/non-compliance|2|||
105597609|NCT00395018|364189984|FG000|On-Treatment|Subject no longer meets study criteria|2|||
105597610|NCT00395018|364189984|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
105597611|NCT00395018|364189984|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
105597612|NCT00395018|364189984|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
105597613|NCT04439799|364189985|FG000|Overall Study|Lost to Follow-up|6|||
105597614|NCT04439799|364189986|FG001|Overall Study|Lost to Follow-up|6|||
105597615|NCT04439799|364189985|FG000|Overall Study|Withdrawal by Subject|2|||
105597616|NCT04439799|364189986|FG001|Overall Study|Withdrawal by Subject|6|||
105597617|NCT04439799|364189985|FG000|Overall Study|Adverse Event|2|||
105597618|NCT04439799|364189986|FG001|Overall Study|Adverse Event|5|||
105597619|NCT02878330|364189987|FG000|Overall Study|Death|3|||
105597620|NCT02878330|364189988|FG001|Overall Study|Death|2|||
105597621|NCT02878330|364189987|FG000|Overall Study|Lost to Follow-up|11|||
105597622|NCT02878330|364189988|FG001|Overall Study|Lost to Follow-up|26|||
105597623|NCT02878330|364189987|FG000|Overall Study|Withdrawal by Subject|11|||
105597624|NCT02878330|364189988|FG001|Overall Study|Withdrawal by Subject|21|||
105597625|NCT02878330|364189987|FG000|Overall Study|Other|4|||
105597626|NCT02878330|364189988|FG001|Overall Study|Other|7|||
105597627|NCT00666276|364189997|FG000|Overall Study|Protocol Violation|34|||
105597628|NCT00101010|364190003|FG000|Overall Study|Physician Decision|1|||
105597629|NCT00346151|364190006|FG000|Overall Study|Withdrawal by Subject|3|||
105597630|NCT01184508|364190009|FG000|Overall Study|Adverse Event|4|||
105597631|NCT01184508|364190010|FG001|Overall Study|Adverse Event|6|||
105597632|NCT01184508|364190009|FG000|Overall Study|Lack of Efficacy|1|||
105597633|NCT01184508|364190010|FG001|Overall Study|Lack of Efficacy|1|||
105597634|NCT01184508|364190009|FG000|Overall Study|Lost to Follow-up|1|||
105597635|NCT01184508|364190010|FG001|Overall Study|Lost to Follow-up|1|||
105597636|NCT01184508|364190009|FG000|Overall Study|Physician Decision|1|||
105597637|NCT01184508|364190010|FG001|Overall Study|Physician Decision|0|||
105597638|NCT01184508|364190009|FG000|Overall Study|Protocol Violation|3|||
105597639|NCT01184508|364190010|FG001|Overall Study|Protocol Violation|1|||
105597640|NCT01184508|364190009|FG000|Overall Study|Sponsor Decision|5|||
105597641|NCT01184508|364190010|FG001|Overall Study|Sponsor Decision|2|||
105597642|NCT01184508|364190009|FG000|Overall Study|Withdrawal by Subject|1|||
105597643|NCT01184508|364190010|FG001|Overall Study|Withdrawal by Subject|3|||
105597644|NCT01184508|364190009|FG000|Overall Study|Randomized, Not Treated|0|||
105597645|NCT01184508|364190010|FG001|Overall Study|Randomized, Not Treated|1|||
105597646|NCT00869323|364190011|FG000|Maintenance Therapy|concurrent illness|1|||
105597647|NCT04054635|364190021|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
105597648|NCT04054635|364190022|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
105597649|NCT04054635|364190023|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
105597650|NCT04054635|364190021|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
105597651|NCT04054635|364190022|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
105597652|NCT04054635|364190023|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
105597653|NCT02448446|364190028|FG000|Overall Study|Withdrawal by Subject|1|||
105597654|NCT02448446|364190029|FG001|Overall Study|Withdrawal by Subject|0|||
105597655|NCT02425111|364190030|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
105597656|NCT02425111|364190030|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
105597657|NCT02425111|364190030|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
105597658|NCT02425111|364190030|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
105597659|NCT02425111|364190030|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
105597660|NCT02425111|364190030|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
105597661|NCT03621696|364190031|FG000|Overall Study|Not eligible|0|||
105597662|NCT03621696|364190032|FG001|Overall Study|Not eligible|0|||
105597663|NCT03621696|364190033|FG002|Overall Study|Not eligible|0|||
105597664|NCT03621696|364190034|FG003|Overall Study|Not eligible|5|||
105597665|NCT03621696|364190031|FG000|Overall Study|Withdrawal by Subject|1|||
105597666|NCT03621696|364190032|FG001|Overall Study|Withdrawal by Subject|1|||
105597667|NCT03621696|364190033|FG002|Overall Study|Withdrawal by Subject|1|||
105597668|NCT03621696|364190034|FG003|Overall Study|Withdrawal by Subject|0|||
105597669|NCT03621696|364190031|FG000|Overall Study|Physician Decision|0|||
105597670|NCT03621696|364190032|FG001|Overall Study|Physician Decision|0|||
105597671|NCT03621696|364190033|FG002|Overall Study|Physician Decision|1|||
105597672|NCT03621696|364190034|FG003|Overall Study|Physician Decision|0|||
105597673|NCT00545077|364190035|FG000|Overall Study|Treatment not received|5|||
105597674|NCT00545077|364190036|FG001|Overall Study|Treatment not received|1|||
105597675|NCT00545077|364190035|FG000|Overall Study|Disease Progression|131|||
105597676|NCT00545077|364190036|FG001|Overall Study|Disease Progression|98|||
105597677|NCT00545077|364190035|FG000|Overall Study|Withdrawal by Subject|3|||
105597678|NCT00545077|364190036|FG001|Overall Study|Withdrawal by Subject|14|||
105597679|NCT00545077|364190035|FG000|Overall Study|Physician Decision|6|||
105597680|NCT00545077|364190036|FG001|Overall Study|Physician Decision|3|||
105597681|NCT00545077|364190035|FG000|Overall Study|Lost to Follow-up|2|||
105597682|NCT00545077|364190036|FG001|Overall Study|Lost to Follow-up|0|||
105597683|NCT00545077|364190035|FG000|Overall Study|Protocol Violation|1|||
105597684|NCT00545077|364190036|FG001|Overall Study|Protocol Violation|0|||
105597685|NCT00545077|364190035|FG000|Overall Study|Adverse Event|0|||
105597686|NCT00545077|364190036|FG001|Overall Study|Adverse Event|31|||
105597687|NCT00545077|364190035|FG000|Overall Study|Death|0|||
105597688|NCT00545077|364190036|FG001|Overall Study|Death|8|||
105597689|NCT00463788|364190037|FG000|Overall Study|Progressive Disease|86|||
105597690|NCT00463788|364190038|FG001|Overall Study|Progressive Disease|42|||
105597691|NCT00463788|364190037|FG000|Overall Study|Adverse Event|6|||
105597692|NCT00463788|364190038|FG001|Overall Study|Adverse Event|2|||
105597693|NCT00463788|364190037|FG000|Overall Study|Withdrawal by Subject|6|||
105597694|NCT00463788|364190038|FG001|Overall Study|Withdrawal by Subject|2|||
105597695|NCT00463788|364190037|FG000|Overall Study|Death|4|||
105597696|NCT00463788|364190038|FG001|Overall Study|Death|3|||
105597697|NCT00463788|364190037|FG000|Overall Study|Symptomatic Deterioration|2|||
105597698|NCT00463788|364190038|FG001|Overall Study|Symptomatic Deterioration|3|||
105597699|NCT00463788|364190037|FG000|Overall Study|Lost to Follow-up|1|||
105597700|NCT00463788|364190038|FG001|Overall Study|Lost to Follow-up|0|||
105597701|NCT00463788|364190037|FG000|Overall Study|Protocol Violation|0|||
105597702|NCT00463788|364190038|FG001|Overall Study|Protocol Violation|1|||
105597703|NCT00463788|364190037|FG000|Overall Study|Other|3|||
105597704|NCT00463788|364190038|FG001|Overall Study|Other|0|||
105597705|NCT00463788|364190037|FG000|Overall Study|Randomized but not treated|1|||
105597706|NCT00463788|364190038|FG001|Overall Study|Randomized but not treated|1|||
105597707|NCT00360698|364190039|FG000|Run-In|Physician Decision|0|||
105597708|NCT00360698|364190040|FG001|Run-In|Physician Decision|1|||
105597709|NCT00360698|364190039|FG000|Run-In|Withdrawal by Subject|0|||
105597710|NCT00360698|364190040|FG001|Run-In|Withdrawal by Subject|2|||
105597711|NCT00360698|364190039|FG000|Run-In|Non compliance with treatment procedure|0|||
105597712|NCT00360698|364190040|FG001|Run-In|Non compliance with treatment procedure|1|||
105597713|NCT00360698|364190039|FG000|Run-In|Sponsor request|0|||
105597714|NCT00360698|364190040|FG001|Run-In|Sponsor request|2|||
105597715|NCT00360698|364190039|FG000|Run-In|Patient did not meet inclusion criteria|0|||
105597716|NCT00360698|364190040|FG001|Run-In|Patient did not meet inclusion criteria|1|||
105597717|NCT00360698|364190039|FG000|Run-In|Patient personal reasons|0|||
105597718|NCT00360698|364190040|FG001|Run-In|Patient personal reasons|2|||
105597719|NCT00360698|364190039|FG000|Run-In|Need of insulin with meals|0|||
105597720|NCT00360698|364190040|FG001|Run-In|Need of insulin with meals|1|||
105597721|NCT00360698|364190039|FG000|Treatment Period|Non compliance with treatment procedure|1|||
105597722|NCT00360698|364190040|FG001|Treatment Period|Non compliance with treatment procedure|0|||
105597723|NCT00360698|364190039|FG000|Treatment Period|Early termination by error|0|||
105597724|NCT00360698|364190040|FG001|Treatment Period|Early termination by error|1|||
105597725|NCT05082935|364190041|FG000|Overall Study|Lost to Follow-up|549|||
105597726|NCT05082935|364190042|FG001|Overall Study|Lost to Follow-up|631|||
105597727|NCT05082935|364190041|FG000|Overall Study|Withdrawal by Subject|27|||
105597728|NCT05082935|364190042|FG001|Overall Study|Withdrawal by Subject|58|||
105597729|NCT01444417|364190043|FG000|Overall Study|Ineligibility Determined|0|||
105597730|NCT01444417|364190044|FG001|Overall Study|Ineligibility Determined|1|||
105597731|NCT01444417|364190043|FG000|Overall Study|Withdrawal by Subject|2|||
105597732|NCT01444417|364190044|FG001|Overall Study|Withdrawal by Subject|0|||
105597733|NCT05283395|364190047|FG000|Overall Study|Adverse Event|4|||
105597734|NCT05283395|364190048|FG001|Overall Study|Adverse Event|4|||
105597735|NCT05283395|364190049|FG002|Overall Study|Adverse Event|0|||
105597736|NCT05283395|364190047|FG000|Overall Study|Patient Lost to Follow-Up|0|||
105597737|NCT05283395|364190048|FG001|Overall Study|Patient Lost to Follow-Up|0|||
105597738|NCT05283395|364190049|FG002|Overall Study|Patient Lost to Follow-Up|1|||
105597739|NCT05283395|364190047|FG000|Overall Study|Patient Withdrawal|2|||
105597740|NCT05283395|364190048|FG001|Overall Study|Patient Withdrawal|4|||
105597741|NCT05283395|364190049|FG002|Overall Study|Patient Withdrawal|2|||
105597742|NCT05283395|364190047|FG000|Overall Study|Investigator Decision|1|||
105597743|NCT05283395|364190048|FG001|Overall Study|Investigator Decision|0|||
105597744|NCT05283395|364190049|FG002|Overall Study|Investigator Decision|1|||
105597745|NCT05283395|364190047|FG000|Overall Study|Enrolled in error|0|||
105597746|NCT05283395|364190048|FG001|Overall Study|Enrolled in error|0|||
105597747|NCT05283395|364190049|FG002|Overall Study|Enrolled in error|1|||
105597748|NCT00712335|364190050|FG000|Overall Study|Withdrawal by Subject|0|||
105597749|NCT00712335|364190051|FG001|Overall Study|Withdrawal by Subject|7|||
105597750|NCT00712335|364190052|FG002|Overall Study|Withdrawal by Subject|2|||
105597751|NCT00712335|364190053|FG003|Overall Study|Withdrawal by Subject|3|||
105597752|NCT00712335|364190054|FG004|Overall Study|Withdrawal by Subject|0|||
105597753|NCT00712335|364190050|FG000|Overall Study|Lost to Follow-up|2|||
105597754|NCT00712335|364190051|FG001|Overall Study|Lost to Follow-up|5|||
105597755|NCT00712335|364190052|FG002|Overall Study|Lost to Follow-up|0|||
105597756|NCT00712335|364190053|FG003|Overall Study|Lost to Follow-up|1|||
105597757|NCT00712335|364190054|FG004|Overall Study|Lost to Follow-up|0|||
105597758|NCT00712335|364190050|FG000|Overall Study|Protocol Violation|1|||
105597759|NCT00712335|364190051|FG001|Overall Study|Protocol Violation|2|||
105597760|NCT00712335|364190052|FG002|Overall Study|Protocol Violation|1|||
105597761|NCT00712335|364190053|FG003|Overall Study|Protocol Violation|0|||
105597762|NCT00712335|364190054|FG004|Overall Study|Protocol Violation|0|||
105597763|NCT00712335|364190050|FG000|Overall Study|Lack of Efficacy|0|||
105597764|NCT00712335|364190051|FG001|Overall Study|Lack of Efficacy|0|||
105597765|NCT00712335|364190052|FG002|Overall Study|Lack of Efficacy|1|||
105597766|NCT00712335|364190053|FG003|Overall Study|Lack of Efficacy|1|||
105597767|NCT00712335|364190054|FG004|Overall Study|Lack of Efficacy|0|||
105597768|NCT00712335|364190050|FG000|Overall Study|Other Reason|0|||
105597769|NCT00712335|364190051|FG001|Overall Study|Other Reason|3|||
105597770|NCT00712335|364190052|FG002|Overall Study|Other Reason|1|||
105597771|NCT00712335|364190053|FG003|Overall Study|Other Reason|0|||
105597772|NCT00712335|364190054|FG004|Overall Study|Other Reason|0|||
105597773|NCT03401112|364190055|FG000|Overall Study|Adverse Event|1|||
105597774|NCT03401112|364190056|FG001|Overall Study|Adverse Event|2|||
105597775|NCT03401112|364190057|FG002|Overall Study|Adverse Event|3|||
105597776|NCT03401112|364190058|FG003|Overall Study|Adverse Event|2|||
105597777|NCT03401112|364190059|FG004|Overall Study|Adverse Event|0|||
105597778|NCT03401112|364190055|FG000|Overall Study|Lost to Follow-up|1|||
105597779|NCT03401112|364190056|FG001|Overall Study|Lost to Follow-up|0|||
105597780|NCT03401112|364190057|FG002|Overall Study|Lost to Follow-up|0|||
105597781|NCT03401112|364190058|FG003|Overall Study|Lost to Follow-up|0|||
105597782|NCT03401112|364190059|FG004|Overall Study|Lost to Follow-up|0|||
105597783|NCT03401112|364190055|FG000|Overall Study|Noncompliance|1|||
105597784|NCT03401112|364190056|FG001|Overall Study|Noncompliance|2|||
105597785|NCT03401112|364190057|FG002|Overall Study|Noncompliance|3|||
105597786|NCT03401112|364190058|FG003|Overall Study|Noncompliance|0|||
105597787|NCT03401112|364190059|FG004|Overall Study|Noncompliance|0|||
105597788|NCT03401112|364190055|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
105597789|NCT03401112|364190056|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
105597790|NCT03401112|364190057|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
105597791|NCT03401112|364190058|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
105597792|NCT03401112|364190059|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
105597793|NCT03401112|364190055|FG000|Overall Study|Withdrawal by Subject|0|||
105597794|NCT03401112|364190056|FG001|Overall Study|Withdrawal by Subject|3|||
105597795|NCT03401112|364190057|FG002|Overall Study|Withdrawal by Subject|2|||
105597796|NCT03401112|364190058|FG003|Overall Study|Withdrawal by Subject|1|||
105597797|NCT03401112|364190059|FG004|Overall Study|Withdrawal by Subject|0|||
105597798|NCT03401112|364190055|FG000|Overall Study|Physician Decision|0|||
105597799|NCT03401112|364190056|FG001|Overall Study|Physician Decision|0|||
105597800|NCT03401112|364190057|FG002|Overall Study|Physician Decision|0|||
105597801|NCT03401112|364190058|FG003|Overall Study|Physician Decision|2|||
105597802|NCT03401112|364190059|FG004|Overall Study|Physician Decision|0|||
105597803|NCT03401112|364190055|FG000|Overall Study|Study was Terminated by Sponsor|0|||
105597804|NCT03401112|364190056|FG001|Overall Study|Study was Terminated by Sponsor|0|||
105597805|NCT03401112|364190057|FG002|Overall Study|Study was Terminated by Sponsor|0|||
105597806|NCT03401112|364190058|FG003|Overall Study|Study was Terminated by Sponsor|1|||
105597807|NCT03401112|364190059|FG004|Overall Study|Study was Terminated by Sponsor|0|||
105597808|NCT03401112|364190055|FG000|Overall Study|Day 1 Assessment not Done|1|||
105597809|NCT03401112|364190056|FG001|Overall Study|Day 1 Assessment not Done|0|||
105597810|NCT03401112|364190057|FG002|Overall Study|Day 1 Assessment not Done|0|||
105597811|NCT03401112|364190058|FG003|Overall Study|Day 1 Assessment not Done|0|||
105597812|NCT03401112|364190059|FG004|Overall Study|Day 1 Assessment not Done|0|||
105597813|NCT03401112|364190055|FG000|Overall Study|Not Dosed|0|||
105597814|NCT03401112|364190056|FG001|Overall Study|Not Dosed|0|||
105597815|NCT03401112|364190057|FG002|Overall Study|Not Dosed|1|||
105597816|NCT03401112|364190058|FG003|Overall Study|Not Dosed|0|||
105597817|NCT03401112|364190059|FG004|Overall Study|Not Dosed|0|||
105597818|NCT03401112|364190055|FG000|Overall Study|Missed Clinical Visit|0|||
105597819|NCT03401112|364190056|FG001|Overall Study|Missed Clinical Visit|0|||
105597820|NCT03401112|364190057|FG002|Overall Study|Missed Clinical Visit|1|||
105597821|NCT03401112|364190058|FG003|Overall Study|Missed Clinical Visit|0|||
105597822|NCT03401112|364190059|FG004|Overall Study|Missed Clinical Visit|0|||
105597823|NCT03401112|364190055|FG000|Overall Study|Missed Doses|0|||
105597824|NCT03401112|364190056|FG001|Overall Study|Missed Doses|0|||
105597825|NCT03401112|364190057|FG002|Overall Study|Missed Doses|1|||
105597826|NCT03401112|364190058|FG003|Overall Study|Missed Doses|0|||
105597827|NCT03401112|364190059|FG004|Overall Study|Missed Doses|0|||
105597828|NCT03475316|364190061|FG000|6 Month Intervention|Adverse Event|2|||
105597829|NCT03475316|364190062|FG001|6 Month Intervention|Adverse Event|1|||
105597830|NCT03475316|364190061|FG000|6 Month Intervention|Withdrawal by Subject|2|||
105597831|NCT03475316|364190062|FG001|6 Month Intervention|Withdrawal by Subject|0|||
105597832|NCT03475316|364190061|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
105597833|NCT03475316|364190062|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
105597834|NCT03475316|364190061|FG000|9 Months|Study stopped due to COVID pandemic|3|||
105597835|NCT03475316|364190062|FG001|9 Months|Study stopped due to COVID pandemic|4|||
105597836|NCT01317420|364190063|FG000|Overall Study|Progressive disease according to RECIST|2|||
105597837|NCT01317420|364190064|FG001|Overall Study|Progressive disease according to RECIST|3|||
105597838|NCT01317420|364190065|FG002|Overall Study|Progressive disease according to RECIST|3|||
105597839|NCT01317420|364190066|FG003|Overall Study|Progressive disease according to RECIST|3|||
105597840|NCT01317420|364190067|FG004|Overall Study|Progressive disease according to RECIST|3|||
105597841|NCT01317420|364190068|FG005|Overall Study|Progressive disease according to RECIST|3|||
105597842|NCT01317420|364190069|FG006|Overall Study|Progressive disease according to RECIST|3|||
105597843|NCT01317420|364190070|FG007|Overall Study|Progressive disease according to RECIST|3|||
105597844|NCT01317420|364190071|FG008|Overall Study|Progressive disease according to RECIST|3|||
105597845|NCT01317420|364190072|FG009|Overall Study|Progressive disease according to RECIST|2|||
105597846|NCT01317420|364190073|FG010|Overall Study|Progressive disease according to RECIST|3|||
105597847|NCT01317420|364190074|FG011|Overall Study|Progressive disease according to RECIST|11|||
105597848|NCT01317420|364190075|FG012|Overall Study|Progressive disease according to RECIST|16|||
105597849|NCT01317420|364190063|FG000|Overall Study|Other adverse event|1|||
105597850|NCT01317420|364190064|FG001|Overall Study|Other adverse event|0|||
105597851|NCT01317420|364190065|FG002|Overall Study|Other adverse event|0|||
105597852|NCT01317420|364190066|FG003|Overall Study|Other adverse event|0|||
105597853|NCT01317420|364190067|FG004|Overall Study|Other adverse event|0|||
105597854|NCT01317420|364190068|FG005|Overall Study|Other adverse event|0|||
105597855|NCT01317420|364190069|FG006|Overall Study|Other adverse event|0|||
105597856|NCT01317420|364190070|FG007|Overall Study|Other adverse event|0|||
105597857|NCT01317420|364190071|FG008|Overall Study|Other adverse event|0|||
105597858|NCT01317420|364190072|FG009|Overall Study|Other adverse event|0|||
105597859|NCT01317420|364190073|FG010|Overall Study|Other adverse event|0|||
105597860|NCT01317420|364190074|FG011|Overall Study|Other adverse event|0|||
105597861|NCT01317420|364190075|FG012|Overall Study|Other adverse event|2|||
105597862|NCT01317420|364190063|FG000|Overall Study|Non-compliant with protocol|0|||
105597863|NCT01317420|364190064|FG001|Overall Study|Non-compliant with protocol|0|||
105597864|NCT01317420|364190065|FG002|Overall Study|Non-compliant with protocol|0|||
105597865|NCT01317420|364190066|FG003|Overall Study|Non-compliant with protocol|0|||
105597866|NCT01317420|364190067|FG004|Overall Study|Non-compliant with protocol|0|||
105597867|NCT01317420|364190068|FG005|Overall Study|Non-compliant with protocol|0|||
105597868|NCT01317420|364190069|FG006|Overall Study|Non-compliant with protocol|0|||
105597869|NCT01317420|364190070|FG007|Overall Study|Non-compliant with protocol|0|||
105597870|NCT01317420|364190071|FG008|Overall Study|Non-compliant with protocol|0|||
105597871|NCT01317420|364190072|FG009|Overall Study|Non-compliant with protocol|0|||
105597872|NCT01317420|364190073|FG010|Overall Study|Non-compliant with protocol|0|||
105597873|NCT01317420|364190074|FG011|Overall Study|Non-compliant with protocol|0|||
105597874|NCT01317420|364190075|FG012|Overall Study|Non-compliant with protocol|1|||
105597875|NCT01317420|364190063|FG000|Overall Study|Refused to cont. taking trial medication|0|||
105597876|NCT01317420|364190064|FG001|Overall Study|Refused to cont. taking trial medication|0|||
105597877|NCT01317420|364190065|FG002|Overall Study|Refused to cont. taking trial medication|0|||
105597878|NCT01317420|364190066|FG003|Overall Study|Refused to cont. taking trial medication|0|||
105597879|NCT01317420|364190067|FG004|Overall Study|Refused to cont. taking trial medication|0|||
105597880|NCT01317420|364190068|FG005|Overall Study|Refused to cont. taking trial medication|0|||
105597881|NCT01317420|364190069|FG006|Overall Study|Refused to cont. taking trial medication|0|||
105597882|NCT01317420|364190070|FG007|Overall Study|Refused to cont. taking trial medication|0|||
105597883|NCT01317420|364190071|FG008|Overall Study|Refused to cont. taking trial medication|0|||
105597884|NCT01317420|364190072|FG009|Overall Study|Refused to cont. taking trial medication|0|||
105597885|NCT01317420|364190073|FG010|Overall Study|Refused to cont. taking trial medication|0|||
105597886|NCT01317420|364190074|FG011|Overall Study|Refused to cont. taking trial medication|0|||
105597887|NCT01317420|364190075|FG012|Overall Study|Refused to cont. taking trial medication|1|||
105597888|NCT01317420|364190063|FG000|Overall Study|Reason other than those specified|0|||
105597889|NCT01317420|364190064|FG001|Overall Study|Reason other than those specified|0|||
105597890|NCT01317420|364190065|FG002|Overall Study|Reason other than those specified|0|||
105597891|NCT01317420|364190066|FG003|Overall Study|Reason other than those specified|0|||
105597892|NCT01317420|364190067|FG004|Overall Study|Reason other than those specified|0|||
105597893|NCT01317420|364190068|FG005|Overall Study|Reason other than those specified|0|||
105597894|NCT01317420|364190069|FG006|Overall Study|Reason other than those specified|0|||
105597895|NCT01317420|364190070|FG007|Overall Study|Reason other than those specified|0|||
105597896|NCT01317420|364190071|FG008|Overall Study|Reason other than those specified|0|||
105597897|NCT01317420|364190072|FG009|Overall Study|Reason other than those specified|1|||
105597898|NCT01317420|364190073|FG010|Overall Study|Reason other than those specified|0|||
105597899|NCT01317420|364190074|FG011|Overall Study|Reason other than those specified|0|||
105597900|NCT01317420|364190075|FG012|Overall Study|Reason other than those specified|0|||
105597901|NCT01430611|364190076|FG000|Overall Study|Adverse Event|0|||
105597902|NCT01430611|364190077|FG001|Overall Study|Adverse Event|1|||
105597903|NCT01430611|364190076|FG000|Overall Study|Protocol Violation|1|||
105597904|NCT01430611|364190077|FG001|Overall Study|Protocol Violation|0|||
105597905|NCT01430611|364190076|FG000|Overall Study|Lost to Follow-up|1|||
105597906|NCT01430611|364190077|FG001|Overall Study|Lost to Follow-up|0|||
105597907|NCT01430611|364190076|FG000|Overall Study|Withdrawal by Subject|15|||
105597908|NCT01430611|364190077|FG001|Overall Study|Withdrawal by Subject|14|||
105597909|NCT02709655|364190079|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
105597910|NCT02709655|364190080|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
105597911|NCT02709655|364190081|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
105597912|NCT02709655|364190082|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
105597913|NCT02709655|364190083|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
105597914|NCT02709655|364190079|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
105597915|NCT02709655|364190080|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
105597916|NCT02709655|364190081|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
105597917|NCT02709655|364190082|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
105597918|NCT02709655|364190083|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
105597919|NCT02709655|364190079|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
105597920|NCT02709655|364190080|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
105597921|NCT02709655|364190081|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
105597922|NCT02709655|364190082|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
105597923|NCT02709655|364190083|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
105597924|NCT02709655|364190079|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
105597925|NCT02709655|364190080|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
105597926|NCT02709655|364190081|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
105597927|NCT02709655|364190082|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
105597928|NCT02709655|364190083|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
105597929|NCT02709655|364190079|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
105597930|NCT02709655|364190080|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
105597931|NCT02709655|364190081|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
105597932|NCT02709655|364190082|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
105597933|NCT02709655|364190083|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
105597934|NCT02709655|364190079|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
105597935|NCT02709655|364190080|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
105597936|NCT02709655|364190081|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
105597937|NCT02709655|364190082|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
105597938|NCT02709655|364190083|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
105597939|NCT02709655|364190079|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
105597940|NCT02709655|364190080|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
105597941|NCT02709655|364190081|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
105597942|NCT02709655|364190082|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
105597943|NCT02709655|364190083|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
105597944|NCT02709655|364190079|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
105597945|NCT02709655|364190080|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
105597946|NCT02709655|364190081|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
105597947|NCT02709655|364190082|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
105597948|NCT02709655|364190083|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
105597949|NCT02709655|364190079|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
105597950|NCT02709655|364190080|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
105597951|NCT02709655|364190081|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
105597952|NCT02709655|364190082|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
105597953|NCT02709655|364190083|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
105597954|NCT02709655|364190079|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
105597955|NCT02709655|364190080|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
105597956|NCT02709655|364190081|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
105597957|NCT02709655|364190082|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
105597958|NCT02709655|364190083|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
105597959|NCT02709655|364190079|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
105597960|NCT02709655|364190080|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
105597961|NCT02709655|364190081|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
105597962|NCT02709655|364190082|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
105597963|NCT02709655|364190083|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
105597964|NCT02709655|364190079|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
105597965|NCT02709655|364190080|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
105597966|NCT02709655|364190081|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
105597967|NCT02709655|364190082|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
105597968|NCT02709655|364190083|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
105597969|NCT02709655|364190079|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
105597970|NCT02709655|364190080|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
105597971|NCT02709655|364190081|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
105597972|NCT02709655|364190082|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
105597973|NCT02709655|364190083|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
105597974|NCT02709655|364190079|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
105597975|NCT02709655|364190080|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
105597976|NCT02709655|364190081|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
105597977|NCT02709655|364190082|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
105597978|NCT02709655|364190083|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
105597979|NCT02709655|364190079|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
105597980|NCT02709655|364190080|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
105597981|NCT02709655|364190081|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
105597982|NCT02709655|364190082|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
105597983|NCT02709655|364190083|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
105597984|NCT02709655|364190079|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
105597985|NCT02709655|364190080|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
105597986|NCT02709655|364190081|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
105597987|NCT02709655|364190082|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
105597988|NCT02709655|364190083|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
105597989|NCT05082025|364190084|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
105597990|NCT04210180|364190085|FG000|Overall Study|Withdrawal by Subject|2|||
105597991|NCT00857649|364190086|FG000|Overall Study|Adverse Event|15|||
105597992|NCT00857649|364190087|FG001|Overall Study|Adverse Event|10|||
105597993|NCT00857649|364190086|FG000|Overall Study|Non-compliance|1|||
105597994|NCT00857649|364190087|FG001|Overall Study|Non-compliance|1|||
105597995|NCT00857649|364190086|FG000|Overall Study|Protocol Violation|2|||
105597996|NCT00857649|364190087|FG001|Overall Study|Protocol Violation|2|||
105597997|NCT00857649|364190086|FG000|Overall Study|Withdrawal of Consent|10|||
105597998|NCT00857649|364190087|FG001|Overall Study|Withdrawal of Consent|7|||
105597999|NCT00857649|364190086|FG000|Overall Study|Nursing Home Placement|2|||
105598000|NCT00857649|364190087|FG001|Overall Study|Nursing Home Placement|9|||
105598001|NCT00857649|364190086|FG000|Overall Study|Other Reasons|1|||
105598002|NCT00857649|364190087|FG001|Overall Study|Other Reasons|3|||
105598003|NCT02158091|364190088|FG000|Overall Study|DLT|2|||
105598004|NCT02158091|364190089|FG001|Overall Study|DLT|1|||
105598005|NCT02158091|364190090|FG002|Overall Study|DLT|0|||
105598006|NCT00997386|364190093|FG000|Overall Study|Death|7|||
105598007|NCT04257058|364191210|FG000|Overall Study|Lost to Follow-up|31|||
105598008|NCT05147233|364191217|FG000|Overall Study|Adverse Event|0|||
105598009|NCT05147233|364191218|FG001|Overall Study|Adverse Event|1|||
105598010|NCT05147233|364191217|FG000|Overall Study|Lost to Follow-up|1|||
105598011|NCT05147233|364191218|FG001|Overall Study|Lost to Follow-up|1|||
105598012|NCT05147233|364191217|FG000|Overall Study|Protocol Violation|0|||
105598013|NCT05147233|364191218|FG001|Overall Study|Protocol Violation|1|||
105598014|NCT05147233|364191217|FG000|Overall Study|Withdrawal by Subject|2|||
105598015|NCT05147233|364191218|FG001|Overall Study|Withdrawal by Subject|1|||
105598016|NCT04513522|364191219|FG000|Overall Study|Other reasons|1|||
105598017|NCT04513522|364191219|FG000|Overall Study|Adverse event unrelated to study drug|9|||
105598018|NCT04513522|364191219|FG000|Overall Study|Study drug toxicity|14|||
105598019|NCT04513522|364191219|FG000|Overall Study|Disease progression|39|||
105598020|NCT04513522|364191219|FG000|Overall Study|Participants withdrew consent|2|||
105598021|NCT03266016|364191220|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
105598022|NCT03266016|364191221|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
105598023|NCT03266016|364191222|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
105598024|NCT03266016|364191223|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
105598025|NCT03266016|364191220|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
105598026|NCT03266016|364191221|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
105598027|NCT03266016|364191222|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
105598028|NCT03266016|364191223|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
105598029|NCT03538041|364191226|FG000|12-Week Treatment Period|Adverse Event|1|||
105598030|NCT03538041|364191227|FG001|12-Week Treatment Period|Adverse Event|1|||
105598031|NCT03538041|364191226|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
105598032|NCT03538041|364191227|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
105598033|NCT03538041|364191226|FG000|Treatment Extension Period|Adverse Event|4|||
105598034|NCT03538041|364191227|FG001|Treatment Extension Period|Adverse Event|1|||
105598035|NCT03538041|364191226|FG000|Treatment Extension Period|Physician Decision|1|||
105598036|NCT03538041|364191227|FG001|Treatment Extension Period|Physician Decision|1|||
105598037|NCT03538041|364191226|FG000|Treatment Extension Period|Lack of Efficacy|1|||
105598038|NCT03538041|364191227|FG001|Treatment Extension Period|Lack of Efficacy|4|||
105598039|NCT03538041|364191226|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
105598040|NCT03538041|364191227|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
105598041|NCT03538041|364191226|FG000|Treatment Extension Period|Death|0|||
105598042|NCT03538041|364191227|FG001|Treatment Extension Period|Death|1|||
105598043|NCT00925899|364191232|FG000|Part 1|Death|1|||
105598044|NCT00925899|364191233|FG001|Part 1|Death|2|||
105598045|NCT00925899|364191232|FG000|Part 1|Withdrawal by Subject|10|||
105598046|NCT00925899|364191233|FG001|Part 1|Withdrawal by Subject|9|||
105598047|NCT03544515|364191234|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
105598048|NCT03544515|364191235|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
105598049|NCT03544515|364191234|FG000|Overall Study|Lost to Follow-up|2|||
105598050|NCT03544515|364191235|FG001|Overall Study|Lost to Follow-up|0|||
105598051|NCT03169244|364191236|FG000|Overall Study|Lost to Follow-up|1|||
105598052|NCT03169244|364191237|FG001|Overall Study|Lost to Follow-up|2|||
105598053|NCT03169244|364191236|FG000|Overall Study|Adverse Event|1|||
105598054|NCT03169244|364191237|FG001|Overall Study|Adverse Event|0|||
105598055|NCT03169244|364191236|FG000|Overall Study|Withdrawal by Subject|2|||
105598056|NCT03169244|364191237|FG001|Overall Study|Withdrawal by Subject|2|||
105598057|NCT03169244|364191236|FG000|Overall Study|Physician Decision|1|||
105598058|NCT03169244|364191237|FG001|Overall Study|Physician Decision|0|||
105598059|NCT01266265|364191240|FG000|Overall Study|Death|95|||
105598060|NCT01266265|364191241|FG001|Overall Study|Death|73|||
105598061|NCT01266265|364191240|FG000|Overall Study|Lost to Follow-up|23|||
105598062|NCT01266265|364191241|FG001|Overall Study|Lost to Follow-up|28|||
105598063|NCT01266265|364191240|FG000|Overall Study|Withdrawal by Subject|13|||
105598064|NCT01266265|364191241|FG001|Overall Study|Withdrawal by Subject|11|||
105598065|NCT01266265|364191240|FG000|Overall Study|Respiratory-related adverse event|2|||
105598066|NCT01266265|364191241|FG001|Overall Study|Respiratory-related adverse event|1|||
105598067|NCT01266265|364191240|FG000|Overall Study|Transferred care to another provider|22|||
105598068|NCT01266265|364191241|FG001|Overall Study|Transferred care to another provider|28|||
105598069|NCT01266265|364191240|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
105598070|NCT01266265|364191241|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
105598071|NCT01266265|364191240|FG000|Overall Study|Enrolled in another clinical study|15|||
105598072|NCT01266265|364191241|FG001|Overall Study|Enrolled in another clinical study|26|||
105598073|NCT01266265|364191240|FG000|Overall Study|Non-compliance|8|||
105598074|NCT01266265|364191241|FG001|Overall Study|Non-compliance|5|||
105598075|NCT01266265|364191240|FG000|Overall Study|Lung transplant|6|||
105598076|NCT01266265|364191241|FG001|Overall Study|Lung transplant|5|||
105598077|NCT01266265|364191240|FG000|Overall Study|Site closed early|4|||
105598078|NCT01266265|364191241|FG001|Overall Study|Site closed early|3|||
105598079|NCT01266265|364191240|FG000|Overall Study|Clinical worsening|1|||
105598080|NCT01266265|364191241|FG001|Overall Study|Clinical worsening|1|||
105598081|NCT00955825|364191242|FG000|Overall Study|Adverse Event|15|||
105598082|NCT00955825|364191243|FG001|Overall Study|Adverse Event|2|||
105598083|NCT00955825|364191242|FG000|Overall Study|Withdrawal by Subject|4|||
105598084|NCT00955825|364191243|FG001|Overall Study|Withdrawal by Subject|6|||
105598085|NCT00955825|364191242|FG000|Overall Study|Any other reason not above-mentioned|7|||
105598086|NCT00955825|364191243|FG001|Overall Study|Any other reason not above-mentioned|9|||
105598087|NCT01759264|364191246|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
105598088|NCT01759264|364191246|FG000|Overall Study|Adverse Event|1|||
105598089|NCT01759264|364191246|FG000|Overall Study|Other|2|||
105598090|NCT01759264|364191246|FG000|Overall Study|Lost to Follow-up|2|||
105598091|NCT01759264|364191246|FG000|Overall Study|Withdrawal by Subject|3|||
105598092|NCT01759264|364191246|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
105598093|NCT00114244|364191248|FG000|Overall Study|Adverse Event|2|||
105598094|NCT00114244|364191249|FG001|Overall Study|Adverse Event|5|||
105598095|NCT00114244|364191248|FG000|Overall Study|Withdrawal by Subject|0|||
105598096|NCT00114244|364191249|FG001|Overall Study|Withdrawal by Subject|2|||
105598097|NCT02383472|364191250|FG000|Overall Study|Withdrawal by Subject|1|||
105598098|NCT02383472|364191251|FG001|Overall Study|Withdrawal by Subject|1|||
105598099|NCT02013830|364191252|FG000|Overall Study|Adverse Event|3|||
105598100|NCT02013830|364191252|FG000|Overall Study|Death|1|||
105598101|NCT02013830|364191252|FG000|Overall Study|Insufficient therapeutic response|25|||
105598102|NCT02013830|364191252|FG000|Overall Study|Refused treatment|1|||
105598103|NCT01111526|364191253|FG000|Overall Study|GVHD Disease Progression|0|||
105598104|NCT01111526|364191254|FG001|Overall Study|GVHD Disease Progression|1|||
105598105|NCT01111526|364191255|FG002|Overall Study|GVHD Disease Progression|2|||
105598106|NCT00186186|364191256|FG000|Overall Study|Lack of Efficacy|3|||
105598107|NCT00186186|364191256|FG000|Overall Study|Withdrawal by Subject|3|||
105598108|NCT00186186|364191256|FG000|Overall Study|Not reported as to reason|2|||
105598109|NCT03622580|364191259|FG000|Overall Study|Death|16|||
105598110|NCT03622580|364191260|FG001|Overall Study|Death|21|||
105598111|NCT03622580|364191261|FG002|Overall Study|Death|13|||
105598112|NCT03622580|364191259|FG000|Overall Study|Adverse Event|6|||
105598113|NCT03622580|364191260|FG001|Overall Study|Adverse Event|6|||
105598114|NCT03622580|364191261|FG002|Overall Study|Adverse Event|5|||
105598115|NCT03622580|364191259|FG000|Overall Study|Withdrawal by Subject|12|||
105598116|NCT03622580|364191260|FG001|Overall Study|Withdrawal by Subject|7|||
105598117|NCT03622580|364191261|FG002|Overall Study|Withdrawal by Subject|19|||
105598118|NCT03622580|364191259|FG000|Overall Study|Lost to Follow-up|12|||
105598119|NCT03622580|364191260|FG001|Overall Study|Lost to Follow-up|9|||
105598120|NCT03622580|364191261|FG002|Overall Study|Lost to Follow-up|9|||
105598121|NCT03622580|364191259|FG000|Overall Study|Protocol Violation|1|||
105598122|NCT03622580|364191260|FG001|Overall Study|Protocol Violation|0|||
105598123|NCT03622580|364191261|FG002|Overall Study|Protocol Violation|1|||
105598124|NCT03622580|364191259|FG000|Overall Study|Physician Decision|3|||
105598125|NCT03622580|364191260|FG001|Overall Study|Physician Decision|0|||
105598126|NCT03622580|364191261|FG002|Overall Study|Physician Decision|1|||
105598127|NCT03622580|364191259|FG000|Overall Study|Pregnancy|0|||
105598128|NCT03622580|364191260|FG001|Overall Study|Pregnancy|1|||
105598129|NCT03622580|364191261|FG002|Overall Study|Pregnancy|0|||
105598130|NCT03622580|364191259|FG000|Overall Study|Lack of Efficacy|0|||
105598131|NCT03622580|364191260|FG001|Overall Study|Lack of Efficacy|0|||
105598132|NCT03622580|364191261|FG002|Overall Study|Lack of Efficacy|1|||
105598133|NCT03622580|364191259|FG000|Overall Study|Other|2|||
105598134|NCT03622580|364191260|FG001|Overall Study|Other|0|||
105598135|NCT03622580|364191261|FG002|Overall Study|Other|3|||
105598136|NCT01140048|364191262|FG000|Overall Study|Physician Decision|1|||
105598137|NCT01140048|364191262|FG000|Overall Study|Withdrawal by Subject|13|||
105598138|NCT01140048|364191262|FG000|Overall Study|Lost to Follow-up|31|||
105598139|NCT00494780|364191263|FG000|Overall Study|Adverse Event|1|||
105598140|NCT00494780|364191264|FG001|Overall Study|Adverse Event|0|||
105598141|NCT00494780|364191263|FG000|Overall Study|Withdrew before Dosed|0|||
105598142|NCT00494780|364191264|FG001|Overall Study|Withdrew before Dosed|1|||
105598143|NCT00494780|364191263|FG000|Overall Study|Progression of Study Disease|7|||
105598144|NCT00494780|364191264|FG001|Overall Study|Progression of Study Disease|8|||
105598145|NCT00494780|364191263|FG000|Overall Study|New Treatment|2|||
105598146|NCT00494780|364191264|FG001|Overall Study|New Treatment|2|||
105598147|NCT00494780|364191263|FG000|Overall Study|Non-compliance|1|||
105598148|NCT00494780|364191264|FG001|Overall Study|Non-compliance|0|||
105598149|NCT00494780|364191263|FG000|Overall Study|Residual Tumour Mass|0|||
105598150|NCT00494780|364191264|FG001|Overall Study|Residual Tumour Mass|1|||
105598151|NCT00494780|364191263|FG000|Overall Study|Insurance Issues|0|||
105598152|NCT00494780|364191264|FG001|Overall Study|Insurance Issues|1|||
105598153|NCT01190007|364191265|FG000|Overall Study|Withdrawal by Subject|4|||
105598154|NCT01190007|364191265|FG000|Overall Study|Adverse Event|8|||
105598155|NCT01190007|364191265|FG000|Overall Study|Difficulty of visit for complications|1|||
105598156|NCT01190007|364191265|FG000|Overall Study|Participant was arrested|1|||
105598157|NCT02314117|364191270|FG000|Overall Study|Lost to Follow-up|9|||
105598158|NCT02314117|364191271|FG001|Overall Study|Lost to Follow-up|14|||
105598159|NCT02314117|364191270|FG000|Overall Study|Withdrawal by Subject|3|||
105598160|NCT02314117|364191271|FG001|Overall Study|Withdrawal by Subject|2|||
105598161|NCT00189202|364191272|FG000|Overall Study|Physician Decision|5|||
105598162|NCT01692938|364191280|FG000|Overall Study|Protocol Deviation|1|||
105598163|NCT01692938|364191281|FG001|Overall Study|Protocol Deviation|1|||
105598164|NCT01692938|364191280|FG000|Overall Study|Study completed prior to site completion|3|||
105598165|NCT01692938|364191281|FG001|Overall Study|Study completed prior to site completion|3|||
105598166|NCT03144674|364191285|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
105598167|NCT03144674|364191286|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
105598168|NCT03144674|364191287|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
105598169|NCT03144674|364191288|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
105598170|NCT03144674|364191285|FG000|Overall Study|Death|3|||
105598171|NCT03144674|364191286|FG001|Overall Study|Death|2|||
105598172|NCT03144674|364191287|FG002|Overall Study|Death|6|||
105598173|NCT03144674|364191288|FG003|Overall Study|Death|24|||
105598174|NCT03144674|364191285|FG000|Overall Study|Lost to Follow-up|0|||
105598175|NCT03144674|364191286|FG001|Overall Study|Lost to Follow-up|1|||
105598176|NCT03144674|364191287|FG002|Overall Study|Lost to Follow-up|0|||
105598177|NCT03144674|364191288|FG003|Overall Study|Lost to Follow-up|4|||
105598178|NCT03144674|364191285|FG000|Overall Study|Withdrawal by Participant|0|||
105598179|NCT03144674|364191286|FG001|Overall Study|Withdrawal by Participant|0|||
105598180|NCT03144674|364191287|FG002|Overall Study|Withdrawal by Participant|2|||
105598181|NCT03144674|364191288|FG003|Overall Study|Withdrawal by Participant|6|||
105598182|NCT03144674|364191285|FG000|Overall Study|Discharged from the Trust|0|||
105598183|NCT03144674|364191286|FG001|Overall Study|Discharged from the Trust|0|||
105598184|NCT03144674|364191287|FG002|Overall Study|Discharged from the Trust|1|||
105598185|NCT03144674|364191288|FG003|Overall Study|Discharged from the Trust|0|||
105598186|NCT03144674|364191285|FG000|Overall Study|Exclusion Criteria Met|0|||
105598187|NCT03144674|364191286|FG001|Overall Study|Exclusion Criteria Met|0|||
105598188|NCT03144674|364191287|FG002|Overall Study|Exclusion Criteria Met|1|||
105598189|NCT03144674|364191288|FG003|Overall Study|Exclusion Criteria Met|0|||
105598190|NCT03144674|364191285|FG000|Overall Study|Changed Physicians|0|||
105598191|NCT03144674|364191286|FG001|Overall Study|Changed Physicians|0|||
105598192|NCT03144674|364191287|FG002|Overall Study|Changed Physicians|0|||
105598193|NCT03144674|364191288|FG003|Overall Study|Changed Physicians|1|||
105598194|NCT03144674|364191285|FG000|Overall Study|Removed for Safety|0|||
105598195|NCT03144674|364191286|FG001|Overall Study|Removed for Safety|0|||
105598196|NCT03144674|364191287|FG002|Overall Study|Removed for Safety|0|||
105598197|NCT03144674|364191288|FG003|Overall Study|Removed for Safety|1|||
105598198|NCT03144674|364191285|FG000|Overall Study|Site Closed|0|||
105598199|NCT03144674|364191286|FG001|Overall Study|Site Closed|0|||
105598200|NCT03144674|364191287|FG002|Overall Study|Site Closed|0|||
105598201|NCT03144674|364191288|FG003|Overall Study|Site Closed|1|||
105598202|NCT03144674|364191285|FG000|Overall Study|Histological Criteria Not Met|0|||
105598203|NCT03144674|364191286|FG001|Overall Study|Histological Criteria Not Met|0|||
105598204|NCT03144674|364191287|FG002|Overall Study|Histological Criteria Not Met|0|||
105598205|NCT03144674|364191288|FG003|Overall Study|Histological Criteria Not Met|1|||
105598206|NCT03144674|364191285|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
105598207|NCT03144674|364191286|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
105598208|NCT03144674|364191287|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
105598209|NCT03144674|364191288|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
105598210|NCT03144674|364191285|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
105598211|NCT03144674|364191286|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
105598212|NCT03144674|364191287|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
105598213|NCT03144674|364191288|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
105598214|NCT00658996|364191291|FG000|First Intervention|Positive slit lamp finding|1|||
105598215|NCT00658996|364191292|FG001|First Intervention|Positive slit lamp finding|0|||
105598216|NCT00658996|364191291|FG000|First Intervention|Lack of lenses|0|||
105598217|NCT00658996|364191292|FG001|First Intervention|Lack of lenses|1|||
105598218|NCT00658996|364191291|FG000|Crossover Period|Physician Decision|1|||
105598219|NCT00658996|364191292|FG001|Crossover Period|Physician Decision|0|||
105598220|NCT00658996|364191291|FG000|Crossover Period|Ineligible|1|||
105598221|NCT00658996|364191292|FG001|Crossover Period|Ineligible|1|||
105598222|NCT00658996|364191291|FG000|Second Intervention|Developed a stye on upper lid|1|||
105598223|NCT00658996|364191292|FG001|Second Intervention|Developed a stye on upper lid|0|||
105598224|NCT00658996|364191291|FG000|Second Intervention|Positive slit lamp finding|0|||
105598225|NCT00658996|364191292|FG001|Second Intervention|Positive slit lamp finding|1|||
105598226|NCT00794118|364191293|FG000|Overall Study|Lost to Follow-up|16|||
105598227|NCT00794118|364191293|FG000|Overall Study|Withdrawal by Subject|9|||
105598228|NCT00794118|364191293|FG000|Overall Study|Changed hospital center|2|||
105598229|NCT01579916|364191296|FG000|Overall Study|Lost to Follow-up|6|||
105598230|NCT01579916|364191297|FG001|Overall Study|Lost to Follow-up|1|||
105598231|NCT01579916|364191296|FG000|Overall Study|Withdrawal by Subject|1|||
105598232|NCT01579916|364191297|FG001|Overall Study|Withdrawal by Subject|1|||
105598233|NCT01579916|364191296|FG000|Overall Study|Death|1|||
105598234|NCT01579916|364191297|FG001|Overall Study|Death|0|||
105598235|NCT01810263|364191298|FG000|Overall Study|Lost to Follow-up|8|||
105598236|NCT01810263|364191299|FG001|Overall Study|Lost to Follow-up|7|||
105598237|NCT04789408|364191301|FG000|Overall Study|Death|4|||
105598238|NCT04789408|364191302|FG001|Overall Study|Death|3|||
105598239|NCT04789408|364191303|FG002|Overall Study|Death|6|||
105598240|NCT04789408|364191301|FG000|Overall Study|Did not meet eligibility criteria|1|||
105598241|NCT04789408|364191302|FG001|Overall Study|Did not meet eligibility criteria|0|||
105598242|NCT04789408|364191303|FG002|Overall Study|Did not meet eligibility criteria|0|||
105598243|NCT04789408|364191301|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
105598244|NCT04789408|364191302|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
105598245|NCT04789408|364191303|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
105598246|NCT04980755|364191304|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
105598247|NCT04980755|364191304|FG000|Body Reprogramming Courses|Work commitment|2|||
105598248|NCT04980755|364191304|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
105598249|NCT04980755|364191304|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
105598250|NCT05328297|364192931|FG000|Overall Study|Adverse Event|5|||
105598251|NCT05328297|364192932|FG001|Overall Study|Adverse Event|7|||
105598252|NCT05328297|364192931|FG000|Overall Study|Withdrawal by Subject|4|||
105598253|NCT05328297|364192932|FG001|Overall Study|Withdrawal by Subject|3|||
105598254|NCT05328297|364192931|FG000|Overall Study|Lack of Efficacy|1|||
105598255|NCT05328297|364192932|FG001|Overall Study|Lack of Efficacy|0|||
105598256|NCT05328297|364192931|FG000|Overall Study|Lost to Follow-up|1|||
105598257|NCT05328297|364192932|FG001|Overall Study|Lost to Follow-up|0|||
105598258|NCT05328297|364192931|FG000|Overall Study|Protocol Violation|1|||
105598259|NCT05328297|364192932|FG001|Overall Study|Protocol Violation|0|||
105598260|NCT05328297|364192931|FG000|Overall Study|Randomized but not treated|1|||
105598261|NCT05328297|364192932|FG001|Overall Study|Randomized but not treated|1|||
105598262|NCT04517864|364192933|FG000|Placebo-Controlled Phase|Adverse Event|1|||
105598263|NCT04517864|364192934|FG001|Placebo-Controlled Phase|Adverse Event|0|||
105598264|NCT04517864|364192935|FG002|Placebo-Controlled Phase|Adverse Event|0|||
105598265|NCT04517864|364192933|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
105598266|NCT04517864|364192934|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
105598267|NCT04517864|364192935|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
105598268|NCT04517864|364192933|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
105598269|NCT04517864|364192934|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
105598270|NCT04517864|364192935|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
105598271|NCT04517864|364192933|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
105598272|NCT04517864|364192934|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
105598273|NCT04517864|364192935|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
105598274|NCT04517864|364192933|FG000|Active Therapy Extension Phase|Adverse Event|1|||
105598275|NCT04517864|364192934|FG001|Active Therapy Extension Phase|Adverse Event|0|||
105598276|NCT04517864|364192935|FG002|Active Therapy Extension Phase|Adverse Event|0|||
105598277|NCT04517864|364192933|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
105598278|NCT04517864|364192934|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
105598279|NCT04517864|364192935|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
105598280|NCT04517864|364192933|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
105598281|NCT04517864|364192934|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
105598282|NCT04517864|364192935|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
105598283|NCT04517864|364192933|FG000|Active Therapy Extension Phase|Physician Decision|1|||
105598284|NCT04517864|364192934|FG001|Active Therapy Extension Phase|Physician Decision|0|||
105598285|NCT04517864|364192935|FG002|Active Therapy Extension Phase|Physician Decision|0|||
105598286|NCT04517864|364192933|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
105598287|NCT04517864|364192934|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
105598288|NCT04517864|364192935|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
105598289|NCT04517864|364192933|FG000|Extension Phase|Adverse Event|0|||
105598290|NCT04517864|364192934|FG001|Extension Phase|Adverse Event|0|||
105598291|NCT04517864|364192935|FG002|Extension Phase|Adverse Event|1|||
105598292|NCT04517864|364192933|FG000|Extension Phase|Lack of Efficacy|0|||
105598293|NCT04517864|364192934|FG001|Extension Phase|Lack of Efficacy|0|||
105598294|NCT04517864|364192935|FG002|Extension Phase|Lack of Efficacy|2|||
105598295|NCT04517864|364192933|FG000|Extension Phase|Study Terminated By Sponsor|0|||
105598296|NCT04517864|364192934|FG001|Extension Phase|Study Terminated By Sponsor|0|||
105598297|NCT04517864|364192935|FG002|Extension Phase|Study Terminated By Sponsor|32|||
105598298|NCT04517864|364192933|FG000|Extension Phase|Withdrawal by Subject|0|||
105598299|NCT04517864|364192934|FG001|Extension Phase|Withdrawal by Subject|0|||
105598300|NCT04517864|364192935|FG002|Extension Phase|Withdrawal by Subject|3|||
105598301|NCT04517864|364192933|FG000|Extension Phase|Approved Drug Available for Indication|0|||
105598302|NCT04517864|364192934|FG001|Extension Phase|Approved Drug Available for Indication|0|||
105598303|NCT04517864|364192935|FG002|Extension Phase|Approved Drug Available for Indication|7|||
105598304|NCT00493649|364192936|FG000|Overall Study|Adverse Event|44|||
105598305|NCT00493649|364192936|FG000|Overall Study|Patient Request|21|||
105598306|NCT00493649|364192936|FG000|Overall Study|Investigator Request|2|||
105598307|NCT00493649|364192936|FG000|Overall Study|Disease Progression|1|||
105598308|NCT00493649|364192936|FG000|Overall Study|Lost to Follow-up|1|||
105598309|NCT00493649|364192936|FG000|Overall Study|Other|13|||
105598310|NCT03175172|364192937|FG000|Overall Study|Death|3|||
105598311|NCT03175172|364192937|FG000|Overall Study|Withdrawal by Subject|3|||
105598312|NCT03175172|364192937|FG000|Overall Study|Lost to Follow-up|1|||
105598313|NCT03175172|364192937|FG000|Overall Study|Study Terminated by Sponsor|3|||
105598314|NCT01662336|364192938|FG000|Overall Study|Adverse Event|1|||
105598315|NCT01662336|364192938|FG000|Overall Study|No longer on LPV/r|30|||
105598316|NCT01662336|364192938|FG000|Overall Study|Other|29|||
105598317|NCT01662336|364192938|FG000|Overall Study|Withdrawal by Subject|6|||
105598318|NCT05731700|364192939|FG000|Overall Study|Death|1|||
105598319|NCT04668339|364192940|FG000|Overall Study|Physician Decision|1|||
105598320|NCT04668339|364192941|FG001|Overall Study|Physician Decision|0|||
105598321|NCT04668339|364192942|FG002|Overall Study|Physician Decision|1|||
105598322|NCT04668339|364192943|FG003|Overall Study|Physician Decision|1|||
105598323|NCT04668339|364192940|FG000|Overall Study|Lost to Follow-up|14|||
105598324|NCT04668339|364192941|FG001|Overall Study|Lost to Follow-up|12|||
105598325|NCT04668339|364192942|FG002|Overall Study|Lost to Follow-up|8|||
105598326|NCT04668339|364192943|FG003|Overall Study|Lost to Follow-up|5|||
105598327|NCT04668339|364192940|FG000|Overall Study|Adverse Event|0|||
105598328|NCT04668339|364192941|FG001|Overall Study|Adverse Event|0|||
105598329|NCT04668339|364192942|FG002|Overall Study|Adverse Event|1|||
105598330|NCT04668339|364192943|FG003|Overall Study|Adverse Event|0|||
105598331|NCT04668339|364192940|FG000|Overall Study|Other than specified|3|||
105598332|NCT04668339|364192941|FG001|Overall Study|Other than specified|0|||
105598333|NCT04668339|364192942|FG002|Overall Study|Other than specified|1|||
105598334|NCT04668339|364192943|FG003|Overall Study|Other than specified|0|||
105598335|NCT04668339|364192940|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
105598336|NCT04668339|364192941|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
105598337|NCT04668339|364192942|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
105598338|NCT04668339|364192943|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
105598339|NCT04668339|364192940|FG000|Overall Study|Vaccine not Administered|0|||
105598340|NCT04668339|364192941|FG001|Overall Study|Vaccine not Administered|0|||
105598341|NCT04668339|364192942|FG002|Overall Study|Vaccine not Administered|1|||
105598342|NCT04668339|364192943|FG003|Overall Study|Vaccine not Administered|0|||
105598343|NCT04668339|364192940|FG000|Overall Study|Protocol Violation|18|||
105598344|NCT04668339|364192941|FG001|Overall Study|Protocol Violation|23|||
105598345|NCT04668339|364192942|FG002|Overall Study|Protocol Violation|12|||
105598346|NCT04668339|364192943|FG003|Overall Study|Protocol Violation|20|||
105598347|NCT04668339|364192940|FG000|Overall Study|Withdrawal by Subject|45|||
105598348|NCT04668339|364192941|FG001|Overall Study|Withdrawal by Subject|46|||
105598349|NCT04668339|364192942|FG002|Overall Study|Withdrawal by Subject|46|||
105598350|NCT04668339|364192943|FG003|Overall Study|Withdrawal by Subject|27|||
105598351|NCT04668339|364192940|FG000|Overall Study|Study Terminated by Sponsor|59|||
105598352|NCT04668339|364192941|FG001|Overall Study|Study Terminated by Sponsor|59|||
105598353|NCT04668339|364192942|FG002|Overall Study|Study Terminated by Sponsor|71|||
105598354|NCT04668339|364192943|FG003|Overall Study|Study Terminated by Sponsor|1|||
105598355|NCT01393119|364192947|FG000|Overall Study|Adverse Event|1|||
105598356|NCT01393119|364192948|FG001|Overall Study|Adverse Event|1|||
105598357|NCT01393119|364192949|FG002|Overall Study|Adverse Event|0|||
105598358|NCT01393119|364192950|FG003|Overall Study|Adverse Event|1|||
105598359|NCT01393119|364192947|FG000|Overall Study|Withdrawal by Subject|0|||
105598360|NCT01393119|364192948|FG001|Overall Study|Withdrawal by Subject|1|||
105598361|NCT01393119|364192949|FG002|Overall Study|Withdrawal by Subject|1|||
105598362|NCT01393119|364192950|FG003|Overall Study|Withdrawal by Subject|0|||
105598363|NCT01393119|364192947|FG000|Overall Study|Lack of Efficacy|1|||
105598364|NCT01393119|364192948|FG001|Overall Study|Lack of Efficacy|0|||
105598365|NCT01393119|364192949|FG002|Overall Study|Lack of Efficacy|2|||
105598366|NCT01393119|364192950|FG003|Overall Study|Lack of Efficacy|1|||
105598367|NCT01393119|364192947|FG000|Overall Study|Protocol Violation|0|||
105598368|NCT01393119|364192948|FG001|Overall Study|Protocol Violation|0|||
105598369|NCT01393119|364192949|FG002|Overall Study|Protocol Violation|1|||
105598370|NCT01393119|364192950|FG003|Overall Study|Protocol Violation|0|||
105598371|NCT01393119|364192947|FG000|Overall Study|Death|0|||
105598372|NCT01393119|364192948|FG001|Overall Study|Death|0|||
105598373|NCT01393119|364192949|FG002|Overall Study|Death|0|||
105598374|NCT01393119|364192950|FG003|Overall Study|Death|1|||
105598375|NCT01393119|364192947|FG000|Overall Study|Randomized but Not treated|1|||
105598376|NCT01393119|364192948|FG001|Overall Study|Randomized but Not treated|0|||
105598377|NCT01393119|364192949|FG002|Overall Study|Randomized but Not treated|1|||
105598378|NCT01393119|364192950|FG003|Overall Study|Randomized but Not treated|1|||
105598379|NCT01393119|364192947|FG000|Overall Study|Sponsor Termination of Study|11|||
105598380|NCT01393119|364192948|FG001|Overall Study|Sponsor Termination of Study|12|||
105598381|NCT01393119|364192949|FG002|Overall Study|Sponsor Termination of Study|9|||
105598382|NCT01393119|364192950|FG003|Overall Study|Sponsor Termination of Study|12|||
105598383|NCT03557008|364192951|FG000|Overall Study|Withdrawal by Subject|2|||
105598384|NCT03557008|364192952|FG001|Overall Study|Withdrawal by Subject|2|||
105598385|NCT03557008|364192951|FG000|Overall Study|Early termination from study|3|||
105598386|NCT03557008|364192952|FG001|Overall Study|Early termination from study|1|||
105598387|NCT05876949|364192955|FG000|Overall Study|Withdrawal by Subject|1|||
105598388|NCT05876949|364192956|FG001|Overall Study|Withdrawal by Subject|3|||
105598389|NCT05876949|364192955|FG000|Overall Study|Physician Decision|0|||
105598390|NCT05876949|364192956|FG001|Overall Study|Physician Decision|2|||
105598391|NCT05876949|364192955|FG000|Overall Study|Death|0|||
105598392|NCT05876949|364192956|FG001|Overall Study|Death|1|||
105598393|NCT03823300|364192957|FG000|Overall Study|Withdrawal by Subject|16|||
105598394|NCT03823300|364192958|FG001|Overall Study|Withdrawal by Subject|22|||
105598395|NCT03823300|364192957|FG000|Overall Study|Death|10|||
105598396|NCT03823300|364192958|FG001|Overall Study|Death|14|||
105598397|NCT03823300|364192957|FG000|Overall Study|Adverse Event|3|||
105598398|NCT03823300|364192958|FG001|Overall Study|Adverse Event|5|||
105598399|NCT03823300|364192957|FG000|Overall Study|Physician Decision|1|||
105598400|NCT03823300|364192958|FG001|Overall Study|Physician Decision|7|||
105598401|NCT03823300|364192957|FG000|Overall Study|Lost to Follow-up|1|||
105598402|NCT03823300|364192958|FG001|Overall Study|Lost to Follow-up|3|||
105598403|NCT03823300|364192957|FG000|Overall Study|Protocol Violation|1|||
105598404|NCT03823300|364192958|FG001|Overall Study|Protocol Violation|1|||
105598405|NCT03823300|364192957|FG000|Overall Study|Lack of Efficacy|1|||
105598406|NCT03823300|364192958|FG001|Overall Study|Lack of Efficacy|1|||
105598407|NCT03823300|364192957|FG000|Overall Study|Not Eligible|0|||
105598408|NCT03823300|364192958|FG001|Overall Study|Not Eligible|1|||
105598409|NCT03823300|364192957|FG000|Overall Study|Other|1|||
105598410|NCT03823300|364192958|FG001|Overall Study|Other|0|||
105598411|NCT00845832|364192960|FG000|Treatment Period|Adverse Event|0|||
105598412|NCT00845832|364192961|FG001|Treatment Period|Adverse Event|2|||
105598413|NCT00845832|364192962|FG002|Treatment Period|Adverse Event|0|||
105598414|NCT00845832|364192960|FG000|Treatment Period|Protocol Violation|1|||
105598415|NCT00845832|364192961|FG001|Treatment Period|Protocol Violation|1|||
105598416|NCT00845832|364192962|FG002|Treatment Period|Protocol Violation|0|||
105598417|NCT00845832|364192960|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
105598418|NCT00845832|364192961|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
105598419|NCT00845832|364192962|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
105598420|NCT00845832|364192960|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
105598421|NCT00845832|364192961|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
105598422|NCT00845832|364192962|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
105598423|NCT01039688|364192968|FG000|Overall Study|Adverse Event|38|||
105598424|NCT01039688|364192969|FG001|Overall Study|Adverse Event|39|||
105598425|NCT01039688|364192970|FG002|Overall Study|Adverse Event|24|||
105598426|NCT01039688|364192968|FG000|Overall Study|Lack of Efficacy|20|||
105598427|NCT01039688|364192969|FG001|Overall Study|Lack of Efficacy|11|||
105598428|NCT01039688|364192970|FG002|Overall Study|Lack of Efficacy|26|||
105598429|NCT01039688|364192968|FG000|Overall Study|Lost to Follow-up|11|||
105598430|NCT01039688|364192969|FG001|Overall Study|Lost to Follow-up|9|||
105598431|NCT01039688|364192970|FG002|Overall Study|Lost to Follow-up|5|||
105598432|NCT01039688|364192968|FG000|Overall Study|Other|13|||
105598433|NCT01039688|364192969|FG001|Overall Study|Other|25|||
105598434|NCT01039688|364192970|FG002|Overall Study|Other|12|||
105598435|NCT01039688|364192968|FG000|Overall Study|Withdrawal by Subject|23|||
105598436|NCT01039688|364192969|FG001|Overall Study|Withdrawal by Subject|27|||
105598437|NCT01039688|364192970|FG002|Overall Study|Withdrawal by Subject|13|||
105598438|NCT01039688|364192968|FG000|Overall Study|Death|2|||
105598439|NCT01039688|364192969|FG001|Overall Study|Death|0|||
105598440|NCT01039688|364192970|FG002|Overall Study|Death|0|||
105598441|NCT00959946|364192972|FG000|Overall Study|Adverse Event|0|||
105598442|NCT00959946|364192973|FG001|Overall Study|Adverse Event|0|||
105598443|NCT00959946|364192974|FG002|Overall Study|Adverse Event|2|||
105598444|NCT00959946|364192975|FG003|Overall Study|Adverse Event|1|||
105598445|NCT00959946|364192976|FG004|Overall Study|Adverse Event|0|||
105598446|NCT00959946|364192977|FG005|Overall Study|Adverse Event|1|||
105598447|NCT00959946|364192978|FG006|Overall Study|Adverse Event|0|||
105598448|NCT00959946|364192979|FG007|Overall Study|Adverse Event|0|||
105598449|NCT00959946|364192972|FG000|Overall Study|Death|0|||
105598450|NCT00959946|364192973|FG001|Overall Study|Death|0|||
105598451|NCT00959946|364192974|FG002|Overall Study|Death|0|||
105598452|NCT00959946|364192975|FG003|Overall Study|Death|0|||
105598453|NCT00959946|364192976|FG004|Overall Study|Death|0|||
105598454|NCT00959946|364192977|FG005|Overall Study|Death|1|||
105598455|NCT00959946|364192978|FG006|Overall Study|Death|0|||
105598456|NCT00959946|364192979|FG007|Overall Study|Death|0|||
105598457|NCT00959946|364192972|FG000|Overall Study|Disease Progression|2|||
105598458|NCT00959946|364192973|FG001|Overall Study|Disease Progression|4|||
105598459|NCT00959946|364192974|FG002|Overall Study|Disease Progression|2|||
105598460|NCT00959946|364192975|FG003|Overall Study|Disease Progression|4|||
105598461|NCT00959946|364192976|FG004|Overall Study|Disease Progression|4|||
105598462|NCT00959946|364192977|FG005|Overall Study|Disease Progression|6|||
105598463|NCT00959946|364192978|FG006|Overall Study|Disease Progression|2|||
105598464|NCT00959946|364192979|FG007|Overall Study|Disease Progression|2|||
105598465|NCT00959946|364192972|FG000|Overall Study|Withdrawal by Subject|0|||
105598466|NCT00959946|364192973|FG001|Overall Study|Withdrawal by Subject|0|||
105598467|NCT00959946|364192974|FG002|Overall Study|Withdrawal by Subject|0|||
105598468|NCT00959946|364192975|FG003|Overall Study|Withdrawal by Subject|0|||
105598469|NCT00959946|364192976|FG004|Overall Study|Withdrawal by Subject|0|||
105598470|NCT00959946|364192977|FG005|Overall Study|Withdrawal by Subject|1|||
105598471|NCT00959946|364192978|FG006|Overall Study|Withdrawal by Subject|0|||
105598472|NCT00959946|364192979|FG007|Overall Study|Withdrawal by Subject|0|||
105598473|NCT01202955|364192982|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
105598474|NCT01202955|364192983|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
105598475|NCT02928224|364192986|FG000|Overall Study|Lost to Follow-up|1|||
105598476|NCT02928224|364192987|FG001|Overall Study|Lost to Follow-up|1|||
105598477|NCT02928224|364192988|FG002|Overall Study|Lost to Follow-up|3|||
105598478|NCT02928224|364192989|FG003|Overall Study|Lost to Follow-up|0|||
105598479|NCT02928224|364192986|FG000|Overall Study|Death|30|||
105598480|NCT02928224|364192987|FG001|Overall Study|Death|209|||
105598481|NCT02928224|364192988|FG002|Overall Study|Death|193|||
105598482|NCT02928224|364192989|FG003|Overall Study|Death|198|||
105598483|NCT02928224|364192986|FG000|Overall Study|Withdrawal by Subject|0|||
105598484|NCT02928224|364192987|FG001|Overall Study|Withdrawal by Subject|3|||
105598485|NCT02928224|364192988|FG002|Overall Study|Withdrawal by Subject|7|||
105598486|NCT02928224|364192989|FG003|Overall Study|Withdrawal by Subject|20|||
105598487|NCT02928224|364192986|FG000|Overall Study|Study participation terminated by sponsor|3|||
105598488|NCT02928224|364192987|FG001|Overall Study|Study participation terminated by sponsor|8|||
105598489|NCT02928224|364192988|FG002|Overall Study|Study participation terminated by sponsor|12|||
105598490|NCT02928224|364192989|FG003|Overall Study|Study participation terminated by sponsor|3|||
105598491|NCT02928224|364192986|FG000|Overall Study|Other|3|||
105598492|NCT02928224|364192987|FG001|Overall Study|Other|3|||
105598493|NCT02928224|364192988|FG002|Overall Study|Other|5|||
105598494|NCT02928224|364192989|FG003|Overall Study|Other|0|||
105598495|NCT04177394|364192992|FG000|Overall Study|Death|16|||
105598496|NCT04177394|364192992|FG000|Overall Study|Withdrawal by Subject|19|||
105598497|NCT04177394|364192992|FG000|Overall Study|Missed visits|61|||
105598498|NCT04177394|364192992|FG000|Overall Study|Expected Visits|15|||
105598499|NCT05061693|364192993|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
105598500|NCT05061693|364192994|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
105598501|NCT05061693|364192995|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
105598502|NCT05061693|364192996|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
105598503|NCT05061693|364192997|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
105598504|NCT05061693|364192998|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
105598505|NCT05061693|364192999|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
105598506|NCT05061693|364193000|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
105598507|NCT05061693|364193001|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
105598508|NCT05061693|364193002|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
105598509|NCT05061693|364193003|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
105598510|NCT05061693|364193004|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
105598511|NCT05061693|364192993|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
105598512|NCT05061693|364192994|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
105598513|NCT05061693|364192995|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
105598514|NCT05061693|364192996|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
105598515|NCT05061693|364192997|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
105598516|NCT05061693|364192998|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
105598517|NCT05061693|364192999|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
105598518|NCT05061693|364193000|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
105598519|NCT05061693|364193001|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
105598520|NCT05061693|364193002|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
105598521|NCT05061693|364193003|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
105598522|NCT05061693|364193004|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
105598523|NCT05061693|364192993|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
105598524|NCT05061693|364192994|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
105598525|NCT05061693|364192995|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
105598526|NCT05061693|364192996|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
105598527|NCT05061693|364192997|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
105598528|NCT05061693|364192998|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
105598529|NCT05061693|364192999|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
105598530|NCT05061693|364193000|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
105598531|NCT05061693|364193001|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
105598532|NCT05061693|364193002|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
105598533|NCT05061693|364193003|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
105598534|NCT05061693|364193004|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
105598535|NCT05061693|364192993|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
105598536|NCT05061693|364192994|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
105598537|NCT05061693|364192995|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
105598538|NCT05061693|364192996|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
105598539|NCT05061693|364192997|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
105598540|NCT05061693|364192998|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
105598541|NCT05061693|364192999|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
105598542|NCT05061693|364193000|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
105598543|NCT05061693|364193001|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
105598544|NCT05061693|364193002|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
105598545|NCT05061693|364193003|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
105598546|NCT05061693|364193004|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
105598547|NCT05061693|364192993|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
105598548|NCT05061693|364192994|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
105598549|NCT05061693|364192995|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
105598550|NCT05061693|364192996|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
105598551|NCT05061693|364192997|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
105598552|NCT05061693|364192998|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
105598553|NCT05061693|364192999|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
105598554|NCT05061693|364193000|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
105598555|NCT05061693|364193001|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
105598556|NCT05061693|364193002|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
105598557|NCT05061693|364193003|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
105598558|NCT05061693|364193004|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
105598559|NCT05061693|364192993|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
105598560|NCT05061693|364192994|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
105598561|NCT05061693|364192995|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
105598562|NCT05061693|364192996|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
105598563|NCT05061693|364192997|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
105598564|NCT05061693|364192998|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
105598565|NCT05061693|364192999|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
105598566|NCT05061693|364193000|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
105598567|NCT05061693|364193001|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
105598568|NCT05061693|364193002|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
105598569|NCT05061693|364193003|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
105598570|NCT05061693|364193004|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
105598571|NCT05061693|364192993|FG000|24-week Extension Period|Adverse Event|0|||
105598572|NCT05061693|364192994|FG001|24-week Extension Period|Adverse Event|0|||
105598573|NCT05061693|364192995|FG002|24-week Extension Period|Adverse Event|0|||
105598574|NCT05061693|364192996|FG003|24-week Extension Period|Adverse Event|0|||
105598575|NCT05061693|364192997|FG004|24-week Extension Period|Adverse Event|0|||
105598576|NCT05061693|364192998|FG005|24-week Extension Period|Adverse Event|0|||
105598577|NCT05061693|364192999|FG006|24-week Extension Period|Adverse Event|0|||
105598578|NCT05061693|364193000|FG007|24-week Extension Period|Adverse Event|2|||
105598579|NCT05061693|364193001|FG008|24-week Extension Period|Adverse Event|2|||
105598580|NCT05061693|364193002|FG009|24-week Extension Period|Adverse Event|0|||
105598581|NCT05061693|364193003|FG010|24-week Extension Period|Adverse Event|1|||
105598582|NCT05061693|364193004|FG011|24-week Extension Period|Adverse Event|3|||
105598583|NCT05061693|364192993|FG000|24-week Extension Period|Lack of Efficacy|0|||
105598584|NCT05061693|364192994|FG001|24-week Extension Period|Lack of Efficacy|0|||
105598585|NCT05061693|364192995|FG002|24-week Extension Period|Lack of Efficacy|0|||
105598586|NCT05061693|364192996|FG003|24-week Extension Period|Lack of Efficacy|0|||
105598587|NCT05061693|364192997|FG004|24-week Extension Period|Lack of Efficacy|0|||
105598588|NCT05061693|364192998|FG005|24-week Extension Period|Lack of Efficacy|0|||
105598589|NCT05061693|364192999|FG006|24-week Extension Period|Lack of Efficacy|0|||
105598590|NCT05061693|364193000|FG007|24-week Extension Period|Lack of Efficacy|0|||
105598591|NCT05061693|364193001|FG008|24-week Extension Period|Lack of Efficacy|0|||
105598592|NCT05061693|364193002|FG009|24-week Extension Period|Lack of Efficacy|0|||
105598593|NCT05061693|364193003|FG010|24-week Extension Period|Lack of Efficacy|2|||
105598594|NCT05061693|364193004|FG011|24-week Extension Period|Lack of Efficacy|0|||
105598595|NCT05061693|364192993|FG000|24-week Extension Period|Lost to Follow-up|0|||
105598596|NCT05061693|364192994|FG001|24-week Extension Period|Lost to Follow-up|0|||
105598597|NCT05061693|364192995|FG002|24-week Extension Period|Lost to Follow-up|0|||
105598598|NCT05061693|364192996|FG003|24-week Extension Period|Lost to Follow-up|0|||
105598599|NCT05061693|364192997|FG004|24-week Extension Period|Lost to Follow-up|0|||
105598600|NCT05061693|364192998|FG005|24-week Extension Period|Lost to Follow-up|0|||
105598601|NCT05061693|364192999|FG006|24-week Extension Period|Lost to Follow-up|1|||
105598602|NCT05061693|364193000|FG007|24-week Extension Period|Lost to Follow-up|0|||
105598603|NCT05061693|364193001|FG008|24-week Extension Period|Lost to Follow-up|1|||
105598604|NCT05061693|364193002|FG009|24-week Extension Period|Lost to Follow-up|1|||
105598605|NCT05061693|364193003|FG010|24-week Extension Period|Lost to Follow-up|0|||
105598606|NCT05061693|364193004|FG011|24-week Extension Period|Lost to Follow-up|0|||
105598607|NCT05061693|364192993|FG000|24-week Extension Period|Withdrawal by Subject|0|||
105598608|NCT05061693|364192994|FG001|24-week Extension Period|Withdrawal by Subject|0|||
105598609|NCT05061693|364192995|FG002|24-week Extension Period|Withdrawal by Subject|0|||
105598610|NCT05061693|364192996|FG003|24-week Extension Period|Withdrawal by Subject|0|||
105598611|NCT05061693|364192997|FG004|24-week Extension Period|Withdrawal by Subject|0|||
105598612|NCT05061693|364192998|FG005|24-week Extension Period|Withdrawal by Subject|0|||
105598613|NCT05061693|364192999|FG006|24-week Extension Period|Withdrawal by Subject|0|||
105598614|NCT05061693|364193000|FG007|24-week Extension Period|Withdrawal by Subject|0|||
105598615|NCT05061693|364193001|FG008|24-week Extension Period|Withdrawal by Subject|1|||
105598616|NCT05061693|364193002|FG009|24-week Extension Period|Withdrawal by Subject|2|||
105598617|NCT05061693|364193003|FG010|24-week Extension Period|Withdrawal by Subject|2|||
105598618|NCT05061693|364193004|FG011|24-week Extension Period|Withdrawal by Subject|1|||
105598619|NCT05061693|364192993|FG000|24-week Extension Period|Sponsor Decision|0|||
105598620|NCT05061693|364192994|FG001|24-week Extension Period|Sponsor Decision|0|||
105598621|NCT05061693|364192995|FG002|24-week Extension Period|Sponsor Decision|0|||
105598622|NCT05061693|364192996|FG003|24-week Extension Period|Sponsor Decision|0|||
105598623|NCT05061693|364192997|FG004|24-week Extension Period|Sponsor Decision|0|||
105598624|NCT05061693|364192998|FG005|24-week Extension Period|Sponsor Decision|0|||
105598625|NCT05061693|364192999|FG006|24-week Extension Period|Sponsor Decision|0|||
105598626|NCT05061693|364193000|FG007|24-week Extension Period|Sponsor Decision|1|||
105598627|NCT05061693|364193001|FG008|24-week Extension Period|Sponsor Decision|0|||
105598628|NCT05061693|364193002|FG009|24-week Extension Period|Sponsor Decision|0|||
105598629|NCT05061693|364193003|FG010|24-week Extension Period|Sponsor Decision|0|||
105598630|NCT05061693|364193004|FG011|24-week Extension Period|Sponsor Decision|0|||
105598631|NCT05061693|364192993|FG000|24-week Extension Period|Site Closure|0|||
105598632|NCT05061693|364192994|FG001|24-week Extension Period|Site Closure|0|||
105598633|NCT05061693|364192995|FG002|24-week Extension Period|Site Closure|0|||
105598634|NCT05061693|364192996|FG003|24-week Extension Period|Site Closure|0|||
105598635|NCT05061693|364192997|FG004|24-week Extension Period|Site Closure|0|||
105598636|NCT05061693|364192998|FG005|24-week Extension Period|Site Closure|0|||
105598637|NCT05061693|364192999|FG006|24-week Extension Period|Site Closure|0|||
105598638|NCT05061693|364193000|FG007|24-week Extension Period|Site Closure|0|||
105598639|NCT05061693|364193001|FG008|24-week Extension Period|Site Closure|1|||
105598640|NCT05061693|364193002|FG009|24-week Extension Period|Site Closure|0|||
105598641|NCT05061693|364193003|FG010|24-week Extension Period|Site Closure|0|||
105598642|NCT05061693|364193004|FG011|24-week Extension Period|Site Closure|1|||
105598643|NCT00442117|364193020|FG000|Overall Study|Adverse Event|3|||
105598644|NCT00442117|364193021|FG001|Overall Study|Adverse Event|2|||
105598645|NCT00442117|364193020|FG000|Overall Study|Lack of Efficacy|2|||
105598646|NCT00442117|364193021|FG001|Overall Study|Lack of Efficacy|6|||
105598647|NCT00442117|364193020|FG000|Overall Study|Lost to Follow-up|1|||
105598648|NCT00442117|364193021|FG001|Overall Study|Lost to Follow-up|2|||
105598649|NCT00442117|364193020|FG000|Overall Study|Withdrawal by Subject|2|||
105598650|NCT00442117|364193021|FG001|Overall Study|Withdrawal by Subject|2|||
105598651|NCT00442117|364193020|FG000|Overall Study|Major Deviation|25|||
105598652|NCT00442117|364193021|FG001|Overall Study|Major Deviation|20|||
105598653|NCT00442117|364193020|FG000|Overall Study|Non compliance with protocol|3|||
105598654|NCT00442117|364193021|FG001|Overall Study|Non compliance with protocol|5|||
105598655|NCT00442117|364193020|FG000|Overall Study|Met Withdrawal Criteria|2|||
105598656|NCT00442117|364193021|FG001|Overall Study|Met Withdrawal Criteria|1|||
105598657|NCT03368664|364193022|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
105598658|NCT03368664|364193022|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
105598659|NCT03368664|364193022|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
105598660|NCT03368664|364193022|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
105598661|NCT01616459|364193023|FG000|Overall Study|Adverse Event|1|||
105598662|NCT01616459|364193024|FG001|Overall Study|Adverse Event|1|||
105598663|NCT01616459|364193025|FG002|Overall Study|Adverse Event|2|||
105598664|NCT01616459|364193026|FG003|Overall Study|Adverse Event|0|||
105598665|NCT01616459|364193023|FG000|Overall Study|Lost to Follow-up|1|||
105598666|NCT01616459|364193024|FG001|Overall Study|Lost to Follow-up|11|||
105598667|NCT01616459|364193025|FG002|Overall Study|Lost to Follow-up|3|||
105598668|NCT01616459|364193026|FG003|Overall Study|Lost to Follow-up|2|||
105598669|NCT01616459|364193023|FG000|Overall Study|Protocol Violation|0|||
105598670|NCT01616459|364193024|FG001|Overall Study|Protocol Violation|0|||
105598671|NCT01616459|364193025|FG002|Overall Study|Protocol Violation|0|||
105598672|NCT01616459|364193026|FG003|Overall Study|Protocol Violation|2|||
105598673|NCT01616459|364193023|FG000|Overall Study|Withdrawal by Subject|2|||
105598674|NCT01616459|364193024|FG001|Overall Study|Withdrawal by Subject|4|||
105598675|NCT01616459|364193025|FG002|Overall Study|Withdrawal by Subject|4|||
105598676|NCT01616459|364193026|FG003|Overall Study|Withdrawal by Subject|4|||
105598677|NCT01616459|364193023|FG000|Overall Study|Other reason|0|||
105598678|NCT01616459|364193024|FG001|Overall Study|Other reason|1|||
105598679|NCT01616459|364193025|FG002|Overall Study|Other reason|1|||
105598680|NCT01616459|364193026|FG003|Overall Study|Other reason|0|||
105598681|NCT01420549|364193027|FG000|Overall Study|Adverse Event|1|||
105598682|NCT01420549|364193028|FG001|Overall Study|Adverse Event|1|||
105598683|NCT01420549|364193027|FG000|Overall Study|Lost to Follow-up|2|||
105598684|NCT01420549|364193028|FG001|Overall Study|Lost to Follow-up|2|||
105598685|NCT01420549|364193027|FG000|Overall Study|Protocol Violation|0|||
105598686|NCT01420549|364193028|FG001|Overall Study|Protocol Violation|1|||
105598687|NCT01420549|364193027|FG000|Overall Study|Non-adherence to medication|4|||
105598688|NCT01420549|364193028|FG001|Overall Study|Non-adherence to medication|1|||
105598689|NCT00589667|364193926|FG000|Overall Study|Adverse Event|2|||
105598690|NCT00589667|364193926|FG000|Overall Study|Withdrawal by Subject|1|||
105598691|NCT02544152|364193932|FG000|Overall Study|Adverse Event|0|||
105598692|NCT02544152|364193933|FG001|Overall Study|Adverse Event|4|||
105598693|NCT02544152|364193932|FG000|Overall Study|Withdrawal by Subject|0|||
105598694|NCT02544152|364193933|FG001|Overall Study|Withdrawal by Subject|3|||
105598695|NCT02544152|364193932|FG000|Overall Study|Other|1|||
105598696|NCT02544152|364193933|FG001|Overall Study|Other|0|||
105598697|NCT00980330|364193936|FG000|Overall Study|Adverse Event|0|||
105598698|NCT00980330|364193937|FG001|Overall Study|Adverse Event|0|||
105598699|NCT00980330|364193938|FG002|Overall Study|Adverse Event|0|||
105598700|NCT00980330|364193939|FG003|Overall Study|Adverse Event|1|||
105598701|NCT00980330|364193940|FG004|Overall Study|Adverse Event|0|||
105598702|NCT00980330|364193941|FG005|Overall Study|Adverse Event|0|||
105598703|NCT00980330|364193942|FG006|Overall Study|Adverse Event|0|||
105598704|NCT00980330|364193936|FG000|Overall Study|Lost to Follow-up|1|||
105598705|NCT00980330|364193937|FG001|Overall Study|Lost to Follow-up|1|||
105598706|NCT00980330|364193938|FG002|Overall Study|Lost to Follow-up|4|||
105598707|NCT00980330|364193939|FG003|Overall Study|Lost to Follow-up|2|||
105598708|NCT00980330|364193940|FG004|Overall Study|Lost to Follow-up|1|||
105598709|NCT00980330|364193941|FG005|Overall Study|Lost to Follow-up|1|||
105598710|NCT00980330|364193942|FG006|Overall Study|Lost to Follow-up|2|||
105598711|NCT00980330|364193936|FG000|Overall Study|Withdrawal by Subject|2|||
105598712|NCT00980330|364193937|FG001|Overall Study|Withdrawal by Subject|4|||
105598713|NCT00980330|364193938|FG002|Overall Study|Withdrawal by Subject|4|||
105598714|NCT00980330|364193939|FG003|Overall Study|Withdrawal by Subject|1|||
105598715|NCT00980330|364193940|FG004|Overall Study|Withdrawal by Subject|3|||
105598716|NCT00980330|364193941|FG005|Overall Study|Withdrawal by Subject|2|||
105598717|NCT00980330|364193942|FG006|Overall Study|Withdrawal by Subject|5|||
105598718|NCT00980330|364193936|FG000|Overall Study|(not specified)|2|||
105598719|NCT00980330|364193937|FG001|Overall Study|(not specified)|0|||
105598720|NCT00980330|364193938|FG002|Overall Study|(not specified)|0|||
105598721|NCT00980330|364193939|FG003|Overall Study|(not specified)|1|||
105598722|NCT00980330|364193940|FG004|Overall Study|(not specified)|1|||
105598723|NCT00980330|364193941|FG005|Overall Study|(not specified)|1|||
105598724|NCT00980330|364193942|FG006|Overall Study|(not specified)|0|||
105598725|NCT00665444|364193943|FG000|Overall Study|Physician Decision|1|||
105598726|NCT00665444|364193943|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
105598727|NCT02957136|364193944|FG000|Overall Study|Withdrawal by Subject|2|||
105598728|NCT02957136|364193945|FG001|Overall Study|Withdrawal by Subject|1|||
105598729|NCT02555215|364193946|FG000|Overall Study|Other|1|||
105598730|NCT02555215|364193946|FG000|Overall Study|Investigator Decision|2|||
105598731|NCT00566527|364193947|FG000|Overall Study|Reason not provided|3|||
105598732|NCT00566527|364193948|FG001|Overall Study|Reason not provided|11|||
105598733|NCT00566527|364193949|FG002|Overall Study|Reason not provided|10|||
105598734|NCT00566527|364193947|FG000|Overall Study|Adverse Event|2|||
105598735|NCT00566527|364193948|FG001|Overall Study|Adverse Event|0|||
105598736|NCT00566527|364193949|FG002|Overall Study|Adverse Event|1|||
105598737|NCT00566527|364193947|FG000|Overall Study|Physician Decision|3|||
105598738|NCT00566527|364193948|FG001|Overall Study|Physician Decision|8|||
105598739|NCT00566527|364193949|FG002|Overall Study|Physician Decision|20|||
105598740|NCT00566527|364193947|FG000|Overall Study|Lost to Follow-up|3|||
105598741|NCT00566527|364193948|FG001|Overall Study|Lost to Follow-up|4|||
105598742|NCT00566527|364193949|FG002|Overall Study|Lost to Follow-up|4|||
105598743|NCT00566527|364193947|FG000|Overall Study|Withdrawal by Subject|6|||
105598744|NCT00566527|364193948|FG001|Overall Study|Withdrawal by Subject|43|||
105598745|NCT00566527|364193949|FG002|Overall Study|Withdrawal by Subject|43|||
105598746|NCT00159783|364193950|FG000|Overall Study|Adverse Event|5|||
105598747|NCT00159783|364193951|FG001|Overall Study|Adverse Event|7|||
105598748|NCT00159783|364193952|FG002|Overall Study|Adverse Event|9|||
105598749|NCT00159783|364193950|FG000|Overall Study|Lack of Efficacy|1|||
105598750|NCT00159783|364193951|FG001|Overall Study|Lack of Efficacy|2|||
105598751|NCT00159783|364193952|FG002|Overall Study|Lack of Efficacy|3|||
105598752|NCT00159783|364193950|FG000|Overall Study|Withdrawal by Subject|7|||
105598753|NCT00159783|364193951|FG001|Overall Study|Withdrawal by Subject|11|||
105598754|NCT00159783|364193952|FG002|Overall Study|Withdrawal by Subject|12|||
105598755|NCT00159783|364193950|FG000|Overall Study|Lost to Follow-up|6|||
105598756|NCT00159783|364193951|FG001|Overall Study|Lost to Follow-up|5|||
105598757|NCT00159783|364193952|FG002|Overall Study|Lost to Follow-up|11|||
105598758|NCT00159783|364193950|FG000|Overall Study|Other|0|||
105598759|NCT00159783|364193951|FG001|Overall Study|Other|2|||
105598760|NCT00159783|364193952|FG002|Overall Study|Other|4|||
105598761|NCT04975308|364193953|FG000|Overall Study|Withdrawal by Subject|6|||
105598762|NCT04975308|364193954|FG001|Overall Study|Withdrawal by Subject|16|||
105598763|NCT04975308|364193955|FG002|Overall Study|Withdrawal by Subject|6|||
105598764|NCT04975308|364193953|FG000|Overall Study|Physician Decision|0|||
105598765|NCT04975308|364193954|FG001|Overall Study|Physician Decision|3|||
105598766|NCT04975308|364193955|FG002|Overall Study|Physician Decision|1|||
105598767|NCT04975308|364193953|FG000|Overall Study|Adverse Event|10|||
105598768|NCT04975308|364193954|FG001|Overall Study|Adverse Event|1|||
105598769|NCT04975308|364193955|FG002|Overall Study|Adverse Event|12|||
105598770|NCT04975308|364193953|FG000|Overall Study|On study treatment (Ongoing)|65|||
105598771|NCT04975308|364193954|FG001|Overall Study|On study treatment (Ongoing)|43|||
105598772|NCT04975308|364193955|FG002|Overall Study|On study treatment (Ongoing)|75|||
105598773|NCT04975308|364193953|FG000|Overall Study|Protocol Deviation|4|||
105598774|NCT04975308|364193954|FG001|Overall Study|Protocol Deviation|3|||
105598775|NCT04975308|364193955|FG002|Overall Study|Protocol Deviation|2|||
105598776|NCT04281485|364193956|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
105598777|NCT04281485|364193957|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
105598778|NCT04281485|364193956|FG000|Overall Study|Ongoing (Safety data collection)|10|||
105598779|NCT04281485|364193957|FG001|Overall Study|Ongoing (Safety data collection)|5|||
105598780|NCT01278394|364193958|FG000|Overall Study|Lost to Follow-up|1|||
105598781|NCT05323734|364193959|FG000|Overall Study|Adverse Event|5|||
105598782|NCT05323734|364193960|FG001|Overall Study|Adverse Event|2|||
105598783|NCT05323734|364193959|FG000|Overall Study|Physician Decision|1|||
105598784|NCT05323734|364193960|FG001|Overall Study|Physician Decision|0|||
105598785|NCT05323734|364193959|FG000|Overall Study|Lack of Efficacy|1|||
105598786|NCT05323734|364193960|FG001|Overall Study|Lack of Efficacy|2|||
105598787|NCT05323734|364193959|FG000|Overall Study|Withdrawal by Subject|2|||
105598788|NCT05323734|364193960|FG001|Overall Study|Withdrawal by Subject|0|||
105598789|NCT05323734|364193959|FG000|Overall Study|Participant Withdrawn Due|0|||
105598790|NCT05323734|364193960|FG001|Overall Study|Participant Withdrawn Due|1|||
105598791|NCT02486718|364193963|FG000|Enrollment Phase|Death|19|||
105598792|NCT02486718|364193964|FG001|Enrollment Phase|Death|0|||
105598793|NCT02486718|364193965|FG002|Enrollment Phase|Death|0|||
105598794|NCT02486718|364193963|FG000|Enrollment Phase|Symptomatic deterioration|1|||
105598795|NCT02486718|364193964|FG001|Enrollment Phase|Symptomatic deterioration|0|||
105598796|NCT02486718|364193965|FG002|Enrollment Phase|Symptomatic deterioration|0|||
105598797|NCT02486718|364193963|FG000|Enrollment Phase|Withdrawal by Subject|86|||
105598798|NCT02486718|364193964|FG001|Enrollment Phase|Withdrawal by Subject|0|||
105598799|NCT02486718|364193965|FG002|Enrollment Phase|Withdrawal by Subject|0|||
105598800|NCT02486718|364193963|FG000|Enrollment Phase|Protocol Violation|18|||
105598801|NCT02486718|364193964|FG001|Enrollment Phase|Protocol Violation|0|||
105598802|NCT02486718|364193965|FG002|Enrollment Phase|Protocol Violation|0|||
105598803|NCT02486718|364193963|FG000|Enrollment Phase|Physician Decision|18|||
105598804|NCT02486718|364193964|FG001|Enrollment Phase|Physician Decision|0|||
105598805|NCT02486718|364193965|FG002|Enrollment Phase|Physician Decision|0|||
105598806|NCT02486718|364193963|FG000|Enrollment Phase|Reason not provided|41|||
105598807|NCT02486718|364193964|FG001|Enrollment Phase|Reason not provided|0|||
105598808|NCT02486718|364193965|FG002|Enrollment Phase|Reason not provided|0|||
105598809|NCT02486718|364193963|FG000|Enrollment Phase|Disease relapse|54|||
105598810|NCT02486718|364193964|FG001|Enrollment Phase|Disease relapse|0|||
105598811|NCT02486718|364193965|FG002|Enrollment Phase|Disease relapse|0|||
105598812|NCT02486718|364193963|FG000|Enrollment Phase|Lost to Follow-up|4|||
105598813|NCT02486718|364193964|FG001|Enrollment Phase|Lost to Follow-up|0|||
105598814|NCT02486718|364193965|FG002|Enrollment Phase|Lost to Follow-up|0|||
105598815|NCT02486718|364193963|FG000|Enrollment Phase|Adverse Event|34|||
105598816|NCT02486718|364193964|FG001|Enrollment Phase|Adverse Event|0|||
105598817|NCT02486718|364193965|FG002|Enrollment Phase|Adverse Event|0|||
105598818|NCT02486718|364193963|FG000|Randomized Phase|Withdrawal by Subject|0|||
105598819|NCT02486718|364193964|FG001|Randomized Phase|Withdrawal by Subject|44|||
105598820|NCT02486718|364193965|FG002|Randomized Phase|Withdrawal by Subject|47|||
105598821|NCT02486718|364193963|FG000|Randomized Phase|Protocol Violation|0|||
105598822|NCT02486718|364193964|FG001|Randomized Phase|Protocol Violation|2|||
105598823|NCT02486718|364193965|FG002|Randomized Phase|Protocol Violation|0|||
105598824|NCT02486718|364193963|FG000|Randomized Phase|Physician Decision|0|||
105598825|NCT02486718|364193964|FG001|Randomized Phase|Physician Decision|0|||
105598826|NCT02486718|364193965|FG002|Randomized Phase|Physician Decision|3|||
105598827|NCT02486718|364193963|FG000|Randomized Phase|Lost to Follow-up|0|||
105598828|NCT02486718|364193964|FG001|Randomized Phase|Lost to Follow-up|5|||
105598829|NCT02486718|364193965|FG002|Randomized Phase|Lost to Follow-up|11|||
105598830|NCT02486718|364193963|FG000|Randomized Phase|Disease Relapse|0|||
105598831|NCT02486718|364193964|FG001|Randomized Phase|Disease Relapse|1|||
105598832|NCT02486718|364193965|FG002|Randomized Phase|Disease Relapse|0|||
105598833|NCT02486718|364193963|FG000|Randomized Phase|Death|0|||
105598834|NCT02486718|364193964|FG001|Randomized Phase|Death|154|||
105598835|NCT02486718|364193965|FG002|Randomized Phase|Death|155|||
105598836|NCT02486718|364193963|FG000|Randomized Phase|Ongoing|0|||
105598837|NCT02486718|364193964|FG001|Randomized Phase|Ongoing|301|||
105598838|NCT02486718|364193965|FG002|Randomized Phase|Ongoing|282|||
105598839|NCT05516108|364193966|FG000|Overall Study|Time Commitment|3|||
105598840|NCT05516108|364193967|FG001|Overall Study|Time Commitment|1|||
105598841|NCT05516108|364193966|FG000|Overall Study|Reason Unknown|2|||
105598842|NCT05516108|364193967|FG001|Overall Study|Reason Unknown|4|||
105598843|NCT03823911|364193968|FG000|Overall Study|Lost to Follow-up|1|||
105598844|NCT03823911|364193969|FG001|Overall Study|Lost to Follow-up|5|||
105598845|NCT03823911|364193970|FG002|Overall Study|Lost to Follow-up|2|||
105598846|NCT03823911|364193968|FG000|Overall Study|Did not meet eligibility criteria|13|||
105598847|NCT03823911|364193969|FG001|Overall Study|Did not meet eligibility criteria|7|||
105598848|NCT03823911|364193970|FG002|Overall Study|Did not meet eligibility criteria|4|||
105598849|NCT03823911|364193968|FG000|Overall Study|Death|0|||
105598850|NCT03823911|364193969|FG001|Overall Study|Death|1|||
105598851|NCT03823911|364193970|FG002|Overall Study|Death|0|||
105598852|NCT01595321|364193971|FG000|Overall Study|Adverse Event|1|||
105598853|NCT01595321|364193972|FG001|Overall Study|Adverse Event|1|||
105598854|NCT01595321|364193973|FG002|Overall Study|Adverse Event|1|||
105598855|NCT01595321|364193971|FG000|Overall Study|Lack of Efficacy|0|||
105598856|NCT01595321|364193972|FG001|Overall Study|Lack of Efficacy|0|||
105598857|NCT01595321|364193973|FG002|Overall Study|Lack of Efficacy|4|||
105598858|NCT01395758|364193982|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
105598859|NCT01395758|364193983|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
105598860|NCT01395758|364193984|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
105598861|NCT00433199|364193985|FG000|Double-Blind Period|Adverse Event|0|||
105598862|NCT00433199|364193986|FG001|Double-Blind Period|Adverse Event|25|||
105598863|NCT00433199|364193985|FG000|Double-Blind Period|Lack of Efficacy|0|||
105598864|NCT00433199|364193986|FG001|Double-Blind Period|Lack of Efficacy|2|||
105598865|NCT00433199|364193985|FG000|Double-Blind Period|Lost to Follow-up|2|||
105598866|NCT00433199|364193986|FG001|Double-Blind Period|Lost to Follow-up|5|||
105598867|NCT00433199|364193985|FG000|Double-Blind Period|Withdrawal by Subject|8|||
105598868|NCT00433199|364193986|FG001|Double-Blind Period|Withdrawal by Subject|19|||
105598869|NCT00433199|364193985|FG000|Double-Blind Period|Protocol Violation|1|||
105598870|NCT00433199|364193986|FG001|Double-Blind Period|Protocol Violation|10|||
105598871|NCT00433199|364193985|FG000|Double-Blind Period|Administrative|1|||
105598872|NCT00433199|364193986|FG001|Double-Blind Period|Administrative|5|||
105598873|NCT00433199|364193985|FG000|Open-Label Period|Adverse Event|0|||
105598874|NCT00433199|364193986|FG001|Open-Label Period|Adverse Event|19|||
105598875|NCT00433199|364193985|FG000|Open-Label Period|Lack of Efficacy|0|||
105598876|NCT00433199|364193986|FG001|Open-Label Period|Lack of Efficacy|2|||
105598877|NCT00433199|364193985|FG000|Open-Label Period|Lost to Follow-up|0|||
105598878|NCT00433199|364193986|FG001|Open-Label Period|Lost to Follow-up|3|||
105598879|NCT00433199|364193985|FG000|Open-Label Period|Withdrawal by Subject|0|||
105598880|NCT00433199|364193986|FG001|Open-Label Period|Withdrawal by Subject|7|||
105598881|NCT00433199|364193985|FG000|Open-Label Period|Protocol Violation|0|||
105598882|NCT00433199|364193986|FG001|Open-Label Period|Protocol Violation|2|||
105598883|NCT00433199|364193985|FG000|Open-Label Period|Administrative|0|||
105598884|NCT00433199|364193986|FG001|Open-Label Period|Administrative|1|||
105598885|NCT00206375|364193987|FG000|Overall Study|Lost to Follow-up|1|||
105598886|NCT00206375|364193988|FG001|Overall Study|Lost to Follow-up|0|||
105598887|NCT00206375|364193989|FG002|Overall Study|Lost to Follow-up|0|||
105598888|NCT00206375|364193987|FG000|Overall Study|Withdrawal by Subject|2|||
105598889|NCT00206375|364193988|FG001|Overall Study|Withdrawal by Subject|1|||
105598890|NCT00206375|364193989|FG002|Overall Study|Withdrawal by Subject|3|||
105598891|NCT00206375|364193987|FG000|Overall Study|Study terminated due to lack of funds|0|||
105598892|NCT00206375|364193988|FG001|Overall Study|Study terminated due to lack of funds|1|||
105598893|NCT00206375|364193989|FG002|Overall Study|Study terminated due to lack of funds|1|||
105598894|NCT01170962|364193990|FG000|Treatment Period|Lack of Efficacy|96|||
105598895|NCT01170962|364193991|FG001|Treatment Period|Lack of Efficacy|91|||
105598896|NCT01170962|364193992|FG002|Treatment Period|Lack of Efficacy|7|||
105598897|NCT01170962|364193990|FG000|Treatment Period|Adverse Event|11|||
105598898|NCT01170962|364193991|FG001|Treatment Period|Adverse Event|12|||
105598899|NCT01170962|364193992|FG002|Treatment Period|Adverse Event|3|||
105598900|NCT01170962|364193990|FG000|Treatment Period|Withdrawal by Subject|2|||
105598901|NCT01170962|364193991|FG001|Treatment Period|Withdrawal by Subject|1|||
105598902|NCT01170962|364193992|FG002|Treatment Period|Withdrawal by Subject|0|||
105598903|NCT01170962|364193990|FG000|Treatment Period|Lost to Follow-up|1|||
105598904|NCT01170962|364193991|FG001|Treatment Period|Lost to Follow-up|1|||
105598905|NCT01170962|364193992|FG002|Treatment Period|Lost to Follow-up|1|||
105598906|NCT01170962|364193990|FG000|Treatment Period|Participant no longer meets criteria|0|||
105598907|NCT01170962|364193991|FG001|Treatment Period|Participant no longer meets criteria|1|||
105598908|NCT01170962|364193992|FG002|Treatment Period|Participant no longer meets criteria|0|||
105598909|NCT01170962|364193990|FG000|Treatment Period|Request to discontinue treatment|7|||
105598910|NCT01170962|364193991|FG001|Treatment Period|Request to discontinue treatment|3|||
105598911|NCT01170962|364193992|FG002|Treatment Period|Request to discontinue treatment|1|||
105598912|NCT01170962|364193990|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
105598913|NCT01170962|364193991|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
105598914|NCT01170962|364193992|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
105598915|NCT01170962|364193990|FG000|Follow up Period|Withdrawal by Subject|14|||
105598916|NCT01170962|364193991|FG001|Follow up Period|Withdrawal by Subject|10|||
105598917|NCT01170962|364193992|FG002|Follow up Period|Withdrawal by Subject|2|||
105598918|NCT01170962|364193990|FG000|Follow up Period|Lost to Follow-up|13|||
105598919|NCT01170962|364193991|FG001|Follow up Period|Lost to Follow-up|8|||
105598920|NCT01170962|364193992|FG002|Follow up Period|Lost to Follow-up|1|||
105598921|NCT01170962|364193990|FG000|Follow up Period|Death|2|||
105598922|NCT01170962|364193991|FG001|Follow up Period|Death|2|||
105598923|NCT01170962|364193992|FG002|Follow up Period|Death|0|||
105598924|NCT01170962|364193990|FG000|Follow up Period|Others|10|||
105598925|NCT01170962|364193991|FG001|Follow up Period|Others|7|||
105598926|NCT01170962|364193992|FG002|Follow up Period|Others|3|||
105598927|NCT02674750|364193993|FG000|Overall Study|Death|4|||
105598928|NCT02674750|364193994|FG001|Overall Study|Death|5|||
105598929|NCT02674750|364193995|FG002|Overall Study|Death|8|||
105598930|NCT02674750|364193993|FG000|Overall Study|Lost to Follow-up|0|||
105598931|NCT02674750|364193994|FG001|Overall Study|Lost to Follow-up|8|||
105598932|NCT02674750|364193995|FG002|Overall Study|Lost to Follow-up|0|||
105598933|NCT02674750|364193993|FG000|Overall Study|Lack of Efficacy|1|||
105598934|NCT02674750|364193994|FG001|Overall Study|Lack of Efficacy|17|||
105598935|NCT02674750|364193995|FG002|Overall Study|Lack of Efficacy|3|||
105598936|NCT02674750|364193993|FG000|Overall Study|Withdrawal by Subject|0|||
105598937|NCT02674750|364193994|FG001|Overall Study|Withdrawal by Subject|7|||
105598938|NCT02674750|364193995|FG002|Overall Study|Withdrawal by Subject|1|||
105598939|NCT02674750|364193993|FG000|Overall Study|Other|0|||
105598940|NCT02674750|364193994|FG001|Overall Study|Other|8|||
105598941|NCT02674750|364193995|FG002|Overall Study|Other|0|||
105598942|NCT00688519|364194000|FG000|Overall Study|Adverse Event|2|||
105598943|NCT00688519|364194001|FG001|Overall Study|Adverse Event|3|||
105598944|NCT00688519|364194000|FG000|Overall Study|Lost to Follow-up|3|||
105598945|NCT00688519|364194001|FG001|Overall Study|Lost to Follow-up|3|||
105598946|NCT00688519|364194000|FG000|Overall Study|Lack of Efficacy|3|||
105598947|NCT00688519|364194001|FG001|Overall Study|Lack of Efficacy|1|||
105598948|NCT00688519|364194000|FG000|Overall Study|Withdrawal by Subject|7|||
105598949|NCT00688519|364194001|FG001|Overall Study|Withdrawal by Subject|6|||
105598950|NCT00688519|364194000|FG000|Overall Study|Prohibited medication|1|||
105598951|NCT00688519|364194001|FG001|Overall Study|Prohibited medication|0|||
105598952|NCT00688519|364194000|FG000|Overall Study|Non-compliance|0|||
105598953|NCT00688519|364194001|FG001|Overall Study|Non-compliance|1|||
105598954|NCT00688519|364194000|FG000|Overall Study|Subject moved out of state|1|||
105598955|NCT00688519|364194001|FG001|Overall Study|Subject moved out of state|0|||
105598956|NCT00688519|364194000|FG000|Overall Study|Investigator decision|1|||
105598957|NCT00688519|364194001|FG001|Overall Study|Investigator decision|0|||
105598958|NCT00688519|364194000|FG000|Overall Study|Subject moved out of area|1|||
105598959|NCT00688519|364194001|FG001|Overall Study|Subject moved out of area|0|||
105598960|NCT00688519|364194000|FG000|Overall Study|Pregnancy|0|||
105598961|NCT00688519|364194001|FG001|Overall Study|Pregnancy|1|||
105598962|NCT01685606|364194002|FG000|Overall Study|Withdrawal by Subject|1|||
105598963|NCT03473340|364194003|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
105598964|NCT03473340|364194004|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
105598965|NCT03473340|364194003|FG000|Overall Study|Withdrawal by Subject|1|||
105598966|NCT03473340|364194004|FG001|Overall Study|Withdrawal by Subject|0|||
105598967|NCT03473340|364194003|FG000|Overall Study|Lost to Follow-up|1|||
105598968|NCT03473340|364194004|FG001|Overall Study|Lost to Follow-up|2|||
105598969|NCT02079844|364194005|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
105598970|NCT02079844|364194006|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
105598971|NCT02079844|364194007|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
105598972|NCT02079844|364194005|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
105598973|NCT02079844|364194006|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
105598974|NCT02079844|364194007|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
105598975|NCT00801983|364194010|FG000|Period 1|Lost to Follow-up|2|||
105598976|NCT00801983|364194011|FG001|Period 1|Lost to Follow-up|0|||
105598977|NCT00801983|364194010|FG000|Period 1|Withdrawal by Subject|2|||
105598978|NCT00801983|364194011|FG001|Period 1|Withdrawal by Subject|8|||
105598979|NCT00801983|364194010|FG000|Period 2|Withdrawal by Subject|2|||
105598980|NCT00801983|364194011|FG001|Period 2|Withdrawal by Subject|1|||
105598981|NCT05094141|364194014|FG000|Overall Study|Death|0|||
105598982|NCT05094141|364194015|FG001|Overall Study|Death|0|||
105598983|NCT05094141|364194016|FG002|Overall Study|Death|1|||
105598984|NCT05094141|364194014|FG000|Overall Study|Withdrawal by Subject|0|||
105598985|NCT05094141|364194015|FG001|Overall Study|Withdrawal by Subject|0|||
105598986|NCT05094141|364194016|FG002|Overall Study|Withdrawal by Subject|1|||
105598987|NCT05094141|364194014|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
105598988|NCT05094141|364194015|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
105598989|NCT05094141|364194016|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
105598990|NCT05094141|364194014|FG000|Overall Study|Did not participate in randomization|0|||
105598991|NCT05094141|364194015|FG001|Overall Study|Did not participate in randomization|0|||
105598992|NCT05094141|364194016|FG002|Overall Study|Did not participate in randomization|33|||
105598993|NCT05219253|364195213|FG000|Overall Study|Withdrawal by Subject|1|||
105598994|NCT05219253|364195214|FG001|Overall Study|Withdrawal by Subject|2|||
105598995|NCT02396316|364195215|FG000|Overall Study|Physician Decision|1|||
105598996|NCT02396316|364195216|FG001|Overall Study|Physician Decision|0|||
105598997|NCT02396316|364195215|FG000|Overall Study|Progressive disease|6|||
105598998|NCT02396316|364195216|FG001|Overall Study|Progressive disease|3|||
105598999|NCT02396316|364195215|FG000|Overall Study|Protocol Violation|0|||
105599000|NCT02396316|364195216|FG001|Overall Study|Protocol Violation|1|||
105599001|NCT02396316|364195215|FG000|Overall Study|Treatment unblinded|0|||
105599002|NCT02396316|364195216|FG001|Overall Study|Treatment unblinded|1|||
105599003|NCT03622593|364195219|FG000|Overall Study|Withdrawal by Subject|11|||
105599004|NCT03622593|364195220|FG001|Overall Study|Withdrawal by Subject|9|||
105599005|NCT03622593|364195221|FG002|Overall Study|Withdrawal by Subject|13|||
105599006|NCT03622593|364195219|FG000|Overall Study|Death|12|||
105599007|NCT03622593|364195220|FG001|Overall Study|Death|9|||
105599008|NCT03622593|364195221|FG002|Overall Study|Death|10|||
105599009|NCT03622593|364195219|FG000|Overall Study|Lost to Follow-up|11|||
105599010|NCT03622593|364195220|FG001|Overall Study|Lost to Follow-up|5|||
105599011|NCT03622593|364195221|FG002|Overall Study|Lost to Follow-up|8|||
105599012|NCT03622593|364195219|FG000|Overall Study|Adverse Event|4|||
105599013|NCT03622593|364195220|FG001|Overall Study|Adverse Event|5|||
105599014|NCT03622593|364195221|FG002|Overall Study|Adverse Event|6|||
105599015|NCT03622593|364195219|FG000|Overall Study|Physician Decision|2|||
105599016|NCT03622593|364195220|FG001|Overall Study|Physician Decision|1|||
105599017|NCT03622593|364195221|FG002|Overall Study|Physician Decision|6|||
105599018|NCT03622593|364195219|FG000|Overall Study|Other|2|||
105599019|NCT03622593|364195220|FG001|Overall Study|Other|2|||
105599020|NCT03622593|364195221|FG002|Overall Study|Other|3|||
105599021|NCT03622593|364195219|FG000|Overall Study|Protocol Violation|0|||
105599022|NCT03622593|364195220|FG001|Overall Study|Protocol Violation|0|||
105599023|NCT03622593|364195221|FG002|Overall Study|Protocol Violation|1|||
105599024|NCT03622593|364195219|FG000|Overall Study|Pregnancy|0|||
105599025|NCT03622593|364195220|FG001|Overall Study|Pregnancy|0|||
105599026|NCT03622593|364195221|FG002|Overall Study|Pregnancy|1|||
105599027|NCT00516321|364195224|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
105599028|NCT00516321|364195225|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
105599029|NCT00516321|364195226|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
105599030|NCT00516321|364195224|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
105599031|NCT00516321|364195225|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
105599032|NCT00516321|364195226|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
105599033|NCT00516321|364195224|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
105599034|NCT00516321|364195225|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
105599035|NCT00516321|364195226|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
105599036|NCT00516321|364195224|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
105599037|NCT00516321|364195225|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
105599038|NCT00516321|364195226|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
105599039|NCT00516321|364195224|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
105599040|NCT00516321|364195225|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
105599041|NCT00516321|364195226|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
105599042|NCT00516321|364195224|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
105599043|NCT00516321|364195225|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
105599044|NCT00516321|364195226|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
105599045|NCT00516321|364195224|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
105599046|NCT00516321|364195225|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
105599047|NCT00516321|364195226|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
105599048|NCT00516321|364195224|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
105599049|NCT00516321|364195225|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
105599050|NCT00516321|364195226|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
105599051|NCT00516321|364195224|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
105599052|NCT00516321|364195225|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
105599053|NCT00516321|364195226|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
105599054|NCT00516321|364195224|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
105599055|NCT00516321|364195225|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
105599056|NCT00516321|364195226|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
105599057|NCT00516321|364195224|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
105599058|NCT00516321|364195225|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
105599059|NCT00516321|364195226|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
105599060|NCT01254019|364195228|FG000|Overall Study|Adverse Event|0|||
105599061|NCT01254019|364195229|FG001|Overall Study|Adverse Event|2|||
105599062|NCT01254019|364195228|FG000|Overall Study|Protocol Violation|1|||
105599063|NCT01254019|364195229|FG001|Overall Study|Protocol Violation|0|||
105599064|NCT01254019|364195228|FG000|Overall Study|Withdrawal by Subject|0|||
105599065|NCT01254019|364195229|FG001|Overall Study|Withdrawal by Subject|2|||
105599066|NCT03615924|364195230|FG000|Overall Study|Withdrawal by Subject|2|||
105599067|NCT03615924|364195231|FG001|Overall Study|Withdrawal by Subject|5|||
105599068|NCT03615924|364195230|FG000|Overall Study|Death|3|||
105599069|NCT03615924|364195231|FG001|Overall Study|Death|1|||
105599070|NCT03615924|364195230|FG000|Overall Study|Lost to Follow-up|1|||
105599071|NCT03615924|364195231|FG001|Overall Study|Lost to Follow-up|0|||
105599072|NCT03615924|364195230|FG000|Overall Study|Randomized in error|1|||
105599073|NCT03615924|364195231|FG001|Overall Study|Randomized in error|0|||
105599074|NCT03615924|364195230|FG000|Overall Study|Study termination by Sponsor|94|||
105599075|NCT03615924|364195231|FG001|Overall Study|Study termination by Sponsor|86|||
105599076|NCT02529995|364195232|FG000|Part A|Ongoing Study at Data Cut-off|14|||
105599077|NCT02529995|364195233|FG001|Part A|Ongoing Study at Data Cut-off|16|||
105599078|NCT02529995|364195232|FG000|Part A|Discontinued Study|1|||
105599079|NCT02529995|364195233|FG001|Part A|Discontinued Study|0|||
105599080|NCT02529995|364195232|FG000|Part B|Ongoing Study at Data Cut-off|0|||
105599081|NCT02529995|364195233|FG001|Part B|Ongoing Study at Data Cut-off|7|||
105599082|NCT02529995|364195232|FG000|Part B|Discontinued Study|6|||
105599083|NCT02529995|364195233|FG001|Part B|Discontinued Study|5|||
105599084|NCT03844269|364195236|FG000|Overall Study|Withdrawal pre-intervention|1|||
105599085|NCT03844269|364195236|FG000|Overall Study|Did not complete the intervention|2|||
105599086|NCT00638963|364195239|FG000|Overall Study|Withdrawal by Subject|1|||
105599087|NCT00638963|364195240|FG001|Overall Study|Withdrawal by Subject|0|||
105599088|NCT02512965|364195241|FG000|Overall Study|Withdrawal by Subject|0|||
105599089|NCT02512965|364195242|FG001|Overall Study|Withdrawal by Subject|4|||
105599090|NCT00835770|364195243|FG000|Overall Study|MS Relapse|17|||
105599091|NCT00835770|364195244|FG001|Overall Study|MS Relapse|23|||
105599092|NCT00835770|364195243|FG000|Overall Study|MS Progression|14|||
105599093|NCT00835770|364195244|FG001|Overall Study|MS Progression|9|||
105599094|NCT00835770|364195243|FG000|Overall Study|Adverse Event|113|||
105599095|NCT00835770|364195244|FG001|Overall Study|Adverse Event|124|||
105599096|NCT00835770|364195243|FG000|Overall Study|Lost to Follow-up|22|||
105599097|NCT00835770|364195244|FG001|Overall Study|Lost to Follow-up|19|||
105599098|NCT00835770|364195243|FG000|Overall Study|Consent Withdrawn|144|||
105599099|NCT00835770|364195244|FG001|Overall Study|Consent Withdrawn|156|||
105599100|NCT00835770|364195243|FG000|Overall Study|Investigator Decision|42|||
105599101|NCT00835770|364195244|FG001|Overall Study|Investigator Decision|42|||
105599102|NCT00835770|364195243|FG000|Overall Study|Participant Non-Compliance|11|||
105599103|NCT00835770|364195244|FG001|Overall Study|Participant Non-Compliance|9|||
105599104|NCT00835770|364195243|FG000|Overall Study|Death|4|||
105599105|NCT00835770|364195244|FG001|Overall Study|Death|6|||
105599106|NCT00835770|364195243|FG000|Overall Study|Other|115|||
105599107|NCT00835770|364195244|FG001|Overall Study|Other|104|||
105599108|NCT00835770|364195243|FG000|Overall Study|Other|2|||
105599109|NCT00835770|364195244|FG001|Overall Study|Other|1|||
105599110|NCT00439569|364195252|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
105599111|NCT00439569|364195252|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
105599112|NCT00439569|364195252|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
105599113|NCT02755116|364195253|FG000|Overall Study|surgery converted to open, pt admitted|3|||
105599114|NCT02755116|364195254|FG001|Overall Study|surgery converted to open, pt admitted|1|||
105599115|NCT00960141|364195262|FG000|Overall Study|Adverse Event|4|||
105599116|NCT00960141|364195263|FG001|Overall Study|Adverse Event|8|||
105599117|NCT00960141|364195264|FG002|Overall Study|Adverse Event|2|||
105599118|NCT00960141|364195262|FG000|Overall Study|Lack of Efficacy|3|||
105599119|NCT00960141|364195263|FG001|Overall Study|Lack of Efficacy|4|||
105599120|NCT00960141|364195264|FG002|Overall Study|Lack of Efficacy|2|||
105599121|NCT00960141|364195262|FG000|Overall Study|Lost to Follow-up|1|||
105599122|NCT00960141|364195263|FG001|Overall Study|Lost to Follow-up|0|||
105599123|NCT00960141|364195264|FG002|Overall Study|Lost to Follow-up|0|||
105599124|NCT00960141|364195262|FG000|Overall Study|Protocol Violation|1|||
105599125|NCT00960141|364195263|FG001|Overall Study|Protocol Violation|3|||
105599126|NCT00960141|364195264|FG002|Overall Study|Protocol Violation|2|||
105599127|NCT00960141|364195262|FG000|Overall Study|Withdrawal by Subject|1|||
105599128|NCT00960141|364195263|FG001|Overall Study|Withdrawal by Subject|2|||
105599129|NCT00960141|364195264|FG002|Overall Study|Withdrawal by Subject|1|||
105599130|NCT00468910|364195268|FG000|Overall Study|Lost to Follow-up|2|||
105599131|NCT00468910|364195269|FG001|Overall Study|Lost to Follow-up|1|||
105599132|NCT00468910|364195268|FG000|Overall Study|Withdrawal by Subject|2|||
105599133|NCT00468910|364195269|FG001|Overall Study|Withdrawal by Subject|1|||
105599134|NCT00468910|364195268|FG000|Overall Study|Medical Contraindication|0|||
105599135|NCT00468910|364195269|FG001|Overall Study|Medical Contraindication|1|||
105599136|NCT04504916|364195270|FG000|Overall Study|Study terminated|7|||
105599137|NCT04504916|364195271|FG001|Overall Study|Study terminated|8|||
105599138|NCT04504916|364195270|FG000|Overall Study|Death|54|||
105599139|NCT04504916|364195271|FG001|Overall Study|Death|18|||
105599140|NCT04504916|364195270|FG000|Overall Study|Lost to Follow-up|1|||
105599141|NCT04504916|364195271|FG001|Overall Study|Lost to Follow-up|1|||
105599142|NCT04504916|364195270|FG000|Overall Study|Withdrawal by Subject|8|||
105599143|NCT04504916|364195271|FG001|Overall Study|Withdrawal by Subject|4|||
105599144|NCT04504916|364195270|FG000|Overall Study|Did not agree to follow-up|0|||
105599145|NCT04504916|364195271|FG001|Overall Study|Did not agree to follow-up|1|||
105599146|NCT01943799|364195272|FG000|Overall Study|Lost to Follow-up|0|||
105599147|NCT01943799|364195273|FG001|Overall Study|Lost to Follow-up|1|||
105599148|NCT01943799|364195274|FG002|Overall Study|Lost to Follow-up|1|||
105599149|NCT01943799|364195275|FG003|Overall Study|Lost to Follow-up|0|||
105599150|NCT01943799|364195272|FG000|Overall Study|Protocol Violation|1|||
105599151|NCT01943799|364195273|FG001|Overall Study|Protocol Violation|0|||
105599152|NCT01943799|364195274|FG002|Overall Study|Protocol Violation|0|||
105599153|NCT01943799|364195275|FG003|Overall Study|Protocol Violation|0|||
105599154|NCT01943799|364195272|FG000|Overall Study|Withdrawal by Subject|4|||
105599155|NCT01943799|364195273|FG001|Overall Study|Withdrawal by Subject|2|||
105599156|NCT01943799|364195274|FG002|Overall Study|Withdrawal by Subject|1|||
105599157|NCT01943799|364195275|FG003|Overall Study|Withdrawal by Subject|0|||
105599158|NCT00373529|364195278|FG000|Overall Study|Physician Decision|19|||
105599159|NCT00373529|364195278|FG000|Overall Study|Withdrawal by Subject|7|||
105599160|NCT00373529|364195278|FG000|Overall Study|Adverse Event|7|||
105599161|NCT00373529|364195278|FG000|Overall Study|Treatment failure|36|||
105599162|NCT00373529|364195278|FG000|Overall Study|Disease recurrence|10|||
105599163|NCT00373529|364195278|FG000|Overall Study|Death|16|||
105599164|NCT00373529|364195278|FG000|Overall Study|Need for treatment prohibited by study|1|||
105599165|NCT00373529|364195278|FG000|Overall Study|Other|8|||
105599166|NCT00373529|364195278|FG000|Overall Study|Failed independent confirmation of AML|3|||
105599167|NCT00373529|364195278|FG000|Overall Study|Consent violation|1|||
105599168|NCT00630786|364195284|FG000|Overall Study|Physician Decision|0|||
105599169|NCT00630786|364195285|FG001|Overall Study|Physician Decision|0|||
105599170|NCT00630786|364195286|FG002|Overall Study|Physician Decision|1|||
105599171|NCT00630786|364195284|FG000|Overall Study|Withdrawal by Subject|0|||
105599172|NCT00630786|364195285|FG001|Overall Study|Withdrawal by Subject|1|||
105599173|NCT00630786|364195286|FG002|Overall Study|Withdrawal by Subject|1|||
105599174|NCT00630786|364195284|FG000|Overall Study|Lost to Follow-up|0|||
105599175|NCT00630786|364195285|FG001|Overall Study|Lost to Follow-up|1|||
105599176|NCT00630786|364195286|FG002|Overall Study|Lost to Follow-up|0|||
105599177|NCT00630786|364195284|FG000|Overall Study|Other|1|||
105599178|NCT00630786|364195285|FG001|Overall Study|Other|0|||
105599179|NCT00630786|364195286|FG002|Overall Study|Other|0|||
105599180|NCT04009577|364195287|FG000|Core Study|Adverse Event|1|||
105599181|NCT04009577|364195288|FG001|Core Study|Adverse Event|0|||
105599182|NCT04009577|364195289|FG002|Core Study|Adverse Event|2|||
105599183|NCT04009577|364195290|FG003|Core Study|Adverse Event|4|||
105599184|NCT04009577|364195287|FG000|Core Study|Withdrawal by Subject|0|||
105599185|NCT04009577|364195288|FG001|Core Study|Withdrawal by Subject|0|||
105599186|NCT04009577|364195289|FG002|Core Study|Withdrawal by Subject|2|||
105599187|NCT04009577|364195290|FG003|Core Study|Withdrawal by Subject|0|||
105599188|NCT04009577|364195287|FG000|Core Study|Other|0|||
105599189|NCT04009577|364195288|FG001|Core Study|Other|0|||
105599190|NCT04009577|364195289|FG002|Core Study|Other|0|||
105599191|NCT04009577|364195290|FG003|Core Study|Other|1|||
105599192|NCT04009577|364195287|FG000|Extension Phase|Adverse Event|0|||
105599193|NCT04009577|364195288|FG001|Extension Phase|Adverse Event|0|||
105599194|NCT04009577|364195289|FG002|Extension Phase|Adverse Event|0|||
105599195|NCT04009577|364195290|FG003|Extension Phase|Adverse Event|1|||
105599196|NCT04009577|364195287|FG000|Extension Phase|Inadequate therapeutic effect|0|||
105599197|NCT04009577|364195288|FG001|Extension Phase|Inadequate therapeutic effect|0|||
105599198|NCT04009577|364195289|FG002|Extension Phase|Inadequate therapeutic effect|1|||
105599199|NCT04009577|364195290|FG003|Extension Phase|Inadequate therapeutic effect|0|||
105599200|NCT04009577|364195287|FG000|Extension Phase|Withdrawal by Subject|0|||
105599201|NCT04009577|364195288|FG001|Extension Phase|Withdrawal by Subject|0|||
105599202|NCT04009577|364195289|FG002|Extension Phase|Withdrawal by Subject|1|||
105599203|NCT04009577|364195290|FG003|Extension Phase|Withdrawal by Subject|0|||
105599204|NCT04009577|364195287|FG000|Extension Phase|Not Treated|0|||
105599205|NCT04009577|364195288|FG001|Extension Phase|Not Treated|0|||
105599206|NCT04009577|364195289|FG002|Extension Phase|Not Treated|2|||
105599207|NCT04009577|364195290|FG003|Extension Phase|Not Treated|0|||
105599208|NCT00958633|364195294|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
105599209|NCT00958633|364195295|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
105599210|NCT00958633|364195296|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
105599211|NCT00958633|364195294|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
105599212|NCT00958633|364195295|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
105599213|NCT00958633|364195296|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
105599214|NCT00958633|364195294|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
105599215|NCT00958633|364195295|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
105599216|NCT00958633|364195296|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
105599217|NCT00958633|364195294|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
105599218|NCT00958633|364195295|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
105599219|NCT00958633|364195296|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
105599220|NCT00958633|364195294|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
105599221|NCT00958633|364195295|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
105599222|NCT00958633|364195296|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
105599223|NCT00958633|364195294|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
105599224|NCT00958633|364195295|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
105599225|NCT00958633|364195296|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
105599226|NCT00958633|364195294|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
105599227|NCT00958633|364195295|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
105599228|NCT00958633|364195296|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
105599229|NCT02261467|364195297|FG000|Overall Study|Enrolled in Error|1|||
105599230|NCT02261467|364195298|FG001|Overall Study|Enrolled in Error|0|||
105599231|NCT02261467|364195297|FG000|Overall Study|Protocol Violation|0|||
105599232|NCT02261467|364195298|FG001|Overall Study|Protocol Violation|1|||
105599233|NCT02261467|364195297|FG000|Overall Study|Personal Reasons|17|||
105599234|NCT02261467|364195298|FG001|Overall Study|Personal Reasons|22|||
105599235|NCT02261467|364195297|FG000|Overall Study|Lost to Follow-up|2|||
105599236|NCT02261467|364195298|FG001|Overall Study|Lost to Follow-up|13|||
105599237|NCT02261467|364195297|FG000|Overall Study|Adverse Event|1|||
105599238|NCT02261467|364195298|FG001|Overall Study|Adverse Event|1|||
105599239|NCT00736853|364195303|FG000|Open-Label Period|Physician Decision|2|||
105599240|NCT00736853|364195304|FG001|Open-Label Period|Physician Decision|0|||
105599241|NCT00736853|364195305|FG002|Open-Label Period|Physician Decision|0|||
105599242|NCT00736853|364195303|FG000|Open-Label Period|Adverse Event|31|||
105599243|NCT00736853|364195304|FG001|Open-Label Period|Adverse Event|0|||
105599244|NCT00736853|364195305|FG002|Open-Label Period|Adverse Event|0|||
105599245|NCT00736853|364195303|FG000|Open-Label Period|Withdrawal by Subject|16|||
105599246|NCT00736853|364195304|FG001|Open-Label Period|Withdrawal by Subject|0|||
105599247|NCT00736853|364195305|FG002|Open-Label Period|Withdrawal by Subject|0|||
105599248|NCT00736853|364195303|FG000|Open-Label Period|Started but not treated|42|||
105599249|NCT00736853|364195304|FG001|Open-Label Period|Started but not treated|0|||
105599250|NCT00736853|364195305|FG002|Open-Label Period|Started but not treated|0|||
105599251|NCT00736853|364195303|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
105599252|NCT00736853|364195304|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
105599253|NCT00736853|364195305|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
105599254|NCT00736853|364195303|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
105599255|NCT00736853|364195304|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
105599256|NCT00736853|364195305|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
105599257|NCT00736853|364195303|FG000|Double-Blind Period|Lack of Efficacy|0|||
105599258|NCT00736853|364195304|FG001|Double-Blind Period|Lack of Efficacy|19|||
105599259|NCT00736853|364195305|FG002|Double-Blind Period|Lack of Efficacy|42|||
105599260|NCT00736853|364195303|FG000|Double-Blind Period|Adverse Event|0|||
105599261|NCT00736853|364195304|FG001|Double-Blind Period|Adverse Event|3|||
105599262|NCT00736853|364195305|FG002|Double-Blind Period|Adverse Event|2|||
105599263|NCT00736853|364195303|FG000|Double-Blind Period|Withdrawal by Subject|0|||
105599264|NCT00736853|364195304|FG001|Double-Blind Period|Withdrawal by Subject|1|||
105599265|NCT00736853|364195305|FG002|Double-Blind Period|Withdrawal by Subject|4|||
105599266|NCT00736853|364195303|FG000|Double-Blind Period|Ineligible to participate the study|0|||
105599267|NCT00736853|364195304|FG001|Double-Blind Period|Ineligible to participate the study|1|||
105599268|NCT00736853|364195305|FG002|Double-Blind Period|Ineligible to participate the study|0|||
105599269|NCT01597258|364195306|FG000|Overall Study|No Drug Administration|1|||
105599270|NCT01199705|364195307|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
105599271|NCT01692730|364195308|FG000|Overall Study|Lost to Follow-up|225|||
105599272|NCT01692730|364195309|FG001|Overall Study|Lost to Follow-up|227|||
105599273|NCT01415349|364195310|FG000|Treatment Period 1|Adverse Event|0|||
105599274|NCT01415349|364195311|FG001|Treatment Period 1|Adverse Event|1|||
105599275|NCT01415349|364195310|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105599276|NCT01415349|364195311|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105599277|NCT01239316|364195312|FG000|Overall Study|Progression/Relapse|11|||
105599278|NCT01239316|364195312|FG000|Overall Study|Adverse Event|1|||
105599279|NCT00774852|364195319|FG000|Overall Study|Adverse Event|9|||
105599280|NCT00774852|364195320|FG001|Overall Study|Adverse Event|6|||
105599281|NCT00774852|364195319|FG000|Overall Study|Death|2|||
105599282|NCT00774852|364195320|FG001|Overall Study|Death|1|||
105599283|NCT00774852|364195319|FG000|Overall Study|Lack of Efficacy|3|||
105599284|NCT00774852|364195320|FG001|Overall Study|Lack of Efficacy|7|||
105599285|NCT00774852|364195319|FG000|Overall Study|Lost to Follow-up|9|||
105599286|NCT00774852|364195320|FG001|Overall Study|Lost to Follow-up|5|||
105599287|NCT00774852|364195319|FG000|Overall Study|Physician Decision|2|||
105599288|NCT00774852|364195320|FG001|Overall Study|Physician Decision|6|||
105599289|NCT00774852|364195319|FG000|Overall Study|Pregnancy|1|||
105599290|NCT00774852|364195320|FG001|Overall Study|Pregnancy|2|||
105599291|NCT00774852|364195319|FG000|Overall Study|Withdrawal by Subject|2|||
105599292|NCT00774852|364195320|FG001|Overall Study|Withdrawal by Subject|2|||
105599293|NCT00774852|364195319|FG000|Overall Study|Non-responder|15|||
105599294|NCT00774852|364195320|FG001|Overall Study|Non-responder|11|||
105599295|NCT00774852|364195319|FG000|Overall Study|Subject non-compliance|0|||
105599296|NCT00774852|364195320|FG001|Overall Study|Subject non-compliance|1|||
105599297|NCT00774852|364195319|FG000|Overall Study|Protocol Violation|1|||
105599298|NCT00774852|364195320|FG001|Overall Study|Protocol Violation|0|||
105599299|NCT00774852|364195319|FG000|Overall Study|Subject received prohibited medication|1|||
105599300|NCT00774852|364195320|FG001|Overall Study|Subject received prohibited medication|0|||
105599301|NCT00818454|364196755|FG000|Treatment Period 1|Adverse Event|0|||
105599302|NCT00818454|364196756|FG001|Treatment Period 1|Adverse Event|1|||
105599303|NCT00818454|364196757|FG002|Treatment Period 1|Adverse Event|0|||
105599304|NCT00818454|364196758|FG003|Treatment Period 1|Adverse Event|0|||
105599305|NCT00818454|364196755|FG000|Treatment Period 1|Other|3|||
105599306|NCT00818454|364196756|FG001|Treatment Period 1|Other|0|||
105599307|NCT00818454|364196757|FG002|Treatment Period 1|Other|0|||
105599308|NCT00818454|364196758|FG003|Treatment Period 1|Other|0|||
105599309|NCT00818454|364196755|FG000|Washout Period of 1 Week|Adverse Event|1|||
105599310|NCT00818454|364196756|FG001|Washout Period of 1 Week|Adverse Event|1|||
105599311|NCT00818454|364196757|FG002|Washout Period of 1 Week|Adverse Event|0|||
105599312|NCT00818454|364196758|FG003|Washout Period of 1 Week|Adverse Event|0|||
105599313|NCT00818454|364196755|FG000|Washout Period of 1 Week|Protocol Violation|2|||
105599314|NCT00818454|364196756|FG001|Washout Period of 1 Week|Protocol Violation|0|||
105599315|NCT00818454|364196757|FG002|Washout Period of 1 Week|Protocol Violation|0|||
105599316|NCT00818454|364196758|FG003|Washout Period of 1 Week|Protocol Violation|0|||
105599317|NCT00818454|364196755|FG000|Washout Period of 1 Week|Other|1|||
105599318|NCT00818454|364196756|FG001|Washout Period of 1 Week|Other|2|||
105599319|NCT00818454|364196757|FG002|Washout Period of 1 Week|Other|0|||
105599320|NCT00818454|364196758|FG003|Washout Period of 1 Week|Other|0|||
105599321|NCT00818454|364196755|FG000|Treatment Period 2|Other|2|||
105599322|NCT00818454|364196756|FG001|Treatment Period 2|Other|1|||
105599323|NCT00818454|364196757|FG002|Treatment Period 2|Other|0|||
105599324|NCT00818454|364196758|FG003|Treatment Period 2|Other|0|||
105599325|NCT00818454|364196755|FG000|Treatment Period 3|Adverse Event|0|||
105599326|NCT00818454|364196756|FG001|Treatment Period 3|Adverse Event|0|||
105599327|NCT00818454|364196757|FG002|Treatment Period 3|Adverse Event|0|||
105599328|NCT00818454|364196758|FG003|Treatment Period 3|Adverse Event|1|||
105599329|NCT01424397|364196762|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
105599330|NCT01424397|364196763|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
105599331|NCT01424397|364196764|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
105599332|NCT01424397|364196765|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
105599333|NCT01424397|364196766|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
105599334|NCT01424397|364196767|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
105599335|NCT01424397|364196768|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
105599336|NCT01424397|364196769|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
105599337|NCT01424397|364196770|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
105599338|NCT01424397|364196771|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
105599339|NCT01424397|364196772|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
105599340|NCT01424397|364196773|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
105599341|NCT01185561|364196775|FG000|Overall Study|Lost to Follow-up|0|||
105599342|NCT01185561|364196776|FG001|Overall Study|Lost to Follow-up|4|||
105599343|NCT01185561|364196775|FG000|Overall Study|Withdrawal by Subject|2|||
105599344|NCT01185561|364196776|FG001|Overall Study|Withdrawal by Subject|8|||
105599345|NCT00071799|364196777|FG000|Overall Study|Adverse Event|19|||
105599346|NCT00071799|364196778|FG001|Overall Study|Adverse Event|10|||
105599347|NCT00071799|364196777|FG000|Overall Study|Protocol Violation|1|||
105599348|NCT00071799|364196778|FG001|Overall Study|Protocol Violation|7|||
105599349|NCT00071799|364196777|FG000|Overall Study|Lost to Follow-up|1|||
105599350|NCT00071799|364196778|FG001|Overall Study|Lost to Follow-up|1|||
105599351|NCT00071799|364196777|FG000|Overall Study|Withdrawal by Subject|15|||
105599352|NCT00071799|364196778|FG001|Overall Study|Withdrawal by Subject|37|||
105599353|NCT00071799|364196777|FG000|Overall Study|Physician Decision|0|||
105599354|NCT00071799|364196778|FG001|Overall Study|Physician Decision|2|||
105599355|NCT00071799|364196777|FG000|Overall Study|Lack of Efficacy|11|||
105599356|NCT00071799|364196778|FG001|Overall Study|Lack of Efficacy|18|||
105599357|NCT00071799|364196777|FG000|Overall Study|Disease Progression|23|||
105599358|NCT00071799|364196778|FG001|Overall Study|Disease Progression|20|||
105599359|NCT00071799|364196777|FG000|Overall Study|Different Central+Local Pathology Review|0|||
105599360|NCT00071799|364196778|FG001|Overall Study|Different Central+Local Pathology Review|1|||
105599361|NCT00071799|364196777|FG000|Overall Study|Not Documented|0|||
105599362|NCT00071799|364196778|FG001|Overall Study|Not Documented|2|||
105599363|NCT03593213|364196781|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
105599364|NCT03593213|364196782|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
105599365|NCT03593213|364196783|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
105599366|NCT03593213|364196784|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
105599367|NCT03593213|364196781|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
105599368|NCT03593213|364196782|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
105599369|NCT03593213|364196783|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
105599370|NCT03593213|364196784|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
105599371|NCT03593213|364196781|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
105599372|NCT03593213|364196782|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
105599373|NCT03593213|364196783|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
105599374|NCT03593213|364196784|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
105599375|NCT03593213|364196781|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
105599376|NCT03593213|364196782|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
105599377|NCT03593213|364196783|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
105599378|NCT03593213|364196784|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
105599379|NCT03593213|364196781|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
105599380|NCT03593213|364196782|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
105599381|NCT03593213|364196783|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
105599382|NCT03593213|364196784|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
105599383|NCT03593213|364196781|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
105599384|NCT03593213|364196782|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
105599385|NCT03593213|364196783|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
105599386|NCT03593213|364196784|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
105599387|NCT03593213|364196781|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
105599388|NCT03593213|364196782|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
105599389|NCT03593213|364196783|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
105599390|NCT03593213|364196784|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
105599391|NCT03593213|364196781|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
105599392|NCT03593213|364196782|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
105599393|NCT03593213|364196783|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
105599394|NCT03593213|364196784|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
105599395|NCT03593213|364196781|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
105599396|NCT03593213|364196782|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
105599397|NCT03593213|364196783|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
105599398|NCT03593213|364196784|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
105599399|NCT03593213|364196781|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
105599400|NCT03593213|364196782|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
105599401|NCT03593213|364196783|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
105599402|NCT03593213|364196784|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
105599403|NCT03593213|364196781|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
105599404|NCT03593213|364196782|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
105599405|NCT03593213|364196783|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
105599406|NCT03593213|364196784|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
105599407|NCT03593213|364196781|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
105599408|NCT03593213|364196782|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
105599409|NCT03593213|364196783|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
105599410|NCT03593213|364196784|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
105599411|NCT03593213|364196781|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
105599412|NCT03593213|364196782|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
105599413|NCT03593213|364196783|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
105599414|NCT03593213|364196784|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
105599415|NCT03593213|364196781|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
105599416|NCT03593213|364196782|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
105599417|NCT03593213|364196783|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
105599418|NCT03593213|364196784|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
105599419|NCT03593213|364196781|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
105599420|NCT03593213|364196782|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
105599421|NCT03593213|364196783|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
105599422|NCT03593213|364196784|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
105599423|NCT03593213|364196781|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
105599424|NCT03593213|364196782|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
105599425|NCT03593213|364196783|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
105599426|NCT03593213|364196784|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
105599427|NCT03593213|364196781|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
105599428|NCT03593213|364196782|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
105599429|NCT03593213|364196783|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
105599430|NCT03593213|364196784|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
105599431|NCT03593213|364196781|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
105599432|NCT03593213|364196782|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
105599433|NCT03593213|364196783|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
105599434|NCT03593213|364196784|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
105599435|NCT03593213|364196781|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
105599436|NCT03593213|364196782|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
105599437|NCT03593213|364196783|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
105599438|NCT03593213|364196784|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
105599439|NCT00668863|364196785|FG000|Overall Study|Objective Progression or Relapse|42|||
105599440|NCT00668863|364196785|FG000|Overall Study|Adverse Event|13|||
105599441|NCT00668863|364196785|FG000|Overall Study|Study Terminated by Sponsor|8|||
105599442|NCT00668863|364196785|FG000|Overall Study|Global Deterioration of Health Status|4|||
105599443|NCT00668863|364196785|FG000|Overall Study|Withdrawal by Subject|1|||
105599444|NCT00668863|364196785|FG000|Overall Study|Surgery|1|||
105599445|NCT00668863|364196785|FG000|Overall Study|Subject's work scheduling problem|1|||
105599446|NCT00668863|364196785|FG000|Overall Study|Physician Decision|1|||
105599447|NCT01124734|364196790|FG000|Overall Study|Disease progression|13|||
105599448|NCT01124734|364196790|FG000|Overall Study|Adverse Event|1|||
105599449|NCT01124734|364196790|FG000|Overall Study|Withdrawal by Subject|1|||
105599450|NCT01124734|364196790|FG000|Overall Study|Elected for alternative treatment|2|||
105599451|NCT02214160|364196791|FG000|Overall Study|Withdrawal by Subject|1|||
105599452|NCT02214160|364196792|FG001|Overall Study|Withdrawal by Subject|0|||
105599453|NCT02214160|364196793|FG002|Overall Study|Withdrawal by Subject|6|||
105599454|NCT02214160|364196791|FG000|Overall Study|Death|2|||
105599455|NCT02214160|364196792|FG001|Overall Study|Death|2|||
105599456|NCT02214160|364196793|FG002|Overall Study|Death|1|||
105599457|NCT02214160|364196791|FG000|Overall Study|Subject Non-Compliance|0|||
105599458|NCT02214160|364196792|FG001|Overall Study|Subject Non-Compliance|3|||
105599459|NCT02214160|364196793|FG002|Overall Study|Subject Non-Compliance|1|||
105599460|NCT02214160|364196791|FG000|Overall Study|Adverse Event|0|||
105599461|NCT02214160|364196792|FG001|Overall Study|Adverse Event|1|||
105599462|NCT02214160|364196793|FG002|Overall Study|Adverse Event|1|||
105599463|NCT02214160|364196791|FG000|Overall Study|Sponsor Decision|0|||
105599464|NCT02214160|364196792|FG001|Overall Study|Sponsor Decision|2|||
105599465|NCT02214160|364196793|FG002|Overall Study|Sponsor Decision|0|||
105599466|NCT02214160|364196791|FG000|Overall Study|Protocol Violation|1|||
105599467|NCT02214160|364196792|FG001|Overall Study|Protocol Violation|0|||
105599468|NCT02214160|364196793|FG002|Overall Study|Protocol Violation|0|||
105599469|NCT02214160|364196791|FG000|Overall Study|Physician Decision|0|||
105599470|NCT02214160|364196792|FG001|Overall Study|Physician Decision|0|||
105599471|NCT02214160|364196793|FG002|Overall Study|Physician Decision|1|||
105599472|NCT01264679|364196794|FG000|Overall Study|Participation in Another Clinical Trial|1|||
105599473|NCT01264679|364196794|FG000|Overall Study|Physician Decision|1|||
105599474|NCT01264679|364196794|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
105599475|NCT01264679|364196794|FG000|Overall Study|Withdrawal by Subject|1|||
105599476|NCT00424645|364196797|FG000|Overall Study|Death|1|||
105599477|NCT00424645|364196798|FG001|Overall Study|Death|0|||
105599478|NCT00468052|364196799|FG000|Overall Study|Protocol Violation|7|||
105599479|NCT00468052|364196800|FG001|Overall Study|Protocol Violation|8|||
105599480|NCT00529789|364196801|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
105599481|NCT00529789|364196801|FG000|Study Period II/III|Adverse Event|3|||
105599482|NCT00529789|364196801|FG000|Study Period II/III|Lack of Efficacy|2|||
105599483|NCT00529789|364196801|FG000|Study Period II/III|Withdrawal by Subject|1|||
105599484|NCT00529789|364196801|FG000|Study Period II/III|Protocol Violation|3|||
105599485|NCT00529789|364196801|FG000|Study Period II/III|Physician Decision|3|||
105599486|NCT00529789|364196801|FG000|Study Period II/III|Lost to Follow-up|3|||
105599487|NCT00529789|364196801|FG000|Study Period IV|Parent/Caregiver Decision|1|||
105599488|NCT00529789|364196801|FG000|Study Period IV|Adverse Event|1|||
105599489|NCT00529789|364196801|FG000|Study Period IV|Lack of Efficacy|1|||
105599490|NCT00529789|364196801|FG000|Study Period IV|Lost to Follow-up|3|||
105599491|NCT01595061|364196802|FG000|Overall Study|Never Treated|3|||
105599492|NCT01595061|364196802|FG000|Overall Study|Inadequate Pathology|1|||
105599493|NCT02204982|364196805|FG000|Overall Study|Patient ineligible-medical monitor|1|||
105599494|NCT02204982|364196806|FG001|Overall Study|Patient ineligible-medical monitor|0|||
105599495|NCT02204982|364196805|FG000|Overall Study|Withdrawal by Subject|1|||
105599496|NCT02204982|364196806|FG001|Overall Study|Withdrawal by Subject|0|||
105599497|NCT02204982|364196805|FG000|Overall Study|Adverse Event|1|||
105599498|NCT02204982|364196806|FG001|Overall Study|Adverse Event|0|||
105599499|NCT02204982|364196805|FG000|Overall Study|Adverse Event and Investigator decision|1|||
105599500|NCT02204982|364196806|FG001|Overall Study|Adverse Event and Investigator decision|0|||
105599501|NCT02204982|364196805|FG000|Overall Study|Physician Decision|0|||
105599502|NCT02204982|364196806|FG001|Overall Study|Physician Decision|2|||
105599503|NCT02204982|364196805|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
105599504|NCT02204982|364196806|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
105599505|NCT02204982|364196805|FG000|Overall Study|Termination of Study bySponsor|0|||
105599506|NCT02204982|364196806|FG001|Overall Study|Termination of Study bySponsor|1|||
105599507|NCT00457743|364196810|FG000|Overall Study|Adverse Event|0|||
105599508|NCT00457743|364196811|FG001|Overall Study|Adverse Event|4|||
105599509|NCT00457743|364196812|FG002|Overall Study|Adverse Event|0|||
105599510|NCT00457743|364196810|FG000|Overall Study|Lack of Efficacy|3|||
105599511|NCT00457743|364196811|FG001|Overall Study|Lack of Efficacy|23|||
105599512|NCT00457743|364196812|FG002|Overall Study|Lack of Efficacy|3|||
105599513|NCT00356265|364196813|FG000|Overall Study|Withdrawal by Subject|0|||
105599514|NCT00356265|364196814|FG001|Overall Study|Withdrawal by Subject|0|||
105599515|NCT00356265|364196815|FG002|Overall Study|Withdrawal by Subject|1|||
105599516|NCT01837966|364196817|FG000|Overall Study|Withdrawal by Subject|2|||
105599517|NCT01837966|364196818|FG001|Overall Study|Withdrawal by Subject|1|||
105599518|NCT01493778|364196824|FG000|Overall Study|Withdrawal by Subject|8|||
105599519|NCT02115139|364196827|FG000|Overall Study|Protocol Violation|1|||
105599520|NCT02115139|364196827|FG000|Overall Study|treatment discontinuation|6|||
105599521|NCT01576484|364196828|FG000|Overall Study|Adverse Event|1|||
105599522|NCT01576484|364196829|FG001|Overall Study|Adverse Event|1|||
105599523|NCT01576484|364196828|FG000|Overall Study|Protocol Violation|0|||
105599524|NCT01576484|364196829|FG001|Overall Study|Protocol Violation|2|||
105599525|NCT01576484|364196828|FG000|Overall Study|Sponsor Decision|2|||
105599526|NCT01576484|364196829|FG001|Overall Study|Sponsor Decision|8|||
105599527|NCT01576484|364196828|FG000|Overall Study|Withdrawal by Subject|0|||
105599528|NCT01576484|364196829|FG001|Overall Study|Withdrawal by Subject|3|||
105599529|NCT01576484|364196828|FG000|Overall Study|Other|2|||
105599530|NCT01576484|364196829|FG001|Overall Study|Other|5|||
105599531|NCT01792830|364196831|FG000|Overall Study|Withdrawal by Subject|22|||
105599532|NCT01792830|364196832|FG001|Overall Study|Withdrawal by Subject|0|||
105599533|NCT01792830|364196833|FG002|Overall Study|Withdrawal by Subject|0|||
105599534|NCT01792830|364196834|FG003|Overall Study|Withdrawal by Subject|2|||
105599535|NCT01792830|364196835|FG004|Overall Study|Withdrawal by Subject|1|||
105599536|NCT01792830|364196836|FG005|Overall Study|Withdrawal by Subject|1|||
105599537|NCT01792830|364196837|FG006|Overall Study|Withdrawal by Subject|1|||
105599538|NCT01792830|364196838|FG007|Overall Study|Withdrawal by Subject|1|||
105599539|NCT01792830|364196839|FG008|Overall Study|Withdrawal by Subject|7|||
105599540|NCT01792830|364196840|FG009|Overall Study|Withdrawal by Subject|0|||
105599541|NCT01792830|364196841|FG010|Overall Study|Withdrawal by Subject|2|||
105599542|NCT01792830|364196831|FG000|Overall Study|Death|3|||
105599543|NCT01792830|364196832|FG001|Overall Study|Death|0|||
105599544|NCT01792830|364196833|FG002|Overall Study|Death|0|||
105599545|NCT01792830|364196834|FG003|Overall Study|Death|1|||
105599546|NCT01792830|364196835|FG004|Overall Study|Death|0|||
105599547|NCT01792830|364196836|FG005|Overall Study|Death|0|||
105599548|NCT01792830|364196837|FG006|Overall Study|Death|1|||
105599549|NCT01792830|364196838|FG007|Overall Study|Death|0|||
105599550|NCT01792830|364196839|FG008|Overall Study|Death|1|||
105599551|NCT01792830|364196840|FG009|Overall Study|Death|0|||
105599552|NCT01792830|364196841|FG010|Overall Study|Death|1|||
105599553|NCT01792830|364196831|FG000|Overall Study|Adverse Event|0|||
105599554|NCT01792830|364196832|FG001|Overall Study|Adverse Event|0|||
105599555|NCT01792830|364196833|FG002|Overall Study|Adverse Event|0|||
105599556|NCT01792830|364196834|FG003|Overall Study|Adverse Event|0|||
105599557|NCT01792830|364196835|FG004|Overall Study|Adverse Event|0|||
105599558|NCT01792830|364196836|FG005|Overall Study|Adverse Event|0|||
105599559|NCT01792830|364196837|FG006|Overall Study|Adverse Event|0|||
105599560|NCT01792830|364196838|FG007|Overall Study|Adverse Event|0|||
105599561|NCT01792830|364196839|FG008|Overall Study|Adverse Event|1|||
105599562|NCT01792830|364196840|FG009|Overall Study|Adverse Event|0|||
105599563|NCT01792830|364196841|FG010|Overall Study|Adverse Event|0|||
105599564|NCT01787760|364196844|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
105599565|NCT01787760|364196845|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
105599566|NCT01787760|364196846|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
105599567|NCT01787760|364196844|FG000|Overall Study|Decompensated on left exotropia|0|||
105599568|NCT01787760|364196845|FG001|Overall Study|Decompensated on left exotropia|0|||
105599569|NCT01787760|364196846|FG002|Overall Study|Decompensated on left exotropia|1|||
105599570|NCT01787760|364196844|FG000|Overall Study|Dryness|0|||
105599571|NCT01787760|364196845|FG001|Overall Study|Dryness|1|||
105599572|NCT01787760|364196846|FG002|Overall Study|Dryness|0|||
105599573|NCT01787760|364196844|FG000|Overall Study|Relocation|1|||
105599574|NCT01787760|364196845|FG001|Overall Study|Relocation|1|||
105599575|NCT01787760|364196846|FG002|Overall Study|Relocation|0|||
105599576|NCT01787760|364196844|FG000|Overall Study|Lens discomfort|3|||
105599577|NCT01787760|364196845|FG001|Overall Study|Lens discomfort|0|||
105599578|NCT01787760|364196846|FG002|Overall Study|Lens discomfort|0|||
105599579|NCT01787760|364196844|FG000|Overall Study|Lens handling difficulty|1|||
105599580|NCT01787760|364196845|FG001|Overall Study|Lens handling difficulty|2|||
105599581|NCT01787760|364196846|FG002|Overall Study|Lens handling difficulty|0|||
105599582|NCT01787760|364196844|FG000|Overall Study|Protocol Violation|6|||
105599583|NCT01787760|364196845|FG001|Overall Study|Protocol Violation|0|||
105599584|NCT01787760|364196846|FG002|Overall Study|Protocol Violation|1|||
105599585|NCT01787760|364196844|FG000|Overall Study|Withdrawal by Subject|5|||
105599586|NCT01787760|364196845|FG001|Overall Study|Withdrawal by Subject|1|||
105599587|NCT01787760|364196846|FG002|Overall Study|Withdrawal by Subject|2|||
105599588|NCT01787760|364196844|FG000|Overall Study|Lost to Follow-up|1|||
105599589|NCT01787760|364196845|FG001|Overall Study|Lost to Follow-up|0|||
105599590|NCT01787760|364196846|FG002|Overall Study|Lost to Follow-up|1|||
105599591|NCT01787760|364196844|FG000|Overall Study|Stroke|1|||
105599592|NCT01787760|364196845|FG001|Overall Study|Stroke|0|||
105599593|NCT01787760|364196846|FG002|Overall Study|Stroke|0|||
105599594|NCT01787760|364196844|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
105599595|NCT01787760|364196845|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
105599596|NCT01787760|364196846|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
105599597|NCT01787760|364196844|FG000|Overall Study|Unsatisfactory physiological response|2|||
105599598|NCT01787760|364196845|FG001|Overall Study|Unsatisfactory physiological response|4|||
105599599|NCT01787760|364196846|FG002|Overall Study|Unsatisfactory physiological response|0|||
105599600|NCT01787760|364196844|FG000|Overall Study|Unsatisfactory visual response|1|||
105599601|NCT01787760|364196845|FG001|Overall Study|Unsatisfactory visual response|1|||
105599602|NCT01787760|364196846|FG002|Overall Study|Unsatisfactory visual response|0|||
105599603|NCT01787760|364196844|FG000|Overall Study|Near vision blur|1|||
105599604|NCT01787760|364196845|FG001|Overall Study|Near vision blur|0|||
105599605|NCT01787760|364196846|FG002|Overall Study|Near vision blur|0|||
105599606|NCT03512756|364196847|FG000|Part 1|Death|23|||
105599607|NCT03512756|364196848|FG001|Part 1|Death|18|||
105599608|NCT03512756|364196849|FG002|Part 1|Death|0|||
105599609|NCT03512756|364196850|FG003|Part 1|Death|0|||
105599610|NCT03512756|364196847|FG000|Part 1|Lost to Follow-up|0|||
105599611|NCT03512756|364196848|FG001|Part 1|Lost to Follow-up|3|||
105599612|NCT03512756|364196849|FG002|Part 1|Lost to Follow-up|0|||
105599613|NCT03512756|364196850|FG003|Part 1|Lost to Follow-up|0|||
105599614|NCT03512756|364196847|FG000|Part 1|Physician Decision|0|||
105599615|NCT03512756|364196848|FG001|Part 1|Physician Decision|1|||
105599616|NCT03512756|364196849|FG002|Part 1|Physician Decision|0|||
105599617|NCT03512756|364196850|FG003|Part 1|Physician Decision|0|||
105599618|NCT03512756|364196847|FG000|Part 1|Withdrawal by Subject|2|||
105599619|NCT03512756|364196848|FG001|Part 1|Withdrawal by Subject|2|||
105599620|NCT03512756|364196849|FG002|Part 1|Withdrawal by Subject|0|||
105599621|NCT03512756|364196850|FG003|Part 1|Withdrawal by Subject|0|||
105599622|NCT03512756|364196847|FG000|Part 2|Death|0|||
105599623|NCT03512756|364196848|FG001|Part 2|Death|0|||
105599624|NCT03512756|364196849|FG002|Part 2|Death|32|||
105599625|NCT03512756|364196850|FG003|Part 2|Death|21|||
105599626|NCT03512756|364196847|FG000|Part 2|Lost to Follow-up|0|||
105599627|NCT03512756|364196848|FG001|Part 2|Lost to Follow-up|0|||
105599628|NCT03512756|364196849|FG002|Part 2|Lost to Follow-up|1|||
105599629|NCT03512756|364196850|FG003|Part 2|Lost to Follow-up|0|||
105599630|NCT03512756|364196847|FG000|Part 2|Physician Decision|0|||
105599631|NCT03512756|364196848|FG001|Part 2|Physician Decision|0|||
105599632|NCT03512756|364196849|FG002|Part 2|Physician Decision|2|||
105599633|NCT03512756|364196850|FG003|Part 2|Physician Decision|4|||
105599634|NCT03512756|364196847|FG000|Part 2|Study Terminated by Sponsor|0|||
105599635|NCT03512756|364196848|FG001|Part 2|Study Terminated by Sponsor|0|||
105599636|NCT03512756|364196849|FG002|Part 2|Study Terminated by Sponsor|2|||
105599637|NCT03512756|364196850|FG003|Part 2|Study Terminated by Sponsor|6|||
105599638|NCT03512756|364196847|FG000|Part 2|Protocol Violation|0|||
105599639|NCT03512756|364196848|FG001|Part 2|Protocol Violation|0|||
105599640|NCT03512756|364196849|FG002|Part 2|Protocol Violation|1|||
105599641|NCT03512756|364196850|FG003|Part 2|Protocol Violation|0|||
105599642|NCT03512756|364196847|FG000|Part 2|Withdrawal by Subject|0|||
105599643|NCT03512756|364196848|FG001|Part 2|Withdrawal by Subject|0|||
105599644|NCT03512756|364196849|FG002|Part 2|Withdrawal by Subject|3|||
105599645|NCT03512756|364196850|FG003|Part 2|Withdrawal by Subject|9|||
105599646|NCT01353963|364196851|FG000|Overall Study|Adverse Event|2|||
105599647|NCT00933400|364196859|FG000|Overall Study|Withdrawal by Subject|21|||
105599648|NCT00933400|364196860|FG001|Overall Study|Withdrawal by Subject|1|||
105599649|NCT01849055|364196861|FG000|Overall Study|Withdrawal by Subject|0|||
105599650|NCT01849055|364196862|FG001|Overall Study|Withdrawal by Subject|0|||
105599651|NCT01849055|364196863|FG002|Overall Study|Withdrawal by Subject|1|||
105599652|NCT01849055|364196864|FG003|Overall Study|Withdrawal by Subject|0|||
105599653|NCT01849055|364196865|FG004|Overall Study|Withdrawal by Subject|0|||
105599654|NCT01849055|364196866|FG005|Overall Study|Withdrawal by Subject|0|||
105599655|NCT02139943|364196871|FG000|Overall Study|Adverse Event|0|||
105599656|NCT02139943|364196872|FG001|Overall Study|Adverse Event|1|||
105599657|NCT02139943|364196873|FG002|Overall Study|Adverse Event|2|||
105599658|NCT02139943|364196871|FG000|Overall Study|Lost to Follow-up|3|||
105599659|NCT02139943|364196872|FG001|Overall Study|Lost to Follow-up|2|||
105599660|NCT02139943|364196873|FG002|Overall Study|Lost to Follow-up|2|||
105599661|NCT02139943|364196871|FG000|Overall Study|Withdrawal by Subject|4|||
105599662|NCT02139943|364196872|FG001|Overall Study|Withdrawal by Subject|3|||
105599663|NCT02139943|364196873|FG002|Overall Study|Withdrawal by Subject|0|||
105599664|NCT02139943|364196871|FG000|Overall Study|Other|0|||
105599665|NCT02139943|364196872|FG001|Overall Study|Other|0|||
105599666|NCT02139943|364196873|FG002|Overall Study|Other|1|||
105599667|NCT02139943|364196871|FG000|Overall Study|Participant wishes to discontinue|2|||
105599668|NCT02139943|364196872|FG001|Overall Study|Participant wishes to discontinue|0|||
105599669|NCT02139943|364196873|FG002|Overall Study|Participant wishes to discontinue|0|||
105599670|NCT02139943|364196871|FG000|Overall Study|Participant in Poor Compliance|1|||
105599671|NCT02139943|364196872|FG001|Overall Study|Participant in Poor Compliance|0|||
105599672|NCT02139943|364196873|FG002|Overall Study|Participant in Poor Compliance|1|||
105599673|NCT02139943|364196871|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
105599674|NCT02139943|364196872|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
105599675|NCT02139943|364196873|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
105599676|NCT01041417|364196874|FG000|Overall Study|Adverse Event|5|||
105599677|NCT01041417|364196875|FG001|Overall Study|Adverse Event|2|||
105599678|NCT01041417|364196874|FG000|Overall Study|Lost to Follow-up|1|||
105599679|NCT01041417|364196875|FG001|Overall Study|Lost to Follow-up|1|||
105599680|NCT01041417|364196874|FG000|Overall Study|Death|1|||
105599681|NCT01041417|364196875|FG001|Overall Study|Death|0|||
105599682|NCT02299375|364196876|FG000|Overall Study|Adverse Event, serious fatal|1|||
105599683|NCT02299375|364196877|FG001|Overall Study|Adverse Event, serious fatal|3|||
105599684|NCT02299375|364196876|FG000|Overall Study|Adverse Event, non-fatal|8|||
105599685|NCT02299375|364196877|FG001|Overall Study|Adverse Event, non-fatal|9|||
105599686|NCT02299375|364196876|FG000|Overall Study|Lack of Efficacy|1|||
105599687|NCT02299375|364196877|FG001|Overall Study|Lack of Efficacy|3|||
105599688|NCT02299375|364196876|FG000|Overall Study|Protocol Violation|1|||
105599689|NCT02299375|364196877|FG001|Overall Study|Protocol Violation|3|||
105599690|NCT02299375|364196876|FG000|Overall Study|Other: Met stopping criteria|1|||
105599691|NCT02299375|364196877|FG001|Overall Study|Other: Met stopping criteria|0|||
105599692|NCT02299375|364196876|FG000|Overall Study|Other: Study closed/terminated|66|||
105599693|NCT02299375|364196877|FG001|Overall Study|Other: Study closed/terminated|55|||
105599694|NCT02299375|364196876|FG000|Overall Study|Lost to Follow-up|0|||
105599695|NCT02299375|364196877|FG001|Overall Study|Lost to Follow-up|2|||
105599696|NCT02299375|364196876|FG000|Overall Study|Physician Decision|1|||
105599697|NCT02299375|364196877|FG001|Overall Study|Physician Decision|1|||
105599698|NCT02299375|364196876|FG000|Overall Study|Withdrawal by Subject|1|||
105599699|NCT02299375|364196877|FG001|Overall Study|Withdrawal by Subject|4|||
105599700|NCT00704184|364196878|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
105599701|NCT00704184|364196879|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
105599702|NCT00704184|364196880|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
105599703|NCT00704184|364196881|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
105599704|NCT00704184|364196882|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
105599705|NCT00704184|364196878|FG000|Open-Label Treatment|Adverse Event|0|||
105599706|NCT00704184|364196879|FG001|Open-Label Treatment|Adverse Event|0|||
105599707|NCT00704184|364196880|FG002|Open-Label Treatment|Adverse Event|2|||
105599708|NCT00704184|364196881|FG003|Open-Label Treatment|Adverse Event|0|||
105599709|NCT00704184|364196882|FG004|Open-Label Treatment|Adverse Event|1|||
105599710|NCT00704184|364196878|FG000|Open-Label Treatment|Lack of Efficacy|0|||
105599711|NCT00704184|364196879|FG001|Open-Label Treatment|Lack of Efficacy|2|||
105599712|NCT00704184|364196880|FG002|Open-Label Treatment|Lack of Efficacy|2|||
105599713|NCT00704184|364196881|FG003|Open-Label Treatment|Lack of Efficacy|2|||
105599714|NCT00704184|364196882|FG004|Open-Label Treatment|Lack of Efficacy|1|||
105599715|NCT00704184|364196878|FG000|Open-Label Treatment|Physician Decision|0|||
105599716|NCT00704184|364196879|FG001|Open-Label Treatment|Physician Decision|0|||
105599717|NCT00704184|364196880|FG002|Open-Label Treatment|Physician Decision|0|||
105599718|NCT00704184|364196881|FG003|Open-Label Treatment|Physician Decision|0|||
105599719|NCT00704184|364196882|FG004|Open-Label Treatment|Physician Decision|1|||
105599720|NCT00704184|364196878|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
105599721|NCT00704184|364196879|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
105599722|NCT00704184|364196880|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
105599723|NCT00704184|364196881|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
105599724|NCT00704184|364196882|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
105599725|NCT01803555|364196885|FG000|Overall Study|Adverse Event|3|||
105599726|NCT01803555|364196886|FG001|Overall Study|Adverse Event|2|||
105599727|NCT01803555|364196885|FG000|Overall Study|Withdrawal by Subject|3|||
105599728|NCT01803555|364196886|FG001|Overall Study|Withdrawal by Subject|3|||
105599729|NCT01803555|364196885|FG000|Overall Study|Non-compliance|1|||
105599730|NCT01803555|364196886|FG001|Overall Study|Non-compliance|1|||
105599731|NCT01803555|364196885|FG000|Overall Study|Protocol Violation|3|||
105599732|NCT01803555|364196886|FG001|Overall Study|Protocol Violation|5|||
105599733|NCT01803555|364196885|FG000|Overall Study|Lost to Follow-up|0|||
105599734|NCT01803555|364196886|FG001|Overall Study|Lost to Follow-up|2|||
105599735|NCT01803555|364196885|FG000|Overall Study|Other than specified|3|||
105599736|NCT01803555|364196886|FG001|Overall Study|Other than specified|5|||
105599737|NCT00203411|364196892|FG000|Follow-up|Progressive Disease|4|||
105599738|NCT01188655|364198479|FG000|Overall Study|Lack of Efficacy|1|||
105599739|NCT01188655|364198479|FG000|Overall Study|Lost to Follow-up|1|||
105599740|NCT01188655|364198479|FG000|Overall Study|Other|11|||
105599741|NCT03086369|364198480|FG000|Overall Study|Lost to Follow-up|1|||
105599742|NCT03086369|364198481|FG001|Overall Study|Lost to Follow-up|0|||
105599743|NCT03086369|364198482|FG002|Overall Study|Lost to Follow-up|0|||
105599744|NCT03086369|364198483|FG003|Overall Study|Lost to Follow-up|2|||
105599745|NCT03086369|364198484|FG004|Overall Study|Lost to Follow-up|1|||
105599746|NCT03086369|364198480|FG000|Overall Study|Physician Decision|0|||
105599747|NCT03086369|364198481|FG001|Overall Study|Physician Decision|0|||
105599748|NCT03086369|364198482|FG002|Overall Study|Physician Decision|0|||
105599749|NCT03086369|364198483|FG003|Overall Study|Physician Decision|1|||
105599750|NCT03086369|364198484|FG004|Overall Study|Physician Decision|2|||
105599751|NCT03086369|364198480|FG000|Overall Study|Withdrawal by Subject|0|||
105599752|NCT03086369|364198481|FG001|Overall Study|Withdrawal by Subject|0|||
105599753|NCT03086369|364198482|FG002|Overall Study|Withdrawal by Subject|0|||
105599754|NCT03086369|364198483|FG003|Overall Study|Withdrawal by Subject|5|||
105599755|NCT03086369|364198484|FG004|Overall Study|Withdrawal by Subject|3|||
105599756|NCT03086369|364198480|FG000|Overall Study|Progressive Disease|0|||
105599757|NCT03086369|364198481|FG001|Overall Study|Progressive Disease|0|||
105599758|NCT03086369|364198482|FG002|Overall Study|Progressive Disease|0|||
105599759|NCT03086369|364198483|FG003|Overall Study|Progressive Disease|1|||
105599760|NCT03086369|364198484|FG004|Overall Study|Progressive Disease|1|||
105599761|NCT00683696|364198487|FG000|Overall Study|Withdrawn due to study closure|337|||
105599762|NCT00683696|364198488|FG001|Overall Study|Withdrawn due to study closure|338|||
105599763|NCT00683696|364198487|FG000|Overall Study|Withdrawn prior to study closure|13|||
105599764|NCT00683696|364198488|FG001|Overall Study|Withdrawn prior to study closure|28|||
105599765|NCT00683696|364198487|FG000|Overall Study|Lost to Follow-up|5|||
105599766|NCT00683696|364198488|FG001|Overall Study|Lost to Follow-up|6|||
105599767|NCT00683696|364198487|FG000|Overall Study|Vital status follow-up only|3|||
105599768|NCT00683696|364198488|FG001|Overall Study|Vital status follow-up only|3|||
105599769|NCT00683696|364198487|FG000|Overall Study|Death|46|||
105599770|NCT00683696|364198488|FG001|Overall Study|Death|30|||
105599771|NCT01875848|364198492|FG000|Overall Study|Withdrawal by Subject|2|||
105599772|NCT01875848|364198493|FG001|Overall Study|Withdrawal by Subject|0|||
105599773|NCT00925587|364198494|FG000|Overall Study|Protocol Specified Criteria|6|||
105599774|NCT00925587|364198495|FG001|Overall Study|Protocol Specified Criteria|6|||
105599775|NCT00925587|364198494|FG000|Overall Study|Physician Decision|4|||
105599776|NCT00925587|364198495|FG001|Overall Study|Physician Decision|1|||
105599777|NCT00925587|364198494|FG000|Overall Study|Protocol Violation|6|||
105599778|NCT00925587|364198495|FG001|Overall Study|Protocol Violation|4|||
105599779|NCT00925587|364198494|FG000|Overall Study|Withdrawal by Subject|9|||
105599780|NCT00925587|364198495|FG001|Overall Study|Withdrawal by Subject|6|||
105599781|NCT00925587|364198494|FG000|Overall Study|Death|5|||
105599782|NCT00925587|364198495|FG001|Overall Study|Death|5|||
105599783|NCT00925587|364198494|FG000|Overall Study|Adverse Event|6|||
105599784|NCT00925587|364198495|FG001|Overall Study|Adverse Event|2|||
105599785|NCT00925587|364198494|FG000|Overall Study|Lost to Follow-up|0|||
105599786|NCT00925587|364198495|FG001|Overall Study|Lost to Follow-up|1|||
105599787|NCT03762668|364198496|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
105599788|NCT03762668|364198497|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
105599789|NCT00178399|364198500|FG000|Overall Study|Physician Decision|4|||
105599790|NCT00178399|364198500|FG000|Overall Study|Withdrawal by Subject|8|||
105599791|NCT00178399|364198500|FG000|Overall Study|Lost to Follow-up|1|||
105599792|NCT04425629|364198505|FG000|Overall Study|Adverse Event|0|||
105599793|NCT04425629|364198506|FG001|Overall Study|Adverse Event|0|||
105599794|NCT04425629|364198507|FG002|Overall Study|Adverse Event|0|||
105599795|NCT04425629|364198508|FG003|Overall Study|Adverse Event|0|||
105599796|NCT04425629|364198509|FG004|Overall Study|Adverse Event|1|||
105599797|NCT04425629|364198510|FG005|Overall Study|Adverse Event|0|||
105599798|NCT04425629|364198511|FG006|Overall Study|Adverse Event|0|||
105599799|NCT04425629|364198512|FG007|Overall Study|Adverse Event|0|||
105599800|NCT04425629|364198513|FG008|Overall Study|Adverse Event|0|||
105599801|NCT04425629|364198514|FG009|Overall Study|Adverse Event|3|||
105599802|NCT04425629|364198515|FG010|Overall Study|Adverse Event|2|||
105599803|NCT04425629|364198516|FG011|Overall Study|Adverse Event|1|||
105599804|NCT04425629|364198517|FG012|Overall Study|Adverse Event|1|||
105599805|NCT04425629|364198518|FG013|Overall Study|Adverse Event|0|||
105599806|NCT04425629|364198519|FG014|Overall Study|Adverse Event|0|||
105599807|NCT04425629|364198520|FG015|Overall Study|Adverse Event|0|||
105599808|NCT04425629|364198521|FG016|Overall Study|Adverse Event|0|||
105599809|NCT04425629|364198522|FG017|Overall Study|Adverse Event|0|||
105599810|NCT04425629|364198523|FG018|Overall Study|Adverse Event|0|||
105599811|NCT04425629|364198505|FG000|Overall Study|Lost to Follow-up|1|||
105599812|NCT04425629|364198506|FG001|Overall Study|Lost to Follow-up|3|||
105599813|NCT04425629|364198507|FG002|Overall Study|Lost to Follow-up|1|||
105599814|NCT04425629|364198508|FG003|Overall Study|Lost to Follow-up|7|||
105599815|NCT04425629|364198509|FG004|Overall Study|Lost to Follow-up|1|||
105599816|NCT04425629|364198510|FG005|Overall Study|Lost to Follow-up|2|||
105599817|NCT04425629|364198511|FG006|Overall Study|Lost to Follow-up|1|||
105599818|NCT04425629|364198512|FG007|Overall Study|Lost to Follow-up|0|||
105599819|NCT04425629|364198513|FG008|Overall Study|Lost to Follow-up|1|||
105599820|NCT04425629|364198514|FG009|Overall Study|Lost to Follow-up|64|||
105599821|NCT04425629|364198515|FG010|Overall Study|Lost to Follow-up|70|||
105599822|NCT04425629|364198516|FG011|Overall Study|Lost to Follow-up|98|||
105599823|NCT04425629|364198517|FG012|Overall Study|Lost to Follow-up|30|||
105599824|NCT04425629|364198518|FG013|Overall Study|Lost to Follow-up|0|||
105599825|NCT04425629|364198519|FG014|Overall Study|Lost to Follow-up|5|||
105599826|NCT04425629|364198520|FG015|Overall Study|Lost to Follow-up|4|||
105599827|NCT04425629|364198521|FG016|Overall Study|Lost to Follow-up|0|||
105599828|NCT04425629|364198522|FG017|Overall Study|Lost to Follow-up|3|||
105599829|NCT04425629|364198523|FG018|Overall Study|Lost to Follow-up|1|||
105599830|NCT04425629|364198505|FG000|Overall Study|Subject Decision|0|||
105599831|NCT04425629|364198506|FG001|Overall Study|Subject Decision|2|||
105599832|NCT04425629|364198507|FG002|Overall Study|Subject Decision|1|||
105599833|NCT04425629|364198508|FG003|Overall Study|Subject Decision|3|||
105599834|NCT04425629|364198509|FG004|Overall Study|Subject Decision|6|||
105599835|NCT04425629|364198510|FG005|Overall Study|Subject Decision|6|||
105599836|NCT04425629|364198511|FG006|Overall Study|Subject Decision|3|||
105599837|NCT04425629|364198512|FG007|Overall Study|Subject Decision|3|||
105599838|NCT04425629|364198513|FG008|Overall Study|Subject Decision|1|||
105599839|NCT04425629|364198514|FG009|Overall Study|Subject Decision|70|||
105599840|NCT04425629|364198515|FG010|Overall Study|Subject Decision|95|||
105599841|NCT04425629|364198516|FG011|Overall Study|Subject Decision|124|||
105599842|NCT04425629|364198517|FG012|Overall Study|Subject Decision|25|||
105599843|NCT04425629|364198518|FG013|Overall Study|Subject Decision|0|||
105599844|NCT04425629|364198519|FG014|Overall Study|Subject Decision|1|||
105599845|NCT04425629|364198520|FG015|Overall Study|Subject Decision|4|||
105599846|NCT04425629|364198521|FG016|Overall Study|Subject Decision|1|||
105599847|NCT04425629|364198522|FG017|Overall Study|Subject Decision|0|||
105599848|NCT04425629|364198523|FG018|Overall Study|Subject Decision|2|||
105599849|NCT04425629|364198505|FG000|Overall Study|Death|0|||
105599850|NCT04425629|364198506|FG001|Overall Study|Death|0|||
105599851|NCT04425629|364198507|FG002|Overall Study|Death|0|||
105599852|NCT04425629|364198508|FG003|Overall Study|Death|0|||
105599853|NCT04425629|364198509|FG004|Overall Study|Death|0|||
105599854|NCT04425629|364198510|FG005|Overall Study|Death|0|||
105599855|NCT04425629|364198511|FG006|Overall Study|Death|0|||
105599856|NCT04425629|364198512|FG007|Overall Study|Death|0|||
105599857|NCT04425629|364198513|FG008|Overall Study|Death|0|||
105599858|NCT04425629|364198514|FG009|Overall Study|Death|11|||
105599859|NCT04425629|364198515|FG010|Overall Study|Death|2|||
105599860|NCT04425629|364198516|FG011|Overall Study|Death|4|||
105599861|NCT04425629|364198517|FG012|Overall Study|Death|0|||
105599862|NCT04425629|364198518|FG013|Overall Study|Death|0|||
105599863|NCT04425629|364198519|FG014|Overall Study|Death|0|||
105599864|NCT04425629|364198520|FG015|Overall Study|Death|0|||
105599865|NCT04425629|364198521|FG016|Overall Study|Death|0|||
105599866|NCT04425629|364198522|FG017|Overall Study|Death|0|||
105599867|NCT04425629|364198523|FG018|Overall Study|Death|0|||
105599868|NCT04425629|364198505|FG000|Overall Study|Sponsor Request|0|||
105599869|NCT04425629|364198506|FG001|Overall Study|Sponsor Request|0|||
105599870|NCT04425629|364198507|FG002|Overall Study|Sponsor Request|0|||
105599871|NCT04425629|364198508|FG003|Overall Study|Sponsor Request|2|||
105599872|NCT04425629|364198509|FG004|Overall Study|Sponsor Request|2|||
105599873|NCT04425629|364198510|FG005|Overall Study|Sponsor Request|2|||
105599874|NCT04425629|364198511|FG006|Overall Study|Sponsor Request|1|||
105599875|NCT04425629|364198512|FG007|Overall Study|Sponsor Request|0|||
105599876|NCT04425629|364198513|FG008|Overall Study|Sponsor Request|0|||
105599877|NCT04425629|364198514|FG009|Overall Study|Sponsor Request|9|||
105599878|NCT04425629|364198515|FG010|Overall Study|Sponsor Request|9|||
105599879|NCT04425629|364198516|FG011|Overall Study|Sponsor Request|10|||
105599880|NCT04425629|364198517|FG012|Overall Study|Sponsor Request|8|||
105599881|NCT04425629|364198518|FG013|Overall Study|Sponsor Request|0|||
105599882|NCT04425629|364198519|FG014|Overall Study|Sponsor Request|0|||
105599883|NCT04425629|364198520|FG015|Overall Study|Sponsor Request|1|||
105599884|NCT04425629|364198521|FG016|Overall Study|Sponsor Request|0|||
105599885|NCT04425629|364198522|FG017|Overall Study|Sponsor Request|0|||
105599886|NCT04425629|364198523|FG018|Overall Study|Sponsor Request|0|||
105599887|NCT04425629|364198505|FG000|Overall Study|Physician Decision|0|||
105599888|NCT04425629|364198506|FG001|Overall Study|Physician Decision|0|||
105599889|NCT04425629|364198507|FG002|Overall Study|Physician Decision|0|||
105599890|NCT04425629|364198508|FG003|Overall Study|Physician Decision|0|||
105599891|NCT04425629|364198509|FG004|Overall Study|Physician Decision|0|||
105599892|NCT04425629|364198510|FG005|Overall Study|Physician Decision|0|||
105599893|NCT04425629|364198511|FG006|Overall Study|Physician Decision|0|||
105599894|NCT04425629|364198512|FG007|Overall Study|Physician Decision|0|||
105599895|NCT04425629|364198513|FG008|Overall Study|Physician Decision|0|||
105599896|NCT04425629|364198514|FG009|Overall Study|Physician Decision|4|||
105599897|NCT04425629|364198515|FG010|Overall Study|Physician Decision|3|||
105599898|NCT04425629|364198516|FG011|Overall Study|Physician Decision|5|||
105599899|NCT04425629|364198517|FG012|Overall Study|Physician Decision|1|||
105599900|NCT04425629|364198518|FG013|Overall Study|Physician Decision|0|||
105599901|NCT04425629|364198519|FG014|Overall Study|Physician Decision|0|||
105599902|NCT04425629|364198520|FG015|Overall Study|Physician Decision|1|||
105599903|NCT04425629|364198521|FG016|Overall Study|Physician Decision|0|||
105599904|NCT04425629|364198522|FG017|Overall Study|Physician Decision|0|||
105599905|NCT04425629|364198523|FG018|Overall Study|Physician Decision|0|||
105599906|NCT04425629|364198505|FG000|Overall Study|Lack of Efficacy|0|||
105599907|NCT04425629|364198506|FG001|Overall Study|Lack of Efficacy|0|||
105599908|NCT04425629|364198507|FG002|Overall Study|Lack of Efficacy|0|||
105599909|NCT04425629|364198508|FG003|Overall Study|Lack of Efficacy|0|||
105599910|NCT04425629|364198509|FG004|Overall Study|Lack of Efficacy|0|||
105599911|NCT04425629|364198510|FG005|Overall Study|Lack of Efficacy|0|||
105599912|NCT04425629|364198511|FG006|Overall Study|Lack of Efficacy|0|||
105599913|NCT04425629|364198512|FG007|Overall Study|Lack of Efficacy|0|||
105599914|NCT04425629|364198513|FG008|Overall Study|Lack of Efficacy|0|||
105599915|NCT04425629|364198514|FG009|Overall Study|Lack of Efficacy|0|||
105599916|NCT04425629|364198515|FG010|Overall Study|Lack of Efficacy|1|||
105599917|NCT04425629|364198516|FG011|Overall Study|Lack of Efficacy|0|||
105599918|NCT04425629|364198517|FG012|Overall Study|Lack of Efficacy|0|||
105599919|NCT04425629|364198518|FG013|Overall Study|Lack of Efficacy|0|||
105599920|NCT04425629|364198519|FG014|Overall Study|Lack of Efficacy|0|||
105599921|NCT04425629|364198520|FG015|Overall Study|Lack of Efficacy|0|||
105599922|NCT04425629|364198521|FG016|Overall Study|Lack of Efficacy|0|||
105599923|NCT04425629|364198522|FG017|Overall Study|Lack of Efficacy|0|||
105599924|NCT04425629|364198523|FG018|Overall Study|Lack of Efficacy|0|||
105599925|NCT00002842|364198526|FG000|Overall Study|ineligible for surgical resection|27|||
105599926|NCT01613716|364198529|FG000|Overall Study|screen failures|3|||
105599927|NCT01613716|364198529|FG000|Overall Study|Lost to Follow-up|4|||
105599928|NCT00414544|364198530|FG000|Overall Study|Lost to Follow-up|14|||
105599929|NCT01765543|364198532|FG000|Overall Study|Death|1|||
105599930|NCT01765543|364198532|FG000|Overall Study|Withdrawal by Subject|2|||
105599931|NCT03454529|364198533|FG000|Overall Study|Did not receive treatment|6|||
105599932|NCT03454529|364198533|FG000|Overall Study|Received < 80% doses|1|||
105599933|NCT02423798|364198540|FG000|Overall Study|Withdrawal by Subject|3|||
105599934|NCT01063972|364198541|FG000|Overall Study|Death|12|||
105599935|NCT01063972|364198542|FG001|Overall Study|Death|11|||
105599936|NCT01063972|364198541|FG000|Overall Study|Incarcerated|2|||
105599937|NCT01063972|364198542|FG001|Overall Study|Incarcerated|1|||
105599938|NCT01236560|364198543|FG000|Overall Study|Adverse Event|0|||
105599939|NCT01236560|364198544|FG001|Overall Study|Adverse Event|2|||
105599940|NCT01236560|364198545|FG002|Overall Study|Adverse Event|1|||
105599941|NCT01236560|364198546|FG003|Overall Study|Adverse Event|3|||
105599942|NCT01236560|364198547|FG004|Overall Study|Adverse Event|0|||
105599943|NCT01236560|364198548|FG005|Overall Study|Adverse Event|0|||
105599944|NCT01236560|364198543|FG000|Overall Study|Death|0|||
105599945|NCT01236560|364198544|FG001|Overall Study|Death|1|||
105599946|NCT01236560|364198545|FG002|Overall Study|Death|0|||
105599947|NCT01236560|364198546|FG003|Overall Study|Death|1|||
105599948|NCT01236560|364198547|FG004|Overall Study|Death|0|||
105599949|NCT01236560|364198548|FG005|Overall Study|Death|0|||
105599950|NCT01236560|364198543|FG000|Overall Study|Lost to Follow-up|0|||
105599951|NCT01236560|364198544|FG001|Overall Study|Lost to Follow-up|1|||
105599952|NCT01236560|364198545|FG002|Overall Study|Lost to Follow-up|1|||
105599953|NCT01236560|364198546|FG003|Overall Study|Lost to Follow-up|0|||
105599954|NCT01236560|364198547|FG004|Overall Study|Lost to Follow-up|0|||
105599955|NCT01236560|364198548|FG005|Overall Study|Lost to Follow-up|0|||
105599956|NCT01236560|364198543|FG000|Overall Study|Physician Decision|0|||
105599957|NCT01236560|364198544|FG001|Overall Study|Physician Decision|1|||
105599958|NCT01236560|364198545|FG002|Overall Study|Physician Decision|8|||
105599959|NCT01236560|364198546|FG003|Overall Study|Physician Decision|0|||
105599960|NCT01236560|364198547|FG004|Overall Study|Physician Decision|0|||
105599961|NCT01236560|364198548|FG005|Overall Study|Physician Decision|0|||
105599962|NCT01236560|364198543|FG000|Overall Study|Withdrawal by Subject|0|||
105599963|NCT01236560|364198544|FG001|Overall Study|Withdrawal by Subject|0|||
105599964|NCT01236560|364198545|FG002|Overall Study|Withdrawal by Subject|1|||
105599965|NCT01236560|364198546|FG003|Overall Study|Withdrawal by Subject|2|||
105599966|NCT01236560|364198547|FG004|Overall Study|Withdrawal by Subject|0|||
105599967|NCT01236560|364198548|FG005|Overall Study|Withdrawal by Subject|0|||
105599968|NCT01236560|364198543|FG000|Overall Study|Progressive disease|5|||
105599969|NCT01236560|364198544|FG001|Overall Study|Progressive disease|19|||
105599970|NCT01236560|364198545|FG002|Overall Study|Progressive disease|9|||
105599971|NCT01236560|364198546|FG003|Overall Study|Progressive disease|16|||
105599972|NCT01236560|364198547|FG004|Overall Study|Progressive disease|0|||
105599973|NCT01236560|364198548|FG005|Overall Study|Progressive disease|0|||
105599974|NCT04590963|364198557|FG000|Overall Study|Death|118|||
105599975|NCT04590963|364198558|FG001|Overall Study|Death|59|||
105599976|NCT04590963|364198557|FG000|Overall Study|Lost to Follow-up|1|||
105599977|NCT04590963|364198558|FG001|Overall Study|Lost to Follow-up|1|||
105599978|NCT04590963|364198557|FG000|Overall Study|Progressive disease|0|||
105599979|NCT04590963|364198558|FG001|Overall Study|Progressive disease|1|||
105599980|NCT04590963|364198557|FG000|Overall Study|Study terminated by sponsor|103|||
105599981|NCT04590963|364198558|FG001|Overall Study|Study terminated by sponsor|50|||
105599982|NCT04590963|364198557|FG000|Overall Study|Withdrawal by Subject|15|||
105599983|NCT04590963|364198558|FG001|Overall Study|Withdrawal by Subject|8|||
105599984|NCT04590963|364198557|FG000|Overall Study|Ongoing at data cut-off|9|||
105599985|NCT04590963|364198558|FG001|Overall Study|Ongoing at data cut-off|4|||
105599986|NCT04590963|364198557|FG000|Overall Study|Screen failure|1|||
105599987|NCT04590963|364198558|FG001|Overall Study|Screen failure|0|||
105599988|NCT05274217|364198559|FG000|Overall Study|Study terminated.|11|||
105599989|NCT05274217|364198560|FG001|Overall Study|Study terminated.|0|||
105599990|NCT04594759|364198561|FG000|Overall Study|Lost to Follow-up|3|||
105599991|NCT03811574|364198562|FG000|Overall Study|Withdrawal by Subject|2|||
105599992|NCT03811574|364198563|FG001|Overall Study|Withdrawal by Subject|4|||
105599993|NCT03811574|364198564|FG002|Overall Study|Withdrawal by Subject|0|||
105599994|NCT01832480|364198565|FG000|Overall Study|Lost to Follow-up|33|||
105599995|NCT01832480|364198566|FG001|Overall Study|Lost to Follow-up|30|||
105599996|NCT01832480|364198565|FG000|Overall Study|Withdrawal by Subject|0|||
105599997|NCT01832480|364198566|FG001|Overall Study|Withdrawal by Subject|2|||
105599998|NCT01832480|364198565|FG000|Overall Study|post randomization ineligible|8|||
105599999|NCT01832480|364198566|FG001|Overall Study|post randomization ineligible|10|||
105600000|NCT05609032|364198567|FG000|Overall Study|Lost to Follow-up|3|||
105600001|NCT05609032|364198568|FG001|Overall Study|Lost to Follow-up|1|||
105600002|NCT05609032|364198567|FG000|Overall Study|Withdrawal by Subject|1|||
105600003|NCT05609032|364198568|FG001|Overall Study|Withdrawal by Subject|0|||
105600004|NCT04305405|364198569|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105600005|NCT04305405|364198570|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105600006|NCT02528188|364198571|FG000|Overall Study|Adverse Event|23|||
105600007|NCT02528188|364198572|FG001|Overall Study|Adverse Event|22|||
105600008|NCT02528188|364198573|FG002|Overall Study|Adverse Event|8|||
105600009|NCT02528188|364198571|FG000|Overall Study|Protocol Violation|4|||
105600010|NCT02528188|364198572|FG001|Overall Study|Protocol Violation|6|||
105600011|NCT02528188|364198573|FG002|Overall Study|Protocol Violation|4|||
105600012|NCT02528188|364198571|FG000|Overall Study|Lack of Efficacy|19|||
105600013|NCT02528188|364198572|FG001|Overall Study|Lack of Efficacy|21|||
105600014|NCT02528188|364198573|FG002|Overall Study|Lack of Efficacy|22|||
105600015|NCT02528188|364198571|FG000|Overall Study|Withdrawal by Subject|97|||
105600016|NCT02528188|364198572|FG001|Overall Study|Withdrawal by Subject|104|||
105600017|NCT02528188|364198573|FG002|Overall Study|Withdrawal by Subject|100|||
105600018|NCT02528188|364198571|FG000|Overall Study|Lost to Follow-up|25|||
105600019|NCT02528188|364198572|FG001|Overall Study|Lost to Follow-up|21|||
105600020|NCT02528188|364198573|FG002|Overall Study|Lost to Follow-up|31|||
105600021|NCT02528188|364198571|FG000|Overall Study|Death|4|||
105600022|NCT02528188|364198572|FG001|Overall Study|Death|4|||
105600023|NCT02528188|364198573|FG002|Overall Study|Death|0|||
105600024|NCT02528188|364198571|FG000|Overall Study|Other|89|||
105600025|NCT02528188|364198572|FG001|Overall Study|Other|91|||
105600026|NCT02528188|364198573|FG002|Overall Study|Other|74|||
105600027|NCT02528188|364198571|FG000|Overall Study|Randomized but not treated|6|||
105600028|NCT02528188|364198572|FG001|Overall Study|Randomized but not treated|7|||
105600029|NCT02528188|364198573|FG002|Overall Study|Randomized but not treated|12|||
105600030|NCT03942042|364198574|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
105600031|NCT03942042|364198575|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
105600032|NCT03942042|364198574|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
105600033|NCT03942042|364198575|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
105600034|NCT03807778|364198581|FG000|Overall Study|Adverse Event|0|||
105600035|NCT03807778|364198582|FG001|Overall Study|Adverse Event|0|||
105600036|NCT03807778|364198583|FG002|Overall Study|Adverse Event|3|||
105600037|NCT03807778|364198584|FG003|Overall Study|Adverse Event|5|||
105600038|NCT03807778|364198581|FG000|Overall Study|Progressive Disease|4|||
105600039|NCT03807778|364198582|FG001|Overall Study|Progressive Disease|2|||
105600040|NCT03807778|364198583|FG002|Overall Study|Progressive Disease|8|||
105600041|NCT03807778|364198584|FG003|Overall Study|Progressive Disease|15|||
105600042|NCT03807778|364198581|FG000|Overall Study|Symptomatic Deterioration|0|||
105600043|NCT03807778|364198582|FG001|Overall Study|Symptomatic Deterioration|1|||
105600044|NCT03807778|364198583|FG002|Overall Study|Symptomatic Deterioration|0|||
105600045|NCT03807778|364198584|FG003|Overall Study|Symptomatic Deterioration|1|||
105600046|NCT03807778|364198581|FG000|Overall Study|Withdrawal by Subject|0|||
105600047|NCT03807778|364198582|FG001|Overall Study|Withdrawal by Subject|1|||
105600048|NCT03807778|364198583|FG002|Overall Study|Withdrawal by Subject|0|||
105600049|NCT03807778|364198584|FG003|Overall Study|Withdrawal by Subject|1|||
105600050|NCT03807778|364198581|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
105600051|NCT03807778|364198582|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
105600052|NCT03807778|364198583|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
105600053|NCT03807778|364198584|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
105600054|NCT05135000|364198585|FG000|Overall Study|Adverse Event|2|||
105600055|NCT05135000|364198586|FG001|Overall Study|Adverse Event|0|||
105600056|NCT05135000|364198585|FG000|Overall Study|Lost to Follow-up|1|||
105600057|NCT05135000|364198586|FG001|Overall Study|Lost to Follow-up|0|||
105600058|NCT05135000|364198585|FG000|Overall Study|Study Terminated by Sponsor|6|||
105600059|NCT05135000|364198586|FG001|Overall Study|Study Terminated by Sponsor|3|||
105600060|NCT03351075|364200064|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
105600061|NCT03351075|364200065|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
105600062|NCT03351075|364200064|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
105600063|NCT03351075|364200065|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
105600064|NCT03351075|364200064|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
105600065|NCT03351075|364200065|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
105600066|NCT03351075|364200064|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
105600067|NCT03351075|364200065|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
105600068|NCT03648762|364200068|FG000|Overall Study|Lost to Follow-up|1|||
105600069|NCT03648762|364200069|FG001|Overall Study|Lost to Follow-up|2|||
105600070|NCT03648762|364200070|FG002|Overall Study|Lost to Follow-up|0|||
105600071|NCT03648762|364200068|FG000|Overall Study|Withdrawal by Subject|5|||
105600072|NCT03648762|364200069|FG001|Overall Study|Withdrawal by Subject|2|||
105600073|NCT03648762|364200070|FG002|Overall Study|Withdrawal by Subject|1|||
105600074|NCT02189252|364200071|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
105600075|NCT02189252|364200072|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
105600076|NCT02189252|364200073|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
105600077|NCT02189252|364200074|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
105600078|NCT02189252|364200071|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
105600079|NCT02189252|364200072|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
105600080|NCT02189252|364200073|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
105600081|NCT02189252|364200074|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
105600082|NCT04603924|364200075|FG000|Overall Study|Not Dosed|2|||
105600083|NCT04603924|364200076|FG001|Overall Study|Not Dosed|1|||
105600084|NCT04603924|364200075|FG000|Overall Study|Withdrawal by Subject|6|||
105600085|NCT04603924|364200076|FG001|Overall Study|Withdrawal by Subject|6|||
105600086|NCT04603924|364200075|FG000|Overall Study|Adverse Event|2|||
105600087|NCT04603924|364200076|FG001|Overall Study|Adverse Event|2|||
105600088|NCT00686855|364200080|FG000|Overall Study|Lost to Follow-up|1|||
105600089|NCT00686855|364200081|FG001|Overall Study|Lost to Follow-up|0|||
105600090|NCT00686855|364200080|FG000|Overall Study|Progressive GVHD|0|||
105600091|NCT00686855|364200081|FG001|Overall Study|Progressive GVHD|1|||
105600092|NCT01867216|364200082|FG000|Overall Study|Withdrawal by Subject|2|||
105600093|NCT01867216|364200083|FG001|Overall Study|Withdrawal by Subject|0|||
105600094|NCT01867216|364200084|FG002|Overall Study|Withdrawal by Subject|0|||
105600095|NCT01867216|364200085|FG003|Overall Study|Withdrawal by Subject|0|||
105600096|NCT01867216|364200086|FG004|Overall Study|Withdrawal by Subject|1|||
105600097|NCT01867216|364200087|FG005|Overall Study|Withdrawal by Subject|0|||
105600098|NCT01867216|364200088|FG006|Overall Study|Withdrawal by Subject|1|||
105600099|NCT01867216|364200082|FG000|Overall Study|Physician Decision|1|||
105600100|NCT01867216|364200083|FG001|Overall Study|Physician Decision|0|||
105600101|NCT01867216|364200084|FG002|Overall Study|Physician Decision|0|||
105600102|NCT01867216|364200085|FG003|Overall Study|Physician Decision|0|||
105600103|NCT01867216|364200086|FG004|Overall Study|Physician Decision|0|||
105600104|NCT01867216|364200087|FG005|Overall Study|Physician Decision|0|||
105600105|NCT01867216|364200088|FG006|Overall Study|Physician Decision|0|||
105600106|NCT01867216|364200082|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
105600107|NCT01867216|364200083|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
105600108|NCT01867216|364200084|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
105600109|NCT01867216|364200085|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
105600110|NCT01867216|364200086|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
105600111|NCT01867216|364200087|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
105600112|NCT01867216|364200088|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
105600113|NCT00714714|364200089|FG000|Overall Study|Adverse Event|1|||
105600114|NCT02567656|364200101|FG000|Overall Study|Premature discontinuation due to PD|1|||
105600115|NCT02567656|364200102|FG001|Overall Study|Premature discontinuation due to PD|1|||
105600116|NCT02567656|364200103|FG002|Overall Study|Premature discontinuation due to PD|2|||
105600117|NCT02567656|364200104|FG003|Overall Study|Premature discontinuation due to PD|0|||
105600118|NCT02567656|364200105|FG004|Overall Study|Premature discontinuation due to PD|0|||
105600119|NCT02567656|364200106|FG005|Overall Study|Premature discontinuation due to PD|0|||
105600120|NCT01582100|364200107|FG000|Overall Study|Adverse Event|1|||
105600121|NCT01582100|364200107|FG000|Overall Study|Withdrawal by Subject|1|||
105600122|NCT01078116|364200110|FG000|Overall Study|Lost to Follow-up|17|||
105600123|NCT01078116|364200110|FG000|Overall Study|Adverse Event|5|||
105600124|NCT01078116|364200110|FG000|Overall Study|Withdrawal by Subject|8|||
105600125|NCT01078116|364200110|FG000|Overall Study|Lack of effectiveness|15|||
105600126|NCT01078116|364200110|FG000|Overall Study|Case report form not completed|3|||
105600127|NCT03644849|364200111|FG000|Overall Study|Lost to Follow-up|1|||
105600128|NCT03644849|364200112|FG001|Overall Study|Lost to Follow-up|3|||
105600129|NCT02564744|364200113|FG000|Overall Study|Investigator decision|0|||
105600130|NCT02564744|364200114|FG001|Overall Study|Investigator decision|0|||
105600131|NCT02564744|364200115|FG002|Overall Study|Investigator decision|0|||
105600132|NCT02564744|364200116|FG003|Overall Study|Investigator decision|0|||
105600133|NCT02564744|364200117|FG004|Overall Study|Investigator decision|1|||
105600134|NCT02564744|364200113|FG000|Overall Study|Death|10|||
105600135|NCT02564744|364200114|FG001|Overall Study|Death|5|||
105600136|NCT02564744|364200115|FG002|Overall Study|Death|4|||
105600137|NCT02564744|364200116|FG003|Overall Study|Death|16|||
105600138|NCT02564744|364200117|FG004|Overall Study|Death|16|||
105600139|NCT02564744|364200113|FG000|Overall Study|End of study Page Missing|0|||
105600140|NCT02564744|364200114|FG001|Overall Study|End of study Page Missing|0|||
105600141|NCT02564744|364200115|FG002|Overall Study|End of study Page Missing|3|||
105600142|NCT02564744|364200116|FG003|Overall Study|End of study Page Missing|3|||
105600143|NCT02564744|364200117|FG004|Overall Study|End of study Page Missing|0|||
105600144|NCT02564744|364200113|FG000|Overall Study|Subject Withdrew Consent|1|||
105600145|NCT02564744|364200114|FG001|Overall Study|Subject Withdrew Consent|1|||
105600146|NCT02564744|364200115|FG002|Overall Study|Subject Withdrew Consent|1|||
105600147|NCT02564744|364200116|FG003|Overall Study|Subject Withdrew Consent|0|||
105600148|NCT02564744|364200117|FG004|Overall Study|Subject Withdrew Consent|2|||
105600149|NCT02564744|364200113|FG000|Overall Study|Lost to Follow-up|0|||
105600150|NCT02564744|364200114|FG001|Overall Study|Lost to Follow-up|1|||
105600151|NCT02564744|364200115|FG002|Overall Study|Lost to Follow-up|0|||
105600152|NCT02564744|364200116|FG003|Overall Study|Lost to Follow-up|0|||
105600153|NCT02564744|364200117|FG004|Overall Study|Lost to Follow-up|1|||
105600154|NCT02564744|364200113|FG000|Overall Study|Reason not specified|1|||
105600155|NCT02564744|364200114|FG001|Overall Study|Reason not specified|0|||
105600156|NCT02564744|364200115|FG002|Overall Study|Reason not specified|0|||
105600157|NCT02564744|364200116|FG003|Overall Study|Reason not specified|0|||
105600158|NCT02564744|364200117|FG004|Overall Study|Reason not specified|0|||
105600159|NCT00508924|364200118|FG000|Overall Study|Protocol Violation|0|||
105600160|NCT00508924|364200119|FG001|Overall Study|Protocol Violation|0|||
105600161|NCT00508924|364200120|FG002|Overall Study|Protocol Violation|1|||
105600162|NCT00508924|364200121|FG003|Overall Study|Protocol Violation|1|||
105600163|NCT02593149|364200126|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
105600164|NCT02593149|364200127|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
105600165|NCT02593149|364200126|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
105600166|NCT02593149|364200127|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
105600167|NCT01460290|364200133|FG000|Overall Study|Adverse Event|3|||
105600168|NCT01460290|364200133|FG000|Overall Study|Elevated liver function|1|||
105600169|NCT02594735|364200134|FG000|Overall Study|Adverse Event|1|||
105600170|NCT02969863|364200135|FG000|Overall Study|Physician Decision|1|||
105600171|NCT02969863|364200136|FG001|Overall Study|Physician Decision|0|||
105600172|NCT02969863|364200137|FG002|Overall Study|Physician Decision|0|||
105600173|NCT02969863|364200138|FG003|Overall Study|Physician Decision|0|||
105600174|NCT02969863|364200139|FG004|Overall Study|Physician Decision|0|||
105600175|NCT02969863|364200140|FG005|Overall Study|Physician Decision|0|||
105600176|NCT01135511|364200141|FG000|Overall Study|Adverse Event|0|||
105600177|NCT01135511|364200142|FG001|Overall Study|Adverse Event|1|||
105600178|NCT01135511|364200143|FG002|Overall Study|Adverse Event|2|||
105600179|NCT01135511|364200144|FG003|Overall Study|Adverse Event|0|||
105600180|NCT01135511|364200145|FG004|Overall Study|Adverse Event|0|||
105600181|NCT01135511|364200146|FG005|Overall Study|Adverse Event|1|||
105600182|NCT01135511|364200147|FG006|Overall Study|Adverse Event|0|||
105600183|NCT01135511|364200148|FG007|Overall Study|Adverse Event|1|||
105600184|NCT01135511|364200149|FG008|Overall Study|Adverse Event|0|||
105600185|NCT01135511|364200141|FG000|Overall Study|Lack of Efficacy|0|||
105600186|NCT01135511|364200142|FG001|Overall Study|Lack of Efficacy|1|||
105600187|NCT01135511|364200143|FG002|Overall Study|Lack of Efficacy|1|||
105600188|NCT01135511|364200144|FG003|Overall Study|Lack of Efficacy|2|||
105600189|NCT01135511|364200145|FG004|Overall Study|Lack of Efficacy|0|||
105600190|NCT01135511|364200146|FG005|Overall Study|Lack of Efficacy|0|||
105600191|NCT01135511|364200147|FG006|Overall Study|Lack of Efficacy|0|||
105600192|NCT01135511|364200148|FG007|Overall Study|Lack of Efficacy|0|||
105600193|NCT01135511|364200149|FG008|Overall Study|Lack of Efficacy|0|||
105600194|NCT01135511|364200141|FG000|Overall Study|Protocol Violation|0|||
105600195|NCT01135511|364200142|FG001|Overall Study|Protocol Violation|0|||
105600196|NCT01135511|364200143|FG002|Overall Study|Protocol Violation|3|||
105600197|NCT01135511|364200144|FG003|Overall Study|Protocol Violation|0|||
105600198|NCT01135511|364200145|FG004|Overall Study|Protocol Violation|0|||
105600199|NCT01135511|364200146|FG005|Overall Study|Protocol Violation|0|||
105600200|NCT01135511|364200147|FG006|Overall Study|Protocol Violation|0|||
105600201|NCT01135511|364200148|FG007|Overall Study|Protocol Violation|0|||
105600202|NCT01135511|364200149|FG008|Overall Study|Protocol Violation|0|||
105600203|NCT01135511|364200141|FG000|Overall Study|Pregnancy|0|||
105600204|NCT01135511|364200142|FG001|Overall Study|Pregnancy|0|||
105600205|NCT01135511|364200143|FG002|Overall Study|Pregnancy|0|||
105600206|NCT01135511|364200144|FG003|Overall Study|Pregnancy|1|||
105600207|NCT01135511|364200145|FG004|Overall Study|Pregnancy|0|||
105600208|NCT01135511|364200146|FG005|Overall Study|Pregnancy|0|||
105600209|NCT01135511|364200147|FG006|Overall Study|Pregnancy|0|||
105600210|NCT01135511|364200148|FG007|Overall Study|Pregnancy|0|||
105600211|NCT01135511|364200149|FG008|Overall Study|Pregnancy|0|||
105600212|NCT01135511|364200141|FG000|Overall Study|could not visit the clinic|0|||
105600213|NCT01135511|364200142|FG001|Overall Study|could not visit the clinic|1|||
105600214|NCT01135511|364200143|FG002|Overall Study|could not visit the clinic|2|||
105600215|NCT01135511|364200144|FG003|Overall Study|could not visit the clinic|0|||
105600216|NCT01135511|364200145|FG004|Overall Study|could not visit the clinic|0|||
105600217|NCT01135511|364200146|FG005|Overall Study|could not visit the clinic|0|||
105600218|NCT01135511|364200147|FG006|Overall Study|could not visit the clinic|0|||
105600219|NCT01135511|364200148|FG007|Overall Study|could not visit the clinic|0|||
105600220|NCT01135511|364200149|FG008|Overall Study|could not visit the clinic|0|||
105600221|NCT01135511|364200141|FG000|Overall Study|noncompliance with study drug taken|0|||
105600222|NCT01135511|364200142|FG001|Overall Study|noncompliance with study drug taken|0|||
105600223|NCT01135511|364200143|FG002|Overall Study|noncompliance with study drug taken|0|||
105600224|NCT01135511|364200144|FG003|Overall Study|noncompliance with study drug taken|0|||
105600225|NCT01135511|364200145|FG004|Overall Study|noncompliance with study drug taken|1|||
105600226|NCT01135511|364200146|FG005|Overall Study|noncompliance with study drug taken|0|||
105600227|NCT01135511|364200147|FG006|Overall Study|noncompliance with study drug taken|0|||
105600228|NCT01135511|364200148|FG007|Overall Study|noncompliance with study drug taken|0|||
105600229|NCT01135511|364200149|FG008|Overall Study|noncompliance with study drug taken|0|||
105600230|NCT01135511|364200141|FG000|Overall Study|Withdrawal by Subject|0|||
105600231|NCT01135511|364200142|FG001|Overall Study|Withdrawal by Subject|0|||
105600232|NCT01135511|364200143|FG002|Overall Study|Withdrawal by Subject|0|||
105600233|NCT01135511|364200144|FG003|Overall Study|Withdrawal by Subject|0|||
105600234|NCT01135511|364200145|FG004|Overall Study|Withdrawal by Subject|0|||
105600235|NCT01135511|364200146|FG005|Overall Study|Withdrawal by Subject|0|||
105600236|NCT01135511|364200147|FG006|Overall Study|Withdrawal by Subject|1|||
105600237|NCT01135511|364200148|FG007|Overall Study|Withdrawal by Subject|0|||
105600238|NCT01135511|364200149|FG008|Overall Study|Withdrawal by Subject|1|||
105600239|NCT02706717|364200150|FG000|Overall Study|Withdrawal by Subject|1|||
105600240|NCT02706717|364200151|FG001|Overall Study|Withdrawal by Subject|8|||
105600241|NCT02706717|364200150|FG000|Overall Study|Lost to Follow-up|0|||
105600242|NCT02706717|364200151|FG001|Overall Study|Lost to Follow-up|1|||
105600243|NCT02706717|364200150|FG000|Overall Study|Physician Decision|0|||
105600244|NCT02706717|364200151|FG001|Overall Study|Physician Decision|1|||
105600245|NCT02706717|364200150|FG000|Overall Study|Death|0|||
105600246|NCT02706717|364200151|FG001|Overall Study|Death|1|||
105600247|NCT03737240|364200152|FG000|Overall Study|Lost to Follow-up|16|||
105600248|NCT03737240|364200153|FG001|Overall Study|Lost to Follow-up|15|||
105600249|NCT02507752|364200155|FG000|Overall Study|Adverse Event|1|||
105600250|NCT02507752|364200155|FG000|Overall Study|Protocol Violation|6|||
105600251|NCT02507752|364200155|FG000|Overall Study|Lost to Follow-up|7|||
105600252|NCT02507752|364200155|FG000|Overall Study|Infusion reaction at first infusion|1|||
105600253|NCT02507752|364200155|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
105600254|NCT02507752|364200155|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
105600255|NCT03740009|364200157|FG000|Overall Study|Physician Decision|9|||
105600256|NCT03740009|364200157|FG000|Overall Study|Lost to Follow-up|1|||
105600257|NCT02202499|364200159|FG000|Overall Study|Cancer diagnosis|0|||
105600258|NCT02202499|364200160|FG001|Overall Study|Cancer diagnosis|0|||
105600259|NCT02202499|364200161|FG002|Overall Study|Cancer diagnosis|1|||
105600260|NCT02202499|364200159|FG000|Overall Study|Moved from area|0|||
105600261|NCT02202499|364200160|FG001|Overall Study|Moved from area|0|||
105600262|NCT02202499|364200161|FG002|Overall Study|Moved from area|1|||
105600263|NCT02202499|364200159|FG000|Overall Study|Declined before randomization|1|||
105600264|NCT02202499|364200160|FG001|Overall Study|Declined before randomization|0|||
105600265|NCT02202499|364200161|FG002|Overall Study|Declined before randomization|0|||
105600266|NCT02202499|364200159|FG000|Overall Study|Auto accident|1|||
105600267|NCT02202499|364200160|FG001|Overall Study|Auto accident|0|||
105600268|NCT02202499|364200161|FG002|Overall Study|Auto accident|0|||
105600269|NCT00535145|364200162|FG000|Phase I|Adverse Event|3|||
105600270|NCT00535145|364200162|FG000|Phase I|Lost to Follow-up|7|||
105600271|NCT00535145|364200162|FG000|Phase I|Withdrawal by Subject|6|||
105600272|NCT00535145|364200162|FG000|Phase I|(eligibility)|8|||
105600273|NCT00535145|364200162|FG000|Phase I|(protocol violation)|1|||
105600274|NCT00535145|364200162|FG000|Phase I|(PI decision)|1|||
105600275|NCT00535145|364200162|FG000|Phase I|(diagnosis)|3|||
105600276|NCT00535145|364200162|FG000|Phase II|Adverse Event|2|||
105600277|NCT00535145|364200162|FG000|Phase II|Lack of Efficacy|1|||
105600278|NCT00535145|364200162|FG000|Phase II|Lost to Follow-up|5|||
105600279|NCT00535145|364200162|FG000|Phase II|Withdrawal by Subject|5|||
105600280|NCT00535145|364200162|FG000|Phase II|Subject non-compliance|2|||
105600281|NCT03260140|364200163|FG000|Overall Study|Death|4|||
105600282|NCT03260140|364200164|FG001|Overall Study|Death|1|||
105600283|NCT03260140|364200163|FG000|Overall Study|Withdrawal by Subject|1|||
105600284|NCT03260140|364200164|FG001|Overall Study|Withdrawal by Subject|4|||
105600285|NCT01236001|364200165|FG000|Overall Study|Adverse Event|5|||
105600286|NCT01236001|364200166|FG001|Overall Study|Adverse Event|14|||
105600287|NCT01236001|364200165|FG000|Overall Study|Lack of Efficacy|6|||
105600288|NCT01236001|364200166|FG001|Overall Study|Lack of Efficacy|6|||
105600289|NCT01236001|364200165|FG000|Overall Study|Lost to Follow-up|6|||
105600290|NCT01236001|364200166|FG001|Overall Study|Lost to Follow-up|1|||
105600291|NCT01236001|364200165|FG000|Overall Study|Incompliance|1|||
105600292|NCT01236001|364200166|FG001|Overall Study|Incompliance|0|||
105600293|NCT01236001|364200165|FG000|Overall Study|Planned Visit After End of Study|0|||
105600294|NCT01236001|364200166|FG001|Overall Study|Planned Visit After End of Study|1|||
105600295|NCT01373346|364200172|FG000|Overall Study|Death|1|||
105600296|NCT01198028|364200173|FG000|Overall Study|Adverse Event|5|||
105600297|NCT01198028|364200173|FG000|Overall Study|Death|3|||
105600298|NCT01198028|364200173|FG000|Overall Study|Physician Decision|2|||
105600299|NCT00357097|364200174|FG000|Overall Study|Did not meet inclusion criteria|5|||
105600300|NCT00357097|364200175|FG001|Overall Study|Did not meet inclusion criteria|3|||
105600301|NCT00357097|364200174|FG000|Overall Study|Adverse Event|34|||
105600302|NCT00357097|364200175|FG001|Overall Study|Adverse Event|6|||
105600303|NCT00357097|364200174|FG000|Overall Study|Withdrawal by Subject|8|||
105600304|NCT00357097|364200175|FG001|Overall Study|Withdrawal by Subject|7|||
105600305|NCT00357097|364200174|FG000|Overall Study|Non-compliance|1|||
105600306|NCT00357097|364200175|FG001|Overall Study|Non-compliance|2|||
105600307|NCT00357097|364200174|FG000|Overall Study|Lack of Efficacy|2|||
105600308|NCT00357097|364200175|FG001|Overall Study|Lack of Efficacy|8|||
105600309|NCT00357097|364200174|FG000|Overall Study|Met Exclusion Criteria|3|||
105600310|NCT00357097|364200175|FG001|Overall Study|Met Exclusion Criteria|1|||
105600311|NCT00357097|364200174|FG000|Overall Study|Other|1|||
105600312|NCT00357097|364200175|FG001|Overall Study|Other|1|||
105600313|NCT00357097|364200174|FG000|Overall Study|Increase of RLS Symptoms|0|||
105600314|NCT00357097|364200175|FG001|Overall Study|Increase of RLS Symptoms|1|||
105600315|NCT00529659|364200176|FG000|Overall Study|Adverse Event|8|||
105600316|NCT00529659|364200177|FG001|Overall Study|Adverse Event|7|||
105600317|NCT00529659|364200176|FG000|Overall Study|Lost to Follow-up|0|||
105600318|NCT00529659|364200177|FG001|Overall Study|Lost to Follow-up|2|||
105600319|NCT00529659|364200176|FG000|Overall Study|Physician Decision|0|||
105600320|NCT00529659|364200177|FG001|Overall Study|Physician Decision|2|||
105600321|NCT00529659|364200176|FG000|Overall Study|Protocol Violation|2|||
105600322|NCT00529659|364200177|FG001|Overall Study|Protocol Violation|6|||
105600323|NCT00529659|364200176|FG000|Overall Study|Withdrawal by Subject|1|||
105600324|NCT00529659|364200177|FG001|Overall Study|Withdrawal by Subject|6|||
105600325|NCT03062358|364200178|FG000|Overall Study|Death|220|||
105600326|NCT03062358|364200179|FG001|Overall Study|Death|127|||
105600327|NCT03062358|364200178|FG000|Overall Study|Withdrawal by Subject|2|||
105600328|NCT03062358|364200179|FG001|Overall Study|Withdrawal by Subject|1|||
105600329|NCT03062358|364200178|FG000|Overall Study|Ongoing in Trial|78|||
105600330|NCT03062358|364200179|FG001|Overall Study|Ongoing in Trial|25|||
105600331|NCT03887650|364200180|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
105600332|NCT03887650|364200181|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
105600333|NCT03887650|364200180|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
105600334|NCT03887650|364200181|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
105600335|NCT03887650|364200180|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
105600336|NCT03887650|364200181|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
105600337|NCT01764464|364200187|FG000|First Intervention|Withdrawal by Subject|1|||
105600338|NCT01764464|364200188|FG001|First Intervention|Withdrawal by Subject|0|||
105600339|NCT01764464|364200187|FG000|First Intervention|Lost to Follow-up|1|||
105600340|NCT01764464|364200188|FG001|First Intervention|Lost to Follow-up|0|||
105600341|NCT01764464|364200187|FG000|First Intervention|Adverse Event|0|||
105600342|NCT01764464|364200188|FG001|First Intervention|Adverse Event|2|||
105600343|NCT01764464|364200187|FG000|First Intervention|did not receive study drug|0|||
105600344|NCT01764464|364200188|FG001|First Intervention|did not receive study drug|1|||
105600345|NCT01764464|364200187|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
105600346|NCT01764464|364200188|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
105600347|NCT01551355|364200193|FG000|Overall Study|Lost to Follow-up|51|||
105600348|NCT01551355|364200194|FG001|Overall Study|Lost to Follow-up|49|||
105600349|NCT01551355|364200195|FG002|Overall Study|Lost to Follow-up|34|||
105600350|NCT01551355|364200196|FG003|Overall Study|Lost to Follow-up|24|||
105600351|NCT01551355|364200197|FG004|Overall Study|Lost to Follow-up|9|||
105600352|NCT01551355|364200198|FG005|Overall Study|Lost to Follow-up|6|||
105600353|NCT02918071|364200200|FG000|Overall Study|Withdrawal by Subject|2|||
105600354|NCT02918071|364200200|FG000|Overall Study|Lost to Follow-up|1|||
105600355|NCT03997916|364200205|FG000|Overall Study|Protocol Violation|35|||
105600356|NCT00840177|364201044|FG000|Overall Study|Adverse Event|5|||
105600357|NCT00840177|364201045|FG001|Overall Study|Adverse Event|1|||
105600358|NCT00840177|364201046|FG002|Overall Study|Adverse Event|1|||
105600359|NCT00840177|364201044|FG000|Overall Study|Refusal unrelated to adverse events|1|||
105600360|NCT00840177|364201045|FG001|Overall Study|Refusal unrelated to adverse events|0|||
105600361|NCT00840177|364201046|FG002|Overall Study|Refusal unrelated to adverse events|1|||
105600362|NCT00840177|364201044|FG000|Overall Study|Progression/relapse|2|||
105600363|NCT00840177|364201045|FG001|Overall Study|Progression/relapse|0|||
105600364|NCT00840177|364201046|FG002|Overall Study|Progression/relapse|0|||
105600365|NCT00840177|364201044|FG000|Overall Study|Death|4|||
105600366|NCT00840177|364201045|FG001|Overall Study|Death|5|||
105600367|NCT00840177|364201046|FG002|Overall Study|Death|5|||
105600368|NCT00840177|364201044|FG000|Overall Study|not protocol specified|6|||
105600369|NCT00840177|364201045|FG001|Overall Study|not protocol specified|3|||
105600370|NCT00840177|364201046|FG002|Overall Study|not protocol specified|0|||
105600371|NCT00840177|364201044|FG000|Overall Study|Ineligible|0|||
105600372|NCT00840177|364201045|FG001|Overall Study|Ineligible|0|||
105600373|NCT00840177|364201046|FG002|Overall Study|Ineligible|3|||
105600374|NCT00840177|364201044|FG000|Overall Study|Did not start treatment|0|||
105600375|NCT00840177|364201045|FG001|Overall Study|Did not start treatment|0|||
105600376|NCT00840177|364201046|FG002|Overall Study|Did not start treatment|1|||
105600377|NCT02731755|364201051|FG000|First Intervention|Withdrawal by Subject|0|||
105600378|NCT02731755|364201052|FG001|First Intervention|Withdrawal by Subject|2|||
105600379|NCT04218110|364201053|FG000|Overall Study|Withdrawal by Subject|0|||
105600380|NCT04218110|364201054|FG001|Overall Study|Withdrawal by Subject|0|||
105600381|NCT04218110|364201055|FG002|Overall Study|Withdrawal by Subject|0|||
105600382|NCT04218110|364201056|FG003|Overall Study|Withdrawal by Subject|1|||
105600383|NCT00799396|364201057|FG000|Clopidogrel Treatment|Adverse Event|6|||
105600384|NCT00799396|364201057|FG000|Clopidogrel Treatment|Physician Decision|5|||
105600385|NCT00799396|364201057|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
105600386|NCT00799396|364201057|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
105600387|NCT00799396|364201057|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
105600388|NCT02242487|364201058|FG000|Overall Study|Adverse Event|13|||
105600389|NCT02242487|364201059|FG001|Overall Study|Adverse Event|15|||
105600390|NCT02242487|364201058|FG000|Overall Study|Lack of Efficacy|4|||
105600391|NCT02242487|364201059|FG001|Overall Study|Lack of Efficacy|6|||
105600392|NCT02242487|364201058|FG000|Overall Study|Protocol Violation|2|||
105600393|NCT02242487|364201059|FG001|Overall Study|Protocol Violation|0|||
105600394|NCT02242487|364201058|FG000|Overall Study|Lost to Follow-up|2|||
105600395|NCT02242487|364201059|FG001|Overall Study|Lost to Follow-up|1|||
105600396|NCT02242487|364201058|FG000|Overall Study|Other - Miscellaneous|4|||
105600397|NCT02242487|364201059|FG001|Overall Study|Other - Miscellaneous|6|||
105600398|NCT02242487|364201058|FG000|Overall Study|Withdrawal by Subject|37|||
105600399|NCT02242487|364201059|FG001|Overall Study|Withdrawal by Subject|19|||
105600400|NCT02755805|364201062|FG000|Overall Study|Lost to Follow-up|1|||
105600401|NCT02755805|364201063|FG001|Overall Study|Lost to Follow-up|2|||
105600402|NCT02755805|364201062|FG000|Overall Study|Refused assessments|1|||
105600403|NCT02755805|364201063|FG001|Overall Study|Refused assessments|0|||
105600404|NCT02755805|364201062|FG000|Overall Study|Withdrawal by Subject|0|||
105600405|NCT02755805|364201063|FG001|Overall Study|Withdrawal by Subject|2|||
105600406|NCT02252042|364201064|FG000|Overall Study|Adverse Event|9|||
105600407|NCT02252042|364201065|FG001|Overall Study|Adverse Event|6|||
105600408|NCT02252042|364201064|FG000|Overall Study|Death|209|||
105600409|NCT02252042|364201065|FG001|Overall Study|Death|217|||
105600410|NCT02252042|364201064|FG000|Overall Study|Physician Decision|0|||
105600411|NCT02252042|364201065|FG001|Overall Study|Physician Decision|2|||
105600412|NCT02252042|364201064|FG000|Overall Study|Transferred to Extension Study|7|||
105600413|NCT02252042|364201065|FG001|Overall Study|Transferred to Extension Study|1|||
105600414|NCT02252042|364201064|FG000|Overall Study|Did Not Continue on Extension Study|7|||
105600415|NCT02252042|364201065|FG001|Overall Study|Did Not Continue on Extension Study|2|||
105600416|NCT02252042|364201064|FG000|Overall Study|Withdrawal by Subject|15|||
105600417|NCT02252042|364201065|FG001|Overall Study|Withdrawal by Subject|20|||
105600418|NCT01177670|364201067|FG000|Overall Study|Study Terminated|115|||
105600419|NCT01177670|364201067|FG000|Overall Study|Physician Decision|50|||
105600420|NCT01177670|364201067|FG000|Overall Study|Withdrawal by Subject|4|||
105600421|NCT00979992|364201068|FG000|Overall Study|Ineligible - inadequate pathology|1|||
105600422|NCT00979992|364201068|FG000|Overall Study|Ineligible - wrong cell type|2|||
105600423|NCT00979992|364201068|FG000|Overall Study|Refused - Never Treated|2|||
105600424|NCT04532528|364201071|FG000|Overall Study|Adverse Event|12|||
105600425|NCT04532528|364201072|FG001|Overall Study|Adverse Event|17|||
105600426|NCT04532528|364201071|FG000|Overall Study|Withdrawal of consent|16|||
105600427|NCT04532528|364201072|FG001|Overall Study|Withdrawal of consent|17|||
105600428|NCT04532528|364201071|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
105600429|NCT04532528|364201072|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
105600430|NCT04532528|364201071|FG000|Overall Study|Lost to Follow-up|69|||
105600431|NCT04532528|364201072|FG001|Overall Study|Lost to Follow-up|68|||
105600432|NCT04532528|364201071|FG000|Overall Study|Administrative problems|12|||
105600433|NCT04532528|364201072|FG001|Overall Study|Administrative problems|14|||
105600434|NCT04532528|364201071|FG000|Overall Study|Death|3|||
105600435|NCT04532528|364201072|FG001|Overall Study|Death|3|||
105600436|NCT04532528|364201071|FG000|Overall Study|Other|38|||
105600437|NCT04532528|364201072|FG001|Overall Study|Other|46|||
105600438|NCT02918279|364201077|FG000|Overall Study|Lost to Follow-up|3|||
105600439|NCT02918279|364201078|FG001|Overall Study|Lost to Follow-up|6|||
105600440|NCT02918279|364201077|FG000|Overall Study|Withdrawal by Subject|5|||
105600441|NCT02918279|364201078|FG001|Overall Study|Withdrawal by Subject|15|||
105600442|NCT02918279|364201077|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105600443|NCT02918279|364201078|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105600444|NCT02918279|364201077|FG000|Overall Study|Other|3|||
105600445|NCT02918279|364201078|FG001|Overall Study|Other|1|||
105600446|NCT00309907|364201079|FG000|Overall Study|Death|4|||
105600447|NCT00309907|364201079|FG000|Overall Study|Physician Decision|1|||
105600448|NCT00309907|364201079|FG000|Overall Study|Ineligible|11|||
105600449|NCT00309907|364201079|FG000|Overall Study|Major infectious event|4|||
105600450|NCT00244855|364201080|FG000|Overall Study|Withdrawal by Subject|0|||
105600451|NCT00244855|364201081|FG001|Overall Study|Withdrawal by Subject|1|||
105600452|NCT00869258|364201082|FG000|Overall Study|Physician Decision|1|||
105600453|NCT00636207|364201083|FG000|Overall Study|Adverse Event|1|||
105600454|NCT00636207|364201084|FG001|Overall Study|Adverse Event|0|||
105600455|NCT00636207|364201085|FG002|Overall Study|Adverse Event|0|||
105600456|NCT00636207|364201086|FG003|Overall Study|Adverse Event|0|||
105600457|NCT00636207|364201087|FG004|Overall Study|Adverse Event|0|||
105600458|NCT00636207|364201088|FG005|Overall Study|Adverse Event|0|||
105600459|NCT00636207|364201089|FG006|Overall Study|Adverse Event|0|||
105600460|NCT00636207|364201083|FG000|Overall Study|Withdrawal by Subject|0|||
105600461|NCT00636207|364201084|FG001|Overall Study|Withdrawal by Subject|1|||
105600462|NCT00636207|364201085|FG002|Overall Study|Withdrawal by Subject|0|||
105600463|NCT00636207|364201086|FG003|Overall Study|Withdrawal by Subject|0|||
105600464|NCT00636207|364201087|FG004|Overall Study|Withdrawal by Subject|1|||
105600465|NCT00636207|364201088|FG005|Overall Study|Withdrawal by Subject|0|||
105600466|NCT00636207|364201089|FG006|Overall Study|Withdrawal by Subject|0|||
105600467|NCT01641198|364201092|FG000|After 12 Months of Function|Lost to Follow-up|3|||
105600468|NCT01641198|364201093|FG001|After 12 Months of Function|Lost to Follow-up|2|||
105600469|NCT01641198|364201094|FG002|After 12 Months of Function|Lost to Follow-up|2|||
105600470|NCT01641198|364201092|FG000|After 12 Months of Function|Protocol Violation|1|||
105600471|NCT01641198|364201093|FG001|After 12 Months of Function|Protocol Violation|0|||
105600472|NCT01641198|364201094|FG002|After 12 Months of Function|Protocol Violation|0|||
105600473|NCT01641198|364201092|FG000|After 12 Months of Function|Adverse Event|0|||
105600474|NCT01641198|364201093|FG001|After 12 Months of Function|Adverse Event|1|||
105600475|NCT01641198|364201094|FG002|After 12 Months of Function|Adverse Event|0|||
105600476|NCT01641198|364201092|FG000|After 24 Months of Function|Lost to Follow-up|4|||
105600477|NCT01641198|364201093|FG001|After 24 Months of Function|Lost to Follow-up|9|||
105600478|NCT01641198|364201094|FG002|After 24 Months of Function|Lost to Follow-up|6|||
105600479|NCT01641198|364201092|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
105600480|NCT01641198|364201093|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
105600481|NCT01641198|364201094|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
105600482|NCT01641198|364201092|FG000|At 15-20 Years of Function|Death|1|||
105600483|NCT01641198|364201093|FG001|At 15-20 Years of Function|Death|0|||
105600484|NCT01641198|364201094|FG002|At 15-20 Years of Function|Death|1|||
105600485|NCT03074331|364201103|FG000|Overall Study|Enrolled but Not Treated|1|||
105600486|NCT03074331|364201103|FG000|Overall Study|Lost to Follow-up|5|||
105600487|NCT03074331|364201103|FG000|Overall Study|Withdrew Consent|1|||
105600488|NCT00539734|364201110|FG000|Overall Study|Protocol Violation|1|||
105600489|NCT05368831|364201111|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
105600490|NCT00223795|364201119|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
105600491|NCT00223795|364201120|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
105600492|NCT00223795|364201119|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
105600493|NCT00223795|364201120|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
105600494|NCT00393484|364201122|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
105600495|NCT00393484|364201123|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
105600496|NCT00393484|364201122|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
105600497|NCT00393484|364201123|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
105600498|NCT00393484|364201122|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
105600499|NCT00393484|364201123|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
105600500|NCT00393484|364201122|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
105600501|NCT00393484|364201123|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
105600502|NCT00393484|364201122|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
105600503|NCT00393484|364201123|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
105600504|NCT00393484|364201122|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
105600505|NCT00393484|364201123|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
105600506|NCT00393484|364201122|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
105600507|NCT00393484|364201123|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
105600508|NCT00393484|364201122|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
105600509|NCT00393484|364201123|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
105600510|NCT00393484|364201122|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
105600511|NCT00393484|364201123|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
105600512|NCT00393484|364201122|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
105600513|NCT00393484|364201123|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
105600514|NCT00411216|364201128|FG000|Overall Study|Ten participants were entered into the c|0|||
105600515|NCT00411216|364201129|FG001|Overall Study|Ten participants were entered into the c|2|||
105600516|NCT01212991|364201130|FG000|Double-blind|Lost to Follow-up|8|||
105600517|NCT01212991|364201131|FG001|Double-blind|Lost to Follow-up|4|||
105600518|NCT01212991|364201132|FG002|Double-blind|Lost to Follow-up|0|||
105600519|NCT01212991|364201130|FG000|Double-blind|Death|699|||
105600520|NCT01212991|364201131|FG001|Double-blind|Death|550|||
105600521|NCT01212991|364201132|FG002|Double-blind|Death|0|||
105600522|NCT01212991|364201130|FG000|Double-blind|Withdrawal by Subject|16|||
105600523|NCT01212991|364201131|FG001|Double-blind|Withdrawal by Subject|19|||
105600524|NCT01212991|364201132|FG002|Double-blind|Withdrawal by Subject|0|||
105600525|NCT01212991|364201130|FG000|Double-blind|Other|7|||
105600526|NCT01212991|364201131|FG001|Double-blind|Other|0|||
105600527|NCT01212991|364201132|FG002|Double-blind|Other|0|||
105600528|NCT01212991|364201130|FG000|Double-blind|Sponsor decision|142|||
105600529|NCT01212991|364201131|FG001|Double-blind|Sponsor decision|38|||
105600530|NCT01212991|364201132|FG002|Double-blind|Sponsor decision|0|||
105600531|NCT01212991|364201130|FG000|Open-label|Death|0|||
105600532|NCT01212991|364201131|FG001|Open-label|Death|0|||
105600533|NCT01212991|364201132|FG002|Open-label|Death|166|||
105600534|NCT01212991|364201130|FG000|Open-label|Lost to Follow-up|0|||
105600535|NCT01212991|364201131|FG001|Open-label|Lost to Follow-up|0|||
105600536|NCT01212991|364201132|FG002|Open-label|Lost to Follow-up|5|||
105600537|NCT01212991|364201130|FG000|Open-label|Withdrawal by Subject|0|||
105600538|NCT01212991|364201131|FG001|Open-label|Withdrawal by Subject|0|||
105600539|NCT01212991|364201132|FG002|Open-label|Withdrawal by Subject|7|||
105600540|NCT01212991|364201130|FG000|Open-label|Sponsor decision|0|||
105600541|NCT01212991|364201131|FG001|Open-label|Sponsor decision|0|||
105600542|NCT01212991|364201132|FG002|Open-label|Sponsor decision|53|||
105600543|NCT01212991|364201130|FG000|Open-label|Other|0|||
105600544|NCT01212991|364201131|FG001|Open-label|Other|0|||
105600545|NCT01212991|364201132|FG002|Open-label|Other|3|||
105600546|NCT02531113|364201133|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
105600547|NCT02531113|364201133|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
105600548|NCT02531113|364201133|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
105600549|NCT02531113|364201133|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
105600550|NCT02531113|364201133|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
105600551|NCT02531113|364201133|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
105600552|NCT02531113|364201133|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
105600553|NCT02531113|364201133|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
105600554|NCT01251354|364201134|FG000|Overall Study|Adverse Event|1|||
105600555|NCT01251354|364201134|FG000|Overall Study|Investigator's Decision|1|||
105600556|NCT01251354|364201134|FG000|Overall Study|Disease Progression|4|||
105600557|NCT00566735|364203190|FG000|Overall Study|Withdrawal by Subject|0|||
105600558|NCT00566735|364203191|FG001|Overall Study|Withdrawal by Subject|1|||
105600559|NCT00566735|364203190|FG000|Overall Study|Refused neuropsychological testing|2|||
105600560|NCT00566735|364203191|FG001|Overall Study|Refused neuropsychological testing|5|||
105600561|NCT00566735|364203190|FG000|Overall Study|Switched into a manic episode|0|||
105600562|NCT00566735|364203191|FG001|Overall Study|Switched into a manic episode|1|||
105600563|NCT01460446|364203193|FG000|Overall Study|Non-compliance|2|||
105600564|NCT01460446|364203194|FG001|Overall Study|Non-compliance|9|||
105600565|NCT01460446|364203193|FG000|Overall Study|Consent Withdrawn|0|||
105600566|NCT01460446|364203194|FG001|Overall Study|Consent Withdrawn|4|||
105600567|NCT01460446|364203193|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
105600568|NCT01460446|364203194|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
105600569|NCT01460446|364203193|FG000|Overall Study|Surgery/Illness|1|||
105600570|NCT01460446|364203194|FG001|Overall Study|Surgery/Illness|1|||
105600571|NCT01460446|364203193|FG000|Overall Study|Pregnancy|1|||
105600572|NCT01460446|364203194|FG001|Overall Study|Pregnancy|0|||
105600573|NCT01460446|364203193|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
105600574|NCT01460446|364203194|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
105600575|NCT01318382|364203196|FG000|Overall Study|Physician Decision|2|||
105600576|NCT01318382|364203196|FG000|Overall Study|Device Malfunction|10|||
105600577|NCT01318382|364203196|FG000|Overall Study|Protocol Violation|1|||
105600578|NCT01599104|364203199|FG000|Overall Study|Withdrawal by Subject|1|||
105600579|NCT01599104|364203200|FG001|Overall Study|Withdrawal by Subject|1|||
105600580|NCT01599104|364203201|FG002|Overall Study|Withdrawal by Subject|2|||
105600581|NCT01599104|364203199|FG000|Overall Study|Technical Problems|1|||
105600582|NCT01599104|364203200|FG001|Overall Study|Technical Problems|0|||
105600583|NCT01599104|364203201|FG002|Overall Study|Technical Problems|0|||
105600584|NCT01599104|364203199|FG000|Overall Study|Physician Decision|3|||
105600585|NCT01599104|364203200|FG001|Overall Study|Physician Decision|2|||
105600586|NCT01599104|364203201|FG002|Overall Study|Physician Decision|2|||
105600587|NCT01599104|364203199|FG000|Overall Study|Non-compliance with study treatment|0|||
105600588|NCT01599104|364203200|FG001|Overall Study|Non-compliance with study treatment|1|||
105600589|NCT01599104|364203201|FG002|Overall Study|Non-compliance with study treatment|0|||
105600590|NCT01599104|364203199|FG000|Overall Study|Lack of Efficacy|4|||
105600591|NCT01599104|364203200|FG001|Overall Study|Lack of Efficacy|4|||
105600592|NCT01599104|364203201|FG002|Overall Study|Lack of Efficacy|10|||
105600593|NCT01599104|364203199|FG000|Overall Study|Adverse Event|7|||
105600594|NCT01599104|364203200|FG001|Overall Study|Adverse Event|6|||
105600595|NCT01599104|364203201|FG002|Overall Study|Adverse Event|12|||
105600596|NCT03452189|364203204|FG000|First Intervention (3 Months)|Adverse Event|1|||
105600597|NCT03452189|364203205|FG001|First Intervention (3 Months)|Adverse Event|0|||
105600598|NCT03452189|364203204|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
105600599|NCT03452189|364203205|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
105600600|NCT01308567|364203210|FG000|Overall Study|Lost to Follow-up|2|||
105600601|NCT01308567|364203211|FG001|Overall Study|Lost to Follow-up|4|||
105600602|NCT01308567|364203212|FG002|Overall Study|Lost to Follow-up|4|||
105600603|NCT00542789|364203213|FG000|Overall Study|Adverse Event|18|||
105600604|NCT00542789|364203214|FG001|Overall Study|Adverse Event|17|||
105600605|NCT00542789|364203213|FG000|Overall Study|Withdrawal by Subject|7|||
105600606|NCT00542789|364203214|FG001|Overall Study|Withdrawal by Subject|3|||
105600607|NCT00542789|364203213|FG000|Overall Study|Protocol Violation|8|||
105600608|NCT00542789|364203214|FG001|Overall Study|Protocol Violation|1|||
105600609|NCT00542789|364203213|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
105600610|NCT00542789|364203214|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
105600611|NCT01571596|364203215|FG000|Overall Study|Adverse Event|2|||
105600612|NCT01571596|364203216|FG001|Overall Study|Adverse Event|0|||
105600613|NCT01571596|364203217|FG002|Overall Study|Adverse Event|0|||
105600614|NCT01571596|364203215|FG000|Overall Study|Study Terminated by the Sponsor|0|||
105600615|NCT01571596|364203216|FG001|Overall Study|Study Terminated by the Sponsor|1|||
105600616|NCT01571596|364203217|FG002|Overall Study|Study Terminated by the Sponsor|1|||
105600617|NCT01113931|364203220|FG000|Overall Study|Adverse Event|2|||
105600618|NCT01113931|364203221|FG001|Overall Study|Adverse Event|2|||
105600619|NCT01113931|364203220|FG000|Overall Study|Physician Decision|0|||
105600620|NCT01113931|364203221|FG001|Overall Study|Physician Decision|2|||
105600621|NCT01113931|364203220|FG000|Overall Study|Lost to Follow-up|12|||
105600622|NCT01113931|364203221|FG001|Overall Study|Lost to Follow-up|9|||
105600623|NCT01113931|364203220|FG000|Overall Study|Various|2|||
105600624|NCT01113931|364203221|FG001|Overall Study|Various|4|||
105600625|NCT01113931|364203220|FG000|Overall Study|Withdrawal by Subject|3|||
105600626|NCT01113931|364203221|FG001|Overall Study|Withdrawal by Subject|0|||
105600627|NCT01149369|364203225|FG000|Overall Study|Adverse Event|6|||
105600628|NCT01149369|364203226|FG001|Overall Study|Adverse Event|3|||
105600629|NCT02767765|364203227|FG000|Overall Study|Adverse Event|4|||
105600630|NCT02767765|364203227|FG000|Overall Study|Death|1|||
105600631|NCT02767765|364203227|FG000|Overall Study|Insufficient response|1|||
105600632|NCT02767765|364203227|FG000|Overall Study|Lost to Follow-up|2|||
105600633|NCT02767765|364203227|FG000|Overall Study|Investigator decision|1|||
105600634|NCT02767765|364203227|FG000|Overall Study|Non-Compliance|1|||
105600635|NCT02767765|364203227|FG000|Overall Study|Withdrawal by Subject|1|||
105600636|NCT01951170|364203228|FG000|Overall Study|Investigator decision|1|||
105600637|NCT01808339|364203232|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
105600638|NCT01808339|364203233|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
105600639|NCT01808339|364203234|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
105600640|NCT01808339|364203235|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
105600641|NCT01808339|364203236|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
105600642|NCT01808339|364203237|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
105600643|NCT01808339|364203232|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105600644|NCT01808339|364203233|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
105600645|NCT01808339|364203234|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105600646|NCT01808339|364203235|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
105600647|NCT01808339|364203236|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105600648|NCT01808339|364203237|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105600649|NCT01808339|364203232|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
105600650|NCT01808339|364203233|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
105600651|NCT01808339|364203234|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
105600652|NCT01808339|364203235|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
105600653|NCT01808339|364203236|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
105600654|NCT01808339|364203237|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
105600655|NCT01040689|364203244|FG000|Overall Study|Adverse Event|0|||
105600656|NCT01040689|364203245|FG001|Overall Study|Adverse Event|0|||
105600657|NCT01040689|364203246|FG002|Overall Study|Adverse Event|2|||
105600658|NCT01040689|364203247|FG003|Overall Study|Adverse Event|4|||
105600659|NCT01040689|364203244|FG000|Overall Study|Lack of Efficacy|0|||
105600660|NCT01040689|364203245|FG001|Overall Study|Lack of Efficacy|0|||
105600661|NCT01040689|364203246|FG002|Overall Study|Lack of Efficacy|1|||
105600662|NCT01040689|364203247|FG003|Overall Study|Lack of Efficacy|0|||
105600663|NCT01040689|364203244|FG000|Overall Study|Lost to Follow-up|1|||
105600664|NCT01040689|364203245|FG001|Overall Study|Lost to Follow-up|0|||
105600665|NCT01040689|364203246|FG002|Overall Study|Lost to Follow-up|0|||
105600666|NCT01040689|364203247|FG003|Overall Study|Lost to Follow-up|0|||
105600667|NCT01040689|364203244|FG000|Overall Study|Withdrawal by Subject|2|||
105600668|NCT01040689|364203245|FG001|Overall Study|Withdrawal by Subject|1|||
105600669|NCT01040689|364203246|FG002|Overall Study|Withdrawal by Subject|1|||
105600670|NCT01040689|364203247|FG003|Overall Study|Withdrawal by Subject|0|||
105600671|NCT01040689|364203244|FG000|Overall Study|Other reasons not listed above|0|||
105600672|NCT01040689|364203245|FG001|Overall Study|Other reasons not listed above|1|||
105600673|NCT01040689|364203246|FG002|Overall Study|Other reasons not listed above|0|||
105600674|NCT01040689|364203247|FG003|Overall Study|Other reasons not listed above|0|||
105600675|NCT00446459|364203252|FG000|8 Months|Protocol Violation|12|||
105600676|NCT00446459|364203252|FG000|12 Months|Protocol Violation|4|||
105600677|NCT00446459|364203252|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
105600678|NCT00774397|364203253|FG000|Overall Study|Adverse Event|1|||
105600679|NCT00774397|364203254|FG001|Overall Study|Adverse Event|3|||
105600680|NCT00774397|364203255|FG002|Overall Study|Adverse Event|16|||
105600681|NCT00774397|364203256|FG003|Overall Study|Adverse Event|8|||
105600682|NCT00774397|364203257|FG004|Overall Study|Adverse Event|8|||
105600683|NCT00774397|364203258|FG005|Overall Study|Adverse Event|3|||
105600684|NCT00774397|364203259|FG006|Overall Study|Adverse Event|16|||
105600685|NCT00774397|364203253|FG000|Overall Study|Lack of Efficacy|11|||
105600686|NCT00774397|364203254|FG001|Overall Study|Lack of Efficacy|4|||
105600687|NCT00774397|364203255|FG002|Overall Study|Lack of Efficacy|5|||
105600688|NCT00774397|364203256|FG003|Overall Study|Lack of Efficacy|3|||
105600689|NCT00774397|364203257|FG004|Overall Study|Lack of Efficacy|27|||
105600690|NCT00774397|364203258|FG005|Overall Study|Lack of Efficacy|15|||
105600691|NCT00774397|364203259|FG006|Overall Study|Lack of Efficacy|9|||
105600692|NCT00774397|364203253|FG000|Overall Study|Protocol Violation|0|||
105600693|NCT00774397|364203254|FG001|Overall Study|Protocol Violation|1|||
105600694|NCT00774397|364203255|FG002|Overall Study|Protocol Violation|3|||
105600695|NCT00774397|364203256|FG003|Overall Study|Protocol Violation|1|||
105600696|NCT00774397|364203257|FG004|Overall Study|Protocol Violation|2|||
105600697|NCT00774397|364203258|FG005|Overall Study|Protocol Violation|1|||
105600698|NCT00774397|364203259|FG006|Overall Study|Protocol Violation|0|||
105600699|NCT00774397|364203253|FG000|Overall Study|Lost to Follow-up|0|||
105600700|NCT00774397|364203254|FG001|Overall Study|Lost to Follow-up|1|||
105600701|NCT00774397|364203255|FG002|Overall Study|Lost to Follow-up|1|||
105600702|NCT00774397|364203256|FG003|Overall Study|Lost to Follow-up|1|||
105600703|NCT00774397|364203257|FG004|Overall Study|Lost to Follow-up|0|||
105600704|NCT00774397|364203258|FG005|Overall Study|Lost to Follow-up|1|||
105600705|NCT00774397|364203259|FG006|Overall Study|Lost to Follow-up|0|||
105600706|NCT00774397|364203253|FG000|Overall Study|Refused to continue trial medication|1|||
105600707|NCT00774397|364203254|FG001|Overall Study|Refused to continue trial medication|3|||
105600708|NCT00774397|364203255|FG002|Overall Study|Refused to continue trial medication|2|||
105600709|NCT00774397|364203256|FG003|Overall Study|Refused to continue trial medication|2|||
105600710|NCT00774397|364203257|FG004|Overall Study|Refused to continue trial medication|6|||
105600711|NCT00774397|364203258|FG005|Overall Study|Refused to continue trial medication|2|||
105600712|NCT00774397|364203259|FG006|Overall Study|Refused to continue trial medication|3|||
105600713|NCT00774397|364203253|FG000|Overall Study|Not treated|0|||
105600714|NCT00774397|364203254|FG001|Overall Study|Not treated|0|||
105600715|NCT00774397|364203255|FG002|Overall Study|Not treated|0|||
105600716|NCT00774397|364203256|FG003|Overall Study|Not treated|0|||
105600717|NCT00774397|364203257|FG004|Overall Study|Not treated|1|||
105600718|NCT00774397|364203258|FG005|Overall Study|Not treated|0|||
105600719|NCT00774397|364203259|FG006|Overall Study|Not treated|1|||
105600720|NCT00774397|364203253|FG000|Overall Study|Other than those stated above|1|||
105600721|NCT00774397|364203254|FG001|Overall Study|Other than those stated above|1|||
105600722|NCT00774397|364203255|FG002|Overall Study|Other than those stated above|3|||
105600723|NCT00774397|364203256|FG003|Overall Study|Other than those stated above|2|||
105600724|NCT00774397|364203257|FG004|Overall Study|Other than those stated above|2|||
105600725|NCT00774397|364203258|FG005|Overall Study|Other than those stated above|0|||
105600726|NCT00774397|364203259|FG006|Overall Study|Other than those stated above|1|||
105600727|NCT02616900|364203262|FG000|Overall Study|Lack of Efficacy|7|||
105600728|NCT02616900|364203262|FG000|Overall Study|Lost to Follow-up|2|||
105600729|NCT02616900|364203262|FG000|Overall Study|Protocol Violation|5|||
105600730|NCT02616900|364203262|FG000|Overall Study|Withdrawal by Subject|3|||
105600731|NCT02616900|364203262|FG000|Overall Study|Incomplete data|6|||
105600732|NCT02499159|364203263|FG000|Randomization|Protocol Violation|1|||
105600733|NCT02499159|364203264|FG001|Randomization|Protocol Violation|1|||
105600734|NCT02499159|364203263|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
105600735|NCT02499159|364203264|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
105600736|NCT02499159|364203263|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
105600737|NCT02499159|364203264|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
105600738|NCT02499159|364203263|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
105600739|NCT02499159|364203264|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
105600740|NCT02499159|364203263|FG000|30-Day Follow-Up Phone Call|Other|1|||
105600741|NCT02499159|364203264|FG001|30-Day Follow-Up Phone Call|Other|0|||
105600742|NCT02601820|364203265|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
105600743|NCT02601820|364203265|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
105600744|NCT02601820|364203265|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
105600745|NCT02601820|364203265|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
105600746|NCT01599793|364203266|FG000|Overall Study|Adverse Event|2|||
105600747|NCT01075217|364203271|FG000|Overall Study|Adverse Event|1|||
105600748|NCT01075217|364203272|FG001|Overall Study|Adverse Event|1|||
105600749|NCT01075217|364203271|FG000|Overall Study|Physician Decision|1|||
105600750|NCT01075217|364203272|FG001|Overall Study|Physician Decision|0|||
105600751|NCT01068743|364203273|FG000|Period 3|Adverse Event|0|||
105600752|NCT01068743|364203274|FG001|Period 3|Adverse Event|1|||
105600753|NCT01068743|364203275|FG002|Period 3|Adverse Event|0|||
105600754|NCT01068743|364203276|FG003|Period 3|Adverse Event|0|||
105600755|NCT00364013|364203277|FG000|Overall Study|Ineligibility determined|4|||
105600756|NCT00364013|364203278|FG001|Overall Study|Ineligibility determined|2|||
105600757|NCT00364013|364203277|FG000|Overall Study|Adverse Event|4|||
105600758|NCT00364013|364203278|FG001|Overall Study|Adverse Event|3|||
105600759|NCT00364013|364203277|FG000|Overall Study|Withdrawal by Subject|13|||
105600760|NCT00364013|364203278|FG001|Overall Study|Withdrawal by Subject|18|||
105600761|NCT00364013|364203277|FG000|Overall Study|Physician Decision|3|||
105600762|NCT00364013|364203278|FG001|Overall Study|Physician Decision|3|||
105600763|NCT00364013|364203277|FG000|Overall Study|Lost to Follow-up|10|||
105600764|NCT00364013|364203278|FG001|Overall Study|Lost to Follow-up|3|||
105600765|NCT00364013|364203277|FG000|Overall Study|Protocol-specified criteria|6|||
105600766|NCT00364013|364203278|FG001|Overall Study|Protocol-specified criteria|6|||
105600767|NCT00364013|364203277|FG000|Overall Study|Other|41|||
105600768|NCT00364013|364203278|FG001|Overall Study|Other|47|||
105600769|NCT00364013|364203277|FG000|Overall Study|Ongoing|20|||
105600770|NCT00364013|364203278|FG001|Overall Study|Ongoing|13|||
105600771|NCT00293293|364203279|FG000|Overall Study|Withdrawal by Subject|1|||
105600772|NCT00293293|364203280|FG001|Overall Study|Withdrawal by Subject|1|||
105600773|NCT00293293|364203279|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
105600774|NCT00293293|364203280|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
105600775|NCT00293293|364203279|FG000|Overall Study|Patient discontinued chemotherapy|0|||
105600776|NCT00293293|364203280|FG001|Overall Study|Patient discontinued chemotherapy|1|||
105600777|NCT01185782|364203285|FG000|Overall Study|Adverse Event|0|||
105600778|NCT01185782|364203286|FG001|Overall Study|Adverse Event|1|||
105600779|NCT01185782|364203285|FG000|Overall Study|Protocol Violation|1|||
105600780|NCT01185782|364203286|FG001|Overall Study|Protocol Violation|0|||
105600781|NCT01185782|364203285|FG000|Overall Study|Poor Response to Treatment|3|||
105600782|NCT01185782|364203286|FG001|Overall Study|Poor Response to Treatment|1|||
105600783|NCT01185782|364203285|FG000|Overall Study|Other|2|||
105600784|NCT01185782|364203286|FG001|Overall Study|Other|5|||
105600785|NCT01185782|364203285|FG000|Overall Study|Randomized but not treated|0|||
105600786|NCT01185782|364203286|FG001|Overall Study|Randomized but not treated|4|||
105600787|NCT00444600|364203287|FG000|Overall Study|Death|7|||
105600788|NCT00444600|364203288|FG001|Overall Study|Death|5|||
105600789|NCT00444600|364203289|FG002|Overall Study|Death|3|||
105600790|NCT00444600|364203290|FG003|Overall Study|Death|2|||
105600791|NCT00444600|364203287|FG000|Overall Study|Dropped|11|||
105600792|NCT00444600|364203288|FG001|Overall Study|Dropped|11|||
105600793|NCT00444600|364203289|FG002|Overall Study|Dropped|7|||
105600794|NCT00444600|364203290|FG003|Overall Study|Dropped|7|||
105600795|NCT00444600|364203287|FG000|Overall Study|Missed visit|1|||
105600796|NCT00444600|364203288|FG001|Overall Study|Missed visit|0|||
105600797|NCT00444600|364203289|FG002|Overall Study|Missed visit|0|||
105600798|NCT00444600|364203290|FG003|Overall Study|Missed visit|1|||
105600799|NCT05132478|364203291|FG000|Overall Study|did not complete survey after consent|1|||
105600800|NCT05132478|364203292|FG001|Overall Study|did not complete survey after consent|1|||
105600801|NCT05132478|364203291|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
105600802|NCT05132478|364203292|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
105600803|NCT00585533|364203293|FG000|Overall Study|objective or symptomatic progression|9|||
105600804|NCT01254188|364203294|FG000|Overall Study|Disease Progression|6|||
105600805|NCT01254188|364203294|FG000|Overall Study|Protocol Violation|6|||
105600806|NCT01254188|364203294|FG000|Overall Study|Pregnancy|2|||
105600807|NCT01254188|364203294|FG000|Overall Study|Death|4|||
105600808|NCT01254188|364203294|FG000|Overall Study|Lost to Follow-up|5|||
105600809|NCT01254188|364203294|FG000|Overall Study|Withdrawal by Subject|7|||
105600810|NCT01254188|364203294|FG000|Overall Study|Adverse Event|43|||
105600811|NCT01254188|364203294|FG000|Overall Study|per investigator discretion|20|||
105600812|NCT01061151|364203295|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
105600813|NCT01061151|364203296|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
105600814|NCT01061151|364203297|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
105600815|NCT01061151|364203298|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
105600816|NCT01061151|364203295|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
105600817|NCT01061151|364203296|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
105600818|NCT01061151|364203297|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
105600819|NCT01061151|364203298|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
105600820|NCT01061151|364203295|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
105600821|NCT01061151|364203296|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
105600822|NCT01061151|364203297|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
105600823|NCT01061151|364203298|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
105600824|NCT01061151|364203295|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
105600825|NCT01061151|364203296|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
105600826|NCT01061151|364203297|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
105600827|NCT01061151|364203298|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
105600828|NCT01061151|364203295|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
105600829|NCT01061151|364203296|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
105600830|NCT01061151|364203297|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
105600831|NCT01061151|364203298|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
105600832|NCT01061151|364203295|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
105600833|NCT01061151|364203296|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
105600834|NCT01061151|364203297|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
105600835|NCT01061151|364203298|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
105600836|NCT01061151|364203295|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
105600837|NCT01061151|364203296|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
105600838|NCT01061151|364203297|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
105600839|NCT01061151|364203298|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
105600840|NCT01061151|364203295|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
105600841|NCT01061151|364203296|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
105600842|NCT01061151|364203297|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
105600843|NCT01061151|364203298|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
105600844|NCT01061151|364203295|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
105600845|NCT01061151|364203296|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
105600846|NCT01061151|364203297|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
105600847|NCT01061151|364203298|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
105600848|NCT01061151|364203295|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
105600849|NCT01061151|364203296|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
105600850|NCT01061151|364203297|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
105600851|NCT01061151|364203298|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
105600852|NCT01061151|364203295|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
105600853|NCT01061151|364203296|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
105600854|NCT01061151|364203297|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
105600855|NCT01061151|364203298|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
105600856|NCT01061151|364203295|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
105600857|NCT01061151|364203296|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
105600858|NCT01061151|364203297|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
105600859|NCT01061151|364203298|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
105600860|NCT01061151|364203295|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
105600861|NCT01061151|364203296|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
105600862|NCT01061151|364203297|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
105600863|NCT01061151|364203298|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
105600864|NCT01061151|364203295|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
105600865|NCT01061151|364203296|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
105600866|NCT01061151|364203297|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
105600867|NCT01061151|364203298|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
105600868|NCT01061151|364203295|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
105600869|NCT01061151|364203296|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
105600870|NCT01061151|364203297|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
105600871|NCT01061151|364203298|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
105600872|NCT01369498|364203299|FG000|Overall Study|Lack of Efficacy|9|||
105600873|NCT01369498|364203300|FG001|Overall Study|Lack of Efficacy|9|||
105600874|NCT01369498|364203301|FG002|Overall Study|Lack of Efficacy|1|||
105600875|NCT01369498|364203302|FG003|Overall Study|Lack of Efficacy|3|||
105600876|NCT01369498|364203299|FG000|Overall Study|Adverse Event|1|||
105600877|NCT01369498|364203300|FG001|Overall Study|Adverse Event|2|||
105600878|NCT01369498|364203301|FG002|Overall Study|Adverse Event|0|||
105600879|NCT01369498|364203302|FG003|Overall Study|Adverse Event|1|||
105600880|NCT01369498|364203299|FG000|Overall Study|Withdrawal of Consent|0|||
105600881|NCT01369498|364203300|FG001|Overall Study|Withdrawal of Consent|1|||
105600882|NCT01369498|364203301|FG002|Overall Study|Withdrawal of Consent|1|||
105600883|NCT01369498|364203302|FG003|Overall Study|Withdrawal of Consent|1|||
105600884|NCT01369498|364203299|FG000|Overall Study|Death|0|||
105600885|NCT01369498|364203300|FG001|Overall Study|Death|0|||
105600886|NCT01369498|364203301|FG002|Overall Study|Death|1|||
105600887|NCT01369498|364203302|FG003|Overall Study|Death|0|||
105600888|NCT01369498|364203299|FG000|Overall Study|Investigator's Discretion|1|||
105600889|NCT01369498|364203300|FG001|Overall Study|Investigator's Discretion|0|||
105600890|NCT01369498|364203301|FG002|Overall Study|Investigator's Discretion|1|||
105600891|NCT01369498|364203302|FG003|Overall Study|Investigator's Discretion|3|||
105600892|NCT01369498|364203299|FG000|Overall Study|Unknown Reason|1|||
105600893|NCT01369498|364203300|FG001|Overall Study|Unknown Reason|0|||
105600894|NCT01369498|364203301|FG002|Overall Study|Unknown Reason|11|||
105600895|NCT01369498|364203302|FG003|Overall Study|Unknown Reason|6|||
105600896|NCT01369498|364203299|FG000|Overall Study|Disease Progression|0|||
105600897|NCT01369498|364203300|FG001|Overall Study|Disease Progression|0|||
105600898|NCT01369498|364203301|FG002|Overall Study|Disease Progression|0|||
105600899|NCT01369498|364203302|FG003|Overall Study|Disease Progression|1|||
105600900|NCT02988817|364203307|FG000|Overall Study|Withdrawal by Subject|1|||
105600901|NCT02988817|364203308|FG001|Overall Study|Withdrawal by Subject|0|||
105600902|NCT02988817|364203309|FG002|Overall Study|Withdrawal by Subject|0|||
105600903|NCT02988817|364203310|FG003|Overall Study|Withdrawal by Subject|1|||
105600904|NCT02988817|364203311|FG004|Overall Study|Withdrawal by Subject|3|||
105600905|NCT02988817|364203312|FG005|Overall Study|Withdrawal by Subject|1|||
105600906|NCT02988817|364203313|FG006|Overall Study|Withdrawal by Subject|2|||
105600907|NCT02988817|364203314|FG007|Overall Study|Withdrawal by Subject|1|||
105600908|NCT02988817|364203315|FG008|Overall Study|Withdrawal by Subject|1|||
105600909|NCT02988817|364203316|FG009|Overall Study|Withdrawal by Subject|1|||
105600910|NCT02988817|364203317|FG010|Overall Study|Withdrawal by Subject|1|||
105600911|NCT02988817|364203318|FG011|Overall Study|Withdrawal by Subject|12|||
105600912|NCT02988817|364203319|FG012|Overall Study|Withdrawal by Subject|6|||
105600913|NCT02988817|364203320|FG013|Overall Study|Withdrawal by Subject|6|||
105600914|NCT02988817|364203321|FG014|Overall Study|Withdrawal by Subject|4|||
105600915|NCT02988817|364203322|FG015|Overall Study|Withdrawal by Subject|5|||
105600916|NCT02988817|364203323|FG016|Overall Study|Withdrawal by Subject|4|||
105600917|NCT02988817|364203324|FG017|Overall Study|Withdrawal by Subject|11|||
105600918|NCT02988817|364203325|FG018|Overall Study|Withdrawal by Subject|4|||
105600919|NCT02988817|364203326|FG019|Overall Study|Withdrawal by Subject|2|||
105600920|NCT02988817|364203307|FG000|Overall Study|Death|0|||
105600921|NCT02988817|364203308|FG001|Overall Study|Death|1|||
105600922|NCT02988817|364203309|FG002|Overall Study|Death|3|||
105600923|NCT02988817|364203310|FG003|Overall Study|Death|1|||
105600924|NCT02988817|364203311|FG004|Overall Study|Death|6|||
105600925|NCT02988817|364203312|FG005|Overall Study|Death|10|||
105600926|NCT02988817|364203313|FG006|Overall Study|Death|1|||
105600927|NCT02988817|364203314|FG007|Overall Study|Death|2|||
105600928|NCT02988817|364203315|FG008|Overall Study|Death|1|||
105600929|NCT02988817|364203316|FG009|Overall Study|Death|5|||
105600930|NCT02988817|364203317|FG010|Overall Study|Death|1|||
105600931|NCT02988817|364203318|FG011|Overall Study|Death|8|||
105600932|NCT02988817|364203319|FG012|Overall Study|Death|9|||
105600933|NCT02988817|364203320|FG013|Overall Study|Death|17|||
105600934|NCT02988817|364203321|FG014|Overall Study|Death|18|||
105600935|NCT02988817|364203322|FG015|Overall Study|Death|30|||
105600936|NCT02988817|364203323|FG016|Overall Study|Death|17|||
105600937|NCT02988817|364203324|FG017|Overall Study|Death|38|||
105600938|NCT02988817|364203325|FG018|Overall Study|Death|14|||
105600939|NCT02988817|364203326|FG019|Overall Study|Death|16|||
105600940|NCT02988817|364203307|FG000|Overall Study|Other|0|||
105600941|NCT02988817|364203308|FG001|Overall Study|Other|0|||
105600942|NCT02988817|364203309|FG002|Overall Study|Other|0|||
105600943|NCT02988817|364203310|FG003|Overall Study|Other|1|||
105600944|NCT02988817|364203311|FG004|Overall Study|Other|1|||
105600945|NCT02988817|364203312|FG005|Overall Study|Other|0|||
105600946|NCT02988817|364203313|FG006|Overall Study|Other|0|||
105600947|NCT02988817|364203314|FG007|Overall Study|Other|0|||
105600948|NCT02988817|364203315|FG008|Overall Study|Other|0|||
105600949|NCT02988817|364203316|FG009|Overall Study|Other|0|||
105600950|NCT02988817|364203317|FG010|Overall Study|Other|0|||
105600951|NCT02988817|364203318|FG011|Overall Study|Other|0|||
105600952|NCT02988817|364203319|FG012|Overall Study|Other|0|||
105600953|NCT02988817|364203320|FG013|Overall Study|Other|0|||
105600954|NCT02988817|364203321|FG014|Overall Study|Other|0|||
105600955|NCT02988817|364203322|FG015|Overall Study|Other|1|||
105600956|NCT02988817|364203323|FG016|Overall Study|Other|0|||
105600957|NCT02988817|364203324|FG017|Overall Study|Other|0|||
105600958|NCT02988817|364203325|FG018|Overall Study|Other|0|||
105600959|NCT02988817|364203326|FG019|Overall Study|Other|0|||
105600960|NCT02988817|364203307|FG000|Overall Study|Lost to Follow-up|0|||
105600961|NCT02988817|364203308|FG001|Overall Study|Lost to Follow-up|0|||
105600962|NCT02988817|364203309|FG002|Overall Study|Lost to Follow-up|0|||
105600963|NCT02988817|364203310|FG003|Overall Study|Lost to Follow-up|0|||
105600964|NCT02988817|364203311|FG004|Overall Study|Lost to Follow-up|0|||
105600965|NCT02988817|364203312|FG005|Overall Study|Lost to Follow-up|0|||
105600966|NCT02988817|364203313|FG006|Overall Study|Lost to Follow-up|0|||
105600967|NCT02988817|364203314|FG007|Overall Study|Lost to Follow-up|0|||
105600968|NCT02988817|364203315|FG008|Overall Study|Lost to Follow-up|1|||
105600969|NCT02988817|364203316|FG009|Overall Study|Lost to Follow-up|0|||
105600970|NCT02988817|364203317|FG010|Overall Study|Lost to Follow-up|1|||
105600971|NCT02988817|364203318|FG011|Overall Study|Lost to Follow-up|1|||
105600972|NCT02988817|364203319|FG012|Overall Study|Lost to Follow-up|0|||
105600973|NCT02988817|364203320|FG013|Overall Study|Lost to Follow-up|0|||
105600974|NCT02988817|364203321|FG014|Overall Study|Lost to Follow-up|1|||
105600975|NCT02988817|364203322|FG015|Overall Study|Lost to Follow-up|1|||
105600976|NCT02988817|364203323|FG016|Overall Study|Lost to Follow-up|2|||
105600977|NCT02988817|364203324|FG017|Overall Study|Lost to Follow-up|3|||
105600978|NCT02988817|364203325|FG018|Overall Study|Lost to Follow-up|0|||
105600979|NCT02988817|364203326|FG019|Overall Study|Lost to Follow-up|0|||
105600980|NCT02988817|364203307|FG000|Overall Study|Sponsor decision|0|||
105600981|NCT02988817|364203308|FG001|Overall Study|Sponsor decision|0|||
105600982|NCT02988817|364203309|FG002|Overall Study|Sponsor decision|0|||
105600983|NCT02988817|364203310|FG003|Overall Study|Sponsor decision|0|||
105600984|NCT02988817|364203311|FG004|Overall Study|Sponsor decision|0|||
105600985|NCT02988817|364203312|FG005|Overall Study|Sponsor decision|0|||
105600986|NCT02988817|364203313|FG006|Overall Study|Sponsor decision|0|||
105600987|NCT02988817|364203314|FG007|Overall Study|Sponsor decision|0|||
105600988|NCT02988817|364203315|FG008|Overall Study|Sponsor decision|0|||
105600989|NCT02988817|364203316|FG009|Overall Study|Sponsor decision|0|||
105600990|NCT02988817|364203317|FG010|Overall Study|Sponsor decision|0|||
105600991|NCT02988817|364203318|FG011|Overall Study|Sponsor decision|1|||
105600992|NCT02988817|364203319|FG012|Overall Study|Sponsor decision|1|||
105600993|NCT02988817|364203320|FG013|Overall Study|Sponsor decision|2|||
105600994|NCT02988817|364203321|FG014|Overall Study|Sponsor decision|2|||
105600995|NCT02988817|364203322|FG015|Overall Study|Sponsor decision|6|||
105600996|NCT02988817|364203323|FG016|Overall Study|Sponsor decision|2|||
105600997|NCT02988817|364203324|FG017|Overall Study|Sponsor decision|3|||
105600998|NCT02988817|364203325|FG018|Overall Study|Sponsor decision|2|||
105600999|NCT02988817|364203326|FG019|Overall Study|Sponsor decision|7|||
105601000|NCT02988817|364203307|FG000|Overall Study|Physician Decision|0|||
105601001|NCT02988817|364203308|FG001|Overall Study|Physician Decision|0|||
105601002|NCT02988817|364203309|FG002|Overall Study|Physician Decision|0|||
105601003|NCT02988817|364203310|FG003|Overall Study|Physician Decision|0|||
105601004|NCT02988817|364203311|FG004|Overall Study|Physician Decision|0|||
105601005|NCT02988817|364203312|FG005|Overall Study|Physician Decision|0|||
105601006|NCT02988817|364203313|FG006|Overall Study|Physician Decision|0|||
105601007|NCT02988817|364203314|FG007|Overall Study|Physician Decision|0|||
105601008|NCT02988817|364203315|FG008|Overall Study|Physician Decision|0|||
105601009|NCT02988817|364203316|FG009|Overall Study|Physician Decision|0|||
105601010|NCT02988817|364203317|FG010|Overall Study|Physician Decision|0|||
105601011|NCT02988817|364203318|FG011|Overall Study|Physician Decision|0|||
105601012|NCT02988817|364203319|FG012|Overall Study|Physician Decision|0|||
105601013|NCT02988817|364203320|FG013|Overall Study|Physician Decision|0|||
105601014|NCT02988817|364203321|FG014|Overall Study|Physician Decision|0|||
105601015|NCT02988817|364203322|FG015|Overall Study|Physician Decision|1|||
105601016|NCT02988817|364203323|FG016|Overall Study|Physician Decision|0|||
105601017|NCT02988817|364203324|FG017|Overall Study|Physician Decision|0|||
105601018|NCT02988817|364203325|FG018|Overall Study|Physician Decision|1|||
105601019|NCT02988817|364203326|FG019|Overall Study|Physician Decision|1|||
105601020|NCT03950622|364203335|FG000|Overall Study|Withdrawal by Subject|1|||
105601021|NCT03950622|364203336|FG001|Overall Study|Withdrawal by Subject|0|||
105601022|NCT03950622|364203335|FG000|Overall Study|Protocol Deviation|0|||
105601023|NCT03950622|364203336|FG001|Overall Study|Protocol Deviation|1|||
105601024|NCT03950622|364203335|FG000|Overall Study|Physician Decision|1|||
105601025|NCT03950622|364203336|FG001|Overall Study|Physician Decision|0|||
105601026|NCT03950622|364203335|FG000|Overall Study|Lost to Follow-up|5|||
105601027|NCT03950622|364203336|FG001|Overall Study|Lost to Follow-up|5|||
105601028|NCT03950622|364203335|FG000|Overall Study|Death|1|||
105601029|NCT03950622|364203336|FG001|Overall Study|Death|1|||
105601030|NCT03752151|364203337|FG000|Overall Study|Withdrawal by Subject|1|||
105601031|NCT03752151|364203337|FG000|Overall Study|Protocol Violation|1|||
105601032|NCT05782231|364203342|FG000|Overall Study|Withdrawal by Subject|1|||
105601033|NCT00510887|364203343|FG000|Overall Study|Lost to Follow-up|1|||
105601034|NCT05510245|364203344|FG000|Overall Study|Withdrawal by Subject|1|||
105601035|NCT05510245|364203345|FG001|Overall Study|Withdrawal by Subject|0|||
105601036|NCT05510245|364203346|FG002|Overall Study|Withdrawal by Subject|0|||
105601037|NCT01759771|364203350|FG000|Overall Study|Withdrawal by Subject|1|||
105601038|NCT01759771|364203351|FG001|Overall Study|Withdrawal by Subject|1|||
105601039|NCT00089544|364204583|FG000|Overall Study|Ineligible|1|||
105601040|NCT00089544|364204584|FG001|Overall Study|Ineligible|0|||
105601041|NCT01972724|364204589|FG000|Double-Blind|Rescue Criteria Met|1|||
105601042|NCT01972724|364204590|FG001|Double-Blind|Rescue Criteria Met|0|||
105601043|NCT01972724|364204591|FG002|Double-Blind|Rescue Criteria Met|0|||
105601044|NCT01972724|364204589|FG000|Double-Blind|Adverse Event|1|||
105601045|NCT01972724|364204590|FG001|Double-Blind|Adverse Event|0|||
105601046|NCT01972724|364204591|FG002|Double-Blind|Adverse Event|0|||
105601047|NCT01972724|364204589|FG000|Double-Blind|Withdrawal of Consent|2|||
105601048|NCT01972724|364204590|FG001|Double-Blind|Withdrawal of Consent|1|||
105601049|NCT01972724|364204591|FG002|Double-Blind|Withdrawal of Consent|0|||
105601050|NCT01972724|364204589|FG000|Double-Blind|Significant Protocol Deviation|5|||
105601051|NCT01972724|364204590|FG001|Double-Blind|Significant Protocol Deviation|8|||
105601052|NCT01972724|364204591|FG002|Double-Blind|Significant Protocol Deviation|0|||
105601053|NCT01972724|364204589|FG000|Open-Label|Withdrew Consent|0|||
105601054|NCT01972724|364204590|FG001|Open-Label|Withdrew Consent|0|||
105601055|NCT01972724|364204591|FG002|Open-Label|Withdrew Consent|3|||
105601056|NCT01972724|364204589|FG000|Open-Label|Significant Protocol Deviation|0|||
105601057|NCT01972724|364204590|FG001|Open-Label|Significant Protocol Deviation|0|||
105601058|NCT01972724|364204591|FG002|Open-Label|Significant Protocol Deviation|2|||
105601059|NCT00391898|364204596|FG000|Overall Study|Adverse Event|3|||
105601060|NCT00391898|364204597|FG001|Overall Study|Adverse Event|0|||
105601061|NCT00391898|364204596|FG000|Overall Study|Other|8|||
105601062|NCT00391898|364204597|FG001|Overall Study|Other|10|||
105601063|NCT01636687|364204598|FG000|Induction Period|Withdrawal by Subject|1|||
105601064|NCT01636687|364204599|FG001|Induction Period|Withdrawal by Subject|0|||
105601065|NCT01636687|364204600|FG002|Induction Period|Withdrawal by Subject|0|||
105601066|NCT01636687|364204601|FG003|Induction Period|Withdrawal by Subject|0|||
105601067|NCT01636687|364204602|FG004|Induction Period|Withdrawal by Subject|0|||
105601068|NCT01636687|364204598|FG000|Induction Period|Adverse Event|1|||
105601069|NCT01636687|364204599|FG001|Induction Period|Adverse Event|0|||
105601070|NCT01636687|364204600|FG002|Induction Period|Adverse Event|0|||
105601071|NCT01636687|364204601|FG003|Induction Period|Adverse Event|0|||
105601072|NCT01636687|364204602|FG004|Induction Period|Adverse Event|1|||
105601073|NCT01636687|364204598|FG000|Induction Period|Lack of Efficacy|0|||
105601074|NCT01636687|364204599|FG001|Induction Period|Lack of Efficacy|0|||
105601075|NCT01636687|364204600|FG002|Induction Period|Lack of Efficacy|0|||
105601076|NCT01636687|364204601|FG003|Induction Period|Lack of Efficacy|0|||
105601077|NCT01636687|364204602|FG004|Induction Period|Lack of Efficacy|1|||
105601078|NCT01636687|364204598|FG000|Induction Period|Physician Decision|1|||
105601079|NCT01636687|364204599|FG001|Induction Period|Physician Decision|0|||
105601080|NCT01636687|364204600|FG002|Induction Period|Physician Decision|0|||
105601081|NCT01636687|364204601|FG003|Induction Period|Physician Decision|0|||
105601082|NCT01636687|364204602|FG004|Induction Period|Physician Decision|0|||
105601083|NCT01636687|364204598|FG000|Maintenance Period|Withdrawal by Subject|2|||
105601084|NCT01636687|364204599|FG001|Maintenance Period|Withdrawal by Subject|0|||
105601085|NCT01636687|364204600|FG002|Maintenance Period|Withdrawal by Subject|2|||
105601086|NCT01636687|364204601|FG003|Maintenance Period|Withdrawal by Subject|0|||
105601087|NCT01636687|364204602|FG004|Maintenance Period|Withdrawal by Subject|0|||
105601088|NCT01636687|364204598|FG000|Maintenance Period|Adverse Event|1|||
105601089|NCT01636687|364204599|FG001|Maintenance Period|Adverse Event|0|||
105601090|NCT01636687|364204600|FG002|Maintenance Period|Adverse Event|0|||
105601091|NCT01636687|364204601|FG003|Maintenance Period|Adverse Event|0|||
105601092|NCT01636687|364204602|FG004|Maintenance Period|Adverse Event|0|||
105601093|NCT01636687|364204598|FG000|Maintenance Period|Lack of Efficacy|4|||
105601094|NCT01636687|364204599|FG001|Maintenance Period|Lack of Efficacy|1|||
105601095|NCT01636687|364204600|FG002|Maintenance Period|Lack of Efficacy|0|||
105601096|NCT01636687|364204601|FG003|Maintenance Period|Lack of Efficacy|0|||
105601097|NCT01636687|364204602|FG004|Maintenance Period|Lack of Efficacy|0|||
105601098|NCT01636687|364204598|FG000|Maintenance Period|Lost to Follow-up|1|||
105601099|NCT01636687|364204599|FG001|Maintenance Period|Lost to Follow-up|1|||
105601100|NCT01636687|364204600|FG002|Maintenance Period|Lost to Follow-up|0|||
105601101|NCT01636687|364204601|FG003|Maintenance Period|Lost to Follow-up|0|||
105601102|NCT01636687|364204602|FG004|Maintenance Period|Lost to Follow-up|1|||
105601103|NCT01636687|364204598|FG000|Maintenance Period|Physician Decision|0|||
105601104|NCT01636687|364204599|FG001|Maintenance Period|Physician Decision|0|||
105601105|NCT01636687|364204600|FG002|Maintenance Period|Physician Decision|0|||
105601106|NCT01636687|364204601|FG003|Maintenance Period|Physician Decision|0|||
105601107|NCT01636687|364204602|FG004|Maintenance Period|Physician Decision|1|||
105601108|NCT01636687|364204598|FG000|Extension Period|technical problems|0|||
105601109|NCT01636687|364204599|FG001|Extension Period|technical problems|1|||
105601110|NCT01636687|364204600|FG002|Extension Period|technical problems|2|||
105601111|NCT01636687|364204601|FG003|Extension Period|technical problems|1|||
105601112|NCT01636687|364204602|FG004|Extension Period|technical problems|0|||
105601113|NCT01636687|364204598|FG000|Extension Period|Adverse Event|4|||
105601114|NCT01636687|364204599|FG001|Extension Period|Adverse Event|3|||
105601115|NCT01636687|364204600|FG002|Extension Period|Adverse Event|2|||
105601116|NCT01636687|364204601|FG003|Extension Period|Adverse Event|1|||
105601117|NCT01636687|364204602|FG004|Extension Period|Adverse Event|0|||
105601118|NCT01636687|364204598|FG000|Extension Period|Lack of Efficacy|7|||
105601119|NCT01636687|364204599|FG001|Extension Period|Lack of Efficacy|0|||
105601120|NCT01636687|364204600|FG002|Extension Period|Lack of Efficacy|2|||
105601121|NCT01636687|364204601|FG003|Extension Period|Lack of Efficacy|1|||
105601122|NCT01636687|364204602|FG004|Extension Period|Lack of Efficacy|0|||
105601123|NCT01636687|364204598|FG000|Extension Period|Lost to Follow-up|1|||
105601124|NCT01636687|364204599|FG001|Extension Period|Lost to Follow-up|0|||
105601125|NCT01636687|364204600|FG002|Extension Period|Lost to Follow-up|1|||
105601126|NCT01636687|364204601|FG003|Extension Period|Lost to Follow-up|0|||
105601127|NCT01636687|364204602|FG004|Extension Period|Lost to Follow-up|0|||
105601128|NCT01636687|364204598|FG000|Extension Period|Physician Decision|1|||
105601129|NCT01636687|364204599|FG001|Extension Period|Physician Decision|0|||
105601130|NCT01636687|364204600|FG002|Extension Period|Physician Decision|0|||
105601131|NCT01636687|364204601|FG003|Extension Period|Physician Decision|1|||
105601132|NCT01636687|364204602|FG004|Extension Period|Physician Decision|0|||
105601133|NCT01636687|364204598|FG000|Extension Period|study terminated by sponsor|33|||
105601134|NCT01636687|364204599|FG001|Extension Period|study terminated by sponsor|50|||
105601135|NCT01636687|364204600|FG002|Extension Period|study terminated by sponsor|17|||
105601136|NCT01636687|364204601|FG003|Extension Period|study terminated by sponsor|23|||
105601137|NCT01636687|364204602|FG004|Extension Period|study terminated by sponsor|0|||
105601138|NCT01636687|364204598|FG000|Extension Period|Withdrawal by Subject|1|||
105601139|NCT01636687|364204599|FG001|Extension Period|Withdrawal by Subject|0|||
105601140|NCT01636687|364204600|FG002|Extension Period|Withdrawal by Subject|1|||
105601141|NCT01636687|364204601|FG003|Extension Period|Withdrawal by Subject|1|||
105601142|NCT01636687|364204602|FG004|Extension Period|Withdrawal by Subject|0|||
105601143|NCT01636687|364204598|FG000|Follow-up Period|Withdrawal by Subject|1|||
105601144|NCT01636687|364204599|FG001|Follow-up Period|Withdrawal by Subject|0|||
105601145|NCT01636687|364204600|FG002|Follow-up Period|Withdrawal by Subject|0|||
105601146|NCT01636687|364204601|FG003|Follow-up Period|Withdrawal by Subject|0|||
105601147|NCT01636687|364204602|FG004|Follow-up Period|Withdrawal by Subject|1|||
105601148|NCT01510717|364204604|FG000|Overall Study|Adverse Event|1|||
105601149|NCT01510717|364204605|FG001|Overall Study|Adverse Event|2|||
105601150|NCT01510717|364204604|FG000|Overall Study|Death|1|||
105601151|NCT01510717|364204605|FG001|Overall Study|Death|0|||
105601152|NCT01510717|364204604|FG000|Overall Study|Lost to Follow-up|0|||
105601153|NCT01510717|364204605|FG001|Overall Study|Lost to Follow-up|1|||
105601154|NCT01510717|364204604|FG000|Overall Study|Withdrawal by Subject|0|||
105601155|NCT01510717|364204605|FG001|Overall Study|Withdrawal by Subject|2|||
105601156|NCT00761605|364204606|FG000|Overall Study|Adverse Event|26|||
105601157|NCT00761605|364204606|FG000|Overall Study|Death|2|||
105601158|NCT00761605|364204606|FG000|Overall Study|Lack of Efficacy|26|||
105601159|NCT00761605|364204606|FG000|Overall Study|Lost to Follow-up|29|||
105601160|NCT00761605|364204606|FG000|Overall Study|Withdrawal by Subject|37|||
105601161|NCT00761605|364204606|FG000|Overall Study|Other|21|||
105601162|NCT03482011|364204607|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
105601163|NCT03482011|364204608|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
105601164|NCT03482011|364204609|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
105601165|NCT03482011|364204610|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
105601166|NCT03482011|364204611|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
105601167|NCT03482011|364204612|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
105601168|NCT03482011|364204613|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
105601169|NCT03482011|364204614|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
105601170|NCT03482011|364204607|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
105601171|NCT03482011|364204608|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
105601172|NCT03482011|364204609|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105601173|NCT03482011|364204610|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105601174|NCT03482011|364204611|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105601175|NCT03482011|364204612|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105601176|NCT03482011|364204613|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105601177|NCT03482011|364204614|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105601178|NCT03482011|364204607|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
105601179|NCT03482011|364204608|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
105601180|NCT03482011|364204609|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
105601181|NCT03482011|364204610|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
105601182|NCT03482011|364204611|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
105601183|NCT03482011|364204612|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
105601184|NCT03482011|364204613|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
105601185|NCT03482011|364204614|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
105601186|NCT03482011|364204607|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
105601187|NCT03482011|364204608|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
105601188|NCT03482011|364204609|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
105601189|NCT03482011|364204610|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
105601190|NCT03482011|364204611|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
105601191|NCT03482011|364204612|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
105601192|NCT03482011|364204613|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
105601193|NCT03482011|364204614|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
105601194|NCT03482011|364204607|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
105601195|NCT03482011|364204608|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
105601196|NCT03482011|364204609|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105601197|NCT03482011|364204610|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105601198|NCT03482011|364204611|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105601199|NCT03482011|364204612|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105601200|NCT03482011|364204613|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105601201|NCT03482011|364204614|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105601202|NCT03482011|364204607|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
105601203|NCT03482011|364204608|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
105601204|NCT03482011|364204609|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
105601205|NCT03482011|364204610|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
105601206|NCT03482011|364204611|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
105601207|NCT03482011|364204612|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
105601208|NCT03482011|364204613|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
105601209|NCT03482011|364204614|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
105601210|NCT03482011|364204607|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
105601211|NCT03482011|364204608|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
105601212|NCT03482011|364204609|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
105601213|NCT03482011|364204610|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
105601214|NCT03482011|364204611|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
105601215|NCT03482011|364204612|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
105601216|NCT03482011|364204613|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
105601217|NCT03482011|364204614|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
105601218|NCT03482011|364204607|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105601219|NCT03482011|364204608|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105601220|NCT03482011|364204609|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105601221|NCT03482011|364204610|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105601222|NCT03482011|364204611|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
105601223|NCT03482011|364204612|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105601224|NCT03482011|364204613|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105601225|NCT03482011|364204614|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
105601226|NCT03482011|364204607|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
105601227|NCT03482011|364204608|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
105601228|NCT03482011|364204609|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
105601229|NCT03482011|364204610|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
105601230|NCT03482011|364204611|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
105601231|NCT03482011|364204612|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
105601232|NCT03482011|364204613|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
105601233|NCT03482011|364204614|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
105601234|NCT03482011|364204607|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105601235|NCT03482011|364204608|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105601236|NCT03482011|364204609|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105601237|NCT03482011|364204610|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
105601238|NCT03482011|364204611|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
105601239|NCT03482011|364204612|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
105601240|NCT03482011|364204613|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
105601241|NCT03482011|364204614|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
105601242|NCT03482011|364204607|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105601243|NCT03482011|364204608|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105601244|NCT03482011|364204609|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105601245|NCT03482011|364204610|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
105601246|NCT03482011|364204611|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105601247|NCT03482011|364204612|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
105601248|NCT03482011|364204613|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
105601249|NCT03482011|364204614|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
105601250|NCT03482011|364204607|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
105601251|NCT03482011|364204608|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
105601252|NCT03482011|364204609|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
105601253|NCT03482011|364204610|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
105601254|NCT03482011|364204611|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
105601255|NCT03482011|364204612|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
105601256|NCT03482011|364204613|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
105601257|NCT03482011|364204614|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
105601258|NCT03482011|364204607|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
105601259|NCT03482011|364204608|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
105601260|NCT03482011|364204609|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
105601261|NCT03482011|364204610|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
105601262|NCT03482011|364204611|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
105601263|NCT03482011|364204612|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
105601264|NCT03482011|364204613|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
105601265|NCT03482011|364204614|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
105601266|NCT03482011|364204607|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
105601267|NCT03482011|364204608|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
105601268|NCT03482011|364204609|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
105601269|NCT03482011|364204610|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
105601270|NCT03482011|364204611|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
105601271|NCT03482011|364204612|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
105601272|NCT03482011|364204613|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
105601273|NCT03482011|364204614|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
105601274|NCT03482011|364204607|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
105601275|NCT03482011|364204608|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
105601276|NCT03482011|364204609|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
105601277|NCT03482011|364204610|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
105601278|NCT03482011|364204611|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
105601279|NCT03482011|364204612|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
105601280|NCT03482011|364204613|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
105601281|NCT03482011|364204614|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
105601282|NCT01546753|364204616|FG000|Overall Study|anxiety|1|||
105601283|NCT01546753|364204617|FG001|Overall Study|anxiety|1|||
105601284|NCT01546753|364204616|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
105601285|NCT01546753|364204617|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
105601286|NCT01000480|364204619|FG000|Induction Phase|Adverse Event|2|||
105601287|NCT01000480|364204619|FG000|Induction Phase|Lost to Follow-up|1|||
105601288|NCT01000480|364204619|FG000|Induction Phase|Physician Decision|1|||
105601289|NCT01000480|364204619|FG000|Induction Phase|Entry Criteria Not Met|3|||
105601290|NCT01000480|364204619|FG000|Concurrent Therapy Phase|Adverse Event|4|||
105601291|NCT01000480|364204619|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
105601292|NCT01000480|364204619|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
105601293|NCT01000480|364204619|FG000|Concurrent Therapy Phase|Physician Decision|1|||
105601294|NCT00174382|364204620|FG000|Overall Study|Death|2|||
105601295|NCT00174382|364204620|FG000|Overall Study|Adverse Event|19|||
105601296|NCT00174382|364204620|FG000|Overall Study|Withdrawal by Subject|6|||
105601297|NCT00174382|364204620|FG000|Overall Study|Protocol Violation|3|||
105601298|NCT00174382|364204620|FG000|Overall Study|Arrived early for last visit in error|1|||
105601299|NCT00174382|364204620|FG000|Overall Study|Subject felt pill not effective enough|1|||
105601300|NCT00174382|364204620|FG000|Overall Study|Lost to Follow-up|1|||
105601301|NCT03903822|364204625|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
105601302|NCT03903822|364204626|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
105601303|NCT03903822|364204627|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
105601304|NCT03903822|364204628|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
105601305|NCT03903822|364204629|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
105601306|NCT03903822|364204630|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
105601307|NCT03903822|364204631|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
105601308|NCT03903822|364204632|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
105601309|NCT03903822|364204625|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
105601310|NCT03903822|364204626|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
105601311|NCT03903822|364204627|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
105601312|NCT03903822|364204628|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
105601313|NCT03903822|364204629|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
105601314|NCT03903822|364204630|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
105601315|NCT03903822|364204631|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
105601316|NCT03903822|364204632|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
105601317|NCT03903822|364204625|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
105601318|NCT03903822|364204626|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
105601319|NCT03903822|364204627|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
105601320|NCT03903822|364204628|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
105601321|NCT03903822|364204629|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
105601322|NCT03903822|364204630|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
105601323|NCT03903822|364204631|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
105601324|NCT03903822|364204632|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
105601325|NCT03903822|364204625|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
105601326|NCT03903822|364204626|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
105601327|NCT03903822|364204627|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
105601328|NCT03903822|364204628|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
105601329|NCT03903822|364204629|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
105601330|NCT03903822|364204630|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
105601331|NCT03903822|364204631|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
105601332|NCT03903822|364204632|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
105601333|NCT03903822|364204625|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
105601334|NCT03903822|364204626|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
105601335|NCT03903822|364204627|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
105601336|NCT03903822|364204628|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
105601337|NCT03903822|364204629|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
105601338|NCT03903822|364204630|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
105601339|NCT03903822|364204631|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
105601340|NCT03903822|364204632|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
105601341|NCT03903822|364204625|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
105601342|NCT03903822|364204626|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
105601343|NCT03903822|364204627|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
105601344|NCT03903822|364204628|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
105601345|NCT03903822|364204629|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
105601346|NCT03903822|364204630|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
105601347|NCT03903822|364204631|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
105601348|NCT03903822|364204632|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
105601349|NCT03903822|364204625|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
105601350|NCT03903822|364204626|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
105601351|NCT03903822|364204627|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
105601352|NCT03903822|364204628|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
105601353|NCT03903822|364204629|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
105601354|NCT03903822|364204630|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
105601355|NCT03903822|364204631|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
105601356|NCT03903822|364204632|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
105601357|NCT03903822|364204625|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
105601358|NCT03903822|364204626|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
105601359|NCT03903822|364204627|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
105601360|NCT03903822|364204628|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
105601361|NCT03903822|364204629|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
105601362|NCT03903822|364204630|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
105601363|NCT03903822|364204631|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
105601364|NCT03903822|364204632|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
105601365|NCT03903822|364204625|FG000|Treatment Phase (6 Weeks)|Other|2|||
105601366|NCT03903822|364204626|FG001|Treatment Phase (6 Weeks)|Other|1|||
105601367|NCT03903822|364204627|FG002|Treatment Phase (6 Weeks)|Other|0|||
105601368|NCT03903822|364204628|FG003|Treatment Phase (6 Weeks)|Other|0|||
105601369|NCT03903822|364204629|FG004|Treatment Phase (6 Weeks)|Other|1|||
105601370|NCT03903822|364204630|FG005|Treatment Phase (6 Weeks)|Other|1|||
105601371|NCT03903822|364204631|FG006|Treatment Phase (6 Weeks)|Other|0|||
105601372|NCT03903822|364204632|FG007|Treatment Phase (6 Weeks)|Other|0|||
105601373|NCT03903822|364204625|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
105601374|NCT03903822|364204626|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
105601375|NCT03903822|364204627|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
105601376|NCT03903822|364204628|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
105601377|NCT03903822|364204629|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
105601378|NCT03903822|364204630|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
105601379|NCT03903822|364204631|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
105601380|NCT03903822|364204632|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
105601381|NCT03903822|364204625|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
105601382|NCT03903822|364204626|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
105601383|NCT03903822|364204627|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
105601384|NCT03903822|364204628|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
105601385|NCT03903822|364204629|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
105601386|NCT03903822|364204630|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
105601387|NCT03903822|364204631|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
105601388|NCT03903822|364204632|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
105601389|NCT03903822|364204625|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
105601390|NCT03903822|364204626|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
105601391|NCT03903822|364204627|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
105601392|NCT03903822|364204628|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
105601393|NCT03903822|364204629|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
105601394|NCT03903822|364204630|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
105601395|NCT03903822|364204631|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
105601396|NCT03903822|364204632|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
105601397|NCT03903822|364204625|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
105601398|NCT03903822|364204626|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
105601399|NCT03903822|364204627|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
105601400|NCT03903822|364204628|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
105601401|NCT03903822|364204629|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
105601402|NCT03903822|364204630|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
105601403|NCT03903822|364204631|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
105601404|NCT03903822|364204632|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
105601405|NCT03903822|364204625|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
105601406|NCT03903822|364204626|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
105601407|NCT03903822|364204627|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
105601408|NCT03903822|364204628|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
105601409|NCT03903822|364204629|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
105601410|NCT03903822|364204630|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
105601411|NCT03903822|364204631|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
105601412|NCT03903822|364204632|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
105601413|NCT03903822|364204625|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
105601414|NCT03903822|364204626|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
105601415|NCT03903822|364204627|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
105601416|NCT03903822|364204628|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
105601417|NCT03903822|364204629|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
105601418|NCT03903822|364204630|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
105601419|NCT03903822|364204631|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
105601420|NCT03903822|364204632|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
105601421|NCT03903822|364204625|FG000|Follow up Phase (4 Weeks)|Other|1|||
105601422|NCT03903822|364204626|FG001|Follow up Phase (4 Weeks)|Other|1|||
105601423|NCT03903822|364204627|FG002|Follow up Phase (4 Weeks)|Other|0|||
105601424|NCT03903822|364204628|FG003|Follow up Phase (4 Weeks)|Other|0|||
105601425|NCT03903822|364204629|FG004|Follow up Phase (4 Weeks)|Other|0|||
105601426|NCT03903822|364204630|FG005|Follow up Phase (4 Weeks)|Other|0|||
105601427|NCT03903822|364204631|FG006|Follow up Phase (4 Weeks)|Other|0|||
105601428|NCT03903822|364204632|FG007|Follow up Phase (4 Weeks)|Other|0|||
105601429|NCT02538107|364204641|FG000|Overall Study|Did not receive any Mircera dose|11|||
105601430|NCT02538107|364204641|FG000|Overall Study|Missing|5|||
105601431|NCT02538107|364204641|FG000|Overall Study|Necessity of dialysis|20|||
105601432|NCT02538107|364204641|FG000|Overall Study|Administration of other ESA|11|||
105601433|NCT02538107|364204641|FG000|Overall Study|No further treatment necessary|18|||
105601434|NCT02538107|364204641|FG000|Overall Study|Withdrawal by Subject|17|||
105601435|NCT02538107|364204641|FG000|Overall Study|Death|4|||
105601436|NCT02538107|364204641|FG000|Overall Study|Administrative reason|5|||
105601437|NCT02538107|364204641|FG000|Overall Study|Adverse Event|4|||
105601438|NCT02538107|364204641|FG000|Overall Study|Surgery|1|||
105601439|NCT02538107|364204641|FG000|Overall Study|Other|7|||
105601440|NCT02538107|364204641|FG000|Overall Study|Not recorded|7|||
105601441|NCT00785512|364204642|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
105601442|NCT00785512|364204643|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
105601443|NCT00785512|364204642|FG000|Overall Study|Adverse Event|0|||
105601444|NCT00785512|364204643|FG001|Overall Study|Adverse Event|0|||
105601445|NCT00785512|364204642|FG000|Overall Study|Lack of Efficacy|0|||
105601446|NCT00785512|364204643|FG001|Overall Study|Lack of Efficacy|2|||
105601447|NCT00785512|364204642|FG000|Overall Study|Withdrawal by Subject|0|||
105601448|NCT00785512|364204643|FG001|Overall Study|Withdrawal by Subject|1|||
105601449|NCT00785512|364204642|FG000|Overall Study|Lost to Follow-up|3|||
105601450|NCT00785512|364204643|FG001|Overall Study|Lost to Follow-up|0|||
105601451|NCT00785512|364204642|FG000|Overall Study|Precedure Refused|0|||
105601452|NCT00785512|364204643|FG001|Overall Study|Precedure Refused|0|||
105601453|NCT00785512|364204642|FG000|Overall Study|IVRS Programing Error|0|||
105601454|NCT00785512|364204643|FG001|Overall Study|IVRS Programing Error|0|||
105601455|NCT00785512|364204642|FG000|Overall Study|Physician Decision|0|||
105601456|NCT00785512|364204643|FG001|Overall Study|Physician Decision|0|||
105601457|NCT00785512|364204642|FG000|Overall Study|Lack of compliance|0|||
105601458|NCT00785512|364204643|FG001|Overall Study|Lack of compliance|1|||
105601459|NCT00546754|364204644|FG000|Overall Study|Serious Adverse Event|1|||
105601460|NCT00546754|364204645|FG001|Overall Study|Serious Adverse Event|1|||
105601461|NCT00546754|364204644|FG000|Overall Study|Adverse Event|11|||
105601462|NCT00546754|364204645|FG001|Overall Study|Adverse Event|16|||
105601463|NCT00546754|364204644|FG000|Overall Study|Lack of Efficacy|1|||
105601464|NCT00546754|364204645|FG001|Overall Study|Lack of Efficacy|1|||
105601465|NCT00546754|364204644|FG000|Overall Study|Lost to Follow-up|9|||
105601466|NCT00546754|364204645|FG001|Overall Study|Lost to Follow-up|15|||
105601467|NCT00546754|364204644|FG000|Overall Study|Protocol Violation|3|||
105601468|NCT00546754|364204645|FG001|Overall Study|Protocol Violation|0|||
105601469|NCT00546754|364204644|FG000|Overall Study|Withdrawal by Subject|6|||
105601470|NCT00546754|364204645|FG001|Overall Study|Withdrawal by Subject|7|||
105601471|NCT00546754|364204644|FG000|Overall Study|Dyspnea|1|||
105601472|NCT00546754|364204645|FG001|Overall Study|Dyspnea|0|||
105601473|NCT00546754|364204644|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
105601474|NCT00546754|364204645|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
105601475|NCT00546754|364204644|FG000|Overall Study|Hip Replacement|1|||
105601476|NCT00546754|364204645|FG001|Overall Study|Hip Replacement|0|||
105601477|NCT00546754|364204644|FG000|Overall Study|Suicide|1|||
105601478|NCT00546754|364204645|FG001|Overall Study|Suicide|0|||
105601479|NCT00546754|364204644|FG000|Overall Study|Missing Cooperation|1|||
105601480|NCT00546754|364204645|FG001|Overall Study|Missing Cooperation|0|||
105601481|NCT00546754|364204644|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
105601482|NCT00546754|364204645|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
105601483|NCT00546754|364204644|FG000|Overall Study|Patient's Decision|0|||
105601484|NCT00546754|364204645|FG001|Overall Study|Patient's Decision|1|||
105601485|NCT00546754|364204644|FG000|Overall Study|Missing|14|||
105601486|NCT00546754|364204645|FG001|Overall Study|Missing|7|||
105601487|NCT00529100|364204648|FG000|Overall Study|Adverse Event|0|||
105601488|NCT00529100|364204649|FG001|Overall Study|Adverse Event|5|||
105601489|NCT00529100|364204648|FG000|Overall Study|Protocol Violation|0|||
105601490|NCT00529100|364204649|FG001|Overall Study|Protocol Violation|1|||
105601491|NCT00529100|364204648|FG000|Overall Study|Progressive Disease|0|||
105601492|NCT00529100|364204649|FG001|Overall Study|Progressive Disease|1|||
105601493|NCT00529100|364204648|FG000|Overall Study|Withdrawal by Subject|0|||
105601494|NCT00529100|364204649|FG001|Overall Study|Withdrawal by Subject|1|||
105601495|NCT00529100|364204648|FG000|Overall Study|Participant Ineligibility|0|||
105601496|NCT00529100|364204649|FG001|Overall Study|Participant Ineligibility|1|||
105601497|NCT03733119|364204650|FG000|Overall Study|Physician Decision|2|||
105601498|NCT03733119|364204651|FG001|Overall Study|Physician Decision|1|||
105601499|NCT03733119|364204650|FG000|Overall Study|ineligible to treat per protocol|0|||
105601500|NCT03733119|364204651|FG001|Overall Study|ineligible to treat per protocol|1|||
105601501|NCT01943916|364204653|FG000|Overall Study|Technically invalid images|10|||
105601502|NCT01943916|364204653|FG000|Overall Study|Enrollment Failure|23|||
105601503|NCT01943916|364204653|FG000|Overall Study|Pilot Phase exclusion|100|||
105601504|NCT01943916|364204653|FG000|Overall Study|Quality Assurance Reader Fail|130|||
105601505|NCT01943916|364204653|FG000|Overall Study|Technical Failure|39|||
105601506|NCT01943916|364204653|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
105601507|NCT01943916|364204653|FG000|Overall Study|No Truth Panel Review|38|||
105601508|NCT01943916|364204653|FG000|Overall Study|Protocol Deviation|1|||
105601509|NCT00311363|364204655|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
105601510|NCT00311363|364204656|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
105601511|NCT00311363|364204657|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
105601512|NCT00311363|364204655|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
105601513|NCT00311363|364204656|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
105601514|NCT00311363|364204657|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
105601515|NCT00311363|364204655|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
105601516|NCT00311363|364204656|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
105601517|NCT00311363|364204657|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
105601518|NCT00311363|364204655|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
105601519|NCT00311363|364204656|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
105601520|NCT00311363|364204657|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
105601521|NCT00311363|364204655|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
105601522|NCT00311363|364204656|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
105601523|NCT00311363|364204657|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
105601524|NCT00311363|364204655|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
105601525|NCT00311363|364204656|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
105601526|NCT00311363|364204657|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
105601527|NCT00311363|364204655|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
105601528|NCT00311363|364204656|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
105601529|NCT00311363|364204657|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
105601530|NCT00311363|364204655|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
105601531|NCT00311363|364204656|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
105601532|NCT00311363|364204657|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
105601533|NCT00311363|364204655|FG000|24-Week Single-Blind Treatment Period|Death|1|||
105601534|NCT00311363|364204656|FG001|24-Week Single-Blind Treatment Period|Death|0|||
105601535|NCT00311363|364204657|FG002|24-Week Single-Blind Treatment Period|Death|0|||
105601536|NCT00311363|364204655|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
105601537|NCT00311363|364204656|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
105601538|NCT00311363|364204657|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
105601539|NCT00311363|364204655|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
105601540|NCT00311363|364204656|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
105601541|NCT00311363|364204657|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
105601542|NCT00311363|364204655|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
105601543|NCT00311363|364204656|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
105601544|NCT00311363|364204657|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
105601545|NCT00311363|364204655|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
105601546|NCT00311363|364204656|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
105601547|NCT00311363|364204657|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
105601548|NCT00311363|364204655|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
105601549|NCT00311363|364204656|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
105601550|NCT00311363|364204657|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
105601551|NCT00311363|364204655|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
105601552|NCT00311363|364204656|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
105601553|NCT00311363|364204657|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
105601554|NCT03830866|364204658|FG000|Overall Study|Death|90|||
105601555|NCT03830866|364204659|FG001|Overall Study|Death|111|||
105601556|NCT03830866|364204658|FG000|Overall Study|Lost to Follow-up|7|||
105601557|NCT03830866|364204659|FG001|Overall Study|Lost to Follow-up|7|||
105601558|NCT03830866|364204658|FG000|Overall Study|Withdrawal by Subject|19|||
105601559|NCT03830866|364204659|FG001|Overall Study|Withdrawal by Subject|16|||
105601560|NCT03830866|364204658|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
105601561|NCT03830866|364204659|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
105601562|NCT03830866|364204658|FG000|Overall Study|Other|1|||
105601563|NCT03830866|364204659|FG001|Overall Study|Other|1|||
105601564|NCT02708108|364204660|FG000|Overall Study|Death|1|||
105601565|NCT02708108|364204661|FG001|Overall Study|Death|2|||
105601566|NCT02708108|364204660|FG000|Overall Study|Regimen change|1|||
105601567|NCT02708108|364204661|FG001|Overall Study|Regimen change|0|||
105601568|NCT02708108|364204660|FG000|Overall Study|No MRD and no imaging available|0|||
105601569|NCT02708108|364204661|FG001|Overall Study|No MRD and no imaging available|1|||
105601570|NCT03764475|364204674|FG000|Overall Study|Adverse Event|11|||
105601571|NCT03764475|364204675|FG001|Overall Study|Adverse Event|2|||
105601572|NCT03764475|364204674|FG000|Overall Study|Lost to Follow-up|24|||
105601573|NCT03764475|364204675|FG001|Overall Study|Lost to Follow-up|10|||
105601574|NCT03764475|364204674|FG000|Overall Study|Withdrawal by Subject|26|||
105601575|NCT03764475|364204675|FG001|Overall Study|Withdrawal by Subject|10|||
105601576|NCT03764475|364204674|FG000|Overall Study|Lack of Efficacy|3|||
105601577|NCT03764475|364204675|FG001|Overall Study|Lack of Efficacy|0|||
105601578|NCT03764475|364204674|FG000|Overall Study|COVID-19 Disruption|2|||
105601579|NCT03764475|364204675|FG001|Overall Study|COVID-19 Disruption|0|||
105601580|NCT00970359|364204677|FG000|Overall Study|Not Treated|4|||
105601581|NCT01565148|364204678|FG000|Overall Study|Withdrawal by Subject|1|||
105601582|NCT01565148|364204679|FG001|Overall Study|Withdrawal by Subject|1|||
105601583|NCT01565148|364204680|FG002|Overall Study|Withdrawal by Subject|1|||
105601584|NCT01565148|364204681|FG003|Overall Study|Withdrawal by Subject|2|||
105601585|NCT01565148|364204678|FG000|Overall Study|Lost to Follow-up|4|||
105601586|NCT01565148|364204679|FG001|Overall Study|Lost to Follow-up|4|||
105601587|NCT01565148|364204680|FG002|Overall Study|Lost to Follow-up|0|||
105601588|NCT01565148|364204681|FG003|Overall Study|Lost to Follow-up|3|||
105601589|NCT01565148|364204678|FG000|Overall Study|Rescue Therapy|8|||
105601590|NCT01565148|364204679|FG001|Overall Study|Rescue Therapy|5|||
105601591|NCT01565148|364204680|FG002|Overall Study|Rescue Therapy|5|||
105601592|NCT01565148|364204681|FG003|Overall Study|Rescue Therapy|8|||
105601593|NCT01565148|364204678|FG000|Overall Study|Death|0|||
105601594|NCT01565148|364204679|FG001|Overall Study|Death|0|||
105601595|NCT01565148|364204680|FG002|Overall Study|Death|1|||
105601596|NCT01565148|364204681|FG003|Overall Study|Death|0|||
105601597|NCT01565148|364204678|FG000|Overall Study|Physician Decision|2|||
105601598|NCT01565148|364204679|FG001|Overall Study|Physician Decision|5|||
105601599|NCT01565148|364204680|FG002|Overall Study|Physician Decision|0|||
105601600|NCT01565148|364204681|FG003|Overall Study|Physician Decision|0|||
105601601|NCT00068601|364204683|FG000|Overall Study|Ineligible|11|||
105601602|NCT00068601|364204684|FG001|Overall Study|Ineligible|13|||
105601603|NCT00068601|364204683|FG000|Overall Study|Not evaluable: withdrew consent|5|||
105601604|NCT00068601|364204684|FG001|Overall Study|Not evaluable: withdrew consent|4|||
105601605|NCT00068601|364204683|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
105601606|NCT00068601|364204684|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
105601607|NCT00068601|364204683|FG000|Overall Study|Death|11|||
105601608|NCT00068601|364204684|FG001|Overall Study|Death|3|||
105601609|NCT00068601|364204683|FG000|Overall Study|Lost to Follow-up|3|||
105601610|NCT00068601|364204684|FG001|Overall Study|Lost to Follow-up|2|||
105601611|NCT00068601|364204683|FG000|Overall Study|Missing primary outcome data|30|||
105601612|NCT00068601|364204684|FG001|Overall Study|Missing primary outcome data|34|||
105601613|NCT00088413|364204685|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
105601614|NCT00088413|364204686|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
105601615|NCT00088413|364204687|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
105601616|NCT00088413|364204688|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
105601617|NCT00088413|364204685|FG000|Overall Study|Adverse Events/Side Effects|0|||
105601618|NCT00088413|364204686|FG001|Overall Study|Adverse Events/Side Effects|1|||
105601619|NCT00088413|364204687|FG002|Overall Study|Adverse Events/Side Effects|1|||
105601620|NCT00088413|364204688|FG003|Overall Study|Adverse Events/Side Effects|0|||
105601621|NCT00088413|364204685|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
105601622|NCT00088413|364204686|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
105601623|NCT00088413|364204687|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
105601624|NCT00088413|364204688|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
105601625|NCT00088413|364204685|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
105601626|NCT00088413|364204686|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
105601627|NCT00088413|364204687|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
105601628|NCT00088413|364204688|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
105601629|NCT00088413|364204685|FG000|Overall Study|Death|0|||
105601630|NCT00088413|364204686|FG001|Overall Study|Death|1|||
105601631|NCT00088413|364204687|FG002|Overall Study|Death|0|||
105601632|NCT00088413|364204688|FG003|Overall Study|Death|0|||
105601633|NCT00088413|364204685|FG000|Overall Study|Progressive disease|9|||
105601634|NCT00088413|364204686|FG001|Overall Study|Progressive disease|11|||
105601635|NCT00088413|364204687|FG002|Overall Study|Progressive disease|8|||
105601636|NCT00088413|364204688|FG003|Overall Study|Progressive disease|14|||
105601637|NCT00088413|364204685|FG000|Overall Study|Other|0|||
105601638|NCT00088413|364204686|FG001|Overall Study|Other|1|||
105601639|NCT00088413|364204687|FG002|Overall Study|Other|0|||
105601640|NCT00088413|364204688|FG003|Overall Study|Other|0|||
105601641|NCT00088413|364204685|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
105601642|NCT00088413|364204686|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
105601643|NCT00088413|364204687|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
105601644|NCT00088413|364204688|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
105601645|NCT03394885|364204698|FG000|Overall Study|Adverse Event|4|||
105601646|NCT03394885|364204698|FG000|Overall Study|Lack of Efficacy|1|||
105601647|NCT03394885|364204698|FG000|Overall Study|Physician Decision|1|||
105601648|NCT03394885|364204698|FG000|Overall Study|Withdrawal by Subject|8|||
105601649|NCT03394885|364204698|FG000|Overall Study|Alternative Therapy|1|||
105601650|NCT00632424|364204699|FG000|Overall Study|Disease Progression|17|||
105601651|NCT00632424|364204699|FG000|Overall Study|Study Drug Toxicity|1|||
105601652|NCT03482635|364204700|FG000|Overall Study|Lack of Efficacy|0|||
105601653|NCT03482635|364204701|FG001|Overall Study|Lack of Efficacy|0|||
105601654|NCT03482635|364204702|FG002|Overall Study|Lack of Efficacy|1|||
105601655|NCT03482635|364204703|FG003|Overall Study|Lack of Efficacy|3|||
105601656|NCT03482635|364204700|FG000|Overall Study|Adverse Event|2|||
105601657|NCT03482635|364204701|FG001|Overall Study|Adverse Event|2|||
105601658|NCT03482635|364204702|FG002|Overall Study|Adverse Event|0|||
105601659|NCT03482635|364204703|FG003|Overall Study|Adverse Event|3|||
105601660|NCT03482635|364204700|FG000|Overall Study|Withdrawal by Subject|2|||
105601661|NCT03482635|364204701|FG001|Overall Study|Withdrawal by Subject|1|||
105601662|NCT03482635|364204702|FG002|Overall Study|Withdrawal by Subject|0|||
105601663|NCT03482635|364204703|FG003|Overall Study|Withdrawal by Subject|1|||
105601664|NCT03482635|364204700|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
105601665|NCT03482635|364204701|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
105601666|NCT03482635|364204702|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
105601667|NCT03482635|364204703|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
105601668|NCT03482635|364204700|FG000|Overall Study|Not treated|0|||
105601669|NCT03482635|364204701|FG001|Overall Study|Not treated|0|||
105601670|NCT03482635|364204702|FG002|Overall Study|Not treated|0|||
105601671|NCT03482635|364204703|FG003|Overall Study|Not treated|1|||
105601672|NCT01170026|364206029|FG000|Overall Study|Lost to Follow-up|4|||
105601673|NCT01170026|364206030|FG001|Overall Study|Lost to Follow-up|2|||
105601674|NCT03783026|364206031|FG000|Treatment Phase|Adverse Event|15|||
105601675|NCT03783026|364206031|FG000|Treatment Phase|Lack of Efficacy|11|||
105601676|NCT03783026|364206031|FG000|Treatment Phase|Withdrawal by Subject|6|||
105601677|NCT03783026|364206031|FG000|Treatment Phase|Lost to Follow-up|2|||
105601678|NCT03783026|364206031|FG000|Treatment Phase|Protocol Deviation|8|||
105601679|NCT03783026|364206031|FG000|Treatment Phase|Did Not Receive Treatment|1|||
105601680|NCT03783026|364206031|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
105601681|NCT04623008|364206032|FG000|Baseline to T2|Withdrawal by Subject|4|||
105601682|NCT04623008|364206033|FG001|Baseline to T2|Withdrawal by Subject|2|||
105601683|NCT04623008|364206032|FG000|Baseline to T3|Withdrawal by Subject|4|||
105601684|NCT04623008|364206033|FG001|Baseline to T3|Withdrawal by Subject|2|||
105601685|NCT03422276|364206034|FG000|Overall Study|Withdrawal by Subject|21|||
105601686|NCT03422276|364206035|FG001|Overall Study|Withdrawal by Subject|25|||
105601687|NCT03422276|364206036|FG002|Overall Study|Withdrawal by Subject|14|||
105601688|NCT03422276|364206037|FG003|Overall Study|Withdrawal by Subject|16|||
105601689|NCT03422276|364206034|FG000|Overall Study|Death|14|||
105601690|NCT03422276|364206035|FG001|Overall Study|Death|21|||
105601691|NCT03422276|364206036|FG002|Overall Study|Death|3|||
105601692|NCT03422276|364206037|FG003|Overall Study|Death|1|||
105601693|NCT03422276|364206034|FG000|Overall Study|Discontinued, ineligible|4|||
105601694|NCT03422276|364206035|FG001|Overall Study|Discontinued, ineligible|3|||
105601695|NCT03422276|364206036|FG002|Overall Study|Discontinued, ineligible|0|||
105601696|NCT03422276|364206037|FG003|Overall Study|Discontinued, ineligible|0|||
105601697|NCT03422276|364206034|FG000|Overall Study|Lost to Follow-up|15|||
105601698|NCT03422276|364206035|FG001|Overall Study|Lost to Follow-up|8|||
105601699|NCT03422276|364206036|FG002|Overall Study|Lost to Follow-up|13|||
105601700|NCT03422276|364206037|FG003|Overall Study|Lost to Follow-up|4|||
105601701|NCT03422276|364206034|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
105601702|NCT03422276|364206035|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
105601703|NCT03422276|364206036|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
105601704|NCT03422276|364206037|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
105601705|NCT03422276|364206034|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
105601706|NCT03422276|364206035|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
105601707|NCT03422276|364206036|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
105601708|NCT03422276|364206037|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
105601709|NCT03422276|364206034|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
105601710|NCT03422276|364206035|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
105601711|NCT03422276|364206036|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
105601712|NCT03422276|364206037|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
105601713|NCT03422276|364206034|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
105601714|NCT03422276|364206035|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
105601715|NCT03422276|364206036|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
105601716|NCT03422276|364206037|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
105601717|NCT03422276|364206034|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
105601718|NCT03422276|364206035|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
105601719|NCT03422276|364206036|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
105601720|NCT03422276|364206037|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
105601721|NCT00304031|364206041|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
105601722|NCT00304031|364206042|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
105601723|NCT00304031|364206043|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
105601724|NCT00304031|364206041|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
105601725|NCT00304031|364206042|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
105601726|NCT00304031|364206043|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
105601727|NCT00304031|364206041|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
105601728|NCT00304031|364206042|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
105601729|NCT00304031|364206043|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
105601730|NCT00304031|364206041|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
105601731|NCT00304031|364206042|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
105601732|NCT00304031|364206043|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
105601733|NCT00304031|364206041|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
105601734|NCT00304031|364206042|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
105601735|NCT00304031|364206043|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
105601736|NCT00304031|364206041|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
105601737|NCT00304031|364206042|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
105601738|NCT00304031|364206043|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
105601739|NCT00304031|364206041|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
105601740|NCT00304031|364206042|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
105601741|NCT00304031|364206043|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
105601742|NCT00304031|364206041|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
105601743|NCT00304031|364206042|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
105601744|NCT00304031|364206043|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
105601745|NCT00304031|364206041|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
105601746|NCT00304031|364206042|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
105601747|NCT00304031|364206043|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
105601748|NCT02407249|364206053|FG000|Overall Study|Did not complete 12-month follow-up|13|||
105601749|NCT02407249|364206053|FG000|Overall Study|Not treated|13|||
105601750|NCT01391832|364206054|FG000|Overall Study|Withdrawal by Subject|21|||
105601751|NCT01391832|364206055|FG001|Overall Study|Withdrawal by Subject|22|||
105601752|NCT01391832|364206054|FG000|Overall Study|Lost to Follow-up|0|||
105601753|NCT01391832|364206055|FG001|Overall Study|Lost to Follow-up|1|||
105601754|NCT03345901|364206056|FG000|Overall Study|The study was terminated|18|||
105601755|NCT04252586|364206062|FG000|Overall Study|Withdrawal by parent/guardian|3|||
105601756|NCT04252586|364206062|FG000|Overall Study|Adverse Event|1|||
105601757|NCT04252586|364206062|FG000|Overall Study|Death|2|||
105601758|NCT04252586|364206062|FG000|Overall Study|Study terminated by sponsor|4|||
105601759|NCT04252586|364206062|FG000|Overall Study|Sponsor request|10|||
105601760|NCT04252586|364206062|FG000|Overall Study|Did not complete treatment period|1|||
105601761|NCT03050814|364206063|FG000|Overall Study|Screen failures|0|||
105601762|NCT03050814|364206064|FG001|Overall Study|Screen failures|0|||
105601763|NCT03050814|364206065|FG002|Overall Study|Screen failures|4|||
105601764|NCT01443845|364206066|FG000|Overall Study|Protocol Violation|43|||
105601765|NCT01443845|364206067|FG001|Overall Study|Protocol Violation|45|||
105601766|NCT01443845|364206066|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
105601767|NCT01443845|364206067|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
105601768|NCT01443845|364206066|FG000|Overall Study|Deterioration in pulmonary function|1|||
105601769|NCT01443845|364206067|FG001|Overall Study|Deterioration in pulmonary function|4|||
105601770|NCT01443845|364206066|FG000|Overall Study|Lack of Efficacy|10|||
105601771|NCT01443845|364206067|FG001|Overall Study|Lack of Efficacy|5|||
105601772|NCT01443845|364206066|FG000|Overall Study|Adverse Event|64|||
105601773|NCT01443845|364206067|FG001|Overall Study|Adverse Event|138|||
105601774|NCT01443845|364206066|FG000|Overall Study|Withdrawal by Subject|63|||
105601775|NCT01443845|364206067|FG001|Overall Study|Withdrawal by Subject|67|||
105601776|NCT01443845|364206066|FG000|Overall Study|Military Conflict - Site Terminated|20|||
105601777|NCT01443845|364206067|FG001|Overall Study|Military Conflict - Site Terminated|21|||
105601778|NCT01443845|364206066|FG000|Overall Study|Lost to Follow-up|9|||
105601779|NCT01443845|364206067|FG001|Overall Study|Lost to Follow-up|13|||
105601780|NCT00332241|364206068|FG000|Overall Study|Lack of Efficacy|6|||
105601781|NCT00332241|364206069|FG001|Overall Study|Lack of Efficacy|1|||
105601782|NCT00332241|364206068|FG000|Overall Study|Adverse Event|3|||
105601783|NCT00332241|364206069|FG001|Overall Study|Adverse Event|5|||
105601784|NCT00332241|364206068|FG000|Overall Study|Withdrawal by Subject|2|||
105601785|NCT00332241|364206069|FG001|Overall Study|Withdrawal by Subject|1|||
105601786|NCT00332241|364206068|FG000|Overall Study|Lost to Follow-up|4|||
105601787|NCT00332241|364206069|FG001|Overall Study|Lost to Follow-up|1|||
105601788|NCT00802464|364206070|FG000|Month 0 - Month 8|Adverse Event|0|||
105601789|NCT00802464|364206071|FG001|Month 0 - Month 8|Adverse Event|1|||
105601790|NCT00802464|364206072|FG002|Month 0 - Month 8|Adverse Event|1|||
105601791|NCT00802464|364206073|FG003|Month 0 - Month 8|Adverse Event|2|||
105601792|NCT00802464|364206070|FG000|Month 0 - Month 8|Protocol Violation|0|||
105601793|NCT00802464|364206071|FG001|Month 0 - Month 8|Protocol Violation|0|||
105601794|NCT00802464|364206072|FG002|Month 0 - Month 8|Protocol Violation|1|||
105601795|NCT00802464|364206073|FG003|Month 0 - Month 8|Protocol Violation|0|||
105601796|NCT00802464|364206070|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
105601797|NCT00802464|364206071|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
105601798|NCT00802464|364206072|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
105601799|NCT00802464|364206073|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
105601800|NCT00802464|364206070|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
105601801|NCT00802464|364206071|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
105601802|NCT00802464|364206072|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
105601803|NCT00802464|364206073|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
105601804|NCT00802464|364206070|FG000|Month 0 - Month 8|Other|0|||
105601805|NCT00802464|364206071|FG001|Month 0 - Month 8|Other|0|||
105601806|NCT00802464|364206072|FG002|Month 0 - Month 8|Other|1|||
105601807|NCT00802464|364206073|FG003|Month 0 - Month 8|Other|0|||
105601808|NCT00802464|364206070|FG000|Month 8 - Month 14|Adverse Event|0|||
105601809|NCT00802464|364206071|FG001|Month 8 - Month 14|Adverse Event|1|||
105601810|NCT00802464|364206072|FG002|Month 8 - Month 14|Adverse Event|0|||
105601811|NCT00802464|364206073|FG003|Month 8 - Month 14|Adverse Event|0|||
105601812|NCT00802464|364206070|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
105601813|NCT00802464|364206071|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
105601814|NCT00802464|364206072|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
105601815|NCT00802464|364206073|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
105601816|NCT00802464|364206070|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
105601817|NCT00802464|364206071|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
105601818|NCT00802464|364206072|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
105601819|NCT00802464|364206073|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
105601820|NCT02584829|364206074|FG000|Overall Study|Physician Decision|1|||
105601821|NCT02584829|364206075|FG001|Overall Study|Physician Decision|0|||
105601822|NCT02584829|364206074|FG000|Overall Study|Withdrawal by Subject|0|||
105601823|NCT02584829|364206075|FG001|Overall Study|Withdrawal by Subject|1|||
105601824|NCT02584829|364206074|FG000|Overall Study|Progressive Disease|0|||
105601825|NCT02584829|364206075|FG001|Overall Study|Progressive Disease|3|||
105601826|NCT02622568|364206084|FG000|Overall Study|Lost to Follow-up|5|||
105601827|NCT02622568|364206085|FG001|Overall Study|Lost to Follow-up|5|||
105601828|NCT04723394|364206086|FG000|Overall Study|Adverse Event|0|||
105601829|NCT04723394|364206087|FG001|Overall Study|Adverse Event|3|||
105601830|NCT04723394|364206086|FG000|Overall Study|Death|8|||
105601831|NCT04723394|364206087|FG001|Overall Study|Death|8|||
105601832|NCT04723394|364206086|FG000|Overall Study|Lost to Follow-up|20|||
105601833|NCT04723394|364206087|FG001|Overall Study|Lost to Follow-up|17|||
105601834|NCT04723394|364206086|FG000|Overall Study|Physician Decision|1|||
105601835|NCT04723394|364206087|FG001|Overall Study|Physician Decision|0|||
105601836|NCT04723394|364206086|FG000|Overall Study|Withdrawal by Subject|20|||
105601837|NCT04723394|364206087|FG001|Overall Study|Withdrawal by Subject|34|||
105601838|NCT04723394|364206086|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
105601839|NCT04723394|364206087|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
105601840|NCT00858117|364206089|FG000|Treatment on Study|Adverse Event|2|||
105601841|NCT00858117|364206089|FG000|Follow up for 5 Years|Death|4|||
105601842|NCT00858117|364206089|FG000|Follow up for 5 Years|No further data collected for study|9|||
105601843|NCT00371787|364206090|FG000|Overall Study|Withdrawal by Subject|3|||
105601844|NCT00371787|364206091|FG001|Overall Study|Withdrawal by Subject|1|||
105601845|NCT00077675|364206092|FG000|Overall Study|Adverse Event|1|||
105601846|NCT00077675|364206093|FG001|Overall Study|Adverse Event|2|||
105601847|NCT00077675|364206092|FG000|Overall Study|Lost to Follow-up|6|||
105601848|NCT00077675|364206093|FG001|Overall Study|Lost to Follow-up|3|||
105601849|NCT00077675|364206092|FG000|Overall Study|Withdrawal by Subject|1|||
105601850|NCT00077675|364206093|FG001|Overall Study|Withdrawal by Subject|0|||
105601851|NCT00077675|364206092|FG000|Overall Study|Other|0|||
105601852|NCT00077675|364206093|FG001|Overall Study|Other|1|||
105601853|NCT00077675|364206092|FG000|Overall Study|Never received study treatment|3|||
105601854|NCT00077675|364206093|FG001|Overall Study|Never received study treatment|3|||
105601855|NCT04425863|364206094|FG000|Overall Study|Death|0|||
105601856|NCT04425863|364206095|FG001|Overall Study|Death|0|||
105601857|NCT04425863|364206096|FG002|Overall Study|Death|1|||
105601858|NCT01854385|364206098|FG000|Pre-Treatment|Withdrawal by Subject|4|||
105601859|NCT01854385|364206098|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
105601860|NCT01854385|364206098|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
105601861|NCT01854385|364206098|FG000|Pre-Treatment|Unable to come for study visits|1|||
105601862|NCT01854385|364206098|FG000|Treatment|Lost to Follow-up|1|||
105601863|NCT00277355|364206103|FG000|Overall Study|Withdrawal by Subject|3|||
105601864|NCT00277355|364206104|FG001|Overall Study|Withdrawal by Subject|3|||
105601865|NCT00277355|364206103|FG000|Overall Study|Lost to Follow-up|2|||
105601866|NCT00277355|364206104|FG001|Overall Study|Lost to Follow-up|2|||
105601867|NCT00277355|364206103|FG000|Overall Study|Adverse Event|5|||
105601868|NCT00277355|364206104|FG001|Overall Study|Adverse Event|0|||
105601869|NCT00277355|364206103|FG000|Overall Study|Death|3|||
105601870|NCT00277355|364206104|FG001|Overall Study|Death|0|||
105601871|NCT00277355|364206103|FG000|Overall Study|Physician Decision|1|||
105601872|NCT00277355|364206104|FG001|Overall Study|Physician Decision|0|||
105601873|NCT02765100|364206105|FG000|Overall Study|subject found ineligible after baseline|1|||
105601874|NCT02765100|364206106|FG001|Overall Study|subject found ineligible after baseline|1|||
105601875|NCT02765100|364206105|FG000|Overall Study|Lost to Follow-up|0|||
105601876|NCT02765100|364206106|FG001|Overall Study|Lost to Follow-up|1|||
105601877|NCT02597920|364206112|FG000|Overall Study|Worsening of other pre-existing disease|0|||
105601878|NCT02597920|364206113|FG001|Overall Study|Worsening of other pre-existing disease|1|||
105601879|NCT02597920|364206114|FG002|Overall Study|Worsening of other pre-existing disease|0|||
105601880|NCT02597920|364206112|FG000|Overall Study|Other adverse event|20|||
105601881|NCT02597920|364206113|FG001|Overall Study|Other adverse event|30|||
105601882|NCT02597920|364206114|FG002|Overall Study|Other adverse event|0|||
105601883|NCT02597920|364206112|FG000|Overall Study|Lost to Follow-up|7|||
105601884|NCT02597920|364206113|FG001|Overall Study|Lost to Follow-up|9|||
105601885|NCT02597920|364206114|FG002|Overall Study|Lost to Follow-up|0|||
105601886|NCT02597920|364206112|FG000|Overall Study|Refuse to continue in the study|3|||
105601887|NCT02597920|364206113|FG001|Overall Study|Refuse to continue in the study|13|||
105601888|NCT02597920|364206114|FG002|Overall Study|Refuse to continue in the study|1|||
105601889|NCT02597920|364206112|FG000|Overall Study|Other than specified|10|||
105601890|NCT02597920|364206113|FG001|Overall Study|Other than specified|31|||
105601891|NCT02597920|364206114|FG002|Overall Study|Other than specified|5|||
105601892|NCT02597920|364206112|FG000|Overall Study|Other|1|||
105601893|NCT02597920|364206113|FG001|Overall Study|Other|0|||
105601894|NCT02597920|364206114|FG002|Overall Study|Other|0|||
105601895|NCT00642850|364206115|FG000|Overall Study|Death|7|||
105601896|NCT00642850|364206115|FG000|Overall Study|Adverse Event|2|||
105601897|NCT00642850|364206115|FG000|Overall Study|Lack of Efficacy|1|||
105601898|NCT00642850|364206115|FG000|Overall Study|Protocol Violation|2|||
105601899|NCT00642850|364206115|FG000|Overall Study|Kidney transplantation|8|||
105601900|NCT00642850|364206115|FG000|Overall Study|Blood transfusion|6|||
105601901|NCT00642850|364206115|FG000|Overall Study|Other reasons|7|||
105601902|NCT04530747|364206122|FG000|Overall Study|Withdrawal by Subject|1|||
105601903|NCT04530747|364206123|FG001|Overall Study|Withdrawal by Subject|0|||
105601904|NCT00529516|364206124|FG000|Overall Study|Adverse Event|2|||
105601905|NCT00529516|364206125|FG001|Overall Study|Adverse Event|1|||
105601906|NCT00529516|364206126|FG002|Overall Study|Adverse Event|0|||
105601907|NCT00529516|364206124|FG000|Overall Study|Withdrawal by Subject|1|||
105601908|NCT00529516|364206125|FG001|Overall Study|Withdrawal by Subject|1|||
105601909|NCT00529516|364206126|FG002|Overall Study|Withdrawal by Subject|0|||
105601910|NCT00529516|364206124|FG000|Overall Study|Lost to Follow-up|0|||
105601911|NCT00529516|364206125|FG001|Overall Study|Lost to Follow-up|0|||
105601912|NCT00529516|364206126|FG002|Overall Study|Lost to Follow-up|1|||
105601913|NCT00807937|364206131|FG000|Overall Study|Adverse Event|12|||
105601914|NCT00807937|364206132|FG001|Overall Study|Adverse Event|12|||
105601915|NCT00807937|364206133|FG002|Overall Study|Adverse Event|5|||
105601916|NCT00807937|364206134|FG003|Overall Study|Adverse Event|4|||
105601917|NCT00807937|364206131|FG000|Overall Study|Protocol Violation|4|||
105601918|NCT00807937|364206132|FG001|Overall Study|Protocol Violation|5|||
105601919|NCT00807937|364206133|FG002|Overall Study|Protocol Violation|3|||
105601920|NCT00807937|364206134|FG003|Overall Study|Protocol Violation|3|||
105601921|NCT00807937|364206131|FG000|Overall Study|Withdrawal by Subject|5|||
105601922|NCT00807937|364206132|FG001|Overall Study|Withdrawal by Subject|4|||
105601923|NCT00807937|364206133|FG002|Overall Study|Withdrawal by Subject|1|||
105601924|NCT00807937|364206134|FG003|Overall Study|Withdrawal by Subject|4|||
105601925|NCT00807937|364206131|FG000|Overall Study|Lost to Follow-up|4|||
105601926|NCT00807937|364206132|FG001|Overall Study|Lost to Follow-up|0|||
105601927|NCT00807937|364206133|FG002|Overall Study|Lost to Follow-up|2|||
105601928|NCT00807937|364206134|FG003|Overall Study|Lost to Follow-up|1|||
105601929|NCT00807937|364206131|FG000|Overall Study|Lack of Efficacy|0|||
105601930|NCT00807937|364206132|FG001|Overall Study|Lack of Efficacy|0|||
105601931|NCT00807937|364206133|FG002|Overall Study|Lack of Efficacy|1|||
105601932|NCT00807937|364206134|FG003|Overall Study|Lack of Efficacy|2|||
105601933|NCT00807937|364206131|FG000|Overall Study|Intake of prohibited medicine|0|||
105601934|NCT00807937|364206132|FG001|Overall Study|Intake of prohibited medicine|0|||
105601935|NCT00807937|364206133|FG002|Overall Study|Intake of prohibited medicine|2|||
105601936|NCT00807937|364206134|FG003|Overall Study|Intake of prohibited medicine|0|||
105601937|NCT00807937|364206131|FG000|Overall Study|All other reasons (not provided)|2|||
105601938|NCT00807937|364206132|FG001|Overall Study|All other reasons (not provided)|4|||
105601939|NCT00807937|364206133|FG002|Overall Study|All other reasons (not provided)|0|||
105601940|NCT00807937|364206134|FG003|Overall Study|All other reasons (not provided)|1|||
105601941|NCT01697969|364206139|FG000|Overall Study|Did not meet inc/exc criteria|3|||
105601942|NCT01561989|364206140|FG000|Overall Study|accural target not met.|5|||
105601943|NCT01561989|364206141|FG001|Overall Study|accural target not met.|6|||
105601944|NCT01061671|364206143|FG000|Overall Study|Withdrawal by Subject|16|||
105601945|NCT01061671|364206144|FG001|Overall Study|Withdrawal by Subject|20|||
105601946|NCT01061671|364206143|FG000|Overall Study|Lost to Follow-up|3|||
105601947|NCT01061671|364206144|FG001|Overall Study|Lost to Follow-up|5|||
105601948|NCT01061671|364206143|FG000|Overall Study|Death|28|||
105601949|NCT01061671|364206144|FG001|Overall Study|Death|30|||
105601950|NCT03565315|364206151|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
105601951|NCT03565315|364206152|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
105601952|NCT03565315|364206153|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
105601953|NCT03565315|364206154|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
105601954|NCT01771731|364206155|FG000|Overall Study|Physician Decision|1|||
105601955|NCT01771731|364206156|FG001|Overall Study|Physician Decision|0|||
105601956|NCT01771731|364206155|FG000|Overall Study|Protocol Violation|0|||
105601957|NCT01771731|364206156|FG001|Overall Study|Protocol Violation|1|||
105601958|NCT01771731|364206155|FG000|Overall Study|Adverse event: Pain Crisis|1|||
105601959|NCT01771731|364206156|FG001|Overall Study|Adverse event: Pain Crisis|1|||
105601960|NCT01199575|364206157|FG000|Overall Study|Withdrawal by Subject|5|||
105601961|NCT04732338|364206163|FG000|Overall Study|Lost to Follow-up|3|||
105601962|NCT04732338|364206164|FG001|Overall Study|Lost to Follow-up|3|||
105601963|NCT03101371|364206167|FG000|Overall Study|Physician Decision|0|||
105601964|NCT03101371|364206168|FG001|Overall Study|Physician Decision|1|||
105601965|NCT03101371|364206167|FG000|Overall Study|Lost to Follow-up|1|||
105601966|NCT03101371|364206168|FG001|Overall Study|Lost to Follow-up|4|||
105601967|NCT03101371|364206167|FG000|Overall Study|Did not meet eligibility criteria|2|||
105601968|NCT03101371|364206168|FG001|Overall Study|Did not meet eligibility criteria|1|||
105601969|NCT02769858|364206175|FG000|Overall Study|Withdrawal by Subject|2|||
105601970|NCT05777785|364207454|FG000|Overall Study|Withdrawal by Subject|5|||
105601971|NCT05777785|364207454|FG000|Overall Study|Lost to Follow-up|1|||
105601972|NCT01823536|364207456|FG000|Overall Study|Lost to Follow-up|1|||
105601973|NCT01823536|364207457|FG001|Overall Study|Lost to Follow-up|0|||
105601974|NCT01823536|364207458|FG002|Overall Study|Lost to Follow-up|0|||
105601975|NCT01823536|364207459|FG003|Overall Study|Lost to Follow-up|1|||
105601976|NCT01823536|364207460|FG004|Overall Study|Lost to Follow-up|1|||
105601977|NCT01823536|364207461|FG005|Overall Study|Lost to Follow-up|0|||
105601978|NCT01823536|364207456|FG000|Overall Study|Protocol Violation|0|||
105601979|NCT01823536|364207457|FG001|Overall Study|Protocol Violation|1|||
105601980|NCT01823536|364207458|FG002|Overall Study|Protocol Violation|0|||
105601981|NCT01823536|364207459|FG003|Overall Study|Protocol Violation|0|||
105601982|NCT01823536|364207460|FG004|Overall Study|Protocol Violation|0|||
105601983|NCT01823536|364207461|FG005|Overall Study|Protocol Violation|0|||
105601984|NCT01823536|364207456|FG000|Overall Study|Withdrawal by Subject|1|||
105601985|NCT01823536|364207457|FG001|Overall Study|Withdrawal by Subject|1|||
105601986|NCT01823536|364207458|FG002|Overall Study|Withdrawal by Subject|0|||
105601987|NCT01823536|364207459|FG003|Overall Study|Withdrawal by Subject|0|||
105601988|NCT01823536|364207460|FG004|Overall Study|Withdrawal by Subject|0|||
105601989|NCT01823536|364207461|FG005|Overall Study|Withdrawal by Subject|0|||
105601990|NCT01823536|364207456|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
105601991|NCT01823536|364207457|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
105601992|NCT01823536|364207458|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
105601993|NCT01823536|364207459|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
105601994|NCT01823536|364207460|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
105601995|NCT01823536|364207461|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
105601996|NCT01823536|364207456|FG000|Overall Study|Met exclusion criterion No 6|0|||
105601997|NCT01823536|364207457|FG001|Overall Study|Met exclusion criterion No 6|0|||
105601998|NCT01823536|364207458|FG002|Overall Study|Met exclusion criterion No 6|0|||
105601999|NCT01823536|364207459|FG003|Overall Study|Met exclusion criterion No 6|1|||
105602000|NCT01823536|364207460|FG004|Overall Study|Met exclusion criterion No 6|0|||
105602001|NCT01823536|364207461|FG005|Overall Study|Met exclusion criterion No 6|0|||
105602002|NCT01823536|364207456|FG000|Overall Study|Subject moved out of the state|0|||
105602003|NCT01823536|364207457|FG001|Overall Study|Subject moved out of the state|0|||
105602004|NCT01823536|364207458|FG002|Overall Study|Subject moved out of the state|0|||
105602005|NCT01823536|364207459|FG003|Overall Study|Subject moved out of the state|0|||
105602006|NCT01823536|364207460|FG004|Overall Study|Subject moved out of the state|1|||
105602007|NCT01823536|364207461|FG005|Overall Study|Subject moved out of the state|0|||
105602008|NCT01622868|364207466|FG000|Overall Study|Protocol Violation|7|||
105602009|NCT01622868|364207467|FG001|Overall Study|Protocol Violation|0|||
105602010|NCT03990649|364207468|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
105602011|NCT03990649|364207469|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
105602012|NCT03990649|364207470|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
105602013|NCT03990649|364207468|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
105602014|NCT03990649|364207469|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
105602015|NCT03990649|364207470|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
105602016|NCT03990649|364207468|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
105602017|NCT03990649|364207469|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
105602018|NCT03990649|364207470|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
105602019|NCT03990649|364207468|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
105602020|NCT03990649|364207469|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
105602021|NCT03990649|364207470|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
105602022|NCT03990649|364207468|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
105602023|NCT03990649|364207469|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
105602024|NCT03990649|364207470|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
105602025|NCT03990649|364207468|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
105602026|NCT03990649|364207469|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
105602027|NCT03990649|364207470|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
105602028|NCT03990649|364207468|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
105602029|NCT03990649|364207469|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
105602030|NCT03990649|364207470|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
105602031|NCT00610649|364207471|FG000|Overall Study|Adverse Event|1|||
105602032|NCT00610649|364207472|FG001|Overall Study|Adverse Event|0|||
105602033|NCT00610649|364207473|FG002|Overall Study|Adverse Event|0|||
105602034|NCT00610649|364207474|FG003|Overall Study|Adverse Event|0|||
105602035|NCT00610649|364207475|FG004|Overall Study|Adverse Event|0|||
105602036|NCT00610649|364207476|FG005|Overall Study|Adverse Event|0|||
105602037|NCT00610649|364207477|FG006|Overall Study|Adverse Event|0|||
105602038|NCT00610649|364207478|FG007|Overall Study|Adverse Event|0|||
105602039|NCT00610649|364207479|FG008|Overall Study|Adverse Event|0|||
105602040|NCT00610649|364207480|FG009|Overall Study|Adverse Event|0|||
105602041|NCT00610649|364207481|FG010|Overall Study|Adverse Event|1|||
105602042|NCT00610649|364207471|FG000|Overall Study|Family Emergency|0|||
105602043|NCT00610649|364207472|FG001|Overall Study|Family Emergency|1|||
105602044|NCT00610649|364207473|FG002|Overall Study|Family Emergency|0|||
105602045|NCT00610649|364207474|FG003|Overall Study|Family Emergency|0|||
105602046|NCT00610649|364207475|FG004|Overall Study|Family Emergency|0|||
105602047|NCT00610649|364207476|FG005|Overall Study|Family Emergency|0|||
105602048|NCT00610649|364207477|FG006|Overall Study|Family Emergency|0|||
105602049|NCT00610649|364207478|FG007|Overall Study|Family Emergency|0|||
105602050|NCT00610649|364207479|FG008|Overall Study|Family Emergency|0|||
105602051|NCT00610649|364207480|FG009|Overall Study|Family Emergency|0|||
105602052|NCT00610649|364207481|FG010|Overall Study|Family Emergency|0|||
105602053|NCT00610649|364207471|FG000|Overall Study|Withdrawal by Subject|0|||
105602054|NCT00610649|364207472|FG001|Overall Study|Withdrawal by Subject|0|||
105602055|NCT00610649|364207473|FG002|Overall Study|Withdrawal by Subject|0|||
105602056|NCT00610649|364207474|FG003|Overall Study|Withdrawal by Subject|0|||
105602057|NCT00610649|364207475|FG004|Overall Study|Withdrawal by Subject|0|||
105602058|NCT00610649|364207476|FG005|Overall Study|Withdrawal by Subject|0|||
105602059|NCT00610649|364207477|FG006|Overall Study|Withdrawal by Subject|0|||
105602060|NCT00610649|364207478|FG007|Overall Study|Withdrawal by Subject|0|||
105602061|NCT00610649|364207479|FG008|Overall Study|Withdrawal by Subject|0|||
105602062|NCT00610649|364207480|FG009|Overall Study|Withdrawal by Subject|1|||
105602063|NCT00610649|364207481|FG010|Overall Study|Withdrawal by Subject|0|||
105602064|NCT00232180|364207482|FG000|Double-blind (DB) Phase|Death|186|||
105602065|NCT00232180|364207483|FG001|Double-blind (DB) Phase|Death|222|||
105602066|NCT00232180|364207484|FG002|Double-blind (DB) Phase|Death|0|||
105602067|NCT00232180|364207482|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
105602068|NCT00232180|364207483|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
105602069|NCT00232180|364207484|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
105602070|NCT00232180|364207482|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
105602071|NCT00232180|364207483|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
105602072|NCT00232180|364207484|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
105602073|NCT00232180|364207482|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
105602074|NCT00232180|364207483|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
105602075|NCT00232180|364207484|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
105602076|NCT00232180|364207482|FG000|Double-blind (DB) Phase|Adverse Event|83|||
105602077|NCT00232180|364207483|FG001|Double-blind (DB) Phase|Adverse Event|100|||
105602078|NCT00232180|364207484|FG002|Double-blind (DB) Phase|Adverse Event|0|||
105602079|NCT00232180|364207482|FG000|Double-blind (DB) Phase|Other|70|||
105602080|NCT00232180|364207483|FG001|Double-blind (DB) Phase|Other|75|||
105602081|NCT00232180|364207484|FG002|Double-blind (DB) Phase|Other|0|||
105602082|NCT00232180|364207482|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
105602083|NCT00232180|364207483|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
105602084|NCT00232180|364207484|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
105602085|NCT00232180|364207482|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
105602086|NCT00232180|364207483|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
105602087|NCT00232180|364207484|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
105602088|NCT00232180|364207482|FG000|Open Label Phase|Death|0|||
105602089|NCT00232180|364207483|FG001|Open Label Phase|Death|0|||
105602090|NCT00232180|364207484|FG002|Open Label Phase|Death|48|||
105602091|NCT00232180|364207482|FG000|Open Label Phase|Lost to Follow-up|0|||
105602092|NCT00232180|364207483|FG001|Open Label Phase|Lost to Follow-up|0|||
105602093|NCT00232180|364207484|FG002|Open Label Phase|Lost to Follow-up|5|||
105602094|NCT00232180|364207482|FG000|Open Label Phase|Protocol Violation|0|||
105602095|NCT00232180|364207483|FG001|Open Label Phase|Protocol Violation|0|||
105602096|NCT00232180|364207484|FG002|Open Label Phase|Protocol Violation|3|||
105602097|NCT00232180|364207482|FG000|Open Label Phase|Study terminated by sponsor|0|||
105602098|NCT00232180|364207483|FG001|Open Label Phase|Study terminated by sponsor|0|||
105602099|NCT00232180|364207484|FG002|Open Label Phase|Study terminated by sponsor|3|||
105602100|NCT00232180|364207482|FG000|Open Label Phase|Withdrawal by Subject|0|||
105602101|NCT00232180|364207483|FG001|Open Label Phase|Withdrawal by Subject|0|||
105602102|NCT00232180|364207484|FG002|Open Label Phase|Withdrawal by Subject|37|||
105602103|NCT00232180|364207482|FG000|Open Label Phase|Other|0|||
105602104|NCT00232180|364207483|FG001|Open Label Phase|Other|0|||
105602105|NCT00232180|364207484|FG002|Open Label Phase|Other|16|||
105602106|NCT00232180|364207482|FG000|Open Label Phase|Adverse Event|0|||
105602107|NCT00232180|364207483|FG001|Open Label Phase|Adverse Event|0|||
105602108|NCT00232180|364207484|FG002|Open Label Phase|Adverse Event|25|||
105602109|NCT00232180|364207482|FG000|Open Label Phase|Laboratory abnormality|0|||
105602110|NCT00232180|364207483|FG001|Open Label Phase|Laboratory abnormality|0|||
105602111|NCT00232180|364207484|FG002|Open Label Phase|Laboratory abnormality|10|||
105602112|NCT00232180|364207482|FG000|Open Label Phase|Randomized but not treated|0|||
105602113|NCT00232180|364207483|FG001|Open Label Phase|Randomized but not treated|0|||
105602114|NCT00232180|364207484|FG002|Open Label Phase|Randomized but not treated|1|||
105602115|NCT02748317|364207485|FG000|Overall Study|Withdrawal by Subject|14|||
105602116|NCT02748317|364207485|FG000|Overall Study|Lost to Follow-up|8|||
105602117|NCT02748317|364207485|FG000|Overall Study|Death|1|||
105602118|NCT00505934|364207486|FG000|Overall Study|Adverse Event|1|||
105602119|NCT00505934|364207486|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
105602120|NCT00505934|364207486|FG000|Overall Study|Other: IV dose needed to be changed|1|||
105602121|NCT02271854|364207505|FG000|Overall Study|Withdrawal by Subject|2|||
105602122|NCT02271854|364207505|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
105602123|NCT02271854|364207505|FG000|Overall Study|Lost to Follow-up|1|||
105602124|NCT01534494|364207506|FG000|Overall Study|Withdrawal by Subject|1|||
105602125|NCT02724592|364207507|FG000|Overall Study|Lost to Follow-up|4|||
105602126|NCT02724592|364207508|FG001|Overall Study|Lost to Follow-up|1|||
105602127|NCT00402246|364207509|FG000|Overall Study|Death|62|||
105602128|NCT00402246|364207510|FG001|Overall Study|Death|58|||
105602129|NCT00402246|364207509|FG000|Overall Study|Lost to Follow-up|20|||
105602130|NCT00402246|364207510|FG001|Overall Study|Lost to Follow-up|28|||
105602131|NCT00402246|364207509|FG000|Overall Study|Withdrawal by Subject|72|||
105602132|NCT00402246|364207510|FG001|Overall Study|Withdrawal by Subject|87|||
105602133|NCT00402246|364207509|FG000|Overall Study|Physician Decision|24|||
105602134|NCT00402246|364207510|FG001|Overall Study|Physician Decision|26|||
105602135|NCT00402246|364207509|FG000|Overall Study|Protocol Violation|25|||
105602136|NCT00402246|364207510|FG001|Overall Study|Protocol Violation|24|||
105602137|NCT00402246|364207509|FG000|Overall Study|Missed Final Visit|1|||
105602138|NCT00402246|364207510|FG001|Overall Study|Missed Final Visit|2|||
105602139|NCT00402246|364207509|FG000|Overall Study|Insurance Issues|2|||
105602140|NCT00402246|364207510|FG001|Overall Study|Insurance Issues|1|||
105602141|NCT00402246|364207509|FG000|Overall Study|Heart Transplant|0|||
105602142|NCT00402246|364207510|FG001|Overall Study|Heart Transplant|1|||
105602143|NCT00402246|364207509|FG000|Overall Study|Patient's device explanted|6|||
105602144|NCT00402246|364207510|FG001|Overall Study|Patient's device explanted|2|||
105602145|NCT00402246|364207509|FG000|Overall Study|Center Closure|5|||
105602146|NCT00402246|364207510|FG001|Overall Study|Center Closure|3|||
105602147|NCT00402246|364207509|FG000|Overall Study|Deterioriating Condition|3|||
105602148|NCT00402246|364207510|FG001|Overall Study|Deterioriating Condition|2|||
105602149|NCT02724956|364207515|FG000|Overall Study|Physician Decision|1|||
105602150|NCT02724956|364207516|FG001|Overall Study|Physician Decision|0|||
105602151|NCT02724956|364207515|FG000|Overall Study|Lack of Efficacy|0|||
105602152|NCT02724956|364207516|FG001|Overall Study|Lack of Efficacy|1|||
105602153|NCT02724956|364207515|FG000|Overall Study|Withdrawal by Subject|0|||
105602154|NCT02724956|364207516|FG001|Overall Study|Withdrawal by Subject|1|||
105602155|NCT05262738|364207517|FG000|Overall Study|Withdrawal by Subject|1|||
105602156|NCT05262738|364207518|FG001|Overall Study|Withdrawal by Subject|0|||
105602157|NCT02932579|364207521|FG000|Overall Study|Withdrawal by Subject|4|||
105602158|NCT02932579|364207522|FG001|Overall Study|Withdrawal by Subject|1|||
105602159|NCT02652442|364207525|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
105602160|NCT00106080|364207528|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
105602161|NCT00106080|364207529|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
105602162|NCT02549170|364207532|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
105602163|NCT02549170|364207533|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
105602164|NCT02549170|364207534|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
105602165|NCT02549170|364207535|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
105602166|NCT02549170|364207536|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
105602167|NCT02549170|364207532|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
105602168|NCT02549170|364207533|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
105602169|NCT02549170|364207534|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
105602170|NCT02549170|364207535|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
105602171|NCT02549170|364207536|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
105602172|NCT02549170|364207532|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
105602173|NCT02549170|364207533|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
105602174|NCT02549170|364207534|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
105602175|NCT02549170|364207535|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
105602176|NCT02549170|364207536|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
105602177|NCT01266122|364207538|FG000|Overall Study|Lost to Follow-up|6|||
105602178|NCT01266122|364207539|FG001|Overall Study|Lost to Follow-up|6|||
105602179|NCT03292913|364207540|FG000|Overall Study|Death|9|||
105602180|NCT03292913|364207541|FG001|Overall Study|Death|3|||
105602181|NCT03292913|364207540|FG000|Overall Study|Lost to Follow-up|49|||
105602182|NCT03292913|364207541|FG001|Overall Study|Lost to Follow-up|49|||
105602183|NCT03292913|364207540|FG000|Overall Study|Withdrawal by Subject|2|||
105602184|NCT03292913|364207541|FG001|Overall Study|Withdrawal by Subject|0|||
105602185|NCT03292913|364207540|FG000|Overall Study|Clinic closed due to COVID|22|||
105602186|NCT03292913|364207541|FG001|Overall Study|Clinic closed due to COVID|36|||
105602187|NCT00421889|364207542|FG000|Overall Study|Adverse Event|1|||
105602188|NCT00421889|364207543|FG001|Overall Study|Adverse Event|0|||
105602189|NCT00421889|364207544|FG002|Overall Study|Adverse Event|1|||
105602190|NCT00421889|364207545|FG003|Overall Study|Adverse Event|1|||
105602191|NCT00421889|364207546|FG004|Overall Study|Adverse Event|1|||
105602192|NCT00421889|364207547|FG005|Overall Study|Adverse Event|4|||
105602193|NCT00421889|364207548|FG006|Overall Study|Adverse Event|1|||
105602194|NCT00421889|364207549|FG007|Overall Study|Adverse Event|0|||
105602195|NCT00421889|364207550|FG008|Overall Study|Adverse Event|2|||
105602196|NCT00421889|364207542|FG000|Overall Study|Withdrawal by Subject|1|||
105602197|NCT00421889|364207543|FG001|Overall Study|Withdrawal by Subject|3|||
105602198|NCT00421889|364207544|FG002|Overall Study|Withdrawal by Subject|0|||
105602199|NCT00421889|364207545|FG003|Overall Study|Withdrawal by Subject|0|||
105602200|NCT00421889|364207546|FG004|Overall Study|Withdrawal by Subject|2|||
105602201|NCT00421889|364207547|FG005|Overall Study|Withdrawal by Subject|0|||
105602202|NCT00421889|364207548|FG006|Overall Study|Withdrawal by Subject|0|||
105602203|NCT00421889|364207549|FG007|Overall Study|Withdrawal by Subject|0|||
105602204|NCT00421889|364207550|FG008|Overall Study|Withdrawal by Subject|0|||
105602205|NCT00421889|364207542|FG000|Overall Study|Death|0|||
105602206|NCT00421889|364207543|FG001|Overall Study|Death|0|||
105602207|NCT00421889|364207544|FG002|Overall Study|Death|0|||
105602208|NCT00421889|364207545|FG003|Overall Study|Death|0|||
105602209|NCT00421889|364207546|FG004|Overall Study|Death|1|||
105602210|NCT00421889|364207547|FG005|Overall Study|Death|1|||
105602211|NCT00421889|364207548|FG006|Overall Study|Death|0|||
105602212|NCT00421889|364207549|FG007|Overall Study|Death|0|||
105602213|NCT00421889|364207550|FG008|Overall Study|Death|0|||
105602214|NCT00421889|364207542|FG000|Overall Study|Progressive disease|3|||
105602215|NCT00421889|364207543|FG001|Overall Study|Progressive disease|2|||
105602216|NCT00421889|364207544|FG002|Overall Study|Progressive disease|2|||
105602217|NCT00421889|364207545|FG003|Overall Study|Progressive disease|3|||
105602218|NCT00421889|364207546|FG004|Overall Study|Progressive disease|2|||
105602219|NCT00421889|364207547|FG005|Overall Study|Progressive disease|21|||
105602220|NCT00421889|364207548|FG006|Overall Study|Progressive disease|3|||
105602221|NCT00421889|364207549|FG007|Overall Study|Progressive disease|1|||
105602222|NCT00421889|364207550|FG008|Overall Study|Progressive disease|5|||
105602223|NCT00421889|364207542|FG000|Overall Study|Patient/Investigator request|0|||
105602224|NCT00421889|364207543|FG001|Overall Study|Patient/Investigator request|0|||
105602225|NCT00421889|364207544|FG002|Overall Study|Patient/Investigator request|0|||
105602226|NCT00421889|364207545|FG003|Overall Study|Patient/Investigator request|0|||
105602227|NCT00421889|364207546|FG004|Overall Study|Patient/Investigator request|0|||
105602228|NCT00421889|364207547|FG005|Overall Study|Patient/Investigator request|9|||
105602229|NCT00421889|364207548|FG006|Overall Study|Patient/Investigator request|0|||
105602230|NCT00421889|364207549|FG007|Overall Study|Patient/Investigator request|1|||
105602231|NCT00421889|364207550|FG008|Overall Study|Patient/Investigator request|3|||
105602232|NCT00421889|364207542|FG000|Overall Study|Lost to Follow-up|0|||
105602233|NCT00421889|364207543|FG001|Overall Study|Lost to Follow-up|0|||
105602234|NCT00421889|364207544|FG002|Overall Study|Lost to Follow-up|0|||
105602235|NCT00421889|364207545|FG003|Overall Study|Lost to Follow-up|0|||
105602236|NCT00421889|364207546|FG004|Overall Study|Lost to Follow-up|0|||
105602237|NCT00421889|364207547|FG005|Overall Study|Lost to Follow-up|0|||
105602238|NCT00421889|364207548|FG006|Overall Study|Lost to Follow-up|0|||
105602239|NCT00421889|364207549|FG007|Overall Study|Lost to Follow-up|0|||
105602240|NCT00421889|364207550|FG008|Overall Study|Lost to Follow-up|1|||
105602241|NCT01839331|364207551|FG000|Overall Study|Early Termination|3|||
105602242|NCT01839331|364207552|FG001|Overall Study|Early Termination|0|||
105602243|NCT01839331|364207553|FG002|Overall Study|Early Termination|1|||
105602244|NCT01839331|364207554|FG003|Overall Study|Early Termination|2|||
105602245|NCT01839331|364207551|FG000|Overall Study|Protocol Violation|1|||
105602246|NCT01839331|364207552|FG001|Overall Study|Protocol Violation|6|||
105602247|NCT01839331|364207553|FG002|Overall Study|Protocol Violation|4|||
105602248|NCT01839331|364207554|FG003|Overall Study|Protocol Violation|3|||
105602249|NCT03051165|364207561|FG000|Overall Study|Withdrawal by Subject|1|||
105602250|NCT03051165|364207561|FG000|Overall Study|Early termination of study|12|||
105602251|NCT02267824|364207563|FG000|Overall Study|Pregnancy|1|||
105602252|NCT02267824|364207564|FG001|Overall Study|Pregnancy|1|||
105602253|NCT02267824|364207563|FG000|Overall Study|Lost to Follow-up|4|||
105602254|NCT02267824|364207564|FG001|Overall Study|Lost to Follow-up|0|||
105602255|NCT02267824|364207563|FG000|Overall Study|Protocol Violation|3|||
105602256|NCT02267824|364207564|FG001|Overall Study|Protocol Violation|0|||
105602257|NCT02267824|364207563|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
105602258|NCT02267824|364207564|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
105602259|NCT00350792|364207565|FG000|Overall Study|Adverse Event|11|||
105602260|NCT00350792|364207565|FG000|Overall Study|Death from Study Disease|1|||
105602261|NCT00350792|364207565|FG000|Overall Study|Death from Study Drug Toxicity|1|||
105602262|NCT00350792|364207565|FG000|Overall Study|Death Not Study Drug Related|2|||
105602263|NCT00350792|364207565|FG000|Overall Study|Protocol Violation|1|||
105602264|NCT00350792|364207565|FG000|Overall Study|Withdrawal by Subject|4|||
105602265|NCT00350792|364207565|FG000|Overall Study|Physician Decision|2|||
105602266|NCT00350792|364207565|FG000|Overall Study|Lack of Efficacy|11|||
105602267|NCT00939510|364207570|FG000|Overall Study|Withdrawal by Subject|1|||
105602268|NCT00520546|364207571|FG000|Overall Study|Withdrawal by Subject|1|||
105602269|NCT00520546|364207571|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
105602270|NCT03036813|364207575|FG000|Overall Study|Adverse Event|6|||
105602271|NCT03036813|364207576|FG001|Overall Study|Adverse Event|11|||
105602272|NCT03036813|364207577|FG002|Overall Study|Adverse Event|6|||
105602273|NCT03036813|364207575|FG000|Overall Study|Withdrawal by Subject|12|||
105602274|NCT03036813|364207576|FG001|Overall Study|Withdrawal by Subject|6|||
105602275|NCT03036813|364207577|FG002|Overall Study|Withdrawal by Subject|10|||
105602276|NCT03036813|364207575|FG000|Overall Study|Lost to Follow-up|1|||
105602277|NCT03036813|364207576|FG001|Overall Study|Lost to Follow-up|1|||
105602278|NCT03036813|364207577|FG002|Overall Study|Lost to Follow-up|0|||
105602279|NCT03036813|364207575|FG000|Overall Study|Physician Decision|2|||
105602280|NCT03036813|364207576|FG001|Overall Study|Physician Decision|1|||
105602281|NCT03036813|364207577|FG002|Overall Study|Physician Decision|1|||
105602282|NCT03036813|364207575|FG000|Overall Study|Non-Compliance|1|||
105602283|NCT03036813|364207576|FG001|Overall Study|Non-Compliance|5|||
105602284|NCT03036813|364207577|FG002|Overall Study|Non-Compliance|3|||
105602285|NCT03036813|364207575|FG000|Overall Study|Pregnancy|0|||
105602286|NCT03036813|364207576|FG001|Overall Study|Pregnancy|0|||
105602287|NCT03036813|364207577|FG002|Overall Study|Pregnancy|1|||
105602288|NCT03036813|364207575|FG000|Overall Study|Other|0|||
105602289|NCT03036813|364207576|FG001|Overall Study|Other|3|||
105602290|NCT03036813|364207577|FG002|Overall Study|Other|5|||
105602291|NCT01736215|364207578|FG000|Overall Study|Early termination of erythropoietin use|1|||
105602292|NCT01736215|364207578|FG000|Overall Study|Adverse Event|4|||
105602293|NCT01736215|364207578|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
105602294|NCT01736215|364207578|FG000|Overall Study|Insufficient data to perform analysis|8|||
105602295|NCT01070069|364207585|FG000|Overall Study|Death|1|||
105602296|NCT01070069|364207586|FG001|Overall Study|Death|0|||
105602297|NCT01070069|364207587|FG002|Overall Study|Death|2|||
105602298|NCT01070069|364207588|FG003|Overall Study|Death|0|||
105602299|NCT01070069|364207589|FG004|Overall Study|Death|1|||
105602300|NCT01070069|364207585|FG000|Overall Study|Withdrawal by Subject|1|||
105602301|NCT01070069|364207586|FG001|Overall Study|Withdrawal by Subject|1|||
105602302|NCT01070069|364207587|FG002|Overall Study|Withdrawal by Subject|4|||
105602303|NCT01070069|364207588|FG003|Overall Study|Withdrawal by Subject|0|||
105602304|NCT01070069|364207589|FG004|Overall Study|Withdrawal by Subject|0|||
105602305|NCT01070069|364207585|FG000|Overall Study|Lost to Follow-up|4|||
105602306|NCT01070069|364207586|FG001|Overall Study|Lost to Follow-up|1|||
105602307|NCT01070069|364207587|FG002|Overall Study|Lost to Follow-up|0|||
105602308|NCT01070069|364207588|FG003|Overall Study|Lost to Follow-up|0|||
105602309|NCT01070069|364207589|FG004|Overall Study|Lost to Follow-up|3|||
105602310|NCT00440011|364207591|FG000|Overall Study|Adverse Event|2|||
105602311|NCT00440011|364207592|FG001|Overall Study|Adverse Event|0|||
105602312|NCT00440011|364207591|FG000|Overall Study|Lost to Follow-up|0|||
105602313|NCT00440011|364207592|FG001|Overall Study|Lost to Follow-up|2|||
105602314|NCT00440011|364207591|FG000|Overall Study|Protocol Violation|1|||
105602315|NCT00440011|364207592|FG001|Overall Study|Protocol Violation|1|||
105602316|NCT00440011|364207591|FG000|Overall Study|Withdrawal by Subject|1|||
105602317|NCT00440011|364207592|FG001|Overall Study|Withdrawal by Subject|0|||
105602318|NCT02538341|364207596|FG000|Overall Study|Lost to Follow-up|51|||
105602319|NCT02538341|364207597|FG001|Overall Study|Lost to Follow-up|46|||
105602320|NCT02538341|364207596|FG000|Overall Study|Withdrawal by Subject|3|||
105602321|NCT02538341|364207597|FG001|Overall Study|Withdrawal by Subject|1|||
105602322|NCT02538341|364207596|FG000|Overall Study|Death|2|||
105602323|NCT02538341|364207597|FG001|Overall Study|Death|0|||
105602324|NCT00419341|364207598|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
105602325|NCT00419341|364207598|FG000|Wash in/Wash Out Period|Adverse Event|2|||
105602326|NCT00419341|364207598|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
105602327|NCT00419341|364207598|FG000|Efficacy Period|Withdrawal by Subject|6|||
105602328|NCT00419341|364207598|FG000|Efficacy Period|Protocol Violation|1|||
105602329|NCT00419341|364207598|FG000|Efficacy Period|Lost to Follow-up|1|||
105602330|NCT00419341|364207598|FG000|Efficacy Period|Non-compliance|1|||
105602331|NCT00419341|364207598|FG000|Efficacy Period|Termination of study site|1|||
105602332|NCT00331136|364207599|FG000|Overall Study|Adverse Event|3|||
105602333|NCT00331136|364207600|FG001|Overall Study|Adverse Event|5|||
105602334|NCT00331136|364207601|FG002|Overall Study|Adverse Event|0|||
105602335|NCT00331136|364207602|FG003|Overall Study|Adverse Event|1|||
105602336|NCT00331136|364207599|FG000|Overall Study|Withdrawal by Subject|0|||
105602337|NCT00331136|364207600|FG001|Overall Study|Withdrawal by Subject|1|||
105602338|NCT00331136|364207601|FG002|Overall Study|Withdrawal by Subject|0|||
105602339|NCT00331136|364207602|FG003|Overall Study|Withdrawal by Subject|0|||
105602340|NCT00331136|364207599|FG000|Overall Study|Lost to Follow-up|0|||
105602341|NCT00331136|364207600|FG001|Overall Study|Lost to Follow-up|1|||
105602342|NCT00331136|364207601|FG002|Overall Study|Lost to Follow-up|0|||
105602343|NCT00331136|364207602|FG003|Overall Study|Lost to Follow-up|0|||
105602344|NCT00331136|364207599|FG000|Overall Study|Protocol Violation|1|||
105602345|NCT00331136|364207600|FG001|Overall Study|Protocol Violation|0|||
105602346|NCT00331136|364207601|FG002|Overall Study|Protocol Violation|0|||
105602347|NCT00331136|364207602|FG003|Overall Study|Protocol Violation|0|||
105602348|NCT00331136|364207599|FG000|Overall Study|Not treated|1|||
105602349|NCT00331136|364207600|FG001|Overall Study|Not treated|0|||
105602350|NCT00331136|364207601|FG002|Overall Study|Not treated|0|||
105602351|NCT00331136|364207602|FG003|Overall Study|Not treated|0|||
105602352|NCT04200365|364207603|FG000|Overall Study|Adverse Event|2|||
105602353|NCT04200365|364207603|FG000|Overall Study|Progressive Disease|4|||
105602354|NCT04200365|364207603|FG000|Overall Study|Lack of Efficacy|1|||
105602355|NCT04200365|364207603|FG000|Overall Study|Study Closure|4|||
105602356|NCT04128319|364207605|FG000|Overall Study|Death|3|||
105602357|NCT01499199|364207606|FG000|Overall Study|Adverse Event|1|||
105602358|NCT01499199|364207606|FG000|Overall Study|Lack of Efficacy|1|||
105602359|NCT02692417|364207607|FG000|Overall Study|Withdrawal by Subject|5|||
105602360|NCT02692417|364207608|FG001|Overall Study|Withdrawal by Subject|1|||
105602361|NCT02692417|364207607|FG000|Overall Study|Adverse Event|1|||
105602362|NCT02692417|364207608|FG001|Overall Study|Adverse Event|0|||
105602363|NCT00716859|364207619|FG000|Overall Study|Adverse Event|4|||
105602364|NCT00716859|364207620|FG001|Overall Study|Adverse Event|1|||
105602365|NCT00716859|364207619|FG000|Overall Study|Lack of Efficacy|3|||
105602366|NCT00716859|364207620|FG001|Overall Study|Lack of Efficacy|0|||
105602367|NCT00716859|364207619|FG000|Overall Study|Withdrawal by Subject|1|||
105602368|NCT00716859|364207620|FG001|Overall Study|Withdrawal by Subject|3|||
105602369|NCT00716859|364207619|FG000|Overall Study|Not treated|1|||
105602370|NCT00716859|364207620|FG001|Overall Study|Not treated|1|||
105602371|NCT04411056|364209241|FG000|Overall Study|surgery cancelled|1|||
105602372|NCT04411056|364209242|FG001|Overall Study|surgery cancelled|0|||
105602373|NCT04411056|364209241|FG000|Overall Study|Equipment problem during intubation|0|||
105602374|NCT04411056|364209242|FG001|Overall Study|Equipment problem during intubation|1|||
105602375|NCT05568615|364209249|FG000|Overall Study|Death|1|||
105602376|NCT05568615|364209249|FG000|Overall Study|Physician Decision|1|||
105602377|NCT03889925|364209250|FG000|Overall Study|Lost to Follow-up|11|||
105602378|NCT03889925|364209251|FG001|Overall Study|Lost to Follow-up|10|||
105602379|NCT04817670|364209252|FG000|Overall Study|Withdrawal by Subject|1|||
105602380|NCT04817670|364209253|FG001|Overall Study|Withdrawal by Subject|0|||
105602381|NCT04817670|364209254|FG002|Overall Study|Withdrawal by Subject|0|||
105602382|NCT04817670|364209255|FG003|Overall Study|Withdrawal by Subject|0|||
105602383|NCT04817670|364209256|FG004|Overall Study|Withdrawal by Subject|0|||
105602384|NCT04817670|364209252|FG000|Overall Study|Lost to Follow-up|0|||
105602385|NCT04817670|364209253|FG001|Overall Study|Lost to Follow-up|0|||
105602386|NCT04817670|364209254|FG002|Overall Study|Lost to Follow-up|1|||
105602387|NCT04817670|364209255|FG003|Overall Study|Lost to Follow-up|0|||
105602388|NCT04817670|364209256|FG004|Overall Study|Lost to Follow-up|0|||
105602389|NCT02411084|364209258|FG000|Overall Study|Lack of Efficacy|6|||
105602390|NCT02411084|364209259|FG001|Overall Study|Lack of Efficacy|3|||
105602391|NCT02411084|364209258|FG000|Overall Study|Death|5|||
105602392|NCT02411084|364209259|FG001|Overall Study|Death|4|||
105602393|NCT02411084|364209258|FG000|Overall Study|Adverse Event|2|||
105602394|NCT02411084|364209259|FG001|Overall Study|Adverse Event|1|||
105602395|NCT02411084|364209258|FG000|Overall Study|Other reasons|0|||
105602396|NCT02411084|364209259|FG001|Overall Study|Other reasons|5|||
105602397|NCT02374463|364209269|FG000|Overall Study|Withdrawal by Subject|3|||
105602398|NCT02374463|364209270|FG001|Overall Study|Withdrawal by Subject|3|||
105602399|NCT01414738|364209278|FG000|Overall Study|Death|26|||
105602400|NCT01414738|364209278|FG000|Overall Study|Refused testing|5|||
105602401|NCT01414738|364209278|FG000|Overall Study|Lost to Follow-up|2|||
105602402|NCT01414738|364209278|FG000|Overall Study|Refused, disease progression|8|||
105602403|NCT01414738|364209278|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
105602404|NCT00978042|364209279|FG000|Initial Treatment Period|Treated in Error|0|||
105602405|NCT00978042|364209280|FG001|Initial Treatment Period|Treated in Error|3|||
105602406|NCT00978042|364209279|FG000|Initial Treatment Period|Ineligibility|1|||
105602407|NCT00978042|364209280|FG001|Initial Treatment Period|Ineligibility|0|||
105602408|NCT00978042|364209279|FG000|Initial Treatment Period|Lost to Follow-up|21|||
105602409|NCT00978042|364209280|FG001|Initial Treatment Period|Lost to Follow-up|3|||
105602410|NCT00978042|364209279|FG000|Initial Treatment Period|Adverse Event|2|||
105602411|NCT00978042|364209280|FG001|Initial Treatment Period|Adverse Event|0|||
105602412|NCT00978042|364209279|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
105602413|NCT00978042|364209280|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
105602414|NCT00978042|364209279|FG000|Initial Treatment Period|Consent withdrawn|22|||
105602415|NCT00978042|364209280|FG001|Initial Treatment Period|Consent withdrawn|9|||
105602416|NCT00978042|364209279|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
105602417|NCT00978042|364209280|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
105602418|NCT02379819|364209281|FG000|Overall Study|Withdrawal by Subject|10|||
105602419|NCT02379819|364209281|FG000|Overall Study|Death|2|||
105602420|NCT02379819|364209281|FG000|Overall Study|Lack of Efficacy|1|||
105602421|NCT02379819|364209281|FG000|Overall Study|Lost to Follow-up|1|||
105602422|NCT04056624|364209282|FG000|Overall Study|Withdrawal by Subject|0|||
105602423|NCT04056624|364209283|FG001|Overall Study|Withdrawal by Subject|0|||
105602424|NCT04056624|364209284|FG002|Overall Study|Withdrawal by Subject|1|||
105602425|NCT04056624|364209282|FG000|Overall Study|Protocol Violation|1|||
105602426|NCT04056624|364209283|FG001|Overall Study|Protocol Violation|2|||
105602427|NCT04056624|364209284|FG002|Overall Study|Protocol Violation|0|||
105602428|NCT00703820|364209285|FG000|Overall Study|Adverse Event|12|||
105602429|NCT00703820|364209286|FG001|Overall Study|Adverse Event|17|||
105602430|NCT00703820|364209285|FG000|Overall Study|Death|5|||
105602431|NCT00703820|364209286|FG001|Overall Study|Death|0|||
105602432|NCT00703820|364209285|FG000|Overall Study|Lack of Efficacy|11|||
105602433|NCT00703820|364209286|FG001|Overall Study|Lack of Efficacy|11|||
105602434|NCT00703820|364209285|FG000|Overall Study|Received non-protocol therapy|1|||
105602435|NCT00703820|364209286|FG001|Overall Study|Received non-protocol therapy|0|||
105602436|NCT00703820|364209285|FG000|Overall Study|Physician Decision|4|||
105602437|NCT00703820|364209286|FG001|Overall Study|Physician Decision|5|||
105602438|NCT00703820|364209285|FG000|Overall Study|Withdrawal by Subject|2|||
105602439|NCT00703820|364209286|FG001|Overall Study|Withdrawal by Subject|1|||
105602440|NCT02092116|364209288|FG000|Overall Study|Withdrawal by Subject|0|||
105602441|NCT02092116|364209289|FG001|Overall Study|Withdrawal by Subject|3|||
105602442|NCT02092116|364209288|FG000|Overall Study|Adverse Event|0|||
105602443|NCT02092116|364209289|FG001|Overall Study|Adverse Event|1|||
105602444|NCT03531840|364209290|FG000|Overall Study|Death on study|3|||
105602445|NCT03531840|364209291|FG001|Overall Study|Death on study|2|||
105602446|NCT03531840|364209292|FG002|Overall Study|Death on study|1|||
105602447|NCT03531840|364209293|FG003|Overall Study|Death on study|2|||
105602448|NCT03531840|364209290|FG000|Overall Study|Death during follow up|2|||
105602449|NCT03531840|364209291|FG001|Overall Study|Death during follow up|3|||
105602450|NCT03531840|364209292|FG002|Overall Study|Death during follow up|4|||
105602451|NCT03531840|364209293|FG003|Overall Study|Death during follow up|1|||
105602452|NCT03451721|364209294|FG000|Overall Study|Death|1|||
105602453|NCT01985334|364209296|FG000|Overall Study|Administrative problems|1|||
105602454|NCT01985334|364209297|FG001|Overall Study|Administrative problems|1|||
105602455|NCT01985334|364209298|FG002|Overall Study|Administrative problems|0|||
105602456|NCT01985334|364209299|FG003|Overall Study|Administrative problems|2|||
105602457|NCT01985334|364209300|FG004|Overall Study|Administrative problems|0|||
105602458|NCT01985334|364209301|FG005|Overall Study|Administrative problems|1|||
105602459|NCT01985334|364209302|FG006|Overall Study|Administrative problems|1|||
105602460|NCT01985334|364209303|FG007|Overall Study|Administrative problems|3|||
105602461|NCT01985334|364209296|FG000|Overall Study|Death|1|||
105602462|NCT01985334|364209297|FG001|Overall Study|Death|0|||
105602463|NCT01985334|364209298|FG002|Overall Study|Death|0|||
105602464|NCT01985334|364209299|FG003|Overall Study|Death|3|||
105602465|NCT01985334|364209300|FG004|Overall Study|Death|0|||
105602466|NCT01985334|364209301|FG005|Overall Study|Death|0|||
105602467|NCT01985334|364209302|FG006|Overall Study|Death|1|||
105602468|NCT01985334|364209303|FG007|Overall Study|Death|2|||
105602469|NCT01985334|364209296|FG000|Overall Study|Worsening of disease|0|||
105602470|NCT01985334|364209297|FG001|Overall Study|Worsening of disease|0|||
105602471|NCT01985334|364209298|FG002|Overall Study|Worsening of disease|0|||
105602472|NCT01985334|364209299|FG003|Overall Study|Worsening of disease|1|||
105602473|NCT01985334|364209300|FG004|Overall Study|Worsening of disease|0|||
105602474|NCT01985334|364209301|FG005|Overall Study|Worsening of disease|3|||
105602475|NCT01985334|364209302|FG006|Overall Study|Worsening of disease|0|||
105602476|NCT01985334|364209303|FG007|Overall Study|Worsening of disease|1|||
105602477|NCT01985334|364209296|FG000|Overall Study|Other|2|||
105602478|NCT01985334|364209297|FG001|Overall Study|Other|9|||
105602479|NCT01985334|364209298|FG002|Overall Study|Other|7|||
105602480|NCT01985334|364209299|FG003|Overall Study|Other|17|||
105602481|NCT01985334|364209300|FG004|Overall Study|Other|4|||
105602482|NCT01985334|364209301|FG005|Overall Study|Other|8|||
105602483|NCT01985334|364209302|FG006|Overall Study|Other|4|||
105602484|NCT01985334|364209303|FG007|Overall Study|Other|7|||
105602485|NCT01985334|364209296|FG000|Overall Study|Protocol deviation|6|||
105602486|NCT01985334|364209297|FG001|Overall Study|Protocol deviation|31|||
105602487|NCT01985334|364209298|FG002|Overall Study|Protocol deviation|25|||
105602488|NCT01985334|364209299|FG003|Overall Study|Protocol deviation|84|||
105602489|NCT01985334|364209300|FG004|Overall Study|Protocol deviation|17|||
105602490|NCT01985334|364209301|FG005|Overall Study|Protocol deviation|47|||
105602491|NCT01985334|364209302|FG006|Overall Study|Protocol deviation|15|||
105602492|NCT01985334|364209303|FG007|Overall Study|Protocol deviation|42|||
105602493|NCT01985334|364209296|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
105602494|NCT01985334|364209297|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
105602495|NCT01985334|364209298|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
105602496|NCT01985334|364209299|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
105602497|NCT01985334|364209300|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
105602498|NCT01985334|364209301|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
105602499|NCT01985334|364209302|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
105602500|NCT01985334|364209303|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
105602501|NCT01985334|364209296|FG000|Overall Study|Subject withdrawal of consent|3|||
105602502|NCT01985334|364209297|FG001|Overall Study|Subject withdrawal of consent|6|||
105602503|NCT01985334|364209298|FG002|Overall Study|Subject withdrawal of consent|2|||
105602504|NCT01985334|364209299|FG003|Overall Study|Subject withdrawal of consent|28|||
105602505|NCT01985334|364209300|FG004|Overall Study|Subject withdrawal of consent|4|||
105602506|NCT01985334|364209301|FG005|Overall Study|Subject withdrawal of consent|19|||
105602507|NCT01985334|364209302|FG006|Overall Study|Subject withdrawal of consent|0|||
105602508|NCT01985334|364209303|FG007|Overall Study|Subject withdrawal of consent|20|||
105602509|NCT01985334|364209296|FG000|Overall Study|Adverse Event|0|||
105602510|NCT01985334|364209297|FG001|Overall Study|Adverse Event|8|||
105602511|NCT01985334|364209298|FG002|Overall Study|Adverse Event|2|||
105602512|NCT01985334|364209299|FG003|Overall Study|Adverse Event|26|||
105602513|NCT01985334|364209300|FG004|Overall Study|Adverse Event|3|||
105602514|NCT01985334|364209301|FG005|Overall Study|Adverse Event|18|||
105602515|NCT01985334|364209302|FG006|Overall Study|Adverse Event|3|||
105602516|NCT01985334|364209303|FG007|Overall Study|Adverse Event|15|||
105602517|NCT01985334|364209296|FG000|Overall Study|Other|4|||
105602518|NCT01985334|364209297|FG001|Overall Study|Other|2|||
105602519|NCT01985334|364209298|FG002|Overall Study|Other|3|||
105602520|NCT01985334|364209299|FG003|Overall Study|Other|10|||
105602521|NCT01985334|364209300|FG004|Overall Study|Other|1|||
105602522|NCT01985334|364209301|FG005|Overall Study|Other|6|||
105602523|NCT01985334|364209302|FG006|Overall Study|Other|2|||
105602524|NCT01985334|364209303|FG007|Overall Study|Other|2|||
105602525|NCT01985334|364209296|FG000|Overall Study|Medication non-compliance|0|||
105602526|NCT01985334|364209297|FG001|Overall Study|Medication non-compliance|4|||
105602527|NCT01985334|364209298|FG002|Overall Study|Medication non-compliance|1|||
105602528|NCT01985334|364209299|FG003|Overall Study|Medication non-compliance|6|||
105602529|NCT01985334|364209300|FG004|Overall Study|Medication non-compliance|2|||
105602530|NCT01985334|364209301|FG005|Overall Study|Medication non-compliance|3|||
105602531|NCT01985334|364209302|FG006|Overall Study|Medication non-compliance|1|||
105602532|NCT01985334|364209303|FG007|Overall Study|Medication non-compliance|3|||
105602533|NCT01985334|364209296|FG000|Overall Study|Use of prohibited treatment|1|||
105602534|NCT01985334|364209297|FG001|Overall Study|Use of prohibited treatment|4|||
105602535|NCT01985334|364209298|FG002|Overall Study|Use of prohibited treatment|1|||
105602536|NCT01985334|364209299|FG003|Overall Study|Use of prohibited treatment|2|||
105602537|NCT01985334|364209300|FG004|Overall Study|Use of prohibited treatment|1|||
105602538|NCT01985334|364209301|FG005|Overall Study|Use of prohibited treatment|6|||
105602539|NCT01985334|364209302|FG006|Overall Study|Use of prohibited treatment|2|||
105602540|NCT01985334|364209303|FG007|Overall Study|Use of prohibited treatment|0|||
105602541|NCT01985334|364209296|FG000|Overall Study|Investigator decision|0|||
105602542|NCT01985334|364209297|FG001|Overall Study|Investigator decision|3|||
105602543|NCT01985334|364209298|FG002|Overall Study|Investigator decision|0|||
105602544|NCT01985334|364209299|FG003|Overall Study|Investigator decision|7|||
105602545|NCT01985334|364209300|FG004|Overall Study|Investigator decision|1|||
105602546|NCT01985334|364209301|FG005|Overall Study|Investigator decision|1|||
105602547|NCT01985334|364209302|FG006|Overall Study|Investigator decision|0|||
105602548|NCT01985334|364209303|FG007|Overall Study|Investigator decision|4|||
105602549|NCT01985334|364209296|FG000|Overall Study|Lost to Follow-up|0|||
105602550|NCT01985334|364209297|FG001|Overall Study|Lost to Follow-up|2|||
105602551|NCT01985334|364209298|FG002|Overall Study|Lost to Follow-up|0|||
105602552|NCT01985334|364209299|FG003|Overall Study|Lost to Follow-up|3|||
105602553|NCT01985334|364209300|FG004|Overall Study|Lost to Follow-up|1|||
105602554|NCT01985334|364209301|FG005|Overall Study|Lost to Follow-up|4|||
105602555|NCT01985334|364209302|FG006|Overall Study|Lost to Follow-up|0|||
105602556|NCT01985334|364209303|FG007|Overall Study|Lost to Follow-up|3|||
105602557|NCT00914589|364209304|FG000|Overall Study|Adverse Event|1|||
105602558|NCT00914589|364209305|FG001|Overall Study|Adverse Event|0|||
105602559|NCT00914589|364209306|FG002|Overall Study|Adverse Event|1|||
105602560|NCT00914589|364209304|FG000|Overall Study|Protocol Violation|8|||
105602561|NCT00914589|364209305|FG001|Overall Study|Protocol Violation|6|||
105602562|NCT00914589|364209306|FG002|Overall Study|Protocol Violation|3|||
105602563|NCT00914589|364209304|FG000|Overall Study|unclassified|16|||
105602564|NCT00914589|364209305|FG001|Overall Study|unclassified|9|||
105602565|NCT00914589|364209306|FG002|Overall Study|unclassified|7|||
105602566|NCT00914589|364209304|FG000|Overall Study|Death|0|||
105602567|NCT00914589|364209305|FG001|Overall Study|Death|1|||
105602568|NCT00914589|364209306|FG002|Overall Study|Death|1|||
105602569|NCT01290341|364209307|FG000|Overall Study|Protocol Violation|7|||
105602570|NCT01290341|364209308|FG001|Overall Study|Protocol Violation|3|||
105602571|NCT01290341|364209307|FG000|Overall Study|Adverse Event|1|||
105602572|NCT01290341|364209308|FG001|Overall Study|Adverse Event|0|||
105602573|NCT01290341|364209307|FG000|Overall Study|Lost to Follow-up|21|||
105602574|NCT01290341|364209308|FG001|Overall Study|Lost to Follow-up|10|||
105602575|NCT01290341|364209307|FG000|Overall Study|Withdrawal by Subject|19|||
105602576|NCT01290341|364209308|FG001|Overall Study|Withdrawal by Subject|5|||
105602577|NCT01290341|364209307|FG000|Overall Study|Negative baseline culture and others|44|||
105602578|NCT01290341|364209308|FG001|Overall Study|Negative baseline culture and others|11|||
105602579|NCT03988023|364209309|FG000|Overall Study|Non-compliance|3|||
105602580|NCT03988023|364209310|FG001|Overall Study|Non-compliance|0|||
105602581|NCT03988023|364209309|FG000|Overall Study|Withdrawal by Subject|39|||
105602582|NCT03988023|364209310|FG001|Overall Study|Withdrawal by Subject|37|||
105602583|NCT03988023|364209309|FG000|Overall Study|Adverse Event|0|||
105602584|NCT03988023|364209310|FG001|Overall Study|Adverse Event|2|||
105602585|NCT03988023|364209309|FG000|Overall Study|Physician Decision|0|||
105602586|NCT03988023|364209310|FG001|Overall Study|Physician Decision|1|||
105602587|NCT03988023|364209309|FG000|Overall Study|Lost to Follow-up|5|||
105602588|NCT03988023|364209310|FG001|Overall Study|Lost to Follow-up|8|||
105602589|NCT03988023|364209309|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
105602590|NCT03988023|364209310|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
105602591|NCT03988023|364209309|FG000|Overall Study|Lack of Efficacy|3|||
105602592|NCT03988023|364209310|FG001|Overall Study|Lack of Efficacy|1|||
105602593|NCT03988023|364209309|FG000|Overall Study|COVID-19 pandemic|225|||
105602594|NCT03988023|364209310|FG001|Overall Study|COVID-19 pandemic|227|||
105602595|NCT02101281|364209311|FG000|Overall Study|Adverse Event|0|||
105602596|NCT02101281|364209312|FG001|Overall Study|Adverse Event|1|||
105602597|NCT03403413|364209313|FG000|Overall Study|Lack of Efficacy|2|||
105602598|NCT02374307|364209316|FG000|3-months Follow-up|Lost to Follow-up|1|||
105602599|NCT02374307|364209317|FG001|3-months Follow-up|Lost to Follow-up|2|||
105602600|NCT02374307|364209316|FG000|3-months Follow-up|Withdrawal by Subject|1|||
105602601|NCT02374307|364209317|FG001|3-months Follow-up|Withdrawal by Subject|4|||
105602602|NCT02374307|364209316|FG000|3-months Follow-up|Death|1|||
105602603|NCT02374307|364209317|FG001|3-months Follow-up|Death|2|||
105602604|NCT02374307|364209316|FG000|3-months Follow-up|Missed first follow-up|5|||
105602605|NCT02374307|364209317|FG001|3-months Follow-up|Missed first follow-up|1|||
105602606|NCT02374307|364209316|FG000|6-months Follow-up|Lost to Follow-up|1|||
105602607|NCT02374307|364209317|FG001|6-months Follow-up|Lost to Follow-up|2|||
105602608|NCT02374307|364209316|FG000|6-months Follow-up|Death|2|||
105602609|NCT02374307|364209317|FG001|6-months Follow-up|Death|1|||
105602610|NCT02374307|364209316|FG000|6-months Follow-up|Withdrawal by Subject|0|||
105602611|NCT02374307|364209317|FG001|6-months Follow-up|Withdrawal by Subject|3|||
105602612|NCT00999167|364209320|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
105602613|NCT00999167|364209321|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
105602614|NCT00999167|364209322|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
105602615|NCT00999167|364209320|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
105602616|NCT00999167|364209321|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
105602617|NCT00999167|364209322|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
105602618|NCT00999167|364209320|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
105602619|NCT00999167|364209321|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
105602620|NCT00999167|364209322|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
105602621|NCT00999167|364209320|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
105602622|NCT00999167|364209321|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
105602623|NCT00999167|364209322|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
105602624|NCT00999167|364209320|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
105602625|NCT00999167|364209321|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
105602626|NCT00999167|364209322|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
105602627|NCT00999167|364209320|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
105602628|NCT00999167|364209321|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
105602629|NCT00999167|364209322|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
105602630|NCT00999167|364209320|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
105602631|NCT00999167|364209321|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
105602632|NCT00999167|364209322|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
105602633|NCT00999167|364209320|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
105602634|NCT00999167|364209321|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
105602635|NCT00999167|364209322|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
105602636|NCT02554786|364209323|FG000|Overall Study|Subject/guardian decision|29|||
105602637|NCT02554786|364209324|FG001|Overall Study|Subject/guardian decision|17|||
105602638|NCT02554786|364209325|FG002|Overall Study|Subject/guardian decision|18|||
105602639|NCT02554786|364209326|FG003|Overall Study|Subject/guardian decision|30|||
105602640|NCT02554786|364209327|FG004|Overall Study|Subject/guardian decision|20|||
105602641|NCT02554786|364209323|FG000|Overall Study|Lost to Follow-up|4|||
105602642|NCT02554786|364209324|FG001|Overall Study|Lost to Follow-up|3|||
105602643|NCT02554786|364209325|FG002|Overall Study|Lost to Follow-up|4|||
105602644|NCT02554786|364209326|FG003|Overall Study|Lost to Follow-up|2|||
105602645|NCT02554786|364209327|FG004|Overall Study|Lost to Follow-up|2|||
105602646|NCT02554786|364209323|FG000|Overall Study|Protocol deviation|1|||
105602647|NCT02554786|364209324|FG001|Overall Study|Protocol deviation|3|||
105602648|NCT02554786|364209325|FG002|Overall Study|Protocol deviation|3|||
105602649|NCT02554786|364209326|FG003|Overall Study|Protocol deviation|4|||
105602650|NCT02554786|364209327|FG004|Overall Study|Protocol deviation|2|||
105602651|NCT02554786|364209323|FG000|Overall Study|Technical problems|1|||
105602652|NCT02554786|364209324|FG001|Overall Study|Technical problems|1|||
105602653|NCT02554786|364209325|FG002|Overall Study|Technical problems|0|||
105602654|NCT02554786|364209326|FG003|Overall Study|Technical problems|2|||
105602655|NCT02554786|364209327|FG004|Overall Study|Technical problems|1|||
105602656|NCT02554786|364209323|FG000|Overall Study|Adverse Event|0|||
105602657|NCT02554786|364209324|FG001|Overall Study|Adverse Event|0|||
105602658|NCT02554786|364209325|FG002|Overall Study|Adverse Event|0|||
105602659|NCT02554786|364209326|FG003|Overall Study|Adverse Event|0|||
105602660|NCT02554786|364209327|FG004|Overall Study|Adverse Event|2|||
105602661|NCT02554786|364209323|FG000|Overall Study|Death|0|||
105602662|NCT02554786|364209324|FG001|Overall Study|Death|0|||
105602663|NCT02554786|364209325|FG002|Overall Study|Death|0|||
105602664|NCT02554786|364209326|FG003|Overall Study|Death|1|||
105602665|NCT02554786|364209327|FG004|Overall Study|Death|0|||
105602666|NCT02554786|364209323|FG000|Overall Study|Non-compliance with study treatment|0|||
105602667|NCT02554786|364209324|FG001|Overall Study|Non-compliance with study treatment|1|||
105602668|NCT02554786|364209325|FG002|Overall Study|Non-compliance with study treatment|1|||
105602669|NCT02554786|364209326|FG003|Overall Study|Non-compliance with study treatment|0|||
105602670|NCT02554786|364209327|FG004|Overall Study|Non-compliance with study treatment|1|||
105602671|NCT02554786|364209323|FG000|Overall Study|Physician Decision|0|||
105602672|NCT02554786|364209324|FG001|Overall Study|Physician Decision|1|||
105602673|NCT02554786|364209325|FG002|Overall Study|Physician Decision|4|||
105602674|NCT02554786|364209326|FG003|Overall Study|Physician Decision|1|||
105602675|NCT02554786|364209327|FG004|Overall Study|Physician Decision|1|||
105602676|NCT02554786|364209323|FG000|Overall Study|Pregnancy|0|||
105602677|NCT02554786|364209324|FG001|Overall Study|Pregnancy|0|||
105602678|NCT02554786|364209325|FG002|Overall Study|Pregnancy|0|||
105602679|NCT02554786|364209326|FG003|Overall Study|Pregnancy|1|||
105602680|NCT02554786|364209327|FG004|Overall Study|Pregnancy|1|||
105602681|NCT03684044|364209328|FG000|Overall Study|Adverse Event|3|||
105602682|NCT03684044|364209329|FG001|Overall Study|Adverse Event|0|||
105602683|NCT03684044|364209328|FG000|Overall Study|Death|4|||
105602684|NCT03684044|364209329|FG001|Overall Study|Death|7|||
105602685|NCT03684044|364209328|FG000|Overall Study|Lost to Follow-up|3|||
105602686|NCT03684044|364209329|FG001|Overall Study|Lost to Follow-up|2|||
105602687|NCT03684044|364209328|FG000|Overall Study|Patient Not Available|0|||
105602688|NCT03684044|364209329|FG001|Overall Study|Patient Not Available|2|||
105602689|NCT03684044|364209328|FG000|Overall Study|Physician Decision|1|||
105602690|NCT03684044|364209329|FG001|Overall Study|Physician Decision|0|||
105602691|NCT03684044|364209328|FG000|Overall Study|Withdrawal by Subject|11|||
105602692|NCT03684044|364209329|FG001|Overall Study|Withdrawal by Subject|9|||
105602693|NCT03703336|364209330|FG000|Overall Study|Parent withdrew consent|29|||
105602694|NCT03703336|364209331|FG001|Overall Study|Parent withdrew consent|8|||
105602695|NCT03703336|364209330|FG000|Overall Study|Migration|3|||
105602696|NCT03703336|364209331|FG001|Overall Study|Migration|3|||
105602697|NCT03703336|364209330|FG000|Overall Study|Protocol Violation|3|||
105602698|NCT03703336|364209331|FG001|Overall Study|Protocol Violation|1|||
105602699|NCT03703336|364209330|FG000|Overall Study|Physician Decision|2|||
105602700|NCT03703336|364209331|FG001|Overall Study|Physician Decision|0|||
105602701|NCT03703336|364209330|FG000|Overall Study|Adverse Event|0|||
105602702|NCT03703336|364209331|FG001|Overall Study|Adverse Event|2|||
105602703|NCT03703336|364209330|FG000|Overall Study|Lost to Follow-up|1|||
105602704|NCT03703336|364209331|FG001|Overall Study|Lost to Follow-up|0|||
105602705|NCT04149002|364209332|FG000|Overall Study|Lost to Follow-up|1|||
105602706|NCT04149002|364209333|FG001|Overall Study|Lost to Follow-up|0|||
105602707|NCT04149002|364209332|FG000|Overall Study|Withdrawal by Subject|1|||
105602708|NCT04149002|364209333|FG001|Overall Study|Withdrawal by Subject|0|||
105602709|NCT00396084|364209339|FG000|Overall Study|Adverse Event|0|||
105602710|NCT00396084|364209340|FG001|Overall Study|Adverse Event|0|||
105602711|NCT00396084|364209341|FG002|Overall Study|Adverse Event|0|||
105602712|NCT00396084|364209342|FG003|Overall Study|Adverse Event|0|||
105602713|NCT00396084|364209343|FG004|Overall Study|Adverse Event|1|||
105602714|NCT00396084|364209344|FG005|Overall Study|Adverse Event|2|||
105602715|NCT00396084|364209339|FG000|Overall Study|Withdrawal by Subject|0|||
105602716|NCT00396084|364209340|FG001|Overall Study|Withdrawal by Subject|0|||
105602717|NCT00396084|364209341|FG002|Overall Study|Withdrawal by Subject|0|||
105602718|NCT00396084|364209342|FG003|Overall Study|Withdrawal by Subject|1|||
105602719|NCT00396084|364209343|FG004|Overall Study|Withdrawal by Subject|0|||
105602720|NCT00396084|364209344|FG005|Overall Study|Withdrawal by Subject|0|||
105602721|NCT01248936|364209351|FG000|Overall Study|Sponsor Decision|259|||
105602722|NCT01248936|364209351|FG000|Overall Study|Progression of Disease|50|||
105602723|NCT01248936|364209351|FG000|Overall Study|Death|26|||
105602724|NCT01248936|364209351|FG000|Overall Study|Withdrawal of Consent|20|||
105602725|NCT01248936|364209351|FG000|Overall Study|Adverse Event|8|||
105602726|NCT01248936|364209351|FG000|Overall Study|Lost to Follow-up|7|||
105602727|NCT01248936|364209351|FG000|Overall Study|Refused Treatment|1|||
105602728|NCT01248936|364209351|FG000|Overall Study|Other reason|3|||
105602729|NCT03485950|364209352|FG000|Overall Study|Adverse Event|1|||
105602730|NCT03485950|364209353|FG001|Overall Study|Adverse Event|0|||
105602731|NCT03485950|364209352|FG000|Overall Study|Death|3|||
105602732|NCT03485950|364209353|FG001|Overall Study|Death|2|||
105602733|NCT03485950|364209352|FG000|Overall Study|Withdrawal by Subject|3|||
105602734|NCT03485950|364209353|FG001|Overall Study|Withdrawal by Subject|0|||
105602735|NCT02539225|364209362|FG000|Part A|Adverse Event|13|||
105602736|NCT02539225|364209363|FG001|Part A|Adverse Event|4|||
105602737|NCT02539225|364209362|FG000|Part A|Withdrawal by Subject|2|||
105602738|NCT02539225|364209363|FG001|Part A|Withdrawal by Subject|4|||
105602739|NCT02539225|364209362|FG000|Part A|Physician Decision|4|||
105602740|NCT02539225|364209363|FG001|Part A|Physician Decision|7|||
105602741|NCT02539225|364209362|FG000|Part A|Did Not Receive study Drug|1|||
105602742|NCT02539225|364209363|FG001|Part A|Did Not Receive study Drug|1|||
105602743|NCT02539225|364209362|FG000|Pre Treatment for Part B|Progressive disease|1|||
105602744|NCT02539225|364209363|FG001|Pre Treatment for Part B|Progressive disease|1|||
105602745|NCT02539225|364209362|FG000|Pre Treatment for Part B|Adverse Event|1|||
105602746|NCT02539225|364209363|FG001|Pre Treatment for Part B|Adverse Event|1|||
105602747|NCT02539225|364209362|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
105602748|NCT02539225|364209363|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
105602749|NCT02539225|364209362|FG000|Pre Treatment for Part B|Physician Decision|2|||
105602750|NCT02539225|364209363|FG001|Pre Treatment for Part B|Physician Decision|0|||
105602751|NCT02539225|364209362|FG000|Part B|Adverse Event|4|||
105602752|NCT02539225|364209363|FG001|Part B|Adverse Event|4|||
105602753|NCT02539225|364209362|FG000|Part B|Withdrawal by Subject|0|||
105602754|NCT02539225|364209363|FG001|Part B|Withdrawal by Subject|3|||
105602755|NCT02539225|364209362|FG000|Part B|Physician Decision|0|||
105602756|NCT02539225|364209363|FG001|Part B|Physician Decision|9|||
105602757|NCT02318134|364209375|FG000|Overall Study|Withdrawal by Subject|2|||
105602758|NCT02318134|364209376|FG001|Overall Study|Withdrawal by Subject|1|||
105602759|NCT02409667|364209377|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
105602760|NCT02409667|364209378|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
105602761|NCT02409667|364209379|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
105602762|NCT02409667|364209380|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
105602763|NCT02409667|364209381|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
105602764|NCT02409667|364209377|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
105602765|NCT02409667|364209378|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
105602766|NCT02409667|364209379|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
105602767|NCT02409667|364209380|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
105602768|NCT02409667|364209381|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
105602769|NCT02409667|364209377|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
105602770|NCT02409667|364209378|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
105602771|NCT02409667|364209379|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
105602772|NCT02409667|364209380|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
105602773|NCT02409667|364209381|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
105602774|NCT02409667|364209377|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
105602775|NCT02409667|364209378|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
105602776|NCT02409667|364209379|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
105602777|NCT02409667|364209380|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
105602778|NCT02409667|364209381|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
105602779|NCT02409667|364209377|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
105602780|NCT02409667|364209378|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
105602781|NCT02409667|364209379|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
105602782|NCT02409667|364209380|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
105602783|NCT02409667|364209381|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
105602784|NCT02409667|364209377|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
105602785|NCT02409667|364209378|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
105602786|NCT02409667|364209379|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
105602787|NCT02409667|364209380|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
105602788|NCT02409667|364209381|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
105602789|NCT02409667|364209377|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
105602790|NCT02409667|364209378|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
105602791|NCT02409667|364209379|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
105602792|NCT02409667|364209380|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
105602793|NCT02409667|364209381|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
105602794|NCT02409667|364209377|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
105602795|NCT02409667|364209378|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
105602796|NCT02409667|364209379|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
105602797|NCT02409667|364209380|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
105602798|NCT02409667|364209381|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
105602799|NCT02409667|364209377|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
105602800|NCT02409667|364209378|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
105602801|NCT02409667|364209379|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
105602802|NCT02409667|364209380|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
105602803|NCT02409667|364209381|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
105602804|NCT02409667|364209377|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
105602805|NCT02409667|364209378|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
105602806|NCT02409667|364209379|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
105602807|NCT02409667|364209380|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
105602808|NCT02409667|364209381|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
105602809|NCT02409667|364209377|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
105602810|NCT02409667|364209378|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
105602811|NCT02409667|364209379|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
105602812|NCT02409667|364209380|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
105602813|NCT02409667|364209381|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
105602814|NCT02409667|364209377|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
105602815|NCT02409667|364209378|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
105602816|NCT02409667|364209379|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
105602817|NCT02409667|364209380|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
105602818|NCT02409667|364209381|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
105602819|NCT02409667|364209377|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
105602820|NCT02409667|364209378|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
105602821|NCT02409667|364209379|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
105602822|NCT02409667|364209380|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
105602823|NCT02409667|364209381|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
105602824|NCT02409667|364209377|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
105602825|NCT02409667|364209378|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
105602826|NCT02409667|364209379|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
105602827|NCT02409667|364209380|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
105602828|NCT02409667|364209381|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
105602829|NCT02409667|364209377|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
105602830|NCT02409667|364209378|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
105602831|NCT02409667|364209379|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
105602832|NCT02409667|364209380|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
105602833|NCT02409667|364209381|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
105602834|NCT02409667|364209377|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
105602835|NCT02409667|364209378|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
105602836|NCT02409667|364209379|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
105602837|NCT02409667|364209380|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
105602838|NCT02409667|364209381|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
105602839|NCT01925339|364209382|FG000|Overall Study|Adverse Event|2|||
105602840|NCT01925339|364209383|FG001|Overall Study|Adverse Event|0|||
105602841|NCT01538719|364209384|FG000|Overall Study|Lost to Follow-up|2|||
105602842|NCT01538719|364209385|FG001|Overall Study|Lost to Follow-up|0|||
105602843|NCT02556138|364209386|FG000|Overall Study|Withdrawal by Subject|1|||
105602844|NCT04048382|364209387|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
105602845|NCT04048382|364209388|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
105602846|NCT04048382|364209387|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
105602847|NCT04048382|364209388|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
105602848|NCT04048382|364209387|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
105602849|NCT04048382|364209388|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
105602850|NCT01205048|364209390|FG000|Overall Study|Withdrawal by Subject|14|||
105602851|NCT01205048|364209390|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
105602852|NCT01205048|364209390|FG000|Overall Study|Lost to Follow-up|4|||
105602853|NCT01205048|364209390|FG000|Overall Study|Other|2|||
105602854|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
105602855|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
105602856|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
105602857|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
105602858|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
105602859|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
105602860|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
105602861|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
105602862|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
105602863|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
105602864|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
105602865|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
105602866|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
105602867|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
105602868|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
105602869|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
105602870|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
105602871|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
105602872|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
105602873|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
105602874|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
105602875|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
105602876|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
105602877|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
105602878|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
105602879|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
105602880|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
105602881|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
105602882|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
105602883|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
105602884|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
105602885|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
105602886|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
105602887|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
105602888|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
105602889|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
105602890|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
105602891|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
105602892|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
105602893|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
105602894|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
105602895|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
105602896|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
105602897|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
105602898|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
105602899|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
105602900|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
105602901|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
105602902|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
105602903|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
105602904|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
105602905|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
105602906|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
105602907|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
105602908|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105602909|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
105602910|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105602911|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105602912|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105602913|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105602914|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105602915|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105602916|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105602917|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
105602918|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
105602919|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
105602920|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
105602921|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
105602922|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
105602923|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
105602924|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
105602925|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
105602926|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
105602927|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
105602928|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
105602929|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
105602930|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
105602931|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
105602932|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
105602933|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
105602934|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
105602935|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
105602936|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
105602937|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
105602938|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
105602939|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
105602940|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
105602941|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
105602942|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
105602943|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
105602944|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
105602945|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
105602946|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
105602947|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
105602948|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
105602949|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
105602950|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
105602951|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
105602952|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
105602953|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105602954|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
105602955|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
105602956|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105602957|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105602958|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105602959|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105602960|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105602961|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105602962|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
105602963|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
105602964|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
105602965|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
105602966|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
105602967|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
105602968|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
105602969|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
105602970|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
105602971|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
105602972|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
105602973|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
105602974|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
105602975|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
105602976|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
105602977|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
105602978|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
105602979|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
105602980|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
105602981|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
105602982|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
105602983|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
105602984|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
105602985|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
105602986|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
105602987|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
105602988|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
105602989|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
105602990|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
105602991|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
105602992|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
105602993|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
105602994|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
105602995|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
105602996|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
105602997|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
105602998|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
105602999|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
105603000|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
105603001|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
105603002|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
105603003|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
105603004|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
105603005|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
105603006|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
105603007|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
105603008|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
105603009|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
105603010|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
105603011|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
105603012|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
105603013|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
105603014|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
105603015|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
105603016|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
105603017|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
105603018|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
105603019|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
105626702|NCT04186819|364298168|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
105603020|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
105603021|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
105603022|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
105603023|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
105603024|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
105603025|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
105603026|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
105603027|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
105603028|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
105603029|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
105603030|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
105603031|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
105603032|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
105603033|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
105603034|NCT03598790|364211215|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
105603035|NCT03598790|364211216|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
105603036|NCT03598790|364211217|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
105603037|NCT03598790|364211218|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
105603038|NCT03598790|364211219|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
105603039|NCT03598790|364211220|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
105603040|NCT03598790|364211221|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
105603041|NCT03598790|364211222|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
105603042|NCT03598790|364211223|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
105603043|NCT03598790|364211215|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105603044|NCT03598790|364211216|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105603045|NCT03598790|364211217|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105603046|NCT03598790|364211218|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
105603047|NCT03598790|364211219|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
105603048|NCT03598790|364211220|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
105603049|NCT03598790|364211221|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105603050|NCT03598790|364211222|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105603051|NCT03598790|364211223|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105603052|NCT03598790|364211215|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
105603053|NCT03598790|364211216|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
105603054|NCT03598790|364211217|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
105603055|NCT03598790|364211218|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
105603056|NCT03598790|364211219|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
105603057|NCT03598790|364211220|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
105603058|NCT03598790|364211221|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
105603059|NCT03598790|364211222|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
105603060|NCT03598790|364211223|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
105603061|NCT03598790|364211215|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105603062|NCT03598790|364211216|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105603063|NCT03598790|364211217|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105603064|NCT03598790|364211218|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
105603065|NCT03598790|364211219|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105603066|NCT03598790|364211220|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105603067|NCT03598790|364211221|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105603068|NCT03598790|364211222|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105603069|NCT03598790|364211223|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105603070|NCT03598790|364211215|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
105603071|NCT03598790|364211216|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
105603072|NCT03598790|364211217|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
105603073|NCT03598790|364211218|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
105603074|NCT03598790|364211219|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
105603075|NCT03598790|364211220|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
105603076|NCT03598790|364211221|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
105603077|NCT03598790|364211222|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
105603078|NCT03598790|364211223|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
105603079|NCT03598790|364211215|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
105603080|NCT03598790|364211216|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
105603081|NCT03598790|364211217|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
105603082|NCT03598790|364211218|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
105603083|NCT03598790|364211219|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
105603084|NCT03598790|364211220|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
105603085|NCT03598790|364211221|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
105603086|NCT03598790|364211222|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
105603087|NCT03598790|364211223|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
105603088|NCT03215927|364211224|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
105603089|NCT03215927|364211225|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
105603090|NCT03215927|364211224|FG000|Open Label Extension|Adverse Event|1|||
105603091|NCT03215927|364211225|FG001|Open Label Extension|Adverse Event|0|||
105603092|NCT03215927|364211224|FG000|Open Label Extension|Lack of Efficacy|1|||
105603093|NCT03215927|364211225|FG001|Open Label Extension|Lack of Efficacy|0|||
105603094|NCT03215927|364211224|FG000|Open Label Extension|Death|0|||
105603095|NCT03215927|364211225|FG001|Open Label Extension|Death|1|||
105603096|NCT03122886|364211226|FG000|Overall Study|Withdrawal by Subject|1|||
105603097|NCT03122886|364211227|FG001|Overall Study|Withdrawal by Subject|2|||
105603098|NCT03785782|364211230|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
105603099|NCT03785782|364211231|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
105603100|NCT03785782|364211230|FG000|Overall Study|Withdrawal by Subject|1|||
105603101|NCT03785782|364211231|FG001|Overall Study|Withdrawal by Subject|1|||
105603102|NCT03785782|364211230|FG000|Overall Study|insufficient image quality.|3|||
105603103|NCT03785782|364211231|FG001|Overall Study|insufficient image quality.|0|||
105603104|NCT03779048|364211232|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
105603105|NCT03779048|364211233|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
105603106|NCT03779048|364211234|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
105603107|NCT03779048|364211232|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
105603108|NCT03779048|364211233|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
105603109|NCT03779048|364211234|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
105603110|NCT03779048|364211232|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
105603111|NCT03779048|364211233|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
105603112|NCT03779048|364211234|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
105603113|NCT02279095|364211242|FG000|Overall Study|Non-Compliance|1|||
105603114|NCT02279095|364211242|FG000|Overall Study|Withdrawal by Subject|8|||
105603115|NCT02279095|364211242|FG000|Overall Study|Adverse Event|2|||
105603116|NCT02279095|364211242|FG000|Overall Study|Other|7|||
105603117|NCT02279095|364211242|FG000|Overall Study|Lost to Follow-up|1|||
105603118|NCT05938413|364211243|FG000|Overall Study|Lost to Follow-up|1|||
105603119|NCT05938413|364211244|FG001|Overall Study|Lost to Follow-up|7|||
105603120|NCT05938413|364211243|FG000|Overall Study|Withdrawal by Subject|1|||
105603121|NCT05938413|364211244|FG001|Overall Study|Withdrawal by Subject|1|||
105603122|NCT03073941|364211246|FG000|Overall Study|Received non-study device intraoperatively|0|||
105603123|NCT03073941|364211247|FG001|Overall Study|Received non-study device intraoperatively|2|||
105603124|NCT03073941|364211246|FG000|Overall Study|Death|1|||
105603125|NCT03073941|364211247|FG001|Overall Study|Death|0|||
105603126|NCT03073941|364211246|FG000|Overall Study|Withdrawal by Subject|1|||
105603127|NCT03073941|364211247|FG001|Overall Study|Withdrawal by Subject|3|||
105603128|NCT03073941|364211246|FG000|Overall Study|Lost to Follow-up|5|||
105603129|NCT03073941|364211247|FG001|Overall Study|Lost to Follow-up|4|||
105603130|NCT03073941|364211246|FG000|Overall Study|Adverse Event|4|||
105603131|NCT03073941|364211247|FG001|Overall Study|Adverse Event|2|||
105603132|NCT03073941|364211246|FG000|Overall Study|Met an exclusion criterion|0|||
105603133|NCT03073941|364211247|FG001|Overall Study|Met an exclusion criterion|1|||
105603134|NCT04250883|364211249|FG000|Overall Study|Lost to Follow-up|1|||
105603135|NCT04250883|364211250|FG001|Overall Study|Lost to Follow-up|0|||
105603136|NCT04588259|364211251|FG000|Run-in Period|Run-in failure|0|||
105603137|NCT04588259|364211252|FG001|Run-in Period|Run-in failure|23|||
105603138|NCT04588259|364211251|FG000|Run-in Period|Withdrawn before randomisation|0|||
105603139|NCT04588259|364211252|FG001|Run-in Period|Withdrawn before randomisation|8|||
105603140|NCT04588259|364211251|FG000|Treatment Period|Withdrawal by Subject|6|||
105603141|NCT04588259|364211252|FG001|Treatment Period|Withdrawal by Subject|6|||
105603142|NCT04188379|364211256|FG000|Overall Study|Withdrawal by Subject|10|||
105603143|NCT04188379|364211257|FG001|Overall Study|Withdrawal by Subject|3|||
105603144|NCT04188379|364211256|FG000|Overall Study|Physician Decision|0|||
105603145|NCT04188379|364211257|FG001|Overall Study|Physician Decision|1|||
105603146|NCT04188379|364211256|FG000|Overall Study|Adverse Event|3|||
105603147|NCT04188379|364211257|FG001|Overall Study|Adverse Event|1|||
105603148|NCT04188379|364211256|FG000|Overall Study|Pregnancy|1|||
105603149|NCT04188379|364211257|FG001|Overall Study|Pregnancy|0|||
105603150|NCT04188379|364211256|FG000|Overall Study|Lack of Efficacy|8|||
105603151|NCT04188379|364211257|FG001|Overall Study|Lack of Efficacy|5|||
105603152|NCT04188379|364211256|FG000|Overall Study|Other|0|||
105603153|NCT04188379|364211257|FG001|Overall Study|Other|3|||
105603154|NCT04153565|364211258|FG000|Overall Study|Death|13|||
105603155|NCT00722046|364211261|FG000|Overall Study|Adverse Event|0|||
105603156|NCT00722046|364211262|FG001|Overall Study|Adverse Event|1|||
105603157|NCT00722046|364211263|FG002|Overall Study|Adverse Event|2|||
105603158|NCT00722046|364211264|FG003|Overall Study|Adverse Event|1|||
105603159|NCT00722046|364211265|FG004|Overall Study|Adverse Event|2|||
105603160|NCT00722046|364211266|FG005|Overall Study|Adverse Event|1|||
105603161|NCT00722046|364211267|FG006|Overall Study|Adverse Event|0|||
105603162|NCT00722046|364211261|FG000|Overall Study|Death|0|||
105603163|NCT00722046|364211262|FG001|Overall Study|Death|1|||
105603164|NCT00722046|364211263|FG002|Overall Study|Death|0|||
105603165|NCT00722046|364211264|FG003|Overall Study|Death|0|||
105603166|NCT00722046|364211265|FG004|Overall Study|Death|0|||
105603167|NCT00722046|364211266|FG005|Overall Study|Death|0|||
105603168|NCT00722046|364211267|FG006|Overall Study|Death|2|||
105603169|NCT00722046|364211261|FG000|Overall Study|Protocol Violation|1|||
105603170|NCT00722046|364211262|FG001|Overall Study|Protocol Violation|0|||
105603171|NCT00722046|364211263|FG002|Overall Study|Protocol Violation|0|||
105603172|NCT00722046|364211264|FG003|Overall Study|Protocol Violation|0|||
105603173|NCT00722046|364211265|FG004|Overall Study|Protocol Violation|0|||
105603174|NCT00722046|364211266|FG005|Overall Study|Protocol Violation|1|||
105603175|NCT00722046|364211267|FG006|Overall Study|Protocol Violation|0|||
105603176|NCT00722046|364211261|FG000|Overall Study|Withdrawal by Subject|3|||
105603177|NCT00722046|364211262|FG001|Overall Study|Withdrawal by Subject|3|||
105603178|NCT00722046|364211263|FG002|Overall Study|Withdrawal by Subject|4|||
105603179|NCT00722046|364211264|FG003|Overall Study|Withdrawal by Subject|4|||
105603180|NCT00722046|364211265|FG004|Overall Study|Withdrawal by Subject|4|||
105603181|NCT00722046|364211266|FG005|Overall Study|Withdrawal by Subject|7|||
105603182|NCT00722046|364211267|FG006|Overall Study|Withdrawal by Subject|3|||
105603183|NCT00722046|364211261|FG000|Overall Study|Randomized, but not treated|1|||
105603184|NCT00722046|364211262|FG001|Overall Study|Randomized, but not treated|1|||
105603185|NCT00722046|364211263|FG002|Overall Study|Randomized, but not treated|0|||
105603186|NCT00722046|364211264|FG003|Overall Study|Randomized, but not treated|2|||
105603187|NCT00722046|364211265|FG004|Overall Study|Randomized, but not treated|0|||
105603188|NCT00722046|364211266|FG005|Overall Study|Randomized, but not treated|0|||
105603189|NCT00722046|364211267|FG006|Overall Study|Randomized, but not treated|0|||
105603190|NCT00722046|364211261|FG000|Overall Study|Other|0|||
105603191|NCT00722046|364211262|FG001|Overall Study|Other|0|||
105603192|NCT00722046|364211263|FG002|Overall Study|Other|1|||
105603193|NCT00722046|364211264|FG003|Overall Study|Other|1|||
105603194|NCT00722046|364211265|FG004|Overall Study|Other|3|||
105603195|NCT00722046|364211266|FG005|Overall Study|Other|2|||
105603196|NCT00722046|364211267|FG006|Overall Study|Other|1|||
105603317|NCT04903288|364211274|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
105603318|NCT04903288|364211274|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
105603319|NCT04903288|364211274|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
105603320|NCT04903288|364211274|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
105603321|NCT05773313|364211277|FG000|Overall Study|Lost to Follow-up|3|||
105603322|NCT04259450|364211278|FG000|Overall Study|Adverse event/ Toxicity|0|||
105603323|NCT04259450|364211279|FG001|Overall Study|Adverse event/ Toxicity|3|||
105603324|NCT04259450|364211280|FG002|Overall Study|Adverse event/ Toxicity|0|||
105603325|NCT04259450|364211281|FG003|Overall Study|Adverse event/ Toxicity|1|||
105603326|NCT04259450|364211282|FG004|Overall Study|Adverse event/ Toxicity|0|||
105603327|NCT04259450|364211283|FG005|Overall Study|Adverse event/ Toxicity|0|||
105603328|NCT04259450|364211284|FG006|Overall Study|Adverse event/ Toxicity|0|||
105603329|NCT04259450|364211285|FG007|Overall Study|Adverse event/ Toxicity|1|||
105603330|NCT04259450|364211286|FG008|Overall Study|Adverse event/ Toxicity|0|||
105603331|NCT04259450|364211287|FG009|Overall Study|Adverse event/ Toxicity|3|||
105603332|NCT04259450|364211278|FG000|Overall Study|Disease progression|2|||
105603333|NCT04259450|364211279|FG001|Overall Study|Disease progression|3|||
105603334|NCT04259450|364211280|FG002|Overall Study|Disease progression|4|||
105603335|NCT04259450|364211281|FG003|Overall Study|Disease progression|4|||
105603336|NCT04259450|364211282|FG004|Overall Study|Disease progression|6|||
105603337|NCT04259450|364211283|FG005|Overall Study|Disease progression|6|||
105603338|NCT04259450|364211284|FG006|Overall Study|Disease progression|6|||
105603339|NCT04259450|364211285|FG007|Overall Study|Disease progression|15|||
105603340|NCT04259450|364211286|FG008|Overall Study|Disease progression|6|||
105603341|NCT04259450|364211287|FG009|Overall Study|Disease progression|18|||
105603342|NCT04259450|364211278|FG000|Overall Study|Death|0|||
105603343|NCT04259450|364211279|FG001|Overall Study|Death|0|||
105603344|NCT04259450|364211280|FG002|Overall Study|Death|0|||
105603345|NCT04259450|364211281|FG003|Overall Study|Death|0|||
105603346|NCT04259450|364211282|FG004|Overall Study|Death|0|||
105603347|NCT04259450|364211283|FG005|Overall Study|Death|0|||
105603348|NCT04259450|364211284|FG006|Overall Study|Death|0|||
105603349|NCT04259450|364211285|FG007|Overall Study|Death|1|||
105603350|NCT04259450|364211286|FG008|Overall Study|Death|1|||
105603351|NCT04259450|364211287|FG009|Overall Study|Death|0|||
105603352|NCT04259450|364211278|FG000|Overall Study|Withdrawal by Subject|0|||
105603353|NCT04259450|364211279|FG001|Overall Study|Withdrawal by Subject|0|||
105603354|NCT04259450|364211280|FG002|Overall Study|Withdrawal by Subject|0|||
105603355|NCT04259450|364211281|FG003|Overall Study|Withdrawal by Subject|0|||
105603356|NCT04259450|364211282|FG004|Overall Study|Withdrawal by Subject|0|||
105603357|NCT04259450|364211283|FG005|Overall Study|Withdrawal by Subject|0|||
105603358|NCT04259450|364211284|FG006|Overall Study|Withdrawal by Subject|0|||
105603359|NCT04259450|364211285|FG007|Overall Study|Withdrawal by Subject|1|||
105603360|NCT04259450|364211286|FG008|Overall Study|Withdrawal by Subject|0|||
105603361|NCT04259450|364211287|FG009|Overall Study|Withdrawal by Subject|0|||
105603362|NCT04259450|364211278|FG000|Overall Study|Other than listed|0|||
105603363|NCT04259450|364211279|FG001|Overall Study|Other than listed|0|||
105603364|NCT04259450|364211280|FG002|Overall Study|Other than listed|0|||
105603365|NCT04259450|364211281|FG003|Overall Study|Other than listed|0|||
105603366|NCT04259450|364211282|FG004|Overall Study|Other than listed|0|||
105603367|NCT04259450|364211283|FG005|Overall Study|Other than listed|0|||
105603368|NCT04259450|364211284|FG006|Overall Study|Other than listed|0|||
105603369|NCT04259450|364211285|FG007|Overall Study|Other than listed|1|||
105603370|NCT04259450|364211286|FG008|Overall Study|Other than listed|1|||
105603371|NCT04259450|364211287|FG009|Overall Study|Other than listed|2|||
105603372|NCT05137236|364211288|FG000|Part A|Other than Specified|1|||
105603373|NCT05137236|364211289|FG001|Part A|Other than Specified|0|||
105603374|NCT05137236|364211290|FG002|Part A|Other than Specified|0|||
105603375|NCT05137236|364211291|FG003|Part A|Other than Specified|0|||
105603376|NCT05137236|364211292|FG004|Part A|Other than Specified|0|||
105603377|NCT05137236|364211293|FG005|Part A|Other than Specified|0|||
105603378|NCT05137236|364211294|FG006|Part A|Other than Specified|0|||
105603379|NCT05137236|364211295|FG007|Part A|Other than Specified|0|||
105603380|NCT05137236|364211288|FG000|Part A|Withdrawal by Subject|0|||
105603381|NCT05137236|364211289|FG001|Part A|Withdrawal by Subject|4|||
105603382|NCT05137236|364211290|FG002|Part A|Withdrawal by Subject|1|||
105603383|NCT05137236|364211291|FG003|Part A|Withdrawal by Subject|1|||
105603384|NCT05137236|364211292|FG004|Part A|Withdrawal by Subject|3|||
105603385|NCT05137236|364211293|FG005|Part A|Withdrawal by Subject|2|||
105603386|NCT05137236|364211294|FG006|Part A|Withdrawal by Subject|0|||
105603387|NCT05137236|364211295|FG007|Part A|Withdrawal by Subject|0|||
105603388|NCT05137236|364211288|FG000|Part A|Lost to Follow-up|5|||
105603389|NCT05137236|364211289|FG001|Part A|Lost to Follow-up|7|||
105603390|NCT05137236|364211290|FG002|Part A|Lost to Follow-up|1|||
105603391|NCT05137236|364211291|FG003|Part A|Lost to Follow-up|3|||
105603392|NCT05137236|364211292|FG004|Part A|Lost to Follow-up|3|||
105603393|NCT05137236|364211293|FG005|Part A|Lost to Follow-up|8|||
105603394|NCT05137236|364211294|FG006|Part A|Lost to Follow-up|0|||
105603395|NCT05137236|364211295|FG007|Part A|Lost to Follow-up|0|||
105603396|NCT05137236|364211288|FG000|Part B|Withdrawal by Subject|0|||
105603397|NCT05137236|364211289|FG001|Part B|Withdrawal by Subject|0|||
105603398|NCT05137236|364211290|FG002|Part B|Withdrawal by Subject|0|||
105603399|NCT05137236|364211291|FG003|Part B|Withdrawal by Subject|0|||
105603400|NCT05137236|364211292|FG004|Part B|Withdrawal by Subject|0|||
105603401|NCT05137236|364211293|FG005|Part B|Withdrawal by Subject|0|||
105603402|NCT05137236|364211294|FG006|Part B|Withdrawal by Subject|0|||
105603403|NCT05137236|364211295|FG007|Part B|Withdrawal by Subject|2|||
105603404|NCT05137236|364211288|FG000|Part B|Lost to Follow-up|0|||
105603405|NCT05137236|364211289|FG001|Part B|Lost to Follow-up|0|||
105603406|NCT05137236|364211290|FG002|Part B|Lost to Follow-up|0|||
105603407|NCT05137236|364211291|FG003|Part B|Lost to Follow-up|0|||
105603408|NCT05137236|364211292|FG004|Part B|Lost to Follow-up|0|||
105603409|NCT05137236|364211293|FG005|Part B|Lost to Follow-up|0|||
105603410|NCT05137236|364211294|FG006|Part B|Lost to Follow-up|5|||
105603411|NCT05137236|364211295|FG007|Part B|Lost to Follow-up|5|||
105603412|NCT05137236|364211288|FG000|Part B|Death|0|||
105603413|NCT05137236|364211289|FG001|Part B|Death|0|||
105603414|NCT05137236|364211290|FG002|Part B|Death|0|||
105603415|NCT05137236|364211291|FG003|Part B|Death|0|||
105603416|NCT05137236|364211292|FG004|Part B|Death|0|||
105603417|NCT05137236|364211293|FG005|Part B|Death|0|||
105603418|NCT05137236|364211294|FG006|Part B|Death|0|||
105603419|NCT05137236|364211295|FG007|Part B|Death|2|||
105603420|NCT00434304|364211296|FG000|Overall Study|Adverse Event|14|||
105603421|NCT00434304|364211296|FG000|Overall Study|Lack of Efficacy|2|||
105603422|NCT00434304|364211296|FG000|Overall Study|Withdrawal by Subject|4|||
105603423|NCT00431834|364211299|FG000|Overall Study|Withdrawal by Subject|7|||
105603424|NCT00431834|364211299|FG000|Overall Study|Death|3|||
105603425|NCT00431834|364211299|FG000|Overall Study|Missed Endpoint Visit|2|||
105603426|NCT00431834|364211299|FG000|Overall Study|Lost to Follow-up|1|||
105603427|NCT04512482|364211300|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
105603428|NCT04512482|364211301|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
105603429|NCT04711135|364211304|FG000|Overall Study|Physician Decision|0|||
105603430|NCT04711135|364211305|FG001|Overall Study|Physician Decision|1|||
105603431|NCT04711135|364211304|FG000|Overall Study|Ongoing treatment|0|||
105603432|NCT04711135|364211305|FG001|Overall Study|Ongoing treatment|1|||
105603433|NCT03447249|364211309|FG000|Overall Study|Adverse Event|1|||
105603434|NCT03447249|364211310|FG001|Overall Study|Adverse Event|0|||
105603435|NCT03447249|364211309|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
105603436|NCT03447249|364211310|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
105603437|NCT03447249|364211309|FG000|Overall Study|Other|3|||
105603438|NCT03447249|364211310|FG001|Overall Study|Other|0|||
105603439|NCT00988858|364211311|FG000|Overall Study|Adverse Event|7|||
105603440|NCT00988858|364211311|FG000|Overall Study|Death|1|||
105603441|NCT00988858|364211311|FG000|Overall Study|Physician Decision|1|||
105603442|NCT00988858|364211311|FG000|Overall Study|Sponsor Decision|1|||
105603443|NCT00609336|364211315|FG000|Overall Study|Protocol Violation|3|||
105603444|NCT00609336|364211315|FG000|Overall Study|Death|1|||
105603445|NCT00609336|364211315|FG000|Overall Study|LA or Met at Surgery|9|||
105603446|NCT02238483|364211316|FG000|Overall Study|Withdrawal by Subject|2|||
105603447|NCT02238483|364211317|FG001|Overall Study|Withdrawal by Subject|7|||
105603448|NCT02238483|364211316|FG000|Overall Study|Lost to Follow-up|1|||
105603449|NCT02238483|364211317|FG001|Overall Study|Lost to Follow-up|1|||
105603450|NCT02238483|364211316|FG000|Overall Study|Protocol Violation|1|||
105603451|NCT02238483|364211317|FG001|Overall Study|Protocol Violation|2|||
105603452|NCT02238483|364211316|FG000|Overall Study|Death|1|||
105603453|NCT02238483|364211317|FG001|Overall Study|Death|0|||
105603454|NCT02238483|364211316|FG000|Overall Study|Adverse Event|7|||
105603455|NCT02238483|364211317|FG001|Overall Study|Adverse Event|3|||
105603456|NCT02238483|364211316|FG000|Overall Study|Withdrawn due to physician decision|1|||
105603457|NCT02238483|364211317|FG001|Overall Study|Withdrawn due to physician decision|0|||
105603458|NCT02238483|364211316|FG000|Overall Study|Completion status not recorded|1|||
105603459|NCT02238483|364211317|FG001|Overall Study|Completion status not recorded|1|||
105603460|NCT02238483|364211316|FG000|Overall Study|Illness in family member|1|||
105603461|NCT02238483|364211317|FG001|Overall Study|Illness in family member|0|||
105603462|NCT02574455|364211319|FG000|Overall Study|Death|197|||
105603463|NCT02574455|364211320|FG001|Overall Study|Death|210|||
105603464|NCT02574455|364211319|FG000|Overall Study|Withdrawal of Consent|11|||
105603465|NCT02574455|364211320|FG001|Overall Study|Withdrawal of Consent|28|||
105603466|NCT02574455|364211319|FG000|Overall Study|Lost to Follow-up|4|||
105603467|NCT02574455|364211320|FG001|Overall Study|Lost to Follow-up|4|||
105603468|NCT02574455|364211319|FG000|Overall Study|Sponsor's Decision|55|||
105603469|NCT02574455|364211320|FG001|Overall Study|Sponsor's Decision|20|||
105603470|NCT00390299|364211325|FG000|Overall Study|Cancellation|1|||
105603471|NCT00390299|364211326|FG001|Overall Study|Cancellation|0|||
105603472|NCT00390299|364211327|FG002|Overall Study|Cancellation|0|||
105603473|NCT00390299|364211328|FG003|Overall Study|Cancellation|0|||
105603474|NCT00390299|364211329|FG004|Overall Study|Cancellation|0|||
105603475|NCT01388361|364211333|FG000|Overall Study|Adverse Event|0|||
105603476|NCT01388361|364211334|FG001|Overall Study|Adverse Event|5|||
105603477|NCT01388361|364211335|FG002|Overall Study|Adverse Event|1|||
105603478|NCT01388361|364211333|FG000|Overall Study|Protocol Violation|0|||
105603479|NCT01388361|364211334|FG001|Overall Study|Protocol Violation|0|||
105603480|NCT01388361|364211335|FG002|Overall Study|Protocol Violation|2|||
105603481|NCT01388361|364211333|FG000|Overall Study|Withdrawal criteria|12|||
105603482|NCT01388361|364211334|FG001|Overall Study|Withdrawal criteria|7|||
105603483|NCT01388361|364211335|FG002|Overall Study|Withdrawal criteria|10|||
105603484|NCT01388361|364211333|FG000|Overall Study|Unclassified|0|||
105603485|NCT01388361|364211334|FG001|Overall Study|Unclassified|0|||
105603486|NCT01388361|364211335|FG002|Overall Study|Unclassified|1|||
105603487|NCT01747486|364211336|FG000|Stage 1|Physician Decision|3|||
105603488|NCT01747486|364211337|FG001|Stage 1|Physician Decision|0|||
105603489|NCT01747486|364211336|FG000|Stage 1|Withdrawal by Subject|4|||
105603490|NCT01747486|364211337|FG001|Stage 1|Withdrawal by Subject|3|||
105603491|NCT01747486|364211336|FG000|Stage 1|Disease progression|4|||
105603492|NCT01747486|364211337|FG001|Stage 1|Disease progression|9|||
105603493|NCT01747486|364211336|FG000|Stage 1|Death|1|||
105603494|NCT01747486|364211337|FG001|Stage 1|Death|1|||
105603495|NCT01747486|364211336|FG000|Stage 2|Physician Decision|2|||
105603496|NCT01747486|364211337|FG001|Stage 2|Physician Decision|0|||
105603497|NCT01747486|364211336|FG000|Stage 2|Withdrawal by Subject|1|||
105603498|NCT01747486|364211337|FG001|Stage 2|Withdrawal by Subject|0|||
105603499|NCT01747486|364211336|FG000|Stage 2|New Cancer Therapy|3|||
105603500|NCT01747486|364211337|FG001|Stage 2|New Cancer Therapy|0|||
105603501|NCT01747486|364211336|FG000|Stage 2|Disease Progression|3|||
105603502|NCT01747486|364211337|FG001|Stage 2|Disease Progression|0|||
105603503|NCT00065260|364211338|FG000|Overall Study|Death|0|||
105603504|NCT00065260|364211339|FG001|Overall Study|Death|1|||
105603505|NCT03750968|364211340|FG000|Overall Study|Adverse Event|2|||
105603506|NCT03750968|364211341|FG001|Overall Study|Adverse Event|0|||
105603507|NCT03750968|364211340|FG000|Overall Study|Lost to Follow-up|1|||
105603508|NCT03750968|364211341|FG001|Overall Study|Lost to Follow-up|3|||
105603509|NCT03432858|364211342|FG000|Overall Study|Protocol Violation|2|||
105603510|NCT03432858|364211343|FG001|Overall Study|Protocol Violation|1|||
105603511|NCT03432858|364211344|FG002|Overall Study|Protocol Violation|9|||
105603512|NCT03432858|364211342|FG000|Overall Study|Withdrawal by Subject|0|||
105603513|NCT03432858|364211343|FG001|Overall Study|Withdrawal by Subject|1|||
105603514|NCT03432858|364211344|FG002|Overall Study|Withdrawal by Subject|1|||
105603515|NCT03432858|364211342|FG000|Overall Study|Procedure canceled/rescheduled|0|||
105603516|NCT03432858|364211343|FG001|Overall Study|Procedure canceled/rescheduled|9|||
105603517|NCT03432858|364211344|FG002|Overall Study|Procedure canceled/rescheduled|6|||
105603518|NCT03432858|364211342|FG000|Overall Study|Required postop mobilization with splinting|0|||
105603519|NCT03432858|364211343|FG001|Overall Study|Required postop mobilization with splinting|0|||
105603520|NCT03432858|364211344|FG002|Overall Study|Required postop mobilization with splinting|1|||
105603521|NCT01044303|364211347|FG000|Overall Study|Lost to Follow-up|2|||
105603522|NCT01255670|364211350|FG000|Overall Study|Adverse Event|10|||
105603523|NCT01255670|364211351|FG001|Overall Study|Adverse Event|10|||
105603524|NCT01255670|364211350|FG000|Overall Study|Lost to Follow-up|16|||
105603525|NCT01255670|364211351|FG001|Overall Study|Lost to Follow-up|10|||
105603526|NCT01037985|364211352|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
105603527|NCT01037985|364211353|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
105603528|NCT01037985|364211352|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
105603529|NCT01037985|364211353|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
105603530|NCT01037985|364211352|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
105603531|NCT01037985|364211353|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
105603532|NCT01037985|364211352|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
105603533|NCT01037985|364211353|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
105603534|NCT02269475|364211354|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
105603535|NCT02269475|364211355|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
105603536|NCT02269475|364211354|FG000|Overall Study|Withdrawal by Subject|0|||
105603537|NCT02269475|364211355|FG001|Overall Study|Withdrawal by Subject|1|||
105603538|NCT02730871|364211356|FG000|Overall Study|Adverse Event|6|||
105603539|NCT02730871|364211357|FG001|Overall Study|Adverse Event|0|||
105603540|NCT03664960|364211358|FG000|Overall Study|Adverse Event|0|||
105603541|NCT03664960|364211359|FG001|Overall Study|Adverse Event|3|||
105603542|NCT03664960|364211358|FG000|Overall Study|Lost to Follow-up|3|||
105603543|NCT03664960|364211359|FG001|Overall Study|Lost to Follow-up|2|||
105603544|NCT03664960|364211358|FG000|Overall Study|Physician Decision|1|||
105603545|NCT03664960|364211359|FG001|Overall Study|Physician Decision|0|||
105603546|NCT03664960|364211358|FG000|Overall Study|Withdrawal by Subject|3|||
105603547|NCT03664960|364211359|FG001|Overall Study|Withdrawal by Subject|14|||
105603548|NCT03664960|364211358|FG000|Overall Study|Sponsor Decision|1|||
105603549|NCT03664960|364211359|FG001|Overall Study|Sponsor Decision|1|||
105603550|NCT03664960|364211358|FG000|Overall Study|Other|1|||
105603551|NCT03664960|364211359|FG001|Overall Study|Other|2|||
105603552|NCT00823472|364211360|FG000|Overall Study|Physician Decision|24|||
105603553|NCT00823472|364211361|FG001|Overall Study|Physician Decision|28|||
105603554|NCT04019444|364211362|FG000|Overall Study|Withdrawal by Subject|0|||
105603555|NCT04019444|364211363|FG001|Overall Study|Withdrawal by Subject|1|||
105603556|NCT04019444|364211364|FG002|Overall Study|Withdrawal by Subject|0|||
105603557|NCT04019444|364211365|FG003|Overall Study|Withdrawal by Subject|1|||
105603558|NCT04019444|364211362|FG000|Overall Study|Solicited Event|0|||
105603559|NCT04019444|364211363|FG001|Overall Study|Solicited Event|0|||
105603560|NCT04019444|364211364|FG002|Overall Study|Solicited Event|2|||
105603561|NCT04019444|364211365|FG003|Overall Study|Solicited Event|0|||
105603562|NCT01609218|364211366|FG000|Period 1|Adverse Event|3|||
105603563|NCT01609218|364211367|FG001|Period 1|Adverse Event|5|||
105603564|NCT01609218|364211366|FG000|Period 1|Sponsor Decision|0|||
105603565|NCT01609218|364211367|FG001|Period 1|Sponsor Decision|1|||
105603566|NCT01609218|364211366|FG000|Period 2|Adverse Event|1|||
105603567|NCT01609218|364211367|FG001|Period 2|Adverse Event|0|||
105603568|NCT01303445|364211370|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
105603569|NCT01303445|364211371|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
105603570|NCT01303445|364211370|FG000|Second Intervention (7 Days)|Adverse Event|0|||
105603571|NCT01303445|364211371|FG001|Second Intervention (7 Days)|Adverse Event|2|||
105603572|NCT01303445|364211370|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
105603573|NCT01303445|364211371|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
105603574|NCT01303445|364211370|FG000|Washout (14 Days)|Protocol Violation|1|||
105603575|NCT01303445|364211371|FG001|Washout (14 Days)|Protocol Violation|0|||
105603576|NCT01303445|364211370|FG000|Washout (14 Days)|Lost to Follow-up|0|||
105603577|NCT01303445|364211371|FG001|Washout (14 Days)|Lost to Follow-up|2|||
105603578|NCT01303445|364211370|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
105603579|NCT01303445|364211371|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
105603580|NCT01303445|364211370|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
105603581|NCT01303445|364211371|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
105603582|NCT03759379|364212520|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
105603583|NCT03759379|364212521|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
105603584|NCT03759379|364212520|FG000|Treatment Period|Death|2|||
105603585|NCT03759379|364212521|FG001|Treatment Period|Death|3|||
105603586|NCT03759379|364212520|FG000|Treatment Period|Lost to Follow-up|1|||
105603587|NCT03759379|364212521|FG001|Treatment Period|Lost to Follow-up|0|||
105603588|NCT03759379|364212520|FG000|Treatment Period|Physician Decision|0|||
105603589|NCT03759379|364212521|FG001|Treatment Period|Physician Decision|1|||
105603590|NCT05985044|364212522|FG000|Overall Study|Death|6|||
105603591|NCT05985044|364212522|FG000|Overall Study|Lost to Follow-up|4|||
105603592|NCT05985044|364212522|FG000|Overall Study|Incapacitation|3|||
105603593|NCT05985044|364212522|FG000|Overall Study|Withdrawal by Subject|2|||
105603594|NCT02763319|364212526|FG000|Overall Study|Adverse Event|12|||
105603595|NCT02763319|364212527|FG001|Overall Study|Adverse Event|3|||
105603596|NCT02763319|364212526|FG000|Overall Study|Death|123|||
105603597|NCT02763319|364212527|FG001|Overall Study|Death|123|||
105603598|NCT02763319|364212526|FG000|Overall Study|Lost to Follow-up|6|||
105603599|NCT02763319|364212527|FG001|Overall Study|Lost to Follow-up|7|||
105603600|NCT02763319|364212526|FG000|Overall Study|Noncompliance with Study Drug|2|||
105603601|NCT02763319|364212527|FG001|Overall Study|Noncompliance with Study Drug|0|||
105603602|NCT02763319|364212526|FG000|Overall Study|"Captured as Other in Database"|29|||
105603603|NCT02763319|364212527|FG001|Overall Study|"Captured as Other in Database"|34|||
105603604|NCT02763319|364212526|FG000|Overall Study|Physician Decision|1|||
105603605|NCT02763319|364212527|FG001|Overall Study|Physician Decision|7|||
105603606|NCT02763319|364212526|FG000|Overall Study|Progressive Disease|24|||
105603607|NCT02763319|364212527|FG001|Overall Study|Progressive Disease|27|||
105603608|NCT02763319|364212526|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
105603609|NCT02763319|364212527|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
105603610|NCT02763319|364212526|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
105603611|NCT02763319|364212527|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
105603612|NCT02763319|364212526|FG000|Overall Study|Withdrawal by Subject|26|||
105603613|NCT02763319|364212527|FG001|Overall Study|Withdrawal by Subject|25|||
105603614|NCT01939899|364212528|FG000|Lead-in Dose Finding Phase|Death|0|||
105603615|NCT01939899|364212529|FG001|Lead-in Dose Finding Phase|Death|3|||
105603616|NCT01939899|364212530|FG002|Lead-in Dose Finding Phase|Death|1|||
105603617|NCT01939899|364212531|FG003|Lead-in Dose Finding Phase|Death|0|||
105603618|NCT01939899|364212532|FG004|Lead-in Dose Finding Phase|Death|0|||
105603619|NCT01939899|364212528|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
105603620|NCT01939899|364212529|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
105603621|NCT01939899|364212530|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
105603622|NCT01939899|364212531|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
105603623|NCT01939899|364212532|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
105603624|NCT01939899|364212528|FG000|Lead-in Dose Finding Phase|Other|0|||
105603625|NCT01939899|364212529|FG001|Lead-in Dose Finding Phase|Other|0|||
105603626|NCT01939899|364212530|FG002|Lead-in Dose Finding Phase|Other|1|||
105603627|NCT01939899|364212531|FG003|Lead-in Dose Finding Phase|Other|0|||
105603628|NCT01939899|364212532|FG004|Lead-in Dose Finding Phase|Other|0|||
105603629|NCT01939899|364212528|FG000|Phase 2|Withdrawal by Subject|0|||
105603630|NCT01939899|364212529|FG001|Phase 2|Withdrawal by Subject|0|||
105603631|NCT01939899|364212530|FG002|Phase 2|Withdrawal by Subject|0|||
105603632|NCT01939899|364212531|FG003|Phase 2|Withdrawal by Subject|2|||
105603633|NCT01939899|364212532|FG004|Phase 2|Withdrawal by Subject|0|||
105603634|NCT01939899|364212528|FG000|Phase 2|Disease Progression|0|||
105603635|NCT01939899|364212529|FG001|Phase 2|Disease Progression|0|||
105603636|NCT01939899|364212530|FG002|Phase 2|Disease Progression|0|||
105603637|NCT01939899|364212531|FG003|Phase 2|Disease Progression|9|||
105603638|NCT01939899|364212532|FG004|Phase 2|Disease Progression|1|||
105603639|NCT00585052|364212533|FG000|Overall Study|Withdrawal by Subject|1|||
105603640|NCT05119855|364212534|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
105603641|NCT05119855|364212535|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
105603642|NCT05119855|364212534|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
105603643|NCT05119855|364212535|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
105603644|NCT05119855|364212534|FG000|Overall Study|Lost to Follow-up|6|||
105603645|NCT05119855|364212535|FG001|Overall Study|Lost to Follow-up|8|||
105603646|NCT02675244|364212537|FG000|Overall Study|Death|9|||
105603647|NCT02675244|364212538|FG001|Overall Study|Death|6|||
105603648|NCT02675244|364212537|FG000|Overall Study|Withdrawal by Subject|3|||
105603649|NCT02675244|364212538|FG001|Overall Study|Withdrawal by Subject|6|||
105603650|NCT02675244|364212537|FG000|Overall Study|Lost to Follow-up|1|||
105603651|NCT02675244|364212538|FG001|Overall Study|Lost to Follow-up|1|||
105603652|NCT02675244|364212537|FG000|Overall Study|Ongoing at 2 Years|190|||
105603653|NCT02675244|364212538|FG001|Overall Study|Ongoing at 2 Years|185|||
105603654|NCT05489484|364212539|FG000|Overall Study|withdrawn|1|||
105603655|NCT02462759|364212542|FG000|Part 1: Double Blind|Death|1|||
105603656|NCT02462759|364212543|FG001|Part 1: Double Blind|Death|0|||
105603657|NCT02462759|364212544|FG002|Part 1: Double Blind|Death|0|||
105603658|NCT04328727|364212550|FG000|Overall Study|Guardian Decision|1|||
105603659|NCT04328727|364212550|FG000|Overall Study|Participant decision|4|||
105603660|NCT04328727|364212550|FG000|Overall Study|Death|3|||
105603661|NCT04629950|364212551|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
105603662|NCT04629950|364212552|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
105603663|NCT04629950|364212553|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
105603664|NCT04629950|364212554|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
105603665|NCT04629950|364212551|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
105603666|NCT04629950|364212552|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
105603667|NCT04629950|364212553|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
105603668|NCT04629950|364212554|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
105603669|NCT04629950|364212551|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
105603670|NCT04629950|364212552|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
105603671|NCT04629950|364212553|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
105603672|NCT04629950|364212554|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
105603673|NCT04629950|364212551|FG000|Extension Study|Withdrawal by Subject|0|||
105603674|NCT04629950|364212552|FG001|Extension Study|Withdrawal by Subject|0|||
105603675|NCT04629950|364212553|FG002|Extension Study|Withdrawal by Subject|1|||
105603676|NCT04629950|364212554|FG003|Extension Study|Withdrawal by Subject|0|||
105603677|NCT04629950|364212551|FG000|Extension Study|Adverse Event|0|||
105603678|NCT04629950|364212552|FG001|Extension Study|Adverse Event|0|||
105603679|NCT04629950|364212553|FG002|Extension Study|Adverse Event|0|||
105603680|NCT04629950|364212554|FG003|Extension Study|Adverse Event|1|||
105603681|NCT02088853|364212555|FG000|Overall Study|Pregnancy|1|||
105603682|NCT02088853|364212556|FG001|Overall Study|Pregnancy|0|||
105603683|NCT04583423|364212558|FG000|Overall Study|Lost to Follow-up|0|||
105603684|NCT04583423|364212559|FG001|Overall Study|Lost to Follow-up|1|||
105603685|NCT04583423|364212560|FG002|Overall Study|Lost to Follow-up|0|||
105603686|NCT04583423|364212561|FG003|Overall Study|Lost to Follow-up|2|||
105603687|NCT04583423|364212558|FG000|Overall Study|Study Terminated by Sponsor|32|||
105603688|NCT04583423|364212559|FG001|Overall Study|Study Terminated by Sponsor|35|||
105603689|NCT04583423|364212560|FG002|Overall Study|Study Terminated by Sponsor|36|||
105603690|NCT04583423|364212561|FG003|Overall Study|Study Terminated by Sponsor|33|||
105603691|NCT04583423|364212558|FG000|Overall Study|Withdrawal by Subject|3|||
105603692|NCT04583423|364212559|FG001|Overall Study|Withdrawal by Subject|1|||
105603693|NCT04583423|364212560|FG002|Overall Study|Withdrawal by Subject|2|||
105603694|NCT04583423|364212561|FG003|Overall Study|Withdrawal by Subject|1|||
105603695|NCT04704284|364212562|FG000|Overall Study|Withdrawal by Subject|1|||
105603696|NCT01017146|364212568|FG000|Overall Study|Adverse Event|11|||
105603697|NCT01017146|364212569|FG001|Overall Study|Adverse Event|1|||
105603698|NCT01017146|364212568|FG000|Overall Study|Lost to Follow-up|14|||
105603699|NCT01017146|364212569|FG001|Overall Study|Lost to Follow-up|14|||
105603700|NCT01017146|364212568|FG000|Overall Study|Noncompliance with Study Product|1|||
105603701|NCT01017146|364212569|FG001|Overall Study|Noncompliance with Study Product|1|||
105603702|NCT01017146|364212568|FG000|Overall Study|Withdrawal by Subject|32|||
105603703|NCT01017146|364212569|FG001|Overall Study|Withdrawal by Subject|16|||
105603704|NCT01017146|364212568|FG000|Overall Study|Relocation|0|||
105603705|NCT01017146|364212569|FG001|Overall Study|Relocation|4|||
105603706|NCT01017146|364212568|FG000|Overall Study|Pregnancy|2|||
105603707|NCT01017146|364212569|FG001|Overall Study|Pregnancy|1|||
105603708|NCT01017146|364212568|FG000|Overall Study|Protocol Violation|2|||
105603709|NCT01017146|364212569|FG001|Overall Study|Protocol Violation|0|||
105603710|NCT01017146|364212568|FG000|Overall Study|Took Excluded Medication|2|||
105603711|NCT01017146|364212569|FG001|Overall Study|Took Excluded Medication|0|||
105603712|NCT01017146|364212568|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
105603713|NCT01017146|364212569|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
105603714|NCT01017146|364212568|FG000|Overall Study|Change in Work Situation|1|||
105603715|NCT01017146|364212569|FG001|Overall Study|Change in Work Situation|0|||
105603716|NCT00976937|364212574|FG000|Overall Study|Adverse Event|4|||
105603717|NCT00976937|364212575|FG001|Overall Study|Adverse Event|5|||
105603718|NCT00976937|364212574|FG000|Overall Study|Lost to Follow-up|2|||
105603719|NCT00976937|364212575|FG001|Overall Study|Lost to Follow-up|1|||
105603720|NCT00976937|364212574|FG000|Overall Study|Withdrawal by Subject|5|||
105603721|NCT00976937|364212575|FG001|Overall Study|Withdrawal by Subject|3|||
105603722|NCT00976937|364212574|FG000|Overall Study|Poor compliance to protocol|3|||
105603723|NCT00976937|364212575|FG001|Overall Study|Poor compliance to protocol|0|||
105603724|NCT00976937|364212574|FG000|Overall Study|Personal and Familial Reason|2|||
105603725|NCT00976937|364212575|FG001|Overall Study|Personal and Familial Reason|2|||
105603726|NCT02372253|364212579|FG000|Overall Study|Non Compliance|2|||
105603727|NCT02372253|364212580|FG001|Overall Study|Non Compliance|0|||
105603728|NCT03201562|364212581|FG000|Overall Study|Physician Decision|0|||
105603729|NCT03201562|364212582|FG001|Overall Study|Physician Decision|0|||
105603730|NCT03201562|364212583|FG002|Overall Study|Physician Decision|1|||
105603731|NCT03201562|364212581|FG000|Overall Study|Adverse Event|0|||
105603732|NCT03201562|364212582|FG001|Overall Study|Adverse Event|0|||
105603733|NCT03201562|364212583|FG002|Overall Study|Adverse Event|1|||
105603734|NCT03201562|364212581|FG000|Overall Study|Lost to Follow-up|0|||
105603735|NCT03201562|364212582|FG001|Overall Study|Lost to Follow-up|1|||
105603736|NCT03201562|364212583|FG002|Overall Study|Lost to Follow-up|2|||
105603737|NCT00001277|364212584|FG000|Overall Study|Adverse Event|0|||
105603738|NCT00001277|364212585|FG001|Overall Study|Adverse Event|0|||
105603739|NCT00001277|364212586|FG002|Overall Study|Adverse Event|1|||
105603740|NCT00001277|364212584|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
105603741|NCT00001277|364212585|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
105603742|NCT00001277|364212586|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
105603743|NCT04484935|364212587|FG000|Overall Study|Other|0|||
105603744|NCT04484935|364212588|FG001|Overall Study|Other|1|||
105603745|NCT04484935|364212587|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105603746|NCT04484935|364212588|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105603747|NCT04484935|364212587|FG000|Overall Study|Lost to Follow-up|1|||
105603748|NCT04484935|364212588|FG001|Overall Study|Lost to Follow-up|0|||
105603749|NCT04484935|364212587|FG000|Overall Study|Death|2|||
105603750|NCT04484935|364212588|FG001|Overall Study|Death|1|||
105603751|NCT02178098|364212589|FG000|Overall Study|Withdrawal by Subject|0|||
105603752|NCT02178098|364212590|FG001|Overall Study|Withdrawal by Subject|6|||
105603753|NCT02178098|364212589|FG000|Overall Study|Adverse Event|1|||
105603754|NCT02178098|364212590|FG001|Overall Study|Adverse Event|2|||
105603755|NCT02178098|364212589|FG000|Overall Study|Protocol Violation|1|||
105603756|NCT02178098|364212590|FG001|Overall Study|Protocol Violation|1|||
105603757|NCT02178098|364212589|FG000|Overall Study|Lost to Follow-up|0|||
105603758|NCT02178098|364212590|FG001|Overall Study|Lost to Follow-up|1|||
105603759|NCT02178098|364212589|FG000|Overall Study|Sponsor Request|1|||
105603760|NCT02178098|364212590|FG001|Overall Study|Sponsor Request|0|||
105603761|NCT02178098|364212589|FG000|Overall Study|Other|2|||
105603762|NCT02178098|364212590|FG001|Overall Study|Other|2|||
105603763|NCT01109524|364212592|FG000|Overall Study|Disease Progression|29|||
105603764|NCT01109524|364212592|FG000|Overall Study|Study Drug toxicity|6|||
105603765|NCT01109524|364212592|FG000|Overall Study|Adverse Event|4|||
105603766|NCT01109524|364212592|FG000|Overall Study|Withdrawal by Subject|2|||
105603767|NCT01109524|364212592|FG000|Overall Study|Maximum clinical benefit|3|||
105603768|NCT01109524|364212592|FG000|Overall Study|Death|2|||
105603769|NCT01109524|364212592|FG000|Overall Study|No longer meets criteria|2|||
105603770|NCT01109524|364212592|FG000|Overall Study|Participant requested to end treatment|4|||
105603771|NCT01109524|364212592|FG000|Overall Study|Other|5|||
105603772|NCT00031694|364212593|FG000|Overall Study|Adverse Event|12|||
105603773|NCT00031694|364212593|FG000|Overall Study|Death|2|||
105603774|NCT00031694|364212593|FG000|Overall Study|Withdrawal by Subject|5|||
105603775|NCT04428112|364212597|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
105603776|NCT04428112|364212598|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
105603777|NCT04428112|364212597|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
105603778|NCT04428112|364212598|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
105603779|NCT04428112|364212597|FG000|Overall Study|Withdrawal by Subject|9|||
105603780|NCT04428112|364212598|FG001|Overall Study|Withdrawal by Subject|4|||
105603781|NCT04428112|364212597|FG000|Overall Study|Lost to Follow-up|27|||
105603782|NCT04428112|364212598|FG001|Overall Study|Lost to Follow-up|7|||
105603783|NCT04992390|364212600|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
105603784|NCT04992390|364212601|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
105603785|NCT04992390|364212602|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
105603786|NCT04992390|364212600|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
105603787|NCT04992390|364212601|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
105603788|NCT04992390|364212602|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
105603789|NCT04992390|364212600|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
105603790|NCT04992390|364212601|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
105603791|NCT04992390|364212602|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
105603792|NCT04992390|364212600|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
105603793|NCT04992390|364212601|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
105603794|NCT04992390|364212602|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
105603795|NCT04992390|364212600|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
105603796|NCT04992390|364212601|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
105603797|NCT04992390|364212602|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
105603798|NCT04992390|364212600|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
105603799|NCT04992390|364212601|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
105603800|NCT04992390|364212602|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
105603801|NCT04992390|364212600|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
105603802|NCT04992390|364212601|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
105603803|NCT04992390|364212602|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
105603804|NCT04992390|364212600|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
105603805|NCT04992390|364212601|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
105603806|NCT04992390|364212602|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
105603807|NCT04992390|364212600|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
105603808|NCT04992390|364212601|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
105603809|NCT04992390|364212602|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
105603810|NCT04992390|364212600|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
105603811|NCT04992390|364212601|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
105603812|NCT04992390|364212602|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
105603813|NCT04992390|364212600|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
105603814|NCT04992390|364212601|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
105603815|NCT04992390|364212602|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
105603816|NCT04992390|364212600|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
105603817|NCT04992390|364212601|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
105603818|NCT04992390|364212602|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
105603819|NCT04992390|364212600|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
105603820|NCT04992390|364212601|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
105603821|NCT04992390|364212602|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
105603822|NCT04992390|364212600|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
105603823|NCT04992390|364212601|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
105603824|NCT04992390|364212602|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
105603825|NCT04992390|364212600|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
105603826|NCT04992390|364212601|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
105603827|NCT04992390|364212602|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
105603828|NCT04992390|364212600|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
105603829|NCT04992390|364212601|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
105603830|NCT04992390|364212602|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
105603831|NCT01207492|364212604|FG000|Overall Study|Still on study|1|||
105603832|NCT01207492|364212604|FG000|Overall Study|Withdrawal by Subject|9|||
105603833|NCT01207492|364212604|FG000|Overall Study|Physician Decision|1|||
105603834|NCT01207492|364212604|FG000|Overall Study|Progressive disease|3|||
105603835|NCT01207492|364212604|FG000|Overall Study|Toxicity|1|||
105603836|NCT02807779|364212605|FG000|Overall Study|Lost to Follow-up|1|||
105603837|NCT02807779|364212606|FG001|Overall Study|Lost to Follow-up|0|||
105603838|NCT02807779|364212607|FG002|Overall Study|Lost to Follow-up|0|||
105603839|NCT02807779|364212605|FG000|Overall Study|Physician Decision|2|||
105603840|NCT02807779|364212606|FG001|Overall Study|Physician Decision|0|||
105603841|NCT02807779|364212607|FG002|Overall Study|Physician Decision|1|||
105603842|NCT02807779|364212605|FG000|Overall Study|Death|1|||
105603843|NCT02807779|364212606|FG001|Overall Study|Death|1|||
105603844|NCT02807779|364212607|FG002|Overall Study|Death|0|||
105603845|NCT03312907|364213462|FG000|Overall Study|Adverse Event|1|||
105603846|NCT03312907|364213463|FG001|Overall Study|Adverse Event|6|||
105603847|NCT03312907|364213464|FG002|Overall Study|Adverse Event|1|||
105603848|NCT03312907|364213462|FG000|Overall Study|Protocol Violation|2|||
105603849|NCT03312907|364213463|FG001|Overall Study|Protocol Violation|3|||
105603850|NCT03312907|364213464|FG002|Overall Study|Protocol Violation|4|||
105603851|NCT03312907|364213462|FG000|Overall Study|Lost to Follow-up|2|||
105603852|NCT03312907|364213463|FG001|Overall Study|Lost to Follow-up|3|||
105603853|NCT03312907|364213464|FG002|Overall Study|Lost to Follow-up|2|||
105603854|NCT03312907|364213462|FG000|Overall Study|Physician Decision|3|||
105603855|NCT03312907|364213463|FG001|Overall Study|Physician Decision|4|||
105603856|NCT03312907|364213464|FG002|Overall Study|Physician Decision|2|||
105603857|NCT03312907|364213462|FG000|Overall Study|Withdrawal by Subject|9|||
105603858|NCT03312907|364213463|FG001|Overall Study|Withdrawal by Subject|14|||
105603859|NCT03312907|364213464|FG002|Overall Study|Withdrawal by Subject|10|||
105603860|NCT03725722|364213465|FG000|Overall Study|Lack of Efficacy|2|||
105603861|NCT03725722|364213466|FG001|Overall Study|Lack of Efficacy|1|||
105603862|NCT03725722|364213467|FG002|Overall Study|Lack of Efficacy|2|||
105603863|NCT03725722|364213468|FG003|Overall Study|Lack of Efficacy|0|||
105603864|NCT03725722|364213469|FG004|Overall Study|Lack of Efficacy|2|||
105603865|NCT03725722|364213465|FG000|Overall Study|Adverse Event|2|||
105603866|NCT03725722|364213466|FG001|Overall Study|Adverse Event|2|||
105603867|NCT03725722|364213467|FG002|Overall Study|Adverse Event|1|||
105603868|NCT03725722|364213468|FG003|Overall Study|Adverse Event|0|||
105603869|NCT03725722|364213469|FG004|Overall Study|Adverse Event|6|||
105603870|NCT03725722|364213465|FG000|Overall Study|Withdrawal by Subject|4|||
105603871|NCT03725722|364213466|FG001|Overall Study|Withdrawal by Subject|1|||
105603872|NCT03725722|364213467|FG002|Overall Study|Withdrawal by Subject|0|||
105603873|NCT03725722|364213468|FG003|Overall Study|Withdrawal by Subject|4|||
105603874|NCT03725722|364213469|FG004|Overall Study|Withdrawal by Subject|4|||
105603875|NCT03725722|364213465|FG000|Overall Study|Lost to Follow-up|3|||
105603876|NCT03725722|364213466|FG001|Overall Study|Lost to Follow-up|1|||
105603877|NCT03725722|364213467|FG002|Overall Study|Lost to Follow-up|2|||
105603878|NCT03725722|364213468|FG003|Overall Study|Lost to Follow-up|2|||
105603879|NCT03725722|364213469|FG004|Overall Study|Lost to Follow-up|1|||
105603880|NCT03725722|364213465|FG000|Overall Study|Personal reasons|0|||
105603881|NCT03725722|364213466|FG001|Overall Study|Personal reasons|0|||
105603882|NCT03725722|364213467|FG002|Overall Study|Personal reasons|1|||
105603883|NCT03725722|364213468|FG003|Overall Study|Personal reasons|0|||
105603884|NCT03725722|364213469|FG004|Overall Study|Personal reasons|1|||
105603885|NCT03725722|364213465|FG000|Overall Study|COVID-19 situation|0|||
105603886|NCT03725722|364213466|FG001|Overall Study|COVID-19 situation|1|||
105603887|NCT03725722|364213467|FG002|Overall Study|COVID-19 situation|0|||
105603888|NCT03725722|364213468|FG003|Overall Study|COVID-19 situation|0|||
105603889|NCT03725722|364213469|FG004|Overall Study|COVID-19 situation|0|||
105603890|NCT03189524|364213472|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
105603891|NCT03189524|364213473|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
105603892|NCT03189524|364213474|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
105603893|NCT03189524|364213472|FG000|Overall Study|Death|2|||
105603894|NCT03189524|364213473|FG001|Overall Study|Death|2|||
105603895|NCT03189524|364213474|FG002|Overall Study|Death|1|||
105603896|NCT03189524|364213472|FG000|Overall Study|Lost to Follow-up|1|||
105603897|NCT03189524|364213473|FG001|Overall Study|Lost to Follow-up|0|||
105603898|NCT03189524|364213474|FG002|Overall Study|Lost to Follow-up|8|||
105603899|NCT03189524|364213472|FG000|Overall Study|Withdrawal by Subject|1|||
105603900|NCT03189524|364213473|FG001|Overall Study|Withdrawal by Subject|1|||
105603901|NCT03189524|364213474|FG002|Overall Study|Withdrawal by Subject|3|||
105603902|NCT03189524|364213472|FG000|Overall Study|Progressive Disease|0|||
105603903|NCT03189524|364213473|FG001|Overall Study|Progressive Disease|2|||
105603904|NCT03189524|364213474|FG002|Overall Study|Progressive Disease|0|||
105603905|NCT01780298|364213475|FG000|Overall Study|Physician Decision|1|||
105603906|NCT01780298|364213476|FG001|Overall Study|Physician Decision|5|||
105603907|NCT01780298|364213477|FG002|Overall Study|Physician Decision|1|||
105603908|NCT01780298|364213478|FG003|Overall Study|Physician Decision|1|||
105603909|NCT01780298|364213475|FG000|Overall Study|Subject not matched|1|||
105603910|NCT01780298|364213476|FG001|Overall Study|Subject not matched|0|||
105603911|NCT01780298|364213477|FG002|Overall Study|Subject not matched|1|||
105603912|NCT01780298|364213478|FG003|Overall Study|Subject not matched|0|||
105603913|NCT01780298|364213475|FG000|Overall Study|Adverse Event|0|||
105603914|NCT01780298|364213476|FG001|Overall Study|Adverse Event|0|||
105603915|NCT01780298|364213477|FG002|Overall Study|Adverse Event|2|||
105603916|NCT01780298|364213478|FG003|Overall Study|Adverse Event|0|||
105603917|NCT04139668|364213479|FG000|Overall Study|Withdrawal by Subject|1|||
105603918|NCT01843374|364213480|FG000|Overall Study|Death|155|||
105603919|NCT01843374|364213481|FG001|Overall Study|Death|313|||
105603920|NCT01843374|364213480|FG000|Overall Study|Withdrawal by Subject|14|||
105603921|NCT01843374|364213481|FG001|Overall Study|Withdrawal by Subject|20|||
105603922|NCT01843374|364213480|FG000|Overall Study|Withdrawing due to Other reason|20|||
105603923|NCT01843374|364213481|FG001|Overall Study|Withdrawing due to Other reason|46|||
105603924|NCT04755660|364213484|FG000|Overall Study|Lost to Follow-up|1|||
105603925|NCT04755660|364213485|FG001|Overall Study|Lost to Follow-up|1|||
105603926|NCT04755660|364213486|FG002|Overall Study|Lost to Follow-up|0|||
105603927|NCT04755660|364213484|FG000|Overall Study|Withdrawal by Subject|0|||
105603928|NCT04755660|364213485|FG001|Overall Study|Withdrawal by Subject|1|||
105603929|NCT04755660|364213486|FG002|Overall Study|Withdrawal by Subject|1|||
105603930|NCT04755660|364213484|FG000|Overall Study|Physician Decision|0|||
105603931|NCT04755660|364213485|FG001|Overall Study|Physician Decision|0|||
105603932|NCT04755660|364213486|FG002|Overall Study|Physician Decision|1|||
105603933|NCT03613740|364213490|FG000|Overall Study|Lost to Follow-up|1|||
105603934|NCT03613740|364213491|FG001|Overall Study|Lost to Follow-up|1|||
105603935|NCT04279574|364213492|FG000|Overall Study|Death|1|||
105603936|NCT04279574|364213493|FG001|Overall Study|Death|0|||
105603937|NCT04279574|364213492|FG000|Overall Study|lost restoration, tooth fracture|1|||
105603938|NCT04279574|364213493|FG001|Overall Study|lost restoration, tooth fracture|0|||
105603939|NCT04279574|364213492|FG000|Overall Study|Lost to Follow-up|0|||
105603940|NCT04279574|364213493|FG001|Overall Study|Lost to Follow-up|1|||
105603941|NCT01693120|364213495|FG000|Enrollment|Lost to Follow-up|1|||
105603942|NCT01693120|364213495|FG000|Enrollment|Withdrawal by Subject|10|||
105603943|NCT01693120|364213495|FG000|Enrollment|Protocol Violation|46|||
105603944|NCT01693120|364213495|FG000|Enrollment|Physician Decision|3|||
105603945|NCT01693120|364213495|FG000|Enrollment|Adverse Event|1|||
105603946|NCT01693120|364213495|FG000|Enrollment|Study closed|8|||
105603947|NCT01693120|364213495|FG000|Enrollment|Other|1|||
105603948|NCT01693120|364213495|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
105603949|NCT01693120|364213495|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
105603950|NCT01693120|364213495|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
105603951|NCT01693120|364213495|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
105603952|NCT01693120|364213495|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
105603953|NCT03936660|364213496|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
105603954|NCT03936660|364213497|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
105603955|NCT00093015|364213502|FG000|Overall Study|Withdrawal by Subject|194|||
105603956|NCT00093015|364213503|FG001|Overall Study|Withdrawal by Subject|171|||
105603957|NCT00093015|364213502|FG000|Overall Study|Lost to Follow-up|96|||
105603958|NCT00093015|364213503|FG001|Overall Study|Lost to Follow-up|108|||
105603959|NCT00093015|364213502|FG000|Overall Study|Death|375|||
105603960|NCT00093015|364213503|FG001|Overall Study|Death|385|||
105603961|NCT00522951|364213506|FG000|Period 1|body motion|0|||
105603962|NCT00522951|364213507|FG001|Period 1|body motion|1|||
105603963|NCT00522951|364213506|FG000|Washout Period|Adverse Event|0|||
105603964|NCT00522951|364213507|FG001|Washout Period|Adverse Event|1|||
105603965|NCT00522951|364213506|FG000|Washout Period|Death|0|||
105603966|NCT00522951|364213507|FG001|Washout Period|Death|1|||
105603967|NCT00522951|364213506|FG000|Period 2|Withdrawal by Subject|1|||
105603968|NCT00522951|364213507|FG001|Period 2|Withdrawal by Subject|0|||
105603969|NCT00522951|364213506|FG000|Period 2|residual contrast medium|1|||
105603970|NCT00522951|364213507|FG001|Period 2|residual contrast medium|1|||
105603971|NCT03930420|364213508|FG000|Overall Study|Withdrawal by Subject|7|||
105603972|NCT03930420|364213509|FG001|Overall Study|Withdrawal by Subject|9|||
105603973|NCT04556981|364213510|FG000|Overall Study|Death|0|||
105603974|NCT04556981|364213511|FG001|Overall Study|Death|1|||
105603975|NCT04556981|364213510|FG000|Overall Study|Lost to Follow-up|2|||
105603976|NCT04556981|364213511|FG001|Overall Study|Lost to Follow-up|11|||
105603977|NCT04556981|364213510|FG000|Overall Study|Moved from the study area|1|||
105603978|NCT04556981|364213511|FG001|Overall Study|Moved from the study area|4|||
105603979|NCT04556981|364213510|FG000|Overall Study|Withdrawal by Subject|2|||
105603980|NCT04556981|364213511|FG001|Overall Study|Withdrawal by Subject|2|||
105603981|NCT04556981|364213510|FG000|Overall Study|Other|2|||
105603982|NCT04556981|364213511|FG001|Overall Study|Other|1|||
105603983|NCT00580866|364213512|FG000|Overall Study|Lost to Follow-up|2|||
105603984|NCT00580866|364213513|FG001|Overall Study|Lost to Follow-up|2|||
105603985|NCT02677896|364213514|FG000|Double Blind Period (up to 35 Months)|Death|117|||
105603986|NCT02677896|364213515|FG001|Double Blind Period (up to 35 Months)|Death|197|||
105603987|NCT02677896|364213514|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
105603988|NCT02677896|364213515|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
105603989|NCT02677896|364213514|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
105603990|NCT02677896|364213515|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
105603991|NCT02677896|364213514|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
105603992|NCT02677896|364213515|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
105603993|NCT02677896|364213514|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
105603994|NCT02677896|364213515|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
105603995|NCT02677896|364213514|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
105603996|NCT02677896|364213515|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
105603997|NCT02677896|364213514|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
105603998|NCT02677896|364213515|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
105603999|NCT02677896|364213514|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
105604000|NCT02677896|364213515|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
105604001|NCT02677896|364213514|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
105604002|NCT02677896|364213515|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
105604003|NCT02677896|364213514|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
105604004|NCT02677896|364213515|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
105604005|NCT02677896|364213514|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
105604006|NCT02677896|364213515|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
105604007|NCT02677896|364213514|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
105604008|NCT02677896|364213515|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
105604009|NCT02677896|364213514|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
105604010|NCT02677896|364213515|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
105604011|NCT02677896|364213514|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
105604012|NCT02677896|364213515|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
105604013|NCT02321514|364213516|FG000|Overall Study|Death|15|||
105604014|NCT02321514|364213516|FG000|Overall Study|Missed Visit|7|||
105604015|NCT02321514|364213516|FG000|Overall Study|Study Exit|3|||
105604016|NCT03690206|364213528|FG000|Overall Study|Withdrawal by Subject|2|||
105604017|NCT03690206|364213529|FG001|Overall Study|Withdrawal by Subject|0|||
105604018|NCT03690206|364213530|FG002|Overall Study|Withdrawal by Subject|0|||
105604019|NCT03690206|364213528|FG000|Overall Study|ICF withdrawal|2|||
105604020|NCT03690206|364213529|FG001|Overall Study|ICF withdrawal|0|||
105604021|NCT03690206|364213530|FG002|Overall Study|ICF withdrawal|0|||
105604022|NCT04939246|364213531|FG000|After Treatment|Death|4|||
105604023|NCT04939246|364213531|FG000|After Treatment|Lost to Follow-up|1|||
105604024|NCT04939246|364213531|FG000|After Treatment|Discharged to hospice|2|||
105604025|NCT04402294|364213532|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
105604026|NCT04402294|364213533|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
105604027|NCT04402294|364213532|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
105604028|NCT04402294|364213533|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
105604029|NCT05656911|364214721|FG000|Treatment Phase|Physician Decision|2|||
105604030|NCT05656911|364214722|FG001|Treatment Phase|Physician Decision|0|||
105604031|NCT05656911|364214721|FG000|Treatment Phase|Lack of Efficacy|6|||
105604032|NCT05656911|364214722|FG001|Treatment Phase|Lack of Efficacy|3|||
105604033|NCT05656911|364214721|FG000|Treatment Phase|Subject Decision|4|||
105604034|NCT05656911|364214722|FG001|Treatment Phase|Subject Decision|2|||
105604035|NCT05656911|364214721|FG000|Treatment Phase|Other Reasons|1|||
105604036|NCT05656911|364214722|FG001|Treatment Phase|Other Reasons|0|||
105604037|NCT05656911|364214721|FG000|Treatment Phase|Adverse Event|3|||
105604038|NCT05656911|364214722|FG001|Treatment Phase|Adverse Event|1|||
105604039|NCT05656911|364214721|FG000|Follow-up Phase|Subject Decision|0|||
105604040|NCT05656911|364214722|FG001|Follow-up Phase|Subject Decision|1|||
105604041|NCT05656911|364214721|FG000|Follow-up Phase|Missing|1|||
105604042|NCT05656911|364214722|FG001|Follow-up Phase|Missing|0|||
105604043|NCT00670046|364214731|FG000|Overall Study|Lost to Follow-up|1|||
105604044|NCT00670046|364214732|FG001|Overall Study|Lost to Follow-up|1|||
105604045|NCT00670046|364214731|FG000|Overall Study|Withdrawal by Subject|0|||
105604046|NCT00670046|364214732|FG001|Overall Study|Withdrawal by Subject|1|||
105604047|NCT02566902|364214733|FG000|Overall Study|Protocol Violation|2|||
105604048|NCT02566902|364214734|FG001|Overall Study|Protocol Violation|1|||
105604049|NCT01471691|364214735|FG000|Overall Study|Lack of Efficacy|0|||
105604050|NCT01471691|364214736|FG001|Overall Study|Lack of Efficacy|1|||
105604051|NCT02461628|364214740|FG000|Overall Study|Refused to complete survey|4|||
105604052|NCT02461628|364214741|FG001|Overall Study|Refused to complete survey|7|||
105604053|NCT04759833|364214742|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
105604054|NCT04759833|364214743|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
105604055|NCT04759833|364214744|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
105604056|NCT04759833|364214745|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
105604057|NCT04759833|364214746|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
105604058|NCT04759833|364214742|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
105604059|NCT04759833|364214743|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
105604060|NCT04759833|364214744|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
105604061|NCT04759833|364214745|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
105604062|NCT04759833|364214746|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
105604063|NCT04759833|364214742|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
105604064|NCT04759833|364214743|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
105604065|NCT04759833|364214744|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
105604066|NCT04759833|364214745|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
105604067|NCT04759833|364214746|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
105604068|NCT04759833|364214742|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
105604069|NCT04759833|364214743|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
105604070|NCT04759833|364214744|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
105604071|NCT04759833|364214745|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
105604072|NCT04759833|364214746|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
105604073|NCT04759833|364214742|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
105604074|NCT04759833|364214743|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
105604075|NCT04759833|364214744|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
105604076|NCT04759833|364214745|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
105604077|NCT04759833|364214746|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
105604078|NCT04759833|364214742|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
105604079|NCT04759833|364214743|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
105604080|NCT04759833|364214744|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
105604081|NCT04759833|364214745|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
105604082|NCT04759833|364214746|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
105604083|NCT04759833|364214742|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
105604084|NCT04759833|364214743|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
105604085|NCT04759833|364214744|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
105604086|NCT04759833|364214745|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
105604087|NCT04759833|364214746|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
105604088|NCT04759833|364214742|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
105604089|NCT04759833|364214743|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
105604090|NCT04759833|364214744|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
105604091|NCT04759833|364214745|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
105604092|NCT04759833|364214746|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
105604093|NCT04759833|364214742|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
105604094|NCT04759833|364214743|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
105604095|NCT04759833|364214744|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
105604096|NCT04759833|364214745|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
105604097|NCT04759833|364214746|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
105604098|NCT04759833|364214742|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
105604099|NCT04759833|364214743|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
105604100|NCT04759833|364214744|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
105604101|NCT04759833|364214745|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
105604102|NCT04759833|364214746|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
105604103|NCT04759833|364214742|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
105604104|NCT04759833|364214743|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
105604105|NCT04759833|364214744|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
105604106|NCT04759833|364214745|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
105604107|NCT04759833|364214746|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
105604108|NCT04759833|364214742|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
105604109|NCT04759833|364214743|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
105604110|NCT04759833|364214744|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
105604111|NCT04759833|364214745|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
105604112|NCT04759833|364214746|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
105604113|NCT04759833|364214742|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
105604114|NCT04759833|364214743|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
105604115|NCT04759833|364214744|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
105604116|NCT04759833|364214745|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
105604117|NCT04759833|364214746|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
105604118|NCT01610297|364214747|FG000|Overall Study|Lost to Follow-up|1|||
105604119|NCT02121002|364214748|FG000|Overall Study|Physician Decision|2|||
105604120|NCT02121002|364214749|FG001|Overall Study|Physician Decision|0|||
105604121|NCT02121002|364214750|FG002|Overall Study|Physician Decision|0|||
105604122|NCT02121002|364214748|FG000|Overall Study|Withdrawal by Subject|3|||
105604123|NCT02121002|364214749|FG001|Overall Study|Withdrawal by Subject|1|||
105604124|NCT02121002|364214750|FG002|Overall Study|Withdrawal by Subject|4|||
105604125|NCT02121002|364214748|FG000|Overall Study|Protocol Violation|1|||
105604126|NCT02121002|364214749|FG001|Overall Study|Protocol Violation|2|||
105604127|NCT02121002|364214750|FG002|Overall Study|Protocol Violation|4|||
105604128|NCT02121002|364214748|FG000|Overall Study|Concomitant therapy|0|||
105604129|NCT02121002|364214749|FG001|Overall Study|Concomitant therapy|1|||
105604130|NCT02121002|364214750|FG002|Overall Study|Concomitant therapy|1|||
105604131|NCT02121002|364214748|FG000|Overall Study|Others|1|||
105604132|NCT02121002|364214749|FG001|Overall Study|Others|0|||
105604133|NCT02121002|364214750|FG002|Overall Study|Others|1|||
105604134|NCT02740231|364214751|FG000|Overall Study|Withdrawal by Subject|1|||
105604135|NCT02740231|364214752|FG001|Overall Study|Withdrawal by Subject|1|||
105604136|NCT02740231|364214753|FG002|Overall Study|Withdrawal by Subject|1|||
105604137|NCT02740231|364214754|FG003|Overall Study|Withdrawal by Subject|0|||
105604138|NCT02740231|364214751|FG000|Overall Study|Lack of Efficacy|0|||
105604139|NCT02740231|364214752|FG001|Overall Study|Lack of Efficacy|1|||
105604140|NCT02740231|364214753|FG002|Overall Study|Lack of Efficacy|0|||
105604141|NCT02740231|364214754|FG003|Overall Study|Lack of Efficacy|4|||
105604142|NCT02740231|364214751|FG000|Overall Study|Lost to Follow-up|1|||
105604143|NCT02740231|364214752|FG001|Overall Study|Lost to Follow-up|3|||
105604144|NCT02740231|364214753|FG002|Overall Study|Lost to Follow-up|0|||
105604145|NCT02740231|364214754|FG003|Overall Study|Lost to Follow-up|3|||
105604146|NCT02740231|364214751|FG000|Overall Study|Adverse Event|0|||
105604147|NCT02740231|364214752|FG001|Overall Study|Adverse Event|1|||
105604148|NCT02740231|364214753|FG002|Overall Study|Adverse Event|0|||
105604149|NCT02740231|364214754|FG003|Overall Study|Adverse Event|1|||
105604150|NCT00243503|364214755|FG000|Overall Study|Adverse Event|11|||
105604151|NCT00243503|364214755|FG000|Overall Study|Withdrawal by Subject|1|||
105604152|NCT00243503|364214755|FG000|Overall Study|Lack of Efficacy|44|||
105604153|NCT00243503|364214755|FG000|Overall Study|Death|1|||
105604154|NCT00243503|364214755|FG000|Overall Study|Other|1|||
105604155|NCT02538900|364214756|FG000|Overall Study|Death|2|||
105604156|NCT02538900|364214757|FG001|Overall Study|Death|2|||
105604157|NCT02538900|364214758|FG002|Overall Study|Death|2|||
105604158|NCT02538900|364214756|FG000|Overall Study|Withdrawal by Subject|18|||
105604159|NCT02538900|364214757|FG001|Overall Study|Withdrawal by Subject|16|||
105604160|NCT02538900|364214758|FG002|Overall Study|Withdrawal by Subject|15|||
105604161|NCT02874534|364214761|FG000|Overall Study|Withdrawal by Subject|5|||
105604162|NCT02874534|364214762|FG001|Overall Study|Withdrawal by Subject|8|||
105604163|NCT02874534|364214761|FG000|Overall Study|Lost to Follow-up|2|||
105604164|NCT02874534|364214762|FG001|Overall Study|Lost to Follow-up|2|||
105604165|NCT02874534|364214761|FG000|Overall Study|Ongoing in study|1|||
105604166|NCT02874534|364214762|FG001|Overall Study|Ongoing in study|1|||
105604167|NCT04431726|364214766|FG000|Overall Study|Ongoing in the Study|55|||
105604168|NCT03076515|364214767|FG000|Overall Study|DMC decision based on interim analysis|25|||
105604169|NCT03076515|364214768|FG001|Overall Study|DMC decision based on interim analysis|29|||
105604170|NCT01102231|364214769|FG000|Overall Study|Protocol Violation|3|||
105604171|NCT01102231|364214769|FG000|Overall Study|Lack of Efficacy|2|||
105604172|NCT01102231|364214769|FG000|Overall Study|Death|2|||
105604173|NCT01102231|364214769|FG000|Overall Study|Adverse Event|3|||
105604174|NCT01102231|364214769|FG000|Overall Study|Withdrawal by Subject|1|||
105604175|NCT01102231|364214769|FG000|Overall Study|Did not received the treatment|4|||
105604176|NCT00296036|364214770|FG000|Overall Study|Withdrawal by Subject|1|||
105604177|NCT00296036|364214771|FG001|Overall Study|Withdrawal by Subject|0|||
105604178|NCT00296036|364214772|FG002|Overall Study|Withdrawal by Subject|2|||
105604179|NCT00296036|364214773|FG003|Overall Study|Withdrawal by Subject|1|||
105604180|NCT00296036|364214774|FG004|Overall Study|Withdrawal by Subject|2|||
105604181|NCT00296036|364214775|FG005|Overall Study|Withdrawal by Subject|1|||
105604182|NCT00296036|364214770|FG000|Overall Study|Protocol Violation|0|||
105604183|NCT00296036|364214771|FG001|Overall Study|Protocol Violation|0|||
105604184|NCT00296036|364214772|FG002|Overall Study|Protocol Violation|0|||
105604185|NCT00296036|364214773|FG003|Overall Study|Protocol Violation|0|||
105604186|NCT00296036|364214774|FG004|Overall Study|Protocol Violation|0|||
105604187|NCT00296036|364214775|FG005|Overall Study|Protocol Violation|3|||
105604188|NCT03655262|364214776|FG000|Overall Study|Withdrawal by Subject|0|||
105604189|NCT03655262|364214777|FG001|Overall Study|Withdrawal by Subject|0|||
105604190|NCT03655262|364214778|FG002|Overall Study|Withdrawal by Subject|1|||
105604191|NCT01989455|364214779|FG000|Overall Study|Adverse Event|0|||
105604192|NCT01989455|364214780|FG001|Overall Study|Adverse Event|1|||
105604193|NCT01989455|364214781|FG002|Overall Study|Adverse Event|0|||
105604194|NCT01989455|364214782|FG003|Overall Study|Adverse Event|0|||
105604195|NCT01989455|364214783|FG004|Overall Study|Adverse Event|0|||
105604196|NCT01989455|364214779|FG000|Overall Study|Withdrawal by Subject|0|||
105604197|NCT01989455|364214780|FG001|Overall Study|Withdrawal by Subject|1|||
105604198|NCT01989455|364214781|FG002|Overall Study|Withdrawal by Subject|0|||
105604199|NCT01989455|364214782|FG003|Overall Study|Withdrawal by Subject|0|||
105604200|NCT01989455|364214783|FG004|Overall Study|Withdrawal by Subject|0|||
105604201|NCT01989455|364214779|FG000|Overall Study|Technical problems with infusion|0|||
105604202|NCT01989455|364214780|FG001|Overall Study|Technical problems with infusion|0|||
105604203|NCT01989455|364214781|FG002|Overall Study|Technical problems with infusion|1|||
105604204|NCT01989455|364214782|FG003|Overall Study|Technical problems with infusion|0|||
105604205|NCT01989455|364214783|FG004|Overall Study|Technical problems with infusion|1|||
105604206|NCT04452318|364214784|FG000|Overall Study|Physician Decision|1|||
105604207|NCT04452318|364214785|FG001|Overall Study|Physician Decision|2|||
105604208|NCT04452318|364214786|FG002|Overall Study|Physician Decision|0|||
105604209|NCT04452318|364214787|FG003|Overall Study|Physician Decision|2|||
105604210|NCT04452318|364214788|FG004|Overall Study|Physician Decision|0|||
105604211|NCT04452318|364214789|FG005|Overall Study|Physician Decision|2|||
105604212|NCT04452318|364214790|FG006|Overall Study|Physician Decision|5|||
105604213|NCT04452318|364214784|FG000|Overall Study|Death|2|||
105604214|NCT04452318|364214785|FG001|Overall Study|Death|3|||
105604215|NCT04452318|364214786|FG002|Overall Study|Death|0|||
105604216|NCT04452318|364214787|FG003|Overall Study|Death|0|||
105604217|NCT04452318|364214788|FG004|Overall Study|Death|0|||
105604218|NCT04452318|364214789|FG005|Overall Study|Death|0|||
105604219|NCT04452318|364214790|FG006|Overall Study|Death|0|||
105604220|NCT04452318|364214784|FG000|Overall Study|Lost to Follow-up|38|||
105604221|NCT04452318|364214785|FG001|Overall Study|Lost to Follow-up|28|||
105604222|NCT04452318|364214786|FG002|Overall Study|Lost to Follow-up|0|||
105604223|NCT04452318|364214787|FG003|Overall Study|Lost to Follow-up|3|||
105604224|NCT04452318|364214788|FG004|Overall Study|Lost to Follow-up|3|||
105604225|NCT04452318|364214789|FG005|Overall Study|Lost to Follow-up|2|||
105604226|NCT04452318|364214790|FG006|Overall Study|Lost to Follow-up|1|||
105604227|NCT04452318|364214784|FG000|Overall Study|Withdrawal by Subject|46|||
105604228|NCT04452318|364214785|FG001|Overall Study|Withdrawal by Subject|40|||
105604229|NCT04452318|364214786|FG002|Overall Study|Withdrawal by Subject|0|||
105604230|NCT04452318|364214787|FG003|Overall Study|Withdrawal by Subject|18|||
105604231|NCT04452318|364214788|FG004|Overall Study|Withdrawal by Subject|6|||
105604232|NCT04452318|364214789|FG005|Overall Study|Withdrawal by Subject|8|||
105604233|NCT04452318|364214790|FG006|Overall Study|Withdrawal by Subject|6|||
105604234|NCT05052996|364214793|FG000|Overall Study|Still on study|0|||
105604235|NCT05052996|364214794|FG001|Overall Study|Still on study|0|||
105604236|NCT05052996|364214795|FG002|Overall Study|Still on study|47|||
105604237|NCT05052996|364214796|FG003|Overall Study|Still on study|44|||
105604238|NCT05052996|364214793|FG000|Overall Study|Cohort terminated by sponsor|21|||
105604239|NCT05052996|364214794|FG001|Overall Study|Cohort terminated by sponsor|12|||
105604240|NCT05052996|364214795|FG002|Overall Study|Cohort terminated by sponsor|0|||
105604241|NCT05052996|364214796|FG003|Overall Study|Cohort terminated by sponsor|0|||
105604242|NCT05052996|364214793|FG000|Overall Study|Withdrew consent|1|||
105604243|NCT05052996|364214794|FG001|Overall Study|Withdrew consent|0|||
105604244|NCT05052996|364214795|FG002|Overall Study|Withdrew consent|1|||
105604245|NCT05052996|364214796|FG003|Overall Study|Withdrew consent|2|||
105604246|NCT05052996|364214793|FG000|Overall Study|Lost to Follow-up|1|||
105604247|NCT05052996|364214794|FG001|Overall Study|Lost to Follow-up|0|||
105604248|NCT05052996|364214795|FG002|Overall Study|Lost to Follow-up|0|||
105604249|NCT05052996|364214796|FG003|Overall Study|Lost to Follow-up|2|||
105604250|NCT05052996|364214793|FG000|Overall Study|Adverse Event|0|||
105604251|NCT05052996|364214794|FG001|Overall Study|Adverse Event|0|||
105604252|NCT05052996|364214795|FG002|Overall Study|Adverse Event|2|||
105604253|NCT05052996|364214796|FG003|Overall Study|Adverse Event|0|||
105604254|NCT05052996|364214793|FG000|Overall Study|Randomized but never treated|0|||
105604255|NCT05052996|364214794|FG001|Overall Study|Randomized but never treated|0|||
105604256|NCT05052996|364214795|FG002|Overall Study|Randomized but never treated|1|||
105604257|NCT05052996|364214796|FG003|Overall Study|Randomized but never treated|1|||
105604258|NCT05052996|364214793|FG000|Overall Study|Protocol Violation|1|||
105604259|NCT05052996|364214794|FG001|Overall Study|Protocol Violation|0|||
105604260|NCT05052996|364214795|FG002|Overall Study|Protocol Violation|0|||
105604261|NCT05052996|364214796|FG003|Overall Study|Protocol Violation|0|||
105604262|NCT03951805|364214797|FG000|Overall Study|Adverse Event|1|||
105604263|NCT03951805|364214798|FG001|Overall Study|Adverse Event|0|||
105604264|NCT03951805|364214799|FG002|Overall Study|Adverse Event|0|||
105604265|NCT03951805|364214800|FG003|Overall Study|Adverse Event|0|||
105604266|NCT00604669|364214801|FG000|Overall Study|lack of information in chart|7|||
105604267|NCT01695954|364214802|FG000|Overall Study|Withdrawal by Subject|4|||
105604268|NCT01695954|364214803|FG001|Overall Study|Withdrawal by Subject|0|||
105604269|NCT01695954|364214802|FG000|Overall Study|Adverse Event|0|||
105604270|NCT01695954|364214803|FG001|Overall Study|Adverse Event|2|||
105604271|NCT00595413|364214810|FG000|Overall Study|Adverse Event|0|||
105604272|NCT00595413|364214811|FG001|Overall Study|Adverse Event|2|||
105604273|NCT00595413|364214812|FG002|Overall Study|Adverse Event|1|||
105604274|NCT00595413|364214813|FG003|Overall Study|Adverse Event|1|||
105604275|NCT00595413|364214810|FG000|Overall Study|Lost to Follow-up|2|||
105604276|NCT00595413|364214811|FG001|Overall Study|Lost to Follow-up|2|||
105604277|NCT00595413|364214812|FG002|Overall Study|Lost to Follow-up|1|||
105604278|NCT00595413|364214813|FG003|Overall Study|Lost to Follow-up|3|||
105604279|NCT00595413|364214810|FG000|Overall Study|Death|0|||
105604280|NCT00595413|364214811|FG001|Overall Study|Death|0|||
105604281|NCT00595413|364214812|FG002|Overall Study|Death|1|||
105604282|NCT00595413|364214813|FG003|Overall Study|Death|0|||
105604283|NCT00595413|364214810|FG000|Overall Study|Other|5|||
105604284|NCT00595413|364214811|FG001|Overall Study|Other|1|||
105604285|NCT00595413|364214812|FG002|Overall Study|Other|5|||
105604286|NCT00595413|364214813|FG003|Overall Study|Other|0|||
105604287|NCT03233633|364214814|FG000|Overall Study|Adverse Event|2|||
105604288|NCT03233633|364214814|FG000|Overall Study|Less Than 3 Days of Data|6|||
105604289|NCT02568683|364214815|FG000|Overall Study|Death|0|||
105604290|NCT02568683|364214816|FG001|Overall Study|Death|2|||
105604291|NCT02568683|364214815|FG000|Overall Study|Withdrew Consent|1|||
105604292|NCT02568683|364214816|FG001|Overall Study|Withdrew Consent|0|||
105604293|NCT02568683|364214815|FG000|Overall Study|Study Terminated By Sponsor|5|||
105604294|NCT02568683|364214816|FG001|Overall Study|Study Terminated By Sponsor|2|||
105604295|NCT01084707|364214817|FG000|Overall Study|Withdrawal by Subject|6|||
105604296|NCT00901901|364214818|FG000|Treatment Period|Adverse Event|120|||
105604297|NCT00901901|364214819|FG001|Treatment Period|Adverse Event|128|||
105604298|NCT00901901|364214818|FG000|Treatment Period|Withdrawal by Subject|26|||
105604299|NCT00901901|364214819|FG001|Treatment Period|Withdrawal by Subject|24|||
105604300|NCT00901901|364214818|FG000|Treatment Period|Physician Decision|2|||
105604301|NCT00901901|364214819|FG001|Treatment Period|Physician Decision|2|||
105604302|NCT00901901|364214818|FG000|Treatment Period|Lost to Follow-up|3|||
105604303|NCT00901901|364214819|FG001|Treatment Period|Lost to Follow-up|5|||
105604304|NCT00901901|364214818|FG000|Treatment Period|Noncompliance with study medication|4|||
105604305|NCT00901901|364214819|FG001|Treatment Period|Noncompliance with study medication|1|||
105604306|NCT00901901|364214818|FG000|Treatment Period|Missing|1|||
105604307|NCT00901901|364214819|FG001|Treatment Period|Missing|0|||
105604308|NCT00901901|364214818|FG000|Treatment Period|Never treated|0|||
105604309|NCT00901901|364214819|FG001|Treatment Period|Never treated|3|||
105604310|NCT00901901|364214818|FG000|Treatment Period|Protocol driven decision point|0|||
105604311|NCT00901901|364214819|FG001|Treatment Period|Protocol driven decision point|2|||
105604312|NCT00901901|364214818|FG000|Treatment Period|Study terminated by sponsor|2|||
105604313|NCT00901901|364214819|FG001|Treatment Period|Study terminated by sponsor|0|||
105604314|NCT00901901|364214818|FG000|Treatment Period|Protocol Violation|5|||
105604315|NCT00901901|364214819|FG001|Treatment Period|Protocol Violation|9|||
105604316|NCT00901901|364214818|FG000|Treatment Period|Switch to commercial drug|1|||
105604317|NCT00901901|364214819|FG001|Treatment Period|Switch to commercial drug|1|||
105604318|NCT00901901|364214818|FG000|Treatment Period|Transfer to treatment continuation study|5|||
105604319|NCT00901901|364214819|FG001|Treatment Period|Transfer to treatment continuation study|2|||
105604320|NCT00901901|364214818|FG000|Follow-up Period|Death|181|||
105604321|NCT00901901|364214819|FG001|Follow-up Period|Death|208|||
105604322|NCT00901901|364214818|FG000|Follow-up Period|Protocol driven decision point|47|||
105604323|NCT00901901|364214819|FG001|Follow-up Period|Protocol driven decision point|36|||
105604324|NCT00901901|364214818|FG000|Follow-up Period|Withdrawal by Subject|6|||
105604325|NCT00901901|364214819|FG001|Follow-up Period|Withdrawal by Subject|9|||
105604326|NCT00901901|364214818|FG000|Follow-up Period|Lost to Follow-up|12|||
105604327|NCT00901901|364214819|FG001|Follow-up Period|Lost to Follow-up|8|||
105604328|NCT00901901|364214818|FG000|Follow-up Period|Missing|94|||
105604329|NCT00901901|364214819|FG001|Follow-up Period|Missing|80|||
105604330|NCT00087139|364214820|FG000|Overall Study|Adverse Event|18|||
105604331|NCT00087139|364214821|FG001|Overall Study|Adverse Event|17|||
105604332|NCT00087139|364214822|FG002|Overall Study|Adverse Event|13|||
105604333|NCT00087139|364214820|FG000|Overall Study|Death|2|||
105604334|NCT00087139|364214821|FG001|Overall Study|Death|1|||
105604335|NCT00087139|364214822|FG002|Overall Study|Death|0|||
105604336|NCT00087139|364214820|FG000|Overall Study|Withdrawal by Subject|3|||
105604337|NCT00087139|364214821|FG001|Overall Study|Withdrawal by Subject|2|||
105604338|NCT00087139|364214822|FG002|Overall Study|Withdrawal by Subject|2|||
105604339|NCT00087139|364214820|FG000|Overall Study|Physician Decision|1|||
105604340|NCT00087139|364214821|FG001|Overall Study|Physician Decision|1|||
105604341|NCT00087139|364214822|FG002|Overall Study|Physician Decision|1|||
105604342|NCT00087139|364214820|FG000|Overall Study|Disease progression|9|||
105604343|NCT00087139|364214821|FG001|Overall Study|Disease progression|19|||
105604344|NCT00087139|364214822|FG002|Overall Study|Disease progression|12|||
105604345|NCT00087139|364214820|FG000|Overall Study|Ineligible|4|||
105604346|NCT00087139|364214821|FG001|Overall Study|Ineligible|7|||
105604347|NCT00087139|364214822|FG002|Overall Study|Ineligible|4|||
105604348|NCT00087139|364214820|FG000|Overall Study|Symptomatic deterioration|1|||
105604349|NCT00087139|364214821|FG001|Overall Study|Symptomatic deterioration|1|||
105604350|NCT00087139|364214822|FG002|Overall Study|Symptomatic deterioration|3|||
105604351|NCT00087139|364214820|FG000|Overall Study|Use of coumadin|1|||
105604352|NCT00087139|364214821|FG001|Overall Study|Use of coumadin|0|||
105604353|NCT00087139|364214822|FG002|Overall Study|Use of coumadin|0|||
105604354|NCT00087139|364214820|FG000|Overall Study|Response achieved|0|||
105604355|NCT00087139|364214821|FG001|Overall Study|Response achieved|1|||
105604356|NCT00087139|364214822|FG002|Overall Study|Response achieved|0|||
105604357|NCT00087139|364214820|FG000|Overall Study|Extradural disease|0|||
105604358|NCT00087139|364214821|FG001|Overall Study|Extradural disease|0|||
105604359|NCT00087139|364214822|FG002|Overall Study|Extradural disease|1|||
105604360|NCT00976495|364214823|FG000|Overall Study|Withdrawal by Subject|0|||
105604361|NCT00976495|364214824|FG001|Overall Study|Withdrawal by Subject|1|||
105604362|NCT00976495|364214825|FG002|Overall Study|Withdrawal by Subject|0|||
105604363|NCT02272816|364214826|FG000|Overall Study|Adverse Event|1|||
105604364|NCT05171777|364214827|FG000|Treatment Crossover Period|Adverse Event|9|||
105604365|NCT05171777|364214828|FG001|Treatment Crossover Period|Adverse Event|6|||
105604366|NCT05171777|364214829|FG002|Treatment Crossover Period|Adverse Event|0|||
105604367|NCT05171777|364214830|FG003|Treatment Crossover Period|Adverse Event|0|||
105604368|NCT05171777|364214827|FG000|Treatment Crossover Period|Death|5|||
105604369|NCT05171777|364214828|FG001|Treatment Crossover Period|Death|5|||
105604370|NCT05171777|364214829|FG002|Treatment Crossover Period|Death|0|||
105604371|NCT05171777|364214830|FG003|Treatment Crossover Period|Death|0|||
105604372|NCT05171777|364214827|FG000|Treatment Crossover Period|Disease Relapse|0|||
105604373|NCT05171777|364214828|FG001|Treatment Crossover Period|Disease Relapse|1|||
105604374|NCT05171777|364214829|FG002|Treatment Crossover Period|Disease Relapse|0|||
105604375|NCT05171777|364214830|FG003|Treatment Crossover Period|Disease Relapse|0|||
105604376|NCT05171777|364214827|FG000|Treatment Crossover Period|Reason not Specified|2|||
105604377|NCT05171777|364214828|FG001|Treatment Crossover Period|Reason not Specified|1|||
105604378|NCT05171777|364214829|FG002|Treatment Crossover Period|Reason not Specified|0|||
105604379|NCT05171777|364214830|FG003|Treatment Crossover Period|Reason not Specified|0|||
105604380|NCT05171777|364214827|FG000|Treatment Crossover Period|Physician Decision|0|||
105604381|NCT05171777|364214828|FG001|Treatment Crossover Period|Physician Decision|1|||
105604382|NCT05171777|364214829|FG002|Treatment Crossover Period|Physician Decision|0|||
105604383|NCT05171777|364214830|FG003|Treatment Crossover Period|Physician Decision|0|||
105604384|NCT05171777|364214827|FG000|Treatment Crossover Period|Progressive Disease|13|||
105604385|NCT05171777|364214828|FG001|Treatment Crossover Period|Progressive Disease|9|||
105604386|NCT05171777|364214829|FG002|Treatment Crossover Period|Progressive Disease|0|||
105604387|NCT05171777|364214830|FG003|Treatment Crossover Period|Progressive Disease|0|||
105604388|NCT05171777|364214827|FG000|Treatment Crossover Period|Protocol Violation|0|||
105604389|NCT05171777|364214828|FG001|Treatment Crossover Period|Protocol Violation|2|||
105604390|NCT05171777|364214829|FG002|Treatment Crossover Period|Protocol Violation|0|||
105604391|NCT05171777|364214830|FG003|Treatment Crossover Period|Protocol Violation|0|||
105604392|NCT05171777|364214827|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
105604393|NCT05171777|364214828|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
105604394|NCT05171777|364214829|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
105604395|NCT05171777|364214830|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
105604396|NCT05171777|364214827|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
105604397|NCT05171777|364214828|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
105604398|NCT05171777|364214829|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
105604399|NCT05171777|364214830|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
105604400|NCT05171777|364214827|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
105604401|NCT05171777|364214828|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
105604402|NCT05171777|364214829|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
105604403|NCT05171777|364214830|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
105604404|NCT05171777|364214827|FG000|Treatment Continuation Period|Death|0|||
105604405|NCT05171777|364214828|FG001|Treatment Continuation Period|Death|0|||
105604406|NCT05171777|364214829|FG002|Treatment Continuation Period|Death|1|||
105604407|NCT05171777|364214830|FG003|Treatment Continuation Period|Death|6|||
105604408|NCT05171777|364214827|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
105604409|NCT05171777|364214828|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
105604410|NCT05171777|364214829|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
105604411|NCT05171777|364214830|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
105604412|NCT01083316|364214831|FG000|Overall Study|Adverse Event|2|||
105604413|NCT01083316|364214831|FG000|Overall Study|Withdrawal by Subject|1|||
105604414|NCT04766034|364214837|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
105604415|NCT04766034|364214838|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
105604416|NCT04766034|364214839|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
105604417|NCT04766034|364214840|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
105604418|NCT04766034|364214841|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
105604419|NCT04766034|364214837|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
105604420|NCT04766034|364214838|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
105604421|NCT04766034|364214839|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
105604422|NCT04766034|364214840|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
105604423|NCT04766034|364214841|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
105604424|NCT04766034|364214837|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
105604425|NCT04766034|364214838|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
105604426|NCT04766034|364214839|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
105604427|NCT04766034|364214840|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
105604428|NCT04766034|364214841|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
105604429|NCT04766034|364214837|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
105604430|NCT04766034|364214838|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
105604431|NCT04766034|364214839|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
105604432|NCT04766034|364214840|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
105604433|NCT04766034|364214841|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
105604434|NCT05028582|364214850|FG000|Overall Study|Lost to Follow-up|11|||
105604435|NCT05028582|364214851|FG001|Overall Study|Lost to Follow-up|9|||
105604436|NCT05028582|364214850|FG000|Overall Study|Withdrawal by Subject|9|||
105604437|NCT05028582|364214851|FG001|Overall Study|Withdrawal by Subject|10|||
105604438|NCT05028582|364214850|FG000|Overall Study|Adverse Event|5|||
105604439|NCT05028582|364214851|FG001|Overall Study|Adverse Event|2|||
105604440|NCT05028582|364214850|FG000|Overall Study|Miscellaneous|3|||
105604441|NCT05028582|364214851|FG001|Overall Study|Miscellaneous|2|||
105604442|NCT05028582|364214850|FG000|Overall Study|Lack of Efficacy|3|||
105604443|NCT05028582|364214851|FG001|Overall Study|Lack of Efficacy|1|||
105604444|NCT05028582|364214850|FG000|Overall Study|Physician Decision|0|||
105604445|NCT05028582|364214851|FG001|Overall Study|Physician Decision|1|||
105604446|NCT04994509|364214852|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
105604447|NCT04994509|364214853|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
105604448|NCT04994509|364214854|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
105604449|NCT04994509|364214852|FG000|Overall Study|Withdrew Consent|73|||
105604450|NCT04994509|364214853|FG001|Overall Study|Withdrew Consent|72|||
105604451|NCT04994509|364214854|FG002|Overall Study|Withdrew Consent|46|||
105604452|NCT04994509|364214852|FG000|Overall Study|Lost to Follow-up|39|||
105604453|NCT04994509|364214853|FG001|Overall Study|Lost to Follow-up|36|||
105604454|NCT04994509|364214854|FG002|Overall Study|Lost to Follow-up|26|||
105604455|NCT04994509|364214852|FG000|Overall Study|HIV-1 Infection|4|||
105604456|NCT04994509|364214853|FG001|Overall Study|HIV-1 Infection|20|||
105604457|NCT04994509|364214854|FG002|Overall Study|HIV-1 Infection|12|||
105604458|NCT04994509|364214852|FG000|Overall Study|Investigator's Discretion|9|||
105604459|NCT04994509|364214853|FG001|Overall Study|Investigator's Discretion|8|||
105604460|NCT04994509|364214854|FG002|Overall Study|Investigator's Discretion|11|||
105604461|NCT04994509|364214852|FG000|Overall Study|Randomized but Never Treated|10|||
105604462|NCT04994509|364214853|FG001|Overall Study|Randomized but Never Treated|10|||
105604463|NCT04994509|364214854|FG002|Overall Study|Randomized but Never Treated|3|||
105604464|NCT04994509|364214852|FG000|Overall Study|Pregnancy|5|||
105604465|NCT04994509|364214853|FG001|Overall Study|Pregnancy|5|||
105604466|NCT04994509|364214854|FG002|Overall Study|Pregnancy|0|||
105604467|NCT04994509|364214852|FG000|Overall Study|Death|0|||
105604468|NCT04994509|364214853|FG001|Overall Study|Death|5|||
105604469|NCT04994509|364214854|FG002|Overall Study|Death|0|||
105604470|NCT04994509|364214852|FG000|Overall Study|Adverse Event|2|||
105604471|NCT04994509|364214853|FG001|Overall Study|Adverse Event|1|||
105604472|NCT04994509|364214854|FG002|Overall Study|Adverse Event|0|||
105604473|NCT04994509|364214852|FG000|Overall Study|Non-compliance With Study Drug|1|||
105604474|NCT04994509|364214853|FG001|Overall Study|Non-compliance With Study Drug|1|||
105604475|NCT04994509|364214854|FG002|Overall Study|Non-compliance With Study Drug|1|||
105604476|NCT04994509|364214852|FG000|Overall Study|Withdrew Assent|3|||
105604477|NCT04994509|364214853|FG001|Overall Study|Withdrew Assent|0|||
105604478|NCT04994509|364214854|FG002|Overall Study|Withdrew Assent|0|||
105604479|NCT04994509|364214852|FG000|Overall Study|Protocol Violation|1|||
105604480|NCT04994509|364214853|FG001|Overall Study|Protocol Violation|0|||
105604481|NCT04994509|364214854|FG002|Overall Study|Protocol Violation|0|||
105604482|NCT01959698|364214855|FG000|Overall Study|Adverse Event|0|||
105604483|NCT01959698|364214856|FG001|Overall Study|Adverse Event|0|||
105604484|NCT01959698|364214857|FG002|Overall Study|Adverse Event|0|||
105604485|NCT01959698|364214858|FG003|Overall Study|Adverse Event|0|||
105604486|NCT01959698|364214859|FG004|Overall Study|Adverse Event|0|||
105604487|NCT01959698|364214860|FG005|Overall Study|Adverse Event|0|||
105604488|NCT01959698|364214861|FG006|Overall Study|Adverse Event|1|||
105604489|NCT01959698|364214855|FG000|Overall Study|Physician Decision|1|||
105604490|NCT01959698|364214856|FG001|Overall Study|Physician Decision|0|||
105604491|NCT01959698|364214857|FG002|Overall Study|Physician Decision|1|||
105604492|NCT01959698|364214858|FG003|Overall Study|Physician Decision|2|||
105604493|NCT01959698|364214859|FG004|Overall Study|Physician Decision|0|||
105604494|NCT01959698|364214860|FG005|Overall Study|Physician Decision|3|||
105604495|NCT01959698|364214861|FG006|Overall Study|Physician Decision|3|||
105604496|NCT01853748|364217323|FG000|Allocation|Withdrawal by Subject|1|||
105604497|NCT01853748|364217324|FG001|Allocation|Withdrawal by Subject|13|||
105604498|NCT01853748|364217323|FG000|Allocation|not sufficient to receive intervention|0|||
105604499|NCT01853748|364217324|FG001|Allocation|not sufficient to receive intervention|1|||
105604500|NCT01853748|364217323|FG000|Follow-Up|Withdrawal by Subject|7|||
105604501|NCT01853748|364217324|FG001|Follow-Up|Withdrawal by Subject|6|||
105604502|NCT01853748|364217323|FG000|Follow-Up|Adverse Event|67|||
105604503|NCT01853748|364217324|FG001|Follow-Up|Adverse Event|7|||
105604504|NCT01853748|364217323|FG000|Follow-Up|not available for data collection|16|||
105604505|NCT01853748|364217324|FG001|Follow-Up|not available for data collection|4|||
105604506|NCT03960463|364217325|FG000|Overall Study|Withdrawal by Subject|2|||
105604507|NCT03960463|364217326|FG001|Overall Study|Withdrawal by Subject|0|||
105604508|NCT05194917|364217327|FG000|Overall Study|Lost to Follow-up|7|||
105604509|NCT05194917|364217328|FG001|Overall Study|Lost to Follow-up|5|||
105604510|NCT05194917|364217329|FG002|Overall Study|Lost to Follow-up|6|||
105604511|NCT05194917|364217330|FG003|Overall Study|Lost to Follow-up|5|||
105604512|NCT04922021|364217331|FG000|Overall Study|Withdrawal by Subject|4|||
105604513|NCT04922021|364217332|FG001|Overall Study|Withdrawal by Subject|10|||
105604514|NCT04922021|364217331|FG000|Overall Study|Adverse Event|2|||
105604515|NCT04922021|364217332|FG001|Overall Study|Adverse Event|2|||
105604516|NCT04922021|364217331|FG000|Overall Study|Lack of Efficacy|0|||
105604517|NCT04922021|364217332|FG001|Overall Study|Lack of Efficacy|1|||
105604518|NCT04922021|364217331|FG000|Overall Study|Multiple reasons|1|||
105604519|NCT04922021|364217332|FG001|Overall Study|Multiple reasons|0|||
105604520|NCT05644444|364217337|FG000|Tolerance Phase|Adverse Event|0|||
105604521|NCT05644444|364217338|FG001|Tolerance Phase|Adverse Event|2|||
105604522|NCT05644444|364217337|FG000|Treatment Phase|Adverse Event|0|||
105604523|NCT05644444|364217338|FG001|Treatment Phase|Adverse Event|2|||
105604524|NCT02576509|364217342|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
105604525|NCT02576509|364217343|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
105604526|NCT02576509|364217342|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
105604527|NCT02576509|364217343|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
105604528|NCT02576509|364217342|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
105604529|NCT02576509|364217343|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
105604530|NCT02576509|364217342|FG000|Treatment Period|Disease progression|263|||
105604531|NCT02576509|364217343|FG001|Treatment Period|Disease progression|244|||
105604532|NCT02576509|364217342|FG000|Treatment Period|Study drug toxicity|37|||
105604533|NCT02576509|364217343|FG001|Treatment Period|Study drug toxicity|41|||
105604534|NCT02576509|364217342|FG000|Treatment Period|Death|1|||
105604535|NCT02576509|364217343|FG001|Treatment Period|Death|1|||
105604536|NCT02576509|364217342|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
105604537|NCT02576509|364217343|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
105604538|NCT02576509|364217342|FG000|Treatment Period|Participant request to stop treatment|8|||
105604539|NCT02576509|364217343|FG001|Treatment Period|Participant request to stop treatment|18|||
105604540|NCT02576509|364217342|FG000|Treatment Period|Participant withdrew consent|3|||
105604541|NCT02576509|364217343|FG001|Treatment Period|Participant withdrew consent|7|||
105604542|NCT02576509|364217342|FG000|Treatment Period|Lost to Follow-up|0|||
105604543|NCT02576509|364217343|FG001|Treatment Period|Lost to Follow-up|1|||
105604544|NCT02576509|364217342|FG000|Treatment Period|Maximum clinical benefit|1|||
105604545|NCT02576509|364217343|FG001|Treatment Period|Maximum clinical benefit|0|||
105604546|NCT02576509|364217342|FG000|Treatment Period|Poor/non-compliance|1|||
105604547|NCT02576509|364217343|FG001|Treatment Period|Poor/non-compliance|1|||
105604548|NCT02576509|364217342|FG000|Treatment Period|Participant no longer meets criteria|1|||
105604549|NCT02576509|364217343|FG001|Treatment Period|Participant no longer meets criteria|0|||
105604550|NCT02576509|364217342|FG000|Treatment Period|Other reason|12|||
105604551|NCT02576509|364217343|FG001|Treatment Period|Other reason|8|||
105604552|NCT02576509|364217342|FG000|Treatment Period|NOT REPORTED|1|||
105604553|NCT02576509|364217343|FG001|Treatment Period|NOT REPORTED|0|||
105604554|NCT02576509|364217342|FG000|Treatment Period|Administrative reason by sponsor|0|||
105604555|NCT02576509|364217343|FG001|Treatment Period|Administrative reason by sponsor|1|||
105604556|NCT01259401|364217350|FG000|4-month Follow-up|Death|0|||
105604557|NCT01259401|364217351|FG001|4-month Follow-up|Death|1|||
105604558|NCT01259401|364217350|FG000|4-month Follow-up|Lost to Follow-up|0|||
105604559|NCT01259401|364217351|FG001|4-month Follow-up|Lost to Follow-up|1|||
105604560|NCT03954184|364217352|FG000|Overall Study|Lost to Follow-up|500|||
105604561|NCT03954184|364217353|FG001|Overall Study|Lost to Follow-up|0|||
105604562|NCT03398200|364217354|FG000|Overall Study|Withdrawal by Subject|0|||
105604563|NCT03398200|364217355|FG001|Overall Study|Withdrawal by Subject|1|||
105604564|NCT02652260|364217356|FG000|Base Study|Pregnancy|0|||
105604565|NCT02652260|364217357|FG001|Base Study|Pregnancy|1|||
105604566|NCT02652260|364217356|FG000|Base Study|Withdrawal by Subject|0|||
105604567|NCT02652260|364217357|FG001|Base Study|Withdrawal by Subject|1|||
105604568|NCT02652260|364217356|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
105604569|NCT02652260|364217357|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
105604570|NCT02652260|364217356|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
105604571|NCT02652260|364217357|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
105604572|NCT02652260|364217356|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
105604573|NCT02652260|364217357|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
105604574|NCT02652260|364217356|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
105604575|NCT02652260|364217357|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
105604576|NCT02652260|364217356|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
105604577|NCT02652260|364217357|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
105604578|NCT02652260|364217356|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
105604579|NCT02652260|364217357|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
105604580|NCT02652260|364217356|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
105604581|NCT02652260|364217357|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
105604582|NCT02652260|364217356|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
105604583|NCT02652260|364217357|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
105604584|NCT02652260|364217356|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
105604585|NCT02652260|364217357|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
105604586|NCT02652260|364217356|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
105604587|NCT02652260|364217357|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
105604588|NCT02652260|364217356|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
105604589|NCT02652260|364217357|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
105604590|NCT02652260|364217356|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
105604591|NCT02652260|364217357|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
105604592|NCT02723955|364217358|FG000|Escalation Phase|Death|1|||
105604593|NCT02723955|364217359|FG001|Escalation Phase|Death|1|||
105604594|NCT02723955|364217360|FG002|Escalation Phase|Death|2|||
105604595|NCT02723955|364217361|FG003|Escalation Phase|Death|7|||
105604596|NCT02723955|364217362|FG004|Escalation Phase|Death|18|||
105604597|NCT02723955|364217363|FG005|Escalation Phase|Death|17|||
105604598|NCT02723955|364217364|FG006|Escalation Phase|Death|11|||
105604599|NCT02723955|364217365|FG007|Escalation Phase|Death|21|||
105604600|NCT02723955|364217366|FG008|Escalation Phase|Death|3|||
105604601|NCT02723955|364217367|FG009|Escalation Phase|Death|0|||
105604602|NCT02723955|364217368|FG010|Escalation Phase|Death|0|||
105604603|NCT02723955|364217369|FG011|Escalation Phase|Death|0|||
105604604|NCT02723955|364217370|FG012|Escalation Phase|Death|2|||
105604605|NCT02723955|364217371|FG013|Escalation Phase|Death|4|||
105604606|NCT02723955|364217372|FG014|Escalation Phase|Death|5|||
105604607|NCT02723955|364217373|FG015|Escalation Phase|Death|6|||
105604608|NCT02723955|364217374|FG016|Escalation Phase|Death|6|||
105604609|NCT02723955|364217375|FG017|Escalation Phase|Death|7|||
105604610|NCT02723955|364217376|FG018|Escalation Phase|Death|1|||
105604611|NCT02723955|364217377|FG019|Escalation Phase|Death|3|||
105604612|NCT02723955|364217378|FG020|Escalation Phase|Death|13|||
105604613|NCT02723955|364217379|FG021|Escalation Phase|Death|3|||
105604614|NCT02723955|364217380|FG022|Escalation Phase|Death|2|||
105604615|NCT02723955|364217381|FG023|Escalation Phase|Death|4|||
105604616|NCT02723955|364217382|FG024|Escalation Phase|Death|31|||
105604617|NCT02723955|364217383|FG025|Escalation Phase|Death|7|||
105604618|NCT02723955|364217384|FG026|Escalation Phase|Death|13|||
105604619|NCT02723955|364217385|FG027|Escalation Phase|Death|0|||
105604620|NCT02723955|364217386|FG028|Escalation Phase|Death|1|||
105604621|NCT02723955|364217387|FG029|Escalation Phase|Death|0|||
105604622|NCT02723955|364217388|FG030|Escalation Phase|Death|0|||
105604623|NCT02723955|364217389|FG031|Escalation Phase|Death|0|||
105604624|NCT02723955|364217390|FG032|Escalation Phase|Death|0|||
105604625|NCT02723955|364217391|FG033|Escalation Phase|Death|0|||
105604626|NCT02723955|364217392|FG034|Escalation Phase|Death|0|||
105604627|NCT02723955|364217393|FG035|Escalation Phase|Death|0|||
105604628|NCT02723955|364217394|FG036|Escalation Phase|Death|0|||
105604629|NCT02723955|364217395|FG037|Escalation Phase|Death|0|||
105604630|NCT02723955|364217396|FG038|Escalation Phase|Death|0|||
105604631|NCT02723955|364217397|FG039|Escalation Phase|Death|0|||
105604632|NCT02723955|364217398|FG040|Escalation Phase|Death|0|||
105604633|NCT02723955|364217399|FG041|Escalation Phase|Death|0|||
105604634|NCT02723955|364217400|FG042|Escalation Phase|Death|0|||
105604635|NCT02723955|364217358|FG000|Escalation Phase|Lost to Follow-up|0|||
105604636|NCT02723955|364217359|FG001|Escalation Phase|Lost to Follow-up|0|||
105604637|NCT02723955|364217360|FG002|Escalation Phase|Lost to Follow-up|0|||
105604638|NCT02723955|364217361|FG003|Escalation Phase|Lost to Follow-up|0|||
105604639|NCT02723955|364217362|FG004|Escalation Phase|Lost to Follow-up|0|||
105604640|NCT02723955|364217363|FG005|Escalation Phase|Lost to Follow-up|2|||
105604641|NCT02723955|364217364|FG006|Escalation Phase|Lost to Follow-up|1|||
105604642|NCT02723955|364217365|FG007|Escalation Phase|Lost to Follow-up|1|||
105604643|NCT02723955|364217366|FG008|Escalation Phase|Lost to Follow-up|1|||
105604644|NCT02723955|364217367|FG009|Escalation Phase|Lost to Follow-up|0|||
105604645|NCT02723955|364217368|FG010|Escalation Phase|Lost to Follow-up|0|||
105604646|NCT02723955|364217369|FG011|Escalation Phase|Lost to Follow-up|0|||
105604647|NCT02723955|364217370|FG012|Escalation Phase|Lost to Follow-up|1|||
105604648|NCT02723955|364217371|FG013|Escalation Phase|Lost to Follow-up|0|||
105604649|NCT02723955|364217372|FG014|Escalation Phase|Lost to Follow-up|0|||
105604650|NCT02723955|364217373|FG015|Escalation Phase|Lost to Follow-up|0|||
105604651|NCT02723955|364217374|FG016|Escalation Phase|Lost to Follow-up|1|||
105604652|NCT02723955|364217375|FG017|Escalation Phase|Lost to Follow-up|2|||
105604653|NCT02723955|364217376|FG018|Escalation Phase|Lost to Follow-up|0|||
105604654|NCT02723955|364217377|FG019|Escalation Phase|Lost to Follow-up|1|||
105604655|NCT02723955|364217378|FG020|Escalation Phase|Lost to Follow-up|2|||
105604656|NCT02723955|364217379|FG021|Escalation Phase|Lost to Follow-up|1|||
105604657|NCT02723955|364217380|FG022|Escalation Phase|Lost to Follow-up|0|||
105604658|NCT02723955|364217381|FG023|Escalation Phase|Lost to Follow-up|0|||
105604659|NCT02723955|364217382|FG024|Escalation Phase|Lost to Follow-up|1|||
105604660|NCT02723955|364217383|FG025|Escalation Phase|Lost to Follow-up|1|||
105604661|NCT02723955|364217384|FG026|Escalation Phase|Lost to Follow-up|3|||
105604662|NCT02723955|364217385|FG027|Escalation Phase|Lost to Follow-up|0|||
105604663|NCT02723955|364217386|FG028|Escalation Phase|Lost to Follow-up|1|||
105604664|NCT02723955|364217387|FG029|Escalation Phase|Lost to Follow-up|0|||
105604665|NCT02723955|364217388|FG030|Escalation Phase|Lost to Follow-up|0|||
105604666|NCT02723955|364217389|FG031|Escalation Phase|Lost to Follow-up|0|||
105604667|NCT02723955|364217390|FG032|Escalation Phase|Lost to Follow-up|0|||
105604668|NCT02723955|364217391|FG033|Escalation Phase|Lost to Follow-up|0|||
105604669|NCT02723955|364217392|FG034|Escalation Phase|Lost to Follow-up|0|||
105604670|NCT02723955|364217393|FG035|Escalation Phase|Lost to Follow-up|0|||
105604671|NCT02723955|364217394|FG036|Escalation Phase|Lost to Follow-up|0|||
105604672|NCT02723955|364217395|FG037|Escalation Phase|Lost to Follow-up|0|||
105604673|NCT02723955|364217396|FG038|Escalation Phase|Lost to Follow-up|0|||
105604674|NCT02723955|364217397|FG039|Escalation Phase|Lost to Follow-up|0|||
105604675|NCT02723955|364217398|FG040|Escalation Phase|Lost to Follow-up|0|||
105604676|NCT02723955|364217399|FG041|Escalation Phase|Lost to Follow-up|0|||
105604677|NCT02723955|364217400|FG042|Escalation Phase|Lost to Follow-up|0|||
105604678|NCT02723955|364217358|FG000|Escalation Phase|Physician Decision|0|||
105604679|NCT02723955|364217359|FG001|Escalation Phase|Physician Decision|0|||
105604680|NCT02723955|364217360|FG002|Escalation Phase|Physician Decision|0|||
105604681|NCT02723955|364217361|FG003|Escalation Phase|Physician Decision|0|||
105604682|NCT02723955|364217362|FG004|Escalation Phase|Physician Decision|0|||
105604683|NCT02723955|364217363|FG005|Escalation Phase|Physician Decision|2|||
105604684|NCT02723955|364217364|FG006|Escalation Phase|Physician Decision|0|||
105604685|NCT02723955|364217365|FG007|Escalation Phase|Physician Decision|0|||
105604686|NCT02723955|364217366|FG008|Escalation Phase|Physician Decision|0|||
105604687|NCT02723955|364217367|FG009|Escalation Phase|Physician Decision|0|||
105604688|NCT02723955|364217368|FG010|Escalation Phase|Physician Decision|0|||
105604689|NCT02723955|364217369|FG011|Escalation Phase|Physician Decision|0|||
105604690|NCT02723955|364217370|FG012|Escalation Phase|Physician Decision|0|||
105604691|NCT02723955|364217371|FG013|Escalation Phase|Physician Decision|0|||
105604692|NCT02723955|364217372|FG014|Escalation Phase|Physician Decision|0|||
105604693|NCT02723955|364217373|FG015|Escalation Phase|Physician Decision|0|||
105604694|NCT02723955|364217374|FG016|Escalation Phase|Physician Decision|0|||
105604695|NCT02723955|364217375|FG017|Escalation Phase|Physician Decision|0|||
105604696|NCT02723955|364217376|FG018|Escalation Phase|Physician Decision|0|||
105604697|NCT02723955|364217377|FG019|Escalation Phase|Physician Decision|0|||
105604698|NCT02723955|364217378|FG020|Escalation Phase|Physician Decision|0|||
105604699|NCT02723955|364217379|FG021|Escalation Phase|Physician Decision|0|||
105604700|NCT02723955|364217380|FG022|Escalation Phase|Physician Decision|0|||
105604701|NCT02723955|364217381|FG023|Escalation Phase|Physician Decision|0|||
105604702|NCT02723955|364217382|FG024|Escalation Phase|Physician Decision|0|||
105604703|NCT02723955|364217383|FG025|Escalation Phase|Physician Decision|0|||
105604704|NCT02723955|364217384|FG026|Escalation Phase|Physician Decision|2|||
105604705|NCT02723955|364217385|FG027|Escalation Phase|Physician Decision|0|||
105604706|NCT02723955|364217386|FG028|Escalation Phase|Physician Decision|0|||
105604707|NCT02723955|364217387|FG029|Escalation Phase|Physician Decision|0|||
105604708|NCT02723955|364217388|FG030|Escalation Phase|Physician Decision|0|||
105604709|NCT02723955|364217389|FG031|Escalation Phase|Physician Decision|0|||
105604710|NCT02723955|364217390|FG032|Escalation Phase|Physician Decision|0|||
105604711|NCT02723955|364217391|FG033|Escalation Phase|Physician Decision|0|||
105604712|NCT02723955|364217392|FG034|Escalation Phase|Physician Decision|0|||
105604713|NCT02723955|364217393|FG035|Escalation Phase|Physician Decision|0|||
105604714|NCT02723955|364217394|FG036|Escalation Phase|Physician Decision|0|||
105604715|NCT02723955|364217395|FG037|Escalation Phase|Physician Decision|0|||
105604716|NCT02723955|364217396|FG038|Escalation Phase|Physician Decision|0|||
105604717|NCT02723955|364217397|FG039|Escalation Phase|Physician Decision|0|||
105604718|NCT02723955|364217398|FG040|Escalation Phase|Physician Decision|0|||
105604719|NCT02723955|364217399|FG041|Escalation Phase|Physician Decision|0|||
105604720|NCT02723955|364217400|FG042|Escalation Phase|Physician Decision|0|||
105604721|NCT02723955|364217358|FG000|Escalation Phase|Withdrawal by Subject|0|||
105604722|NCT02723955|364217359|FG001|Escalation Phase|Withdrawal by Subject|0|||
105604723|NCT02723955|364217360|FG002|Escalation Phase|Withdrawal by Subject|0|||
105604724|NCT02723955|364217361|FG003|Escalation Phase|Withdrawal by Subject|0|||
105604725|NCT02723955|364217362|FG004|Escalation Phase|Withdrawal by Subject|1|||
105604726|NCT02723955|364217363|FG005|Escalation Phase|Withdrawal by Subject|1|||
105604727|NCT02723955|364217364|FG006|Escalation Phase|Withdrawal by Subject|1|||
105604728|NCT02723955|364217365|FG007|Escalation Phase|Withdrawal by Subject|1|||
105604729|NCT02723955|364217366|FG008|Escalation Phase|Withdrawal by Subject|0|||
105604730|NCT02723955|364217367|FG009|Escalation Phase|Withdrawal by Subject|0|||
105604731|NCT02723955|364217368|FG010|Escalation Phase|Withdrawal by Subject|0|||
105604732|NCT02723955|364217369|FG011|Escalation Phase|Withdrawal by Subject|0|||
105604733|NCT02723955|364217370|FG012|Escalation Phase|Withdrawal by Subject|1|||
105604734|NCT02723955|364217371|FG013|Escalation Phase|Withdrawal by Subject|0|||
105604735|NCT02723955|364217372|FG014|Escalation Phase|Withdrawal by Subject|0|||
105604736|NCT02723955|364217373|FG015|Escalation Phase|Withdrawal by Subject|0|||
105604737|NCT02723955|364217374|FG016|Escalation Phase|Withdrawal by Subject|1|||
105604738|NCT02723955|364217375|FG017|Escalation Phase|Withdrawal by Subject|0|||
105604739|NCT02723955|364217376|FG018|Escalation Phase|Withdrawal by Subject|0|||
105604740|NCT02723955|364217377|FG019|Escalation Phase|Withdrawal by Subject|0|||
105604741|NCT02723955|364217378|FG020|Escalation Phase|Withdrawal by Subject|0|||
105604742|NCT02723955|364217379|FG021|Escalation Phase|Withdrawal by Subject|0|||
105604743|NCT02723955|364217380|FG022|Escalation Phase|Withdrawal by Subject|0|||
105604744|NCT02723955|364217381|FG023|Escalation Phase|Withdrawal by Subject|2|||
105604745|NCT02723955|364217382|FG024|Escalation Phase|Withdrawal by Subject|0|||
105604746|NCT02723955|364217383|FG025|Escalation Phase|Withdrawal by Subject|1|||
105604747|NCT02723955|364217384|FG026|Escalation Phase|Withdrawal by Subject|0|||
105604748|NCT02723955|364217385|FG027|Escalation Phase|Withdrawal by Subject|0|||
105604749|NCT02723955|364217386|FG028|Escalation Phase|Withdrawal by Subject|1|||
105604750|NCT02723955|364217387|FG029|Escalation Phase|Withdrawal by Subject|0|||
105604751|NCT02723955|364217388|FG030|Escalation Phase|Withdrawal by Subject|0|||
105604752|NCT02723955|364217389|FG031|Escalation Phase|Withdrawal by Subject|0|||
105604753|NCT02723955|364217390|FG032|Escalation Phase|Withdrawal by Subject|0|||
105604754|NCT02723955|364217391|FG033|Escalation Phase|Withdrawal by Subject|0|||
105604755|NCT02723955|364217392|FG034|Escalation Phase|Withdrawal by Subject|0|||
105604756|NCT02723955|364217393|FG035|Escalation Phase|Withdrawal by Subject|0|||
105604757|NCT02723955|364217394|FG036|Escalation Phase|Withdrawal by Subject|0|||
105604758|NCT02723955|364217395|FG037|Escalation Phase|Withdrawal by Subject|0|||
105604759|NCT02723955|364217396|FG038|Escalation Phase|Withdrawal by Subject|0|||
105604760|NCT02723955|364217397|FG039|Escalation Phase|Withdrawal by Subject|0|||
105604761|NCT02723955|364217398|FG040|Escalation Phase|Withdrawal by Subject|0|||
105604762|NCT02723955|364217399|FG041|Escalation Phase|Withdrawal by Subject|0|||
105604763|NCT02723955|364217400|FG042|Escalation Phase|Withdrawal by Subject|0|||
105604764|NCT02723955|364217358|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604765|NCT02723955|364217359|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604766|NCT02723955|364217360|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604767|NCT02723955|364217361|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604768|NCT02723955|364217362|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
105604769|NCT02723955|364217363|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
105604770|NCT02723955|364217364|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
105604771|NCT02723955|364217365|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
105604772|NCT02723955|364217366|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
105604773|NCT02723955|364217367|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604774|NCT02723955|364217368|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604775|NCT02723955|364217369|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604776|NCT02723955|364217370|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604777|NCT02723955|364217371|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604778|NCT02723955|364217372|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604779|NCT02723955|364217373|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604780|NCT02723955|364217374|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604781|NCT02723955|364217375|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604782|NCT02723955|364217376|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604783|NCT02723955|364217377|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604784|NCT02723955|364217378|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604785|NCT02723955|364217379|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604786|NCT02723955|364217380|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604787|NCT02723955|364217381|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604788|NCT02723955|364217382|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604789|NCT02723955|364217383|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604790|NCT02723955|364217384|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604791|NCT02723955|364217385|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604792|NCT02723955|364217386|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604793|NCT02723955|364217387|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604794|NCT02723955|364217388|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604795|NCT02723955|364217389|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604796|NCT02723955|364217390|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604797|NCT02723955|364217391|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604798|NCT02723955|364217392|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604799|NCT02723955|364217393|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604800|NCT02723955|364217394|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604801|NCT02723955|364217395|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604802|NCT02723955|364217396|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604803|NCT02723955|364217397|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604804|NCT02723955|364217398|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604805|NCT02723955|364217399|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604806|NCT02723955|364217400|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105604807|NCT02723955|364217358|FG000|Escalation Phase|Site Closed|0|||
105604808|NCT02723955|364217359|FG001|Escalation Phase|Site Closed|0|||
105604809|NCT02723955|364217360|FG002|Escalation Phase|Site Closed|0|||
105604810|NCT02723955|364217361|FG003|Escalation Phase|Site Closed|0|||
105604811|NCT02723955|364217362|FG004|Escalation Phase|Site Closed|0|||
105604812|NCT02723955|364217363|FG005|Escalation Phase|Site Closed|0|||
105604813|NCT02723955|364217364|FG006|Escalation Phase|Site Closed|0|||
105604814|NCT02723955|364217365|FG007|Escalation Phase|Site Closed|0|||
105604815|NCT02723955|364217366|FG008|Escalation Phase|Site Closed|0|||
105604816|NCT02723955|364217367|FG009|Escalation Phase|Site Closed|0|||
105604817|NCT02723955|364217368|FG010|Escalation Phase|Site Closed|0|||
105604818|NCT02723955|364217369|FG011|Escalation Phase|Site Closed|0|||
105604819|NCT02723955|364217370|FG012|Escalation Phase|Site Closed|0|||
105604820|NCT02723955|364217371|FG013|Escalation Phase|Site Closed|0|||
105604821|NCT02723955|364217372|FG014|Escalation Phase|Site Closed|0|||
105604822|NCT02723955|364217373|FG015|Escalation Phase|Site Closed|1|||
105604823|NCT02723955|364217374|FG016|Escalation Phase|Site Closed|0|||
105604824|NCT02723955|364217375|FG017|Escalation Phase|Site Closed|2|||
105604825|NCT02723955|364217376|FG018|Escalation Phase|Site Closed|0|||
105604826|NCT02723955|364217377|FG019|Escalation Phase|Site Closed|0|||
105604827|NCT02723955|364217378|FG020|Escalation Phase|Site Closed|1|||
105604828|NCT02723955|364217379|FG021|Escalation Phase|Site Closed|0|||
105604829|NCT02723955|364217380|FG022|Escalation Phase|Site Closed|0|||
105604830|NCT02723955|364217381|FG023|Escalation Phase|Site Closed|0|||
105604831|NCT02723955|364217382|FG024|Escalation Phase|Site Closed|3|||
105604832|NCT02723955|364217383|FG025|Escalation Phase|Site Closed|1|||
105604833|NCT02723955|364217384|FG026|Escalation Phase|Site Closed|3|||
105604834|NCT02723955|364217385|FG027|Escalation Phase|Site Closed|1|||
105604835|NCT02723955|364217386|FG028|Escalation Phase|Site Closed|1|||
105604836|NCT02723955|364217387|FG029|Escalation Phase|Site Closed|0|||
105604837|NCT02723955|364217388|FG030|Escalation Phase|Site Closed|0|||
105604838|NCT02723955|364217389|FG031|Escalation Phase|Site Closed|0|||
105604839|NCT02723955|364217390|FG032|Escalation Phase|Site Closed|0|||
105604840|NCT02723955|364217391|FG033|Escalation Phase|Site Closed|0|||
105604841|NCT02723955|364217392|FG034|Escalation Phase|Site Closed|0|||
105604842|NCT02723955|364217393|FG035|Escalation Phase|Site Closed|0|||
105604843|NCT02723955|364217394|FG036|Escalation Phase|Site Closed|0|||
105604844|NCT02723955|364217395|FG037|Escalation Phase|Site Closed|0|||
105604845|NCT02723955|364217396|FG038|Escalation Phase|Site Closed|0|||
105604846|NCT02723955|364217397|FG039|Escalation Phase|Site Closed|0|||
105604847|NCT02723955|364217398|FG040|Escalation Phase|Site Closed|0|||
105604848|NCT02723955|364217399|FG041|Escalation Phase|Site Closed|0|||
105604849|NCT02723955|364217400|FG042|Escalation Phase|Site Closed|0|||
105604850|NCT02723955|364217358|FG000|Expansion Phase|Death|0|||
105604851|NCT02723955|364217359|FG001|Expansion Phase|Death|0|||
105604852|NCT02723955|364217360|FG002|Expansion Phase|Death|0|||
105604853|NCT02723955|364217361|FG003|Expansion Phase|Death|0|||
105604854|NCT02723955|364217362|FG004|Expansion Phase|Death|0|||
105604855|NCT02723955|364217363|FG005|Expansion Phase|Death|0|||
105604856|NCT02723955|364217364|FG006|Expansion Phase|Death|0|||
105604857|NCT02723955|364217365|FG007|Expansion Phase|Death|0|||
105604858|NCT02723955|364217366|FG008|Expansion Phase|Death|0|||
105604859|NCT02723955|364217367|FG009|Expansion Phase|Death|25|||
105604860|NCT02723955|364217368|FG010|Expansion Phase|Death|69|||
105604861|NCT02723955|364217369|FG011|Expansion Phase|Death|48|||
105604862|NCT02723955|364217370|FG012|Expansion Phase|Death|0|||
105604863|NCT02723955|364217371|FG013|Expansion Phase|Death|0|||
105604864|NCT02723955|364217372|FG014|Expansion Phase|Death|0|||
105604865|NCT02723955|364217373|FG015|Expansion Phase|Death|0|||
105604866|NCT02723955|364217374|FG016|Expansion Phase|Death|0|||
105604867|NCT02723955|364217375|FG017|Expansion Phase|Death|0|||
105604868|NCT02723955|364217376|FG018|Expansion Phase|Death|0|||
105604869|NCT02723955|364217377|FG019|Expansion Phase|Death|0|||
105604870|NCT02723955|364217378|FG020|Expansion Phase|Death|0|||
105604871|NCT02723955|364217379|FG021|Expansion Phase|Death|0|||
105604872|NCT02723955|364217380|FG022|Expansion Phase|Death|0|||
105604873|NCT02723955|364217381|FG023|Expansion Phase|Death|0|||
105604874|NCT02723955|364217382|FG024|Expansion Phase|Death|0|||
105604875|NCT02723955|364217383|FG025|Expansion Phase|Death|0|||
105604876|NCT02723955|364217384|FG026|Expansion Phase|Death|0|||
105604877|NCT02723955|364217385|FG027|Expansion Phase|Death|0|||
105604878|NCT02723955|364217386|FG028|Expansion Phase|Death|0|||
105604879|NCT02723955|364217387|FG029|Expansion Phase|Death|12|||
105604880|NCT02723955|364217388|FG030|Expansion Phase|Death|202|||
105604881|NCT02723955|364217389|FG031|Expansion Phase|Death|31|||
105604882|NCT02723955|364217390|FG032|Expansion Phase|Death|17|||
105604883|NCT02723955|364217391|FG033|Expansion Phase|Death|2|||
105604884|NCT02723955|364217392|FG034|Expansion Phase|Death|3|||
105604885|NCT02723955|364217393|FG035|Expansion Phase|Death|3|||
105604886|NCT02723955|364217394|FG036|Expansion Phase|Death|1|||
105604887|NCT02723955|364217395|FG037|Expansion Phase|Death|0|||
105604888|NCT02723955|364217396|FG038|Expansion Phase|Death|0|||
105604889|NCT02723955|364217397|FG039|Expansion Phase|Death|0|||
105604890|NCT02723955|364217398|FG040|Expansion Phase|Death|0|||
105604891|NCT02723955|364217399|FG041|Expansion Phase|Death|0|||
105604892|NCT02723955|364217400|FG042|Expansion Phase|Death|0|||
105604893|NCT02723955|364217358|FG000|Expansion Phase|Lost to Follow-up|0|||
105604894|NCT02723955|364217359|FG001|Expansion Phase|Lost to Follow-up|0|||
105604895|NCT02723955|364217360|FG002|Expansion Phase|Lost to Follow-up|0|||
105604896|NCT02723955|364217361|FG003|Expansion Phase|Lost to Follow-up|0|||
105604897|NCT02723955|364217362|FG004|Expansion Phase|Lost to Follow-up|0|||
105604898|NCT02723955|364217363|FG005|Expansion Phase|Lost to Follow-up|0|||
105604899|NCT02723955|364217364|FG006|Expansion Phase|Lost to Follow-up|0|||
105604900|NCT02723955|364217365|FG007|Expansion Phase|Lost to Follow-up|0|||
105604901|NCT02723955|364217366|FG008|Expansion Phase|Lost to Follow-up|0|||
105604902|NCT02723955|364217367|FG009|Expansion Phase|Lost to Follow-up|0|||
105604903|NCT02723955|364217368|FG010|Expansion Phase|Lost to Follow-up|4|||
105604904|NCT02723955|364217369|FG011|Expansion Phase|Lost to Follow-up|1|||
105604905|NCT02723955|364217370|FG012|Expansion Phase|Lost to Follow-up|0|||
105604906|NCT02723955|364217371|FG013|Expansion Phase|Lost to Follow-up|0|||
105604907|NCT02723955|364217372|FG014|Expansion Phase|Lost to Follow-up|0|||
105604908|NCT02723955|364217373|FG015|Expansion Phase|Lost to Follow-up|0|||
105604909|NCT02723955|364217374|FG016|Expansion Phase|Lost to Follow-up|0|||
105604910|NCT02723955|364217375|FG017|Expansion Phase|Lost to Follow-up|0|||
105604911|NCT02723955|364217376|FG018|Expansion Phase|Lost to Follow-up|0|||
105604912|NCT02723955|364217377|FG019|Expansion Phase|Lost to Follow-up|0|||
105604913|NCT02723955|364217378|FG020|Expansion Phase|Lost to Follow-up|0|||
105604914|NCT02723955|364217379|FG021|Expansion Phase|Lost to Follow-up|0|||
105604915|NCT02723955|364217380|FG022|Expansion Phase|Lost to Follow-up|0|||
105604916|NCT02723955|364217381|FG023|Expansion Phase|Lost to Follow-up|0|||
105604917|NCT02723955|364217382|FG024|Expansion Phase|Lost to Follow-up|0|||
105604918|NCT02723955|364217383|FG025|Expansion Phase|Lost to Follow-up|0|||
105604919|NCT02723955|364217384|FG026|Expansion Phase|Lost to Follow-up|0|||
105604920|NCT02723955|364217385|FG027|Expansion Phase|Lost to Follow-up|0|||
105604921|NCT02723955|364217386|FG028|Expansion Phase|Lost to Follow-up|0|||
105604922|NCT02723955|364217387|FG029|Expansion Phase|Lost to Follow-up|1|||
105604923|NCT02723955|364217388|FG030|Expansion Phase|Lost to Follow-up|19|||
105604924|NCT02723955|364217389|FG031|Expansion Phase|Lost to Follow-up|2|||
105604925|NCT02723955|364217390|FG032|Expansion Phase|Lost to Follow-up|1|||
105604926|NCT02723955|364217391|FG033|Expansion Phase|Lost to Follow-up|0|||
105604927|NCT02723955|364217392|FG034|Expansion Phase|Lost to Follow-up|0|||
105604928|NCT02723955|364217393|FG035|Expansion Phase|Lost to Follow-up|0|||
105604929|NCT02723955|364217394|FG036|Expansion Phase|Lost to Follow-up|0|||
105604930|NCT02723955|364217395|FG037|Expansion Phase|Lost to Follow-up|0|||
105604931|NCT02723955|364217396|FG038|Expansion Phase|Lost to Follow-up|0|||
105604932|NCT02723955|364217397|FG039|Expansion Phase|Lost to Follow-up|0|||
105604933|NCT02723955|364217398|FG040|Expansion Phase|Lost to Follow-up|0|||
105604934|NCT02723955|364217399|FG041|Expansion Phase|Lost to Follow-up|0|||
105604935|NCT02723955|364217400|FG042|Expansion Phase|Lost to Follow-up|0|||
105604936|NCT02723955|364217358|FG000|Expansion Phase|Physician Decision|0|||
105604937|NCT02723955|364217359|FG001|Expansion Phase|Physician Decision|0|||
105604938|NCT02723955|364217360|FG002|Expansion Phase|Physician Decision|0|||
105604939|NCT02723955|364217361|FG003|Expansion Phase|Physician Decision|0|||
105604940|NCT02723955|364217362|FG004|Expansion Phase|Physician Decision|0|||
105604941|NCT02723955|364217363|FG005|Expansion Phase|Physician Decision|0|||
105604942|NCT02723955|364217364|FG006|Expansion Phase|Physician Decision|0|||
105604943|NCT02723955|364217365|FG007|Expansion Phase|Physician Decision|0|||
105604944|NCT02723955|364217366|FG008|Expansion Phase|Physician Decision|0|||
105604945|NCT02723955|364217367|FG009|Expansion Phase|Physician Decision|0|||
105604946|NCT02723955|364217368|FG010|Expansion Phase|Physician Decision|0|||
105604947|NCT02723955|364217369|FG011|Expansion Phase|Physician Decision|0|||
105604948|NCT02723955|364217370|FG012|Expansion Phase|Physician Decision|0|||
105604949|NCT02723955|364217371|FG013|Expansion Phase|Physician Decision|0|||
105604950|NCT02723955|364217372|FG014|Expansion Phase|Physician Decision|0|||
105604951|NCT02723955|364217373|FG015|Expansion Phase|Physician Decision|0|||
105604952|NCT02723955|364217374|FG016|Expansion Phase|Physician Decision|0|||
105604953|NCT02723955|364217375|FG017|Expansion Phase|Physician Decision|0|||
105604954|NCT02723955|364217376|FG018|Expansion Phase|Physician Decision|0|||
105604955|NCT02723955|364217377|FG019|Expansion Phase|Physician Decision|0|||
105604956|NCT02723955|364217378|FG020|Expansion Phase|Physician Decision|0|||
105604957|NCT02723955|364217379|FG021|Expansion Phase|Physician Decision|0|||
105604958|NCT02723955|364217380|FG022|Expansion Phase|Physician Decision|0|||
105604959|NCT02723955|364217381|FG023|Expansion Phase|Physician Decision|0|||
105604960|NCT02723955|364217382|FG024|Expansion Phase|Physician Decision|0|||
105604961|NCT02723955|364217383|FG025|Expansion Phase|Physician Decision|0|||
105604962|NCT02723955|364217384|FG026|Expansion Phase|Physician Decision|0|||
105604963|NCT02723955|364217385|FG027|Expansion Phase|Physician Decision|0|||
105604964|NCT02723955|364217386|FG028|Expansion Phase|Physician Decision|0|||
105604965|NCT02723955|364217387|FG029|Expansion Phase|Physician Decision|0|||
105604966|NCT02723955|364217388|FG030|Expansion Phase|Physician Decision|1|||
105604967|NCT02723955|364217389|FG031|Expansion Phase|Physician Decision|1|||
105604968|NCT02723955|364217390|FG032|Expansion Phase|Physician Decision|0|||
105604969|NCT02723955|364217391|FG033|Expansion Phase|Physician Decision|0|||
105604970|NCT02723955|364217392|FG034|Expansion Phase|Physician Decision|0|||
105604971|NCT02723955|364217393|FG035|Expansion Phase|Physician Decision|0|||
105604972|NCT02723955|364217394|FG036|Expansion Phase|Physician Decision|0|||
105604973|NCT02723955|364217395|FG037|Expansion Phase|Physician Decision|0|||
105604974|NCT02723955|364217396|FG038|Expansion Phase|Physician Decision|0|||
105604975|NCT02723955|364217397|FG039|Expansion Phase|Physician Decision|0|||
105604976|NCT02723955|364217398|FG040|Expansion Phase|Physician Decision|0|||
105604977|NCT02723955|364217399|FG041|Expansion Phase|Physician Decision|0|||
105604978|NCT02723955|364217400|FG042|Expansion Phase|Physician Decision|0|||
105604979|NCT02723955|364217358|FG000|Expansion Phase|Withdrawal by Subject|0|||
105604980|NCT02723955|364217359|FG001|Expansion Phase|Withdrawal by Subject|0|||
105604981|NCT02723955|364217360|FG002|Expansion Phase|Withdrawal by Subject|0|||
105604982|NCT02723955|364217361|FG003|Expansion Phase|Withdrawal by Subject|0|||
105604983|NCT02723955|364217362|FG004|Expansion Phase|Withdrawal by Subject|0|||
105604984|NCT02723955|364217363|FG005|Expansion Phase|Withdrawal by Subject|0|||
105604985|NCT02723955|364217364|FG006|Expansion Phase|Withdrawal by Subject|0|||
105604986|NCT02723955|364217365|FG007|Expansion Phase|Withdrawal by Subject|0|||
105604987|NCT02723955|364217366|FG008|Expansion Phase|Withdrawal by Subject|0|||
105604988|NCT02723955|364217367|FG009|Expansion Phase|Withdrawal by Subject|2|||
105604989|NCT02723955|364217368|FG010|Expansion Phase|Withdrawal by Subject|1|||
105604990|NCT02723955|364217369|FG011|Expansion Phase|Withdrawal by Subject|0|||
105604991|NCT02723955|364217370|FG012|Expansion Phase|Withdrawal by Subject|0|||
105604992|NCT02723955|364217371|FG013|Expansion Phase|Withdrawal by Subject|0|||
105604993|NCT02723955|364217372|FG014|Expansion Phase|Withdrawal by Subject|0|||
105604994|NCT02723955|364217373|FG015|Expansion Phase|Withdrawal by Subject|0|||
105604995|NCT02723955|364217374|FG016|Expansion Phase|Withdrawal by Subject|0|||
105604996|NCT02723955|364217375|FG017|Expansion Phase|Withdrawal by Subject|0|||
105604997|NCT02723955|364217376|FG018|Expansion Phase|Withdrawal by Subject|0|||
105604998|NCT02723955|364217377|FG019|Expansion Phase|Withdrawal by Subject|0|||
105604999|NCT02723955|364217378|FG020|Expansion Phase|Withdrawal by Subject|0|||
105605000|NCT02723955|364217379|FG021|Expansion Phase|Withdrawal by Subject|0|||
105605001|NCT02723955|364217380|FG022|Expansion Phase|Withdrawal by Subject|0|||
105605002|NCT02723955|364217381|FG023|Expansion Phase|Withdrawal by Subject|0|||
105605003|NCT02723955|364217382|FG024|Expansion Phase|Withdrawal by Subject|0|||
105605004|NCT02723955|364217383|FG025|Expansion Phase|Withdrawal by Subject|0|||
105605005|NCT02723955|364217384|FG026|Expansion Phase|Withdrawal by Subject|0|||
105605006|NCT02723955|364217385|FG027|Expansion Phase|Withdrawal by Subject|0|||
105605007|NCT02723955|364217386|FG028|Expansion Phase|Withdrawal by Subject|0|||
105605008|NCT02723955|364217387|FG029|Expansion Phase|Withdrawal by Subject|0|||
105605009|NCT02723955|364217388|FG030|Expansion Phase|Withdrawal by Subject|8|||
105605010|NCT02723955|364217389|FG031|Expansion Phase|Withdrawal by Subject|4|||
105605011|NCT02723955|364217390|FG032|Expansion Phase|Withdrawal by Subject|0|||
105605012|NCT02723955|364217391|FG033|Expansion Phase|Withdrawal by Subject|0|||
105605013|NCT02723955|364217392|FG034|Expansion Phase|Withdrawal by Subject|0|||
105605014|NCT02723955|364217393|FG035|Expansion Phase|Withdrawal by Subject|1|||
105605015|NCT02723955|364217394|FG036|Expansion Phase|Withdrawal by Subject|0|||
105605016|NCT02723955|364217395|FG037|Expansion Phase|Withdrawal by Subject|0|||
105605017|NCT02723955|364217396|FG038|Expansion Phase|Withdrawal by Subject|0|||
105605018|NCT02723955|364217397|FG039|Expansion Phase|Withdrawal by Subject|0|||
105605019|NCT02723955|364217398|FG040|Expansion Phase|Withdrawal by Subject|0|||
105605020|NCT02723955|364217399|FG041|Expansion Phase|Withdrawal by Subject|0|||
105605021|NCT02723955|364217400|FG042|Expansion Phase|Withdrawal by Subject|0|||
105605022|NCT02723955|364217358|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605023|NCT02723955|364217359|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605024|NCT02723955|364217360|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605025|NCT02723955|364217361|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605026|NCT02723955|364217362|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605027|NCT02723955|364217363|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605028|NCT02723955|364217364|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605029|NCT02723955|364217365|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605030|NCT02723955|364217366|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605031|NCT02723955|364217367|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
105605032|NCT02723955|364217368|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
105605033|NCT02723955|364217369|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
105605034|NCT02723955|364217370|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605035|NCT02723955|364217371|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605036|NCT02723955|364217372|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605037|NCT02723955|364217373|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605038|NCT02723955|364217374|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605039|NCT02723955|364217375|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605040|NCT02723955|364217376|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605041|NCT02723955|364217377|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605042|NCT02723955|364217378|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605043|NCT02723955|364217379|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605044|NCT02723955|364217380|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605045|NCT02723955|364217381|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605046|NCT02723955|364217382|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605047|NCT02723955|364217383|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605048|NCT02723955|364217384|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605049|NCT02723955|364217385|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605050|NCT02723955|364217386|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605051|NCT02723955|364217387|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605052|NCT02723955|364217388|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
105605053|NCT02723955|364217389|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605054|NCT02723955|364217390|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605055|NCT02723955|364217391|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605056|NCT02723955|364217392|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605057|NCT02723955|364217393|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605058|NCT02723955|364217394|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605059|NCT02723955|364217395|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605060|NCT02723955|364217396|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605061|NCT02723955|364217397|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605062|NCT02723955|364217398|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605063|NCT02723955|364217399|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605064|NCT02723955|364217400|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105605065|NCT02723955|364217358|FG000|Expansion Phase|Site Closed|0|||
105605066|NCT02723955|364217359|FG001|Expansion Phase|Site Closed|0|||
105605067|NCT02723955|364217360|FG002|Expansion Phase|Site Closed|0|||
105605068|NCT02723955|364217361|FG003|Expansion Phase|Site Closed|0|||
105605069|NCT02723955|364217362|FG004|Expansion Phase|Site Closed|0|||
105605070|NCT02723955|364217363|FG005|Expansion Phase|Site Closed|0|||
105605071|NCT02723955|364217364|FG006|Expansion Phase|Site Closed|0|||
105605072|NCT02723955|364217365|FG007|Expansion Phase|Site Closed|0|||
105605073|NCT02723955|364217366|FG008|Expansion Phase|Site Closed|0|||
105605074|NCT02723955|364217367|FG009|Expansion Phase|Site Closed|1|||
105605075|NCT02723955|364217368|FG010|Expansion Phase|Site Closed|2|||
105605076|NCT02723955|364217369|FG011|Expansion Phase|Site Closed|6|||
105605077|NCT02723955|364217370|FG012|Expansion Phase|Site Closed|0|||
105605078|NCT02723955|364217371|FG013|Expansion Phase|Site Closed|0|||
105605079|NCT02723955|364217372|FG014|Expansion Phase|Site Closed|0|||
105605080|NCT02723955|364217373|FG015|Expansion Phase|Site Closed|0|||
105605081|NCT02723955|364217374|FG016|Expansion Phase|Site Closed|0|||
105605082|NCT02723955|364217375|FG017|Expansion Phase|Site Closed|0|||
105605083|NCT02723955|364217376|FG018|Expansion Phase|Site Closed|0|||
105605084|NCT02723955|364217377|FG019|Expansion Phase|Site Closed|0|||
105605085|NCT02723955|364217378|FG020|Expansion Phase|Site Closed|0|||
105605086|NCT02723955|364217379|FG021|Expansion Phase|Site Closed|0|||
105605087|NCT02723955|364217380|FG022|Expansion Phase|Site Closed|0|||
105605088|NCT02723955|364217381|FG023|Expansion Phase|Site Closed|0|||
105605089|NCT02723955|364217382|FG024|Expansion Phase|Site Closed|0|||
105605090|NCT02723955|364217383|FG025|Expansion Phase|Site Closed|0|||
105605091|NCT02723955|364217384|FG026|Expansion Phase|Site Closed|0|||
105605092|NCT02723955|364217385|FG027|Expansion Phase|Site Closed|0|||
105605093|NCT02723955|364217386|FG028|Expansion Phase|Site Closed|0|||
105605094|NCT02723955|364217387|FG029|Expansion Phase|Site Closed|0|||
105605095|NCT02723955|364217388|FG030|Expansion Phase|Site Closed|8|||
105605096|NCT02723955|364217389|FG031|Expansion Phase|Site Closed|4|||
105605097|NCT02723955|364217390|FG032|Expansion Phase|Site Closed|2|||
105605098|NCT02723955|364217391|FG033|Expansion Phase|Site Closed|2|||
105605099|NCT02723955|364217392|FG034|Expansion Phase|Site Closed|0|||
105605100|NCT02723955|364217393|FG035|Expansion Phase|Site Closed|0|||
105605101|NCT02723955|364217394|FG036|Expansion Phase|Site Closed|0|||
105605102|NCT02723955|364217395|FG037|Expansion Phase|Site Closed|0|||
105605103|NCT02723955|364217396|FG038|Expansion Phase|Site Closed|0|||
105605104|NCT02723955|364217397|FG039|Expansion Phase|Site Closed|0|||
105605105|NCT02723955|364217398|FG040|Expansion Phase|Site Closed|0|||
105605106|NCT02723955|364217399|FG041|Expansion Phase|Site Closed|0|||
105605107|NCT02723955|364217400|FG042|Expansion Phase|Site Closed|0|||
105605108|NCT02723955|364217358|FG000|Crossover/ Re-treatment Phase|Death|0|||
105605109|NCT02723955|364217359|FG001|Crossover/ Re-treatment Phase|Death|0|||
105605110|NCT02723955|364217360|FG002|Crossover/ Re-treatment Phase|Death|0|||
105605111|NCT02723955|364217361|FG003|Crossover/ Re-treatment Phase|Death|0|||
105605112|NCT02723955|364217362|FG004|Crossover/ Re-treatment Phase|Death|0|||
105605113|NCT02723955|364217363|FG005|Crossover/ Re-treatment Phase|Death|0|||
105605114|NCT02723955|364217364|FG006|Crossover/ Re-treatment Phase|Death|0|||
105605115|NCT02723955|364217365|FG007|Crossover/ Re-treatment Phase|Death|0|||
105605116|NCT02723955|364217366|FG008|Crossover/ Re-treatment Phase|Death|0|||
105605117|NCT02723955|364217367|FG009|Crossover/ Re-treatment Phase|Death|0|||
105605118|NCT02723955|364217368|FG010|Crossover/ Re-treatment Phase|Death|0|||
105605119|NCT02723955|364217369|FG011|Crossover/ Re-treatment Phase|Death|0|||
105605120|NCT02723955|364217370|FG012|Crossover/ Re-treatment Phase|Death|0|||
105605121|NCT02723955|364217371|FG013|Crossover/ Re-treatment Phase|Death|0|||
105605122|NCT02723955|364217372|FG014|Crossover/ Re-treatment Phase|Death|0|||
105605123|NCT02723955|364217373|FG015|Crossover/ Re-treatment Phase|Death|0|||
105605124|NCT02723955|364217374|FG016|Crossover/ Re-treatment Phase|Death|0|||
105605125|NCT02723955|364217375|FG017|Crossover/ Re-treatment Phase|Death|0|||
105605126|NCT02723955|364217376|FG018|Crossover/ Re-treatment Phase|Death|0|||
105605127|NCT02723955|364217377|FG019|Crossover/ Re-treatment Phase|Death|0|||
105605128|NCT02723955|364217378|FG020|Crossover/ Re-treatment Phase|Death|0|||
105605129|NCT02723955|364217379|FG021|Crossover/ Re-treatment Phase|Death|0|||
105605130|NCT02723955|364217380|FG022|Crossover/ Re-treatment Phase|Death|0|||
105605131|NCT02723955|364217381|FG023|Crossover/ Re-treatment Phase|Death|0|||
105605132|NCT02723955|364217382|FG024|Crossover/ Re-treatment Phase|Death|0|||
105605133|NCT02723955|364217383|FG025|Crossover/ Re-treatment Phase|Death|0|||
105605134|NCT02723955|364217384|FG026|Crossover/ Re-treatment Phase|Death|0|||
105605135|NCT02723955|364217385|FG027|Crossover/ Re-treatment Phase|Death|0|||
105605136|NCT02723955|364217386|FG028|Crossover/ Re-treatment Phase|Death|0|||
105605137|NCT02723955|364217387|FG029|Crossover/ Re-treatment Phase|Death|0|||
105605138|NCT02723955|364217388|FG030|Crossover/ Re-treatment Phase|Death|0|||
105605139|NCT02723955|364217389|FG031|Crossover/ Re-treatment Phase|Death|0|||
105605140|NCT02723955|364217390|FG032|Crossover/ Re-treatment Phase|Death|0|||
105605141|NCT02723955|364217391|FG033|Crossover/ Re-treatment Phase|Death|0|||
105605142|NCT02723955|364217392|FG034|Crossover/ Re-treatment Phase|Death|0|||
105605143|NCT02723955|364217393|FG035|Crossover/ Re-treatment Phase|Death|0|||
105605144|NCT02723955|364217394|FG036|Crossover/ Re-treatment Phase|Death|0|||
105605145|NCT02723955|364217395|FG037|Crossover/ Re-treatment Phase|Death|1|||
105605146|NCT02723955|364217396|FG038|Crossover/ Re-treatment Phase|Death|14|||
105605147|NCT02723955|364217397|FG039|Crossover/ Re-treatment Phase|Death|32|||
105605148|NCT02723955|364217398|FG040|Crossover/ Re-treatment Phase|Death|2|||
105605149|NCT02723955|364217399|FG041|Crossover/ Re-treatment Phase|Death|1|||
105605150|NCT02723955|364217400|FG042|Crossover/ Re-treatment Phase|Death|0|||
105605151|NCT02723955|364217358|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605152|NCT02723955|364217359|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605153|NCT02723955|364217360|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605154|NCT02723955|364217361|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605155|NCT02723955|364217362|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605156|NCT02723955|364217363|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605157|NCT02723955|364217364|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605158|NCT02723955|364217365|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605159|NCT02723955|364217366|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605160|NCT02723955|364217367|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605161|NCT02723955|364217368|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605162|NCT02723955|364217369|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605163|NCT02723955|364217370|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605164|NCT02723955|364217371|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605165|NCT02723955|364217372|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605166|NCT02723955|364217373|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605167|NCT02723955|364217374|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605168|NCT02723955|364217375|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605169|NCT02723955|364217376|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605170|NCT02723955|364217377|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605171|NCT02723955|364217378|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605172|NCT02723955|364217379|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605173|NCT02723955|364217380|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605174|NCT02723955|364217381|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605175|NCT02723955|364217382|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605176|NCT02723955|364217383|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605177|NCT02723955|364217384|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605178|NCT02723955|364217385|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605179|NCT02723955|364217386|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605180|NCT02723955|364217387|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605181|NCT02723955|364217388|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605182|NCT02723955|364217389|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605183|NCT02723955|364217390|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605184|NCT02723955|364217391|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605185|NCT02723955|364217392|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605186|NCT02723955|364217393|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605187|NCT02723955|364217394|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605188|NCT02723955|364217395|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605189|NCT02723955|364217396|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605190|NCT02723955|364217397|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
105605191|NCT02723955|364217398|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605192|NCT02723955|364217399|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605193|NCT02723955|364217400|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105605194|NCT02723955|364217358|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605195|NCT02723955|364217359|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605196|NCT02723955|364217360|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605197|NCT02723955|364217361|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605198|NCT02723955|364217362|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605199|NCT02723955|364217363|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605200|NCT02723955|364217364|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605201|NCT02723955|364217365|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605202|NCT02723955|364217366|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605203|NCT02723955|364217367|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605204|NCT02723955|364217368|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605205|NCT02723955|364217369|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605206|NCT02723955|364217370|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605207|NCT02723955|364217371|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605208|NCT02723955|364217372|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605209|NCT02723955|364217373|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605210|NCT02723955|364217374|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605211|NCT02723955|364217375|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605212|NCT02723955|364217376|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605213|NCT02723955|364217377|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605214|NCT02723955|364217378|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605215|NCT02723955|364217379|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605216|NCT02723955|364217380|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605217|NCT02723955|364217381|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605218|NCT02723955|364217382|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605219|NCT02723955|364217383|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605220|NCT02723955|364217384|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605221|NCT02723955|364217385|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605222|NCT02723955|364217386|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605223|NCT02723955|364217387|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605224|NCT02723955|364217388|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605225|NCT02723955|364217389|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605226|NCT02723955|364217390|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605227|NCT02723955|364217391|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605228|NCT02723955|364217392|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605229|NCT02723955|364217393|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605230|NCT02723955|364217394|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605231|NCT02723955|364217395|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605232|NCT02723955|364217396|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
105605233|NCT02723955|364217397|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
105605234|NCT02723955|364217398|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605235|NCT02723955|364217399|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
105605236|NCT02723955|364217400|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
105605237|NCT02723955|364217358|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
105605238|NCT02723955|364217359|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
105605239|NCT02723955|364217360|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
105605240|NCT02723955|364217361|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
105605241|NCT02723955|364217362|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
105605242|NCT02723955|364217363|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
105605243|NCT02723955|364217364|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
105605244|NCT02723955|364217365|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
105605245|NCT02723955|364217366|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
105605246|NCT02723955|364217367|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
105605247|NCT02723955|364217368|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
105605248|NCT02723955|364217369|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
105605249|NCT02723955|364217370|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
105605250|NCT02723955|364217371|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
105605251|NCT02723955|364217372|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
105605252|NCT02723955|364217373|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
105605253|NCT02723955|364217374|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
105605254|NCT02723955|364217375|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
105605255|NCT02723955|364217376|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
105605256|NCT02723955|364217377|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
105605257|NCT02723955|364217378|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
105605258|NCT02723955|364217379|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
105605259|NCT02723955|364217380|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
105605260|NCT02723955|364217381|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
105605261|NCT02723955|364217382|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
105605262|NCT02723955|364217383|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
105605263|NCT02723955|364217384|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
105605264|NCT02723955|364217385|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
105605265|NCT02723955|364217386|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
105605266|NCT02723955|364217387|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
105605267|NCT02723955|364217388|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
105605268|NCT02723955|364217389|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
105605269|NCT02723955|364217390|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
105605270|NCT02723955|364217391|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
105605271|NCT02723955|364217392|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
105605272|NCT02723955|364217393|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
105605273|NCT02723955|364217394|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
105605274|NCT02723955|364217395|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
105605275|NCT02723955|364217396|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
105605276|NCT02723955|364217397|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
105605277|NCT02723955|364217398|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
105605278|NCT02723955|364217399|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
105605279|NCT02723955|364217400|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
105605280|NCT04300647|364217401|FG000|Pre-Crossover|Death|19|||
105605281|NCT04300647|364217402|FG001|Pre-Crossover|Death|58|||
105605282|NCT04300647|364217403|FG002|Pre-Crossover|Death|0|||
105605283|NCT04300647|364217401|FG000|Pre-Crossover|Lost to Follow-up|0|||
105605284|NCT04300647|364217402|FG001|Pre-Crossover|Lost to Follow-up|3|||
105605285|NCT04300647|364217403|FG002|Pre-Crossover|Lost to Follow-up|0|||
105605286|NCT04300647|364217401|FG000|Pre-Crossover|Withdrawal by Subject|2|||
105605287|NCT04300647|364217402|FG001|Pre-Crossover|Withdrawal by Subject|4|||
105605288|NCT04300647|364217403|FG002|Pre-Crossover|Withdrawal by Subject|0|||
105605289|NCT04300647|364217401|FG000|Pre-Crossover|On-going in Study|24|||
105605290|NCT04300647|364217402|FG001|Pre-Crossover|On-going in Study|61|||
105605291|NCT04300647|364217403|FG002|Pre-Crossover|On-going in Study|0|||
105605292|NCT04300647|364217401|FG000|Post-Crossover|Death|0|||
105605293|NCT04300647|364217402|FG001|Post-Crossover|Death|0|||
105605294|NCT04300647|364217403|FG002|Post-Crossover|Death|3|||
105605295|NCT04300647|364217401|FG000|Post-Crossover|Lost to Follow-up|0|||
105605296|NCT04300647|364217402|FG001|Post-Crossover|Lost to Follow-up|0|||
105605297|NCT04300647|364217403|FG002|Post-Crossover|Lost to Follow-up|1|||
105605298|NCT04300647|364217401|FG000|Post-Crossover|Withdrawal by Subject|0|||
105605299|NCT04300647|364217402|FG001|Post-Crossover|Withdrawal by Subject|0|||
105605300|NCT04300647|364217403|FG002|Post-Crossover|Withdrawal by Subject|1|||
105605301|NCT04300647|364217401|FG000|Post-Crossover|On-going in Study|0|||
105605302|NCT04300647|364217402|FG001|Post-Crossover|On-going in Study|0|||
105605303|NCT04300647|364217403|FG002|Post-Crossover|On-going in Study|8|||
105605304|NCT04999085|364217404|FG000|Overall Study|Death|1|||
105605305|NCT05057897|364217405|FG000|Overall Study|Site closure|2|||
105605306|NCT05057897|364217406|FG001|Overall Study|Site closure|2|||
105605307|NCT05057897|364217405|FG000|Overall Study|Death|1|||
105605308|NCT05057897|364217406|FG001|Overall Study|Death|0|||
105605309|NCT01353313|364217407|FG000|Overall Study|Lost to Follow-up|22|||
105605310|NCT01353313|364217408|FG001|Overall Study|Lost to Follow-up|23|||
105605311|NCT01353313|364217407|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
105605312|NCT01353313|364217408|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
105605313|NCT02824029|364217409|FG000|Overall Study|Didn't receive treatment|2|||
105605314|NCT02824029|364217409|FG000|Overall Study|Patient decision to discontinue treatment|3|||
105605315|NCT02824029|364217409|FG000|Overall Study|Non-compliant|5|||
105605316|NCT02824029|364217409|FG000|Overall Study|Progression of disease|15|||
105605317|NCT02824029|364217409|FG000|Overall Study|Inadequate response to therapy|2|||
105605318|NCT02824029|364217409|FG000|Overall Study|Possible progression per treating physician|1|||
105605319|NCT02581215|364217412|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
105605320|NCT02581215|364217413|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
105605321|NCT02581215|364217412|FG000|Overall Study|Eligibility Criteria Not Met|0|||
105605322|NCT02581215|364217413|FG001|Overall Study|Eligibility Criteria Not Met|1|||
105605323|NCT02780388|364217414|FG000|Overall Study|Lost to Follow-up|0|||
105605324|NCT02780388|364217415|FG001|Overall Study|Lost to Follow-up|1|||
105605325|NCT02780388|364217416|FG002|Overall Study|Lost to Follow-up|0|||
105605326|NCT02780388|364217417|FG003|Overall Study|Lost to Follow-up|0|||
105605327|NCT02780388|364217418|FG004|Overall Study|Lost to Follow-up|0|||
105605328|NCT02780388|364217414|FG000|Overall Study|Withdrawal by Subject|1|||
105605329|NCT02780388|364217415|FG001|Overall Study|Withdrawal by Subject|1|||
105605330|NCT02780388|364217416|FG002|Overall Study|Withdrawal by Subject|0|||
105605331|NCT02780388|364217417|FG003|Overall Study|Withdrawal by Subject|0|||
105605332|NCT02780388|364217418|FG004|Overall Study|Withdrawal by Subject|0|||
105605333|NCT02015520|364217428|FG000|Overall Study|Lack of Efficacy|1|||
105605334|NCT02015520|364217429|FG001|Overall Study|Lack of Efficacy|0|||
105605335|NCT02015520|364217430|FG002|Overall Study|Lack of Efficacy|3|||
105605336|NCT02015520|364217431|FG003|Overall Study|Lack of Efficacy|2|||
105605337|NCT02015520|364217428|FG000|Overall Study|Adverse Event|0|||
105605338|NCT02015520|364217429|FG001|Overall Study|Adverse Event|0|||
105605339|NCT02015520|364217430|FG002|Overall Study|Adverse Event|0|||
105605340|NCT02015520|364217431|FG003|Overall Study|Adverse Event|1|||
105605341|NCT02015520|364217428|FG000|Overall Study|Withdrawal by Subject|2|||
105605342|NCT02015520|364217429|FG001|Overall Study|Withdrawal by Subject|2|||
105605343|NCT02015520|364217430|FG002|Overall Study|Withdrawal by Subject|1|||
105605344|NCT02015520|364217431|FG003|Overall Study|Withdrawal by Subject|0|||
105605345|NCT02015520|364217428|FG000|Overall Study|Death|1|||
105605346|NCT02015520|364217429|FG001|Overall Study|Death|0|||
105605347|NCT02015520|364217430|FG002|Overall Study|Death|0|||
105605348|NCT02015520|364217431|FG003|Overall Study|Death|0|||
105605349|NCT02015520|364217428|FG000|Overall Study|Lost to Follow-up|0|||
105605350|NCT02015520|364217429|FG001|Overall Study|Lost to Follow-up|0|||
105605351|NCT02015520|364217430|FG002|Overall Study|Lost to Follow-up|1|||
105605352|NCT02015520|364217431|FG003|Overall Study|Lost to Follow-up|0|||
105605353|NCT02015520|364217428|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
105605354|NCT02015520|364217429|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
105605355|NCT02015520|364217430|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
105605356|NCT02015520|364217431|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
105605357|NCT02015520|364217428|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
105605358|NCT02015520|364217429|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
105605359|NCT02015520|364217430|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
105605360|NCT02015520|364217431|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
105605361|NCT02058108|364217432|FG000|Overall Study|Abnormal Laboratory Values|0|||
105605362|NCT02058108|364217433|FG001|Overall Study|Abnormal Laboratory Values|1|||
105605363|NCT02058108|364217432|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
105605364|NCT02058108|364217433|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
105605365|NCT02058108|364217432|FG000|Overall Study|No longer requires study drug|0|||
105605366|NCT02058108|364217433|FG001|Overall Study|No longer requires study drug|1|||
105605367|NCT02058108|364217432|FG000|Overall Study|Withdrawal by Subject|1|||
105605368|NCT02058108|364217433|FG001|Overall Study|Withdrawal by Subject|0|||
105605369|NCT02058108|364217432|FG000|Overall Study|Administrative problems|3|||
105605370|NCT02058108|364217433|FG001|Overall Study|Administrative problems|3|||
105605371|NCT02058108|364217432|FG000|Overall Study|Protocol Violation|0|||
105605372|NCT02058108|364217433|FG001|Overall Study|Protocol Violation|1|||
105605373|NCT00727909|364217434|FG000|Overall Study|Withdrawal by Subject|5|||
105605374|NCT00727909|364217435|FG001|Overall Study|Withdrawal by Subject|11|||
105605375|NCT00727909|364217436|FG002|Overall Study|Withdrawal by Subject|8|||
105605376|NCT00727909|364217437|FG003|Overall Study|Withdrawal by Subject|5|||
105605377|NCT00727909|364217434|FG000|Overall Study|Death|0|||
105605378|NCT00727909|364217435|FG001|Overall Study|Death|0|||
105605379|NCT00727909|364217436|FG002|Overall Study|Death|1|||
105605380|NCT00727909|364217437|FG003|Overall Study|Death|0|||
105605381|NCT03756571|364217438|FG000|Overall Study|Lost to Follow-up|1|||
105605382|NCT03756571|364217439|FG001|Overall Study|Lost to Follow-up|1|||
105605383|NCT00111813|364217440|FG000|Overall Study|Adverse Event|1|||
105605384|NCT00111813|364217441|FG001|Overall Study|Adverse Event|2|||
105605385|NCT00111813|364217442|FG002|Overall Study|Adverse Event|4|||
105605386|NCT00111813|364217443|FG003|Overall Study|Adverse Event|2|||
105605387|NCT00111813|364217444|FG004|Overall Study|Adverse Event|2|||
105605388|NCT00111813|364217445|FG005|Overall Study|Adverse Event|2|||
105605389|NCT00111813|364217440|FG000|Overall Study|Progressive disease|2|||
105605390|NCT00111813|364217441|FG001|Overall Study|Progressive disease|1|||
105605391|NCT00111813|364217442|FG002|Overall Study|Progressive disease|5|||
105605392|NCT00111813|364217443|FG003|Overall Study|Progressive disease|3|||
105605393|NCT00111813|364217444|FG004|Overall Study|Progressive disease|4|||
105605394|NCT00111813|364217445|FG005|Overall Study|Progressive disease|3|||
105605395|NCT00111813|364217440|FG000|Overall Study|Lack of Efficacy|0|||
105605396|NCT00111813|364217441|FG001|Overall Study|Lack of Efficacy|0|||
105605397|NCT00111813|364217442|FG002|Overall Study|Lack of Efficacy|0|||
105605398|NCT00111813|364217443|FG003|Overall Study|Lack of Efficacy|0|||
105605399|NCT00111813|364217444|FG004|Overall Study|Lack of Efficacy|0|||
105605400|NCT00111813|364217445|FG005|Overall Study|Lack of Efficacy|1|||
105605401|NCT00111813|364217440|FG000|Overall Study|Other|0|||
105605402|NCT00111813|364217441|FG001|Overall Study|Other|0|||
105605403|NCT00111813|364217442|FG002|Overall Study|Other|1|||
105605404|NCT00111813|364217443|FG003|Overall Study|Other|0|||
105605405|NCT00111813|364217444|FG004|Overall Study|Other|0|||
105605406|NCT00111813|364217445|FG005|Overall Study|Other|0|||
105605407|NCT00998881|364217446|FG000|Overall Study|Adverse Event|2|||
105605408|NCT00998881|364217447|FG001|Overall Study|Adverse Event|2|||
105605409|NCT00998881|364217446|FG000|Overall Study|Lack of Efficacy|1|||
105605410|NCT00998881|364217447|FG001|Overall Study|Lack of Efficacy|0|||
105605411|NCT00998881|364217446|FG000|Overall Study|Physician Decision|3|||
105605412|NCT00998881|364217447|FG001|Overall Study|Physician Decision|0|||
105605413|NCT00998881|364217446|FG000|Overall Study|Withdrawal by Subject|1|||
105605414|NCT00998881|364217447|FG001|Overall Study|Withdrawal by Subject|0|||
105605415|NCT00998881|364217446|FG000|Overall Study|Personal matter|1|||
105605416|NCT00998881|364217447|FG001|Overall Study|Personal matter|0|||
105605417|NCT00818246|364217448|FG000|Overall Study|Impossible to match pictures|5|||
105605418|NCT01007396|364217449|FG000|Overall Study|Lost to Follow-up|47|||
105605419|NCT02590432|364217450|FG000|Open-label Treatment Period|Adverse Event|97|||
105605420|NCT02590432|364217451|FG001|Open-label Treatment Period|Adverse Event|79|||
105605421|NCT02590432|364217452|FG002|Open-label Treatment Period|Adverse Event|0|||
105605422|NCT02590432|364217453|FG003|Open-label Treatment Period|Adverse Event|0|||
105605423|NCT02590432|364217454|FG004|Open-label Treatment Period|Adverse Event|0|||
105605424|NCT02590432|364217455|FG005|Open-label Treatment Period|Adverse Event|0|||
105605425|NCT02590432|364217456|FG006|Open-label Treatment Period|Adverse Event|0|||
105605426|NCT02590432|364217457|FG007|Open-label Treatment Period|Adverse Event|0|||
105605427|NCT02590432|364217458|FG008|Open-label Treatment Period|Adverse Event|0|||
105605428|NCT02590432|364217450|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
105605429|NCT02590432|364217451|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
105605430|NCT02590432|364217452|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
105605431|NCT02590432|364217453|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
105605432|NCT02590432|364217454|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
105605433|NCT02590432|364217455|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
105605434|NCT02590432|364217456|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
105605435|NCT02590432|364217457|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
105605436|NCT02590432|364217458|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
105605437|NCT02590432|364217450|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
105605438|NCT02590432|364217451|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
105605439|NCT02590432|364217452|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
105605440|NCT02590432|364217453|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
105605441|NCT02590432|364217454|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
105605442|NCT02590432|364217455|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
105605443|NCT02590432|364217456|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
105605444|NCT02590432|364217457|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
105605445|NCT02590432|364217458|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
105605446|NCT02590432|364217450|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
105605447|NCT02590432|364217451|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
105605448|NCT02590432|364217452|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
105605449|NCT02590432|364217453|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
105605450|NCT02590432|364217454|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
105605451|NCT02590432|364217455|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
105605452|NCT02590432|364217456|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
105605453|NCT02590432|364217457|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
105605454|NCT02590432|364217458|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
105605455|NCT02590432|364217450|FG000|Open-label Treatment Period|Protocol Violation|10|||
105605456|NCT02590432|364217451|FG001|Open-label Treatment Period|Protocol Violation|4|||
105605457|NCT02590432|364217452|FG002|Open-label Treatment Period|Protocol Violation|0|||
105605458|NCT02590432|364217453|FG003|Open-label Treatment Period|Protocol Violation|0|||
105605459|NCT02590432|364217454|FG004|Open-label Treatment Period|Protocol Violation|0|||
105605460|NCT02590432|364217455|FG005|Open-label Treatment Period|Protocol Violation|0|||
105605461|NCT02590432|364217456|FG006|Open-label Treatment Period|Protocol Violation|0|||
105605462|NCT02590432|364217457|FG007|Open-label Treatment Period|Protocol Violation|0|||
105605463|NCT02590432|364217458|FG008|Open-label Treatment Period|Protocol Violation|0|||
105605464|NCT02590432|364217450|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
105605465|NCT02590432|364217451|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
105605466|NCT02590432|364217452|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
105605467|NCT02590432|364217453|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
105605468|NCT02590432|364217454|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
105605469|NCT02590432|364217455|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
105605470|NCT02590432|364217456|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
105605471|NCT02590432|364217457|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
105605472|NCT02590432|364217458|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
105605473|NCT02590432|364217450|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
105605474|NCT02590432|364217451|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
105605475|NCT02590432|364217452|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
105605476|NCT02590432|364217453|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
105605477|NCT02590432|364217454|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
105605478|NCT02590432|364217455|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
105605479|NCT02590432|364217456|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
105605480|NCT02590432|364217457|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
105605481|NCT02590432|364217458|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
105605482|NCT02590432|364217450|FG000|Double-blind Treatment Period|Adverse Event|0|||
105605483|NCT02590432|364217451|FG001|Double-blind Treatment Period|Adverse Event|0|||
105605484|NCT02590432|364217452|FG002|Double-blind Treatment Period|Adverse Event|14|||
105605485|NCT02590432|364217453|FG003|Double-blind Treatment Period|Adverse Event|12|||
105605486|NCT02590432|364217454|FG004|Double-blind Treatment Period|Adverse Event|6|||
105605487|NCT02590432|364217455|FG005|Double-blind Treatment Period|Adverse Event|22|||
105605488|NCT02590432|364217456|FG006|Double-blind Treatment Period|Adverse Event|20|||
105605489|NCT02590432|364217457|FG007|Double-blind Treatment Period|Adverse Event|0|||
105605490|NCT02590432|364217458|FG008|Double-blind Treatment Period|Adverse Event|0|||
105605491|NCT02590432|364217450|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
105605492|NCT02590432|364217451|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
105605493|NCT02590432|364217452|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
105605494|NCT02590432|364217453|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
105605495|NCT02590432|364217454|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
105605496|NCT02590432|364217455|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
105605497|NCT02590432|364217456|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
105605498|NCT02590432|364217457|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
105605499|NCT02590432|364217458|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
105605500|NCT02590432|364217450|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
105605501|NCT02590432|364217451|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
105605502|NCT02590432|364217452|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
105605503|NCT02590432|364217453|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
105605504|NCT02590432|364217454|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
105605505|NCT02590432|364217455|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
105605506|NCT02590432|364217456|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
105605507|NCT02590432|364217457|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
105605508|NCT02590432|364217458|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
105605509|NCT02590432|364217450|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
105605510|NCT02590432|364217451|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
105605511|NCT02590432|364217452|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
105605512|NCT02590432|364217453|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
105605513|NCT02590432|364217454|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
105605514|NCT02590432|364217455|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
105605515|NCT02590432|364217456|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
105605516|NCT02590432|364217457|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
105605517|NCT02590432|364217458|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
105605518|NCT02590432|364217450|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
105605519|NCT02590432|364217451|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
105605520|NCT02590432|364217452|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
105605521|NCT02590432|364217453|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
105605522|NCT02590432|364217454|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
105605523|NCT02590432|364217455|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
105605524|NCT02590432|364217456|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
105605525|NCT02590432|364217457|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
105605526|NCT02590432|364217458|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
105605527|NCT02590432|364217450|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
105605528|NCT02590432|364217451|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
105605529|NCT02590432|364217452|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
105605530|NCT02590432|364217453|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
105605531|NCT02590432|364217454|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
105605532|NCT02590432|364217455|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
105605533|NCT02590432|364217456|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
105605534|NCT02590432|364217457|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
105605535|NCT02590432|364217458|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
105605536|NCT02590432|364217450|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
105605537|NCT02590432|364217451|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
105605538|NCT02590432|364217452|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
105605539|NCT02590432|364217453|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
105605540|NCT02590432|364217454|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
105605541|NCT02590432|364217455|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
105605542|NCT02590432|364217456|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
105605543|NCT02590432|364217457|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
105605544|NCT02590432|364217458|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
105605545|NCT02590432|364217450|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
105605546|NCT02590432|364217451|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
105605547|NCT02590432|364217452|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
105605548|NCT02590432|364217453|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
105605549|NCT02590432|364217454|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
105605550|NCT02590432|364217455|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
105605551|NCT02590432|364217456|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
105605552|NCT02590432|364217457|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
105605553|NCT02590432|364217458|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
105605554|NCT02590432|364217450|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
105605555|NCT02590432|364217451|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
105605556|NCT02590432|364217452|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
105605557|NCT02590432|364217453|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
105605558|NCT02590432|364217454|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
105439804|NCT02147288|363615080|FG009|Overall Study|post-operative hematoma|0|||
105439805|NCT02147288|363615071|FG000|Overall Study|complications from concurrent hernia rep|0|||
105439806|NCT02147288|363615072|FG001|Overall Study|complications from concurrent hernia rep|1|||
105439807|NCT02147288|363615073|FG002|Overall Study|complications from concurrent hernia rep|0|||
105439808|NCT02147288|363615074|FG003|Overall Study|complications from concurrent hernia rep|0|||
105439809|NCT02147288|363615075|FG004|Overall Study|complications from concurrent hernia rep|0|||
105439810|NCT02147288|363615076|FG005|Overall Study|complications from concurrent hernia rep|0|||
105439811|NCT02147288|363615077|FG006|Overall Study|complications from concurrent hernia rep|0|||
105439812|NCT02147288|363615078|FG007|Overall Study|complications from concurrent hernia rep|0|||
105439813|NCT02147288|363615079|FG008|Overall Study|complications from concurrent hernia rep|0|||
105605559|NCT02590432|364217455|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
105605560|NCT02590432|364217456|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
105605561|NCT02590432|364217457|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
105605562|NCT02590432|364217458|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
105605563|NCT02590432|364217450|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
105605564|NCT02590432|364217451|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
105605565|NCT02590432|364217452|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
105605566|NCT02590432|364217453|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
105605567|NCT02590432|364217454|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
105605568|NCT02590432|364217455|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
105605569|NCT02590432|364217456|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
105605570|NCT02590432|364217457|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
105605571|NCT02590432|364217458|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
105605572|NCT02590432|364217450|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
105605573|NCT02590432|364217451|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
105605574|NCT02590432|364217452|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
105605575|NCT02590432|364217453|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
105605576|NCT02590432|364217454|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
105605577|NCT02590432|364217455|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
105605578|NCT02590432|364217456|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
105605579|NCT02590432|364217457|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
105605580|NCT02590432|364217458|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
105605581|NCT02590432|364217450|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
105605582|NCT02590432|364217451|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
105605583|NCT02590432|364217452|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
105605584|NCT02590432|364217453|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
105605585|NCT02590432|364217454|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
105605586|NCT02590432|364217455|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
105605587|NCT02590432|364217456|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
105605588|NCT02590432|364217457|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
105605589|NCT02590432|364217458|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
105605590|NCT01619410|364217459|FG000|Overall Study|Lost to Follow-up|7|||
105605591|NCT01619410|364217460|FG001|Overall Study|Lost to Follow-up|4|||
105605592|NCT04788641|364217465|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
105605593|NCT04788641|364217466|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
105605594|NCT04788641|364217467|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
105605595|NCT04788641|364217468|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
105605596|NCT04788641|364217465|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
105605597|NCT04788641|364217466|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
105605598|NCT04788641|364217467|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
105605599|NCT04788641|364217468|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
105605600|NCT04788641|364217465|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
105605601|NCT04788641|364217466|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
105605602|NCT04788641|364217467|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
105605603|NCT04788641|364217468|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
105605604|NCT01340066|364217469|FG000|Placebo Run in Period|Screen Failures|27|||
105605605|NCT01340066|364217470|FG001|Placebo Run in Period|Screen Failures|0|||
105605606|NCT01340066|364217471|FG002|Placebo Run in Period|Screen Failures|0|||
105605607|NCT01340066|364217469|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
105605608|NCT01340066|364217470|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
105605609|NCT01340066|364217471|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
105605610|NCT01340066|364217469|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
105605611|NCT01340066|364217470|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
105605612|NCT01340066|364217471|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
105605613|NCT01340066|364217469|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
105605614|NCT01340066|364217470|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
105605615|NCT01340066|364217471|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
105605616|NCT02789020|364217472|FG000|Overall Study|Withdrawal by Subject|6|||
105605617|NCT02789020|364217473|FG001|Overall Study|Withdrawal by Subject|5|||
105605618|NCT01198145|364217488|FG000|Overall Study|Withdrawal by Subject|1|||
105605619|NCT01198145|364217489|FG001|Overall Study|Withdrawal by Subject|1|||
105605620|NCT00603954|364217490|FG000|Overall Study|Protocol Violation|1|||
105605621|NCT00603954|364217491|FG001|Overall Study|Protocol Violation|2|||
105605622|NCT03380390|364217492|FG000|Overall Study|Adverse Event|3|||
105605623|NCT02886286|364217493|FG000|Overall Study|pump motor stall|0|||
105605624|NCT02886286|364217494|FG001|Overall Study|pump motor stall|1|||
105605625|NCT01127373|364217495|FG000|Overall Study|Not Treated|3|||
105605626|NCT01127373|364217495|FG000|Overall Study|Lost to Follow-up|7|||
105605627|NCT01127373|364217495|FG000|Overall Study|Withdrawal by Subject|1|||
105605628|NCT01127373|364217495|FG000|Overall Study|Disease progression|1|||
105605629|NCT02477605|364217498|FG000|Overall Study|Discontinued prior to treatment|1|||
105605630|NCT02477605|364217499|FG001|Overall Study|Discontinued prior to treatment|0|||
105605631|NCT02477605|364217498|FG000|Overall Study|Lost to Follow-up|0|||
105605632|NCT02477605|364217499|FG001|Overall Study|Lost to Follow-up|2|||
105605633|NCT02477605|364217498|FG000|Overall Study|Withdrawal by Subject|0|||
105605634|NCT02477605|364217499|FG001|Overall Study|Withdrawal by Subject|1|||
105605635|NCT02477605|364217498|FG000|Overall Study|Administered gas during surgery|0|||
105605636|NCT02477605|364217499|FG001|Overall Study|Administered gas during surgery|1|||
105605637|NCT02794480|364217500|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
105605638|NCT02794480|364217501|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
105605639|NCT02794480|364217502|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
105605640|NCT02794480|364217503|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
105605641|NCT02794480|364217500|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
105605642|NCT02794480|364217501|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
105605643|NCT02794480|364217502|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
105605644|NCT02794480|364217503|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
105605645|NCT02794480|364217500|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105605646|NCT02794480|364217501|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105605647|NCT02794480|364217502|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105605648|NCT02794480|364217503|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
105605649|NCT02794480|364217500|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105605650|NCT02794480|364217501|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
105605651|NCT02794480|364217502|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105605652|NCT02794480|364217503|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
105605653|NCT02794480|364217500|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
105605654|NCT02794480|364217501|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105605655|NCT02794480|364217502|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105605656|NCT02794480|364217503|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
105605657|NCT03101930|364217504|FG000|Overall Study|Withdrawal by Subject|2|||
105605658|NCT03101930|364217505|FG001|Overall Study|Withdrawal by Subject|1|||
105605659|NCT03101930|364217506|FG002|Overall Study|Withdrawal by Subject|2|||
105605660|NCT00262301|364217507|FG000|Double-blind Phase|Lost to Follow-up|1|||
105605661|NCT00262301|364217508|FG001|Double-blind Phase|Lost to Follow-up|0|||
105605662|NCT00262301|364217509|FG002|Double-blind Phase|Lost to Follow-up|0|||
105605663|NCT00262301|364217507|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
105605664|NCT00262301|364217508|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
105605665|NCT00262301|364217509|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
105605666|NCT04154384|364217517|FG000|Overall Study|Lost to Follow-up|24|||
105605667|NCT04154384|364217518|FG001|Overall Study|Lost to Follow-up|33|||
105605668|NCT04154384|364217519|FG002|Overall Study|Lost to Follow-up|0|||
105605669|NCT04154384|364217517|FG000|Overall Study|Withdrawal by Subject|7|||
105605670|NCT04154384|364217518|FG001|Overall Study|Withdrawal by Subject|18|||
105605671|NCT04154384|364217519|FG002|Overall Study|Withdrawal by Subject|0|||
105605672|NCT04154384|364217517|FG000|Overall Study|Missing outcome data|1|||
105605673|NCT04154384|364217518|FG001|Overall Study|Missing outcome data|0|||
105605674|NCT04154384|364217519|FG002|Overall Study|Missing outcome data|0|||
105605675|NCT01136876|364217520|FG000|Overall Study|Lost to Follow-up|0|||
105605676|NCT01136876|364217521|FG001|Overall Study|Lost to Follow-up|1|||
105605677|NCT01136876|364217520|FG000|Overall Study|Physician Decision|3|||
105605678|NCT01136876|364217521|FG001|Overall Study|Physician Decision|5|||
105605679|NCT01136876|364217520|FG000|Overall Study|Missing NGAL measurement|2|||
105605680|NCT01136876|364217521|FG001|Overall Study|Missing NGAL measurement|5|||
105605681|NCT05048186|364217522|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
105605682|NCT05048186|364217523|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
105605683|NCT05048186|364217522|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
105605684|NCT05048186|364217523|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
105605685|NCT02412748|364217524|FG000|Overall Study|Lost to Follow-up|38|||
105605686|NCT02412748|364217525|FG001|Overall Study|Lost to Follow-up|39|||
105605687|NCT02742519|364217528|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
105605688|NCT02742519|364217529|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
105605689|NCT02742519|364217530|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
105605690|NCT02742519|364217528|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
105605691|NCT02742519|364217529|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
105605692|NCT02742519|364217530|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
105605693|NCT02742519|364217528|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
105605694|NCT02742519|364217529|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
105605695|NCT02742519|364217530|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
105605696|NCT01094184|364217533|FG000|Overall Study|Death|35|||
105605697|NCT01094184|364217534|FG001|Overall Study|Death|11|||
105605698|NCT03988842|364217535|FG000|Overall Study|Death|1|||
105605699|NCT01976312|364217536|FG000|Overall Study|Pregnancy|0|||
105605700|NCT01976312|364217537|FG001|Overall Study|Pregnancy|1|||
105605701|NCT01976312|364217536|FG000|Overall Study|Lost to Follow-up|2|||
105605702|NCT01976312|364217537|FG001|Overall Study|Lost to Follow-up|0|||
105605703|NCT01976312|364217536|FG000|Overall Study|Withdrawal by Subject|7|||
105605704|NCT01976312|364217537|FG001|Overall Study|Withdrawal by Subject|2|||
105605705|NCT01976312|364217536|FG000|Overall Study|Adverse Event|6|||
105605706|NCT01976312|364217537|FG001|Overall Study|Adverse Event|6|||
105605707|NCT01976312|364217536|FG000|Overall Study|Protocol Violation|2|||
105605708|NCT01976312|364217537|FG001|Overall Study|Protocol Violation|0|||
105605709|NCT04814186|364219077|FG000|Treatment Phase|Adverse Event|1|||
105605710|NCT04814186|364219077|FG000|Treatment Phase|Death|6|||
105605711|NCT04814186|364219077|FG000|Treatment Phase|Withdrawal by Subject|2|||
105605712|NCT04814186|364219077|FG000|Treatment Phase|Other|1|||
105605713|NCT04814186|364219077|FG000|Follow-Up Phase|Adverse Event|1|||
105605714|NCT04814186|364219077|FG000|Follow-Up Phase|Death|6|||
105605715|NCT04814186|364219077|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
105605716|NCT04814186|364219077|FG000|Follow-Up Phase|Other|1|||
105605717|NCT04043455|364219105|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
105605718|NCT04043455|364219106|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
105605719|NCT04043455|364219107|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
105605720|NCT04043455|364219108|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
105605721|NCT04043455|364219109|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
105605722|NCT04043455|364219110|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
105605723|NCT04043455|364219105|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
105605724|NCT04043455|364219106|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
105605725|NCT04043455|364219107|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
105605726|NCT04043455|364219108|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
105605727|NCT04043455|364219109|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
105605728|NCT04043455|364219110|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
105605729|NCT04043455|364219105|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
105605730|NCT04043455|364219106|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
105605731|NCT04043455|364219107|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
105605732|NCT04043455|364219108|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
105605733|NCT04043455|364219109|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
105605734|NCT04043455|364219110|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
105605735|NCT04043455|364219105|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
105605736|NCT04043455|364219106|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
105605737|NCT04043455|364219107|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
105605738|NCT04043455|364219108|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
105605739|NCT04043455|364219109|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
105605740|NCT04043455|364219110|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
105605741|NCT04043455|364219105|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
105605742|NCT04043455|364219106|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
105605743|NCT04043455|364219107|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
105605744|NCT04043455|364219108|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
105605745|NCT04043455|364219109|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
105605746|NCT04043455|364219110|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
105605747|NCT04043455|364219105|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
105605748|NCT04043455|364219106|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
105605749|NCT04043455|364219107|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
105605750|NCT04043455|364219108|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
105605751|NCT04043455|364219109|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
105605752|NCT04043455|364219110|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
105605753|NCT04043455|364219105|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
105605754|NCT04043455|364219106|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
105605755|NCT04043455|364219107|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
105605756|NCT04043455|364219108|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
105605757|NCT04043455|364219109|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
105605758|NCT04043455|364219110|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
105605759|NCT04043455|364219105|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
105605760|NCT04043455|364219106|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
105605761|NCT04043455|364219107|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
105605762|NCT04043455|364219108|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
105605763|NCT04043455|364219109|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
105605764|NCT04043455|364219110|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
105605765|NCT04043455|364219105|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
105605766|NCT04043455|364219106|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
105605767|NCT04043455|364219107|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
105605768|NCT04043455|364219108|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
105605769|NCT04043455|364219109|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
105605770|NCT04043455|364219110|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
105605771|NCT04043455|364219105|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
105605772|NCT04043455|364219106|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
105605773|NCT04043455|364219107|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
105605774|NCT04043455|364219108|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
105605775|NCT04043455|364219109|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
105605776|NCT04043455|364219110|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
105605777|NCT04043455|364219105|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
105605778|NCT04043455|364219106|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
105605779|NCT04043455|364219107|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
105605780|NCT04043455|364219108|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
105605781|NCT04043455|364219109|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
105605782|NCT04043455|364219110|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
105605783|NCT04688450|364219113|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
105605784|NCT04688450|364219113|FG000|Overall Study|Withdrawal by Subject|1|||
105605785|NCT02544074|364219116|FG000|Overall Study|Withdrawal by Subject|0|||
105605786|NCT02544074|364219117|FG001|Overall Study|Withdrawal by Subject|1|||
105605787|NCT02544074|364219118|FG002|Overall Study|Withdrawal by Subject|0|||
105605788|NCT02544074|364219119|FG003|Overall Study|Withdrawal by Subject|0|||
105605789|NCT02544074|364219120|FG004|Overall Study|Withdrawal by Subject|0|||
105605790|NCT02544074|364219121|FG005|Overall Study|Withdrawal by Subject|0|||
105605791|NCT02544074|364219122|FG006|Overall Study|Withdrawal by Subject|0|||
105605792|NCT02544074|364219123|FG007|Overall Study|Withdrawal by Subject|0|||
105605793|NCT02544074|364219124|FG008|Overall Study|Withdrawal by Subject|0|||
105605794|NCT02544074|364219125|FG009|Overall Study|Withdrawal by Subject|0|||
105605795|NCT02544074|364219126|FG010|Overall Study|Withdrawal by Subject|0|||
105605796|NCT02544074|364219127|FG011|Overall Study|Withdrawal by Subject|0|||
105605797|NCT02544074|364219128|FG012|Overall Study|Withdrawal by Subject|0|||
105605798|NCT02544074|364219129|FG013|Overall Study|Withdrawal by Subject|0|||
105605799|NCT02544074|364219130|FG014|Overall Study|Withdrawal by Subject|0|||
105605800|NCT02544074|364219131|FG015|Overall Study|Withdrawal by Subject|0|||
105605801|NCT02544074|364219132|FG016|Overall Study|Withdrawal by Subject|0|||
105605802|NCT02544074|364219133|FG017|Overall Study|Withdrawal by Subject|0|||
105605803|NCT02544074|364219134|FG018|Overall Study|Withdrawal by Subject|0|||
105605804|NCT02544074|364219135|FG019|Overall Study|Withdrawal by Subject|0|||
105605805|NCT02544074|364219136|FG020|Overall Study|Withdrawal by Subject|0|||
105605806|NCT02544074|364219116|FG000|Overall Study|Tablet error|0|||
105605807|NCT02544074|364219117|FG001|Overall Study|Tablet error|0|||
105605808|NCT02544074|364219118|FG002|Overall Study|Tablet error|0|||
105605809|NCT02544074|364219119|FG003|Overall Study|Tablet error|0|||
105605810|NCT02544074|364219120|FG004|Overall Study|Tablet error|0|||
105605811|NCT02544074|364219121|FG005|Overall Study|Tablet error|1|||
105605812|NCT02544074|364219122|FG006|Overall Study|Tablet error|0|||
105605813|NCT02544074|364219123|FG007|Overall Study|Tablet error|0|||
105605814|NCT02544074|364219124|FG008|Overall Study|Tablet error|0|||
105605815|NCT02544074|364219125|FG009|Overall Study|Tablet error|1|||
105605816|NCT02544074|364219126|FG010|Overall Study|Tablet error|0|||
105605817|NCT02544074|364219127|FG011|Overall Study|Tablet error|0|||
105605818|NCT02544074|364219128|FG012|Overall Study|Tablet error|0|||
105605819|NCT02544074|364219129|FG013|Overall Study|Tablet error|0|||
105605820|NCT02544074|364219130|FG014|Overall Study|Tablet error|0|||
105605821|NCT02544074|364219131|FG015|Overall Study|Tablet error|0|||
105605822|NCT02544074|364219132|FG016|Overall Study|Tablet error|0|||
105605823|NCT02544074|364219133|FG017|Overall Study|Tablet error|0|||
105605824|NCT02544074|364219134|FG018|Overall Study|Tablet error|0|||
105605825|NCT02544074|364219135|FG019|Overall Study|Tablet error|0|||
105605826|NCT02544074|364219136|FG020|Overall Study|Tablet error|0|||
105605827|NCT01643070|364219141|FG000|Overall Study|Withdrawal by Subject|3|||
105605828|NCT01643070|364219142|FG001|Overall Study|Withdrawal by Subject|1|||
105605829|NCT01643070|364219141|FG000|Overall Study|Death|1|||
105605830|NCT01643070|364219142|FG001|Overall Study|Death|0|||
105605831|NCT01643070|364219141|FG000|Overall Study|Pregressive disease|0|||
105605832|NCT01643070|364219142|FG001|Overall Study|Pregressive disease|2|||
105605833|NCT05644002|364219146|FG000|Overall Study|Lost to Follow-up|1|||
105605834|NCT05644002|364219147|FG001|Overall Study|Lost to Follow-up|2|||
105605835|NCT05644002|364219146|FG000|Overall Study|Withdrawal by Subject|0|||
105605836|NCT05644002|364219147|FG001|Overall Study|Withdrawal by Subject|1|||
105605837|NCT03821844|364219151|FG000|Overall Study|Death|37|||
105605838|NCT03821844|364219152|FG001|Overall Study|Death|31|||
105605839|NCT03821844|364219151|FG000|Overall Study|Discharged|10|||
105605840|NCT03821844|364219152|FG001|Overall Study|Discharged|14|||
105605841|NCT03821844|364219151|FG000|Overall Study|Not present in facility at followup|2|||
105605842|NCT03821844|364219152|FG001|Overall Study|Not present in facility at followup|3|||
105605843|NCT02980276|364219153|FG000|Overall Study|Withdrawal by Subject|4|||
105605844|NCT02980276|364219154|FG001|Overall Study|Withdrawal by Subject|4|||
105605845|NCT02980276|364219153|FG000|Overall Study|Physician Decision|0|||
105605846|NCT02980276|364219154|FG001|Overall Study|Physician Decision|1|||
105605847|NCT02980276|364219153|FG000|Overall Study|Lost to Follow-up|18|||
105605848|NCT02980276|364219154|FG001|Overall Study|Lost to Follow-up|18|||
105605849|NCT02980276|364219153|FG000|Overall Study|Death|1|||
105605850|NCT02980276|364219154|FG001|Overall Study|Death|0|||
105605851|NCT02980276|364219153|FG000|Overall Study|Miscellaneous other|10|||
105605852|NCT02980276|364219154|FG001|Overall Study|Miscellaneous other|4|||
105605853|NCT03554265|364219165|FG000|Overall Study|Withdrawal by Subject|2|||
105605854|NCT03554265|364219166|FG001|Overall Study|Withdrawal by Subject|2|||
105605855|NCT03554265|364219167|FG002|Overall Study|Withdrawal by Subject|3|||
105605856|NCT03554265|364219165|FG000|Overall Study|Physician Decision|0|||
105605857|NCT03554265|364219166|FG001|Overall Study|Physician Decision|0|||
105605858|NCT03554265|364219167|FG002|Overall Study|Physician Decision|1|||
105605859|NCT03025789|364219168|FG000|Overall Study|Lack of Efficacy|6|||
105605860|NCT03025789|364219169|FG001|Overall Study|Lack of Efficacy|1|||
105605861|NCT03025789|364219168|FG000|Overall Study|Death|1|||
105605862|NCT03025789|364219169|FG001|Overall Study|Death|0|||
105605863|NCT03025789|364219168|FG000|Overall Study|Withdrawal by Subject|0|||
105605864|NCT03025789|364219169|FG001|Overall Study|Withdrawal by Subject|2|||
105605865|NCT02605837|364219172|FG000|Overall Study|Adverse Event|3|||
105605866|NCT02605837|364219173|FG001|Overall Study|Adverse Event|1|||
105605867|NCT02605837|364219172|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105605868|NCT02605837|364219173|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105605869|NCT02605837|364219172|FG000|Overall Study|Withdrawal by Subject|8|||
105605870|NCT02605837|364219173|FG001|Overall Study|Withdrawal by Subject|8|||
105605871|NCT02605837|364219172|FG000|Overall Study|Physician Decision|0|||
105605872|NCT02605837|364219173|FG001|Overall Study|Physician Decision|1|||
105605873|NCT05672667|364219175|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
105605874|NCT04524390|364219176|FG000|Double Blind|Consent Withdrawal by subject|2|||
105605875|NCT04524390|364219177|FG001|Double Blind|Consent Withdrawal by subject|1|||
105605876|NCT04524390|364219178|FG002|Double Blind|Consent Withdrawal by subject|0|||
105605877|NCT04524390|364219176|FG000|Double Blind|Adverse Event|5|||
105605878|NCT04524390|364219177|FG001|Double Blind|Adverse Event|3|||
105605879|NCT04524390|364219178|FG002|Double Blind|Adverse Event|0|||
105605880|NCT04524390|364219176|FG000|Double Blind|Liver Transplant|5|||
105605881|NCT04524390|364219177|FG001|Double Blind|Liver Transplant|6|||
105605882|NCT04524390|364219178|FG002|Double Blind|Liver Transplant|0|||
105605883|NCT04524390|364219176|FG000|Double Blind|Disease Progression|0|||
105605884|NCT04524390|364219177|FG001|Double Blind|Disease Progression|1|||
105605885|NCT04524390|364219178|FG002|Double Blind|Disease Progression|0|||
105605886|NCT04524390|364219176|FG000|Open-Label|Drug interruption criteria|0|||
105605887|NCT04524390|364219177|FG001|Open-Label|Drug interruption criteria|0|||
105605888|NCT04524390|364219178|FG002|Open-Label|Drug interruption criteria|1|||
105605889|NCT04524390|364219176|FG000|Open-Label|Liver Transplant|0|||
105605890|NCT04524390|364219177|FG001|Open-Label|Liver Transplant|0|||
105605891|NCT04524390|364219178|FG002|Open-Label|Liver Transplant|1|||
105605892|NCT04524390|364219176|FG000|Open-Label|Disease Progression|0|||
105605893|NCT04524390|364219177|FG001|Open-Label|Disease Progression|0|||
105605894|NCT04524390|364219178|FG002|Open-Label|Disease Progression|1|||
105605895|NCT04524390|364219176|FG000|Open-Label|Adverse Event|0|||
105605896|NCT04524390|364219177|FG001|Open-Label|Adverse Event|0|||
105605897|NCT04524390|364219178|FG002|Open-Label|Adverse Event|3|||
105605898|NCT04524390|364219176|FG000|Open-Label|Study Termination by sponsor|0|||
105605899|NCT04524390|364219177|FG001|Open-Label|Study Termination by sponsor|0|||
105605900|NCT04524390|364219178|FG002|Open-Label|Study Termination by sponsor|45|||
105605901|NCT02837510|364219179|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
105605902|NCT02837510|364219180|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
105605903|NCT02837510|364219179|FG000|Washout (2 Weeks)|Adverse Event|0|||
105605904|NCT02837510|364219180|FG001|Washout (2 Weeks)|Adverse Event|1|||
105605905|NCT02837510|364219179|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
105605906|NCT02837510|364219180|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
105605907|NCT02837510|364219179|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
105605908|NCT02837510|364219180|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
105605909|NCT02837510|364219179|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
105605910|NCT02837510|364219180|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
105605911|NCT02837510|364219179|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
105605912|NCT02837510|364219180|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
105605913|NCT03088813|364219181|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
105605914|NCT03088813|364219182|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
105605915|NCT03088813|364219183|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
105605916|NCT03088813|364219184|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
105605917|NCT03088813|364219181|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
105605918|NCT03088813|364219182|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
105605919|NCT03088813|364219183|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
105605920|NCT03088813|364219184|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
105605921|NCT03088813|364219181|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
105605922|NCT03088813|364219182|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
105605923|NCT03088813|364219183|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
105605924|NCT03088813|364219184|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
105605925|NCT03088813|364219181|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
105605926|NCT03088813|364219182|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
105605927|NCT03088813|364219183|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
105605928|NCT03088813|364219184|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
105605929|NCT03088813|364219181|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
105605930|NCT03088813|364219182|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
105605931|NCT03088813|364219183|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
105605932|NCT03088813|364219184|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
105605933|NCT03088813|364219181|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
105605934|NCT03088813|364219182|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
105605935|NCT03088813|364219183|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
105605936|NCT03088813|364219184|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
105605937|NCT03088813|364219181|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
105605938|NCT03088813|364219182|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
105605939|NCT03088813|364219183|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
105605940|NCT03088813|364219184|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
105605941|NCT03873779|364219185|FG000|Overall Study|Withdrawal by Subject|1|||
105605942|NCT04527146|364219186|FG000|Overall Study|Withdrawal by Subject|12|||
105605943|NCT04527146|364219187|FG001|Overall Study|Withdrawal by Subject|15|||
105605944|NCT04527146|364219188|FG002|Overall Study|Withdrawal by Subject|7|||
105605945|NCT04527146|364219189|FG003|Overall Study|Withdrawal by Subject|16|||
105605946|NCT04527146|364219186|FG000|Overall Study|Lost to Follow-up|13|||
105605947|NCT04527146|364219187|FG001|Overall Study|Lost to Follow-up|9|||
105605948|NCT04527146|364219188|FG002|Overall Study|Lost to Follow-up|16|||
105605949|NCT04527146|364219189|FG003|Overall Study|Lost to Follow-up|13|||
105605950|NCT04527146|364219186|FG000|Overall Study|Death|0|||
105605951|NCT04527146|364219187|FG001|Overall Study|Death|1|||
105605952|NCT04527146|364219188|FG002|Overall Study|Death|1|||
105605953|NCT04527146|364219189|FG003|Overall Study|Death|0|||
105605954|NCT04527146|364219186|FG000|Overall Study|Adverse Event|0|||
105605955|NCT04527146|364219187|FG001|Overall Study|Adverse Event|0|||
105605956|NCT04527146|364219188|FG002|Overall Study|Adverse Event|1|||
105605957|NCT04527146|364219189|FG003|Overall Study|Adverse Event|0|||
105605958|NCT04527146|364219186|FG000|Overall Study|Ineligible after randomization|2|||
105605959|NCT04527146|364219187|FG001|Overall Study|Ineligible after randomization|0|||
105605960|NCT04527146|364219188|FG002|Overall Study|Ineligible after randomization|2|||
105605961|NCT04527146|364219189|FG003|Overall Study|Ineligible after randomization|2|||
105605962|NCT04527146|364219186|FG000|Overall Study|Moved to a different group|6|||
105605963|NCT04527146|364219187|FG001|Overall Study|Moved to a different group|3|||
105605964|NCT04527146|364219188|FG002|Overall Study|Moved to a different group|0|||
105605965|NCT04527146|364219189|FG003|Overall Study|Moved to a different group|2|||
105605966|NCT05107401|364219190|FG000|Overall Study|Lost to Follow-up|13|||
105605967|NCT05107401|364219191|FG001|Overall Study|Lost to Follow-up|12|||
105605968|NCT04878354|364219192|FG000|Overall Study|Adverse Event|4|||
105605969|NCT04878354|364219193|FG001|Overall Study|Adverse Event|13|||
105605970|NCT04878354|364219192|FG000|Overall Study|Withdrawal by Subject|14|||
105605971|NCT04878354|364219193|FG001|Overall Study|Withdrawal by Subject|12|||
105605972|NCT04878354|364219192|FG000|Overall Study|Lost to Follow-up|4|||
105605973|NCT04878354|364219193|FG001|Overall Study|Lost to Follow-up|1|||
105605974|NCT04878354|364219192|FG000|Overall Study|Lack of Efficacy|1|||
105605975|NCT04878354|364219193|FG001|Overall Study|Lack of Efficacy|0|||
105605976|NCT04878354|364219192|FG000|Overall Study|Protocol Violation|0|||
105605977|NCT04878354|364219193|FG001|Overall Study|Protocol Violation|1|||
105605978|NCT04878354|364219192|FG000|Overall Study|"Reason stated as other in CRF"|2|||
105605979|NCT04878354|364219193|FG001|Overall Study|"Reason stated as other in CRF"|3|||
105605980|NCT06194214|364219194|FG000|Overall Study|Adverse Event|1|||
105605981|NCT04608045|364219197|FG000|Overall Study|Physician Decision|1|||
105605982|NCT03517553|364219198|FG000|Overall Study|Withdrawal by Subject|2|||
105605983|NCT04048681|364219199|FG000|Overall Study|family emergency|0|||
105605984|NCT04048681|364219200|FG001|Overall Study|family emergency|0|||
105605985|NCT04048681|364219201|FG002|Overall Study|family emergency|0|||
105605986|NCT04048681|364219202|FG003|Overall Study|family emergency|1|||
105605987|NCT04048681|364219203|FG004|Overall Study|family emergency|0|||
105605988|NCT02647905|364219206|FG000|Overall Study|Lost to Follow-up|1|||
105605989|NCT02647905|364219206|FG000|Overall Study|Withdrawal by Subject|2|||
105605990|NCT00792636|364219207|FG000|Overall Study|Protocol Violation|17|||
105605991|NCT00792636|364219208|FG001|Overall Study|Protocol Violation|23|||
105605992|NCT00792636|364219209|FG002|Overall Study|Protocol Violation|20|||
105605993|NCT00792636|364219207|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
105605994|NCT00792636|364219208|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
105605995|NCT00792636|364219209|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
105605996|NCT00792636|364219207|FG000|Overall Study|Lost to Follow-up|13|||
105605997|NCT00792636|364219208|FG001|Overall Study|Lost to Follow-up|19|||
105605998|NCT00792636|364219209|FG002|Overall Study|Lost to Follow-up|14|||
105605999|NCT00792636|364219207|FG000|Overall Study|Withdrew Consent|10|||
105606000|NCT00792636|364219208|FG001|Overall Study|Withdrew Consent|13|||
105606001|NCT00792636|364219209|FG002|Overall Study|Withdrew Consent|9|||
105606002|NCT00792636|364219207|FG000|Overall Study|Lack of Efficacy|3|||
105606003|NCT00792636|364219208|FG001|Overall Study|Lack of Efficacy|4|||
105606004|NCT00792636|364219209|FG002|Overall Study|Lack of Efficacy|13|||
105606005|NCT00792636|364219207|FG000|Overall Study|Adverse Event|4|||
105606006|NCT00792636|364219208|FG001|Overall Study|Adverse Event|2|||
105606007|NCT00792636|364219209|FG002|Overall Study|Adverse Event|3|||
105606008|NCT00792636|364219207|FG000|Overall Study|Investigator Discretion|2|||
105606009|NCT00792636|364219208|FG001|Overall Study|Investigator Discretion|0|||
105606010|NCT00792636|364219209|FG002|Overall Study|Investigator Discretion|2|||
105606011|NCT01046136|364219210|FG000|Overall Study|Withdrawal by Subject|0|||
105606012|NCT01046136|364219211|FG001|Overall Study|Withdrawal by Subject|4|||
105606013|NCT01046136|364219210|FG000|Overall Study|Physician Decision|1|||
105606014|NCT01046136|364219211|FG001|Overall Study|Physician Decision|1|||
105606015|NCT01046136|364219210|FG000|Overall Study|Lost to Follow-up|3|||
105606016|NCT01046136|364219211|FG001|Overall Study|Lost to Follow-up|3|||
105606017|NCT04579250|364219212|FG000|Overall Study|Withdrawal by Subject|1|||
105606018|NCT04579250|364219213|FG001|Overall Study|Withdrawal by Subject|1|||
105606019|NCT04579250|364219214|FG002|Overall Study|Withdrawal by Subject|0|||
105606020|NCT04579250|364219212|FG000|Overall Study|Lost to Follow-up|1|||
105606021|NCT04579250|364219213|FG001|Overall Study|Lost to Follow-up|1|||
105606022|NCT04579250|364219214|FG002|Overall Study|Lost to Follow-up|0|||
105606023|NCT04579250|364219212|FG000|Overall Study|Moved from area|0|||
105606024|NCT04579250|364219213|FG001|Overall Study|Moved from area|1|||
105606025|NCT04579250|364219214|FG002|Overall Study|Moved from area|2|||
105606026|NCT00411151|364219220|FG000|Overall Study|Death|38|||
105606027|NCT00411151|364219220|FG000|Overall Study|Withdrawal by Subject|2|||
105606028|NCT00411151|364219220|FG000|Overall Study|Lost to Follow-up|2|||
105606029|NCT00411151|364219220|FG000|Overall Study|Protocol Violation|1|||
105606030|NCT00411151|364219220|FG000|Overall Study|Trial prematurely closed|4|||
105606031|NCT01227265|364219224|FG000|Overall Study|Did Not Receive Treatment|1|||
105606032|NCT01227265|364219225|FG001|Overall Study|Did Not Receive Treatment|2|||
105606033|NCT01227265|364219226|FG002|Overall Study|Did Not Receive Treatment|0|||
105606034|NCT01227265|364219224|FG000|Overall Study|Administrative|1|||
105606035|NCT01227265|364219225|FG001|Overall Study|Administrative|0|||
105606036|NCT01227265|364219226|FG002|Overall Study|Administrative|2|||
105606037|NCT01227265|364219224|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
105606038|NCT01227265|364219225|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
105606039|NCT01227265|364219226|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
105606040|NCT01227265|364219224|FG000|Overall Study|Protocol Violation|2|||
105606041|NCT01227265|364219225|FG001|Overall Study|Protocol Violation|1|||
105606042|NCT01227265|364219226|FG002|Overall Study|Protocol Violation|0|||
105606043|NCT01227265|364219224|FG000|Overall Study|Withdrawal by Subject|7|||
105606044|NCT01227265|364219225|FG001|Overall Study|Withdrawal by Subject|7|||
105606045|NCT01227265|364219226|FG002|Overall Study|Withdrawal by Subject|3|||
105606046|NCT01227265|364219224|FG000|Overall Study|Lost to Follow-up|2|||
105606047|NCT01227265|364219225|FG001|Overall Study|Lost to Follow-up|0|||
105606048|NCT01227265|364219226|FG002|Overall Study|Lost to Follow-up|3|||
105606049|NCT01227265|364219224|FG000|Overall Study|Adverse Event|6|||
105606050|NCT01227265|364219225|FG001|Overall Study|Adverse Event|10|||
105606051|NCT01227265|364219226|FG002|Overall Study|Adverse Event|5|||
105606052|NCT03892564|364219228|FG000|Overall Study|Withdrawal by Subject|2|||
105606053|NCT03481816|364219229|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
105606054|NCT03481816|364219230|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
105606055|NCT03481816|364219229|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
105606056|NCT03481816|364219230|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
105606057|NCT03481816|364219229|FG000|Dose Expansion|Withdrawal by Subject|0|||
105606058|NCT03481816|364219230|FG001|Dose Expansion|Withdrawal by Subject|2|||
105606059|NCT03481816|364219229|FG000|Dose Expansion|Physician Decision|0|||
105606060|NCT03481816|364219230|FG001|Dose Expansion|Physician Decision|5|||
105606061|NCT01091168|364219233|FG000|Overall Study|Progressive disease|250|||
105606062|NCT01091168|364219234|FG001|Overall Study|Progressive disease|234|||
105606063|NCT01091168|364219233|FG000|Overall Study|Adverse Event|21|||
105606064|NCT01091168|364219234|FG001|Overall Study|Adverse Event|24|||
105606065|NCT01091168|364219233|FG000|Overall Study|Lost to Follow-up|0|||
105606066|NCT01091168|364219234|FG001|Overall Study|Lost to Follow-up|1|||
105606067|NCT01091168|364219233|FG000|Overall Study|Physician, patient's decision, other|27|||
105606068|NCT01091168|364219234|FG001|Overall Study|Physician, patient's decision, other|37|||
105606069|NCT05665595|364220972|FG000|Overall Study|Ongoing|692|||
105606070|NCT05665595|364220973|FG001|Overall Study|Ongoing|698|||
105606071|NCT05665595|364220972|FG000|Overall Study|Withdrawal by Subject|2|||
105606072|NCT05665595|364220973|FG001|Overall Study|Withdrawal by Subject|2|||
105606073|NCT05665595|364220972|FG000|Overall Study|Lost to Follow-up|1|||
105606074|NCT05665595|364220973|FG001|Overall Study|Lost to Follow-up|0|||
105606075|NCT05665595|364220972|FG000|Overall Study|Death|6|||
105606076|NCT05665595|364220973|FG001|Overall Study|Death|1|||
105606077|NCT03237481|364220976|FG000|Overall Study|Lost to Follow-up|1|||
105606078|NCT03237481|364220977|FG001|Overall Study|Lost to Follow-up|0|||
105606079|NCT03237481|364220978|FG002|Overall Study|Lost to Follow-up|0|||
105606080|NCT03237481|364220976|FG000|Overall Study|Protocol Violation|1|||
105606081|NCT03237481|364220977|FG001|Overall Study|Protocol Violation|0|||
105606082|NCT03237481|364220978|FG002|Overall Study|Protocol Violation|0|||
105606083|NCT03237481|364220976|FG000|Overall Study|Withdrawal by Subject|3|||
105606084|NCT03237481|364220977|FG001|Overall Study|Withdrawal by Subject|2|||
105606085|NCT03237481|364220978|FG002|Overall Study|Withdrawal by Subject|1|||
105606086|NCT01216176|364220979|FG000|Overall Study|Adverse Event|0|||
105606087|NCT01216176|364220980|FG001|Overall Study|Adverse Event|8|||
105606088|NCT01216176|364220981|FG002|Overall Study|Adverse Event|0|||
105606089|NCT01216176|364220979|FG000|Overall Study|Physician Decision|0|||
105606090|NCT01216176|364220980|FG001|Overall Study|Physician Decision|0|||
105606091|NCT01216176|364220981|FG002|Overall Study|Physician Decision|1|||
105606092|NCT04278586|364220982|FG000|Overall Study|Withdrawal by Subject|13|||
105606093|NCT04278586|364220983|FG001|Overall Study|Withdrawal by Subject|6|||
105606094|NCT04278586|364220982|FG000|Overall Study|Lost to Follow-up|37|||
105606095|NCT04278586|364220983|FG001|Overall Study|Lost to Follow-up|24|||
105606096|NCT04038957|364220988|FG000|Overall Study|Withdrawal by Subject|1|||
105606097|NCT04038957|364220988|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
105606098|NCT03103321|364220989|FG000|Overall Study|Protocol Violation|1|||
105606099|NCT03103321|364220990|FG001|Overall Study|Protocol Violation|1|||
105606100|NCT03103321|364220991|FG002|Overall Study|Protocol Violation|1|||
105606101|NCT03103321|364220992|FG003|Overall Study|Protocol Violation|0|||
105606102|NCT04247542|364220993|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
105606103|NCT04247542|364220994|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
105606104|NCT04247542|364220995|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
105606105|NCT04247542|364220993|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
105606106|NCT04247542|364220994|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
105606107|NCT04247542|364220995|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
105606108|NCT03438188|364220997|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
105606109|NCT03438188|364220998|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
105606110|NCT03438188|364220999|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
105606111|NCT03438188|364220997|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
105606112|NCT03438188|364220998|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
105606113|NCT03438188|364220999|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
105606114|NCT03438188|364220997|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
105606115|NCT03438188|364220998|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
105606116|NCT03438188|364220999|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
105606117|NCT03438188|364220997|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
105606118|NCT03438188|364220998|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
105606119|NCT03438188|364220999|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
105606120|NCT03438188|364220997|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
105606121|NCT03438188|364220998|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
105606122|NCT03438188|364220999|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
105606123|NCT02991807|364221003|FG000|Overall Study|Withdrawal by Subject|2|||
105606124|NCT02991807|364221004|FG001|Overall Study|Withdrawal by Subject|1|||
105606125|NCT02991807|364221003|FG000|Overall Study|Physician Decision|0|||
105606126|NCT02991807|364221004|FG001|Overall Study|Physician Decision|1|||
105606127|NCT02991807|364221003|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
105606128|NCT02991807|364221004|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
105606129|NCT02553642|364221005|FG000|Overall Study|Withdrawal by Subject|0|||
105606130|NCT02553642|364221006|FG001|Overall Study|Withdrawal by Subject|3|||
105606131|NCT02553642|364221005|FG000|Overall Study|Physician Decision|0|||
105606132|NCT02553642|364221006|FG001|Overall Study|Physician Decision|1|||
105606133|NCT02553642|364221005|FG000|Overall Study|Additional cancer dx|0|||
105606134|NCT02553642|364221006|FG001|Overall Study|Additional cancer dx|1|||
105606135|NCT02553642|364221005|FG000|Overall Study|Never started treatment|0|||
105606136|NCT02553642|364221006|FG001|Overall Study|Never started treatment|1|||
105606137|NCT03456076|364221014|FG000|Overall Study|Withdrawal by Subject|5|||
105606138|NCT03456076|364221015|FG001|Overall Study|Withdrawal by Subject|9|||
105606139|NCT03456076|364221014|FG000|Overall Study|Protocol deviation|0|||
105606140|NCT03456076|364221015|FG001|Overall Study|Protocol deviation|1|||
105606141|NCT03456076|364221014|FG000|Overall Study|Lost to Follow-up|0|||
105606142|NCT03456076|364221015|FG001|Overall Study|Lost to Follow-up|1|||
105606143|NCT03456076|364221014|FG000|Overall Study|Death|2|||
105606144|NCT03456076|364221015|FG001|Overall Study|Death|5|||
105606145|NCT03456076|364221014|FG000|Overall Study|Study ongoing|123|||
105606146|NCT03456076|364221015|FG001|Overall Study|Study ongoing|111|||
105606147|NCT03112174|364221016|FG000|Overall Study|Withdrawal by Subject|3|||
105606148|NCT03112174|364221017|FG001|Overall Study|Withdrawal by Subject|0|||
105606149|NCT03112174|364221018|FG002|Overall Study|Withdrawal by Subject|11|||
105606150|NCT03112174|364221019|FG003|Overall Study|Withdrawal by Subject|9|||
105606151|NCT03112174|364221020|FG004|Overall Study|Withdrawal by Subject|7|||
105606152|NCT03112174|364221016|FG000|Overall Study|Lost to Follow-up|1|||
105606153|NCT03112174|364221017|FG001|Overall Study|Lost to Follow-up|1|||
105606154|NCT03112174|364221018|FG002|Overall Study|Lost to Follow-up|2|||
105606155|NCT03112174|364221019|FG003|Overall Study|Lost to Follow-up|3|||
105606156|NCT03112174|364221020|FG004|Overall Study|Lost to Follow-up|2|||
105606157|NCT03112174|364221016|FG000|Overall Study|Death|8|||
105606158|NCT03112174|364221017|FG001|Overall Study|Death|3|||
105606159|NCT03112174|364221018|FG002|Overall Study|Death|67|||
105606160|NCT03112174|364221019|FG003|Overall Study|Death|73|||
105606161|NCT03112174|364221020|FG004|Overall Study|Death|18|||
105606162|NCT03112174|364221016|FG000|Overall Study|Other, Not Specified|1|||
105606163|NCT03112174|364221017|FG001|Overall Study|Other, Not Specified|0|||
105606164|NCT03112174|364221018|FG002|Overall Study|Other, Not Specified|1|||
105606165|NCT03112174|364221019|FG003|Overall Study|Other, Not Specified|2|||
105606166|NCT03112174|364221020|FG004|Overall Study|Other, Not Specified|0|||
105606167|NCT04437433|364221021|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
105606168|NCT04437433|364221022|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
105606169|NCT04437433|364221021|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
105606170|NCT04437433|364221022|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
105606171|NCT04437433|364221021|FG000|Overall Study|Adverse Event|9|||
105606172|NCT04437433|364221022|FG001|Overall Study|Adverse Event|0|||
105606173|NCT04437433|364221021|FG000|Overall Study|Lack of Efficacy|4|||
105606174|NCT04437433|364221022|FG001|Overall Study|Lack of Efficacy|0|||
105606175|NCT04437433|364221021|FG000|Overall Study|Withdrawal by Subject|4|||
105606176|NCT04437433|364221022|FG001|Overall Study|Withdrawal by Subject|1|||
105606177|NCT04437433|364221021|FG000|Overall Study|Protocol Deviation|0|||
105606178|NCT04437433|364221022|FG001|Overall Study|Protocol Deviation|1|||
105606179|NCT04437433|364221021|FG000|Overall Study|Other, not specified|0|||
105606180|NCT04437433|364221022|FG001|Overall Study|Other, not specified|1|||
105606181|NCT00894543|364221023|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
105606182|NCT00894543|364221024|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
105606183|NCT00894543|364221023|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
105606184|NCT00894543|364221024|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
105606185|NCT01532388|364221025|FG000|3-month Follow-up|Lost to Follow-up|68|||
105606186|NCT01532388|364221026|FG001|3-month Follow-up|Lost to Follow-up|68|||
105606187|NCT01532388|364221025|FG000|6-month Follow-up|Lost to Follow-up|74|||
105606188|NCT01532388|364221026|FG001|6-month Follow-up|Lost to Follow-up|66|||
105606189|NCT01532388|364221025|FG000|12-month Follow-up|Lost to Follow-up|69|||
105606190|NCT01532388|364221026|FG001|12-month Follow-up|Lost to Follow-up|67|||
105606191|NCT03446157|364221028|FG000|Overall Study|Death|11|||
105606192|NCT03446157|364221029|FG001|Overall Study|Death|9|||
105606193|NCT03446157|364221028|FG000|Overall Study|Lost to Follow-up|0|||
105606194|NCT03446157|364221029|FG001|Overall Study|Lost to Follow-up|1|||
105606195|NCT03446157|364221028|FG000|Overall Study|Withdrawal by Subject|2|||
105606196|NCT03446157|364221029|FG001|Overall Study|Withdrawal by Subject|1|||
105606197|NCT01772472|364221034|FG000|Overall Study|Death|126|||
105606198|NCT01772472|364221035|FG001|Overall Study|Death|94|||
105606199|NCT01772472|364221034|FG000|Overall Study|Lost to Follow-up|51|||
105606200|NCT01772472|364221035|FG001|Overall Study|Lost to Follow-up|50|||
105606201|NCT01772472|364221034|FG000|Overall Study|Other|9|||
105606202|NCT01772472|364221035|FG001|Overall Study|Other|7|||
105606203|NCT01772472|364221034|FG000|Overall Study|Physician Decision|1|||
105606204|NCT01772472|364221035|FG001|Overall Study|Physician Decision|7|||
105606205|NCT01772472|364221034|FG000|Overall Study|Withdrawal by Subject|115|||
105606206|NCT01772472|364221035|FG001|Overall Study|Withdrawal by Subject|90|||
105606207|NCT01772472|364221034|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
105606208|NCT01772472|364221035|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
105606209|NCT02697136|364221036|FG000|Overall Study|Adverse Event|3|||
105606210|NCT02697136|364221037|FG001|Overall Study|Adverse Event|0|||
105606211|NCT02923180|364221046|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
105606212|NCT02923180|364221046|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
105606213|NCT05198310|364221047|FG000|Overall Study|Lost to Follow-up|0|||
105606214|NCT05198310|364221048|FG001|Overall Study|Lost to Follow-up|1|||
105606215|NCT05198310|364221049|FG002|Overall Study|Lost to Follow-up|0|||
105606216|NCT05198310|364221050|FG003|Overall Study|Lost to Follow-up|0|||
105606217|NCT05198310|364221051|FG004|Overall Study|Lost to Follow-up|0|||
105606218|NCT05198310|364221052|FG005|Overall Study|Lost to Follow-up|0|||
105606219|NCT05198310|364221053|FG006|Overall Study|Lost to Follow-up|0|||
105606220|NCT05198310|364221054|FG007|Overall Study|Lost to Follow-up|0|||
105606221|NCT05198310|364221047|FG000|Overall Study|Withdrawal by Subject|0|||
105606222|NCT05198310|364221048|FG001|Overall Study|Withdrawal by Subject|0|||
105606223|NCT05198310|364221049|FG002|Overall Study|Withdrawal by Subject|0|||
105606224|NCT05198310|364221050|FG003|Overall Study|Withdrawal by Subject|2|||
105606225|NCT05198310|364221051|FG004|Overall Study|Withdrawal by Subject|0|||
105606226|NCT05198310|364221052|FG005|Overall Study|Withdrawal by Subject|2|||
105606227|NCT05198310|364221053|FG006|Overall Study|Withdrawal by Subject|1|||
105606228|NCT05198310|364221054|FG007|Overall Study|Withdrawal by Subject|3|||
105606233|NCT04950127|364221062|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
105606234|NCT04950127|364221063|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
105606235|NCT04950127|364221064|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
105606236|NCT04950127|364221065|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
105606237|NCT04950127|364221066|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
105606238|NCT04950127|364221067|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
105606239|NCT04950127|364221062|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
105606240|NCT04950127|364221063|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
105606241|NCT04950127|364221064|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
105606242|NCT04950127|364221065|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
105606243|NCT04950127|364221066|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
105606244|NCT04950127|364221067|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
105606245|NCT04950127|364221062|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
105606246|NCT04950127|364221063|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
105606247|NCT04950127|364221064|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
105606248|NCT04950127|364221065|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
105606249|NCT04950127|364221066|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
105606250|NCT04950127|364221067|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
105606251|NCT04950127|364221062|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
105606252|NCT04950127|364221063|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
105606253|NCT04950127|364221064|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
105606254|NCT04950127|364221065|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
105606255|NCT04950127|364221066|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
105606256|NCT04950127|364221067|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
105606257|NCT04950127|364221062|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
105606258|NCT04950127|364221063|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
105606259|NCT04950127|364221064|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
105606260|NCT04950127|364221065|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
105606261|NCT04950127|364221066|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
105606262|NCT04950127|364221067|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
105606263|NCT03833167|364221072|FG000|Overall Study|Withdrawal by Subject|4|||
105606264|NCT03833167|364221073|FG001|Overall Study|Withdrawal by Subject|6|||
105606265|NCT03833167|364221072|FG000|Overall Study|Ongoing|186|||
105606266|NCT03833167|364221073|FG001|Overall Study|Ongoing|194|||
105606267|NCT03833167|364221072|FG000|Overall Study|Lost to Follow-up|1|||
105606268|NCT03833167|364221073|FG001|Overall Study|Lost to Follow-up|1|||
105606269|NCT03833167|364221072|FG000|Overall Study|Physician Decision|0|||
105606270|NCT03833167|364221073|FG001|Overall Study|Physician Decision|2|||
105606271|NCT03833167|364221072|FG000|Overall Study|Death|34|||
105606272|NCT03833167|364221073|FG001|Overall Study|Death|22|||
105606273|NCT03271489|364221075|FG000|Double-Blind (DB) Period|Adverse Event|4|||
105606274|NCT03271489|364221076|FG001|Double-Blind (DB) Period|Adverse Event|1|||
105606275|NCT03271489|364221075|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
105606276|NCT03271489|364221076|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
105606277|NCT03271489|364221075|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
105606278|NCT03271489|364221076|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
105606279|NCT03271489|364221075|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
105606280|NCT03271489|364221076|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
105606281|NCT03271489|364221075|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
105606282|NCT03271489|364221076|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
105606283|NCT03271489|364221075|FG000|Double-Blind (DB) Period|Other|6|||
105606284|NCT03271489|364221076|FG001|Double-Blind (DB) Period|Other|1|||
105606285|NCT03271489|364221075|FG000|Double-Blind (DB) Period|Missing|1|||
105606286|NCT03271489|364221076|FG001|Double-Blind (DB) Period|Missing|0|||
105606287|NCT03271489|364221075|FG000|Open-Label (OL) Period|Adverse Event|2|||
105606288|NCT03271489|364221076|FG001|Open-Label (OL) Period|Adverse Event|0|||
105606289|NCT03271489|364221075|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
105606290|NCT03271489|364221076|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
105606291|NCT03271489|364221075|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
105606292|NCT03271489|364221076|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
105606293|NCT03271489|364221075|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
105606294|NCT03271489|364221076|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
105606295|NCT03271489|364221075|FG000|Open-Label (OL) Period|No Specified|2|||
105606296|NCT03271489|364221076|FG001|Open-Label (OL) Period|No Specified|2|||
105606297|NCT03271489|364221075|FG000|Open-Label (OL) Period|Missing|2|||
105606298|NCT03271489|364221076|FG001|Open-Label (OL) Period|Missing|0|||
105606299|NCT03271489|364221075|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
105606300|NCT03271489|364221076|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
105606301|NCT03271489|364221075|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
105606302|NCT03271489|364221076|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
105606303|NCT03271489|364221075|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
105606304|NCT03271489|364221076|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
105606305|NCT03271489|364221075|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
105606306|NCT03271489|364221076|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
105606307|NCT03271489|364221075|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
105606308|NCT03271489|364221076|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
105606309|NCT03271489|364221075|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
105606310|NCT03271489|364221076|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
105606311|NCT03271489|364221075|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
105606312|NCT03271489|364221076|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
105606313|NCT03271489|364221075|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
105606314|NCT03271489|364221076|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
105606315|NCT02860130|364221077|FG000|Overall Study|Adverse Event|2|||
105606316|NCT02860130|364221078|FG001|Overall Study|Adverse Event|3|||
105606317|NCT02860130|364221077|FG000|Overall Study|Protocol Violation|1|||
105606318|NCT02860130|364221078|FG001|Overall Study|Protocol Violation|1|||
105606319|NCT02860130|364221077|FG000|Overall Study|Withdrawal by Subject|0|||
105606320|NCT02860130|364221078|FG001|Overall Study|Withdrawal by Subject|2|||
105606321|NCT02860130|364221077|FG000|Overall Study|Physician Decision|2|||
105606322|NCT02860130|364221078|FG001|Overall Study|Physician Decision|2|||
105606323|NCT02860130|364221077|FG000|Overall Study|Other|2|||
105606324|NCT02860130|364221078|FG001|Overall Study|Other|1|||
105606325|NCT03330795|364221079|FG000|Overall Study|Death|3|||
105606326|NCT03330795|364221079|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
105606327|NCT05064735|364221080|FG000|Overall Study|Withdrawal by Subject|7|||
105606328|NCT05064735|364221081|FG001|Overall Study|Withdrawal by Subject|8|||
105606329|NCT05064735|364221080|FG000|Overall Study|Lost to Follow-up|7|||
105606330|NCT05064735|364221081|FG001|Overall Study|Lost to Follow-up|2|||
105606331|NCT05064735|364221080|FG000|Overall Study|Physician Decision|2|||
105606332|NCT05064735|364221081|FG001|Overall Study|Physician Decision|1|||
105606333|NCT05064735|364221080|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
105606334|NCT05064735|364221081|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
105606335|NCT05064735|364221080|FG000|Overall Study|Site Closure|7|||
105606336|NCT05064735|364221081|FG001|Overall Study|Site Closure|2|||
105606337|NCT04157348|364221082|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
105606338|NCT04157348|364221083|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
105606339|NCT04157348|364221082|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
105606340|NCT04157348|364221083|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
105606341|NCT04157348|364221082|FG000|Double-blind Treatment Period|Adverse Event|0|||
105606342|NCT04157348|364221083|FG001|Double-blind Treatment Period|Adverse Event|1|||
105606343|NCT04157348|364221082|FG000|Open-label Extension Period|Adverse Event|1|||
105606344|NCT04157348|364221083|FG001|Open-label Extension Period|Adverse Event|1|||
105606345|NCT04157348|364221082|FG000|Open-label Extension Period|Death|0|||
105606346|NCT04157348|364221083|FG001|Open-label Extension Period|Death|1|||
105606347|NCT04157348|364221082|FG000|Open-label Extension Period|Lack of Efficacy|2|||
105606348|NCT04157348|364221083|FG001|Open-label Extension Period|Lack of Efficacy|2|||
105606349|NCT04157348|364221082|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
105606350|NCT04157348|364221083|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
105606351|NCT04157348|364221082|FG000|Open-label Extension Period|Ongoing|60|||
105606352|NCT04157348|364221083|FG001|Open-label Extension Period|Ongoing|57|||
105606353|NCT04157348|364221082|FG000|Open-label Extension Period|other reasons|1|||
105606354|NCT04157348|364221083|FG001|Open-label Extension Period|other reasons|1|||
105606355|NCT04757610|364221086|FG000|Overall Study|Adverse Event|13|||
105606356|NCT04757610|364221087|FG001|Overall Study|Adverse Event|10|||
105606357|NCT04757610|364221088|FG002|Overall Study|Adverse Event|5|||
105606358|NCT04757610|364221086|FG000|Overall Study|Death|5|||
105606359|NCT04757610|364221087|FG001|Overall Study|Death|13|||
105606360|NCT04757610|364221088|FG002|Overall Study|Death|8|||
105606361|NCT04757610|364221086|FG000|Overall Study|Lack of Efficacy|1|||
105606362|NCT04757610|364221087|FG001|Overall Study|Lack of Efficacy|2|||
105606363|NCT04757610|364221088|FG002|Overall Study|Lack of Efficacy|3|||
105606364|NCT04757610|364221086|FG000|Overall Study|Lost to Follow-up|7|||
105606365|NCT04757610|364221087|FG001|Overall Study|Lost to Follow-up|2|||
105606366|NCT04757610|364221088|FG002|Overall Study|Lost to Follow-up|7|||
105606367|NCT04757610|364221086|FG000|Overall Study|Physician Decision|4|||
105606368|NCT04757610|364221087|FG001|Overall Study|Physician Decision|1|||
105606369|NCT04757610|364221088|FG002|Overall Study|Physician Decision|2|||
105606370|NCT04757610|364221086|FG000|Overall Study|Withdrawal by Subject|26|||
105606371|NCT04757610|364221087|FG001|Overall Study|Withdrawal by Subject|25|||
105606372|NCT04757610|364221088|FG002|Overall Study|Withdrawal by Subject|25|||
105606373|NCT04757610|364221086|FG000|Overall Study|Study Terminated by Sponsor|105|||
105606374|NCT04757610|364221087|FG001|Overall Study|Study Terminated by Sponsor|105|||
105606375|NCT04757610|364221088|FG002|Overall Study|Study Terminated by Sponsor|110|||
105606376|NCT04757610|364221086|FG000|Overall Study|Randomized in Error|1|||
105606377|NCT04757610|364221087|FG001|Overall Study|Randomized in Error|0|||
105606378|NCT04757610|364221088|FG002|Overall Study|Randomized in Error|0|||
105606379|NCT00567489|364221089|FG000|Overall Study|Adverse Event|6|||
105606380|NCT00567489|364221090|FG001|Overall Study|Adverse Event|14|||
105606381|NCT00567489|364221089|FG000|Overall Study|Physician Decision|0|||
105606382|NCT00567489|364221090|FG001|Overall Study|Physician Decision|4|||
105606383|NCT00567489|364221089|FG000|Overall Study|Withdrawal by Subject|0|||
105606384|NCT00567489|364221090|FG001|Overall Study|Withdrawal by Subject|2|||
105606385|NCT00567489|364221089|FG000|Overall Study|Renal Transplantation|0|||
105606386|NCT00567489|364221090|FG001|Overall Study|Renal Transplantation|3|||
105606387|NCT00567489|364221089|FG000|Overall Study|Other|1|||
105606388|NCT00567489|364221090|FG001|Overall Study|Other|0|||
105606389|NCT02671435|364221092|FG000|Overall Study|Death|1|||
105606390|NCT02671435|364221093|FG001|Overall Study|Death|3|||
105606391|NCT02671435|364221094|FG002|Overall Study|Death|0|||
105606392|NCT02671435|364221095|FG003|Overall Study|Death|16|||
105606393|NCT02671435|364221096|FG004|Overall Study|Death|14|||
105606394|NCT02671435|364221097|FG005|Overall Study|Death|29|||
105606395|NCT02671435|364221098|FG006|Overall Study|Death|34|||
105606396|NCT02671435|364221099|FG007|Overall Study|Death|28|||
105606397|NCT02671435|364221100|FG008|Overall Study|Death|19|||
105606398|NCT02671435|364221101|FG009|Overall Study|Death|10|||
105606399|NCT02671435|364221102|FG010|Overall Study|Death|8|||
105606400|NCT02671435|364221103|FG011|Overall Study|Death|29|||
105606401|NCT02671435|364221104|FG012|Overall Study|Death|29|||
105606402|NCT02671435|364221105|FG013|Overall Study|Death|29|||
105606403|NCT02671435|364221106|FG014|Overall Study|Death|27|||
105606404|NCT02671435|364221092|FG000|Overall Study|Lost to Follow-up|0|||
105606405|NCT02671435|364221093|FG001|Overall Study|Lost to Follow-up|0|||
105606406|NCT02671435|364221094|FG002|Overall Study|Lost to Follow-up|1|||
105606407|NCT02671435|364221095|FG003|Overall Study|Lost to Follow-up|0|||
105606408|NCT02671435|364221096|FG004|Overall Study|Lost to Follow-up|1|||
105606409|NCT02671435|364221097|FG005|Overall Study|Lost to Follow-up|1|||
105606410|NCT02671435|364221098|FG006|Overall Study|Lost to Follow-up|2|||
105606411|NCT02671435|364221099|FG007|Overall Study|Lost to Follow-up|2|||
105606412|NCT02671435|364221100|FG008|Overall Study|Lost to Follow-up|0|||
105606413|NCT02671435|364221101|FG009|Overall Study|Lost to Follow-up|2|||
105606414|NCT02671435|364221102|FG010|Overall Study|Lost to Follow-up|0|||
105606415|NCT02671435|364221103|FG011|Overall Study|Lost to Follow-up|3|||
105606416|NCT02671435|364221104|FG012|Overall Study|Lost to Follow-up|3|||
105606417|NCT02671435|364221105|FG013|Overall Study|Lost to Follow-up|2|||
105606418|NCT02671435|364221106|FG014|Overall Study|Lost to Follow-up|0|||
105606419|NCT02671435|364221092|FG000|Overall Study|Withdrawal by Subject|2|||
105606420|NCT02671435|364221093|FG001|Overall Study|Withdrawal by Subject|0|||
105606421|NCT02671435|364221094|FG002|Overall Study|Withdrawal by Subject|2|||
105606422|NCT02671435|364221095|FG003|Overall Study|Withdrawal by Subject|2|||
105606423|NCT02671435|364221096|FG004|Overall Study|Withdrawal by Subject|2|||
105606424|NCT02671435|364221097|FG005|Overall Study|Withdrawal by Subject|7|||
105606425|NCT02671435|364221098|FG006|Overall Study|Withdrawal by Subject|2|||
105606426|NCT02671435|364221099|FG007|Overall Study|Withdrawal by Subject|7|||
105606427|NCT02671435|364221100|FG008|Overall Study|Withdrawal by Subject|1|||
105606428|NCT02671435|364221101|FG009|Overall Study|Withdrawal by Subject|1|||
105606429|NCT02671435|364221102|FG010|Overall Study|Withdrawal by Subject|2|||
105606430|NCT02671435|364221103|FG011|Overall Study|Withdrawal by Subject|4|||
105606431|NCT02671435|364221104|FG012|Overall Study|Withdrawal by Subject|4|||
105606432|NCT02671435|364221105|FG013|Overall Study|Withdrawal by Subject|4|||
105606433|NCT02671435|364221106|FG014|Overall Study|Withdrawal by Subject|2|||
105606434|NCT02671435|364221092|FG000|Overall Study|Un-specified|0|||
105606435|NCT02671435|364221093|FG001|Overall Study|Un-specified|0|||
105606436|NCT02671435|364221094|FG002|Overall Study|Un-specified|0|||
105606437|NCT02671435|364221095|FG003|Overall Study|Un-specified|0|||
105606438|NCT02671435|364221096|FG004|Overall Study|Un-specified|1|||
105606439|NCT02671435|364221097|FG005|Overall Study|Un-specified|3|||
105606440|NCT02671435|364221098|FG006|Overall Study|Un-specified|2|||
105606441|NCT02671435|364221099|FG007|Overall Study|Un-specified|3|||
105606442|NCT02671435|364221100|FG008|Overall Study|Un-specified|0|||
105606443|NCT02671435|364221101|FG009|Overall Study|Un-specified|5|||
105606444|NCT02671435|364221102|FG010|Overall Study|Un-specified|8|||
105606445|NCT02671435|364221103|FG011|Overall Study|Un-specified|4|||
105606446|NCT02671435|364221104|FG012|Overall Study|Un-specified|5|||
105606447|NCT02671435|364221105|FG013|Overall Study|Un-specified|9|||
105606448|NCT02671435|364221106|FG014|Overall Study|Un-specified|8|||
105606449|NCT01721291|364221107|FG000|Overall Study|Withdrawal by Subject|1|||
105606450|NCT01721291|364221108|FG001|Overall Study|Withdrawal by Subject|0|||
105606451|NCT01721291|364221107|FG000|Overall Study|did not like the treatment|1|||
105606452|NCT01721291|364221108|FG001|Overall Study|did not like the treatment|0|||
105606453|NCT06450405|364221109|FG000|Overall Study|Study funding terminated.|0|||
105606454|NCT06450405|364221110|FG001|Overall Study|Study funding terminated.|2|||
105606455|NCT03529110|364221755|FG000|Overall Study|Progressive Disease|66|||
105606456|NCT03529110|364221756|FG001|Overall Study|Progressive Disease|158|||
105606457|NCT03529110|364221755|FG000|Overall Study|Clinical Progression|4|||
105606458|NCT03529110|364221756|FG001|Overall Study|Clinical Progression|12|||
105606459|NCT03529110|364221755|FG000|Overall Study|Adverse Event|35|||
105606460|NCT03529110|364221756|FG001|Overall Study|Adverse Event|17|||
105606461|NCT03529110|364221755|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
105606462|NCT03529110|364221756|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
105606463|NCT03529110|364221755|FG000|Overall Study|Lack of Efficacy|3|||
105606464|NCT03529110|364221756|FG001|Overall Study|Lack of Efficacy|3|||
105606465|NCT03529110|364221755|FG000|Overall Study|Physician Decision|2|||
105606466|NCT03529110|364221756|FG001|Overall Study|Physician Decision|8|||
105606467|NCT03529110|364221755|FG000|Overall Study|Miscellaneous|2|||
105606468|NCT03529110|364221756|FG001|Overall Study|Miscellaneous|5|||
105606469|NCT05696080|364221757|FG000|Overall Study|Lost to Follow-up|2|||
105606470|NCT05696080|364221758|FG001|Overall Study|Lost to Follow-up|1|||
105606471|NCT05696080|364221757|FG000|Overall Study|Physician Decision|1|||
105606472|NCT05696080|364221758|FG001|Overall Study|Physician Decision|0|||
105606473|NCT05696080|364221757|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105606474|NCT05696080|364221758|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
105606475|NCT05696080|364221757|FG000|Overall Study|Withdrawal by Subject|12|||
105606476|NCT05696080|364221758|FG001|Overall Study|Withdrawal by Subject|0|||
105606477|NCT03397108|364221761|FG000|Overall Study|Lost to Follow-up|15|||
105606478|NCT03397108|364221762|FG001|Overall Study|Lost to Follow-up|0|||
105606479|NCT03397108|364221761|FG000|Overall Study|Insufficient milk production|3|||
105606480|NCT03397108|364221762|FG001|Overall Study|Insufficient milk production|2|||
105606481|NCT03397108|364221761|FG000|Overall Study|Withdrawal by Subject|2|||
105606482|NCT03397108|364221762|FG001|Overall Study|Withdrawal by Subject|0|||
105606483|NCT02562235|364221763|FG000|Overall Study|Adverse Event|3|||
105606484|NCT05096819|364221764|FG000|Overall Study|Withdrawal by Subject|3|||
105606485|NCT05096819|364221765|FG001|Overall Study|Withdrawal by Subject|0|||
105606486|NCT05307783|364221777|FG000|Overall Study|Death|7|||
105606487|NCT05307783|364221777|FG000|Overall Study|Lost to Follow-up|4|||
105606488|NCT00567398|364221778|FG000|Overall Study|Adverse Event|6|||
105606489|NCT00567398|364221779|FG001|Overall Study|Adverse Event|14|||
105606490|NCT00567398|364221778|FG000|Overall Study|Physician Decision|0|||
105606491|NCT00567398|364221779|FG001|Overall Study|Physician Decision|4|||
105606492|NCT00567398|364221778|FG000|Overall Study|Withdrawal by Subject|0|||
105606493|NCT00567398|364221779|FG001|Overall Study|Withdrawal by Subject|2|||
105606494|NCT00567398|364221778|FG000|Overall Study|Renal Transplantation|0|||
105606495|NCT00567398|364221779|FG001|Overall Study|Renal Transplantation|3|||
105606496|NCT00567398|364221778|FG000|Overall Study|Other|1|||
105606497|NCT00567398|364221779|FG001|Overall Study|Other|0|||
105606498|NCT01121991|364221780|FG000|Overall Study|Lack of Ovarian Response|2|||
105606499|NCT01121991|364221780|FG000|Overall Study|No Oocytes Retrieved|3|||
105606500|NCT01121991|364221780|FG000|Overall Study|No Fertilization|1|||
105606501|NCT01426412|364221790|FG000|Overall Study|Withdrawal by Subject|1|||
105606502|NCT01426412|364221791|FG001|Overall Study|Withdrawal by Subject|0|||
105606503|NCT01426412|364221792|FG002|Overall Study|Withdrawal by Subject|0|||
105606504|NCT01426412|364221793|FG003|Overall Study|Withdrawal by Subject|0|||
105606505|NCT01426412|364221794|FG004|Overall Study|Withdrawal by Subject|1|||
105606506|NCT01426412|364221795|FG005|Overall Study|Withdrawal by Subject|0|||
105606507|NCT01426412|364221796|FG006|Overall Study|Withdrawal by Subject|0|||
105606508|NCT01426412|364221797|FG007|Overall Study|Withdrawal by Subject|3|||
105606509|NCT01426412|364221798|FG008|Overall Study|Withdrawal by Subject|1|||
105606510|NCT05450458|364221799|FG000|Overall Study|Lost to Follow-up|4|||
105606511|NCT03939312|364221802|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
105606512|NCT03939312|364221802|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
105606513|NCT03939312|364221802|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
105606514|NCT03939312|364221802|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
105606515|NCT03939312|364221802|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
105606516|NCT03939312|364221802|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
105606517|NCT03939312|364221802|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
105606518|NCT03939312|364221802|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
105606519|NCT03939312|364221802|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
105606520|NCT03939312|364221802|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
105606521|NCT03939312|364221802|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
105606522|NCT03939312|364221802|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
105606523|NCT06024174|364221803|FG000|Overall Study|Other Reasons|1|||
105606524|NCT06024174|364221803|FG000|Overall Study|Study terminated by Sponsor|4|||
105606525|NCT04567615|364221804|FG000|Randomization|Participant withdrew consent|1|||
105606526|NCT04567615|364221805|FG001|Randomization|Participant withdrew consent|0|||
105606527|NCT04567615|364221806|FG002|Randomization|Participant withdrew consent|0|||
105606528|NCT04567615|364221804|FG000|Randomization|Adverse event unrelated to study drug|0|||
105606529|NCT04567615|364221805|FG001|Randomization|Adverse event unrelated to study drug|1|||
105606530|NCT04567615|364221806|FG002|Randomization|Adverse event unrelated to study drug|0|||
105606531|NCT04567615|364221804|FG000|Treatment Period|Participant Withdrew Consent|2|||
105606532|NCT04567615|364221805|FG001|Treatment Period|Participant Withdrew Consent|5|||
105606533|NCT04567615|364221806|FG002|Treatment Period|Participant Withdrew Consent|1|||
105606534|NCT04567615|364221804|FG000|Treatment Period|Death|1|||
105606535|NCT04567615|364221805|FG001|Treatment Period|Death|2|||
105606536|NCT04567615|364221806|FG002|Treatment Period|Death|0|||
105606537|NCT04567615|364221804|FG000|Treatment Period|Lost to Follow-up|0|||
105606538|NCT04567615|364221805|FG001|Treatment Period|Lost to Follow-up|1|||
105606539|NCT04567615|364221806|FG002|Treatment Period|Lost to Follow-up|0|||
105606540|NCT04567615|364221804|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
105606541|NCT04567615|364221805|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
105606542|NCT04567615|364221806|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
105606543|NCT04567615|364221804|FG000|Treatment Period|Disease Progression|85|||
105606544|NCT04567615|364221805|FG001|Treatment Period|Disease Progression|63|||
105606545|NCT04567615|364221806|FG002|Treatment Period|Disease Progression|16|||
105606546|NCT04567615|364221804|FG000|Treatment Period|Study Drug Toxicity|3|||
105606547|NCT04567615|364221805|FG001|Treatment Period|Study Drug Toxicity|10|||
105606548|NCT04567615|364221806|FG002|Treatment Period|Study Drug Toxicity|4|||
105606549|NCT04567615|364221804|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
105606550|NCT04567615|364221805|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
105606551|NCT04567615|364221806|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
105606552|NCT04567615|364221804|FG000|Treatment Period|Other Reasons|1|||
105606553|NCT04567615|364221805|FG001|Treatment Period|Other Reasons|2|||
105606554|NCT04567615|364221806|FG002|Treatment Period|Other Reasons|0|||
105606555|NCT04567615|364221804|FG000|Treatment Period|Still On-going Treatment|21|||
105606556|NCT04567615|364221805|FG001|Treatment Period|Still On-going Treatment|22|||
105606557|NCT04567615|364221806|FG002|Treatment Period|Still On-going Treatment|2|||
105606558|NCT05505045|364224286|FG000|Overall Study|Withdrawal by Subject|2|||
105606559|NCT05505045|364224287|FG001|Overall Study|Withdrawal by Subject|1|||
105606560|NCT01012817|364224288|FG000|Overall Study|Withdrawal by Subject|0|||
105606561|NCT01012817|364224289|FG001|Overall Study|Withdrawal by Subject|0|||
105606562|NCT01012817|364224290|FG002|Overall Study|Withdrawal by Subject|0|||
105606563|NCT01012817|364224291|FG003|Overall Study|Withdrawal by Subject|1|||
105606564|NCT01012817|364224292|FG004|Overall Study|Withdrawal by Subject|0|||
105606565|NCT01012817|364224293|FG005|Overall Study|Withdrawal by Subject|0|||
105606566|NCT01012817|364224294|FG006|Overall Study|Withdrawal by Subject|0|||
105606567|NCT01012817|364224295|FG007|Overall Study|Withdrawal by Subject|1|||
105606568|NCT01012817|364224296|FG008|Overall Study|Withdrawal by Subject|0|||
105606569|NCT01012817|364224297|FG009|Overall Study|Withdrawal by Subject|0|||
105606570|NCT01012817|364224298|FG010|Overall Study|Withdrawal by Subject|1|||
105606571|NCT01012817|364224299|FG011|Overall Study|Withdrawal by Subject|1|||
105606572|NCT01012817|364224300|FG012|Overall Study|Withdrawal by Subject|0|||
105606573|NCT01012817|364224301|FG013|Overall Study|Withdrawal by Subject|1|||
105606574|NCT01012817|364224288|FG000|Overall Study|Adverse Event|0|||
105606575|NCT01012817|364224289|FG001|Overall Study|Adverse Event|0|||
105606576|NCT01012817|364224290|FG002|Overall Study|Adverse Event|0|||
105606577|NCT01012817|364224291|FG003|Overall Study|Adverse Event|0|||
105606578|NCT01012817|364224292|FG004|Overall Study|Adverse Event|0|||
105606579|NCT01012817|364224293|FG005|Overall Study|Adverse Event|1|||
105606580|NCT01012817|364224294|FG006|Overall Study|Adverse Event|0|||
105606581|NCT01012817|364224295|FG007|Overall Study|Adverse Event|0|||
105606582|NCT01012817|364224296|FG008|Overall Study|Adverse Event|0|||
105606583|NCT01012817|364224297|FG009|Overall Study|Adverse Event|0|||
105606584|NCT01012817|364224298|FG010|Overall Study|Adverse Event|1|||
105606585|NCT01012817|364224299|FG011|Overall Study|Adverse Event|0|||
105606586|NCT01012817|364224300|FG012|Overall Study|Adverse Event|0|||
105606587|NCT01012817|364224301|FG013|Overall Study|Adverse Event|1|||
105606588|NCT01600014|364224302|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
105606589|NCT01600014|364224303|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
105606590|NCT01600014|364224302|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
105606591|NCT01600014|364224303|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
105606592|NCT01600014|364224302|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
105606593|NCT01600014|364224303|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
105606594|NCT01600014|364224302|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
105606595|NCT01600014|364224303|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
105606596|NCT01600014|364224302|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
105606597|NCT01600014|364224303|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
105606598|NCT01600014|364224302|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
105606599|NCT01600014|364224303|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
105606600|NCT01600014|364224302|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
105606601|NCT01600014|364224303|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
105606602|NCT01600014|364224302|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
105606603|NCT01600014|364224303|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
105606604|NCT01600014|364224302|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
105606605|NCT01600014|364224303|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
105606606|NCT01600014|364224302|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
105606607|NCT01600014|364224303|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
105606608|NCT01600014|364224302|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
105606609|NCT01600014|364224303|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
105606610|NCT01600014|364224302|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
105606611|NCT01600014|364224303|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
105606612|NCT01600014|364224302|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
105606613|NCT01600014|364224303|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
105606614|NCT01600014|364224302|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
105606615|NCT01600014|364224303|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
105606616|NCT01600014|364224302|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
105606617|NCT01600014|364224303|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
105606618|NCT01600014|364224302|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
105606619|NCT01600014|364224303|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
105606620|NCT01600014|364224302|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
105606621|NCT01600014|364224303|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
105606622|NCT03152786|364224307|FG000|Overall Study|Withdrawal by Subject|2|||
105606623|NCT03152786|364224308|FG001|Overall Study|Withdrawal by Subject|1|||
105606624|NCT04923347|364224309|FG000|Overall Study|Withdrawal by Subject|14|||
105606625|NCT03481660|364224310|FG000|Overall Study|Adverse Event|5|||
105606626|NCT03481660|364224311|FG001|Overall Study|Adverse Event|4|||
105606627|NCT03481660|364224310|FG000|Overall Study|Death|13|||
105606628|NCT03481660|364224311|FG001|Overall Study|Death|9|||
105606629|NCT03481660|364224310|FG000|Overall Study|Lost to Follow-up|2|||
105606630|NCT03481660|364224311|FG001|Overall Study|Lost to Follow-up|2|||
105606631|NCT03481660|364224310|FG000|Overall Study|Physician Decision|2|||
105606632|NCT03481660|364224311|FG001|Overall Study|Physician Decision|3|||
105606633|NCT03481660|364224310|FG000|Overall Study|Withdrawal by Subject|14|||
105606634|NCT03481660|364224311|FG001|Overall Study|Withdrawal by Subject|7|||
105606635|NCT03398148|364224312|FG000|Substudy 1 Period 1|Adverse Event|5|||
105606636|NCT03398148|364224313|FG001|Substudy 1 Period 1|Adverse Event|2|||
105606637|NCT03398148|364224314|FG002|Substudy 1 Period 1|Adverse Event|2|||
105606638|NCT03398148|364224315|FG003|Substudy 1 Period 1|Adverse Event|0|||
105606639|NCT03398148|364224316|FG004|Substudy 1 Period 1|Adverse Event|8|||
105606640|NCT03398148|364224317|FG005|Substudy 1 Period 1|Adverse Event|0|||
105606641|NCT03398148|364224318|FG006|Substudy 1 Period 1|Adverse Event|0|||
105606642|NCT03398148|364224319|FG007|Substudy 1 Period 1|Adverse Event|0|||
105606643|NCT03398148|364224320|FG008|Substudy 1 Period 1|Adverse Event|0|||
105606644|NCT03398148|364224321|FG009|Substudy 1 Period 1|Adverse Event|0|||
105606645|NCT03398148|364224322|FG010|Substudy 1 Period 1|Adverse Event|0|||
105606646|NCT03398148|364224323|FG011|Substudy 1 Period 1|Adverse Event|0|||
105606647|NCT03398148|364224324|FG012|Substudy 1 Period 1|Adverse Event|0|||
105606648|NCT03398148|364224325|FG013|Substudy 1 Period 1|Adverse Event|0|||
105606649|NCT03398148|364224326|FG014|Substudy 1 Period 1|Adverse Event|0|||
105606650|NCT03398148|364224312|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
105606651|NCT03398148|364224313|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
105606652|NCT03398148|364224314|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
105606653|NCT03398148|364224315|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
105606654|NCT03398148|364224316|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
105606655|NCT03398148|364224317|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
105606656|NCT03398148|364224318|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
105606657|NCT03398148|364224319|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
105606658|NCT03398148|364224320|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
105606659|NCT03398148|364224321|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
105606660|NCT03398148|364224322|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
105606661|NCT03398148|364224323|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
105606662|NCT03398148|364224324|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
105606663|NCT03398148|364224325|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
105606664|NCT03398148|364224326|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
105606665|NCT03398148|364224312|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
105606666|NCT03398148|364224313|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
105606667|NCT03398148|364224314|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
105606668|NCT03398148|364224315|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
105606669|NCT03398148|364224316|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
105606670|NCT03398148|364224317|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
105606671|NCT03398148|364224318|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
105606672|NCT03398148|364224319|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
105606673|NCT03398148|364224320|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
105606674|NCT03398148|364224321|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
105606675|NCT03398148|364224322|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
105606676|NCT03398148|364224323|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
105606677|NCT03398148|364224324|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
105606678|NCT03398148|364224325|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
105606679|NCT03398148|364224326|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
105606680|NCT03398148|364224312|FG000|Substudy 1 Period 1|Other|0|||
105606681|NCT03398148|364224313|FG001|Substudy 1 Period 1|Other|1|||
105606682|NCT03398148|364224314|FG002|Substudy 1 Period 1|Other|0|||
105606683|NCT03398148|364224315|FG003|Substudy 1 Period 1|Other|0|||
105606684|NCT03398148|364224316|FG004|Substudy 1 Period 1|Other|3|||
105606685|NCT03398148|364224317|FG005|Substudy 1 Period 1|Other|0|||
105606686|NCT03398148|364224318|FG006|Substudy 1 Period 1|Other|0|||
105606687|NCT03398148|364224319|FG007|Substudy 1 Period 1|Other|0|||
105606688|NCT03398148|364224320|FG008|Substudy 1 Period 1|Other|0|||
105606689|NCT03398148|364224321|FG009|Substudy 1 Period 1|Other|0|||
105606690|NCT03398148|364224322|FG010|Substudy 1 Period 1|Other|0|||
105606691|NCT03398148|364224323|FG011|Substudy 1 Period 1|Other|0|||
105606692|NCT03398148|364224324|FG012|Substudy 1 Period 1|Other|0|||
105606693|NCT03398148|364224325|FG013|Substudy 1 Period 1|Other|0|||
105606694|NCT03398148|364224326|FG014|Substudy 1 Period 1|Other|0|||
105606695|NCT03398148|364224312|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
105606696|NCT03398148|364224313|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
105606697|NCT03398148|364224314|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
105606698|NCT03398148|364224315|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
105606699|NCT03398148|364224316|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
105606700|NCT03398148|364224317|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
105606701|NCT03398148|364224318|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
105606702|NCT03398148|364224319|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
105606703|NCT03398148|364224320|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
105606704|NCT03398148|364224321|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
105606705|NCT03398148|364224322|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
105606706|NCT03398148|364224323|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
105606707|NCT03398148|364224324|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
105606708|NCT03398148|364224325|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
105606709|NCT03398148|364224326|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
105606710|NCT03398148|364224312|FG000|Substudy 1 Period 2|Adverse Event|0|||
105606711|NCT03398148|364224313|FG001|Substudy 1 Period 2|Adverse Event|0|||
105606712|NCT03398148|364224314|FG002|Substudy 1 Period 2|Adverse Event|0|||
105606713|NCT03398148|364224315|FG003|Substudy 1 Period 2|Adverse Event|0|||
105606714|NCT03398148|364224316|FG004|Substudy 1 Period 2|Adverse Event|0|||
105606715|NCT03398148|364224317|FG005|Substudy 1 Period 2|Adverse Event|2|||
105606716|NCT03398148|364224318|FG006|Substudy 1 Period 2|Adverse Event|4|||
105606717|NCT03398148|364224319|FG007|Substudy 1 Period 2|Adverse Event|0|||
105606718|NCT03398148|364224320|FG008|Substudy 1 Period 2|Adverse Event|0|||
105606719|NCT03398148|364224321|FG009|Substudy 1 Period 2|Adverse Event|0|||
105606720|NCT03398148|364224322|FG010|Substudy 1 Period 2|Adverse Event|0|||
105606721|NCT03398148|364224323|FG011|Substudy 1 Period 2|Adverse Event|0|||
105606722|NCT03398148|364224324|FG012|Substudy 1 Period 2|Adverse Event|0|||
105606723|NCT03398148|364224325|FG013|Substudy 1 Period 2|Adverse Event|0|||
105606724|NCT03398148|364224326|FG014|Substudy 1 Period 2|Adverse Event|0|||
105606725|NCT03398148|364224312|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
105606726|NCT03398148|364224313|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
105606727|NCT03398148|364224314|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
105606728|NCT03398148|364224315|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
105606729|NCT03398148|364224316|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
105606730|NCT03398148|364224317|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
105606731|NCT03398148|364224318|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
105606732|NCT03398148|364224319|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
105606733|NCT03398148|364224320|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
105606734|NCT03398148|364224321|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
105606735|NCT03398148|364224322|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
105606736|NCT03398148|364224323|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
105606737|NCT03398148|364224324|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
105606738|NCT03398148|364224325|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
105606739|NCT03398148|364224326|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
105606740|NCT03398148|364224312|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
105606741|NCT03398148|364224313|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
105606742|NCT03398148|364224314|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
105606743|NCT03398148|364224315|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
105606744|NCT03398148|364224316|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
105606745|NCT03398148|364224317|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
105606746|NCT03398148|364224318|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
105606747|NCT03398148|364224319|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
105606748|NCT03398148|364224320|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
105606749|NCT03398148|364224321|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
105606750|NCT03398148|364224322|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
105606751|NCT03398148|364224323|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
105606752|NCT03398148|364224324|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
105606753|NCT03398148|364224325|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
105606754|NCT03398148|364224326|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
105606755|NCT03398148|364224312|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606756|NCT03398148|364224313|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606757|NCT03398148|364224314|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606758|NCT03398148|364224315|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606759|NCT03398148|364224316|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606760|NCT03398148|364224317|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606761|NCT03398148|364224318|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
105606762|NCT03398148|364224319|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606763|NCT03398148|364224320|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606764|NCT03398148|364224321|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606765|NCT03398148|364224322|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606766|NCT03398148|364224323|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606767|NCT03398148|364224324|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606768|NCT03398148|364224325|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606769|NCT03398148|364224326|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606770|NCT03398148|364224312|FG000|Substudy 1 Period 2|Other|0|||
105606771|NCT03398148|364224313|FG001|Substudy 1 Period 2|Other|0|||
105606772|NCT03398148|364224314|FG002|Substudy 1 Period 2|Other|0|||
105606773|NCT03398148|364224315|FG003|Substudy 1 Period 2|Other|0|||
105606774|NCT03398148|364224316|FG004|Substudy 1 Period 2|Other|0|||
105606775|NCT03398148|364224317|FG005|Substudy 1 Period 2|Other|0|||
105606776|NCT03398148|364224318|FG006|Substudy 1 Period 2|Other|1|||
105606777|NCT03398148|364224319|FG007|Substudy 1 Period 2|Other|0|||
105606778|NCT03398148|364224320|FG008|Substudy 1 Period 2|Other|0|||
105606779|NCT03398148|364224321|FG009|Substudy 1 Period 2|Other|0|||
105606780|NCT03398148|364224322|FG010|Substudy 1 Period 2|Other|0|||
105606781|NCT03398148|364224323|FG011|Substudy 1 Period 2|Other|0|||
105606782|NCT03398148|364224324|FG012|Substudy 1 Period 2|Other|0|||
105606783|NCT03398148|364224325|FG013|Substudy 1 Period 2|Other|0|||
105606784|NCT03398148|364224326|FG014|Substudy 1 Period 2|Other|0|||
105606785|NCT03398148|364224312|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
105606786|NCT03398148|364224313|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
105606787|NCT03398148|364224314|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
105606788|NCT03398148|364224315|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
105606789|NCT03398148|364224316|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
105606790|NCT03398148|364224317|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
105606791|NCT03398148|364224318|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
105606792|NCT03398148|364224319|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
105606793|NCT03398148|364224320|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
105606794|NCT03398148|364224321|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
105606795|NCT03398148|364224322|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
105606796|NCT03398148|364224323|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
105606797|NCT03398148|364224324|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
105606798|NCT03398148|364224325|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
105606799|NCT03398148|364224326|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
105606800|NCT03398148|364224312|FG000|Substudy 2 Period 1|Adverse Event|0|||
105606801|NCT03398148|364224313|FG001|Substudy 2 Period 1|Adverse Event|0|||
105606802|NCT03398148|364224314|FG002|Substudy 2 Period 1|Adverse Event|0|||
105606803|NCT03398148|364224315|FG003|Substudy 2 Period 1|Adverse Event|0|||
105606804|NCT03398148|364224316|FG004|Substudy 2 Period 1|Adverse Event|0|||
105606805|NCT03398148|364224317|FG005|Substudy 2 Period 1|Adverse Event|0|||
105606806|NCT03398148|364224318|FG006|Substudy 2 Period 1|Adverse Event|0|||
105606807|NCT03398148|364224319|FG007|Substudy 2 Period 1|Adverse Event|0|||
105606808|NCT03398148|364224320|FG008|Substudy 2 Period 1|Adverse Event|0|||
105606809|NCT03398148|364224321|FG009|Substudy 2 Period 1|Adverse Event|12|||
105606810|NCT03398148|364224322|FG010|Substudy 2 Period 1|Adverse Event|2|||
105606811|NCT03398148|364224323|FG011|Substudy 2 Period 1|Adverse Event|0|||
105606812|NCT03398148|364224324|FG012|Substudy 2 Period 1|Adverse Event|0|||
105606813|NCT03398148|364224325|FG013|Substudy 2 Period 1|Adverse Event|0|||
105606814|NCT03398148|364224326|FG014|Substudy 2 Period 1|Adverse Event|0|||
105606815|NCT03398148|364224312|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
105606816|NCT03398148|364224313|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
105606817|NCT03398148|364224314|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
105606818|NCT03398148|364224315|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
105606819|NCT03398148|364224316|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
105606820|NCT03398148|364224317|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
105606821|NCT03398148|364224318|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
105606822|NCT03398148|364224319|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
105606823|NCT03398148|364224320|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
105606824|NCT03398148|364224321|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
105606825|NCT03398148|364224322|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
105606826|NCT03398148|364224323|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
105606827|NCT03398148|364224324|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
105606828|NCT03398148|364224325|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
105606829|NCT03398148|364224326|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
105606830|NCT03398148|364224312|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
105606831|NCT03398148|364224313|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
105606832|NCT03398148|364224314|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
105606833|NCT03398148|364224315|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
105606834|NCT03398148|364224316|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
105606835|NCT03398148|364224317|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
105606836|NCT03398148|364224318|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
105606837|NCT03398148|364224319|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
105606838|NCT03398148|364224320|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
105606839|NCT03398148|364224321|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
105606840|NCT03398148|364224322|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
105606841|NCT03398148|364224323|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
105606842|NCT03398148|364224324|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
105606843|NCT03398148|364224325|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
105606844|NCT03398148|364224326|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
105606845|NCT03398148|364224312|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
105606846|NCT03398148|364224313|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
105606847|NCT03398148|364224314|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
105606848|NCT03398148|364224315|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
105606849|NCT03398148|364224316|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
105606850|NCT03398148|364224317|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
105606851|NCT03398148|364224318|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
105606852|NCT03398148|364224319|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
105606853|NCT03398148|364224320|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
105606854|NCT03398148|364224321|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
105606855|NCT03398148|364224322|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
105606856|NCT03398148|364224323|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
105606857|NCT03398148|364224324|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
105606858|NCT03398148|364224325|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
105606859|NCT03398148|364224326|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
105606860|NCT03398148|364224312|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606861|NCT03398148|364224313|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606862|NCT03398148|364224314|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606863|NCT03398148|364224315|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606864|NCT03398148|364224316|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606865|NCT03398148|364224317|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606866|NCT03398148|364224318|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606867|NCT03398148|364224319|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606868|NCT03398148|364224320|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606869|NCT03398148|364224321|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606870|NCT03398148|364224322|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
105606871|NCT03398148|364224323|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606872|NCT03398148|364224324|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606873|NCT03398148|364224325|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606874|NCT03398148|364224326|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105606875|NCT03398148|364224312|FG000|Substudy 2 Period 1|Other|0|||
105606876|NCT03398148|364224313|FG001|Substudy 2 Period 1|Other|0|||
105606877|NCT03398148|364224314|FG002|Substudy 2 Period 1|Other|0|||
105606878|NCT03398148|364224315|FG003|Substudy 2 Period 1|Other|0|||
105606879|NCT03398148|364224316|FG004|Substudy 2 Period 1|Other|0|||
105606880|NCT03398148|364224317|FG005|Substudy 2 Period 1|Other|0|||
105606881|NCT03398148|364224318|FG006|Substudy 2 Period 1|Other|0|||
105606882|NCT03398148|364224319|FG007|Substudy 2 Period 1|Other|0|||
105606883|NCT03398148|364224320|FG008|Substudy 2 Period 1|Other|0|||
105606884|NCT03398148|364224321|FG009|Substudy 2 Period 1|Other|4|||
105606885|NCT03398148|364224322|FG010|Substudy 2 Period 1|Other|4|||
105606886|NCT03398148|364224323|FG011|Substudy 2 Period 1|Other|0|||
105606887|NCT03398148|364224324|FG012|Substudy 2 Period 1|Other|0|||
105606888|NCT03398148|364224325|FG013|Substudy 2 Period 1|Other|0|||
105606889|NCT03398148|364224326|FG014|Substudy 2 Period 1|Other|0|||
105606890|NCT03398148|364224312|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
105606891|NCT03398148|364224313|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
105606892|NCT03398148|364224314|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
105606893|NCT03398148|364224315|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
105606894|NCT03398148|364224316|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
105606895|NCT03398148|364224317|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
105606896|NCT03398148|364224318|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
105606897|NCT03398148|364224319|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
105606898|NCT03398148|364224320|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
105606899|NCT03398148|364224321|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
105606900|NCT03398148|364224322|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
105606901|NCT03398148|364224323|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
105606902|NCT03398148|364224324|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
105606903|NCT03398148|364224325|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
105606904|NCT03398148|364224326|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
105606905|NCT03398148|364224312|FG000|Substudy 2 Period 2|Adverse Event|0|||
105606906|NCT03398148|364224313|FG001|Substudy 2 Period 2|Adverse Event|0|||
105606907|NCT03398148|364224314|FG002|Substudy 2 Period 2|Adverse Event|0|||
105606908|NCT03398148|364224315|FG003|Substudy 2 Period 2|Adverse Event|0|||
105606909|NCT03398148|364224316|FG004|Substudy 2 Period 2|Adverse Event|0|||
105606910|NCT03398148|364224317|FG005|Substudy 2 Period 2|Adverse Event|0|||
105606911|NCT03398148|364224318|FG006|Substudy 2 Period 2|Adverse Event|0|||
105606912|NCT03398148|364224319|FG007|Substudy 2 Period 2|Adverse Event|0|||
105606913|NCT03398148|364224320|FG008|Substudy 2 Period 2|Adverse Event|0|||
105606914|NCT03398148|364224321|FG009|Substudy 2 Period 2|Adverse Event|0|||
105606915|NCT03398148|364224322|FG010|Substudy 2 Period 2|Adverse Event|0|||
105606916|NCT03398148|364224323|FG011|Substudy 2 Period 2|Adverse Event|0|||
105606917|NCT03398148|364224324|FG012|Substudy 2 Period 2|Adverse Event|0|||
105606918|NCT03398148|364224325|FG013|Substudy 2 Period 2|Adverse Event|1|||
105606919|NCT03398148|364224326|FG014|Substudy 2 Period 2|Adverse Event|3|||
105606920|NCT03398148|364224312|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
105606921|NCT03398148|364224313|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
105606922|NCT03398148|364224314|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
105606923|NCT03398148|364224315|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
105606924|NCT03398148|364224316|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
105606925|NCT03398148|364224317|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
105606926|NCT03398148|364224318|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
105606927|NCT03398148|364224319|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
105606928|NCT03398148|364224320|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
105606929|NCT03398148|364224321|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
105606930|NCT03398148|364224322|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
105606931|NCT03398148|364224323|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
105606932|NCT03398148|364224324|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
105606933|NCT03398148|364224325|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
105606934|NCT03398148|364224326|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
105606935|NCT03398148|364224312|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
105606936|NCT03398148|364224313|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
105606937|NCT03398148|364224314|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
105606938|NCT03398148|364224315|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
105606939|NCT03398148|364224316|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
105606940|NCT03398148|364224317|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
105606941|NCT03398148|364224318|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
105606942|NCT03398148|364224319|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
105606943|NCT03398148|364224320|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
105606944|NCT03398148|364224321|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
105606945|NCT03398148|364224322|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
105606946|NCT03398148|364224323|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
105606947|NCT03398148|364224324|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
105606948|NCT03398148|364224325|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
105606949|NCT03398148|364224326|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
105606950|NCT03398148|364224312|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
105606951|NCT03398148|364224313|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
105606952|NCT03398148|364224314|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
105606953|NCT03398148|364224315|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
105606954|NCT03398148|364224316|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
105606955|NCT03398148|364224317|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
105606956|NCT03398148|364224318|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
105606957|NCT03398148|364224319|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
105606958|NCT03398148|364224320|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
105606959|NCT03398148|364224321|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
105606960|NCT03398148|364224322|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
105606961|NCT03398148|364224323|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
105606962|NCT03398148|364224324|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
105606963|NCT03398148|364224325|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
105606964|NCT03398148|364224326|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
105606965|NCT03398148|364224312|FG000|Substudy 2 Period 2|Other|0|||
105606966|NCT03398148|364224313|FG001|Substudy 2 Period 2|Other|0|||
105606967|NCT03398148|364224314|FG002|Substudy 2 Period 2|Other|0|||
105606968|NCT03398148|364224315|FG003|Substudy 2 Period 2|Other|0|||
105606969|NCT03398148|364224316|FG004|Substudy 2 Period 2|Other|0|||
105606970|NCT03398148|364224317|FG005|Substudy 2 Period 2|Other|0|||
105606971|NCT03398148|364224318|FG006|Substudy 2 Period 2|Other|0|||
105606972|NCT03398148|364224319|FG007|Substudy 2 Period 2|Other|0|||
105606973|NCT03398148|364224320|FG008|Substudy 2 Period 2|Other|0|||
105606974|NCT03398148|364224321|FG009|Substudy 2 Period 2|Other|0|||
105606975|NCT03398148|364224322|FG010|Substudy 2 Period 2|Other|0|||
105606976|NCT03398148|364224323|FG011|Substudy 2 Period 2|Other|0|||
105606977|NCT03398148|364224324|FG012|Substudy 2 Period 2|Other|0|||
105606978|NCT03398148|364224325|FG013|Substudy 2 Period 2|Other|1|||
105606979|NCT03398148|364224326|FG014|Substudy 2 Period 2|Other|1|||
105606980|NCT03398148|364224312|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
105606981|NCT03398148|364224313|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
105606982|NCT03398148|364224314|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
105606983|NCT03398148|364224315|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
105606984|NCT03398148|364224316|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
105606985|NCT03398148|364224317|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
105606986|NCT03398148|364224318|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
105606987|NCT03398148|364224319|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
105606988|NCT03398148|364224320|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
105606989|NCT03398148|364224321|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
105606990|NCT03398148|364224322|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
105606991|NCT03398148|364224323|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
105606992|NCT03398148|364224324|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
105606993|NCT03398148|364224325|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
105606994|NCT03398148|364224326|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
105606995|NCT02791230|364224327|FG000|Overall Study|Adverse Event|10|||
105606996|NCT02791230|364224328|FG001|Overall Study|Adverse Event|9|||
105606997|NCT02791230|364224329|FG002|Overall Study|Adverse Event|66|||
105606998|NCT02791230|364224327|FG000|Overall Study|Death|38|||
105606999|NCT02791230|364224328|FG001|Overall Study|Death|25|||
105607000|NCT02791230|364224329|FG002|Overall Study|Death|184|||
105607001|NCT02791230|364224327|FG000|Overall Study|Lack of Efficacy|1|||
105607002|NCT02791230|364224328|FG001|Overall Study|Lack of Efficacy|0|||
105607003|NCT02791230|364224329|FG002|Overall Study|Lack of Efficacy|3|||
105607004|NCT02791230|364224327|FG000|Overall Study|Lost to Follow-up|0|||
105607005|NCT02791230|364224328|FG001|Overall Study|Lost to Follow-up|0|||
105607006|NCT02791230|364224329|FG002|Overall Study|Lost to Follow-up|10|||
105607007|NCT02791230|364224327|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
105607008|NCT02791230|364224328|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
105607009|NCT02791230|364224329|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
105607010|NCT02791230|364224327|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
105607011|NCT02791230|364224328|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
105607012|NCT02791230|364224329|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
105607013|NCT02791230|364224327|FG000|Overall Study|Study sites terminated by sponsor|1|||
105607014|NCT02791230|364224328|FG001|Overall Study|Study sites terminated by sponsor|0|||
105607015|NCT02791230|364224329|FG002|Overall Study|Study sites terminated by sponsor|5|||
105607016|NCT02791230|364224327|FG000|Overall Study|Other|9|||
105607017|NCT02791230|364224328|FG001|Overall Study|Other|1|||
105607018|NCT02791230|364224329|FG002|Overall Study|Other|28|||
105607019|NCT02791230|364224327|FG000|Overall Study|Protocol Violation|0|||
105607020|NCT02791230|364224328|FG001|Overall Study|Protocol Violation|0|||
105607021|NCT02791230|364224329|FG002|Overall Study|Protocol Violation|4|||
105607022|NCT02791230|364224327|FG000|Overall Study|Withdrawal by Subject|24|||
105607023|NCT02791230|364224328|FG001|Overall Study|Withdrawal by Subject|13|||
105607024|NCT02791230|364224329|FG002|Overall Study|Withdrawal by Subject|172|||
105607025|NCT02791230|364224327|FG000|Overall Study|Enrolled but not treated|0|||
105607026|NCT02791230|364224328|FG001|Overall Study|Enrolled but not treated|0|||
105607027|NCT02791230|364224329|FG002|Overall Study|Enrolled but not treated|5|||
105607028|NCT04201834|364224337|FG000|Overall Study|Screen fail|1|||
105607029|NCT00212355|364224338|FG000|Overall Study|Adverse Event|1|||
105607030|NCT00212355|364224338|FG000|Overall Study|Withdrawal by Subject|1|||
105607031|NCT00212355|364224338|FG000|Overall Study|A change of address|1|||
105607032|NCT04310735|364224343|FG000|Overall Study|Withdrawal by Subject|1|||
105607033|NCT04310735|364224344|FG001|Overall Study|Withdrawal by Subject|3|||
105607034|NCT04310735|364224345|FG002|Overall Study|Withdrawal by Subject|8|||
105607035|NCT04310735|364224343|FG000|Overall Study|Equipment malfunction|0|||
105607036|NCT04310735|364224344|FG001|Overall Study|Equipment malfunction|1|||
105607037|NCT04310735|364224345|FG002|Overall Study|Equipment malfunction|0|||
105607038|NCT03012841|364224346|FG000|Overall Study|Protocol Violation|0|||
105607039|NCT03012841|364224347|FG001|Overall Study|Protocol Violation|10|||
105607040|NCT03012841|364224346|FG000|Overall Study|Lost to Follow-up|6|||
105607041|NCT03012841|364224347|FG001|Overall Study|Lost to Follow-up|1|||
105607042|NCT03012841|364224346|FG000|Overall Study|Withdrawal by Subject|6|||
105607043|NCT03012841|364224347|FG001|Overall Study|Withdrawal by Subject|0|||
105607044|NCT03012841|364224346|FG000|Overall Study|Unable to complete 12 month visit|6|||
105607045|NCT03012841|364224347|FG001|Overall Study|Unable to complete 12 month visit|0|||
105607046|NCT03012841|364224346|FG000|Overall Study|Subject relocation|1|||
105607047|NCT03012841|364224347|FG001|Overall Study|Subject relocation|0|||
105607048|NCT03012841|364224346|FG000|Overall Study|Seasonal winter travel|1|||
105607049|NCT03012841|364224347|FG001|Overall Study|Seasonal winter travel|0|||
105607050|NCT03012841|364224346|FG000|Overall Study|Physician Decision|0|||
105607051|NCT03012841|364224347|FG001|Overall Study|Physician Decision|2|||
105607052|NCT03012841|364224346|FG000|Overall Study|No ablation performed|0|||
105607053|NCT03012841|364224347|FG001|Overall Study|No ablation performed|2|||
105607054|NCT03012841|364224346|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
105607055|NCT03012841|364224347|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
105607056|NCT03012841|364224346|FG000|Overall Study|Insurance change|0|||
105607057|NCT03012841|364224347|FG001|Overall Study|Insurance change|1|||
105607058|NCT03769168|364224348|FG000|Overall Study|Adverse Event|0|||
105607059|NCT03769168|364224349|FG001|Overall Study|Adverse Event|1|||
105607060|NCT03769168|364224348|FG000|Overall Study|Lack of Efficacy|2|||
105607061|NCT03769168|364224349|FG001|Overall Study|Lack of Efficacy|4|||
105607062|NCT03769168|364224348|FG000|Overall Study|Post study access to treatment|3|||
105607063|NCT03769168|364224349|FG001|Overall Study|Post study access to treatment|11|||
105607064|NCT03769168|364224348|FG000|Overall Study|Physician Decision|1|||
105607065|NCT03769168|364224349|FG001|Overall Study|Physician Decision|4|||
105607066|NCT03769168|364224348|FG000|Overall Study|Subject Decision|2|||
105607067|NCT03769168|364224349|FG001|Overall Study|Subject Decision|4|||
105607068|NCT03769168|364224348|FG000|Overall Study|Guardian decision|1|||
105607069|NCT03769168|364224349|FG001|Overall Study|Guardian decision|0|||
105607070|NCT04486716|364224350|FG000|Overall Study|Subject decision|6|||
105607071|NCT04486716|364224350|FG000|Overall Study|Adverse Event|5|||
105607072|NCT04486716|364224350|FG000|Overall Study|Lost to Follow-up|1|||
105607073|NCT04486716|364224350|FG000|Overall Study|Physician Decision|1|||
105607074|NCT04486716|364224350|FG000|Overall Study|Enrolled subjects not treated|9|||
105607075|NCT01649271|364224351|FG000|Overall Study|Progressive disease|4|||
105607076|NCT01649271|364224352|FG001|Overall Study|Progressive disease|5|||
105607077|NCT01649271|364224351|FG000|Overall Study|Other Adverse Event|0|||
105607078|NCT01649271|364224352|FG001|Overall Study|Other Adverse Event|2|||
105607079|NCT01649271|364224351|FG000|Overall Study|Withdrawal by Subject|1|||
105607080|NCT01649271|364224352|FG001|Overall Study|Withdrawal by Subject|0|||
105607081|NCT01649271|364224351|FG000|Overall Study|Other than stated above|1|||
105607082|NCT01649271|364224352|FG001|Overall Study|Other than stated above|0|||
105607083|NCT04842500|364224357|FG000|Overall Study|Withdrawal by Subject|4|||
105607084|NCT04842500|364224358|FG001|Overall Study|Withdrawal by Subject|1|||
105607085|NCT04842500|364224359|FG002|Overall Study|Withdrawal by Subject|2|||
105607086|NCT04842500|364224360|FG003|Overall Study|Withdrawal by Subject|3|||
105607087|NCT04842500|364224357|FG000|Overall Study|Protocol Violation|1|||
105607088|NCT04842500|364224358|FG001|Overall Study|Protocol Violation|0|||
105607089|NCT04842500|364224359|FG002|Overall Study|Protocol Violation|0|||
105607090|NCT04842500|364224360|FG003|Overall Study|Protocol Violation|1|||
105607091|NCT05756075|364224363|FG000|Overall Study|Withdrawal by Subject|16|||
105607092|NCT05756075|364224364|FG001|Overall Study|Withdrawal by Subject|9|||
105607093|NCT00092534|364224365|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
105607094|NCT00092534|364224366|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
105607095|NCT00092534|364224367|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
105607096|NCT00092534|364224368|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
105607097|NCT00092534|364224369|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
105607098|NCT00092534|364224365|FG000|Base Study Vaccination Period|Adverse Event|3|||
105607099|NCT00092534|364224366|FG001|Base Study Vaccination Period|Adverse Event|1|||
105607100|NCT00092534|364224367|FG002|Base Study Vaccination Period|Adverse Event|0|||
105607101|NCT00092534|364224368|FG003|Base Study Vaccination Period|Adverse Event|0|||
105607102|NCT00092534|364224369|FG004|Base Study Vaccination Period|Adverse Event|0|||
105607103|NCT00092534|364224365|FG000|Base Study Vaccination Period|Death|5|||
105607104|NCT00092534|364224366|FG001|Base Study Vaccination Period|Death|4|||
105607105|NCT00092534|364224367|FG002|Base Study Vaccination Period|Death|0|||
105607106|NCT00092534|364224368|FG003|Base Study Vaccination Period|Death|0|||
105607107|NCT00092534|364224369|FG004|Base Study Vaccination Period|Death|0|||
105607108|NCT00092534|364224365|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
105607109|NCT00092534|364224366|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
105607110|NCT00092534|364224367|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
105607111|NCT00092534|364224368|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
105607112|NCT00092534|364224369|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
105607113|NCT00092534|364224365|FG000|Base Study Vaccination Period|Physician Decision|1|||
105607114|NCT00092534|364224366|FG001|Base Study Vaccination Period|Physician Decision|0|||
105607115|NCT00092534|364224367|FG002|Base Study Vaccination Period|Physician Decision|0|||
105607116|NCT00092534|364224368|FG003|Base Study Vaccination Period|Physician Decision|0|||
105607117|NCT00092534|364224369|FG004|Base Study Vaccination Period|Physician Decision|0|||
105607118|NCT00092534|364224365|FG000|Base Study Vaccination Period|Pregnancy|9|||
105607119|NCT00092534|364224366|FG001|Base Study Vaccination Period|Pregnancy|7|||
105607120|NCT00092534|364224367|FG002|Base Study Vaccination Period|Pregnancy|0|||
105607121|NCT00092534|364224368|FG003|Base Study Vaccination Period|Pregnancy|0|||
105607122|NCT00092534|364224369|FG004|Base Study Vaccination Period|Pregnancy|0|||
105607123|NCT00092534|364224365|FG000|Base Study Vaccination Period|Protocol Violation|2|||
105607124|NCT00092534|364224366|FG001|Base Study Vaccination Period|Protocol Violation|1|||
105607125|NCT00092534|364224367|FG002|Base Study Vaccination Period|Protocol Violation|0|||
105607126|NCT00092534|364224368|FG003|Base Study Vaccination Period|Protocol Violation|0|||
105607127|NCT00092534|364224369|FG004|Base Study Vaccination Period|Protocol Violation|0|||
105607128|NCT00092534|364224365|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
105607129|NCT00092534|364224366|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
105607130|NCT00092534|364224367|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
105607131|NCT00092534|364224368|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
105607132|NCT00092534|364224369|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
105607133|NCT00092534|364224365|FG000|Base Study Vaccination Period|Moved|14|||
105607134|NCT00092534|364224366|FG001|Base Study Vaccination Period|Moved|12|||
105607135|NCT00092534|364224367|FG002|Base Study Vaccination Period|Moved|0|||
105607136|NCT00092534|364224368|FG003|Base Study Vaccination Period|Moved|0|||
105607137|NCT00092534|364224369|FG004|Base Study Vaccination Period|Moved|0|||
105607138|NCT00092534|364224365|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
105607139|NCT00092534|364224366|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
105607140|NCT00092534|364224367|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
105607141|NCT00092534|364224368|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
105607142|NCT00092534|364224369|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
105607143|NCT00092534|364224365|FG000|Base Study Vaccination Period|Travel|1|||
105607144|NCT00092534|364224366|FG001|Base Study Vaccination Period|Travel|0|||
105607145|NCT00092534|364224367|FG002|Base Study Vaccination Period|Travel|0|||
105607146|NCT00092534|364224368|FG003|Base Study Vaccination Period|Travel|0|||
105607147|NCT00092534|364224369|FG004|Base Study Vaccination Period|Travel|0|||
105607148|NCT00092534|364224365|FG000|Base Study Vaccination Period|Site Closed|0|||
105607149|NCT00092534|364224366|FG001|Base Study Vaccination Period|Site Closed|1|||
105607150|NCT00092534|364224367|FG002|Base Study Vaccination Period|Site Closed|0|||
105607151|NCT00092534|364224368|FG003|Base Study Vaccination Period|Site Closed|0|||
105607152|NCT00092534|364224369|FG004|Base Study Vaccination Period|Site Closed|0|||
105607153|NCT00092534|364224365|FG000|Base Study Follow-Up Period|Adverse Event|2|||
105607154|NCT00092534|364224366|FG001|Base Study Follow-Up Period|Adverse Event|4|||
105607155|NCT00092534|364224367|FG002|Base Study Follow-Up Period|Adverse Event|0|||
105607156|NCT00092534|364224368|FG003|Base Study Follow-Up Period|Adverse Event|0|||
105607157|NCT00092534|364224369|FG004|Base Study Follow-Up Period|Adverse Event|0|||
105607158|NCT00092534|364224365|FG000|Base Study Follow-Up Period|Death|2|||
105607159|NCT00092534|364224366|FG001|Base Study Follow-Up Period|Death|1|||
105607160|NCT00092534|364224367|FG002|Base Study Follow-Up Period|Death|0|||
105607161|NCT00092534|364224368|FG003|Base Study Follow-Up Period|Death|0|||
105607162|NCT00092534|364224369|FG004|Base Study Follow-Up Period|Death|0|||
105607163|NCT00092534|364224365|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
105607164|NCT00092534|364224366|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
105607165|NCT00092534|364224367|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
105607166|NCT00092534|364224368|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
105607167|NCT00092534|364224369|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
105607168|NCT00092534|364224365|FG000|Base Study Follow-Up Period|Pregnancy|6|||
105607169|NCT00092534|364224366|FG001|Base Study Follow-Up Period|Pregnancy|10|||
105607170|NCT00092534|364224367|FG002|Base Study Follow-Up Period|Pregnancy|0|||
105607171|NCT00092534|364224368|FG003|Base Study Follow-Up Period|Pregnancy|0|||
105607172|NCT00092534|364224369|FG004|Base Study Follow-Up Period|Pregnancy|0|||
105607173|NCT00092534|364224365|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
105607174|NCT00092534|364224366|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
105607175|NCT00092534|364224367|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
105607176|NCT00092534|364224368|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
105607177|NCT00092534|364224369|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
105607178|NCT00092534|364224365|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
105607179|NCT00092534|364224366|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
105607180|NCT00092534|364224367|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
105607181|NCT00092534|364224368|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
105607182|NCT00092534|364224369|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
105607183|NCT00092534|364224365|FG000|Base Study Follow-Up Period|Moved|62|||
105607184|NCT00092534|364224366|FG001|Base Study Follow-Up Period|Moved|58|||
105607185|NCT00092534|364224367|FG002|Base Study Follow-Up Period|Moved|0|||
105607186|NCT00092534|364224368|FG003|Base Study Follow-Up Period|Moved|0|||
105607187|NCT00092534|364224369|FG004|Base Study Follow-Up Period|Moved|0|||
105607188|NCT00092534|364224365|FG000|Base Study Follow-Up Period|Travel|10|||
105607189|NCT00092534|364224366|FG001|Base Study Follow-Up Period|Travel|7|||
105607190|NCT00092534|364224367|FG002|Base Study Follow-Up Period|Travel|0|||
105607191|NCT00092534|364224368|FG003|Base Study Follow-Up Period|Travel|0|||
105607192|NCT00092534|364224369|FG004|Base Study Follow-Up Period|Travel|0|||
105607193|NCT00092534|364224365|FG000|Base Study Follow-Up Period|Site Closed|0|||
105607194|NCT00092534|364224366|FG001|Base Study Follow-Up Period|Site Closed|2|||
105607195|NCT00092534|364224367|FG002|Base Study Follow-Up Period|Site Closed|0|||
105607196|NCT00092534|364224368|FG003|Base Study Follow-Up Period|Site Closed|0|||
105607197|NCT00092534|364224369|FG004|Base Study Follow-Up Period|Site Closed|0|||
105607198|NCT00092534|364224365|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
105607199|NCT00092534|364224366|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
105607200|NCT00092534|364224367|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
105607201|NCT00092534|364224368|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
105607202|NCT00092534|364224369|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
105607203|NCT00092534|364224365|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
105607204|NCT00092534|364224366|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
105607205|NCT00092534|364224367|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
105607206|NCT00092534|364224368|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
105607207|NCT00092534|364224369|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
105607208|NCT00092534|364224365|FG000|Base Study EXT|Lost to Follow-up|0|||
105607209|NCT00092534|364224366|FG001|Base Study EXT|Lost to Follow-up|0|||
105607210|NCT00092534|364224367|FG002|Base Study EXT|Lost to Follow-up|41|||
105607211|NCT00092534|364224368|FG003|Base Study EXT|Lost to Follow-up|0|||
105607212|NCT00092534|364224369|FG004|Base Study EXT|Lost to Follow-up|0|||
105607213|NCT00092534|364224365|FG000|Base Study EXT|Physician Decision|0|||
105607214|NCT00092534|364224366|FG001|Base Study EXT|Physician Decision|0|||
105607215|NCT00092534|364224367|FG002|Base Study EXT|Physician Decision|1|||
105607216|NCT00092534|364224368|FG003|Base Study EXT|Physician Decision|0|||
105607217|NCT00092534|364224369|FG004|Base Study EXT|Physician Decision|0|||
105607218|NCT00092534|364224365|FG000|Base Study EXT|Pregnancy|0|||
105607219|NCT00092534|364224366|FG001|Base Study EXT|Pregnancy|0|||
105607220|NCT00092534|364224367|FG002|Base Study EXT|Pregnancy|12|||
105607221|NCT00092534|364224368|FG003|Base Study EXT|Pregnancy|0|||
105607222|NCT00092534|364224369|FG004|Base Study EXT|Pregnancy|0|||
105607223|NCT00092534|364224365|FG000|Base Study EXT|Withdrawal by Subject|0|||
105607224|NCT00092534|364224366|FG001|Base Study EXT|Withdrawal by Subject|0|||
105607225|NCT00092534|364224367|FG002|Base Study EXT|Withdrawal by Subject|18|||
105607226|NCT00092534|364224368|FG003|Base Study EXT|Withdrawal by Subject|0|||
105607227|NCT00092534|364224369|FG004|Base Study EXT|Withdrawal by Subject|0|||
105607228|NCT00092534|364224365|FG000|Base Study EXT|Participant moved|0|||
105607229|NCT00092534|364224366|FG001|Base Study EXT|Participant moved|0|||
105607230|NCT00092534|364224367|FG002|Base Study EXT|Participant moved|6|||
105607231|NCT00092534|364224368|FG003|Base Study EXT|Participant moved|0|||
105607232|NCT00092534|364224369|FG004|Base Study EXT|Participant moved|0|||
105607233|NCT00092534|364224365|FG000|Base Study EXT|Travel|0|||
105607234|NCT00092534|364224366|FG001|Base Study EXT|Travel|0|||
105607235|NCT00092534|364224367|FG002|Base Study EXT|Travel|2|||
105607236|NCT00092534|364224368|FG003|Base Study EXT|Travel|0|||
105607237|NCT00092534|364224369|FG004|Base Study EXT|Travel|0|||
105607238|NCT00092534|364224365|FG000|Base Study EXT|Site closed|0|||
105607239|NCT00092534|364224366|FG001|Base Study EXT|Site closed|0|||
105607240|NCT00092534|364224367|FG002|Base Study EXT|Site closed|21|||
105607241|NCT00092534|364224368|FG003|Base Study EXT|Site closed|0|||
105607242|NCT00092534|364224369|FG004|Base Study EXT|Site closed|0|||
105607243|NCT00092534|364224365|FG000|Base Study EXT|Study ended|0|||
105607244|NCT00092534|364224366|FG001|Base Study EXT|Study ended|0|||
105607245|NCT00092534|364224367|FG002|Base Study EXT|Study ended|29|||
105607246|NCT00092534|364224368|FG003|Base Study EXT|Study ended|0|||
105607247|NCT00092534|364224369|FG004|Base Study EXT|Study ended|0|||
105607248|NCT00092534|364224365|FG000|Base Study EXT|Protocol Violation|0|||
105607249|NCT00092534|364224366|FG001|Base Study EXT|Protocol Violation|0|||
105607250|NCT00092534|364224367|FG002|Base Study EXT|Protocol Violation|15|||
105607251|NCT00092534|364224368|FG003|Base Study EXT|Protocol Violation|0|||
105607252|NCT00092534|364224369|FG004|Base Study EXT|Protocol Violation|0|||
105607253|NCT00092534|364224365|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
105607254|NCT00092534|364224366|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
105607255|NCT00092534|364224367|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
105607256|NCT00092534|364224368|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
105607257|NCT00092534|364224369|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
105607258|NCT04065048|364224370|FG000|Overall Study|Withdrawal by Subject|1|||
105607259|NCT04065048|364224371|FG001|Overall Study|Withdrawal by Subject|2|||
105607260|NCT04065048|364224372|FG002|Overall Study|Withdrawal by Subject|1|||
105607261|NCT04065048|364224373|FG003|Overall Study|Withdrawal by Subject|1|||
105607262|NCT04065048|364224370|FG000|Overall Study|Adverse Event|1|||
105607263|NCT04065048|364224371|FG001|Overall Study|Adverse Event|0|||
105607264|NCT04065048|364224372|FG002|Overall Study|Adverse Event|1|||
105607265|NCT04065048|364224373|FG003|Overall Study|Adverse Event|0|||
105607266|NCT01998984|364224374|FG000|Overall Study|Adverse Event|0|||
105607267|NCT01998984|364224375|FG001|Overall Study|Adverse Event|0|||
105607268|NCT01998984|364224376|FG002|Overall Study|Adverse Event|0|||
105607269|NCT01998984|364224377|FG003|Overall Study|Adverse Event|1|||
105607270|NCT01998984|364224374|FG000|Overall Study|Lost to Follow-up|0|||
105607271|NCT01998984|364224375|FG001|Overall Study|Lost to Follow-up|1|||
105607272|NCT01998984|364224376|FG002|Overall Study|Lost to Follow-up|0|||
105607273|NCT01998984|364224377|FG003|Overall Study|Lost to Follow-up|1|||
105607274|NCT01998984|364224374|FG000|Overall Study|Withdrawal by Subject|0|||
105607275|NCT01998984|364224375|FG001|Overall Study|Withdrawal by Subject|0|||
105607276|NCT01998984|364224376|FG002|Overall Study|Withdrawal by Subject|1|||
105607277|NCT01998984|364224377|FG003|Overall Study|Withdrawal by Subject|0|||
105607278|NCT01998984|364224374|FG000|Overall Study|Other|0|||
105607279|NCT01998984|364224375|FG001|Overall Study|Other|0|||
105607280|NCT01998984|364224376|FG002|Overall Study|Other|0|||
105607281|NCT01998984|364224377|FG003|Overall Study|Other|1|||
105607282|NCT03845465|364224379|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
105607283|NCT03845465|364224380|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
105607284|NCT03845465|364224379|FG000|6-month Data Collection|Withdrawal by Subject|0|||
105607285|NCT03845465|364224380|FG001|6-month Data Collection|Withdrawal by Subject|2|||
105607286|NCT03845465|364224379|FG000|12-month Data Collection|Withdrawal by Subject|0|||
105607287|NCT03845465|364224380|FG001|12-month Data Collection|Withdrawal by Subject|2|||
105607288|NCT04907474|364224381|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
105607289|NCT04907474|364224382|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
105607290|NCT04714320|364224388|FG000|Overall Study|Voluntary Withdrawal|4|||
105607291|NCT04714320|364224389|FG001|Overall Study|Voluntary Withdrawal|1|||
105607292|NCT04714320|364224390|FG002|Overall Study|Voluntary Withdrawal|2|||
105607293|NCT04714320|364224388|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
105607294|NCT04714320|364224389|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
105607295|NCT04714320|364224390|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
105607296|NCT04714320|364224388|FG000|Overall Study|Reason Not Specified|1|||
105607297|NCT04714320|364224389|FG001|Overall Study|Reason Not Specified|3|||
105607298|NCT04714320|364224390|FG002|Overall Study|Reason Not Specified|3|||
105607299|NCT03299049|364224391|FG000|Overall Study|On-going|486|||
105607300|NCT03299049|364224392|FG001|Overall Study|On-going|481|||
105607301|NCT03299049|364224391|FG000|Overall Study|Withdrawal by Subject|6|||
105607302|NCT03299049|364224392|FG001|Overall Study|Withdrawal by Subject|21|||
105607303|NCT03299049|364224391|FG000|Overall Study|Physician Decision|5|||
105607304|NCT03299049|364224392|FG001|Overall Study|Physician Decision|1|||
105607305|NCT03299049|364224391|FG000|Overall Study|Lost to Follow-up|2|||
105607306|NCT03299049|364224392|FG001|Overall Study|Lost to Follow-up|0|||
105607307|NCT03299049|364224391|FG000|Overall Study|Pregnancy|1|||
105607308|NCT03299049|364224392|FG001|Overall Study|Pregnancy|3|||
105607309|NCT03299049|364224391|FG000|Overall Study|Protocol Violation|1|||
105607310|NCT03299049|364224392|FG001|Overall Study|Protocol Violation|1|||
105607311|NCT03299049|364224391|FG000|Overall Study|Lack of Efficacy|9|||
105607312|NCT03299049|364224392|FG001|Overall Study|Lack of Efficacy|3|||
105607313|NCT03299049|364224391|FG000|Overall Study|Adverse Event|12|||
105607314|NCT03299049|364224392|FG001|Overall Study|Adverse Event|13|||
105607315|NCT05369208|364224393|FG000|Core Phase|Prohibited Medication Required|2|||
105607316|NCT05369208|364224393|FG000|Core Phase|Adverse Event|1|||
105607317|NCT05369208|364224393|FG000|Core Phase|Lack of Efficacy|1|||
105607318|NCT04023526|364224394|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
105607319|NCT04023526|364224395|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
105607320|NCT04023526|364224394|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
105607321|NCT04023526|364224395|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
105607322|NCT05075408|364224396|FG000|Overall Study|Withdrawal by Subject|5|||
105607323|NCT05075408|364224397|FG001|Overall Study|Withdrawal by Subject|3|||
105607324|NCT05075408|364224398|FG002|Overall Study|Withdrawal by Subject|4|||
105607325|NCT05075408|364224396|FG000|Overall Study|Adverse Event|5|||
105607326|NCT05075408|364224397|FG001|Overall Study|Adverse Event|7|||
105607327|NCT05075408|364224398|FG002|Overall Study|Adverse Event|8|||
105607328|NCT05075408|364224396|FG000|Overall Study|Protocol Violation|0|||
105607329|NCT05075408|364224397|FG001|Overall Study|Protocol Violation|1|||
105607330|NCT05075408|364224398|FG002|Overall Study|Protocol Violation|0|||
105607331|NCT05075408|364224396|FG000|Overall Study|Lost to Follow-up|2|||
105607332|NCT05075408|364224397|FG001|Overall Study|Lost to Follow-up|1|||
105607333|NCT05075408|364224398|FG002|Overall Study|Lost to Follow-up|1|||
105607334|NCT05075408|364224396|FG000|Overall Study|Physician Decision|1|||
105607335|NCT05075408|364224397|FG001|Overall Study|Physician Decision|0|||
105607336|NCT05075408|364224398|FG002|Overall Study|Physician Decision|0|||
105607337|NCT05075408|364224396|FG000|Overall Study|Other-unspecified|3|||
105607338|NCT05075408|364224397|FG001|Overall Study|Other-unspecified|2|||
105607339|NCT05075408|364224398|FG002|Overall Study|Other-unspecified|0|||
105607340|NCT04540913|364224399|FG000|Overall Study|Withdrawal by Subject|14|||
105607341|NCT04540913|364224400|FG001|Overall Study|Withdrawal by Subject|3|||
105607342|NCT04468776|364224401|FG000|Overall Study|Lost to Follow-up|4|||
105607343|NCT04468776|364224402|FG001|Overall Study|Lost to Follow-up|3|||
105607344|NCT04468776|364224403|FG002|Overall Study|Lost to Follow-up|4|||
105607345|NCT04468776|364224401|FG000|Overall Study|Withdrawal by Subject|1|||
105607346|NCT04468776|364224402|FG001|Overall Study|Withdrawal by Subject|10|||
105607347|NCT04468776|364224403|FG002|Overall Study|Withdrawal by Subject|4|||
105607348|NCT04468776|364224401|FG000|Overall Study|Physician Decision|0|||
105607349|NCT04468776|364224402|FG001|Overall Study|Physician Decision|1|||
105607350|NCT04468776|364224403|FG002|Overall Study|Physician Decision|1|||
105607351|NCT05613205|364224404|FG000|Overall Study|Lost to Follow-up|0|||
105607352|NCT05613205|364224405|FG001|Overall Study|Lost to Follow-up|0|||
105607353|NCT05613205|364224406|FG002|Overall Study|Lost to Follow-up|1|||
105607354|NCT05613205|364224407|FG003|Overall Study|Lost to Follow-up|1|||
105607355|NCT05613205|364224408|FG004|Overall Study|Lost to Follow-up|0|||
105607356|NCT05613205|364224404|FG000|Overall Study|Withdrawal by Subject|0|||
105607357|NCT05613205|364224405|FG001|Overall Study|Withdrawal by Subject|0|||
105607358|NCT05613205|364224406|FG002|Overall Study|Withdrawal by Subject|1|||
105607359|NCT05613205|364224407|FG003|Overall Study|Withdrawal by Subject|1|||
105607360|NCT05613205|364224408|FG004|Overall Study|Withdrawal by Subject|0|||
105607361|NCT05338086|364224411|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
105607362|NCT05338086|364224412|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
105607363|NCT05338086|364224413|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
105607364|NCT05338086|364224414|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
105607365|NCT05338086|364224415|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
105607366|NCT05338086|364224411|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
105607367|NCT05338086|364224412|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
105607368|NCT05338086|364224413|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
105607369|NCT05338086|364224414|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
105607370|NCT05338086|364224415|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
105607371|NCT05338086|364224411|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
105607372|NCT05338086|364224412|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
105607373|NCT05338086|364224413|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
105607374|NCT05338086|364224414|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
105607375|NCT05338086|364224415|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
105607376|NCT05338086|364224411|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
105607377|NCT05338086|364224412|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
105607378|NCT05338086|364224413|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
105607379|NCT05338086|364224414|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
105607380|NCT05338086|364224415|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
105607381|NCT05338086|364224411|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
105607382|NCT05338086|364224412|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
105607383|NCT05338086|364224413|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
105607384|NCT05338086|364224414|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
105607385|NCT05338086|364224415|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
105607386|NCT05338086|364224411|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
105607387|NCT05338086|364224412|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
105607388|NCT05338086|364224413|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
105607389|NCT05338086|364224414|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
105607390|NCT05338086|364224415|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
105607391|NCT05338086|364224411|FG000|Transition Period (M12 to M18)|Death|0|||
105607392|NCT05338086|364224412|FG001|Transition Period (M12 to M18)|Death|0|||
105607393|NCT05338086|364224413|FG002|Transition Period (M12 to M18)|Death|1|||
105607394|NCT05338086|364224414|FG003|Transition Period (M12 to M18)|Death|0|||
105607395|NCT05338086|364224415|FG004|Transition Period (M12 to M18)|Death|0|||
105607396|NCT05338086|364224411|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
105607397|NCT05338086|364224412|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
105607398|NCT05338086|364224413|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
105607399|NCT05338086|364224414|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
105607400|NCT05338086|364224415|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
105607401|NCT05338086|364224411|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
105607402|NCT05338086|364224412|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
105607403|NCT05338086|364224413|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
105607404|NCT05338086|364224414|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
105607405|NCT05338086|364224415|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
105607406|NCT05338086|364224411|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
105607407|NCT05338086|364224412|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
105607408|NCT05338086|364224413|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
105607409|NCT05338086|364224414|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
105607410|NCT05338086|364224415|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
105607411|NCT04840199|364224416|FG000|Overall Study|Study Terminated by Sponsor|8|||
105607412|NCT04840199|364224417|FG001|Overall Study|Study Terminated by Sponsor|9|||
105607413|NCT04840199|364224416|FG000|Overall Study|Lost to Follow-up|0|||
105607414|NCT04840199|364224417|FG001|Overall Study|Lost to Follow-up|2|||
105607415|NCT04840199|364224416|FG000|Overall Study|Withdrawal by Subject|2|||
105607416|NCT04840199|364224417|FG001|Overall Study|Withdrawal by Subject|0|||
105607417|NCT04840199|364224416|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
105607418|NCT04840199|364224417|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
105607419|NCT04440176|364224418|FG000|Overall Study|Withdrawal by Subject|5|||
105607420|NCT04440176|364224419|FG001|Overall Study|Withdrawal by Subject|3|||
105607421|NCT04440176|364224418|FG000|Overall Study|Withdrawal by parent/guardian|4|||
105607422|NCT04440176|364224419|FG001|Overall Study|Withdrawal by parent/guardian|5|||
105607423|NCT04440176|364224418|FG000|Overall Study|Adverse Event|2|||
105607424|NCT04440176|364224419|FG001|Overall Study|Adverse Event|6|||
105607425|NCT04440176|364224418|FG000|Overall Study|Lost to Follow-up|22|||
105607426|NCT04440176|364224419|FG001|Overall Study|Lost to Follow-up|23|||
105607427|NCT04440176|364224418|FG000|Overall Study|Medication error without associated adverse event|0|||
105607428|NCT04440176|364224419|FG001|Overall Study|Medication error without associated adverse event|1|||
105607429|NCT04440176|364224418|FG000|Overall Study|No longer met eligibility criteria|7|||
105607430|NCT04440176|364224419|FG001|Overall Study|No longer met eligibility criteria|1|||
105607431|NCT04440176|364224418|FG000|Overall Study|Other|1|||
105607432|NCT04440176|364224419|FG001|Overall Study|Other|2|||
105607433|NCT04440176|364224418|FG000|Overall Study|Protocol deviation|6|||
105607434|NCT04440176|364224419|FG001|Overall Study|Protocol deviation|8|||
105607435|NCT04440176|364224418|FG000|Overall Study|Randomized but not vaccinated|6|||
105607436|NCT04440176|364224419|FG001|Overall Study|Randomized but not vaccinated|3|||
105607437|NCT03656562|364224431|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
105607438|NCT03656562|364224432|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
105607439|NCT03656562|364224433|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
105607440|NCT03656562|364224434|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
105607441|NCT03656562|364224431|FG000|Overall Study|Physician Decision|1|||
105607442|NCT03656562|364224432|FG001|Overall Study|Physician Decision|2|||
105607443|NCT03656562|364224433|FG002|Overall Study|Physician Decision|0|||
105607444|NCT03656562|364224434|FG003|Overall Study|Physician Decision|0|||
105607445|NCT03656562|364224431|FG000|Overall Study|Subject Decision|3|||
105607446|NCT03656562|364224432|FG001|Overall Study|Subject Decision|5|||
105607447|NCT03656562|364224433|FG002|Overall Study|Subject Decision|0|||
105607448|NCT03656562|364224434|FG003|Overall Study|Subject Decision|2|||
105607449|NCT04112316|364224435|FG000|First Period (8 Weeks)|Protocol Violation|1|||
105607450|NCT04112316|364224436|FG001|First Period (8 Weeks)|Protocol Violation|0|||
105607451|NCT04112316|364224435|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
105607452|NCT04112316|364224436|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
105607453|NCT05215847|364224437|FG000|Overall Study|Lost to Follow-up|1|||
105607454|NCT00409838|364224440|FG000|Short-term Period|Adverse Event|0|||
105607455|NCT00409838|364224441|FG001|Short-term Period|Adverse Event|1|||
105607456|NCT00409838|364224440|FG000|Short-term Period|Lost to Follow-up|0|||
105607457|NCT00409838|364224441|FG001|Short-term Period|Lost to Follow-up|1|||
105607458|NCT00409838|364224440|FG000|Short-term Period|Withdrawal by Subject|2|||
105607459|NCT00409838|364224441|FG001|Short-term Period|Withdrawal by Subject|3|||
105607460|NCT00409838|364224440|FG000|Short-term Period|Never Treated|1|||
105607461|NCT00409838|364224441|FG001|Short-term Period|Never Treated|0|||
105607462|NCT00409838|364224440|FG000|Long-term Extension Period|Adverse Event|10|||
105607463|NCT00409838|364224441|FG001|Long-term Extension Period|Adverse Event|0|||
105607464|NCT00409838|364224440|FG000|Long-term Extension Period|Death|1|||
105607465|NCT00409838|364224441|FG001|Long-term Extension Period|Death|0|||
105607466|NCT00409838|364224440|FG000|Long-term Extension Period|Lack of Efficacy|2|||
105607467|NCT00409838|364224441|FG001|Long-term Extension Period|Lack of Efficacy|0|||
105607468|NCT00409838|364224440|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
105607469|NCT00409838|364224441|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
105607470|NCT00409838|364224440|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
105607471|NCT00409838|364224441|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
105607472|NCT00409838|364224440|FG000|Long-term Extension Period|Pregnancy|1|||
105607473|NCT00409838|364224441|FG001|Long-term Extension Period|Pregnancy|0|||
105607474|NCT02006758|364224442|FG000|Overall Study|Protocol Violation|1|||
105607475|NCT02006758|364224442|FG000|Overall Study|Death|1|||
105607476|NCT02006758|364224442|FG000|Overall Study|Lost to Follow-up|4|||
105607477|NCT02006758|364224442|FG000|Overall Study|Withdrawal by Subject|4|||
105607478|NCT02006758|364224442|FG000|Overall Study|Procedurally excluded|1|||
105607479|NCT02006758|364224442|FG000|Overall Study|Other|2|||
105607480|NCT03283371|364224444|FG000|Placebo-controlled|Adverse Event|1|||
105607481|NCT03283371|364224445|FG001|Placebo-controlled|Adverse Event|1|||
105607482|NCT03283371|364224446|FG002|Placebo-controlled|Adverse Event|0|||
105607483|NCT03283371|364224447|FG003|Placebo-controlled|Adverse Event|0|||
105607484|NCT03283371|364224444|FG000|Placebo-controlled|Lack of Efficacy|1|||
105607485|NCT03283371|364224445|FG001|Placebo-controlled|Lack of Efficacy|0|||
105607486|NCT03283371|364224446|FG002|Placebo-controlled|Lack of Efficacy|0|||
105607487|NCT03283371|364224447|FG003|Placebo-controlled|Lack of Efficacy|0|||
105607488|NCT03283371|364224444|FG000|Placebo-controlled|Withdrawal by Subject|1|||
105607489|NCT03283371|364224445|FG001|Placebo-controlled|Withdrawal by Subject|1|||
105607490|NCT03283371|364224446|FG002|Placebo-controlled|Withdrawal by Subject|0|||
105607491|NCT03283371|364224447|FG003|Placebo-controlled|Withdrawal by Subject|0|||
105607492|NCT03283371|364224444|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
105607493|NCT03283371|364224445|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
105607494|NCT03283371|364224446|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
105607495|NCT03283371|364224447|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
105607496|NCT03283371|364224444|FG000|Open-label Phase|Adverse Event|0|||
105607497|NCT03283371|364224445|FG001|Open-label Phase|Adverse Event|0|||
105607498|NCT03283371|364224446|FG002|Open-label Phase|Adverse Event|2|||
105607499|NCT03283371|364224447|FG003|Open-label Phase|Adverse Event|0|||
105607500|NCT03283371|364224444|FG000|Open-label Phase|Withdrawal by Subject|0|||
105607501|NCT03283371|364224445|FG001|Open-label Phase|Withdrawal by Subject|0|||
105607502|NCT03283371|364224446|FG002|Open-label Phase|Withdrawal by Subject|1|||
105607503|NCT03283371|364224447|FG003|Open-label Phase|Withdrawal by Subject|0|||
105607504|NCT03283371|364224444|FG000|Open-label Phase|Other|0|||
105607505|NCT03283371|364224445|FG001|Open-label Phase|Other|0|||
105607506|NCT03283371|364224446|FG002|Open-label Phase|Other|1|||
105607507|NCT03283371|364224447|FG003|Open-label Phase|Other|1|||
105607508|NCT04600752|364224448|FG000|Overall Study|Physician Decision|0|||
105607509|NCT04600752|364224449|FG001|Overall Study|Physician Decision|0|||
105607510|NCT04600752|364224450|FG002|Overall Study|Physician Decision|1|||
105607511|NCT04600752|364224448|FG000|Overall Study|Adverse Event|0|||
105607512|NCT04600752|364224449|FG001|Overall Study|Adverse Event|1|||
105607513|NCT04600752|364224450|FG002|Overall Study|Adverse Event|0|||
105607514|NCT04600752|364224448|FG000|Overall Study|Withdrawal by Subject|2|||
105607515|NCT04600752|364224449|FG001|Overall Study|Withdrawal by Subject|1|||
105607516|NCT04600752|364224450|FG002|Overall Study|Withdrawal by Subject|0|||
105607517|NCT04600752|364224448|FG000|Overall Study|Lack of Efficacy|1|||
105607518|NCT04600752|364224449|FG001|Overall Study|Lack of Efficacy|0|||
105607519|NCT04600752|364224450|FG002|Overall Study|Lack of Efficacy|0|||
105607520|NCT00632203|364224453|FG000|Overall Study|Did not start study treatment|1|||
105607521|NCT00632203|364224454|FG001|Overall Study|Did not start study treatment|0|||
105607522|NCT00448669|364224464|FG000|Overall Study|Lost to Follow-up|52|||
105607523|NCT00448669|364224465|FG001|Overall Study|Lost to Follow-up|63|||
105607524|NCT00448669|364224464|FG000|Overall Study|Withdrawal by Subject|90|||
105607525|NCT00448669|364224465|FG001|Overall Study|Withdrawal by Subject|74|||
105607526|NCT00448669|364224464|FG000|Overall Study|Relocated|49|||
105607527|NCT00448669|364224465|FG001|Overall Study|Relocated|36|||
105607528|NCT00448669|364224464|FG000|Overall Study|Were withdrawn by investigator|10|||
105607529|NCT00448669|364224465|FG001|Overall Study|Were withdrawn by investigator|6|||
105607530|NCT00448669|364224464|FG000|Overall Study|Death|2|||
105607531|NCT00448669|364224465|FG001|Overall Study|Death|4|||
105607532|NCT00448669|364224464|FG000|Overall Study|Had other reasons|5|||
105607533|NCT00448669|364224465|FG001|Overall Study|Had other reasons|6|||
105607534|NCT00448669|364224464|FG000|Overall Study|HIV-infected at enrollment|1|||
105607535|NCT00448669|364224465|FG001|Overall Study|HIV-infected at enrollment|2|||
105607536|NCT00448669|364224464|FG000|Overall Study|Never started drug|9|||
105607537|NCT00448669|364224465|FG001|Overall Study|Never started drug|7|||
105607538|NCT03771352|364224469|FG000|Overall Study|Screen failure|2|||
105607539|NCT03771352|364224469|FG000|Overall Study|Withdrawal by Subject|2|||
105607540|NCT03338816|364224470|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
105607541|NCT03338816|364224471|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
105607542|NCT03338816|364224472|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
105607543|NCT03338816|364224473|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
105607544|NCT03338816|364224470|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
105607545|NCT03338816|364224471|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
105607546|NCT03338816|364224472|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
105607547|NCT03338816|364224473|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
105607548|NCT03338816|364224470|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
105607549|NCT03338816|364224471|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
105607550|NCT03338816|364224472|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
105607551|NCT03338816|364224473|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
105607552|NCT03338816|364224470|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
105607553|NCT03338816|364224471|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
105607554|NCT03338816|364224472|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
105607555|NCT03338816|364224473|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
105607556|NCT03338816|364224470|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
105607557|NCT03338816|364224471|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
105607558|NCT03338816|364224472|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
105607559|NCT03338816|364224473|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
105607560|NCT03338816|364224470|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
105607561|NCT03338816|364224471|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
105607562|NCT03338816|364224472|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
105607563|NCT03338816|364224473|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
105607564|NCT03338816|364224470|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
105607565|NCT03338816|364224471|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
105607566|NCT03338816|364224472|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
105607567|NCT03338816|364224473|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
105607568|NCT04238247|364224474|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
105607569|NCT04238247|364224475|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
105607570|NCT04238247|364224476|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
105607571|NCT04238247|364224477|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
105607572|NCT04238247|364224474|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
105607573|NCT04238247|364224475|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
105607574|NCT04238247|364224476|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
105607575|NCT04238247|364224477|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
105607576|NCT04238247|364224474|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
105607577|NCT04238247|364224475|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
105607578|NCT04238247|364224476|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
105607579|NCT04238247|364224477|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
105607580|NCT04238247|364224474|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
105607581|NCT04238247|364224475|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
105607582|NCT04238247|364224476|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
105607583|NCT04238247|364224477|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
105607584|NCT03092726|364224478|FG000|Overall Study|Adverse Event|3|||
105607585|NCT03092726|364224479|FG001|Overall Study|Adverse Event|10|||
105607586|NCT03092726|364224478|FG000|Overall Study|Lack of Efficacy|0|||
105607587|NCT03092726|364224479|FG001|Overall Study|Lack of Efficacy|1|||
105607588|NCT03092726|364224478|FG000|Overall Study|Lost to Follow-up|1|||
105607589|NCT03092726|364224479|FG001|Overall Study|Lost to Follow-up|0|||
105607590|NCT03092726|364224478|FG000|Overall Study|Withdrawal by Subject|5|||
105607591|NCT03092726|364224479|FG001|Overall Study|Withdrawal by Subject|3|||
105607592|NCT01948661|364224480|FG000|Overall Study|Withdrawal by Subject|2|||
105607593|NCT01948661|364224481|FG001|Overall Study|Withdrawal by Subject|4|||
105607594|NCT00632749|364224482|FG000|Overall Study|Progressive disease|3|||
105607595|NCT00632749|364224483|FG001|Overall Study|Progressive disease|2|||
105607596|NCT00632749|364224484|FG002|Overall Study|Progressive disease|2|||
105607597|NCT00632749|364224485|FG003|Overall Study|Progressive disease|2|||
105607598|NCT00632749|364224486|FG004|Overall Study|Progressive disease|4|||
105607599|NCT00632749|364224487|FG005|Overall Study|Progressive disease|4|||
105607600|NCT00632749|364224488|FG006|Overall Study|Progressive disease|3|||
105607601|NCT00632749|364224489|FG007|Overall Study|Progressive disease|2|||
105607602|NCT00632749|364224490|FG008|Overall Study|Progressive disease|3|||
105607603|NCT00632749|364224491|FG009|Overall Study|Progressive disease|2|||
105607604|NCT00632749|364224492|FG010|Overall Study|Progressive disease|4|||
105607605|NCT00632749|364224493|FG011|Overall Study|Progressive disease|3|||
105607606|NCT00632749|364224494|FG012|Overall Study|Progressive disease|2|||
105607607|NCT00632749|364224495|FG013|Overall Study|Progressive disease|4|||
105607608|NCT00632749|364224482|FG000|Overall Study|Other Adverse event|1|||
105607609|NCT00632749|364224483|FG001|Overall Study|Other Adverse event|1|||
105607610|NCT00632749|364224484|FG002|Overall Study|Other Adverse event|1|||
105607611|NCT00632749|364224485|FG003|Overall Study|Other Adverse event|1|||
105607612|NCT00632749|364224486|FG004|Overall Study|Other Adverse event|2|||
105607613|NCT00632749|364224487|FG005|Overall Study|Other Adverse event|4|||
105607614|NCT00632749|364224488|FG006|Overall Study|Other Adverse event|1|||
105607615|NCT00632749|364224489|FG007|Overall Study|Other Adverse event|2|||
105607616|NCT00632749|364224490|FG008|Overall Study|Other Adverse event|2|||
105607617|NCT00632749|364224491|FG009|Overall Study|Other Adverse event|0|||
105607618|NCT00632749|364224492|FG010|Overall Study|Other Adverse event|1|||
105607619|NCT00632749|364224493|FG011|Overall Study|Other Adverse event|0|||
105607620|NCT00632749|364224494|FG012|Overall Study|Other Adverse event|1|||
105607621|NCT00632749|364224495|FG013|Overall Study|Other Adverse event|0|||
105607622|NCT00632749|364224482|FG000|Overall Study|Refuse to continue medication|0|||
105607623|NCT00632749|364224483|FG001|Overall Study|Refuse to continue medication|0|||
105607624|NCT00632749|364224484|FG002|Overall Study|Refuse to continue medication|0|||
105607625|NCT00632749|364224485|FG003|Overall Study|Refuse to continue medication|1|||
105607626|NCT00632749|364224486|FG004|Overall Study|Refuse to continue medication|0|||
105607627|NCT00632749|364224487|FG005|Overall Study|Refuse to continue medication|0|||
105607628|NCT00632749|364224488|FG006|Overall Study|Refuse to continue medication|0|||
105607629|NCT00632749|364224489|FG007|Overall Study|Refuse to continue medication|0|||
105607630|NCT00632749|364224490|FG008|Overall Study|Refuse to continue medication|0|||
105607631|NCT00632749|364224491|FG009|Overall Study|Refuse to continue medication|1|||
105607632|NCT00632749|364224492|FG010|Overall Study|Refuse to continue medication|0|||
105607633|NCT00632749|364224493|FG011|Overall Study|Refuse to continue medication|0|||
105607634|NCT00632749|364224494|FG012|Overall Study|Refuse to continue medication|0|||
105607635|NCT00632749|364224495|FG013|Overall Study|Refuse to continue medication|0|||
105607636|NCT00632749|364224482|FG000|Overall Study|Reason other than those specified above|0|||
105607637|NCT00632749|364224483|FG001|Overall Study|Reason other than those specified above|2|||
105607638|NCT00632749|364224484|FG002|Overall Study|Reason other than those specified above|0|||
105607639|NCT00632749|364224485|FG003|Overall Study|Reason other than those specified above|0|||
105607640|NCT00632749|364224486|FG004|Overall Study|Reason other than those specified above|1|||
105607641|NCT00632749|364224487|FG005|Overall Study|Reason other than those specified above|0|||
105607642|NCT00632749|364224488|FG006|Overall Study|Reason other than those specified above|1|||
105607643|NCT00632749|364224489|FG007|Overall Study|Reason other than those specified above|0|||
105607644|NCT00632749|364224490|FG008|Overall Study|Reason other than those specified above|0|||
105607645|NCT00632749|364224491|FG009|Overall Study|Reason other than those specified above|0|||
105607646|NCT00632749|364224492|FG010|Overall Study|Reason other than those specified above|2|||
105607647|NCT00632749|364224493|FG011|Overall Study|Reason other than those specified above|1|||
105607648|NCT00632749|364224494|FG012|Overall Study|Reason other than those specified above|0|||
105607649|NCT00632749|364224495|FG013|Overall Study|Reason other than those specified above|2|||
105607650|NCT04218266|364224496|FG000|Overall Study|Death|1|||
105607651|NCT04218266|364224497|FG001|Overall Study|Death|2|||
105607652|NCT04218266|364224498|FG002|Overall Study|Death|3|||
105607653|NCT04218266|364224496|FG000|Overall Study|Adverse Event|13|||
105607654|NCT04218266|364224497|FG001|Overall Study|Adverse Event|14|||
105607655|NCT04218266|364224498|FG002|Overall Study|Adverse Event|11|||
105607656|NCT04218266|364224496|FG000|Overall Study|Other|7|||
105607657|NCT04218266|364224497|FG001|Overall Study|Other|5|||
105607658|NCT04218266|364224498|FG002|Overall Study|Other|14|||
105607659|NCT04218266|364224496|FG000|Overall Study|Physician Decision|1|||
105607660|NCT04218266|364224497|FG001|Overall Study|Physician Decision|3|||
105607661|NCT04218266|364224498|FG002|Overall Study|Physician Decision|2|||
105607662|NCT04218266|364224496|FG000|Overall Study|Non-compliance with study drug|0|||
105607663|NCT04218266|364224497|FG001|Overall Study|Non-compliance with study drug|0|||
105607664|NCT04218266|364224498|FG002|Overall Study|Non-compliance with study drug|1|||
105607665|NCT04218266|364224496|FG000|Overall Study|Withdrawal by Subject|1|||
105607666|NCT04218266|364224497|FG001|Overall Study|Withdrawal by Subject|3|||
105607667|NCT04218266|364224498|FG002|Overall Study|Withdrawal by Subject|1|||
105607668|NCT04218266|364224496|FG000|Overall Study|Study drug never administered|2|||
105607669|NCT04218266|364224497|FG001|Overall Study|Study drug never administered|0|||
105607670|NCT04218266|364224498|FG002|Overall Study|Study drug never administered|0|||
105607671|NCT04820686|364224501|FG000|Overall Study|Withdrawal by Subject|5|||
105607672|NCT04820686|364224502|FG001|Overall Study|Withdrawal by Subject|2|||
105607673|NCT04820686|364224503|FG002|Overall Study|Withdrawal by Subject|3|||
105607674|NCT04820686|364224501|FG000|Overall Study|Study Termination|25|||
105607675|NCT04820686|364224502|FG001|Overall Study|Study Termination|13|||
105607676|NCT04820686|364224503|FG002|Overall Study|Study Termination|14|||
105607677|NCT04820686|364224501|FG000|Overall Study|Adverse Event|0|||
105607678|NCT04820686|364224502|FG001|Overall Study|Adverse Event|1|||
105607679|NCT04820686|364224503|FG002|Overall Study|Adverse Event|0|||
105607680|NCT05134337|364226220|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
105607681|NCT05134337|364226221|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
105607682|NCT05478525|364226227|FG000|Overall Study|Withdrawal by Subject|0|||
105607683|NCT05478525|364226228|FG001|Overall Study|Withdrawal by Subject|1|||
105607684|NCT05478525|364226229|FG002|Overall Study|Withdrawal by Subject|2|||
105607685|NCT05478525|364226230|FG003|Overall Study|Withdrawal by Subject|0|||
105607686|NCT05478525|364226227|FG000|Overall Study|COVID-19 Infection|2|||
105607687|NCT05478525|364226228|FG001|Overall Study|COVID-19 Infection|0|||
105607688|NCT05478525|364226229|FG002|Overall Study|COVID-19 Infection|1|||
105607689|NCT05478525|364226230|FG003|Overall Study|COVID-19 Infection|1|||
105607690|NCT00410761|364226231|FG000|Overall Study|Adverse Event|29|||
105607691|NCT00410761|364226232|FG001|Overall Study|Adverse Event|3|||
105607692|NCT00410761|364226231|FG000|Overall Study|objective disease progression|71|||
105607693|NCT00410761|364226232|FG001|Overall Study|objective disease progression|55|||
105607694|NCT00410761|364226231|FG000|Overall Study|Withdrawal by Subject|8|||
105607695|NCT00410761|364226232|FG001|Overall Study|Withdrawal by Subject|4|||
105607696|NCT00410761|364226231|FG000|Overall Study|Other|12|||
105607697|NCT00410761|364226232|FG001|Overall Study|Other|9|||
105607698|NCT00410761|364226231|FG000|Overall Study|Never received randomised treatment|0|||
105607699|NCT00410761|364226232|FG001|Overall Study|Never received randomised treatment|1|||
105607700|NCT05104697|364226233|FG000|Overall Study|Withdrawal by Subject|0|||
105607701|NCT05104697|364226234|FG001|Overall Study|Withdrawal by Subject|1|||
105607702|NCT05056246|364226235|FG000|Overall Study|Adverse Event|0|||
105607703|NCT05056246|364226236|FG001|Overall Study|Adverse Event|0|||
105607704|NCT05056246|364226237|FG002|Overall Study|Adverse Event|0|||
105607705|NCT05056246|364226238|FG003|Overall Study|Adverse Event|0|||
105607706|NCT05056246|364226239|FG004|Overall Study|Adverse Event|1|||
105607707|NCT05056246|364226235|FG000|Overall Study|Lost to Follow-up|0|||
105607708|NCT05056246|364226236|FG001|Overall Study|Lost to Follow-up|0|||
105607709|NCT05056246|364226237|FG002|Overall Study|Lost to Follow-up|0|||
105607710|NCT05056246|364226238|FG003|Overall Study|Lost to Follow-up|2|||
105607711|NCT05056246|364226239|FG004|Overall Study|Lost to Follow-up|0|||
105607712|NCT05056246|364226235|FG000|Overall Study|Withdrawal by Subject|0|||
105607713|NCT05056246|364226236|FG001|Overall Study|Withdrawal by Subject|1|||
105607714|NCT05056246|364226237|FG002|Overall Study|Withdrawal by Subject|0|||
105607715|NCT05056246|364226238|FG003|Overall Study|Withdrawal by Subject|0|||
105607716|NCT05056246|364226239|FG004|Overall Study|Withdrawal by Subject|0|||
105607717|NCT05386238|364226240|FG000|Overall Study|Lost to Follow-up|3|||
105607718|NCT05386238|364226241|FG001|Overall Study|Lost to Follow-up|2|||
105607719|NCT05386238|364226240|FG000|Overall Study|Withdrawal by Subject|0|||
105607720|NCT05386238|364226241|FG001|Overall Study|Withdrawal by Subject|1|||
105607721|NCT03899961|364226242|FG000|Overall Study|-delivery prior to|2|||
105607722|NCT03899961|364226243|FG001|Overall Study|-delivery prior to|7|||
105607723|NCT03899961|364226242|FG000|Overall Study|req general anesth|1|||
105607724|NCT03899961|364226243|FG001|Overall Study|req general anesth|2|||
105607725|NCT03899961|364226242|FG000|Overall Study|capacity|5|||
105607726|NCT03899961|364226243|FG001|Overall Study|capacity|6|||
105607727|NCT03899961|364226242|FG000|Overall Study|Withdrawal by Subject|1|||
105607728|NCT03899961|364226243|FG001|Overall Study|Withdrawal by Subject|1|||
105607729|NCT03324984|364226250|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
105607730|NCT03324984|364226251|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
105607731|NCT02152137|364226259|FG000|Overall Study|Withdrawal by Subject|1|||
105607732|NCT02152137|364226259|FG000|Overall Study|Originally assigned to Arm B|3|||
105607733|NCT01903811|364226266|FG000|Overall Study|No measurable disease|1|||
105607734|NCT01903811|364226267|FG001|Overall Study|No measurable disease|1|||
105607735|NCT01903811|364226266|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
105607736|NCT01903811|364226267|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
105607737|NCT01903811|364226266|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
105607738|NCT01903811|364226267|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
105607739|NCT01903811|364226266|FG000|Overall Study|Withdrawal by Subject|0|||
105607740|NCT01903811|364226267|FG001|Overall Study|Withdrawal by Subject|1|||
105607741|NCT00979576|364226273|FG000|Combination Treatment Phase|Progressive disease|3|||
105607742|NCT00979576|364226274|FG001|Combination Treatment Phase|Progressive disease|1|||
105607743|NCT00979576|364226275|FG002|Combination Treatment Phase|Progressive disease|5|||
105607744|NCT00979576|364226273|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
105607745|NCT00979576|364226274|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
105607746|NCT00979576|364226275|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
105607747|NCT00979576|364226273|FG000|Combination Treatment Phase|Adverse Event|0|||
105607748|NCT00979576|364226274|FG001|Combination Treatment Phase|Adverse Event|2|||
105607749|NCT00979576|364226275|FG002|Combination Treatment Phase|Adverse Event|2|||
105607750|NCT00979576|364226273|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
105607751|NCT00979576|364226274|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
105607752|NCT00979576|364226275|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
105607753|NCT03575052|364226279|FG000|Overall Study|Adverse Event|6|||
105607754|NCT03575052|364226280|FG001|Overall Study|Adverse Event|10|||
105607755|NCT03575052|364226279|FG000|Overall Study|Not further specified|5|||
105607756|NCT03575052|364226280|FG001|Overall Study|Not further specified|7|||
105607757|NCT03575052|364226279|FG000|Overall Study|Withdrawal by Subject|5|||
105607758|NCT03575052|364226280|FG001|Overall Study|Withdrawal by Subject|6|||
105607759|NCT03575052|364226279|FG000|Overall Study|Lost to Follow-up|3|||
105607760|NCT03575052|364226280|FG001|Overall Study|Lost to Follow-up|0|||
105607761|NCT03575052|364226279|FG000|Overall Study|Death|2|||
105607762|NCT03575052|364226280|FG001|Overall Study|Death|1|||
105607763|NCT03575052|364226279|FG000|Overall Study|Lack of Efficacy|2|||
105607764|NCT03575052|364226280|FG001|Overall Study|Lack of Efficacy|1|||
105607765|NCT03575052|364226279|FG000|Overall Study|Study drug noncompliance|1|||
105607766|NCT03575052|364226280|FG001|Overall Study|Study drug noncompliance|2|||
105607767|NCT03575052|364226279|FG000|Overall Study|Protocol Violation|0|||
105607768|NCT03575052|364226280|FG001|Overall Study|Protocol Violation|2|||
105607769|NCT03575052|364226279|FG000|Overall Study|Physician Decision|1|||
105607770|NCT03575052|364226280|FG001|Overall Study|Physician Decision|0|||
105607771|NCT03271151|364226281|FG000|Overall Study|Lost to Follow-up|1|||
105607772|NCT03271151|364226282|FG001|Overall Study|Lost to Follow-up|3|||
105607773|NCT03271151|364226281|FG000|Overall Study|Withdrawal by Subject|1|||
105607774|NCT03271151|364226282|FG001|Overall Study|Withdrawal by Subject|0|||
105607775|NCT04093362|364226283|FG000|Overall Study|Study Termination|1|||
105607776|NCT04093362|364226284|FG001|Overall Study|Study Termination|1|||
105607777|NCT04093362|364226283|FG000|Overall Study|Withdrawal of Consent|1|||
105607778|NCT04093362|364226284|FG001|Overall Study|Withdrawal of Consent|0|||
105607779|NCT04093362|364226283|FG000|Overall Study|Death|1|||
105607780|NCT04093362|364226284|FG001|Overall Study|Death|3|||
105607781|NCT04093362|364226283|FG000|Overall Study|Reason not Specified|1|||
105607782|NCT04093362|364226284|FG001|Overall Study|Reason not Specified|2|||
105607783|NCT00753090|364226287|FG000|Overall Study|Withdrawal by Subject|10|||
105607784|NCT00753090|364226288|FG001|Overall Study|Withdrawal by Subject|10|||
105607785|NCT00753090|364226287|FG000|Overall Study|Death|17|||
105607786|NCT00753090|364226288|FG001|Overall Study|Death|6|||
105607787|NCT00753090|364226287|FG000|Overall Study|Study Prosthesis Removed|12|||
105607788|NCT00753090|364226288|FG001|Overall Study|Study Prosthesis Removed|3|||
105607789|NCT00753090|364226287|FG000|Overall Study|Lost to Follow-up|2|||
105607790|NCT00753090|364226288|FG001|Overall Study|Lost to Follow-up|2|||
105607791|NCT00753090|364226287|FG000|Overall Study|Other|127|||
105607792|NCT00753090|364226288|FG001|Overall Study|Other|75|||
105607793|NCT02201108|364226289|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
105607794|NCT02201108|364226290|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
105607795|NCT02201108|364226291|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
105607796|NCT02201108|364226289|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
105607797|NCT02201108|364226290|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
105607798|NCT02201108|364226291|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
105607799|NCT02201108|364226289|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
105607800|NCT02201108|364226290|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
105607801|NCT02201108|364226291|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
105607802|NCT02201108|364226289|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
105607803|NCT02201108|364226290|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
105607804|NCT02201108|364226291|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
105607805|NCT02201108|364226289|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
105607806|NCT02201108|364226290|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
105607807|NCT02201108|364226291|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
105607808|NCT02201108|364226289|FG000|Open Label Period (up to Week 192)|Other reason|4|||
105607809|NCT02201108|364226290|FG001|Open Label Period (up to Week 192)|Other reason|7|||
105607810|NCT02201108|364226291|FG002|Open Label Period (up to Week 192)|Other reason|0|||
105607811|NCT02201108|364226289|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
105607812|NCT02201108|364226290|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
105607813|NCT02201108|364226291|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
105607814|NCT02201108|364226289|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
105607815|NCT02201108|364226290|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
105607816|NCT02201108|364226291|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
105607817|NCT02201108|364226289|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
105607818|NCT02201108|364226290|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
105607819|NCT02201108|364226291|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
105607820|NCT04118452|364226301|FG000|Overall Study|Lost to Follow-up|5|||
105607821|NCT04118452|364226302|FG001|Overall Study|Lost to Follow-up|5|||
105607822|NCT04118452|364226301|FG000|Overall Study|Withdrawal by Subject|17|||
105607823|NCT04118452|364226302|FG001|Overall Study|Withdrawal by Subject|17|||
105607824|NCT04934722|364226303|FG000|Overall Study|Death|4|||
105607825|NCT04934722|364226304|FG001|Overall Study|Death|3|||
105607826|NCT04934722|364226303|FG000|Overall Study|Participants Ongoing|88|||
105607827|NCT04934722|364226304|FG001|Overall Study|Participants Ongoing|91|||
105607828|NCT04847999|364226305|FG000|Overall Study|Lost to Follow-up|0|||
105607829|NCT04847999|364226306|FG001|Overall Study|Lost to Follow-up|1|||
105607830|NCT02879448|364226307|FG000|Overall Study|Death|251|||
105607831|NCT02879448|364226308|FG001|Overall Study|Death|263|||
105607832|NCT02879448|364226307|FG000|Overall Study|Lost to Follow-up|23|||
105607833|NCT02879448|364226308|FG001|Overall Study|Lost to Follow-up|28|||
105607834|NCT02879448|364226307|FG000|Overall Study|Withdrawal by Subject|42|||
105607835|NCT02879448|364226308|FG001|Overall Study|Withdrawal by Subject|79|||
105607836|NCT02879448|364226307|FG000|Overall Study|Other Reasons|8|||
105607837|NCT02879448|364226308|FG001|Overall Study|Other Reasons|12|||
105607838|NCT03433339|364226309|FG000|Overall Study|Lost to Follow-up|2|||
105607839|NCT03433339|364226310|FG001|Overall Study|Lost to Follow-up|0|||
105607840|NCT03433339|364226309|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
105607841|NCT03433339|364226310|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
105607842|NCT03433339|364226309|FG000|Overall Study|Withdrawal by Subject|0|||
105607843|NCT03433339|364226310|FG001|Overall Study|Withdrawal by Subject|2|||
105607844|NCT05952076|364226312|FG000|Overall Study|Death|1|||
105607845|NCT05952076|364226313|FG001|Overall Study|Death|1|||
105607846|NCT05952076|364226312|FG000|Overall Study|Lost to Follow-up|0|||
105607847|NCT05952076|364226313|FG001|Overall Study|Lost to Follow-up|1|||
105607848|NCT05086744|364226333|FG000|Part A|Adverse Event|0|||
105607849|NCT05086744|364226334|FG001|Part A|Adverse Event|1|||
105607850|NCT05086744|364226333|FG000|Part A|Lack of Efficacy|3|||
105607851|NCT05086744|364226334|FG001|Part A|Lack of Efficacy|0|||
105607852|NCT05086744|364226333|FG000|Part A|Protocol deviation|1|||
105607853|NCT05086744|364226334|FG001|Part A|Protocol deviation|0|||
105607854|NCT05086744|364226333|FG000|Part A|Subject decision|1|||
105607855|NCT05086744|364226334|FG001|Part A|Subject decision|0|||
105607856|NCT05086744|364226333|FG000|Part B|Adverse Event|0|||
105607857|NCT05086744|364226334|FG001|Part B|Adverse Event|1|||
105607858|NCT05086744|364226333|FG000|Part B|Lack of Efficacy|0|||
105607859|NCT05086744|364226334|FG001|Part B|Lack of Efficacy|1|||
105607860|NCT05086744|364226333|FG000|Part B|Study terminated by sponsor|1|||
105607861|NCT05086744|364226334|FG001|Part B|Study terminated by sponsor|6|||
105607862|NCT05415436|364226335|FG000|Overall Study|Surgeon cancelled procedure|1|||
105607863|NCT05415436|364226336|FG001|Overall Study|Surgeon cancelled procedure|0|||
105607864|NCT05415436|364226335|FG000|Overall Study|Death|1|||
105607865|NCT05415436|364226336|FG001|Overall Study|Death|0|||
105607866|NCT04300231|364226337|FG000|Overall Study|Protocol Violation|4|||
105607867|NCT04300231|364226338|FG001|Overall Study|Protocol Violation|3|||
105607868|NCT04300231|364226339|FG002|Overall Study|Protocol Violation|0|||
105607869|NCT04300231|364226340|FG003|Overall Study|Protocol Violation|2|||
105607870|NCT03775109|364226341|FG000|Overall Study|Adverse Event|1|||
105607871|NCT03775109|364226342|FG001|Overall Study|Adverse Event|0|||
105607872|NCT03775109|364226341|FG000|Overall Study|COVID-19 outbreak|2|||
105607873|NCT03775109|364226342|FG001|Overall Study|COVID-19 outbreak|0|||
105607874|NCT03775109|364226341|FG000|Overall Study|Lost to Follow-up|0|||
105607875|NCT03775109|364226342|FG001|Overall Study|Lost to Follow-up|2|||
105607876|NCT03775109|364226341|FG000|Overall Study|Withdrawal by Subject|1|||
105607877|NCT03775109|364226342|FG001|Overall Study|Withdrawal by Subject|1|||
105607878|NCT03775109|364226341|FG000|Overall Study|Death|0|||
105607879|NCT03775109|364226342|FG001|Overall Study|Death|1|||
105607880|NCT03775109|364226341|FG000|Overall Study|Lack of Efficacy|1|||
105607881|NCT03775109|364226342|FG001|Overall Study|Lack of Efficacy|0|||
105607882|NCT04823611|364226343|FG000|Overall Study|Adverse Event|2|||
105607883|NCT04823611|364226344|FG001|Overall Study|Adverse Event|0|||
105607884|NCT04823611|364226345|FG002|Overall Study|Adverse Event|1|||
105607885|NCT04823611|364226346|FG003|Overall Study|Adverse Event|0|||
105607886|NCT04823611|364226347|FG004|Overall Study|Adverse Event|0|||
105607887|NCT04823611|364226348|FG005|Overall Study|Adverse Event|0|||
105607888|NCT04823611|364226349|FG006|Overall Study|Adverse Event|0|||
105607889|NCT01250769|364226351|FG000|Overall Study|Withdrawal by Subject|0|||
105607890|NCT01250769|364226352|FG001|Overall Study|Withdrawal by Subject|1|||
105607891|NCT01250769|364226353|FG002|Overall Study|Withdrawal by Subject|1|||
105607892|NCT01250769|364226354|FG003|Overall Study|Withdrawal by Subject|0|||
105607893|NCT01250769|364226351|FG000|Overall Study|Adverse Event|0|||
105607894|NCT01250769|364226352|FG001|Overall Study|Adverse Event|0|||
105607895|NCT01250769|364226353|FG002|Overall Study|Adverse Event|1|||
105607896|NCT01250769|364226354|FG003|Overall Study|Adverse Event|0|||
105607897|NCT04110054|364226355|FG000|Overall Study|COVID-19 reason other than AE|0|||
105607898|NCT04110054|364226356|FG001|Overall Study|COVID-19 reason other than AE|0|||
105607899|NCT04110054|364226357|FG002|Overall Study|COVID-19 reason other than AE|2|||
105607900|NCT04110054|364226358|FG003|Overall Study|COVID-19 reason other than AE|0|||
105607901|NCT04110054|364226355|FG000|Overall Study|Withdrawal by Subject|0|||
105607902|NCT04110054|364226356|FG001|Overall Study|Withdrawal by Subject|3|||
105607903|NCT04110054|364226357|FG002|Overall Study|Withdrawal by Subject|2|||
105607904|NCT04110054|364226358|FG003|Overall Study|Withdrawal by Subject|0|||
105607905|NCT04110054|364226355|FG000|Overall Study|Adverse Event|1|||
105607906|NCT04110054|364226356|FG001|Overall Study|Adverse Event|1|||
105607907|NCT04110054|364226357|FG002|Overall Study|Adverse Event|4|||
105607908|NCT04110054|364226358|FG003|Overall Study|Adverse Event|3|||
105607909|NCT01095796|364226359|FG000|Overall Study|Randomized but Not Treated|5|||
105607910|NCT01095796|364226360|FG001|Overall Study|Randomized but Not Treated|2|||
105607911|NCT01095796|364226359|FG000|Overall Study|Adverse Event|9|||
105607912|NCT01095796|364226360|FG001|Overall Study|Adverse Event|19|||
105607913|NCT01095796|364226359|FG000|Overall Study|Death|3|||
105607914|NCT01095796|364226360|FG001|Overall Study|Death|2|||
105607915|NCT01095796|364226359|FG000|Overall Study|Pregnancy|2|||
105607916|NCT01095796|364226360|FG001|Overall Study|Pregnancy|0|||
105607917|NCT01095796|364226359|FG000|Overall Study|Lack of Efficacy|5|||
105607918|NCT01095796|364226360|FG001|Overall Study|Lack of Efficacy|3|||
105607919|NCT01095796|364226359|FG000|Overall Study|Investigator's Discretion|7|||
105607920|NCT01095796|364226360|FG001|Overall Study|Investigator's Discretion|2|||
105607921|NCT01095796|364226359|FG000|Overall Study|Withdrew Consent|16|||
105607922|NCT01095796|364226360|FG001|Overall Study|Withdrew Consent|22|||
105607923|NCT01095796|364226359|FG000|Overall Study|Lost to Follow-up|27|||
105607924|NCT01095796|364226360|FG001|Overall Study|Lost to Follow-up|29|||
105607925|NCT01095796|364226359|FG000|Overall Study|Participant Noncompliance|5|||
105607926|NCT01095796|364226360|FG001|Overall Study|Participant Noncompliance|10|||
105607927|NCT01095796|364226359|FG000|Overall Study|Protocol Violation|1|||
105607928|NCT01095796|364226360|FG001|Overall Study|Protocol Violation|0|||
105607929|NCT01095796|364226359|FG000|Overall Study|Participant Transferred to Another Study|215|||
105607930|NCT01095796|364226360|FG001|Overall Study|Participant Transferred to Another Study|200|||
105607931|NCT02638337|364226361|FG000|Overall Study|Adverse Event|6|||
105607932|NCT02638337|364226362|FG001|Overall Study|Adverse Event|10|||
105607933|NCT02638337|364226361|FG000|Overall Study|Protocol Violation|3|||
105607934|NCT02638337|364226362|FG001|Overall Study|Protocol Violation|0|||
105607935|NCT02638337|364226361|FG000|Overall Study|Withdrawal by Subject|13|||
105607936|NCT02638337|364226362|FG001|Overall Study|Withdrawal by Subject|16|||
105607937|NCT02638337|364226361|FG000|Overall Study|Lost to Follow-up|7|||
105607938|NCT02638337|364226362|FG001|Overall Study|Lost to Follow-up|7|||
105607939|NCT02638337|364226361|FG000|Overall Study|Other - Miscellaneous|4|||
105607940|NCT02638337|364226362|FG001|Overall Study|Other - Miscellaneous|3|||
105607941|NCT01494922|364226363|FG000|Overall Study|Adverse Event|1|||
105607942|NCT04377308|364226364|FG000|Overall Study|Withdrawal by Subject|0|||
105607943|NCT04377308|364226365|FG001|Overall Study|Withdrawal by Subject|1|||
105607944|NCT02759016|364226366|FG000|Overall Study|Not treated with BI 836826|1|||
105607945|NCT02759016|364226367|FG001|Overall Study|Not treated with BI 836826|0|||
105607946|NCT02759016|364226366|FG000|Overall Study|Progressive disease|1|||
105607947|NCT02759016|364226367|FG001|Overall Study|Progressive disease|0|||
105607948|NCT02759016|364226366|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
105607949|NCT02759016|364226367|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
105607950|NCT02759016|364226366|FG000|Overall Study|Other not defined above|2|||
105607951|NCT02759016|364226367|FG001|Overall Study|Other not defined above|1|||
105607952|NCT03527160|364226368|FG000|Overall Study|No urine collected|13|||
105607953|NCT03527160|364226368|FG000|Overall Study|No clinical serum creatinine collected|6|||
105607954|NCT03527160|364226368|FG000|Overall Study|Did not meet inclusion|2|||
105607955|NCT02891915|364226369|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
105607956|NCT02891915|364226370|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
105607957|NCT02891915|364226369|FG000|Overall Study|Withdrawal by Subject|3|||
105607958|NCT02891915|364226370|FG001|Overall Study|Withdrawal by Subject|3|||
105607959|NCT02891915|364226369|FG000|Overall Study|Became Ineligible After Enrollment|2|||
105607960|NCT02891915|364226370|FG001|Overall Study|Became Ineligible After Enrollment|1|||
105607961|NCT02891915|364226369|FG000|Overall Study|Lost to Follow-up|1|||
105607962|NCT02891915|364226370|FG001|Overall Study|Lost to Follow-up|4|||
105607963|NCT02891915|364226369|FG000|Overall Study|Physician Decision|1|||
105607964|NCT02891915|364226370|FG001|Overall Study|Physician Decision|0|||
105607965|NCT00709098|364226373|FG000|Double-blind Period|Withdrawal of consent|3|||
105607966|NCT00709098|364226374|FG001|Double-blind Period|Withdrawal of consent|3|||
105607967|NCT00709098|364226375|FG002|Double-blind Period|Withdrawal of consent|0|||
105607968|NCT00709098|364226373|FG000|Double-blind Period|Administrative reason|1|||
105607969|NCT00709098|364226374|FG001|Double-blind Period|Administrative reason|3|||
105607970|NCT00709098|364226375|FG002|Double-blind Period|Administrative reason|0|||
105607971|NCT00709098|364226373|FG000|Double-blind Period|Death|1|||
105607972|NCT00709098|364226374|FG001|Double-blind Period|Death|1|||
105607973|NCT00709098|364226375|FG002|Double-blind Period|Death|0|||
105607974|NCT00709098|364226373|FG000|Double-blind Period|Lost to Follow-up|1|||
105607975|NCT00709098|364226374|FG001|Double-blind Period|Lost to Follow-up|1|||
105607976|NCT00709098|364226375|FG002|Double-blind Period|Lost to Follow-up|0|||
105607977|NCT00709098|364226373|FG000|Open-label Period|Withdrawal of consent|0|||
105607978|NCT00709098|364226374|FG001|Open-label Period|Withdrawal of consent|0|||
105607979|NCT00709098|364226375|FG002|Open-label Period|Withdrawal of consent|7|||
105607980|NCT00709098|364226373|FG000|Open-label Period|Administrative reason|0|||
105607981|NCT00709098|364226374|FG001|Open-label Period|Administrative reason|0|||
105607982|NCT00709098|364226375|FG002|Open-label Period|Administrative reason|5|||
105607983|NCT00709098|364226373|FG000|Open-label Period|Death|0|||
105607984|NCT00709098|364226374|FG001|Open-label Period|Death|0|||
105607985|NCT00709098|364226375|FG002|Open-label Period|Death|1|||
105607986|NCT00709098|364226373|FG000|Open-label Period|Lost to Follow-up|0|||
105607987|NCT00709098|364226374|FG001|Open-label Period|Lost to Follow-up|0|||
105607988|NCT00709098|364226375|FG002|Open-label Period|Lost to Follow-up|1|||
105607989|NCT03582722|364226376|FG000|Overall Study|Lost to Follow-up|1|||
105607990|NCT03582722|364226377|FG001|Overall Study|Lost to Follow-up|4|||
105607991|NCT03582722|364226376|FG000|Overall Study|Withdrawal by Subject|3|||
105607992|NCT03582722|364226377|FG001|Overall Study|Withdrawal by Subject|3|||
105607993|NCT00788671|364228014|FG000|Overall Study|Death|2|||
105607994|NCT00788671|364228014|FG000|Overall Study|Unable to biopsy|1|||
105607995|NCT00788671|364228014|FG000|Overall Study|Withdrawal by Subject|4|||
105607996|NCT00788671|364228014|FG000|Overall Study|IUD expulsed|1|||
105607997|NCT00788671|364228014|FG000|Overall Study|Lost to follow up|2|||
105607998|NCT04104321|364228016|FG000|Overall Study|didn't take the study drug|3|||
105607999|NCT03481777|364228017|FG000|Overall Study|Withdrawal by Subject|36|||
105608000|NCT03481777|364228018|FG001|Overall Study|Withdrawal by Subject|31|||
105608001|NCT03481777|364228017|FG000|Overall Study|Non stroke = non target population|277|||
105608002|NCT03481777|364228018|FG001|Overall Study|Non stroke = non target population|254|||
105608003|NCT03683069|364228019|FG000|Overall Study|see limitations|12|||
105608004|NCT03683069|364228020|FG001|Overall Study|see limitations|13|||
105608005|NCT04941287|364228021|FG000|Overall Study|Rapid decline before starting treatment|3|||
105608006|NCT04941287|364228022|FG001|Overall Study|Rapid decline before starting treatment|1|||
105608007|NCT03547908|364228030|FG000|Blinded Phase|Lost to Follow-up|3|||
105608008|NCT03547908|364228031|FG001|Blinded Phase|Lost to Follow-up|3|||
105608009|NCT03547908|364228032|FG002|Blinded Phase|Lost to Follow-up|0|||
105608010|NCT03547908|364228033|FG003|Blinded Phase|Lost to Follow-up|0|||
105608011|NCT03547908|364228030|FG000|Blinded Phase|Withdrew Consent|2|||
105608012|NCT03547908|364228031|FG001|Blinded Phase|Withdrew Consent|3|||
105608013|NCT03547908|364228032|FG002|Blinded Phase|Withdrew Consent|0|||
105608014|NCT03547908|364228033|FG003|Blinded Phase|Withdrew Consent|0|||
105608015|NCT03547908|364228030|FG000|Blinded Phase|Investigator's Discretion|2|||
105608016|NCT03547908|364228031|FG001|Blinded Phase|Investigator's Discretion|1|||
105608017|NCT03547908|364228032|FG002|Blinded Phase|Investigator's Discretion|0|||
105608018|NCT03547908|364228033|FG003|Blinded Phase|Investigator's Discretion|0|||
105608019|NCT03547908|364228030|FG000|Blinded Phase|Death|2|||
105608020|NCT03547908|364228031|FG001|Blinded Phase|Death|0|||
105608021|NCT03547908|364228032|FG002|Blinded Phase|Death|0|||
105608022|NCT03547908|364228033|FG003|Blinded Phase|Death|0|||
105608023|NCT03547908|364228030|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
105608024|NCT03547908|364228031|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
105608025|NCT03547908|364228032|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
105608026|NCT03547908|364228033|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
105608027|NCT03547908|364228030|FG000|Blinded Phase|Adverse Event|1|||
105608028|NCT03547908|364228031|FG001|Blinded Phase|Adverse Event|0|||
105608029|NCT03547908|364228032|FG002|Blinded Phase|Adverse Event|0|||
105608030|NCT03547908|364228033|FG003|Blinded Phase|Adverse Event|0|||
105608031|NCT03547908|364228030|FG000|Blinded Phase|Randomized But Never Treated|1|||
105608032|NCT03547908|364228031|FG001|Blinded Phase|Randomized But Never Treated|0|||
105608033|NCT03547908|364228032|FG002|Blinded Phase|Randomized But Never Treated|0|||
105608034|NCT03547908|364228033|FG003|Blinded Phase|Randomized But Never Treated|0|||
105608035|NCT03547908|364228030|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
105608036|NCT03547908|364228031|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
105608037|NCT03547908|364228032|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
105608038|NCT03547908|364228033|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
105608039|NCT03547908|364228030|FG000|Open-label Extension Phase|Death|0|||
105608040|NCT03547908|364228031|FG001|Open-label Extension Phase|Death|0|||
105608041|NCT03547908|364228032|FG002|Open-label Extension Phase|Death|1|||
105608042|NCT03547908|364228033|FG003|Open-label Extension Phase|Death|0|||
105608043|NCT03346538|364228034|FG000|Overall Study|Physician Decision|0|||
105608044|NCT03346538|364228035|FG001|Overall Study|Physician Decision|1|||
105608045|NCT03346538|364228036|FG002|Overall Study|Physician Decision|0|||
105608046|NCT03346538|364228034|FG000|Overall Study|Withdrawal by Subject|3|||
105608047|NCT03346538|364228035|FG001|Overall Study|Withdrawal by Subject|2|||
105608048|NCT03346538|364228036|FG002|Overall Study|Withdrawal by Subject|0|||
105608049|NCT03346538|364228034|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
105608050|NCT03346538|364228035|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
105608051|NCT03346538|364228036|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
105608052|NCT05419505|364228037|FG000|Overall Study|Adverse Event|0|||
105608053|NCT05419505|364228038|FG001|Overall Study|Adverse Event|0|||
105608054|NCT05419505|364228039|FG002|Overall Study|Adverse Event|0|||
105608055|NCT05419505|364228040|FG003|Overall Study|Adverse Event|1|||
105608056|NCT05419505|364228041|FG004|Overall Study|Adverse Event|0|||
105608057|NCT05419505|364228042|FG005|Overall Study|Adverse Event|0|||
105608058|NCT05419505|364228043|FG006|Overall Study|Adverse Event|0|||
105608059|NCT05419505|364228044|FG007|Overall Study|Adverse Event|0|||
105608060|NCT05419505|364228037|FG000|Overall Study|Withdrawal by Subject|1|||
105608061|NCT05419505|364228038|FG001|Overall Study|Withdrawal by Subject|2|||
105608062|NCT05419505|364228039|FG002|Overall Study|Withdrawal by Subject|0|||
105608063|NCT05419505|364228040|FG003|Overall Study|Withdrawal by Subject|0|||
105608064|NCT05419505|364228041|FG004|Overall Study|Withdrawal by Subject|0|||
105608065|NCT05419505|364228042|FG005|Overall Study|Withdrawal by Subject|0|||
105608066|NCT05419505|364228043|FG006|Overall Study|Withdrawal by Subject|1|||
105608067|NCT05419505|364228044|FG007|Overall Study|Withdrawal by Subject|0|||
105608068|NCT05419505|364228037|FG000|Overall Study|Lost to Follow-up|2|||
105608069|NCT05419505|364228038|FG001|Overall Study|Lost to Follow-up|1|||
105608070|NCT05419505|364228039|FG002|Overall Study|Lost to Follow-up|0|||
105608071|NCT05419505|364228040|FG003|Overall Study|Lost to Follow-up|0|||
105608072|NCT05419505|364228041|FG004|Overall Study|Lost to Follow-up|1|||
105608073|NCT05419505|364228042|FG005|Overall Study|Lost to Follow-up|2|||
105608074|NCT05419505|364228043|FG006|Overall Study|Lost to Follow-up|0|||
105608075|NCT05419505|364228044|FG007|Overall Study|Lost to Follow-up|1|||
105608076|NCT03358875|364228045|FG000|Overall Study|Death|409|||
105608077|NCT03358875|364228046|FG001|Overall Study|Death|223|||
105608078|NCT03358875|364228045|FG000|Overall Study|Study Closed by Sponsor|66|||
105608079|NCT03358875|364228046|FG001|Overall Study|Study Closed by Sponsor|29|||
105608080|NCT03358875|364228045|FG000|Overall Study|Withdrawal by Subject|13|||
105608081|NCT03358875|364228046|FG001|Overall Study|Withdrawal by Subject|16|||
105608082|NCT03358875|364228045|FG000|Overall Study|Lost to Follow-up|13|||
105608083|NCT03358875|364228046|FG001|Overall Study|Lost to Follow-up|2|||
105608084|NCT03358875|364228045|FG000|Overall Study|Miscellaneous|33|||
105608085|NCT03358875|364228046|FG001|Overall Study|Miscellaneous|0|||
105608086|NCT03358875|364228045|FG000|Overall Study|Remained on Study|1|||
105608087|NCT03358875|364228046|FG001|Overall Study|Remained on Study|0|||
105608088|NCT04855760|364228047|FG000|Overall Study|Adverse Event|21|||
105608089|NCT04855760|364228047|FG000|Overall Study|Withdrawal by Subject|116|||
105608090|NCT04855760|364228047|FG000|Overall Study|Lack of Efficacy|21|||
105608091|NCT04855760|364228047|FG000|Overall Study|Lost to Follow-up|49|||
105608092|NCT04855760|364228047|FG000|Overall Study|Protocol Violation|2|||
105608093|NCT04855760|364228047|FG000|Overall Study|Physician Decision|5|||
105608094|NCT04855760|364228047|FG000|Overall Study|Pregnancy|1|||
105608095|NCT04855760|364228047|FG000|Overall Study|Non-Compliance with Study Drug|11|||
105608096|NCT04855760|364228047|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
105608097|NCT04855760|364228047|FG000|Overall Study|Study Completed by Sponsor|202|||
105608098|NCT04855760|364228047|FG000|Overall Study|Other|13|||
105608099|NCT01631214|364228055|FG000|Overall Study|Withdrawal by Subject|276|||
105608100|NCT01631214|364228056|FG001|Overall Study|Withdrawal by Subject|290|||
105608101|NCT01631214|364228055|FG000|Overall Study|Death|113|||
105608102|NCT01631214|364228056|FG001|Overall Study|Death|106|||
105608103|NCT01631214|364228055|FG000|Overall Study|Lost to Follow-up|54|||
105608104|NCT01631214|364228056|FG001|Overall Study|Lost to Follow-up|40|||
105608105|NCT01631214|364228055|FG000|Overall Study|Adverse Event|45|||
105608106|NCT01631214|364228056|FG001|Overall Study|Adverse Event|45|||
105608107|NCT01631214|364228055|FG000|Overall Study|Other|22|||
105608108|NCT01631214|364228056|FG001|Overall Study|Other|19|||
105608109|NCT01631214|364228055|FG000|Overall Study|Noncompliance|16|||
105608110|NCT01631214|364228056|FG001|Overall Study|Noncompliance|15|||
105608111|NCT01631214|364228055|FG000|Overall Study|Requirement for Alternative Therapy|8|||
105608112|NCT01631214|364228056|FG001|Overall Study|Requirement for Alternative Therapy|3|||
105608113|NCT01631214|364228055|FG000|Overall Study|Protocol Deviation|4|||
105608114|NCT01631214|364228056|FG001|Overall Study|Protocol Deviation|3|||
105608115|NCT01631214|364228055|FG000|Overall Study|Ineligibility determined|5|||
105608116|NCT01631214|364228056|FG001|Overall Study|Ineligibility determined|2|||
105608117|NCT01631214|364228055|FG000|Overall Study|Administrative Decision|1|||
105608118|NCT01631214|364228056|FG001|Overall Study|Administrative Decision|0|||
105608119|NCT03602014|364228058|FG000|Overall Study|Lost to Follow-up|2|||
105608120|NCT03602014|364228059|FG001|Overall Study|Lost to Follow-up|0|||
105608121|NCT03602014|364228060|FG002|Overall Study|Lost to Follow-up|0|||
105608122|NCT04533022|364228061|FG000|Overall Study|Withdrawal by Subject|15|||
105608123|NCT04533022|364228061|FG000|Overall Study|Adverse Event|6|||
105608124|NCT04533022|364228061|FG000|Overall Study|Death|1|||
105608125|NCT04533022|364228061|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
105608126|NCT04533022|364228061|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
105608127|NCT04732494|364228063|FG000|Overall Study|Death|39|||
105608128|NCT04732494|364228064|FG001|Overall Study|Death|36|||
105608129|NCT04732494|364228063|FG000|Overall Study|Study Closed by Sponsor|20|||
105608130|NCT04732494|364228064|FG001|Overall Study|Study Closed by Sponsor|15|||
105608131|NCT04732494|364228063|FG000|Overall Study|Withdrawal by Subject|2|||
105608132|NCT04732494|364228064|FG001|Overall Study|Withdrawal by Subject|7|||
105608133|NCT04732494|364228063|FG000|Overall Study|Lost to Follow-up|1|||
105608134|NCT04732494|364228064|FG001|Overall Study|Lost to Follow-up|5|||
105608135|NCT03055858|364228065|FG000|Overall Study|Death|9|||
105608136|NCT03055858|364228065|FG000|Overall Study|Withdrawal by Subject|11|||
105608137|NCT03055858|364228065|FG000|Overall Study|Lost to Follow-up|6|||
105608138|NCT03055858|364228065|FG000|Overall Study|Missed Follow-Up Visits|18|||
105608139|NCT05288283|364228067|FG000|Overall Study|Study Terminated Early|1|||
105608140|NCT05288283|364228068|FG001|Overall Study|Study Terminated Early|1|||
105608141|NCT01704079|364228073|FG000|Overall Study|Withdrawal by Subject|5|||
105608142|NCT01704079|364228074|FG001|Overall Study|Withdrawal by Subject|7|||
105608143|NCT01704079|364228073|FG000|Overall Study|Lost to Follow-up|2|||
105608144|NCT01704079|364228074|FG001|Overall Study|Lost to Follow-up|5|||
105608145|NCT01704079|364228073|FG000|Overall Study|Adverse Event|4|||
105608146|NCT01704079|364228074|FG001|Overall Study|Adverse Event|7|||
105608147|NCT01704079|364228073|FG000|Overall Study|Protocol Violation|1|||
105608148|NCT01704079|364228074|FG001|Overall Study|Protocol Violation|0|||
105608149|NCT01704079|364228073|FG000|Overall Study|Subject noncompliance|2|||
105608150|NCT01704079|364228074|FG001|Overall Study|Subject noncompliance|3|||
105608151|NCT01704079|364228073|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
105608152|NCT01704079|364228074|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
105608153|NCT05986565|364228077|FG000|Overall Study|Lost to Follow-up|8|||
105608154|NCT05986565|364228078|FG001|Overall Study|Lost to Follow-up|3|||
105608155|NCT05986565|364228077|FG000|Overall Study|Withdrawal by Subject|0|||
105608156|NCT05986565|364228078|FG001|Overall Study|Withdrawal by Subject|1|||
105608157|NCT03089398|364228082|FG000|Overall Study|Death|4|||
105608158|NCT03089398|364228083|FG001|Overall Study|Death|9|||
105608159|NCT03089398|364228082|FG000|Overall Study|Lost to Follow-up|21|||
105608160|NCT03089398|364228083|FG001|Overall Study|Lost to Follow-up|30|||
105608161|NCT03089398|364228082|FG000|Overall Study|Withdrawal by Subject|2|||
105608162|NCT03089398|364228083|FG001|Overall Study|Withdrawal by Subject|2|||
105608163|NCT02300298|364228084|FG000|Disposition for Nintedanib|Progressive disease|10|||
105608164|NCT02300298|364228085|FG001|Disposition for Nintedanib|Progressive disease|0|||
105608165|NCT02300298|364228084|FG000|Disposition for Docetaxel|Progressive disease|0|||
105608166|NCT02300298|364228085|FG001|Disposition for Docetaxel|Progressive disease|6|||
105608167|NCT02300298|364228084|FG000|Disposition for Docetaxel|other adverse event|0|||
105608168|NCT02300298|364228085|FG001|Disposition for Docetaxel|other adverse event|4|||
105608169|NCT00150813|364228086|FG000|Overall Study|Adverse Event|1|||
105608170|NCT00150813|364228086|FG000|Overall Study|Lack of Efficacy|1|||
105608171|NCT00150813|364228086|FG000|Overall Study|Lost to Follow-up|5|||
105608172|NCT00150813|364228086|FG000|Overall Study|Withdrawal by Subject|5|||
105608173|NCT00150813|364228086|FG000|Overall Study|Remission|3|||
105608174|NCT00150813|364228086|FG000|Overall Study|Planned pregancy|1|||
105608175|NCT00150813|364228086|FG000|Overall Study|Switch to commercially available LEV|2|||
105608176|NCT03285763|364228087|FG000|Overall Study|Death|470|||
105608177|NCT03285763|364228087|FG000|Overall Study|Lost to Follow-up|18|||
105608178|NCT03285763|364228087|FG000|Overall Study|Physician Decision|2|||
105608179|NCT03285763|364228087|FG000|Overall Study|Study Terminated By Sponsor|79|||
105608180|NCT03285763|364228087|FG000|Overall Study|Withdrawal by Subject|33|||
105608181|NCT03624972|364228088|FG000|Overall Study|Lost to Follow-up|2|||
105608182|NCT03624972|364228089|FG001|Overall Study|Lost to Follow-up|0|||
105608183|NCT03624972|364228090|FG002|Overall Study|Lost to Follow-up|0|||
105608184|NCT03624972|364228088|FG000|Overall Study|Withdrawal by Subject|0|||
105608185|NCT03624972|364228089|FG001|Overall Study|Withdrawal by Subject|2|||
105608186|NCT03624972|364228090|FG002|Overall Study|Withdrawal by Subject|0|||
105608187|NCT05444192|364228091|FG000|Overall Study|Lost to Follow-up|1|||
105608188|NCT05444192|364228092|FG001|Overall Study|Lost to Follow-up|0|||
105608189|NCT00650104|364228102|FG000|Overall Study|Adverse Event|17|||
105608190|NCT00650104|364228102|FG000|Overall Study|Death|2|||
105608191|NCT00650104|364228102|FG000|Overall Study|Withdrawal by Subject|11|||
105608192|NCT00650104|364228102|FG000|Overall Study|Physician Decision|7|||
105608193|NCT00650104|364228102|FG000|Overall Study|Lost to Follow-up|1|||
105608194|NCT00650104|364228102|FG000|Overall Study|Non-compliance|2|||
105608195|NCT00650104|364228102|FG000|Overall Study|Sponsor Terminated Dosing|1|||
105608196|NCT00931710|364228103|FG000|Overall Study|Adverse Event|16|||
105608197|NCT00931710|364228104|FG001|Overall Study|Adverse Event|10|||
105608198|NCT00931710|364228103|FG000|Overall Study|Abnormal test procedure results|2|||
105608199|NCT00931710|364228104|FG001|Overall Study|Abnormal test procedure results|0|||
105608200|NCT00931710|364228103|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
105608201|NCT00931710|364228104|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
105608202|NCT00931710|364228103|FG000|Overall Study|Patient withdrew consent|4|||
105608203|NCT00931710|364228104|FG001|Overall Study|Patient withdrew consent|9|||
105608204|NCT00931710|364228103|FG000|Overall Study|Lost to Follow-up|6|||
105608205|NCT00931710|364228104|FG001|Overall Study|Lost to Follow-up|5|||
105608206|NCT00931710|364228103|FG000|Overall Study|Protocol deviation|1|||
105608207|NCT00931710|364228104|FG001|Overall Study|Protocol deviation|2|||
105608208|NCT05623345|364228113|FG000|Overall Study|Withdrawal by Subject|14|||
105608209|NCT05623345|364228114|FG001|Overall Study|Withdrawal by Subject|0|||
105608210|NCT05623345|364228115|FG002|Overall Study|Withdrawal by Subject|9|||
105608211|NCT05623345|364228116|FG003|Overall Study|Withdrawal by Subject|20|||
105608212|NCT05623345|364228113|FG000|Overall Study|Lost to Follow-up|3|||
105608213|NCT05623345|364228114|FG001|Overall Study|Lost to Follow-up|0|||
105608214|NCT05623345|364228115|FG002|Overall Study|Lost to Follow-up|7|||
105608215|NCT05623345|364228116|FG003|Overall Study|Lost to Follow-up|2|||
105608216|NCT05623345|364228113|FG000|Overall Study|Termination of Study By Sponsor|37|||
105608217|NCT05623345|364228114|FG001|Overall Study|Termination of Study By Sponsor|4|||
105608218|NCT05623345|364228115|FG002|Overall Study|Termination of Study By Sponsor|40|||
105608219|NCT05623345|364228116|FG003|Overall Study|Termination of Study By Sponsor|38|||
105608220|NCT01385176|364228117|FG000|Randomization Phase|Death|1|||
105608221|NCT01385176|364228118|FG001|Randomization Phase|Death|2|||
105608222|NCT01385176|364228117|FG000|6-18 Month All VNS Active|Death|1|||
105608223|NCT01385176|364228118|FG001|6-18 Month All VNS Active|Death|2|||
105608224|NCT01385176|364228117|FG000|6-18 Month All VNS Active|Physician Decision|0|||
105608225|NCT01385176|364228118|FG001|6-18 Month All VNS Active|Physician Decision|1|||
105608226|NCT01385176|364228117|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
105608227|NCT01385176|364228118|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
105608228|NCT01385176|364228117|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
105608229|NCT01385176|364228118|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
105608230|NCT05384730|364228121|FG000|Overall Study|Adverse Event|1|||
105608231|NCT05384730|364228122|FG001|Overall Study|Adverse Event|0|||
105608232|NCT05384730|364228121|FG000|Overall Study|Lack of social support|2|||
105608233|NCT05384730|364228122|FG001|Overall Study|Lack of social support|0|||
105608234|NCT05384730|364228121|FG000|Overall Study|Hospital readmission|2|||
105608235|NCT05384730|364228122|FG001|Overall Study|Hospital readmission|0|||
105608236|NCT05384730|364228121|FG000|Overall Study|Disease progression|5|||
105608237|NCT05384730|364228122|FG001|Overall Study|Disease progression|0|||
105608238|NCT05384730|364228121|FG000|Overall Study|Overwhelmed with College commitments|0|||
105608239|NCT05384730|364228122|FG001|Overall Study|Overwhelmed with College commitments|2|||
105608240|NCT05633407|364228129|FG000|Overall Study|Physician Decision|2|||
105608241|NCT05633407|364228130|FG001|Overall Study|Physician Decision|0|||
105608242|NCT05633407|364228129|FG000|Overall Study|Adverse Event|1|||
105608243|NCT05633407|364228130|FG001|Overall Study|Adverse Event|0|||
105608244|NCT05633407|364228129|FG000|Overall Study|Withdrawal by Subject|1|||
105608245|NCT05633407|364228130|FG001|Overall Study|Withdrawal by Subject|0|||
105608246|NCT05633407|364228129|FG000|Overall Study|Other|1|||
105608247|NCT05633407|364228130|FG001|Overall Study|Other|1|||
105608248|NCT05512962|364228131|FG000|Overall Study|Withdrawal by Subject|1|||
105608249|NCT05512962|364228132|FG001|Overall Study|Withdrawal by Subject|0|||
105608250|NCT03014453|364228134|FG000|Overall Study|Lost to Follow-up|12|||
105608251|NCT03014453|364228134|FG000|Overall Study|Discontinued GER|3|||
105608252|NCT03014453|364228134|FG000|Overall Study|Excluded|19|||
105608253|NCT03014453|364228134|FG000|Overall Study|Refused to take part in|37|||
105608254|NCT02965846|364228139|FG000|Overall Study|Lost to Follow-up|1|||
105608255|NCT02965846|364228140|FG001|Overall Study|Lost to Follow-up|0|||
105608256|NCT02965846|364228141|FG002|Overall Study|Lost to Follow-up|0|||
105608257|NCT02965846|364228139|FG000|Overall Study|Withdrawal by Subject|0|||
105608258|NCT02965846|364228140|FG001|Overall Study|Withdrawal by Subject|1|||
105608259|NCT02965846|364228141|FG002|Overall Study|Withdrawal by Subject|0|||
105608260|NCT02965846|364228139|FG000|Overall Study|Study Terminated By Sponsor|4|||
105608261|NCT02965846|364228140|FG001|Overall Study|Study Terminated By Sponsor|4|||
105608262|NCT02965846|364228141|FG002|Overall Study|Study Terminated By Sponsor|0|||
105608263|NCT02965846|364228139|FG000|Overall Study|Participants not randomized|0|||
105608264|NCT02965846|364228140|FG001|Overall Study|Participants not randomized|0|||
105608265|NCT02965846|364228141|FG002|Overall Study|Participants not randomized|33|||
105608266|NCT00593489|364228142|FG000|Allocation|did not attend workshop; allocation not|2|||
105608267|NCT00593489|364228143|FG001|Allocation|did not attend workshop; allocation not|1|||
105608268|NCT00611559|364228144|FG000|Overall Study|Lost to Follow-up|0|||
105608269|NCT00611559|364228145|FG001|Overall Study|Lost to Follow-up|1|||
105608270|NCT00611559|364228146|FG002|Overall Study|Lost to Follow-up|0|||
105608271|NCT00611559|364228144|FG000|Overall Study|Protocol Violation|1|||
105608272|NCT00611559|364228145|FG001|Overall Study|Protocol Violation|0|||
105608273|NCT00611559|364228146|FG002|Overall Study|Protocol Violation|1|||
105608274|NCT00879333|364228147|FG000|Overall Study|Adverse Event|94|||
105608275|NCT00879333|364228148|FG001|Overall Study|Adverse Event|34|||
105608276|NCT00879333|364228147|FG000|Overall Study|Abnormal Laboratory Value|1|||
105608277|NCT00879333|364228148|FG001|Overall Study|Abnormal Laboratory Value|0|||
105608278|NCT00879333|364228147|FG000|Overall Study|Withdrawal by Subject|20|||
105608279|NCT00879333|364228148|FG001|Overall Study|Withdrawal by Subject|7|||
105608280|NCT00879333|364228147|FG000|Overall Study|Lost to Follow-up|2|||
105608281|NCT00879333|364228148|FG001|Overall Study|Lost to Follow-up|1|||
105608282|NCT00879333|364228147|FG000|Overall Study|Administrative Problems|2|||
105608283|NCT00879333|364228148|FG001|Overall Study|Administrative Problems|0|||
105608284|NCT00879333|364228147|FG000|Overall Study|Death|16|||
105608285|NCT00879333|364228148|FG001|Overall Study|Death|5|||
105608286|NCT00879333|364228147|FG000|Overall Study|Disease Progression|292|||
105608287|NCT00879333|364228148|FG001|Overall Study|Disease Progression|169|||
105608288|NCT00879333|364228147|FG000|Overall Study|Protocol Violation|1|||
105608289|NCT00879333|364228148|FG001|Overall Study|Protocol Violation|1|||
105608290|NCT00951379|364228149|FG000|Overall Study|Adverse Event|4|||
105608291|NCT00951379|364228150|FG001|Overall Study|Adverse Event|1|||
105608292|NCT00951379|364228149|FG000|Overall Study|Withdrawal by Subject|1|||
105608293|NCT00951379|364228150|FG001|Overall Study|Withdrawal by Subject|0|||
105608294|NCT00951379|364228149|FG000|Overall Study|Noncompliance|1|||
105608295|NCT00951379|364228150|FG001|Overall Study|Noncompliance|0|||
105608296|NCT00951379|364228149|FG000|Overall Study|Disease Progression|0|||
105608297|NCT00951379|364228150|FG001|Overall Study|Disease Progression|1|||
105608298|NCT03069313|364228151|FG000|Overall Study|Adverse Event|5|||
105608299|NCT01011946|364228152|FG000|Overall Study|Transferred to another hospital|2|||
105608300|NCT01011946|364228152|FG000|Overall Study|No pathological lab value|1|||
105608301|NCT01424670|364228155|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
105608302|NCT01424670|364228156|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
105608303|NCT01424670|364228155|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
105608304|NCT01424670|364228156|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
105608305|NCT01424670|364228155|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
105608306|NCT01424670|364228156|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
105608307|NCT01424670|364228155|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
105608308|NCT01424670|364228156|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
105608309|NCT01424670|364228155|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
105608310|NCT01424670|364228156|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
105608311|NCT01424670|364228155|FG000|Continuation Period|Adverse Event|13|||
105608312|NCT01424670|364228156|FG001|Continuation Period|Adverse Event|5|||
105608313|NCT01424670|364228155|FG000|Continuation Period|Lost to Follow-up|2|||
105608314|NCT01424670|364228156|FG001|Continuation Period|Lost to Follow-up|0|||
105608315|NCT01424670|364228155|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
105608316|NCT01424670|364228156|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
105608317|NCT01424670|364228155|FG000|Continuation Period|Physician Decision|5|||
105608318|NCT01424670|364228156|FG001|Continuation Period|Physician Decision|4|||
105608319|NCT01424670|364228155|FG000|Continuation Period|Withdrawal by Subject|13|||
105608320|NCT01424670|364228156|FG001|Continuation Period|Withdrawal by Subject|4|||
105608321|NCT00761189|364228157|FG000|Overall Study|Adverse Event|42|||
105608322|NCT00761189|364228157|FG000|Overall Study|Lack of Efficacy|45|||
105608323|NCT00761189|364228157|FG000|Overall Study|Lost to Follow-up|36|||
105608324|NCT00761189|364228157|FG000|Overall Study|Withdrawal by Subject|49|||
105608325|NCT00761189|364228157|FG000|Overall Study|Other|13|||
105608326|NCT03912831|364228158|FG000|Overall Study|Death|1|||
105608327|NCT03912831|364228159|FG001|Overall Study|Death|1|||
105608328|NCT03912831|364228160|FG002|Overall Study|Death|1|||
105608329|NCT03912831|364228161|FG003|Overall Study|Death|1|||
105608330|NCT03912831|364228162|FG004|Overall Study|Death|1|||
105608331|NCT03912831|364228163|FG005|Overall Study|Death|1|||
105608332|NCT03912831|364228158|FG000|Overall Study|Reason not Specified|0|||
105608333|NCT03912831|364228159|FG001|Overall Study|Reason not Specified|0|||
105608334|NCT03912831|364228160|FG002|Overall Study|Reason not Specified|0|||
105608335|NCT03912831|364228161|FG003|Overall Study|Reason not Specified|0|||
105608336|NCT03912831|364228162|FG004|Overall Study|Reason not Specified|1|||
105608337|NCT03912831|364228163|FG005|Overall Study|Reason not Specified|0|||
105608338|NCT03912831|364228158|FG000|Overall Study|Withdrawal by Participant|0|||
105608339|NCT03912831|364228159|FG001|Overall Study|Withdrawal by Participant|0|||
105608340|NCT03912831|364228160|FG002|Overall Study|Withdrawal by Participant|0|||
105608341|NCT03912831|364228161|FG003|Overall Study|Withdrawal by Participant|0|||
105608342|NCT03912831|364228162|FG004|Overall Study|Withdrawal by Participant|1|||
105608343|NCT03912831|364228163|FG005|Overall Study|Withdrawal by Participant|0|||
105608344|NCT03416023|364229545|FG000|Overall Study|Exclusion criteria failure|1|||
105608345|NCT03416023|364229545|FG000|Overall Study|Withdrawal by Subject|6|||
105608346|NCT03416023|364229545|FG000|Overall Study|Explanted|7|||
105608347|NCT03416023|364229545|FG000|Overall Study|Physician Decision|1|||
105608348|NCT03416023|364229545|FG000|Overall Study|Lost to Follow-up|1|||
105608349|NCT03416023|364229545|FG000|Overall Study|Death|1|||
105608350|NCT05510232|364229546|FG000|Overall Study|Withdrawal by Subject|2|||
105608351|NCT05510232|364229547|FG001|Overall Study|Withdrawal by Subject|7|||
105608352|NCT05510232|364229548|FG002|Overall Study|Withdrawal by Subject|6|||
105608353|NCT04143061|364229549|FG000|Overall Study|Protocol Deviation|0|||
105608354|NCT04143061|364229550|FG001|Overall Study|Protocol Deviation|0|||
105608355|NCT04143061|364229551|FG002|Overall Study|Protocol Deviation|0|||
105608356|NCT04143061|364229552|FG003|Overall Study|Protocol Deviation|0|||
105608357|NCT04143061|364229553|FG004|Overall Study|Protocol Deviation|0|||
105608358|NCT04143061|364229554|FG005|Overall Study|Protocol Deviation|0|||
105608359|NCT04143061|364229555|FG006|Overall Study|Protocol Deviation|5|||
105608360|NCT04143061|364229556|FG007|Overall Study|Protocol Deviation|5|||
105608361|NCT04143061|364229549|FG000|Overall Study|Withdrawal by Subject|2|||
105608362|NCT04143061|364229550|FG001|Overall Study|Withdrawal by Subject|0|||
105608363|NCT04143061|364229551|FG002|Overall Study|Withdrawal by Subject|0|||
105608364|NCT04143061|364229552|FG003|Overall Study|Withdrawal by Subject|0|||
105608365|NCT04143061|364229553|FG004|Overall Study|Withdrawal by Subject|0|||
105608366|NCT04143061|364229554|FG005|Overall Study|Withdrawal by Subject|1|||
105608367|NCT04143061|364229555|FG006|Overall Study|Withdrawal by Subject|0|||
105608368|NCT04143061|364229556|FG007|Overall Study|Withdrawal by Subject|0|||
105608369|NCT04143061|364229549|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105608370|NCT04143061|364229550|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105608371|NCT04143061|364229551|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105608372|NCT04143061|364229552|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
105608373|NCT04143061|364229553|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
105608374|NCT04143061|364229554|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
105608375|NCT04143061|364229555|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
105608376|NCT04143061|364229556|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
105608377|NCT03289039|364229557|FG000|Overall Study|Withdrawal by Subject|0|||
105608378|NCT03289039|364229558|FG001|Overall Study|Withdrawal by Subject|1|||
105608379|NCT03289039|364229557|FG000|Overall Study|Became ineligible prior to treatment start|0|||
105608380|NCT03289039|364229558|FG001|Overall Study|Became ineligible prior to treatment start|1|||
105608381|NCT03289039|364229557|FG000|Overall Study|progressed before treatment start|1|||
105608382|NCT03289039|364229558|FG001|Overall Study|progressed before treatment start|0|||
105608383|NCT02728557|364229559|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
105608384|NCT02728557|364229560|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
105608385|NCT02728557|364229559|FG000|Overall Study|Dissatisfaction with research tasks|0|||
105608386|NCT02728557|364229560|FG001|Overall Study|Dissatisfaction with research tasks|1|||
105608387|NCT02728557|364229559|FG000|Overall Study|Scheduling or change in availability|1|||
105608388|NCT02728557|364229560|FG001|Overall Study|Scheduling or change in availability|1|||
105608389|NCT03416010|364229561|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
105608390|NCT03416010|364229562|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
105608391|NCT03416010|364229561|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
105608392|NCT03416010|364229562|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
105608393|NCT03416010|364229561|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
105608394|NCT03416010|364229562|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
105608395|NCT03416010|364229561|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
105608396|NCT03416010|364229562|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
105608397|NCT03416010|364229561|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
105608398|NCT03416010|364229562|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
105608399|NCT03416010|364229561|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
105608400|NCT03416010|364229562|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
105608401|NCT03416010|364229561|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
105608402|NCT03416010|364229562|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
105608403|NCT05113966|364229563|FG000|Overall Study|Death|21|||
105608404|NCT05113966|364229563|FG000|Overall Study|Study Terminated by Sponsor|9|||
105608405|NCT05386355|364229564|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
105608406|NCT05386355|364229565|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
105608407|NCT05386355|364229566|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
105608408|NCT05386355|364229567|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
105608409|NCT05058391|364229579|FG000|Overall Study|Adverse Event|1|||
105608410|NCT03584516|364229580|FG000|Part 1|Death|2|||
105608411|NCT03584516|364229581|FG001|Part 1|Death|3|||
105608412|NCT03584516|364229582|FG002|Part 1|Death|0|||
105608413|NCT03584516|364229583|FG003|Part 1|Death|0|||
105608414|NCT03584516|364229584|FG004|Part 1|Death|0|||
105608415|NCT03584516|364229585|FG005|Part 1|Death|0|||
105608416|NCT03584516|364229580|FG000|Part 1|Withdrawal by Subject|2|||
105608417|NCT03584516|364229581|FG001|Part 1|Withdrawal by Subject|0|||
105608418|NCT03584516|364229582|FG002|Part 1|Withdrawal by Subject|0|||
105608419|NCT03584516|364229583|FG003|Part 1|Withdrawal by Subject|0|||
105608420|NCT03584516|364229584|FG004|Part 1|Withdrawal by Subject|0|||
105608421|NCT03584516|364229585|FG005|Part 1|Withdrawal by Subject|0|||
105608422|NCT03584516|364229580|FG000|Part 1|Lost to Follow-up|1|||
105608423|NCT03584516|364229581|FG001|Part 1|Lost to Follow-up|0|||
105608424|NCT03584516|364229582|FG002|Part 1|Lost to Follow-up|0|||
105608425|NCT03584516|364229583|FG003|Part 1|Lost to Follow-up|0|||
105608426|NCT03584516|364229584|FG004|Part 1|Lost to Follow-up|0|||
105608427|NCT03584516|364229585|FG005|Part 1|Lost to Follow-up|0|||
105608428|NCT03584516|364229580|FG000|Part 1|Study Terminated by Sponsor|0|||
105608429|NCT03584516|364229581|FG001|Part 1|Study Terminated by Sponsor|2|||
105608430|NCT03584516|364229582|FG002|Part 1|Study Terminated by Sponsor|0|||
105608431|NCT03584516|364229583|FG003|Part 1|Study Terminated by Sponsor|0|||
105608432|NCT03584516|364229584|FG004|Part 1|Study Terminated by Sponsor|0|||
105608433|NCT03584516|364229585|FG005|Part 1|Study Terminated by Sponsor|0|||
105608434|NCT03584516|364229580|FG000|Part 1 Expansion|Death|0|||
105608435|NCT03584516|364229581|FG001|Part 1 Expansion|Death|0|||
105608436|NCT03584516|364229582|FG002|Part 1 Expansion|Death|9|||
105608437|NCT03584516|364229583|FG003|Part 1 Expansion|Death|8|||
105608438|NCT03584516|364229584|FG004|Part 1 Expansion|Death|4|||
105608439|NCT03584516|364229585|FG005|Part 1 Expansion|Death|5|||
105608440|NCT03584516|364229580|FG000|Part 1 Expansion|Lost to Follow-up|0|||
105608441|NCT03584516|364229581|FG001|Part 1 Expansion|Lost to Follow-up|0|||
105608442|NCT03584516|364229582|FG002|Part 1 Expansion|Lost to Follow-up|0|||
105608443|NCT03584516|364229583|FG003|Part 1 Expansion|Lost to Follow-up|1|||
105608444|NCT03584516|364229584|FG004|Part 1 Expansion|Lost to Follow-up|0|||
105608445|NCT03584516|364229585|FG005|Part 1 Expansion|Lost to Follow-up|0|||
105608446|NCT03584516|364229580|FG000|Part 1 Expansion|Physician Decision|0|||
105608447|NCT03584516|364229581|FG001|Part 1 Expansion|Physician Decision|0|||
105608448|NCT03584516|364229582|FG002|Part 1 Expansion|Physician Decision|4|||
105608449|NCT03584516|364229583|FG003|Part 1 Expansion|Physician Decision|3|||
105608450|NCT03584516|364229584|FG004|Part 1 Expansion|Physician Decision|2|||
105608451|NCT03584516|364229585|FG005|Part 1 Expansion|Physician Decision|3|||
105608452|NCT03584516|364229580|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
105608453|NCT03584516|364229581|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
105608454|NCT03584516|364229582|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
105608455|NCT03584516|364229583|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
105608456|NCT03584516|364229584|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
105608457|NCT03584516|364229585|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
105608458|NCT03584516|364229580|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
105608459|NCT03584516|364229581|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
105608460|NCT03584516|364229582|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
105608461|NCT03584516|364229583|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
105608462|NCT03584516|364229584|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
105608463|NCT03584516|364229585|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
105608464|NCT03584516|364229580|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
105608465|NCT03584516|364229581|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
105608466|NCT03584516|364229582|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
105608467|NCT03584516|364229583|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
105608468|NCT03584516|364229584|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
105608469|NCT03584516|364229585|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
105608470|NCT03584516|364229580|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
105608471|NCT03584516|364229581|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
105608472|NCT03584516|364229582|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
105608473|NCT03584516|364229583|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
105608474|NCT03584516|364229584|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
105608475|NCT03584516|364229585|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
105608476|NCT04868110|364229589|FG000|Overall Study|Withdrawal by Subject|3|||
105608477|NCT04868110|364229590|FG001|Overall Study|Withdrawal by Subject|4|||
105608478|NCT03263026|364229591|FG000|Overall Study|Withdrawal by Subject|1|||
105608479|NCT03263026|364229592|FG001|Overall Study|Withdrawal by Subject|0|||
105608480|NCT03263026|364229591|FG000|Overall Study|Death|1|||
105608481|NCT03263026|364229592|FG001|Overall Study|Death|0|||
105608482|NCT03263026|364229591|FG000|Overall Study|Other/ Various|41|||
105608483|NCT03263026|364229592|FG001|Overall Study|Other/ Various|29|||
105608484|NCT03833245|364229595|FG000|Overall Study|Death|0|||
105608485|NCT03833245|364229596|FG001|Overall Study|Death|1|||
105608486|NCT05608005|364229608|FG000|Overall Study|Adverse Event|2|||
105608487|NCT05608005|364229609|FG001|Overall Study|Adverse Event|1|||
105608488|NCT05608005|364229610|FG002|Overall Study|Adverse Event|3|||
105608489|NCT05608005|364229608|FG000|Overall Study|Protocol Violation|2|||
105608490|NCT05608005|364229609|FG001|Overall Study|Protocol Violation|3|||
105608491|NCT05608005|364229610|FG002|Overall Study|Protocol Violation|0|||
105608492|NCT05608005|364229608|FG000|Overall Study|Withdrawal by Subject|10|||
105608493|NCT05608005|364229609|FG001|Overall Study|Withdrawal by Subject|12|||
105608494|NCT05608005|364229610|FG002|Overall Study|Withdrawal by Subject|4|||
105608495|NCT05608005|364229608|FG000|Overall Study|Lost to Follow-up|25|||
105608496|NCT05608005|364229609|FG001|Overall Study|Lost to Follow-up|27|||
105608497|NCT05608005|364229610|FG002|Overall Study|Lost to Follow-up|15|||
105608498|NCT05608005|364229608|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
105608499|NCT05608005|364229609|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
105608500|NCT05608005|364229610|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
105608501|NCT03739996|364229611|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
105608502|NCT03739996|364229611|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
105608503|NCT03739996|364229611|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
105608504|NCT03739996|364229611|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
105608505|NCT03739996|364229611|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
105608506|NCT03739996|364229611|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
105608507|NCT03739996|364229611|FG000|Step 3 (SOC ART)|Death|1|||
105608508|NCT03739996|364229611|FG000|Step 3 (SOC ART)|Participant moved|1|||
105608509|NCT05387447|364229612|FG000|Overall Study|Participants changed their minds about study participation.|3|||
105608510|NCT05387447|364229613|FG001|Overall Study|Participants changed their minds about study participation.|5|||
105608511|NCT01673984|364229614|FG000|Overall Study|Adverse Event|1|||
105608512|NCT01673984|364229615|FG001|Overall Study|Adverse Event|0|||
105608513|NCT01673984|364229614|FG000|Overall Study|Study termination|9|||
105608514|NCT01673984|364229615|FG001|Overall Study|Study termination|6|||
105608515|NCT05062265|364229616|FG000|Overall Study|Withdrawal by Subject|1|||
105608516|NCT05062265|364229617|FG001|Overall Study|Withdrawal by Subject|0|||
105608517|NCT02919449|364229621|FG000|Overall Study|Withdrawal by Subject|1|||
105608518|NCT02919449|364229621|FG000|Overall Study|Investigator decision|1|||
105608519|NCT01376700|364229622|FG000|Overall Study|Sponsor terminated study early|8|||
105608520|NCT01376700|364229622|FG000|Overall Study|Low or high titer inhibitor|8|||
105608521|NCT02500758|364229623|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
105608522|NCT02500758|364229624|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
105608523|NCT02500758|364229623|FG000|Washout (1 Week)|Lost to Follow-up|2|||
105608524|NCT02500758|364229624|FG001|Washout (1 Week)|Lost to Follow-up|2|||
105608525|NCT02500758|364229623|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
105608526|NCT02500758|364229624|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
105608527|NCT02500758|364229623|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
105608528|NCT02500758|364229624|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
105608529|NCT02500758|364229623|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
105608530|NCT02500758|364229624|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
105608531|NCT03578536|364229625|FG000|Overall Study|Lost to Follow-up|1|||
105608532|NCT02063724|364229627|FG000|Overall Study|Disease progression|1|||
105608533|NCT04436107|364229628|FG000|Overall Study|Sponsor Ended Study|2|||
105608534|NCT04436107|364229629|FG001|Overall Study|Sponsor Ended Study|4|||
105608535|NCT04436107|364229630|FG002|Overall Study|Sponsor Ended Study|8|||
105608536|NCT04436107|364229631|FG003|Overall Study|Sponsor Ended Study|20|||
105608537|NCT04436107|364229628|FG000|Overall Study|Death|3|||
105608538|NCT04436107|364229629|FG001|Overall Study|Death|5|||
105608539|NCT04436107|364229630|FG002|Overall Study|Death|3|||
105608540|NCT04436107|364229631|FG003|Overall Study|Death|18|||
105608541|NCT04436107|364229628|FG000|Overall Study|Withdrawal by Subject|1|||
105608542|NCT04436107|364229629|FG001|Overall Study|Withdrawal by Subject|1|||
105608543|NCT04436107|364229630|FG002|Overall Study|Withdrawal by Subject|0|||
105608544|NCT04436107|364229631|FG003|Overall Study|Withdrawal by Subject|1|||
105608545|NCT04287985|364229632|FG000|Overall Study|Adverse Event|1|||
105608546|NCT04287985|364229633|FG001|Overall Study|Adverse Event|0|||
105608547|NCT04287985|364229634|FG002|Overall Study|Adverse Event|0|||
105608548|NCT04287985|364229635|FG003|Overall Study|Adverse Event|0|||
105608549|NCT04287985|364229632|FG000|Overall Study|Protocol Violation|0|||
105608550|NCT04287985|364229633|FG001|Overall Study|Protocol Violation|1|||
105608551|NCT04287985|364229634|FG002|Overall Study|Protocol Violation|0|||
105608552|NCT04287985|364229635|FG003|Overall Study|Protocol Violation|0|||
105608553|NCT04287985|364229632|FG000|Overall Study|Physician Decision|0|||
105608554|NCT04287985|364229633|FG001|Overall Study|Physician Decision|0|||
105608555|NCT04287985|364229634|FG002|Overall Study|Physician Decision|0|||
105608556|NCT04287985|364229635|FG003|Overall Study|Physician Decision|1|||
105608557|NCT04287985|364229632|FG000|Overall Study|Withdrawal by Subject|2|||
105608558|NCT04287985|364229633|FG001|Overall Study|Withdrawal by Subject|1|||
105608559|NCT04287985|364229634|FG002|Overall Study|Withdrawal by Subject|1|||
105608560|NCT04287985|364229635|FG003|Overall Study|Withdrawal by Subject|2|||
105608561|NCT04116736|364229636|FG000|Overall Study|Withdrew consent during study|3|||
105608562|NCT04116736|364229637|FG001|Overall Study|Withdrew consent during study|1|||
105608563|NCT04116736|364229636|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
105608564|NCT04116736|364229637|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
105608565|NCT04116736|364229636|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
105608566|NCT04116736|364229637|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
105608567|NCT04116736|364229636|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
105608568|NCT04116736|364229637|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
105608569|NCT04116736|364229636|FG000|Overall Study|Subject was enrolled in error|2|||
105608570|NCT04116736|364229637|FG001|Overall Study|Subject was enrolled in error|0|||
105608571|NCT04116736|364229636|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
105608572|NCT04116736|364229637|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
105608573|NCT04116736|364229636|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
105608574|NCT04116736|364229637|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
105608575|NCT04116736|364229636|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
105608576|NCT04116736|364229637|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
105608577|NCT00274469|364229642|FG000|Overall Study|Death|63|||
105608578|NCT00274469|364229643|FG001|Overall Study|Death|74|||
105608579|NCT00274469|364229642|FG000|Overall Study|Did not consent to OS follow-up|16|||
105608580|NCT00274469|364229643|FG001|Overall Study|Did not consent to OS follow-up|19|||
105608581|NCT02811679|364229645|FG000|Overall Study|Adverse Event|1|||
105608582|NCT02811679|364229645|FG000|Overall Study|Lack of Efficacy|6|||
105608583|NCT02811679|364229645|FG000|Overall Study|Early study closure due to slow accrual|3|||
105608584|NCT03941860|364229646|FG000|Overall Study|Withdrawal by Subject|0|||
105608585|NCT03941860|364229647|FG001|Overall Study|Withdrawal by Subject|1|||
105608586|NCT02140645|364229648|FG000|Overall Study|Not linked|5489|||
105608587|NCT02140645|364229649|FG001|Overall Study|Not linked|61654|||
105608588|NCT02140645|364229650|FG002|Overall Study|Not linked|4236|||
105608589|NCT02140645|364229651|FG003|Overall Study|Not linked|13833|||
105608590|NCT02140645|364229652|FG004|Overall Study|Not linked|3286|||
105608591|NCT02140645|364229653|FG005|Overall Study|Not linked|70896|||
105608592|NCT01872078|364229654|FG000|Overall Study|Adverse Event|0|||
105608593|NCT01872078|364229655|FG001|Overall Study|Adverse Event|0|||
105608594|NCT01872078|364229656|FG002|Overall Study|Adverse Event|1|||
105608595|NCT01872078|364229657|FG003|Overall Study|Adverse Event|0|||
105608596|NCT01872078|364229654|FG000|Overall Study|Dose administration non-compliance|0|||
105608597|NCT01872078|364229655|FG001|Overall Study|Dose administration non-compliance|0|||
105608598|NCT01872078|364229656|FG002|Overall Study|Dose administration non-compliance|0|||
105608599|NCT01872078|364229657|FG003|Overall Study|Dose administration non-compliance|1|||
105608600|NCT01872078|364229654|FG000|Overall Study|Protocol Violation|0|||
105608601|NCT01872078|364229655|FG001|Overall Study|Protocol Violation|0|||
105608602|NCT01872078|364229656|FG002|Overall Study|Protocol Violation|1|||
105608603|NCT01872078|364229657|FG003|Overall Study|Protocol Violation|0|||
105608604|NCT01872078|364229654|FG000|Overall Study|Withdrawal by Subject|0|||
105608605|NCT01872078|364229655|FG001|Overall Study|Withdrawal by Subject|0|||
105608606|NCT01872078|364229656|FG002|Overall Study|Withdrawal by Subject|1|||
105608607|NCT01872078|364229657|FG003|Overall Study|Withdrawal by Subject|0|||
105608608|NCT01872078|364229654|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
105608609|NCT01872078|364229655|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
105608610|NCT01872078|364229656|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
105608611|NCT01872078|364229657|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
105608612|NCT03580369|364229658|FG000|Overall Study|No treatment due to mis-randomization|1|||
105608613|NCT03580369|364229659|FG001|Overall Study|No treatment due to mis-randomization|0|||
105608614|NCT03580369|364229660|FG002|Overall Study|No treatment due to mis-randomization|0|||
105608615|NCT03580369|364229661|FG003|Overall Study|No treatment due to mis-randomization|0|||
105608616|NCT03580369|364229662|FG004|Overall Study|No treatment due to mis-randomization|3|||
105608617|NCT03580369|364229663|FG005|Overall Study|No treatment due to mis-randomization|0|||
105608618|NCT03580369|364229664|FG006|Overall Study|No treatment due to mis-randomization|0|||
105608619|NCT03580369|364229665|FG007|Overall Study|No treatment due to mis-randomization|0|||
105608620|NCT03580369|364229658|FG000|Overall Study|Reason unknown|0|||
105608621|NCT03580369|364229659|FG001|Overall Study|Reason unknown|0|||
105608622|NCT03580369|364229660|FG002|Overall Study|Reason unknown|1|||
105608623|NCT03580369|364229661|FG003|Overall Study|Reason unknown|0|||
105608624|NCT03580369|364229662|FG004|Overall Study|Reason unknown|0|||
105608625|NCT03580369|364229663|FG005|Overall Study|Reason unknown|0|||
105608626|NCT03580369|364229664|FG006|Overall Study|Reason unknown|0|||
105608627|NCT03580369|364229665|FG007|Overall Study|Reason unknown|0|||
105608628|NCT03580369|364229658|FG000|Overall Study|Technical problems|0|||
105608629|NCT03580369|364229659|FG001|Overall Study|Technical problems|0|||
105608630|NCT03580369|364229660|FG002|Overall Study|Technical problems|0|||
105608631|NCT03580369|364229661|FG003|Overall Study|Technical problems|0|||
105608632|NCT03580369|364229662|FG004|Overall Study|Technical problems|1|||
105608633|NCT03580369|364229663|FG005|Overall Study|Technical problems|0|||
105608634|NCT03580369|364229664|FG006|Overall Study|Technical problems|2|||
105608635|NCT03580369|364229665|FG007|Overall Study|Technical problems|0|||
105608636|NCT03580369|364229658|FG000|Overall Study|Pregnancy|2|||
105608637|NCT03580369|364229659|FG001|Overall Study|Pregnancy|0|||
105608638|NCT03580369|364229660|FG002|Overall Study|Pregnancy|3|||
105608639|NCT03580369|364229661|FG003|Overall Study|Pregnancy|0|||
105608640|NCT03580369|364229662|FG004|Overall Study|Pregnancy|2|||
105608641|NCT03580369|364229663|FG005|Overall Study|Pregnancy|0|||
105608642|NCT03580369|364229664|FG006|Overall Study|Pregnancy|0|||
105608643|NCT03580369|364229665|FG007|Overall Study|Pregnancy|0|||
105608644|NCT03580369|364229658|FG000|Overall Study|Lost to Follow-up|2|||
105608645|NCT03580369|364229659|FG001|Overall Study|Lost to Follow-up|0|||
105608646|NCT03580369|364229660|FG002|Overall Study|Lost to Follow-up|2|||
105608647|NCT03580369|364229661|FG003|Overall Study|Lost to Follow-up|0|||
105608648|NCT03580369|364229662|FG004|Overall Study|Lost to Follow-up|3|||
105608649|NCT03580369|364229663|FG005|Overall Study|Lost to Follow-up|0|||
105608650|NCT03580369|364229664|FG006|Overall Study|Lost to Follow-up|1|||
105608651|NCT03580369|364229665|FG007|Overall Study|Lost to Follow-up|0|||
105608652|NCT03580369|364229658|FG000|Overall Study|Physician Decision|4|||
105608653|NCT03580369|364229659|FG001|Overall Study|Physician Decision|0|||
105608654|NCT03580369|364229660|FG002|Overall Study|Physician Decision|4|||
105608655|NCT03580369|364229661|FG003|Overall Study|Physician Decision|1|||
105608656|NCT03580369|364229662|FG004|Overall Study|Physician Decision|1|||
105608657|NCT03580369|364229663|FG005|Overall Study|Physician Decision|0|||
105608658|NCT03580369|364229664|FG006|Overall Study|Physician Decision|0|||
105608659|NCT03580369|364229665|FG007|Overall Study|Physician Decision|0|||
105608660|NCT03580369|364229658|FG000|Overall Study|Lack of Efficacy|3|||
105608661|NCT03580369|364229659|FG001|Overall Study|Lack of Efficacy|0|||
105608662|NCT03580369|364229660|FG002|Overall Study|Lack of Efficacy|7|||
105608663|NCT03580369|364229661|FG003|Overall Study|Lack of Efficacy|0|||
105608664|NCT03580369|364229662|FG004|Overall Study|Lack of Efficacy|2|||
105608665|NCT03580369|364229663|FG005|Overall Study|Lack of Efficacy|0|||
105608666|NCT03580369|364229664|FG006|Overall Study|Lack of Efficacy|3|||
105608667|NCT03580369|364229665|FG007|Overall Study|Lack of Efficacy|0|||
105608668|NCT03580369|364229658|FG000|Overall Study|Protocol Violation|6|||
105608669|NCT03580369|364229659|FG001|Overall Study|Protocol Violation|0|||
105608670|NCT03580369|364229660|FG002|Overall Study|Protocol Violation|6|||
105608671|NCT03580369|364229661|FG003|Overall Study|Protocol Violation|1|||
105608672|NCT03580369|364229662|FG004|Overall Study|Protocol Violation|8|||
105608673|NCT03580369|364229663|FG005|Overall Study|Protocol Violation|2|||
105608674|NCT03580369|364229664|FG006|Overall Study|Protocol Violation|1|||
105608675|NCT03580369|364229665|FG007|Overall Study|Protocol Violation|0|||
105608676|NCT03580369|364229658|FG000|Overall Study|Adverse Event|7|||
105608677|NCT03580369|364229659|FG001|Overall Study|Adverse Event|0|||
105608678|NCT03580369|364229660|FG002|Overall Study|Adverse Event|14|||
105608679|NCT03580369|364229661|FG003|Overall Study|Adverse Event|1|||
105608680|NCT03580369|364229662|FG004|Overall Study|Adverse Event|6|||
105608681|NCT03580369|364229663|FG005|Overall Study|Adverse Event|0|||
105608682|NCT03580369|364229664|FG006|Overall Study|Adverse Event|1|||
105608683|NCT03580369|364229665|FG007|Overall Study|Adverse Event|0|||
105608684|NCT03580369|364229658|FG000|Overall Study|Withdrawal by Subject|19|||
105608685|NCT03580369|364229659|FG001|Overall Study|Withdrawal by Subject|0|||
105608686|NCT03580369|364229660|FG002|Overall Study|Withdrawal by Subject|17|||
105608687|NCT03580369|364229661|FG003|Overall Study|Withdrawal by Subject|0|||
105608688|NCT03580369|364229662|FG004|Overall Study|Withdrawal by Subject|16|||
105608689|NCT03580369|364229663|FG005|Overall Study|Withdrawal by Subject|1|||
105608690|NCT03580369|364229664|FG006|Overall Study|Withdrawal by Subject|7|||
105608691|NCT03580369|364229665|FG007|Overall Study|Withdrawal by Subject|0|||
105608692|NCT02119650|364229666|FG000|Overall Study|Adverse Event|3|||
105608693|NCT02119650|364229667|FG001|Overall Study|Adverse Event|4|||
105608694|NCT02119650|364229666|FG000|Overall Study|Subject decision|2|||
105608695|NCT02119650|364229667|FG001|Overall Study|Subject decision|3|||
105608696|NCT02119650|364229666|FG000|Overall Study|Disease progression|11|||
105608697|NCT02119650|364229667|FG001|Overall Study|Disease progression|14|||
105608698|NCT02119650|364229666|FG000|Overall Study|Death|5|||
105608699|NCT02119650|364229667|FG001|Overall Study|Death|1|||
105608700|NCT02119650|364229666|FG000|Overall Study|Noncompliance with study treatment|1|||
105608701|NCT02119650|364229667|FG001|Overall Study|Noncompliance with study treatment|1|||
105608702|NCT02119650|364229666|FG000|Overall Study|Study terminated by the sponsor|1|||
105608703|NCT02119650|364229667|FG001|Overall Study|Study terminated by the sponsor|0|||
105608704|NCT02119650|364229666|FG000|Overall Study|Physician Decision|0|||
105608705|NCT02119650|364229667|FG001|Overall Study|Physician Decision|2|||
105608706|NCT02119650|364229666|FG000|Overall Study|Multiple reasons for termination|2|||
105608707|NCT02119650|364229667|FG001|Overall Study|Multiple reasons for termination|1|||
105608708|NCT02910713|364229669|FG000|Overall Study|Protocol Violation|2|||
105608709|NCT02910713|364229669|FG000|Overall Study|Subject Choice|4|||
105608710|NCT02910713|364229669|FG000|Overall Study|Received One Application|10|||
105608711|NCT02910713|364229669|FG000|Overall Study|Received Neither Application|18|||
105608712|NCT02910713|364229669|FG000|Overall Study|Enrollment cap|7|||
105608713|NCT02910713|364229669|FG000|Overall Study|Investigator Discretion|1|||
105608714|NCT03744312|364231232|FG000|Overall Study|Withdrawal by Subject|0|||
105608715|NCT03744312|364231233|FG001|Overall Study|Withdrawal by Subject|1|||
105608716|NCT03744312|364231232|FG000|Overall Study|Screen fail|0|||
105608717|NCT03744312|364231233|FG001|Overall Study|Screen fail|1|||
105608718|NCT00186992|364231234|FG000|Overall Study|Withdrawal by Subject|5|||
105608719|NCT00186992|364231234|FG000|Overall Study|Physician's discretion|13|||
105608720|NCT00186992|364231234|FG000|Overall Study|PI Discretion|4|||
105608721|NCT00186992|364231234|FG000|Overall Study|Ineligible|2|||
105608722|NCT00186992|364231234|FG000|Overall Study|Lost to Follow-up|2|||
105608723|NCT00186992|364231234|FG000|Overall Study|Still on Study|9|||
105608724|NCT02392429|364231235|FG000|Screening|Screen failure|15|||
105608725|NCT02392429|364231235|FG000|Enrolled Participants|Ineligible due to disease|3|||
105608726|NCT02392429|364231235|FG000|Enrolled Participants|Withdrawal by Subject|4|||
105608727|NCT02392429|364231235|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
105608728|NCT02392429|364231235|FG000|Evaluable|Death|5|||
105608729|NCT02392429|364231235|FG000|Evaluable|Withdrawal by Subject|1|||
105608730|NCT02392429|364231235|FG000|Evaluable|Adverse Event|1|||
105608731|NCT02392429|364231235|FG000|Evaluable|remission bone marrow biopsy|3|||
105608732|NCT05307978|364231236|FG000|Overall Study|Lost to Follow-up|0|||
105608733|NCT05307978|364231237|FG001|Overall Study|Lost to Follow-up|1|||
105608734|NCT05307978|364231238|FG002|Overall Study|Lost to Follow-up|0|||
105608735|NCT05307978|364231239|FG003|Overall Study|Lost to Follow-up|4|||
105608736|NCT05307978|364231240|FG004|Overall Study|Lost to Follow-up|0|||
105608737|NCT05307978|364231241|FG005|Overall Study|Lost to Follow-up|0|||
105608738|NCT05307978|364231242|FG006|Overall Study|Lost to Follow-up|1|||
105608739|NCT04607044|364231243|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
105608740|NCT04607044|364231243|FG000|Overall Study|Adverse Event|1|||
105608741|NCT04607044|364231243|FG000|Overall Study|Did not receive study device|3|||
105608742|NCT04607044|364231243|FG000|Overall Study|Death|1|||
105608743|NCT04396366|364231244|FG000|Overall Study|Adverse Event|1|||
105608744|NCT04396366|364231245|FG001|Overall Study|Adverse Event|0|||
105608745|NCT04059354|364231248|FG000|Overall Study|COVID-19 pandemic|3|||
105608746|NCT05403801|364231249|FG000|Overall Study|Withdrawal by Subject|2|||
105608747|NCT02396199|364231257|FG000|Overall Study|Lost to Follow-up|1|||
105608748|NCT02396199|364231257|FG000|Overall Study|Death|4|||
105608749|NCT01064440|364231265|FG000|Overall Study|Lost to Follow-up|1|||
105608750|NCT01064440|364231266|FG001|Overall Study|Lost to Follow-up|1|||
105608751|NCT01064440|364231267|FG002|Overall Study|Lost to Follow-up|1|||
105608752|NCT01064440|364231265|FG000|Overall Study|Non-compliance|0|||
105608753|NCT01064440|364231266|FG001|Overall Study|Non-compliance|1|||
105608754|NCT01064440|364231267|FG002|Overall Study|Non-compliance|0|||
105608755|NCT01064440|364231265|FG000|Overall Study|Death|1|||
105608756|NCT01064440|364231266|FG001|Overall Study|Death|0|||
105608757|NCT01064440|364231267|FG002|Overall Study|Death|1|||
105608758|NCT01064440|364231265|FG000|Overall Study|Withdrawal by Subject|0|||
105608759|NCT01064440|364231266|FG001|Overall Study|Withdrawal by Subject|1|||
105608760|NCT01064440|364231267|FG002|Overall Study|Withdrawal by Subject|1|||
105608761|NCT01064440|364231265|FG000|Overall Study|Other: amputation|1|||
105608762|NCT01064440|364231266|FG001|Overall Study|Other: amputation|0|||
105608763|NCT01064440|364231267|FG002|Overall Study|Other: amputation|0|||
105608764|NCT04337372|364231268|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
105608765|NCT04337372|364231269|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
105608766|NCT04337372|364231270|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
105608767|NCT04337372|364231271|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
105608768|NCT04337372|364231268|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
105608769|NCT04337372|364231269|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
105608770|NCT04337372|364231270|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
105608771|NCT04337372|364231271|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
105608772|NCT04337372|364231268|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
105608773|NCT04337372|364231269|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
105608774|NCT04337372|364231270|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
105608775|NCT04337372|364231271|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
105608776|NCT04337372|364231268|FG000|Day 2: EEG Measures|Protocol Violation|6|||
105608777|NCT04337372|364231269|FG001|Day 2: EEG Measures|Protocol Violation|6|||
105608778|NCT04337372|364231270|FG002|Day 2: EEG Measures|Protocol Violation|5|||
105608779|NCT04337372|364231271|FG003|Day 2: EEG Measures|Protocol Violation|17|||
105608780|NCT04883645|364231272|FG000|Overall Study|Death|1|||
105608781|NCT03460236|364231273|FG000|Overall Study|failed radiographic screening|16|||
105608782|NCT03460236|364231273|FG000|Overall Study|Withdrawal by Subject|11|||
105608783|NCT05687903|364231274|FG000|Overall Study|Protocol Deviation|1|||
105608784|NCT05687903|364231275|FG001|Overall Study|Protocol Deviation|1|||
105608785|NCT05687903|364231276|FG002|Overall Study|Protocol Deviation|0|||
105608786|NCT05687903|364231277|FG003|Overall Study|Protocol Deviation|1|||
105608787|NCT05687903|364231278|FG004|Overall Study|Protocol Deviation|0|||
105608788|NCT03424811|364231279|FG000|Overall Study|Lost to Follow-up|9|||
105608789|NCT03424811|364231280|FG001|Overall Study|Lost to Follow-up|0|||
105608790|NCT02473250|364231281|FG000|Overall Study|Lost to Follow-up|10|||
105608791|NCT02473250|364231281|FG000|Overall Study|Physician Decision|5|||
105608792|NCT02473250|364231281|FG000|Overall Study|Did not tolerate medication washout|3|||
105608793|NCT02473250|364231281|FG000|Overall Study|Antidepressant effect of divalproex|2|||
105608794|NCT06066541|364231284|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
105608795|NCT06066541|364231285|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
105608796|NCT06066541|364231286|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
105608797|NCT06066541|364231287|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
105608798|NCT06066541|364231288|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
105608799|NCT06066541|364231289|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
105608800|NCT06066541|364231290|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
105608801|NCT06066541|364231284|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
105608802|NCT06066541|364231285|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
105608803|NCT06066541|364231286|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
105608804|NCT06066541|364231287|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
105608805|NCT06066541|364231288|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
105608806|NCT06066541|364231289|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
105608807|NCT06066541|364231290|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
105608808|NCT01898494|364231291|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
105608809|NCT01898494|364231292|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
105608810|NCT01898494|364231293|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
105608811|NCT01898494|364231294|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
105608812|NCT01898494|364231295|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
105608813|NCT01898494|364231291|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
105608814|NCT01898494|364231292|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
105608815|NCT01898494|364231293|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
105608816|NCT01898494|364231294|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
105608817|NCT01898494|364231295|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
105608818|NCT01898494|364231291|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
105608819|NCT01898494|364231292|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
105608820|NCT01898494|364231293|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
105608821|NCT01898494|364231294|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
105608822|NCT01898494|364231295|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
105608823|NCT01898494|364231291|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
105608824|NCT01898494|364231292|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
105608825|NCT01898494|364231293|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
105608826|NCT01898494|364231294|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
105608827|NCT01898494|364231295|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
105608828|NCT01898494|364231291|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
105608829|NCT01898494|364231292|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
105608830|NCT01898494|364231293|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
105608831|NCT01898494|364231294|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
105608832|NCT01898494|364231295|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
105608833|NCT01898494|364231291|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
105608834|NCT01898494|364231292|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
105608835|NCT01898494|364231293|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
105608836|NCT01898494|364231294|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
105608837|NCT01898494|364231295|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
105608838|NCT01898494|364231291|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
105608839|NCT01898494|364231292|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
105608840|NCT01898494|364231293|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
105608841|NCT01898494|364231294|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
105608842|NCT01898494|364231295|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
105608843|NCT01898494|364231291|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
105608844|NCT01898494|364231292|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
105608845|NCT01898494|364231293|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
105608846|NCT01898494|364231294|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
105608847|NCT01898494|364231295|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
105608848|NCT01898494|364231291|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
105608849|NCT01898494|364231292|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
105608850|NCT01898494|364231293|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
105608851|NCT01898494|364231294|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
105608852|NCT01898494|364231295|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
105608853|NCT01898494|364231291|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
105608854|NCT01898494|364231292|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
105608855|NCT01898494|364231293|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
105608856|NCT01898494|364231294|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
105608857|NCT01898494|364231295|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
105608858|NCT01898494|364231291|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
105608859|NCT01898494|364231292|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
105608860|NCT01898494|364231293|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
105608861|NCT01898494|364231294|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
105608862|NCT01898494|364231295|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
105608863|NCT01898494|364231291|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
105608864|NCT01898494|364231292|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
105608865|NCT01898494|364231293|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
105608866|NCT01898494|364231294|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
105608867|NCT01898494|364231295|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
105608868|NCT01898494|364231291|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
105608869|NCT01898494|364231292|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
105608870|NCT01898494|364231293|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
105608871|NCT01898494|364231294|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
105608872|NCT01898494|364231295|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
105608873|NCT01898494|364231291|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
105608874|NCT01898494|364231292|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
105608875|NCT01898494|364231293|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
105608876|NCT01898494|364231294|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
105608877|NCT01898494|364231295|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
105608878|NCT02819843|364231296|FG000|Overall Study|Disease progression before RT|0|||
105608879|NCT02819843|364231297|FG001|Overall Study|Disease progression before RT|1|||
105608880|NCT02163447|364231298|FG000|Overall Study|Withdrawal by Subject|2|||
105608881|NCT02163447|364231299|FG001|Overall Study|Withdrawal by Subject|0|||
105608882|NCT02163447|364231300|FG002|Overall Study|Withdrawal by Subject|1|||
105608883|NCT02163447|364231298|FG000|Overall Study|Lost to Follow-up|1|||
105608884|NCT02163447|364231299|FG001|Overall Study|Lost to Follow-up|3|||
105608885|NCT02163447|364231300|FG002|Overall Study|Lost to Follow-up|0|||
105608886|NCT02163447|364231298|FG000|Overall Study|Moved out of study area|2|||
105608887|NCT02163447|364231299|FG001|Overall Study|Moved out of study area|3|||
105608888|NCT02163447|364231300|FG002|Overall Study|Moved out of study area|2|||
105608889|NCT02163447|364231298|FG000|Overall Study|Became HIV infected at time of delivery|1|||
105608890|NCT02163447|364231299|FG001|Overall Study|Became HIV infected at time of delivery|0|||
105608891|NCT02163447|364231300|FG002|Overall Study|Became HIV infected at time of delivery|0|||
105608892|NCT01718743|364231305|FG000|Overall Study|Physician Decision|7|||
105608893|NCT01718743|364231305|FG000|Overall Study|Withdrawal by Subject|14|||
105608894|NCT01718743|364231305|FG000|Overall Study|Progressive Disease|22|||
105608895|NCT01718743|364231305|FG000|Overall Study|Toxicity|1|||
105608896|NCT01718743|364231305|FG000|Overall Study|Malignancy|1|||
105608897|NCT03897686|364231306|FG000|Overall Study|Protocol Violation|1|||
105608898|NCT03897686|364231307|FG001|Overall Study|Protocol Violation|1|||
105608899|NCT03897686|364231306|FG000|Overall Study|Withdrawal by Subject|1|||
105608900|NCT03897686|364231307|FG001|Overall Study|Withdrawal by Subject|1|||
105608901|NCT03948763|364231308|FG000|Overall Study|Sponsor's decision|0|||
105608902|NCT03948763|364231309|FG001|Overall Study|Sponsor's decision|2|||
105608903|NCT03948763|364231310|FG002|Overall Study|Sponsor's decision|6|||
105608904|NCT03948763|364231311|FG003|Overall Study|Sponsor's decision|4|||
105608905|NCT03948763|364231312|FG004|Overall Study|Sponsor's decision|0|||
105608906|NCT03948763|364231308|FG000|Overall Study|Physician Decision|0|||
105608907|NCT03948763|364231309|FG001|Overall Study|Physician Decision|0|||
105608908|NCT03948763|364231310|FG002|Overall Study|Physician Decision|1|||
105608909|NCT03948763|364231311|FG003|Overall Study|Physician Decision|0|||
105608910|NCT03948763|364231312|FG004|Overall Study|Physician Decision|0|||
105608911|NCT03948763|364231308|FG000|Overall Study|Lost to Follow-up|0|||
105608912|NCT03948763|364231309|FG001|Overall Study|Lost to Follow-up|0|||
105608913|NCT03948763|364231310|FG002|Overall Study|Lost to Follow-up|0|||
105608914|NCT03948763|364231311|FG003|Overall Study|Lost to Follow-up|0|||
105608915|NCT03948763|364231312|FG004|Overall Study|Lost to Follow-up|1|||
105608916|NCT03948763|364231308|FG000|Overall Study|Death|2|||
105608917|NCT03948763|364231309|FG001|Overall Study|Death|12|||
105608918|NCT03948763|364231310|FG002|Overall Study|Death|13|||
105608919|NCT03948763|364231311|FG003|Overall Study|Death|10|||
105608920|NCT03948763|364231312|FG004|Overall Study|Death|11|||
105608921|NCT03948763|364231308|FG000|Overall Study|Withdrawal by Subject|1|||
105608922|NCT03948763|364231309|FG001|Overall Study|Withdrawal by Subject|1|||
105608923|NCT03948763|364231310|FG002|Overall Study|Withdrawal by Subject|0|||
105608924|NCT03948763|364231311|FG003|Overall Study|Withdrawal by Subject|2|||
105608925|NCT03948763|364231312|FG004|Overall Study|Withdrawal by Subject|4|||
105608926|NCT06023082|364231322|FG000|Overall Study|Withdrawal by Subject|2|||
105608927|NCT06023082|364231322|FG000|Overall Study|Lost to Follow-up|15|||
105608928|NCT06023082|364231322|FG000|Overall Study|Side effects|5|||
105608929|NCT05136404|364231323|FG000|Period 1|Adverse Event|0|||
105608930|NCT05136404|364231324|FG001|Period 1|Adverse Event|1|||
105608931|NCT05136404|364231325|FG002|Period 1|Adverse Event|1|||
105608932|NCT05136404|364231323|FG000|Period 2|Inappropriate Behavior|0|||
105608933|NCT05136404|364231324|FG001|Period 2|Inappropriate Behavior|0|||
105608934|NCT05136404|364231325|FG002|Period 2|Inappropriate Behavior|1|||
105608935|NCT05136404|364231323|FG000|Period 3|Adverse Event|0|||
105608936|NCT05136404|364231324|FG001|Period 3|Adverse Event|0|||
105608937|NCT05136404|364231325|FG002|Period 3|Adverse Event|1|||
105608938|NCT03347383|364231326|FG000|Overall Study|Death|39|||
105608939|NCT03347383|364231326|FG000|Overall Study|Withdrawal by Subject|3|||
105608940|NCT03347383|364231326|FG000|Overall Study|Lost to Follow-up|9|||
105608941|NCT05691452|364231327|FG000|Overall Study|Withdrawal by Subject|1|||
105608942|NCT05691452|364231328|FG001|Overall Study|Withdrawal by Subject|1|||
105608943|NCT05691452|364231329|FG002|Overall Study|Withdrawal by Subject|0|||
105608944|NCT05691452|364231327|FG000|Overall Study|Physician Decision|1|||
105608945|NCT05691452|364231328|FG001|Overall Study|Physician Decision|0|||
105608946|NCT05691452|364231329|FG002|Overall Study|Physician Decision|0|||
105608947|NCT05691452|364231327|FG000|Overall Study|Lost to Follow-up|0|||
105608948|NCT05691452|364231328|FG001|Overall Study|Lost to Follow-up|0|||
105608949|NCT05691452|364231329|FG002|Overall Study|Lost to Follow-up|1|||
105608950|NCT05691452|364231327|FG000|Overall Study|Adverse Event|0|||
105608951|NCT05691452|364231328|FG001|Overall Study|Adverse Event|0|||
105608952|NCT05691452|364231329|FG002|Overall Study|Adverse Event|1|||
105608953|NCT05054374|364231332|FG000|Overall Study|Withdrawal by Subject|1|||
105608954|NCT05054374|364231333|FG001|Overall Study|Withdrawal by Subject|0|||
105608955|NCT05054374|364231334|FG002|Overall Study|Withdrawal by Subject|0|||
105608956|NCT05054374|364231335|FG003|Overall Study|Withdrawal by Subject|0|||
105608957|NCT05054374|364231332|FG000|Overall Study|Progressive Disease|5|||
105608958|NCT05054374|364231333|FG001|Overall Study|Progressive Disease|0|||
105608959|NCT05054374|364231334|FG002|Overall Study|Progressive Disease|0|||
105608960|NCT05054374|364231335|FG003|Overall Study|Progressive Disease|0|||
105608961|NCT04251533|364231343|FG000|Overall Study|Progressive disease|33|||
105608962|NCT04251533|364231344|FG001|Overall Study|Progressive disease|29|||
105608963|NCT04251533|364231345|FG002|Overall Study|Progressive disease|22|||
105608964|NCT04251533|364231343|FG000|Overall Study|Death|5|||
105608965|NCT04251533|364231344|FG001|Overall Study|Death|1|||
105608966|NCT04251533|364231345|FG002|Overall Study|Death|3|||
105608967|NCT04251533|364231343|FG000|Overall Study|Physician Decision|3|||
105608968|NCT04251533|364231344|FG001|Overall Study|Physician Decision|2|||
105608969|NCT04251533|364231345|FG002|Overall Study|Physician Decision|4|||
105608970|NCT04251533|364231343|FG000|Overall Study|Participant decision|1|||
105608971|NCT04251533|364231344|FG001|Overall Study|Participant decision|3|||
105608972|NCT04251533|364231345|FG002|Overall Study|Participant decision|1|||
105608973|NCT04251533|364231343|FG000|Overall Study|Adverse Event|2|||
105608974|NCT04251533|364231344|FG001|Overall Study|Adverse Event|1|||
105608975|NCT04251533|364231345|FG002|Overall Study|Adverse Event|1|||
105608976|NCT04314895|364231346|FG000|Overall Study|Lost to Follow-up|1|||
105608977|NCT04314895|364231346|FG000|Overall Study|Death|10|||
105608978|NCT04314895|364231346|FG000|Overall Study|Physician Decision|2|||
105608979|NCT03361748|364231350|FG000|Overall Study|Death|77|||
105608980|NCT03361748|364231350|FG000|Overall Study|Lost to Follow-up|4|||
105608981|NCT03361748|364231350|FG000|Overall Study|Withdrawal by Subject|20|||
105608982|NCT05575076|364231351|FG000|Overall Study|Adverse Event|24|||
105608983|NCT05575076|364231351|FG000|Overall Study|Death|7|||
105608984|NCT05575076|364231351|FG000|Overall Study|Lost to Follow-up|16|||
105608985|NCT05575076|364231351|FG000|Overall Study|Non-Compliance|3|||
105608986|NCT05575076|364231351|FG000|Overall Study|Physician Decision|6|||
105608987|NCT05575076|364231351|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
105608988|NCT05575076|364231351|FG000|Overall Study|Withdrawal by Subject|71|||
105608989|NCT05575076|364231351|FG000|Overall Study|Study Terminated by Sponsor|630|||
105608990|NCT05575076|364231351|FG000|Overall Study|Other|17|||
105608991|NCT04093752|364231352|FG000|Overall Study|Adverse Event|7|||
105608992|NCT04093752|364231353|FG001|Overall Study|Adverse Event|19|||
105608993|NCT04093752|364231354|FG002|Overall Study|Adverse Event|18|||
105608994|NCT04093752|364231355|FG003|Overall Study|Adverse Event|4|||
105608995|NCT04093752|364231352|FG000|Overall Study|Withdrawal by Subject|6|||
105608996|NCT04093752|364231353|FG001|Overall Study|Withdrawal by Subject|6|||
105608997|NCT04093752|364231354|FG002|Overall Study|Withdrawal by Subject|8|||
105608998|NCT04093752|364231355|FG003|Overall Study|Withdrawal by Subject|20|||
105608999|NCT04093752|364231352|FG000|Overall Study|Lost to Follow-up|2|||
105609000|NCT04093752|364231353|FG001|Overall Study|Lost to Follow-up|1|||
105609001|NCT04093752|364231354|FG002|Overall Study|Lost to Follow-up|1|||
105609002|NCT04093752|364231355|FG003|Overall Study|Lost to Follow-up|1|||
105609003|NCT04093752|364231352|FG000|Overall Study|Death|0|||
105609004|NCT04093752|364231353|FG001|Overall Study|Death|0|||
105609005|NCT04093752|364231354|FG002|Overall Study|Death|1|||
105609006|NCT04093752|364231355|FG003|Overall Study|Death|2|||
105609007|NCT04093752|364231352|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
105609008|NCT04093752|364231353|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
105609009|NCT04093752|364231354|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
105609010|NCT04093752|364231355|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
105609011|NCT04093752|364231352|FG000|Overall Study|Covid 19|0|||
105609012|NCT04093752|364231353|FG001|Overall Study|Covid 19|0|||
105609013|NCT04093752|364231354|FG002|Overall Study|Covid 19|0|||
105609014|NCT04093752|364231355|FG003|Overall Study|Covid 19|1|||
105609015|NCT04093752|364231352|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
105609016|NCT04093752|364231353|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
105609017|NCT04093752|364231354|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
105609018|NCT04093752|364231355|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
105609019|NCT04093752|364231352|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
105609020|NCT04093752|364231353|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
105609021|NCT04093752|364231354|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
105609022|NCT04093752|364231355|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
105609023|NCT04093752|364231352|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
105609024|NCT04093752|364231353|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
105609025|NCT04093752|364231354|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
105609026|NCT04093752|364231355|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
105609027|NCT02376790|364231356|FG000|Overall Study|Withdrawal by Subject|43|||
105609028|NCT02376790|364231357|FG001|Overall Study|Withdrawal by Subject|36|||
105609029|NCT02376790|364231358|FG002|Overall Study|Withdrawal by Subject|37|||
105609030|NCT02376790|364231356|FG000|Overall Study|Decision by Sponsor|2|||
105609031|NCT02376790|364231357|FG001|Overall Study|Decision by Sponsor|1|||
105609032|NCT02376790|364231358|FG002|Overall Study|Decision by Sponsor|4|||
105609033|NCT02376790|364231356|FG000|Overall Study|Lost to Follow-up|15|||
105609034|NCT02376790|364231357|FG001|Overall Study|Lost to Follow-up|10|||
105609035|NCT02376790|364231358|FG002|Overall Study|Lost to Follow-up|12|||
105609036|NCT02829918|364231363|FG000|Overall Study|Death|2|||
105609037|NCT02829918|364231363|FG000|Overall Study|Withdrawal by Subject|4|||
105609038|NCT02829918|364231363|FG000|Overall Study|Adverse Event|1|||
105609039|NCT02829918|364231363|FG000|Overall Study|Progression|1|||
105609040|NCT04442126|364231367|FG000|Overall Study|Withdrawal by Subject|0|||
105609041|NCT04442126|364231368|FG001|Overall Study|Withdrawal by Subject|0|||
105609042|NCT04442126|364231369|FG002|Overall Study|Withdrawal by Subject|0|||
105609043|NCT04442126|364231370|FG003|Overall Study|Withdrawal by Subject|2|||
105609044|NCT04442126|364231371|FG004|Overall Study|Withdrawal by Subject|1|||
105609045|NCT04442126|364231372|FG005|Overall Study|Withdrawal by Subject|0|||
105609046|NCT04442126|364231373|FG006|Overall Study|Withdrawal by Subject|1|||
105609047|NCT04442126|364231374|FG007|Overall Study|Withdrawal by Subject|1|||
105609048|NCT04442126|364231375|FG008|Overall Study|Withdrawal by Subject|3|||
105609049|NCT04442126|364231367|FG000|Overall Study|Death|1|||
105609050|NCT04442126|364231368|FG001|Overall Study|Death|0|||
105609051|NCT04442126|364231369|FG002|Overall Study|Death|0|||
105609052|NCT04442126|364231370|FG003|Overall Study|Death|1|||
105609053|NCT04442126|364231371|FG004|Overall Study|Death|2|||
105609054|NCT04442126|364231372|FG005|Overall Study|Death|2|||
105609055|NCT04442126|364231373|FG006|Overall Study|Death|4|||
105609056|NCT04442126|364231374|FG007|Overall Study|Death|1|||
105609057|NCT04442126|364231375|FG008|Overall Study|Death|5|||
105609058|NCT04442126|364231367|FG000|Overall Study|Study Terminated by Sponsor|0|||
105609059|NCT04442126|364231368|FG001|Overall Study|Study Terminated by Sponsor|0|||
105609060|NCT04442126|364231369|FG002|Overall Study|Study Terminated by Sponsor|0|||
105609061|NCT04442126|364231370|FG003|Overall Study|Study Terminated by Sponsor|0|||
105609062|NCT04442126|364231371|FG004|Overall Study|Study Terminated by Sponsor|0|||
105609063|NCT04442126|364231372|FG005|Overall Study|Study Terminated by Sponsor|1|||
105609064|NCT04442126|364231373|FG006|Overall Study|Study Terminated by Sponsor|4|||
105609065|NCT04442126|364231374|FG007|Overall Study|Study Terminated by Sponsor|2|||
105609066|NCT04442126|364231375|FG008|Overall Study|Study Terminated by Sponsor|10|||
105609067|NCT04442126|364231367|FG000|Overall Study|Lost to Follow-up|0|||
105609068|NCT04442126|364231368|FG001|Overall Study|Lost to Follow-up|0|||
105609069|NCT04442126|364231369|FG002|Overall Study|Lost to Follow-up|0|||
105609070|NCT04442126|364231370|FG003|Overall Study|Lost to Follow-up|0|||
105609071|NCT04442126|364231371|FG004|Overall Study|Lost to Follow-up|0|||
105609072|NCT04442126|364231372|FG005|Overall Study|Lost to Follow-up|0|||
105609073|NCT04442126|364231373|FG006|Overall Study|Lost to Follow-up|0|||
105609074|NCT04442126|364231374|FG007|Overall Study|Lost to Follow-up|1|||
105609075|NCT04442126|364231375|FG008|Overall Study|Lost to Follow-up|2|||
105609076|NCT04442126|364231367|FG000|Overall Study|Progressive Disease|0|||
105609077|NCT04442126|364231368|FG001|Overall Study|Progressive Disease|1|||
105609078|NCT04442126|364231369|FG002|Overall Study|Progressive Disease|3|||
105609079|NCT04442126|364231370|FG003|Overall Study|Progressive Disease|0|||
105609080|NCT04442126|364231371|FG004|Overall Study|Progressive Disease|3|||
105609081|NCT04442126|364231372|FG005|Overall Study|Progressive Disease|0|||
105609082|NCT04442126|364231373|FG006|Overall Study|Progressive Disease|0|||
105609083|NCT04442126|364231374|FG007|Overall Study|Progressive Disease|0|||
105609084|NCT04442126|364231375|FG008|Overall Study|Progressive Disease|0|||
105609085|NCT04442126|364231367|FG000|Overall Study|Other|0|||
105609086|NCT04442126|364231368|FG001|Overall Study|Other|0|||
105609087|NCT04442126|364231369|FG002|Overall Study|Other|0|||
105609088|NCT04442126|364231370|FG003|Overall Study|Other|0|||
105609089|NCT04442126|364231371|FG004|Overall Study|Other|0|||
105609090|NCT04442126|364231372|FG005|Overall Study|Other|0|||
105609091|NCT04442126|364231373|FG006|Overall Study|Other|0|||
105609092|NCT04442126|364231374|FG007|Overall Study|Other|0|||
105609093|NCT04442126|364231375|FG008|Overall Study|Other|1|||
105609094|NCT03767517|364231379|FG000|Overall Study|Lost to Follow-up|16|||
105609095|NCT03767517|364231380|FG001|Overall Study|Lost to Follow-up|10|||
105609096|NCT03767517|364231379|FG000|Overall Study|Death|2|||
105609097|NCT03767517|364231380|FG001|Overall Study|Death|3|||
105609098|NCT04774237|364231381|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
105609099|NCT04774237|364231382|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
105609100|NCT04774237|364231383|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
105609101|NCT04774237|364231384|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
105609102|NCT04774237|364231385|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
105609103|NCT04774237|364231386|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
105609104|NCT03021486|364232193|FG000|Overall Study|Withdrawal by Subject|1|||
105609105|NCT03021486|364232194|FG001|Overall Study|Withdrawal by Subject|1|||
105609106|NCT03021486|364232195|FG002|Overall Study|Withdrawal by Subject|3|||
105609107|NCT03021486|364232193|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
105609108|NCT03021486|364232194|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
105609109|NCT03021486|364232195|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
105609110|NCT03055377|364232196|FG000|Treatment Phase|Lost to Follow-up|28|||
105609111|NCT03055377|364232197|FG001|Treatment Phase|Lost to Follow-up|24|||
105609112|NCT03055377|364232196|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
105609113|NCT03055377|364232197|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
105609114|NCT00739648|364232211|FG000|Overall Study|Adverse Event|3|||
105609115|NCT00739648|364232212|FG001|Overall Study|Adverse Event|15|||
105609116|NCT00739648|364232211|FG000|Overall Study|Withdrawal by Subject|13|||
105609117|NCT00739648|364232212|FG001|Overall Study|Withdrawal by Subject|25|||
105609118|NCT00739648|364232211|FG000|Overall Study|Lost to Follow-up|4|||
105609119|NCT00739648|364232212|FG001|Overall Study|Lost to Follow-up|7|||
105609120|NCT00739648|364232211|FG000|Overall Study|Death|2|||
105609121|NCT00739648|364232212|FG001|Overall Study|Death|0|||
105609122|NCT00739648|364232211|FG000|Overall Study|Do not know|4|||
105609123|NCT00739648|364232212|FG001|Overall Study|Do not know|6|||
105609124|NCT05110495|364232213|FG000|Overall Study|Lost to Follow-up|1|||
105609125|NCT05110495|364232213|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
105609126|NCT02630823|364232217|FG000|Overall Study|Withdrawal by Subject|1|||
105609127|NCT02630823|364232217|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
105609128|NCT03655132|364232218|FG000|Overall Study|Lost to Follow-up|2|||
105609129|NCT03655132|364232219|FG001|Overall Study|Lost to Follow-up|1|||
105609130|NCT03655132|364232218|FG000|Overall Study|Withdrawal by Subject|0|||
105609131|NCT03655132|364232219|FG001|Overall Study|Withdrawal by Subject|1|||
105609132|NCT03655132|364232218|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
105609133|NCT03655132|364232219|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
105609134|NCT05439603|364232227|FG000|Overall Study|met withdrawal criteria|2|||
105609135|NCT03101904|364232228|FG000|Wash Out (10 Days)|Adverse Event|1|||
105609136|NCT03101904|364232229|FG001|Wash Out (10 Days)|Adverse Event|0|||
105609137|NCT03101904|364232228|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
105609138|NCT03101904|364232229|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
105609139|NCT02682316|364232230|FG000|Overall Study|Benign Final Pathology|27|||
105609140|NCT02682316|364232231|FG001|Overall Study|Benign Final Pathology|26|||
105609141|NCT02682316|364232230|FG000|Overall Study|Reoperation before 30 days|7|||
105609142|NCT02682316|364232231|FG001|Overall Study|Reoperation before 30 days|6|||
105609143|NCT02682316|364232230|FG000|Overall Study|Ineligible|1|||
105609144|NCT02682316|364232231|FG001|Overall Study|Ineligible|0|||
105609145|NCT02682316|364232230|FG000|Overall Study|Death|1|||
105609146|NCT02682316|364232231|FG001|Overall Study|Death|0|||
105609147|NCT02682316|364232230|FG000|Overall Study|Lost to Follow-up|7|||
105609148|NCT02682316|364232231|FG001|Overall Study|Lost to Follow-up|3|||
105609149|NCT01857934|364232232|FG000|Overall Study|Relapse or progression|2|||
105609150|NCT01857934|364232232|FG000|Overall Study|Unacceptable toxicity|3|||
105609151|NCT01857934|364232232|FG000|Overall Study|Unwillingness or inability to comply|2|||
105609152|NCT01857934|364232232|FG000|Overall Study|Physician Decision|3|||
105609153|NCT04703322|364232233|FG000|Overall Study|Ongoing|8|||
105609154|NCT04703322|364232233|FG000|Overall Study|Withdrawal by Subject|1|||
105609155|NCT01057433|364232234|FG000|Overall Study|Adverse Event|1|||
105609156|NCT01101451|364232237|FG000|Overall Study|Eligible and never treated|0|||
105609157|NCT01101451|364232238|FG001|Overall Study|Eligible and never treated|5|||
105609158|NCT01101451|364232237|FG000|Overall Study|Ineligible and treated|12|||
105609159|NCT01101451|364232238|FG001|Overall Study|Ineligible and treated|8|||
105609160|NCT01101451|364232237|FG000|Overall Study|Ineligible and never treated|2|||
105609161|NCT01101451|364232238|FG001|Overall Study|Ineligible and never treated|2|||
105609162|NCT02814838|364232243|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
105609163|NCT02814838|364232244|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
105609164|NCT02814838|364232243|FG000|Overall Study|Consent withdrawal|1|||
105609165|NCT02814838|364232244|FG001|Overall Study|Consent withdrawal|1|||
105609166|NCT00073749|364232245|FG000|Overall Study|Disease Progression|2|||
105609167|NCT00073749|364232246|FG001|Overall Study|Disease Progression|0|||
105609168|NCT00073749|364232247|FG002|Overall Study|Disease Progression|3|||
105609169|NCT00073749|364232248|FG003|Overall Study|Disease Progression|2|||
105609170|NCT00073749|364232249|FG004|Overall Study|Disease Progression|3|||
105609171|NCT00073749|364232250|FG005|Overall Study|Disease Progression|1|||
105609172|NCT00073749|364232251|FG006|Overall Study|Disease Progression|3|||
105609173|NCT00073749|364232245|FG000|Overall Study|Death|0|||
105609174|NCT00073749|364232246|FG001|Overall Study|Death|1|||
105609175|NCT00073749|364232247|FG002|Overall Study|Death|1|||
105609176|NCT00073749|364232248|FG003|Overall Study|Death|0|||
105609177|NCT00073749|364232249|FG004|Overall Study|Death|0|||
105609178|NCT00073749|364232250|FG005|Overall Study|Death|0|||
105609179|NCT00073749|364232251|FG006|Overall Study|Death|29|||
105609180|NCT00073749|364232245|FG000|Overall Study|Adverse Event|0|||
105609181|NCT00073749|364232246|FG001|Overall Study|Adverse Event|3|||
105609182|NCT00073749|364232247|FG002|Overall Study|Adverse Event|6|||
105609183|NCT00073749|364232248|FG003|Overall Study|Adverse Event|4|||
105609184|NCT00073749|364232249|FG004|Overall Study|Adverse Event|2|||
105609185|NCT00073749|364232250|FG005|Overall Study|Adverse Event|1|||
105609186|NCT00073749|364232251|FG006|Overall Study|Adverse Event|0|||
105609187|NCT00073749|364232245|FG000|Overall Study|Physician Decision|0|||
105609188|NCT00073749|364232246|FG001|Overall Study|Physician Decision|0|||
105609189|NCT00073749|364232247|FG002|Overall Study|Physician Decision|1|||
105609190|NCT00073749|364232248|FG003|Overall Study|Physician Decision|0|||
105609191|NCT00073749|364232249|FG004|Overall Study|Physician Decision|0|||
105609192|NCT00073749|364232250|FG005|Overall Study|Physician Decision|2|||
105609193|NCT00073749|364232251|FG006|Overall Study|Physician Decision|0|||
105609194|NCT00073749|364232245|FG000|Overall Study|Withdrawal by Subject|0|||
105609195|NCT00073749|364232246|FG001|Overall Study|Withdrawal by Subject|1|||
105609196|NCT00073749|364232247|FG002|Overall Study|Withdrawal by Subject|0|||
105609197|NCT00073749|364232248|FG003|Overall Study|Withdrawal by Subject|0|||
105609198|NCT00073749|364232249|FG004|Overall Study|Withdrawal by Subject|1|||
105609199|NCT00073749|364232250|FG005|Overall Study|Withdrawal by Subject|0|||
105609200|NCT00073749|364232251|FG006|Overall Study|Withdrawal by Subject|2|||
105609201|NCT00073749|364232245|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
105609202|NCT00073749|364232246|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
105609203|NCT00073749|364232247|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
105609204|NCT00073749|364232248|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
105609205|NCT00073749|364232249|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
105609206|NCT00073749|364232250|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
105609207|NCT00073749|364232251|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
105609208|NCT00073749|364232245|FG000|Overall Study|Lost to Follow-up|0|||
105609209|NCT00073749|364232246|FG001|Overall Study|Lost to Follow-up|0|||
105609210|NCT00073749|364232247|FG002|Overall Study|Lost to Follow-up|0|||
105609211|NCT00073749|364232248|FG003|Overall Study|Lost to Follow-up|0|||
105609212|NCT00073749|364232249|FG004|Overall Study|Lost to Follow-up|0|||
105609213|NCT00073749|364232250|FG005|Overall Study|Lost to Follow-up|0|||
105609214|NCT00073749|364232251|FG006|Overall Study|Lost to Follow-up|2|||
105609215|NCT00073749|364232245|FG000|Overall Study|Other|0|||
105609216|NCT00073749|364232246|FG001|Overall Study|Other|0|||
105609217|NCT00073749|364232247|FG002|Overall Study|Other|0|||
105609218|NCT00073749|364232248|FG003|Overall Study|Other|0|||
105609219|NCT00073749|364232249|FG004|Overall Study|Other|0|||
105609220|NCT00073749|364232250|FG005|Overall Study|Other|2|||
105609221|NCT00073749|364232251|FG006|Overall Study|Other|0|||
105609222|NCT04999592|364232253|FG000|Overall Study|Withdrawal by Subject|1|||
105609223|NCT04999592|364232254|FG001|Overall Study|Withdrawal by Subject|0|||
105609224|NCT01361711|364232255|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
105609225|NCT01361711|364232255|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
105609226|NCT01361711|364232255|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
105609227|NCT01361711|364232255|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
105609228|NCT01361711|364232255|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
105609229|NCT01361711|364232255|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
105609230|NCT01361711|364232255|FG000|Completed Week 18 of Treatment|Other|9|||
105609231|NCT01361711|364232255|FG000|10 Year Follow-up|Still in follow-up|22|||
105609232|NCT01361711|364232255|FG000|10 Year Follow-up|Death|7|||
105609233|NCT01361711|364232255|FG000|10 Year Follow-up|Developed new cancer|1|||
105609234|NCT01361711|364232255|FG000|10 Year Follow-up|Lost to Follow-up|2|||
105609235|NCT01361711|364232255|FG000|10 Year Follow-up|New treatment started|6|||
105609236|NCT01361711|364232255|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
105609237|NCT01361711|364232255|FG000|10 Year Follow-up|Progressive Disease|1|||
105609238|NCT04095104|364232256|FG000|Overall Study|Withdrawal by Subject|0|||
105609239|NCT04095104|364232257|FG001|Overall Study|Withdrawal by Subject|1|||
105609240|NCT03396588|364232258|FG000|Overall Study|Physician Decision|2|||
105609241|NCT03396588|364232259|FG001|Overall Study|Physician Decision|3|||
105609242|NCT05179395|364232260|FG000|Overall Study|Lack of Efficacy|1|||
105609243|NCT00812461|364232261|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
105609244|NCT00812461|364232262|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
105609245|NCT00812461|364232261|FG000|All Treated Patients|Adverse Event|8|||
105609246|NCT00812461|364232262|FG001|All Treated Patients|Adverse Event|15|||
105609247|NCT00812461|364232261|FG000|All Treated Patients|Lack of Efficacy|13|||
105609248|NCT00812461|364232262|FG001|All Treated Patients|Lack of Efficacy|7|||
105609249|NCT00812461|364232261|FG000|All Treated Patients|Non-compliance|6|||
105609250|NCT00812461|364232262|FG001|All Treated Patients|Non-compliance|9|||
105609251|NCT00812461|364232261|FG000|All Treated Patients|Protocol Violation|36|||
105609252|NCT00812461|364232262|FG001|All Treated Patients|Protocol Violation|27|||
105609253|NCT00812461|364232261|FG000|All Treated Patients|Withdrawal by Subject|45|||
105609254|NCT00812461|364232262|FG001|All Treated Patients|Withdrawal by Subject|54|||
105609255|NCT00812461|364232261|FG000|All Treated Patients|Lost to Follow-up|11|||
105609256|NCT00812461|364232262|FG001|All Treated Patients|Lost to Follow-up|14|||
105609257|NCT00812461|364232261|FG000|All Treated Patients|Other Reason|13|||
105609258|NCT00812461|364232262|FG001|All Treated Patients|Other Reason|21|||
105609259|NCT04924062|364233307|FG000|Overall Study|Death|49|||
105609260|NCT04924062|364233308|FG001|Overall Study|Death|63|||
105609261|NCT04924062|364233307|FG000|Overall Study|Participant On-going|26|||
105609262|NCT04924062|364233308|FG001|Overall Study|Participant On-going|20|||
105609263|NCT02525692|364233312|FG000|Overall Study|Withdrawal by Subject|1|||
105609264|NCT02525692|364233313|FG001|Overall Study|Withdrawal by Subject|1|||
105609265|NCT02525692|364233314|FG002|Overall Study|Withdrawal by Subject|0|||
105609266|NCT02525692|364233315|FG003|Overall Study|Withdrawal by Subject|5|||
105609267|NCT02525692|364233316|FG004|Overall Study|Withdrawal by Subject|0|||
105609268|NCT02525692|364233317|FG005|Overall Study|Withdrawal by Subject|1|||
105609269|NCT02525692|364233312|FG000|Overall Study|Death|16|||
105609270|NCT02525692|364233313|FG001|Overall Study|Death|18|||
105609271|NCT02525692|364233314|FG002|Overall Study|Death|7|||
105609272|NCT02525692|364233315|FG003|Overall Study|Death|20|||
105609273|NCT02525692|364233316|FG004|Overall Study|Death|3|||
105609274|NCT02525692|364233317|FG005|Overall Study|Death|6|||
105609275|NCT02525692|364233312|FG000|Overall Study|Lost to Follow-up|0|||
105609276|NCT02525692|364233313|FG001|Overall Study|Lost to Follow-up|0|||
105609277|NCT02525692|364233314|FG002|Overall Study|Lost to Follow-up|1|||
105609278|NCT02525692|364233315|FG003|Overall Study|Lost to Follow-up|5|||
105609279|NCT02525692|364233316|FG004|Overall Study|Lost to Follow-up|0|||
105609280|NCT02525692|364233317|FG005|Overall Study|Lost to Follow-up|0|||
105609281|NCT04869982|364233318|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
105609282|NCT04869982|364233319|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
105609283|NCT04869982|364233318|FG000|Overall Study|Migrated / moved from the study area|1|||
105609284|NCT04869982|364233319|FG001|Overall Study|Migrated / moved from the study area|1|||
105609285|NCT04869982|364233318|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
105609286|NCT04869982|364233319|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
105609287|NCT04869982|364233318|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
105609288|NCT04869982|364233319|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
105609289|NCT04869982|364233318|FG000|Overall Study|Solicited adverse event|2|||
105609290|NCT04869982|364233319|FG001|Overall Study|Solicited adverse event|1|||
105609291|NCT03857620|364233320|FG000|Overall Study|Death|4|||
105609292|NCT03857620|364233321|FG001|Overall Study|Death|5|||
105609293|NCT03857620|364233322|FG002|Overall Study|Death|7|||
105609294|NCT03857620|364233320|FG000|Overall Study|Lost to Follow-up|2|||
105609295|NCT03857620|364233321|FG001|Overall Study|Lost to Follow-up|5|||
105609296|NCT03857620|364233322|FG002|Overall Study|Lost to Follow-up|3|||
105609297|NCT03857620|364233320|FG000|Overall Study|Disease progression or relapse after study registration|1|||
105609298|NCT03857620|364233321|FG001|Overall Study|Disease progression or relapse after study registration|5|||
105609299|NCT03857620|364233322|FG002|Overall Study|Disease progression or relapse after study registration|1|||
105609300|NCT03857620|364233320|FG000|Overall Study|Ineligible|5|||
105609301|NCT03857620|364233321|FG001|Overall Study|Ineligible|0|||
105609302|NCT03857620|364233322|FG002|Overall Study|Ineligible|2|||
105609303|NCT03857620|364233320|FG000|Overall Study|No malignancy|1|||
105609304|NCT03857620|364233321|FG001|Overall Study|No malignancy|0|||
105609305|NCT03857620|364233322|FG002|Overall Study|No malignancy|1|||
105609306|NCT03857620|364233320|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
105609307|NCT03857620|364233321|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
105609308|NCT03857620|364233322|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
105609309|NCT03857620|364233320|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
105609310|NCT03857620|364233321|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
105609311|NCT03857620|364233322|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
105609312|NCT03857620|364233320|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
105609313|NCT03857620|364233321|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
105609314|NCT03857620|364233322|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
105609315|NCT03857620|364233320|FG000|Overall Study|Surgery not performed, patient decision|0|||
105609316|NCT03857620|364233321|FG001|Overall Study|Surgery not performed, patient decision|3|||
105609317|NCT03857620|364233322|FG002|Overall Study|Surgery not performed, patient decision|1|||
105609318|NCT03857620|364233320|FG000|Overall Study|Surgery not performed, other reason|3|||
105609319|NCT03857620|364233321|FG001|Overall Study|Surgery not performed, other reason|1|||
105609320|NCT03857620|364233322|FG002|Overall Study|Surgery not performed, other reason|4|||
105609321|NCT03857620|364233320|FG000|Overall Study|Worsening performance status after surgery performed|0|||
105609322|NCT03857620|364233321|FG001|Overall Study|Worsening performance status after surgery performed|1|||
105609323|NCT03857620|364233322|FG002|Overall Study|Worsening performance status after surgery performed|1|||
105609324|NCT04586920|364233325|FG000|Overall Study|Lost to Follow-up|0|||
105609325|NCT04586920|364233326|FG001|Overall Study|Lost to Follow-up|0|||
105609326|NCT04586920|364233327|FG002|Overall Study|Lost to Follow-up|0|||
105609327|NCT04586920|364233328|FG003|Overall Study|Lost to Follow-up|0|||
105609328|NCT04586920|364233329|FG004|Overall Study|Lost to Follow-up|0|||
105609329|NCT04586920|364233330|FG005|Overall Study|Lost to Follow-up|0|||
105609330|NCT04586920|364233331|FG006|Overall Study|Lost to Follow-up|1|||
105609331|NCT04586920|364233332|FG007|Overall Study|Lost to Follow-up|1|||
105609332|NCT04586920|364233333|FG008|Overall Study|Lost to Follow-up|0|||
105609333|NCT04586920|364233334|FG009|Overall Study|Lost to Follow-up|1|||
105609334|NCT04586920|364233335|FG010|Overall Study|Lost to Follow-up|0|||
105609335|NCT04586920|364233336|FG011|Overall Study|Lost to Follow-up|0|||
105609336|NCT04586920|364233337|FG012|Overall Study|Lost to Follow-up|0|||
105609337|NCT04586920|364233338|FG013|Overall Study|Lost to Follow-up|1|||
105609338|NCT04586920|364233339|FG014|Overall Study|Lost to Follow-up|0|||
105609339|NCT04586920|364233340|FG015|Overall Study|Lost to Follow-up|0|||
105609340|NCT04586920|364233341|FG016|Overall Study|Lost to Follow-up|0|||
105609341|NCT04586920|364233342|FG017|Overall Study|Lost to Follow-up|0|||
105609342|NCT04586920|364233325|FG000|Overall Study|Withdrawal by Subject|0|||
105609343|NCT04586920|364233326|FG001|Overall Study|Withdrawal by Subject|0|||
105609344|NCT04586920|364233327|FG002|Overall Study|Withdrawal by Subject|0|||
105609345|NCT04586920|364233328|FG003|Overall Study|Withdrawal by Subject|0|||
105609346|NCT04586920|364233329|FG004|Overall Study|Withdrawal by Subject|0|||
105609347|NCT04586920|364233330|FG005|Overall Study|Withdrawal by Subject|0|||
105609348|NCT04586920|364233331|FG006|Overall Study|Withdrawal by Subject|0|||
105609349|NCT04586920|364233332|FG007|Overall Study|Withdrawal by Subject|1|||
105609350|NCT04586920|364233333|FG008|Overall Study|Withdrawal by Subject|0|||
105609351|NCT04586920|364233334|FG009|Overall Study|Withdrawal by Subject|1|||
105609352|NCT04586920|364233335|FG010|Overall Study|Withdrawal by Subject|0|||
105609353|NCT04586920|364233336|FG011|Overall Study|Withdrawal by Subject|1|||
105609354|NCT04586920|364233337|FG012|Overall Study|Withdrawal by Subject|0|||
105609355|NCT04586920|364233338|FG013|Overall Study|Withdrawal by Subject|0|||
105609356|NCT04586920|364233339|FG014|Overall Study|Withdrawal by Subject|0|||
105609357|NCT04586920|364233340|FG015|Overall Study|Withdrawal by Subject|0|||
105609358|NCT04586920|364233341|FG016|Overall Study|Withdrawal by Subject|0|||
105609359|NCT04586920|364233342|FG017|Overall Study|Withdrawal by Subject|0|||
105609360|NCT03819686|364233346|FG000|Overall Study|Lost to Follow-up|2|||
105609361|NCT03819686|364233347|FG001|Overall Study|Lost to Follow-up|3|||
105609362|NCT06143670|364233348|FG000|Overall Study|Lost to Follow-up|0|||
105609363|NCT06143670|364233349|FG001|Overall Study|Lost to Follow-up|1|||
105609364|NCT06143670|364233348|FG000|Overall Study|Withdrawal by Subject|3|||
105609365|NCT06143670|364233349|FG001|Overall Study|Withdrawal by Subject|0|||
105609366|NCT03747484|364233350|FG000|Overall Study|Lack of Efficacy|0|||
105609367|NCT03747484|364233351|FG001|Overall Study|Lack of Efficacy|1|||
105609368|NCT03747484|364233352|FG002|Overall Study|Lack of Efficacy|1|||
105609369|NCT03747484|364233353|FG003|Overall Study|Lack of Efficacy|2|||
105609370|NCT03747484|364233354|FG004|Overall Study|Lack of Efficacy|2|||
105609371|NCT04905407|364233355|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
105609372|NCT04905407|364233356|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
105609373|NCT04905407|364233357|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
105609374|NCT04905407|364233358|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
105609375|NCT04905407|364233355|FG000|Part 1 and Part 2|Death|7|||
105609376|NCT04905407|364233356|FG001|Part 1 and Part 2|Death|7|||
105609377|NCT04905407|364233357|FG002|Part 1 and Part 2|Death|7|||
105609378|NCT04905407|364233358|FG003|Part 1 and Part 2|Death|0|||
105609379|NCT04905407|364233355|FG000|Part 1 and Part 2|Other than specified|0|||
105609380|NCT04905407|364233356|FG001|Part 1 and Part 2|Other than specified|0|||
105609381|NCT04905407|364233357|FG002|Part 1 and Part 2|Other than specified|1|||
105609382|NCT04905407|364233358|FG003|Part 1 and Part 2|Other than specified|0|||
105609383|NCT04905407|364233355|FG000|Part 3|Death|0|||
105609384|NCT04905407|364233356|FG001|Part 3|Death|0|||
105609385|NCT04905407|364233357|FG002|Part 3|Death|0|||
105609386|NCT04905407|364233358|FG003|Part 3|Death|2|||
105609387|NCT01938547|364233367|FG000|Overall Study|Physician Decision|1|||
105609388|NCT05141903|364233368|FG000|Overall Study|Withdrawal by Subject|0|||
105609389|NCT05141903|364233369|FG001|Overall Study|Withdrawal by Subject|1|||
105609390|NCT05141903|364233370|FG002|Overall Study|Withdrawal by Subject|1|||
105609391|NCT05141903|364233371|FG003|Overall Study|Withdrawal by Subject|0|||
105609392|NCT05141903|364233372|FG004|Overall Study|Withdrawal by Subject|0|||
105609393|NCT05141903|364233368|FG000|Overall Study|Other|1|||
105609394|NCT05141903|364233369|FG001|Overall Study|Other|1|||
105609395|NCT05141903|364233370|FG002|Overall Study|Other|0|||
105609396|NCT05141903|364233371|FG003|Overall Study|Other|0|||
105609397|NCT05141903|364233372|FG004|Overall Study|Other|0|||
105609398|NCT05418296|364233375|FG000|Overall Study|Withdrawal by Subject|4|||
105609399|NCT05418296|364233376|FG001|Overall Study|Withdrawal by Subject|1|||
105609400|NCT05382936|364233377|FG000|Overall Study|Progressive Disease|3|||
105609401|NCT05382936|364233378|FG001|Overall Study|Progressive Disease|5|||
105609402|NCT05382936|364233379|FG002|Overall Study|Progressive Disease|2|||
105609403|NCT05382936|364233380|FG003|Overall Study|Progressive Disease|5|||
105609404|NCT05382936|364233377|FG000|Overall Study|Adverse Event|0|||
105609405|NCT05382936|364233378|FG001|Overall Study|Adverse Event|1|||
105609406|NCT05382936|364233379|FG002|Overall Study|Adverse Event|1|||
105609407|NCT05382936|364233380|FG003|Overall Study|Adverse Event|0|||
105609408|NCT05382936|364233377|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
105609409|NCT05382936|364233378|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
105609410|NCT05382936|364233379|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
105609411|NCT05382936|364233380|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
105609412|NCT05382936|364233377|FG000|Overall Study|Withdrawal by Subject|0|||
105609413|NCT05382936|364233378|FG001|Overall Study|Withdrawal by Subject|0|||
105609414|NCT05382936|364233379|FG002|Overall Study|Withdrawal by Subject|1|||
105609415|NCT05382936|364233380|FG003|Overall Study|Withdrawal by Subject|1|||
105609416|NCT05927753|364233382|FG000|Overall Study|Withdrawal by Subject|0|||
105609417|NCT05927753|364233383|FG001|Overall Study|Withdrawal by Subject|2|||
105609418|NCT05927753|364233382|FG000|Overall Study|Physician Decision|0|||
105609419|NCT05927753|364233383|FG001|Overall Study|Physician Decision|1|||
105609420|NCT00601900|364233392|FG000|Overall Study|Withdrawal by Subject|0|||
105609421|NCT00601900|364233393|FG001|Overall Study|Withdrawal by Subject|3|||
105609422|NCT04450342|364233395|FG000|Overall Study|Adverse Event|1|||
105609423|NCT04450342|364233396|FG001|Overall Study|Adverse Event|1|||
105609424|NCT04450342|364233397|FG002|Overall Study|Adverse Event|0|||
105609425|NCT04450342|364233395|FG000|Overall Study|Device not used|1|||
105609426|NCT04450342|364233396|FG001|Overall Study|Device not used|0|||
105609427|NCT04450342|364233397|FG002|Overall Study|Device not used|0|||
105609428|NCT04450342|364233395|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
105609429|NCT04450342|364233396|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
105609430|NCT04450342|364233397|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
105609431|NCT04450342|364233395|FG000|Overall Study|Physician Decision|1|||
105609432|NCT04450342|364233396|FG001|Overall Study|Physician Decision|0|||
105609433|NCT04450342|364233397|FG002|Overall Study|Physician Decision|1|||
105609434|NCT04450342|364233395|FG000|Overall Study|Protocol Deviation|0|||
105609435|NCT04450342|364233396|FG001|Overall Study|Protocol Deviation|1|||
105609436|NCT04450342|364233397|FG002|Overall Study|Protocol Deviation|0|||
105609437|NCT04450342|364233395|FG000|Overall Study|Reoperation|1|||
105609438|NCT04450342|364233396|FG001|Overall Study|Reoperation|1|||
105609439|NCT04450342|364233397|FG002|Overall Study|Reoperation|0|||
105609440|NCT04450342|364233395|FG000|Overall Study|Screen Failures|0|||
105609441|NCT04450342|364233396|FG001|Overall Study|Screen Failures|0|||
105609442|NCT04450342|364233397|FG002|Overall Study|Screen Failures|2|||
105609443|NCT04450342|364233395|FG000|Overall Study|Site Terminated by Sponsor|1|||
105609444|NCT04450342|364233396|FG001|Overall Study|Site Terminated by Sponsor|1|||
105609445|NCT04450342|364233397|FG002|Overall Study|Site Terminated by Sponsor|1|||
105609446|NCT04450342|364233395|FG000|Overall Study|Study Terminated by Sponsor|31|||
105609447|NCT04450342|364233396|FG001|Overall Study|Study Terminated by Sponsor|29|||
105609448|NCT04450342|364233397|FG002|Overall Study|Study Terminated by Sponsor|6|||
105609449|NCT04450342|364233395|FG000|Overall Study|Withdrawal by Subject|0|||
105609450|NCT04450342|364233396|FG001|Overall Study|Withdrawal by Subject|1|||
105609451|NCT04450342|364233397|FG002|Overall Study|Withdrawal by Subject|2|||
105609452|NCT00220740|364233398|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
105609453|NCT00220740|364233399|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
105609454|NCT00220740|364233398|FG000|Efficacy Period|Adverse Event|1|||
105609455|NCT00220740|364233399|FG001|Efficacy Period|Adverse Event|1|||
105609456|NCT00220740|364233398|FG000|Efficacy Period|Withdrawal by Subject|1|||
105609457|NCT00220740|364233399|FG001|Efficacy Period|Withdrawal by Subject|0|||
105609458|NCT00220740|364233398|FG000|Efficacy Period|Protocol Violation|1|||
105609459|NCT00220740|364233399|FG001|Efficacy Period|Protocol Violation|0|||
105609460|NCT00220740|364233398|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
105609461|NCT00220740|364233399|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
105609462|NCT05268302|364233400|FG000|Overall Study|Death|0|||
105609463|NCT05268302|364233401|FG001|Overall Study|Death|1|||
105609464|NCT02516241|364233402|FG000|Overall Study|Death|255|||
105609465|NCT02516241|364233403|FG001|Overall Study|Death|262|||
105609466|NCT02516241|364233404|FG002|Overall Study|Death|270|||
105609467|NCT02516241|364233402|FG000|Overall Study|Lost to Follow-up|1|||
105609468|NCT02516241|364233403|FG001|Overall Study|Lost to Follow-up|1|||
105609469|NCT02516241|364233404|FG002|Overall Study|Lost to Follow-up|3|||
105609470|NCT02516241|364233402|FG000|Overall Study|Withdrawal by Subject|2|||
105609471|NCT02516241|364233403|FG001|Overall Study|Withdrawal by Subject|7|||
105609472|NCT02516241|364233404|FG002|Overall Study|Withdrawal by Subject|12|||
105609473|NCT02516241|364233402|FG000|Overall Study|participants ongoing at data cut-off|84|||
105609474|NCT02516241|364233403|FG001|Overall Study|participants ongoing at data cut-off|76|||
105609475|NCT02516241|364233404|FG002|Overall Study|participants ongoing at data cut-off|59|||
105609476|NCT02596126|364233405|FG000|Overall Study|Lost to Follow-up|12|||
105609477|NCT02596126|364233406|FG001|Overall Study|Lost to Follow-up|21|||
105609478|NCT02596126|364233405|FG000|Overall Study|Protocol Violation|7|||
105609479|NCT02596126|364233406|FG001|Overall Study|Protocol Violation|9|||
105609480|NCT05792423|364233409|FG000|Overall Study|Withdrawal by Subject|2|||
105609481|NCT02471638|364233410|FG000|Overall Study|Early Term Withdrawal|10|||
105609482|NCT03651895|364235015|FG000|First Drug Assignment|Adverse Event|4|||
105609483|NCT03651895|364235016|FG001|First Drug Assignment|Adverse Event|5|||
105609484|NCT03651895|364235015|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
105609485|NCT03651895|364235016|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
105609486|NCT04052516|364235028|FG000|Overall Study|Withdrawal by Subject|4|||
105609487|NCT04052516|364235029|FG001|Overall Study|Withdrawal by Subject|5|||
105609488|NCT04052516|364235030|FG002|Overall Study|Withdrawal by Subject|6|||
105609489|NCT04052516|364235028|FG000|Overall Study|Adverse Event|3|||
105609490|NCT04052516|364235029|FG001|Overall Study|Adverse Event|2|||
105609491|NCT04052516|364235030|FG002|Overall Study|Adverse Event|8|||
105609492|NCT04052516|364235028|FG000|Overall Study|Lost to Follow-up|2|||
105609493|NCT04052516|364235029|FG001|Overall Study|Lost to Follow-up|5|||
105609494|NCT04052516|364235030|FG002|Overall Study|Lost to Follow-up|3|||
105609495|NCT04052516|364235028|FG000|Overall Study|Protocol Violation|1|||
105609496|NCT04052516|364235029|FG001|Overall Study|Protocol Violation|1|||
105609497|NCT04052516|364235030|FG002|Overall Study|Protocol Violation|0|||
105609498|NCT04052516|364235028|FG000|Overall Study|Death|1|||
105609499|NCT04052516|364235029|FG001|Overall Study|Death|0|||
105609500|NCT04052516|364235030|FG002|Overall Study|Death|0|||
105609501|NCT04052516|364235028|FG000|Overall Study|Physician Decision|0|||
105609502|NCT04052516|364235029|FG001|Overall Study|Physician Decision|1|||
105609503|NCT04052516|364235030|FG002|Overall Study|Physician Decision|0|||
105609504|NCT04052516|364235028|FG000|Overall Study|Pregnancy|1|||
105609505|NCT04052516|364235029|FG001|Overall Study|Pregnancy|0|||
105609506|NCT04052516|364235030|FG002|Overall Study|Pregnancy|0|||
105609507|NCT04052516|364235028|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
105609508|NCT04052516|364235029|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
105609509|NCT04052516|364235030|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
105609510|NCT04052516|364235028|FG000|Overall Study|Reason not recorded|0|||
105609511|NCT04052516|364235029|FG001|Overall Study|Reason not recorded|1|||
105609512|NCT04052516|364235030|FG002|Overall Study|Reason not recorded|0|||
105609513|NCT03157167|364235031|FG000|Overall Study|Withdrawal by Subject|1|||
105609514|NCT03157167|364235032|FG001|Overall Study|Withdrawal by Subject|0|||
105609515|NCT03157167|364235033|FG002|Overall Study|Withdrawal by Subject|0|||
105609516|NCT02597946|364235038|FG000|Overall Study|Withdrawal by Subject|1|||
105609517|NCT02597946|364235038|FG000|Overall Study|Progressive disease|16|||
105609518|NCT02597946|364235038|FG000|Overall Study|Other than above|1|||
105609519|NCT04521478|364235042|FG000|Overall Study|Protocol Violation|2|||
105609520|NCT04521478|364235043|FG001|Overall Study|Protocol Violation|0|||
105609521|NCT04521478|364235044|FG002|Overall Study|Protocol Violation|1|||
105609522|NCT04521478|364235045|FG003|Overall Study|Protocol Violation|0|||
105609523|NCT04521478|364235046|FG004|Overall Study|Protocol Violation|0|||
105609524|NCT04521478|364235047|FG005|Overall Study|Protocol Violation|0|||
105609525|NCT04521478|364235042|FG000|Overall Study|Technical Problems|0|||
105609526|NCT04521478|364235043|FG001|Overall Study|Technical Problems|0|||
105609527|NCT04521478|364235044|FG002|Overall Study|Technical Problems|0|||
105609528|NCT04521478|364235045|FG003|Overall Study|Technical Problems|1|||
105609529|NCT04521478|364235046|FG004|Overall Study|Technical Problems|0|||
105609530|NCT04521478|364235047|FG005|Overall Study|Technical Problems|0|||
105609531|NCT04521478|364235042|FG000|Overall Study|Burden of Study Procedures|1|||
105609532|NCT04521478|364235043|FG001|Overall Study|Burden of Study Procedures|0|||
105609533|NCT04521478|364235044|FG002|Overall Study|Burden of Study Procedures|0|||
105609534|NCT04521478|364235045|FG003|Overall Study|Burden of Study Procedures|1|||
105609535|NCT04521478|364235046|FG004|Overall Study|Burden of Study Procedures|0|||
105609536|NCT04521478|364235047|FG005|Overall Study|Burden of Study Procedures|1|||
105609537|NCT04521478|364235042|FG000|Overall Study|Lack of Efficacy|0|||
105609538|NCT04521478|364235043|FG001|Overall Study|Lack of Efficacy|0|||
105609539|NCT04521478|364235044|FG002|Overall Study|Lack of Efficacy|0|||
105609540|NCT04521478|364235045|FG003|Overall Study|Lack of Efficacy|0|||
105609541|NCT04521478|364235046|FG004|Overall Study|Lack of Efficacy|1|||
105609542|NCT04521478|364235047|FG005|Overall Study|Lack of Efficacy|1|||
105609543|NCT04521478|364235042|FG000|Overall Study|Adverse Event|7|||
105609544|NCT04521478|364235043|FG001|Overall Study|Adverse Event|0|||
105609545|NCT04521478|364235044|FG002|Overall Study|Adverse Event|2|||
105609546|NCT04521478|364235045|FG003|Overall Study|Adverse Event|1|||
105609547|NCT04521478|364235046|FG004|Overall Study|Adverse Event|2|||
105609548|NCT04521478|364235047|FG005|Overall Study|Adverse Event|7|||
105609549|NCT04521478|364235042|FG000|Overall Study|No Reason Available|0|||
105609550|NCT04521478|364235043|FG001|Overall Study|No Reason Available|2|||
105609551|NCT04521478|364235044|FG002|Overall Study|No Reason Available|0|||
105609552|NCT04521478|364235045|FG003|Overall Study|No Reason Available|0|||
105609553|NCT04521478|364235046|FG004|Overall Study|No Reason Available|1|||
105609554|NCT04521478|364235047|FG005|Overall Study|No Reason Available|0|||
105609555|NCT04521478|364235042|FG000|Overall Study|Other than listed|3|||
105609556|NCT04521478|364235043|FG001|Overall Study|Other than listed|3|||
105609557|NCT04521478|364235044|FG002|Overall Study|Other than listed|3|||
105609558|NCT04521478|364235045|FG003|Overall Study|Other than listed|2|||
105609559|NCT04521478|364235046|FG004|Overall Study|Other than listed|3|||
105609560|NCT04521478|364235047|FG005|Overall Study|Other than listed|3|||
105609561|NCT04521478|364235042|FG000|Overall Study|Not treated|0|||
105609562|NCT04521478|364235043|FG001|Overall Study|Not treated|0|||
105609563|NCT04521478|364235044|FG002|Overall Study|Not treated|0|||
105609564|NCT04521478|364235045|FG003|Overall Study|Not treated|0|||
105609565|NCT04521478|364235046|FG004|Overall Study|Not treated|0|||
105609566|NCT04521478|364235047|FG005|Overall Study|Not treated|1|||
105609567|NCT03625882|364235048|FG000|Overall Study|Protocol Violation|3|||
105609568|NCT02840474|364235057|FG000|Overall Study|Lost to Follow-up|1|||
105609569|NCT02840474|364235058|FG001|Overall Study|Lost to Follow-up|0|||
105609570|NCT01757665|364235059|FG000|Overall Study|Still on Study - Visit Completed|240|||
105609571|NCT01757665|364235060|FG001|Overall Study|Still on Study - Visit Completed|30|||
105609572|NCT01757665|364235059|FG000|Overall Study|Still on Study - Visit Pending|398|||
105609573|NCT01757665|364235060|FG001|Overall Study|Still on Study - Visit Pending|40|||
105609574|NCT01757665|364235059|FG000|Overall Study|Still on Study - Missed Visit|14|||
105609575|NCT01757665|364235060|FG001|Overall Study|Still on Study - Missed Visit|1|||
105609576|NCT01757665|364235059|FG000|Overall Study|Death|25|||
105609577|NCT01757665|364235060|FG001|Overall Study|Death|8|||
105609578|NCT01757665|364235059|FG000|Overall Study|Explant|1|||
105609579|NCT01757665|364235060|FG001|Overall Study|Explant|2|||
105609580|NCT01757665|364235059|FG000|Overall Study|Withdrawal by Subject|10|||
105609581|NCT01757665|364235060|FG001|Overall Study|Withdrawal by Subject|0|||
105609582|NCT01757665|364235059|FG000|Overall Study|Lost to Follow-up|1|||
105609583|NCT01757665|364235060|FG001|Overall Study|Lost to Follow-up|1|||
105609584|NCT01757665|364235059|FG000|Overall Study|Not Implanted with Device|5|||
105609585|NCT01757665|364235060|FG001|Overall Study|Not Implanted with Device|1|||
105609586|NCT04850807|364235063|FG000|Overall Study|Death|50|||
105609587|NCT04850807|364235064|FG001|Overall Study|Death|55|||
105609588|NCT04850807|364235063|FG000|Overall Study|Discharged|17|||
105609589|NCT04850807|364235064|FG001|Overall Study|Discharged|13|||
105609590|NCT04850807|364235063|FG000|Overall Study|Incomplete baseline data|3|||
105609591|NCT04850807|364235064|FG001|Overall Study|Incomplete baseline data|2|||
105609592|NCT02187003|364235066|FG000|Overall Study|Adverse Event|2|||
105609593|NCT02187003|364235067|FG001|Overall Study|Adverse Event|0|||
105609594|NCT02187003|364235066|FG000|Overall Study|Lost to Follow-up|14|||
105609595|NCT02187003|364235067|FG001|Overall Study|Lost to Follow-up|10|||
105609596|NCT02187003|364235066|FG000|Overall Study|Withdrawal by Subject|3|||
105609597|NCT02187003|364235067|FG001|Overall Study|Withdrawal by Subject|7|||
105609598|NCT02187003|364235066|FG000|Overall Study|Protocol Violation|2|||
105609599|NCT02187003|364235067|FG001|Overall Study|Protocol Violation|4|||
105609600|NCT02187003|364235066|FG000|Overall Study|Other|5|||
105609601|NCT02187003|364235067|FG001|Overall Study|Other|5|||
105609602|NCT02187003|364235066|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105609603|NCT02187003|364235067|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
105609604|NCT05816551|364235070|FG000|Overall Study|Withdrawal by Subject|0|||
105609605|NCT05816551|364235071|FG001|Overall Study|Withdrawal by Subject|1|||
105609606|NCT05816551|364235070|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
105609607|NCT05816551|364235071|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
105609608|NCT04419168|364235072|FG000|Overall Study|Protocol Violation|1|||
105609609|NCT04419168|364235073|FG001|Overall Study|Protocol Violation|1|||
105609610|NCT04419168|364235072|FG000|Overall Study|Lost to Follow-up|7|||
105609611|NCT04419168|364235073|FG001|Overall Study|Lost to Follow-up|7|||
105609612|NCT04419168|364235072|FG000|Overall Study|Missed 6-month Visit|48|||
105609613|NCT04419168|364235073|FG001|Overall Study|Missed 6-month Visit|45|||
105609614|NCT03113500|364235076|FG000|Overall Study|Withdrawal by Subject|1|||
105609615|NCT06311084|364235078|FG000|Overall Study|Lost to Follow-up|14|||
105609616|NCT02312960|364235083|FG000|Overall Study|Death|24|||
105609617|NCT02312960|364235084|FG001|Overall Study|Death|32|||
105609618|NCT02312960|364235085|FG002|Overall Study|Death|25|||
105609619|NCT02312960|364235086|FG003|Overall Study|Death|11|||
105609620|NCT02312960|364235087|FG004|Overall Study|Death|5|||
105609621|NCT02312960|364235088|FG005|Overall Study|Death|5|||
105609622|NCT02312960|364235089|FG006|Overall Study|Death|8|||
105609623|NCT02312960|364235090|FG007|Overall Study|Death|5|||
105609624|NCT02312960|364235091|FG008|Overall Study|Death|7|||
105609625|NCT02312960|364235092|FG009|Overall Study|Death|3|||
105609626|NCT02312960|364235093|FG010|Overall Study|Death|3|||
105609627|NCT02312960|364235094|FG011|Overall Study|Death|1|||
105609628|NCT02312960|364235095|FG012|Overall Study|Death|25|||
105609629|NCT02312960|364235096|FG013|Overall Study|Death|19|||
105609630|NCT02312960|364235083|FG000|Overall Study|Missing|0|||
105609631|NCT02312960|364235084|FG001|Overall Study|Missing|0|||
105609632|NCT02312960|364235085|FG002|Overall Study|Missing|2|||
105609633|NCT02312960|364235086|FG003|Overall Study|Missing|0|||
105609634|NCT02312960|364235087|FG004|Overall Study|Missing|0|||
105609635|NCT02312960|364235088|FG005|Overall Study|Missing|0|||
105609636|NCT02312960|364235089|FG006|Overall Study|Missing|0|||
105609637|NCT02312960|364235090|FG007|Overall Study|Missing|0|||
105609638|NCT02312960|364235091|FG008|Overall Study|Missing|0|||
105609639|NCT02312960|364235092|FG009|Overall Study|Missing|0|||
105609640|NCT02312960|364235093|FG010|Overall Study|Missing|0|||
105609641|NCT02312960|364235094|FG011|Overall Study|Missing|0|||
105609642|NCT02312960|364235095|FG012|Overall Study|Missing|0|||
105609643|NCT02312960|364235096|FG013|Overall Study|Missing|0|||
105609644|NCT02312960|364235083|FG000|Overall Study|Lost to Follow-up|0|||
105609645|NCT02312960|364235084|FG001|Overall Study|Lost to Follow-up|0|||
105609646|NCT02312960|364235085|FG002|Overall Study|Lost to Follow-up|1|||
105609647|NCT02312960|364235086|FG003|Overall Study|Lost to Follow-up|0|||
105609648|NCT02312960|364235087|FG004|Overall Study|Lost to Follow-up|0|||
105609649|NCT02312960|364235088|FG005|Overall Study|Lost to Follow-up|0|||
105609650|NCT02312960|364235089|FG006|Overall Study|Lost to Follow-up|1|||
105609651|NCT02312960|364235090|FG007|Overall Study|Lost to Follow-up|1|||
105609652|NCT02312960|364235091|FG008|Overall Study|Lost to Follow-up|0|||
105609653|NCT02312960|364235092|FG009|Overall Study|Lost to Follow-up|1|||
105609654|NCT02312960|364235093|FG010|Overall Study|Lost to Follow-up|0|||
105609655|NCT02312960|364235094|FG011|Overall Study|Lost to Follow-up|0|||
105609656|NCT02312960|364235095|FG012|Overall Study|Lost to Follow-up|1|||
105609657|NCT02312960|364235096|FG013|Overall Study|Lost to Follow-up|0|||
105609658|NCT02312960|364235083|FG000|Overall Study|Withdrawal by Subject|1|||
105609659|NCT02312960|364235084|FG001|Overall Study|Withdrawal by Subject|2|||
105609660|NCT02312960|364235085|FG002|Overall Study|Withdrawal by Subject|0|||
105609661|NCT02312960|364235086|FG003|Overall Study|Withdrawal by Subject|0|||
105609662|NCT02312960|364235087|FG004|Overall Study|Withdrawal by Subject|1|||
105609663|NCT02312960|364235088|FG005|Overall Study|Withdrawal by Subject|0|||
105609664|NCT02312960|364235089|FG006|Overall Study|Withdrawal by Subject|1|||
105609665|NCT02312960|364235090|FG007|Overall Study|Withdrawal by Subject|2|||
105609666|NCT02312960|364235091|FG008|Overall Study|Withdrawal by Subject|2|||
105609667|NCT02312960|364235092|FG009|Overall Study|Withdrawal by Subject|3|||
105609668|NCT02312960|364235093|FG010|Overall Study|Withdrawal by Subject|0|||
105609669|NCT02312960|364235094|FG011|Overall Study|Withdrawal by Subject|0|||
105609670|NCT02312960|364235095|FG012|Overall Study|Withdrawal by Subject|2|||
105609671|NCT02312960|364235096|FG013|Overall Study|Withdrawal by Subject|0|||
105609672|NCT04820855|364235097|FG000|Overall Study|Lost to Follow-up|6|||
105609673|NCT04820855|364235098|FG001|Overall Study|Lost to Follow-up|9|||
105609674|NCT02437318|364235099|FG000|Overall Study|Progressive disease|207|||
105609675|NCT02437318|364235100|FG001|Overall Study|Progressive disease|240|||
105609676|NCT02437318|364235099|FG000|Overall Study|Subject/guardian decision|24|||
105609677|NCT02437318|364235100|FG001|Overall Study|Subject/guardian decision|11|||
105609678|NCT02437318|364235099|FG000|Overall Study|Physician Decision|29|||
105609679|NCT02437318|364235100|FG001|Overall Study|Physician Decision|22|||
105609680|NCT02437318|364235099|FG000|Overall Study|Adverse Event|14|||
105609681|NCT02437318|364235100|FG001|Overall Study|Adverse Event|4|||
105609682|NCT02437318|364235099|FG000|Overall Study|Death|4|||
105609683|NCT02437318|364235100|FG001|Overall Study|Death|4|||
105609684|NCT02437318|364235099|FG000|Overall Study|Protocol deviation|5|||
105609685|NCT02437318|364235100|FG001|Overall Study|Protocol deviation|7|||
105609686|NCT02437318|364235099|FG000|Overall Study|Sponsor decision|1|||
105609687|NCT02437318|364235100|FG001|Overall Study|Sponsor decision|0|||
105609688|NCT03526861|364235101|FG000|Initial Treatment Period|Not dosed|1|||
105609689|NCT03526861|364235102|FG001|Initial Treatment Period|Not dosed|1|||
105609690|NCT03526861|364235103|FG002|Initial Treatment Period|Not dosed|1|||
105609691|NCT03526861|364235104|FG003|Initial Treatment Period|Not dosed|0|||
105609692|NCT03526861|364235105|FG004|Initial Treatment Period|Not dosed|0|||
105609693|NCT03526861|364235106|FG005|Initial Treatment Period|Not dosed|0|||
105609694|NCT03526861|364235107|FG006|Initial Treatment Period|Not dosed|0|||
105609695|NCT03526861|364235108|FG007|Initial Treatment Period|Not dosed|0|||
105609696|NCT03526861|364235109|FG008|Initial Treatment Period|Not dosed|0|||
105609697|NCT03526861|364235101|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
105609698|NCT03526861|364235102|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
105609699|NCT03526861|364235103|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
105609700|NCT03526861|364235104|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609701|NCT03526861|364235105|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609702|NCT03526861|364235106|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609703|NCT03526861|364235107|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609704|NCT03526861|364235108|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609705|NCT03526861|364235109|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609706|NCT03526861|364235101|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
105609707|NCT03526861|364235102|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
105609708|NCT03526861|364235103|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
105609709|NCT03526861|364235104|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
105609710|NCT03526861|364235105|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
105609711|NCT03526861|364235106|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
105609712|NCT03526861|364235107|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
105609713|NCT03526861|364235108|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
105609714|NCT03526861|364235109|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
105609715|NCT03526861|364235101|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
105609716|NCT03526861|364235102|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
105609717|NCT03526861|364235103|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
105609718|NCT03526861|364235104|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
105609719|NCT03526861|364235105|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
105609720|NCT03526861|364235106|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
105609721|NCT03526861|364235107|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
105609722|NCT03526861|364235108|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
105609723|NCT03526861|364235109|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
105609724|NCT03526861|364235101|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
105609725|NCT03526861|364235102|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
105609726|NCT03526861|364235103|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
105609727|NCT03526861|364235104|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
105609728|NCT03526861|364235105|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
105609729|NCT03526861|364235106|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
105609730|NCT03526861|364235107|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
105609731|NCT03526861|364235108|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
105609732|NCT03526861|364235109|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
105609733|NCT03526861|364235101|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609734|NCT03526861|364235102|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609735|NCT03526861|364235103|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609736|NCT03526861|364235104|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
105609737|NCT03526861|364235105|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609738|NCT03526861|364235106|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609739|NCT03526861|364235107|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609740|NCT03526861|364235108|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609741|NCT03526861|364235109|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609742|NCT03526861|364235101|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
105609743|NCT03526861|364235102|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
105609744|NCT03526861|364235103|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
105609745|NCT03526861|364235104|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
105609746|NCT03526861|364235105|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
105609747|NCT03526861|364235106|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
105609748|NCT03526861|364235107|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
105609749|NCT03526861|364235108|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
105609750|NCT03526861|364235109|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
105609751|NCT03526861|364235101|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
105609752|NCT03526861|364235102|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
105609753|NCT03526861|364235103|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
105609754|NCT03526861|364235104|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
105609755|NCT03526861|364235105|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
105609756|NCT03526861|364235106|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
105609757|NCT03526861|364235107|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
105609758|NCT03526861|364235108|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
105609759|NCT03526861|364235109|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
105609760|NCT03526861|364235101|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609761|NCT03526861|364235102|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609762|NCT03526861|364235103|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609763|NCT03526861|364235104|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609764|NCT03526861|364235105|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609765|NCT03526861|364235106|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609766|NCT03526861|364235107|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609767|NCT03526861|364235108|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
105609768|NCT03526861|364235109|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
105609769|NCT03281291|364235110|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
105609770|NCT03281291|364235111|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
105609771|NCT03281291|364235112|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
105609772|NCT03281291|364235113|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
105609773|NCT03281291|364235114|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
105609774|NCT03281291|364235110|FG000|Overall Study|Protocol Deviation|2|||
105609775|NCT03281291|364235111|FG001|Overall Study|Protocol Deviation|0|||
105609776|NCT03281291|364235112|FG002|Overall Study|Protocol Deviation|1|||
105609777|NCT03281291|364235113|FG003|Overall Study|Protocol Deviation|2|||
105609778|NCT03281291|364235114|FG004|Overall Study|Protocol Deviation|1|||
105609779|NCT03281291|364235110|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
105609780|NCT03281291|364235111|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
105609781|NCT03281291|364235112|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
105609782|NCT03281291|364235113|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
105609783|NCT03281291|364235114|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
105609784|NCT03281291|364235110|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
105609785|NCT03281291|364235111|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
105609786|NCT03281291|364235112|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
105609787|NCT03281291|364235113|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
105609788|NCT03281291|364235114|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
105609789|NCT03281291|364235110|FG000|Overall Study|Lost to Follow-up|10|||
105609790|NCT03281291|364235111|FG001|Overall Study|Lost to Follow-up|10|||
105609791|NCT03281291|364235112|FG002|Overall Study|Lost to Follow-up|4|||
105609792|NCT03281291|364235113|FG003|Overall Study|Lost to Follow-up|6|||
105609793|NCT03281291|364235114|FG004|Overall Study|Lost to Follow-up|10|||
105609794|NCT03281291|364235110|FG000|Overall Study|Other|0|||
105609795|NCT03281291|364235111|FG001|Overall Study|Other|2|||
105609796|NCT03281291|364235112|FG002|Overall Study|Other|0|||
105609797|NCT03281291|364235113|FG003|Overall Study|Other|2|||
105609798|NCT03281291|364235114|FG004|Overall Study|Other|1|||
105609799|NCT01809691|364235115|FG000|Overall Study|Currently on Treatment|192|||
105609800|NCT01809691|364235116|FG001|Overall Study|Currently on Treatment|100|||
105609801|NCT01809691|364235115|FG000|Overall Study|No Protocol Treatment|10|||
105609802|NCT01809691|364235116|FG001|Overall Study|No Protocol Treatment|11|||
105609803|NCT01809691|364235115|FG000|Overall Study|Adverse Event|80|||
105609804|NCT01809691|364235116|FG001|Overall Study|Adverse Event|21|||
105609805|NCT01809691|364235115|FG000|Overall Study|Disease Progression|226|||
105609806|NCT01809691|364235116|FG001|Overall Study|Disease Progression|372|||
105609807|NCT01809691|364235115|FG000|Overall Study|Death|26|||
105609808|NCT01809691|364235116|FG001|Overall Study|Death|13|||
105609809|NCT01809691|364235115|FG000|Overall Study|Participant Refusal|70|||
105609810|NCT01809691|364235116|FG001|Overall Study|Participant Refusal|72|||
105609811|NCT01809691|364235115|FG000|Overall Study|Other, Not Specified|34|||
105609812|NCT01809691|364235116|FG001|Overall Study|Other, Not Specified|52|||
105609813|NCT03385629|364235117|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
105609814|NCT03385629|364235118|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
105609815|NCT03385629|364235117|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
105609816|NCT03385629|364235118|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
105609817|NCT03385629|364235117|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
105609818|NCT03385629|364235118|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
105609819|NCT03978871|364235120|FG000|Overall Study|Lost to Follow-up|11|||
105609820|NCT03978871|364235121|FG001|Overall Study|Lost to Follow-up|12|||
105609821|NCT04285567|364235124|FG000|Overall Study|Death|3|||
105609822|NCT04285567|364235125|FG001|Overall Study|Death|3|||
105609823|NCT04285567|364235124|FG000|Overall Study|Lost to Follow-up|1|||
105609824|NCT04285567|364235125|FG001|Overall Study|Lost to Follow-up|1|||
105609825|NCT04285567|364235124|FG000|Overall Study|Reason Not Specified|1|||
105609826|NCT04285567|364235125|FG001|Overall Study|Reason Not Specified|1|||
105609827|NCT04285567|364235124|FG000|Overall Study|Physician Decision|2|||
105609828|NCT04285567|364235125|FG001|Overall Study|Physician Decision|1|||
105609829|NCT04285567|364235124|FG000|Overall Study|Withdrawal by Subject|2|||
105609830|NCT04285567|364235125|FG001|Overall Study|Withdrawal by Subject|6|||
105609831|NCT04285567|364235124|FG000|Overall Study|Adverse Event|1|||
105609832|NCT04285567|364235125|FG001|Overall Study|Adverse Event|0|||
105609833|NCT04285567|364235124|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
105609834|NCT04285567|364235125|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
105609835|NCT05319860|364235127|FG000|Overall Study|Death|1|||
105609836|NCT05319860|364235128|FG001|Overall Study|Death|1|||
105609837|NCT05319860|364235127|FG000|Overall Study|Lost to Follow-up|3|||
105609838|NCT05319860|364235128|FG001|Overall Study|Lost to Follow-up|1|||
105609839|NCT05319860|364235127|FG000|Overall Study|Withdrawal by Subject|1|||
105609840|NCT05319860|364235128|FG001|Overall Study|Withdrawal by Subject|7|||
105609841|NCT04854096|364235129|FG000|Overall Study|Adverse Event|1|||
105609842|NCT04854096|364235130|FG001|Overall Study|Adverse Event|0|||
105609843|NCT04854096|364235129|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
105609844|NCT04854096|364235130|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
105609845|NCT04854096|364235129|FG000|Overall Study|Withdrawal by Subject|1|||
105609846|NCT04854096|364235130|FG001|Overall Study|Withdrawal by Subject|0|||
105609847|NCT04854096|364235129|FG000|Overall Study|Other reasons|1|||
105609848|NCT04854096|364235130|FG001|Overall Study|Other reasons|0|||
105609849|NCT02349412|364236180|FG000|Overall Study|Withdrawal by Subject|7|||
105609850|NCT02349412|364236181|FG001|Overall Study|Withdrawal by Subject|7|||
105609851|NCT03940703|364236182|FG000|Overall Study|Still under treatment|31|||
105609852|NCT03940703|364236183|FG001|Overall Study|Still under treatment|0|||
105609853|NCT05320432|364236186|FG000|Overall Study|Withdrawal by Subject|0|||
105609854|NCT05320432|364236187|FG001|Overall Study|Withdrawal by Subject|2|||
105609855|NCT03484702|364236188|FG000|Treatment Period|Death|3|||
105609856|NCT03484702|364236189|FG001|Treatment Period|Death|1|||
105609857|NCT03484702|364236190|FG002|Treatment Period|Death|0|||
105609858|NCT03484702|364236191|FG003|Treatment Period|Death|0|||
105609859|NCT03484702|364236192|FG004|Treatment Period|Death|0|||
105609860|NCT03484702|364236193|FG005|Treatment Period|Death|0|||
105609861|NCT03484702|364236188|FG000|Treatment Period|Adverse Event|1|||
105609862|NCT03484702|364236189|FG001|Treatment Period|Adverse Event|0|||
105609863|NCT03484702|364236190|FG002|Treatment Period|Adverse Event|0|||
105609864|NCT03484702|364236191|FG003|Treatment Period|Adverse Event|0|||
105609865|NCT03484702|364236192|FG004|Treatment Period|Adverse Event|0|||
105609866|NCT03484702|364236193|FG005|Treatment Period|Adverse Event|0|||
105609867|NCT03484702|364236188|FG000|Treatment Period|Participant Withdrew from Study|0|||
105609868|NCT03484702|364236189|FG001|Treatment Period|Participant Withdrew from Study|1|||
105609869|NCT03484702|364236190|FG002|Treatment Period|Participant Withdrew from Study|0|||
105609870|NCT03484702|364236191|FG003|Treatment Period|Participant Withdrew from Study|0|||
105609871|NCT03484702|364236192|FG004|Treatment Period|Participant Withdrew from Study|0|||
105609872|NCT03484702|364236193|FG005|Treatment Period|Participant Withdrew from Study|0|||
105609873|NCT03484702|364236188|FG000|Treatment Period|Physician Decision|0|||
105609874|NCT03484702|364236189|FG001|Treatment Period|Physician Decision|1|||
105609875|NCT03484702|364236190|FG002|Treatment Period|Physician Decision|0|||
105609876|NCT03484702|364236191|FG003|Treatment Period|Physician Decision|0|||
105609877|NCT03484702|364236192|FG004|Treatment Period|Physician Decision|0|||
105609878|NCT03484702|364236193|FG005|Treatment Period|Physician Decision|1|||
105609879|NCT04716634|364236199|FG000|Overall Study|Death|24|||
105609880|NCT04716634|364236200|FG001|Overall Study|Death|24|||
105609881|NCT04716634|364236201|FG002|Overall Study|Death|8|||
105609882|NCT04716634|364236199|FG000|Overall Study|Closed by Sponsor|4|||
105609883|NCT04716634|364236200|FG001|Overall Study|Closed by Sponsor|4|||
105609884|NCT04716634|364236201|FG002|Overall Study|Closed by Sponsor|5|||
105609885|NCT04716634|364236199|FG000|Overall Study|Lost to Follow-up|1|||
105609886|NCT04716634|364236200|FG001|Overall Study|Lost to Follow-up|0|||
105609887|NCT04716634|364236201|FG002|Overall Study|Lost to Follow-up|1|||
105609888|NCT04716634|364236199|FG000|Overall Study|Withdrawal by Subject|0|||
105609889|NCT04716634|364236200|FG001|Overall Study|Withdrawal by Subject|0|||
105609890|NCT04716634|364236201|FG002|Overall Study|Withdrawal by Subject|1|||
105609891|NCT02287311|364236211|FG000|Cohort 1: Dose Level 1|Death|2|||
105609892|NCT02287311|364236212|FG001|Cohort 1: Dose Level 1|Death|0|||
105609893|NCT02287311|364236213|FG002|Cohort 1: Dose Level 1|Death|0|||
105609894|NCT02287311|364236214|FG003|Cohort 1: Dose Level 1|Death|3|||
105609895|NCT02287311|364236215|FG004|Cohort 1: Dose Level 1|Death|0|||
105609896|NCT02287311|364236216|FG005|Cohort 1: Dose Level 1|Death|0|||
105609897|NCT02287311|364236217|FG006|Cohort 1: Dose Level 1|Death|1|||
105609898|NCT02287311|364236218|FG007|Cohort 1: Dose Level 1|Death|0|||
105609899|NCT02287311|364236219|FG008|Cohort 1: Dose Level 1|Death|0|||
105609900|NCT02287311|364236211|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
105609901|NCT02287311|364236212|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
105609902|NCT02287311|364236213|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
105609903|NCT02287311|364236214|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
105609904|NCT02287311|364236215|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
105609905|NCT02287311|364236216|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
105609906|NCT02287311|364236217|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
105609907|NCT02287311|364236218|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
105609908|NCT02287311|364236219|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
105609909|NCT02287311|364236211|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
105609910|NCT02287311|364236212|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
105609911|NCT02287311|364236213|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
105609912|NCT02287311|364236214|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
105609913|NCT02287311|364236215|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
105609914|NCT02287311|364236216|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
105609915|NCT02287311|364236217|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
105609916|NCT02287311|364236218|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
105609917|NCT02287311|364236219|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
105609918|NCT02287311|364236211|FG000|Cohort 2: Dose Level 2|Death|0|||
105609919|NCT02287311|364236212|FG001|Cohort 2: Dose Level 2|Death|2|||
105609920|NCT02287311|364236213|FG002|Cohort 2: Dose Level 2|Death|0|||
105609921|NCT02287311|364236214|FG003|Cohort 2: Dose Level 2|Death|0|||
105609922|NCT02287311|364236215|FG004|Cohort 2: Dose Level 2|Death|2|||
105609923|NCT02287311|364236216|FG005|Cohort 2: Dose Level 2|Death|0|||
105609924|NCT02287311|364236217|FG006|Cohort 2: Dose Level 2|Death|0|||
105609925|NCT02287311|364236218|FG007|Cohort 2: Dose Level 2|Death|2|||
105609926|NCT02287311|364236219|FG008|Cohort 2: Dose Level 2|Death|0|||
105609927|NCT02287311|364236211|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
105609928|NCT02287311|364236212|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
105609929|NCT02287311|364236213|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
105609930|NCT02287311|364236214|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
105609931|NCT02287311|364236215|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
105609932|NCT02287311|364236216|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
105609933|NCT02287311|364236217|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
105609934|NCT02287311|364236218|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
105609935|NCT02287311|364236219|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
105609936|NCT02287311|364236211|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
105609937|NCT02287311|364236212|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
105609938|NCT02287311|364236213|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
105609939|NCT02287311|364236214|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
105609940|NCT02287311|364236215|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
105609941|NCT02287311|364236216|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
105609942|NCT02287311|364236217|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
105609943|NCT02287311|364236218|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
105609944|NCT02287311|364236219|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
105609945|NCT02287311|364236211|FG000|Cohort 3: Dose Level 3|Death|0|||
105609946|NCT02287311|364236212|FG001|Cohort 3: Dose Level 3|Death|0|||
105609947|NCT02287311|364236213|FG002|Cohort 3: Dose Level 3|Death|4|||
105609948|NCT02287311|364236214|FG003|Cohort 3: Dose Level 3|Death|0|||
105609949|NCT02287311|364236215|FG004|Cohort 3: Dose Level 3|Death|0|||
105609950|NCT02287311|364236216|FG005|Cohort 3: Dose Level 3|Death|4|||
105609951|NCT02287311|364236217|FG006|Cohort 3: Dose Level 3|Death|0|||
105609952|NCT02287311|364236218|FG007|Cohort 3: Dose Level 3|Death|0|||
105609953|NCT02287311|364236219|FG008|Cohort 3: Dose Level 3|Death|2|||
105609954|NCT02287311|364236211|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
105609955|NCT02287311|364236212|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
105609956|NCT02287311|364236213|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
105609957|NCT02287311|364236214|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
105609958|NCT02287311|364236215|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
105609959|NCT02287311|364236216|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
105609960|NCT02287311|364236217|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
105609961|NCT02287311|364236218|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
105609962|NCT02287311|364236219|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
105609963|NCT02287311|364236211|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
105609964|NCT02287311|364236212|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
105609965|NCT02287311|364236213|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
105609966|NCT02287311|364236214|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
105609967|NCT02287311|364236215|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
105609968|NCT02287311|364236216|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
105609969|NCT02287311|364236217|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
105609970|NCT02287311|364236218|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
105609971|NCT02287311|364236219|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
105609972|NCT03896516|364236220|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
105609973|NCT03896516|364236221|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
105609974|NCT03896516|364236220|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
105609975|NCT03896516|364236221|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
105609976|NCT03896516|364236220|FG000|Washout Period|Physician Decision|3|||
105609977|NCT03896516|364236221|FG001|Washout Period|Physician Decision|1|||
105609978|NCT03896516|364236220|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
105609979|NCT03896516|364236221|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
105609980|NCT03648840|364236226|FG000|First IV Infusion Session|Adverse Event|0|||
105609981|NCT03648840|364236227|FG001|First IV Infusion Session|Adverse Event|2|||
105609982|NCT03648840|364236226|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
105609983|NCT03648840|364236227|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
105609984|NCT03648840|364236226|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
105609985|NCT03648840|364236227|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
105609986|NCT03648840|364236226|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
105609987|NCT03648840|364236227|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
105609988|NCT05063994|364236231|FG000|Cortef Run-In|Withdrawal of Consent|1|||
105609989|NCT05063994|364236232|FG001|Cortef Run-In|Withdrawal of Consent|0|||
105609990|NCT05063994|364236233|FG002|Cortef Run-In|Withdrawal of Consent|0|||
105609991|NCT05063994|364236231|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
105609992|NCT05063994|364236232|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
105609993|NCT05063994|364236233|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
105609994|NCT05063994|364236231|FG000|Treatment|Physician Decision|0|||
105609995|NCT05063994|364236232|FG001|Treatment|Physician Decision|0|||
105609996|NCT05063994|364236233|FG002|Treatment|Physician Decision|1|||
105609997|NCT05063994|364236231|FG000|Treatment|Withdrawal by Subject|0|||
105609998|NCT05063994|364236232|FG001|Treatment|Withdrawal by Subject|0|||
105609999|NCT05063994|364236233|FG002|Treatment|Withdrawal by Subject|1|||
105610000|NCT05063994|364236231|FG000|Treatment|Withdrawal of Consent|0|||
105610001|NCT05063994|364236232|FG001|Treatment|Withdrawal of Consent|0|||
105610002|NCT05063994|364236233|FG002|Treatment|Withdrawal of Consent|1|||
105610003|NCT04538417|364236237|FG000|Overall Study|Withdrawal by Subject|2|||
105610004|NCT02867384|364236254|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
105610005|NCT02867384|364236255|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
105610006|NCT02867384|364236256|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
105610007|NCT02867384|364236254|FG000|Overall Study|Progression/ Relapse|15|||
105610008|NCT02867384|364236255|FG001|Overall Study|Progression/ Relapse|19|||
105610009|NCT02867384|364236256|FG002|Overall Study|Progression/ Relapse|0|||
105610010|NCT02867384|364236254|FG000|Overall Study|Adverse Event|13|||
105610011|NCT02867384|364236255|FG001|Overall Study|Adverse Event|1|||
105610012|NCT02867384|364236256|FG002|Overall Study|Adverse Event|0|||
105610013|NCT02867384|364236254|FG000|Overall Study|Withdrawal by Subject|6|||
105610014|NCT02867384|364236255|FG001|Overall Study|Withdrawal by Subject|5|||
105610015|NCT02867384|364236256|FG002|Overall Study|Withdrawal by Subject|0|||
105610016|NCT02867384|364236254|FG000|Overall Study|Physician Decision|1|||
105610017|NCT02867384|364236255|FG001|Overall Study|Physician Decision|2|||
105610018|NCT02867384|364236256|FG002|Overall Study|Physician Decision|0|||
105610019|NCT02867384|364236254|FG000|Overall Study|Patient compliance|1|||
105610020|NCT02867384|364236255|FG001|Overall Study|Patient compliance|0|||
105610021|NCT02867384|364236256|FG002|Overall Study|Patient compliance|0|||
105610022|NCT02867384|364236254|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
105610023|NCT02867384|364236255|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
105610024|NCT02867384|364236256|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
105610025|NCT02867384|364236254|FG000|Overall Study|Never start treatment|0|||
105610026|NCT02867384|364236255|FG001|Overall Study|Never start treatment|0|||
105610027|NCT02867384|364236256|FG002|Overall Study|Never start treatment|3|||
105610028|NCT03161379|364236261|FG000|Overall Study|Withdrawal by Subject|4|||
105610029|NCT03161379|364236261|FG000|Overall Study|disease progression during chemotherapy|5|||
105610030|NCT03161379|364236261|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
105610031|NCT03161379|364236261|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
105610032|NCT02549339|364236265|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
105610033|NCT02549339|364236266|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
105610034|NCT02549339|364236265|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
105610035|NCT02549339|364236266|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
105610036|NCT02549339|364236265|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
105610037|NCT02549339|364236266|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
105610038|NCT02549339|364236265|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
105610039|NCT02549339|364236266|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
105610040|NCT02549339|364236265|FG000|12-month Follow-up|Lack of Efficacy|0|||
105610041|NCT02549339|364236266|FG001|12-month Follow-up|Lack of Efficacy|2|||
105610042|NCT02549339|364236265|FG000|12-month Follow-up|Withdrawal by Subject|8|||
105610043|NCT02549339|364236266|FG001|12-month Follow-up|Withdrawal by Subject|3|||
105610044|NCT02549339|364236265|FG000|12-month Follow-up|Lost to Follow-up|1|||
105610045|NCT02549339|364236266|FG001|12-month Follow-up|Lost to Follow-up|3|||
105610046|NCT02549339|364236265|FG000|12-month Follow-up|Other|0|||
105610047|NCT02549339|364236266|FG001|12-month Follow-up|Other|3|||
105610048|NCT03016169|364236267|FG000|Overall Study|Lost to Follow-up|4|||
105610049|NCT03016169|364236267|FG000|Overall Study|Death|54|||
105610050|NCT03016169|364236267|FG000|Overall Study|Device Explant|11|||
105610051|NCT03016169|364236267|FG000|Overall Study|Withdrawal by Subject|19|||
105610052|NCT03016169|364236267|FG000|Overall Study|Other Reasons|1|||
105610053|NCT02592330|364236268|FG000|Overall Study|Withdrawal by Subject|1|||
105610054|NCT02592330|364236269|FG001|Overall Study|Withdrawal by Subject|0|||
105610055|NCT02592330|364236268|FG000|Overall Study|Failed Biopsy|1|||
105610056|NCT02592330|364236269|FG001|Overall Study|Failed Biopsy|0|||
105610057|NCT00920621|364236270|FG000|Overall Study|Lost to Follow-up|16|||
105610058|NCT00920621|364236271|FG001|Overall Study|Lost to Follow-up|17|||
105610059|NCT00920621|364236272|FG002|Overall Study|Lost to Follow-up|19|||
105610060|NCT00920621|364236273|FG003|Overall Study|Lost to Follow-up|21|||
105610061|NCT00920621|364236270|FG000|Overall Study|Fetal/neonatal deaths|16|||
105610062|NCT00920621|364236271|FG001|Overall Study|Fetal/neonatal deaths|14|||
105610063|NCT00920621|364236272|FG002|Overall Study|Fetal/neonatal deaths|16|||
105610064|NCT00920621|364236273|FG003|Overall Study|Fetal/neonatal deaths|14|||
105610065|NCT00920621|364236270|FG000|Overall Study|Blood sample not collected|22|||
105610066|NCT00920621|364236271|FG001|Overall Study|Blood sample not collected|14|||
105610067|NCT00920621|364236272|FG002|Overall Study|Blood sample not collected|0|||
105610068|NCT00920621|364236273|FG003|Overall Study|Blood sample not collected|0|||
105610069|NCT04710576|364236274|FG000|Overall Study|Participants still in the study|73|||
105610070|NCT04710576|364236275|FG001|Overall Study|Participants still in the study|70|||
105610071|NCT04710576|364236276|FG002|Overall Study|Participants still in the study|60|||
105610072|NCT04710576|364236274|FG000|Overall Study|Death|2|||
105610073|NCT04710576|364236275|FG001|Overall Study|Death|7|||
105610074|NCT04710576|364236276|FG002|Overall Study|Death|12|||
105610075|NCT04710576|364236274|FG000|Overall Study|Withdrawal by Subject|4|||
105610076|NCT04710576|364236275|FG001|Overall Study|Withdrawal by Subject|3|||
105610077|NCT04710576|364236276|FG002|Overall Study|Withdrawal by Subject|7|||
105610078|NCT04710576|364236274|FG000|Overall Study|Sponsor decision|1|||
105610079|NCT04710576|364236275|FG001|Overall Study|Sponsor decision|0|||
105610080|NCT04710576|364236276|FG002|Overall Study|Sponsor decision|0|||
105610081|NCT01566695|364236277|FG000|Overall Study|Lack of Efficacy|1|||
105610082|NCT01566695|364236278|FG001|Overall Study|Lack of Efficacy|0|||
105610083|NCT01566695|364236277|FG000|Overall Study|Adverse Event|3|||
105610084|NCT01566695|364236278|FG001|Overall Study|Adverse Event|0|||
105610085|NCT01566695|364236277|FG000|Overall Study|Death|79|||
105610086|NCT01566695|364236278|FG001|Overall Study|Death|86|||
105610087|NCT01566695|364236277|FG000|Overall Study|Withdrawal by Subject|13|||
105610088|NCT01566695|364236278|FG001|Overall Study|Withdrawal by Subject|12|||
105610089|NCT01566695|364236277|FG000|Overall Study|Lost to Follow-up|0|||
105610090|NCT01566695|364236278|FG001|Overall Study|Lost to Follow-up|3|||
105610091|NCT01566695|364236277|FG000|Overall Study|Other reasons|11|||
105610092|NCT01566695|364236278|FG001|Overall Study|Other reasons|8|||
105610093|NCT05089734|364236286|FG000|Overall Study|Still on study|122|||
105610094|NCT05089734|364236287|FG001|Overall Study|Still on study|101|||
105610095|NCT05089734|364236286|FG000|Overall Study|Death|161|||
105610096|NCT05089734|364236287|FG001|Overall Study|Death|179|||
105610097|NCT05089734|364236286|FG000|Overall Study|Withdrew consent|11|||
105610098|NCT05089734|364236287|FG001|Overall Study|Withdrew consent|24|||
105610099|NCT05089734|364236286|FG000|Overall Study|Lost to Follow-up|5|||
105610100|NCT05089734|364236287|FG001|Overall Study|Lost to Follow-up|0|||
105626699|NCT04186819|364298168|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
105626700|NCT04186819|364298168|FG000|Overall Study|Physician Decision|1|||
105610101|NCT05038566|364237346|FG000|Overall Study|Technical Difficulties with the Device|0|||
105610102|NCT05038566|364237347|FG001|Overall Study|Technical Difficulties with the Device|1|||
105610103|NCT04842643|364237348|FG000|Overall Study|Physician Decision|1|||
105610104|NCT04842643|364237348|FG000|Overall Study|Other|1|||
105610105|NCT04511702|364237353|FG000|Overall Study|Lost to Follow-up|3|||
105610106|NCT04511702|364237354|FG001|Overall Study|Lost to Follow-up|0|||
105610107|NCT04511702|364237355|FG002|Overall Study|Lost to Follow-up|4|||
105610108|NCT04511702|364237353|FG000|Overall Study|Withdrawal by Subject|17|||
105610109|NCT04511702|364237354|FG001|Overall Study|Withdrawal by Subject|1|||
105610110|NCT04511702|364237355|FG002|Overall Study|Withdrawal by Subject|8|||
105610111|NCT01894061|364237356|FG000|Overall Study|Screen failure|1|||
105610112|NCT01894061|364237356|FG000|Overall Study|Withdrawal by Subject|1|||
105610113|NCT04402489|364237357|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
105610114|NCT04402489|364237358|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
105610115|NCT04402489|364237359|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
105610116|NCT04402489|364237360|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
105610117|NCT04402489|364237361|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
105610118|NCT04402489|364237357|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
105610119|NCT04402489|364237358|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
105610120|NCT04402489|364237359|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
105610121|NCT04402489|364237360|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
105610122|NCT04402489|364237361|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
105610123|NCT04402489|364237357|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
105610124|NCT04402489|364237358|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
105610125|NCT04402489|364237359|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
105610126|NCT04402489|364237360|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
105610127|NCT04402489|364237361|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
105610128|NCT04402489|364237357|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
105610129|NCT04402489|364237358|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
105610130|NCT04402489|364237359|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
105610131|NCT04402489|364237360|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
105610132|NCT04402489|364237361|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
105610133|NCT04402489|364237357|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
105610134|NCT04402489|364237358|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
105610135|NCT04402489|364237359|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
105610136|NCT04402489|364237360|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
105610137|NCT04402489|364237361|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
105610138|NCT04402489|364237357|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
105610139|NCT04402489|364237358|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
105610140|NCT04402489|364237359|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
105610141|NCT04402489|364237360|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
105610142|NCT04402489|364237361|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
105610143|NCT03192891|364237362|FG000|Overall Study|Lost to Follow-up|55|||
105610144|NCT04593472|364237363|FG000|Overall Study|Death|31|||
105610145|NCT04593472|364237364|FG001|Overall Study|Death|27|||
105610146|NCT04593472|364237363|FG000|Overall Study|Withdrawal by Subject|12|||
105610147|NCT04593472|364237364|FG001|Overall Study|Withdrawal by Subject|12|||
105610148|NCT04593472|364237363|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
105610149|NCT04593472|364237364|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
105610150|NCT04593472|364237363|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
105610151|NCT04593472|364237364|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
105610152|NCT04593472|364237363|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
105610153|NCT04593472|364237364|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
105610154|NCT04593472|364237363|FG000|Overall Study|Lost to Follow-up|0|||
105610155|NCT04593472|364237364|FG001|Overall Study|Lost to Follow-up|2|||
105610156|NCT04593472|364237363|FG000|Overall Study|Still collecting 24-month assessment|17|||
105610157|NCT04593472|364237364|FG001|Overall Study|Still collecting 24-month assessment|10|||
105610158|NCT04178733|364237365|FG000|Overall Study|Investigator Decision|0|||
105610159|NCT04178733|364237366|FG001|Overall Study|Investigator Decision|0|||
105610160|NCT04178733|364237367|FG002|Overall Study|Investigator Decision|0|||
105610161|NCT04178733|364237368|FG003|Overall Study|Investigator Decision|1|||
105610162|NCT04178733|364237369|FG004|Overall Study|Investigator Decision|2|||
105610163|NCT03391466|364237372|FG000|Overall Study|Death|82|||
105610164|NCT03391466|364237373|FG001|Overall Study|Death|85|||
105610165|NCT03391466|364237372|FG000|Overall Study|Still on study|93|||
105610166|NCT03391466|364237373|FG001|Overall Study|Still on study|74|||
105610167|NCT03391466|364237372|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
105610168|NCT03391466|364237373|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
105610169|NCT03391466|364237372|FG000|Overall Study|Lost to Follow-up|5|||
105610170|NCT03391466|364237373|FG001|Overall Study|Lost to Follow-up|5|||
105610171|NCT03391466|364237372|FG000|Overall Study|Investigator decision|0|||
105610172|NCT03391466|364237373|FG001|Overall Study|Investigator decision|1|||
105610173|NCT03391466|364237372|FG000|Overall Study|Other|0|||
105610174|NCT03391466|364237373|FG001|Overall Study|Other|1|||
105610175|NCT05461131|364237382|FG000|Overall Study|Lost to Follow-up|0|||
105610176|NCT05461131|364237383|FG001|Overall Study|Lost to Follow-up|2|||
105610177|NCT04630262|364237384|FG000|Overall Study|Intraoperative Screen Failure|5|||
105610178|NCT04630262|364237384|FG000|Overall Study|Study terminated prematurely|71|||
105610179|NCT04630262|364237384|FG000|Overall Study|Withdrawal by Subject|2|||
105610180|NCT04630262|364237384|FG000|Overall Study|Physician Decision|2|||
105610181|NCT01195831|364237385|FG000|Overall Study|Lost to Follow-up|2|||
105610182|NCT01195831|364237386|FG001|Overall Study|Lost to Follow-up|4|||
105610183|NCT01195831|364237385|FG000|Overall Study|Withdrawal by Subject|2|||
105610184|NCT01195831|364237386|FG001|Overall Study|Withdrawal by Subject|2|||
105610185|NCT01195831|364237385|FG000|Overall Study|Adverse Event|4|||
105610186|NCT01195831|364237386|FG001|Overall Study|Adverse Event|2|||
105610187|NCT01195831|364237385|FG000|Overall Study|Protocol Violation|0|||
105610188|NCT01195831|364237386|FG001|Overall Study|Protocol Violation|2|||
105610189|NCT03692676|364237391|FG000|Overall Study|exclude patients with prior use|4424|||
105610190|NCT03692676|364237392|FG001|Overall Study|exclude patients with prior use|24726|||
105610191|NCT03692676|364237393|FG002|Overall Study|exclude patients with prior use|0|||
105610192|NCT03692676|364237394|FG003|Overall Study|exclude patients with prior use|0|||
105610193|NCT03692676|364237391|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
105610194|NCT03692676|364237392|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
105610195|NCT03692676|364237393|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
105610196|NCT03692676|364237394|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
105610197|NCT03692676|364237391|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
105610198|NCT03692676|364237392|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
105610199|NCT03692676|364237393|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
105610200|NCT03692676|364237394|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
105610201|NCT03692676|364237391|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
105610202|NCT03692676|364237392|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
105610203|NCT03692676|364237393|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
105610204|NCT03692676|364237394|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
105610205|NCT03692676|364237391|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
105610206|NCT03692676|364237392|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
105610207|NCT03692676|364237393|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
105610208|NCT03692676|364237394|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
105610209|NCT03692676|364237391|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
105610210|NCT03692676|364237392|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
105610211|NCT03692676|364237393|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
105610212|NCT03692676|364237394|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
105610213|NCT03692676|364237391|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
105610214|NCT03692676|364237392|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
105610215|NCT03692676|364237393|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
105610216|NCT03692676|364237394|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
105610217|NCT03692676|364237391|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
105610218|NCT03692676|364237392|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
105610219|NCT03692676|364237393|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
105610220|NCT03692676|364237394|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
105610221|NCT03692676|364237391|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
105610222|NCT03692676|364237392|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
105610223|NCT03692676|364237393|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
105610224|NCT03692676|364237394|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
105610225|NCT03692676|364237391|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
105610226|NCT03692676|364237392|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
105610227|NCT03692676|364237393|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
105610228|NCT03692676|364237394|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
105610229|NCT03692676|364237391|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
105610230|NCT03692676|364237392|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
105610231|NCT03692676|364237393|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
105610232|NCT03692676|364237394|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
105610233|NCT03692676|364237391|FG000|Overall Study|Other|0|||
105610234|NCT03692676|364237392|FG001|Overall Study|Other|805|||
105610235|NCT03692676|364237393|FG002|Overall Study|Other|758|||
105610236|NCT03692676|364237394|FG003|Overall Study|Other|277|||
105610237|NCT03692676|364237391|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
105610238|NCT03692676|364237392|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
105610239|NCT03692676|364237393|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
105610240|NCT03692676|364237394|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
105610241|NCT04638998|364237395|FG000|Overall Study|Withdrawal by Subject|1|||
105610242|NCT04638998|364237396|FG001|Overall Study|Withdrawal by Subject|3|||
105610243|NCT04549168|364237397|FG000|Randomization Phase|Adverse Event|0|||
105610244|NCT04549168|364237398|FG001|Randomization Phase|Adverse Event|0|||
105610245|NCT04549168|364237399|FG002|Randomization Phase|Adverse Event|1|||
105610246|NCT04549168|364237397|FG000|Randomization Phase|Other|0|||
105610247|NCT04549168|364237398|FG001|Randomization Phase|Other|2|||
105610248|NCT04549168|364237399|FG002|Randomization Phase|Other|0|||
105610249|NCT04549168|364237397|FG000|Randomization Phase|Withdrawal by Subject|0|||
105610250|NCT04549168|364237398|FG001|Randomization Phase|Withdrawal by Subject|2|||
105610251|NCT04549168|364237399|FG002|Randomization Phase|Withdrawal by Subject|1|||
105610252|NCT04725240|364237403|FG000|Overall Study|Adverse Event|2|||
105610253|NCT03147287|364237406|FG000|Overall Study|Randomized Not Treated|2|||
105610254|NCT03147287|364237407|FG001|Overall Study|Randomized Not Treated|1|||
105610255|NCT03147287|364237408|FG002|Overall Study|Randomized Not Treated|1|||
105610256|NCT03147287|364237406|FG000|Overall Study|Progressive Disease RECIST|31|||
105610257|NCT03147287|364237407|FG001|Overall Study|Progressive Disease RECIST|72|||
105610258|NCT03147287|364237408|FG002|Overall Study|Progressive Disease RECIST|32|||
105610259|NCT03147287|364237406|FG000|Overall Study|Progressive Disease not RECIST|13|||
105610260|NCT03147287|364237407|FG001|Overall Study|Progressive Disease not RECIST|21|||
105610261|NCT03147287|364237408|FG002|Overall Study|Progressive Disease not RECIST|13|||
105610262|NCT03147287|364237406|FG000|Overall Study|Physician Decision|1|||
105610263|NCT03147287|364237407|FG001|Overall Study|Physician Decision|2|||
105610264|NCT03147287|364237408|FG002|Overall Study|Physician Decision|1|||
105610265|NCT03147287|364237406|FG000|Overall Study|Intercurrent illness|0|||
105610266|NCT03147287|364237407|FG001|Overall Study|Intercurrent illness|1|||
105610267|NCT03147287|364237408|FG002|Overall Study|Intercurrent illness|0|||
105610268|NCT03147287|364237406|FG000|Overall Study|Withdrawal by Subject|2|||
105610269|NCT03147287|364237407|FG001|Overall Study|Withdrawal by Subject|3|||
105610270|NCT03147287|364237408|FG002|Overall Study|Withdrawal by Subject|2|||
105610271|NCT03147287|364237406|FG000|Overall Study|Patient Non-Compliance|0|||
105610272|NCT03147287|364237407|FG001|Overall Study|Patient Non-Compliance|2|||
105610273|NCT03147287|364237408|FG002|Overall Study|Patient Non-Compliance|0|||
105610274|NCT03147287|364237406|FG000|Overall Study|Patient moved|0|||
105610275|NCT03147287|364237407|FG001|Overall Study|Patient moved|1|||
105610276|NCT03147287|364237408|FG002|Overall Study|Patient moved|0|||
105610277|NCT03147287|364237406|FG000|Overall Study|Arm A crossover without PD|1|||
105610278|NCT03147287|364237407|FG001|Overall Study|Arm A crossover without PD|0|||
105610279|NCT03147287|364237408|FG002|Overall Study|Arm A crossover without PD|0|||
105610280|NCT03147287|364237406|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
105610281|NCT03147287|364237407|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
105610282|NCT03147287|364237408|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
105610283|NCT01820260|364237409|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
105610284|NCT01820260|364237410|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
105610285|NCT01820260|364237411|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
105610286|NCT01820260|364237412|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
105610287|NCT01820260|364237413|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
105610288|NCT01820260|364237414|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
105610289|NCT01820260|364237415|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
105610290|NCT01820260|364237416|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
105610291|NCT01820260|364237417|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
105610292|NCT01820260|364237418|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
105610293|NCT01820260|364237419|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
105610294|NCT01820260|364237420|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
105610295|NCT01820260|364237421|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
105610296|NCT01820260|364237422|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
105610297|NCT01820260|364237409|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
105610298|NCT01820260|364237410|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
105610299|NCT01820260|364237411|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
105610300|NCT01820260|364237412|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
105610301|NCT01820260|364237413|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
105610302|NCT01820260|364237414|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
105610303|NCT01820260|364237415|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
105610304|NCT01820260|364237416|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
105610305|NCT01820260|364237417|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
105610306|NCT01820260|364237418|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
105610307|NCT01820260|364237419|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
105610308|NCT01820260|364237420|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
105610309|NCT01820260|364237421|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
105610310|NCT01820260|364237422|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
105610311|NCT00616967|364237424|FG000|Overall Study|Withdrawal by Subject|0|||
105610312|NCT00616967|364237425|FG001|Overall Study|Withdrawal by Subject|0|||
105610313|NCT00616967|364237426|FG002|Overall Study|Withdrawal by Subject|1|||
105610314|NCT02249949|364237427|FG000|Overall Study|Cancelled prior to treatment|2|||
105610315|NCT05524233|364237445|FG000|Overall Study|Lost to Follow-up|2|||
105610316|NCT05524233|364237445|FG000|Overall Study|Adverse Event|2|||
105610317|NCT05524233|364237445|FG000|Overall Study|Withdrawal by Subject|1|||
105610318|NCT03453619|364237446|FG000|Core Study (Part A)|Physician Decision|0|||
105610319|NCT03453619|364237447|FG001|Core Study (Part A)|Physician Decision|0|||
105610320|NCT03453619|364237448|FG002|Core Study (Part A)|Physician Decision|2|||
105610321|NCT03453619|364237449|FG003|Core Study (Part A)|Physician Decision|0|||
105610322|NCT03453619|364237446|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
105610323|NCT03453619|364237447|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
105610324|NCT03453619|364237448|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
105610325|NCT03453619|364237449|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
105610326|NCT03453619|364237446|FG000|Core Study (Part A)|Other|0|||
105610327|NCT03453619|364237447|FG001|Core Study (Part A)|Other|1|||
105610328|NCT03453619|364237448|FG002|Core Study (Part A)|Other|0|||
105610329|NCT03453619|364237449|FG003|Core Study (Part A)|Other|0|||
105610330|NCT03453619|364237446|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
105610331|NCT03453619|364237447|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
105610332|NCT03453619|364237448|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
105610333|NCT03453619|364237449|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
105610334|NCT03453619|364237446|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
105610335|NCT03453619|364237447|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
105610336|NCT03453619|364237448|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
105610337|NCT03453619|364237449|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
105610338|NCT03453619|364237446|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
105610339|NCT03453619|364237447|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
105610340|NCT03453619|364237448|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
105610341|NCT03453619|364237449|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
105610342|NCT03453619|364237446|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
105610343|NCT03453619|364237447|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
105610344|NCT03453619|364237448|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
105610345|NCT03453619|364237449|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
105610346|NCT04089371|364237450|FG000|Overall Study|Withdrawal by Subject|0|||
105610347|NCT04089371|364237451|FG001|Overall Study|Withdrawal by Subject|1|||
105610348|NCT04089371|364237450|FG000|Overall Study|Study terminated early|0|||
105610349|NCT04089371|364237451|FG001|Overall Study|Study terminated early|9|||
105610350|NCT04382898|364237452|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
105610351|NCT04382898|364237453|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
105610352|NCT04382898|364237454|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
105610353|NCT04382898|364237455|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
105610354|NCT04382898|364237456|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
105610355|NCT04382898|364237452|FG000|Part 1: Dose Titration|Death|6|||
105610356|NCT04382898|364237453|FG001|Part 1: Dose Titration|Death|0|||
105610357|NCT04382898|364237454|FG002|Part 1: Dose Titration|Death|0|||
105610358|NCT04382898|364237455|FG003|Part 1: Dose Titration|Death|0|||
105610359|NCT04382898|364237456|FG004|Part 1: Dose Titration|Death|0|||
105610360|NCT04382898|364237452|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105610361|NCT04382898|364237453|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105610362|NCT04382898|364237454|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
105610363|NCT04382898|364237455|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105610364|NCT04382898|364237456|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105610365|NCT04382898|364237452|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
105610366|NCT04382898|364237453|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
105610367|NCT04382898|364237454|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
105610368|NCT04382898|364237455|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
105610369|NCT04382898|364237456|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
105610370|NCT04382898|364237452|FG000|Part 2: Dose Expansion|Death|0|||
105610371|NCT04382898|364237453|FG001|Part 2: Dose Expansion|Death|17|||
105610372|NCT04382898|364237454|FG002|Part 2: Dose Expansion|Death|13|||
105610373|NCT04382898|364237455|FG003|Part 2: Dose Expansion|Death|1|||
105610374|NCT04382898|364237456|FG004|Part 2: Dose Expansion|Death|0|||
105610375|NCT04382898|364237452|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
105610376|NCT04382898|364237453|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
105610377|NCT04382898|364237454|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
105610378|NCT04382898|364237455|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
105610379|NCT04382898|364237456|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
105610380|NCT04382898|364237452|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
105610381|NCT04382898|364237453|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
105610382|NCT04382898|364237454|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
105610383|NCT04382898|364237455|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
105610384|NCT04382898|364237456|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
105610385|NCT04382898|364237452|FG000|Part 2: Dose Expansion|Other|0|||
105610386|NCT04382898|364237453|FG001|Part 2: Dose Expansion|Other|0|||
105610387|NCT04382898|364237454|FG002|Part 2: Dose Expansion|Other|1|||
105610388|NCT04382898|364237455|FG003|Part 2: Dose Expansion|Other|0|||
105610389|NCT04382898|364237456|FG004|Part 2: Dose Expansion|Other|0|||
105610390|NCT02543281|364237457|FG000|Overall Study|Lost to Follow-up|0|||
105610391|NCT02543281|364237458|FG001|Overall Study|Lost to Follow-up|0|||
105610392|NCT02543281|364237459|FG002|Overall Study|Lost to Follow-up|1|||
105610393|NCT04541706|364237466|FG000|Overall Study|Withdrawal by Subject|3|||
105610394|NCT04541706|364237466|FG000|Overall Study|Progressive disease|33|||
105610395|NCT04541706|364237466|FG000|Overall Study|Physician Decision|1|||
105610396|NCT04541706|364237466|FG000|Overall Study|Lost to Follow-up|2|||
105610397|NCT04541706|364237466|FG000|Overall Study|Death|5|||
105610398|NCT04541706|364237466|FG000|Overall Study|Adverse Event|1|||
105610401|NCT02365766|364237487|FG000|Overall Study|Withdrawal by Subject|0|||
105610402|NCT02365766|364237488|FG001|Overall Study|Withdrawal by Subject|0|||
105610403|NCT02365766|364237489|FG002|Overall Study|Withdrawal by Subject|1|||
105610404|NCT02365766|364237487|FG000|Overall Study|Eligibility Criteria Not Met|0|||
105610405|NCT02365766|364237488|FG001|Overall Study|Eligibility Criteria Not Met|0|||
105610406|NCT02365766|364237489|FG002|Overall Study|Eligibility Criteria Not Met|1|||
105610407|NCT05215314|364237490|FG000|Overall Study|Lost to Follow-up|2|||
105610408|NCT05215314|364237491|FG001|Overall Study|Lost to Follow-up|2|||
105610409|NCT05215314|364237490|FG000|Overall Study|Withdrawal by Subject|2|||
105610410|NCT05215314|364237491|FG001|Overall Study|Withdrawal by Subject|0|||
105610411|NCT05215314|364237490|FG000|Overall Study|Physician Decision|1|||
105610412|NCT05215314|364237491|FG001|Overall Study|Physician Decision|0|||
105610413|NCT04401800|364237492|FG000|Overall Study|Death|17|||
105610414|NCT04401800|364237492|FG000|Overall Study|Lost to Follow-up|5|||
105610415|NCT04401800|364237492|FG000|Overall Study|Withdrawal by Subject|4|||
105610416|NCT03514017|364237493|FG000|Overall Study|Death|1|||
105610417|NCT03514017|364237493|FG000|Overall Study|Adverse Event|1|||
105610418|NCT05919082|364238622|FG000|Overall Study|Adverse Event|3|||
105610419|NCT05919082|364238623|FG001|Overall Study|Adverse Event|0|||
105610420|NCT05919082|364238622|FG000|Overall Study|Lost to Follow-up|0|||
105610421|NCT05919082|364238623|FG001|Overall Study|Lost to Follow-up|1|||
105610422|NCT05919082|364238622|FG000|Overall Study|Withdrawal by Subject|8|||
105610423|NCT05919082|364238623|FG001|Overall Study|Withdrawal by Subject|9|||
105610424|NCT05919082|364238622|FG000|Overall Study|Lack of Efficacy|0|||
105610425|NCT05919082|364238623|FG001|Overall Study|Lack of Efficacy|1|||
105610426|NCT05919082|364238622|FG000|Overall Study|Investigator Decision|1|||
105610427|NCT05919082|364238623|FG001|Overall Study|Investigator Decision|0|||
105610428|NCT03692611|364238624|FG000|Overall Study|Found to be ineligible postrandomization|3|||
105610429|NCT03692611|364238625|FG001|Overall Study|Found to be ineligible postrandomization|0|||
105610430|NCT03713086|364238626|FG000|Overall Study|Withdrawal by Subject|0|||
105610431|NCT03713086|364238627|FG001|Overall Study|Withdrawal by Subject|2|||
105610432|NCT03713086|364238628|FG002|Overall Study|Withdrawal by Subject|1|||
105610433|NCT03713086|364238629|FG003|Overall Study|Withdrawal by Subject|0|||
105610434|NCT03713086|364238626|FG000|Overall Study|Lost to Follow-up|0|||
105610435|NCT03713086|364238627|FG001|Overall Study|Lost to Follow-up|1|||
105610436|NCT03713086|364238628|FG002|Overall Study|Lost to Follow-up|0|||
105610437|NCT03713086|364238629|FG003|Overall Study|Lost to Follow-up|1|||
105610438|NCT04490915|364238630|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
105610439|NCT04490915|364238631|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
105610440|NCT04490915|364238630|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105610441|NCT04490915|364238631|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105610442|NCT04490915|364238630|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105610443|NCT04490915|364238631|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
105610444|NCT04490915|364238630|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
105610445|NCT04490915|364238631|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
105610446|NCT04490915|364238630|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
105610447|NCT04490915|364238631|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
105610448|NCT04490915|364238630|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
105610449|NCT04490915|364238631|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
105610450|NCT04490915|364238630|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
105610451|NCT04490915|364238631|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
105610452|NCT03052608|364238632|FG000|Treatment Phase|Adverse Event|10|||
105610453|NCT03052608|364238633|FG001|Treatment Phase|Adverse Event|12|||
105610454|NCT03052608|364238632|FG000|Treatment Phase|Death|6|||
105610455|NCT03052608|364238633|FG001|Treatment Phase|Death|4|||
105610456|NCT03052608|364238632|FG000|Treatment Phase|Withdrawal by Subject|4|||
105610457|NCT03052608|364238633|FG001|Treatment Phase|Withdrawal by Subject|12|||
105610458|NCT03052608|364238632|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
105610459|NCT03052608|364238633|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
105610460|NCT03052608|364238632|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
105610461|NCT03052608|364238633|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
105610462|NCT03052608|364238632|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
105610463|NCT03052608|364238633|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
105610464|NCT03052608|364238632|FG000|Treatment Phase|Ongoing|103|||
105610465|NCT03052608|364238633|FG001|Treatment Phase|Ongoing|31|||
105610466|NCT03052608|364238632|FG000|Long-Term Follow-up Phase|Death|23|||
105610467|NCT03052608|364238633|FG001|Long-Term Follow-up Phase|Death|28|||
105610468|NCT03052608|364238632|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
105610469|NCT03052608|364238633|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
105610470|NCT03052608|364238632|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
105610471|NCT03052608|364238633|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
105610472|NCT03052608|364238632|FG000|Long-Term Follow-up Phase|Ongoing|122|||
105610473|NCT03052608|364238633|FG001|Long-Term Follow-up Phase|Ongoing|99|||
105610474|NCT02662062|364238637|FG000|Overall Study|Withdrawal by Subject|1|||
105610475|NCT03988634|364238638|FG000|Double-Blind|Adverse Event|4|||
105610476|NCT03988634|364238639|FG001|Double-Blind|Adverse Event|0|||
105610477|NCT03988634|364238640|FG002|Double-Blind|Adverse Event|0|||
105610478|NCT03988634|364238638|FG000|Double-Blind|Death|18|||
105610479|NCT03988634|364238639|FG001|Double-Blind|Death|26|||
105610480|NCT03988634|364238640|FG002|Double-Blind|Death|0|||
105610481|NCT03988634|364238638|FG000|Double-Blind|Lost to Follow-up|6|||
105610482|NCT03988634|364238639|FG001|Double-Blind|Lost to Follow-up|7|||
105610483|NCT03988634|364238640|FG002|Double-Blind|Lost to Follow-up|0|||
105610484|NCT03988634|364238638|FG000|Double-Blind|Physician Decision|9|||
105610485|NCT03988634|364238639|FG001|Double-Blind|Physician Decision|5|||
105610486|NCT03988634|364238640|FG002|Double-Blind|Physician Decision|0|||
105610487|NCT03988634|364238638|FG000|Double-Blind|Subject decision|24|||
105610488|NCT03988634|364238639|FG001|Double-Blind|Subject decision|13|||
105610489|NCT03988634|364238640|FG002|Double-Blind|Subject decision|0|||
105610490|NCT03988634|364238638|FG000|Open-Label|Adverse Event|0|||
105610491|NCT03988634|364238639|FG001|Open-Label|Adverse Event|0|||
105610492|NCT03988634|364238640|FG002|Open-Label|Adverse Event|7|||
105610493|NCT03988634|364238638|FG000|Open-Label|Physician Decision|0|||
105610494|NCT03988634|364238639|FG001|Open-Label|Physician Decision|0|||
105610495|NCT03988634|364238640|FG002|Open-Label|Physician Decision|1|||
105610496|NCT03988634|364238638|FG000|Open-Label|Technical problems|0|||
105610497|NCT03988634|364238639|FG001|Open-Label|Technical problems|0|||
105610498|NCT03988634|364238640|FG002|Open-Label|Technical problems|1|||
105610499|NCT05406921|364238641|FG000|Overall Study|Withdrawal by Subject|25|||
105610500|NCT05406921|364238642|FG001|Overall Study|Withdrawal by Subject|0|||
105610501|NCT05406921|364238643|FG002|Overall Study|Withdrawal by Subject|25|||
105610502|NCT05406921|364238641|FG000|Overall Study|Protocol Violation|0|||
105610503|NCT05406921|364238642|FG001|Overall Study|Protocol Violation|12|||
105610504|NCT05406921|364238643|FG002|Overall Study|Protocol Violation|0|||
105610505|NCT00676715|364238647|FG000|Treatment Period (TP)|Adverse Event|0|||
105610506|NCT00676715|364238648|FG001|Treatment Period (TP)|Adverse Event|3|||
105610507|NCT00676715|364238649|FG002|Treatment Period (TP)|Adverse Event|2|||
105610508|NCT00676715|364238650|FG003|Treatment Period (TP)|Adverse Event|2|||
105610509|NCT00676715|364238647|FG000|Treatment Period (TP)|Death|0|||
105610510|NCT00676715|364238648|FG001|Treatment Period (TP)|Death|0|||
105610511|NCT00676715|364238649|FG002|Treatment Period (TP)|Death|1|||
105610512|NCT00676715|364238650|FG003|Treatment Period (TP)|Death|0|||
105610513|NCT00676715|364238647|FG000|Treatment Period (TP)|Failure to return|1|||
105610514|NCT00676715|364238648|FG001|Treatment Period (TP)|Failure to return|0|||
105610515|NCT00676715|364238649|FG002|Treatment Period (TP)|Failure to return|0|||
105610516|NCT00676715|364238650|FG003|Treatment Period (TP)|Failure to return|0|||
105610517|NCT00676715|364238647|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
105610518|NCT00676715|364238648|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
105610519|NCT00676715|364238649|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
105610520|NCT00676715|364238650|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
105610521|NCT00676715|364238647|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
105610522|NCT00676715|364238648|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
105610523|NCT00676715|364238649|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
105610524|NCT00676715|364238650|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
105610525|NCT00676715|364238647|FG000|Treatment Period (TP)|Withdrew consent|3|||
105610526|NCT00676715|364238648|FG001|Treatment Period (TP)|Withdrew consent|3|||
105610527|NCT00676715|364238649|FG002|Treatment Period (TP)|Withdrew consent|3|||
105610528|NCT00676715|364238650|FG003|Treatment Period (TP)|Withdrew consent|3|||
105610529|NCT00676715|364238647|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
105610530|NCT00676715|364238648|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
105610531|NCT00676715|364238649|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
105610532|NCT00676715|364238650|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
105610533|NCT00676715|364238647|FG000|Treatment Period (TP)|Administrative|0|||
105610534|NCT00676715|364238648|FG001|Treatment Period (TP)|Administrative|0|||
105610535|NCT00676715|364238649|FG002|Treatment Period (TP)|Administrative|0|||
105610536|NCT00676715|364238650|FG003|Treatment Period (TP)|Administrative|1|||
105610537|NCT00676715|364238647|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
105610538|NCT00676715|364238648|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
105610539|NCT00676715|364238649|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
105610540|NCT00676715|364238650|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
105610541|NCT00676715|364238647|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
105610542|NCT00676715|364238648|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
105610543|NCT00676715|364238649|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
105610544|NCT00676715|364238650|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
105610545|NCT00676715|364238647|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
105610546|NCT00676715|364238648|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
105610547|NCT00676715|364238649|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
105610548|NCT00676715|364238650|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
105610549|NCT00676715|364238647|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
105610550|NCT00676715|364238648|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
105610551|NCT00676715|364238649|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
105610552|NCT00676715|364238650|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
105610553|NCT00676715|364238647|FG000|Treatment-free Period (TFP)|Death|1|||
105610554|NCT00676715|364238648|FG001|Treatment-free Period (TFP)|Death|1|||
105610555|NCT00676715|364238649|FG002|Treatment-free Period (TFP)|Death|1|||
105610556|NCT00676715|364238650|FG003|Treatment-free Period (TFP)|Death|0|||
105610557|NCT00676715|364238647|FG000|Open Label Extension (OLE)|Reason not provided|3|||
105610558|NCT00676715|364238648|FG001|Open Label Extension (OLE)|Reason not provided|4|||
105610559|NCT00676715|364238649|FG002|Open Label Extension (OLE)|Reason not provided|1|||
105610560|NCT00676715|364238650|FG003|Open Label Extension (OLE)|Reason not provided|4|||
105610561|NCT00676715|364238647|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
105610562|NCT00676715|364238648|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
105610563|NCT00676715|364238649|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
105610564|NCT00676715|364238650|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
105610565|NCT00676715|364238647|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
105610566|NCT00676715|364238648|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
105610567|NCT00676715|364238649|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
105610568|NCT00676715|364238650|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
105610569|NCT00676715|364238647|FG000|Open Label Extension (OLE)|Adverse Event|0|||
105610570|NCT00676715|364238648|FG001|Open Label Extension (OLE)|Adverse Event|3|||
105610571|NCT00676715|364238649|FG002|Open Label Extension (OLE)|Adverse Event|1|||
105610572|NCT00676715|364238650|FG003|Open Label Extension (OLE)|Adverse Event|0|||
105610573|NCT00676715|364238647|FG000|Open Label Extension (OLE)|Death|2|||
105610574|NCT00676715|364238648|FG001|Open Label Extension (OLE)|Death|0|||
105610575|NCT00676715|364238649|FG002|Open Label Extension (OLE)|Death|2|||
105610576|NCT00676715|364238650|FG003|Open Label Extension (OLE)|Death|2|||
105610577|NCT04831281|364238651|FG000|Overall Study|Adverse Event|1|||
105610578|NCT04831281|364238652|FG001|Overall Study|Adverse Event|0|||
105610579|NCT04831281|364238653|FG002|Overall Study|Adverse Event|3|||
105610580|NCT04831281|364238651|FG000|Overall Study|Withdrawal by Subject|0|||
105610581|NCT04831281|364238652|FG001|Overall Study|Withdrawal by Subject|1|||
105610582|NCT04831281|364238653|FG002|Overall Study|Withdrawal by Subject|2|||
105610583|NCT04831281|364238651|FG000|Overall Study|Undetermined|1|||
105610584|NCT04831281|364238652|FG001|Overall Study|Undetermined|1|||
105610585|NCT04831281|364238653|FG002|Overall Study|Undetermined|0|||
105610586|NCT05059262|364238654|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
105610587|NCT05059262|364238655|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
105610588|NCT05059262|364238654|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
105610589|NCT05059262|364238655|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
105610590|NCT05059262|364238654|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
105610591|NCT05059262|364238655|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
105610592|NCT05059262|364238654|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
105610593|NCT05059262|364238655|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
105610594|NCT05059262|364238654|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
105610595|NCT05059262|364238655|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
105610596|NCT05059262|364238654|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
105610597|NCT05059262|364238655|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
105610598|NCT05059262|364238654|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
105610599|NCT05059262|364238655|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
105610600|NCT05059262|364238654|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
105610601|NCT05059262|364238655|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
105610602|NCT05059262|364238654|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
105610603|NCT05059262|364238655|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
105610604|NCT04060355|364238658|FG000|Overall Study|Lost to Follow-up|41|||
105610605|NCT01707030|364238677|FG000|Overall Study|Death|1|||
105610606|NCT01707030|364238678|FG001|Overall Study|Death|1|||
105610607|NCT01707030|364238677|FG000|Overall Study|Withdrawal by Subject|2|||
105610608|NCT01707030|364238678|FG001|Overall Study|Withdrawal by Subject|3|||
105610609|NCT01707030|364238677|FG000|Overall Study|Lost to Follow-up|8|||
105610610|NCT01707030|364238678|FG001|Overall Study|Lost to Follow-up|13|||
105610611|NCT04258709|364238682|FG000|Overall Study|Lost to Follow-up|10|||
105610612|NCT04258709|364238683|FG001|Overall Study|Lost to Follow-up|4|||
105610613|NCT04258709|364238682|FG000|Overall Study|Withdrawal by Subject|1|||
105610614|NCT04258709|364238683|FG001|Overall Study|Withdrawal by Subject|0|||
105610615|NCT04258709|364238682|FG000|Overall Study|Fetal demise|0|||
105610616|NCT04258709|364238683|FG001|Overall Study|Fetal demise|1|||
105610617|NCT04258709|364238682|FG000|Overall Study|Protocol Violation|1|||
105610618|NCT04258709|364238683|FG001|Overall Study|Protocol Violation|1|||
105610619|NCT04263311|364238684|FG000|Overall Study|Lost to Follow-up|1|||
105610620|NCT04263311|364238685|FG001|Overall Study|Lost to Follow-up|2|||
105610621|NCT04263311|364238686|FG002|Overall Study|Lost to Follow-up|0|||
105610622|NCT04263311|364238684|FG000|Overall Study|Health Issues|1|||
105610623|NCT04263311|364238685|FG001|Overall Study|Health Issues|0|||
105610624|NCT04263311|364238686|FG002|Overall Study|Health Issues|0|||
105610625|NCT04263311|364238684|FG000|Overall Study|Left the country|1|||
105610626|NCT04263311|364238685|FG001|Overall Study|Left the country|0|||
105610627|NCT04263311|364238686|FG002|Overall Study|Left the country|0|||
105610628|NCT04263311|364238684|FG000|Overall Study|Unable to maintain time commitment|1|||
105610629|NCT04263311|364238685|FG001|Overall Study|Unable to maintain time commitment|0|||
105610630|NCT04263311|364238686|FG002|Overall Study|Unable to maintain time commitment|0|||
105610631|NCT04263311|364238684|FG000|Overall Study|No longer interested|1|||
105610632|NCT04263311|364238685|FG001|Overall Study|No longer interested|0|||
105610633|NCT04263311|364238686|FG002|Overall Study|No longer interested|0|||
105610634|NCT04263311|364238684|FG000|Overall Study|Ineligible post consent|0|||
105610635|NCT04263311|364238685|FG001|Overall Study|Ineligible post consent|0|||
105610636|NCT04263311|364238686|FG002|Overall Study|Ineligible post consent|5|||
105610637|NCT03090152|364238687|FG000|Overall Study|Withdrawal by Subject|0|||
105610638|NCT03090152|364238688|FG001|Overall Study|Withdrawal by Subject|2|||
105610639|NCT03090152|364238689|FG002|Overall Study|Withdrawal by Subject|1|||
105610640|NCT03090152|364238687|FG000|Overall Study|Surgery Canceled|1|||
105610641|NCT03090152|364238688|FG001|Overall Study|Surgery Canceled|0|||
105610642|NCT03090152|364238689|FG002|Overall Study|Surgery Canceled|0|||
105610643|NCT03090152|364238687|FG000|Overall Study|Epidural catheter could not be placed|0|||
105610644|NCT03090152|364238688|FG001|Overall Study|Epidural catheter could not be placed|2|||
105610645|NCT03090152|364238689|FG002|Overall Study|Epidural catheter could not be placed|0|||
105610646|NCT04673929|364238690|FG000|Overall Study|Death|73|||
105610647|NCT04673929|364238690|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
105610648|NCT04024813|364238691|FG000|Overall Study|Study terminated by Sponsor|1|||
105610649|NCT05633953|364238692|FG000|Overall Study|Adverse Event|7|||
105610650|NCT05633953|364238692|FG000|Overall Study|Death|30|||
105610651|NCT05633953|364238692|FG000|Overall Study|Lost to Follow-up|1|||
105610652|NCT05633953|364238692|FG000|Overall Study|Osilodrostat discontinued|4|||
105610653|NCT05633953|364238692|FG000|Overall Study|Physician Decision|1|||
105610654|NCT05633953|364238692|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
105610655|NCT05633953|364238692|FG000|Overall Study|Progressive disease|2|||
105610656|NCT03047928|364238693|FG000|Overall Study|Adverse Event|0|||
105610657|NCT03047928|364238694|FG001|Overall Study|Adverse Event|2|||
105610658|NCT03047928|364238695|FG002|Overall Study|Adverse Event|0|||
105610659|NCT03047928|364238693|FG000|Overall Study|Protocol Violation|0|||
105610660|NCT03047928|364238694|FG001|Overall Study|Protocol Violation|1|||
105610661|NCT03047928|364238695|FG002|Overall Study|Protocol Violation|0|||
105610662|NCT03047928|364238693|FG000|Overall Study|included in another protocol|0|||
105610663|NCT03047928|364238694|FG001|Overall Study|included in another protocol|1|||
105610664|NCT03047928|364238695|FG002|Overall Study|included in another protocol|0|||
105610665|NCT05324124|364238696|FG000|Period 1|Withdrawal by Subject|1|||
105610666|NCT05324124|364238697|FG001|Period 1|Withdrawal by Subject|0|||
105610667|NCT05324124|364238696|FG000|Period 1|Physician Decision|0|||
105610668|NCT05324124|364238697|FG001|Period 1|Physician Decision|1|||
105610669|NCT03763708|364238715|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
105610670|NCT03763708|364238716|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
105610671|NCT03763708|364238717|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
105610672|NCT03763708|364238718|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
105610673|NCT03763708|364238719|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
105610674|NCT03763708|364238720|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
105610675|NCT03763708|364238721|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
105610676|NCT03763708|364238722|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
105610677|NCT03763708|364238723|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
105610678|NCT03763708|364238715|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
105610679|NCT03763708|364238716|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
105610680|NCT03763708|364238717|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
105610681|NCT03763708|364238718|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
105610682|NCT03763708|364238719|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
105610683|NCT03763708|364238720|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
105610684|NCT03763708|364238721|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
105610685|NCT03763708|364238722|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
105610686|NCT03763708|364238723|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
105610687|NCT03763708|364238715|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
105610688|NCT03763708|364238716|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
105610689|NCT03763708|364238717|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
105610690|NCT03763708|364238718|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
105610691|NCT03763708|364238719|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
105610692|NCT03763708|364238720|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
105610693|NCT03763708|364238721|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
105610694|NCT03763708|364238722|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
105610695|NCT03763708|364238723|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
105610696|NCT03763708|364238715|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
105610697|NCT03763708|364238716|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
105610698|NCT03763708|364238717|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
105610699|NCT03763708|364238718|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
105610700|NCT03763708|364238719|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
105610701|NCT03763708|364238720|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
105610702|NCT03763708|364238721|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
105610703|NCT03763708|364238722|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
105610704|NCT03763708|364238723|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
105610705|NCT03763708|364238715|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
105610706|NCT03763708|364238716|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
105610707|NCT03763708|364238717|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
105610708|NCT03763708|364238718|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
105610709|NCT03763708|364238719|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
105610710|NCT03763708|364238720|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
105610711|NCT03763708|364238721|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
105610712|NCT03763708|364238722|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
105610713|NCT03763708|364238723|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
105610714|NCT03763708|364238715|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
105610715|NCT03763708|364238716|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
105610716|NCT03763708|364238717|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
105610717|NCT03763708|364238718|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
105610718|NCT03763708|364238719|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
105610719|NCT03763708|364238720|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
105610720|NCT03763708|364238721|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
105610721|NCT03763708|364238722|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
105610722|NCT03763708|364238723|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
105610723|NCT03763708|364238715|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
105610724|NCT03763708|364238716|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
105610725|NCT03763708|364238717|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
105610726|NCT03763708|364238718|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
105610727|NCT03763708|364238719|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
105610728|NCT03763708|364238720|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
105610729|NCT03763708|364238721|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
105610730|NCT03763708|364238722|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
105610731|NCT03763708|364238723|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
105610732|NCT03763708|364238715|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
105610733|NCT03763708|364238716|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
105610734|NCT03763708|364238717|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
105610735|NCT03763708|364238718|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
105610736|NCT03763708|364238719|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
105610737|NCT03763708|364238720|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
105610738|NCT03763708|364238721|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
105610739|NCT03763708|364238722|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
105610740|NCT03763708|364238723|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
105610741|NCT03763708|364238715|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
105610742|NCT03763708|364238716|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
105610743|NCT03763708|364238717|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
105610744|NCT03763708|364238718|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
105610745|NCT03763708|364238719|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
105610746|NCT03763708|364238720|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
105610747|NCT03763708|364238721|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
105610748|NCT03763708|364238722|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
105610749|NCT03763708|364238723|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
105610750|NCT03138512|364238724|FG000|Randomization|Participants withdrew consent|0|||
105610751|NCT03138512|364238725|FG001|Randomization|Participants withdrew consent|1|||
105610752|NCT03138512|364238726|FG002|Randomization|Participants withdrew consent|1|||
105610753|NCT03138512|364238727|FG003|Randomization|Participants withdrew consent|0|||
105610754|NCT03138512|364238728|FG004|Randomization|Participants withdrew consent|0|||
105610755|NCT03138512|364238724|FG000|Randomization|Participant no longer meets study criteria|0|||
105610756|NCT03138512|364238725|FG001|Randomization|Participant no longer meets study criteria|3|||
105610757|NCT03138512|364238726|FG002|Randomization|Participant no longer meets study criteria|1|||
105610758|NCT03138512|364238727|FG003|Randomization|Participant no longer meets study criteria|1|||
105610759|NCT03138512|364238728|FG004|Randomization|Participant no longer meets study criteria|3|||
105610760|NCT03138512|364238724|FG000|Randomization|Other reasons|1|||
105610761|NCT03138512|364238725|FG001|Randomization|Other reasons|0|||
105610762|NCT03138512|364238726|FG002|Randomization|Other reasons|0|||
105610763|NCT03138512|364238727|FG003|Randomization|Other reasons|0|||
105610764|NCT03138512|364238728|FG004|Randomization|Other reasons|0|||
105610765|NCT03138512|364238724|FG000|Treatment Part A|Disease recurrence|10|||
105610766|NCT03138512|364238725|FG001|Treatment Part A|Disease recurrence|20|||
105610767|NCT03138512|364238726|FG002|Treatment Part A|Disease recurrence|0|||
105610768|NCT03138512|364238727|FG003|Treatment Part A|Disease recurrence|0|||
105610769|NCT03138512|364238728|FG004|Treatment Part A|Disease recurrence|0|||
105610770|NCT03138512|364238724|FG000|Treatment Part A|Study Drug Toxicity|132|||
105610771|NCT03138512|364238725|FG001|Treatment Part A|Study Drug Toxicity|5|||
105610772|NCT03138512|364238726|FG002|Treatment Part A|Study Drug Toxicity|0|||
105610773|NCT03138512|364238727|FG003|Treatment Part A|Study Drug Toxicity|0|||
105610774|NCT03138512|364238728|FG004|Treatment Part A|Study Drug Toxicity|0|||
105610775|NCT03138512|364238724|FG000|Treatment Part A|Death|1|||
105610776|NCT03138512|364238725|FG001|Treatment Part A|Death|0|||
105610777|NCT03138512|364238726|FG002|Treatment Part A|Death|0|||
105610778|NCT03138512|364238727|FG003|Treatment Part A|Death|0|||
105610779|NCT03138512|364238728|FG004|Treatment Part A|Death|0|||
105610780|NCT03138512|364238724|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
105610781|NCT03138512|364238725|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
105610782|NCT03138512|364238726|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
105610783|NCT03138512|364238727|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
105610784|NCT03138512|364238728|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
105610785|NCT03138512|364238724|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
105610786|NCT03138512|364238725|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
105610787|NCT03138512|364238726|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
105610788|NCT03138512|364238727|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
105610789|NCT03138512|364238728|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
105610790|NCT03138512|364238724|FG000|Treatment Part A|Participant withdrew consent|2|||
105610791|NCT03138512|364238725|FG001|Treatment Part A|Participant withdrew consent|4|||
105610792|NCT03138512|364238726|FG002|Treatment Part A|Participant withdrew consent|0|||
105610793|NCT03138512|364238727|FG003|Treatment Part A|Participant withdrew consent|0|||
105610794|NCT03138512|364238728|FG004|Treatment Part A|Participant withdrew consent|0|||
105610795|NCT03138512|364238724|FG000|Treatment Part A|Lost to Follow-up|0|||
105610796|NCT03138512|364238725|FG001|Treatment Part A|Lost to Follow-up|1|||
105610797|NCT03138512|364238726|FG002|Treatment Part A|Lost to Follow-up|0|||
105610798|NCT03138512|364238727|FG003|Treatment Part A|Lost to Follow-up|0|||
105610799|NCT03138512|364238728|FG004|Treatment Part A|Lost to Follow-up|0|||
105610800|NCT03138512|364238724|FG000|Treatment Part A|Poor/non-compliance|1|||
105610801|NCT03138512|364238725|FG001|Treatment Part A|Poor/non-compliance|0|||
105610802|NCT03138512|364238726|FG002|Treatment Part A|Poor/non-compliance|0|||
105610803|NCT03138512|364238727|FG003|Treatment Part A|Poor/non-compliance|0|||
105610804|NCT03138512|364238728|FG004|Treatment Part A|Poor/non-compliance|0|||
105610805|NCT03138512|364238724|FG000|Treatment Part A|Pregnancy|0|||
105610806|NCT03138512|364238725|FG001|Treatment Part A|Pregnancy|1|||
105610807|NCT03138512|364238726|FG002|Treatment Part A|Pregnancy|0|||
105610808|NCT03138512|364238727|FG003|Treatment Part A|Pregnancy|0|||
105610809|NCT03138512|364238728|FG004|Treatment Part A|Pregnancy|0|||
105610810|NCT03138512|364238724|FG000|Treatment Part A|Other reasons|11|||
105610811|NCT03138512|364238725|FG001|Treatment Part A|Other reasons|8|||
105610812|NCT03138512|364238726|FG002|Treatment Part A|Other reasons|0|||
105610813|NCT03138512|364238727|FG003|Treatment Part A|Other reasons|0|||
105610814|NCT03138512|364238728|FG004|Treatment Part A|Other reasons|0|||
105610815|NCT03138512|364238724|FG000|Treatment Part B|Disease recurrence|0|||
105610816|NCT03138512|364238725|FG001|Treatment Part B|Disease recurrence|0|||
105610817|NCT03138512|364238726|FG002|Treatment Part B|Disease recurrence|6|||
105610818|NCT03138512|364238727|FG003|Treatment Part B|Disease recurrence|12|||
105610819|NCT03138512|364238728|FG004|Treatment Part B|Disease recurrence|10|||
105610820|NCT03138512|364238724|FG000|Treatment Part B|Study drug toxicity|0|||
105610821|NCT03138512|364238725|FG001|Treatment Part B|Study drug toxicity|0|||
105610822|NCT03138512|364238726|FG002|Treatment Part B|Study drug toxicity|63|||
105610823|NCT03138512|364238727|FG003|Treatment Part B|Study drug toxicity|3|||
105610824|NCT03138512|364238728|FG004|Treatment Part B|Study drug toxicity|45|||
105610825|NCT03138512|364238724|FG000|Treatment Part B|Death|0|||
105610826|NCT03138512|364238725|FG001|Treatment Part B|Death|0|||
105610827|NCT03138512|364238726|FG002|Treatment Part B|Death|1|||
105610828|NCT03138512|364238727|FG003|Treatment Part B|Death|0|||
105610829|NCT03138512|364238728|FG004|Treatment Part B|Death|0|||
105610830|NCT03138512|364238724|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
105610831|NCT03138512|364238725|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
105610832|NCT03138512|364238726|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
105610833|NCT03138512|364238727|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
105610834|NCT03138512|364238728|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
105610835|NCT03138512|364238724|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
105610836|NCT03138512|364238725|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
105610837|NCT03138512|364238726|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
105610838|NCT03138512|364238727|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
105610839|NCT03138512|364238728|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
105610840|NCT03138512|364238724|FG000|Treatment Part B|Participant withdrew consent|0|||
105610841|NCT03138512|364238725|FG001|Treatment Part B|Participant withdrew consent|0|||
105610842|NCT03138512|364238726|FG002|Treatment Part B|Participant withdrew consent|1|||
105610843|NCT03138512|364238727|FG003|Treatment Part B|Participant withdrew consent|1|||
105610844|NCT03138512|364238728|FG004|Treatment Part B|Participant withdrew consent|2|||
105610845|NCT03138512|364238724|FG000|Treatment Part B|Lost to Follow-up|0|||
105610846|NCT03138512|364238725|FG001|Treatment Part B|Lost to Follow-up|0|||
105610847|NCT03138512|364238726|FG002|Treatment Part B|Lost to Follow-up|0|||
105610848|NCT03138512|364238727|FG003|Treatment Part B|Lost to Follow-up|1|||
105610849|NCT03138512|364238728|FG004|Treatment Part B|Lost to Follow-up|0|||
105610850|NCT03138512|364238724|FG000|Treatment Part B|Poor/non-compliance|0|||
105610851|NCT03138512|364238725|FG001|Treatment Part B|Poor/non-compliance|0|||
105610852|NCT03138512|364238726|FG002|Treatment Part B|Poor/non-compliance|1|||
105610853|NCT03138512|364238727|FG003|Treatment Part B|Poor/non-compliance|1|||
105610854|NCT03138512|364238728|FG004|Treatment Part B|Poor/non-compliance|1|||
105610855|NCT03138512|364238724|FG000|Treatment Part B|Other reasons|0|||
105610856|NCT03138512|364238725|FG001|Treatment Part B|Other reasons|0|||
105610857|NCT03138512|364238726|FG002|Treatment Part B|Other reasons|3|||
105610858|NCT03138512|364238727|FG003|Treatment Part B|Other reasons|1|||
105610859|NCT03138512|364238728|FG004|Treatment Part B|Other reasons|5|||
105610860|NCT03317405|364238729|FG000|Overall Study|Withdrawal by Subject|1|||
105610861|NCT03317405|364238730|FG001|Overall Study|Withdrawal by Subject|0|||
105610862|NCT03317405|364238731|FG002|Overall Study|Withdrawal by Subject|0|||
105610863|NCT03317405|364238729|FG000|Overall Study|Physician Decision|0|||
105610864|NCT03317405|364238730|FG001|Overall Study|Physician Decision|0|||
105610865|NCT03317405|364238731|FG002|Overall Study|Physician Decision|1|||
105610866|NCT03317405|364238729|FG000|Overall Study|Surgery Rescheduled|0|||
105610867|NCT03317405|364238730|FG001|Overall Study|Surgery Rescheduled|1|||
105610868|NCT03317405|364238731|FG002|Overall Study|Surgery Rescheduled|0|||
105610869|NCT05323084|364238732|FG000|Period 2 - Washout|Lost to Follow-up|0|||
105610870|NCT05323084|364238733|FG001|Period 2 - Washout|Lost to Follow-up|1|||
105610871|NCT04060654|364238740|FG000|Overall Study|Withdrawal by Subject|1|||
105610872|NCT04060654|364238740|FG000|Overall Study|Lost to Follow-up|5|||
105610873|NCT04533347|364238741|FG000|Overall Study|Adverse Event|1|||
105610874|NCT04533347|364238742|FG001|Overall Study|Adverse Event|2|||
105610875|NCT04533347|364238741|FG000|Overall Study|Lost to Follow-up|2|||
105610876|NCT04533347|364238742|FG001|Overall Study|Lost to Follow-up|0|||
105610877|NCT04533347|364238741|FG000|Overall Study|Withdrawal by Subject|1|||
105610878|NCT04533347|364238742|FG001|Overall Study|Withdrawal by Subject|0|||
105610879|NCT03774082|364238746|FG000|Overall Study|Death|6|||
105610880|NCT03774082|364238747|FG001|Overall Study|Death|3|||
105610881|NCT03774082|364238748|FG002|Overall Study|Death|2|||
105610882|NCT03774082|364238746|FG000|Overall Study|Subject decision|0|||
105610883|NCT03774082|364238747|FG001|Overall Study|Subject decision|3|||
105610884|NCT03774082|364238748|FG002|Overall Study|Subject decision|0|||
105610885|NCT03774082|364238746|FG000|Overall Study|Lost to Follow-up|2|||
105610886|NCT03774082|364238747|FG001|Overall Study|Lost to Follow-up|0|||
105610887|NCT03774082|364238748|FG002|Overall Study|Lost to Follow-up|0|||
105610888|NCT03774082|364238746|FG000|Overall Study|Guardian decision|0|||
105610889|NCT03774082|364238747|FG001|Overall Study|Guardian decision|0|||
105610890|NCT03774082|364238748|FG002|Overall Study|Guardian decision|1|||
105610891|NCT03774082|364238746|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
105610892|NCT03774082|364238747|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
105610893|NCT03774082|364238748|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
105610894|NCT04173663|364239950|FG000|Overall Study|Withdrawal by Subject|1|||
105610895|NCT04173663|364239951|FG001|Overall Study|Withdrawal by Subject|6|||
105610896|NCT04173663|364239950|FG000|Overall Study|Lost to Follow-up|17|||
105610897|NCT04173663|364239951|FG001|Overall Study|Lost to Follow-up|24|||
105610898|NCT02651324|364239957|FG000|Overall Study|drug not administered, due dispensing issue|1|||
105610899|NCT02651324|364239958|FG001|Overall Study|drug not administered, due dispensing issue|0|||
105610900|NCT04833777|364239961|FG000|Overall Study|Lost to Follow-up|1|||
105610901|NCT04833777|364239962|FG001|Overall Study|Lost to Follow-up|0|||
105610902|NCT01180634|364239965|FG000|Overall Study|Adverse Event|4|||
105610903|NCT01180634|364239966|FG001|Overall Study|Adverse Event|1|||
105610904|NCT01180634|364239965|FG000|Overall Study|Miscellaneous|2|||
105610905|NCT01180634|364239966|FG001|Overall Study|Miscellaneous|0|||
105610906|NCT01180634|364239965|FG000|Overall Study|Withdrawal by Subject|4|||
105610907|NCT01180634|364239966|FG001|Overall Study|Withdrawal by Subject|0|||
105610908|NCT05009251|364239969|FG000|Overall Study|Protocol Violation|100|||
105610909|NCT05009251|364239970|FG001|Overall Study|Protocol Violation|105|||
105610910|NCT05009251|364239971|FG002|Overall Study|Protocol Violation|119|||
105610911|NCT05009251|364239972|FG003|Overall Study|Protocol Violation|120|||
105610912|NCT05009251|364239973|FG004|Overall Study|Protocol Violation|119|||
105610913|NCT05009251|364239969|FG000|Overall Study|Death|25|||
105610914|NCT05009251|364239970|FG001|Overall Study|Death|22|||
105610915|NCT05009251|364239971|FG002|Overall Study|Death|24|||
105610916|NCT05009251|364239972|FG003|Overall Study|Death|19|||
105610917|NCT05009251|364239973|FG004|Overall Study|Death|15|||
105610918|NCT05249439|364239976|FG000|Overall Study|Withdrawal by Subject|2|||
105610919|NCT05249439|364239977|FG001|Overall Study|Withdrawal by Subject|5|||
105610920|NCT05249439|364239976|FG000|Overall Study|Physician Decision|3|||
105610921|NCT05249439|364239977|FG001|Overall Study|Physician Decision|1|||
105610922|NCT03786783|364239978|FG000|Overall Study|Death|1|||
105610923|NCT03786783|364239978|FG000|Overall Study|Physician Decision|6|||
105610924|NCT03786783|364239978|FG000|Overall Study|Withdrawal by Subject|2|||
105610925|NCT03786783|364239978|FG000|Overall Study|Disease Progression|7|||
105610926|NCT03786783|364239978|FG000|Overall Study|Patient/Parent Refusal|4|||
105610927|NCT02910583|364239979|FG000|Overall Study|Death|7|||
105610928|NCT02910583|364239980|FG001|Overall Study|Death|3|||
105610929|NCT02910583|364239979|FG000|Overall Study|Lost to Follow-up|1|||
105610930|NCT02910583|364239980|FG001|Overall Study|Lost to Follow-up|0|||
105610931|NCT02910583|364239979|FG000|Overall Study|Withdrawal by Subject|12|||
105610932|NCT02910583|364239980|FG001|Overall Study|Withdrawal by Subject|8|||
105610933|NCT02910583|364239979|FG000|Overall Study|Other, Not Specified|6|||
105610934|NCT02910583|364239980|FG001|Overall Study|Other, Not Specified|3|||
105610935|NCT02097420|364239984|FG000|Overall Study|Death|6|||
105610936|NCT02097420|364239984|FG000|Overall Study|Valve explanted|13|||
105610937|NCT02097420|364239984|FG000|Overall Study|Other Reason|1|||
105610938|NCT01331005|364239985|FG000|Overall Study|Lost to Follow-up|2|||
105610939|NCT01331005|364239986|FG001|Overall Study|Lost to Follow-up|1|||
105610940|NCT01331005|364239985|FG000|Overall Study|Withdrawal by Subject|2|||
105610941|NCT01331005|364239986|FG001|Overall Study|Withdrawal by Subject|3|||
105610942|NCT00667251|364239987|FG000|Overall Study|Disease progression|232|||
105610943|NCT00667251|364239988|FG001|Overall Study|Disease progression|203|||
105610944|NCT00667251|364239987|FG000|Overall Study|Toxicity|44|||
105610945|NCT00667251|364239988|FG001|Overall Study|Toxicity|23|||
105610946|NCT00667251|364239987|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
105610947|NCT00667251|364239988|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
105626701|NCT04186819|364298168|FG000|Overall Study|RP Delayed|1|||
105610948|NCT00667251|364239987|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
105610949|NCT00667251|364239988|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
105610950|NCT00667251|364239987|FG000|Overall Study|Symptomatic progression|8|||
105610951|NCT00667251|364239988|FG001|Overall Study|Symptomatic progression|4|||
105610952|NCT00667251|364239987|FG000|Overall Study|Death|6|||
105610953|NCT00667251|364239988|FG001|Overall Study|Death|11|||
105610954|NCT00667251|364239987|FG000|Overall Study|Intercurrent illness|5|||
105610955|NCT00667251|364239988|FG001|Overall Study|Intercurrent illness|6|||
105610956|NCT00667251|364239987|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
105610957|NCT00667251|364239988|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
105610958|NCT00667251|364239987|FG000|Overall Study|Randomized not Treated|4|||
105610959|NCT00667251|364239988|FG001|Overall Study|Randomized not Treated|1|||
105610960|NCT02728076|364239989|FG000|Overall Study|Physician Decision|4|||
105610961|NCT05691309|364239990|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
105610962|NCT05691309|364239990|FG000|Overall Study|vancomycin levels not evaluable|2|||
105610963|NCT01140880|364239991|FG000|Overall Study|Death|0|||
105610964|NCT01140880|364239992|FG001|Overall Study|Death|1|||
105610965|NCT01140880|364239991|FG000|Overall Study|Withdrawal by Subject|6|||
105610966|NCT01140880|364239992|FG001|Overall Study|Withdrawal by Subject|3|||
105610967|NCT01140880|364239991|FG000|Overall Study|Lost to Follow-up|8|||
105610968|NCT01140880|364239992|FG001|Overall Study|Lost to Follow-up|10|||
105610969|NCT01140880|364239991|FG000|Overall Study|Protocol Violation|0|||
105610970|NCT01140880|364239992|FG001|Overall Study|Protocol Violation|30|||
105610971|NCT02724878|364239993|FG000|Overall Study|Still on Active Therapy|15|||
105610972|NCT02724878|364239993|FG000|Overall Study|Disease Progression|31|||
105610973|NCT02724878|364239993|FG000|Overall Study|Toxicity|5|||
105610974|NCT02724878|364239993|FG000|Overall Study|Death|1|||
105610975|NCT02724878|364239993|FG000|Overall Study|Withdrawal by Subject|4|||
105610976|NCT02724878|364239993|FG000|Overall Study|Lost to Follow-up|2|||
105610977|NCT02724878|364239993|FG000|Overall Study|Protocol Violation|1|||
105610978|NCT02724878|364239993|FG000|Overall Study|Ineligible for Study Drug|5|||
105610979|NCT02724878|364239993|FG000|Overall Study|not started|1|||
105610980|NCT04838262|364239997|FG000|Overall Study|Withdrawal by Subject|9|||
105610981|NCT04838262|364239998|FG001|Overall Study|Withdrawal by Subject|4|||
105610982|NCT05082909|364240001|FG000|Overall Study|Protocol Violation|0|||
105610983|NCT05082909|364240002|FG001|Overall Study|Protocol Violation|0|||
105610984|NCT05082909|364240003|FG002|Overall Study|Protocol Violation|1|||
105610985|NCT05082909|364240004|FG003|Overall Study|Protocol Violation|0|||
105610986|NCT05082909|364240005|FG004|Overall Study|Protocol Violation|0|||
105610987|NCT05082909|364240006|FG005|Overall Study|Protocol Violation|0|||
105610988|NCT02729311|364240009|FG000|Overall Study|Withdrawal by Subject|8|||
105610989|NCT02729311|364240010|FG001|Overall Study|Withdrawal by Subject|2|||
105610990|NCT04950660|364240011|FG000|Overall Study|Protocol Violation|4|||
105610991|NCT04950660|364240012|FG001|Overall Study|Protocol Violation|2|||
105610992|NCT04950660|364240011|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
105610993|NCT04950660|364240012|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
105610994|NCT04950660|364240011|FG000|Overall Study|Withdrawal by Subject|0|||
105610995|NCT04950660|364240012|FG001|Overall Study|Withdrawal by Subject|1|||
105610996|NCT04950660|364240011|FG000|Overall Study|Hypotension|1|||
105610997|NCT04950660|364240012|FG001|Overall Study|Hypotension|0|||
105610998|NCT04783935|364240015|FG000|Overall Study|Withdrawal by Subject|6|||
105610999|NCT04783935|364240015|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
105611000|NCT04783935|364240015|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
105611001|NCT04783935|364240015|FG000|Overall Study|Lost to Follow-up|3|||
105611002|NCT04783935|364240015|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
105611003|NCT06074523|364240019|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
105611004|NCT06074523|364240019|FG000|Overall Study|Withdrawal by Subject|1|||
105611005|NCT04245501|364240020|FG000|Overall Study|Adverse Event|2|||
105611006|NCT04245501|364240021|FG001|Overall Study|Adverse Event|0|||
105611007|NCT04245501|364240020|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
105611008|NCT04245501|364240021|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
105611009|NCT01426425|364240022|FG000|Overall Study|Exited prior to EP study|22|||
105611010|NCT01426425|364240022|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
105611011|NCT01426425|364240022|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
105611012|NCT00512070|364240023|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
105611013|NCT00512070|364240024|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
105611014|NCT00512070|364240025|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
105611015|NCT00512070|364240023|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
105611016|NCT00512070|364240024|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
105611017|NCT00512070|364240025|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
105611018|NCT05337748|364240026|FG000|Overall Study|Withdrawal by Subject|1|||
105611019|NCT05337748|364240027|FG001|Overall Study|Withdrawal by Subject|0|||
105611020|NCT05337748|364240026|FG000|Overall Study|Death|1|||
105611021|NCT05337748|364240027|FG001|Overall Study|Death|0|||
105611022|NCT04321031|364240030|FG000|Overall Study|Adverse Event|0|||
105611023|NCT04321031|364240031|FG001|Overall Study|Adverse Event|2|||
105611024|NCT04321031|364240032|FG002|Overall Study|Adverse Event|2|||
105611025|NCT04321031|364240033|FG003|Overall Study|Adverse Event|2|||
105611026|NCT04321031|364240034|FG004|Overall Study|Adverse Event|2|||
105611027|NCT04321031|364240035|FG005|Overall Study|Adverse Event|2|||
105611028|NCT04321031|364240036|FG006|Overall Study|Adverse Event|0|||
105611029|NCT04321031|364240030|FG000|Overall Study|Lost to Follow-up|0|||
105611030|NCT04321031|364240031|FG001|Overall Study|Lost to Follow-up|0|||
105611031|NCT04321031|364240032|FG002|Overall Study|Lost to Follow-up|0|||
105611032|NCT04321031|364240033|FG003|Overall Study|Lost to Follow-up|1|||
105611033|NCT04321031|364240034|FG004|Overall Study|Lost to Follow-up|0|||
105611034|NCT04321031|364240035|FG005|Overall Study|Lost to Follow-up|2|||
105611035|NCT04321031|364240036|FG006|Overall Study|Lost to Follow-up|1|||
105611036|NCT04321031|364240030|FG000|Overall Study|Withdrawal by Subject|2|||
105611037|NCT04321031|364240031|FG001|Overall Study|Withdrawal by Subject|2|||
105611038|NCT04321031|364240032|FG002|Overall Study|Withdrawal by Subject|1|||
105611039|NCT04321031|364240033|FG003|Overall Study|Withdrawal by Subject|3|||
105611040|NCT04321031|364240034|FG004|Overall Study|Withdrawal by Subject|1|||
105611041|NCT04321031|364240035|FG005|Overall Study|Withdrawal by Subject|0|||
105611042|NCT04321031|364240036|FG006|Overall Study|Withdrawal by Subject|1|||
105611043|NCT04321031|364240030|FG000|Overall Study|Non-compliance with study drug|0|||
105611044|NCT04321031|364240031|FG001|Overall Study|Non-compliance with study drug|0|||
105611045|NCT04321031|364240032|FG002|Overall Study|Non-compliance with study drug|0|||
105611046|NCT04321031|364240033|FG003|Overall Study|Non-compliance with study drug|0|||
105611047|NCT04321031|364240034|FG004|Overall Study|Non-compliance with study drug|0|||
105611048|NCT04321031|364240035|FG005|Overall Study|Non-compliance with study drug|1|||
105611049|NCT04321031|364240036|FG006|Overall Study|Non-compliance with study drug|0|||
105611050|NCT04321031|364240030|FG000|Overall Study|Other|0|||
105611051|NCT04321031|364240031|FG001|Overall Study|Other|0|||
105611052|NCT04321031|364240032|FG002|Overall Study|Other|0|||
105611053|NCT04321031|364240033|FG003|Overall Study|Other|1|||
105611054|NCT04321031|364240034|FG004|Overall Study|Other|0|||
105611055|NCT04321031|364240035|FG005|Overall Study|Other|0|||
105611056|NCT04321031|364240036|FG006|Overall Study|Other|0|||
105611057|NCT02900924|364240037|FG000|Overall Study|Death|52|||
105611058|NCT02900924|364240037|FG000|Overall Study|Lost to Follow-up|4|||
105611059|NCT02900924|364240037|FG000|Overall Study|Withdrawal by Subject|20|||
105611060|NCT02900924|364240037|FG000|Overall Study|Missed Visit|33|||
105611061|NCT03126019|364240039|FG000|Overall Study|Death|5|||
105611062|NCT03126019|364240040|FG001|Overall Study|Death|27|||
105611063|NCT03126019|364240039|FG000|Overall Study|Lost to Follow-up|2|||
105611064|NCT03126019|364240040|FG001|Overall Study|Lost to Follow-up|4|||
105611065|NCT03126019|364240039|FG000|Overall Study|Withdrawal by Subject|1|||
105611066|NCT03126019|364240040|FG001|Overall Study|Withdrawal by Subject|9|||
105611067|NCT03126019|364240039|FG000|Overall Study|Physician Decision|1|||
105611068|NCT03126019|364240040|FG001|Overall Study|Physician Decision|0|||
105611069|NCT03126019|364240039|FG000|Overall Study|Transitioned to Rollover Study|0|||
105611070|NCT03126019|364240040|FG001|Overall Study|Transitioned to Rollover Study|11|||
105611071|NCT03126019|364240039|FG000|Overall Study|Did Not Return to Site for Care|0|||
105611072|NCT03126019|364240040|FG001|Overall Study|Did Not Return to Site for Care|1|||
105611073|NCT03126019|364240039|FG000|Overall Study|Site Closed|0|||
105611074|NCT03126019|364240040|FG001|Overall Study|Site Closed|1|||
105611075|NCT02960893|364240042|FG000|Randomization Phase (8-week)|Adverse Event|5|||
105611076|NCT02960893|364240043|FG001|Randomization Phase (8-week)|Adverse Event|0|||
105611077|NCT02960893|364240042|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
105611078|NCT02960893|364240043|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
105611079|NCT02960893|364240042|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
105611080|NCT02960893|364240043|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
105611081|NCT02960893|364240042|FG000|Extension Phase (48-week)|Adverse Event|2|||
105611082|NCT02960893|364240043|FG001|Extension Phase (48-week)|Adverse Event|3|||
105611083|NCT02960893|364240042|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
105611084|NCT02960893|364240043|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
105611085|NCT02960893|364240042|FG000|Extension Phase (48-week)|Other Reason|2|||
105611086|NCT02960893|364240043|FG001|Extension Phase (48-week)|Other Reason|1|||
105611087|NCT02960893|364240042|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
105611088|NCT02960893|364240043|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
105611089|NCT02960893|364240042|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
105611090|NCT02960893|364240043|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
105611091|NCT05687916|364240045|FG000|Overall Study|Adverse Event|1|||
105611092|NCT05687916|364240046|FG001|Overall Study|Adverse Event|2|||
105611093|NCT05687916|364240047|FG002|Overall Study|Adverse Event|0|||
105611094|NCT05687916|364240045|FG000|Overall Study|Withdrawal by Subject|1|||
105611095|NCT05687916|364240046|FG001|Overall Study|Withdrawal by Subject|0|||
105611096|NCT05687916|364240047|FG002|Overall Study|Withdrawal by Subject|1|||
105611097|NCT05687916|364240045|FG000|Overall Study|Protocol Violation|0|||
105611098|NCT05687916|364240046|FG001|Overall Study|Protocol Violation|2|||
105611099|NCT05687916|364240047|FG002|Overall Study|Protocol Violation|1|||
105611100|NCT05687916|364240045|FG000|Overall Study|Reason not Specified|1|||
105611101|NCT05687916|364240046|FG001|Overall Study|Reason not Specified|0|||
105611102|NCT05687916|364240047|FG002|Overall Study|Reason not Specified|0|||
105611103|NCT05609760|364240054|FG000|Overall Study|Lost to Follow-up|0|||
105611104|NCT05609760|364240055|FG001|Overall Study|Lost to Follow-up|1|||
105611105|NCT05609760|364240054|FG000|Overall Study|Withdrawal by Subject|1|||
105611106|NCT05609760|364240055|FG001|Overall Study|Withdrawal by Subject|0|||
105611107|NCT04049643|364240056|FG000|Overall Study|Lack of Efficacy|1|||
105611108|NCT04049643|364240057|FG001|Overall Study|Lack of Efficacy|1|||
105611109|NCT04049643|364240058|FG002|Overall Study|Lack of Efficacy|0|||
105611110|NCT04049643|364240056|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
105611111|NCT04049643|364240057|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
105611112|NCT04049643|364240058|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
105611113|NCT03930342|364240059|FG000|Overall Study|Lost to Follow-up|70|||
105611114|NCT03930342|364240060|FG001|Overall Study|Lost to Follow-up|77|||
105611115|NCT02029443|364242054|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
105611116|NCT02029443|364242055|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
105611117|NCT02029443|364242056|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
105611118|NCT02029443|364242057|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
105611119|NCT02029443|364242058|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
105611120|NCT02029443|364242054|FG000|Overall Study|Death|13|||
105611121|NCT02029443|364242055|FG001|Overall Study|Death|2|||
105611122|NCT02029443|364242056|FG002|Overall Study|Death|2|||
105611123|NCT02029443|364242057|FG003|Overall Study|Death|11|||
105611124|NCT02029443|364242058|FG004|Overall Study|Death|2|||
105611125|NCT02029443|364242054|FG000|Overall Study|Lost to Follow-up|1|||
105611126|NCT02029443|364242055|FG001|Overall Study|Lost to Follow-up|0|||
105611127|NCT02029443|364242056|FG002|Overall Study|Lost to Follow-up|1|||
105611128|NCT02029443|364242057|FG003|Overall Study|Lost to Follow-up|1|||
105611129|NCT02029443|364242058|FG004|Overall Study|Lost to Follow-up|0|||
105611130|NCT02029443|364242054|FG000|Overall Study|Started other anti-cancer therapy|17|||
105611131|NCT02029443|364242055|FG001|Overall Study|Started other anti-cancer therapy|4|||
105611132|NCT02029443|364242056|FG002|Overall Study|Started other anti-cancer therapy|7|||
105611133|NCT02029443|364242057|FG003|Overall Study|Started other anti-cancer therapy|9|||
105611134|NCT02029443|364242058|FG004|Overall Study|Started other anti-cancer therapy|3|||
105611135|NCT02029443|364242054|FG000|Overall Study|Withdrawal by Subject|3|||
105611136|NCT02029443|364242055|FG001|Overall Study|Withdrawal by Subject|1|||
105611137|NCT02029443|364242056|FG002|Overall Study|Withdrawal by Subject|1|||
105611138|NCT02029443|364242057|FG003|Overall Study|Withdrawal by Subject|1|||
105611139|NCT02029443|364242058|FG004|Overall Study|Withdrawal by Subject|0|||
105611140|NCT02029443|364242054|FG000|Overall Study|Other|6|||
105611141|NCT02029443|364242055|FG001|Overall Study|Other|6|||
105611142|NCT02029443|364242056|FG002|Overall Study|Other|4|||
105611143|NCT02029443|364242057|FG003|Overall Study|Other|2|||
105611144|NCT02029443|364242058|FG004|Overall Study|Other|0|||
105611145|NCT05021640|364242066|FG000|Overall Study|Lost to Follow-up|0|||
105611146|NCT05021640|364242067|FG001|Overall Study|Lost to Follow-up|0|||
105611147|NCT05021640|364242068|FG002|Overall Study|Lost to Follow-up|0|||
105611148|NCT05021640|364242069|FG003|Overall Study|Lost to Follow-up|0|||
105611149|NCT05021640|364242070|FG004|Overall Study|Lost to Follow-up|1|||
105611150|NCT04737772|364242071|FG000|Phase 2 Study|Lost to Follow-up|15|||
105611151|NCT04737772|364242072|FG001|Phase 2 Study|Lost to Follow-up|15|||
105611152|NCT04737772|364242071|FG000|Phase 2 Study|Withdrawal by Subject|0|||
105611153|NCT04737772|364242072|FG001|Phase 2 Study|Withdrawal by Subject|1|||
105611154|NCT04737772|364242071|FG000|Phase 2 Study|Did not take any coaching calls|4|||
105611155|NCT04737772|364242072|FG001|Phase 2 Study|Did not take any coaching calls|0|||
105611156|NCT04737772|364242071|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
105611157|NCT04737772|364242072|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
105611158|NCT04737772|364242071|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
105611159|NCT04737772|364242072|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
105611160|NCT04083235|364242075|FG000|Overall Study|Death|252|||
105611161|NCT04083235|364242076|FG001|Overall Study|Death|277|||
105611162|NCT04083235|364242075|FG000|Overall Study|Withdrawal by Subject|13|||
105611163|NCT04083235|364242076|FG001|Overall Study|Withdrawal by Subject|17|||
105611164|NCT04083235|364242075|FG000|Overall Study|Lost to Follow-up|1|||
105611165|NCT04083235|364242076|FG001|Overall Study|Lost to Follow-up|1|||
105611166|NCT04083235|364242075|FG000|Overall Study|Does not meet entry criteria|1|||
105611167|NCT04083235|364242076|FG001|Overall Study|Does not meet entry criteria|0|||
105611168|NCT04083235|364242075|FG000|Overall Study|Did not receive treatment|13|||
105611169|NCT04083235|364242076|FG001|Overall Study|Did not receive treatment|8|||
105611170|NCT04083235|364242075|FG000|Overall Study|Ongoing at the time of DCO|44|||
105611171|NCT04083235|364242076|FG001|Overall Study|Ongoing at the time of DCO|7|||
105611172|NCT02727699|364242077|FG000|Overall Study|Adverse Event|2|||
105611173|NCT02727699|364242078|FG001|Overall Study|Adverse Event|0|||
105611174|NCT02727699|364242077|FG000|Overall Study|Withdrawal by Subject|5|||
105611175|NCT02727699|364242078|FG001|Overall Study|Withdrawal by Subject|3|||
105611176|NCT02727699|364242077|FG000|Overall Study|Protocol Violation|0|||
105611177|NCT02727699|364242078|FG001|Overall Study|Protocol Violation|1|||
105611178|NCT02727699|364242077|FG000|Overall Study|Physician Decision|0|||
105611179|NCT02727699|364242078|FG001|Overall Study|Physician Decision|1|||
105611180|NCT02727699|364242077|FG000|Overall Study|Lost to Follow-up|1|||
105611181|NCT02727699|364242078|FG001|Overall Study|Lost to Follow-up|0|||
105611182|NCT02727699|364242077|FG000|Overall Study|Sponsor Decision|1|||
105611183|NCT02727699|364242078|FG001|Overall Study|Sponsor Decision|0|||
105611184|NCT05458011|364242085|FG000|DB Period (12 Weeks)|Adverse Event|2|||
105611185|NCT05458011|364242086|FG001|DB Period (12 Weeks)|Adverse Event|1|||
105611186|NCT05458011|364242087|FG002|DB Period (12 Weeks)|Adverse Event|1|||
105611187|NCT05458011|364242085|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
105611188|NCT05458011|364242086|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
105611189|NCT05458011|364242087|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
105611190|NCT05458011|364242085|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
105611191|NCT05458011|364242086|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
105611192|NCT05458011|364242087|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
105611193|NCT05458011|364242085|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
105611194|NCT05458011|364242086|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
105611195|NCT05458011|364242087|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
105611196|NCT05458011|364242085|FG000|OL Period (12 Weeks)|Adverse Event|1|||
105611197|NCT05458011|364242086|FG001|OL Period (12 Weeks)|Adverse Event|2|||
105611198|NCT05458011|364242087|FG002|OL Period (12 Weeks)|Adverse Event|1|||
105611199|NCT05458011|364242085|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
105611200|NCT05458011|364242086|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
105611201|NCT05458011|364242087|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
105611202|NCT02671903|364242088|FG000|Period 0 (Run-In)|Death|0|||
105611203|NCT02671903|364242089|FG001|Period 0 (Run-In)|Death|0|||
105611204|NCT02671903|364242090|FG002|Period 0 (Run-In)|Death|3|||
105611205|NCT02671903|364242088|FG000|Period 0 (Run-In)|Physician Decision|0|||
105611206|NCT02671903|364242089|FG001|Period 0 (Run-In)|Physician Decision|0|||
105611207|NCT02671903|364242090|FG002|Period 0 (Run-In)|Physician Decision|4|||
105611208|NCT02671903|364242088|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
105611209|NCT02671903|364242089|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
105611210|NCT02671903|364242090|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
105611211|NCT02671903|364242088|FG000|Period 0 (Run-In)|Protocol Violation|0|||
105611212|NCT02671903|364242089|FG001|Period 0 (Run-In)|Protocol Violation|0|||
105611213|NCT02671903|364242090|FG002|Period 0 (Run-In)|Protocol Violation|1|||
105611214|NCT02671903|364242088|FG000|Period 0 (Run-In)|Adverse Event|0|||
105611215|NCT02671903|364242089|FG001|Period 0 (Run-In)|Adverse Event|0|||
105611216|NCT02671903|364242090|FG002|Period 0 (Run-In)|Adverse Event|1|||
105611217|NCT02671903|364242088|FG000|Period 0 (Run-In)|Implantation Failure|0|||
105611218|NCT02671903|364242089|FG001|Period 0 (Run-In)|Implantation Failure|0|||
105611219|NCT02671903|364242090|FG002|Period 0 (Run-In)|Implantation Failure|2|||
105611220|NCT02671903|364242088|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
105611221|NCT02671903|364242089|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
105611222|NCT02671903|364242090|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
105611223|NCT02992925|364242091|FG000|Cohort 2|Physician Decision|0|||
105611224|NCT02992925|364242092|FG001|Cohort 2|Physician Decision|0|||
105611225|NCT02992925|364242093|FG002|Cohort 2|Physician Decision|1|||
105611226|NCT02992925|364242094|FG003|Cohort 2|Physician Decision|0|||
105611227|NCT02992925|364242091|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
105611228|NCT02992925|364242092|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
105611229|NCT02992925|364242093|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
105611230|NCT02992925|364242094|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
105611231|NCT01804816|364242095|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
105611232|NCT01804816|364242095|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
105611233|NCT04421378|364242096|FG000|Overall Study|Adverse Event|2|||
105611234|NCT04421378|364242097|FG001|Overall Study|Adverse Event|7|||
105611235|NCT04421378|364242098|FG002|Overall Study|Adverse Event|0|||
105611236|NCT04421378|364242099|FG003|Overall Study|Adverse Event|1|||
105611237|NCT04421378|364242100|FG004|Overall Study|Adverse Event|0|||
105611238|NCT04421378|364242096|FG000|Overall Study|Physician Decision|1|||
105611239|NCT04421378|364242097|FG001|Overall Study|Physician Decision|2|||
105611240|NCT04421378|364242098|FG002|Overall Study|Physician Decision|0|||
105611241|NCT04421378|364242099|FG003|Overall Study|Physician Decision|0|||
105611242|NCT04421378|364242100|FG004|Overall Study|Physician Decision|0|||
105611243|NCT04421378|364242096|FG000|Overall Study|Progressive Disease|16|||
105611244|NCT04421378|364242097|FG001|Overall Study|Progressive Disease|4|||
105611245|NCT04421378|364242098|FG002|Overall Study|Progressive Disease|18|||
105611246|NCT04421378|364242099|FG003|Overall Study|Progressive Disease|11|||
105611247|NCT04421378|364242100|FG004|Overall Study|Progressive Disease|3|||
105611248|NCT04421378|364242096|FG000|Overall Study|Study Terminated by Sponsor|0|||
105611249|NCT04421378|364242097|FG001|Overall Study|Study Terminated by Sponsor|1|||
105611250|NCT04421378|364242098|FG002|Overall Study|Study Terminated by Sponsor|1|||
105611251|NCT04421378|364242099|FG003|Overall Study|Study Terminated by Sponsor|0|||
105611252|NCT04421378|364242100|FG004|Overall Study|Study Terminated by Sponsor|0|||
105611253|NCT04421378|364242096|FG000|Overall Study|Withdrawal by Subject|3|||
105611254|NCT04421378|364242097|FG001|Overall Study|Withdrawal by Subject|1|||
105611255|NCT04421378|364242098|FG002|Overall Study|Withdrawal by Subject|0|||
105611256|NCT04421378|364242099|FG003|Overall Study|Withdrawal by Subject|2|||
105611257|NCT04421378|364242100|FG004|Overall Study|Withdrawal by Subject|0|||
105611258|NCT04421378|364242096|FG000|Overall Study|Other|1|||
105611259|NCT04421378|364242097|FG001|Overall Study|Other|0|||
105611260|NCT04421378|364242098|FG002|Overall Study|Other|0|||
105611261|NCT04421378|364242099|FG003|Overall Study|Other|0|||
105611262|NCT04421378|364242100|FG004|Overall Study|Other|0|||
105611263|NCT04150718|364242101|FG000|Overall Study|Withdrawal by Subject|2|||
105611264|NCT04150718|364242102|FG001|Overall Study|Withdrawal by Subject|7|||
105611265|NCT04150718|364242103|FG002|Overall Study|Withdrawal by Subject|1|||
105611266|NCT04150718|364242101|FG000|Overall Study|Lost to Follow-up|1|||
105611267|NCT04150718|364242102|FG001|Overall Study|Lost to Follow-up|2|||
105611268|NCT04150718|364242103|FG002|Overall Study|Lost to Follow-up|0|||
105611269|NCT04150718|364242101|FG000|Overall Study|Ineligible|1|||
105611270|NCT04150718|364242102|FG001|Overall Study|Ineligible|0|||
105611271|NCT04150718|364242103|FG002|Overall Study|Ineligible|10|||
105611272|NCT03958955|364242104|FG000|Overall Study|Adverse Event|1|||
105611273|NCT02927769|364242106|FG000|Induction Phase|Study drug toxicity|1|||
105611274|NCT02927769|364242107|FG001|Induction Phase|Study drug toxicity|1|||
105611275|NCT02927769|364242106|FG000|Induction Phase|Disease progression|0|||
105611276|NCT02927769|364242107|FG001|Induction Phase|Disease progression|1|||
105611277|NCT02927769|364242106|FG000|Intensification Phase|Study drug toxicity|1|||
105611278|NCT02927769|364242107|FG001|Intensification Phase|Study drug toxicity|0|||
105611279|NCT02807636|364242108|FG000|Overall Study|Lost to Follow-up|10|||
105611280|NCT02807636|364242109|FG001|Overall Study|Lost to Follow-up|13|||
105611281|NCT02807636|364242110|FG002|Overall Study|Lost to Follow-up|6|||
105611282|NCT02807636|364242108|FG000|Overall Study|Protocol Deviation|1|||
105611283|NCT02807636|364242109|FG001|Overall Study|Protocol Deviation|0|||
105611284|NCT02807636|364242110|FG002|Overall Study|Protocol Deviation|0|||
105611285|NCT02807636|364242108|FG000|Overall Study|Symptomatic Deterioration|0|||
105611286|NCT02807636|364242109|FG001|Overall Study|Symptomatic Deterioration|1|||
105611287|NCT02807636|364242110|FG002|Overall Study|Symptomatic Deterioration|0|||
105611288|NCT02807636|364242108|FG000|Overall Study|Withdrawal by Subject|39|||
105611289|NCT02807636|364242109|FG001|Overall Study|Withdrawal by Subject|28|||
105611290|NCT02807636|364242110|FG002|Overall Study|Withdrawal by Subject|24|||
105611291|NCT02807636|364242108|FG000|Overall Study|Death|303|||
105611292|NCT02807636|364242109|FG001|Overall Study|Death|332|||
105611293|NCT02807636|364242110|FG002|Overall Study|Death|272|||
105611294|NCT02807636|364242108|FG000|Overall Study|Study Terminated By Sponsor|47|||
105611295|NCT02807636|364242109|FG001|Overall Study|Study Terminated By Sponsor|76|||
105611296|NCT02807636|364242110|FG002|Overall Study|Study Terminated By Sponsor|60|||
105611297|NCT02807636|364242108|FG000|Overall Study|Physician Decision|0|||
105611298|NCT02807636|364242109|FG001|Overall Study|Physician Decision|1|||
105611299|NCT02807636|364242110|FG002|Overall Study|Physician Decision|0|||
105611300|NCT04088630|364242111|FG000|Overall Study|Lost to Follow-up|3|||
105611301|NCT04088630|364242112|FG001|Overall Study|Lost to Follow-up|2|||
105611302|NCT04088630|364242113|FG002|Overall Study|Lost to Follow-up|6|||
105611303|NCT04088630|364242111|FG000|Overall Study|Death|3|||
105611304|NCT04088630|364242112|FG001|Overall Study|Death|1|||
105611305|NCT04088630|364242113|FG002|Overall Study|Death|1|||
105611306|NCT04088630|364242111|FG000|Overall Study|Physician Decision|0|||
105611307|NCT04088630|364242112|FG001|Overall Study|Physician Decision|1|||
105611308|NCT04088630|364242113|FG002|Overall Study|Physician Decision|1|||
105611309|NCT03175029|364242116|FG000|Overall Study|Withdrawal by Subject|2|||
105611310|NCT03175029|364242117|FG001|Overall Study|Withdrawal by Subject|1|||
105611311|NCT03175029|364242116|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
105611312|NCT03175029|364242117|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
105611313|NCT02287610|364242118|FG000|Overall Study|Lost to Follow-up|3|||
105611314|NCT02287610|364242118|FG000|Overall Study|Withdrawal by Subject|8|||
105611315|NCT02287610|364242118|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
105611316|NCT03932682|364242135|FG000|Overall Study|Death|1|||
105611317|NCT03932682|364242136|FG001|Overall Study|Death|2|||
105611318|NCT03932682|364242135|FG000|Overall Study|Withdrawal by Subject|37|||
105611319|NCT03932682|364242136|FG001|Overall Study|Withdrawal by Subject|45|||
105611320|NCT03932682|364242135|FG000|Overall Study|Lost to Follow-up|19|||
105611321|NCT03932682|364242136|FG001|Overall Study|Lost to Follow-up|25|||
105611322|NCT03932682|364242135|FG000|Overall Study|Protocol Violation|0|||
105611323|NCT03932682|364242136|FG001|Overall Study|Protocol Violation|2|||
105611324|NCT03932682|364242135|FG000|Overall Study|Other|9|||
105611325|NCT03932682|364242136|FG001|Overall Study|Other|23|||
105611326|NCT05536440|364242139|FG000|Overall Study|Adverse Event|0|||
105611327|NCT05536440|364242140|FG001|Overall Study|Adverse Event|0|||
105611328|NCT05536440|364242141|FG002|Overall Study|Adverse Event|0|||
105611329|NCT05536440|364242142|FG003|Overall Study|Adverse Event|0|||
105611330|NCT05536440|364242143|FG004|Overall Study|Adverse Event|0|||
105611331|NCT05536440|364242144|FG005|Overall Study|Adverse Event|0|||
105611332|NCT05536440|364242145|FG006|Overall Study|Adverse Event|0|||
105611333|NCT05536440|364242146|FG007|Overall Study|Adverse Event|0|||
105611334|NCT05536440|364242147|FG008|Overall Study|Adverse Event|1|||
105611335|NCT05470400|364242148|FG000|Overall Study|Lost to Follow-up|0|||
105611336|NCT05470400|364242149|FG001|Overall Study|Lost to Follow-up|0|||
105611337|NCT05470400|364242150|FG002|Overall Study|Lost to Follow-up|0|||
105611338|NCT05470400|364242151|FG003|Overall Study|Lost to Follow-up|0|||
105611339|NCT05470400|364242152|FG004|Overall Study|Lost to Follow-up|0|||
105611340|NCT05470400|364242153|FG005|Overall Study|Lost to Follow-up|0|||
105611341|NCT05470400|364242154|FG006|Overall Study|Lost to Follow-up|0|||
105611342|NCT05470400|364242155|FG007|Overall Study|Lost to Follow-up|1|||
105611343|NCT05470400|364242148|FG000|Overall Study|Withdrawal by Subject|1|||
105611344|NCT05470400|364242149|FG001|Overall Study|Withdrawal by Subject|0|||
105611345|NCT05470400|364242150|FG002|Overall Study|Withdrawal by Subject|0|||
105611346|NCT05470400|364242151|FG003|Overall Study|Withdrawal by Subject|0|||
105611347|NCT05470400|364242152|FG004|Overall Study|Withdrawal by Subject|0|||
105611348|NCT05470400|364242153|FG005|Overall Study|Withdrawal by Subject|1|||
105611349|NCT05470400|364242154|FG006|Overall Study|Withdrawal by Subject|0|||
105611350|NCT05470400|364242155|FG007|Overall Study|Withdrawal by Subject|2|||
105611351|NCT05956002|364242157|FG000|Treatment Period 3|Adverse Event|0|||
105611352|NCT05956002|364242158|FG001|Treatment Period 3|Adverse Event|0|||
105611353|NCT05956002|364242159|FG002|Treatment Period 3|Adverse Event|1|||
105611354|NCT05956002|364242160|FG003|Treatment Period 3|Adverse Event|0|||
105611355|NCT04179500|364242161|FG000|Treatment|Withdrawal by Subject|1|||
105611356|NCT04179500|364242161|FG000|Treatment|Adverse Event|2|||
105611357|NCT04179500|364242161|FG000|Treatment|pyrazinamide resistance|1|||
105611358|NCT02307565|364242166|FG000|Overall Study|Adverse Event|3|||
105611359|NCT02307565|364242167|FG001|Overall Study|Adverse Event|2|||
105611360|NCT02307565|364242166|FG000|Overall Study|Withdrawal by Subject|2|||
105611361|NCT02307565|364242167|FG001|Overall Study|Withdrawal by Subject|2|||
105611362|NCT04382404|364242168|FG000|Overall Study|Adverse Event|1|||
105611363|NCT04382404|364242168|FG000|Overall Study|Lost to Follow-up|2|||
105611364|NCT04294225|364242169|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
105611365|NCT04294225|364242169|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
105611366|NCT04294225|364242169|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
105611367|NCT04294225|364242169|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
105611368|NCT04294225|364242169|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
105611369|NCT03738228|364242170|FG000|Overall Study|Never received study treatment|2|||
105611370|NCT03738228|364242171|FG001|Overall Study|Never received study treatment|2|||
105611371|NCT04927065|364242180|FG000|First Booster|Adverse Event|1|||
105611372|NCT04927065|364242181|FG001|First Booster|Adverse Event|0|||
105611373|NCT04927065|364242182|FG002|First Booster|Adverse Event|0|||
105611374|NCT04927065|364242183|FG003|First Booster|Adverse Event|0|||
105611375|NCT04927065|364242184|FG004|First Booster|Adverse Event|0|||
105611376|NCT04927065|364242185|FG005|First Booster|Adverse Event|0|||
105611377|NCT04927065|364242186|FG006|First Booster|Adverse Event|0|||
105611378|NCT04927065|364242187|FG007|First Booster|Adverse Event|1|||
105611379|NCT04927065|364242188|FG008|First Booster|Adverse Event|0|||
105611380|NCT04927065|364242189|FG009|First Booster|Adverse Event|0|||
105611381|NCT04927065|364242190|FG010|First Booster|Adverse Event|0|||
105611382|NCT04927065|364242191|FG011|First Booster|Adverse Event|0|||
105611383|NCT04927065|364242192|FG012|First Booster|Adverse Event|0|||
105611384|NCT04927065|364242193|FG013|First Booster|Adverse Event|0|||
105611385|NCT04927065|364242194|FG014|First Booster|Adverse Event|0|||
105611386|NCT04927065|364242195|FG015|First Booster|Adverse Event|0|||
105611387|NCT04927065|364242180|FG000|First Booster|Death|1|||
105611388|NCT04927065|364242181|FG001|First Booster|Death|0|||
105611389|NCT04927065|364242182|FG002|First Booster|Death|0|||
105611390|NCT04927065|364242183|FG003|First Booster|Death|1|||
105611391|NCT04927065|364242184|FG004|First Booster|Death|0|||
105611392|NCT04927065|364242185|FG005|First Booster|Death|1|||
105611393|NCT04927065|364242186|FG006|First Booster|Death|0|||
105611394|NCT04927065|364242187|FG007|First Booster|Death|0|||
105611395|NCT04927065|364242188|FG008|First Booster|Death|0|||
105611396|NCT04927065|364242189|FG009|First Booster|Death|0|||
105611397|NCT04927065|364242190|FG010|First Booster|Death|0|||
105611398|NCT04927065|364242191|FG011|First Booster|Death|0|||
105611399|NCT04927065|364242192|FG012|First Booster|Death|0|||
105611400|NCT04927065|364242193|FG013|First Booster|Death|0|||
105611401|NCT04927065|364242194|FG014|First Booster|Death|0|||
105611402|NCT04927065|364242195|FG015|First Booster|Death|0|||
105611403|NCT04927065|364242180|FG000|First Booster|Lost to Follow-up|8|||
105611404|NCT04927065|364242181|FG001|First Booster|Lost to Follow-up|20|||
105611405|NCT04927065|364242182|FG002|First Booster|Lost to Follow-up|0|||
105611406|NCT04927065|364242183|FG003|First Booster|Lost to Follow-up|11|||
105611407|NCT04927065|364242184|FG004|First Booster|Lost to Follow-up|43|||
105611408|NCT04927065|364242185|FG005|First Booster|Lost to Follow-up|30|||
105611409|NCT04927065|364242186|FG006|First Booster|Lost to Follow-up|28|||
105611410|NCT04927065|364242187|FG007|First Booster|Lost to Follow-up|23|||
105611411|NCT04927065|364242188|FG008|First Booster|Lost to Follow-up|4|||
105611412|NCT04927065|364242189|FG009|First Booster|Lost to Follow-up|15|||
105611413|NCT04927065|364242190|FG010|First Booster|Lost to Follow-up|0|||
105611414|NCT04927065|364242191|FG011|First Booster|Lost to Follow-up|0|||
105611415|NCT04927065|364242192|FG012|First Booster|Lost to Follow-up|0|||
105611416|NCT04927065|364242193|FG013|First Booster|Lost to Follow-up|0|||
105611417|NCT04927065|364242194|FG014|First Booster|Lost to Follow-up|0|||
105611418|NCT04927065|364242195|FG015|First Booster|Lost to Follow-up|0|||
105611419|NCT04927065|364242180|FG000|First Booster|Physician Decision|1|||
105611420|NCT04927065|364242181|FG001|First Booster|Physician Decision|0|||
105611421|NCT04927065|364242182|FG002|First Booster|Physician Decision|0|||
105611422|NCT04927065|364242183|FG003|First Booster|Physician Decision|3|||
105611423|NCT04927065|364242184|FG004|First Booster|Physician Decision|1|||
105611424|NCT04927065|364242185|FG005|First Booster|Physician Decision|1|||
105611425|NCT04927065|364242186|FG006|First Booster|Physician Decision|0|||
105611426|NCT04927065|364242187|FG007|First Booster|Physician Decision|3|||
105611427|NCT04927065|364242188|FG008|First Booster|Physician Decision|0|||
105611428|NCT04927065|364242189|FG009|First Booster|Physician Decision|0|||
105611429|NCT04927065|364242190|FG010|First Booster|Physician Decision|0|||
105611430|NCT04927065|364242191|FG011|First Booster|Physician Decision|0|||
105611431|NCT04927065|364242192|FG012|First Booster|Physician Decision|0|||
105611432|NCT04927065|364242193|FG013|First Booster|Physician Decision|0|||
105611433|NCT04927065|364242194|FG014|First Booster|Physician Decision|0|||
105611434|NCT04927065|364242195|FG015|First Booster|Physician Decision|0|||
105611435|NCT04927065|364242180|FG000|First Booster|Protocol Violation|4|||
105611436|NCT04927065|364242181|FG001|First Booster|Protocol Violation|4|||
105611437|NCT04927065|364242182|FG002|First Booster|Protocol Violation|0|||
105611438|NCT04927065|364242183|FG003|First Booster|Protocol Violation|3|||
105611439|NCT04927065|364242184|FG004|First Booster|Protocol Violation|0|||
105611440|NCT04927065|364242185|FG005|First Booster|Protocol Violation|0|||
105611441|NCT04927065|364242186|FG006|First Booster|Protocol Violation|0|||
105611442|NCT04927065|364242187|FG007|First Booster|Protocol Violation|2|||
105611443|NCT04927065|364242188|FG008|First Booster|Protocol Violation|0|||
105611444|NCT04927065|364242189|FG009|First Booster|Protocol Violation|0|||
105611445|NCT04927065|364242190|FG010|First Booster|Protocol Violation|0|||
105611446|NCT04927065|364242191|FG011|First Booster|Protocol Violation|0|||
105611447|NCT04927065|364242192|FG012|First Booster|Protocol Violation|0|||
105611448|NCT04927065|364242193|FG013|First Booster|Protocol Violation|0|||
105611449|NCT04927065|364242194|FG014|First Booster|Protocol Violation|0|||
105611450|NCT04927065|364242195|FG015|First Booster|Protocol Violation|0|||
105611451|NCT04927065|364242180|FG000|First Booster|Withdrawal by Subject|8|||
105611452|NCT04927065|364242181|FG001|First Booster|Withdrawal by Subject|23|||
105611453|NCT04927065|364242182|FG002|First Booster|Withdrawal by Subject|0|||
105611454|NCT04927065|364242183|FG003|First Booster|Withdrawal by Subject|19|||
105611455|NCT04927065|364242184|FG004|First Booster|Withdrawal by Subject|20|||
105611456|NCT04927065|364242185|FG005|First Booster|Withdrawal by Subject|15|||
105611457|NCT04927065|364242186|FG006|First Booster|Withdrawal by Subject|6|||
105611458|NCT04927065|364242187|FG007|First Booster|Withdrawal by Subject|24|||
105611459|NCT04927065|364242188|FG008|First Booster|Withdrawal by Subject|0|||
105611460|NCT04927065|364242189|FG009|First Booster|Withdrawal by Subject|4|||
105611461|NCT04927065|364242190|FG010|First Booster|Withdrawal by Subject|0|||
105611462|NCT04927065|364242191|FG011|First Booster|Withdrawal by Subject|0|||
105611463|NCT04927065|364242192|FG012|First Booster|Withdrawal by Subject|0|||
105611464|NCT04927065|364242193|FG013|First Booster|Withdrawal by Subject|0|||
105611465|NCT04927065|364242194|FG014|First Booster|Withdrawal by Subject|0|||
105611466|NCT04927065|364242195|FG015|First Booster|Withdrawal by Subject|0|||
105611467|NCT04927065|364242180|FG000|First Booster|Other Than Specified|1|||
105611468|NCT04927065|364242181|FG001|First Booster|Other Than Specified|1|||
105611469|NCT04927065|364242182|FG002|First Booster|Other Than Specified|0|||
105611470|NCT04927065|364242183|FG003|First Booster|Other Than Specified|1|||
105611471|NCT04927065|364242184|FG004|First Booster|Other Than Specified|2|||
105611472|NCT04927065|364242185|FG005|First Booster|Other Than Specified|3|||
105611473|NCT04927065|364242186|FG006|First Booster|Other Than Specified|2|||
105611474|NCT04927065|364242187|FG007|First Booster|Other Than Specified|6|||
105611475|NCT04927065|364242188|FG008|First Booster|Other Than Specified|0|||
105611476|NCT04927065|364242189|FG009|First Booster|Other Than Specified|4|||
105611477|NCT04927065|364242190|FG010|First Booster|Other Than Specified|0|||
105611478|NCT04927065|364242191|FG011|First Booster|Other Than Specified|0|||
105611479|NCT04927065|364242192|FG012|First Booster|Other Than Specified|0|||
105611480|NCT04927065|364242193|FG013|First Booster|Other Than Specified|0|||
105611481|NCT04927065|364242194|FG014|First Booster|Other Than Specified|0|||
105611482|NCT04927065|364242195|FG015|First Booster|Other Than Specified|0|||
105611483|NCT04927065|364242180|FG000|Second Booster|Death|0|||
105611484|NCT04927065|364242181|FG001|Second Booster|Death|0|||
105611485|NCT04927065|364242182|FG002|Second Booster|Death|0|||
105611486|NCT04927065|364242183|FG003|Second Booster|Death|0|||
105611487|NCT04927065|364242184|FG004|Second Booster|Death|0|||
105611488|NCT04927065|364242185|FG005|Second Booster|Death|0|||
105611489|NCT04927065|364242186|FG006|Second Booster|Death|0|||
105611490|NCT04927065|364242187|FG007|Second Booster|Death|0|||
105611491|NCT04927065|364242188|FG008|Second Booster|Death|0|||
105611492|NCT04927065|364242189|FG009|Second Booster|Death|0|||
105611493|NCT04927065|364242190|FG010|Second Booster|Death|2|||
105611494|NCT04927065|364242191|FG011|Second Booster|Death|0|||
105611495|NCT04927065|364242192|FG012|Second Booster|Death|2|||
105611496|NCT04927065|364242193|FG013|Second Booster|Death|2|||
105611497|NCT04927065|364242194|FG014|Second Booster|Death|0|||
105611498|NCT04927065|364242195|FG015|Second Booster|Death|0|||
105611499|NCT04927065|364242180|FG000|Second Booster|Lost to Follow-up|0|||
105611500|NCT04927065|364242181|FG001|Second Booster|Lost to Follow-up|0|||
105611501|NCT04927065|364242182|FG002|Second Booster|Lost to Follow-up|3|||
105611502|NCT04927065|364242183|FG003|Second Booster|Lost to Follow-up|0|||
105611503|NCT04927065|364242184|FG004|Second Booster|Lost to Follow-up|0|||
105611504|NCT04927065|364242185|FG005|Second Booster|Lost to Follow-up|0|||
105611505|NCT04927065|364242186|FG006|Second Booster|Lost to Follow-up|0|||
105611506|NCT04927065|364242187|FG007|Second Booster|Lost to Follow-up|0|||
105611507|NCT04927065|364242188|FG008|Second Booster|Lost to Follow-up|0|||
105611508|NCT04927065|364242189|FG009|Second Booster|Lost to Follow-up|0|||
105611509|NCT04927065|364242190|FG010|Second Booster|Lost to Follow-up|14|||
105611510|NCT04927065|364242191|FG011|Second Booster|Lost to Follow-up|10|||
105611511|NCT04927065|364242192|FG012|Second Booster|Lost to Follow-up|13|||
105611512|NCT04927065|364242193|FG013|Second Booster|Lost to Follow-up|16|||
105611513|NCT04927065|364242194|FG014|Second Booster|Lost to Follow-up|0|||
105611514|NCT04927065|364242195|FG015|Second Booster|Lost to Follow-up|0|||
105611515|NCT04927065|364242180|FG000|Second Booster|Physician Decision|0|||
105611516|NCT04927065|364242181|FG001|Second Booster|Physician Decision|0|||
105611517|NCT04927065|364242182|FG002|Second Booster|Physician Decision|0|||
105611518|NCT04927065|364242183|FG003|Second Booster|Physician Decision|0|||
105611519|NCT04927065|364242184|FG004|Second Booster|Physician Decision|0|||
105611520|NCT04927065|364242185|FG005|Second Booster|Physician Decision|0|||
105611521|NCT04927065|364242186|FG006|Second Booster|Physician Decision|0|||
105611522|NCT04927065|364242187|FG007|Second Booster|Physician Decision|0|||
105611523|NCT04927065|364242188|FG008|Second Booster|Physician Decision|0|||
105611524|NCT04927065|364242189|FG009|Second Booster|Physician Decision|0|||
105611525|NCT04927065|364242190|FG010|Second Booster|Physician Decision|0|||
105611526|NCT04927065|364242191|FG011|Second Booster|Physician Decision|3|||
105611527|NCT04927065|364242192|FG012|Second Booster|Physician Decision|0|||
105611528|NCT04927065|364242193|FG013|Second Booster|Physician Decision|1|||
105611529|NCT04927065|364242194|FG014|Second Booster|Physician Decision|0|||
105611530|NCT04927065|364242195|FG015|Second Booster|Physician Decision|0|||
105611531|NCT04927065|364242180|FG000|Second Booster|Withdrawal by Subject|0|||
105611532|NCT04927065|364242181|FG001|Second Booster|Withdrawal by Subject|0|||
105611533|NCT04927065|364242182|FG002|Second Booster|Withdrawal by Subject|4|||
105611534|NCT04927065|364242183|FG003|Second Booster|Withdrawal by Subject|0|||
105611535|NCT04927065|364242184|FG004|Second Booster|Withdrawal by Subject|0|||
105611536|NCT04927065|364242185|FG005|Second Booster|Withdrawal by Subject|0|||
105611537|NCT04927065|364242186|FG006|Second Booster|Withdrawal by Subject|0|||
105611538|NCT04927065|364242187|FG007|Second Booster|Withdrawal by Subject|0|||
105611539|NCT04927065|364242188|FG008|Second Booster|Withdrawal by Subject|0|||
105611540|NCT04927065|364242189|FG009|Second Booster|Withdrawal by Subject|0|||
105611541|NCT04927065|364242190|FG010|Second Booster|Withdrawal by Subject|3|||
105611542|NCT04927065|364242191|FG011|Second Booster|Withdrawal by Subject|16|||
105611543|NCT04927065|364242192|FG012|Second Booster|Withdrawal by Subject|13|||
105611544|NCT04927065|364242193|FG013|Second Booster|Withdrawal by Subject|9|||
105611545|NCT04927065|364242194|FG014|Second Booster|Withdrawal by Subject|0|||
105611546|NCT04927065|364242195|FG015|Second Booster|Withdrawal by Subject|0|||
105611547|NCT04927065|364242180|FG000|Second Booster|Other Than Specified|0|||
105611548|NCT04927065|364242181|FG001|Second Booster|Other Than Specified|0|||
105611549|NCT04927065|364242182|FG002|Second Booster|Other Than Specified|0|||
105611550|NCT04927065|364242183|FG003|Second Booster|Other Than Specified|0|||
105611551|NCT04927065|364242184|FG004|Second Booster|Other Than Specified|0|||
105611552|NCT04927065|364242185|FG005|Second Booster|Other Than Specified|0|||
105611553|NCT04927065|364242186|FG006|Second Booster|Other Than Specified|0|||
105611554|NCT04927065|364242187|FG007|Second Booster|Other Than Specified|0|||
105611555|NCT04927065|364242188|FG008|Second Booster|Other Than Specified|0|||
105611556|NCT04927065|364242189|FG009|Second Booster|Other Than Specified|0|||
105611557|NCT04927065|364242190|FG010|Second Booster|Other Than Specified|1|||
105611558|NCT04927065|364242191|FG011|Second Booster|Other Than Specified|1|||
105611559|NCT04927065|364242192|FG012|Second Booster|Other Than Specified|4|||
105611560|NCT04927065|364242193|FG013|Second Booster|Other Than Specified|0|||
105611561|NCT04927065|364242194|FG014|Second Booster|Other Than Specified|0|||
105611562|NCT04927065|364242195|FG015|Second Booster|Other Than Specified|0|||
105611563|NCT04927065|364242180|FG000|Third Booster|Lost to Follow-up|0|||
105611564|NCT04927065|364242181|FG001|Third Booster|Lost to Follow-up|0|||
105611565|NCT04927065|364242182|FG002|Third Booster|Lost to Follow-up|0|||
105611566|NCT04927065|364242183|FG003|Third Booster|Lost to Follow-up|0|||
105611567|NCT04927065|364242184|FG004|Third Booster|Lost to Follow-up|0|||
105611568|NCT04927065|364242185|FG005|Third Booster|Lost to Follow-up|0|||
105611569|NCT04927065|364242186|FG006|Third Booster|Lost to Follow-up|0|||
105611570|NCT04927065|364242187|FG007|Third Booster|Lost to Follow-up|0|||
105611571|NCT04927065|364242188|FG008|Third Booster|Lost to Follow-up|0|||
105611572|NCT04927065|364242189|FG009|Third Booster|Lost to Follow-up|0|||
105611573|NCT04927065|364242190|FG010|Third Booster|Lost to Follow-up|0|||
105611574|NCT04927065|364242191|FG011|Third Booster|Lost to Follow-up|0|||
105611575|NCT04927065|364242192|FG012|Third Booster|Lost to Follow-up|0|||
105611576|NCT04927065|364242193|FG013|Third Booster|Lost to Follow-up|0|||
105611577|NCT04927065|364242194|FG014|Third Booster|Lost to Follow-up|0|||
105611578|NCT04927065|364242195|FG015|Third Booster|Lost to Follow-up|1|||
105611579|NCT04927065|364242180|FG000|Third Booster|Withdrawal by Subject|0|||
105611580|NCT04927065|364242181|FG001|Third Booster|Withdrawal by Subject|0|||
105611581|NCT04927065|364242182|FG002|Third Booster|Withdrawal by Subject|0|||
105611582|NCT04927065|364242183|FG003|Third Booster|Withdrawal by Subject|0|||
105611583|NCT04927065|364242184|FG004|Third Booster|Withdrawal by Subject|0|||
105611584|NCT04927065|364242185|FG005|Third Booster|Withdrawal by Subject|0|||
105611585|NCT04927065|364242186|FG006|Third Booster|Withdrawal by Subject|0|||
105611586|NCT04927065|364242187|FG007|Third Booster|Withdrawal by Subject|0|||
105611587|NCT04927065|364242188|FG008|Third Booster|Withdrawal by Subject|0|||
105611588|NCT04927065|364242189|FG009|Third Booster|Withdrawal by Subject|0|||
105611589|NCT04927065|364242190|FG010|Third Booster|Withdrawal by Subject|0|||
105611590|NCT04927065|364242191|FG011|Third Booster|Withdrawal by Subject|0|||
105611591|NCT04927065|364242192|FG012|Third Booster|Withdrawal by Subject|0|||
105611592|NCT04927065|364242193|FG013|Third Booster|Withdrawal by Subject|0|||
105611593|NCT04927065|364242194|FG014|Third Booster|Withdrawal by Subject|0|||
105611594|NCT04927065|364242195|FG015|Third Booster|Withdrawal by Subject|1|||
105611595|NCT04588298|364242206|FG000|Overall Study|Adverse Event|0|||
105611596|NCT04588298|364242207|FG001|Overall Study|Adverse Event|0|||
105611597|NCT04588298|364242208|FG002|Overall Study|Adverse Event|1|||
105611598|NCT04588298|364242209|FG003|Overall Study|Adverse Event|0|||
105611599|NCT04588298|364242210|FG004|Overall Study|Adverse Event|2|||
105611600|NCT04588298|364242206|FG000|Overall Study|Withdrawal by Subject|1|||
105611601|NCT04588298|364242207|FG001|Overall Study|Withdrawal by Subject|0|||
105611602|NCT04588298|364242208|FG002|Overall Study|Withdrawal by Subject|0|||
105611603|NCT04588298|364242209|FG003|Overall Study|Withdrawal by Subject|1|||
105611604|NCT04588298|364242210|FG004|Overall Study|Withdrawal by Subject|0|||
105611605|NCT03846505|364242211|FG000|Treatment Phase|Withdrawal by Subject|9|||
105611606|NCT03846505|364242212|FG001|Treatment Phase|Withdrawal by Subject|11|||
105611607|NCT03846505|364242211|FG000|Treatment Phase|Lost to Follow-up|6|||
105611608|NCT03846505|364242212|FG001|Treatment Phase|Lost to Follow-up|2|||
105611609|NCT03846505|364242211|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
105611610|NCT03846505|364242212|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
105611611|NCT03846505|364242211|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
105611612|NCT03846505|364242212|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
105611613|NCT05520190|364242213|FG000|Overall Study|Lost to Follow-up|7|||
105611614|NCT05520190|364242213|FG000|Overall Study|Withdrawal by Subject|2|||
105611615|NCT03683719|364242214|FG000|Overall Study|Lack of Efficacy|1|||
105611616|NCT03683719|364242215|FG001|Overall Study|Lack of Efficacy|3|||
105611617|NCT03683719|364242216|FG002|Overall Study|Lack of Efficacy|4|||
105611618|NCT03683719|364242217|FG003|Overall Study|Lack of Efficacy|0|||
105611619|NCT03683719|364242218|FG004|Overall Study|Lack of Efficacy|4|||
105611620|NCT03683719|364242214|FG000|Overall Study|Adverse Event|6|||
105611621|NCT03683719|364242215|FG001|Overall Study|Adverse Event|6|||
105611622|NCT03683719|364242216|FG002|Overall Study|Adverse Event|0|||
105611623|NCT03683719|364242217|FG003|Overall Study|Adverse Event|1|||
105611624|NCT03683719|364242218|FG004|Overall Study|Adverse Event|3|||
105611625|NCT03683719|364242214|FG000|Overall Study|Withdrawal by Subject|4|||
105611626|NCT03683719|364242215|FG001|Overall Study|Withdrawal by Subject|4|||
105611627|NCT03683719|364242216|FG002|Overall Study|Withdrawal by Subject|3|||
105611628|NCT03683719|364242217|FG003|Overall Study|Withdrawal by Subject|5|||
105611629|NCT03683719|364242218|FG004|Overall Study|Withdrawal by Subject|5|||
105611630|NCT03683719|364242214|FG000|Overall Study|Lost to Follow-up|1|||
105611631|NCT03683719|364242215|FG001|Overall Study|Lost to Follow-up|0|||
105611632|NCT03683719|364242216|FG002|Overall Study|Lost to Follow-up|0|||
105611633|NCT03683719|364242217|FG003|Overall Study|Lost to Follow-up|1|||
105611634|NCT03683719|364242218|FG004|Overall Study|Lost to Follow-up|1|||
105611635|NCT03683719|364242214|FG000|Overall Study|Other personal reasons|0|||
105611636|NCT03683719|364242215|FG001|Overall Study|Other personal reasons|0|||
105611637|NCT03683719|364242216|FG002|Overall Study|Other personal reasons|1|||
105611638|NCT03683719|364242217|FG003|Overall Study|Other personal reasons|0|||
105611639|NCT03683719|364242218|FG004|Overall Study|Other personal reasons|1|||
105611640|NCT03907397|364242219|FG000|Overall Study|Lost to Follow-up|0|||
105611641|NCT03907397|364242220|FG001|Overall Study|Lost to Follow-up|1|||
105611642|NCT03907397|364242219|FG000|Overall Study|Physician Decision|2|||
105611643|NCT03907397|364242220|FG001|Overall Study|Physician Decision|1|||
105611644|NCT03907397|364242219|FG000|Overall Study|Withdrawal by Subject|5|||
105611645|NCT03907397|364242220|FG001|Overall Study|Withdrawal by Subject|4|||
105611646|NCT03907397|364242219|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
105611647|NCT03907397|364242220|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
105611648|NCT03376321|364243716|FG000|Overall Study|Other|5|||
105611649|NCT03376321|364243717|FG001|Overall Study|Other|1|||
105611650|NCT03376321|364243716|FG000|Overall Study|Withdrawal by Subject|8|||
105611651|NCT03376321|364243717|FG001|Overall Study|Withdrawal by Subject|14|||
105611652|NCT03376321|364243716|FG000|Overall Study|Lost to Follow-up|1|||
105611653|NCT03376321|364243717|FG001|Overall Study|Lost to Follow-up|7|||
105611654|NCT03376321|364243716|FG000|Overall Study|Death|4|||
105611655|NCT03376321|364243717|FG001|Overall Study|Death|0|||
105611656|NCT03376321|364243716|FG000|Overall Study|Randomized, not treated|5|||
105611657|NCT03376321|364243717|FG001|Overall Study|Randomized, not treated|3|||
105611658|NCT04034251|364243718|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
105611659|NCT04034251|364243719|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
105611660|NCT04034251|364243720|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
105611661|NCT05034952|364243721|FG000|Overall Study|Adverse Event|1|||
105611662|NCT05034952|364243722|FG001|Overall Study|Adverse Event|0|||
105611663|NCT05034952|364243723|FG002|Overall Study|Adverse Event|0|||
105611664|NCT05034952|364243724|FG003|Overall Study|Adverse Event|0|||
105611665|NCT05034952|364243721|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
105611666|NCT05034952|364243722|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
105611667|NCT05034952|364243723|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
105611668|NCT05034952|364243724|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
105611669|NCT05034952|364243721|FG000|Overall Study|Lost to Follow-up|1|||
105611670|NCT05034952|364243722|FG001|Overall Study|Lost to Follow-up|4|||
105611671|NCT05034952|364243723|FG002|Overall Study|Lost to Follow-up|3|||
105611672|NCT05034952|364243724|FG003|Overall Study|Lost to Follow-up|3|||
105611673|NCT05034952|364243721|FG000|Overall Study|Other|0|||
105611674|NCT05034952|364243722|FG001|Overall Study|Other|0|||
105611675|NCT05034952|364243723|FG002|Overall Study|Other|0|||
105611676|NCT05034952|364243724|FG003|Overall Study|Other|1|||
105611677|NCT00961571|364243727|FG000|Overall Study|Physician Decision|39|||
105611678|NCT00170573|364243735|FG000|Overall Study|Violation of inclusion criteria|13|||
105611679|NCT05563246|364243746|FG000|Overall Study|Withdrawal by Subject|1|||
105611680|NCT05563246|364243747|FG001|Overall Study|Withdrawal by Subject|2|||
105611681|NCT05563246|364243748|FG002|Overall Study|Withdrawal by Subject|0|||
105611682|NCT05563246|364243749|FG003|Overall Study|Withdrawal by Subject|0|||
105611683|NCT05563246|364243746|FG000|Overall Study|Protocol Deviation|0|||
105611684|NCT05563246|364243747|FG001|Overall Study|Protocol Deviation|1|||
105611685|NCT05563246|364243748|FG002|Overall Study|Protocol Deviation|0|||
105611686|NCT05563246|364243749|FG003|Overall Study|Protocol Deviation|0|||
105611687|NCT05563246|364243746|FG000|Overall Study|Physician Decision|0|||
105611688|NCT05563246|364243747|FG001|Overall Study|Physician Decision|1|||
105611689|NCT05563246|364243748|FG002|Overall Study|Physician Decision|0|||
105611690|NCT05563246|364243749|FG003|Overall Study|Physician Decision|0|||
105611691|NCT05563246|364243746|FG000|Overall Study|Adverse Event|0|||
105611692|NCT05563246|364243747|FG001|Overall Study|Adverse Event|0|||
105611693|NCT05563246|364243748|FG002|Overall Study|Adverse Event|2|||
105611694|NCT05563246|364243749|FG003|Overall Study|Adverse Event|0|||
105611695|NCT05563246|364243746|FG000|Overall Study|Lost to Follow-up|0|||
105611696|NCT05563246|364243747|FG001|Overall Study|Lost to Follow-up|0|||
105611697|NCT05563246|364243748|FG002|Overall Study|Lost to Follow-up|1|||
105611698|NCT05563246|364243749|FG003|Overall Study|Lost to Follow-up|0|||
105611699|NCT04784559|364243754|FG000|Overall Study|Withdrawal by Subject|3|||
105611700|NCT04784559|364243755|FG001|Overall Study|Withdrawal by Subject|2|||
105611701|NCT04784559|364243756|FG002|Overall Study|Withdrawal by Subject|1|||
105611702|NCT04784559|364243754|FG000|Overall Study|Death|2|||
105611703|NCT04784559|364243755|FG001|Overall Study|Death|1|||
105611704|NCT04784559|364243756|FG002|Overall Study|Death|2|||
105611705|NCT04784559|364243754|FG000|Overall Study|Lost to Follow-up|0|||
105611706|NCT04784559|364243755|FG001|Overall Study|Lost to Follow-up|0|||
105611707|NCT04784559|364243756|FG002|Overall Study|Lost to Follow-up|2|||
105611708|NCT04784559|364243754|FG000|Overall Study|Participant worsened, PI decision|1|||
105611709|NCT04784559|364243755|FG001|Overall Study|Participant worsened, PI decision|0|||
105611710|NCT04784559|364243756|FG002|Overall Study|Participant worsened, PI decision|0|||
105611711|NCT04784559|364243754|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
105611712|NCT04784559|364243755|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
105611713|NCT04784559|364243756|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
105611714|NCT04784559|364243754|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
105611715|NCT04784559|364243755|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
105611716|NCT04784559|364243756|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
105611717|NCT04784559|364243754|FG000|Overall Study|Did not meet all inclusion criteria|0|||
105611718|NCT04784559|364243755|FG001|Overall Study|Did not meet all inclusion criteria|1|||
105611719|NCT04784559|364243756|FG002|Overall Study|Did not meet all inclusion criteria|0|||
105611720|NCT04784559|364243754|FG000|Overall Study|The participant was transferred to IRCU|0|||
105611721|NCT04784559|364243755|FG001|Overall Study|The participant was transferred to IRCU|1|||
105611722|NCT04784559|364243756|FG002|Overall Study|The participant was transferred to IRCU|0|||
105611723|NCT04784559|364243754|FG000|Overall Study|SAE|0|||
105611724|NCT04784559|364243755|FG001|Overall Study|SAE|1|||
105611725|NCT04784559|364243756|FG002|Overall Study|SAE|0|||
105611726|NCT04784559|364243754|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
105611727|NCT04784559|364243755|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
105611728|NCT04784559|364243756|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
105611729|NCT01580488|364243759|FG000|Overall Study|Withdrawal by Subject|1|||
105611730|NCT04936035|364243760|FG000|Overall Study|Adverse Event|0|||
105611731|NCT04936035|364243761|FG001|Overall Study|Adverse Event|1|||
105611732|NCT04936035|364243762|FG002|Overall Study|Adverse Event|0|||
105611733|NCT04936035|364243763|FG003|Overall Study|Adverse Event|0|||
105611734|NCT04936035|364243764|FG004|Overall Study|Adverse Event|0|||
105611735|NCT04936035|364243760|FG000|Overall Study|Death|0|||
105611736|NCT04936035|364243761|FG001|Overall Study|Death|0|||
105611737|NCT04936035|364243762|FG002|Overall Study|Death|0|||
105611738|NCT04936035|364243763|FG003|Overall Study|Death|1|||
105611739|NCT04936035|364243764|FG004|Overall Study|Death|0|||
105611740|NCT04936035|364243760|FG000|Overall Study|Lost to Follow-up|0|||
105611741|NCT04936035|364243761|FG001|Overall Study|Lost to Follow-up|1|||
105611742|NCT04936035|364243762|FG002|Overall Study|Lost to Follow-up|1|||
105611743|NCT04936035|364243763|FG003|Overall Study|Lost to Follow-up|2|||
105611744|NCT04936035|364243764|FG004|Overall Study|Lost to Follow-up|1|||
105611745|NCT04936035|364243760|FG000|Overall Study|Physician Decision|0|||
105611746|NCT04936035|364243761|FG001|Overall Study|Physician Decision|1|||
105611747|NCT04936035|364243762|FG002|Overall Study|Physician Decision|0|||
105611748|NCT04936035|364243763|FG003|Overall Study|Physician Decision|0|||
105611749|NCT04936035|364243764|FG004|Overall Study|Physician Decision|0|||
105611750|NCT04936035|364243760|FG000|Overall Study|Protocol Deviation|0|||
105611751|NCT04936035|364243761|FG001|Overall Study|Protocol Deviation|0|||
105611752|NCT04936035|364243762|FG002|Overall Study|Protocol Deviation|1|||
105611753|NCT04936035|364243763|FG003|Overall Study|Protocol Deviation|0|||
105611754|NCT04936035|364243764|FG004|Overall Study|Protocol Deviation|0|||
105611755|NCT04936035|364243760|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
105611756|NCT04936035|364243761|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
105611757|NCT04936035|364243762|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
105611758|NCT04936035|364243763|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
105611759|NCT04936035|364243764|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
105611760|NCT04936035|364243760|FG000|Overall Study|Reason Unknown|0|||
105611761|NCT04936035|364243761|FG001|Overall Study|Reason Unknown|0|||
105611762|NCT04936035|364243762|FG002|Overall Study|Reason Unknown|0|||
105611763|NCT04936035|364243763|FG003|Overall Study|Reason Unknown|0|||
105611764|NCT04936035|364243764|FG004|Overall Study|Reason Unknown|1|||
105611765|NCT04936035|364243760|FG000|Overall Study|Withdrawal by Subject|1|||
105611766|NCT04936035|364243761|FG001|Overall Study|Withdrawal by Subject|0|||
105611767|NCT04936035|364243762|FG002|Overall Study|Withdrawal by Subject|0|||
105611768|NCT04936035|364243763|FG003|Overall Study|Withdrawal by Subject|0|||
105611769|NCT04936035|364243764|FG004|Overall Study|Withdrawal by Subject|0|||
105611770|NCT04936035|364243760|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
105611771|NCT04936035|364243761|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
105611772|NCT04936035|364243762|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
105611773|NCT04936035|364243763|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
105611774|NCT04936035|364243764|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
105611775|NCT04936035|364243760|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
105611776|NCT04936035|364243761|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
105611777|NCT04936035|364243762|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
105611778|NCT04936035|364243763|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
105611779|NCT04936035|364243764|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
105611780|NCT04936035|364243760|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
105611781|NCT04936035|364243761|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
105611782|NCT04936035|364243762|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
105611783|NCT04936035|364243763|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
105611784|NCT04936035|364243764|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
105611785|NCT03366649|364243767|FG000|Overall Study|Failed preoperative screening|4|||
105611786|NCT03366649|364243768|FG001|Overall Study|Failed preoperative screening|0|||
105611787|NCT03366649|364243769|FG002|Overall Study|Failed preoperative screening|0|||
105611788|NCT03366649|364243767|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
105611789|NCT03366649|364243768|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
105611790|NCT03366649|364243769|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
105611791|NCT03673111|364243771|FG000|Overall Study|Protocol Violation|0|||
105611792|NCT03673111|364243772|FG001|Overall Study|Protocol Violation|0|||
105611793|NCT03673111|364243773|FG002|Overall Study|Protocol Violation|0|||
105611794|NCT03673111|364243774|FG003|Overall Study|Protocol Violation|0|||
105611795|NCT03673111|364243775|FG004|Overall Study|Protocol Violation|0|||
105611796|NCT03673111|364243776|FG005|Overall Study|Protocol Violation|0|||
105611797|NCT03673111|364243777|FG006|Overall Study|Protocol Violation|0|||
105611798|NCT03673111|364243778|FG007|Overall Study|Protocol Violation|0|||
105611799|NCT03673111|364243779|FG008|Overall Study|Protocol Violation|0|||
105611800|NCT03673111|364243780|FG009|Overall Study|Protocol Violation|0|||
105611801|NCT03673111|364243781|FG010|Overall Study|Protocol Violation|1|||
105611802|NCT03673111|364243782|FG011|Overall Study|Protocol Violation|0|||
105611803|NCT03673111|364243783|FG012|Overall Study|Protocol Violation|0|||
105611804|NCT03673111|364243784|FG013|Overall Study|Protocol Violation|0|||
105611805|NCT03673111|364243771|FG000|Overall Study|Adverse Event|1|||
105611806|NCT03673111|364243772|FG001|Overall Study|Adverse Event|0|||
105611807|NCT03673111|364243773|FG002|Overall Study|Adverse Event|0|||
105611808|NCT03673111|364243774|FG003|Overall Study|Adverse Event|0|||
105611809|NCT03673111|364243775|FG004|Overall Study|Adverse Event|0|||
105611810|NCT03673111|364243776|FG005|Overall Study|Adverse Event|0|||
105611811|NCT03673111|364243777|FG006|Overall Study|Adverse Event|0|||
105611812|NCT03673111|364243778|FG007|Overall Study|Adverse Event|0|||
105611813|NCT03673111|364243779|FG008|Overall Study|Adverse Event|0|||
105611814|NCT03673111|364243780|FG009|Overall Study|Adverse Event|0|||
105611815|NCT03673111|364243781|FG010|Overall Study|Adverse Event|0|||
105611816|NCT03673111|364243782|FG011|Overall Study|Adverse Event|0|||
105611817|NCT03673111|364243783|FG012|Overall Study|Adverse Event|0|||
105611818|NCT03673111|364243784|FG013|Overall Study|Adverse Event|0|||
105611819|NCT03792555|364243788|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
105611820|NCT03792555|364243789|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
105611821|NCT03792555|364243790|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
105611822|NCT03792555|364243788|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
105611823|NCT03792555|364243789|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
105611824|NCT03792555|364243790|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
105611825|NCT03792555|364243788|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
105611826|NCT03792555|364243789|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
105611827|NCT03792555|364243790|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
105611828|NCT04485039|364243794|FG000|TPOXX Only|Adverse Event|2|||
105611829|NCT04485039|364243794|FG000|TPOXX Only|Physician Decision|1|||
105611830|NCT04485039|364243794|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
105611831|NCT04485039|364243794|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
105611832|NCT04005716|364243795|FG000|Overall Study|Death|175|||
105611833|NCT04005716|364243796|FG001|Overall Study|Death|196|||
105611834|NCT04005716|364243795|FG000|Overall Study|Withdrawal by Subject|1|||
105611835|NCT04005716|364243796|FG001|Overall Study|Withdrawal by Subject|6|||
105611836|NCT04005716|364243795|FG000|Overall Study|Lost to Follow-up|2|||
105611837|NCT04005716|364243796|FG001|Overall Study|Lost to Follow-up|2|||
105611838|NCT03892616|364243797|FG000|Washout Period 2|Met discontinuation criterion|0|||
105611839|NCT03892616|364243798|FG001|Washout Period 2|Met discontinuation criterion|0|||
105611840|NCT03892616|364243799|FG002|Washout Period 2|Met discontinuation criterion|0|||
105611841|NCT03892616|364243800|FG003|Washout Period 2|Met discontinuation criterion|0|||
105611842|NCT03892616|364243801|FG004|Washout Period 2|Met discontinuation criterion|0|||
105611843|NCT03892616|364243802|FG005|Washout Period 2|Met discontinuation criterion|0|||
105611844|NCT03892616|364243803|FG006|Washout Period 2|Met discontinuation criterion|0|||
105611845|NCT03892616|364243804|FG007|Washout Period 2|Met discontinuation criterion|0|||
105611846|NCT03892616|364243805|FG008|Washout Period 2|Met discontinuation criterion|1|||
105611847|NCT03892616|364243806|FG009|Washout Period 2|Met discontinuation criterion|0|||
105611848|NCT03892616|364243807|FG010|Washout Period 2|Met discontinuation criterion|0|||
105611849|NCT03892616|364243808|FG011|Washout Period 2|Met discontinuation criterion|0|||
105611850|NCT00378105|364243810|FG000|Overall Study|Adverse Event|3|||
105611851|NCT00378105|364243811|FG001|Overall Study|Adverse Event|1|||
105611852|NCT00378105|364243810|FG000|Overall Study|Withdrawal by Subject|3|||
105611853|NCT00378105|364243811|FG001|Overall Study|Withdrawal by Subject|3|||
105611854|NCT00378105|364243810|FG000|Overall Study|Death|1|||
105611855|NCT00378105|364243811|FG001|Overall Study|Death|0|||
105611856|NCT00378105|364243810|FG000|Overall Study|Going to transplant|7|||
105611857|NCT00378105|364243811|FG001|Overall Study|Going to transplant|8|||
105611858|NCT00378105|364243810|FG000|Overall Study|Progressive disease|3|||
105611859|NCT00378105|364243811|FG001|Overall Study|Progressive disease|3|||
105611860|NCT00378105|364243810|FG000|Overall Study|remain on study|3|||
105611861|NCT00378105|364243811|FG001|Overall Study|remain on study|11|||
105611862|NCT00378105|364243810|FG000|Overall Study|Physician Decision|0|||
105611863|NCT00378105|364243811|FG001|Overall Study|Physician Decision|2|||
105611864|NCT00378105|364243810|FG000|Overall Study|Going non-protocol therapy|0|||
105611865|NCT00378105|364243811|FG001|Overall Study|Going non-protocol therapy|1|||
105611866|NCT00378105|364243810|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
105611867|NCT00378105|364243811|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
105611868|NCT02120456|364243812|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
105611869|NCT02120456|364243813|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
105611870|NCT02120456|364243814|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
105611871|NCT02120456|364243815|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
105611872|NCT02120456|364243816|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
105611873|NCT02120456|364243817|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
105611874|NCT02120456|364243818|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
105611875|NCT02120456|364243819|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
105611876|NCT02120456|364243820|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
105611877|NCT02120456|364243812|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
105611878|NCT02120456|364243813|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
105611879|NCT02120456|364243814|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
105611880|NCT02120456|364243815|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
105611881|NCT02120456|364243816|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
105611882|NCT02120456|364243817|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
105611883|NCT02120456|364243818|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
105611884|NCT02120456|364243819|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
105611885|NCT02120456|364243820|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
105611886|NCT02120456|364243812|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
105611887|NCT02120456|364243813|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
105611888|NCT02120456|364243814|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
105611889|NCT02120456|364243815|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
105611890|NCT02120456|364243816|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
105611891|NCT02120456|364243817|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
105611892|NCT02120456|364243818|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
105611893|NCT02120456|364243819|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
105611894|NCT02120456|364243820|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
105611895|NCT05192200|364243821|FG000|Treatment Period|Other|1|||
105611896|NCT05192200|364243821|FG000|Treatment Period|Lack of Efficacy|1|||
105611897|NCT05192200|364243821|FG000|Treatment Period|Withdrawal by Subject|1|||
105611898|NCT05192200|364243821|FG000|Follow-up|Withdrawal by Subject|1|||
105611899|NCT04241068|364243823|FG000|Core Treatment Period|Adverse Event|91|||
105611900|NCT04241068|364243823|FG000|Core Treatment Period|Change of Treatment|4|||
105611901|NCT04241068|364243823|FG000|Core Treatment Period|Consent Withdrawn|143|||
105611902|NCT04241068|364243823|FG000|Core Treatment Period|Death|26|||
105611903|NCT04241068|364243823|FG000|Core Treatment Period|Disease Progression|67|||
105611904|NCT04241068|364243823|FG000|Core Treatment Period|Investigator Decision|40|||
105611905|NCT04241068|364243823|FG000|Core Treatment Period|Loss of Capacity|9|||
105611906|NCT04241068|364243823|FG000|Core Treatment Period|Lost to Follow-up|11|||
105611907|NCT04241068|364243823|FG000|Core Treatment Period|Relocation|4|||
105611908|NCT04241068|364243823|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
105611909|NCT04241068|364243823|FG000|Core Treatment Period|Study Visit Burden|40|||
105611910|NCT04241068|364243823|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
105611911|NCT04241068|364243823|FG000|Core Treatment Period|Missing|2|||
105611912|NCT04241068|364243823|FG000|Core Treatment Period|Reason Not Specified|41|||
105611913|NCT04241068|364243823|FG000|LTE Period|Adverse Event|19|||
105611914|NCT04241068|364243823|FG000|LTE Period|Change of Treatment|1|||
105611915|NCT04241068|364243823|FG000|LTE Period|Consent Withdrawn|71|||
105611916|NCT04241068|364243823|FG000|LTE Period|Death|8|||
105611917|NCT04241068|364243823|FG000|LTE Period|Disease Progression|11|||
105611918|NCT04241068|364243823|FG000|LTE Period|Investigator Decision|12|||
105611919|NCT04241068|364243823|FG000|LTE Period|Loss of Capacity|2|||
105611920|NCT04241068|364243823|FG000|LTE Period|Lost to Follow-up|7|||
105611921|NCT04241068|364243823|FG000|LTE Period|Relocation|6|||
105611922|NCT04241068|364243823|FG000|LTE Period|Site Terminated by Sponsor|26|||
105611923|NCT04241068|364243823|FG000|LTE Period|Study Terminated by Sponsor|276|||
105611924|NCT04241068|364243823|FG000|LTE Period|Study Visit Burden|10|||
105611925|NCT04241068|364243823|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
105611926|NCT04241068|364243823|FG000|LTE Period|Reason Not Specified|65|||
105611927|NCT01785719|364243827|FG000|4-week Baseline Evaluation|Physician Decision|1|||
105611928|NCT01785719|364243828|FG001|4-week Baseline Evaluation|Physician Decision|0|||
105611929|NCT01785719|364243827|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
105611930|NCT01785719|364243828|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
105611931|NCT01785719|364243827|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
105611932|NCT01785719|364243828|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
105611933|NCT01785719|364243827|FG000|4-week Baseline Evaluation|Pregnancy|0|||
105611934|NCT01785719|364243828|FG001|4-week Baseline Evaluation|Pregnancy|2|||
105611935|NCT01785719|364243827|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
105611936|NCT01785719|364243828|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
105611937|NCT01785719|364243827|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
105611938|NCT01785719|364243828|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
105611939|NCT01785719|364243827|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
105611940|NCT01785719|364243828|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
105611941|NCT01785719|364243827|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
105611942|NCT01785719|364243828|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
105611943|NCT01785719|364243827|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
105611944|NCT01785719|364243828|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
105611945|NCT01785719|364243827|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
105611946|NCT01785719|364243828|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
105611947|NCT01785719|364243827|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
105611948|NCT01785719|364243828|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
105611949|NCT01785719|364243827|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
105611950|NCT01785719|364243828|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
105611951|NCT01785719|364243827|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
105611952|NCT01785719|364243828|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
105611953|NCT01785719|364243827|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
105611954|NCT01785719|364243828|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
105611955|NCT01785719|364243827|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
105611956|NCT01785719|364243828|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
105611957|NCT03443323|364243829|FG000|Overall Study|Lost to Follow-up|2|||
105611958|NCT03443323|364243830|FG001|Overall Study|Lost to Follow-up|2|||
105611959|NCT03443323|364243829|FG000|Overall Study|PI withdrawal|1|||
105611960|NCT03443323|364243830|FG001|Overall Study|PI withdrawal|0|||
105611961|NCT04831216|364243837|FG000|Overall Study|Lost to Follow-up|32|||
105611962|NCT02913872|364243840|FG000|Overall Study|Withdrawal by Subject|1|||
105611963|NCT04391894|364243841|FG000|Overall Study|Adverse Event|1|||
105611964|NCT04391894|364243842|FG001|Overall Study|Adverse Event|1|||
105611965|NCT04391894|364243843|FG002|Overall Study|Adverse Event|1|||
105611966|NCT04391894|364243844|FG003|Overall Study|Adverse Event|1|||
105611967|NCT04391894|364243845|FG004|Overall Study|Adverse Event|1|||
105611968|NCT04391894|364243841|FG000|Overall Study|Lost to Follow-up|1|||
105611969|NCT04391894|364243842|FG001|Overall Study|Lost to Follow-up|0|||
105611970|NCT04391894|364243843|FG002|Overall Study|Lost to Follow-up|0|||
105611971|NCT04391894|364243844|FG003|Overall Study|Lost to Follow-up|0|||
105611972|NCT04391894|364243845|FG004|Overall Study|Lost to Follow-up|0|||
105611973|NCT04391894|364243841|FG000|Overall Study|Protocol Violation|0|||
105611974|NCT04391894|364243842|FG001|Overall Study|Protocol Violation|0|||
105611975|NCT04391894|364243843|FG002|Overall Study|Protocol Violation|0|||
105611976|NCT04391894|364243844|FG003|Overall Study|Protocol Violation|1|||
105611977|NCT04391894|364243845|FG004|Overall Study|Protocol Violation|0|||
105611978|NCT04391894|364243841|FG000|Overall Study|Withdrawal by Subject|2|||
105611979|NCT04391894|364243842|FG001|Overall Study|Withdrawal by Subject|0|||
105611980|NCT04391894|364243843|FG002|Overall Study|Withdrawal by Subject|3|||
105611981|NCT04391894|364243844|FG003|Overall Study|Withdrawal by Subject|0|||
105611982|NCT04391894|364243845|FG004|Overall Study|Withdrawal by Subject|1|||
105611983|NCT04391894|364243841|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
105611984|NCT04391894|364243842|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
105611985|NCT04391894|364243843|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
105611986|NCT04391894|364243844|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
105611987|NCT04391894|364243845|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
105611988|NCT02323321|364243846|FG000|Overall Study|Re-Transplant|1|||
105611989|NCT02323321|364243846|FG000|Overall Study|Death|12|||
105611990|NCT00446225|364243847|FG000|Overall Study|Protocol Violation|1|||
105611991|NCT00446225|364243848|FG001|Overall Study|Protocol Violation|0|||
105611992|NCT03150810|364243849|FG000|Overall Study|Death|4|||
105611993|NCT03150810|364243850|FG001|Overall Study|Death|8|||
105611994|NCT03150810|364243851|FG002|Overall Study|Death|7|||
105611995|NCT03150810|364243852|FG003|Overall Study|Death|2|||
105611996|NCT03150810|364243853|FG004|Overall Study|Death|2|||
105611997|NCT03150810|364243854|FG005|Overall Study|Death|10|||
105611998|NCT03150810|364243855|FG006|Overall Study|Death|8|||
105611999|NCT03150810|364243856|FG007|Overall Study|Death|6|||
105612000|NCT03150810|364243857|FG008|Overall Study|Death|18|||
105612001|NCT03150810|364243858|FG009|Overall Study|Death|3|||
105612002|NCT03150810|364243859|FG010|Overall Study|Death|19|||
105612003|NCT03150810|364243860|FG011|Overall Study|Death|1|||
105612004|NCT03150810|364243861|FG012|Overall Study|Death|19|||
105612005|NCT03150810|364243849|FG000|Overall Study|Withdrawal by Subject|0|||
105612006|NCT03150810|364243850|FG001|Overall Study|Withdrawal by Subject|1|||
105612007|NCT03150810|364243851|FG002|Overall Study|Withdrawal by Subject|1|||
105612008|NCT03150810|364243852|FG003|Overall Study|Withdrawal by Subject|1|||
105612009|NCT03150810|364243853|FG004|Overall Study|Withdrawal by Subject|0|||
105612010|NCT03150810|364243854|FG005|Overall Study|Withdrawal by Subject|0|||
105612011|NCT03150810|364243855|FG006|Overall Study|Withdrawal by Subject|2|||
105612012|NCT03150810|364243856|FG007|Overall Study|Withdrawal by Subject|0|||
105612013|NCT03150810|364243857|FG008|Overall Study|Withdrawal by Subject|2|||
105612014|NCT03150810|364243858|FG009|Overall Study|Withdrawal by Subject|0|||
105612015|NCT03150810|364243859|FG010|Overall Study|Withdrawal by Subject|1|||
105612016|NCT03150810|364243860|FG011|Overall Study|Withdrawal by Subject|0|||
105612017|NCT03150810|364243861|FG012|Overall Study|Withdrawal by Subject|1|||
105612018|NCT03150810|364243849|FG000|Overall Study|Sponsor Decision|0|||
105612019|NCT03150810|364243850|FG001|Overall Study|Sponsor Decision|2|||
105612020|NCT03150810|364243851|FG002|Overall Study|Sponsor Decision|0|||
105612021|NCT03150810|364243852|FG003|Overall Study|Sponsor Decision|0|||
105612022|NCT03150810|364243853|FG004|Overall Study|Sponsor Decision|1|||
105612023|NCT03150810|364243854|FG005|Overall Study|Sponsor Decision|1|||
105612024|NCT03150810|364243855|FG006|Overall Study|Sponsor Decision|0|||
105612025|NCT03150810|364243856|FG007|Overall Study|Sponsor Decision|0|||
105612026|NCT03150810|364243857|FG008|Overall Study|Sponsor Decision|1|||
105612027|NCT03150810|364243858|FG009|Overall Study|Sponsor Decision|0|||
105612028|NCT03150810|364243859|FG010|Overall Study|Sponsor Decision|0|||
105612029|NCT03150810|364243860|FG011|Overall Study|Sponsor Decision|0|||
105612030|NCT03150810|364243861|FG012|Overall Study|Sponsor Decision|5|||
105612031|NCT03150810|364243849|FG000|Overall Study|Lost to Follow-up|0|||
105612032|NCT03150810|364243850|FG001|Overall Study|Lost to Follow-up|1|||
105612033|NCT03150810|364243851|FG002|Overall Study|Lost to Follow-up|1|||
105612034|NCT03150810|364243852|FG003|Overall Study|Lost to Follow-up|0|||
105612035|NCT03150810|364243853|FG004|Overall Study|Lost to Follow-up|0|||
105612036|NCT03150810|364243854|FG005|Overall Study|Lost to Follow-up|0|||
105612037|NCT03150810|364243855|FG006|Overall Study|Lost to Follow-up|1|||
105612038|NCT03150810|364243856|FG007|Overall Study|Lost to Follow-up|0|||
105612039|NCT03150810|364243857|FG008|Overall Study|Lost to Follow-up|0|||
105612040|NCT03150810|364243858|FG009|Overall Study|Lost to Follow-up|0|||
105612041|NCT03150810|364243859|FG010|Overall Study|Lost to Follow-up|1|||
105612042|NCT03150810|364243860|FG011|Overall Study|Lost to Follow-up|0|||
105612043|NCT03150810|364243861|FG012|Overall Study|Lost to Follow-up|0|||
105612044|NCT03150810|364243849|FG000|Overall Study|Physician Decision|0|||
105612045|NCT03150810|364243850|FG001|Overall Study|Physician Decision|0|||
105612046|NCT03150810|364243851|FG002|Overall Study|Physician Decision|0|||
105612047|NCT03150810|364243852|FG003|Overall Study|Physician Decision|0|||
105612048|NCT03150810|364243853|FG004|Overall Study|Physician Decision|0|||
105612049|NCT03150810|364243854|FG005|Overall Study|Physician Decision|1|||
105612050|NCT03150810|364243855|FG006|Overall Study|Physician Decision|1|||
105612051|NCT03150810|364243856|FG007|Overall Study|Physician Decision|0|||
105612052|NCT03150810|364243857|FG008|Overall Study|Physician Decision|0|||
105612053|NCT03150810|364243858|FG009|Overall Study|Physician Decision|0|||
105612054|NCT03150810|364243859|FG010|Overall Study|Physician Decision|0|||
105612055|NCT03150810|364243860|FG011|Overall Study|Physician Decision|0|||
105612056|NCT03150810|364243861|FG012|Overall Study|Physician Decision|0|||
105612057|NCT03150810|364243849|FG000|Overall Study|Site withdrawal from study|0|||
105612058|NCT03150810|364243850|FG001|Overall Study|Site withdrawal from study|1|||
105612059|NCT03150810|364243851|FG002|Overall Study|Site withdrawal from study|0|||
105612060|NCT03150810|364243852|FG003|Overall Study|Site withdrawal from study|0|||
105612061|NCT03150810|364243853|FG004|Overall Study|Site withdrawal from study|0|||
105612062|NCT03150810|364243854|FG005|Overall Study|Site withdrawal from study|0|||
105612063|NCT03150810|364243855|FG006|Overall Study|Site withdrawal from study|0|||
105612064|NCT03150810|364243856|FG007|Overall Study|Site withdrawal from study|0|||
105612065|NCT03150810|364243857|FG008|Overall Study|Site withdrawal from study|0|||
105612066|NCT03150810|364243858|FG009|Overall Study|Site withdrawal from study|1|||
105612067|NCT03150810|364243859|FG010|Overall Study|Site withdrawal from study|1|||
105612068|NCT03150810|364243860|FG011|Overall Study|Site withdrawal from study|0|||
105612069|NCT03150810|364243861|FG012|Overall Study|Site withdrawal from study|0|||
105612070|NCT03150810|364243849|FG000|Overall Study|Hospice|0|||
105612071|NCT03150810|364243850|FG001|Overall Study|Hospice|0|||
105612072|NCT03150810|364243851|FG002|Overall Study|Hospice|0|||
105612073|NCT03150810|364243852|FG003|Overall Study|Hospice|0|||
105612074|NCT03150810|364243853|FG004|Overall Study|Hospice|0|||
105612075|NCT03150810|364243854|FG005|Overall Study|Hospice|1|||
105612076|NCT03150810|364243855|FG006|Overall Study|Hospice|0|||
105612077|NCT03150810|364243856|FG007|Overall Study|Hospice|0|||
105612078|NCT03150810|364243857|FG008|Overall Study|Hospice|0|||
105612079|NCT03150810|364243858|FG009|Overall Study|Hospice|0|||
105612080|NCT03150810|364243859|FG010|Overall Study|Hospice|0|||
105612081|NCT03150810|364243860|FG011|Overall Study|Hospice|0|||
105612082|NCT03150810|364243861|FG012|Overall Study|Hospice|0|||
105612083|NCT03150810|364243849|FG000|Overall Study|Participant relocated abroad.|0|||
105612084|NCT03150810|364243850|FG001|Overall Study|Participant relocated abroad.|0|||
105612085|NCT03150810|364243851|FG002|Overall Study|Participant relocated abroad.|0|||
105612086|NCT03150810|364243852|FG003|Overall Study|Participant relocated abroad.|0|||
105612087|NCT03150810|364243853|FG004|Overall Study|Participant relocated abroad.|0|||
105612088|NCT03150810|364243854|FG005|Overall Study|Participant relocated abroad.|1|||
105612089|NCT03150810|364243855|FG006|Overall Study|Participant relocated abroad.|0|||
105612090|NCT03150810|364243856|FG007|Overall Study|Participant relocated abroad.|0|||
105612091|NCT03150810|364243857|FG008|Overall Study|Participant relocated abroad.|0|||
105612092|NCT03150810|364243858|FG009|Overall Study|Participant relocated abroad.|0|||
105612093|NCT03150810|364243859|FG010|Overall Study|Participant relocated abroad.|0|||
105612094|NCT03150810|364243860|FG011|Overall Study|Participant relocated abroad.|0|||
105612095|NCT03150810|364243861|FG012|Overall Study|Participant relocated abroad.|0|||
105612096|NCT03150810|364243849|FG000|Overall Study|Transferred care to oncologist|0|||
105612097|NCT03150810|364243850|FG001|Overall Study|Transferred care to oncologist|0|||
105612098|NCT03150810|364243851|FG002|Overall Study|Transferred care to oncologist|0|||
105612099|NCT03150810|364243852|FG003|Overall Study|Transferred care to oncologist|0|||
105612100|NCT03150810|364243853|FG004|Overall Study|Transferred care to oncologist|0|||
105612101|NCT03150810|364243854|FG005|Overall Study|Transferred care to oncologist|0|||
105612102|NCT03150810|364243855|FG006|Overall Study|Transferred care to oncologist|2|||
105612103|NCT03150810|364243856|FG007|Overall Study|Transferred care to oncologist|0|||
105612104|NCT03150810|364243857|FG008|Overall Study|Transferred care to oncologist|0|||
105612105|NCT03150810|364243858|FG009|Overall Study|Transferred care to oncologist|0|||
105612106|NCT03150810|364243859|FG010|Overall Study|Transferred care to oncologist|0|||
105612107|NCT03150810|364243860|FG011|Overall Study|Transferred care to oncologist|0|||
105612108|NCT03150810|364243861|FG012|Overall Study|Transferred care to oncologist|0|||
105612109|NCT04925986|364243862|FG000|Overall Study|Death|0|||
105612110|NCT04925986|364243863|FG001|Overall Study|Death|0|||
105612111|NCT04925986|364243864|FG002|Overall Study|Death|2|||
105612112|NCT04925986|364243865|FG003|Overall Study|Death|0|||
105612113|NCT04925986|364243862|FG000|Overall Study|Lack of Efficacy|1|||
105612114|NCT04925986|364243863|FG001|Overall Study|Lack of Efficacy|2|||
105612115|NCT04925986|364243864|FG002|Overall Study|Lack of Efficacy|0|||
105612116|NCT04925986|364243865|FG003|Overall Study|Lack of Efficacy|1|||
105612117|NCT04925986|364243862|FG000|Overall Study|Withdrawal by Subject|0|||
105612118|NCT04925986|364243863|FG001|Overall Study|Withdrawal by Subject|0|||
105612119|NCT04925986|364243864|FG002|Overall Study|Withdrawal by Subject|1|||
105612120|NCT04925986|364243865|FG003|Overall Study|Withdrawal by Subject|2|||
105612121|NCT05351554|364243869|FG000|Overall Study|Study terminated by sponsor|1|||
105612122|NCT05093829|364243870|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
105612123|NCT05093829|364243871|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
105612124|NCT05093829|364243872|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
105612125|NCT05093829|364243873|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
105612126|NCT05093829|364243874|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
105612127|NCT05302596|364243875|FG000|Overall Study|Withdrawal by Subject|1|||
105612128|NCT05302596|364243876|FG001|Overall Study|Withdrawal by Subject|1|||
105612129|NCT03779204|364245852|FG000|Overall Study|Lost to Follow-up|2|||
105612130|NCT03779204|364245853|FG001|Overall Study|Lost to Follow-up|0|||
105612131|NCT02954341|364245854|FG000|Overall Study|Attempted Implant unsuccessful|5|||
105612132|NCT02954341|364245854|FG000|Overall Study|Death|90|||
105612133|NCT02954341|364245854|FG000|Overall Study|Withdrawal by Subject|4|||
105612134|NCT02954341|364245854|FG000|Overall Study|Physician Decision|13|||
105612135|NCT02954341|364245854|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
105612136|NCT02954341|364245854|FG000|Overall Study|Not implanted due to physician's decision|1|||
105612137|NCT02954341|364245854|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
105612138|NCT05227209|364245858|FG000|Overall Study|Adverse Event|11|||
105612139|NCT05227209|364245858|FG000|Overall Study|Lost to Follow-up|1|||
105612140|NCT05227209|364245858|FG000|Overall Study|Withdrawal by Subject|7|||
105612141|NCT05227209|364245858|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
105612142|NCT03056755|364245860|FG000|Treatment- Core Phase|Progressive disease|89|||
105612143|NCT03056755|364245861|FG001|Treatment- Core Phase|Progressive disease|88|||
105612144|NCT03056755|364245862|FG002|Treatment- Core Phase|Progressive disease|90|||
105612145|NCT03056755|364245860|FG000|Treatment- Core Phase|Adverse Event|20|||
105612146|NCT03056755|364245861|FG001|Treatment- Core Phase|Adverse Event|14|||
105612147|NCT03056755|364245862|FG002|Treatment- Core Phase|Adverse Event|13|||
105612148|NCT03056755|364245860|FG000|Treatment- Core Phase|Physician Decision|7|||
105612149|NCT03056755|364245861|FG001|Treatment- Core Phase|Physician Decision|13|||
105612150|NCT03056755|364245862|FG002|Treatment- Core Phase|Physician Decision|5|||
105612151|NCT03056755|364245860|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
105612152|NCT03056755|364245861|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
105612153|NCT03056755|364245862|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
105612154|NCT03056755|364245860|FG000|Treatment- Core Phase|Death|3|||
105612155|NCT03056755|364245861|FG001|Treatment- Core Phase|Death|2|||
105612156|NCT03056755|364245862|FG002|Treatment- Core Phase|Death|4|||
105612157|NCT03056755|364245860|FG000|Treatment- Core Phase|Protocol deviation|1|||
105612158|NCT03056755|364245861|FG001|Treatment- Core Phase|Protocol deviation|1|||
105612159|NCT03056755|364245862|FG002|Treatment- Core Phase|Protocol deviation|0|||
105612160|NCT03056755|364245860|FG000|Treatment- Core Phase|Technical problems|1|||
105612161|NCT03056755|364245861|FG001|Treatment- Core Phase|Technical problems|0|||
105612162|NCT03056755|364245862|FG002|Treatment- Core Phase|Technical problems|0|||
105612163|NCT03056755|364245860|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
105612164|NCT03056755|364245861|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
105612165|NCT03056755|364245862|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
105612166|NCT03056755|364245860|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
105612167|NCT03056755|364245861|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
105612168|NCT03056755|364245862|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
105612169|NCT03056755|364245860|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
105612170|NCT03056755|364245861|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
105612171|NCT03056755|364245862|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
105612172|NCT03056755|364245860|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
105612173|NCT03056755|364245861|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
105612174|NCT03056755|364245862|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
105612175|NCT05273749|364245863|FG000|Overall Study|Adverse Event|14|||
105612176|NCT05273749|364245864|FG001|Overall Study|Adverse Event|8|||
105612177|NCT05273749|364245863|FG000|Overall Study|Lack of Efficacy|2|||
105612178|NCT05273749|364245864|FG001|Overall Study|Lack of Efficacy|8|||
105612179|NCT05273749|364245863|FG000|Overall Study|Physician Decision|0|||
105612180|NCT05273749|364245864|FG001|Overall Study|Physician Decision|2|||
105612181|NCT05273749|364245863|FG000|Overall Study|Withdrawal by Subject|14|||
105612182|NCT05273749|364245864|FG001|Overall Study|Withdrawal by Subject|16|||
105612183|NCT05273749|364245863|FG000|Overall Study|Lost to Follow-up|10|||
105612184|NCT05273749|364245864|FG001|Overall Study|Lost to Follow-up|10|||
105612185|NCT05273749|364245863|FG000|Overall Study|Pregnancy|1|||
105612186|NCT05273749|364245864|FG001|Overall Study|Pregnancy|0|||
105612187|NCT05273749|364245863|FG000|Overall Study|Non-Compliance|3|||
105612188|NCT05273749|364245864|FG001|Overall Study|Non-Compliance|2|||
105612189|NCT05273749|364245863|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
105612190|NCT05273749|364245864|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
105612191|NCT04806594|364245865|FG000|Overall Study|Withdrawal by Subject|2|||
105612192|NCT04806594|364245865|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
105612193|NCT03143153|364245868|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
105612194|NCT03143153|364245869|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
105612195|NCT03143153|364245870|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
105612196|NCT03143153|364245868|FG000|Pre-Treatment|Participant withdrew consent|0|||
105612197|NCT03143153|364245869|FG001|Pre-Treatment|Participant withdrew consent|1|||
105612198|NCT03143153|364245870|FG002|Pre-Treatment|Participant withdrew consent|12|||
105612199|NCT03143153|364245868|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
105612200|NCT03143153|364245869|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
105612201|NCT03143153|364245870|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
105612202|NCT03143153|364245868|FG000|Pre-Treatment|Other Reasons|1|||
105612203|NCT03143153|364245869|FG001|Pre-Treatment|Other Reasons|2|||
105612204|NCT03143153|364245870|FG002|Pre-Treatment|Other Reasons|1|||
105612205|NCT03143153|364245868|FG000|Pre-Treatment|Disease Progression|1|||
105612206|NCT03143153|364245869|FG001|Pre-Treatment|Disease Progression|1|||
105612207|NCT03143153|364245870|FG002|Pre-Treatment|Disease Progression|2|||
105612208|NCT03143153|364245868|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
105612209|NCT03143153|364245869|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
105612210|NCT03143153|364245870|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
105612211|NCT03143153|364245868|FG000|Treatment|Disease progression|174|||
105612212|NCT03143153|364245869|FG001|Treatment|Disease progression|184|||
105612213|NCT03143153|364245870|FG002|Treatment|Disease progression|193|||
105612214|NCT03143153|364245868|FG000|Treatment|Study drug toxicity|59|||
105612215|NCT03143153|364245869|FG001|Treatment|Study drug toxicity|33|||
105612216|NCT03143153|364245870|FG002|Treatment|Study drug toxicity|40|||
105612217|NCT03143153|364245868|FG000|Treatment|Death|5|||
105612218|NCT03143153|364245869|FG001|Treatment|Death|3|||
105612219|NCT03143153|364245870|FG002|Treatment|Death|4|||
105612220|NCT03143153|364245868|FG000|Treatment|Adverse event unrelated to study drug|19|||
105612221|NCT03143153|364245869|FG001|Treatment|Adverse event unrelated to study drug|28|||
105612222|NCT03143153|364245870|FG002|Treatment|Adverse event unrelated to study drug|12|||
105612223|NCT03143153|364245868|FG000|Treatment|Participant request to discontinue study treatment|13|||
105612224|NCT03143153|364245869|FG001|Treatment|Participant request to discontinue study treatment|15|||
105612225|NCT03143153|364245870|FG002|Treatment|Participant request to discontinue study treatment|20|||
105612226|NCT03143153|364245868|FG000|Treatment|Participant withdrew consent|3|||
105612227|NCT03143153|364245869|FG001|Treatment|Participant withdrew consent|4|||
105612228|NCT03143153|364245870|FG002|Treatment|Participant withdrew consent|12|||
105612229|NCT03143153|364245868|FG000|Treatment|Pregnancy|1|||
105612230|NCT03143153|364245869|FG001|Treatment|Pregnancy|0|||
105612231|NCT03143153|364245870|FG002|Treatment|Pregnancy|0|||
105612232|NCT03143153|364245868|FG000|Treatment|Maximum clinical benefit|1|||
105612233|NCT03143153|364245869|FG001|Treatment|Maximum clinical benefit|3|||
105612234|NCT03143153|364245870|FG002|Treatment|Maximum clinical benefit|4|||
105612235|NCT03143153|364245868|FG000|Treatment|Completed treatment as per Protocol|13|||
105612236|NCT03143153|364245869|FG001|Treatment|Completed treatment as per Protocol|8|||
105612237|NCT03143153|364245870|FG002|Treatment|Completed treatment as per Protocol|0|||
105612238|NCT03143153|364245868|FG000|Treatment|Other reasons|12|||
105612239|NCT03143153|364245869|FG001|Treatment|Other reasons|7|||
105612240|NCT03143153|364245870|FG002|Treatment|Other reasons|15|||
105612241|NCT03143153|364245868|FG000|Treatment|Not reported|1|||
105612242|NCT03143153|364245869|FG001|Treatment|Not reported|0|||
105612243|NCT03143153|364245870|FG002|Treatment|Not reported|0|||
105612244|NCT02312557|364245871|FG000|Overall Study|Survival follow-up|4|||
105612245|NCT04237298|364245872|FG000|Overall Study|Lost to Follow-up|4|||
105612246|NCT04237298|364245873|FG001|Overall Study|Lost to Follow-up|5|||
105612247|NCT04318548|364245874|FG000|Overall Study|Adverse Event|0|||
105612248|NCT04318548|364245875|FG001|Overall Study|Adverse Event|0|||
105612249|NCT04318548|364245876|FG002|Overall Study|Adverse Event|1|||
105612250|NCT04318548|364245874|FG000|Overall Study|Lost to Follow-up|6|||
105612251|NCT04318548|364245875|FG001|Overall Study|Lost to Follow-up|13|||
105612252|NCT04318548|364245876|FG002|Overall Study|Lost to Follow-up|9|||
105612253|NCT04318548|364245874|FG000|Overall Study|Protocol Violation|1|||
105612254|NCT04318548|364245875|FG001|Overall Study|Protocol Violation|0|||
105612255|NCT04318548|364245876|FG002|Overall Study|Protocol Violation|2|||
105612256|NCT04318548|364245874|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
105612257|NCT04318548|364245875|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
105612258|NCT04318548|364245876|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
105612259|NCT04318548|364245874|FG000|Overall Study|Migrated / moved from the study area|0|||
105612260|NCT04318548|364245875|FG001|Overall Study|Migrated / moved from the study area|0|||
105612261|NCT04318548|364245876|FG002|Overall Study|Migrated / moved from the study area|1|||
105612262|NCT04318548|364245874|FG000|Overall Study|Other|1|||
105612263|NCT04318548|364245875|FG001|Overall Study|Other|2|||
105612264|NCT04318548|364245876|FG002|Overall Study|Other|3|||
105612265|NCT02530671|364245877|FG000|Overall Study|Lost to Follow-up|2|||
105612266|NCT02530671|364245878|FG001|Overall Study|Lost to Follow-up|0|||
105612267|NCT02530671|364245877|FG000|Overall Study|Withdrawal by Subject|1|||
105612268|NCT02530671|364245878|FG001|Overall Study|Withdrawal by Subject|0|||
105612269|NCT02736409|364245879|FG000|Overall Study|Withdrawal by Subject|4|||
105612270|NCT02736409|364245880|FG001|Overall Study|Withdrawal by Subject|2|||
105612271|NCT02736409|364245881|FG002|Overall Study|Withdrawal by Subject|17|||
105612272|NCT02736409|364245882|FG003|Overall Study|Withdrawal by Subject|3|||
105612273|NCT02736409|364245879|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105612274|NCT02736409|364245880|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105612275|NCT02736409|364245881|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105612276|NCT02736409|364245882|FG003|Overall Study|Non-Compliance with Study Drug|1|||
105612277|NCT02736409|364245879|FG000|Overall Study|Adverse Event|0|||
105612278|NCT02736409|364245880|FG001|Overall Study|Adverse Event|1|||
105612279|NCT02736409|364245881|FG002|Overall Study|Adverse Event|5|||
105612280|NCT02736409|364245882|FG003|Overall Study|Adverse Event|4|||
105612281|NCT02736409|364245879|FG000|Overall Study|Other|0|||
105612282|NCT02736409|364245880|FG001|Overall Study|Other|0|||
105612283|NCT02736409|364245881|FG002|Overall Study|Other|1|||
105612284|NCT02736409|364245882|FG003|Overall Study|Other|1|||
105612285|NCT02736409|364245879|FG000|Overall Study|Pregnancy|0|||
105612286|NCT02736409|364245880|FG001|Overall Study|Pregnancy|0|||
105612287|NCT02736409|364245881|FG002|Overall Study|Pregnancy|1|||
105612288|NCT02736409|364245882|FG003|Overall Study|Pregnancy|0|||
105612289|NCT02736409|364245879|FG000|Overall Study|Lost to Follow-up|0|||
105612290|NCT02736409|364245880|FG001|Overall Study|Lost to Follow-up|0|||
105612291|NCT02736409|364245881|FG002|Overall Study|Lost to Follow-up|2|||
105612292|NCT02736409|364245882|FG003|Overall Study|Lost to Follow-up|1|||
105612293|NCT02736409|364245879|FG000|Overall Study|Physician Decision|0|||
105612294|NCT02736409|364245880|FG001|Overall Study|Physician Decision|0|||
105612295|NCT02736409|364245881|FG002|Overall Study|Physician Decision|0|||
105612296|NCT02736409|364245882|FG003|Overall Study|Physician Decision|2|||
105612297|NCT05247489|364245883|FG000|Overall Study|Lost to Follow-up|5|||
105612298|NCT05247489|364245884|FG001|Overall Study|Lost to Follow-up|1|||
105612299|NCT05247489|364245883|FG000|Overall Study|Withdrawal by Subject|6|||
105612300|NCT05247489|364245884|FG001|Overall Study|Withdrawal by Subject|7|||
105612301|NCT05247489|364245883|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
105612302|NCT05247489|364245884|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
105612303|NCT05247489|364245883|FG000|Overall Study|Left Country|1|||
105612304|NCT05247489|364245884|FG001|Overall Study|Left Country|0|||
105612305|NCT05247489|364245883|FG000|Overall Study|Noncompliance with Investigational Product|1|||
105612306|NCT05247489|364245884|FG001|Overall Study|Noncompliance with Investigational Product|0|||
105612307|NCT05247489|364245883|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
105612308|NCT05247489|364245884|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
105612309|NCT03771898|364245885|FG000|Overall Study|Adverse Event|1|||
105612310|NCT03771898|364245886|FG001|Overall Study|Adverse Event|0|||
105612311|NCT03771898|364245887|FG002|Overall Study|Adverse Event|0|||
105612312|NCT03771898|364245888|FG003|Overall Study|Adverse Event|0|||
105612313|NCT03771898|364245889|FG004|Overall Study|Adverse Event|0|||
105612314|NCT03771898|364245885|FG000|Overall Study|Lost to Follow-up|1|||
105612315|NCT03771898|364245886|FG001|Overall Study|Lost to Follow-up|1|||
105612316|NCT03771898|364245887|FG002|Overall Study|Lost to Follow-up|1|||
105612317|NCT03771898|364245888|FG003|Overall Study|Lost to Follow-up|0|||
105612318|NCT03771898|364245889|FG004|Overall Study|Lost to Follow-up|0|||
105612319|NCT03771898|364245885|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105612320|NCT03771898|364245886|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105612321|NCT03771898|364245887|FG002|Overall Study|Withdrawal by parent/guardian|0|||
105612322|NCT03771898|364245888|FG003|Overall Study|Withdrawal by parent/guardian|0|||
105612323|NCT03771898|364245889|FG004|Overall Study|Withdrawal by parent/guardian|0|||
105612324|NCT03771898|364245885|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
105612325|NCT03771898|364245886|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
105612326|NCT03771898|364245887|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
105612327|NCT03771898|364245888|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
105612328|NCT03771898|364245889|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
105612329|NCT04390048|364245890|FG000|Overall Study|Withdrawal by Subject|1|||
105612330|NCT04390048|364245891|FG001|Overall Study|Withdrawal by Subject|3|||
105612331|NCT01415154|364245892|FG000|Overall Study|Lack of Efficacy|4|||
105612332|NCT01415154|364245893|FG001|Overall Study|Lack of Efficacy|5|||
105612333|NCT01415154|364245892|FG000|Overall Study|Withdrawal by Subject|7|||
105612334|NCT01415154|364245893|FG001|Overall Study|Withdrawal by Subject|8|||
105612335|NCT01415154|364245892|FG000|Overall Study|Lost to Follow-up|1|||
105612336|NCT01415154|364245893|FG001|Overall Study|Lost to Follow-up|4|||
105612337|NCT01415154|364245892|FG000|Overall Study|Protocol Violation|0|||
105612338|NCT01415154|364245893|FG001|Overall Study|Protocol Violation|1|||
105612339|NCT01415154|364245892|FG000|Overall Study|Satisfactory Response|0|||
105612340|NCT01415154|364245893|FG001|Overall Study|Satisfactory Response|1|||
105612341|NCT01415154|364245892|FG000|Overall Study|Adverse Event|1|||
105612342|NCT01415154|364245893|FG001|Overall Study|Adverse Event|1|||
105612343|NCT06283173|364245894|FG000|Overall Study|Did not show for first visit|10|||
105612344|NCT06283173|364245894|FG000|Overall Study|Lost to Follow-up|12|||
105612345|NCT06283173|364245894|FG000|Overall Study|Physician Decision|7|||
105612346|NCT03332017|364245895|FG000|Overall Study|Lost to Follow-up|1|||
105612347|NCT03332017|364245896|FG001|Overall Study|Lost to Follow-up|2|||
105612348|NCT03332017|364245895|FG000|Overall Study|Death|17|||
105612349|NCT03332017|364245896|FG001|Overall Study|Death|16|||
105612350|NCT03332017|364245895|FG000|Overall Study|Withdrawal by Subject|6|||
105612351|NCT03332017|364245896|FG001|Overall Study|Withdrawal by Subject|14|||
105612352|NCT03332017|364245895|FG000|Overall Study|Other|1|||
105612353|NCT03332017|364245896|FG001|Overall Study|Other|3|||
105612354|NCT03332017|364245895|FG000|Overall Study|Remained in Study (Ongoing)|47|||
105612355|NCT03332017|364245896|FG001|Overall Study|Remained in Study (Ongoing)|110|||
105612356|NCT01261312|364245897|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
105612357|NCT01261312|364245898|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
105612358|NCT01261312|364245899|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
105612359|NCT01261312|364245900|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
105612360|NCT01261312|364245901|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
105612361|NCT01261312|364245902|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
105612362|NCT01261312|364245903|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
105612363|NCT01261312|364245904|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
105612364|NCT01261312|364245905|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
105612365|NCT01261312|364245906|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
105612366|NCT01261312|364245907|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
105612367|NCT01261312|364245908|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
105612368|NCT01261312|364245909|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
105612369|NCT01261312|364245897|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
105612370|NCT01261312|364245898|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
105612371|NCT01261312|364245899|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
105612372|NCT01261312|364245900|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
105612373|NCT01261312|364245901|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
105612374|NCT01261312|364245902|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
105612375|NCT01261312|364245903|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
105612376|NCT01261312|364245904|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
105612377|NCT01261312|364245905|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
105612378|NCT01261312|364245906|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
105612379|NCT01261312|364245907|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
105612380|NCT01261312|364245908|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
105612381|NCT01261312|364245909|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
105612382|NCT01261312|364245897|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
105612383|NCT01261312|364245898|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
105612384|NCT01261312|364245899|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
105612385|NCT01261312|364245900|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
105612386|NCT01261312|364245901|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
105612387|NCT01261312|364245902|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
105612388|NCT01261312|364245903|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
105612389|NCT01261312|364245904|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
105612390|NCT01261312|364245905|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
105612391|NCT01261312|364245906|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
105612392|NCT01261312|364245907|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
105612393|NCT01261312|364245908|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
105612394|NCT01261312|364245909|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
105612395|NCT01261312|364245897|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
105612396|NCT01261312|364245898|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
105612397|NCT01261312|364245899|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
105612398|NCT01261312|364245900|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
105612399|NCT01261312|364245901|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
105612400|NCT01261312|364245902|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
105612401|NCT01261312|364245903|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
105612402|NCT01261312|364245904|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
105612403|NCT01261312|364245905|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
105612404|NCT01261312|364245906|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
105612405|NCT01261312|364245907|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
105612406|NCT01261312|364245908|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
105612407|NCT01261312|364245909|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
105612408|NCT01261312|364245897|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
105612409|NCT01261312|364245898|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
105612410|NCT01261312|364245899|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
105612411|NCT01261312|364245900|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
105612412|NCT01261312|364245901|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
105612413|NCT01261312|364245902|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
105612414|NCT01261312|364245903|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
105612415|NCT01261312|364245904|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
105612416|NCT01261312|364245905|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
105612417|NCT01261312|364245906|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
105612418|NCT01261312|364245907|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
105612419|NCT01261312|364245908|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
105612420|NCT01261312|364245909|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
105612421|NCT01261312|364245897|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
105612422|NCT01261312|364245898|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
105612423|NCT01261312|364245899|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
105612424|NCT01261312|364245900|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
105612425|NCT01261312|364245901|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
105612426|NCT01261312|364245902|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
105612427|NCT01261312|364245903|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
105612428|NCT01261312|364245904|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
105612429|NCT01261312|364245905|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
105612430|NCT01261312|364245906|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
105612431|NCT01261312|364245907|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
105612432|NCT01261312|364245908|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
105612433|NCT01261312|364245909|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
105612434|NCT01261312|364245897|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
105612435|NCT01261312|364245898|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
105612436|NCT01261312|364245899|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
105612437|NCT01261312|364245900|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
105612438|NCT01261312|364245901|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
105612439|NCT01261312|364245902|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
105612440|NCT01261312|364245903|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
105612441|NCT01261312|364245904|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
105612442|NCT01261312|364245905|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
105612443|NCT01261312|364245906|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
105612444|NCT01261312|364245907|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
105612445|NCT01261312|364245908|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
105612446|NCT01261312|364245909|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
105612447|NCT01261312|364245897|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
105612448|NCT01261312|364245898|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
105612449|NCT01261312|364245899|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
105612450|NCT01261312|364245900|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
105612451|NCT01261312|364245901|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
105612452|NCT01261312|364245902|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
105612453|NCT01261312|364245903|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
105612454|NCT01261312|364245904|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
105612455|NCT01261312|364245905|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
105612456|NCT01261312|364245906|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
105612457|NCT01261312|364245907|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
105612458|NCT01261312|364245908|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
105612459|NCT01261312|364245909|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
105612460|NCT01261312|364245897|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
105612461|NCT01261312|364245898|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
105612462|NCT01261312|364245899|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
105612463|NCT01261312|364245900|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
105612464|NCT01261312|364245901|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
105612465|NCT01261312|364245902|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
105612466|NCT01261312|364245903|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
105612467|NCT01261312|364245904|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
105612468|NCT01261312|364245905|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
105612469|NCT01261312|364245906|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
105612470|NCT01261312|364245907|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
105612471|NCT01261312|364245908|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
105612472|NCT01261312|364245909|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
105612473|NCT01261312|364245897|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
105612474|NCT01261312|364245898|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
105612475|NCT01261312|364245899|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
105612476|NCT01261312|364245900|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
105612477|NCT01261312|364245901|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
105612478|NCT01261312|364245902|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
105612479|NCT01261312|364245903|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
105612480|NCT01261312|364245904|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
105612481|NCT01261312|364245905|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
105612482|NCT01261312|364245906|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
105612483|NCT01261312|364245907|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
105612484|NCT01261312|364245908|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
105612485|NCT01261312|364245909|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
105612486|NCT01261312|364245897|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
105612487|NCT01261312|364245898|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
105612488|NCT01261312|364245899|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
105612489|NCT01261312|364245900|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
105612490|NCT01261312|364245901|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
105612491|NCT01261312|364245902|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
105612492|NCT01261312|364245903|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
105612493|NCT01261312|364245904|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
105612494|NCT01261312|364245905|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
105612495|NCT01261312|364245906|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
105612496|NCT01261312|364245907|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
105612497|NCT01261312|364245908|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
105612498|NCT01261312|364245909|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
105612499|NCT01261312|364245897|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
105612500|NCT01261312|364245898|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
105612501|NCT01261312|364245899|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
105612502|NCT01261312|364245900|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
105612503|NCT01261312|364245901|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
105612504|NCT01261312|364245902|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
105612505|NCT01261312|364245903|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
105612506|NCT01261312|364245904|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
105612507|NCT01261312|364245905|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
105612508|NCT01261312|364245906|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
105612509|NCT01261312|364245907|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
105612510|NCT01261312|364245908|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
105612511|NCT01261312|364245909|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
105612512|NCT01261312|364245897|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
105612513|NCT01261312|364245898|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
105612514|NCT01261312|364245899|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
105612515|NCT01261312|364245900|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
105612516|NCT01261312|364245901|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
105612517|NCT01261312|364245902|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
105612518|NCT01261312|364245903|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
105612519|NCT01261312|364245904|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
105612520|NCT01261312|364245905|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
105612521|NCT01261312|364245906|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
105612522|NCT01261312|364245907|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
105612523|NCT01261312|364245908|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
105612524|NCT01261312|364245909|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
105612525|NCT01261312|364245897|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
105612526|NCT01261312|364245898|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
105612527|NCT01261312|364245899|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
105612528|NCT01261312|364245900|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
105612529|NCT01261312|364245901|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
105612530|NCT01261312|364245902|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
105612531|NCT01261312|364245903|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
105612532|NCT01261312|364245904|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
105612533|NCT01261312|364245905|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
105612534|NCT01261312|364245906|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
105612535|NCT01261312|364245907|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
105612536|NCT01261312|364245908|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
105612537|NCT01261312|364245909|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
105612538|NCT01261312|364245897|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
105612539|NCT01261312|364245898|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
105612540|NCT01261312|364245899|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
105612541|NCT01261312|364245900|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
105612542|NCT01261312|364245901|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
105612543|NCT01261312|364245902|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
105612544|NCT01261312|364245903|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
105612545|NCT01261312|364245904|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
105612546|NCT01261312|364245905|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
105612547|NCT01261312|364245906|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
105612548|NCT01261312|364245907|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
105612549|NCT01261312|364245908|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
105612550|NCT01261312|364245909|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
105612551|NCT01261312|364245897|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
105612552|NCT01261312|364245898|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
105612553|NCT01261312|364245899|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
105612554|NCT01261312|364245900|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
105612555|NCT01261312|364245901|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
105612556|NCT01261312|364245902|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
105612557|NCT01261312|364245903|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
105612558|NCT01261312|364245904|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
105612559|NCT01261312|364245905|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
105612560|NCT01261312|364245906|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
105612561|NCT01261312|364245907|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
105612562|NCT01261312|364245908|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
105612563|NCT01261312|364245909|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
105612564|NCT01261312|364245897|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
105612565|NCT01261312|364245898|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
105612566|NCT01261312|364245899|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
105612567|NCT01261312|364245900|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
105612568|NCT01261312|364245901|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
105612569|NCT01261312|364245902|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
105612570|NCT01261312|364245903|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
105612571|NCT01261312|364245904|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
105612572|NCT01261312|364245905|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
105612573|NCT01261312|364245906|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
105612574|NCT01261312|364245907|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
105612575|NCT01261312|364245908|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
105612576|NCT01261312|364245909|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
105612577|NCT01261312|364245897|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
105612578|NCT01261312|364245898|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
105612579|NCT01261312|364245899|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
105612580|NCT01261312|364245900|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
105612581|NCT01261312|364245901|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
105612582|NCT01261312|364245902|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
105612583|NCT01261312|364245903|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
105612584|NCT01261312|364245904|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
105612585|NCT01261312|364245905|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
105612586|NCT01261312|364245906|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
105612587|NCT01261312|364245907|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
105612588|NCT01261312|364245908|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
105612589|NCT01261312|364245909|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
105612590|NCT01261312|364245897|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
105612591|NCT01261312|364245898|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
105612592|NCT01261312|364245899|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
105612593|NCT01261312|364245900|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
105612594|NCT01261312|364245901|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
105612595|NCT01261312|364245902|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
105612596|NCT01261312|364245903|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
105612597|NCT01261312|364245904|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
105612598|NCT01261312|364245905|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
105612599|NCT01261312|364245906|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
105612600|NCT01261312|364245907|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
105612601|NCT01261312|364245908|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
105612602|NCT01261312|364245909|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
105612603|NCT01261312|364245897|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
105612604|NCT01261312|364245898|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
105612605|NCT01261312|364245899|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
105612606|NCT01261312|364245900|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
105612607|NCT01261312|364245901|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
105612608|NCT01261312|364245902|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
105612609|NCT01261312|364245903|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
105612610|NCT01261312|364245904|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
105612611|NCT01261312|364245905|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
105612612|NCT01261312|364245906|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
105612613|NCT01261312|364245907|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
105612614|NCT01261312|364245908|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
105612615|NCT01261312|364245909|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
105612616|NCT01261312|364245897|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
105612617|NCT01261312|364245898|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
105612618|NCT01261312|364245899|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
105612619|NCT01261312|364245900|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
105612620|NCT01261312|364245901|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
105612621|NCT01261312|364245902|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
105612622|NCT01261312|364245903|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
105612623|NCT01261312|364245904|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
105612624|NCT01261312|364245905|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
105612625|NCT01261312|364245906|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
105612626|NCT01261312|364245907|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
105612627|NCT01261312|364245908|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
105612628|NCT01261312|364245909|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
105612629|NCT01261312|364245897|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
105612630|NCT01261312|364245898|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
105612631|NCT01261312|364245899|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
105612632|NCT01261312|364245900|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
105612633|NCT01261312|364245901|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
105612634|NCT01261312|364245902|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
105612635|NCT01261312|364245903|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
105612636|NCT01261312|364245904|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
105612637|NCT01261312|364245905|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
105612638|NCT01261312|364245906|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
105612639|NCT01261312|364245907|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
105612640|NCT01261312|364245908|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
105612641|NCT01261312|364245909|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
105612642|NCT01261312|364245897|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
105439814|NCT02147288|363615080|FG009|Overall Study|complications from concurrent hernia rep|0|||
105439815|NCT00861471|363615081|FG000|Overall Study|Withdrawal by Subject|1|||
105439816|NCT00861471|363615081|FG000|Overall Study|Adverse Event|2|||
105439817|NCT00861471|363615081|FG000|Overall Study|Lack of Efficacy|3|||
105439818|NCT00861471|363615081|FG000|Overall Study|treatment for lumbar laminectomy|1|||
105439819|NCT00861471|363615081|FG000|Overall Study|Physician Decision|2|||
105439820|NCT00445770|363615084|FG000|Overall Study|Adverse Event|9|||
105439821|NCT00445770|363615085|FG001|Overall Study|Adverse Event|15|||
105439822|NCT00445770|363615086|FG002|Overall Study|Adverse Event|19|||
105439823|NCT00445770|363615084|FG000|Overall Study|Lack of Efficacy|38|||
105439824|NCT00445770|363615085|FG001|Overall Study|Lack of Efficacy|13|||
105439825|NCT00445770|363615086|FG002|Overall Study|Lack of Efficacy|6|||
105439826|NCT00445770|363615084|FG000|Overall Study|Lost to Follow-up|0|||
105439827|NCT00445770|363615085|FG001|Overall Study|Lost to Follow-up|2|||
105439828|NCT00445770|363615086|FG002|Overall Study|Lost to Follow-up|0|||
105439829|NCT00445770|363615084|FG000|Overall Study|Other|6|||
105439830|NCT00445770|363615085|FG001|Overall Study|Other|5|||
105439831|NCT00445770|363615086|FG002|Overall Study|Other|6|||
105439832|NCT00965419|363615087|FG000|Open Label Treatment for Responders|Adverse Event|33|||
105439833|NCT00965419|363615087|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
105439834|NCT00965419|363615087|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
105439835|NCT00965419|363615087|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
105439836|NCT00965419|363615087|FG000|Open Label Treatment for Responders|Physician Decision|6|||
105612643|NCT01261312|364245898|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
105612644|NCT01261312|364245899|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
105612645|NCT01261312|364245900|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
105612646|NCT01261312|364245901|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
105612647|NCT01261312|364245902|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
105612648|NCT01261312|364245903|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
105612649|NCT01261312|364245904|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
105612650|NCT01261312|364245905|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
105612651|NCT01261312|364245906|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
105612652|NCT01261312|364245907|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
105612653|NCT01261312|364245908|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
105612654|NCT01261312|364245909|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
105612655|NCT01261312|364245897|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
105612656|NCT01261312|364245898|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
105612657|NCT01261312|364245899|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
105612658|NCT01261312|364245900|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
105612659|NCT01261312|364245901|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
105612660|NCT01261312|364245902|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
105612661|NCT01261312|364245903|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
105612662|NCT01261312|364245904|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
105612663|NCT01261312|364245905|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
105612664|NCT01261312|364245906|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
105612665|NCT01261312|364245907|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
105612666|NCT01261312|364245908|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
105612667|NCT01261312|364245909|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
105612668|NCT01261312|364245897|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
105612669|NCT01261312|364245898|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
105612670|NCT01261312|364245899|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
105612671|NCT01261312|364245900|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
105612672|NCT01261312|364245901|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
105612673|NCT01261312|364245902|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
105612674|NCT01261312|364245903|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
105612675|NCT01261312|364245904|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
105612676|NCT01261312|364245905|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
105612677|NCT01261312|364245906|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
105612678|NCT01261312|364245907|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
105612679|NCT01261312|364245908|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
105612680|NCT01261312|364245909|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
105612681|NCT01261312|364245897|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
105612682|NCT01261312|364245898|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
105612683|NCT01261312|364245899|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
105612684|NCT01261312|364245900|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
105612685|NCT01261312|364245901|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
105612686|NCT01261312|364245902|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
105612687|NCT01261312|364245903|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
105612688|NCT01261312|364245904|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
105612689|NCT01261312|364245905|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
105612690|NCT01261312|364245906|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
105612691|NCT01261312|364245907|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
105612692|NCT01261312|364245908|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
105612693|NCT01261312|364245909|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
105612694|NCT01261312|364245897|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
105612695|NCT01261312|364245898|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
105612696|NCT01261312|364245899|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
105612697|NCT01261312|364245900|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
105612698|NCT01261312|364245901|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
105612699|NCT01261312|364245902|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
105612700|NCT01261312|364245903|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
105612701|NCT01261312|364245904|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
105612702|NCT01261312|364245905|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
105612703|NCT01261312|364245906|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
105612704|NCT01261312|364245907|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
105612705|NCT01261312|364245908|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
105612706|NCT01261312|364245909|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
105612707|NCT01261312|364245897|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
105612708|NCT01261312|364245898|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
105612709|NCT01261312|364245899|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
105612710|NCT01261312|364245900|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
105612711|NCT01261312|364245901|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
105612712|NCT01261312|364245902|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
105612713|NCT01261312|364245903|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
105612714|NCT01261312|364245904|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
105612715|NCT01261312|364245905|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
105612716|NCT01261312|364245906|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
105612717|NCT01261312|364245907|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
105612718|NCT01261312|364245908|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
105612719|NCT01261312|364245909|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
105612720|NCT02281955|364245922|FG000|Overall Study|Death|1|||
105612721|NCT04021602|364245932|FG000|Overall Study|Lost to Follow-up|3|||
105612722|NCT04021602|364245933|FG001|Overall Study|Lost to Follow-up|3|||
105612723|NCT04021602|364245934|FG002|Overall Study|Lost to Follow-up|1|||
105612724|NCT04021602|364245932|FG000|Overall Study|Adverse Event|1|||
105612725|NCT04021602|364245933|FG001|Overall Study|Adverse Event|0|||
105612726|NCT04021602|364245934|FG002|Overall Study|Adverse Event|1|||
105612727|NCT01744782|364245935|FG000|Overall Study|Death|1|||
105612728|NCT04649359|364245936|FG000|Overall Study|Withdrawal by Subject|7|||
105612729|NCT04649359|364245937|FG001|Overall Study|Withdrawal by Subject|7|||
105612730|NCT04649359|364245936|FG000|Overall Study|Death|41|||
105612731|NCT04649359|364245937|FG001|Overall Study|Death|26|||
105612732|NCT04649359|364245936|FG000|Overall Study|Ongoing in the study|75|||
105612733|NCT04649359|364245937|FG001|Overall Study|Ongoing in the study|31|||
105612734|NCT02243709|364245940|FG000|Phase 1|Lost to Follow-up|0|||
105612735|NCT02243709|364245941|FG001|Phase 1|Lost to Follow-up|1|||
105612736|NCT02243709|364245940|FG000|Phase 1|Withdrawal by Subject|1|||
105612737|NCT02243709|364245941|FG001|Phase 1|Withdrawal by Subject|0|||
105612738|NCT02243709|364245940|FG000|Phase 1|Protocol Violation|0|||
105612739|NCT02243709|364245941|FG001|Phase 1|Protocol Violation|1|||
105612740|NCT02243709|364245940|FG000|Phase 1|Adverse Event|0|||
105612741|NCT02243709|364245941|FG001|Phase 1|Adverse Event|1|||
105612742|NCT04229992|364245943|FG000|Overall Study|Withdrawal by Subject|0|||
105612743|NCT04229992|364245944|FG001|Overall Study|Withdrawal by Subject|2|||
105612744|NCT04229992|364245945|FG002|Overall Study|Withdrawal by Subject|1|||
105612745|NCT04229992|364245946|FG003|Overall Study|Withdrawal by Subject|1|||
105612746|NCT04229992|364245943|FG000|Overall Study|Adverse Event|1|||
105612747|NCT04229992|364245944|FG001|Overall Study|Adverse Event|1|||
105612748|NCT04229992|364245945|FG002|Overall Study|Adverse Event|3|||
105612749|NCT04229992|364245946|FG003|Overall Study|Adverse Event|1|||
105612750|NCT04229992|364245943|FG000|Overall Study|Lost to Follow-up|0|||
105612751|NCT04229992|364245944|FG001|Overall Study|Lost to Follow-up|0|||
105612752|NCT04229992|364245945|FG002|Overall Study|Lost to Follow-up|0|||
105612753|NCT04229992|364245946|FG003|Overall Study|Lost to Follow-up|1|||
105612754|NCT02455557|364245947|FG000|Overall Study|Withdrawal by Subject|2|||
105612755|NCT03707951|364245948|FG000|Overall Study|Lost to Follow-up|8|||
105612756|NCT03707951|364245949|FG001|Overall Study|Lost to Follow-up|17|||
105612757|NCT03707951|364245948|FG000|Overall Study|Withdrawal by Subject|6|||
105612758|NCT03707951|364245949|FG001|Overall Study|Withdrawal by Subject|6|||
105612759|NCT04169373|364245950|FG000|Week 1 to Week 14|Adverse Event|1|||
105612760|NCT04169373|364245951|FG001|Week 1 to Week 14|Adverse Event|0|||
105612761|NCT04169373|364245952|FG002|Week 1 to Week 14|Adverse Event|1|||
105612762|NCT04169373|364245953|FG003|Week 1 to Week 14|Adverse Event|2|||
105612763|NCT04169373|364245950|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
105612764|NCT04169373|364245951|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
105612765|NCT04169373|364245952|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
105612766|NCT04169373|364245953|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
105612767|NCT04169373|364245950|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
105612768|NCT04169373|364245951|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
105612769|NCT04169373|364245952|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
105612770|NCT04169373|364245953|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
105612771|NCT04169373|364245950|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
105612772|NCT04169373|364245951|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
105612773|NCT04169373|364245952|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
105612774|NCT04169373|364245953|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
105612775|NCT04169373|364245950|FG000|Week 1 to Week 14|Other|1|||
105612776|NCT04169373|364245951|FG001|Week 1 to Week 14|Other|3|||
105612777|NCT04169373|364245952|FG002|Week 1 to Week 14|Other|3|||
105612778|NCT04169373|364245953|FG003|Week 1 to Week 14|Other|5|||
105612779|NCT04169373|364245950|FG000|Week 14 to Week 52|Adverse Event|1|||
105612780|NCT04169373|364245951|FG001|Week 14 to Week 52|Adverse Event|0|||
105612781|NCT04169373|364245952|FG002|Week 14 to Week 52|Adverse Event|0|||
105612782|NCT04169373|364245953|FG003|Week 14 to Week 52|Adverse Event|1|||
105612783|NCT04169373|364245950|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
105612784|NCT04169373|364245951|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
105612785|NCT04169373|364245952|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
105612786|NCT04169373|364245953|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
105612787|NCT04169373|364245950|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
105612788|NCT04169373|364245951|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
105612789|NCT04169373|364245952|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
105612790|NCT04169373|364245953|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
105612791|NCT04169373|364245950|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
105612792|NCT04169373|364245951|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
105612793|NCT04169373|364245952|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
105612794|NCT04169373|364245953|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
105612795|NCT04169373|364245950|FG000|Week 14 to Week 52|Other|4|||
105612796|NCT04169373|364245951|FG001|Week 14 to Week 52|Other|5|||
105612797|NCT04169373|364245952|FG002|Week 14 to Week 52|Other|4|||
105612798|NCT04169373|364245953|FG003|Week 14 to Week 52|Other|5|||
105612799|NCT04169373|364245950|FG000|Week 14 to Week 52|Ongoing|0|||
105612800|NCT04169373|364245951|FG001|Week 14 to Week 52|Ongoing|1|||
105612801|NCT04169373|364245952|FG002|Week 14 to Week 52|Ongoing|0|||
105612802|NCT04169373|364245953|FG003|Week 14 to Week 52|Ongoing|0|||
105612803|NCT04610892|364245954|FG000|Overall Study|Adverse Event|1|||
105612804|NCT04610892|364245955|FG001|Overall Study|Adverse Event|0|||
105612805|NCT04610892|364245956|FG002|Overall Study|Adverse Event|0|||
105612806|NCT04610892|364245957|FG003|Overall Study|Adverse Event|1|||
105612807|NCT04610892|364245958|FG004|Overall Study|Adverse Event|3|||
105612808|NCT04610892|364245954|FG000|Overall Study|Death|0|||
105612809|NCT04610892|364245955|FG001|Overall Study|Death|1|||
105612810|NCT04610892|364245956|FG002|Overall Study|Death|0|||
105612811|NCT04610892|364245957|FG003|Overall Study|Death|1|||
105612812|NCT04610892|364245958|FG004|Overall Study|Death|0|||
105612813|NCT04610892|364245954|FG000|Overall Study|Withdrawal by Subject|3|||
105612814|NCT04610892|364245955|FG001|Overall Study|Withdrawal by Subject|2|||
105612815|NCT04610892|364245956|FG002|Overall Study|Withdrawal by Subject|0|||
105612816|NCT04610892|364245957|FG003|Overall Study|Withdrawal by Subject|6|||
105612817|NCT04610892|364245958|FG004|Overall Study|Withdrawal by Subject|6|||
105612818|NCT04610892|364245954|FG000|Overall Study|Subjects who did not receive treatment|1|||
105612819|NCT04610892|364245955|FG001|Overall Study|Subjects who did not receive treatment|0|||
105612820|NCT04610892|364245956|FG002|Overall Study|Subjects who did not receive treatment|0|||
105612821|NCT04610892|364245957|FG003|Overall Study|Subjects who did not receive treatment|0|||
105612822|NCT04610892|364245958|FG004|Overall Study|Subjects who did not receive treatment|2|||
105612823|NCT04896476|364245964|FG000|Overall Study|Withdrawal by Subject|1|||
105612824|NCT04896476|364245964|FG000|Overall Study|Lost to Follow-up|2|||
105612825|NCT03476187|364245965|FG000|Overall Study|Protocol Violation|7|||
105612826|NCT03476187|364245965|FG000|Overall Study|Physician Decision|5|||
105612827|NCT03135548|364245966|FG000|Overall Study|Lost to Follow-up|3|||
105612828|NCT03135548|364245967|FG001|Overall Study|Lost to Follow-up|0|||
105612829|NCT03135548|364245968|FG002|Overall Study|Lost to Follow-up|0|||
105612830|NCT03135548|364245966|FG000|Overall Study|Withdrawal by Subject|2|||
105612831|NCT03135548|364245967|FG001|Overall Study|Withdrawal by Subject|2|||
105612832|NCT03135548|364245968|FG002|Overall Study|Withdrawal by Subject|1|||
105612833|NCT03135548|364245966|FG000|Overall Study|Other than listed|0|||
105612834|NCT03135548|364245967|FG001|Overall Study|Other than listed|2|||
105612835|NCT03135548|364245968|FG002|Overall Study|Other than listed|2|||
105612836|NCT03924986|364245969|FG000|Overall Study|Death|57|||
105612837|NCT03924986|364245970|FG001|Overall Study|Death|66|||
105612838|NCT03924986|364245969|FG000|Overall Study|Study Concluded by Sponsor|51|||
105612839|NCT03924986|364245970|FG001|Overall Study|Study Concluded by Sponsor|41|||
105612840|NCT03924986|364245969|FG000|Overall Study|Withdrawal by Subject|15|||
105612841|NCT03924986|364245970|FG001|Overall Study|Withdrawal by Subject|20|||
105612842|NCT03924986|364245969|FG000|Overall Study|Lost to Follow-up|7|||
105612843|NCT03924986|364245970|FG001|Overall Study|Lost to Follow-up|5|||
105612844|NCT03924986|364245969|FG000|Overall Study|Miscellaneous|1|||
105612845|NCT03924986|364245970|FG001|Overall Study|Miscellaneous|0|||
105612846|NCT03056040|364245973|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
105612847|NCT03056040|364245974|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
105612848|NCT03056040|364245973|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
105612849|NCT03056040|364245974|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
105612850|NCT03056040|364245973|FG000|Primary Evaluation Period|Pregnancy|0|||
105612851|NCT03056040|364245974|FG001|Primary Evaluation Period|Pregnancy|1|||
105612852|NCT03056040|364245973|FG000|Primary Evaluation Period|Randomized, not treated|1|||
105612853|NCT03056040|364245974|FG001|Primary Evaluation Period|Randomized, not treated|1|||
105612854|NCT03056040|364245973|FG000|Extension Period|Physician Decision|3|||
105612855|NCT03056040|364245974|FG001|Extension Period|Physician Decision|3|||
105612856|NCT03056040|364245973|FG000|Extension Period|Lost to Follow-up|0|||
105612857|NCT03056040|364245974|FG001|Extension Period|Lost to Follow-up|1|||
105612858|NCT03056040|364245973|FG000|Extension Period|Death|0|||
105612859|NCT03056040|364245974|FG001|Extension Period|Death|3|||
105612860|NCT03056040|364245973|FG000|Extension Period|Withdrawal by Subject|1|||
105612861|NCT03056040|364245974|FG001|Extension Period|Withdrawal by Subject|0|||
105612862|NCT03232138|364245988|FG000|Overall Study|Physician Decision|1|||
105612863|NCT03232138|364245989|FG001|Overall Study|Physician Decision|0|||
105612864|NCT03232138|364245988|FG000|Overall Study|Adverse Event|2|||
105612865|NCT03232138|364245989|FG001|Overall Study|Adverse Event|0|||
105612866|NCT03232138|364245988|FG000|Overall Study|Withdrawal by Subject|1|||
105612867|NCT03232138|364245989|FG001|Overall Study|Withdrawal by Subject|2|||
105612868|NCT05051124|364245990|FG000|Overall Study|Lost to Follow-up|2|||
105612869|NCT05051124|364245990|FG000|Overall Study|Withdrawal by Subject|1|||
105612870|NCT05051124|364245990|FG000|Overall Study|Residential relocation|2|||
105612871|NCT05051124|364245990|FG000|Overall Study|Death|1|||
105612872|NCT04924660|364245991|FG000|United States|Death|29|||
105612873|NCT04924660|364245992|FG001|United States|Death|32|||
105612874|NCT04924660|364245993|FG002|United States|Death|34|||
105612875|NCT04924660|364245994|FG003|United States|Death|25|||
105612876|NCT04924660|364245995|FG004|United States|Death|26|||
105612877|NCT04924660|364245996|FG005|United States|Death|23|||
105612878|NCT04924660|364245991|FG000|United States|Lost to Follow-up|15|||
105612879|NCT04924660|364245992|FG001|United States|Lost to Follow-up|10|||
105612880|NCT04924660|364245993|FG002|United States|Lost to Follow-up|13|||
105612881|NCT04924660|364245994|FG003|United States|Lost to Follow-up|5|||
105612882|NCT04924660|364245995|FG004|United States|Lost to Follow-up|19|||
105612883|NCT04924660|364245996|FG005|United States|Lost to Follow-up|20|||
105612884|NCT04924660|364245991|FG000|United States|Withdrawal by Subject|8|||
105612885|NCT04924660|364245992|FG001|United States|Withdrawal by Subject|3|||
105612886|NCT04924660|364245993|FG002|United States|Withdrawal by Subject|3|||
105612887|NCT04924660|364245994|FG003|United States|Withdrawal by Subject|3|||
105612888|NCT04924660|364245995|FG004|United States|Withdrawal by Subject|8|||
105612889|NCT04924660|364245996|FG005|United States|Withdrawal by Subject|4|||
105612890|NCT04924660|364245991|FG000|Spain|Death|0|||
105612891|NCT04924660|364245992|FG001|Spain|Death|0|||
105612892|NCT04924660|364245993|FG002|Spain|Death|0|||
105612893|NCT04924660|364245994|FG003|Spain|Death|0|||
105612894|NCT04924660|364245995|FG004|Spain|Death|0|||
105612895|NCT04924660|364245996|FG005|Spain|Death|2|||
105612896|NCT04924660|364245991|FG000|Spain|Lost to Follow-up|0|||
105612897|NCT04924660|364245992|FG001|Spain|Lost to Follow-up|0|||
105612898|NCT04924660|364245993|FG002|Spain|Lost to Follow-up|0|||
105612899|NCT04924660|364245994|FG003|Spain|Lost to Follow-up|0|||
105612900|NCT04924660|364245995|FG004|Spain|Lost to Follow-up|1|||
105612901|NCT04924660|364245996|FG005|Spain|Lost to Follow-up|0|||
105612902|NCT04924660|364245991|FG000|Brazil|Death|0|||
105612903|NCT04924660|364245992|FG001|Brazil|Death|0|||
105612904|NCT04924660|364245993|FG002|Brazil|Death|0|||
105612905|NCT04924660|364245994|FG003|Brazil|Death|0|||
105612906|NCT04924660|364245995|FG004|Brazil|Death|1|||
105612907|NCT04924660|364245996|FG005|Brazil|Death|0|||
105612908|NCT04924660|364245991|FG000|Italy|Lost to Follow-up|0|||
105612909|NCT04924660|364245992|FG001|Italy|Lost to Follow-up|0|||
105612910|NCT04924660|364245993|FG002|Italy|Lost to Follow-up|0|||
105612911|NCT04924660|364245994|FG003|Italy|Lost to Follow-up|0|||
105612912|NCT04924660|364245995|FG004|Italy|Lost to Follow-up|0|||
105612913|NCT04924660|364245996|FG005|Italy|Lost to Follow-up|1|||
105612914|NCT04924660|364245991|FG000|South Africa|Death|0|||
105612915|NCT04924660|364245992|FG001|South Africa|Death|0|||
105612916|NCT04924660|364245993|FG002|South Africa|Death|0|||
105612917|NCT04924660|364245994|FG003|South Africa|Death|0|||
105612918|NCT04924660|364245995|FG004|South Africa|Death|0|||
105612919|NCT04924660|364245996|FG005|South Africa|Death|1|||
105612920|NCT04924660|364245991|FG000|South Africa|Lost to Follow-up|0|||
105612921|NCT04924660|364245992|FG001|South Africa|Lost to Follow-up|0|||
105612922|NCT04924660|364245993|FG002|South Africa|Lost to Follow-up|0|||
105612923|NCT04924660|364245994|FG003|South Africa|Lost to Follow-up|0|||
105612924|NCT04924660|364245995|FG004|South Africa|Lost to Follow-up|0|||
105612925|NCT04924660|364245996|FG005|South Africa|Lost to Follow-up|1|||
105612926|NCT02962895|364245999|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
105612927|NCT02962895|364246000|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
105612928|NCT02962895|364246001|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
105612929|NCT02962895|364246002|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
105612930|NCT02962895|364246003|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
105612931|NCT02962895|364246004|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
105612932|NCT02962895|364246005|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
105612933|NCT02962895|364245999|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
105612934|NCT02962895|364246000|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
105612935|NCT02962895|364246001|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
105612936|NCT02962895|364246002|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
105612937|NCT02962895|364246003|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
105612938|NCT02962895|364246004|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
105612939|NCT02962895|364246005|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
105612940|NCT02962895|364245999|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
105612941|NCT02962895|364246000|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
105612942|NCT02962895|364246001|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
105612943|NCT02962895|364246002|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
105612944|NCT02962895|364246003|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
105612945|NCT02962895|364246004|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
105612946|NCT02962895|364246005|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
105612947|NCT02962895|364245999|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
105612948|NCT02962895|364246000|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
105612949|NCT02962895|364246001|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
105612950|NCT02962895|364246002|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
105612951|NCT02962895|364246003|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
105612952|NCT02962895|364246004|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
105612953|NCT02962895|364246005|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
105612954|NCT02962895|364245999|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
105612955|NCT02962895|364246000|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
105612956|NCT02962895|364246001|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
105612957|NCT02962895|364246002|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
105612958|NCT02962895|364246003|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
105612959|NCT02962895|364246004|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
105612960|NCT02962895|364246005|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
105612961|NCT02962895|364245999|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
105612962|NCT02962895|364246000|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
105612963|NCT02962895|364246001|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
105612964|NCT02962895|364246002|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
105612965|NCT02962895|364246003|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
105612966|NCT02962895|364246004|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
105612967|NCT02962895|364246005|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
105612968|NCT02962895|364245999|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
105612969|NCT02962895|364246000|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
105612970|NCT02962895|364246001|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
105612971|NCT02962895|364246002|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
105612972|NCT02962895|364246003|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
105612973|NCT02962895|364246004|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
105612974|NCT02962895|364246005|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
105612975|NCT02962895|364245999|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
105612976|NCT02962895|364246000|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
105612977|NCT02962895|364246001|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
105612978|NCT02962895|364246002|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
105612979|NCT02962895|364246003|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
105612980|NCT02962895|364246004|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
105612981|NCT02962895|364246005|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
105612982|NCT02962895|364245999|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
105612983|NCT02962895|364246000|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
105612984|NCT02962895|364246001|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
105612985|NCT02962895|364246002|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
105612986|NCT02962895|364246003|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
105612987|NCT02962895|364246004|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
105612988|NCT02962895|364246005|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
105612989|NCT02962895|364245999|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
105612990|NCT02962895|364246000|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
105612991|NCT02962895|364246001|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
105612992|NCT02962895|364246002|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
105612993|NCT02962895|364246003|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
105612994|NCT02962895|364246004|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
105612995|NCT02962895|364246005|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
105612996|NCT02962895|364245999|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
105612997|NCT02962895|364246000|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
105612998|NCT02962895|364246001|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
105612999|NCT02962895|364246002|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
105613000|NCT02962895|364246003|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
105613001|NCT02962895|364246004|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
105613002|NCT02962895|364246005|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
105613003|NCT02962895|364245999|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
105613004|NCT02962895|364246000|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
105613005|NCT02962895|364246001|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
105613006|NCT02962895|364246002|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
105613007|NCT02962895|364246003|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
105613008|NCT02962895|364246004|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
105613009|NCT02962895|364246005|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
105613010|NCT02962895|364245999|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
105613011|NCT02962895|364246000|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
105613012|NCT02962895|364246001|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
105613013|NCT02962895|364246002|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
105613014|NCT02962895|364246003|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
105613015|NCT02962895|364246004|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
105613016|NCT02962895|364246005|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
105613017|NCT02962895|364245999|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
105613018|NCT02962895|364246000|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
105613019|NCT02962895|364246001|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
105613020|NCT02962895|364246002|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
105613021|NCT02962895|364246003|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
105613022|NCT02962895|364246004|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
105613023|NCT02962895|364246005|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
105613024|NCT02979522|364246006|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
105613025|NCT02979522|364246007|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
105613026|NCT02979522|364246006|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
105613027|NCT02979522|364246007|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
105613028|NCT05282173|364246008|FG000|Overall Study|Missed|3|||
105613029|NCT05282173|364246009|FG001|Overall Study|Missed|2|||
105613030|NCT05282173|364246010|FG002|Overall Study|Missed|4|||
105613031|NCT05374837|364247407|FG000|Overall Study|Lost to Follow-up|17|||
105613032|NCT05374837|364247408|FG001|Overall Study|Lost to Follow-up|18|||
105613033|NCT03470922|364247409|FG000|Overall Study|Death|107|||
105613034|NCT03470922|364247410|FG001|Overall Study|Death|118|||
105613035|NCT03470922|364247409|FG000|Overall Study|Lost to Follow-up|5|||
105613036|NCT03470922|364247410|FG001|Overall Study|Lost to Follow-up|5|||
105613037|NCT03470922|364247409|FG000|Overall Study|Participant Withdrew Consent|4|||
105613038|NCT03470922|364247410|FG001|Overall Study|Participant Withdrew Consent|9|||
105613039|NCT03470922|364247409|FG000|Overall Study|Other reasons|1|||
105613040|NCT03470922|364247410|FG001|Overall Study|Other reasons|0|||
105613041|NCT03470922|364247409|FG000|Overall Study|Not reported|1|||
105613042|NCT03470922|364247410|FG001|Overall Study|Not reported|0|||
105613043|NCT03393975|364247411|FG000|Urgent Treatment Period|Physician Decision|0|||
105613044|NCT03393975|364247412|FG001|Urgent Treatment Period|Physician Decision|0|||
105613045|NCT03393975|364247413|FG002|Urgent Treatment Period|Physician Decision|0|||
105613046|NCT03393975|364247414|FG003|Urgent Treatment Period|Physician Decision|1|||
105613047|NCT03393975|364247411|FG000|Prophylaxis Period 1|Reason not Specified|0|||
105613048|NCT03393975|364247412|FG001|Prophylaxis Period 1|Reason not Specified|1|||
105613049|NCT03393975|364247413|FG002|Prophylaxis Period 1|Reason not Specified|0|||
105613050|NCT03393975|364247414|FG003|Prophylaxis Period 1|Reason not Specified|0|||
105613051|NCT03393975|364247411|FG000|Prophylaxis Period 2|Reason not Specified|0|||
105613052|NCT03393975|364247412|FG001|Prophylaxis Period 2|Reason not Specified|1|||
105613053|NCT03393975|364247413|FG002|Prophylaxis Period 2|Reason not Specified|0|||
105613054|NCT03393975|364247414|FG003|Prophylaxis Period 2|Reason not Specified|0|||
105613055|NCT04353661|364247416|FG000|Overall Study|Protocol Violation|0|||
105613056|NCT04353661|364247417|FG001|Overall Study|Protocol Violation|0|||
105613057|NCT04353661|364247418|FG002|Overall Study|Protocol Violation|1|||
105613058|NCT04353661|364247416|FG000|Overall Study|Study termination by the Sponsor|1|||
105613059|NCT04353661|364247417|FG001|Overall Study|Study termination by the Sponsor|1|||
105613060|NCT04353661|364247418|FG002|Overall Study|Study termination by the Sponsor|1|||
105613061|NCT03131648|364247419|FG000|Initial Treatment Period|Not dosed|2|||
105613062|NCT03131648|364247420|FG001|Initial Treatment Period|Not dosed|2|||
105613063|NCT03131648|364247421|FG002|Initial Treatment Period|Not dosed|0|||
105613064|NCT03131648|364247422|FG003|Initial Treatment Period|Not dosed|0|||
105613065|NCT03131648|364247423|FG004|Initial Treatment Period|Not dosed|0|||
105613066|NCT03131648|364247424|FG005|Initial Treatment Period|Not dosed|0|||
105613067|NCT03131648|364247425|FG006|Initial Treatment Period|Not dosed|0|||
105613068|NCT03131648|364247426|FG007|Initial Treatment Period|Not dosed|0|||
105613069|NCT03131648|364247419|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
105613070|NCT03131648|364247420|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
105613071|NCT03131648|364247421|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105613072|NCT03131648|364247422|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105613073|NCT03131648|364247423|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105613074|NCT03131648|364247424|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105613075|NCT03131648|364247425|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105613076|NCT03131648|364247426|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105613077|NCT03131648|364247419|FG000|Open-label Treatment|Discontinued IMP|0|||
105613078|NCT03131648|364247420|FG001|Open-label Treatment|Discontinued IMP|0|||
105613079|NCT03131648|364247421|FG002|Open-label Treatment|Discontinued IMP|0|||
105613080|NCT03131648|364247422|FG003|Open-label Treatment|Discontinued IMP|0|||
105613081|NCT03131648|364247423|FG004|Open-label Treatment|Discontinued IMP|0|||
105613082|NCT03131648|364247424|FG005|Open-label Treatment|Discontinued IMP|0|||
105613083|NCT03131648|364247425|FG006|Open-label Treatment|Discontinued IMP|112|||
105613084|NCT03131648|364247426|FG007|Open-label Treatment|Discontinued IMP|0|||
105613085|NCT03131648|364247419|FG000|Open-label Treatment|Completed Week 50|0|||
105613086|NCT03131648|364247420|FG001|Open-label Treatment|Completed Week 50|0|||
105613087|NCT03131648|364247421|FG002|Open-label Treatment|Completed Week 50|0|||
105613088|NCT03131648|364247422|FG003|Open-label Treatment|Completed Week 50|0|||
105613089|NCT03131648|364247423|FG004|Open-label Treatment|Completed Week 50|0|||
105613090|NCT03131648|364247424|FG005|Open-label Treatment|Completed Week 50|0|||
105613091|NCT03131648|364247425|FG006|Open-label Treatment|Completed Week 50|6|||
105613092|NCT03131648|364247426|FG007|Open-label Treatment|Completed Week 50|0|||
105613093|NCT03131648|364247419|FG000|Maintenance Treatment Period|Not dosed|0|||
105613094|NCT03131648|364247420|FG001|Maintenance Treatment Period|Not dosed|0|||
105613095|NCT03131648|364247421|FG002|Maintenance Treatment Period|Not dosed|3|||
105613096|NCT03131648|364247422|FG003|Maintenance Treatment Period|Not dosed|2|||
105613097|NCT03131648|364247423|FG004|Maintenance Treatment Period|Not dosed|1|||
105613098|NCT03131648|364247424|FG005|Maintenance Treatment Period|Not dosed|0|||
105613099|NCT03131648|364247425|FG006|Maintenance Treatment Period|Not dosed|0|||
105613100|NCT03131648|364247426|FG007|Maintenance Treatment Period|Not dosed|0|||
105613101|NCT03131648|364247419|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
105613102|NCT03131648|364247420|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
105613103|NCT03131648|364247421|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
105613104|NCT03131648|364247422|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
105613105|NCT03131648|364247423|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
105613106|NCT03131648|364247424|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
105613107|NCT03131648|364247425|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
105613108|NCT03131648|364247426|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
105613109|NCT03131648|364247419|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
105613110|NCT03131648|364247420|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
105613111|NCT03131648|364247421|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
105613112|NCT03131648|364247422|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
105613113|NCT03131648|364247423|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
105613114|NCT03131648|364247424|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
105613115|NCT03131648|364247425|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
105613116|NCT03131648|364247426|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
105613117|NCT03131648|364247419|FG000|Maintenance Treatment Period|Completed Week 50|0|||
105613118|NCT03131648|364247420|FG001|Maintenance Treatment Period|Completed Week 50|0|||
105613119|NCT03131648|364247421|FG002|Maintenance Treatment Period|Completed Week 50|0|||
105613120|NCT03131648|364247422|FG003|Maintenance Treatment Period|Completed Week 50|0|||
105613121|NCT03131648|364247423|FG004|Maintenance Treatment Period|Completed Week 50|1|||
105613122|NCT03131648|364247424|FG005|Maintenance Treatment Period|Completed Week 50|0|||
105613123|NCT03131648|364247425|FG006|Maintenance Treatment Period|Completed Week 50|0|||
105613124|NCT03131648|364247426|FG007|Maintenance Treatment Period|Completed Week 50|0|||
105613125|NCT03131648|364247419|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
105613126|NCT03131648|364247420|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
105613127|NCT03131648|364247421|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
105613128|NCT03131648|364247422|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
105613129|NCT03131648|364247423|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
105613130|NCT03131648|364247424|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
105613131|NCT03131648|364247425|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
105613132|NCT03131648|364247426|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
105613133|NCT04401267|364247427|FG000|Overall Study|Death|0|||
105613134|NCT04401267|364247428|FG001|Overall Study|Death|1|||
105613135|NCT04401267|364247427|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
105613136|NCT04401267|364247428|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
105613137|NCT04401267|364247427|FG000|Overall Study|Found to be Ineligible|1|||
105613138|NCT04401267|364247428|FG001|Overall Study|Found to be Ineligible|0|||
105613139|NCT02995434|364247438|FG000|Overall Study|Adverse Event|1|||
105613140|NCT02995434|364247439|FG001|Overall Study|Adverse Event|0|||
105613141|NCT02995434|364247438|FG000|Overall Study|Withdrawal by Subject|6|||
105613142|NCT02995434|364247439|FG001|Overall Study|Withdrawal by Subject|3|||
105613143|NCT04956861|364247441|FG000|Overall Study|Withdrawal by Subject|4|||
105613144|NCT04956861|364247442|FG001|Overall Study|Withdrawal by Subject|4|||
105613145|NCT04956861|364247443|FG002|Overall Study|Withdrawal by Subject|2|||
105613146|NCT04956861|364247441|FG000|Overall Study|Physician Decision|4|||
105613147|NCT04956861|364247442|FG001|Overall Study|Physician Decision|5|||
105613148|NCT04956861|364247443|FG002|Overall Study|Physician Decision|1|||
105613149|NCT05229120|364247448|FG000|Overall Study|Withdrawal by Subject|8|||
105613150|NCT05862870|364247449|FG000|Overall Study|Lost to Follow-up|3|||
105613151|NCT04556656|364247450|FG000|Overall Study|Withdrawal by Subject|14|||
105613152|NCT04556656|364247451|FG001|Overall Study|Withdrawal by Subject|12|||
105613153|NCT04556656|364247450|FG000|Overall Study|Physician Decision|1|||
105613154|NCT04556656|364247451|FG001|Overall Study|Physician Decision|0|||
105613155|NCT04556656|364247450|FG000|Overall Study|Adverse Event|4|||
105613156|NCT04556656|364247451|FG001|Overall Study|Adverse Event|7|||
105613157|NCT04556656|364247450|FG000|Overall Study|Death|4|||
105613158|NCT04556656|364247451|FG001|Overall Study|Death|0|||
105613159|NCT04556656|364247450|FG000|Overall Study|Lost to Follow-up|3|||
105613160|NCT04556656|364247451|FG001|Overall Study|Lost to Follow-up|2|||
105613161|NCT04556656|364247450|FG000|Overall Study|Not further specified|2|||
105613162|NCT04556656|364247451|FG001|Overall Study|Not further specified|1|||
105613163|NCT03615326|364247461|FG000|Overall Study|Death|266|||
105613164|NCT03615326|364247462|FG001|Overall Study|Death|286|||
105613165|NCT03615326|364247463|FG002|Overall Study|Death|14|||
105613166|NCT03615326|364247464|FG003|Overall Study|Death|17|||
105613167|NCT03615326|364247461|FG000|Overall Study|Lost to Follow-up|0|||
105613168|NCT03615326|364247462|FG001|Overall Study|Lost to Follow-up|1|||
105613169|NCT03615326|364247463|FG002|Overall Study|Lost to Follow-up|0|||
105613170|NCT03615326|364247464|FG003|Overall Study|Lost to Follow-up|0|||
105613171|NCT03615326|364247461|FG000|Overall Study|Withdrawal by Subject|1|||
105613172|NCT03615326|364247462|FG001|Overall Study|Withdrawal by Subject|3|||
105613173|NCT03615326|364247463|FG002|Overall Study|Withdrawal by Subject|0|||
105613174|NCT03615326|364247464|FG003|Overall Study|Withdrawal by Subject|0|||
105613175|NCT03615326|364247461|FG000|Overall Study|Participants Ongoing|83|||
105613176|NCT03615326|364247462|FG001|Overall Study|Participants Ongoing|58|||
105613177|NCT03615326|364247463|FG002|Overall Study|Participants Ongoing|6|||
105613178|NCT03615326|364247464|FG003|Overall Study|Participants Ongoing|3|||
105613179|NCT01416831|364247465|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
105613180|NCT01416831|364247466|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
105613181|NCT04812535|364247470|FG000|Overall Study|Withdrawal by Subject|0|||
105613182|NCT04812535|364247471|FG001|Overall Study|Withdrawal by Subject|0|||
105613183|NCT04812535|364247472|FG002|Overall Study|Withdrawal by Subject|0|||
105613184|NCT04812535|364247473|FG003|Overall Study|Withdrawal by Subject|1|||
105613185|NCT04812535|364247470|FG000|Overall Study|Death|7|||
105613186|NCT04812535|364247471|FG001|Overall Study|Death|2|||
105613187|NCT04812535|364247472|FG002|Overall Study|Death|4|||
105613188|NCT04812535|364247473|FG003|Overall Study|Death|1|||
105613189|NCT04812535|364247470|FG000|Overall Study|Due to premature study termination by sponsor|2|||
105613190|NCT04812535|364247471|FG001|Overall Study|Due to premature study termination by sponsor|0|||
105613191|NCT04812535|364247472|FG002|Overall Study|Due to premature study termination by sponsor|1|||
105613192|NCT04812535|364247473|FG003|Overall Study|Due to premature study termination by sponsor|3|||
105613193|NCT03436745|364247474|FG000|Overall Study|Ineligible|0|||
105613194|NCT03436745|364247475|FG001|Overall Study|Ineligible|0|||
105613195|NCT03436745|364247476|FG002|Overall Study|Ineligible|1|||
105613196|NCT03336333|364247477|FG000|Overall Study|Remained on study at time of data cut-off|202|||
105613197|NCT03336333|364247478|FG001|Overall Study|Remained on study at time of data cut-off|219|||
105613198|NCT03336333|364247479|FG002|Overall Study|Remained on study at time of data cut-off|102|||
105613199|NCT03336333|364247477|FG000|Overall Study|Death|14|||
105613200|NCT03336333|364247478|FG001|Overall Study|Death|16|||
105613201|NCT03336333|364247479|FG002|Overall Study|Death|8|||
105613202|NCT03336333|364247477|FG000|Overall Study|Withdrawal by Subject|16|||
105613203|NCT03336333|364247478|FG001|Overall Study|Withdrawal by Subject|5|||
105613204|NCT03336333|364247479|FG002|Overall Study|Withdrawal by Subject|1|||
105613205|NCT03336333|364247477|FG000|Overall Study|Physician Decision|5|||
105613206|NCT03336333|364247478|FG001|Overall Study|Physician Decision|1|||
105613207|NCT03336333|364247479|FG002|Overall Study|Physician Decision|0|||
105613208|NCT03336333|364247477|FG000|Overall Study|Lost to Follow-up|1|||
105613209|NCT03336333|364247478|FG001|Overall Study|Lost to Follow-up|0|||
105613210|NCT03336333|364247479|FG002|Overall Study|Lost to Follow-up|0|||
105613211|NCT03406871|364247480|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
105613212|NCT03406871|364247481|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
105613213|NCT03406871|364247482|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
105613214|NCT03406871|364247480|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
105613215|NCT03406871|364247481|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
105613216|NCT03406871|364247482|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
105613217|NCT03406871|364247480|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
105613218|NCT03406871|364247481|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
105613219|NCT03406871|364247482|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
105613220|NCT03406871|364247480|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
105613221|NCT03406871|364247481|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
105613222|NCT03406871|364247482|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
105613223|NCT03406871|364247480|FG000|Expansion Cohort(Final Analysis)|Death|0|||
105613224|NCT03406871|364247481|FG001|Expansion Cohort(Final Analysis)|Death|1|||
105613225|NCT03406871|364247482|FG002|Expansion Cohort(Final Analysis)|Death|0|||
105613226|NCT03406871|364247480|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
105613227|NCT03406871|364247481|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
105613228|NCT03406871|364247482|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
105613229|NCT01748448|364247483|FG000|Treatment Period|Consent withdrawn by subject|1|||
105613230|NCT01748448|364247484|FG001|Treatment Period|Consent withdrawn by subject|0|||
105613231|NCT01748448|364247483|FG000|Treatment Period|Adverse Event|1|||
105613232|NCT01748448|364247484|FG001|Treatment Period|Adverse Event|0|||
105613233|NCT01748448|364247483|FG000|Treatment Period|Personal|0|||
105613234|NCT01748448|364247484|FG001|Treatment Period|Personal|1|||
105613235|NCT05948670|364247486|FG000|Overall Study|Protocol Violation|6|||
105613236|NCT05948670|364247487|FG001|Overall Study|Protocol Violation|8|||
105613237|NCT05948670|364247486|FG000|Overall Study|Withdrawal by Subject|0|||
105613238|NCT05948670|364247487|FG001|Overall Study|Withdrawal by Subject|1|||
105613239|NCT03699709|364247490|FG000|Overall Study|Death|1|||
105613240|NCT03699709|364247491|FG001|Overall Study|Death|2|||
105613241|NCT03699709|364247490|FG000|Overall Study|Lost to Follow-up|10|||
105613242|NCT03699709|364247491|FG001|Overall Study|Lost to Follow-up|3|||
105613243|NCT03699709|364247490|FG000|Overall Study|Withdrawal by Subject|5|||
105613244|NCT03699709|364247491|FG001|Overall Study|Withdrawal by Subject|0|||
105613245|NCT03699709|364247490|FG000|Overall Study|incarcerated|1|||
105613246|NCT03699709|364247491|FG001|Overall Study|incarcerated|0|||
105613247|NCT03699709|364247490|FG000|Overall Study|scheduled, but no show|0|||
105613248|NCT03699709|364247491|FG001|Overall Study|scheduled, but no show|1|||
105613249|NCT02907099|364247492|FG000|Overall Study|Adverse Event|1|||
105613250|NCT02907099|364247492|FG000|Overall Study|Withdrawal by Subject|2|||
105613251|NCT02907099|364247492|FG000|Overall Study|Screen Fail|2|||
105613252|NCT03988608|364247494|FG000|Overall Study|Adverse Event|1|||
105613253|NCT03988608|364247494|FG000|Overall Study|Lost to Follow-up|1|||
105613254|NCT03988608|364247494|FG000|Overall Study|Withdrawal by Subject|3|||
105613255|NCT03988608|364247494|FG000|Overall Study|Death|1|||
105613256|NCT02689284|364247497|FG000|Overall Study|Adverse Event|1|||
105613257|NCT02689284|364247498|FG001|Overall Study|Adverse Event|8|||
105613258|NCT02689284|364247497|FG000|Overall Study|Death|0|||
105613259|NCT02689284|364247498|FG001|Overall Study|Death|1|||
105613260|NCT02689284|364247497|FG000|Overall Study|Physician Decision|1|||
105613261|NCT02689284|364247498|FG001|Overall Study|Physician Decision|2|||
105613262|NCT02689284|364247497|FG000|Overall Study|Withdrawal by Subject|0|||
105613263|NCT02689284|364247498|FG001|Overall Study|Withdrawal by Subject|1|||
105613264|NCT02689284|364247497|FG000|Overall Study|progression of cancer|1|||
105613265|NCT02689284|364247498|FG001|Overall Study|progression of cancer|72|||
105613266|NCT02689284|364247497|FG000|Overall Study|decreased heart function|0|||
105613267|NCT02689284|364247498|FG001|Overall Study|decreased heart function|1|||
105613268|NCT02689284|364247497|FG000|Overall Study|concern for anemia|0|||
105613269|NCT02689284|364247498|FG001|Overall Study|concern for anemia|1|||
105613270|NCT02689284|364247497|FG000|Overall Study|no measurable cancer for evaluation|0|||
105613271|NCT02689284|364247498|FG001|Overall Study|no measurable cancer for evaluation|1|||
105613272|NCT05592418|364247499|FG000|Overall Study|Adverse Event|1|||
105613273|NCT05592418|364247500|FG001|Overall Study|Adverse Event|0|||
105613274|NCT05592418|364247499|FG000|Overall Study|Lost to Follow-up|1|||
105613275|NCT05592418|364247500|FG001|Overall Study|Lost to Follow-up|3|||
105613276|NCT05592418|364247499|FG000|Overall Study|Withdrawal by Subject|2|||
105613277|NCT05592418|364247500|FG001|Overall Study|Withdrawal by Subject|7|||
105613278|NCT05569252|364247503|FG000|Overall Study|Adverse event (central vision loss)|1|||
105613279|NCT05569252|364247504|FG001|Overall Study|Adverse event (central vision loss)|0|||
105613280|NCT05569252|364247505|FG002|Overall Study|Adverse event (central vision loss)|0|||
105613281|NCT05569252|364247506|FG003|Overall Study|Adverse event (central vision loss)|0|||
105613282|NCT04557124|364247507|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
105613283|NCT04557124|364247508|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
105613284|NCT04557124|364247507|FG000|Mid-point (1 Month)|Missed testing|5|||
105613285|NCT04557124|364247508|FG001|Mid-point (1 Month)|Missed testing|4|||
105613286|NCT04557124|364247507|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
105613287|NCT04557124|364247508|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
105613288|NCT04557124|364247507|FG000|Post-testing (2 Months)|Missed testing|1|||
105613289|NCT04557124|364247508|FG001|Post-testing (2 Months)|Missed testing|5|||
105613290|NCT04557124|364247507|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
105613291|NCT04557124|364247508|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
105613292|NCT04557124|364247507|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
105613293|NCT04557124|364247508|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
105613294|NCT03665597|364247509|FG000|Period 1|Adverse Event|1|||
105613295|NCT03665597|364247510|FG001|Period 1|Adverse Event|0|||
105613296|NCT03665597|364247511|FG002|Period 1|Adverse Event|0|||
105613297|NCT03665597|364247512|FG003|Period 1|Adverse Event|1|||
105613298|NCT03665597|364247513|FG004|Period 1|Adverse Event|0|||
105613299|NCT03665597|364247514|FG005|Period 1|Adverse Event|0|||
105613300|NCT03665597|364247515|FG006|Period 1|Adverse Event|0|||
105613301|NCT03665597|364247509|FG000|Period 1|Screen Failure|0|||
105613302|NCT03665597|364247510|FG001|Period 1|Screen Failure|0|||
105613303|NCT03665597|364247511|FG002|Period 1|Screen Failure|0|||
105613304|NCT03665597|364247512|FG003|Period 1|Screen Failure|1|||
105613305|NCT03665597|364247513|FG004|Period 1|Screen Failure|0|||
105613306|NCT03665597|364247514|FG005|Period 1|Screen Failure|0|||
105613307|NCT03665597|364247515|FG006|Period 1|Screen Failure|0|||
105613308|NCT03665597|364247509|FG000|Period 1|Death|0|||
105613309|NCT03665597|364247510|FG001|Period 1|Death|0|||
105613310|NCT03665597|364247511|FG002|Period 1|Death|0|||
105613311|NCT03665597|364247512|FG003|Period 1|Death|0|||
105613312|NCT03665597|364247513|FG004|Period 1|Death|0|||
105613313|NCT03665597|364247514|FG005|Period 1|Death|0|||
105613314|NCT03665597|364247515|FG006|Period 1|Death|45|||
105613315|NCT03665597|364247509|FG000|Period 1|Withdrawal by Subject|0|||
105613316|NCT03665597|364247510|FG001|Period 1|Withdrawal by Subject|0|||
105613317|NCT03665597|364247511|FG002|Period 1|Withdrawal by Subject|0|||
105613318|NCT03665597|364247512|FG003|Period 1|Withdrawal by Subject|0|||
105613319|NCT03665597|364247513|FG004|Period 1|Withdrawal by Subject|0|||
105613320|NCT03665597|364247514|FG005|Period 1|Withdrawal by Subject|0|||
105613321|NCT03665597|364247515|FG006|Period 1|Withdrawal by Subject|5|||
105613322|NCT03665597|364247509|FG000|Period 2|Adverse Event|0|||
105613323|NCT03665597|364247510|FG001|Period 2|Adverse Event|0|||
105613324|NCT03665597|364247511|FG002|Period 2|Adverse Event|0|||
105613325|NCT03665597|364247512|FG003|Period 2|Adverse Event|0|||
105613326|NCT03665597|364247513|FG004|Period 2|Adverse Event|0|||
105613327|NCT03665597|364247514|FG005|Period 2|Adverse Event|1|||
105613328|NCT03665597|364247515|FG006|Period 2|Adverse Event|0|||
105613329|NCT03665597|364247509|FG000|Period 3|Adverse Event|0|||
105613330|NCT03665597|364247510|FG001|Period 3|Adverse Event|1|||
105613331|NCT03665597|364247511|FG002|Period 3|Adverse Event|0|||
105613332|NCT03665597|364247512|FG003|Period 3|Adverse Event|0|||
105613333|NCT03665597|364247513|FG004|Period 3|Adverse Event|0|||
105613334|NCT03665597|364247514|FG005|Period 3|Adverse Event|0|||
105613335|NCT03665597|364247515|FG006|Period 3|Adverse Event|0|||
105613336|NCT03665597|364247509|FG000|Period 3|Death|0|||
105613337|NCT03665597|364247510|FG001|Period 3|Death|0|||
105613338|NCT03665597|364247511|FG002|Period 3|Death|0|||
105613339|NCT03665597|364247512|FG003|Period 3|Death|0|||
105613340|NCT03665597|364247513|FG004|Period 3|Death|1|||
105613341|NCT03665597|364247514|FG005|Period 3|Death|0|||
105613342|NCT03665597|364247515|FG006|Period 3|Death|0|||
105613343|NCT03665597|364247509|FG000|Period 4|Adverse Event|2|||
105613344|NCT03665597|364247510|FG001|Period 4|Adverse Event|2|||
105613345|NCT03665597|364247511|FG002|Period 4|Adverse Event|2|||
105613346|NCT03665597|364247512|FG003|Period 4|Adverse Event|2|||
105613347|NCT03665597|364247513|FG004|Period 4|Adverse Event|1|||
105613348|NCT03665597|364247514|FG005|Period 4|Adverse Event|0|||
105613349|NCT03665597|364247515|FG006|Period 4|Adverse Event|0|||
105613350|NCT03665597|364247509|FG000|Period 4|Death|0|||
105613351|NCT03665597|364247510|FG001|Period 4|Death|0|||
105613352|NCT03665597|364247511|FG002|Period 4|Death|2|||
105613353|NCT03665597|364247512|FG003|Period 4|Death|0|||
105613354|NCT03665597|364247513|FG004|Period 4|Death|0|||
105613355|NCT03665597|364247514|FG005|Period 4|Death|0|||
105613356|NCT03665597|364247515|FG006|Period 4|Death|0|||
105613357|NCT03665597|364247509|FG000|Period 4|Physician Decision|1|||
105613358|NCT03665597|364247510|FG001|Period 4|Physician Decision|2|||
105613359|NCT03665597|364247511|FG002|Period 4|Physician Decision|0|||
105613360|NCT03665597|364247512|FG003|Period 4|Physician Decision|0|||
105613361|NCT03665597|364247513|FG004|Period 4|Physician Decision|0|||
105613362|NCT03665597|364247514|FG005|Period 4|Physician Decision|0|||
105613363|NCT03665597|364247515|FG006|Period 4|Physician Decision|0|||
105613364|NCT03920111|364247518|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
105613365|NCT03920111|364247519|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
105613366|NCT03920111|364247520|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
105613367|NCT03110315|364247523|FG000|Overall Study|Withdrawal by Subject|1|||
105613368|NCT03110315|364247524|FG001|Overall Study|Withdrawal by Subject|0|||
105613369|NCT04176965|364247528|FG000|Overall Study|Death|1|||
105613370|NCT04176965|364247529|FG001|Overall Study|Death|2|||
105613371|NCT04176965|364247528|FG000|Overall Study|Lost to Follow-up|10|||
105613372|NCT04176965|364247529|FG001|Overall Study|Lost to Follow-up|2|||
105613373|NCT04176965|364247528|FG000|Overall Study|Withdrawal by Subject|6|||
105613374|NCT04176965|364247529|FG001|Overall Study|Withdrawal by Subject|1|||
105613375|NCT04209465|364247530|FG000|Overall Study|Adverse Event|0|||
105613376|NCT04209465|364247531|FG001|Overall Study|Adverse Event|0|||
105613377|NCT04209465|364247532|FG002|Overall Study|Adverse Event|0|||
105613378|NCT04209465|364247533|FG003|Overall Study|Adverse Event|0|||
105613379|NCT04209465|364247534|FG004|Overall Study|Adverse Event|0|||
105613380|NCT04209465|364247535|FG005|Overall Study|Adverse Event|1|||
105613381|NCT04209465|364247536|FG006|Overall Study|Adverse Event|0|||
105613382|NCT04209465|364247537|FG007|Overall Study|Adverse Event|0|||
105613383|NCT04209465|364247538|FG008|Overall Study|Adverse Event|1|||
105613384|NCT04209465|364247539|FG009|Overall Study|Adverse Event|0|||
105613385|NCT04209465|364247540|FG010|Overall Study|Adverse Event|2|||
105613386|NCT04209465|364247541|FG011|Overall Study|Adverse Event|1|||
105613387|NCT04209465|364247542|FG012|Overall Study|Adverse Event|1|||
105613388|NCT04209465|364247530|FG000|Overall Study|Death|1|||
105613389|NCT04209465|364247531|FG001|Overall Study|Death|0|||
105613390|NCT04209465|364247532|FG002|Overall Study|Death|0|||
105613391|NCT04209465|364247533|FG003|Overall Study|Death|0|||
105613392|NCT04209465|364247534|FG004|Overall Study|Death|2|||
105613393|NCT04209465|364247535|FG005|Overall Study|Death|7|||
105613394|NCT04209465|364247536|FG006|Overall Study|Death|2|||
105613395|NCT04209465|364247537|FG007|Overall Study|Death|2|||
105613396|NCT04209465|364247538|FG008|Overall Study|Death|1|||
105613397|NCT04209465|364247539|FG009|Overall Study|Death|1|||
105613398|NCT04209465|364247540|FG010|Overall Study|Death|1|||
105613399|NCT04209465|364247541|FG011|Overall Study|Death|0|||
105613400|NCT04209465|364247542|FG012|Overall Study|Death|10|||
105613401|NCT04209465|364247530|FG000|Overall Study|Physician Decision|0|||
105613402|NCT04209465|364247531|FG001|Overall Study|Physician Decision|1|||
105613403|NCT04209465|364247532|FG002|Overall Study|Physician Decision|0|||
105613404|NCT04209465|364247533|FG003|Overall Study|Physician Decision|0|||
105613405|NCT04209465|364247534|FG004|Overall Study|Physician Decision|0|||
105613406|NCT04209465|364247535|FG005|Overall Study|Physician Decision|0|||
105613407|NCT04209465|364247536|FG006|Overall Study|Physician Decision|0|||
105613408|NCT04209465|364247537|FG007|Overall Study|Physician Decision|0|||
105613409|NCT04209465|364247538|FG008|Overall Study|Physician Decision|0|||
105613410|NCT04209465|364247539|FG009|Overall Study|Physician Decision|0|||
105613411|NCT04209465|364247540|FG010|Overall Study|Physician Decision|0|||
105613412|NCT04209465|364247541|FG011|Overall Study|Physician Decision|0|||
105613413|NCT04209465|364247542|FG012|Overall Study|Physician Decision|0|||
105613414|NCT04209465|364247530|FG000|Overall Study|Progressive Disease|0|||
105613415|NCT04209465|364247531|FG001|Overall Study|Progressive Disease|0|||
105613416|NCT04209465|364247532|FG002|Overall Study|Progressive Disease|1|||
105613417|NCT04209465|364247533|FG003|Overall Study|Progressive Disease|2|||
105613418|NCT04209465|364247534|FG004|Overall Study|Progressive Disease|8|||
105613419|NCT04209465|364247535|FG005|Overall Study|Progressive Disease|5|||
105613420|NCT04209465|364247536|FG006|Overall Study|Progressive Disease|3|||
105613421|NCT04209465|364247537|FG007|Overall Study|Progressive Disease|4|||
105613422|NCT04209465|364247538|FG008|Overall Study|Progressive Disease|1|||
105613423|NCT04209465|364247539|FG009|Overall Study|Progressive Disease|3|||
105613424|NCT04209465|364247540|FG010|Overall Study|Progressive Disease|2|||
105613425|NCT04209465|364247541|FG011|Overall Study|Progressive Disease|1|||
105613426|NCT04209465|364247542|FG012|Overall Study|Progressive Disease|0|||
105613427|NCT04209465|364247530|FG000|Overall Study|Withdrawal by Subject|0|||
105613428|NCT04209465|364247531|FG001|Overall Study|Withdrawal by Subject|0|||
105613429|NCT04209465|364247532|FG002|Overall Study|Withdrawal by Subject|0|||
105613430|NCT04209465|364247533|FG003|Overall Study|Withdrawal by Subject|0|||
105613431|NCT04209465|364247534|FG004|Overall Study|Withdrawal by Subject|0|||
105613432|NCT04209465|364247535|FG005|Overall Study|Withdrawal by Subject|1|||
105613433|NCT04209465|364247536|FG006|Overall Study|Withdrawal by Subject|2|||
105613434|NCT04209465|364247537|FG007|Overall Study|Withdrawal by Subject|0|||
105613435|NCT04209465|364247538|FG008|Overall Study|Withdrawal by Subject|1|||
105613436|NCT04209465|364247539|FG009|Overall Study|Withdrawal by Subject|0|||
105613437|NCT04209465|364247540|FG010|Overall Study|Withdrawal by Subject|0|||
105613438|NCT04209465|364247541|FG011|Overall Study|Withdrawal by Subject|2|||
105613439|NCT04209465|364247542|FG012|Overall Study|Withdrawal by Subject|2|||
105613440|NCT04209465|364247530|FG000|Overall Study|Lost to Follow-up|0|||
105613441|NCT04209465|364247531|FG001|Overall Study|Lost to Follow-up|0|||
105613442|NCT04209465|364247532|FG002|Overall Study|Lost to Follow-up|0|||
105613443|NCT04209465|364247533|FG003|Overall Study|Lost to Follow-up|0|||
105613444|NCT04209465|364247534|FG004|Overall Study|Lost to Follow-up|0|||
105613445|NCT04209465|364247535|FG005|Overall Study|Lost to Follow-up|1|||
105613446|NCT04209465|364247536|FG006|Overall Study|Lost to Follow-up|0|||
105613447|NCT04209465|364247537|FG007|Overall Study|Lost to Follow-up|0|||
105613448|NCT04209465|364247538|FG008|Overall Study|Lost to Follow-up|1|||
105613449|NCT04209465|364247539|FG009|Overall Study|Lost to Follow-up|0|||
105613450|NCT04209465|364247540|FG010|Overall Study|Lost to Follow-up|0|||
105613451|NCT04209465|364247541|FG011|Overall Study|Lost to Follow-up|1|||
105613452|NCT04209465|364247542|FG012|Overall Study|Lost to Follow-up|0|||
105613453|NCT04209465|364247530|FG000|Overall Study|Started new therapy|0|||
105613454|NCT04209465|364247531|FG001|Overall Study|Started new therapy|0|||
105613455|NCT04209465|364247532|FG002|Overall Study|Started new therapy|0|||
105613456|NCT04209465|364247533|FG003|Overall Study|Started new therapy|0|||
105613457|NCT04209465|364247534|FG004|Overall Study|Started new therapy|0|||
105613458|NCT04209465|364247535|FG005|Overall Study|Started new therapy|1|||
105613459|NCT04209465|364247536|FG006|Overall Study|Started new therapy|0|||
105613460|NCT04209465|364247537|FG007|Overall Study|Started new therapy|0|||
105613461|NCT04209465|364247538|FG008|Overall Study|Started new therapy|0|||
105613462|NCT04209465|364247539|FG009|Overall Study|Started new therapy|0|||
105613463|NCT04209465|364247540|FG010|Overall Study|Started new therapy|0|||
105613464|NCT04209465|364247541|FG011|Overall Study|Started new therapy|0|||
105613465|NCT04209465|364247542|FG012|Overall Study|Started new therapy|0|||
105613466|NCT04209465|364247530|FG000|Overall Study|Study terminated early by sponsor|0|||
105613467|NCT04209465|364247531|FG001|Overall Study|Study terminated early by sponsor|0|||
105613468|NCT04209465|364247532|FG002|Overall Study|Study terminated early by sponsor|0|||
105613469|NCT04209465|364247533|FG003|Overall Study|Study terminated early by sponsor|0|||
105613470|NCT04209465|364247534|FG004|Overall Study|Study terminated early by sponsor|0|||
105613471|NCT04209465|364247535|FG005|Overall Study|Study terminated early by sponsor|0|||
105613472|NCT04209465|364247536|FG006|Overall Study|Study terminated early by sponsor|3|||
105613473|NCT04209465|364247537|FG007|Overall Study|Study terminated early by sponsor|0|||
105613474|NCT04209465|364247538|FG008|Overall Study|Study terminated early by sponsor|0|||
105613475|NCT04209465|364247539|FG009|Overall Study|Study terminated early by sponsor|0|||
105613476|NCT04209465|364247540|FG010|Overall Study|Study terminated early by sponsor|0|||
105613477|NCT04209465|364247541|FG011|Overall Study|Study terminated early by sponsor|0|||
105613478|NCT04209465|364247542|FG012|Overall Study|Study terminated early by sponsor|3|||
105613479|NCT04209465|364247530|FG000|Overall Study|Other|0|||
105613480|NCT04209465|364247531|FG001|Overall Study|Other|0|||
105613481|NCT04209465|364247532|FG002|Overall Study|Other|0|||
105613482|NCT04209465|364247533|FG003|Overall Study|Other|0|||
105613483|NCT04209465|364247534|FG004|Overall Study|Other|0|||
105613484|NCT04209465|364247535|FG005|Overall Study|Other|0|||
105613485|NCT04209465|364247536|FG006|Overall Study|Other|0|||
105613486|NCT04209465|364247537|FG007|Overall Study|Other|0|||
105613487|NCT04209465|364247538|FG008|Overall Study|Other|1|||
105613488|NCT04209465|364247539|FG009|Overall Study|Other|0|||
105613489|NCT04209465|364247540|FG010|Overall Study|Other|0|||
105613490|NCT04209465|364247541|FG011|Overall Study|Other|0|||
105613491|NCT04209465|364247542|FG012|Overall Study|Other|0|||
105613492|NCT05030233|364247543|FG000|Overall Study|withdrawn for transfer|1|||
105613493|NCT05030233|364247544|FG001|Overall Study|withdrawn for transfer|0|||
105613494|NCT03365882|364247545|FG000|Randomization|Still Receiving Protocol Treatment|2|||
105613495|NCT03365882|364247546|FG001|Randomization|Still Receiving Protocol Treatment|0|||
105613496|NCT03365882|364247545|FG000|Randomization|Adverse Event|1|||
105613497|NCT03365882|364247546|FG001|Randomization|Adverse Event|2|||
105613498|NCT03365882|364247545|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
105613499|NCT03365882|364247546|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
105613500|NCT03365882|364247545|FG000|Randomization|Progression/Relapse|21|||
105613501|NCT03365882|364247546|FG001|Randomization|Progression/Relapse|3|||
105613502|NCT03365882|364247545|FG000|Randomization|Death|1|||
105613503|NCT03365882|364247546|FG001|Randomization|Death|0|||
105613504|NCT03365882|364247545|FG000|Randomization|Other - Not Protocol Specified|1|||
105613505|NCT03365882|364247546|FG001|Randomization|Other - Not Protocol Specified|1|||
105613506|NCT03365882|364247545|FG000|Randomization|Major Protocol Deviation|0|||
105613507|NCT03365882|364247546|FG001|Randomization|Major Protocol Deviation|1|||
105613508|NCT03365882|364247545|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
105613509|NCT03365882|364247546|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
105613510|NCT03365882|364247545|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
105613511|NCT03365882|364247546|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
105613512|NCT03365882|364247545|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
105613513|NCT03365882|364247546|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
105613514|NCT03365882|364247545|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
105613515|NCT03365882|364247546|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
105613516|NCT04437615|364247547|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
105613517|NCT02506959|364249544|FG000|Overall Study|Physician Decision|2|||
105613518|NCT02506959|364249545|FG001|Overall Study|Physician Decision|1|||
105613519|NCT03338790|364249554|FG000|Overall Study|Disease Progression|65|||
105613520|NCT03338790|364249555|FG001|Overall Study|Disease Progression|43|||
105613521|NCT03338790|364249556|FG002|Overall Study|Disease Progression|50|||
105613522|NCT03338790|364249557|FG003|Overall Study|Disease Progression|37|||
105613523|NCT03338790|364249554|FG000|Overall Study|Study Drug Toxicity|9|||
105613524|NCT03338790|364249555|FG001|Overall Study|Study Drug Toxicity|8|||
105613525|NCT03338790|364249556|FG002|Overall Study|Study Drug Toxicity|15|||
105613526|NCT03338790|364249557|FG003|Overall Study|Study Drug Toxicity|0|||
105613527|NCT03338790|364249554|FG000|Overall Study|Death|1|||
105613528|NCT03338790|364249555|FG001|Overall Study|Death|1|||
105613529|NCT03338790|364249556|FG002|Overall Study|Death|1|||
105613530|NCT03338790|364249557|FG003|Overall Study|Death|0|||
105613531|NCT03338790|364249554|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
105613532|NCT03338790|364249555|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
105613533|NCT03338790|364249556|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
105613534|NCT03338790|364249557|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
105613535|NCT03338790|364249554|FG000|Overall Study|Participant request to discontinue study treatment|3|||
105613536|NCT03338790|364249555|FG001|Overall Study|Participant request to discontinue study treatment|3|||
105613537|NCT03338790|364249556|FG002|Overall Study|Participant request to discontinue study treatment|2|||
105613538|NCT03338790|364249557|FG003|Overall Study|Participant request to discontinue study treatment|1|||
105613539|NCT03338790|364249554|FG000|Overall Study|Poor/non-compliance|0|||
105613540|NCT03338790|364249555|FG001|Overall Study|Poor/non-compliance|1|||
105613541|NCT03338790|364249556|FG002|Overall Study|Poor/non-compliance|0|||
105613542|NCT03338790|364249557|FG003|Overall Study|Poor/non-compliance|0|||
105613543|NCT03338790|364249554|FG000|Overall Study|Participant withdrew consent|1|||
105613544|NCT03338790|364249555|FG001|Overall Study|Participant withdrew consent|0|||
105613545|NCT03338790|364249556|FG002|Overall Study|Participant withdrew consent|1|||
105613546|NCT03338790|364249557|FG003|Overall Study|Participant withdrew consent|1|||
105613547|NCT03338790|364249554|FG000|Overall Study|Other reasons|0|||
105613548|NCT03338790|364249555|FG001|Overall Study|Other reasons|5|||
105613549|NCT03338790|364249556|FG002|Overall Study|Other reasons|0|||
105613550|NCT03338790|364249557|FG003|Overall Study|Other reasons|2|||
105613551|NCT03338790|364249554|FG000|Overall Study|Not reported|0|||
105613552|NCT03338790|364249555|FG001|Overall Study|Not reported|0|||
105613553|NCT03338790|364249556|FG002|Overall Study|Not reported|1|||
105613554|NCT03338790|364249557|FG003|Overall Study|Not reported|0|||
105613555|NCT03338790|364249554|FG000|Overall Study|Completed treatment period|1|||
105613556|NCT03338790|364249555|FG001|Overall Study|Completed treatment period|2|||
105613557|NCT03338790|364249556|FG002|Overall Study|Completed treatment period|0|||
105613558|NCT03338790|364249557|FG003|Overall Study|Completed treatment period|0|||
105613559|NCT02783300|364249558|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613560|NCT02783300|364249559|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613561|NCT02783300|364249560|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613562|NCT02783300|364249561|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613563|NCT02783300|364249562|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613564|NCT02783300|364249563|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613565|NCT02783300|364249564|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
105613566|NCT02783300|364249565|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613567|NCT02783300|364249566|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613568|NCT02783300|364249567|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613569|NCT02783300|364249568|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613570|NCT02783300|364249569|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613571|NCT02783300|364249570|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613572|NCT02783300|364249571|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613573|NCT02783300|364249572|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613574|NCT02783300|364249573|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613575|NCT02783300|364249574|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613576|NCT02783300|364249575|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613577|NCT02783300|364249576|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613578|NCT02783300|364249577|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613579|NCT02783300|364249578|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613580|NCT02783300|364249579|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613581|NCT02783300|364249580|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613582|NCT02783300|364249581|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613583|NCT02783300|364249582|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613584|NCT02783300|364249583|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613585|NCT02783300|364249584|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
105613586|NCT02783300|364249558|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613587|NCT02783300|364249559|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613588|NCT02783300|364249560|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613589|NCT02783300|364249561|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
105613590|NCT02783300|364249562|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613591|NCT02783300|364249563|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613592|NCT02783300|364249564|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613593|NCT02783300|364249565|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613594|NCT02783300|364249566|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613595|NCT02783300|364249567|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613596|NCT02783300|364249568|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613597|NCT02783300|364249569|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613598|NCT02783300|364249570|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613599|NCT02783300|364249571|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613600|NCT02783300|364249572|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613601|NCT02783300|364249573|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613602|NCT02783300|364249574|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613603|NCT02783300|364249575|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613604|NCT02783300|364249576|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613605|NCT02783300|364249577|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613606|NCT02783300|364249578|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613607|NCT02783300|364249579|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613608|NCT02783300|364249580|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613609|NCT02783300|364249581|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613610|NCT02783300|364249582|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613611|NCT02783300|364249583|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613612|NCT02783300|364249584|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
105613613|NCT02783300|364249558|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
105613614|NCT02783300|364249559|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
105613615|NCT02783300|364249560|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
105613616|NCT02783300|364249561|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
105613617|NCT02783300|364249562|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
105613618|NCT02783300|364249563|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
105613619|NCT02783300|364249564|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
105613620|NCT02783300|364249565|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
105613621|NCT02783300|364249566|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
105613622|NCT02783300|364249567|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
105613623|NCT02783300|364249568|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
105613624|NCT02783300|364249569|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
105613625|NCT02783300|364249570|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
105613626|NCT02783300|364249571|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
105613627|NCT02783300|364249572|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
105613628|NCT02783300|364249573|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
105613629|NCT02783300|364249574|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
105613630|NCT02783300|364249575|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
105613631|NCT02783300|364249576|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
105613632|NCT02783300|364249577|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
105613633|NCT02783300|364249578|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
105613634|NCT02783300|364249579|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
105613635|NCT02783300|364249580|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
105613636|NCT02783300|364249581|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
105613637|NCT02783300|364249582|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
105613638|NCT02783300|364249583|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
105613639|NCT02783300|364249584|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
105613640|NCT02783300|364249558|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613641|NCT02783300|364249559|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613642|NCT02783300|364249560|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613643|NCT02783300|364249561|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613644|NCT02783300|364249562|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613645|NCT02783300|364249563|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613646|NCT02783300|364249564|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
105613647|NCT02783300|364249565|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613648|NCT02783300|364249566|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613649|NCT02783300|364249567|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613650|NCT02783300|364249568|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613651|NCT02783300|364249569|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613652|NCT02783300|364249570|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
105613653|NCT02783300|364249571|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613654|NCT02783300|364249572|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613655|NCT02783300|364249573|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613656|NCT02783300|364249574|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613657|NCT02783300|364249575|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613658|NCT02783300|364249576|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613659|NCT02783300|364249577|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613660|NCT02783300|364249578|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613661|NCT02783300|364249579|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613662|NCT02783300|364249580|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613663|NCT02783300|364249581|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613664|NCT02783300|364249582|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613665|NCT02783300|364249583|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613666|NCT02783300|364249584|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
105613667|NCT02783300|364249558|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613668|NCT02783300|364249559|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613669|NCT02783300|364249560|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613670|NCT02783300|364249561|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613671|NCT02783300|364249562|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
105613672|NCT02783300|364249563|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613673|NCT02783300|364249564|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
105613674|NCT02783300|364249565|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613675|NCT02783300|364249566|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613676|NCT02783300|364249567|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
105613677|NCT02783300|364249568|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613678|NCT02783300|364249569|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613679|NCT02783300|364249570|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
105613680|NCT02783300|364249571|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613681|NCT02783300|364249572|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613682|NCT02783300|364249573|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613683|NCT02783300|364249574|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613684|NCT02783300|364249575|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613685|NCT02783300|364249576|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613686|NCT02783300|364249577|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613687|NCT02783300|364249578|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613688|NCT02783300|364249579|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613689|NCT02783300|364249580|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613690|NCT02783300|364249581|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613691|NCT02783300|364249582|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613692|NCT02783300|364249583|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613693|NCT02783300|364249584|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
105613694|NCT02783300|364249558|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613695|NCT02783300|364249559|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613696|NCT02783300|364249560|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613697|NCT02783300|364249561|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613698|NCT02783300|364249562|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613699|NCT02783300|364249563|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613700|NCT02783300|364249564|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613701|NCT02783300|364249565|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613702|NCT02783300|364249566|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613703|NCT02783300|364249567|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613704|NCT02783300|364249568|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613705|NCT02783300|364249569|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613706|NCT02783300|364249570|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613707|NCT02783300|364249571|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613708|NCT02783300|364249572|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613709|NCT02783300|364249573|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
105613710|NCT02783300|364249574|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613711|NCT02783300|364249575|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
105613712|NCT02783300|364249576|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
105613713|NCT02783300|364249577|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
105613714|NCT02783300|364249578|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613715|NCT02783300|364249579|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613716|NCT02783300|364249580|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613717|NCT02783300|364249581|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613718|NCT02783300|364249582|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
105613719|NCT02783300|364249583|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613720|NCT02783300|364249584|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
105613721|NCT02783300|364249558|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613722|NCT02783300|364249559|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613723|NCT02783300|364249560|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613724|NCT02783300|364249561|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613725|NCT02783300|364249562|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613726|NCT02783300|364249563|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613727|NCT02783300|364249564|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613728|NCT02783300|364249565|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613729|NCT02783300|364249566|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613730|NCT02783300|364249567|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613731|NCT02783300|364249568|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613732|NCT02783300|364249569|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613733|NCT02783300|364249570|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613734|NCT02783300|364249571|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613735|NCT02783300|364249572|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613736|NCT02783300|364249573|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613737|NCT02783300|364249574|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
105613738|NCT02783300|364249575|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613739|NCT02783300|364249576|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
105613740|NCT02783300|364249577|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
105613741|NCT02783300|364249578|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613742|NCT02783300|364249579|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613743|NCT02783300|364249580|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613744|NCT02783300|364249581|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613745|NCT02783300|364249582|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613746|NCT02783300|364249583|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613747|NCT02783300|364249584|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
105613748|NCT02783300|364249558|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613749|NCT02783300|364249559|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613750|NCT02783300|364249560|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613751|NCT02783300|364249561|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613752|NCT02783300|364249562|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613753|NCT02783300|364249563|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613754|NCT02783300|364249564|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613755|NCT02783300|364249565|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613756|NCT02783300|364249566|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613757|NCT02783300|364249567|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613758|NCT02783300|364249568|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613759|NCT02783300|364249569|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613760|NCT02783300|364249570|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613761|NCT02783300|364249571|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613762|NCT02783300|364249572|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613763|NCT02783300|364249573|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613764|NCT02783300|364249574|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
105613765|NCT02783300|364249575|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613766|NCT02783300|364249576|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
105613767|NCT02783300|364249577|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
105613768|NCT02783300|364249578|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
105613769|NCT02783300|364249579|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613770|NCT02783300|364249580|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613771|NCT02783300|364249581|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613772|NCT02783300|364249582|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613773|NCT02783300|364249583|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613774|NCT02783300|364249584|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
105613775|NCT02783300|364249558|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613776|NCT02783300|364249559|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613777|NCT02783300|364249560|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613778|NCT02783300|364249561|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613779|NCT02783300|364249562|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613780|NCT02783300|364249563|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613781|NCT02783300|364249564|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613782|NCT02783300|364249565|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613783|NCT02783300|364249566|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613784|NCT02783300|364249567|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613785|NCT02783300|364249568|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613786|NCT02783300|364249569|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613787|NCT02783300|364249570|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613788|NCT02783300|364249571|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613789|NCT02783300|364249572|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613790|NCT02783300|364249573|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
105613791|NCT02783300|364249574|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613792|NCT02783300|364249575|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613793|NCT02783300|364249576|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613794|NCT02783300|364249577|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613795|NCT02783300|364249578|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613796|NCT02783300|364249579|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613797|NCT02783300|364249580|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
105613798|NCT02783300|364249581|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613799|NCT02783300|364249582|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613800|NCT02783300|364249583|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613801|NCT02783300|364249584|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
105613802|NCT02783300|364249558|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613803|NCT02783300|364249559|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613804|NCT02783300|364249560|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613805|NCT02783300|364249561|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613806|NCT02783300|364249562|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613807|NCT02783300|364249563|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613808|NCT02783300|364249564|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613809|NCT02783300|364249565|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613810|NCT02783300|364249566|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613811|NCT02783300|364249567|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613812|NCT02783300|364249568|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613813|NCT02783300|364249569|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613814|NCT02783300|364249570|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613815|NCT02783300|364249571|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
105613816|NCT02783300|364249572|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
105613817|NCT02783300|364249573|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
105613818|NCT02783300|364249574|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
105613819|NCT02783300|364249575|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613820|NCT02783300|364249576|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
105613821|NCT02783300|364249577|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
105613822|NCT02783300|364249578|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613823|NCT02783300|364249579|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613824|NCT02783300|364249580|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613825|NCT02783300|364249581|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613826|NCT02783300|364249582|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613827|NCT02783300|364249583|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613828|NCT02783300|364249584|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
105613829|NCT02783300|364249558|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
105613830|NCT02783300|364249559|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
105613831|NCT02783300|364249560|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
105613832|NCT02783300|364249561|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
105613833|NCT02783300|364249562|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
105613834|NCT02783300|364249563|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
105613835|NCT02783300|364249564|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
105613836|NCT02783300|364249565|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
105613837|NCT02783300|364249566|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
105613838|NCT02783300|364249567|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
105613839|NCT02783300|364249568|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
105613840|NCT02783300|364249569|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
105613841|NCT02783300|364249570|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
105613842|NCT02783300|364249571|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
105613843|NCT02783300|364249572|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
105613844|NCT02783300|364249573|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
105613845|NCT02783300|364249574|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
105613846|NCT02783300|364249575|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
105613847|NCT02783300|364249576|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
105613848|NCT02783300|364249577|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
105613849|NCT02783300|364249578|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
105613850|NCT02783300|364249579|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
105613851|NCT02783300|364249580|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
105613852|NCT02783300|364249581|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
105613853|NCT02783300|364249582|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
105613854|NCT02783300|364249583|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
105613855|NCT02783300|364249584|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
105613856|NCT02783300|364249558|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613857|NCT02783300|364249559|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613858|NCT02783300|364249560|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613859|NCT02783300|364249561|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613860|NCT02783300|364249562|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613861|NCT02783300|364249563|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613862|NCT02783300|364249564|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613863|NCT02783300|364249565|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613864|NCT02783300|364249566|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613865|NCT02783300|364249567|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613866|NCT02783300|364249568|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613867|NCT02783300|364249569|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613868|NCT02783300|364249570|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613869|NCT02783300|364249571|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613870|NCT02783300|364249572|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613871|NCT02783300|364249573|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613872|NCT02783300|364249574|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613873|NCT02783300|364249575|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613874|NCT02783300|364249576|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613875|NCT02783300|364249577|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613876|NCT02783300|364249578|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613877|NCT02783300|364249579|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613878|NCT02783300|364249580|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613879|NCT02783300|364249581|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613880|NCT02783300|364249582|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613881|NCT02783300|364249583|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
105613882|NCT02783300|364249584|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
105613883|NCT02783300|364249558|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613884|NCT02783300|364249559|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613885|NCT02783300|364249560|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613886|NCT02783300|364249561|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613887|NCT02783300|364249562|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613888|NCT02783300|364249563|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613889|NCT02783300|364249564|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613890|NCT02783300|364249565|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613891|NCT02783300|364249566|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613892|NCT02783300|364249567|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613893|NCT02783300|364249568|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613894|NCT02783300|364249569|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613895|NCT02783300|364249570|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613896|NCT02783300|364249571|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613897|NCT02783300|364249572|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613898|NCT02783300|364249573|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613899|NCT02783300|364249574|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613900|NCT02783300|364249575|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613901|NCT02783300|364249576|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613902|NCT02783300|364249577|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613903|NCT02783300|364249578|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613904|NCT02783300|364249579|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613905|NCT02783300|364249580|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613906|NCT02783300|364249581|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613907|NCT02783300|364249582|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613908|NCT02783300|364249583|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
105613909|NCT02783300|364249584|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
105613910|NCT03535272|364249585|FG000|Overall Study|Lost to Follow-up|71|||
105613911|NCT03535272|364249586|FG001|Overall Study|Lost to Follow-up|73|||
105613912|NCT04177823|364249592|FG000|Overall Study|Physician Decision|1|||
105613913|NCT04177823|364249592|FG000|Overall Study|Withdrawal by Subject|1|||
105613914|NCT05178316|364249593|FG000|Overall Study|Adverse Event|5|||
105613915|NCT05178316|364249594|FG001|Overall Study|Adverse Event|4|||
105613916|NCT05178316|364249595|FG002|Overall Study|Adverse Event|9|||
105613917|NCT05178316|364249593|FG000|Overall Study|Enrolled in Error|1|||
105613918|NCT05178316|364249594|FG001|Overall Study|Enrolled in Error|2|||
105613919|NCT05178316|364249595|FG002|Overall Study|Enrolled in Error|1|||
105613920|NCT05178316|364249593|FG000|Overall Study|Lost to Follow-up|3|||
105613921|NCT05178316|364249594|FG001|Overall Study|Lost to Follow-up|15|||
105613922|NCT05178316|364249595|FG002|Overall Study|Lost to Follow-up|11|||
105613923|NCT05178316|364249593|FG000|Overall Study|Noncompliance|1|||
105613924|NCT05178316|364249594|FG001|Overall Study|Noncompliance|3|||
105613925|NCT05178316|364249595|FG002|Overall Study|Noncompliance|1|||
105613926|NCT05178316|364249593|FG000|Overall Study|Other|0|||
105613927|NCT05178316|364249594|FG001|Overall Study|Other|1|||
105613928|NCT05178316|364249595|FG002|Overall Study|Other|0|||
105613929|NCT05178316|364249593|FG000|Overall Study|Physician Decision|0|||
105613930|NCT05178316|364249594|FG001|Overall Study|Physician Decision|3|||
105613931|NCT05178316|364249595|FG002|Overall Study|Physician Decision|2|||
105613932|NCT05178316|364249593|FG000|Overall Study|Protocol deviation|1|||
105613933|NCT05178316|364249594|FG001|Overall Study|Protocol deviation|0|||
105613934|NCT05178316|364249595|FG002|Overall Study|Protocol deviation|1|||
105613935|NCT05178316|364249593|FG000|Overall Study|Sponsor decision|1|||
105613936|NCT05178316|364249594|FG001|Overall Study|Sponsor decision|0|||
105613937|NCT05178316|364249595|FG002|Overall Study|Sponsor decision|1|||
105613938|NCT05178316|364249593|FG000|Overall Study|Withdrawal by Subject|5|||
105613939|NCT05178316|364249594|FG001|Overall Study|Withdrawal by Subject|11|||
105613940|NCT05178316|364249595|FG002|Overall Study|Withdrawal by Subject|5|||
105613941|NCT04347161|364249596|FG000|Overall Study|Death|0|||
105613942|NCT04347161|364249597|FG001|Overall Study|Death|2|||
105613943|NCT04347161|364249596|FG000|Overall Study|Withdrawal by Subject|1|||
105613944|NCT04347161|364249597|FG001|Overall Study|Withdrawal by Subject|0|||
105613945|NCT04347161|364249596|FG000|Overall Study|Lost to Follow-up|0|||
105613946|NCT04347161|364249597|FG001|Overall Study|Lost to Follow-up|1|||
105613947|NCT04347161|364249596|FG000|Overall Study|No longer on study medication|1|||
105613948|NCT04347161|364249597|FG001|Overall Study|No longer on study medication|1|||
105613949|NCT04887129|364249598|FG000|Overall Study|Lost to Follow-up|0|||
105613950|NCT04887129|364249599|FG001|Overall Study|Lost to Follow-up|24|||
105613951|NCT04887129|364249598|FG000|Overall Study|Withdrawal by Subject|9|||
105613952|NCT04887129|364249599|FG001|Overall Study|Withdrawal by Subject|57|||
105613953|NCT04887129|364249598|FG000|Overall Study|Other|2|||
105613954|NCT04887129|364249599|FG001|Overall Study|Other|9|||
105613955|NCT03792256|364249603|FG000|Overall Study|Death|0|||
105613956|NCT03792256|364249604|FG001|Overall Study|Death|1|||
105613957|NCT03792256|364249603|FG000|Overall Study|Lack of Efficacy|0|||
105613958|NCT03792256|364249604|FG001|Overall Study|Lack of Efficacy|1|||
105613959|NCT03792256|364249603|FG000|Overall Study|Withdrawal by Subject|0|||
105613960|NCT03792256|364249604|FG001|Overall Study|Withdrawal by Subject|1|||
105613961|NCT05177848|364249616|FG000|Overall Study|Lost to Follow-up|1|||
105613962|NCT05177848|364249617|FG001|Overall Study|Lost to Follow-up|4|||
105613963|NCT05177848|364249616|FG000|Overall Study|Discontinued|2|||
105613964|NCT05177848|364249617|FG001|Overall Study|Discontinued|1|||
105613965|NCT05516147|364249618|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
105613966|NCT05048238|364249623|FG000|Overall Study|Withdrawal by Subject|1|||
105613967|NCT00450658|364249624|FG000|Overall Study|Adverse Event|24|||
105613968|NCT00450658|364249625|FG001|Overall Study|Adverse Event|15|||
105613969|NCT00450658|364249624|FG000|Overall Study|Withdrawal by Subject|43|||
105613970|NCT00450658|364249625|FG001|Overall Study|Withdrawal by Subject|26|||
105613971|NCT00450658|364249624|FG000|Overall Study|Lost to Follow-up|22|||
105613972|NCT00450658|364249625|FG001|Overall Study|Lost to Follow-up|5|||
105613973|NCT00450658|364249624|FG000|Overall Study|UGI ulcer|33|||
105613974|NCT00450658|364249625|FG001|Overall Study|UGI ulcer|34|||
105613975|NCT00450658|364249624|FG000|Overall Study|misc|21|||
105613976|NCT00450658|364249625|FG001|Overall Study|misc|10|||
105613977|NCT04764448|364249626|FG000|Overall Study|Study terminated by sponsor|2|||
105613978|NCT04764448|364249627|FG001|Overall Study|Study terminated by sponsor|2|||
105613979|NCT04764448|364249628|FG002|Overall Study|Study terminated by sponsor|5|||
105613980|NCT04764448|364249626|FG000|Overall Study|Withdrawal by Subject|3|||
105613981|NCT04764448|364249627|FG001|Overall Study|Withdrawal by Subject|3|||
105613982|NCT04764448|364249628|FG002|Overall Study|Withdrawal by Subject|1|||
105613983|NCT01084876|364249631|FG000|Main Study Treatment Period|Adverse Event|12|||
105613984|NCT01084876|364249632|FG001|Main Study Treatment Period|Adverse Event|7|||
105613985|NCT01084876|364249631|FG000|Main Study Treatment Period|Disease Progression|41|||
105613986|NCT01084876|364249632|FG001|Main Study Treatment Period|Disease Progression|24|||
105613987|NCT01084876|364249631|FG000|Main Study Treatment Period|Physician Decision|2|||
105613988|NCT01084876|364249632|FG001|Main Study Treatment Period|Physician Decision|0|||
105613989|NCT01084876|364249631|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
105613990|NCT01084876|364249632|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
105613991|NCT01084876|364249631|FG000|Main Study Treatment Period|Other Reason|0|||
105613992|NCT01084876|364249632|FG001|Main Study Treatment Period|Other Reason|1|||
105613993|NCT01084876|364249631|FG000|Main Study Treatment Period|Other|0|||
105613994|NCT01084876|364249632|FG001|Main Study Treatment Period|Other|1|||
105613995|NCT01084876|364249631|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
105613996|NCT01084876|364249632|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
105613997|NCT01084876|364249631|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
105613998|NCT01084876|364249632|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
105613999|NCT01084876|364249631|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
105614000|NCT01084876|364249632|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
105614001|NCT01084876|364249631|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
105614002|NCT01084876|364249632|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
105614003|NCT01084876|364249631|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
105614004|NCT01084876|364249632|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
105614005|NCT01084876|364249631|FG000|Treatment Period Beyond Cycle 8|Other|6|||
105614006|NCT01084876|364249632|FG001|Treatment Period Beyond Cycle 8|Other|9|||
105614007|NCT04727554|364249633|FG000|Overall Study|Lost to Follow-up|0|||
105614008|NCT04727554|364249634|FG001|Overall Study|Lost to Follow-up|1|||
105614009|NCT04727554|364249633|FG000|Overall Study|Death|2|||
105614010|NCT04727554|364249634|FG001|Overall Study|Death|6|||
105614011|NCT04727554|364249633|FG000|Overall Study|Withdrawal by Subject|1|||
105614012|NCT04727554|364249634|FG001|Overall Study|Withdrawal by Subject|0|||
105614013|NCT05256706|364249637|FG000|Overall Study|Lost to Follow-up|9|||
105614014|NCT05256706|364249638|FG001|Overall Study|Lost to Follow-up|3|||
105614015|NCT05256706|364249637|FG000|Overall Study|Withdrawal by Subject|7|||
105614016|NCT05256706|364249638|FG001|Overall Study|Withdrawal by Subject|11|||
105614017|NCT05256706|364249637|FG000|Overall Study|Screen Failures|3|||
105614018|NCT05256706|364249638|FG001|Overall Study|Screen Failures|0|||
105614019|NCT03720795|364249640|FG000|Phase 1|Lost to Follow-up|4|||
105614020|NCT03720795|364249640|FG000|Phase 1|Withdrawal by Subject|6|||
105614021|NCT03720795|364249640|FG000|Phase 1|Protocol Violation|1|||
105614022|NCT03720795|364249640|FG000|Phase 1|Other|1|||
105614023|NCT03720795|364249640|FG000|Phase 2|Lost to Follow-up|5|||
105614024|NCT03720795|364249640|FG000|Phase 2|Withdrawal by Subject|10|||
105614025|NCT03720795|364249640|FG000|Phase 2|Protocol Violation|2|||
105614026|NCT03720795|364249640|FG000|3 Month Follow Up|Lost to Follow-up|2|||
105614027|NCT03891667|364249645|FG000|Overall Study|Physician Decision|1|||
105614028|NCT03891667|364249646|FG001|Overall Study|Physician Decision|1|||
105614029|NCT03891667|364249645|FG000|Overall Study|COVID related pause|1|||
105614030|NCT03891667|364249646|FG001|Overall Study|COVID related pause|0|||
105614031|NCT03891667|364249645|FG000|Overall Study|Withdrawal by Subject|0|||
105614032|NCT03891667|364249646|FG001|Overall Study|Withdrawal by Subject|1|||
105614033|NCT03891667|364249645|FG000|Overall Study|Adverse Event|0|||
105614034|NCT03891667|364249646|FG001|Overall Study|Adverse Event|1|||
105614035|NCT03018288|364249647|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
105614036|NCT03018288|364249648|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
105614037|NCT03018288|364249649|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
105614038|NCT03018288|364249650|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
105614039|NCT03018288|364249647|FG000|Overall Study|Participant withdrew consent.|0|||
105614040|NCT03018288|364249648|FG001|Overall Study|Participant withdrew consent.|0|||
105614041|NCT03018288|364249649|FG002|Overall Study|Participant withdrew consent.|1|||
105614042|NCT03018288|364249650|FG003|Overall Study|Participant withdrew consent.|0|||
105614043|NCT03018288|364249647|FG000|Overall Study|Switched to alternative treatment.|0|||
105614044|NCT03018288|364249648|FG001|Overall Study|Switched to alternative treatment.|0|||
105614045|NCT03018288|364249649|FG002|Overall Study|Switched to alternative treatment.|1|||
105614046|NCT03018288|364249650|FG003|Overall Study|Switched to alternative treatment.|0|||
105614047|NCT03018288|364249647|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
105614048|NCT03018288|364249648|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
105614049|NCT03018288|364249649|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
105614050|NCT03018288|364249650|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
105614051|NCT03018288|364249647|FG000|Overall Study|Screen failures|0|||
105614052|NCT03018288|364249648|FG001|Overall Study|Screen failures|0|||
105614053|NCT03018288|364249649|FG002|Overall Study|Screen failures|0|||
105614054|NCT03018288|364249650|FG003|Overall Study|Screen failures|51|||
105614055|NCT03018288|364249647|FG000|Overall Study|Chose treatment outside of UNC|0|||
105614056|NCT03018288|364249648|FG001|Overall Study|Chose treatment outside of UNC|0|||
105614057|NCT03018288|364249649|FG002|Overall Study|Chose treatment outside of UNC|0|||
105614058|NCT03018288|364249650|FG003|Overall Study|Chose treatment outside of UNC|1|||
105614059|NCT03018288|364249647|FG000|Overall Study|Unable to comply with protocol requirements|1|||
105614060|NCT03018288|364249648|FG001|Overall Study|Unable to comply with protocol requirements|1|||
105614061|NCT03018288|364249649|FG002|Overall Study|Unable to comply with protocol requirements|0|||
105614062|NCT03018288|364249650|FG003|Overall Study|Unable to comply with protocol requirements|1|||
105614063|NCT03018288|364249647|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
105614064|NCT03018288|364249648|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
105614065|NCT03018288|364249649|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
105614066|NCT03018288|364249650|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
105614067|NCT03018288|364249647|FG000|Overall Study|Physician Decision|0|||
105614068|NCT03018288|364249648|FG001|Overall Study|Physician Decision|0|||
105614069|NCT03018288|364249649|FG002|Overall Study|Physician Decision|0|||
105614070|NCT03018288|364249650|FG003|Overall Study|Physician Decision|1|||
105614071|NCT05134233|364249655|FG000|Overall Study|Pregnancy|1|||
105614072|NCT05134233|364249655|FG000|Overall Study|MEP value too low|2|||
105614073|NCT05134233|364249655|FG000|Overall Study|Lost to Follow-up|1|||
105614074|NCT01573442|364249656|FG000|Overall Study|Cancels|9|||
105614075|NCT01573442|364249657|FG001|Overall Study|Cancels|10|||
105614076|NCT05710107|364249669|FG000|Overall Study|Withdrawal by Subject|1|||
105614077|NCT05710107|364249670|FG001|Overall Study|Withdrawal by Subject|1|||
105614078|NCT05710107|364249669|FG000|Overall Study|Lost to Follow-up|8|||
105614079|NCT05710107|364249670|FG001|Overall Study|Lost to Follow-up|9|||
105614080|NCT05710107|364249669|FG000|Overall Study|Unable to place assigned block|2|||
105614081|NCT05710107|364249670|FG001|Overall Study|Unable to place assigned block|0|||
105614082|NCT05710107|364249669|FG000|Overall Study|Withdrawn by study team|0|||
105614083|NCT05710107|364249670|FG001|Overall Study|Withdrawn by study team|1|||
105614084|NCT02724631|364249671|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
105614085|NCT04166773|364249672|FG000|Overall Study|Adverse Event|2|||
105614086|NCT04166773|364249673|FG001|Overall Study|Adverse Event|0|||
105614087|NCT04166773|364249674|FG002|Overall Study|Adverse Event|2|||
105614088|NCT04166773|364249675|FG003|Overall Study|Adverse Event|1|||
105614089|NCT04166773|364249672|FG000|Overall Study|Lost to Follow-up|4|||
105614090|NCT04166773|364249673|FG001|Overall Study|Lost to Follow-up|2|||
105614091|NCT04166773|364249674|FG002|Overall Study|Lost to Follow-up|1|||
105614092|NCT04166773|364249675|FG003|Overall Study|Lost to Follow-up|3|||
105614093|NCT04166773|364249672|FG000|Overall Study|Physician Decision|0|||
105614094|NCT04166773|364249673|FG001|Overall Study|Physician Decision|0|||
105614095|NCT04166773|364249674|FG002|Overall Study|Physician Decision|0|||
105614096|NCT04166773|364249675|FG003|Overall Study|Physician Decision|1|||
105614097|NCT04166773|364249672|FG000|Overall Study|Withdrawal by Subject|1|||
105614098|NCT04166773|364249673|FG001|Overall Study|Withdrawal by Subject|1|||
105614099|NCT04166773|364249674|FG002|Overall Study|Withdrawal by Subject|2|||
105614100|NCT04166773|364249675|FG003|Overall Study|Withdrawal by Subject|5|||
105614101|NCT04072822|364249676|FG000|Treatment|Adverse Event|9|||
105614102|NCT04072822|364249677|FG001|Treatment|Adverse Event|5|||
105614103|NCT04072822|364249676|FG000|Treatment|Met Stopping Criteria|13|||
105614104|NCT04072822|364249677|FG001|Treatment|Met Stopping Criteria|24|||
105614105|NCT04072822|364249676|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
105614106|NCT04072822|364249677|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
105614107|NCT04072822|364249676|FG000|Treatment|Withdrawal by Subject|0|||
105614108|NCT04072822|364249677|FG001|Treatment|Withdrawal by Subject|2|||
105614109|NCT04072822|364249676|FG000|Treatment|Death|0|||
105614110|NCT04072822|364249677|FG001|Treatment|Death|2|||
105614111|NCT04072822|364249676|FG000|Treatment|Lost to Follow-up|11|||
105614112|NCT04072822|364249677|FG001|Treatment|Lost to Follow-up|3|||
105614113|NCT04072822|364249676|FG000|Treatment|Physician Decision|1|||
105614114|NCT04072822|364249677|FG001|Treatment|Physician Decision|0|||
105614115|NCT04072822|364249676|FG000|Treatment|Other|7|||
105614116|NCT04072822|364249677|FG001|Treatment|Other|9|||
105614117|NCT04072822|364249676|FG000|Follow-up|Withdrawal by Subject|1|||
105614118|NCT04072822|364249677|FG001|Follow-up|Withdrawal by Subject|0|||
105614119|NCT04072822|364249676|FG000|Follow-up|Lost to Follow-up|5|||
105614120|NCT04072822|364249677|FG001|Follow-up|Lost to Follow-up|4|||
105614121|NCT04763265|364249681|FG000|Overall Study|Adverse Event|1|||
105614122|NCT04763265|364249682|FG001|Overall Study|Adverse Event|0|||
105614123|NCT04763265|364249681|FG000|Overall Study|Lost to Follow-up|2|||
105614124|NCT04763265|364249682|FG001|Overall Study|Lost to Follow-up|4|||
105614125|NCT04763265|364249681|FG000|Overall Study|Withdrawal by Subject|0|||
105614126|NCT04763265|364249682|FG001|Overall Study|Withdrawal by Subject|1|||
105614127|NCT05076708|364249683|FG000|Overall Study|Withdrawal by Subject|4|||
105614128|NCT05076708|364249683|FG000|Overall Study|Lost to study during switch phase|8|||
105614129|NCT04221490|364249687|FG000|At 30 Days Follow-up|Death|7|||
105614130|NCT04221490|364249687|FG000|At 30 Days Follow-up|Missed Visit|4|||
105614131|NCT04221490|364249687|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
105614132|NCT04221490|364249687|FG000|At 6 Months Follow-up|Death|9|||
105614133|NCT04221490|364249687|FG000|At 6 Months Follow-up|Physician Decision|1|||
105614134|NCT04221490|364249687|FG000|At 6 Months Follow-up|Missed Visit|8|||
105614135|NCT04221490|364249687|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
105614136|NCT04456517|364249690|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
105614137|NCT04456517|364249691|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
105614138|NCT04055090|364249692|FG000|Overall Study|screen failure|1|||
105614139|NCT04055090|364249693|FG001|Overall Study|screen failure|0|||
105614140|NCT04055090|364249692|FG000|Overall Study|Withdrawal by Subject|1|||
105614141|NCT04055090|364249693|FG001|Overall Study|Withdrawal by Subject|0|||
105614142|NCT02919683|364249694|FG000|Post-Surgery Follow-Up|Death|2|||
105614143|NCT02919683|364249695|FG001|Post-Surgery Follow-Up|Death|2|||
105614144|NCT02919683|364249694|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
105614145|NCT02919683|364249695|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
105614146|NCT03468218|364249698|FG000|Overall Study|Adverse Event|5|||
105614147|NCT03468218|364249698|FG000|Overall Study|Progressive Disease|16|||
105614148|NCT03468218|364249698|FG000|Overall Study|Death|1|||
105614149|NCT03468218|364249698|FG000|Overall Study|Alternate therapy|1|||
105614150|NCT03468218|364249698|FG000|Overall Study|Withdrawal by Subject|2|||
105614151|NCT03033576|364249699|FG000|Overall Study|Ineligible|1|||
105614152|NCT03033576|364249700|FG001|Overall Study|Ineligible|1|||
105614153|NCT03033576|364249699|FG000|Overall Study|Adverse Event|4|||
105614154|NCT03033576|364249700|FG001|Overall Study|Adverse Event|20|||
105614155|NCT03033576|364249699|FG000|Overall Study|Progression/relapse|9|||
105614156|NCT03033576|364249700|FG001|Overall Study|Progression/relapse|36|||
105614157|NCT03033576|364249699|FG000|Overall Study|Death|1|||
105614158|NCT03033576|364249700|FG001|Overall Study|Death|1|||
105614159|NCT03033576|364249699|FG000|Overall Study|Patient refusal|1|||
105614160|NCT03033576|364249700|FG001|Overall Study|Patient refusal|6|||
105614161|NCT03033576|364249699|FG000|Overall Study|Other, unspecified reasons|0|||
105614162|NCT03033576|364249700|FG001|Overall Study|Other, unspecified reasons|4|||
105614163|NCT03033576|364249699|FG000|Overall Study|Currently on protocol therapy|0|||
105614164|NCT03033576|364249700|FG001|Overall Study|Currently on protocol therapy|2|||
105614165|NCT02485938|364249701|FG000|Overall Study|Withdrawal of consent|2|||
105614166|NCT02485938|364249702|FG001|Overall Study|Withdrawal of consent|0|||
105614167|NCT03315754|364250996|FG000|Overall Study|COVID-19 complications leading to death|1|||
105614168|NCT03315754|364250996|FG000|Overall Study|insurance coverage issue|1|||
105614169|NCT03623321|364250997|FG000|Overall Study|Adverse Event|32|||
105614170|NCT03623321|364250997|FG000|Overall Study|Death|9|||
105614171|NCT03623321|364250997|FG000|Overall Study|Lack of Efficacy|9|||
105614172|NCT03623321|364250997|FG000|Overall Study|Lost to Follow-up|6|||
105614173|NCT03623321|364250997|FG000|Overall Study|Noncompliance with study drug|6|||
105614174|NCT03623321|364250997|FG000|Overall Study|Use of prohibited medication|3|||
105614175|NCT03623321|364250997|FG000|Overall Study|Physician Decision|5|||
105614176|NCT03623321|364250997|FG000|Overall Study|Protocol Violation|1|||
105614177|NCT03623321|364250997|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
105614178|NCT03623321|364250997|FG000|Overall Study|Not further specified|43|||
105614179|NCT04492007|364251000|FG000|Overall Study|Lost to Follow-up|1|||
105614180|NCT04492007|364251001|FG001|Overall Study|Lost to Follow-up|1|||
105614181|NCT04492007|364251002|FG002|Overall Study|Lost to Follow-up|2|||
105614182|NCT04492007|364251003|FG003|Overall Study|Lost to Follow-up|2|||
105614183|NCT04492007|364251000|FG000|Overall Study|Protocol Violation|1|||
105614184|NCT04492007|364251001|FG001|Overall Study|Protocol Violation|1|||
105614185|NCT04492007|364251002|FG002|Overall Study|Protocol Violation|1|||
105614186|NCT04492007|364251003|FG003|Overall Study|Protocol Violation|1|||
105614187|NCT04492007|364251000|FG000|Overall Study|Withdrawal by Subject|0|||
105614188|NCT04492007|364251001|FG001|Overall Study|Withdrawal by Subject|0|||
105614189|NCT04492007|364251002|FG002|Overall Study|Withdrawal by Subject|1|||
105614190|NCT04492007|364251003|FG003|Overall Study|Withdrawal by Subject|1|||
105614191|NCT05369403|364251006|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
105614192|NCT05369403|364251007|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
105614193|NCT05369403|364251008|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
105614194|NCT05369403|364251006|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
105614195|NCT05369403|364251007|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
105614196|NCT05369403|364251008|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
105614197|NCT05369403|364251006|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
105614198|NCT05369403|364251007|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
105614199|NCT05369403|364251008|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
105614200|NCT05369403|364251006|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
105614201|NCT05369403|364251007|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
105614202|NCT05369403|364251008|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
105614203|NCT05369403|364251006|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
105614204|NCT05369403|364251007|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
105614205|NCT05369403|364251008|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
105614206|NCT05369403|364251006|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
105614207|NCT05369403|364251007|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
105614208|NCT05369403|364251008|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
105614209|NCT05369403|364251006|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
105614210|NCT05369403|364251007|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
105614211|NCT05369403|364251008|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
105614212|NCT05369403|364251006|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
105614213|NCT05369403|364251007|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
105614214|NCT05369403|364251008|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
105614215|NCT05369403|364251006|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
105614216|NCT05369403|364251007|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
105614217|NCT05369403|364251008|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
105614218|NCT05369403|364251006|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
105614219|NCT05369403|364251007|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
105614220|NCT05369403|364251008|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
105614221|NCT05369403|364251006|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
105614222|NCT05369403|364251007|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
105614223|NCT05369403|364251008|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
105614224|NCT05368103|364251014|FG000|Overall Study|Withdrawal by Subject|4|||
105614225|NCT05368103|364251014|FG000|Overall Study|Lost to Follow-up|1|||
105614226|NCT05368103|364251014|FG000|Overall Study|Lack of Efficacy|3|||
105614227|NCT03675282|364251015|FG000|Overall Study|Lost to Follow-up|4|||
105614228|NCT03675282|364251016|FG001|Overall Study|Lost to Follow-up|8|||
105614229|NCT03675282|364251017|FG002|Overall Study|Lost to Follow-up|1|||
105614230|NCT03675282|364251018|FG003|Overall Study|Lost to Follow-up|0|||
105614231|NCT03675282|364251019|FG004|Overall Study|Lost to Follow-up|2|||
105614232|NCT03675282|364251020|FG005|Overall Study|Lost to Follow-up|7|||
105614233|NCT03675282|364251015|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
105614234|NCT03675282|364251016|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
105614235|NCT03675282|364251017|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
105614236|NCT03675282|364251018|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
105614237|NCT03675282|364251019|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
105614238|NCT03675282|364251020|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
105614239|NCT03675282|364251015|FG000|Overall Study|Physician Decision|1|||
105614240|NCT03675282|364251016|FG001|Overall Study|Physician Decision|0|||
105614241|NCT03675282|364251017|FG002|Overall Study|Physician Decision|0|||
105614242|NCT03675282|364251018|FG003|Overall Study|Physician Decision|0|||
105614243|NCT03675282|364251019|FG004|Overall Study|Physician Decision|0|||
105614244|NCT03675282|364251020|FG005|Overall Study|Physician Decision|0|||
105614245|NCT05875142|364251024|FG000|Overall Study|Lost to Follow-up|0|||
105614246|NCT05875142|364251025|FG001|Overall Study|Lost to Follow-up|1|||
105614247|NCT05875142|364251026|FG002|Overall Study|Lost to Follow-up|1|||
105614248|NCT05784662|364251027|FG000|Overall Study|Lost to Follow-up|21|||
105614249|NCT05784662|364251028|FG001|Overall Study|Lost to Follow-up|17|||
105614250|NCT03425331|364251032|FG000|Overall Study|Withdrawal by Subject|1|||
105614251|NCT03425331|364251032|FG000|Overall Study|Death|1|||
105614252|NCT03425331|364251032|FG000|Overall Study|Adverse Event|1|||
105614253|NCT03425331|364251032|FG000|Overall Study|Disease Progression|2|||
105614254|NCT04274764|364251033|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
105614255|NCT04274764|364251034|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
105614256|NCT02677298|364251037|FG000|Double Blind Phase|Adverse Event|2|||
105614257|NCT02677298|364251038|FG001|Double Blind Phase|Adverse Event|1|||
105614258|NCT02677298|364251039|FG002|Double Blind Phase|Adverse Event|0|||
105614259|NCT02677298|364251037|FG000|Double Blind Phase|Physician Decision|5|||
105614260|NCT02677298|364251038|FG001|Double Blind Phase|Physician Decision|0|||
105614261|NCT02677298|364251039|FG002|Double Blind Phase|Physician Decision|0|||
105614262|NCT02677298|364251037|FG000|Double Blind Phase|Lost to Follow-up|11|||
105614263|NCT02677298|364251038|FG001|Double Blind Phase|Lost to Follow-up|7|||
105614264|NCT02677298|364251039|FG002|Double Blind Phase|Lost to Follow-up|0|||
105614265|NCT02677298|364251037|FG000|Double Blind Phase|Withdrawal by Subject|11|||
105614266|NCT02677298|364251038|FG001|Double Blind Phase|Withdrawal by Subject|8|||
105614267|NCT02677298|364251039|FG002|Double Blind Phase|Withdrawal by Subject|0|||
105614268|NCT02677298|364251037|FG000|Double Blind Phase|No study drug available at site|0|||
105614269|NCT02677298|364251038|FG001|Double Blind Phase|No study drug available at site|1|||
105614270|NCT02677298|364251039|FG002|Double Blind Phase|No study drug available at site|0|||
105614271|NCT02677298|364251037|FG000|Open Label Phase|Adverse Event|0|||
105614272|NCT02677298|364251038|FG001|Open Label Phase|Adverse Event|0|||
105614273|NCT02677298|364251039|FG002|Open Label Phase|Adverse Event|4|||
105614274|NCT02677298|364251037|FG000|Open Label Phase|Physician Decision|0|||
105614275|NCT02677298|364251038|FG001|Open Label Phase|Physician Decision|0|||
105614276|NCT02677298|364251039|FG002|Open Label Phase|Physician Decision|1|||
105614277|NCT02677298|364251037|FG000|Open Label Phase|Lost to Follow-up|0|||
105614278|NCT02677298|364251038|FG001|Open Label Phase|Lost to Follow-up|0|||
105614279|NCT02677298|364251039|FG002|Open Label Phase|Lost to Follow-up|17|||
105614280|NCT02677298|364251037|FG000|Open Label Phase|Withdrawal by Subject|0|||
105614281|NCT02677298|364251038|FG001|Open Label Phase|Withdrawal by Subject|0|||
105614282|NCT02677298|364251039|FG002|Open Label Phase|Withdrawal by Subject|38|||
105614283|NCT03611621|364251040|FG000|Overall Study|Graft loss|3|||
105614284|NCT03611621|364251040|FG000|Overall Study|Death|3|||
105614285|NCT03611621|364251040|FG000|Overall Study|Lost to Follow-up|1|||
105614286|NCT03039023|364251041|FG000|Overall Study|Withdrawal by Subject|1|||
105614287|NCT03039023|364251042|FG001|Overall Study|Withdrawal by Subject|0|||
105614288|NCT03039023|364251043|FG002|Overall Study|Withdrawal by Subject|1|||
105614289|NCT03039023|364251044|FG003|Overall Study|Withdrawal by Subject|1|||
105614290|NCT03039023|364251045|FG004|Overall Study|Withdrawal by Subject|0|||
105614291|NCT03039023|364251041|FG000|Overall Study|Physician Decision|0|||
105614292|NCT03039023|364251042|FG001|Overall Study|Physician Decision|0|||
105614293|NCT03039023|364251043|FG002|Overall Study|Physician Decision|0|||
105614294|NCT03039023|364251044|FG003|Overall Study|Physician Decision|1|||
105614295|NCT03039023|364251045|FG004|Overall Study|Physician Decision|0|||
105614296|NCT04739956|364251058|FG000|Overall Study|Withdrawal by Subject|1|||
105614297|NCT04739956|364251059|FG001|Overall Study|Withdrawal by Subject|1|||
105614298|NCT03853746|364251066|FG000|Overall Study|Withdrawal by Subject|1|||
105614299|NCT05763823|364251067|FG000|Overall Study|Death|6|||
105614300|NCT05763823|364251067|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105614301|NCT05763823|364251067|FG000|Overall Study|Withdrawal by Subject|6|||
105614302|NCT00999804|364251070|FG000|Overall Study|Lack of Efficacy|9|||
105614303|NCT00999804|364251071|FG001|Overall Study|Lack of Efficacy|2|||
105614304|NCT00999804|364251070|FG000|Overall Study|Adverse Event|4|||
105614305|NCT00999804|364251071|FG001|Overall Study|Adverse Event|3|||
105614306|NCT00999804|364251070|FG000|Overall Study|Withdrawal by Subject|4|||
105614307|NCT00999804|364251071|FG001|Overall Study|Withdrawal by Subject|0|||
105614308|NCT00999804|364251070|FG000|Overall Study|Death|1|||
105614309|NCT00999804|364251071|FG001|Overall Study|Death|0|||
105614310|NCT00999804|364251070|FG000|Overall Study|Ineligible|3|||
105614311|NCT00999804|364251071|FG001|Overall Study|Ineligible|0|||
105614312|NCT05028634|364251073|FG000|Overall Study|Withdrawal by Subject|0|||
105614313|NCT05028634|364251074|FG001|Overall Study|Withdrawal by Subject|1|||
105614314|NCT01997840|364251077|FG000|Overall Study|Lost to Follow-up|0|||
105614315|NCT01997840|364251078|FG001|Overall Study|Lost to Follow-up|0|||
105614316|NCT01997840|364251079|FG002|Overall Study|Lost to Follow-up|1|||
105614317|NCT01997840|364251080|FG003|Overall Study|Lost to Follow-up|0|||
105614318|NCT01997840|364251077|FG000|Overall Study|Withdrawal by participant|0|||
105614319|NCT01997840|364251078|FG001|Overall Study|Withdrawal by participant|0|||
105614320|NCT01997840|364251079|FG002|Overall Study|Withdrawal by participant|8|||
105614321|NCT01997840|364251080|FG003|Overall Study|Withdrawal by participant|1|||
105614322|NCT01997840|364251077|FG000|Overall Study|Physician Decision|0|||
105614323|NCT01997840|364251078|FG001|Overall Study|Physician Decision|0|||
105614324|NCT01997840|364251079|FG002|Overall Study|Physician Decision|3|||
105614325|NCT01997840|364251080|FG003|Overall Study|Physician Decision|0|||
105614326|NCT01997840|364251077|FG000|Overall Study|Progressive disease|3|||
105614327|NCT01997840|364251078|FG001|Overall Study|Progressive disease|4|||
105614328|NCT01997840|364251079|FG002|Overall Study|Progressive disease|57|||
105614329|NCT01997840|364251080|FG003|Overall Study|Progressive disease|8|||
105614330|NCT01997840|364251077|FG000|Overall Study|Other reasons|0|||
105614331|NCT01997840|364251078|FG001|Overall Study|Other reasons|0|||
105614332|NCT01997840|364251079|FG002|Overall Study|Other reasons|1|||
105614333|NCT01997840|364251080|FG003|Overall Study|Other reasons|0|||
105614334|NCT01997840|364251077|FG000|Overall Study|Adverse Event|0|||
105614335|NCT01997840|364251078|FG001|Overall Study|Adverse Event|0|||
105614336|NCT01997840|364251079|FG002|Overall Study|Adverse Event|15|||
105614337|NCT01997840|364251080|FG003|Overall Study|Adverse Event|2|||
105614338|NCT04410042|364251083|FG000|Overall Study|Not Eligible|1|||
105614339|NCT04410042|364251084|FG001|Overall Study|Not Eligible|1|||
105614340|NCT03850678|364251087|FG000|Overall Study|Withdrawal by Subject|3|||
105614341|NCT03850678|364251088|FG001|Overall Study|Withdrawal by Subject|0|||
105614342|NCT03850678|364251087|FG000|Overall Study|Experimenter Error|1|||
105614343|NCT03850678|364251088|FG001|Overall Study|Experimenter Error|1|||
105614344|NCT03850678|364251087|FG000|Overall Study|Did Not Condition To Experiment|7|||
105614345|NCT03850678|364251088|FG001|Overall Study|Did Not Condition To Experiment|2|||
105614346|NCT03746015|364251090|FG000|Overall Study|Withdrawal of Consent|1|||
105614347|NCT03746015|364251091|FG001|Overall Study|Withdrawal of Consent|0|||
105614348|NCT03746015|364251092|FG002|Overall Study|Withdrawal of Consent|0|||
105614349|NCT04971395|364251107|FG000|Overall Study|Withdrawal by Subject|0|||
105614350|NCT04971395|364251108|FG001|Overall Study|Withdrawal by Subject|1|||
105614351|NCT04971395|364251109|FG002|Overall Study|Withdrawal by Subject|0|||
105614352|NCT04717492|364251110|FG000|Overall Study|Withdrawal by Subject|2|||
105614353|NCT04717492|364251111|FG001|Overall Study|Withdrawal by Subject|13|||
105614354|NCT04717492|364251110|FG000|Overall Study|Lost to Follow-up|2|||
105614355|NCT04717492|364251111|FG001|Overall Study|Lost to Follow-up|9|||
105614356|NCT03771417|364251112|FG000|Overall Study|Withdrawal by Subject|1|||
105614357|NCT03771417|364251113|FG001|Overall Study|Withdrawal by Subject|0|||
105614358|NCT03771417|364251114|FG002|Overall Study|Withdrawal by Subject|0|||
105614359|NCT03771417|364251112|FG000|Overall Study|Covid-19 Shutdown|0|||
105614360|NCT03771417|364251113|FG001|Overall Study|Covid-19 Shutdown|1|||
105614361|NCT03771417|364251114|FG002|Overall Study|Covid-19 Shutdown|0|||
105614362|NCT03557697|364251115|FG000|Overall Study|Withdrawal by Subject|2|||
105614363|NCT03557697|364251116|FG001|Overall Study|Withdrawal by Subject|4|||
105614364|NCT06491433|364251117|FG000|Overall Study|Protocol Violation|51|||
105614365|NCT06491433|364251117|FG000|Overall Study|consent withdrawal|2|||
105614366|NCT06491433|364251117|FG000|Overall Study|screen failure|1|||
105614367|NCT04876118|364251130|FG000|Overall Study|Pregnancy|1|||
105614368|NCT04876118|364251130|FG000|Overall Study|Withdrawal by Subject|14|||
105614369|NCT03457142|364252856|FG000|Overall Study|Death|1|||
105614370|NCT03770273|364252857|FG000|Overall Study|Adverse Event|2|||
105614371|NCT03770273|364252858|FG001|Overall Study|Adverse Event|0|||
105614372|NCT03770273|364252857|FG000|Overall Study|Lost to Follow-up|1|||
105614373|NCT03770273|364252858|FG001|Overall Study|Lost to Follow-up|1|||
105614374|NCT01999075|364252859|FG000|Overall Study|Lost to Follow-up|0|||
105614375|NCT01999075|364252860|FG001|Overall Study|Lost to Follow-up|2|||
105614376|NCT01999075|364252859|FG000|Overall Study|Withdrawal by Subject|2|||
105614377|NCT01999075|364252860|FG001|Overall Study|Withdrawal by Subject|7|||
105614378|NCT01999075|364252859|FG000|Overall Study|Enrolled in drug trial|3|||
105614379|NCT01999075|364252860|FG001|Overall Study|Enrolled in drug trial|1|||
105614380|NCT01999075|364252859|FG000|Overall Study|Became ineligible|0|||
105614381|NCT01999075|364252860|FG001|Overall Study|Became ineligible|2|||
105614382|NCT04562649|364252861|FG000|Overall Study|Withdrawal by Subject|11|||
105614383|NCT04562649|364252862|FG001|Overall Study|Withdrawal by Subject|8|||
105614384|NCT04562649|364252861|FG000|Overall Study|Lost to Follow-up|26|||
105614385|NCT04562649|364252862|FG001|Overall Study|Lost to Follow-up|20|||
105614386|NCT03445988|364252868|FG000|Overall Study|Lost to Follow-up|14|||
105614387|NCT03445988|364252869|FG001|Overall Study|Lost to Follow-up|26|||
105614388|NCT03445988|364252870|FG002|Overall Study|Lost to Follow-up|27|||
105614389|NCT03445988|364252871|FG003|Overall Study|Lost to Follow-up|66|||
105614390|NCT03445988|364252868|FG000|Overall Study|Withdrawal by Subject|7|||
105614391|NCT03445988|364252869|FG001|Overall Study|Withdrawal by Subject|4|||
105614392|NCT03445988|364252870|FG002|Overall Study|Withdrawal by Subject|3|||
105614393|NCT03445988|364252871|FG003|Overall Study|Withdrawal by Subject|5|||
105614394|NCT03445988|364252868|FG000|Overall Study|Death (unrelated to study)|5|||
105614395|NCT03445988|364252869|FG001|Overall Study|Death (unrelated to study)|1|||
105614396|NCT03445988|364252870|FG002|Overall Study|Death (unrelated to study)|2|||
105614397|NCT03445988|364252871|FG003|Overall Study|Death (unrelated to study)|4|||
105614398|NCT04977947|364252872|FG000|Overall Study|Lost to Follow-up|1|||
105614399|NCT04977947|364252873|FG001|Overall Study|Lost to Follow-up|1|||
105614400|NCT04029688|364252874|FG000|Overall Study|Death|8|||
105614401|NCT04029688|364252875|FG001|Overall Study|Death|3|||
105614402|NCT04029688|364252876|FG002|Overall Study|Death|6|||
105614403|NCT04029688|364252877|FG003|Overall Study|Death|2|||
105614404|NCT04029688|364252878|FG004|Overall Study|Death|5|||
105614405|NCT04029688|364252879|FG005|Overall Study|Death|0|||
105614406|NCT04029688|364252880|FG006|Overall Study|Death|2|||
105614407|NCT04029688|364252881|FG007|Overall Study|Death|3|||
105614408|NCT04029688|364252874|FG000|Overall Study|Study Terminated by Sponsor|0|||
105614409|NCT04029688|364252875|FG001|Overall Study|Study Terminated by Sponsor|0|||
105614410|NCT04029688|364252876|FG002|Overall Study|Study Terminated by Sponsor|0|||
105614411|NCT04029688|364252877|FG003|Overall Study|Study Terminated by Sponsor|0|||
105614412|NCT04029688|364252878|FG004|Overall Study|Study Terminated by Sponsor|1|||
105614413|NCT04029688|364252879|FG005|Overall Study|Study Terminated by Sponsor|3|||
105614414|NCT04029688|364252880|FG006|Overall Study|Study Terminated by Sponsor|1|||
105614415|NCT04029688|364252881|FG007|Overall Study|Study Terminated by Sponsor|3|||
105614416|NCT04029688|364252874|FG000|Overall Study|Withdrawal by Subject|0|||
105614417|NCT04029688|364252875|FG001|Overall Study|Withdrawal by Subject|0|||
105614418|NCT04029688|364252876|FG002|Overall Study|Withdrawal by Subject|0|||
105614419|NCT04029688|364252877|FG003|Overall Study|Withdrawal by Subject|1|||
105614420|NCT04029688|364252878|FG004|Overall Study|Withdrawal by Subject|0|||
105614421|NCT04029688|364252879|FG005|Overall Study|Withdrawal by Subject|0|||
105614422|NCT04029688|364252880|FG006|Overall Study|Withdrawal by Subject|0|||
105614423|NCT04029688|364252881|FG007|Overall Study|Withdrawal by Subject|0|||
105614424|NCT04130438|364252882|FG000|Overall Study|Lost to Follow-up|0|||
105614425|NCT04130438|364252883|FG001|Overall Study|Lost to Follow-up|0|||
105614426|NCT04130438|364252884|FG002|Overall Study|Lost to Follow-up|1|||
105614427|NCT04142788|364252885|FG000|Overall Study|Trial terminated prematurely|2|||
105614428|NCT04142788|364252886|FG001|Overall Study|Trial terminated prematurely|2|||
105614429|NCT01494662|364252887|FG000|Overall Study|Withdrawal by Subject|0|||
105614430|NCT01494662|364252888|FG001|Overall Study|Withdrawal by Subject|0|||
105614431|NCT01494662|364252889|FG002|Overall Study|Withdrawal by Subject|1|||
105614432|NCT01494662|364252890|FG003|Overall Study|Withdrawal by Subject|0|||
105614433|NCT01494662|364252891|FG004|Overall Study|Withdrawal by Subject|0|||
105614434|NCT01494662|364252892|FG005|Overall Study|Withdrawal by Subject|0|||
105614435|NCT01494662|364252893|FG006|Overall Study|Withdrawal by Subject|0|||
105614436|NCT01494662|364252887|FG000|Overall Study|Physician Decision|0|||
105614437|NCT01494662|364252888|FG001|Overall Study|Physician Decision|0|||
105614438|NCT01494662|364252889|FG002|Overall Study|Physician Decision|1|||
105614439|NCT01494662|364252890|FG003|Overall Study|Physician Decision|0|||
105614440|NCT01494662|364252891|FG004|Overall Study|Physician Decision|0|||
105614441|NCT01494662|364252892|FG005|Overall Study|Physician Decision|0|||
105614442|NCT01494662|364252893|FG006|Overall Study|Physician Decision|0|||
105614443|NCT05311384|364252894|FG000|Overall Study|Uncontrolled health conditions|2|||
105614444|NCT05311384|364252894|FG000|Overall Study|Withdrawal by Subject|1|||
105614445|NCT04322643|364252895|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
105614446|NCT04256941|364252903|FG000|Overall Study|Withdrawal by Subject|0|||
105614447|NCT04256941|364252904|FG001|Overall Study|Withdrawal by Subject|1|||
105614448|NCT04256941|364252903|FG000|Overall Study|Death|1|||
105614449|NCT04256941|364252904|FG001|Overall Study|Death|0|||
105614450|NCT04256941|364252903|FG000|Overall Study|Disease Progession|0|||
105614451|NCT04256941|364252904|FG001|Overall Study|Disease Progession|2|||
105614452|NCT05659537|364252905|FG000|Overall Study|Adverse Event|5|||
105614453|NCT05659537|364252905|FG000|Overall Study|Lost to Follow-up|4|||
105614454|NCT05659537|364252905|FG000|Overall Study|Withdrawal by Subject|13|||
105614455|NCT05659537|364252905|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
105614456|NCT05659537|364252905|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
105614457|NCT05659537|364252905|FG000|Overall Study|Participant was suffering from anaemia|1|||
105614458|NCT03953508|364252906|FG000|Baseline|Lost to Follow-up|3|||
105614459|NCT03953508|364252907|FG001|Baseline|Lost to Follow-up|2|||
105614460|NCT03953508|364252906|FG000|6-month Follow-up|Lost to Follow-up|62|||
105614461|NCT03953508|364252907|FG001|6-month Follow-up|Lost to Follow-up|70|||
105614462|NCT03269136|364252908|FG000|Part 1: Dose Escalation|Other|0|||
105614463|NCT03269136|364252909|FG001|Part 1: Dose Escalation|Other|0|||
105614464|NCT03269136|364252910|FG002|Part 1: Dose Escalation|Other|0|||
105614465|NCT03269136|364252911|FG003|Part 1: Dose Escalation|Other|0|||
105614466|NCT03269136|364252912|FG004|Part 1: Dose Escalation|Other|0|||
105614467|NCT03269136|364252913|FG005|Part 1: Dose Escalation|Other|0|||
105614468|NCT03269136|364252914|FG006|Part 1: Dose Escalation|Other|0|||
105614469|NCT03269136|364252915|FG007|Part 1: Dose Escalation|Other|0|||
105614470|NCT03269136|364252916|FG008|Part 1: Dose Escalation|Other|0|||
105614471|NCT03269136|364252917|FG009|Part 1: Dose Escalation|Other|0|||
105614472|NCT03269136|364252918|FG010|Part 1: Dose Escalation|Other|1|||
105614473|NCT03269136|364252919|FG011|Part 1: Dose Escalation|Other|1|||
105614474|NCT03269136|364252920|FG012|Part 1: Dose Escalation|Other|1|||
105614475|NCT03269136|364252921|FG013|Part 1: Dose Escalation|Other|0|||
105614476|NCT03269136|364252922|FG014|Part 1: Dose Escalation|Other|3|||
105614477|NCT03269136|364252923|FG015|Part 1: Dose Escalation|Other|1|||
105614478|NCT03269136|364252924|FG016|Part 1: Dose Escalation|Other|1|||
105614479|NCT03269136|364252925|FG017|Part 1: Dose Escalation|Other|0|||
105614480|NCT03269136|364252908|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
105614481|NCT03269136|364252909|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
105614482|NCT03269136|364252910|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
105614483|NCT03269136|364252911|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
105614484|NCT03269136|364252912|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
105614485|NCT03269136|364252913|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
105614486|NCT03269136|364252914|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
105614487|NCT03269136|364252915|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
105614488|NCT03269136|364252916|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
105614489|NCT03269136|364252917|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
105614490|NCT03269136|364252918|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
105614491|NCT03269136|364252919|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
105614492|NCT03269136|364252920|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
105614493|NCT03269136|364252921|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
105614494|NCT03269136|364252922|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
105614495|NCT03269136|364252923|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
105614496|NCT03269136|364252924|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
105614497|NCT03269136|364252925|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
105614498|NCT03269136|364252908|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614499|NCT03269136|364252909|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614500|NCT03269136|364252910|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614501|NCT03269136|364252911|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614502|NCT03269136|364252912|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614503|NCT03269136|364252913|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614504|NCT03269136|364252914|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614505|NCT03269136|364252915|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
105614506|NCT03269136|364252916|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614507|NCT03269136|364252917|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614508|NCT03269136|364252918|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614509|NCT03269136|364252919|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614510|NCT03269136|364252920|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614511|NCT03269136|364252921|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614512|NCT03269136|364252922|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614513|NCT03269136|364252923|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614514|NCT03269136|364252924|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614515|NCT03269136|364252925|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
105614516|NCT03269136|364252908|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614517|NCT03269136|364252909|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614518|NCT03269136|364252910|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614519|NCT03269136|364252911|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614520|NCT03269136|364252912|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614521|NCT03269136|364252913|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614522|NCT03269136|364252914|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614523|NCT03269136|364252915|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614524|NCT03269136|364252916|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614525|NCT03269136|364252917|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
105614526|NCT03269136|364252918|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614527|NCT03269136|364252919|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614528|NCT03269136|364252920|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614529|NCT03269136|364252921|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614530|NCT03269136|364252922|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614531|NCT03269136|364252923|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614532|NCT03269136|364252924|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614533|NCT03269136|364252925|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
105614534|NCT03269136|364252908|FG000|Part 1: Dose Escalation|Death|0|||
105614535|NCT03269136|364252909|FG001|Part 1: Dose Escalation|Death|0|||
105614536|NCT03269136|364252910|FG002|Part 1: Dose Escalation|Death|0|||
105614537|NCT03269136|364252911|FG003|Part 1: Dose Escalation|Death|0|||
105614538|NCT03269136|364252912|FG004|Part 1: Dose Escalation|Death|0|||
105614539|NCT03269136|364252913|FG005|Part 1: Dose Escalation|Death|0|||
105614540|NCT03269136|364252914|FG006|Part 1: Dose Escalation|Death|0|||
105614541|NCT03269136|364252915|FG007|Part 1: Dose Escalation|Death|0|||
105614542|NCT03269136|364252916|FG008|Part 1: Dose Escalation|Death|0|||
105614543|NCT03269136|364252917|FG009|Part 1: Dose Escalation|Death|1|||
105614544|NCT03269136|364252918|FG010|Part 1: Dose Escalation|Death|0|||
105614545|NCT03269136|364252919|FG011|Part 1: Dose Escalation|Death|1|||
105614546|NCT03269136|364252920|FG012|Part 1: Dose Escalation|Death|0|||
105614547|NCT03269136|364252921|FG013|Part 1: Dose Escalation|Death|1|||
105614548|NCT03269136|364252922|FG014|Part 1: Dose Escalation|Death|0|||
105614549|NCT03269136|364252923|FG015|Part 1: Dose Escalation|Death|0|||
105614550|NCT03269136|364252924|FG016|Part 1: Dose Escalation|Death|2|||
105614551|NCT03269136|364252925|FG017|Part 1: Dose Escalation|Death|0|||
105614552|NCT03269136|364252908|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
105614553|NCT03269136|364252909|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
105614554|NCT03269136|364252910|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
105614555|NCT03269136|364252911|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
105614556|NCT03269136|364252912|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
105614557|NCT03269136|364252913|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
105614558|NCT03269136|364252914|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
105614559|NCT03269136|364252915|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
105614560|NCT03269136|364252916|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
105614561|NCT03269136|364252917|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
105614562|NCT03269136|364252918|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
105614563|NCT03269136|364252919|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
105614564|NCT03269136|364252920|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
105614565|NCT03269136|364252921|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
105614566|NCT03269136|364252922|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
105614567|NCT03269136|364252923|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
105614568|NCT03269136|364252924|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
105614569|NCT03269136|364252925|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
105614570|NCT03269136|364252908|FG000|Part 1: Dose Escalation|Adverse Event|0|||
105614571|NCT03269136|364252909|FG001|Part 1: Dose Escalation|Adverse Event|0|||
105614572|NCT03269136|364252910|FG002|Part 1: Dose Escalation|Adverse Event|0|||
105614573|NCT03269136|364252911|FG003|Part 1: Dose Escalation|Adverse Event|0|||
105614574|NCT03269136|364252912|FG004|Part 1: Dose Escalation|Adverse Event|0|||
105614575|NCT03269136|364252913|FG005|Part 1: Dose Escalation|Adverse Event|0|||
105614576|NCT03269136|364252914|FG006|Part 1: Dose Escalation|Adverse Event|2|||
105614577|NCT03269136|364252915|FG007|Part 1: Dose Escalation|Adverse Event|0|||
105614578|NCT03269136|364252916|FG008|Part 1: Dose Escalation|Adverse Event|0|||
105614579|NCT03269136|364252917|FG009|Part 1: Dose Escalation|Adverse Event|0|||
105614580|NCT03269136|364252918|FG010|Part 1: Dose Escalation|Adverse Event|1|||
105614581|NCT03269136|364252919|FG011|Part 1: Dose Escalation|Adverse Event|2|||
105614582|NCT03269136|364252920|FG012|Part 1: Dose Escalation|Adverse Event|0|||
105614583|NCT03269136|364252921|FG013|Part 1: Dose Escalation|Adverse Event|1|||
105614584|NCT03269136|364252922|FG014|Part 1: Dose Escalation|Adverse Event|0|||
105614585|NCT03269136|364252923|FG015|Part 1: Dose Escalation|Adverse Event|0|||
105614586|NCT03269136|364252924|FG016|Part 1: Dose Escalation|Adverse Event|1|||
105614587|NCT03269136|364252925|FG017|Part 1: Dose Escalation|Adverse Event|0|||
105614588|NCT03269136|364252908|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
105614589|NCT03269136|364252909|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
105614590|NCT03269136|364252910|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
105614591|NCT03269136|364252911|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
105614592|NCT03269136|364252912|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
105614593|NCT03269136|364252913|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
105614594|NCT03269136|364252914|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
105614595|NCT03269136|364252915|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
105614596|NCT03269136|364252916|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
105614597|NCT03269136|364252917|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
105614598|NCT03269136|364252918|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
105614599|NCT03269136|364252919|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
105614600|NCT03269136|364252920|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
105614601|NCT03269136|364252921|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
105614602|NCT03269136|364252922|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
105614603|NCT03269136|364252923|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
105614604|NCT03269136|364252924|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
105614605|NCT03269136|364252925|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
105614606|NCT03269136|364252908|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105614607|NCT03269136|364252909|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105614608|NCT03269136|364252910|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105614609|NCT03269136|364252911|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105614610|NCT03269136|364252912|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105614611|NCT03269136|364252913|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105614612|NCT03269136|364252914|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105614613|NCT03269136|364252915|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105614614|NCT03269136|364252916|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105614615|NCT03269136|364252917|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105614616|NCT03269136|364252918|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105614617|NCT03269136|364252919|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105614618|NCT03269136|364252920|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
105614619|NCT03269136|364252921|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
105614620|NCT03269136|364252922|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
105614621|NCT03269136|364252923|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105614622|NCT03269136|364252924|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
105614623|NCT03269136|364252925|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105614624|NCT03269136|364252908|FG000|Part 2A: Dose Expansion|Other|0|||
105614625|NCT03269136|364252909|FG001|Part 2A: Dose Expansion|Other|0|||
105614626|NCT03269136|364252910|FG002|Part 2A: Dose Expansion|Other|0|||
105614627|NCT03269136|364252911|FG003|Part 2A: Dose Expansion|Other|0|||
105614628|NCT03269136|364252912|FG004|Part 2A: Dose Expansion|Other|0|||
105614629|NCT03269136|364252913|FG005|Part 2A: Dose Expansion|Other|0|||
105614630|NCT03269136|364252914|FG006|Part 2A: Dose Expansion|Other|0|||
105614631|NCT03269136|364252915|FG007|Part 2A: Dose Expansion|Other|0|||
105614632|NCT03269136|364252916|FG008|Part 2A: Dose Expansion|Other|0|||
105614633|NCT03269136|364252917|FG009|Part 2A: Dose Expansion|Other|0|||
105614634|NCT03269136|364252918|FG010|Part 2A: Dose Expansion|Other|0|||
105614635|NCT03269136|364252919|FG011|Part 2A: Dose Expansion|Other|0|||
105614636|NCT03269136|364252920|FG012|Part 2A: Dose Expansion|Other|0|||
105614637|NCT03269136|364252921|FG013|Part 2A: Dose Expansion|Other|0|||
105614638|NCT03269136|364252922|FG014|Part 2A: Dose Expansion|Other|0|||
105614639|NCT03269136|364252923|FG015|Part 2A: Dose Expansion|Other|0|||
105614640|NCT03269136|364252924|FG016|Part 2A: Dose Expansion|Other|0|||
105614641|NCT03269136|364252925|FG017|Part 2A: Dose Expansion|Other|1|||
105614642|NCT03269136|364252908|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614643|NCT03269136|364252909|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614644|NCT03269136|364252910|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614645|NCT03269136|364252911|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614646|NCT03269136|364252912|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614647|NCT03269136|364252913|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614648|NCT03269136|364252914|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614649|NCT03269136|364252915|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614650|NCT03269136|364252916|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614651|NCT03269136|364252917|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614652|NCT03269136|364252918|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614653|NCT03269136|364252919|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614654|NCT03269136|364252920|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614655|NCT03269136|364252921|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614656|NCT03269136|364252922|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614657|NCT03269136|364252923|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614658|NCT03269136|364252924|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
105614659|NCT03269136|364252925|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
105614660|NCT03269136|364252908|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
105614661|NCT03269136|364252909|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
105614662|NCT03269136|364252910|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
105614663|NCT03269136|364252911|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
105614664|NCT03269136|364252912|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
105614665|NCT03269136|364252913|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
105614666|NCT03269136|364252914|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
105614667|NCT03269136|364252915|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
105614668|NCT03269136|364252916|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
105614669|NCT03269136|364252917|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
105614670|NCT03269136|364252918|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
105614671|NCT03269136|364252919|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
105614672|NCT03269136|364252920|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
105614673|NCT03269136|364252921|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
105614674|NCT03269136|364252922|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
105614675|NCT03269136|364252923|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
105614676|NCT03269136|364252924|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
105614677|NCT03269136|364252925|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
105614678|NCT03269136|364252908|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
105614679|NCT03269136|364252909|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
105614680|NCT03269136|364252910|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
105614681|NCT03269136|364252911|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
105614682|NCT03269136|364252912|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
105614683|NCT03269136|364252913|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
105614684|NCT03269136|364252914|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
105614685|NCT03269136|364252915|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
105614686|NCT03269136|364252916|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
105614687|NCT03269136|364252917|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
105614688|NCT03269136|364252918|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
105614689|NCT03269136|364252919|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
105614690|NCT03269136|364252920|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
105614691|NCT03269136|364252921|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
105614692|NCT03269136|364252922|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
105614693|NCT03269136|364252923|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
105614694|NCT03269136|364252924|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
105614695|NCT03269136|364252925|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
105614696|NCT03269136|364252908|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
105614697|NCT03269136|364252909|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
105614698|NCT03269136|364252910|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
105614699|NCT03269136|364252911|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
105614700|NCT03269136|364252912|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
105614701|NCT03269136|364252913|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
105614702|NCT03269136|364252914|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
105614703|NCT03269136|364252915|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
105614704|NCT03269136|364252916|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
105614705|NCT03269136|364252917|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
105614706|NCT03269136|364252918|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
105614707|NCT03269136|364252919|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
105614708|NCT03269136|364252920|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
105614709|NCT03269136|364252921|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
105614710|NCT03269136|364252922|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
105614711|NCT03269136|364252923|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
105614712|NCT03269136|364252924|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
105614713|NCT03269136|364252925|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
105614714|NCT03766009|364252929|FG000|Usual Care|Death|0|||
105614715|NCT03766009|364252930|FG001|Usual Care|Death|0|||
105614716|NCT03766009|364252931|FG002|Usual Care|Death|0|||
105614717|NCT03766009|364252932|FG003|Usual Care|Death|1|||
105614718|NCT03766009|364252933|FG004|Usual Care|Death|0|||
105614719|NCT03766009|364252934|FG005|Usual Care|Death|0|||
105614720|NCT03766009|364252929|FG000|Usual Care|Lost to Follow-up|0|||
105614721|NCT03766009|364252930|FG001|Usual Care|Lost to Follow-up|0|||
105614722|NCT03766009|364252931|FG002|Usual Care|Lost to Follow-up|0|||
105614723|NCT03766009|364252932|FG003|Usual Care|Lost to Follow-up|1|||
105614724|NCT03766009|364252933|FG004|Usual Care|Lost to Follow-up|0|||
105614725|NCT03766009|364252934|FG005|Usual Care|Lost to Follow-up|0|||
105614726|NCT03766009|364252929|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
105614727|NCT03766009|364252930|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
105614728|NCT03766009|364252931|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
105614729|NCT03766009|364252932|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
105614730|NCT03766009|364252933|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
105614731|NCT03766009|364252934|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
105614732|NCT03766009|364252929|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
105614733|NCT03766009|364252930|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
105614734|NCT03766009|364252931|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
105614735|NCT03766009|364252932|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
105614736|NCT03766009|364252933|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
105614737|NCT03766009|364252934|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
105614738|NCT03766009|364252929|FG000|Usual Care|No treatment or declined surgery|0|||
105614739|NCT03766009|364252930|FG001|Usual Care|No treatment or declined surgery|0|||
105614740|NCT03766009|364252931|FG002|Usual Care|No treatment or declined surgery|0|||
105614741|NCT03766009|364252932|FG003|Usual Care|No treatment or declined surgery|2|||
105614742|NCT03766009|364252933|FG004|Usual Care|No treatment or declined surgery|0|||
105614743|NCT03766009|364252934|FG005|Usual Care|No treatment or declined surgery|0|||
105614744|NCT03766009|364252929|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
105614745|NCT03766009|364252930|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
105614746|NCT03766009|364252931|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
105614747|NCT03766009|364252932|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
105614748|NCT03766009|364252933|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
105614749|NCT03766009|364252934|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
105614750|NCT03766009|364252929|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
105614751|NCT03766009|364252930|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
105614752|NCT03766009|364252931|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
105614753|NCT03766009|364252932|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
105614754|NCT03766009|364252933|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
105614755|NCT03766009|364252934|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
105614756|NCT03766009|364252929|FG000|Usual Care|Ineligible|0|||
105614757|NCT03766009|364252930|FG001|Usual Care|Ineligible|1|||
105614758|NCT03766009|364252931|FG002|Usual Care|Ineligible|0|||
105614759|NCT03766009|364252932|FG003|Usual Care|Ineligible|0|||
105614760|NCT03766009|364252933|FG004|Usual Care|Ineligible|0|||
105614761|NCT03766009|364252934|FG005|Usual Care|Ineligible|0|||
105614762|NCT03766009|364252929|FG000|Usual Care|Other: Staff turnover|0|||
105614763|NCT03766009|364252930|FG001|Usual Care|Other: Staff turnover|0|||
105614764|NCT03766009|364252931|FG002|Usual Care|Other: Staff turnover|0|||
105614765|NCT03766009|364252932|FG003|Usual Care|Other: Staff turnover|0|||
105614766|NCT03766009|364252933|FG004|Usual Care|Other: Staff turnover|0|||
105614767|NCT03766009|364252934|FG005|Usual Care|Other: Staff turnover|2|||
105614768|NCT05071807|364252940|FG000|Overall Study|Withdrawal by Subject|4|||
105614769|NCT05071807|364252941|FG001|Overall Study|Withdrawal by Subject|0|||
105614770|NCT05071807|364252940|FG000|Overall Study|Unrelated medical issues|3|||
105614771|NCT05071807|364252941|FG001|Overall Study|Unrelated medical issues|0|||
105614772|NCT05071807|364252940|FG000|Overall Study|Relocated|0|||
105614773|NCT05071807|364252941|FG001|Overall Study|Relocated|1|||
105614774|NCT04072380|364252951|FG000|Overall Study|Adverse Event|4|||
105614775|NCT04072380|364252952|FG001|Overall Study|Adverse Event|6|||
105614776|NCT04072380|364252953|FG002|Overall Study|Adverse Event|0|||
105614777|NCT04072380|364252951|FG000|Overall Study|Withdrawal by Subject|3|||
105614778|NCT04072380|364252952|FG001|Overall Study|Withdrawal by Subject|1|||
105614779|NCT04072380|364252953|FG002|Overall Study|Withdrawal by Subject|1|||
105614780|NCT04072380|364252951|FG000|Overall Study|Physician Decision|2|||
105614781|NCT04072380|364252952|FG001|Overall Study|Physician Decision|0|||
105614782|NCT04072380|364252953|FG002|Overall Study|Physician Decision|0|||
105614783|NCT04072380|364252951|FG000|Overall Study|Protocol Violation|0|||
105614784|NCT04072380|364252952|FG001|Overall Study|Protocol Violation|2|||
105614785|NCT04072380|364252953|FG002|Overall Study|Protocol Violation|3|||
105614786|NCT04072380|364252951|FG000|Overall Study|Intercurrent Illness and Others|3|||
105614787|NCT04072380|364252952|FG001|Overall Study|Intercurrent Illness and Others|5|||
105614788|NCT04072380|364252953|FG002|Overall Study|Intercurrent Illness and Others|6|||
105614789|NCT03652688|364252954|FG000|Baseline|Withdrawal by Subject|0|||
105614790|NCT03652688|364252955|FG001|Baseline|Withdrawal by Subject|3|||
105614791|NCT03652688|364252954|FG000|Follow-up|Lost to Follow-up|56|||
105614792|NCT03652688|364252955|FG001|Follow-up|Lost to Follow-up|54|||
105614793|NCT05551637|364252956|FG000|Overall Study|Lack of Efficacy|0|||
105614794|NCT05551637|364252957|FG001|Overall Study|Lack of Efficacy|6|||
105614795|NCT05551637|364252956|FG000|Overall Study|Lost to Follow-up|1|||
105614796|NCT05551637|364252957|FG001|Overall Study|Lost to Follow-up|1|||
105614797|NCT04782973|364252960|FG000|Overall Study|Withdrawal by Subject|5|||
105614798|NCT04782973|364252960|FG000|Overall Study|Protocol Violation|6|||
105614799|NCT04782973|364252960|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
105614800|NCT03611491|364252961|FG000|Overall Study|Lost to Follow-up|1|||
105614801|NCT05478499|364252962|FG000|Overall Study|Adverse Event|4|||
105614802|NCT05478499|364252963|FG001|Overall Study|Adverse Event|2|||
105614803|NCT05478499|364252962|FG000|Overall Study|Withdrawal by Subject|3|||
105614804|NCT05478499|364252963|FG001|Overall Study|Withdrawal by Subject|2|||
105614805|NCT05478499|364252962|FG000|Overall Study|Lack of Efficacy|1|||
105614806|NCT05478499|364252963|FG001|Overall Study|Lack of Efficacy|0|||
105614807|NCT05478499|364252962|FG000|Overall Study|Lost to Follow-up|1|||
105614808|NCT05478499|364252963|FG001|Overall Study|Lost to Follow-up|0|||
105614809|NCT05478499|364252962|FG000|Overall Study|Other reasons|0|||
105614810|NCT05478499|364252963|FG001|Overall Study|Other reasons|1|||
105614811|NCT04509674|364252964|FG000|Overall Study|Not treated|33|||
105614812|NCT04509674|364252965|FG001|Overall Study|Not treated|26|||
105614813|NCT04509674|364252964|FG000|Overall Study|Protocol Violation|9|||
105614814|NCT04509674|364252965|FG001|Overall Study|Protocol Violation|10|||
105614815|NCT04509674|364252964|FG000|Overall Study|Lost to Follow-up|31|||
105614816|NCT04509674|364252965|FG001|Overall Study|Lost to Follow-up|39|||
105614817|NCT04509674|364252964|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
105614818|NCT04509674|364252965|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
105614819|NCT04509674|364252964|FG000|Overall Study|Adverse event, serious fatal event|11|||
105614820|NCT04509674|364252965|FG001|Overall Study|Adverse event, serious fatal event|4|||
105614821|NCT04509674|364252964|FG000|Overall Study|Adverse event, non-fatal event|107|||
105614822|NCT04509674|364252965|FG001|Overall Study|Adverse event, non-fatal event|118|||
105614823|NCT04509674|364252964|FG000|Overall Study|Other reason than listed|106|||
105614824|NCT04509674|364252965|FG001|Overall Study|Other reason than listed|95|||
105614825|NCT04633122|364252969|FG000|Overall Study|Remained on treatment|19|||
105614826|NCT04633122|364252970|FG001|Overall Study|Remained on treatment|14|||
105614827|NCT04633122|364252969|FG000|Overall Study|Survival follow-up stopped|22|||
105614828|NCT04633122|364252970|FG001|Overall Study|Survival follow-up stopped|25|||
105614829|NCT04799899|364252975|FG000|Overall Study|Lost to Follow-up|2|||
105614830|NCT04799899|364252976|FG001|Overall Study|Lost to Follow-up|4|||
105614831|NCT04185298|364252978|FG000|Overall Study|Lost to Follow-up|1|||
105614832|NCT04185298|364252979|FG001|Overall Study|Lost to Follow-up|3|||
105614833|NCT04185298|364252978|FG000|Overall Study|Withdrawal by Subject|0|||
105614834|NCT04185298|364252979|FG001|Overall Study|Withdrawal by Subject|3|||
105614835|NCT01798498|364252980|FG000|Overall Study|Lost to Follow-up|1|||
105614836|NCT03896789|364252982|FG000|Baseline|Lost to Follow-up|1|||
105614837|NCT03896789|364252983|FG001|Baseline|Lost to Follow-up|2|||
105614838|NCT03896789|364252982|FG000|Baseline|Death|3|||
105614839|NCT03896789|364252983|FG001|Baseline|Death|6|||
105614840|NCT03896789|364252982|FG000|Post-Randomization|Lost to Follow-up|12|||
105614841|NCT03896789|364252983|FG001|Post-Randomization|Lost to Follow-up|11|||
105614842|NCT03896789|364252982|FG000|Post-Randomization|Death|12|||
105614843|NCT03896789|364252983|FG001|Post-Randomization|Death|13|||
105614844|NCT03447470|364252984|FG000|Overall Study|Death|0|||
105614845|NCT03447470|364252985|FG001|Overall Study|Death|1|||
105614846|NCT03447470|364252986|FG002|Overall Study|Death|3|||
105614847|NCT03447470|364252987|FG003|Overall Study|Death|0|||
105614848|NCT03447470|364252988|FG004|Overall Study|Death|1|||
105614849|NCT03447470|364252989|FG005|Overall Study|Death|0|||
105614850|NCT03447470|364252990|FG006|Overall Study|Death|3|||
105614851|NCT03447470|364252991|FG007|Overall Study|Death|3|||
105614852|NCT03447470|364252992|FG008|Overall Study|Death|1|||
105614853|NCT03447470|364252984|FG000|Overall Study|Withdrawal by Subject|1|||
105614854|NCT03447470|364252985|FG001|Overall Study|Withdrawal by Subject|0|||
105614855|NCT03447470|364252986|FG002|Overall Study|Withdrawal by Subject|0|||
105614856|NCT03447470|364252987|FG003|Overall Study|Withdrawal by Subject|0|||
105614857|NCT03447470|364252988|FG004|Overall Study|Withdrawal by Subject|1|||
105614858|NCT03447470|364252989|FG005|Overall Study|Withdrawal by Subject|0|||
105614859|NCT03447470|364252990|FG006|Overall Study|Withdrawal by Subject|1|||
105614860|NCT03447470|364252991|FG007|Overall Study|Withdrawal by Subject|1|||
105614861|NCT03447470|364252992|FG008|Overall Study|Withdrawal by Subject|3|||
105614862|NCT03447470|364252984|FG000|Overall Study|Treatment discontinued|3|||
105614863|NCT03447470|364252985|FG001|Overall Study|Treatment discontinued|2|||
105614864|NCT03447470|364252986|FG002|Overall Study|Treatment discontinued|4|||
105614865|NCT03447470|364252987|FG003|Overall Study|Treatment discontinued|6|||
105614866|NCT03447470|364252988|FG004|Overall Study|Treatment discontinued|2|||
105614867|NCT03447470|364252989|FG005|Overall Study|Treatment discontinued|1|||
105614868|NCT03447470|364252990|FG006|Overall Study|Treatment discontinued|2|||
105614869|NCT03447470|364252991|FG007|Overall Study|Treatment discontinued|4|||
105614870|NCT03447470|364252992|FG008|Overall Study|Treatment discontinued|3|||
105614871|NCT01606215|364252993|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
105614872|NCT01606215|364252994|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
105614873|NCT05184192|364252996|FG000|Overall Study|Lost to Follow-up|4|||
105614874|NCT05184192|364252997|FG001|Overall Study|Lost to Follow-up|7|||
105614875|NCT05184192|364252996|FG000|Overall Study|Adverse Event|1|||
105614876|NCT05184192|364252997|FG001|Overall Study|Adverse Event|4|||
105614877|NCT05184192|364252996|FG000|Overall Study|PI withdrawal|1|||
105614878|NCT05184192|364252997|FG001|Overall Study|PI withdrawal|2|||
105614879|NCT05184192|364252996|FG000|Overall Study|Withdrew due to adverse effect|1|||
105614880|NCT05184192|364252997|FG001|Overall Study|Withdrew due to adverse effect|0|||
105614881|NCT05184192|364252996|FG000|Overall Study|Medication schedule|1|||
105614882|NCT05184192|364252997|FG001|Overall Study|Medication schedule|0|||
105614883|NCT05184192|364252996|FG000|Overall Study|Concern for adverse effects|0|||
105614884|NCT05184192|364252997|FG001|Overall Study|Concern for adverse effects|4|||
105614885|NCT03945292|364252998|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
105614886|NCT03945292|364252999|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
105614887|NCT03945292|364253000|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
105614888|NCT03945292|364253001|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
105614889|NCT03945292|364253002|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
105614890|NCT03945292|364253003|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
105614891|NCT03945292|364253004|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
105614892|NCT03945292|364253005|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
105614893|NCT03945292|364252998|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
105614894|NCT03945292|364252999|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
105614895|NCT03945292|364253000|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
105614896|NCT03945292|364253001|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
105614897|NCT03945292|364253002|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
105614898|NCT03945292|364253003|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
105614899|NCT03945292|364253004|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
105614900|NCT03945292|364253005|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
105614901|NCT03945292|364252998|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
105614902|NCT03945292|364252999|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
105614903|NCT03945292|364253000|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
105614904|NCT03945292|364253001|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
105614905|NCT03945292|364253002|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
105614906|NCT03945292|364253003|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
105614907|NCT03945292|364253004|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
105614908|NCT03945292|364253005|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
105614909|NCT05364671|364253012|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
105614910|NCT05364671|364253013|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
105614911|NCT05364671|364253012|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
105614912|NCT05364671|364253013|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
105614913|NCT05364671|364253012|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
105614914|NCT05364671|364253013|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
105614915|NCT05364671|364253012|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
105614916|NCT05364671|364253013|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
105614917|NCT05364671|364253012|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
105614918|NCT05364671|364253013|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
105614919|NCT00418886|364254395|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
105614920|NCT00418886|364254396|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
105614921|NCT00418886|364254395|FG000|Randomized Period|Death|122|||
105614922|NCT00418886|364254396|FG001|Randomized Period|Death|147|||
105614923|NCT00418886|364254395|FG000|Randomized Period|Withdrawal by Subject|9|||
105614924|NCT00418886|364254396|FG001|Randomized Period|Withdrawal by Subject|10|||
105614925|NCT00418886|364254395|FG000|Randomized Period|Lost to Follow-up|4|||
105614926|NCT00418886|364254396|FG001|Randomized Period|Lost to Follow-up|6|||
105614927|NCT00418886|364254395|FG000|Randomized Period|withdrawn due to other reason|1|||
105614928|NCT00418886|364254396|FG001|Randomized Period|withdrawn due to other reason|0|||
105614929|NCT00418886|364254395|FG000|Randomized Period|randomised but no treatment received|0|||
105614930|NCT00418886|364254396|FG001|Randomized Period|randomised but no treatment received|1|||
105614931|NCT01413100|364254397|FG000|Overall Study|Withdrawal by Subject|1|||
105614932|NCT02076113|364254400|FG000|Overall Study|Lost to Follow-up|4|||
105614933|NCT02076113|364254401|FG001|Overall Study|Lost to Follow-up|1|||
105614934|NCT02076113|364254400|FG000|Overall Study|Withdrawal by Subject|2|||
105614935|NCT02076113|364254401|FG001|Overall Study|Withdrawal by Subject|3|||
105614936|NCT02076113|364254400|FG000|Overall Study|Death|1|||
105614937|NCT02076113|364254401|FG001|Overall Study|Death|3|||
105614938|NCT04760678|364254402|FG000|Overall Study|Death|13|||
105614939|NCT04760678|364254402|FG000|Overall Study|Lost to Follow-up|48|||
105614940|NCT04760678|364254402|FG000|Overall Study|Withdrawal by Subject|1|||
105614941|NCT02921230|364254405|FG000|Overall Study|Withdrawal by Subject|20|||
105614942|NCT02921230|364254406|FG001|Overall Study|Withdrawal by Subject|8|||
105614943|NCT02921230|364254405|FG000|Overall Study|Death|12|||
105614944|NCT02921230|364254406|FG001|Overall Study|Death|3|||
105614945|NCT02921230|364254405|FG000|Overall Study|Protocol Violation|17|||
105614946|NCT02921230|364254406|FG001|Overall Study|Protocol Violation|6|||
105614947|NCT02921230|364254405|FG000|Overall Study|Early completion|5|||
105614948|NCT02921230|364254406|FG001|Overall Study|Early completion|1|||
105614949|NCT02921230|364254405|FG000|Overall Study|Pending data entry|1|||
105614950|NCT02921230|364254406|FG001|Overall Study|Pending data entry|0|||
105614951|NCT03436290|364254407|FG000|Overall Study|Post-randomization Exclusion|1|||
105614952|NCT03436290|364254408|FG001|Overall Study|Post-randomization Exclusion|0|||
105614953|NCT03436290|364254407|FG000|Overall Study|Death|6|||
105614954|NCT03436290|364254408|FG001|Overall Study|Death|0|||
105614955|NCT03436290|364254407|FG000|Overall Study|Withdrawal by Subject|4|||
105614956|NCT03436290|364254408|FG001|Overall Study|Withdrawal by Subject|0|||
105614957|NCT03436290|364254407|FG000|Overall Study|Protocol Violation|30|||
105614958|NCT03436290|364254408|FG001|Overall Study|Protocol Violation|0|||
105614959|NCT03519581|364254409|FG000|Overall Study|Lost to Follow-up|3|||
105614960|NCT03519581|364254410|FG001|Overall Study|Lost to Follow-up|2|||
105614961|NCT03519581|364254409|FG000|Overall Study|Adverse Event|5|||
105614962|NCT03519581|364254410|FG001|Overall Study|Adverse Event|2|||
105614963|NCT03519581|364254409|FG000|Overall Study|Withdrawal by Subject|2|||
105614964|NCT03519581|364254410|FG001|Overall Study|Withdrawal by Subject|0|||
105614965|NCT03519581|364254409|FG000|Overall Study|Change to insurance|2|||
105614966|NCT03519581|364254410|FG001|Overall Study|Change to insurance|1|||
105614967|NCT03519581|364254409|FG000|Overall Study|Other|2|||
105614968|NCT03519581|364254410|FG001|Overall Study|Other|4|||
105614969|NCT05268393|364254411|FG000|Overall Study|Withdrawal by Subject|2|||
105614970|NCT05268393|364254412|FG001|Overall Study|Withdrawal by Subject|1|||
105614971|NCT03396926|364254413|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
105614972|NCT03396926|364254414|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
105614973|NCT06414213|364254415|FG000|Overall Study|Lost to Follow-up|1|||
105614974|NCT06414213|364254416|FG001|Overall Study|Lost to Follow-up|1|||
105614975|NCT06414213|364254417|FG002|Overall Study|Lost to Follow-up|3|||
105614976|NCT04515576|364254418|FG000|Overall Study|Withdrawal by Subject|0|||
105614977|NCT04515576|364254419|FG001|Overall Study|Withdrawal by Subject|0|||
105614978|NCT04515576|364254420|FG002|Overall Study|Withdrawal by Subject|0|||
105614979|NCT04515576|364254421|FG003|Overall Study|Withdrawal by Subject|0|||
105614980|NCT04515576|364254422|FG004|Overall Study|Withdrawal by Subject|0|||
105614981|NCT04515576|364254423|FG005|Overall Study|Withdrawal by Subject|1|||
105614982|NCT01081951|364254424|FG000|Overall Study|Death|54|||
105614983|NCT01081951|364254425|FG001|Overall Study|Death|47|||
105614984|NCT01081951|364254424|FG000|Overall Study|Withdrawal by Subject|2|||
105614985|NCT01081951|364254425|FG001|Overall Study|Withdrawal by Subject|6|||
105614986|NCT01081951|364254424|FG000|Overall Study|Allocated treatment but did not take it|0|||
105614987|NCT01081951|364254425|FG001|Overall Study|Allocated treatment but did not take it|1|||
105614988|NCT01081951|364254424|FG000|Overall Study|Lost to Follow-up|0|||
105614989|NCT01081951|364254425|FG001|Overall Study|Lost to Follow-up|1|||
105614990|NCT04728347|364254429|FG000|Overall Study|Sponsor decision|0|||
105614991|NCT04728347|364254430|FG001|Overall Study|Sponsor decision|0|||
105614992|NCT04728347|364254431|FG002|Overall Study|Sponsor decision|1|||
105614993|NCT04728347|364254432|FG003|Overall Study|Sponsor decision|0|||
105614994|NCT04011722|364254434|FG000|30 Days|Death|5|||
105614995|NCT04011722|364254435|FG001|30 Days|Death|1|||
105614996|NCT04011722|364254434|FG000|1 Year|Death|13|||
105614997|NCT04011722|364254435|FG001|1 Year|Death|5|||
105614998|NCT04011722|364254434|FG000|1 Year|Withdrawal by Subject|8|||
105614999|NCT04011722|364254435|FG001|1 Year|Withdrawal by Subject|2|||
105615000|NCT04011722|364254434|FG000|1 Year|Missed Visit|6|||
105615001|NCT04011722|364254435|FG001|1 Year|Missed Visit|1|||
105615002|NCT04011722|364254434|FG000|1 Year|Pending Visit|0|||
105615003|NCT04011722|364254435|FG001|1 Year|Pending Visit|11|||
105615004|NCT04011722|364254434|FG000|1 Year|Not Yet Due|0|||
105615005|NCT04011722|364254435|FG001|1 Year|Not Yet Due|9|||
105615006|NCT04011722|364254434|FG000|2 Year|Death|16|||
105615007|NCT04011722|364254435|FG001|2 Year|Death|1|||
105615008|NCT04011722|364254434|FG000|2 Year|Withdrawal by Subject|10|||
105615009|NCT04011722|364254435|FG001|2 Year|Withdrawal by Subject|1|||
105615010|NCT04011722|364254434|FG000|2 Year|Missed Visit|9|||
105615011|NCT04011722|364254435|FG001|2 Year|Missed Visit|0|||
105615012|NCT04011722|364254434|FG000|2 Year|Visit Pending|1|||
105615013|NCT04011722|364254435|FG001|2 Year|Visit Pending|3|||
105615014|NCT04011722|364254434|FG000|2 Year|Not Yet Due|43|||
105615015|NCT04011722|364254435|FG001|2 Year|Not Yet Due|54|||
105615016|NCT04011722|364254434|FG000|3 Year|Death|10|||
105615017|NCT04011722|364254435|FG001|3 Year|Death|0|||
105615018|NCT04011722|364254434|FG000|3 Year|Withdrawal by Subject|2|||
105615019|NCT04011722|364254435|FG001|3 Year|Withdrawal by Subject|0|||
105615020|NCT04011722|364254434|FG000|3 Year|Missed Visit|2|||
105615021|NCT04011722|364254435|FG001|3 Year|Missed Visit|0|||
105615022|NCT04011722|364254434|FG000|3 Year|Pending Visit|34|||
105615023|NCT04011722|364254435|FG001|3 Year|Pending Visit|0|||
105615024|NCT04011722|364254434|FG000|3 Year|Not Yet Due|99|||
105615025|NCT04011722|364254435|FG001|3 Year|Not Yet Due|0|||
105615026|NCT02924272|364254436|FG000|Overall Study|Site Terminated by Sponsor|4|||
105615027|NCT02924272|364254437|FG001|Overall Study|Site Terminated by Sponsor|1|||
105615028|NCT02924272|364254436|FG000|Overall Study|Withdrawal by Subject|2|||
105615029|NCT02924272|364254437|FG001|Overall Study|Withdrawal by Subject|0|||
105615030|NCT02924272|364254436|FG000|Overall Study|Adverse Event|3|||
105615031|NCT02924272|364254437|FG001|Overall Study|Adverse Event|0|||
105615032|NCT02924272|364254436|FG000|Overall Study|Progressive Disease|11|||
105615033|NCT02924272|364254437|FG001|Overall Study|Progressive Disease|8|||
105615034|NCT02924272|364254436|FG000|Overall Study|Clinical Deterioration|1|||
105615035|NCT02924272|364254437|FG001|Overall Study|Clinical Deterioration|0|||
105615036|NCT02924272|364254436|FG000|Overall Study|Death|1|||
105615037|NCT02924272|364254437|FG001|Overall Study|Death|0|||
105615038|NCT02924272|364254436|FG000|Overall Study|Reason Not Specified|1|||
105615039|NCT02924272|364254437|FG001|Overall Study|Reason Not Specified|0|||
105615040|NCT02100813|364254440|FG000|Overall Study|Adverse Event|0|||
105615041|NCT02100813|364254441|FG001|Overall Study|Adverse Event|0|||
105615042|NCT02100813|364254442|FG002|Overall Study|Adverse Event|0|||
105615043|NCT02100813|364254443|FG003|Overall Study|Adverse Event|0|||
105615044|NCT02100813|364254444|FG004|Overall Study|Adverse Event|0|||
105615045|NCT02100813|364254445|FG005|Overall Study|Adverse Event|0|||
105615046|NCT02100813|364254446|FG006|Overall Study|Adverse Event|0|||
105615047|NCT02100813|364254447|FG007|Overall Study|Adverse Event|1|||
105615048|NCT04952909|364254448|FG000|Overall Study|Death|3|||
105615049|NCT05308004|364254449|FG000|Overall Study|Not seen by Palliative Care NP|0|||
105615050|NCT05308004|364254450|FG001|Overall Study|Not seen by Palliative Care NP|1|||
105615051|NCT03575897|364254451|FG000|Overall Study|Lost to Follow-up|12|||
105615052|NCT03575897|364254452|FG001|Overall Study|Lost to Follow-up|13|||
105615053|NCT04552223|364254453|FG000|Overall Study|Withdrawal by Subject|1|||
105615054|NCT04856163|364254454|FG000|Overall Study|Lost to Follow-up|97|||
105615055|NCT04856163|364254455|FG001|Overall Study|Lost to Follow-up|100|||
105615056|NCT03869866|364254458|FG000|Overall Study|Protocol Violation|1|||
105615057|NCT03869866|364254458|FG000|Overall Study|Withdrawal by Subject|3|||
105615058|NCT00506519|364254469|FG000|Overall Study|Death|4|||
105615059|NCT00506519|364254470|FG001|Overall Study|Death|6|||
105615060|NCT00506519|364254471|FG002|Overall Study|Death|0|||
105615061|NCT00506519|364254469|FG000|Overall Study|Adverse Event|1|||
105615062|NCT00506519|364254470|FG001|Overall Study|Adverse Event|0|||
105615063|NCT00506519|364254471|FG002|Overall Study|Adverse Event|0|||
105615064|NCT01186367|364254472|FG000|Overall Study|Lost to Follow-up|7|||
105615065|NCT01186367|364254473|FG001|Overall Study|Lost to Follow-up|4|||
105615066|NCT01186367|364254474|FG002|Overall Study|Lost to Follow-up|7|||
105615067|NCT01186367|364254472|FG000|Overall Study|Did not receive study treatment|0|||
105615068|NCT01186367|364254473|FG001|Overall Study|Did not receive study treatment|1|||
105615069|NCT01186367|364254474|FG002|Overall Study|Did not receive study treatment|0|||
105615070|NCT00881621|364254475|FG000|Overall Study|Physician Decision|34|||
105615071|NCT05116787|364254480|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
105615072|NCT05116787|364254481|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
105615073|NCT05116787|364254480|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
105615074|NCT05116787|364254481|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
105615075|NCT05116787|364254480|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
105615076|NCT05116787|364254481|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
105615077|NCT05116787|364254480|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
105615078|NCT05116787|364254481|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
105615079|NCT02737436|364254482|FG000|Washout Period|Lost to Follow-up|5|||
105615080|NCT02737436|364254483|FG001|Washout Period|Lost to Follow-up|11|||
105615081|NCT02737436|364254482|FG000|Data Analysis|Scanning data problems|5|||
105615082|NCT02737436|364254483|FG001|Data Analysis|Scanning data problems|8|||
105615083|NCT06393088|364254485|FG000|Overall Study|Withdrawal by Subject|0|||
105615084|NCT06393088|364254486|FG001|Overall Study|Withdrawal by Subject|2|||
105615085|NCT02515773|364254487|FG000|Overall Study|Withdrawal by Subject|12|||
105615086|NCT02515773|364254488|FG001|Overall Study|Withdrawal by Subject|2|||
105615087|NCT02515773|364254487|FG000|Overall Study|Lost to Follow-up|119|||
105615088|NCT02515773|364254488|FG001|Overall Study|Lost to Follow-up|126|||
105615089|NCT02515773|364254487|FG000|Overall Study|Discharged from Clinic Services|53|||
105615090|NCT02515773|364254488|FG001|Overall Study|Discharged from Clinic Services|84|||
105615091|NCT02515773|364254487|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
105615092|NCT02515773|364254488|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
105615093|NCT02515773|364254487|FG000|Overall Study|Follow-up at non-study site|8|||
105615094|NCT02515773|364254488|FG001|Overall Study|Follow-up at non-study site|16|||
105615095|NCT02515773|364254487|FG000|Overall Study|Moved from area|9|||
105615096|NCT02515773|364254488|FG001|Overall Study|Moved from area|14|||
105615097|NCT01160211|364254489|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
105615098|NCT01160211|364254490|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
105615099|NCT01160211|364254491|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
105615100|NCT01160211|364254489|FG000|Overall Study|Lost to Follow-up|4|||
105615101|NCT01160211|364254490|FG001|Overall Study|Lost to Follow-up|8|||
105615102|NCT01160211|364254491|FG002|Overall Study|Lost to Follow-up|4|||
105615103|NCT01160211|364254489|FG000|Overall Study|Physician Decision|1|||
105615104|NCT01160211|364254490|FG001|Overall Study|Physician Decision|0|||
105615105|NCT01160211|364254491|FG002|Overall Study|Physician Decision|0|||
105615106|NCT01160211|364254489|FG000|Overall Study|Withdrawal by Subject|4|||
105615107|NCT01160211|364254490|FG001|Overall Study|Withdrawal by Subject|2|||
105615108|NCT01160211|364254491|FG002|Overall Study|Withdrawal by Subject|2|||
105615109|NCT01160211|364254489|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
105615110|NCT01160211|364254490|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
105615111|NCT01160211|364254491|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
105615112|NCT03829410|364254492|FG000|Overall Study|Adverse Event|1|||
105615113|NCT03829410|364254493|FG001|Overall Study|Adverse Event|0|||
105615114|NCT03829410|364254494|FG002|Overall Study|Adverse Event|1|||
105615115|NCT03829410|364254495|FG003|Overall Study|Adverse Event|4|||
105615116|NCT03829410|364254492|FG000|Overall Study|Physician Decision|0|||
105615117|NCT03829410|364254493|FG001|Overall Study|Physician Decision|0|||
105615118|NCT03829410|364254494|FG002|Overall Study|Physician Decision|0|||
105615119|NCT03829410|364254495|FG003|Overall Study|Physician Decision|2|||
105615120|NCT03829410|364254492|FG000|Overall Study|Disease Progressing|3|||
105615121|NCT03829410|364254493|FG001|Overall Study|Disease Progressing|4|||
105615122|NCT03829410|364254494|FG002|Overall Study|Disease Progressing|2|||
105615123|NCT03829410|364254495|FG003|Overall Study|Disease Progressing|31|||
105615124|NCT03829410|364254492|FG000|Overall Study|Miscellaneous|2|||
105615125|NCT03829410|364254493|FG001|Overall Study|Miscellaneous|4|||
105615126|NCT03829410|364254494|FG002|Overall Study|Miscellaneous|3|||
105615127|NCT03829410|364254495|FG003|Overall Study|Miscellaneous|10|||
105615128|NCT04342494|364254496|FG000|Overall Study|Questionnaire partially completed|1|||
105615129|NCT04342494|364254497|FG001|Overall Study|Questionnaire partially completed|0|||
105615130|NCT04342494|364254498|FG002|Overall Study|Questionnaire partially completed|2|||
105615131|NCT04342494|364254499|FG003|Overall Study|Questionnaire partially completed|0|||
105615132|NCT04342494|364254500|FG004|Overall Study|Questionnaire partially completed|1|||
105615133|NCT04342494|364254496|FG000|Overall Study|Lost to Follow-up|49|||
105615134|NCT04342494|364254497|FG001|Overall Study|Lost to Follow-up|38|||
105615135|NCT04342494|364254498|FG002|Overall Study|Lost to Follow-up|34|||
105615136|NCT04342494|364254499|FG003|Overall Study|Lost to Follow-up|34|||
105615137|NCT04342494|364254500|FG004|Overall Study|Lost to Follow-up|35|||
105615138|NCT05409183|364254501|FG000|Complete Study|Adverse Event|1|||
105615139|NCT05409183|364254502|FG001|Complete Study|Adverse Event|2|||
105615140|NCT05409183|364254501|FG000|Complete Study|Withdrawal by Subject|3|||
105615141|NCT05409183|364254502|FG001|Complete Study|Withdrawal by Subject|0|||
105615142|NCT05292365|364254505|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
105615143|NCT05292365|364254506|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
105615144|NCT05292365|364254507|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
105615145|NCT05292365|364254508|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
105615146|NCT05453773|364254509|FG000|Overall Study|Withdrawal by Subject|3|||
105615147|NCT05453773|364254509|FG000|Overall Study|Lost to Follow-up|3|||
105615148|NCT05453773|364254509|FG000|Overall Study|Difficult Blood Draw|3|||
105615149|NCT02023866|364254512|FG000|Overall Study|Non-compliance|2|||
105615150|NCT02023866|364254512|FG000|Overall Study|Adverse Event|3|||
105615151|NCT02023866|364254512|FG000|Overall Study|Withdrawal by Subject|1|||
105615152|NCT04987320|364254515|FG000|Overall Study|Withdrawal by Subject|0|||
105615153|NCT04987320|364254516|FG001|Overall Study|Withdrawal by Subject|1|||
105615154|NCT04091750|364254517|FG000|Overall Study|Adverse Event|4|||
105615155|NCT04091750|364254517|FG000|Overall Study|Withdrawal by Subject|1|||
105615156|NCT04473222|364254518|FG000|Overall Study|Lost to Follow-up|13|||
105615157|NCT04473222|364254519|FG001|Overall Study|Lost to Follow-up|13|||
105615158|NCT04473222|364254518|FG000|Overall Study|Withdrawal by Subject|0|||
105615159|NCT04473222|364254519|FG001|Overall Study|Withdrawal by Subject|1|||
105615160|NCT04473222|364254518|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
105615161|NCT04473222|364254519|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
105615162|NCT00227344|364254520|FG000|Overall Study|study terminated early|12|||
105615163|NCT00227344|364254521|FG001|Overall Study|study terminated early|5|||
105615164|NCT05057247|364254527|FG000|Overall Study|Death|4|||
105615165|NCT05057247|364254527|FG000|Overall Study|Physician Decision|3|||
105615166|NCT05057247|364254527|FG000|Overall Study|Progressive Disease|7|||
105615167|NCT05057247|364254527|FG000|Overall Study|Withdrawal by Subject|3|||
105615168|NCT05057247|364254527|FG000|Overall Study|Adverse Event|6|||
105615169|NCT05057247|364254527|FG000|Overall Study|Subject Non-Compliance|1|||
105615170|NCT05057247|364254527|FG000|Overall Study|On treatment|2|||
105615171|NCT03596866|364254528|FG000|Overall Study|Ongoing at Data Cut-off|91|||
105615172|NCT03596866|364254529|FG001|Overall Study|Ongoing at Data Cut-off|101|||
105615173|NCT03596866|364254528|FG000|Overall Study|Randomized but Never Received Drug|0|||
105615174|NCT03596866|364254529|FG001|Overall Study|Randomized but Never Received Drug|1|||
105615175|NCT03596866|364254528|FG000|Overall Study|Death|27|||
105615176|NCT03596866|364254529|FG001|Overall Study|Death|14|||
105615177|NCT03596866|364254528|FG000|Overall Study|Withdrawal by Subject|6|||
105615178|NCT03596866|364254529|FG001|Overall Study|Withdrawal by Subject|5|||
105615179|NCT03596866|364254528|FG000|Overall Study|Lost to Follow-up|1|||
105615180|NCT03596866|364254529|FG001|Overall Study|Lost to Follow-up|1|||
105615181|NCT03596866|364254528|FG000|Overall Study|Reason Not Specified|0|||
105615182|NCT03596866|364254529|FG001|Overall Study|Reason Not Specified|1|||
105615183|NCT02035787|364255769|FG000|Overall Study- 12 Months|Adverse Event|3|||
105615184|NCT02035787|364255770|FG001|Overall Study- 12 Months|Adverse Event|0|||
105615185|NCT02035787|364255769|FG000|Overall Study- 12 Months|Complete response|4|||
105615186|NCT02035787|364255770|FG001|Overall Study- 12 Months|Complete response|1|||
105615187|NCT02035787|364255769|FG000|Overall Study- 12 Months|Protocol Violation|1|||
105615188|NCT02035787|364255770|FG001|Overall Study- 12 Months|Protocol Violation|1|||
105615189|NCT03338933|364255771|FG000|Screening Visit|Lost to Follow-up|1|||
105615190|NCT03338933|364255772|FG001|Screening Visit|Lost to Follow-up|3|||
105615191|NCT03338933|364255773|FG002|Screening Visit|Lost to Follow-up|1|||
105615192|NCT03338933|364255774|FG003|Screening Visit|Lost to Follow-up|4|||
105615193|NCT03338933|364255771|FG000|Screening Visit|Screen fail after consent|2|||
105615194|NCT03338933|364255772|FG001|Screening Visit|Screen fail after consent|7|||
105615195|NCT03338933|364255773|FG002|Screening Visit|Screen fail after consent|1|||
105615196|NCT03338933|364255774|FG003|Screening Visit|Screen fail after consent|4|||
105615197|NCT03338933|364255771|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
105615198|NCT03338933|364255772|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
105615199|NCT03338933|364255773|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
105615200|NCT03338933|364255774|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
105615201|NCT03338933|364255771|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
105615202|NCT03338933|364255772|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
105615203|NCT03338933|364255773|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
105615204|NCT03338933|364255774|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
105615205|NCT03338933|364255771|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
105615206|NCT03338933|364255772|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
105615207|NCT03338933|364255773|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
105615208|NCT03338933|364255774|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
105615209|NCT05371652|364255775|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
105615210|NCT05371652|364255775|FG000|Overall Study|Withdrawal by Subject|12|||
105615211|NCT05371652|364255775|FG000|Overall Study|Adverse Event|1|||
105615212|NCT05371652|364255775|FG000|Overall Study|Other|11|||
105615213|NCT03302494|364255776|FG000|Overall Study|Other|7|||
105615214|NCT03302494|364255777|FG001|Overall Study|Other|4|||
105615215|NCT03302494|364255778|FG002|Overall Study|Other|6|||
105615216|NCT03302494|364255776|FG000|Overall Study|Withdrawal by Subject|10|||
105615217|NCT03302494|364255777|FG001|Overall Study|Withdrawal by Subject|2|||
105615218|NCT03302494|364255778|FG002|Overall Study|Withdrawal by Subject|9|||
105615219|NCT03302494|364255776|FG000|Overall Study|Study Terminated by Sponsor|32|||
105615220|NCT03302494|364255777|FG001|Overall Study|Study Terminated by Sponsor|29|||
105615221|NCT03302494|364255778|FG002|Overall Study|Study Terminated by Sponsor|30|||
105615222|NCT03302494|364255776|FG000|Overall Study|Physician Decision|1|||
105615223|NCT03302494|364255777|FG001|Overall Study|Physician Decision|0|||
105615224|NCT03302494|364255778|FG002|Overall Study|Physician Decision|1|||
105615225|NCT03302494|364255776|FG000|Overall Study|Lost to Follow-up|1|||
105615226|NCT03302494|364255777|FG001|Overall Study|Lost to Follow-up|3|||
105615227|NCT03302494|364255778|FG002|Overall Study|Lost to Follow-up|3|||
105615228|NCT03302494|364255776|FG000|Overall Study|Death|13|||
105615229|NCT03302494|364255777|FG001|Overall Study|Death|11|||
105615230|NCT03302494|364255778|FG002|Overall Study|Death|4|||
105615231|NCT03302494|364255776|FG000|Overall Study|Adverse Event|1|||
105615232|NCT03302494|364255777|FG001|Overall Study|Adverse Event|2|||
105615233|NCT03302494|364255778|FG002|Overall Study|Adverse Event|0|||
105615234|NCT03302494|364255776|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
105615235|NCT03302494|364255777|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
105615236|NCT03302494|364255778|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
105615237|NCT03936322|364255779|FG000|Overall Study|Lost to Follow-up|1|||
105615238|NCT03936322|364255779|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
105615239|NCT04359108|364255780|FG000|Overall Study|Withdrawal by Subject|1|||
105615240|NCT04359108|364255781|FG001|Overall Study|Withdrawal by Subject|0|||
105615241|NCT04359108|364255780|FG000|Overall Study|Unable or too feeble to walk independently|0|||
105615242|NCT04359108|364255781|FG001|Overall Study|Unable or too feeble to walk independently|2|||
105615243|NCT04359108|364255780|FG000|Overall Study|Argus II system stopped functioning|0|||
105615244|NCT04359108|364255781|FG001|Overall Study|Argus II system stopped functioning|1|||
105615245|NCT04359108|364255780|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
105615246|NCT04359108|364255781|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
105615247|NCT03719443|364255785|FG000|Overall Study|Lost to Follow-up|0|||
105615248|NCT03719443|364255786|FG001|Overall Study|Lost to Follow-up|0|||
105615249|NCT03719443|364255787|FG002|Overall Study|Lost to Follow-up|1|||
105615250|NCT03719443|364255788|FG003|Overall Study|Lost to Follow-up|0|||
105615251|NCT03719443|364255789|FG004|Overall Study|Lost to Follow-up|1|||
105615252|NCT03719443|364255790|FG005|Overall Study|Lost to Follow-up|0|||
105615253|NCT03719443|364255791|FG006|Overall Study|Lost to Follow-up|1|||
105615254|NCT03719443|364255785|FG000|Overall Study|Withdrawal by Subject|0|||
105615255|NCT03719443|364255786|FG001|Overall Study|Withdrawal by Subject|0|||
105615256|NCT03719443|364255787|FG002|Overall Study|Withdrawal by Subject|1|||
105615257|NCT03719443|364255788|FG003|Overall Study|Withdrawal by Subject|0|||
105615258|NCT03719443|364255789|FG004|Overall Study|Withdrawal by Subject|0|||
105615259|NCT03719443|364255790|FG005|Overall Study|Withdrawal by Subject|0|||
105615260|NCT03719443|364255791|FG006|Overall Study|Withdrawal by Subject|0|||
105615261|NCT06205407|364255792|FG000|Period 2|Withdrawal by Subject|0|||
105615262|NCT06205407|364255793|FG001|Period 2|Withdrawal by Subject|1|||
105615263|NCT06205407|364255792|FG000|Period 2|Adverse Event|2|||
105615264|NCT06205407|364255793|FG001|Period 2|Adverse Event|1|||
105615265|NCT04516967|364255794|FG000|Core Phase|Adverse Event|2|||
105615266|NCT04516967|364255795|FG001|Core Phase|Adverse Event|1|||
105615267|NCT04516967|364255796|FG002|Core Phase|Adverse Event|0|||
105615268|NCT04516967|364255794|FG000|Core Phase|Physician Decision|1|||
105615269|NCT04516967|364255795|FG001|Core Phase|Physician Decision|1|||
105615270|NCT04516967|364255796|FG002|Core Phase|Physician Decision|0|||
105615271|NCT04516967|364255794|FG000|Core Phase|Lack of Efficacy|7|||
105615272|NCT04516967|364255795|FG001|Core Phase|Lack of Efficacy|18|||
105615273|NCT04516967|364255796|FG002|Core Phase|Lack of Efficacy|0|||
105615274|NCT04676022|364255797|FG000|Overall Study|Screen Failure/|1|||
105615275|NCT04676022|364255798|FG001|Overall Study|Screen Failure/|1|||
105615276|NCT04676022|364255799|FG002|Overall Study|Screen Failure/|85|||
105615277|NCT04676022|364255797|FG000|Overall Study|Lost to Follow-up|1|||
105615278|NCT04676022|364255798|FG001|Overall Study|Lost to Follow-up|1|||
105615279|NCT04676022|364255799|FG002|Overall Study|Lost to Follow-up|0|||
105615280|NCT04676022|364255797|FG000|Overall Study|Adverse Event|2|||
105615281|NCT04676022|364255798|FG001|Overall Study|Adverse Event|0|||
105615282|NCT04676022|364255799|FG002|Overall Study|Adverse Event|1|||
105615283|NCT04676022|364255797|FG000|Overall Study|Physician Decision|2|||
105615284|NCT04676022|364255798|FG001|Overall Study|Physician Decision|0|||
105615285|NCT04676022|364255799|FG002|Overall Study|Physician Decision|1|||
105615286|NCT04676022|364255797|FG000|Overall Study|Withdrawal by Subject|3|||
105615287|NCT04676022|364255798|FG001|Overall Study|Withdrawal by Subject|1|||
105615288|NCT04676022|364255799|FG002|Overall Study|Withdrawal by Subject|6|||
105615289|NCT04676022|364255797|FG000|Overall Study|Will not move forward with permanent implant|6|||
105615290|NCT04676022|364255798|FG001|Overall Study|Will not move forward with permanent implant|0|||
105615291|NCT04676022|364255799|FG002|Overall Study|Will not move forward with permanent implant|0|||
105615292|NCT04676022|364255797|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
105615293|NCT04676022|364255798|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
105615294|NCT04676022|364255799|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
105615295|NCT03194217|364255800|FG000|Overall Study|Adverse Event|0|||
105615296|NCT03194217|364255801|FG001|Overall Study|Adverse Event|2|||
105615297|NCT03194217|364255802|FG002|Overall Study|Adverse Event|3|||
105615298|NCT03194217|364255803|FG003|Overall Study|Adverse Event|3|||
105615299|NCT03194217|364255800|FG000|Overall Study|Failure to meet randomisation criteria|0|||
105615300|NCT03194217|364255801|FG001|Overall Study|Failure to meet randomisation criteria|0|||
105615301|NCT03194217|364255802|FG002|Overall Study|Failure to meet randomisation criteria|0|||
105615302|NCT03194217|364255803|FG003|Overall Study|Failure to meet randomisation criteria|1|||
105615303|NCT03194217|364255800|FG000|Overall Study|Other|0|||
105615304|NCT03194217|364255801|FG001|Overall Study|Other|1|||
105615305|NCT03194217|364255802|FG002|Overall Study|Other|1|||
105615306|NCT03194217|364255803|FG003|Overall Study|Other|0|||
105615307|NCT05835336|364255804|FG000|Overall Study|Withdrawal by Subject|5|||
105615308|NCT05835336|364255804|FG000|Overall Study|Did not complete the personalization process|3|||
105615309|NCT02936752|364255805|FG000|Overall Study|Death|2|||
105615310|NCT02936752|364255806|FG001|Overall Study|Death|1|||
105615311|NCT02936752|364255805|FG000|Overall Study|Physician Decision|4|||
105615312|NCT02936752|364255806|FG001|Overall Study|Physician Decision|0|||
105615313|NCT02936752|364255805|FG000|Overall Study|Withdrawal by Subject|0|||
105615314|NCT02936752|364255806|FG001|Overall Study|Withdrawal by Subject|2|||
105615315|NCT05894577|364255807|FG000|Overall Study|No receipt of study drug|14|||
105615316|NCT05894577|364255808|FG001|Overall Study|No receipt of study drug|13|||
105615317|NCT05894577|364255807|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
105615318|NCT05894577|364255808|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
105615319|NCT05894577|364255807|FG000|Overall Study|Screen Fail|2|||
105615320|NCT05894577|364255808|FG001|Overall Study|Screen Fail|0|||
105615321|NCT05894577|364255807|FG000|Overall Study|Study drug recall|86|||
105615322|NCT05894577|364255808|FG001|Overall Study|Study drug recall|63|||
105615323|NCT06516705|364255828|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
105615324|NCT06516705|364255829|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
105615325|NCT06516705|364255828|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
105615326|NCT06516705|364255829|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
105615327|NCT06516705|364255828|FG000|T3 ( 3 Month After Education)|covid-19|1|||
105615328|NCT06516705|364255829|FG001|T3 ( 3 Month After Education)|covid-19|2|||
105615329|NCT06516705|364255828|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
105615330|NCT06516705|364255829|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
105615331|NCT06516705|364255828|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
105615332|NCT06516705|364255829|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
105615333|NCT06516705|364255828|FG000|T4 ( 6 Month After Education)|covid-19|3|||
105615334|NCT06516705|364255829|FG001|T4 ( 6 Month After Education)|covid-19|2|||
105615335|NCT06516705|364255828|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
105615336|NCT06516705|364255829|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
105615337|NCT05579899|364255831|FG000|Overall Study|Lost to Follow-up|3|||
105615338|NCT05579899|364255832|FG001|Overall Study|Lost to Follow-up|1|||
105615339|NCT05579899|364255831|FG000|Overall Study|Adverse Event|0|||
105615340|NCT05579899|364255832|FG001|Overall Study|Adverse Event|3|||
105615341|NCT05579899|364255831|FG000|Overall Study|Pregnancy|0|||
105615342|NCT05579899|364255832|FG001|Overall Study|Pregnancy|1|||
105615343|NCT05579899|364255831|FG000|Overall Study|Withdrawal by Subject|0|||
105615344|NCT05579899|364255832|FG001|Overall Study|Withdrawal by Subject|3|||
105615345|NCT04064164|364255835|FG000|Overall Study|Withdrawal by Subject|8|||
105615346|NCT04064164|364255836|FG001|Overall Study|Withdrawal by Subject|8|||
105615347|NCT03199469|364255839|FG000|Overall Study|Randomized, not treated|0|||
105615348|NCT03199469|364255840|FG001|Overall Study|Randomized, not treated|3|||
105615349|NCT03199469|364255839|FG000|Overall Study|Withdrawal by Subject|1|||
105615350|NCT03199469|364255840|FG001|Overall Study|Withdrawal by Subject|0|||
105615351|NCT03199469|364255839|FG000|Overall Study|Death|1|||
105615352|NCT03199469|364255840|FG001|Overall Study|Death|3|||
105615353|NCT03199469|364255839|FG000|Overall Study|Ongoing|5|||
105615354|NCT03199469|364255840|FG001|Overall Study|Ongoing|14|||
105615355|NCT03307343|364255841|FG000|Overall Study|Withdrawal by Subject|1|||
105615356|NCT03307343|364255842|FG001|Overall Study|Withdrawal by Subject|2|||
105615357|NCT03307343|364255841|FG000|Overall Study|Pregnancy|0|||
105615358|NCT03307343|364255842|FG001|Overall Study|Pregnancy|2|||
105615359|NCT03307343|364255841|FG000|Overall Study|Physician Decision|1|||
105615360|NCT03307343|364255842|FG001|Overall Study|Physician Decision|0|||
105615361|NCT03307343|364255841|FG000|Overall Study|Lost to Follow-up|0|||
105615362|NCT03307343|364255842|FG001|Overall Study|Lost to Follow-up|2|||
105615363|NCT03241745|364255843|FG000|Overall Study|Adverse Event|7|||
105615364|NCT03241745|364255843|FG000|Overall Study|Death|1|||
105615365|NCT03241745|364255843|FG000|Overall Study|Withdrawal by Subject|5|||
105615366|NCT03241745|364255843|FG000|Overall Study|Treatment delay >28 days|2|||
105615367|NCT03241745|364255843|FG000|Overall Study|Lack of Efficacy|14|||
105615368|NCT03524118|364255844|FG000|Overall Study|Lost to Follow-up|0|||
105615369|NCT03524118|364255845|FG001|Overall Study|Lost to Follow-up|0|||
105615370|NCT03524118|364255846|FG002|Overall Study|Lost to Follow-up|0|||
105615371|NCT03524118|364255847|FG003|Overall Study|Lost to Follow-up|0|||
105615372|NCT03524118|364255848|FG004|Overall Study|Lost to Follow-up|1|||
105615373|NCT03524118|364255849|FG005|Overall Study|Lost to Follow-up|0|||
105615374|NCT03524118|364255844|FG000|Overall Study|Other|0|||
105615375|NCT03524118|364255845|FG001|Overall Study|Other|1|||
105615376|NCT03524118|364255846|FG002|Overall Study|Other|0|||
105615377|NCT03524118|364255847|FG003|Overall Study|Other|0|||
105615378|NCT03524118|364255848|FG004|Overall Study|Other|1|||
105615379|NCT03524118|364255849|FG005|Overall Study|Other|1|||
105615380|NCT03524118|364255844|FG000|Overall Study|Physician Decision|0|||
105615381|NCT03524118|364255845|FG001|Overall Study|Physician Decision|0|||
105615382|NCT03524118|364255846|FG002|Overall Study|Physician Decision|0|||
105615383|NCT03524118|364255847|FG003|Overall Study|Physician Decision|0|||
105615384|NCT03524118|364255848|FG004|Overall Study|Physician Decision|1|||
105615385|NCT03524118|364255849|FG005|Overall Study|Physician Decision|0|||
105615386|NCT03524118|364255844|FG000|Overall Study|Protocol Violation|0|||
105615387|NCT03524118|364255845|FG001|Overall Study|Protocol Violation|0|||
105615388|NCT03524118|364255846|FG002|Overall Study|Protocol Violation|1|||
105615389|NCT03524118|364255847|FG003|Overall Study|Protocol Violation|0|||
105615390|NCT03524118|364255848|FG004|Overall Study|Protocol Violation|1|||
105615391|NCT03524118|364255849|FG005|Overall Study|Protocol Violation|0|||
105615392|NCT03524118|364255844|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105615393|NCT03524118|364255845|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
105615394|NCT03524118|364255846|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105615395|NCT03524118|364255847|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
105615396|NCT03524118|364255848|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
105615397|NCT03524118|364255849|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
105615398|NCT04624633|364255855|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
105615399|NCT04624633|364255856|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
105615400|NCT04624633|364255855|FG000|Overall Study|Death|1|||
105615401|NCT04624633|364255856|FG001|Overall Study|Death|0|||
105615402|NCT04316871|364255857|FG000|Overall Study|Protocol Violation|2|||
105615403|NCT04316871|364255858|FG001|Overall Study|Protocol Violation|2|||
105615404|NCT04316871|364255859|FG002|Overall Study|Protocol Violation|2|||
105615405|NCT04316871|364255860|FG003|Overall Study|Protocol Violation|2|||
105615406|NCT04650269|364255861|FG000|Overall Study|Death|3|||
105615407|NCT04650269|364255861|FG000|Overall Study|Lost to Follow-up|6|||
105615408|NCT01437709|364255862|FG000|Overall Study|Adverse Event|0|||
105615409|NCT01437709|364255863|FG001|Overall Study|Adverse Event|1|||
105615410|NCT01437709|364255864|FG002|Overall Study|Adverse Event|0|||
105615411|NCT01437709|364255862|FG000|Overall Study|Pt trasnferred care|0|||
105615412|NCT01437709|364255863|FG001|Overall Study|Pt trasnferred care|1|||
105615413|NCT01437709|364255864|FG002|Overall Study|Pt trasnferred care|0|||
105615414|NCT01902173|364255865|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
105615415|NCT01902173|364255866|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
105615416|NCT01902173|364255867|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
105615417|NCT01902173|364255868|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
105615418|NCT01902173|364255869|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
105615419|NCT01902173|364255870|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
105615420|NCT01902173|364255865|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
105615421|NCT01902173|364255866|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
105615422|NCT01902173|364255867|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
105615423|NCT01902173|364255868|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
105615424|NCT01902173|364255869|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
105615425|NCT01902173|364255870|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
105615426|NCT01902173|364255865|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
105615427|NCT01902173|364255866|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
105615428|NCT01902173|364255867|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
105615429|NCT01902173|364255868|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
105615430|NCT01902173|364255869|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
105615431|NCT01902173|364255870|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
105615432|NCT01902173|364255865|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
105615433|NCT01902173|364255866|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
105615434|NCT01902173|364255867|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
105615435|NCT01902173|364255868|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
105615436|NCT01902173|364255869|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
105615437|NCT01902173|364255870|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
105615438|NCT01902173|364255865|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
105615439|NCT01902173|364255866|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
105615440|NCT01902173|364255867|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
105615441|NCT01902173|364255868|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
105615442|NCT01902173|364255869|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
105615443|NCT01902173|364255870|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
105615444|NCT01902173|364255865|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
105615445|NCT01902173|364255866|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
105615446|NCT01902173|364255867|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
105615447|NCT01902173|364255868|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
105615448|NCT01902173|364255869|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
105615449|NCT01902173|364255870|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
105615450|NCT01902173|364255865|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
105615451|NCT01902173|364255866|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
105615452|NCT01902173|364255867|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
105615453|NCT01902173|364255868|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
105615454|NCT01902173|364255869|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
105615455|NCT01902173|364255870|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
105615456|NCT01902173|364255865|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
105615457|NCT01902173|364255866|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
105615458|NCT01902173|364255867|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
105615459|NCT01902173|364255868|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
105615460|NCT01902173|364255869|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
105615461|NCT01902173|364255870|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
105615462|NCT01902173|364255865|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
105615463|NCT01902173|364255866|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
105615464|NCT01902173|364255867|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
105615465|NCT01902173|364255868|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
105615466|NCT01902173|364255869|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
105615467|NCT01902173|364255870|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
105615468|NCT01902173|364255865|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
105615469|NCT01902173|364255866|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
105615470|NCT01902173|364255867|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
105615471|NCT01902173|364255868|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
105615472|NCT01902173|364255869|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
105615473|NCT01902173|364255870|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
105615474|NCT01902173|364255865|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
105615475|NCT01902173|364255866|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
105615476|NCT01902173|364255867|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
105615477|NCT01902173|364255868|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
105615478|NCT01902173|364255869|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
105615479|NCT01902173|364255870|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
105615480|NCT01902173|364255865|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
105615481|NCT01902173|364255866|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
105615482|NCT01902173|364255867|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
105615483|NCT01902173|364255868|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
105615484|NCT01902173|364255869|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
105615485|NCT01902173|364255870|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
105615486|NCT01902173|364255865|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
105615487|NCT01902173|364255866|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
105615488|NCT01902173|364255867|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
105615489|NCT01902173|364255868|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
105615490|NCT01902173|364255869|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
105615491|NCT01902173|364255870|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
105615492|NCT01902173|364255865|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
105615493|NCT01902173|364255866|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
105615494|NCT01902173|364255867|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
105615495|NCT01902173|364255868|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
105615496|NCT01902173|364255869|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
105615497|NCT01902173|364255870|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
105615498|NCT01824394|364255871|FG000|Overall Study|Early Termination|1|||
105615499|NCT01824394|364255872|FG001|Overall Study|Early Termination|1|||
105615500|NCT01824394|364255873|FG002|Overall Study|Early Termination|3|||
105615501|NCT01824394|364255871|FG000|Overall Study|Withdrawn due to Study Termination|91|||
105615502|NCT01824394|364255872|FG001|Overall Study|Withdrawn due to Study Termination|83|||
105615503|NCT01824394|364255873|FG002|Overall Study|Withdrawn due to Study Termination|41|||
105615504|NCT01824394|364255871|FG000|Overall Study|Lost to Follow-up|0|||
105615505|NCT01824394|364255872|FG001|Overall Study|Lost to Follow-up|9|||
105615506|NCT01824394|364255873|FG002|Overall Study|Lost to Follow-up|3|||
105615507|NCT01824394|364255871|FG000|Overall Study|Death|3|||
105615508|NCT01824394|364255872|FG001|Overall Study|Death|2|||
105615509|NCT01824394|364255873|FG002|Overall Study|Death|4|||
105615510|NCT01824394|364255871|FG000|Overall Study|Discontinued Subjects|1|||
105615511|NCT01824394|364255872|FG001|Overall Study|Discontinued Subjects|1|||
105615512|NCT01824394|364255873|FG002|Overall Study|Discontinued Subjects|2|||
105615513|NCT01824394|364255871|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
105615514|NCT01824394|364255872|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
105615515|NCT01824394|364255873|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
105615516|NCT01987895|364255877|FG000|Overall Study|Withdrawal by Subject|12|||
105615517|NCT01987895|364255878|FG001|Overall Study|Withdrawal by Subject|7|||
105615518|NCT01987895|364255877|FG000|Overall Study|Physician Decision|8|||
105615519|NCT01987895|364255878|FG001|Overall Study|Physician Decision|10|||
105615520|NCT01987895|364255877|FG000|Overall Study|Death|7|||
105615521|NCT01987895|364255878|FG001|Overall Study|Death|7|||
105615522|NCT01987895|364255877|FG000|Overall Study|Lost to Follow-up|3|||
105615523|NCT01987895|364255878|FG001|Overall Study|Lost to Follow-up|5|||
105615524|NCT01987895|364255877|FG000|Overall Study|randomized before giving IC|0|||
105615525|NCT01987895|364255878|FG001|Overall Study|randomized before giving IC|1|||
105615526|NCT02359890|364255879|FG000|Overall Study|Not meeting eligibility|4|||
105615527|NCT02359890|364255879|FG000|Overall Study|Never treated with study catheter|6|||
105615528|NCT04015167|364255882|FG000|Overall Study|Lost to Follow-up|40|||
105615529|NCT04015167|364255882|FG000|Overall Study|Adverse Event|5|||
105615530|NCT04015167|364255882|FG000|Overall Study|Withdrawal by Subject|2|||
105615531|NCT04015167|364255882|FG000|Overall Study|Subject went to jail|1|||
105615532|NCT04788511|364255883|FG000|Overall Study|Withdrawal by Subject|2|||
105615533|NCT04788511|364255884|FG001|Overall Study|Withdrawal by Subject|1|||
105615534|NCT04788511|364255883|FG000|Overall Study|Lost to Follow-up|2|||
105615535|NCT04788511|364255884|FG001|Overall Study|Lost to Follow-up|7|||
105615536|NCT04788511|364255883|FG000|Overall Study|Death|3|||
105615537|NCT04788511|364255884|FG001|Overall Study|Death|4|||
105615538|NCT04277442|364255885|FG000|Overall Study|Death|1|||
105615539|NCT02975882|364257352|FG000|Overall Study|Adverse Event|1|||
105615540|NCT02975882|364257353|FG001|Overall Study|Adverse Event|2|||
105615541|NCT02975882|364257354|FG002|Overall Study|Adverse Event|1|||
105615542|NCT02975882|364257355|FG003|Overall Study|Adverse Event|1|||
105615543|NCT02975882|364257352|FG000|Overall Study|Death|0|||
105615544|NCT02975882|364257353|FG001|Overall Study|Death|1|||
105615545|NCT02975882|364257354|FG002|Overall Study|Death|0|||
105615546|NCT02975882|364257355|FG003|Overall Study|Death|0|||
105615547|NCT02975882|364257352|FG000|Overall Study|Lack of Efficacy|3|||
105615548|NCT02975882|364257353|FG001|Overall Study|Lack of Efficacy|7|||
105615549|NCT02975882|364257354|FG002|Overall Study|Lack of Efficacy|4|||
105615550|NCT02975882|364257355|FG003|Overall Study|Lack of Efficacy|3|||
105615551|NCT02975882|364257352|FG000|Overall Study|Physician Decision|0|||
105615552|NCT02975882|364257353|FG001|Overall Study|Physician Decision|2|||
105615553|NCT02975882|364257354|FG002|Overall Study|Physician Decision|4|||
105615554|NCT02975882|364257355|FG003|Overall Study|Physician Decision|2|||
105615555|NCT02975882|364257352|FG000|Overall Study|Ineligible|0|||
105615556|NCT02975882|364257353|FG001|Overall Study|Ineligible|1|||
105615557|NCT02975882|364257354|FG002|Overall Study|Ineligible|0|||
105615558|NCT02975882|364257355|FG003|Overall Study|Ineligible|0|||
105615559|NCT03903146|364257356|FG000|Overall Study|Lost to Follow-up|6|||
105615560|NCT03903146|364257357|FG001|Overall Study|Lost to Follow-up|4|||
105615561|NCT03903146|364257356|FG000|Overall Study|Withdrawal by Subject|0|||
105615562|NCT03903146|364257357|FG001|Overall Study|Withdrawal by Subject|1|||
105615563|NCT05434078|364257359|FG000|Overall Study|Lost to Follow-up|2|||
105615564|NCT05434078|364257360|FG001|Overall Study|Lost to Follow-up|1|||
105615565|NCT05434078|364257359|FG000|Overall Study|Withdrawal by Subject|1|||
105615566|NCT05434078|364257360|FG001|Overall Study|Withdrawal by Subject|0|||
105615567|NCT02734290|364257361|FG000|Overall Study|Adverse Event|1|||
105615568|NCT02734290|364257362|FG001|Overall Study|Adverse Event|0|||
105615569|NCT02734290|364257361|FG000|Overall Study|Death|1|||
105615570|NCT02734290|364257362|FG001|Overall Study|Death|0|||
105615571|NCT03867500|364257363|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
105615572|NCT03897465|364257365|FG000|Overall Study|Lost to Follow-up|2|||
105615573|NCT03897465|364257366|FG001|Overall Study|Lost to Follow-up|1|||
105615574|NCT03897465|364257365|FG000|Overall Study|Adverse Event|2|||
105615575|NCT03897465|364257366|FG001|Overall Study|Adverse Event|0|||
105615576|NCT03897465|364257365|FG000|Overall Study|complete healing by V2|1|||
105615577|NCT03897465|364257366|FG001|Overall Study|complete healing by V2|0|||
105615578|NCT03897465|364257365|FG000|Overall Study|occurence of exclusion criterion|1|||
105615579|NCT03897465|364257366|FG001|Overall Study|occurence of exclusion criterion|1|||
105615580|NCT03897465|364257365|FG000|Overall Study|Other|1|||
105615581|NCT03897465|364257366|FG001|Overall Study|Other|0|||
105615582|NCT04225039|364257368|FG000|Overall Study|Withdrawal by Subject|1|||
105615583|NCT04225039|364257369|FG001|Overall Study|Withdrawal by Subject|0|||
105615584|NCT04225039|364257370|FG002|Overall Study|Withdrawal by Subject|0|||
105615585|NCT04225039|364257371|FG003|Overall Study|Withdrawal by Subject|1|||
105615586|NCT04225039|364257368|FG000|Overall Study|Currently active on study treatment|0|||
105615587|NCT04225039|364257369|FG001|Overall Study|Currently active on study treatment|1|||
105615588|NCT04225039|364257370|FG002|Overall Study|Currently active on study treatment|0|||
105615589|NCT04225039|364257371|FG003|Overall Study|Currently active on study treatment|0|||
105615590|NCT04225039|364257368|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
105615591|NCT04225039|364257369|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
105615592|NCT04225039|364257370|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
105615593|NCT04225039|364257371|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
105615594|NCT04225039|364257368|FG000|Overall Study|Ineligible for treatment|0|||
105615595|NCT04225039|364257369|FG001|Overall Study|Ineligible for treatment|0|||
105615596|NCT04225039|364257370|FG002|Overall Study|Ineligible for treatment|0|||
105615597|NCT04225039|364257371|FG003|Overall Study|Ineligible for treatment|4|||
105615598|NCT02577835|364257372|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
105615599|NCT04749615|364257373|FG000|Overall Study|Lost to Follow-up|6|||
105615600|NCT04749615|364257374|FG001|Overall Study|Lost to Follow-up|10|||
105615601|NCT05119023|364257380|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
105615602|NCT05119023|364257380|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
105615603|NCT05119023|364257380|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
105615604|NCT02274662|364257385|FG000|Overall Study|Death|1|||
105615605|NCT02274662|364257385|FG000|Overall Study|Lost to Follow-up|3|||
105615606|NCT04806451|364257386|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
105615607|NCT04806451|364257387|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
105615608|NCT04806451|364257386|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
105615609|NCT04806451|364257387|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
105615610|NCT04806451|364257386|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
105615611|NCT04806451|364257387|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
105615612|NCT04489771|364257390|FG000|Overall Study|Death|27|||
105615613|NCT04489771|364257391|FG001|Overall Study|Death|25|||
105615614|NCT04489771|364257390|FG000|Overall Study|Withdrawal by Subject|1|||
105615615|NCT04489771|364257391|FG001|Overall Study|Withdrawal by Subject|0|||
105615616|NCT04489771|364257390|FG000|Overall Study|Participants Ongoing in Study|50|||
105615617|NCT04489771|364257391|FG001|Overall Study|Participants Ongoing in Study|51|||
105615618|NCT03197662|364257392|FG000|Overall Study|Withdrawn by family|0|||
105615619|NCT03197662|364257393|FG001|Overall Study|Withdrawn by family|2|||
105615620|NCT01214616|364257398|FG000|Overall Study|Progressive disease|2|||
105615621|NCT01214616|364257399|FG001|Overall Study|Progressive disease|2|||
105615622|NCT01214616|364257400|FG002|Overall Study|Progressive disease|2|||
105615623|NCT01214616|364257401|FG003|Overall Study|Progressive disease|4|||
105615624|NCT01214616|364257398|FG000|Overall Study|Dose limiting toxicity|0|||
105615625|NCT01214616|364257399|FG001|Overall Study|Dose limiting toxicity|2|||
105615626|NCT01214616|364257400|FG002|Overall Study|Dose limiting toxicity|0|||
105615627|NCT01214616|364257401|FG003|Overall Study|Dose limiting toxicity|0|||
105615628|NCT01214616|364257398|FG000|Overall Study|Other adverse events|0|||
105615629|NCT01214616|364257399|FG001|Overall Study|Other adverse events|1|||
105615630|NCT01214616|364257400|FG002|Overall Study|Other adverse events|1|||
105615631|NCT01214616|364257401|FG003|Overall Study|Other adverse events|1|||
105615632|NCT01214616|364257398|FG000|Overall Study|Withdrawal by Subject|1|||
105615633|NCT01214616|364257399|FG001|Overall Study|Withdrawal by Subject|0|||
105615634|NCT01214616|364257400|FG002|Overall Study|Withdrawal by Subject|0|||
105615635|NCT01214616|364257401|FG003|Overall Study|Withdrawal by Subject|1|||
105615636|NCT04059484|364257410|FG000|Overall Study|Adverse Event|2|||
105615637|NCT04059484|364257411|FG001|Overall Study|Adverse Event|5|||
105615638|NCT04059484|364257410|FG000|Overall Study|Withdrawal by Subject|5|||
105615639|NCT04059484|364257411|FG001|Overall Study|Withdrawal by Subject|3|||
105615640|NCT04059484|364257410|FG000|Overall Study|Progressive disease|112|||
105615641|NCT04059484|364257411|FG001|Overall Study|Progressive disease|112|||
105615642|NCT04059484|364257410|FG000|Overall Study|Other|8|||
105615643|NCT04059484|364257411|FG001|Overall Study|Other|3|||
105615644|NCT04059484|364257410|FG000|Overall Study|Ongoing|20|||
105615645|NCT04059484|364257411|FG001|Overall Study|Ongoing|20|||
105615646|NCT02949362|364257412|FG000|Retrospective Period|Inform consent not signed by participant|4|||
105615647|NCT02949362|364257413|FG001|Retrospective Period|Inform consent not signed by participant|1|||
105615648|NCT02949362|364257414|FG002|Retrospective Period|Inform consent not signed by participant|0|||
105615649|NCT02949362|364257415|FG003|Retrospective Period|Inform consent not signed by participant|0|||
105615650|NCT02949362|364257412|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
105615651|NCT02949362|364257413|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
105615652|NCT02949362|364257414|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
105615653|NCT02949362|364257415|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
105615654|NCT02949362|364257412|FG000|Prospective Period|Other|0|||
105615655|NCT02949362|364257413|FG001|Prospective Period|Other|0|||
105615656|NCT02949362|364257414|FG002|Prospective Period|Other|0|||
105615657|NCT02949362|364257415|FG003|Prospective Period|Other|4|||
105615658|NCT01000961|364257416|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
105615659|NCT01000961|364257417|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
105615660|NCT01000961|364257416|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
105615661|NCT01000961|364257417|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
105615662|NCT04719390|364257421|FG000|Overall Study|Withdrawal by Subject|1|||
105615663|NCT04292223|364257422|FG000|Overall Study|Adverse Event|1|||
105615664|NCT04292223|364257422|FG000|Overall Study|Lost to Follow-up|1|||
105615665|NCT04292223|364257422|FG000|Overall Study|Noncompliance with study drug|2|||
105615666|NCT04292223|364257422|FG000|Overall Study|Patient moved out of the state|1|||
105615667|NCT04683744|364257426|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
105615668|NCT04683744|364257427|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
105615669|NCT04683744|364257428|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
105615670|NCT04927364|364257435|FG000|Overall Study|Withdrawal by Subject|3|||
105615671|NCT04927364|364257435|FG000|Overall Study|Unable to complete preassessment MRI|1|||
105615672|NCT05087992|364257436|FG000|Overall Study|Adverse Event|0|||
105615673|NCT05087992|364257437|FG001|Overall Study|Adverse Event|1|||
105615674|NCT05087992|364257438|FG002|Overall Study|Adverse Event|0|||
105615675|NCT05087992|364257436|FG000|Overall Study|Withdrawal by Subject|2|||
105615676|NCT05087992|364257437|FG001|Overall Study|Withdrawal by Subject|0|||
105615677|NCT05087992|364257438|FG002|Overall Study|Withdrawal by Subject|0|||
105615678|NCT05087992|364257436|FG000|Overall Study|clinical disease progression|3|||
105615679|NCT05087992|364257437|FG001|Overall Study|clinical disease progression|1|||
105615680|NCT05087992|364257438|FG002|Overall Study|clinical disease progression|0|||
105615681|NCT05087992|364257436|FG000|Overall Study|objective disease progression|4|||
105615682|NCT05087992|364257437|FG001|Overall Study|objective disease progression|1|||
105615683|NCT05087992|364257438|FG002|Overall Study|objective disease progression|0|||
105615684|NCT04293055|364257439|FG000|Overall Study|Lost to Follow-up|1|||
105615685|NCT04293055|364257440|FG001|Overall Study|Lost to Follow-up|1|||
105615686|NCT04293055|364257439|FG000|Overall Study|Did not trigger randomization|6|||
105615687|NCT04293055|364257440|FG001|Overall Study|Did not trigger randomization|5|||
105615688|NCT03560609|364257441|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
105615689|NCT03560609|364257442|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
105615690|NCT00433329|364257453|FG000|Overall Study|Adverse Event|9|||
105615691|NCT00433329|364257453|FG000|Overall Study|Death|4|||
105615692|NCT00433329|364257453|FG000|Overall Study|Withdrew consent|3|||
105615693|NCT00433329|364257453|FG000|Overall Study|Discontinued sildenafil|2|||
105615694|NCT00433329|364257453|FG000|Overall Study|Moved out of state|1|||
105615695|NCT00433329|364257453|FG000|Overall Study|Lost to Follow-up|1|||
105615696|NCT00433329|364257453|FG000|Overall Study|Physician Decision|1|||
105615697|NCT04195698|364257454|FG000|Overall Study|Adverse Event|4|||
105615698|NCT04195698|364257455|FG001|Overall Study|Adverse Event|11|||
105615699|NCT04195698|364257454|FG000|Overall Study|Withdrawal by Subject|9|||
105615700|NCT04195698|364257455|FG001|Overall Study|Withdrawal by Subject|10|||
105615701|NCT04195698|364257454|FG000|Overall Study|Lost to Follow-up|5|||
105615702|NCT04195698|364257455|FG001|Overall Study|Lost to Follow-up|4|||
105615703|NCT04195698|364257454|FG000|Overall Study|Lack of Efficacy|2|||
105615704|NCT04195698|364257455|FG001|Overall Study|Lack of Efficacy|10|||
105615705|NCT04195698|364257454|FG000|Overall Study|Other|5|||
105615706|NCT04195698|364257455|FG001|Overall Study|Other|4|||
105615707|NCT05459688|364257456|FG000|Overall Study|Lost to Follow-up|6|||
105615708|NCT05459688|364257456|FG000|Overall Study|Physician Decision|1|||
105615709|NCT05459688|364257456|FG000|Overall Study|Withdrawal by Subject|19|||
105615710|NCT05459688|364257456|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
105615711|NCT06424236|364257457|FG000|Overall Study|Adverse Event|0|||
105615712|NCT06424236|364257458|FG001|Overall Study|Adverse Event|1|||
105615713|NCT06424236|364257459|FG002|Overall Study|Adverse Event|0|||
105615714|NCT06424236|364257457|FG000|Overall Study|Withdrawal by Subject|3|||
105615715|NCT06424236|364257458|FG001|Overall Study|Withdrawal by Subject|1|||
105615716|NCT06424236|364257459|FG002|Overall Study|Withdrawal by Subject|2|||
105615717|NCT06424236|364257457|FG000|Overall Study|Physician Decision|0|||
105615718|NCT06424236|364257458|FG001|Overall Study|Physician Decision|1|||
105615719|NCT06424236|364257459|FG002|Overall Study|Physician Decision|0|||
105615720|NCT06424236|364257457|FG000|Overall Study|Study Terminated by Sponsor|11|||
105615721|NCT06424236|364257458|FG001|Overall Study|Study Terminated by Sponsor|20|||
105615722|NCT06424236|364257459|FG002|Overall Study|Study Terminated by Sponsor|16|||
105615723|NCT06424236|364257457|FG000|Overall Study|Lost to Follow-up|0|||
105615724|NCT06424236|364257458|FG001|Overall Study|Lost to Follow-up|1|||
105615725|NCT06424236|364257459|FG002|Overall Study|Lost to Follow-up|0|||
105615726|NCT06424236|364257457|FG000|Overall Study|Disease Progression|0|||
105615727|NCT06424236|364257458|FG001|Overall Study|Disease Progression|1|||
105615728|NCT06424236|364257459|FG002|Overall Study|Disease Progression|2|||
105615729|NCT06424236|364257457|FG000|Overall Study|Other|0|||
105615730|NCT06424236|364257458|FG001|Overall Study|Other|0|||
105615731|NCT06424236|364257459|FG002|Overall Study|Other|1|||
105615732|NCT02817776|364257466|FG000|Overall Study|Excluded|33|||
105615733|NCT02817776|364257466|FG000|Overall Study|Lost to Follow-up|20|||
105615734|NCT02817776|364257466|FG000|Overall Study|Withdrawal by Subject|33|||
105615735|NCT02817776|364257466|FG000|Overall Study|Death|2|||
105615736|NCT04066244|364257467|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
105615737|NCT04066244|364257468|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
105615738|NCT04066244|364257469|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
105615739|NCT04066244|364257470|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
105615740|NCT04066244|364257471|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
105615741|NCT04066244|364257472|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
105615742|NCT04066244|364257467|FG000|Part 2 (Cohort 5)|Death|0|||
105615743|NCT04066244|364257468|FG001|Part 2 (Cohort 5)|Death|0|||
105615744|NCT04066244|364257469|FG002|Part 2 (Cohort 5)|Death|0|||
105615745|NCT04066244|364257470|FG003|Part 2 (Cohort 5)|Death|0|||
105615746|NCT04066244|364257471|FG004|Part 2 (Cohort 5)|Death|0|||
105615747|NCT04066244|364257472|FG005|Part 2 (Cohort 5)|Death|2|||
105615748|NCT04066244|364257467|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
105615749|NCT04066244|364257468|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
105615750|NCT04066244|364257469|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
105615751|NCT04066244|364257470|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
105615752|NCT04066244|364257471|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
105615753|NCT04066244|364257472|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
105615754|NCT04066244|364257467|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
105615755|NCT04066244|364257468|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
105615756|NCT04066244|364257469|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
105615757|NCT04066244|364257470|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
105615758|NCT04066244|364257471|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
105615759|NCT04066244|364257472|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
105615760|NCT03382652|364257474|FG000|Overall Study|Lost to Follow-up|6|||
105615761|NCT03382652|364257474|FG000|Overall Study|Death|4|||
105615762|NCT03382652|364257474|FG000|Overall Study|Revision|5|||
105615763|NCT03382652|364257474|FG000|Overall Study|Patient withdrew|3|||
105615764|NCT03382652|364257474|FG000|Overall Study|Other reasons|21|||
105615765|NCT04810650|364257475|FG000|Overall Study|Disenrolled in error|0|||
105615766|NCT04810650|364257476|FG001|Overall Study|Disenrolled in error|0|||
105615767|NCT04810650|364257477|FG002|Overall Study|Disenrolled in error|0|||
105615768|NCT04810650|364257478|FG003|Overall Study|Disenrolled in error|0|||
105615769|NCT04810650|364257479|FG004|Overall Study|Disenrolled in error|0|||
105615770|NCT04810650|364257480|FG005|Overall Study|Disenrolled in error|0|||
105615771|NCT04810650|364257481|FG006|Overall Study|Disenrolled in error|0|||
105615772|NCT04810650|364257482|FG007|Overall Study|Disenrolled in error|0|||
105615773|NCT04810650|364257483|FG008|Overall Study|Disenrolled in error|1|||
105615774|NCT04810650|364257484|FG009|Overall Study|Disenrolled in error|0|||
105615775|NCT04810650|364257485|FG010|Overall Study|Disenrolled in error|0|||
105615776|NCT04810650|364257486|FG011|Overall Study|Disenrolled in error|0|||
105615777|NCT04810650|364257487|FG012|Overall Study|Disenrolled in error|0|||
105615778|NCT04810650|364257488|FG013|Overall Study|Disenrolled in error|0|||
105615779|NCT04810650|364257475|FG000|Overall Study|Death|0|||
105615780|NCT04810650|364257476|FG001|Overall Study|Death|0|||
105615781|NCT04810650|364257477|FG002|Overall Study|Death|0|||
105615782|NCT04810650|364257478|FG003|Overall Study|Death|0|||
105615783|NCT04810650|364257479|FG004|Overall Study|Death|0|||
105615784|NCT04810650|364257480|FG005|Overall Study|Death|0|||
105615785|NCT04810650|364257481|FG006|Overall Study|Death|2|||
105615786|NCT04810650|364257482|FG007|Overall Study|Death|2|||
105615787|NCT04810650|364257483|FG008|Overall Study|Death|0|||
105615788|NCT04810650|364257484|FG009|Overall Study|Death|1|||
105615789|NCT04810650|364257485|FG010|Overall Study|Death|0|||
105615790|NCT04810650|364257486|FG011|Overall Study|Death|0|||
105615791|NCT04810650|364257487|FG012|Overall Study|Death|2|||
105615792|NCT04810650|364257488|FG013|Overall Study|Death|1|||
105615793|NCT04810650|364257475|FG000|Overall Study|Moved/transferred care|0|||
105615794|NCT04810650|364257476|FG001|Overall Study|Moved/transferred care|0|||
105615795|NCT04810650|364257477|FG002|Overall Study|Moved/transferred care|0|||
105615796|NCT04810650|364257478|FG003|Overall Study|Moved/transferred care|0|||
105615797|NCT04810650|364257479|FG004|Overall Study|Moved/transferred care|0|||
105615798|NCT04810650|364257480|FG005|Overall Study|Moved/transferred care|0|||
105615799|NCT04810650|364257481|FG006|Overall Study|Moved/transferred care|0|||
105615800|NCT04810650|364257482|FG007|Overall Study|Moved/transferred care|1|||
105615801|NCT04810650|364257483|FG008|Overall Study|Moved/transferred care|12|||
105615802|NCT04810650|364257484|FG009|Overall Study|Moved/transferred care|10|||
105615803|NCT04810650|364257485|FG010|Overall Study|Moved/transferred care|0|||
105615804|NCT04810650|364257486|FG011|Overall Study|Moved/transferred care|0|||
105615805|NCT04810650|364257487|FG012|Overall Study|Moved/transferred care|0|||
105615806|NCT04810650|364257488|FG013|Overall Study|Moved/transferred care|0|||
105615807|NCT04810650|364257475|FG000|Overall Study|Lost to Follow-up|15|||
105615808|NCT04810650|364257476|FG001|Overall Study|Lost to Follow-up|12|||
105615809|NCT04810650|364257477|FG002|Overall Study|Lost to Follow-up|7|||
105615810|NCT04810650|364257478|FG003|Overall Study|Lost to Follow-up|9|||
105615811|NCT04810650|364257479|FG004|Overall Study|Lost to Follow-up|10|||
105615812|NCT04810650|364257480|FG005|Overall Study|Lost to Follow-up|6|||
105615813|NCT04810650|364257481|FG006|Overall Study|Lost to Follow-up|0|||
105615814|NCT04810650|364257482|FG007|Overall Study|Lost to Follow-up|0|||
105615815|NCT04810650|364257483|FG008|Overall Study|Lost to Follow-up|0|||
105615816|NCT04810650|364257484|FG009|Overall Study|Lost to Follow-up|0|||
105615817|NCT04810650|364257485|FG010|Overall Study|Lost to Follow-up|1|||
105615818|NCT04810650|364257486|FG011|Overall Study|Lost to Follow-up|0|||
105615819|NCT04810650|364257487|FG012|Overall Study|Lost to Follow-up|3|||
105615820|NCT04810650|364257488|FG013|Overall Study|Lost to Follow-up|9|||
105615821|NCT04810650|364257475|FG000|Overall Study|Participant declined|0|||
105615822|NCT04810650|364257476|FG001|Overall Study|Participant declined|0|||
105615823|NCT04810650|364257477|FG002|Overall Study|Participant declined|0|||
105615824|NCT04810650|364257478|FG003|Overall Study|Participant declined|0|||
105615825|NCT04810650|364257479|FG004|Overall Study|Participant declined|0|||
105615826|NCT04810650|364257480|FG005|Overall Study|Participant declined|0|||
105615827|NCT04810650|364257481|FG006|Overall Study|Participant declined|0|||
105615828|NCT04810650|364257482|FG007|Overall Study|Participant declined|0|||
105615829|NCT04810650|364257483|FG008|Overall Study|Participant declined|0|||
105615830|NCT04810650|364257484|FG009|Overall Study|Participant declined|0|||
105615831|NCT04810650|364257485|FG010|Overall Study|Participant declined|2|||
105615832|NCT04810650|364257486|FG011|Overall Study|Participant declined|0|||
105615833|NCT04810650|364257487|FG012|Overall Study|Participant declined|0|||
105615834|NCT04810650|364257488|FG013|Overall Study|Participant declined|0|||
105615835|NCT04025554|364257498|FG000|Overall Study|Adverse Event|3|||
105615836|NCT02489903|364257499|FG000|Screening|Screen Failure|24|||
105615837|NCT02489903|364257500|FG001|Screening|Screen Failure|0|||
105615838|NCT02489903|364257501|FG002|Screening|Screen Failure|0|||
105615839|NCT02489903|364257502|FG003|Screening|Screen Failure|8|||
105615840|NCT02489903|364257499|FG000|Randomized and Received Treatment|Protocol Violation|0|||
105615841|NCT02489903|364257500|FG001|Randomized and Received Treatment|Protocol Violation|1|||
105615842|NCT02489903|364257501|FG002|Randomized and Received Treatment|Protocol Violation|0|||
105615843|NCT02489903|364257502|FG003|Randomized and Received Treatment|Protocol Violation|0|||
105615844|NCT02489903|364257499|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
105615845|NCT02489903|364257500|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
105615846|NCT02489903|364257501|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
105615847|NCT02489903|364257502|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
105615848|NCT02489903|364257499|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
105615849|NCT02489903|364257500|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
105615850|NCT02489903|364257501|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
105615851|NCT02489903|364257502|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
105615852|NCT02489903|364257499|FG000|Randomized and Received Treatment|Death|10|||
105615853|NCT02489903|364257500|FG001|Randomized and Received Treatment|Death|1|||
105615854|NCT02489903|364257501|FG002|Randomized and Received Treatment|Death|0|||
105615855|NCT02489903|364257502|FG003|Randomized and Received Treatment|Death|0|||
105615856|NCT01396278|364260065|FG000|Overall Study|Adverse Event|0|||
105615857|NCT01396278|364260066|FG001|Overall Study|Adverse Event|0|||
105615858|NCT01396278|364260067|FG002|Overall Study|Adverse Event|0|||
105615859|NCT01396278|364260068|FG003|Overall Study|Adverse Event|2|||
105615860|NCT01396278|364260069|FG004|Overall Study|Adverse Event|0|||
105615861|NCT01396278|364260065|FG000|Overall Study|Withdraw due to trial termination|2|||
105615862|NCT01396278|364260066|FG001|Overall Study|Withdraw due to trial termination|1|||
105615863|NCT01396278|364260067|FG002|Overall Study|Withdraw due to trial termination|1|||
105615864|NCT01396278|364260068|FG003|Overall Study|Withdraw due to trial termination|0|||
105615865|NCT01396278|364260069|FG004|Overall Study|Withdraw due to trial termination|2|||
105615866|NCT05653427|364260070|FG000|Overall Study|Study Terminated by Sponsor|13|||
105615867|NCT01415882|364260071|FG000|Overall Study|Ineligible|1|||
105615868|NCT01415882|364260072|FG001|Overall Study|Ineligible|0|||
105615869|NCT01415882|364260073|FG002|Overall Study|Ineligible|0|||
105615870|NCT01415882|364260074|FG003|Overall Study|Ineligible|3|||
105615871|NCT01415882|364260075|FG004|Overall Study|Ineligible|0|||
105615872|NCT01415882|364260071|FG000|Overall Study|Withdrawal by Subject|0|||
105615873|NCT01415882|364260072|FG001|Overall Study|Withdrawal by Subject|1|||
105615874|NCT01415882|364260073|FG002|Overall Study|Withdrawal by Subject|0|||
105615875|NCT01415882|364260074|FG003|Overall Study|Withdrawal by Subject|1|||
105615876|NCT01415882|364260075|FG004|Overall Study|Withdrawal by Subject|0|||
105615877|NCT02908477|364260086|FG000|Overall Study|Withdrawal by Subject|8|||
105615878|NCT02908477|364260087|FG001|Overall Study|Withdrawal by Subject|28|||
105615879|NCT02140554|364260088|FG000|Overall Study|Withdrawal of consent|1|||
105615880|NCT02140554|364260089|FG001|Overall Study|Withdrawal of consent|0|||
105615881|NCT02140554|364260090|FG002|Overall Study|Withdrawal of consent|4|||
105615882|NCT02140554|364260088|FG000|Overall Study|Physician Decision|1|||
105615883|NCT02140554|364260089|FG001|Overall Study|Physician Decision|0|||
105615884|NCT02140554|364260090|FG002|Overall Study|Physician Decision|2|||
105615885|NCT02140554|364260088|FG000|Overall Study|Death|0|||
105615886|NCT02140554|364260089|FG001|Overall Study|Death|0|||
105615887|NCT02140554|364260090|FG002|Overall Study|Death|1|||
105615888|NCT02140554|364260088|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
105615889|NCT02140554|364260089|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
105615890|NCT02140554|364260090|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
105615891|NCT05590403|364260091|FG000|Overall Study|Lost to Follow-up|13|||
105615892|NCT05590403|364260092|FG001|Overall Study|Lost to Follow-up|1|||
105615893|NCT05590403|364260093|FG002|Overall Study|Lost to Follow-up|7|||
105615894|NCT05590403|364260094|FG003|Overall Study|Lost to Follow-up|3|||
105615895|NCT05590403|364260095|FG004|Overall Study|Lost to Follow-up|4|||
105615896|NCT05590403|364260091|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
105615897|NCT05590403|364260092|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
105615898|NCT05590403|364260093|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
105615899|NCT05590403|364260094|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
105615900|NCT05590403|364260095|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
105615901|NCT05590403|364260091|FG000|Overall Study|Other|2|||
105615902|NCT05590403|364260092|FG001|Overall Study|Other|0|||
105615903|NCT05590403|364260093|FG002|Overall Study|Other|2|||
105615904|NCT05590403|364260094|FG003|Overall Study|Other|2|||
105615905|NCT05590403|364260095|FG004|Overall Study|Other|0|||
105615906|NCT05590403|364260091|FG000|Overall Study|Migrated / moved from the study area|1|||
105615907|NCT05590403|364260092|FG001|Overall Study|Migrated / moved from the study area|1|||
105615908|NCT05590403|364260093|FG002|Overall Study|Migrated / moved from the study area|0|||
105615909|NCT05590403|364260094|FG003|Overall Study|Migrated / moved from the study area|3|||
105615910|NCT05590403|364260095|FG004|Overall Study|Migrated / moved from the study area|1|||
105615911|NCT05590403|364260091|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
105615912|NCT05590403|364260092|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
105615913|NCT05590403|364260093|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
105615914|NCT05590403|364260094|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
105615915|NCT05590403|364260095|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
105615916|NCT04526704|364260096|FG000|Overall Study|Adverse Event|1|||
105615917|NCT04526704|364260097|FG001|Overall Study|Adverse Event|0|||
105615918|NCT04526704|364260096|FG000|Overall Study|Physician Decision|1|||
105615919|NCT04526704|364260097|FG001|Overall Study|Physician Decision|0|||
105615920|NCT04526704|364260096|FG000|Overall Study|Withdrawal by Subject|2|||
105615921|NCT04526704|364260097|FG001|Overall Study|Withdrawal by Subject|0|||
105615922|NCT05179837|364260099|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
105615923|NCT05179837|364260099|FG000|Overall Study|Device malfunctioned|1|||
105615924|NCT05179837|364260099|FG000|Overall Study|Image quality too low|2|||
105615925|NCT03158129|364260100|FG000|Overall Study|Adverse Event|0|||
105615926|NCT03158129|364260101|FG001|Overall Study|Adverse Event|1|||
105615927|NCT03158129|364260102|FG002|Overall Study|Adverse Event|0|||
105615928|NCT03158129|364260103|FG003|Overall Study|Adverse Event|0|||
105615929|NCT03158129|364260100|FG000|Overall Study|Death|0|||
105615930|NCT03158129|364260101|FG001|Overall Study|Death|0|||
105615931|NCT03158129|364260102|FG002|Overall Study|Death|0|||
105615932|NCT03158129|364260103|FG003|Overall Study|Death|1|||
105615933|NCT03158129|364260100|FG000|Overall Study|High surgical risk|1|||
105615934|NCT03158129|364260101|FG001|Overall Study|High surgical risk|1|||
105615935|NCT03158129|364260102|FG002|Overall Study|High surgical risk|0|||
105615936|NCT03158129|364260103|FG003|Overall Study|High surgical risk|0|||
105615937|NCT03158129|364260100|FG000|Overall Study|Progression|1|||
105615938|NCT03158129|364260101|FG001|Overall Study|Progression|1|||
105615939|NCT03158129|364260102|FG002|Overall Study|Progression|0|||
105615940|NCT03158129|364260103|FG003|Overall Study|Progression|0|||
105615941|NCT03158129|364260100|FG000|Overall Study|Lack of resectability|0|||
105615942|NCT03158129|364260101|FG001|Overall Study|Lack of resectability|1|||
105615943|NCT03158129|364260102|FG002|Overall Study|Lack of resectability|0|||
105615944|NCT03158129|364260103|FG003|Overall Study|Lack of resectability|0|||
105615945|NCT03158129|364260100|FG000|Overall Study|Declined surgery|0|||
105615946|NCT03158129|364260101|FG001|Overall Study|Declined surgery|1|||
105615947|NCT03158129|364260102|FG002|Overall Study|Declined surgery|0|||
105615948|NCT03158129|364260103|FG003|Overall Study|Declined surgery|0|||
105615949|NCT03158129|364260100|FG000|Overall Study|No longer surgical candidate|0|||
105615950|NCT03158129|364260101|FG001|Overall Study|No longer surgical candidate|0|||
105615951|NCT03158129|364260102|FG002|Overall Study|No longer surgical candidate|0|||
105615952|NCT03158129|364260103|FG003|Overall Study|No longer surgical candidate|1|||
105615953|NCT02105766|364260108|FG000|Overall Study|Physician Decision|1|||
105615954|NCT02105766|364260109|FG001|Overall Study|Physician Decision|1|||
105615955|NCT02105766|364260110|FG002|Overall Study|Physician Decision|0|||
105615956|NCT02105766|364260108|FG000|Overall Study|Lost to Follow-up|2|||
105615957|NCT02105766|364260109|FG001|Overall Study|Lost to Follow-up|0|||
105615958|NCT02105766|364260110|FG002|Overall Study|Lost to Follow-up|0|||
105615959|NCT02105766|364260108|FG000|Overall Study|Death|1|||
105615960|NCT02105766|364260109|FG001|Overall Study|Death|1|||
105615961|NCT02105766|364260110|FG002|Overall Study|Death|0|||
105615962|NCT03701399|364260111|FG000|Overall Study|Adverse Event|3|||
105615963|NCT03701399|364260112|FG001|Overall Study|Adverse Event|5|||
105615964|NCT03701399|364260111|FG000|Overall Study|Withdrawal by Subject|6|||
105615965|NCT03701399|364260112|FG001|Overall Study|Withdrawal by Subject|3|||
105615966|NCT03701399|364260111|FG000|Overall Study|Investigators decision|1|||
105615967|NCT03701399|364260112|FG001|Overall Study|Investigators decision|2|||
105615968|NCT03701399|364260111|FG000|Overall Study|Lost to Follow-up|1|||
105615969|NCT03701399|364260112|FG001|Overall Study|Lost to Follow-up|2|||
105615970|NCT03701399|364260111|FG000|Overall Study|Death|1|||
105615971|NCT03701399|364260112|FG001|Overall Study|Death|1|||
105615972|NCT03701399|364260111|FG000|Overall Study|Randomized but not treated|1|||
105615973|NCT03701399|364260112|FG001|Overall Study|Randomized but not treated|0|||
105615974|NCT02985957|364260113|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105615975|NCT02985957|364260114|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105615976|NCT02985957|364260115|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105615977|NCT02985957|364260116|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105615978|NCT02985957|364260117|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
105615979|NCT02985957|364260118|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105615980|NCT02985957|364260119|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105615981|NCT02985957|364260113|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
105615982|NCT02985957|364260114|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
105615983|NCT02985957|364260115|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
105615984|NCT02985957|364260116|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
105615985|NCT02985957|364260117|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
105615986|NCT02985957|364260118|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
105615987|NCT02985957|364260119|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
105615988|NCT02985957|364260113|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
105615989|NCT02985957|364260114|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
105615990|NCT02985957|364260115|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
105615991|NCT02985957|364260116|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
105615992|NCT02985957|364260117|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
105615993|NCT02985957|364260118|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
105615994|NCT02985957|364260119|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
105615995|NCT02985957|364260113|FG000|Treatment Period|Death|0|||
105615996|NCT02985957|364260114|FG001|Treatment Period|Death|0|||
105615997|NCT02985957|364260115|FG002|Treatment Period|Death|0|||
105615998|NCT02985957|364260116|FG003|Treatment Period|Death|0|||
105615999|NCT02985957|364260117|FG004|Treatment Period|Death|1|||
105616000|NCT02985957|364260118|FG005|Treatment Period|Death|0|||
105616001|NCT02985957|364260119|FG006|Treatment Period|Death|0|||
105616002|NCT02985957|364260113|FG000|Treatment Period|Participant withdrew consent|0|||
105616003|NCT02985957|364260114|FG001|Treatment Period|Participant withdrew consent|0|||
105616004|NCT02985957|364260115|FG002|Treatment Period|Participant withdrew consent|0|||
105616005|NCT02985957|364260116|FG003|Treatment Period|Participant withdrew consent|1|||
105616006|NCT02985957|364260117|FG004|Treatment Period|Participant withdrew consent|3|||
105616007|NCT02985957|364260118|FG005|Treatment Period|Participant withdrew consent|0|||
105616008|NCT02985957|364260119|FG006|Treatment Period|Participant withdrew consent|1|||
105616009|NCT02985957|364260113|FG000|Treatment Period|Lost to Follow-up|0|||
105616010|NCT02985957|364260114|FG001|Treatment Period|Lost to Follow-up|0|||
105616011|NCT02985957|364260115|FG002|Treatment Period|Lost to Follow-up|0|||
105616012|NCT02985957|364260116|FG003|Treatment Period|Lost to Follow-up|0|||
105616013|NCT02985957|364260117|FG004|Treatment Period|Lost to Follow-up|1|||
105616014|NCT02985957|364260118|FG005|Treatment Period|Lost to Follow-up|0|||
105616015|NCT02985957|364260119|FG006|Treatment Period|Lost to Follow-up|0|||
105616016|NCT02985957|364260113|FG000|Treatment Period|Other reasons|0|||
105616017|NCT02985957|364260114|FG001|Treatment Period|Other reasons|0|||
105616018|NCT02985957|364260115|FG002|Treatment Period|Other reasons|1|||
105616019|NCT02985957|364260116|FG003|Treatment Period|Other reasons|3|||
105616020|NCT02985957|364260117|FG004|Treatment Period|Other reasons|6|||
105616021|NCT02985957|364260118|FG005|Treatment Period|Other reasons|0|||
105616022|NCT02985957|364260119|FG006|Treatment Period|Other reasons|1|||
105616023|NCT02985957|364260113|FG000|Treatment Period|Not reported|0|||
105616024|NCT02985957|364260114|FG001|Treatment Period|Not reported|1|||
105616025|NCT02985957|364260115|FG002|Treatment Period|Not reported|2|||
105616026|NCT02985957|364260116|FG003|Treatment Period|Not reported|5|||
105616027|NCT02985957|364260117|FG004|Treatment Period|Not reported|0|||
105616028|NCT02985957|364260118|FG005|Treatment Period|Not reported|0|||
105616029|NCT02985957|364260119|FG006|Treatment Period|Not reported|0|||
105616030|NCT02985957|364260113|FG000|Treatment Period|Maximum clinical benefit|0|||
105616031|NCT02985957|364260114|FG001|Treatment Period|Maximum clinical benefit|0|||
105616032|NCT02985957|364260115|FG002|Treatment Period|Maximum clinical benefit|1|||
105616033|NCT02985957|364260116|FG003|Treatment Period|Maximum clinical benefit|1|||
105616034|NCT02985957|364260117|FG004|Treatment Period|Maximum clinical benefit|0|||
105616035|NCT02985957|364260118|FG005|Treatment Period|Maximum clinical benefit|0|||
105616036|NCT02985957|364260119|FG006|Treatment Period|Maximum clinical benefit|2|||
105616037|NCT02985957|364260113|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
105616038|NCT02985957|364260114|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
105616039|NCT02985957|364260115|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
105616040|NCT02985957|364260116|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
105616041|NCT02985957|364260117|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
105616042|NCT02985957|364260118|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
105616043|NCT02985957|364260119|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
105616044|NCT02985957|364260113|FG000|Treatment Period|Study drug toxicity|1|||
105616045|NCT02985957|364260114|FG001|Treatment Period|Study drug toxicity|23|||
105616046|NCT02985957|364260115|FG002|Treatment Period|Study drug toxicity|20|||
105616047|NCT02985957|364260116|FG003|Treatment Period|Study drug toxicity|11|||
105616048|NCT02985957|364260117|FG004|Treatment Period|Study drug toxicity|19|||
105616049|NCT02985957|364260118|FG005|Treatment Period|Study drug toxicity|3|||
105616050|NCT02985957|364260119|FG006|Treatment Period|Study drug toxicity|5|||
105616051|NCT02985957|364260113|FG000|Treatment Period|Disease progression|0|||
105616052|NCT02985957|364260114|FG001|Treatment Period|Disease progression|16|||
105616053|NCT02985957|364260115|FG002|Treatment Period|Disease progression|20|||
105616054|NCT02985957|364260116|FG003|Treatment Period|Disease progression|39|||
105616055|NCT02985957|364260117|FG004|Treatment Period|Disease progression|29|||
105616056|NCT02985957|364260118|FG005|Treatment Period|Disease progression|11|||
105616057|NCT02985957|364260119|FG006|Treatment Period|Disease progression|28|||
105616058|NCT02985957|364260113|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
105616059|NCT02985957|364260114|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
105616060|NCT02985957|364260115|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
105616061|NCT02985957|364260116|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
105616062|NCT02985957|364260117|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
105616063|NCT02985957|364260118|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
105616064|NCT02985957|364260119|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
105616065|NCT02985957|364260113|FG000|Treatment Period|Poor/Non-Compliance|0|||
105616066|NCT02985957|364260114|FG001|Treatment Period|Poor/Non-Compliance|0|||
105616067|NCT02985957|364260115|FG002|Treatment Period|Poor/Non-Compliance|0|||
105616068|NCT02985957|364260116|FG003|Treatment Period|Poor/Non-Compliance|0|||
105616069|NCT02985957|364260117|FG004|Treatment Period|Poor/Non-Compliance|1|||
105616070|NCT02985957|364260118|FG005|Treatment Period|Poor/Non-Compliance|1|||
105616071|NCT02985957|364260119|FG006|Treatment Period|Poor/Non-Compliance|0|||
105616072|NCT02985957|364260113|FG000|Treatment Period|Continuing in Treatment Period|0|||
105616073|NCT02985957|364260114|FG001|Treatment Period|Continuing in Treatment Period|1|||
105616074|NCT02985957|364260115|FG002|Treatment Period|Continuing in Treatment Period|0|||
105616075|NCT02985957|364260116|FG003|Treatment Period|Continuing in Treatment Period|4|||
105616076|NCT02985957|364260117|FG004|Treatment Period|Continuing in Treatment Period|4|||
105616077|NCT02985957|364260118|FG005|Treatment Period|Continuing in Treatment Period|0|||
105616078|NCT02985957|364260119|FG006|Treatment Period|Continuing in Treatment Period|0|||
105616079|NCT05481320|364260122|FG000|Overall Study|Withdrawal by Subject|1|||
105616080|NCT05481320|364260123|FG001|Overall Study|Withdrawal by Subject|1|||
105616081|NCT05481320|364260122|FG000|Overall Study|Care recipent passed away|0|||
105616082|NCT05481320|364260123|FG001|Overall Study|Care recipent passed away|1|||
105616083|NCT05481320|364260122|FG000|Overall Study|Out-of-window assessment|0|||
105616084|NCT05481320|364260123|FG001|Overall Study|Out-of-window assessment|1|||
105616085|NCT05481320|364260122|FG000|Overall Study|No longer a primary caregiver|3|||
105616086|NCT05481320|364260123|FG001|Overall Study|No longer a primary caregiver|0|||
105616087|NCT05481320|364260122|FG000|Overall Study|Unable to contact|1|||
105616088|NCT05481320|364260123|FG001|Overall Study|Unable to contact|0|||
105616089|NCT03721952|364260125|FG000|Overall Study|Lost to Follow-up|0|||
105616090|NCT03721952|364260126|FG001|Overall Study|Lost to Follow-up|0|||
105616091|NCT03721952|364260127|FG002|Overall Study|Lost to Follow-up|2|||
105616092|NCT03721952|364260128|FG003|Overall Study|Lost to Follow-up|0|||
105616093|NCT03721952|364260129|FG004|Overall Study|Lost to Follow-up|0|||
105616094|NCT03721952|364260125|FG000|Overall Study|Protocol Violation|0|||
105616095|NCT03721952|364260126|FG001|Overall Study|Protocol Violation|1|||
105616096|NCT03721952|364260127|FG002|Overall Study|Protocol Violation|0|||
105616097|NCT03721952|364260128|FG003|Overall Study|Protocol Violation|0|||
105616098|NCT03721952|364260129|FG004|Overall Study|Protocol Violation|0|||
105616099|NCT03721952|364260125|FG000|Overall Study|Withdrawal by Subject|1|||
105616100|NCT03721952|364260126|FG001|Overall Study|Withdrawal by Subject|0|||
105616101|NCT03721952|364260127|FG002|Overall Study|Withdrawal by Subject|40|||
105616102|NCT03721952|364260128|FG003|Overall Study|Withdrawal by Subject|28|||
105616103|NCT03721952|364260129|FG004|Overall Study|Withdrawal by Subject|0|||
105616104|NCT04495894|364260131|FG000|Overall Study|Withdrawal by Subject|2|||
105616105|NCT04495894|364260132|FG001|Overall Study|Withdrawal by Subject|0|||
105616106|NCT04495894|364260133|FG002|Overall Study|Withdrawal by Subject|2|||
105616107|NCT04495894|364260134|FG003|Overall Study|Withdrawal by Subject|3|||
105616108|NCT04495894|364260131|FG000|Overall Study|Early termination|0|||
105616109|NCT04495894|364260132|FG001|Overall Study|Early termination|0|||
105616110|NCT04495894|364260133|FG002|Overall Study|Early termination|3|||
105616111|NCT04495894|364260134|FG003|Overall Study|Early termination|0|||
105616112|NCT03364647|364260135|FG000|Overall Study|Withdrawal by Subject|3|||
105616113|NCT03364647|364260136|FG001|Overall Study|Withdrawal by Subject|1|||
105616114|NCT03476460|364260137|FG000|Overall Study|Withdrawal by Subject|3|||
105616115|NCT03476460|364260138|FG001|Overall Study|Withdrawal by Subject|2|||
105616116|NCT03476460|364260137|FG000|Overall Study|Non-compliance with treatment|3|||
105616117|NCT03476460|364260138|FG001|Overall Study|Non-compliance with treatment|0|||
105616118|NCT03476460|364260137|FG000|Overall Study|Missing laboratory tests|5|||
105616119|NCT03476460|364260138|FG001|Overall Study|Missing laboratory tests|5|||
105616120|NCT03476460|364260137|FG000|Overall Study|Adverse Event|0|||
105616121|NCT03476460|364260138|FG001|Overall Study|Adverse Event|1|||
105616122|NCT03023410|364260143|FG000|Overall Study|study termination|0|||
105616123|NCT03023410|364260144|FG001|Overall Study|study termination|1|||
105616124|NCT00470704|364260145|FG000|Overall Study|Withdrawal by Subject|4|||
105616125|NCT00470704|364260146|FG001|Overall Study|Withdrawal by Subject|3|||
105616126|NCT00470704|364260145|FG000|Overall Study|Relapse/Progression|37|||
105616127|NCT00470704|364260146|FG001|Overall Study|Relapse/Progression|42|||
105616128|NCT00470704|364260145|FG000|Overall Study|toxicity|0|||
105616129|NCT00470704|364260146|FG001|Overall Study|toxicity|1|||
105616130|NCT04019873|364260147|FG000|Overall Study|Discontinued from the treatment|1|||
105616131|NCT04019873|364260148|FG001|Overall Study|Discontinued from the treatment|39|||
105616132|NCT04019873|364260149|FG002|Overall Study|Discontinued from the treatment|2|||
105616133|NCT03694418|364260156|FG000|Overall Study|Lost to Follow-up|115|||
105616134|NCT03694418|364260157|FG001|Overall Study|Lost to Follow-up|23|||
105616135|NCT03694418|364260158|FG002|Overall Study|Lost to Follow-up|12|||
105616136|NCT03694418|364260159|FG003|Overall Study|Lost to Follow-up|12|||
105616137|NCT03694418|364260160|FG004|Overall Study|Lost to Follow-up|13|||
105616138|NCT04592549|364260164|FG000|Overall Study|Withdrawal by Subject|0|||
105616139|NCT04592549|364260165|FG001|Overall Study|Withdrawal by Subject|1|||
105616140|NCT04592549|364260166|FG002|Overall Study|Withdrawal by Subject|0|||
105616141|NCT04592549|364260167|FG003|Overall Study|Withdrawal by Subject|1|||
105616142|NCT04592549|364260168|FG004|Overall Study|Withdrawal by Subject|1|||
105616143|NCT04592549|364260169|FG005|Overall Study|Withdrawal by Subject|0|||
105616144|NCT04592549|364260164|FG000|Overall Study|Lost to Follow-up|2|||
105616145|NCT04592549|364260165|FG001|Overall Study|Lost to Follow-up|0|||
105616146|NCT04592549|364260166|FG002|Overall Study|Lost to Follow-up|0|||
105616147|NCT04592549|364260167|FG003|Overall Study|Lost to Follow-up|1|||
105616148|NCT04592549|364260168|FG004|Overall Study|Lost to Follow-up|1|||
105616149|NCT04592549|364260169|FG005|Overall Study|Lost to Follow-up|1|||
105616150|NCT00085735|364260170|FG000|Overall Study|Adverse Event|1|||
105616151|NCT00085735|364260171|FG001|Overall Study|Adverse Event|0|||
105616152|NCT00085735|364260172|FG002|Overall Study|Adverse Event|0|||
105616153|NCT00085735|364260173|FG003|Overall Study|Adverse Event|0|||
105616154|NCT00085735|364260174|FG004|Overall Study|Adverse Event|0|||
105616155|NCT00085735|364260175|FG005|Overall Study|Adverse Event|0|||
105616156|NCT00085735|364260170|FG000|Overall Study|Lack of Efficacy|2|||
105616157|NCT00085735|364260171|FG001|Overall Study|Lack of Efficacy|4|||
105616158|NCT00085735|364260172|FG002|Overall Study|Lack of Efficacy|6|||
105616159|NCT00085735|364260173|FG003|Overall Study|Lack of Efficacy|3|||
105616160|NCT00085735|364260174|FG004|Overall Study|Lack of Efficacy|4|||
105616161|NCT00085735|364260175|FG005|Overall Study|Lack of Efficacy|3|||
105616162|NCT00085735|364260170|FG000|Overall Study|Lost to Follow-up|0|||
105616163|NCT00085735|364260171|FG001|Overall Study|Lost to Follow-up|1|||
105616164|NCT00085735|364260172|FG002|Overall Study|Lost to Follow-up|0|||
105616165|NCT00085735|364260173|FG003|Overall Study|Lost to Follow-up|0|||
105616166|NCT00085735|364260174|FG004|Overall Study|Lost to Follow-up|1|||
105616167|NCT00085735|364260175|FG005|Overall Study|Lost to Follow-up|0|||
105616168|NCT00085735|364260170|FG000|Overall Study|Physician Decision|2|||
105616169|NCT00085735|364260171|FG001|Overall Study|Physician Decision|3|||
105616170|NCT00085735|364260172|FG002|Overall Study|Physician Decision|2|||
105616171|NCT00085735|364260173|FG003|Overall Study|Physician Decision|3|||
105616172|NCT00085735|364260174|FG004|Overall Study|Physician Decision|11|||
105616173|NCT00085735|364260175|FG005|Overall Study|Physician Decision|8|||
105616174|NCT00085735|364260170|FG000|Overall Study|Protocol Violation|1|||
105616175|NCT00085735|364260171|FG001|Overall Study|Protocol Violation|0|||
105616176|NCT00085735|364260172|FG002|Overall Study|Protocol Violation|0|||
105616177|NCT00085735|364260173|FG003|Overall Study|Protocol Violation|0|||
105616178|NCT00085735|364260174|FG004|Overall Study|Protocol Violation|0|||
105616179|NCT00085735|364260175|FG005|Overall Study|Protocol Violation|0|||
105616180|NCT00085735|364260170|FG000|Overall Study|Withdrawal by Subject|1|||
105616181|NCT00085735|364260171|FG001|Overall Study|Withdrawal by Subject|0|||
105616182|NCT00085735|364260172|FG002|Overall Study|Withdrawal by Subject|4|||
105616183|NCT00085735|364260173|FG003|Overall Study|Withdrawal by Subject|5|||
105616184|NCT00085735|364260174|FG004|Overall Study|Withdrawal by Subject|7|||
105616185|NCT00085735|364260175|FG005|Overall Study|Withdrawal by Subject|8|||
105616186|NCT00085735|364260170|FG000|Overall Study|Patient ineligible|1|||
105616187|NCT00085735|364260171|FG001|Overall Study|Patient ineligible|0|||
105616188|NCT00085735|364260172|FG002|Overall Study|Patient ineligible|3|||
105616189|NCT00085735|364260173|FG003|Overall Study|Patient ineligible|7|||
105616190|NCT00085735|364260174|FG004|Overall Study|Patient ineligible|17|||
105616191|NCT00085735|364260175|FG005|Overall Study|Patient ineligible|8|||
105616192|NCT00085735|364260170|FG000|Overall Study|Excess residual disease|2|||
105616193|NCT00085735|364260171|FG001|Overall Study|Excess residual disease|2|||
105616194|NCT00085735|364260172|FG002|Overall Study|Excess residual disease|1|||
105616195|NCT00085735|364260173|FG003|Overall Study|Excess residual disease|1|||
105616196|NCT00085735|364260174|FG004|Overall Study|Excess residual disease|1|||
105616197|NCT00085735|364260175|FG005|Overall Study|Excess residual disease|4|||
105616198|NCT00085735|364260170|FG000|Overall Study|Reason not documented|1|||
105616199|NCT00085735|364260171|FG001|Overall Study|Reason not documented|0|||
105616200|NCT00085735|364260172|FG002|Overall Study|Reason not documented|1|||
105616201|NCT00085735|364260173|FG003|Overall Study|Reason not documented|0|||
105616202|NCT00085735|364260174|FG004|Overall Study|Reason not documented|1|||
105616203|NCT00085735|364260175|FG005|Overall Study|Reason not documented|0|||
105616204|NCT00085735|364260170|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
105616205|NCT00085735|364260171|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
105616206|NCT00085735|364260172|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
105616207|NCT00085735|364260173|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
105616208|NCT00085735|364260174|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
105616209|NCT00085735|364260175|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
105616210|NCT04625283|364260179|FG000|Overall Study|post randomization exclusion|28|||
105616211|NCT04625283|364260180|FG001|Overall Study|post randomization exclusion|20|||
105616212|NCT02262728|364260181|FG000|Follow-up Phase (3 Years)|Death|0|||
105616213|NCT02262728|364260182|FG001|Follow-up Phase (3 Years)|Death|1|||
105616214|NCT02262728|364260181|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
105616215|NCT02262728|364260182|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
105616216|NCT02262728|364260181|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
105616217|NCT02262728|364260182|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
105616218|NCT04332926|364260185|FG000|Overall Study|Withdrawal by Subject|6|||
105616219|NCT04332926|364260185|FG000|Overall Study|Physician Decision|6|||
105616220|NCT05071053|364260186|FG000|Overall Study|Ongoing study treatment at the time of primary analysis completion|2|||
105616221|NCT05071053|364260186|FG000|Overall Study|Progressive disease|28|||
105616222|NCT05071053|364260186|FG000|Overall Study|Adverse Event|5|||
105616223|NCT04111536|364260189|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
105616224|NCT04111536|364260190|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
105616225|NCT04111536|364260189|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
105616226|NCT04111536|364260190|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
105616227|NCT04111536|364260189|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
105616228|NCT04111536|364260190|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
105616229|NCT04111536|364260189|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
105616230|NCT04111536|364260190|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
105616231|NCT05783102|364260191|FG000|Overall Study|Lost to Follow-up|1|||
105616232|NCT05783102|364260191|FG000|Overall Study|Withdrawal by Subject|2|||
105616233|NCT03544281|364260192|FG000|Main Study Phase|Death|3|||
105616234|NCT03544281|364260193|FG001|Main Study Phase|Death|2|||
105616235|NCT03544281|364260194|FG002|Main Study Phase|Death|6|||
105616236|NCT03544281|364260195|FG003|Main Study Phase|Death|8|||
105616237|NCT03544281|364260196|FG004|Main Study Phase|Death|4|||
105616238|NCT03544281|364260197|FG005|Main Study Phase|Death|2|||
105616239|NCT03544281|364260198|FG006|Main Study Phase|Death|4|||
105616240|NCT03544281|364260199|FG007|Main Study Phase|Death|5|||
105616241|NCT03544281|364260200|FG008|Main Study Phase|Death|5|||
105616242|NCT03544281|364260201|FG009|Main Study Phase|Death|8|||
105616243|NCT03544281|364260202|FG010|Main Study Phase|Death|6|||
105616244|NCT03544281|364260203|FG011|Main Study Phase|Death|4|||
105616245|NCT03544281|364260204|FG012|Main Study Phase|Death|0|||
105616246|NCT03544281|364260205|FG013|Main Study Phase|Death|0|||
105616247|NCT03544281|364260206|FG014|Main Study Phase|Death|0|||
105616248|NCT03544281|364260207|FG015|Main Study Phase|Death|0|||
105616249|NCT03544281|364260208|FG016|Main Study Phase|Death|0|||
105616250|NCT03544281|364260209|FG017|Main Study Phase|Death|0|||
105616251|NCT03544281|364260210|FG018|Main Study Phase|Death|0|||
105616252|NCT03544281|364260211|FG019|Main Study Phase|Death|0|||
105616253|NCT03544281|364260212|FG020|Main Study Phase|Death|0|||
105616254|NCT03544281|364260213|FG021|Main Study Phase|Death|0|||
105616255|NCT03544281|364260192|FG000|Main Study Phase|Lost to Follow-up|0|||
105616256|NCT03544281|364260193|FG001|Main Study Phase|Lost to Follow-up|0|||
105616257|NCT03544281|364260194|FG002|Main Study Phase|Lost to Follow-up|0|||
105616258|NCT03544281|364260195|FG003|Main Study Phase|Lost to Follow-up|0|||
105616259|NCT03544281|364260196|FG004|Main Study Phase|Lost to Follow-up|0|||
105616260|NCT03544281|364260197|FG005|Main Study Phase|Lost to Follow-up|0|||
105616261|NCT03544281|364260198|FG006|Main Study Phase|Lost to Follow-up|0|||
105616262|NCT03544281|364260199|FG007|Main Study Phase|Lost to Follow-up|0|||
105616263|NCT03544281|364260200|FG008|Main Study Phase|Lost to Follow-up|0|||
105616264|NCT03544281|364260201|FG009|Main Study Phase|Lost to Follow-up|0|||
105616265|NCT03544281|364260202|FG010|Main Study Phase|Lost to Follow-up|1|||
105616266|NCT03544281|364260203|FG011|Main Study Phase|Lost to Follow-up|0|||
105616267|NCT03544281|364260204|FG012|Main Study Phase|Lost to Follow-up|0|||
105616268|NCT03544281|364260205|FG013|Main Study Phase|Lost to Follow-up|0|||
105616269|NCT03544281|364260206|FG014|Main Study Phase|Lost to Follow-up|0|||
105616270|NCT03544281|364260207|FG015|Main Study Phase|Lost to Follow-up|0|||
105616271|NCT03544281|364260208|FG016|Main Study Phase|Lost to Follow-up|0|||
105616272|NCT03544281|364260209|FG017|Main Study Phase|Lost to Follow-up|0|||
105616273|NCT03544281|364260210|FG018|Main Study Phase|Lost to Follow-up|0|||
105616274|NCT03544281|364260211|FG019|Main Study Phase|Lost to Follow-up|0|||
105616275|NCT03544281|364260212|FG020|Main Study Phase|Lost to Follow-up|0|||
105616276|NCT03544281|364260213|FG021|Main Study Phase|Lost to Follow-up|0|||
105616277|NCT03544281|364260192|FG000|Main Study Phase|Physician Decision|0|||
105616278|NCT03544281|364260193|FG001|Main Study Phase|Physician Decision|0|||
105616279|NCT03544281|364260194|FG002|Main Study Phase|Physician Decision|0|||
105616280|NCT03544281|364260195|FG003|Main Study Phase|Physician Decision|0|||
105616281|NCT03544281|364260196|FG004|Main Study Phase|Physician Decision|0|||
105616282|NCT03544281|364260197|FG005|Main Study Phase|Physician Decision|0|||
105616283|NCT03544281|364260198|FG006|Main Study Phase|Physician Decision|0|||
105616284|NCT03544281|364260199|FG007|Main Study Phase|Physician Decision|1|||
105616285|NCT03544281|364260200|FG008|Main Study Phase|Physician Decision|0|||
105616286|NCT03544281|364260201|FG009|Main Study Phase|Physician Decision|0|||
105616287|NCT03544281|364260202|FG010|Main Study Phase|Physician Decision|0|||
105616288|NCT03544281|364260203|FG011|Main Study Phase|Physician Decision|0|||
105616289|NCT03544281|364260204|FG012|Main Study Phase|Physician Decision|0|||
105616290|NCT03544281|364260205|FG013|Main Study Phase|Physician Decision|0|||
105616291|NCT03544281|364260206|FG014|Main Study Phase|Physician Decision|0|||
105616292|NCT03544281|364260207|FG015|Main Study Phase|Physician Decision|0|||
105616293|NCT03544281|364260208|FG016|Main Study Phase|Physician Decision|0|||
105616294|NCT03544281|364260209|FG017|Main Study Phase|Physician Decision|0|||
105616295|NCT03544281|364260210|FG018|Main Study Phase|Physician Decision|0|||
105616296|NCT03544281|364260211|FG019|Main Study Phase|Physician Decision|0|||
105616297|NCT03544281|364260212|FG020|Main Study Phase|Physician Decision|0|||
105616298|NCT03544281|364260213|FG021|Main Study Phase|Physician Decision|0|||
105616299|NCT03544281|364260192|FG000|Main Study Phase|Withdrawal by Subject|2|||
105616300|NCT03544281|364260193|FG001|Main Study Phase|Withdrawal by Subject|0|||
105616301|NCT03544281|364260194|FG002|Main Study Phase|Withdrawal by Subject|1|||
105616302|NCT03544281|364260195|FG003|Main Study Phase|Withdrawal by Subject|2|||
105616303|NCT03544281|364260196|FG004|Main Study Phase|Withdrawal by Subject|0|||
105616304|NCT03544281|364260197|FG005|Main Study Phase|Withdrawal by Subject|0|||
105616305|NCT03544281|364260198|FG006|Main Study Phase|Withdrawal by Subject|0|||
105616306|NCT03544281|364260199|FG007|Main Study Phase|Withdrawal by Subject|0|||
105616307|NCT03544281|364260200|FG008|Main Study Phase|Withdrawal by Subject|2|||
105616308|NCT03544281|364260201|FG009|Main Study Phase|Withdrawal by Subject|3|||
105616309|NCT03544281|364260202|FG010|Main Study Phase|Withdrawal by Subject|0|||
105616310|NCT03544281|364260203|FG011|Main Study Phase|Withdrawal by Subject|4|||
105616311|NCT03544281|364260204|FG012|Main Study Phase|Withdrawal by Subject|0|||
105616312|NCT03544281|364260205|FG013|Main Study Phase|Withdrawal by Subject|0|||
105616313|NCT03544281|364260206|FG014|Main Study Phase|Withdrawal by Subject|0|||
105616314|NCT03544281|364260207|FG015|Main Study Phase|Withdrawal by Subject|0|||
105616315|NCT03544281|364260208|FG016|Main Study Phase|Withdrawal by Subject|0|||
105616316|NCT03544281|364260209|FG017|Main Study Phase|Withdrawal by Subject|0|||
105616317|NCT03544281|364260210|FG018|Main Study Phase|Withdrawal by Subject|0|||
105616318|NCT03544281|364260211|FG019|Main Study Phase|Withdrawal by Subject|0|||
105616319|NCT03544281|364260212|FG020|Main Study Phase|Withdrawal by Subject|0|||
105616320|NCT03544281|364260213|FG021|Main Study Phase|Withdrawal by Subject|0|||
105616321|NCT03544281|364260192|FG000|Main Study Phase|Ongoing|3|||
105616322|NCT03544281|364260193|FG001|Main Study Phase|Ongoing|1|||
105616323|NCT03544281|364260194|FG002|Main Study Phase|Ongoing|2|||
105616324|NCT03544281|364260195|FG003|Main Study Phase|Ongoing|4|||
105616325|NCT03544281|364260196|FG004|Main Study Phase|Ongoing|2|||
105616326|NCT03544281|364260197|FG005|Main Study Phase|Ongoing|4|||
105616327|NCT03544281|364260198|FG006|Main Study Phase|Ongoing|4|||
105616328|NCT03544281|364260199|FG007|Main Study Phase|Ongoing|0|||
105616329|NCT03544281|364260200|FG008|Main Study Phase|Ongoing|2|||
105616330|NCT03544281|364260201|FG009|Main Study Phase|Ongoing|2|||
105616331|NCT03544281|364260202|FG010|Main Study Phase|Ongoing|1|||
105616332|NCT03544281|364260203|FG011|Main Study Phase|Ongoing|0|||
105616333|NCT03544281|364260204|FG012|Main Study Phase|Ongoing|0|||
105616334|NCT03544281|364260205|FG013|Main Study Phase|Ongoing|0|||
105616335|NCT03544281|364260206|FG014|Main Study Phase|Ongoing|0|||
105616336|NCT03544281|364260207|FG015|Main Study Phase|Ongoing|0|||
105616337|NCT03544281|364260208|FG016|Main Study Phase|Ongoing|0|||
105616338|NCT03544281|364260209|FG017|Main Study Phase|Ongoing|0|||
105616339|NCT03544281|364260210|FG018|Main Study Phase|Ongoing|0|||
105616340|NCT03544281|364260211|FG019|Main Study Phase|Ongoing|0|||
105616341|NCT03544281|364260212|FG020|Main Study Phase|Ongoing|0|||
105616342|NCT03544281|364260213|FG021|Main Study Phase|Ongoing|0|||
105616343|NCT03544281|364260192|FG000|Main Study Phase|Investigator Site Closed|0|||
105616344|NCT03544281|364260193|FG001|Main Study Phase|Investigator Site Closed|0|||
105616345|NCT03544281|364260194|FG002|Main Study Phase|Investigator Site Closed|0|||
105616346|NCT03544281|364260195|FG003|Main Study Phase|Investigator Site Closed|0|||
105616347|NCT03544281|364260196|FG004|Main Study Phase|Investigator Site Closed|0|||
105616348|NCT03544281|364260197|FG005|Main Study Phase|Investigator Site Closed|0|||
105616349|NCT03544281|364260198|FG006|Main Study Phase|Investigator Site Closed|0|||
105616350|NCT03544281|364260199|FG007|Main Study Phase|Investigator Site Closed|0|||
105616351|NCT03544281|364260200|FG008|Main Study Phase|Investigator Site Closed|0|||
105616352|NCT03544281|364260201|FG009|Main Study Phase|Investigator Site Closed|1|||
105616353|NCT03544281|364260202|FG010|Main Study Phase|Investigator Site Closed|0|||
105616354|NCT03544281|364260203|FG011|Main Study Phase|Investigator Site Closed|0|||
105616355|NCT03544281|364260204|FG012|Main Study Phase|Investigator Site Closed|0|||
105616356|NCT03544281|364260205|FG013|Main Study Phase|Investigator Site Closed|0|||
105616357|NCT03544281|364260206|FG014|Main Study Phase|Investigator Site Closed|0|||
105616358|NCT03544281|364260207|FG015|Main Study Phase|Investigator Site Closed|0|||
105616359|NCT03544281|364260208|FG016|Main Study Phase|Investigator Site Closed|0|||
105616360|NCT03544281|364260209|FG017|Main Study Phase|Investigator Site Closed|0|||
105616361|NCT03544281|364260210|FG018|Main Study Phase|Investigator Site Closed|0|||
105616362|NCT03544281|364260211|FG019|Main Study Phase|Investigator Site Closed|0|||
105616363|NCT03544281|364260212|FG020|Main Study Phase|Investigator Site Closed|0|||
105616364|NCT03544281|364260213|FG021|Main Study Phase|Investigator Site Closed|0|||
105616365|NCT03544281|364260192|FG000|Main Study Phase|Did not receive study treatment|0|||
105616366|NCT03544281|364260193|FG001|Main Study Phase|Did not receive study treatment|0|||
105616367|NCT03544281|364260194|FG002|Main Study Phase|Did not receive study treatment|0|||
105616368|NCT03544281|364260195|FG003|Main Study Phase|Did not receive study treatment|0|||
105616369|NCT03544281|364260196|FG004|Main Study Phase|Did not receive study treatment|0|||
105616370|NCT03544281|364260197|FG005|Main Study Phase|Did not receive study treatment|0|||
105616371|NCT03544281|364260198|FG006|Main Study Phase|Did not receive study treatment|1|||
105616372|NCT03544281|364260199|FG007|Main Study Phase|Did not receive study treatment|0|||
105616373|NCT03544281|364260200|FG008|Main Study Phase|Did not receive study treatment|0|||
105616374|NCT03544281|364260201|FG009|Main Study Phase|Did not receive study treatment|0|||
105616375|NCT03544281|364260202|FG010|Main Study Phase|Did not receive study treatment|0|||
105616376|NCT03544281|364260203|FG011|Main Study Phase|Did not receive study treatment|0|||
105616377|NCT03544281|364260204|FG012|Main Study Phase|Did not receive study treatment|0|||
105616378|NCT03544281|364260205|FG013|Main Study Phase|Did not receive study treatment|0|||
105616379|NCT03544281|364260206|FG014|Main Study Phase|Did not receive study treatment|0|||
105616380|NCT03544281|364260207|FG015|Main Study Phase|Did not receive study treatment|0|||
105616381|NCT03544281|364260208|FG016|Main Study Phase|Did not receive study treatment|0|||
105616382|NCT03544281|364260209|FG017|Main Study Phase|Did not receive study treatment|0|||
105616383|NCT03544281|364260210|FG018|Main Study Phase|Did not receive study treatment|0|||
105616384|NCT03544281|364260211|FG019|Main Study Phase|Did not receive study treatment|0|||
105616385|NCT03544281|364260212|FG020|Main Study Phase|Did not receive study treatment|0|||
105616386|NCT03544281|364260213|FG021|Main Study Phase|Did not receive study treatment|0|||
105616387|NCT03544281|364260192|FG000|PACT Phase|Adverse Event|0|||
105616388|NCT03544281|364260193|FG001|PACT Phase|Adverse Event|0|||
105616389|NCT03544281|364260194|FG002|PACT Phase|Adverse Event|0|||
105616390|NCT03544281|364260195|FG003|PACT Phase|Adverse Event|0|||
105616391|NCT03544281|364260196|FG004|PACT Phase|Adverse Event|0|||
105616392|NCT03544281|364260197|FG005|PACT Phase|Adverse Event|0|||
105616393|NCT03544281|364260198|FG006|PACT Phase|Adverse Event|0|||
105616394|NCT03544281|364260199|FG007|PACT Phase|Adverse Event|0|||
105616395|NCT03544281|364260200|FG008|PACT Phase|Adverse Event|0|||
105616396|NCT03544281|364260201|FG009|PACT Phase|Adverse Event|0|||
105616397|NCT03544281|364260202|FG010|PACT Phase|Adverse Event|0|||
105616398|NCT03544281|364260203|FG011|PACT Phase|Adverse Event|0|||
105616399|NCT03544281|364260204|FG012|PACT Phase|Adverse Event|1|||
105616400|NCT03544281|364260205|FG013|PACT Phase|Adverse Event|0|||
105616401|NCT03544281|364260206|FG014|PACT Phase|Adverse Event|0|||
105616402|NCT03544281|364260207|FG015|PACT Phase|Adverse Event|0|||
105616403|NCT03544281|364260208|FG016|PACT Phase|Adverse Event|0|||
105616404|NCT03544281|364260209|FG017|PACT Phase|Adverse Event|1|||
105616405|NCT03544281|364260210|FG018|PACT Phase|Adverse Event|1|||
105616406|NCT03544281|364260211|FG019|PACT Phase|Adverse Event|0|||
105616407|NCT03544281|364260212|FG020|PACT Phase|Adverse Event|0|||
105616408|NCT03544281|364260213|FG021|PACT Phase|Adverse Event|0|||
105616409|NCT03092518|364260214|FG000|Overall Study|Ineligible|2|||
105616410|NCT05949788|364260220|FG000|Overall Study|severe birth deformity|2|||
105616411|NCT05949788|364260221|FG001|Overall Study|severe birth deformity|7|||
105616412|NCT05949788|364260220|FG000|Overall Study|twin-twin transfusion syndrome|2|||
105616413|NCT05949788|364260221|FG001|Overall Study|twin-twin transfusion syndrome|7|||
105616414|NCT05949788|364260220|FG000|Overall Study|neonatal hemolytic disease|3|||
105616415|NCT05949788|364260221|FG001|Overall Study|neonatal hemolytic disease|8|||
105616416|NCT05949788|364260220|FG000|Overall Study|death within 14 days after birth|2|||
105616417|NCT05949788|364260221|FG001|Overall Study|death within 14 days after birth|6|||
105616418|NCT05949788|364260220|FG000|Overall Study|transfer to another hospital|2|||
105616419|NCT05949788|364260221|FG001|Overall Study|transfer to another hospital|6|||
105616420|NCT05213390|364260222|FG000|Overall Study|Withdrawal by Subject|2|||
105616421|NCT05213390|364260222|FG000|Overall Study|Lost to Follow-up|12|||
105616422|NCT05213390|364260222|FG000|Overall Study|Protocol Violation|9|||
105616423|NCT03524612|364260231|FG000|Overall Study|Lack of Efficacy|10|||
105616424|NCT03524612|364260231|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
105616425|NCT03524612|364260231|FG000|Overall Study|Adverse Event|10|||
105616426|NCT03524612|364260231|FG000|Overall Study|Withdrawal by Subject|7|||
105616427|NCT03524612|364260231|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
105616428|NCT03524612|364260231|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
105616429|NCT03524612|364260231|FG000|Overall Study|New therapy for study indication|6|||
105616430|NCT03524612|364260231|FG000|Overall Study|Death|3|||
105616431|NCT03524612|364260231|FG000|Overall Study|Lost to Follow-up|2|||
105616432|NCT03524612|364260231|FG000|Overall Study|Protocol Violation|1|||
105616433|NCT03448107|364260233|FG000|Overall Study|Lost to Follow-up|229|||
105616434|NCT03448107|364260234|FG001|Overall Study|Lost to Follow-up|258|||
105616435|NCT03115476|364260235|FG000|LP0084-1369|Death|1|||
105616436|NCT03115476|364260236|FG001|LP0084-1369|Death|0|||
105616437|NCT03115476|364260237|FG002|LP0084-1369|Death|2|||
105616438|NCT03115476|364260235|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
105616439|NCT03115476|364260236|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
105616440|NCT03115476|364260237|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
105616441|NCT05533632|364260242|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
105616442|NCT05533632|364260242|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
105616443|NCT05533632|364260242|FG000|Overall Study|Lost to Follow-up|1|||
105616444|NCT05533632|364260242|FG000|Overall Study|Withdrawal by Subject|4|||
105616445|NCT05533632|364260242|FG000|Overall Study|Adverse Event|4|||
105616446|NCT05144009|364260243|FG000|Overall Study|Lost to Follow-up|0|||
105616447|NCT05144009|364260244|FG001|Overall Study|Lost to Follow-up|1|||
105616448|NCT05144009|364260243|FG000|Overall Study|Study Termination by the Sponsor|11|||
105616449|NCT05144009|364260244|FG001|Overall Study|Study Termination by the Sponsor|11|||
105616450|NCT05144009|364260243|FG000|Overall Study|Disease Progression|1|||
105616451|NCT05144009|364260244|FG001|Overall Study|Disease Progression|0|||
105616452|NCT05144009|364260243|FG000|Overall Study|Participant Decision|0|||
105616453|NCT05144009|364260244|FG001|Overall Study|Participant Decision|2|||
105616454|NCT05144009|364260243|FG000|Overall Study|Death|5|||
105616455|NCT05144009|364260244|FG001|Overall Study|Death|10|||
105616456|NCT05084508|364260249|FG000|Overall Study|Lost to Follow-up|6|||
105616457|NCT05084508|364260250|FG001|Overall Study|Lost to Follow-up|3|||
105616458|NCT05084508|364260251|FG002|Overall Study|Lost to Follow-up|7|||
105616459|NCT05084508|364260252|FG003|Overall Study|Lost to Follow-up|3|||
105616460|NCT05084508|364260249|FG000|Overall Study|Withdrawal by Subject|0|||
105616461|NCT05084508|364260250|FG001|Overall Study|Withdrawal by Subject|2|||
105616462|NCT05084508|364260251|FG002|Overall Study|Withdrawal by Subject|3|||
105616463|NCT05084508|364260252|FG003|Overall Study|Withdrawal by Subject|1|||
105616464|NCT05084508|364260249|FG000|Overall Study|Other|0|||
105616465|NCT05084508|364260250|FG001|Overall Study|Other|0|||
105616466|NCT05084508|364260251|FG002|Overall Study|Other|0|||
105616467|NCT05084508|364260252|FG003|Overall Study|Other|1|||
105616468|NCT05296525|364260253|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
105616469|NCT05296525|364260254|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
105616470|NCT05296525|364260255|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
105616471|NCT05296525|364260256|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
105616472|NCT01420237|364260259|FG000|Overall Study|Death|13|||
105616473|NCT01420237|364260259|FG000|Overall Study|Withdrawal by Subject|41|||
105616474|NCT01420237|364260259|FG000|Overall Study|Lost to Follow-up|32|||
105616475|NCT01420237|364260259|FG000|Overall Study|Adverse Event|10|||
105616476|NCT01420237|364260259|FG000|Overall Study|Investigative Site Termination|43|||
105616477|NCT01420237|364260259|FG000|Overall Study|Censored because study device not implanted|21|||
105616478|NCT01420237|364260259|FG000|Overall Study|Censored because surgery not performed|2|||
105616479|NCT01420237|364260259|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
105616480|NCT01420237|364260259|FG000|Overall Study|Sponsor terminated study early|127|||
105616481|NCT05269667|364260260|FG000|Overall Study|Study Terminated by Sponsor|4|||
105616482|NCT04948697|364260261|FG000|Overall Study|Progressive disease|27|||
105616483|NCT04948697|364260262|FG001|Overall Study|Progressive disease|18|||
105616484|NCT04948697|364260261|FG000|Overall Study|Adverse Event|14|||
105616485|NCT04948697|364260262|FG001|Overall Study|Adverse Event|4|||
105616486|NCT04948697|364260261|FG000|Overall Study|Participant moved to long term extension study|7|||
105616487|NCT04948697|364260262|FG001|Overall Study|Participant moved to long term extension study|4|||
105616488|NCT04948697|364260261|FG000|Overall Study|Withdrawal by Subject|10|||
105616489|NCT04948697|364260262|FG001|Overall Study|Withdrawal by Subject|0|||
105616490|NCT04948697|364260261|FG000|Overall Study|Closed by Sponsor|3|||
105616491|NCT04948697|364260262|FG001|Overall Study|Closed by Sponsor|2|||
105616492|NCT04948697|364260261|FG000|Overall Study|Physician Decision|0|||
105616493|NCT04948697|364260262|FG001|Overall Study|Physician Decision|2|||
105616494|NCT04948697|364260261|FG000|Overall Study|Lost to Follow-up|0|||
105616495|NCT04948697|364260262|FG001|Overall Study|Lost to Follow-up|1|||
105616496|NCT04948697|364260261|FG000|Overall Study|Other-Miscellaneous|1|||
105616497|NCT04948697|364260262|FG001|Overall Study|Other-Miscellaneous|0|||
105616498|NCT04948697|364260261|FG000|Overall Study|Randomized but not treated|0|||
105616499|NCT04948697|364260262|FG001|Overall Study|Randomized but not treated|1|||
105616500|NCT04338061|364260263|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
105616501|NCT04338061|364260264|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
105616502|NCT04338061|364260263|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
105616503|NCT04338061|364260264|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
105616504|NCT04338061|364260263|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
105616505|NCT04338061|364260264|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
105616506|NCT04338061|364260263|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
105616507|NCT04338061|364260264|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
105616508|NCT04338061|364260263|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
105616509|NCT04338061|364260264|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
105616510|NCT04338061|364260263|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
105616511|NCT04338061|364260264|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
105616512|NCT04338061|364260263|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
105616513|NCT04338061|364260264|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
105616514|NCT04338061|364260263|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
105616515|NCT04338061|364260264|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
105616516|NCT04338061|364260263|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
105616517|NCT04338061|364260264|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
105616518|NCT04338061|364260263|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
105616519|NCT04338061|364260264|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
105616520|NCT04338061|364260263|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
105616521|NCT04338061|364260264|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
105616522|NCT04338061|364260263|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
105616523|NCT04338061|364260264|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
105616524|NCT04599062|364260265|FG000|Overall Study|Physician Decision|1|||
105616525|NCT04599062|364260266|FG001|Overall Study|Physician Decision|0|||
105616526|NCT03631784|364260268|FG000|Overall Study|Participants Ongoing|1|||
105616527|NCT03631784|364260269|FG001|Overall Study|Participants Ongoing|0|||
105616528|NCT03631784|364260268|FG000|Overall Study|Withdrawal by Subject|3|||
105616529|NCT03631784|364260269|FG001|Overall Study|Withdrawal by Subject|3|||
105616530|NCT03631784|364260268|FG000|Overall Study|Sponsor's Decision|36|||
105616531|NCT03631784|364260269|FG001|Overall Study|Sponsor's Decision|52|||
105616532|NCT03631784|364260268|FG000|Overall Study|Lost to Follow-up|1|||
105616533|NCT03631784|364260269|FG001|Overall Study|Lost to Follow-up|0|||
105616534|NCT03631784|364260268|FG000|Overall Study|Death|71|||
105616535|NCT03631784|364260269|FG001|Overall Study|Death|49|||
105616536|NCT03020199|364260272|FG000|Treatment Period|Adverse Event|0|||
105616537|NCT03020199|364260273|FG001|Treatment Period|Adverse Event|2|||
105616538|NCT03020199|364260272|FG000|Treatment Period|Lack of Efficacy|1|||
105616539|NCT03020199|364260273|FG001|Treatment Period|Lack of Efficacy|6|||
105616540|NCT03020199|364260272|FG000|Treatment Period|Lost to Follow-up|1|||
105616541|NCT03020199|364260273|FG001|Treatment Period|Lost to Follow-up|6|||
105616542|NCT03020199|364260272|FG000|Treatment Period|Physician Decision|0|||
105616543|NCT03020199|364260273|FG001|Treatment Period|Physician Decision|1|||
105616544|NCT03020199|364260272|FG000|Treatment Period|Subject/guardian decision|8|||
105616545|NCT03020199|364260273|FG001|Treatment Period|Subject/guardian decision|15|||
105616546|NCT03020199|364260272|FG000|Treatment Period|Subjects not treated|3|||
105616547|NCT03020199|364260273|FG001|Treatment Period|Subjects not treated|4|||
105616548|NCT03020199|364260272|FG000|Follow-up Period|Disease relapse|32|||
105616549|NCT03020199|364260273|FG001|Follow-up Period|Disease relapse|7|||
105616550|NCT03020199|364260272|FG000|Follow-up Period|Lack of Efficacy|1|||
105616551|NCT03020199|364260273|FG001|Follow-up Period|Lack of Efficacy|2|||
105616552|NCT03020199|364260272|FG000|Follow-up Period|Lost to Follow-up|4|||
105616553|NCT03020199|364260273|FG001|Follow-up Period|Lost to Follow-up|6|||
105616554|NCT03020199|364260272|FG000|Follow-up Period|Physician Decision|2|||
105616555|NCT03020199|364260273|FG001|Follow-up Period|Physician Decision|2|||
105616556|NCT03020199|364260272|FG000|Follow-up Period|Protocol Violation|1|||
105616557|NCT03020199|364260273|FG001|Follow-up Period|Protocol Violation|2|||
105616558|NCT03020199|364260272|FG000|Follow-up Period|Study terminated by Sponsor|6|||
105616559|NCT03020199|364260273|FG001|Follow-up Period|Study terminated by Sponsor|3|||
105616560|NCT03020199|364260272|FG000|Follow-up Period|Subject/guardian decision|14|||
105616561|NCT03020199|364260273|FG001|Follow-up Period|Subject/guardian decision|9|||
105616562|NCT04042233|364260274|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
105616563|NCT04042233|364260275|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
105616564|NCT04042233|364260274|FG000|Overall Study|Protocol Violation|0|||
105616565|NCT04042233|364260275|FG001|Overall Study|Protocol Violation|2|||
105616566|NCT04907851|364260276|FG000|Overall Study|Consent withdrawn|1|||
105616567|NCT04907851|364260277|FG001|Overall Study|Consent withdrawn|2|||
105616568|NCT04907851|364260278|FG002|Overall Study|Consent withdrawn|0|||
105616569|NCT04907851|364260276|FG000|Overall Study|Death|5|||
105616570|NCT04907851|364260277|FG001|Overall Study|Death|15|||
105616571|NCT04907851|364260278|FG002|Overall Study|Death|10|||
105616572|NCT00753545|364262163|FG000|Overall Study|Death|98|||
105616573|NCT00753545|364262164|FG001|Overall Study|Death|112|||
105616574|NCT00753545|364262163|FG000|Overall Study|Lost to Follow-up|2|||
105616575|NCT00753545|364262164|FG001|Overall Study|Lost to Follow-up|3|||
105616576|NCT00753545|364262163|FG000|Overall Study|Protocol Violation|1|||
105616577|NCT00753545|364262164|FG001|Overall Study|Protocol Violation|0|||
105616578|NCT00753545|364262163|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
105616579|NCT00753545|364262164|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
105616580|NCT06190691|364262165|FG000|Overall Study|Adverse Event|2|||
105616581|NCT06190691|364262166|FG001|Overall Study|Adverse Event|0|||
105616582|NCT06190691|364262167|FG002|Overall Study|Adverse Event|0|||
105616583|NCT06190691|364262168|FG003|Overall Study|Adverse Event|0|||
105616584|NCT05746455|364262169|FG000|Overall Study|Discharged from Clinical Service|1|||
105616585|NCT05746455|364262169|FG000|Overall Study|Lost to Follow-up|1|||
105616586|NCT03016754|364262170|FG000|Overall Study|Death|5|||
105616587|NCT03016754|364262171|FG001|Overall Study|Death|4|||
105616588|NCT03016754|364262172|FG002|Overall Study|Death|5|||
105616589|NCT03016754|364262173|FG003|Overall Study|Death|1|||
105616590|NCT03016754|364262170|FG000|Overall Study|Lost to Follow-up|23|||
105616591|NCT03016754|364262171|FG001|Overall Study|Lost to Follow-up|17|||
105616592|NCT03016754|364262172|FG002|Overall Study|Lost to Follow-up|4|||
105616593|NCT03016754|364262173|FG003|Overall Study|Lost to Follow-up|2|||
105616594|NCT03016754|364262170|FG000|Overall Study|Withdrawal by Subject|6|||
105616595|NCT03016754|364262171|FG001|Overall Study|Withdrawal by Subject|6|||
105616596|NCT03016754|364262172|FG002|Overall Study|Withdrawal by Subject|2|||
105616597|NCT03016754|364262173|FG003|Overall Study|Withdrawal by Subject|2|||
105616598|NCT03016754|364262170|FG000|Overall Study|Other/Unknown|2|||
105616599|NCT03016754|364262171|FG001|Overall Study|Other/Unknown|4|||
105616600|NCT03016754|364262172|FG002|Overall Study|Other/Unknown|2|||
105616601|NCT03016754|364262173|FG003|Overall Study|Other/Unknown|1|||
105616602|NCT03016754|364262170|FG000|Overall Study|Protocol Violation|0|||
105616603|NCT03016754|364262171|FG001|Overall Study|Protocol Violation|0|||
105616604|NCT03016754|364262172|FG002|Overall Study|Protocol Violation|0|||
105616605|NCT03016754|364262173|FG003|Overall Study|Protocol Violation|4|||
105616606|NCT03839940|364262174|FG000|Overall Study|Withdrawal by Subject|3|||
105616607|NCT03839940|364262175|FG001|Overall Study|Withdrawal by Subject|0|||
105616608|NCT03839940|364262174|FG000|Overall Study|Protocol Violation|0|||
105616609|NCT03839940|364262175|FG001|Overall Study|Protocol Violation|1|||
105616610|NCT03839940|364262174|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
105616611|NCT03839940|364262175|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
105616612|NCT04295798|364262181|FG000|Overall Study|Lost to Follow-up|1|||
105616613|NCT02362503|364262183|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
105616614|NCT02362503|364262184|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
105616615|NCT02362503|364262185|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
105616616|NCT02362503|364262183|FG000|Double-blind Period-Up to 8 Days|Death|1|||
105616617|NCT02362503|364262184|FG001|Double-blind Period-Up to 8 Days|Death|0|||
105616618|NCT02362503|364262185|FG002|Double-blind Period-Up to 8 Days|Death|0|||
105616619|NCT02362503|364262183|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
105616620|NCT02362503|364262184|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
105616621|NCT02362503|364262185|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
105616622|NCT02362503|364262183|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
105616623|NCT02362503|364262184|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
105616624|NCT02362503|364262185|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
105616625|NCT02362503|364262183|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
105616626|NCT02362503|364262184|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
105616627|NCT02362503|364262185|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
105616628|NCT02362503|364262183|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
105616629|NCT02362503|364262184|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
105616630|NCT02362503|364262185|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
105616631|NCT02362503|364262183|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
105616632|NCT02362503|364262184|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
105616633|NCT02362503|364262185|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
105616634|NCT02362503|364262183|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
105616635|NCT02362503|364262184|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
105616636|NCT02362503|364262185|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
105616637|NCT02362503|364262183|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
105616638|NCT02362503|364262184|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
105616639|NCT02362503|364262185|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
105616640|NCT02362503|364262183|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
105616641|NCT02362503|364262184|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
105616642|NCT02362503|364262185|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
105616643|NCT02362503|364262183|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
105616644|NCT02362503|364262184|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
105616645|NCT02362503|364262185|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
105616646|NCT02362503|364262183|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
105616647|NCT02362503|364262184|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
105616648|NCT02362503|364262185|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
105616649|NCT02362503|364262183|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
105616650|NCT02362503|364262184|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
105616651|NCT02362503|364262185|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
105616652|NCT02362503|364262183|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
105616653|NCT02362503|364262184|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
105616654|NCT02362503|364262185|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
105616655|NCT02919306|364262186|FG000|Overall Study|Withdrawal by Subject|1|||
105616656|NCT02919306|364262187|FG001|Overall Study|Withdrawal by Subject|0|||
105616657|NCT02919306|364262186|FG000|Overall Study|Protocol Violation|1|||
105616658|NCT02919306|364262187|FG001|Overall Study|Protocol Violation|0|||
105616659|NCT01959425|364262194|FG000|Overall Study|Withdrawal by Subject|5|||
105616660|NCT01959425|364262195|FG001|Overall Study|Withdrawal by Subject|4|||
105616661|NCT01959425|364262194|FG000|Overall Study|Lost to Follow-up|1|||
105616662|NCT01959425|364262195|FG001|Overall Study|Lost to Follow-up|0|||
105616663|NCT01959425|364262194|FG000|Overall Study|Discontinued Subjects|6|||
105616664|NCT01959425|364262195|FG001|Overall Study|Discontinued Subjects|4|||
105616665|NCT05256017|364262204|FG000|Treatment Period|Withdrawal by Subject|1|||
105616666|NCT05256017|364262205|FG001|Treatment Period|Withdrawal by Subject|1|||
105616667|NCT05256017|364262204|FG000|Follow-up|Lost to Follow-up|7|||
105616668|NCT05256017|364262205|FG001|Follow-up|Lost to Follow-up|1|||
105616669|NCT05256017|364262204|FG000|Follow-up|Withdrawal by Subject|1|||
105616670|NCT05256017|364262205|FG001|Follow-up|Withdrawal by Subject|0|||
105616671|NCT05256017|364262204|FG000|Follow-up|Death|0|||
105616672|NCT05256017|364262205|FG001|Follow-up|Death|1|||
105616673|NCT01073566|364262206|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
105616674|NCT01073566|364262207|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
105616675|NCT05780437|364262210|FG000|Overall Study|Withdrawal by Subject|22|||
105616676|NCT05780437|364262211|FG001|Overall Study|Withdrawal by Subject|16|||
105616677|NCT03640312|364262212|FG000|Overall Study|Lost to Follow-up|3|||
105616678|NCT03640312|364262213|FG001|Overall Study|Lost to Follow-up|6|||
105616679|NCT03452579|364262218|FG000|Overall Study|Death|0|||
105616680|NCT03452579|364262219|FG001|Overall Study|Death|1|||
105616681|NCT03452579|364262218|FG000|Overall Study|Withdrawal by Subject|2|||
105616682|NCT03452579|364262219|FG001|Overall Study|Withdrawal by Subject|0|||
105616683|NCT03452579|364262218|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
105616684|NCT03452579|364262219|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
105616685|NCT03452579|364262218|FG000|Overall Study|Physician Decision|1|||
105616686|NCT03452579|364262219|FG001|Overall Study|Physician Decision|1|||
105616687|NCT03452579|364262218|FG000|Overall Study|Adverse Event|1|||
105616688|NCT03452579|364262219|FG001|Overall Study|Adverse Event|4|||
105616689|NCT04858321|364262220|FG000|Overall Study|Withdrawal by Subject|3|||
105616690|NCT01539083|364262221|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
105616691|NCT01539083|364262222|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
105616692|NCT01539083|364262223|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
105616693|NCT01539083|364262221|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
105616694|NCT01539083|364262222|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
105616695|NCT01539083|364262223|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
105616696|NCT01539083|364262221|FG000|Before Randomization (VCD Induction)|Death|6|||
105616697|NCT01539083|364262222|FG001|Before Randomization (VCD Induction)|Death|0|||
105616698|NCT01539083|364262223|FG002|Before Randomization (VCD Induction)|Death|0|||
105616699|NCT01539083|364262221|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
105616700|NCT01539083|364262222|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
105616701|NCT01539083|364262223|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
105616702|NCT01539083|364262221|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
105616703|NCT01539083|364262222|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
105616704|NCT01539083|364262223|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
105616705|NCT01539083|364262221|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
105616706|NCT01539083|364262222|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
105616707|NCT01539083|364262223|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
105616708|NCT01539083|364262221|FG000|Before Randomization (VCD Induction)|Other|5|||
105616709|NCT01539083|364262222|FG001|Before Randomization (VCD Induction)|Other|0|||
105616710|NCT01539083|364262223|FG002|Before Randomization (VCD Induction)|Other|0|||
105616711|NCT01539083|364262221|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
105616712|NCT01539083|364262222|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
105616713|NCT01539083|364262223|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
105616714|NCT01539083|364262221|FG000|After Randomization (TP and VTP)|Other|0|||
105616715|NCT01539083|364262222|FG001|After Randomization (TP and VTP)|Other|1|||
105616716|NCT01539083|364262223|FG002|After Randomization (TP and VTP)|Other|1|||
105616717|NCT01539083|364262221|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
105616718|NCT01539083|364262222|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
105616719|NCT01539083|364262223|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
105616720|NCT01539083|364262221|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
105616721|NCT01539083|364262222|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
105616722|NCT01539083|364262223|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
105616723|NCT01539083|364262221|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
105616724|NCT01539083|364262222|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
105616725|NCT01539083|364262223|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
105616726|NCT01539083|364262221|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
105616727|NCT01539083|364262222|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
105616728|NCT01539083|364262223|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
105616729|NCT01539083|364262221|FG000|After Randomization (TP and VTP)|Death|0|||
105616730|NCT01539083|364262222|FG001|After Randomization (TP and VTP)|Death|6|||
105616731|NCT01539083|364262223|FG002|After Randomization (TP and VTP)|Death|11|||
105616732|NCT04350463|364262236|FG000|Overall Study|Other reason|0|||
105616733|NCT04350463|364262237|FG001|Overall Study|Other reason|0|||
105616734|NCT04350463|364262238|FG002|Overall Study|Other reason|0|||
105616735|NCT04350463|364262239|FG003|Overall Study|Other reason|1|||
105616736|NCT04350463|364262236|FG000|Overall Study|Lost to Follow-up|0|||
105616737|NCT04350463|364262237|FG001|Overall Study|Lost to Follow-up|0|||
105616738|NCT04350463|364262238|FG002|Overall Study|Lost to Follow-up|0|||
105616739|NCT04350463|364262239|FG003|Overall Study|Lost to Follow-up|2|||
105616740|NCT04350463|364262236|FG000|Overall Study|Withdrawal by Subject|4|||
105616741|NCT04350463|364262237|FG001|Overall Study|Withdrawal by Subject|0|||
105616742|NCT04350463|364262238|FG002|Overall Study|Withdrawal by Subject|1|||
105616743|NCT04350463|364262239|FG003|Overall Study|Withdrawal by Subject|4|||
105616744|NCT04350463|364262236|FG000|Overall Study|Adverse Event|0|||
105616745|NCT04350463|364262237|FG001|Overall Study|Adverse Event|0|||
105616746|NCT04350463|364262238|FG002|Overall Study|Adverse Event|0|||
105616747|NCT04350463|364262239|FG003|Overall Study|Adverse Event|2|||
105616748|NCT04350463|364262236|FG000|Overall Study|Death|27|||
105616749|NCT04350463|364262237|FG001|Overall Study|Death|2|||
105616750|NCT04350463|364262238|FG002|Overall Study|Death|13|||
105616751|NCT04350463|364262239|FG003|Overall Study|Death|26|||
105616752|NCT04187833|364262240|FG000|Overall Study|Withdrawal by Subject|1|||
105616753|NCT02268253|364262241|FG000|Stage 1|Withdrawal by Subject|1|||
105616754|NCT02268253|364262242|FG001|Stage 1|Withdrawal by Subject|0|||
105616755|NCT02268253|364262243|FG002|Stage 1|Withdrawal by Subject|0|||
105616756|NCT02268253|364262244|FG003|Stage 1|Withdrawal by Subject|0|||
105616757|NCT02268253|364262245|FG004|Stage 1|Withdrawal by Subject|0|||
105616758|NCT02268253|364262246|FG005|Stage 1|Withdrawal by Subject|0|||
105616759|NCT02268253|364262247|FG006|Stage 1|Withdrawal by Subject|0|||
105616760|NCT02268253|364262241|FG000|Stage 1|Death|0|||
105616761|NCT02268253|364262242|FG001|Stage 1|Death|2|||
105616762|NCT02268253|364262243|FG002|Stage 1|Death|2|||
105616763|NCT02268253|364262244|FG003|Stage 1|Death|2|||
105616764|NCT02268253|364262245|FG004|Stage 1|Death|1|||
105616765|NCT02268253|364262246|FG005|Stage 1|Death|1|||
105616766|NCT02268253|364262247|FG006|Stage 1|Death|0|||
105616767|NCT02268253|364262241|FG000|Stage 2|Disease Recurrence/ Progression|0|||
105616768|NCT02268253|364262242|FG001|Stage 2|Disease Recurrence/ Progression|0|||
105616769|NCT02268253|364262243|FG002|Stage 2|Disease Recurrence/ Progression|1|||
105616770|NCT02268253|364262244|FG003|Stage 2|Disease Recurrence/ Progression|0|||
105616771|NCT02268253|364262245|FG004|Stage 2|Disease Recurrence/ Progression|0|||
105616772|NCT02268253|364262246|FG005|Stage 2|Disease Recurrence/ Progression|0|||
105616773|NCT02268253|364262247|FG006|Stage 2|Disease Recurrence/ Progression|0|||
105616774|NCT02268253|364262241|FG000|Stage 2|Withdrawal by Subject|0|||
105616775|NCT02268253|364262242|FG001|Stage 2|Withdrawal by Subject|0|||
105616776|NCT02268253|364262243|FG002|Stage 2|Withdrawal by Subject|2|||
105616777|NCT02268253|364262244|FG003|Stage 2|Withdrawal by Subject|0|||
105616778|NCT02268253|364262245|FG004|Stage 2|Withdrawal by Subject|0|||
105616779|NCT02268253|364262246|FG005|Stage 2|Withdrawal by Subject|2|||
105616780|NCT02268253|364262247|FG006|Stage 2|Withdrawal by Subject|0|||
105616781|NCT02268253|364262241|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
105616782|NCT02268253|364262242|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
105616783|NCT02268253|364262243|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
105616784|NCT02268253|364262244|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
105616785|NCT02268253|364262245|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
105616786|NCT02268253|364262246|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
105616787|NCT02268253|364262247|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
105616788|NCT02268253|364262241|FG000|Stage 2|Death|0|||
105616789|NCT02268253|364262242|FG001|Stage 2|Death|0|||
105616790|NCT02268253|364262243|FG002|Stage 2|Death|19|||
105616791|NCT02268253|364262244|FG003|Stage 2|Death|0|||
105616792|NCT02268253|364262245|FG004|Stage 2|Death|0|||
105616793|NCT02268253|364262246|FG005|Stage 2|Death|20|||
105616794|NCT02268253|364262247|FG006|Stage 2|Death|1|||
105616795|NCT02268253|364262241|FG000|Stage 2|Lost to Follow-up|0|||
105616796|NCT02268253|364262242|FG001|Stage 2|Lost to Follow-up|0|||
105616797|NCT02268253|364262243|FG002|Stage 2|Lost to Follow-up|0|||
105616798|NCT02268253|364262244|FG003|Stage 2|Lost to Follow-up|0|||
105616799|NCT02268253|364262245|FG004|Stage 2|Lost to Follow-up|0|||
105616800|NCT02268253|364262246|FG005|Stage 2|Lost to Follow-up|4|||
105616801|NCT02268253|364262247|FG006|Stage 2|Lost to Follow-up|0|||
105616802|NCT02268253|364262241|FG000|Stage 2|Transferred to Hospice|0|||
105616803|NCT02268253|364262242|FG001|Stage 2|Transferred to Hospice|0|||
105616804|NCT02268253|364262243|FG002|Stage 2|Transferred to Hospice|0|||
105616805|NCT02268253|364262244|FG003|Stage 2|Transferred to Hospice|0|||
105616806|NCT02268253|364262245|FG004|Stage 2|Transferred to Hospice|0|||
105616807|NCT02268253|364262246|FG005|Stage 2|Transferred to Hospice|2|||
105616808|NCT02268253|364262247|FG006|Stage 2|Transferred to Hospice|0|||
105616809|NCT02268253|364262241|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
105616810|NCT02268253|364262242|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
105616811|NCT02268253|364262243|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
105616812|NCT02268253|364262244|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
105616813|NCT02268253|364262245|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
105616814|NCT02268253|364262246|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
105616815|NCT02268253|364262247|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
105616816|NCT02268253|364262241|FG000|Stage 3A|Withdrawal by Subject|0|||
105616817|NCT02268253|364262242|FG001|Stage 3A|Withdrawal by Subject|0|||
105616818|NCT02268253|364262243|FG002|Stage 3A|Withdrawal by Subject|2|||
105616819|NCT02268253|364262244|FG003|Stage 3A|Withdrawal by Subject|0|||
105616820|NCT02268253|364262245|FG004|Stage 3A|Withdrawal by Subject|0|||
105616821|NCT02268253|364262246|FG005|Stage 3A|Withdrawal by Subject|0|||
105616822|NCT02268253|364262247|FG006|Stage 3A|Withdrawal by Subject|0|||
105616823|NCT02268253|364262241|FG000|Stage 3A|Physician Decision|0|||
105616824|NCT02268253|364262242|FG001|Stage 3A|Physician Decision|0|||
105616825|NCT02268253|364262243|FG002|Stage 3A|Physician Decision|2|||
105616826|NCT02268253|364262244|FG003|Stage 3A|Physician Decision|0|||
105616827|NCT02268253|364262245|FG004|Stage 3A|Physician Decision|0|||
105616828|NCT02268253|364262246|FG005|Stage 3A|Physician Decision|0|||
105616829|NCT02268253|364262247|FG006|Stage 3A|Physician Decision|0|||
105616830|NCT02268253|364262241|FG000|Stage 3A|Study Terminated by Sponsor|0|||
105616831|NCT02268253|364262242|FG001|Stage 3A|Study Terminated by Sponsor|0|||
105616832|NCT02268253|364262243|FG002|Stage 3A|Study Terminated by Sponsor|2|||
105616833|NCT02268253|364262244|FG003|Stage 3A|Study Terminated by Sponsor|0|||
105616834|NCT02268253|364262245|FG004|Stage 3A|Study Terminated by Sponsor|0|||
105616835|NCT02268253|364262246|FG005|Stage 3A|Study Terminated by Sponsor|0|||
105616836|NCT02268253|364262247|FG006|Stage 3A|Study Terminated by Sponsor|0|||
105616837|NCT02268253|364262241|FG000|Stage 3A|Lost to Follow-up|0|||
105616838|NCT02268253|364262242|FG001|Stage 3A|Lost to Follow-up|0|||
105616839|NCT02268253|364262243|FG002|Stage 3A|Lost to Follow-up|1|||
105616840|NCT02268253|364262244|FG003|Stage 3A|Lost to Follow-up|0|||
105616841|NCT02268253|364262245|FG004|Stage 3A|Lost to Follow-up|0|||
105616842|NCT02268253|364262246|FG005|Stage 3A|Lost to Follow-up|0|||
105616843|NCT02268253|364262247|FG006|Stage 3A|Lost to Follow-up|0|||
105616844|NCT02268253|364262241|FG000|Stage 3A|Death|0|||
105616845|NCT02268253|364262242|FG001|Stage 3A|Death|0|||
105616846|NCT02268253|364262243|FG002|Stage 3A|Death|5|||
105616847|NCT02268253|364262244|FG003|Stage 3A|Death|0|||
105616848|NCT02268253|364262245|FG004|Stage 3A|Death|0|||
105616849|NCT02268253|364262246|FG005|Stage 3A|Death|0|||
105616850|NCT02268253|364262247|FG006|Stage 3A|Death|0|||
105616851|NCT05714761|364262248|FG000|Overall Study|Lost to Follow-up|3|||
105616852|NCT05714761|364262248|FG000|Overall Study|Withdrawal by Subject|3|||
105616853|NCT05714761|364262248|FG000|Overall Study|unblinding of sensor data|1|||
105616854|NCT05714761|364262248|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
105616855|NCT05714761|364262248|FG000|Overall Study|did not return second CGM sensor|4|||
105616856|NCT06037369|364262251|FG000|Overall Study|Lost to Follow-up|0|||
105616857|NCT06037369|364262252|FG001|Overall Study|Lost to Follow-up|1|||
105616858|NCT05603143|364262253|FG000|Overall Study|Withdrew consent|6|||
105616859|NCT05603143|364262254|FG001|Overall Study|Withdrew consent|2|||
105616860|NCT05603143|364262253|FG000|Overall Study|Randomized but never treated|0|||
105616861|NCT05603143|364262254|FG001|Overall Study|Randomized but never treated|3|||
105616862|NCT05603143|364262253|FG000|Overall Study|Adverse Event|2|||
105616863|NCT05603143|364262254|FG001|Overall Study|Adverse Event|0|||
105616864|NCT05603143|364262253|FG000|Overall Study|Death|0|||
105616865|NCT05603143|364262254|FG001|Overall Study|Death|1|||
105616866|NCT05603143|364262253|FG000|Overall Study|Investigator's discretion|1|||
105616867|NCT05603143|364262254|FG001|Overall Study|Investigator's discretion|0|||
105616868|NCT05603143|364262253|FG000|Overall Study|Lost to Follow-up|0|||
105616869|NCT05603143|364262254|FG001|Overall Study|Lost to Follow-up|1|||
105616870|NCT05603143|364262253|FG000|Overall Study|Protocol Violation|0|||
105616871|NCT05603143|364262254|FG001|Overall Study|Protocol Violation|1|||
105616872|NCT03097549|364262255|FG000|Overall Study|Withdrawal by Subject|1|||
105616873|NCT03097549|364262256|FG001|Overall Study|Withdrawal by Subject|0|||
105616874|NCT03097549|364262255|FG000|Overall Study|Lost to Follow-up|1|||
105616875|NCT03097549|364262256|FG001|Overall Study|Lost to Follow-up|0|||
105616876|NCT05647304|364262257|FG000|Overall Study|Withdrawal by Subject|1|||
105616877|NCT05647304|364262258|FG001|Overall Study|Withdrawal by Subject|0|||
105616878|NCT04505904|364262259|FG000|Overall Study|Withdrawal by Subject|1|||
105616879|NCT04505904|364262260|FG001|Overall Study|Withdrawal by Subject|2|||
105616880|NCT04505904|364262261|FG002|Overall Study|Withdrawal by Subject|0|||
105616881|NCT04505904|364262262|FG003|Overall Study|Withdrawal by Subject|0|||
105616882|NCT04505904|364262259|FG000|Overall Study|Physician Decision|1|||
105616883|NCT04505904|364262260|FG001|Overall Study|Physician Decision|0|||
105616884|NCT04505904|364262261|FG002|Overall Study|Physician Decision|0|||
105616885|NCT04505904|364262262|FG003|Overall Study|Physician Decision|0|||
105616886|NCT04505904|364262259|FG000|Overall Study|Adverse Event|0|||
105616887|NCT04505904|364262260|FG001|Overall Study|Adverse Event|1|||
105616888|NCT04505904|364262261|FG002|Overall Study|Adverse Event|0|||
105616889|NCT04505904|364262262|FG003|Overall Study|Adverse Event|0|||
105616890|NCT02547233|364262265|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
105616891|NCT02547233|364262266|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
105616892|NCT02547233|364262265|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
105616893|NCT02547233|364262266|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
105616894|NCT02547233|364262265|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
105616895|NCT02547233|364262266|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
105616896|NCT02547233|364262265|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
105616897|NCT02547233|364262266|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
105616898|NCT02547233|364262265|FG000|12-month Follow-up|Withdrawal by Subject|10|||
105616899|NCT02547233|364262266|FG001|12-month Follow-up|Withdrawal by Subject|10|||
105616900|NCT02547233|364262265|FG000|12-month Follow-up|Lost to Follow-up|3|||
105616901|NCT02547233|364262266|FG001|12-month Follow-up|Lost to Follow-up|3|||
105616902|NCT02547233|364262265|FG000|12-month Follow-up|Lack of Efficacy|1|||
105616903|NCT02547233|364262266|FG001|12-month Follow-up|Lack of Efficacy|2|||
105616904|NCT02547233|364262265|FG000|12-month Follow-up|Protocol Violation|0|||
105616905|NCT02547233|364262266|FG001|12-month Follow-up|Protocol Violation|1|||
105616906|NCT02547233|364262265|FG000|12-month Follow-up|Other|0|||
105616907|NCT02547233|364262266|FG001|12-month Follow-up|Other|1|||
105616908|NCT06019559|364262267|FG000|Overall Study|Withdrawal by Subject|7|||
105616909|NCT06019559|364262268|FG001|Overall Study|Withdrawal by Subject|6|||
105616910|NCT06019559|364262269|FG002|Overall Study|Withdrawal by Subject|5|||
105616911|NCT06019559|364262267|FG000|Overall Study|Lost to Follow-up|2|||
105616912|NCT06019559|364262268|FG001|Overall Study|Lost to Follow-up|0|||
105616913|NCT06019559|364262269|FG002|Overall Study|Lost to Follow-up|3|||
105616914|NCT01824537|364262270|FG000|Overall Study|Lost to Follow-up|78|||
105616915|NCT01824537|364262271|FG001|Overall Study|Lost to Follow-up|87|||
105616916|NCT02547987|364262272|FG000|Overall Study|Withdrawal by Subject|1|||
105616917|NCT02547987|364262272|FG000|Overall Study|Adverse Event|2|||
105616918|NCT04282148|364262273|FG000|Overall Study|Death|7|||
105616919|NCT04282148|364262273|FG000|Overall Study|Withdrawal by Subject|1|||
105616920|NCT04282148|364262273|FG000|Overall Study|Physician Decision|1|||
105616921|NCT02146378|364262274|FG000|Overall Study|No information of administration|2|||
105616922|NCT06181760|364262277|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
105616923|NCT06181760|364262278|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
105616924|NCT06181760|364262279|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
105616925|NCT06181760|364262280|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
105616926|NCT04770532|364262281|FG000|Overall Study|Withdrawal by Subject|0|||
105616927|NCT04770532|364262282|FG001|Overall Study|Withdrawal by Subject|3|||
105616928|NCT04770532|364262281|FG000|Overall Study|Physician Decision|1|||
105616929|NCT04770532|364262282|FG001|Overall Study|Physician Decision|0|||
105616930|NCT04770532|364262281|FG000|Overall Study|Death|2|||
105616931|NCT04770532|364262282|FG001|Overall Study|Death|2|||
105616932|NCT04623671|364262284|FG000|Overall Study|Adverse Event|0|||
105616933|NCT04623671|364262285|FG001|Overall Study|Adverse Event|1|||
105616934|NCT04623671|364262284|FG000|Overall Study|Lost to Follow-up|2|||
105616935|NCT04623671|364262285|FG001|Overall Study|Lost to Follow-up|1|||
105616936|NCT04623671|364262284|FG000|Overall Study|Death|5|||
105616937|NCT04623671|364262285|FG001|Overall Study|Death|5|||
105616938|NCT04663737|364262286|FG000|Overall Study|Withdrawal by Subject|2|||
105616939|NCT04663737|364262287|FG001|Overall Study|Withdrawal by Subject|0|||
105616940|NCT04016662|364262288|FG000|Run-In Phase|Death|1|||
105616941|NCT04016662|364262288|FG000|Run-In Phase|Withdrawal by Subject|11|||
105616942|NCT04016662|364262288|FG000|Run-In Phase|Not meeting screening eligibility|9|||
105616943|NCT04016662|364262288|FG000|Run-In Phase|Physician Decision|3|||
105616944|NCT04016662|364262288|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
105616945|NCT04016662|364262288|FG000|PLGS (12 Weeks)|Death|1|||
105616946|NCT04016662|364262288|FG000|SAP (12 Weeks)|Death|1|||
105616947|NCT04542317|364262292|FG000|Overall Study|Care recipients passed away|18|||
105616948|NCT04542317|364262293|FG001|Overall Study|Care recipients passed away|13|||
105616949|NCT04542317|364262292|FG000|Overall Study|No longer a primary caregiver|5|||
105616950|NCT04542317|364262293|FG001|Overall Study|No longer a primary caregiver|1|||
105616951|NCT04542317|364262292|FG000|Overall Study|Withdrawal by Subject|4|||
105616952|NCT04542317|364262293|FG001|Overall Study|Withdrawal by Subject|2|||
105616953|NCT04542317|364262292|FG000|Overall Study|Caregivers passed away|0|||
105616954|NCT04542317|364262293|FG001|Overall Study|Caregivers passed away|2|||
105616955|NCT03976362|364262296|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
105616956|NCT03976362|364262297|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
105616957|NCT03976362|364262298|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
105616958|NCT03976362|364262296|FG000|Induction Phase|Death|62|||
105616959|NCT03976362|364262297|FG001|Induction Phase|Death|0|||
105616960|NCT03976362|364262298|FG002|Induction Phase|Death|0|||
105616961|NCT03976362|364262296|FG000|Maintenance Phase|Participants Ongoing|0|||
105616962|NCT03976362|364262297|FG001|Maintenance Phase|Participants Ongoing|106|||
105616963|NCT03976362|364262298|FG002|Maintenance Phase|Participants Ongoing|103|||
105616964|NCT03976362|364262296|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105616965|NCT03976362|364262297|FG001|Maintenance Phase|Withdrawal by Subject|4|||
105616966|NCT03976362|364262298|FG002|Maintenance Phase|Withdrawal by Subject|4|||
105616967|NCT03976362|364262296|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
105616968|NCT03976362|364262297|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
105616969|NCT03976362|364262298|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
105616970|NCT03976362|364262296|FG000|Maintenance Phase|Death|0|||
105616971|NCT03976362|364262297|FG001|Maintenance Phase|Death|186|||
105616972|NCT03976362|364262298|FG002|Maintenance Phase|Death|187|||
105616973|NCT00613106|364262299|FG000|Overall Study|Adverse Event|3|||
105616974|NCT00613106|364262300|FG001|Overall Study|Adverse Event|1|||
105616975|NCT00613106|364262299|FG000|Overall Study|Withdrawal by Subject|6|||
105616976|NCT00613106|364262300|FG001|Overall Study|Withdrawal by Subject|3|||
105616977|NCT00613106|364262299|FG000|Overall Study|Lost to Follow-up|7|||
105616978|NCT00613106|364262300|FG001|Overall Study|Lost to Follow-up|2|||
105616979|NCT00613106|364262299|FG000|Overall Study|misc|4|||
105616980|NCT00613106|364262300|FG001|Overall Study|misc|3|||
105616981|NCT05126433|364262305|FG000|Overall Study|Withdrawal by Subject|3|||
105616982|NCT05126433|364262306|FG001|Overall Study|Withdrawal by Subject|0|||
105616983|NCT05126433|364262307|FG002|Overall Study|Withdrawal by Subject|4|||
105616984|NCT05126433|364262305|FG000|Overall Study|Death|9|||
105616985|NCT05126433|364262306|FG001|Overall Study|Death|3|||
105616986|NCT05126433|364262307|FG002|Overall Study|Death|5|||
105616987|NCT05126433|364262305|FG000|Overall Study|Study Terminated by sponsor|0|||
105616988|NCT05126433|364262306|FG001|Overall Study|Study Terminated by sponsor|1|||
105616989|NCT05126433|364262307|FG002|Overall Study|Study Terminated by sponsor|2|||
105616990|NCT05126433|364262305|FG000|Overall Study|Progressive Disease|1|||
105616991|NCT05126433|364262306|FG001|Overall Study|Progressive Disease|4|||
105616992|NCT05126433|364262307|FG002|Overall Study|Progressive Disease|3|||
105616993|NCT05126433|364262305|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
105616994|NCT05126433|364262306|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
105616995|NCT05126433|364262307|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
105616996|NCT03907878|364262308|FG000|Treatment Period|Withdrawal by Subject|5|||
105616997|NCT03907878|364262308|FG000|Treatment Period|Adverse Event|4|||
105616998|NCT03907878|364262308|FG000|Treatment Period|Lack of Efficacy|1|||
105616999|NCT03907878|364262308|FG000|Treatment Period|Protocol Violation|1|||
105617000|NCT03907878|364262308|FG000|Follow-up Period|Adverse Event|3|||
105617001|NCT03907878|364262308|FG000|Follow-up Period|Withdrawal by Subject|3|||
105617002|NCT00777036|364262310|FG000|On Treatment|Reason Not Specified|4|||
105617003|NCT00777036|364262311|FG001|On Treatment|Reason Not Specified|7|||
105617004|NCT00777036|364262312|FG002|On Treatment|Reason Not Specified|12|||
105617005|NCT00777036|364262310|FG000|On Treatment|Failure to Meet Study Criteria|0|||
105617006|NCT00777036|364262311|FG001|On Treatment|Failure to Meet Study Criteria|1|||
105617007|NCT00777036|364262312|FG002|On Treatment|Failure to Meet Study Criteria|0|||
105617008|NCT00777036|364262310|FG000|On Treatment|Non-compliance with Study Drug|1|||
105617009|NCT00777036|364262311|FG001|On Treatment|Non-compliance with Study Drug|0|||
105617010|NCT00777036|364262312|FG002|On Treatment|Non-compliance with Study Drug|0|||
105617011|NCT00777036|364262310|FG000|On Treatment|Maximum Clinical Benefit|2|||
105617012|NCT00777036|364262311|FG001|On Treatment|Maximum Clinical Benefit|0|||
105617013|NCT00777036|364262312|FG002|On Treatment|Maximum Clinical Benefit|1|||
105617014|NCT00777036|364262310|FG000|On Treatment|Withdrawal by Subject|3|||
105617015|NCT00777036|364262311|FG001|On Treatment|Withdrawal by Subject|2|||
105617016|NCT00777036|364262312|FG002|On Treatment|Withdrawal by Subject|3|||
105617017|NCT00777036|364262310|FG000|On Treatment|Death|0|||
105617018|NCT00777036|364262311|FG001|On Treatment|Death|2|||
105617019|NCT00777036|364262312|FG002|On Treatment|Death|0|||
105617020|NCT00777036|364262310|FG000|On Treatment|Study Drug Toxicity|0|||
105617021|NCT00777036|364262311|FG001|On Treatment|Study Drug Toxicity|0|||
105617022|NCT00777036|364262312|FG002|On Treatment|Study Drug Toxicity|1|||
105617023|NCT00777036|364262310|FG000|On Treatment|Progressive Disease|5|||
105617024|NCT00777036|364262311|FG001|On Treatment|Progressive Disease|4|||
105617025|NCT00777036|364262312|FG002|On Treatment|Progressive Disease|6|||
105617026|NCT00777036|364262310|FG000|Follow-Up|Lost to Follow-up|1|||
105617027|NCT00777036|364262311|FG001|Follow-Up|Lost to Follow-up|0|||
105617028|NCT00777036|364262312|FG002|Follow-Up|Lost to Follow-up|0|||
105617029|NCT00777036|364262310|FG000|Follow-Up|Reason Not Specified|2|||
105617030|NCT00777036|364262311|FG001|Follow-Up|Reason Not Specified|0|||
105617031|NCT00777036|364262312|FG002|Follow-Up|Reason Not Specified|0|||
105617032|NCT00777036|364262310|FG000|Follow-Up|Withdrawal by Subject|1|||
105617033|NCT00777036|364262311|FG001|Follow-Up|Withdrawal by Subject|0|||
105617034|NCT00777036|364262312|FG002|Follow-Up|Withdrawal by Subject|4|||
105617035|NCT00777036|364262310|FG000|Follow-Up|Death|1|||
105617036|NCT00777036|364262311|FG001|Follow-Up|Death|8|||
105617037|NCT00777036|364262312|FG002|Follow-Up|Death|0|||
105617038|NCT00324805|364262313|FG000|Overall Study|Adverse Event|62|||
105617039|NCT00324805|364262314|FG001|Overall Study|Adverse Event|203|||
105617040|NCT00324805|364262313|FG000|Overall Study|Progression|7|||
105617041|NCT00324805|364262314|FG001|Overall Study|Progression|35|||
105617042|NCT00324805|364262313|FG000|Overall Study|Withdrawal by Subject|51|||
105617043|NCT00324805|364262314|FG001|Overall Study|Withdrawal by Subject|174|||
105617044|NCT00324805|364262313|FG000|Overall Study|Death|6|||
105617045|NCT00324805|364262314|FG001|Overall Study|Death|9|||
105617046|NCT00324805|364262313|FG000|Overall Study|Alternative therapy|4|||
105617047|NCT00324805|364262314|FG001|Overall Study|Alternative therapy|8|||
105617048|NCT00324805|364262313|FG000|Overall Study|Other complicating disease|1|||
105617049|NCT00324805|364262314|FG001|Overall Study|Other complicating disease|9|||
105617050|NCT00324805|364262313|FG000|Overall Study|Other reasons|7|||
105617051|NCT00324805|364262314|FG001|Overall Study|Other reasons|26|||
105617052|NCT00324805|364262313|FG000|Overall Study|Other|0|||
105617053|NCT00324805|364262314|FG001|Overall Study|Other|2|||
105617054|NCT00324805|364262313|FG000|Overall Study|Did not start therapy|12|||
105617055|NCT00324805|364262314|FG001|Overall Study|Did not start therapy|17|||
105617056|NCT03852472|364262315|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
105617057|NCT03852472|364262316|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
105617058|NCT03852472|364262317|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
105617059|NCT03852472|364262318|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
105617060|NCT03852472|364262319|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
105617061|NCT03852472|364262315|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
105617062|NCT03852472|364262316|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
105617063|NCT03852472|364262317|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
105617064|NCT03852472|364262318|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
105617065|NCT03852472|364262319|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
105617066|NCT03852472|364262315|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
105617067|NCT03852472|364262316|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
105617068|NCT03852472|364262317|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
105617069|NCT03852472|364262318|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
105617070|NCT03852472|364262319|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
105617071|NCT03852472|364262315|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
105617072|NCT03852472|364262316|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
105617073|NCT03852472|364262317|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
105617074|NCT03852472|364262318|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
105617075|NCT03852472|364262319|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
105617076|NCT03852472|364262315|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
105617077|NCT03852472|364262316|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
105617078|NCT03852472|364262317|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
105617079|NCT03852472|364262318|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
105617080|NCT03852472|364262319|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
105617081|NCT03852472|364262315|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
105617082|NCT03852472|364262316|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
105617083|NCT03852472|364262317|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
105617084|NCT03852472|364262318|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
105617085|NCT03852472|364262319|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
105617086|NCT03852472|364262315|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
105617087|NCT03852472|364262316|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
105617088|NCT03852472|364262317|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
105617089|NCT03852472|364262318|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
105617090|NCT03852472|364262319|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
105617091|NCT03852472|364262315|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
105617092|NCT03852472|364262316|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
105617093|NCT03852472|364262317|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
105617094|NCT03852472|364262318|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
105617095|NCT03852472|364262319|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
105617096|NCT03852472|364262315|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
105617097|NCT03852472|364262316|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
105617098|NCT03852472|364262317|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
105617099|NCT03852472|364262318|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
105617100|NCT03852472|364262319|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
105617101|NCT03852472|364262315|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
105617102|NCT03852472|364262316|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
105617103|NCT03852472|364262317|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
105617104|NCT03852472|364262318|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
105617105|NCT03852472|364262319|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
105617106|NCT03852472|364262315|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
105617107|NCT03852472|364262316|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
105617108|NCT03852472|364262317|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
105617109|NCT03852472|364262318|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
105617110|NCT03852472|364262319|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
105617111|NCT03852472|364262315|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
105617112|NCT03852472|364262316|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
105617113|NCT03852472|364262317|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
105617114|NCT03852472|364262318|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
105617115|NCT03852472|364262319|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
105617116|NCT03852472|364262315|FG000|Period 2 - Week 44|Adverse Event|0|||
105617117|NCT03852472|364262316|FG001|Period 2 - Week 44|Adverse Event|3|||
105617118|NCT03852472|364262317|FG002|Period 2 - Week 44|Adverse Event|1|||
105617119|NCT03852472|364262318|FG003|Period 2 - Week 44|Adverse Event|2|||
105617120|NCT03852472|364262319|FG004|Period 2 - Week 44|Adverse Event|2|||
105617121|NCT03852472|364262315|FG000|Period 2 - Week 44|COVID-19 Related|0|||
105617122|NCT03852472|364262316|FG001|Period 2 - Week 44|COVID-19 Related|0|||
105617123|NCT03852472|364262317|FG002|Period 2 - Week 44|COVID-19 Related|0|||
105617124|NCT03852472|364262318|FG003|Period 2 - Week 44|COVID-19 Related|1|||
105617125|NCT03852472|364262319|FG004|Period 2 - Week 44|COVID-19 Related|0|||
105617126|NCT03852472|364262315|FG000|Period 2 - Week 44|Reason not stated|0|||
105617127|NCT03852472|364262316|FG001|Period 2 - Week 44|Reason not stated|0|||
105617128|NCT03852472|364262317|FG002|Period 2 - Week 44|Reason not stated|0|||
105617129|NCT03852472|364262318|FG003|Period 2 - Week 44|Reason not stated|0|||
105617130|NCT03852472|364262319|FG004|Period 2 - Week 44|Reason not stated|1|||
105617131|NCT04880863|364262320|FG000|Overall Study|Adverse Event|1|||
105617132|NCT04880863|364262320|FG000|Overall Study|Patient decision|2|||
105617133|NCT04880863|364262320|FG000|Overall Study|Confirmed Disease Progression|15|||
105617134|NCT04880863|364262320|FG000|Overall Study|Death|3|||
105617135|NCT04880863|364262320|FG000|Overall Study|Physician Decision|4|||
105617136|NCT04880863|364262320|FG000|Overall Study|Unconfirmed Disease Progression|4|||
105617137|NCT04880863|364262320|FG000|Overall Study|Withdrawal by Subject|2|||
105617138|NCT04880863|364262320|FG000|Overall Study|Study discontinuation by the sponsor|4|||
105617139|NCT04880863|364262320|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
105617140|NCT04880863|364262320|FG000|Overall Study|Not received study drug NAP|2|||
105617141|NCT00554788|364264320|FG000|Overall Study|Adverse Event|0|||
105617142|NCT00554788|364264321|FG001|Overall Study|Adverse Event|1|||
105617143|NCT00554788|364264322|FG002|Overall Study|Adverse Event|2|||
105617144|NCT00554788|364264320|FG000|Overall Study|Lost to Follow-up|4|||
105617145|NCT00554788|364264321|FG001|Overall Study|Lost to Follow-up|3|||
105617146|NCT00554788|364264322|FG002|Overall Study|Lost to Follow-up|3|||
105617147|NCT00554788|364264320|FG000|Overall Study|Physician Decision|1|||
105617148|NCT00554788|364264321|FG001|Overall Study|Physician Decision|1|||
105617149|NCT00554788|364264322|FG002|Overall Study|Physician Decision|3|||
105617150|NCT00554788|364264320|FG000|Overall Study|Withdrawal by Subject|0|||
105617151|NCT00554788|364264321|FG001|Overall Study|Withdrawal by Subject|0|||
105617152|NCT00554788|364264322|FG002|Overall Study|Withdrawal by Subject|1|||
105617153|NCT00554788|364264320|FG000|Overall Study|Refusal of further protocol therapy|0|||
105617154|NCT00554788|364264321|FG001|Overall Study|Refusal of further protocol therapy|1|||
105617155|NCT00554788|364264322|FG002|Overall Study|Refusal of further protocol therapy|1|||
105617156|NCT00554788|364264320|FG000|Overall Study|Progressive disease|0|||
105617157|NCT00554788|364264321|FG001|Overall Study|Progressive disease|0|||
105617158|NCT00554788|364264322|FG002|Overall Study|Progressive disease|3|||
105617159|NCT00554788|364264320|FG000|Overall Study|Ineligible|2|||
105617160|NCT00554788|364264321|FG001|Overall Study|Ineligible|0|||
105617161|NCT00554788|364264322|FG002|Overall Study|Ineligible|1|||
105617162|NCT04963270|364264324|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
105617163|NCT04963270|364264325|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
105617164|NCT04963270|364264326|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
105617165|NCT04963270|364264327|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
105617166|NCT04963270|364264324|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
105617167|NCT04963270|364264325|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
105617168|NCT04963270|364264326|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
105617169|NCT04963270|364264327|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
105617170|NCT04963270|364264324|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
105617171|NCT04963270|364264325|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
105617172|NCT04963270|364264326|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
105617173|NCT04963270|364264327|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
105617174|NCT04963270|364264324|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
105617175|NCT04963270|364264325|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
105617176|NCT04963270|364264326|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
105617177|NCT04963270|364264327|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
105617178|NCT04963270|364264324|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
105617179|NCT04963270|364264325|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
105617180|NCT04963270|364264326|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
105617181|NCT04963270|364264327|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
105617182|NCT04963270|364264324|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
105617183|NCT04963270|364264325|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
105617184|NCT04963270|364264326|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
105617185|NCT04963270|364264327|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
105617186|NCT04963270|364264324|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
105617187|NCT04963270|364264325|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
105617188|NCT04963270|364264326|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
105617189|NCT04963270|364264327|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
105617190|NCT04963270|364264324|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
105617191|NCT04963270|364264325|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
105617192|NCT04963270|364264326|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
105617193|NCT04963270|364264327|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
105617194|NCT04963270|364264324|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
105617195|NCT04963270|364264325|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
105617196|NCT04963270|364264326|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
105617197|NCT04963270|364264327|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
105617198|NCT04963270|364264324|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
105617199|NCT04963270|364264325|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
105617200|NCT04963270|364264326|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
105617201|NCT04963270|364264327|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
105617202|NCT04963270|364264324|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
105617203|NCT04963270|364264325|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
105617204|NCT04963270|364264326|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
105617205|NCT04963270|364264327|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
105617206|NCT04963270|364264324|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
105617207|NCT04963270|364264325|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
105617208|NCT04963270|364264326|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
105617209|NCT04963270|364264327|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
105617210|NCT04963270|364264324|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
105617211|NCT04963270|364264325|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
105617212|NCT04963270|364264326|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
105617213|NCT04963270|364264327|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
105617214|NCT04963270|364264324|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
105617215|NCT04963270|364264325|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
105617216|NCT04963270|364264326|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
105617217|NCT04963270|364264327|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
105617218|NCT01842542|364264328|FG000|Overall Study|Withdrawal by Subject|2|||
105617219|NCT01842542|364264328|FG000|Overall Study|Lack of Efficacy|1|||
105617220|NCT01842542|364264328|FG000|Overall Study|Protocol Non-compliance|2|||
105617221|NCT01842542|364264328|FG000|Overall Study|Lost to Follow-up|1|||
105617222|NCT04908722|364264329|FG000|Overall Study|Protocol deviation|1|||
105617223|NCT04908722|364264330|FG001|Overall Study|Protocol deviation|0|||
105617224|NCT04908722|364264331|FG002|Overall Study|Protocol deviation|0|||
105617225|NCT04908722|364264332|FG003|Overall Study|Protocol deviation|0|||
105617226|NCT04908722|364264333|FG004|Overall Study|Protocol deviation|0|||
105617227|NCT04908722|364264334|FG005|Overall Study|Protocol deviation|1|||
105617228|NCT04908722|364264329|FG000|Overall Study|Lost to Follow-up|33|||
105617229|NCT04908722|364264330|FG001|Overall Study|Lost to Follow-up|33|||
105617230|NCT04908722|364264331|FG002|Overall Study|Lost to Follow-up|36|||
105617231|NCT04908722|364264332|FG003|Overall Study|Lost to Follow-up|30|||
105617232|NCT04908722|364264333|FG004|Overall Study|Lost to Follow-up|32|||
105617233|NCT04908722|364264334|FG005|Overall Study|Lost to Follow-up|34|||
105617234|NCT04908722|364264329|FG000|Overall Study|Physician Decision|1|||
105617235|NCT04908722|364264330|FG001|Overall Study|Physician Decision|1|||
105617236|NCT04908722|364264331|FG002|Overall Study|Physician Decision|1|||
105617237|NCT04908722|364264332|FG003|Overall Study|Physician Decision|2|||
105617238|NCT04908722|364264333|FG004|Overall Study|Physician Decision|0|||
105617239|NCT04908722|364264334|FG005|Overall Study|Physician Decision|0|||
105617240|NCT04908722|364264329|FG000|Overall Study|Death|1|||
105617241|NCT04908722|364264330|FG001|Overall Study|Death|0|||
105617242|NCT04908722|364264331|FG002|Overall Study|Death|0|||
105617243|NCT04908722|364264332|FG003|Overall Study|Death|0|||
105617244|NCT04908722|364264333|FG004|Overall Study|Death|0|||
105617245|NCT04908722|364264334|FG005|Overall Study|Death|1|||
105617246|NCT04908722|364264329|FG000|Overall Study|Withdrawal by Subject|12|||
105617247|NCT04908722|364264330|FG001|Overall Study|Withdrawal by Subject|8|||
105617248|NCT04908722|364264331|FG002|Overall Study|Withdrawal by Subject|7|||
105617249|NCT04908722|364264332|FG003|Overall Study|Withdrawal by Subject|6|||
105617250|NCT04908722|364264333|FG004|Overall Study|Withdrawal by Subject|12|||
105617251|NCT04908722|364264334|FG005|Overall Study|Withdrawal by Subject|14|||
105617252|NCT04908722|364264329|FG000|Overall Study|Other|3|||
105617253|NCT04908722|364264330|FG001|Overall Study|Other|1|||
105617254|NCT04908722|364264331|FG002|Overall Study|Other|3|||
105617255|NCT04908722|364264332|FG003|Overall Study|Other|2|||
105617256|NCT04908722|364264333|FG004|Overall Study|Other|4|||
105617257|NCT04908722|364264334|FG005|Overall Study|Other|1|||
105617258|NCT04908722|364264329|FG000|Overall Study|Initiated prohibited medication|0|||
105617259|NCT04908722|364264330|FG001|Overall Study|Initiated prohibited medication|0|||
105617260|NCT04908722|364264331|FG002|Overall Study|Initiated prohibited medication|0|||
105617261|NCT04908722|364264332|FG003|Overall Study|Initiated prohibited medication|1|||
105617262|NCT04908722|364264333|FG004|Overall Study|Initiated prohibited medication|0|||
105617263|NCT04908722|364264334|FG005|Overall Study|Initiated prohibited medication|1|||
105617264|NCT04908722|364264329|FG000|Overall Study|Randomized but not vaccinated|3|||
105617265|NCT04908722|364264330|FG001|Overall Study|Randomized but not vaccinated|1|||
105617266|NCT04908722|364264331|FG002|Overall Study|Randomized but not vaccinated|2|||
105617267|NCT04908722|364264332|FG003|Overall Study|Randomized but not vaccinated|2|||
105617268|NCT04908722|364264333|FG004|Overall Study|Randomized but not vaccinated|3|||
105617269|NCT04908722|364264334|FG005|Overall Study|Randomized but not vaccinated|4|||
105617270|NCT03339713|364264337|FG000|Overall Study|Lost to Follow-up|2|||
105617271|NCT03339713|364264338|FG001|Overall Study|Lost to Follow-up|1|||
105617272|NCT03339713|364264337|FG000|Overall Study|Protocol Violation|1|||
105617273|NCT03339713|364264338|FG001|Overall Study|Protocol Violation|0|||
105617274|NCT03339713|364264337|FG000|Overall Study|Withdrawal by Subject|1|||
105617275|NCT03339713|364264338|FG001|Overall Study|Withdrawal by Subject|1|||
105617276|NCT02619838|364264341|FG000|Overall Study|Lost to Follow-up|9|||
105617277|NCT02619838|364264341|FG000|Overall Study|Withdrawal by Subject|15|||
105617278|NCT03371381|364264342|FG000|Overall Study|Death|5|||
105617279|NCT03371381|364264342|FG000|Overall Study|Study terminated by sponsor|3|||
105617280|NCT03371381|364264342|FG000|Overall Study|Other|4|||
105617281|NCT02979327|364264343|FG000|First Intervention|Protocol Violation|1|||
105617282|NCT02979327|364264344|FG001|First Intervention|Protocol Violation|0|||
105617283|NCT05020249|364264345|FG000|Overall Study|Protocol Violation|1|||
105617284|NCT05020249|364264346|FG001|Overall Study|Protocol Violation|0|||
105617285|NCT03474679|364264353|FG000|Overall Study|Death|7|||
105617286|NCT03474679|364264353|FG000|Overall Study|Withdrawal by Subject|1|||
105617287|NCT03536754|364264354|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
105617288|NCT03536754|364264355|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
105617289|NCT03536754|364264356|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
105617290|NCT03536754|364264357|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
105617291|NCT03536754|364264358|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
105617292|NCT03536754|364264354|FG000|Open Label Extension|Other|0|||
105617293|NCT03536754|364264355|FG001|Open Label Extension|Other|0|||
105617294|NCT03536754|364264356|FG002|Open Label Extension|Other|0|||
105617295|NCT03536754|364264357|FG003|Open Label Extension|Other|0|||
105617296|NCT03536754|364264358|FG004|Open Label Extension|Other|1|||
105617297|NCT05794243|364264364|FG000|Overall Study|Withdrawal by Subject|1|||
105617298|NCT05794243|364264365|FG001|Overall Study|Withdrawal by Subject|0|||
105617299|NCT05794243|364264366|FG002|Overall Study|Withdrawal by Subject|1|||
105617300|NCT05794243|364264364|FG000|Overall Study|Physician Decision|0|||
105617301|NCT05794243|364264365|FG001|Overall Study|Physician Decision|3|||
105617302|NCT05794243|364264366|FG002|Overall Study|Physician Decision|1|||
105617303|NCT04149704|364264371|FG000|Three Month Follow-up|Death|2|||
105617304|NCT04149704|364264372|FG001|Three Month Follow-up|Death|0|||
105617305|NCT04149704|364264373|FG002|Three Month Follow-up|Death|0|||
105617306|NCT04149704|364264374|FG003|Three Month Follow-up|Death|0|||
105617307|NCT04149704|364264371|FG000|Three Month Follow-up|Lost to Follow-up|1|||
105617308|NCT04149704|364264372|FG001|Three Month Follow-up|Lost to Follow-up|4|||
105617309|NCT04149704|364264373|FG002|Three Month Follow-up|Lost to Follow-up|5|||
105617310|NCT04149704|364264374|FG003|Three Month Follow-up|Lost to Follow-up|5|||
105617311|NCT04149704|364264371|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
105617312|NCT04149704|364264372|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
105617313|NCT04149704|364264373|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
105617314|NCT04149704|364264374|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
105617315|NCT04149704|364264371|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
105617316|NCT04149704|364264372|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
105617317|NCT04149704|364264373|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
105617318|NCT04149704|364264374|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
105617319|NCT04376502|364264375|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
105617320|NCT04632992|364264377|FG000|Overall Study|Adverse Event|0|||
105617321|NCT04632992|364264378|FG001|Overall Study|Adverse Event|0|||
105617322|NCT04632992|364264379|FG002|Overall Study|Adverse Event|0|||
105617323|NCT04632992|364264380|FG003|Overall Study|Adverse Event|0|||
105617324|NCT04632992|364264381|FG004|Overall Study|Adverse Event|0|||
105617325|NCT04632992|364264382|FG005|Overall Study|Adverse Event|0|||
105617326|NCT04632992|364264383|FG006|Overall Study|Adverse Event|0|||
105617327|NCT04632992|364264384|FG007|Overall Study|Adverse Event|0|||
105617328|NCT04632992|364264385|FG008|Overall Study|Adverse Event|0|||
105617329|NCT04632992|364264386|FG009|Overall Study|Adverse Event|0|||
105617330|NCT04632992|364264387|FG010|Overall Study|Adverse Event|0|||
105617331|NCT04632992|364264388|FG011|Overall Study|Adverse Event|0|||
105617332|NCT04632992|364264389|FG012|Overall Study|Adverse Event|1|||
105617333|NCT04632992|364264390|FG013|Overall Study|Adverse Event|0|||
105617334|NCT04632992|364264377|FG000|Overall Study|Death|17|||
105617335|NCT04632992|364264378|FG001|Overall Study|Death|1|||
105617336|NCT04632992|364264379|FG002|Overall Study|Death|14|||
105617337|NCT04632992|364264380|FG003|Overall Study|Death|14|||
105617338|NCT04632992|364264381|FG004|Overall Study|Death|13|||
105617339|NCT04632992|364264382|FG005|Overall Study|Death|6|||
105617340|NCT04632992|364264383|FG006|Overall Study|Death|7|||
105617341|NCT04632992|364264384|FG007|Overall Study|Death|12|||
105617342|NCT04632992|364264385|FG008|Overall Study|Death|15|||
105617343|NCT04632992|364264386|FG009|Overall Study|Death|20|||
105617344|NCT04632992|364264387|FG010|Overall Study|Death|8|||
105617345|NCT04632992|364264388|FG011|Overall Study|Death|2|||
105617346|NCT04632992|364264389|FG012|Overall Study|Death|10|||
105617347|NCT04632992|364264390|FG013|Overall Study|Death|1|||
105617348|NCT04632992|364264377|FG000|Overall Study|Lost to Follow-up|1|||
105617349|NCT04632992|364264378|FG001|Overall Study|Lost to Follow-up|0|||
105617350|NCT04632992|364264379|FG002|Overall Study|Lost to Follow-up|1|||
105617351|NCT04632992|364264380|FG003|Overall Study|Lost to Follow-up|0|||
105617352|NCT04632992|364264381|FG004|Overall Study|Lost to Follow-up|2|||
105617353|NCT04632992|364264382|FG005|Overall Study|Lost to Follow-up|0|||
105617354|NCT04632992|364264383|FG006|Overall Study|Lost to Follow-up|1|||
105617355|NCT04632992|364264384|FG007|Overall Study|Lost to Follow-up|1|||
105617356|NCT04632992|364264385|FG008|Overall Study|Lost to Follow-up|1|||
105617357|NCT04632992|364264386|FG009|Overall Study|Lost to Follow-up|1|||
105617358|NCT04632992|364264387|FG010|Overall Study|Lost to Follow-up|2|||
105617359|NCT04632992|364264388|FG011|Overall Study|Lost to Follow-up|0|||
105617360|NCT04632992|364264389|FG012|Overall Study|Lost to Follow-up|0|||
105617361|NCT04632992|364264390|FG013|Overall Study|Lost to Follow-up|0|||
105617362|NCT04632992|364264377|FG000|Overall Study|Reason not Specified|2|||
105617363|NCT04632992|364264378|FG001|Overall Study|Reason not Specified|0|||
105617364|NCT04632992|364264379|FG002|Overall Study|Reason not Specified|1|||
105617365|NCT04632992|364264380|FG003|Overall Study|Reason not Specified|1|||
105617366|NCT04632992|364264381|FG004|Overall Study|Reason not Specified|0|||
105617367|NCT04632992|364264382|FG005|Overall Study|Reason not Specified|0|||
105617368|NCT04632992|364264383|FG006|Overall Study|Reason not Specified|0|||
105617369|NCT04632992|364264384|FG007|Overall Study|Reason not Specified|0|||
105617370|NCT04632992|364264385|FG008|Overall Study|Reason not Specified|0|||
105617371|NCT04632992|364264386|FG009|Overall Study|Reason not Specified|0|||
105617372|NCT04632992|364264387|FG010|Overall Study|Reason not Specified|1|||
105617373|NCT04632992|364264388|FG011|Overall Study|Reason not Specified|0|||
105617374|NCT04632992|364264389|FG012|Overall Study|Reason not Specified|0|||
105617375|NCT04632992|364264390|FG013|Overall Study|Reason not Specified|0|||
105617376|NCT04632992|364264377|FG000|Overall Study|Physician Decision|0|||
105617377|NCT04632992|364264378|FG001|Overall Study|Physician Decision|0|||
105617378|NCT04632992|364264379|FG002|Overall Study|Physician Decision|0|||
105617379|NCT04632992|364264380|FG003|Overall Study|Physician Decision|2|||
105617380|NCT04632992|364264381|FG004|Overall Study|Physician Decision|1|||
105617381|NCT04632992|364264382|FG005|Overall Study|Physician Decision|0|||
105617382|NCT04632992|364264383|FG006|Overall Study|Physician Decision|0|||
105617383|NCT04632992|364264384|FG007|Overall Study|Physician Decision|0|||
105617384|NCT04632992|364264385|FG008|Overall Study|Physician Decision|0|||
105617385|NCT04632992|364264386|FG009|Overall Study|Physician Decision|0|||
105617386|NCT04632992|364264387|FG010|Overall Study|Physician Decision|0|||
105617387|NCT04632992|364264388|FG011|Overall Study|Physician Decision|0|||
105617388|NCT04632992|364264389|FG012|Overall Study|Physician Decision|3|||
105617389|NCT04632992|364264390|FG013|Overall Study|Physician Decision|0|||
105617390|NCT04632992|364264377|FG000|Overall Study|Progressive Disease|0|||
105617391|NCT04632992|364264378|FG001|Overall Study|Progressive Disease|0|||
105617392|NCT04632992|364264379|FG002|Overall Study|Progressive Disease|0|||
105617393|NCT04632992|364264380|FG003|Overall Study|Progressive Disease|0|||
105617394|NCT04632992|364264381|FG004|Overall Study|Progressive Disease|1|||
105617395|NCT04632992|364264382|FG005|Overall Study|Progressive Disease|0|||
105617396|NCT04632992|364264383|FG006|Overall Study|Progressive Disease|0|||
105617397|NCT04632992|364264384|FG007|Overall Study|Progressive Disease|0|||
105617398|NCT04632992|364264385|FG008|Overall Study|Progressive Disease|0|||
105617399|NCT04632992|364264386|FG009|Overall Study|Progressive Disease|1|||
105617400|NCT04632992|364264387|FG010|Overall Study|Progressive Disease|1|||
105617401|NCT04632992|364264388|FG011|Overall Study|Progressive Disease|0|||
105617402|NCT04632992|364264389|FG012|Overall Study|Progressive Disease|2|||
105617403|NCT04632992|364264390|FG013|Overall Study|Progressive Disease|0|||
105617404|NCT04632992|364264377|FG000|Overall Study|Withdrawal by Subject|4|||
105617405|NCT04632992|364264378|FG001|Overall Study|Withdrawal by Subject|1|||
105617406|NCT04632992|364264379|FG002|Overall Study|Withdrawal by Subject|5|||
105617407|NCT04632992|364264380|FG003|Overall Study|Withdrawal by Subject|4|||
105617408|NCT04632992|364264381|FG004|Overall Study|Withdrawal by Subject|3|||
105617409|NCT04632992|364264382|FG005|Overall Study|Withdrawal by Subject|3|||
105617410|NCT04632992|364264383|FG006|Overall Study|Withdrawal by Subject|0|||
105617411|NCT04632992|364264384|FG007|Overall Study|Withdrawal by Subject|5|||
105617412|NCT04632992|364264385|FG008|Overall Study|Withdrawal by Subject|0|||
105617413|NCT04632992|364264386|FG009|Overall Study|Withdrawal by Subject|2|||
105617414|NCT04632992|364264387|FG010|Overall Study|Withdrawal by Subject|8|||
105617415|NCT04632992|364264388|FG011|Overall Study|Withdrawal by Subject|0|||
105617416|NCT04632992|364264389|FG012|Overall Study|Withdrawal by Subject|1|||
105617417|NCT04632992|364264390|FG013|Overall Study|Withdrawal by Subject|1|||
105617418|NCT02677805|364264391|FG000|Double Blind Phase|Lost to Follow-up|8|||
105617419|NCT02677805|364264392|FG001|Double Blind Phase|Lost to Follow-up|3|||
105617420|NCT02677805|364264393|FG002|Double Blind Phase|Lost to Follow-up|0|||
105617421|NCT02677805|364264391|FG000|Double Blind Phase|Withdrawal by Subject|5|||
105617422|NCT02677805|364264392|FG001|Double Blind Phase|Withdrawal by Subject|2|||
105617423|NCT02677805|364264393|FG002|Double Blind Phase|Withdrawal by Subject|0|||
105617424|NCT02677805|364264391|FG000|Open Label Phase|Lost to Follow-up|0|||
105617425|NCT02677805|364264392|FG001|Open Label Phase|Lost to Follow-up|0|||
105617426|NCT02677805|364264393|FG002|Open Label Phase|Lost to Follow-up|10|||
105617427|NCT02677805|364264391|FG000|Open Label Phase|Withdrawal by Subject|0|||
105617428|NCT02677805|364264392|FG001|Open Label Phase|Withdrawal by Subject|0|||
105617429|NCT02677805|364264393|FG002|Open Label Phase|Withdrawal by Subject|6|||
105617430|NCT05008835|364264395|FG000|Overall Study|Adverse Event|5|||
105617431|NCT05008835|364264396|FG001|Overall Study|Adverse Event|2|||
105617432|NCT05008835|364264397|FG002|Overall Study|Adverse Event|1|||
105617433|NCT05008835|364264395|FG000|Overall Study|Lack of Efficacy|0|||
105617434|NCT05008835|364264396|FG001|Overall Study|Lack of Efficacy|0|||
105617435|NCT05008835|364264397|FG002|Overall Study|Lack of Efficacy|1|||
105617436|NCT05008835|364264395|FG000|Overall Study|Study terminated by sponsor|0|||
105617437|NCT05008835|364264396|FG001|Overall Study|Study terminated by sponsor|0|||
105617438|NCT05008835|364264397|FG002|Overall Study|Study terminated by sponsor|1|||
105617439|NCT05008835|364264395|FG000|Overall Study|Not further specified|3|||
105617440|NCT05008835|364264396|FG001|Overall Study|Not further specified|2|||
105617441|NCT05008835|364264397|FG002|Overall Study|Not further specified|1|||
105617442|NCT04171999|364264398|FG000|Overall Study|deemed ineligible after randomization|2|||
105617443|NCT04171999|364264399|FG001|Overall Study|deemed ineligible after randomization|1|||
105617444|NCT03858634|364264406|FG000|Overall Study|Withdrawal by Subject|1|||
105617445|NCT03858634|364264407|FG001|Overall Study|Withdrawal by Subject|0|||
105617446|NCT03858634|364264406|FG000|Overall Study|Adverse Event|1|||
105617447|NCT03858634|364264407|FG001|Overall Study|Adverse Event|0|||
105617448|NCT03858634|364264406|FG000|Overall Study|Lost to Follow-up|0|||
105617449|NCT03858634|364264407|FG001|Overall Study|Lost to Follow-up|1|||
105617450|NCT03858634|364264406|FG000|Overall Study|Other, Not Specified|1|||
105617451|NCT03858634|364264407|FG001|Overall Study|Other, Not Specified|1|||
105617452|NCT04629716|364264409|FG000|Overall Study|Lost to Follow-up|7|||
105617453|NCT04629716|364264410|FG001|Overall Study|Lost to Follow-up|3|||
105617454|NCT04537715|364264411|FG000|Overall Study|Death|3|||
105617455|NCT04537715|364264412|FG001|Overall Study|Death|1|||
105617456|NCT04537715|364264411|FG000|Overall Study|Withdrawal by Subject|3|||
105617457|NCT04537715|364264412|FG001|Overall Study|Withdrawal by Subject|1|||
105617458|NCT04537715|364264411|FG000|Overall Study|Other|4|||
105617459|NCT04537715|364264412|FG001|Overall Study|Other|3|||
105617460|NCT04537715|364264411|FG000|Overall Study|Progressive disease|1|||
105617461|NCT04537715|364264412|FG001|Overall Study|Progressive disease|0|||
105617462|NCT02683447|364264414|FG000|Overall Study|Lost to Follow-up|2|||
105617463|NCT02310646|364264415|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
105617464|NCT02310646|364264416|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
105617465|NCT02310646|364264415|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
105617466|NCT02310646|364264416|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
105617467|NCT04568603|364264425|FG000|Overall Study|Physician Decision|1|||
105617468|NCT04137367|364264426|FG000|Overall Study|Lost to Follow-up|8|||
105617469|NCT04137367|364264427|FG001|Overall Study|Lost to Follow-up|6|||
105617470|NCT04137367|364264428|FG002|Overall Study|Lost to Follow-up|4|||
105617471|NCT04065841|364264447|FG000|Overall Study|Adverse Event|4|||
105617472|NCT04065841|364264448|FG001|Overall Study|Adverse Event|2|||
105617473|NCT04065841|364264449|FG002|Overall Study|Adverse Event|10|||
105617474|NCT04065841|364264450|FG003|Overall Study|Adverse Event|1|||
105617475|NCT04065841|364264447|FG000|Overall Study|Lost to Follow-up|1|||
105617476|NCT04065841|364264448|FG001|Overall Study|Lost to Follow-up|2|||
105617477|NCT04065841|364264449|FG002|Overall Study|Lost to Follow-up|2|||
105617478|NCT04065841|364264450|FG003|Overall Study|Lost to Follow-up|2|||
105617479|NCT04065841|364264447|FG000|Overall Study|Physician Decision|1|||
105617480|NCT04065841|364264448|FG001|Overall Study|Physician Decision|0|||
105617481|NCT04065841|364264449|FG002|Overall Study|Physician Decision|0|||
105617482|NCT04065841|364264450|FG003|Overall Study|Physician Decision|0|||
105617483|NCT04065841|364264447|FG000|Overall Study|Protocol Violation|0|||
105617484|NCT04065841|364264448|FG001|Overall Study|Protocol Violation|1|||
105617485|NCT04065841|364264449|FG002|Overall Study|Protocol Violation|0|||
105617486|NCT04065841|364264450|FG003|Overall Study|Protocol Violation|0|||
105617487|NCT04065841|364264447|FG000|Overall Study|Study terminated by Sponsor|22|||
105617488|NCT04065841|364264448|FG001|Overall Study|Study terminated by Sponsor|16|||
105617489|NCT04065841|364264449|FG002|Overall Study|Study terminated by Sponsor|28|||
105617490|NCT04065841|364264450|FG003|Overall Study|Study terminated by Sponsor|17|||
105617491|NCT04065841|364264447|FG000|Overall Study|Withdrawal by Subject|1|||
105617492|NCT04065841|364264448|FG001|Overall Study|Withdrawal by Subject|1|||
105617493|NCT04065841|364264449|FG002|Overall Study|Withdrawal by Subject|2|||
105617494|NCT04065841|364264450|FG003|Overall Study|Withdrawal by Subject|0|||
105617495|NCT02998268|364264453|FG000|Overall Study|Adverse Event|0|||
105617496|NCT02998268|364264454|FG001|Overall Study|Adverse Event|2|||
105617497|NCT02998268|364264453|FG000|Overall Study|Withdrawal by Subject|0|||
105617498|NCT02998268|364264454|FG001|Overall Study|Withdrawal by Subject|1|||
105617499|NCT03652389|364264458|FG000|Overall Study|Lost to Follow-up|1|||
105617500|NCT03652389|364264459|FG001|Overall Study|Lost to Follow-up|5|||
105617501|NCT03652389|364264458|FG000|Overall Study|Withdrawal by Subject|5|||
105617502|NCT03652389|364264459|FG001|Overall Study|Withdrawal by Subject|1|||
105617503|NCT03652389|364264458|FG000|Overall Study|New diagnosis|2|||
105617504|NCT03652389|364264459|FG001|Overall Study|New diagnosis|0|||
105617505|NCT04568486|364264474|FG000|Overall Study|Withdrawal by Subject|26|||
105617506|NCT04568486|364264474|FG000|Overall Study|Lost to Follow-up|7|||
105617507|NCT03931174|364264481|FG000|Providers|Staff left organization|26|||
105617508|NCT03931174|364264482|FG001|Providers|Staff left organization|25|||
105617509|NCT03931174|364264481|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
105617510|NCT03931174|364264482|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
105617511|NCT03931174|364264481|FG000|Providers|Lost to Follow-up|4|||
105617512|NCT03931174|364264482|FG001|Providers|Lost to Follow-up|4|||
105617513|NCT03931174|364264481|FG000|Patients|Post-consent screening failure|1|||
105617514|NCT03931174|364264482|FG001|Patients|Post-consent screening failure|1|||
105617515|NCT03931174|364264481|FG000|Patients|Death|1|||
105617516|NCT03931174|364264482|FG001|Patients|Death|1|||
105617517|NCT03931174|364264481|FG000|Patients|Lost to Follow-up|60|||
105617518|NCT03931174|364264482|FG001|Patients|Lost to Follow-up|89|||
105617519|NCT01824875|364266287|FG000|Overall Study|Disease progression|22|||
105617520|NCT01824875|364266288|FG001|Overall Study|Disease progression|15|||
105617521|NCT01824875|364266287|FG000|Overall Study|Withdrawal by Subject|5|||
105617522|NCT01824875|364266288|FG001|Overall Study|Withdrawal by Subject|4|||
105617523|NCT01824875|364266287|FG000|Overall Study|Adverse Event|4|||
105617524|NCT01824875|364266288|FG001|Overall Study|Adverse Event|10|||
105617525|NCT01824875|364266287|FG000|Overall Study|Alternative therapy|3|||
105617526|NCT01824875|364266288|FG001|Overall Study|Alternative therapy|0|||
105617527|NCT01824875|364266287|FG000|Overall Study|Complicating disease|1|||
105617528|NCT01824875|364266288|FG001|Overall Study|Complicating disease|0|||
105617529|NCT01824875|364266287|FG000|Overall Study|Physician Decision|0|||
105617530|NCT01824875|364266288|FG001|Overall Study|Physician Decision|1|||
105617531|NCT01824875|364266287|FG000|Overall Study|Non-compliance|1|||
105617532|NCT01824875|364266288|FG001|Overall Study|Non-compliance|1|||
105617533|NCT01824875|364266287|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
105617534|NCT01824875|364266288|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
105617535|NCT01824875|364266287|FG000|Overall Study|Administrative issues|0|||
105617536|NCT01824875|364266288|FG001|Overall Study|Administrative issues|2|||
105617537|NCT01824875|364266287|FG000|Overall Study|Ineligible or never started treatment|9|||
105617538|NCT01824875|364266288|FG001|Overall Study|Ineligible or never started treatment|5|||
105617539|NCT01824875|364266287|FG000|Overall Study|Other|0|||
105617540|NCT01824875|364266288|FG001|Overall Study|Other|2|||
105617541|NCT01098812|364266289|FG000|Overall Study|Death|2|||
105617542|NCT01098812|364266290|FG001|Overall Study|Death|0|||
105617543|NCT01098812|364266291|FG002|Overall Study|Death|1|||
105617544|NCT01098812|364266289|FG000|Overall Study|Lost to Follow-up|0|||
105617545|NCT01098812|364266290|FG001|Overall Study|Lost to Follow-up|1|||
105617546|NCT01098812|364266291|FG002|Overall Study|Lost to Follow-up|0|||
105617547|NCT01369355|364266292|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
105617548|NCT01369355|364266293|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
105617549|NCT01369355|364266294|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
105617550|NCT01369355|364266295|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
105617551|NCT01369355|364266296|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
105617552|NCT01369355|364266297|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
105617553|NCT01369355|364266298|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
105617554|NCT01369355|364266299|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
105617555|NCT01369355|364266300|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
105617556|NCT01369355|364266292|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
105617557|NCT01369355|364266293|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
105617558|NCT01369355|364266294|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
105617559|NCT01369355|364266295|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
105617560|NCT01369355|364266296|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
105617561|NCT01369355|364266297|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
105617562|NCT01369355|364266298|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
105617563|NCT01369355|364266299|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
105617564|NCT01369355|364266300|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
105617565|NCT01369355|364266292|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
105617566|NCT01369355|364266293|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
105617567|NCT01369355|364266294|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
105617568|NCT01369355|364266295|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
105617569|NCT01369355|364266296|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
105617570|NCT01369355|364266297|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
105617571|NCT01369355|364266298|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
105617572|NCT01369355|364266299|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
105617573|NCT01369355|364266300|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
105617574|NCT01369355|364266292|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
105617575|NCT01369355|364266293|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
105617576|NCT01369355|364266294|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
105617577|NCT01369355|364266295|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
105617578|NCT01369355|364266296|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
105617579|NCT01369355|364266297|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
105617580|NCT01369355|364266298|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
105617581|NCT01369355|364266299|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
105617582|NCT01369355|364266300|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
105617583|NCT01369355|364266292|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
105617584|NCT01369355|364266293|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
105617585|NCT01369355|364266294|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
105617586|NCT01369355|364266295|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
105617587|NCT01369355|364266296|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
105617588|NCT01369355|364266297|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
105617589|NCT01369355|364266298|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
105617590|NCT01369355|364266299|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
105617591|NCT01369355|364266300|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
105617592|NCT01369355|364266292|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
105617593|NCT01369355|364266293|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
105617594|NCT01369355|364266294|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
105617595|NCT01369355|364266295|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
105617596|NCT01369355|364266296|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
105617597|NCT01369355|364266297|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
105617598|NCT01369355|364266298|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
105617599|NCT01369355|364266299|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
105617600|NCT01369355|364266300|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
105617601|NCT01369355|364266292|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
105617602|NCT01369355|364266293|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
105617603|NCT01369355|364266294|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
105617604|NCT01369355|364266295|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
105617605|NCT01369355|364266296|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
105617606|NCT01369355|364266297|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
105617607|NCT01369355|364266298|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
105617608|NCT01369355|364266299|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
105617609|NCT01369355|364266300|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
105617610|NCT01369355|364266292|FG000|Long-term Extension (Week 44-272)|Death|0|||
105617611|NCT01369355|364266293|FG001|Long-term Extension (Week 44-272)|Death|0|||
105617612|NCT01369355|364266294|FG002|Long-term Extension (Week 44-272)|Death|0|||
105617613|NCT01369355|364266295|FG003|Long-term Extension (Week 44-272)|Death|0|||
105617614|NCT01369355|364266296|FG004|Long-term Extension (Week 44-272)|Death|0|||
105617615|NCT01369355|364266297|FG005|Long-term Extension (Week 44-272)|Death|0|||
105617616|NCT01369355|364266298|FG006|Long-term Extension (Week 44-272)|Death|0|||
105617617|NCT01369355|364266299|FG007|Long-term Extension (Week 44-272)|Death|1|||
105617618|NCT01369355|364266300|FG008|Long-term Extension (Week 44-272)|Death|3|||
105617619|NCT01369355|364266292|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
105617620|NCT01369355|364266293|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
105617621|NCT01369355|364266294|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
105617622|NCT01369355|364266295|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
105617623|NCT01369355|364266296|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
105617624|NCT01369355|364266297|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
105617625|NCT01369355|364266298|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
105617626|NCT01369355|364266299|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
105617627|NCT01369355|364266300|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
105617628|NCT01369355|364266292|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
105617629|NCT01369355|364266293|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
105617630|NCT01369355|364266294|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
105617631|NCT01369355|364266295|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
105617632|NCT01369355|364266296|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
105617633|NCT01369355|364266297|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
105617634|NCT01369355|364266298|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
105617635|NCT01369355|364266299|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
105617636|NCT01369355|364266300|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
105617637|NCT01369355|364266292|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
105617638|NCT01369355|364266293|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
105617639|NCT01369355|364266294|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
105617640|NCT01369355|364266295|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
105617641|NCT01369355|364266296|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
105617642|NCT01369355|364266297|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
105617643|NCT01369355|364266298|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
105617644|NCT01369355|364266299|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
105617645|NCT01369355|364266300|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
105617646|NCT01369355|364266292|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
105617647|NCT01369355|364266293|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
105617648|NCT01369355|364266294|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
105617649|NCT01369355|364266295|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
105617650|NCT01369355|364266296|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
105617651|NCT01369355|364266297|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
105617652|NCT01369355|364266298|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
105617653|NCT01369355|364266299|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
105617654|NCT01369355|364266300|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
105617655|NCT01369355|364266292|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
105617656|NCT01369355|364266293|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
105617657|NCT01369355|364266294|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
105617658|NCT01369355|364266295|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
105617659|NCT01369355|364266296|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
105617660|NCT01369355|364266297|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
105617661|NCT01369355|364266298|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
105617662|NCT01369355|364266299|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
105617663|NCT01369355|364266300|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
105617664|NCT01369355|364266292|FG000|Long-term Extension (Week 44-272)|Other|0|||
105617665|NCT01369355|364266293|FG001|Long-term Extension (Week 44-272)|Other|0|||
105617666|NCT01369355|364266294|FG002|Long-term Extension (Week 44-272)|Other|0|||
105617667|NCT01369355|364266295|FG003|Long-term Extension (Week 44-272)|Other|0|||
105617668|NCT01369355|364266296|FG004|Long-term Extension (Week 44-272)|Other|0|||
105617669|NCT01369355|364266297|FG005|Long-term Extension (Week 44-272)|Other|0|||
105617670|NCT01369355|364266298|FG006|Long-term Extension (Week 44-272)|Other|110|||
105617671|NCT01369355|364266299|FG007|Long-term Extension (Week 44-272)|Other|9|||
105617672|NCT01369355|364266300|FG008|Long-term Extension (Week 44-272)|Other|17|||
105617673|NCT02319759|364266303|FG000|Week 0 - 16|Lack of Efficacy|1|||
105617674|NCT02319759|364266304|FG001|Week 0 - 16|Lack of Efficacy|0|||
105617675|NCT02319759|364266305|FG002|Week 0 - 16|Lack of Efficacy|0|||
105617676|NCT02319759|364266306|FG003|Week 0 - 16|Lack of Efficacy|0|||
105617677|NCT02319759|364266307|FG004|Week 0 - 16|Lack of Efficacy|0|||
105617678|NCT02319759|364266303|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
105617679|NCT02319759|364266304|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
105617680|NCT02319759|364266305|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
105617681|NCT02319759|364266306|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
105617682|NCT02319759|364266307|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
105617683|NCT02319759|364266303|FG000|Week 16 - 24|Lack of Efficacy|1|||
105617684|NCT02319759|364266304|FG001|Week 16 - 24|Lack of Efficacy|0|||
105617685|NCT02319759|364266305|FG002|Week 16 - 24|Lack of Efficacy|1|||
105617686|NCT02319759|364266306|FG003|Week 16 - 24|Lack of Efficacy|0|||
105617687|NCT02319759|364266307|FG004|Week 16 - 24|Lack of Efficacy|0|||
105617688|NCT02319759|364266303|FG000|Week 16 - 24|Lost to Follow-up|1|||
105617689|NCT02319759|364266304|FG001|Week 16 - 24|Lost to Follow-up|0|||
105617690|NCT02319759|364266305|FG002|Week 16 - 24|Lost to Follow-up|0|||
105617691|NCT02319759|364266306|FG003|Week 16 - 24|Lost to Follow-up|0|||
105617692|NCT02319759|364266307|FG004|Week 16 - 24|Lost to Follow-up|0|||
105617693|NCT02319759|364266303|FG000|Week 16 - 24|Withdrawal by Subject|0|||
105617694|NCT02319759|364266304|FG001|Week 16 - 24|Withdrawal by Subject|0|||
105617695|NCT02319759|364266305|FG002|Week 16 - 24|Withdrawal by Subject|2|||
105617696|NCT02319759|364266306|FG003|Week 16 - 24|Withdrawal by Subject|0|||
105617697|NCT02319759|364266307|FG004|Week 16 - 24|Withdrawal by Subject|0|||
105617698|NCT02319759|364266303|FG000|Week 24 - 56|Adverse Event|0|||
105617699|NCT02319759|364266304|FG001|Week 24 - 56|Adverse Event|0|||
105617700|NCT02319759|364266305|FG002|Week 24 - 56|Adverse Event|2|||
105617701|NCT02319759|364266306|FG003|Week 24 - 56|Adverse Event|0|||
105617702|NCT02319759|364266307|FG004|Week 24 - 56|Adverse Event|0|||
105617703|NCT02319759|364266303|FG000|Week 24 - 56|Lack of Efficacy|0|||
105617704|NCT02319759|364266304|FG001|Week 24 - 56|Lack of Efficacy|0|||
105617705|NCT02319759|364266305|FG002|Week 24 - 56|Lack of Efficacy|0|||
105617706|NCT02319759|364266306|FG003|Week 24 - 56|Lack of Efficacy|2|||
105617707|NCT02319759|364266307|FG004|Week 24 - 56|Lack of Efficacy|1|||
105617708|NCT02319759|364266303|FG000|Week 24 - 56|Withdrawal by Subject|0|||
105617709|NCT02319759|364266304|FG001|Week 24 - 56|Withdrawal by Subject|1|||
105617710|NCT02319759|364266305|FG002|Week 24 - 56|Withdrawal by Subject|0|||
105617711|NCT02319759|364266306|FG003|Week 24 - 56|Withdrawal by Subject|0|||
105617712|NCT02319759|364266307|FG004|Week 24 - 56|Withdrawal by Subject|0|||
105617713|NCT02319759|364266303|FG000|Week 24 - 56|Lost to Follow-up|0|||
105617714|NCT02319759|364266304|FG001|Week 24 - 56|Lost to Follow-up|0|||
105617715|NCT02319759|364266305|FG002|Week 24 - 56|Lost to Follow-up|0|||
105617716|NCT02319759|364266306|FG003|Week 24 - 56|Lost to Follow-up|0|||
105617717|NCT02319759|364266307|FG004|Week 24 - 56|Lost to Follow-up|1|||
105617718|NCT05540665|364266309|FG000|Overall Study|Study terminated by sponsor|6|||
105617719|NCT05540665|364266310|FG001|Overall Study|Study terminated by sponsor|6|||
105617720|NCT05540665|364266311|FG002|Overall Study|Study terminated by sponsor|7|||
105617721|NCT03462030|364266312|FG000|Overall Study|Withdrawal by Subject|1|||
105617722|NCT03462030|364266313|FG001|Overall Study|Withdrawal by Subject|1|||
105617723|NCT02879695|364266314|FG000|Overall Study|Did not start study treatment|2|||
105617724|NCT02879695|364266315|FG001|Overall Study|Did not start study treatment|0|||
105617725|NCT02879695|364266316|FG002|Overall Study|Did not start study treatment|3|||
105617726|NCT02879695|364266317|FG003|Overall Study|Did not start study treatment|0|||
105617727|NCT02675751|364266318|FG000|Overall Study|Lost to Follow-up|16|||
105617728|NCT02598388|364266319|FG000|Overall Study|Lost to Follow-up|1|||
105617729|NCT02598388|364266320|FG001|Overall Study|Lost to Follow-up|0|||
105617730|NCT02598388|364266321|FG002|Overall Study|Lost to Follow-up|1|||
105617731|NCT02598388|364266322|FG003|Overall Study|Lost to Follow-up|0|||
105617732|NCT02598388|364266323|FG004|Overall Study|Lost to Follow-up|5|||
105617733|NCT02598388|364266324|FG005|Overall Study|Lost to Follow-up|1|||
105617734|NCT02598388|364266325|FG006|Overall Study|Lost to Follow-up|2|||
105617735|NCT02598388|364266326|FG007|Overall Study|Lost to Follow-up|1|||
105617736|NCT02598388|364266327|FG008|Overall Study|Lost to Follow-up|0|||
105617737|NCT02598388|364266328|FG009|Overall Study|Lost to Follow-up|0|||
105617738|NCT02598388|364266329|FG010|Overall Study|Lost to Follow-up|1|||
105617739|NCT02598388|364266330|FG011|Overall Study|Lost to Follow-up|0|||
105617740|NCT02598388|364266319|FG000|Overall Study|Withdrawal by Subject|0|||
105617741|NCT02598388|364266320|FG001|Overall Study|Withdrawal by Subject|0|||
105617742|NCT02598388|364266321|FG002|Overall Study|Withdrawal by Subject|0|||
105617743|NCT02598388|364266322|FG003|Overall Study|Withdrawal by Subject|0|||
105617744|NCT02598388|364266323|FG004|Overall Study|Withdrawal by Subject|2|||
105617745|NCT02598388|364266324|FG005|Overall Study|Withdrawal by Subject|0|||
105617746|NCT02598388|364266325|FG006|Overall Study|Withdrawal by Subject|2|||
105617747|NCT02598388|364266326|FG007|Overall Study|Withdrawal by Subject|0|||
105617748|NCT02598388|364266327|FG008|Overall Study|Withdrawal by Subject|0|||
105617749|NCT02598388|364266328|FG009|Overall Study|Withdrawal by Subject|1|||
105617750|NCT02598388|364266329|FG010|Overall Study|Withdrawal by Subject|0|||
105617751|NCT02598388|364266330|FG011|Overall Study|Withdrawal by Subject|0|||
105617752|NCT02598388|364266319|FG000|Overall Study|Other|0|||
105617753|NCT02598388|364266320|FG001|Overall Study|Other|0|||
105617754|NCT02598388|364266321|FG002|Overall Study|Other|1|||
105617755|NCT02598388|364266322|FG003|Overall Study|Other|0|||
105617756|NCT02598388|364266323|FG004|Overall Study|Other|3|||
105617757|NCT02598388|364266324|FG005|Overall Study|Other|0|||
105617758|NCT02598388|364266325|FG006|Overall Study|Other|1|||
105617759|NCT02598388|364266326|FG007|Overall Study|Other|0|||
105617760|NCT02598388|364266327|FG008|Overall Study|Other|0|||
105617761|NCT02598388|364266328|FG009|Overall Study|Other|0|||
105617762|NCT02598388|364266329|FG010|Overall Study|Other|0|||
105617763|NCT02598388|364266330|FG011|Overall Study|Other|0|||
105617764|NCT02438722|364266333|FG000|Overall Study|Adverse Event|12|||
105617765|NCT02438722|364266334|FG001|Overall Study|Adverse Event|9|||
105617766|NCT02438722|364266333|FG000|Overall Study|Refusal unrelated to AE|2|||
105617767|NCT02438722|364266334|FG001|Overall Study|Refusal unrelated to AE|5|||
105617768|NCT02438722|364266333|FG000|Overall Study|Disease progression/relapse|46|||
105617769|NCT02438722|364266334|FG001|Overall Study|Disease progression/relapse|51|||
105617770|NCT02438722|364266333|FG000|Overall Study|Death|0|||
105617771|NCT02438722|364266334|FG001|Overall Study|Death|3|||
105617772|NCT02438722|364266333|FG000|Overall Study|Physician Decision|2|||
105617773|NCT02438722|364266334|FG001|Overall Study|Physician Decision|2|||
105617774|NCT02438722|364266333|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
105617775|NCT02438722|364266334|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
105617776|NCT02438722|364266333|FG000|Overall Study|Withdrawal by Subject|0|||
105617777|NCT02438722|364266334|FG001|Overall Study|Withdrawal by Subject|1|||
105617778|NCT02438722|364266333|FG000|Overall Study|On protocol treatment|15|||
105617779|NCT02438722|364266334|FG001|Overall Study|On protocol treatment|14|||
105617780|NCT02438722|364266333|FG000|Overall Study|Did not receive protocol treatment|5|||
105617781|NCT02438722|364266334|FG001|Overall Study|Did not receive protocol treatment|0|||
105617782|NCT05006872|364266338|FG000|Overall Study|Lost to Follow-up|37|||
105617783|NCT05006872|364266339|FG001|Overall Study|Lost to Follow-up|31|||
105617784|NCT02761057|364266345|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
105617785|NCT02761057|364266346|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
105617786|NCT02761057|364266347|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
105617787|NCT02761057|364266348|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
105617788|NCT02761057|364266345|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
105617789|NCT02761057|364266346|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
105617790|NCT02761057|364266347|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
105617791|NCT02761057|364266348|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
105617792|NCT02761057|364266345|FG000|Overall Study|Currently On Study Treatment|0|||
105617793|NCT02761057|364266346|FG001|Overall Study|Currently On Study Treatment|3|||
105617794|NCT02761057|364266347|FG002|Overall Study|Currently On Study Treatment|0|||
105617795|NCT02761057|364266348|FG003|Overall Study|Currently On Study Treatment|0|||
105617796|NCT02761057|364266345|FG000|Overall Study|Adverse Event|11|||
105617797|NCT02761057|364266346|FG001|Overall Study|Adverse Event|9|||
105617798|NCT02761057|364266347|FG002|Overall Study|Adverse Event|5|||
105617799|NCT02761057|364266348|FG003|Overall Study|Adverse Event|3|||
105617800|NCT02761057|364266345|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
105617801|NCT02761057|364266346|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
105617802|NCT02761057|364266347|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
105617803|NCT02761057|364266348|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
105617804|NCT02761057|364266345|FG000|Overall Study|Progression/Relapse|29|||
105617805|NCT02761057|364266346|FG001|Overall Study|Progression/Relapse|27|||
105617806|NCT02761057|364266347|FG002|Overall Study|Progression/Relapse|20|||
105617807|NCT02761057|364266348|FG003|Overall Study|Progression/Relapse|23|||
105617808|NCT02761057|364266345|FG000|Overall Study|Death|2|||
105617809|NCT02761057|364266346|FG001|Overall Study|Death|2|||
105617810|NCT02761057|364266347|FG002|Overall Study|Death|1|||
105617811|NCT02761057|364266348|FG003|Overall Study|Death|1|||
105617812|NCT02761057|364266345|FG000|Overall Study|Other - Not Protocol Specified|2|||
105617813|NCT02761057|364266346|FG001|Overall Study|Other - Not Protocol Specified|1|||
105617814|NCT02761057|364266347|FG002|Overall Study|Other - Not Protocol Specified|2|||
105617815|NCT02761057|364266348|FG003|Overall Study|Other - Not Protocol Specified|0|||
105617816|NCT06132282|364266352|FG000|Overall Study|Lost to Follow-up|31|||
105617817|NCT04652700|364266359|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
105617818|NCT04652700|364266360|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
105617819|NCT04652700|364266359|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
105617820|NCT04652700|364266360|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
105617821|NCT04652700|364266359|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
105617822|NCT04652700|364266360|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
105617823|NCT04652700|364266359|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
105617824|NCT04652700|364266360|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
105617825|NCT04652700|364266359|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
105617826|NCT04652700|364266360|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
105617827|NCT04652700|364266359|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
105617828|NCT04652700|364266360|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
105617829|NCT04652700|364266359|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
105617830|NCT04652700|364266360|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
105617831|NCT04652700|364266359|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
105617832|NCT04652700|364266360|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
105617833|NCT04652700|364266359|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
105617834|NCT04652700|364266360|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
105617835|NCT05362487|364266361|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
105617836|NCT04096040|364266362|FG000|Overall Study|Protocol Violation|12|||
105617837|NCT04096040|364266362|FG000|Overall Study|Non-compliant site|4|||
105617838|NCT04439357|364266363|FG000|Overall Study|Disease Progression|4|||
105617839|NCT03808818|364266371|FG000|Overall Study|Death|6|||
105617840|NCT03808818|364266372|FG001|Overall Study|Death|6|||
105617841|NCT03808818|364266371|FG000|Overall Study|Withdrawal by Subject|7|||
105617842|NCT03808818|364266372|FG001|Overall Study|Withdrawal by Subject|18|||
105617843|NCT03808818|364266371|FG000|Overall Study|Lost to Follow-up|31|||
105617844|NCT03808818|364266372|FG001|Overall Study|Lost to Follow-up|33|||
105617845|NCT04676763|364266373|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
105617846|NCT04676763|364266374|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
105617847|NCT04676763|364266375|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
105617848|NCT04676763|364266373|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
105617849|NCT04676763|364266374|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
105617850|NCT04676763|364266375|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
105617851|NCT04676763|364266373|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
105617852|NCT04676763|364266374|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
105617853|NCT04676763|364266375|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
105617854|NCT03150173|364266376|FG000|Overall Study|Lost to Follow-up|13|||
105617855|NCT03150173|364266377|FG001|Overall Study|Lost to Follow-up|5|||
105617856|NCT05415722|364266378|FG000|Overall Study|Lost to Follow-up|0|||
105617857|NCT05415722|364266379|FG001|Overall Study|Lost to Follow-up|2|||
105617858|NCT05415722|364266380|FG002|Overall Study|Lost to Follow-up|0|||
105617859|NCT05415722|364266381|FG003|Overall Study|Lost to Follow-up|1|||
105617860|NCT05415722|364266382|FG004|Overall Study|Lost to Follow-up|0|||
105617861|NCT05415722|364266383|FG005|Overall Study|Lost to Follow-up|0|||
105617862|NCT05415722|364266384|FG006|Overall Study|Lost to Follow-up|1|||
105617863|NCT05415722|364266378|FG000|Overall Study|Physician Decision|0|||
105617864|NCT05415722|364266379|FG001|Overall Study|Physician Decision|0|||
105617865|NCT05415722|364266380|FG002|Overall Study|Physician Decision|0|||
105617866|NCT05415722|364266381|FG003|Overall Study|Physician Decision|1|||
105617867|NCT05415722|364266382|FG004|Overall Study|Physician Decision|0|||
105617868|NCT05415722|364266383|FG005|Overall Study|Physician Decision|0|||
105617869|NCT05415722|364266384|FG006|Overall Study|Physician Decision|1|||
105617870|NCT05415722|364266378|FG000|Overall Study|Protocol Violation|0|||
105617871|NCT05415722|364266379|FG001|Overall Study|Protocol Violation|0|||
105617872|NCT05415722|364266380|FG002|Overall Study|Protocol Violation|0|||
105617873|NCT05415722|364266381|FG003|Overall Study|Protocol Violation|1|||
105617874|NCT05415722|364266382|FG004|Overall Study|Protocol Violation|0|||
105617875|NCT05415722|364266383|FG005|Overall Study|Protocol Violation|0|||
105617876|NCT05415722|364266384|FG006|Overall Study|Protocol Violation|0|||
105617877|NCT05415722|364266378|FG000|Overall Study|Sponsor Discretion|0|||
105617878|NCT05415722|364266379|FG001|Overall Study|Sponsor Discretion|0|||
105617879|NCT05415722|364266380|FG002|Overall Study|Sponsor Discretion|0|||
105617880|NCT05415722|364266381|FG003|Overall Study|Sponsor Discretion|0|||
105617881|NCT05415722|364266382|FG004|Overall Study|Sponsor Discretion|1|||
105617882|NCT05415722|364266383|FG005|Overall Study|Sponsor Discretion|1|||
105617883|NCT05415722|364266384|FG006|Overall Study|Sponsor Discretion|0|||
105617884|NCT05415722|364266378|FG000|Overall Study|Withdrawal by Subject|0|||
105617885|NCT05415722|364266379|FG001|Overall Study|Withdrawal by Subject|1|||
105617886|NCT05415722|364266380|FG002|Overall Study|Withdrawal by Subject|0|||
105617887|NCT05415722|364266381|FG003|Overall Study|Withdrawal by Subject|1|||
105617888|NCT05415722|364266382|FG004|Overall Study|Withdrawal by Subject|1|||
105617889|NCT05415722|364266383|FG005|Overall Study|Withdrawal by Subject|0|||
105617890|NCT05415722|364266384|FG006|Overall Study|Withdrawal by Subject|1|||
105617891|NCT03031470|364266398|FG000|Overall Study|Adverse Event|3|||
105617892|NCT03031470|364266399|FG001|Overall Study|Adverse Event|0|||
105617893|NCT03031470|364266398|FG000|Overall Study|Death|3|||
105617894|NCT03031470|364266399|FG001|Overall Study|Death|1|||
105617895|NCT03031470|364266398|FG000|Overall Study|Lost to Follow-up|1|||
105617896|NCT03031470|364266399|FG001|Overall Study|Lost to Follow-up|1|||
105617897|NCT03031470|364266398|FG000|Overall Study|Withdrawal by Subject|1|||
105617898|NCT03031470|364266399|FG001|Overall Study|Withdrawal by Subject|0|||
105617899|NCT03031470|364266398|FG000|Overall Study|Protocol entry criteria not met|0|||
105617900|NCT03031470|364266399|FG001|Overall Study|Protocol entry criteria not met|1|||
105617901|NCT03031470|364266398|FG000|Overall Study|Cancel the operation|0|||
105617902|NCT03031470|364266399|FG001|Overall Study|Cancel the operation|1|||
105617903|NCT03461276|364266400|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
105617904|NCT03461276|364266401|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
105617905|NCT03461276|364266400|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
105617906|NCT03461276|364266401|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
105617907|NCT03461276|364266400|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
105617908|NCT03461276|364266401|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
105617909|NCT03461276|364266400|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
105617910|NCT03461276|364266401|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
105617911|NCT03461276|364266400|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
105617912|NCT03461276|364266401|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
105617913|NCT03461276|364266400|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
105617914|NCT03461276|364266401|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
105617915|NCT03461276|364266400|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
105617916|NCT03461276|364266401|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
105617917|NCT03461276|364266400|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
105617918|NCT03461276|364266401|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
105617919|NCT03461276|364266400|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
105617920|NCT03461276|364266401|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
105617921|NCT03461276|364266400|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
105617922|NCT03461276|364266401|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
105617923|NCT01802788|364266403|FG000|Overall Study|Withdrawal by Subject|102|||
105617924|NCT01802788|364266404|FG001|Overall Study|Withdrawal by Subject|5|||
105617925|NCT01802788|364266403|FG000|Overall Study|Death|382|||
105617926|NCT01802788|364266404|FG001|Overall Study|Death|18|||
105617927|NCT01802788|364266403|FG000|Overall Study|Lost to Follow-up|31|||
105617928|NCT01802788|364266404|FG001|Overall Study|Lost to Follow-up|2|||
105617929|NCT01802788|364266403|FG000|Overall Study|Physician Decision|3|||
105617930|NCT01802788|364266404|FG001|Overall Study|Physician Decision|0|||
105617931|NCT01802788|364266403|FG000|Overall Study|Patient Non-Compliance|1|||
105617932|NCT01802788|364266404|FG001|Overall Study|Patient Non-Compliance|0|||
105617933|NCT01802788|364266403|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
105617934|NCT01802788|364266404|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
105617935|NCT01802788|364266403|FG000|Overall Study|Other Reasons|19|||
105617936|NCT01802788|364266404|FG001|Overall Study|Other Reasons|0|||
105617937|NCT04700163|364266405|FG000|Overall Study|Lost to Follow-up|0|||
105617938|NCT04700163|364266406|FG001|Overall Study|Lost to Follow-up|0|||
105617939|NCT04700163|364266407|FG002|Overall Study|Lost to Follow-up|0|||
105617940|NCT04700163|364266408|FG003|Overall Study|Lost to Follow-up|0|||
105617941|NCT04700163|364266409|FG004|Overall Study|Lost to Follow-up|0|||
105617942|NCT04700163|364266410|FG005|Overall Study|Lost to Follow-up|1|||
105617943|NCT03848065|364266411|FG000|Overall Study|Death|0|||
105617944|NCT03848065|364266412|FG001|Overall Study|Death|1|||
105617945|NCT03848065|364266413|FG002|Overall Study|Death|0|||
105617946|NCT03848065|364266411|FG000|Overall Study|Lost to Follow-up|0|||
105617947|NCT03848065|364266412|FG001|Overall Study|Lost to Follow-up|0|||
105617948|NCT03848065|364266413|FG002|Overall Study|Lost to Follow-up|1|||
105617949|NCT03848065|364266411|FG000|Overall Study|Physician Decision|0|||
105617950|NCT03848065|364266412|FG001|Overall Study|Physician Decision|0|||
105617951|NCT03848065|364266413|FG002|Overall Study|Physician Decision|1|||
105617952|NCT03496168|364266414|FG000|Overall Study|Other Reasons|1|||
105617953|NCT03496168|364266414|FG000|Overall Study|Adverse Event|1|||
105617954|NCT03865498|364266415|FG000|Overall Study|Lack of Efficacy|12|||
105617955|NCT03865498|364266416|FG001|Overall Study|Lack of Efficacy|11|||
105617956|NCT03865498|364266415|FG000|Overall Study|Lost to Follow-up|125|||
105617957|NCT03865498|364266416|FG001|Overall Study|Lost to Follow-up|133|||
105617958|NCT03865498|364266415|FG000|Overall Study|Withdrawal by Subject|2|||
105617959|NCT03865498|364266416|FG001|Overall Study|Withdrawal by Subject|4|||
105617960|NCT02043678|364266421|FG000|Overall Study|Never treated|11|||
105617961|NCT02043678|364266422|FG001|Overall Study|Never treated|9|||
105617962|NCT02043678|364266421|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
105617963|NCT02043678|364266422|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
105617964|NCT02043678|364266421|FG000|Overall Study|AE without clinical PD|54|||
105617965|NCT02043678|364266422|FG001|Overall Study|AE without clinical PD|36|||
105617966|NCT02043678|364266421|FG000|Overall Study|Lost to Follow-up|1|||
105617967|NCT02043678|364266422|FG001|Overall Study|Lost to Follow-up|1|||
105617968|NCT02043678|364266421|FG000|Overall Study|Other|10|||
105617969|NCT02043678|364266422|FG001|Overall Study|Other|14|||
105617970|NCT02043678|364266421|FG000|Overall Study|Clinical PD|114|||
105617971|NCT02043678|364266422|FG001|Overall Study|Clinical PD|148|||
105617972|NCT02043678|364266421|FG000|Overall Study|Radiological PD|100|||
105617973|NCT02043678|364266422|FG001|Overall Study|Radiological PD|90|||
105617974|NCT02043678|364266421|FG000|Overall Study|Protocol-driven decision point|59|||
105617975|NCT02043678|364266422|FG001|Overall Study|Protocol-driven decision point|58|||
105617976|NCT02043678|364266421|FG000|Overall Study|Withdrawal by Subject|16|||
105617977|NCT02043678|364266422|FG001|Overall Study|Withdrawal by Subject|20|||
105617978|NCT02043678|364266421|FG000|Overall Study|Protocol Violation|1|||
105617979|NCT02043678|364266422|FG001|Overall Study|Protocol Violation|0|||
105617980|NCT02043678|364266421|FG000|Overall Study|Deterioration of general conditions|1|||
105617981|NCT02043678|364266422|FG001|Overall Study|Deterioration of general conditions|1|||
105617982|NCT02043678|364266421|FG000|Overall Study|Logistical difficulties|2|||
105617983|NCT02043678|364266422|FG001|Overall Study|Logistical difficulties|0|||
105617984|NCT02043678|364266421|FG000|Overall Study|Non-compliance with study drug|3|||
105617985|NCT02043678|364266422|FG001|Overall Study|Non-compliance with study drug|1|||
105617986|NCT02043678|364266421|FG000|Overall Study|Physician Decision|4|||
105617987|NCT02043678|364266422|FG001|Overall Study|Physician Decision|3|||
105617988|NCT02043678|364266421|FG000|Overall Study|Subject decision|0|||
105617989|NCT02043678|364266422|FG001|Overall Study|Subject decision|1|||
105617990|NCT02043678|364266421|FG000|Overall Study|Switching to other therapy|3|||
105617991|NCT02043678|364266422|FG001|Overall Study|Switching to other therapy|2|||
105617992|NCT02043678|364266421|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
105617993|NCT02043678|364266422|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
105617994|NCT02043678|364266421|FG000|Overall Study|Missing|1|||
105617995|NCT02043678|364266422|FG001|Overall Study|Missing|0|||
105617996|NCT02043678|364266421|FG000|Overall Study|Adverse Event|0|||
105617997|NCT02043678|364266422|FG001|Overall Study|Adverse Event|1|||
105617998|NCT03314454|364266423|FG000|Overall Study|Protocol Violation|1|||
105617999|NCT05543629|364266424|FG000|Overall Study|Death|1|||
105618000|NCT05543629|364266425|FG001|Overall Study|Death|0|||
105618001|NCT05543629|364266426|FG002|Overall Study|Death|1|||
105618002|NCT05543629|364266427|FG003|Overall Study|Death|0|||
105618003|NCT05543629|364266428|FG004|Overall Study|Death|0|||
105618004|NCT05543629|364266429|FG005|Overall Study|Death|1|||
105618005|NCT05543629|364266430|FG006|Overall Study|Death|2|||
105618006|NCT05543629|364266431|FG007|Overall Study|Death|2|||
105618007|NCT05543629|364266424|FG000|Overall Study|Other Reasons|0|||
105618008|NCT05543629|364266425|FG001|Overall Study|Other Reasons|0|||
105618009|NCT05543629|364266426|FG002|Overall Study|Other Reasons|0|||
105618010|NCT05543629|364266427|FG003|Overall Study|Other Reasons|0|||
105618011|NCT05543629|364266428|FG004|Overall Study|Other Reasons|1|||
105618012|NCT05543629|364266429|FG005|Overall Study|Other Reasons|0|||
105618013|NCT05543629|364266430|FG006|Overall Study|Other Reasons|0|||
105618014|NCT05543629|364266431|FG007|Overall Study|Other Reasons|0|||
105618015|NCT05543629|364266424|FG000|Overall Study|Physician Decision|0|||
105618016|NCT05543629|364266425|FG001|Overall Study|Physician Decision|0|||
105618017|NCT05543629|364266426|FG002|Overall Study|Physician Decision|3|||
105618018|NCT05543629|364266427|FG003|Overall Study|Physician Decision|0|||
105618019|NCT05543629|364266428|FG004|Overall Study|Physician Decision|0|||
105618020|NCT05543629|364266429|FG005|Overall Study|Physician Decision|0|||
105618021|NCT05543629|364266430|FG006|Overall Study|Physician Decision|1|||
105618022|NCT05543629|364266431|FG007|Overall Study|Physician Decision|0|||
105618023|NCT05543629|364266424|FG000|Overall Study|Study terminated by Sponsor|1|||
105618024|NCT05543629|364266425|FG001|Overall Study|Study terminated by Sponsor|0|||
105618025|NCT05543629|364266426|FG002|Overall Study|Study terminated by Sponsor|0|||
105618026|NCT05543629|364266427|FG003|Overall Study|Study terminated by Sponsor|1|||
105618027|NCT05543629|364266428|FG004|Overall Study|Study terminated by Sponsor|0|||
105618028|NCT05543629|364266429|FG005|Overall Study|Study terminated by Sponsor|4|||
105618029|NCT05543629|364266430|FG006|Overall Study|Study terminated by Sponsor|1|||
105618030|NCT05543629|364266431|FG007|Overall Study|Study terminated by Sponsor|0|||
105618031|NCT05543629|364266424|FG000|Overall Study|Withdrawal by Subject|1|||
105618032|NCT05543629|364266425|FG001|Overall Study|Withdrawal by Subject|1|||
105618033|NCT05543629|364266426|FG002|Overall Study|Withdrawal by Subject|0|||
105618034|NCT05543629|364266427|FG003|Overall Study|Withdrawal by Subject|2|||
105618035|NCT05543629|364266428|FG004|Overall Study|Withdrawal by Subject|1|||
105618036|NCT05543629|364266429|FG005|Overall Study|Withdrawal by Subject|1|||
105618037|NCT05543629|364266430|FG006|Overall Study|Withdrawal by Subject|1|||
105618038|NCT05543629|364266431|FG007|Overall Study|Withdrawal by Subject|1|||
105618039|NCT05543629|364266424|FG000|Overall Study|Not Reported|2|||
105618040|NCT05543629|364266425|FG001|Overall Study|Not Reported|2|||
105618041|NCT05543629|364266426|FG002|Overall Study|Not Reported|0|||
105618042|NCT05543629|364266427|FG003|Overall Study|Not Reported|0|||
105618043|NCT05543629|364266428|FG004|Overall Study|Not Reported|1|||
105618044|NCT05543629|364266429|FG005|Overall Study|Not Reported|1|||
105618045|NCT05543629|364266430|FG006|Overall Study|Not Reported|3|||
105618046|NCT05543629|364266431|FG007|Overall Study|Not Reported|0|||
105618047|NCT04499924|364266432|FG000|Overall Study|Study termination by sponsor|4|||
105618048|NCT04499924|364266433|FG001|Overall Study|Study termination by sponsor|6|||
105618049|NCT04499924|364266432|FG000|Overall Study|Withdrawal by Subject|1|||
105618050|NCT04499924|364266433|FG001|Overall Study|Withdrawal by Subject|3|||
105618051|NCT03322267|364266436|FG000|Overall Study|Lack of Efficacy|11|||
105618052|NCT03322267|364266436|FG000|Overall Study|Adverse Event|1|||
105618053|NCT03322267|364266436|FG000|Overall Study|Withdrawal by Subject|2|||
105618054|NCT01919554|364266437|FG000|Overall Study|Withdrawal by Subject|0|||
105618055|NCT01919554|364266438|FG001|Overall Study|Withdrawal by Subject|0|||
105618056|NCT01919554|364266439|FG002|Overall Study|Withdrawal by Subject|1|||
105618057|NCT01919554|364266440|FG003|Overall Study|Withdrawal by Subject|1|||
105618058|NCT04719832|364266443|FG000|Overall Study|Adverse Event|2|||
105618059|NCT04719832|364266444|FG001|Overall Study|Adverse Event|0|||
105618060|NCT04719832|364266443|FG000|Overall Study|Lack of Efficacy|2|||
105618061|NCT04719832|364266444|FG001|Overall Study|Lack of Efficacy|4|||
105618062|NCT04719832|364266443|FG000|Overall Study|Lost to Follow-up|0|||
105618063|NCT04719832|364266444|FG001|Overall Study|Lost to Follow-up|2|||
105618064|NCT04719832|364266443|FG000|Overall Study|Physician Decision|0|||
105618065|NCT04719832|364266444|FG001|Overall Study|Physician Decision|1|||
105618066|NCT04719832|364266443|FG000|Overall Study|Pregnancy|1|||
105618067|NCT04719832|364266444|FG001|Overall Study|Pregnancy|1|||
105618068|NCT04719832|364266443|FG000|Overall Study|Withdrawal by Subject|5|||
105618069|NCT04719832|364266444|FG001|Overall Study|Withdrawal by Subject|5|||
105618070|NCT04719832|364266443|FG000|Overall Study|Randomized, not treated|0|||
105618071|NCT04719832|364266444|FG001|Overall Study|Randomized, not treated|2|||
105618072|NCT04719832|364266443|FG000|Overall Study|GCP violations|4|||
105618073|NCT04719832|364266444|FG001|Overall Study|GCP violations|7|||
105618074|NCT04898673|364266445|FG000|Overall Study|Screenfail|1|||
105618075|NCT04898673|364266446|FG001|Overall Study|Screenfail|0|||
105618076|NCT04797897|364266447|FG000|Overall Study|Study Termination by Sponsor|1|||
105618077|NCT04797897|364266448|FG001|Overall Study|Study Termination by Sponsor|1|||
105618078|NCT05670587|364266449|FG000|Overall Study|Withdrawal by Subject|3|||
105618079|NCT01197378|364266451|FG000|Overall Study|Adverse Event|3|||
105618080|NCT01197378|364266451|FG000|Overall Study|Withdrawal by Subject|1|||
105618081|NCT01197378|364266451|FG000|Overall Study|Physician Decision|1|||
105618082|NCT01197378|364266451|FG000|Overall Study|Other|2|||
105618083|NCT03134196|364267798|FG000|Overall Study|Death|2|||
105618084|NCT03134196|364267799|FG001|Overall Study|Death|1|||
105618085|NCT03134196|364267798|FG000|Overall Study|Lost to Follow-up|13|||
105618086|NCT03134196|364267799|FG001|Overall Study|Lost to Follow-up|15|||
105618087|NCT03134196|364267798|FG000|Overall Study|Physician Decision|0|||
105618088|NCT03134196|364267799|FG001|Overall Study|Physician Decision|1|||
105618089|NCT03134196|364267798|FG000|Overall Study|Withdrawal by Subject|19|||
105618090|NCT03134196|364267799|FG001|Overall Study|Withdrawal by Subject|12|||
105618091|NCT03134196|364267798|FG000|Overall Study|Site Unable to Contact Participant|2|||
105618092|NCT03134196|364267799|FG001|Overall Study|Site Unable to Contact Participant|0|||
105618093|NCT03134196|364267798|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
105618094|NCT03134196|364267799|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
105618095|NCT03134196|364267798|FG000|Overall Study|Scheduling Conflict|1|||
105618096|NCT03134196|364267799|FG001|Overall Study|Scheduling Conflict|0|||
105618097|NCT01715285|364267800|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
105618098|NCT01715285|364267801|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
105618099|NCT01715285|364267802|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
105618100|NCT01715285|364267800|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
105618101|NCT01715285|364267801|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
105618102|NCT01715285|364267802|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
105618103|NCT01715285|364267800|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
105618104|NCT01715285|364267801|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
105618105|NCT01715285|364267802|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
105618106|NCT01715285|364267800|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
105618107|NCT01715285|364267801|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
105618108|NCT01715285|364267802|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
105618109|NCT01715285|364267800|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
105618110|NCT01715285|364267801|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
105618111|NCT01715285|364267802|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
105618112|NCT01715285|364267800|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
105618113|NCT01715285|364267801|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
105618114|NCT01715285|364267802|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
105618115|NCT01715285|364267800|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
105618116|NCT01715285|364267801|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
105618117|NCT01715285|364267802|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
105618118|NCT01715285|364267800|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
105618119|NCT01715285|364267801|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
105618120|NCT01715285|364267802|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
105618121|NCT01715285|364267800|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
105618122|NCT01715285|364267801|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
105618123|NCT01715285|364267802|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
105618124|NCT01715285|364267800|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
105618125|NCT01715285|364267801|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
105618126|NCT01715285|364267802|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
105618127|NCT01715285|364267800|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
105618128|NCT01715285|364267801|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
105618129|NCT01715285|364267802|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
105618130|NCT01715285|364267800|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
105618131|NCT01715285|364267801|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
105618132|NCT01715285|364267802|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
105618133|NCT01715285|364267800|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
105618134|NCT01715285|364267801|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
105618135|NCT01715285|364267802|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
105618136|NCT01715285|364267800|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
105618137|NCT01715285|364267801|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
105618138|NCT01715285|364267802|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
105618139|NCT03628924|364267810|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
105618140|NCT03628924|364267811|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
105618141|NCT03628924|364267812|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
105618142|NCT03628924|364267813|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
105618143|NCT03628924|364267814|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
105618144|NCT03628924|364267815|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
105618145|NCT03628924|364267816|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
105618146|NCT03628924|364267810|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
105618147|NCT03628924|364267811|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
105618148|NCT03628924|364267812|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
105618149|NCT03628924|364267813|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
105618150|NCT03628924|364267814|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
105618151|NCT03628924|364267815|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
105618152|NCT03628924|364267816|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
105618153|NCT03628924|364267810|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
105618154|NCT03628924|364267811|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
105618155|NCT03628924|364267812|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
105618156|NCT03628924|364267813|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
105618157|NCT03628924|364267814|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
105618158|NCT03628924|364267815|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
105618159|NCT03628924|364267816|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
105618160|NCT03628924|364267810|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
105618161|NCT03628924|364267811|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
105618162|NCT03628924|364267812|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
105618163|NCT03628924|364267813|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
105618164|NCT03628924|364267814|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
105618165|NCT03628924|364267815|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
105618166|NCT03628924|364267816|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
105618167|NCT03628924|364267810|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
105618168|NCT03628924|364267811|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
105618169|NCT03628924|364267812|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
105618170|NCT03628924|364267813|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
105618171|NCT03628924|364267814|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
105618172|NCT03628924|364267815|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
105618173|NCT03628924|364267816|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
105618174|NCT03628924|364267810|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
105618175|NCT03628924|364267811|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
105618176|NCT03628924|364267812|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
105618177|NCT03628924|364267813|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
105618178|NCT03628924|364267814|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
105618179|NCT03628924|364267815|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
105618180|NCT03628924|364267816|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
105618181|NCT03628924|364267810|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
105618182|NCT03628924|364267811|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
105618183|NCT03628924|364267812|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
105618184|NCT03628924|364267813|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
105618185|NCT03628924|364267814|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
105618186|NCT03628924|364267815|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
105618187|NCT03628924|364267816|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
105618188|NCT03628924|364267810|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
105618189|NCT03628924|364267811|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
105618190|NCT03628924|364267812|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
105618191|NCT03628924|364267813|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
105618192|NCT03628924|364267814|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
105618193|NCT03628924|364267815|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
105618194|NCT03628924|364267816|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
105618195|NCT03628924|364267810|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
105618196|NCT03628924|364267811|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
105618197|NCT03628924|364267812|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
105618198|NCT03628924|364267813|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
105618199|NCT03628924|364267814|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
105618200|NCT03628924|364267815|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
105618201|NCT03628924|364267816|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
105618202|NCT03628924|364267810|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
105618203|NCT03628924|364267811|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
105618204|NCT03628924|364267812|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
105618205|NCT03628924|364267813|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
105618206|NCT03628924|364267814|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
105618207|NCT03628924|364267815|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
105618208|NCT03628924|364267816|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
105618209|NCT04971681|364267820|FG000|Followup|Lost to Follow-up|1|||
105618210|NCT04971681|364267821|FG001|Followup|Lost to Follow-up|0|||
105618211|NCT06215521|364267825|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
105618212|NCT06215521|364267826|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
105618213|NCT06215521|364267827|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
105618214|NCT06215521|364267828|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
105618215|NCT06215521|364267829|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
105618216|NCT06215521|364267830|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
105618217|NCT03603600|364267831|FG000|Overall Study|Withdrawal by Subject|5|||
105618218|NCT03603600|364267832|FG001|Overall Study|Withdrawal by Subject|7|||
105618219|NCT03603600|364267831|FG000|Overall Study|Lost to Follow-up|2|||
105618220|NCT03603600|364267832|FG001|Overall Study|Lost to Follow-up|3|||
105618221|NCT03603600|364267831|FG000|Overall Study|Death|3|||
105618222|NCT03603600|364267832|FG001|Overall Study|Death|1|||
105618223|NCT03603600|364267831|FG000|Overall Study|Physician Decision|2|||
105618224|NCT03603600|364267832|FG001|Overall Study|Physician Decision|1|||
105618225|NCT03603600|364267831|FG000|Overall Study|Other reason|1|||
105618226|NCT03603600|364267832|FG001|Overall Study|Other reason|0|||
105618227|NCT04973254|364267833|FG000|Overall Study|Not adherent|0|||
105618228|NCT04973254|364267834|FG001|Overall Study|Not adherent|1|||
105618229|NCT04973254|364267835|FG002|Overall Study|Not adherent|0|||
105618230|NCT05457647|364267836|FG000|Overall Study|Lost to Follow-up|3|||
105618231|NCT04938492|364267837|FG000|Overall Study|Lost to Follow-up|17|||
105618232|NCT04938492|364267838|FG001|Overall Study|Lost to Follow-up|18|||
105618233|NCT05257486|364267844|FG000|Overall Study|Protocol Violation|3|||
105618234|NCT03021096|364267845|FG000|Overall Study|Lost to Follow-up|4|||
105618235|NCT03021096|364267845|FG000|Overall Study|Protocol Violation|2|||
105618236|NCT04564742|364267848|FG000|Overall Study|Lost to Follow-up|1|||
105618237|NCT04564742|364267849|FG001|Overall Study|Lost to Follow-up|0|||
105618238|NCT04564742|364267848|FG000|Overall Study|Consent Withdrawal|4|||
105618239|NCT04564742|364267849|FG001|Overall Study|Consent Withdrawal|4|||
105618240|NCT03313076|364267853|FG000|Overall Study|Withdrawal by Subject|2|||
105618241|NCT03313076|364267854|FG001|Overall Study|Withdrawal by Subject|0|||
105618242|NCT03313076|364267855|FG002|Overall Study|Withdrawal by Subject|0|||
105618243|NCT03313076|364267856|FG003|Overall Study|Withdrawal by Subject|0|||
105618244|NCT03313076|364267853|FG000|Overall Study|Lost to Follow-up|0|||
105618245|NCT03313076|364267854|FG001|Overall Study|Lost to Follow-up|2|||
105618246|NCT03313076|364267855|FG002|Overall Study|Lost to Follow-up|2|||
105618247|NCT03313076|364267856|FG003|Overall Study|Lost to Follow-up|2|||
105618248|NCT04119843|364267857|FG000|Overall Study|Adverse Event|3|||
105618249|NCT04119843|364267857|FG000|Overall Study|Death|1|||
105618250|NCT05869383|364267858|FG000|Overall Study|Withdrawal by Subject|2|||
105618251|NCT05869383|364267859|FG001|Overall Study|Withdrawal by Subject|0|||
105618252|NCT03270501|364267864|FG000|Overall Study|Screen failure|6|||
105618253|NCT03270501|364267864|FG000|Overall Study|Lost to Follow-up|2|||
105618254|NCT03270501|364267864|FG000|Overall Study|Adverse Event|1|||
105618255|NCT01648023|364267865|FG000|Overall Study|Screen Fail Post Randomization|1|||
105618256|NCT01648023|364267866|FG001|Overall Study|Screen Fail Post Randomization|2|||
105618257|NCT00764751|364267871|FG000|Overall Study|Adverse Event|1|||
105618258|NCT00764751|364267872|FG001|Overall Study|Adverse Event|1|||
105618259|NCT00764751|364267871|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
105618260|NCT00764751|364267872|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
105618261|NCT03011333|364267881|FG000|Overall Study|Lost to Follow-up|0|||
105618262|NCT03011333|364267882|FG001|Overall Study|Lost to Follow-up|1|||
105618263|NCT03011333|364267883|FG002|Overall Study|Lost to Follow-up|0|||
105618264|NCT03011333|364267884|FG003|Overall Study|Lost to Follow-up|1|||
105618265|NCT03011333|364267885|FG004|Overall Study|Lost to Follow-up|4|||
105618266|NCT03011333|364267886|FG005|Overall Study|Lost to Follow-up|4|||
105618267|NCT03011333|364267887|FG006|Overall Study|Lost to Follow-up|5|||
105618268|NCT04492722|364267891|FG000|Overall Study|Adverse Event|7|||
105618269|NCT04492722|364267892|FG001|Overall Study|Adverse Event|2|||
105618270|NCT04492722|364267893|FG002|Overall Study|Adverse Event|3|||
105618271|NCT04492722|364267894|FG003|Overall Study|Adverse Event|0|||
105618272|NCT04492722|364267891|FG000|Overall Study|Death|0|||
105618273|NCT04492722|364267892|FG001|Overall Study|Death|0|||
105618274|NCT04492722|364267893|FG002|Overall Study|Death|0|||
105618275|NCT04492722|364267894|FG003|Overall Study|Death|1|||
105618276|NCT04492722|364267891|FG000|Overall Study|Lost to Follow-up|0|||
105618277|NCT04492722|364267892|FG001|Overall Study|Lost to Follow-up|1|||
105618278|NCT04492722|364267893|FG002|Overall Study|Lost to Follow-up|0|||
105618279|NCT04492722|364267894|FG003|Overall Study|Lost to Follow-up|1|||
105618280|NCT04492722|364267891|FG000|Overall Study|Physician Decision|0|||
105618281|NCT04492722|364267892|FG001|Overall Study|Physician Decision|3|||
105618282|NCT04492722|364267893|FG002|Overall Study|Physician Decision|1|||
105618283|NCT04492722|364267894|FG003|Overall Study|Physician Decision|1|||
105618284|NCT04492722|364267891|FG000|Overall Study|Withdrawal by Subject|6|||
105618285|NCT04492722|364267892|FG001|Overall Study|Withdrawal by Subject|6|||
105618286|NCT04492722|364267893|FG002|Overall Study|Withdrawal by Subject|0|||
105618287|NCT04492722|364267894|FG003|Overall Study|Withdrawal by Subject|3|||
105618288|NCT04492722|364267891|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
105618289|NCT04492722|364267892|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
105618290|NCT04492722|364267893|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
105618291|NCT04492722|364267894|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
105618292|NCT04492722|364267891|FG000|Overall Study|Due to Covid-19 pandemic|7|||
105618293|NCT04492722|364267892|FG001|Overall Study|Due to Covid-19 pandemic|3|||
105618294|NCT04492722|364267893|FG002|Overall Study|Due to Covid-19 pandemic|7|||
105618295|NCT04492722|364267894|FG003|Overall Study|Due to Covid-19 pandemic|6|||
105618296|NCT04492722|364267891|FG000|Overall Study|Failure to meet randomisation criteria|2|||
105618297|NCT04492722|364267892|FG001|Overall Study|Failure to meet randomisation criteria|3|||
105618298|NCT04492722|364267893|FG002|Overall Study|Failure to meet randomisation criteria|4|||
105618299|NCT04492722|364267894|FG003|Overall Study|Failure to meet randomisation criteria|2|||
105618300|NCT04492722|364267891|FG000|Overall Study|Early termination from the study|54|||
105618301|NCT04492722|364267892|FG001|Overall Study|Early termination from the study|51|||
105618302|NCT04492722|364267893|FG002|Overall Study|Early termination from the study|50|||
105618303|NCT04492722|364267894|FG003|Overall Study|Early termination from the study|50|||
105618304|NCT04492722|364267891|FG000|Overall Study|Missing|3|||
105618305|NCT04492722|364267892|FG001|Overall Study|Missing|0|||
105618306|NCT04492722|364267893|FG002|Overall Study|Missing|0|||
105618307|NCT04492722|364267894|FG003|Overall Study|Missing|5|||
105618308|NCT04492722|364267891|FG000|Overall Study|Participants who did not receive treatment|0|||
105618309|NCT04492722|364267892|FG001|Overall Study|Participants who did not receive treatment|1|||
105618310|NCT04492722|364267893|FG002|Overall Study|Participants who did not receive treatment|4|||
105618311|NCT04492722|364267894|FG003|Overall Study|Participants who did not receive treatment|0|||
105618312|NCT05329220|364267897|FG000|Active Trial Period|Adverse Event|0|||
105618313|NCT05329220|364267898|FG001|Active Trial Period|Adverse Event|0|||
105618314|NCT05329220|364267899|FG002|Active Trial Period|Adverse Event|0|||
105618315|NCT05329220|364267900|FG003|Active Trial Period|Adverse Event|0|||
105618316|NCT05329220|364267901|FG004|Active Trial Period|Adverse Event|1|||
105618317|NCT05329220|364267902|FG005|Active Trial Period|Adverse Event|0|||
105618318|NCT05329220|364267897|FG000|Active Trial Period|Lost to Follow-up|0|||
105618319|NCT05329220|364267898|FG001|Active Trial Period|Lost to Follow-up|0|||
105618320|NCT05329220|364267899|FG002|Active Trial Period|Lost to Follow-up|0|||
105618321|NCT05329220|364267900|FG003|Active Trial Period|Lost to Follow-up|0|||
105618322|NCT05329220|364267901|FG004|Active Trial Period|Lost to Follow-up|32|||
105618323|NCT05329220|364267902|FG005|Active Trial Period|Lost to Follow-up|28|||
105618324|NCT05329220|364267897|FG000|Active Trial Period|Physician Decision|0|||
105618325|NCT05329220|364267898|FG001|Active Trial Period|Physician Decision|0|||
105618326|NCT05329220|364267899|FG002|Active Trial Period|Physician Decision|0|||
105618327|NCT05329220|364267900|FG003|Active Trial Period|Physician Decision|0|||
105618328|NCT05329220|364267901|FG004|Active Trial Period|Physician Decision|2|||
105618329|NCT05329220|364267902|FG005|Active Trial Period|Physician Decision|0|||
105618330|NCT05329220|364267897|FG000|Active Trial Period|Protocol Violation|0|||
105618331|NCT05329220|364267898|FG001|Active Trial Period|Protocol Violation|0|||
105618332|NCT05329220|364267899|FG002|Active Trial Period|Protocol Violation|0|||
105618333|NCT05329220|364267900|FG003|Active Trial Period|Protocol Violation|0|||
105618334|NCT05329220|364267901|FG004|Active Trial Period|Protocol Violation|1|||
105618335|NCT05329220|364267902|FG005|Active Trial Period|Protocol Violation|3|||
105618336|NCT05329220|364267897|FG000|Active Trial Period|Withdrawal by Subject|0|||
105618337|NCT05329220|364267898|FG001|Active Trial Period|Withdrawal by Subject|0|||
105618338|NCT05329220|364267899|FG002|Active Trial Period|Withdrawal by Subject|0|||
105618339|NCT05329220|364267900|FG003|Active Trial Period|Withdrawal by Subject|1|||
105618340|NCT05329220|364267901|FG004|Active Trial Period|Withdrawal by Subject|12|||
105618341|NCT05329220|364267902|FG005|Active Trial Period|Withdrawal by Subject|13|||
105618342|NCT05329220|364267897|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
105618343|NCT05329220|364267898|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
105618344|NCT05329220|364267899|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
105618345|NCT05329220|364267900|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
105618346|NCT05329220|364267901|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
105618347|NCT05329220|364267902|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
105618348|NCT05329220|364267897|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
105618349|NCT05329220|364267898|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
105618350|NCT05329220|364267899|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
105618351|NCT05329220|364267900|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
105618352|NCT05329220|364267901|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
105618353|NCT05329220|364267902|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
105618354|NCT05329220|364267897|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
105618355|NCT05329220|364267898|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
105618356|NCT05329220|364267899|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
105618357|NCT05329220|364267900|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
105618358|NCT05329220|364267901|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
105618359|NCT05329220|364267902|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
105618360|NCT05329220|364267897|FG000|Follow-up Period|Adverse Event|0|||
105618361|NCT05329220|364267898|FG001|Follow-up Period|Adverse Event|0|||
105618362|NCT05329220|364267899|FG002|Follow-up Period|Adverse Event|0|||
105618363|NCT05329220|364267900|FG003|Follow-up Period|Adverse Event|0|||
105618364|NCT05329220|364267901|FG004|Follow-up Period|Adverse Event|2|||
105618365|NCT05329220|364267902|FG005|Follow-up Period|Adverse Event|1|||
105618366|NCT05329220|364267897|FG000|Follow-up Period|Death|0|||
105618367|NCT05329220|364267898|FG001|Follow-up Period|Death|0|||
105618368|NCT05329220|364267899|FG002|Follow-up Period|Death|1|||
105618369|NCT05329220|364267900|FG003|Follow-up Period|Death|1|||
105618370|NCT05329220|364267901|FG004|Follow-up Period|Death|0|||
105618371|NCT05329220|364267902|FG005|Follow-up Period|Death|1|||
105618372|NCT05329220|364267897|FG000|Follow-up Period|Lost to Follow-up|0|||
105618373|NCT05329220|364267898|FG001|Follow-up Period|Lost to Follow-up|1|||
105618374|NCT05329220|364267899|FG002|Follow-up Period|Lost to Follow-up|2|||
105618375|NCT05329220|364267900|FG003|Follow-up Period|Lost to Follow-up|2|||
105618376|NCT05329220|364267901|FG004|Follow-up Period|Lost to Follow-up|113|||
105618377|NCT05329220|364267902|FG005|Follow-up Period|Lost to Follow-up|89|||
105618378|NCT05329220|364267897|FG000|Follow-up Period|Physician Decision|0|||
105618379|NCT05329220|364267898|FG001|Follow-up Period|Physician Decision|0|||
105618380|NCT05329220|364267899|FG002|Follow-up Period|Physician Decision|0|||
105618381|NCT05329220|364267900|FG003|Follow-up Period|Physician Decision|0|||
105618382|NCT05329220|364267901|FG004|Follow-up Period|Physician Decision|2|||
105618383|NCT05329220|364267902|FG005|Follow-up Period|Physician Decision|2|||
105618384|NCT05329220|364267897|FG000|Follow-up Period|Protocol Violation|0|||
105618385|NCT05329220|364267898|FG001|Follow-up Period|Protocol Violation|0|||
105618386|NCT05329220|364267899|FG002|Follow-up Period|Protocol Violation|0|||
105618387|NCT05329220|364267900|FG003|Follow-up Period|Protocol Violation|0|||
105618388|NCT05329220|364267901|FG004|Follow-up Period|Protocol Violation|0|||
105618389|NCT05329220|364267902|FG005|Follow-up Period|Protocol Violation|1|||
105618390|NCT05329220|364267897|FG000|Follow-up Period|Withdrawal by Subject|0|||
105618391|NCT05329220|364267898|FG001|Follow-up Period|Withdrawal by Subject|0|||
105618392|NCT05329220|364267899|FG002|Follow-up Period|Withdrawal by Subject|1|||
105618393|NCT05329220|364267900|FG003|Follow-up Period|Withdrawal by Subject|1|||
105618394|NCT05329220|364267901|FG004|Follow-up Period|Withdrawal by Subject|34|||
105618395|NCT05329220|364267902|FG005|Follow-up Period|Withdrawal by Subject|35|||
105618396|NCT05329220|364267897|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
105618397|NCT05329220|364267898|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
105618398|NCT05329220|364267899|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
105618399|NCT05329220|364267900|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
105618400|NCT05329220|364267901|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
105618401|NCT05329220|364267902|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
105618402|NCT05329220|364267897|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
105618403|NCT05329220|364267898|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
105618404|NCT05329220|364267899|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
105618405|NCT05329220|364267900|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
105618406|NCT05329220|364267901|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
105618407|NCT05329220|364267902|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
105618408|NCT05329220|364267897|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
105618409|NCT05329220|364267898|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
105618410|NCT05329220|364267899|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
105618411|NCT05329220|364267900|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
105618412|NCT05329220|364267901|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
105618413|NCT05329220|364267902|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
105618414|NCT05329220|364267897|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
105618415|NCT05329220|364267898|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
105618416|NCT05329220|364267899|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
105618417|NCT05329220|364267900|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
105618418|NCT05329220|364267901|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
105618419|NCT05329220|364267902|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
105618420|NCT05329220|364267897|FG000|Follow-up Period|EARLY TERMINATION|0|||
105618421|NCT05329220|364267898|FG001|Follow-up Period|EARLY TERMINATION|0|||
105618422|NCT05329220|364267899|FG002|Follow-up Period|EARLY TERMINATION|0|||
105618423|NCT05329220|364267900|FG003|Follow-up Period|EARLY TERMINATION|0|||
105618424|NCT05329220|364267901|FG004|Follow-up Period|EARLY TERMINATION|0|||
105618425|NCT05329220|364267902|FG005|Follow-up Period|EARLY TERMINATION|1|||
105618426|NCT05329220|364267897|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
105618427|NCT05329220|364267898|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
105618428|NCT05329220|364267899|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
105618429|NCT05329220|364267900|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
105618430|NCT05329220|364267901|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
105618431|NCT05329220|364267902|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
105618432|NCT05329220|364267897|FG000|Follow-up Period|DROPPED|0|||
105618433|NCT05329220|364267898|FG001|Follow-up Period|DROPPED|0|||
105618434|NCT05329220|364267899|FG002|Follow-up Period|DROPPED|0|||
105618435|NCT05329220|364267900|FG003|Follow-up Period|DROPPED|0|||
105618436|NCT05329220|364267901|FG004|Follow-up Period|DROPPED|0|||
105618437|NCT05329220|364267902|FG005|Follow-up Period|DROPPED|1|||
105618438|NCT05329220|364267897|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
105618439|NCT05329220|364267898|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
105618440|NCT05329220|364267899|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
105618441|NCT05329220|364267900|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
105618442|NCT05329220|364267901|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
105618443|NCT05329220|364267902|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
105618444|NCT05808257|364267905|FG000|Overall Study|Lost to Follow-up|8|||
105618445|NCT05808257|364267906|FG001|Overall Study|Lost to Follow-up|8|||
105618446|NCT05792085|364267907|FG000|Overall Study|Death|0|||
105618447|NCT05792085|364267908|FG001|Overall Study|Death|0|||
105618448|NCT05792085|364267909|FG002|Overall Study|Death|0|||
105618449|NCT05792085|364267910|FG003|Overall Study|Death|0|||
105618450|NCT05792085|364267911|FG004|Overall Study|Death|1|||
105618451|NCT05977530|364267914|FG000|Overall Study|Withdrawal by Subject|1|||
105618452|NCT05977530|364267914|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
105618453|NCT01467427|364267924|FG000|Overall Study|Withdrawal by Subject|1|||
105618454|NCT01467427|364267925|FG001|Overall Study|Withdrawal by Subject|0|||
105618455|NCT01467427|364267924|FG000|Overall Study|Not continuing in extension phase|0|||
105618456|NCT01467427|364267925|FG001|Overall Study|Not continuing in extension phase|2|||
105618457|NCT01467427|364267924|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
105618458|NCT01467427|364267925|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
105618459|NCT01467427|364267924|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
105618460|NCT01467427|364267925|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
105618461|NCT01467427|364267924|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
105618462|NCT01467427|364267925|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
105618463|NCT01467427|364267924|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
105618464|NCT01467427|364267925|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
105618465|NCT03161028|364267926|FG000|Overall Study|Withdrawal by Subject|6|||
105618466|NCT03161028|364267927|FG001|Overall Study|Withdrawal by Subject|4|||
105618467|NCT03161028|364267926|FG000|Overall Study|Adverse Event|5|||
105618468|NCT03161028|364267927|FG001|Overall Study|Adverse Event|1|||
105618469|NCT03161028|364267926|FG000|Overall Study|Study drug side effects|2|||
105618470|NCT03161028|364267927|FG001|Overall Study|Study drug side effects|2|||
105618471|NCT03161028|364267926|FG000|Overall Study|Administrative PD/UP|4|||
105618472|NCT03161028|364267927|FG001|Overall Study|Administrative PD/UP|2|||
105618473|NCT03161028|364267926|FG000|Overall Study|Lost to Follow-up|2|||
105618474|NCT03161028|364267927|FG001|Overall Study|Lost to Follow-up|0|||
105618475|NCT03161028|364267926|FG000|Overall Study|Unable to comply with procedures|1|||
105618476|NCT03161028|364267927|FG001|Overall Study|Unable to comply with procedures|1|||
105618477|NCT06232590|364267928|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
105618478|NCT06232590|364267929|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
105618479|NCT05566639|364267936|FG000|Overall Study|Adverse Event|1|||
105618480|NCT05566639|364267937|FG001|Overall Study|Adverse Event|1|||
105618481|NCT05566639|364267936|FG000|Overall Study|Serious Adverse Event|1|||
105618482|NCT05566639|364267937|FG001|Overall Study|Serious Adverse Event|3|||
105618483|NCT05566639|364267936|FG000|Overall Study|Death|44|||
105618484|NCT05566639|364267937|FG001|Overall Study|Death|45|||
105618485|NCT05566639|364267936|FG000|Overall Study|Lost to Follow-up|467|||
105618486|NCT05566639|364267937|FG001|Overall Study|Lost to Follow-up|461|||
105618487|NCT05566639|364267936|FG000|Overall Study|Physician Decision|45|||
105618488|NCT05566639|364267937|FG001|Overall Study|Physician Decision|44|||
105618489|NCT05566639|364267936|FG000|Overall Study|Protocol Deviation|4|||
105618490|NCT05566639|364267937|FG001|Overall Study|Protocol Deviation|4|||
105618491|NCT05566639|364267936|FG000|Overall Study|Withdrawal by Subject|277|||
105618492|NCT05566639|364267937|FG001|Overall Study|Withdrawal by Subject|271|||
105618493|NCT05566639|364267936|FG000|Overall Study|Other Than Specified|52|||
105618494|NCT05566639|364267937|FG001|Overall Study|Other Than Specified|64|||
105618495|NCT02364557|364267939|FG000|Overall Study|Protocol Violation|3|||
105618496|NCT02364557|364267940|FG001|Overall Study|Protocol Violation|1|||
105618497|NCT03785964|364267942|FG000|Overall Study|Adverse Event|14|||
105618498|NCT03785964|364267943|FG001|Overall Study|Adverse Event|1|||
105618499|NCT03785964|364267942|FG000|Overall Study|Unqualified Clinical Progression|1|||
105618500|NCT03785964|364267943|FG001|Overall Study|Unqualified Clinical Progression|1|||
105618501|NCT03785964|364267942|FG000|Overall Study|Participant non-compliance|1|||
105618502|NCT03785964|364267943|FG001|Overall Study|Participant non-compliance|1|||
105618503|NCT03785964|364267942|FG000|Overall Study|Not treated|1|||
105618504|NCT03785964|364267943|FG001|Overall Study|Not treated|0|||
105618505|NCT03785964|364267942|FG000|Overall Study|Other reason|5|||
105618506|NCT03785964|364267943|FG001|Overall Study|Other reason|11|||
105618507|NCT03785964|364267942|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
105618508|NCT03785964|364267943|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
105618509|NCT04550221|364267944|FG000|Overall Study|Lost to Follow-up|0|||
105618510|NCT04550221|364267945|FG001|Overall Study|Lost to Follow-up|4|||
105618511|NCT04550221|364267944|FG000|Overall Study|Withdrawn|3|||
105618512|NCT04550221|364267945|FG001|Overall Study|Withdrawn|0|||
105618513|NCT04550221|364267944|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
105618514|NCT04550221|364267945|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
105618515|NCT04802967|364269953|FG000|Part B|Withdrawal by Subject|0|||
105618516|NCT04802967|364269954|FG001|Part B|Withdrawal by Subject|0|||
105618517|NCT04802967|364269955|FG002|Part B|Withdrawal by Subject|0|||
105618518|NCT04802967|364269956|FG003|Part B|Withdrawal by Subject|0|||
105618519|NCT04802967|364269957|FG004|Part B|Withdrawal by Subject|0|||
105618520|NCT04802967|364269958|FG005|Part B|Withdrawal by Subject|1|||
105618521|NCT04802967|364269959|FG006|Part B|Withdrawal by Subject|0|||
105618522|NCT04802967|364269960|FG007|Part B|Withdrawal by Subject|0|||
105618523|NCT04802967|364269961|FG008|Part B|Withdrawal by Subject|0|||
105618524|NCT04802967|364269962|FG009|Part B|Withdrawal by Subject|0|||
105618525|NCT01129102|364269963|FG000|Overall Study|No study drug treatment|2|||
105618526|NCT01129102|364269964|FG001|Overall Study|No study drug treatment|3|||
105618527|NCT01129102|364269965|FG002|Overall Study|No study drug treatment|1|||
105618528|NCT01129102|364269963|FG000|Overall Study|Withdrawal by Subject|2|||
105618529|NCT01129102|364269964|FG001|Overall Study|Withdrawal by Subject|0|||
105618530|NCT01129102|364269965|FG002|Overall Study|Withdrawal by Subject|3|||
105618531|NCT01129102|364269963|FG000|Overall Study|Protocol Violation|0|||
105618532|NCT01129102|364269964|FG001|Overall Study|Protocol Violation|1|||
105618533|NCT01129102|364269965|FG002|Overall Study|Protocol Violation|1|||
105618534|NCT01129102|364269963|FG000|Overall Study|Pregnancy|0|||
105618535|NCT01129102|364269964|FG001|Overall Study|Pregnancy|0|||
105618536|NCT01129102|364269965|FG002|Overall Study|Pregnancy|1|||
105618537|NCT01129102|364269963|FG000|Overall Study|Adverse Event|2|||
105618538|NCT01129102|364269964|FG001|Overall Study|Adverse Event|2|||
105618539|NCT01129102|364269965|FG002|Overall Study|Adverse Event|1|||
105618540|NCT01129102|364269963|FG000|Overall Study|Lost to Follow-up|2|||
105618541|NCT01129102|364269964|FG001|Overall Study|Lost to Follow-up|0|||
105618542|NCT01129102|364269965|FG002|Overall Study|Lost to Follow-up|0|||
105618543|NCT03379675|364269968|FG000|Overall Study|Lost to Follow-up|0|||
105618544|NCT03379675|364269969|FG001|Overall Study|Lost to Follow-up|1|||
105618545|NCT03379675|364269970|FG002|Overall Study|Lost to Follow-up|0|||
105618546|NCT03379675|364269968|FG000|Overall Study|Adverse Event|2|||
105618547|NCT03379675|364269969|FG001|Overall Study|Adverse Event|0|||
105618548|NCT03379675|364269970|FG002|Overall Study|Adverse Event|0|||
105618549|NCT03379675|364269968|FG000|Overall Study|Withdrawal by Subject|2|||
105618550|NCT03379675|364269969|FG001|Overall Study|Withdrawal by Subject|1|||
105618551|NCT03379675|364269970|FG002|Overall Study|Withdrawal by Subject|2|||
105618552|NCT03381196|364269971|FG000|Overall Study|Withdrawal by Subject|7|||
105618553|NCT03381196|364269972|FG001|Overall Study|Withdrawal by Subject|7|||
105618554|NCT03381196|364269971|FG000|Overall Study|Other|0|||
105618555|NCT03381196|364269972|FG001|Overall Study|Other|1|||
105618556|NCT03381196|364269971|FG000|Overall Study|Lost to Follow-up|5|||
105618557|NCT03381196|364269972|FG001|Overall Study|Lost to Follow-up|4|||
105618558|NCT03381196|364269971|FG000|Overall Study|Death|0|||
105618559|NCT03381196|364269972|FG001|Overall Study|Death|1|||
105618560|NCT03381196|364269971|FG000|Overall Study|Adverse Event|1|||
105618561|NCT03381196|364269972|FG001|Overall Study|Adverse Event|0|||
105618562|NCT03381196|364269971|FG000|Overall Study|Randomized, not treated|3|||
105618563|NCT03381196|364269972|FG001|Overall Study|Randomized, not treated|6|||
105618564|NCT05499377|364269983|FG000|Overall Study|Withdrawal by Subject|2|||
105618565|NCT05499377|364269984|FG001|Overall Study|Withdrawal by Subject|0|||
105618566|NCT05499377|364269983|FG000|Overall Study|Physician Decision|1|||
105618567|NCT05499377|364269984|FG001|Overall Study|Physician Decision|0|||
105618568|NCT02573493|364269985|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
105618569|NCT02573493|364269986|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
105618570|NCT02573493|364269987|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
105618571|NCT02573493|364269988|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
105618572|NCT03854227|364269989|FG000|Overall Study|Adverse Event|0|||
105618573|NCT03854227|364269990|FG001|Overall Study|Adverse Event|0|||
105618574|NCT03854227|364269991|FG002|Overall Study|Adverse Event|0|||
105618575|NCT03854227|364269992|FG003|Overall Study|Adverse Event|1|||
105618576|NCT03854227|364269993|FG004|Overall Study|Adverse Event|0|||
105618577|NCT03854227|364269994|FG005|Overall Study|Adverse Event|0|||
105618578|NCT03854227|364269995|FG006|Overall Study|Adverse Event|1|||
105618579|NCT03854227|364269996|FG007|Overall Study|Adverse Event|0|||
105618580|NCT03854227|364269997|FG008|Overall Study|Adverse Event|0|||
105618581|NCT03854227|364269998|FG009|Overall Study|Adverse Event|3|||
105618582|NCT03854227|364269999|FG010|Overall Study|Adverse Event|0|||
105618583|NCT03854227|364270000|FG011|Overall Study|Adverse Event|1|||
105618584|NCT03854227|364269989|FG000|Overall Study|Death|0|||
105618585|NCT03854227|364269990|FG001|Overall Study|Death|0|||
105618586|NCT03854227|364269991|FG002|Overall Study|Death|0|||
105618587|NCT03854227|364269992|FG003|Overall Study|Death|0|||
105618588|NCT03854227|364269993|FG004|Overall Study|Death|0|||
105618589|NCT03854227|364269994|FG005|Overall Study|Death|1|||
105618590|NCT03854227|364269995|FG006|Overall Study|Death|0|||
105618591|NCT03854227|364269996|FG007|Overall Study|Death|0|||
105618592|NCT03854227|364269997|FG008|Overall Study|Death|0|||
105618593|NCT03854227|364269998|FG009|Overall Study|Death|1|||
105618594|NCT03854227|364269999|FG010|Overall Study|Death|0|||
105618595|NCT03854227|364270000|FG011|Overall Study|Death|1|||
105618596|NCT03854227|364269989|FG000|Overall Study|Physician Decision|0|||
105618597|NCT03854227|364269990|FG001|Overall Study|Physician Decision|0|||
105618598|NCT03854227|364269991|FG002|Overall Study|Physician Decision|0|||
105618599|NCT03854227|364269992|FG003|Overall Study|Physician Decision|0|||
105618600|NCT03854227|364269993|FG004|Overall Study|Physician Decision|0|||
105618601|NCT03854227|364269994|FG005|Overall Study|Physician Decision|1|||
105618602|NCT03854227|364269995|FG006|Overall Study|Physician Decision|0|||
105618603|NCT03854227|364269996|FG007|Overall Study|Physician Decision|0|||
105618604|NCT03854227|364269997|FG008|Overall Study|Physician Decision|1|||
105618605|NCT03854227|364269998|FG009|Overall Study|Physician Decision|1|||
105618606|NCT03854227|364269999|FG010|Overall Study|Physician Decision|0|||
105618607|NCT03854227|364270000|FG011|Overall Study|Physician Decision|1|||
105618608|NCT03854227|364269989|FG000|Overall Study|Progressive disease|1|||
105618609|NCT03854227|364269990|FG001|Overall Study|Progressive disease|1|||
105618610|NCT03854227|364269991|FG002|Overall Study|Progressive disease|1|||
105618611|NCT03854227|364269992|FG003|Overall Study|Progressive disease|2|||
105618612|NCT03854227|364269993|FG004|Overall Study|Progressive disease|3|||
105618613|NCT03854227|364269994|FG005|Overall Study|Progressive disease|1|||
105618614|NCT03854227|364269995|FG006|Overall Study|Progressive disease|2|||
105618615|NCT03854227|364269996|FG007|Overall Study|Progressive disease|5|||
105618616|NCT03854227|364269997|FG008|Overall Study|Progressive disease|2|||
105618617|NCT03854227|364269998|FG009|Overall Study|Progressive disease|5|||
105618618|NCT03854227|364269999|FG010|Overall Study|Progressive disease|1|||
105618619|NCT03854227|364270000|FG011|Overall Study|Progressive disease|6|||
105618620|NCT03854227|364269989|FG000|Overall Study|Study terminated by sponsor|0|||
105618621|NCT03854227|364269990|FG001|Overall Study|Study terminated by sponsor|0|||
105618622|NCT03854227|364269991|FG002|Overall Study|Study terminated by sponsor|0|||
105618623|NCT03854227|364269992|FG003|Overall Study|Study terminated by sponsor|0|||
105618624|NCT03854227|364269993|FG004|Overall Study|Study terminated by sponsor|0|||
105618625|NCT03854227|364269994|FG005|Overall Study|Study terminated by sponsor|0|||
105618626|NCT03854227|364269995|FG006|Overall Study|Study terminated by sponsor|0|||
105618627|NCT03854227|364269996|FG007|Overall Study|Study terminated by sponsor|0|||
105618628|NCT03854227|364269997|FG008|Overall Study|Study terminated by sponsor|0|||
105618629|NCT03854227|364269998|FG009|Overall Study|Study terminated by sponsor|1|||
105618630|NCT03854227|364269999|FG010|Overall Study|Study terminated by sponsor|0|||
105618631|NCT03854227|364270000|FG011|Overall Study|Study terminated by sponsor|0|||
105618632|NCT03854227|364269989|FG000|Overall Study|Withdrawal by Subject|0|||
105618633|NCT03854227|364269990|FG001|Overall Study|Withdrawal by Subject|0|||
105618634|NCT03854227|364269991|FG002|Overall Study|Withdrawal by Subject|1|||
105618635|NCT03854227|364269992|FG003|Overall Study|Withdrawal by Subject|0|||
105618636|NCT03854227|364269993|FG004|Overall Study|Withdrawal by Subject|0|||
105618637|NCT03854227|364269994|FG005|Overall Study|Withdrawal by Subject|0|||
105618638|NCT03854227|364269995|FG006|Overall Study|Withdrawal by Subject|0|||
105618639|NCT03854227|364269996|FG007|Overall Study|Withdrawal by Subject|0|||
105618640|NCT03854227|364269997|FG008|Overall Study|Withdrawal by Subject|0|||
105618641|NCT03854227|364269998|FG009|Overall Study|Withdrawal by Subject|1|||
105618642|NCT03854227|364269999|FG010|Overall Study|Withdrawal by Subject|1|||
105618643|NCT03854227|364270000|FG011|Overall Study|Withdrawal by Subject|0|||
105618644|NCT03854227|364269989|FG000|Overall Study|Disease relapse|0|||
105618645|NCT03854227|364269990|FG001|Overall Study|Disease relapse|0|||
105618646|NCT03854227|364269991|FG002|Overall Study|Disease relapse|0|||
105618647|NCT03854227|364269992|FG003|Overall Study|Disease relapse|0|||
105618648|NCT03854227|364269993|FG004|Overall Study|Disease relapse|0|||
105618649|NCT03854227|364269994|FG005|Overall Study|Disease relapse|0|||
105618650|NCT03854227|364269995|FG006|Overall Study|Disease relapse|0|||
105618651|NCT03854227|364269996|FG007|Overall Study|Disease relapse|0|||
105618652|NCT03854227|364269997|FG008|Overall Study|Disease relapse|1|||
105618653|NCT03854227|364269998|FG009|Overall Study|Disease relapse|0|||
105618654|NCT03854227|364269999|FG010|Overall Study|Disease relapse|0|||
105618655|NCT03854227|364270000|FG011|Overall Study|Disease relapse|0|||
105618656|NCT03854227|364269989|FG000|Overall Study|Global deterioration of health status|0|||
105618657|NCT03854227|364269990|FG001|Overall Study|Global deterioration of health status|0|||
105618658|NCT03854227|364269991|FG002|Overall Study|Global deterioration of health status|0|||
105618659|NCT03854227|364269992|FG003|Overall Study|Global deterioration of health status|0|||
105618660|NCT03854227|364269993|FG004|Overall Study|Global deterioration of health status|0|||
105618661|NCT03854227|364269994|FG005|Overall Study|Global deterioration of health status|1|||
105618662|NCT03854227|364269995|FG006|Overall Study|Global deterioration of health status|0|||
105618663|NCT03854227|364269996|FG007|Overall Study|Global deterioration of health status|1|||
105618664|NCT03854227|364269997|FG008|Overall Study|Global deterioration of health status|0|||
105618665|NCT03854227|364269998|FG009|Overall Study|Global deterioration of health status|0|||
105618666|NCT03854227|364269999|FG010|Overall Study|Global deterioration of health status|0|||
105618667|NCT03854227|364270000|FG011|Overall Study|Global deterioration of health status|0|||
105618668|NCT03854227|364269989|FG000|Overall Study|Refused further treatment|0|||
105618669|NCT03854227|364269990|FG001|Overall Study|Refused further treatment|0|||
105618670|NCT03854227|364269991|FG002|Overall Study|Refused further treatment|0|||
105618671|NCT03854227|364269992|FG003|Overall Study|Refused further treatment|0|||
105618672|NCT03854227|364269993|FG004|Overall Study|Refused further treatment|0|||
105618673|NCT03854227|364269994|FG005|Overall Study|Refused further treatment|0|||
105618674|NCT03854227|364269995|FG006|Overall Study|Refused further treatment|0|||
105618675|NCT03854227|364269996|FG007|Overall Study|Refused further treatment|0|||
105618676|NCT03854227|364269997|FG008|Overall Study|Refused further treatment|0|||
105618677|NCT03854227|364269998|FG009|Overall Study|Refused further treatment|1|||
105618678|NCT03854227|364269999|FG010|Overall Study|Refused further treatment|0|||
105618679|NCT03854227|364270000|FG011|Overall Study|Refused further treatment|1|||
105618680|NCT03854227|364269989|FG000|Overall Study|Other|0|||
105618681|NCT03854227|364269990|FG001|Overall Study|Other|0|||
105618682|NCT03854227|364269991|FG002|Overall Study|Other|0|||
105618683|NCT03854227|364269992|FG003|Overall Study|Other|0|||
105618684|NCT03854227|364269993|FG004|Overall Study|Other|0|||
105618685|NCT03854227|364269994|FG005|Overall Study|Other|0|||
105618686|NCT03854227|364269995|FG006|Overall Study|Other|0|||
105618687|NCT03854227|364269996|FG007|Overall Study|Other|0|||
105618688|NCT03854227|364269997|FG008|Overall Study|Other|1|||
105618689|NCT03854227|364269998|FG009|Overall Study|Other|1|||
105618690|NCT03854227|364269999|FG010|Overall Study|Other|0|||
105618691|NCT03854227|364270000|FG011|Overall Study|Other|0|||
105618692|NCT03748953|364270004|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
105618693|NCT03748953|364270005|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
105618694|NCT03748953|364270004|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
105618695|NCT03748953|364270005|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
105618696|NCT03748953|364270004|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
105618697|NCT03748953|364270005|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
105618698|NCT03748953|364270004|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
105618699|NCT03748953|364270005|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
105618700|NCT03748953|364270004|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
105618701|NCT03748953|364270005|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
105618702|NCT02276885|364270006|FG000|Overall Study|Withdrawal by Subject|2|||
105618703|NCT02276885|364270007|FG001|Overall Study|Withdrawal by Subject|0|||
105618704|NCT02276885|364270006|FG000|Overall Study|Lost to Follow-up|5|||
105618705|NCT02276885|364270007|FG001|Overall Study|Lost to Follow-up|2|||
105618706|NCT04044768|364270009|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
105618707|NCT04044768|364270010|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
105618708|NCT05089019|364270012|FG000|Period 1|Withdrawal by Subject|0|||
105618709|NCT05089019|364270013|FG001|Period 1|Withdrawal by Subject|1|||
105618710|NCT05089019|364270012|FG000|Washout Period|Adverse Event|3|||
105618711|NCT05089019|364270013|FG001|Washout Period|Adverse Event|4|||
105618712|NCT05089019|364270012|FG000|Washout Period|Lost to Follow-up|1|||
105618713|NCT05089019|364270013|FG001|Washout Period|Lost to Follow-up|0|||
105618714|NCT05089019|364270012|FG000|Washout Period|Physician Decision|2|||
105618715|NCT05089019|364270013|FG001|Washout Period|Physician Decision|0|||
105618716|NCT05089019|364270012|FG000|Washout Period|Withdrawal by Subject|6|||
105618717|NCT05089019|364270013|FG001|Washout Period|Withdrawal by Subject|3|||
105618718|NCT05089019|364270012|FG000|Period 2|Adverse Event|4|||
105618719|NCT05089019|364270013|FG001|Period 2|Adverse Event|2|||
105618720|NCT05089019|364270012|FG000|Period 2|Lost to Follow-up|1|||
105618721|NCT05089019|364270013|FG001|Period 2|Lost to Follow-up|0|||
105618722|NCT05089019|364270012|FG000|Period 2|Withdrawal by Subject|0|||
105618723|NCT05089019|364270013|FG001|Period 2|Withdrawal by Subject|1|||
105618724|NCT05170009|364270014|FG000|Overall Study|Physician Decision|0|||
105618725|NCT05170009|364270015|FG001|Overall Study|Physician Decision|1|||
105618726|NCT03904147|364270017|FG000|Overall Study|Death|15|||
105618727|NCT03904147|364270018|FG001|Overall Study|Death|13|||
105618728|NCT03904147|364270019|FG002|Overall Study|Death|15|||
105618729|NCT03904147|364270017|FG000|Overall Study|Withdrawal by Subject|7|||
105618730|NCT03904147|364270018|FG001|Overall Study|Withdrawal by Subject|12|||
105618731|NCT03904147|364270019|FG002|Overall Study|Withdrawal by Subject|1|||
105618732|NCT03904147|364270017|FG000|Overall Study|1Y visit completed after 365 days|1|||
105618733|NCT03904147|364270018|FG001|Overall Study|1Y visit completed after 365 days|1|||
105618734|NCT03904147|364270019|FG002|Overall Study|1Y visit completed after 365 days|0|||
105618735|NCT02841579|364270020|FG000|Overall Study|Death|1|||
105618736|NCT02841579|364270020|FG000|Overall Study|Adverse Event|1|||
105618737|NCT02841579|364270020|FG000|Overall Study|Lack of Efficacy|9|||
105618738|NCT04233216|364270023|FG000|Overall Study|Lost to Follow-up|1|||
105618739|NCT04233216|364270024|FG001|Overall Study|Lost to Follow-up|0|||
105618740|NCT04233216|364270025|FG002|Overall Study|Lost to Follow-up|2|||
105618741|NCT04233216|364270026|FG003|Overall Study|Lost to Follow-up|0|||
105618742|NCT04233216|364270023|FG000|Overall Study|Physician Decision|0|||
105618743|NCT04233216|364270024|FG001|Overall Study|Physician Decision|3|||
105618744|NCT04233216|364270025|FG002|Overall Study|Physician Decision|0|||
105618745|NCT04233216|364270026|FG003|Overall Study|Physician Decision|2|||
105618746|NCT04233216|364270023|FG000|Overall Study|Withdrawal by Subject|0|||
105618747|NCT04233216|364270024|FG001|Overall Study|Withdrawal by Subject|2|||
105618748|NCT04233216|364270025|FG002|Overall Study|Withdrawal by Subject|1|||
105618749|NCT04233216|364270026|FG003|Overall Study|Withdrawal by Subject|0|||
105618750|NCT04137289|364270027|FG000|Overall Study|Death|0|||
105618751|NCT04137289|364270028|FG001|Overall Study|Death|0|||
105618752|NCT04137289|364270029|FG002|Overall Study|Death|0|||
105618753|NCT04137289|364270030|FG003|Overall Study|Death|0|||
105618754|NCT04137289|364270031|FG004|Overall Study|Death|0|||
105618755|NCT04137289|364270032|FG005|Overall Study|Death|0|||
105618756|NCT04137289|364270033|FG006|Overall Study|Death|1|||
105618757|NCT04137289|364270034|FG007|Overall Study|Death|0|||
105618758|NCT04137289|364270035|FG008|Overall Study|Death|0|||
105618759|NCT04137289|364270027|FG000|Overall Study|Clinical disease progression|0|||
105618760|NCT04137289|364270028|FG001|Overall Study|Clinical disease progression|0|||
105618761|NCT04137289|364270029|FG002|Overall Study|Clinical disease progression|0|||
105618762|NCT04137289|364270030|FG003|Overall Study|Clinical disease progression|4|||
105618763|NCT04137289|364270031|FG004|Overall Study|Clinical disease progression|4|||
105618764|NCT04137289|364270032|FG005|Overall Study|Clinical disease progression|2|||
105618765|NCT04137289|364270033|FG006|Overall Study|Clinical disease progression|5|||
105618766|NCT04137289|364270034|FG007|Overall Study|Clinical disease progression|1|||
105618767|NCT04137289|364270035|FG008|Overall Study|Clinical disease progression|0|||
105618768|NCT04137289|364270027|FG000|Overall Study|Lost to Follow-up|0|||
105618769|NCT04137289|364270028|FG001|Overall Study|Lost to Follow-up|0|||
105618770|NCT04137289|364270029|FG002|Overall Study|Lost to Follow-up|0|||
105618771|NCT04137289|364270030|FG003|Overall Study|Lost to Follow-up|1|||
105618772|NCT04137289|364270031|FG004|Overall Study|Lost to Follow-up|0|||
105618773|NCT04137289|364270032|FG005|Overall Study|Lost to Follow-up|0|||
105618774|NCT04137289|364270033|FG006|Overall Study|Lost to Follow-up|0|||
105618775|NCT04137289|364270034|FG007|Overall Study|Lost to Follow-up|0|||
105618776|NCT04137289|364270035|FG008|Overall Study|Lost to Follow-up|0|||
105618777|NCT04137289|364270027|FG000|Overall Study|Adverse Event|0|||
105618778|NCT04137289|364270028|FG001|Overall Study|Adverse Event|0|||
105618779|NCT04137289|364270029|FG002|Overall Study|Adverse Event|1|||
105618780|NCT04137289|364270030|FG003|Overall Study|Adverse Event|0|||
105618781|NCT04137289|364270031|FG004|Overall Study|Adverse Event|0|||
105618782|NCT04137289|364270032|FG005|Overall Study|Adverse Event|1|||
105618783|NCT04137289|364270033|FG006|Overall Study|Adverse Event|0|||
105618784|NCT04137289|364270034|FG007|Overall Study|Adverse Event|0|||
105618785|NCT04137289|364270035|FG008|Overall Study|Adverse Event|0|||
105618786|NCT04137289|364270027|FG000|Overall Study|Lack of clinical benefit|0|||
105618787|NCT04137289|364270028|FG001|Overall Study|Lack of clinical benefit|0|||
105618788|NCT04137289|364270029|FG002|Overall Study|Lack of clinical benefit|0|||
105618789|NCT04137289|364270030|FG003|Overall Study|Lack of clinical benefit|0|||
105618790|NCT04137289|364270031|FG004|Overall Study|Lack of clinical benefit|0|||
105618791|NCT04137289|364270032|FG005|Overall Study|Lack of clinical benefit|0|||
105618792|NCT04137289|364270033|FG006|Overall Study|Lack of clinical benefit|0|||
105618793|NCT04137289|364270034|FG007|Overall Study|Lack of clinical benefit|0|||
105618794|NCT04137289|364270035|FG008|Overall Study|Lack of clinical benefit|1|||
105618795|NCT04137289|364270027|FG000|Overall Study|Objective disease progression|1|||
105618796|NCT04137289|364270028|FG001|Overall Study|Objective disease progression|1|||
105618797|NCT04137289|364270029|FG002|Overall Study|Objective disease progression|6|||
105618798|NCT04137289|364270030|FG003|Overall Study|Objective disease progression|18|||
105618799|NCT04137289|364270031|FG004|Overall Study|Objective disease progression|12|||
105618800|NCT04137289|364270032|FG005|Overall Study|Objective disease progression|20|||
105618801|NCT04137289|364270033|FG006|Overall Study|Objective disease progression|18|||
105618802|NCT04137289|364270034|FG007|Overall Study|Objective disease progression|7|||
105618803|NCT04137289|364270035|FG008|Overall Study|Objective disease progression|6|||
105618804|NCT04307355|364270036|FG000|Overall Study|Non-Compliance|3|||
105618805|NCT04307355|364270037|FG001|Overall Study|Non-Compliance|3|||
105618806|NCT04307355|364270038|FG002|Overall Study|Non-Compliance|0|||
105618807|NCT04225273|364270042|FG000|Overall Study|Lost to Follow-up|3|||
105618808|NCT04413708|364270044|FG000|Overall Study|Lost to Follow-up|1|||
105618809|NCT04413708|364270045|FG001|Overall Study|Lost to Follow-up|2|||
105618810|NCT04074759|364270051|FG000|Overall Study|Withdrawal by Subject|0|||
105618811|NCT04074759|364270052|FG001|Overall Study|Withdrawal by Subject|0|||
105618812|NCT04074759|364270053|FG002|Overall Study|Withdrawal by Subject|0|||
105618813|NCT04074759|364270054|FG003|Overall Study|Withdrawal by Subject|0|||
105618814|NCT04074759|364270055|FG004|Overall Study|Withdrawal by Subject|0|||
105618815|NCT04074759|364270056|FG005|Overall Study|Withdrawal by Subject|2|||
105618816|NCT04074759|364270057|FG006|Overall Study|Withdrawal by Subject|0|||
105618817|NCT04074759|364270058|FG007|Overall Study|Withdrawal by Subject|2|||
105618818|NCT04074759|364270059|FG008|Overall Study|Withdrawal by Subject|1|||
105618819|NCT04074759|364270060|FG009|Overall Study|Withdrawal by Subject|2|||
105618820|NCT04074759|364270061|FG010|Overall Study|Withdrawal by Subject|9|||
105618821|NCT04074759|364270062|FG011|Overall Study|Withdrawal by Subject|2|||
105618822|NCT04074759|364270063|FG012|Overall Study|Withdrawal by Subject|1|||
105618823|NCT04074759|364270064|FG013|Overall Study|Withdrawal by Subject|3|||
105618824|NCT04074759|364270065|FG014|Overall Study|Withdrawal by Subject|2|||
105618825|NCT04074759|364270066|FG015|Overall Study|Withdrawal by Subject|0|||
105618826|NCT04074759|364270067|FG016|Overall Study|Withdrawal by Subject|0|||
105618827|NCT04074759|364270068|FG017|Overall Study|Withdrawal by Subject|3|||
105618828|NCT04074759|364270069|FG018|Overall Study|Withdrawal by Subject|1|||
105618829|NCT04074759|364270051|FG000|Overall Study|Death|1|||
105618830|NCT04074759|364270052|FG001|Overall Study|Death|0|||
105618831|NCT04074759|364270053|FG002|Overall Study|Death|1|||
105618832|NCT04074759|364270054|FG003|Overall Study|Death|1|||
105618833|NCT04074759|364270055|FG004|Overall Study|Death|2|||
105618834|NCT04074759|364270056|FG005|Overall Study|Death|0|||
105618835|NCT04074759|364270057|FG006|Overall Study|Death|1|||
105618836|NCT04074759|364270058|FG007|Overall Study|Death|0|||
105618837|NCT04074759|364270059|FG008|Overall Study|Death|3|||
105618838|NCT04074759|364270060|FG009|Overall Study|Death|2|||
105618839|NCT04074759|364270061|FG010|Overall Study|Death|4|||
105618840|NCT04074759|364270062|FG011|Overall Study|Death|1|||
105618841|NCT04074759|364270063|FG012|Overall Study|Death|0|||
105618842|NCT04074759|364270064|FG013|Overall Study|Death|2|||
105618843|NCT04074759|364270065|FG014|Overall Study|Death|1|||
105618844|NCT04074759|364270066|FG015|Overall Study|Death|0|||
105618845|NCT04074759|364270067|FG016|Overall Study|Death|1|||
105618846|NCT04074759|364270068|FG017|Overall Study|Death|0|||
105618847|NCT04074759|364270069|FG018|Overall Study|Death|1|||
105618848|NCT04074759|364270051|FG000|Overall Study|Lost to Follow-up|0|||
105618849|NCT04074759|364270052|FG001|Overall Study|Lost to Follow-up|0|||
105618850|NCT04074759|364270053|FG002|Overall Study|Lost to Follow-up|0|||
105618851|NCT04074759|364270054|FG003|Overall Study|Lost to Follow-up|0|||
105618852|NCT04074759|364270055|FG004|Overall Study|Lost to Follow-up|0|||
105618853|NCT04074759|364270056|FG005|Overall Study|Lost to Follow-up|0|||
105618854|NCT04074759|364270057|FG006|Overall Study|Lost to Follow-up|0|||
105618855|NCT04074759|364270058|FG007|Overall Study|Lost to Follow-up|0|||
105618856|NCT04074759|364270059|FG008|Overall Study|Lost to Follow-up|0|||
105618857|NCT04074759|364270060|FG009|Overall Study|Lost to Follow-up|0|||
105618858|NCT04074759|364270061|FG010|Overall Study|Lost to Follow-up|1|||
105618859|NCT04074759|364270062|FG011|Overall Study|Lost to Follow-up|0|||
105618860|NCT04074759|364270063|FG012|Overall Study|Lost to Follow-up|0|||
105618861|NCT04074759|364270064|FG013|Overall Study|Lost to Follow-up|0|||
105618862|NCT04074759|364270065|FG014|Overall Study|Lost to Follow-up|0|||
105618863|NCT04074759|364270066|FG015|Overall Study|Lost to Follow-up|0|||
105618864|NCT04074759|364270067|FG016|Overall Study|Lost to Follow-up|1|||
105618865|NCT04074759|364270068|FG017|Overall Study|Lost to Follow-up|0|||
105618866|NCT04074759|364270069|FG018|Overall Study|Lost to Follow-up|1|||
105618867|NCT04074759|364270051|FG000|Overall Study|Other|0|||
105618868|NCT04074759|364270052|FG001|Overall Study|Other|1|||
105618869|NCT04074759|364270053|FG002|Overall Study|Other|1|||
105618870|NCT04074759|364270054|FG003|Overall Study|Other|0|||
105618871|NCT04074759|364270055|FG004|Overall Study|Other|2|||
105618872|NCT04074759|364270056|FG005|Overall Study|Other|1|||
105618873|NCT04074759|364270057|FG006|Overall Study|Other|2|||
105618874|NCT04074759|364270058|FG007|Overall Study|Other|1|||
105618875|NCT04074759|364270059|FG008|Overall Study|Other|1|||
105618876|NCT04074759|364270060|FG009|Overall Study|Other|4|||
105618877|NCT04074759|364270061|FG010|Overall Study|Other|4|||
105618878|NCT04074759|364270062|FG011|Overall Study|Other|2|||
105618879|NCT04074759|364270063|FG012|Overall Study|Other|0|||
105618880|NCT04074759|364270064|FG013|Overall Study|Other|0|||
105618881|NCT04074759|364270065|FG014|Overall Study|Other|0|||
105618882|NCT04074759|364270066|FG015|Overall Study|Other|1|||
105618883|NCT04074759|364270067|FG016|Overall Study|Other|0|||
105618884|NCT04074759|364270068|FG017|Overall Study|Other|0|||
105618885|NCT04074759|364270069|FG018|Overall Study|Other|0|||
105618886|NCT04074759|364270051|FG000|Overall Study|Missing end of study status|0|||
105618887|NCT04074759|364270052|FG001|Overall Study|Missing end of study status|0|||
105618888|NCT04074759|364270053|FG002|Overall Study|Missing end of study status|0|||
105618889|NCT04074759|364270054|FG003|Overall Study|Missing end of study status|0|||
105618890|NCT04074759|364270055|FG004|Overall Study|Missing end of study status|0|||
105618891|NCT04074759|364270056|FG005|Overall Study|Missing end of study status|0|||
105618892|NCT04074759|364270057|FG006|Overall Study|Missing end of study status|0|||
105618893|NCT04074759|364270058|FG007|Overall Study|Missing end of study status|0|||
105618894|NCT04074759|364270059|FG008|Overall Study|Missing end of study status|0|||
105618895|NCT04074759|364270060|FG009|Overall Study|Missing end of study status|0|||
105618896|NCT04074759|364270061|FG010|Overall Study|Missing end of study status|2|||
105618897|NCT04074759|364270062|FG011|Overall Study|Missing end of study status|0|||
105618898|NCT04074759|364270063|FG012|Overall Study|Missing end of study status|0|||
105618899|NCT04074759|364270064|FG013|Overall Study|Missing end of study status|0|||
105618900|NCT04074759|364270065|FG014|Overall Study|Missing end of study status|0|||
105618901|NCT04074759|364270066|FG015|Overall Study|Missing end of study status|0|||
105618902|NCT04074759|364270067|FG016|Overall Study|Missing end of study status|1|||
105618903|NCT04074759|364270068|FG017|Overall Study|Missing end of study status|0|||
105618904|NCT04074759|364270069|FG018|Overall Study|Missing end of study status|0|||
105618905|NCT04032704|364270070|FG000|Part A|Withdrawal by Subject|0|||
105618906|NCT04032704|364270071|FG001|Part A|Withdrawal by Subject|0|||
105618907|NCT04032704|364270072|FG002|Part A|Withdrawal by Subject|3|||
105618908|NCT04032704|364270073|FG003|Part A|Withdrawal by Subject|0|||
105618909|NCT04032704|364270074|FG004|Part A|Withdrawal by Subject|1|||
105618910|NCT04032704|364270075|FG005|Part A|Withdrawal by Subject|7|||
105618911|NCT04032704|364270076|FG006|Part A|Withdrawal by Subject|0|||
105618912|NCT04032704|364270077|FG007|Part A|Withdrawal by Subject|0|||
105618913|NCT04032704|364270078|FG008|Part A|Withdrawal by Subject|0|||
105618914|NCT04032704|364270079|FG009|Part A|Withdrawal by Subject|0|||
105618915|NCT04032704|364270080|FG010|Part A|Withdrawal by Subject|0|||
105618916|NCT04032704|364270081|FG011|Part A|Withdrawal by Subject|0|||
105618917|NCT04032704|364270082|FG012|Part A|Withdrawal by Subject|0|||
105618918|NCT04032704|364270083|FG013|Part A|Withdrawal by Subject|0|||
105618919|NCT04032704|364270084|FG014|Part A|Withdrawal by Subject|0|||
105618920|NCT04032704|364270085|FG015|Part A|Withdrawal by Subject|0|||
105618921|NCT04032704|364270086|FG016|Part A|Withdrawal by Subject|0|||
105618922|NCT04032704|364270087|FG017|Part A|Withdrawal by Subject|0|||
105618923|NCT04032704|364270070|FG000|Part A|Lost to Follow-up|1|||
105618924|NCT04032704|364270071|FG001|Part A|Lost to Follow-up|0|||
105618925|NCT04032704|364270072|FG002|Part A|Lost to Follow-up|0|||
105618926|NCT04032704|364270073|FG003|Part A|Lost to Follow-up|0|||
105618927|NCT04032704|364270074|FG004|Part A|Lost to Follow-up|0|||
105618928|NCT04032704|364270075|FG005|Part A|Lost to Follow-up|0|||
105618929|NCT04032704|364270076|FG006|Part A|Lost to Follow-up|0|||
105618930|NCT04032704|364270077|FG007|Part A|Lost to Follow-up|0|||
105618931|NCT04032704|364270078|FG008|Part A|Lost to Follow-up|0|||
105618932|NCT04032704|364270079|FG009|Part A|Lost to Follow-up|0|||
105618933|NCT04032704|364270080|FG010|Part A|Lost to Follow-up|0|||
105618934|NCT04032704|364270081|FG011|Part A|Lost to Follow-up|0|||
105618935|NCT04032704|364270082|FG012|Part A|Lost to Follow-up|0|||
105618936|NCT04032704|364270083|FG013|Part A|Lost to Follow-up|0|||
105618937|NCT04032704|364270084|FG014|Part A|Lost to Follow-up|0|||
105618938|NCT04032704|364270085|FG015|Part A|Lost to Follow-up|0|||
105618939|NCT04032704|364270086|FG016|Part A|Lost to Follow-up|0|||
105618940|NCT04032704|364270087|FG017|Part A|Lost to Follow-up|0|||
105618941|NCT04032704|364270070|FG000|Part A|Death|9|||
105618942|NCT04032704|364270071|FG001|Part A|Death|2|||
105618943|NCT04032704|364270072|FG002|Part A|Death|10|||
105618944|NCT04032704|364270073|FG003|Part A|Death|7|||
105618945|NCT04032704|364270074|FG004|Part A|Death|4|||
105618946|NCT04032704|364270075|FG005|Part A|Death|5|||
105618947|NCT04032704|364270076|FG006|Part A|Death|0|||
105618948|NCT04032704|364270077|FG007|Part A|Death|0|||
105618949|NCT04032704|364270078|FG008|Part A|Death|0|||
105618950|NCT04032704|364270079|FG009|Part A|Death|0|||
105618951|NCT04032704|364270080|FG010|Part A|Death|0|||
105618952|NCT04032704|364270081|FG011|Part A|Death|0|||
105618953|NCT04032704|364270082|FG012|Part A|Death|0|||
105618954|NCT04032704|364270083|FG013|Part A|Death|0|||
105618955|NCT04032704|364270084|FG014|Part A|Death|0|||
105618956|NCT04032704|364270085|FG015|Part A|Death|0|||
105618957|NCT04032704|364270086|FG016|Part A|Death|0|||
105618958|NCT04032704|364270087|FG017|Part A|Death|0|||
105618959|NCT04032704|364270070|FG000|Part B|Other|0|||
105618960|NCT04032704|364270071|FG001|Part B|Other|0|||
105618961|NCT04032704|364270072|FG002|Part B|Other|0|||
105618962|NCT04032704|364270073|FG003|Part B|Other|0|||
105618963|NCT04032704|364270074|FG004|Part B|Other|0|||
105618964|NCT04032704|364270075|FG005|Part B|Other|0|||
105618965|NCT04032704|364270076|FG006|Part B|Other|0|||
105618966|NCT04032704|364270077|FG007|Part B|Other|1|||
105618967|NCT04032704|364270078|FG008|Part B|Other|2|||
105618968|NCT04032704|364270079|FG009|Part B|Other|1|||
105618969|NCT04032704|364270080|FG010|Part B|Other|1|||
105618970|NCT04032704|364270081|FG011|Part B|Other|1|||
105618971|NCT04032704|364270082|FG012|Part B|Other|5|||
105618972|NCT04032704|364270083|FG013|Part B|Other|13|||
105618973|NCT04032704|364270084|FG014|Part B|Other|0|||
105618974|NCT04032704|364270085|FG015|Part B|Other|0|||
105618975|NCT04032704|364270086|FG016|Part B|Other|0|||
105618976|NCT04032704|364270087|FG017|Part B|Other|0|||
105618977|NCT04032704|364270070|FG000|Part B|Study termination by Sponsor|0|||
105618978|NCT04032704|364270071|FG001|Part B|Study termination by Sponsor|0|||
105618979|NCT04032704|364270072|FG002|Part B|Study termination by Sponsor|0|||
105618980|NCT04032704|364270073|FG003|Part B|Study termination by Sponsor|0|||
105618981|NCT04032704|364270074|FG004|Part B|Study termination by Sponsor|0|||
105618982|NCT04032704|364270075|FG005|Part B|Study termination by Sponsor|0|||
105618983|NCT04032704|364270076|FG006|Part B|Study termination by Sponsor|0|||
105618984|NCT04032704|364270077|FG007|Part B|Study termination by Sponsor|0|||
105618985|NCT04032704|364270078|FG008|Part B|Study termination by Sponsor|1|||
105618986|NCT04032704|364270079|FG009|Part B|Study termination by Sponsor|0|||
105618987|NCT04032704|364270080|FG010|Part B|Study termination by Sponsor|0|||
105618988|NCT04032704|364270081|FG011|Part B|Study termination by Sponsor|0|||
105618989|NCT04032704|364270082|FG012|Part B|Study termination by Sponsor|0|||
105618990|NCT04032704|364270083|FG013|Part B|Study termination by Sponsor|0|||
105618991|NCT04032704|364270084|FG014|Part B|Study termination by Sponsor|0|||
105618992|NCT04032704|364270085|FG015|Part B|Study termination by Sponsor|0|||
105618993|NCT04032704|364270086|FG016|Part B|Study termination by Sponsor|0|||
105618994|NCT04032704|364270087|FG017|Part B|Study termination by Sponsor|0|||
105618995|NCT04032704|364270070|FG000|Part B|Withdrawal by Subject|0|||
105618996|NCT04032704|364270071|FG001|Part B|Withdrawal by Subject|0|||
105618997|NCT04032704|364270072|FG002|Part B|Withdrawal by Subject|0|||
105618998|NCT04032704|364270073|FG003|Part B|Withdrawal by Subject|0|||
105618999|NCT04032704|364270074|FG004|Part B|Withdrawal by Subject|0|||
105619000|NCT04032704|364270075|FG005|Part B|Withdrawal by Subject|0|||
105619001|NCT04032704|364270076|FG006|Part B|Withdrawal by Subject|3|||
105619002|NCT04032704|364270077|FG007|Part B|Withdrawal by Subject|2|||
105619003|NCT04032704|364270078|FG008|Part B|Withdrawal by Subject|2|||
105619004|NCT04032704|364270079|FG009|Part B|Withdrawal by Subject|1|||
105619005|NCT04032704|364270080|FG010|Part B|Withdrawal by Subject|4|||
105619006|NCT04032704|364270081|FG011|Part B|Withdrawal by Subject|6|||
105619007|NCT04032704|364270082|FG012|Part B|Withdrawal by Subject|2|||
105619008|NCT04032704|364270083|FG013|Part B|Withdrawal by Subject|1|||
105619009|NCT04032704|364270084|FG014|Part B|Withdrawal by Subject|0|||
105619010|NCT04032704|364270085|FG015|Part B|Withdrawal by Subject|1|||
105619011|NCT04032704|364270086|FG016|Part B|Withdrawal by Subject|0|||
105619012|NCT04032704|364270087|FG017|Part B|Withdrawal by Subject|0|||
105619013|NCT04032704|364270070|FG000|Part B|Lost to Follow-up|0|||
105619014|NCT04032704|364270071|FG001|Part B|Lost to Follow-up|0|||
105619015|NCT04032704|364270072|FG002|Part B|Lost to Follow-up|0|||
105619016|NCT04032704|364270073|FG003|Part B|Lost to Follow-up|0|||
105619017|NCT04032704|364270074|FG004|Part B|Lost to Follow-up|0|||
105619018|NCT04032704|364270075|FG005|Part B|Lost to Follow-up|0|||
105619019|NCT04032704|364270076|FG006|Part B|Lost to Follow-up|0|||
105619020|NCT04032704|364270077|FG007|Part B|Lost to Follow-up|0|||
105619021|NCT04032704|364270078|FG008|Part B|Lost to Follow-up|0|||
105619022|NCT04032704|364270079|FG009|Part B|Lost to Follow-up|0|||
105619023|NCT04032704|364270080|FG010|Part B|Lost to Follow-up|0|||
105619024|NCT04032704|364270081|FG011|Part B|Lost to Follow-up|1|||
105619025|NCT04032704|364270082|FG012|Part B|Lost to Follow-up|0|||
105619026|NCT04032704|364270083|FG013|Part B|Lost to Follow-up|0|||
105619027|NCT04032704|364270084|FG014|Part B|Lost to Follow-up|0|||
105619028|NCT04032704|364270085|FG015|Part B|Lost to Follow-up|0|||
105619029|NCT04032704|364270086|FG016|Part B|Lost to Follow-up|0|||
105619030|NCT04032704|364270087|FG017|Part B|Lost to Follow-up|0|||
105619031|NCT04032704|364270070|FG000|Part B|Death|0|||
105619032|NCT04032704|364270071|FG001|Part B|Death|0|||
105619033|NCT04032704|364270072|FG002|Part B|Death|0|||
105619034|NCT04032704|364270073|FG003|Part B|Death|0|||
105619035|NCT04032704|364270074|FG004|Part B|Death|0|||
105619036|NCT04032704|364270075|FG005|Part B|Death|0|||
105619037|NCT04032704|364270076|FG006|Part B|Death|13|||
105619038|NCT04032704|364270077|FG007|Part B|Death|13|||
105619039|NCT04032704|364270078|FG008|Part B|Death|14|||
105619040|NCT04032704|364270079|FG009|Part B|Death|12|||
105619041|NCT04032704|364270080|FG010|Part B|Death|12|||
105619042|NCT04032704|364270081|FG011|Part B|Death|13|||
105619043|NCT04032704|364270082|FG012|Part B|Death|7|||
105619044|NCT04032704|364270083|FG013|Part B|Death|17|||
105619045|NCT04032704|364270084|FG014|Part B|Death|2|||
105619046|NCT04032704|364270085|FG015|Part B|Death|1|||
105619047|NCT04032704|364270086|FG016|Part B|Death|2|||
105619048|NCT04032704|364270087|FG017|Part B|Death|2|||
105619049|NCT02861300|364270091|FG000|Overall Study|Death|0|||
105619050|NCT02861300|364270092|FG001|Overall Study|Death|0|||
105619051|NCT02861300|364270093|FG002|Overall Study|Death|0|||
105619052|NCT02861300|364270094|FG003|Overall Study|Death|0|||
105619053|NCT02861300|364270095|FG004|Overall Study|Death|0|||
105619054|NCT02861300|364270096|FG005|Overall Study|Death|0|||
105619055|NCT02861300|364270097|FG006|Overall Study|Death|24|||
105619056|NCT02861300|364270091|FG000|Overall Study|Delay in treatment|0|||
105619057|NCT02861300|364270092|FG001|Overall Study|Delay in treatment|0|||
105619058|NCT02861300|364270093|FG002|Overall Study|Delay in treatment|0|||
105619059|NCT02861300|364270094|FG003|Overall Study|Delay in treatment|0|||
105619060|NCT02861300|364270095|FG004|Overall Study|Delay in treatment|0|||
105619061|NCT02861300|364270096|FG005|Overall Study|Delay in treatment|1|||
105619062|NCT02861300|364270097|FG006|Overall Study|Delay in treatment|0|||
105619063|NCT02861300|364270091|FG000|Overall Study|Disease Progression|0|||
105619064|NCT02861300|364270092|FG001|Overall Study|Disease Progression|1|||
105619065|NCT02861300|364270093|FG002|Overall Study|Disease Progression|0|||
105619066|NCT02861300|364270094|FG003|Overall Study|Disease Progression|0|||
105619067|NCT02861300|364270095|FG004|Overall Study|Disease Progression|0|||
105619068|NCT02861300|364270096|FG005|Overall Study|Disease Progression|0|||
105619069|NCT02861300|364270097|FG006|Overall Study|Disease Progression|2|||
105619070|NCT02861300|364270091|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
105619071|NCT02861300|364270092|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
105619072|NCT02861300|364270093|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
105619073|NCT02861300|364270094|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
105619074|NCT02861300|364270095|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
105619075|NCT02861300|364270096|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
105619076|NCT02861300|364270097|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
105619077|NCT02861300|364270091|FG000|Overall Study|Clinical Complications|0|||
105619078|NCT02861300|364270092|FG001|Overall Study|Clinical Complications|0|||
105619079|NCT02861300|364270093|FG002|Overall Study|Clinical Complications|0|||
105619080|NCT02861300|364270094|FG003|Overall Study|Clinical Complications|0|||
105619081|NCT02861300|364270095|FG004|Overall Study|Clinical Complications|0|||
105619082|NCT02861300|364270096|FG005|Overall Study|Clinical Complications|0|||
105619083|NCT02861300|364270097|FG006|Overall Study|Clinical Complications|1|||
105619084|NCT02465268|364270098|FG000|Overall Study|Withdrawal by Subject|4|||
105619085|NCT02465268|364270099|FG001|Overall Study|Withdrawal by Subject|3|||
105619086|NCT02465268|364270100|FG002|Overall Study|Withdrawal by Subject|1|||
105619087|NCT02465268|364270098|FG000|Overall Study|Not evaluable per protocol criteria|3|||
105619088|NCT02465268|364270099|FG001|Overall Study|Not evaluable per protocol criteria|2|||
105619089|NCT02465268|364270100|FG002|Overall Study|Not evaluable per protocol criteria|1|||
105619090|NCT02465268|364270098|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
105619091|NCT02465268|364270099|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
105619092|NCT02465268|364270100|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
105619093|NCT02465268|364270098|FG000|Overall Study|Study drug did not pass QA/QC|1|||
105619094|NCT02465268|364270099|FG001|Overall Study|Study drug did not pass QA/QC|0|||
105619095|NCT02465268|364270100|FG002|Overall Study|Study drug did not pass QA/QC|0|||
105619096|NCT02465268|364270098|FG000|Overall Study|Adverse Event|0|||
105619097|NCT02465268|364270099|FG001|Overall Study|Adverse Event|1|||
105619098|NCT02465268|364270100|FG002|Overall Study|Adverse Event|0|||
105619099|NCT02465268|364270098|FG000|Overall Study|Physician Decision|0|||
105619100|NCT02465268|364270099|FG001|Overall Study|Physician Decision|1|||
105619101|NCT02465268|364270100|FG002|Overall Study|Physician Decision|0|||
105619102|NCT02365467|364270101|FG000|Overall Study|Death|3|||
105619103|NCT03252847|364270102|FG000|Overall Study|Withdrawal by Subject|0|||
105619104|NCT03252847|364270103|FG001|Overall Study|Withdrawal by Subject|0|||
105619105|NCT03252847|364270104|FG002|Overall Study|Withdrawal by Subject|1|||
105619106|NCT03252847|364270105|FG003|Overall Study|Withdrawal by Subject|0|||
105619107|NCT03252847|364270106|FG004|Overall Study|Withdrawal by Subject|0|||
105619108|NCT03252847|364270107|FG005|Overall Study|Withdrawal by Subject|0|||
105619109|NCT03252847|364270108|FG006|Overall Study|Withdrawal by Subject|0|||
105619110|NCT03252847|364270102|FG000|Overall Study|Other: Patient decision|0|||
105619111|NCT03252847|364270103|FG001|Overall Study|Other: Patient decision|0|||
105619112|NCT03252847|364270104|FG002|Overall Study|Other: Patient decision|0|||
105619113|NCT03252847|364270105|FG003|Overall Study|Other: Patient decision|0|||
105619114|NCT03252847|364270106|FG004|Overall Study|Other: Patient decision|1|||
105619115|NCT03252847|364270107|FG005|Overall Study|Other: Patient decision|0|||
105619116|NCT03252847|364270108|FG006|Overall Study|Other: Patient decision|0|||
105619117|NCT03133546|364270113|FG000|Overall Study|Death|46|||
105619118|NCT03133546|364270114|FG001|Overall Study|Death|43|||
105619119|NCT03133546|364270113|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
105619120|NCT03133546|364270114|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
105619121|NCT00736723|364270118|FG000|Overall Study|Withdrawal by Subject|4|||
105619122|NCT00736723|364270119|FG001|Overall Study|Withdrawal by Subject|3|||
105619123|NCT03492216|364270120|FG000|Overall Study|Death|1|||
105619124|NCT03492216|364270121|FG001|Overall Study|Death|0|||
105619125|NCT03492216|364270122|FG002|Overall Study|Death|4|||
105619126|NCT03492216|364270123|FG003|Overall Study|Death|0|||
105619127|NCT03492216|364270120|FG000|Overall Study|Withdrawal by Subject|5|||
105619128|NCT03492216|364270121|FG001|Overall Study|Withdrawal by Subject|3|||
105619129|NCT03492216|364270122|FG002|Overall Study|Withdrawal by Subject|1|||
105619130|NCT03492216|364270123|FG003|Overall Study|Withdrawal by Subject|1|||
105619131|NCT03492216|364270120|FG000|Overall Study|Lost to Follow-up|9|||
105619132|NCT03492216|364270121|FG001|Overall Study|Lost to Follow-up|2|||
105619133|NCT03492216|364270122|FG002|Overall Study|Lost to Follow-up|7|||
105619134|NCT03492216|364270123|FG003|Overall Study|Lost to Follow-up|8|||
105619135|NCT03492216|364270120|FG000|Overall Study|Moved|5|||
105619136|NCT03492216|364270121|FG001|Overall Study|Moved|3|||
105619137|NCT03492216|364270122|FG002|Overall Study|Moved|3|||
105619138|NCT03492216|364270123|FG003|Overall Study|Moved|5|||
105619139|NCT03492216|364270120|FG000|Overall Study|Too ill|0|||
105619140|NCT03492216|364270121|FG001|Overall Study|Too ill|1|||
105619141|NCT03492216|364270122|FG002|Overall Study|Too ill|0|||
105619142|NCT03492216|364270123|FG003|Overall Study|Too ill|0|||
105619143|NCT03492216|364270120|FG000|Overall Study|Incarcerated|0|||
105619144|NCT03492216|364270121|FG001|Overall Study|Incarcerated|0|||
105619145|NCT03492216|364270122|FG002|Overall Study|Incarcerated|2|||
105619146|NCT03492216|364270123|FG003|Overall Study|Incarcerated|0|||
105619147|NCT00686335|364271714|FG000|Run-in Period|Adverse Event|1|||
105619148|NCT00686335|364271714|FG000|Run-in Period|asthma exacerbation|1|||
105619149|NCT00686335|364271714|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
105619150|NCT03668236|364271715|FG000|90-day Follow-up|Withdrawal by Subject|3|||
105619151|NCT03668236|364271716|FG001|90-day Follow-up|Withdrawal by Subject|2|||
105619152|NCT03668236|364271715|FG000|90-day Follow-up|Lost to Follow-up|3|||
105619153|NCT03668236|364271716|FG001|90-day Follow-up|Lost to Follow-up|1|||
105619154|NCT03668236|364271715|FG000|Baseline Characteristics|Lost to Follow-up|9|||
105619155|NCT03668236|364271716|FG001|Baseline Characteristics|Lost to Follow-up|5|||
105619156|NCT03668236|364271715|FG000|1-year Follow-up|Withdrawal by Subject|17|||
105619157|NCT03668236|364271716|FG001|1-year Follow-up|Withdrawal by Subject|15|||
105619158|NCT05672069|364271717|FG000|Overall Study|Implant removal|1|||
105619159|NCT05672069|364271717|FG000|Overall Study|Lost to Follow-up|2|||
105619160|NCT02191618|364271722|FG000|Overall Study|Withdrawal by Subject|3|||
105619161|NCT02191618|364271722|FG000|Overall Study|Missed Visit|4|||
105619162|NCT01593917|364271723|FG000|Overall Study|Death|67|||
105619163|NCT01593917|364271723|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
105619164|NCT01593917|364271723|FG000|Overall Study|Withdrawal by Subject|23|||
105619165|NCT01593917|364271723|FG000|Overall Study|Lost to Follow-up|12|||
105619166|NCT01593917|364271723|FG000|Overall Study|Protocol Violation|5|||
105619167|NCT01593917|364271723|FG000|Overall Study|Physician Decision|3|||
105619168|NCT04171141|364271724|FG000|Overall Study|Adverse Event|0|||
105619169|NCT04171141|364271725|FG001|Overall Study|Adverse Event|0|||
105619170|NCT04171141|364271726|FG002|Overall Study|Adverse Event|2|||
105619171|NCT04171141|364271727|FG003|Overall Study|Adverse Event|0|||
105619172|NCT04171141|364271728|FG004|Overall Study|Adverse Event|0|||
105619173|NCT04171141|364271729|FG005|Overall Study|Adverse Event|0|||
105619174|NCT04171141|364271730|FG006|Overall Study|Adverse Event|0|||
105619175|NCT04171141|364271731|FG007|Overall Study|Adverse Event|0|||
105619176|NCT04171141|364271732|FG008|Overall Study|Adverse Event|0|||
105619177|NCT04171141|364271733|FG009|Overall Study|Adverse Event|0|||
105619178|NCT04171141|364271734|FG010|Overall Study|Adverse Event|0|||
105619179|NCT04171141|364271735|FG011|Overall Study|Adverse Event|0|||
105619180|NCT04171141|364271736|FG012|Overall Study|Adverse Event|0|||
105619181|NCT04171141|364271737|FG013|Overall Study|Adverse Event|2|||
105619182|NCT04171141|364271738|FG014|Overall Study|Adverse Event|0|||
105619183|NCT04171141|364271739|FG015|Overall Study|Adverse Event|0|||
105619184|NCT04171141|364271724|FG000|Overall Study|Physician Decision|0|||
105619185|NCT04171141|364271725|FG001|Overall Study|Physician Decision|0|||
105619186|NCT04171141|364271726|FG002|Overall Study|Physician Decision|0|||
105619187|NCT04171141|364271727|FG003|Overall Study|Physician Decision|0|||
105619188|NCT04171141|364271728|FG004|Overall Study|Physician Decision|1|||
105619189|NCT04171141|364271729|FG005|Overall Study|Physician Decision|0|||
105619190|NCT04171141|364271730|FG006|Overall Study|Physician Decision|0|||
105619191|NCT04171141|364271731|FG007|Overall Study|Physician Decision|0|||
105619192|NCT04171141|364271732|FG008|Overall Study|Physician Decision|0|||
105619193|NCT04171141|364271733|FG009|Overall Study|Physician Decision|0|||
105619194|NCT04171141|364271734|FG010|Overall Study|Physician Decision|0|||
105619195|NCT04171141|364271735|FG011|Overall Study|Physician Decision|0|||
105619196|NCT04171141|364271736|FG012|Overall Study|Physician Decision|0|||
105619197|NCT04171141|364271737|FG013|Overall Study|Physician Decision|0|||
105619198|NCT04171141|364271738|FG014|Overall Study|Physician Decision|0|||
105619199|NCT04171141|364271739|FG015|Overall Study|Physician Decision|1|||
105619200|NCT04171141|364271724|FG000|Overall Study|Progressive disease|2|||
105619201|NCT04171141|364271725|FG001|Overall Study|Progressive disease|3|||
105619202|NCT04171141|364271726|FG002|Overall Study|Progressive disease|4|||
105619203|NCT04171141|364271727|FG003|Overall Study|Progressive disease|7|||
105619204|NCT04171141|364271728|FG004|Overall Study|Progressive disease|1|||
105619205|NCT04171141|364271729|FG005|Overall Study|Progressive disease|8|||
105619206|NCT04171141|364271730|FG006|Overall Study|Progressive disease|4|||
105619207|NCT04171141|364271731|FG007|Overall Study|Progressive disease|6|||
105619208|NCT04171141|364271732|FG008|Overall Study|Progressive disease|7|||
105619209|NCT04171141|364271733|FG009|Overall Study|Progressive disease|3|||
105619210|NCT04171141|364271734|FG010|Overall Study|Progressive disease|4|||
105619211|NCT04171141|364271735|FG011|Overall Study|Progressive disease|3|||
105619212|NCT04171141|364271736|FG012|Overall Study|Progressive disease|4|||
105619213|NCT04171141|364271737|FG013|Overall Study|Progressive disease|2|||
105619214|NCT04171141|364271738|FG014|Overall Study|Progressive disease|4|||
105619215|NCT04171141|364271739|FG015|Overall Study|Progressive disease|1|||
105619216|NCT04171141|364271724|FG000|Overall Study|Withdrawal by Subject|0|||
105619217|NCT04171141|364271725|FG001|Overall Study|Withdrawal by Subject|0|||
105619218|NCT04171141|364271726|FG002|Overall Study|Withdrawal by Subject|0|||
105619219|NCT04171141|364271727|FG003|Overall Study|Withdrawal by Subject|1|||
105619220|NCT04171141|364271728|FG004|Overall Study|Withdrawal by Subject|0|||
105619221|NCT04171141|364271729|FG005|Overall Study|Withdrawal by Subject|0|||
105619222|NCT04171141|364271730|FG006|Overall Study|Withdrawal by Subject|1|||
105619223|NCT04171141|364271731|FG007|Overall Study|Withdrawal by Subject|0|||
105619224|NCT04171141|364271732|FG008|Overall Study|Withdrawal by Subject|0|||
105619225|NCT04171141|364271733|FG009|Overall Study|Withdrawal by Subject|1|||
105619226|NCT04171141|364271734|FG010|Overall Study|Withdrawal by Subject|0|||
105619227|NCT04171141|364271735|FG011|Overall Study|Withdrawal by Subject|0|||
105619228|NCT04171141|364271736|FG012|Overall Study|Withdrawal by Subject|0|||
105619229|NCT04171141|364271737|FG013|Overall Study|Withdrawal by Subject|0|||
105619230|NCT04171141|364271738|FG014|Overall Study|Withdrawal by Subject|0|||
105619231|NCT04171141|364271739|FG015|Overall Study|Withdrawal by Subject|0|||
105619232|NCT04171141|364271724|FG000|Overall Study|Global deterioration of health status|0|||
105619233|NCT04171141|364271725|FG001|Overall Study|Global deterioration of health status|0|||
105619234|NCT04171141|364271726|FG002|Overall Study|Global deterioration of health status|0|||
105619235|NCT04171141|364271727|FG003|Overall Study|Global deterioration of health status|1|||
105619236|NCT04171141|364271728|FG004|Overall Study|Global deterioration of health status|0|||
105619237|NCT04171141|364271729|FG005|Overall Study|Global deterioration of health status|2|||
105619238|NCT04171141|364271730|FG006|Overall Study|Global deterioration of health status|1|||
105619239|NCT04171141|364271731|FG007|Overall Study|Global deterioration of health status|0|||
105619240|NCT04171141|364271732|FG008|Overall Study|Global deterioration of health status|1|||
105619241|NCT04171141|364271733|FG009|Overall Study|Global deterioration of health status|0|||
105619242|NCT04171141|364271734|FG010|Overall Study|Global deterioration of health status|0|||
105619243|NCT04171141|364271735|FG011|Overall Study|Global deterioration of health status|0|||
105619244|NCT04171141|364271736|FG012|Overall Study|Global deterioration of health status|0|||
105619245|NCT04171141|364271737|FG013|Overall Study|Global deterioration of health status|0|||
105619246|NCT04171141|364271738|FG014|Overall Study|Global deterioration of health status|1|||
105619247|NCT04171141|364271739|FG015|Overall Study|Global deterioration of health status|1|||
105619248|NCT04908397|364271740|FG000|Overall Study|Withdrawal by Subject|2|||
105619249|NCT01943409|364271743|FG000|Overall Study|resumed oral/entral|24|||
105619250|NCT01943409|364271744|FG001|Overall Study|resumed oral/entral|20|||
105619251|NCT01943409|364271743|FG000|Overall Study|Protocol Violation|14|||
105619252|NCT01943409|364271744|FG001|Overall Study|Protocol Violation|24|||
105619253|NCT01943409|364271743|FG000|Overall Study|Death|3|||
105619254|NCT01943409|364271744|FG001|Overall Study|Death|1|||
105619255|NCT01943409|364271743|FG000|Overall Study|Withdrawal by Subject|4|||
105619256|NCT01943409|364271744|FG001|Overall Study|Withdrawal by Subject|3|||
105619257|NCT04858451|364271747|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
105619258|NCT04858451|364271748|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
105619259|NCT04858451|364271749|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
105619260|NCT04858451|364271750|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
105619261|NCT04858451|364271751|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
105619262|NCT04858451|364271752|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
105619263|NCT04858451|364271753|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
105619264|NCT04858451|364271754|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
105619265|NCT04858451|364271755|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
105619266|NCT04858451|364271747|FG000|Part 2|Discontinued|0|||
105619267|NCT04858451|364271748|FG001|Part 2|Discontinued|0|||
105619268|NCT04858451|364271749|FG002|Part 2|Discontinued|0|||
105619269|NCT04858451|364271750|FG003|Part 2|Discontinued|0|||
105619270|NCT04858451|364271751|FG004|Part 2|Discontinued|0|||
105619271|NCT04858451|364271752|FG005|Part 2|Discontinued|0|||
105619272|NCT04858451|364271753|FG006|Part 2|Discontinued|0|||
105619273|NCT04858451|364271754|FG007|Part 2|Discontinued|0|||
105619274|NCT04858451|364271755|FG008|Part 2|Discontinued|63|||
105619275|NCT03216057|364271756|FG000|Overall Study|Lost to Follow-up|2|||
105619276|NCT03216057|364271757|FG001|Overall Study|Lost to Follow-up|2|||
105619277|NCT04662931|364271758|FG000|Overall Study|Withdrawal by Subject|17|||
105619278|NCT04662931|364271758|FG000|Overall Study|Death|3|||
105619279|NCT04662931|364271758|FG000|Overall Study|Lost to Follow-up|3|||
105619280|NCT04662931|364271758|FG000|Overall Study|Guardian Decision|1|||
105619281|NCT05270408|364271759|FG000|Started Treatment|Withdrawal by Subject|0|||
105619282|NCT05270408|364271760|FG001|Started Treatment|Withdrawal by Subject|0|||
105619283|NCT05270408|364271761|FG002|Started Treatment|Withdrawal by Subject|3|||
105619284|NCT05270408|364271759|FG000|Started Treatment|Adverse Event|0|||
105619285|NCT05270408|364271760|FG001|Started Treatment|Adverse Event|0|||
105619286|NCT05270408|364271761|FG002|Started Treatment|Adverse Event|1|||
105619287|NCT05270408|364271759|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
105619288|NCT05270408|364271760|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
105619289|NCT05270408|364271761|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
105619290|NCT03768505|364271762|FG000|Overall Study|sponsor decision|76|||
105619291|NCT03768505|364271762|FG000|Overall Study|Death|35|||
105619292|NCT03768505|364271762|FG000|Overall Study|Other -Various|30|||
105619293|NCT03768505|364271762|FG000|Overall Study|Withdrawal by Subject|22|||
105619294|NCT03768505|364271762|FG000|Overall Study|Lost to Follow-up|6|||
105619295|NCT02815566|364271765|FG000|Overall Study|Adverse Event|1|||
105619296|NCT02815566|364271766|FG001|Overall Study|Adverse Event|1|||
105619297|NCT02815566|364271765|FG000|Overall Study|Withdrawal by Subject|1|||
105619298|NCT02815566|364271766|FG001|Overall Study|Withdrawal by Subject|0|||
105619299|NCT02815566|364271765|FG000|Overall Study|Lost to Follow-up|0|||
105619300|NCT02815566|364271766|FG001|Overall Study|Lost to Follow-up|1|||
105619301|NCT01501955|364271767|FG000|Overall Study|Withdrawal by Subject|1|||
105619302|NCT01501955|364271768|FG001|Overall Study|Withdrawal by Subject|0|||
105619303|NCT01501955|364271767|FG000|Overall Study|Adverse Event|1|||
105619304|NCT01501955|364271768|FG001|Overall Study|Adverse Event|3|||
105619305|NCT04298983|364271776|FG000|Overall Study|Adverse Event|4|||
105619306|NCT04298983|364271776|FG000|Overall Study|Lack of Efficacy|3|||
105619307|NCT04005794|364271779|FG000|Overall Study|Lost to Follow-up|0|||
105619308|NCT04005794|364271780|FG001|Overall Study|Lost to Follow-up|4|||
105619309|NCT04005794|364271781|FG002|Overall Study|Lost to Follow-up|0|||
105619310|NCT04313972|364271784|FG000|Overall Study|Withdrawal by Subject|0|||
105619311|NCT04313972|364271785|FG001|Overall Study|Withdrawal by Subject|1|||
105619312|NCT05877976|364271786|FG000|Overall Study|Lost to Follow-up|31|||
105619313|NCT02547363|364271787|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
105619314|NCT02547363|364271788|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
105619315|NCT02547363|364271787|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
105619316|NCT02547363|364271788|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
105619317|NCT02547363|364271787|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
105619318|NCT02547363|364271788|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
105619319|NCT02547363|364271787|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
105619320|NCT02547363|364271788|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
105619321|NCT02547363|364271787|FG000|12-month Follow-up|Withdrawal by Subject|4|||
105619322|NCT02547363|364271788|FG001|12-month Follow-up|Withdrawal by Subject|3|||
105619323|NCT02547363|364271787|FG000|12-month Follow-up|Lost to Follow-up|4|||
105619324|NCT02547363|364271788|FG001|12-month Follow-up|Lost to Follow-up|1|||
105619325|NCT02547363|364271787|FG000|12-month Follow-up|Lack of Efficacy|1|||
105619326|NCT02547363|364271788|FG001|12-month Follow-up|Lack of Efficacy|1|||
105619327|NCT02547363|364271787|FG000|12-month Follow-up|Other|1|||
105619328|NCT02547363|364271788|FG001|12-month Follow-up|Other|0|||
105619329|NCT00248287|364271790|FG000|Overall Study|Adverse Event|11|||
105619330|NCT00248287|364271791|FG001|Overall Study|Adverse Event|10|||
105619331|NCT00248287|364271790|FG000|Overall Study|Death|1|||
105619332|NCT00248287|364271791|FG001|Overall Study|Death|0|||
105619333|NCT00248287|364271790|FG000|Overall Study|Lost to Follow-up|0|||
105619334|NCT00248287|364271791|FG001|Overall Study|Lost to Follow-up|1|||
105619335|NCT00248287|364271790|FG000|Overall Study|Investigator Request|4|||
105619336|NCT00248287|364271791|FG001|Overall Study|Investigator Request|3|||
105619337|NCT00248287|364271790|FG000|Overall Study|Patient Request|5|||
105619338|NCT00248287|364271791|FG001|Overall Study|Patient Request|3|||
105619339|NCT00248287|364271790|FG000|Overall Study|Other|3|||
105619340|NCT00248287|364271791|FG001|Overall Study|Other|2|||
105619341|NCT02714257|364271792|FG000|Overall Study|Withdrawal by Subject|6|||
105619342|NCT02714257|364271793|FG001|Overall Study|Withdrawal by Subject|11|||
105619343|NCT02714257|364271792|FG000|Overall Study|Death|3|||
105619344|NCT02714257|364271793|FG001|Overall Study|Death|4|||
105619345|NCT02714257|364271792|FG000|Overall Study|Lost to Follow-up|1|||
105619346|NCT02714257|364271793|FG001|Overall Study|Lost to Follow-up|6|||
105619347|NCT05201079|364271794|FG000|Overall Study|Adverse Event|7|||
105619348|NCT05201079|364271795|FG001|Overall Study|Adverse Event|11|||
105619349|NCT05201079|364271794|FG000|Overall Study|Death|1|||
105619350|NCT05201079|364271795|FG001|Overall Study|Death|1|||
105619351|NCT05201079|364271794|FG000|Overall Study|Lack of Efficacy|0|||
105619352|NCT05201079|364271795|FG001|Overall Study|Lack of Efficacy|2|||
105619353|NCT05201079|364271794|FG000|Overall Study|Lost to Follow-up|0|||
105619354|NCT05201079|364271795|FG001|Overall Study|Lost to Follow-up|1|||
105619355|NCT05201079|364271794|FG000|Overall Study|Physician Decision|1|||
105619356|NCT05201079|364271795|FG001|Overall Study|Physician Decision|1|||
105619357|NCT05201079|364271794|FG000|Overall Study|Protocol Violation|1|||
105619358|NCT05201079|364271795|FG001|Overall Study|Protocol Violation|0|||
105619359|NCT05201079|364271794|FG000|Overall Study|Withdrawal by Subject|1|||
105619360|NCT05201079|364271795|FG001|Overall Study|Withdrawal by Subject|0|||
105619361|NCT05201079|364271794|FG000|Overall Study|Forbidden medication|9|||
105619362|NCT05201079|364271795|FG001|Overall Study|Forbidden medication|5|||
105619363|NCT05201079|364271794|FG000|Overall Study|Transfer to another hospital|0|||
105619364|NCT05201079|364271795|FG001|Overall Study|Transfer to another hospital|1|||
105619365|NCT05201079|364271794|FG000|Overall Study|Clinical condition|1|||
105619366|NCT05201079|364271795|FG001|Overall Study|Clinical condition|0|||
105619367|NCT05201079|364271794|FG000|Overall Study|SAE and sepsis|1|||
105619368|NCT05201079|364271795|FG001|Overall Study|SAE and sepsis|0|||
105619369|NCT01210807|364271808|FG000|Overall Study|Lost to Follow-up|1|||
105619370|NCT01210807|364271809|FG001|Overall Study|Lost to Follow-up|2|||
105619371|NCT01210807|364271808|FG000|Overall Study|Not implanted bilaterally|2|||
105619372|NCT01210807|364271809|FG001|Overall Study|Not implanted bilaterally|1|||
105619373|NCT05281562|364271811|FG000|Overall Study|Ineligible patient|1|||
105619374|NCT05281562|364271812|FG001|Overall Study|Ineligible patient|0|||
105619375|NCT06457802|364271814|FG000|Overall Study|Early termination of study prior to participant completion|2|||
105619376|NCT06457802|364271815|FG001|Overall Study|Early termination of study prior to participant completion|2|||
105619377|NCT05386030|364271817|FG000|Overall Study|Death|1|||
105619378|NCT05386030|364271818|FG001|Overall Study|Death|0|||
105619379|NCT05386030|364271817|FG000|Overall Study|Physician Decision|2|||
105619380|NCT05386030|364271818|FG001|Overall Study|Physician Decision|1|||
105619381|NCT05386030|364271817|FG000|Overall Study|Lost to Follow-up|19|||
105619382|NCT05386030|364271818|FG001|Overall Study|Lost to Follow-up|7|||
105619383|NCT05386030|364271817|FG000|Overall Study|Withdrawal by Subject|20|||
105619384|NCT05386030|364271818|FG001|Overall Study|Withdrawal by Subject|10|||
105619385|NCT05386030|364271817|FG000|Overall Study|Eligibility criteria violation|1|||
105619386|NCT05386030|364271818|FG001|Overall Study|Eligibility criteria violation|1|||
105619387|NCT05386030|364271817|FG000|Overall Study|Personal Reasons|1|||
105619388|NCT05386030|364271818|FG001|Overall Study|Personal Reasons|0|||
105619389|NCT05940194|364271825|FG000|Overall Study|Adverse Event|0|||
105619390|NCT05940194|364271826|FG001|Overall Study|Adverse Event|1|||
105619391|NCT05940194|364271827|FG002|Overall Study|Adverse Event|0|||
105619392|NCT05940194|364271825|FG000|Overall Study|Migrated/Moved from the study area|2|||
105619393|NCT05940194|364271826|FG001|Overall Study|Migrated/Moved from the study area|2|||
105619394|NCT05940194|364271827|FG002|Overall Study|Migrated/Moved from the study area|4|||
105619395|NCT03024437|364271828|FG000|Overall Study|Adverse Event|0|||
105619396|NCT03024437|364271829|FG001|Overall Study|Adverse Event|1|||
105619397|NCT03024437|364271830|FG002|Overall Study|Adverse Event|3|||
105619398|NCT03024437|364271831|FG003|Overall Study|Adverse Event|5|||
105619399|NCT03024437|364271832|FG004|Overall Study|Adverse Event|0|||
105619400|NCT03024437|364271828|FG000|Overall Study|Physician Decision|1|||
105619401|NCT03024437|364271829|FG001|Overall Study|Physician Decision|0|||
105619402|NCT03024437|364271830|FG002|Overall Study|Physician Decision|0|||
105619403|NCT03024437|364271831|FG003|Overall Study|Physician Decision|1|||
105619404|NCT03024437|364271832|FG004|Overall Study|Physician Decision|0|||
105619405|NCT03024437|364271828|FG000|Overall Study|Disease progression, relapse|1|||
105619406|NCT03024437|364271829|FG001|Overall Study|Disease progression, relapse|0|||
105619407|NCT03024437|364271830|FG002|Overall Study|Disease progression, relapse|0|||
105619408|NCT03024437|364271831|FG003|Overall Study|Disease progression, relapse|3|||
105619409|NCT03024437|364271832|FG004|Overall Study|Disease progression, relapse|0|||
105619410|NCT03024437|364271828|FG000|Overall Study|Disease progression, refractory disease|4|||
105619411|NCT03024437|364271829|FG001|Overall Study|Disease progression, refractory disease|4|||
105619412|NCT03024437|364271830|FG002|Overall Study|Disease progression, refractory disease|2|||
105619413|NCT03024437|364271831|FG003|Overall Study|Disease progression, refractory disease|2|||
105619414|NCT03024437|364271832|FG004|Overall Study|Disease progression, refractory disease|1|||
105619415|NCT03024437|364271828|FG000|Overall Study|Newly diagnosed cancer|0|||
105619416|NCT03024437|364271829|FG001|Overall Study|Newly diagnosed cancer|0|||
105619417|NCT03024437|364271830|FG002|Overall Study|Newly diagnosed cancer|0|||
105619418|NCT03024437|364271831|FG003|Overall Study|Newly diagnosed cancer|1|||
105619419|NCT03024437|364271832|FG004|Overall Study|Newly diagnosed cancer|0|||
105619420|NCT03024437|364271828|FG000|Overall Study|Moved out of state|0|||
105619421|NCT03024437|364271829|FG001|Overall Study|Moved out of state|1|||
105619422|NCT03024437|364271830|FG002|Overall Study|Moved out of state|0|||
105619423|NCT03024437|364271831|FG003|Overall Study|Moved out of state|0|||
105619424|NCT03024437|364271832|FG004|Overall Study|Moved out of state|0|||
105619425|NCT03024437|364271828|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
105619426|NCT03024437|364271829|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
105619427|NCT03024437|364271830|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
105619428|NCT03024437|364271831|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
105619429|NCT03024437|364271832|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
105619430|NCT02606422|364271833|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
105619431|NCT02606422|364271834|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
105619432|NCT02606422|364271833|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
105619433|NCT02606422|364271834|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
105619434|NCT02606422|364271833|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
105619435|NCT02606422|364271834|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
105619436|NCT02606422|364271833|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
105619437|NCT02606422|364271834|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
105619438|NCT02601313|364271835|FG000|Overall Study|Death|2|||
105619439|NCT02601313|364271836|FG001|Overall Study|Death|41|||
105619440|NCT02601313|364271837|FG002|Overall Study|Death|6|||
105619441|NCT02601313|364271835|FG000|Overall Study|Enrolled but never treated|0|||
105619442|NCT02601313|364271836|FG001|Overall Study|Enrolled but never treated|6|||
105619443|NCT02601313|364271837|FG002|Overall Study|Enrolled but never treated|3|||
105619444|NCT02601313|364271835|FG000|Overall Study|Enrolled, did not initiate AC|4|||
105619445|NCT02601313|364271836|FG001|Overall Study|Enrolled, did not initiate AC|0|||
105619446|NCT02601313|364271837|FG002|Overall Study|Enrolled, did not initiate AC|0|||
105619447|NCT02601313|364271835|FG000|Overall Study|Full consent withdrawal|0|||
105619448|NCT02601313|364271836|FG001|Overall Study|Full consent withdrawal|3|||
105619449|NCT02601313|364271837|FG002|Overall Study|Full consent withdrawal|2|||
105619450|NCT02601313|364271835|FG000|Overall Study|Lost to Follow-up|0|||
105619451|NCT02601313|364271836|FG001|Overall Study|Lost to Follow-up|1|||
105619452|NCT02601313|364271837|FG002|Overall Study|Lost to Follow-up|1|||
105619453|NCT04501614|364271838|FG000|Overall Study|Study Terminated by Sponsor|6|||
105619454|NCT04501614|364271839|FG001|Overall Study|Study Terminated by Sponsor|3|||
105619455|NCT04501614|364271838|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
105619456|NCT04501614|364271839|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
105619457|NCT05239455|364271841|FG000|Overall Study|Adverse Event|1|||
105619458|NCT05239455|364271841|FG000|Overall Study|Sponsor Decision|5|||
105619459|NCT05239455|364271841|FG000|Overall Study|Incomplete Blood Collection|1|||
105619460|NCT01799265|364271842|FG000|Overall Study|Lost to Follow-up|1|||
105619461|NCT01799265|364271843|FG001|Overall Study|Lost to Follow-up|0|||
105619462|NCT01799265|364271842|FG000|Overall Study|Protocol Violation|2|||
105619463|NCT01799265|364271843|FG001|Overall Study|Protocol Violation|1|||
105619464|NCT01799265|364271842|FG000|Overall Study|inadequate sleep study|0|||
105619465|NCT01799265|364271843|FG001|Overall Study|inadequate sleep study|2|||
105619466|NCT05704543|364271844|FG000|Overall Study|Withdrawal by Subject|1|||
105619467|NCT05704543|364271845|FG001|Overall Study|Withdrawal by Subject|1|||
105619468|NCT05704543|364271846|FG002|Overall Study|Withdrawal by Subject|0|||
105619469|NCT05704543|364271847|FG003|Overall Study|Withdrawal by Subject|2|||
105619470|NCT05704543|364271844|FG000|Overall Study|Lost to Follow-up|1|||
105619471|NCT05704543|364271845|FG001|Overall Study|Lost to Follow-up|2|||
105619472|NCT05704543|364271846|FG002|Overall Study|Lost to Follow-up|0|||
105619473|NCT05704543|364271847|FG003|Overall Study|Lost to Follow-up|0|||
105619474|NCT04830800|364271850|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
105619475|NCT04830800|364271851|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
105619476|NCT04830800|364271852|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
105619477|NCT04830800|364271853|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
105619478|NCT04830800|364271854|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
105619479|NCT04909801|364271855|FG000|Overall Study|Lack of Efficacy|2|||
105619480|NCT04909801|364271856|FG001|Overall Study|Lack of Efficacy|1|||
105619481|NCT04909801|364271855|FG000|Overall Study|Adverse Event|1|||
105619482|NCT04909801|364271856|FG001|Overall Study|Adverse Event|2|||
105619483|NCT04909801|364271855|FG000|Overall Study|Participant request to discontinue study treatment|1|||
105619484|NCT04909801|364271856|FG001|Overall Study|Participant request to discontinue study treatment|2|||
105619485|NCT04909801|364271855|FG000|Overall Study|Withdrawal by Subject|2|||
105619486|NCT04909801|364271856|FG001|Overall Study|Withdrawal by Subject|1|||
105619487|NCT04909801|364271855|FG000|Overall Study|other reasons|1|||
105619488|NCT04909801|364271856|FG001|Overall Study|other reasons|1|||
105619489|NCT01946789|364271857|FG000|Overall Study|Death|0|||
105619490|NCT01946789|364271858|FG001|Overall Study|Death|2|||
105619491|NCT01946789|364271859|FG002|Overall Study|Death|1|||
105619492|NCT01946789|364271860|FG003|Overall Study|Death|1|||
105619493|NCT01946789|364271861|FG004|Overall Study|Death|1|||
105619494|NCT01946789|364271862|FG005|Overall Study|Death|1|||
105619495|NCT01946789|364271863|FG006|Overall Study|Death|3|||
105619496|NCT01946789|364271864|FG007|Overall Study|Death|1|||
105619497|NCT01946789|364271865|FG008|Overall Study|Death|2|||
105619498|NCT01946789|364271857|FG000|Overall Study|Progressive Disease|0|||
105619499|NCT01946789|364271858|FG001|Overall Study|Progressive Disease|0|||
105619500|NCT01946789|364271859|FG002|Overall Study|Progressive Disease|1|||
105619501|NCT01946789|364271860|FG003|Overall Study|Progressive Disease|0|||
105619502|NCT01946789|364271861|FG004|Overall Study|Progressive Disease|0|||
105619503|NCT01946789|364271862|FG005|Overall Study|Progressive Disease|2|||
105619504|NCT01946789|364271863|FG006|Overall Study|Progressive Disease|0|||
105619505|NCT01946789|364271864|FG007|Overall Study|Progressive Disease|0|||
105619506|NCT01946789|364271865|FG008|Overall Study|Progressive Disease|0|||
105619507|NCT01946789|364271857|FG000|Overall Study|Withdrawal by Subject|0|||
105619508|NCT01946789|364271858|FG001|Overall Study|Withdrawal by Subject|0|||
105619509|NCT01946789|364271859|FG002|Overall Study|Withdrawal by Subject|0|||
105619510|NCT01946789|364271860|FG003|Overall Study|Withdrawal by Subject|2|||
105619511|NCT01946789|364271861|FG004|Overall Study|Withdrawal by Subject|1|||
105619512|NCT01946789|364271862|FG005|Overall Study|Withdrawal by Subject|0|||
105619513|NCT01946789|364271863|FG006|Overall Study|Withdrawal by Subject|1|||
105619514|NCT01946789|364271864|FG007|Overall Study|Withdrawal by Subject|0|||
105619515|NCT01946789|364271865|FG008|Overall Study|Withdrawal by Subject|0|||
105619516|NCT05399485|364273580|FG000|DBT Phase|Other|6|||
105619517|NCT05399485|364273581|FG001|DBT Phase|Other|5|||
105619518|NCT05399485|364273580|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
105619519|NCT05399485|364273581|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
105619520|NCT05399485|364273580|FG000|DBT Phase|Withdrawal by Subject|3|||
105619521|NCT05399485|364273581|FG001|DBT Phase|Withdrawal by Subject|2|||
105619522|NCT05399485|364273580|FG000|DBT Phase|Protocol Violation|2|||
105619523|NCT05399485|364273581|FG001|DBT Phase|Protocol Violation|1|||
105619524|NCT05399485|364273580|FG000|DBT Phase|Physician Decision|0|||
105619525|NCT05399485|364273581|FG001|DBT Phase|Physician Decision|1|||
105619526|NCT05399485|364273580|FG000|DBT Phase|Adverse Event|2|||
105619527|NCT05399485|364273581|FG001|DBT Phase|Adverse Event|1|||
105619528|NCT05399485|364273580|FG000|OLE Phase|Not reported|0|||
105619529|NCT05399485|364273581|FG001|OLE Phase|Not reported|1|||
105619530|NCT05399485|364273580|FG000|OLE Phase|Other|3|||
105619531|NCT05399485|364273581|FG001|OLE Phase|Other|3|||
105619532|NCT05399485|364273580|FG000|OLE Phase|Withdrawal by Subject|8|||
105619533|NCT05399485|364273581|FG001|OLE Phase|Withdrawal by Subject|5|||
105619534|NCT05399485|364273580|FG000|OLE Phase|Pregnancy|0|||
105619535|NCT05399485|364273581|FG001|OLE Phase|Pregnancy|1|||
105619536|NCT05399485|364273580|FG000|OLE Phase|Physician Decision|2|||
105619537|NCT05399485|364273581|FG001|OLE Phase|Physician Decision|0|||
105619538|NCT05399485|364273580|FG000|OLE Phase|Adverse Event|0|||
105619539|NCT05399485|364273581|FG001|OLE Phase|Adverse Event|1|||
105619540|NCT05399485|364273580|FG000|OLE Phase|Ongoing in the OLE Phase|141|||
105619541|NCT05399485|364273581|FG001|OLE Phase|Ongoing in the OLE Phase|140|||
105619542|NCT03287817|364273592|FG000|Overall Study|Progressive disease|4|||
105619543|NCT03287817|364273593|FG001|Overall Study|Progressive disease|2|||
105619544|NCT03287817|364273594|FG002|Overall Study|Progressive disease|3|||
105619545|NCT03287817|364273595|FG003|Overall Study|Progressive disease|10|||
105619546|NCT03287817|364273596|FG004|Overall Study|Progressive disease|8|||
105619547|NCT03287817|364273592|FG000|Overall Study|Death|0|||
105619548|NCT03287817|364273593|FG001|Overall Study|Death|0|||
105619549|NCT03287817|364273594|FG002|Overall Study|Death|2|||
105619550|NCT03287817|364273595|FG003|Overall Study|Death|3|||
105619551|NCT03287817|364273596|FG004|Overall Study|Death|4|||
105619552|NCT03287817|364273592|FG000|Overall Study|Physician Decision|0|||
105619553|NCT03287817|364273593|FG001|Overall Study|Physician Decision|0|||
105619554|NCT03287817|364273594|FG002|Overall Study|Physician Decision|0|||
105619555|NCT03287817|364273595|FG003|Overall Study|Physician Decision|1|||
105619556|NCT03287817|364273596|FG004|Overall Study|Physician Decision|0|||
105619557|NCT03287817|364273592|FG000|Overall Study|Withdrawal by Subject|0|||
105619558|NCT03287817|364273593|FG001|Overall Study|Withdrawal by Subject|0|||
105619559|NCT03287817|364273594|FG002|Overall Study|Withdrawal by Subject|0|||
105619560|NCT03287817|364273595|FG003|Overall Study|Withdrawal by Subject|0|||
105619561|NCT03287817|364273596|FG004|Overall Study|Withdrawal by Subject|4|||
105619562|NCT02696707|364273597|FG000|Per Protocol Population|Physician Decision|2|||
105619563|NCT02696707|364273598|FG001|Per Protocol Population|Physician Decision|1|||
105619564|NCT02696707|364273597|FG000|Per Protocol Population|Participant Decision|0|||
105619565|NCT02696707|364273598|FG001|Per Protocol Population|Participant Decision|2|||
105619566|NCT02696707|364273597|FG000|Completed Study as Planned|Reason = LVEF|2|||
105619567|NCT02696707|364273598|FG001|Completed Study as Planned|Reason = LVEF|2|||
105619568|NCT02696707|364273597|FG000|Completed Study as Planned|Protocol Violation|2|||
105619569|NCT02696707|364273598|FG001|Completed Study as Planned|Protocol Violation|6|||
105619570|NCT02696707|364273597|FG000|Completed Study as Planned|Metastatic disease|3|||
105619571|NCT02696707|364273598|FG001|Completed Study as Planned|Metastatic disease|0|||
105619572|NCT02696707|364273597|FG000|Completed Study as Planned|Location|1|||
105619573|NCT02696707|364273598|FG001|Completed Study as Planned|Location|1|||
105619574|NCT03812679|364273601|FG000|Overall Study|Adverse Event|2|||
105619575|NCT03812679|364273601|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
105619576|NCT03812679|364273601|FG000|Overall Study|Renal transplant|1|||
105619577|NCT03812679|364273601|FG000|Overall Study|Withdrawal by Subject|1|||
105619578|NCT03812679|364273601|FG000|Overall Study|Termination of study|2|||
105619579|NCT03812679|364273601|FG000|Overall Study|Water device replacement|1|||
105619580|NCT05486078|364273602|FG000|Overall Study|4 drop out and one withdrawn|5|||
105619581|NCT01574274|364273603|FG000|Overall Study|Ineligible|0|||
105619582|NCT01574274|364273604|FG001|Overall Study|Ineligible|1|||
105619583|NCT01574274|364273603|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
105619584|NCT01574274|364273604|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
105619585|NCT01574274|364273603|FG000|Overall Study|Ph+ B-ALL|3|||
105619586|NCT01574274|364273604|FG001|Overall Study|Ph+ B-ALL|4|||
105619587|NCT01574274|364273603|FG000|Overall Study|Induction Death|2|||
105619588|NCT01574274|364273604|FG001|Overall Study|Induction Death|0|||
105619589|NCT01574274|364273603|FG000|Overall Study|Induction Failure|4|||
105619590|NCT01574274|364273604|FG001|Overall Study|Induction Failure|1|||
105619591|NCT01574274|364273603|FG000|Overall Study|Adverse Event|16|||
105619592|NCT01574274|364273604|FG001|Overall Study|Adverse Event|13|||
105619593|NCT01574274|364273603|FG000|Overall Study|Remission Death|1|||
105619594|NCT01574274|364273604|FG001|Overall Study|Remission Death|0|||
105619595|NCT01574274|364273603|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
105619596|NCT01574274|364273604|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
105619597|NCT01574274|364273603|FG000|Overall Study|Other, unknown|3|||
105619598|NCT01574274|364273604|FG001|Overall Study|Other, unknown|2|||
105619599|NCT04231149|364273605|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
105619600|NCT04231149|364273606|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
105619601|NCT04231149|364273607|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
105619602|NCT04231149|364273608|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
105619603|NCT04231149|364273609|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
105619604|NCT02993159|364273611|FG000|Overall Study|Withdrawal by Subject|1|||
105619605|NCT02993159|364273612|FG001|Overall Study|Withdrawal by Subject|3|||
105619606|NCT02993159|364273611|FG000|Overall Study|Protocol Violation|1|||
105619607|NCT02993159|364273612|FG001|Overall Study|Protocol Violation|0|||
105619608|NCT02993159|364273611|FG000|Overall Study|Opted out of surgery|2|||
105619609|NCT02993159|364273612|FG001|Overall Study|Opted out of surgery|0|||
105619610|NCT02993159|364273611|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
105619611|NCT02993159|364273612|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
105619612|NCT02993159|364273611|FG000|Overall Study|Physician Decision|0|||
105619613|NCT02993159|364273612|FG001|Overall Study|Physician Decision|1|||
105619614|NCT05034328|364273613|FG000|Overall Study|Protocol Violation|1|||
105619615|NCT05034328|364273614|FG001|Overall Study|Protocol Violation|0|||
105619616|NCT05034328|364273613|FG000|Overall Study|Lost to Follow-up|0|||
105619617|NCT05034328|364273614|FG001|Overall Study|Lost to Follow-up|10|||
105619618|NCT05399459|364273616|FG000|Overall Study|Randomized but not treated|29|||
105619619|NCT05399459|364273617|FG001|Overall Study|Randomized but not treated|30|||
105619620|NCT05399459|364273618|FG002|Overall Study|Randomized but not treated|38|||
105619621|NCT05399459|364273616|FG000|Overall Study|Lost to Follow-up|1|||
105619622|NCT05399459|364273617|FG001|Overall Study|Lost to Follow-up|0|||
105619623|NCT05399459|364273618|FG002|Overall Study|Lost to Follow-up|0|||
105619624|NCT04992520|364273619|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
105619625|NCT04992520|364273620|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
105619626|NCT04992520|364273621|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
105619627|NCT04992520|364273622|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
105619628|NCT04992520|364273623|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
105619629|NCT04992520|364273624|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
105619630|NCT04992520|364273619|FG000|Part A: First Challenge|Non-compliance|0|||
105619631|NCT04992520|364273620|FG001|Part A: First Challenge|Non-compliance|0|||
105619632|NCT04992520|364273621|FG002|Part A: First Challenge|Non-compliance|0|||
105619633|NCT04992520|364273622|FG003|Part A: First Challenge|Non-compliance|1|||
105619634|NCT04992520|364273623|FG004|Part A: First Challenge|Non-compliance|0|||
105619635|NCT04992520|364273624|FG005|Part A: First Challenge|Non-compliance|0|||
105619636|NCT04992520|364273619|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
105619637|NCT04992520|364273620|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
105619638|NCT04992520|364273621|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
105619639|NCT04992520|364273622|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
105619640|NCT04992520|364273623|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
105619641|NCT04992520|364273624|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
105619642|NCT04992520|364273619|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
105619643|NCT04992520|364273620|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
105619644|NCT04992520|364273621|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
105619645|NCT04992520|364273622|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
105619646|NCT04992520|364273623|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
105619647|NCT04992520|364273624|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
105619648|NCT02231164|364273628|FG000|Overall Study|Adverse Event|1|||
105619649|NCT02231164|364273629|FG001|Overall Study|Adverse Event|1|||
105619650|NCT02231164|364273628|FG000|Overall Study|Lack of Efficacy|4|||
105619651|NCT02231164|364273629|FG001|Overall Study|Lack of Efficacy|3|||
105619652|NCT02231164|364273628|FG000|Overall Study|Withdrawal by Subject|1|||
105619653|NCT02231164|364273629|FG001|Overall Study|Withdrawal by Subject|2|||
105619654|NCT02969707|364273631|FG000|Overall Study|Withdrawal by Subject|6|||
105619655|NCT02969707|364273632|FG001|Overall Study|Withdrawal by Subject|5|||
105619656|NCT02969707|364273631|FG000|Overall Study|Severe anxiety|0|||
105619657|NCT02969707|364273632|FG001|Overall Study|Severe anxiety|1|||
105619658|NCT02969707|364273631|FG000|Overall Study|Positive toxicology screen|0|||
105619659|NCT02969707|364273632|FG001|Overall Study|Positive toxicology screen|2|||
105619660|NCT02969707|364273631|FG000|Overall Study|Claustrophobia|2|||
105619661|NCT02969707|364273632|FG001|Overall Study|Claustrophobia|2|||
105619662|NCT02969707|364273631|FG000|Overall Study|Non-compliance|1|||
105619663|NCT02969707|364273632|FG001|Overall Study|Non-compliance|2|||
105619664|NCT01175356|364273633|FG000|Overall Study|Death|1|||
105619665|NCT01175356|364273633|FG000|Overall Study|Lack of Efficacy|12|||
105619666|NCT01175356|364273633|FG000|Overall Study|Lost to Follow-up|1|||
105619667|NCT01175356|364273633|FG000|Overall Study|Physician Decision|23|||
105619668|NCT01175356|364273633|FG000|Overall Study|Ineligible|1|||
105619669|NCT01175356|364273633|FG000|Overall Study|Treatment Slot Not Available|18|||
105619670|NCT01175356|364273633|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
105619671|NCT01175356|364273633|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
105619672|NCT01175356|364273633|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
105619673|NCT01175356|364273633|FG000|Overall Study|Inadequate stem cell for transplant|1|||
105619674|NCT01175356|364273633|FG000|Overall Study|Initiation other tx prior to completion|9|||
105619675|NCT05583578|364273636|FG000|Overall Study|Withdrawal by Subject|2|||
105619676|NCT05583578|364273637|FG001|Overall Study|Withdrawal by Subject|0|||
105619677|NCT04314713|364273639|FG000|Overall Study|Lost to Follow-up|0|||
105619678|NCT04314713|364273640|FG001|Overall Study|Lost to Follow-up|0|||
105619679|NCT04314713|364273641|FG002|Overall Study|Lost to Follow-up|0|||
105619680|NCT04314713|364273642|FG003|Overall Study|Lost to Follow-up|1|||
105619681|NCT04314713|364273643|FG004|Overall Study|Lost to Follow-up|0|||
105619682|NCT04314713|364273644|FG005|Overall Study|Lost to Follow-up|0|||
105619683|NCT02427464|364273645|FG000|Overall Study|Adverse Event|6|||
105619684|NCT02427464|364273646|FG001|Overall Study|Adverse Event|1|||
105619685|NCT02427464|364273645|FG000|Overall Study|Lost to Follow-up|16|||
105619686|NCT02427464|364273646|FG001|Overall Study|Lost to Follow-up|5|||
105619687|NCT02427464|364273645|FG000|Overall Study|Physician Decision|2|||
105619688|NCT02427464|364273646|FG001|Overall Study|Physician Decision|0|||
105619689|NCT02427464|364273645|FG000|Overall Study|Withdrawal by Subject|10|||
105619690|NCT02427464|364273646|FG001|Overall Study|Withdrawal by Subject|8|||
105619691|NCT02427464|364273645|FG000|Overall Study|Noncompliance|16|||
105619692|NCT02427464|364273646|FG001|Overall Study|Noncompliance|10|||
105619693|NCT04145440|364273647|FG000|Overall Study|Physician Decision|3|||
105619694|NCT04145440|364273648|FG001|Overall Study|Physician Decision|0|||
105619695|NCT04145440|364273647|FG000|Overall Study|Use of prohibited therapy|2|||
105619696|NCT04145440|364273648|FG001|Overall Study|Use of prohibited therapy|3|||
105619697|NCT04248725|364273660|FG000|Post-Treatment|Lost to Follow-up|6|||
105619698|NCT04248725|364273661|FG001|Post-Treatment|Lost to Follow-up|5|||
105619699|NCT04248725|364273660|FG000|6-Month Follow Up|Lost to Follow-up|9|||
105619700|NCT04248725|364273661|FG001|6-Month Follow Up|Lost to Follow-up|8|||
105619701|NCT04436276|364273667|FG000|Overall Study|Adverse Event|0|||
105619702|NCT04436276|364273668|FG001|Overall Study|Adverse Event|0|||
105619703|NCT04436276|364273669|FG002|Overall Study|Adverse Event|0|||
105619704|NCT04436276|364273670|FG003|Overall Study|Adverse Event|0|||
105619705|NCT04436276|364273671|FG004|Overall Study|Adverse Event|0|||
105619706|NCT04436276|364273672|FG005|Overall Study|Adverse Event|0|||
105619707|NCT04436276|364273673|FG006|Overall Study|Adverse Event|0|||
105619708|NCT04436276|364273674|FG007|Overall Study|Adverse Event|0|||
105619709|NCT04436276|364273675|FG008|Overall Study|Adverse Event|0|||
105619710|NCT04436276|364273676|FG009|Overall Study|Adverse Event|0|||
105619711|NCT04436276|364273677|FG010|Overall Study|Adverse Event|0|||
105619712|NCT04436276|364273678|FG011|Overall Study|Adverse Event|0|||
105619713|NCT04436276|364273679|FG012|Overall Study|Adverse Event|0|||
105619714|NCT04436276|364273680|FG013|Overall Study|Adverse Event|0|||
105619715|NCT04436276|364273681|FG014|Overall Study|Adverse Event|0|||
105619716|NCT04436276|364273682|FG015|Overall Study|Adverse Event|0|||
105619717|NCT04436276|364273683|FG016|Overall Study|Adverse Event|1|||
105619718|NCT04436276|364273684|FG017|Overall Study|Adverse Event|0|||
105619719|NCT04436276|364273685|FG018|Overall Study|Adverse Event|0|||
105619720|NCT04436276|364273686|FG019|Overall Study|Adverse Event|0|||
105619721|NCT04436276|364273687|FG020|Overall Study|Adverse Event|0|||
105619722|NCT04436276|364273688|FG021|Overall Study|Adverse Event|0|||
105619723|NCT04436276|364273689|FG022|Overall Study|Adverse Event|0|||
105619724|NCT04436276|364273667|FG000|Overall Study|Death|0|||
105619725|NCT04436276|364273668|FG001|Overall Study|Death|0|||
105619726|NCT04436276|364273669|FG002|Overall Study|Death|0|||
105619727|NCT04436276|364273670|FG003|Overall Study|Death|0|||
105619728|NCT04436276|364273671|FG004|Overall Study|Death|0|||
105619729|NCT04436276|364273672|FG005|Overall Study|Death|0|||
105619730|NCT04436276|364273673|FG006|Overall Study|Death|0|||
105619731|NCT04436276|364273674|FG007|Overall Study|Death|0|||
105619732|NCT04436276|364273675|FG008|Overall Study|Death|0|||
105619733|NCT04436276|364273676|FG009|Overall Study|Death|0|||
105619734|NCT04436276|364273677|FG010|Overall Study|Death|0|||
105619735|NCT04436276|364273678|FG011|Overall Study|Death|0|||
105619736|NCT04436276|364273679|FG012|Overall Study|Death|1|||
105619737|NCT04436276|364273680|FG013|Overall Study|Death|0|||
105619738|NCT04436276|364273681|FG014|Overall Study|Death|1|||
105619739|NCT04436276|364273682|FG015|Overall Study|Death|0|||
105619740|NCT04436276|364273683|FG016|Overall Study|Death|0|||
105619741|NCT04436276|364273684|FG017|Overall Study|Death|0|||
105619742|NCT04436276|364273685|FG018|Overall Study|Death|0|||
105619743|NCT04436276|364273686|FG019|Overall Study|Death|2|||
105619744|NCT04436276|364273687|FG020|Overall Study|Death|0|||
105619745|NCT04436276|364273688|FG021|Overall Study|Death|1|||
105619746|NCT04436276|364273689|FG022|Overall Study|Death|0|||
105619747|NCT04436276|364273667|FG000|Overall Study|Lost to Follow-up|0|||
105619748|NCT04436276|364273668|FG001|Overall Study|Lost to Follow-up|2|||
105619749|NCT04436276|364273669|FG002|Overall Study|Lost to Follow-up|2|||
105619750|NCT04436276|364273670|FG003|Overall Study|Lost to Follow-up|1|||
105619751|NCT04436276|364273671|FG004|Overall Study|Lost to Follow-up|4|||
105619752|NCT04436276|364273672|FG005|Overall Study|Lost to Follow-up|1|||
105619753|NCT04436276|364273673|FG006|Overall Study|Lost to Follow-up|0|||
105619754|NCT04436276|364273674|FG007|Overall Study|Lost to Follow-up|0|||
105619755|NCT04436276|364273675|FG008|Overall Study|Lost to Follow-up|1|||
105619756|NCT04436276|364273676|FG009|Overall Study|Lost to Follow-up|0|||
105619757|NCT04436276|364273677|FG010|Overall Study|Lost to Follow-up|5|||
105619758|NCT04436276|364273678|FG011|Overall Study|Lost to Follow-up|5|||
105619759|NCT04436276|364273679|FG012|Overall Study|Lost to Follow-up|4|||
105619760|NCT04436276|364273680|FG013|Overall Study|Lost to Follow-up|1|||
105619761|NCT04436276|364273681|FG014|Overall Study|Lost to Follow-up|7|||
105619762|NCT04436276|364273682|FG015|Overall Study|Lost to Follow-up|7|||
105619763|NCT04436276|364273683|FG016|Overall Study|Lost to Follow-up|1|||
105619764|NCT04436276|364273684|FG017|Overall Study|Lost to Follow-up|0|||
105619765|NCT04436276|364273685|FG018|Overall Study|Lost to Follow-up|1|||
105619766|NCT04436276|364273686|FG019|Overall Study|Lost to Follow-up|1|||
105619767|NCT04436276|364273687|FG020|Overall Study|Lost to Follow-up|2|||
105619768|NCT04436276|364273688|FG021|Overall Study|Lost to Follow-up|1|||
105619769|NCT04436276|364273689|FG022|Overall Study|Lost to Follow-up|1|||
105619770|NCT04436276|364273667|FG000|Overall Study|Physician Decision|1|||
105619771|NCT04436276|364273668|FG001|Overall Study|Physician Decision|0|||
105619772|NCT04436276|364273669|FG002|Overall Study|Physician Decision|2|||
105619773|NCT04436276|364273670|FG003|Overall Study|Physician Decision|1|||
105619774|NCT04436276|364273671|FG004|Overall Study|Physician Decision|0|||
105619775|NCT04436276|364273672|FG005|Overall Study|Physician Decision|0|||
105619776|NCT04436276|364273673|FG006|Overall Study|Physician Decision|0|||
105619777|NCT04436276|364273674|FG007|Overall Study|Physician Decision|0|||
105619778|NCT04436276|364273675|FG008|Overall Study|Physician Decision|0|||
105619779|NCT04436276|364273676|FG009|Overall Study|Physician Decision|0|||
105619780|NCT04436276|364273677|FG010|Overall Study|Physician Decision|0|||
105619781|NCT04436276|364273678|FG011|Overall Study|Physician Decision|1|||
105619782|NCT04436276|364273679|FG012|Overall Study|Physician Decision|2|||
105619783|NCT04436276|364273680|FG013|Overall Study|Physician Decision|0|||
105619784|NCT04436276|364273681|FG014|Overall Study|Physician Decision|0|||
105619785|NCT04436276|364273682|FG015|Overall Study|Physician Decision|0|||
105619786|NCT04436276|364273683|FG016|Overall Study|Physician Decision|0|||
105619787|NCT04436276|364273684|FG017|Overall Study|Physician Decision|0|||
105619788|NCT04436276|364273685|FG018|Overall Study|Physician Decision|0|||
105619789|NCT04436276|364273686|FG019|Overall Study|Physician Decision|0|||
105619790|NCT04436276|364273687|FG020|Overall Study|Physician Decision|1|||
105619791|NCT04436276|364273688|FG021|Overall Study|Physician Decision|2|||
105619792|NCT04436276|364273689|FG022|Overall Study|Physician Decision|0|||
105619793|NCT04436276|364273667|FG000|Overall Study|Protocol Violation|0|||
105619794|NCT04436276|364273668|FG001|Overall Study|Protocol Violation|0|||
105619795|NCT04436276|364273669|FG002|Overall Study|Protocol Violation|0|||
105619796|NCT04436276|364273670|FG003|Overall Study|Protocol Violation|0|||
105619797|NCT04436276|364273671|FG004|Overall Study|Protocol Violation|0|||
105619798|NCT04436276|364273672|FG005|Overall Study|Protocol Violation|0|||
105619799|NCT04436276|364273673|FG006|Overall Study|Protocol Violation|0|||
105619800|NCT04436276|364273674|FG007|Overall Study|Protocol Violation|0|||
105619801|NCT04436276|364273675|FG008|Overall Study|Protocol Violation|0|||
105619802|NCT04436276|364273676|FG009|Overall Study|Protocol Violation|0|||
105619803|NCT04436276|364273677|FG010|Overall Study|Protocol Violation|0|||
105619804|NCT04436276|364273678|FG011|Overall Study|Protocol Violation|0|||
105619805|NCT04436276|364273679|FG012|Overall Study|Protocol Violation|0|||
105619806|NCT04436276|364273680|FG013|Overall Study|Protocol Violation|1|||
105619807|NCT04436276|364273681|FG014|Overall Study|Protocol Violation|0|||
105619808|NCT04436276|364273682|FG015|Overall Study|Protocol Violation|1|||
105619809|NCT04436276|364273683|FG016|Overall Study|Protocol Violation|0|||
105619810|NCT04436276|364273684|FG017|Overall Study|Protocol Violation|0|||
105619811|NCT04436276|364273685|FG018|Overall Study|Protocol Violation|0|||
105619812|NCT04436276|364273686|FG019|Overall Study|Protocol Violation|0|||
105619813|NCT04436276|364273687|FG020|Overall Study|Protocol Violation|0|||
105619814|NCT04436276|364273688|FG021|Overall Study|Protocol Violation|0|||
105619815|NCT04436276|364273689|FG022|Overall Study|Protocol Violation|0|||
105619816|NCT04436276|364273667|FG000|Overall Study|Withdrawal by Subject|25|||
105619817|NCT04436276|364273668|FG001|Overall Study|Withdrawal by Subject|22|||
105619818|NCT04436276|364273669|FG002|Overall Study|Withdrawal by Subject|24|||
105619819|NCT04436276|364273670|FG003|Overall Study|Withdrawal by Subject|23|||
105619820|NCT04436276|364273671|FG004|Overall Study|Withdrawal by Subject|14|||
105619821|NCT04436276|364273672|FG005|Overall Study|Withdrawal by Subject|0|||
105619822|NCT04436276|364273673|FG006|Overall Study|Withdrawal by Subject|0|||
105619823|NCT04436276|364273674|FG007|Overall Study|Withdrawal by Subject|1|||
105619824|NCT04436276|364273675|FG008|Overall Study|Withdrawal by Subject|0|||
105619825|NCT04436276|364273676|FG009|Overall Study|Withdrawal by Subject|1|||
105619826|NCT04436276|364273677|FG010|Overall Study|Withdrawal by Subject|17|||
105619827|NCT04436276|364273678|FG011|Overall Study|Withdrawal by Subject|7|||
105619828|NCT04436276|364273679|FG012|Overall Study|Withdrawal by Subject|10|||
105619829|NCT04436276|364273680|FG013|Overall Study|Withdrawal by Subject|6|||
105619830|NCT04436276|364273681|FG014|Overall Study|Withdrawal by Subject|20|||
105619831|NCT04436276|364273682|FG015|Overall Study|Withdrawal by Subject|6|||
105619832|NCT04436276|364273683|FG016|Overall Study|Withdrawal by Subject|11|||
105619833|NCT04436276|364273684|FG017|Overall Study|Withdrawal by Subject|4|||
105619834|NCT04436276|364273685|FG018|Overall Study|Withdrawal by Subject|14|||
105619835|NCT04436276|364273686|FG019|Overall Study|Withdrawal by Subject|24|||
105619836|NCT04436276|364273687|FG020|Overall Study|Withdrawal by Subject|24|||
105619837|NCT04436276|364273688|FG021|Overall Study|Withdrawal by Subject|16|||
105619838|NCT04436276|364273689|FG022|Overall Study|Withdrawal by Subject|14|||
105619839|NCT04436276|364273667|FG000|Overall Study|Other|3|||
105619840|NCT04436276|364273668|FG001|Overall Study|Other|2|||
105619841|NCT04436276|364273669|FG002|Overall Study|Other|5|||
105619842|NCT04436276|364273670|FG003|Overall Study|Other|9|||
105619843|NCT04436276|364273671|FG004|Overall Study|Other|23|||
105619844|NCT04436276|364273672|FG005|Overall Study|Other|1|||
105619845|NCT04436276|364273673|FG006|Overall Study|Other|0|||
105619846|NCT04436276|364273674|FG007|Overall Study|Other|0|||
105619847|NCT04436276|364273675|FG008|Overall Study|Other|0|||
105619848|NCT04436276|364273676|FG009|Overall Study|Other|0|||
105619849|NCT04436276|364273677|FG010|Overall Study|Other|3|||
105619850|NCT04436276|364273678|FG011|Overall Study|Other|1|||
105619851|NCT04436276|364273679|FG012|Overall Study|Other|1|||
105619852|NCT04436276|364273680|FG013|Overall Study|Other|2|||
105619853|NCT04436276|364273681|FG014|Overall Study|Other|3|||
105619854|NCT04436276|364273682|FG015|Overall Study|Other|0|||
105619855|NCT04436276|364273683|FG016|Overall Study|Other|0|||
105619856|NCT04436276|364273684|FG017|Overall Study|Other|6|||
105619857|NCT04436276|364273685|FG018|Overall Study|Other|1|||
105619858|NCT04436276|364273686|FG019|Overall Study|Other|0|||
105619859|NCT04436276|364273687|FG020|Overall Study|Other|2|||
105619860|NCT04436276|364273688|FG021|Overall Study|Other|2|||
105619861|NCT04436276|364273689|FG022|Overall Study|Other|60|||
105619862|NCT05477186|364273690|FG000|Overall Study|Vaccine not administered|0|||
105619863|NCT05477186|364273691|FG001|Overall Study|Vaccine not administered|2|||
105619864|NCT05477186|364273692|FG002|Overall Study|Vaccine not administered|1|||
105619865|NCT05477186|364273693|FG003|Overall Study|Vaccine not administered|0|||
105619866|NCT05477186|364273694|FG004|Overall Study|Vaccine not administered|1|||
105619867|NCT05477186|364273695|FG005|Overall Study|Vaccine not administered|0|||
105619868|NCT05477186|364273696|FG006|Overall Study|Vaccine not administered|0|||
105619869|NCT05477186|364273690|FG000|Overall Study|Withdrawal by Subject|1|||
105619870|NCT05477186|364273691|FG001|Overall Study|Withdrawal by Subject|0|||
105619871|NCT05477186|364273692|FG002|Overall Study|Withdrawal by Subject|0|||
105619872|NCT05477186|364273693|FG003|Overall Study|Withdrawal by Subject|0|||
105619873|NCT05477186|364273694|FG004|Overall Study|Withdrawal by Subject|0|||
105619874|NCT05477186|364273695|FG005|Overall Study|Withdrawal by Subject|1|||
105619875|NCT05477186|364273696|FG006|Overall Study|Withdrawal by Subject|0|||
105619876|NCT05477186|364273690|FG000|Overall Study|Lost to Follow-up|1|||
105619877|NCT05477186|364273691|FG001|Overall Study|Lost to Follow-up|0|||
105619878|NCT05477186|364273692|FG002|Overall Study|Lost to Follow-up|2|||
105619879|NCT05477186|364273693|FG003|Overall Study|Lost to Follow-up|1|||
105619880|NCT05477186|364273694|FG004|Overall Study|Lost to Follow-up|1|||
105619881|NCT05477186|364273695|FG005|Overall Study|Lost to Follow-up|0|||
105619882|NCT05477186|364273696|FG006|Overall Study|Lost to Follow-up|2|||
105619883|NCT05297565|364273705|FG000|Overall Study|Other Reasons|0|||
105619884|NCT05297565|364273706|FG001|Overall Study|Other Reasons|1|||
105619885|NCT05297565|364273705|FG000|Overall Study|Physician Decision|0|||
105619886|NCT05297565|364273706|FG001|Overall Study|Physician Decision|1|||
105619887|NCT05297565|364273705|FG000|Overall Study|Disease recurrence|1|||
105619888|NCT05297565|364273706|FG001|Overall Study|Disease recurrence|0|||
105619889|NCT05496231|364273707|FG000|Overall Study|Adverse Event|1|||
105619890|NCT05496231|364273708|FG001|Overall Study|Adverse Event|1|||
105619891|NCT05496231|364273709|FG002|Overall Study|Adverse Event|0|||
105619892|NCT05496231|364273710|FG003|Overall Study|Adverse Event|4|||
105619893|NCT05496231|364273707|FG000|Overall Study|Withdrawal by Subject|5|||
105619894|NCT05496231|364273708|FG001|Overall Study|Withdrawal by Subject|5|||
105619895|NCT05496231|364273709|FG002|Overall Study|Withdrawal by Subject|4|||
105619896|NCT05496231|364273710|FG003|Overall Study|Withdrawal by Subject|11|||
105619897|NCT05496231|364273707|FG000|Overall Study|Migrated/moved from the study area|3|||
105619898|NCT05496231|364273708|FG001|Overall Study|Migrated/moved from the study area|5|||
105619899|NCT05496231|364273709|FG002|Overall Study|Migrated/moved from the study area|3|||
105619900|NCT05496231|364273710|FG003|Overall Study|Migrated/moved from the study area|3|||
105619901|NCT05496231|364273707|FG000|Overall Study|Lost to Follow-up|13|||
105619902|NCT05496231|364273708|FG001|Overall Study|Lost to Follow-up|6|||
105619903|NCT05496231|364273709|FG002|Overall Study|Lost to Follow-up|11|||
105619904|NCT05496231|364273710|FG003|Overall Study|Lost to Follow-up|6|||
105619905|NCT05496231|364273707|FG000|Overall Study|Other|9|||
105619906|NCT05496231|364273708|FG001|Overall Study|Other|7|||
105619907|NCT05496231|364273709|FG002|Overall Study|Other|7|||
105619908|NCT05496231|364273710|FG003|Overall Study|Other|8|||
105619909|NCT01267955|364273711|FG000|Stage 1 (6 Months)|Death|3|||
105619910|NCT01267955|364273711|FG000|Stage 2 (6 Months)|Death|5|||
105619911|NCT01267955|364273711|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
105619912|NCT02589522|364273715|FG000|Overall Study|Physician Decision|1|||
105619913|NCT02589522|364273716|FG001|Overall Study|Physician Decision|2|||
105619914|NCT02589522|364273717|FG002|Overall Study|Physician Decision|0|||
105619915|NCT02589522|364273715|FG000|Overall Study|Did not start treatment|1|||
105619916|NCT02589522|364273716|FG001|Overall Study|Did not start treatment|0|||
105619917|NCT02589522|364273717|FG002|Overall Study|Did not start treatment|0|||
105619918|NCT04159415|364273718|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
105619919|NCT04159415|364273719|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
105619920|NCT04159415|364273720|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
105619921|NCT04159415|364273721|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
105619922|NCT04159415|364273722|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
105619923|NCT04159415|364273723|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
105619924|NCT04159415|364273724|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
105619925|NCT04159415|364273725|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
105619926|NCT03800654|364273726|FG000|Overall Study|Time constraints|3|||
105619927|NCT03800654|364273727|FG001|Overall Study|Time constraints|3|||
105619928|NCT03800654|364273728|FG002|Overall Study|Time constraints|3|||
105619929|NCT03800654|364273726|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
105619930|NCT03800654|364273727|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
105619931|NCT03800654|364273728|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
105619932|NCT03800654|364273726|FG000|Overall Study|Lost to Follow-up|2|||
105619933|NCT03800654|364273727|FG001|Overall Study|Lost to Follow-up|1|||
105619934|NCT03800654|364273728|FG002|Overall Study|Lost to Follow-up|6|||
105619935|NCT03800654|364273726|FG000|Overall Study|Medical Health Issue|0|||
105619936|NCT03800654|364273727|FG001|Overall Study|Medical Health Issue|0|||
105619937|NCT03800654|364273728|FG002|Overall Study|Medical Health Issue|1|||
105619938|NCT03800654|364273726|FG000|Overall Study|Personal Issues|0|||
105619939|NCT03800654|364273727|FG001|Overall Study|Personal Issues|2|||
105619940|NCT03800654|364273728|FG002|Overall Study|Personal Issues|0|||
105619941|NCT03800654|364273726|FG000|Overall Study|Protocol Violation|0|||
105619942|NCT03800654|364273727|FG001|Overall Study|Protocol Violation|1|||
105619943|NCT03800654|364273728|FG002|Overall Study|Protocol Violation|0|||
105619944|NCT03459729|364273729|FG000|Overall Study|Physician Decision|2|||
105619945|NCT06182033|364273730|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
105619946|NCT06182033|364273731|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
105619947|NCT06182033|364273730|FG000|Overall Study|Target child relocation|1|||
105619948|NCT06182033|364273731|FG001|Overall Study|Target child relocation|1|||
105619949|NCT06182033|364273730|FG000|Overall Study|Withdrawal by Subject|1|||
105619950|NCT06182033|364273731|FG001|Overall Study|Withdrawal by Subject|0|||
105619961|NCT03084536|364273734|FG000|Overall Study|Determined to be ineligible|0|||
105619962|NCT03084536|364273735|FG001|Overall Study|Determined to be ineligible|0|||
105619963|NCT03084536|364273736|FG002|Overall Study|Determined to be ineligible|16|||
105619964|NCT03084536|364273734|FG000|Overall Study|Withdrawal by Subject|0|||
105619965|NCT03084536|364273735|FG001|Overall Study|Withdrawal by Subject|0|||
105619966|NCT03084536|364273736|FG002|Overall Study|Withdrawal by Subject|4|||
105619967|NCT03084536|364273734|FG000|Overall Study|Physician Decision|0|||
105619968|NCT03084536|364273735|FG001|Overall Study|Physician Decision|0|||
105619969|NCT03084536|364273736|FG002|Overall Study|Physician Decision|3|||
105619970|NCT03084536|364273734|FG000|Overall Study|Death|0|||
105619971|NCT03084536|364273735|FG001|Overall Study|Death|0|||
105619972|NCT03084536|364273736|FG002|Overall Study|Death|1|||
105619973|NCT03084536|364273734|FG000|Overall Study|Lost to Follow-up|0|||
105619974|NCT03084536|364273735|FG001|Overall Study|Lost to Follow-up|0|||
105619975|NCT03084536|364273736|FG002|Overall Study|Lost to Follow-up|1|||
105619976|NCT03084536|364273734|FG000|Overall Study|Protocol Violation|0|||
105619977|NCT03084536|364273735|FG001|Overall Study|Protocol Violation|0|||
105619978|NCT03084536|364273736|FG002|Overall Study|Protocol Violation|1|||
105619979|NCT03084536|364273734|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
105619980|NCT03084536|364273735|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
105619981|NCT03084536|364273736|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
105619982|NCT05374798|364273742|FG000|Overall Study|Lost to Follow-up|2|||
105619983|NCT05374798|364273742|FG000|Overall Study|Withdrawal by Subject|2|||
105619984|NCT05374798|364273742|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
105619985|NCT01275677|364273743|FG000|Overall Study|Not at risk for recurrence.|1|||
105619986|NCT01275677|364273744|FG001|Overall Study|Not at risk for recurrence.|1|||
105619987|NCT01275677|364273743|FG000|Overall Study|No follow-up|26|||
105619988|NCT01275677|364273744|FG001|Overall Study|No follow-up|37|||
105619989|NCT01275677|364273743|FG000|Overall Study|No clinical follow up.|1|||
105619990|NCT01275677|364273744|FG001|Overall Study|No clinical follow up.|4|||
105619991|NCT04857723|364273745|FG000|Overall Study|Withdrawal by Subject|2|||
105619992|NCT05809453|364275197|FG000|Overall Study|Withdrawal by Subject|1|||
105619993|NCT05809453|364275198|FG001|Overall Study|Withdrawal by Subject|0|||
105619994|NCT05809453|364275199|FG002|Overall Study|Withdrawal by Subject|0|||
105619995|NCT05809453|364275200|FG003|Overall Study|Withdrawal by Subject|0|||
105619996|NCT05251909|364275205|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
105619997|NCT05251909|364275206|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
105619998|NCT06181227|364275207|FG000|Overall Study|Study terminated by sponsor|7|||
105619999|NCT06181227|364275208|FG001|Overall Study|Study terminated by sponsor|9|||
105620000|NCT05543915|364275209|FG000|Overall Study|Lost to Follow-up|0|||
105620001|NCT05543915|364275210|FG001|Overall Study|Lost to Follow-up|1|||
105620002|NCT04250194|364275211|FG000|Overall Study|Declined to schedule biopsy|6|||
105620003|NCT04250194|364275212|FG001|Overall Study|Declined to schedule biopsy|10|||
105620004|NCT04250194|364275211|FG000|Overall Study|Medically Unfit for Biopsy|2|||
105620005|NCT04250194|364275212|FG001|Overall Study|Medically Unfit for Biopsy|1|||
105620006|NCT04250194|364275211|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
105620007|NCT04250194|364275212|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
105620008|NCT04250194|364275211|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
105620009|NCT04250194|364275212|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
105620010|NCT04250194|364275211|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
105620011|NCT04250194|364275212|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
105620012|NCT03257410|364275213|FG000|Overall Study|Adverse Event|2|||
105620013|NCT03257410|364275214|FG001|Overall Study|Adverse Event|3|||
105620014|NCT03257410|364275213|FG000|Overall Study|Protocol Violation|1|||
105620015|NCT03257410|364275214|FG001|Overall Study|Protocol Violation|2|||
105620016|NCT03257410|364275213|FG000|Overall Study|Lost to Follow-up|1|||
105620017|NCT03257410|364275214|FG001|Overall Study|Lost to Follow-up|0|||
105620018|NCT03257410|364275213|FG000|Overall Study|Withdrawal by Subject|1|||
105620019|NCT03257410|364275214|FG001|Overall Study|Withdrawal by Subject|2|||
105620020|NCT03257410|364275213|FG000|Overall Study|Physician Decision|1|||
105620021|NCT03257410|364275214|FG001|Overall Study|Physician Decision|1|||
105620022|NCT03257410|364275213|FG000|Overall Study|Renal transplantation|2|||
105620023|NCT03257410|364275214|FG001|Overall Study|Renal transplantation|0|||
105620024|NCT03257410|364275213|FG000|Overall Study|Switch to peritoneal dialysis|1|||
105620025|NCT03257410|364275214|FG001|Overall Study|Switch to peritoneal dialysis|0|||
105620026|NCT03257410|364275213|FG000|Overall Study|Death|3|||
105620027|NCT03257410|364275214|FG001|Overall Study|Death|2|||
105620028|NCT03257410|364275213|FG000|Overall Study|Change to another dialysis center|2|||
105620029|NCT03257410|364275214|FG001|Overall Study|Change to another dialysis center|2|||
105620030|NCT03257410|364275213|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
105620031|NCT03257410|364275214|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
105620032|NCT03257410|364275213|FG000|Overall Study|Miscellaneous|2|||
105620033|NCT03257410|364275214|FG001|Overall Study|Miscellaneous|2|||
105620034|NCT03257410|364275213|FG000|Overall Study|Other|0|||
105620035|NCT03257410|364275214|FG001|Overall Study|Other|1|||
105620036|NCT02561247|364275215|FG000|Overall Study|Protocol Violation|1|||
105620037|NCT02561247|364275215|FG000|Overall Study|Withdrawal by Subject|1|||
105620038|NCT02561247|364275215|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
105620039|NCT03625167|364275218|FG000|Overall Study|Protocol Violation|5|||
105620040|NCT06103188|364275219|FG000|Overall Study|Lost to Follow-up|1|||
105620041|NCT06103188|364275220|FG001|Overall Study|Lost to Follow-up|6|||
105620042|NCT06103188|364275221|FG002|Overall Study|Lost to Follow-up|4|||
105620043|NCT04979442|364275226|FG000|Overall Study|Death|43|||
105620044|NCT04979442|364275227|FG001|Overall Study|Death|30|||
105620045|NCT04979442|364275226|FG000|Overall Study|Withdrawal by Subject|8|||
105620046|NCT04979442|364275227|FG001|Overall Study|Withdrawal by Subject|13|||
105620047|NCT04979442|364275226|FG000|Overall Study|Physician Decision|1|||
105620048|NCT04979442|364275227|FG001|Overall Study|Physician Decision|1|||
105620049|NCT04979442|364275226|FG000|Overall Study|Lost to Follow-up|0|||
105620050|NCT04979442|364275227|FG001|Overall Study|Lost to Follow-up|2|||
105620051|NCT04979442|364275226|FG000|Overall Study|do not want to continue|0|||
105620052|NCT04979442|364275227|FG001|Overall Study|do not want to continue|1|||
105620053|NCT04103580|364275233|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
105620054|NCT04103580|364275234|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
105620055|NCT04103580|364275233|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
105620056|NCT04103580|364275234|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
105620057|NCT04103580|364275233|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
105620058|NCT04103580|364275234|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
105620059|NCT04103580|364275233|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
105620060|NCT04103580|364275234|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
105620061|NCT04103580|364275233|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
105620062|NCT04103580|364275234|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
105620063|NCT04103580|364275233|FG000|Phase 1 Active Caregiving|Other|3|||
105620064|NCT04103580|364275234|FG001|Phase 1 Active Caregiving|Other|3|||
105620065|NCT04103580|364275233|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
105620066|NCT04103580|364275234|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
105620067|NCT04103580|364275233|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
105620068|NCT04103580|364275234|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
105620069|NCT04103580|364275233|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
105620070|NCT04103580|364275234|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
105620071|NCT04103580|364275233|FG000|Phase 2 Bereavement|Other|8|||
105620072|NCT04103580|364275234|FG001|Phase 2 Bereavement|Other|6|||
105620073|NCT03766685|364275237|FG000|Overall Study|Lost to Follow-up|1|||
105620074|NCT03766685|364275238|FG001|Overall Study|Lost to Follow-up|1|||
105620075|NCT03766685|364275239|FG002|Overall Study|Lost to Follow-up|0|||
105620076|NCT03766685|364275240|FG003|Overall Study|Lost to Follow-up|0|||
105620077|NCT03766685|364275237|FG000|Overall Study|Adverse Event, not fatal|0|||
105620078|NCT03766685|364275238|FG001|Overall Study|Adverse Event, not fatal|1|||
105620079|NCT03766685|364275239|FG002|Overall Study|Adverse Event, not fatal|0|||
105620080|NCT03766685|364275240|FG003|Overall Study|Adverse Event, not fatal|1|||
105620081|NCT03766685|364275237|FG000|Overall Study|Withdrawal by Subject|0|||
105620082|NCT03766685|364275238|FG001|Overall Study|Withdrawal by Subject|2|||
105620083|NCT03766685|364275239|FG002|Overall Study|Withdrawal by Subject|0|||
105620084|NCT03766685|364275240|FG003|Overall Study|Withdrawal by Subject|0|||
105620085|NCT03766685|364275237|FG000|Overall Study|Protocol Violation|0|||
105620086|NCT03766685|364275238|FG001|Overall Study|Protocol Violation|1|||
105620087|NCT03766685|364275239|FG002|Overall Study|Protocol Violation|0|||
105620088|NCT03766685|364275240|FG003|Overall Study|Protocol Violation|0|||
105620089|NCT03766685|364275237|FG000|Overall Study|Non-compliance|0|||
105620090|NCT03766685|364275238|FG001|Overall Study|Non-compliance|2|||
105620091|NCT03766685|364275239|FG002|Overall Study|Non-compliance|0|||
105620092|NCT03766685|364275240|FG003|Overall Study|Non-compliance|0|||
105620093|NCT03656510|364275241|FG000|Overall Study|Lost to Follow-up|1|||
105620094|NCT03656510|364275242|FG001|Overall Study|Lost to Follow-up|0|||
105620095|NCT03656510|364275243|FG002|Overall Study|Lost to Follow-up|0|||
105620096|NCT03656510|364275244|FG003|Overall Study|Lost to Follow-up|0|||
105620097|NCT03656510|364275245|FG004|Overall Study|Lost to Follow-up|0|||
105620098|NCT03656510|364275246|FG005|Overall Study|Lost to Follow-up|0|||
105620099|NCT03656510|364275241|FG000|Overall Study|Withdrawal by Subject|1|||
105620100|NCT03656510|364275242|FG001|Overall Study|Withdrawal by Subject|1|||
105620101|NCT03656510|364275243|FG002|Overall Study|Withdrawal by Subject|0|||
105620102|NCT03656510|364275244|FG003|Overall Study|Withdrawal by Subject|1|||
105620103|NCT03656510|364275245|FG004|Overall Study|Withdrawal by Subject|0|||
105620104|NCT03656510|364275246|FG005|Overall Study|Withdrawal by Subject|0|||
105620105|NCT04524442|364275251|FG000|Overall Study|Subject Decision|1|||
105620106|NCT05228457|364275252|FG000|Overall Study|Withdrawal by Subject|1|||
105620107|NCT05228457|364275253|FG001|Overall Study|Withdrawal by Subject|1|||
105620108|NCT01152450|364275259|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
105620109|NCT01152450|364275260|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
105620110|NCT01152450|364275261|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
105620111|NCT01152450|364275262|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
105620112|NCT01152450|364275263|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
105620113|NCT01152450|364275264|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
105620114|NCT01152450|364275259|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
105620115|NCT01152450|364275260|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
105620116|NCT01152450|364275261|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
105620117|NCT01152450|364275262|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
105620118|NCT01152450|364275263|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
105620119|NCT01152450|364275264|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
105620120|NCT01152450|364275259|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
105620121|NCT01152450|364275260|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
105620122|NCT01152450|364275261|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
105620123|NCT01152450|364275262|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
105620124|NCT01152450|364275263|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
105620125|NCT01152450|364275264|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
105620126|NCT01544114|364275269|FG000|Overall Study|Withdrawal by Subject|0|||
105620127|NCT01544114|364275270|FG001|Overall Study|Withdrawal by Subject|0|||
105620128|NCT01544114|364275271|FG002|Overall Study|Withdrawal by Subject|3|||
105620129|NCT01544114|364275269|FG000|Overall Study|Lost to Follow-up|0|||
105620130|NCT01544114|364275270|FG001|Overall Study|Lost to Follow-up|2|||
105620131|NCT01544114|364275271|FG002|Overall Study|Lost to Follow-up|0|||
105620132|NCT01544114|364275269|FG000|Overall Study|Adverse Event|1|||
105620133|NCT01544114|364275270|FG001|Overall Study|Adverse Event|1|||
105620134|NCT01544114|364275271|FG002|Overall Study|Adverse Event|2|||
105620135|NCT01544114|364275269|FG000|Overall Study|Protocol Violation|0|||
105620136|NCT01544114|364275270|FG001|Overall Study|Protocol Violation|1|||
105620137|NCT01544114|364275271|FG002|Overall Study|Protocol Violation|0|||
105620138|NCT04625465|364275272|FG000|Overall Study|Lost to Follow-up|2|||
105620139|NCT04625465|364275273|FG001|Overall Study|Lost to Follow-up|2|||
105620140|NCT04625465|364275274|FG002|Overall Study|Lost to Follow-up|1|||
105620141|NCT04625465|364275275|FG003|Overall Study|Lost to Follow-up|0|||
105620142|NCT04625465|364275276|FG004|Overall Study|Lost to Follow-up|0|||
105620143|NCT04625465|364275277|FG005|Overall Study|Lost to Follow-up|2|||
105620144|NCT04625465|364275278|FG006|Overall Study|Lost to Follow-up|0|||
105620145|NCT04625465|364275279|FG007|Overall Study|Lost to Follow-up|0|||
105620146|NCT04625465|364275272|FG000|Overall Study|Death|1|||
105620147|NCT04625465|364275273|FG001|Overall Study|Death|0|||
105620148|NCT04625465|364275274|FG002|Overall Study|Death|0|||
105620149|NCT04625465|364275275|FG003|Overall Study|Death|0|||
105620150|NCT04625465|364275276|FG004|Overall Study|Death|0|||
105620151|NCT04625465|364275277|FG005|Overall Study|Death|0|||
105620152|NCT04625465|364275278|FG006|Overall Study|Death|0|||
105620153|NCT04625465|364275279|FG007|Overall Study|Death|0|||
105620154|NCT04625465|364275272|FG000|Overall Study|Withdrawal by Subject|1|||
105620155|NCT04625465|364275273|FG001|Overall Study|Withdrawal by Subject|0|||
105620156|NCT04625465|364275274|FG002|Overall Study|Withdrawal by Subject|4|||
105620157|NCT04625465|364275275|FG003|Overall Study|Withdrawal by Subject|4|||
105620158|NCT04625465|364275276|FG004|Overall Study|Withdrawal by Subject|4|||
105620159|NCT04625465|364275277|FG005|Overall Study|Withdrawal by Subject|0|||
105620160|NCT04625465|364275278|FG006|Overall Study|Withdrawal by Subject|0|||
105620161|NCT04625465|364275279|FG007|Overall Study|Withdrawal by Subject|0|||
105620162|NCT04577963|364275286|FG000|Part 2|Death|0|||
105620163|NCT04577963|364275287|FG001|Part 2|Death|1|||
105620164|NCT04577963|364275288|FG002|Part 2|Death|8|||
105620165|NCT04577963|364275289|FG003|Part 2|Death|0|||
105620166|NCT04577963|364275290|FG004|Part 2|Death|20|||
105620167|NCT04577963|364275286|FG000|Part 2|Lost to Follow-up|0|||
105620168|NCT04577963|364275287|FG001|Part 2|Lost to Follow-up|0|||
105620169|NCT04577963|364275288|FG002|Part 2|Lost to Follow-up|0|||
105620170|NCT04577963|364275289|FG003|Part 2|Lost to Follow-up|0|||
105620171|NCT04577963|364275290|FG004|Part 2|Lost to Follow-up|2|||
105620172|NCT04577963|364275286|FG000|Part 2|Withdrawal by Subject|0|||
105620173|NCT04577963|364275287|FG001|Part 2|Withdrawal by Subject|0|||
105620174|NCT04577963|364275288|FG002|Part 2|Withdrawal by Subject|0|||
105620175|NCT04577963|364275289|FG003|Part 2|Withdrawal by Subject|0|||
105620176|NCT04577963|364275290|FG004|Part 2|Withdrawal by Subject|10|||
105620177|NCT04577963|364275286|FG000|Part 2|Progressive disease|0|||
105620178|NCT04577963|364275287|FG001|Part 2|Progressive disease|0|||
105620179|NCT04577963|364275288|FG002|Part 2|Progressive disease|0|||
105620180|NCT04577963|364275289|FG003|Part 2|Progressive disease|0|||
105620181|NCT04577963|364275290|FG004|Part 2|Progressive disease|2|||
105620182|NCT04577963|364275286|FG000|Part 2|Investigator decision|0|||
105620183|NCT04577963|364275287|FG001|Part 2|Investigator decision|0|||
105620184|NCT04577963|364275288|FG002|Part 2|Investigator decision|0|||
105620185|NCT04577963|364275289|FG003|Part 2|Investigator decision|0|||
105620186|NCT04577963|364275290|FG004|Part 2|Investigator decision|1|||
105620187|NCT04577963|364275286|FG000|Part 2|Sponsor terminated study|0|||
105620188|NCT04577963|364275287|FG001|Part 2|Sponsor terminated study|0|||
105620189|NCT04577963|364275288|FG002|Part 2|Sponsor terminated study|3|||
105620190|NCT04577963|364275289|FG003|Part 2|Sponsor terminated study|1|||
105620191|NCT04577963|364275290|FG004|Part 2|Sponsor terminated study|4|||
105620192|NCT04081103|364275291|FG000|Overall Study|Adverse Event|1|||
105620193|NCT04081103|364275292|FG001|Overall Study|Adverse Event|1|||
105620194|NCT04081103|364275293|FG002|Overall Study|Adverse Event|1|||
105620195|NCT04081103|364275291|FG000|Overall Study|Physician Decision|0|||
105620196|NCT04081103|364275292|FG001|Overall Study|Physician Decision|0|||
105620197|NCT04081103|364275293|FG002|Overall Study|Physician Decision|1|||
105620198|NCT03571581|364275294|FG000|Overall Study|Death|2|||
105620199|NCT03571581|364275294|FG000|Overall Study|Withdrawal by Subject|2|||
105620200|NCT02823145|364275295|FG000|Enrollment|Other|1|||
105620201|NCT02823145|364275296|FG001|Enrollment|Other|0|||
105620202|NCT02823145|364275295|FG000|Treatment|Adverse Event|0|||
105620203|NCT02823145|364275296|FG001|Treatment|Adverse Event|11|||
105620204|NCT02823145|364275295|FG000|Treatment|Death|0|||
105620205|NCT02823145|364275296|FG001|Treatment|Death|3|||
105620206|NCT02823145|364275295|FG000|Treatment|Family Decision|0|||
105620207|NCT02823145|364275296|FG001|Treatment|Family Decision|1|||
105620208|NCT02823145|364275295|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
105620209|NCT02823145|364275296|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
105620210|NCT02823145|364275295|FG000|Treatment|Lack of Efficacy|0|||
105620211|NCT02823145|364275296|FG001|Treatment|Lack of Efficacy|48|||
105620212|NCT02823145|364275295|FG000|Treatment|Non-Compliance With E-Diary|0|||
105620213|NCT02823145|364275296|FG001|Treatment|Non-Compliance With E-Diary|1|||
105620214|NCT02823145|364275295|FG000|Treatment|Physician Decision|0|||
105620215|NCT02823145|364275296|FG001|Treatment|Physician Decision|2|||
105620216|NCT02823145|364275295|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
105620217|NCT02823145|364275296|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
105620218|NCT02823145|364275295|FG000|Treatment|Subject needed to take prohibited medication|0|||
105620219|NCT02823145|364275296|FG001|Treatment|Subject needed to take prohibited medication|1|||
105620220|NCT02823145|364275295|FG000|Treatment|Subject transferred to direct access programme|0|||
105620221|NCT02823145|364275296|FG001|Treatment|Subject transferred to direct access programme|1|||
105620222|NCT02823145|364275295|FG000|Treatment|Switching to commercially available drug|0|||
105620223|NCT02823145|364275296|FG001|Treatment|Switching to commercially available drug|11|||
105620224|NCT02823145|364275295|FG000|Treatment|Transitioned to commercial supply of medication|0|||
105620225|NCT02823145|364275296|FG001|Treatment|Transitioned to commercial supply of medication|1|||
105620226|NCT02823145|364275295|FG000|Treatment|Withdrawal By Caregiver|0|||
105620227|NCT02823145|364275296|FG001|Treatment|Withdrawal By Caregiver|1|||
105620228|NCT02823145|364275295|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
105620229|NCT02823145|364275296|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
105620230|NCT02823145|364275295|FG000|Treatment|Withdrawal by Subject|0|||
105620231|NCT02823145|364275296|FG001|Treatment|Withdrawal by Subject|16|||
105620232|NCT02823145|364275295|FG000|Treatment|Reason unknown|0|||
105620233|NCT02823145|364275296|FG001|Treatment|Reason unknown|1|||
105620234|NCT03221426|364275297|FG000|Overall Study|Ongoing in study|212|||
105620235|NCT03221426|364275298|FG001|Overall Study|Ongoing in study|193|||
105620236|NCT03221426|364275299|FG002|Overall Study|Ongoing in study|61|||
105620237|NCT03221426|364275300|FG003|Overall Study|Ongoing in study|55|||
105620238|NCT03221426|364275297|FG000|Overall Study|Withdrawal by Subject|12|||
105620239|NCT03221426|364275298|FG001|Overall Study|Withdrawal by Subject|4|||
105620240|NCT03221426|364275299|FG002|Overall Study|Withdrawal by Subject|2|||
105620241|NCT03221426|364275300|FG003|Overall Study|Withdrawal by Subject|3|||
105620242|NCT03221426|364275297|FG000|Overall Study|Lost to Follow-up|4|||
105620243|NCT03221426|364275298|FG001|Overall Study|Lost to Follow-up|1|||
105620244|NCT03221426|364275299|FG002|Overall Study|Lost to Follow-up|1|||
105620245|NCT03221426|364275300|FG003|Overall Study|Lost to Follow-up|0|||
105620246|NCT03221426|364275297|FG000|Overall Study|Death|174|||
105620247|NCT03221426|364275298|FG001|Overall Study|Death|204|||
105620248|NCT03221426|364275299|FG002|Overall Study|Death|36|||
105620249|NCT03221426|364275300|FG003|Overall Study|Death|45|||
105620250|NCT04828005|364275301|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
105620251|NCT04828005|364275302|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
105620252|NCT04828005|364275303|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
105620253|NCT04828005|364275304|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
105620254|NCT04828005|364275301|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
105620255|NCT04828005|364275302|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
105620256|NCT04828005|364275303|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
105620257|NCT04828005|364275304|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
105620258|NCT04828005|364275301|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
105620259|NCT04828005|364275302|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
105620260|NCT04828005|364275303|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
105620261|NCT04828005|364275304|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
105620262|NCT04828005|364275301|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
105620263|NCT04828005|364275302|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
105620264|NCT04828005|364275303|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
105620265|NCT04828005|364275304|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
105620266|NCT04828005|364275301|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
105620267|NCT04828005|364275302|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
105620268|NCT04828005|364275303|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
105620269|NCT04828005|364275304|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
105620270|NCT04828005|364275301|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
105620271|NCT04828005|364275302|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
105620272|NCT04828005|364275303|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
105620273|NCT04828005|364275304|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
105620274|NCT04828005|364275301|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
105620275|NCT04828005|364275302|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
105620276|NCT04828005|364275303|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
105620277|NCT04828005|364275304|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
105620278|NCT04828005|364275301|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
105620279|NCT04828005|364275302|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
105620280|NCT04828005|364275303|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
105620281|NCT04828005|364275304|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
105620282|NCT04828005|364275301|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
105620283|NCT04828005|364275302|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
105620284|NCT04828005|364275303|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
105620285|NCT04828005|364275304|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
105620286|NCT02425904|364276567|FG000|Overall Study|Lost to Follow-up|1|||
105620287|NCT02425904|364276568|FG001|Overall Study|Lost to Follow-up|0|||
105620288|NCT02425904|364276567|FG000|Overall Study|Withdrawal by Subject|2|||
105620289|NCT02425904|364276568|FG001|Overall Study|Withdrawal by Subject|0|||
105620290|NCT02425904|364276567|FG000|Overall Study|Death|0|||
105620291|NCT02425904|364276568|FG001|Overall Study|Death|3|||
105620292|NCT03916185|364276569|FG000|Overall Study|Lost to Follow-up|0|||
105620293|NCT03916185|364276570|FG001|Overall Study|Lost to Follow-up|1|||
105620294|NCT03916185|364276571|FG002|Overall Study|Lost to Follow-up|0|||
105620295|NCT03916185|364276572|FG003|Overall Study|Lost to Follow-up|0|||
105620296|NCT03916185|364276569|FG000|Overall Study|Moved|1|||
105620297|NCT03916185|364276570|FG001|Overall Study|Moved|0|||
105620298|NCT03916185|364276571|FG002|Overall Study|Moved|0|||
105620299|NCT03916185|364276572|FG003|Overall Study|Moved|1|||
105620300|NCT03916185|364276569|FG000|Overall Study|Not Able to Get to Clinic|1|||
105620301|NCT03916185|364276570|FG001|Overall Study|Not Able to Get to Clinic|0|||
105620302|NCT03916185|364276571|FG002|Overall Study|Not Able to Get to Clinic|0|||
105620303|NCT03916185|364276572|FG003|Overall Study|Not Able to Get to Clinic|0|||
105620304|NCT04564027|364276573|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
105620305|NCT04564027|364276574|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
105620306|NCT04564027|364276575|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
105620307|NCT04564027|364276576|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
105620308|NCT02116530|364276577|FG000|Overall Study|Withdrawal by Subject|1|||
105620309|NCT02116530|364276578|FG001|Overall Study|Withdrawal by Subject|2|||
105620310|NCT02116530|364276577|FG000|Overall Study|Adverse Event|4|||
105620311|NCT02116530|364276578|FG001|Overall Study|Adverse Event|0|||
105620312|NCT02116530|364276577|FG000|Overall Study|Physician Decision|1|||
105620313|NCT02116530|364276578|FG001|Overall Study|Physician Decision|0|||
105620314|NCT02116530|364276577|FG000|Overall Study|Lost to Follow-up|1|||
105620315|NCT02116530|364276578|FG001|Overall Study|Lost to Follow-up|0|||
105620316|NCT02116530|364276577|FG000|Overall Study|Other Medical Problems|2|||
105620317|NCT02116530|364276578|FG001|Overall Study|Other Medical Problems|2|||
105620318|NCT02927236|364276581|FG000|Characterization Phase|Physician Decision|0|||
105620319|NCT02927236|364276582|FG001|Characterization Phase|Physician Decision|3|||
105620320|NCT02927236|364276583|FG002|Characterization Phase|Physician Decision|0|||
105620321|NCT02927236|364276584|FG003|Characterization Phase|Physician Decision|2|||
105620322|NCT02927236|364276581|FG000|Characterization Phase|Lost to Follow-up|0|||
105620323|NCT02927236|364276582|FG001|Characterization Phase|Lost to Follow-up|0|||
105620324|NCT02927236|364276583|FG002|Characterization Phase|Lost to Follow-up|0|||
105620325|NCT02927236|364276584|FG003|Characterization Phase|Lost to Follow-up|3|||
105620326|NCT02927236|364276581|FG000|Characterization Phase|Withdrawal by Subject|1|||
105620327|NCT02927236|364276582|FG001|Characterization Phase|Withdrawal by Subject|0|||
105620328|NCT02927236|364276583|FG002|Characterization Phase|Withdrawal by Subject|0|||
105620329|NCT02927236|364276584|FG003|Characterization Phase|Withdrawal by Subject|1|||
105620330|NCT02927236|364276581|FG000|Treatment Phase|Adverse Event|1|||
105620331|NCT02927236|364276582|FG001|Treatment Phase|Adverse Event|0|||
105620332|NCT02927236|364276583|FG002|Treatment Phase|Adverse Event|1|||
105620333|NCT02927236|364276584|FG003|Treatment Phase|Adverse Event|1|||
105620334|NCT02927236|364276581|FG000|Treatment Phase|Protocol Violation|3|||
105620335|NCT02927236|364276582|FG001|Treatment Phase|Protocol Violation|0|||
105620336|NCT02927236|364276583|FG002|Treatment Phase|Protocol Violation|0|||
105620337|NCT02927236|364276584|FG003|Treatment Phase|Protocol Violation|1|||
105620338|NCT02927236|364276581|FG000|Treatment Phase|Lost to Follow-up|1|||
105620339|NCT02927236|364276582|FG001|Treatment Phase|Lost to Follow-up|0|||
105620340|NCT02927236|364276583|FG002|Treatment Phase|Lost to Follow-up|0|||
105620341|NCT02927236|364276584|FG003|Treatment Phase|Lost to Follow-up|0|||
105620342|NCT02927236|364276581|FG000|Follow-up Phase|Lost to Follow-up|1|||
105620343|NCT02927236|364276582|FG001|Follow-up Phase|Lost to Follow-up|0|||
105620344|NCT02927236|364276583|FG002|Follow-up Phase|Lost to Follow-up|1|||
105620345|NCT02927236|364276584|FG003|Follow-up Phase|Lost to Follow-up|0|||
105620346|NCT01733316|364276591|FG000|RP103 Phase|Non-compliance|1|||
105620347|NCT01733316|364276591|FG000|Long Term Extension Phase|Adverse Event|1|||
105620348|NCT01733316|364276591|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
105620349|NCT01733316|364276591|FG000|Long Term Extension Phase|Sponsor Decision|2|||
105620350|NCT04508309|364276592|FG000|Overall Study|Death|0|||
105620351|NCT04508309|364276593|FG001|Overall Study|Death|0|||
105620352|NCT04508309|364276594|FG002|Overall Study|Death|0|||
105620353|NCT04508309|364276595|FG003|Overall Study|Death|0|||
105620354|NCT04508309|364276596|FG004|Overall Study|Death|1|||
105620355|NCT04508309|364276592|FG000|Overall Study|Lost to Follow-up|0|||
105620356|NCT04508309|364276593|FG001|Overall Study|Lost to Follow-up|0|||
105620357|NCT04508309|364276594|FG002|Overall Study|Lost to Follow-up|1|||
105620358|NCT04508309|364276595|FG003|Overall Study|Lost to Follow-up|1|||
105620359|NCT04508309|364276596|FG004|Overall Study|Lost to Follow-up|0|||
105620360|NCT04508309|364276592|FG000|Overall Study|Withdrawal by Subject|0|||
105620361|NCT04508309|364276593|FG001|Overall Study|Withdrawal by Subject|0|||
105620362|NCT04508309|364276594|FG002|Overall Study|Withdrawal by Subject|0|||
105620363|NCT04508309|364276595|FG003|Overall Study|Withdrawal by Subject|0|||
105620364|NCT04508309|364276596|FG004|Overall Study|Withdrawal by Subject|1|||
105620365|NCT05139810|364276599|FG000|Overall Study|Voluntary Withdrawal|2|||
105620366|NCT05139810|364276600|FG001|Overall Study|Voluntary Withdrawal|1|||
105620367|NCT05139810|364276601|FG002|Overall Study|Voluntary Withdrawal|0|||
105620368|NCT05139810|364276599|FG000|Overall Study|Pregnancy|1|||
105620369|NCT05139810|364276600|FG001|Overall Study|Pregnancy|0|||
105620370|NCT05139810|364276601|FG002|Overall Study|Pregnancy|0|||
105620371|NCT05139810|364276599|FG000|Overall Study|Roll Over to CS7|19|||
105620372|NCT05139810|364276600|FG001|Overall Study|Roll Over to CS7|44|||
105620373|NCT05139810|364276601|FG002|Overall Study|Roll Over to CS7|20|||
105620374|NCT04914676|364276602|FG000|Overall Study|Study termination|3|||
105620375|NCT04914676|364276603|FG001|Overall Study|Study termination|0|||
105620376|NCT03085810|364276604|FG000|Main Study|Withdrawal by Subject|77|||
105620377|NCT03085810|364276605|FG001|Main Study|Withdrawal by Subject|0|||
105620378|NCT03085810|364276606|FG002|Main Study|Withdrawal by Subject|0|||
105620379|NCT03085810|364276604|FG000|Main Study|Terminated By Sponsor|14|||
105620380|NCT03085810|364276605|FG001|Main Study|Terminated By Sponsor|0|||
105620381|NCT03085810|364276606|FG002|Main Study|Terminated By Sponsor|0|||
105620382|NCT03085810|364276604|FG000|Main Study|Protocol Violation|15|||
105620383|NCT03085810|364276605|FG001|Main Study|Protocol Violation|0|||
105620384|NCT03085810|364276606|FG002|Main Study|Protocol Violation|0|||
105620385|NCT03085810|364276604|FG000|Main Study|Physician Decision|13|||
105620386|NCT03085810|364276605|FG001|Main Study|Physician Decision|0|||
105620387|NCT03085810|364276606|FG002|Main Study|Physician Decision|0|||
105620388|NCT03085810|364276604|FG000|Main Study|Lost to Follow-up|17|||
105620389|NCT03085810|364276605|FG001|Main Study|Lost to Follow-up|0|||
105620390|NCT03085810|364276606|FG002|Main Study|Lost to Follow-up|0|||
105620391|NCT03085810|364276604|FG000|Main Study|Adverse Event|25|||
105620392|NCT03085810|364276605|FG001|Main Study|Adverse Event|0|||
105620393|NCT03085810|364276606|FG002|Main Study|Adverse Event|0|||
105620394|NCT03085810|364276604|FG000|Main Study|Pregnancy|7|||
105620395|NCT03085810|364276605|FG001|Main Study|Pregnancy|0|||
105620396|NCT03085810|364276606|FG002|Main Study|Pregnancy|0|||
105620397|NCT03085810|364276604|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
105620398|NCT03085810|364276605|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
105620399|NCT03085810|364276606|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
105620400|NCT03085810|364276604|FG000|Main Study|Lack of Efficacy|10|||
105620401|NCT03085810|364276605|FG001|Main Study|Lack of Efficacy|0|||
105620402|NCT03085810|364276606|FG002|Main Study|Lack of Efficacy|0|||
105620403|NCT03085810|364276604|FG000|Main Study|Death|12|||
105620404|NCT03085810|364276605|FG001|Main Study|Death|0|||
105620405|NCT03085810|364276606|FG002|Main Study|Death|0|||
105620406|NCT03085810|364276604|FG000|Main Study|Disease progression|1|||
105620407|NCT03085810|364276605|FG001|Main Study|Disease progression|0|||
105620408|NCT03085810|364276606|FG002|Main Study|Disease progression|0|||
105620409|NCT03085810|364276604|FG000|Main Study|Site Closure|3|||
105620410|NCT03085810|364276605|FG001|Main Study|Site Closure|0|||
105620411|NCT03085810|364276606|FG002|Main Study|Site Closure|0|||
105620412|NCT03085810|364276604|FG000|Main Study|Planned pregnancy|17|||
105620413|NCT03085810|364276605|FG001|Main Study|Planned pregnancy|0|||
105620414|NCT03085810|364276606|FG002|Main Study|Planned pregnancy|0|||
105620415|NCT03085810|364276604|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
105620416|NCT03085810|364276605|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
105620417|NCT03085810|364276606|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
105620418|NCT03085810|364276604|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
105620419|NCT03085810|364276605|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
105620420|NCT03085810|364276606|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
105620421|NCT03085810|364276604|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
105620422|NCT03085810|364276605|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
105620423|NCT03085810|364276606|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
105620424|NCT03085810|364276604|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
105620425|NCT03085810|364276605|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
105620426|NCT03085810|364276606|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
105620427|NCT05546411|364276607|FG000|Overall Study|Progressive Disease|1|||
105620428|NCT05546411|364276608|FG001|Overall Study|Progressive Disease|0|||
105620429|NCT05546411|364276607|FG000|Overall Study|Adverse Event|0|||
105620430|NCT05546411|364276608|FG001|Overall Study|Adverse Event|1|||
105620431|NCT05546411|364276607|FG000|Overall Study|Metastatic disease|1|||
105620432|NCT05546411|364276608|FG001|Overall Study|Metastatic disease|0|||
105620433|NCT02966873|364276613|FG000|Overall Study|Lost to Follow-up|16|||
105620434|NCT02966873|364276614|FG001|Overall Study|Lost to Follow-up|15|||
105620435|NCT02460458|364276621|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
105620436|NCT02460458|364276621|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
105620437|NCT02460458|364276621|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
105620438|NCT02460458|364276621|FG000|First Prospective Phase|Lost to Follow-up|84|||
105620439|NCT02460458|364276621|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
105620440|NCT04447755|364276623|FG000|Overall Study|Death|8|||
105620441|NCT04447755|364276624|FG001|Overall Study|Death|14|||
105620442|NCT04447755|364276625|FG002|Overall Study|Death|8|||
105620443|NCT04447755|364276626|FG003|Overall Study|Death|9|||
105620444|NCT04447755|364276627|FG004|Overall Study|Death|7|||
105620445|NCT04447755|364276628|FG005|Overall Study|Death|7|||
105620446|NCT04447755|364276629|FG006|Overall Study|Death|40|||
105620447|NCT04447755|364276623|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105620448|NCT04447755|364276624|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
105620449|NCT04447755|364276625|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105620450|NCT04447755|364276626|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
105620451|NCT04447755|364276627|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
105620452|NCT04447755|364276628|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
105620453|NCT04447755|364276629|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
105620454|NCT04447755|364276623|FG000|Overall Study|Ongoing in Study|1|||
105620455|NCT04447755|364276624|FG001|Overall Study|Ongoing in Study|2|||
105620456|NCT04447755|364276625|FG002|Overall Study|Ongoing in Study|0|||
105620457|NCT04447755|364276626|FG003|Overall Study|Ongoing in Study|0|||
105620458|NCT04447755|364276627|FG004|Overall Study|Ongoing in Study|2|||
105620459|NCT04447755|364276628|FG005|Overall Study|Ongoing in Study|2|||
105620460|NCT04447755|364276629|FG006|Overall Study|Ongoing in Study|26|||
105620461|NCT04200456|364276630|FG000|Overall Study|Physician Decision|0|||
105620462|NCT04200456|364276631|FG001|Overall Study|Physician Decision|1|||
105620463|NCT04200456|364276630|FG000|Overall Study|Withdrawal by Subject|2|||
105620464|NCT04200456|364276631|FG001|Overall Study|Withdrawal by Subject|2|||
105620465|NCT04200456|364276630|FG000|Overall Study|Lack of Efficacy|1|||
105620466|NCT04200456|364276631|FG001|Overall Study|Lack of Efficacy|1|||
105620467|NCT04200456|364276630|FG000|Overall Study|Adverse event, non-fatal|0|||
105620468|NCT04200456|364276631|FG001|Overall Study|Adverse event, non-fatal|1|||
105620469|NCT04200456|364276630|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
105620470|NCT04200456|364276631|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
105620471|NCT02723591|364276633|FG000|Overall Study|Adverse Event|48|||
105620472|NCT02723591|364276634|FG001|Overall Study|Adverse Event|40|||
105620473|NCT02723591|364276633|FG000|Overall Study|Death|2|||
105620474|NCT02723591|364276634|FG001|Overall Study|Death|2|||
105620475|NCT02723591|364276633|FG000|Overall Study|Lack of Efficacy|4|||
105620476|NCT02723591|364276634|FG001|Overall Study|Lack of Efficacy|3|||
105620477|NCT02723591|364276633|FG000|Overall Study|Lost to Follow-up|1|||
105620478|NCT02723591|364276634|FG001|Overall Study|Lost to Follow-up|7|||
105620479|NCT02723591|364276633|FG000|Overall Study|Protocol Violation|20|||
105620480|NCT02723591|364276634|FG001|Overall Study|Protocol Violation|23|||
105620481|NCT02723591|364276633|FG000|Overall Study|Withdrawal by Subject|4|||
105620482|NCT02723591|364276634|FG001|Overall Study|Withdrawal by Subject|8|||
105620483|NCT02723591|364276633|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
105620484|NCT02723591|364276634|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
105620485|NCT02723591|364276633|FG000|Overall Study|Miscellaneous|5|||
105620486|NCT02723591|364276634|FG001|Overall Study|Miscellaneous|6|||
105620487|NCT05070728|364276635|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
105620488|NCT05070728|364276636|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
105620489|NCT03852719|364276643|FG000|Overall Study|Still on study after Week 192|37|||
105620490|NCT03852719|364276644|FG001|Overall Study|Still on study after Week 192|35|||
105620491|NCT03852719|364276645|FG002|Overall Study|Still on study after Week 192|35|||
105620492|NCT03852719|364276643|FG000|Overall Study|Withdrawal of consent|5|||
105620493|NCT03852719|364276644|FG001|Overall Study|Withdrawal of consent|8|||
105620494|NCT03852719|364276645|FG002|Overall Study|Withdrawal of consent|7|||
105620495|NCT03852719|364276643|FG000|Overall Study|Physician Decision|0|||
105620496|NCT03852719|364276644|FG001|Overall Study|Physician Decision|1|||
105620497|NCT03852719|364276645|FG002|Overall Study|Physician Decision|1|||
105620498|NCT03852719|364276643|FG000|Overall Study|Pregnancy|2|||
105620499|NCT03852719|364276644|FG001|Overall Study|Pregnancy|1|||
105620500|NCT03852719|364276645|FG002|Overall Study|Pregnancy|0|||
105620501|NCT03852719|364276643|FG000|Overall Study|Death|1|||
105620502|NCT03852719|364276644|FG001|Overall Study|Death|0|||
105620503|NCT03852719|364276645|FG002|Overall Study|Death|0|||
105620504|NCT03852719|364276643|FG000|Overall Study|Reason not Specified|3|||
105620505|NCT03852719|364276644|FG001|Overall Study|Reason not Specified|2|||
105620506|NCT03852719|364276645|FG002|Overall Study|Reason not Specified|2|||
105620507|NCT03852719|364276643|FG000|Overall Study|Adverse Event|1|||
105620508|NCT03852719|364276644|FG001|Overall Study|Adverse Event|0|||
105620509|NCT03852719|364276645|FG002|Overall Study|Adverse Event|4|||
105620510|NCT03852719|364276643|FG000|Overall Study|Progressive disease|1|||
105620511|NCT03852719|364276644|FG001|Overall Study|Progressive disease|2|||
105620512|NCT03852719|364276645|FG002|Overall Study|Progressive disease|1|||
105620513|NCT03852719|364276643|FG000|Overall Study|Lost to Follow-up|1|||
105620514|NCT03852719|364276644|FG001|Overall Study|Lost to Follow-up|0|||
105620515|NCT03852719|364276645|FG002|Overall Study|Lost to Follow-up|0|||
105620516|NCT02589795|364276647|FG000|Overall Study|Lost to Follow-up|1|||
105620517|NCT02589795|364276648|FG001|Overall Study|Lost to Follow-up|0|||
105620518|NCT02589795|364276649|FG002|Overall Study|Lost to Follow-up|0|||
105620519|NCT02589795|364276647|FG000|Overall Study|Withdrawal by Subject|0|||
105620520|NCT02589795|364276648|FG001|Overall Study|Withdrawal by Subject|0|||
105620521|NCT02589795|364276649|FG002|Overall Study|Withdrawal by Subject|2|||
105620522|NCT02589795|364276647|FG000|Overall Study|Protocol Violation|0|||
105620523|NCT02589795|364276648|FG001|Overall Study|Protocol Violation|0|||
105620524|NCT02589795|364276649|FG002|Overall Study|Protocol Violation|1|||
105620525|NCT03599661|364276650|FG000|Overall Study|Lost to Follow-up|9|||
105620526|NCT04811040|364276655|FG000|Overall Study|Lost to Follow-up|2|||
105620527|NCT04811040|364276656|FG001|Overall Study|Lost to Follow-up|0|||
105620528|NCT04811040|364276657|FG002|Overall Study|Lost to Follow-up|0|||
105620529|NCT04811040|364276658|FG003|Overall Study|Lost to Follow-up|0|||
105620530|NCT04811040|364276655|FG000|Overall Study|Withdrew consent|1|||
105620531|NCT04811040|364276656|FG001|Overall Study|Withdrew consent|1|||
105620532|NCT04811040|364276657|FG002|Overall Study|Withdrew consent|0|||
105620533|NCT04811040|364276658|FG003|Overall Study|Withdrew consent|0|||
105620534|NCT04117347|364276659|FG000|Overall Study|Adverse Event|0|||
105620535|NCT04117347|364276660|FG001|Overall Study|Adverse Event|0|||
105620536|NCT04117347|364276661|FG002|Overall Study|Adverse Event|1|||
105620537|NCT04117347|364276659|FG000|Overall Study|No time for study|0|||
105620538|NCT04117347|364276660|FG001|Overall Study|No time for study|2|||
105620539|NCT04117347|364276661|FG002|Overall Study|No time for study|0|||
105620540|NCT04117347|364276659|FG000|Overall Study|Family emergency|1|||
105620541|NCT04117347|364276660|FG001|Overall Study|Family emergency|0|||
105620542|NCT04117347|364276661|FG002|Overall Study|Family emergency|0|||
105620543|NCT03691935|364276662|FG000|Overall Study|Physician Decision|2|||
105620544|NCT03691935|364276663|FG001|Overall Study|Physician Decision|1|||
105620545|NCT03691935|364276662|FG000|Overall Study|Adverse Event|3|||
105620546|NCT03691935|364276663|FG001|Overall Study|Adverse Event|0|||
105620547|NCT02521493|364276670|FG000|Overall Study|Death|3|||
105620548|NCT02521493|364276671|FG001|Overall Study|Death|4|||
105620549|NCT02521493|364276672|FG002|Overall Study|Death|1|||
105620550|NCT02521493|364276670|FG000|Overall Study|Physician Decision|19|||
105620551|NCT02521493|364276671|FG001|Overall Study|Physician Decision|1|||
105620552|NCT02521493|364276672|FG002|Overall Study|Physician Decision|2|||
105620553|NCT02521493|364276670|FG000|Overall Study|Withdrawal by Subject|3|||
105620554|NCT02521493|364276671|FG001|Overall Study|Withdrawal by Subject|0|||
105620555|NCT02521493|364276672|FG002|Overall Study|Withdrawal by Subject|0|||
105620556|NCT02521493|364276670|FG000|Overall Study|Ineligible|0|||
105620557|NCT02521493|364276671|FG001|Overall Study|Ineligible|1|||
105620558|NCT02521493|364276672|FG002|Overall Study|Ineligible|0|||
105620559|NCT02521493|364276670|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
105620560|NCT02521493|364276671|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
105620561|NCT02521493|364276672|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
105620562|NCT02521493|364276670|FG000|Overall Study|No MRD result|0|||
105620563|NCT02521493|364276671|FG001|Overall Study|No MRD result|0|||
105620564|NCT02521493|364276672|FG002|Overall Study|No MRD result|4|||
105620565|NCT03034356|364276673|FG000|Baseline|Lost to Follow-up|2|||
105620566|NCT03034356|364276674|FG001|Baseline|Lost to Follow-up|4|||
105620567|NCT03034356|364276673|FG000|Baseline|Withdrawal by Subject|2|||
105620568|NCT03034356|364276674|FG001|Baseline|Withdrawal by Subject|0|||
105620569|NCT03034356|364276673|FG000|Baseline|Physician Decision|0|||
105620570|NCT03034356|364276674|FG001|Baseline|Physician Decision|1|||
105620571|NCT03034356|364276673|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
105620572|NCT03034356|364276674|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
105620573|NCT03034356|364276673|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
105620574|NCT03034356|364276674|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
105620575|NCT03034356|364276673|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
105620576|NCT03034356|364276674|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
105620577|NCT03034356|364276673|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
105620578|NCT03034356|364276674|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
105620579|NCT05309291|364276675|FG000|Overall Study|Adverse Event|0|||
105620580|NCT05309291|364276676|FG001|Overall Study|Adverse Event|1|||
105620581|NCT05209152|364276681|FG000|Overall Study|Sponsor decision|1|||
105620582|NCT05209152|364276682|FG001|Overall Study|Sponsor decision|2|||
105620583|NCT05209152|364276681|FG000|Overall Study|Death|3|||
105620584|NCT05209152|364276682|FG001|Overall Study|Death|1|||
105620585|NCT05292391|364276685|FG000|Overall Study|Lost to Follow-up|0|||
105620586|NCT05292391|364276686|FG001|Overall Study|Lost to Follow-up|0|||
105620587|NCT05292391|364276687|FG002|Overall Study|Lost to Follow-up|0|||
105620588|NCT05292391|364276688|FG003|Overall Study|Lost to Follow-up|1|||
105620589|NCT05292391|364276689|FG004|Overall Study|Lost to Follow-up|0|||
105620590|NCT03213691|364278328|FG000|Overall Study|Adverse Event|2|||
105620591|NCT03213691|364278328|FG000|Overall Study|Death|3|||
105620592|NCT03213691|364278328|FG000|Overall Study|Physician Decision|1|||
105620593|NCT03213691|364278328|FG000|Overall Study|Progressive Disease|14|||
105620594|NCT03213691|364278328|FG000|Overall Study|Ineligible|1|||
105620595|NCT03058289|364278334|FG000|Overall Study|Radiographic Deterioration|0|||
105620596|NCT03058289|364278335|FG001|Overall Study|Radiographic Deterioration|3|||
105620597|NCT03058289|364278336|FG002|Overall Study|Radiographic Deterioration|1|||
105620598|NCT03058289|364278337|FG003|Overall Study|Radiographic Deterioration|2|||
105620599|NCT03058289|364278338|FG004|Overall Study|Radiographic Deterioration|6|||
105620600|NCT03058289|364278339|FG005|Overall Study|Radiographic Deterioration|3|||
105620601|NCT03058289|364278340|FG006|Overall Study|Radiographic Deterioration|0|||
105620602|NCT03058289|364278341|FG007|Overall Study|Radiographic Deterioration|4|||
105620603|NCT03058289|364278342|FG008|Overall Study|Radiographic Deterioration|2|||
105620604|NCT03058289|364278334|FG000|Overall Study|Adverse Event|2|||
105620605|NCT03058289|364278335|FG001|Overall Study|Adverse Event|0|||
105620606|NCT03058289|364278336|FG002|Overall Study|Adverse Event|1|||
105620607|NCT03058289|364278337|FG003|Overall Study|Adverse Event|3|||
105620608|NCT03058289|364278338|FG004|Overall Study|Adverse Event|1|||
105620609|NCT03058289|364278339|FG005|Overall Study|Adverse Event|0|||
105620610|NCT03058289|364278340|FG006|Overall Study|Adverse Event|1|||
105620611|NCT03058289|364278341|FG007|Overall Study|Adverse Event|3|||
105620612|NCT03058289|364278342|FG008|Overall Study|Adverse Event|0|||
105620613|NCT03058289|364278334|FG000|Overall Study|Withdrawal by Subject|0|||
105620614|NCT03058289|364278335|FG001|Overall Study|Withdrawal by Subject|0|||
105620615|NCT03058289|364278336|FG002|Overall Study|Withdrawal by Subject|0|||
105620616|NCT03058289|364278337|FG003|Overall Study|Withdrawal by Subject|2|||
105620617|NCT03058289|364278338|FG004|Overall Study|Withdrawal by Subject|0|||
105620618|NCT03058289|364278339|FG005|Overall Study|Withdrawal by Subject|2|||
105620619|NCT03058289|364278340|FG006|Overall Study|Withdrawal by Subject|0|||
105620620|NCT03058289|364278341|FG007|Overall Study|Withdrawal by Subject|4|||
105620621|NCT03058289|364278342|FG008|Overall Study|Withdrawal by Subject|1|||
105620622|NCT03058289|364278334|FG000|Overall Study|Physician Decision|1|||
105620623|NCT03058289|364278335|FG001|Overall Study|Physician Decision|0|||
105620624|NCT03058289|364278336|FG002|Overall Study|Physician Decision|0|||
105620625|NCT03058289|364278337|FG003|Overall Study|Physician Decision|2|||
105620626|NCT03058289|364278338|FG004|Overall Study|Physician Decision|1|||
105620627|NCT03058289|364278339|FG005|Overall Study|Physician Decision|0|||
105620628|NCT03058289|364278340|FG006|Overall Study|Physician Decision|2|||
105620629|NCT03058289|364278341|FG007|Overall Study|Physician Decision|3|||
105620630|NCT03058289|364278342|FG008|Overall Study|Physician Decision|0|||
105620631|NCT03058289|364278334|FG000|Overall Study|Clinical Deterioration|2|||
105620632|NCT03058289|364278335|FG001|Overall Study|Clinical Deterioration|0|||
105620633|NCT03058289|364278336|FG002|Overall Study|Clinical Deterioration|0|||
105620634|NCT03058289|364278337|FG003|Overall Study|Clinical Deterioration|2|||
105620635|NCT03058289|364278338|FG004|Overall Study|Clinical Deterioration|1|||
105620636|NCT03058289|364278339|FG005|Overall Study|Clinical Deterioration|1|||
105620637|NCT03058289|364278340|FG006|Overall Study|Clinical Deterioration|0|||
105620638|NCT03058289|364278341|FG007|Overall Study|Clinical Deterioration|3|||
105620639|NCT03058289|364278342|FG008|Overall Study|Clinical Deterioration|2|||
105620640|NCT03058289|364278334|FG000|Overall Study|Lost to Follow-up|0|||
105620641|NCT03058289|364278335|FG001|Overall Study|Lost to Follow-up|0|||
105620642|NCT03058289|364278336|FG002|Overall Study|Lost to Follow-up|0|||
105620643|NCT03058289|364278337|FG003|Overall Study|Lost to Follow-up|0|||
105620644|NCT03058289|364278338|FG004|Overall Study|Lost to Follow-up|1|||
105620645|NCT03058289|364278339|FG005|Overall Study|Lost to Follow-up|0|||
105620646|NCT03058289|364278340|FG006|Overall Study|Lost to Follow-up|0|||
105620647|NCT03058289|364278341|FG007|Overall Study|Lost to Follow-up|0|||
105620648|NCT03058289|364278342|FG008|Overall Study|Lost to Follow-up|0|||
105620649|NCT03058289|364278334|FG000|Overall Study|Refused Further Treatment|0|||
105620650|NCT03058289|364278335|FG001|Overall Study|Refused Further Treatment|0|||
105620651|NCT03058289|364278336|FG002|Overall Study|Refused Further Treatment|1|||
105620652|NCT03058289|364278337|FG003|Overall Study|Refused Further Treatment|0|||
105620653|NCT03058289|364278338|FG004|Overall Study|Refused Further Treatment|1|||
105620654|NCT03058289|364278339|FG005|Overall Study|Refused Further Treatment|0|||
105620655|NCT03058289|364278340|FG006|Overall Study|Refused Further Treatment|0|||
105620656|NCT03058289|364278341|FG007|Overall Study|Refused Further Treatment|0|||
105620657|NCT03058289|364278342|FG008|Overall Study|Refused Further Treatment|0|||
105620658|NCT03058289|364278334|FG000|Overall Study|Rapid Progression of Disease|0|||
105620659|NCT03058289|364278335|FG001|Overall Study|Rapid Progression of Disease|0|||
105620660|NCT03058289|364278336|FG002|Overall Study|Rapid Progression of Disease|0|||
105620661|NCT03058289|364278337|FG003|Overall Study|Rapid Progression of Disease|1|||
105620662|NCT03058289|364278338|FG004|Overall Study|Rapid Progression of Disease|0|||
105620663|NCT03058289|364278339|FG005|Overall Study|Rapid Progression of Disease|0|||
105620664|NCT03058289|364278340|FG006|Overall Study|Rapid Progression of Disease|0|||
105620665|NCT03058289|364278341|FG007|Overall Study|Rapid Progression of Disease|0|||
105620666|NCT03058289|364278342|FG008|Overall Study|Rapid Progression of Disease|0|||
105620667|NCT02305888|364278346|FG000|Overall Study|Lost to Follow-up|0|||
105620668|NCT02305888|364278347|FG001|Overall Study|Lost to Follow-up|0|||
105620669|NCT02305888|364278348|FG002|Overall Study|Lost to Follow-up|1|||
105620670|NCT02305888|364278346|FG000|Overall Study|Adverse Event|0|||
105620671|NCT02305888|364278347|FG001|Overall Study|Adverse Event|1|||
105620672|NCT02305888|364278348|FG002|Overall Study|Adverse Event|0|||
105620673|NCT05436262|364278351|FG000|Pre-Randomization|Withdrawal by Subject|1|||
105620674|NCT05436262|364278352|FG001|Pre-Randomization|Withdrawal by Subject|0|||
105620675|NCT05436262|364278353|FG002|Pre-Randomization|Withdrawal by Subject|0|||
105620676|NCT05436262|364278351|FG000|Randomization|Withdrawal by Subject|0|||
105620677|NCT05436262|364278352|FG001|Randomization|Withdrawal by Subject|1|||
105620678|NCT05436262|364278353|FG002|Randomization|Withdrawal by Subject|0|||
105620679|NCT03952338|364278354|FG000|Overall Study|Lost to Follow-up|11|||
105620680|NCT03952338|364278355|FG001|Overall Study|Lost to Follow-up|17|||
105620681|NCT03952338|364278354|FG000|Overall Study|Withdrawal by Subject|1|||
105620682|NCT03952338|364278355|FG001|Overall Study|Withdrawal by Subject|1|||
105620683|NCT03952338|364278354|FG000|Overall Study|Protocol Violation|1|||
105620684|NCT03952338|364278355|FG001|Overall Study|Protocol Violation|0|||
105620685|NCT03816332|364278358|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
105620686|NCT03816332|364278358|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
105620687|NCT03710603|364278359|FG000|Overall Study|Adverse Event|1|||
105620688|NCT03710603|364278360|FG001|Overall Study|Adverse Event|0|||
105620689|NCT03710603|364278359|FG000|Overall Study|Death|44|||
105620690|NCT03710603|364278360|FG001|Overall Study|Death|34|||
105620691|NCT03710603|364278359|FG000|Overall Study|Lost to Follow-up|3|||
105620692|NCT03710603|364278360|FG001|Overall Study|Lost to Follow-up|5|||
105620693|NCT03710603|364278359|FG000|Overall Study|Withdrawal by Subject|11|||
105620694|NCT03710603|364278360|FG001|Overall Study|Withdrawal by Subject|10|||
105620695|NCT01456949|364278361|FG000|Enrollment|PI death- incomplete data|6|||
105620696|NCT01456949|364278361|FG000|Enrollment|Death|1|||
105620697|NCT01456949|364278361|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
105620698|NCT01456949|364278361|FG000|Enrollment|Physician Decision|10|||
105620699|NCT01456949|364278361|FG000|Enrollment|Withdrawal by Subject|7|||
105620700|NCT01456949|364278361|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
105620701|NCT01456949|364278361|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
105620702|NCT01456949|364278361|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
105620703|NCT01456949|364278361|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
105620704|NCT01456949|364278361|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
105620705|NCT01456949|364278361|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
105620706|NCT01456949|364278361|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
105620707|NCT01456949|364278361|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
105620708|NCT02626533|364278362|FG000|Overall Study|Protocol Violation|14|||
105620709|NCT02626533|364278362|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
105620710|NCT02626533|364278362|FG000|Overall Study|Withdrawal by Subject|1|||
105620711|NCT04753697|364278363|FG000|Induction Phase|Withdrawal by Subject|12|||
105620712|NCT04753697|364278364|FG001|Induction Phase|Withdrawal by Subject|5|||
105620713|NCT04753697|364278365|FG002|Induction Phase|Withdrawal by Subject|6|||
105620714|NCT04753697|364278363|FG000|Induction Phase|Physician Decision|1|||
105620715|NCT04753697|364278364|FG001|Induction Phase|Physician Decision|0|||
105620716|NCT04753697|364278365|FG002|Induction Phase|Physician Decision|0|||
105620717|NCT04753697|364278363|FG000|Induction Phase|Lost to Follow-up|2|||
105620718|NCT04753697|364278364|FG001|Induction Phase|Lost to Follow-up|2|||
105620719|NCT04753697|364278365|FG002|Induction Phase|Lost to Follow-up|1|||
105620720|NCT04753697|364278363|FG000|Induction Phase|Lack of Efficacy|1|||
105620721|NCT04753697|364278364|FG001|Induction Phase|Lack of Efficacy|0|||
105620722|NCT04753697|364278365|FG002|Induction Phase|Lack of Efficacy|0|||
105620723|NCT04753697|364278363|FG000|Maintenance Phase|Physician Decision|0|||
105620724|NCT04753697|364278364|FG001|Maintenance Phase|Physician Decision|0|||
105620725|NCT04753697|364278365|FG002|Maintenance Phase|Physician Decision|1|||
105620726|NCT04753697|364278363|FG000|Maintenance Phase|Withdrawal by Subject|3|||
105620727|NCT04753697|364278364|FG001|Maintenance Phase|Withdrawal by Subject|4|||
105620728|NCT04753697|364278365|FG002|Maintenance Phase|Withdrawal by Subject|6|||
105620729|NCT04753697|364278363|FG000|Maintenance Phase|Lost to Follow-up|2|||
105620730|NCT04753697|364278364|FG001|Maintenance Phase|Lost to Follow-up|2|||
105620731|NCT04753697|364278365|FG002|Maintenance Phase|Lost to Follow-up|0|||
105620732|NCT04753697|364278363|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
105620733|NCT04753697|364278364|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
105620734|NCT04753697|364278365|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
105620735|NCT04753697|364278363|FG000|Maintenance Phase|Adverse Event|0|||
105620736|NCT04753697|364278364|FG001|Maintenance Phase|Adverse Event|1|||
105620737|NCT04753697|364278365|FG002|Maintenance Phase|Adverse Event|1|||
105620738|NCT04753697|364278363|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
105620739|NCT04753697|364278364|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
105620740|NCT04753697|364278365|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
105620741|NCT04850898|364278368|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
105620742|NCT04850898|364278369|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
105620743|NCT03701763|364278370|FG000|Placebo-controlled Phase|Adverse Event|1|||
105620744|NCT03701763|364278371|FG001|Placebo-controlled Phase|Adverse Event|5|||
105620745|NCT03701763|364278372|FG002|Placebo-controlled Phase|Adverse Event|0|||
105620746|NCT03701763|364278373|FG003|Placebo-controlled Phase|Adverse Event|0|||
105620747|NCT03701763|364278370|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
105620748|NCT03701763|364278371|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
105620749|NCT03701763|364278372|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
105620750|NCT03701763|364278373|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
105620751|NCT03701763|364278370|FG000|Placebo-controlled Phase|Miscellaneous|2|||
105620752|NCT03701763|364278371|FG001|Placebo-controlled Phase|Miscellaneous|0|||
105620753|NCT03701763|364278372|FG002|Placebo-controlled Phase|Miscellaneous|0|||
105620754|NCT03701763|364278373|FG003|Placebo-controlled Phase|Miscellaneous|0|||
105620755|NCT03701763|364278370|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
105620756|NCT03701763|364278371|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
105620757|NCT03701763|364278372|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
105620758|NCT03701763|364278373|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
105620759|NCT03701763|364278370|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
105620760|NCT03701763|364278371|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
105620761|NCT03701763|364278372|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
105620762|NCT03701763|364278373|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
105620763|NCT03701763|364278370|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
105620764|NCT03701763|364278371|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
105620765|NCT03701763|364278372|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
105620766|NCT03701763|364278373|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
105620767|NCT03701763|364278370|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
105620768|NCT03701763|364278371|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
105620769|NCT03701763|364278372|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
105620770|NCT03701763|364278373|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
105620771|NCT03701763|364278370|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
105620772|NCT03701763|364278371|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
105620773|NCT03701763|364278372|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
105620774|NCT03701763|364278373|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
105620775|NCT03701763|364278370|FG000|Apremilast Extension Phase|Adverse Event|0|||
105620776|NCT03701763|364278371|FG001|Apremilast Extension Phase|Adverse Event|0|||
105620777|NCT03701763|364278372|FG002|Apremilast Extension Phase|Adverse Event|3|||
105620778|NCT03701763|364278373|FG003|Apremilast Extension Phase|Adverse Event|1|||
105620779|NCT03701763|364278370|FG000|Apremilast Extension Phase|Miscellaneous|0|||
105620780|NCT03701763|364278371|FG001|Apremilast Extension Phase|Miscellaneous|0|||
105620781|NCT03701763|364278372|FG002|Apremilast Extension Phase|Miscellaneous|2|||
105620782|NCT03701763|364278373|FG003|Apremilast Extension Phase|Miscellaneous|1|||
105620783|NCT03701763|364278370|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
105620784|NCT03701763|364278371|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
105620785|NCT03701763|364278372|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
105620786|NCT03701763|364278373|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
105620787|NCT03701763|364278370|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
105620788|NCT03701763|364278371|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
105620789|NCT03701763|364278372|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
105620790|NCT03701763|364278373|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
105620791|NCT03701763|364278370|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
105620792|NCT03701763|364278371|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
105620793|NCT03701763|364278372|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
105620794|NCT03701763|364278373|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
105620795|NCT03701763|364278370|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
105620796|NCT03701763|364278371|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
105620797|NCT03701763|364278372|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
105620798|NCT03701763|364278373|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
105620799|NCT03701763|364278370|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
105620800|NCT03701763|364278371|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
105620801|NCT03701763|364278372|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
105620802|NCT03701763|364278373|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
105620803|NCT03701763|364278370|FG000|14-Week Observational Follow-up Phase|Other|0|||
105620804|NCT03701763|364278371|FG001|14-Week Observational Follow-up Phase|Other|0|||
105620805|NCT03701763|364278372|FG002|14-Week Observational Follow-up Phase|Other|1|||
105620806|NCT03701763|364278373|FG003|14-Week Observational Follow-up Phase|Other|0|||
105620807|NCT03701763|364278370|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
105620808|NCT03701763|364278371|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
105620809|NCT03701763|364278372|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
105620810|NCT03701763|364278373|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
105620811|NCT03701763|364278370|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
105620812|NCT03701763|364278371|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
105620813|NCT03701763|364278372|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
105620814|NCT03701763|364278373|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
105620815|NCT00592852|364278374|FG000|Overall Study|Non-compliance|1|||
105620816|NCT00592852|364278374|FG000|Overall Study|Adverse Event|3|||
105620817|NCT00592852|364278374|FG000|Overall Study|Found ineligible|1|||
105620818|NCT00592852|364278374|FG000|Overall Study|Withdrawal by Subject|1|||
105620819|NCT05194956|364278376|FG000|Washout Period|Withdrawal by Subject|0|||
105620820|NCT05194956|364278377|FG001|Washout Period|Withdrawal by Subject|2|||
105620821|NCT05446870|364278400|FG000|Overall Study|Death|6|||
105620822|NCT05446870|364278401|FG001|Overall Study|Death|2|||
105620823|NCT05446870|364278400|FG000|Overall Study|Lost to Follow-up|0|||
105620824|NCT05446870|364278401|FG001|Overall Study|Lost to Follow-up|1|||
105620825|NCT05446870|364278400|FG000|Overall Study|Physician Decision|27|||
105620826|NCT05446870|364278401|FG001|Overall Study|Physician Decision|25|||
105620827|NCT05446870|364278400|FG000|Overall Study|Withdrawal by Subject|3|||
105620828|NCT05446870|364278401|FG001|Overall Study|Withdrawal by Subject|2|||
105620829|NCT05446870|364278400|FG000|Overall Study|Study Ongoing|37|||
105620830|NCT05446870|364278401|FG001|Overall Study|Study Ongoing|43|||
105620831|NCT04299464|364278408|FG000|Overall Study|Adverse Event|1|||
105620832|NCT04299464|364278409|FG001|Overall Study|Adverse Event|0|||
105620833|NCT04299464|364278410|FG002|Overall Study|Adverse Event|2|||
105620834|NCT04299464|364278408|FG000|Overall Study|Non-compliance with Study Drug|1|||
105620835|NCT04299464|364278409|FG001|Overall Study|Non-compliance with Study Drug|0|||
105620836|NCT04299464|364278410|FG002|Overall Study|Non-compliance with Study Drug|0|||
105620837|NCT04299464|364278408|FG000|Overall Study|Reason not Specified|0|||
105620838|NCT04299464|364278409|FG001|Overall Study|Reason not Specified|1|||
105620839|NCT04299464|364278410|FG002|Overall Study|Reason not Specified|3|||
105620840|NCT04299464|364278408|FG000|Overall Study|Physician Decision|0|||
105620841|NCT04299464|364278409|FG001|Overall Study|Physician Decision|1|||
105620842|NCT04299464|364278410|FG002|Overall Study|Physician Decision|1|||
105620843|NCT04299464|364278408|FG000|Overall Study|Withdrawal by Subject|0|||
105620844|NCT04299464|364278409|FG001|Overall Study|Withdrawal by Subject|2|||
105620845|NCT04299464|364278410|FG002|Overall Study|Withdrawal by Subject|1|||
105620846|NCT05192109|364278418|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
105620847|NCT05192109|364278419|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
105620848|NCT05192109|364278420|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
105620849|NCT05192109|364278421|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
105620850|NCT05192109|364278418|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
105620851|NCT05192109|364278419|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
105620852|NCT05192109|364278420|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
105620853|NCT05192109|364278421|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
105620854|NCT04498390|364278422|FG000|Overall Study|Adverse Event|0|||
105620855|NCT04498390|364278423|FG001|Overall Study|Adverse Event|0|||
105620856|NCT04498390|364278424|FG002|Overall Study|Adverse Event|1|||
105620857|NCT04498390|364278425|FG003|Overall Study|Adverse Event|0|||
105620858|NCT04498390|364278426|FG004|Overall Study|Adverse Event|0|||
105620859|NCT04498390|364278422|FG000|Overall Study|Withdrawal by Subject|0|||
105620860|NCT04498390|364278423|FG001|Overall Study|Withdrawal by Subject|0|||
105620861|NCT04498390|364278424|FG002|Overall Study|Withdrawal by Subject|0|||
105620862|NCT04498390|364278425|FG003|Overall Study|Withdrawal by Subject|1|||
105620863|NCT04498390|364278426|FG004|Overall Study|Withdrawal by Subject|0|||
105620864|NCT05318937|364278427|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105620865|NCT05318937|364278428|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105620866|NCT05318937|364278427|FG000|Overall Study|Lost to Follow-up|0|||
105620867|NCT05318937|364278428|FG001|Overall Study|Lost to Follow-up|1|||
105620868|NCT05318937|364278427|FG000|Overall Study|Withdrawal by Subject|0|||
105620869|NCT05318937|364278428|FG001|Overall Study|Withdrawal by Subject|2|||
105620870|NCT05318937|364278427|FG000|Overall Study|Protocol Violation|0|||
105620871|NCT05318937|364278428|FG001|Overall Study|Protocol Violation|1|||
105620872|NCT04515849|364278429|FG000|Overall Study|Adverse Event|0|||
105620873|NCT04515849|364278430|FG001|Overall Study|Adverse Event|0|||
105620874|NCT04515849|364278431|FG002|Overall Study|Adverse Event|0|||
105620875|NCT04515849|364278432|FG003|Overall Study|Adverse Event|1|||
105620876|NCT04515849|364278433|FG004|Overall Study|Adverse Event|2|||
105620877|NCT04515849|364278429|FG000|Overall Study|Death|2|||
105620878|NCT04515849|364278430|FG001|Overall Study|Death|0|||
105620879|NCT04515849|364278431|FG002|Overall Study|Death|0|||
105620880|NCT04515849|364278432|FG003|Overall Study|Death|0|||
105620881|NCT04515849|364278433|FG004|Overall Study|Death|0|||
105620882|NCT04515849|364278429|FG000|Overall Study|Other:family emergency|0|||
105620883|NCT04515849|364278430|FG001|Overall Study|Other:family emergency|0|||
105620884|NCT04515849|364278431|FG002|Overall Study|Other:family emergency|0|||
105620885|NCT04515849|364278432|FG003|Overall Study|Other:family emergency|1|||
105620886|NCT04515849|364278433|FG004|Overall Study|Other:family emergency|0|||
105620887|NCT04515849|364278429|FG000|Overall Study|Other:randomised by error|0|||
105620888|NCT04515849|364278430|FG001|Overall Study|Other:randomised by error|1|||
105620889|NCT04515849|364278431|FG002|Overall Study|Other:randomised by error|0|||
105620890|NCT04515849|364278432|FG003|Overall Study|Other:randomised by error|0|||
105620891|NCT04515849|364278433|FG004|Overall Study|Other:randomised by error|0|||
105620892|NCT04515849|364278429|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
105620893|NCT04515849|364278430|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
105620894|NCT04515849|364278431|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
105620895|NCT04515849|364278432|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
105620896|NCT04515849|364278433|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
105620897|NCT04515849|364278429|FG000|Overall Study|Physician Decision|0|||
105620898|NCT04515849|364278430|FG001|Overall Study|Physician Decision|1|||
105620899|NCT04515849|364278431|FG002|Overall Study|Physician Decision|0|||
105620900|NCT04515849|364278432|FG003|Overall Study|Physician Decision|0|||
105620901|NCT04515849|364278433|FG004|Overall Study|Physician Decision|0|||
105620902|NCT04515849|364278429|FG000|Overall Study|Withdrawal by Subject|1|||
105620903|NCT04515849|364278430|FG001|Overall Study|Withdrawal by Subject|2|||
105620904|NCT04515849|364278431|FG002|Overall Study|Withdrawal by Subject|1|||
105620905|NCT04515849|364278432|FG003|Overall Study|Withdrawal by Subject|0|||
105620906|NCT04515849|364278433|FG004|Overall Study|Withdrawal by Subject|0|||
105620907|NCT01868997|364278434|FG000|Overall Study|Adverse Event|2|||
105620908|NCT01868997|364278435|FG001|Overall Study|Adverse Event|5|||
105620909|NCT01868997|364278434|FG000|Overall Study|Lack of Efficacy|2|||
105620910|NCT01868997|364278435|FG001|Overall Study|Lack of Efficacy|0|||
105620911|NCT01868997|364278434|FG000|Overall Study|Other|3|||
105620912|NCT01868997|364278435|FG001|Overall Study|Other|1|||
105620913|NCT05370040|364278436|FG000|Overall Study|Lost to Follow-up|0|||
105620914|NCT05370040|364278437|FG001|Overall Study|Lost to Follow-up|0|||
105620915|NCT05370040|364278438|FG002|Overall Study|Lost to Follow-up|1|||
105620916|NCT05370040|364278439|FG003|Overall Study|Lost to Follow-up|0|||
105620917|NCT05370040|364278440|FG004|Overall Study|Lost to Follow-up|1|||
105620918|NCT05370040|364278441|FG005|Overall Study|Lost to Follow-up|0|||
105620919|NCT04766892|364278443|FG000|Overall Study|Withdrawal by Subject|1|||
105620920|NCT04766892|364278443|FG000|Overall Study|Lost to Follow-up|1|||
105620921|NCT04766892|364278443|FG000|Overall Study|Adverse Event|3|||
105620922|NCT04766892|364278443|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
105620923|NCT06122194|364278447|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
105620924|NCT06122194|364278448|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
105620925|NCT06122194|364278449|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
105620926|NCT06122194|364278450|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
105620927|NCT04409353|364278451|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
105620928|NCT04409353|364278452|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
105620929|NCT04409353|364278453|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
105620930|NCT04409353|364278451|FG000|Overall Study|Lost to Follow-up|6|||
105620931|NCT04409353|364278452|FG001|Overall Study|Lost to Follow-up|8|||
105620932|NCT04409353|364278453|FG002|Overall Study|Lost to Follow-up|7|||
105620933|NCT04409353|364278451|FG000|Overall Study|Major surgery during participation window|4|||
105620934|NCT04409353|364278452|FG001|Overall Study|Major surgery during participation window|3|||
105620935|NCT04409353|364278453|FG002|Overall Study|Major surgery during participation window|3|||
105620936|NCT04409353|364278451|FG000|Overall Study|Life event occurred during participation window|3|||
105620937|NCT04409353|364278452|FG001|Overall Study|Life event occurred during participation window|2|||
105620938|NCT04409353|364278453|FG002|Overall Study|Life event occurred during participation window|4|||
105620939|NCT04409353|364278451|FG000|Overall Study|Lack of Efficacy|4|||
105620940|NCT04409353|364278452|FG001|Overall Study|Lack of Efficacy|1|||
105620941|NCT04409353|364278453|FG002|Overall Study|Lack of Efficacy|3|||
105620942|NCT04409353|364278451|FG000|Overall Study|Adverse Event|2|||
105620943|NCT04409353|364278452|FG001|Overall Study|Adverse Event|1|||
105620944|NCT04409353|364278453|FG002|Overall Study|Adverse Event|1|||
105620945|NCT04409353|364278451|FG000|Overall Study|Disease burden - unable to participate|0|||
105620946|NCT04409353|364278452|FG001|Overall Study|Disease burden - unable to participate|1|||
105620947|NCT04409353|364278453|FG002|Overall Study|Disease burden - unable to participate|1|||
105620948|NCT04409353|364278451|FG000|Overall Study|Intervention too complicated|1|||
105620949|NCT04409353|364278452|FG001|Overall Study|Intervention too complicated|0|||
105620950|NCT04409353|364278453|FG002|Overall Study|Intervention too complicated|1|||
105620951|NCT03519178|364278456|FG000|PF-06873600 Treatment|Adverse Event|0|||
105620952|NCT03519178|364278457|FG001|PF-06873600 Treatment|Adverse Event|0|||
105620953|NCT03519178|364278458|FG002|PF-06873600 Treatment|Adverse Event|0|||
105620954|NCT03519178|364278459|FG003|PF-06873600 Treatment|Adverse Event|0|||
105620955|NCT03519178|364278460|FG004|PF-06873600 Treatment|Adverse Event|0|||
105620956|NCT03519178|364278461|FG005|PF-06873600 Treatment|Adverse Event|0|||
105620957|NCT03519178|364278462|FG006|PF-06873600 Treatment|Adverse Event|0|||
105620958|NCT03519178|364278463|FG007|PF-06873600 Treatment|Adverse Event|2|||
105620959|NCT03519178|364278464|FG008|PF-06873600 Treatment|Adverse Event|1|||
105620960|NCT03519178|364278465|FG009|PF-06873600 Treatment|Adverse Event|0|||
105620961|NCT03519178|364278466|FG010|PF-06873600 Treatment|Adverse Event|0|||
105620962|NCT03519178|364278467|FG011|PF-06873600 Treatment|Adverse Event|0|||
105620963|NCT03519178|364278468|FG012|PF-06873600 Treatment|Adverse Event|1|||
105620964|NCT03519178|364278469|FG013|PF-06873600 Treatment|Adverse Event|3|||
105620965|NCT03519178|364278470|FG014|PF-06873600 Treatment|Adverse Event|2|||
105620966|NCT03519178|364278456|FG000|PF-06873600 Treatment|Death|0|||
105620967|NCT03519178|364278457|FG001|PF-06873600 Treatment|Death|0|||
105620968|NCT03519178|364278458|FG002|PF-06873600 Treatment|Death|0|||
105620969|NCT03519178|364278459|FG003|PF-06873600 Treatment|Death|0|||
105620970|NCT03519178|364278460|FG004|PF-06873600 Treatment|Death|0|||
105620971|NCT03519178|364278461|FG005|PF-06873600 Treatment|Death|0|||
105620972|NCT03519178|364278462|FG006|PF-06873600 Treatment|Death|0|||
105620973|NCT03519178|364278463|FG007|PF-06873600 Treatment|Death|0|||
105620974|NCT03519178|364278464|FG008|PF-06873600 Treatment|Death|1|||
105620975|NCT03519178|364278465|FG009|PF-06873600 Treatment|Death|1|||
105620976|NCT03519178|364278466|FG010|PF-06873600 Treatment|Death|0|||
105620977|NCT03519178|364278467|FG011|PF-06873600 Treatment|Death|0|||
105620978|NCT03519178|364278468|FG012|PF-06873600 Treatment|Death|0|||
105620979|NCT03519178|364278469|FG013|PF-06873600 Treatment|Death|0|||
105620980|NCT03519178|364278470|FG014|PF-06873600 Treatment|Death|1|||
105620981|NCT03519178|364278456|FG000|PF-06873600 Treatment|Physician Decision|0|||
105620982|NCT03519178|364278457|FG001|PF-06873600 Treatment|Physician Decision|0|||
105620983|NCT03519178|364278458|FG002|PF-06873600 Treatment|Physician Decision|0|||
105620984|NCT03519178|364278459|FG003|PF-06873600 Treatment|Physician Decision|0|||
105620985|NCT03519178|364278460|FG004|PF-06873600 Treatment|Physician Decision|0|||
105620986|NCT03519178|364278461|FG005|PF-06873600 Treatment|Physician Decision|0|||
105620987|NCT03519178|364278462|FG006|PF-06873600 Treatment|Physician Decision|0|||
105620988|NCT03519178|364278463|FG007|PF-06873600 Treatment|Physician Decision|1|||
105620989|NCT03519178|364278464|FG008|PF-06873600 Treatment|Physician Decision|0|||
105620990|NCT03519178|364278465|FG009|PF-06873600 Treatment|Physician Decision|0|||
105620991|NCT03519178|364278466|FG010|PF-06873600 Treatment|Physician Decision|1|||
105620992|NCT03519178|364278467|FG011|PF-06873600 Treatment|Physician Decision|0|||
105620993|NCT03519178|364278468|FG012|PF-06873600 Treatment|Physician Decision|0|||
105620994|NCT03519178|364278469|FG013|PF-06873600 Treatment|Physician Decision|4|||
105620995|NCT03519178|364278470|FG014|PF-06873600 Treatment|Physician Decision|1|||
105620996|NCT03519178|364278456|FG000|PF-06873600 Treatment|Progressive disease|1|||
105620997|NCT03519178|364278457|FG001|PF-06873600 Treatment|Progressive disease|1|||
105620998|NCT03519178|364278458|FG002|PF-06873600 Treatment|Progressive disease|1|||
105620999|NCT03519178|364278459|FG003|PF-06873600 Treatment|Progressive disease|1|||
105621000|NCT03519178|364278460|FG004|PF-06873600 Treatment|Progressive disease|6|||
105621001|NCT03519178|364278461|FG005|PF-06873600 Treatment|Progressive disease|7|||
105621002|NCT03519178|364278462|FG006|PF-06873600 Treatment|Progressive disease|3|||
105621003|NCT03519178|364278463|FG007|PF-06873600 Treatment|Progressive disease|7|||
105621004|NCT03519178|364278464|FG008|PF-06873600 Treatment|Progressive disease|3|||
105621005|NCT03519178|364278465|FG009|PF-06873600 Treatment|Progressive disease|5|||
105621006|NCT03519178|364278466|FG010|PF-06873600 Treatment|Progressive disease|4|||
105621007|NCT03519178|364278467|FG011|PF-06873600 Treatment|Progressive disease|3|||
105621008|NCT03519178|364278468|FG012|PF-06873600 Treatment|Progressive disease|4|||
105621009|NCT03519178|364278469|FG013|PF-06873600 Treatment|Progressive disease|28|||
105621010|NCT03519178|364278470|FG014|PF-06873600 Treatment|Progressive disease|7|||
105621011|NCT03519178|364278456|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
105621012|NCT03519178|364278457|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
105621013|NCT03519178|364278458|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
105621014|NCT03519178|364278459|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
105621015|NCT03519178|364278460|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
105621016|NCT03519178|364278461|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
105621017|NCT03519178|364278462|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
105621018|NCT03519178|364278463|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
105621019|NCT03519178|364278464|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
105621020|NCT03519178|364278465|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
105621021|NCT03519178|364278466|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
105621022|NCT03519178|364278467|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
105621023|NCT03519178|364278468|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
105621024|NCT03519178|364278469|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
105621025|NCT03519178|364278470|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
105621026|NCT03519178|364278456|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
105621027|NCT03519178|364278457|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
105621028|NCT03519178|364278458|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
105621029|NCT03519178|364278459|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
105621030|NCT03519178|364278460|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
105621031|NCT03519178|364278461|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
105621032|NCT03519178|364278462|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
105621033|NCT03519178|364278463|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
105621034|NCT03519178|364278464|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
105621035|NCT03519178|364278465|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
105621036|NCT03519178|364278466|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
105621037|NCT03519178|364278467|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
105621038|NCT03519178|364278468|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
105621039|NCT03519178|364278469|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
105621040|NCT03519178|364278470|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
105621041|NCT03519178|364278456|FG000|PF-06873600 Treatment|Refused further treatment|0|||
105621042|NCT03519178|364278457|FG001|PF-06873600 Treatment|Refused further treatment|1|||
105621043|NCT03519178|364278458|FG002|PF-06873600 Treatment|Refused further treatment|0|||
105621044|NCT03519178|364278459|FG003|PF-06873600 Treatment|Refused further treatment|0|||
105621045|NCT03519178|364278460|FG004|PF-06873600 Treatment|Refused further treatment|1|||
105621046|NCT03519178|364278461|FG005|PF-06873600 Treatment|Refused further treatment|0|||
105621047|NCT03519178|364278462|FG006|PF-06873600 Treatment|Refused further treatment|0|||
105621048|NCT03519178|364278463|FG007|PF-06873600 Treatment|Refused further treatment|0|||
105621049|NCT03519178|364278464|FG008|PF-06873600 Treatment|Refused further treatment|0|||
105621050|NCT03519178|364278465|FG009|PF-06873600 Treatment|Refused further treatment|0|||
105621051|NCT03519178|364278466|FG010|PF-06873600 Treatment|Refused further treatment|0|||
105621052|NCT03519178|364278467|FG011|PF-06873600 Treatment|Refused further treatment|0|||
105621053|NCT03519178|364278468|FG012|PF-06873600 Treatment|Refused further treatment|0|||
105621054|NCT03519178|364278469|FG013|PF-06873600 Treatment|Refused further treatment|0|||
105621055|NCT03519178|364278470|FG014|PF-06873600 Treatment|Refused further treatment|1|||
105621056|NCT03519178|364278456|FG000|PF-06873600 Treatment|Other|0|||
105621057|NCT03519178|364278457|FG001|PF-06873600 Treatment|Other|0|||
105621058|NCT03519178|364278458|FG002|PF-06873600 Treatment|Other|0|||
105621059|NCT03519178|364278459|FG003|PF-06873600 Treatment|Other|0|||
105621060|NCT03519178|364278460|FG004|PF-06873600 Treatment|Other|0|||
105621061|NCT03519178|364278461|FG005|PF-06873600 Treatment|Other|0|||
105621062|NCT03519178|364278462|FG006|PF-06873600 Treatment|Other|0|||
105621063|NCT03519178|364278463|FG007|PF-06873600 Treatment|Other|0|||
105621064|NCT03519178|364278464|FG008|PF-06873600 Treatment|Other|1|||
105621065|NCT03519178|364278465|FG009|PF-06873600 Treatment|Other|0|||
105621066|NCT03519178|364278466|FG010|PF-06873600 Treatment|Other|0|||
105621067|NCT03519178|364278467|FG011|PF-06873600 Treatment|Other|0|||
105621068|NCT03519178|364278468|FG012|PF-06873600 Treatment|Other|0|||
105621069|NCT03519178|364278469|FG013|PF-06873600 Treatment|Other|1|||
105621070|NCT03519178|364278470|FG014|PF-06873600 Treatment|Other|3|||
105621071|NCT03519178|364278456|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
105621072|NCT03519178|364278457|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
105621073|NCT03519178|364278458|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
105621074|NCT03519178|364278459|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
105621075|NCT03519178|364278460|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
105621076|NCT03519178|364278461|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
105621077|NCT03519178|364278462|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
105621078|NCT03519178|364278463|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
105621079|NCT03519178|364278464|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
105621080|NCT03519178|364278465|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
105621081|NCT03519178|364278466|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
105621082|NCT03519178|364278467|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
105621083|NCT03519178|364278468|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
105621084|NCT03519178|364278469|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
105621085|NCT03519178|364278470|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
105621086|NCT03519178|364278456|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
105621087|NCT03519178|364278457|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
105621088|NCT03519178|364278458|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
105621089|NCT03519178|364278459|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
105621090|NCT03519178|364278460|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
105621091|NCT03519178|364278461|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
105621092|NCT03519178|364278462|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
105621093|NCT03519178|364278463|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
105621094|NCT03519178|364278464|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
105621095|NCT03519178|364278465|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
105621096|NCT03519178|364278466|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
105621097|NCT03519178|364278467|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
105621098|NCT03519178|364278468|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
105621099|NCT03519178|364278469|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
105621100|NCT03519178|364278470|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
105621101|NCT03519178|364278456|FG000|PF-06873600 Treatment|Ongoing|0|||
105621102|NCT03519178|364278457|FG001|PF-06873600 Treatment|Ongoing|0|||
105621103|NCT03519178|364278458|FG002|PF-06873600 Treatment|Ongoing|0|||
105621104|NCT03519178|364278459|FG003|PF-06873600 Treatment|Ongoing|0|||
105621105|NCT03519178|364278460|FG004|PF-06873600 Treatment|Ongoing|0|||
105621106|NCT03519178|364278461|FG005|PF-06873600 Treatment|Ongoing|0|||
105621107|NCT03519178|364278462|FG006|PF-06873600 Treatment|Ongoing|0|||
105621108|NCT03519178|364278463|FG007|PF-06873600 Treatment|Ongoing|0|||
105621109|NCT03519178|364278464|FG008|PF-06873600 Treatment|Ongoing|0|||
105621110|NCT03519178|364278465|FG009|PF-06873600 Treatment|Ongoing|0|||
105621111|NCT03519178|364278466|FG010|PF-06873600 Treatment|Ongoing|0|||
105621112|NCT03519178|364278467|FG011|PF-06873600 Treatment|Ongoing|0|||
105621113|NCT03519178|364278468|FG012|PF-06873600 Treatment|Ongoing|0|||
105621114|NCT03519178|364278469|FG013|PF-06873600 Treatment|Ongoing|1|||
105621115|NCT03519178|364278470|FG014|PF-06873600 Treatment|Ongoing|6|||
105621116|NCT03519178|364278456|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
105621117|NCT03519178|364278457|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
105621118|NCT03519178|364278458|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
105621119|NCT03519178|364278459|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
105621120|NCT03519178|364278460|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
105621121|NCT03519178|364278461|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
105621122|NCT03519178|364278462|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
105621123|NCT03519178|364278463|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
105621124|NCT03519178|364278464|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
105621125|NCT03519178|364278465|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
105621126|NCT03519178|364278466|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
105621127|NCT03519178|364278467|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
105621128|NCT03519178|364278468|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
105621129|NCT03519178|364278469|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
105621130|NCT03519178|364278470|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
105621131|NCT03519178|364278456|FG000|Disposition for Fluvestrant Treatment|Death|0|||
105621132|NCT03519178|364278457|FG001|Disposition for Fluvestrant Treatment|Death|0|||
105621133|NCT03519178|364278458|FG002|Disposition for Fluvestrant Treatment|Death|0|||
105621134|NCT03519178|364278459|FG003|Disposition for Fluvestrant Treatment|Death|0|||
105621135|NCT03519178|364278460|FG004|Disposition for Fluvestrant Treatment|Death|0|||
105621136|NCT03519178|364278461|FG005|Disposition for Fluvestrant Treatment|Death|0|||
105621137|NCT03519178|364278462|FG006|Disposition for Fluvestrant Treatment|Death|0|||
105621138|NCT03519178|364278463|FG007|Disposition for Fluvestrant Treatment|Death|0|||
105621139|NCT03519178|364278464|FG008|Disposition for Fluvestrant Treatment|Death|0|||
105621140|NCT03519178|364278465|FG009|Disposition for Fluvestrant Treatment|Death|1|||
105621141|NCT03519178|364278466|FG010|Disposition for Fluvestrant Treatment|Death|0|||
105621142|NCT03519178|364278467|FG011|Disposition for Fluvestrant Treatment|Death|0|||
105621143|NCT03519178|364278468|FG012|Disposition for Fluvestrant Treatment|Death|0|||
105621144|NCT03519178|364278469|FG013|Disposition for Fluvestrant Treatment|Death|0|||
105621145|NCT03519178|364278470|FG014|Disposition for Fluvestrant Treatment|Death|1|||
105621146|NCT03519178|364278456|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
105621147|NCT03519178|364278457|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
105621148|NCT03519178|364278458|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
105621149|NCT03519178|364278459|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
105621150|NCT03519178|364278460|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
105621151|NCT03519178|364278461|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
105621152|NCT03519178|364278462|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
105621153|NCT03519178|364278463|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
105621154|NCT03519178|364278464|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
105621155|NCT03519178|364278465|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
105621156|NCT03519178|364278466|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
105621157|NCT03519178|364278467|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
105621158|NCT03519178|364278468|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
105621159|NCT03519178|364278469|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
105621160|NCT03519178|364278470|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
105621161|NCT03519178|364278456|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
105621162|NCT03519178|364278457|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
105621163|NCT03519178|364278458|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
105621164|NCT03519178|364278459|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
105621165|NCT03519178|364278460|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
105621166|NCT03519178|364278461|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
105621167|NCT03519178|364278462|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
105621168|NCT03519178|364278463|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
105621169|NCT03519178|364278464|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
105621170|NCT03519178|364278465|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
105621171|NCT03519178|364278466|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
105621172|NCT03519178|364278467|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
105621173|NCT03519178|364278468|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
105621174|NCT03519178|364278469|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
105621175|NCT03519178|364278470|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
105621176|NCT03519178|364278456|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
105621177|NCT03519178|364278457|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
105621178|NCT03519178|364278458|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
105621179|NCT03519178|364278459|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
105621180|NCT03519178|364278460|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
105621181|NCT03519178|364278461|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
105621182|NCT03519178|364278462|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
105621183|NCT03519178|364278463|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
105621184|NCT03519178|364278464|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
105621185|NCT03519178|364278465|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
105621186|NCT03519178|364278466|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
105621187|NCT03519178|364278467|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
105621188|NCT03519178|364278468|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
105621189|NCT03519178|364278469|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
105621190|NCT03519178|364278470|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
105621191|NCT03519178|364278456|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
105621192|NCT03519178|364278457|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
105621193|NCT03519178|364278458|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
105621194|NCT03519178|364278459|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
105621195|NCT03519178|364278460|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
105621196|NCT03519178|364278461|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
105621197|NCT03519178|364278462|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
105621198|NCT03519178|364278463|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
105621199|NCT03519178|364278464|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
105621200|NCT03519178|364278465|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
105621201|NCT03519178|364278466|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
105621202|NCT03519178|364278467|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
105621203|NCT03519178|364278468|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
105621204|NCT03519178|364278469|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
105621205|NCT03519178|364278470|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
105621206|NCT03519178|364278456|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
105621207|NCT03519178|364278457|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
105621208|NCT03519178|364278458|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
105621209|NCT03519178|364278459|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
105621210|NCT03519178|364278460|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
105621211|NCT03519178|364278461|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
105621212|NCT03519178|364278462|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
105621213|NCT03519178|364278463|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
105621214|NCT03519178|364278464|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
105621215|NCT03519178|364278465|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
105621216|NCT03519178|364278466|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
105621217|NCT03519178|364278467|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
105621218|NCT03519178|364278468|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
105621219|NCT03519178|364278469|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
105621220|NCT03519178|364278470|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
105621221|NCT03519178|364278456|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
105621222|NCT03519178|364278457|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
105621223|NCT03519178|364278458|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
105621224|NCT03519178|364278459|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
105621225|NCT03519178|364278460|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
105621226|NCT03519178|364278461|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
105621227|NCT03519178|364278462|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
105621228|NCT03519178|364278463|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
105621229|NCT03519178|364278464|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
105621230|NCT03519178|364278465|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
105621231|NCT03519178|364278466|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
105621232|NCT03519178|364278467|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
105621233|NCT03519178|364278468|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
105621234|NCT03519178|364278469|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
105621235|NCT03519178|364278470|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
105621236|NCT03519178|364278456|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
105621237|NCT03519178|364278457|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
105621238|NCT03519178|364278458|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
105621239|NCT03519178|364278459|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
105621240|NCT03519178|364278460|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
105621241|NCT03519178|364278461|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
105621242|NCT03519178|364278462|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
105621243|NCT03519178|364278463|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
105621244|NCT03519178|364278464|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
105621245|NCT03519178|364278465|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
105621246|NCT03519178|364278466|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
105621247|NCT03519178|364278467|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
105621248|NCT03519178|364278468|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
105621249|NCT03519178|364278469|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
105621250|NCT03519178|364278470|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
105621251|NCT03519178|364278456|FG000|Disposition for Fluvestrant Treatment|Other|0|||
105621252|NCT03519178|364278457|FG001|Disposition for Fluvestrant Treatment|Other|0|||
105621253|NCT03519178|364278458|FG002|Disposition for Fluvestrant Treatment|Other|0|||
105621254|NCT03519178|364278459|FG003|Disposition for Fluvestrant Treatment|Other|0|||
105621255|NCT03519178|364278460|FG004|Disposition for Fluvestrant Treatment|Other|0|||
105621256|NCT03519178|364278461|FG005|Disposition for Fluvestrant Treatment|Other|0|||
105621257|NCT03519178|364278462|FG006|Disposition for Fluvestrant Treatment|Other|0|||
105621258|NCT03519178|364278463|FG007|Disposition for Fluvestrant Treatment|Other|0|||
105621259|NCT03519178|364278464|FG008|Disposition for Fluvestrant Treatment|Other|0|||
105621260|NCT03519178|364278465|FG009|Disposition for Fluvestrant Treatment|Other|0|||
105621261|NCT03519178|364278466|FG010|Disposition for Fluvestrant Treatment|Other|0|||
105621262|NCT03519178|364278467|FG011|Disposition for Fluvestrant Treatment|Other|0|||
105621263|NCT03519178|364278468|FG012|Disposition for Fluvestrant Treatment|Other|0|||
105621264|NCT03519178|364278469|FG013|Disposition for Fluvestrant Treatment|Other|1|||
105621265|NCT03519178|364278470|FG014|Disposition for Fluvestrant Treatment|Other|3|||
105621266|NCT03519178|364278456|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
105621267|NCT03519178|364278457|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
105621268|NCT03519178|364278458|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
105621269|NCT03519178|364278459|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
105621270|NCT03519178|364278460|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
105621271|NCT03519178|364278461|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
105621272|NCT03519178|364278462|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
105621273|NCT03519178|364278463|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
105621274|NCT03519178|364278464|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
105621275|NCT03519178|364278465|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
105621276|NCT03519178|364278466|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
105621277|NCT03519178|364278467|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
105621278|NCT03519178|364278468|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
105621279|NCT03519178|364278469|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
105621280|NCT03519178|364278470|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
105621281|NCT03519178|364278456|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
105621282|NCT03519178|364278457|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
105621283|NCT03519178|364278458|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
105621284|NCT03519178|364278459|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
105621285|NCT03519178|364278460|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
105621286|NCT03519178|364278461|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
105621287|NCT03519178|364278462|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
105621288|NCT03519178|364278463|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
105621289|NCT03519178|364278464|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
105621290|NCT03519178|364278465|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
105621291|NCT03519178|364278466|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
105621292|NCT03519178|364278467|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
105621293|NCT03519178|364278468|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
105621294|NCT03519178|364278469|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
105621295|NCT03519178|364278470|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
105621296|NCT03519178|364278456|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
105621297|NCT03519178|364278457|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
105621298|NCT03519178|364278458|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
105621299|NCT03519178|364278459|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
105621300|NCT03519178|364278460|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
105621301|NCT03519178|364278461|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
105621302|NCT03519178|364278462|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
105621303|NCT03519178|364278463|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
105621304|NCT03519178|364278464|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
105621305|NCT03519178|364278465|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
105621306|NCT03519178|364278466|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
105621307|NCT03519178|364278467|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
105621308|NCT03519178|364278468|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
105621309|NCT03519178|364278469|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
105621310|NCT03519178|364278470|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
105621311|NCT03519178|364278456|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
105621312|NCT03519178|364278457|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
105621313|NCT03519178|364278458|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
105621314|NCT03519178|364278459|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
105621315|NCT03519178|364278460|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
105621316|NCT03519178|364278461|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
105621317|NCT03519178|364278462|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
105621318|NCT03519178|364278463|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
105621319|NCT03519178|364278464|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
105621320|NCT03519178|364278465|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
105621321|NCT03519178|364278466|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
105621322|NCT03519178|364278467|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
105621323|NCT03519178|364278468|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
105621324|NCT03519178|364278469|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
105621325|NCT03519178|364278470|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
105621326|NCT03519178|364278456|FG000|Follow-Up|Death|0|||
105621327|NCT03519178|364278457|FG001|Follow-Up|Death|0|||
105621328|NCT03519178|364278458|FG002|Follow-Up|Death|1|||
105621329|NCT03519178|364278459|FG003|Follow-Up|Death|0|||
105621330|NCT03519178|364278460|FG004|Follow-Up|Death|0|||
105621331|NCT03519178|364278461|FG005|Follow-Up|Death|0|||
105621332|NCT03519178|364278462|FG006|Follow-Up|Death|0|||
105621333|NCT03519178|364278463|FG007|Follow-Up|Death|0|||
105621334|NCT03519178|364278464|FG008|Follow-Up|Death|3|||
105621335|NCT03519178|364278465|FG009|Follow-Up|Death|1|||
105621336|NCT03519178|364278466|FG010|Follow-Up|Death|0|||
105621337|NCT03519178|364278467|FG011|Follow-Up|Death|0|||
105621338|NCT03519178|364278468|FG012|Follow-Up|Death|2|||
105621339|NCT03519178|364278469|FG013|Follow-Up|Death|0|||
105621340|NCT03519178|364278470|FG014|Follow-Up|Death|0|||
105621341|NCT03519178|364278456|FG000|Follow-Up|Lost to Follow-up|0|||
105621342|NCT03519178|364278457|FG001|Follow-Up|Lost to Follow-up|0|||
105621343|NCT03519178|364278458|FG002|Follow-Up|Lost to Follow-up|0|||
105621344|NCT03519178|364278459|FG003|Follow-Up|Lost to Follow-up|0|||
105621345|NCT03519178|364278460|FG004|Follow-Up|Lost to Follow-up|0|||
105621346|NCT03519178|364278461|FG005|Follow-Up|Lost to Follow-up|3|||
105621347|NCT03519178|364278462|FG006|Follow-Up|Lost to Follow-up|1|||
105621348|NCT03519178|364278463|FG007|Follow-Up|Lost to Follow-up|4|||
105621349|NCT03519178|364278464|FG008|Follow-Up|Lost to Follow-up|1|||
105621350|NCT03519178|364278465|FG009|Follow-Up|Lost to Follow-up|0|||
105621351|NCT03519178|364278466|FG010|Follow-Up|Lost to Follow-up|0|||
105621352|NCT03519178|364278467|FG011|Follow-Up|Lost to Follow-up|0|||
105621353|NCT03519178|364278468|FG012|Follow-Up|Lost to Follow-up|0|||
105621354|NCT03519178|364278469|FG013|Follow-Up|Lost to Follow-up|0|||
105621355|NCT03519178|364278470|FG014|Follow-Up|Lost to Follow-up|0|||
105621356|NCT03519178|364278456|FG000|Follow-Up|Withdrawal by Subject|1|||
105621357|NCT03519178|364278457|FG001|Follow-Up|Withdrawal by Subject|2|||
105621358|NCT03519178|364278458|FG002|Follow-Up|Withdrawal by Subject|2|||
105621359|NCT03519178|364278459|FG003|Follow-Up|Withdrawal by Subject|3|||
105621360|NCT03519178|364278460|FG004|Follow-Up|Withdrawal by Subject|5|||
105621361|NCT03519178|364278461|FG005|Follow-Up|Withdrawal by Subject|1|||
105621362|NCT03519178|364278462|FG006|Follow-Up|Withdrawal by Subject|2|||
105621363|NCT03519178|364278463|FG007|Follow-Up|Withdrawal by Subject|6|||
105621364|NCT03519178|364278464|FG008|Follow-Up|Withdrawal by Subject|5|||
105621365|NCT03519178|364278465|FG009|Follow-Up|Withdrawal by Subject|2|||
105621366|NCT03519178|364278466|FG010|Follow-Up|Withdrawal by Subject|3|||
105621367|NCT03519178|364278467|FG011|Follow-Up|Withdrawal by Subject|5|||
105621368|NCT03519178|364278468|FG012|Follow-Up|Withdrawal by Subject|2|||
105621369|NCT03519178|364278469|FG013|Follow-Up|Withdrawal by Subject|0|||
105621370|NCT03519178|364278470|FG014|Follow-Up|Withdrawal by Subject|0|||
105621371|NCT03519178|364278456|FG000|Follow-Up|Other|0|||
105621372|NCT03519178|364278457|FG001|Follow-Up|Other|0|||
105621373|NCT03519178|364278458|FG002|Follow-Up|Other|0|||
105621374|NCT03519178|364278459|FG003|Follow-Up|Other|0|||
105621375|NCT03519178|364278460|FG004|Follow-Up|Other|0|||
105621376|NCT03519178|364278461|FG005|Follow-Up|Other|0|||
105621377|NCT03519178|364278462|FG006|Follow-Up|Other|0|||
105621378|NCT03519178|364278463|FG007|Follow-Up|Other|1|||
105621379|NCT03519178|364278464|FG008|Follow-Up|Other|0|||
105621380|NCT03519178|364278465|FG009|Follow-Up|Other|0|||
105621381|NCT03519178|364278466|FG010|Follow-Up|Other|0|||
105621382|NCT03519178|364278467|FG011|Follow-Up|Other|0|||
105621383|NCT03519178|364278468|FG012|Follow-Up|Other|0|||
105621384|NCT03519178|364278469|FG013|Follow-Up|Other|0|||
105621385|NCT03519178|364278470|FG014|Follow-Up|Other|0|||
105621386|NCT03519178|364278456|FG000|Long-term Follow-up|Death|0|||
105621387|NCT03519178|364278457|FG001|Long-term Follow-up|Death|0|||
105621388|NCT03519178|364278458|FG002|Long-term Follow-up|Death|0|||
105621389|NCT03519178|364278459|FG003|Long-term Follow-up|Death|0|||
105621390|NCT03519178|364278460|FG004|Long-term Follow-up|Death|0|||
105621391|NCT03519178|364278461|FG005|Long-term Follow-up|Death|0|||
105621392|NCT03519178|364278462|FG006|Long-term Follow-up|Death|0|||
105621393|NCT03519178|364278463|FG007|Long-term Follow-up|Death|0|||
105621394|NCT03519178|364278464|FG008|Long-term Follow-up|Death|0|||
105621395|NCT03519178|364278465|FG009|Long-term Follow-up|Death|0|||
105621396|NCT03519178|364278466|FG010|Long-term Follow-up|Death|0|||
105621397|NCT03519178|364278467|FG011|Long-term Follow-up|Death|0|||
105621398|NCT03519178|364278468|FG012|Long-term Follow-up|Death|0|||
105621399|NCT03519178|364278469|FG013|Long-term Follow-up|Death|4|||
105621400|NCT03519178|364278470|FG014|Long-term Follow-up|Death|4|||
105621401|NCT03519178|364278456|FG000|Long-term Follow-up|Lost to Follow-up|0|||
105621402|NCT03519178|364278457|FG001|Long-term Follow-up|Lost to Follow-up|0|||
105621403|NCT03519178|364278458|FG002|Long-term Follow-up|Lost to Follow-up|0|||
105621404|NCT03519178|364278459|FG003|Long-term Follow-up|Lost to Follow-up|0|||
105621405|NCT03519178|364278460|FG004|Long-term Follow-up|Lost to Follow-up|0|||
105621406|NCT03519178|364278461|FG005|Long-term Follow-up|Lost to Follow-up|0|||
105621407|NCT03519178|364278462|FG006|Long-term Follow-up|Lost to Follow-up|0|||
105621408|NCT03519178|364278463|FG007|Long-term Follow-up|Lost to Follow-up|0|||
105621409|NCT03519178|364278464|FG008|Long-term Follow-up|Lost to Follow-up|0|||
105621410|NCT03519178|364278465|FG009|Long-term Follow-up|Lost to Follow-up|0|||
105621411|NCT03519178|364278466|FG010|Long-term Follow-up|Lost to Follow-up|0|||
105621412|NCT03519178|364278467|FG011|Long-term Follow-up|Lost to Follow-up|0|||
105621413|NCT03519178|364278468|FG012|Long-term Follow-up|Lost to Follow-up|0|||
105621414|NCT03519178|364278469|FG013|Long-term Follow-up|Lost to Follow-up|1|||
105621415|NCT03519178|364278470|FG014|Long-term Follow-up|Lost to Follow-up|1|||
105621416|NCT03519178|364278456|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
105621417|NCT03519178|364278457|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
105621418|NCT03519178|364278458|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
105621419|NCT03519178|364278459|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
105621420|NCT03519178|364278460|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
105621421|NCT03519178|364278461|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
105621422|NCT03519178|364278462|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
105621423|NCT03519178|364278463|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
105621424|NCT03519178|364278464|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
105621425|NCT03519178|364278465|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
105621426|NCT03519178|364278466|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
105621427|NCT03519178|364278467|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
105621428|NCT03519178|364278468|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
105621429|NCT03519178|364278469|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
105621430|NCT03519178|364278470|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
105621431|NCT03519178|364278456|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
105621432|NCT03519178|364278457|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
105621433|NCT03519178|364278458|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
105621434|NCT03519178|364278459|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
105621435|NCT03519178|364278460|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
105621436|NCT03519178|364278461|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
105621437|NCT03519178|364278462|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
105621438|NCT03519178|364278463|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
105621439|NCT03519178|364278464|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
105621440|NCT03519178|364278465|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
105621441|NCT03519178|364278466|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
105621442|NCT03519178|364278467|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
105621443|NCT03519178|364278468|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
105621444|NCT03519178|364278469|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
105621445|NCT03519178|364278470|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
105621446|NCT03519178|364278456|FG000|Long-term Follow-up|Other|0|||
105621447|NCT03519178|364278457|FG001|Long-term Follow-up|Other|0|||
105621448|NCT03519178|364278458|FG002|Long-term Follow-up|Other|0|||
105621449|NCT03519178|364278459|FG003|Long-term Follow-up|Other|0|||
105621450|NCT03519178|364278460|FG004|Long-term Follow-up|Other|0|||
105621451|NCT03519178|364278461|FG005|Long-term Follow-up|Other|0|||
105621452|NCT03519178|364278462|FG006|Long-term Follow-up|Other|0|||
105621453|NCT03519178|364278463|FG007|Long-term Follow-up|Other|0|||
105621454|NCT03519178|364278464|FG008|Long-term Follow-up|Other|0|||
105621455|NCT03519178|364278465|FG009|Long-term Follow-up|Other|0|||
105621456|NCT03519178|364278466|FG010|Long-term Follow-up|Other|0|||
105621457|NCT03519178|364278467|FG011|Long-term Follow-up|Other|0|||
105621458|NCT03519178|364278468|FG012|Long-term Follow-up|Other|0|||
105621459|NCT03519178|364278469|FG013|Long-term Follow-up|Other|0|||
105621460|NCT03519178|364278470|FG014|Long-term Follow-up|Other|1|||
105621461|NCT03519178|364278456|FG000|Long-term Follow-up|Ongoing|0|||
105621462|NCT03519178|364278457|FG001|Long-term Follow-up|Ongoing|0|||
105621463|NCT03519178|364278458|FG002|Long-term Follow-up|Ongoing|0|||
105621464|NCT03519178|364278459|FG003|Long-term Follow-up|Ongoing|0|||
105621465|NCT03519178|364278460|FG004|Long-term Follow-up|Ongoing|0|||
105621466|NCT03519178|364278461|FG005|Long-term Follow-up|Ongoing|0|||
105621467|NCT03519178|364278462|FG006|Long-term Follow-up|Ongoing|0|||
105621468|NCT03519178|364278463|FG007|Long-term Follow-up|Ongoing|0|||
105621469|NCT03519178|364278464|FG008|Long-term Follow-up|Ongoing|0|||
105621470|NCT03519178|364278465|FG009|Long-term Follow-up|Ongoing|0|||
105621471|NCT03519178|364278466|FG010|Long-term Follow-up|Ongoing|0|||
105621472|NCT03519178|364278467|FG011|Long-term Follow-up|Ongoing|0|||
105621473|NCT03519178|364278468|FG012|Long-term Follow-up|Ongoing|0|||
105621474|NCT03519178|364278469|FG013|Long-term Follow-up|Ongoing|1|||
105621475|NCT03519178|364278470|FG014|Long-term Follow-up|Ongoing|0|||
105621476|NCT03663569|364280128|FG000|Overall Study|Discontinuation of study|11|||
105621477|NCT03663569|364280128|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
105621478|NCT03663569|364280128|FG000|Overall Study|Deceased patient|6|||
105621479|NCT03663569|364280128|FG000|Overall Study|Lost to Follow-up|18|||
105621480|NCT03663569|364280128|FG000|Overall Study|Withdrawal of consent|5|||
105621481|NCT03663569|364280128|FG000|Overall Study|Patient's request|11|||
105621482|NCT03663569|364280128|FG000|Overall Study|Adverse Event|4|||
105621483|NCT03663569|364280128|FG000|Overall Study|Not come to second visit|3|||
105621484|NCT03663569|364280128|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
105621485|NCT03663569|364280128|FG000|Overall Study|Serious adverse event|1|||
105621486|NCT00104676|364280129|FG000|Overall Study|Death|3|||
105621487|NCT00104676|364280130|FG001|Overall Study|Death|2|||
105621488|NCT00104676|364280129|FG000|Overall Study|Withdrawal by Subject|0|||
105621489|NCT00104676|364280130|FG001|Overall Study|Withdrawal by Subject|2|||
105621490|NCT00104676|364280129|FG000|Overall Study|treatment interruption|4|||
105621491|NCT00104676|364280130|FG001|Overall Study|treatment interruption|10|||
105621492|NCT05622812|364280131|FG000|Overall Study|Withdrawal by Subject|1|||
105621493|NCT05622812|364280132|FG001|Overall Study|Withdrawal by Subject|4|||
105621494|NCT05622812|364280131|FG000|Overall Study|Lost to Follow-up|2|||
105621495|NCT05622812|364280132|FG001|Overall Study|Lost to Follow-up|1|||
105621496|NCT02844465|364280140|FG000|Overall Study|Screen Failure|36|||
105621497|NCT02844465|364280140|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
105621498|NCT02844465|364280140|FG000|Overall Study|Withdrawal by Subject|5|||
105621499|NCT02844465|364280140|FG000|Overall Study|Lost to Follow-up|1|||
105621500|NCT02844465|364280140|FG000|Overall Study|Retreatment|1|||
105621501|NCT03819153|364280144|FG000|Overall Study|Withdrawal by Subject|20|||
105621502|NCT03819153|364280145|FG001|Overall Study|Withdrawal by Subject|28|||
105621503|NCT03819153|364280144|FG000|Overall Study|Lost to Follow-up|23|||
105621504|NCT03819153|364280145|FG001|Overall Study|Lost to Follow-up|30|||
105621505|NCT05029622|364280146|FG000|Overall Study|Lost to Follow-up|1|||
105621506|NCT05671653|364280147|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
105621507|NCT05671653|364280148|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
105621508|NCT05671653|364280149|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
105621509|NCT05671653|364280150|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
105621510|NCT05671653|364280151|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
105621511|NCT05671653|364280152|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
105621512|NCT05671653|364280153|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
105621513|NCT05671653|364280154|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
105621514|NCT05671653|364280155|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
105621515|NCT05671653|364280156|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
105621516|NCT05671653|364280157|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
105621517|NCT05671653|364280158|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
105621518|NCT05671653|364280159|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
105621519|NCT05671653|364280147|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
105621520|NCT05671653|364280148|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
105621521|NCT05671653|364280149|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
105621522|NCT05671653|364280150|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
105621523|NCT05671653|364280151|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
105621524|NCT05671653|364280152|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
105621525|NCT05671653|364280153|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
105621526|NCT05671653|364280154|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
105621527|NCT05671653|364280155|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
105621528|NCT05671653|364280156|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
105621529|NCT05671653|364280157|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
105621530|NCT05671653|364280158|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
105621531|NCT05671653|364280159|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
105621532|NCT05671653|364280147|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
105621533|NCT05671653|364280148|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
105621534|NCT05671653|364280149|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
105621535|NCT05671653|364280150|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
105621536|NCT05671653|364280151|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
105621537|NCT05671653|364280152|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
105621538|NCT05671653|364280153|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
105621539|NCT05671653|364280154|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
105621540|NCT05671653|364280155|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
105621541|NCT05671653|364280156|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
105621542|NCT05671653|364280157|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
105621543|NCT05671653|364280158|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
105621544|NCT05671653|364280159|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
105621545|NCT05671653|364280147|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
105621546|NCT05671653|364280148|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
105621547|NCT05671653|364280149|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
105621548|NCT05671653|364280150|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
105621549|NCT05671653|364280151|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
105621550|NCT05671653|364280152|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
105621551|NCT05671653|364280153|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
105621552|NCT05671653|364280154|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
105621553|NCT05671653|364280155|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
105621554|NCT05671653|364280156|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
105621555|NCT05671653|364280157|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
105621556|NCT05671653|364280158|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
105621557|NCT05671653|364280159|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
105621558|NCT05671653|364280147|FG000|Cohort 2 Period 2|Adverse Event|0|||
105621559|NCT05671653|364280148|FG001|Cohort 2 Period 2|Adverse Event|0|||
105621560|NCT05671653|364280149|FG002|Cohort 2 Period 2|Adverse Event|0|||
105621561|NCT05671653|364280150|FG003|Cohort 2 Period 2|Adverse Event|0|||
105621562|NCT05671653|364280151|FG004|Cohort 2 Period 2|Adverse Event|0|||
105621563|NCT05671653|364280152|FG005|Cohort 2 Period 2|Adverse Event|0|||
105621564|NCT05671653|364280153|FG006|Cohort 2 Period 2|Adverse Event|0|||
105621565|NCT05671653|364280154|FG007|Cohort 2 Period 2|Adverse Event|0|||
105621566|NCT05671653|364280155|FG008|Cohort 2 Period 2|Adverse Event|0|||
105621567|NCT05671653|364280156|FG009|Cohort 2 Period 2|Adverse Event|0|||
105621568|NCT05671653|364280157|FG010|Cohort 2 Period 2|Adverse Event|1|||
105621569|NCT05671653|364280158|FG011|Cohort 2 Period 2|Adverse Event|0|||
105621570|NCT05671653|364280159|FG012|Cohort 2 Period 2|Adverse Event|0|||
105621571|NCT05671653|364280147|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
105621572|NCT05671653|364280148|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
105621573|NCT05671653|364280149|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
105621574|NCT05671653|364280150|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
105621575|NCT05671653|364280151|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
105621576|NCT05671653|364280152|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
105621577|NCT05671653|364280153|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
105621578|NCT05671653|364280154|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
105621579|NCT05671653|364280155|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
105621580|NCT05671653|364280156|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
105621581|NCT05671653|364280157|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
105621582|NCT05671653|364280158|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
105621583|NCT05671653|364280159|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
105621584|NCT05671653|364280147|FG000|Cohort 2 Period 2|Pregnancy|0|||
105621585|NCT05671653|364280148|FG001|Cohort 2 Period 2|Pregnancy|0|||
105621586|NCT05671653|364280149|FG002|Cohort 2 Period 2|Pregnancy|0|||
105621587|NCT05671653|364280150|FG003|Cohort 2 Period 2|Pregnancy|0|||
105621588|NCT05671653|364280151|FG004|Cohort 2 Period 2|Pregnancy|0|||
105621589|NCT05671653|364280152|FG005|Cohort 2 Period 2|Pregnancy|0|||
105621590|NCT05671653|364280153|FG006|Cohort 2 Period 2|Pregnancy|0|||
105621591|NCT05671653|364280154|FG007|Cohort 2 Period 2|Pregnancy|0|||
105621592|NCT05671653|364280155|FG008|Cohort 2 Period 2|Pregnancy|0|||
105621593|NCT05671653|364280156|FG009|Cohort 2 Period 2|Pregnancy|0|||
105621594|NCT05671653|364280157|FG010|Cohort 2 Period 2|Pregnancy|1|||
105621595|NCT05671653|364280158|FG011|Cohort 2 Period 2|Pregnancy|0|||
105621596|NCT05671653|364280159|FG012|Cohort 2 Period 2|Pregnancy|0|||
105621597|NCT05671653|364280147|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
105621598|NCT05671653|364280148|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
105621599|NCT05671653|364280149|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
105621600|NCT05671653|364280150|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
105621601|NCT05671653|364280151|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
105621602|NCT05671653|364280152|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
105621603|NCT05671653|364280153|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
105621604|NCT05671653|364280154|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
105621605|NCT05671653|364280155|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
105621606|NCT05671653|364280156|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
105621607|NCT05671653|364280157|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
105621608|NCT05671653|364280158|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
105621609|NCT05671653|364280159|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
105621610|NCT05671653|364280147|FG000|Cohort 2 Period 2|Other|0|||
105621611|NCT05671653|364280148|FG001|Cohort 2 Period 2|Other|0|||
105621612|NCT05671653|364280149|FG002|Cohort 2 Period 2|Other|0|||
105621613|NCT05671653|364280150|FG003|Cohort 2 Period 2|Other|0|||
105621614|NCT05671653|364280151|FG004|Cohort 2 Period 2|Other|0|||
105621615|NCT05671653|364280152|FG005|Cohort 2 Period 2|Other|0|||
105621616|NCT05671653|364280153|FG006|Cohort 2 Period 2|Other|0|||
105621617|NCT05671653|364280154|FG007|Cohort 2 Period 2|Other|0|||
105621618|NCT05671653|364280155|FG008|Cohort 2 Period 2|Other|0|||
105621619|NCT05671653|364280156|FG009|Cohort 2 Period 2|Other|0|||
105621620|NCT05671653|364280157|FG010|Cohort 2 Period 2|Other|1|||
105621621|NCT05671653|364280158|FG011|Cohort 2 Period 2|Other|0|||
105621622|NCT05671653|364280159|FG012|Cohort 2 Period 2|Other|0|||
105621623|NCT05671653|364280147|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
105621624|NCT05671653|364280148|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
105621625|NCT05671653|364280149|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
105621626|NCT05671653|364280150|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
105621627|NCT05671653|364280151|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
105621628|NCT05671653|364280152|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
105621629|NCT05671653|364280153|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
105621630|NCT05671653|364280154|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
105621631|NCT05671653|364280155|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
105621632|NCT05671653|364280156|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
105621633|NCT05671653|364280157|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
105621634|NCT05671653|364280158|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
105621635|NCT05671653|364280159|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
105621636|NCT03604692|364280165|FG000|Overall Study|Investigator's Decision|0|||
105621637|NCT03604692|364280166|FG001|Overall Study|Investigator's Decision|0|||
105621638|NCT03604692|364280167|FG002|Overall Study|Investigator's Decision|0|||
105621639|NCT03604692|364280168|FG003|Overall Study|Investigator's Decision|1|||
105621640|NCT03604692|364280169|FG004|Overall Study|Investigator's Decision|0|||
105621641|NCT03604692|364280170|FG005|Overall Study|Investigator's Decision|7|||
105621642|NCT03604692|364280165|FG000|Overall Study|Withdrawal by Subject|0|||
105621643|NCT03604692|364280166|FG001|Overall Study|Withdrawal by Subject|0|||
105621644|NCT03604692|364280167|FG002|Overall Study|Withdrawal by Subject|0|||
105621645|NCT03604692|364280168|FG003|Overall Study|Withdrawal by Subject|0|||
105621646|NCT03604692|364280169|FG004|Overall Study|Withdrawal by Subject|0|||
105621647|NCT03604692|364280170|FG005|Overall Study|Withdrawal by Subject|2|||
105621648|NCT03604692|364280165|FG000|Overall Study|Progressive Disease|1|||
105621649|NCT03604692|364280166|FG001|Overall Study|Progressive Disease|0|||
105621650|NCT03604692|364280167|FG002|Overall Study|Progressive Disease|1|||
105621651|NCT03604692|364280168|FG003|Overall Study|Progressive Disease|0|||
105621652|NCT03604692|364280169|FG004|Overall Study|Progressive Disease|3|||
105621653|NCT03604692|364280170|FG005|Overall Study|Progressive Disease|4|||
105621654|NCT03604692|364280165|FG000|Overall Study|Difficulty Coming into Site.|0|||
105621655|NCT03604692|364280166|FG001|Overall Study|Difficulty Coming into Site.|0|||
105621656|NCT03604692|364280167|FG002|Overall Study|Difficulty Coming into Site.|0|||
105621657|NCT03604692|364280168|FG003|Overall Study|Difficulty Coming into Site.|0|||
105621658|NCT03604692|364280169|FG004|Overall Study|Difficulty Coming into Site.|0|||
105621659|NCT03604692|364280170|FG005|Overall Study|Difficulty Coming into Site.|1|||
105621660|NCT03604692|364280165|FG000|Overall Study|Death|0|||
105621661|NCT03604692|364280166|FG001|Overall Study|Death|0|||
105621662|NCT03604692|364280167|FG002|Overall Study|Death|1|||
105621663|NCT03604692|364280168|FG003|Overall Study|Death|0|||
105621664|NCT03604692|364280169|FG004|Overall Study|Death|0|||
105621665|NCT03604692|364280170|FG005|Overall Study|Death|0|||
105621666|NCT03604692|364280165|FG000|Overall Study|Drug Intolerance|0|||
105621667|NCT03604692|364280166|FG001|Overall Study|Drug Intolerance|0|||
105621668|NCT03604692|364280167|FG002|Overall Study|Drug Intolerance|0|||
105621669|NCT03604692|364280168|FG003|Overall Study|Drug Intolerance|1|||
105621670|NCT03604692|364280169|FG004|Overall Study|Drug Intolerance|0|||
105621671|NCT03604692|364280170|FG005|Overall Study|Drug Intolerance|0|||
105621672|NCT03604692|364280165|FG000|Overall Study|Noncompliance with follow-up visit|0|||
105621673|NCT03604692|364280166|FG001|Overall Study|Noncompliance with follow-up visit|0|||
105621674|NCT03604692|364280167|FG002|Overall Study|Noncompliance with follow-up visit|0|||
105621675|NCT03604692|364280168|FG003|Overall Study|Noncompliance with follow-up visit|1|||
105621676|NCT03604692|364280169|FG004|Overall Study|Noncompliance with follow-up visit|0|||
105621677|NCT03604692|364280170|FG005|Overall Study|Noncompliance with follow-up visit|0|||
105621678|NCT03604692|364280165|FG000|Overall Study|Continuing Treatment/In Follow-Up|0|||
105621679|NCT03604692|364280166|FG001|Overall Study|Continuing Treatment/In Follow-Up|0|||
105621680|NCT03604692|364280167|FG002|Overall Study|Continuing Treatment/In Follow-Up|1|||
105621681|NCT03604692|364280168|FG003|Overall Study|Continuing Treatment/In Follow-Up|1|||
105621682|NCT03604692|364280169|FG004|Overall Study|Continuing Treatment/In Follow-Up|0|||
105621683|NCT03604692|364280170|FG005|Overall Study|Continuing Treatment/In Follow-Up|0|||
105621684|NCT03604692|364280165|FG000|Overall Study|Not Treated|0|||
105621685|NCT03604692|364280166|FG001|Overall Study|Not Treated|0|||
105621686|NCT03604692|364280167|FG002|Overall Study|Not Treated|0|||
105621687|NCT03604692|364280168|FG003|Overall Study|Not Treated|0|||
105621688|NCT03604692|364280169|FG004|Overall Study|Not Treated|1|||
105621689|NCT03604692|364280170|FG005|Overall Study|Not Treated|0|||
105621690|NCT03899259|364280171|FG000|Overall Study|Adverse Event|5|||
105621691|NCT03899259|364280172|FG001|Overall Study|Adverse Event|4|||
105621692|NCT03899259|364280173|FG002|Overall Study|Adverse Event|6|||
105621693|NCT03899259|364280171|FG000|Overall Study|Lack of Efficacy|5|||
105621694|NCT03899259|364280172|FG001|Overall Study|Lack of Efficacy|0|||
105621695|NCT03899259|364280173|FG002|Overall Study|Lack of Efficacy|2|||
105621696|NCT03899259|364280171|FG000|Overall Study|Pregnancy|3|||
105621697|NCT03899259|364280172|FG001|Overall Study|Pregnancy|0|||
105621698|NCT03899259|364280173|FG002|Overall Study|Pregnancy|1|||
105621699|NCT03899259|364280171|FG000|Overall Study|Physician Decision|0|||
105621700|NCT03899259|364280172|FG001|Overall Study|Physician Decision|1|||
105621701|NCT03899259|364280173|FG002|Overall Study|Physician Decision|0|||
105621702|NCT03899259|364280171|FG000|Overall Study|Protocol Deviation|1|||
105621703|NCT03899259|364280172|FG001|Overall Study|Protocol Deviation|1|||
105621704|NCT03899259|364280173|FG002|Overall Study|Protocol Deviation|1|||
105621705|NCT03899259|364280171|FG000|Overall Study|Withdrawal by Subject|8|||
105621706|NCT03899259|364280172|FG001|Overall Study|Withdrawal by Subject|10|||
105621707|NCT03899259|364280173|FG002|Overall Study|Withdrawal by Subject|12|||
105621708|NCT03899259|364280171|FG000|Overall Study|Lost to Follow-up|5|||
105621709|NCT03899259|364280172|FG001|Overall Study|Lost to Follow-up|6|||
105621710|NCT03899259|364280173|FG002|Overall Study|Lost to Follow-up|2|||
105621711|NCT03899259|364280171|FG000|Overall Study|Lack of Adherence|1|||
105621712|NCT03899259|364280172|FG001|Overall Study|Lack of Adherence|0|||
105621713|NCT03899259|364280173|FG002|Overall Study|Lack of Adherence|0|||
105621714|NCT03899259|364280171|FG000|Overall Study|Screen Failure|1|||
105621715|NCT03899259|364280172|FG001|Overall Study|Screen Failure|0|||
105621716|NCT03899259|364280173|FG002|Overall Study|Screen Failure|0|||
105621717|NCT03899259|364280171|FG000|Overall Study|Ongoing Study Participation|127|||
105621718|NCT03899259|364280172|FG001|Overall Study|Ongoing Study Participation|134|||
105621719|NCT03899259|364280173|FG002|Overall Study|Ongoing Study Participation|210|||
105621720|NCT01959607|364280176|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
105621721|NCT01959607|364280177|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
105621722|NCT01959607|364280178|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
105621723|NCT01959607|364280179|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
105621724|NCT03913442|364280180|FG000|Overall Study|Adverse Event|0|||
105621725|NCT03913442|364280181|FG001|Overall Study|Adverse Event|3|||
105621726|NCT03913442|364280180|FG000|Overall Study|Withdrawal by Subject|5|||
105621727|NCT03913442|364280181|FG001|Overall Study|Withdrawal by Subject|5|||
105621728|NCT03913442|364280180|FG000|Overall Study|Terminations|2|||
105621729|NCT03913442|364280181|FG001|Overall Study|Terminations|1|||
105621730|NCT03913442|364280180|FG000|Overall Study|Lost to Follow-up|2|||
105621731|NCT03913442|364280181|FG001|Overall Study|Lost to Follow-up|2|||
105621732|NCT04054193|364280190|FG000|Cycle 1|Physician Decision|1|||
105621733|NCT04054193|364280190|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
105621734|NCT04054193|364280190|FG000|Cycle 1|Allocated but not treated|3|||
105621735|NCT04054193|364280190|FG000|Cycles 2-3|Physician Decision|2|||
105621736|NCT04054193|364280190|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
105621737|NCT04054193|364280190|FG000|Cycles 2-3|Various reasons|17|||
105621738|NCT05073458|364280191|FG000|24-week Double-blind Period|Adverse Event|1|||
105621739|NCT05073458|364280192|FG001|24-week Double-blind Period|Adverse Event|0|||
105621740|NCT05073458|364280191|FG000|24-week Double-blind Period|Physician Decision|1|||
105621741|NCT05073458|364280192|FG001|24-week Double-blind Period|Physician Decision|0|||
105621742|NCT05073458|364280191|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
105621743|NCT05073458|364280192|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
105621744|NCT05073458|364280191|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
105621745|NCT05073458|364280192|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
105621746|NCT05073458|364280191|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
105621747|NCT05073458|364280192|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
105621748|NCT05073458|364280191|FG000|24-week Open-label Period|Adverse Event|1|||
105621749|NCT05073458|364280192|FG001|24-week Open-label Period|Adverse Event|2|||
105621750|NCT03235544|364280193|FG000|Overall Study|Death|11|||
105621751|NCT03235544|364280194|FG001|Overall Study|Death|31|||
105621752|NCT03235544|364280195|FG002|Overall Study|Death|19|||
105621753|NCT03235544|364280196|FG003|Overall Study|Death|34|||
105621754|NCT03235544|364280193|FG000|Overall Study|Lost to Follow-up|0|||
105621755|NCT03235544|364280194|FG001|Overall Study|Lost to Follow-up|1|||
105621756|NCT03235544|364280195|FG002|Overall Study|Lost to Follow-up|1|||
105621757|NCT03235544|364280196|FG003|Overall Study|Lost to Follow-up|1|||
105621758|NCT03235544|364280193|FG000|Overall Study|Withdrawal by Subject|0|||
105621759|NCT03235544|364280194|FG001|Overall Study|Withdrawal by Subject|3|||
105621760|NCT03235544|364280195|FG002|Overall Study|Withdrawal by Subject|1|||
105621761|NCT03235544|364280196|FG003|Overall Study|Withdrawal by Subject|5|||
105621762|NCT03235544|364280193|FG000|Overall Study|Disease Progression|0|||
105621763|NCT03235544|364280194|FG001|Overall Study|Disease Progression|1|||
105621764|NCT03235544|364280195|FG002|Overall Study|Disease Progression|0|||
105621765|NCT03235544|364280196|FG003|Overall Study|Disease Progression|2|||
105621766|NCT03235544|364280193|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
105621767|NCT03235544|364280194|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
105621768|NCT03235544|364280195|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
105621769|NCT03235544|364280196|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
105621770|NCT03235544|364280193|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
105621771|NCT03235544|364280194|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
105621772|NCT03235544|364280195|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
105621773|NCT03235544|364280196|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
105621774|NCT00950742|364280197|FG000|Overall Study|Other Adverse Event|1|||
105621775|NCT00950742|364280198|FG001|Overall Study|Other Adverse Event|0|||
105621776|NCT00950742|364280197|FG000|Overall Study|Withdrawal by Subject|3|||
105621777|NCT00950742|364280198|FG001|Overall Study|Withdrawal by Subject|0|||
105621778|NCT00950742|364280197|FG000|Overall Study|Progressive Disease|6|||
105621779|NCT00950742|364280198|FG001|Overall Study|Progressive Disease|2|||
105621780|NCT00950742|364280197|FG000|Overall Study|Dose limiting toxicity|6|||
105621781|NCT00950742|364280198|FG001|Overall Study|Dose limiting toxicity|0|||
105621782|NCT05299073|364280199|FG000|Overall Study|Withdrawal by Subject|0|||
105621783|NCT05299073|364280200|FG001|Overall Study|Withdrawal by Subject|0|||
105621784|NCT05299073|364280201|FG002|Overall Study|Withdrawal by Subject|1|||
105621785|NCT05299073|364280199|FG000|Overall Study|Adverse Event|0|||
105621786|NCT05299073|364280200|FG001|Overall Study|Adverse Event|1|||
105621787|NCT05299073|364280201|FG002|Overall Study|Adverse Event|0|||
105621788|NCT05299073|364280199|FG000|Overall Study|Lost to Follow-up|0|||
105621789|NCT05299073|364280200|FG001|Overall Study|Lost to Follow-up|1|||
105621790|NCT05299073|364280201|FG002|Overall Study|Lost to Follow-up|0|||
105621791|NCT05446168|364280204|FG000|Overall Study|Physician Decision|0|||
105621792|NCT05446168|364280205|FG001|Overall Study|Physician Decision|1|||
105621793|NCT05452460|364280207|FG000|Overall Study|Lost to Follow-up|3|||
105621794|NCT05452460|364280208|FG001|Overall Study|Lost to Follow-up|3|||
105621795|NCT05452460|364280207|FG000|Overall Study|Did not receive intervention|1|||
105621796|NCT05452460|364280208|FG001|Overall Study|Did not receive intervention|0|||
105621797|NCT03511664|364280214|FG000|Overall Study|Death|457|||
105621798|NCT03511664|364280215|FG001|Overall Study|Death|201|||
105621799|NCT03511664|364280216|FG002|Overall Study|Death|21|||
105621800|NCT03511664|364280214|FG000|Overall Study|Withdrew consent|40|||
105621801|NCT03511664|364280215|FG001|Overall Study|Withdrew consent|63|||
105621802|NCT03511664|364280216|FG002|Overall Study|Withdrew consent|3|||
105621803|NCT03511664|364280214|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
105621804|NCT03511664|364280215|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
105621805|NCT03511664|364280216|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
105621806|NCT03511664|364280214|FG000|Overall Study|Lost to Follow-up|8|||
105621807|NCT03511664|364280215|FG001|Overall Study|Lost to Follow-up|5|||
105621808|NCT03511664|364280216|FG002|Overall Study|Lost to Follow-up|0|||
105621809|NCT03511664|364280214|FG000|Overall Study|Physician Decision|2|||
105621810|NCT03511664|364280215|FG001|Overall Study|Physician Decision|1|||
105621811|NCT03511664|364280216|FG002|Overall Study|Physician Decision|0|||
105621812|NCT03511664|364280214|FG000|Overall Study|Patient non-compliance|1|||
105621813|NCT03511664|364280215|FG001|Overall Study|Patient non-compliance|0|||
105621814|NCT03511664|364280216|FG002|Overall Study|Patient non-compliance|0|||
105621815|NCT01828099|364280218|FG000|Treatment Period|Adverse Event|24|||
105621816|NCT01828099|364280219|FG001|Treatment Period|Adverse Event|23|||
105621817|NCT01828099|364280218|FG000|Treatment Period|Death|10|||
105621818|NCT01828099|364280219|FG001|Treatment Period|Death|12|||
105621819|NCT01828099|364280218|FG000|Treatment Period|Lost to Follow-up|2|||
105621820|NCT01828099|364280219|FG001|Treatment Period|Lost to Follow-up|1|||
105621821|NCT01828099|364280218|FG000|Treatment Period|Non-compliance with study treatment|1|||
105621822|NCT01828099|364280219|FG001|Treatment Period|Non-compliance with study treatment|0|||
105621823|NCT01828099|364280218|FG000|Treatment Period|Physician Decision|17|||
105621824|NCT01828099|364280219|FG001|Treatment Period|Physician Decision|16|||
105621825|NCT01828099|364280218|FG000|Treatment Period|Progressive disease|99|||
105621826|NCT01828099|364280219|FG001|Treatment Period|Progressive disease|107|||
105621827|NCT01828099|364280218|FG000|Treatment Period|Subject/guardian decision|22|||
105621828|NCT01828099|364280219|FG001|Treatment Period|Subject/guardian decision|26|||
105621829|NCT01828099|364280218|FG000|Treatment Period|Study terminated by Sponsor|13|||
105621830|NCT01828099|364280219|FG001|Treatment Period|Study terminated by Sponsor|1|||
105621831|NCT01828099|364280218|FG000|Treatment Period|Protocol deviation|1|||
105621832|NCT01828099|364280219|FG001|Treatment Period|Protocol deviation|0|||
105621833|NCT01828099|364280218|FG000|Treatment Period|No longer requires treatment|0|||
105621834|NCT01828099|364280219|FG001|Treatment Period|No longer requires treatment|1|||
105621835|NCT01828099|364280218|FG000|Extension-treatment Phase|Adverse Event|0|||
105621836|NCT01828099|364280219|FG001|Extension-treatment Phase|Adverse Event|17|||
105621837|NCT01828099|364280218|FG000|Extension-treatment Phase|Death|0|||
105621838|NCT01828099|364280219|FG001|Extension-treatment Phase|Death|11|||
105621839|NCT01828099|364280218|FG000|Extension-treatment Phase|Physician Decision|0|||
105621840|NCT01828099|364280219|FG001|Extension-treatment Phase|Physician Decision|5|||
105621841|NCT01828099|364280218|FG000|Extension-treatment Phase|Progressive disease|0|||
105621842|NCT01828099|364280219|FG001|Extension-treatment Phase|Progressive disease|54|||
105621843|NCT01828099|364280218|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
105621844|NCT01828099|364280219|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
105621845|NCT01828099|364280218|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
105621846|NCT01828099|364280219|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
105621847|NCT05246670|364280220|FG000|Overall Study|Withdrawal by Subject|2|||
105621848|NCT05246670|364280221|FG001|Overall Study|Withdrawal by Subject|3|||
105621849|NCT05246670|364280222|FG002|Overall Study|Withdrawal by Subject|0|||
105621850|NCT05246670|364280223|FG003|Overall Study|Withdrawal by Subject|1|||
105621851|NCT05246670|364280220|FG000|Overall Study|Adverse Event|0|||
105621852|NCT05246670|364280221|FG001|Overall Study|Adverse Event|0|||
105621853|NCT05246670|364280222|FG002|Overall Study|Adverse Event|1|||
105621854|NCT05246670|364280223|FG003|Overall Study|Adverse Event|0|||
105621855|NCT05246670|364280220|FG000|Overall Study|Physician Decision|1|||
105621856|NCT05246670|364280221|FG001|Overall Study|Physician Decision|0|||
105621857|NCT05246670|364280222|FG002|Overall Study|Physician Decision|0|||
105621858|NCT05246670|364280223|FG003|Overall Study|Physician Decision|0|||
105621859|NCT05246670|364280220|FG000|Overall Study|Protocol Violation|1|||
105621860|NCT05246670|364280221|FG001|Overall Study|Protocol Violation|0|||
105621861|NCT05246670|364280222|FG002|Overall Study|Protocol Violation|0|||
105621862|NCT05246670|364280223|FG003|Overall Study|Protocol Violation|0|||
105621863|NCT05485779|364280224|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
105621864|NCT05485779|364280225|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
105621865|NCT05485779|364280226|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
105621866|NCT05485779|364280227|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
105621867|NCT05485779|364280228|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
105621868|NCT05485779|364280229|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
105621869|NCT05485779|364280230|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
105621870|NCT05485779|364280231|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
105621871|NCT05485779|364280232|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
105621872|NCT05485779|364280233|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
105621873|NCT05485779|364280234|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
105621874|NCT05485779|364280224|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
105621875|NCT05485779|364280225|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
105621876|NCT05485779|364280226|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
105621877|NCT05485779|364280227|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
105621878|NCT05485779|364280228|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
105621879|NCT05485779|364280229|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
105621880|NCT05485779|364280230|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
105621881|NCT05485779|364280231|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
105621882|NCT05485779|364280232|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
105621883|NCT05485779|364280233|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
105621884|NCT05485779|364280234|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
105621885|NCT05485779|364280224|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
105621886|NCT05485779|364280225|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
105621887|NCT05485779|364280226|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
105621888|NCT05485779|364280227|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
105621889|NCT05485779|364280228|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
105621890|NCT05485779|364280229|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
105621891|NCT05485779|364280230|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
105621892|NCT05485779|364280231|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
105621893|NCT05485779|364280232|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
105621894|NCT05485779|364280233|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
105621895|NCT05485779|364280234|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
105621896|NCT03463044|364280235|FG000|Overall Study|Lost to Follow-up|0|||
105621897|NCT03463044|364280236|FG001|Overall Study|Lost to Follow-up|0|||
105621898|NCT03463044|364280237|FG002|Overall Study|Lost to Follow-up|0|||
105621899|NCT03463044|364280238|FG003|Overall Study|Lost to Follow-up|0|||
105621900|NCT03463044|364280239|FG004|Overall Study|Lost to Follow-up|0|||
105621901|NCT03463044|364280240|FG005|Overall Study|Lost to Follow-up|0|||
105621902|NCT03463044|364280241|FG006|Overall Study|Lost to Follow-up|0|||
105621903|NCT03463044|364280242|FG007|Overall Study|Lost to Follow-up|1|||
105621904|NCT03463044|364280243|FG008|Overall Study|Lost to Follow-up|0|||
105621905|NCT05764525|364280244|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
105621906|NCT05764525|364280245|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
105621907|NCT05764525|364280244|FG000|Overall Study|Withdrawal by Subject|4|||
105621908|NCT05764525|364280245|FG001|Overall Study|Withdrawal by Subject|8|||
105621909|NCT05764525|364280244|FG000|Overall Study|Physician Decision|1|||
105621910|NCT05764525|364280245|FG001|Overall Study|Physician Decision|0|||
105621911|NCT05576155|364280246|FG000|Overall Study|Withdrawal by Subject|1|||
105621912|NCT05576155|364280247|FG001|Overall Study|Withdrawal by Subject|1|||
105621913|NCT05907174|364280248|FG000|3-Month Assessment|Withdrawal by Subject|0|||
105621914|NCT05907174|364280249|FG001|3-Month Assessment|Withdrawal by Subject|0|||
105621915|NCT05907174|364280250|FG002|3-Month Assessment|Withdrawal by Subject|0|||
105621916|NCT05907174|364280251|FG003|3-Month Assessment|Withdrawal by Subject|1|||
105621917|NCT05907174|364280248|FG000|3-Month Assessment|Lost to Follow-up|1|||
105621918|NCT05907174|364280249|FG001|3-Month Assessment|Lost to Follow-up|1|||
105621919|NCT05907174|364280250|FG002|3-Month Assessment|Lost to Follow-up|1|||
105621920|NCT05907174|364280251|FG003|3-Month Assessment|Lost to Follow-up|1|||
105621921|NCT05907174|364280248|FG000|6-Month Assessment|Death|0|||
105621922|NCT05907174|364280249|FG001|6-Month Assessment|Death|0|||
105621923|NCT05907174|364280250|FG002|6-Month Assessment|Death|3|||
105621924|NCT05907174|364280251|FG003|6-Month Assessment|Death|0|||
105621925|NCT05907174|364280248|FG000|6-Month Assessment|Withdrawal by Subject|0|||
105621926|NCT05907174|364280249|FG001|6-Month Assessment|Withdrawal by Subject|0|||
105621927|NCT05907174|364280250|FG002|6-Month Assessment|Withdrawal by Subject|1|||
105621928|NCT05907174|364280251|FG003|6-Month Assessment|Withdrawal by Subject|1|||
105621929|NCT05907174|364280248|FG000|6-Month Assessment|Lost to Follow-up|0|||
105621930|NCT05907174|364280249|FG001|6-Month Assessment|Lost to Follow-up|1|||
105621931|NCT05907174|364280250|FG002|6-Month Assessment|Lost to Follow-up|1|||
105621932|NCT05907174|364280251|FG003|6-Month Assessment|Lost to Follow-up|1|||
105621933|NCT02694822|364280256|FG000|Phase 1|Death|2|||
105621934|NCT02694822|364280257|FG001|Phase 1|Death|1|||
105621935|NCT02694822|364280258|FG002|Phase 1|Death|6|||
105621936|NCT02694822|364280259|FG003|Phase 1|Death|6|||
105621937|NCT02694822|364280260|FG004|Phase 1|Death|3|||
105621938|NCT02694822|364280261|FG005|Phase 1|Death|0|||
105621939|NCT02694822|364280256|FG000|Phase 1|Withdrawal by Subject|2|||
105621940|NCT02694822|364280257|FG001|Phase 1|Withdrawal by Subject|2|||
105621941|NCT02694822|364280258|FG002|Phase 1|Withdrawal by Subject|4|||
105621942|NCT02694822|364280259|FG003|Phase 1|Withdrawal by Subject|8|||
105621943|NCT02694822|364280260|FG004|Phase 1|Withdrawal by Subject|1|||
105621944|NCT02694822|364280261|FG005|Phase 1|Withdrawal by Subject|0|||
105621945|NCT02694822|364280256|FG000|Phase 2|Death|0|||
105621946|NCT02694822|364280257|FG001|Phase 2|Death|0|||
105621947|NCT02694822|364280258|FG002|Phase 2|Death|0|||
105621948|NCT02694822|364280259|FG003|Phase 2|Death|0|||
105621949|NCT02694822|364280260|FG004|Phase 2|Death|0|||
105621950|NCT02694822|364280261|FG005|Phase 2|Death|26|||
105621951|NCT02694822|364280256|FG000|Phase 2|Withdrawal by Subject|0|||
105621952|NCT02694822|364280257|FG001|Phase 2|Withdrawal by Subject|0|||
105621953|NCT02694822|364280258|FG002|Phase 2|Withdrawal by Subject|0|||
105621954|NCT02694822|364280259|FG003|Phase 2|Withdrawal by Subject|0|||
105621955|NCT02694822|364280260|FG004|Phase 2|Withdrawal by Subject|0|||
105621956|NCT02694822|364280261|FG005|Phase 2|Withdrawal by Subject|13|||
105621957|NCT02694822|364280256|FG000|Phase 2|Administrative Study Closure|0|||
105621958|NCT02694822|364280257|FG001|Phase 2|Administrative Study Closure|0|||
105621959|NCT02694822|364280258|FG002|Phase 2|Administrative Study Closure|0|||
105621960|NCT02694822|364280259|FG003|Phase 2|Administrative Study Closure|0|||
105621961|NCT02694822|364280260|FG004|Phase 2|Administrative Study Closure|0|||
105621962|NCT02694822|364280261|FG005|Phase 2|Administrative Study Closure|2|||
105621963|NCT02694822|364280256|FG000|Phase 2|Lost to Follow-up|0|||
105621964|NCT02694822|364280257|FG001|Phase 2|Lost to Follow-up|0|||
105621965|NCT02694822|364280258|FG002|Phase 2|Lost to Follow-up|0|||
105621966|NCT02694822|364280259|FG003|Phase 2|Lost to Follow-up|0|||
105621967|NCT02694822|364280260|FG004|Phase 2|Lost to Follow-up|0|||
105621968|NCT02694822|364280261|FG005|Phase 2|Lost to Follow-up|1|||
105621969|NCT02694822|364280256|FG000|Phase 2|Participant Transferred to Another Site|0|||
105621970|NCT02694822|364280257|FG001|Phase 2|Participant Transferred to Another Site|0|||
105621971|NCT02694822|364280258|FG002|Phase 2|Participant Transferred to Another Site|0|||
105621972|NCT02694822|364280259|FG003|Phase 2|Participant Transferred to Another Site|0|||
105621973|NCT02694822|364280260|FG004|Phase 2|Participant Transferred to Another Site|0|||
105621974|NCT02694822|364280261|FG005|Phase 2|Participant Transferred to Another Site|1|||
105621975|NCT02424617|364280264|FG000|Overall Study|Adverse Event|0|||
105621976|NCT02424617|364280265|FG001|Overall Study|Adverse Event|1|||
105621977|NCT02424617|364280266|FG002|Overall Study|Adverse Event|0|||
105621978|NCT02424617|364280267|FG003|Overall Study|Adverse Event|0|||
105621979|NCT02424617|364280264|FG000|Overall Study|Investigator Decision|0|||
105621980|NCT02424617|364280265|FG001|Overall Study|Investigator Decision|0|||
105621981|NCT02424617|364280266|FG002|Overall Study|Investigator Decision|0|||
105621982|NCT02424617|364280267|FG003|Overall Study|Investigator Decision|1|||
105621983|NCT02424617|364280264|FG000|Overall Study|Withdrawal by Subject|1|||
105621984|NCT02424617|364280265|FG001|Overall Study|Withdrawal by Subject|1|||
105621985|NCT02424617|364280266|FG002|Overall Study|Withdrawal by Subject|0|||
105621986|NCT02424617|364280267|FG003|Overall Study|Withdrawal by Subject|1|||
105621987|NCT02424617|364280264|FG000|Overall Study|Progressive Disease|7|||
105621988|NCT02424617|364280265|FG001|Overall Study|Progressive Disease|6|||
105621989|NCT02424617|364280266|FG002|Overall Study|Progressive Disease|11|||
105621990|NCT02424617|364280267|FG003|Overall Study|Progressive Disease|10|||
105621991|NCT02424617|364280264|FG000|Overall Study|Other|0|||
105621992|NCT02424617|364280265|FG001|Overall Study|Other|0|||
105621993|NCT02424617|364280266|FG002|Overall Study|Other|0|||
105621994|NCT02424617|364280267|FG003|Overall Study|Other|1|||
105621995|NCT01712490|364280278|FG000|Overall Study|Ongoing|601|||
105621996|NCT01712490|364280279|FG001|Overall Study|Ongoing|586|||
105621997|NCT01712490|364280278|FG000|Overall Study|Other|11|||
105621998|NCT01712490|364280279|FG001|Overall Study|Other|11|||
105621999|NCT01712490|364280278|FG000|Overall Study|Withdrawal by Subject|36|||
105622000|NCT01712490|364280279|FG001|Overall Study|Withdrawal by Subject|44|||
105622001|NCT01712490|364280278|FG000|Overall Study|Lost to Follow-up|16|||
105622002|NCT01712490|364280279|FG001|Overall Study|Lost to Follow-up|29|||
105622003|NCT04875195|364280282|FG000|Overall Study|Death|9|||
105622004|NCT04875195|364280283|FG001|Overall Study|Death|3|||
105622005|NCT04875195|364280282|FG000|Overall Study|Withdrawal by Subject|2|||
105622006|NCT04875195|364280283|FG001|Overall Study|Withdrawal by Subject|1|||
105622007|NCT04875195|364280282|FG000|Overall Study|Ongoing in study|49|||
105622008|NCT04875195|364280283|FG001|Overall Study|Ongoing in study|2|||
105622009|NCT02315703|364280284|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
105622010|NCT02315703|364280285|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
105622011|NCT02315703|364280286|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
105622012|NCT02315703|364280287|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
105622013|NCT02315703|364280288|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
105622014|NCT02315703|364280289|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
105622015|NCT02315703|364280290|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
105622016|NCT02315703|364280291|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
105622017|NCT02315703|364280284|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
105622018|NCT02315703|364280285|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
105622019|NCT02315703|364280286|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
105622020|NCT02315703|364280287|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
105622021|NCT02315703|364280288|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
105622022|NCT02315703|364280289|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
105622023|NCT02315703|364280290|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
105622024|NCT02315703|364280291|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
105622025|NCT02315703|364280284|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
105622026|NCT02315703|364280285|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
105622027|NCT02315703|364280286|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
105622028|NCT02315703|364280287|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
105622029|NCT02315703|364280288|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
105622030|NCT02315703|364280289|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
105622031|NCT02315703|364280290|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
105622032|NCT02315703|364280291|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
105622033|NCT02315703|364280284|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
105622034|NCT02315703|364280285|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
105622035|NCT02315703|364280286|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
105622036|NCT02315703|364280287|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
105622037|NCT02315703|364280288|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
105622038|NCT02315703|364280289|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
105622039|NCT02315703|364280290|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
105622040|NCT02315703|364280291|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
105622041|NCT02315703|364280284|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
105622042|NCT02315703|364280285|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
105622043|NCT02315703|364280286|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
105622044|NCT02315703|364280287|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
105622045|NCT02315703|364280288|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
105622046|NCT02315703|364280289|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
105622047|NCT02315703|364280290|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
105622048|NCT02315703|364280291|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
105622049|NCT02315703|364280284|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
105622050|NCT02315703|364280285|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
105622051|NCT02315703|364280286|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
105622052|NCT02315703|364280287|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
105622053|NCT02315703|364280288|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
105622054|NCT02315703|364280289|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
105622055|NCT02315703|364280290|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
105622056|NCT02315703|364280291|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
105622057|NCT02315703|364280284|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
105622058|NCT02315703|364280285|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
105622059|NCT02315703|364280286|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
105622060|NCT02315703|364280287|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
105622061|NCT02315703|364280288|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
105622062|NCT02315703|364280289|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
105622063|NCT02315703|364280290|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
105622064|NCT02315703|364280291|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
105622065|NCT02315703|364280284|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
105622066|NCT02315703|364280285|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
105622067|NCT02315703|364280286|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
105622068|NCT02315703|364280287|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
105622069|NCT02315703|364280288|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
105622070|NCT02315703|364280289|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
105622071|NCT02315703|364280290|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
105622072|NCT02315703|364280291|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
105622073|NCT02315703|364280284|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
105622074|NCT02315703|364280285|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
105622075|NCT02315703|364280286|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
105622076|NCT02315703|364280287|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
105622077|NCT02315703|364280288|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
105622078|NCT02315703|364280289|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
105622079|NCT02315703|364280290|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
105622080|NCT02315703|364280291|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
105622081|NCT03240016|364282003|FG000|Overall Study|Adverse Event|9|||
105622082|NCT03240016|364282003|FG000|Overall Study|Withdrawal by Subject|7|||
105622083|NCT03240016|364282003|FG000|Overall Study|Death|1|||
105622084|NCT03240016|364282003|FG000|Overall Study|Physician Decision|2|||
105622085|NCT05200403|364282004|FG000|Overall Study|Withdrawal by Subject|4|||
105622086|NCT05200403|364282005|FG001|Overall Study|Withdrawal by Subject|2|||
105622087|NCT05200403|364282006|FG002|Overall Study|Withdrawal by Subject|6|||
105622088|NCT05299723|364282007|FG000|Overall Study|Withdrawal by Subject|0|||
105622089|NCT05299723|364282008|FG001|Overall Study|Withdrawal by Subject|2|||
105622090|NCT05299723|364282009|FG002|Overall Study|Withdrawal by Subject|0|||
105622091|NCT03220035|364282011|FG000|Overall Study|Adverse Event|1|||
105622092|NCT03220035|364282011|FG000|Overall Study|Protocol Violation|1|||
105622093|NCT03220035|364282011|FG000|Overall Study|Progressive Disease|2|||
105622094|NCT00696111|364282012|FG000|Overall Study|Withdrawal by Subject|17|||
105622095|NCT02593773|364282013|FG000|Overall Study|Voluntary Withdrawal|3|||
105622096|NCT02593773|364282013|FG000|Overall Study|Study Terminated by Sponsor|31|||
105622097|NCT02593773|364282013|FG000|Overall Study|Death|1|||
105622098|NCT04201262|364282014|FG000|Overall Study|Adverse Event|1|||
105622099|NCT04201262|364282015|FG001|Overall Study|Adverse Event|2|||
105622100|NCT04201262|364282014|FG000|Overall Study|Continuing in the study|57|||
105622101|NCT04201262|364282015|FG001|Overall Study|Continuing in the study|0|||
105622102|NCT04201262|364282014|FG000|Overall Study|Withdrawal by Subject|0|||
105622103|NCT04201262|364282015|FG001|Overall Study|Withdrawal by Subject|1|||
105622104|NCT02151981|364282016|FG000|Overall Study|Death|184|||
105622105|NCT02151981|364282017|FG001|Overall Study|Death|88|||
105622106|NCT02151981|364282016|FG000|Overall Study|Lost to Follow-up|7|||
105622107|NCT02151981|364282017|FG001|Overall Study|Lost to Follow-up|1|||
105622108|NCT02151981|364282016|FG000|Overall Study|Withdrawal by Subject|27|||
105622109|NCT02151981|364282017|FG001|Overall Study|Withdrawal by Subject|21|||
105622110|NCT02151981|364282016|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105622111|NCT02151981|364282017|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
105622112|NCT02151981|364282016|FG000|Overall Study|Other reasons|1|||
105622113|NCT02151981|364282017|FG001|Overall Study|Other reasons|2|||
105622114|NCT05645757|364282023|FG000|Overall Study|Enrolled but treatment not administered|0|||
105622115|NCT05645757|364282024|FG001|Overall Study|Enrolled but treatment not administered|0|||
105622116|NCT05645757|364282025|FG002|Overall Study|Enrolled but treatment not administered|0|||
105622117|NCT05645757|364282026|FG003|Overall Study|Enrolled but treatment not administered|0|||
105622118|NCT05645757|364282027|FG004|Overall Study|Enrolled but treatment not administered|1|||
105622119|NCT05645757|364282028|FG005|Overall Study|Enrolled but treatment not administered|1|||
105622120|NCT05645757|364282029|FG006|Overall Study|Enrolled but treatment not administered|0|||
105622121|NCT05645757|364282030|FG007|Overall Study|Enrolled but treatment not administered|0|||
105622122|NCT04447040|364282033|FG000|Overall Study|Lost to Follow-up|2|||
105622123|NCT04447040|364282034|FG001|Overall Study|Lost to Follow-up|1|||
105622124|NCT04447040|364282035|FG002|Overall Study|Lost to Follow-up|3|||
105622125|NCT04447040|364282036|FG003|Overall Study|Lost to Follow-up|3|||
105622126|NCT04447040|364282037|FG004|Overall Study|Lost to Follow-up|1|||
105622127|NCT04447040|364282038|FG005|Overall Study|Lost to Follow-up|3|||
105622128|NCT04447040|364282033|FG000|Overall Study|Withdrawal by Subject|0|||
105622129|NCT04447040|364282034|FG001|Overall Study|Withdrawal by Subject|1|||
105622130|NCT04447040|364282035|FG002|Overall Study|Withdrawal by Subject|1|||
105622131|NCT04447040|364282036|FG003|Overall Study|Withdrawal by Subject|1|||
105622132|NCT04447040|364282037|FG004|Overall Study|Withdrawal by Subject|0|||
105622133|NCT04447040|364282038|FG005|Overall Study|Withdrawal by Subject|0|||
105622134|NCT03905798|364282039|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
105622135|NCT01928394|364282040|FG000|Treatment Period|Disease progression|17|||
105622136|NCT01928394|364282041|FG001|Treatment Period|Disease progression|2|||
105622137|NCT01928394|364282042|FG002|Treatment Period|Disease progression|12|||
105622138|NCT01928394|364282043|FG003|Treatment Period|Disease progression|48|||
105622139|NCT01928394|364282044|FG004|Treatment Period|Disease progression|3|||
105622140|NCT01928394|364282045|FG005|Treatment Period|Disease progression|25|||
105622141|NCT01928394|364282046|FG006|Treatment Period|Disease progression|38|||
105622142|NCT01928394|364282047|FG007|Treatment Period|Disease progression|16|||
105622143|NCT01928394|364282048|FG008|Treatment Period|Disease progression|3|||
105622144|NCT01928394|364282049|FG009|Treatment Period|Disease progression|11|||
105622145|NCT01928394|364282050|FG010|Treatment Period|Disease progression|22|||
105622146|NCT01928394|364282051|FG011|Treatment Period|Disease progression|73|||
105622147|NCT01928394|364282052|FG012|Treatment Period|Disease progression|38|||
105622148|NCT01928394|364282053|FG013|Treatment Period|Disease progression|118|||
105622149|NCT01928394|364282054|FG014|Treatment Period|Disease progression|59|||
105622150|NCT01928394|364282055|FG015|Treatment Period|Disease progression|1|||
105622151|NCT01928394|364282056|FG016|Treatment Period|Disease progression|43|||
105622152|NCT01928394|364282057|FG017|Treatment Period|Disease progression|56|||
105622153|NCT01928394|364282058|FG018|Treatment Period|Disease progression|50|||
105622154|NCT01928394|364282059|FG019|Treatment Period|Disease progression|71|||
105622155|NCT01928394|364282060|FG020|Treatment Period|Disease progression|30|||
105622156|NCT01928394|364282061|FG021|Treatment Period|Disease progression|31|||
105622157|NCT01928394|364282062|FG022|Treatment Period|Disease progression|31|||
105622158|NCT01928394|364282040|FG000|Treatment Period|Study drug toxicity|1|||
105622159|NCT01928394|364282041|FG001|Treatment Period|Study drug toxicity|1|||
105622160|NCT01928394|364282042|FG002|Treatment Period|Study drug toxicity|3|||
105622161|NCT01928394|364282043|FG003|Treatment Period|Study drug toxicity|3|||
105622162|NCT01928394|364282044|FG004|Treatment Period|Study drug toxicity|0|||
105622163|NCT01928394|364282045|FG005|Treatment Period|Study drug toxicity|9|||
105622164|NCT01928394|364282046|FG006|Treatment Period|Study drug toxicity|7|||
105622165|NCT01928394|364282047|FG007|Treatment Period|Study drug toxicity|1|||
105622166|NCT01928394|364282048|FG008|Treatment Period|Study drug toxicity|0|||
105622167|NCT01928394|364282049|FG009|Treatment Period|Study drug toxicity|5|||
105622168|NCT01928394|364282050|FG010|Treatment Period|Study drug toxicity|2|||
105622169|NCT01928394|364282051|FG011|Treatment Period|Study drug toxicity|3|||
105622170|NCT01928394|364282052|FG012|Treatment Period|Study drug toxicity|7|||
105622171|NCT01928394|364282053|FG013|Treatment Period|Study drug toxicity|5|||
105622172|NCT01928394|364282054|FG014|Treatment Period|Study drug toxicity|12|||
105622173|NCT01928394|364282055|FG015|Treatment Period|Study drug toxicity|0|||
105622174|NCT01928394|364282056|FG016|Treatment Period|Study drug toxicity|3|||
105622175|NCT01928394|364282057|FG017|Treatment Period|Study drug toxicity|3|||
105622176|NCT01928394|364282058|FG018|Treatment Period|Study drug toxicity|12|||
105622177|NCT01928394|364282059|FG019|Treatment Period|Study drug toxicity|15|||
105622178|NCT01928394|364282060|FG020|Treatment Period|Study drug toxicity|4|||
105622179|NCT01928394|364282061|FG021|Treatment Period|Study drug toxicity|7|||
105622180|NCT01928394|364282062|FG022|Treatment Period|Study drug toxicity|4|||
105622181|NCT01928394|364282040|FG000|Treatment Period|AE unrelated to study drug|0|||
105622182|NCT01928394|364282041|FG001|Treatment Period|AE unrelated to study drug|0|||
105622183|NCT01928394|364282042|FG002|Treatment Period|AE unrelated to study drug|2|||
105622184|NCT01928394|364282043|FG003|Treatment Period|AE unrelated to study drug|3|||
105622185|NCT01928394|364282044|FG004|Treatment Period|AE unrelated to study drug|0|||
105622186|NCT01928394|364282045|FG005|Treatment Period|AE unrelated to study drug|5|||
105622187|NCT01928394|364282046|FG006|Treatment Period|AE unrelated to study drug|1|||
105622188|NCT01928394|364282047|FG007|Treatment Period|AE unrelated to study drug|0|||
105622189|NCT01928394|364282048|FG008|Treatment Period|AE unrelated to study drug|0|||
105622190|NCT01928394|364282049|FG009|Treatment Period|AE unrelated to study drug|2|||
105622191|NCT01928394|364282050|FG010|Treatment Period|AE unrelated to study drug|0|||
105622192|NCT01928394|364282051|FG011|Treatment Period|AE unrelated to study drug|12|||
105622193|NCT01928394|364282052|FG012|Treatment Period|AE unrelated to study drug|6|||
105622194|NCT01928394|364282053|FG013|Treatment Period|AE unrelated to study drug|13|||
105622195|NCT01928394|364282054|FG014|Treatment Period|AE unrelated to study drug|6|||
105622196|NCT01928394|364282055|FG015|Treatment Period|AE unrelated to study drug|1|||
105622197|NCT01928394|364282056|FG016|Treatment Period|AE unrelated to study drug|1|||
105622198|NCT01928394|364282057|FG017|Treatment Period|AE unrelated to study drug|6|||
105622199|NCT01928394|364282058|FG018|Treatment Period|AE unrelated to study drug|3|||
105622200|NCT01928394|364282059|FG019|Treatment Period|AE unrelated to study drug|5|||
105622201|NCT01928394|364282060|FG020|Treatment Period|AE unrelated to study drug|1|||
105622202|NCT01928394|364282061|FG021|Treatment Period|AE unrelated to study drug|1|||
105622203|NCT01928394|364282062|FG022|Treatment Period|AE unrelated to study drug|0|||
105622204|NCT01928394|364282040|FG000|Treatment Period|Participant request to stop therapy|0|||
105622205|NCT01928394|364282041|FG001|Treatment Period|Participant request to stop therapy|0|||
105622206|NCT01928394|364282042|FG002|Treatment Period|Participant request to stop therapy|0|||
105622207|NCT01928394|364282043|FG003|Treatment Period|Participant request to stop therapy|0|||
105622208|NCT01928394|364282044|FG004|Treatment Period|Participant request to stop therapy|0|||
105622209|NCT01928394|364282045|FG005|Treatment Period|Participant request to stop therapy|3|||
105622210|NCT01928394|364282046|FG006|Treatment Period|Participant request to stop therapy|3|||
105622211|NCT01928394|364282047|FG007|Treatment Period|Participant request to stop therapy|0|||
105622212|NCT01928394|364282048|FG008|Treatment Period|Participant request to stop therapy|0|||
105622213|NCT01928394|364282049|FG009|Treatment Period|Participant request to stop therapy|0|||
105622214|NCT01928394|364282050|FG010|Treatment Period|Participant request to stop therapy|3|||
105622215|NCT01928394|364282051|FG011|Treatment Period|Participant request to stop therapy|2|||
105622216|NCT01928394|364282052|FG012|Treatment Period|Participant request to stop therapy|1|||
105622217|NCT01928394|364282053|FG013|Treatment Period|Participant request to stop therapy|2|||
105622218|NCT01928394|364282054|FG014|Treatment Period|Participant request to stop therapy|4|||
105622219|NCT01928394|364282055|FG015|Treatment Period|Participant request to stop therapy|0|||
105622220|NCT01928394|364282056|FG016|Treatment Period|Participant request to stop therapy|1|||
105622221|NCT01928394|364282057|FG017|Treatment Period|Participant request to stop therapy|3|||
105622222|NCT01928394|364282058|FG018|Treatment Period|Participant request to stop therapy|1|||
105622223|NCT01928394|364282059|FG019|Treatment Period|Participant request to stop therapy|1|||
105622224|NCT01928394|364282060|FG020|Treatment Period|Participant request to stop therapy|3|||
105622225|NCT01928394|364282061|FG021|Treatment Period|Participant request to stop therapy|1|||
105622226|NCT01928394|364282062|FG022|Treatment Period|Participant request to stop therapy|3|||
105622227|NCT01928394|364282040|FG000|Treatment Period|Participant withdrew consent|0|||
105622228|NCT01928394|364282041|FG001|Treatment Period|Participant withdrew consent|0|||
105622229|NCT01928394|364282042|FG002|Treatment Period|Participant withdrew consent|1|||
105622230|NCT01928394|364282043|FG003|Treatment Period|Participant withdrew consent|1|||
105622231|NCT01928394|364282044|FG004|Treatment Period|Participant withdrew consent|0|||
105622232|NCT01928394|364282045|FG005|Treatment Period|Participant withdrew consent|1|||
105622233|NCT01928394|364282046|FG006|Treatment Period|Participant withdrew consent|0|||
105622234|NCT01928394|364282047|FG007|Treatment Period|Participant withdrew consent|1|||
105622235|NCT01928394|364282048|FG008|Treatment Period|Participant withdrew consent|0|||
105622236|NCT01928394|364282049|FG009|Treatment Period|Participant withdrew consent|0|||
105622237|NCT01928394|364282050|FG010|Treatment Period|Participant withdrew consent|1|||
105622238|NCT01928394|364282051|FG011|Treatment Period|Participant withdrew consent|1|||
105622239|NCT01928394|364282052|FG012|Treatment Period|Participant withdrew consent|1|||
105622240|NCT01928394|364282053|FG013|Treatment Period|Participant withdrew consent|0|||
105622241|NCT01928394|364282054|FG014|Treatment Period|Participant withdrew consent|2|||
105622242|NCT01928394|364282055|FG015|Treatment Period|Participant withdrew consent|0|||
105622243|NCT01928394|364282056|FG016|Treatment Period|Participant withdrew consent|2|||
105622244|NCT01928394|364282057|FG017|Treatment Period|Participant withdrew consent|1|||
105622245|NCT01928394|364282058|FG018|Treatment Period|Participant withdrew consent|1|||
105622246|NCT01928394|364282059|FG019|Treatment Period|Participant withdrew consent|1|||
105622247|NCT01928394|364282060|FG020|Treatment Period|Participant withdrew consent|0|||
105622248|NCT01928394|364282061|FG021|Treatment Period|Participant withdrew consent|2|||
105622249|NCT01928394|364282062|FG022|Treatment Period|Participant withdrew consent|0|||
105622250|NCT01928394|364282040|FG000|Treatment Period|Poor/non-compliance|0|||
105622251|NCT01928394|364282041|FG001|Treatment Period|Poor/non-compliance|0|||
105622252|NCT01928394|364282042|FG002|Treatment Period|Poor/non-compliance|0|||
105622253|NCT01928394|364282043|FG003|Treatment Period|Poor/non-compliance|1|||
105622254|NCT01928394|364282044|FG004|Treatment Period|Poor/non-compliance|0|||
105622255|NCT01928394|364282045|FG005|Treatment Period|Poor/non-compliance|0|||
105622256|NCT01928394|364282046|FG006|Treatment Period|Poor/non-compliance|0|||
105622257|NCT01928394|364282047|FG007|Treatment Period|Poor/non-compliance|0|||
105622258|NCT01928394|364282048|FG008|Treatment Period|Poor/non-compliance|0|||
105622259|NCT01928394|364282049|FG009|Treatment Period|Poor/non-compliance|0|||
105622260|NCT01928394|364282050|FG010|Treatment Period|Poor/non-compliance|0|||
105622261|NCT01928394|364282051|FG011|Treatment Period|Poor/non-compliance|0|||
105622262|NCT01928394|364282052|FG012|Treatment Period|Poor/non-compliance|1|||
105622263|NCT01928394|364282053|FG013|Treatment Period|Poor/non-compliance|0|||
105622264|NCT01928394|364282054|FG014|Treatment Period|Poor/non-compliance|1|||
105622265|NCT01928394|364282055|FG015|Treatment Period|Poor/non-compliance|0|||
105622266|NCT01928394|364282056|FG016|Treatment Period|Poor/non-compliance|0|||
105622267|NCT01928394|364282057|FG017|Treatment Period|Poor/non-compliance|1|||
105622268|NCT01928394|364282058|FG018|Treatment Period|Poor/non-compliance|0|||
105622269|NCT01928394|364282059|FG019|Treatment Period|Poor/non-compliance|1|||
105622270|NCT01928394|364282060|FG020|Treatment Period|Poor/non-compliance|0|||
105622271|NCT01928394|364282061|FG021|Treatment Period|Poor/non-compliance|0|||
105622272|NCT01928394|364282062|FG022|Treatment Period|Poor/non-compliance|0|||
105622273|NCT01928394|364282040|FG000|Treatment Period|other reason|0|||
105622274|NCT01928394|364282041|FG001|Treatment Period|other reason|0|||
105622275|NCT01928394|364282042|FG002|Treatment Period|other reason|0|||
105622276|NCT01928394|364282043|FG003|Treatment Period|other reason|0|||
105622277|NCT01928394|364282044|FG004|Treatment Period|other reason|0|||
105622278|NCT01928394|364282045|FG005|Treatment Period|other reason|0|||
105622279|NCT01928394|364282046|FG006|Treatment Period|other reason|0|||
105622280|NCT01928394|364282047|FG007|Treatment Period|other reason|0|||
105622281|NCT01928394|364282048|FG008|Treatment Period|other reason|0|||
105622282|NCT01928394|364282049|FG009|Treatment Period|other reason|0|||
105622283|NCT01928394|364282050|FG010|Treatment Period|other reason|1|||
105622284|NCT01928394|364282051|FG011|Treatment Period|other reason|1|||
105622285|NCT01928394|364282052|FG012|Treatment Period|other reason|1|||
105622286|NCT01928394|364282053|FG013|Treatment Period|other reason|0|||
105622287|NCT01928394|364282054|FG014|Treatment Period|other reason|1|||
105622288|NCT01928394|364282055|FG015|Treatment Period|other reason|0|||
105622289|NCT01928394|364282056|FG016|Treatment Period|other reason|0|||
105622290|NCT01928394|364282057|FG017|Treatment Period|other reason|0|||
105622291|NCT01928394|364282058|FG018|Treatment Period|other reason|2|||
105622292|NCT01928394|364282059|FG019|Treatment Period|other reason|2|||
105622293|NCT01928394|364282060|FG020|Treatment Period|other reason|0|||
105622294|NCT01928394|364282061|FG021|Treatment Period|other reason|0|||
105622295|NCT01928394|364282062|FG022|Treatment Period|other reason|0|||
105622296|NCT01928394|364282040|FG000|Treatment Period|Maximum clinical benefit|0|||
105622297|NCT01928394|364282041|FG001|Treatment Period|Maximum clinical benefit|0|||
105622298|NCT01928394|364282042|FG002|Treatment Period|Maximum clinical benefit|0|||
105622299|NCT01928394|364282043|FG003|Treatment Period|Maximum clinical benefit|0|||
105622300|NCT01928394|364282044|FG004|Treatment Period|Maximum clinical benefit|0|||
105622301|NCT01928394|364282045|FG005|Treatment Period|Maximum clinical benefit|0|||
105622302|NCT01928394|364282046|FG006|Treatment Period|Maximum clinical benefit|0|||
105622303|NCT01928394|364282047|FG007|Treatment Period|Maximum clinical benefit|0|||
105622304|NCT01928394|364282048|FG008|Treatment Period|Maximum clinical benefit|0|||
105622305|NCT01928394|364282049|FG009|Treatment Period|Maximum clinical benefit|0|||
105622306|NCT01928394|364282050|FG010|Treatment Period|Maximum clinical benefit|1|||
105622307|NCT01928394|364282051|FG011|Treatment Period|Maximum clinical benefit|1|||
105622308|NCT01928394|364282052|FG012|Treatment Period|Maximum clinical benefit|0|||
105622309|NCT01928394|364282053|FG013|Treatment Period|Maximum clinical benefit|0|||
105622310|NCT01928394|364282054|FG014|Treatment Period|Maximum clinical benefit|1|||
105622311|NCT01928394|364282055|FG015|Treatment Period|Maximum clinical benefit|0|||
105622312|NCT01928394|364282056|FG016|Treatment Period|Maximum clinical benefit|0|||
105622313|NCT01928394|364282057|FG017|Treatment Period|Maximum clinical benefit|1|||
105622314|NCT01928394|364282058|FG018|Treatment Period|Maximum clinical benefit|1|||
105622315|NCT01928394|364282059|FG019|Treatment Period|Maximum clinical benefit|0|||
105622316|NCT01928394|364282060|FG020|Treatment Period|Maximum clinical benefit|2|||
105622317|NCT01928394|364282061|FG021|Treatment Period|Maximum clinical benefit|0|||
105622318|NCT01928394|364282062|FG022|Treatment Period|Maximum clinical benefit|0|||
105622319|NCT01928394|364282040|FG000|Treatment Period|Lost to Follow-up|0|||
105622320|NCT01928394|364282041|FG001|Treatment Period|Lost to Follow-up|0|||
105622321|NCT01928394|364282042|FG002|Treatment Period|Lost to Follow-up|0|||
105622322|NCT01928394|364282043|FG003|Treatment Period|Lost to Follow-up|0|||
105622323|NCT01928394|364282044|FG004|Treatment Period|Lost to Follow-up|0|||
105622324|NCT01928394|364282045|FG005|Treatment Period|Lost to Follow-up|0|||
105622325|NCT01928394|364282046|FG006|Treatment Period|Lost to Follow-up|0|||
105622326|NCT01928394|364282047|FG007|Treatment Period|Lost to Follow-up|0|||
105622327|NCT01928394|364282048|FG008|Treatment Period|Lost to Follow-up|0|||
105622328|NCT01928394|364282049|FG009|Treatment Period|Lost to Follow-up|0|||
105622329|NCT01928394|364282050|FG010|Treatment Period|Lost to Follow-up|0|||
105622330|NCT01928394|364282051|FG011|Treatment Period|Lost to Follow-up|0|||
105622331|NCT01928394|364282052|FG012|Treatment Period|Lost to Follow-up|0|||
105622332|NCT01928394|364282053|FG013|Treatment Period|Lost to Follow-up|0|||
105622333|NCT01928394|364282054|FG014|Treatment Period|Lost to Follow-up|0|||
105622334|NCT01928394|364282055|FG015|Treatment Period|Lost to Follow-up|0|||
105622335|NCT01928394|364282056|FG016|Treatment Period|Lost to Follow-up|0|||
105622336|NCT01928394|364282057|FG017|Treatment Period|Lost to Follow-up|0|||
105622337|NCT01928394|364282058|FG018|Treatment Period|Lost to Follow-up|0|||
105622338|NCT01928394|364282059|FG019|Treatment Period|Lost to Follow-up|0|||
105622339|NCT01928394|364282060|FG020|Treatment Period|Lost to Follow-up|0|||
105622340|NCT01928394|364282061|FG021|Treatment Period|Lost to Follow-up|0|||
105622341|NCT01928394|364282062|FG022|Treatment Period|Lost to Follow-up|1|||
105622342|NCT01928394|364282040|FG000|Treatment Period|Death|0|||
105622343|NCT01928394|364282041|FG001|Treatment Period|Death|0|||
105622344|NCT01928394|364282042|FG002|Treatment Period|Death|0|||
105622345|NCT01928394|364282043|FG003|Treatment Period|Death|0|||
105622346|NCT01928394|364282044|FG004|Treatment Period|Death|0|||
105622347|NCT01928394|364282045|FG005|Treatment Period|Death|0|||
105622348|NCT01928394|364282046|FG006|Treatment Period|Death|0|||
105622349|NCT01928394|364282047|FG007|Treatment Period|Death|0|||
105622350|NCT01928394|364282048|FG008|Treatment Period|Death|0|||
105622351|NCT01928394|364282049|FG009|Treatment Period|Death|0|||
105622352|NCT01928394|364282050|FG010|Treatment Period|Death|0|||
105622353|NCT01928394|364282051|FG011|Treatment Period|Death|0|||
105622354|NCT01928394|364282052|FG012|Treatment Period|Death|0|||
105622355|NCT01928394|364282053|FG013|Treatment Period|Death|1|||
105622356|NCT01928394|364282054|FG014|Treatment Period|Death|2|||
105622357|NCT01928394|364282055|FG015|Treatment Period|Death|0|||
105622358|NCT01928394|364282056|FG016|Treatment Period|Death|0|||
105622359|NCT01928394|364282057|FG017|Treatment Period|Death|0|||
105622360|NCT01928394|364282058|FG018|Treatment Period|Death|0|||
105622361|NCT01928394|364282059|FG019|Treatment Period|Death|0|||
105622362|NCT01928394|364282060|FG020|Treatment Period|Death|0|||
105622363|NCT01928394|364282061|FG021|Treatment Period|Death|0|||
105622364|NCT01928394|364282062|FG022|Treatment Period|Death|0|||
105622365|NCT01928394|364282040|FG000|Follow-up Period|Participant withdrew consent|3|||
105622366|NCT01928394|364282041|FG001|Follow-up Period|Participant withdrew consent|0|||
105622367|NCT01928394|364282042|FG002|Follow-up Period|Participant withdrew consent|1|||
105622368|NCT01928394|364282043|FG003|Follow-up Period|Participant withdrew consent|4|||
105622369|NCT01928394|364282044|FG004|Follow-up Period|Participant withdrew consent|0|||
105622370|NCT01928394|364282045|FG005|Follow-up Period|Participant withdrew consent|2|||
105622371|NCT01928394|364282046|FG006|Follow-up Period|Participant withdrew consent|5|||
105622372|NCT01928394|364282047|FG007|Follow-up Period|Participant withdrew consent|1|||
105622373|NCT01928394|364282048|FG008|Follow-up Period|Participant withdrew consent|0|||
105622374|NCT01928394|364282049|FG009|Follow-up Period|Participant withdrew consent|0|||
105622375|NCT01928394|364282050|FG010|Follow-up Period|Participant withdrew consent|5|||
105622376|NCT01928394|364282051|FG011|Follow-up Period|Participant withdrew consent|8|||
105622377|NCT01928394|364282052|FG012|Follow-up Period|Participant withdrew consent|2|||
105622378|NCT01928394|364282053|FG013|Follow-up Period|Participant withdrew consent|12|||
105622379|NCT01928394|364282054|FG014|Follow-up Period|Participant withdrew consent|7|||
105622380|NCT01928394|364282055|FG015|Follow-up Period|Participant withdrew consent|0|||
105622381|NCT01928394|364282056|FG016|Follow-up Period|Participant withdrew consent|5|||
105622382|NCT01928394|364282057|FG017|Follow-up Period|Participant withdrew consent|3|||
105622383|NCT01928394|364282058|FG018|Follow-up Period|Participant withdrew consent|2|||
105622384|NCT01928394|364282059|FG019|Follow-up Period|Participant withdrew consent|7|||
105622385|NCT01928394|364282060|FG020|Follow-up Period|Participant withdrew consent|4|||
105622386|NCT01928394|364282061|FG021|Follow-up Period|Participant withdrew consent|6|||
105622387|NCT01928394|364282062|FG022|Follow-up Period|Participant withdrew consent|2|||
105622388|NCT01928394|364282040|FG000|Follow-up Period|Death|0|||
105622389|NCT01928394|364282041|FG001|Follow-up Period|Death|0|||
105622390|NCT01928394|364282042|FG002|Follow-up Period|Death|2|||
105622391|NCT01928394|364282043|FG003|Follow-up Period|Death|6|||
105622392|NCT01928394|364282044|FG004|Follow-up Period|Death|0|||
105622393|NCT01928394|364282045|FG005|Follow-up Period|Death|6|||
105622394|NCT01928394|364282046|FG006|Follow-up Period|Death|6|||
105622395|NCT01928394|364282047|FG007|Follow-up Period|Death|2|||
105622396|NCT01928394|364282048|FG008|Follow-up Period|Death|1|||
105622397|NCT01928394|364282049|FG009|Follow-up Period|Death|2|||
105622398|NCT01928394|364282050|FG010|Follow-up Period|Death|4|||
105622399|NCT01928394|364282051|FG011|Follow-up Period|Death|12|||
105622400|NCT01928394|364282052|FG012|Follow-up Period|Death|11|||
105622401|NCT01928394|364282053|FG013|Follow-up Period|Death|25|||
105622402|NCT01928394|364282054|FG014|Follow-up Period|Death|18|||
105622403|NCT01928394|364282055|FG015|Follow-up Period|Death|0|||
105622404|NCT01928394|364282056|FG016|Follow-up Period|Death|6|||
105622405|NCT01928394|364282057|FG017|Follow-up Period|Death|5|||
105622406|NCT01928394|364282058|FG018|Follow-up Period|Death|13|||
105622407|NCT01928394|364282059|FG019|Follow-up Period|Death|13|||
105622408|NCT01928394|364282060|FG020|Follow-up Period|Death|5|||
105622409|NCT01928394|364282061|FG021|Follow-up Period|Death|3|||
105622410|NCT01928394|364282062|FG022|Follow-up Period|Death|2|||
105622411|NCT01928394|364282040|FG000|Follow-up Period|other reason|0|||
105622412|NCT01928394|364282041|FG001|Follow-up Period|other reason|0|||
105622413|NCT01928394|364282042|FG002|Follow-up Period|other reason|0|||
105622414|NCT01928394|364282043|FG003|Follow-up Period|other reason|0|||
105622415|NCT01928394|364282044|FG004|Follow-up Period|other reason|0|||
105622416|NCT01928394|364282045|FG005|Follow-up Period|other reason|0|||
105622417|NCT01928394|364282046|FG006|Follow-up Period|other reason|1|||
105622418|NCT01928394|364282047|FG007|Follow-up Period|other reason|3|||
105622419|NCT01928394|364282048|FG008|Follow-up Period|other reason|0|||
105622420|NCT01928394|364282049|FG009|Follow-up Period|other reason|0|||
105622421|NCT01928394|364282050|FG010|Follow-up Period|other reason|2|||
105622422|NCT01928394|364282051|FG011|Follow-up Period|other reason|1|||
105622423|NCT01928394|364282052|FG012|Follow-up Period|other reason|0|||
105622424|NCT01928394|364282053|FG013|Follow-up Period|other reason|1|||
105622425|NCT01928394|364282054|FG014|Follow-up Period|other reason|4|||
105622426|NCT01928394|364282055|FG015|Follow-up Period|other reason|0|||
105622427|NCT01928394|364282056|FG016|Follow-up Period|other reason|2|||
105622428|NCT01928394|364282057|FG017|Follow-up Period|other reason|0|||
105622429|NCT01928394|364282058|FG018|Follow-up Period|other reason|1|||
105622430|NCT01928394|364282059|FG019|Follow-up Period|other reason|1|||
105622431|NCT01928394|364282060|FG020|Follow-up Period|other reason|0|||
105622432|NCT01928394|364282061|FG021|Follow-up Period|other reason|0|||
105622433|NCT01928394|364282062|FG022|Follow-up Period|other reason|1|||
105622434|NCT01928394|364282040|FG000|Follow-up Period|Lost to Follow-up|0|||
105622435|NCT01928394|364282041|FG001|Follow-up Period|Lost to Follow-up|0|||
105622436|NCT01928394|364282042|FG002|Follow-up Period|Lost to Follow-up|0|||
105622437|NCT01928394|364282043|FG003|Follow-up Period|Lost to Follow-up|0|||
105622438|NCT01928394|364282044|FG004|Follow-up Period|Lost to Follow-up|0|||
105622439|NCT01928394|364282045|FG005|Follow-up Period|Lost to Follow-up|0|||
105622440|NCT01928394|364282046|FG006|Follow-up Period|Lost to Follow-up|0|||
105622441|NCT01928394|364282047|FG007|Follow-up Period|Lost to Follow-up|0|||
105622442|NCT01928394|364282048|FG008|Follow-up Period|Lost to Follow-up|0|||
105622443|NCT01928394|364282049|FG009|Follow-up Period|Lost to Follow-up|0|||
105622444|NCT01928394|364282050|FG010|Follow-up Period|Lost to Follow-up|0|||
105622445|NCT01928394|364282051|FG011|Follow-up Period|Lost to Follow-up|1|||
105622446|NCT01928394|364282052|FG012|Follow-up Period|Lost to Follow-up|1|||
105622447|NCT01928394|364282053|FG013|Follow-up Period|Lost to Follow-up|0|||
105622448|NCT01928394|364282054|FG014|Follow-up Period|Lost to Follow-up|1|||
105622449|NCT01928394|364282055|FG015|Follow-up Period|Lost to Follow-up|0|||
105622450|NCT01928394|364282056|FG016|Follow-up Period|Lost to Follow-up|1|||
105622451|NCT01928394|364282057|FG017|Follow-up Period|Lost to Follow-up|0|||
105622452|NCT01928394|364282058|FG018|Follow-up Period|Lost to Follow-up|0|||
105622453|NCT01928394|364282059|FG019|Follow-up Period|Lost to Follow-up|0|||
105622454|NCT01928394|364282060|FG020|Follow-up Period|Lost to Follow-up|0|||
105622455|NCT01928394|364282061|FG021|Follow-up Period|Lost to Follow-up|0|||
105622456|NCT01928394|364282062|FG022|Follow-up Period|Lost to Follow-up|1|||
105622457|NCT03676192|364282063|FG000|Induction Study Period|Adverse Event|21|||
105622458|NCT03676192|364282064|FG001|Induction Study Period|Adverse Event|20|||
105622459|NCT03676192|364282063|FG000|Induction Study Period|Death|23|||
105622460|NCT03676192|364282064|FG001|Induction Study Period|Death|20|||
105622461|NCT03676192|364282063|FG000|Induction Study Period|Lost to Follow-up|3|||
105622462|NCT03676192|364282064|FG001|Induction Study Period|Lost to Follow-up|3|||
105622463|NCT03676192|364282063|FG000|Induction Study Period|Physician Decision|6|||
105622464|NCT03676192|364282064|FG001|Induction Study Period|Physician Decision|3|||
105622465|NCT03676192|364282063|FG000|Induction Study Period|Progressive Disease|32|||
105622466|NCT03676192|364282064|FG001|Induction Study Period|Progressive Disease|21|||
105622467|NCT03676192|364282063|FG000|Induction Study Period|Protocol Violation|1|||
105622468|NCT03676192|364282064|FG001|Induction Study Period|Protocol Violation|2|||
105622469|NCT03676192|364282063|FG000|Induction Study Period|Withdrawal by Subject|20|||
105622470|NCT03676192|364282064|FG001|Induction Study Period|Withdrawal by Subject|15|||
105622471|NCT03334630|364282065|FG000|Overall Study|Withdrawal by Subject|7|||
105622472|NCT03334630|364282066|FG001|Overall Study|Withdrawal by Subject|7|||
105622473|NCT03334630|364282065|FG000|Overall Study|Lost to Follow-up|3|||
105622474|NCT03334630|364282066|FG001|Overall Study|Lost to Follow-up|1|||
105622475|NCT03334630|364282065|FG000|Overall Study|Adverse Event|0|||
105622476|NCT03334630|364282066|FG001|Overall Study|Adverse Event|1|||
105622477|NCT03334630|364282065|FG000|Overall Study|Physician Decision|1|||
105622478|NCT03334630|364282066|FG001|Overall Study|Physician Decision|1|||
105622479|NCT03334630|364282065|FG000|Overall Study|Enrollment closed|2|||
105622480|NCT03334630|364282066|FG001|Overall Study|Enrollment closed|1|||
105622481|NCT03334630|364282065|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
105622482|NCT03334630|364282066|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
105622483|NCT03334630|364282065|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
105622484|NCT03334630|364282066|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
105622485|NCT04079218|364282071|FG000|Overall Study|Death|1|||
105622486|NCT04079218|364282072|FG001|Overall Study|Death|0|||
105622487|NCT04079218|364282071|FG000|Overall Study|Withdrawal by Subject|3|||
105622488|NCT04079218|364282072|FG001|Overall Study|Withdrawal by Subject|0|||
105622489|NCT04079218|364282071|FG000|Overall Study|Physician Decision|4|||
105622490|NCT04079218|364282072|FG001|Overall Study|Physician Decision|0|||
105622491|NCT04079218|364282071|FG000|Overall Study|Lost to Follow-up|0|||
105622492|NCT04079218|364282072|FG001|Overall Study|Lost to Follow-up|1|||
105622493|NCT03030261|364282073|FG000|Overall Study|Still receiving continuation therapy|5|||
105622494|NCT05093842|364282079|FG000|Overall Study|Pregnancy loss|1|||
105622495|NCT05093842|364282080|FG001|Overall Study|Pregnancy loss|1|||
105622496|NCT05093842|364282079|FG000|Overall Study|Lost to Follow-up|6|||
105622497|NCT05093842|364282080|FG001|Overall Study|Lost to Follow-up|0|||
105622498|NCT05093842|364282079|FG000|Overall Study|Physician Decision|0|||
105622499|NCT05093842|364282080|FG001|Overall Study|Physician Decision|1|||
105622500|NCT03910478|364282081|FG000|Overall Study|Death|13|||
105622501|NCT03910478|364282082|FG001|Overall Study|Death|6|||
105622502|NCT03910478|364282081|FG000|Overall Study|Withdrawal by Subject|23|||
105622503|NCT03910478|364282082|FG001|Overall Study|Withdrawal by Subject|2|||
105622504|NCT03910478|364282081|FG000|Overall Study|Physician Decision|5|||
105622505|NCT03910478|364282082|FG001|Overall Study|Physician Decision|0|||
105622506|NCT03910478|364282081|FG000|Overall Study|Protocol Violation|1|||
105622507|NCT03910478|364282082|FG001|Overall Study|Protocol Violation|0|||
105622508|NCT03910478|364282081|FG000|Overall Study|Failure to meet continuation criteria|2|||
105622509|NCT03910478|364282082|FG001|Overall Study|Failure to meet continuation criteria|0|||
105622510|NCT03910478|364282081|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
105622511|NCT03910478|364282082|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
105622512|NCT04971109|364282083|FG000|Overall Study|Adverse Event|4|||
105622513|NCT04971109|364282084|FG001|Overall Study|Adverse Event|3|||
105622514|NCT04971109|364282083|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
105622515|NCT04971109|364282084|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
105622516|NCT04971109|364282083|FG000|Overall Study|Lost to Follow-up|8|||
105622517|NCT04971109|364282084|FG001|Overall Study|Lost to Follow-up|2|||
105622518|NCT04971109|364282083|FG000|Overall Study|Physician Decision|5|||
105622519|NCT04971109|364282084|FG001|Overall Study|Physician Decision|0|||
105622520|NCT04971109|364282083|FG000|Overall Study|Protocol Violation|0|||
105622521|NCT04971109|364282084|FG001|Overall Study|Protocol Violation|1|||
105622522|NCT04971109|364282083|FG000|Overall Study|Withdrawal by Subject|18|||
105622523|NCT04971109|364282084|FG001|Overall Study|Withdrawal by Subject|3|||
105622524|NCT04971109|364282083|FG000|Overall Study|Subject was randomized in error|1|||
105622525|NCT04971109|364282084|FG001|Overall Study|Subject was randomized in error|0|||
105622526|NCT05293171|364282085|FG000|Washout 5 to 7 Days|Adverse Event|1|||
105622527|NCT05293171|364282086|FG001|Washout 5 to 7 Days|Adverse Event|1|||
105622528|NCT05293171|364282087|FG002|Washout 5 to 7 Days|Adverse Event|0|||
105622529|NCT05293171|364282088|FG003|Washout 5 to 7 Days|Adverse Event|0|||
105622530|NCT05293171|364282089|FG004|Washout 5 to 7 Days|Adverse Event|0|||
105622531|NCT05293171|364282090|FG005|Washout 5 to 7 Days|Adverse Event|0|||
105622532|NCT05293171|364282091|FG006|Washout 5 to 7 Days|Adverse Event|0|||
105622533|NCT05293171|364282092|FG007|Washout 5 to 7 Days|Adverse Event|0|||
105622534|NCT05293171|364282093|FG008|Washout 5 to 7 Days|Adverse Event|0|||
105622535|NCT05293171|364282094|FG009|Washout 5 to 7 Days|Adverse Event|0|||
105622536|NCT05293171|364282095|FG010|Washout 5 to 7 Days|Adverse Event|0|||
105622537|NCT05293171|364282096|FG011|Washout 5 to 7 Days|Adverse Event|0|||
105622538|NCT05293171|364282085|FG000|Washout 5 to 7 Days|Adverse Event|0|||
105622539|NCT05293171|364282086|FG001|Washout 5 to 7 Days|Adverse Event|0|||
105622540|NCT05293171|364282087|FG002|Washout 5 to 7 Days|Adverse Event|0|||
105622541|NCT05293171|364282088|FG003|Washout 5 to 7 Days|Adverse Event|0|||
105622542|NCT05293171|364282089|FG004|Washout 5 to 7 Days|Adverse Event|0|||
105622543|NCT05293171|364282090|FG005|Washout 5 to 7 Days|Adverse Event|1|||
105622544|NCT05293171|364282091|FG006|Washout 5 to 7 Days|Adverse Event|0|||
105622545|NCT05293171|364282092|FG007|Washout 5 to 7 Days|Adverse Event|0|||
105622546|NCT05293171|364282093|FG008|Washout 5 to 7 Days|Adverse Event|0|||
105622547|NCT05293171|364282094|FG009|Washout 5 to 7 Days|Adverse Event|0|||
105622548|NCT05293171|364282095|FG010|Washout 5 to 7 Days|Adverse Event|0|||
105622549|NCT05293171|364282096|FG011|Washout 5 to 7 Days|Adverse Event|0|||
105622550|NCT03987022|364282098|FG000|Overall Study|Lost to Follow-up|2|||
105622551|NCT03987022|364282099|FG001|Overall Study|Lost to Follow-up|2|||
105622552|NCT03987022|364282098|FG000|Overall Study|Withdrawal by Subject|1|||
105622553|NCT03987022|364282099|FG001|Overall Study|Withdrawal by Subject|0|||
105622554|NCT03478956|364282101|FG000|Randomized Treatment Period|Adverse Event|1|||
105622555|NCT03478956|364282102|FG001|Randomized Treatment Period|Adverse Event|0|||
105622556|NCT03478956|364282103|FG002|Randomized Treatment Period|Adverse Event|0|||
105622557|NCT03478956|364282104|FG003|Randomized Treatment Period|Adverse Event|0|||
105622558|NCT03478956|364282101|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
105622559|NCT03478956|364282102|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
105622560|NCT03478956|364282103|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
105622561|NCT03478956|364282104|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
105622562|NCT03478956|364282101|FG000|Open Label Extension Period|Adverse Event|0|||
105622563|NCT03478956|364282102|FG001|Open Label Extension Period|Adverse Event|0|||
105622564|NCT03478956|364282103|FG002|Open Label Extension Period|Adverse Event|4|||
105622565|NCT03478956|364282104|FG003|Open Label Extension Period|Adverse Event|0|||
105622566|NCT03478956|364282101|FG000|Open Label Extension Period|Lack of Efficacy|0|||
105622567|NCT03478956|364282102|FG001|Open Label Extension Period|Lack of Efficacy|0|||
105622568|NCT03478956|364282103|FG002|Open Label Extension Period|Lack of Efficacy|8|||
105622569|NCT03478956|364282104|FG003|Open Label Extension Period|Lack of Efficacy|0|||
105622570|NCT03478956|364282101|FG000|Open Label Extension Period|Reason Not Provided|0|||
105622571|NCT03478956|364282102|FG001|Open Label Extension Period|Reason Not Provided|0|||
105622572|NCT03478956|364282103|FG002|Open Label Extension Period|Reason Not Provided|1|||
105622573|NCT03478956|364282104|FG003|Open Label Extension Period|Reason Not Provided|0|||
105622574|NCT03478956|364282101|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
105622575|NCT03478956|364282102|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
105622576|NCT03478956|364282103|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
105622577|NCT03478956|364282104|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
105622578|NCT03478956|364282101|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
105622579|NCT03478956|364282102|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
105622580|NCT03478956|364282103|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
105622581|NCT03478956|364282104|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
105622582|NCT03478956|364282101|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
105622583|NCT03478956|364282102|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
105622584|NCT03478956|364282103|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
105622585|NCT03478956|364282104|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
105622586|NCT04800211|364282105|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
105622587|NCT04800211|364282106|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
105622588|NCT04800211|364282107|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
105622589|NCT04800211|364282105|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
105622590|NCT04800211|364282106|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
105622591|NCT04800211|364282107|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
105622592|NCT04800211|364282105|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
105622593|NCT04800211|364282106|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
105622594|NCT04800211|364282107|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
105622595|NCT04800211|364282105|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
105622596|NCT04800211|364282106|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
105622597|NCT04800211|364282107|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
105622598|NCT04800211|364282105|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
105622599|NCT04800211|364282106|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
105622600|NCT04800211|364282107|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
105622601|NCT04800211|364282105|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
105622602|NCT04800211|364282106|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
105622603|NCT04800211|364282107|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
105622604|NCT04800211|364282105|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
105622605|NCT04800211|364282106|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
105622606|NCT04800211|364282107|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
105622607|NCT04800211|364282105|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
105622608|NCT04800211|364282106|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
105622609|NCT04800211|364282107|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
105622610|NCT04800211|364282105|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
105622611|NCT04800211|364282106|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
105622612|NCT04800211|364282107|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
105622613|NCT04800211|364282105|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
105622614|NCT04800211|364282106|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
105622615|NCT04800211|364282107|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
105622616|NCT04800211|364282105|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
105622617|NCT04800211|364282106|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
105622618|NCT04800211|364282107|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
105622619|NCT05975840|364282108|FG000|Overall Study|Other|1|||
105622620|NCT05975840|364282109|FG001|Overall Study|Other|0|||
105622621|NCT05975840|364282110|FG002|Overall Study|Other|0|||
105622622|NCT05975840|364282111|FG003|Overall Study|Other|0|||
105622623|NCT05975840|364282112|FG004|Overall Study|Other|1|||
105622624|NCT05975840|364282113|FG005|Overall Study|Other|0|||
105622625|NCT05975840|364282114|FG006|Overall Study|Other|0|||
105622626|NCT05975840|364282115|FG007|Overall Study|Other|0|||
105622627|NCT05975840|364282108|FG000|Overall Study|Lost to Follow-up|3|||
105622628|NCT05975840|364282109|FG001|Overall Study|Lost to Follow-up|6|||
105622629|NCT05975840|364282110|FG002|Overall Study|Lost to Follow-up|3|||
105622630|NCT05975840|364282111|FG003|Overall Study|Lost to Follow-up|1|||
105622631|NCT05975840|364282112|FG004|Overall Study|Lost to Follow-up|4|||
105622632|NCT05975840|364282113|FG005|Overall Study|Lost to Follow-up|1|||
105622633|NCT05975840|364282114|FG006|Overall Study|Lost to Follow-up|2|||
105622634|NCT05975840|364282115|FG007|Overall Study|Lost to Follow-up|4|||
105622635|NCT05975840|364282108|FG000|Overall Study|Migrated/moved from the study area|1|||
105622636|NCT05975840|364282109|FG001|Overall Study|Migrated/moved from the study area|0|||
105622637|NCT05975840|364282110|FG002|Overall Study|Migrated/moved from the study area|0|||
105622638|NCT05975840|364282111|FG003|Overall Study|Migrated/moved from the study area|0|||
105622639|NCT05975840|364282112|FG004|Overall Study|Migrated/moved from the study area|0|||
105622640|NCT05975840|364282113|FG005|Overall Study|Migrated/moved from the study area|0|||
105622641|NCT05975840|364282114|FG006|Overall Study|Migrated/moved from the study area|0|||
105622642|NCT05975840|364282115|FG007|Overall Study|Migrated/moved from the study area|0|||
105622643|NCT05975840|364282108|FG000|Overall Study|Withdrawal by Subject|0|||
105622644|NCT05975840|364282109|FG001|Overall Study|Withdrawal by Subject|5|||
105622645|NCT05975840|364282110|FG002|Overall Study|Withdrawal by Subject|2|||
105622646|NCT05975840|364282111|FG003|Overall Study|Withdrawal by Subject|2|||
105622647|NCT05975840|364282112|FG004|Overall Study|Withdrawal by Subject|0|||
105622648|NCT05975840|364282113|FG005|Overall Study|Withdrawal by Subject|2|||
105622649|NCT05975840|364282114|FG006|Overall Study|Withdrawal by Subject|2|||
105622650|NCT05975840|364282115|FG007|Overall Study|Withdrawal by Subject|1|||
105622651|NCT05975840|364282108|FG000|Overall Study|Protocol Violation|0|||
105622652|NCT05975840|364282109|FG001|Overall Study|Protocol Violation|1|||
105622653|NCT05975840|364282110|FG002|Overall Study|Protocol Violation|0|||
105622654|NCT05975840|364282111|FG003|Overall Study|Protocol Violation|0|||
105622655|NCT05975840|364282112|FG004|Overall Study|Protocol Violation|0|||
105622656|NCT05975840|364282113|FG005|Overall Study|Protocol Violation|0|||
105622657|NCT05975840|364282114|FG006|Overall Study|Protocol Violation|0|||
105622658|NCT05975840|364282115|FG007|Overall Study|Protocol Violation|0|||
105622659|NCT05975840|364282108|FG000|Overall Study|Adverse Event|0|||
105622660|NCT05975840|364282109|FG001|Overall Study|Adverse Event|0|||
105622661|NCT05975840|364282110|FG002|Overall Study|Adverse Event|0|||
105622662|NCT05975840|364282111|FG003|Overall Study|Adverse Event|1|||
105622663|NCT05975840|364282112|FG004|Overall Study|Adverse Event|0|||
105622664|NCT05975840|364282113|FG005|Overall Study|Adverse Event|0|||
105622665|NCT05975840|364282114|FG006|Overall Study|Adverse Event|0|||
105622666|NCT05975840|364282115|FG007|Overall Study|Adverse Event|0|||
105622667|NCT05975840|364282108|FG000|Overall Study|Death|0|||
105622668|NCT05975840|364282109|FG001|Overall Study|Death|1|||
105622669|NCT05975840|364282110|FG002|Overall Study|Death|0|||
105622670|NCT05975840|364282111|FG003|Overall Study|Death|0|||
105622671|NCT05975840|364282112|FG004|Overall Study|Death|0|||
105622672|NCT05975840|364282113|FG005|Overall Study|Death|0|||
105622673|NCT05975840|364282114|FG006|Overall Study|Death|0|||
105622674|NCT05975840|364282115|FG007|Overall Study|Death|1|||
105622675|NCT05646355|364282126|FG000|Overall Study|Lost to Follow-up|1|||
105622676|NCT05646355|364282127|FG001|Overall Study|Lost to Follow-up|0|||
105622677|NCT05646355|364282126|FG000|Overall Study|translated materials not available for pilot|2|||
105622678|NCT05646355|364282127|FG001|Overall Study|translated materials not available for pilot|0|||
105622679|NCT05646355|364282126|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
105622680|NCT05646355|364282127|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
105622681|NCT02152995|364282128|FG000|Overall Study|Withdrawal by Subject|1|||
105622682|NCT02152995|364282129|FG001|Overall Study|Withdrawal by Subject|0|||
105622683|NCT03476343|364282131|FG000|Overall Study|Clinical exam moved to another scanner|7|||
105622684|NCT03476343|364282131|FG000|Overall Study|Clinical order cancelled|4|||
105622685|NCT03476343|364282131|FG000|Overall Study|Neonate did not settle down for the scan|1|||
105622686|NCT03088878|364282132|FG000|Overall Study|Adverse Event|0|||
105622687|NCT03088878|364282133|FG001|Overall Study|Adverse Event|0|||
105622688|NCT03088878|364282134|FG002|Overall Study|Adverse Event|0|||
105622689|NCT03088878|364282135|FG003|Overall Study|Adverse Event|0|||
105622690|NCT03088878|364282136|FG004|Overall Study|Adverse Event|4|||
105622691|NCT03088878|364282137|FG005|Overall Study|Adverse Event|2|||
105622692|NCT03088878|364282138|FG006|Overall Study|Adverse Event|1|||
105622693|NCT03088878|364282139|FG007|Overall Study|Adverse Event|0|||
105622694|NCT03088878|364282140|FG008|Overall Study|Adverse Event|0|||
105622695|NCT03088878|364282141|FG009|Overall Study|Adverse Event|0|||
105622696|NCT03088878|364282142|FG010|Overall Study|Adverse Event|0|||
105622697|NCT03088878|364282143|FG011|Overall Study|Adverse Event|0|||
105622698|NCT03088878|364282144|FG012|Overall Study|Adverse Event|5|||
105622699|NCT03088878|364282145|FG013|Overall Study|Adverse Event|3|||
105622700|NCT03088878|364282132|FG000|Overall Study|Clinical Progression|0|||
105622701|NCT03088878|364282133|FG001|Overall Study|Clinical Progression|0|||
105622702|NCT03088878|364282134|FG002|Overall Study|Clinical Progression|0|||
105622703|NCT03088878|364282135|FG003|Overall Study|Clinical Progression|0|||
105622704|NCT03088878|364282136|FG004|Overall Study|Clinical Progression|2|||
105622705|NCT03088878|364282137|FG005|Overall Study|Clinical Progression|0|||
105622706|NCT03088878|364282138|FG006|Overall Study|Clinical Progression|0|||
105622707|NCT03088878|364282139|FG007|Overall Study|Clinical Progression|0|||
105622708|NCT03088878|364282140|FG008|Overall Study|Clinical Progression|0|||
105622709|NCT03088878|364282141|FG009|Overall Study|Clinical Progression|0|||
105622710|NCT03088878|364282142|FG010|Overall Study|Clinical Progression|0|||
105622711|NCT03088878|364282143|FG011|Overall Study|Clinical Progression|0|||
105622712|NCT03088878|364282144|FG012|Overall Study|Clinical Progression|0|||
105622713|NCT03088878|364282145|FG013|Overall Study|Clinical Progression|0|||
105622714|NCT03088878|364282132|FG000|Overall Study|Death|0|||
105622715|NCT03088878|364282133|FG001|Overall Study|Death|0|||
105622716|NCT03088878|364282134|FG002|Overall Study|Death|0|||
105622717|NCT03088878|364282135|FG003|Overall Study|Death|0|||
105622718|NCT03088878|364282136|FG004|Overall Study|Death|2|||
105622719|NCT03088878|364282137|FG005|Overall Study|Death|0|||
105622720|NCT03088878|364282138|FG006|Overall Study|Death|0|||
105622721|NCT03088878|364282139|FG007|Overall Study|Death|0|||
105622722|NCT03088878|364282140|FG008|Overall Study|Death|0|||
105622723|NCT03088878|364282141|FG009|Overall Study|Death|0|||
105622724|NCT03088878|364282142|FG010|Overall Study|Death|0|||
105622725|NCT03088878|364282143|FG011|Overall Study|Death|1|||
105622726|NCT03088878|364282144|FG012|Overall Study|Death|0|||
105622727|NCT03088878|364282145|FG013|Overall Study|Death|0|||
105622728|NCT03088878|364282132|FG000|Overall Study|Disease Progression|1|||
105622729|NCT03088878|364282133|FG001|Overall Study|Disease Progression|2|||
105622730|NCT03088878|364282134|FG002|Overall Study|Disease Progression|3|||
105622731|NCT03088878|364282135|FG003|Overall Study|Disease Progression|0|||
105622732|NCT03088878|364282136|FG004|Overall Study|Disease Progression|3|||
105622733|NCT03088878|364282137|FG005|Overall Study|Disease Progression|0|||
105622734|NCT03088878|364282138|FG006|Overall Study|Disease Progression|0|||
105622735|NCT03088878|364282139|FG007|Overall Study|Disease Progression|0|||
105622736|NCT03088878|364282140|FG008|Overall Study|Disease Progression|0|||
105622737|NCT03088878|364282141|FG009|Overall Study|Disease Progression|0|||
105622738|NCT03088878|364282142|FG010|Overall Study|Disease Progression|0|||
105622739|NCT03088878|364282143|FG011|Overall Study|Disease Progression|0|||
105622740|NCT03088878|364282144|FG012|Overall Study|Disease Progression|1|||
105622741|NCT03088878|364282145|FG013|Overall Study|Disease Progression|1|||
105622742|NCT03088878|364282132|FG000|Overall Study|Initiation of Alternative Treatment|0|||
105622743|NCT03088878|364282133|FG001|Overall Study|Initiation of Alternative Treatment|0|||
105622744|NCT03088878|364282134|FG002|Overall Study|Initiation of Alternative Treatment|0|||
105622745|NCT03088878|364282135|FG003|Overall Study|Initiation of Alternative Treatment|1|||
105622746|NCT03088878|364282136|FG004|Overall Study|Initiation of Alternative Treatment|0|||
105622747|NCT03088878|364282137|FG005|Overall Study|Initiation of Alternative Treatment|0|||
105622748|NCT03088878|364282138|FG006|Overall Study|Initiation of Alternative Treatment|0|||
105622749|NCT03088878|364282139|FG007|Overall Study|Initiation of Alternative Treatment|1|||
105622750|NCT03088878|364282140|FG008|Overall Study|Initiation of Alternative Treatment|1|||
105622751|NCT03088878|364282141|FG009|Overall Study|Initiation of Alternative Treatment|0|||
105622752|NCT03088878|364282142|FG010|Overall Study|Initiation of Alternative Treatment|0|||
105622753|NCT03088878|364282143|FG011|Overall Study|Initiation of Alternative Treatment|0|||
105622754|NCT03088878|364282144|FG012|Overall Study|Initiation of Alternative Treatment|0|||
105622755|NCT03088878|364282145|FG013|Overall Study|Initiation of Alternative Treatment|0|||
105622756|NCT03088878|364282132|FG000|Overall Study|Withdrawal by Subject|0|||
105622757|NCT03088878|364282133|FG001|Overall Study|Withdrawal by Subject|0|||
105622758|NCT03088878|364282134|FG002|Overall Study|Withdrawal by Subject|0|||
105622759|NCT03088878|364282135|FG003|Overall Study|Withdrawal by Subject|1|||
105622760|NCT03088878|364282136|FG004|Overall Study|Withdrawal by Subject|4|||
105622761|NCT03088878|364282137|FG005|Overall Study|Withdrawal by Subject|1|||
105622762|NCT03088878|364282138|FG006|Overall Study|Withdrawal by Subject|1|||
105622763|NCT03088878|364282139|FG007|Overall Study|Withdrawal by Subject|0|||
105622764|NCT03088878|364282140|FG008|Overall Study|Withdrawal by Subject|1|||
105622765|NCT03088878|364282141|FG009|Overall Study|Withdrawal by Subject|2|||
105622766|NCT03088878|364282142|FG010|Overall Study|Withdrawal by Subject|0|||
105622767|NCT03088878|364282143|FG011|Overall Study|Withdrawal by Subject|2|||
105622768|NCT03088878|364282144|FG012|Overall Study|Withdrawal by Subject|1|||
105622769|NCT03088878|364282145|FG013|Overall Study|Withdrawal by Subject|0|||
105622770|NCT03088878|364282132|FG000|Overall Study|Terminated by Sponsor|2|||
105622771|NCT03088878|364282133|FG001|Overall Study|Terminated by Sponsor|1|||
105622772|NCT03088878|364282134|FG002|Overall Study|Terminated by Sponsor|0|||
105622773|NCT03088878|364282135|FG003|Overall Study|Terminated by Sponsor|1|||
105622774|NCT03088878|364282136|FG004|Overall Study|Terminated by Sponsor|6|||
105622775|NCT03088878|364282137|FG005|Overall Study|Terminated by Sponsor|0|||
105622776|NCT03088878|364282138|FG006|Overall Study|Terminated by Sponsor|0|||
105622777|NCT03088878|364282139|FG007|Overall Study|Terminated by Sponsor|0|||
105622778|NCT03088878|364282140|FG008|Overall Study|Terminated by Sponsor|0|||
105622779|NCT03088878|364282141|FG009|Overall Study|Terminated by Sponsor|0|||
105622780|NCT03088878|364282142|FG010|Overall Study|Terminated by Sponsor|3|||
105622781|NCT03088878|364282143|FG011|Overall Study|Terminated by Sponsor|13|||
105622782|NCT03088878|364282144|FG012|Overall Study|Terminated by Sponsor|2|||
105622783|NCT03088878|364282145|FG013|Overall Study|Terminated by Sponsor|1|||
105622784|NCT03088878|364282132|FG000|Overall Study|Completed 2 years of Treatment|0|||
105622785|NCT03088878|364282133|FG001|Overall Study|Completed 2 years of Treatment|0|||
105622786|NCT03088878|364282134|FG002|Overall Study|Completed 2 years of Treatment|0|||
105622787|NCT03088878|364282135|FG003|Overall Study|Completed 2 years of Treatment|0|||
105622788|NCT03088878|364282136|FG004|Overall Study|Completed 2 years of Treatment|0|||
105622789|NCT03088878|364282137|FG005|Overall Study|Completed 2 years of Treatment|0|||
105622790|NCT03088878|364282138|FG006|Overall Study|Completed 2 years of Treatment|1|||
105622791|NCT03088878|364282139|FG007|Overall Study|Completed 2 years of Treatment|0|||
105622792|NCT03088878|364282140|FG008|Overall Study|Completed 2 years of Treatment|0|||
105622793|NCT03088878|364282141|FG009|Overall Study|Completed 2 years of Treatment|1|||
105622794|NCT03088878|364282142|FG010|Overall Study|Completed 2 years of Treatment|0|||
105622795|NCT03088878|364282143|FG011|Overall Study|Completed 2 years of Treatment|0|||
105622796|NCT03088878|364282144|FG012|Overall Study|Completed 2 years of Treatment|8|||
105622797|NCT03088878|364282145|FG013|Overall Study|Completed 2 years of Treatment|3|||
105622798|NCT03088878|364282132|FG000|Overall Study|Physician Decision|0|||
105622799|NCT03088878|364282133|FG001|Overall Study|Physician Decision|0|||
105622800|NCT03088878|364282134|FG002|Overall Study|Physician Decision|0|||
105622801|NCT03088878|364282135|FG003|Overall Study|Physician Decision|0|||
105622802|NCT03088878|364282136|FG004|Overall Study|Physician Decision|0|||
105622803|NCT03088878|364282137|FG005|Overall Study|Physician Decision|0|||
105622804|NCT03088878|364282138|FG006|Overall Study|Physician Decision|0|||
105622805|NCT03088878|364282139|FG007|Overall Study|Physician Decision|2|||
105622806|NCT03088878|364282140|FG008|Overall Study|Physician Decision|1|||
105622807|NCT03088878|364282141|FG009|Overall Study|Physician Decision|0|||
105622808|NCT03088878|364282142|FG010|Overall Study|Physician Decision|0|||
105622809|NCT03088878|364282143|FG011|Overall Study|Physician Decision|0|||
105622810|NCT03088878|364282144|FG012|Overall Study|Physician Decision|0|||
105622811|NCT03088878|364282145|FG013|Overall Study|Physician Decision|1|||
105622812|NCT03088878|364282132|FG000|Overall Study|COVID Related noncompliance|0|||
105622813|NCT03088878|364282133|FG001|Overall Study|COVID Related noncompliance|0|||
105622814|NCT03088878|364282134|FG002|Overall Study|COVID Related noncompliance|0|||
105622815|NCT03088878|364282135|FG003|Overall Study|COVID Related noncompliance|0|||
105622816|NCT03088878|364282136|FG004|Overall Study|COVID Related noncompliance|0|||
105622817|NCT03088878|364282137|FG005|Overall Study|COVID Related noncompliance|0|||
105622818|NCT03088878|364282138|FG006|Overall Study|COVID Related noncompliance|0|||
105622819|NCT03088878|364282139|FG007|Overall Study|COVID Related noncompliance|0|||
105622820|NCT03088878|364282140|FG008|Overall Study|COVID Related noncompliance|0|||
105622821|NCT03088878|364282141|FG009|Overall Study|COVID Related noncompliance|0|||
105622822|NCT03088878|364282142|FG010|Overall Study|COVID Related noncompliance|0|||
105622823|NCT03088878|364282143|FG011|Overall Study|COVID Related noncompliance|0|||
105622824|NCT03088878|364282144|FG012|Overall Study|COVID Related noncompliance|0|||
105622825|NCT03088878|364282145|FG013|Overall Study|COVID Related noncompliance|1|||
105622826|NCT03088878|364282132|FG000|Overall Study|Drug or Study Noncompliance|0|||
105622827|NCT03088878|364282133|FG001|Overall Study|Drug or Study Noncompliance|0|||
105622828|NCT03088878|364282134|FG002|Overall Study|Drug or Study Noncompliance|0|||
105622829|NCT03088878|364282135|FG003|Overall Study|Drug or Study Noncompliance|0|||
105622830|NCT03088878|364282136|FG004|Overall Study|Drug or Study Noncompliance|0|||
105622831|NCT03088878|364282137|FG005|Overall Study|Drug or Study Noncompliance|0|||
105622832|NCT03088878|364282138|FG006|Overall Study|Drug or Study Noncompliance|0|||
105622833|NCT03088878|364282139|FG007|Overall Study|Drug or Study Noncompliance|0|||
105622834|NCT03088878|364282140|FG008|Overall Study|Drug or Study Noncompliance|0|||
105622835|NCT03088878|364282141|FG009|Overall Study|Drug or Study Noncompliance|0|||
105622836|NCT03088878|364282142|FG010|Overall Study|Drug or Study Noncompliance|0|||
105622837|NCT03088878|364282143|FG011|Overall Study|Drug or Study Noncompliance|0|||
105622838|NCT03088878|364282144|FG012|Overall Study|Drug or Study Noncompliance|1|||
105622839|NCT03088878|364282145|FG013|Overall Study|Drug or Study Noncompliance|0|||
105622840|NCT02724969|364282146|FG000|Overall Study|Lost to Follow-up|12|||
105622841|NCT02724969|364282147|FG001|Overall Study|Lost to Follow-up|6|||
105622842|NCT02724969|364282146|FG000|Overall Study|Withdrawal by Subject|3|||
105622843|NCT02724969|364282147|FG001|Overall Study|Withdrawal by Subject|3|||
105622844|NCT02724969|364282146|FG000|Overall Study|Infant demise|0|||
105622845|NCT02724969|364282147|FG001|Overall Study|Infant demise|2|||
105622846|NCT03362476|364282149|FG000|Overall Study|Withdrawal by Subject|0|||
105622847|NCT03362476|364282150|FG001|Overall Study|Withdrawal by Subject|1|||
105622848|NCT04230681|364282151|FG000|Overall Study|Physician Decision|2|||
105622849|NCT04230681|364282152|FG001|Overall Study|Physician Decision|3|||
105622850|NCT04230681|364282151|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
105622851|NCT04230681|364282152|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
105622852|NCT04230681|364282151|FG000|Overall Study|IV inadvertently removed|0|||
105622853|NCT04230681|364282152|FG001|Overall Study|IV inadvertently removed|1|||
105622854|NCT03527043|364283771|FG000|Overall Study|Withdrawal by Subject|1|||
105622855|NCT03527043|364283772|FG001|Overall Study|Withdrawal by Subject|0|||
105622856|NCT03974178|364283773|FG000|Overall Study|Death|0|||
105622857|NCT03974178|364283774|FG001|Overall Study|Death|1|||
105622858|NCT02433379|364283779|FG000|Overall Study|Screen Failures|55|||
105622859|NCT02433379|364283779|FG000|Overall Study|Death|57|||
105622860|NCT02433379|364283779|FG000|Overall Study|Total Withdrawals|209|||
105622861|NCT03483038|364283780|FG000|Overall Study|Subjects still in follow-up|18|||
105622862|NCT02505984|364283781|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
105622863|NCT02505984|364283782|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
105622864|NCT02505984|364283781|FG000|Overall Study|Unreliable self-report data|1|||
105622865|NCT02505984|364283782|FG001|Overall Study|Unreliable self-report data|0|||
105622866|NCT02505984|364283781|FG000|Overall Study|Study blind opened during assessment|0|||
105622867|NCT02505984|364283782|FG001|Overall Study|Study blind opened during assessment|1|||
105622868|NCT02505984|364283781|FG000|Overall Study|Noncompliance with study protocol|0|||
105622869|NCT02505984|364283782|FG001|Overall Study|Noncompliance with study protocol|1|||
105622870|NCT04362254|364283789|FG000|Overall Study|Adverse Event|1|||
105622871|NCT04362254|364283789|FG000|Overall Study|Protocol Violation|1|||
105622872|NCT04362254|364283789|FG000|Overall Study|Due to early termination of the trial|10|||
105622873|NCT04568434|364283790|FG000|Overall Study|Voluntary Withdrawal|0|||
105622874|NCT04568434|364283791|FG001|Overall Study|Voluntary Withdrawal|1|||
105622875|NCT04568434|364283792|FG002|Overall Study|Voluntary Withdrawal|1|||
105622876|NCT04568434|364283790|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
105622877|NCT04568434|364283791|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
105622878|NCT04568434|364283792|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
105622879|NCT04568434|364283790|FG000|Overall Study|Investigator Judgement|1|||
105622880|NCT04568434|364283791|FG001|Overall Study|Investigator Judgement|0|||
105622881|NCT04568434|364283792|FG002|Overall Study|Investigator Judgement|0|||
105622882|NCT05469464|364283793|FG000|Overall Study|Withdrawal by Subject|8|||
105622883|NCT05469464|364283794|FG001|Overall Study|Withdrawal by Subject|7|||
105622884|NCT05469464|364283795|FG002|Overall Study|Withdrawal by Subject|4|||
105622885|NCT05469464|364283796|FG003|Overall Study|Withdrawal by Subject|5|||
105622886|NCT05469464|364283793|FG000|Overall Study|Adverse Event|8|||
105622887|NCT05469464|364283794|FG001|Overall Study|Adverse Event|14|||
105622888|NCT05469464|364283795|FG002|Overall Study|Adverse Event|13|||
105622889|NCT05469464|364283796|FG003|Overall Study|Adverse Event|2|||
105622890|NCT05469464|364283793|FG000|Overall Study|Lost to Follow-up|2|||
105622891|NCT05469464|364283794|FG001|Overall Study|Lost to Follow-up|5|||
105622892|NCT05469464|364283795|FG002|Overall Study|Lost to Follow-up|3|||
105622893|NCT05469464|364283796|FG003|Overall Study|Lost to Follow-up|3|||
105622894|NCT05469464|364283793|FG000|Overall Study|Lack of Efficacy|4|||
105622895|NCT05469464|364283794|FG001|Overall Study|Lack of Efficacy|1|||
105622896|NCT05469464|364283795|FG002|Overall Study|Lack of Efficacy|2|||
105622897|NCT05469464|364283796|FG003|Overall Study|Lack of Efficacy|2|||
105622898|NCT05469464|364283793|FG000|Overall Study|Physician Decision|0|||
105622899|NCT05469464|364283794|FG001|Overall Study|Physician Decision|0|||
105622900|NCT05469464|364283795|FG002|Overall Study|Physician Decision|0|||
105622901|NCT05469464|364283796|FG003|Overall Study|Physician Decision|1|||
105622902|NCT04730739|364283800|FG000|Overall Study|Death|1|||
105622903|NCT05170841|364283802|FG000|Single Dose Phase|Adverse Event|1|||
105622904|NCT05170841|364283803|FG001|Single Dose Phase|Adverse Event|2|||
105622905|NCT05170841|364283804|FG002|Single Dose Phase|Adverse Event|0|||
105622906|NCT05170841|364283805|FG003|Single Dose Phase|Adverse Event|2|||
105622907|NCT05170841|364283802|FG000|Multiple Dose Phase|Adverse Event|1|||
105622908|NCT05170841|364283803|FG001|Multiple Dose Phase|Adverse Event|2|||
105622909|NCT05170841|364283804|FG002|Multiple Dose Phase|Adverse Event|1|||
105622910|NCT05170841|364283805|FG003|Multiple Dose Phase|Adverse Event|4|||
105622911|NCT05170841|364283802|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
105622912|NCT05170841|364283803|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
105622913|NCT05170841|364283804|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
105622914|NCT05170841|364283805|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
105622915|NCT03308877|364283808|FG000|Overall Study|Lost to Follow-up|32|||
105622916|NCT03308877|364283809|FG001|Overall Study|Lost to Follow-up|28|||
105622917|NCT05123586|364283810|FG000|Overall Study|Physician Decision|1|||
105622918|NCT05123586|364283811|FG001|Overall Study|Physician Decision|1|||
105622919|NCT05123586|364283810|FG000|Overall Study|Withdrawal by Subject|0|||
105622920|NCT05123586|364283811|FG001|Overall Study|Withdrawal by Subject|3|||
105622921|NCT04865289|364283816|FG000|Overall Study|Participant ongoing in study|47|||
105622922|NCT04865289|364283817|FG001|Overall Study|Participant ongoing in study|35|||
105622923|NCT04865289|364283816|FG000|Overall Study|Death|27|||
105622924|NCT04865289|364283817|FG001|Overall Study|Death|21|||
105622925|NCT04677738|364283827|FG000|Overall Study|Withdrawal by Subject|4|||
105622926|NCT04677738|364283828|FG001|Overall Study|Withdrawal by Subject|2|||
105622927|NCT04707469|364283829|FG000|Overall Study|Site closure|0|||
105622928|NCT04707469|364283830|FG001|Overall Study|Site closure|2|||
105622929|NCT04707469|364283831|FG002|Overall Study|Site closure|0|||
105622930|NCT04707469|364283829|FG000|Overall Study|Physician Decision|2|||
105622931|NCT04707469|364283830|FG001|Overall Study|Physician Decision|2|||
105622932|NCT04707469|364283831|FG002|Overall Study|Physician Decision|2|||
105622933|NCT04707469|364283829|FG000|Overall Study|Death|1|||
105622934|NCT04707469|364283830|FG001|Overall Study|Death|6|||
105622935|NCT04707469|364283831|FG002|Overall Study|Death|2|||
105622936|NCT04707469|364283829|FG000|Overall Study|Lost to Follow-up|9|||
105622937|NCT04707469|364283830|FG001|Overall Study|Lost to Follow-up|19|||
105622938|NCT04707469|364283831|FG002|Overall Study|Lost to Follow-up|14|||
105622939|NCT04707469|364283829|FG000|Overall Study|Withdrawal by Subject|17|||
105622940|NCT04707469|364283830|FG001|Overall Study|Withdrawal by Subject|16|||
105622941|NCT04707469|364283831|FG002|Overall Study|Withdrawal by Subject|12|||
105622942|NCT03734679|364283844|FG000|Overall Study|Missed Visit|1|||
105622943|NCT03249090|364283850|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
105622944|NCT03249090|364283851|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
105622945|NCT03249090|364283850|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
105622946|NCT03249090|364283851|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
105622947|NCT03249090|364283850|FG000|3 Month Time Point|Voluntary withdrawal|6|||
105622948|NCT03249090|364283851|FG001|3 Month Time Point|Voluntary withdrawal|3|||
105622949|NCT03249090|364283850|FG000|3 Month Time Point|Changed oncology practice|4|||
105622950|NCT03249090|364283851|FG001|3 Month Time Point|Changed oncology practice|2|||
105622951|NCT03249090|364283850|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
105622952|NCT03249090|364283851|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
105622953|NCT03249090|364283850|FG000|12 Month Time Point|Voluntary withdrawal|35|||
105622954|NCT03249090|364283851|FG001|12 Month Time Point|Voluntary withdrawal|4|||
105622955|NCT03249090|364283850|FG000|12 Month Time Point|Changed oncology practice|20|||
105622956|NCT03249090|364283851|FG001|12 Month Time Point|Changed oncology practice|9|||
105622957|NCT04635423|364283855|FG000|Overall Study|Ongoing|493|||
105622958|NCT04635423|364283856|FG001|Overall Study|Ongoing|501|||
105622959|NCT04635423|364283855|FG000|Overall Study|Withdrawal by Subject|36|||
105622960|NCT04635423|364283856|FG001|Overall Study|Withdrawal by Subject|29|||
105622961|NCT02733159|364283857|FG000|Overall Study|Adverse Event|1|||
105622962|NCT02733159|364283857|FG000|Overall Study|Lack of disease progression|1|||
105622963|NCT01346540|364283860|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
105622964|NCT01346540|364283861|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
105622965|NCT01346540|364283860|FG000|Overall Study|Adverse Event|0|||
105622966|NCT01346540|364283861|FG001|Overall Study|Adverse Event|4|||
105622967|NCT05216406|364283862|FG000|Overall Study|Lost to Follow-up|8|||
105622968|NCT05216406|364283863|FG001|Overall Study|Lost to Follow-up|9|||
105622969|NCT05974501|364283866|FG000|Overall Study|Physician Decision|0|||
105622970|NCT05974501|364283867|FG001|Overall Study|Physician Decision|1|||
105622971|NCT01236781|364283874|FG000|Overall Study|Ineligible|2|||
105622972|NCT01236781|364283875|FG001|Overall Study|Ineligible|1|||
105622973|NCT01236781|364283874|FG000|Overall Study|Did not complete study imaging|5|||
105622974|NCT01236781|364283875|FG001|Overall Study|Did not complete study imaging|0|||
105622975|NCT04587453|364283876|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
105622976|NCT04587453|364283877|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
105622977|NCT03213665|364283878|FG000|Overall Study|Adverse Event|1|||
105622978|NCT03213665|364283878|FG000|Overall Study|Physician Decision|2|||
105622979|NCT03213665|364283878|FG000|Overall Study|Withdrawal by Subject|3|||
105622980|NCT03213665|364283878|FG000|Overall Study|Progressive Disease|13|||
105622981|NCT03325985|364283879|FG000|Overall Study|Lost to Follow-up|122|||
105622982|NCT03325985|364283880|FG001|Overall Study|Lost to Follow-up|26|||
105622983|NCT03325985|364283881|FG002|Overall Study|Lost to Follow-up|141|||
105622984|NCT03325985|364283882|FG003|Overall Study|Lost to Follow-up|28|||
105622985|NCT03325985|364283879|FG000|Overall Study|Death|99|||
105622986|NCT03325985|364283880|FG001|Overall Study|Death|36|||
105622987|NCT03325985|364283881|FG002|Overall Study|Death|94|||
105622988|NCT03325985|364283882|FG003|Overall Study|Death|32|||
105622989|NCT03056573|364283883|FG000|Overall Study|Death|2|||
105622990|NCT03056573|364283884|FG001|Overall Study|Death|4|||
105622991|NCT03056573|364283883|FG000|Overall Study|Withdrawal by Subject|2|||
105622992|NCT03056573|364283884|FG001|Overall Study|Withdrawal by Subject|0|||
105622993|NCT03056573|364283883|FG000|Overall Study|Lost to Follow-up|1|||
105622994|NCT03056573|364283884|FG001|Overall Study|Lost to Follow-up|1|||
105622995|NCT03556293|364283885|FG000|Overall Study|Ineligible for analysis|1904|||
105622996|NCT03556293|364283886|FG001|Overall Study|Ineligible for analysis|1471|||
105622997|NCT03556293|364283887|FG002|Overall Study|Ineligible for analysis|1091|||
105622998|NCT03556293|364283888|FG003|Overall Study|Ineligible for analysis|1269|||
105622999|NCT05104463|364283889|FG000|Overall Study|Adverse Event|1|||
105623000|NCT05104463|364283890|FG001|Overall Study|Adverse Event|1|||
105623001|NCT05104463|364283889|FG000|Overall Study|Lost to Follow-up|1|||
105623002|NCT05104463|364283890|FG001|Overall Study|Lost to Follow-up|1|||
105623003|NCT05104463|364283889|FG000|Overall Study|Physician Decision|1|||
105623004|NCT05104463|364283890|FG001|Overall Study|Physician Decision|0|||
105623005|NCT05104463|364283889|FG000|Overall Study|Protocol Violation|0|||
105623006|NCT05104463|364283890|FG001|Overall Study|Protocol Violation|2|||
105623007|NCT05104463|364283889|FG000|Overall Study|Withdrawal by Subject|1|||
105623008|NCT05104463|364283890|FG001|Overall Study|Withdrawal by Subject|1|||
105623009|NCT05002088|364285428|FG000|Overall Study|Withdrawal by Subject|9|||
105623010|NCT05002088|364285429|FG001|Overall Study|Withdrawal by Subject|0|||
105623011|NCT05002088|364285428|FG000|Overall Study|Lost to Follow-up|0|||
105623012|NCT05002088|364285429|FG001|Overall Study|Lost to Follow-up|1|||
105623013|NCT05002088|364285428|FG000|Overall Study|Death|16|||
105623014|NCT05002088|364285429|FG001|Overall Study|Death|2|||
105623015|NCT05002088|364285428|FG000|Overall Study|Protocol Violation|25|||
105623016|NCT05002088|364285429|FG001|Overall Study|Protocol Violation|7|||
105623017|NCT04068181|364285430|FG000|Overall Study|Death|17|||
105623018|NCT04068181|364285431|FG001|Overall Study|Death|12|||
105623019|NCT04068181|364285432|FG002|Overall Study|Death|4|||
105623020|NCT04068181|364285433|FG003|Overall Study|Death|7|||
105623021|NCT04068181|364285430|FG000|Overall Study|Lost to Follow-up|1|||
105623022|NCT04068181|364285431|FG001|Overall Study|Lost to Follow-up|0|||
105623023|NCT04068181|364285432|FG002|Overall Study|Lost to Follow-up|0|||
105623024|NCT04068181|364285433|FG003|Overall Study|Lost to Follow-up|0|||
105623025|NCT04068181|364285430|FG000|Overall Study|Withdrawal of consent from study|3|||
105623026|NCT04068181|364285431|FG001|Overall Study|Withdrawal of consent from study|0|||
105623027|NCT04068181|364285432|FG002|Overall Study|Withdrawal of consent from study|0|||
105623028|NCT04068181|364285433|FG003|Overall Study|Withdrawal of consent from study|0|||
105623029|NCT02134925|364285436|FG000|Overall Study|Withdrawal by Subject|1|||
105623030|NCT02134925|364285437|FG001|Overall Study|Withdrawal by Subject|0|||
105623031|NCT02134925|364285436|FG000|Overall Study|Cancel|1|||
105623032|NCT02134925|364285437|FG001|Overall Study|Cancel|6|||
105623033|NCT04770402|364285444|FG000|Overall Study|Lost to Follow-up|1|||
105623034|NCT04770402|364285445|FG001|Overall Study|Lost to Follow-up|2|||
105623035|NCT04770402|364285444|FG000|Overall Study|Non-compliance|1|||
105623036|NCT04770402|364285445|FG001|Overall Study|Non-compliance|0|||
105623037|NCT04770402|364285444|FG000|Overall Study|Withdrawal by Subject|0|||
105623038|NCT04770402|364285445|FG001|Overall Study|Withdrawal by Subject|1|||
105623039|NCT05274074|364285446|FG000|Overall Study|Lost to Follow-up|2|||
105623040|NCT05274074|364285447|FG001|Overall Study|Lost to Follow-up|3|||
105623041|NCT05274074|364285446|FG000|Overall Study|Withdrawal by Subject|1|||
105623042|NCT05274074|364285447|FG001|Overall Study|Withdrawal by Subject|2|||
105623043|NCT01208662|364285452|FG000|Induction and Consolidation|Disease Progression|23|||
105623044|NCT01208662|364285453|FG001|Induction and Consolidation|Disease Progression|13|||
105623045|NCT01208662|364285454|FG002|Induction and Consolidation|Disease Progression|0|||
105623046|NCT01208662|364285452|FG000|Induction and Consolidation|Adverse Event|16|||
105623047|NCT01208662|364285453|FG001|Induction and Consolidation|Adverse Event|18|||
105623048|NCT01208662|364285454|FG002|Induction and Consolidation|Adverse Event|2|||
105623049|NCT01208662|364285452|FG000|Induction and Consolidation|MD or Participant Decision|16|||
105623050|NCT01208662|364285453|FG001|Induction and Consolidation|MD or Participant Decision|34|||
105623051|NCT01208662|364285454|FG002|Induction and Consolidation|MD or Participant Decision|4|||
105623052|NCT01208662|364285452|FG000|Induction and Consolidation|Death|1|||
105623053|NCT01208662|364285453|FG001|Induction and Consolidation|Death|3|||
105623054|NCT01208662|364285454|FG002|Induction and Consolidation|Death|1|||
105623055|NCT01208662|364285452|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
105623056|NCT01208662|364285453|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
105623057|NCT01208662|364285454|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
105623058|NCT01208662|364285452|FG000|Maintenance|Disease Progression|156|||
105623059|NCT01208662|364285453|FG001|Maintenance|Disease Progression|102|||
105623060|NCT01208662|364285454|FG002|Maintenance|Disease Progression|0|||
105623061|NCT01208662|364285452|FG000|Maintenance|Adverse Event|12|||
105623062|NCT01208662|364285453|FG001|Maintenance|Adverse Event|28|||
105623063|NCT01208662|364285454|FG002|Maintenance|Adverse Event|0|||
105623064|NCT01208662|364285452|FG000|Maintenance|MD or Participant Decision|24|||
105623065|NCT01208662|364285453|FG001|Maintenance|MD or Participant Decision|36|||
105623066|NCT01208662|364285454|FG002|Maintenance|MD or Participant Decision|0|||
105623067|NCT01208662|364285452|FG000|Maintenance|Death|0|||
105623068|NCT01208662|364285453|FG001|Maintenance|Death|3|||
105623069|NCT01208662|364285454|FG002|Maintenance|Death|0|||
105623070|NCT01208662|364285452|FG000|Maintenance|Discontinued for other reasons|21|||
105623071|NCT01208662|364285453|FG001|Maintenance|Discontinued for other reasons|31|||
105623072|NCT01208662|364285454|FG002|Maintenance|Discontinued for other reasons|0|||
105623073|NCT01208662|364285452|FG000|Maintenance|Still on Treatment|78|||
105623074|NCT01208662|364285453|FG001|Maintenance|Still on Treatment|89|||
105623075|NCT01208662|364285454|FG002|Maintenance|Still on Treatment|0|||
105623076|NCT04076618|364285455|FG000|Overall Study|Lost to Follow-up|2|||
105623077|NCT04076618|364285456|FG001|Overall Study|Lost to Follow-up|1|||
105623078|NCT04076618|364285457|FG002|Overall Study|Lost to Follow-up|3|||
105623079|NCT04076618|364285455|FG000|Overall Study|Withdrawal by Subject|3|||
105623080|NCT04076618|364285456|FG001|Overall Study|Withdrawal by Subject|1|||
105623081|NCT04076618|364285457|FG002|Overall Study|Withdrawal by Subject|2|||
105623082|NCT04076618|364285455|FG000|Overall Study|Relocated out of state|0|||
105623083|NCT04076618|364285456|FG001|Overall Study|Relocated out of state|2|||
105623084|NCT04076618|364285457|FG002|Overall Study|Relocated out of state|0|||
105623085|NCT04076618|364285455|FG000|Overall Study|COVID concerns|0|||
105623086|NCT04076618|364285456|FG001|Overall Study|COVID concerns|1|||
105623087|NCT04076618|364285457|FG002|Overall Study|COVID concerns|0|||
105623088|NCT04076618|364285455|FG000|Overall Study|Adverse Event|0|||
105623089|NCT04076618|364285456|FG001|Overall Study|Adverse Event|0|||
105623090|NCT04076618|364285457|FG002|Overall Study|Adverse Event|2|||
105623091|NCT04707625|364285458|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
105623092|NCT00321048|364285459|FG000|Overall Study|Withdrawal by Subject|6|||
105623093|NCT00321048|364285460|FG001|Overall Study|Withdrawal by Subject|8|||
105623094|NCT04433208|364285461|FG000|Overall Study|Withdrawal by Subject|0|||
105623095|NCT04433208|364285462|FG001|Overall Study|Withdrawal by Subject|1|||
105623096|NCT04433208|364285463|FG002|Overall Study|Withdrawal by Subject|1|||
105623097|NCT04433208|364285464|FG003|Overall Study|Withdrawal by Subject|0|||
105623098|NCT04433208|364285465|FG004|Overall Study|Withdrawal by Subject|2|||
105623099|NCT04433208|364285466|FG005|Overall Study|Withdrawal by Subject|1|||
105623100|NCT04433208|364285461|FG000|Overall Study|Lost to Follow-up|0|||
105623101|NCT04433208|364285462|FG001|Overall Study|Lost to Follow-up|0|||
105623102|NCT04433208|364285463|FG002|Overall Study|Lost to Follow-up|0|||
105623103|NCT04433208|364285464|FG003|Overall Study|Lost to Follow-up|0|||
105623104|NCT04433208|364285465|FG004|Overall Study|Lost to Follow-up|0|||
105623105|NCT04433208|364285466|FG005|Overall Study|Lost to Follow-up|1|||
105623106|NCT06473662|364285467|FG000|Overall Study|Withdrawal by Subject|1|||
105623107|NCT06473662|364285468|FG001|Overall Study|Withdrawal by Subject|6|||
105623108|NCT06473662|364285469|FG002|Overall Study|Withdrawal by Subject|5|||
105623109|NCT06473662|364285467|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
105623110|NCT06473662|364285468|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
105623111|NCT06473662|364285469|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
105623112|NCT06473662|364285467|FG000|Overall Study|Starting HbA1c below 7%|0|||
105623113|NCT06473662|364285468|FG001|Overall Study|Starting HbA1c below 7%|1|||
105623114|NCT06473662|364285469|FG002|Overall Study|Starting HbA1c below 7%|1|||
105623115|NCT06473662|364285467|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
105623116|NCT06473662|364285468|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
105623117|NCT06473662|364285469|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
105623118|NCT06473662|364285467|FG000|Overall Study|Did not take medication|2|||
105623119|NCT06473662|364285468|FG001|Overall Study|Did not take medication|3|||
105623120|NCT06473662|364285469|FG002|Overall Study|Did not take medication|2|||
105623121|NCT03209973|364285470|FG000|Overall Study|Withdrawal by Subject|7|||
105623122|NCT03209973|364285470|FG000|Overall Study|Lost to Follow-up|2|||
105623123|NCT03209973|364285470|FG000|Overall Study|Death|8|||
105623124|NCT03209973|364285470|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
105623125|NCT03209973|364285470|FG000|Overall Study|Sponsor Decision|18|||
105623126|NCT03209973|364285470|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
105623127|NCT03209973|364285470|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
105623128|NCT04066205|364285471|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
105623129|NCT04066205|364285472|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
105623130|NCT04066205|364285471|FG000|T2 Immediate Post-Intervention|did not respond|5|||
105623131|NCT04066205|364285472|FG001|T2 Immediate Post-Intervention|did not respond|3|||
105623132|NCT04778397|364285475|FG000|Overall Study|Death|59|||
105623133|NCT04778397|364285476|FG001|Overall Study|Death|54|||
105623134|NCT04778397|364285477|FG002|Overall Study|Death|11|||
105623135|NCT04778397|364285478|FG003|Overall Study|Death|9|||
105623136|NCT04778397|364285475|FG000|Overall Study|Study Terminated by Sponsor|34|||
105623137|NCT04778397|364285476|FG001|Overall Study|Study Terminated by Sponsor|42|||
105623138|NCT04778397|364285477|FG002|Overall Study|Study Terminated by Sponsor|15|||
105623139|NCT04778397|364285478|FG003|Overall Study|Study Terminated by Sponsor|12|||
105623140|NCT04778397|364285475|FG000|Overall Study|Withdrew Consent|5|||
105623141|NCT04778397|364285476|FG001|Overall Study|Withdrew Consent|4|||
105623142|NCT04778397|364285477|FG002|Overall Study|Withdrew Consent|1|||
105623143|NCT04778397|364285478|FG003|Overall Study|Withdrew Consent|1|||
105623144|NCT04778397|364285475|FG000|Overall Study|Reason Not Specified|1|||
105623145|NCT04778397|364285476|FG001|Overall Study|Reason Not Specified|3|||
105623146|NCT04778397|364285477|FG002|Overall Study|Reason Not Specified|0|||
105623147|NCT04778397|364285478|FG003|Overall Study|Reason Not Specified|2|||
105623148|NCT04778397|364285475|FG000|Overall Study|Lost to Follow-up|2|||
105623149|NCT04778397|364285476|FG001|Overall Study|Lost to Follow-up|1|||
105623150|NCT04778397|364285477|FG002|Overall Study|Lost to Follow-up|0|||
105623151|NCT04778397|364285478|FG003|Overall Study|Lost to Follow-up|1|||
105623152|NCT04294641|364285479|FG000|Overall Study|Screen failure|4|||
105623153|NCT05906784|364285480|FG000|Overall Study|Lost to Follow-up|2|||
105623154|NCT05906784|364285481|FG001|Overall Study|Lost to Follow-up|1|||
105623155|NCT05906784|364285482|FG002|Overall Study|Lost to Follow-up|1|||
105623156|NCT05906784|364285483|FG003|Overall Study|Lost to Follow-up|1|||
105623157|NCT00792948|364285486|FG000|Overall Study|Adverse Event|6|||
105623158|NCT00792948|364285486|FG000|Overall Study|Death|4|||
105623159|NCT00792948|364285486|FG000|Overall Study|Withdrawal by Subject|3|||
105623160|NCT00792948|364285486|FG000|Overall Study|Ineligible|2|||
105623161|NCT00792948|364285486|FG000|Overall Study|Insurance denial - not treated|1|||
105623162|NCT00792948|364285486|FG000|Overall Study|Physician Decision|11|||
105623163|NCT00792948|364285486|FG000|Overall Study|Protocol Violation|1|||
105623164|NCT04359654|364285495|FG000|Overall Study|Withdrawal by Subject|1|||
105623165|NCT04359654|364285496|FG001|Overall Study|Withdrawal by Subject|0|||
105623166|NCT04359654|364285495|FG000|Overall Study|Adverse Event|0|||
105623167|NCT04359654|364285496|FG001|Overall Study|Adverse Event|1|||
105623168|NCT03523572|364285502|FG000|Dose Escalation|Progressive disease|1|||
105623169|NCT03523572|364285503|FG001|Dose Escalation|Progressive disease|0|||
105623170|NCT03523572|364285504|FG002|Dose Escalation|Progressive disease|0|||
105623171|NCT03523572|364285505|FG003|Dose Escalation|Progressive disease|0|||
105623172|NCT03523572|364285506|FG004|Dose Escalation|Progressive disease|0|||
105623173|NCT03523572|364285507|FG005|Dose Escalation|Progressive disease|0|||
105623174|NCT03523572|364285502|FG000|Dose Escalation|Clinical Progression|0|||
105623175|NCT03523572|364285503|FG001|Dose Escalation|Clinical Progression|1|||
105623176|NCT03523572|364285504|FG002|Dose Escalation|Clinical Progression|0|||
105623177|NCT03523572|364285505|FG003|Dose Escalation|Clinical Progression|0|||
105623178|NCT03523572|364285506|FG004|Dose Escalation|Clinical Progression|0|||
105623179|NCT03523572|364285507|FG005|Dose Escalation|Clinical Progression|0|||
105623180|NCT03523572|364285502|FG000|Dose Escalation|Adverse Event|2|||
105623181|NCT03523572|364285503|FG001|Dose Escalation|Adverse Event|0|||
105623182|NCT03523572|364285504|FG002|Dose Escalation|Adverse Event|0|||
105623183|NCT03523572|364285505|FG003|Dose Escalation|Adverse Event|0|||
105623184|NCT03523572|364285506|FG004|Dose Escalation|Adverse Event|0|||
105623185|NCT03523572|364285507|FG005|Dose Escalation|Adverse Event|0|||
105623186|NCT03523572|364285502|FG000|Dose Escalation|Physician Decision|1|||
105623187|NCT03523572|364285503|FG001|Dose Escalation|Physician Decision|1|||
105623188|NCT03523572|364285504|FG002|Dose Escalation|Physician Decision|0|||
105623189|NCT03523572|364285505|FG003|Dose Escalation|Physician Decision|0|||
105623190|NCT03523572|364285506|FG004|Dose Escalation|Physician Decision|0|||
105623191|NCT03523572|364285507|FG005|Dose Escalation|Physician Decision|0|||
105623192|NCT03523572|364285502|FG000|Dose Expansion|Progressive Disease|0|||
105623193|NCT03523572|364285503|FG001|Dose Expansion|Progressive Disease|0|||
105623194|NCT03523572|364285504|FG002|Dose Expansion|Progressive Disease|9|||
105623195|NCT03523572|364285505|FG003|Dose Expansion|Progressive Disease|11|||
105623196|NCT03523572|364285506|FG004|Dose Expansion|Progressive Disease|15|||
105623197|NCT03523572|364285507|FG005|Dose Expansion|Progressive Disease|2|||
105623198|NCT03523572|364285502|FG000|Dose Expansion|Clinical Progression|0|||
105623199|NCT03523572|364285503|FG001|Dose Expansion|Clinical Progression|0|||
105623200|NCT03523572|364285504|FG002|Dose Expansion|Clinical Progression|2|||
105623201|NCT03523572|364285505|FG003|Dose Expansion|Clinical Progression|2|||
105623202|NCT03523572|364285506|FG004|Dose Expansion|Clinical Progression|2|||
105623203|NCT03523572|364285507|FG005|Dose Expansion|Clinical Progression|0|||
105623204|NCT03523572|364285502|FG000|Dose Expansion|Adverse Event|0|||
105623205|NCT03523572|364285503|FG001|Dose Expansion|Adverse Event|0|||
105623206|NCT03523572|364285504|FG002|Dose Expansion|Adverse Event|10|||
105623207|NCT03523572|364285505|FG003|Dose Expansion|Adverse Event|1|||
105623208|NCT03523572|364285506|FG004|Dose Expansion|Adverse Event|5|||
105623209|NCT03523572|364285507|FG005|Dose Expansion|Adverse Event|2|||
105623210|NCT03523572|364285502|FG000|Dose Expansion|Withdrawal by Subject|0|||
105623211|NCT03523572|364285503|FG001|Dose Expansion|Withdrawal by Subject|0|||
105623212|NCT03523572|364285504|FG002|Dose Expansion|Withdrawal by Subject|1|||
105623213|NCT03523572|364285505|FG003|Dose Expansion|Withdrawal by Subject|1|||
105623214|NCT03523572|364285506|FG004|Dose Expansion|Withdrawal by Subject|0|||
105623215|NCT03523572|364285507|FG005|Dose Expansion|Withdrawal by Subject|0|||
105623216|NCT03523572|364285502|FG000|Dose Expansion|Physician Decision|0|||
105623217|NCT03523572|364285503|FG001|Dose Expansion|Physician Decision|0|||
105623218|NCT03523572|364285504|FG002|Dose Expansion|Physician Decision|1|||
105623219|NCT03523572|364285505|FG003|Dose Expansion|Physician Decision|0|||
105623220|NCT03523572|364285506|FG004|Dose Expansion|Physician Decision|1|||
105623221|NCT03523572|364285507|FG005|Dose Expansion|Physician Decision|0|||
105623222|NCT03523572|364285502|FG000|Dose Expansion|Miscellaneous|0|||
105623223|NCT03523572|364285503|FG001|Dose Expansion|Miscellaneous|0|||
105623224|NCT03523572|364285504|FG002|Dose Expansion|Miscellaneous|0|||
105623225|NCT03523572|364285505|FG003|Dose Expansion|Miscellaneous|0|||
105623226|NCT03523572|364285506|FG004|Dose Expansion|Miscellaneous|3|||
105623227|NCT03523572|364285507|FG005|Dose Expansion|Miscellaneous|0|||
105623228|NCT05269966|364285508|FG000|Overall Study|Adverse Event|4|||
105623229|NCT05269966|364285508|FG000|Overall Study|Withdrawal by Subject|1|||
105623230|NCT05269966|364285508|FG000|Overall Study|Lost to Follow-up|4|||
105623231|NCT05269966|364285508|FG000|Overall Study|Physician Decision|1|||
105623232|NCT04685135|364285509|FG000|Overall Study|Death|126|||
105623233|NCT04685135|364285510|FG001|Overall Study|Death|53|||
105623234|NCT04685135|364285509|FG000|Overall Study|Withdrawal by Subject|12|||
105623235|NCT04685135|364285510|FG001|Overall Study|Withdrawal by Subject|16|||
105623236|NCT02603887|364285511|FG000|Stage 1|Adverse Event|4|||
105623237|NCT02603887|364285511|FG000|Stage 1|Disease progression|1|||
105623238|NCT02603887|364285511|FG000|Stage 2|FDA guidance|1|||
105623239|NCT03711474|364285523|FG000|Overall Study|Physician Decision|2|||
105623240|NCT03711474|364285524|FG001|Overall Study|Physician Decision|0|||
105623241|NCT03069352|364285525|FG000|Overall Study|Ongoing|12|||
105623242|NCT03069352|364285526|FG001|Overall Study|Ongoing|40|||
105623243|NCT04270942|364285527|FG000|Overall Study|Death|1|||
105623244|NCT05147116|364285532|FG000|Overall Study|Withdrawal by Subject|0|||
105623245|NCT05147116|364285533|FG001|Overall Study|Withdrawal by Subject|1|||
105623246|NCT04197336|364285534|FG000|Overall Study|Withdrawal by Subject|1|||
105623247|NCT04101357|364285535|FG000|Overall Study|Death|1|||
105623248|NCT04101357|364285536|FG001|Overall Study|Death|1|||
105623249|NCT04101357|364285537|FG002|Overall Study|Death|1|||
105623250|NCT04101357|364285538|FG003|Overall Study|Death|2|||
105623251|NCT04101357|364285539|FG004|Overall Study|Death|4|||
105623252|NCT04101357|364285540|FG005|Overall Study|Death|11|||
105623253|NCT04101357|364285541|FG006|Overall Study|Death|4|||
105623254|NCT04101357|364285542|FG007|Overall Study|Death|4|||
105623255|NCT04101357|364285543|FG008|Overall Study|Death|5|||
105623256|NCT04101357|364285544|FG009|Overall Study|Death|2|||
105623257|NCT04101357|364285545|FG010|Overall Study|Death|3|||
105623258|NCT04101357|364285535|FG000|Overall Study|Trial closure|0|||
105623259|NCT04101357|364285536|FG001|Overall Study|Trial closure|0|||
105623260|NCT04101357|364285537|FG002|Overall Study|Trial closure|0|||
105623261|NCT04101357|364285538|FG003|Overall Study|Trial closure|0|||
105623262|NCT04101357|364285539|FG004|Overall Study|Trial closure|0|||
105623263|NCT04101357|364285540|FG005|Overall Study|Trial closure|2|||
105623264|NCT04101357|364285541|FG006|Overall Study|Trial closure|2|||
105623265|NCT04101357|364285542|FG007|Overall Study|Trial closure|0|||
105623266|NCT04101357|364285543|FG008|Overall Study|Trial closure|0|||
105623267|NCT04101357|364285544|FG009|Overall Study|Trial closure|0|||
105623268|NCT04101357|364285545|FG010|Overall Study|Trial closure|1|||
105623269|NCT04101357|364285535|FG000|Overall Study|Lost to Follow-up|0|||
105623270|NCT04101357|364285536|FG001|Overall Study|Lost to Follow-up|0|||
105623271|NCT04101357|364285537|FG002|Overall Study|Lost to Follow-up|0|||
105623272|NCT04101357|364285538|FG003|Overall Study|Lost to Follow-up|1|||
105623273|NCT04101357|364285539|FG004|Overall Study|Lost to Follow-up|0|||
105623274|NCT04101357|364285540|FG005|Overall Study|Lost to Follow-up|0|||
105623275|NCT04101357|364285541|FG006|Overall Study|Lost to Follow-up|0|||
105623276|NCT04101357|364285542|FG007|Overall Study|Lost to Follow-up|1|||
105623277|NCT04101357|364285543|FG008|Overall Study|Lost to Follow-up|0|||
105623278|NCT04101357|364285544|FG009|Overall Study|Lost to Follow-up|0|||
105623279|NCT04101357|364285545|FG010|Overall Study|Lost to Follow-up|0|||
105623280|NCT04101357|364285535|FG000|Overall Study|Withdrawal by Subject|1|||
105623281|NCT04101357|364285536|FG001|Overall Study|Withdrawal by Subject|0|||
105623282|NCT04101357|364285537|FG002|Overall Study|Withdrawal by Subject|0|||
105623283|NCT04101357|364285538|FG003|Overall Study|Withdrawal by Subject|0|||
105623284|NCT04101357|364285539|FG004|Overall Study|Withdrawal by Subject|0|||
105623285|NCT04101357|364285540|FG005|Overall Study|Withdrawal by Subject|0|||
105623286|NCT04101357|364285541|FG006|Overall Study|Withdrawal by Subject|0|||
105623287|NCT04101357|364285542|FG007|Overall Study|Withdrawal by Subject|0|||
105623288|NCT04101357|364285543|FG008|Overall Study|Withdrawal by Subject|1|||
105623289|NCT04101357|364285544|FG009|Overall Study|Withdrawal by Subject|1|||
105623290|NCT04101357|364285545|FG010|Overall Study|Withdrawal by Subject|0|||
105623291|NCT04101357|364285535|FG000|Overall Study|Other|0|||
105623292|NCT04101357|364285536|FG001|Overall Study|Other|0|||
105623293|NCT04101357|364285537|FG002|Overall Study|Other|0|||
105623294|NCT04101357|364285538|FG003|Overall Study|Other|0|||
105623295|NCT04101357|364285539|FG004|Overall Study|Other|0|||
105623296|NCT04101357|364285540|FG005|Overall Study|Other|1|||
105623297|NCT04101357|364285541|FG006|Overall Study|Other|2|||
105623298|NCT04101357|364285542|FG007|Overall Study|Other|1|||
105623299|NCT04101357|364285543|FG008|Overall Study|Other|0|||
105623300|NCT04101357|364285544|FG009|Overall Study|Other|0|||
105623301|NCT04101357|364285545|FG010|Overall Study|Other|0|||
105623302|NCT04101357|364285535|FG000|Overall Study|Enrolled but not treated|0|||
105623303|NCT04101357|364285536|FG001|Overall Study|Enrolled but not treated|0|||
105623304|NCT04101357|364285537|FG002|Overall Study|Enrolled but not treated|0|||
105623305|NCT04101357|364285538|FG003|Overall Study|Enrolled but not treated|0|||
105623306|NCT04101357|364285539|FG004|Overall Study|Enrolled but not treated|0|||
105623307|NCT04101357|364285540|FG005|Overall Study|Enrolled but not treated|1|||
105623308|NCT04101357|364285541|FG006|Overall Study|Enrolled but not treated|1|||
105623309|NCT04101357|364285542|FG007|Overall Study|Enrolled but not treated|0|||
105623310|NCT04101357|364285543|FG008|Overall Study|Enrolled but not treated|0|||
105623311|NCT04101357|364285544|FG009|Overall Study|Enrolled but not treated|0|||
105623312|NCT04101357|364285545|FG010|Overall Study|Enrolled but not treated|0|||
105623313|NCT02497950|364285550|FG000|Overall Study|Death|209|||
105623314|NCT02497950|364285550|FG000|Overall Study|Transplanted|85|||
105623315|NCT02497950|364285550|FG000|Overall Study|Explanted|8|||
105623316|NCT02497950|364285550|FG000|Overall Study|Device Permanently Deactivated|4|||
105623317|NCT02497950|364285550|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
105623318|NCT02497950|364285550|FG000|Overall Study|Lost to Follow-up|6|||
105623319|NCT02497950|364285550|FG000|Overall Study|Withdrawal by Subject|2|||
105623320|NCT02497950|364285550|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
105623321|NCT02497950|364285550|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
105623322|NCT02887521|364285551|FG000|Overall Study|Withdrawal by Subject|0|||
105623323|NCT02887521|364285552|FG001|Overall Study|Withdrawal by Subject|3|||
105623324|NCT02709161|364285557|FG000|Overall Study|Withdrawal by Subject|1|||
105623325|NCT02709161|364285558|FG001|Overall Study|Withdrawal by Subject|0|||
105623326|NCT03852550|364285564|FG000|Overall Study|Lost to Follow-up|4|||
105623327|NCT03852550|364285565|FG001|Overall Study|Lost to Follow-up|3|||
105623328|NCT03852550|364285564|FG000|Overall Study|Only parent outcomes completed|0|||
105623329|NCT03852550|364285565|FG001|Overall Study|Only parent outcomes completed|1|||
105623330|NCT03852550|364285564|FG000|Overall Study|Withdrawal by Subject|1|||
105623331|NCT03852550|364285565|FG001|Overall Study|Withdrawal by Subject|0|||
105623332|NCT03756662|364285566|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
105623333|NCT04295512|364285569|FG000|Overall Study|Lack of family response to schedule assessment|0|||
105623334|NCT04295512|364285570|FG001|Overall Study|Lack of family response to schedule assessment|0|||
105623335|NCT04295512|364285571|FG002|Overall Study|Lack of family response to schedule assessment|0|||
105623336|NCT04295512|364285572|FG003|Overall Study|Lack of family response to schedule assessment|2|||
105623337|NCT04295512|364285569|FG000|Overall Study|Therapist did not refer eligible family|7|||
105623338|NCT04295512|364285570|FG001|Overall Study|Therapist did not refer eligible family|7|||
105623339|NCT04295512|364285571|FG002|Overall Study|Therapist did not refer eligible family|0|||
105623340|NCT04295512|364285572|FG003|Overall Study|Therapist did not refer eligible family|0|||
105623341|NCT05623228|364285581|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
105623342|NCT05623228|364285582|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
105623343|NCT05623228|364285583|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
105623344|NCT05623228|364285584|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
105623345|NCT05623228|364285585|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
105623346|NCT05623228|364285586|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
105623347|NCT05623228|364285587|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
105623348|NCT05623228|364285588|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
105623349|NCT05623228|364285581|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
105623350|NCT05623228|364285582|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
105623351|NCT05623228|364285583|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
105623352|NCT05623228|364285584|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
105623353|NCT05623228|364285585|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
105623354|NCT05623228|364285586|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
105623355|NCT05623228|364285587|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
105623356|NCT05623228|364285588|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
105623357|NCT04871529|364285591|FG000|Overall Study|Withdrawal by Subject|0|||
105623358|NCT04871529|364285592|FG001|Overall Study|Withdrawal by Subject|1|||
105623359|NCT04871529|364285591|FG000|Overall Study|Death|0|||
105623360|NCT04871529|364285592|FG001|Overall Study|Death|1|||
105623361|NCT04871529|364285591|FG000|Overall Study|Not protocol specified|0|||
105623362|NCT04871529|364285592|FG001|Overall Study|Not protocol specified|1|||
105623363|NCT01796197|364285593|FG000|Overall Study|Lost to Follow-up|1|||
105623364|NCT01796197|364285593|FG000|Overall Study|Lack of Efficacy|1|||
105623365|NCT02684227|364285594|FG000|Overall Study|Adverse Event|1|||
105623366|NCT02684227|364285595|FG001|Overall Study|Adverse Event|7|||
105623367|NCT02684227|364285594|FG000|Overall Study|Death|0|||
105623368|NCT02684227|364285595|FG001|Overall Study|Death|2|||
105623369|NCT02684227|364285594|FG000|Overall Study|Withdrawal by Subject|0|||
105623370|NCT02684227|364285595|FG001|Overall Study|Withdrawal by Subject|1|||
105623371|NCT02684227|364285594|FG000|Overall Study|Progressive Disease|0|||
105623372|NCT02684227|364285595|FG001|Overall Study|Progressive Disease|2|||
105623373|NCT03606408|364285597|FG000|Overall Study|Adverse Event|13|||
105623374|NCT03606408|364285597|FG000|Overall Study|Withdrawal by Subject|7|||
105623375|NCT03606408|364285597|FG000|Overall Study|Physician Decision|4|||
105623376|NCT03606408|364285597|FG000|Overall Study|Lack of Efficacy|2|||
105623377|NCT03606408|364285597|FG000|Overall Study|Death|1|||
105623378|NCT03606408|364285597|FG000|Overall Study|new therapy for study indication|1|||
105623379|NCT04689256|364285598|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
105623380|NCT04689256|364285599|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
105623381|NCT05526430|364287242|FG000|Overall Study|Withdrawal by Subject|0|||
105623382|NCT05526430|364287243|FG001|Overall Study|Withdrawal by Subject|2|||
105623383|NCT05526430|364287244|FG002|Overall Study|Withdrawal by Subject|0|||
105623384|NCT05526430|364287245|FG003|Overall Study|Withdrawal by Subject|0|||
105623385|NCT03687086|364287246|FG000|Overall Study|Withdrawal by Subject|3|||
105623386|NCT03687086|364287247|FG001|Overall Study|Withdrawal by Subject|4|||
105623387|NCT03687086|364287246|FG000|Overall Study|Lost to Follow-up|1|||
105623388|NCT03687086|364287247|FG001|Overall Study|Lost to Follow-up|1|||
105623389|NCT03687086|364287246|FG000|Overall Study|Death|1|||
105623390|NCT03687086|364287247|FG001|Overall Study|Death|0|||
105623391|NCT03687086|364287246|FG000|Overall Study|Incomplete assessment|0|||
105623392|NCT03687086|364287247|FG001|Overall Study|Incomplete assessment|2|||
105623393|NCT05934942|364287248|FG000|Run-in Period|Not treated|1|||
105623394|NCT05934942|364287248|FG000|Run-in Period|Withdrawal by Subject|1|||
105623395|NCT00539591|364287249|FG000|Overall Study|Toxicity|3|||
105623396|NCT00539591|364287250|FG001|Overall Study|Toxicity|0|||
105623397|NCT00539591|364287251|FG002|Overall Study|Toxicity|0|||
105623398|NCT00539591|364287249|FG000|Overall Study|Disease progression|2|||
105623399|NCT00539591|364287250|FG001|Overall Study|Disease progression|2|||
105623400|NCT00539591|364287251|FG002|Overall Study|Disease progression|3|||
105623401|NCT03924635|364287252|FG000|Overall Study|Withdrawal by Subject|2|||
105623402|NCT03924635|364287253|FG001|Overall Study|Withdrawal by Subject|4|||
105623403|NCT02038777|364287254|FG000|Overall Study|Death|0|||
105623404|NCT02038777|364287255|FG001|Overall Study|Death|2|||
105623405|NCT02038777|364287256|FG002|Overall Study|Death|0|||
105623406|NCT02038777|364287257|FG003|Overall Study|Death|1|||
105623407|NCT02038777|364287258|FG004|Overall Study|Death|2|||
105623408|NCT02038777|364287259|FG005|Overall Study|Death|4|||
105623409|NCT02038777|364287260|FG006|Overall Study|Death|0|||
105623410|NCT02038777|364287261|FG007|Overall Study|Death|11|||
105623411|NCT02038777|364287254|FG000|Overall Study|Lost to Follow-up|0|||
105623412|NCT02038777|364287255|FG001|Overall Study|Lost to Follow-up|0|||
105623413|NCT02038777|364287256|FG002|Overall Study|Lost to Follow-up|0|||
105623414|NCT02038777|364287257|FG003|Overall Study|Lost to Follow-up|1|||
105623415|NCT02038777|364287258|FG004|Overall Study|Lost to Follow-up|0|||
105623416|NCT02038777|364287259|FG005|Overall Study|Lost to Follow-up|0|||
105623417|NCT02038777|364287260|FG006|Overall Study|Lost to Follow-up|0|||
105623418|NCT02038777|364287261|FG007|Overall Study|Lost to Follow-up|0|||
105623419|NCT02038777|364287254|FG000|Overall Study|Other|0|||
105623420|NCT02038777|364287255|FG001|Overall Study|Other|1|||
105623421|NCT02038777|364287256|FG002|Overall Study|Other|0|||
105623422|NCT02038777|364287257|FG003|Overall Study|Other|2|||
105623423|NCT02038777|364287258|FG004|Overall Study|Other|1|||
105623424|NCT02038777|364287259|FG005|Overall Study|Other|0|||
105623425|NCT02038777|364287260|FG006|Overall Study|Other|0|||
105623426|NCT02038777|364287261|FG007|Overall Study|Other|0|||
105623427|NCT02038777|364287254|FG000|Overall Study|Randomized but not treated|0|||
105623428|NCT02038777|364287255|FG001|Overall Study|Randomized but not treated|1|||
105623429|NCT02038777|364287256|FG002|Overall Study|Randomized but not treated|0|||
105623430|NCT02038777|364287257|FG003|Overall Study|Randomized but not treated|0|||
105623431|NCT02038777|364287258|FG004|Overall Study|Randomized but not treated|0|||
105623432|NCT02038777|364287259|FG005|Overall Study|Randomized but not treated|0|||
105623433|NCT02038777|364287260|FG006|Overall Study|Randomized but not treated|0|||
105623434|NCT02038777|364287261|FG007|Overall Study|Randomized but not treated|0|||
105623435|NCT02038777|364287254|FG000|Overall Study|Started Chemotherapy|1|||
105623436|NCT02038777|364287255|FG001|Overall Study|Started Chemotherapy|0|||
105623437|NCT02038777|364287256|FG002|Overall Study|Started Chemotherapy|3|||
105623438|NCT02038777|364287257|FG003|Overall Study|Started Chemotherapy|0|||
105623439|NCT02038777|364287258|FG004|Overall Study|Started Chemotherapy|0|||
105623440|NCT02038777|364287259|FG005|Overall Study|Started Chemotherapy|0|||
105623441|NCT02038777|364287260|FG006|Overall Study|Started Chemotherapy|0|||
105623442|NCT02038777|364287261|FG007|Overall Study|Started Chemotherapy|0|||
105623443|NCT02038777|364287254|FG000|Overall Study|participation terminated by sponsor|0|||
105623444|NCT02038777|364287255|FG001|Overall Study|participation terminated by sponsor|0|||
105623445|NCT02038777|364287256|FG002|Overall Study|participation terminated by sponsor|0|||
105623446|NCT02038777|364287257|FG003|Overall Study|participation terminated by sponsor|0|||
105623447|NCT02038777|364287258|FG004|Overall Study|participation terminated by sponsor|0|||
105623448|NCT02038777|364287259|FG005|Overall Study|participation terminated by sponsor|0|||
105623449|NCT02038777|364287260|FG006|Overall Study|participation terminated by sponsor|1|||
105623450|NCT02038777|364287261|FG007|Overall Study|participation terminated by sponsor|1|||
105623451|NCT04471246|364287262|FG000|Overall Study|Lost to Follow-up|2|||
105623452|NCT04471246|364287263|FG001|Overall Study|Lost to Follow-up|2|||
105623453|NCT04826471|364287264|FG000|Overall Study|Lost to Follow-up|2|||
105623454|NCT04826471|364287264|FG000|Overall Study|Protocol Violation|3|||
105623455|NCT04826471|364287264|FG000|Overall Study|Withdrawal by Subject|1|||
105623456|NCT03386578|364287265|FG000|PK Component|Lost to Follow-up|0|||
105623457|NCT03386578|364287266|FG001|PK Component|Lost to Follow-up|1|||
105623458|NCT03386578|364287267|FG002|PK Component|Lost to Follow-up|0|||
105623459|NCT03386578|364287268|FG003|PK Component|Lost to Follow-up|0|||
105623460|NCT03386578|364287269|FG004|PK Component|Lost to Follow-up|0|||
105623461|NCT03386578|364287270|FG005|PK Component|Lost to Follow-up|0|||
105623462|NCT03386578|364287271|FG006|PK Component|Lost to Follow-up|1|||
105623463|NCT03386578|364287272|FG007|PK Component|Lost to Follow-up|0|||
105623464|NCT03386578|364287273|FG008|PK Component|Lost to Follow-up|0|||
105623465|NCT03386578|364287274|FG009|PK Component|Lost to Follow-up|0|||
105623466|NCT03386578|364287265|FG000|PK Component|Stillbirth/Abortion|0|||
105623467|NCT03386578|364287266|FG001|PK Component|Stillbirth/Abortion|0|||
105623468|NCT03386578|364287267|FG002|PK Component|Stillbirth/Abortion|0|||
105623469|NCT03386578|364287268|FG003|PK Component|Stillbirth/Abortion|0|||
105623470|NCT03386578|364287269|FG004|PK Component|Stillbirth/Abortion|0|||
105623471|NCT03386578|364287270|FG005|PK Component|Stillbirth/Abortion|2|||
105623472|NCT03386578|364287271|FG006|PK Component|Stillbirth/Abortion|0|||
105623473|NCT03386578|364287272|FG007|PK Component|Stillbirth/Abortion|0|||
105623474|NCT03386578|364287273|FG008|PK Component|Stillbirth/Abortion|0|||
105623475|NCT03386578|364287274|FG009|PK Component|Stillbirth/Abortion|0|||
105623476|NCT03386578|364287265|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
105623477|NCT03386578|364287266|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
105623478|NCT03386578|364287267|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
105623479|NCT03386578|364287268|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
105623480|NCT03386578|364287269|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
105623481|NCT03386578|364287270|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
105623482|NCT03386578|364287271|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
105623483|NCT03386578|364287272|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
105623484|NCT03386578|364287273|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
105623485|NCT03386578|364287274|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
105623486|NCT03386578|364287265|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
105623487|NCT03386578|364287266|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
105623488|NCT03386578|364287267|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
105623489|NCT03386578|364287268|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
105623490|NCT03386578|364287269|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
105623491|NCT03386578|364287270|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
105623492|NCT03386578|364287271|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
105623493|NCT03386578|364287272|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
105623494|NCT03386578|364287273|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
105623495|NCT03386578|364287274|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
105623496|NCT03386578|364287265|FG000|PrEP Comparison Component Step 1|Death|0|||
105623497|NCT03386578|364287266|FG001|PrEP Comparison Component Step 1|Death|0|||
105623498|NCT03386578|364287267|FG002|PrEP Comparison Component Step 1|Death|1|||
105623499|NCT03386578|364287268|FG003|PrEP Comparison Component Step 1|Death|0|||
105623500|NCT03386578|364287269|FG004|PrEP Comparison Component Step 1|Death|0|||
105623501|NCT03386578|364287270|FG005|PrEP Comparison Component Step 1|Death|0|||
105623502|NCT03386578|364287271|FG006|PrEP Comparison Component Step 1|Death|0|||
105623503|NCT03386578|364287272|FG007|PrEP Comparison Component Step 1|Death|9|||
105623504|NCT03386578|364287273|FG008|PrEP Comparison Component Step 1|Death|5|||
105623505|NCT03386578|364287274|FG009|PrEP Comparison Component Step 1|Death|0|||
105623506|NCT03386578|364287265|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
105623507|NCT03386578|364287266|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
105623508|NCT03386578|364287267|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
105623509|NCT03386578|364287268|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
105623510|NCT03386578|364287269|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
105623511|NCT03386578|364287270|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
105623512|NCT03386578|364287271|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
105623513|NCT03386578|364287272|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
105623514|NCT03386578|364287273|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
105623515|NCT03386578|364287274|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
105623516|NCT03386578|364287265|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
105623517|NCT03386578|364287266|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
105623518|NCT03386578|364287267|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
105623519|NCT03386578|364287268|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
105623520|NCT03386578|364287269|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
105623521|NCT03386578|364287270|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
105623522|NCT03386578|364287271|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
105623523|NCT03386578|364287272|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
105623524|NCT03386578|364287273|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
105623525|NCT03386578|364287274|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
105623526|NCT03386578|364287265|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
105623527|NCT03386578|364287266|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
105623528|NCT03386578|364287267|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
105623529|NCT03386578|364287268|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
105623530|NCT03386578|364287269|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
105623531|NCT03386578|364287270|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
105623532|NCT03386578|364287271|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
105623533|NCT03386578|364287272|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
105623534|NCT03386578|364287273|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
105623535|NCT03386578|364287274|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
105623536|NCT01960452|364287275|FG000|Overall Study|Withdrawal by Subject|2|||
105623537|NCT01960452|364287276|FG001|Overall Study|Withdrawal by Subject|1|||
105623538|NCT01960452|364287275|FG000|Overall Study|Sleep apnea in Night 1|1|||
105623539|NCT01960452|364287276|FG001|Overall Study|Sleep apnea in Night 1|0|||
105623540|NCT01960452|364287275|FG000|Overall Study|Poor Sleep in Night 1|0|||
105623541|NCT01960452|364287276|FG001|Overall Study|Poor Sleep in Night 1|2|||
105623542|NCT01960452|364287275|FG000|Overall Study|No Sex/Age Match Night 1|1|||
105623543|NCT01960452|364287276|FG001|Overall Study|No Sex/Age Match Night 1|0|||
105623544|NCT01960452|364287275|FG000|Overall Study|No Sex/Age Match Night 2|0|||
105623545|NCT01960452|364287276|FG001|Overall Study|No Sex/Age Match Night 2|2|||
105623546|NCT01960452|364287275|FG000|Overall Study|Technical Difficulties Night 2|2|||
105623547|NCT01960452|364287276|FG001|Overall Study|Technical Difficulties Night 2|0|||
105623548|NCT04414722|364287279|FG000|Overall Study|Lost to Follow-up|3|||
105623549|NCT04414722|364287280|FG001|Overall Study|Lost to Follow-up|4|||
105623550|NCT04414722|364287281|FG002|Overall Study|Lost to Follow-up|3|||
105623551|NCT04414722|364287282|FG003|Overall Study|Lost to Follow-up|2|||
105623552|NCT04414722|364287283|FG004|Overall Study|Lost to Follow-up|3|||
105623553|NCT04414722|364287279|FG000|Overall Study|Withdrawal by Subject|6|||
105623554|NCT04414722|364287280|FG001|Overall Study|Withdrawal by Subject|3|||
105623555|NCT04414722|364287281|FG002|Overall Study|Withdrawal by Subject|1|||
105623556|NCT04414722|364287282|FG003|Overall Study|Withdrawal by Subject|5|||
105623557|NCT04414722|364287283|FG004|Overall Study|Withdrawal by Subject|1|||
105623558|NCT04414722|364287279|FG000|Overall Study|Physician Decision|0|||
105623559|NCT04414722|364287280|FG001|Overall Study|Physician Decision|1|||
105623560|NCT04414722|364287281|FG002|Overall Study|Physician Decision|2|||
105623561|NCT04414722|364287282|FG003|Overall Study|Physician Decision|0|||
105623562|NCT04414722|364287283|FG004|Overall Study|Physician Decision|0|||
105623563|NCT04414722|364287279|FG000|Overall Study|Non-participatory|0|||
105623564|NCT04414722|364287280|FG001|Overall Study|Non-participatory|1|||
105623565|NCT04414722|364287281|FG002|Overall Study|Non-participatory|1|||
105623566|NCT04414722|364287282|FG003|Overall Study|Non-participatory|0|||
105623567|NCT04414722|364287283|FG004|Overall Study|Non-participatory|0|||
105623568|NCT04690582|364287293|FG000|Overall Study|Withdrawal by Subject|6|||
105623569|NCT04690582|364287294|FG001|Overall Study|Withdrawal by Subject|4|||
105623570|NCT03625115|364287299|FG000|Overall Study|Withdrawal by Subject|4|||
105623571|NCT03625115|364287300|FG001|Overall Study|Withdrawal by Subject|7|||
105623572|NCT03625115|364287299|FG000|Overall Study|Lost to Follow-up|17|||
105623573|NCT03625115|364287300|FG001|Overall Study|Lost to Follow-up|24|||
105623574|NCT05868382|364287301|FG000|Overall Study|Lost to Follow-up|5|||
105623575|NCT05868382|364287302|FG001|Overall Study|Lost to Follow-up|0|||
105623576|NCT05868382|364287303|FG002|Overall Study|Lost to Follow-up|6|||
105623577|NCT05868382|364287304|FG003|Overall Study|Lost to Follow-up|4|||
105623578|NCT05868382|364287305|FG004|Overall Study|Lost to Follow-up|2|||
105623579|NCT05868382|364287306|FG005|Overall Study|Lost to Follow-up|6|||
105623580|NCT05868382|364287301|FG000|Overall Study|Withdrawal by Subject|1|||
105623581|NCT05868382|364287302|FG001|Overall Study|Withdrawal by Subject|0|||
105623582|NCT05868382|364287303|FG002|Overall Study|Withdrawal by Subject|0|||
105623583|NCT05868382|364287304|FG003|Overall Study|Withdrawal by Subject|0|||
105623584|NCT05868382|364287305|FG004|Overall Study|Withdrawal by Subject|1|||
105623585|NCT05868382|364287306|FG005|Overall Study|Withdrawal by Subject|0|||
105623586|NCT04585815|364287307|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
105623587|NCT04585815|364287308|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
105623588|NCT04585815|364287309|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
105623589|NCT04585815|364287310|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
105623590|NCT04585815|364287311|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
105623591|NCT04585815|364287312|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
105623592|NCT04585815|364287313|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
105623593|NCT04585815|364287307|FG000|Sub-study A- Treatment Phase|Death|0|||
105623594|NCT04585815|364287308|FG001|Sub-study A- Treatment Phase|Death|1|||
105623595|NCT04585815|364287309|FG002|Sub-study A- Treatment Phase|Death|0|||
105623596|NCT04585815|364287310|FG003|Sub-study A- Treatment Phase|Death|0|||
105623597|NCT04585815|364287311|FG004|Sub-study A- Treatment Phase|Death|0|||
105623598|NCT04585815|364287312|FG005|Sub-study A- Treatment Phase|Death|0|||
105623599|NCT04585815|364287313|FG006|Sub-study A- Treatment Phase|Death|0|||
105623600|NCT04585815|364287307|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
105623601|NCT04585815|364287308|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
105623602|NCT04585815|364287309|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
105623603|NCT04585815|364287310|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
105623604|NCT04585815|364287311|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
105623605|NCT04585815|364287312|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
105623606|NCT04585815|364287313|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
105623607|NCT04585815|364287307|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
105623608|NCT04585815|364287308|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
105623609|NCT04585815|364287309|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
105623610|NCT04585815|364287310|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
105623611|NCT04585815|364287311|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
105623612|NCT04585815|364287312|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
105623613|NCT04585815|364287313|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
105623614|NCT04585815|364287307|FG000|Sub-study A- Treatment Phase|Other|1|||
105623615|NCT04585815|364287308|FG001|Sub-study A- Treatment Phase|Other|0|||
105623616|NCT04585815|364287309|FG002|Sub-study A- Treatment Phase|Other|0|||
105623617|NCT04585815|364287310|FG003|Sub-study A- Treatment Phase|Other|0|||
105623618|NCT04585815|364287311|FG004|Sub-study A- Treatment Phase|Other|0|||
105623619|NCT04585815|364287312|FG005|Sub-study A- Treatment Phase|Other|0|||
105623620|NCT04585815|364287313|FG006|Sub-study A- Treatment Phase|Other|0|||
105623621|NCT04585815|364287307|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
105623622|NCT04585815|364287308|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
105623623|NCT04585815|364287309|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
105623624|NCT04585815|364287310|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
105623625|NCT04585815|364287311|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
105623626|NCT04585815|364287312|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
105623627|NCT04585815|364287313|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
105623628|NCT04585815|364287307|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
105623629|NCT04585815|364287308|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
105623630|NCT04585815|364287309|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
105623631|NCT04585815|364287310|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
105623632|NCT04585815|364287311|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
105623633|NCT04585815|364287312|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
105623634|NCT04585815|364287313|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
105623635|NCT04585815|364287307|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
105623636|NCT04585815|364287308|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
105623637|NCT04585815|364287309|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
105623638|NCT04585815|364287310|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
105623639|NCT04585815|364287311|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
105623640|NCT04585815|364287312|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
105623641|NCT04585815|364287313|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
105623642|NCT04585815|364287307|FG000|Sub-study B- Treatment Phase|Death|0|||
105623643|NCT04585815|364287308|FG001|Sub-study B- Treatment Phase|Death|0|||
105623644|NCT04585815|364287309|FG002|Sub-study B- Treatment Phase|Death|0|||
105623645|NCT04585815|364287310|FG003|Sub-study B- Treatment Phase|Death|1|||
105623646|NCT04585815|364287311|FG004|Sub-study B- Treatment Phase|Death|0|||
105623647|NCT04585815|364287312|FG005|Sub-study B- Treatment Phase|Death|0|||
105623648|NCT04585815|364287313|FG006|Sub-study B- Treatment Phase|Death|0|||
105623649|NCT04585815|364287307|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
105623650|NCT04585815|364287308|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
105623651|NCT04585815|364287309|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
105623652|NCT04585815|364287310|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
105623653|NCT04585815|364287311|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
105623654|NCT04585815|364287312|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
105623655|NCT04585815|364287313|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
105623656|NCT04585815|364287307|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
105623657|NCT04585815|364287308|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
105623658|NCT04585815|364287309|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
105623659|NCT04585815|364287310|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
105623660|NCT04585815|364287311|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
105623661|NCT04585815|364287312|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
105623662|NCT04585815|364287313|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
105623663|NCT04585815|364287307|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
105623664|NCT04585815|364287308|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
105623665|NCT04585815|364287309|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
105623666|NCT04585815|364287310|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
105623667|NCT04585815|364287311|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
105623668|NCT04585815|364287312|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
105623669|NCT04585815|364287313|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
105623670|NCT04585815|364287307|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
105623671|NCT04585815|364287308|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
105623672|NCT04585815|364287309|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
105623673|NCT04585815|364287310|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
105623674|NCT04585815|364287311|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
105623675|NCT04585815|364287312|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
105623676|NCT04585815|364287313|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
105623677|NCT04585815|364287307|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
105623678|NCT04585815|364287308|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
105623679|NCT04585815|364287309|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
105623680|NCT04585815|364287310|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
105623681|NCT04585815|364287311|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
105623682|NCT04585815|364287312|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
105623683|NCT04585815|364287313|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
105623684|NCT04585815|364287307|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
105623685|NCT04585815|364287308|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
105623686|NCT04585815|364287309|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
105623687|NCT04585815|364287310|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
105623688|NCT04585815|364287311|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
105623689|NCT04585815|364287312|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
105623690|NCT04585815|364287313|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
105623691|NCT04585815|364287307|FG000|Sub-study B- Follow-up Phase|Death|0|||
105623692|NCT04585815|364287308|FG001|Sub-study B- Follow-up Phase|Death|0|||
105623693|NCT04585815|364287309|FG002|Sub-study B- Follow-up Phase|Death|1|||
105623694|NCT04585815|364287310|FG003|Sub-study B- Follow-up Phase|Death|3|||
105623695|NCT04585815|364287311|FG004|Sub-study B- Follow-up Phase|Death|0|||
105623696|NCT04585815|364287312|FG005|Sub-study B- Follow-up Phase|Death|0|||
105623697|NCT04585815|364287313|FG006|Sub-study B- Follow-up Phase|Death|1|||
105623698|NCT05167864|364287316|FG000|Overall Study|Lost to Follow-up|7|||
105623699|NCT05167864|364287317|FG001|Overall Study|Lost to Follow-up|6|||
105623700|NCT05167864|364287318|FG002|Overall Study|Lost to Follow-up|7|||
105623701|NCT05167864|364287319|FG003|Overall Study|Lost to Follow-up|9|||
105623702|NCT04059185|364287320|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
105623703|NCT04059185|364287321|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
105623704|NCT04059185|364287322|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
105623705|NCT04059185|364287320|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
105623706|NCT04059185|364287321|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
105623707|NCT04059185|364287322|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
105623708|NCT04059185|364287320|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
105623709|NCT04059185|364287321|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
105623710|NCT04059185|364287322|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
105623711|NCT04059185|364287320|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
105623712|NCT04059185|364287321|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
105623713|NCT04059185|364287322|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
105623714|NCT04059185|364287320|FG000|Longitudinal Assessment-Adults Only|Death|4|||
105623715|NCT04059185|364287321|FG001|Longitudinal Assessment-Adults Only|Death|4|||
105623716|NCT04059185|364287322|FG002|Longitudinal Assessment-Adults Only|Death|3|||
105623717|NCT03295721|364287327|FG000|Overall Study|Adverse Event|1|||
105623718|NCT03295721|364287328|FG001|Overall Study|Adverse Event|0|||
105623719|NCT03295721|364287329|FG002|Overall Study|Adverse Event|0|||
105623720|NCT03295721|364287327|FG000|Overall Study|Lost to Follow-up|1|||
105623721|NCT03295721|364287328|FG001|Overall Study|Lost to Follow-up|1|||
105623722|NCT03295721|364287329|FG002|Overall Study|Lost to Follow-up|1|||
105623723|NCT03295721|364287327|FG000|Overall Study|Withdrawal by Subject|1|||
105623724|NCT03295721|364287328|FG001|Overall Study|Withdrawal by Subject|0|||
105623725|NCT03295721|364287329|FG002|Overall Study|Withdrawal by Subject|1|||
105623726|NCT03295721|364287327|FG000|Overall Study|Death|0|||
105623727|NCT03295721|364287328|FG001|Overall Study|Death|0|||
105623728|NCT03295721|364287329|FG002|Overall Study|Death|1|||
105623729|NCT01651403|364287337|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
105623730|NCT01651403|364287338|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
105623731|NCT01651403|364287337|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
105623732|NCT01651403|364287338|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
105623733|NCT01651403|364287337|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
105623734|NCT01651403|364287338|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
105623735|NCT01651403|364287337|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
105623736|NCT01651403|364287338|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
105623737|NCT01651403|364287337|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
105623738|NCT01651403|364287338|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
105623739|NCT01651403|364287337|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
105623740|NCT01651403|364287338|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
105623741|NCT00429364|364287342|FG000|Overall Study|Withdrawal by Subject|11|||
105623742|NCT00429364|364287343|FG001|Overall Study|Withdrawal by Subject|5|||
105623743|NCT00429364|364287342|FG000|Overall Study|Physician Decision|4|||
105623744|NCT00429364|364287343|FG001|Overall Study|Physician Decision|2|||
105623745|NCT00429364|364287342|FG000|Overall Study|Lost to Follow-up|7|||
105623746|NCT00429364|364287343|FG001|Overall Study|Lost to Follow-up|6|||
105623747|NCT00429364|364287342|FG000|Overall Study|Death|0|||
105623748|NCT00429364|364287343|FG001|Overall Study|Death|1|||
105623749|NCT00429364|364287342|FG000|Overall Study|Underwent aortic root surgery|10|||
105623750|NCT00429364|364287343|FG001|Overall Study|Underwent aortic root surgery|18|||
105623751|NCT00429364|364287342|FG000|Overall Study|Pregnancy|0|||
105623752|NCT00429364|364287343|FG001|Overall Study|Pregnancy|1|||
105623753|NCT04032847|364287344|FG000|Overall Study|Study termination by sponsor|8|||
105623754|NCT04032847|364287345|FG001|Overall Study|Study termination by sponsor|0|||
105623755|NCT04032847|364287346|FG002|Overall Study|Study termination by sponsor|4|||
105623756|NCT04032847|364287344|FG000|Overall Study|Death|12|||
105623757|NCT04032847|364287345|FG001|Overall Study|Death|0|||
105623758|NCT04032847|364287346|FG002|Overall Study|Death|0|||
105623759|NCT04032847|364287344|FG000|Overall Study|Progressive disease|2|||
105623760|NCT04032847|364287345|FG001|Overall Study|Progressive disease|0|||
105623761|NCT04032847|364287346|FG002|Overall Study|Progressive disease|1|||
105623762|NCT04862234|364287349|FG000|Overall Study|Surgery cancellation|1|||
105623763|NCT04862234|364287350|FG001|Overall Study|Surgery cancellation|2|||
105623764|NCT04862234|364287349|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
105623765|NCT04862234|364287350|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
105623766|NCT04862234|364287349|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
105623767|NCT04862234|364287350|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
105623768|NCT03292484|364287351|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
105623769|NCT03292484|364287351|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
105623770|NCT03292484|364287351|FG000|Overall Study|Protocol Violation|2|||
105623771|NCT03292484|364287351|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
105623772|NCT03292484|364287351|FG000|Overall Study|Sponsor decision|349|||
105623773|NCT03292484|364287351|FG000|Overall Study|Lost to Follow-up|7|||
105623774|NCT03292484|364287351|FG000|Overall Study|Coronavirus Disease 2019|1|||
105623775|NCT03292484|364287351|FG000|Overall Study|Other|20|||
105623776|NCT03381586|364287361|FG000|Overall Study|Adverse Event|1|||
105623777|NCT03381586|364287362|FG001|Overall Study|Adverse Event|1|||
105623778|NCT03381586|364287361|FG000|Overall Study|Protocol Violation|1|||
105623779|NCT03381586|364287362|FG001|Overall Study|Protocol Violation|0|||
105623780|NCT03381586|364287361|FG000|Overall Study|Withdrawal by Subject|1|||
105623781|NCT03381586|364287362|FG001|Overall Study|Withdrawal by Subject|2|||
105623782|NCT04086121|364287367|FG000|Overall Study|Other than listed|8|||
105623783|NCT04086121|364287367|FG000|Overall Study|Withdrawal by Subject|3|||
105623784|NCT04086121|364287367|FG000|Overall Study|Lost to Follow-up|2|||
105623785|NCT04086121|364287367|FG000|Overall Study|Adverse Event|1|||
105623786|NCT05962814|364287377|FG000|Overall Study|failed eligibility|1|||
105623787|NCT02668692|364289048|FG000|Overall Study|Adverse Event|1|||
105623788|NCT02668692|364289049|FG001|Overall Study|Adverse Event|0|||
105623789|NCT04314778|364289050|FG000|Overall Study|Lost to Follow-up|5|||
105623790|NCT04314778|364289051|FG001|Overall Study|Lost to Follow-up|3|||
105623791|NCT04024020|364289052|FG000|Overall Study|Withdrawal by Subject|2|||
105623792|NCT04024020|364289053|FG001|Overall Study|Withdrawal by Subject|2|||
105623793|NCT05863156|364289090|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
105623794|NCT05863156|364289091|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
105623795|NCT05863156|364289092|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
105623796|NCT04141891|364289103|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
105623797|NCT04141891|364289104|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
105623798|NCT04141891|364289103|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
105623799|NCT04141891|364289104|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
105623800|NCT04141891|364289103|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
105623801|NCT04141891|364289104|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
105623802|NCT04141891|364289103|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
105623803|NCT04141891|364289104|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
105623804|NCT04141891|364289103|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
105623805|NCT04141891|364289104|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
105623806|NCT04141891|364289103|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
105623807|NCT04141891|364289104|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
105623808|NCT04141891|364289103|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
105623809|NCT04141891|364289104|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
105623810|NCT04141891|364289103|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
105623811|NCT04141891|364289104|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
105623812|NCT04141891|364289103|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
105623813|NCT04141891|364289104|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
105623814|NCT04141891|364289103|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
105623815|NCT04141891|364289104|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
105623816|NCT04141891|364289103|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
105623817|NCT04141891|364289104|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
105623818|NCT04141891|364289103|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
105623819|NCT04141891|364289104|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
105623820|NCT04141891|364289103|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
105623821|NCT04141891|364289104|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
105623822|NCT04141891|364289103|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
105623823|NCT04141891|364289104|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
105623824|NCT03626220|364289105|FG000|Overall Study|Withdrawal by Subject|2|||
105623825|NCT03626220|364289106|FG001|Overall Study|Withdrawal by Subject|0|||
105623826|NCT04625725|364289107|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
105623827|NCT04625725|364289108|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
105623828|NCT04625725|364289109|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
105623829|NCT04625725|364289110|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
105623830|NCT04625725|364289111|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
105623831|NCT04625725|364289112|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
105623832|NCT04625725|364289107|FG000|Provent Main Study|Withdrawal by Subject|242|||
105623833|NCT04625725|364289108|FG001|Provent Main Study|Withdrawal by Subject|144|||
105623834|NCT04625725|364289109|FG002|Provent Main Study|Withdrawal by Subject|0|||
105623835|NCT04625725|364289110|FG003|Provent Main Study|Withdrawal by Subject|0|||
105623836|NCT04625725|364289111|FG004|Provent Main Study|Withdrawal by Subject|0|||
105623837|NCT04625725|364289112|FG005|Provent Main Study|Withdrawal by Subject|0|||
105623838|NCT04625725|364289107|FG000|Provent Main Study|Physician Decision|5|||
105623839|NCT04625725|364289108|FG001|Provent Main Study|Physician Decision|0|||
105623840|NCT04625725|364289109|FG002|Provent Main Study|Physician Decision|0|||
105623841|NCT04625725|364289110|FG003|Provent Main Study|Physician Decision|0|||
105623842|NCT04625725|364289111|FG004|Provent Main Study|Physician Decision|0|||
105623843|NCT04625725|364289112|FG005|Provent Main Study|Physician Decision|0|||
105623844|NCT04625725|364289107|FG000|Provent Main Study|Protocol Violation|1|||
105623845|NCT04625725|364289108|FG001|Provent Main Study|Protocol Violation|0|||
105623846|NCT04625725|364289109|FG002|Provent Main Study|Protocol Violation|0|||
105623847|NCT04625725|364289110|FG003|Provent Main Study|Protocol Violation|0|||
105623848|NCT04625725|364289111|FG004|Provent Main Study|Protocol Violation|0|||
105623849|NCT04625725|364289112|FG005|Provent Main Study|Protocol Violation|0|||
105623850|NCT04625725|364289107|FG000|Provent Main Study|Lost to Follow-up|357|||
105623851|NCT04625725|364289108|FG001|Provent Main Study|Lost to Follow-up|200|||
105623852|NCT04625725|364289109|FG002|Provent Main Study|Lost to Follow-up|0|||
105623853|NCT04625725|364289110|FG003|Provent Main Study|Lost to Follow-up|0|||
105623854|NCT04625725|364289111|FG004|Provent Main Study|Lost to Follow-up|0|||
105623855|NCT04625725|364289112|FG005|Provent Main Study|Lost to Follow-up|0|||
105623856|NCT04625725|364289107|FG000|Provent Main Study|Death|22|||
105623857|NCT04625725|364289108|FG001|Provent Main Study|Death|10|||
105623858|NCT04625725|364289109|FG002|Provent Main Study|Death|0|||
105623859|NCT04625725|364289110|FG003|Provent Main Study|Death|0|||
105623860|NCT04625725|364289111|FG004|Provent Main Study|Death|0|||
105623861|NCT04625725|364289112|FG005|Provent Main Study|Death|0|||
105623862|NCT04625725|364289107|FG000|Provent Main Study|Adverse Event|2|||
105623863|NCT04625725|364289108|FG001|Provent Main Study|Adverse Event|1|||
105623864|NCT04625725|364289109|FG002|Provent Main Study|Adverse Event|0|||
105623865|NCT04625725|364289110|FG003|Provent Main Study|Adverse Event|0|||
105623866|NCT04625725|364289111|FG004|Provent Main Study|Adverse Event|0|||
105623867|NCT04625725|364289112|FG005|Provent Main Study|Adverse Event|0|||
105623868|NCT04625725|364289107|FG000|Provent Main Study|Participants dosed in sub-study|310|||
105623869|NCT04625725|364289108|FG001|Provent Main Study|Participants dosed in sub-study|193|||
105623870|NCT04625725|364289109|FG002|Provent Main Study|Participants dosed in sub-study|0|||
105623871|NCT04625725|364289110|FG003|Provent Main Study|Participants dosed in sub-study|0|||
105623872|NCT04625725|364289111|FG004|Provent Main Study|Participants dosed in sub-study|0|||
105623873|NCT04625725|364289112|FG005|Provent Main Study|Participants dosed in sub-study|0|||
105623874|NCT04625725|364289107|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
105623875|NCT04625725|364289108|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
105623876|NCT04625725|364289109|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
105623877|NCT04625725|364289110|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
105623878|NCT04625725|364289111|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
105623879|NCT04625725|364289112|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
105623880|NCT04625725|364289107|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
105623881|NCT04625725|364289108|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
105623882|NCT04625725|364289109|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
105623883|NCT04625725|364289110|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
105623884|NCT04625725|364289111|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
105623885|NCT04625725|364289112|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
105623886|NCT04625725|364289107|FG000|Provent Main Study|INCARCERATION|3|||
105623887|NCT04625725|364289108|FG001|Provent Main Study|INCARCERATION|0|||
105623888|NCT04625725|364289109|FG002|Provent Main Study|INCARCERATION|0|||
105623889|NCT04625725|364289110|FG003|Provent Main Study|INCARCERATION|0|||
105623890|NCT04625725|364289111|FG004|Provent Main Study|INCARCERATION|0|||
105623891|NCT04625725|364289112|FG005|Provent Main Study|INCARCERATION|0|||
105623892|NCT04625725|364289107|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
105623893|NCT04625725|364289108|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
105623894|NCT04625725|364289109|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
105623895|NCT04625725|364289110|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
105623896|NCT04625725|364289111|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
105623897|NCT04625725|364289112|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
105623898|NCT04625725|364289107|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
105623899|NCT04625725|364289108|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
105623900|NCT04625725|364289109|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
105623901|NCT04625725|364289110|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
105623902|NCT04625725|364289111|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
105623903|NCT04625725|364289112|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
105623904|NCT04625725|364289107|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
105623905|NCT04625725|364289108|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
105623906|NCT04625725|364289109|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
105623907|NCT04625725|364289110|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
105623908|NCT04625725|364289111|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
105623909|NCT04625725|364289112|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
105623910|NCT04625725|364289107|FG000|Provent Main Study|MISSING REASON|0|||
105623911|NCT04625725|364289108|FG001|Provent Main Study|MISSING REASON|1|||
105623912|NCT04625725|364289109|FG002|Provent Main Study|MISSING REASON|0|||
105623913|NCT04625725|364289110|FG003|Provent Main Study|MISSING REASON|0|||
105623914|NCT04625725|364289111|FG004|Provent Main Study|MISSING REASON|0|||
105623915|NCT04625725|364289112|FG005|Provent Main Study|MISSING REASON|0|||
105623916|NCT04625725|364289107|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
105623917|NCT04625725|364289108|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
105623918|NCT04625725|364289109|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
105623919|NCT04625725|364289110|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
105623920|NCT04625725|364289111|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
105623921|NCT04625725|364289112|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
105623922|NCT04625725|364289107|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
105623923|NCT04625725|364289108|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
105623924|NCT04625725|364289109|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
105623925|NCT04625725|364289110|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
105623926|NCT04625725|364289111|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
105623927|NCT04625725|364289112|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
105623928|NCT04625725|364289107|FG000|Provent Sub Study|Lost to Follow-up|0|||
105623929|NCT04625725|364289108|FG001|Provent Sub Study|Lost to Follow-up|0|||
105623930|NCT04625725|364289109|FG002|Provent Sub Study|Lost to Follow-up|20|||
105623931|NCT04625725|364289110|FG003|Provent Sub Study|Lost to Follow-up|10|||
105623932|NCT04625725|364289111|FG004|Provent Sub Study|Lost to Follow-up|6|||
105623933|NCT04625725|364289112|FG005|Provent Sub Study|Lost to Follow-up|4|||
105623934|NCT04625725|364289107|FG000|Provent Sub Study|Death|0|||
105623935|NCT04625725|364289108|FG001|Provent Sub Study|Death|0|||
105623936|NCT04625725|364289109|FG002|Provent Sub Study|Death|8|||
105623937|NCT04625725|364289110|FG003|Provent Sub Study|Death|5|||
105623938|NCT04625725|364289111|FG004|Provent Sub Study|Death|0|||
105623939|NCT04625725|364289112|FG005|Provent Sub Study|Death|1|||
105623940|NCT04625725|364289107|FG000|Provent Sub Study|Adverse Event|0|||
105623941|NCT04625725|364289108|FG001|Provent Sub Study|Adverse Event|0|||
105623942|NCT04625725|364289109|FG002|Provent Sub Study|Adverse Event|0|||
105623943|NCT04625725|364289110|FG003|Provent Sub Study|Adverse Event|0|||
105623944|NCT04625725|364289111|FG004|Provent Sub Study|Adverse Event|0|||
105623945|NCT04625725|364289112|FG005|Provent Sub Study|Adverse Event|1|||
105623946|NCT04625725|364289107|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
105623947|NCT04625725|364289108|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
105623948|NCT04625725|364289109|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
105623949|NCT04625725|364289110|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
105623950|NCT04625725|364289111|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
105623951|NCT04625725|364289112|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
105623952|NCT04625725|364289107|FG000|Provent Sub Study|Withdrawal by Subject|0|||
105623953|NCT04625725|364289108|FG001|Provent Sub Study|Withdrawal by Subject|0|||
105623954|NCT04625725|364289109|FG002|Provent Sub Study|Withdrawal by Subject|11|||
105623955|NCT04625725|364289110|FG003|Provent Sub Study|Withdrawal by Subject|13|||
105623956|NCT04625725|364289111|FG004|Provent Sub Study|Withdrawal by Subject|5|||
105623957|NCT04625725|364289112|FG005|Provent Sub Study|Withdrawal by Subject|6|||
105623958|NCT04625725|364289107|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
105623959|NCT04625725|364289108|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
105623960|NCT04625725|364289109|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
105623961|NCT04625725|364289110|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
105623962|NCT04625725|364289111|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
105623963|NCT04625725|364289112|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
105623964|NCT04737330|364289113|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
105623965|NCT04737330|364289114|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
105623966|NCT04737330|364289113|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
105623967|NCT04737330|364289114|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
105623968|NCT04737330|364289113|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
105623969|NCT04737330|364289114|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
105623970|NCT04737330|364289113|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
105623971|NCT04737330|364289114|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
105623972|NCT04737330|364289113|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
105623973|NCT04737330|364289114|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
105623974|NCT04737330|364289113|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
105623975|NCT04737330|364289114|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
105623976|NCT01828112|364289121|FG000|Treatment Phase|Adverse Event|7|||
105623977|NCT01828112|364289122|FG001|Treatment Phase|Adverse Event|8|||
105623978|NCT01828112|364289123|FG002|Treatment Phase|Adverse Event|0|||
105623979|NCT01828112|364289121|FG000|Treatment Phase|Death|9|||
105623980|NCT01828112|364289122|FG001|Treatment Phase|Death|5|||
105623981|NCT01828112|364289123|FG002|Treatment Phase|Death|0|||
105623982|NCT01828112|364289121|FG000|Treatment Phase|No longer required treatment|0|||
105623983|NCT01828112|364289122|FG001|Treatment Phase|No longer required treatment|1|||
105623984|NCT01828112|364289123|FG002|Treatment Phase|No longer required treatment|0|||
105623985|NCT01828112|364289121|FG000|Treatment Phase|Physician Decision|6|||
105623986|NCT01828112|364289122|FG001|Treatment Phase|Physician Decision|7|||
105623987|NCT01828112|364289123|FG002|Treatment Phase|Physician Decision|0|||
105623988|NCT01828112|364289121|FG000|Treatment Phase|Pregnancy|1|||
105623989|NCT01828112|364289122|FG001|Treatment Phase|Pregnancy|0|||
105623990|NCT01828112|364289123|FG002|Treatment Phase|Pregnancy|0|||
105623991|NCT01828112|364289121|FG000|Treatment Phase|Progressive disease|79|||
105623992|NCT01828112|364289122|FG001|Treatment Phase|Progressive disease|87|||
105623993|NCT01828112|364289123|FG002|Treatment Phase|Progressive disease|0|||
105623994|NCT01828112|364289121|FG000|Treatment Phase|Study terminated by sponsor|1|||
105623995|NCT01828112|364289122|FG001|Treatment Phase|Study terminated by sponsor|0|||
105623996|NCT01828112|364289123|FG002|Treatment Phase|Study terminated by sponsor|0|||
105623997|NCT01828112|364289121|FG000|Treatment Phase|Subject/guardian decision|12|||
105623998|NCT01828112|364289122|FG001|Treatment Phase|Subject/guardian decision|8|||
105623999|NCT01828112|364289123|FG002|Treatment Phase|Subject/guardian decision|0|||
105624000|NCT01828112|364289121|FG000|Extension Treatment Phase|Adverse Event|0|||
105624001|NCT01828112|364289122|FG001|Extension Treatment Phase|Adverse Event|0|||
105624002|NCT01828112|364289123|FG002|Extension Treatment Phase|Adverse Event|6|||
105624003|NCT01828112|364289121|FG000|Extension Treatment Phase|Death|0|||
105624004|NCT01828112|364289122|FG001|Extension Treatment Phase|Death|0|||
105624005|NCT01828112|364289123|FG002|Extension Treatment Phase|Death|17|||
105624006|NCT01828112|364289121|FG000|Extension Treatment Phase|Physician Decision|0|||
105624007|NCT01828112|364289122|FG001|Extension Treatment Phase|Physician Decision|0|||
105624008|NCT01828112|364289123|FG002|Extension Treatment Phase|Physician Decision|5|||
105624009|NCT01828112|364289121|FG000|Extension Treatment Phase|Progressive disease|0|||
105624010|NCT01828112|364289122|FG001|Extension Treatment Phase|Progressive disease|0|||
105624011|NCT01828112|364289123|FG002|Extension Treatment Phase|Progressive disease|46|||
105624012|NCT01828112|364289121|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
105624013|NCT01828112|364289122|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
105624014|NCT01828112|364289123|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
105624015|NCT01828112|364289121|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
105624016|NCT01828112|364289122|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
105624017|NCT01828112|364289123|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
105624018|NCT03298451|364289129|FG000|Overall Study|Death|275|||
105624019|NCT03298451|364289130|FG001|Overall Study|Death|260|||
105624020|NCT03298451|364289131|FG002|Overall Study|Death|122|||
105624021|NCT03298451|364289132|FG003|Overall Study|Death|280|||
105624022|NCT03298451|364289129|FG000|Overall Study|Lost to Follow-up|1|||
105624023|NCT03298451|364289130|FG001|Overall Study|Lost to Follow-up|1|||
105624024|NCT03298451|364289131|FG002|Overall Study|Lost to Follow-up|0|||
105624025|NCT03298451|364289132|FG003|Overall Study|Lost to Follow-up|7|||
105624026|NCT03298451|364289129|FG000|Overall Study|Withdrawal by Subject|9|||
105624027|NCT03298451|364289130|FG001|Overall Study|Withdrawal by Subject|7|||
105624028|NCT03298451|364289131|FG002|Overall Study|Withdrawal by Subject|1|||
105624029|NCT03298451|364289132|FG003|Overall Study|Withdrawal by Subject|20|||
105624030|NCT04308681|364289137|FG000|Pre-Treatment|Not reported|1|||
105624031|NCT04308681|364289138|FG001|Pre-Treatment|Not reported|1|||
105624032|NCT04308681|364289139|FG002|Pre-Treatment|Not reported|0|||
105624033|NCT04308681|364289140|FG003|Pre-Treatment|Not reported|0|||
105624034|NCT04308681|364289141|FG004|Pre-Treatment|Not reported|0|||
105624035|NCT04308681|364289142|FG005|Pre-Treatment|Not reported|2|||
105624036|NCT04308681|364289143|FG006|Pre-Treatment|Not reported|0|||
105624037|NCT04308681|364289144|FG007|Pre-Treatment|Not reported|0|||
105624038|NCT04308681|364289137|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
105624039|NCT04308681|364289138|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
105624040|NCT04308681|364289139|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
105624041|NCT04308681|364289140|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
105624042|NCT04308681|364289141|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
105624043|NCT04308681|364289142|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
105624044|NCT04308681|364289143|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
105624045|NCT04308681|364289144|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
105624046|NCT04308681|364289137|FG000|Treatment up to Week 26|Other reasons|2|||
105624047|NCT04308681|364289138|FG001|Treatment up to Week 26|Other reasons|0|||
105624048|NCT04308681|364289139|FG002|Treatment up to Week 26|Other reasons|0|||
105624049|NCT04308681|364289140|FG003|Treatment up to Week 26|Other reasons|0|||
105624050|NCT04308681|364289141|FG004|Treatment up to Week 26|Other reasons|1|||
105624051|NCT04308681|364289142|FG005|Treatment up to Week 26|Other reasons|1|||
105624052|NCT04308681|364289143|FG006|Treatment up to Week 26|Other reasons|0|||
105624053|NCT04308681|364289144|FG007|Treatment up to Week 26|Other reasons|0|||
105624054|NCT04308681|364289137|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
105624055|NCT04308681|364289138|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
105624056|NCT04308681|364289139|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
105624057|NCT04308681|364289140|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
105624058|NCT04308681|364289141|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
105624059|NCT04308681|364289142|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
105624060|NCT04308681|364289143|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
105624061|NCT04308681|364289144|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
105624062|NCT04308681|364289137|FG000|Treatment up to Week 26|Adverse Event|6|||
105624063|NCT04308681|364289138|FG001|Treatment up to Week 26|Adverse Event|5|||
105624064|NCT04308681|364289139|FG002|Treatment up to Week 26|Adverse Event|5|||
105624065|NCT04308681|364289140|FG003|Treatment up to Week 26|Adverse Event|0|||
105624066|NCT04308681|364289141|FG004|Treatment up to Week 26|Adverse Event|6|||
105624067|NCT04308681|364289142|FG005|Treatment up to Week 26|Adverse Event|1|||
105624068|NCT04308681|364289143|FG006|Treatment up to Week 26|Adverse Event|0|||
105624069|NCT04308681|364289144|FG007|Treatment up to Week 26|Adverse Event|0|||
105624070|NCT04308681|364289137|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
105624071|NCT04308681|364289138|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
105624072|NCT04308681|364289139|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
105624073|NCT04308681|364289140|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
105624074|NCT04308681|364289141|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
105624075|NCT04308681|364289142|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
105624076|NCT04308681|364289143|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
105624077|NCT04308681|364289144|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
105624078|NCT04308681|364289137|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
105624079|NCT04308681|364289138|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
105624080|NCT04308681|364289139|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
105624081|NCT04308681|364289140|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
105624082|NCT04308681|364289141|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
105624083|NCT04308681|364289142|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
105624084|NCT04308681|364289143|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
105624085|NCT04308681|364289144|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
105624086|NCT04308681|364289137|FG000|OTE - 26 Weeks|Death|0|||
105624087|NCT04308681|364289138|FG001|OTE - 26 Weeks|Death|1|||
105624088|NCT04308681|364289139|FG002|OTE - 26 Weeks|Death|0|||
105624089|NCT04308681|364289140|FG003|OTE - 26 Weeks|Death|0|||
105624090|NCT04308681|364289141|FG004|OTE - 26 Weeks|Death|0|||
105624091|NCT04308681|364289142|FG005|OTE - 26 Weeks|Death|0|||
105624092|NCT04308681|364289143|FG006|OTE - 26 Weeks|Death|1|||
105624093|NCT04308681|364289144|FG007|OTE - 26 Weeks|Death|0|||
105624094|NCT04308681|364289137|FG000|OTE - 26 Weeks|Adverse Event|0|||
105624095|NCT04308681|364289138|FG001|OTE - 26 Weeks|Adverse Event|2|||
105624096|NCT04308681|364289139|FG002|OTE - 26 Weeks|Adverse Event|8|||
105624097|NCT04308681|364289140|FG003|OTE - 26 Weeks|Adverse Event|3|||
105624098|NCT04308681|364289141|FG004|OTE - 26 Weeks|Adverse Event|0|||
105624099|NCT04308681|364289142|FG005|OTE - 26 Weeks|Adverse Event|1|||
105624100|NCT04308681|364289143|FG006|OTE - 26 Weeks|Adverse Event|2|||
105624101|NCT04308681|364289144|FG007|OTE - 26 Weeks|Adverse Event|0|||
105624102|NCT04308681|364289137|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
105624103|NCT04308681|364289138|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
105624104|NCT04308681|364289139|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
105624105|NCT04308681|364289140|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
105624106|NCT04308681|364289141|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
105624107|NCT04308681|364289142|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
105624108|NCT04308681|364289143|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
105624109|NCT04308681|364289144|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
105624110|NCT05565820|364289145|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
105624111|NCT05565820|364289146|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
105624112|NCT05565820|364289145|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
105624113|NCT05565820|364289146|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
105624114|NCT02446236|364289147|FG000|Overall Study|Screen Failure|1|||
105624115|NCT02446236|364289148|FG001|Overall Study|Screen Failure|0|||
105624116|NCT02446236|364289149|FG002|Overall Study|Screen Failure|1|||
105624117|NCT02446236|364289147|FG000|Overall Study|Actively Receiving Therapy|0|||
105624118|NCT02446236|364289148|FG001|Overall Study|Actively Receiving Therapy|0|||
105624119|NCT02446236|364289149|FG002|Overall Study|Actively Receiving Therapy|1|||
105624120|NCT05090683|364289152|FG000|Overall Study|Lost to Follow-up|10|||
105624121|NCT05090683|364289153|FG001|Overall Study|Lost to Follow-up|2|||
105624122|NCT05090683|364289152|FG000|Overall Study|Withdrawal by Subject|15|||
105624123|NCT05090683|364289153|FG001|Overall Study|Withdrawal by Subject|0|||
105624124|NCT05184452|364289154|FG000|Overall Study|Lost to Follow-up|0|||
105624125|NCT05184452|364289155|FG001|Overall Study|Lost to Follow-up|0|||
105624126|NCT05184452|364289156|FG002|Overall Study|Lost to Follow-up|0|||
105624127|NCT05184452|364289157|FG003|Overall Study|Lost to Follow-up|0|||
105624128|NCT05184452|364289158|FG004|Overall Study|Lost to Follow-up|0|||
105624129|NCT05184452|364289159|FG005|Overall Study|Lost to Follow-up|2|||
105624130|NCT05184452|364289160|FG006|Overall Study|Lost to Follow-up|0|||
105624131|NCT05184452|364289161|FG007|Overall Study|Lost to Follow-up|0|||
105624132|NCT05184452|364289162|FG008|Overall Study|Lost to Follow-up|0|||
105624133|NCT05184452|364289163|FG009|Overall Study|Lost to Follow-up|1|||
105624134|NCT05184452|364289154|FG000|Overall Study|Withdrawal by Subject|0|||
105624135|NCT05184452|364289155|FG001|Overall Study|Withdrawal by Subject|0|||
105624136|NCT05184452|364289156|FG002|Overall Study|Withdrawal by Subject|0|||
105624137|NCT05184452|364289157|FG003|Overall Study|Withdrawal by Subject|0|||
105624138|NCT05184452|364289158|FG004|Overall Study|Withdrawal by Subject|0|||
105624139|NCT05184452|364289159|FG005|Overall Study|Withdrawal by Subject|1|||
105624140|NCT05184452|364289160|FG006|Overall Study|Withdrawal by Subject|0|||
105624141|NCT05184452|364289161|FG007|Overall Study|Withdrawal by Subject|0|||
105624142|NCT05184452|364289162|FG008|Overall Study|Withdrawal by Subject|0|||
105624143|NCT05184452|364289163|FG009|Overall Study|Withdrawal by Subject|1|||
105624144|NCT05586490|364289164|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
105624145|NCT05586490|364289165|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
105624146|NCT05586490|364289166|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
105624147|NCT05586490|364289167|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
105624148|NCT05586490|364289168|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
105624149|NCT05586490|364289164|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
105624150|NCT05586490|364289165|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
105624151|NCT05586490|364289166|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
105624152|NCT05586490|364289167|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
105624153|NCT05586490|364289168|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
105624154|NCT05586490|364289164|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
105624155|NCT05586490|364289165|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
105624156|NCT05586490|364289166|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
105624157|NCT05586490|364289167|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
105624158|NCT05586490|364289168|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
105624159|NCT04786119|364289171|FG000|Overall Study|Withdrawal by Subject|2|||
105624160|NCT05873556|364289172|FG000|Overall Study|Lost to Follow-up|4|||
105624161|NCT05873556|364289173|FG001|Overall Study|Lost to Follow-up|1|||
105624162|NCT05828017|364289174|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
105624163|NCT05012163|364289175|FG000|Overall Study|Protocol Violation|0|||
105624164|NCT05012163|364289176|FG001|Overall Study|Protocol Violation|0|||
105624165|NCT05012163|364289177|FG002|Overall Study|Protocol Violation|1|||
105624166|NCT05012163|364289178|FG003|Overall Study|Protocol Violation|1|||
105624167|NCT04615273|364289179|FG000|Overall Study|Withdrawal by Subject|3|||
105624168|NCT04615273|364289180|FG001|Overall Study|Withdrawal by Subject|1|||
105624169|NCT04615273|364289181|FG002|Overall Study|Withdrawal by Subject|2|||
105624170|NCT04615273|364289179|FG000|Overall Study|Adverse Event|1|||
105624171|NCT04615273|364289180|FG001|Overall Study|Adverse Event|0|||
105624172|NCT04615273|364289181|FG002|Overall Study|Adverse Event|1|||
105624173|NCT04615273|364289179|FG000|Overall Study|Lost to Follow-up|0|||
105624174|NCT04615273|364289180|FG001|Overall Study|Lost to Follow-up|1|||
105624175|NCT04615273|364289181|FG002|Overall Study|Lost to Follow-up|0|||
105624176|NCT04615273|364289179|FG000|Overall Study|Physician Decision|0|||
105624177|NCT04615273|364289180|FG001|Overall Study|Physician Decision|0|||
105624178|NCT04615273|364289181|FG002|Overall Study|Physician Decision|1|||
105624179|NCT04615273|364289179|FG000|Overall Study|Other|0|||
105624180|NCT04615273|364289180|FG001|Overall Study|Other|1|||
105624181|NCT04615273|364289181|FG002|Overall Study|Other|0|||
105624182|NCT04615273|364289179|FG000|Overall Study|Randomized but not treated|1|||
105624183|NCT04615273|364289180|FG001|Overall Study|Randomized but not treated|3|||
105624184|NCT04615273|364289181|FG002|Overall Study|Randomized but not treated|1|||
105624185|NCT05076266|364289182|FG000|Overall Study|Survey not complete - Participant refusal|2|||
105624186|NCT05076266|364289183|FG001|Overall Study|Survey not complete - Participant refusal|0|||
105624187|NCT04003246|364289184|FG000|Overall Study|Death|9|||
105624188|NCT02142803|364289185|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
105624189|NCT02142803|364289186|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
105624190|NCT02142803|364289187|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
105624191|NCT02142803|364289188|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
105624192|NCT05524402|364289189|FG000|Overall Study|Withdrawal by Subject|3|||
105624193|NCT05524402|364289190|FG001|Overall Study|Withdrawal by Subject|1|||
105624194|NCT05524402|364289189|FG000|Overall Study|Lost to Follow-up|2|||
105624195|NCT05524402|364289190|FG001|Overall Study|Lost to Follow-up|1|||
105624196|NCT04428203|364289191|FG000|Overall Study|Adverse Event|1|||
105624197|NCT04428203|364289192|FG001|Overall Study|Adverse Event|0|||
105624198|NCT04428203|364289193|FG002|Overall Study|Adverse Event|0|||
105624199|NCT04428203|364289191|FG000|Overall Study|Withdrawal by Subject|1|||
105624200|NCT04428203|364289192|FG001|Overall Study|Withdrawal by Subject|0|||
105624201|NCT04428203|364289193|FG002|Overall Study|Withdrawal by Subject|1|||
105624202|NCT05237284|364289195|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
105624203|NCT05237284|364289196|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
105624204|NCT05237284|364289197|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
105624205|NCT05237284|364289198|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
105624206|NCT05237284|364289195|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
105624207|NCT05237284|364289196|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
105624208|NCT05237284|364289197|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
105624209|NCT05237284|364289198|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
105624210|NCT05237284|364289195|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
105624211|NCT05237284|364289196|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
105624212|NCT05237284|364289197|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
105624213|NCT05237284|364289198|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
105624214|NCT05237284|364289195|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
105624215|NCT05237284|364289196|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
105624216|NCT05237284|364289197|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
105624217|NCT05237284|364289198|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
105624218|NCT05237284|364289195|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
105624219|NCT05237284|364289196|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
105624220|NCT05237284|364289197|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
105624221|NCT05237284|364289198|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
105624222|NCT05237284|364289195|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
105624223|NCT05237284|364289196|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
105624224|NCT05237284|364289197|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
105624225|NCT05237284|364289198|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
105624226|NCT05237284|364289195|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
105624227|NCT05237284|364289196|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
105624228|NCT05237284|364289197|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
105624229|NCT05237284|364289198|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
105624230|NCT05237284|364289195|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
105624231|NCT05237284|364289196|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
105624232|NCT05237284|364289197|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
105624233|NCT05237284|364289198|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
105624234|NCT05237284|364289195|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
105624235|NCT05237284|364289196|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
105624236|NCT05237284|364289197|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
105624237|NCT05237284|364289198|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
105624238|NCT04999111|364289201|FG000|Overall Study|Lost to Follow-up|21|||
105624239|NCT04999111|364289202|FG001|Overall Study|Lost to Follow-up|16|||
105624240|NCT04999111|364289203|FG002|Overall Study|Lost to Follow-up|2|||
105624241|NCT04999111|364289204|FG003|Overall Study|Lost to Follow-up|26|||
105624242|NCT04999111|364289205|FG004|Overall Study|Lost to Follow-up|30|||
105624243|NCT04999111|364289206|FG005|Overall Study|Lost to Follow-up|6|||
105624244|NCT04999111|364289201|FG000|Overall Study|Physician Decision|1|||
105624245|NCT04999111|364289202|FG001|Overall Study|Physician Decision|3|||
105624246|NCT04999111|364289203|FG002|Overall Study|Physician Decision|0|||
105624247|NCT04999111|364289204|FG003|Overall Study|Physician Decision|1|||
105624248|NCT04999111|364289205|FG004|Overall Study|Physician Decision|2|||
105624249|NCT04999111|364289206|FG005|Overall Study|Physician Decision|0|||
105624250|NCT04999111|364289201|FG000|Overall Study|Withdrawal by Subject|23|||
105624251|NCT04999111|364289202|FG001|Overall Study|Withdrawal by Subject|29|||
105624252|NCT04999111|364289203|FG002|Overall Study|Withdrawal by Subject|15|||
105624253|NCT04999111|364289204|FG003|Overall Study|Withdrawal by Subject|30|||
105624254|NCT04999111|364289205|FG004|Overall Study|Withdrawal by Subject|35|||
105624255|NCT04999111|364289206|FG005|Overall Study|Withdrawal by Subject|10|||
105624256|NCT04999111|364289201|FG000|Overall Study|Other|6|||
105624257|NCT04999111|364289202|FG001|Overall Study|Other|6|||
105624258|NCT04999111|364289203|FG002|Overall Study|Other|3|||
105624259|NCT04999111|364289204|FG003|Overall Study|Other|8|||
105624260|NCT04999111|364289205|FG004|Overall Study|Other|8|||
105624261|NCT04999111|364289206|FG005|Overall Study|Other|5|||
105624262|NCT04999111|364289201|FG000|Overall Study|Non-compliance with study schedule|1|||
105624263|NCT04999111|364289202|FG001|Overall Study|Non-compliance with study schedule|0|||
105624264|NCT04999111|364289203|FG002|Overall Study|Non-compliance with study schedule|0|||
105624265|NCT04999111|364289204|FG003|Overall Study|Non-compliance with study schedule|1|||
105624266|NCT04999111|364289205|FG004|Overall Study|Non-compliance with study schedule|1|||
105624267|NCT04999111|364289206|FG005|Overall Study|Non-compliance with study schedule|1|||
105624268|NCT04999111|364289201|FG000|Overall Study|Randomized but not vaccinated|1|||
105624269|NCT04999111|364289202|FG001|Overall Study|Randomized but not vaccinated|2|||
105624270|NCT04999111|364289203|FG002|Overall Study|Randomized but not vaccinated|0|||
105624271|NCT04999111|364289204|FG003|Overall Study|Randomized but not vaccinated|3|||
105624272|NCT04999111|364289205|FG004|Overall Study|Randomized but not vaccinated|3|||
105624273|NCT04999111|364289206|FG005|Overall Study|Randomized but not vaccinated|0|||
105624274|NCT04999111|364289201|FG000|Overall Study|Adverse Event|1|||
105624275|NCT04999111|364289202|FG001|Overall Study|Adverse Event|1|||
105624276|NCT04999111|364289203|FG002|Overall Study|Adverse Event|0|||
105624277|NCT04999111|364289204|FG003|Overall Study|Adverse Event|0|||
105624278|NCT04999111|364289205|FG004|Overall Study|Adverse Event|0|||
105624279|NCT04999111|364289206|FG005|Overall Study|Adverse Event|0|||
105624280|NCT04999111|364289201|FG000|Overall Study|Initiated prohibited medication|0|||
105624281|NCT04999111|364289202|FG001|Overall Study|Initiated prohibited medication|0|||
105624282|NCT04999111|364289203|FG002|Overall Study|Initiated prohibited medication|0|||
105624283|NCT04999111|364289204|FG003|Overall Study|Initiated prohibited medication|0|||
105624284|NCT04999111|364289205|FG004|Overall Study|Initiated prohibited medication|1|||
105624285|NCT04999111|364289206|FG005|Overall Study|Initiated prohibited medication|0|||
105624286|NCT04056611|364289208|FG000|Overall Study|Physician Decision|1|||
105624287|NCT03824366|364289218|FG000|Overall Study|Death|1|||
105624288|NCT03824366|364289218|FG000|Overall Study|Previously unidentified metal artifact|1|||
105624289|NCT03824366|364289218|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
105624290|NCT03824366|364289218|FG000|Overall Study|Withdrawal by Subject|1|||
105624291|NCT01627574|364290673|FG000|Overall Study|Withdrawal by Subject|8|||
105624292|NCT01627574|364290674|FG001|Overall Study|Withdrawal by Subject|5|||
105624293|NCT01627574|364290673|FG000|Overall Study|Lost to Follow-up|13|||
105624294|NCT01627574|364290674|FG001|Overall Study|Lost to Follow-up|13|||
105624295|NCT05218096|364290675|FG000|Primary Evaluation|Withdrawal by Subject|0|||
105624296|NCT05218096|364290676|FG001|Primary Evaluation|Withdrawal by Subject|0|||
105624297|NCT05218096|364290677|FG002|Primary Evaluation|Withdrawal by Subject|2|||
105624298|NCT05218096|364290678|FG003|Primary Evaluation|Withdrawal by Subject|0|||
105624299|NCT05218096|364290679|FG004|Primary Evaluation|Withdrawal by Subject|0|||
105624300|NCT05218096|364290675|FG000|Primary Evaluation|Physician Decision|1|||
105624301|NCT05218096|364290676|FG001|Primary Evaluation|Physician Decision|0|||
105624302|NCT05218096|364290677|FG002|Primary Evaluation|Physician Decision|0|||
105624303|NCT05218096|364290678|FG003|Primary Evaluation|Physician Decision|0|||
105624304|NCT05218096|364290679|FG004|Primary Evaluation|Physician Decision|0|||
105624305|NCT05218096|364290675|FG000|Extended Treatment|Clinical Deterioration|1|||
105624306|NCT05218096|364290676|FG001|Extended Treatment|Clinical Deterioration|1|||
105624307|NCT05218096|364290677|FG002|Extended Treatment|Clinical Deterioration|0|||
105624308|NCT05218096|364290678|FG003|Extended Treatment|Clinical Deterioration|0|||
105624309|NCT05218096|364290679|FG004|Extended Treatment|Clinical Deterioration|0|||
105624310|NCT05218096|364290675|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
105624311|NCT05218096|364290676|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
105624312|NCT05218096|364290677|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
105624313|NCT05218096|364290678|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
105624314|NCT05218096|364290679|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
105624315|NCT05218096|364290675|FG000|Extended Treatment|Withdrawal by Subject|1|||
105624316|NCT05218096|364290676|FG001|Extended Treatment|Withdrawal by Subject|3|||
105624317|NCT05218096|364290677|FG002|Extended Treatment|Withdrawal by Subject|0|||
105624318|NCT05218096|364290678|FG003|Extended Treatment|Withdrawal by Subject|2|||
105624319|NCT05218096|364290679|FG004|Extended Treatment|Withdrawal by Subject|2|||
105624320|NCT05218096|364290675|FG000|Extended Treatment|Lack of Efficacy|3|||
105624321|NCT05218096|364290676|FG001|Extended Treatment|Lack of Efficacy|0|||
105624322|NCT05218096|364290677|FG002|Extended Treatment|Lack of Efficacy|0|||
105624323|NCT05218096|364290678|FG003|Extended Treatment|Lack of Efficacy|0|||
105624324|NCT05218096|364290679|FG004|Extended Treatment|Lack of Efficacy|0|||
105624325|NCT05218096|364290675|FG000|Extended Treatment|Physician Decision|0|||
105624326|NCT05218096|364290676|FG001|Extended Treatment|Physician Decision|1|||
105624327|NCT05218096|364290677|FG002|Extended Treatment|Physician Decision|0|||
105624328|NCT05218096|364290678|FG003|Extended Treatment|Physician Decision|0|||
105624329|NCT05218096|364290679|FG004|Extended Treatment|Physician Decision|0|||
105624330|NCT05218096|364290675|FG000|Open-label Extension|Adverse Event|1|||
105624331|NCT05218096|364290676|FG001|Open-label Extension|Adverse Event|0|||
105624332|NCT05218096|364290677|FG002|Open-label Extension|Adverse Event|0|||
105624333|NCT05218096|364290678|FG003|Open-label Extension|Adverse Event|0|||
105624334|NCT05218096|364290679|FG004|Open-label Extension|Adverse Event|1|||
105624335|NCT05218096|364290675|FG000|Open-label Extension|Pregnancy|0|||
105624336|NCT05218096|364290676|FG001|Open-label Extension|Pregnancy|0|||
105624337|NCT05218096|364290677|FG002|Open-label Extension|Pregnancy|0|||
105624338|NCT05218096|364290678|FG003|Open-label Extension|Pregnancy|0|||
105624339|NCT05218096|364290679|FG004|Open-label Extension|Pregnancy|1|||
105624340|NCT05218096|364290675|FG000|Open-label Extension|Lack of Efficacy|1|||
105624341|NCT05218096|364290676|FG001|Open-label Extension|Lack of Efficacy|2|||
105624342|NCT05218096|364290677|FG002|Open-label Extension|Lack of Efficacy|0|||
105624343|NCT05218096|364290678|FG003|Open-label Extension|Lack of Efficacy|0|||
105624344|NCT05218096|364290679|FG004|Open-label Extension|Lack of Efficacy|0|||
105624345|NCT05218096|364290675|FG000|Open-label Extension|Lost to Follow-up|1|||
105624346|NCT05218096|364290676|FG001|Open-label Extension|Lost to Follow-up|0|||
105624347|NCT05218096|364290677|FG002|Open-label Extension|Lost to Follow-up|0|||
105624348|NCT05218096|364290678|FG003|Open-label Extension|Lost to Follow-up|0|||
105624349|NCT05218096|364290679|FG004|Open-label Extension|Lost to Follow-up|0|||
105624350|NCT05218096|364290675|FG000|Open-label Extension|Death|0|||
105624351|NCT05218096|364290676|FG001|Open-label Extension|Death|0|||
105624352|NCT05218096|364290677|FG002|Open-label Extension|Death|0|||
105624353|NCT05218096|364290678|FG003|Open-label Extension|Death|1|||
105624354|NCT05218096|364290679|FG004|Open-label Extension|Death|0|||
105624355|NCT05218096|364290675|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
105624356|NCT05218096|364290676|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
105624357|NCT05218096|364290677|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
105624358|NCT05218096|364290678|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
105624359|NCT05218096|364290679|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
105624360|NCT01009788|364290685|FG000|Overall Study|Withdrawal by Subject|1|||
105624361|NCT01009788|364290686|FG001|Overall Study|Withdrawal by Subject|0|||
105624362|NCT02974621|364290691|FG000|Overall Study|Didn't receive study treatment|1|||
105624363|NCT02974621|364290692|FG001|Overall Study|Didn't receive study treatment|10|||
105624364|NCT01309672|364290693|FG000|Overall Study|Lack of Efficacy|20|||
105624365|NCT01309672|364290693|FG000|Overall Study|Other|9|||
105624366|NCT01309672|364290693|FG000|Overall Study|Adverse Event|5|||
105624367|NCT01309672|364290693|FG000|Overall Study|Withdrawal by Subject|3|||
105624368|NCT01254864|364290694|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
105624369|NCT01254864|364290695|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
105624370|NCT01254864|364290696|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
105624371|NCT01254864|364290694|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
105624372|NCT01254864|364290695|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
105624373|NCT01254864|364290696|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
105624374|NCT01254864|364290694|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
105624375|NCT01254864|364290695|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
105624376|NCT01254864|364290696|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
105624377|NCT01254864|364290694|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
105624378|NCT01254864|364290695|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
105624379|NCT01254864|364290696|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
105624380|NCT01254864|364290694|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
105624381|NCT01254864|364290695|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
105624382|NCT01254864|364290696|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
105624383|NCT01254864|364290694|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
105624384|NCT01254864|364290695|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
105624385|NCT01254864|364290696|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
105624386|NCT01254864|364290694|FG000|Randomization Phase|Adverse Event|0|||
105624387|NCT01254864|364290695|FG001|Randomization Phase|Adverse Event|5|||
105624388|NCT01254864|364290696|FG002|Randomization Phase|Adverse Event|17|||
105624389|NCT01254864|364290694|FG000|Randomization Phase|Death|0|||
105624390|NCT01254864|364290695|FG001|Randomization Phase|Death|1|||
105624391|NCT01254864|364290696|FG002|Randomization Phase|Death|0|||
105624392|NCT01254864|364290694|FG000|Randomization Phase|Lost to Follow-up|0|||
105624393|NCT01254864|364290695|FG001|Randomization Phase|Lost to Follow-up|0|||
105624394|NCT01254864|364290696|FG002|Randomization Phase|Lost to Follow-up|1|||
105624395|NCT01254864|364290694|FG000|Randomization Phase|Physician Decision|0|||
105624396|NCT01254864|364290695|FG001|Randomization Phase|Physician Decision|20|||
105624397|NCT01254864|364290696|FG002|Randomization Phase|Physician Decision|25|||
105624398|NCT01254864|364290694|FG000|Randomization Phase|Withdrawal by Subject|0|||
105624399|NCT01254864|364290695|FG001|Randomization Phase|Withdrawal by Subject|4|||
105624400|NCT01254864|364290696|FG002|Randomization Phase|Withdrawal by Subject|2|||
105624401|NCT01254864|364290694|FG000|Randomization Phase|Non-Compliance|0|||
105624402|NCT01254864|364290695|FG001|Randomization Phase|Non-Compliance|1|||
105624403|NCT01254864|364290696|FG002|Randomization Phase|Non-Compliance|0|||
105624404|NCT01254864|364290694|FG000|Randomization Phase|Comorbidities|0|||
105624405|NCT01254864|364290695|FG001|Randomization Phase|Comorbidities|2|||
105624406|NCT01254864|364290696|FG002|Randomization Phase|Comorbidities|1|||
105624407|NCT05267470|364290702|FG000|Overall Study|Decision by sponsor|0|||
105624408|NCT05267470|364290703|FG001|Overall Study|Decision by sponsor|3|||
105624409|NCT05267470|364290704|FG002|Overall Study|Decision by sponsor|19|||
105624410|NCT05267470|364290705|FG003|Overall Study|Decision by sponsor|7|||
105624411|NCT05267470|364290706|FG004|Overall Study|Decision by sponsor|3|||
105624412|NCT05267470|364290702|FG000|Overall Study|Withdrawal by Subject|1|||
105624413|NCT05267470|364290703|FG001|Overall Study|Withdrawal by Subject|1|||
105624414|NCT05267470|364290704|FG002|Overall Study|Withdrawal by Subject|2|||
105624415|NCT05267470|364290705|FG003|Overall Study|Withdrawal by Subject|2|||
105624416|NCT05267470|364290706|FG004|Overall Study|Withdrawal by Subject|0|||
105624417|NCT05267470|364290702|FG000|Overall Study|Death|3|||
105624418|NCT05267470|364290703|FG001|Overall Study|Death|5|||
105624419|NCT05267470|364290704|FG002|Overall Study|Death|8|||
105624420|NCT05267470|364290705|FG003|Overall Study|Death|18|||
105624421|NCT05267470|364290706|FG004|Overall Study|Death|1|||
105624422|NCT05267470|364290702|FG000|Overall Study|Lost to Follow-up|0|||
105624423|NCT05267470|364290703|FG001|Overall Study|Lost to Follow-up|0|||
105624424|NCT05267470|364290704|FG002|Overall Study|Lost to Follow-up|0|||
105624425|NCT05267470|364290705|FG003|Overall Study|Lost to Follow-up|1|||
105624426|NCT05267470|364290706|FG004|Overall Study|Lost to Follow-up|0|||
105624427|NCT05290493|364290707|FG000|Overall Study|Withdrawal by Subject|2|||
105624428|NCT05290493|364290708|FG001|Overall Study|Withdrawal by Subject|2|||
105624429|NCT05290493|364290707|FG000|Overall Study|Adverse Event|1|||
105624430|NCT05290493|364290708|FG001|Overall Study|Adverse Event|0|||
105624431|NCT03677141|364290717|FG000|Overall Study|Death|2|||
105624432|NCT03677141|364290718|FG001|Overall Study|Death|1|||
105624433|NCT03677141|364290719|FG002|Overall Study|Death|6|||
105624434|NCT03677141|364290720|FG003|Overall Study|Death|9|||
105624435|NCT03677141|364290721|FG004|Overall Study|Death|5|||
105624436|NCT03677141|364290722|FG005|Overall Study|Death|3|||
105624437|NCT03677141|364290717|FG000|Overall Study|Lost to Follow-up|0|||
105624438|NCT03677141|364290718|FG001|Overall Study|Lost to Follow-up|0|||
105624439|NCT03677141|364290719|FG002|Overall Study|Lost to Follow-up|0|||
105624440|NCT03677141|364290720|FG003|Overall Study|Lost to Follow-up|2|||
105624441|NCT03677141|364290721|FG004|Overall Study|Lost to Follow-up|0|||
105624442|NCT03677141|364290722|FG005|Overall Study|Lost to Follow-up|0|||
105624443|NCT03677141|364290717|FG000|Overall Study|Screen failure or enrolled in error|0|||
105624444|NCT03677141|364290718|FG001|Overall Study|Screen failure or enrolled in error|0|||
105624445|NCT03677141|364290719|FG002|Overall Study|Screen failure or enrolled in error|0|||
105624446|NCT03677141|364290720|FG003|Overall Study|Screen failure or enrolled in error|0|||
105624447|NCT03677141|364290721|FG004|Overall Study|Screen failure or enrolled in error|2|||
105624448|NCT03677141|364290722|FG005|Overall Study|Screen failure or enrolled in error|0|||
105624449|NCT03677141|364290717|FG000|Overall Study|Physician Decision|0|||
105624450|NCT03677141|364290718|FG001|Overall Study|Physician Decision|0|||
105624451|NCT03677141|364290719|FG002|Overall Study|Physician Decision|0|||
105624452|NCT03677141|364290720|FG003|Overall Study|Physician Decision|0|||
105624453|NCT03677141|364290721|FG004|Overall Study|Physician Decision|1|||
105624454|NCT03677141|364290722|FG005|Overall Study|Physician Decision|0|||
105624455|NCT03677141|364290717|FG000|Overall Study|Withdrawal by Subject|0|||
105624456|NCT03677141|364290718|FG001|Overall Study|Withdrawal by Subject|0|||
105624457|NCT03677141|364290719|FG002|Overall Study|Withdrawal by Subject|1|||
105624458|NCT03677141|364290720|FG003|Overall Study|Withdrawal by Subject|1|||
105624459|NCT03677141|364290721|FG004|Overall Study|Withdrawal by Subject|1|||
105624460|NCT03677141|364290722|FG005|Overall Study|Withdrawal by Subject|0|||
105624461|NCT04132518|364290736|FG000|Overall Study|Prematurely withdrawn from the study|0|||
105624462|NCT04132518|364290737|FG001|Overall Study|Prematurely withdrawn from the study|9|||
105624463|NCT04132518|364290738|FG002|Overall Study|Prematurely withdrawn from the study|1|||
105624464|NCT02361216|364290739|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
105624465|NCT02361216|364290740|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
105624466|NCT02361216|364290739|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
105624467|NCT02361216|364290740|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
105624468|NCT02361216|364290739|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
105624469|NCT02361216|364290740|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
105624470|NCT02361216|364290739|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
105624471|NCT02361216|364290740|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
105624472|NCT02361216|364290739|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
105624473|NCT02361216|364290740|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
105624474|NCT02361216|364290739|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
105624475|NCT02361216|364290740|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
105624476|NCT04709419|364290741|FG000|Overall Study|Physician Decision|1|||
105624477|NCT04709419|364290742|FG001|Overall Study|Physician Decision|0|||
105624478|NCT05683340|364290743|FG000|Overall Study|Adverse Event|1|||
105624479|NCT05683340|364290744|FG001|Overall Study|Adverse Event|1|||
105624480|NCT05683340|364290743|FG000|Overall Study|Protocol Violation|1|||
105624481|NCT05683340|364290744|FG001|Overall Study|Protocol Violation|0|||
105624482|NCT05683340|364290743|FG000|Overall Study|Withdrawal by Subject|0|||
105624483|NCT05683340|364290744|FG001|Overall Study|Withdrawal by Subject|2|||
105624484|NCT02224144|364290748|FG000|Overall Study|Lost to Follow-up|3|||
105624485|NCT02224144|364290749|FG001|Overall Study|Lost to Follow-up|1|||
105624486|NCT02224144|364290748|FG000|Overall Study|Death|2|||
105624487|NCT02224144|364290749|FG001|Overall Study|Death|0|||
105624488|NCT02224144|364290748|FG000|Overall Study|Withdrawal by Subject|0|||
105624489|NCT02224144|364290749|FG001|Overall Study|Withdrawal by Subject|1|||
105624490|NCT03505008|364290750|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
105624491|NCT03505008|364290751|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
105624492|NCT03505008|364290752|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
105624493|NCT03505008|364290753|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
105624494|NCT03505008|364290750|FG000|Before Week 24 Randomization|Adverse Event|10|||
105624495|NCT03505008|364290751|FG001|Before Week 24 Randomization|Adverse Event|0|||
105624496|NCT03505008|364290752|FG002|Before Week 24 Randomization|Adverse Event|0|||
105624497|NCT03505008|364290753|FG003|Before Week 24 Randomization|Adverse Event|0|||
105624498|NCT03505008|364290750|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
105624499|NCT03505008|364290751|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
105624500|NCT03505008|364290752|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
105624501|NCT03505008|364290753|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
105624502|NCT03505008|364290750|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
105624503|NCT03505008|364290751|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
105624504|NCT03505008|364290752|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
105624505|NCT03505008|364290753|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
105624506|NCT03505008|364290750|FG000|Before Week 24 Randomization|Physician Decision|2|||
105624507|NCT03505008|364290751|FG001|Before Week 24 Randomization|Physician Decision|0|||
105624508|NCT03505008|364290752|FG002|Before Week 24 Randomization|Physician Decision|0|||
105624509|NCT03505008|364290753|FG003|Before Week 24 Randomization|Physician Decision|0|||
105624510|NCT03505008|364290750|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
105624511|NCT03505008|364290751|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
105624512|NCT03505008|364290752|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
105624513|NCT03505008|364290753|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
105624514|NCT03505008|364290750|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
105624515|NCT03505008|364290751|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
105624516|NCT03505008|364290752|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
105624517|NCT03505008|364290753|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
105624518|NCT03505008|364290750|FG000|Before Week 24 Randomization|Complication|1|||
105624519|NCT03505008|364290751|FG001|Before Week 24 Randomization|Complication|0|||
105624520|NCT03505008|364290752|FG002|Before Week 24 Randomization|Complication|0|||
105624521|NCT03505008|364290753|FG003|Before Week 24 Randomization|Complication|0|||
105624522|NCT03505008|364290750|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
105624523|NCT03505008|364290751|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
105624524|NCT03505008|364290752|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
105624525|NCT03505008|364290753|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
105624526|NCT03505008|364290750|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
105624527|NCT03505008|364290751|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
105624528|NCT03505008|364290752|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
105624529|NCT03505008|364290753|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
105624530|NCT03505008|364290750|FG000|After Week 24 Randomization|Adverse Event|0|||
105624531|NCT03505008|364290751|FG001|After Week 24 Randomization|Adverse Event|1|||
105624532|NCT03505008|364290752|FG002|After Week 24 Randomization|Adverse Event|2|||
105624533|NCT03505008|364290753|FG003|After Week 24 Randomization|Adverse Event|2|||
105624534|NCT03505008|364290750|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
105624535|NCT03505008|364290751|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
105624536|NCT03505008|364290752|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
105624537|NCT03505008|364290753|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
105624538|NCT03505008|364290750|FG000|After Week 24 Randomization|Protocol Violation|0|||
105624539|NCT03505008|364290751|FG001|After Week 24 Randomization|Protocol Violation|0|||
105624540|NCT03505008|364290752|FG002|After Week 24 Randomization|Protocol Violation|1|||
105624541|NCT03505008|364290753|FG003|After Week 24 Randomization|Protocol Violation|0|||
105624542|NCT02437136|364290754|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
105624543|NCT02437136|364290755|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
105624544|NCT02437136|364290756|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
105624545|NCT02437136|364290757|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
105624546|NCT02437136|364290758|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
105624547|NCT02437136|364290759|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
105624548|NCT02437136|364290760|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
105624549|NCT02437136|364290754|FG000|Expansion (Phase 2)|Death|0|||
105624550|NCT02437136|364290755|FG001|Expansion (Phase 2)|Death|0|||
105624551|NCT02437136|364290756|FG002|Expansion (Phase 2)|Death|0|||
105624552|NCT02437136|364290757|FG003|Expansion (Phase 2)|Death|6|||
105624553|NCT02437136|364290758|FG004|Expansion (Phase 2)|Death|37|||
105624554|NCT02437136|364290759|FG005|Expansion (Phase 2)|Death|29|||
105624555|NCT02437136|364290760|FG006|Expansion (Phase 2)|Death|24|||
105624556|NCT02437136|364290754|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
105624557|NCT02437136|364290755|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
105624558|NCT02437136|364290756|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
105624559|NCT02437136|364290757|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
105624560|NCT02437136|364290758|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
105624561|NCT02437136|364290759|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
105624562|NCT02437136|364290760|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
105624563|NCT02437136|364290754|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
105624564|NCT02437136|364290755|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
105624565|NCT02437136|364290756|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
105624566|NCT02437136|364290757|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
105624567|NCT02437136|364290758|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
105624568|NCT02437136|364290759|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
105624569|NCT02437136|364290760|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
105624570|NCT02056834|364290761|FG000|Overall Study|Lost to Follow-up|7|||
105624571|NCT03156465|364290771|FG000|Overall Study|Withdrawal by Subject|2|||
105624572|NCT05524116|364290772|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
105624573|NCT05524116|364290773|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
105624574|NCT05524116|364290772|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
105624575|NCT05524116|364290773|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
105624576|NCT05524116|364290772|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
105624577|NCT05524116|364290773|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
105624578|NCT05524116|364290772|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
105624579|NCT05524116|364290773|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
105624580|NCT05524116|364290772|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
105624581|NCT05524116|364290773|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
105624582|NCT03580356|364290785|FG000|Treatment Period|Withdrawal by Subject|13|||
105624583|NCT03580356|364290786|FG001|Treatment Period|Withdrawal by Subject|0|||
105624584|NCT03580356|364290787|FG002|Treatment Period|Withdrawal by Subject|13|||
105624585|NCT03580356|364290788|FG003|Treatment Period|Withdrawal by Subject|1|||
105624586|NCT03580356|364290789|FG004|Treatment Period|Withdrawal by Subject|17|||
105624587|NCT03580356|364290790|FG005|Treatment Period|Withdrawal by Subject|0|||
105624588|NCT03580356|364290791|FG006|Treatment Period|Withdrawal by Subject|5|||
105624589|NCT03580356|364290792|FG007|Treatment Period|Withdrawal by Subject|0|||
105624590|NCT03580356|364290785|FG000|Treatment Period|Adverse Event|10|||
105624591|NCT03580356|364290786|FG001|Treatment Period|Adverse Event|0|||
105624592|NCT03580356|364290787|FG002|Treatment Period|Adverse Event|13|||
105624593|NCT03580356|364290788|FG003|Treatment Period|Adverse Event|0|||
105624594|NCT03580356|364290789|FG004|Treatment Period|Adverse Event|5|||
105624595|NCT03580356|364290790|FG005|Treatment Period|Adverse Event|0|||
105624596|NCT03580356|364290791|FG006|Treatment Period|Adverse Event|8|||
105624597|NCT03580356|364290792|FG007|Treatment Period|Adverse Event|0|||
105624598|NCT03580356|364290785|FG000|Treatment Period|Protocol Violation|5|||
105624599|NCT03580356|364290786|FG001|Treatment Period|Protocol Violation|0|||
105624600|NCT03580356|364290787|FG002|Treatment Period|Protocol Violation|6|||
105624601|NCT03580356|364290788|FG003|Treatment Period|Protocol Violation|1|||
105624602|NCT03580356|364290789|FG004|Treatment Period|Protocol Violation|9|||
105624603|NCT03580356|364290790|FG005|Treatment Period|Protocol Violation|1|||
105624604|NCT03580356|364290791|FG006|Treatment Period|Protocol Violation|1|||
105624605|NCT03580356|364290792|FG007|Treatment Period|Protocol Violation|0|||
105624606|NCT03580356|364290785|FG000|Treatment Period|Lack of Efficacy|6|||
105624607|NCT03580356|364290786|FG001|Treatment Period|Lack of Efficacy|0|||
105624608|NCT03580356|364290787|FG002|Treatment Period|Lack of Efficacy|2|||
105624609|NCT03580356|364290788|FG003|Treatment Period|Lack of Efficacy|0|||
105624610|NCT03580356|364290789|FG004|Treatment Period|Lack of Efficacy|3|||
105624611|NCT03580356|364290790|FG005|Treatment Period|Lack of Efficacy|0|||
105624612|NCT03580356|364290791|FG006|Treatment Period|Lack of Efficacy|3|||
105624613|NCT03580356|364290792|FG007|Treatment Period|Lack of Efficacy|0|||
105624614|NCT03580356|364290785|FG000|Treatment Period|Pregnancy|1|||
105624615|NCT03580356|364290786|FG001|Treatment Period|Pregnancy|0|||
105624616|NCT03580356|364290787|FG002|Treatment Period|Pregnancy|7|||
105624617|NCT03580356|364290788|FG003|Treatment Period|Pregnancy|0|||
105624618|NCT03580356|364290789|FG004|Treatment Period|Pregnancy|2|||
105624619|NCT03580356|364290790|FG005|Treatment Period|Pregnancy|0|||
105624620|NCT03580356|364290791|FG006|Treatment Period|Pregnancy|1|||
105624621|NCT03580356|364290792|FG007|Treatment Period|Pregnancy|0|||
105624622|NCT03580356|364290785|FG000|Treatment Period|Physician Decision|2|||
105624623|NCT03580356|364290786|FG001|Treatment Period|Physician Decision|0|||
105624624|NCT03580356|364290787|FG002|Treatment Period|Physician Decision|1|||
105624625|NCT03580356|364290788|FG003|Treatment Period|Physician Decision|0|||
105624626|NCT03580356|364290789|FG004|Treatment Period|Physician Decision|4|||
105624627|NCT03580356|364290790|FG005|Treatment Period|Physician Decision|0|||
105624628|NCT03580356|364290791|FG006|Treatment Period|Physician Decision|2|||
105624629|NCT03580356|364290792|FG007|Treatment Period|Physician Decision|0|||
105624630|NCT03580356|364290785|FG000|Treatment Period|Lost to Follow-up|1|||
105624631|NCT03580356|364290786|FG001|Treatment Period|Lost to Follow-up|1|||
105624632|NCT03580356|364290787|FG002|Treatment Period|Lost to Follow-up|1|||
105624633|NCT03580356|364290788|FG003|Treatment Period|Lost to Follow-up|0|||
105624634|NCT03580356|364290789|FG004|Treatment Period|Lost to Follow-up|3|||
105624635|NCT03580356|364290790|FG005|Treatment Period|Lost to Follow-up|0|||
105624636|NCT03580356|364290791|FG006|Treatment Period|Lost to Follow-up|1|||
105624637|NCT03580356|364290792|FG007|Treatment Period|Lost to Follow-up|0|||
105624638|NCT03580356|364290785|FG000|Treatment Period|Death|0|||
105624639|NCT03580356|364290786|FG001|Treatment Period|Death|0|||
105624640|NCT03580356|364290787|FG002|Treatment Period|Death|1|||
105624641|NCT03580356|364290788|FG003|Treatment Period|Death|0|||
105624642|NCT03580356|364290789|FG004|Treatment Period|Death|0|||
105624643|NCT03580356|364290790|FG005|Treatment Period|Death|0|||
105624644|NCT03580356|364290791|FG006|Treatment Period|Death|0|||
105624645|NCT03580356|364290792|FG007|Treatment Period|Death|0|||
105624646|NCT03580356|364290785|FG000|Treatment Period|Technical problems|0|||
105624647|NCT03580356|364290786|FG001|Treatment Period|Technical problems|0|||
105624648|NCT03580356|364290787|FG002|Treatment Period|Technical problems|0|||
105624649|NCT03580356|364290788|FG003|Treatment Period|Technical problems|0|||
105624650|NCT03580356|364290789|FG004|Treatment Period|Technical problems|1|||
105624651|NCT03580356|364290790|FG005|Treatment Period|Technical problems|0|||
105624652|NCT03580356|364290791|FG006|Treatment Period|Technical problems|0|||
105624653|NCT03580356|364290792|FG007|Treatment Period|Technical problems|0|||
105624654|NCT03580356|364290785|FG000|Treatment Period|Misrandomized, no treatment|0|||
105624655|NCT03580356|364290786|FG001|Treatment Period|Misrandomized, no treatment|0|||
105624656|NCT03580356|364290787|FG002|Treatment Period|Misrandomized, no treatment|1|||
105624657|NCT03580356|364290788|FG003|Treatment Period|Misrandomized, no treatment|0|||
105624658|NCT03580356|364290789|FG004|Treatment Period|Misrandomized, no treatment|2|||
105624659|NCT03580356|364290790|FG005|Treatment Period|Misrandomized, no treatment|0|||
105624660|NCT03580356|364290791|FG006|Treatment Period|Misrandomized, no treatment|0|||
105624661|NCT03580356|364290792|FG007|Treatment Period|Misrandomized, no treatment|0|||
105624662|NCT03580356|364290785|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
105624663|NCT03580356|364290786|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
105624664|NCT03580356|364290787|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
105624665|NCT03580356|364290788|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
105624666|NCT03580356|364290789|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
105624667|NCT03580356|364290790|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
105624668|NCT03580356|364290791|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
105624669|NCT03580356|364290792|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
105624670|NCT03580356|364290785|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
105624671|NCT03580356|364290786|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
105624672|NCT03580356|364290787|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
105624673|NCT03580356|364290788|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
105624674|NCT03580356|364290789|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
105624675|NCT03580356|364290790|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
105624676|NCT03580356|364290791|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
105624677|NCT03580356|364290792|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
105624678|NCT03580356|364290785|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
105624679|NCT03580356|364290786|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
105624680|NCT03580356|364290787|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
105624681|NCT03580356|364290788|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
105624682|NCT03580356|364290789|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
105624683|NCT03580356|364290790|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
105624684|NCT03580356|364290791|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
105624685|NCT03580356|364290792|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
105624686|NCT03580356|364290785|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
105624687|NCT03580356|364290786|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
105624688|NCT03580356|364290787|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
105624689|NCT03580356|364290788|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
105624690|NCT03580356|364290789|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
105624691|NCT03580356|364290790|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
105624692|NCT03580356|364290791|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
105624693|NCT03580356|364290792|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
105624694|NCT03580356|364290785|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
105624695|NCT03580356|364290786|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
105624696|NCT03580356|364290787|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
105624697|NCT03580356|364290788|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
105624698|NCT03580356|364290789|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
105624699|NCT03580356|364290790|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
105624700|NCT03580356|364290791|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
105624701|NCT03580356|364290792|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
105624702|NCT03580356|364290785|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
105624703|NCT03580356|364290786|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
105624704|NCT03580356|364290787|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
105624705|NCT03580356|364290788|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
105624706|NCT03580356|364290789|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
105624707|NCT03580356|364290790|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
105624708|NCT03580356|364290791|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
105624709|NCT03580356|364290792|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
105624710|NCT03580356|364290785|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
105624711|NCT03580356|364290786|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
105624712|NCT03580356|364290787|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
105624713|NCT03580356|364290788|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
105624714|NCT03580356|364290789|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
105624715|NCT03580356|364290790|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
105624716|NCT03580356|364290791|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
105624717|NCT03580356|364290792|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
105624718|NCT05715528|364290793|FG000|Overall Study|Randomized but never treated|11|||
105624719|NCT05715528|364290794|FG001|Overall Study|Randomized but never treated|13|||
105624720|NCT05715528|364290793|FG000|Overall Study|Withdrew consent|7|||
105624721|NCT05715528|364290794|FG001|Overall Study|Withdrew consent|15|||
105624722|NCT05715528|364290793|FG000|Overall Study|Lost to Follow-up|5|||
105624723|NCT05715528|364290794|FG001|Overall Study|Lost to Follow-up|13|||
105624724|NCT05715528|364290793|FG000|Overall Study|Investigator's discretion|3|||
105624725|NCT05715528|364290794|FG001|Overall Study|Investigator's discretion|1|||
105624726|NCT05715528|364290793|FG000|Overall Study|Protocol Violation|2|||
105624727|NCT05715528|364290794|FG001|Overall Study|Protocol Violation|0|||
105624728|NCT05715528|364290793|FG000|Overall Study|Non-compliance with study drug|0|||
105624729|NCT05715528|364290794|FG001|Overall Study|Non-compliance with study drug|1|||
105624730|NCT03118518|364290795|FG000|Overall Study|Early Exit after treatment|2|||
105624731|NCT03118518|364290796|FG001|Overall Study|Early Exit after treatment|8|||
105624732|NCT03118518|364290795|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
105624733|NCT03118518|364290796|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
105624734|NCT04544007|364290800|FG000|Overall Study|Withdrawal by Subject|1|||
105624735|NCT04544007|364290800|FG000|Overall Study|Confirmed Progressive Disease|1|||
105624736|NCT04456296|364290808|FG000|Overall Study|Withdrawal by Subject|14|||
105624737|NCT04456296|364290809|FG001|Overall Study|Withdrawal by Subject|21|||
105624738|NCT04456296|364290810|FG002|Overall Study|Withdrawal by Subject|21|||
105624739|NCT04456296|364290808|FG000|Overall Study|Adverse Event|2|||
105624740|NCT04456296|364290809|FG001|Overall Study|Adverse Event|2|||
105624741|NCT04456296|364290810|FG002|Overall Study|Adverse Event|2|||
105624742|NCT04456296|364290808|FG000|Overall Study|Death|1|||
105624743|NCT04456296|364290809|FG001|Overall Study|Death|0|||
105624744|NCT04456296|364290810|FG002|Overall Study|Death|0|||
105624745|NCT04456296|364290808|FG000|Overall Study|Lost to Follow-up|3|||
105624746|NCT04456296|364290809|FG001|Overall Study|Lost to Follow-up|5|||
105624747|NCT04456296|364290810|FG002|Overall Study|Lost to Follow-up|6|||
105624748|NCT04456296|364290808|FG000|Overall Study|Other than specified|0|||
105624749|NCT04456296|364290809|FG001|Overall Study|Other than specified|1|||
105624750|NCT04456296|364290810|FG002|Overall Study|Other than specified|4|||
105624751|NCT04456296|364290808|FG000|Overall Study|Randomized, not treated|2|||
105624752|NCT04456296|364290809|FG001|Overall Study|Randomized, not treated|1|||
105624753|NCT04456296|364290810|FG002|Overall Study|Randomized, not treated|0|||
105624754|NCT05736458|364290811|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
105624755|NCT05736458|364290812|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
105624756|NCT05736458|364290813|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
105624757|NCT05736458|364290811|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
105624758|NCT05736458|364290812|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
105624759|NCT05736458|364290813|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
105624760|NCT05736458|364290811|FG000|TMS/fMRI #1|Physician Decision|0|||
105624761|NCT05736458|364290812|FG001|TMS/fMRI #1|Physician Decision|0|||
105624762|NCT05736458|364290813|FG002|TMS/fMRI #1|Physician Decision|2|||
105624763|NCT05736458|364290811|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
105624764|NCT05736458|364290812|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
105624765|NCT05736458|364290813|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
105624766|NCT04247802|364290819|FG000|Overall Study|Withdrawal by Subject|1|||
105624767|NCT04247802|364290820|FG001|Overall Study|Withdrawal by Subject|3|||
105624768|NCT04247802|364290819|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
105624769|NCT04247802|364290820|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
105624770|NCT04629339|364290821|FG000|Overall Study|Death|1|||
105624771|NCT04629339|364290822|FG001|Overall Study|Death|0|||
105624772|NCT04629339|364290823|FG002|Overall Study|Death|2|||
105624773|NCT04629339|364290824|FG003|Overall Study|Death|2|||
105624774|NCT04629339|364290825|FG004|Overall Study|Death|0|||
105624775|NCT04629339|364290821|FG000|Overall Study|Disease Progression|0|||
105624776|NCT04629339|364290822|FG001|Overall Study|Disease Progression|0|||
105624777|NCT04629339|364290823|FG002|Overall Study|Disease Progression|1|||
105624778|NCT04629339|364290824|FG003|Overall Study|Disease Progression|1|||
105624779|NCT04629339|364290825|FG004|Overall Study|Disease Progression|0|||
105624780|NCT04629339|364290821|FG000|Overall Study|Lost to Follow-up|0|||
105624781|NCT04629339|364290822|FG001|Overall Study|Lost to Follow-up|0|||
105624782|NCT04629339|364290823|FG002|Overall Study|Lost to Follow-up|0|||
105624783|NCT04629339|364290824|FG003|Overall Study|Lost to Follow-up|1|||
105624784|NCT04629339|364290825|FG004|Overall Study|Lost to Follow-up|0|||
105624785|NCT04629339|364290821|FG000|Overall Study|Physician Decision|0|||
105624786|NCT04629339|364290822|FG001|Overall Study|Physician Decision|1|||
105624787|NCT04629339|364290823|FG002|Overall Study|Physician Decision|0|||
105624788|NCT04629339|364290824|FG003|Overall Study|Physician Decision|0|||
105624789|NCT04629339|364290825|FG004|Overall Study|Physician Decision|0|||
105624790|NCT04629339|364290821|FG000|Overall Study|Study Terminated by Sponsor|0|||
105624791|NCT04629339|364290822|FG001|Overall Study|Study Terminated by Sponsor|0|||
105624792|NCT04629339|364290823|FG002|Overall Study|Study Terminated by Sponsor|0|||
105624793|NCT04629339|364290824|FG003|Overall Study|Study Terminated by Sponsor|1|||
105624794|NCT04629339|364290825|FG004|Overall Study|Study Terminated by Sponsor|0|||
105624795|NCT04629339|364290821|FG000|Overall Study|Withdrawal by Subject|0|||
105624796|NCT04629339|364290822|FG001|Overall Study|Withdrawal by Subject|0|||
105624797|NCT04629339|364290823|FG002|Overall Study|Withdrawal by Subject|2|||
105624798|NCT04629339|364290824|FG003|Overall Study|Withdrawal by Subject|2|||
105624799|NCT04629339|364290825|FG004|Overall Study|Withdrawal by Subject|0|||
105624800|NCT02052882|364292599|FG000|Overall Study|Not treated|11|||
105624801|NCT02052882|364292599|FG000|Overall Study|Protocol Violation|1|||
105624802|NCT02052882|364292599|FG000|Overall Study|Inadequate testing|1|||
105624803|NCT03389802|364292603|FG000|Overall Study|Lack of Efficacy|3|||
105624804|NCT03389802|364292604|FG001|Overall Study|Lack of Efficacy|3|||
105624805|NCT03389802|364292605|FG002|Overall Study|Lack of Efficacy|13|||
105624806|NCT03389802|364292606|FG003|Overall Study|Lack of Efficacy|6|||
105624807|NCT03389802|364292607|FG004|Overall Study|Lack of Efficacy|1|||
105624808|NCT03389802|364292603|FG000|Overall Study|Adverse Event|0|||
105624809|NCT03389802|364292604|FG001|Overall Study|Adverse Event|0|||
105624810|NCT03389802|364292605|FG002|Overall Study|Adverse Event|1|||
105624811|NCT03389802|364292606|FG003|Overall Study|Adverse Event|0|||
105624812|NCT03389802|364292607|FG004|Overall Study|Adverse Event|4|||
105624813|NCT03389802|364292603|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
105624814|NCT03389802|364292604|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
105624815|NCT03389802|364292605|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
105624816|NCT03389802|364292606|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
105624817|NCT03389802|364292607|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
105624818|NCT02240238|364292610|FG000|Phase 1|Adverse Event|0|||
105624819|NCT02240238|364292611|FG001|Phase 1|Adverse Event|0|||
105624820|NCT02240238|364292612|FG002|Phase 1|Adverse Event|0|||
105624821|NCT02240238|364292613|FG003|Phase 1|Adverse Event|0|||
105624822|NCT02240238|364292614|FG004|Phase 1|Adverse Event|0|||
105624823|NCT02240238|364292615|FG005|Phase 1|Adverse Event|0|||
105624824|NCT02240238|364292616|FG006|Phase 1|Adverse Event|3|||
105624825|NCT02240238|364292617|FG007|Phase 1|Adverse Event|1|||
105624826|NCT02240238|364292618|FG008|Phase 1|Adverse Event|0|||
105624827|NCT02240238|364292619|FG009|Phase 1|Adverse Event|0|||
105624828|NCT02240238|364292620|FG010|Phase 1|Adverse Event|0|||
105624829|NCT02240238|364292621|FG011|Phase 1|Adverse Event|0|||
105624830|NCT02240238|364292610|FG000|Phase 1|Death|0|||
105624831|NCT02240238|364292611|FG001|Phase 1|Death|0|||
105624832|NCT02240238|364292612|FG002|Phase 1|Death|0|||
105624833|NCT02240238|364292613|FG003|Phase 1|Death|0|||
105624834|NCT02240238|364292614|FG004|Phase 1|Death|0|||
105624835|NCT02240238|364292615|FG005|Phase 1|Death|1|||
105624836|NCT02240238|364292616|FG006|Phase 1|Death|0|||
105624837|NCT02240238|364292617|FG007|Phase 1|Death|0|||
105624838|NCT02240238|364292618|FG008|Phase 1|Death|0|||
105624839|NCT02240238|364292619|FG009|Phase 1|Death|0|||
105624840|NCT02240238|364292620|FG010|Phase 1|Death|0|||
105624841|NCT02240238|364292621|FG011|Phase 1|Death|0|||
105624842|NCT02240238|364292610|FG000|Phase 1|Sponsor termination|0|||
105624843|NCT02240238|364292611|FG001|Phase 1|Sponsor termination|0|||
105624844|NCT02240238|364292612|FG002|Phase 1|Sponsor termination|0|||
105624845|NCT02240238|364292613|FG003|Phase 1|Sponsor termination|0|||
105624846|NCT02240238|364292614|FG004|Phase 1|Sponsor termination|0|||
105624847|NCT02240238|364292615|FG005|Phase 1|Sponsor termination|1|||
105624848|NCT02240238|364292616|FG006|Phase 1|Sponsor termination|0|||
105624849|NCT02240238|364292617|FG007|Phase 1|Sponsor termination|0|||
105624850|NCT02240238|364292618|FG008|Phase 1|Sponsor termination|0|||
105624851|NCT02240238|364292619|FG009|Phase 1|Sponsor termination|0|||
105624852|NCT02240238|364292620|FG010|Phase 1|Sponsor termination|0|||
105624853|NCT02240238|364292621|FG011|Phase 1|Sponsor termination|0|||
105624854|NCT02240238|364292610|FG000|Phase 1|Withdrawal by Subject|0|||
105624855|NCT02240238|364292611|FG001|Phase 1|Withdrawal by Subject|0|||
105624856|NCT02240238|364292612|FG002|Phase 1|Withdrawal by Subject|0|||
105624857|NCT02240238|364292613|FG003|Phase 1|Withdrawal by Subject|0|||
105624858|NCT02240238|364292614|FG004|Phase 1|Withdrawal by Subject|0|||
105624859|NCT02240238|364292615|FG005|Phase 1|Withdrawal by Subject|2|||
105624860|NCT02240238|364292616|FG006|Phase 1|Withdrawal by Subject|0|||
105624861|NCT02240238|364292617|FG007|Phase 1|Withdrawal by Subject|0|||
105624862|NCT02240238|364292618|FG008|Phase 1|Withdrawal by Subject|0|||
105624863|NCT02240238|364292619|FG009|Phase 1|Withdrawal by Subject|0|||
105624864|NCT02240238|364292620|FG010|Phase 1|Withdrawal by Subject|0|||
105624865|NCT02240238|364292621|FG011|Phase 1|Withdrawal by Subject|0|||
105624866|NCT02240238|364292610|FG000|Phase 1|Physician Decision|0|||
105624867|NCT02240238|364292611|FG001|Phase 1|Physician Decision|0|||
105624868|NCT02240238|364292612|FG002|Phase 1|Physician Decision|0|||
105624869|NCT02240238|364292613|FG003|Phase 1|Physician Decision|0|||
105624870|NCT02240238|364292614|FG004|Phase 1|Physician Decision|0|||
105624871|NCT02240238|364292615|FG005|Phase 1|Physician Decision|2|||
105624872|NCT02240238|364292616|FG006|Phase 1|Physician Decision|0|||
105624873|NCT02240238|364292617|FG007|Phase 1|Physician Decision|0|||
105624874|NCT02240238|364292618|FG008|Phase 1|Physician Decision|0|||
105624875|NCT02240238|364292619|FG009|Phase 1|Physician Decision|0|||
105624876|NCT02240238|364292620|FG010|Phase 1|Physician Decision|0|||
105624877|NCT02240238|364292621|FG011|Phase 1|Physician Decision|0|||
105624878|NCT02240238|364292610|FG000|Phase 2|Adverse Event|0|||
105624879|NCT02240238|364292611|FG001|Phase 2|Adverse Event|0|||
105624880|NCT02240238|364292612|FG002|Phase 2|Adverse Event|0|||
105624881|NCT02240238|364292613|FG003|Phase 2|Adverse Event|0|||
105624882|NCT02240238|364292614|FG004|Phase 2|Adverse Event|0|||
105624883|NCT02240238|364292615|FG005|Phase 2|Adverse Event|0|||
105624884|NCT02240238|364292616|FG006|Phase 2|Adverse Event|0|||
105624885|NCT02240238|364292617|FG007|Phase 2|Adverse Event|0|||
105624886|NCT02240238|364292618|FG008|Phase 2|Adverse Event|0|||
105624887|NCT02240238|364292619|FG009|Phase 2|Adverse Event|7|||
105624888|NCT02240238|364292620|FG010|Phase 2|Adverse Event|14|||
105624889|NCT02240238|364292621|FG011|Phase 2|Adverse Event|2|||
105624890|NCT02240238|364292610|FG000|Phase 2|Death|0|||
105624891|NCT02240238|364292611|FG001|Phase 2|Death|0|||
105624892|NCT02240238|364292612|FG002|Phase 2|Death|0|||
105624893|NCT02240238|364292613|FG003|Phase 2|Death|0|||
105624894|NCT02240238|364292614|FG004|Phase 2|Death|0|||
105624895|NCT02240238|364292615|FG005|Phase 2|Death|0|||
105624896|NCT02240238|364292616|FG006|Phase 2|Death|0|||
105624897|NCT02240238|364292617|FG007|Phase 2|Death|0|||
105624898|NCT02240238|364292618|FG008|Phase 2|Death|0|||
105624899|NCT02240238|364292619|FG009|Phase 2|Death|3|||
105624900|NCT02240238|364292620|FG010|Phase 2|Death|2|||
105624901|NCT02240238|364292621|FG011|Phase 2|Death|1|||
105624902|NCT02240238|364292610|FG000|Phase 2|Disease progression|0|||
105624903|NCT02240238|364292611|FG001|Phase 2|Disease progression|0|||
105624904|NCT02240238|364292612|FG002|Phase 2|Disease progression|0|||
105624905|NCT02240238|364292613|FG003|Phase 2|Disease progression|0|||
105624906|NCT02240238|364292614|FG004|Phase 2|Disease progression|0|||
105624907|NCT02240238|364292615|FG005|Phase 2|Disease progression|0|||
105624908|NCT02240238|364292616|FG006|Phase 2|Disease progression|0|||
105624909|NCT02240238|364292617|FG007|Phase 2|Disease progression|0|||
105624910|NCT02240238|364292618|FG008|Phase 2|Disease progression|0|||
105624911|NCT02240238|364292619|FG009|Phase 2|Disease progression|5|||
105624912|NCT02240238|364292620|FG010|Phase 2|Disease progression|11|||
105624913|NCT02240238|364292621|FG011|Phase 2|Disease progression|1|||
105624914|NCT02240238|364292610|FG000|Phase 2|Withdrawal by Subject|0|||
105624915|NCT02240238|364292611|FG001|Phase 2|Withdrawal by Subject|0|||
105624916|NCT02240238|364292612|FG002|Phase 2|Withdrawal by Subject|0|||
105624917|NCT02240238|364292613|FG003|Phase 2|Withdrawal by Subject|0|||
105624918|NCT02240238|364292614|FG004|Phase 2|Withdrawal by Subject|0|||
105624919|NCT02240238|364292615|FG005|Phase 2|Withdrawal by Subject|0|||
105624920|NCT02240238|364292616|FG006|Phase 2|Withdrawal by Subject|0|||
105624921|NCT02240238|364292617|FG007|Phase 2|Withdrawal by Subject|0|||
105624922|NCT02240238|364292618|FG008|Phase 2|Withdrawal by Subject|0|||
105624923|NCT02240238|364292619|FG009|Phase 2|Withdrawal by Subject|1|||
105624924|NCT02240238|364292620|FG010|Phase 2|Withdrawal by Subject|1|||
105624925|NCT02240238|364292621|FG011|Phase 2|Withdrawal by Subject|0|||
105624926|NCT02240238|364292610|FG000|Phase 2|Physician Decision|0|||
105624927|NCT02240238|364292611|FG001|Phase 2|Physician Decision|0|||
105624928|NCT02240238|364292612|FG002|Phase 2|Physician Decision|0|||
105624929|NCT02240238|364292613|FG003|Phase 2|Physician Decision|0|||
105624930|NCT02240238|364292614|FG004|Phase 2|Physician Decision|0|||
105624931|NCT02240238|364292615|FG005|Phase 2|Physician Decision|0|||
105624932|NCT02240238|364292616|FG006|Phase 2|Physician Decision|0|||
105624933|NCT02240238|364292617|FG007|Phase 2|Physician Decision|0|||
105624934|NCT02240238|364292618|FG008|Phase 2|Physician Decision|0|||
105624935|NCT02240238|364292619|FG009|Phase 2|Physician Decision|1|||
105624936|NCT02240238|364292620|FG010|Phase 2|Physician Decision|3|||
105624937|NCT02240238|364292621|FG011|Phase 2|Physician Decision|0|||
105624938|NCT02240238|364292610|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
105624939|NCT02240238|364292611|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
105624940|NCT02240238|364292612|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
105624941|NCT02240238|364292613|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
105624942|NCT02240238|364292614|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
105624943|NCT02240238|364292615|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
105624944|NCT02240238|364292616|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
105624945|NCT02240238|364292617|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
105624946|NCT02240238|364292618|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
105624947|NCT02240238|364292619|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
105624948|NCT02240238|364292620|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
105624949|NCT02240238|364292621|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
105624950|NCT02240238|364292610|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
105624951|NCT02240238|364292611|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
105624952|NCT02240238|364292612|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
105624953|NCT02240238|364292613|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
105624954|NCT02240238|364292614|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
105624955|NCT02240238|364292615|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
105624956|NCT02240238|364292616|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
105624957|NCT02240238|364292617|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
105624958|NCT02240238|364292618|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
105624959|NCT02240238|364292619|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
105624960|NCT02240238|364292620|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
105624961|NCT02240238|364292621|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
105624962|NCT02240238|364292610|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
105624963|NCT02240238|364292611|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
105624964|NCT02240238|364292612|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
105624965|NCT02240238|364292613|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
105624966|NCT02240238|364292614|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
105624967|NCT02240238|364292615|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
105624968|NCT02240238|364292616|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
105624969|NCT02240238|364292617|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
105624970|NCT02240238|364292618|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
105624971|NCT02240238|364292619|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
105624972|NCT02240238|364292620|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
105624973|NCT02240238|364292621|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
105624974|NCT02240238|364292610|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
105624975|NCT02240238|364292611|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
105624976|NCT02240238|364292612|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
105624977|NCT02240238|364292613|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
105624978|NCT02240238|364292614|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
105624979|NCT02240238|364292615|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
105624980|NCT02240238|364292616|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
105624981|NCT02240238|364292617|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
105624982|NCT02240238|364292618|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
105624983|NCT02240238|364292619|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
105624984|NCT02240238|364292620|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
105624985|NCT02240238|364292621|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
105624986|NCT02240238|364292610|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
105624987|NCT02240238|364292611|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
105624988|NCT02240238|364292612|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
105624989|NCT02240238|364292613|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
105624990|NCT02240238|364292614|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
105624991|NCT02240238|364292615|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
105624992|NCT02240238|364292616|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
105624993|NCT02240238|364292617|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
105624994|NCT02240238|364292618|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
105624995|NCT02240238|364292619|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
105624996|NCT02240238|364292620|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
105624997|NCT02240238|364292621|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
105624998|NCT02240238|364292610|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
105624999|NCT02240238|364292611|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
105625000|NCT02240238|364292612|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
105625001|NCT02240238|364292613|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
105625002|NCT02240238|364292614|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
105625003|NCT02240238|364292615|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
105625004|NCT02240238|364292616|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
105625005|NCT02240238|364292617|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
105625006|NCT02240238|364292618|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
105625007|NCT02240238|364292619|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
105625008|NCT02240238|364292620|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
105625009|NCT02240238|364292621|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
105625010|NCT02240238|364292610|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
105625011|NCT02240238|364292611|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
105625012|NCT02240238|364292612|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
105625013|NCT02240238|364292613|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
105625014|NCT02240238|364292614|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
105625015|NCT02240238|364292615|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
105625016|NCT02240238|364292616|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
105625017|NCT02240238|364292617|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
105625018|NCT02240238|364292618|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
105625019|NCT02240238|364292619|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
105625020|NCT02240238|364292620|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
105625021|NCT02240238|364292621|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
105625022|NCT02240238|364292610|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
105625023|NCT02240238|364292611|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
105625024|NCT02240238|364292612|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
105625025|NCT02240238|364292613|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
105625026|NCT02240238|364292614|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
105625027|NCT02240238|364292615|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
105625028|NCT02240238|364292616|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
105625029|NCT02240238|364292617|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
105625030|NCT02240238|364292618|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
105625031|NCT02240238|364292619|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
105625032|NCT02240238|364292620|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
105625033|NCT02240238|364292621|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
105625034|NCT04797195|364292622|FG000|Overall Study|Death|8|||
105625035|NCT04797195|364292623|FG001|Overall Study|Death|15|||
105625036|NCT04797195|364292622|FG000|Overall Study|Change from PD|15|||
105625037|NCT04797195|364292623|FG001|Overall Study|Change from PD|15|||
105625038|NCT04797195|364292622|FG000|Overall Study|Withdrawal by Subject|3|||
105625039|NCT04797195|364292623|FG001|Overall Study|Withdrawal by Subject|2|||
105625040|NCT04304144|364292624|FG000|DLT Observation Period|Physician Decision|0|||
105625041|NCT04304144|364292625|FG001|DLT Observation Period|Physician Decision|1|||
105625042|NCT04304144|364292626|FG002|DLT Observation Period|Physician Decision|0|||
105625043|NCT04304144|364292627|FG003|DLT Observation Period|Physician Decision|0|||
105625044|NCT04304144|364292624|FG000|Continued Treatment Period|Adverse Event|0|||
105625045|NCT04304144|364292625|FG001|Continued Treatment Period|Adverse Event|1|||
105625046|NCT04304144|364292626|FG002|Continued Treatment Period|Adverse Event|0|||
105625047|NCT04304144|364292627|FG003|Continued Treatment Period|Adverse Event|0|||
105625048|NCT04304144|364292624|FG000|Continued Treatment Period|Death|0|||
105625049|NCT04304144|364292625|FG001|Continued Treatment Period|Death|0|||
105625050|NCT04304144|364292626|FG002|Continued Treatment Period|Death|1|||
105625051|NCT04304144|364292627|FG003|Continued Treatment Period|Death|2|||
105625052|NCT04304144|364292624|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
105625053|NCT04304144|364292625|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
105625054|NCT04304144|364292626|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
105625055|NCT04304144|364292627|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
105625056|NCT04304144|364292624|FG000|Continued Treatment Period|Other than specified|2|||
105625057|NCT04304144|364292625|FG001|Continued Treatment Period|Other than specified|0|||
105625058|NCT04304144|364292626|FG002|Continued Treatment Period|Other than specified|1|||
105625059|NCT04304144|364292627|FG003|Continued Treatment Period|Other than specified|1|||
105625060|NCT04660539|364292628|FG000|Overall Study|Adverse Event|10|||
105625061|NCT04660539|364292628|FG000|Overall Study|Lack of Efficacy|4|||
105625062|NCT04660539|364292628|FG000|Overall Study|Lost to Follow-up|5|||
105625063|NCT04660539|364292628|FG000|Overall Study|Non-Compliance With Study Drug|3|||
105625064|NCT04660539|364292628|FG000|Overall Study|Reason not Specified|12|||
105625065|NCT04660539|364292628|FG000|Overall Study|Pregnancy|2|||
105625066|NCT04660539|364292628|FG000|Overall Study|Protocol Violation|2|||
105625067|NCT04660539|364292628|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
105625068|NCT04660539|364292628|FG000|Overall Study|Withdrawal by Subject|21|||
105625069|NCT03655028|364292631|FG000|12-weeks Follow up|Death|1|||
105625070|NCT03655028|364292632|FG001|12-weeks Follow up|Death|0|||
105625071|NCT03655028|364292631|FG000|12-weeks Follow up|Physician Decision|3|||
105625072|NCT03655028|364292632|FG001|12-weeks Follow up|Physician Decision|3|||
105625073|NCT03655028|364292631|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
105625074|NCT03655028|364292632|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
105625075|NCT03655028|364292631|FG000|12-weeks Follow up|Lost to Follow-up|4|||
105625076|NCT03655028|364292632|FG001|12-weeks Follow up|Lost to Follow-up|4|||
105625077|NCT03655028|364292631|FG000|24-weeks|Lost to Follow-up|1|||
105625078|NCT03655028|364292632|FG001|24-weeks|Lost to Follow-up|1|||
105625079|NCT03655028|364292631|FG000|24-weeks|Death|0|||
105625080|NCT03655028|364292632|FG001|24-weeks|Death|1|||
105625081|NCT03513302|364292633|FG000|First Intervention (14 Days)|Screen failure|15|||
105625082|NCT03513302|364292634|FG001|First Intervention (14 Days)|Screen failure|16|||
105625083|NCT00746096|364292635|FG000|Overall Study|Adverse Event|1|||
105625084|NCT00746096|364292636|FG001|Overall Study|Adverse Event|0|||
105625085|NCT00746096|364292635|FG000|Overall Study|Withdrawal by Subject|5|||
105625086|NCT00746096|364292636|FG001|Overall Study|Withdrawal by Subject|1|||
105625087|NCT00746096|364292635|FG000|Overall Study|Lost to Follow-up|2|||
105625088|NCT00746096|364292636|FG001|Overall Study|Lost to Follow-up|1|||
105625089|NCT00746096|364292635|FG000|Overall Study|Protocol Violation|1|||
105625090|NCT00746096|364292636|FG001|Overall Study|Protocol Violation|0|||
105625091|NCT00746096|364292635|FG000|Overall Study|No study drug treatment|1|||
105625092|NCT00746096|364292636|FG001|Overall Study|No study drug treatment|1|||
105625093|NCT05425420|364292653|FG000|Overall Study|Physician Decision|1|||
105625094|NCT05425420|364292653|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
105625095|NCT04599634|364292659|FG000|Overall Study|Dose limiting toxicity|0|||
105625096|NCT04599634|364292660|FG001|Overall Study|Dose limiting toxicity|0|||
105625097|NCT04599634|364292661|FG002|Overall Study|Dose limiting toxicity|2|||
105625098|NCT04599634|364292662|FG003|Overall Study|Dose limiting toxicity|0|||
105625099|NCT03733925|364292663|FG000|Overall Study|Lost to Follow-up|1|||
105625100|NCT03733925|364292663|FG000|Overall Study|Withdrawal by Subject|2|||
105625101|NCT03733925|364292663|FG000|Overall Study|Adverse Event|2|||
105625102|NCT03733925|364292663|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105625103|NCT03213873|364292664|FG000|Overall Study|Withdrawal by Subject|8|||
105625104|NCT03213873|364292665|FG001|Overall Study|Withdrawal by Subject|9|||
105625105|NCT03213873|364292664|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
105625106|NCT03213873|364292665|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
105625107|NCT03213873|364292664|FG000|Overall Study|Lost to Follow-up|0|||
105625108|NCT03213873|364292665|FG001|Overall Study|Lost to Follow-up|2|||
105625109|NCT05245071|364292666|FG000|Overall Study|Progressive disease|16|||
105625110|NCT05245071|364292666|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
105625111|NCT05245071|364292666|FG000|Overall Study|Ongoing study intervention|4|||
105625112|NCT02676973|364292667|FG000|Overall Study|Withdrawal by Subject|9|||
105625113|NCT02676973|364292668|FG001|Overall Study|Withdrawal by Subject|8|||
105625114|NCT02676973|364292669|FG002|Overall Study|Withdrawal by Subject|11|||
105625115|NCT02676973|364292667|FG000|Overall Study|Lost to Follow-up|8|||
105625116|NCT02676973|364292668|FG001|Overall Study|Lost to Follow-up|12|||
105625117|NCT02676973|364292669|FG002|Overall Study|Lost to Follow-up|8|||
105625118|NCT02676973|364292667|FG000|Overall Study|Death|2|||
105625119|NCT02676973|364292668|FG001|Overall Study|Death|1|||
105625120|NCT02676973|364292669|FG002|Overall Study|Death|5|||
105625121|NCT02631746|364292675|FG000|Overall Study|Lack of Efficacy|3|||
105625122|NCT04571619|364292676|FG000|Phase 1|Death|22|||
105625123|NCT04571619|364292677|FG001|Phase 1|Death|18|||
105625124|NCT04571619|364292676|FG000|Phase 1|Withdrawal by Subject|7|||
105625125|NCT04571619|364292677|FG001|Phase 1|Withdrawal by Subject|2|||
105625126|NCT04571619|364292676|FG000|Phase 2|Death|13|||
105625127|NCT04571619|364292677|FG001|Phase 2|Death|16|||
105625128|NCT04571619|364292676|FG000|Phase 2|Withdrawal by Subject|6|||
105625129|NCT04571619|364292677|FG001|Phase 2|Withdrawal by Subject|4|||
105625130|NCT04469270|364292694|FG000|Overall Study|Adverse Event|2|||
105625131|NCT04469270|364292695|FG001|Overall Study|Adverse Event|0|||
105625132|NCT04469270|364292694|FG000|Overall Study|Lost to Follow-up|4|||
105625133|NCT04469270|364292695|FG001|Overall Study|Lost to Follow-up|3|||
105625134|NCT04469270|364292694|FG000|Overall Study|Withdrawal by Subject|7|||
105625135|NCT04469270|364292695|FG001|Overall Study|Withdrawal by Subject|3|||
105625136|NCT04469270|364292694|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
105625137|NCT04469270|364292695|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
105625138|NCT04469270|364292694|FG000|Overall Study|missing|1|||
105625139|NCT04469270|364292695|FG001|Overall Study|missing|0|||
105625140|NCT04209855|364292696|FG000|Overall Study|Adverse Event|20|||
105625141|NCT04209855|364292697|FG001|Overall Study|Adverse Event|28|||
105625142|NCT04209855|364292696|FG000|Overall Study|Death|3|||
105625143|NCT04209855|364292697|FG001|Overall Study|Death|1|||
105625144|NCT04209855|364292696|FG000|Overall Study|Principal Investigator (PI) Discretion|4|||
105625145|NCT04209855|364292697|FG001|Overall Study|Principal Investigator (PI) Discretion|9|||
105625146|NCT04209855|364292696|FG000|Overall Study|Participant Withdrew Consent to Treatment|4|||
105625147|NCT04209855|364292697|FG001|Overall Study|Participant Withdrew Consent to Treatment|11|||
105625148|NCT04209855|364292696|FG000|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|4|||
105625149|NCT04209855|364292697|FG001|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|15|||
105625150|NCT04209855|364292696|FG000|Overall Study|Progressive Disease|154|||
105625151|NCT04209855|364292697|FG001|Overall Study|Progressive Disease|145|||
105625152|NCT04209855|364292696|FG000|Overall Study|Protocol Deviation|1|||
105625153|NCT04209855|364292697|FG001|Overall Study|Protocol Deviation|1|||
105625154|NCT04209855|364292696|FG000|Overall Study|Other Than Specified|5|||
105625155|NCT04209855|364292697|FG001|Overall Study|Other Than Specified|10|||
105625156|NCT02003924|364292700|FG000|Double-blind Phase|Lost to Follow-up|2|||
105625157|NCT02003924|364292701|FG001|Double-blind Phase|Lost to Follow-up|1|||
105625158|NCT02003924|364292702|FG002|Double-blind Phase|Lost to Follow-up|0|||
105625159|NCT02003924|364292700|FG000|Double-blind Phase|Protocol Violation|1|||
105625160|NCT02003924|364292701|FG001|Double-blind Phase|Protocol Violation|2|||
105625161|NCT02003924|364292702|FG002|Double-blind Phase|Protocol Violation|0|||
105625162|NCT02003924|364292700|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
105625163|NCT02003924|364292701|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
105625164|NCT02003924|364292702|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
105625165|NCT02003924|364292700|FG000|Double-blind Phase|Disease Progression|229|||
105625166|NCT02003924|364292701|FG001|Double-blind Phase|Disease Progression|247|||
105625167|NCT02003924|364292702|FG002|Double-blind Phase|Disease Progression|0|||
105625168|NCT02003924|364292700|FG000|Double-blind Phase|Adverse Event|120|||
105625169|NCT02003924|364292701|FG001|Double-blind Phase|Adverse Event|31|||
105625170|NCT02003924|364292702|FG002|Double-blind Phase|Adverse Event|0|||
105625171|NCT02003924|364292700|FG000|Double-blind Phase|Randomized But not Treated|3|||
105625172|NCT02003924|364292701|FG001|Double-blind Phase|Randomized But not Treated|3|||
105625173|NCT02003924|364292702|FG002|Double-blind Phase|Randomized But not Treated|0|||
105625174|NCT02003924|364292700|FG000|Double-blind Phase|Other|29|||
105625175|NCT02003924|364292701|FG001|Double-blind Phase|Other|50|||
105625176|NCT02003924|364292702|FG002|Double-blind Phase|Other|0|||
105625177|NCT02003924|364292700|FG000|Open-label Phase|Lost to Follow-up|0|||
105625178|NCT02003924|364292701|FG001|Open-label Phase|Lost to Follow-up|0|||
105625179|NCT02003924|364292702|FG002|Open-label Phase|Lost to Follow-up|1|||
105625180|NCT02003924|364292700|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
105625181|NCT02003924|364292701|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
105625182|NCT02003924|364292702|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
105625183|NCT02003924|364292700|FG000|Open-label Phase|Disease Progression|59|||
105625184|NCT02003924|364292701|FG001|Open-label Phase|Disease Progression|0|||
105625185|NCT02003924|364292702|FG002|Open-label Phase|Disease Progression|5|||
105625186|NCT02003924|364292700|FG000|Open-label Phase|Adverse Event|25|||
105625187|NCT02003924|364292701|FG001|Open-label Phase|Adverse Event|0|||
105625188|NCT02003924|364292702|FG002|Open-label Phase|Adverse Event|10|||
105625189|NCT02003924|364292700|FG000|Open-label Phase|Other|7|||
105625190|NCT02003924|364292701|FG001|Open-label Phase|Other|0|||
105625191|NCT02003924|364292702|FG002|Open-label Phase|Other|0|||
105625192|NCT02003924|364292700|FG000|Long-term Follow-up Phase|Death|288|||
105625193|NCT02003924|364292701|FG001|Long-term Follow-up Phase|Death|174|||
105625194|NCT02003924|364292702|FG002|Long-term Follow-up Phase|Death|4|||
105625195|NCT02003924|364292700|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
105625196|NCT02003924|364292701|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
105625197|NCT02003924|364292702|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
105625198|NCT02003924|364292700|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
105625199|NCT02003924|364292701|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
105625200|NCT02003924|364292702|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
105625201|NCT02003924|364292700|FG000|Long-term Follow-up Phase|Other|5|||
105625202|NCT02003924|364292701|FG001|Long-term Follow-up Phase|Other|2|||
105625203|NCT02003924|364292702|FG002|Long-term Follow-up Phase|Other|1|||
105625204|NCT02998528|364292703|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
105625205|NCT02998528|364292704|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
105625206|NCT02998528|364292705|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
105625207|NCT02998528|364292703|FG000|Randomization Period|Participant withdrew consent|0|||
105625208|NCT02998528|364292704|FG001|Randomization Period|Participant withdrew consent|3|||
105625209|NCT02998528|364292705|FG002|Randomization Period|Participant withdrew consent|0|||
105625210|NCT02998528|364292703|FG000|Randomization Period|Participant no longer meets study criteria|1|||
105625211|NCT02998528|364292704|FG001|Randomization Period|Participant no longer meets study criteria|3|||
105625212|NCT02998528|364292705|FG002|Randomization Period|Participant no longer meets study criteria|2|||
105625213|NCT02998528|364292703|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
105625214|NCT02998528|364292704|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
105625215|NCT02998528|364292705|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
105625216|NCT02998528|364292703|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
105625217|NCT02998528|364292704|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
105625218|NCT02998528|364292705|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
105625219|NCT02998528|364292703|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
105625220|NCT02998528|364292704|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
105625221|NCT02998528|364292705|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
105625222|NCT02998528|364292703|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
105625223|NCT02998528|364292704|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
105625224|NCT02998528|364292705|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
105625225|NCT02998528|364292703|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
105625226|NCT02998528|364292704|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
105625227|NCT02998528|364292705|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
105625228|NCT02998528|364292703|FG000|Neoadjuvant Treatment Period|Death|1|||
105625229|NCT02998528|364292704|FG001|Neoadjuvant Treatment Period|Death|0|||
105625230|NCT02998528|364292705|FG002|Neoadjuvant Treatment Period|Death|0|||
105625231|NCT02998528|364292703|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
105625232|NCT02998528|364292704|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
105625233|NCT02998528|364292705|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
105625234|NCT02998528|364292703|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
105625235|NCT02998528|364292704|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
105625236|NCT02998528|364292705|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
105625237|NCT02998528|364292703|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
105625238|NCT02998528|364292704|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
105625239|NCT02998528|364292705|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
105625240|NCT02998528|364292703|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
105625241|NCT02998528|364292704|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
105625242|NCT02998528|364292705|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
105625243|NCT02998528|364292703|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
105625244|NCT02998528|364292704|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
105625245|NCT02998528|364292705|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
105625246|NCT02998528|364292703|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
105625247|NCT02998528|364292704|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
105625248|NCT02998528|364292705|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
105625249|NCT03485729|364292709|FG000|Overall Study|Withdrawal by Subject|0|||
105625250|NCT03485729|364292710|FG001|Overall Study|Withdrawal by Subject|0|||
105625251|NCT03485729|364292711|FG002|Overall Study|Withdrawal by Subject|1|||
105625252|NCT03485729|364292709|FG000|Overall Study|Disease progression|8|||
105625253|NCT03485729|364292710|FG001|Overall Study|Disease progression|13|||
105625254|NCT03485729|364292711|FG002|Overall Study|Disease progression|1|||
105625255|NCT03485729|364292709|FG000|Overall Study|Hospice care|1|||
105625256|NCT03485729|364292710|FG001|Overall Study|Hospice care|0|||
105625257|NCT03485729|364292711|FG002|Overall Study|Hospice care|0|||
105625258|NCT03485729|364292709|FG000|Overall Study|Poor performance status|1|||
105625259|NCT03485729|364292710|FG001|Overall Study|Poor performance status|0|||
105625260|NCT03485729|364292711|FG002|Overall Study|Poor performance status|0|||
105625261|NCT03485729|364292709|FG000|Overall Study|Illness|0|||
105625262|NCT03485729|364292710|FG001|Overall Study|Illness|1|||
105625263|NCT03485729|364292711|FG002|Overall Study|Illness|0|||
105625264|NCT04880733|364292712|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
105625265|NCT04880733|364292713|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
105625266|NCT04880733|364292714|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
105625267|NCT04880733|364292712|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
105625268|NCT04880733|364292713|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
105625269|NCT04880733|364292714|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
105625270|NCT04880733|364292712|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
105625271|NCT04880733|364292713|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
105625272|NCT04880733|364292714|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
105625273|NCT04880733|364292712|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
105625274|NCT04880733|364292713|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
105625275|NCT04880733|364292714|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
105625276|NCT04880733|364292712|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
105625277|NCT04880733|364292713|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
105625278|NCT04880733|364292714|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
105625279|NCT02990338|364292717|FG000|Overall Study|Randomized and not treated|4|||
105625280|NCT02990338|364292718|FG001|Overall Study|Randomized and not treated|2|||
105625281|NCT02990338|364292717|FG000|Overall Study|Adverse Event|23|||
105625282|NCT02990338|364292718|FG001|Overall Study|Adverse Event|22|||
105625283|NCT02990338|364292717|FG000|Overall Study|Progressive disease|118|||
105625284|NCT02990338|364292718|FG001|Overall Study|Progressive disease|107|||
105625285|NCT02990338|364292717|FG000|Overall Study|Poor compliance to protocol|0|||
105625286|NCT02990338|364292718|FG001|Overall Study|Poor compliance to protocol|1|||
105625287|NCT02990338|364292717|FG000|Overall Study|Withdrawal by Subject|6|||
105625288|NCT02990338|364292718|FG001|Overall Study|Withdrawal by Subject|8|||
105625289|NCT02990338|364292717|FG000|Overall Study|Physician's decision|2|||
105625290|NCT02990338|364292718|FG001|Overall Study|Physician's decision|6|||
105625291|NCT02990338|364292717|FG000|Overall Study|Treatment extension study|0|||
105625292|NCT02990338|364292718|FG001|Overall Study|Treatment extension study|6|||
105625293|NCT02990338|364292717|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
105625294|NCT02990338|364292718|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
105625295|NCT02990338|364292717|FG000|Overall Study|Continue with therapy available commercially|0|||
105625296|NCT02990338|364292718|FG001|Overall Study|Continue with therapy available commercially|1|||
105625297|NCT04158739|364292721|FG000|Overall Study|Adverse Event|1|||
105625298|NCT04158739|364292722|FG001|Overall Study|Adverse Event|0|||
105625299|NCT04158739|364292721|FG000|Overall Study|Death|0|||
105625300|NCT04158739|364292722|FG001|Overall Study|Death|1|||
105625301|NCT04158739|364292721|FG000|Overall Study|Lack of Efficacy|3|||
105625302|NCT04158739|364292722|FG001|Overall Study|Lack of Efficacy|7|||
105625303|NCT04158739|364292721|FG000|Overall Study|Physician Decision|0|||
105625304|NCT04158739|364292722|FG001|Overall Study|Physician Decision|1|||
105625305|NCT04158739|364292721|FG000|Overall Study|Withdrawal by Subject|3|||
105625306|NCT04158739|364292722|FG001|Overall Study|Withdrawal by Subject|0|||
105625307|NCT02865538|364292724|FG000|Overall Study|Withdrawal by Subject|0|||
105625308|NCT02865538|364292725|FG001|Overall Study|Withdrawal by Subject|0|||
105625309|NCT02865538|364292726|FG002|Overall Study|Withdrawal by Subject|1|||
105625310|NCT02865538|364292727|FG003|Overall Study|Withdrawal by Subject|0|||
105625311|NCT02865538|364292728|FG004|Overall Study|Withdrawal by Subject|0|||
105625312|NCT02865538|364292724|FG000|Overall Study|Lost to Follow-up|1|||
105625313|NCT02865538|364292725|FG001|Overall Study|Lost to Follow-up|0|||
105625314|NCT02865538|364292726|FG002|Overall Study|Lost to Follow-up|0|||
105625315|NCT02865538|364292727|FG003|Overall Study|Lost to Follow-up|0|||
105625316|NCT02865538|364292728|FG004|Overall Study|Lost to Follow-up|0|||
105625317|NCT04678856|364292729|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
105625318|NCT04678856|364292730|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
105625319|NCT04678856|364292729|FG000|Overall Study|Withdrawal by Subject|5|||
105625320|NCT04678856|364292730|FG001|Overall Study|Withdrawal by Subject|1|||
105625321|NCT05618587|364293974|FG000|Overall Study|Lost to Follow-up|2|||
105625322|NCT05618587|364293975|FG001|Overall Study|Lost to Follow-up|0|||
105625323|NCT05256654|364293976|FG000|Overall Study|Adverse Event|0|||
105625324|NCT05256654|364293977|FG001|Overall Study|Adverse Event|0|||
105625325|NCT05256654|364293978|FG002|Overall Study|Adverse Event|1|||
105625326|NCT05256654|364293979|FG003|Overall Study|Adverse Event|0|||
105625327|NCT05256654|364293976|FG000|Overall Study|Lost to Follow-up|0|||
105625328|NCT05256654|364293977|FG001|Overall Study|Lost to Follow-up|0|||
105625329|NCT05256654|364293978|FG002|Overall Study|Lost to Follow-up|0|||
105625330|NCT05256654|364293979|FG003|Overall Study|Lost to Follow-up|1|||
105625331|NCT05256654|364293976|FG000|Overall Study|Withdrawal by Subject|1|||
105625332|NCT05256654|364293977|FG001|Overall Study|Withdrawal by Subject|2|||
105625333|NCT05256654|364293978|FG002|Overall Study|Withdrawal by Subject|1|||
105625334|NCT05256654|364293979|FG003|Overall Study|Withdrawal by Subject|3|||
105625335|NCT05256654|364293976|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
105625336|NCT05256654|364293977|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
105625337|NCT05256654|364293978|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
105625338|NCT05256654|364293979|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
105625339|NCT05256654|364293976|FG000|Overall Study|Other|0|||
105625340|NCT05256654|364293977|FG001|Overall Study|Other|0|||
105625341|NCT05256654|364293978|FG002|Overall Study|Other|0|||
105625342|NCT05256654|364293979|FG003|Overall Study|Other|1|||
105625343|NCT04862416|364293984|FG000|Overall Study|Withdrawal by Subject|0|||
105625344|NCT04862416|364293985|FG001|Overall Study|Withdrawal by Subject|1|||
105625345|NCT04862416|364293986|FG002|Overall Study|Withdrawal by Subject|0|||
105625346|NCT04862416|364293987|FG003|Overall Study|Withdrawal by Subject|1|||
105625347|NCT04862416|364293988|FG004|Overall Study|Withdrawal by Subject|0|||
105625348|NCT04862416|364293989|FG005|Overall Study|Withdrawal by Subject|0|||
105625349|NCT04862416|364293990|FG006|Overall Study|Withdrawal by Subject|0|||
105625350|NCT04862416|364293991|FG007|Overall Study|Withdrawal by Subject|0|||
105625351|NCT03442309|364293992|FG000|Overall Study|Lost to Follow-up|1676|||
105625352|NCT03442309|364293993|FG001|Overall Study|Lost to Follow-up|1642|||
105625353|NCT02970318|364293994|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
105625354|NCT02970318|364293995|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
105625355|NCT02970318|364293996|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
105625356|NCT02970318|364293997|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
105625357|NCT02970318|364293994|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
105625358|NCT02970318|364293995|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
105625359|NCT02970318|364293996|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
105625360|NCT02970318|364293997|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
105625361|NCT02970318|364293994|FG000|Overall for Arm A & Main for Arm B|Death|41|||
105625362|NCT02970318|364293995|FG001|Overall for Arm A & Main for Arm B|Death|33|||
105625363|NCT02970318|364293996|FG002|Overall for Arm A & Main for Arm B|Death|0|||
105625364|NCT02970318|364293997|FG003|Overall for Arm A & Main for Arm B|Death|0|||
105625365|NCT02970318|364293994|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
105625366|NCT02970318|364293995|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
105625367|NCT02970318|364293996|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
105625368|NCT02970318|364293997|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
105625369|NCT02970318|364293994|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
105625370|NCT02970318|364293995|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
105625371|NCT02970318|364293996|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
105625372|NCT02970318|364293997|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
105625373|NCT02970318|364293994|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
105625374|NCT02970318|364293995|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
105625375|NCT02970318|364293996|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
105625376|NCT02970318|364293997|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
105625377|NCT02970318|364293994|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
105625378|NCT02970318|364293995|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
105625379|NCT02970318|364293996|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
105625380|NCT02970318|364293997|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
105625381|NCT05204654|364293998|FG000|Overall Study|Study terminated due to time restraint|2|||
105625382|NCT05204654|364293999|FG001|Overall Study|Study terminated due to time restraint|2|||
105625383|NCT01221948|364294000|FG000|Overall Study|Physician Decision|5|||
105625384|NCT01221948|364294000|FG000|Overall Study|Withdrawal by Subject|2|||
105625385|NCT01221948|364294000|FG000|Overall Study|not disclosed|2|||
105625386|NCT01221948|364294000|FG000|Overall Study|Death|1|||
105625387|NCT01221948|364294000|FG000|Overall Study|Protocol Violation|4|||
105625388|NCT05207956|364294003|FG000|Overall Study|Lost to follow up|1|||
105625389|NCT05207956|364294004|FG001|Overall Study|Lost to follow up|2|||
105625390|NCT02296684|364294005|FG000|Overall Study|Withdrawal by Subject|0|||
105625391|NCT02296684|364294006|FG001|Overall Study|Withdrawal by Subject|1|||
105625392|NCT02296684|364294007|FG002|Overall Study|Withdrawal by Subject|1|||
105625393|NCT02296684|364294005|FG000|Overall Study|Death|2|||
105625394|NCT02296684|364294006|FG001|Overall Study|Death|0|||
105625395|NCT02296684|364294007|FG002|Overall Study|Death|0|||
105625396|NCT05280574|364294012|FG000|Overall Study|Withdrawal by Subject|0|||
105625397|NCT05280574|364294013|FG001|Overall Study|Withdrawal by Subject|2|||
105625398|NCT05280574|364294014|FG002|Overall Study|Withdrawal by Subject|0|||
105625399|NCT05838027|364294015|FG000|Overall Study|Lost to Follow-up|5|||
105625400|NCT05838027|364294016|FG001|Overall Study|Lost to Follow-up|1|||
105625401|NCT05838027|364294015|FG000|Overall Study|Withdrawal by Subject|1|||
105625402|NCT05838027|364294016|FG001|Overall Study|Withdrawal by Subject|0|||
105625403|NCT02962076|364294029|FG000|Overall Study|MHED tracer not available|5|||
105625404|NCT02962076|364294029|FG000|Overall Study|Protocol Violation|1|||
105625405|NCT02962076|364294029|FG000|Overall Study|Physician Decision|1|||
105625406|NCT02780700|364294030|FG000|Overall Study|Progressive disease|1|||
105625407|NCT03926130|364294033|FG000|Overall Study|Adverse Event|9|||
105625408|NCT03926130|364294034|FG001|Overall Study|Adverse Event|11|||
105625409|NCT03926130|364294035|FG002|Overall Study|Adverse Event|2|||
105625410|NCT03926130|364294036|FG003|Overall Study|Adverse Event|0|||
105625411|NCT03926130|364294033|FG000|Overall Study|Death|2|||
105625412|NCT03926130|364294034|FG001|Overall Study|Death|0|||
105625413|NCT03926130|364294035|FG002|Overall Study|Death|1|||
105625414|NCT03926130|364294036|FG003|Overall Study|Death|0|||
105625415|NCT03926130|364294033|FG000|Overall Study|Lack of Efficacy|14|||
105625416|NCT03926130|364294034|FG001|Overall Study|Lack of Efficacy|11|||
105625417|NCT03926130|364294035|FG002|Overall Study|Lack of Efficacy|7|||
105625418|NCT03926130|364294036|FG003|Overall Study|Lack of Efficacy|1|||
105625419|NCT03926130|364294033|FG000|Overall Study|Lost to Follow-up|0|||
105625420|NCT03926130|364294034|FG001|Overall Study|Lost to Follow-up|7|||
105625421|NCT03926130|364294035|FG002|Overall Study|Lost to Follow-up|1|||
105625422|NCT03926130|364294036|FG003|Overall Study|Lost to Follow-up|0|||
105625423|NCT03926130|364294033|FG000|Overall Study|As Reported by Investigator|2|||
105625424|NCT03926130|364294034|FG001|Overall Study|As Reported by Investigator|6|||
105625425|NCT03926130|364294035|FG002|Overall Study|As Reported by Investigator|6|||
105625426|NCT03926130|364294036|FG003|Overall Study|As Reported by Investigator|0|||
105625427|NCT03926130|364294033|FG000|Overall Study|Physician Decision|3|||
105625428|NCT03926130|364294034|FG001|Overall Study|Physician Decision|2|||
105625429|NCT03926130|364294035|FG002|Overall Study|Physician Decision|1|||
105625430|NCT03926130|364294036|FG003|Overall Study|Physician Decision|0|||
105625431|NCT03926130|364294033|FG000|Overall Study|Pregnancy|2|||
105625432|NCT03926130|364294034|FG001|Overall Study|Pregnancy|2|||
105625433|NCT03926130|364294035|FG002|Overall Study|Pregnancy|1|||
105625434|NCT03926130|364294036|FG003|Overall Study|Pregnancy|0|||
105625435|NCT03926130|364294033|FG000|Overall Study|Withdrawal by Subject|20|||
105625436|NCT03926130|364294034|FG001|Overall Study|Withdrawal by Subject|28|||
105625437|NCT03926130|364294035|FG002|Overall Study|Withdrawal by Subject|18|||
105625438|NCT03926130|364294036|FG003|Overall Study|Withdrawal by Subject|1|||
105625439|NCT03926130|364294033|FG000|Overall Study|Non-Compliance|1|||
105625440|NCT03926130|364294034|FG001|Overall Study|Non-Compliance|1|||
105625441|NCT03926130|364294035|FG002|Overall Study|Non-Compliance|0|||
105625442|NCT03926130|364294036|FG003|Overall Study|Non-Compliance|0|||
105625443|NCT03926130|364294033|FG000|Overall Study|Disposition Not Captured|0|||
105625444|NCT03926130|364294034|FG001|Overall Study|Disposition Not Captured|2|||
105625445|NCT03926130|364294035|FG002|Overall Study|Disposition Not Captured|1|||
105625446|NCT03926130|364294036|FG003|Overall Study|Disposition Not Captured|0|||
105625447|NCT01730937|364294037|FG000|Overall Study|Protocol Violation|5|||
105625448|NCT01730937|364294038|FG001|Overall Study|Protocol Violation|11|||
105625449|NCT02852655|364294046|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
105625450|NCT02852655|364294047|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
105625451|NCT02852655|364294048|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
105625452|NCT02852655|364294046|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
105625453|NCT02852655|364294047|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
105625454|NCT02852655|364294048|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
105625455|NCT02852655|364294046|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
105625456|NCT02852655|364294047|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
105625457|NCT02852655|364294048|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
105625458|NCT02852655|364294046|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
105625459|NCT02852655|364294047|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
105625460|NCT02852655|364294048|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
105625461|NCT02852655|364294046|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
105625462|NCT02852655|364294047|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
105625463|NCT02852655|364294048|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
105625464|NCT02852655|364294046|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
105625465|NCT02852655|364294047|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
105625466|NCT02852655|364294048|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
105625467|NCT02852655|364294046|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
105625468|NCT02852655|364294047|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
105625469|NCT02852655|364294048|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
105625470|NCT02852655|364294046|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
105625471|NCT02852655|364294047|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
105625472|NCT02852655|364294048|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
105625473|NCT02852655|364294046|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
105625474|NCT02852655|364294047|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
105625475|NCT02852655|364294048|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
105625476|NCT04186845|364294057|FG000|Overall Study|Death|2|||
105625477|NCT04186845|364294057|FG000|Overall Study|Lost to Follow-up|1|||
105625478|NCT04186845|364294057|FG000|Overall Study|Physician Decision|1|||
105625479|NCT04186845|364294057|FG000|Overall Study|Protocol Violation|1|||
105625480|NCT04186845|364294057|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
105625481|NCT04186845|364294057|FG000|Overall Study|Biopsy ordered but not done|1|||
105625482|NCT04186845|364294057|FG000|Overall Study|It was previously confirmed|1|||
105625483|NCT04186845|364294057|FG000|Overall Study|Patient cancelled scheduled scans|2|||
105625484|NCT04186845|364294057|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
105625485|NCT04186845|364294057|FG000|Overall Study|Subject refused confirmatory imaging|1|||
105625486|NCT04186845|364294057|FG000|Overall Study|Too small to biopsy|1|||
105625487|NCT05069896|364294058|FG000|Overall Study|Adverse Event|0|||
105625488|NCT05069896|364294059|FG001|Overall Study|Adverse Event|1|||
105625489|NCT05069896|364294060|FG002|Overall Study|Adverse Event|1|||
105625490|NCT05069896|364294061|FG003|Overall Study|Adverse Event|0|||
105625491|NCT05069896|364294062|FG004|Overall Study|Adverse Event|0|||
105625492|NCT05069896|364294063|FG005|Overall Study|Adverse Event|0|||
105625493|NCT05069896|364294058|FG000|Overall Study|Lost to Follow-up|0|||
105625494|NCT05069896|364294059|FG001|Overall Study|Lost to Follow-up|0|||
105625495|NCT05069896|364294060|FG002|Overall Study|Lost to Follow-up|1|||
105625496|NCT05069896|364294061|FG003|Overall Study|Lost to Follow-up|0|||
105625497|NCT05069896|364294062|FG004|Overall Study|Lost to Follow-up|1|||
105625498|NCT05069896|364294063|FG005|Overall Study|Lost to Follow-up|2|||
105625499|NCT04068831|364294064|FG000|Overall Study|Disease Progression|10|||
105625500|NCT04068831|364294065|FG001|Overall Study|Disease Progression|8|||
105625501|NCT04820322|364294066|FG000|Overall Study|Adverse Event|1|||
105625502|NCT04820322|364294067|FG001|Overall Study|Adverse Event|0|||
105625503|NCT03640286|364294073|FG000|Overall Study|Adverse Event|6|||
105625504|NCT03640286|364294074|FG001|Overall Study|Adverse Event|6|||
105625505|NCT03640286|364294073|FG000|Overall Study|Lost to Follow-up|3|||
105625506|NCT03640286|364294074|FG001|Overall Study|Lost to Follow-up|6|||
105625507|NCT03640286|364294073|FG000|Overall Study|Pregnancy|1|||
105625508|NCT03640286|364294074|FG001|Overall Study|Pregnancy|0|||
105625509|NCT03640286|364294073|FG000|Overall Study|Withdrawal by Subject|10|||
105625510|NCT03640286|364294074|FG001|Overall Study|Withdrawal by Subject|10|||
105625511|NCT03640286|364294073|FG000|Overall Study|Non-compliance|4|||
105625512|NCT03640286|364294074|FG001|Overall Study|Non-compliance|10|||
105625513|NCT03640286|364294073|FG000|Overall Study|Medication change|1|||
105625514|NCT03640286|364294074|FG001|Overall Study|Medication change|0|||
105625515|NCT03640286|364294073|FG000|Overall Study|Other|1|||
105625516|NCT03640286|364294074|FG001|Overall Study|Other|2|||
105625517|NCT03640286|364294073|FG000|Overall Study|Joined another lifestyle program|0|||
105625518|NCT03640286|364294074|FG001|Overall Study|Joined another lifestyle program|1|||
105625519|NCT03181516|364294075|FG000|Overall Study|Withdrawal by Subject|14|||
105625520|NCT03181516|364294076|FG001|Overall Study|Withdrawal by Subject|7|||
105625521|NCT03181516|364294075|FG000|Overall Study|Lost to Follow-up|2|||
105625522|NCT03181516|364294076|FG001|Overall Study|Lost to Follow-up|2|||
105625523|NCT02834390|364294077|FG000|Induction Phase|Progressive disease|0|||
105625524|NCT02834390|364294078|FG001|Induction Phase|Progressive disease|1|||
105625525|NCT02834390|364294077|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
105625526|NCT02834390|364294078|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
105625527|NCT02834390|364294077|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
105625528|NCT02834390|364294078|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
105625529|NCT02834390|364294077|FG000|Consolidation Phase|Physician Decision|1|||
105625530|NCT02834390|364294078|FG001|Consolidation Phase|Physician Decision|1|||
105625531|NCT03536884|364294079|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
105625532|NCT03536884|364294080|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
105625533|NCT03536884|364294081|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
105625534|NCT03536884|364294082|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
105625535|NCT03536884|364294083|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
105625536|NCT03536884|364294084|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
105625537|NCT03536884|364294085|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
105625538|NCT03536884|364294086|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
105625539|NCT03536884|364294087|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
105625540|NCT03536884|364294088|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
105625541|NCT03536884|364294089|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
105625542|NCT03536884|364294090|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
105625543|NCT03536884|364294079|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
105625544|NCT03536884|364294080|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
105625545|NCT03536884|364294081|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
105625546|NCT03536884|364294082|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
105625547|NCT03536884|364294083|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
105625548|NCT03536884|364294084|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
105625549|NCT03536884|364294085|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
105625550|NCT03536884|364294086|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
105625551|NCT03536884|364294087|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
105625552|NCT03536884|364294088|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
105625553|NCT03536884|364294089|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
105625554|NCT03536884|364294090|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
105625555|NCT03536884|364294079|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
105625556|NCT03536884|364294080|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
105625557|NCT03536884|364294081|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
105625558|NCT03536884|364294082|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
105625559|NCT03536884|364294083|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
105625560|NCT03536884|364294084|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
105625561|NCT03536884|364294085|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
105625562|NCT03536884|364294086|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
105625563|NCT03536884|364294087|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
105625564|NCT03536884|364294088|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
105625565|NCT03536884|364294089|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
105625566|NCT03536884|364294090|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
105625567|NCT03536884|364294079|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
105625568|NCT03536884|364294080|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
105625569|NCT03536884|364294081|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
105625570|NCT03536884|364294082|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
105625571|NCT03536884|364294083|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
105625572|NCT03536884|364294084|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
105625573|NCT03536884|364294085|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
105625574|NCT03536884|364294086|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
105625575|NCT03536884|364294087|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
105625576|NCT03536884|364294088|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
105625577|NCT03536884|364294089|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
105625578|NCT03536884|364294090|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
105625579|NCT03536884|364294079|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
105625580|NCT03536884|364294080|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
105625581|NCT03536884|364294081|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
105625582|NCT03536884|364294082|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
105625583|NCT03536884|364294083|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
105625584|NCT03536884|364294084|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
105625585|NCT03536884|364294085|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
105625586|NCT03536884|364294086|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
105625587|NCT03536884|364294087|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
105625588|NCT03536884|364294088|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
105625589|NCT03536884|364294089|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
105625590|NCT03536884|364294090|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
105625591|NCT03536884|364294079|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
105625592|NCT03536884|364294080|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
105625593|NCT03536884|364294081|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
105625594|NCT03536884|364294082|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
105625595|NCT03536884|364294083|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
105625596|NCT03536884|364294084|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
105625597|NCT03536884|364294085|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
105625598|NCT03536884|364294086|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
105625599|NCT03536884|364294087|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
105625600|NCT03536884|364294088|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
105625601|NCT03536884|364294089|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
105625602|NCT03536884|364294090|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
105625603|NCT03536884|364294079|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
105625604|NCT03536884|364294080|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
105625605|NCT03536884|364294081|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
105625606|NCT03536884|364294082|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
105625607|NCT03536884|364294083|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
105625608|NCT03536884|364294084|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
105625609|NCT03536884|364294085|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
105625610|NCT03536884|364294086|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
105625611|NCT03536884|364294087|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
105625612|NCT03536884|364294088|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
105625613|NCT03536884|364294089|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
105625614|NCT03536884|364294090|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
105625615|NCT03536884|364294079|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
105625616|NCT03536884|364294080|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
105625617|NCT03536884|364294081|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
105625618|NCT03536884|364294082|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
105625619|NCT03536884|364294083|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
105625620|NCT03536884|364294084|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
105625621|NCT03536884|364294085|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
105625622|NCT03536884|364294086|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
105625623|NCT03536884|364294087|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
105625624|NCT03536884|364294088|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
105625625|NCT03536884|364294089|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
105625626|NCT03536884|364294090|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
105625627|NCT03536884|364294079|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
105625628|NCT03536884|364294080|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
105625629|NCT03536884|364294081|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
105625630|NCT03536884|364294082|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
105625631|NCT03536884|364294083|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
105625632|NCT03536884|364294084|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
105625633|NCT03536884|364294085|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
105625634|NCT03536884|364294086|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
105625635|NCT03536884|364294087|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
105625636|NCT03536884|364294088|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
105625637|NCT03536884|364294089|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
105625638|NCT03536884|364294090|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
105625639|NCT03536884|364294079|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
105625640|NCT03536884|364294080|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
105625641|NCT03536884|364294081|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
105625642|NCT03536884|364294082|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
105625643|NCT03536884|364294083|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
105625644|NCT03536884|364294084|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
105625645|NCT03536884|364294085|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
105625646|NCT03536884|364294086|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
105625647|NCT03536884|364294087|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
105625648|NCT03536884|364294088|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
105625649|NCT03536884|364294089|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
105625650|NCT03536884|364294090|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
105625651|NCT03536884|364294079|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
105625652|NCT03536884|364294080|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
105625653|NCT03536884|364294081|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
105625654|NCT03536884|364294082|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
105625655|NCT03536884|364294083|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
105625656|NCT03536884|364294084|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
105625657|NCT03536884|364294085|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
105625658|NCT03536884|364294086|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
105625659|NCT03536884|364294087|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
105625660|NCT03536884|364294088|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
105625661|NCT03536884|364294089|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
105625662|NCT03536884|364294090|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
105625663|NCT03536884|364294079|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
105625664|NCT03536884|364294080|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
105625665|NCT03536884|364294081|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
105625666|NCT03536884|364294082|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
105625667|NCT03536884|364294083|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
105625668|NCT03536884|364294084|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
105625669|NCT03536884|364294085|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
105625670|NCT03536884|364294086|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
105625671|NCT03536884|364294087|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
105625672|NCT03536884|364294088|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
105625673|NCT03536884|364294089|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
105625674|NCT03536884|364294090|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
105625675|NCT03536884|364294079|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
105625676|NCT03536884|364294080|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
105625677|NCT03536884|364294081|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
105625678|NCT03536884|364294082|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
105625679|NCT03536884|364294083|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
105625680|NCT03536884|364294084|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
105625681|NCT03536884|364294085|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
105625682|NCT03536884|364294086|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
105625683|NCT03536884|364294087|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
105625684|NCT03536884|364294088|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
105625685|NCT03536884|364294089|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
105625686|NCT03536884|364294090|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
105625687|NCT03536884|364294079|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
105625688|NCT03536884|364294080|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
105625689|NCT03536884|364294081|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
105625690|NCT03536884|364294082|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
105625691|NCT03536884|364294083|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
105625692|NCT03536884|364294084|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
105625693|NCT03536884|364294085|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
105625694|NCT03536884|364294086|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
105625695|NCT03536884|364294087|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
105625696|NCT03536884|364294088|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
105625697|NCT03536884|364294089|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
105625698|NCT03536884|364294090|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
105625699|NCT03536884|364294079|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
105625700|NCT03536884|364294080|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
105625701|NCT03536884|364294081|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
105625702|NCT03536884|364294082|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
105625703|NCT03536884|364294083|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
105625704|NCT03536884|364294084|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
105625705|NCT03536884|364294085|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
105625706|NCT03536884|364294086|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
105625707|NCT03536884|364294087|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
105625708|NCT03536884|364294088|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
105625709|NCT03536884|364294089|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
105625710|NCT03536884|364294090|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
105625711|NCT03536884|364294079|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
105625712|NCT03536884|364294080|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
105625713|NCT03536884|364294081|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
105625714|NCT03536884|364294082|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
105625715|NCT03536884|364294083|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
105625716|NCT03536884|364294084|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
105625717|NCT03536884|364294085|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
105625718|NCT03536884|364294086|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
105625719|NCT03536884|364294087|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
105625720|NCT03536884|364294088|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
105625721|NCT03536884|364294089|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
105625722|NCT03536884|364294090|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
105625723|NCT03536884|364294079|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
105625724|NCT03536884|364294080|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
105625725|NCT03536884|364294081|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
105625726|NCT03536884|364294082|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
105625727|NCT03536884|364294083|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
105625728|NCT03536884|364294084|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
105625729|NCT03536884|364294085|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
105625730|NCT03536884|364294086|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
105625731|NCT03536884|364294087|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
105625732|NCT03536884|364294088|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
105625733|NCT03536884|364294089|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
105625734|NCT03536884|364294090|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
105625735|NCT03536884|364294079|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
105625736|NCT03536884|364294080|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
105625737|NCT03536884|364294081|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
105625738|NCT03536884|364294082|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
105625739|NCT03536884|364294083|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
105625740|NCT03536884|364294084|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
105625741|NCT03536884|364294085|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
105625742|NCT03536884|364294086|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
105625743|NCT03536884|364294087|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
105625744|NCT03536884|364294088|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
105625745|NCT03536884|364294089|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
105625746|NCT03536884|364294090|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
105625747|NCT03536884|364294079|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
105625748|NCT03536884|364294080|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
105625749|NCT03536884|364294081|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
105625750|NCT03536884|364294082|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
105625751|NCT03536884|364294083|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
105625752|NCT03536884|364294084|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
105625753|NCT03536884|364294085|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
105625754|NCT03536884|364294086|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
105625755|NCT03536884|364294087|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
105625756|NCT03536884|364294088|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
105625757|NCT03536884|364294089|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
105625758|NCT03536884|364294090|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
105625759|NCT03536884|364294079|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
105625760|NCT03536884|364294080|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
105625761|NCT03536884|364294081|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
105625762|NCT03536884|364294082|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
105625763|NCT03536884|364294083|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
105625764|NCT03536884|364294084|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
105625765|NCT03536884|364294085|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
105625766|NCT03536884|364294086|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
105625767|NCT03536884|364294087|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
105625768|NCT03536884|364294088|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
105625769|NCT03536884|364294089|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
105625770|NCT03536884|364294090|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
105625771|NCT03536884|364294079|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
105625772|NCT03536884|364294080|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
105625773|NCT03536884|364294081|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
105625774|NCT03536884|364294082|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
105625775|NCT03536884|364294083|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
105625776|NCT03536884|364294084|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
105625777|NCT03536884|364294085|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
105625778|NCT03536884|364294086|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
105625779|NCT03536884|364294087|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
105625780|NCT03536884|364294088|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
105625781|NCT03536884|364294089|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
105625782|NCT03536884|364294090|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
105625783|NCT03536884|364294079|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105625784|NCT03536884|364294080|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105625785|NCT03536884|364294081|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105625786|NCT03536884|364294082|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105625787|NCT03536884|364294083|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105625788|NCT03536884|364294084|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105625789|NCT03536884|364294085|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105625790|NCT03536884|364294086|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105625791|NCT03536884|364294087|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105625792|NCT03536884|364294088|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
105625793|NCT03536884|364294089|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
105625794|NCT03536884|364294090|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
105625795|NCT03536884|364294079|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105625796|NCT03536884|364294080|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105625797|NCT03536884|364294081|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105625798|NCT03536884|364294082|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105625799|NCT03536884|364294083|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105625800|NCT03536884|364294084|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105625801|NCT03536884|364294085|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105625802|NCT03536884|364294086|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105625803|NCT03536884|364294087|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105625804|NCT03536884|364294088|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
105625805|NCT03536884|364294089|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
105625806|NCT03536884|364294090|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
105625807|NCT03536884|364294079|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
105625808|NCT03536884|364294080|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
105625809|NCT03536884|364294081|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
105625810|NCT03536884|364294082|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
105625811|NCT03536884|364294083|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
105625812|NCT03536884|364294084|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
105625813|NCT03536884|364294085|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
105625814|NCT03536884|364294086|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
105625815|NCT03536884|364294087|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
105625816|NCT03536884|364294088|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
105625817|NCT03536884|364294089|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
105625818|NCT03536884|364294090|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
105625819|NCT03536884|364294079|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
105625820|NCT03536884|364294080|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
105625821|NCT03536884|364294081|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
105625822|NCT03536884|364294082|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
105625823|NCT03536884|364294083|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
105625824|NCT03536884|364294084|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
105625825|NCT03536884|364294085|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
105625826|NCT03536884|364294086|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
105625827|NCT03536884|364294087|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
105625828|NCT03536884|364294088|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
105625829|NCT03536884|364294089|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
105625830|NCT03536884|364294090|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
105625831|NCT03536884|364294079|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
105625832|NCT03536884|364294080|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
105625833|NCT03536884|364294081|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
105625834|NCT03536884|364294082|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
105625835|NCT03536884|364294083|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
105625836|NCT03536884|364294084|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
105625837|NCT03536884|364294085|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
105625838|NCT03536884|364294086|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
105625839|NCT03536884|364294087|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
105625840|NCT03536884|364294088|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
105625841|NCT03536884|364294089|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
105625842|NCT03536884|364294090|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
105625843|NCT04804540|364294095|FG000|Overall Study|Adverse Event|26|||
105625844|NCT04804540|364294096|FG001|Overall Study|Adverse Event|13|||
105625845|NCT01828021|364294097|FG000|Overall Study|Adverse Event|5|||
105625846|NCT01828021|364294097|FG000|Overall Study|Lack of Efficacy|17|||
105625847|NCT01828021|364294097|FG000|Overall Study|Withdrawal by Subject|2|||
105625848|NCT01828021|364294097|FG000|Overall Study|Ileal obstruction, unrelated|1|||
105625849|NCT02413489|364294098|FG000|Overall Study|Death|11|||
105625850|NCT02413489|364294099|FG001|Overall Study|Death|3|||
105625851|NCT02413489|364294100|FG002|Overall Study|Death|4|||
105625852|NCT02413489|364294098|FG000|Overall Study|Withdrawal by Subject|2|||
105625853|NCT02413489|364294099|FG001|Overall Study|Withdrawal by Subject|0|||
105625854|NCT02413489|364294100|FG002|Overall Study|Withdrawal by Subject|0|||
105625855|NCT02413489|364294098|FG000|Overall Study|Study Terminated By Sponsor|2|||
105625856|NCT02413489|364294099|FG001|Overall Study|Study Terminated By Sponsor|13|||
105625857|NCT02413489|364294100|FG002|Overall Study|Study Terminated By Sponsor|1|||
105625858|NCT04479761|364294101|FG000|Overall Study|could not perform the balance tasks|1|||
105625859|NCT04479761|364294102|FG001|Overall Study|could not perform the balance tasks|0|||
105625860|NCT04479761|364294103|FG002|Overall Study|could not perform the balance tasks|0|||
105625861|NCT04479761|364294101|FG000|Overall Study|Adverse Event|1|||
105625862|NCT04479761|364294102|FG001|Overall Study|Adverse Event|0|||
105625863|NCT04479761|364294103|FG002|Overall Study|Adverse Event|0|||
105625864|NCT04479761|364294101|FG000|Overall Study|one control did not meet screening criteria|0|||
105625865|NCT04479761|364294102|FG001|Overall Study|one control did not meet screening criteria|0|||
105625866|NCT04479761|364294103|FG002|Overall Study|one control did not meet screening criteria|1|||
105625867|NCT04479761|364294101|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
105625868|NCT04479761|364294102|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
105625869|NCT04479761|364294103|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
105625870|NCT04063878|364294104|FG000|Overall Study|Withdrawal by Subject|2|||
105625871|NCT04063878|364294104|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
105625872|NCT01199133|364294105|FG000|Year 1|Adverse Event|16|||
105625873|NCT01199133|364294106|FG001|Year 1|Adverse Event|4|||
105625874|NCT01199133|364294105|FG000|Year 1|Withdrawal by Subject|8|||
105625875|NCT01199133|364294106|FG001|Year 1|Withdrawal by Subject|4|||
105625876|NCT01199133|364294105|FG000|Year 1|Any other reason not above-mentioned|6|||
105625877|NCT01199133|364294106|FG001|Year 1|Any other reason not above-mentioned|7|||
105625878|NCT01199133|364294105|FG000|Year 2|Adverse Event|1|||
105625879|NCT01199133|364294106|FG001|Year 2|Adverse Event|0|||
105625880|NCT01199133|364294105|FG000|Year 2|Withdrawal by Subject|1|||
105625881|NCT01199133|364294106|FG001|Year 2|Withdrawal by Subject|1|||
105625882|NCT01199133|364294105|FG000|Year 2|Any other reason not above-mentioned|1|||
105625883|NCT01199133|364294106|FG001|Year 2|Any other reason not above-mentioned|2|||
105625884|NCT04778410|364294108|FG000|Safety Run-in Period|Death|5|||
105625885|NCT04778410|364294109|FG001|Safety Run-in Period|Death|6|||
105625886|NCT04778410|364294110|FG002|Safety Run-in Period|Death|0|||
105625887|NCT04778410|364294111|FG003|Safety Run-in Period|Death|0|||
105625888|NCT04778410|364294112|FG004|Safety Run-in Period|Death|0|||
105625889|NCT04778410|364294113|FG005|Safety Run-in Period|Death|0|||
105625890|NCT04778410|364294108|FG000|Phase 2 Period|Death|0|||
105625891|NCT04778410|364294109|FG001|Phase 2 Period|Death|0|||
105625892|NCT04778410|364294110|FG002|Phase 2 Period|Death|0|||
105625893|NCT04778410|364294111|FG003|Phase 2 Period|Death|5|||
105625894|NCT04778410|364294112|FG004|Phase 2 Period|Death|18|||
105625895|NCT04778410|364294113|FG005|Phase 2 Period|Death|0|||
105625896|NCT04778410|364294108|FG000|Phase 2 Period|Lost to Follow-up|0|||
105625897|NCT04778410|364294109|FG001|Phase 2 Period|Lost to Follow-up|0|||
105625898|NCT04778410|364294110|FG002|Phase 2 Period|Lost to Follow-up|0|||
105625899|NCT04778410|364294111|FG003|Phase 2 Period|Lost to Follow-up|1|||
105625900|NCT04778410|364294112|FG004|Phase 2 Period|Lost to Follow-up|1|||
105625901|NCT04778410|364294113|FG005|Phase 2 Period|Lost to Follow-up|0|||
105625902|NCT04778410|364294108|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
105625903|NCT04778410|364294109|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
105625904|NCT04778410|364294110|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
105625905|NCT04778410|364294111|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
105625906|NCT04778410|364294112|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
105625907|NCT04778410|364294113|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
105625908|NCT04778410|364294108|FG000|Phase 2 Period|Withdrew Consent|0|||
105625909|NCT04778410|364294109|FG001|Phase 2 Period|Withdrew Consent|0|||
105625910|NCT04778410|364294110|FG002|Phase 2 Period|Withdrew Consent|0|||
105625911|NCT04778410|364294111|FG003|Phase 2 Period|Withdrew Consent|0|||
105625912|NCT04778410|364294112|FG004|Phase 2 Period|Withdrew Consent|2|||
105625913|NCT04778410|364294113|FG005|Phase 2 Period|Withdrew Consent|0|||
105625914|NCT00964392|364294116|FG000|Overall Study|Withdrawal by Subject|4|||
105625915|NCT00964392|364294117|FG001|Overall Study|Withdrawal by Subject|6|||
105625916|NCT00964392|364294116|FG000|Overall Study|Lost to Follow-up|4|||
105625917|NCT00964392|364294117|FG001|Overall Study|Lost to Follow-up|10|||
105625918|NCT00964392|364294116|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
105625919|NCT00964392|364294117|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
105625920|NCT00964392|364294116|FG000|Overall Study|Not completed|44|||
105625921|NCT00964392|364294117|FG001|Overall Study|Not completed|168|||
105625922|NCT04271046|364294118|FG000|Overall Study|Death|0|||
105625923|NCT04271046|364294119|FG001|Overall Study|Death|2|||
105625924|NCT04271046|364294120|FG002|Overall Study|Death|0|||
105625925|NCT04271046|364294121|FG003|Overall Study|Death|2|||
105625926|NCT04271046|364294118|FG000|Overall Study|Lost to Follow-up|12|||
105625927|NCT04271046|364294119|FG001|Overall Study|Lost to Follow-up|12|||
105625928|NCT04271046|364294120|FG002|Overall Study|Lost to Follow-up|11|||
105625929|NCT04271046|364294121|FG003|Overall Study|Lost to Follow-up|11|||
105625930|NCT04271046|364294118|FG000|Overall Study|Patient with Dementia Died|2|||
105625931|NCT04271046|364294119|FG001|Overall Study|Patient with Dementia Died|0|||
105625932|NCT04271046|364294120|FG002|Overall Study|Patient with Dementia Died|2|||
105625933|NCT04271046|364294121|FG003|Overall Study|Patient with Dementia Died|0|||
105625934|NCT04271046|364294118|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
105625935|NCT04271046|364294119|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
105625936|NCT04271046|364294120|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
105625937|NCT04271046|364294121|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
105625938|NCT00303459|364294122|FG000|Overall Study|Death|33|||
105625939|NCT00303459|364294123|FG001|Overall Study|Death|44|||
105625940|NCT00303459|364294122|FG000|Overall Study|Withdrawal of consent|32|||
105625941|NCT00303459|364294123|FG001|Overall Study|Withdrawal of consent|26|||
105625942|NCT00303459|364294122|FG000|Overall Study|Lost to Follow-up|5|||
105625943|NCT00303459|364294123|FG001|Overall Study|Lost to Follow-up|4|||
105625944|NCT00303459|364294122|FG000|Overall Study|Administrative reason|7|||
105625945|NCT00303459|364294123|FG001|Overall Study|Administrative reason|7|||
105625946|NCT00303459|364294122|FG000|Overall Study|Decision by the investigator|5|||
105625947|NCT00303459|364294123|FG001|Overall Study|Decision by the investigator|7|||
105625948|NCT00303459|364294122|FG000|Overall Study|Lung transplantation|1|||
105625949|NCT00303459|364294123|FG001|Overall Study|Lung transplantation|1|||
105625950|NCT01570361|364294124|FG000|Overall Study|Subject discontinued|1|||
105625951|NCT01570361|364294125|FG001|Overall Study|Subject discontinued|2|||
105625952|NCT01570361|364294124|FG000|Overall Study|Sponsor closing the study|51|||
105625953|NCT01570361|364294125|FG001|Overall Study|Sponsor closing the study|50|||
105625954|NCT01570361|364294124|FG000|Overall Study|Subject excluded|5|||
105625955|NCT01570361|364294125|FG001|Overall Study|Subject excluded|3|||
105625956|NCT01570361|364294124|FG000|Overall Study|Subject withdrew consent|14|||
105625957|NCT01570361|364294125|FG001|Overall Study|Subject withdrew consent|9|||
105625958|NCT01570361|364294124|FG000|Overall Study|Adverse Event|2|||
105625959|NCT01570361|364294125|FG001|Overall Study|Adverse Event|1|||
105625960|NCT01570361|364294124|FG000|Overall Study|Lost to Follow-up|4|||
105625961|NCT01570361|364294125|FG001|Overall Study|Lost to Follow-up|4|||
105625962|NCT01570361|364294124|FG000|Overall Study|Death|5|||
105625963|NCT01570361|364294125|FG001|Overall Study|Death|4|||
105625964|NCT01570361|364294124|FG000|Overall Study|Other|0|||
105625965|NCT01570361|364294125|FG001|Overall Study|Other|2|||
105625966|NCT03673501|364295289|FG000|Overall Study|Participants ongoing.|36|||
105625967|NCT03673501|364295290|FG001|Overall Study|Participants ongoing.|24|||
105625968|NCT03714815|364295291|FG000|Overall Study|Physician Decision|2|||
105625969|NCT03714815|364295291|FG000|Overall Study|Withdrawal by Subject|2|||
105625970|NCT03714815|364295291|FG000|Overall Study|Death|11|||
105625971|NCT01909934|364295296|FG000|Overall Study|Ongoing|23|||
105625972|NCT01909934|364295296|FG000|Overall Study|Withdrawal by Subject|3|||
105625973|NCT01909934|364295296|FG000|Overall Study|Lost to Follow-up|1|||
105625974|NCT01909934|364295296|FG000|Overall Study|Withdrawal of Informed Consent|1|||
105625975|NCT01909934|364295296|FG000|Overall Study|Death|22|||
105625976|NCT02906007|364295297|FG000|Overall Study|Physician Decision|0|||
105625977|NCT02906007|364295298|FG001|Overall Study|Physician Decision|0|||
105625978|NCT02906007|364295299|FG002|Overall Study|Physician Decision|1|||
105625979|NCT02906007|364295297|FG000|Overall Study|Died|1|||
105625980|NCT02906007|364295298|FG001|Overall Study|Died|0|||
105625981|NCT02906007|364295299|FG002|Overall Study|Died|0|||
105625982|NCT04741776|364295301|FG000|Overall Study|Withdrawal by Subject|7|||
105625983|NCT04741776|364295302|FG001|Overall Study|Withdrawal by Subject|10|||
105625984|NCT04741776|364295303|FG002|Overall Study|Withdrawal by Subject|10|||
105625985|NCT04741776|364295304|FG003|Overall Study|Withdrawal by Subject|17|||
105625986|NCT04741776|364295301|FG000|Overall Study|Death|0|||
105625987|NCT04741776|364295302|FG001|Overall Study|Death|0|||
105625988|NCT04741776|364295303|FG002|Overall Study|Death|1|||
105625989|NCT04741776|364295304|FG003|Overall Study|Death|0|||
105625990|NCT04659603|364295309|FG000|Overall Study|Ongoing study treatment at the time of primary analysis completion|0|||
105625991|NCT04659603|364295310|FG001|Overall Study|Ongoing study treatment at the time of primary analysis completion|0|||
105625992|NCT04659603|364295311|FG002|Overall Study|Ongoing study treatment at the time of primary analysis completion|6|||
105625993|NCT04659603|364295309|FG000|Overall Study|Withdrawal by Subject|0|||
105625994|NCT04659603|364295310|FG001|Overall Study|Withdrawal by Subject|5|||
105625995|NCT04659603|364295311|FG002|Overall Study|Withdrawal by Subject|0|||
105625996|NCT04659603|364295309|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
105625997|NCT04659603|364295310|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
105625998|NCT04659603|364295311|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
105625999|NCT05405985|364295312|FG000|Overall Study|Withdrawal by Subject|1|||
105626000|NCT05405985|364295313|FG001|Overall Study|Withdrawal by Subject|0|||
105626001|NCT04282980|364295314|FG000|Overall Study|Remained on treatment|6|||
105626002|NCT04282980|364295314|FG000|Overall Study|Survival follow-up|11|||
105626003|NCT04282980|364295314|FG000|Overall Study|Withdrawal of informed consent|1|||
105626004|NCT04282980|364295314|FG000|Overall Study|Lost to Follow-up|1|||
105626005|NCT05035654|364295316|FG000|Overall Study|Physician Decision|0|||
105626006|NCT05035654|364295317|FG001|Overall Study|Physician Decision|1|||
105626007|NCT05035654|364295318|FG002|Overall Study|Physician Decision|0|||
105626008|NCT05035654|364295316|FG000|Overall Study|Adverse Event|0|||
105626009|NCT05035654|364295317|FG001|Overall Study|Adverse Event|1|||
105626010|NCT05035654|364295318|FG002|Overall Study|Adverse Event|0|||
105626011|NCT05035654|364295316|FG000|Overall Study|Withdrawal by Subject|0|||
105626012|NCT05035654|364295317|FG001|Overall Study|Withdrawal by Subject|0|||
105626013|NCT05035654|364295318|FG002|Overall Study|Withdrawal by Subject|4|||
105626014|NCT05035654|364295316|FG000|Overall Study|Bilateral Dislodgement|1|||
105626015|NCT05035654|364295317|FG001|Overall Study|Bilateral Dislodgement|0|||
105626016|NCT05035654|364295318|FG002|Overall Study|Bilateral Dislodgement|0|||
105626017|NCT04679935|364295320|FG000|Overall Study|Death|0|||
105626018|NCT04679935|364295321|FG001|Overall Study|Death|1|||
105626019|NCT02988661|364295322|FG000|Overall Study|Death|2|||
105626020|NCT02988661|364295323|FG001|Overall Study|Death|18|||
105626021|NCT02988661|364295322|FG000|Overall Study|Lost to Follow-up|0|||
105626022|NCT02988661|364295323|FG001|Overall Study|Lost to Follow-up|33|||
105626023|NCT02988661|364295322|FG000|Overall Study|Withdrawal by Subject|0|||
105626024|NCT02988661|364295323|FG001|Overall Study|Withdrawal by Subject|6|||
105626025|NCT02988661|364295322|FG000|Overall Study|Unable to complete the 18-month survey|1|||
105626026|NCT02988661|364295323|FG001|Overall Study|Unable to complete the 18-month survey|27|||
105626027|NCT02839265|364295324|FG000|Overall Study|Screen Failure|2|||
105626028|NCT02839265|364295324|FG000|Overall Study|Death|1|||
105626029|NCT02839265|364295324|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
105626030|NCT04451772|364295338|FG000|Overall Study|Adverse Event|1|||
105626031|NCT04451772|364295339|FG001|Overall Study|Adverse Event|0|||
105626032|NCT04451772|364295340|FG002|Overall Study|Adverse Event|1|||
105626033|NCT04451772|364295341|FG003|Overall Study|Adverse Event|1|||
105626034|NCT04451772|364295342|FG004|Overall Study|Adverse Event|0|||
105626035|NCT04451772|364295343|FG005|Overall Study|Adverse Event|3|||
105626036|NCT04451772|364295338|FG000|Overall Study|Withdrawal by Subject|2|||
105626037|NCT04451772|364295339|FG001|Overall Study|Withdrawal by Subject|7|||
105626038|NCT04451772|364295340|FG002|Overall Study|Withdrawal by Subject|2|||
105626039|NCT04451772|364295341|FG003|Overall Study|Withdrawal by Subject|1|||
105626040|NCT04451772|364295342|FG004|Overall Study|Withdrawal by Subject|1|||
105626041|NCT04451772|364295343|FG005|Overall Study|Withdrawal by Subject|0|||
105626042|NCT04451772|364295338|FG000|Overall Study|Other, not specified|1|||
105626043|NCT04451772|364295339|FG001|Overall Study|Other, not specified|2|||
105626044|NCT04451772|364295340|FG002|Overall Study|Other, not specified|1|||
105626045|NCT04451772|364295341|FG003|Overall Study|Other, not specified|0|||
105626046|NCT04451772|364295342|FG004|Overall Study|Other, not specified|0|||
105626047|NCT04451772|364295343|FG005|Overall Study|Other, not specified|1|||
105626048|NCT04451772|364295338|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
105626049|NCT04451772|364295339|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
105626050|NCT04451772|364295340|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
105626051|NCT04451772|364295341|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
105626052|NCT04451772|364295342|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
105626053|NCT04451772|364295343|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
105626054|NCT04311632|364295344|FG000|Overall Study|Withdrawal by Subject|0|||
105626055|NCT04311632|364295345|FG001|Overall Study|Withdrawal by Subject|0|||
105626056|NCT04311632|364295346|FG002|Overall Study|Withdrawal by Subject|1|||
105626057|NCT04934072|364295347|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
105626058|NCT04934072|364295348|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
105626059|NCT04934072|364295349|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
105626060|NCT04934072|364295350|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
105626061|NCT04934072|364295351|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
105626062|NCT04934072|364295347|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
105626063|NCT04934072|364295348|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
105626064|NCT04934072|364295349|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
105626065|NCT04934072|364295350|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
105626066|NCT04934072|364295351|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
105626067|NCT04934072|364295347|FG000|Day 0 to Week 52|Other|3|||
105626068|NCT04934072|364295348|FG001|Day 0 to Week 52|Other|1|||
105626069|NCT04934072|364295349|FG002|Day 0 to Week 52|Other|0|||
105626070|NCT04934072|364295350|FG003|Day 0 to Week 52|Other|0|||
105626071|NCT04934072|364295351|FG004|Day 0 to Week 52|Other|0|||
105626072|NCT04934072|364295347|FG000|Day 0 to Week 52|Adverse Event|1|||
105626073|NCT04934072|364295348|FG001|Day 0 to Week 52|Adverse Event|3|||
105626074|NCT04934072|364295349|FG002|Day 0 to Week 52|Adverse Event|0|||
105626075|NCT04934072|364295350|FG003|Day 0 to Week 52|Adverse Event|0|||
105626076|NCT04934072|364295351|FG004|Day 0 to Week 52|Adverse Event|0|||
105626077|NCT04934072|364295347|FG000|Week 52 to Week 78|Adverse Event|0|||
105626078|NCT04934072|364295348|FG001|Week 52 to Week 78|Adverse Event|0|||
105626079|NCT04934072|364295349|FG002|Week 52 to Week 78|Adverse Event|0|||
105626080|NCT04934072|364295350|FG003|Week 52 to Week 78|Adverse Event|1|||
105626081|NCT04934072|364295351|FG004|Week 52 to Week 78|Adverse Event|1|||
105626082|NCT04934072|364295347|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
105626083|NCT04934072|364295348|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
105626084|NCT04934072|364295349|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
105626085|NCT04934072|364295350|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
105626086|NCT04934072|364295351|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
105626087|NCT04934072|364295347|FG000|Week 52 to Week 78|Other|0|||
105626088|NCT04934072|364295348|FG001|Week 52 to Week 78|Other|0|||
105626089|NCT04934072|364295349|FG002|Week 52 to Week 78|Other|1|||
105626090|NCT04934072|364295350|FG003|Week 52 to Week 78|Other|0|||
105626091|NCT04934072|364295351|FG004|Week 52 to Week 78|Other|0|||
105626092|NCT05424380|364295359|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
105626093|NCT05424380|364295360|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
105626094|NCT05424380|364295361|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
105626095|NCT05424380|364295362|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
105626096|NCT05424380|364295363|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
105626097|NCT05424380|364295364|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
105626098|NCT05424380|364295359|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
105626099|NCT05424380|364295360|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
105626100|NCT05424380|364295361|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
105626101|NCT05424380|364295362|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
105626102|NCT05424380|364295363|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
105626103|NCT05424380|364295364|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
105626104|NCT05424380|364295359|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
105626105|NCT05424380|364295360|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
105626106|NCT05424380|364295361|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
105626107|NCT05424380|364295362|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
105626108|NCT05424380|364295363|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
105626109|NCT05424380|364295364|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
105626110|NCT05424380|364295359|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
105626111|NCT05424380|364295360|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
105626112|NCT05424380|364295361|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
105626113|NCT05424380|364295362|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
105626114|NCT05424380|364295363|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
105626115|NCT05424380|364295364|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
105626116|NCT05424380|364295359|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
105626117|NCT05424380|364295360|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
105626118|NCT05424380|364295361|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
105626119|NCT05424380|364295362|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
105626120|NCT05424380|364295363|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
105626121|NCT05424380|364295364|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
105626122|NCT05424380|364295359|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
105626123|NCT05424380|364295360|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
105626124|NCT05424380|364295361|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
105626125|NCT05424380|364295362|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
105626126|NCT05424380|364295363|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
105626127|NCT05424380|364295364|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
105626128|NCT05424380|364295359|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
105626129|NCT05424380|364295360|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
105626130|NCT05424380|364295361|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
105626131|NCT05424380|364295362|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
105626132|NCT05424380|364295363|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
105626133|NCT05424380|364295364|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
105626134|NCT05424380|364295359|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
105626135|NCT05424380|364295360|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
105626136|NCT05424380|364295361|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
105626137|NCT05424380|364295362|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
105626138|NCT05424380|364295363|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
105626139|NCT05424380|364295364|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
105626140|NCT05424380|364295359|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
105626141|NCT05424380|364295360|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
105626142|NCT05424380|364295361|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
105626143|NCT05424380|364295362|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
105626144|NCT05424380|364295363|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
105626145|NCT05424380|364295364|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
105626146|NCT05424380|364295359|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
105626147|NCT05424380|364295360|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
105626148|NCT05424380|364295361|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
105626149|NCT05424380|364295362|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
105626150|NCT05424380|364295363|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
105626151|NCT05424380|364295364|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
105626152|NCT05424380|364295359|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
105626153|NCT05424380|364295360|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
105626154|NCT05424380|364295361|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
105626155|NCT05424380|364295362|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
105626156|NCT05424380|364295363|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
105626157|NCT05424380|364295364|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
105626158|NCT05424380|364295359|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
105626159|NCT05424380|364295360|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
105626160|NCT05424380|364295361|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
105626161|NCT05424380|364295362|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
105626162|NCT05424380|364295363|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
105626163|NCT05424380|364295364|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
105626164|NCT05424380|364295359|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
105626165|NCT05424380|364295360|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
105626166|NCT05424380|364295361|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
105626167|NCT05424380|364295362|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
105626168|NCT05424380|364295363|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
105626169|NCT05424380|364295364|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
105626170|NCT05424380|364295359|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
105626171|NCT05424380|364295360|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
105626172|NCT05424380|364295361|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
105626173|NCT05424380|364295362|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
105626174|NCT05424380|364295363|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
105626175|NCT05424380|364295364|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
105626176|NCT02909686|364295365|FG000|Overall Study|Physician Decision|3|||
105626177|NCT02909686|364295365|FG000|Overall Study|Withdrawal by Subject|2|||
105626178|NCT02828358|364295370|FG000|Overall Study|Physician Decision|7|||
105626179|NCT02828358|364295371|FG001|Overall Study|Physician Decision|1|||
105626180|NCT02828358|364295370|FG000|Overall Study|Treatment Failure|6|||
105626181|NCT02828358|364295371|FG001|Overall Study|Treatment Failure|0|||
105626182|NCT02828358|364295370|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
105626183|NCT02828358|364295371|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
105626184|NCT02828358|364295370|FG000|Overall Study|Refusal of further protocol therapy|2|||
105626185|NCT02828358|364295371|FG001|Overall Study|Refusal of further protocol therapy|0|||
105626186|NCT02828358|364295370|FG000|Overall Study|Relapse|25|||
105626187|NCT02828358|364295371|FG001|Overall Study|Relapse|0|||
105626188|NCT02828358|364295370|FG000|Overall Study|Still on therapy|5|||
105626189|NCT02828358|364295371|FG001|Overall Study|Still on therapy|0|||
105626190|NCT05172232|364295372|FG000|Overall Study|Lost to Follow-up|3|||
105626191|NCT02575950|364295373|FG000|Overall Study|Withdrawal by Subject|0|||
105626192|NCT02575950|364295374|FG001|Overall Study|Withdrawal by Subject|0|||
105626193|NCT02575950|364295375|FG002|Overall Study|Withdrawal by Subject|0|||
105626194|NCT02575950|364295376|FG003|Overall Study|Withdrawal by Subject|2|||
105626195|NCT02575950|364295373|FG000|Overall Study|Lost to Follow-up|0|||
105626196|NCT02575950|364295374|FG001|Overall Study|Lost to Follow-up|1|||
105626197|NCT02575950|364295375|FG002|Overall Study|Lost to Follow-up|0|||
105626198|NCT02575950|364295376|FG003|Overall Study|Lost to Follow-up|3|||
105626199|NCT05422885|364295377|FG000|Overall Study|Lost to Follow-up|1|||
105626200|NCT05422885|364295377|FG000|Overall Study|Withdrawal by Subject|2|||
105626201|NCT04129554|364295378|FG000|Overall Study|Withdrawal by Subject|4|||
105626202|NCT04129554|364295379|FG001|Overall Study|Withdrawal by Subject|3|||
105626203|NCT04129554|364295378|FG000|Overall Study|Other|0|||
105626204|NCT04129554|364295379|FG001|Overall Study|Other|2|||
105626205|NCT02492711|364295382|FG000|Overall Study|Adverse Event|9|||
105626206|NCT02492711|364295383|FG001|Overall Study|Adverse Event|9|||
105626207|NCT02492711|364295384|FG002|Overall Study|Adverse Event|2|||
105626208|NCT02492711|364295382|FG000|Overall Study|Death|3|||
105626209|NCT02492711|364295383|FG001|Overall Study|Death|3|||
105626210|NCT02492711|364295384|FG002|Overall Study|Death|0|||
105626211|NCT02492711|364295382|FG000|Overall Study|Withdrawal by Subject|10|||
105626212|NCT02492711|364295383|FG001|Overall Study|Withdrawal by Subject|16|||
105626213|NCT02492711|364295384|FG002|Overall Study|Withdrawal by Subject|5|||
105626214|NCT02492711|364295382|FG000|Overall Study|Physician Decision|10|||
105626215|NCT02492711|364295383|FG001|Overall Study|Physician Decision|6|||
105626216|NCT02492711|364295384|FG002|Overall Study|Physician Decision|4|||
105626217|NCT02492711|364295382|FG000|Overall Study|Lost to Follow-up|0|||
105626218|NCT02492711|364295383|FG001|Overall Study|Lost to Follow-up|0|||
105626219|NCT02492711|364295384|FG002|Overall Study|Lost to Follow-up|1|||
105626220|NCT02492711|364295382|FG000|Overall Study|study treatment delay|2|||
105626221|NCT02492711|364295383|FG001|Overall Study|study treatment delay|1|||
105626222|NCT02492711|364295384|FG002|Overall Study|study treatment delay|0|||
105626223|NCT02492711|364295382|FG000|Overall Study|change in chemotherapy|0|||
105626224|NCT02492711|364295383|FG001|Overall Study|change in chemotherapy|1|||
105626225|NCT02492711|364295384|FG002|Overall Study|change in chemotherapy|0|||
105626226|NCT02492711|364295382|FG000|Overall Study|never treated|2|||
105626227|NCT02492711|364295383|FG001|Overall Study|never treated|4|||
105626228|NCT02492711|364295384|FG002|Overall Study|never treated|0|||
105626229|NCT02492711|364295382|FG000|Overall Study|Other|0|||
105626230|NCT02492711|364295383|FG001|Overall Study|Other|0|||
105626231|NCT02492711|364295384|FG002|Overall Study|Other|1|||
105626232|NCT03672916|364296796|FG000|Overall Study|Death|6|||
105626233|NCT03672916|364296796|FG000|Overall Study|Lost to Follow-up|29|||
105626234|NCT03672916|364296796|FG000|Overall Study|Adverse Event|6|||
105626235|NCT03672916|364296796|FG000|Overall Study|Withdrawal by Subject|11|||
105626236|NCT05363163|364296804|FG000|Overall Study|Withdrawal by Subject|13|||
105626237|NCT01314105|364296805|FG000|Overall Study|Progressive Disease|6|||
105626238|NCT01314105|364296806|FG001|Overall Study|Progressive Disease|10|||
105626239|NCT01314105|364296805|FG000|Overall Study|Refused to continue taking medication|0|||
105626240|NCT01314105|364296806|FG001|Overall Study|Refused to continue taking medication|1|||
105626241|NCT01314105|364296805|FG000|Overall Study|Other Adverse Event|1|||
105626242|NCT01314105|364296806|FG001|Overall Study|Other Adverse Event|1|||
105626243|NCT06106022|364296807|FG000|Overall Study|Lost to Follow-up|1|||
105626244|NCT06106022|364296808|FG001|Overall Study|Lost to Follow-up|0|||
105626245|NCT06106022|364296807|FG000|Overall Study|Voluntary Withdrawal|0|||
105626246|NCT06106022|364296808|FG001|Overall Study|Voluntary Withdrawal|2|||
105626247|NCT03276676|364296809|FG000|Overall Study|Withdrawal by Subject|2|||
105626248|NCT03276676|364296810|FG001|Overall Study|Withdrawal by Subject|1|||
105626249|NCT04089865|364296811|FG000|Overall Study|Withdrawal by Subject|2|||
105626250|NCT04089865|364296812|FG001|Overall Study|Withdrawal by Subject|2|||
105626251|NCT04089865|364296813|FG002|Overall Study|Withdrawal by Subject|7|||
105626252|NCT04089865|364296814|FG003|Overall Study|Withdrawal by Subject|2|||
105626253|NCT03583333|364296815|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
105626254|NCT03583333|364296816|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
105626255|NCT03583333|364296815|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
105626256|NCT03583333|364296816|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
105626257|NCT03583333|364296815|FG000|Overall Study|Withdrawal by Subject|9|||
105626258|NCT03583333|364296816|FG001|Overall Study|Withdrawal by Subject|5|||
105626259|NCT03583333|364296815|FG000|Overall Study|Physician Decision|3|||
105626260|NCT03583333|364296816|FG001|Overall Study|Physician Decision|2|||
105626261|NCT03583333|364296815|FG000|Overall Study|Death|12|||
105626262|NCT03583333|364296816|FG001|Overall Study|Death|7|||
105626263|NCT00323856|364296821|FG000|Overall Study|Withdrawal by Subject|1|||
105626264|NCT00323856|364296821|FG000|Overall Study|Was uncooperative and noncompliant|1|||
105626265|NCT00323856|364296821|FG000|Overall Study|Reason not specified|1|||
105626266|NCT00323856|364296821|FG000|Overall Study|Missing|2|||
105626267|NCT04580914|364296822|FG000|Overall Study|Withdrawal by Subject|6|||
105626268|NCT04580914|364296822|FG000|Overall Study|Lost to Follow-up|2|||
105626269|NCT05660434|364296828|FG000|Overall Study|Never obtained study materials|2|||
105626270|NCT05660434|364296829|FG001|Overall Study|Never obtained study materials|1|||
105626271|NCT03858517|364296830|FG000|Overall Study|Adverse Event|1|||
105626272|NCT03858517|364296830|FG000|Overall Study|Lost to Follow-up|1|||
105626273|NCT03858517|364296830|FG000|Overall Study|removed for being incarcerated|1|||
105626274|NCT03858517|364296830|FG000|Overall Study|Sponsor Closure|48|||
105626275|NCT06037668|364296834|FG000|Overall Study|Lost to Follow-up|1|||
105626276|NCT06037668|364296835|FG001|Overall Study|Lost to Follow-up|1|||
105626277|NCT06037668|364296834|FG000|Overall Study|Protocol Violation|1|||
105626278|NCT06037668|364296835|FG001|Overall Study|Protocol Violation|0|||
105626279|NCT06037668|364296834|FG000|Overall Study|Withdrawal by Subject|1|||
105626280|NCT06037668|364296835|FG001|Overall Study|Withdrawal by Subject|0|||
105626281|NCT06037668|364296834|FG000|Overall Study|Other Study Discontinuation Reason|1|||
105626282|NCT06037668|364296835|FG001|Overall Study|Other Study Discontinuation Reason|0|||
105626283|NCT05224544|364296836|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
105626284|NCT05224544|364296837|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
105626285|NCT03213678|364296839|FG000|Overall Study|Death|1|||
105626286|NCT03213678|364296839|FG000|Overall Study|Physician Decision|1|||
105626287|NCT03213678|364296839|FG000|Overall Study|Progressive disease|16|||
105626288|NCT04218851|364296840|FG000|Overall Study|Death|1|||
105626289|NCT04218851|364296841|FG001|Overall Study|Death|3|||
105626290|NCT00844415|364296842|FG000|Overall Study|Withdrawal by Subject|1|||
105626291|NCT05285137|364296845|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
105626292|NCT05285137|364296846|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
105626293|NCT05285137|364296847|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
105626294|NCT05285137|364296848|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
105626295|NCT05285137|364296849|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
105626296|NCT05285137|364296850|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
105626297|NCT05285137|364296851|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
105626298|NCT05285137|364296852|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
105626299|NCT05285137|364296853|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
105626300|NCT05285137|364296845|FG000|Overall Study|Lost to Follow-up|0|||
105626301|NCT05285137|364296846|FG001|Overall Study|Lost to Follow-up|0|||
105626302|NCT05285137|364296847|FG002|Overall Study|Lost to Follow-up|1|||
105626303|NCT05285137|364296848|FG003|Overall Study|Lost to Follow-up|3|||
105626304|NCT05285137|364296849|FG004|Overall Study|Lost to Follow-up|0|||
105626305|NCT05285137|364296850|FG005|Overall Study|Lost to Follow-up|0|||
105626306|NCT05285137|364296851|FG006|Overall Study|Lost to Follow-up|1|||
105626307|NCT05285137|364296852|FG007|Overall Study|Lost to Follow-up|0|||
105626308|NCT05285137|364296853|FG008|Overall Study|Lost to Follow-up|0|||
105626309|NCT05285137|364296845|FG000|Overall Study|Physician Decision|0|||
105626310|NCT05285137|364296846|FG001|Overall Study|Physician Decision|1|||
105626311|NCT05285137|364296847|FG002|Overall Study|Physician Decision|0|||
105626312|NCT05285137|364296848|FG003|Overall Study|Physician Decision|0|||
105626313|NCT05285137|364296849|FG004|Overall Study|Physician Decision|0|||
105626314|NCT05285137|364296850|FG005|Overall Study|Physician Decision|0|||
105626315|NCT05285137|364296851|FG006|Overall Study|Physician Decision|0|||
105626316|NCT05285137|364296852|FG007|Overall Study|Physician Decision|0|||
105626317|NCT05285137|364296853|FG008|Overall Study|Physician Decision|0|||
105626318|NCT05285137|364296845|FG000|Overall Study|Pregnancy|0|||
105626319|NCT05285137|364296846|FG001|Overall Study|Pregnancy|0|||
105626320|NCT05285137|364296847|FG002|Overall Study|Pregnancy|0|||
105626321|NCT05285137|364296848|FG003|Overall Study|Pregnancy|0|||
105626322|NCT05285137|364296849|FG004|Overall Study|Pregnancy|0|||
105626323|NCT05285137|364296850|FG005|Overall Study|Pregnancy|0|||
105626324|NCT05285137|364296851|FG006|Overall Study|Pregnancy|1|||
105626325|NCT05285137|364296852|FG007|Overall Study|Pregnancy|0|||
105626326|NCT05285137|364296853|FG008|Overall Study|Pregnancy|0|||
105626327|NCT05285137|364296845|FG000|Overall Study|Withdrawal by Subject|0|||
105626328|NCT05285137|364296846|FG001|Overall Study|Withdrawal by Subject|1|||
105626329|NCT05285137|364296847|FG002|Overall Study|Withdrawal by Subject|2|||
105626330|NCT05285137|364296848|FG003|Overall Study|Withdrawal by Subject|1|||
105626331|NCT05285137|364296849|FG004|Overall Study|Withdrawal by Subject|0|||
105626332|NCT05285137|364296850|FG005|Overall Study|Withdrawal by Subject|0|||
105626333|NCT05285137|364296851|FG006|Overall Study|Withdrawal by Subject|0|||
105626334|NCT05285137|364296852|FG007|Overall Study|Withdrawal by Subject|0|||
105626335|NCT05285137|364296853|FG008|Overall Study|Withdrawal by Subject|1|||
105626336|NCT03717935|364296854|FG000|Overall Study|Withdrawal by Subject|0|||
105626337|NCT03717935|364296855|FG001|Overall Study|Withdrawal by Subject|2|||
105626338|NCT01820611|364296856|FG000|Overall Study|Death|8|||
105626339|NCT01820611|364296856|FG000|Overall Study|Adverse Event|1|||
105626340|NCT01820611|364296856|FG000|Overall Study|Withdrawal by Subject|9|||
105626341|NCT02473445|364296857|FG000|Overall Study|Withdrawal by Subject|2|||
105626342|NCT02473445|364296857|FG000|Overall Study|Sponsor Decision|20|||
105626343|NCT04881461|364296858|FG000|Overall Study|Adverse Event|2|||
105626344|NCT04881461|364296859|FG001|Overall Study|Adverse Event|4|||
105626345|NCT04881461|364296858|FG000|Overall Study|Withdrawal by Subject|19|||
105626346|NCT04881461|364296859|FG001|Overall Study|Withdrawal by Subject|19|||
105626347|NCT04881461|364296858|FG000|Overall Study|Lost to Follow-up|4|||
105626348|NCT04881461|364296859|FG001|Overall Study|Lost to Follow-up|4|||
105626349|NCT04881461|364296858|FG000|Overall Study|Lack of Efficacy|1|||
105626350|NCT04881461|364296859|FG001|Overall Study|Lack of Efficacy|0|||
105626351|NCT04881461|364296858|FG000|Overall Study|"Reason stated as other in CRF"|1|||
105626352|NCT04881461|364296859|FG001|Overall Study|"Reason stated as other in CRF"|2|||
105626353|NCT03484819|364296860|FG000|Overall Study|Death|2|||
105626354|NCT03484819|364296860|FG000|Overall Study|Adverse Event|2|||
105626355|NCT03484819|364296860|FG000|Overall Study|Physician Decision|1|||
105626356|NCT03484819|364296860|FG000|Overall Study|Withdrawal by Subject|2|||
105626357|NCT03484819|364296860|FG000|Overall Study|Disease Progression|4|||
105626358|NCT03484819|364296860|FG000|Overall Study|Complicating Condition|1|||
105626359|NCT03015532|364296861|FG000|Overall Study|Adverse Event|0|||
105626360|NCT03015532|364296862|FG001|Overall Study|Adverse Event|0|||
105626361|NCT03015532|364296863|FG002|Overall Study|Adverse Event|0|||
105626362|NCT03015532|364296864|FG003|Overall Study|Adverse Event|0|||
105626363|NCT03015532|364296865|FG004|Overall Study|Adverse Event|0|||
105626364|NCT03015532|364296866|FG005|Overall Study|Adverse Event|2|||
105626365|NCT03015532|364296867|FG006|Overall Study|Adverse Event|1|||
105626366|NCT03015532|364296868|FG007|Overall Study|Adverse Event|0|||
105626367|NCT03015532|364296861|FG000|Overall Study|Withdrawal by Subject|0|||
105626368|NCT03015532|364296862|FG001|Overall Study|Withdrawal by Subject|0|||
105626369|NCT03015532|364296863|FG002|Overall Study|Withdrawal by Subject|0|||
105626370|NCT03015532|364296864|FG003|Overall Study|Withdrawal by Subject|0|||
105626371|NCT03015532|364296865|FG004|Overall Study|Withdrawal by Subject|0|||
105626372|NCT03015532|364296866|FG005|Overall Study|Withdrawal by Subject|0|||
105626373|NCT03015532|364296867|FG006|Overall Study|Withdrawal by Subject|1|||
105626374|NCT03015532|364296868|FG007|Overall Study|Withdrawal by Subject|0|||
105626375|NCT05970861|364296869|FG000|Overall Study|Physician Decision|4|||
105626376|NCT05970861|364296870|FG001|Overall Study|Physician Decision|4|||
105626377|NCT05970861|364296869|FG000|Overall Study|Lost to Follow-up|4|||
105626378|NCT05970861|364296870|FG001|Overall Study|Lost to Follow-up|3|||
105626379|NCT02997202|364296874|FG000|Overall Study|Miscellaneous|2|||
105626380|NCT02997202|364296875|FG001|Overall Study|Miscellaneous|2|||
105626381|NCT02997202|364296874|FG000|Overall Study|Withdrawal by Subject|8|||
105626382|NCT02997202|364296875|FG001|Overall Study|Withdrawal by Subject|12|||
105626383|NCT02997202|364296874|FG000|Overall Study|Lost to Follow-up|5|||
105626384|NCT02997202|364296875|FG001|Overall Study|Lost to Follow-up|3|||
105626385|NCT02997202|364296874|FG000|Overall Study|Death|41|||
105626386|NCT02997202|364296875|FG001|Overall Study|Death|45|||
105626387|NCT05100628|364296879|FG000|Overall Study|Progressive Disease|1|||
105626388|NCT05100628|364296880|FG001|Overall Study|Progressive Disease|0|||
105626389|NCT05100628|364296881|FG002|Overall Study|Progressive Disease|0|||
105626390|NCT05100628|364296882|FG003|Overall Study|Progressive Disease|0|||
105626391|NCT05100628|364296879|FG000|Overall Study|Study Terminated by Sponsor|0|||
105626392|NCT05100628|364296880|FG001|Overall Study|Study Terminated by Sponsor|0|||
105626393|NCT05100628|364296881|FG002|Overall Study|Study Terminated by Sponsor|3|||
105626394|NCT05100628|364296882|FG003|Overall Study|Study Terminated by Sponsor|0|||
105626395|NCT05100628|364296879|FG000|Overall Study|unkown|0|||
105626396|NCT05100628|364296880|FG001|Overall Study|unkown|1|||
105626397|NCT05100628|364296881|FG002|Overall Study|unkown|0|||
105626398|NCT05100628|364296882|FG003|Overall Study|unkown|0|||
105626399|NCT01121588|364296892|FG000|Overall Study|Death|5|||
105626400|NCT01121588|364296893|FG001|Overall Study|Death|3|||
105626401|NCT01121588|364296894|FG002|Overall Study|Death|13|||
105626402|NCT01121588|364296892|FG000|Overall Study|Study Terminated by Sponsor|1|||
105626403|NCT01121588|364296893|FG001|Overall Study|Study Terminated by Sponsor|1|||
105626404|NCT01121588|364296894|FG002|Overall Study|Study Terminated by Sponsor|0|||
105626405|NCT01121588|364296892|FG000|Overall Study|Participant Refused Further Followup|2|||
105626406|NCT01121588|364296893|FG001|Overall Study|Participant Refused Further Followup|0|||
105626407|NCT01121588|364296894|FG002|Overall Study|Participant Refused Further Followup|2|||
105626408|NCT01121588|364296892|FG000|Overall Study|Lost to Follow-up|0|||
105626409|NCT01121588|364296893|FG001|Overall Study|Lost to Follow-up|1|||
105626410|NCT01121588|364296894|FG002|Overall Study|Lost to Follow-up|1|||
105626411|NCT01121588|364296892|FG000|Overall Study|Non-Specified Reasons|9|||
105626412|NCT01121588|364296893|FG001|Overall Study|Non-Specified Reasons|4|||
105626413|NCT01121588|364296894|FG002|Overall Study|Non-Specified Reasons|2|||
105626414|NCT02782676|364296895|FG000|Overall Study|Lost to Follow-up|0|||
105626415|NCT02782676|364296896|FG001|Overall Study|Lost to Follow-up|1|||
105626416|NCT05513937|364296900|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
105626417|NCT05513937|364296901|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
105626418|NCT05513937|364296902|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
105626419|NCT05513937|364296903|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
105626420|NCT05513937|364296900|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
105626421|NCT05513937|364296901|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
105626422|NCT05513937|364296902|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
105626423|NCT05513937|364296903|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
105626424|NCT05513937|364296900|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
105626425|NCT05513937|364296901|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
105626426|NCT05513937|364296902|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
105626427|NCT05513937|364296903|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
105626428|NCT05513937|364296900|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
105626429|NCT05513937|364296901|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
105626430|NCT05513937|364296902|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
105626431|NCT05513937|364296903|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
105626432|NCT05513937|364296900|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
105626433|NCT05513937|364296901|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
105626434|NCT05513937|364296902|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
105626435|NCT05513937|364296903|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
105626436|NCT05513937|364296900|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
105626437|NCT05513937|364296901|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
105626438|NCT05513937|364296902|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
105626439|NCT05513937|364296903|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
105626440|NCT04924400|364296904|FG000|Overall Study|Lost to Follow-up|3|||
105626441|NCT04924400|364296905|FG001|Overall Study|Lost to Follow-up|0|||
105626442|NCT04424316|364296908|FG000|Overall Study|Adverse Event|0|||
105626443|NCT04424316|364296909|FG001|Overall Study|Adverse Event|1|||
105626444|NCT04424316|364296910|FG002|Overall Study|Adverse Event|0|||
105626445|NCT04424316|364296911|FG003|Overall Study|Adverse Event|0|||
105626446|NCT04424316|364296908|FG000|Overall Study|Death|1|||
105626447|NCT04424316|364296909|FG001|Overall Study|Death|0|||
105626448|NCT04424316|364296910|FG002|Overall Study|Death|8|||
105626449|NCT04424316|364296911|FG003|Overall Study|Death|14|||
105626450|NCT04424316|364296908|FG000|Overall Study|Lost to Follow-up|93|||
105626451|NCT04424316|364296909|FG001|Overall Study|Lost to Follow-up|88|||
105626452|NCT04424316|364296910|FG002|Overall Study|Lost to Follow-up|224|||
105626453|NCT04424316|364296911|FG003|Overall Study|Lost to Follow-up|211|||
105626454|NCT04424316|364296908|FG000|Overall Study|No longer met eligibility criteria|1|||
105626455|NCT04424316|364296909|FG001|Overall Study|No longer met eligibility criteria|0|||
105626456|NCT04424316|364296910|FG002|Overall Study|No longer met eligibility criteria|0|||
105626457|NCT04424316|364296911|FG003|Overall Study|No longer met eligibility criteria|0|||
105626458|NCT04424316|364296908|FG000|Overall Study|Other|15|||
105626459|NCT04424316|364296909|FG001|Overall Study|Other|11|||
105626460|NCT04424316|364296910|FG002|Overall Study|Other|34|||
105626461|NCT04424316|364296911|FG003|Overall Study|Other|45|||
105626462|NCT04424316|364296908|FG000|Overall Study|Physician Decision|1|||
105626463|NCT04424316|364296909|FG001|Overall Study|Physician Decision|0|||
105626464|NCT04424316|364296910|FG002|Overall Study|Physician Decision|1|||
105626465|NCT04424316|364296911|FG003|Overall Study|Physician Decision|1|||
105626466|NCT04424316|364296908|FG000|Overall Study|Protocol Violation|0|||
105626467|NCT04424316|364296909|FG001|Overall Study|Protocol Violation|1|||
105626468|NCT04424316|364296910|FG002|Overall Study|Protocol Violation|0|||
105626469|NCT04424316|364296911|FG003|Overall Study|Protocol Violation|0|||
105626470|NCT04424316|364296908|FG000|Overall Study|Withdrawal by Subject|71|||
105626471|NCT04424316|364296909|FG001|Overall Study|Withdrawal by Subject|77|||
105626472|NCT04424316|364296910|FG002|Overall Study|Withdrawal by Subject|0|||
105626473|NCT04424316|364296911|FG003|Overall Study|Withdrawal by Subject|0|||
105626474|NCT04424316|364296908|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105626475|NCT04424316|364296909|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105626476|NCT04424316|364296910|FG002|Overall Study|Withdrawal by parent/guardian|74|||
105626477|NCT04424316|364296911|FG003|Overall Study|Withdrawal by parent/guardian|81|||
105626478|NCT04424316|364296908|FG000|Overall Study|Randomized but not vaccinated|13|||
105626479|NCT04424316|364296909|FG001|Overall Study|Randomized but not vaccinated|21|||
105626480|NCT04424316|364296910|FG002|Overall Study|Randomized but not vaccinated|0|||
105626481|NCT04424316|364296911|FG003|Overall Study|Randomized but not vaccinated|0|||
105626482|NCT04424316|364296908|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
105626483|NCT04424316|364296909|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
105626484|NCT04424316|364296910|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
105626485|NCT04424316|364296911|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
105626486|NCT03993392|364296912|FG000|Overall Study|Withdrawal by Subject|3|||
105626487|NCT03993392|364296912|FG000|Overall Study|Lost to Follow-up|2|||
105626488|NCT03993392|364296912|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
105626489|NCT02510235|364296913|FG000|Overall Study|Withdrawal by Subject|1|||
105626490|NCT02510235|364296914|FG001|Overall Study|Withdrawal by Subject|0|||
105626491|NCT04505410|364296915|FG000|Overall Study|Adverse Event|2|||
105626492|NCT04505410|364296916|FG001|Overall Study|Adverse Event|0|||
105626493|NCT04505410|364296915|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
105626494|NCT04505410|364296916|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
105626495|NCT04505410|364296915|FG000|Overall Study|did not want to follow diet|1|||
105626496|NCT04505410|364296916|FG001|Overall Study|did not want to follow diet|0|||
105626497|NCT04505410|364296915|FG000|Overall Study|flare up of ulcerative colitis|0|||
105626498|NCT04505410|364296916|FG001|Overall Study|flare up of ulcerative colitis|1|||
105626499|NCT04505410|364296915|FG000|Overall Study|Lost to Follow-up|0|||
105626500|NCT04505410|364296916|FG001|Overall Study|Lost to Follow-up|2|||
105626501|NCT04505410|364296915|FG000|Overall Study|Lost to Follow-up|1|||
105626502|NCT04505410|364296916|FG001|Overall Study|Lost to Follow-up|0|||
105626503|NCT04505410|364296915|FG000|Overall Study|initiated another diet on their own|0|||
105626504|NCT04505410|364296916|FG001|Overall Study|initiated another diet on their own|2|||
105626505|NCT05525104|364296917|FG000|Overall Study|Failed caudal analgesia|1|||
105626506|NCT05525104|364296918|FG001|Overall Study|Failed caudal analgesia|3|||
105626507|NCT05525104|364296917|FG000|Overall Study|Premedication needed|0|||
105626508|NCT05525104|364296918|FG001|Overall Study|Premedication needed|1|||
105626509|NCT05525104|364296917|FG000|Overall Study|Protocol Violation|10|||
105626510|NCT05525104|364296918|FG001|Overall Study|Protocol Violation|0|||
105626511|NCT05525104|364296917|FG000|Overall Study|Cancelled operation|1|||
105626512|NCT05525104|364296918|FG001|Overall Study|Cancelled operation|0|||
105626513|NCT03990883|364296919|FG000|Blinded Treatment Phase|Adverse Event|1|||
105626514|NCT03990883|364296920|FG001|Blinded Treatment Phase|Adverse Event|1|||
105626515|NCT03990883|364296921|FG002|Blinded Treatment Phase|Adverse Event|0|||
105626516|NCT03990883|364296919|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
105626517|NCT03990883|364296920|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
105626518|NCT03990883|364296921|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
105626519|NCT03990883|364296919|FG000|Blinded Treatment Phase|Physician Decision|1|||
105626520|NCT03990883|364296920|FG001|Blinded Treatment Phase|Physician Decision|0|||
105626521|NCT03990883|364296921|FG002|Blinded Treatment Phase|Physician Decision|0|||
105626522|NCT03990883|364296919|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
105626523|NCT03990883|364296920|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
105626524|NCT03990883|364296921|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
105626525|NCT03990883|364296919|FG000|Blinded Treatment Phase|COVID-19|3|||
105626526|NCT03990883|364296920|FG001|Blinded Treatment Phase|COVID-19|2|||
105626527|NCT03990883|364296921|FG002|Blinded Treatment Phase|COVID-19|0|||
105626528|NCT03990883|364296919|FG000|Blinded Treatment Phase|Personal Reasons|6|||
105626529|NCT03990883|364296920|FG001|Blinded Treatment Phase|Personal Reasons|3|||
105626530|NCT03990883|364296921|FG002|Blinded Treatment Phase|Personal Reasons|0|||
105626531|NCT03990883|364296919|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
105626532|NCT03990883|364296920|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
105626533|NCT03990883|364296921|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
105626534|NCT03990883|364296919|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
105626535|NCT03990883|364296920|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
105626536|NCT03990883|364296921|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
105626537|NCT03990883|364296919|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
105626538|NCT03990883|364296920|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
105626539|NCT03990883|364296921|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
105626540|NCT05533190|364298106|FG000|Overall Study|Lost to Follow-up|19|||
105626541|NCT05533190|364298107|FG001|Overall Study|Lost to Follow-up|7|||
105626542|NCT05533190|364298106|FG000|Overall Study|Failed to download app|1|||
105626543|NCT05533190|364298107|FG001|Overall Study|Failed to download app|0|||
105626544|NCT05533190|364298106|FG000|Overall Study|Thought app was a scam|1|||
105626545|NCT05533190|364298107|FG001|Overall Study|Thought app was a scam|0|||
105626546|NCT05533190|364298106|FG000|Overall Study|Withdrawal by Subject|2|||
105626547|NCT05533190|364298107|FG001|Overall Study|Withdrawal by Subject|0|||
105626548|NCT05552508|364298108|FG000|Overall Study|Adverse Event|3|||
105626549|NCT02367040|364298112|FG000|Overall Study|Lost to Follow-up|1|||
105626550|NCT02367040|364298113|FG001|Overall Study|Lost to Follow-up|1|||
105626551|NCT02367040|364298112|FG000|Overall Study|Lack of Efficacy|1|||
105626552|NCT02367040|364298113|FG001|Overall Study|Lack of Efficacy|0|||
105626553|NCT02367040|364298112|FG000|Overall Study|Additional primary malignancy|0|||
105626554|NCT02367040|364298113|FG001|Overall Study|Additional primary malignancy|1|||
105626555|NCT02367040|364298112|FG000|Overall Study|AE not associated with clinical disease progression|114|||
105626556|NCT02367040|364298113|FG001|Overall Study|AE not associated with clinical disease progression|11|||
105626557|NCT02367040|364298112|FG000|Overall Study|AE associated with clinical disease progression|1|||
105626558|NCT02367040|364298113|FG001|Overall Study|AE associated with clinical disease progression|3|||
105626559|NCT02367040|364298112|FG000|Overall Study|Physician Decision|2|||
105626560|NCT02367040|364298113|FG001|Overall Study|Physician Decision|8|||
105626561|NCT02367040|364298112|FG000|Overall Study|Non-compliance with study drug|1|||
105626562|NCT02367040|364298113|FG001|Overall Study|Non-compliance with study drug|0|||
105626563|NCT02367040|364298112|FG000|Overall Study|Failure to meet continuation criteria|1|||
105626564|NCT02367040|364298113|FG001|Overall Study|Failure to meet continuation criteria|0|||
105626565|NCT02367040|364298112|FG000|Overall Study|Switching to other therapy|2|||
105626566|NCT02367040|364298113|FG001|Overall Study|Switching to other therapy|0|||
105626567|NCT02367040|364298112|FG000|Overall Study|Withdrawal by Subject|46|||
105626568|NCT02367040|364298113|FG001|Overall Study|Withdrawal by Subject|16|||
105626569|NCT02367040|364298112|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
105626570|NCT02367040|364298113|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
105626571|NCT02367040|364298112|FG000|Overall Study|Patient decision|39|||
105626572|NCT02367040|364298113|FG001|Overall Study|Patient decision|14|||
105626573|NCT02367040|364298112|FG000|Overall Study|Required procedure failed|1|||
105626574|NCT02367040|364298113|FG001|Overall Study|Required procedure failed|0|||
105626575|NCT02367040|364298112|FG000|Overall Study|Randomized by mistake with study treatment|1|||
105626576|NCT02367040|364298113|FG001|Overall Study|Randomized by mistake with study treatment|0|||
105626577|NCT02367040|364298112|FG000|Overall Study|Protocol Violation|1|||
105626578|NCT02367040|364298113|FG001|Overall Study|Protocol Violation|0|||
105626579|NCT02367040|364298112|FG000|Overall Study|Progressive disease - radiological progression|51|||
105626580|NCT02367040|364298113|FG001|Overall Study|Progressive disease - radiological progression|78|||
105626581|NCT02367040|364298112|FG000|Overall Study|Progressive disease - clinical progression|6|||
105626582|NCT02367040|364298113|FG001|Overall Study|Progressive disease - clinical progression|6|||
105626583|NCT02367040|364298112|FG000|Overall Study|Drug not administered|3|||
105626584|NCT02367040|364298113|FG001|Overall Study|Drug not administered|2|||
105626585|NCT02367040|364298112|FG000|Overall Study|Progressive disease|0|||
105626586|NCT02367040|364298113|FG001|Overall Study|Progressive disease|1|||
105626587|NCT02367040|364298112|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
105626588|NCT02367040|364298113|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
105626589|NCT02367040|364298112|FG000|Overall Study|Death|2|||
105626590|NCT02367040|364298113|FG001|Overall Study|Death|0|||
105626591|NCT01917084|364298116|FG000|Overall Study|Withdrawal by Subject|1|||
105626592|NCT03571386|364298118|FG000|Overall Study|scheduling conflict|4|||
105626593|NCT03571386|364298119|FG001|Overall Study|scheduling conflict|0|||
105626594|NCT03571386|364298118|FG000|Overall Study|Withdrawal by Subject|15|||
105626595|NCT03571386|364298119|FG001|Overall Study|Withdrawal by Subject|5|||
105626596|NCT05856435|364298126|FG000|Overall Study|Lost to Follow-up|6|||
105626597|NCT04605159|364298127|FG000|Overall Study|Adverse Event|6|||
105626598|NCT04605159|364298128|FG001|Overall Study|Adverse Event|3|||
105626599|NCT04605159|364298129|FG002|Overall Study|Adverse Event|21|||
105626600|NCT04605159|364298130|FG003|Overall Study|Adverse Event|4|||
105626601|NCT04605159|364298127|FG000|Overall Study|Lost to Follow-up|74|||
105626602|NCT04605159|364298128|FG001|Overall Study|Lost to Follow-up|45|||
105626603|NCT04605159|364298129|FG002|Overall Study|Lost to Follow-up|119|||
105626604|NCT04605159|364298130|FG003|Overall Study|Lost to Follow-up|80|||
105626605|NCT04605159|364298127|FG000|Overall Study|Protocol Violation|4|||
105626606|NCT04605159|364298128|FG001|Overall Study|Protocol Violation|5|||
105626607|NCT04605159|364298129|FG002|Overall Study|Protocol Violation|2|||
105626608|NCT04605159|364298130|FG003|Overall Study|Protocol Violation|0|||
105626609|NCT04605159|364298127|FG000|Overall Study|Withdrawal by Subject|66|||
105626610|NCT04605159|364298128|FG001|Overall Study|Withdrawal by Subject|37|||
105626611|NCT04605159|364298129|FG002|Overall Study|Withdrawal by Subject|68|||
105626612|NCT04605159|364298130|FG003|Overall Study|Withdrawal by Subject|50|||
105626613|NCT04605159|364298127|FG000|Overall Study|Migrated / moved from the study area|32|||
105626614|NCT04605159|364298128|FG001|Overall Study|Migrated / moved from the study area|22|||
105626615|NCT04605159|364298129|FG002|Overall Study|Migrated / moved from the study area|41|||
105626616|NCT04605159|364298130|FG003|Overall Study|Migrated / moved from the study area|21|||
105626617|NCT04605159|364298127|FG000|Overall Study|Other|1|||
105626618|NCT04605159|364298128|FG001|Overall Study|Other|2|||
105626619|NCT04605159|364298129|FG002|Overall Study|Other|7|||
105626620|NCT04605159|364298130|FG003|Overall Study|Other|3|||
105626621|NCT02323880|364298131|FG000|Overall Study|Adverse Event|2|||
105626622|NCT02323880|364298132|FG001|Overall Study|Adverse Event|0|||
105626623|NCT02323880|364298133|FG002|Overall Study|Adverse Event|1|||
105626624|NCT02323880|364298134|FG003|Overall Study|Adverse Event|1|||
105626625|NCT02323880|364298135|FG004|Overall Study|Adverse Event|1|||
105626626|NCT02323880|364298136|FG005|Overall Study|Adverse Event|0|||
105626627|NCT02323880|364298137|FG006|Overall Study|Adverse Event|1|||
105626628|NCT02323880|364298138|FG007|Overall Study|Adverse Event|0|||
105626629|NCT02323880|364298131|FG000|Overall Study|Death|0|||
105626630|NCT02323880|364298132|FG001|Overall Study|Death|0|||
105626631|NCT02323880|364298133|FG002|Overall Study|Death|0|||
105626632|NCT02323880|364298134|FG003|Overall Study|Death|0|||
105626633|NCT02323880|364298135|FG004|Overall Study|Death|0|||
105626634|NCT02323880|364298136|FG005|Overall Study|Death|1|||
105626635|NCT02323880|364298137|FG006|Overall Study|Death|0|||
105626636|NCT02323880|364298138|FG007|Overall Study|Death|0|||
105626637|NCT02323880|364298131|FG000|Overall Study|Lack of Efficacy|4|||
105626638|NCT02323880|364298132|FG001|Overall Study|Lack of Efficacy|11|||
105626639|NCT02323880|364298133|FG002|Overall Study|Lack of Efficacy|5|||
105626640|NCT02323880|364298134|FG003|Overall Study|Lack of Efficacy|5|||
105626641|NCT02323880|364298135|FG004|Overall Study|Lack of Efficacy|4|||
105626642|NCT02323880|364298136|FG005|Overall Study|Lack of Efficacy|8|||
105626643|NCT02323880|364298137|FG006|Overall Study|Lack of Efficacy|4|||
105626644|NCT02323880|364298138|FG007|Overall Study|Lack of Efficacy|6|||
105626645|NCT02323880|364298131|FG000|Overall Study|Physician Decision|0|||
105626646|NCT02323880|364298132|FG001|Overall Study|Physician Decision|0|||
105626647|NCT02323880|364298133|FG002|Overall Study|Physician Decision|0|||
105626648|NCT02323880|364298134|FG003|Overall Study|Physician Decision|0|||
105626649|NCT02323880|364298135|FG004|Overall Study|Physician Decision|1|||
105626650|NCT02323880|364298136|FG005|Overall Study|Physician Decision|1|||
105626651|NCT02323880|364298137|FG006|Overall Study|Physician Decision|1|||
105626652|NCT02323880|364298138|FG007|Overall Study|Physician Decision|0|||
105626653|NCT02323880|364298131|FG000|Overall Study|Withdrawal by Subject|0|||
105626654|NCT02323880|364298132|FG001|Overall Study|Withdrawal by Subject|2|||
105626655|NCT02323880|364298133|FG002|Overall Study|Withdrawal by Subject|0|||
105626656|NCT02323880|364298134|FG003|Overall Study|Withdrawal by Subject|0|||
105626657|NCT02323880|364298135|FG004|Overall Study|Withdrawal by Subject|0|||
105626658|NCT02323880|364298136|FG005|Overall Study|Withdrawal by Subject|0|||
105626659|NCT02323880|364298137|FG006|Overall Study|Withdrawal by Subject|0|||
105626660|NCT02323880|364298138|FG007|Overall Study|Withdrawal by Subject|0|||
105626661|NCT02278211|364298139|FG000|Overall Study|Unable to analyse PET scan|2|||
105626662|NCT04167553|364298140|FG000|Overall Study|Withdrawal by Subject|1|||
105626663|NCT04167553|364298141|FG001|Overall Study|Withdrawal by Subject|0|||
105626703|NCT04186819|364298168|FG000|Overall Study|Subject declined for financial reasons|1|||
105626704|NCT04186819|364298168|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
105626705|NCT04186819|364298168|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
105626706|NCT04186819|364298168|FG000|Overall Study|The subject opted for other treatment option|2|||
105626707|NCT04186819|364298168|FG000|Overall Study|The subject opted for other treatment options|1|||
105626708|NCT04186819|364298168|FG000|Overall Study|Withdrawal by Subject|3|||
105626709|NCT04186819|364298168|FG000|Overall Study|Reason not specified|1|||
105626710|NCT03988621|364298169|FG000|Overall Study|Lost to Follow-up|16|||
105626711|NCT03988621|364298170|FG001|Overall Study|Lost to Follow-up|17|||
105626712|NCT03988621|364298169|FG000|Overall Study|Withdrawal by Subject|14|||
105626713|NCT03988621|364298170|FG001|Overall Study|Withdrawal by Subject|7|||
105626714|NCT03988621|364298169|FG000|Overall Study|Patient Lost to Follow Up|15|||
105626715|NCT03988621|364298170|FG001|Overall Study|Patient Lost to Follow Up|15|||
105626716|NCT03988621|364298169|FG000|Overall Study|Patient death|1|||
105626717|NCT03988621|364298170|FG001|Overall Study|Patient death|5|||
105626718|NCT05013385|364298171|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
105626719|NCT03914469|364298176|FG000|Overall Study|Lost to Follow-up|1|||
105626720|NCT03914469|364298177|FG001|Overall Study|Lost to Follow-up|4|||
105626721|NCT03252288|364298180|FG000|Overall Study|Death|1|||
105626722|NCT03252288|364298181|FG001|Overall Study|Death|0|||
105626723|NCT03252288|364298182|FG002|Overall Study|Death|0|||
105626724|NCT03252288|364298180|FG000|Overall Study|Death|11|||
105626725|NCT03252288|364298181|FG001|Overall Study|Death|0|||
105626726|NCT03252288|364298182|FG002|Overall Study|Death|0|||
105626727|NCT03252288|364298180|FG000|Overall Study|Withdrawal by Subject|2|||
105626728|NCT03252288|364298181|FG001|Overall Study|Withdrawal by Subject|0|||
105626729|NCT03252288|364298182|FG002|Overall Study|Withdrawal by Subject|0|||
105626730|NCT03252288|364298180|FG000|Overall Study|Lost to Follow-up|79|||
105626731|NCT03252288|364298181|FG001|Overall Study|Lost to Follow-up|0|||
105626732|NCT03252288|364298182|FG002|Overall Study|Lost to Follow-up|0|||
105626733|NCT03252288|364298180|FG000|Overall Study|Loss of baseline data on tablets|6|||
105626734|NCT03252288|364298181|FG001|Overall Study|Loss of baseline data on tablets|0|||
105626735|NCT03252288|364298182|FG002|Overall Study|Loss of baseline data on tablets|0|||
105626736|NCT00677365|364298183|FG000|Overall Study|Adverse Event|2|||
105626737|NCT00677365|364298184|FG001|Overall Study|Adverse Event|1|||
105626738|NCT00677365|364298185|FG002|Overall Study|Adverse Event|1|||
105626739|NCT00677365|364298186|FG003|Overall Study|Adverse Event|2|||
105626740|NCT00677365|364298183|FG000|Overall Study|Withdrawal by Subject|0|||
105626741|NCT00677365|364298184|FG001|Overall Study|Withdrawal by Subject|0|||
105626742|NCT00677365|364298185|FG002|Overall Study|Withdrawal by Subject|1|||
105626743|NCT00677365|364298186|FG003|Overall Study|Withdrawal by Subject|0|||
105626744|NCT00677365|364298183|FG000|Overall Study|Other reason|0|||
105626745|NCT00677365|364298184|FG001|Overall Study|Other reason|0|||
105626746|NCT00677365|364298185|FG002|Overall Study|Other reason|0|||
105626747|NCT00677365|364298186|FG003|Overall Study|Other reason|1|||
105626748|NCT05900154|364298187|FG000|Follow-Up Period|Lost to Follow-up|1|||
105626749|NCT05900154|364298188|FG001|Follow-Up Period|Lost to Follow-up|2|||
105626750|NCT05900154|364298189|FG002|Follow-Up Period|Lost to Follow-up|1|||
105626751|NCT05900154|364298190|FG003|Follow-Up Period|Lost to Follow-up|0|||
105626752|NCT05900154|364298191|FG004|Follow-Up Period|Lost to Follow-up|1|||
105626753|NCT05900154|364298192|FG005|Follow-Up Period|Lost to Follow-up|1|||
105626754|NCT02874742|364298193|FG000|Overall Study|Death|0|||
105626755|NCT02874742|364298194|FG001|Overall Study|Death|1|||
105626756|NCT02874742|364298195|FG002|Overall Study|Death|0|||
105626757|NCT02874742|364298193|FG000|Overall Study|Lost to Follow-up|5|||
105626758|NCT02874742|364298194|FG001|Overall Study|Lost to Follow-up|4|||
105626759|NCT02874742|364298195|FG002|Overall Study|Lost to Follow-up|1|||
105626760|NCT02874742|364298193|FG000|Overall Study|Withdrawal by Subject|17|||
105626761|NCT02874742|364298194|FG001|Overall Study|Withdrawal by Subject|8|||
105626762|NCT02874742|364298195|FG002|Overall Study|Withdrawal by Subject|0|||
105626763|NCT02874742|364298193|FG000|Overall Study|Other|4|||
105626764|NCT02874742|364298194|FG001|Overall Study|Other|1|||
105626765|NCT02874742|364298195|FG002|Overall Study|Other|0|||
105626766|NCT02874742|364298193|FG000|Overall Study|Progressive Disease|1|||
105626767|NCT02874742|364298194|FG001|Overall Study|Progressive Disease|0|||
105626768|NCT02874742|364298195|FG002|Overall Study|Progressive Disease|0|||
105626769|NCT02874742|364298193|FG000|Overall Study|Screen Failure|0|||
105626770|NCT02874742|364298194|FG001|Overall Study|Screen Failure|2|||
105626771|NCT02874742|364298195|FG002|Overall Study|Screen Failure|0|||
105626772|NCT04623775|364298196|FG000|Randomization|No Longer Meets Study Criteria|2|||
105626773|NCT04623775|364298197|FG001|Randomization|No Longer Meets Study Criteria|1|||
105626774|NCT04623775|364298198|FG002|Randomization|No Longer Meets Study Criteria|0|||
105626775|NCT04623775|364298199|FG003|Randomization|No Longer Meets Study Criteria|0|||
105626776|NCT04623775|364298196|FG000|Randomization|Withdrew Consent|0|||
105626777|NCT04623775|364298197|FG001|Randomization|Withdrew Consent|0|||
105626778|NCT04623775|364298198|FG002|Randomization|Withdrew Consent|0|||
105626779|NCT04623775|364298199|FG003|Randomization|Withdrew Consent|1|||
105626780|NCT04623775|364298196|FG000|Randomization|Other Reasons|0|||
105626781|NCT04623775|364298197|FG001|Randomization|Other Reasons|0|||
105626782|NCT04623775|364298198|FG002|Randomization|Other Reasons|0|||
105626783|NCT04623775|364298199|FG003|Randomization|Other Reasons|1|||
105626784|NCT04623775|364298196|FG000|Treatment Period|participant withdrew consent|4|||
105626785|NCT04623775|364298197|FG001|Treatment Period|participant withdrew consent|0|||
105626786|NCT04623775|364298198|FG002|Treatment Period|participant withdrew consent|1|||
105626787|NCT04623775|364298199|FG003|Treatment Period|participant withdrew consent|2|||
105626788|NCT04623775|364298196|FG000|Treatment Period|Death|3|||
105626789|NCT04623775|364298197|FG001|Treatment Period|Death|1|||
105626790|NCT04623775|364298198|FG002|Treatment Period|Death|4|||
105626791|NCT04623775|364298199|FG003|Treatment Period|Death|2|||
105626792|NCT04623775|364298196|FG000|Treatment Period|Lost to Follow-up|0|||
105626793|NCT04623775|364298197|FG001|Treatment Period|Lost to Follow-up|2|||
105626794|NCT04623775|364298198|FG002|Treatment Period|Lost to Follow-up|0|||
105626795|NCT04623775|364298199|FG003|Treatment Period|Lost to Follow-up|0|||
105626796|NCT04623775|364298196|FG000|Treatment Period|poor/non compliance|0|||
105626797|NCT04623775|364298197|FG001|Treatment Period|poor/non compliance|0|||
105626798|NCT04623775|364298198|FG002|Treatment Period|poor/non compliance|1|||
105626799|NCT04623775|364298199|FG003|Treatment Period|poor/non compliance|0|||
105626800|NCT04623775|364298196|FG000|Treatment Period|participant no longer meets study criteria|0|||
105626801|NCT04623775|364298197|FG001|Treatment Period|participant no longer meets study criteria|1|||
105626802|NCT04623775|364298198|FG002|Treatment Period|participant no longer meets study criteria|0|||
105626803|NCT04623775|364298199|FG003|Treatment Period|participant no longer meets study criteria|0|||
105626804|NCT04623775|364298196|FG000|Treatment Period|administrative reasons by sponsor|3|||
105626805|NCT04623775|364298197|FG001|Treatment Period|administrative reasons by sponsor|2|||
105626806|NCT04623775|364298198|FG002|Treatment Period|administrative reasons by sponsor|0|||
105626807|NCT04623775|364298199|FG003|Treatment Period|administrative reasons by sponsor|0|||
105626808|NCT04623775|364298196|FG000|Treatment Period|other reasons|2|||
105626809|NCT04623775|364298197|FG001|Treatment Period|other reasons|0|||
105626810|NCT04623775|364298198|FG002|Treatment Period|other reasons|1|||
105626811|NCT04623775|364298199|FG003|Treatment Period|other reasons|1|||
105626812|NCT04623775|364298196|FG000|Treatment Period|disease progression|40|||
105626813|NCT04623775|364298197|FG001|Treatment Period|disease progression|35|||
105626814|NCT04623775|364298198|FG002|Treatment Period|disease progression|63|||
105626815|NCT04623775|364298199|FG003|Treatment Period|disease progression|63|||
105626816|NCT04623775|364298196|FG000|Treatment Period|study drug toxicity|12|||
105626817|NCT04623775|364298197|FG001|Treatment Period|study drug toxicity|15|||
105626818|NCT04623775|364298198|FG002|Treatment Period|study drug toxicity|13|||
105626819|NCT04623775|364298199|FG003|Treatment Period|study drug toxicity|12|||
105626820|NCT04623775|364298196|FG000|Treatment Period|AE unrelated to study drug|4|||
105626821|NCT04623775|364298197|FG001|Treatment Period|AE unrelated to study drug|9|||
105626822|NCT04623775|364298198|FG002|Treatment Period|AE unrelated to study drug|12|||
105626823|NCT04623775|364298199|FG003|Treatment Period|AE unrelated to study drug|9|||
105626824|NCT04623775|364298196|FG000|Treatment Period|participant request to discontinue treatment|0|||
105626825|NCT04623775|364298197|FG001|Treatment Period|participant request to discontinue treatment|2|||
105626826|NCT04623775|364298198|FG002|Treatment Period|participant request to discontinue treatment|2|||
105626827|NCT04623775|364298199|FG003|Treatment Period|participant request to discontinue treatment|0|||
105626828|NCT04583280|364298202|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
105626829|NCT04583280|364298203|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
105626830|NCT03498521|364298204|FG000|Overall Study|Death|191|||
105626831|NCT03498521|364298205|FG001|Overall Study|Death|64|||
105626832|NCT03498521|364298206|FG002|Overall Study|Death|72|||
105626833|NCT03498521|364298204|FG000|Overall Study|Exclusion criteria|1|||
105626834|NCT03498521|364298205|FG001|Overall Study|Exclusion criteria|0|||
105626835|NCT03498521|364298206|FG002|Overall Study|Exclusion criteria|0|||
105626836|NCT03498521|364298204|FG000|Overall Study|Lost to Follow-up|3|||
105626837|NCT03498521|364298205|FG001|Overall Study|Lost to Follow-up|3|||
105626838|NCT03498521|364298206|FG002|Overall Study|Lost to Follow-up|3|||
105626839|NCT03498521|364298204|FG000|Overall Study|No profile due to technical failure|1|||
105626840|NCT03498521|364298205|FG001|Overall Study|No profile due to technical failure|0|||
105626841|NCT03498521|364298206|FG002|Overall Study|No profile due to technical failure|0|||
105626842|NCT03498521|364298204|FG000|Overall Study|Physician Decision|0|||
105626843|NCT03498521|364298205|FG001|Overall Study|Physician Decision|1|||
105626844|NCT03498521|364298206|FG002|Overall Study|Physician Decision|0|||
105626845|NCT03498521|364298204|FG000|Overall Study|Withdrawal by Subject|9|||
105626846|NCT03498521|364298205|FG001|Overall Study|Withdrawal by Subject|6|||
105626847|NCT03498521|364298206|FG002|Overall Study|Withdrawal by Subject|2|||
105626848|NCT03498521|364298204|FG000|Overall Study|Study ongoing|121|||
105626849|NCT03498521|364298205|FG001|Overall Study|Study ongoing|36|||
105626850|NCT03498521|364298206|FG002|Overall Study|Study ongoing|15|||
105626851|NCT02326974|364298212|FG000|Overall Study|Withdrawal by Subject|2|||
105626852|NCT02326974|364298212|FG000|Overall Study|failed heterogenity evaluation|5|||
105626853|NCT04173247|364298213|FG000|Overall Study|Withdrawal by Subject|0|||
105626854|NCT04173247|364298214|FG001|Overall Study|Withdrawal by Subject|2|||
105626855|NCT04173247|364298213|FG000|Overall Study|Death|1|||
105626856|NCT04173247|364298214|FG001|Overall Study|Death|0|||
105626857|NCT04173247|364298213|FG000|Overall Study|Physician Decision|1|||
105626858|NCT04173247|364298214|FG001|Overall Study|Physician Decision|0|||
105626859|NCT02938520|364298218|FG000|Overall Study|On-going at the time of analysis|258|||
105626860|NCT02938520|364298219|FG001|Overall Study|On-going at the time of analysis|261|||
105626861|NCT02938520|364298218|FG000|Overall Study|Physician Decision|2|||
105626862|NCT02938520|364298219|FG001|Overall Study|Physician Decision|5|||
105626863|NCT02938520|364298218|FG000|Overall Study|Lost to Follow-up|2|||
105626864|NCT02938520|364298219|FG001|Overall Study|Lost to Follow-up|2|||
105626865|NCT02938520|364298218|FG000|Overall Study|Withdrawal by Subject|7|||
105626866|NCT02938520|364298219|FG001|Overall Study|Withdrawal by Subject|7|||
105626867|NCT02938520|364298218|FG000|Overall Study|Protocol Violation|0|||
105626868|NCT02938520|364298219|FG001|Overall Study|Protocol Violation|1|||
105626869|NCT02938520|364298218|FG000|Overall Study|Lack of Efficacy|5|||
105626870|NCT02938520|364298219|FG001|Overall Study|Lack of Efficacy|3|||
105626871|NCT02938520|364298218|FG000|Overall Study|Adverse Event|9|||
105626872|NCT02938520|364298219|FG001|Overall Study|Adverse Event|4|||
105626873|NCT02518048|364298220|FG000|Overall Study|Withdrawal by Subject|1|||
105626874|NCT04679389|364298221|FG000|Overall Study|Adverse Event|1|||
105626875|NCT04679389|364298222|FG001|Overall Study|Adverse Event|0|||
105626876|NCT04679389|364298221|FG000|Overall Study|Protocol Violation|2|||
105626877|NCT04679389|364298222|FG001|Overall Study|Protocol Violation|0|||
105626878|NCT04679389|364298221|FG000|Overall Study|Physician Decision|3|||
105626879|NCT04679389|364298222|FG001|Overall Study|Physician Decision|5|||
105626880|NCT04679389|364298221|FG000|Overall Study|Withdrawal by Subject|5|||
105626881|NCT04679389|364298222|FG001|Overall Study|Withdrawal by Subject|7|||
105626882|NCT05123027|364298227|FG000|Overall Study|Lost to Follow-up|17|||
105626883|NCT05123027|364298228|FG001|Overall Study|Lost to Follow-up|22|||
105626884|NCT05123027|364298227|FG000|Overall Study|Incarceration|3|||
105626885|NCT05123027|364298228|FG001|Overall Study|Incarceration|4|||
105626886|NCT05123027|364298227|FG000|Overall Study|Death|2|||
105626887|NCT05123027|364298228|FG001|Overall Study|Death|2|||
105626888|NCT05123027|364298227|FG000|Overall Study|Other|2|||
105626889|NCT05123027|364298228|FG001|Overall Study|Other|0|||
105626890|NCT01447719|364299547|FG000|Overall Study|Image acquisition failure|2|||
105626891|NCT01447719|364299547|FG000|Overall Study|Invalid image or not imaged|3|||
105626892|NCT01447719|364299547|FG000|Overall Study|Subject still living at end of study|79|||
105626893|NCT01447719|364299547|FG000|Overall Study|Withdrawal by Subject|2|||
105626894|NCT01447719|364299547|FG000|Overall Study|Family withdrew autopsy consent|7|||
105626895|NCT04084574|364299551|FG000|Overall Study|Lost to Follow-up|1|||
105626896|NCT04084574|364299552|FG001|Overall Study|Lost to Follow-up|0|||
105626897|NCT04084574|364299551|FG000|Overall Study|Physician Decision|1|||
105626898|NCT04084574|364299552|FG001|Overall Study|Physician Decision|0|||
105626899|NCT04084574|364299551|FG000|Overall Study|Relocated out of state|1|||
105626900|NCT04084574|364299552|FG001|Overall Study|Relocated out of state|0|||
105626901|NCT06655818|364299553|FG000|Overall Study|Withdrawal by Subject|1|||
105626902|NCT02944968|364299557|FG000|Overall Study|Subject excluded before study procedure|1|||
105626903|NCT02944968|364299557|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
105626904|NCT02905331|364299558|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
105626905|NCT02905331|364299559|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
105626906|NCT02905331|364299560|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
105626907|NCT02905331|364299558|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
105626908|NCT02905331|364299559|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
105626909|NCT02905331|364299560|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
105626910|NCT02905331|364299558|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
105626911|NCT02905331|364299559|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
105626912|NCT02905331|364299560|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
105626913|NCT02905331|364299558|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
105626914|NCT02905331|364299559|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
105626915|NCT02905331|364299560|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
105626916|NCT02905331|364299558|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
105626917|NCT02905331|364299559|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
105626918|NCT02905331|364299560|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
105626919|NCT03681262|364299561|FG000|Overall Study|Continuing on study|3|||
105626920|NCT03681262|364299562|FG001|Overall Study|Continuing on study|3|||
105626921|NCT03681262|364299561|FG000|Overall Study|Lost to Follow-up|1|||
105626922|NCT03681262|364299562|FG001|Overall Study|Lost to Follow-up|0|||
105626923|NCT02095691|364299563|FG000|Overall Study|Physician Decision|1|||
105626924|NCT02890329|364299571|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
105626925|NCT02890329|364299572|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
105626926|NCT02890329|364299573|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
105626927|NCT02890329|364299574|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
105626928|NCT02890329|364299575|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
105626929|NCT02890329|364299576|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
105626930|NCT02890329|364299571|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
105626931|NCT02890329|364299572|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
105626932|NCT02890329|364299573|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
105626933|NCT02890329|364299574|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
105626934|NCT02890329|364299575|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
105626935|NCT02890329|364299576|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
105626936|NCT02890329|364299571|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
105626937|NCT02890329|364299572|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
105626938|NCT02890329|364299573|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
105626939|NCT02890329|364299574|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
105626940|NCT02890329|364299575|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
105626941|NCT02890329|364299576|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
105626942|NCT02890329|364299571|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
105626943|NCT02890329|364299572|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
105626944|NCT02890329|364299573|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
105626945|NCT02890329|364299574|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
105626946|NCT02890329|364299575|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
105626947|NCT02890329|364299576|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
105626948|NCT04102111|364299578|FG000|Overall Study|Withdrawal by Subject|2|||
105626949|NCT04102111|364299579|FG001|Overall Study|Withdrawal by Subject|3|||
105626950|NCT04102111|364299578|FG000|Overall Study|Adverse Event|1|||
105626951|NCT04102111|364299579|FG001|Overall Study|Adverse Event|1|||
105626952|NCT04102111|364299578|FG000|Overall Study|Study terminated by sponsor|1|||
105626953|NCT04102111|364299579|FG001|Overall Study|Study terminated by sponsor|3|||
105626954|NCT00887198|364299580|FG000|Randomized Period|Ongoing|42|||
105626955|NCT00887198|364299581|FG001|Randomized Period|Ongoing|0|||
105626956|NCT00887198|364299582|FG002|Randomized Period|Ongoing|0|||
105626957|NCT00887198|364299580|FG000|Randomized Period|Adverse Event|50|||
105626958|NCT00887198|364299581|FG001|Randomized Period|Adverse Event|33|||
105626959|NCT00887198|364299582|FG002|Randomized Period|Adverse Event|0|||
105626960|NCT00887198|364299580|FG000|Randomized Period|Lost to Follow-up|1|||
105626961|NCT00887198|364299581|FG001|Randomized Period|Lost to Follow-up|0|||
105626962|NCT00887198|364299582|FG002|Randomized Period|Lost to Follow-up|0|||
105626963|NCT00887198|364299580|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
105626964|NCT00887198|364299581|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
105626965|NCT00887198|364299582|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
105626966|NCT00887198|364299580|FG000|Randomized Period|Withdrawal by Subject|41|||
105626967|NCT00887198|364299581|FG001|Randomized Period|Withdrawal by Subject|56|||
105626968|NCT00887198|364299582|FG002|Randomized Period|Withdrawal by Subject|0|||
105626969|NCT00887198|364299580|FG000|Randomized Period|Progressive disease|366|||
105626970|NCT00887198|364299581|FG001|Randomized Period|Progressive disease|370|||
105626971|NCT00887198|364299582|FG002|Randomized Period|Progressive disease|0|||
105626972|NCT00887198|364299580|FG000|Randomized Period|Other|42|||
105626973|NCT00887198|364299581|FG001|Randomized Period|Other|30|||
105626974|NCT00887198|364299582|FG002|Randomized Period|Other|0|||
105626975|NCT00887198|364299580|FG000|Randomized Period|Randomized, Not treated|4|||
105626976|NCT00887198|364299581|FG001|Randomized Period|Randomized, Not treated|2|||
105626977|NCT00887198|364299582|FG002|Randomized Period|Randomized, Not treated|0|||
105626978|NCT00887198|364299580|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
105626979|NCT00887198|364299581|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
105626980|NCT00887198|364299582|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
105626981|NCT00887198|364299580|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
105626982|NCT00887198|364299581|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
105626983|NCT00887198|364299582|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
105626984|NCT00887198|364299580|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
105626985|NCT00887198|364299581|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
105440420|NCT02834247|363616792|FG000|Dose Expansion Phase|Death|0|||
105626986|NCT00887198|364299582|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
105626987|NCT00887198|364299580|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
105626988|NCT00887198|364299581|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
105626989|NCT00887198|364299582|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
105626990|NCT00887198|364299580|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
105626991|NCT00887198|364299581|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
105626992|NCT00887198|364299582|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
105626993|NCT00887198|364299580|FG000|Cross Over (Placebo to AA)|Other|0|||
105626994|NCT00887198|364299581|FG001|Cross Over (Placebo to AA)|Other|0|||
105626995|NCT00887198|364299582|FG002|Cross Over (Placebo to AA)|Other|19|||
105626996|NCT02542631|364299583|FG000|Overall Study|Adverse Event|1|||
105626997|NCT02542631|364299584|FG001|Overall Study|Adverse Event|1|||
105626998|NCT02542631|364299583|FG000|Overall Study|Sponsor Termination|1|||
105626999|NCT02542631|364299584|FG001|Overall Study|Sponsor Termination|0|||
105627000|NCT02542631|364299583|FG000|Overall Study|Withdrawal by Subject|11|||
105627001|NCT02542631|364299584|FG001|Overall Study|Withdrawal by Subject|16|||
105627002|NCT02542631|364299583|FG000|Overall Study|Protocol Violation|1|||
105627003|NCT02542631|364299584|FG001|Overall Study|Protocol Violation|1|||
105627004|NCT02542631|364299583|FG000|Overall Study|Physician Decision|6|||
105627005|NCT02542631|364299584|FG001|Overall Study|Physician Decision|4|||
105627006|NCT02542631|364299583|FG000|Overall Study|Lost to Follow-up|6|||
105627007|NCT02542631|364299584|FG001|Overall Study|Lost to Follow-up|5|||
105627008|NCT02542631|364299583|FG000|Overall Study|Death|1|||
105627009|NCT02542631|364299584|FG001|Overall Study|Death|2|||
105627010|NCT02542631|364299583|FG000|Overall Study|Other|2|||
105627011|NCT02542631|364299584|FG001|Overall Study|Other|1|||
105627012|NCT02542631|364299583|FG000|Overall Study|Used Prohibited Medication|2|||
105627013|NCT02542631|364299584|FG001|Overall Study|Used Prohibited Medication|1|||
105627014|NCT03334695|364299585|FG000|Overall Study|Lost to Follow-up|3|||
105627015|NCT03334695|364299586|FG001|Overall Study|Lost to Follow-up|3|||
105627016|NCT03334695|364299585|FG000|Overall Study|Physician Decision|1|||
105627017|NCT03334695|364299586|FG001|Overall Study|Physician Decision|2|||
105627018|NCT03334695|364299585|FG000|Overall Study|Protocol Violation|0|||
105627019|NCT03334695|364299586|FG001|Overall Study|Protocol Violation|1|||
105627020|NCT02641730|364299587|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
105627021|NCT02641730|364299588|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
105627022|NCT02641730|364299589|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
105627023|NCT02641730|364299590|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
105627024|NCT02641730|364299591|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
105627025|NCT02641730|364299587|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
105627026|NCT02641730|364299588|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
105627027|NCT02641730|364299589|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
105627028|NCT02641730|364299590|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
105627029|NCT02641730|364299591|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
105627030|NCT02641730|364299587|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
105627031|NCT02641730|364299588|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
105627032|NCT02641730|364299589|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
105627033|NCT02641730|364299590|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
105627034|NCT02641730|364299591|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
105627035|NCT02641730|364299587|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
105627036|NCT02641730|364299588|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
105627037|NCT02641730|364299589|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
105627038|NCT02641730|364299590|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
105627039|NCT02641730|364299591|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
105627040|NCT02641730|364299587|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
105627041|NCT02641730|364299588|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
105627042|NCT02641730|364299589|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
105627043|NCT02641730|364299590|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
105627044|NCT02641730|364299591|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
105627045|NCT02641730|364299587|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
105627046|NCT02641730|364299588|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
105627047|NCT02641730|364299589|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
105627048|NCT02641730|364299590|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
105627049|NCT02641730|364299591|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
105627050|NCT05007080|364299592|FG000|Overall Study|Lost to Follow-up|0|||
105627051|NCT05007080|364299593|FG001|Overall Study|Lost to Follow-up|1|||
105627052|NCT05007080|364299594|FG002|Overall Study|Lost to Follow-up|0|||
105627053|NCT05007080|364299595|FG003|Overall Study|Lost to Follow-up|1|||
105627054|NCT05007080|364299596|FG004|Overall Study|Lost to Follow-up|1|||
105627055|NCT05007080|364299597|FG005|Overall Study|Lost to Follow-up|1|||
105627056|NCT05007080|364299592|FG000|Overall Study|Death|0|||
105627057|NCT05007080|364299593|FG001|Overall Study|Death|1|||
105627058|NCT05007080|364299594|FG002|Overall Study|Death|0|||
105627059|NCT05007080|364299595|FG003|Overall Study|Death|0|||
105627060|NCT05007080|364299596|FG004|Overall Study|Death|0|||
105627061|NCT05007080|364299597|FG005|Overall Study|Death|0|||
105627062|NCT05007080|364299592|FG000|Overall Study|Withdrawal by Subject|1|||
105627063|NCT05007080|364299593|FG001|Overall Study|Withdrawal by Subject|2|||
105627064|NCT05007080|364299594|FG002|Overall Study|Withdrawal by Subject|0|||
105627065|NCT05007080|364299595|FG003|Overall Study|Withdrawal by Subject|2|||
105627066|NCT05007080|364299596|FG004|Overall Study|Withdrawal by Subject|1|||
105627067|NCT05007080|364299597|FG005|Overall Study|Withdrawal by Subject|1|||
105627068|NCT05007080|364299592|FG000|Overall Study|Other|1|||
105627069|NCT05007080|364299593|FG001|Overall Study|Other|0|||
105627070|NCT05007080|364299594|FG002|Overall Study|Other|1|||
105627071|NCT05007080|364299595|FG003|Overall Study|Other|1|||
105627072|NCT05007080|364299596|FG004|Overall Study|Other|0|||
105627073|NCT05007080|364299597|FG005|Overall Study|Other|2|||
105627074|NCT05007080|364299592|FG000|Overall Study|Randomized not vaccinated|0|||
105627075|NCT05007080|364299593|FG001|Overall Study|Randomized not vaccinated|0|||
105627076|NCT05007080|364299594|FG002|Overall Study|Randomized not vaccinated|0|||
105627077|NCT05007080|364299595|FG003|Overall Study|Randomized not vaccinated|0|||
105627078|NCT05007080|364299596|FG004|Overall Study|Randomized not vaccinated|0|||
105627079|NCT05007080|364299597|FG005|Overall Study|Randomized not vaccinated|1|||
105627080|NCT00319046|364299598|FG000|Overall Study|withdrawal of subject's consent|7|||
105627081|NCT00319046|364299598|FG000|Overall Study|administrative reason|1|||
105627082|NCT05147584|364299599|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
105627083|NCT05460871|364299600|FG000|Overall Study|Withdrawal by Subject|1|||
105627084|NCT05460871|364299601|FG001|Overall Study|Withdrawal by Subject|2|||
105627085|NCT02938923|364299602|FG000|Overall Study|Death|1|||
105627086|NCT02938923|364299603|FG001|Overall Study|Death|0|||
105627087|NCT02938923|364299604|FG002|Overall Study|Death|0|||
105627088|NCT02938923|364299602|FG000|Overall Study|Physician Decision|0|||
105627089|NCT02938923|364299603|FG001|Overall Study|Physician Decision|2|||
105627090|NCT02938923|364299604|FG002|Overall Study|Physician Decision|0|||
105627091|NCT02938923|364299602|FG000|Overall Study|Withdrawal by Subject|0|||
105627092|NCT02938923|364299603|FG001|Overall Study|Withdrawal by Subject|1|||
105627093|NCT02938923|364299604|FG002|Overall Study|Withdrawal by Subject|1|||
105627094|NCT00721149|364299607|FG000|Overall Study|Physician Decision|1|||
105627095|NCT04614948|364299617|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
105627096|NCT04614948|364299618|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
105627097|NCT04614948|364299619|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
105627098|NCT04614948|364299617|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
105627099|NCT04614948|364299618|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
105627100|NCT04614948|364299619|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
105627101|NCT04614948|364299617|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
105627102|NCT04614948|364299618|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
105627103|NCT04614948|364299619|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
105627104|NCT04614948|364299617|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
105627105|NCT04614948|364299618|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
105627106|NCT04614948|364299619|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
105627107|NCT04614948|364299617|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
105627108|NCT04614948|364299618|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
105627109|NCT04614948|364299619|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
105627110|NCT04614948|364299617|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
105627111|NCT04614948|364299618|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
105627112|NCT04614948|364299619|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
105627113|NCT04614948|364299617|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
105627114|NCT04614948|364299618|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
105627115|NCT04614948|364299619|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
105627116|NCT04614948|364299617|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
105627117|NCT04614948|364299618|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
105627118|NCT04614948|364299619|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
105627119|NCT04614948|364299617|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
105627120|NCT04614948|364299618|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
105627121|NCT04614948|364299619|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
105627122|NCT04614948|364299617|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
105627123|NCT04614948|364299618|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
105627124|NCT04614948|364299619|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
105627125|NCT04614948|364299617|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
105627126|NCT04614948|364299618|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
105627127|NCT04614948|364299619|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
105627128|NCT04614948|364299617|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
105627129|NCT04614948|364299618|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
105627130|NCT04614948|364299619|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
105627131|NCT04614948|364299617|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
105627132|NCT04614948|364299618|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
105627133|NCT04614948|364299619|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
105627134|NCT04614948|364299617|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
105627135|NCT04614948|364299618|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
105627136|NCT04614948|364299619|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
105627137|NCT04614948|364299617|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
105627138|NCT04614948|364299618|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
105627139|NCT04614948|364299619|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
105627140|NCT04614948|364299617|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
105627141|NCT04614948|364299618|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
105627142|NCT04614948|364299619|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
105627143|NCT04614948|364299617|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
105627144|NCT04614948|364299618|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
105627145|NCT04614948|364299619|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
105627146|NCT04614948|364299617|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
105627147|NCT04614948|364299618|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
105627148|NCT04614948|364299619|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
105627149|NCT04614948|364299617|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
105627150|NCT04614948|364299618|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
105627151|NCT04614948|364299619|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
105627152|NCT04614948|364299617|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
105627153|NCT04614948|364299618|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
105627154|NCT04614948|364299619|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
105627155|NCT04614948|364299617|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
105627156|NCT04614948|364299618|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
105627157|NCT04614948|364299619|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
105627158|NCT04614948|364299617|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
105627159|NCT04614948|364299618|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
105627160|NCT04614948|364299619|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
105627161|NCT04614948|364299617|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
105627162|NCT04614948|364299618|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
105627163|NCT04614948|364299619|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
105627164|NCT00631475|364299622|FG000|Overall Study|Death|18|||
105627165|NCT00631475|364299622|FG000|Overall Study|Adverse Event|14|||
105627166|NCT00631475|364299622|FG000|Overall Study|Withdrew consent|5|||
105627167|NCT00631475|364299622|FG000|Overall Study|Preparation for lung transplant|8|||
105627168|NCT04055012|364299623|FG000|Overall Study|Withdrawal by Subject|1|||
105627169|NCT04055012|364299624|FG001|Overall Study|Withdrawal by Subject|3|||
105627170|NCT04055012|364299625|FG002|Overall Study|Withdrawal by Subject|1|||
105627171|NCT04055012|364299626|FG003|Overall Study|Withdrawal by Subject|0|||
105627172|NCT04055012|364299623|FG000|Overall Study|Metformin Recall|1|||
105627173|NCT04055012|364299624|FG001|Overall Study|Metformin Recall|1|||
105627174|NCT04055012|364299625|FG002|Overall Study|Metformin Recall|1|||
105627175|NCT04055012|364299626|FG003|Overall Study|Metformin Recall|0|||
105627176|NCT03218826|364299627|FG000|Overall Study|Non-compliance with protocol|1|||
105627177|NCT03218826|364299628|FG001|Overall Study|Non-compliance with protocol|0|||
105627178|NCT03218826|364299629|FG002|Overall Study|Non-compliance with protocol|2|||
105627179|NCT03218826|364299630|FG003|Overall Study|Non-compliance with protocol|1|||
105627180|NCT03218826|364299631|FG004|Overall Study|Non-compliance with protocol|1|||
105627181|NCT05158504|364299632|FG000|Overall Study|Lost to Follow-up|2|||
105627182|NCT05158504|364299633|FG001|Overall Study|Lost to Follow-up|3|||
105627183|NCT03606512|364299636|FG000|Overall Study|Lost to Follow-up|0|||
105627184|NCT03606512|364299637|FG001|Overall Study|Lost to Follow-up|1|||
105627185|NCT03606512|364299636|FG000|Overall Study|'moved from study area|0|||
105627186|NCT03606512|364299637|FG001|Overall Study|'moved from study area|1|||
105627187|NCT02846545|364299640|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
105627188|NCT02846545|364299641|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
105627189|NCT02846545|364299640|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
105627190|NCT02846545|364299641|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
105627191|NCT02846545|364299640|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
105627192|NCT02846545|364299641|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
105627193|NCT02846545|364299640|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
105627194|NCT02846545|364299641|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
105627195|NCT02846545|364299640|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
105627196|NCT02846545|364299641|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
105627197|NCT03691298|364299644|FG000|Overall Study|Lost to Follow-up|8|||
105627198|NCT03691298|364299644|FG000|Overall Study|Sponsor terminated study|2|||
105627199|NCT03663205|364299648|FG000|Overall Study|Death|144|||
105627200|NCT03663205|364299649|FG001|Overall Study|Death|69|||
105627201|NCT03663205|364299648|FG000|Overall Study|Sponsor decision|53|||
105627202|NCT03663205|364299649|FG001|Overall Study|Sponsor decision|19|||
105627203|NCT03663205|364299648|FG000|Overall Study|Withdrawal by Subject|8|||
105627204|NCT03663205|364299649|FG001|Overall Study|Withdrawal by Subject|11|||
105627205|NCT03663205|364299648|FG000|Overall Study|Lost to Follow-up|7|||
105627206|NCT03663205|364299649|FG001|Overall Study|Lost to Follow-up|9|||
105627207|NCT03663205|364299648|FG000|Overall Study|Transferred to long term extension study|11|||
105627208|NCT03663205|364299649|FG001|Overall Study|Transferred to long term extension study|3|||
105627209|NCT03652272|364299650|FG000|3 Month|Withdrawal by Subject|1|||
105627210|NCT03652272|364299651|FG001|3 Month|Withdrawal by Subject|1|||
105627211|NCT03652272|364299650|FG000|3 Month|Lost to Follow-up|16|||
105627212|NCT03652272|364299651|FG001|3 Month|Lost to Follow-up|14|||
105627213|NCT02577354|364299652|FG000|Overall Study|Lack of Efficacy|4|||
105627214|NCT02577354|364299653|FG001|Overall Study|Lack of Efficacy|4|||
105627215|NCT02577354|364299652|FG000|Overall Study|Lost to Follow-up|3|||
105627216|NCT02577354|364299653|FG001|Overall Study|Lost to Follow-up|1|||
105627217|NCT02577354|364299652|FG000|Overall Study|Missed Visit|4|||
105627218|NCT02577354|364299653|FG001|Overall Study|Missed Visit|3|||
105627219|NCT02577354|364299652|FG000|Overall Study|Adverse Event|4|||
105627220|NCT02577354|364299653|FG001|Overall Study|Adverse Event|5|||
105627221|NCT04214834|364300129|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
105627222|NCT04214834|364300130|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
105627223|NCT02163694|364300133|FG000|Overall Study|Adverse event- related to progression|4|||
105627224|NCT02163694|364300134|FG001|Overall Study|Adverse event- related to progression|10|||
105627225|NCT02163694|364300133|FG000|Overall Study|Adverse event- not related to progression|7|||
105627226|NCT02163694|364300134|FG001|Overall Study|Adverse event- not related to progression|22|||
105627227|NCT02163694|364300133|FG000|Overall Study|Withdrew consent|13|||
105627228|NCT02163694|364300134|FG001|Overall Study|Withdrew consent|28|||
105627229|NCT02163694|364300133|FG000|Overall Study|Lost to Follow-up|2|||
105627230|NCT02163694|364300134|FG001|Overall Study|Lost to Follow-up|2|||
105627231|NCT02163694|364300133|FG000|Overall Study|Sponsor discontinued study|3|||
105627232|NCT02163694|364300134|FG001|Overall Study|Sponsor discontinued study|29|||
105627233|NCT02163694|364300133|FG000|Overall Study|Progressive disease per protocol|125|||
105627234|NCT02163694|364300134|FG001|Overall Study|Progressive disease per protocol|224|||
105627235|NCT02163694|364300133|FG000|Overall Study|Other, not specified|17|||
105627236|NCT02163694|364300134|FG001|Overall Study|Other, not specified|22|||
105627237|NCT02163694|364300133|FG000|Overall Study|Randomized but Not Treated|1|||
105627238|NCT02163694|364300134|FG001|Overall Study|Randomized but Not Treated|0|||
105627239|NCT02163694|364300133|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
105627240|NCT02163694|364300134|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
105627241|NCT03884101|364300139|FG000|Overall Study|Participant Ongoing in Study|202|||
105627242|NCT03884101|364300140|FG001|Overall Study|Participant Ongoing in Study|186|||
105627243|NCT03884101|364300139|FG000|Overall Study|Death|212|||
105627244|NCT03884101|364300140|FG001|Overall Study|Death|224|||
105627245|NCT03884101|364300139|FG000|Overall Study|Lost to Follow-up|0|||
105627246|NCT03884101|364300140|FG001|Overall Study|Lost to Follow-up|1|||
105627247|NCT03884101|364300139|FG000|Overall Study|Withdrawal by Subject|6|||
105627248|NCT03884101|364300140|FG001|Overall Study|Withdrawal by Subject|11|||
105627249|NCT00412607|364300149|FG000|Overall Study|Withdrawal by Subject|9|||
105627250|NCT00412607|364300149|FG000|Overall Study|Lost to Follow-up|19|||
105627251|NCT00412607|364300149|FG000|Overall Study|Death|61|||
105627252|NCT00412607|364300149|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
105627253|NCT03245840|364300150|FG000|Overall Study|Adverse Event|6|||
105627254|NCT03245840|364300151|FG001|Overall Study|Adverse Event|0|||
105627255|NCT03245840|364300150|FG000|Overall Study|Death|2|||
105627256|NCT03245840|364300151|FG001|Overall Study|Death|0|||
105627257|NCT03245840|364300150|FG000|Overall Study|Withdrawal by Subject|31|||
105627258|NCT03245840|364300151|FG001|Overall Study|Withdrawal by Subject|1|||
105627259|NCT03245840|364300150|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
105627260|NCT03245840|364300151|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105627261|NCT03245840|364300150|FG000|Overall Study|Physician Decision|4|||
105627262|NCT03245840|364300151|FG001|Overall Study|Physician Decision|1|||
105627263|NCT03245840|364300150|FG000|Overall Study|Study Terminated by Sponsor|56|||
105627264|NCT03245840|364300151|FG001|Overall Study|Study Terminated by Sponsor|6|||
105627265|NCT03245840|364300150|FG000|Overall Study|Site Terminated by Sponsor|4|||
105627266|NCT03245840|364300151|FG001|Overall Study|Site Terminated by Sponsor|0|||
105627267|NCT03245840|364300150|FG000|Overall Study|Lost to Follow-up|12|||
105440421|NCT02834247|363616793|FG001|Dose Expansion Phase|Death|0|||
105627268|NCT03245840|364300151|FG001|Overall Study|Lost to Follow-up|2|||
105627269|NCT03245840|364300150|FG000|Overall Study|Pregnancy|2|||
105627270|NCT03245840|364300151|FG001|Overall Study|Pregnancy|0|||
105627271|NCT03245840|364300150|FG000|Overall Study|Non-Compliance with Study Drug|2|||
105627272|NCT03245840|364300151|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105627273|NCT03245840|364300150|FG000|Overall Study|Not treated|1|||
105627274|NCT03245840|364300151|FG001|Overall Study|Not treated|1|||
105627275|NCT05836012|364300159|FG000|Overall Study|Lost to Follow-up|1|||
105627276|NCT05836012|364300160|FG001|Overall Study|Lost to Follow-up|0|||
105627277|NCT05836012|364300159|FG000|Overall Study|Withdrawal by Subject|1|||
105627278|NCT05836012|364300160|FG001|Overall Study|Withdrawal by Subject|3|||
105627279|NCT05836012|364300159|FG000|Overall Study|Reason not included in pre-specified categories|2|||
105627280|NCT05836012|364300160|FG001|Overall Study|Reason not included in pre-specified categories|1|||
105627281|NCT05112900|364300162|FG000|Overall Study|Withdrawal by Subject|960|||
105627282|NCT05112900|364300163|FG001|Overall Study|Withdrawal by Subject|921|||
105627283|NCT05112900|364300164|FG002|Overall Study|Withdrawal by Subject|968|||
105627284|NCT00319111|364300165|FG000|Overall Study|Adverse Event|20|||
105627285|NCT00319111|364300165|FG000|Overall Study|Withdrawal of consent|11|||
105627286|NCT00319111|364300165|FG000|Overall Study|Death|9|||
105627287|NCT00319111|364300165|FG000|Overall Study|Lack of clinical improvement|4|||
105627288|NCT00319111|364300165|FG000|Overall Study|Administrative|2|||
105627289|NCT00319111|364300165|FG000|Overall Study|Treatment failure|1|||
105627290|NCT05541484|364300171|FG000|Overall Study|Withdrawal by Subject|1|||
105627291|NCT05541484|364300172|FG001|Overall Study|Withdrawal by Subject|0|||
105627292|NCT03370913|364301000|FG000|Overall Study|Death|1|||
105627293|NCT03370913|364301000|FG000|Overall Study|Lost to Follow-up|1|||
105627294|NCT04633538|364301001|FG000|Overall Study|Death|1|||
105627295|NCT04633538|364301001|FG000|Overall Study|Lost to Follow-up|3|||
105627296|NCT04633538|364301001|FG000|Overall Study|Withdrawal by Subject|1|||
105627297|NCT05070741|364301002|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
105627298|NCT04560179|364301004|FG000|Overall Study|Physician Decision|1|||
105627299|NCT04560179|364301005|FG001|Overall Study|Physician Decision|0|||
105627300|NCT04560179|364301006|FG002|Overall Study|Physician Decision|0|||
105627301|NCT04560179|364301007|FG003|Overall Study|Physician Decision|0|||
105627302|NCT04560179|364301008|FG004|Overall Study|Physician Decision|0|||
105627303|NCT04560179|364301004|FG000|Overall Study|Adverse Event|0|||
105627304|NCT04560179|364301005|FG001|Overall Study|Adverse Event|0|||
105627305|NCT04560179|364301006|FG002|Overall Study|Adverse Event|0|||
105627306|NCT04560179|364301007|FG003|Overall Study|Adverse Event|1|||
105627307|NCT04560179|364301008|FG004|Overall Study|Adverse Event|0|||
105627308|NCT03582033|364301011|FG000|Part A|Other|0|||
105627309|NCT03582033|364301012|FG001|Part A|Other|0|||
105627310|NCT03582033|364301013|FG002|Part A|Other|0|||
105627311|NCT03582033|364301014|FG003|Part A|Other|0|||
105627312|NCT03582033|364301015|FG004|Part A|Other|2|||
105627313|NCT03582033|364301016|FG005|Part A|Other|0|||
105627314|NCT03582033|364301017|FG006|Part A|Other|0|||
105627315|NCT03582033|364301018|FG007|Part A|Other|0|||
105627316|NCT03582033|364301019|FG008|Part A|Other|0|||
105627317|NCT03582033|364301020|FG009|Part A|Other|0|||
105627318|NCT03582033|364301011|FG000|Part A|Death|1|||
105627319|NCT03582033|364301012|FG001|Part A|Death|1|||
105627320|NCT03582033|364301013|FG002|Part A|Death|2|||
105627321|NCT03582033|364301014|FG003|Part A|Death|4|||
105627322|NCT03582033|364301015|FG004|Part A|Death|11|||
105627323|NCT03582033|364301016|FG005|Part A|Death|0|||
105627324|NCT03582033|364301017|FG006|Part A|Death|0|||
105627325|NCT03582033|364301018|FG007|Part A|Death|0|||
105627326|NCT03582033|364301019|FG008|Part A|Death|0|||
105627327|NCT03582033|364301020|FG009|Part A|Death|0|||
105627328|NCT03582033|364301011|FG000|Part A|Lost to Follow-up|0|||
105627329|NCT03582033|364301012|FG001|Part A|Lost to Follow-up|0|||
105627330|NCT03582033|364301013|FG002|Part A|Lost to Follow-up|0|||
105627331|NCT03582033|364301014|FG003|Part A|Lost to Follow-up|0|||
105627332|NCT03582033|364301015|FG004|Part A|Lost to Follow-up|1|||
105627333|NCT03582033|364301016|FG005|Part A|Lost to Follow-up|0|||
105627334|NCT03582033|364301017|FG006|Part A|Lost to Follow-up|0|||
105627335|NCT03582033|364301018|FG007|Part A|Lost to Follow-up|0|||
105627336|NCT03582033|364301019|FG008|Part A|Lost to Follow-up|0|||
105627337|NCT03582033|364301020|FG009|Part A|Lost to Follow-up|0|||
105627338|NCT03582033|364301011|FG000|Part A|Study terminated by sponsor|0|||
105627339|NCT03582033|364301012|FG001|Part A|Study terminated by sponsor|0|||
105627340|NCT03582033|364301013|FG002|Part A|Study terminated by sponsor|0|||
105627341|NCT03582033|364301014|FG003|Part A|Study terminated by sponsor|2|||
105627342|NCT03582033|364301015|FG004|Part A|Study terminated by sponsor|1|||
105627343|NCT03582033|364301016|FG005|Part A|Study terminated by sponsor|0|||
105627344|NCT03582033|364301017|FG006|Part A|Study terminated by sponsor|0|||
105627345|NCT03582033|364301018|FG007|Part A|Study terminated by sponsor|0|||
105627346|NCT03582033|364301019|FG008|Part A|Study terminated by sponsor|0|||
105627347|NCT03582033|364301020|FG009|Part A|Study terminated by sponsor|0|||
105627348|NCT03582033|364301011|FG000|Part A|Withdrawal by Subject|1|||
105627349|NCT03582033|364301012|FG001|Part A|Withdrawal by Subject|1|||
105627350|NCT03582033|364301013|FG002|Part A|Withdrawal by Subject|0|||
105627351|NCT03582033|364301014|FG003|Part A|Withdrawal by Subject|1|||
105627352|NCT03582033|364301015|FG004|Part A|Withdrawal by Subject|7|||
105627353|NCT03582033|364301016|FG005|Part A|Withdrawal by Subject|0|||
105627354|NCT03582033|364301017|FG006|Part A|Withdrawal by Subject|0|||
105627355|NCT03582033|364301018|FG007|Part A|Withdrawal by Subject|0|||
105627356|NCT03582033|364301019|FG008|Part A|Withdrawal by Subject|0|||
105627357|NCT03582033|364301020|FG009|Part A|Withdrawal by Subject|0|||
105627358|NCT03582033|364301011|FG000|Part B|Death|0|||
105627359|NCT03582033|364301012|FG001|Part B|Death|0|||
105627360|NCT03582033|364301013|FG002|Part B|Death|0|||
105627361|NCT03582033|364301014|FG003|Part B|Death|0|||
105627362|NCT03582033|364301015|FG004|Part B|Death|0|||
105627363|NCT03582033|364301016|FG005|Part B|Death|2|||
105627364|NCT03582033|364301017|FG006|Part B|Death|0|||
105627365|NCT03582033|364301018|FG007|Part B|Death|0|||
105627366|NCT03582033|364301019|FG008|Part B|Death|0|||
105627367|NCT03582033|364301020|FG009|Part B|Death|0|||
105627368|NCT03582033|364301011|FG000|Part B|Study terminated by sponsor|0|||
105627369|NCT03582033|364301012|FG001|Part B|Study terminated by sponsor|0|||
105627370|NCT03582033|364301013|FG002|Part B|Study terminated by sponsor|0|||
105627371|NCT03582033|364301014|FG003|Part B|Study terminated by sponsor|0|||
105627372|NCT03582033|364301015|FG004|Part B|Study terminated by sponsor|0|||
105627373|NCT03582033|364301016|FG005|Part B|Study terminated by sponsor|12|||
105627374|NCT03582033|364301017|FG006|Part B|Study terminated by sponsor|0|||
105627375|NCT03582033|364301018|FG007|Part B|Study terminated by sponsor|0|||
105627376|NCT03582033|364301019|FG008|Part B|Study terminated by sponsor|0|||
105627377|NCT03582033|364301020|FG009|Part B|Study terminated by sponsor|0|||
105627378|NCT03582033|364301011|FG000|Part B|Withdrawal by Subject|0|||
105627379|NCT03582033|364301012|FG001|Part B|Withdrawal by Subject|0|||
105627380|NCT03582033|364301013|FG002|Part B|Withdrawal by Subject|0|||
105627381|NCT03582033|364301014|FG003|Part B|Withdrawal by Subject|0|||
105627382|NCT03582033|364301015|FG004|Part B|Withdrawal by Subject|0|||
105627383|NCT03582033|364301016|FG005|Part B|Withdrawal by Subject|6|||
105627384|NCT03582033|364301017|FG006|Part B|Withdrawal by Subject|0|||
105627385|NCT03582033|364301018|FG007|Part B|Withdrawal by Subject|0|||
105627386|NCT03582033|364301019|FG008|Part B|Withdrawal by Subject|0|||
105627387|NCT03582033|364301020|FG009|Part B|Withdrawal by Subject|0|||
105627388|NCT03582033|364301011|FG000|Part C|Other|0|||
105627389|NCT03582033|364301012|FG001|Part C|Other|0|||
105627390|NCT03582033|364301013|FG002|Part C|Other|0|||
105627391|NCT03582033|364301014|FG003|Part C|Other|0|||
105627392|NCT03582033|364301015|FG004|Part C|Other|0|||
105627393|NCT03582033|364301016|FG005|Part C|Other|0|||
105627394|NCT03582033|364301017|FG006|Part C|Other|2|||
105627395|NCT03582033|364301018|FG007|Part C|Other|0|||
105627396|NCT03582033|364301019|FG008|Part C|Other|0|||
105627397|NCT03582033|364301020|FG009|Part C|Other|0|||
105627398|NCT03582033|364301011|FG000|Part C|Death|0|||
105627399|NCT03582033|364301012|FG001|Part C|Death|0|||
105627400|NCT03582033|364301013|FG002|Part C|Death|0|||
105627401|NCT03582033|364301014|FG003|Part C|Death|0|||
105627402|NCT03582033|364301015|FG004|Part C|Death|0|||
105627403|NCT03582033|364301016|FG005|Part C|Death|0|||
105627404|NCT03582033|364301017|FG006|Part C|Death|6|||
105627405|NCT03582033|364301018|FG007|Part C|Death|1|||
105627406|NCT03582033|364301019|FG008|Part C|Death|2|||
105627407|NCT03582033|364301020|FG009|Part C|Death|0|||
105627408|NCT03582033|364301011|FG000|Part C|Study terminated by sponsor|0|||
105627409|NCT03582033|364301012|FG001|Part C|Study terminated by sponsor|0|||
105627410|NCT03582033|364301013|FG002|Part C|Study terminated by sponsor|0|||
105627411|NCT03582033|364301014|FG003|Part C|Study terminated by sponsor|0|||
105627412|NCT03582033|364301015|FG004|Part C|Study terminated by sponsor|0|||
105627413|NCT03582033|364301016|FG005|Part C|Study terminated by sponsor|0|||
105627414|NCT03582033|364301017|FG006|Part C|Study terminated by sponsor|3|||
105627415|NCT03582033|364301018|FG007|Part C|Study terminated by sponsor|3|||
105627416|NCT03582033|364301019|FG008|Part C|Study terminated by sponsor|2|||
105627417|NCT03582033|364301020|FG009|Part C|Study terminated by sponsor|0|||
105627418|NCT03582033|364301011|FG000|Part C|Withdrawal by Subject|0|||
105627419|NCT03582033|364301012|FG001|Part C|Withdrawal by Subject|0|||
105627420|NCT03582033|364301013|FG002|Part C|Withdrawal by Subject|0|||
105627421|NCT03582033|364301014|FG003|Part C|Withdrawal by Subject|0|||
105627422|NCT03582033|364301015|FG004|Part C|Withdrawal by Subject|0|||
105627423|NCT03582033|364301016|FG005|Part C|Withdrawal by Subject|0|||
105627424|NCT03582033|364301017|FG006|Part C|Withdrawal by Subject|1|||
105627425|NCT03582033|364301018|FG007|Part C|Withdrawal by Subject|2|||
105627426|NCT03582033|364301019|FG008|Part C|Withdrawal by Subject|1|||
105627427|NCT03582033|364301020|FG009|Part C|Withdrawal by Subject|0|||
105627428|NCT03582033|364301011|FG000|Part D|Death|0|||
105627429|NCT03582033|364301012|FG001|Part D|Death|0|||
105627430|NCT03582033|364301013|FG002|Part D|Death|0|||
105627431|NCT03582033|364301014|FG003|Part D|Death|0|||
105627432|NCT03582033|364301015|FG004|Part D|Death|0|||
105627433|NCT03582033|364301016|FG005|Part D|Death|0|||
105627434|NCT03582033|364301017|FG006|Part D|Death|0|||
105627435|NCT03582033|364301018|FG007|Part D|Death|0|||
105627436|NCT03582033|364301019|FG008|Part D|Death|0|||
105627437|NCT03582033|364301020|FG009|Part D|Death|1|||
105627438|NCT03582033|364301011|FG000|Part D|Study terminated by sponsor|0|||
105627439|NCT03582033|364301012|FG001|Part D|Study terminated by sponsor|0|||
105627440|NCT03582033|364301013|FG002|Part D|Study terminated by sponsor|0|||
105627441|NCT03582033|364301014|FG003|Part D|Study terminated by sponsor|0|||
105627442|NCT03582033|364301015|FG004|Part D|Study terminated by sponsor|0|||
105627443|NCT03582033|364301016|FG005|Part D|Study terminated by sponsor|0|||
105627444|NCT03582033|364301017|FG006|Part D|Study terminated by sponsor|0|||
105627445|NCT03582033|364301018|FG007|Part D|Study terminated by sponsor|0|||
105627446|NCT03582033|364301019|FG008|Part D|Study terminated by sponsor|0|||
105627447|NCT03582033|364301020|FG009|Part D|Study terminated by sponsor|4|||
105627448|NCT04631016|364301021|FG000|Overall Study|Adverse Event|3|||
105627449|NCT04631016|364301022|FG001|Overall Study|Adverse Event|0|||
105627450|NCT04631016|364301021|FG000|Overall Study|Withdrawal by Subject|5|||
105627451|NCT04631016|364301022|FG001|Overall Study|Withdrawal by Subject|4|||
105627452|NCT04631016|364301021|FG000|Overall Study|Reason unspecified|1|||
105627453|NCT04631016|364301022|FG001|Overall Study|Reason unspecified|0|||
105627454|NCT04631016|364301021|FG000|Overall Study|Failure to meet randomization criteria|2|||
105627455|NCT04631016|364301022|FG001|Overall Study|Failure to meet randomization criteria|1|||
105627456|NCT04109066|364301023|FG000|Pre-treatment|Participant withdrew consent|2|||
105627457|NCT04109066|364301024|FG001|Pre-treatment|Participant withdrew consent|0|||
105627458|NCT04109066|364301023|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
105627459|NCT04109066|364301024|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
105627460|NCT04109066|364301023|FG000|Treatment|Lack of Efficacy|2|||
105627461|NCT04109066|364301024|FG001|Treatment|Lack of Efficacy|4|||
105627462|NCT04109066|364301023|FG000|Treatment|Adverse Event|23|||
105627463|NCT04109066|364301024|FG001|Treatment|Adverse Event|7|||
105627464|NCT04109066|364301023|FG000|Treatment|Participant request to discontinue Study treatment|15|||
105627465|NCT04109066|364301024|FG001|Treatment|Participant request to discontinue Study treatment|14|||
105627466|NCT04109066|364301023|FG000|Treatment|Withdrawal by Subject|8|||
105627467|NCT04109066|364301024|FG001|Treatment|Withdrawal by Subject|8|||
105627468|NCT04109066|364301023|FG000|Treatment|Death|3|||
105627469|NCT04109066|364301024|FG001|Treatment|Death|0|||
105627470|NCT04109066|364301023|FG000|Treatment|Participant no longer meets study criteria|2|||
105627471|NCT04109066|364301024|FG001|Treatment|Participant no longer meets study criteria|2|||
105627472|NCT04109066|364301023|FG000|Treatment|Administrative reasons by sponsor|2|||
105627473|NCT04109066|364301024|FG001|Treatment|Administrative reasons by sponsor|3|||
105627474|NCT04109066|364301023|FG000|Treatment|Other reasons|17|||
105627475|NCT04109066|364301024|FG001|Treatment|Other reasons|23|||
105627476|NCT04109066|364301023|FG000|Treatment|Disease Progression|4|||
105627477|NCT04109066|364301024|FG001|Treatment|Disease Progression|7|||
105627478|NCT04109066|364301023|FG000|Treatment|Study drug toxicity|12|||
105627479|NCT04109066|364301024|FG001|Treatment|Study drug toxicity|5|||
105627480|NCT04109066|364301023|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
105627481|NCT04109066|364301024|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
105627482|NCT04109066|364301023|FG000|Treatment|Disease Recurrence|0|||
105627483|NCT04109066|364301024|FG001|Treatment|Disease Recurrence|2|||
105627484|NCT04109066|364301023|FG000|Treatment|Not reported|4|||
105627485|NCT04109066|364301024|FG001|Treatment|Not reported|8|||
105627486|NCT05652010|364301025|FG000|First Intervention|Withdrawal by Subject|0|||
105627487|NCT05652010|364301026|FG001|First Intervention|Withdrawal by Subject|1|||
105627488|NCT05652010|364301025|FG000|Second Intervention|Withdrawal by Subject|1|||
105627489|NCT05652010|364301026|FG001|Second Intervention|Withdrawal by Subject|0|||
105627490|NCT04163991|364301038|FG000|Overall Study|Adverse Event|0|||
105627491|NCT04163991|364301039|FG001|Overall Study|Adverse Event|0|||
105627492|NCT04163991|364301040|FG002|Overall Study|Adverse Event|0|||
105627493|NCT04163991|364301041|FG003|Overall Study|Adverse Event|1|||
105627494|NCT04163991|364301042|FG004|Overall Study|Adverse Event|0|||
105627495|NCT04163991|364301038|FG000|Overall Study|Death|0|||
105627496|NCT04163991|364301039|FG001|Overall Study|Death|0|||
105627497|NCT04163991|364301040|FG002|Overall Study|Death|1|||
105627498|NCT04163991|364301041|FG003|Overall Study|Death|0|||
105627499|NCT04163991|364301042|FG004|Overall Study|Death|0|||
105627500|NCT04163991|364301038|FG000|Overall Study|Lost to Follow-up|0|||
105627501|NCT04163991|364301039|FG001|Overall Study|Lost to Follow-up|1|||
105627502|NCT04163991|364301040|FG002|Overall Study|Lost to Follow-up|0|||
105627503|NCT04163991|364301041|FG003|Overall Study|Lost to Follow-up|0|||
105627504|NCT04163991|364301042|FG004|Overall Study|Lost to Follow-up|0|||
105627505|NCT04163991|364301038|FG000|Overall Study|Withdrawal by Subject|1|||
105627506|NCT04163991|364301039|FG001|Overall Study|Withdrawal by Subject|1|||
105627507|NCT04163991|364301040|FG002|Overall Study|Withdrawal by Subject|3|||
105627508|NCT04163991|364301041|FG003|Overall Study|Withdrawal by Subject|1|||
105627509|NCT04163991|364301042|FG004|Overall Study|Withdrawal by Subject|1|||
105627510|NCT04163991|364301038|FG000|Overall Study|Other, Not Specified|0|||
105627511|NCT04163991|364301039|FG001|Overall Study|Other, Not Specified|1|||
105627512|NCT04163991|364301040|FG002|Overall Study|Other, Not Specified|1|||
105627513|NCT04163991|364301041|FG003|Overall Study|Other, Not Specified|1|||
105627514|NCT04163991|364301042|FG004|Overall Study|Other, Not Specified|0|||
105627515|NCT04214418|364301043|FG000|Overall Study|Withdrawal by Subject|1|||
105627516|NCT04214418|364301044|FG001|Overall Study|Withdrawal by Subject|0|||
105627517|NCT04214418|364301045|FG002|Overall Study|Withdrawal by Subject|0|||
105627518|NCT04214418|364301046|FG003|Overall Study|Withdrawal by Subject|0|||
105627519|NCT04214418|364301047|FG004|Overall Study|Withdrawal by Subject|0|||
105627520|NCT04214418|364301048|FG005|Overall Study|Withdrawal by Subject|0|||
105627521|NCT04214418|364301043|FG000|Overall Study|Adverse Event|0|||
105627522|NCT04214418|364301044|FG001|Overall Study|Adverse Event|2|||
105627523|NCT04214418|364301045|FG002|Overall Study|Adverse Event|0|||
105627524|NCT04214418|364301046|FG003|Overall Study|Adverse Event|0|||
105627525|NCT04214418|364301047|FG004|Overall Study|Adverse Event|0|||
105627526|NCT04214418|364301048|FG005|Overall Study|Adverse Event|0|||
105627527|NCT04214418|364301043|FG000|Overall Study|Death|1|||
105627528|NCT04214418|364301044|FG001|Overall Study|Death|0|||
105627529|NCT04214418|364301045|FG002|Overall Study|Death|0|||
105627530|NCT04214418|364301046|FG003|Overall Study|Death|0|||
105627531|NCT04214418|364301047|FG004|Overall Study|Death|0|||
105627532|NCT04214418|364301048|FG005|Overall Study|Death|0|||
105627533|NCT04206787|364301051|FG000|Overall Study|Other than listed|2|||
105627534|NCT04206787|364301051|FG000|Overall Study|Investigator decision|1|||
105627535|NCT04206787|364301051|FG000|Overall Study|Death|25|||
105627536|NCT04206787|364301051|FG000|Overall Study|Lost to Follow-up|9|||
105627537|NCT04206787|364301051|FG000|Overall Study|Withdrawal of consent|9|||
105627538|NCT05008055|364301052|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
105627539|NCT05008055|364301053|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
105627540|NCT05008055|364301054|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
105627541|NCT04635059|364301055|FG000|Overall Study|Study terminated early.|4|||
105627542|NCT03011034|364301060|FG000|Overall Study|Adverse Event|1|||
105627543|NCT03011034|364301061|FG001|Overall Study|Adverse Event|0|||
105627544|NCT02777593|364301062|FG000|Overall Study|Still in study|1|||
105627545|NCT02777593|364301063|FG001|Overall Study|Still in study|32|||
105627546|NCT02777593|364301064|FG002|Overall Study|Still in study|3|||
105627547|NCT02777593|364301065|FG003|Overall Study|Still in study|6|||
105627548|NCT02777593|364301066|FG004|Overall Study|Still in study|5|||
105627549|NCT02777593|364301062|FG000|Overall Study|Death|21|||
105627550|NCT02777593|364301063|FG001|Overall Study|Death|28|||
105627551|NCT02777593|364301064|FG002|Overall Study|Death|0|||
105627552|NCT02777593|364301065|FG003|Overall Study|Death|5|||
105627553|NCT02777593|364301066|FG004|Overall Study|Death|0|||
105627554|NCT02777593|364301062|FG000|Overall Study|Withdrawal by Subject|8|||
105627555|NCT02777593|364301063|FG001|Overall Study|Withdrawal by Subject|4|||
105627556|NCT02777593|364301064|FG002|Overall Study|Withdrawal by Subject|1|||
105627557|NCT02777593|364301065|FG003|Overall Study|Withdrawal by Subject|1|||
105627558|NCT02777593|364301066|FG004|Overall Study|Withdrawal by Subject|0|||
105627559|NCT02777593|364301062|FG000|Overall Study|Lost to Follow-up|8|||
105627560|NCT02777593|364301063|FG001|Overall Study|Lost to Follow-up|16|||
105627561|NCT02777593|364301064|FG002|Overall Study|Lost to Follow-up|5|||
105627562|NCT02777593|364301065|FG003|Overall Study|Lost to Follow-up|0|||
105627563|NCT02777593|364301066|FG004|Overall Study|Lost to Follow-up|1|||
105627564|NCT02777593|364301062|FG000|Overall Study|Physician Decision|2|||
105627565|NCT02777593|364301063|FG001|Overall Study|Physician Decision|2|||
105627566|NCT02777593|364301064|FG002|Overall Study|Physician Decision|0|||
105627567|NCT02777593|364301065|FG003|Overall Study|Physician Decision|0|||
105627568|NCT02777593|364301066|FG004|Overall Study|Physician Decision|0|||
105627569|NCT02777593|364301062|FG000|Overall Study|Discontinued due to Other|1|||
105627570|NCT02777593|364301063|FG001|Overall Study|Discontinued due to Other|0|||
105627571|NCT02777593|364301064|FG002|Overall Study|Discontinued due to Other|0|||
105627572|NCT02777593|364301065|FG003|Overall Study|Discontinued due to Other|0|||
105627573|NCT02777593|364301066|FG004|Overall Study|Discontinued due to Other|0|||
105627574|NCT04743973|364301067|FG000|Overall Study|Withdrawal by Subject|5|||
105627575|NCT05654662|364301068|FG000|Overall Study|Withdrawal by Subject|1|||
105627576|NCT05654662|364301069|FG001|Overall Study|Withdrawal by Subject|0|||
105627577|NCT05654662|364301068|FG000|Overall Study|A death in the family|1|||
105627578|NCT05654662|364301069|FG001|Overall Study|A death in the family|0|||
105627579|NCT04157517|364301070|FG000|Overall Study|Death|1|||
105627580|NCT04157517|364301071|FG001|Overall Study|Death|2|||
105627581|NCT04157517|364301072|FG002|Overall Study|Death|2|||
105627582|NCT04157517|364301073|FG003|Overall Study|Death|3|||
105627583|NCT04157517|364301074|FG004|Overall Study|Death|3|||
105627584|NCT04157517|364301075|FG005|Overall Study|Death|4|||
105627585|NCT04157517|364301076|FG006|Overall Study|Death|1|||
105627586|NCT04157517|364301077|FG007|Overall Study|Death|2|||
105627587|NCT04157517|364301078|FG008|Overall Study|Death|4|||
105627588|NCT04157517|364301079|FG009|Overall Study|Death|0|||
105627589|NCT04157517|364301070|FG000|Overall Study|Withdrawal by Subject|1|||
105627590|NCT04157517|364301071|FG001|Overall Study|Withdrawal by Subject|1|||
105627591|NCT04157517|364301072|FG002|Overall Study|Withdrawal by Subject|1|||
105627592|NCT04157517|364301073|FG003|Overall Study|Withdrawal by Subject|0|||
105627593|NCT04157517|364301074|FG004|Overall Study|Withdrawal by Subject|0|||
105627594|NCT04157517|364301075|FG005|Overall Study|Withdrawal by Subject|1|||
105627595|NCT04157517|364301076|FG006|Overall Study|Withdrawal by Subject|0|||
105627596|NCT04157517|364301077|FG007|Overall Study|Withdrawal by Subject|0|||
105627597|NCT04157517|364301078|FG008|Overall Study|Withdrawal by Subject|1|||
105627598|NCT04157517|364301079|FG009|Overall Study|Withdrawal by Subject|0|||
105627599|NCT04157517|364301070|FG000|Overall Study|Other|1|||
105627600|NCT04157517|364301071|FG001|Overall Study|Other|0|||
105627601|NCT04157517|364301072|FG002|Overall Study|Other|0|||
105627602|NCT04157517|364301073|FG003|Overall Study|Other|0|||
105627603|NCT04157517|364301074|FG004|Overall Study|Other|0|||
105627604|NCT04157517|364301075|FG005|Overall Study|Other|1|||
105627605|NCT04157517|364301076|FG006|Overall Study|Other|2|||
105627606|NCT04157517|364301077|FG007|Overall Study|Other|7|||
105627607|NCT04157517|364301078|FG008|Overall Study|Other|7|||
105627608|NCT04157517|364301079|FG009|Overall Study|Other|0|||
105627609|NCT04565990|364301865|FG000|Overall Study|Death|5|||
105627610|NCT04565990|364301865|FG000|Overall Study|Lost to Follow-up|1|||
105627611|NCT04565990|364301865|FG000|Overall Study|Withdrawal by Subject|1|||
105627612|NCT04797858|364301866|FG000|Overall Study|Withdrawal by Subject|0|||
105627613|NCT04797858|364301867|FG001|Overall Study|Withdrawal by Subject|1|||
105627614|NCT04797858|364301866|FG000|Overall Study|Excluded due to administrative error|7|||
105627615|NCT04797858|364301867|FG001|Overall Study|Excluded due to administrative error|8|||
105627616|NCT00942877|364301868|FG000|Overall Study|Refused further treatment|1|||
105627617|NCT00942877|364301869|FG001|Overall Study|Refused further treatment|1|||
105627618|NCT00942877|364301868|FG000|Overall Study|Patient was not treated|1|||
105627619|NCT00942877|364301869|FG001|Overall Study|Patient was not treated|0|||
105627620|NCT00942877|364301868|FG000|Overall Study|Adverse Event|1|||
105627621|NCT00942877|364301869|FG001|Overall Study|Adverse Event|0|||
105627622|NCT00942877|364301868|FG000|Overall Study|Progressive disease|42|||
105627623|NCT00942877|364301869|FG001|Overall Study|Progressive disease|3|||
105627624|NCT01385202|364301870|FG000|Overall Study|Lost to Follow-up|6|||
105627625|NCT01385202|364301870|FG000|Overall Study|Not Eligible|11|||
105627626|NCT01385202|364301870|FG000|Overall Study|Withdrawn|1|||
105627627|NCT05830799|364301874|FG000|Overall Study|Withdrawal by Subject|1|||
105627628|NCT05205161|364301884|FG000|Overall Study|Study terminated by sponsor|3|||
105627629|NCT05205161|364301885|FG001|Overall Study|Study terminated by sponsor|3|||
105627630|NCT05205161|364301886|FG002|Overall Study|Study terminated by sponsor|1|||
105627631|NCT04524689|364301893|FG000|Overall Study|Withdrawal by Subject|1|||
105627632|NCT04524689|364301894|FG001|Overall Study|Withdrawal by Subject|1|||
105627633|NCT04524689|364301895|FG002|Overall Study|Withdrawal by Subject|0|||
105627634|NCT04524689|364301896|FG003|Overall Study|Withdrawal by Subject|0|||
105627635|NCT04524689|364301897|FG004|Overall Study|Withdrawal by Subject|1|||
105627636|NCT04524689|364301898|FG005|Overall Study|Withdrawal by Subject|0|||
105627637|NCT04524689|364301893|FG000|Overall Study|Not related to Coronavirus disease 2019|2|||
105627638|NCT04524689|364301894|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
105627639|NCT04524689|364301895|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
105627640|NCT04524689|364301896|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
105627641|NCT04524689|364301897|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
105627642|NCT04524689|364301898|FG005|Overall Study|Not related to Coronavirus disease 2019|0|||
105627643|NCT04524689|364301893|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|12|||
105627644|NCT04524689|364301894|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
105627645|NCT04524689|364301895|FG002|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
105627646|NCT04524689|364301896|FG003|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
105627647|NCT04524689|364301897|FG004|Overall Study|Ongoing study treatment at the time of primary analysis|5|||
105627648|NCT04524689|364301898|FG005|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
105627649|NCT04369911|364301900|FG000|Overall Study|Lost to Follow-up|3|||
105627650|NCT04369911|364301901|FG001|Overall Study|Lost to Follow-up|3|||
105627651|NCT04369911|364301900|FG000|Overall Study|Withdrawal by Subject|1|||
105627652|NCT04369911|364301901|FG001|Overall Study|Withdrawal by Subject|2|||
105627653|NCT05741294|364301904|FG000|Overall Study|Lost to Follow-up|3|||
105627654|NCT05741294|364301904|FG000|Overall Study|Protocol deviation|3|||
105627655|NCT05741294|364301904|FG000|Overall Study|Withdrawal by Subject|1|||
105627656|NCT05451693|364301905|FG000|Overall Study|Withdrawal by Subject|1|||
105627657|NCT05451693|364301906|FG001|Overall Study|Withdrawal by Subject|1|||
105627658|NCT04707768|364301913|FG000|Overall Study|Adverse Event|9|||
105627659|NCT04707768|364301914|FG001|Overall Study|Adverse Event|18|||
105627660|NCT04707768|364301915|FG002|Overall Study|Adverse Event|3|||
105627661|NCT04707768|364301913|FG000|Overall Study|Investigator's Discretion|8|||
105440422|NCT02834247|363616794|FG002|Dose Expansion Phase|Death|0|||
105627662|NCT04707768|364301914|FG001|Overall Study|Investigator's Discretion|4|||
105627663|NCT04707768|364301915|FG002|Overall Study|Investigator's Discretion|3|||
105627664|NCT04707768|364301913|FG000|Overall Study|Withdrawal by Subject|6|||
105627665|NCT04707768|364301914|FG001|Overall Study|Withdrawal by Subject|8|||
105627666|NCT04707768|364301915|FG002|Overall Study|Withdrawal by Subject|2|||
105627667|NCT04707768|364301913|FG000|Overall Study|Lack of Efficacy|1|||
105627668|NCT04707768|364301914|FG001|Overall Study|Lack of Efficacy|3|||
105627669|NCT04707768|364301915|FG002|Overall Study|Lack of Efficacy|0|||
105627670|NCT04707768|364301913|FG000|Overall Study|Lost to Follow-up|0|||
105627671|NCT04707768|364301914|FG001|Overall Study|Lost to Follow-up|0|||
105627672|NCT04707768|364301915|FG002|Overall Study|Lost to Follow-up|3|||
105627673|NCT04707768|364301913|FG000|Overall Study|Death|13|||
105627674|NCT04707768|364301914|FG001|Overall Study|Death|11|||
105627675|NCT04707768|364301915|FG002|Overall Study|Death|13|||
105627676|NCT04707768|364301913|FG000|Overall Study|Protocol Violation|2|||
105627677|NCT04707768|364301914|FG001|Overall Study|Protocol Violation|1|||
105627678|NCT04707768|364301915|FG002|Overall Study|Protocol Violation|0|||
105627679|NCT04707768|364301913|FG000|Overall Study|Non Compliance with Study Drug|1|||
105627680|NCT04707768|364301914|FG001|Overall Study|Non Compliance with Study Drug|0|||
105627681|NCT04707768|364301915|FG002|Overall Study|Non Compliance with Study Drug|0|||
105627682|NCT04707768|364301913|FG000|Overall Study|Transplant|4|||
105627683|NCT04707768|364301914|FG001|Overall Study|Transplant|4|||
105627684|NCT04707768|364301915|FG002|Overall Study|Transplant|8|||
105627685|NCT04707768|364301913|FG000|Overall Study|Other|9|||
105627686|NCT04707768|364301914|FG001|Overall Study|Other|5|||
105627687|NCT04707768|364301915|FG002|Overall Study|Other|2|||
105627688|NCT03372057|364301916|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
105627689|NCT03372057|364301917|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
105627690|NCT03372057|364301918|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
105627691|NCT03372057|364301916|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
105627692|NCT03372057|364301917|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
105627693|NCT03372057|364301918|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
105627694|NCT03372057|364301916|FG000|Dose Optimization Phase|Death|16|||
105627695|NCT03372057|364301917|FG001|Dose Optimization Phase|Death|11|||
105627696|NCT03372057|364301918|FG002|Dose Optimization Phase|Death|0|||
105627697|NCT03372057|364301916|FG000|Expansion Phase|Withdrawal by Subject|0|||
105627698|NCT03372057|364301917|FG001|Expansion Phase|Withdrawal by Subject|0|||
105627699|NCT03372057|364301918|FG002|Expansion Phase|Withdrawal by Subject|4|||
105627700|NCT03372057|364301916|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
105627701|NCT03372057|364301917|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
105627702|NCT03372057|364301918|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
105627703|NCT03372057|364301916|FG000|Expansion Phase|Death|0|||
105627704|NCT03372057|364301917|FG001|Expansion Phase|Death|0|||
105627705|NCT03372057|364301918|FG002|Expansion Phase|Death|78|||
105627706|NCT03372057|364301916|FG000|Expansion Phase|Progressive Disease|0|||
105627707|NCT03372057|364301917|FG001|Expansion Phase|Progressive Disease|0|||
105627708|NCT03372057|364301918|FG002|Expansion Phase|Progressive Disease|1|||
105627709|NCT03372057|364301916|FG000|Expansion Phase|Adverse Event|0|||
105627710|NCT03372057|364301917|FG001|Expansion Phase|Adverse Event|0|||
105627711|NCT03372057|364301918|FG002|Expansion Phase|Adverse Event|1|||
105627712|NCT04477304|364301919|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
105627713|NCT04477304|364301920|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
105627714|NCT03333915|364301921|FG000|Overall Study|Lost to Follow-up|0|||
105627715|NCT03333915|364301922|FG001|Overall Study|Lost to Follow-up|0|||
105627716|NCT03333915|364301923|FG002|Overall Study|Lost to Follow-up|1|||
105627717|NCT03333915|364301924|FG003|Overall Study|Lost to Follow-up|0|||
105627718|NCT03333915|364301925|FG004|Overall Study|Lost to Follow-up|0|||
105627719|NCT03333915|364301921|FG000|Overall Study|Disease Progression|0|||
105627720|NCT03333915|364301922|FG001|Overall Study|Disease Progression|1|||
105627721|NCT03333915|364301923|FG002|Overall Study|Disease Progression|0|||
105627722|NCT03333915|364301924|FG003|Overall Study|Disease Progression|0|||
105627723|NCT03333915|364301925|FG004|Overall Study|Disease Progression|0|||
105627724|NCT03333915|364301921|FG000|Overall Study|Death|0|||
105627725|NCT03333915|364301922|FG001|Overall Study|Death|0|||
105627726|NCT03333915|364301923|FG002|Overall Study|Death|0|||
105627727|NCT03333915|364301924|FG003|Overall Study|Death|37|||
105627728|NCT03333915|364301925|FG004|Overall Study|Death|18|||
105627729|NCT03333915|364301921|FG000|Overall Study|Sponsor's Decision|0|||
105627730|NCT03333915|364301922|FG001|Overall Study|Sponsor's Decision|0|||
105627731|NCT03333915|364301923|FG002|Overall Study|Sponsor's Decision|0|||
105627732|NCT03333915|364301924|FG003|Overall Study|Sponsor's Decision|48|||
105627733|NCT03333915|364301925|FG004|Overall Study|Sponsor's Decision|4|||
105627734|NCT03333915|364301921|FG000|Overall Study|Withdrawal by Subject|0|||
105627735|NCT03333915|364301922|FG001|Overall Study|Withdrawal by Subject|0|||
105627736|NCT03333915|364301923|FG002|Overall Study|Withdrawal by Subject|0|||
105627737|NCT03333915|364301924|FG003|Overall Study|Withdrawal by Subject|5|||
105627738|NCT03333915|364301925|FG004|Overall Study|Withdrawal by Subject|1|||
105627739|NCT04078152|364301926|FG000|Overall Study|Other|83|||
105627740|NCT04078152|364301927|FG001|Overall Study|Other|22|||
105627741|NCT04078152|364301928|FG002|Overall Study|Other|25|||
105627742|NCT04078152|364301926|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
105627743|NCT04078152|364301927|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
105627744|NCT04078152|364301928|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
105627745|NCT04078152|364301926|FG000|Overall Study|Withdrawal by Subject|5|||
105627746|NCT04078152|364301927|FG001|Overall Study|Withdrawal by Subject|0|||
105627747|NCT04078152|364301928|FG002|Overall Study|Withdrawal by Subject|1|||
105627748|NCT04078152|364301926|FG000|Overall Study|Death|10|||
105627749|NCT04078152|364301927|FG001|Overall Study|Death|2|||
105627750|NCT04078152|364301928|FG002|Overall Study|Death|12|||
105627751|NCT04078152|364301926|FG000|Overall Study|Adverse Event|1|||
105627752|NCT04078152|364301927|FG001|Overall Study|Adverse Event|0|||
105627753|NCT04078152|364301928|FG002|Overall Study|Adverse Event|0|||
105627754|NCT03547271|364301933|FG000|Overall Study|Adverse Event|1|||
105627755|NCT03547271|364301934|FG001|Overall Study|Adverse Event|1|||
105627756|NCT03547271|364301935|FG002|Overall Study|Adverse Event|0|||
105627757|NCT03547271|364301936|FG003|Overall Study|Adverse Event|0|||
105627758|NCT03547271|364301933|FG000|Overall Study|Protocol deviation|5|||
105627759|NCT03547271|364301934|FG001|Overall Study|Protocol deviation|7|||
105627760|NCT03547271|364301935|FG002|Overall Study|Protocol deviation|3|||
105627761|NCT03547271|364301936|FG003|Overall Study|Protocol deviation|0|||
105627762|NCT03547271|364301933|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
105627763|NCT03547271|364301934|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
105627764|NCT03547271|364301935|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
105627765|NCT03547271|364301936|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
105627766|NCT03547271|364301933|FG000|Overall Study|Lost to Follow-up|3|||
105627767|NCT03547271|364301934|FG001|Overall Study|Lost to Follow-up|3|||
105627768|NCT03547271|364301935|FG002|Overall Study|Lost to Follow-up|1|||
105627769|NCT03547271|364301936|FG003|Overall Study|Lost to Follow-up|0|||
105627770|NCT03279978|364301937|FG000|Overall Study|Withdrawal by Subject|0|||
105627771|NCT03279978|364301938|FG001|Overall Study|Withdrawal by Subject|1|||
105627772|NCT03279978|364301939|FG002|Overall Study|Withdrawal by Subject|0|||
105627773|NCT03279978|364301940|FG003|Overall Study|Withdrawal by Subject|0|||
105627774|NCT03279978|364301941|FG004|Overall Study|Withdrawal by Subject|0|||
105627775|NCT03279978|364301942|FG005|Overall Study|Withdrawal by Subject|0|||
105627776|NCT03279978|364301943|FG006|Overall Study|Withdrawal by Subject|0|||
105627777|NCT03279978|364301944|FG007|Overall Study|Withdrawal by Subject|0|||
105627778|NCT03279978|364301945|FG008|Overall Study|Withdrawal by Subject|0|||
105627779|NCT03279978|364301946|FG009|Overall Study|Withdrawal by Subject|1|||
105627780|NCT03279978|364301937|FG000|Overall Study|Lost to Follow-up|1|||
105627781|NCT03279978|364301938|FG001|Overall Study|Lost to Follow-up|0|||
105627782|NCT03279978|364301939|FG002|Overall Study|Lost to Follow-up|1|||
105627783|NCT03279978|364301940|FG003|Overall Study|Lost to Follow-up|0|||
105627784|NCT03279978|364301941|FG004|Overall Study|Lost to Follow-up|0|||
105627785|NCT03279978|364301942|FG005|Overall Study|Lost to Follow-up|0|||
105627786|NCT03279978|364301943|FG006|Overall Study|Lost to Follow-up|0|||
105627787|NCT03279978|364301944|FG007|Overall Study|Lost to Follow-up|0|||
105627788|NCT03279978|364301945|FG008|Overall Study|Lost to Follow-up|0|||
105627789|NCT03279978|364301946|FG009|Overall Study|Lost to Follow-up|0|||
105627790|NCT03279978|364301937|FG000|Overall Study|Other than stated above|0|||
105627791|NCT03279978|364301938|FG001|Overall Study|Other than stated above|0|||
105627792|NCT03279978|364301939|FG002|Overall Study|Other than stated above|0|||
105627793|NCT03279978|364301940|FG003|Overall Study|Other than stated above|0|||
105627794|NCT03279978|364301941|FG004|Overall Study|Other than stated above|0|||
105627795|NCT03279978|364301942|FG005|Overall Study|Other than stated above|0|||
105627796|NCT03279978|364301943|FG006|Overall Study|Other than stated above|1|||
105627797|NCT03279978|364301944|FG007|Overall Study|Other than stated above|0|||
105627798|NCT03279978|364301945|FG008|Overall Study|Other than stated above|0|||
105627799|NCT03279978|364301946|FG009|Overall Study|Other than stated above|0|||
105627800|NCT04675034|364303077|FG000|Overall Study|Lost to Follow-up|1|||
105627801|NCT04675034|364303078|FG001|Overall Study|Lost to Follow-up|1|||
105627802|NCT04675034|364303079|FG002|Overall Study|Lost to Follow-up|0|||
105627803|NCT04675034|364303080|FG003|Overall Study|Lost to Follow-up|2|||
105627804|NCT04675034|364303081|FG004|Overall Study|Lost to Follow-up|0|||
105627805|NCT04675034|364303077|FG000|Overall Study|Protocol Violation|1|||
105627806|NCT04675034|364303078|FG001|Overall Study|Protocol Violation|0|||
105627807|NCT04675034|364303079|FG002|Overall Study|Protocol Violation|0|||
105627808|NCT04675034|364303080|FG003|Overall Study|Protocol Violation|1|||
105627809|NCT04675034|364303081|FG004|Overall Study|Protocol Violation|3|||
105627810|NCT04675034|364303077|FG000|Overall Study|Withdrawal by Subject|9|||
105627811|NCT04675034|364303078|FG001|Overall Study|Withdrawal by Subject|3|||
105627812|NCT04675034|364303079|FG002|Overall Study|Withdrawal by Subject|4|||
105627813|NCT04675034|364303080|FG003|Overall Study|Withdrawal by Subject|8|||
105627814|NCT04675034|364303081|FG004|Overall Study|Withdrawal by Subject|6|||
105627815|NCT05953740|364303084|FG000|Period 1|Physician Decision|0|||
105627816|NCT05953740|364303085|FG001|Period 1|Physician Decision|1|||
105627817|NCT05953740|364303086|FG002|Period 1|Physician Decision|0|||
105627818|NCT05953740|364303087|FG003|Period 1|Physician Decision|0|||
105627819|NCT05953740|364303088|FG004|Period 1|Physician Decision|0|||
105627820|NCT05953740|364303089|FG005|Period 1|Physician Decision|0|||
105627821|NCT05953740|364303090|FG006|Period 1|Physician Decision|0|||
105627822|NCT05953740|364303091|FG007|Period 1|Physician Decision|0|||
105627823|NCT05953740|364303084|FG000|Period 2|Withdrawal by Subject|0|||
105627824|NCT05953740|364303085|FG001|Period 2|Withdrawal by Subject|1|||
105627825|NCT05953740|364303086|FG002|Period 2|Withdrawal by Subject|1|||
105627826|NCT05953740|364303087|FG003|Period 2|Withdrawal by Subject|0|||
105627827|NCT05953740|364303088|FG004|Period 2|Withdrawal by Subject|0|||
105627828|NCT05953740|364303089|FG005|Period 2|Withdrawal by Subject|0|||
105627829|NCT05953740|364303090|FG006|Period 2|Withdrawal by Subject|0|||
105627830|NCT05953740|364303091|FG007|Period 2|Withdrawal by Subject|0|||
105627831|NCT03880955|364303092|FG000|Overall Study|Adverse Event|1|||
105627832|NCT03880955|364303092|FG000|Overall Study|Death|1|||
105627833|NCT03880955|364303092|FG000|Overall Study|Lost to Follow-up|12|||
105627834|NCT03880955|364303092|FG000|Overall Study|Withdrawal by Subject|4|||
105627835|NCT03880955|364303092|FG000|Overall Study|Missing- Study Site Closed|27|||
105627836|NCT05985395|364303097|FG000|Overall Study|Physician Decision|2|||
105627837|NCT05985395|364303098|FG001|Overall Study|Physician Decision|1|||
105627838|NCT05985395|364303097|FG000|Overall Study|Withdrawal by Subject|1|||
105627839|NCT05985395|364303098|FG001|Overall Study|Withdrawal by Subject|0|||
105627840|NCT05890105|364303099|FG000|Overall Study|Adverse Event|1|||
105627841|NCT05890105|364303100|FG001|Overall Study|Adverse Event|0|||
105627842|NCT05890105|364303101|FG002|Overall Study|Adverse Event|0|||
105627843|NCT05890105|364303099|FG000|Overall Study|Other|1|||
105627844|NCT05890105|364303100|FG001|Overall Study|Other|2|||
105627845|NCT05890105|364303101|FG002|Overall Study|Other|0|||
105627846|NCT00450216|364303102|FG000|Overall Study|Adverse Event|38|||
105627847|NCT00450216|364303103|FG001|Overall Study|Adverse Event|23|||
105627848|NCT00450216|364303102|FG000|Overall Study|Withdrawal by Subject|48|||
105627849|NCT00450216|364303103|FG001|Overall Study|Withdrawal by Subject|26|||
105627850|NCT00450216|364303102|FG000|Overall Study|Lost to Follow-up|16|||
105627851|NCT00450216|364303103|FG001|Overall Study|Lost to Follow-up|9|||
105627852|NCT00450216|364303102|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
105627853|NCT00450216|364303103|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
105627854|NCT00450216|364303102|FG000|Overall Study|misc|21|||
105627855|NCT00450216|364303103|FG001|Overall Study|misc|20|||
105627856|NCT03248479|364303109|FG000|Overall Study|Death|12|||
105627857|NCT03248479|364303110|FG001|Overall Study|Death|44|||
105627858|NCT03248479|364303111|FG002|Overall Study|Death|1|||
105627859|NCT03248479|364303112|FG003|Overall Study|Death|72|||
105627860|NCT03248479|364303113|FG004|Overall Study|Death|17|||
105627861|NCT03248479|364303114|FG005|Overall Study|Death|6|||
105627862|NCT03248479|364303115|FG006|Overall Study|Death|1|||
105627863|NCT03248479|364303116|FG007|Overall Study|Death|14|||
105627864|NCT03248479|364303117|FG008|Overall Study|Death|3|||
105627865|NCT03248479|364303118|FG009|Overall Study|Death|7|||
105627866|NCT03248479|364303119|FG010|Overall Study|Death|3|||
105627867|NCT03248479|364303120|FG011|Overall Study|Death|1|||
105627868|NCT03248479|364303121|FG012|Overall Study|Death|1|||
105627869|NCT03248479|364303109|FG000|Overall Study|Study terminated by sponsor|12|||
105627870|NCT03248479|364303110|FG001|Overall Study|Study terminated by sponsor|15|||
105627871|NCT03248479|364303111|FG002|Overall Study|Study terminated by sponsor|0|||
105627872|NCT03248479|364303112|FG003|Overall Study|Study terminated by sponsor|5|||
105627873|NCT03248479|364303113|FG004|Overall Study|Study terminated by sponsor|0|||
105627874|NCT03248479|364303114|FG005|Overall Study|Study terminated by sponsor|0|||
105627875|NCT03248479|364303115|FG006|Overall Study|Study terminated by sponsor|0|||
105627876|NCT03248479|364303116|FG007|Overall Study|Study terminated by sponsor|1|||
105627877|NCT03248479|364303117|FG008|Overall Study|Study terminated by sponsor|1|||
105627878|NCT03248479|364303118|FG009|Overall Study|Study terminated by sponsor|0|||
105627879|NCT03248479|364303119|FG010|Overall Study|Study terminated by sponsor|5|||
105627880|NCT03248479|364303120|FG011|Overall Study|Study terminated by sponsor|4|||
105627881|NCT03248479|364303121|FG012|Overall Study|Study terminated by sponsor|0|||
105627882|NCT03248479|364303109|FG000|Overall Study|Consent withdrawn|6|||
105627883|NCT03248479|364303110|FG001|Overall Study|Consent withdrawn|3|||
105627884|NCT03248479|364303111|FG002|Overall Study|Consent withdrawn|0|||
105627885|NCT03248479|364303112|FG003|Overall Study|Consent withdrawn|9|||
105627886|NCT03248479|364303113|FG004|Overall Study|Consent withdrawn|1|||
105627887|NCT03248479|364303114|FG005|Overall Study|Consent withdrawn|0|||
105627888|NCT03248479|364303115|FG006|Overall Study|Consent withdrawn|0|||
105627889|NCT03248479|364303116|FG007|Overall Study|Consent withdrawn|1|||
105627890|NCT03248479|364303117|FG008|Overall Study|Consent withdrawn|0|||
105627891|NCT03248479|364303118|FG009|Overall Study|Consent withdrawn|3|||
105627892|NCT03248479|364303119|FG010|Overall Study|Consent withdrawn|1|||
105627893|NCT03248479|364303120|FG011|Overall Study|Consent withdrawn|0|||
105627894|NCT03248479|364303121|FG012|Overall Study|Consent withdrawn|1|||
105627895|NCT03248479|364303109|FG000|Overall Study|Lost to Follow-up|2|||
105627896|NCT03248479|364303110|FG001|Overall Study|Lost to Follow-up|1|||
105627897|NCT03248479|364303111|FG002|Overall Study|Lost to Follow-up|0|||
105627898|NCT03248479|364303112|FG003|Overall Study|Lost to Follow-up|0|||
105627899|NCT03248479|364303113|FG004|Overall Study|Lost to Follow-up|0|||
105627900|NCT03248479|364303114|FG005|Overall Study|Lost to Follow-up|0|||
105627901|NCT03248479|364303115|FG006|Overall Study|Lost to Follow-up|0|||
105627902|NCT03248479|364303116|FG007|Overall Study|Lost to Follow-up|0|||
105627903|NCT03248479|364303117|FG008|Overall Study|Lost to Follow-up|0|||
105627904|NCT03248479|364303118|FG009|Overall Study|Lost to Follow-up|0|||
105627905|NCT03248479|364303119|FG010|Overall Study|Lost to Follow-up|0|||
105627906|NCT03248479|364303120|FG011|Overall Study|Lost to Follow-up|0|||
105627907|NCT03248479|364303121|FG012|Overall Study|Lost to Follow-up|1|||
105627908|NCT03248479|364303109|FG000|Overall Study|Not reported|0|||
105627909|NCT03248479|364303110|FG001|Overall Study|Not reported|0|||
105627910|NCT03248479|364303111|FG002|Overall Study|Not reported|0|||
105627911|NCT03248479|364303112|FG003|Overall Study|Not reported|1|||
105627912|NCT03248479|364303113|FG004|Overall Study|Not reported|1|||
105627913|NCT03248479|364303114|FG005|Overall Study|Not reported|0|||
105627914|NCT03248479|364303115|FG006|Overall Study|Not reported|0|||
105627915|NCT03248479|364303116|FG007|Overall Study|Not reported|1|||
105627916|NCT03248479|364303117|FG008|Overall Study|Not reported|1|||
105627917|NCT03248479|364303118|FG009|Overall Study|Not reported|0|||
105627918|NCT03248479|364303119|FG010|Overall Study|Not reported|0|||
105627919|NCT03248479|364303120|FG011|Overall Study|Not reported|0|||
105627920|NCT03248479|364303121|FG012|Overall Study|Not reported|0|||
105627921|NCT03735979|364303124|FG000|Overall Study|Lost to Follow-up|1|||
105627922|NCT03735979|364303125|FG001|Overall Study|Lost to Follow-up|12|||
105627923|NCT03735979|364303126|FG002|Overall Study|Lost to Follow-up|14|||
105627924|NCT03735979|364303124|FG000|Overall Study|Withdrawal by Subject|1|||
105627925|NCT03735979|364303125|FG001|Overall Study|Withdrawal by Subject|5|||
105627926|NCT03735979|364303126|FG002|Overall Study|Withdrawal by Subject|2|||
105627927|NCT03735979|364303124|FG000|Overall Study|Not due to the above reasons|1|||
105627928|NCT03735979|364303125|FG001|Overall Study|Not due to the above reasons|0|||
105627929|NCT03735979|364303126|FG002|Overall Study|Not due to the above reasons|0|||
105627930|NCT05454514|364303127|FG000|Overall Study|Withdrawal by Subject|4|||
105627931|NCT01438853|364303132|FG000|Overall Study|Death|0|||
105627932|NCT01438853|364303133|FG001|Overall Study|Death|0|||
105627933|NCT01438853|364303134|FG002|Overall Study|Death|0|||
105627934|NCT01438853|364303135|FG003|Overall Study|Death|1|||
105627935|NCT01438853|364303132|FG000|Overall Study|Withdrawal by Subject|0|||
105627936|NCT01438853|364303133|FG001|Overall Study|Withdrawal by Subject|0|||
105627937|NCT01438853|364303134|FG002|Overall Study|Withdrawal by Subject|1|||
105627938|NCT01438853|364303135|FG003|Overall Study|Withdrawal by Subject|0|||
105627939|NCT01949662|364303136|FG000|Overall Study|Death|9|||
105627940|NCT01949662|364303137|FG001|Overall Study|Death|7|||
105627941|NCT01949662|364303136|FG000|Overall Study|Discharged before an agitation event|8|||
105627942|NCT01949662|364303137|FG001|Overall Study|Discharged before an agitation event|3|||
105627943|NCT01949662|364303136|FG000|Overall Study|Dropped out|1|||
105627944|NCT01949662|364303137|FG001|Overall Study|Dropped out|3|||
105627945|NCT01949662|364303136|FG000|Overall Study|Ineligible|0|||
105627946|NCT01949662|364303137|FG001|Overall Study|Ineligible|1|||
105627947|NCT04622046|364303138|FG000|Intervention Period|Adverse Event|1|||
105627948|NCT04622046|364303138|FG000|Intervention Period|Withdrawal by Subject|2|||
105627949|NCT04622046|364303138|FG000|Extension Period|Ongoing in the Extension Period|21|||
105627950|NCT03165955|364303139|FG000|Treatment|Withdrawal by Subject|3|||
105627951|NCT03165955|364303139|FG000|Treatment|Death|1|||
105627952|NCT03165955|364303139|FG000|Treatment|Adverse Event|1|||
105627953|NCT03165955|364303139|FG000|Treatment|Progressive disease|3|||
105627954|NCT02994927|364303140|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105627955|NCT02994927|364303141|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105627956|NCT02994927|364303140|FG000|Overall Study|Did not meet eligibility criteria|0|||
105627957|NCT02994927|364303141|FG001|Overall Study|Did not meet eligibility criteria|1|||
105627958|NCT02994927|364303140|FG000|Overall Study|Physician Decision|4|||
105627959|NCT02994927|364303141|FG001|Overall Study|Physician Decision|3|||
105627960|NCT02994927|364303140|FG000|Overall Study|Death|4|||
105627961|NCT02994927|364303141|FG001|Overall Study|Death|2|||
105627962|NCT02994927|364303140|FG000|Overall Study|Adverse Event|2|||
105627963|NCT02994927|364303141|FG001|Overall Study|Adverse Event|1|||
105627964|NCT02994927|364303140|FG000|Overall Study|Withdrawal by Subject|3|||
105627965|NCT02994927|364303141|FG001|Overall Study|Withdrawal by Subject|6|||
105627966|NCT02994927|364303140|FG000|Overall Study|Lost to Follow-up|2|||
105627967|NCT02994927|364303141|FG001|Overall Study|Lost to Follow-up|1|||
105627968|NCT04499521|364303145|FG000|Overall Study|Disease Progression|1|||
105627969|NCT04499521|364303146|FG001|Overall Study|Disease Progression|0|||
105627970|NCT04626427|364303148|FG000|Overall Study|Death|1|||
105627971|NCT04626427|364303148|FG000|Overall Study|Withdrawal by Subject|1|||
105627972|NCT04626427|364303148|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
105627973|NCT04626427|364303148|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
105627974|NCT03781089|364304007|FG000|Overall Study|Constipation|1|||
105627975|NCT03781089|364304008|FG001|Overall Study|Constipation|0|||
105627976|NCT03781089|364304007|FG000|Overall Study|Positive pregnancy test|0|||
105627977|NCT03781089|364304008|FG001|Overall Study|Positive pregnancy test|1|||
105627978|NCT05020353|364304009|FG000|Overall Study|Protocol Violation|7|||
105627979|NCT05020353|364304009|FG000|Overall Study|Withdrawal by Subject|33|||
105627980|NCT04427007|364304012|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
105627981|NCT04427007|364304013|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
105627982|NCT04633278|364304014|FG000|Overall Study|Adverse Event|1|||
105627983|NCT04633278|364304015|FG001|Overall Study|Adverse Event|0|||
105627984|NCT04633278|364304014|FG000|Overall Study|Withdrawal by Subject|1|||
105627985|NCT04633278|364304015|FG001|Overall Study|Withdrawal by Subject|0|||
105627986|NCT04633278|364304014|FG000|Overall Study|Death|11|||
105627987|NCT04633278|364304015|FG001|Overall Study|Death|7|||
105627988|NCT04633278|364304014|FG000|Overall Study|Sponsor Decision|3|||
105627989|NCT04633278|364304015|FG001|Overall Study|Sponsor Decision|0|||
105627990|NCT04633278|364304014|FG000|Overall Study|Not Listed|1|||
105627991|NCT04633278|364304015|FG001|Overall Study|Not Listed|0|||
105627992|NCT03505710|364304016|FG000|Overall Study|Progressive Disease|24|||
105627993|NCT03505710|364304017|FG001|Overall Study|Progressive Disease|17|||
105627994|NCT03505710|364304018|FG002|Overall Study|Progressive Disease|43|||
105627995|NCT03505710|364304016|FG000|Overall Study|Clinical Progression|6|||
105627996|NCT03505710|364304017|FG001|Overall Study|Clinical Progression|8|||
105627997|NCT03505710|364304018|FG002|Overall Study|Clinical Progression|3|||
105627998|NCT03505710|364304016|FG000|Overall Study|Adverse Event|12|||
105627999|NCT03505710|364304017|FG001|Overall Study|Adverse Event|6|||
105628000|NCT03505710|364304018|FG002|Overall Study|Adverse Event|28|||
105628001|NCT03505710|364304016|FG000|Overall Study|Withdrawal by Subject|1|||
105628002|NCT03505710|364304017|FG001|Overall Study|Withdrawal by Subject|3|||
105628003|NCT03505710|364304018|FG002|Overall Study|Withdrawal by Subject|7|||
105628004|NCT03505710|364304016|FG000|Overall Study|Physician Decision|1|||
105628005|NCT03505710|364304017|FG001|Overall Study|Physician Decision|1|||
105628006|NCT03505710|364304018|FG002|Overall Study|Physician Decision|2|||
105628007|NCT03505710|364304016|FG000|Overall Study|Death|4|||
105628008|NCT03505710|364304017|FG001|Overall Study|Death|5|||
105628009|NCT03505710|364304018|FG002|Overall Study|Death|6|||
105628010|NCT03505710|364304016|FG000|Overall Study|Other Reasons|1|||
105628011|NCT03505710|364304017|FG001|Overall Study|Other Reasons|1|||
105628012|NCT03505710|364304018|FG002|Overall Study|Other Reasons|1|||
105628013|NCT03505710|364304016|FG000|Overall Study|Study Terminated by Sponsor|0|||
105628014|NCT03505710|364304017|FG001|Overall Study|Study Terminated by Sponsor|0|||
105628015|NCT03505710|364304018|FG002|Overall Study|Study Terminated by Sponsor|1|||
105628016|NCT00942734|364304019|FG000|Overall Study|Adverse Event|2|||
105628017|NCT00942734|364304019|FG000|Overall Study|Protocol Violation|3|||
105628018|NCT00942734|364304019|FG000|Overall Study|Disease Progression|2|||
105628019|NCT00942734|364304019|FG000|Overall Study|Physician Decision|1|||
105628020|NCT06010836|364304022|FG000|Overall Study|Lost to Follow-up|2|||
105628021|NCT06010836|364304023|FG001|Overall Study|Lost to Follow-up|2|||
105628022|NCT06010836|364304022|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
105628023|NCT06010836|364304023|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
105628024|NCT06010836|364304022|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
105628025|NCT06010836|364304023|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
105628026|NCT06010836|364304022|FG000|Overall Study|Did not receive intervention discussion|0|||
105628027|NCT06010836|364304023|FG001|Overall Study|Did not receive intervention discussion|4|||
105628028|NCT04496752|364304024|FG000|Second Assessment|Lost to Follow-up|3|||
105628029|NCT04496752|364304025|FG001|Second Assessment|Lost to Follow-up|3|||
105628030|NCT04496752|364304024|FG000|Second Assessment|Adverse Event|2|||
105628031|NCT04496752|364304025|FG001|Second Assessment|Adverse Event|0|||
105628032|NCT03884439|364304047|FG000|Overall Study|No informed consent for publication of study results|38|||
105628033|NCT03884439|364304047|FG000|Overall Study|Contract violation/deficiency|7|||
105628034|NCT02624050|364304050|FG000|Overall Study|Physician Decision|4|||
105628035|NCT02624050|364304051|FG001|Overall Study|Physician Decision|0|||
105628036|NCT02624050|364304050|FG000|Overall Study|Protocol Violation|2|||
105628037|NCT02624050|364304051|FG001|Overall Study|Protocol Violation|0|||
105628038|NCT02933489|364304057|FG000|Overall Study|Ineligible|3|||
105628039|NCT02933489|364304058|FG001|Overall Study|Ineligible|3|||
105440423|NCT02834247|363616795|FG003|Dose Expansion Phase|Death|8|||
105628040|NCT02933489|364304057|FG000|Overall Study|Withdrawal by Subject|27|||
105628041|NCT02933489|364304058|FG001|Overall Study|Withdrawal by Subject|18|||
105628042|NCT02933489|364304057|FG000|Overall Study|Unable to complete exams (other)|14|||
105628043|NCT02933489|364304058|FG001|Overall Study|Unable to complete exams (other)|7|||
105628044|NCT04330040|364304059|FG000|Overall Study|Other: Adverse event|5|||
105628045|NCT04330040|364304060|FG001|Overall Study|Other: Adverse event|0|||
105628046|NCT04330040|364304061|FG002|Overall Study|Other: Adverse event|0|||
105628047|NCT04330040|364304059|FG000|Overall Study|Disease progression|38|||
105628048|NCT04330040|364304060|FG001|Overall Study|Disease progression|10|||
105628049|NCT04330040|364304061|FG002|Overall Study|Disease progression|0|||
105628050|NCT04330040|364304059|FG000|Overall Study|Physician Decision|5|||
105628051|NCT04330040|364304060|FG001|Overall Study|Physician Decision|3|||
105628052|NCT04330040|364304061|FG002|Overall Study|Physician Decision|0|||
105628053|NCT04330040|364304059|FG000|Overall Study|Lost to Follow-up|1|||
105628054|NCT04330040|364304060|FG001|Overall Study|Lost to Follow-up|1|||
105628055|NCT04330040|364304061|FG002|Overall Study|Lost to Follow-up|0|||
105628056|NCT04330040|364304059|FG000|Overall Study|Death|2|||
105628057|NCT04330040|364304060|FG001|Overall Study|Death|1|||
105628058|NCT04330040|364304061|FG002|Overall Study|Death|0|||
105628059|NCT04330040|364304059|FG000|Overall Study|Withdrawal by Subject|3|||
105628060|NCT04330040|364304060|FG001|Overall Study|Withdrawal by Subject|3|||
105628061|NCT04330040|364304061|FG002|Overall Study|Withdrawal by Subject|0|||
105628062|NCT04330040|364304059|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
105628063|NCT04330040|364304060|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
105628064|NCT04330040|364304061|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
105628065|NCT04330040|364304059|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
105628066|NCT04330040|364304060|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
105628067|NCT04330040|364304061|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
105628068|NCT04330040|364304059|FG000|Overall Study|Other: Disease progression|1|||
105628069|NCT04330040|364304060|FG001|Overall Study|Other: Disease progression|0|||
105628070|NCT04330040|364304061|FG002|Overall Study|Other: Disease progression|0|||
105628071|NCT04330040|364304059|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
105628072|NCT04330040|364304060|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
105628073|NCT04330040|364304061|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
105628074|NCT04330040|364304059|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
105628075|NCT04330040|364304060|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
105628076|NCT04330040|364304061|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
105628077|NCT04330040|364304059|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
105628078|NCT04330040|364304060|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
105628079|NCT04330040|364304061|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
105628080|NCT00626795|364304062|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
105628081|NCT00626795|364304063|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
105628082|NCT00626795|364304064|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
105628083|NCT00626795|364304062|FG000|Blinded Treatment|Lack of Efficacy|2|||
105628084|NCT00626795|364304063|FG001|Blinded Treatment|Lack of Efficacy|0|||
105628085|NCT00626795|364304064|FG002|Blinded Treatment|Lack of Efficacy|0|||
105628086|NCT00626795|364304062|FG000|Blinded Treatment|Unacceptable adverse event|0|||
105628087|NCT00626795|364304063|FG001|Blinded Treatment|Unacceptable adverse event|0|||
105628088|NCT00626795|364304064|FG002|Blinded Treatment|Unacceptable adverse event|1|||
105628089|NCT00626795|364304062|FG000|Blinded Treatment|Protocol Violation|0|||
105628090|NCT00626795|364304063|FG001|Blinded Treatment|Protocol Violation|1|||
105628091|NCT00626795|364304064|FG002|Blinded Treatment|Protocol Violation|1|||
105628092|NCT00626795|364304062|FG000|Blinded Treatment|Withdrawal by Subject|1|||
105628093|NCT00626795|364304063|FG001|Blinded Treatment|Withdrawal by Subject|1|||
105628094|NCT00626795|364304064|FG002|Blinded Treatment|Withdrawal by Subject|0|||
105628095|NCT00626795|364304062|FG000|Blinded Treatment|Other reasons|2|||
105628096|NCT00626795|364304063|FG001|Blinded Treatment|Other reasons|0|||
105628097|NCT00626795|364304064|FG002|Blinded Treatment|Other reasons|2|||
105628098|NCT00626795|364304062|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
105628099|NCT00626795|364304063|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
105628100|NCT00626795|364304064|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
105628101|NCT03092674|364304067|FG000|Overall Study|Adverse Event or Side Effects|1|||
105628102|NCT03092674|364304068|FG001|Overall Study|Adverse Event or Side Effects|4|||
105628103|NCT03092674|364304069|FG002|Overall Study|Adverse Event or Side Effects|4|||
105628104|NCT03092674|364304067|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
105628105|NCT03092674|364304068|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
105628106|NCT03092674|364304069|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
105628107|NCT03092674|364304067|FG000|Overall Study|Progression/Relapse|5|||
105628108|NCT03092674|364304068|FG001|Overall Study|Progression/Relapse|4|||
105628109|NCT03092674|364304069|FG002|Overall Study|Progression/Relapse|8|||
105628110|NCT03092674|364304067|FG000|Overall Study|Death|4|||
105628111|NCT03092674|364304068|FG001|Overall Study|Death|8|||
105628112|NCT03092674|364304069|FG002|Overall Study|Death|2|||
105628113|NCT03092674|364304067|FG000|Overall Study|Other - Not Protocol Specified|11|||
105628114|NCT03092674|364304068|FG001|Overall Study|Other - Not Protocol Specified|8|||
105628115|NCT03092674|364304069|FG002|Overall Study|Other - Not Protocol Specified|8|||
105628116|NCT03587805|364304070|FG000|Overall Study|Adverse Event|72|||
105628117|NCT03587805|364304070|FG000|Overall Study|Death|1|||
105628118|NCT03587805|364304070|FG000|Overall Study|Lost to Follow-up|78|||
105628119|NCT03587805|364304070|FG000|Overall Study|Withdrawal by Subject|105|||
105628120|NCT03587805|364304070|FG000|Overall Study|Lack of Efficacy|119|||
105628121|NCT03587805|364304070|FG000|Overall Study|Reason unknown|26|||
105628122|NCT03587805|364304070|FG000|Overall Study|COVID_19 pandemic|4|||
105628123|NCT03587805|364304070|FG000|Overall Study|Various reasons|121|||
105628124|NCT03587805|364304070|FG000|Overall Study|Withdrawal by parent/guardian|3|||
105628125|NCT03982186|364304071|FG000|Overall Study|Lost to Follow-up|0|||
105628126|NCT03982186|364304072|FG001|Overall Study|Lost to Follow-up|1|||
105628127|NCT03982186|364304073|FG002|Overall Study|Lost to Follow-up|2|||
105628128|NCT03982186|364304074|FG003|Overall Study|Lost to Follow-up|1|||
105628129|NCT03982186|364304075|FG004|Overall Study|Lost to Follow-up|1|||
105628130|NCT03982186|364304076|FG005|Overall Study|Lost to Follow-up|0|||
105628131|NCT03982186|364304071|FG000|Overall Study|Physician Decision|0|||
105628132|NCT03982186|364304072|FG001|Overall Study|Physician Decision|1|||
105628133|NCT03982186|364304073|FG002|Overall Study|Physician Decision|0|||
105628134|NCT03982186|364304074|FG003|Overall Study|Physician Decision|0|||
105628135|NCT03982186|364304075|FG004|Overall Study|Physician Decision|0|||
105628136|NCT03982186|364304076|FG005|Overall Study|Physician Decision|0|||
105628137|NCT03982186|364304071|FG000|Overall Study|Withdrawal by Subject|3|||
105628138|NCT03982186|364304072|FG001|Overall Study|Withdrawal by Subject|4|||
105628139|NCT03982186|364304073|FG002|Overall Study|Withdrawal by Subject|1|||
105628140|NCT03982186|364304074|FG003|Overall Study|Withdrawal by Subject|7|||
105628141|NCT03982186|364304075|FG004|Overall Study|Withdrawal by Subject|2|||
105628142|NCT03982186|364304076|FG005|Overall Study|Withdrawal by Subject|0|||
105628143|NCT03982186|364304071|FG000|Overall Study|Randomized and not treated|0|||
105628144|NCT03982186|364304072|FG001|Overall Study|Randomized and not treated|0|||
105628145|NCT03982186|364304073|FG002|Overall Study|Randomized and not treated|0|||
105628146|NCT03982186|364304074|FG003|Overall Study|Randomized and not treated|1|||
105628147|NCT03982186|364304075|FG004|Overall Study|Randomized and not treated|0|||
105628148|NCT03982186|364304076|FG005|Overall Study|Randomized and not treated|0|||
105628149|NCT03367156|364304906|FG000|Overall Study|Lack of interest|3|||
105628150|NCT03367156|364304907|FG001|Overall Study|Lack of interest|1|||
105628151|NCT03367156|364304906|FG000|Overall Study|Death|2|||
105628152|NCT03367156|364304907|FG001|Overall Study|Death|0|||
105628153|NCT03367156|364304906|FG000|Overall Study|Lost to Follow-up|2|||
105628154|NCT03367156|364304907|FG001|Overall Study|Lost to Follow-up|1|||
105628155|NCT03367156|364304906|FG000|Overall Study|Became ineligible|1|||
105628156|NCT03367156|364304907|FG001|Overall Study|Became ineligible|2|||
105628157|NCT03367156|364304906|FG000|Overall Study|Hospitalization|1|||
105628158|NCT03367156|364304907|FG001|Overall Study|Hospitalization|0|||
105628159|NCT03367156|364304906|FG000|Overall Study|Concerned about Treatment|11|||
105628160|NCT03367156|364304907|FG001|Overall Study|Concerned about Treatment|3|||
105628161|NCT03367156|364304906|FG000|Overall Study|Started new treatment|4|||
105628162|NCT03367156|364304907|FG001|Overall Study|Started new treatment|1|||
105628163|NCT03106740|364304908|FG000|Overall Study|Lost to Follow-up|2|||
105628164|NCT03106740|364304909|FG001|Overall Study|Lost to Follow-up|2|||
105628165|NCT03106740|364304908|FG000|Overall Study|Withdrawal by Subject|2|||
105628166|NCT03106740|364304909|FG001|Overall Study|Withdrawal by Subject|4|||
105628167|NCT03106740|364304908|FG000|Overall Study|Physician Decision|0|||
105628168|NCT03106740|364304909|FG001|Overall Study|Physician Decision|1|||
105628169|NCT03106740|364304908|FG000|Overall Study|Partial data|1|||
105628170|NCT03106740|364304909|FG001|Overall Study|Partial data|0|||
105628171|NCT01586910|364304911|FG000|Overall Study|Death|4|||
105628172|NCT01586910|364304912|FG001|Overall Study|Death|4|||
105628173|NCT01586910|364304911|FG000|Overall Study|Withdrawal by Subject|6|||
105628174|NCT01586910|364304912|FG001|Overall Study|Withdrawal by Subject|43|||
105628175|NCT01586910|364304911|FG000|Overall Study|Physician withdrew Subject|5|||
105628176|NCT01586910|364304912|FG001|Overall Study|Physician withdrew Subject|24|||
105628177|NCT05507437|364304913|FG000|Overall Study|Withdrawal by Subject|1|||
105628178|NCT05507437|364304914|FG001|Overall Study|Withdrawal by Subject|1|||
105628179|NCT05507437|364304913|FG000|Overall Study|Death|3|||
105628180|NCT05507437|364304914|FG001|Overall Study|Death|0|||
105628181|NCT03636490|364304915|FG000|Overall Study|Dropped out or incomplete data|141|||
105628182|NCT02246127|364304916|FG000|First Course Treatment|Adverse Event|9|||
105628183|NCT02246127|364304917|FG001|First Course Treatment|Adverse Event|7|||
105628184|NCT02246127|364304916|FG000|First Course Treatment|Withdrawal by Subject|6|||
105628185|NCT02246127|364304917|FG001|First Course Treatment|Withdrawal by Subject|7|||
105628186|NCT02246127|364304916|FG000|First Course Treatment|Physician Decision|9|||
105628187|NCT02246127|364304917|FG001|First Course Treatment|Physician Decision|9|||
105628188|NCT02246127|364304916|FG000|First Course Treatment|Death|3|||
105628189|NCT02246127|364304917|FG001|First Course Treatment|Death|3|||
105628190|NCT02246127|364304916|FG000|First Course Treatment|Not reported reasons|6|||
105628191|NCT02246127|364304917|FG001|First Course Treatment|Not reported reasons|7|||
105628192|NCT02246127|364304916|FG000|First Course Treatment|Not treated|3|||
105628193|NCT02246127|364304917|FG001|First Course Treatment|Not treated|3|||
105628194|NCT05311176|364304918|FG000|Overall Study|Death|6|||
105628195|NCT05311176|364304918|FG000|Overall Study|Sponsor discontinued the study|1|||
105628196|NCT04967599|364304924|FG000|Overall Study|Lost to Follow-up|35|||
105628197|NCT04967599|364304925|FG001|Overall Study|Lost to Follow-up|19|||
105628198|NCT04967599|364304926|FG002|Overall Study|Lost to Follow-up|23|||
105628199|NCT03662022|364304933|FG000|Year 1 2019|prevalent case|83|||
105628200|NCT03662022|364304934|FG001|Year 1 2019|prevalent case|116|||
105628201|NCT03662022|364304935|FG002|Year 1 2019|prevalent case|158|||
105628202|NCT03662022|364304936|FG003|Year 1 2019|prevalent case|99|||
105628203|NCT03662022|364304933|FG000|Year 2 2020|incident case|18|||
105628204|NCT03662022|364304934|FG001|Year 2 2020|incident case|18|||
105628205|NCT03662022|364304935|FG002|Year 2 2020|incident case|16|||
105628206|NCT03662022|364304936|FG003|Year 2 2020|incident case|26|||
105628207|NCT03662022|364304933|FG000|Year 2 2020|other case|18|||
105628208|NCT03662022|364304934|FG001|Year 2 2020|other case|16|||
105628209|NCT03662022|364304935|FG002|Year 2 2020|other case|16|||
105628210|NCT03662022|364304936|FG003|Year 2 2020|other case|24|||
105628211|NCT03662022|364304933|FG000|Year 2 2020|Lost to Follow-up|1633|||
105628212|NCT03662022|364304934|FG001|Year 2 2020|Lost to Follow-up|1183|||
105628213|NCT03662022|364304935|FG002|Year 2 2020|Lost to Follow-up|1381|||
105628214|NCT03662022|364304936|FG003|Year 2 2020|Lost to Follow-up|2858|||
105628215|NCT03662022|364304933|FG000|Year 3 2021|incident case|24|||
105628216|NCT03662022|364304934|FG001|Year 3 2021|incident case|27|||
105628217|NCT03662022|364304935|FG002|Year 3 2021|incident case|24|||
105628218|NCT03662022|364304936|FG003|Year 3 2021|incident case|11|||
105628219|NCT03662022|364304933|FG000|Year 3 2021|other case|4|||
105628220|NCT03662022|364304934|FG001|Year 3 2021|other case|15|||
105628221|NCT03662022|364304935|FG002|Year 3 2021|other case|10|||
105628222|NCT03662022|364304936|FG003|Year 3 2021|other case|14|||
105628223|NCT03662022|364304933|FG000|Year 3 2021|Lost to Follow-up|179|||
105628224|NCT03662022|364304934|FG001|Year 3 2021|Lost to Follow-up|244|||
105628225|NCT03662022|364304935|FG002|Year 3 2021|Lost to Follow-up|480|||
105628226|NCT03662022|364304936|FG003|Year 3 2021|Lost to Follow-up|477|||
105628227|NCT03662022|364304933|FG000|Year 4 2022|incident case|25|||
105628228|NCT03662022|364304934|FG001|Year 4 2022|incident case|41|||
105628229|NCT03662022|364304935|FG002|Year 4 2022|incident case|28|||
105628230|NCT03662022|364304936|FG003|Year 4 2022|incident case|7|||
105628231|NCT03662022|364304933|FG000|Year 4 2022|other case|8|||
105628232|NCT03662022|364304934|FG001|Year 4 2022|other case|19|||
105628233|NCT03662022|364304935|FG002|Year 4 2022|other case|13|||
105628234|NCT03662022|364304936|FG003|Year 4 2022|other case|7|||
105628235|NCT03662022|364304933|FG000|Year 4 2022|Lost to Follow-up|986|||
105628236|NCT03662022|364304934|FG001|Year 4 2022|Lost to Follow-up|1079|||
105628237|NCT03662022|364304935|FG002|Year 4 2022|Lost to Follow-up|1236|||
105628238|NCT03662022|364304936|FG003|Year 4 2022|Lost to Follow-up|1826|||
105628239|NCT04490109|364304937|FG000|Overall Study|Lost to Follow-up|3|||
105628240|NCT04490109|364304938|FG001|Overall Study|Lost to Follow-up|10|||
105628241|NCT04490109|364304939|FG002|Overall Study|Lost to Follow-up|4|||
105628242|NCT04490109|364304937|FG000|Overall Study|Withdrawal by Subject|8|||
105628243|NCT04490109|364304938|FG001|Overall Study|Withdrawal by Subject|6|||
105628244|NCT04490109|364304939|FG002|Overall Study|Withdrawal by Subject|9|||
105628245|NCT04490109|364304937|FG000|Overall Study|Physician Decision|0|||
105628246|NCT04490109|364304938|FG001|Overall Study|Physician Decision|2|||
105628247|NCT04490109|364304939|FG002|Overall Study|Physician Decision|3|||
105628248|NCT04490109|364304937|FG000|Overall Study|Adverse Event|2|||
105628249|NCT04490109|364304938|FG001|Overall Study|Adverse Event|1|||
105628250|NCT04490109|364304939|FG002|Overall Study|Adverse Event|0|||
105628251|NCT04490109|364304937|FG000|Overall Study|Significant Non-Compliance|2|||
105628252|NCT04490109|364304938|FG001|Overall Study|Significant Non-Compliance|4|||
105628253|NCT04490109|364304939|FG002|Overall Study|Significant Non-Compliance|4|||
105628254|NCT04490109|364304937|FG000|Overall Study|Significant Clinical Event|0|||
105628255|NCT04490109|364304938|FG001|Overall Study|Significant Clinical Event|1|||
105628256|NCT04490109|364304939|FG002|Overall Study|Significant Clinical Event|0|||
105628257|NCT04490109|364304937|FG000|Overall Study|Other Reason|4|||
105628258|NCT04490109|364304938|FG001|Overall Study|Other Reason|1|||
105628259|NCT04490109|364304939|FG002|Overall Study|Other Reason|1|||
105628260|NCT03817983|364304940|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
105628261|NCT03817983|364304941|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
105628262|NCT03817983|364304942|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
105628263|NCT04908930|364304943|FG000|Overall Study|Lost to Follow-up|1|||
105628264|NCT04908930|364304944|FG001|Overall Study|Lost to Follow-up|1|||
105628265|NCT04908930|364304945|FG002|Overall Study|Lost to Follow-up|0|||
105628266|NCT04908930|364304946|FG003|Overall Study|Lost to Follow-up|0|||
105628267|NCT04908930|364304947|FG004|Overall Study|Lost to Follow-up|0|||
105628268|NCT04908930|364304943|FG000|Overall Study|hardware in mouth|1|||
105628269|NCT04908930|364304944|FG001|Overall Study|hardware in mouth|1|||
105628270|NCT04908930|364304945|FG002|Overall Study|hardware in mouth|0|||
105628271|NCT04908930|364304946|FG003|Overall Study|hardware in mouth|0|||
105628272|NCT04908930|364304947|FG004|Overall Study|hardware in mouth|0|||
105628273|NCT04908930|364304943|FG000|Overall Study|wrong team|1|||
105628274|NCT04908930|364304944|FG001|Overall Study|wrong team|0|||
105628275|NCT04908930|364304945|FG002|Overall Study|wrong team|0|||
105628276|NCT04908930|364304946|FG003|Overall Study|wrong team|0|||
105628277|NCT04908930|364304947|FG004|Overall Study|wrong team|0|||
105628278|NCT04908930|364304943|FG000|Overall Study|quit team|2|||
105628279|NCT04908930|364304944|FG001|Overall Study|quit team|4|||
105628280|NCT04908930|364304945|FG002|Overall Study|quit team|0|||
105628281|NCT04908930|364304946|FG003|Overall Study|quit team|0|||
105628282|NCT04908930|364304947|FG004|Overall Study|quit team|0|||
105628283|NCT04908930|364304943|FG000|Overall Study|Withdrawal by Subject|1|||
105628284|NCT04908930|364304944|FG001|Overall Study|Withdrawal by Subject|2|||
105628285|NCT04908930|364304945|FG002|Overall Study|Withdrawal by Subject|0|||
105628286|NCT04908930|364304946|FG003|Overall Study|Withdrawal by Subject|0|||
105628287|NCT04908930|364304947|FG004|Overall Study|Withdrawal by Subject|0|||
105628288|NCT04908930|364304943|FG000|Overall Study|parent not liking program|0|||
105628289|NCT04908930|364304944|FG001|Overall Study|parent not liking program|1|||
105628290|NCT04908930|364304945|FG002|Overall Study|parent not liking program|0|||
105628291|NCT04908930|364304946|FG003|Overall Study|parent not liking program|0|||
105628292|NCT04908930|364304947|FG004|Overall Study|parent not liking program|0|||
105628293|NCT05785130|364304950|FG000|Overall Study|Withdrawal by Subject|1|||
105628294|NCT05785130|364304951|FG001|Overall Study|Withdrawal by Subject|0|||
105628295|NCT05785130|364304950|FG000|Overall Study|Lack of Efficacy|0|||
105628296|NCT05785130|364304951|FG001|Overall Study|Lack of Efficacy|1|||
105628297|NCT02532621|364304956|FG000|Overall Study|Death|3|||
105628298|NCT02532621|364304956|FG000|Overall Study|Lost to Follow-up|3|||
105628299|NCT02532621|364304956|FG000|Overall Study|Withdrawal by Subject|6|||
105628300|NCT02532621|364304956|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
105628301|NCT02532621|364304956|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
105628302|NCT03522298|364304957|FG000|Overall Study|Adverse Event|1|||
105628303|NCT03522298|364304958|FG001|Overall Study|Adverse Event|0|||
105628304|NCT03522298|364304959|FG002|Overall Study|Adverse Event|0|||
105628305|NCT03522298|364304960|FG003|Overall Study|Adverse Event|1|||
105628306|NCT03522298|364304957|FG000|Overall Study|Death|2|||
105628307|NCT03522298|364304958|FG001|Overall Study|Death|4|||
105628308|NCT03522298|364304959|FG002|Overall Study|Death|8|||
105628309|NCT03522298|364304960|FG003|Overall Study|Death|8|||
105628310|NCT03522298|364304957|FG000|Overall Study|Patient decision|0|||
105628311|NCT03522298|364304958|FG001|Overall Study|Patient decision|2|||
105628312|NCT03522298|364304959|FG002|Overall Study|Patient decision|2|||
105628313|NCT03522298|364304960|FG003|Overall Study|Patient decision|2|||
105628314|NCT04761198|364304970|FG000|Overall Study|Progressive Disease|1|||
105628315|NCT04761198|364304971|FG001|Overall Study|Progressive Disease|0|||
105628316|NCT04761198|364304972|FG002|Overall Study|Progressive Disease|0|||
105628317|NCT04761198|364304973|FG003|Overall Study|Progressive Disease|1|||
105628318|NCT04761198|364304974|FG004|Overall Study|Progressive Disease|4|||
105628319|NCT04761198|364304975|FG005|Overall Study|Progressive Disease|1|||
105628320|NCT04761198|364304976|FG006|Overall Study|Progressive Disease|2|||
105628321|NCT04761198|364304970|FG000|Overall Study|Protocol Violation|0|||
105628322|NCT04761198|364304971|FG001|Overall Study|Protocol Violation|0|||
105628323|NCT04761198|364304972|FG002|Overall Study|Protocol Violation|0|||
105628324|NCT04761198|364304973|FG003|Overall Study|Protocol Violation|0|||
105628325|NCT04761198|364304974|FG004|Overall Study|Protocol Violation|1|||
105628326|NCT04761198|364304975|FG005|Overall Study|Protocol Violation|0|||
105628327|NCT04761198|364304976|FG006|Overall Study|Protocol Violation|0|||
105628328|NCT04761198|364304970|FG000|Overall Study|Death|2|||
105628329|NCT04761198|364304971|FG001|Overall Study|Death|1|||
105628330|NCT04761198|364304972|FG002|Overall Study|Death|2|||
105628331|NCT04761198|364304973|FG003|Overall Study|Death|5|||
105628332|NCT04761198|364304974|FG004|Overall Study|Death|14|||
105628333|NCT04761198|364304975|FG005|Overall Study|Death|2|||
105628334|NCT04761198|364304976|FG006|Overall Study|Death|5|||
105628335|NCT04761198|364304970|FG000|Overall Study|Lost to Follow-up|0|||
105628336|NCT04761198|364304971|FG001|Overall Study|Lost to Follow-up|0|||
105628337|NCT04761198|364304972|FG002|Overall Study|Lost to Follow-up|0|||
105628338|NCT04761198|364304973|FG003|Overall Study|Lost to Follow-up|0|||
105628339|NCT04761198|364304974|FG004|Overall Study|Lost to Follow-up|1|||
105628340|NCT04761198|364304975|FG005|Overall Study|Lost to Follow-up|0|||
105628341|NCT04761198|364304976|FG006|Overall Study|Lost to Follow-up|0|||
105628342|NCT04761198|364304970|FG000|Overall Study|Withdrawal by Subject|2|||
105628343|NCT04761198|364304971|FG001|Overall Study|Withdrawal by Subject|0|||
105628344|NCT04761198|364304972|FG002|Overall Study|Withdrawal by Subject|1|||
105628345|NCT04761198|364304973|FG003|Overall Study|Withdrawal by Subject|0|||
105628346|NCT04761198|364304974|FG004|Overall Study|Withdrawal by Subject|2|||
105628347|NCT04761198|364304975|FG005|Overall Study|Withdrawal by Subject|0|||
105628348|NCT04761198|364304976|FG006|Overall Study|Withdrawal by Subject|1|||
105628349|NCT04761198|364304970|FG000|Overall Study|Study Terminated by Sponsor|6|||
105628350|NCT04761198|364304971|FG001|Overall Study|Study Terminated by Sponsor|0|||
105628351|NCT04761198|364304972|FG002|Overall Study|Study Terminated by Sponsor|5|||
105628352|NCT04761198|364304973|FG003|Overall Study|Study Terminated by Sponsor|3|||
105628353|NCT04761198|364304974|FG004|Overall Study|Study Terminated by Sponsor|10|||
105628354|NCT04761198|364304975|FG005|Overall Study|Study Terminated by Sponsor|1|||
105628355|NCT04761198|364304976|FG006|Overall Study|Study Terminated by Sponsor|2|||
105628356|NCT03493542|364304984|FG000|Base Study|Withdrawal by Subject|0|||
105628357|NCT03493542|364304985|FG001|Base Study|Withdrawal by Subject|4|||
105628358|NCT03493542|364304986|FG002|Base Study|Withdrawal by Subject|0|||
105628359|NCT03493542|364304984|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
105628360|NCT03493542|364304985|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
105628361|NCT03493542|364304986|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
105628362|NCT03493542|364304984|FG000|Extension Study|Withdrawal by Subject|0|||
105628363|NCT03493542|364304985|FG001|Extension Study|Withdrawal by Subject|0|||
105628364|NCT03493542|364304986|FG002|Extension Study|Withdrawal by Subject|25|||
105628365|NCT05485935|364304987|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
105628366|NCT05485935|364304988|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
105628367|NCT05485935|364304987|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
105628368|NCT05485935|364304988|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
105628369|NCT05485935|364304987|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
105628370|NCT05485935|364304988|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
105628371|NCT05485935|364304987|FG000|Period 2 (T2 and V3)|loss of contact|0|||
105628372|NCT05485935|364304988|FG001|Period 2 (T2 and V3)|loss of contact|1|||
105628373|NCT04093869|364304990|FG000|Overall Study|Death|0|||
105628374|NCT04093869|364304991|FG001|Overall Study|Death|1|||
105628375|NCT04093869|364304990|FG000|Overall Study|Withdrawal by Subject|1|||
105628376|NCT04093869|364304991|FG001|Overall Study|Withdrawal by Subject|0|||
105628377|NCT04780581|364304992|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
105628378|NCT04780581|364304993|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
105628379|NCT04780581|364304992|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
105628380|NCT04780581|364304993|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
105628381|NCT01756300|364304994|FG000|Overall Study|Death|1|||
105628382|NCT01756300|364304994|FG000|Overall Study|Withdrawal by Subject|1|||
105628383|NCT05866926|364304995|FG000|Overall Study|Death|16|||
105628384|NCT05866926|364304996|FG001|Overall Study|Death|9|||
105628385|NCT05866926|364304995|FG000|Overall Study|Lost to Follow-up|0|||
105628386|NCT05866926|364304996|FG001|Overall Study|Lost to Follow-up|1|||
105628387|NCT05866926|364304995|FG000|Overall Study|Adverse Event|1|||
105628388|NCT05866926|364304996|FG001|Overall Study|Adverse Event|0|||
105628389|NCT05866926|364304995|FG000|Overall Study|Withdrawal by Subject|5|||
105628390|NCT05866926|364304996|FG001|Overall Study|Withdrawal by Subject|1|||
105628391|NCT05866926|364304995|FG000|Overall Study|Disease progression|1|||
105628392|NCT05866926|364304996|FG001|Overall Study|Disease progression|0|||
105628393|NCT05866926|364304995|FG000|Overall Study|other causes|2|||
105628394|NCT05866926|364304996|FG001|Overall Study|other causes|1|||
105628395|NCT06065735|364305657|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
105628396|NCT06065735|364305658|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
105628397|NCT06065735|364305659|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
105628398|NCT06065735|364305657|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
105628399|NCT06065735|364305658|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
105628400|NCT06065735|364305659|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
105628401|NCT06065735|364305657|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
105628402|NCT06065735|364305658|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
105628403|NCT06065735|364305659|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
105628404|NCT06065735|364305657|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
105628405|NCT06065735|364305658|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
105628406|NCT06065735|364305659|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
105628407|NCT06065735|364305657|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
105628408|NCT06065735|364305658|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
105628409|NCT06065735|364305659|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
105628410|NCT05718687|364305660|FG000|Overall Study|Withdrawal by Subject|3|||
105628411|NCT03418740|364305661|FG000|Overall Study|Lost to Follow-up|13|||
105628412|NCT03418740|364305661|FG000|Overall Study|Scheduling Issues|7|||
105628413|NCT03418740|364305661|FG000|Overall Study|Withdrawal by Subject|2|||
105628414|NCT03418740|364305661|FG000|Overall Study|Unable to Continue Consent|1|||
105628415|NCT05215054|364305666|FG000|Overall Study|Lost to Follow-up|1|||
105628416|NCT05215054|364305667|FG001|Overall Study|Lost to Follow-up|1|||
105628417|NCT05215054|364305666|FG000|Overall Study|Protocol Violation|1|||
105628418|NCT05215054|364305667|FG001|Overall Study|Protocol Violation|1|||
105628419|NCT05215054|364305666|FG000|Overall Study|Withdrawal by Subject|4|||
105628420|NCT05215054|364305667|FG001|Overall Study|Withdrawal by Subject|4|||
105628421|NCT01897441|364305669|FG000|Overall Study|Lost to Follow-up|0|||
105628422|NCT01897441|364305670|FG001|Overall Study|Lost to Follow-up|0|||
105628423|NCT01897441|364305671|FG002|Overall Study|Lost to Follow-up|1|||
105628424|NCT01897441|364305672|FG003|Overall Study|Lost to Follow-up|0|||
105628425|NCT01897441|364305673|FG004|Overall Study|Lost to Follow-up|0|||
105628426|NCT01897441|364305674|FG005|Overall Study|Lost to Follow-up|0|||
105628427|NCT01897441|364305669|FG000|Overall Study|Withdrawal by Subject|0|||
105628428|NCT01897441|364305670|FG001|Overall Study|Withdrawal by Subject|0|||
105628429|NCT01897441|364305671|FG002|Overall Study|Withdrawal by Subject|0|||
105628430|NCT01897441|364305672|FG003|Overall Study|Withdrawal by Subject|0|||
105628431|NCT01897441|364305673|FG004|Overall Study|Withdrawal by Subject|1|||
105628432|NCT01897441|364305674|FG005|Overall Study|Withdrawal by Subject|0|||
105628433|NCT01897441|364305669|FG000|Overall Study|Withdrawn by Provider|0|||
105628434|NCT01897441|364305670|FG001|Overall Study|Withdrawn by Provider|2|||
105628435|NCT01897441|364305671|FG002|Overall Study|Withdrawn by Provider|0|||
105628436|NCT01897441|364305672|FG003|Overall Study|Withdrawn by Provider|0|||
105628437|NCT01897441|364305673|FG004|Overall Study|Withdrawn by Provider|0|||
105628438|NCT01897441|364305674|FG005|Overall Study|Withdrawn by Provider|0|||
105628439|NCT05424718|364305678|FG000|Overall Study|Lost to Follow-up|5|||
105628440|NCT05424718|364305679|FG001|Overall Study|Lost to Follow-up|4|||
105628441|NCT02461134|364305680|FG000|Overall Study|Adverse Event|1|||
105628442|NCT03533257|364305681|FG000|Overall Study|Adverse Event|4|||
105628443|NCT03533257|364305682|FG001|Overall Study|Adverse Event|2|||
105628444|NCT03533257|364305681|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
105628445|NCT03533257|364305682|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
105628446|NCT04159519|364305683|FG000|Overall Study|Adverse Event|1|||
105628447|NCT04159519|364305684|FG001|Overall Study|Adverse Event|1|||
105628448|NCT04159519|364305683|FG000|Overall Study|Lack of Efficacy|1|||
105628449|NCT04159519|364305684|FG001|Overall Study|Lack of Efficacy|0|||
105628450|NCT04159519|364305683|FG000|Overall Study|Discontinued from study|1|||
105628451|NCT04159519|364305684|FG001|Overall Study|Discontinued from study|0|||
105628452|NCT04159519|364305683|FG000|Overall Study|Protocol Violation|1|||
105628453|NCT04159519|364305684|FG001|Overall Study|Protocol Violation|1|||
105628454|NCT04159519|364305683|FG000|Overall Study|Withdrawal by Subject|4|||
105628455|NCT04159519|364305684|FG001|Overall Study|Withdrawal by Subject|4|||
105628456|NCT02325154|364305692|FG000|Overall Study|Physician Decision|1|||
105628457|NCT00709956|364305693|FG000|Overall Study|Withdrawal by Subject|1|||
105628458|NCT00709956|364305694|FG001|Overall Study|Withdrawal by Subject|1|||
105628459|NCT00709956|364305693|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
105628460|NCT00709956|364305694|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
105628461|NCT01105091|364305695|FG000|Overall Study|Death|2|||
105628462|NCT01105091|364305696|FG001|Overall Study|Death|0|||
105628463|NCT02765412|364305697|FG000|Overall Study|Death|482|||
105628464|NCT02765412|364305698|FG001|Overall Study|Death|855|||
105628465|NCT04464564|364306161|FG000|Period A (Placebo lead-in)|Other|5|||
105628466|NCT04464564|364306162|FG001|Period A (Placebo lead-in)|Other|0|||
105628467|NCT04464564|364306163|FG002|Period A (Placebo lead-in)|Other|0|||
105628468|NCT04464564|364306164|FG003|Period A (Placebo lead-in)|Other|0|||
105628469|NCT04464564|364306161|FG000|Period B (Randomization Period)|Adverse Event|0|||
105628470|NCT04464564|364306162|FG001|Period B (Randomization Period)|Adverse Event|1|||
105628471|NCT04464564|364306163|FG002|Period B (Randomization Period)|Adverse Event|2|||
105628472|NCT04464564|364306164|FG003|Period B (Randomization Period)|Adverse Event|8|||
105628473|NCT04464564|364306161|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
105628474|NCT04464564|364306162|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
105628475|NCT04464564|364306163|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
105628476|NCT04464564|364306164|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
105628477|NCT04464564|364306161|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
105628478|NCT04464564|364306162|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
105628479|NCT04464564|364306163|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
105628480|NCT04464564|364306164|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
105628481|NCT04464564|364306161|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
105628482|NCT04464564|364306162|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
105628483|NCT04464564|364306163|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
105628484|NCT04464564|364306164|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
105628485|NCT04464564|364306161|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
105628486|NCT04464564|364306162|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
105628487|NCT04464564|364306163|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
105628488|NCT04464564|364306164|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
105628489|NCT04464564|364306161|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
105628490|NCT04464564|364306162|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
105628491|NCT04464564|364306163|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
105628492|NCT04464564|364306164|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
105628493|NCT04464564|364306161|FG000|Period B (Randomization Period)|Reason not Specified|0|||
105628494|NCT04464564|364306162|FG001|Period B (Randomization Period)|Reason not Specified|3|||
105628495|NCT04464564|364306163|FG002|Period B (Randomization Period)|Reason not Specified|3|||
105628496|NCT04464564|364306164|FG003|Period B (Randomization Period)|Reason not Specified|3|||
105628497|NCT04389957|364306170|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
105628498|NCT04389957|364306171|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
105628499|NCT04389957|364306172|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
105628500|NCT04389957|364306173|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
105628501|NCT04389957|364306174|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
105628502|NCT03635424|364306175|FG000|Overall Study|Adverse Event|1|||
105628503|NCT03635424|364306175|FG000|Overall Study|Death|1|||
105628504|NCT03635424|364306175|FG000|Overall Study|Device not implanted|1|||
105628505|NCT03812614|364306176|FG000|Intervention|Withdrawal by Subject|7|||
105628506|NCT03812614|364306177|FG001|Intervention|Withdrawal by Subject|2|||
105628507|NCT03812614|364306178|FG002|Intervention|Withdrawal by Subject|7|||
105628508|NCT03812614|364306179|FG003|Intervention|Withdrawal by Subject|2|||
105628509|NCT03812614|364306176|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
105628510|NCT03812614|364306177|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
105628511|NCT03812614|364306178|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
105628512|NCT03812614|364306179|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
105628513|NCT03812614|364306176|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
105628514|NCT03812614|364306177|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
105628515|NCT03812614|364306178|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
105628516|NCT03812614|364306179|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
105628517|NCT03812614|364306176|FG000|6-month Follow-up|Lost to Follow-up|0|||
105628518|NCT03812614|364306177|FG001|6-month Follow-up|Lost to Follow-up|0|||
105628519|NCT03812614|364306178|FG002|6-month Follow-up|Lost to Follow-up|12|||
105628520|NCT03812614|364306179|FG003|6-month Follow-up|Lost to Follow-up|8|||
105628521|NCT03812614|364306176|FG000|12-month Follow-up|Lost to Follow-up|18|||
105628522|NCT03812614|364306177|FG001|12-month Follow-up|Lost to Follow-up|17|||
105628523|NCT03812614|364306178|FG002|12-month Follow-up|Lost to Follow-up|5|||
105628524|NCT03812614|364306179|FG003|12-month Follow-up|Lost to Follow-up|2|||
105628525|NCT03744676|364306180|FG000|Pre-Treatment Phase|Disease related complications|2|||
105628526|NCT03744676|364306180|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
105628527|NCT03744676|364306180|FG000|Pre-Treatment Phase|Death|7|||
105628528|NCT03744676|364306180|FG000|Pre-Treatment Phase|Other Reasons|7|||
105628529|NCT03744676|364306180|FG000|Treatment Phase|Participant withdrew consent|8|||
105628530|NCT03744676|364306180|FG000|Treatment Phase|Death|33|||
105628531|NCT03744676|364306180|FG000|Treatment Phase|other reasons|6|||
105628532|NCT04586244|364306181|FG000|Overall Study|Lost to Follow-up|1|||
105628533|NCT04586244|364306182|FG001|Overall Study|Lost to Follow-up|0|||
105628534|NCT04586244|364306183|FG002|Overall Study|Lost to Follow-up|0|||
105628535|NCT04586244|364306184|FG003|Overall Study|Lost to Follow-up|1|||
105628536|NCT04586244|364306185|FG004|Overall Study|Lost to Follow-up|0|||
105628537|NCT04586244|364306181|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
105628538|NCT04586244|364306182|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
105628539|NCT04586244|364306183|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
105628540|NCT04586244|364306184|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
105628541|NCT04586244|364306185|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
105628542|NCT04795245|364306187|FG000|Overall Study|Unkown reason|7|||
105628543|NCT04795245|364306187|FG000|Overall Study|Death|17|||
105628544|NCT04795245|364306187|FG000|Overall Study|Other than listed|19|||
105628545|NCT04795245|364306187|FG000|Overall Study|Adverse Event|143|||
105628546|NCT04795245|364306187|FG000|Overall Study|Progressive disease|512|||
105628547|NCT04795245|364306187|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
105628548|NCT03904576|364306188|FG000|Washout Period|Protocol Violation|1|||
105628549|NCT03904576|364306189|FG001|Washout Period|Protocol Violation|1|||
105628550|NCT02919917|364306190|FG000|Overall Study|Withdrawal by Subject|4|||
105628551|NCT02919917|364306191|FG001|Overall Study|Withdrawal by Subject|8|||
105628552|NCT04174560|364306192|FG000|Overall Study|Lost to Follow-up|1|||
105628553|NCT04174560|364306193|FG001|Overall Study|Lost to Follow-up|0|||
105628554|NCT04174560|364306194|FG002|Overall Study|Lost to Follow-up|0|||
105628555|NCT04174560|364306195|FG003|Overall Study|Lost to Follow-up|0|||
105628556|NCT04174560|364306192|FG000|Overall Study|Withdrawal by Subject|0|||
105628557|NCT04174560|364306193|FG001|Overall Study|Withdrawal by Subject|0|||
105628558|NCT04174560|364306194|FG002|Overall Study|Withdrawal by Subject|2|||
105628559|NCT04174560|364306195|FG003|Overall Study|Withdrawal by Subject|0|||
105628560|NCT03250676|364306200|FG000|Overall Study|Adverse Event|0|||
105628561|NCT03250676|364306201|FG001|Overall Study|Adverse Event|0|||
105628562|NCT03250676|364306202|FG002|Overall Study|Adverse Event|0|||
105628563|NCT03250676|364306203|FG003|Overall Study|Adverse Event|1|||
105628564|NCT03250676|364306204|FG004|Overall Study|Adverse Event|2|||
105628565|NCT03250676|364306205|FG005|Overall Study|Adverse Event|9|||
105628566|NCT03250676|364306200|FG000|Overall Study|Withdrawal by Subject|1|||
105628567|NCT03250676|364306201|FG001|Overall Study|Withdrawal by Subject|0|||
105628568|NCT03250676|364306202|FG002|Overall Study|Withdrawal by Subject|0|||
105628569|NCT03250676|364306203|FG003|Overall Study|Withdrawal by Subject|1|||
105628570|NCT03250676|364306204|FG004|Overall Study|Withdrawal by Subject|1|||
105628571|NCT03250676|364306205|FG005|Overall Study|Withdrawal by Subject|2|||
105628572|NCT03250676|364306200|FG000|Overall Study|Physician Decision|0|||
105628573|NCT03250676|364306201|FG001|Overall Study|Physician Decision|0|||
105628574|NCT03250676|364306202|FG002|Overall Study|Physician Decision|0|||
105628575|NCT03250676|364306203|FG003|Overall Study|Physician Decision|2|||
105628576|NCT03250676|364306204|FG004|Overall Study|Physician Decision|0|||
105628577|NCT03250676|364306205|FG005|Overall Study|Physician Decision|3|||
105628578|NCT03250676|364306200|FG000|Overall Study|Withdrawal of consent|0|||
105628579|NCT03250676|364306201|FG001|Overall Study|Withdrawal of consent|0|||
105628580|NCT03250676|364306202|FG002|Overall Study|Withdrawal of consent|2|||
105628581|NCT03250676|364306203|FG003|Overall Study|Withdrawal of consent|0|||
105628582|NCT03250676|364306204|FG004|Overall Study|Withdrawal of consent|0|||
105628583|NCT03250676|364306205|FG005|Overall Study|Withdrawal of consent|2|||
105628584|NCT03250676|364306200|FG000|Overall Study|Other|1|||
105628585|NCT03250676|364306201|FG001|Overall Study|Other|0|||
105628586|NCT03250676|364306202|FG002|Overall Study|Other|0|||
105628587|NCT03250676|364306203|FG003|Overall Study|Other|0|||
105628588|NCT03250676|364306204|FG004|Overall Study|Other|0|||
105628589|NCT03250676|364306205|FG005|Overall Study|Other|0|||
105628590|NCT03250676|364306200|FG000|Overall Study|Disease progression|4|||
105628591|NCT03250676|364306201|FG001|Overall Study|Disease progression|12|||
105628592|NCT03250676|364306202|FG002|Overall Study|Disease progression|9|||
105628593|NCT03250676|364306203|FG003|Overall Study|Disease progression|7|||
105628594|NCT03250676|364306204|FG004|Overall Study|Disease progression|4|||
105628595|NCT03250676|364306205|FG005|Overall Study|Disease progression|88|||
105628596|NCT04166513|364306206|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
105628597|NCT04166513|364306207|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
105628598|NCT04166513|364306208|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
105628599|NCT04166513|364306209|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
105628600|NCT04166513|364306206|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
105628601|NCT04166513|364306207|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
105628602|NCT04166513|364306208|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
105628603|NCT04166513|364306209|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
105628604|NCT04166513|364306206|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
105628605|NCT04166513|364306207|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
105628606|NCT04166513|364306208|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
105628607|NCT04166513|364306209|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
105628608|NCT04166513|364306206|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
105628609|NCT04166513|364306207|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
105628610|NCT04166513|364306208|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
105628611|NCT04166513|364306209|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
105628612|NCT04166513|364306206|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
105628613|NCT04166513|364306207|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
105628614|NCT04166513|364306208|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
105628615|NCT04166513|364306209|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
105628616|NCT01651000|364306212|FG000|Overall Study|Adverse Event|2|||
105628617|NCT01651000|364306213|FG001|Overall Study|Adverse Event|8|||
105628618|NCT01651000|364306212|FG000|Overall Study|Lost to Follow-up|3|||
105628619|NCT01651000|364306213|FG001|Overall Study|Lost to Follow-up|2|||
105628620|NCT01651000|364306212|FG000|Overall Study|Protocol Violation|0|||
105628621|NCT01651000|364306213|FG001|Overall Study|Protocol Violation|3|||
105628622|NCT01651000|364306212|FG000|Overall Study|Withdrawal by Subject|2|||
105628623|NCT01651000|364306213|FG001|Overall Study|Withdrawal by Subject|10|||
105628624|NCT01651000|364306212|FG000|Overall Study|Subject noncompliance|0|||
105628625|NCT01651000|364306213|FG001|Overall Study|Subject noncompliance|3|||
105628626|NCT01651000|364306212|FG000|Overall Study|Lack of Efficacy|1|||
105628627|NCT01651000|364306213|FG001|Overall Study|Lack of Efficacy|1|||
105628628|NCT01651000|364306212|FG000|Overall Study|Physician Decision|1|||
105628629|NCT01651000|364306213|FG001|Overall Study|Physician Decision|0|||
105628630|NCT01651000|364306212|FG000|Overall Study|Administrative reason|1|||
105628631|NCT01651000|364306213|FG001|Overall Study|Administrative reason|0|||
105628632|NCT01651000|364306212|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
105628633|NCT01651000|364306213|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
105628634|NCT00447980|364306510|FG000|Overall Study|Withdrawal by Subject|1|||
105628635|NCT00447980|364306511|FG001|Overall Study|Withdrawal by Subject|1|||
105628636|NCT00447980|364306512|FG002|Overall Study|Withdrawal by Subject|4|||
105628637|NCT00447980|364306513|FG003|Overall Study|Withdrawal by Subject|4|||
105628638|NCT00447980|364306510|FG000|Overall Study|Lost to Follow-up|1|||
105628639|NCT00447980|364306511|FG001|Overall Study|Lost to Follow-up|1|||
105628640|NCT00447980|364306512|FG002|Overall Study|Lost to Follow-up|0|||
105628641|NCT00447980|364306513|FG003|Overall Study|Lost to Follow-up|0|||
105628642|NCT00447980|364306510|FG000|Overall Study|Did not proceed with surgery|3|||
105628643|NCT00447980|364306511|FG001|Overall Study|Did not proceed with surgery|3|||
105628644|NCT00447980|364306512|FG002|Overall Study|Did not proceed with surgery|2|||
105628645|NCT00447980|364306513|FG003|Overall Study|Did not proceed with surgery|2|||
105628646|NCT01880515|364306517|FG000|Overall Study|Lost to Follow-up|3|||
105628647|NCT01880515|364306518|FG001|Overall Study|Lost to Follow-up|2|||
105628648|NCT01880515|364306517|FG000|Overall Study|Disease Progression|5|||
105628649|NCT01880515|364306518|FG001|Overall Study|Disease Progression|7|||
105628650|NCT03286114|364306526|FG000|Overall Study|Adverse Event|6|||
105628651|NCT03286114|364306526|FG000|Overall Study|Death|3|||
105628652|NCT05247034|364306527|FG000|Overall Study|Lost to Follow-up|3|||
105628653|NCT05247034|364306528|FG001|Overall Study|Lost to Follow-up|2|||
105628654|NCT05247034|364306527|FG000|Overall Study|Organizational problems when attending appointments|1|||
105628655|NCT05247034|364306528|FG001|Overall Study|Organizational problems when attending appointments|0|||
105628656|NCT02076009|364306529|FG000|Overall Study|Death|172|||
105628657|NCT02076009|364306530|FG001|Overall Study|Death|153|||
105628658|NCT02076009|364306529|FG000|Overall Study|Withdrawal by Subject|16|||
105628659|NCT02076009|364306530|FG001|Overall Study|Withdrawal by Subject|12|||
105628660|NCT02076009|364306529|FG000|Overall Study|Lost to Follow-up|4|||
105628661|NCT02076009|364306530|FG001|Overall Study|Lost to Follow-up|2|||
105628662|NCT02076009|364306529|FG000|Overall Study|Progressive Disease|1|||
105628663|NCT02076009|364306530|FG001|Overall Study|Progressive Disease|0|||
105628664|NCT02076009|364306529|FG000|Overall Study|Physician Decision|0|||
105628665|NCT02076009|364306530|FG001|Overall Study|Physician Decision|1|||
105628666|NCT02076009|364306529|FG000|Overall Study|End of data collection|90|||
105628667|NCT02076009|364306530|FG001|Overall Study|End of data collection|118|||
105628668|NCT03983382|364306531|FG000|Overall Study|Death|1|||
105628669|NCT03983382|364306531|FG000|Overall Study|Lost to Follow-up|3|||
105628670|NCT03983382|364306531|FG000|Overall Study|Physician Decision|2|||
105628671|NCT03983382|364306531|FG000|Overall Study|Withdrawal by Subject|10|||
105628672|NCT03983382|364306531|FG000|Overall Study|Change in cancer treatment|2|||
105628673|NCT04174170|364306534|FG000|Placebo Run-in Period|Not Randomized|38|||
105628674|NCT04174170|364306535|FG001|Placebo Run-in Period|Not Randomized|0|||
105628675|NCT04174170|364306536|FG002|Placebo Run-in Period|Not Randomized|0|||
105628676|NCT04174170|364306537|FG003|Placebo Run-in Period|Not Randomized|0|||
105628677|NCT04174170|364306534|FG000|Double Blind Treatment Period|Adverse Event|0|||
105628678|NCT04174170|364306535|FG001|Double Blind Treatment Period|Adverse Event|9|||
105628679|NCT04174170|364306536|FG002|Double Blind Treatment Period|Adverse Event|9|||
105628680|NCT04174170|364306537|FG003|Double Blind Treatment Period|Adverse Event|8|||
105628681|NCT04174170|364306534|FG000|Double Blind Treatment Period|Death|0|||
105628682|NCT04174170|364306535|FG001|Double Blind Treatment Period|Death|1|||
105628683|NCT04174170|364306536|FG002|Double Blind Treatment Period|Death|0|||
105628684|NCT04174170|364306537|FG003|Double Blind Treatment Period|Death|0|||
105628685|NCT04174170|364306534|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
105628686|NCT04174170|364306535|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
105628687|NCT04174170|364306536|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
105628688|NCT04174170|364306537|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
105628689|NCT04174170|364306534|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
105628690|NCT04174170|364306535|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
105628691|NCT04174170|364306536|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
105628692|NCT04174170|364306537|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
105628693|NCT04174170|364306534|FG000|Double Blind Treatment Period|Physician Decision|0|||
105628694|NCT04174170|364306535|FG001|Double Blind Treatment Period|Physician Decision|1|||
105628695|NCT04174170|364306536|FG002|Double Blind Treatment Period|Physician Decision|0|||
105628696|NCT04174170|364306537|FG003|Double Blind Treatment Period|Physician Decision|1|||
105628697|NCT04174170|364306534|FG000|Double Blind Treatment Period|Pregnancy|0|||
105628698|NCT04174170|364306535|FG001|Double Blind Treatment Period|Pregnancy|1|||
105628699|NCT04174170|364306536|FG002|Double Blind Treatment Period|Pregnancy|0|||
105628700|NCT04174170|364306537|FG003|Double Blind Treatment Period|Pregnancy|1|||
105628701|NCT04174170|364306534|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
105628702|NCT04174170|364306535|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
105628703|NCT04174170|364306536|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
105628704|NCT04174170|364306537|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
105628705|NCT04174170|364306534|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
105628706|NCT04174170|364306535|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
105628707|NCT04174170|364306536|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
105628708|NCT04174170|364306537|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
105628709|NCT04174170|364306534|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
105628710|NCT04174170|364306535|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
105628711|NCT04174170|364306536|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
105628712|NCT04174170|364306537|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
105628713|NCT03008382|364306546|FG000|Overall Study|Withdrawal by Subject|2|||
105628714|NCT03008382|364306547|FG001|Overall Study|Withdrawal by Subject|5|||
105628715|NCT03008382|364306548|FG002|Overall Study|Withdrawal by Subject|2|||
105628716|NCT03008382|364306549|FG003|Overall Study|Withdrawal by Subject|0|||
105628717|NCT03008382|364306546|FG000|Overall Study|Protocol Violation|1|||
105628718|NCT03008382|364306547|FG001|Overall Study|Protocol Violation|0|||
105628719|NCT03008382|364306548|FG002|Overall Study|Protocol Violation|0|||
105628720|NCT03008382|364306549|FG003|Overall Study|Protocol Violation|0|||
105628721|NCT03008382|364306546|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
105628722|NCT03008382|364306547|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
105628723|NCT03008382|364306548|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
105628724|NCT03008382|364306549|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
105628725|NCT03008382|364306546|FG000|Overall Study|Lost to Follow-up|0|||
105628726|NCT03008382|364306547|FG001|Overall Study|Lost to Follow-up|0|||
105628727|NCT03008382|364306548|FG002|Overall Study|Lost to Follow-up|1|||
105628728|NCT03008382|364306549|FG003|Overall Study|Lost to Follow-up|0|||
105628729|NCT03008382|364306546|FG000|Overall Study|Screenfail|0|||
105628730|NCT03008382|364306547|FG001|Overall Study|Screenfail|0|||
105628731|NCT03008382|364306548|FG002|Overall Study|Screenfail|2|||
105628732|NCT03008382|364306549|FG003|Overall Study|Screenfail|0|||
105628733|NCT04244175|364306773|FG000|Overall Study|Adverse Event|3|||
105628734|NCT04244175|364306774|FG001|Overall Study|Adverse Event|2|||
105628735|NCT04244175|364306775|FG002|Overall Study|Adverse Event|5|||
105628736|NCT04244175|364306773|FG000|Overall Study|Lack of Efficacy|1|||
105628737|NCT04244175|364306774|FG001|Overall Study|Lack of Efficacy|0|||
105628738|NCT04244175|364306775|FG002|Overall Study|Lack of Efficacy|1|||
105628739|NCT04244175|364306773|FG000|Overall Study|Lost to Follow-up|1|||
105628740|NCT04244175|364306774|FG001|Overall Study|Lost to Follow-up|0|||
105628741|NCT04244175|364306775|FG002|Overall Study|Lost to Follow-up|0|||
105628742|NCT04244175|364306773|FG000|Overall Study|Non-compliance with study drug|1|||
105628743|NCT04244175|364306774|FG001|Overall Study|Non-compliance with study drug|0|||
105628744|NCT04244175|364306775|FG002|Overall Study|Non-compliance with study drug|1|||
105628745|NCT04244175|364306773|FG000|Overall Study|Protocol deviation|0|||
105628746|NCT04244175|364306774|FG001|Overall Study|Protocol deviation|1|||
105628747|NCT04244175|364306775|FG002|Overall Study|Protocol deviation|0|||
105628748|NCT04244175|364306773|FG000|Overall Study|Withdrawal by Subject|1|||
105628749|NCT04244175|364306774|FG001|Overall Study|Withdrawal by Subject|3|||
105628750|NCT04244175|364306775|FG002|Overall Study|Withdrawal by Subject|1|||
105628751|NCT04244175|364306773|FG000|Overall Study|Other, not specified|0|||
105628752|NCT04244175|364306774|FG001|Overall Study|Other, not specified|1|||
105628753|NCT04244175|364306775|FG002|Overall Study|Other, not specified|2|||
105628754|NCT04046549|364306783|FG000|Overall Study|Adverse Event|1|||
105628755|NCT04046549|364306783|FG000|Overall Study|Physician Decision|1|||
105628756|NCT04046549|364306783|FG000|Overall Study|Withdrawal by Subject|3|||
105628757|NCT04046549|364306783|FG000|Overall Study|Other, Not Specified|5|||
105628758|NCT02806726|364306784|FG000|Overall Study|Lost to Follow-up|1|||
105628759|NCT05129501|364306785|FG000|Overall Study|Lost to Follow-up|54|||
105628760|NCT05129501|364306786|FG001|Overall Study|Lost to Follow-up|41|||
105628761|NCT04281498|364306787|FG000|Overall Study|Progression of disease|1|||
105628762|NCT04281498|364306787|FG000|Overall Study|Planned SCT|1|||
105628763|NCT04281498|364306787|FG000|Overall Study|Alternative Treatment|1|||
105628764|NCT01527188|364306788|FG000|Overall Study|Adverse Event|5|||
105628765|NCT01527188|364306789|FG001|Overall Study|Adverse Event|5|||
105628766|NCT01527188|364306790|FG002|Overall Study|Adverse Event|11|||
105628767|NCT01527188|364306791|FG003|Overall Study|Adverse Event|0|||
105628768|NCT01527188|364306788|FG000|Overall Study|Withdrawal by Subject|3|||
105628769|NCT01527188|364306789|FG001|Overall Study|Withdrawal by Subject|6|||
105628770|NCT01527188|364306790|FG002|Overall Study|Withdrawal by Subject|4|||
105628771|NCT01527188|364306791|FG003|Overall Study|Withdrawal by Subject|4|||
105628772|NCT01527188|364306788|FG000|Overall Study|Any other reason not above-mentioned|6|||
105628773|NCT01527188|364306789|FG001|Overall Study|Any other reason not above-mentioned|7|||
105628774|NCT01527188|364306790|FG002|Overall Study|Any other reason not above-mentioned|8|||
105628775|NCT01527188|364306791|FG003|Overall Study|Any other reason not above-mentioned|8|||
105628776|NCT01553149|364306792|FG000|Overall Study|Adverse Event|0|||
105628777|NCT01553149|364306793|FG001|Overall Study|Adverse Event|9|||
105628778|NCT01553149|364306792|FG000|Overall Study|Physician Decision|5|||
105628779|NCT01553149|364306793|FG001|Overall Study|Physician Decision|10|||
105628780|NCT01553149|364306792|FG000|Overall Study|Ineligible|0|||
105628781|NCT01553149|364306793|FG001|Overall Study|Ineligible|1|||
105628782|NCT04644029|364307021|FG000|Overall Study|Death|1|||
105628783|NCT04644029|364307022|FG001|Overall Study|Death|0|||
105628784|NCT04644029|364307021|FG000|Overall Study|Physician Decision|1|||
105628785|NCT04644029|364307022|FG001|Overall Study|Physician Decision|2|||
105628786|NCT04644029|364307021|FG000|Overall Study|Withdrawal by Subject|21|||
105628787|NCT04644029|364307022|FG001|Overall Study|Withdrawal by Subject|19|||
105628788|NCT04644029|364307021|FG000|Overall Study|Lost to Follow-up|31|||
105628789|NCT04644029|364307022|FG001|Overall Study|Lost to Follow-up|34|||
105628790|NCT04644029|364307021|FG000|Overall Study|Study Terminated by Sponsor|308|||
105628791|NCT04644029|364307022|FG001|Overall Study|Study Terminated by Sponsor|309|||
105628792|NCT04644029|364307021|FG000|Overall Study|Randomized in Error|2|||
105628793|NCT04644029|364307022|FG001|Overall Study|Randomized in Error|1|||
105628794|NCT04644029|364307021|FG000|Overall Study|Other|0|||
105628795|NCT04644029|364307022|FG001|Overall Study|Other|1|||
105628796|NCT04227899|364307023|FG000|Overall Study|Withdrawal by Subject|6|||
105628797|NCT04227899|364307024|FG001|Overall Study|Withdrawal by Subject|3|||
105628798|NCT04227899|364307023|FG000|Overall Study|Death|12|||
105628799|NCT04227899|364307024|FG001|Overall Study|Death|6|||
105628800|NCT04227899|364307023|FG000|Overall Study|Lost to Follow-up|2|||
105628801|NCT04227899|364307024|FG001|Overall Study|Lost to Follow-up|1|||
105628802|NCT02989662|364307029|FG000|Overall Study|Lost to Follow-up|0|||
105628803|NCT02989662|364307030|FG001|Overall Study|Lost to Follow-up|0|||
105628804|NCT02989662|364307031|FG002|Overall Study|Lost to Follow-up|0|||
105628805|NCT02989662|364307032|FG003|Overall Study|Lost to Follow-up|2|||
105628806|NCT02989662|364307029|FG000|Overall Study|Physician Decision|3|||
105628807|NCT02989662|364307030|FG001|Overall Study|Physician Decision|0|||
105628808|NCT02989662|364307031|FG002|Overall Study|Physician Decision|0|||
105628809|NCT02989662|364307032|FG003|Overall Study|Physician Decision|0|||
105628810|NCT02989662|364307029|FG000|Overall Study|Withdrawal by Subject|1|||
105628811|NCT02989662|364307030|FG001|Overall Study|Withdrawal by Subject|0|||
105628812|NCT02989662|364307031|FG002|Overall Study|Withdrawal by Subject|0|||
105628813|NCT02989662|364307032|FG003|Overall Study|Withdrawal by Subject|0|||
105628814|NCT03552965|364307035|FG000|Overall Study|Death|1|||
105628815|NCT03552965|364307036|FG001|Overall Study|Death|1|||
105628816|NCT03552965|364307035|FG000|Overall Study|Lost to Follow-up|1|||
105628817|NCT03552965|364307036|FG001|Overall Study|Lost to Follow-up|1|||
105628818|NCT03552965|364307035|FG000|Overall Study|Physician Decision|1|||
105628819|NCT03552965|364307036|FG001|Overall Study|Physician Decision|1|||
105628820|NCT03552965|364307035|FG000|Overall Study|Withdrawal by Subject|0|||
105628821|NCT03552965|364307036|FG001|Overall Study|Withdrawal by Subject|2|||
105628822|NCT03552965|364307035|FG000|Overall Study|Continuation not in patient best interest|1|||
105628823|NCT03552965|364307036|FG001|Overall Study|Continuation not in patient best interest|0|||
105628824|NCT03552965|364307035|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
105628825|NCT03552965|364307036|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
105628826|NCT01220531|364307038|FG000|Overall Study|Death|7|||
105628827|NCT01220531|364307038|FG000|Overall Study|Lost to Follow-up|1|||
105628828|NCT04873232|364307041|FG000|Overall Study|Lost to Follow-up|1|||
105628829|NCT04873232|364307042|FG001|Overall Study|Lost to Follow-up|4|||
105628830|NCT04873232|364307041|FG000|Overall Study|Withdrawal by Subject|1|||
105628831|NCT04873232|364307042|FG001|Overall Study|Withdrawal by Subject|0|||
105628832|NCT05267639|364307603|FG000|Overall Study|Withdrawal by Subject|1|||
105628833|NCT05267639|364307604|FG001|Overall Study|Withdrawal by Subject|0|||
105628834|NCT03417284|364307608|FG000|Overall Study|Inadequate supply on study drug|1|||
105628835|NCT03417284|364307609|FG001|Overall Study|Inadequate supply on study drug|0|||
105628836|NCT03417284|364307610|FG002|Overall Study|Inadequate supply on study drug|0|||
105628837|NCT03417284|364307611|FG003|Overall Study|Inadequate supply on study drug|0|||
105628838|NCT03417284|364307608|FG000|Overall Study|Disease Progression|0|||
105628839|NCT03417284|364307609|FG001|Overall Study|Disease Progression|0|||
105628840|NCT03417284|364307610|FG002|Overall Study|Disease Progression|1|||
105628841|NCT03417284|364307611|FG003|Overall Study|Disease Progression|0|||
105628842|NCT05132400|364307612|FG000|Overall Study|Withdrawal by Subject|14|||
105628843|NCT05132400|364307613|FG001|Overall Study|Withdrawal by Subject|8|||
105628844|NCT05132400|364307612|FG000|Overall Study|Lost to Follow-up|132|||
105628845|NCT05132400|364307613|FG001|Overall Study|Lost to Follow-up|121|||
105628846|NCT03934931|364307616|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
105628847|NCT03934931|364307617|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
105628848|NCT03934931|364307618|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
105628849|NCT02720068|364307619|FG000|Overall Study|Adverse Event|0|||
105628850|NCT02720068|364307620|FG001|Overall Study|Adverse Event|0|||
105628851|NCT02720068|364307621|FG002|Overall Study|Adverse Event|0|||
105628852|NCT02720068|364307622|FG003|Overall Study|Adverse Event|0|||
105628853|NCT02720068|364307623|FG004|Overall Study|Adverse Event|0|||
105628854|NCT02720068|364307624|FG005|Overall Study|Adverse Event|0|||
105628855|NCT02720068|364307625|FG006|Overall Study|Adverse Event|0|||
105628856|NCT02720068|364307626|FG007|Overall Study|Adverse Event|0|||
105628857|NCT02720068|364307627|FG008|Overall Study|Adverse Event|0|||
105628858|NCT02720068|364307628|FG009|Overall Study|Adverse Event|0|||
105628859|NCT02720068|364307629|FG010|Overall Study|Adverse Event|0|||
105628860|NCT02720068|364307630|FG011|Overall Study|Adverse Event|1|||
105628861|NCT02720068|364307631|FG012|Overall Study|Adverse Event|0|||
105628862|NCT02720068|364307632|FG013|Overall Study|Adverse Event|0|||
105628863|NCT02720068|364307633|FG014|Overall Study|Adverse Event|0|||
105628864|NCT02720068|364307634|FG015|Overall Study|Adverse Event|0|||
105628865|NCT02720068|364307635|FG016|Overall Study|Adverse Event|0|||
105628866|NCT02720068|364307636|FG017|Overall Study|Adverse Event|0|||
105628867|NCT02720068|364307619|FG000|Overall Study|Death|1|||
105628868|NCT02720068|364307620|FG001|Overall Study|Death|3|||
105628869|NCT02720068|364307621|FG002|Overall Study|Death|2|||
105628870|NCT02720068|364307622|FG003|Overall Study|Death|1|||
105628871|NCT02720068|364307623|FG004|Overall Study|Death|2|||
105628872|NCT02720068|364307624|FG005|Overall Study|Death|1|||
105628873|NCT02720068|364307625|FG006|Overall Study|Death|2|||
105628874|NCT02720068|364307626|FG007|Overall Study|Death|2|||
105628875|NCT02720068|364307627|FG008|Overall Study|Death|3|||
105628876|NCT02720068|364307628|FG009|Overall Study|Death|1|||
105628877|NCT02720068|364307629|FG010|Overall Study|Death|20|||
105628878|NCT02720068|364307630|FG011|Overall Study|Death|166|||
105628879|NCT02720068|364307631|FG012|Overall Study|Death|34|||
105628880|NCT02720068|364307632|FG013|Overall Study|Death|30|||
105628881|NCT02720068|364307633|FG014|Overall Study|Death|45|||
105628882|NCT02720068|364307634|FG015|Overall Study|Death|16|||
105628883|NCT02720068|364307635|FG016|Overall Study|Death|20|||
105628884|NCT02720068|364307636|FG017|Overall Study|Death|28|||
105628885|NCT02720068|364307619|FG000|Overall Study|Lost to Follow-up|0|||
105628886|NCT02720068|364307620|FG001|Overall Study|Lost to Follow-up|0|||
105628887|NCT02720068|364307621|FG002|Overall Study|Lost to Follow-up|0|||
105628888|NCT02720068|364307622|FG003|Overall Study|Lost to Follow-up|0|||
105628889|NCT02720068|364307623|FG004|Overall Study|Lost to Follow-up|0|||
105628890|NCT02720068|364307624|FG005|Overall Study|Lost to Follow-up|0|||
105628891|NCT02720068|364307625|FG006|Overall Study|Lost to Follow-up|0|||
105628892|NCT02720068|364307626|FG007|Overall Study|Lost to Follow-up|0|||
105628893|NCT02720068|364307627|FG008|Overall Study|Lost to Follow-up|0|||
105628894|NCT02720068|364307628|FG009|Overall Study|Lost to Follow-up|0|||
105628895|NCT02720068|364307629|FG010|Overall Study|Lost to Follow-up|0|||
105628896|NCT02720068|364307630|FG011|Overall Study|Lost to Follow-up|1|||
105628897|NCT02720068|364307631|FG012|Overall Study|Lost to Follow-up|0|||
105628898|NCT02720068|364307632|FG013|Overall Study|Lost to Follow-up|1|||
105628899|NCT02720068|364307633|FG014|Overall Study|Lost to Follow-up|2|||
105628900|NCT02720068|364307634|FG015|Overall Study|Lost to Follow-up|0|||
105628901|NCT02720068|364307635|FG016|Overall Study|Lost to Follow-up|0|||
105628902|NCT02720068|364307636|FG017|Overall Study|Lost to Follow-up|1|||
105628903|NCT02720068|364307619|FG000|Overall Study|Physician Decision|0|||
105628904|NCT02720068|364307620|FG001|Overall Study|Physician Decision|0|||
105628905|NCT02720068|364307621|FG002|Overall Study|Physician Decision|0|||
105628906|NCT02720068|364307622|FG003|Overall Study|Physician Decision|1|||
105628907|NCT02720068|364307623|FG004|Overall Study|Physician Decision|0|||
105628908|NCT02720068|364307624|FG005|Overall Study|Physician Decision|0|||
105628909|NCT02720068|364307625|FG006|Overall Study|Physician Decision|0|||
105628910|NCT02720068|364307626|FG007|Overall Study|Physician Decision|0|||
105628911|NCT02720068|364307627|FG008|Overall Study|Physician Decision|0|||
105628912|NCT02720068|364307628|FG009|Overall Study|Physician Decision|0|||
105628913|NCT02720068|364307629|FG010|Overall Study|Physician Decision|0|||
105628914|NCT02720068|364307630|FG011|Overall Study|Physician Decision|1|||
105628915|NCT02720068|364307631|FG012|Overall Study|Physician Decision|0|||
105628916|NCT02720068|364307632|FG013|Overall Study|Physician Decision|0|||
105628917|NCT02720068|364307633|FG014|Overall Study|Physician Decision|0|||
105628918|NCT02720068|364307634|FG015|Overall Study|Physician Decision|0|||
105628919|NCT02720068|364307635|FG016|Overall Study|Physician Decision|0|||
105628920|NCT02720068|364307636|FG017|Overall Study|Physician Decision|1|||
105628921|NCT02720068|364307619|FG000|Overall Study|Progressive Disease|2|||
105628922|NCT02720068|364307620|FG001|Overall Study|Progressive Disease|3|||
105628923|NCT02720068|364307621|FG002|Overall Study|Progressive Disease|1|||
105628924|NCT02720068|364307622|FG003|Overall Study|Progressive Disease|1|||
105628925|NCT02720068|364307623|FG004|Overall Study|Progressive Disease|1|||
105628926|NCT02720068|364307624|FG005|Overall Study|Progressive Disease|2|||
105628927|NCT02720068|364307625|FG006|Overall Study|Progressive Disease|1|||
105628928|NCT02720068|364307626|FG007|Overall Study|Progressive Disease|1|||
105628929|NCT02720068|364307627|FG008|Overall Study|Progressive Disease|0|||
105628930|NCT02720068|364307628|FG009|Overall Study|Progressive Disease|1|||
105628931|NCT02720068|364307629|FG010|Overall Study|Progressive Disease|0|||
105628932|NCT02720068|364307630|FG011|Overall Study|Progressive Disease|4|||
105628933|NCT02720068|364307631|FG012|Overall Study|Progressive Disease|1|||
105628934|NCT02720068|364307632|FG013|Overall Study|Progressive Disease|0|||
105628935|NCT02720068|364307633|FG014|Overall Study|Progressive Disease|0|||
105628936|NCT02720068|364307634|FG015|Overall Study|Progressive Disease|0|||
105628937|NCT02720068|364307635|FG016|Overall Study|Progressive Disease|0|||
105628938|NCT02720068|364307636|FG017|Overall Study|Progressive Disease|0|||
105628939|NCT02720068|364307619|FG000|Overall Study|Sponsor Decision|0|||
105628940|NCT02720068|364307620|FG001|Overall Study|Sponsor Decision|0|||
105628941|NCT02720068|364307621|FG002|Overall Study|Sponsor Decision|0|||
105628942|NCT02720068|364307622|FG003|Overall Study|Sponsor Decision|0|||
105628943|NCT02720068|364307623|FG004|Overall Study|Sponsor Decision|0|||
105628944|NCT02720068|364307624|FG005|Overall Study|Sponsor Decision|0|||
105628945|NCT02720068|364307625|FG006|Overall Study|Sponsor Decision|0|||
105628946|NCT02720068|364307626|FG007|Overall Study|Sponsor Decision|0|||
105628947|NCT02720068|364307627|FG008|Overall Study|Sponsor Decision|0|||
105628948|NCT02720068|364307628|FG009|Overall Study|Sponsor Decision|0|||
105628949|NCT02720068|364307629|FG010|Overall Study|Sponsor Decision|0|||
105628950|NCT02720068|364307630|FG011|Overall Study|Sponsor Decision|6|||
105628951|NCT02720068|364307631|FG012|Overall Study|Sponsor Decision|3|||
105628952|NCT02720068|364307632|FG013|Overall Study|Sponsor Decision|2|||
105628953|NCT02720068|364307633|FG014|Overall Study|Sponsor Decision|4|||
105628954|NCT02720068|364307634|FG015|Overall Study|Sponsor Decision|4|||
105628955|NCT02720068|364307635|FG016|Overall Study|Sponsor Decision|0|||
105628956|NCT02720068|364307636|FG017|Overall Study|Sponsor Decision|8|||
105628957|NCT02720068|364307619|FG000|Overall Study|Withdrawal by Subject|0|||
105628958|NCT02720068|364307620|FG001|Overall Study|Withdrawal by Subject|0|||
105628959|NCT02720068|364307621|FG002|Overall Study|Withdrawal by Subject|0|||
105628960|NCT02720068|364307622|FG003|Overall Study|Withdrawal by Subject|0|||
105628961|NCT02720068|364307623|FG004|Overall Study|Withdrawal by Subject|0|||
105628962|NCT02720068|364307624|FG005|Overall Study|Withdrawal by Subject|0|||
105628963|NCT02720068|364307625|FG006|Overall Study|Withdrawal by Subject|0|||
105628964|NCT02720068|364307626|FG007|Overall Study|Withdrawal by Subject|0|||
105628965|NCT02720068|364307627|FG008|Overall Study|Withdrawal by Subject|0|||
105628966|NCT02720068|364307628|FG009|Overall Study|Withdrawal by Subject|1|||
105628967|NCT02720068|364307629|FG010|Overall Study|Withdrawal by Subject|0|||
105628968|NCT02720068|364307630|FG011|Overall Study|Withdrawal by Subject|27|||
105628969|NCT02720068|364307631|FG012|Overall Study|Withdrawal by Subject|2|||
105628970|NCT02720068|364307632|FG013|Overall Study|Withdrawal by Subject|8|||
105628971|NCT02720068|364307633|FG014|Overall Study|Withdrawal by Subject|7|||
105628972|NCT02720068|364307634|FG015|Overall Study|Withdrawal by Subject|0|||
105628973|NCT02720068|364307635|FG016|Overall Study|Withdrawal by Subject|0|||
105628974|NCT02720068|364307636|FG017|Overall Study|Withdrawal by Subject|2|||
105628975|NCT02720068|364307619|FG000|Overall Study|Protocol Violation|0|||
105628976|NCT02720068|364307620|FG001|Overall Study|Protocol Violation|0|||
105628977|NCT02720068|364307621|FG002|Overall Study|Protocol Violation|0|||
105628978|NCT02720068|364307622|FG003|Overall Study|Protocol Violation|0|||
105628979|NCT02720068|364307623|FG004|Overall Study|Protocol Violation|0|||
105628980|NCT02720068|364307624|FG005|Overall Study|Protocol Violation|0|||
105628981|NCT02720068|364307625|FG006|Overall Study|Protocol Violation|0|||
105628982|NCT02720068|364307626|FG007|Overall Study|Protocol Violation|0|||
105628983|NCT02720068|364307627|FG008|Overall Study|Protocol Violation|0|||
105628984|NCT02720068|364307628|FG009|Overall Study|Protocol Violation|0|||
105628985|NCT02720068|364307629|FG010|Overall Study|Protocol Violation|1|||
105628986|NCT02720068|364307630|FG011|Overall Study|Protocol Violation|0|||
105628987|NCT02720068|364307631|FG012|Overall Study|Protocol Violation|0|||
105628988|NCT02720068|364307632|FG013|Overall Study|Protocol Violation|0|||
105628989|NCT02720068|364307633|FG014|Overall Study|Protocol Violation|1|||
105628990|NCT02720068|364307634|FG015|Overall Study|Protocol Violation|0|||
105628991|NCT02720068|364307635|FG016|Overall Study|Protocol Violation|1|||
105628992|NCT02720068|364307636|FG017|Overall Study|Protocol Violation|0|||
105628993|NCT02467270|364307639|FG000|Overall Study|Participants Never Treated|0|||
105628994|NCT02467270|364307640|FG001|Overall Study|Participants Never Treated|1|||
105628995|NCT02467270|364307641|FG002|Overall Study|Participants Never Treated|0|||
105628996|NCT02467270|364307639|FG000|Overall Study|Ongoing|50|||
105628997|NCT02467270|364307640|FG001|Overall Study|Ongoing|41|||
105628998|NCT02467270|364307641|FG002|Overall Study|Ongoing|43|||
105628999|NCT02467270|364307639|FG000|Overall Study|Adverse Event|16|||
105629000|NCT02467270|364307640|FG001|Overall Study|Adverse Event|15|||
105629001|NCT02467270|364307641|FG002|Overall Study|Adverse Event|14|||
105629002|NCT02467270|364307639|FG000|Overall Study|Progressive Disease|7|||
105629003|NCT02467270|364307640|FG001|Overall Study|Progressive Disease|7|||
105629004|NCT02467270|364307641|FG002|Overall Study|Progressive Disease|4|||
105629005|NCT02467270|364307639|FG000|Overall Study|Death|2|||
105629006|NCT02467270|364307640|FG001|Overall Study|Death|0|||
105629007|NCT02467270|364307641|FG002|Overall Study|Death|2|||
105629008|NCT02467270|364307639|FG000|Overall Study|Lack of Efficacy|12|||
105629009|NCT02467270|364307640|FG001|Overall Study|Lack of Efficacy|18|||
105629010|NCT02467270|364307641|FG002|Overall Study|Lack of Efficacy|23|||
105629011|NCT02467270|364307639|FG000|Overall Study|Non-compliance With Study Drug|0|||
105629012|NCT02467270|364307640|FG001|Overall Study|Non-compliance With Study Drug|2|||
105629013|NCT02467270|364307641|FG002|Overall Study|Non-compliance With Study Drug|1|||
105629014|NCT02467270|364307639|FG000|Overall Study|Lost to Follow-up|2|||
105629015|NCT02467270|364307640|FG001|Overall Study|Lost to Follow-up|1|||
105629016|NCT02467270|364307641|FG002|Overall Study|Lost to Follow-up|0|||
105629017|NCT02467270|364307639|FG000|Overall Study|Pregnancy|0|||
105629018|NCT02467270|364307640|FG001|Overall Study|Pregnancy|1|||
105629019|NCT02467270|364307641|FG002|Overall Study|Pregnancy|0|||
105629020|NCT02467270|364307639|FG000|Overall Study|Physician Decision|0|||
105629021|NCT02467270|364307640|FG001|Overall Study|Physician Decision|4|||
105629022|NCT02467270|364307641|FG002|Overall Study|Physician Decision|1|||
105629023|NCT02467270|364307639|FG000|Overall Study|Withdrawal by Subject|4|||
105629024|NCT02467270|364307640|FG001|Overall Study|Withdrawal by Subject|3|||
105629025|NCT02467270|364307641|FG002|Overall Study|Withdrawal by Subject|5|||
105629026|NCT02467270|364307639|FG000|Overall Study|Reason not Specified|1|||
105629027|NCT02467270|364307640|FG001|Overall Study|Reason not Specified|2|||
105629028|NCT02467270|364307641|FG002|Overall Study|Reason not Specified|1|||
105629029|NCT05157841|364307642|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
105629030|NCT05157841|364307643|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
105629031|NCT05157841|364307644|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
105629032|NCT05157841|364307642|FG000|Part A (14 Days)|Adverse Event|1|||
105629033|NCT05157841|364307643|FG001|Part A (14 Days)|Adverse Event|0|||
105629034|NCT05157841|364307644|FG002|Part A (14 Days)|Adverse Event|0|||
105629035|NCT05157841|364307642|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
105629036|NCT05157841|364307643|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
105629037|NCT05157841|364307644|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
105629038|NCT06262347|364307653|FG000|Overall Study|Lost to Follow-up|4|||
105629039|NCT06262347|364307654|FG001|Overall Study|Lost to Follow-up|3|||
105629040|NCT06262347|364307653|FG000|Overall Study|Withdrawal by Subject|0|||
105629041|NCT06262347|364307654|FG001|Overall Study|Withdrawal by Subject|1|||
105629042|NCT03803774|364307655|FG000|Dose Escalation|Withdrawal by Subject|0|||
105629043|NCT03803774|364307656|FG001|Dose Escalation|Withdrawal by Subject|0|||
105629044|NCT03803774|364307657|FG002|Dose Escalation|Withdrawal by Subject|0|||
105629045|NCT03803774|364307658|FG003|Dose Escalation|Withdrawal by Subject|1|||
105629046|NCT03803774|364307659|FG004|Dose Escalation|Withdrawal by Subject|0|||
105629047|NCT04408755|364307660|FG000|Period A (Placebo lead-in)|Other|11|||
105629048|NCT04408755|364307661|FG001|Period A (Placebo lead-in)|Other|0|||
105629049|NCT04408755|364307662|FG002|Period A (Placebo lead-in)|Other|0|||
105629050|NCT04408755|364307663|FG003|Period A (Placebo lead-in)|Other|0|||
105629051|NCT04408755|364307660|FG000|Period B (Randomization Period)|Adverse Event|0|||
105629052|NCT04408755|364307661|FG001|Period B (Randomization Period)|Adverse Event|3|||
105629053|NCT04408755|364307662|FG002|Period B (Randomization Period)|Adverse Event|0|||
105629054|NCT04408755|364307663|FG003|Period B (Randomization Period)|Adverse Event|1|||
105629055|NCT04408755|364307660|FG000|Period B (Randomization Period)|Death|0|||
105629056|NCT04408755|364307661|FG001|Period B (Randomization Period)|Death|0|||
105629057|NCT04408755|364307662|FG002|Period B (Randomization Period)|Death|1|||
105629058|NCT04408755|364307663|FG003|Period B (Randomization Period)|Death|0|||
105629059|NCT04408755|364307660|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
105629060|NCT04408755|364307661|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
105629061|NCT04408755|364307662|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
105629062|NCT04408755|364307663|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
105629063|NCT04408755|364307660|FG000|Period B (Randomization Period)|Physician Decision|0|||
105629064|NCT04408755|364307661|FG001|Period B (Randomization Period)|Physician Decision|0|||
105629065|NCT04408755|364307662|FG002|Period B (Randomization Period)|Physician Decision|1|||
105629066|NCT04408755|364307663|FG003|Period B (Randomization Period)|Physician Decision|0|||
105629067|NCT04408755|364307660|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
105629068|NCT04408755|364307661|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
105629069|NCT04408755|364307662|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
105629070|NCT04408755|364307663|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
105629071|NCT04408755|364307660|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
105629072|NCT04408755|364307661|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
105629073|NCT04408755|364307662|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
105629074|NCT04408755|364307663|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
105629075|NCT04408755|364307660|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
105629076|NCT04408755|364307661|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
105629077|NCT04408755|364307662|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
105629078|NCT04408755|364307663|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
105629079|NCT04408755|364307660|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
105629080|NCT04408755|364307661|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
105629081|NCT04408755|364307662|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
105629082|NCT04408755|364307663|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
105629083|NCT04408755|364307660|FG000|Period B (Randomization Period)|Reason not Specified|0|||
105629084|NCT04408755|364307661|FG001|Period B (Randomization Period)|Reason not Specified|1|||
105629085|NCT04408755|364307662|FG002|Period B (Randomization Period)|Reason not Specified|0|||
105629086|NCT04408755|364307663|FG003|Period B (Randomization Period)|Reason not Specified|2|||
105629087|NCT03872466|364307664|FG000|Overall Study|Withdrawal by Subject|1|||
105629088|NCT03872466|364307665|FG001|Overall Study|Withdrawal by Subject|0|||
105629089|NCT03872466|364307664|FG000|Overall Study|Physician Decision|2|||
105629090|NCT03872466|364307665|FG001|Overall Study|Physician Decision|0|||
105629091|NCT01778686|364307666|FG000|Overall Study|Adverse Event|0|||
105629092|NCT01778686|364307667|FG001|Overall Study|Adverse Event|0|||
105629093|NCT01778686|364307668|FG002|Overall Study|Adverse Event|1|||
105629094|NCT04012567|364307669|FG000|Overall Study|Lost to Follow-up|0|||
105629095|NCT04012567|364307670|FG001|Overall Study|Lost to Follow-up|1|||
105629096|NCT04012567|364307669|FG000|Overall Study|Withdrawal by Subject|1|||
105629097|NCT04012567|364307670|FG001|Overall Study|Withdrawal by Subject|0|||
105629098|NCT06059443|364307671|FG000|Overall Study|Withdrawal by Subject|2|||
105629099|NCT06059443|364307672|FG001|Overall Study|Withdrawal by Subject|0|||
105629100|NCT06059443|364307671|FG000|Overall Study|Lost to Follow-up|2|||
105629101|NCT06059443|364307672|FG001|Overall Study|Lost to Follow-up|2|||
105629102|NCT03512301|364308247|FG000|Overall Study|Protocol Violation|2|||
105629103|NCT03512301|364308247|FG000|Overall Study|Did Not Qualify|3|||
105629104|NCT03512301|364308247|FG000|Overall Study|Age-ineligible|1|||
105629105|NCT03512301|364308247|FG000|Overall Study|Inadequate fluency with the English language|3|||
105629106|NCT02701283|364308254|FG000|Overall Study|Death|25|||
105629107|NCT02701283|364308255|FG001|Overall Study|Death|29|||
105629108|NCT02701283|364308256|FG002|Overall Study|Death|19|||
105629109|NCT02701283|364308254|FG000|Overall Study|Lost to Follow-up|3|||
105629110|NCT02701283|364308255|FG001|Overall Study|Lost to Follow-up|8|||
105629111|NCT02701283|364308256|FG002|Overall Study|Lost to Follow-up|1|||
105629112|NCT02701283|364308254|FG000|Overall Study|Withdrawal by Subject|12|||
105629113|NCT02701283|364308255|FG001|Overall Study|Withdrawal by Subject|41|||
105629114|NCT02701283|364308256|FG002|Overall Study|Withdrawal by Subject|1|||
105629115|NCT02701283|364308254|FG000|Overall Study|Missed 2-year visit|22|||
105629116|NCT02701283|364308255|FG001|Overall Study|Missed 2-year visit|27|||
105629117|NCT02701283|364308256|FG002|Overall Study|Missed 2-year visit|0|||
105629118|NCT02701283|364308254|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
105629119|NCT02701283|364308255|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
105629120|NCT02701283|364308256|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
105629121|NCT05707351|364308257|FG000|Overall Study|Withdrawal by Subject|2|||
105629122|NCT05707351|364308257|FG000|Overall Study|Reason Not Specified|1|||
105629123|NCT01366092|364308258|FG000|Overall Study|Progressive cGVHD|2|||
105629124|NCT01366092|364308258|FG000|Overall Study|Physician Decision|1|||
105629125|NCT01366092|364308258|FG000|Overall Study|Withdrawal by Subject|1|||
105629126|NCT03142009|364308259|FG000|Overall Study|Lost to Follow-up|45|||
105629127|NCT03142009|364308260|FG001|Overall Study|Lost to Follow-up|30|||
105629128|NCT01499368|364308261|FG000|Overall Study|Did not meet I/E criteria|8|||
105629129|NCT01499368|364308262|FG001|Overall Study|Did not meet I/E criteria|4|||
105629130|NCT01499368|364308263|FG002|Overall Study|Did not meet I/E criteria|4|||
105629131|NCT01499368|364308261|FG000|Overall Study|Prohibited Concomitant medication|1|||
105629132|NCT01499368|364308262|FG001|Overall Study|Prohibited Concomitant medication|1|||
105629133|NCT01499368|364308263|FG002|Overall Study|Prohibited Concomitant medication|0|||
105629134|NCT01499368|364308261|FG000|Overall Study|Withdrawal by Subject|11|||
105629135|NCT01499368|364308262|FG001|Overall Study|Withdrawal by Subject|10|||
105629136|NCT01499368|364308263|FG002|Overall Study|Withdrawal by Subject|8|||
105629137|NCT01499368|364308261|FG000|Overall Study|Lost to Follow-up|3|||
105629138|NCT01499368|364308262|FG001|Overall Study|Lost to Follow-up|2|||
105629139|NCT01499368|364308263|FG002|Overall Study|Lost to Follow-up|5|||
105629140|NCT01499368|364308261|FG000|Overall Study|Adverse Event|4|||
105629141|NCT01499368|364308262|FG001|Overall Study|Adverse Event|0|||
105629142|NCT01499368|364308263|FG002|Overall Study|Adverse Event|2|||
105629143|NCT01499368|364308261|FG000|Overall Study|Physician Decision|0|||
105629144|NCT01499368|364308262|FG001|Overall Study|Physician Decision|1|||
105629145|NCT01499368|364308263|FG002|Overall Study|Physician Decision|0|||
105629146|NCT01499368|364308261|FG000|Overall Study|Deviation from visit window|0|||
105629147|NCT01499368|364308262|FG001|Overall Study|Deviation from visit window|0|||
105629148|NCT01499368|364308263|FG002|Overall Study|Deviation from visit window|1|||
105629149|NCT01499368|364308261|FG000|Overall Study|Error of Prescriptions|0|||
105629150|NCT01499368|364308262|FG001|Overall Study|Error of Prescriptions|0|||
105629151|NCT01499368|364308263|FG002|Overall Study|Error of Prescriptions|1|||
105629152|NCT05771467|364308265|FG000|Overall Study|Lost to Follow-up|6|||
105629153|NCT05771467|364308266|FG001|Overall Study|Lost to Follow-up|3|||
105629154|NCT02951052|364308267|FG000|Overall Study|Adverse Event|13|||
105629155|NCT02951052|364308268|FG001|Overall Study|Adverse Event|5|||
105629156|NCT02951052|364308267|FG000|Overall Study|Withdrawal by Subject|1|||
105629157|NCT02951052|364308268|FG001|Overall Study|Withdrawal by Subject|5|||
105629158|NCT02951052|364308267|FG000|Overall Study|Physician Decision|2|||
105629159|NCT02951052|364308268|FG001|Overall Study|Physician Decision|0|||
105629160|NCT02951052|364308267|FG000|Overall Study|Lost to Follow-up|1|||
105629161|NCT02951052|364308268|FG001|Overall Study|Lost to Follow-up|1|||
105629162|NCT02951052|364308267|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
105629163|NCT02951052|364308268|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
105629164|NCT02951052|364308267|FG000|Overall Study|Protocol Violation|5|||
105629165|NCT02951052|364308268|FG001|Overall Study|Protocol Violation|3|||
105629166|NCT02951052|364308267|FG000|Overall Study|Lack of Efficacy|3|||
105629167|NCT02951052|364308268|FG001|Overall Study|Lack of Efficacy|4|||
105629168|NCT02951052|364308267|FG000|Overall Study|Ongoing|1|||
105629169|NCT02951052|364308268|FG001|Overall Study|Ongoing|0|||
105629170|NCT01265537|364308273|FG000|Overall Study|Adverse Event|2|||
105629171|NCT01265537|364308274|FG001|Overall Study|Adverse Event|1|||
105629172|NCT01265537|364308273|FG000|Overall Study|Physician Decision|0|||
105629173|NCT01265537|364308274|FG001|Overall Study|Physician Decision|1|||
105629174|NCT00994643|364309289|FG000|Overall Study|Withdrawal by Subject|1|||
105629175|NCT04595331|364309290|FG000|Overall Study|Withdrawal by Subject|0|||
105629176|NCT04595331|364309291|FG001|Overall Study|Withdrawal by Subject|1|||
105629177|NCT04595331|364309290|FG000|Overall Study|Lost to Follow-up|0|||
105629178|NCT04595331|364309291|FG001|Overall Study|Lost to Follow-up|5|||
105629179|NCT04595331|364309290|FG000|Overall Study|Medical reason|0|||
105629180|NCT04595331|364309291|FG001|Overall Study|Medical reason|1|||
105629181|NCT02611687|364309297|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
105629182|NCT02611687|364309298|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
105629183|NCT03705793|364309299|FG000|Overall Study|Lost to Follow-up|3|||
105629184|NCT03705793|364309300|FG001|Overall Study|Lost to Follow-up|4|||
105629185|NCT03705793|364309299|FG000|Overall Study|Withdrawal by Subject|2|||
105629186|NCT03705793|364309300|FG001|Overall Study|Withdrawal by Subject|1|||
105629187|NCT02719574|364309301|FG000|Phase 1 (Dose Escalation)|Other|0|||
105629188|NCT02719574|364309302|FG001|Phase 1 (Dose Escalation)|Other|2|||
105629189|NCT02719574|364309303|FG002|Phase 1 (Dose Escalation)|Other|1|||
105629190|NCT02719574|364309304|FG003|Phase 1 (Dose Escalation)|Other|2|||
105629191|NCT02719574|364309305|FG004|Phase 1 (Dose Escalation)|Other|2|||
105629192|NCT02719574|364309306|FG005|Phase 1 (Dose Escalation)|Other|0|||
105629193|NCT02719574|364309307|FG006|Phase 1 (Dose Escalation)|Other|0|||
105629194|NCT02719574|364309308|FG007|Phase 1 (Dose Escalation)|Other|0|||
105629195|NCT02719574|364309309|FG008|Phase 1 (Dose Escalation)|Other|0|||
105629196|NCT02719574|364309310|FG009|Phase 1 (Dose Escalation)|Other|0|||
105629197|NCT02719574|364309311|FG010|Phase 1 (Dose Escalation)|Other|0|||
105629198|NCT02719574|364309312|FG011|Phase 1 (Dose Escalation)|Other|0|||
105629199|NCT02719574|364309313|FG012|Phase 1 (Dose Escalation)|Other|0|||
105629200|NCT02719574|364309314|FG013|Phase 1 (Dose Escalation)|Other|0|||
105629201|NCT02719574|364309315|FG014|Phase 1 (Dose Escalation)|Other|0|||
105629202|NCT02719574|364309316|FG015|Phase 1 (Dose Escalation)|Other|0|||
105629203|NCT02719574|364309317|FG016|Phase 1 (Dose Escalation)|Other|0|||
105629204|NCT02719574|364309301|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
105629205|NCT02719574|364309302|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
105629206|NCT02719574|364309303|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
105629207|NCT02719574|364309304|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
105629208|NCT02719574|364309305|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
105629209|NCT02719574|364309306|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
105629210|NCT02719574|364309307|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
105629211|NCT02719574|364309308|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
105629212|NCT02719574|364309309|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
105629213|NCT02719574|364309310|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
105629214|NCT02719574|364309311|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
105629215|NCT02719574|364309312|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
105629216|NCT02719574|364309313|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
105629217|NCT02719574|364309314|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
105629218|NCT02719574|364309315|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
105629219|NCT02719574|364309316|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
105629220|NCT02719574|364309317|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
105629221|NCT02719574|364309301|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
105629222|NCT02719574|364309302|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
105629223|NCT02719574|364309303|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
105629224|NCT02719574|364309304|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
105629225|NCT02719574|364309305|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
105629226|NCT02719574|364309306|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
105629227|NCT02719574|364309307|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
105629228|NCT02719574|364309308|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
105629229|NCT02719574|364309309|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
105629230|NCT02719574|364309310|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
105629231|NCT02719574|364309311|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
105629232|NCT02719574|364309312|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
105629233|NCT02719574|364309313|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
105629234|NCT02719574|364309314|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
105629235|NCT02719574|364309315|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
105629236|NCT02719574|364309316|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
105629237|NCT02719574|364309317|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
105629238|NCT02719574|364309301|FG000|Phase 1 (Dose Escalation)|Death|2|||
105629239|NCT02719574|364309302|FG001|Phase 1 (Dose Escalation)|Death|1|||
105629240|NCT02719574|364309303|FG002|Phase 1 (Dose Escalation)|Death|1|||
105629241|NCT02719574|364309304|FG003|Phase 1 (Dose Escalation)|Death|0|||
105629242|NCT02719574|364309305|FG004|Phase 1 (Dose Escalation)|Death|0|||
105629243|NCT02719574|364309306|FG005|Phase 1 (Dose Escalation)|Death|0|||
105629244|NCT02719574|364309307|FG006|Phase 1 (Dose Escalation)|Death|0|||
105629245|NCT02719574|364309308|FG007|Phase 1 (Dose Escalation)|Death|0|||
105629246|NCT02719574|364309309|FG008|Phase 1 (Dose Escalation)|Death|0|||
105629247|NCT02719574|364309310|FG009|Phase 1 (Dose Escalation)|Death|0|||
105629248|NCT02719574|364309311|FG010|Phase 1 (Dose Escalation)|Death|0|||
105629249|NCT02719574|364309312|FG011|Phase 1 (Dose Escalation)|Death|0|||
105629250|NCT02719574|364309313|FG012|Phase 1 (Dose Escalation)|Death|0|||
105629251|NCT02719574|364309314|FG013|Phase 1 (Dose Escalation)|Death|0|||
105629252|NCT02719574|364309315|FG014|Phase 1 (Dose Escalation)|Death|0|||
105629253|NCT02719574|364309316|FG015|Phase 1 (Dose Escalation)|Death|0|||
105629254|NCT02719574|364309317|FG016|Phase 1 (Dose Escalation)|Death|0|||
105629255|NCT02719574|364309301|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
105629256|NCT02719574|364309302|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
105629257|NCT02719574|364309303|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
105629258|NCT02719574|364309304|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
105629259|NCT02719574|364309305|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
105629260|NCT02719574|364309306|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
105629261|NCT02719574|364309307|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
105629262|NCT02719574|364309308|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
105629263|NCT02719574|364309309|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
105629264|NCT02719574|364309310|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
105629265|NCT02719574|364309311|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
105629266|NCT02719574|364309312|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
105629267|NCT02719574|364309313|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
105629268|NCT02719574|364309314|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
105629269|NCT02719574|364309315|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
105629270|NCT02719574|364309316|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
105629271|NCT02719574|364309317|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
105629272|NCT02719574|364309301|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
105629273|NCT02719574|364309302|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
105629274|NCT02719574|364309303|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
105629275|NCT02719574|364309304|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
105629276|NCT02719574|364309305|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
105629277|NCT02719574|364309306|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
105629278|NCT02719574|364309307|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
105629279|NCT02719574|364309308|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
105629280|NCT02719574|364309309|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
105629281|NCT02719574|364309310|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
105629282|NCT02719574|364309311|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
105629283|NCT02719574|364309312|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
105629284|NCT02719574|364309313|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
105629285|NCT02719574|364309314|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
105629286|NCT02719574|364309315|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
105629287|NCT02719574|364309316|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
105629288|NCT02719574|364309317|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
105629289|NCT02719574|364309301|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629290|NCT02719574|364309302|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629291|NCT02719574|364309303|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
105629292|NCT02719574|364309304|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629293|NCT02719574|364309305|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629294|NCT02719574|364309306|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629295|NCT02719574|364309307|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629296|NCT02719574|364309308|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629297|NCT02719574|364309309|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629298|NCT02719574|364309310|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629299|NCT02719574|364309311|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629300|NCT02719574|364309312|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629301|NCT02719574|364309313|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629302|NCT02719574|364309314|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629303|NCT02719574|364309315|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629304|NCT02719574|364309316|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629305|NCT02719574|364309317|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105629306|NCT02719574|364309301|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
105629307|NCT02719574|364309302|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
105629308|NCT02719574|364309303|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
105629309|NCT02719574|364309304|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
105629310|NCT02719574|364309305|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
105629311|NCT02719574|364309306|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
105629312|NCT02719574|364309307|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
105629313|NCT02719574|364309308|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
105629314|NCT02719574|364309309|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
105629315|NCT02719574|364309310|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
105629316|NCT02719574|364309311|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
105629317|NCT02719574|364309312|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
105629318|NCT02719574|364309313|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
105629319|NCT02719574|364309314|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
105629320|NCT02719574|364309315|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
105629321|NCT02719574|364309316|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
105629322|NCT02719574|364309317|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
105629323|NCT02719574|364309301|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
105629324|NCT02719574|364309302|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
105629325|NCT02719574|364309303|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
105629326|NCT02719574|364309304|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
105629327|NCT02719574|364309305|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
105629328|NCT02719574|364309306|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
105629329|NCT02719574|364309307|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
105629330|NCT02719574|364309308|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
105629331|NCT02719574|364309309|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
105629332|NCT02719574|364309310|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
105629333|NCT02719574|364309311|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
105629334|NCT02719574|364309312|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
105629335|NCT02719574|364309313|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
105629336|NCT02719574|364309314|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
105629337|NCT02719574|364309315|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
105629338|NCT02719574|364309316|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
105629339|NCT02719574|364309317|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
105629340|NCT02719574|364309301|FG000|Phase 1 (Dose Expansion)|Death|0|||
105629341|NCT02719574|364309302|FG001|Phase 1 (Dose Expansion)|Death|0|||
105629342|NCT02719574|364309303|FG002|Phase 1 (Dose Expansion)|Death|0|||
105629343|NCT02719574|364309304|FG003|Phase 1 (Dose Expansion)|Death|0|||
105629344|NCT02719574|364309305|FG004|Phase 1 (Dose Expansion)|Death|0|||
105629345|NCT02719574|364309306|FG005|Phase 1 (Dose Expansion)|Death|0|||
105629346|NCT02719574|364309307|FG006|Phase 1 (Dose Expansion)|Death|1|||
105629347|NCT02719574|364309308|FG007|Phase 1 (Dose Expansion)|Death|6|||
105629348|NCT02719574|364309309|FG008|Phase 1 (Dose Expansion)|Death|0|||
105629349|NCT02719574|364309310|FG009|Phase 1 (Dose Expansion)|Death|0|||
105629350|NCT02719574|364309311|FG010|Phase 1 (Dose Expansion)|Death|0|||
105629351|NCT02719574|364309312|FG011|Phase 1 (Dose Expansion)|Death|0|||
105629352|NCT02719574|364309313|FG012|Phase 1 (Dose Expansion)|Death|0|||
105629353|NCT02719574|364309314|FG013|Phase 1 (Dose Expansion)|Death|0|||
105629354|NCT02719574|364309315|FG014|Phase 1 (Dose Expansion)|Death|0|||
105629355|NCT02719574|364309316|FG015|Phase 1 (Dose Expansion)|Death|0|||
105629356|NCT02719574|364309317|FG016|Phase 1 (Dose Expansion)|Death|0|||
105629357|NCT02719574|364309301|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
105629358|NCT02719574|364309302|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
105629359|NCT02719574|364309303|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
105629360|NCT02719574|364309304|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
105629361|NCT02719574|364309305|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
105629362|NCT02719574|364309306|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
105629363|NCT02719574|364309307|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
105629364|NCT02719574|364309308|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
105629365|NCT02719574|364309309|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
105629366|NCT02719574|364309310|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
105629367|NCT02719574|364309311|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
105629368|NCT02719574|364309312|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
105629369|NCT02719574|364309313|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
105629370|NCT02719574|364309314|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
105629371|NCT02719574|364309315|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
105629372|NCT02719574|364309316|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
105629373|NCT02719574|364309317|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
105629374|NCT02719574|364309301|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
105629375|NCT02719574|364309302|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
105629376|NCT02719574|364309303|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
105629377|NCT02719574|364309304|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
105629378|NCT02719574|364309305|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
105629379|NCT02719574|364309306|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
105629380|NCT02719574|364309307|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
105629381|NCT02719574|364309308|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
105629382|NCT02719574|364309309|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
105629383|NCT02719574|364309310|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
105629384|NCT02719574|364309311|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
105629385|NCT02719574|364309312|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
105629386|NCT02719574|364309313|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
105629387|NCT02719574|364309314|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
105629388|NCT02719574|364309315|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
105629389|NCT02719574|364309316|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
105629390|NCT02719574|364309317|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
105629391|NCT02719574|364309301|FG000|Phase 1 (Dose Expansion)|Other|0|||
105629392|NCT02719574|364309302|FG001|Phase 1 (Dose Expansion)|Other|0|||
105629393|NCT02719574|364309303|FG002|Phase 1 (Dose Expansion)|Other|0|||
105629394|NCT02719574|364309304|FG003|Phase 1 (Dose Expansion)|Other|0|||
105629395|NCT02719574|364309305|FG004|Phase 1 (Dose Expansion)|Other|0|||
105629396|NCT02719574|364309306|FG005|Phase 1 (Dose Expansion)|Other|0|||
105629397|NCT02719574|364309307|FG006|Phase 1 (Dose Expansion)|Other|1|||
105629398|NCT02719574|364309308|FG007|Phase 1 (Dose Expansion)|Other|7|||
105629399|NCT02719574|364309309|FG008|Phase 1 (Dose Expansion)|Other|0|||
105629400|NCT02719574|364309310|FG009|Phase 1 (Dose Expansion)|Other|0|||
105629401|NCT02719574|364309311|FG010|Phase 1 (Dose Expansion)|Other|0|||
105629402|NCT02719574|364309312|FG011|Phase 1 (Dose Expansion)|Other|0|||
105629403|NCT02719574|364309313|FG012|Phase 1 (Dose Expansion)|Other|0|||
105629404|NCT02719574|364309314|FG013|Phase 1 (Dose Expansion)|Other|0|||
105629405|NCT02719574|364309315|FG014|Phase 1 (Dose Expansion)|Other|0|||
105629406|NCT02719574|364309316|FG015|Phase 1 (Dose Expansion)|Other|0|||
105629407|NCT02719574|364309317|FG016|Phase 1 (Dose Expansion)|Other|0|||
105629408|NCT02719574|364309301|FG000|Phase 2|Protocol Defined Disease Progression|0|||
105629409|NCT02719574|364309302|FG001|Phase 2|Protocol Defined Disease Progression|0|||
105629410|NCT02719574|364309303|FG002|Phase 2|Protocol Defined Disease Progression|0|||
105629411|NCT02719574|364309304|FG003|Phase 2|Protocol Defined Disease Progression|0|||
105629412|NCT02719574|364309305|FG004|Phase 2|Protocol Defined Disease Progression|0|||
105629413|NCT02719574|364309306|FG005|Phase 2|Protocol Defined Disease Progression|0|||
105629414|NCT02719574|364309307|FG006|Phase 2|Protocol Defined Disease Progression|0|||
105629415|NCT02719574|364309308|FG007|Phase 2|Protocol Defined Disease Progression|0|||
105629416|NCT02719574|364309309|FG008|Phase 2|Protocol Defined Disease Progression|0|||
105629417|NCT02719574|364309310|FG009|Phase 2|Protocol Defined Disease Progression|65|||
105629418|NCT02719574|364309311|FG010|Phase 2|Protocol Defined Disease Progression|8|||
105629419|NCT02719574|364309312|FG011|Phase 2|Protocol Defined Disease Progression|2|||
105629420|NCT02719574|364309313|FG012|Phase 2|Protocol Defined Disease Progression|4|||
105629421|NCT02719574|364309314|FG013|Phase 2|Protocol Defined Disease Progression|9|||
105629422|NCT02719574|364309315|FG014|Phase 2|Protocol Defined Disease Progression|11|||
105629423|NCT02719574|364309316|FG015|Phase 2|Protocol Defined Disease Progression|3|||
105629424|NCT02719574|364309317|FG016|Phase 2|Protocol Defined Disease Progression|4|||
105629425|NCT02719574|364309301|FG000|Phase 2|Adverse Event|0|||
105629426|NCT02719574|364309302|FG001|Phase 2|Adverse Event|0|||
105629427|NCT02719574|364309303|FG002|Phase 2|Adverse Event|0|||
105629428|NCT02719574|364309304|FG003|Phase 2|Adverse Event|0|||
105629429|NCT02719574|364309305|FG004|Phase 2|Adverse Event|0|||
105629430|NCT02719574|364309306|FG005|Phase 2|Adverse Event|0|||
105629431|NCT02719574|364309307|FG006|Phase 2|Adverse Event|0|||
105629432|NCT02719574|364309308|FG007|Phase 2|Adverse Event|0|||
105629433|NCT02719574|364309309|FG008|Phase 2|Adverse Event|0|||
105629434|NCT02719574|364309310|FG009|Phase 2|Adverse Event|27|||
105629435|NCT02719574|364309311|FG010|Phase 2|Adverse Event|0|||
105629436|NCT02719574|364309312|FG011|Phase 2|Adverse Event|1|||
105629437|NCT02719574|364309313|FG012|Phase 2|Adverse Event|1|||
105629438|NCT02719574|364309314|FG013|Phase 2|Adverse Event|1|||
105629439|NCT02719574|364309315|FG014|Phase 2|Adverse Event|2|||
105629440|NCT02719574|364309316|FG015|Phase 2|Adverse Event|2|||
105629441|NCT02719574|364309317|FG016|Phase 2|Adverse Event|3|||
105629442|NCT02719574|364309301|FG000|Phase 2|Other|0|||
105629443|NCT02719574|364309302|FG001|Phase 2|Other|0|||
105629444|NCT02719574|364309303|FG002|Phase 2|Other|0|||
105629445|NCT02719574|364309304|FG003|Phase 2|Other|0|||
105629446|NCT02719574|364309305|FG004|Phase 2|Other|0|||
105629447|NCT02719574|364309306|FG005|Phase 2|Other|0|||
105629448|NCT02719574|364309307|FG006|Phase 2|Other|0|||
105629449|NCT02719574|364309308|FG007|Phase 2|Other|0|||
105629450|NCT02719574|364309309|FG008|Phase 2|Other|0|||
105629451|NCT02719574|364309310|FG009|Phase 2|Other|20|||
105629452|NCT02719574|364309311|FG010|Phase 2|Other|7|||
105629453|NCT02719574|364309312|FG011|Phase 2|Other|0|||
105629454|NCT02719574|364309313|FG012|Phase 2|Other|5|||
105629455|NCT02719574|364309314|FG013|Phase 2|Other|7|||
105629456|NCT02719574|364309315|FG014|Phase 2|Other|0|||
105629457|NCT02719574|364309316|FG015|Phase 2|Other|1|||
105629458|NCT02719574|364309317|FG016|Phase 2|Other|4|||
105629459|NCT02719574|364309301|FG000|Phase 2|Transplant|0|||
105629460|NCT02719574|364309302|FG001|Phase 2|Transplant|0|||
105629461|NCT02719574|364309303|FG002|Phase 2|Transplant|0|||
105629462|NCT02719574|364309304|FG003|Phase 2|Transplant|0|||
105629463|NCT02719574|364309305|FG004|Phase 2|Transplant|0|||
105629464|NCT02719574|364309306|FG005|Phase 2|Transplant|0|||
105629465|NCT02719574|364309307|FG006|Phase 2|Transplant|0|||
105629466|NCT02719574|364309308|FG007|Phase 2|Transplant|0|||
105629467|NCT02719574|364309309|FG008|Phase 2|Transplant|0|||
105629468|NCT02719574|364309310|FG009|Phase 2|Transplant|15|||
105629469|NCT02719574|364309311|FG010|Phase 2|Transplant|2|||
105629470|NCT02719574|364309312|FG011|Phase 2|Transplant|0|||
105629471|NCT02719574|364309313|FG012|Phase 2|Transplant|6|||
105629472|NCT02719574|364309314|FG013|Phase 2|Transplant|1|||
105629473|NCT02719574|364309315|FG014|Phase 2|Transplant|1|||
105629474|NCT02719574|364309316|FG015|Phase 2|Transplant|0|||
105629475|NCT02719574|364309317|FG016|Phase 2|Transplant|0|||
105629476|NCT02719574|364309301|FG000|Phase 2|Death|0|||
105629477|NCT02719574|364309302|FG001|Phase 2|Death|0|||
105629478|NCT02719574|364309303|FG002|Phase 2|Death|0|||
105629479|NCT02719574|364309304|FG003|Phase 2|Death|0|||
105629480|NCT02719574|364309305|FG004|Phase 2|Death|0|||
105629481|NCT02719574|364309306|FG005|Phase 2|Death|0|||
105629482|NCT02719574|364309307|FG006|Phase 2|Death|0|||
105629483|NCT02719574|364309308|FG007|Phase 2|Death|0|||
105629484|NCT02719574|364309309|FG008|Phase 2|Death|0|||
105629485|NCT02719574|364309310|FG009|Phase 2|Death|14|||
105629486|NCT02719574|364309311|FG010|Phase 2|Death|0|||
105629487|NCT02719574|364309312|FG011|Phase 2|Death|0|||
105629488|NCT02719574|364309313|FG012|Phase 2|Death|1|||
105629489|NCT02719574|364309314|FG013|Phase 2|Death|1|||
105629490|NCT02719574|364309315|FG014|Phase 2|Death|2|||
105629491|NCT02719574|364309316|FG015|Phase 2|Death|0|||
105629492|NCT02719574|364309317|FG016|Phase 2|Death|0|||
105629493|NCT02719574|364309301|FG000|Phase 2|Investigator Decision|0|||
105629494|NCT02719574|364309302|FG001|Phase 2|Investigator Decision|0|||
105629495|NCT02719574|364309303|FG002|Phase 2|Investigator Decision|0|||
105629496|NCT02719574|364309304|FG003|Phase 2|Investigator Decision|0|||
105629497|NCT02719574|364309305|FG004|Phase 2|Investigator Decision|0|||
105629498|NCT02719574|364309306|FG005|Phase 2|Investigator Decision|0|||
105629499|NCT02719574|364309307|FG006|Phase 2|Investigator Decision|0|||
105629500|NCT02719574|364309308|FG007|Phase 2|Investigator Decision|0|||
105629501|NCT02719574|364309309|FG008|Phase 2|Investigator Decision|0|||
105629502|NCT02719574|364309310|FG009|Phase 2|Investigator Decision|6|||
105629503|NCT02719574|364309311|FG010|Phase 2|Investigator Decision|1|||
105629504|NCT02719574|364309312|FG011|Phase 2|Investigator Decision|2|||
105629505|NCT02719574|364309313|FG012|Phase 2|Investigator Decision|3|||
105629506|NCT02719574|364309314|FG013|Phase 2|Investigator Decision|1|||
105629507|NCT02719574|364309315|FG014|Phase 2|Investigator Decision|3|||
105629508|NCT02719574|364309316|FG015|Phase 2|Investigator Decision|2|||
105629509|NCT02719574|364309317|FG016|Phase 2|Investigator Decision|0|||
105629510|NCT02719574|364309301|FG000|Phase 2|Withdrawal by Subject|0|||
105629511|NCT02719574|364309302|FG001|Phase 2|Withdrawal by Subject|0|||
105629512|NCT02719574|364309303|FG002|Phase 2|Withdrawal by Subject|0|||
105629513|NCT02719574|364309304|FG003|Phase 2|Withdrawal by Subject|0|||
105629514|NCT02719574|364309305|FG004|Phase 2|Withdrawal by Subject|0|||
105629515|NCT02719574|364309306|FG005|Phase 2|Withdrawal by Subject|0|||
105629516|NCT02719574|364309307|FG006|Phase 2|Withdrawal by Subject|0|||
105629517|NCT02719574|364309308|FG007|Phase 2|Withdrawal by Subject|0|||
105629518|NCT02719574|364309309|FG008|Phase 2|Withdrawal by Subject|0|||
105629519|NCT02719574|364309310|FG009|Phase 2|Withdrawal by Subject|5|||
105629520|NCT02719574|364309311|FG010|Phase 2|Withdrawal by Subject|0|||
105629521|NCT02719574|364309312|FG011|Phase 2|Withdrawal by Subject|0|||
105629522|NCT02719574|364309313|FG012|Phase 2|Withdrawal by Subject|0|||
105629523|NCT02719574|364309314|FG013|Phase 2|Withdrawal by Subject|1|||
105629524|NCT02719574|364309315|FG014|Phase 2|Withdrawal by Subject|1|||
105629525|NCT02719574|364309316|FG015|Phase 2|Withdrawal by Subject|2|||
105629526|NCT02719574|364309317|FG016|Phase 2|Withdrawal by Subject|0|||
105629527|NCT02719574|364309301|FG000|Phase 2|Protocol Violation|0|||
105629528|NCT02719574|364309302|FG001|Phase 2|Protocol Violation|0|||
105629529|NCT02719574|364309303|FG002|Phase 2|Protocol Violation|0|||
105629530|NCT02719574|364309304|FG003|Phase 2|Protocol Violation|0|||
105629531|NCT02719574|364309305|FG004|Phase 2|Protocol Violation|0|||
105629532|NCT02719574|364309306|FG005|Phase 2|Protocol Violation|0|||
105629533|NCT02719574|364309307|FG006|Phase 2|Protocol Violation|0|||
105629534|NCT02719574|364309308|FG007|Phase 2|Protocol Violation|0|||
105629535|NCT02719574|364309309|FG008|Phase 2|Protocol Violation|0|||
105629536|NCT02719574|364309310|FG009|Phase 2|Protocol Violation|1|||
105629537|NCT02719574|364309311|FG010|Phase 2|Protocol Violation|0|||
105629538|NCT02719574|364309312|FG011|Phase 2|Protocol Violation|0|||
105629539|NCT02719574|364309313|FG012|Phase 2|Protocol Violation|0|||
105629540|NCT02719574|364309314|FG013|Phase 2|Protocol Violation|0|||
105629541|NCT02719574|364309315|FG014|Phase 2|Protocol Violation|0|||
105629542|NCT02719574|364309316|FG015|Phase 2|Protocol Violation|0|||
105629543|NCT02719574|364309317|FG016|Phase 2|Protocol Violation|0|||
105629544|NCT00113360|364309321|FG000|Overall Study|Adverse Event|3|||
105629545|NCT00113360|364309321|FG000|Overall Study|Subject required surgery|1|||
105629546|NCT00113360|364309321|FG000|Overall Study|Did not meet eligibility criteria|3|||
105629547|NCT03635567|364309322|FG000|Overall Study|Lost to Follow-up|4|||
105629548|NCT03635567|364309323|FG001|Overall Study|Lost to Follow-up|1|||
105629549|NCT03635567|364309322|FG000|Overall Study|Withdrawal by Subject|11|||
105629550|NCT03635567|364309323|FG001|Overall Study|Withdrawal by Subject|16|||
105629551|NCT03635567|364309322|FG000|Overall Study|Sponsor Decision|99|||
105629552|NCT03635567|364309323|FG001|Overall Study|Sponsor Decision|57|||
105629553|NCT03635567|364309322|FG000|Overall Study|Death|194|||
105629554|NCT03635567|364309323|FG001|Overall Study|Death|235|||
105629555|NCT00495677|364309324|FG000|Stage 1 (25 Days)|Adverse Event|0|||
105629556|NCT00495677|364309325|FG001|Stage 1 (25 Days)|Adverse Event|0|||
105629557|NCT00495677|364309326|FG002|Stage 1 (25 Days)|Adverse Event|1|||
105629558|NCT00495677|364309327|FG003|Stage 1 (25 Days)|Adverse Event|0|||
105629559|NCT00495677|364309328|FG004|Stage 1 (25 Days)|Adverse Event|0|||
105629560|NCT00495677|364309329|FG005|Stage 1 (25 Days)|Adverse Event|0|||
105629561|NCT00495677|364309330|FG006|Stage 1 (25 Days)|Adverse Event|0|||
105629562|NCT03875313|364309331|FG000|Overall Study|Withdrawal by Subject|1|||
105629563|NCT03875313|364309332|FG001|Overall Study|Withdrawal by Subject|3|||
105629564|NCT03875313|364309333|FG002|Overall Study|Withdrawal by Subject|0|||
105629565|NCT03875313|364309334|FG003|Overall Study|Withdrawal by Subject|0|||
105629566|NCT03875313|364309335|FG004|Overall Study|Withdrawal by Subject|0|||
105629567|NCT03875313|364309331|FG000|Overall Study|Death|0|||
105629568|NCT03875313|364309332|FG001|Overall Study|Death|0|||
105629569|NCT03875313|364309333|FG002|Overall Study|Death|0|||
105629570|NCT03875313|364309334|FG003|Overall Study|Death|0|||
105629571|NCT03875313|364309335|FG004|Overall Study|Death|1|||
105629572|NCT03875313|364309331|FG000|Overall Study|Lost to Follow-up|0|||
105629573|NCT03875313|364309332|FG001|Overall Study|Lost to Follow-up|0|||
105629574|NCT03875313|364309333|FG002|Overall Study|Lost to Follow-up|0|||
105629575|NCT03875313|364309334|FG003|Overall Study|Lost to Follow-up|0|||
105629576|NCT03875313|364309335|FG004|Overall Study|Lost to Follow-up|1|||
105629577|NCT03875313|364309331|FG000|Overall Study|Study Termination by Sponsor|0|||
105629578|NCT03875313|364309332|FG001|Overall Study|Study Termination by Sponsor|1|||
105629579|NCT03875313|364309333|FG002|Overall Study|Study Termination by Sponsor|1|||
105629580|NCT03875313|364309334|FG003|Overall Study|Study Termination by Sponsor|0|||
105629581|NCT03875313|364309335|FG004|Overall Study|Study Termination by Sponsor|1|||
105629582|NCT03875313|364309331|FG000|Overall Study|New Anticancer Treatment|0|||
105629583|NCT03875313|364309332|FG001|Overall Study|New Anticancer Treatment|1|||
105629584|NCT03875313|364309333|FG002|Overall Study|New Anticancer Treatment|2|||
105629585|NCT03875313|364309334|FG003|Overall Study|New Anticancer Treatment|1|||
105629586|NCT03875313|364309335|FG004|Overall Study|New Anticancer Treatment|0|||
105629587|NCT03875313|364309331|FG000|Overall Study|Other, Not Specified|2|||
105629588|NCT03875313|364309332|FG001|Overall Study|Other, Not Specified|11|||
105629589|NCT03875313|364309333|FG002|Overall Study|Other, Not Specified|3|||
105629590|NCT03875313|364309334|FG003|Overall Study|Other, Not Specified|3|||
105629591|NCT03875313|364309335|FG004|Overall Study|Other, Not Specified|1|||
105629592|NCT03868930|364309336|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
105629593|NCT03868930|364309337|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
105629594|NCT03868930|364309336|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
105629595|NCT03868930|364309337|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
105629596|NCT03868930|364309336|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
105629597|NCT03868930|364309337|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
105629598|NCT03868930|364309336|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
105629599|NCT03868930|364309337|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
105629600|NCT03868930|364309336|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
105629601|NCT03868930|364309337|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
105629602|NCT01046825|364309339|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
105629603|NCT01046825|364309340|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
105629604|NCT01046825|364309341|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
105629605|NCT01046825|364309342|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
105629606|NCT01046825|364309343|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
105629607|NCT01046825|364309339|FG000|Overall Study|Physician Decision|0|||
105629608|NCT01046825|364309340|FG001|Overall Study|Physician Decision|1|||
105629609|NCT01046825|364309341|FG002|Overall Study|Physician Decision|2|||
105629610|NCT01046825|364309342|FG003|Overall Study|Physician Decision|0|||
105629611|NCT01046825|364309343|FG004|Overall Study|Physician Decision|0|||
105629612|NCT01046825|364309339|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
105629613|NCT01046825|364309340|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
105629614|NCT01046825|364309341|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
105629615|NCT01046825|364309342|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
105629616|NCT01046825|364309343|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
105629617|NCT01046825|364309339|FG000|Overall Study|Found to be ineligible|0|||
105629618|NCT01046825|364309340|FG001|Overall Study|Found to be ineligible|1|||
105629619|NCT01046825|364309341|FG002|Overall Study|Found to be ineligible|0|||
105629620|NCT01046825|364309342|FG003|Overall Study|Found to be ineligible|0|||
105629621|NCT01046825|364309343|FG004|Overall Study|Found to be ineligible|0|||
105629622|NCT01046825|364309339|FG000|Overall Study|Death|0|||
105629623|NCT01046825|364309340|FG001|Overall Study|Death|0|||
105629624|NCT01046825|364309341|FG002|Overall Study|Death|0|||
105629625|NCT01046825|364309342|FG003|Overall Study|Death|1|||
105629626|NCT01046825|364309343|FG004|Overall Study|Death|0|||
105629627|NCT01046825|364309339|FG000|Overall Study|Did not submit biology samples|0|||
105629628|NCT01046825|364309340|FG001|Overall Study|Did not submit biology samples|0|||
105629629|NCT01046825|364309341|FG002|Overall Study|Did not submit biology samples|0|||
105629630|NCT01046825|364309342|FG003|Overall Study|Did not submit biology samples|0|||
105629631|NCT01046825|364309343|FG004|Overall Study|Did not submit biology samples|13|||
105629632|NCT04933474|364309345|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
105629633|NCT04933474|364309346|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
105629634|NCT04933474|364309345|FG000|Overall Study|Lost to Follow-up|19|||
105629635|NCT04933474|364309346|FG001|Overall Study|Lost to Follow-up|9|||
105629636|NCT04933474|364309345|FG000|Overall Study|Life Burden - unable to participate|6|||
105629637|NCT04933474|364309346|FG001|Overall Study|Life Burden - unable to participate|2|||
105629638|NCT04933474|364309345|FG000|Overall Study|Disease Burden - unable to participate|4|||
105629639|NCT04933474|364309346|FG001|Overall Study|Disease Burden - unable to participate|1|||
105629640|NCT04933474|364309345|FG000|Overall Study|Surgery/Hospitalization|1|||
105629641|NCT04933474|364309346|FG001|Overall Study|Surgery/Hospitalization|2|||
105629642|NCT04933474|364309345|FG000|Overall Study|Dissatisfied with Intervention|1|||
105629643|NCT04933474|364309346|FG001|Overall Study|Dissatisfied with Intervention|1|||
105629644|NCT04933474|364309345|FG000|Overall Study|Withdrew interest in participation|1|||
105629645|NCT04933474|364309346|FG001|Overall Study|Withdrew interest in participation|0|||
105629646|NCT04933474|364309345|FG000|Overall Study|Had previously enrolled in the study|0|||
105629647|NCT04933474|364309346|FG001|Overall Study|Had previously enrolled in the study|1|||
105629648|NCT04993677|364309347|FG000|Overall Study|Lost to Follow-up|1|||
105629649|NCT04993677|364309348|FG001|Overall Study|Lost to Follow-up|0|||
105629650|NCT04993677|364309349|FG002|Overall Study|Lost to Follow-up|0|||
105629651|NCT04993677|364309350|FG003|Overall Study|Lost to Follow-up|0|||
105629652|NCT04993677|364309347|FG000|Overall Study|Death|11|||
105629653|NCT04993677|364309348|FG001|Overall Study|Death|8|||
105629654|NCT04993677|364309349|FG002|Overall Study|Death|3|||
105629655|NCT04993677|364309350|FG003|Overall Study|Death|1|||
105629656|NCT04993677|364309347|FG000|Overall Study|Subject withdrawal of consent|4|||
105629657|NCT04993677|364309348|FG001|Overall Study|Subject withdrawal of consent|3|||
105629658|NCT04993677|364309349|FG002|Overall Study|Subject withdrawal of consent|0|||
105629659|NCT04993677|364309350|FG003|Overall Study|Subject withdrawal of consent|2|||
105629660|NCT04993677|364309347|FG000|Overall Study|Study termination by sponsor|3|||
105629661|NCT04993677|364309348|FG001|Overall Study|Study termination by sponsor|25|||
105629662|NCT04993677|364309349|FG002|Overall Study|Study termination by sponsor|3|||
105629663|NCT04993677|364309350|FG003|Overall Study|Study termination by sponsor|3|||
105629664|NCT04993677|364309347|FG000|Overall Study|Other|2|||
105629665|NCT04993677|364309348|FG001|Overall Study|Other|3|||
105629666|NCT04993677|364309349|FG002|Overall Study|Other|3|||
105629667|NCT04993677|364309350|FG003|Overall Study|Other|2|||
105629668|NCT04664881|364309351|FG000|Overall Study|Withdrawal by Subject|1|||
105629669|NCT04664881|364309352|FG001|Overall Study|Withdrawal by Subject|8|||
105629670|NCT04664881|364309351|FG000|Overall Study|Physician Decision|0|||
105629671|NCT04664881|364309352|FG001|Overall Study|Physician Decision|5|||
105629672|NCT04664881|364309351|FG000|Overall Study|Lost to Follow-up|1|||
105629673|NCT04664881|364309352|FG001|Overall Study|Lost to Follow-up|0|||
105629674|NCT03767335|364309368|FG000|Overall Study|Physician Decision|1|||
105629675|NCT03767335|364309369|FG001|Overall Study|Physician Decision|1|||
105629676|NCT03767335|364309370|FG002|Overall Study|Physician Decision|0|||
105629677|NCT03767335|364309368|FG000|Overall Study|Withdrawal by Subject|0|||
105629678|NCT03767335|364309369|FG001|Overall Study|Withdrawal by Subject|0|||
105629679|NCT03767335|364309370|FG002|Overall Study|Withdrawal by Subject|6|||
105629680|NCT03767335|364309368|FG000|Overall Study|Participant excluded from efficacy population|0|||
105629681|NCT03767335|364309369|FG001|Overall Study|Participant excluded from efficacy population|0|||
105629682|NCT03767335|364309370|FG002|Overall Study|Participant excluded from efficacy population|1|||
105629683|NCT03767335|364309368|FG000|Overall Study|Death|0|||
105629684|NCT03767335|364309369|FG001|Overall Study|Death|0|||
105629685|NCT03767335|364309370|FG002|Overall Study|Death|2|||
105629686|NCT03767335|364309368|FG000|Overall Study|Progressive Disease|2|||
105629687|NCT03767335|364309369|FG001|Overall Study|Progressive Disease|2|||
105629688|NCT03767335|364309370|FG002|Overall Study|Progressive Disease|2|||
105629689|NCT03767335|364309368|FG000|Overall Study|Disease progression needing additional medication|0|||
105629690|NCT03767335|364309369|FG001|Overall Study|Disease progression needing additional medication|0|||
105629691|NCT03767335|364309370|FG002|Overall Study|Disease progression needing additional medication|17|||
105629692|NCT03767335|364309368|FG000|Overall Study|Sponsor decision|0|||
105629693|NCT03767335|364309369|FG001|Overall Study|Sponsor decision|0|||
105629694|NCT03767335|364309370|FG002|Overall Study|Sponsor decision|2|||
105629695|NCT03767335|364309368|FG000|Overall Study|Other Medical Reasons|0|||
105629696|NCT03767335|364309369|FG001|Overall Study|Other Medical Reasons|0|||
105629697|NCT03767335|364309370|FG002|Overall Study|Other Medical Reasons|3|||
105629698|NCT03242915|364309373|FG000|Overall Study|Adverse Event|5|||
105629699|NCT03242915|364309374|FG001|Overall Study|Adverse Event|1|||
105629700|NCT03242915|364309373|FG000|Overall Study|Withdrawal by Subject|0|||
105629701|NCT03242915|364309374|FG001|Overall Study|Withdrawal by Subject|2|||
105629702|NCT03242915|364309373|FG000|Overall Study|Physician Decision|4|||
105629703|NCT03242915|364309374|FG001|Overall Study|Physician Decision|1|||
105629704|NCT03733626|364309375|FG000|Overall Study|Physician Decision|4|||
105629705|NCT03733626|364309376|FG001|Overall Study|Physician Decision|4|||
105629706|NCT03881696|364309382|FG000|Overall Study|Adverse Event|2|||
105629707|NCT03881696|364309383|FG001|Overall Study|Adverse Event|0|||
105629708|NCT03881696|364309382|FG000|Overall Study|Withdrawal by Subject|2|||
105629709|NCT03881696|364309383|FG001|Overall Study|Withdrawal by Subject|0|||
105629710|NCT03881696|364309382|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
105629711|NCT03881696|364309383|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
105629712|NCT03881696|364309382|FG000|Overall Study|Failure to meet continuation criteria|1|||
105629713|NCT03881696|364309383|FG001|Overall Study|Failure to meet continuation criteria|0|||
105629714|NCT02206828|364309386|FG000|Overall Study|Lost to Follow-up|7|||
105629715|NCT00945724|364309390|FG000|Overall Study|Withdrawal by Subject|2|||
105629716|NCT00945724|364309390|FG000|Overall Study|Physician Decision|1|||
105629717|NCT00945724|364309390|FG000|Overall Study|Adverse Event|5|||
105629718|NCT00945724|364309390|FG000|Overall Study|Second malignancy|1|||
105629719|NCT04772534|364310213|FG000|Overall Study|Physician Decision|1|||
105629720|NCT04772534|364310214|FG001|Overall Study|Physician Decision|0|||
105629721|NCT04772534|364310215|FG002|Overall Study|Physician Decision|0|||
105629722|NCT04772534|364310213|FG000|Overall Study|Withdrawal by Subject|3|||
105629723|NCT04772534|364310214|FG001|Overall Study|Withdrawal by Subject|0|||
105629724|NCT04772534|364310215|FG002|Overall Study|Withdrawal by Subject|1|||
105629725|NCT03786926|364310221|FG000|Overall Study|Adverse Event|0|||
105629726|NCT03786926|364310222|FG001|Overall Study|Adverse Event|0|||
105629727|NCT03786926|364310223|FG002|Overall Study|Adverse Event|0|||
105629728|NCT03786926|364310224|FG003|Overall Study|Adverse Event|0|||
105629729|NCT03786926|364310225|FG004|Overall Study|Adverse Event|0|||
105629730|NCT03786926|364310226|FG005|Overall Study|Adverse Event|0|||
105629731|NCT03786926|364310227|FG006|Overall Study|Adverse Event|0|||
105629732|NCT03786926|364310228|FG007|Overall Study|Adverse Event|1|||
105629733|NCT03786926|364310229|FG008|Overall Study|Adverse Event|1|||
105629734|NCT03786926|364310230|FG009|Overall Study|Adverse Event|0|||
105629735|NCT03786926|364310231|FG010|Overall Study|Adverse Event|1|||
105629736|NCT03786926|364310221|FG000|Overall Study|Progressive disease|3|||
105629737|NCT03786926|364310222|FG001|Overall Study|Progressive disease|0|||
105629738|NCT03786926|364310223|FG002|Overall Study|Progressive disease|3|||
105629739|NCT03786926|364310224|FG003|Overall Study|Progressive disease|1|||
105629740|NCT03786926|364310225|FG004|Overall Study|Progressive disease|2|||
105629741|NCT03786926|364310226|FG005|Overall Study|Progressive disease|2|||
105629742|NCT03786926|364310227|FG006|Overall Study|Progressive disease|1|||
105629743|NCT03786926|364310228|FG007|Overall Study|Progressive disease|6|||
105629744|NCT03786926|364310229|FG008|Overall Study|Progressive disease|1|||
105629745|NCT03786926|364310230|FG009|Overall Study|Progressive disease|1|||
105629746|NCT03786926|364310231|FG010|Overall Study|Progressive disease|1|||
105629747|NCT03786926|364310221|FG000|Overall Study|Death|0|||
105629748|NCT03786926|364310222|FG001|Overall Study|Death|1|||
105629749|NCT03786926|364310223|FG002|Overall Study|Death|1|||
105629750|NCT03786926|364310224|FG003|Overall Study|Death|0|||
105629751|NCT03786926|364310225|FG004|Overall Study|Death|0|||
105629752|NCT03786926|364310226|FG005|Overall Study|Death|0|||
105629753|NCT03786926|364310227|FG006|Overall Study|Death|0|||
105629754|NCT03786926|364310228|FG007|Overall Study|Death|0|||
105629755|NCT03786926|364310229|FG008|Overall Study|Death|0|||
105629756|NCT03786926|364310230|FG009|Overall Study|Death|1|||
105629757|NCT03786926|364310231|FG010|Overall Study|Death|2|||
105629758|NCT03786926|364310221|FG000|Overall Study|Physician Decision|0|||
105629759|NCT03786926|364310222|FG001|Overall Study|Physician Decision|1|||
105629760|NCT03786926|364310223|FG002|Overall Study|Physician Decision|0|||
105629761|NCT03786926|364310224|FG003|Overall Study|Physician Decision|1|||
105629762|NCT03786926|364310225|FG004|Overall Study|Physician Decision|2|||
105629763|NCT03786926|364310226|FG005|Overall Study|Physician Decision|0|||
105629764|NCT03786926|364310227|FG006|Overall Study|Physician Decision|0|||
105629765|NCT03786926|364310228|FG007|Overall Study|Physician Decision|2|||
105629766|NCT03786926|364310229|FG008|Overall Study|Physician Decision|1|||
105629767|NCT03786926|364310230|FG009|Overall Study|Physician Decision|1|||
105629768|NCT03786926|364310231|FG010|Overall Study|Physician Decision|0|||
105629769|NCT03786926|364310221|FG000|Overall Study|Withdrawal by Subject|0|||
105629770|NCT03786926|364310222|FG001|Overall Study|Withdrawal by Subject|1|||
105629771|NCT03786926|364310223|FG002|Overall Study|Withdrawal by Subject|1|||
105629772|NCT03786926|364310224|FG003|Overall Study|Withdrawal by Subject|0|||
105629773|NCT03786926|364310225|FG004|Overall Study|Withdrawal by Subject|0|||
105629774|NCT03786926|364310226|FG005|Overall Study|Withdrawal by Subject|0|||
105629775|NCT03786926|364310227|FG006|Overall Study|Withdrawal by Subject|1|||
105629776|NCT03786926|364310228|FG007|Overall Study|Withdrawal by Subject|0|||
105629777|NCT03786926|364310229|FG008|Overall Study|Withdrawal by Subject|1|||
105629778|NCT03786926|364310230|FG009|Overall Study|Withdrawal by Subject|0|||
105629779|NCT03786926|364310231|FG010|Overall Study|Withdrawal by Subject|1|||
105629780|NCT03786926|364310221|FG000|Overall Study|Study terminated by Sponsor|0|||
105629781|NCT03786926|364310222|FG001|Overall Study|Study terminated by Sponsor|0|||
105629782|NCT03786926|364310223|FG002|Overall Study|Study terminated by Sponsor|0|||
105629783|NCT03786926|364310224|FG003|Overall Study|Study terminated by Sponsor|0|||
105629784|NCT03786926|364310225|FG004|Overall Study|Study terminated by Sponsor|1|||
105629785|NCT03786926|364310226|FG005|Overall Study|Study terminated by Sponsor|0|||
105629786|NCT03786926|364310227|FG006|Overall Study|Study terminated by Sponsor|0|||
105629787|NCT03786926|364310228|FG007|Overall Study|Study terminated by Sponsor|4|||
105629788|NCT03786926|364310229|FG008|Overall Study|Study terminated by Sponsor|0|||
105629789|NCT03786926|364310230|FG009|Overall Study|Study terminated by Sponsor|0|||
105629790|NCT03786926|364310231|FG010|Overall Study|Study terminated by Sponsor|0|||
105629791|NCT03786926|364310221|FG000|Overall Study|Anti-neoplasm treatment|0|||
105629792|NCT03786926|364310222|FG001|Overall Study|Anti-neoplasm treatment|0|||
105629793|NCT03786926|364310223|FG002|Overall Study|Anti-neoplasm treatment|0|||
105629794|NCT03786926|364310224|FG003|Overall Study|Anti-neoplasm treatment|0|||
105629795|NCT03786926|364310225|FG004|Overall Study|Anti-neoplasm treatment|1|||
105629796|NCT03786926|364310226|FG005|Overall Study|Anti-neoplasm treatment|0|||
105629797|NCT03786926|364310227|FG006|Overall Study|Anti-neoplasm treatment|1|||
105629798|NCT03786926|364310228|FG007|Overall Study|Anti-neoplasm treatment|0|||
105629799|NCT03786926|364310229|FG008|Overall Study|Anti-neoplasm treatment|0|||
105629800|NCT03786926|364310230|FG009|Overall Study|Anti-neoplasm treatment|0|||
105629801|NCT03786926|364310231|FG010|Overall Study|Anti-neoplasm treatment|0|||
105629802|NCT03786926|364310221|FG000|Overall Study|Other|0|||
105629803|NCT03786926|364310222|FG001|Overall Study|Other|0|||
105629804|NCT03786926|364310223|FG002|Overall Study|Other|0|||
105629805|NCT03786926|364310224|FG003|Overall Study|Other|1|||
105629806|NCT03786926|364310225|FG004|Overall Study|Other|0|||
105629807|NCT03786926|364310226|FG005|Overall Study|Other|1|||
105629808|NCT03786926|364310227|FG006|Overall Study|Other|0|||
105629809|NCT03786926|364310228|FG007|Overall Study|Other|0|||
105629810|NCT03786926|364310229|FG008|Overall Study|Other|2|||
105629811|NCT03786926|364310230|FG009|Overall Study|Other|0|||
105629812|NCT03786926|364310231|FG010|Overall Study|Other|0|||
105629813|NCT06152224|364310232|FG000|Overall Study|Withdrawal by Subject|1|||
105629814|NCT06152224|364310233|FG001|Overall Study|Withdrawal by Subject|0|||
105629815|NCT06152224|364310232|FG000|Overall Study|Lost to Follow-up|0|||
105629816|NCT06152224|364310233|FG001|Overall Study|Lost to Follow-up|1|||
105629817|NCT06152224|364310232|FG000|Overall Study|On Follow Up|18|||
105629818|NCT06152224|364310233|FG001|Overall Study|On Follow Up|18|||
105629819|NCT04495621|364310234|FG000|Overall Study|Withdrawal by Subject|0|||
105629820|NCT04495621|364310235|FG001|Overall Study|Withdrawal by Subject|3|||
105629821|NCT04495621|364310234|FG000|Overall Study|Death|7|||
105629822|NCT04495621|364310235|FG001|Overall Study|Death|11|||
105629823|NCT04495621|364310234|FG000|Overall Study|Investigator Decision|0|||
105629824|NCT04495621|364310235|FG001|Overall Study|Investigator Decision|7|||
105629825|NCT04495621|364310234|FG000|Overall Study|Lost to Follow-up|0|||
105629826|NCT04495621|364310235|FG001|Overall Study|Lost to Follow-up|1|||
105629827|NCT05875701|364310243|FG000|Overall Study|Lost to Follow-up|2|||
105629828|NCT05875701|364310244|FG001|Overall Study|Lost to Follow-up|0|||
105629829|NCT05875701|364310243|FG000|Overall Study|Withdrawal by Subject|1|||
105629830|NCT05875701|364310244|FG001|Overall Study|Withdrawal by Subject|1|||
105629831|NCT05988398|364310250|FG000|Overall Study|Lack of time|21|||
105629832|NCT05988398|364310251|FG001|Overall Study|Lack of time|0|||
105629833|NCT05988398|364310250|FG000|Overall Study|Absent from school|0|||
105629834|NCT05988398|364310251|FG001|Overall Study|Absent from school|38|||
105629835|NCT05988398|364310250|FG000|Overall Study|Chose not to participate|0|||
105629836|NCT05988398|364310251|FG001|Overall Study|Chose not to participate|42|||
105629837|NCT05988398|364310250|FG000|Overall Study|Other commitments (e.g., sports)|0|||
105629838|NCT05988398|364310251|FG001|Overall Study|Other commitments (e.g., sports)|25|||
105629839|NCT02726386|364310259|FG000|Overall Study|Adverse Event|17|||
105629840|NCT02726386|364310260|FG001|Overall Study|Adverse Event|20|||
105629841|NCT02726386|364310259|FG000|Overall Study|Withdrawal by Subject|14|||
105629842|NCT02726386|364310260|FG001|Overall Study|Withdrawal by Subject|28|||
105629843|NCT02726386|364310259|FG000|Overall Study|Other reasons|7|||
105629844|NCT02726386|364310260|FG001|Overall Study|Other reasons|8|||
105629845|NCT04490356|364310263|FG000|Overall Study|Lost to Follow-up|1|||
105629846|NCT03816397|364310264|FG000|Overall Study|Censored at interim analysis date.|13|||
105629847|NCT03816397|364310265|FG001|Overall Study|Censored at interim analysis date.|6|||
105629848|NCT03816397|364310264|FG000|Overall Study|Withdrawal by Subject|1|||
105629849|NCT03816397|364310265|FG001|Overall Study|Withdrawal by Subject|1|||
105629850|NCT03213457|364310274|FG000|Screening Period|Withdrawal by Subject|0|||
105629851|NCT03213457|364310275|FG001|Screening Period|Withdrawal by Subject|1|||
105629852|NCT03213457|364310276|FG002|Screening Period|Withdrawal by Subject|0|||
105629853|NCT03213457|364310274|FG000|Screening Period|Other|1|||
105629854|NCT03213457|364310275|FG001|Screening Period|Other|0|||
105629855|NCT03213457|364310276|FG002|Screening Period|Other|0|||
105629856|NCT03213457|364310274|FG000|Double-Blind Period|Adverse Event|3|||
105629857|NCT03213457|364310275|FG001|Double-Blind Period|Adverse Event|2|||
105629858|NCT03213457|364310276|FG002|Double-Blind Period|Adverse Event|7|||
105629859|NCT03213457|364310274|FG000|Double-Blind Period|Withdrawal by Subject|14|||
105629860|NCT03213457|364310275|FG001|Double-Blind Period|Withdrawal by Subject|2|||
105629861|NCT03213457|364310276|FG002|Double-Blind Period|Withdrawal by Subject|14|||
105629862|NCT03213457|364310274|FG000|Double-Blind Period|Lost to Follow-up|2|||
105629863|NCT03213457|364310275|FG001|Double-Blind Period|Lost to Follow-up|3|||
105629864|NCT03213457|364310276|FG002|Double-Blind Period|Lost to Follow-up|9|||
105629865|NCT03213457|364310274|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
105629866|NCT03213457|364310275|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
105629867|NCT03213457|364310276|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
105629868|NCT03213457|364310274|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
105629869|NCT03213457|364310275|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
105629870|NCT03213457|364310276|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
105629871|NCT03213457|364310274|FG000|Double-Blind Period|Pregnancy|5|||
105629872|NCT03213457|364310275|FG001|Double-Blind Period|Pregnancy|0|||
105629873|NCT03213457|364310276|FG002|Double-Blind Period|Pregnancy|0|||
105629874|NCT03213457|364310274|FG000|Double-Blind Period|Other|10|||
105629875|NCT03213457|364310275|FG001|Double-Blind Period|Other|3|||
105629876|NCT03213457|364310276|FG002|Double-Blind Period|Other|17|||
105629877|NCT03213457|364310274|FG000|Open-Label Period|Adverse Event|1|||
105629878|NCT03213457|364310275|FG001|Open-Label Period|Adverse Event|2|||
105629879|NCT03213457|364310276|FG002|Open-Label Period|Adverse Event|2|||
105629880|NCT03213457|364310274|FG000|Open-Label Period|Withdrawal by Subject|12|||
105629881|NCT03213457|364310275|FG001|Open-Label Period|Withdrawal by Subject|5|||
105629882|NCT03213457|364310276|FG002|Open-Label Period|Withdrawal by Subject|24|||
105629883|NCT03213457|364310274|FG000|Open-Label Period|Lost to Follow-up|1|||
105629884|NCT03213457|364310275|FG001|Open-Label Period|Lost to Follow-up|2|||
105629885|NCT03213457|364310276|FG002|Open-Label Period|Lost to Follow-up|8|||
105629886|NCT03213457|364310274|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
105629887|NCT03213457|364310275|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
105629888|NCT03213457|364310276|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
105629889|NCT03213457|364310274|FG000|Open-Label Period|Non-compliance with study procedures|1|||
105629890|NCT03213457|364310275|FG001|Open-Label Period|Non-compliance with study procedures|1|||
105629891|NCT03213457|364310276|FG002|Open-Label Period|Non-compliance with study procedures|2|||
105629892|NCT03213457|364310274|FG000|Open-Label Period|Exclusionary medications|0|||
105629893|NCT03213457|364310275|FG001|Open-Label Period|Exclusionary medications|0|||
105629894|NCT03213457|364310276|FG002|Open-Label Period|Exclusionary medications|1|||
105629895|NCT03213457|364310274|FG000|Open-Label Period|Other|1|||
105629896|NCT03213457|364310275|FG001|Open-Label Period|Other|1|||
105629897|NCT03213457|364310276|FG002|Open-Label Period|Other|6|||
105629898|NCT03213457|364310274|FG000|Follow-Up Period|Adverse Event|16|||
105629899|NCT03213457|364310275|FG001|Follow-Up Period|Adverse Event|8|||
105629900|NCT03213457|364310276|FG002|Follow-Up Period|Adverse Event|37|||
105629901|NCT03213457|364310274|FG000|Follow-Up Period|Withdrawal by Subject|18|||
105629902|NCT03213457|364310275|FG001|Follow-Up Period|Withdrawal by Subject|11|||
105629903|NCT03213457|364310276|FG002|Follow-Up Period|Withdrawal by Subject|55|||
105629904|NCT03213457|364310274|FG000|Follow-Up Period|Lost to Follow-up|28|||
105629905|NCT03213457|364310275|FG001|Follow-Up Period|Lost to Follow-up|15|||
105629906|NCT03213457|364310276|FG002|Follow-Up Period|Lost to Follow-up|50|||
105629907|NCT03213457|364310274|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
105629908|NCT03213457|364310275|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
105629909|NCT03213457|364310276|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
105629910|NCT03213457|364310274|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
105629911|NCT03213457|364310275|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
105629912|NCT03213457|364310276|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
105629913|NCT03213457|364310274|FG000|Follow-Up Period|Pregnancy|7|||
105629914|NCT03213457|364310275|FG001|Follow-Up Period|Pregnancy|0|||
105629915|NCT03213457|364310276|FG002|Follow-Up Period|Pregnancy|18|||
105629916|NCT03213457|364310274|FG000|Follow-Up Period|Exclusionary medications|1|||
105629917|NCT03213457|364310275|FG001|Follow-Up Period|Exclusionary medications|1|||
105629918|NCT03213457|364310276|FG002|Follow-Up Period|Exclusionary medications|5|||
105629919|NCT03213457|364310274|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
105629920|NCT03213457|364310275|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
105629921|NCT03213457|364310276|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
105629922|NCT03213457|364310274|FG000|Follow-Up Period|Other|14|||
105629923|NCT03213457|364310275|FG001|Follow-Up Period|Other|10|||
105629924|NCT03213457|364310276|FG002|Follow-Up Period|Other|31|||
105629925|NCT04940624|364310277|FG000|Overall Study|Adverse Event|4|||
105629926|NCT04940624|364310278|FG001|Overall Study|Adverse Event|11|||
105629927|NCT04940624|364310277|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105629928|NCT04940624|364310278|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
105629929|NCT04940624|364310277|FG000|Overall Study|Physician Decision|1|||
105629930|NCT04940624|364310278|FG001|Overall Study|Physician Decision|0|||
105629931|NCT04940624|364310277|FG000|Overall Study|Lost to Follow-up|1|||
105629932|NCT04940624|364310278|FG001|Overall Study|Lost to Follow-up|0|||
105629933|NCT04940624|364310277|FG000|Overall Study|Reason Not Specified|1|||
105629934|NCT04940624|364310278|FG001|Overall Study|Reason Not Specified|0|||
105629935|NCT05934292|364310280|FG000|Overall Study|Lost to Follow-up|0|||
105629936|NCT05934292|364310281|FG001|Overall Study|Lost to Follow-up|0|||
105629937|NCT05934292|364310282|FG002|Overall Study|Lost to Follow-up|1|||
105629938|NCT05934292|364310283|FG003|Overall Study|Lost to Follow-up|0|||
105629939|NCT04479787|364310284|FG000|Through 6 Months|Withdrawal by Subject|16|||
105629940|NCT04479787|364310285|FG001|Through 6 Months|Withdrawal by Subject|14|||
105629941|NCT04479787|364310284|FG000|Through 6 Months|Unsuccessful Trial|17|||
105629942|NCT04479787|364310285|FG001|Through 6 Months|Unsuccessful Trial|0|||
105629943|NCT04479787|364310284|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
105629944|NCT04479787|364310285|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
105629945|NCT04479787|364310284|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
105629946|NCT04479787|364310285|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
105629947|NCT04479787|364310284|FG000|Through 6 Months|Lost to Follow-up|3|||
105629948|NCT04479787|364310285|FG001|Through 6 Months|Lost to Follow-up|2|||
105629949|NCT04479787|364310284|FG000|Through 6 Months|Death|3|||
105629950|NCT04479787|364310285|FG001|Through 6 Months|Death|0|||
105629951|NCT04479787|364310284|FG000|Through 6 Months|Inclusion/Exclusion|2|||
105629952|NCT04479787|364310285|FG001|Through 6 Months|Inclusion/Exclusion|1|||
105629953|NCT04479787|364310284|FG000|Through 6 Months|Subject Became Pregnant|1|||
105629954|NCT04479787|364310285|FG001|Through 6 Months|Subject Became Pregnant|1|||
105629955|NCT04479787|364310284|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
105629956|NCT04479787|364310285|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
105629957|NCT04479787|364310284|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
105629958|NCT04479787|364310285|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
105629959|NCT04479787|364310284|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
105629960|NCT04479787|364310285|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
105629961|NCT04479787|364310284|FG000|After 6 Months|Withdrawal by Subject|3|||
105629962|NCT04479787|364310285|FG001|After 6 Months|Withdrawal by Subject|13|||
105629963|NCT04479787|364310284|FG000|After 6 Months|Unsuccessful Trial|0|||
105629964|NCT04479787|364310285|FG001|After 6 Months|Unsuccessful Trial|7|||
105629965|NCT04479787|364310284|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
105629966|NCT04479787|364310285|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
105629967|NCT04479787|364310284|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
105629968|NCT04479787|364310285|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
105629969|NCT04479787|364310284|FG000|After 6 Months|Death|2|||
105629970|NCT04479787|364310285|FG001|After 6 Months|Death|0|||
105629971|NCT04479787|364310284|FG000|After 6 Months|Lost to Follow-up|1|||
105629972|NCT04479787|364310285|FG001|After 6 Months|Lost to Follow-up|1|||
105629973|NCT04479787|364310284|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
105629974|NCT04479787|364310285|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
105629975|NCT04479787|364310284|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
105629976|NCT04479787|364310285|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
105629977|NCT04479787|364310284|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
105629978|NCT04479787|364310285|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
105629979|NCT04479787|364310284|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
105629980|NCT04479787|364310285|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
105629981|NCT04165213|364310868|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
105629982|NCT04165213|364310869|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
105629983|NCT04165213|364310868|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
105629984|NCT04165213|364310869|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
105629985|NCT04165213|364310868|FG000|Clinician Enrollment|Termination from site|0|||
105629986|NCT04165213|364310869|FG001|Clinician Enrollment|Termination from site|1|||
105629987|NCT04165213|364310868|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
105629988|NCT04165213|364310869|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
105629989|NCT04165213|364310868|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
105629990|NCT04165213|364310869|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
105629991|NCT04165213|364310868|FG000|Caregiver Enrollment|Physician Decision|1|||
105629992|NCT04165213|364310869|FG001|Caregiver Enrollment|Physician Decision|0|||
105629993|NCT04165213|364310868|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
105629994|NCT04165213|364310869|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
105629995|NCT04165213|364310868|FG000|Caregiver Enrollment|PLWD death|2|||
105629996|NCT04165213|364310869|FG001|Caregiver Enrollment|PLWD death|0|||
105629997|NCT04165213|364310868|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
105629998|NCT04165213|364310869|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
105629999|NCT04165213|364310868|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
105630000|NCT04165213|364310869|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
105630001|NCT04165213|364310868|FG000|PLWD Enrollment|Lost to Follow-up|1|||
105630002|NCT04165213|364310869|FG001|PLWD Enrollment|Lost to Follow-up|1|||
105630003|NCT04165213|364310868|FG000|PLWD Enrollment|Physician Decision|1|||
105630004|NCT04165213|364310869|FG001|PLWD Enrollment|Physician Decision|0|||
105630005|NCT04165213|364310868|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
105630006|NCT04165213|364310869|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
105630007|NCT04165213|364310868|FG000|PLWD Enrollment|Death|2|||
105630008|NCT04165213|364310869|FG001|PLWD Enrollment|Death|0|||
105630009|NCT04165213|364310868|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
105630010|NCT04165213|364310869|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
105630011|NCT02231749|364310870|FG000|Overall Study|Disease progression|229|||
105630012|NCT02231749|364310871|FG001|Overall Study|Disease progression|297|||
105630013|NCT02231749|364310870|FG000|Overall Study|Study Drug Toxicity|134|||
105630014|NCT02231749|364310871|FG001|Overall Study|Study Drug Toxicity|63|||
105630015|NCT02231749|364310870|FG000|Overall Study|Death|1|||
105630016|NCT02231749|364310871|FG001|Overall Study|Death|1|||
105630017|NCT02231749|364310870|FG000|Overall Study|AE unrelated to Study drug|32|||
105630018|NCT02231749|364310871|FG001|Overall Study|AE unrelated to Study drug|31|||
105630019|NCT02231749|364310870|FG000|Overall Study|Participant's request to discontinue|10|||
105630020|NCT02231749|364310871|FG001|Overall Study|Participant's request to discontinue|21|||
105630021|NCT02231749|364310870|FG000|Overall Study|Participant withdrew Consent|8|||
105630022|NCT02231749|364310871|FG001|Overall Study|Participant withdrew Consent|15|||
105630023|NCT02231749|364310870|FG000|Overall Study|Lost to Follow-up|1|||
105630024|NCT02231749|364310871|FG001|Overall Study|Lost to Follow-up|2|||
105630025|NCT02231749|364310870|FG000|Overall Study|Maximum Clinical Benefit|5|||
105630026|NCT02231749|364310871|FG001|Overall Study|Maximum Clinical Benefit|8|||
105630027|NCT02231749|364310870|FG000|Overall Study|Poor/Non-Compliance|0|||
105630028|NCT02231749|364310871|FG001|Overall Study|Poor/Non-Compliance|3|||
105630029|NCT02231749|364310870|FG000|Overall Study|Pregnancy|1|||
105630030|NCT02231749|364310871|FG001|Overall Study|Pregnancy|0|||
105630031|NCT02231749|364310870|FG000|Overall Study|other|0|||
105630032|NCT02231749|364310871|FG001|Overall Study|other|8|||
105630033|NCT02231749|364310870|FG000|Overall Study|No longer meets Study Criteria|1|||
105630034|NCT02231749|364310871|FG001|Overall Study|No longer meets Study Criteria|0|||
105630035|NCT04194450|364310874|FG000|Overall Study|not eligible|1|||
105630036|NCT04194450|364310875|FG001|Overall Study|not eligible|0|||
105630037|NCT00357682|364310877|FG000|Overall Study|Did not receive allocated Treatment|10|||
105630038|NCT00357682|364310878|FG001|Overall Study|Did not receive allocated Treatment|9|||
105630039|NCT00357682|364310879|FG002|Overall Study|Did not receive allocated Treatment|9|||
105630040|NCT00357682|364310880|FG003|Overall Study|Did not receive allocated Treatment|10|||
105630041|NCT00357682|364310877|FG000|Overall Study|Withdrew consent|6|||
105630042|NCT00357682|364310878|FG001|Overall Study|Withdrew consent|6|||
105630043|NCT00357682|364310879|FG002|Overall Study|Withdrew consent|5|||
105630044|NCT00357682|364310880|FG003|Overall Study|Withdrew consent|5|||
105630045|NCT00357682|364310877|FG000|Overall Study|Lost to Follow-up|39|||
105630046|NCT00357682|364310878|FG001|Overall Study|Lost to Follow-up|33|||
105630047|NCT00357682|364310879|FG002|Overall Study|Lost to Follow-up|26|||
105630048|NCT00357682|364310880|FG003|Overall Study|Lost to Follow-up|35|||
105630049|NCT00357682|364310877|FG000|Overall Study|Adverse Event|24|||
105630050|NCT00357682|364310878|FG001|Overall Study|Adverse Event|32|||
105630051|NCT00357682|364310879|FG002|Overall Study|Adverse Event|22|||
105630052|NCT00357682|364310880|FG003|Overall Study|Adverse Event|27|||
105630053|NCT00357682|364310877|FG000|Overall Study|Physician Decision|32|||
105630054|NCT00357682|364310878|FG001|Overall Study|Physician Decision|20|||
105630055|NCT00357682|364310879|FG002|Overall Study|Physician Decision|24|||
105630056|NCT00357682|364310880|FG003|Overall Study|Physician Decision|30|||
105630057|NCT00357682|364310877|FG000|Overall Study|Patient decision|73|||
105630058|NCT00357682|364310878|FG001|Overall Study|Patient decision|80|||
105630059|NCT00357682|364310879|FG002|Overall Study|Patient decision|51|||
105630060|NCT00357682|364310880|FG003|Overall Study|Patient decision|59|||
105630061|NCT00357682|364310877|FG000|Overall Study|Other reason|157|||
105630062|NCT00357682|364310878|FG001|Overall Study|Other reason|130|||
105630063|NCT00357682|364310879|FG002|Overall Study|Other reason|114|||
105630064|NCT00357682|364310880|FG003|Overall Study|Other reason|99|||
105630065|NCT03782116|364310890|FG000|Completed Intervetion|Lost to Follow-up|11|||
105630066|NCT03782116|364310891|FG001|Completed Intervetion|Lost to Follow-up|7|||
105630067|NCT03782116|364310890|FG000|Completed Intervetion|Withdrawal by Subject|6|||
105630068|NCT03782116|364310891|FG001|Completed Intervetion|Withdrawal by Subject|5|||
105630069|NCT03782116|364310890|FG000|Included in Analysis|Protocol Violation|5|||
105630070|NCT03782116|364310891|FG001|Included in Analysis|Protocol Violation|5|||
105630071|NCT03774472|364310898|FG000|Overall Study|Physician Decision|1|||
105630072|NCT03774472|364310899|FG001|Overall Study|Physician Decision|0|||
105630073|NCT03774472|364310900|FG002|Overall Study|Physician Decision|0|||
105630074|NCT03774472|364310898|FG000|Overall Study|Progression prior to 4 weeks|0|||
105630075|NCT03774472|364310899|FG001|Overall Study|Progression prior to 4 weeks|1|||
105630076|NCT03774472|364310900|FG002|Overall Study|Progression prior to 4 weeks|0|||
105630077|NCT03774472|364310898|FG000|Overall Study|Withdrawal by Subject|0|||
105630078|NCT03774472|364310899|FG001|Overall Study|Withdrawal by Subject|1|||
105630079|NCT03774472|364310900|FG002|Overall Study|Withdrawal by Subject|0|||
105630080|NCT05601882|364310905|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
105630081|NCT05601882|364310906|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
105630082|NCT05601882|364310907|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
105630083|NCT05601882|364310908|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
105630084|NCT05601882|364310905|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
105630085|NCT05601882|364310906|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
105630086|NCT05601882|364310907|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
105630087|NCT05601882|364310908|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
105630088|NCT05601882|364310905|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
105630089|NCT05601882|364310906|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
105630090|NCT05601882|364310907|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
105630091|NCT05601882|364310908|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
105630092|NCT05601882|364310905|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
105630093|NCT05601882|364310906|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
105630094|NCT05601882|364310907|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
105630095|NCT05601882|364310908|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
105630096|NCT05601882|364310905|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
105630097|NCT05601882|364310906|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
105630098|NCT05601882|364310907|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
105630099|NCT05601882|364310908|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
105630100|NCT05601882|364310905|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
105630101|NCT05601882|364310906|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
105630102|NCT05601882|364310907|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
105630103|NCT05601882|364310908|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
105630104|NCT03834740|364310913|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
105630105|NCT03834740|364310914|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
105630106|NCT03834740|364310915|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
105630107|NCT04305327|364310916|FG000|Overall Study|Study early termination|2|||
105630108|NCT04305327|364310917|FG001|Overall Study|Study early termination|5|||
105630109|NCT04305327|364310918|FG002|Overall Study|Study early termination|2|||
105630110|NCT04305327|364310919|FG003|Overall Study|Study early termination|2|||
105630111|NCT04305327|364310916|FG000|Overall Study|Withdrawal by Subject|0|||
105630112|NCT04305327|364310917|FG001|Overall Study|Withdrawal by Subject|1|||
105630113|NCT04305327|364310918|FG002|Overall Study|Withdrawal by Subject|0|||
105630114|NCT04305327|364310919|FG003|Overall Study|Withdrawal by Subject|0|||
105630115|NCT03891758|364310920|FG000|Overall Study|Adverse Event|2|||
105630116|NCT03891758|364310921|FG001|Overall Study|Adverse Event|0|||
105630117|NCT03891758|364310920|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105630118|NCT03891758|364310921|FG001|Overall Study|Withdrawal by parent/guardian|2|||
105630119|NCT00115934|364310922|FG000|Overall Study|Lost to Follow-up|1|||
105630120|NCT00115934|364310923|FG001|Overall Study|Lost to Follow-up|0|||
105630121|NCT00115934|364310922|FG000|Overall Study|Did not receive intervention|3|||
105630122|NCT00115934|364310923|FG001|Overall Study|Did not receive intervention|2|||
105630123|NCT01773993|364311264|FG000|Overall Study|No Visit After Treatment|35|||
105630124|NCT00328783|364311265|FG000|Overall Study|Could not tolerate ABC|21|||
105630125|NCT00328783|364311265|FG000|Overall Study|No heart in RT field|4|||
105630126|NCT00328783|364311265|FG000|Overall Study|Withdrawal by Subject|1|||
105630127|NCT03725332|364311267|FG000|Overall Study|Adverse Event|5|||
105630128|NCT03725332|364311268|FG001|Overall Study|Adverse Event|10|||
105630129|NCT03725332|364311267|FG000|Overall Study|Death|1|||
105630130|NCT03725332|364311268|FG001|Overall Study|Death|3|||
105630131|NCT03725332|364311267|FG000|Overall Study|Lost to Follow-up|43|||
105630132|NCT03725332|364311268|FG001|Overall Study|Lost to Follow-up|122|||
105630133|NCT03725332|364311267|FG000|Overall Study|Withdrawal by Subject|0|||
105630134|NCT03725332|364311268|FG001|Overall Study|Withdrawal by Subject|1|||
105630135|NCT03725332|364311267|FG000|Overall Study|Duplicate enrollment|0|||
105630136|NCT03725332|364311268|FG001|Overall Study|Duplicate enrollment|1|||
105630137|NCT03725332|364311267|FG000|Overall Study|Did not consent|0|||
105630138|NCT03725332|364311268|FG001|Overall Study|Did not consent|1|||
105630139|NCT01830595|364311269|FG000|First Period|Withdrawal by Subject|1|||
105630140|NCT01830595|364311270|FG001|First Period|Withdrawal by Subject|3|||
105630141|NCT01830595|364311269|FG000|Washout|Withdrawal by Subject|2|||
105630142|NCT01830595|364311270|FG001|Washout|Withdrawal by Subject|2|||
105630143|NCT03414684|364311275|FG000|First-course Treatment|Complete response|0|||
105630144|NCT03414684|364311276|FG001|First-course Treatment|Complete response|1|||
105630145|NCT03414684|364311275|FG000|First-course Treatment|Intercurrent illness|1|||
105630146|NCT03414684|364311276|FG001|First-course Treatment|Intercurrent illness|0|||
105630147|NCT03414684|364311275|FG000|First-course Treatment|Progressive Disease|31|||
105630148|NCT03414684|364311276|FG001|First-course Treatment|Progressive Disease|32|||
105630149|NCT03414684|364311275|FG000|First-course Treatment|Adverse Event|1|||
105630150|NCT03414684|364311276|FG001|First-course Treatment|Adverse Event|2|||
105630151|NCT03414684|364311275|FG000|First-course Treatment|Physician Decision|0|||
105630152|NCT03414684|364311276|FG001|First-course Treatment|Physician Decision|1|||
105630153|NCT03414684|364311275|FG000|First-course Treatment|Withdrawal by Subject|0|||
105630154|NCT03414684|364311276|FG001|First-course Treatment|Withdrawal by Subject|1|||
105630155|NCT03414684|364311275|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
105630156|NCT03414684|364311276|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
105630157|NCT03414684|364311275|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
105630158|NCT03414684|364311276|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
105630159|NCT03414684|364311275|FG000|First-course Treatment|Still on treatment|3|||
105630160|NCT03414684|364311276|FG001|First-course Treatment|Still on treatment|0|||
105630161|NCT03414684|364311275|FG000|First-course Treatment|Never started protocol therapy|2|||
105630162|NCT03414684|364311276|FG001|First-course Treatment|Never started protocol therapy|1|||
105630163|NCT03414684|364311275|FG000|Crossover Treatment|Progressive disease|0|||
105630164|NCT03414684|364311276|FG001|Crossover Treatment|Progressive disease|12|||
105630165|NCT03414684|364311275|FG000|Crossover Treatment|Adverse Event|0|||
105630166|NCT03414684|364311276|FG001|Crossover Treatment|Adverse Event|3|||
105630167|NCT03414684|364311275|FG000|Crossover Treatment|Physician Decision|0|||
105630168|NCT03414684|364311276|FG001|Crossover Treatment|Physician Decision|1|||
105630169|NCT03414684|364311275|FG000|Crossover Treatment|Still on treatment|0|||
105630170|NCT03414684|364311276|FG001|Crossover Treatment|Still on treatment|2|||
105630171|NCT03215706|364311286|FG000|Randomization|Adverse Event unrelated to study drug|1|||
105630172|NCT03215706|364311287|FG001|Randomization|Adverse Event unrelated to study drug|0|||
105630173|NCT03215706|364311286|FG000|Randomization|participant withdrew consent|1|||
105630174|NCT03215706|364311287|FG001|Randomization|participant withdrew consent|3|||
105630175|NCT03215706|364311286|FG000|Randomization|no longer meets study criteria|1|||
105630176|NCT03215706|364311287|FG001|Randomization|no longer meets study criteria|4|||
105630177|NCT03215706|364311286|FG000|Randomization|other reasons|0|||
105630178|NCT03215706|364311287|FG001|Randomization|other reasons|2|||
105630179|NCT03215706|364311286|FG000|Treatment Period|Disease Progression|150|||
105630180|NCT03215706|364311287|FG001|Treatment Period|Disease Progression|142|||
105630181|NCT03215706|364311286|FG000|Treatment Period|Study Drug Toxicity|53|||
105630182|NCT03215706|364311287|FG001|Treatment Period|Study Drug Toxicity|21|||
105630183|NCT03215706|364311286|FG000|Treatment Period|Death|2|||
105630184|NCT03215706|364311287|FG001|Treatment Period|Death|1|||
105630185|NCT03215706|364311286|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
105630186|NCT03215706|364311287|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
105630187|NCT03215706|364311286|FG000|Treatment Period|Request to D/C treatment|1|||
105630188|NCT03215706|364311287|FG001|Treatment Period|Request to D/C treatment|6|||
105630189|NCT03215706|364311286|FG000|Treatment Period|Participant withdrew consent|3|||
105630190|NCT03215706|364311287|FG001|Treatment Period|Participant withdrew consent|4|||
105630191|NCT03215706|364311286|FG000|Treatment Period|Lost to Follow-up|0|||
105630192|NCT03215706|364311287|FG001|Treatment Period|Lost to Follow-up|1|||
105630193|NCT03215706|364311286|FG000|Treatment Period|Other Reasons|4|||
105630194|NCT03215706|364311287|FG001|Treatment Period|Other Reasons|5|||
105630195|NCT03215706|364311286|FG000|Treatment Period|Ongoing in the treatment period|105|||
105630196|NCT03215706|364311287|FG001|Treatment Period|Ongoing in the treatment period|43|||
105630197|NCT00593840|364311288|FG000|Overall Study|Withdrawal by Subject|1|||
105630198|NCT02566889|364312170|FG000|Overall Study|Withdrawal by Subject|3|||
105630199|NCT02566889|364312171|FG001|Overall Study|Withdrawal by Subject|1|||
105630200|NCT02566889|364312170|FG000|Overall Study|Adverse Event|4|||
105630201|NCT02566889|364312171|FG001|Overall Study|Adverse Event|2|||
105630202|NCT02566889|364312170|FG000|Overall Study|Other|6|||
105630203|NCT02566889|364312171|FG001|Overall Study|Other|2|||
105630204|NCT00739908|364312172|FG000|Overall Study|Adverse Event|5|||
105630205|NCT00739908|364312173|FG001|Overall Study|Adverse Event|6|||
105630206|NCT00739908|364312172|FG000|Overall Study|Withdrawal by Subject|4|||
105630207|NCT00739908|364312173|FG001|Overall Study|Withdrawal by Subject|2|||
105630208|NCT00739908|364312172|FG000|Overall Study|Lost to Follow-up|14|||
105630209|NCT00739908|364312173|FG001|Overall Study|Lost to Follow-up|9|||
105630210|NCT00739908|364312172|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
105630211|NCT00739908|364312173|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
105630212|NCT00739908|364312172|FG000|Overall Study|Non-Compliance With Study Medication|0|||
105630213|NCT00739908|364312173|FG001|Overall Study|Non-Compliance With Study Medication|3|||
105630214|NCT00739908|364312172|FG000|Overall Study|Lack of Efficacy|0|||
105630215|NCT00739908|364312173|FG001|Overall Study|Lack of Efficacy|1|||
105630216|NCT00739908|364312172|FG000|Overall Study|Relocation|0|||
105630217|NCT00739908|364312173|FG001|Overall Study|Relocation|1|||
105630218|NCT02075554|364312175|FG000|Overall Study|Lost to Follow-up|7|||
105630219|NCT02075554|364312175|FG000|Overall Study|Withdrawal by Subject|5|||
105630220|NCT02075554|364312175|FG000|Overall Study|Physician Decision|3|||
105630221|NCT03248492|364312176|FG000|Overall Study|Progressive Disease|24|||
105630222|NCT03248492|364312177|FG001|Overall Study|Progressive Disease|23|||
105630223|NCT03248492|364312178|FG002|Overall Study|Progressive Disease|11|||
105630224|NCT03248492|364312179|FG003|Overall Study|Progressive Disease|66|||
105630225|NCT03248492|364312180|FG004|Overall Study|Progressive Disease|1|||
105630226|NCT03248492|364312176|FG000|Overall Study|Adverse Event|14|||
105630227|NCT03248492|364312177|FG001|Overall Study|Adverse Event|13|||
105630228|NCT03248492|364312178|FG002|Overall Study|Adverse Event|9|||
105630229|NCT03248492|364312179|FG003|Overall Study|Adverse Event|22|||
105630230|NCT03248492|364312180|FG004|Overall Study|Adverse Event|2|||
105630231|NCT03248492|364312176|FG000|Overall Study|Withdrawal by Subject|5|||
105630232|NCT03248492|364312177|FG001|Overall Study|Withdrawal by Subject|4|||
105630233|NCT03248492|364312178|FG002|Overall Study|Withdrawal by Subject|0|||
105630234|NCT03248492|364312179|FG003|Overall Study|Withdrawal by Subject|8|||
105630235|NCT03248492|364312180|FG004|Overall Study|Withdrawal by Subject|1|||
105630236|NCT03248492|364312176|FG000|Overall Study|Physician Decision|1|||
105630237|NCT03248492|364312177|FG001|Overall Study|Physician Decision|1|||
105630238|NCT03248492|364312178|FG002|Overall Study|Physician Decision|1|||
105630239|NCT03248492|364312179|FG003|Overall Study|Physician Decision|7|||
105630240|NCT03248492|364312180|FG004|Overall Study|Physician Decision|0|||
105630241|NCT03248492|364312176|FG000|Overall Study|Death|1|||
105630242|NCT03248492|364312177|FG001|Overall Study|Death|1|||
105630243|NCT03248492|364312178|FG002|Overall Study|Death|0|||
105630244|NCT03248492|364312179|FG003|Overall Study|Death|6|||
105630245|NCT03248492|364312180|FG004|Overall Study|Death|0|||
105630246|NCT03248492|364312176|FG000|Overall Study|Study Terminated by Sponsor|3|||
105630247|NCT03248492|364312177|FG001|Overall Study|Study Terminated by Sponsor|1|||
105630248|NCT03248492|364312178|FG002|Overall Study|Study Terminated by Sponsor|0|||
105630249|NCT03248492|364312179|FG003|Overall Study|Study Terminated by Sponsor|7|||
105630250|NCT03248492|364312180|FG004|Overall Study|Study Terminated by Sponsor|0|||
105630251|NCT03248492|364312176|FG000|Overall Study|Other|2|||
105630252|NCT03248492|364312177|FG001|Overall Study|Other|5|||
105630253|NCT03248492|364312178|FG002|Overall Study|Other|0|||
105630254|NCT03248492|364312179|FG003|Overall Study|Other|14|||
105630255|NCT03248492|364312180|FG004|Overall Study|Other|0|||
105630256|NCT04757753|364312185|FG000|Overall Study|Lost to Follow-up|7|||
105630257|NCT04757753|364312186|FG001|Overall Study|Lost to Follow-up|7|||
105630258|NCT04757753|364312185|FG000|Overall Study|Withdrawal by Subject|0|||
105630259|NCT04757753|364312186|FG001|Overall Study|Withdrawal by Subject|3|||
105630260|NCT04757753|364312185|FG000|Overall Study|Endodontic treatment failure|1|||
105630261|NCT04757753|364312186|FG001|Overall Study|Endodontic treatment failure|2|||
105630262|NCT04757753|364312185|FG000|Overall Study|Tooth fracture/extraction|3|||
105630263|NCT04757753|364312186|FG001|Overall Study|Tooth fracture/extraction|0|||
105630264|NCT00308997|364312188|FG000|Overall Study|Subject feigned clinical data|0|||
105630265|NCT00308997|364312189|FG001|Overall Study|Subject feigned clinical data|1|||
105630266|NCT00308997|364312188|FG000|Overall Study|Unable to tolerate intervention|1|||
105630267|NCT00308997|364312189|FG001|Overall Study|Unable to tolerate intervention|0|||
105630268|NCT03201939|364312191|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
105630269|NCT03201939|364312192|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
105630270|NCT06688357|364312198|FG000|Overall Study|Adverse Event|0|||
105630271|NCT06688357|364312199|FG001|Overall Study|Adverse Event|1|||
105630272|NCT05116774|364312200|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
105630273|NCT05116774|364312201|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
105630274|NCT05116774|364312200|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
105630275|NCT05116774|364312201|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
105630276|NCT05116774|364312200|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
105630277|NCT05116774|364312201|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
105630278|NCT05116774|364312200|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
105630279|NCT05116774|364312201|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
105630280|NCT05289037|364312202|FG000|Overall Study|Withdrawal by Subject|7|||
105630281|NCT05289037|364312203|FG001|Overall Study|Withdrawal by Subject|0|||
105630282|NCT05289037|364312204|FG002|Overall Study|Withdrawal by Subject|3|||
105630283|NCT05289037|364312205|FG003|Overall Study|Withdrawal by Subject|3|||
105630284|NCT05289037|364312206|FG004|Overall Study|Withdrawal by Subject|1|||
105630285|NCT05289037|364312207|FG005|Overall Study|Withdrawal by Subject|5|||
105630286|NCT05289037|364312208|FG006|Overall Study|Withdrawal by Subject|2|||
105630287|NCT05289037|364312209|FG007|Overall Study|Withdrawal by Subject|1|||
105630288|NCT05289037|364312210|FG008|Overall Study|Withdrawal by Subject|2|||
105630289|NCT05289037|364312211|FG009|Overall Study|Withdrawal by Subject|2|||
105630290|NCT05289037|364312212|FG010|Overall Study|Withdrawal by Subject|1|||
105630291|NCT05289037|364312213|FG011|Overall Study|Withdrawal by Subject|0|||
105630292|NCT05289037|364312214|FG012|Overall Study|Withdrawal by Subject|1|||
105630293|NCT05289037|364312215|FG013|Overall Study|Withdrawal by Subject|2|||
105630294|NCT05289037|364312216|FG014|Overall Study|Withdrawal by Subject|0|||
105630295|NCT05289037|364312217|FG015|Overall Study|Withdrawal by Subject|3|||
105630296|NCT05289037|364312218|FG016|Overall Study|Withdrawal by Subject|3|||
105630297|NCT05289037|364312202|FG000|Overall Study|Lost to Follow-up|1|||
105630298|NCT05289037|364312203|FG001|Overall Study|Lost to Follow-up|4|||
105630299|NCT05289037|364312204|FG002|Overall Study|Lost to Follow-up|3|||
105630300|NCT05289037|364312205|FG003|Overall Study|Lost to Follow-up|3|||
105630301|NCT05289037|364312206|FG004|Overall Study|Lost to Follow-up|3|||
105630302|NCT05289037|364312207|FG005|Overall Study|Lost to Follow-up|2|||
105630303|NCT05289037|364312208|FG006|Overall Study|Lost to Follow-up|3|||
105630304|NCT05289037|364312209|FG007|Overall Study|Lost to Follow-up|2|||
105630305|NCT05289037|364312210|FG008|Overall Study|Lost to Follow-up|2|||
105630306|NCT05289037|364312211|FG009|Overall Study|Lost to Follow-up|1|||
105630307|NCT05289037|364312212|FG010|Overall Study|Lost to Follow-up|3|||
105630308|NCT05289037|364312213|FG011|Overall Study|Lost to Follow-up|4|||
105630309|NCT05289037|364312214|FG012|Overall Study|Lost to Follow-up|2|||
105630310|NCT05289037|364312215|FG013|Overall Study|Lost to Follow-up|7|||
105630311|NCT05289037|364312216|FG014|Overall Study|Lost to Follow-up|4|||
105630312|NCT05289037|364312217|FG015|Overall Study|Lost to Follow-up|6|||
105630313|NCT05289037|364312218|FG016|Overall Study|Lost to Follow-up|4|||
105630314|NCT05289037|364312202|FG000|Overall Study|Death|0|||
105630315|NCT05289037|364312203|FG001|Overall Study|Death|0|||
105630316|NCT05289037|364312204|FG002|Overall Study|Death|0|||
105630317|NCT05289037|364312205|FG003|Overall Study|Death|0|||
105630318|NCT05289037|364312206|FG004|Overall Study|Death|0|||
105630319|NCT05289037|364312207|FG005|Overall Study|Death|1|||
105630320|NCT05289037|364312208|FG006|Overall Study|Death|0|||
105630321|NCT05289037|364312209|FG007|Overall Study|Death|0|||
105630322|NCT05289037|364312210|FG008|Overall Study|Death|0|||
105630323|NCT05289037|364312211|FG009|Overall Study|Death|0|||
105630324|NCT05289037|364312212|FG010|Overall Study|Death|0|||
105630325|NCT05289037|364312213|FG011|Overall Study|Death|0|||
105630326|NCT05289037|364312214|FG012|Overall Study|Death|0|||
105630327|NCT05289037|364312215|FG013|Overall Study|Death|0|||
105630328|NCT05289037|364312216|FG014|Overall Study|Death|1|||
105630329|NCT05289037|364312217|FG015|Overall Study|Death|0|||
105630330|NCT05289037|364312218|FG016|Overall Study|Death|0|||
105630331|NCT05289037|364312202|FG000|Overall Study|Did not receive vaccine|0|||
105630332|NCT05289037|364312203|FG001|Overall Study|Did not receive vaccine|3|||
105630333|NCT05289037|364312204|FG002|Overall Study|Did not receive vaccine|0|||
105630334|NCT05289037|364312205|FG003|Overall Study|Did not receive vaccine|0|||
105630335|NCT05289037|364312206|FG004|Overall Study|Did not receive vaccine|1|||
105630336|NCT05289037|364312207|FG005|Overall Study|Did not receive vaccine|1|||
105630337|NCT05289037|364312208|FG006|Overall Study|Did not receive vaccine|1|||
105630338|NCT05289037|364312209|FG007|Overall Study|Did not receive vaccine|0|||
105630339|NCT05289037|364312210|FG008|Overall Study|Did not receive vaccine|0|||
105630340|NCT05289037|364312211|FG009|Overall Study|Did not receive vaccine|0|||
105630341|NCT05289037|364312212|FG010|Overall Study|Did not receive vaccine|0|||
105630342|NCT05289037|364312213|FG011|Overall Study|Did not receive vaccine|0|||
105630343|NCT05289037|364312214|FG012|Overall Study|Did not receive vaccine|0|||
105630344|NCT05289037|364312215|FG013|Overall Study|Did not receive vaccine|0|||
105630345|NCT05289037|364312216|FG014|Overall Study|Did not receive vaccine|1|||
105630346|NCT05289037|364312217|FG015|Overall Study|Did not receive vaccine|0|||
105630347|NCT05289037|364312218|FG016|Overall Study|Did not receive vaccine|0|||
105630348|NCT05289037|364312202|FG000|Overall Study|Unable to make last visit|0|||
105630349|NCT05289037|364312203|FG001|Overall Study|Unable to make last visit|0|||
105630350|NCT05289037|364312204|FG002|Overall Study|Unable to make last visit|1|||
105630351|NCT05289037|364312205|FG003|Overall Study|Unable to make last visit|0|||
105630352|NCT05289037|364312206|FG004|Overall Study|Unable to make last visit|0|||
105630353|NCT05289037|364312207|FG005|Overall Study|Unable to make last visit|0|||
105630354|NCT05289037|364312208|FG006|Overall Study|Unable to make last visit|0|||
105630355|NCT05289037|364312209|FG007|Overall Study|Unable to make last visit|0|||
105630356|NCT05289037|364312210|FG008|Overall Study|Unable to make last visit|0|||
105630357|NCT05289037|364312211|FG009|Overall Study|Unable to make last visit|0|||
105630358|NCT05289037|364312212|FG010|Overall Study|Unable to make last visit|0|||
105630359|NCT05289037|364312213|FG011|Overall Study|Unable to make last visit|0|||
105630360|NCT05289037|364312214|FG012|Overall Study|Unable to make last visit|0|||
105630361|NCT05289037|364312215|FG013|Overall Study|Unable to make last visit|0|||
105630362|NCT05289037|364312216|FG014|Overall Study|Unable to make last visit|0|||
105630363|NCT05289037|364312217|FG015|Overall Study|Unable to make last visit|0|||
105630364|NCT05289037|364312218|FG016|Overall Study|Unable to make last visit|0|||
105630365|NCT05289037|364312202|FG000|Overall Study|Protocol deviation|0|||
105630366|NCT05289037|364312203|FG001|Overall Study|Protocol deviation|0|||
105630367|NCT05289037|364312204|FG002|Overall Study|Protocol deviation|0|||
105630368|NCT05289037|364312205|FG003|Overall Study|Protocol deviation|0|||
105630369|NCT05289037|364312206|FG004|Overall Study|Protocol deviation|0|||
105630370|NCT05289037|364312207|FG005|Overall Study|Protocol deviation|0|||
105630371|NCT05289037|364312208|FG006|Overall Study|Protocol deviation|0|||
105630372|NCT05289037|364312209|FG007|Overall Study|Protocol deviation|0|||
105630373|NCT05289037|364312210|FG008|Overall Study|Protocol deviation|0|||
105630374|NCT05289037|364312211|FG009|Overall Study|Protocol deviation|0|||
105630375|NCT05289037|364312212|FG010|Overall Study|Protocol deviation|0|||
105630376|NCT05289037|364312213|FG011|Overall Study|Protocol deviation|0|||
105630377|NCT05289037|364312214|FG012|Overall Study|Protocol deviation|0|||
105630378|NCT05289037|364312215|FG013|Overall Study|Protocol deviation|0|||
105630379|NCT05289037|364312216|FG014|Overall Study|Protocol deviation|0|||
105630380|NCT05289037|364312217|FG015|Overall Study|Protocol deviation|1|||
105630381|NCT05289037|364312218|FG016|Overall Study|Protocol deviation|0|||
105630382|NCT04505722|364312220|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
105630383|NCT04505722|364312221|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
105630384|NCT04505722|364312222|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
105630385|NCT04505722|364312220|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
105630386|NCT04505722|364312221|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
105630387|NCT04505722|364312222|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
105630388|NCT04505722|364312220|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
105630389|NCT04505722|364312221|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
105630390|NCT04505722|364312222|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
105630391|NCT04505722|364312220|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
105630392|NCT04505722|364312221|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
105630393|NCT04505722|364312222|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
105630394|NCT04505722|364312220|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
105630395|NCT04505722|364312221|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
105630396|NCT04505722|364312222|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
105630397|NCT04505722|364312220|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
105630398|NCT04505722|364312221|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
105630399|NCT04505722|364312222|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
105630400|NCT04505722|364312220|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
105630401|NCT04505722|364312221|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
105630402|NCT04505722|364312222|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
105630403|NCT04505722|364312220|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
105630404|NCT04505722|364312221|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
105630405|NCT04505722|364312222|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
105630406|NCT04505722|364312220|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
105630407|NCT04505722|364312221|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
105630408|NCT04505722|364312222|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
105630409|NCT04505722|364312220|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
105630410|NCT04505722|364312221|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
105630411|NCT04505722|364312222|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
105630412|NCT04505722|364312220|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
105630413|NCT04505722|364312221|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
105630414|NCT04505722|364312222|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
105630415|NCT04505722|364312220|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
105630416|NCT04505722|364312221|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
105630417|NCT04505722|364312222|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
105630418|NCT04505722|364312220|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
105630419|NCT04505722|364312221|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
105630420|NCT04505722|364312222|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
105630421|NCT04505722|364312220|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
105630422|NCT04505722|364312221|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
105630423|NCT04505722|364312222|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
105630424|NCT04505722|364312220|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
105630425|NCT04505722|364312221|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
105630426|NCT04505722|364312222|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
105630427|NCT01639131|364312777|FG000|Overall Study|Disease Progression|6|||
105630428|NCT04121546|364312785|FG000|Overall Study|Lost to Follow-up|1|||
105630429|NCT04121546|364312786|FG001|Overall Study|Lost to Follow-up|3|||
105630430|NCT04129164|364312789|FG000|Overall Study|Non-compliance with procedures|0|||
105630431|NCT04129164|364312790|FG001|Overall Study|Non-compliance with procedures|0|||
105630432|NCT04129164|364312791|FG002|Overall Study|Non-compliance with procedures|2|||
105630433|NCT04129164|364312792|FG003|Overall Study|Non-compliance with procedures|0|||
105630434|NCT04129164|364312789|FG000|Overall Study|Adverse Event|0|||
105630435|NCT04129164|364312790|FG001|Overall Study|Adverse Event|0|||
105630436|NCT04129164|364312791|FG002|Overall Study|Adverse Event|2|||
105630437|NCT04129164|364312792|FG003|Overall Study|Adverse Event|0|||
105630438|NCT04129164|364312789|FG000|Overall Study|Pregnancy|0|||
105630439|NCT04129164|364312790|FG001|Overall Study|Pregnancy|0|||
105630440|NCT04129164|364312791|FG002|Overall Study|Pregnancy|0|||
105630441|NCT04129164|364312792|FG003|Overall Study|Pregnancy|1|||
105630442|NCT04129164|364312789|FG000|Overall Study|Withdrawal by Subject|3|||
105630443|NCT04129164|364312790|FG001|Overall Study|Withdrawal by Subject|2|||
105630444|NCT04129164|364312791|FG002|Overall Study|Withdrawal by Subject|4|||
105630445|NCT04129164|364312792|FG003|Overall Study|Withdrawal by Subject|6|||
105630446|NCT04129164|364312789|FG000|Overall Study|Death|0|||
105630447|NCT04129164|364312790|FG001|Overall Study|Death|1|||
105630448|NCT04129164|364312791|FG002|Overall Study|Death|0|||
105630449|NCT04129164|364312792|FG003|Overall Study|Death|0|||
105630450|NCT04129164|364312789|FG000|Overall Study|Lost to Follow-up|0|||
105630451|NCT04129164|364312790|FG001|Overall Study|Lost to Follow-up|1|||
105630452|NCT04129164|364312791|FG002|Overall Study|Lost to Follow-up|0|||
105630453|NCT04129164|364312792|FG003|Overall Study|Lost to Follow-up|0|||
105630454|NCT03705390|364312798|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
105630455|NCT03705390|364312798|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
105630456|NCT00087685|364312799|FG000|Overall Study|Adverse Event|5|||
105630457|NCT00087685|364312799|FG000|Overall Study|Non-Compliance|1|||
105630458|NCT00087685|364312799|FG000|Overall Study|Progressive Disease|5|||
105630459|NCT00087685|364312799|FG000|Overall Study|Withdrawal by Subject|3|||
105630460|NCT04908514|364312802|FG000|Overall Study|Lost to Follow-up|2|||
105630461|NCT04908514|364312802|FG000|Overall Study|Withdrawal by Subject|1|||
105630462|NCT05714059|364312803|FG000|Overall Study|Withdrawal by Subject|2|||
105630463|NCT05714059|364312804|FG001|Overall Study|Withdrawal by Subject|2|||
105630464|NCT05714059|364312803|FG000|Overall Study|Adverse Event|0|||
105630465|NCT05714059|364312804|FG001|Overall Study|Adverse Event|1|||
105630466|NCT05714059|364312803|FG000|Overall Study|Lost to Follow-up|0|||
105630467|NCT05714059|364312804|FG001|Overall Study|Lost to Follow-up|1|||
105630468|NCT05714059|364312803|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
105630469|NCT05714059|364312804|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
105630470|NCT05714059|364312803|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
105630471|NCT05714059|364312804|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
105630472|NCT04899674|364312805|FG000|Test|Adverse Event|1|||
105630473|NCT04059406|364312806|FG000|Overall Study|Early Treatment Termination|5|||
105630474|NCT04059406|364312807|FG001|Overall Study|Early Treatment Termination|5|||
105630475|NCT04059406|364312808|FG002|Overall Study|Early Treatment Termination|15|||
105630476|NCT03150862|364312813|FG000|Overall Study|Death|2|||
105630477|NCT03150862|364312814|FG001|Overall Study|Death|7|||
105630478|NCT03150862|364312815|FG002|Overall Study|Death|8|||
105630479|NCT03150862|364312816|FG003|Overall Study|Death|27|||
105630480|NCT03150862|364312817|FG004|Overall Study|Death|4|||
105630481|NCT03150862|364312818|FG005|Overall Study|Death|8|||
105630482|NCT03150862|364312819|FG006|Overall Study|Death|6|||
105630483|NCT03150862|364312820|FG007|Overall Study|Death|21|||
105630484|NCT03150862|364312813|FG000|Overall Study|Withdrawal by Subject|1|||
105630485|NCT03150862|364312814|FG001|Overall Study|Withdrawal by Subject|1|||
105630486|NCT03150862|364312815|FG002|Overall Study|Withdrawal by Subject|0|||
105630487|NCT03150862|364312816|FG003|Overall Study|Withdrawal by Subject|3|||
105630488|NCT03150862|364312817|FG004|Overall Study|Withdrawal by Subject|1|||
105630489|NCT03150862|364312818|FG005|Overall Study|Withdrawal by Subject|1|||
105630490|NCT03150862|364312819|FG006|Overall Study|Withdrawal by Subject|1|||
105630491|NCT03150862|364312820|FG007|Overall Study|Withdrawal by Subject|3|||
105630492|NCT03150862|364312813|FG000|Overall Study|Lost to Follow-up|0|||
105630493|NCT03150862|364312814|FG001|Overall Study|Lost to Follow-up|0|||
105630494|NCT03150862|364312815|FG002|Overall Study|Lost to Follow-up|1|||
105630495|NCT03150862|364312816|FG003|Overall Study|Lost to Follow-up|0|||
105630496|NCT03150862|364312817|FG004|Overall Study|Lost to Follow-up|0|||
105630497|NCT03150862|364312818|FG005|Overall Study|Lost to Follow-up|0|||
105630498|NCT03150862|364312819|FG006|Overall Study|Lost to Follow-up|0|||
105630499|NCT03150862|364312820|FG007|Overall Study|Lost to Follow-up|2|||
105630500|NCT03150862|364312813|FG000|Overall Study|Sponsor's decision|0|||
105630501|NCT03150862|364312814|FG001|Overall Study|Sponsor's decision|0|||
105630502|NCT03150862|364312815|FG002|Overall Study|Sponsor's decision|0|||
105630503|NCT03150862|364312816|FG003|Overall Study|Sponsor's decision|10|||
105630504|NCT03150862|364312817|FG004|Overall Study|Sponsor's decision|3|||
105630505|NCT03150862|364312818|FG005|Overall Study|Sponsor's decision|0|||
105630506|NCT03150862|364312819|FG006|Overall Study|Sponsor's decision|1|||
105630507|NCT03150862|364312820|FG007|Overall Study|Sponsor's decision|1|||
105630508|NCT03150862|364312813|FG000|Overall Study|Change in Methylation status|0|||
105630509|NCT03150862|364312814|FG001|Overall Study|Change in Methylation status|0|||
105630510|NCT03150862|364312815|FG002|Overall Study|Change in Methylation status|0|||
105630511|NCT03150862|364312816|FG003|Overall Study|Change in Methylation status|0|||
105630512|NCT03150862|364312817|FG004|Overall Study|Change in Methylation status|1|||
105630513|NCT03150862|364312818|FG005|Overall Study|Change in Methylation status|0|||
105630514|NCT03150862|364312819|FG006|Overall Study|Change in Methylation status|0|||
105630515|NCT03150862|364312820|FG007|Overall Study|Change in Methylation status|0|||
105630516|NCT03150862|364312813|FG000|Overall Study|Roll over in to Long Term Extension|0|||
105630517|NCT03150862|364312814|FG001|Overall Study|Roll over in to Long Term Extension|0|||
105630518|NCT03150862|364312815|FG002|Overall Study|Roll over in to Long Term Extension|0|||
105630519|NCT03150862|364312816|FG003|Overall Study|Roll over in to Long Term Extension|0|||
105630520|NCT03150862|364312817|FG004|Overall Study|Roll over in to Long Term Extension|0|||
105630521|NCT03150862|364312818|FG005|Overall Study|Roll over in to Long Term Extension|0|||
105630522|NCT03150862|364312819|FG006|Overall Study|Roll over in to Long Term Extension|0|||
105630523|NCT03150862|364312820|FG007|Overall Study|Roll over in to Long Term Extension|1|||
105630524|NCT03150862|364312813|FG000|Overall Study|Progressive Disease|0|||
105630525|NCT03150862|364312814|FG001|Overall Study|Progressive Disease|0|||
105630526|NCT03150862|364312815|FG002|Overall Study|Progressive Disease|0|||
105630527|NCT03150862|364312816|FG003|Overall Study|Progressive Disease|0|||
105630528|NCT03150862|364312817|FG004|Overall Study|Progressive Disease|0|||
105630529|NCT03150862|364312818|FG005|Overall Study|Progressive Disease|0|||
105630530|NCT03150862|364312819|FG006|Overall Study|Progressive Disease|0|||
105630531|NCT03150862|364312820|FG007|Overall Study|Progressive Disease|2|||
105630532|NCT03280030|364312823|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
105630533|NCT03280030|364312824|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
105630534|NCT03280030|364312825|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
105630535|NCT03280030|364312823|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
105630536|NCT03280030|364312824|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
105630537|NCT03280030|364312825|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
105630538|NCT03280030|364312823|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
105630539|NCT03280030|364312824|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
105630540|NCT03280030|364312825|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
105630541|NCT03280030|364312823|FG000|Part 2 - Efficacy|Adverse Event|0|||
105630542|NCT03280030|364312824|FG001|Part 2 - Efficacy|Adverse Event|4|||
105630543|NCT03280030|364312825|FG002|Part 2 - Efficacy|Adverse Event|6|||
105630544|NCT03280030|364312823|FG000|Part 2 - Efficacy|Death|0|||
105630545|NCT03280030|364312824|FG001|Part 2 - Efficacy|Death|3|||
105630546|NCT03280030|364312825|FG002|Part 2 - Efficacy|Death|0|||
105630547|NCT03280030|364312823|FG000|Part 2 - Efficacy|Physician Decision|0|||
105630548|NCT03280030|364312824|FG001|Part 2 - Efficacy|Physician Decision|10|||
105630549|NCT03280030|364312825|FG002|Part 2 - Efficacy|Physician Decision|16|||
105630550|NCT03280030|364312823|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
105630551|NCT03280030|364312824|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
105630552|NCT03280030|364312825|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
105630553|NCT03280030|364312823|FG000|Part 2 - Efficacy|Progressive disease|0|||
105630554|NCT03280030|364312824|FG001|Part 2 - Efficacy|Progressive disease|7|||
105630555|NCT03280030|364312825|FG002|Part 2 - Efficacy|Progressive disease|5|||
105630556|NCT02039401|364312826|FG000|Overall Study|Adverse Event|0|||
105630557|NCT02039401|364312827|FG001|Overall Study|Adverse Event|1|||
105630558|NCT03867201|364312828|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
105630559|NCT03867201|364312829|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
105630560|NCT03867201|364312828|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
105630561|NCT03867201|364312829|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
105630562|NCT03867201|364312828|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
105630563|NCT03867201|364312829|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
105630564|NCT03867201|364312828|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
105630565|NCT03867201|364312829|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
105630566|NCT03867201|364312828|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
105630567|NCT03867201|364312829|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
105630568|NCT03867201|364312828|FG000|Open-Label Period From Week 12|Adverse Event|5|||
105630569|NCT03867201|364312829|FG001|Open-Label Period From Week 12|Adverse Event|11|||
105630570|NCT03867201|364312828|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
105630571|NCT03867201|364312829|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
105630572|NCT03867201|364312828|FG000|Open-Label Period From Week 12|Physician Decision|6|||
105630573|NCT03867201|364312829|FG001|Open-Label Period From Week 12|Physician Decision|3|||
105630574|NCT03867201|364312828|FG000|Open-Label Period From Week 12|Pregnancy|2|||
105630575|NCT03867201|364312829|FG001|Open-Label Period From Week 12|Pregnancy|2|||
105630576|NCT03867201|364312828|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
105630577|NCT03867201|364312829|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
105630578|NCT03867201|364312828|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
105630579|NCT03867201|364312829|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
105630580|NCT03867201|364312828|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
105630581|NCT03867201|364312829|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
105630582|NCT03867201|364312828|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
105630583|NCT03867201|364312829|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
105630584|NCT05795153|364313343|FG000|Overall Study|Adverse Event|2|||
105630585|NCT05795153|364313343|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105630586|NCT05795153|364313343|FG000|Overall Study|Lost to Follow-up|1|||
105630587|NCT05795153|364313343|FG000|Overall Study|Subject decision|2|||
105630588|NCT05180539|364313346|FG000|Overall Study|Lost to Follow-up|27|||
105630589|NCT05180539|364313347|FG001|Overall Study|Lost to Follow-up|30|||
105630590|NCT02866942|364313351|FG000|Overall Study|Invalid consent|1|||
105630591|NCT00439270|364313352|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
105630592|NCT00439270|364313353|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
105630593|NCT00439270|364313354|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
105630594|NCT00439270|364313355|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
105630595|NCT00439270|364313356|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
105630596|NCT00439270|364313352|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
105630597|NCT00439270|364313353|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
105630598|NCT00439270|364313354|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
105630599|NCT00439270|364313355|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
105630600|NCT00439270|364313356|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
105630601|NCT00439270|364313352|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
105630602|NCT00439270|364313353|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
105630603|NCT00439270|364313354|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
105630604|NCT00439270|364313355|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
105630605|NCT00439270|364313356|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
105630606|NCT00439270|364313352|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
105630607|NCT00439270|364313353|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
105630608|NCT00439270|364313354|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
105630609|NCT00439270|364313355|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
105630610|NCT00439270|364313356|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
105630611|NCT00439270|364313352|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
105630612|NCT00439270|364313353|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
105630613|NCT00439270|364313354|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
105630614|NCT00439270|364313355|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
105630615|NCT00439270|364313356|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
105630616|NCT00439270|364313352|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
105630617|NCT00439270|364313353|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
105630618|NCT00439270|364313354|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
105630619|NCT00439270|364313355|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
105630620|NCT00439270|364313356|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
105630621|NCT00439270|364313352|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
105630622|NCT00439270|364313353|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
105630623|NCT00439270|364313354|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
105630624|NCT00439270|364313355|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
105630625|NCT00439270|364313356|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
105630626|NCT00439270|364313352|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
105630627|NCT00439270|364313353|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
105630628|NCT00439270|364313354|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
105630629|NCT00439270|364313355|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
105630630|NCT00439270|364313356|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
105630631|NCT00439270|364313352|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
105630632|NCT00439270|364313353|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
105630633|NCT00439270|364313354|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
105630634|NCT00439270|364313355|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
105630635|NCT00439270|364313356|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
105630636|NCT00439270|364313352|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
105630637|NCT00439270|364313353|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
105630638|NCT00439270|364313354|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
105630639|NCT00439270|364313355|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
105630640|NCT00439270|364313356|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
105630641|NCT00312208|364313357|FG000|Overall Study|Adverse Event|97|||
105630642|NCT00312208|364313358|FG001|Overall Study|Adverse Event|61|||
105630643|NCT00312208|364313357|FG000|Overall Study|Protocol Violation|5|||
105630644|NCT00312208|364313358|FG001|Overall Study|Protocol Violation|3|||
105630645|NCT00312208|364313357|FG000|Overall Study|Death|2|||
105630646|NCT00312208|364313358|FG001|Overall Study|Death|1|||
105630647|NCT00312208|364313357|FG000|Overall Study|Lack of Efficacy|7|||
105630648|NCT00312208|364313358|FG001|Overall Study|Lack of Efficacy|4|||
105630649|NCT00312208|364313357|FG000|Overall Study|Lost to Follow-up|3|||
105630650|NCT00312208|364313358|FG001|Overall Study|Lost to Follow-up|5|||
105630651|NCT00312208|364313357|FG000|Overall Study|Withdrawal by Subject|53|||
105630652|NCT00312208|364313358|FG001|Overall Study|Withdrawal by Subject|42|||
105630653|NCT00312208|364313357|FG000|Overall Study|Other|5|||
105630654|NCT00312208|364313358|FG001|Overall Study|Other|7|||
105630655|NCT01313559|364313365|FG000|Overall Study|Withdrawal by Subject|1|||
105630656|NCT01313559|364313366|FG001|Overall Study|Withdrawal by Subject|2|||
105630657|NCT01313559|364313365|FG000|Overall Study|Disease progression|1|||
105630658|NCT01313559|364313366|FG001|Overall Study|Disease progression|0|||
105630659|NCT01313559|364313365|FG000|Overall Study|Rising PSA|2|||
105630660|NCT01313559|364313366|FG001|Overall Study|Rising PSA|0|||
105630661|NCT02656706|364313367|FG000|Overall Study|Insurance Denial|1|||
105630662|NCT03222609|364313369|FG000|Overall Study|Withdrew consent|2|||
105630663|NCT03222609|364313370|FG001|Overall Study|Withdrew consent|3|||
105630664|NCT03222609|364313371|FG002|Overall Study|Withdrew consent|4|||
105630665|NCT03222609|364313372|FG003|Overall Study|Withdrew consent|2|||
105630666|NCT03222609|364313369|FG000|Overall Study|Lost to Follow-up|1|||
105630667|NCT03222609|364313370|FG001|Overall Study|Lost to Follow-up|0|||
105630668|NCT03222609|364313371|FG002|Overall Study|Lost to Follow-up|0|||
105630669|NCT03222609|364313372|FG003|Overall Study|Lost to Follow-up|0|||
105630670|NCT03222609|364313369|FG000|Overall Study|Death|16|||
105630671|NCT03222609|364313370|FG001|Overall Study|Death|13|||
105630672|NCT03222609|364313371|FG002|Overall Study|Death|9|||
105630673|NCT03222609|364313372|FG003|Overall Study|Death|6|||
105630674|NCT03222609|364313369|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
105630675|NCT03222609|364313370|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
105630676|NCT03222609|364313371|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
105630677|NCT03222609|364313372|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
105630678|NCT04158141|364313373|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
105630679|NCT04158141|364313374|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
105630680|NCT04158141|364313375|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
105630681|NCT04158141|364313373|FG000|Step 1: Registration|Adverse Event|1|||
105630682|NCT04158141|364313374|FG001|Step 1: Registration|Adverse Event|0|||
105630683|NCT04158141|364313375|FG002|Step 1: Registration|Adverse Event|0|||
105630684|NCT04158141|364313373|FG000|Step 1: Registration|Withdrawal by Subject|1|||
105630685|NCT04158141|364313374|FG001|Step 1: Registration|Withdrawal by Subject|0|||
105630686|NCT04158141|364313375|FG002|Step 1: Registration|Withdrawal by Subject|0|||
105630687|NCT04158141|364313373|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
105630688|NCT04158141|364313374|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
105630689|NCT04158141|364313375|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
105630690|NCT01084863|364313376|FG000|Main Study Treatment Period|Disease progression|11|||
105630691|NCT01084863|364313377|FG001|Main Study Treatment Period|Disease progression|7|||
105630692|NCT01084863|364313376|FG000|Main Study Treatment Period|Adverse Event|5|||
105630693|NCT01084863|364313377|FG001|Main Study Treatment Period|Adverse Event|3|||
105630694|NCT01084863|364313376|FG000|Main Study Treatment Period|Other Reason|0|||
105630695|NCT01084863|364313377|FG001|Main Study Treatment Period|Other Reason|1|||
105630696|NCT01084863|364313376|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
105630697|NCT01084863|364313377|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
105630698|NCT01084863|364313376|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
105630699|NCT01084863|364313377|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
105630700|NCT01084863|364313376|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
105630701|NCT01084863|364313377|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
105630702|NCT01084863|364313376|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
105630703|NCT01084863|364313377|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
105630704|NCT01084863|364313376|FG000|Treatment Period Beyond Cycle 8|Other|0|||
105630705|NCT01084863|364313377|FG001|Treatment Period Beyond Cycle 8|Other|1|||
105630706|NCT01084863|364313376|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
105630707|NCT01084863|364313377|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
105630708|NCT00319696|364313378|FG000|Overall Study|Adverse Event|36|||
105630709|NCT00319696|364313378|FG000|Overall Study|withdrawal of consent|14|||
105630710|NCT00319696|364313378|FG000|Overall Study|administrative|7|||
105630711|NCT00319696|364313378|FG000|Overall Study|Lost to Follow-up|3|||
105630712|NCT03275285|364313383|FG000|Overall Study|Ongoing|45|||
105630713|NCT03275285|364313384|FG001|Overall Study|Ongoing|69|||
105630714|NCT06191679|364313385|FG000|Baseline|Lost to Follow-up|1|||
105630715|NCT06191679|364313386|FG001|Baseline|Lost to Follow-up|0|||
105630716|NCT06191679|364313387|FG002|Baseline|Lost to Follow-up|1|||
105630717|NCT06191679|364313388|FG003|Baseline|Lost to Follow-up|0|||
105630718|NCT06191679|364313385|FG000|Allocation to Group|Withdrawal by Subject|0|||
105630719|NCT06191679|364313386|FG001|Allocation to Group|Withdrawal by Subject|1|||
105630720|NCT06191679|364313387|FG002|Allocation to Group|Withdrawal by Subject|2|||
105630721|NCT06191679|364313388|FG003|Allocation to Group|Withdrawal by Subject|0|||
105630722|NCT06191679|364313385|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
105630723|NCT06191679|364313386|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
105630724|NCT06191679|364313387|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
105630725|NCT06191679|364313388|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
105630726|NCT06191679|364313385|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
105630727|NCT06191679|364313386|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
105630728|NCT06191679|364313387|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
105630729|NCT06191679|364313388|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
105630730|NCT06191679|364313385|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
105630731|NCT06191679|364313386|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
105630732|NCT06191679|364313387|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
105630733|NCT06191679|364313388|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
105630734|NCT03997474|364313392|FG000|Overall Study|Death|6|||
105630735|NCT03997474|364313393|FG001|Overall Study|Death|2|||
105630736|NCT03997474|364313394|FG002|Overall Study|Death|1|||
105630737|NCT03997474|364313392|FG000|Overall Study|Physician Decision|2|||
105630738|NCT03997474|364313393|FG001|Overall Study|Physician Decision|0|||
105630739|NCT03997474|364313394|FG002|Overall Study|Physician Decision|0|||
105630740|NCT03997474|364313392|FG000|Overall Study|study terminated by sponsor|1|||
105630741|NCT03997474|364313393|FG001|Overall Study|study terminated by sponsor|0|||
105630742|NCT03997474|364313394|FG002|Overall Study|study terminated by sponsor|1|||
105630743|NCT04980300|364313395|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
105630744|NCT04980300|364313396|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
105630745|NCT04980300|364313395|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
105630746|NCT04980300|364313396|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
105630747|NCT04980300|364313395|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
105630748|NCT04980300|364313396|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
105630749|NCT04980300|364313395|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
105630750|NCT04980300|364313396|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
105630751|NCT05529992|364313398|FG000|Overall Study|Withdrawal by Subject|1|||
105630752|NCT05039021|364314229|FG000|Overall Study|Death|1|||
105630753|NCT05039021|364314229|FG000|Overall Study|Lost to Follow-up|3|||
105630754|NCT04518943|364314230|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
105630755|NCT04518943|364314231|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
105630756|NCT04518943|364314232|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
105630757|NCT04518943|364314233|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
105630758|NCT04518943|364314234|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
105630759|NCT04518943|364314235|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
105630760|NCT04518943|364314236|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
105630761|NCT04518943|364314237|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
105630762|NCT04518943|364314238|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
105630763|NCT04518943|364314239|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
105630764|NCT04518943|364314240|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
105630765|NCT04518943|364314241|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
105630766|NCT04518943|364314242|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
105630767|NCT04518943|364314243|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
105630768|NCT04518943|364314244|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
105630769|NCT04518943|364314245|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
105630770|NCT05412004|364314246|FG000|Overall Study|Adverse Event|0|||
105630771|NCT05412004|364314247|FG001|Overall Study|Adverse Event|2|||
105630772|NCT05412004|364314248|FG002|Overall Study|Adverse Event|1|||
105630773|NCT05412004|364314249|FG003|Overall Study|Adverse Event|5|||
105630774|NCT05412004|364314246|FG000|Overall Study|Assigned Treatment by Mistake|5|||
105630775|NCT05412004|364314247|FG001|Overall Study|Assigned Treatment by Mistake|10|||
105630776|NCT05412004|364314248|FG002|Overall Study|Assigned Treatment by Mistake|2|||
105630777|NCT05412004|364314249|FG003|Overall Study|Assigned Treatment by Mistake|5|||
105630778|NCT05412004|364314246|FG000|Overall Study|Lost to Follow-up|3|||
105630779|NCT05412004|364314247|FG001|Overall Study|Lost to Follow-up|0|||
105630780|NCT05412004|364314248|FG002|Overall Study|Lost to Follow-up|0|||
105630781|NCT05412004|364314249|FG003|Overall Study|Lost to Follow-up|0|||
105630782|NCT05412004|364314246|FG000|Overall Study|Patient could not travel to site|0|||
105630783|NCT05412004|364314247|FG001|Overall Study|Patient could not travel to site|1|||
105630784|NCT05412004|364314248|FG002|Overall Study|Patient could not travel to site|0|||
105630785|NCT05412004|364314249|FG003|Overall Study|Patient could not travel to site|0|||
105630786|NCT05412004|364314246|FG000|Overall Study|Physician Decision|0|||
105630787|NCT05412004|364314247|FG001|Overall Study|Physician Decision|1|||
105630788|NCT05412004|364314248|FG002|Overall Study|Physician Decision|0|||
105630789|NCT05412004|364314249|FG003|Overall Study|Physician Decision|0|||
105630790|NCT05412004|364314246|FG000|Overall Study|Pregnancy|0|||
105630791|NCT05412004|364314247|FG001|Overall Study|Pregnancy|1|||
105630792|NCT05412004|364314248|FG002|Overall Study|Pregnancy|0|||
105630793|NCT05412004|364314249|FG003|Overall Study|Pregnancy|0|||
105630794|NCT05412004|364314246|FG000|Overall Study|Protocol Violation|1|||
105630795|NCT05412004|364314247|FG001|Overall Study|Protocol Violation|0|||
105630796|NCT05412004|364314248|FG002|Overall Study|Protocol Violation|0|||
105630797|NCT05412004|364314249|FG003|Overall Study|Protocol Violation|0|||
105630798|NCT05412004|364314246|FG000|Overall Study|Withdrawal by Subject|4|||
105630799|NCT05412004|364314247|FG001|Overall Study|Withdrawal by Subject|19|||
105630800|NCT05412004|364314248|FG002|Overall Study|Withdrawal by Subject|4|||
105630801|NCT05412004|364314249|FG003|Overall Study|Withdrawal by Subject|14|||
105630802|NCT05412004|364314246|FG000|Overall Study|Screen Failure|0|||
105630803|NCT05412004|364314247|FG001|Overall Study|Screen Failure|0|||
105630804|NCT05412004|364314248|FG002|Overall Study|Screen Failure|0|||
105630805|NCT05412004|364314249|FG003|Overall Study|Screen Failure|1|||
105630806|NCT05412004|364314246|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
105630807|NCT05412004|364314247|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
105630808|NCT05412004|364314248|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
105630809|NCT05412004|364314249|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
105630810|NCT00968149|364314250|FG000|Overall Study|Adverse Event|5|||
105630811|NCT00968149|364314251|FG001|Overall Study|Adverse Event|1|||
105630812|NCT00968149|364314250|FG000|Overall Study|Lack of Efficacy|0|||
105630813|NCT00968149|364314251|FG001|Overall Study|Lack of Efficacy|4|||
105630814|NCT00968149|364314250|FG000|Overall Study|Lost to Follow-up|0|||
105630815|NCT00968149|364314251|FG001|Overall Study|Lost to Follow-up|1|||
105630816|NCT00968149|364314250|FG000|Overall Study|Protocol Violation|4|||
105630817|NCT00968149|364314251|FG001|Overall Study|Protocol Violation|0|||
105630818|NCT00968149|364314250|FG000|Overall Study|Withdrawal by Subject|2|||
105630819|NCT00968149|364314251|FG001|Overall Study|Withdrawal by Subject|0|||
105630820|NCT03699163|364314252|FG000|Overall Study|Physician Decision|12|||
105630821|NCT03699163|364314253|FG001|Overall Study|Physician Decision|0|||
105630822|NCT03699163|364314252|FG000|Overall Study|failed QC measures|205|||
105630823|NCT03699163|364314253|FG001|Overall Study|failed QC measures|206|||
105630824|NCT01574716|364314261|FG000|Part 1|Death|3|||
105630825|NCT01574716|364314262|FG001|Part 1|Death|1|||
105630826|NCT01574716|364314263|FG002|Part 1|Death|8|||
105630827|NCT01574716|364314264|FG003|Part 1|Death|0|||
105630828|NCT01574716|364314265|FG004|Part 1|Death|0|||
105630829|NCT01574716|364314261|FG000|Part 1|Discontinuation of study by sponsor|0|||
105630830|NCT01574716|364314262|FG001|Part 1|Discontinuation of study by sponsor|0|||
105630831|NCT01574716|364314263|FG002|Part 1|Discontinuation of study by sponsor|1|||
105630832|NCT01574716|364314264|FG003|Part 1|Discontinuation of study by sponsor|0|||
105630833|NCT01574716|364314265|FG004|Part 1|Discontinuation of study by sponsor|0|||
105630834|NCT01574716|364314261|FG000|Part 1|Withdrawal by Subject|0|||
105630835|NCT01574716|364314262|FG001|Part 1|Withdrawal by Subject|2|||
105630836|NCT01574716|364314263|FG002|Part 1|Withdrawal by Subject|0|||
105630837|NCT01574716|364314264|FG003|Part 1|Withdrawal by Subject|0|||
105630838|NCT01574716|364314265|FG004|Part 1|Withdrawal by Subject|0|||
105630839|NCT01574716|364314261|FG000|Part 1|Lost to Follow-up|0|||
105630840|NCT01574716|364314262|FG001|Part 1|Lost to Follow-up|1|||
105630841|NCT01574716|364314263|FG002|Part 1|Lost to Follow-up|0|||
105630842|NCT01574716|364314264|FG003|Part 1|Lost to Follow-up|0|||
105630843|NCT01574716|364314265|FG004|Part 1|Lost to Follow-up|0|||
105630844|NCT01574716|364314261|FG000|Part 2|Progressive disease|0|||
105630845|NCT01574716|364314262|FG001|Part 2|Progressive disease|0|||
105630846|NCT01574716|364314263|FG002|Part 2|Progressive disease|0|||
105630847|NCT01574716|364314264|FG003|Part 2|Progressive disease|1|||
105630848|NCT01574716|364314265|FG004|Part 2|Progressive disease|0|||
105630849|NCT01574716|364314261|FG000|Part 2|Death|0|||
105630850|NCT01574716|364314262|FG001|Part 2|Death|0|||
105630851|NCT01574716|364314263|FG002|Part 2|Death|0|||
105630852|NCT01574716|364314264|FG003|Part 2|Death|76|||
105630853|NCT01574716|364314265|FG004|Part 2|Death|35|||
105630854|NCT01574716|364314261|FG000|Part 2|Discontinuation of study by sponsor|0|||
105630855|NCT01574716|364314262|FG001|Part 2|Discontinuation of study by sponsor|0|||
105630856|NCT01574716|364314263|FG002|Part 2|Discontinuation of study by sponsor|0|||
105630857|NCT01574716|364314264|FG003|Part 2|Discontinuation of study by sponsor|51|||
105630858|NCT01574716|364314265|FG004|Part 2|Discontinuation of study by sponsor|31|||
105630859|NCT01574716|364314261|FG000|Part 2|Withdrawal by Subject|0|||
105630860|NCT01574716|364314262|FG001|Part 2|Withdrawal by Subject|0|||
105630861|NCT01574716|364314263|FG002|Part 2|Withdrawal by Subject|0|||
105630862|NCT01574716|364314264|FG003|Part 2|Withdrawal by Subject|5|||
105630863|NCT01574716|364314265|FG004|Part 2|Withdrawal by Subject|4|||
105630864|NCT01574716|364314261|FG000|Part 2|Brain metastases|0|||
105630865|NCT01574716|364314262|FG001|Part 2|Brain metastases|0|||
105630866|NCT01574716|364314263|FG002|Part 2|Brain metastases|0|||
105630867|NCT01574716|364314264|FG003|Part 2|Brain metastases|1|||
105630868|NCT01574716|364314265|FG004|Part 2|Brain metastases|0|||
105630869|NCT01574716|364314261|FG000|Part 2|Lost to Follow-up|0|||
105630870|NCT01574716|364314262|FG001|Part 2|Lost to Follow-up|0|||
105630871|NCT01574716|364314263|FG002|Part 2|Lost to Follow-up|0|||
105630872|NCT01574716|364314264|FG003|Part 2|Lost to Follow-up|3|||
105630873|NCT01574716|364314265|FG004|Part 2|Lost to Follow-up|0|||
105630874|NCT02633215|364314266|FG000|Overall Study|Lost to Follow-up|2|||
105630875|NCT02633215|364314267|FG001|Overall Study|Lost to Follow-up|3|||
105630876|NCT03709706|364314269|FG000|Overall Study|Adverse Event|0|||
105630877|NCT03709706|364314270|FG001|Overall Study|Adverse Event|1|||
105630878|NCT03709706|364314269|FG000|Overall Study|Physician Decision|14|||
105630879|NCT03709706|364314270|FG001|Overall Study|Physician Decision|8|||
105630880|NCT03709706|364314269|FG000|Overall Study|Withdrawal by Subject|2|||
105630881|NCT03709706|364314270|FG001|Overall Study|Withdrawal by Subject|1|||
105630882|NCT03709706|364314269|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
105630883|NCT03709706|364314270|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
105630884|NCT04868617|364314271|FG000|Overall Study|Death|1|||
105630885|NCT04868617|364314272|FG001|Overall Study|Death|0|||
105630886|NCT04868617|364314271|FG000|Overall Study|Adverse Event|1|||
105630887|NCT04868617|364314272|FG001|Overall Study|Adverse Event|0|||
105630888|NCT04868617|364314271|FG000|Overall Study|Withdrawal by Subject|1|||
105630889|NCT04868617|364314272|FG001|Overall Study|Withdrawal by Subject|0|||
105630890|NCT04868617|364314271|FG000|Overall Study|Device deficiency|1|||
105630891|NCT04868617|364314272|FG001|Overall Study|Device deficiency|0|||
105630892|NCT03183050|364314273|FG000|Overall Study|Lost to Follow-up|23|||
105630893|NCT02754596|364314282|FG000|Overall Study|Withdrawal by Subject|3|||
105630894|NCT02754596|364314283|FG001|Overall Study|Withdrawal by Subject|4|||
105630895|NCT02754596|364314284|FG002|Overall Study|Withdrawal by Subject|0|||
105630896|NCT02754596|364314282|FG000|Overall Study|Physician Decision|1|||
105630897|NCT02754596|364314283|FG001|Overall Study|Physician Decision|1|||
105630898|NCT02754596|364314284|FG002|Overall Study|Physician Decision|1|||
105630899|NCT02754596|364314282|FG000|Overall Study|Lost to Follow-up|1|||
105630900|NCT02754596|364314283|FG001|Overall Study|Lost to Follow-up|1|||
105630901|NCT02754596|364314284|FG002|Overall Study|Lost to Follow-up|2|||
105630902|NCT02754596|364314282|FG000|Overall Study|Death|0|||
105630903|NCT02754596|364314283|FG001|Overall Study|Death|2|||
105630904|NCT02754596|364314284|FG002|Overall Study|Death|0|||
105630905|NCT02754596|364314282|FG000|Overall Study|Adverse Event|1|||
105630906|NCT02754596|364314283|FG001|Overall Study|Adverse Event|0|||
105630907|NCT02754596|364314284|FG002|Overall Study|Adverse Event|1|||
105630908|NCT02754596|364314282|FG000|Overall Study|Other|1|||
105630909|NCT02754596|364314283|FG001|Overall Study|Other|0|||
105630910|NCT02754596|364314284|FG002|Overall Study|Other|0|||
105630911|NCT02107261|364314285|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
105630912|NCT02107261|364314286|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
105630913|NCT02107261|364314285|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
105630914|NCT02107261|364314286|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
105630915|NCT05018143|364314288|FG000|Overall Study|Lost to Follow-up|5|||
105630916|NCT05018143|364314289|FG001|Overall Study|Lost to Follow-up|4|||
105630917|NCT05018143|364314288|FG000|Overall Study|Withdrawal by Subject|0|||
105630918|NCT05018143|364314289|FG001|Overall Study|Withdrawal by Subject|1|||
105630925|NCT05155306|364314291|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
105630926|NCT05155306|364314292|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
105630927|NCT05155306|364314293|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
105630928|NCT05155306|364314294|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
105630929|NCT05155306|364314291|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
105630930|NCT05155306|364314292|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
105630931|NCT05155306|364314293|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
105630932|NCT05155306|364314294|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
105630933|NCT03477175|364314297|FG000|Overall Study|Unable to travel due to COVID-19|0|||
105630934|NCT03477175|364314298|FG001|Overall Study|Unable to travel due to COVID-19|1|||
105630935|NCT03477175|364314297|FG000|Overall Study|Physician Decision|1|||
105630936|NCT03477175|364314298|FG001|Overall Study|Physician Decision|0|||
105630937|NCT03477175|364314297|FG000|Overall Study|Transitioned to commercial drug|6|||
105630938|NCT03477175|364314298|FG001|Overall Study|Transitioned to commercial drug|6|||
105630939|NCT03477175|364314297|FG000|Overall Study|Lost to Follow-up|1|||
105630940|NCT03477175|364314298|FG001|Overall Study|Lost to Follow-up|1|||
105630941|NCT03477175|364314297|FG000|Overall Study|Withdrawal by Subject|3|||
105630942|NCT03477175|364314298|FG001|Overall Study|Withdrawal by Subject|1|||
105630943|NCT03477175|364314297|FG000|Overall Study|Adverse Event|1|||
105630944|NCT03477175|364314298|FG001|Overall Study|Adverse Event|5|||
105630945|NCT03477175|364314297|FG000|Overall Study|Disease Progression|7|||
105630946|NCT03477175|364314298|FG001|Overall Study|Disease Progression|7|||
105630947|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
105630948|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
105630949|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
105630950|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
105630951|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
105630952|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
105630953|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
105630954|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
105630955|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
105630956|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
105630957|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
105630958|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
105630959|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
105630960|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
105630961|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
105630962|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
105630963|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
105630964|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
105630965|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
105630966|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
105630967|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
105630968|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
105630969|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
105630970|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
105630971|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
105630972|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
105630973|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
105630974|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
105630975|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
105630976|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
105630977|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
105630978|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
105630979|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
105630980|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
105630981|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
105630982|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
105630983|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
105630984|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
105630985|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
105630986|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
105630987|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
105630988|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
105630989|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
105630990|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
105630991|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
105630992|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
105630993|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
105630994|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
105630995|NCT03524092|364314299|FG000|Loss of Response Rescue Period|Adverse Event|0|||
105630996|NCT03524092|364314300|FG001|Loss of Response Rescue Period|Adverse Event|0|||
105630997|NCT03524092|364314301|FG002|Loss of Response Rescue Period|Adverse Event|0|||
105630998|NCT03524092|364314302|FG003|Loss of Response Rescue Period|Adverse Event|2|||
105630999|NCT03524092|364314303|FG004|Loss of Response Rescue Period|Adverse Event|0|||
105631000|NCT03524092|364314304|FG005|Loss of Response Rescue Period|Adverse Event|0|||
105631001|NCT03524092|364314299|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
105631002|NCT03524092|364314300|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
105631003|NCT03524092|364314301|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
105631004|NCT03524092|364314302|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
105631005|NCT03524092|364314303|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
105631006|NCT03524092|364314304|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
105631007|NCT03524092|364314299|FG000|Loss of Response Rescue Period|Pregnancy|0|||
105631008|NCT03524092|364314300|FG001|Loss of Response Rescue Period|Pregnancy|0|||
105631009|NCT03524092|364314301|FG002|Loss of Response Rescue Period|Pregnancy|0|||
105631010|NCT03524092|364314302|FG003|Loss of Response Rescue Period|Pregnancy|1|||
105631011|NCT03524092|364314303|FG004|Loss of Response Rescue Period|Pregnancy|0|||
105631012|NCT03524092|364314304|FG005|Loss of Response Rescue Period|Pregnancy|0|||
105631013|NCT03524092|364314299|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
105631014|NCT03524092|364314300|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
105631015|NCT03524092|364314301|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
105631016|NCT03524092|364314302|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
105631017|NCT03524092|364314303|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
105631018|NCT03524092|364314304|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
105631019|NCT03524092|364314299|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
105631020|NCT03524092|364314300|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
105631021|NCT03524092|364314301|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
105631022|NCT03524092|364314302|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
105631023|NCT03524092|364314303|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
105631024|NCT03524092|364314304|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
105631025|NCT03524092|364314299|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
105631026|NCT03524092|364314300|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
105631027|NCT03524092|364314301|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
105631028|NCT03524092|364314302|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
105631029|NCT03524092|364314303|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
105631030|NCT03524092|364314304|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
105631031|NCT03524092|364314299|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
105631032|NCT03524092|364314300|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
105631033|NCT03524092|364314301|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
105631034|NCT03524092|364314302|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
105631035|NCT03524092|364314303|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
105631036|NCT03524092|364314304|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
105631037|NCT03524092|364314299|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
105631038|NCT03524092|364314300|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
105631039|NCT03524092|364314301|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
105631040|NCT03524092|364314302|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
105631041|NCT03524092|364314303|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
105631042|NCT03524092|364314304|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
105631043|NCT03524092|364314299|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
105631044|NCT03524092|364314300|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
105631045|NCT03524092|364314301|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
105631046|NCT03524092|364314302|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
105631047|NCT03524092|364314303|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
105631048|NCT03524092|364314304|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
105631049|NCT03524092|364314299|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
105631050|NCT03524092|364314300|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
105631051|NCT03524092|364314301|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
105631052|NCT03524092|364314302|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
105631053|NCT03524092|364314303|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
105631054|NCT03524092|364314304|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
105631055|NCT03524092|364314299|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
105631056|NCT03524092|364314300|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
105631057|NCT03524092|364314301|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
105631058|NCT03524092|364314302|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
105631059|NCT03524092|364314303|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
105631060|NCT03524092|364314304|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
105631061|NCT03524092|364314299|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
105631062|NCT03524092|364314300|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
105631063|NCT03524092|364314301|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
105631064|NCT03524092|364314302|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
105631065|NCT03524092|364314303|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
105631066|NCT03524092|364314304|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
105631067|NCT03524092|364314299|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
105631068|NCT03524092|364314300|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
105631069|NCT03524092|364314301|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
105631070|NCT03524092|364314302|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
105631071|NCT03524092|364314303|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
105631072|NCT03524092|364314304|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
105631073|NCT03524092|364314299|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
105631074|NCT03524092|364314300|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
105631075|NCT03524092|364314301|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
105631076|NCT03524092|364314302|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
105631077|NCT03524092|364314303|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
105631078|NCT03524092|364314304|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
105631079|NCT03524092|364314299|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
105631080|NCT03524092|364314300|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
105631081|NCT03524092|364314301|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
105631082|NCT03524092|364314302|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
105631083|NCT03524092|364314303|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
105631084|NCT03524092|364314304|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
105631085|NCT05139992|364314305|FG000|Overall Study|Withdrawal by Subject|12|||
105631086|NCT05139992|364314305|FG000|Overall Study|Lost to Follow-up|6|||
105631087|NCT01208974|364314306|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
105631088|NCT01208974|364314307|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
105631089|NCT01208974|364314308|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
105631090|NCT01208974|364314309|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
105631091|NCT01208974|364314306|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
105631092|NCT01208974|364314307|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
105631093|NCT01208974|364314308|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
105631094|NCT01208974|364314309|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
105631095|NCT01208974|364314306|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
105631096|NCT01208974|364314307|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
105631097|NCT01208974|364314308|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
105631098|NCT01208974|364314309|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
105631099|NCT05521516|364314310|FG000|Overall Study|Withdrawal by Subject|1|||
105631100|NCT05521516|364314311|FG001|Overall Study|Withdrawal by Subject|1|||
105631101|NCT03593226|364314312|FG000|Overall Study|Disease progression|6|||
105631102|NCT03593226|364314313|FG001|Overall Study|Disease progression|13|||
105631103|NCT03593226|364314314|FG002|Overall Study|Disease progression|5|||
105631104|NCT03593226|364314315|FG003|Overall Study|Disease progression|6|||
105631105|NCT03593226|364314312|FG000|Overall Study|Adverse Event|0|||
105631106|NCT03593226|364314313|FG001|Overall Study|Adverse Event|1|||
105631107|NCT03593226|364314314|FG002|Overall Study|Adverse Event|0|||
105631108|NCT03593226|364314315|FG003|Overall Study|Adverse Event|0|||
105631109|NCT03593226|364314312|FG000|Overall Study|Withdrawal by Subject|0|||
105631110|NCT03593226|364314313|FG001|Overall Study|Withdrawal by Subject|4|||
105631111|NCT03593226|364314314|FG002|Overall Study|Withdrawal by Subject|1|||
105631112|NCT03593226|364314315|FG003|Overall Study|Withdrawal by Subject|0|||
105631113|NCT03593226|364314312|FG000|Overall Study|Physician Decision|0|||
105631114|NCT03593226|364314313|FG001|Overall Study|Physician Decision|1|||
105631115|NCT03593226|364314314|FG002|Overall Study|Physician Decision|0|||
105631116|NCT03593226|364314315|FG003|Overall Study|Physician Decision|0|||
105631117|NCT03593226|364314312|FG000|Overall Study|Clinical disease progression|0|||
105631118|NCT03593226|364314313|FG001|Overall Study|Clinical disease progression|0|||
105631119|NCT03593226|364314314|FG002|Overall Study|Clinical disease progression|1|||
105631120|NCT03593226|364314315|FG003|Overall Study|Clinical disease progression|0|||
105631121|NCT03656718|364314316|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
105631122|NCT03656718|364314317|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
105631123|NCT03656718|364314318|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
105631124|NCT03656718|364314319|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
105631125|NCT03656718|364314320|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
105631126|NCT03656718|364314321|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
105631127|NCT03656718|364314322|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
105631128|NCT03656718|364314316|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
105631129|NCT03656718|364314317|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
105631130|NCT03656718|364314318|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
105631131|NCT03656718|364314319|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
105631132|NCT03656718|364314320|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
105631133|NCT03656718|364314321|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
105631134|NCT03656718|364314322|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
105631135|NCT03656718|364314316|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
105631136|NCT03656718|364314317|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
105631137|NCT03656718|364314318|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
105631138|NCT03656718|364314319|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
105631139|NCT03656718|364314320|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
105631140|NCT03656718|364314321|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
105631141|NCT03656718|364314322|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
105631142|NCT03656718|364314316|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
105631143|NCT03656718|364314317|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
105631144|NCT03656718|364314318|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
105631145|NCT03656718|364314319|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
105631146|NCT03656718|364314320|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
105631147|NCT03656718|364314321|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
105631148|NCT03656718|364314322|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
105631149|NCT03656718|364314316|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
105631150|NCT03656718|364314317|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
105631151|NCT03656718|364314318|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
105631152|NCT03656718|364314319|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
105631153|NCT03656718|364314320|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
105631154|NCT03656718|364314321|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
105631155|NCT03656718|364314322|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
105631156|NCT03656718|364314316|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
105631157|NCT03656718|364314317|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
105631158|NCT03656718|364314318|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
105631159|NCT03656718|364314319|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
105631160|NCT03656718|364314320|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
105631161|NCT03656718|364314321|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
105631162|NCT03656718|364314322|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
105631163|NCT03656718|364314316|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
105631164|NCT03656718|364314317|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
105631165|NCT03656718|364314318|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
105631166|NCT03656718|364314319|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
105631167|NCT03656718|364314320|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
105631168|NCT03656718|364314321|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
105631169|NCT03656718|364314322|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
105631170|NCT03656718|364314316|FG000|Treatment Period Part C|Disease progression|0|||
105631171|NCT03656718|364314317|FG001|Treatment Period Part C|Disease progression|0|||
105631172|NCT03656718|364314318|FG002|Treatment Period Part C|Disease progression|0|||
105631173|NCT03656718|364314319|FG003|Treatment Period Part C|Disease progression|0|||
105631174|NCT03656718|364314320|FG004|Treatment Period Part C|Disease progression|12|||
105631175|NCT03656718|364314321|FG005|Treatment Period Part C|Disease progression|0|||
105631176|NCT03656718|364314322|FG006|Treatment Period Part C|Disease progression|0|||
105631177|NCT03656718|364314316|FG000|Treatment Period Part C|Death|0|||
105631178|NCT03656718|364314317|FG001|Treatment Period Part C|Death|0|||
105631179|NCT03656718|364314318|FG002|Treatment Period Part C|Death|0|||
105631180|NCT03656718|364314319|FG003|Treatment Period Part C|Death|0|||
105631181|NCT03656718|364314320|FG004|Treatment Period Part C|Death|1|||
105631182|NCT03656718|364314321|FG005|Treatment Period Part C|Death|0|||
105631183|NCT03656718|364314322|FG006|Treatment Period Part C|Death|0|||
105631184|NCT03656718|364314316|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
105631185|NCT03656718|364314317|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
105631186|NCT03656718|364314318|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
105631187|NCT03656718|364314319|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
105631188|NCT03656718|364314320|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
105631189|NCT03656718|364314321|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
105631190|NCT03656718|364314322|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
105631191|NCT03656718|364314316|FG000|Treatment Period Part C|Other reasons|0|||
105631192|NCT03656718|364314317|FG001|Treatment Period Part C|Other reasons|0|||
105631193|NCT03656718|364314318|FG002|Treatment Period Part C|Other reasons|0|||
105631194|NCT03656718|364314319|FG003|Treatment Period Part C|Other reasons|0|||
105631195|NCT03656718|364314320|FG004|Treatment Period Part C|Other reasons|1|||
105631196|NCT03656718|364314321|FG005|Treatment Period Part C|Other reasons|0|||
105631197|NCT03656718|364314322|FG006|Treatment Period Part C|Other reasons|0|||
105631198|NCT03656718|364314316|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
105631199|NCT03656718|364314317|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
105631200|NCT03656718|364314318|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
105631201|NCT03656718|364314319|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
105631202|NCT03656718|364314320|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
105631203|NCT03656718|364314321|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
105631204|NCT03656718|364314322|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
105631205|NCT03789110|364314323|FG000|Overall Study|Adverse Event|2|||
105631206|NCT03789110|364314323|FG000|Overall Study|Physician Decision|1|||
105631207|NCT03789110|364314323|FG000|Overall Study|Withdrawal by Subject|2|||
105631208|NCT03789110|364314323|FG000|Overall Study|Lack of Efficacy|22|||
105631209|NCT03789110|364314323|FG000|Overall Study|still on treatment|3|||
105631210|NCT00227266|364314324|FG000|Overall Study|Withdrawal by Subject|0|||
105631211|NCT00227266|364314325|FG001|Overall Study|Withdrawal by Subject|0|||
105631212|NCT00227266|364314326|FG002|Overall Study|Withdrawal by Subject|1|||
105631213|NCT00227266|364314324|FG000|Overall Study|Protocol Violation|1|||
105631214|NCT00227266|364314325|FG001|Overall Study|Protocol Violation|0|||
105631215|NCT00227266|364314326|FG002|Overall Study|Protocol Violation|1|||
105631216|NCT00227266|364314324|FG000|Overall Study|Excessive weight gain|0|||
105631217|NCT00227266|364314325|FG001|Overall Study|Excessive weight gain|0|||
105631218|NCT00227266|364314326|FG002|Overall Study|Excessive weight gain|2|||
105631219|NCT03959423|364314327|FG000|Overall Study|Withdrawal by Subject|2|||
105631220|NCT03959423|364314328|FG001|Overall Study|Withdrawal by Subject|3|||
105631221|NCT03959423|364314327|FG000|Overall Study|Physician Decision|0|||
105631222|NCT03959423|364314328|FG001|Overall Study|Physician Decision|1|||
105631223|NCT03959423|364314327|FG000|Overall Study|Lost to Follow-up|1|||
105631224|NCT03959423|364314328|FG001|Overall Study|Lost to Follow-up|0|||
105631225|NCT03959423|364314327|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
105631226|NCT03959423|364314328|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105631227|NCT04039113|364314329|FG000|Overall Study|Withdrawal by Subject|8|||
105631228|NCT04039113|364314330|FG001|Overall Study|Withdrawal by Subject|11|||
105631229|NCT04039113|364314329|FG000|Overall Study|Lost to Follow-up|1|||
105631230|NCT04039113|364314330|FG001|Overall Study|Lost to Follow-up|1|||
105631231|NCT04039113|364314329|FG000|Overall Study|Adverse Event|2|||
105631232|NCT04039113|364314330|FG001|Overall Study|Adverse Event|2|||
105631233|NCT04039113|364314329|FG000|Overall Study|Death|2|||
105631234|NCT04039113|364314330|FG001|Overall Study|Death|4|||
105631235|NCT04039113|364314329|FG000|Overall Study|Site Closure|6|||
105631236|NCT04039113|364314330|FG001|Overall Study|Site Closure|0|||
105631237|NCT04039113|364314329|FG000|Overall Study|Failure to meet randomisation criteria|4|||
105631238|NCT04039113|364314330|FG001|Overall Study|Failure to meet randomisation criteria|0|||
105631239|NCT00353496|364314331|FG000|Overall Study|Adverse Event|1|||
105631240|NCT00353496|364314332|FG001|Overall Study|Adverse Event|0|||
105631241|NCT00353496|364314331|FG000|Overall Study|Protocol Violation|2|||
105631242|NCT00353496|364314332|FG001|Overall Study|Protocol Violation|2|||
105631243|NCT00353496|364314331|FG000|Overall Study|Withdrawal by Subject|3|||
105631244|NCT00353496|364314332|FG001|Overall Study|Withdrawal by Subject|4|||
105631245|NCT00353496|364314331|FG000|Overall Study|Physician Decision|6|||
105631246|NCT00353496|364314332|FG001|Overall Study|Physician Decision|9|||
105631247|NCT00353496|364314331|FG000|Overall Study|Not otherwise specified|4|||
105631248|NCT00353496|364314332|FG001|Overall Study|Not otherwise specified|2|||
105631249|NCT01470144|364314333|FG000|Overall Study|Adverse Event|2|||
105631250|NCT01470144|364314333|FG000|Overall Study|Death|1|||
105631251|NCT01470144|364314333|FG000|Overall Study|Lung transplant|6|||
105631252|NCT01470144|364314333|FG000|Overall Study|Patient's and investigator's decision|1|||
105631253|NCT03776812|364315035|FG000|Overall Study|Death|27|||
105631254|NCT03776812|364315036|FG001|Overall Study|Death|19|||
105631255|NCT03776812|364315037|FG002|Overall Study|Death|29|||
105631256|NCT03776812|364315035|FG000|Overall Study|Withdrawal by Subject|1|||
105631257|NCT03776812|364315036|FG001|Overall Study|Withdrawal by Subject|7|||
105631258|NCT03776812|364315037|FG002|Overall Study|Withdrawal by Subject|1|||
105631259|NCT03776812|364315035|FG000|Overall Study|Lost to Follow-up|0|||
105631260|NCT03776812|364315036|FG001|Overall Study|Lost to Follow-up|1|||
105631261|NCT03776812|364315037|FG002|Overall Study|Lost to Follow-up|0|||
105631262|NCT03776812|364315035|FG000|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
105631263|NCT03776812|364315036|FG001|Overall Study|Still on study as of March 22, 2021 data cutoff date|33|||
105631264|NCT03776812|364315037|FG002|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
105631265|NCT01260896|364315040|FG000|First Intervention|Withdrawn Due to Emesis|2|||
105631266|NCT01260896|364315041|FG001|First Intervention|Withdrawn Due to Emesis|0|||
105631267|NCT03357952|364315050|FG000|Overall Study|Withdrawal by Subject|0|||
105631268|NCT03357952|364315051|FG001|Overall Study|Withdrawal by Subject|1|||
105631269|NCT03357952|364315050|FG000|Overall Study|Sponsor Decision|9|||
105631270|NCT03357952|364315051|FG001|Overall Study|Sponsor Decision|0|||
105631271|NCT04018495|364315052|FG000|Overall Study|Physician Decision|1|||
105631272|NCT04121741|364315053|FG000|Overall Study|Protocol Violation|1|||
105631273|NCT04121741|364315054|FG001|Overall Study|Protocol Violation|0|||
105631274|NCT04121741|364315055|FG002|Overall Study|Protocol Violation|0|||
105631275|NCT04121741|364315056|FG003|Overall Study|Protocol Violation|0|||
105631276|NCT04121741|364315057|FG004|Overall Study|Protocol Violation|0|||
105631277|NCT04121741|364315058|FG005|Overall Study|Protocol Violation|0|||
105631278|NCT04088227|364315059|FG000|Overall Study|Withdrawal by Subject|1|||
105631279|NCT04088227|364315060|FG001|Overall Study|Withdrawal by Subject|0|||
105631280|NCT04088227|364315059|FG000|Overall Study|Surgery postponed >5weeks|1|||
105631281|NCT04088227|364315060|FG001|Overall Study|Surgery postponed >5weeks|0|||
105631282|NCT04517435|364315077|FG000|Overall Study|Withdrawal by Subject|0|||
105631283|NCT04517435|364315078|FG001|Overall Study|Withdrawal by Subject|0|||
105631284|NCT04517435|364315079|FG002|Overall Study|Withdrawal by Subject|1|||
105631285|NCT04517435|364315077|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
105631286|NCT04517435|364315078|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
105631287|NCT04517435|364315079|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
105631288|NCT01038778|364315080|FG000|Overall Study|Withdrawal by Subject|0|||
105631289|NCT01038778|364315081|FG001|Overall Study|Withdrawal by Subject|2|||
105631290|NCT01038778|364315082|FG002|Overall Study|Withdrawal by Subject|3|||
105631291|NCT04926740|364315083|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
105631292|NCT04926740|364315084|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
105631293|NCT04926740|364315083|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
105631294|NCT04926740|364315084|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
105631295|NCT03211247|364315085|FG000|Overall Study|Adverse Event|8|||
105631296|NCT03211247|364315086|FG001|Overall Study|Adverse Event|0|||
105631297|NCT03211247|364315087|FG002|Overall Study|Adverse Event|1|||
105631298|NCT03211247|364315088|FG003|Overall Study|Adverse Event|0|||
105631299|NCT03211247|364315089|FG004|Overall Study|Adverse Event|0|||
105631300|NCT03211247|364315085|FG000|Overall Study|Lost to Follow-up|2|||
105631301|NCT03211247|364315086|FG001|Overall Study|Lost to Follow-up|1|||
105631302|NCT03211247|364315087|FG002|Overall Study|Lost to Follow-up|0|||
105631303|NCT03211247|364315088|FG003|Overall Study|Lost to Follow-up|0|||
105631304|NCT03211247|364315089|FG004|Overall Study|Lost to Follow-up|0|||
105631305|NCT03211247|364315085|FG000|Overall Study|Physician Decision|1|||
105631306|NCT03211247|364315086|FG001|Overall Study|Physician Decision|2|||
105631307|NCT03211247|364315087|FG002|Overall Study|Physician Decision|0|||
105631308|NCT03211247|364315088|FG003|Overall Study|Physician Decision|0|||
105631309|NCT03211247|364315089|FG004|Overall Study|Physician Decision|0|||
105631310|NCT03211247|364315085|FG000|Overall Study|Non-compliance with study drug|2|||
105631311|NCT03211247|364315086|FG001|Overall Study|Non-compliance with study drug|0|||
105631312|NCT03211247|364315087|FG002|Overall Study|Non-compliance with study drug|0|||
105631313|NCT03211247|364315088|FG003|Overall Study|Non-compliance with study drug|0|||
105631314|NCT03211247|364315089|FG004|Overall Study|Non-compliance with study drug|0|||
105631315|NCT03211247|364315085|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
105631316|NCT03211247|364315086|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
105631317|NCT03211247|364315087|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
105631318|NCT03211247|364315088|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
105631319|NCT03211247|364315089|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
105631320|NCT03211247|364315085|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
105631321|NCT03211247|364315086|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
105631322|NCT03211247|364315087|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
105631323|NCT03211247|364315088|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
105631324|NCT03211247|364315089|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
105631325|NCT03211247|364315085|FG000|Overall Study|Protocol Violation|0|||
105631326|NCT03211247|364315086|FG001|Overall Study|Protocol Violation|1|||
105631327|NCT03211247|364315087|FG002|Overall Study|Protocol Violation|0|||
105631328|NCT03211247|364315088|FG003|Overall Study|Protocol Violation|0|||
105631329|NCT03211247|364315089|FG004|Overall Study|Protocol Violation|0|||
105631330|NCT00747565|364315090|FG000|Overall Study|Withdrawal by Subject|10|||
105631331|NCT00747565|364315091|FG001|Overall Study|Withdrawal by Subject|6|||
105631332|NCT00747565|364315090|FG000|Overall Study|Lost to Follow-up|4|||
105631333|NCT00747565|364315091|FG001|Overall Study|Lost to Follow-up|1|||
105631334|NCT03777657|364315092|FG000|Overall Study|Death|397|||
105631335|NCT03777657|364315093|FG001|Overall Study|Death|431|||
105631336|NCT03777657|364315092|FG000|Overall Study|Study Closed by Sponsor|77|||
105631337|NCT03777657|364315093|FG001|Overall Study|Study Closed by Sponsor|38|||
105631338|NCT03777657|364315092|FG000|Overall Study|Withdrawal by Subject|20|||
105631339|NCT03777657|364315093|FG001|Overall Study|Withdrawal by Subject|17|||
105631340|NCT03777657|364315092|FG000|Overall Study|Lost to Follow-up|6|||
105631341|NCT03777657|364315093|FG001|Overall Study|Lost to Follow-up|10|||
105631342|NCT00545545|364315096|FG000|Overall Study|Progressive Neoplastic Disease|1|||
105631343|NCT00545545|364315097|FG001|Overall Study|Progressive Neoplastic Disease|5|||
105631344|NCT00545545|364315098|FG002|Overall Study|Progressive Neoplastic Disease|0|||
105631345|NCT00545545|364315099|FG003|Overall Study|Progressive Neoplastic Disease|4|||
105631346|NCT00545545|364315100|FG004|Overall Study|Progressive Neoplastic Disease|8|||
105631347|NCT00545545|364315101|FG005|Overall Study|Progressive Neoplastic Disease|7|||
105631348|NCT00545545|364315096|FG000|Overall Study|Withdrawal by Subject|0|||
105631349|NCT00545545|364315097|FG001|Overall Study|Withdrawal by Subject|1|||
105631350|NCT00545545|364315098|FG002|Overall Study|Withdrawal by Subject|0|||
105631351|NCT00545545|364315099|FG003|Overall Study|Withdrawal by Subject|0|||
105631352|NCT00545545|364315100|FG004|Overall Study|Withdrawal by Subject|0|||
105631353|NCT00545545|364315101|FG005|Overall Study|Withdrawal by Subject|0|||
105631354|NCT00545545|364315096|FG000|Overall Study|Physician Decision|1|||
105631355|NCT00545545|364315097|FG001|Overall Study|Physician Decision|0|||
105631356|NCT00545545|364315098|FG002|Overall Study|Physician Decision|0|||
105631357|NCT00545545|364315099|FG003|Overall Study|Physician Decision|0|||
105631358|NCT00545545|364315100|FG004|Overall Study|Physician Decision|0|||
105631359|NCT00545545|364315101|FG005|Overall Study|Physician Decision|1|||
105631360|NCT00545545|364315096|FG000|Overall Study|Irinotecan intolerance|1|||
105631361|NCT00545545|364315097|FG001|Overall Study|Irinotecan intolerance|1|||
105631362|NCT00545545|364315098|FG002|Overall Study|Irinotecan intolerance|0|||
105631363|NCT00545545|364315099|FG003|Overall Study|Irinotecan intolerance|0|||
105631364|NCT00545545|364315100|FG004|Overall Study|Irinotecan intolerance|0|||
105631365|NCT00545545|364315101|FG005|Overall Study|Irinotecan intolerance|0|||
105631366|NCT00545545|364315096|FG000|Overall Study|No target lesions to track post surgery|0|||
105631367|NCT00545545|364315097|FG001|Overall Study|No target lesions to track post surgery|0|||
105631368|NCT00545545|364315098|FG002|Overall Study|No target lesions to track post surgery|0|||
105631369|NCT00545545|364315099|FG003|Overall Study|No target lesions to track post surgery|0|||
105631370|NCT00545545|364315100|FG004|Overall Study|No target lesions to track post surgery|1|||
105631371|NCT00545545|364315101|FG005|Overall Study|No target lesions to track post surgery|1|||
105631372|NCT02500576|364315102|FG000|Overall Study|Adverse Event|0|||
105631373|NCT02500576|364315103|FG001|Overall Study|Adverse Event|1|||
105631374|NCT02500576|364315102|FG000|Overall Study|Death|2|||
105631375|NCT02500576|364315103|FG001|Overall Study|Death|1|||
105631376|NCT02500576|364315102|FG000|Overall Study|Lack of Efficacy|5|||
105631377|NCT02500576|364315103|FG001|Overall Study|Lack of Efficacy|5|||
105631378|NCT02500576|364315102|FG000|Overall Study|Withdrawal by Subject|1|||
105631379|NCT02500576|364315103|FG001|Overall Study|Withdrawal by Subject|1|||
105631380|NCT03691493|364315106|FG000|Overall Study|Withdrawal by Subject|1|||
105631381|NCT05827068|364315107|FG000|Overall Study|Lost to Follow-up|1|||
105631382|NCT05827068|364315108|FG001|Overall Study|Lost to Follow-up|4|||
105631383|NCT05827068|364315109|FG002|Overall Study|Lost to Follow-up|1|||
105631384|NCT05827068|364315110|FG003|Overall Study|Lost to Follow-up|1|||
105631385|NCT05827068|364315111|FG004|Overall Study|Lost to Follow-up|2|||
105631386|NCT05827068|364315112|FG005|Overall Study|Lost to Follow-up|4|||
105631387|NCT05827068|364315113|FG006|Overall Study|Lost to Follow-up|1|||
105631388|NCT05827068|364315107|FG000|Overall Study|Withdrawal by Subject|4|||
105631389|NCT05827068|364315108|FG001|Overall Study|Withdrawal by Subject|0|||
105631390|NCT05827068|364315109|FG002|Overall Study|Withdrawal by Subject|1|||
105631391|NCT05827068|364315110|FG003|Overall Study|Withdrawal by Subject|2|||
105631392|NCT05827068|364315111|FG004|Overall Study|Withdrawal by Subject|3|||
105631393|NCT05827068|364315112|FG005|Overall Study|Withdrawal by Subject|0|||
105631394|NCT05827068|364315113|FG006|Overall Study|Withdrawal by Subject|1|||
105631395|NCT05827068|364315107|FG000|Overall Study|Physician Decision|0|||
105631396|NCT05827068|364315108|FG001|Overall Study|Physician Decision|0|||
105631397|NCT05827068|364315109|FG002|Overall Study|Physician Decision|0|||
105631398|NCT05827068|364315110|FG003|Overall Study|Physician Decision|0|||
105631399|NCT05827068|364315111|FG004|Overall Study|Physician Decision|1|||
105631400|NCT05827068|364315112|FG005|Overall Study|Physician Decision|0|||
105631401|NCT05827068|364315113|FG006|Overall Study|Physician Decision|1|||
105631402|NCT05827068|364315107|FG000|Overall Study|Other Than Specified|0|||
105631403|NCT05827068|364315108|FG001|Overall Study|Other Than Specified|1|||
105631404|NCT05827068|364315109|FG002|Overall Study|Other Than Specified|0|||
105631405|NCT05827068|364315110|FG003|Overall Study|Other Than Specified|0|||
105631406|NCT05827068|364315111|FG004|Overall Study|Other Than Specified|0|||
105631407|NCT05827068|364315112|FG005|Overall Study|Other Than Specified|0|||
105631408|NCT05827068|364315113|FG006|Overall Study|Other Than Specified|0|||
105631409|NCT04300023|364315123|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
105631410|NCT04300023|364315124|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
105631411|NCT01855750|364315125|FG000|Overall Study|Death|78|||
105631412|NCT01855750|364315126|FG001|Overall Study|Death|78|||
105631413|NCT01855750|364315125|FG000|Overall Study|Lost to Follow-up|9|||
105631414|NCT01855750|364315126|FG001|Overall Study|Lost to Follow-up|23|||
105631415|NCT01855750|364315125|FG000|Overall Study|Withdrawal by Subject|35|||
105631416|NCT01855750|364315126|FG001|Overall Study|Withdrawal by Subject|28|||
105631417|NCT01855750|364315125|FG000|Overall Study|Sponsor ends the study|297|||
105631418|NCT01855750|364315126|FG001|Overall Study|Sponsor ends the study|290|||
105631419|NCT04977583|364316169|FG000|Overall Study|Lost to Follow-up|8|||
105631420|NCT04977583|364316170|FG001|Overall Study|Lost to Follow-up|4|||
105631421|NCT04977583|364316171|FG002|Overall Study|Lost to Follow-up|13|||
105631422|NCT04977583|364316169|FG000|Overall Study|Withdrawal by Subject|3|||
105631423|NCT04977583|364316170|FG001|Overall Study|Withdrawal by Subject|2|||
105631424|NCT04977583|364316171|FG002|Overall Study|Withdrawal by Subject|1|||
105631425|NCT02422615|364316174|FG000|Treatment Period|Progressive disease|314|||
105631426|NCT02422615|364316175|FG001|Treatment Period|Progressive disease|200|||
105631427|NCT02422615|364316174|FG000|Treatment Period|Adverse Event|51|||
105631428|NCT02422615|364316175|FG001|Treatment Period|Adverse Event|9|||
105631429|NCT02422615|364316174|FG000|Treatment Period|Physician Decision|32|||
105631430|NCT02422615|364316175|FG001|Treatment Period|Physician Decision|8|||
105631431|NCT02422615|364316174|FG000|Treatment Period|Subject/guardian decision|38|||
105631432|NCT02422615|364316175|FG001|Treatment Period|Subject/guardian decision|8|||
105631433|NCT02422615|364316174|FG000|Treatment Period|Death|2|||
105631434|NCT02422615|364316175|FG001|Treatment Period|Death|1|||
105631435|NCT02422615|364316174|FG000|Treatment Period|Technical problems|0|||
105631436|NCT02422615|364316175|FG001|Treatment Period|Technical problems|1|||
105631437|NCT02422615|364316174|FG000|Treatment Period|Protocol deviation|1|||
105631438|NCT02422615|364316175|FG001|Treatment Period|Protocol deviation|1|||
105631439|NCT02422615|364316174|FG000|Treatment Period|Study terminated as per protocol|46|||
105631440|NCT02422615|364316175|FG001|Treatment Period|Study terminated as per protocol|14|||
105631441|NCT02422615|364316174|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
105631442|NCT02422615|364316175|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
105631443|NCT02422615|364316174|FG000|Post-treatment Efficacy Follow-up|Death|2|||
105631444|NCT02422615|364316175|FG001|Post-treatment Efficacy Follow-up|Death|1|||
105631445|NCT02422615|364316174|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
105631446|NCT02422615|364316175|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
105631447|NCT02422615|364316174|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
105631448|NCT02422615|364316175|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
105631449|NCT02422615|364316174|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
105631450|NCT02422615|364316175|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
105631451|NCT02422615|364316174|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
105631452|NCT02422615|364316175|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
105631453|NCT00557492|364316176|FG000|Overall Study|Change in health insurance|1|||
105631454|NCT00945321|364316177|FG000|Period 1|Adverse Event|0|||
105631455|NCT00945321|364316178|FG001|Period 1|Adverse Event|0|||
105631456|NCT00945321|364316179|FG002|Period 1|Adverse Event|0|||
105631457|NCT00945321|364316180|FG003|Period 1|Adverse Event|0|||
105631458|NCT00945321|364316181|FG004|Period 1|Adverse Event|1|||
105631459|NCT00945321|364316182|FG005|Period 1|Adverse Event|0|||
105631460|NCT00945321|364316177|FG000|Period 4|Lost to Follow-up|0|||
105631461|NCT00945321|364316178|FG001|Period 4|Lost to Follow-up|0|||
105631462|NCT00945321|364316179|FG002|Period 4|Lost to Follow-up|0|||
105631463|NCT00945321|364316180|FG003|Period 4|Lost to Follow-up|0|||
105631464|NCT00945321|364316181|FG004|Period 4|Lost to Follow-up|0|||
105631465|NCT00945321|364316182|FG005|Period 4|Lost to Follow-up|1|||
105631466|NCT01105975|364316183|FG000|Overall Study|Adverse Event|2|||
105631467|NCT01105975|364316184|FG001|Overall Study|Adverse Event|1|||
105631468|NCT01105975|364316185|FG002|Overall Study|Adverse Event|5|||
105631469|NCT01105975|364316186|FG003|Overall Study|Adverse Event|1|||
105631470|NCT01105975|364316187|FG004|Overall Study|Adverse Event|0|||
105631471|NCT01105975|364316188|FG005|Overall Study|Adverse Event|1|||
105631472|NCT01105975|364316189|FG006|Overall Study|Adverse Event|2|||
105631473|NCT01105975|364316190|FG007|Overall Study|Adverse Event|4|||
105631474|NCT01105975|364316191|FG008|Overall Study|Adverse Event|1|||
105631475|NCT01105975|364316192|FG009|Overall Study|Adverse Event|4|||
105631476|NCT01105975|364316183|FG000|Overall Study|Withdrawal by Subject|2|||
105631477|NCT01105975|364316184|FG001|Overall Study|Withdrawal by Subject|2|||
105631478|NCT01105975|364316185|FG002|Overall Study|Withdrawal by Subject|2|||
105631479|NCT01105975|364316186|FG003|Overall Study|Withdrawal by Subject|0|||
105631480|NCT01105975|364316187|FG004|Overall Study|Withdrawal by Subject|4|||
105631481|NCT01105975|364316188|FG005|Overall Study|Withdrawal by Subject|1|||
105631482|NCT01105975|364316189|FG006|Overall Study|Withdrawal by Subject|2|||
105631483|NCT01105975|364316190|FG007|Overall Study|Withdrawal by Subject|1|||
105631484|NCT01105975|364316191|FG008|Overall Study|Withdrawal by Subject|0|||
105631485|NCT01105975|364316192|FG009|Overall Study|Withdrawal by Subject|3|||
105631486|NCT01105975|364316183|FG000|Overall Study|Lost to Follow-up|1|||
105631487|NCT01105975|364316184|FG001|Overall Study|Lost to Follow-up|0|||
105631488|NCT01105975|364316185|FG002|Overall Study|Lost to Follow-up|0|||
105631489|NCT01105975|364316186|FG003|Overall Study|Lost to Follow-up|1|||
105631490|NCT01105975|364316187|FG004|Overall Study|Lost to Follow-up|1|||
105631491|NCT01105975|364316188|FG005|Overall Study|Lost to Follow-up|0|||
105631492|NCT01105975|364316189|FG006|Overall Study|Lost to Follow-up|0|||
105631493|NCT01105975|364316190|FG007|Overall Study|Lost to Follow-up|0|||
105631494|NCT01105975|364316191|FG008|Overall Study|Lost to Follow-up|1|||
105631495|NCT01105975|364316192|FG009|Overall Study|Lost to Follow-up|0|||
105631496|NCT01105975|364316183|FG000|Overall Study|Physician Decision|0|||
105631497|NCT01105975|364316184|FG001|Overall Study|Physician Decision|0|||
105631498|NCT01105975|364316185|FG002|Overall Study|Physician Decision|0|||
105631499|NCT01105975|364316186|FG003|Overall Study|Physician Decision|0|||
105631500|NCT01105975|364316187|FG004|Overall Study|Physician Decision|0|||
105631501|NCT01105975|364316188|FG005|Overall Study|Physician Decision|0|||
105631502|NCT01105975|364316189|FG006|Overall Study|Physician Decision|2|||
105631503|NCT01105975|364316190|FG007|Overall Study|Physician Decision|0|||
105631504|NCT01105975|364316191|FG008|Overall Study|Physician Decision|0|||
105631505|NCT01105975|364316192|FG009|Overall Study|Physician Decision|0|||
105631506|NCT01105975|364316183|FG000|Overall Study|Protocol Violation|0|||
105631507|NCT01105975|364316184|FG001|Overall Study|Protocol Violation|2|||
105631508|NCT01105975|364316185|FG002|Overall Study|Protocol Violation|2|||
105631509|NCT01105975|364316186|FG003|Overall Study|Protocol Violation|0|||
105631510|NCT01105975|364316187|FG004|Overall Study|Protocol Violation|1|||
105631511|NCT01105975|364316188|FG005|Overall Study|Protocol Violation|1|||
105631512|NCT01105975|364316189|FG006|Overall Study|Protocol Violation|1|||
105631513|NCT01105975|364316190|FG007|Overall Study|Protocol Violation|1|||
105631514|NCT01105975|364316191|FG008|Overall Study|Protocol Violation|2|||
105631515|NCT01105975|364316192|FG009|Overall Study|Protocol Violation|2|||
105631516|NCT01105975|364316183|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
105631517|NCT01105975|364316184|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
105631518|NCT01105975|364316185|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
105631519|NCT01105975|364316186|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
105631520|NCT01105975|364316187|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
105631521|NCT01105975|364316188|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
105631522|NCT01105975|364316189|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
105631523|NCT01105975|364316190|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
105631524|NCT01105975|364316191|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
105631525|NCT01105975|364316192|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
105631526|NCT03653364|364316193|FG000|Overall Study|Withdrawal by Subject|1|||
105631527|NCT03653364|364316193|FG000|Overall Study|Enrolled in Error|1|||
105631528|NCT03653364|364316193|FG000|Overall Study|Death|1|||
105631529|NCT01566890|364316202|FG000|Overall Study|Adverse Event|1|||
105631530|NCT01566890|364316203|FG001|Overall Study|Adverse Event|0|||
105631531|NCT01566890|364316204|FG002|Overall Study|Adverse Event|0|||
105631532|NCT01566890|364316205|FG003|Overall Study|Adverse Event|0|||
105631533|NCT01566890|364316206|FG004|Overall Study|Adverse Event|0|||
105631534|NCT01566890|364316202|FG000|Overall Study|Withdrawal by Subject|3|||
105631535|NCT01566890|364316203|FG001|Overall Study|Withdrawal by Subject|1|||
105631536|NCT01566890|364316204|FG002|Overall Study|Withdrawal by Subject|1|||
105631537|NCT01566890|364316205|FG003|Overall Study|Withdrawal by Subject|1|||
105631538|NCT01566890|364316206|FG004|Overall Study|Withdrawal by Subject|0|||
105631539|NCT01566890|364316202|FG000|Overall Study|Screen failure|6|||
105631540|NCT01566890|364316203|FG001|Overall Study|Screen failure|0|||
105631541|NCT01566890|364316204|FG002|Overall Study|Screen failure|1|||
105631542|NCT01566890|364316205|FG003|Overall Study|Screen failure|1|||
105631543|NCT01566890|364316206|FG004|Overall Study|Screen failure|0|||
105631544|NCT01566890|364316202|FG000|Overall Study|Incomplete CEU data|1|||
105631545|NCT01566890|364316203|FG001|Overall Study|Incomplete CEU data|3|||
105631546|NCT01566890|364316204|FG002|Overall Study|Incomplete CEU data|5|||
105631547|NCT01566890|364316205|FG003|Overall Study|Incomplete CEU data|8|||
105631548|NCT01566890|364316206|FG004|Overall Study|Incomplete CEU data|0|||
105631549|NCT01566890|364316202|FG000|Overall Study|Lost to Follow-up|0|||
105631550|NCT01566890|364316203|FG001|Overall Study|Lost to Follow-up|0|||
105631551|NCT01566890|364316204|FG002|Overall Study|Lost to Follow-up|4|||
105631552|NCT01566890|364316205|FG003|Overall Study|Lost to Follow-up|4|||
105631553|NCT01566890|364316206|FG004|Overall Study|Lost to Follow-up|0|||
105631554|NCT01566890|364316202|FG000|Overall Study|Other|0|||
105631555|NCT01566890|364316203|FG001|Overall Study|Other|0|||
105631556|NCT01566890|364316204|FG002|Overall Study|Other|0|||
105631557|NCT01566890|364316205|FG003|Overall Study|Other|0|||
105631558|NCT01566890|364316206|FG004|Overall Study|Other|7|||
105631559|NCT02284113|364316207|FG000|Overall Study|Adverse Event|1|||
105631560|NCT02284113|364316208|FG001|Overall Study|Adverse Event|0|||
105631561|NCT02284113|364316207|FG000|Overall Study|non-compliance|0|||
105631562|NCT02284113|364316208|FG001|Overall Study|non-compliance|1|||
105631563|NCT02284113|364316207|FG000|Overall Study|Withdrawal by Subject|0|||
105631564|NCT02284113|364316208|FG001|Overall Study|Withdrawal by Subject|1|||
105631565|NCT02284113|364316207|FG000|Overall Study|not provided|0|||
105631566|NCT02284113|364316208|FG001|Overall Study|not provided|1|||
105631567|NCT02284113|364316207|FG000|Overall Study|surgery cancelled|2|||
105631568|NCT02284113|364316208|FG001|Overall Study|surgery cancelled|0|||
105631569|NCT00003222|364316215|FG000|Overall Study|Physician Decision|0|||
105631570|NCT00003222|364316216|FG001|Overall Study|Physician Decision|1|||
105631571|NCT03885232|364316219|FG000|Overall Study|Lost to Follow-up|74|||
105631572|NCT03885232|364316220|FG001|Overall Study|Lost to Follow-up|32|||
105631573|NCT03885232|364316219|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
105631574|NCT03885232|364316220|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
105631575|NCT03473223|364316221|FG000|Overall Study|Lost to Follow-up|1|||
105631576|NCT03473223|364316222|FG001|Overall Study|Lost to Follow-up|1|||
105631577|NCT03473223|364316221|FG000|Overall Study|Withdrawal by Subject|47|||
105631578|NCT03473223|364316222|FG001|Overall Study|Withdrawal by Subject|42|||
105631579|NCT03473223|364316221|FG000|Overall Study|Indirect contact|32|||
105631580|NCT03473223|364316222|FG001|Overall Study|Indirect contact|29|||
105631581|NCT03473223|364316221|FG000|Overall Study|Other (Not specified)|32|||
105631582|NCT03473223|364316222|FG001|Overall Study|Other (Not specified)|20|||
105631583|NCT04755595|364316223|FG000|Overall Study|Lost to Follow-up|1|||
105631584|NCT02078648|364316224|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
105631585|NCT02078648|364316225|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
105631586|NCT02078648|364316224|FG000|Overall Study|Adverse Event|0|||
105631587|NCT02078648|364316225|FG001|Overall Study|Adverse Event|1|||
105631588|NCT02078648|364316224|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
105631589|NCT02078648|364316225|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
105631590|NCT02078648|364316224|FG000|Overall Study|Withdrawal by Subject|3|||
105631591|NCT02078648|364316225|FG001|Overall Study|Withdrawal by Subject|1|||
105631592|NCT02078648|364316224|FG000|Overall Study|Investigator Decision|5|||
105631593|NCT02078648|364316225|FG001|Overall Study|Investigator Decision|7|||
105631594|NCT02078648|364316224|FG000|Overall Study|Death|1|||
105631595|NCT02078648|364316225|FG001|Overall Study|Death|1|||
105631596|NCT02078648|364316224|FG000|Overall Study|Undefined|0|||
105631597|NCT02078648|364316225|FG001|Overall Study|Undefined|1|||
105631598|NCT05464732|364316226|FG000|Overall Study|Lost to Follow-up|0|||
105631599|NCT05464732|364316227|FG001|Overall Study|Lost to Follow-up|1|||
105631600|NCT05464732|364316226|FG000|Overall Study|Adverse Event|1|||
105631601|NCT05464732|364316227|FG001|Overall Study|Adverse Event|0|||
105631602|NCT04882917|364316231|FG000|Overall Study|Adverse Event|0|||
105631603|NCT04882917|364316232|FG001|Overall Study|Adverse Event|1|||
105631604|NCT04882917|364316233|FG002|Overall Study|Adverse Event|2|||
105631605|NCT04882917|364316234|FG003|Overall Study|Adverse Event|2|||
105631606|NCT04882917|364316231|FG000|Overall Study|Withdrawal by Subject|1|||
105631607|NCT04882917|364316232|FG001|Overall Study|Withdrawal by Subject|0|||
105631608|NCT04882917|364316233|FG002|Overall Study|Withdrawal by Subject|2|||
105631609|NCT04882917|364316234|FG003|Overall Study|Withdrawal by Subject|1|||
105631610|NCT04882917|364316231|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
105631611|NCT04882917|364316232|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
105631612|NCT04882917|364316233|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
105631613|NCT04882917|364316234|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
105631614|NCT00319020|364316235|FG000|Overall Study|Death|2|||
105631615|NCT00319020|364316236|FG001|Overall Study|Death|2|||
105631616|NCT00319020|364316235|FG000|Overall Study|Withdrawal by Subject|4|||
105631617|NCT00319020|364316236|FG001|Overall Study|Withdrawal by Subject|1|||
105631618|NCT00319020|364316235|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
105631619|NCT00319020|364316236|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
105631620|NCT00319020|364316235|FG000|Overall Study|Administrative reason|0|||
105631621|NCT00319020|364316236|FG001|Overall Study|Administrative reason|5|||
105631622|NCT00319020|364316235|FG000|Overall Study|Disease progression|0|||
105631623|NCT00319020|364316236|FG001|Overall Study|Disease progression|2|||
105631624|NCT00319020|364316235|FG000|Overall Study|Transplant|0|||
105631625|NCT00319020|364316236|FG001|Overall Study|Transplant|1|||
105631626|NCT00319020|364316235|FG000|Overall Study|Treatment failure|0|||
105631627|NCT00319020|364316236|FG001|Overall Study|Treatment failure|1|||
105631628|NCT00319020|364316235|FG000|Overall Study|Adverse Event|0|||
105631629|NCT00319020|364316236|FG001|Overall Study|Adverse Event|1|||
105631630|NCT05786612|364316238|FG000|Overall Study|Adverse Event|1|||
105631631|NCT05786612|364316239|FG001|Overall Study|Adverse Event|2|||
105631632|NCT05786612|364316238|FG000|Overall Study|one screening failure|0|||
105631633|NCT05786612|364316239|FG001|Overall Study|one screening failure|2|||
105631634|NCT00748709|364316242|FG000|Overall Study|Progressive disease|15|||
105631635|NCT00748709|364316242|FG000|Overall Study|Drug reducing Toxity|2|||
105631636|NCT00748709|364316242|FG000|Overall Study|Other Adverse Event|1|||
105631637|NCT00748709|364316242|FG000|Overall Study|Withdrawal by Subject|1|||
105631638|NCT00748709|364316242|FG000|Overall Study|Other Reasons|1|||
105631639|NCT05485805|364316245|FG000|Overall Study|Withdrawal by Subject|1|||
105631640|NCT05485805|364316246|FG001|Overall Study|Withdrawal by Subject|2|||
105631641|NCT05485805|364316247|FG002|Overall Study|Withdrawal by Subject|2|||
105631642|NCT05485805|364316248|FG003|Overall Study|Withdrawal by Subject|0|||
105631643|NCT05485805|364316249|FG004|Overall Study|Withdrawal by Subject|2|||
105631644|NCT05485805|364316245|FG000|Overall Study|Adverse Event|0|||
105631645|NCT05485805|364316246|FG001|Overall Study|Adverse Event|1|||
105631646|NCT05485805|364316247|FG002|Overall Study|Adverse Event|0|||
105631647|NCT05485805|364316248|FG003|Overall Study|Adverse Event|0|||
105631648|NCT05485805|364316249|FG004|Overall Study|Adverse Event|0|||
105631649|NCT05485805|364316245|FG000|Overall Study|Lost to Follow-up|1|||
105631650|NCT05485805|364316246|FG001|Overall Study|Lost to Follow-up|1|||
105631651|NCT05485805|364316247|FG002|Overall Study|Lost to Follow-up|3|||
105631652|NCT05485805|364316248|FG003|Overall Study|Lost to Follow-up|1|||
105631653|NCT05485805|364316249|FG004|Overall Study|Lost to Follow-up|0|||
105631654|NCT04218357|364316250|FG000|1st Allocation|Withdrawal by Subject|1|||
105631655|NCT04218357|364316251|FG001|1st Allocation|Withdrawal by Subject|0|||
105631656|NCT06140290|364316252|FG000|Period 1|Adverse Event|1|||
105631657|NCT06140290|364316253|FG001|Period 1|Adverse Event|0|||
105631658|NCT06140290|364316252|FG000|Period 2|Assigned but not treated|0|||
105631659|NCT06140290|364316253|FG001|Period 2|Assigned but not treated|1|||
105631660|NCT06140290|364316252|FG000|Period 2|Withdrawal by Subject|0|||
105631661|NCT06140290|364316253|FG001|Period 2|Withdrawal by Subject|1|||
105631662|NCT03140670|364316923|FG000|Overall Study|Withdrawal by Subject|2|||
105631663|NCT03140670|364316923|FG000|Overall Study|Lost to Follow-up|1|||
105631664|NCT03140670|364316923|FG000|Overall Study|Physician Decision|1|||
105631665|NCT00220805|364316924|FG000|Overall Study|Adverse Event|1|||
105631666|NCT00220805|364316925|FG001|Overall Study|Adverse Event|3|||
105631667|NCT00220805|364316924|FG000|Overall Study|Withdrawal by Subject|3|||
105631668|NCT00220805|364316925|FG001|Overall Study|Withdrawal by Subject|0|||
105631669|NCT00220805|364316924|FG000|Overall Study|Lack of Efficacy|1|||
105631670|NCT00220805|364316925|FG001|Overall Study|Lack of Efficacy|0|||
105631671|NCT00220805|364316924|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
105631672|NCT00220805|364316925|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
105631673|NCT00536120|364316926|FG000|Overall Study|Lost to Follow-up|1|||
105631674|NCT00536120|364316927|FG001|Overall Study|Lost to Follow-up|0|||
105631675|NCT00536120|364316926|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
105631676|NCT00536120|364316927|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
105631677|NCT00536120|364316926|FG000|Overall Study|Non-compliance|1|||
105631678|NCT00536120|364316927|FG001|Overall Study|Non-compliance|0|||
105631679|NCT00536120|364316926|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
105631680|NCT00536120|364316927|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
105631681|NCT00536120|364316926|FG000|Overall Study|Steroid Use|0|||
105631682|NCT00536120|364316927|FG001|Overall Study|Steroid Use|2|||
105631683|NCT00536120|364316926|FG000|Overall Study|Missed Study Visit|0|||
105631684|NCT00536120|364316927|FG001|Overall Study|Missed Study Visit|1|||
105631685|NCT01982682|364316930|FG000|Overall Study|Physician Decision|1|||
105631686|NCT00146172|364316931|FG000|Overall Study|Adverse Event|0|||
105631687|NCT00146172|364316932|FG001|Overall Study|Adverse Event|0|||
105631688|NCT00146172|364316933|FG002|Overall Study|Adverse Event|1|||
105631689|NCT00146172|364316934|FG003|Overall Study|Adverse Event|1|||
105631690|NCT00146172|364316935|FG004|Overall Study|Adverse Event|0|||
105631691|NCT00146172|364316936|FG005|Overall Study|Adverse Event|2|||
105631692|NCT00146172|364316937|FG006|Overall Study|Adverse Event|3|||
105631693|NCT00146172|364316938|FG007|Overall Study|Adverse Event|10|||
105631694|NCT00146172|364316931|FG000|Overall Study|Lost to Follow-up|0|||
105631695|NCT00146172|364316932|FG001|Overall Study|Lost to Follow-up|0|||
105631696|NCT00146172|364316933|FG002|Overall Study|Lost to Follow-up|0|||
105631697|NCT00146172|364316934|FG003|Overall Study|Lost to Follow-up|0|||
105631698|NCT00146172|364316935|FG004|Overall Study|Lost to Follow-up|0|||
105631699|NCT00146172|364316936|FG005|Overall Study|Lost to Follow-up|0|||
105631700|NCT00146172|364316937|FG006|Overall Study|Lost to Follow-up|0|||
105631701|NCT00146172|364316938|FG007|Overall Study|Lost to Follow-up|1|||
105631702|NCT00146172|364316931|FG000|Overall Study|Disease Progression|2|||
105631703|NCT00146172|364316932|FG001|Overall Study|Disease Progression|4|||
105631704|NCT00146172|364316933|FG002|Overall Study|Disease Progression|2|||
105631705|NCT00146172|364316934|FG003|Overall Study|Disease Progression|5|||
105631706|NCT00146172|364316935|FG004|Overall Study|Disease Progression|2|||
105631707|NCT00146172|364316936|FG005|Overall Study|Disease Progression|2|||
105631708|NCT00146172|364316937|FG006|Overall Study|Disease Progression|1|||
105631709|NCT00146172|364316938|FG007|Overall Study|Disease Progression|22|||
105631710|NCT00146172|364316931|FG000|Overall Study|Death|0|||
105631711|NCT00146172|364316932|FG001|Overall Study|Death|0|||
105631712|NCT00146172|364316933|FG002|Overall Study|Death|0|||
105631713|NCT00146172|364316934|FG003|Overall Study|Death|0|||
105631714|NCT00146172|364316935|FG004|Overall Study|Death|0|||
105631715|NCT00146172|364316936|FG005|Overall Study|Death|0|||
105631716|NCT00146172|364316937|FG006|Overall Study|Death|1|||
105631717|NCT00146172|364316938|FG007|Overall Study|Death|0|||
105631718|NCT00146172|364316931|FG000|Overall Study|Physician Decision|0|||
105631719|NCT00146172|364316932|FG001|Overall Study|Physician Decision|0|||
105631720|NCT00146172|364316933|FG002|Overall Study|Physician Decision|0|||
105631721|NCT00146172|364316934|FG003|Overall Study|Physician Decision|0|||
105631722|NCT00146172|364316935|FG004|Overall Study|Physician Decision|0|||
105631723|NCT00146172|364316936|FG005|Overall Study|Physician Decision|0|||
105631724|NCT00146172|364316937|FG006|Overall Study|Physician Decision|0|||
105631725|NCT00146172|364316938|FG007|Overall Study|Physician Decision|1|||
105631726|NCT00146172|364316931|FG000|Overall Study|Withdrawal by Subject|0|||
105631727|NCT00146172|364316932|FG001|Overall Study|Withdrawal by Subject|0|||
105631728|NCT00146172|364316933|FG002|Overall Study|Withdrawal by Subject|0|||
105631729|NCT00146172|364316934|FG003|Overall Study|Withdrawal by Subject|0|||
105631730|NCT00146172|364316935|FG004|Overall Study|Withdrawal by Subject|0|||
105631731|NCT00146172|364316936|FG005|Overall Study|Withdrawal by Subject|1|||
105631732|NCT00146172|364316937|FG006|Overall Study|Withdrawal by Subject|1|||
105631733|NCT00146172|364316938|FG007|Overall Study|Withdrawal by Subject|4|||
105631734|NCT00146172|364316931|FG000|Overall Study|Symptomatic Deterioration|1|||
105631735|NCT00146172|364316932|FG001|Overall Study|Symptomatic Deterioration|0|||
105631736|NCT00146172|364316933|FG002|Overall Study|Symptomatic Deterioration|1|||
105631737|NCT00146172|364316934|FG003|Overall Study|Symptomatic Deterioration|0|||
105631738|NCT00146172|364316935|FG004|Overall Study|Symptomatic Deterioration|1|||
105631739|NCT00146172|364316936|FG005|Overall Study|Symptomatic Deterioration|2|||
105631740|NCT00146172|364316937|FG006|Overall Study|Symptomatic Deterioration|0|||
105631741|NCT00146172|364316938|FG007|Overall Study|Symptomatic Deterioration|2|||
105631742|NCT00623194|364316940|FG000|Overall Study|Lack of Efficacy|1|||
105631743|NCT00623194|364316940|FG000|Overall Study|Protocol Violation|3|||
105631744|NCT00623194|364316940|FG000|Overall Study|Unclassified|1|||
105631745|NCT03170648|364316943|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
105631746|NCT03170648|364316943|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
105631747|NCT03660930|364316944|FG000|Overall Study|Adverse Event|0|||
105631748|NCT03660930|364316945|FG001|Overall Study|Adverse Event|0|||
105631749|NCT03660930|364316946|FG002|Overall Study|Adverse Event|0|||
105631750|NCT03660930|364316947|FG003|Overall Study|Adverse Event|2|||
105631751|NCT03660930|364316948|FG004|Overall Study|Adverse Event|0|||
105631752|NCT03660930|364316949|FG005|Overall Study|Adverse Event|1|||
105631753|NCT03660930|364316950|FG006|Overall Study|Adverse Event|0|||
105631754|NCT03660930|364316951|FG007|Overall Study|Adverse Event|0|||
105631755|NCT03660930|364316944|FG000|Overall Study|Withdrawal by Subject|0|||
105631756|NCT03660930|364316945|FG001|Overall Study|Withdrawal by Subject|0|||
105631757|NCT03660930|364316946|FG002|Overall Study|Withdrawal by Subject|0|||
105631758|NCT03660930|364316947|FG003|Overall Study|Withdrawal by Subject|0|||
105631759|NCT03660930|364316948|FG004|Overall Study|Withdrawal by Subject|0|||
105631760|NCT03660930|364316949|FG005|Overall Study|Withdrawal by Subject|1|||
105631761|NCT03660930|364316950|FG006|Overall Study|Withdrawal by Subject|0|||
105631762|NCT03660930|364316951|FG007|Overall Study|Withdrawal by Subject|0|||
105631763|NCT03509909|364316953|FG000|Overall Study|Withdrawal by Subject|16|||
105631764|NCT03509909|364316954|FG001|Overall Study|Withdrawal by Subject|9|||
105631765|NCT03509909|364316953|FG000|Overall Study|Lost to Follow-up|3|||
105631766|NCT03509909|364316954|FG001|Overall Study|Lost to Follow-up|4|||
105631767|NCT03509909|364316953|FG000|Overall Study|Adverse Event|2|||
105631768|NCT03509909|364316954|FG001|Overall Study|Adverse Event|0|||
105631769|NCT01983683|364316962|FG000|Overall Study|Withdrawal by Subject|14|||
105631770|NCT01983683|364316963|FG001|Overall Study|Withdrawal by Subject|18|||
105631771|NCT01983683|364316962|FG000|Overall Study|Death|11|||
105631772|NCT01983683|364316963|FG001|Overall Study|Death|15|||
105631773|NCT01983683|364316962|FG000|Overall Study|Physician Decision|8|||
105631774|NCT01983683|364316963|FG001|Overall Study|Physician Decision|9|||
105631775|NCT01983683|364316962|FG000|Overall Study|Lost to Follow-up|4|||
105631776|NCT01983683|364316963|FG001|Overall Study|Lost to Follow-up|8|||
105631777|NCT01983683|364316962|FG000|Overall Study|Sponsor Decision|1|||
105631778|NCT01983683|364316963|FG001|Overall Study|Sponsor Decision|1|||
105631779|NCT02678689|364316964|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
105631780|NCT02678689|364316965|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
105631781|NCT03160885|364316966|FG000|Initial Treatment Period|Not dosed|2|||
105631782|NCT03160885|364316967|FG001|Initial Treatment Period|Not dosed|0|||
105631783|NCT03160885|364316968|FG002|Initial Treatment Period|Not dosed|0|||
105631784|NCT03160885|364316969|FG003|Initial Treatment Period|Not dosed|0|||
105631785|NCT03160885|364316970|FG004|Initial Treatment Period|Not dosed|0|||
105631786|NCT03160885|364316971|FG005|Initial Treatment Period|Not dosed|0|||
105631787|NCT03160885|364316972|FG006|Initial Treatment Period|Not dosed|0|||
105631788|NCT03160885|364316966|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
105631789|NCT03160885|364316967|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
105631790|NCT03160885|364316968|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105631791|NCT03160885|364316969|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105631792|NCT03160885|364316970|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105631793|NCT03160885|364316971|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105631794|NCT03160885|364316972|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105631795|NCT03160885|364316966|FG000|Open-label Treatment|Not dosed|0|||
105631796|NCT03160885|364316967|FG001|Open-label Treatment|Not dosed|0|||
105631797|NCT03160885|364316968|FG002|Open-label Treatment|Not dosed|0|||
105631798|NCT03160885|364316969|FG003|Open-label Treatment|Not dosed|0|||
105631799|NCT03160885|364316970|FG004|Open-label Treatment|Not dosed|0|||
105631800|NCT03160885|364316971|FG005|Open-label Treatment|Not dosed|0|||
105631801|NCT03160885|364316972|FG006|Open-label Treatment|Not dosed|2|||
105631802|NCT03160885|364316966|FG000|Open-label Treatment|Discontinued IMP|0|||
105631803|NCT03160885|364316967|FG001|Open-label Treatment|Discontinued IMP|0|||
105631804|NCT03160885|364316968|FG002|Open-label Treatment|Discontinued IMP|0|||
105631805|NCT03160885|364316969|FG003|Open-label Treatment|Discontinued IMP|0|||
105631806|NCT03160885|364316970|FG004|Open-label Treatment|Discontinued IMP|0|||
105631807|NCT03160885|364316971|FG005|Open-label Treatment|Discontinued IMP|0|||
105631808|NCT03160885|364316972|FG006|Open-label Treatment|Discontinued IMP|131|||
105631809|NCT03160885|364316966|FG000|Open-label Treatment|Completed Week 50|0|||
105631810|NCT03160885|364316967|FG001|Open-label Treatment|Completed Week 50|0|||
105631811|NCT03160885|364316968|FG002|Open-label Treatment|Completed Week 50|0|||
105631812|NCT03160885|364316969|FG003|Open-label Treatment|Completed Week 50|0|||
105631813|NCT03160885|364316970|FG004|Open-label Treatment|Completed Week 50|0|||
105631814|NCT03160885|364316971|FG005|Open-label Treatment|Completed Week 50|0|||
105631815|NCT03160885|364316972|FG006|Open-label Treatment|Completed Week 50|4|||
105631816|NCT03160885|364316966|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
105631817|NCT03160885|364316967|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
105631818|NCT03160885|364316968|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
105631819|NCT03160885|364316969|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
105631820|NCT03160885|364316970|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
105631821|NCT03160885|364316971|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
105631822|NCT03160885|364316972|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
105631823|NCT03160885|364316966|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
105631824|NCT03160885|364316967|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
105631825|NCT03160885|364316968|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
105631826|NCT03160885|364316969|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
105631827|NCT03160885|364316970|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
105631828|NCT03160885|364316971|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
105631829|NCT03160885|364316972|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
105631830|NCT03160885|364316966|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
105631831|NCT03160885|364316967|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
105631832|NCT03160885|364316968|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
105631833|NCT03160885|364316969|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
105631834|NCT03160885|364316970|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
105631835|NCT03160885|364316971|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
105631836|NCT03160885|364316972|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
105631837|NCT03160885|364316966|FG000|Maintenance Treatment Period|Completed Week 50|0|||
105631838|NCT03160885|364316967|FG001|Maintenance Treatment Period|Completed Week 50|0|||
105631839|NCT03160885|364316968|FG002|Maintenance Treatment Period|Completed Week 50|1|||
105631840|NCT03160885|364316969|FG003|Maintenance Treatment Period|Completed Week 50|0|||
105631841|NCT03160885|364316970|FG004|Maintenance Treatment Period|Completed Week 50|0|||
105631842|NCT03160885|364316971|FG005|Maintenance Treatment Period|Completed Week 50|0|||
105631843|NCT03160885|364316972|FG006|Maintenance Treatment Period|Completed Week 50|0|||
105631844|NCT03425682|364316973|FG000|Overall Study|Lost to Follow-up|2|||
105631845|NCT03425682|364316974|FG001|Overall Study|Lost to Follow-up|4|||
105631846|NCT03425682|364316973|FG000|Overall Study|Withdrawal by Subject|0|||
105631847|NCT03425682|364316974|FG001|Overall Study|Withdrawal by Subject|3|||
105631848|NCT03425682|364316973|FG000|Overall Study|Subject did not meet I/E|4|||
105631849|NCT03425682|364316974|FG001|Overall Study|Subject did not meet I/E|10|||
105631850|NCT03978637|364316978|FG000|Overall Study|Death|0|||
105631851|NCT03978637|364316979|FG001|Overall Study|Death|2|||
105631852|NCT03978637|364316980|FG002|Overall Study|Death|2|||
105631853|NCT03978637|364316981|FG003|Overall Study|Death|0|||
105631854|NCT03978637|364316978|FG000|Overall Study|Withdrawal by Subject|0|||
105631855|NCT03978637|364316979|FG001|Overall Study|Withdrawal by Subject|0|||
105631856|NCT03978637|364316980|FG002|Overall Study|Withdrawal by Subject|1|||
105631857|NCT03978637|364316981|FG003|Overall Study|Withdrawal by Subject|0|||
105631858|NCT03978637|364316978|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
105631859|NCT03978637|364316979|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
105631860|NCT03978637|364316980|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
105631861|NCT03978637|364316981|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
105631862|NCT03277989|364316985|FG000|Overall Study|Lost to Follow-up|6|||
105631863|NCT03277989|364316985|FG000|Overall Study|Adverse Event|6|||
105631864|NCT03277989|364316985|FG000|Overall Study|Withdrawal by Subject|3|||
105631865|NCT03277989|364316985|FG000|Overall Study|Didn't Receive Study Device|7|||
105631866|NCT03277989|364316985|FG000|Overall Study|Site Closure|26|||
105631867|NCT03277989|364316985|FG000|Overall Study|Sponsor Closure|107|||
105631868|NCT03227861|364316988|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
105631869|NCT03227861|364316988|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
105631870|NCT03227861|364316988|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
105631871|NCT03227861|364316988|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
105631872|NCT03227861|364316988|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
105631873|NCT03227861|364316988|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
105631874|NCT03227861|364316988|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
105631875|NCT03227861|364316988|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
105631876|NCT03227861|364316988|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
105631877|NCT03227861|364316988|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
105631878|NCT00490139|364316993|FG000|Overall Study|Lost to Follow-up|249|||
105631879|NCT00490139|364316994|FG001|Overall Study|Lost to Follow-up|216|||
105631880|NCT00490139|364316995|FG002|Overall Study|Lost to Follow-up|205|||
105631881|NCT00490139|364316996|FG003|Overall Study|Lost to Follow-up|229|||
105631882|NCT00490139|364316993|FG000|Overall Study|Withdrawal by Subject|333|||
105631883|NCT00490139|364316994|FG001|Overall Study|Withdrawal by Subject|322|||
105631884|NCT00490139|364316995|FG002|Overall Study|Withdrawal by Subject|396|||
105631885|NCT00490139|364316996|FG003|Overall Study|Withdrawal by Subject|295|||
105631886|NCT00490139|364316993|FG000|Overall Study|Patient did not sign ICF 12|169|||
105631887|NCT00490139|364316994|FG001|Overall Study|Patient did not sign ICF 12|176|||
105631888|NCT00490139|364316995|FG002|Overall Study|Patient did not sign ICF 12|139|||
105631889|NCT00490139|364316996|FG003|Overall Study|Patient did not sign ICF 12|167|||
105631890|NCT00490139|364316993|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
105631891|NCT00490139|364316994|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
105631892|NCT00490139|364316995|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
105631893|NCT00490139|364316996|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
105631894|NCT00490139|364316993|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
105631895|NCT00490139|364316994|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
105631896|NCT00490139|364316995|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
105631897|NCT00490139|364316996|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
105631898|NCT00490139|364316993|FG000|Overall Study|Other reasons as defined per protocol|98|||
105631899|NCT00490139|364316994|FG001|Overall Study|Other reasons as defined per protocol|84|||
105631900|NCT00490139|364316995|FG002|Overall Study|Other reasons as defined per protocol|82|||
105631901|NCT00490139|364316996|FG003|Overall Study|Other reasons as defined per protocol|105|||
105631902|NCT04484623|364316998|FG000|Overall Study|Lost to Follow-up|0|||
105631903|NCT04484623|364316999|FG001|Overall Study|Lost to Follow-up|1|||
105631904|NCT04484623|364316998|FG000|Overall Study|Protocol Deviation|1|||
105631905|NCT04484623|364316999|FG001|Overall Study|Protocol Deviation|0|||
105631906|NCT04484623|364316998|FG000|Overall Study|Physician Decision|1|||
105631907|NCT04484623|364316999|FG001|Overall Study|Physician Decision|0|||
105631908|NCT04484623|364316998|FG000|Overall Study|Withdrawal by Subject|11|||
105631909|NCT04484623|364316999|FG001|Overall Study|Withdrawal by Subject|8|||
105631910|NCT04484623|364316998|FG000|Overall Study|Ongoing|94|||
105631911|NCT04484623|364316999|FG001|Overall Study|Ongoing|84|||
105631912|NCT05293717|364317000|FG000|Overall Study|Physician Decision|1|||
105631913|NCT03876457|364318253|FG000|Overall Study|Lost to Follow-up|1|||
105631914|NCT03876457|364318254|FG001|Overall Study|Lost to Follow-up|3|||
105631915|NCT01036724|364318255|FG000|Overall Study|Adverse Event|1|||
105631916|NCT01036724|364318256|FG001|Overall Study|Adverse Event|2|||
105631917|NCT01036724|364318255|FG000|Overall Study|Lack of Efficacy|1|||
105631918|NCT01036724|364318256|FG001|Overall Study|Lack of Efficacy|1|||
105631919|NCT01036724|364318255|FG000|Overall Study|Protocol Violation|4|||
105631920|NCT01036724|364318256|FG001|Overall Study|Protocol Violation|5|||
105631921|NCT01596972|364318257|FG000|Overall Study|Physician Decision|1|||
105631922|NCT01596972|364318258|FG001|Overall Study|Physician Decision|9|||
105631923|NCT01596972|364318257|FG000|Overall Study|Lost to Follow-up|0|||
105631924|NCT01596972|364318258|FG001|Overall Study|Lost to Follow-up|4|||
105631925|NCT01596972|364318257|FG000|Overall Study|Withdrawal by Subject|0|||
105631926|NCT01596972|364318258|FG001|Overall Study|Withdrawal by Subject|1|||
105631927|NCT02438137|364318264|FG000|Overall Study|Lost to Follow-up|3|||
105631928|NCT02438137|364318265|FG001|Overall Study|Lost to Follow-up|2|||
105631929|NCT02438137|364318264|FG000|Overall Study|Adverse Event|1|||
105631930|NCT02438137|364318265|FG001|Overall Study|Adverse Event|0|||
105631931|NCT02438137|364318264|FG000|Overall Study|Withdrawal by Subject|4|||
105631932|NCT02438137|364318265|FG001|Overall Study|Withdrawal by Subject|3|||
105631933|NCT02438137|364318264|FG000|Overall Study|Physician Decision|0|||
105631934|NCT02438137|364318265|FG001|Overall Study|Physician Decision|1|||
105631935|NCT02291913|364318266|FG000|Overall Study|Progressive Disease|32|||
105631936|NCT02291913|364318266|FG000|Overall Study|Adverse Event|11|||
105631937|NCT02291913|364318266|FG000|Overall Study|Death|2|||
105631938|NCT02291913|364318266|FG000|Overall Study|Physician Decision|1|||
105631939|NCT02291913|364318266|FG000|Overall Study|Withdrawal by Subject|1|||
105631940|NCT02291913|364318266|FG000|Overall Study|Protocol Violation|1|||
105631941|NCT01637402|364318267|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
105631942|NCT01637402|364318268|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
105631943|NCT01637402|364318267|FG000|Standard Dose Regimen|Adverse Event|1|||
105631944|NCT01637402|364318268|FG001|Standard Dose Regimen|Adverse Event|0|||
105631945|NCT01637402|364318267|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
105631946|NCT01637402|364318268|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
105631947|NCT01637402|364318267|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
105631948|NCT01637402|364318268|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
105631949|NCT01637402|364318267|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
105631950|NCT01637402|364318268|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
105631951|NCT01637402|364318267|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
105631952|NCT01637402|364318268|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
105631953|NCT04876417|364318271|FG000|Overall Study|Lost to Follow-up|5|||
105631954|NCT04876417|364318272|FG001|Overall Study|Lost to Follow-up|8|||
105631955|NCT04876417|364318273|FG002|Overall Study|Lost to Follow-up|0|||
105631956|NCT04876417|364318274|FG003|Overall Study|Lost to Follow-up|0|||
105631957|NCT02285270|364318275|FG000|Overall Study|Lost to Follow-up|1|||
105631958|NCT02285270|364318275|FG000|Overall Study|Physician Decision|3|||
105631959|NCT02285270|364318275|FG000|Overall Study|Determined to be ineligible|1|||
105631960|NCT02111096|364318276|FG000|Overall Study|Adverse Event|4|||
105631961|NCT02111096|364318277|FG001|Overall Study|Adverse Event|1|||
105631962|NCT02111096|364318278|FG002|Overall Study|Adverse Event|2|||
105631963|NCT02111096|364318276|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105631964|NCT02111096|364318277|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105631965|NCT02111096|364318278|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105631966|NCT02111096|364318276|FG000|Overall Study|Lost to Follow Up|1|||
105631967|NCT02111096|364318277|FG001|Overall Study|Lost to Follow Up|1|||
105631968|NCT02111096|364318278|FG002|Overall Study|Lost to Follow Up|1|||
105631969|NCT02111096|364318276|FG000|Overall Study|Physician Decision|0|||
105631970|NCT02111096|364318277|FG001|Overall Study|Physician Decision|1|||
105631971|NCT02111096|364318278|FG002|Overall Study|Physician Decision|0|||
105631972|NCT02111096|364318276|FG000|Overall Study|Protocol Violation|1|||
105631973|NCT02111096|364318277|FG001|Overall Study|Protocol Violation|0|||
105631974|NCT02111096|364318278|FG002|Overall Study|Protocol Violation|1|||
105631975|NCT02111096|364318276|FG000|Overall Study|Terminated by Sponsor|53|||
105631976|NCT02111096|364318277|FG001|Overall Study|Terminated by Sponsor|35|||
105631977|NCT02111096|364318278|FG002|Overall Study|Terminated by Sponsor|54|||
105631978|NCT02111096|364318276|FG000|Overall Study|Withdrawal by Subject|4|||
105631979|NCT02111096|364318277|FG001|Overall Study|Withdrawal by Subject|2|||
105631980|NCT02111096|364318278|FG002|Overall Study|Withdrawal by Subject|8|||
105631981|NCT03801148|364318279|FG000|Period 1 (2 Days)|Adverse Event|1|||
105631982|NCT03801148|364318280|FG001|Period 1 (2 Days)|Adverse Event|1|||
105631983|NCT03801148|364318281|FG002|Period 1 (2 Days)|Adverse Event|0|||
105631984|NCT03801148|364318282|FG003|Period 1 (2 Days)|Adverse Event|0|||
105631985|NCT03801148|364318279|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
105631986|NCT03801148|364318280|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
105631987|NCT03801148|364318281|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
105631988|NCT03801148|364318282|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
105631989|NCT03801148|364318279|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105631990|NCT03801148|364318280|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105631991|NCT03801148|364318281|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
105631992|NCT03801148|364318282|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105631993|NCT03801148|364318279|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
105631994|NCT03801148|364318280|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
105631995|NCT03801148|364318281|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
105631996|NCT03801148|364318282|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
105631997|NCT03621735|364318283|FG000|Overall Study|Withdrawal by Subject|13|||
105631998|NCT03621735|364318284|FG001|Overall Study|Withdrawal by Subject|13|||
105631999|NCT04334317|364318285|FG000|Overall Study|Adverse Event|1|||
105632000|NCT04334317|364318286|FG001|Overall Study|Adverse Event|2|||
105632001|NCT04334317|364318287|FG002|Overall Study|Adverse Event|0|||
105632002|NCT04334317|364318288|FG003|Overall Study|Adverse Event|0|||
105632003|NCT04334317|364318285|FG000|Overall Study|Protocol Deviation|0|||
105632004|NCT04334317|364318286|FG001|Overall Study|Protocol Deviation|1|||
105632005|NCT04334317|364318287|FG002|Overall Study|Protocol Deviation|0|||
105632006|NCT04334317|364318288|FG003|Overall Study|Protocol Deviation|0|||
105632007|NCT04334317|364318285|FG000|Overall Study|Withdrawal by Subject|2|||
105632008|NCT04334317|364318286|FG001|Overall Study|Withdrawal by Subject|2|||
105632009|NCT04334317|364318287|FG002|Overall Study|Withdrawal by Subject|0|||
105632010|NCT04334317|364318288|FG003|Overall Study|Withdrawal by Subject|0|||
105632011|NCT00605306|364318291|FG000|Overall Study|Adverse Event|0|||
105632012|NCT00605306|364318292|FG001|Overall Study|Adverse Event|1|||
105632013|NCT00372775|364318293|FG000|Overall Study|Adverse Event|8|||
105632014|NCT00372775|364318293|FG000|Overall Study|Death|15|||
105632015|NCT00372775|364318293|FG000|Overall Study|Objective progression or relapse|30|||
105632016|NCT00372775|364318293|FG000|Overall Study|Global deterioration of health status|6|||
105632017|NCT00372775|364318293|FG000|Overall Study|Withdrawal by Subject|1|||
105632018|NCT00372775|364318293|FG000|Overall Study|Other|1|||
105632019|NCT00372775|364318293|FG000|Overall Study|Not Treated|2|||
105632020|NCT00686595|364318296|FG000|Overall Study|Adverse Event|3|||
105632021|NCT00686595|364318296|FG000|Overall Study|Protocol Violation|1|||
105632022|NCT00686595|364318296|FG000|Overall Study|Lost to Follow-up|1|||
105632023|NCT00686595|364318296|FG000|Overall Study|Lack of Efficacy|1|||
105632024|NCT00686595|364318296|FG000|Overall Study|Poor Compliance|1|||
105632025|NCT01970007|364318300|FG000|Overall Study|Death|5|||
105632026|NCT01970007|364318300|FG000|Overall Study|Withdrawal by Subject|23|||
105632027|NCT01970007|364318300|FG000|Overall Study|Lost to Follow-up|24|||
105632028|NCT01970007|364318300|FG000|Overall Study|"Other endpoint"|3|||
105632029|NCT00754065|364318301|FG000|Overall Study|Never received treatment|12|||
105632030|NCT00754065|364318302|FG001|Overall Study|Never received treatment|2|||
105632031|NCT00754065|364318301|FG000|Overall Study|Adverse Event|19|||
105632032|NCT00754065|364318302|FG001|Overall Study|Adverse Event|25|||
105632033|NCT00754065|364318301|FG000|Overall Study|Lost to Follow-up|7|||
105632034|NCT00754065|364318302|FG001|Overall Study|Lost to Follow-up|11|||
105632035|NCT00754065|364318301|FG000|Overall Study|Protocol Violation|12|||
105632036|NCT00754065|364318302|FG001|Overall Study|Protocol Violation|10|||
105632037|NCT00754065|364318301|FG000|Overall Study|Withdrawal by Subject|4|||
105632038|NCT00754065|364318302|FG001|Overall Study|Withdrawal by Subject|5|||
105632039|NCT00754065|364318301|FG000|Overall Study|Pregnancy|6|||
105632040|NCT00754065|364318302|FG001|Overall Study|Pregnancy|0|||
105632041|NCT00754065|364318301|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
105632042|NCT00754065|364318302|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
105632043|NCT01074294|364318304|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
105632044|NCT01074294|364318305|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
105632045|NCT01074294|364318306|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
105632046|NCT01074294|364318307|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
105632047|NCT01074294|364318304|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
105632048|NCT01074294|364318305|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
105632049|NCT01074294|364318306|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
105632050|NCT01074294|364318307|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
105632051|NCT01074294|364318304|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
105632052|NCT01074294|364318305|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
105632053|NCT01074294|364318306|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
105632054|NCT01074294|364318307|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
105632055|NCT01074294|364318304|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
105632056|NCT01074294|364318305|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
105632057|NCT01074294|364318306|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
105632058|NCT01074294|364318307|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
105632059|NCT01074294|364318304|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
105632060|NCT01074294|364318305|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
105632061|NCT01074294|364318306|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
105632062|NCT01074294|364318307|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
105632063|NCT01074294|364318304|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
105632064|NCT01074294|364318305|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
105632065|NCT01074294|364318306|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
105632066|NCT01074294|364318307|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
105632067|NCT01074294|364318304|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
105632068|NCT01074294|364318305|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
105632069|NCT01074294|364318306|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
105632070|NCT01074294|364318307|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
105632071|NCT01074294|364318304|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
105632072|NCT01074294|364318305|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
105632073|NCT01074294|364318306|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
105632074|NCT01074294|364318307|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
105632075|NCT01074294|364318304|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
105632076|NCT01074294|364318305|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
105632077|NCT01074294|364318306|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
105632078|NCT01074294|364318307|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
105632079|NCT01074294|364318304|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
105632080|NCT01074294|364318305|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
105632081|NCT01074294|364318306|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
105632082|NCT01074294|364318307|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
105632083|NCT01074294|364318304|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
105632084|NCT01074294|364318305|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
105632085|NCT01074294|364318306|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
105632086|NCT01074294|364318307|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
105632087|NCT01074294|364318304|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
105632088|NCT01074294|364318305|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
105632089|NCT01074294|364318306|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
105632090|NCT01074294|364318307|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
105632091|NCT01074294|364318304|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
105632092|NCT01074294|364318305|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
105632093|NCT01074294|364318306|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
105632094|NCT01074294|364318307|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
105632095|NCT01394276|364318308|FG000|Overall Study|Related Adverse event (AEs)|15|||
105632096|NCT01394276|364318308|FG000|Overall Study|Not related AEs|9|||
105632097|NCT01394276|364318308|FG000|Overall Study|Remission of disease|2|||
105632098|NCT01394276|364318308|FG000|Overall Study|Insufficient therapeutic effect|17|||
105632099|NCT01394276|364318308|FG000|Overall Study|Insufficient compliance|9|||
105632100|NCT01394276|364318308|FG000|Overall Study|Lost to Follow-up|5|||
105632101|NCT01394276|364318308|FG000|Overall Study|Participant moved to another site|1|||
105632102|NCT01394276|364318308|FG000|Overall Study|Pregnancy|1|||
105632103|NCT01394276|364318308|FG000|Overall Study|unavailability of drug at the Hospital|2|||
105632104|NCT01394276|364318308|FG000|Overall Study|Symptoms of concurrent diseases|1|||
105632105|NCT01315132|364318312|FG000|Overall Study|not treated due to disease progression|1|||
105632106|NCT02787005|364318313|FG000|Overall Study|Adverse Event|24|||
105632107|NCT02787005|364318314|FG001|Overall Study|Adverse Event|9|||
105632108|NCT02787005|364318315|FG002|Overall Study|Adverse Event|9|||
105632109|NCT02787005|364318316|FG003|Overall Study|Adverse Event|7|||
105632110|NCT02787005|364318317|FG004|Overall Study|Adverse Event|2|||
105632111|NCT02787005|364318313|FG000|Overall Study|Death|100|||
105632112|NCT02787005|364318314|FG001|Overall Study|Death|53|||
105632113|NCT02787005|364318315|FG002|Overall Study|Death|48|||
105632114|NCT02787005|364318316|FG003|Overall Study|Death|69|||
105632115|NCT02787005|364318317|FG004|Overall Study|Death|38|||
105632116|NCT02787005|364318313|FG000|Overall Study|Sponsor Decision|7|||
105632117|NCT02787005|364318314|FG001|Overall Study|Sponsor Decision|4|||
105632118|NCT02787005|364318315|FG002|Overall Study|Sponsor Decision|0|||
105632119|NCT02787005|364318316|FG003|Overall Study|Sponsor Decision|4|||
105632120|NCT02787005|364318317|FG004|Overall Study|Sponsor Decision|5|||
105632121|NCT02787005|364318313|FG000|Overall Study|Withdrawal by Subject|2|||
105632122|NCT02787005|364318314|FG001|Overall Study|Withdrawal by Subject|1|||
105632123|NCT02787005|364318315|FG002|Overall Study|Withdrawal by Subject|1|||
105632124|NCT02787005|364318316|FG003|Overall Study|Withdrawal by Subject|0|||
105632125|NCT02787005|364318317|FG004|Overall Study|Withdrawal by Subject|1|||
105632126|NCT02787005|364318313|FG000|Overall Study|Screen Failure|0|||
105632127|NCT02787005|364318314|FG001|Overall Study|Screen Failure|2|||
105632128|NCT02787005|364318315|FG002|Overall Study|Screen Failure|0|||
105632129|NCT02787005|364318316|FG003|Overall Study|Screen Failure|0|||
105632130|NCT02787005|364318317|FG004|Overall Study|Screen Failure|1|||
105632131|NCT02787005|364318313|FG000|Overall Study|Lost to Follow-up|0|||
105632132|NCT02787005|364318314|FG001|Overall Study|Lost to Follow-up|0|||
105632133|NCT02787005|364318315|FG002|Overall Study|Lost to Follow-up|0|||
105632134|NCT02787005|364318316|FG003|Overall Study|Lost to Follow-up|1|||
105632135|NCT02787005|364318317|FG004|Overall Study|Lost to Follow-up|0|||
105632136|NCT02397096|364318318|FG000|Day 1 to Week 24|Adverse Event|7|||
105632137|NCT02397096|364318319|FG001|Day 1 to Week 24|Adverse Event|1|||
105632138|NCT02397096|364318318|FG000|Day 1 to Week 24|Death|1|||
105632139|NCT02397096|364318319|FG001|Day 1 to Week 24|Death|0|||
105632140|NCT02397096|364318318|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
105632141|NCT02397096|364318319|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
105632142|NCT02397096|364318318|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
105632143|NCT02397096|364318319|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
105632144|NCT02397096|364318318|FG000|Day 1 to Week 24|Physician Decision|2|||
105632145|NCT02397096|364318319|FG001|Day 1 to Week 24|Physician Decision|3|||
105632146|NCT02397096|364318318|FG000|Day 1 to Week 24|Protocol Violation|1|||
105632147|NCT02397096|364318319|FG001|Day 1 to Week 24|Protocol Violation|4|||
105632148|NCT02397096|364318318|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
105632149|NCT02397096|364318319|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
105632150|NCT02397096|364318318|FG000|Day 1 to Week 24|Randomized, not treated|3|||
105632151|NCT02397096|364318319|FG001|Day 1 to Week 24|Randomized, not treated|0|||
105632152|NCT02397096|364318318|FG000|Week 24 to Week 48|Adverse Event|6|||
105632153|NCT02397096|364318319|FG001|Week 24 to Week 48|Adverse Event|2|||
105632154|NCT02397096|364318318|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
105632155|NCT02397096|364318319|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
105632156|NCT02397096|364318318|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
105632157|NCT02397096|364318319|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
105632158|NCT02397096|364318318|FG000|Week 24 to Week 48|Physician Decision|2|||
105632159|NCT02397096|364318319|FG001|Week 24 to Week 48|Physician Decision|1|||
105632160|NCT02397096|364318318|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
105632161|NCT02397096|364318319|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
105632162|NCT02397096|364318318|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
105632163|NCT02397096|364318319|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
105632164|NCT02397096|364318318|FG000|Study Extension 1|Adverse Event|7|||
105632165|NCT02397096|364318319|FG001|Study Extension 1|Adverse Event|5|||
105632166|NCT02397096|364318318|FG000|Study Extension 1|Death|1|||
105632167|NCT02397096|364318319|FG001|Study Extension 1|Death|0|||
105632168|NCT02397096|364318318|FG000|Study Extension 1|Lack of Efficacy|2|||
105632169|NCT02397096|364318319|FG001|Study Extension 1|Lack of Efficacy|5|||
105632170|NCT02397096|364318318|FG000|Study Extension 1|Lost to Follow-up|2|||
105632171|NCT02397096|364318319|FG001|Study Extension 1|Lost to Follow-up|3|||
105632172|NCT02397096|364318318|FG000|Study Extension 1|Non-compliance with study drug|3|||
105632173|NCT02397096|364318319|FG001|Study Extension 1|Non-compliance with study drug|0|||
105632174|NCT02397096|364318318|FG000|Study Extension 1|Physician Decision|4|||
105632175|NCT02397096|364318319|FG001|Study Extension 1|Physician Decision|2|||
105632176|NCT02397096|364318318|FG000|Study Extension 1|Pregnancy|1|||
105632177|NCT02397096|364318319|FG001|Study Extension 1|Pregnancy|0|||
105632178|NCT02397096|364318318|FG000|Study Extension 1|Protocol Violation|0|||
105632179|NCT02397096|364318319|FG001|Study Extension 1|Protocol Violation|1|||
105632180|NCT02397096|364318318|FG000|Study Extension 1|Withdrawal by Subject|21|||
105632181|NCT02397096|364318319|FG001|Study Extension 1|Withdrawal by Subject|7|||
105632182|NCT02397096|364318318|FG000|Study Extension 2|Adverse Event|3|||
105632183|NCT02397096|364318319|FG001|Study Extension 2|Adverse Event|3|||
105632184|NCT02397096|364318318|FG000|Study Extension 2|Availability of study medication locally|152|||
105632185|NCT02397096|364318319|FG001|Study Extension 2|Availability of study medication locally|64|||
105632186|NCT02397096|364318318|FG000|Study Extension 2|Death|2|||
105632187|NCT02397096|364318319|FG001|Study Extension 2|Death|0|||
105632188|NCT02397096|364318318|FG000|Study Extension 2|Lack of Efficacy|1|||
105632189|NCT02397096|364318319|FG001|Study Extension 2|Lack of Efficacy|0|||
105632190|NCT02397096|364318318|FG000|Study Extension 2|Lost to Follow-up|2|||
105632191|NCT02397096|364318319|FG001|Study Extension 2|Lost to Follow-up|1|||
105632192|NCT02397096|364318318|FG000|Study Extension 2|Non-compliance with study drug|1|||
105632193|NCT02397096|364318319|FG001|Study Extension 2|Non-compliance with study drug|0|||
105632194|NCT02397096|364318318|FG000|Study Extension 2|Physician Decision|2|||
105632195|NCT02397096|364318319|FG001|Study Extension 2|Physician Decision|5|||
105632196|NCT02397096|364318318|FG000|Study Extension 2|Pregnancy|1|||
105632197|NCT02397096|364318319|FG001|Study Extension 2|Pregnancy|0|||
105632198|NCT02397096|364318318|FG000|Study Extension 2|Withdrawal by Subject|10|||
105632199|NCT02397096|364318319|FG001|Study Extension 2|Withdrawal by Subject|3|||
105632200|NCT02397096|364318318|FG000|Study Extension 3|Adverse Event|1|||
105632201|NCT02397096|364318319|FG001|Study Extension 3|Adverse Event|0|||
105632202|NCT02397096|364318318|FG000|Study Extension 3|Availability of study medication locally|11|||
105632203|NCT02397096|364318319|FG001|Study Extension 3|Availability of study medication locally|3|||
105632204|NCT02397096|364318318|FG000|Study Extension 3|Lost to Follow-up|1|||
105632205|NCT02397096|364318319|FG001|Study Extension 3|Lost to Follow-up|0|||
105632206|NCT02397096|364318318|FG000|Study Extension 3|Withdrawal by Subject|2|||
105632207|NCT02397096|364318319|FG001|Study Extension 3|Withdrawal by Subject|1|||
105632208|NCT04795167|364318322|FG000|Overall Study|Death|1|||
105632209|NCT04795167|364318323|FG001|Overall Study|Death|18|||
105632210|NCT04795167|364318324|FG002|Overall Study|Death|1|||
105632211|NCT04795167|364318322|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
105632212|NCT04795167|364318323|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
105632213|NCT04795167|364318324|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
105632214|NCT03840902|364318325|FG000|Overall Study|Randomized but not treated|1|||
105632215|NCT03840902|364318326|FG001|Overall Study|Randomized but not treated|1|||
105632216|NCT04337931|364318328|FG000|Overall Study|Death|4|||
105632217|NCT04337931|364318329|FG001|Overall Study|Death|1|||
105632218|NCT04337931|364318330|FG002|Overall Study|Death|7|||
105632219|NCT04337931|364318328|FG000|Overall Study|Withdrawal by Subject|0|||
105632220|NCT04337931|364318329|FG001|Overall Study|Withdrawal by Subject|1|||
105632221|NCT04337931|364318330|FG002|Overall Study|Withdrawal by Subject|0|||
105632222|NCT04337931|364318328|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
105632223|NCT04337931|364318329|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
105632224|NCT04337931|364318330|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
105632225|NCT04337931|364318328|FG000|Overall Study|Study terminated by sponsor|3|||
105632226|NCT04337931|364318329|FG001|Overall Study|Study terminated by sponsor|6|||
105632227|NCT04337931|364318330|FG002|Overall Study|Study terminated by sponsor|2|||
105632228|NCT04337931|364318328|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
105632229|NCT04337931|364318329|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
105632230|NCT04337931|364318330|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
105632231|NCT04337931|364318328|FG000|Overall Study|Colorectal cancer treatment|1|||
105632232|NCT04337931|364318329|FG001|Overall Study|Colorectal cancer treatment|0|||
105632233|NCT04337931|364318330|FG002|Overall Study|Colorectal cancer treatment|0|||
105632234|NCT04337931|364318328|FG000|Overall Study|Participant decision|0|||
105632235|NCT04337931|364318329|FG001|Overall Study|Participant decision|1|||
105632236|NCT04337931|364318330|FG002|Overall Study|Participant decision|0|||
105632237|NCT04153890|364318333|FG000|Overall Study|Lost to Follow-up|9|||
105632238|NCT04153890|364318334|FG001|Overall Study|Lost to Follow-up|0|||
105632239|NCT04153890|364318335|FG002|Overall Study|Lost to Follow-up|9|||
105632240|NCT04153890|364318336|FG003|Overall Study|Lost to Follow-up|0|||
105632241|NCT04153890|364318333|FG000|Overall Study|Death|0|||
105632242|NCT04153890|364318334|FG001|Overall Study|Death|2|||
105632243|NCT04153890|364318335|FG002|Overall Study|Death|0|||
105632244|NCT04153890|364318336|FG003|Overall Study|Death|0|||
105632245|NCT04153890|364318333|FG000|Overall Study|Withdrawal by Subject|0|||
105632246|NCT04153890|364318334|FG001|Overall Study|Withdrawal by Subject|0|||
105632247|NCT04153890|364318335|FG002|Overall Study|Withdrawal by Subject|0|||
105632248|NCT04153890|364318336|FG003|Overall Study|Withdrawal by Subject|2|||
105632249|NCT02307682|364318339|FG000|Overall Study|Adverse Event|9|||
105632250|NCT02307682|364318340|FG001|Overall Study|Adverse Event|8|||
105632251|NCT02307682|364318341|FG002|Overall Study|Adverse Event|12|||
105632252|NCT02307682|364318339|FG000|Overall Study|Lack of Efficacy|1|||
105632253|NCT02307682|364318340|FG001|Overall Study|Lack of Efficacy|0|||
105632254|NCT02307682|364318341|FG002|Overall Study|Lack of Efficacy|1|||
105632255|NCT02307682|364318339|FG000|Overall Study|Physician Decision|2|||
105632256|NCT02307682|364318340|FG001|Overall Study|Physician Decision|2|||
105632257|NCT02307682|364318341|FG002|Overall Study|Physician Decision|8|||
105632258|NCT02307682|364318339|FG000|Overall Study|Progressive Disease|1|||
105632259|NCT02307682|364318340|FG001|Overall Study|Progressive Disease|0|||
105632260|NCT02307682|364318341|FG002|Overall Study|Progressive Disease|0|||
105632261|NCT02307682|364318339|FG000|Overall Study|Withdrawal by Subject|26|||
105632262|NCT02307682|364318340|FG001|Overall Study|Withdrawal by Subject|34|||
105632263|NCT02307682|364318341|FG002|Overall Study|Withdrawal by Subject|23|||
105632264|NCT02307682|364318339|FG000|Overall Study|Death|9|||
105632265|NCT02307682|364318340|FG001|Overall Study|Death|7|||
105632266|NCT02307682|364318341|FG002|Overall Study|Death|12|||
105632267|NCT02307682|364318339|FG000|Overall Study|Lost to Follow-up|1|||
105632268|NCT02307682|364318340|FG001|Overall Study|Lost to Follow-up|5|||
105632269|NCT02307682|364318341|FG002|Overall Study|Lost to Follow-up|6|||
105632270|NCT02307682|364318339|FG000|Overall Study|Protocol Deviation|0|||
105632271|NCT02307682|364318340|FG001|Overall Study|Protocol Deviation|0|||
105632272|NCT02307682|364318341|FG002|Overall Study|Protocol Deviation|2|||
105632273|NCT02307682|364318339|FG000|Overall Study|Other|1|||
105632274|NCT02307682|364318340|FG001|Overall Study|Other|1|||
105632275|NCT02307682|364318341|FG002|Overall Study|Other|0|||
105632276|NCT02549352|364318344|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
105632277|NCT02549352|364318345|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
105632278|NCT02549352|364318344|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
105632279|NCT02549352|364318345|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
105632280|NCT02549352|364318344|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
105632281|NCT02549352|364318345|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
105632282|NCT02549352|364318344|FG000|12-month Follow-up|Withdrawal by Subject|4|||
105632283|NCT02549352|364318345|FG001|12-month Follow-up|Withdrawal by Subject|5|||
105632284|NCT02549352|364318344|FG000|12-month Follow-up|Lost to Follow-up|3|||
105632285|NCT02549352|364318345|FG001|12-month Follow-up|Lost to Follow-up|2|||
105632286|NCT02549352|364318344|FG000|12-month Follow-up|Death|0|||
105632287|NCT02549352|364318345|FG001|12-month Follow-up|Death|1|||
105632288|NCT02549352|364318344|FG000|12-month Follow-up|Protocol Violation|0|||
105632289|NCT02549352|364318345|FG001|12-month Follow-up|Protocol Violation|1|||
105632290|NCT02549352|364318344|FG000|12-month Follow-up|Other|1|||
105632291|NCT02549352|364318345|FG001|12-month Follow-up|Other|3|||
105632292|NCT05704725|364318346|FG000|Overall Study|Lost to Follow-up|0|||
105632293|NCT05704725|364318347|FG001|Overall Study|Lost to Follow-up|1|||
105632294|NCT05704725|364318346|FG000|Overall Study|Withdrawal by Subject|1|||
105632295|NCT05704725|364318347|FG001|Overall Study|Withdrawal by Subject|0|||
105632296|NCT03002194|364319258|FG000|Overall Study|Lost to Follow-up|6|||
105632297|NCT03002194|364319258|FG000|Overall Study|Adverse Event|1|||
105632298|NCT03002194|364319258|FG000|Overall Study|Lack of Efficacy|1|||
105632299|NCT03002194|364319258|FG000|Overall Study|Withdrawal by Subject|2|||
105632300|NCT01288443|364319261|FG000|Overall Study|Adverse Event|0|||
105632301|NCT01288443|364319262|FG001|Overall Study|Adverse Event|0|||
105632302|NCT01288443|364319263|FG002|Overall Study|Adverse Event|1|||
105632303|NCT01288443|364319264|FG003|Overall Study|Adverse Event|1|||
105632304|NCT01288443|364319265|FG004|Overall Study|Adverse Event|3|||
105632305|NCT01288443|364319266|FG005|Overall Study|Adverse Event|1|||
105632306|NCT01288443|364319261|FG000|Overall Study|Poor compliance to protocol|0|||
105632307|NCT01288443|364319262|FG001|Overall Study|Poor compliance to protocol|0|||
105632308|NCT01288443|364319263|FG002|Overall Study|Poor compliance to protocol|0|||
105632309|NCT01288443|364319264|FG003|Overall Study|Poor compliance to protocol|0|||
105632310|NCT01288443|364319265|FG004|Overall Study|Poor compliance to protocol|0|||
105632311|NCT01288443|364319266|FG005|Overall Study|Poor compliance to protocol|1|||
105632312|NCT01288443|364319261|FG000|Overall Study|Participant Moved|0|||
105632313|NCT01288443|364319262|FG001|Overall Study|Participant Moved|0|||
105632314|NCT01288443|364319263|FG002|Overall Study|Participant Moved|0|||
105632315|NCT01288443|364319264|FG003|Overall Study|Participant Moved|1|||
105632316|NCT01288443|364319265|FG004|Overall Study|Participant Moved|2|||
105632317|NCT01288443|364319266|FG005|Overall Study|Participant Moved|1|||
105632318|NCT01288443|364319261|FG000|Overall Study|Consent withdrawn by Participant|0|||
105632319|NCT01288443|364319262|FG001|Overall Study|Consent withdrawn by Participant|0|||
105632320|NCT01288443|364319263|FG002|Overall Study|Consent withdrawn by Participant|0|||
105632321|NCT01288443|364319264|FG003|Overall Study|Consent withdrawn by Participant|0|||
105632322|NCT01288443|364319265|FG004|Overall Study|Consent withdrawn by Participant|0|||
105632323|NCT01288443|364319266|FG005|Overall Study|Consent withdrawn by Participant|1|||
105632324|NCT01288443|364319261|FG000|Overall Study|Lost to Follow-up|0|||
105632325|NCT01288443|364319262|FG001|Overall Study|Lost to Follow-up|1|||
105632326|NCT01288443|364319263|FG002|Overall Study|Lost to Follow-up|0|||
105632327|NCT01288443|364319264|FG003|Overall Study|Lost to Follow-up|0|||
105632328|NCT01288443|364319265|FG004|Overall Study|Lost to Follow-up|0|||
105632329|NCT01288443|364319266|FG005|Overall Study|Lost to Follow-up|0|||
105632330|NCT01288443|364319261|FG000|Overall Study|Study drug auto-injector administration|0|||
105632331|NCT01288443|364319262|FG001|Overall Study|Study drug auto-injector administration|0|||
105632332|NCT01288443|364319263|FG002|Overall Study|Study drug auto-injector administration|0|||
105632333|NCT01288443|364319264|FG003|Overall Study|Study drug auto-injector administration|0|||
105632334|NCT01288443|364319265|FG004|Overall Study|Study drug auto-injector administration|1|||
105632335|NCT01288443|364319266|FG005|Overall Study|Study drug auto-injector administration|1|||
105632336|NCT01288443|364319261|FG000|Overall Study|Other than above|0|||
105632337|NCT01288443|364319262|FG001|Overall Study|Other than above|0|||
105632338|NCT01288443|364319263|FG002|Overall Study|Other than above|0|||
105632339|NCT01288443|364319264|FG003|Overall Study|Other than above|2|||
105632340|NCT01288443|364319265|FG004|Overall Study|Other than above|1|||
105632341|NCT01288443|364319266|FG005|Overall Study|Other than above|0|||
105632342|NCT01092416|364319268|FG000|Enrollment|Atherectomy device not inserted|3|||
105632343|NCT01092416|364319268|FG000|30-Day Follow-up|Death|2|||
105632344|NCT01092416|364319268|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
105632345|NCT01092416|364319268|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
105632346|NCT01092416|364319268|FG000|12-Month Follow-up|Death|16|||
105632347|NCT01092416|364319268|FG000|12-Month Follow-up|Lost to Follow-up|4|||
105632348|NCT01092416|364319268|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
105632349|NCT01092416|364319268|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
105632350|NCT01092416|364319268|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
105632351|NCT00366249|364319269|FG000|Overall Study|Adverse Event|53|||
105632352|NCT00366249|364319270|FG001|Overall Study|Adverse Event|28|||
105632353|NCT00366249|364319269|FG000|Overall Study|Death|0|||
105632354|NCT00366249|364319270|FG001|Overall Study|Death|1|||
105632355|NCT00366249|364319269|FG000|Overall Study|Physician Decision|5|||
105632356|NCT00366249|364319270|FG001|Overall Study|Physician Decision|2|||
105632357|NCT00366249|364319269|FG000|Overall Study|Lost to Follow-up|2|||
105632358|NCT00366249|364319270|FG001|Overall Study|Lost to Follow-up|0|||
105632359|NCT00366249|364319269|FG000|Overall Study|Protocol Violation|1|||
105632360|NCT00366249|364319270|FG001|Overall Study|Protocol Violation|2|||
105632361|NCT00366249|364319269|FG000|Overall Study|Withdrawal by Subject|18|||
105632362|NCT00366249|364319270|FG001|Overall Study|Withdrawal by Subject|4|||
105632363|NCT00366249|364319269|FG000|Overall Study|Lack of Efficacy|21|||
105632364|NCT00366249|364319270|FG001|Overall Study|Lack of Efficacy|21|||
105632365|NCT00366249|364319269|FG000|Overall Study|Most due to osteomylitis status|31|||
105632366|NCT00366249|364319270|FG001|Overall Study|Most due to osteomylitis status|20|||
105632367|NCT00246805|364319271|FG000|Phase 1|Lost to Follow-up|1|||
105632368|NCT00246805|364319272|FG001|Phase 1|Lost to Follow-up|0|||
105632369|NCT00609869|364319273|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
105632370|NCT00609869|364319273|FG000|Overall Study|Severe hematologic toxicity|1|||
105632371|NCT00609869|364319273|FG000|Overall Study|Withdrawal by Subject|1|||
105632372|NCT00609869|364319273|FG000|Overall Study|Seizures|1|||
105632373|NCT00609869|364319273|FG000|Overall Study|Severe tumor flare reaction|1|||
105632374|NCT00609869|364319273|FG000|Overall Study|Hepatitis B infection|1|||
105632375|NCT00609869|364319273|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
105632376|NCT00609869|364319273|FG000|Overall Study|Mantle cell: not evaluable|4|||
105632377|NCT01627561|364319274|FG000|Overall Study|Lost to Follow-up|1|||
105632378|NCT01627561|364319275|FG001|Overall Study|Lost to Follow-up|0|||
105632379|NCT01627561|364319274|FG000|Overall Study|Withdrawal by Subject|0|||
105632380|NCT01627561|364319275|FG001|Overall Study|Withdrawal by Subject|1|||
105632381|NCT01627561|364319274|FG000|Overall Study|Migrated/moved from study area|0|||
105632382|NCT01627561|364319275|FG001|Overall Study|Migrated/moved from study area|2|||
105632383|NCT02941549|364319276|FG000|Overall Study|Adverse Event|1|||
105632384|NCT02941549|364319277|FG001|Overall Study|Adverse Event|0|||
105632385|NCT02941549|364319278|FG002|Overall Study|Adverse Event|0|||
105632386|NCT02941549|364319276|FG000|Overall Study|Withdrawal by Subject|2|||
105632387|NCT02941549|364319277|FG001|Overall Study|Withdrawal by Subject|1|||
105632388|NCT02941549|364319278|FG002|Overall Study|Withdrawal by Subject|2|||
105632389|NCT01579318|364319281|FG000|Overall Study|Disease Progression|1|||
105632390|NCT02347332|364319285|FG000|Overall Study|Not treated|5|||
105632391|NCT02347332|364319286|FG001|Overall Study|Not treated|2|||
105632392|NCT02347332|364319285|FG000|Overall Study|Progressive disease|141|||
105632393|NCT02347332|364319286|FG001|Overall Study|Progressive disease|159|||
105632394|NCT02347332|364319285|FG000|Overall Study|Adverse Event|50|||
105632395|NCT02347332|364319286|FG001|Overall Study|Adverse Event|41|||
105632396|NCT02347332|364319285|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
105632397|NCT02347332|364319286|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
105632398|NCT02347332|364319285|FG000|Overall Study|Protocol Violation|1|||
105632399|NCT02347332|364319286|FG001|Overall Study|Protocol Violation|1|||
105632400|NCT02347332|364319285|FG000|Overall Study|Lost to Follow-up|2|||
105632401|NCT02347332|364319286|FG001|Overall Study|Lost to Follow-up|1|||
105632402|NCT02347332|364319285|FG000|Overall Study|Physician Decision|4|||
105632403|NCT02347332|364319286|FG001|Overall Study|Physician Decision|3|||
105632404|NCT02347332|364319285|FG000|Overall Study|Withdrawal by Subject|20|||
105632405|NCT02347332|364319286|FG001|Overall Study|Withdrawal by Subject|14|||
105632406|NCT02347332|364319285|FG000|Overall Study|Protocol requirement|1|||
105632407|NCT02347332|364319286|FG001|Overall Study|Protocol requirement|1|||
105632408|NCT02347332|364319285|FG000|Overall Study|Switch Post-Trial program|0|||
105632409|NCT02347332|364319286|FG001|Overall Study|Switch Post-Trial program|1|||
105632410|NCT02502526|364319287|FG000|Overall Study|Lost to Follow-up|2|||
105632411|NCT02502526|364319288|FG001|Overall Study|Lost to Follow-up|2|||
105632412|NCT02502526|364319289|FG002|Overall Study|Lost to Follow-up|3|||
105632413|NCT02502526|364319287|FG000|Overall Study|Withdrawal by Subject|0|||
105632414|NCT02502526|364319288|FG001|Overall Study|Withdrawal by Subject|1|||
105632415|NCT02502526|364319289|FG002|Overall Study|Withdrawal by Subject|1|||
105632416|NCT02502526|364319287|FG000|Overall Study|Disqualified due to cataract grading|0|||
105632417|NCT02502526|364319288|FG001|Overall Study|Disqualified due to cataract grading|0|||
105632418|NCT02502526|364319289|FG002|Overall Study|Disqualified due to cataract grading|1|||
105632419|NCT02502526|364319287|FG000|Overall Study|Enrollment suspension|4|||
105632420|NCT02502526|364319288|FG001|Overall Study|Enrollment suspension|1|||
105632421|NCT02502526|364319289|FG002|Overall Study|Enrollment suspension|1|||
105632422|NCT00918333|364319290|FG000|Overall Study|Drug not taken per protocol|1|||
105632423|NCT00918333|364319291|FG001|Overall Study|Drug not taken per protocol|0|||
105632424|NCT00918333|364319290|FG000|Overall Study|Inadequate amount of drugs provided|1|||
105632425|NCT00918333|364319291|FG001|Overall Study|Inadequate amount of drugs provided|4|||
105632426|NCT00918333|364319290|FG000|Overall Study|Ineligible|1|||
105632427|NCT00918333|364319291|FG001|Overall Study|Ineligible|0|||
105632428|NCT00918333|364319290|FG000|Overall Study|Withdrawal by Subject|0|||
105632429|NCT00918333|364319291|FG001|Overall Study|Withdrawal by Subject|1|||
105632430|NCT00112359|364319294|FG000|Overall Study|Unrelated adverse event|16|||
105632431|NCT00112359|364319295|FG001|Overall Study|Unrelated adverse event|8|||
105632432|NCT00112359|364319294|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
105632433|NCT00112359|364319295|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
105632434|NCT00112359|364319294|FG000|Overall Study|Related adverse event|5|||
105632435|NCT00112359|364319295|FG001|Overall Study|Related adverse event|3|||
105632436|NCT00112359|364319294|FG000|Overall Study|Lost to Follow-up|0|||
105632437|NCT00112359|364319295|FG001|Overall Study|Lost to Follow-up|1|||
105632438|NCT00112359|364319294|FG000|Overall Study|Personal/administrative|1|||
105632439|NCT00112359|364319295|FG001|Overall Study|Personal/administrative|1|||
105632440|NCT00112359|364319294|FG000|Overall Study|Other|3|||
105632441|NCT00112359|364319295|FG001|Overall Study|Other|0|||
105632442|NCT00857766|364319296|FG000|Overall Study|Adverse Event|13|||
105632443|NCT00857766|364319297|FG001|Overall Study|Adverse Event|12|||
105632444|NCT00857766|364319296|FG000|Overall Study|Protocol Violation|11|||
105632445|NCT00857766|364319297|FG001|Overall Study|Protocol Violation|11|||
105632446|NCT00857766|364319296|FG000|Overall Study|Lost to Follow-up|1|||
105632447|NCT00857766|364319297|FG001|Overall Study|Lost to Follow-up|0|||
105632448|NCT00857766|364319296|FG000|Overall Study|Investigator Discretion|2|||
105632449|NCT00857766|364319297|FG001|Overall Study|Investigator Discretion|3|||
105632450|NCT00857766|364319296|FG000|Overall Study|Participant Withdrew Consent|4|||
105632451|NCT00857766|364319297|FG001|Overall Study|Participant Withdrew Consent|4|||
105632452|NCT01961609|364319298|FG000|Initiation|Missing|3|||
105632453|NCT01961609|364319299|FG001|Initiation|Missing|2|||
105632454|NCT01961609|364319300|FG002|Initiation|Missing|0|||
105632455|NCT01961609|364319301|FG003|Initiation|Missing|0|||
105632456|NCT01961609|364319298|FG000|Initiation|Protocol deviation|1|||
105632457|NCT01961609|364319299|FG001|Initiation|Protocol deviation|0|||
105632458|NCT01961609|364319300|FG002|Initiation|Protocol deviation|0|||
105632459|NCT01961609|364319301|FG003|Initiation|Protocol deviation|0|||
105632460|NCT01961609|364319298|FG000|Initiation|Death|0|||
105632461|NCT01961609|364319299|FG001|Initiation|Death|1|||
105632462|NCT01961609|364319300|FG002|Initiation|Death|0|||
105632463|NCT01961609|364319301|FG003|Initiation|Death|0|||
105632464|NCT01961609|364319298|FG000|Initiation|Administrative problems|1|||
105632465|NCT01961609|364319299|FG001|Initiation|Administrative problems|0|||
105632466|NCT01961609|364319300|FG002|Initiation|Administrative problems|0|||
105632467|NCT01961609|364319301|FG003|Initiation|Administrative problems|0|||
105632468|NCT01961609|364319298|FG000|Initiation|Withdrawal by Subject|1|||
105632469|NCT01961609|364319299|FG001|Initiation|Withdrawal by Subject|2|||
105632470|NCT01961609|364319300|FG002|Initiation|Withdrawal by Subject|0|||
105632471|NCT01961609|364319301|FG003|Initiation|Withdrawal by Subject|0|||
105632472|NCT01961609|364319298|FG000|Initiation|Lack of Efficacy|2|||
105632473|NCT01961609|364319299|FG001|Initiation|Lack of Efficacy|1|||
105632474|NCT01961609|364319300|FG002|Initiation|Lack of Efficacy|0|||
105632475|NCT01961609|364319301|FG003|Initiation|Lack of Efficacy|0|||
105632476|NCT01961609|364319298|FG000|Initiation|Abnormal lab values|0|||
105632477|NCT01961609|364319299|FG001|Initiation|Abnormal lab values|1|||
105632478|NCT01961609|364319300|FG002|Initiation|Abnormal lab values|0|||
105632479|NCT01961609|364319301|FG003|Initiation|Abnormal lab values|0|||
105632480|NCT01961609|364319298|FG000|Initiation|Adverse Event|3|||
105632481|NCT01961609|364319299|FG001|Initiation|Adverse Event|5|||
105632482|NCT01961609|364319300|FG002|Initiation|Adverse Event|0|||
105632483|NCT01961609|364319301|FG003|Initiation|Adverse Event|0|||
105632484|NCT01961609|364319298|FG000|Initiation|Randomized but not treated|1|||
105632485|NCT01961609|364319299|FG001|Initiation|Randomized but not treated|1|||
105632486|NCT01961609|364319300|FG002|Initiation|Randomized but not treated|0|||
105632487|NCT01961609|364319301|FG003|Initiation|Randomized but not treated|0|||
105632488|NCT01961609|364319298|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
105632489|NCT01961609|364319299|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
105632490|NCT01961609|364319300|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
105632491|NCT01961609|364319301|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
105632492|NCT01961609|364319298|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
105632493|NCT01961609|364319299|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
105632494|NCT01961609|364319300|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
105632495|NCT01961609|364319301|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
105632496|NCT01961609|364319298|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
105632497|NCT01961609|364319299|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
105632498|NCT01961609|364319300|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
105632499|NCT01961609|364319301|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
105632500|NCT01961609|364319298|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
105632501|NCT01961609|364319299|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
105632502|NCT01961609|364319300|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
105632503|NCT01961609|364319301|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
105632504|NCT01961609|364319298|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
105632505|NCT01961609|364319299|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
105632506|NCT01961609|364319300|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
105632507|NCT01961609|364319301|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
105632508|NCT01961609|364319298|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
105632509|NCT01961609|364319299|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
105632510|NCT01961609|364319300|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
105632511|NCT01961609|364319301|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
105632512|NCT01961609|364319298|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
105632513|NCT01961609|364319299|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
105632514|NCT01961609|364319300|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
105632515|NCT01961609|364319301|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
105632516|NCT01961609|364319298|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
105632517|NCT01961609|364319299|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
105632518|NCT01961609|364319300|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
105632519|NCT01961609|364319301|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
105632520|NCT01961609|364319298|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
105632521|NCT01961609|364319299|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
105632522|NCT01961609|364319300|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
105632523|NCT01961609|364319301|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
105632524|NCT01961609|364319298|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
105632525|NCT01961609|364319299|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
105632526|NCT01961609|364319300|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
105632527|NCT01961609|364319301|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
105632528|NCT01961609|364319298|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
105632529|NCT01961609|364319299|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
105632530|NCT01961609|364319300|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
105632531|NCT01961609|364319301|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
105632532|NCT01961609|364319298|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
105632533|NCT01961609|364319299|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
105632534|NCT01961609|364319300|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
105632535|NCT01961609|364319301|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
105632536|NCT01753999|364319302|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
105632537|NCT01753999|364319303|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
105632538|NCT01753999|364319302|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
105632539|NCT01753999|364319303|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
105632540|NCT01753999|364319302|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
105632541|NCT01753999|364319303|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
105632542|NCT01753999|364319302|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
105632543|NCT01753999|364319303|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
105632544|NCT01753999|364319302|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
105632545|NCT01753999|364319303|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
105632546|NCT01753999|364319302|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
105632547|NCT01753999|364319303|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
105632548|NCT04436289|364319304|FG000|Overall Study|Death prior to hospital discharge|8|||
105632549|NCT04436289|364319305|FG001|Overall Study|Death prior to hospital discharge|5|||
105632550|NCT04436289|364319306|FG002|Overall Study|Death prior to hospital discharge|0|||
105632551|NCT04436289|364319307|FG003|Overall Study|Death prior to hospital discharge|1|||
105632552|NCT04436289|364319304|FG000|Overall Study|Withdrawal by Subject|0|||
105632553|NCT04436289|364319305|FG001|Overall Study|Withdrawal by Subject|1|||
105632554|NCT04436289|364319306|FG002|Overall Study|Withdrawal by Subject|4|||
105632555|NCT04436289|364319307|FG003|Overall Study|Withdrawal by Subject|0|||
105632556|NCT04436289|364319304|FG000|Overall Study|Extended hospital stay|0|||
105632557|NCT04436289|364319305|FG001|Overall Study|Extended hospital stay|1|||
105632558|NCT04436289|364319306|FG002|Overall Study|Extended hospital stay|0|||
105632559|NCT04436289|364319307|FG003|Overall Study|Extended hospital stay|0|||
105632560|NCT04436289|364319304|FG000|Overall Study|Lost to Follow-up|0|||
105632561|NCT04436289|364319305|FG001|Overall Study|Lost to Follow-up|4|||
105632562|NCT04436289|364319306|FG002|Overall Study|Lost to Follow-up|1|||
105632563|NCT04436289|364319307|FG003|Overall Study|Lost to Follow-up|3|||
105632564|NCT02972359|364319309|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
105632565|NCT02972359|364319309|FG000|Overall Study|Lack of Efficacy|1|||
105632566|NCT02972359|364319309|FG000|Overall Study|Adverse Event|4|||
105632567|NCT02972359|364319309|FG000|Overall Study|Death|1|||
105632568|NCT02972359|364319309|FG000|Overall Study|Withdrawal by Subject|30|||
105632569|NCT02972359|364319309|FG000|Overall Study|Protocol Violation|1|||
105632570|NCT02972359|364319309|FG000|Overall Study|Lost to Follow-up|26|||
105632571|NCT02972359|364319309|FG000|Overall Study|Other reasons|5|||
105632572|NCT02972359|364319309|FG000|Overall Study|Missing|1|||
105632573|NCT01371994|364319313|FG000|Overall Study|Adverse Event|3|||
105632574|NCT01371994|364319314|FG001|Overall Study|Adverse Event|6|||
105632575|NCT01371994|364319313|FG000|Overall Study|Lack of Efficacy|3|||
105632576|NCT01371994|364319314|FG001|Overall Study|Lack of Efficacy|0|||
105632577|NCT01371994|364319313|FG000|Overall Study|Withdrawal by Subject|13|||
105632578|NCT01371994|364319314|FG001|Overall Study|Withdrawal by Subject|7|||
105632579|NCT01371994|364319313|FG000|Overall Study|Lost to Follow-up|1|||
105632580|NCT01371994|364319314|FG001|Overall Study|Lost to Follow-up|1|||
105632581|NCT01371994|364319313|FG000|Overall Study|Protocol Violation|24|||
105632582|NCT01371994|364319314|FG001|Overall Study|Protocol Violation|17|||
105632583|NCT01371994|364319313|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
105632584|NCT01371994|364319314|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
105632585|NCT01371994|364319313|FG000|Overall Study|Physician Decision|1|||
105632586|NCT01371994|364319314|FG001|Overall Study|Physician Decision|1|||
105632587|NCT01371994|364319313|FG000|Overall Study|Miscellaneous Reasons|6|||
105632588|NCT01371994|364319314|FG001|Overall Study|Miscellaneous Reasons|4|||
105632589|NCT01675492|364319317|FG000|Overall Study|study completed early - product approval|42|||
105632590|NCT04021862|364319318|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
105632591|NCT04021862|364319319|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
105632592|NCT04021862|364319320|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
105632593|NCT04021862|364319321|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
105632594|NCT04021862|364319322|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
105632595|NCT04021862|364319323|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
105632596|NCT04021862|364319318|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
105632597|NCT04021862|364319319|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
105632598|NCT04021862|364319320|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
105632599|NCT04021862|364319321|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
105632600|NCT04021862|364319322|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
105632601|NCT04021862|364319323|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
105632602|NCT04021862|364319318|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
105632603|NCT04021862|364319319|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
105632604|NCT04021862|364319320|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
105632605|NCT04021862|364319321|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
105632606|NCT04021862|364319322|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
105632607|NCT04021862|364319323|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
105632608|NCT04021862|364319318|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
105632609|NCT04021862|364319319|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
105632610|NCT04021862|364319320|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
105632611|NCT04021862|364319321|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
105632612|NCT04021862|364319322|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
105632613|NCT04021862|364319323|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
105632614|NCT04021862|364319318|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
105632615|NCT04021862|364319319|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
105632616|NCT04021862|364319320|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
105632617|NCT04021862|364319321|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
105632618|NCT04021862|364319322|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
105632619|NCT04021862|364319323|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
105632620|NCT02415127|364319324|FG000|Overall Study|Adverse Event|1|||
105632621|NCT02415127|364319325|FG001|Overall Study|Adverse Event|0|||
105632622|NCT05525572|364319327|FG000|Overall Study|Lost to Follow-up|2|||
105632623|NCT05025384|364319328|FG000|Overall Study|Physician Decision|5|||
105632624|NCT05025384|364319329|FG001|Overall Study|Physician Decision|6|||
105632625|NCT04057131|364319330|FG000|Overall Study|Protocol Violation|24|||
105632626|NCT03170349|364319336|FG000|From Implant to the 30-Day Visit|Death|1|||
105632627|NCT03170349|364319336|FG000|From 30-Day to 6-Month Visit|Death|3|||
105632628|NCT03170349|364319336|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
105632629|NCT03170349|364319336|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
105632630|NCT03170349|364319336|FG000|From 6-Month to 1-Year Visit|Death|6|||
105632631|NCT03170349|364319336|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
105632632|NCT03170349|364319336|FG000|From 1-Year to 2-Year Visit|Death|13|||
105632633|NCT03170349|364319336|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
105632634|NCT03170349|364319336|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
105632635|NCT03170349|364319336|FG000|From 2-Year to 3-Year Visit|Death|10|||
105632636|NCT03170349|364319336|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
105632637|NCT03170349|364319336|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
105632638|NCT03170349|364319336|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
105632639|NCT01958021|364319339|FG000|Treatment|Progressive disease|206|||
105632640|NCT01958021|364319340|FG001|Treatment|Progressive disease|265|||
105632641|NCT01958021|364319339|FG000|Treatment|Adverse Event|38|||
105632642|NCT01958021|364319340|FG001|Treatment|Adverse Event|10|||
105632643|NCT01958021|364319339|FG000|Treatment|Subject/guardian decision|29|||
105632644|NCT01958021|364319340|FG001|Treatment|Subject/guardian decision|25|||
105632645|NCT01958021|364319339|FG000|Treatment|Physician Decision|28|||
105632646|NCT01958021|364319340|FG001|Treatment|Physician Decision|21|||
105632647|NCT01958021|364319339|FG000|Treatment|Death|6|||
105632648|NCT01958021|364319340|FG001|Treatment|Death|1|||
105632649|NCT01958021|364319339|FG000|Treatment|Protocol deviation|3|||
105632650|NCT01958021|364319340|FG001|Treatment|Protocol deviation|1|||
105632651|NCT01958021|364319339|FG000|Treatment|Sponsor decision|24|||
105632652|NCT01958021|364319340|FG001|Treatment|Sponsor decision|11|||
105632653|NCT01958021|364319339|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
105632654|NCT01958021|364319340|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
105632655|NCT01958021|364319339|FG000|Post-treatment Efficacy Follow-up|Death|1|||
105632656|NCT01958021|364319340|FG001|Post-treatment Efficacy Follow-up|Death|0|||
105632657|NCT01958021|364319339|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
105632658|NCT01958021|364319340|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
105632659|NCT01958021|364319339|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
105632660|NCT01958021|364319340|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
105632661|NCT01958021|364319339|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
105632662|NCT01958021|364319340|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
105632663|NCT01958021|364319339|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
105632664|NCT01958021|364319340|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
105632665|NCT01958021|364319339|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
105632666|NCT01958021|364319340|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
105632667|NCT05470114|364319341|FG000|Overall Study|Withdrawal by Subject|1|||
105632668|NCT05470114|364319342|FG001|Overall Study|Withdrawal by Subject|0|||
105632669|NCT05470114|364319341|FG000|Overall Study|Lost to Follow-up|1|||
105632670|NCT05470114|364319342|FG001|Overall Study|Lost to Follow-up|0|||
105632671|NCT02325466|364320488|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
105632672|NCT02325466|364320489|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
105632673|NCT02325466|364320490|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
105632674|NCT02325466|364320488|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
105632675|NCT02325466|364320489|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
105632676|NCT02325466|364320490|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
105632677|NCT02325466|364320488|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
105632678|NCT02325466|364320489|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
105632679|NCT02325466|364320490|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
105632680|NCT02325466|364320488|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
105632681|NCT02325466|364320489|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
105632682|NCT02325466|364320490|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
105632683|NCT02325466|364320488|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
105632684|NCT02325466|364320489|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
105632685|NCT02325466|364320490|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
105632686|NCT02325466|364320488|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
105632687|NCT02325466|364320489|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
105632688|NCT02325466|364320490|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
105632689|NCT02325466|364320488|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
105632690|NCT02325466|364320489|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
105632691|NCT02325466|364320490|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
105632692|NCT02325466|364320488|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
105632693|NCT02325466|364320489|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
105632694|NCT02325466|364320490|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
105632695|NCT02325466|364320488|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
105632696|NCT02325466|364320489|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
105632697|NCT02325466|364320490|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
105632698|NCT01812759|364320491|FG000|Overall Study|Physician Decision|0|||
105632699|NCT01812759|364320492|FG001|Overall Study|Physician Decision|0|||
105632700|NCT01812759|364320493|FG002|Overall Study|Physician Decision|1|||
105632701|NCT00360269|364320494|FG000|Overall Study|Lost to Follow-up|7|||
105632702|NCT00360269|364320495|FG001|Overall Study|Lost to Follow-up|9|||
105632703|NCT00360269|364320494|FG000|Overall Study|Physician Decision|1|||
105632704|NCT00360269|364320495|FG001|Overall Study|Physician Decision|2|||
105632705|NCT00360269|364320494|FG000|Overall Study|Adverse Event|1|||
105632706|NCT00360269|364320495|FG001|Overall Study|Adverse Event|0|||
105632707|NCT00360269|364320494|FG000|Overall Study|Withdrawal by Subject|1|||
105632708|NCT00360269|364320495|FG001|Overall Study|Withdrawal by Subject|1|||
105632709|NCT01184326|364320496|FG000|Overall Study|Adverse Event|1|||
105632710|NCT01184326|364320497|FG001|Overall Study|Adverse Event|2|||
105632711|NCT01184326|364320498|FG002|Overall Study|Adverse Event|0|||
105632712|NCT01184326|364320496|FG000|Overall Study|Death|0|||
105632713|NCT01184326|364320497|FG001|Overall Study|Death|0|||
105632714|NCT01184326|364320498|FG002|Overall Study|Death|1|||
105632715|NCT01184326|364320496|FG000|Overall Study|Withdrawal by Subject|0|||
105632716|NCT01184326|364320497|FG001|Overall Study|Withdrawal by Subject|0|||
105632717|NCT01184326|364320498|FG002|Overall Study|Withdrawal by Subject|1|||
105632718|NCT01184326|364320496|FG000|Overall Study|Physician Decision|1|||
105632719|NCT01184326|364320497|FG001|Overall Study|Physician Decision|1|||
105632720|NCT01184326|364320498|FG002|Overall Study|Physician Decision|0|||
105632721|NCT01184326|364320496|FG000|Overall Study|Disease Progression|1|||
105632722|NCT01184326|364320497|FG001|Overall Study|Disease Progression|3|||
105632723|NCT01184326|364320498|FG002|Overall Study|Disease Progression|12|||
105632724|NCT01268306|364320499|FG000|Overall Study|Lost to Follow-up|1|||
105632725|NCT04545619|364320501|FG000|Overall Study|due to equipment challenges|1|||
105632726|NCT01988402|364320509|FG000|Overall Study|Adverse Event|1|||
105632727|NCT01988402|364320510|FG001|Overall Study|Adverse Event|2|||
105632728|NCT01988402|364320509|FG000|Overall Study|Withdrawal by Subject|1|||
105632729|NCT01988402|364320510|FG001|Overall Study|Withdrawal by Subject|0|||
105632730|NCT00571649|364320513|FG000|Treatment Period|Adverse Event|438|||
105632731|NCT00571649|364320514|FG001|Treatment Period|Adverse Event|385|||
105632732|NCT00571649|364320513|FG000|Treatment Period|Clinical endpoint reached|50|||
105632733|NCT00571649|364320514|FG001|Treatment Period|Clinical endpoint reached|56|||
105632734|NCT00571649|364320513|FG000|Treatment Period|Withdrawal by Subject|285|||
105632735|NCT00571649|364320514|FG001|Treatment Period|Withdrawal by Subject|255|||
105632736|NCT00571649|364320513|FG000|Treatment Period|Death|76|||
105632737|NCT00571649|364320514|FG001|Treatment Period|Death|59|||
105632738|NCT00571649|364320513|FG000|Treatment Period|Physician Decision|8|||
105632739|NCT00571649|364320514|FG001|Treatment Period|Physician Decision|9|||
105632740|NCT00571649|364320513|FG000|Treatment Period|Lost to Follow-up|43|||
105632741|NCT00571649|364320514|FG001|Treatment Period|Lost to Follow-up|41|||
105632742|NCT00571649|364320513|FG000|Treatment Period|Non-compliant with study medication|88|||
105632743|NCT00571649|364320514|FG001|Treatment Period|Non-compliant with study medication|89|||
105632744|NCT00571649|364320513|FG000|Treatment Period|Patient convenience|11|||
105632745|NCT00571649|364320514|FG001|Treatment Period|Patient convenience|13|||
105632746|NCT00571649|364320513|FG000|Treatment Period|Protocol Violation|90|||
105632747|NCT00571649|364320514|FG001|Treatment Period|Protocol Violation|92|||
105632748|NCT00571649|364320513|FG000|Treatment Period|Technical problems|3|||
105632749|NCT00571649|364320514|FG001|Treatment Period|Technical problems|5|||
105632750|NCT00571649|364320513|FG000|Follow-up Period|Adverse Event|46|||
105632751|NCT00571649|364320514|FG001|Follow-up Period|Adverse Event|40|||
105632752|NCT00571649|364320513|FG000|Follow-up Period|Clinical endpoint reached|5|||
105632753|NCT00571649|364320514|FG001|Follow-up Period|Clinical endpoint reached|2|||
105632754|NCT00571649|364320513|FG000|Follow-up Period|Withdrawal by Subject|119|||
105632755|NCT00571649|364320514|FG001|Follow-up Period|Withdrawal by Subject|115|||
105632756|NCT00571649|364320513|FG000|Follow-up Period|Death|132|||
105632757|NCT00571649|364320514|FG001|Follow-up Period|Death|133|||
105632758|NCT00571649|364320513|FG000|Follow-up Period|Physician Decision|7|||
105632759|NCT00571649|364320514|FG001|Follow-up Period|Physician Decision|13|||
105632760|NCT00571649|364320513|FG000|Follow-up Period|Lost to Follow-up|95|||
105632761|NCT00571649|364320514|FG001|Follow-up Period|Lost to Follow-up|92|||
105632762|NCT00571649|364320513|FG000|Follow-up Period|Patient convenience|136|||
105632763|NCT00571649|364320514|FG001|Follow-up Period|Patient convenience|121|||
105632764|NCT00571649|364320513|FG000|Follow-up Period|Protocol Violation|5|||
105632765|NCT00571649|364320514|FG001|Follow-up Period|Protocol Violation|12|||
105632766|NCT01218659|364320515|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
105632767|NCT01218659|364320516|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
105632768|NCT01218659|364320517|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
105632769|NCT01218659|364320515|FG000|18-Month Randomized Period|Did not receive study drug|0|||
105632770|NCT01218659|364320516|FG001|18-Month Randomized Period|Did not receive study drug|3|||
105632771|NCT01218659|364320517|FG002|18-Month Randomized Period|Did not receive study drug|0|||
105632772|NCT01218659|364320515|FG000|12-Month OLE|Withdrawal by Subject|0|||
105632773|NCT01218659|364320516|FG001|12-Month OLE|Withdrawal by Subject|0|||
105632774|NCT01218659|364320517|FG002|12-Month OLE|Withdrawal by Subject|2|||
105632775|NCT01218659|364320515|FG000|12-Month OLE|Physician Decision|0|||
105632776|NCT01218659|364320516|FG001|12-Month OLE|Physician Decision|0|||
105632777|NCT01218659|364320517|FG002|12-Month OLE|Physician Decision|1|||
105632778|NCT01218659|364320515|FG000|12-Month OLE|Lost to Follow-up|0|||
105632779|NCT01218659|364320516|FG001|12-Month OLE|Lost to Follow-up|0|||
105632780|NCT01218659|364320517|FG002|12-Month OLE|Lost to Follow-up|1|||
105632781|NCT01218659|364320515|FG000|12-Month OLE|Pregnancy|0|||
105632782|NCT01218659|364320516|FG001|12-Month OLE|Pregnancy|0|||
105632783|NCT01218659|364320517|FG002|12-Month OLE|Pregnancy|1|||
105632784|NCT01218659|364320515|FG000|12-Month OLE|Lack of Efficacy|0|||
105632785|NCT01218659|364320516|FG001|12-Month OLE|Lack of Efficacy|0|||
105632786|NCT01218659|364320517|FG002|12-Month OLE|Lack of Efficacy|1|||
105632787|NCT01218659|364320515|FG000|12-Month OLE|Declined to participate in the OLE|0|||
105632788|NCT01218659|364320516|FG001|12-Month OLE|Declined to participate in the OLE|0|||
105632789|NCT01218659|364320517|FG002|12-Month OLE|Declined to participate in the OLE|4|||
105632790|NCT00776009|364320522|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
105632791|NCT00776009|364320523|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
105632792|NCT00776009|364320524|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
105632793|NCT00776009|364320525|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
105632794|NCT00776009|364320526|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
105632795|NCT00776009|364320527|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
105632796|NCT00776009|364320522|FG000|Period 1: First Intervention|Protocol Violation|0|||
105632797|NCT00776009|364320523|FG001|Period 1: First Intervention|Protocol Violation|1|||
105632798|NCT00776009|364320524|FG002|Period 1: First Intervention|Protocol Violation|0|||
105632799|NCT00776009|364320525|FG003|Period 1: First Intervention|Protocol Violation|0|||
105632800|NCT00776009|364320526|FG004|Period 1: First Intervention|Protocol Violation|1|||
105632801|NCT00776009|364320527|FG005|Period 1: First Intervention|Protocol Violation|0|||
105632802|NCT00776009|364320522|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
105632803|NCT00776009|364320523|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
105632804|NCT00776009|364320524|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
105632805|NCT00776009|364320525|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
105632806|NCT00776009|364320526|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
105632807|NCT00776009|364320527|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
105632808|NCT00776009|364320522|FG000|Period 2: Second Intervention|Protocol Violation|1|||
105632809|NCT00776009|364320523|FG001|Period 2: Second Intervention|Protocol Violation|0|||
105632810|NCT00776009|364320524|FG002|Period 2: Second Intervention|Protocol Violation|1|||
105632811|NCT00776009|364320525|FG003|Period 2: Second Intervention|Protocol Violation|0|||
105632812|NCT00776009|364320526|FG004|Period 2: Second Intervention|Protocol Violation|0|||
105632813|NCT00776009|364320527|FG005|Period 2: Second Intervention|Protocol Violation|0|||
105632814|NCT00776009|364320522|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
105632815|NCT00776009|364320523|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
105632816|NCT00776009|364320524|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
105632817|NCT00776009|364320525|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
105632818|NCT00776009|364320526|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
105632819|NCT00776009|364320527|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
105632820|NCT01640951|364320532|FG000|Overall Study|Adverse Event|8|||
105632821|NCT01640951|364320533|FG001|Overall Study|Adverse Event|3|||
105632822|NCT01640951|364320534|FG002|Overall Study|Adverse Event|10|||
105632823|NCT01640951|364320535|FG003|Overall Study|Adverse Event|6|||
105632824|NCT01640951|364320536|FG004|Overall Study|Adverse Event|1|||
105632825|NCT01640951|364320537|FG005|Overall Study|Adverse Event|11|||
105632826|NCT01640951|364320538|FG006|Overall Study|Adverse Event|1|||
105632827|NCT01640951|364320539|FG007|Overall Study|Adverse Event|3|||
105632828|NCT01640951|364320532|FG000|Overall Study|Lack of Efficacy|20|||
105632829|NCT01640951|364320533|FG001|Overall Study|Lack of Efficacy|1|||
105632830|NCT01640951|364320534|FG002|Overall Study|Lack of Efficacy|7|||
105632831|NCT01640951|364320535|FG003|Overall Study|Lack of Efficacy|14|||
105632832|NCT01640951|364320536|FG004|Overall Study|Lack of Efficacy|0|||
105632833|NCT01640951|364320537|FG005|Overall Study|Lack of Efficacy|6|||
105632834|NCT01640951|364320538|FG006|Overall Study|Lack of Efficacy|5|||
105632835|NCT01640951|364320539|FG007|Overall Study|Lack of Efficacy|6|||
105632836|NCT01640951|364320532|FG000|Overall Study|Lost to Follow-up|1|||
105632837|NCT01640951|364320533|FG001|Overall Study|Lost to Follow-up|0|||
105632838|NCT01640951|364320534|FG002|Overall Study|Lost to Follow-up|6|||
105632839|NCT01640951|364320535|FG003|Overall Study|Lost to Follow-up|2|||
105632840|NCT01640951|364320536|FG004|Overall Study|Lost to Follow-up|2|||
105632841|NCT01640951|364320537|FG005|Overall Study|Lost to Follow-up|3|||
105632842|NCT01640951|364320538|FG006|Overall Study|Lost to Follow-up|1|||
105632843|NCT01640951|364320539|FG007|Overall Study|Lost to Follow-up|1|||
105632844|NCT01640951|364320532|FG000|Overall Study|Non-compliance with study treatment|0|||
105632845|NCT01640951|364320533|FG001|Overall Study|Non-compliance with study treatment|0|||
105632846|NCT01640951|364320534|FG002|Overall Study|Non-compliance with study treatment|1|||
105632847|NCT01640951|364320535|FG003|Overall Study|Non-compliance with study treatment|1|||
105632848|NCT01640951|364320536|FG004|Overall Study|Non-compliance with study treatment|1|||
105632849|NCT01640951|364320537|FG005|Overall Study|Non-compliance with study treatment|4|||
105632850|NCT01640951|364320538|FG006|Overall Study|Non-compliance with study treatment|1|||
105632851|NCT01640951|364320539|FG007|Overall Study|Non-compliance with study treatment|0|||
105632852|NCT01640951|364320532|FG000|Overall Study|Physician Decision|2|||
105632853|NCT01640951|364320533|FG001|Overall Study|Physician Decision|5|||
105632854|NCT01640951|364320534|FG002|Overall Study|Physician Decision|2|||
105632855|NCT01640951|364320535|FG003|Overall Study|Physician Decision|2|||
105632856|NCT01640951|364320536|FG004|Overall Study|Physician Decision|2|||
105632857|NCT01640951|364320537|FG005|Overall Study|Physician Decision|3|||
105632858|NCT01640951|364320538|FG006|Overall Study|Physician Decision|3|||
105632859|NCT01640951|364320539|FG007|Overall Study|Physician Decision|0|||
105632860|NCT01640951|364320532|FG000|Overall Study|Pregnancy|3|||
105632861|NCT01640951|364320533|FG001|Overall Study|Pregnancy|0|||
105632862|NCT01640951|364320534|FG002|Overall Study|Pregnancy|0|||
105632863|NCT01640951|364320535|FG003|Overall Study|Pregnancy|4|||
105632864|NCT01640951|364320536|FG004|Overall Study|Pregnancy|0|||
105632865|NCT01640951|364320537|FG005|Overall Study|Pregnancy|0|||
105632866|NCT01640951|364320538|FG006|Overall Study|Pregnancy|2|||
105632867|NCT01640951|364320539|FG007|Overall Study|Pregnancy|0|||
105632868|NCT01640951|364320532|FG000|Overall Study|Protocol Deviation|0|||
105632869|NCT01640951|364320533|FG001|Overall Study|Protocol Deviation|1|||
105632870|NCT01640951|364320534|FG002|Overall Study|Protocol Deviation|2|||
105632871|NCT01640951|364320535|FG003|Overall Study|Protocol Deviation|1|||
105632872|NCT01640951|364320536|FG004|Overall Study|Protocol Deviation|0|||
105632873|NCT01640951|364320537|FG005|Overall Study|Protocol Deviation|1|||
105632874|NCT01640951|364320538|FG006|Overall Study|Protocol Deviation|0|||
105632875|NCT01640951|364320539|FG007|Overall Study|Protocol Deviation|0|||
105632876|NCT01640951|364320532|FG000|Overall Study|Subject/Guardian decision|12|||
105632877|NCT01640951|364320533|FG001|Overall Study|Subject/Guardian decision|4|||
105632878|NCT01640951|364320534|FG002|Overall Study|Subject/Guardian decision|13|||
105632879|NCT01640951|364320535|FG003|Overall Study|Subject/Guardian decision|15|||
105632880|NCT01640951|364320536|FG004|Overall Study|Subject/Guardian decision|7|||
105632881|NCT01640951|364320537|FG005|Overall Study|Subject/Guardian decision|19|||
105632882|NCT01640951|364320538|FG006|Overall Study|Subject/Guardian decision|5|||
105632883|NCT01640951|364320539|FG007|Overall Study|Subject/Guardian decision|4|||
105632884|NCT01640951|364320532|FG000|Overall Study|Death|0|||
105632885|NCT01640951|364320533|FG001|Overall Study|Death|1|||
105632886|NCT01640951|364320534|FG002|Overall Study|Death|1|||
105632887|NCT01640951|364320535|FG003|Overall Study|Death|0|||
105632888|NCT01640951|364320536|FG004|Overall Study|Death|0|||
105632889|NCT01640951|364320537|FG005|Overall Study|Death|0|||
105632890|NCT01640951|364320538|FG006|Overall Study|Death|0|||
105632891|NCT01640951|364320539|FG007|Overall Study|Death|2|||
105632892|NCT00582972|364320540|FG000|Overall Study|Protocol Violation|2|||
105632893|NCT03066609|364320541|FG000|INDUCTION|Pregnancy|0|||
105632894|NCT03066609|364320542|FG001|INDUCTION|Pregnancy|0|||
105632895|NCT03066609|364320543|FG002|INDUCTION|Pregnancy|1|||
105632896|NCT03066609|364320544|FG003|INDUCTION|Pregnancy|0|||
105632897|NCT03066609|364320541|FG000|INDUCTION|Lack of Efficacy|0|||
105632898|NCT03066609|364320542|FG001|INDUCTION|Lack of Efficacy|0|||
105632899|NCT03066609|364320543|FG002|INDUCTION|Lack of Efficacy|1|||
105632900|NCT03066609|364320544|FG003|INDUCTION|Lack of Efficacy|0|||
105632901|NCT03066609|364320541|FG000|INDUCTION|Adverse Event|2|||
105632902|NCT03066609|364320542|FG001|INDUCTION|Adverse Event|2|||
105632903|NCT03066609|364320543|FG002|INDUCTION|Adverse Event|0|||
105632904|NCT03066609|364320544|FG003|INDUCTION|Adverse Event|0|||
105632905|NCT03066609|364320541|FG000|MAINTENANCE|Adverse Event|0|||
105632906|NCT03066609|364320542|FG001|MAINTENANCE|Adverse Event|0|||
105632907|NCT03066609|364320543|FG002|MAINTENANCE|Adverse Event|0|||
105632908|NCT03066609|364320544|FG003|MAINTENANCE|Adverse Event|1|||
105632909|NCT03066609|364320541|FG000|MAINTENANCE|Withdrawal by Subject|4|||
105632910|NCT03066609|364320542|FG001|MAINTENANCE|Withdrawal by Subject|2|||
105632911|NCT03066609|364320543|FG002|MAINTENANCE|Withdrawal by Subject|1|||
105632912|NCT03066609|364320544|FG003|MAINTENANCE|Withdrawal by Subject|1|||
105632913|NCT03066609|364320541|FG000|MAINTENANCE|Lost to Follow-up|0|||
105632914|NCT03066609|364320542|FG001|MAINTENANCE|Lost to Follow-up|1|||
105632915|NCT03066609|364320543|FG002|MAINTENANCE|Lost to Follow-up|1|||
105632916|NCT03066609|364320544|FG003|MAINTENANCE|Lost to Follow-up|0|||
105632917|NCT03066609|364320541|FG000|MAINTENANCE|Pregnancy|1|||
105632918|NCT03066609|364320542|FG001|MAINTENANCE|Pregnancy|0|||
105632919|NCT03066609|364320543|FG002|MAINTENANCE|Pregnancy|0|||
105632920|NCT03066609|364320544|FG003|MAINTENANCE|Pregnancy|0|||
105632921|NCT03066609|364320541|FG000|MAINTENANCE|Lack of Efficacy|2|||
105632922|NCT03066609|364320542|FG001|MAINTENANCE|Lack of Efficacy|1|||
105632923|NCT03066609|364320543|FG002|MAINTENANCE|Lack of Efficacy|0|||
105632924|NCT03066609|364320544|FG003|MAINTENANCE|Lack of Efficacy|1|||
105632925|NCT03066609|364320541|FG000|OVERALL STUDY|Adverse Event|2|||
105632926|NCT03066609|364320542|FG001|OVERALL STUDY|Adverse Event|2|||
105632927|NCT03066609|364320543|FG002|OVERALL STUDY|Adverse Event|0|||
105632928|NCT03066609|364320544|FG003|OVERALL STUDY|Adverse Event|1|||
105632929|NCT03066609|364320541|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
105632930|NCT03066609|364320542|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
105632931|NCT03066609|364320543|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
105632932|NCT03066609|364320544|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
105632933|NCT03066609|364320541|FG000|OVERALL STUDY|Lost to Follow-up|1|||
105632934|NCT03066609|364320542|FG001|OVERALL STUDY|Lost to Follow-up|1|||
105632935|NCT03066609|364320543|FG002|OVERALL STUDY|Lost to Follow-up|1|||
105632936|NCT03066609|364320544|FG003|OVERALL STUDY|Lost to Follow-up|1|||
105632937|NCT03066609|364320541|FG000|OVERALL STUDY|Pregnancy|1|||
105632938|NCT03066609|364320542|FG001|OVERALL STUDY|Pregnancy|0|||
105632939|NCT03066609|364320543|FG002|OVERALL STUDY|Pregnancy|1|||
105632940|NCT03066609|364320544|FG003|OVERALL STUDY|Pregnancy|0|||
105632941|NCT03066609|364320541|FG000|OVERALL STUDY|Lack of Efficacy|2|||
105632942|NCT03066609|364320542|FG001|OVERALL STUDY|Lack of Efficacy|1|||
105632943|NCT03066609|364320543|FG002|OVERALL STUDY|Lack of Efficacy|1|||
105632944|NCT03066609|364320544|FG003|OVERALL STUDY|Lack of Efficacy|1|||
105632945|NCT03066609|364320541|FG000|OVERALL STUDY|discontinued follow up|0|||
105632946|NCT03066609|364320542|FG001|OVERALL STUDY|discontinued follow up|2|||
105632947|NCT03066609|364320543|FG002|OVERALL STUDY|discontinued follow up|0|||
105632948|NCT03066609|364320544|FG003|OVERALL STUDY|discontinued follow up|0|||
105632949|NCT03355573|364320545|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
105632950|NCT03355573|364320545|FG000|Overall Study|Sponsor's decision|1|||
105632951|NCT03355573|364320545|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
105632952|NCT03355573|364320545|FG000|Overall Study|PI's decision|2|||
105632953|NCT03355573|364320545|FG000|Overall Study|Withdrawal by Subject|23|||
105632954|NCT03355573|364320545|FG000|Overall Study|Lost to Follow-up|4|||
105632955|NCT03355573|364320545|FG000|Overall Study|Lack of Efficacy|2|||
105632956|NCT03355573|364320545|FG000|Overall Study|Adverse Event, non-fatal|17|||
105632957|NCT03355573|364320545|FG000|Overall Study|Adverse Event, serious fatal|2|||
105632958|NCT01211184|364320554|FG000|Overall Study|Withdrawal by Subject|0|||
105632959|NCT01211184|364320555|FG001|Overall Study|Withdrawal by Subject|2|||
105632960|NCT01211184|364320556|FG002|Overall Study|Withdrawal by Subject|1|||
105632961|NCT01421667|364320557|FG000|Overall Study|Withdrawal by Subject|0|||
105632962|NCT01421667|364320558|FG001|Overall Study|Withdrawal by Subject|1|||
105632963|NCT01421667|364320559|FG002|Overall Study|Withdrawal by Subject|2|||
105632964|NCT01421667|364320560|FG003|Overall Study|Withdrawal by Subject|1|||
105632965|NCT01421667|364320557|FG000|Overall Study|Lost to Follow-up|0|||
105632966|NCT01421667|364320558|FG001|Overall Study|Lost to Follow-up|1|||
105632967|NCT01421667|364320559|FG002|Overall Study|Lost to Follow-up|0|||
105632968|NCT01421667|364320560|FG003|Overall Study|Lost to Follow-up|0|||
105632969|NCT00982644|364320561|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
105632970|NCT00982644|364320562|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
105632971|NCT00982644|364320561|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
105632972|NCT00982644|364320562|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
105632973|NCT00982644|364320561|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
105632974|NCT00982644|364320562|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
105632975|NCT00982644|364320561|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
105632976|NCT00982644|364320562|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
105632977|NCT00982644|364320561|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
105632978|NCT00982644|364320562|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
105632979|NCT00982644|364320561|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
105632980|NCT00982644|364320562|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
105632981|NCT00982644|364320561|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
105632982|NCT00982644|364320562|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
105632983|NCT00982644|364320561|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
105632984|NCT00982644|364320562|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
105632985|NCT00982644|364320561|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
105632986|NCT00982644|364320562|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
105632987|NCT00982644|364320561|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
105632988|NCT00982644|364320562|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
105632989|NCT00822120|364320563|FG000|Initial Registration|Adverse Event|1|||
105632990|NCT00822120|364320564|FG001|Initial Registration|Adverse Event|0|||
105632991|NCT00822120|364320565|FG002|Initial Registration|Adverse Event|0|||
105632992|NCT00822120|364320566|FG003|Initial Registration|Adverse Event|0|||
105632993|NCT00822120|364320567|FG004|Initial Registration|Adverse Event|0|||
105632994|NCT00822120|364320568|FG005|Initial Registration|Adverse Event|0|||
105632995|NCT00822120|364320563|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
105632996|NCT00822120|364320564|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
105632997|NCT00822120|364320565|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
105632998|NCT00822120|364320566|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
105632999|NCT00822120|364320567|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
105633000|NCT00822120|364320568|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
105633001|NCT00822120|364320563|FG000|Initial Registration|Reasons not Protocol Specified|2|||
105633002|NCT00822120|364320564|FG001|Initial Registration|Reasons not Protocol Specified|0|||
105633003|NCT00822120|364320565|FG002|Initial Registration|Reasons not Protocol Specified|0|||
105633004|NCT00822120|364320566|FG003|Initial Registration|Reasons not Protocol Specified|0|||
105633005|NCT00822120|364320567|FG004|Initial Registration|Reasons not Protocol Specified|0|||
105633006|NCT00822120|364320568|FG005|Initial Registration|Reasons not Protocol Specified|0|||
105633007|NCT00822120|364320563|FG000|Initial Registration|Ineligible|22|||
105633008|NCT00822120|364320564|FG001|Initial Registration|Ineligible|1|||
105633009|NCT00822120|364320565|FG002|Initial Registration|Ineligible|0|||
105633010|NCT00822120|364320566|FG003|Initial Registration|Ineligible|0|||
105633011|NCT00822120|364320567|FG004|Initial Registration|Ineligible|0|||
105633012|NCT00822120|364320568|FG005|Initial Registration|Ineligible|0|||
105633013|NCT00822120|364320563|FG000|PET-directed Therapy|Adverse Event|0|||
105633014|NCT00822120|364320564|FG001|PET-directed Therapy|Adverse Event|0|||
105633015|NCT00822120|364320565|FG002|PET-directed Therapy|Adverse Event|0|||
105633016|NCT00822120|364320566|FG003|PET-directed Therapy|Adverse Event|1|||
105633017|NCT00822120|364320567|FG004|PET-directed Therapy|Adverse Event|0|||
105633018|NCT00822120|364320568|FG005|PET-directed Therapy|Adverse Event|0|||
105633019|NCT00822120|364320563|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
105633020|NCT00822120|364320564|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
105633021|NCT00822120|364320565|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
105633022|NCT00822120|364320566|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
105633023|NCT00822120|364320567|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
105633024|NCT00822120|364320568|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
105633025|NCT00822120|364320563|FG000|PET-directed Therapy|Death|0|||
105633026|NCT00822120|364320564|FG001|PET-directed Therapy|Death|0|||
105633027|NCT00822120|364320565|FG002|PET-directed Therapy|Death|0|||
105633028|NCT00822120|364320566|FG003|PET-directed Therapy|Death|2|||
105633029|NCT00822120|364320567|FG004|PET-directed Therapy|Death|0|||
105633030|NCT00822120|364320568|FG005|PET-directed Therapy|Death|0|||
105633031|NCT00822120|364320563|FG000|PET-directed Therapy|Protocol Violation|0|||
105633032|NCT00822120|364320564|FG001|PET-directed Therapy|Protocol Violation|0|||
105633033|NCT00822120|364320565|FG002|PET-directed Therapy|Protocol Violation|0|||
105633034|NCT00822120|364320566|FG003|PET-directed Therapy|Protocol Violation|6|||
105633035|NCT00822120|364320567|FG004|PET-directed Therapy|Protocol Violation|0|||
105633036|NCT00822120|364320568|FG005|PET-directed Therapy|Protocol Violation|0|||
105633037|NCT01218009|364320569|FG000|Overall Study|Protocol Violation|2|||
105633038|NCT01218009|364320570|FG001|Overall Study|Protocol Violation|1|||
105633039|NCT01218009|364320569|FG000|Overall Study|Withdrawal by Subject|3|||
105633040|NCT01218009|364320570|FG001|Overall Study|Withdrawal by Subject|1|||
105633041|NCT01218009|364320569|FG000|Overall Study|Sponsor terminated study|161|||
105633042|NCT01218009|364320570|FG001|Overall Study|Sponsor terminated study|163|||
105633043|NCT00503906|364320573|FG000|Overall Study|Withdrawal by Subject|1|||
105633044|NCT01324310|364320574|FG000|Overall Study|Adverse Event|1|||
105633045|NCT01324310|364320574|FG000|Overall Study|Disease Progression|1|||
105633046|NCT04060212|364320576|FG000|Overall Study|Withdrawal by Subject|7|||
105633047|NCT00174252|364320577|FG000|Overall Study|Protocol Violation|2|||
105633048|NCT01171976|364320578|FG000|Overall Study|Protocol Violation|0|||
105633049|NCT01171976|364320579|FG001|Overall Study|Protocol Violation|0|||
105633050|NCT01171976|364320580|FG002|Overall Study|Protocol Violation|1|||
105633051|NCT01171976|364320578|FG000|Overall Study|Death|2|||
105633052|NCT01171976|364320579|FG001|Overall Study|Death|4|||
105633053|NCT01171976|364320580|FG002|Overall Study|Death|1|||
105633054|NCT01171976|364320578|FG000|Overall Study|Lost to Follow-up|4|||
105633055|NCT01171976|364320579|FG001|Overall Study|Lost to Follow-up|0|||
105633056|NCT01171976|364320580|FG002|Overall Study|Lost to Follow-up|2|||
105633057|NCT01171976|364320578|FG000|Overall Study|Withdrawal by Subject|1|||
105633058|NCT01171976|364320579|FG001|Overall Study|Withdrawal by Subject|5|||
105633059|NCT01171976|364320580|FG002|Overall Study|Withdrawal by Subject|6|||
105633060|NCT01171976|364320578|FG000|Overall Study|Abnormal test result|1|||
105633061|NCT01171976|364320579|FG001|Overall Study|Abnormal test result|0|||
105633062|NCT01171976|364320580|FG002|Overall Study|Abnormal test result|0|||
105633063|NCT01171976|364320578|FG000|Overall Study|Adverse Event|6|||
105633064|NCT01171976|364320579|FG001|Overall Study|Adverse Event|2|||
105633065|NCT01171976|364320580|FG002|Overall Study|Adverse Event|5|||
105633066|NCT02844439|364320581|FG000|Overall Study|Withdrawal by Subject|1|||
105633067|NCT02844439|364320581|FG000|Overall Study|Lost to Follow-up|2|||
105633068|NCT02844439|364320581|FG000|Overall Study|Termination by Sponsor|4|||
105633069|NCT02844439|364320581|FG000|Overall Study|Death|28|||
105633070|NCT02844439|364320581|FG000|Overall Study|Other|5|||
105633071|NCT03304587|364320584|FG000|Overall Study|Headache after intervention|0|||
105633072|NCT03304587|364320585|FG001|Overall Study|Headache after intervention|1|||
105633073|NCT03304587|364320584|FG000|Overall Study|Withdrawal by Subject|1|||
105633074|NCT03304587|364320585|FG001|Overall Study|Withdrawal by Subject|0|||
105633075|NCT01458366|364320587|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
105633076|NCT01458366|364320588|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
105633077|NCT01458366|364320589|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
105633078|NCT01458366|364320590|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
105633079|NCT01458366|364320591|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
105633080|NCT01458366|364320587|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
105633081|NCT01458366|364320588|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
105633082|NCT01458366|364320589|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
105633083|NCT01458366|364320590|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
105633084|NCT01458366|364320591|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
105633085|NCT01387516|364320592|FG000|Overall Study|Lost to Follow-up|4|||
105633086|NCT01387516|364320593|FG001|Overall Study|Lost to Follow-up|4|||
105633087|NCT01387516|364320594|FG002|Overall Study|Lost to Follow-up|2|||
105633088|NCT01387516|364320595|FG003|Overall Study|Lost to Follow-up|3|||
105633089|NCT01387516|364320592|FG000|Overall Study|Withdrawal by Subject|1|||
105633090|NCT01387516|364320593|FG001|Overall Study|Withdrawal by Subject|1|||
105633091|NCT01387516|364320594|FG002|Overall Study|Withdrawal by Subject|2|||
105633092|NCT01387516|364320595|FG003|Overall Study|Withdrawal by Subject|0|||
105633093|NCT01387516|364320592|FG000|Overall Study|Death|0|||
105633094|NCT01387516|364320593|FG001|Overall Study|Death|0|||
105633095|NCT01387516|364320594|FG002|Overall Study|Death|0|||
105633096|NCT01387516|364320595|FG003|Overall Study|Death|1|||
105633097|NCT02337686|364320597|FG000|Overall Study|Adverse Event|1|||
105633098|NCT03516942|364320598|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
105633099|NCT03516942|364320598|FG000|Registration Through Baseline Survey Com|Death|8|||
105633100|NCT03516942|364320598|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
105633101|NCT03516942|364320598|FG000|T0: Baseline|LOST|13|||
105633102|NCT03516942|364320598|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
105633103|NCT03516942|364320598|FG000|T1: 3 Months Survey|Death|10|||
105633104|NCT03516942|364320598|FG000|T1: 3 Months Survey|Lost|163|||
105633105|NCT03516942|364320598|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
105633106|NCT03516942|364320598|FG000|T2: 6 Month Survey|Death|14|||
105633107|NCT03516942|364320598|FG000|T2: 6 Month Survey|Lost|180|||
105633108|NCT03516942|364320598|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
105633109|NCT03516942|364320598|FG000|T3: 12 Month Survey|Death|19|||
105633110|NCT03516942|364320598|FG000|T3: 12 Month Survey|Lost|209|||
105633111|NCT02401815|364320599|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633112|NCT02401815|364320600|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633113|NCT02401815|364320601|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633114|NCT02401815|364320602|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
105633115|NCT02401815|364320603|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633116|NCT02401815|364320604|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633117|NCT02401815|364320605|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633118|NCT02401815|364320606|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633119|NCT02401815|364320607|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633120|NCT02401815|364320608|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633121|NCT02401815|364320599|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
105633122|NCT02401815|364320600|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105633123|NCT02401815|364320601|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105633124|NCT02401815|364320602|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
105633125|NCT02401815|364320603|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105633126|NCT02401815|364320604|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105633127|NCT02401815|364320605|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105633128|NCT02401815|364320606|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105633129|NCT02401815|364320607|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105633130|NCT02401815|364320608|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105633131|NCT02401815|364320599|FG000|Dose Escalation (up to 670 Days)|Death|1|||
105633132|NCT02401815|364320600|FG001|Dose Escalation (up to 670 Days)|Death|2|||
105633133|NCT02401815|364320601|FG002|Dose Escalation (up to 670 Days)|Death|3|||
105633134|NCT02401815|364320602|FG003|Dose Escalation (up to 670 Days)|Death|5|||
105633135|NCT02401815|364320603|FG004|Dose Escalation (up to 670 Days)|Death|4|||
105633136|NCT02401815|364320604|FG005|Dose Escalation (up to 670 Days)|Death|0|||
105633137|NCT02401815|364320605|FG006|Dose Escalation (up to 670 Days)|Death|0|||
105633138|NCT02401815|364320606|FG007|Dose Escalation (up to 670 Days)|Death|0|||
105633139|NCT02401815|364320607|FG008|Dose Escalation (up to 670 Days)|Death|0|||
105633140|NCT02401815|364320608|FG009|Dose Escalation (up to 670 Days)|Death|0|||
105633141|NCT02401815|364320599|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633142|NCT02401815|364320600|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
105633143|NCT02401815|364320601|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633144|NCT02401815|364320602|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633145|NCT02401815|364320603|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
105633146|NCT02401815|364320604|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633147|NCT02401815|364320605|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633148|NCT02401815|364320606|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633149|NCT02401815|364320607|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633150|NCT02401815|364320608|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633151|NCT02401815|364320599|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
105633152|NCT02401815|364320600|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633153|NCT02401815|364320601|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633154|NCT02401815|364320602|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633155|NCT02401815|364320603|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
105633156|NCT02401815|364320604|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633157|NCT02401815|364320605|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633158|NCT02401815|364320606|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633159|NCT02401815|364320607|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633160|NCT02401815|364320608|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633161|NCT02401815|364320599|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633162|NCT02401815|364320600|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633163|NCT02401815|364320601|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633164|NCT02401815|364320602|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633165|NCT02401815|364320603|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633166|NCT02401815|364320604|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
105633167|NCT02401815|364320605|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633168|NCT02401815|364320606|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633169|NCT02401815|364320607|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633170|NCT02401815|364320608|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633171|NCT02401815|364320599|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633172|NCT02401815|364320600|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633173|NCT02401815|364320601|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633174|NCT02401815|364320602|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633175|NCT02401815|364320603|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633176|NCT02401815|364320604|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633177|NCT02401815|364320605|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
105633178|NCT02401815|364320606|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633179|NCT02401815|364320607|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633180|NCT02401815|364320608|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633181|NCT02401815|364320599|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633182|NCT02401815|364320600|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633183|NCT02401815|364320601|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633184|NCT02401815|364320602|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633185|NCT02401815|364320603|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633186|NCT02401815|364320604|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
105633187|NCT02401815|364320605|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
105633188|NCT02401815|364320606|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633189|NCT02401815|364320607|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633190|NCT02401815|364320608|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633191|NCT02401815|364320599|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633192|NCT02401815|364320600|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633193|NCT02401815|364320601|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633194|NCT02401815|364320602|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633195|NCT02401815|364320603|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633196|NCT02401815|364320604|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
105633197|NCT02401815|364320605|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633198|NCT02401815|364320606|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633199|NCT02401815|364320607|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633200|NCT02401815|364320608|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633201|NCT02401815|364320599|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
105633202|NCT02401815|364320600|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
105633203|NCT02401815|364320601|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
105633204|NCT02401815|364320602|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
105633205|NCT02401815|364320603|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
105633206|NCT02401815|364320604|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
105633207|NCT02401815|364320605|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
105633208|NCT02401815|364320606|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
105633209|NCT02401815|364320607|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
105633210|NCT02401815|364320608|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
105633211|NCT02401815|364320599|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633212|NCT02401815|364320600|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633213|NCT02401815|364320601|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633214|NCT02401815|364320602|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633215|NCT02401815|364320603|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633216|NCT02401815|364320604|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633217|NCT02401815|364320605|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633218|NCT02401815|364320606|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633219|NCT02401815|364320607|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
105633220|NCT02401815|364320608|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
105633221|NCT02401815|364320599|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633222|NCT02401815|364320600|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633223|NCT02401815|364320601|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633224|NCT02401815|364320602|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633225|NCT02401815|364320603|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633226|NCT02401815|364320604|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633227|NCT02401815|364320605|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633228|NCT02401815|364320606|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633229|NCT02401815|364320607|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633230|NCT02401815|364320608|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
105633231|NCT02401815|364320599|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633232|NCT02401815|364320600|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633233|NCT02401815|364320601|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633234|NCT02401815|364320602|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633235|NCT02401815|364320603|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633236|NCT02401815|364320604|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633237|NCT02401815|364320605|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633238|NCT02401815|364320606|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633239|NCT02401815|364320607|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
105633240|NCT02401815|364320608|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633241|NCT02401815|364320599|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105633242|NCT02401815|364320600|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105633243|NCT02401815|364320601|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105633244|NCT02401815|364320602|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105633245|NCT02401815|364320603|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105633246|NCT02401815|364320604|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105633247|NCT02401815|364320605|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105633248|NCT02401815|364320606|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
105633249|NCT02401815|364320607|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105633250|NCT02401815|364320608|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
105633251|NCT04551066|364320611|FG000|Overall Study|Death|5|||
105633252|NCT04551066|364320612|FG001|Overall Study|Death|3|||
105633253|NCT04551066|364320611|FG000|Overall Study|Lost to Follow-up|1|||
105633254|NCT04551066|364320612|FG001|Overall Study|Lost to Follow-up|0|||
105633255|NCT04551066|364320611|FG000|Overall Study|Sponsor Decision|103|||
105633256|NCT04551066|364320612|FG001|Overall Study|Sponsor Decision|117|||
105633257|NCT04551066|364320611|FG000|Overall Study|Withdrawal by Subject|8|||
105633258|NCT04551066|364320612|FG001|Overall Study|Withdrawal by Subject|2|||
105633259|NCT04551066|364320611|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
105633260|NCT04551066|364320612|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
105633261|NCT04551066|364320611|FG000|Overall Study|Adverse Event|2|||
105633262|NCT04551066|364320612|FG001|Overall Study|Adverse Event|0|||
105633263|NCT04551066|364320611|FG000|Overall Study|Physician Decision|2|||
105633264|NCT04551066|364320612|FG001|Overall Study|Physician Decision|0|||
105633265|NCT04551066|364320611|FG000|Overall Study|Protocol Violation|1|||
105633266|NCT04551066|364320612|FG001|Overall Study|Protocol Violation|0|||
105633267|NCT04551066|364320611|FG000|Overall Study|Lack of Efficacy|0|||
105633268|NCT04551066|364320612|FG001|Overall Study|Lack of Efficacy|1|||
105633269|NCT04551066|364320611|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
105633270|NCT04551066|364320612|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
105633271|NCT04701203|364320613|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
105633272|NCT04701203|364320614|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
105633273|NCT04701203|364320615|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
105633274|NCT04701203|364320613|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
105633275|NCT04701203|364320614|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
105633276|NCT04701203|364320615|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
105633277|NCT04701203|364320613|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
105633278|NCT04701203|364320614|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
105633279|NCT04701203|364320615|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
105633280|NCT04701203|364320613|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
105633281|NCT04701203|364320614|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
105633282|NCT04701203|364320615|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
105633283|NCT02798471|364320618|FG000|Overall Study|Adverse Event|7|||
105633284|NCT02798471|364320619|FG001|Overall Study|Adverse Event|2|||
105633285|NCT02798471|364320618|FG000|Overall Study|Physician Decision|3|||
105633286|NCT02798471|364320619|FG001|Overall Study|Physician Decision|7|||
105633287|NCT02798471|364320618|FG000|Overall Study|Death|2|||
105633288|NCT02798471|364320619|FG001|Overall Study|Death|3|||
105633289|NCT02798471|364320618|FG000|Overall Study|Lost to Follow-up|0|||
105633290|NCT02798471|364320619|FG001|Overall Study|Lost to Follow-up|1|||
105633291|NCT02798471|364320618|FG000|Overall Study|Other|5|||
105633292|NCT02798471|364320619|FG001|Overall Study|Other|3|||
105633293|NCT02798471|364320618|FG000|Overall Study|Subject withdrew consent|0|||
105633294|NCT02798471|364320619|FG001|Overall Study|Subject withdrew consent|6|||
105633295|NCT02798471|364320618|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
105633296|NCT02798471|364320619|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
105633297|NCT02798471|364320618|FG000|Overall Study|Randomized, but not treated|0|||
105633298|NCT02798471|364320619|FG001|Overall Study|Randomized, but not treated|2|||
105633299|NCT01266642|364320620|FG000|Overall Study|Protocol Violation|0|||
105633300|NCT01266642|364320621|FG001|Overall Study|Protocol Violation|1|||
105633301|NCT02386098|364322309|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
105633302|NCT02386098|364322310|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
105633303|NCT02386098|364322311|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
105633304|NCT02386098|364322312|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
105633305|NCT02386098|364322313|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
105633306|NCT02386098|364322309|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
105633307|NCT02386098|364322310|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
105633308|NCT02386098|364322311|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
105633309|NCT02386098|364322312|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
105633310|NCT02386098|364322313|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
105633311|NCT02386098|364322309|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
105633312|NCT02386098|364322310|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
105633313|NCT02386098|364322311|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
105633314|NCT02386098|364322312|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
105633315|NCT02386098|364322313|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
105633316|NCT02386098|364322309|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
105633317|NCT02386098|364322310|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
105633318|NCT02386098|364322311|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
105633319|NCT02386098|364322312|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
105633320|NCT02386098|364322313|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
105633321|NCT02386098|364322309|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
105633322|NCT02386098|364322310|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
105633323|NCT02386098|364322311|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
105633324|NCT02386098|364322312|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
105633325|NCT02386098|364322313|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
105633326|NCT02386098|364322309|FG000|Stage 1 (96 Weeks)|Other|1|||
105633327|NCT02386098|364322310|FG001|Stage 1 (96 Weeks)|Other|0|||
105633328|NCT02386098|364322311|FG002|Stage 1 (96 Weeks)|Other|0|||
105633329|NCT02386098|364322312|FG003|Stage 1 (96 Weeks)|Other|0|||
105633330|NCT02386098|364322313|FG004|Stage 1 (96 Weeks)|Other|0|||
105633331|NCT02386098|364322309|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
105633332|NCT02386098|364322310|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
105633333|NCT02386098|364322311|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
105633334|NCT02386098|364322312|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
105633335|NCT02386098|364322313|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
105633336|NCT04503681|364322319|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
105633337|NCT04503681|364322320|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
105633338|NCT02760654|364322321|FG000|Overall Study|Lost to Follow-up|3|||
105633339|NCT02760654|364322322|FG001|Overall Study|Lost to Follow-up|3|||
105633340|NCT02760654|364322321|FG000|Overall Study|Withdrawal by Subject|4|||
105633341|NCT02760654|364322322|FG001|Overall Study|Withdrawal by Subject|3|||
105633342|NCT00210106|364322323|FG000|Overall Study|Death|1|||
105633343|NCT00210106|364322323|FG000|Overall Study|Protocol Violation|13|||
105633344|NCT00786864|364322324|FG000|Overall Study|Lost to Follow-up|0|||
105633345|NCT00786864|364322325|FG001|Overall Study|Lost to Follow-up|1|||
105633346|NCT00786864|364322324|FG000|Overall Study|Sustained serious back injury|1|||
105633347|NCT00786864|364322325|FG001|Overall Study|Sustained serious back injury|0|||
105633348|NCT01084694|364322326|FG000|Overall Study|Withdrawal by Subject|2|||
105633349|NCT01084694|364322327|FG001|Overall Study|Withdrawal by Subject|1|||
105633350|NCT01084694|364322326|FG000|Overall Study|Death|2|||
105633351|NCT01084694|364322327|FG001|Overall Study|Death|12|||
105633352|NCT01084694|364322326|FG000|Overall Study|eligibility not maintained|2|||
105633353|NCT01084694|364322327|FG001|Overall Study|eligibility not maintained|7|||
105633354|NCT00065182|364322336|FG000|Overall Study|Adverse Event|24|||
105633355|NCT00065182|364322337|FG001|Overall Study|Adverse Event|17|||
105633356|NCT00065182|364322336|FG000|Overall Study|Lost to Follow-up|0|||
105633357|NCT00065182|364322337|FG001|Overall Study|Lost to Follow-up|4|||
105633358|NCT00065182|364322336|FG000|Overall Study|Protocol Violation|3|||
105633359|NCT00065182|364322337|FG001|Overall Study|Protocol Violation|4|||
105633360|NCT00065182|364322336|FG000|Overall Study|Serious adverse events (SAE)|1|||
105633361|NCT00065182|364322337|FG001|Overall Study|Serious adverse events (SAE)|0|||
105633362|NCT00065182|364322336|FG000|Overall Study|Sponsor Decision|11|||
105633363|NCT00065182|364322337|FG001|Overall Study|Sponsor Decision|7|||
105633364|NCT00065182|364322336|FG000|Overall Study|Withdrawal by Subject|8|||
105633365|NCT00065182|364322337|FG001|Overall Study|Withdrawal by Subject|3|||
105633366|NCT00065182|364322336|FG000|Overall Study|No clinical benefit|1|||
105633367|NCT00065182|364322337|FG001|Overall Study|No clinical benefit|0|||
105633368|NCT00065182|364322336|FG000|Overall Study|Death|0|||
105633369|NCT00065182|364322337|FG001|Overall Study|Death|1|||
105633370|NCT00065182|364322336|FG000|Overall Study|Decline in Status|0|||
105633371|NCT00065182|364322337|FG001|Overall Study|Decline in Status|1|||
105633372|NCT04213807|364322338|FG000|Overall Study|Physician Decision|0|||
105633373|NCT04213807|364322339|FG001|Overall Study|Physician Decision|0|||
105633374|NCT04213807|364322340|FG002|Overall Study|Physician Decision|1|||
105633375|NCT00336505|364322343|FG000|Overall Study|Adverse Event|10|||
105633376|NCT00336505|364322344|FG001|Overall Study|Adverse Event|9|||
105633377|NCT00336505|364322343|FG000|Overall Study|Lack of Efficacy|8|||
105633378|NCT00336505|364322344|FG001|Overall Study|Lack of Efficacy|4|||
105633379|NCT00336505|364322343|FG000|Overall Study|Lost to Follow-up|7|||
105633380|NCT00336505|364322344|FG001|Overall Study|Lost to Follow-up|4|||
105633381|NCT00336505|364322343|FG000|Overall Study|Withdrawal by Subject|5|||
105633382|NCT00336505|364322344|FG001|Overall Study|Withdrawal by Subject|3|||
105633383|NCT00336505|364322343|FG000|Overall Study|Other|7|||
105633384|NCT00336505|364322344|FG001|Overall Study|Other|7|||
105633385|NCT01561300|364322345|FG000|Run in on Placebo|Adverse Event|1|||
105633386|NCT01561300|364322346|FG001|Run in on Placebo|Adverse Event|0|||
105633387|NCT00890591|364322347|FG000|Overall Study|Lack of Efficacy|20|||
105633388|NCT03601715|364322348|FG000|Second Intervention|Lost to Follow-up|1|||
105633389|NCT03601715|364322349|FG001|Second Intervention|Lost to Follow-up|1|||
105633390|NCT03601715|364322350|FG002|Second Intervention|Lost to Follow-up|0|||
105633391|NCT00713596|364322351|FG000|Overall Study|Study was terminated|2|||
105633392|NCT00713596|364322352|FG001|Overall Study|Study was terminated|3|||
105633393|NCT00713596|364322353|FG002|Overall Study|Study was terminated|2|||
105633394|NCT03170882|364322354|FG000|Overall Study|Death|17|||
105633395|NCT03170882|364322355|FG001|Overall Study|Death|29|||
105633396|NCT03170882|364322354|FG000|Overall Study|Lost to Follow-up|0|||
105633397|NCT03170882|364322355|FG001|Overall Study|Lost to Follow-up|1|||
105633398|NCT03170882|364322354|FG000|Overall Study|Withdrawal by Subject|4|||
105633399|NCT03170882|364322355|FG001|Overall Study|Withdrawal by Subject|7|||
105633400|NCT03170882|364322354|FG000|Overall Study|Reason not Specified|28|||
105633401|NCT03170882|364322355|FG001|Overall Study|Reason not Specified|36|||
105633402|NCT03683576|364322374|FG000|Overall Study|Withdrawal by Subject|2|||
105633403|NCT03683576|364322375|FG001|Overall Study|Withdrawal by Subject|0|||
105633404|NCT03683576|364322376|FG002|Overall Study|Withdrawal by Subject|8|||
105633405|NCT03683576|364322377|FG003|Overall Study|Withdrawal by Subject|3|||
105633406|NCT03683576|364322374|FG000|Overall Study|Adverse Event|3|||
105633407|NCT03683576|364322375|FG001|Overall Study|Adverse Event|0|||
105633408|NCT03683576|364322376|FG002|Overall Study|Adverse Event|0|||
105633409|NCT03683576|364322377|FG003|Overall Study|Adverse Event|4|||
105633410|NCT03683576|364322374|FG000|Overall Study|Lack of Efficacy|1|||
105633411|NCT03683576|364322375|FG001|Overall Study|Lack of Efficacy|0|||
105633412|NCT03683576|364322376|FG002|Overall Study|Lack of Efficacy|1|||
105633413|NCT03683576|364322377|FG003|Overall Study|Lack of Efficacy|1|||
105633414|NCT03683576|364322374|FG000|Overall Study|Lost to Follow-up|0|||
105633415|NCT03683576|364322375|FG001|Overall Study|Lost to Follow-up|1|||
105633416|NCT03683576|364322376|FG002|Overall Study|Lost to Follow-up|2|||
105633417|NCT03683576|364322377|FG003|Overall Study|Lost to Follow-up|0|||
105633418|NCT03683576|364322374|FG000|Overall Study|Other, Not Specified|0|||
105633419|NCT03683576|364322375|FG001|Overall Study|Other, Not Specified|2|||
105633420|NCT03683576|364322376|FG002|Overall Study|Other, Not Specified|0|||
105633421|NCT03683576|364322377|FG003|Overall Study|Other, Not Specified|0|||
105633422|NCT03683576|364322374|FG000|Overall Study|Protocol Violation|0|||
105633423|NCT03683576|364322375|FG001|Overall Study|Protocol Violation|1|||
105633424|NCT03683576|364322376|FG002|Overall Study|Protocol Violation|1|||
105633425|NCT03683576|364322377|FG003|Overall Study|Protocol Violation|0|||
105633426|NCT03500549|364322380|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
105633427|NCT03500549|364322381|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
105633428|NCT03500549|364322380|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
105633429|NCT03500549|364322381|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
105633430|NCT01400958|364322384|FG000|Overall Study|Physician Decision|0|||
105633431|NCT01400958|364322385|FG001|Overall Study|Physician Decision|1|||
105633432|NCT01400958|364322384|FG000|Overall Study|Withdrawal by Subject|0|||
105633433|NCT01400958|364322385|FG001|Overall Study|Withdrawal by Subject|1|||
105633434|NCT01400958|364322384|FG000|Overall Study|Adverse Event|1|||
105633435|NCT01400958|364322385|FG001|Overall Study|Adverse Event|0|||
105633436|NCT01738438|364322386|FG000|Overall Study|Disease Progression|32|||
105633437|NCT01738438|364322386|FG000|Overall Study|Adverse Event|3|||
105633438|NCT02928172|364322387|FG000|Overall Study|Device did not record data|1|||
105633439|NCT01532999|364322388|FG000|Overall Study|Lost to Follow-up|14|||
105633440|NCT01532999|364322389|FG001|Overall Study|Lost to Follow-up|8|||
105633441|NCT01532999|364322388|FG000|Overall Study|Physician Decision|1|||
105633442|NCT01532999|364322389|FG001|Overall Study|Physician Decision|2|||
105633443|NCT01532999|364322388|FG000|Overall Study|Withdrawal by Subject|5|||
105633444|NCT01532999|364322389|FG001|Overall Study|Withdrawal by Subject|0|||
105633445|NCT01532999|364322388|FG000|Overall Study|Relocated|2|||
105633446|NCT01532999|364322389|FG001|Overall Study|Relocated|0|||
105633447|NCT01532999|364322388|FG000|Overall Study|should not have been randomized|1|||
105633448|NCT01532999|364322389|FG001|Overall Study|should not have been randomized|0|||
105633449|NCT01532999|364322388|FG000|Overall Study|substantial noncompliance|2|||
105633450|NCT01532999|364322389|FG001|Overall Study|substantial noncompliance|0|||
105633451|NCT01532999|364322388|FG000|Overall Study|no show for week 9 assessments|6|||
105633452|NCT01532999|364322389|FG001|Overall Study|no show for week 9 assessments|4|||
105633453|NCT01532999|364322388|FG000|Overall Study|Adverse Event|0|||
105633454|NCT01532999|364322389|FG001|Overall Study|Adverse Event|1|||
105633455|NCT01532999|364322388|FG000|Overall Study|incarcerated|0|||
105633456|NCT01532999|364322389|FG001|Overall Study|incarcerated|1|||
105633457|NCT01532999|364322388|FG000|Overall Study|New job|0|||
105633458|NCT01532999|364322389|FG001|Overall Study|New job|2|||
105633459|NCT00918203|364322390|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
105633460|NCT00918203|364322391|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
105633461|NCT00918203|364322392|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
105633462|NCT00918203|364322390|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
105633463|NCT00918203|364322391|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
105633464|NCT00918203|364322392|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
105633465|NCT00918203|364322390|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
105633466|NCT00918203|364322391|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
105633467|NCT00918203|364322392|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
105633468|NCT00918203|364322390|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
105633469|NCT00918203|364322391|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
105633470|NCT00918203|364322392|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
105633471|NCT00309166|364322395|FG000|Overall Study|Adverse event, non-fatal|1|||
105633472|NCT00309166|364322396|FG001|Overall Study|Adverse event, non-fatal|0|||
105633473|NCT00309166|364322395|FG000|Overall Study|Withdrawal by Subject|4|||
105633474|NCT00309166|364322396|FG001|Overall Study|Withdrawal by Subject|3|||
105633475|NCT00701701|364322399|FG000|Overall Study|Withdrawal by Subject|0|||
105633476|NCT00701701|364322400|FG001|Overall Study|Withdrawal by Subject|1|||
105633477|NCT00701701|364322399|FG000|Overall Study|Adverse Event|0|||
105633478|NCT00701701|364322400|FG001|Overall Study|Adverse Event|1|||
105633479|NCT02598661|364322401|FG000|Overall Study|Death|27|||
105633480|NCT02598661|364322402|FG001|Overall Study|Death|34|||
105633481|NCT02598661|364322403|FG002|Overall Study|Death|14|||
105633482|NCT02598661|364322404|FG003|Overall Study|Death|1|||
105633483|NCT02598661|364322405|FG004|Overall Study|Death|0|||
105633484|NCT02598661|364322401|FG000|Overall Study|Lost to Follow-up|2|||
105633485|NCT02598661|364322402|FG001|Overall Study|Lost to Follow-up|3|||
105633486|NCT02598661|364322403|FG002|Overall Study|Lost to Follow-up|2|||
105633487|NCT02598661|364322404|FG003|Overall Study|Lost to Follow-up|0|||
105633488|NCT02598661|364322405|FG004|Overall Study|Lost to Follow-up|0|||
105633489|NCT02598661|364322401|FG000|Overall Study|Withdrawal by Subject|13|||
105633490|NCT02598661|364322402|FG001|Overall Study|Withdrawal by Subject|24|||
105633491|NCT02598661|364322403|FG002|Overall Study|Withdrawal by Subject|14|||
105633492|NCT02598661|364322404|FG003|Overall Study|Withdrawal by Subject|1|||
105633493|NCT02598661|364322405|FG004|Overall Study|Withdrawal by Subject|1|||
105633494|NCT02598661|364322401|FG000|Overall Study|Adverse Event|0|||
105633495|NCT02598661|364322402|FG001|Overall Study|Adverse Event|0|||
105633496|NCT02598661|364322403|FG002|Overall Study|Adverse Event|1|||
105633497|NCT02598661|364322404|FG003|Overall Study|Adverse Event|0|||
105633498|NCT02598661|364322405|FG004|Overall Study|Adverse Event|0|||
105633499|NCT02598661|364322401|FG000|Overall Study|Randomized, Never Treated|0|||
105633500|NCT02598661|364322402|FG001|Overall Study|Randomized, Never Treated|0|||
105633501|NCT02598661|364322403|FG002|Overall Study|Randomized, Never Treated|0|||
105633502|NCT02598661|364322404|FG003|Overall Study|Randomized, Never Treated|0|||
105633503|NCT02598661|364322405|FG004|Overall Study|Randomized, Never Treated|1|||
105633504|NCT02016872|364322408|FG000|Overall Study|Withdrawal by Subject|10|||
105633505|NCT02016872|364322408|FG000|Overall Study|Death Progression|2|||
105633506|NCT02016872|364322408|FG000|Overall Study|No FMISO scan|1|||
105633507|NCT02016872|364322408|FG000|Overall Study|Ineligible|2|||
105633508|NCT05251363|364322417|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
105633509|NCT05251363|364322417|FG000|Overall Study After Implant Period|Death|9|||
105633510|NCT05251363|364322417|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
105633511|NCT05251363|364322417|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
105633512|NCT05251363|364322417|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
105633513|NCT05251363|364322417|FG000|Overall Study After Implant Period|Physician Decision|1|||
105633514|NCT05251363|364322417|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
105633515|NCT02761187|364322418|FG000|Overall Study|Too ill to Participate|13|||
105633516|NCT02761187|364322419|FG001|Overall Study|Too ill to Participate|8|||
105633517|NCT02761187|364322418|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
105633518|NCT02761187|364322419|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
105633519|NCT02761187|364322418|FG000|Overall Study|Patient withdrew consent|64|||
105633520|NCT02761187|364322419|FG001|Overall Study|Patient withdrew consent|58|||
105633521|NCT02761187|364322418|FG000|Overall Study|Physician discretion|4|||
105633522|NCT02761187|364322419|FG001|Overall Study|Physician discretion|8|||
105633523|NCT02761187|364322418|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
105633524|NCT02761187|364322419|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
105633525|NCT02761187|364322418|FG000|Overall Study|On Hospice|20|||
105633526|NCT02761187|364322419|FG001|Overall Study|On Hospice|26|||
105633527|NCT02761187|364322418|FG000|Overall Study|Deceased|474|||
105633528|NCT02761187|364322419|FG001|Overall Study|Deceased|642|||
105633529|NCT02761187|364322418|FG000|Overall Study|Lost to Follow-up|73|||
105633530|NCT02761187|364322419|FG001|Overall Study|Lost to Follow-up|63|||
105633531|NCT02761187|364322418|FG000|Overall Study|Due to study discontinued at site|100|||
105633532|NCT02761187|364322419|FG001|Overall Study|Due to study discontinued at site|85|||
105633533|NCT02761187|364322418|FG000|Overall Study|Reason not Specified|1484|||
105633534|NCT02761187|364322419|FG001|Overall Study|Reason not Specified|937|||
105633535|NCT03835754|364322422|FG000|Overall Study|Death|4|||
105633536|NCT02517268|364322428|FG000|Overall Study|Withdrawal by Subject|1|||
105633537|NCT02517268|364322429|FG001|Overall Study|Withdrawal by Subject|0|||
105633538|NCT05630833|364322430|FG000|Overall Study|Adverse Event|3|||
105633539|NCT05630833|364322431|FG001|Overall Study|Adverse Event|0|||
105633540|NCT05630833|364322430|FG000|Overall Study|Lack of Efficacy|0|||
105633541|NCT05630833|364322431|FG001|Overall Study|Lack of Efficacy|1|||
105633542|NCT05630833|364322430|FG000|Overall Study|Lost to Follow-up|1|||
105633543|NCT05630833|364322431|FG001|Overall Study|Lost to Follow-up|0|||
105633544|NCT05630833|364322430|FG000|Overall Study|Withdrawal by Subject|3|||
105633545|NCT05630833|364322431|FG001|Overall Study|Withdrawal by Subject|1|||
105633546|NCT04445831|364322432|FG000|Overall Study|Withdrawal by Subject|2|||
105633547|NCT04445831|364322433|FG001|Overall Study|Withdrawal by Subject|1|||
105633548|NCT04445831|364322434|FG002|Overall Study|Withdrawal by Subject|1|||
105633549|NCT04445831|364322435|FG003|Overall Study|Withdrawal by Subject|0|||
105633550|NCT04445831|364322436|FG004|Overall Study|Withdrawal by Subject|0|||
105633551|NCT04445831|364322437|FG005|Overall Study|Withdrawal by Subject|0|||
105633552|NCT04445831|364322438|FG006|Overall Study|Withdrawal by Subject|0|||
105633553|NCT04445831|364322432|FG000|Overall Study|Subject withdrawal by caregiver|0|||
105633554|NCT04445831|364322433|FG001|Overall Study|Subject withdrawal by caregiver|1|||
105633555|NCT04445831|364322434|FG002|Overall Study|Subject withdrawal by caregiver|0|||
105633556|NCT04445831|364322435|FG003|Overall Study|Subject withdrawal by caregiver|0|||
105633557|NCT04445831|364322436|FG004|Overall Study|Subject withdrawal by caregiver|0|||
105633558|NCT04445831|364322437|FG005|Overall Study|Subject withdrawal by caregiver|0|||
105633559|NCT04445831|364322438|FG006|Overall Study|Subject withdrawal by caregiver|0|||
105633560|NCT02751528|364322450|FG000|Overall Study|Withdrawal by Subject|1|||
105633561|NCT02751528|364322450|FG000|Overall Study|Adverse Event|1|||
105633562|NCT05810285|364322452|FG000|Overall Study|Death|4|||
105633563|NCT05810285|364322453|FG001|Overall Study|Death|21|||
105633564|NCT05810285|364322452|FG000|Overall Study|Adverse Event|18|||
105633565|NCT05810285|364322453|FG001|Overall Study|Adverse Event|16|||
105633566|NCT04649047|364322454|FG000|Overall Study|Withdrawal by Subject|3|||
105633567|NCT02488408|364322455|FG000|Part A|Adverse Event|2|||
105633568|NCT02488408|364322456|FG001|Part A|Adverse Event|0|||
105633569|NCT02488408|364322457|FG002|Part A|Adverse Event|0|||
105633570|NCT02488408|364322458|FG003|Part A|Adverse Event|0|||
105633571|NCT02488408|364322459|FG004|Part A|Adverse Event|0|||
105633572|NCT02488408|364322460|FG005|Part A|Adverse Event|0|||
105633573|NCT02488408|364322461|FG006|Part A|Adverse Event|0|||
105633574|NCT02488408|364322462|FG007|Part A|Adverse Event|0|||
105633575|NCT02488408|364322463|FG008|Part A|Adverse Event|0|||
105633576|NCT02488408|364322464|FG009|Part A|Adverse Event|0|||
105633577|NCT02488408|364322455|FG000|Part A|Death|1|||
105633578|NCT02488408|364322456|FG001|Part A|Death|5|||
105633579|NCT02488408|364322457|FG002|Part A|Death|0|||
105633580|NCT02488408|364322458|FG003|Part A|Death|0|||
105633581|NCT02488408|364322459|FG004|Part A|Death|3|||
105633582|NCT02488408|364322460|FG005|Part A|Death|0|||
105633583|NCT02488408|364322461|FG006|Part A|Death|0|||
105633584|NCT02488408|364322462|FG007|Part A|Death|0|||
105633585|NCT02488408|364322463|FG008|Part A|Death|0|||
105633586|NCT02488408|364322464|FG009|Part A|Death|0|||
105633587|NCT02488408|364322455|FG000|Part A|Disease Progression|2|||
105633588|NCT02488408|364322456|FG001|Part A|Disease Progression|8|||
105633589|NCT02488408|364322457|FG002|Part A|Disease Progression|2|||
105633590|NCT02488408|364322458|FG003|Part A|Disease Progression|3|||
105633591|NCT02488408|364322459|FG004|Part A|Disease Progression|4|||
105633592|NCT02488408|364322460|FG005|Part A|Disease Progression|0|||
105633593|NCT02488408|364322461|FG006|Part A|Disease Progression|0|||
105633594|NCT02488408|364322462|FG007|Part A|Disease Progression|0|||
105633595|NCT02488408|364322463|FG008|Part A|Disease Progression|0|||
105633596|NCT02488408|364322464|FG009|Part A|Disease Progression|0|||
105633597|NCT02488408|364322455|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
105633598|NCT02488408|364322456|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
105633599|NCT02488408|364322457|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
105633600|NCT02488408|364322458|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
105633601|NCT02488408|364322459|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
105633602|NCT02488408|364322460|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
105633603|NCT02488408|364322461|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
105633604|NCT02488408|364322462|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
105633605|NCT02488408|364322463|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
105633606|NCT02488408|364322464|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
105633607|NCT02488408|364322455|FG000|Part A|Investigator Decision|0|||
105633608|NCT02488408|364322456|FG001|Part A|Investigator Decision|1|||
105633609|NCT02488408|364322457|FG002|Part A|Investigator Decision|1|||
105633610|NCT02488408|364322458|FG003|Part A|Investigator Decision|0|||
105633611|NCT02488408|364322459|FG004|Part A|Investigator Decision|0|||
105633612|NCT02488408|364322460|FG005|Part A|Investigator Decision|0|||
105633613|NCT02488408|364322461|FG006|Part A|Investigator Decision|0|||
105633614|NCT02488408|364322462|FG007|Part A|Investigator Decision|0|||
105633615|NCT02488408|364322463|FG008|Part A|Investigator Decision|0|||
105633616|NCT02488408|364322464|FG009|Part A|Investigator Decision|0|||
105633617|NCT02488408|364322455|FG000|Part A|Withdrawal by Subject|0|||
105633618|NCT02488408|364322456|FG001|Part A|Withdrawal by Subject|0|||
105633619|NCT02488408|364322457|FG002|Part A|Withdrawal by Subject|2|||
105633620|NCT02488408|364322458|FG003|Part A|Withdrawal by Subject|0|||
105633621|NCT02488408|364322459|FG004|Part A|Withdrawal by Subject|0|||
105633622|NCT02488408|364322460|FG005|Part A|Withdrawal by Subject|0|||
105633623|NCT02488408|364322461|FG006|Part A|Withdrawal by Subject|0|||
105633624|NCT02488408|364322462|FG007|Part A|Withdrawal by Subject|0|||
105633625|NCT02488408|364322463|FG008|Part A|Withdrawal by Subject|0|||
105633626|NCT02488408|364322464|FG009|Part A|Withdrawal by Subject|0|||
105633627|NCT02488408|364322455|FG000|Part A|Other|1|||
105633628|NCT02488408|364322456|FG001|Part A|Other|0|||
105633629|NCT02488408|364322457|FG002|Part A|Other|0|||
105633630|NCT02488408|364322458|FG003|Part A|Other|0|||
105633631|NCT02488408|364322459|FG004|Part A|Other|0|||
105633632|NCT02488408|364322460|FG005|Part A|Other|0|||
105633633|NCT02488408|364322461|FG006|Part A|Other|0|||
105633634|NCT02488408|364322462|FG007|Part A|Other|0|||
105633635|NCT02488408|364322463|FG008|Part A|Other|0|||
105633636|NCT02488408|364322464|FG009|Part A|Other|0|||
105633637|NCT02488408|364322455|FG000|Part B|Adverse Event|0|||
105633638|NCT02488408|364322456|FG001|Part B|Adverse Event|0|||
105633639|NCT02488408|364322457|FG002|Part B|Adverse Event|0|||
105633640|NCT02488408|364322458|FG003|Part B|Adverse Event|0|||
105633641|NCT02488408|364322459|FG004|Part B|Adverse Event|0|||
105633642|NCT02488408|364322460|FG005|Part B|Adverse Event|2|||
105633643|NCT02488408|364322461|FG006|Part B|Adverse Event|2|||
105633644|NCT02488408|364322462|FG007|Part B|Adverse Event|7|||
105633645|NCT02488408|364322463|FG008|Part B|Adverse Event|2|||
105633646|NCT02488408|364322464|FG009|Part B|Adverse Event|2|||
105633647|NCT02488408|364322455|FG000|Part B|Death|0|||
105633648|NCT02488408|364322456|FG001|Part B|Death|0|||
105633649|NCT02488408|364322457|FG002|Part B|Death|0|||
105633650|NCT02488408|364322458|FG003|Part B|Death|0|||
105633651|NCT02488408|364322459|FG004|Part B|Death|0|||
105633652|NCT02488408|364322460|FG005|Part B|Death|3|||
105633653|NCT02488408|364322461|FG006|Part B|Death|1|||
105633654|NCT02488408|364322462|FG007|Part B|Death|2|||
105633655|NCT02488408|364322463|FG008|Part B|Death|2|||
105633656|NCT02488408|364322464|FG009|Part B|Death|2|||
105633657|NCT02488408|364322455|FG000|Part B|Death due to Disease Progression|0|||
105633658|NCT02488408|364322456|FG001|Part B|Death due to Disease Progression|0|||
105633659|NCT02488408|364322457|FG002|Part B|Death due to Disease Progression|0|||
105633660|NCT02488408|364322458|FG003|Part B|Death due to Disease Progression|0|||
105633661|NCT02488408|364322459|FG004|Part B|Death due to Disease Progression|0|||
105633662|NCT02488408|364322460|FG005|Part B|Death due to Disease Progression|2|||
105633663|NCT02488408|364322461|FG006|Part B|Death due to Disease Progression|2|||
105633664|NCT02488408|364322462|FG007|Part B|Death due to Disease Progression|1|||
105633665|NCT02488408|364322463|FG008|Part B|Death due to Disease Progression|1|||
105633666|NCT02488408|364322464|FG009|Part B|Death due to Disease Progression|1|||
105633667|NCT02488408|364322455|FG000|Part B|Disease Progression|0|||
105633668|NCT02488408|364322456|FG001|Part B|Disease Progression|0|||
105633669|NCT02488408|364322457|FG002|Part B|Disease Progression|0|||
105633670|NCT02488408|364322458|FG003|Part B|Disease Progression|0|||
105633671|NCT02488408|364322459|FG004|Part B|Disease Progression|0|||
105633672|NCT02488408|364322460|FG005|Part B|Disease Progression|6|||
105633673|NCT02488408|364322461|FG006|Part B|Disease Progression|9|||
105633674|NCT02488408|364322462|FG007|Part B|Disease Progression|7|||
105633675|NCT02488408|364322463|FG008|Part B|Disease Progression|9|||
105633676|NCT02488408|364322464|FG009|Part B|Disease Progression|11|||
105633677|NCT02488408|364322455|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
105633678|NCT02488408|364322456|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
105633679|NCT02488408|364322457|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
105633680|NCT02488408|364322458|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
105633681|NCT02488408|364322459|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
105633682|NCT02488408|364322460|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
105633683|NCT02488408|364322461|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
105633684|NCT02488408|364322462|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
105633685|NCT02488408|364322463|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
105633686|NCT02488408|364322464|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
105633687|NCT02488408|364322455|FG000|Part B|Investigator Decision|0|||
105633688|NCT02488408|364322456|FG001|Part B|Investigator Decision|0|||
105633689|NCT02488408|364322457|FG002|Part B|Investigator Decision|0|||
105633690|NCT02488408|364322458|FG003|Part B|Investigator Decision|0|||
105633691|NCT02488408|364322459|FG004|Part B|Investigator Decision|0|||
105633692|NCT02488408|364322460|FG005|Part B|Investigator Decision|0|||
105633693|NCT02488408|364322461|FG006|Part B|Investigator Decision|1|||
105633694|NCT02488408|364322462|FG007|Part B|Investigator Decision|0|||
105633695|NCT02488408|364322463|FG008|Part B|Investigator Decision|2|||
105633696|NCT02488408|364322464|FG009|Part B|Investigator Decision|1|||
105633697|NCT00719888|364322465|FG000|Overall Study|Death|24|||
105633698|NCT00719888|364322466|FG001|Overall Study|Death|9|||
105633699|NCT00719888|364322465|FG000|Overall Study|Relapse|8|||
105633700|NCT00719888|364322466|FG001|Overall Study|Relapse|3|||
105633701|NCT00719888|364322465|FG000|Overall Study|Physician Decision|1|||
105633702|NCT00719888|364322466|FG001|Overall Study|Physician Decision|0|||
105633703|NCT00719888|364322465|FG000|Overall Study|Withdrawal by Subject|1|||
105633704|NCT00719888|364322466|FG001|Overall Study|Withdrawal by Subject|0|||
105633705|NCT03664804|364322467|FG000|Overall Study|Withdrawal by Subject|7|||
105633706|NCT03459196|364323996|FG000|Overall Study|Subject didn't receive study catheter|2|||
105633707|NCT04530487|364323997|FG000|Overall Study|Death|1|||
105633708|NCT00655499|364324004|FG000|Overall Study|not eligible|4|||
105633709|NCT03752684|364324006|FG000|Overall Study|Lost to Follow-up|4|||
105633710|NCT03352713|364324009|FG000|Overall Study|Lost to Follow-up|8|||
105633711|NCT03352713|364324009|FG000|Overall Study|Withdrawn by investigator|5|||
105633712|NCT03352713|364324009|FG000|Overall Study|Completed 0 EMAs|8|||
105633713|NCT03352713|364324009|FG000|Overall Study|Device incompatible/stolen|5|||
105633714|NCT00048932|364324010|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
105633715|NCT00048932|364324011|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
105633716|NCT00048932|364324012|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
105633717|NCT00048932|364324010|FG000|Double Blind Period (DB)|Adverse Event|51|||
105633718|NCT00048932|364324011|FG001|Double Blind Period (DB)|Adverse Event|19|||
105633719|NCT00048932|364324012|FG002|Double Blind Period (DB)|Adverse Event|0|||
105633720|NCT00048932|364324010|FG000|Double Blind Period (DB)|Death|5|||
105633721|NCT00048932|364324011|FG001|Double Blind Period (DB)|Death|3|||
105633722|NCT00048932|364324012|FG002|Double Blind Period (DB)|Death|0|||
105633723|NCT00048932|364324010|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
105633724|NCT00048932|364324011|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
105633725|NCT00048932|364324012|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
105633726|NCT00048932|364324010|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
105633727|NCT00048932|364324011|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
105633728|NCT00048932|364324012|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
105633729|NCT00048932|364324010|FG000|Double Blind Period (DB)|Relocation|1|||
105633730|NCT00048932|364324011|FG001|Double Blind Period (DB)|Relocation|0|||
105633731|NCT00048932|364324012|FG002|Double Blind Period (DB)|Relocation|0|||
105633732|NCT00048932|364324010|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
105633733|NCT00048932|364324011|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
105633734|NCT00048932|364324012|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
105633735|NCT00048932|364324010|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
105633736|NCT00048932|364324011|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
105633737|NCT00048932|364324012|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
105633738|NCT00048932|364324010|FG000|Double Blind Period (DB)|Pregnancy|1|||
105633739|NCT00048932|364324011|FG001|Double Blind Period (DB)|Pregnancy|0|||
105633740|NCT00048932|364324012|FG002|Double Blind Period (DB)|Pregnancy|0|||
105633741|NCT00048932|364324010|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
105633742|NCT00048932|364324011|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
105633743|NCT00048932|364324012|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
105633744|NCT00048932|364324010|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
105633745|NCT00048932|364324011|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
105633746|NCT00048932|364324012|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
105633747|NCT00048932|364324010|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
105633748|NCT00048932|364324011|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
105633749|NCT00048932|364324012|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
105633750|NCT00048932|364324010|FG000|Open Label Period (OL)|Death|0|||
105633751|NCT00048932|364324011|FG001|Open Label Period (OL)|Death|0|||
105633752|NCT00048932|364324012|FG002|Open Label Period (OL)|Death|25|||
105633753|NCT00048932|364324010|FG000|Open Label Period (OL)|Adverse Event|0|||
105633754|NCT00048932|364324011|FG001|Open Label Period (OL)|Adverse Event|0|||
105633755|NCT00048932|364324012|FG002|Open Label Period (OL)|Adverse Event|103|||
105633756|NCT00048932|364324010|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
105633757|NCT00048932|364324011|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
105633758|NCT00048932|364324012|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
105633759|NCT00048932|364324010|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
105633760|NCT00048932|364324011|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
105633761|NCT00048932|364324012|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
105633762|NCT00048932|364324010|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
105633763|NCT00048932|364324011|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
105633764|NCT00048932|364324012|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
105633765|NCT00048932|364324010|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
105633766|NCT00048932|364324011|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
105633767|NCT00048932|364324012|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
105633768|NCT00048932|364324010|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
105633769|NCT00048932|364324011|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
105633770|NCT00048932|364324012|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
105633771|NCT00048932|364324010|FG000|Open Label Period (OL)|Pregnancy|0|||
105633772|NCT00048932|364324011|FG001|Open Label Period (OL)|Pregnancy|0|||
105633773|NCT00048932|364324012|FG002|Open Label Period (OL)|Pregnancy|6|||
105633774|NCT00048932|364324010|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
105633775|NCT00048932|364324011|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
105633776|NCT00048932|364324012|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
105633777|NCT00048932|364324010|FG000|Open Label Period (OL)|Investigator Retiring|0|||
105633778|NCT00048932|364324011|FG001|Open Label Period (OL)|Investigator Retiring|0|||
105633779|NCT00048932|364324012|FG002|Open Label Period (OL)|Investigator Retiring|2|||
105633780|NCT00048932|364324010|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
105633781|NCT00048932|364324011|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
105633782|NCT00048932|364324012|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
105633783|NCT00048932|364324010|FG000|Open Label Period (OL)|Participant Relocated|0|||
105633784|NCT00048932|364324011|FG001|Open Label Period (OL)|Participant Relocated|0|||
105633785|NCT00048932|364324012|FG002|Open Label Period (OL)|Participant Relocated|6|||
105633786|NCT00048932|364324010|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
105633787|NCT00048932|364324011|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
105633788|NCT00048932|364324012|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
105633789|NCT00048932|364324010|FG000|Open Label Period (OL)|Site Closure|0|||
105633790|NCT00048932|364324011|FG001|Open Label Period (OL)|Site Closure|0|||
105633791|NCT00048932|364324012|FG002|Open Label Period (OL)|Site Closure|3|||
105633792|NCT00048932|364324010|FG000|Open Label Period (OL)|Trial Terminated|0|||
105633793|NCT00048932|364324011|FG001|Open Label Period (OL)|Trial Terminated|0|||
105633794|NCT00048932|364324012|FG002|Open Label Period (OL)|Trial Terminated|1|||
105633795|NCT00048932|364324010|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
105633796|NCT00048932|364324011|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
105633797|NCT00048932|364324012|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
105633798|NCT00048932|364324010|FG000|Open Label Period (OL)|Patient Decision|0|||
105633799|NCT00048932|364324011|FG001|Open Label Period (OL)|Patient Decision|0|||
105633800|NCT00048932|364324012|FG002|Open Label Period (OL)|Patient Decision|4|||
105633801|NCT00048932|364324010|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
105633802|NCT00048932|364324011|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
105633803|NCT00048932|364324012|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
105633804|NCT00048932|364324010|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
105633805|NCT00048932|364324011|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
105633806|NCT00048932|364324012|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
105633807|NCT00048932|364324010|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
105633808|NCT00048932|364324011|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
105633809|NCT00048932|364324012|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
105633810|NCT00048932|364324010|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
105633811|NCT00048932|364324011|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
105633812|NCT00048932|364324012|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
105633813|NCT00048932|364324010|FG000|Open Label Period (OL)|Investigator Decision|0|||
105633814|NCT00048932|364324011|FG001|Open Label Period (OL)|Investigator Decision|0|||
105633815|NCT00048932|364324012|FG002|Open Label Period (OL)|Investigator Decision|4|||
105633816|NCT00048932|364324010|FG000|Open Label Period (OL)|Site Staff Issues|0|||
105633817|NCT00048932|364324011|FG001|Open Label Period (OL)|Site Staff Issues|0|||
105633818|NCT00048932|364324012|FG002|Open Label Period (OL)|Site Staff Issues|2|||
105633819|NCT00048932|364324010|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
105633820|NCT00048932|364324011|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
105633821|NCT00048932|364324012|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
105633822|NCT00048932|364324010|FG000|Open Label Period (OL)|Participant Surgery|0|||
105633823|NCT00048932|364324011|FG001|Open Label Period (OL)|Participant Surgery|0|||
105633824|NCT00048932|364324012|FG002|Open Label Period (OL)|Participant Surgery|1|||
105633825|NCT04989816|364324016|FG000|Overall Study|Death|77|||
105633826|NCT04989816|364324016|FG000|Overall Study|Lost to Follow-up|3|||
105633827|NCT03214081|364324017|FG000|Overall Study|Case Report Forms Uncollected|9|||
105633828|NCT03214081|364324017|FG000|Overall Study|Protocol Deviation|54|||
105633829|NCT01964300|364324018|FG000|Overall Study|Ineligible after enrollment|0|||
105633830|NCT01964300|364324019|FG001|Overall Study|Ineligible after enrollment|1|||
105633831|NCT01964300|364324018|FG000|Overall Study|Adverse Event|1|||
105633832|NCT01964300|364324019|FG001|Overall Study|Adverse Event|1|||
105633833|NCT01964300|364324018|FG000|Overall Study|Lack of Efficacy|3|||
105633834|NCT01964300|364324019|FG001|Overall Study|Lack of Efficacy|5|||
105633835|NCT01964300|364324018|FG000|Overall Study|Withdrawal by Subject|0|||
105633836|NCT01964300|364324019|FG001|Overall Study|Withdrawal by Subject|1|||
105633837|NCT01964300|364324018|FG000|Overall Study|To receive alternative therapy|1|||
105633838|NCT01964300|364324019|FG001|Overall Study|To receive alternative therapy|2|||
105633839|NCT01964300|364324018|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
105633840|NCT01964300|364324019|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
105633841|NCT01964300|364324018|FG000|Overall Study|Weight criteria not met|0|||
105633842|NCT01964300|364324019|FG001|Overall Study|Weight criteria not met|1|||
105633843|NCT03442777|364324029|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
105633844|NCT03442777|364324030|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
105633845|NCT03442777|364324031|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
105633846|NCT04162210|364324036|FG000|Overall Study|Lost to Follow-up|4|||
105633847|NCT04162210|364324037|FG001|Overall Study|Lost to Follow-up|1|||
105633848|NCT04162210|364324036|FG000|Overall Study|Withdrawal by Subject|17|||
105633849|NCT04162210|364324037|FG001|Overall Study|Withdrawal by Subject|9|||
105633850|NCT04162210|364324036|FG000|Overall Study|Ongoing|113|||
105633851|NCT04162210|364324037|FG001|Overall Study|Ongoing|59|||
105633852|NCT01128595|364324038|FG000|Treatment Period 3|Withdrawal by Subject|0|||
105633853|NCT01128595|364324039|FG001|Treatment Period 3|Withdrawal by Subject|1|||
105633854|NCT01128595|364324040|FG002|Treatment Period 3|Withdrawal by Subject|0|||
105633855|NCT01128595|364324041|FG003|Treatment Period 3|Withdrawal by Subject|0|||
105633856|NCT01750684|364324042|FG000|Overall Study|Death|1|||
105633857|NCT01750684|364324043|FG001|Overall Study|Death|0|||
105633858|NCT01750684|364324042|FG000|Overall Study|Non-compliance with Study Drug|0|||
105633859|NCT01750684|364324043|FG001|Overall Study|Non-compliance with Study Drug|1|||
105633860|NCT01750684|364324042|FG000|Overall Study|Withdrawn by Sponsor|0|||
105633861|NCT01750684|364324043|FG001|Overall Study|Withdrawn by Sponsor|1|||
105633862|NCT01750684|364324042|FG000|Overall Study|Protocol Violation|1|||
105633863|NCT01750684|364324043|FG001|Overall Study|Protocol Violation|0|||
105633864|NCT02568215|364324048|FG000|Overall Study|Death|1|||
105633865|NCT02568215|364324049|FG001|Overall Study|Death|2|||
105633866|NCT02568215|364324050|FG002|Overall Study|Death|0|||
105633867|NCT02568215|364324048|FG000|Overall Study|Physician Decision|2|||
105633868|NCT02568215|364324049|FG001|Overall Study|Physician Decision|2|||
105633869|NCT02568215|364324050|FG002|Overall Study|Physician Decision|2|||
105633870|NCT02568215|364324048|FG000|Overall Study|Lost to Follow-up|29|||
105633871|NCT02568215|364324049|FG001|Overall Study|Lost to Follow-up|32|||
105633872|NCT02568215|364324050|FG002|Overall Study|Lost to Follow-up|41|||
105633873|NCT02568215|364324048|FG000|Overall Study|Withdrawal by Subject|21|||
105633874|NCT02568215|364324049|FG001|Overall Study|Withdrawal by Subject|19|||
105633875|NCT02568215|364324050|FG002|Overall Study|Withdrawal by Subject|22|||
105633876|NCT02568215|364324048|FG000|Overall Study|Protocol Violation|1|||
105633877|NCT02568215|364324049|FG001|Overall Study|Protocol Violation|1|||
105633878|NCT02568215|364324050|FG002|Overall Study|Protocol Violation|0|||
105633879|NCT02568215|364324048|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
105633880|NCT02568215|364324049|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
105633881|NCT02568215|364324050|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
105633882|NCT02568215|364324048|FG000|Overall Study|Other|0|||
105633883|NCT02568215|364324049|FG001|Overall Study|Other|1|||
105633884|NCT02568215|364324050|FG002|Overall Study|Other|4|||
105633885|NCT02185794|364324052|FG000|Overall Study|Enrolled but Never Dosed|1|||
105633886|NCT02185794|364324053|FG001|Overall Study|Enrolled but Never Dosed|6|||
105633887|NCT02185794|364324054|FG002|Overall Study|Enrolled but Never Dosed|3|||
105633888|NCT02185794|364324055|FG003|Overall Study|Enrolled but Never Dosed|1|||
105633889|NCT02185794|364324056|FG004|Overall Study|Enrolled but Never Dosed|1|||
105633890|NCT02185794|364324057|FG005|Overall Study|Enrolled but Never Dosed|0|||
105633891|NCT02185794|364324052|FG000|Overall Study|Investigator's Discretion|1|||
105633892|NCT02185794|364324053|FG001|Overall Study|Investigator's Discretion|0|||
105633893|NCT02185794|364324054|FG002|Overall Study|Investigator's Discretion|1|||
105633894|NCT02185794|364324055|FG003|Overall Study|Investigator's Discretion|2|||
105633895|NCT02185794|364324056|FG004|Overall Study|Investigator's Discretion|2|||
105633896|NCT02185794|364324057|FG005|Overall Study|Investigator's Discretion|15|||
105633897|NCT02185794|364324052|FG000|Overall Study|Withdrew Consent|2|||
105633898|NCT02185794|364324053|FG001|Overall Study|Withdrew Consent|5|||
105633899|NCT02185794|364324054|FG002|Overall Study|Withdrew Consent|10|||
105633900|NCT02185794|364324055|FG003|Overall Study|Withdrew Consent|2|||
105633901|NCT02185794|364324056|FG004|Overall Study|Withdrew Consent|0|||
105633902|NCT02185794|364324057|FG005|Overall Study|Withdrew Consent|0|||
105633903|NCT02185794|364324052|FG000|Overall Study|Lost to Follow-up|1|||
105633904|NCT02185794|364324053|FG001|Overall Study|Lost to Follow-up|2|||
105633905|NCT02185794|364324054|FG002|Overall Study|Lost to Follow-up|2|||
105633906|NCT02185794|364324055|FG003|Overall Study|Lost to Follow-up|3|||
105633907|NCT02185794|364324056|FG004|Overall Study|Lost to Follow-up|0|||
105633908|NCT02185794|364324057|FG005|Overall Study|Lost to Follow-up|1|||
105633909|NCT03244800|364324058|FG000|Overall Study|Adverse Event|0|||
105633910|NCT03244800|364324059|FG001|Overall Study|Adverse Event|1|||
105633911|NCT03244800|364324060|FG002|Overall Study|Adverse Event|0|||
105633912|NCT03244800|364324061|FG003|Overall Study|Adverse Event|1|||
105633913|NCT03244800|364324058|FG000|Overall Study|Withdrew treatment|0|||
105633914|NCT03244800|364324059|FG001|Overall Study|Withdrew treatment|0|||
105633915|NCT03244800|364324060|FG002|Overall Study|Withdrew treatment|0|||
105633916|NCT03244800|364324061|FG003|Overall Study|Withdrew treatment|1|||
105633917|NCT03478969|364324067|FG000|Overall Study|Withdrawal by Subject|4|||
105633918|NCT03478969|364324068|FG001|Overall Study|Withdrawal by Subject|7|||
105633919|NCT03478969|364324069|FG002|Overall Study|Withdrawal by Subject|6|||
105633920|NCT03478969|364324067|FG000|Overall Study|Adverse Event|2|||
105633921|NCT03478969|364324068|FG001|Overall Study|Adverse Event|0|||
105633922|NCT03478969|364324069|FG002|Overall Study|Adverse Event|1|||
105633923|NCT03478969|364324067|FG000|Overall Study|Pregnancy|1|||
105633924|NCT03478969|364324068|FG001|Overall Study|Pregnancy|0|||
105633925|NCT03478969|364324069|FG002|Overall Study|Pregnancy|0|||
105633926|NCT03478969|364324067|FG000|Overall Study|Personal Reasons|1|||
105633927|NCT03478969|364324068|FG001|Overall Study|Personal Reasons|0|||
105633928|NCT03478969|364324069|FG002|Overall Study|Personal Reasons|1|||
105633929|NCT03478969|364324067|FG000|Overall Study|Covid-19|1|||
105633930|NCT03478969|364324068|FG001|Overall Study|Covid-19|4|||
105633931|NCT03478969|364324069|FG002|Overall Study|Covid-19|3|||
105633932|NCT03478969|364324067|FG000|Overall Study|Multiple Reasons|0|||
105633933|NCT03478969|364324068|FG001|Overall Study|Multiple Reasons|1|||
105633934|NCT03478969|364324069|FG002|Overall Study|Multiple Reasons|1|||
105633935|NCT03478969|364324067|FG000|Overall Study|Eligibility Criteria|0|||
105633936|NCT03478969|364324068|FG001|Overall Study|Eligibility Criteria|0|||
105633937|NCT03478969|364324069|FG002|Overall Study|Eligibility Criteria|5|||
105633938|NCT03478969|364324067|FG000|Overall Study|Lost to Follow-up|0|||
105633939|NCT03478969|364324068|FG001|Overall Study|Lost to Follow-up|0|||
105633940|NCT03478969|364324069|FG002|Overall Study|Lost to Follow-up|1|||
105633941|NCT03220724|364324070|FG000|Overall Study|Lost to Follow-up|2|||
105633942|NCT03220724|364324071|FG001|Overall Study|Lost to Follow-up|2|||
105633943|NCT03220724|364324072|FG002|Overall Study|Lost to Follow-up|0|||
105633944|NCT03220724|364324073|FG003|Overall Study|Lost to Follow-up|3|||
105633945|NCT03220724|364324074|FG004|Overall Study|Lost to Follow-up|1|||
105633946|NCT03220724|364324075|FG005|Overall Study|Lost to Follow-up|0|||
105633947|NCT03220724|364324076|FG006|Overall Study|Lost to Follow-up|2|||
105633948|NCT03220724|364324077|FG007|Overall Study|Lost to Follow-up|1|||
105633949|NCT03220724|364324078|FG008|Overall Study|Lost to Follow-up|0|||
105633950|NCT03220724|364324070|FG000|Overall Study|Withdrawal by Subject|1|||
105633951|NCT03220724|364324071|FG001|Overall Study|Withdrawal by Subject|0|||
105633952|NCT03220724|364324072|FG002|Overall Study|Withdrawal by Subject|1|||
105633953|NCT03220724|364324073|FG003|Overall Study|Withdrawal by Subject|0|||
105633954|NCT03220724|364324074|FG004|Overall Study|Withdrawal by Subject|0|||
105633955|NCT03220724|364324075|FG005|Overall Study|Withdrawal by Subject|0|||
105633956|NCT03220724|364324076|FG006|Overall Study|Withdrawal by Subject|0|||
105633957|NCT03220724|364324077|FG007|Overall Study|Withdrawal by Subject|0|||
105633958|NCT03220724|364324078|FG008|Overall Study|Withdrawal by Subject|0|||
105633959|NCT01185600|364324083|FG000|Overall Study|Adverse Event|1|||
105633960|NCT01185600|364324084|FG001|Overall Study|Adverse Event|1|||
105633961|NCT01185600|364324083|FG000|Overall Study|Death|0|||
105633962|NCT01185600|364324084|FG001|Overall Study|Death|1|||
105633963|NCT01185600|364324083|FG000|Overall Study|Lost to Follow-up|0|||
105633964|NCT01185600|364324084|FG001|Overall Study|Lost to Follow-up|5|||
105633965|NCT01185600|364324083|FG000|Overall Study|Physician Decision|29|||
105633966|NCT01185600|364324084|FG001|Overall Study|Physician Decision|35|||
105633967|NCT01185600|364324083|FG000|Overall Study|Withdrawal by Subject|1|||
105633968|NCT01185600|364324084|FG001|Overall Study|Withdrawal by Subject|1|||
105633969|NCT01185600|364324083|FG000|Overall Study|Hold by DSMB|1|||
105633970|NCT01185600|364324084|FG001|Overall Study|Hold by DSMB|2|||
105633971|NCT00724126|364324085|FG000|Overall Study|Adverse Event|2|||
105633972|NCT00724126|364324086|FG001|Overall Study|Adverse Event|0|||
105633973|NCT00724126|364324085|FG000|Overall Study|Withdrawal by Subject|8|||
105633974|NCT00724126|364324086|FG001|Overall Study|Withdrawal by Subject|6|||
105633975|NCT00724126|364324085|FG000|Overall Study|Lost to Follow-up|6|||
105633976|NCT00724126|364324086|FG001|Overall Study|Lost to Follow-up|6|||
105633977|NCT00724126|364324085|FG000|Overall Study|Noncompliance|2|||
105633978|NCT00724126|364324086|FG001|Overall Study|Noncompliance|1|||
105633979|NCT00724126|364324085|FG000|Overall Study|Subject randomized although ineligible|1|||
105633980|NCT00724126|364324086|FG001|Overall Study|Subject randomized although ineligible|1|||
105633981|NCT00724126|364324085|FG000|Overall Study|Subject had to leave vicinity of site|0|||
105633982|NCT00724126|364324086|FG001|Overall Study|Subject had to leave vicinity of site|1|||
105633983|NCT01436175|364324087|FG000|Overall Study|Adverse Event|111|||
105633984|NCT01436175|364324087|FG000|Overall Study|Protocol Violation|49|||
105633985|NCT01436175|364324087|FG000|Overall Study|Withdrawal by Subject|108|||
105633986|NCT01436175|364324087|FG000|Overall Study|Lost to Follow-up|89|||
105633987|NCT01436175|364324087|FG000|Overall Study|Lack of Efficacy|24|||
105633988|NCT01436175|364324087|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
105633989|NCT01436175|364324087|FG000|Overall Study|Other|826|||
105633990|NCT03418922|364324089|FG000|Overall Study|Withdrawal by Subject|0|||
105633991|NCT03418922|364324090|FG001|Overall Study|Withdrawal by Subject|2|||
105633992|NCT03418922|364324089|FG000|Overall Study|Adverse Event|2|||
105633993|NCT03418922|364324090|FG001|Overall Study|Adverse Event|2|||
105633994|NCT03418922|364324089|FG000|Overall Study|Death|0|||
105633995|NCT03418922|364324090|FG001|Overall Study|Death|1|||
105633996|NCT03418922|364324089|FG000|Overall Study|Physician Decision|0|||
105633997|NCT03418922|364324090|FG001|Overall Study|Physician Decision|1|||
105633998|NCT03577106|364324091|FG000|Overall Study|Withdrawal by Subject|3|||
105633999|NCT02797132|364324092|FG000|Part A (15 Days)|Adverse Event|1|||
105634000|NCT02797132|364324092|FG000|Part B (24 Weeks)|Adverse Event|3|||
105634001|NCT01313884|364324094|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
105634002|NCT00263757|364324095|FG000|Overall Study|Withdrawal by Subject|5|||
105634003|NCT00263757|364324096|FG001|Overall Study|Withdrawal by Subject|4|||
105634004|NCT00263757|364324095|FG000|Overall Study|Screen failure|0|||
105634005|NCT00263757|364324096|FG001|Overall Study|Screen failure|1|||
105634006|NCT00263757|364324095|FG000|Overall Study|Adverse Event|3|||
105634007|NCT00263757|364324096|FG001|Overall Study|Adverse Event|3|||
105634008|NCT03712371|364324099|FG000|Overall Study|Lack of Efficacy|0|||
105634009|NCT03712371|364324100|FG001|Overall Study|Lack of Efficacy|0|||
105634010|NCT03712371|364324101|FG002|Overall Study|Lack of Efficacy|0|||
105634011|NCT03712371|364324102|FG003|Overall Study|Lack of Efficacy|1|||
105634012|NCT03521154|364324104|FG000|Overall Study|Ongoing study at data cut-off|111|||
105634013|NCT03521154|364324105|FG001|Overall Study|Ongoing study at data cut-off|52|||
105634014|NCT02964741|364324108|FG000|Overall Study|Protocol Violation|1|||
105634015|NCT02964741|364324109|FG001|Overall Study|Protocol Violation|0|||
105634016|NCT02964741|364324110|FG002|Overall Study|Protocol Violation|0|||
105634017|NCT02964741|364324108|FG000|Overall Study|Withdrawal by Subject|0|||
105634018|NCT02964741|364324109|FG001|Overall Study|Withdrawal by Subject|1|||
105634019|NCT02964741|364324110|FG002|Overall Study|Withdrawal by Subject|0|||
105634020|NCT02964741|364324108|FG000|Overall Study|claustrophobia|1|||
105634021|NCT02964741|364324109|FG001|Overall Study|claustrophobia|0|||
105634022|NCT02964741|364324110|FG002|Overall Study|claustrophobia|0|||
105634023|NCT01212744|364324114|FG000|Overall Study|Withdrawal by Subject|1|||
105634024|NCT02167451|364324116|FG000|Overall Study|Withdrawal by Subject|1|||
105634025|NCT04191824|364324117|FG000|Overall Study|Death|13|||
105634026|NCT04191824|364324118|FG001|Overall Study|Death|12|||
105634027|NCT04191824|364324117|FG000|Overall Study|Lost to Follow-up|456|||
105634028|NCT04191824|364324118|FG001|Overall Study|Lost to Follow-up|435|||
105634029|NCT04191824|364324117|FG000|Overall Study|Physician Decision|2|||
105634030|NCT04191824|364324118|FG001|Overall Study|Physician Decision|1|||
105634031|NCT04191824|364324117|FG000|Overall Study|Protocol Violation|0|||
105634032|NCT04191824|364324118|FG001|Overall Study|Protocol Violation|2|||
105634033|NCT04191824|364324117|FG000|Overall Study|Withdrawal by Subject|16|||
105634034|NCT04191824|364324118|FG001|Overall Study|Withdrawal by Subject|18|||
105634035|NCT04191824|364324117|FG000|Overall Study|Early site closure|24|||
105634036|NCT04191824|364324118|FG001|Overall Study|Early site closure|22|||
105634037|NCT04937504|364324119|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
105634038|NCT04937504|364324120|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
105634039|NCT04937504|364324119|FG000|9 Months Assessment|Lost to Follow-up|3|||
105634040|NCT04937504|364324120|FG001|9 Months Assessment|Lost to Follow-up|2|||
105634041|NCT04306367|364324121|FG000|Overall Study|Progression of Disease|9|||
105634042|NCT04306367|364324121|FG000|Overall Study|Adverse Event|3|||
105634043|NCT04306367|364324121|FG000|Overall Study|Withdrawal by Subject|1|||
105634044|NCT05613907|364324122|FG000|Overall Study|Lost to Follow-up|5|||
105634045|NCT05613907|364324122|FG000|Overall Study|Death|3|||
105634046|NCT05613907|364324122|FG000|Overall Study|Withdrawal by Subject|2|||
105634047|NCT04912856|364324123|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
105634048|NCT04912856|364324124|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
105634049|NCT04912856|364324123|FG000|Overall Study|Not reported in synoptic CSR.|0|||
105634050|NCT04912856|364324124|FG001|Overall Study|Not reported in synoptic CSR.|1|||
105634051|NCT05349838|364324129|FG000|Overall Study|Virological Failure|1|||
105634052|NCT05349838|364324130|FG001|Overall Study|Virological Failure|2|||
105634053|NCT05349838|364324129|FG000|Overall Study|Withdrawal by Subject|2|||
105634054|NCT05349838|364324130|FG001|Overall Study|Withdrawal by Subject|3|||
105634055|NCT05349838|364324129|FG000|Overall Study|Adverse Event|3|||
105634056|NCT05349838|364324130|FG001|Overall Study|Adverse Event|1|||
105634057|NCT05349838|364324129|FG000|Overall Study|Lost to Follow-up|1|||
105634058|NCT05349838|364324130|FG001|Overall Study|Lost to Follow-up|2|||
105634059|NCT05349838|364324129|FG000|Overall Study|Other reasons|5|||
105634060|NCT05349838|364324130|FG001|Overall Study|Other reasons|1|||
105634061|NCT05037513|364324131|FG000|Intervention Period|Lost to Follow-up|1|||
105634062|NCT05037513|364324132|FG001|Intervention Period|Lost to Follow-up|2|||
105634063|NCT05037513|364324131|FG000|Follow Up Period|Lost to Follow-up|16|||
105634064|NCT05037513|364324132|FG001|Follow Up Period|Lost to Follow-up|21|||
105634065|NCT05037513|364324131|FG000|Follow Up Period|Death|0|||
105634066|NCT05037513|364324132|FG001|Follow Up Period|Death|1|||
105634067|NCT05037513|364324131|FG000|Follow Up Period|Incarcerated|4|||
105634068|NCT05037513|364324132|FG001|Follow Up Period|Incarcerated|2|||
105634069|NCT05886777|364324133|FG000|Overall Study|Lost to Follow-up|1|||
105634070|NCT05886777|364324134|FG001|Overall Study|Lost to Follow-up|0|||
105634071|NCT05886777|364324135|FG002|Overall Study|Lost to Follow-up|2|||
105634072|NCT05886777|364324136|FG003|Overall Study|Lost to Follow-up|1|||
105634073|NCT05886777|364324137|FG004|Overall Study|Lost to Follow-up|0|||
105634074|NCT05886777|364324138|FG005|Overall Study|Lost to Follow-up|2|||
105634075|NCT05886777|364324139|FG006|Overall Study|Lost to Follow-up|0|||
105634076|NCT05886777|364324133|FG000|Overall Study|Other|0|||
105634077|NCT05886777|364324134|FG001|Overall Study|Other|2|||
105634078|NCT05886777|364324135|FG002|Overall Study|Other|1|||
105634079|NCT05886777|364324136|FG003|Overall Study|Other|0|||
105634080|NCT05886777|364324137|FG004|Overall Study|Other|0|||
105634081|NCT05886777|364324138|FG005|Overall Study|Other|0|||
105634082|NCT05886777|364324139|FG006|Overall Study|Other|0|||
105634083|NCT05886777|364324133|FG000|Overall Study|Withdrawal by Subject|1|||
105634084|NCT05886777|364324134|FG001|Overall Study|Withdrawal by Subject|0|||
105634085|NCT05886777|364324135|FG002|Overall Study|Withdrawal by Subject|1|||
105634086|NCT05886777|364324136|FG003|Overall Study|Withdrawal by Subject|4|||
105634087|NCT05886777|364324137|FG004|Overall Study|Withdrawal by Subject|3|||
105634088|NCT05886777|364324138|FG005|Overall Study|Withdrawal by Subject|1|||
105634089|NCT05886777|364324139|FG006|Overall Study|Withdrawal by Subject|1|||
105634090|NCT05886777|364324133|FG000|Overall Study|Protocol Violation|0|||
105634091|NCT05886777|364324134|FG001|Overall Study|Protocol Violation|0|||
105634092|NCT05886777|364324135|FG002|Overall Study|Protocol Violation|1|||
105634093|NCT05886777|364324136|FG003|Overall Study|Protocol Violation|0|||
105634094|NCT05886777|364324137|FG004|Overall Study|Protocol Violation|0|||
105634095|NCT05886777|364324138|FG005|Overall Study|Protocol Violation|0|||
105634096|NCT05886777|364324139|FG006|Overall Study|Protocol Violation|0|||
105634097|NCT05886777|364324133|FG000|Overall Study|No longer met eligibility criteria|0|||
105634098|NCT05886777|364324134|FG001|Overall Study|No longer met eligibility criteria|1|||
105634099|NCT05886777|364324135|FG002|Overall Study|No longer met eligibility criteria|0|||
105634100|NCT05886777|364324136|FG003|Overall Study|No longer met eligibility criteria|0|||
105634101|NCT05886777|364324137|FG004|Overall Study|No longer met eligibility criteria|0|||
105634102|NCT05886777|364324138|FG005|Overall Study|No longer met eligibility criteria|0|||
105634103|NCT05886777|364324139|FG006|Overall Study|No longer met eligibility criteria|0|||
105634104|NCT00229658|364325971|FG000|Overall Study|Administrative|2|||
105634105|NCT00229658|364325972|FG001|Overall Study|Administrative|1|||
105634106|NCT00229658|364325971|FG000|Overall Study|Investigator decision|13|||
105634107|NCT00229658|364325972|FG001|Overall Study|Investigator decision|10|||
105634108|NCT00229658|364325971|FG000|Overall Study|Other|80|||
105634109|NCT00229658|364325972|FG001|Overall Study|Other|60|||
105634110|NCT00229658|364325971|FG000|Overall Study|Lost to Follow-up|82|||
105634111|NCT00229658|364325972|FG001|Overall Study|Lost to Follow-up|55|||
105634112|NCT00229658|364325971|FG000|Overall Study|Serious Adverse Event|2|||
105634113|NCT00229658|364325972|FG001|Overall Study|Serious Adverse Event|2|||
105634114|NCT00229658|364325971|FG000|Overall Study|Withdrawal of consent|46|||
105634115|NCT00229658|364325972|FG001|Overall Study|Withdrawal of consent|39|||
105634116|NCT00463229|364325973|FG000|Overall Study|Lost to Follow-up|5|||
105634117|NCT00463229|364325974|FG001|Overall Study|Lost to Follow-up|7|||
105634118|NCT00463229|364325973|FG000|Overall Study|Death|4|||
105634119|NCT00463229|364325974|FG001|Overall Study|Death|3|||
105634120|NCT01500200|364325975|FG000|Stage 1|Adverse Event|1|||
105634121|NCT01500200|364325976|FG001|Stage 1|Adverse Event|4|||
105634122|NCT01500200|364325977|FG002|Stage 1|Adverse Event|5|||
105634123|NCT01500200|364325978|FG003|Stage 1|Adverse Event|0|||
105634124|NCT01500200|364325979|FG004|Stage 1|Adverse Event|0|||
105634125|NCT01500200|364325980|FG005|Stage 1|Adverse Event|0|||
105634126|NCT01500200|364325975|FG000|Stage 1|Lost to Follow-up|2|||
105634127|NCT01500200|364325976|FG001|Stage 1|Lost to Follow-up|2|||
105634128|NCT01500200|364325977|FG002|Stage 1|Lost to Follow-up|1|||
105634129|NCT01500200|364325978|FG003|Stage 1|Lost to Follow-up|0|||
105634130|NCT01500200|364325979|FG004|Stage 1|Lost to Follow-up|0|||
105634131|NCT01500200|364325980|FG005|Stage 1|Lost to Follow-up|0|||
105634132|NCT01500200|364325975|FG000|Stage 1|Withdrawal by Subject|3|||
105634133|NCT01500200|364325976|FG001|Stage 1|Withdrawal by Subject|0|||
105634134|NCT01500200|364325977|FG002|Stage 1|Withdrawal by Subject|0|||
105634135|NCT01500200|364325978|FG003|Stage 1|Withdrawal by Subject|0|||
105634136|NCT01500200|364325979|FG004|Stage 1|Withdrawal by Subject|0|||
105634137|NCT01500200|364325980|FG005|Stage 1|Withdrawal by Subject|0|||
105634138|NCT01500200|364325975|FG000|Stage 1|Noncompliance with Study Drug|1|||
105634139|NCT01500200|364325976|FG001|Stage 1|Noncompliance with Study Drug|0|||
105634140|NCT01500200|364325977|FG002|Stage 1|Noncompliance with Study Drug|0|||
105634141|NCT01500200|364325978|FG003|Stage 1|Noncompliance with Study Drug|0|||
105634142|NCT01500200|364325979|FG004|Stage 1|Noncompliance with Study Drug|0|||
105634143|NCT01500200|364325980|FG005|Stage 1|Noncompliance with Study Drug|0|||
105634144|NCT01500200|364325975|FG000|Stage 1|Physician Decision|1|||
105634145|NCT01500200|364325976|FG001|Stage 1|Physician Decision|0|||
105634146|NCT01500200|364325977|FG002|Stage 1|Physician Decision|0|||
105634147|NCT01500200|364325978|FG003|Stage 1|Physician Decision|0|||
105634148|NCT01500200|364325979|FG004|Stage 1|Physician Decision|0|||
105634149|NCT01500200|364325980|FG005|Stage 1|Physician Decision|0|||
105634150|NCT01500200|364325975|FG000|Stage 2|Adverse Event|0|||
105634151|NCT01500200|364325976|FG001|Stage 2|Adverse Event|0|||
105634152|NCT01500200|364325977|FG002|Stage 2|Adverse Event|0|||
105634153|NCT01500200|364325978|FG003|Stage 2|Adverse Event|0|||
105634154|NCT01500200|364325979|FG004|Stage 2|Adverse Event|5|||
105634155|NCT01500200|364325980|FG005|Stage 2|Adverse Event|4|||
105634156|NCT01952366|364325981|FG000|Overall Study|Death|22|||
105634157|NCT01952366|364325981|FG000|Overall Study|Withdrawal by Subject|9|||
105634158|NCT01767467|364325982|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
105634159|NCT01767467|364325983|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
105634160|NCT01767467|364325982|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
105634161|NCT01767467|364325983|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
105634162|NCT01767467|364325982|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
105634163|NCT01767467|364325983|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
105634164|NCT01767467|364325982|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
105634165|NCT01767467|364325983|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
105634166|NCT01767467|364325982|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
105634167|NCT01767467|364325983|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
105634168|NCT01767467|364325982|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
105634169|NCT01767467|364325983|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
105634170|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
105634171|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
105634172|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
105634173|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
105634174|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
105634175|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
105634176|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
105634177|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
105634178|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
105634179|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
105634180|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
105634181|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
105634182|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
105634183|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
105634184|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
105634185|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
105634186|NCT01359150|364325984|FG000|Overall Study|Lack of Efficacy|1|||
105634187|NCT01359150|364325985|FG001|Overall Study|Lack of Efficacy|1|||
105634188|NCT01359150|364325984|FG000|Overall Study|Withdrawal by Subject|1|||
105634189|NCT01359150|364325985|FG001|Overall Study|Withdrawal by Subject|1|||
105634190|NCT01359150|364325984|FG000|Overall Study|Adverse Event|4|||
105634191|NCT01359150|364325985|FG001|Overall Study|Adverse Event|3|||
105634192|NCT01359150|364325984|FG000|Overall Study|Other|1|||
105634193|NCT01359150|364325985|FG001|Overall Study|Other|0|||
105634194|NCT04860505|364325986|FG000|Overall Study|Lost to Follow-up|2|||
105634195|NCT02406092|364326001|FG000|Overall Study|Screen failure|10|||
105634196|NCT02406092|364326002|FG001|Overall Study|Screen failure|7|||
105634197|NCT02406092|364326001|FG000|Overall Study|Death|22|||
105634198|NCT02406092|364326002|FG001|Overall Study|Death|5|||
105634199|NCT02406092|364326001|FG000|Overall Study|Lost to Follow-up|4|||
105634200|NCT02406092|364326002|FG001|Overall Study|Lost to Follow-up|1|||
105634201|NCT02406092|364326001|FG000|Overall Study|Adverse Event|1|||
105634202|NCT02406092|364326002|FG001|Overall Study|Adverse Event|0|||
105634203|NCT02406092|364326001|FG000|Overall Study|Withdrawal by Subject|1|||
105634204|NCT02406092|364326002|FG001|Overall Study|Withdrawal by Subject|0|||
105634205|NCT00293397|364326003|FG000|Overall Study|Death|2|||
105634206|NCT03631407|364326006|FG000|Overall Study|Withdrawal by Subject|3|||
105634207|NCT03631407|364326007|FG001|Overall Study|Withdrawal by Subject|2|||
105634208|NCT03631407|364326006|FG000|Overall Study|Sponsor Decision|0|||
105634209|NCT03631407|364326007|FG001|Overall Study|Sponsor Decision|2|||
105634210|NCT03631407|364326006|FG000|Overall Study|Death|16|||
105634211|NCT03631407|364326007|FG001|Overall Study|Death|16|||
105634212|NCT03631407|364326006|FG000|Overall Study|Randomized by mistake without study treatment|1|||
105634213|NCT03631407|364326007|FG001|Overall Study|Randomized by mistake without study treatment|0|||
105634214|NCT03041233|364326008|FG000|Overall Study|Death|5|||
105634215|NCT03041233|364326008|FG000|Overall Study|Physician Decision|1|||
105634216|NCT03041233|364326008|FG000|Overall Study|Lost to Follow-up|16|||
105634217|NCT03041233|364326008|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
105634218|NCT03041233|364326008|FG000|Overall Study|Sponsor Request|1|||
105634219|NCT03041233|364326008|FG000|Overall Study|Duplicate subject|1|||
105634220|NCT03041233|364326008|FG000|Overall Study|Re-ablation|1|||
105634221|NCT00811941|364326009|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
105634222|NCT00811941|364326010|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
105634223|NCT00811941|364326009|FG000|All Treated Patients|Adverse Event|2|||
105634224|NCT00811941|364326010|FG001|All Treated Patients|Adverse Event|43|||
105634225|NCT00811941|364326009|FG000|All Treated Patients|Lack of Efficacy|2|||
105634226|NCT00811941|364326010|FG001|All Treated Patients|Lack of Efficacy|3|||
105634227|NCT00811941|364326009|FG000|All Treated Patients|Non-compliance|1|||
105634228|NCT00811941|364326010|FG001|All Treated Patients|Non-compliance|8|||
105634229|NCT00811941|364326009|FG000|All Treated Patients|Protocol Violation|5|||
105634230|NCT00811941|364326010|FG001|All Treated Patients|Protocol Violation|17|||
105634231|NCT00811941|364326009|FG000|All Treated Patients|Withdrawal by Subject|35|||
105634232|NCT00811941|364326010|FG001|All Treated Patients|Withdrawal by Subject|94|||
105634233|NCT00811941|364326009|FG000|All Treated Patients|Lost to Follow-up|3|||
105634234|NCT00811941|364326010|FG001|All Treated Patients|Lost to Follow-up|12|||
105634235|NCT00811941|364326009|FG000|All Treated Patients|Other Reason|4|||
105634236|NCT00811941|364326010|FG001|All Treated Patients|Other Reason|14|||
105634237|NCT03802994|364326011|FG000|Overall Study|Lost to Follow-up|0|||
105634238|NCT03802994|364326012|FG001|Overall Study|Lost to Follow-up|2|||
105634239|NCT03802994|364326013|FG002|Overall Study|Lost to Follow-up|3|||
105634240|NCT03802994|364326014|FG003|Overall Study|Lost to Follow-up|2|||
105634241|NCT03802994|364326015|FG004|Overall Study|Lost to Follow-up|2|||
105634242|NCT05580003|364326018|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634243|NCT05580003|364326019|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634244|NCT05580003|364326020|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634245|NCT05580003|364326021|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634246|NCT05580003|364326022|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634247|NCT05580003|364326023|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634248|NCT05580003|364326024|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
105634249|NCT05580003|364326025|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634250|NCT05580003|364326026|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634251|NCT05580003|364326027|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634252|NCT05580003|364326028|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634253|NCT05580003|364326029|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634254|NCT05580003|364326030|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634255|NCT05580003|364326031|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634256|NCT05580003|364326032|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634257|NCT05580003|364326033|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634258|NCT05580003|364326034|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634259|NCT05580003|364326035|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634260|NCT05580003|364326036|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634261|NCT05580003|364326037|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634262|NCT05580003|364326038|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634263|NCT05580003|364326039|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634264|NCT05580003|364326040|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634265|NCT05580003|364326041|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634266|NCT05580003|364326042|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634267|NCT05580003|364326043|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634268|NCT05580003|364326044|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634269|NCT05580003|364326045|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634270|NCT05580003|364326018|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634271|NCT05580003|364326019|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634272|NCT05580003|364326020|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634273|NCT05580003|364326021|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634274|NCT05580003|364326022|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634275|NCT05580003|364326023|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
105634276|NCT05580003|364326024|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634277|NCT05580003|364326025|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634278|NCT05580003|364326026|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634279|NCT05580003|364326027|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634280|NCT05580003|364326028|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634281|NCT05580003|364326029|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634282|NCT05580003|364326030|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634283|NCT05580003|364326031|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634284|NCT05580003|364326032|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634285|NCT05580003|364326033|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634286|NCT05580003|364326034|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634287|NCT05580003|364326035|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634288|NCT05580003|364326036|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634289|NCT05580003|364326037|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634290|NCT05580003|364326038|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634291|NCT05580003|364326039|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634292|NCT05580003|364326040|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634293|NCT05580003|364326041|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634294|NCT05580003|364326042|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634295|NCT05580003|364326043|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634296|NCT05580003|364326044|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634297|NCT05580003|364326045|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634298|NCT05580003|364326018|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634299|NCT05580003|364326019|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634300|NCT05580003|364326020|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634301|NCT05580003|364326021|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
105634302|NCT05580003|364326022|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634303|NCT05580003|364326023|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634304|NCT05580003|364326024|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634305|NCT05580003|364326025|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634306|NCT05580003|364326026|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634307|NCT05580003|364326027|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634308|NCT05580003|364326028|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634309|NCT05580003|364326029|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634310|NCT05580003|364326030|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634311|NCT05580003|364326031|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634312|NCT05580003|364326032|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634313|NCT05580003|364326033|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634314|NCT05580003|364326034|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634315|NCT05580003|364326035|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634316|NCT05580003|364326036|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634317|NCT05580003|364326037|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634318|NCT05580003|364326038|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634319|NCT05580003|364326039|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634320|NCT05580003|364326040|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634321|NCT05580003|364326041|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634322|NCT05580003|364326042|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634323|NCT05580003|364326043|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634324|NCT05580003|364326044|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634325|NCT05580003|364326045|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634326|NCT05580003|364326018|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634327|NCT05580003|364326019|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
105634328|NCT05580003|364326020|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634329|NCT05580003|364326021|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634330|NCT05580003|364326022|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634331|NCT05580003|364326023|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634332|NCT05580003|364326024|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634333|NCT05580003|364326025|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634334|NCT05580003|364326026|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634335|NCT05580003|364326027|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634336|NCT05580003|364326028|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634337|NCT05580003|364326029|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634338|NCT05580003|364326030|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634339|NCT05580003|364326031|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634340|NCT05580003|364326032|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634341|NCT05580003|364326033|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634342|NCT05580003|364326034|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634343|NCT05580003|364326035|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634344|NCT05580003|364326036|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634345|NCT05580003|364326037|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634346|NCT05580003|364326038|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634347|NCT05580003|364326039|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634348|NCT05580003|364326040|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634349|NCT05580003|364326041|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634350|NCT05580003|364326042|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634351|NCT05580003|364326043|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634352|NCT05580003|364326044|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634353|NCT05580003|364326045|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634354|NCT05580003|364326018|FG000|Part 2 (up to 10 Days)|Other|0|||
105634355|NCT05580003|364326019|FG001|Part 2 (up to 10 Days)|Other|0|||
105634356|NCT05580003|364326020|FG002|Part 2 (up to 10 Days)|Other|0|||
105634357|NCT05580003|364326021|FG003|Part 2 (up to 10 Days)|Other|0|||
105634358|NCT05580003|364326022|FG004|Part 2 (up to 10 Days)|Other|0|||
105634359|NCT05580003|364326023|FG005|Part 2 (up to 10 Days)|Other|0|||
105634360|NCT05580003|364326024|FG006|Part 2 (up to 10 Days)|Other|0|||
105634361|NCT05580003|364326025|FG007|Part 2 (up to 10 Days)|Other|0|||
105634362|NCT05580003|364326026|FG008|Part 2 (up to 10 Days)|Other|0|||
105634363|NCT05580003|364326027|FG009|Part 2 (up to 10 Days)|Other|1|||
105634364|NCT05580003|364326028|FG010|Part 2 (up to 10 Days)|Other|0|||
105634365|NCT05580003|364326029|FG011|Part 2 (up to 10 Days)|Other|0|||
105634366|NCT05580003|364326030|FG012|Part 2 (up to 10 Days)|Other|0|||
105634367|NCT05580003|364326031|FG013|Part 2 (up to 10 Days)|Other|0|||
105634368|NCT05580003|364326032|FG014|Part 2 (up to 10 Days)|Other|0|||
105634369|NCT05580003|364326033|FG015|Part 2 (up to 10 Days)|Other|0|||
105634370|NCT05580003|364326034|FG016|Part 2 (up to 10 Days)|Other|0|||
105634371|NCT05580003|364326035|FG017|Part 2 (up to 10 Days)|Other|0|||
105634372|NCT05580003|364326036|FG018|Part 2 (up to 10 Days)|Other|0|||
105634373|NCT05580003|364326037|FG019|Part 2 (up to 10 Days)|Other|0|||
105634374|NCT05580003|364326038|FG020|Part 2 (up to 10 Days)|Other|0|||
105634375|NCT05580003|364326039|FG021|Part 2 (up to 10 Days)|Other|0|||
105634376|NCT05580003|364326040|FG022|Part 2 (up to 10 Days)|Other|0|||
105634377|NCT05580003|364326041|FG023|Part 2 (up to 10 Days)|Other|0|||
105634378|NCT05580003|364326042|FG024|Part 2 (up to 10 Days)|Other|0|||
105634379|NCT05580003|364326043|FG025|Part 2 (up to 10 Days)|Other|0|||
105634380|NCT05580003|364326044|FG026|Part 2 (up to 10 Days)|Other|0|||
105634381|NCT05580003|364326045|FG027|Part 2 (up to 10 Days)|Other|0|||
105634382|NCT05580003|364326018|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634383|NCT05580003|364326019|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634384|NCT05580003|364326020|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634385|NCT05580003|364326021|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634386|NCT05580003|364326022|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634387|NCT05580003|364326023|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634388|NCT05580003|364326024|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634389|NCT05580003|364326025|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634390|NCT05580003|364326026|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634391|NCT05580003|364326027|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634392|NCT05580003|364326028|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634393|NCT05580003|364326029|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634394|NCT05580003|364326030|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634395|NCT05580003|364326031|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634396|NCT05580003|364326032|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634397|NCT05580003|364326033|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634398|NCT05580003|364326034|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634399|NCT05580003|364326035|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634400|NCT05580003|364326036|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634401|NCT05580003|364326037|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
105634402|NCT05580003|364326038|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634403|NCT05580003|364326039|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634404|NCT05580003|364326040|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634405|NCT05580003|364326041|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634406|NCT05580003|364326042|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634407|NCT05580003|364326043|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634408|NCT05580003|364326044|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634409|NCT05580003|364326045|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634410|NCT05580003|364326018|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634411|NCT05580003|364326019|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634412|NCT05580003|364326020|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634413|NCT05580003|364326021|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634414|NCT05580003|364326022|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634415|NCT05580003|364326023|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634416|NCT05580003|364326024|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634417|NCT05580003|364326025|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634418|NCT05580003|364326026|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634419|NCT05580003|364326027|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634420|NCT05580003|364326028|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634421|NCT05580003|364326029|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634422|NCT05580003|364326030|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634423|NCT05580003|364326031|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634424|NCT05580003|364326032|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634425|NCT05580003|364326033|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634426|NCT05580003|364326034|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634427|NCT05580003|364326035|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634428|NCT05580003|364326036|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634429|NCT05580003|364326037|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634430|NCT05580003|364326038|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
105634431|NCT05580003|364326039|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634432|NCT05580003|364326040|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634433|NCT05580003|364326041|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634434|NCT05580003|364326042|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634435|NCT05580003|364326043|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634436|NCT05580003|364326044|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634437|NCT05580003|364326045|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634438|NCT05580003|364326018|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634439|NCT05580003|364326019|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634440|NCT05580003|364326020|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634441|NCT05580003|364326021|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634442|NCT05580003|364326022|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634443|NCT05580003|364326023|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634444|NCT05580003|364326024|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634445|NCT05580003|364326025|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634446|NCT05580003|364326026|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634447|NCT05580003|364326027|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634448|NCT05580003|364326028|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634449|NCT05580003|364326029|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634450|NCT05580003|364326030|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634451|NCT05580003|364326031|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634452|NCT05580003|364326032|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634453|NCT05580003|364326033|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634454|NCT05580003|364326034|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634455|NCT05580003|364326035|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634456|NCT05580003|364326036|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634457|NCT05580003|364326037|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634458|NCT05580003|364326038|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634459|NCT05580003|364326039|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
105634460|NCT05580003|364326040|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634461|NCT05580003|364326041|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634462|NCT05580003|364326042|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634463|NCT05580003|364326043|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634464|NCT05580003|364326044|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634465|NCT05580003|364326045|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634466|NCT05580003|364326018|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634467|NCT05580003|364326019|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634468|NCT05580003|364326020|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634469|NCT05580003|364326021|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634470|NCT05580003|364326022|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634471|NCT05580003|364326023|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634472|NCT05580003|364326024|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634473|NCT05580003|364326025|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634474|NCT05580003|364326026|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634475|NCT05580003|364326027|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634476|NCT05580003|364326028|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634477|NCT05580003|364326029|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634478|NCT05580003|364326030|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634479|NCT05580003|364326031|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634480|NCT05580003|364326032|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634481|NCT05580003|364326033|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634482|NCT05580003|364326034|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634483|NCT05580003|364326035|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634484|NCT05580003|364326036|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634485|NCT05580003|364326037|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634486|NCT05580003|364326038|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634487|NCT05580003|364326039|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634488|NCT05580003|364326040|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634489|NCT05580003|364326041|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634490|NCT05580003|364326042|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634491|NCT05580003|364326043|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634492|NCT05580003|364326044|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634493|NCT05580003|364326045|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
105634494|NCT05580003|364326018|FG000|Part 6 Period 2 (Day 1)|Other|0|||
105634495|NCT05580003|364326019|FG001|Part 6 Period 2 (Day 1)|Other|0|||
105634496|NCT05580003|364326020|FG002|Part 6 Period 2 (Day 1)|Other|0|||
105634497|NCT05580003|364326021|FG003|Part 6 Period 2 (Day 1)|Other|0|||
105634498|NCT05580003|364326022|FG004|Part 6 Period 2 (Day 1)|Other|0|||
105634499|NCT05580003|364326023|FG005|Part 6 Period 2 (Day 1)|Other|0|||
105634500|NCT05580003|364326024|FG006|Part 6 Period 2 (Day 1)|Other|0|||
105634501|NCT05580003|364326025|FG007|Part 6 Period 2 (Day 1)|Other|0|||
105634502|NCT05580003|364326026|FG008|Part 6 Period 2 (Day 1)|Other|0|||
105634503|NCT05580003|364326027|FG009|Part 6 Period 2 (Day 1)|Other|0|||
105634504|NCT05580003|364326028|FG010|Part 6 Period 2 (Day 1)|Other|0|||
105634505|NCT05580003|364326029|FG011|Part 6 Period 2 (Day 1)|Other|0|||
105634506|NCT05580003|364326030|FG012|Part 6 Period 2 (Day 1)|Other|0|||
105634507|NCT05580003|364326031|FG013|Part 6 Period 2 (Day 1)|Other|0|||
105634508|NCT05580003|364326032|FG014|Part 6 Period 2 (Day 1)|Other|0|||
105634509|NCT05580003|364326033|FG015|Part 6 Period 2 (Day 1)|Other|0|||
105634510|NCT05580003|364326034|FG016|Part 6 Period 2 (Day 1)|Other|0|||
105634511|NCT05580003|364326035|FG017|Part 6 Period 2 (Day 1)|Other|0|||
105634512|NCT05580003|364326036|FG018|Part 6 Period 2 (Day 1)|Other|0|||
105634513|NCT05580003|364326037|FG019|Part 6 Period 2 (Day 1)|Other|0|||
105634514|NCT05580003|364326038|FG020|Part 6 Period 2 (Day 1)|Other|0|||
105634515|NCT05580003|364326039|FG021|Part 6 Period 2 (Day 1)|Other|0|||
105634516|NCT05580003|364326040|FG022|Part 6 Period 2 (Day 1)|Other|0|||
105634517|NCT05580003|364326041|FG023|Part 6 Period 2 (Day 1)|Other|0|||
105634518|NCT05580003|364326042|FG024|Part 6 Period 2 (Day 1)|Other|1|||
105634519|NCT05580003|364326043|FG025|Part 6 Period 2 (Day 1)|Other|0|||
105634520|NCT05580003|364326044|FG026|Part 6 Period 2 (Day 1)|Other|0|||
105634521|NCT05580003|364326045|FG027|Part 6 Period 2 (Day 1)|Other|0|||
105634522|NCT02392234|364326046|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
105634523|NCT02392234|364326047|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
105634524|NCT02392234|364326048|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
105634525|NCT02392234|364326049|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
105634526|NCT02392234|364326050|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
105634527|NCT02392234|364326051|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
105634528|NCT02392234|364326046|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
105634529|NCT02392234|364326047|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
105634530|NCT02392234|364326048|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
105634531|NCT02392234|364326049|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
105634532|NCT02392234|364326050|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
105634533|NCT02392234|364326051|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
105634534|NCT02392234|364326046|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
105634535|NCT02392234|364326047|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
105634536|NCT02392234|364326048|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
105634537|NCT02392234|364326049|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
105634538|NCT02392234|364326050|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
105634539|NCT02392234|364326051|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
105634540|NCT02392234|364326046|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
105634541|NCT02392234|364326047|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
105634542|NCT02392234|364326048|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
105634543|NCT02392234|364326049|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
105634544|NCT02392234|364326050|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
105634545|NCT02392234|364326051|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
105634546|NCT02392234|364326046|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
105634547|NCT02392234|364326047|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
105634548|NCT02392234|364326048|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
105634549|NCT02392234|364326049|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
105634550|NCT02392234|364326050|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
105634551|NCT02392234|364326051|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
105634552|NCT02392234|364326046|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
105634553|NCT02392234|364326047|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
105634554|NCT02392234|364326048|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
105634555|NCT02392234|364326049|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
105634556|NCT02392234|364326050|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
105634557|NCT02392234|364326051|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
105634558|NCT02392234|364326046|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
105634559|NCT02392234|364326047|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
105634560|NCT02392234|364326048|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
105634561|NCT02392234|364326049|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
105634562|NCT02392234|364326050|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
105634563|NCT02392234|364326051|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
105634564|NCT02392234|364326046|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
105634565|NCT02392234|364326047|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
105634566|NCT02392234|364326048|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
105634567|NCT02392234|364326049|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
105634568|NCT02392234|364326050|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
105634569|NCT02392234|364326051|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
105634570|NCT02029235|364326052|FG000|Overall Study|Non-compliance with study meds or diary|4|||
105634571|NCT02029235|364326053|FG001|Overall Study|Non-compliance with study meds or diary|1|||
105634572|NCT02816398|364326055|FG000|Overall Study|Death|5|||
105634573|NCT02816398|364326055|FG000|Overall Study|Lack of Efficacy|8|||
105634574|NCT02816398|364326055|FG000|Overall Study|Lost to Follow-up|1|||
105634575|NCT06303167|364326056|FG000|Overall Study|Ineligible|1|||
105634576|NCT06303167|364326056|FG000|Overall Study|Never start protocol therapy|2|||
105634577|NCT06303167|364326056|FG000|Overall Study|Disease progression|16|||
105634578|NCT02052440|364326057|FG000|Overall Study|Withdrawal by Subject|0|||
105634579|NCT02052440|364326058|FG001|Overall Study|Withdrawal by Subject|1|||
105634580|NCT01367236|364326059|FG000|Overall Study|Withdrawal by Subject|3|||
105634581|NCT01367236|364326060|FG001|Overall Study|Withdrawal by Subject|1|||
105634582|NCT03611075|364326068|FG000|Overall Study|Physician Decision|0|||
105634583|NCT03611075|364326069|FG001|Overall Study|Physician Decision|1|||
105634584|NCT03611075|364326070|FG002|Overall Study|Physician Decision|1|||
105634585|NCT03611075|364326071|FG003|Overall Study|Physician Decision|0|||
105634586|NCT03611075|364326072|FG004|Overall Study|Physician Decision|0|||
105634587|NCT03611075|364326073|FG005|Overall Study|Physician Decision|0|||
105634588|NCT03611075|364326074|FG006|Overall Study|Physician Decision|0|||
105634589|NCT03611075|364326075|FG007|Overall Study|Physician Decision|0|||
105634590|NCT03611075|364326076|FG008|Overall Study|Physician Decision|0|||
105634591|NCT03611075|364326068|FG000|Overall Study|Lost to Follow-up|1|||
105634592|NCT03611075|364326069|FG001|Overall Study|Lost to Follow-up|0|||
105634593|NCT03611075|364326070|FG002|Overall Study|Lost to Follow-up|0|||
105634594|NCT03611075|364326071|FG003|Overall Study|Lost to Follow-up|2|||
105634595|NCT03611075|364326072|FG004|Overall Study|Lost to Follow-up|0|||
105634596|NCT03611075|364326073|FG005|Overall Study|Lost to Follow-up|0|||
105634597|NCT03611075|364326074|FG006|Overall Study|Lost to Follow-up|0|||
105634598|NCT03611075|364326075|FG007|Overall Study|Lost to Follow-up|0|||
105634599|NCT03611075|364326076|FG008|Overall Study|Lost to Follow-up|0|||
105634600|NCT03611075|364326068|FG000|Overall Study|Withdrawal by Subject|0|||
105634601|NCT03611075|364326069|FG001|Overall Study|Withdrawal by Subject|1|||
105634602|NCT03611075|364326070|FG002|Overall Study|Withdrawal by Subject|1|||
105634603|NCT03611075|364326071|FG003|Overall Study|Withdrawal by Subject|1|||
105634604|NCT03611075|364326072|FG004|Overall Study|Withdrawal by Subject|0|||
105634605|NCT03611075|364326073|FG005|Overall Study|Withdrawal by Subject|0|||
105634606|NCT03611075|364326074|FG006|Overall Study|Withdrawal by Subject|1|||
105634607|NCT03611075|364326075|FG007|Overall Study|Withdrawal by Subject|0|||
105634608|NCT03611075|364326076|FG008|Overall Study|Withdrawal by Subject|0|||
105634609|NCT03611075|364326068|FG000|Overall Study|Reason unknown|0|||
105634610|NCT03611075|364326069|FG001|Overall Study|Reason unknown|0|||
105634611|NCT03611075|364326070|FG002|Overall Study|Reason unknown|0|||
105634612|NCT03611075|364326071|FG003|Overall Study|Reason unknown|1|||
105634613|NCT03611075|364326072|FG004|Overall Study|Reason unknown|0|||
105634614|NCT03611075|364326073|FG005|Overall Study|Reason unknown|0|||
105634615|NCT03611075|364326074|FG006|Overall Study|Reason unknown|1|||
105634616|NCT03611075|364326075|FG007|Overall Study|Reason unknown|0|||
105634617|NCT03611075|364326076|FG008|Overall Study|Reason unknown|0|||
105634618|NCT00676091|364326077|FG000|Infant Series|Parent or legal guardian request|10|||
105634619|NCT00676091|364326078|FG001|Infant Series|Parent or legal guardian request|8|||
105634620|NCT00676091|364326077|FG000|Infant Series|Protocol Violation|6|||
105634621|NCT00676091|364326078|FG001|Infant Series|Protocol Violation|3|||
105634622|NCT00676091|364326077|FG000|Infant Series|Adverse Event|2|||
105634623|NCT00676091|364326078|FG001|Infant Series|Adverse Event|3|||
105634624|NCT00676091|364326077|FG000|Infant Series|Failed to return|1|||
105634625|NCT00676091|364326078|FG001|Infant Series|Failed to return|3|||
105634626|NCT00676091|364326077|FG000|Infant Series|Lost to Follow-up|1|||
105634627|NCT00676091|364326078|FG001|Infant Series|Lost to Follow-up|0|||
105634628|NCT00676091|364326077|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
105634629|NCT00676091|364326078|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
105634630|NCT00676091|364326077|FG000|After Infant Series|Adverse Event|0|||
105634631|NCT00676091|364326078|FG001|After Infant Series|Adverse Event|1|||
105634632|NCT00676091|364326077|FG000|After Infant Series|Protocol Violation|0|||
105634633|NCT00676091|364326078|FG001|After Infant Series|Protocol Violation|1|||
105634634|NCT00676091|364326077|FG000|After Infant Series|Failed to return|1|||
105634635|NCT00676091|364326078|FG001|After Infant Series|Failed to return|1|||
105634636|NCT00676091|364326077|FG000|Toddler Dose|Failed to return|2|||
105634637|NCT00676091|364326078|FG001|Toddler Dose|Failed to return|0|||
105634638|NCT00676091|364326077|FG000|Toddler Dose|Parent or legal guardian request|1|||
105634639|NCT00676091|364326078|FG001|Toddler Dose|Parent or legal guardian request|0|||
105634640|NCT02063659|364326079|FG000|Double-Blind Treatment Period|Adverse Event|1|||
105634641|NCT02063659|364326080|FG001|Double-Blind Treatment Period|Adverse Event|2|||
105634642|NCT02063659|364326081|FG002|Double-Blind Treatment Period|Adverse Event|0|||
105634643|NCT02063659|364326082|FG003|Double-Blind Treatment Period|Adverse Event|0|||
105634644|NCT02063659|364326079|FG000|Double-Blind Treatment Period|Physician Decision|1|||
105634645|NCT02063659|364326080|FG001|Double-Blind Treatment Period|Physician Decision|0|||
105634646|NCT02063659|364326081|FG002|Double-Blind Treatment Period|Physician Decision|0|||
105634647|NCT02063659|364326082|FG003|Double-Blind Treatment Period|Physician Decision|0|||
105634648|NCT02063659|364326079|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
105634649|NCT02063659|364326080|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
105634650|NCT02063659|364326081|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
105634651|NCT02063659|364326082|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
105634652|NCT02063659|364326079|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
105634653|NCT02063659|364326080|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
105634654|NCT02063659|364326081|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
105634655|NCT02063659|364326082|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
105634656|NCT02063659|364326079|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
105634657|NCT02063659|364326080|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
105634658|NCT02063659|364326081|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
105634659|NCT02063659|364326082|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
105634660|NCT02063659|364326079|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
105634661|NCT02063659|364326080|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
105634662|NCT02063659|364326081|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
105634663|NCT02063659|364326082|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
105634664|NCT02063659|364326079|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
105634665|NCT02063659|364326080|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
105634666|NCT02063659|364326081|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
105634667|NCT02063659|364326082|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
105634668|NCT02063659|364326079|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
105634669|NCT02063659|364326080|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
105634670|NCT02063659|364326081|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
105634671|NCT02063659|364326082|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
105634672|NCT02408887|364326083|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
105634673|NCT02408887|364326084|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
105634674|NCT02408887|364326083|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
105634675|NCT02408887|364326084|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
105634676|NCT00914966|364326085|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
105634677|NCT00914966|364326085|FG000|Step 1: 1500 Units|Physician Decision|1|||
105634678|NCT00914966|364326085|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
105634679|NCT03333109|364326086|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
105634680|NCT03333109|364326087|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
105634681|NCT03333109|364326088|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
105634682|NCT03333109|364326086|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
105634683|NCT03333109|364326087|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
105634684|NCT03333109|364326088|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
105634685|NCT03333109|364326086|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
105634686|NCT03333109|364326087|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
105634687|NCT03333109|364326088|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
105634688|NCT03333109|364326086|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
105634689|NCT03333109|364326087|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
105634690|NCT03333109|364326088|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
105634691|NCT03333109|364326086|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
105634692|NCT03333109|364326087|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
105634693|NCT03333109|364326088|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
105634694|NCT03333109|364326086|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
105634695|NCT03333109|364326087|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
105634696|NCT03333109|364326088|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
105634697|NCT03333109|364326086|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
105634698|NCT03333109|364326087|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
105634699|NCT03333109|364326088|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
105634700|NCT03333109|364326086|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
105634701|NCT03333109|364326087|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
105634702|NCT03333109|364326088|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
105634703|NCT00589875|364326091|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
105634704|NCT00589875|364326091|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
105634705|NCT03488719|364326092|FG000|Overall Study|Adverse Event|0|||
105634706|NCT03488719|364326093|FG001|Overall Study|Adverse Event|4|||
105634707|NCT03488719|364326094|FG002|Overall Study|Adverse Event|2|||
105634708|NCT03488719|364326092|FG000|Overall Study|Other|0|||
105634709|NCT03488719|364326093|FG001|Overall Study|Other|0|||
105634710|NCT03488719|364326094|FG002|Overall Study|Other|5|||
105634711|NCT03610581|364326099|FG000|Overall Study|Study terminated by sponsor|2|||
105634712|NCT03610581|364326100|FG001|Overall Study|Study terminated by sponsor|0|||
105634713|NCT03610581|364326099|FG000|Overall Study|Other|0|||
105634714|NCT03610581|364326100|FG001|Overall Study|Other|1|||
105634715|NCT03610581|364326099|FG000|Overall Study|Withdrawal by Subject|1|||
105634716|NCT03610581|364326100|FG001|Overall Study|Withdrawal by Subject|0|||
105634717|NCT02609048|364326101|FG000|Overall Study|Adverse Event|3|||
105634718|NCT02609048|364326102|FG001|Overall Study|Adverse Event|0|||
105634719|NCT02609048|364326103|FG002|Overall Study|Adverse Event|0|||
105634720|NCT02609048|364326101|FG000|Overall Study|Randomized but never treated|1|||
105634721|NCT02609048|364326102|FG001|Overall Study|Randomized but never treated|1|||
105634722|NCT02609048|364326103|FG002|Overall Study|Randomized but never treated|1|||
105634723|NCT02609048|364326101|FG000|Overall Study|Withdrawal of informed consent|1|||
105634724|NCT02609048|364326102|FG001|Overall Study|Withdrawal of informed consent|0|||
105634725|NCT02609048|364326103|FG002|Overall Study|Withdrawal of informed consent|0|||
105634726|NCT02609048|364326101|FG000|Overall Study|Reason not specified|6|||
105634727|NCT02609048|364326102|FG001|Overall Study|Reason not specified|9|||
105634728|NCT02609048|364326103|FG002|Overall Study|Reason not specified|9|||
105634729|NCT02830204|364326104|FG000|Overall Study|Death|9|||
105634730|NCT02830204|364326104|FG000|Overall Study|Withdrawal by Subject|1|||
105634731|NCT01690624|364326105|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
105634732|NCT01690624|364326106|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
105634733|NCT01690624|364326107|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
105634734|NCT01690624|364326108|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
105634735|NCT01690624|364326105|FG000|Overall Study|Adverse event (other than DLT)|3|||
105634736|NCT01690624|364326106|FG001|Overall Study|Adverse event (other than DLT)|1|||
105634737|NCT01690624|364326107|FG002|Overall Study|Adverse event (other than DLT)|1|||
105634738|NCT01690624|364326108|FG003|Overall Study|Adverse event (other than DLT)|1|||
105634739|NCT01690624|364326105|FG000|Overall Study|Withdrawal by Subject|0|||
105634740|NCT01690624|364326106|FG001|Overall Study|Withdrawal by Subject|0|||
105634741|NCT01690624|364326107|FG002|Overall Study|Withdrawal by Subject|1|||
105634742|NCT01690624|364326108|FG003|Overall Study|Withdrawal by Subject|0|||
105634743|NCT01690624|364326105|FG000|Overall Study|Sponsor is ending trial|0|||
105634744|NCT01690624|364326106|FG001|Overall Study|Sponsor is ending trial|0|||
105634745|NCT01690624|364326107|FG002|Overall Study|Sponsor is ending trial|0|||
105634746|NCT01690624|364326108|FG003|Overall Study|Sponsor is ending trial|1|||
105634747|NCT01690624|364326105|FG000|Overall Study|Physician Decision|0|||
105634748|NCT01690624|364326106|FG001|Overall Study|Physician Decision|0|||
105634749|NCT01690624|364326107|FG002|Overall Study|Physician Decision|0|||
105634750|NCT01690624|364326108|FG003|Overall Study|Physician Decision|1|||
105634751|NCT01690624|364326105|FG000|Overall Study|Withdrawal by Subject|0|||
105634752|NCT01690624|364326106|FG001|Overall Study|Withdrawal by Subject|1|||
105634753|NCT01690624|364326107|FG002|Overall Study|Withdrawal by Subject|0|||
105634754|NCT01690624|364326108|FG003|Overall Study|Withdrawal by Subject|0|||
105634755|NCT01690624|364326105|FG000|Overall Study|Lack of Efficacy|1|||
105634756|NCT01690624|364326106|FG001|Overall Study|Lack of Efficacy|1|||
105634757|NCT01690624|364326107|FG002|Overall Study|Lack of Efficacy|3|||
105634758|NCT01690624|364326108|FG003|Overall Study|Lack of Efficacy|0|||
105634759|NCT03789656|364326113|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
105634760|NCT03789656|364326114|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
105634761|NCT03789656|364326115|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
105634762|NCT03789656|364326116|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
105634763|NCT03789656|364326117|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
105634764|NCT03789656|364326113|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
105634765|NCT03789656|364326114|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
105634766|NCT03789656|364326115|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
105634767|NCT03789656|364326116|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
105634768|NCT03789656|364326117|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
105634769|NCT03789656|364326113|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
105634770|NCT03789656|364326114|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
105634771|NCT03789656|364326115|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
105634772|NCT03789656|364326116|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
105634773|NCT03789656|364326117|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
105634774|NCT03789656|364326113|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
105634775|NCT03789656|364326114|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
105634776|NCT03789656|364326115|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
105634777|NCT03789656|364326116|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
105634778|NCT03789656|364326117|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
105634779|NCT05071430|364326119|FG000|Overall Study|Adverse Event|1|||
105634780|NCT05071430|364326120|FG001|Overall Study|Adverse Event|2|||
105634781|NCT05071430|364326119|FG000|Overall Study|Lost to Follow-up|4|||
105634782|NCT05071430|364326120|FG001|Overall Study|Lost to Follow-up|4|||
105634783|NCT05071430|364326119|FG000|Overall Study|Protocol Violation|1|||
105634784|NCT05071430|364326120|FG001|Overall Study|Protocol Violation|0|||
105634785|NCT05071430|364326119|FG000|Overall Study|Withdrawal by Subject|3|||
105634786|NCT05071430|364326120|FG001|Overall Study|Withdrawal by Subject|2|||
105634787|NCT05071430|364326119|FG000|Overall Study|Other|1|||
105634788|NCT05071430|364326120|FG001|Overall Study|Other|1|||
105634789|NCT05325294|364326126|FG000|Overall Study|Adverse Event|3|||
105634790|NCT05325294|364326127|FG001|Overall Study|Adverse Event|3|||
105634791|NCT05325294|364326126|FG000|Overall Study|Physician Decision|0|||
105634792|NCT05325294|364326127|FG001|Overall Study|Physician Decision|1|||
105634793|NCT05325294|364326126|FG000|Overall Study|Withdrawal by Subject|0|||
105634794|NCT05325294|364326127|FG001|Overall Study|Withdrawal by Subject|3|||
105634795|NCT05325294|364326126|FG000|Overall Study|Lost to Follow-up|1|||
105634796|NCT05325294|364326127|FG001|Overall Study|Lost to Follow-up|0|||
105634797|NCT05325294|364326126|FG000|Overall Study|Sponsor Request|0|||
105634798|NCT05325294|364326127|FG001|Overall Study|Sponsor Request|2|||
105634799|NCT03773107|364326129|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
105634800|NCT03773107|364326130|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
105634801|NCT03773107|364326131|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
105634802|NCT03773107|364326132|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
105634803|NCT01563185|364326134|FG000|Overall Study|Withdrawal by Subject|1|||
105634804|NCT01563185|364326134|FG000|Overall Study|Non-Compliance with study drug|1|||
105634805|NCT04577651|364326135|FG000|Overall Study|Screen Failure|7|||
105634806|NCT04577651|364326135|FG000|Overall Study|Adverse Event|1|||
105634807|NCT04577651|364326135|FG000|Overall Study|Death|1|||
105634808|NCT04577651|364326135|FG000|Overall Study|Physician Decision|1|||
105634809|NCT04577651|364326135|FG000|Overall Study|Withdrawal by Subject|3|||
105634810|NCT02722434|364327346|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
105634811|NCT02722434|364327347|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
105634812|NCT02722434|364327346|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
105634813|NCT02722434|364327347|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
105634814|NCT04559698|364327357|FG000|Overall Study|Lost to Follow-up|14|||
105634815|NCT04559698|364327358|FG001|Overall Study|Lost to Follow-up|15|||
105634816|NCT04559698|364327357|FG000|Overall Study|Withdrawal by Subject|0|||
105634817|NCT04559698|364327358|FG001|Overall Study|Withdrawal by Subject|1|||
105634818|NCT02200705|364327359|FG000|Overall Study|Excluded|12|||
105634819|NCT02200705|364327359|FG000|Overall Study|Death|21|||
105634820|NCT02200705|364327359|FG000|Overall Study|Withdrawal by Subject|22|||
105634821|NCT02200705|364327359|FG000|Overall Study|Lost to Follow-up|13|||
105634822|NCT02200705|364327359|FG000|Overall Study|Physician Decision|5|||
105634823|NCT02200705|364327359|FG000|Overall Study|Adverse Event|2|||
105634824|NCT05070429|364327361|FG000|Overall Study|Death|0|||
105634825|NCT05070429|364327362|FG001|Overall Study|Death|4|||
105634826|NCT05070429|364327361|FG000|Overall Study|Withdrawal by Subject|2|||
105634827|NCT05070429|364327362|FG001|Overall Study|Withdrawal by Subject|1|||
105634828|NCT05070429|364327361|FG000|Overall Study|Other|15|||
105634829|NCT05070429|364327362|FG001|Overall Study|Other|5|||
105634830|NCT02962284|364327363|FG000|Overall Study|Death|2|||
105634831|NCT02962284|364327364|FG001|Overall Study|Death|0|||
105634832|NCT02962284|364327363|FG000|Overall Study|Progressive disease|2|||
105634833|NCT02962284|364327364|FG001|Overall Study|Progressive disease|3|||
105634834|NCT02962284|364327363|FG000|Overall Study|Withdrawal by Subject|1|||
105634835|NCT02962284|364327364|FG001|Overall Study|Withdrawal by Subject|0|||
105634836|NCT00371345|364327368|FG000|Overall Study|Disease Progression|21|||
105634837|NCT00371345|364327369|FG001|Overall Study|Disease Progression|35|||
105634838|NCT00371345|364327368|FG000|Overall Study|Study Drug Toxicity|1|||
105634839|NCT00371345|364327369|FG001|Overall Study|Study Drug Toxicity|7|||
105634840|NCT00371345|364327368|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
105634841|NCT00371345|364327369|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
105634842|NCT00371345|364327368|FG000|Overall Study|Participant Request|1|||
105634843|NCT00371345|364327369|FG001|Overall Study|Participant Request|1|||
105634844|NCT00371345|364327368|FG000|Overall Study|Participant Withdrew Consent|0|||
105634845|NCT00371345|364327369|FG001|Overall Study|Participant Withdrew Consent|1|||
105634846|NCT00739934|364327373|FG000|Voriconazole IV|Adverse Event|6|||
105634847|NCT00739934|364327373|FG000|Voriconazole Oral|Other|3|||
105634848|NCT03451422|364327374|FG000|Overall Study|Lost to Follow-up|0|||
105634849|NCT03451422|364327375|FG001|Overall Study|Lost to Follow-up|0|||
105634850|NCT03451422|364327376|FG002|Overall Study|Lost to Follow-up|0|||
105634851|NCT03451422|364327377|FG003|Overall Study|Lost to Follow-up|0|||
105634852|NCT03451422|364327378|FG004|Overall Study|Lost to Follow-up|0|||
105634853|NCT03451422|364327379|FG005|Overall Study|Lost to Follow-up|1|||
105634854|NCT03451422|364327374|FG000|Overall Study|Decision by sponsor|1|||
105634855|NCT03451422|364327375|FG001|Overall Study|Decision by sponsor|0|||
105634856|NCT03451422|364327376|FG002|Overall Study|Decision by sponsor|1|||
105634857|NCT03451422|364327377|FG003|Overall Study|Decision by sponsor|0|||
105634858|NCT03451422|364327378|FG004|Overall Study|Decision by sponsor|0|||
105634859|NCT03451422|364327379|FG005|Overall Study|Decision by sponsor|0|||
105634860|NCT03451422|364327374|FG000|Overall Study|Withdrawal by Subject|0|||
105634861|NCT03451422|364327375|FG001|Overall Study|Withdrawal by Subject|0|||
105634862|NCT03451422|364327376|FG002|Overall Study|Withdrawal by Subject|2|||
105634863|NCT03451422|364327377|FG003|Overall Study|Withdrawal by Subject|3|||
105634864|NCT03451422|364327378|FG004|Overall Study|Withdrawal by Subject|2|||
105634865|NCT03451422|364327379|FG005|Overall Study|Withdrawal by Subject|1|||
105634866|NCT00442104|364327381|FG000|Overall Study|Adverse Event|5|||
105634867|NCT00442104|364327381|FG000|Overall Study|Death|2|||
105634868|NCT00442104|364327381|FG000|Overall Study|Lost to Follow-up|3|||
105634869|NCT00442104|364327381|FG000|Overall Study|Withdrawal by Subject|5|||
105634870|NCT00442104|364327381|FG000|Overall Study|Insufficient Clinical Response|10|||
105634871|NCT00442104|364327381|FG000|Overall Study|Other|21|||
105634872|NCT00442104|364327381|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
105634873|NCT01478594|364327382|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
105634874|NCT01478594|364327383|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
105634875|NCT01478594|364327382|FG000|Overall Study|Death|45|||
105634876|NCT01478594|364327383|FG001|Overall Study|Death|18|||
105634877|NCT01478594|364327382|FG000|Overall Study|Lost to Follow-up|3|||
105634878|NCT01478594|364327383|FG001|Overall Study|Lost to Follow-up|1|||
105634879|NCT01478594|364327382|FG000|Overall Study|Withdrawal by Subject|9|||
105634880|NCT01478594|364327383|FG001|Overall Study|Withdrawal by Subject|3|||
105634881|NCT01478594|364327382|FG000|Overall Study|Study Closed by Sponsor|8|||
105634882|NCT01478594|364327383|FG001|Overall Study|Study Closed by Sponsor|5|||
105634883|NCT02788981|364327389|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
105634884|NCT02788981|364327390|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
105634885|NCT01342367|364327391|FG000|Overall Study|Death|1|||
105634886|NCT01342367|364327392|FG001|Overall Study|Death|0|||
105634887|NCT01342367|364327391|FG000|Overall Study|Withdrawal by Subject|1|||
105634888|NCT01342367|364327392|FG001|Overall Study|Withdrawal by Subject|2|||
105634889|NCT00249769|364327393|FG000|Overall Study|Withdrawal by Subject|1|||
105634890|NCT00249769|364327394|FG001|Overall Study|Withdrawal by Subject|10|||
105634891|NCT00249769|364327395|FG002|Overall Study|Withdrawal by Subject|6|||
105634892|NCT00249769|364327393|FG000|Overall Study|Migration from Study Area|1|||
105634893|NCT00249769|364327394|FG001|Overall Study|Migration from Study Area|3|||
105634894|NCT00249769|364327395|FG002|Overall Study|Migration from Study Area|14|||
105634895|NCT00249769|364327393|FG000|Overall Study|Miscellaneous|0|||
105634896|NCT00249769|364327394|FG001|Overall Study|Miscellaneous|2|||
105634897|NCT00249769|364327395|FG002|Overall Study|Miscellaneous|2|||
105634898|NCT00249769|364327393|FG000|Overall Study|Adverse Event|0|||
105634899|NCT00249769|364327394|FG001|Overall Study|Adverse Event|0|||
105634900|NCT00249769|364327395|FG002|Overall Study|Adverse Event|1|||
105634901|NCT00249769|364327393|FG000|Overall Study|Physician Decision|0|||
105634902|NCT00249769|364327394|FG001|Overall Study|Physician Decision|0|||
105634903|NCT00249769|364327395|FG002|Overall Study|Physician Decision|2|||
105634904|NCT00249769|364327393|FG000|Overall Study|Lost to Follow-up|0|||
105634905|NCT00249769|364327394|FG001|Overall Study|Lost to Follow-up|0|||
105634906|NCT00249769|364327395|FG002|Overall Study|Lost to Follow-up|3|||
105634907|NCT02157116|364327396|FG000|Overall Study|Withdrawal by Subject|4|||
105634908|NCT02157116|364327396|FG000|Overall Study|Physician Decision|3|||
105634909|NCT02157116|364327396|FG000|Overall Study|Failed Screening|2|||
105634910|NCT00640159|364327397|FG000|Overall Study|Lost to Follow-up|2|||
105634911|NCT01536093|364327398|FG000|Overall Study|Death|1|||
105634912|NCT01536093|364327399|FG001|Overall Study|Death|2|||
105634913|NCT01536093|364327398|FG000|Overall Study|absence of maternal colostrum|2|||
105634914|NCT01536093|364327399|FG001|Overall Study|absence of maternal colostrum|0|||
105634915|NCT01536093|364327398|FG000|Overall Study|Withdrawal by Subject|0|||
105634916|NCT01536093|364327399|FG001|Overall Study|Withdrawal by Subject|1|||
105634917|NCT04971733|364327400|FG000|Overall Study|Adverse Event|1|||
105634918|NCT04971733|364327401|FG001|Overall Study|Adverse Event|1|||
105634919|NCT04971733|364327400|FG000|Overall Study|Subject choice|2|||
105634920|NCT04971733|364327401|FG001|Overall Study|Subject choice|0|||
105634921|NCT04971733|364327400|FG000|Overall Study|Withdrawal by Subject|1|||
105634922|NCT04971733|364327401|FG001|Overall Study|Withdrawal by Subject|0|||
105634923|NCT04971733|364327400|FG000|Overall Study|Other|1|||
105634924|NCT04971733|364327401|FG001|Overall Study|Other|0|||
105634925|NCT04638816|364327402|FG000|Overall Study|Withdrawal by Subject|0|||
105634926|NCT04638816|364327403|FG001|Overall Study|Withdrawal by Subject|1|||
105634927|NCT04638816|364327402|FG000|Overall Study|Lost to Follow-up|0|||
105634928|NCT04638816|364327403|FG001|Overall Study|Lost to Follow-up|1|||
105634929|NCT02251652|364327407|FG000|Overall Study|Withdrawal by Subject|1|||
105634930|NCT02275611|364327410|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
105634931|NCT02275611|364327411|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
105634932|NCT02275611|364327412|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
105634933|NCT02275611|364327413|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
105634934|NCT00523419|364327414|FG000|Overall Study|Adverse Event|1|||
105634935|NCT00523419|364327414|FG000|Overall Study|Withdrawal by Subject|1|||
105634936|NCT00523419|364327414|FG000|Overall Study|Physician Decision|2|||
105634937|NCT00523419|364327414|FG000|Overall Study|Progressive Disease|22|||
105634938|NCT00523419|364327414|FG000|Overall Study|Death due to Study Disease|4|||
105634939|NCT00523419|364327414|FG000|Overall Study|Death due to Adverse Event|2|||
105634940|NCT00943917|364327417|FG000|Stage I|Adverse Event|1|||
105634941|NCT00943917|364327418|FG001|Stage I|Adverse Event|2|||
105634942|NCT00943917|364327419|FG002|Stage I|Adverse Event|2|||
105634943|NCT00943917|364327420|FG003|Stage I|Adverse Event|0|||
105634944|NCT00943917|364327421|FG004|Stage I|Adverse Event|0|||
105634945|NCT00943917|364327422|FG005|Stage I|Adverse Event|0|||
105634946|NCT00943917|364327423|FG006|Stage I|Adverse Event|0|||
105634947|NCT00943917|364327424|FG007|Stage I|Adverse Event|0|||
105634948|NCT00943917|364327425|FG008|Stage I|Adverse Event|0|||
105634949|NCT00943917|364327426|FG009|Stage I|Adverse Event|0|||
105634950|NCT00943917|364327427|FG010|Stage I|Adverse Event|0|||
105634951|NCT00943917|364327428|FG011|Stage I|Adverse Event|0|||
105634952|NCT00943917|364327429|FG012|Stage I|Adverse Event|0|||
105634953|NCT00943917|364327430|FG013|Stage I|Adverse Event|0|||
105634954|NCT00943917|364327431|FG014|Stage I|Adverse Event|0|||
105634955|NCT00943917|364327417|FG000|Stage I|Lost to Follow-up|0|||
105634956|NCT00943917|364327418|FG001|Stage I|Lost to Follow-up|0|||
105634957|NCT00943917|364327419|FG002|Stage I|Lost to Follow-up|1|||
105634958|NCT00943917|364327420|FG003|Stage I|Lost to Follow-up|0|||
105634959|NCT00943917|364327421|FG004|Stage I|Lost to Follow-up|0|||
105634960|NCT00943917|364327422|FG005|Stage I|Lost to Follow-up|0|||
105634961|NCT00943917|364327423|FG006|Stage I|Lost to Follow-up|0|||
105634962|NCT00943917|364327424|FG007|Stage I|Lost to Follow-up|0|||
105634963|NCT00943917|364327425|FG008|Stage I|Lost to Follow-up|0|||
105634964|NCT00943917|364327426|FG009|Stage I|Lost to Follow-up|0|||
105634965|NCT00943917|364327427|FG010|Stage I|Lost to Follow-up|0|||
105634966|NCT00943917|364327428|FG011|Stage I|Lost to Follow-up|0|||
105634967|NCT00943917|364327429|FG012|Stage I|Lost to Follow-up|0|||
105634968|NCT00943917|364327430|FG013|Stage I|Lost to Follow-up|0|||
105634969|NCT00943917|364327431|FG014|Stage I|Lost to Follow-up|0|||
105634970|NCT00943917|364327417|FG000|Stage I|hyperglycemia|0|||
105634971|NCT00943917|364327418|FG001|Stage I|hyperglycemia|0|||
105634972|NCT00943917|364327419|FG002|Stage I|hyperglycemia|1|||
105634973|NCT00943917|364327420|FG003|Stage I|hyperglycemia|0|||
105634974|NCT00943917|364327421|FG004|Stage I|hyperglycemia|0|||
105634975|NCT00943917|364327422|FG005|Stage I|hyperglycemia|0|||
105634976|NCT00943917|364327423|FG006|Stage I|hyperglycemia|0|||
105634977|NCT00943917|364327424|FG007|Stage I|hyperglycemia|0|||
105634978|NCT00943917|364327425|FG008|Stage I|hyperglycemia|0|||
105634979|NCT00943917|364327426|FG009|Stage I|hyperglycemia|0|||
105634980|NCT00943917|364327427|FG010|Stage I|hyperglycemia|0|||
105634981|NCT00943917|364327428|FG011|Stage I|hyperglycemia|0|||
105634982|NCT00943917|364327429|FG012|Stage I|hyperglycemia|0|||
105634983|NCT00943917|364327430|FG013|Stage I|hyperglycemia|0|||
105634984|NCT00943917|364327431|FG014|Stage I|hyperglycemia|0|||
105634985|NCT00943917|364327417|FG000|Stage I|A1C elevation|1|||
105634986|NCT00943917|364327418|FG001|Stage I|A1C elevation|0|||
105634987|NCT00943917|364327419|FG002|Stage I|A1C elevation|0|||
105634988|NCT00943917|364327420|FG003|Stage I|A1C elevation|0|||
105634989|NCT00943917|364327421|FG004|Stage I|A1C elevation|0|||
105634990|NCT00943917|364327422|FG005|Stage I|A1C elevation|0|||
105634991|NCT00943917|364327423|FG006|Stage I|A1C elevation|0|||
105634992|NCT00943917|364327424|FG007|Stage I|A1C elevation|0|||
105634993|NCT00943917|364327425|FG008|Stage I|A1C elevation|0|||
105634994|NCT00943917|364327426|FG009|Stage I|A1C elevation|0|||
105634995|NCT00943917|364327427|FG010|Stage I|A1C elevation|0|||
105634996|NCT00943917|364327428|FG011|Stage I|A1C elevation|0|||
105634997|NCT00943917|364327429|FG012|Stage I|A1C elevation|0|||
105634998|NCT00943917|364327430|FG013|Stage I|A1C elevation|0|||
105634999|NCT00943917|364327431|FG014|Stage I|A1C elevation|0|||
105635000|NCT00943917|364327417|FG000|Stage I|Withdrawal by Subject|2|||
105635001|NCT00943917|364327418|FG001|Stage I|Withdrawal by Subject|1|||
105635002|NCT00943917|364327419|FG002|Stage I|Withdrawal by Subject|2|||
105635003|NCT00943917|364327420|FG003|Stage I|Withdrawal by Subject|0|||
105635004|NCT00943917|364327421|FG004|Stage I|Withdrawal by Subject|0|||
105635005|NCT00943917|364327422|FG005|Stage I|Withdrawal by Subject|0|||
105635006|NCT00943917|364327423|FG006|Stage I|Withdrawal by Subject|0|||
105635007|NCT00943917|364327424|FG007|Stage I|Withdrawal by Subject|0|||
105635008|NCT00943917|364327425|FG008|Stage I|Withdrawal by Subject|0|||
105635009|NCT00943917|364327426|FG009|Stage I|Withdrawal by Subject|0|||
105635010|NCT00943917|364327427|FG010|Stage I|Withdrawal by Subject|0|||
105635011|NCT00943917|364327428|FG011|Stage I|Withdrawal by Subject|0|||
105635012|NCT00943917|364327429|FG012|Stage I|Withdrawal by Subject|0|||
105635013|NCT00943917|364327430|FG013|Stage I|Withdrawal by Subject|0|||
105635014|NCT00943917|364327431|FG014|Stage I|Withdrawal by Subject|0|||
105635015|NCT00943917|364327417|FG000|Stage II|Adverse Event|0|||
105635016|NCT00943917|364327418|FG001|Stage II|Adverse Event|0|||
105635017|NCT00943917|364327419|FG002|Stage II|Adverse Event|0|||
105635018|NCT00943917|364327420|FG003|Stage II|Adverse Event|0|||
105635019|NCT00943917|364327421|FG004|Stage II|Adverse Event|0|||
105635020|NCT00943917|364327422|FG005|Stage II|Adverse Event|1|||
105635021|NCT00943917|364327423|FG006|Stage II|Adverse Event|3|||
105635022|NCT00943917|364327424|FG007|Stage II|Adverse Event|0|||
105635023|NCT00943917|364327425|FG008|Stage II|Adverse Event|1|||
105635024|NCT00943917|364327426|FG009|Stage II|Adverse Event|0|||
105635025|NCT00943917|364327427|FG010|Stage II|Adverse Event|0|||
105635026|NCT00943917|364327428|FG011|Stage II|Adverse Event|0|||
105635027|NCT00943917|364327429|FG012|Stage II|Adverse Event|0|||
105635028|NCT00943917|364327430|FG013|Stage II|Adverse Event|0|||
105635029|NCT00943917|364327431|FG014|Stage II|Adverse Event|0|||
105635030|NCT00943917|364327417|FG000|Stage II|Withdrawal by Subject|0|||
105635031|NCT00943917|364327418|FG001|Stage II|Withdrawal by Subject|0|||
105635032|NCT00943917|364327419|FG002|Stage II|Withdrawal by Subject|0|||
105635033|NCT00943917|364327420|FG003|Stage II|Withdrawal by Subject|0|||
105635034|NCT00943917|364327421|FG004|Stage II|Withdrawal by Subject|0|||
105635035|NCT00943917|364327422|FG005|Stage II|Withdrawal by Subject|1|||
105635036|NCT00943917|364327423|FG006|Stage II|Withdrawal by Subject|0|||
105635037|NCT00943917|364327424|FG007|Stage II|Withdrawal by Subject|0|||
105635038|NCT00943917|364327425|FG008|Stage II|Withdrawal by Subject|0|||
105635039|NCT00943917|364327426|FG009|Stage II|Withdrawal by Subject|0|||
105635040|NCT00943917|364327427|FG010|Stage II|Withdrawal by Subject|0|||
105635041|NCT00943917|364327428|FG011|Stage II|Withdrawal by Subject|0|||
105635042|NCT00943917|364327429|FG012|Stage II|Withdrawal by Subject|0|||
105635043|NCT00943917|364327430|FG013|Stage II|Withdrawal by Subject|0|||
105635044|NCT00943917|364327431|FG014|Stage II|Withdrawal by Subject|0|||
105635045|NCT00943917|364327417|FG000|Stage II|Pregnancy|0|||
105635046|NCT00943917|364327418|FG001|Stage II|Pregnancy|0|||
105635047|NCT00943917|364327419|FG002|Stage II|Pregnancy|0|||
105635048|NCT00943917|364327420|FG003|Stage II|Pregnancy|0|||
105635049|NCT00943917|364327421|FG004|Stage II|Pregnancy|0|||
105635050|NCT00943917|364327422|FG005|Stage II|Pregnancy|1|||
105635051|NCT00943917|364327423|FG006|Stage II|Pregnancy|0|||
105635052|NCT00943917|364327424|FG007|Stage II|Pregnancy|0|||
105635053|NCT00943917|364327425|FG008|Stage II|Pregnancy|0|||
105635054|NCT00943917|364327426|FG009|Stage II|Pregnancy|0|||
105635055|NCT00943917|364327427|FG010|Stage II|Pregnancy|0|||
105635056|NCT00943917|364327428|FG011|Stage II|Pregnancy|0|||
105635057|NCT00943917|364327429|FG012|Stage II|Pregnancy|0|||
105635058|NCT00943917|364327430|FG013|Stage II|Pregnancy|0|||
105635059|NCT00943917|364327431|FG014|Stage II|Pregnancy|0|||
105635060|NCT00943917|364327417|FG000|Stage II Continuation|Adverse Event|0|||
105635061|NCT00943917|364327418|FG001|Stage II Continuation|Adverse Event|0|||
105635062|NCT00943917|364327419|FG002|Stage II Continuation|Adverse Event|0|||
105635063|NCT00943917|364327420|FG003|Stage II Continuation|Adverse Event|0|||
105635064|NCT00943917|364327421|FG004|Stage II Continuation|Adverse Event|0|||
105635065|NCT00943917|364327422|FG005|Stage II Continuation|Adverse Event|0|||
105635066|NCT00943917|364327423|FG006|Stage II Continuation|Adverse Event|0|||
105635067|NCT00943917|364327424|FG007|Stage II Continuation|Adverse Event|0|||
105635068|NCT00943917|364327425|FG008|Stage II Continuation|Adverse Event|0|||
105635069|NCT00943917|364327426|FG009|Stage II Continuation|Adverse Event|0|||
105635070|NCT00943917|364327427|FG010|Stage II Continuation|Adverse Event|0|||
105635071|NCT00943917|364327428|FG011|Stage II Continuation|Adverse Event|1|||
105635072|NCT00943917|364327429|FG012|Stage II Continuation|Adverse Event|2|||
105635073|NCT00943917|364327430|FG013|Stage II Continuation|Adverse Event|1|||
105635074|NCT00943917|364327431|FG014|Stage II Continuation|Adverse Event|1|||
105635075|NCT00943917|364327417|FG000|Stage II Continuation|Withdrawal by Subject|0|||
105635076|NCT00943917|364327418|FG001|Stage II Continuation|Withdrawal by Subject|0|||
105635077|NCT00943917|364327419|FG002|Stage II Continuation|Withdrawal by Subject|0|||
105635078|NCT00943917|364327420|FG003|Stage II Continuation|Withdrawal by Subject|0|||
105635079|NCT00943917|364327421|FG004|Stage II Continuation|Withdrawal by Subject|0|||
105635080|NCT00943917|364327422|FG005|Stage II Continuation|Withdrawal by Subject|0|||
105635081|NCT00943917|364327423|FG006|Stage II Continuation|Withdrawal by Subject|0|||
105635082|NCT00943917|364327424|FG007|Stage II Continuation|Withdrawal by Subject|0|||
105635083|NCT00943917|364327425|FG008|Stage II Continuation|Withdrawal by Subject|0|||
105635084|NCT00943917|364327426|FG009|Stage II Continuation|Withdrawal by Subject|0|||
105635085|NCT00943917|364327427|FG010|Stage II Continuation|Withdrawal by Subject|0|||
105635086|NCT00943917|364327428|FG011|Stage II Continuation|Withdrawal by Subject|0|||
105635087|NCT00943917|364327429|FG012|Stage II Continuation|Withdrawal by Subject|0|||
105635088|NCT00943917|364327430|FG013|Stage II Continuation|Withdrawal by Subject|1|||
105635089|NCT00943917|364327431|FG014|Stage II Continuation|Withdrawal by Subject|3|||
105635090|NCT00943917|364327417|FG000|Stage II Continuation|Protocol Violation|0|||
105635091|NCT00943917|364327418|FG001|Stage II Continuation|Protocol Violation|0|||
105635092|NCT00943917|364327419|FG002|Stage II Continuation|Protocol Violation|0|||
105635093|NCT00943917|364327420|FG003|Stage II Continuation|Protocol Violation|0|||
105635094|NCT00943917|364327421|FG004|Stage II Continuation|Protocol Violation|0|||
105635095|NCT00943917|364327422|FG005|Stage II Continuation|Protocol Violation|0|||
105635096|NCT00943917|364327423|FG006|Stage II Continuation|Protocol Violation|0|||
105635097|NCT00943917|364327424|FG007|Stage II Continuation|Protocol Violation|0|||
105635098|NCT00943917|364327425|FG008|Stage II Continuation|Protocol Violation|0|||
105635099|NCT00943917|364327426|FG009|Stage II Continuation|Protocol Violation|1|||
105635100|NCT00943917|364327427|FG010|Stage II Continuation|Protocol Violation|0|||
105635101|NCT00943917|364327428|FG011|Stage II Continuation|Protocol Violation|1|||
105635102|NCT00943917|364327429|FG012|Stage II Continuation|Protocol Violation|0|||
105635103|NCT00943917|364327430|FG013|Stage II Continuation|Protocol Violation|0|||
105635104|NCT00943917|364327431|FG014|Stage II Continuation|Protocol Violation|0|||
105635105|NCT00943917|364327417|FG000|Stage II Continuation|hypoglycemia|0|||
105635106|NCT00943917|364327418|FG001|Stage II Continuation|hypoglycemia|0|||
105635107|NCT00943917|364327419|FG002|Stage II Continuation|hypoglycemia|0|||
105635108|NCT00943917|364327420|FG003|Stage II Continuation|hypoglycemia|0|||
105635109|NCT00943917|364327421|FG004|Stage II Continuation|hypoglycemia|0|||
105635110|NCT00943917|364327422|FG005|Stage II Continuation|hypoglycemia|0|||
105635111|NCT00943917|364327423|FG006|Stage II Continuation|hypoglycemia|0|||
105635112|NCT00943917|364327424|FG007|Stage II Continuation|hypoglycemia|0|||
105635113|NCT00943917|364327425|FG008|Stage II Continuation|hypoglycemia|0|||
105635114|NCT00943917|364327426|FG009|Stage II Continuation|hypoglycemia|0|||
105635115|NCT00943917|364327427|FG010|Stage II Continuation|hypoglycemia|0|||
105635116|NCT00943917|364327428|FG011|Stage II Continuation|hypoglycemia|0|||
105635117|NCT00943917|364327429|FG012|Stage II Continuation|hypoglycemia|1|||
105635118|NCT00943917|364327430|FG013|Stage II Continuation|hypoglycemia|0|||
105635119|NCT00943917|364327431|FG014|Stage II Continuation|hypoglycemia|0|||
105635120|NCT00943917|364327417|FG000|Stage II Continuation|A1C elevation|0|||
105635121|NCT00943917|364327418|FG001|Stage II Continuation|A1C elevation|0|||
105635122|NCT00943917|364327419|FG002|Stage II Continuation|A1C elevation|0|||
105635123|NCT00943917|364327420|FG003|Stage II Continuation|A1C elevation|0|||
105635124|NCT00943917|364327421|FG004|Stage II Continuation|A1C elevation|0|||
105635125|NCT00943917|364327422|FG005|Stage II Continuation|A1C elevation|0|||
105635126|NCT00943917|364327423|FG006|Stage II Continuation|A1C elevation|0|||
105635127|NCT00943917|364327424|FG007|Stage II Continuation|A1C elevation|0|||
105635128|NCT00943917|364327425|FG008|Stage II Continuation|A1C elevation|0|||
105635129|NCT00943917|364327426|FG009|Stage II Continuation|A1C elevation|0|||
105635130|NCT00943917|364327427|FG010|Stage II Continuation|A1C elevation|0|||
105635131|NCT00943917|364327428|FG011|Stage II Continuation|A1C elevation|0|||
105635132|NCT00943917|364327429|FG012|Stage II Continuation|A1C elevation|0|||
105635133|NCT00943917|364327430|FG013|Stage II Continuation|A1C elevation|1|||
105635134|NCT00943917|364327431|FG014|Stage II Continuation|A1C elevation|0|||
105635135|NCT02646618|364327436|FG000|Overall Study|Lost to Follow-up|10|||
105635136|NCT02646618|364327437|FG001|Overall Study|Lost to Follow-up|14|||
105635137|NCT00390884|364327438|FG000|Overall Study|Withdrawal by Subject|2|||
105635138|NCT00390884|364327439|FG001|Overall Study|Withdrawal by Subject|2|||
105635139|NCT01588951|364327446|FG000|Overall Study|Ineligible in retrospect|0|||
105635140|NCT01588951|364327447|FG001|Overall Study|Ineligible in retrospect|0|||
105635141|NCT01588951|364327448|FG002|Overall Study|Ineligible in retrospect|1|||
105635142|NCT01593020|364327451|FG000|Overall Study|Adverse Event|1|||
105635143|NCT01593020|364327452|FG001|Overall Study|Adverse Event|1|||
105635144|NCT01593020|364327451|FG000|Overall Study|Death|0|||
105635145|NCT01593020|364327452|FG001|Overall Study|Death|1|||
105635146|NCT01593020|364327451|FG000|Overall Study|Ineligible|1|||
105635147|NCT01593020|364327452|FG001|Overall Study|Ineligible|0|||
105635148|NCT04686266|364327453|FG000|Overall Study|Withdrawal by Subject|0|||
105635149|NCT04686266|364327454|FG001|Overall Study|Withdrawal by Subject|1|||
105635150|NCT03976323|364327459|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
105635151|NCT03976323|364327460|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
105635152|NCT03976323|364327461|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
105635153|NCT03976323|364327459|FG000|Induction Phase|Death|80|||
105635154|NCT03976323|364327460|FG001|Induction Phase|Death|0|||
105635155|NCT03976323|364327461|FG002|Induction Phase|Death|0|||
105635156|NCT03976323|364327459|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
105635157|NCT03976323|364327460|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
105635158|NCT03976323|364327461|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
105635159|NCT03976323|364327459|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105635160|NCT03976323|364327460|FG001|Maintenance Phase|Withdrawal by Subject|9|||
105635161|NCT03976323|364327461|FG002|Maintenance Phase|Withdrawal by Subject|3|||
105635162|NCT03976323|364327459|FG000|Maintenance Phase|Physician Decision|0|||
105635163|NCT03976323|364327460|FG001|Maintenance Phase|Physician Decision|0|||
105635164|NCT03976323|364327461|FG002|Maintenance Phase|Physician Decision|1|||
105635165|NCT03976323|364327459|FG000|Maintenance Phase|Death|0|||
105635166|NCT03976323|364327460|FG001|Maintenance Phase|Death|228|||
105635167|NCT03976323|364327461|FG002|Maintenance Phase|Death|234|||
105635168|NCT02434328|364327462|FG000|Overall Study|Adverse Event|9|||
105635169|NCT02434328|364327463|FG001|Overall Study|Adverse Event|4|||
105635170|NCT02434328|364327462|FG000|Overall Study|Lack of Efficacy|0|||
105635171|NCT02434328|364327463|FG001|Overall Study|Lack of Efficacy|2|||
105635172|NCT02434328|364327462|FG000|Overall Study|Physician Decision|0|||
105635173|NCT02434328|364327463|FG001|Overall Study|Physician Decision|1|||
105635174|NCT02434328|364327462|FG000|Overall Study|Withdrawal by Subject|12|||
105635175|NCT02434328|364327463|FG001|Overall Study|Withdrawal by Subject|21|||
105635176|NCT02434328|364327462|FG000|Overall Study|Death|4|||
105635177|NCT02434328|364327463|FG001|Overall Study|Death|7|||
105635178|NCT02434328|364327462|FG000|Overall Study|Lost to Follow-up|1|||
105635179|NCT02434328|364327463|FG001|Overall Study|Lost to Follow-up|6|||
105635180|NCT02434328|364327462|FG000|Overall Study|Other|4|||
105635181|NCT02434328|364327463|FG001|Overall Study|Other|1|||
105635182|NCT00647387|364327467|FG000|Overall Study|Lost to Follow-up|6|||
105635183|NCT00647387|364327467|FG000|Overall Study|Unsuccessful implant|5|||
105635184|NCT00647387|364327467|FG000|Overall Study|Device explanted|3|||
105635185|NCT00647387|364327467|FG000|Overall Study|Other Reason|3|||
105635186|NCT00647387|364327467|FG000|Overall Study|Death|2|||
105635187|NCT02969356|364327469|FG000|Overall Study|Adverse Event|7|||
105635188|NCT02969356|364327469|FG000|Overall Study|Consent withdrawn|2|||
105635189|NCT02969356|364327469|FG000|Overall Study|Lost to Follow-up|3|||
105635190|NCT02969356|364327469|FG000|Overall Study|Did not need to be reinjected|6|||
105635191|NCT02969356|364327469|FG000|Overall Study|Personal reasons|5|||
105635192|NCT00302211|364327470|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
105635193|NCT00302211|364327471|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
105635194|NCT00302211|364327472|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
105635195|NCT00302211|364327473|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
105635196|NCT00302211|364327474|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
105635197|NCT00302211|364327470|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
105635198|NCT00302211|364327471|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
105635199|NCT00302211|364327472|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
105635200|NCT00302211|364327473|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
105635201|NCT00302211|364327474|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
105635202|NCT00302211|364327470|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
105635203|NCT00302211|364327471|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
105635204|NCT00302211|364327472|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
105635205|NCT00302211|364327473|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
105635206|NCT00302211|364327474|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
105635207|NCT00302211|364327470|FG000|Double Blind Period (New Patients)|Disease progression|0|||
105635208|NCT00302211|364327471|FG001|Double Blind Period (New Patients)|Disease progression|1|||
105635209|NCT00302211|364327472|FG002|Double Blind Period (New Patients)|Disease progression|1|||
105635210|NCT00302211|364327473|FG003|Double Blind Period (New Patients)|Disease progression|0|||
105635211|NCT00302211|364327474|FG004|Double Blind Period (New Patients)|Disease progression|0|||
105635212|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
105635213|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
105635214|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
105635215|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
105635216|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
105635217|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
105635218|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
105635219|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
105635220|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
105635221|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
105635222|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
105635223|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
105635224|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
105635225|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
105635226|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
105635227|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
105635228|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
105635229|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
105635230|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
105635231|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
105635232|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|Death|0|||
105635233|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|Death|0|||
105635234|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|Death|0|||
105635235|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|Death|1|||
105635236|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|Death|1|||
105635237|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
105635238|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
105635239|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
105635240|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
105635241|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
105635242|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
105635243|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
105635244|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
105635245|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
105635246|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
105635247|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
105635248|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
105635249|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
105635250|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
105635251|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
105635252|NCT04439318|364327475|FG000|Overall Study|Ineligible|1|||
105635253|NCT04439318|364327475|FG000|Overall Study|Never Started Treatment|3|||
105635254|NCT04439318|364327475|FG000|Overall Study|Adverse Event|10|||
105635255|NCT04439318|364327475|FG000|Overall Study|Death|2|||
105635256|NCT04439318|364327475|FG000|Overall Study|Disease Progression|25|||
105635257|NCT04439318|364327475|FG000|Overall Study|Other Complicating Disease|2|||
105635258|NCT04439318|364327475|FG000|Overall Study|Withdrawal by Subject|4|||
105635259|NCT04439318|364327475|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
105635260|NCT04439318|364327475|FG000|Overall Study|Non-Compliance|1|||
105635261|NCT04439318|364327475|FG000|Overall Study|Still on Treatment|1|||
105635262|NCT05864209|364329345|FG000|Overall Study|Lost to Follow-up|2|||
105635263|NCT05864209|364329346|FG001|Overall Study|Lost to Follow-up|3|||
105635312|NCT03762850|364329353|FG000|Overall Study|Death|0|||
105635313|NCT03762850|364329354|FG001|Overall Study|Death|1|||
105635314|NCT03762850|364329353|FG000|Overall Study|Lost to Follow-up|0|||
105635315|NCT03762850|364329354|FG001|Overall Study|Lost to Follow-up|1|||
105635316|NCT03762850|364329353|FG000|Overall Study|Physician Decision|0|||
105635317|NCT03762850|364329354|FG001|Overall Study|Physician Decision|1|||
105635318|NCT03762850|364329353|FG000|Overall Study|Withdrawal by Subject|4|||
105635319|NCT03762850|364329354|FG001|Overall Study|Withdrawal by Subject|9|||
105635320|NCT00597376|364329366|FG000|Overall Study|Withdrawal by Subject|4|||
105635321|NCT00597376|364329367|FG001|Overall Study|Withdrawal by Subject|3|||
105635322|NCT00597376|364329366|FG000|Overall Study|Adverse Event|4|||
105635323|NCT00597376|364329367|FG001|Overall Study|Adverse Event|1|||
105635324|NCT00747006|364329368|FG000|Overall Study|Adverse Event|1|||
105635325|NCT00747006|364329369|FG001|Overall Study|Adverse Event|0|||
105635326|NCT00747006|364329370|FG002|Overall Study|Adverse Event|0|||
105635327|NCT00747006|364329368|FG000|Overall Study|Lost to Follow-up|0|||
105635328|NCT00747006|364329369|FG001|Overall Study|Lost to Follow-up|1|||
105635329|NCT00747006|364329370|FG002|Overall Study|Lost to Follow-up|0|||
105635330|NCT00747006|364329368|FG000|Overall Study|Physician Decision|2|||
105635331|NCT00747006|364329369|FG001|Overall Study|Physician Decision|0|||
105635332|NCT00747006|364329370|FG002|Overall Study|Physician Decision|1|||
105635333|NCT00357994|364329371|FG000|Overall Study|Adverse Event|1|||
105635334|NCT00357994|364329372|FG001|Overall Study|Adverse Event|2|||
105635335|NCT00357994|364329371|FG000|Overall Study|Lack of Efficacy|0|||
105635336|NCT00357994|364329372|FG001|Overall Study|Lack of Efficacy|1|||
105635337|NCT00357994|364329371|FG000|Overall Study|Protocol Violation|1|||
105635338|NCT00357994|364329372|FG001|Overall Study|Protocol Violation|0|||
105635339|NCT00692913|364329377|FG000|Overall Study|Adverse Event|8|||
105635340|NCT00692913|364329378|FG001|Overall Study|Adverse Event|4|||
105635341|NCT00692913|364329377|FG000|Overall Study|Lost to Follow-up|3|||
105635342|NCT00692913|364329378|FG001|Overall Study|Lost to Follow-up|5|||
105635343|NCT00692913|364329377|FG000|Overall Study|Physician Decision|2|||
105635344|NCT00692913|364329378|FG001|Overall Study|Physician Decision|0|||
105635345|NCT00692913|364329377|FG000|Overall Study|Protocol Violation|1|||
105635346|NCT00692913|364329378|FG001|Overall Study|Protocol Violation|1|||
105635347|NCT00692913|364329377|FG000|Overall Study|Withdrawal by Subject|15|||
105635348|NCT00692913|364329378|FG001|Overall Study|Withdrawal by Subject|20|||
105635349|NCT04017611|364329379|FG000|Overall Study|Withdrawn prior to completion|1|||
105635350|NCT00754325|364329380|FG000|Initial Treatment|Continuing Active Treatment|4|||
105635351|NCT00754325|364329381|FG001|Initial Treatment|Continuing Active Treatment|5|||
105635352|NCT00754325|364329380|FG000|Initial Treatment|Adverse Event|7|||
105635353|NCT00754325|364329381|FG001|Initial Treatment|Adverse Event|6|||
105635354|NCT00754325|364329380|FG000|Initial Treatment|Withdrawal by Subject|2|||
105635355|NCT00754325|364329381|FG001|Initial Treatment|Withdrawal by Subject|2|||
105635356|NCT00754325|364329380|FG000|Initial Treatment|Physician Decision|2|||
105635357|NCT00754325|364329381|FG001|Initial Treatment|Physician Decision|0|||
105635358|NCT00754325|364329380|FG000|Initial Treatment|Sponsor Request|0|||
105635359|NCT00754325|364329381|FG001|Initial Treatment|Sponsor Request|1|||
105635360|NCT00754325|364329380|FG000|Initial Treatment|Disease Progression|35|||
105635361|NCT00754325|364329381|FG001|Initial Treatment|Disease Progression|35|||
105635362|NCT01641900|364329382|FG000|Overall Study|Withdrawal by Subject|2|||
105635363|NCT01641900|364329383|FG001|Overall Study|Withdrawal by Subject|2|||
105635364|NCT00512252|364329388|FG000|Overall Study|Lost to Follow-up|0|||
105635365|NCT00512252|364329389|FG001|Overall Study|Lost to Follow-up|0|||
105635366|NCT00512252|364329390|FG002|Overall Study|Lost to Follow-up|1|||
105635367|NCT00512252|364329388|FG000|Overall Study|Protocol Violation|0|||
105635368|NCT00512252|364329389|FG001|Overall Study|Protocol Violation|0|||
105635369|NCT00512252|364329390|FG002|Overall Study|Protocol Violation|1|||
105635370|NCT00512252|364329388|FG000|Overall Study|Death|0|||
105635371|NCT00512252|364329389|FG001|Overall Study|Death|0|||
105635372|NCT00512252|364329390|FG002|Overall Study|Death|1|||
105635373|NCT03732807|364329391|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
105635374|NCT03732807|364329392|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
105635375|NCT03732807|364329393|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
105635376|NCT03732807|364329394|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
105635377|NCT03732807|364329395|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
105635378|NCT03732807|364329396|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
105635379|NCT03732807|364329397|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
105635380|NCT03732807|364329391|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
105635381|NCT03732807|364329392|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
105635382|NCT03732807|364329393|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
105635383|NCT03732807|364329394|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
105635384|NCT03732807|364329395|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
105635385|NCT03732807|364329396|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
105635386|NCT03732807|364329397|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
105635387|NCT03732807|364329391|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
105635388|NCT03732807|364329392|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
105635389|NCT03732807|364329393|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
105635390|NCT03732807|364329394|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
105635391|NCT03732807|364329395|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
105635392|NCT03732807|364329396|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
105635393|NCT03732807|364329397|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
105635394|NCT03732807|364329391|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
105635395|NCT03732807|364329392|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
105635396|NCT03732807|364329393|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
105635397|NCT03732807|364329394|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
105635398|NCT03732807|364329395|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
105635399|NCT03732807|364329396|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
105635400|NCT03732807|364329397|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
105635401|NCT03732807|364329391|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
105635402|NCT03732807|364329392|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
105635403|NCT03732807|364329393|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
105635404|NCT03732807|364329394|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
105635405|NCT03732807|364329395|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
105635406|NCT03732807|364329396|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
105635407|NCT03732807|364329397|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
105635408|NCT03732807|364329391|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
105635409|NCT03732807|364329392|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
105635410|NCT03732807|364329393|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
105635411|NCT03732807|364329394|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
105635412|NCT03732807|364329395|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
105635413|NCT03732807|364329396|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
105635414|NCT03732807|364329397|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
105635415|NCT03732807|364329391|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
105635416|NCT03732807|364329392|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
105635417|NCT03732807|364329393|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
105635418|NCT03732807|364329394|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
105635419|NCT03732807|364329395|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
105635420|NCT03732807|364329396|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
105635421|NCT03732807|364329397|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
105635422|NCT03732807|364329391|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
105635423|NCT03732807|364329392|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
105635424|NCT03732807|364329393|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
105635425|NCT03732807|364329394|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
105635426|NCT03732807|364329395|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
105635427|NCT03732807|364329396|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
105635428|NCT03732807|364329397|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
105635429|NCT03732807|364329391|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
105635430|NCT03732807|364329392|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
105635431|NCT03732807|364329393|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
105635432|NCT03732807|364329394|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
105635433|NCT03732807|364329395|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
105635434|NCT03732807|364329396|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
105635435|NCT03732807|364329397|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
105635436|NCT03732807|364329391|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
105635437|NCT03732807|364329392|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
105635438|NCT03732807|364329393|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
105635439|NCT03732807|364329394|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
105635440|NCT03732807|364329395|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
105635441|NCT03732807|364329396|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
105635442|NCT03732807|364329397|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
105635443|NCT03732807|364329391|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
105635444|NCT03732807|364329392|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
105635445|NCT03732807|364329393|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
105635446|NCT03732807|364329394|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
105635447|NCT03732807|364329395|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
105635448|NCT03732807|364329396|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
105635449|NCT03732807|364329397|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
105635450|NCT03732807|364329391|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
105635451|NCT03732807|364329392|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
105635452|NCT03732807|364329393|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
105635453|NCT03732807|364329394|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
105635454|NCT03732807|364329395|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
105635455|NCT03732807|364329396|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
105635456|NCT03732807|364329397|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
105635457|NCT03732807|364329391|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
105635458|NCT03732807|364329392|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
105635459|NCT03732807|364329393|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
105635460|NCT03732807|364329394|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
105635461|NCT03732807|364329395|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
105635462|NCT03732807|364329396|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
105635463|NCT03732807|364329397|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
105635464|NCT03732807|364329391|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
105635465|NCT03732807|364329392|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
105635466|NCT03732807|364329393|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
105635467|NCT03732807|364329394|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
105635468|NCT03732807|364329395|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
105635469|NCT03732807|364329396|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
105635470|NCT03732807|364329397|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
105635471|NCT05405244|364329398|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
105635472|NCT05405244|364329399|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
105635473|NCT05405244|364329398|FG000|Washout (2 Weeks)|Adverse Event|2|||
105635474|NCT05405244|364329399|FG001|Washout (2 Weeks)|Adverse Event|0|||
105635475|NCT05405244|364329398|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
105635476|NCT05405244|364329399|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
105635477|NCT01779700|364329400|FG000|Overall Study|Adverse Event|4|||
105635478|NCT01779700|364329401|FG001|Overall Study|Adverse Event|3|||
105635479|NCT01779700|364329400|FG000|Overall Study|Withdrawal by Subject|0|||
105635480|NCT01779700|364329401|FG001|Overall Study|Withdrawal by Subject|2|||
105635481|NCT02463448|364329402|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
105635482|NCT02463448|364329402|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
105635483|NCT02463448|364329402|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
105635484|NCT02463448|364329402|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
105635485|NCT00093496|364329403|FG000|Overall Study|Protocol Violation|1|||
105635486|NCT00093496|364329404|FG001|Overall Study|Protocol Violation|3|||
105635487|NCT00795184|364329409|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
105635488|NCT00795184|364329410|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
105635489|NCT00683800|364329411|FG000|Overall Study|Adverse Event|195|||
105635490|NCT00683800|364329412|FG001|Overall Study|Adverse Event|102|||
105635491|NCT00683800|364329411|FG000|Overall Study|Death|0|||
105635492|NCT00683800|364329412|FG001|Overall Study|Death|1|||
105635493|NCT00683800|364329411|FG000|Overall Study|Lost to Follow-up|57|||
105635494|NCT00683800|364329412|FG001|Overall Study|Lost to Follow-up|44|||
105635495|NCT00683800|364329411|FG000|Overall Study|Other|5|||
105635496|NCT00683800|364329412|FG001|Overall Study|Other|2|||
105635497|NCT00683800|364329411|FG000|Overall Study|Protocol Violation|13|||
105635498|NCT00683800|364329412|FG001|Overall Study|Protocol Violation|16|||
105635499|NCT00683800|364329411|FG000|Overall Study|Withdrawal by Subject|66|||
105635500|NCT00683800|364329412|FG001|Overall Study|Withdrawal by Subject|64|||
105635501|NCT00683800|364329411|FG000|Overall Study|Lack of Efficacy|61|||
105635502|NCT00683800|364329412|FG001|Overall Study|Lack of Efficacy|104|||
105635503|NCT00683800|364329411|FG000|Overall Study|Randomized, not treated|35|||
105635504|NCT00683800|364329412|FG001|Overall Study|Randomized, not treated|33|||
105635505|NCT00205179|364329415|FG000|Overall Study|Death|0|||
105635506|NCT00205179|364329416|FG001|Overall Study|Death|2|||
105635507|NCT00205179|364329415|FG000|Overall Study|Physician Decision|1|||
105635508|NCT00205179|364329416|FG001|Overall Study|Physician Decision|1|||
105635509|NCT00205179|364329415|FG000|Overall Study|Adverse Event|1|||
105635510|NCT00205179|364329416|FG001|Overall Study|Adverse Event|1|||
105635511|NCT00586313|364329417|FG000|Overall Study|Lack of Efficacy|2|||
105635512|NCT01932970|364329441|FG000|Overall Study|Withdrawal by Subject|5|||
105635513|NCT01932970|364329441|FG000|Overall Study|Death|1|||
105635514|NCT01932970|364329441|FG000|Overall Study|Lost to Follow-up|2|||
105635515|NCT01932970|364329441|FG000|Overall Study|Protocol Specified Criteria|10|||
105635516|NCT01700205|364329442|FG000|Overall Study|Withdrawal by Subject|13|||
105635517|NCT01700205|364329443|FG001|Overall Study|Withdrawal by Subject|13|||
105635518|NCT01700205|364329442|FG000|Overall Study|Protocol Violation|2|||
105635519|NCT01700205|364329443|FG001|Overall Study|Protocol Violation|2|||
105635520|NCT03489369|364329446|FG000|Overall Study|Documented Progressive Disease|3|||
105635521|NCT03489369|364329447|FG001|Overall Study|Documented Progressive Disease|2|||
105635522|NCT03489369|364329448|FG002|Overall Study|Documented Progressive Disease|3|||
105635523|NCT03489369|364329449|FG003|Overall Study|Documented Progressive Disease|6|||
105635524|NCT03489369|364329446|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
105635525|NCT03489369|364329447|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
105635526|NCT03489369|364329448|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
105635527|NCT03489369|364329449|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
105635528|NCT01968967|364329450|FG000|Treatment Period|Other|22|||
105635529|NCT01968967|364329451|FG001|Treatment Period|Other|22|||
105635530|NCT01968967|364329452|FG002|Treatment Period|Other|0|||
105635531|NCT01968967|364329453|FG003|Treatment Period|Other|0|||
105635532|NCT01968967|364329454|FG004|Treatment Period|Other|0|||
105635533|NCT01968967|364329450|FG000|Treatment Period|Withdrawal by Subject|71|||
105635534|NCT01968967|364329451|FG001|Treatment Period|Withdrawal by Subject|61|||
105635535|NCT01968967|364329452|FG002|Treatment Period|Withdrawal by Subject|0|||
105635536|NCT01968967|364329453|FG003|Treatment Period|Withdrawal by Subject|0|||
105635537|NCT01968967|364329454|FG004|Treatment Period|Withdrawal by Subject|0|||
105635538|NCT01968967|364329450|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
105635539|NCT01968967|364329451|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
105635540|NCT01968967|364329452|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
105635541|NCT01968967|364329453|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
105635542|NCT01968967|364329454|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
105635543|NCT01968967|364329450|FG000|Treatment Period|Lost to Follow-up|26|||
105635544|NCT01968967|364329451|FG001|Treatment Period|Lost to Follow-up|31|||
105635545|NCT01968967|364329452|FG002|Treatment Period|Lost to Follow-up|0|||
105635546|NCT01968967|364329453|FG003|Treatment Period|Lost to Follow-up|0|||
105635547|NCT01968967|364329454|FG004|Treatment Period|Lost to Follow-up|0|||
105635548|NCT01968967|364329450|FG000|Treatment Period|Protocol Violation|1|||
105635549|NCT01968967|364329451|FG001|Treatment Period|Protocol Violation|2|||
105635550|NCT01968967|364329452|FG002|Treatment Period|Protocol Violation|0|||
105635551|NCT01968967|364329453|FG003|Treatment Period|Protocol Violation|0|||
105635552|NCT01968967|364329454|FG004|Treatment Period|Protocol Violation|0|||
105635553|NCT01968967|364329450|FG000|Treatment Period|Adverse Event|9|||
105635554|NCT01968967|364329451|FG001|Treatment Period|Adverse Event|8|||
105635555|NCT01968967|364329452|FG002|Treatment Period|Adverse Event|0|||
105635556|NCT01968967|364329453|FG003|Treatment Period|Adverse Event|0|||
105635557|NCT01968967|364329454|FG004|Treatment Period|Adverse Event|0|||
105635558|NCT01968967|364329450|FG000|Treatment Period|Death|9|||
105635559|NCT01968967|364329451|FG001|Treatment Period|Death|2|||
105635560|NCT01968967|364329452|FG002|Treatment Period|Death|0|||
105635561|NCT01968967|364329453|FG003|Treatment Period|Death|0|||
105635562|NCT01968967|364329454|FG004|Treatment Period|Death|0|||
105635563|NCT01968967|364329450|FG000|Treatment Period|Randomized Not Treated|6|||
105635564|NCT01968967|364329451|FG001|Treatment Period|Randomized Not Treated|5|||
105635565|NCT01968967|364329452|FG002|Treatment Period|Randomized Not Treated|0|||
105635566|NCT01968967|364329453|FG003|Treatment Period|Randomized Not Treated|0|||
105635567|NCT01968967|364329454|FG004|Treatment Period|Randomized Not Treated|0|||
105635568|NCT01968967|364329450|FG000|Extension Period|Withdrew Consent|0|||
105635569|NCT01968967|364329451|FG001|Extension Period|Withdrew Consent|0|||
105635570|NCT01968967|364329452|FG002|Extension Period|Withdrew Consent|2|||
105635571|NCT01968967|364329453|FG003|Extension Period|Withdrew Consent|0|||
105635572|NCT01968967|364329454|FG004|Extension Period|Withdrew Consent|5|||
105635573|NCT01787032|364329459|FG000|Overall Study|Protocol Violation|0|||
105635574|NCT01787032|364329460|FG001|Overall Study|Protocol Violation|0|||
105635575|NCT01787032|364329461|FG002|Overall Study|Protocol Violation|0|||
105635576|NCT01787032|364329462|FG003|Overall Study|Protocol Violation|0|||
105635577|NCT01787032|364329463|FG004|Overall Study|Protocol Violation|1|||
105635578|NCT01787032|364329464|FG005|Overall Study|Protocol Violation|1|||
105635579|NCT01953692|364329467|FG000|Overall Study|Adverse Event|5|||
105635580|NCT01953692|364329468|FG001|Overall Study|Adverse Event|2|||
105635581|NCT01953692|364329469|FG002|Overall Study|Adverse Event|4|||
105635582|NCT01953692|364329470|FG003|Overall Study|Adverse Event|2|||
105635583|NCT01953692|364329471|FG004|Overall Study|Adverse Event|1|||
105635584|NCT01953692|364329472|FG005|Overall Study|Adverse Event|2|||
105635585|NCT01953692|364329473|FG006|Overall Study|Adverse Event|0|||
105635586|NCT01953692|364329474|FG007|Overall Study|Adverse Event|0|||
105635587|NCT01953692|364329475|FG008|Overall Study|Adverse Event|0|||
105635588|NCT01953692|364329467|FG000|Overall Study|Clinical Progression|0|||
105635589|NCT01953692|364329468|FG001|Overall Study|Clinical Progression|15|||
105635590|NCT01953692|364329469|FG002|Overall Study|Clinical Progression|7|||
105635591|NCT01953692|364329470|FG003|Overall Study|Clinical Progression|5|||
105635592|NCT01953692|364329471|FG004|Overall Study|Clinical Progression|0|||
105635593|NCT01953692|364329472|FG005|Overall Study|Clinical Progression|7|||
105635594|NCT01953692|364329473|FG006|Overall Study|Clinical Progression|20|||
105635595|NCT01953692|364329474|FG007|Overall Study|Clinical Progression|3|||
105635596|NCT01953692|364329475|FG008|Overall Study|Clinical Progression|3|||
105635597|NCT01953692|364329467|FG000|Overall Study|Death|5|||
105635598|NCT01953692|364329468|FG001|Overall Study|Death|0|||
105635599|NCT01953692|364329469|FG002|Overall Study|Death|2|||
105635600|NCT01953692|364329470|FG003|Overall Study|Death|2|||
105635601|NCT01953692|364329471|FG004|Overall Study|Death|1|||
105635602|NCT01953692|364329472|FG005|Overall Study|Death|3|||
105635603|NCT01953692|364329473|FG006|Overall Study|Death|6|||
105635604|NCT01953692|364329474|FG007|Overall Study|Death|2|||
105635605|NCT01953692|364329475|FG008|Overall Study|Death|1|||
105635606|NCT01953692|364329467|FG000|Overall Study|Excluded Medication|1|||
105635607|NCT01953692|364329468|FG001|Overall Study|Excluded Medication|0|||
105635608|NCT01953692|364329469|FG002|Overall Study|Excluded Medication|0|||
105635609|NCT01953692|364329470|FG003|Overall Study|Excluded Medication|0|||
105635610|NCT01953692|364329471|FG004|Overall Study|Excluded Medication|0|||
105635611|NCT01953692|364329472|FG005|Overall Study|Excluded Medication|0|||
105635612|NCT01953692|364329473|FG006|Overall Study|Excluded Medication|0|||
105635613|NCT01953692|364329474|FG007|Overall Study|Excluded Medication|0|||
105635614|NCT01953692|364329475|FG008|Overall Study|Excluded Medication|0|||
105635615|NCT01953692|364329467|FG000|Overall Study|Lost to Follow-up|1|||
105635616|NCT01953692|364329468|FG001|Overall Study|Lost to Follow-up|0|||
105635617|NCT01953692|364329469|FG002|Overall Study|Lost to Follow-up|3|||
105635618|NCT01953692|364329470|FG003|Overall Study|Lost to Follow-up|1|||
105635619|NCT01953692|364329471|FG004|Overall Study|Lost to Follow-up|0|||
105635620|NCT01953692|364329472|FG005|Overall Study|Lost to Follow-up|1|||
105635621|NCT01953692|364329473|FG006|Overall Study|Lost to Follow-up|0|||
105635622|NCT01953692|364329474|FG007|Overall Study|Lost to Follow-up|0|||
105635623|NCT01953692|364329475|FG008|Overall Study|Lost to Follow-up|0|||
105635624|NCT01953692|364329467|FG000|Overall Study|Physician Decision|11|||
105635625|NCT01953692|364329468|FG001|Overall Study|Physician Decision|4|||
105635626|NCT01953692|364329469|FG002|Overall Study|Physician Decision|2|||
105635627|NCT01953692|364329470|FG003|Overall Study|Physician Decision|2|||
105635628|NCT01953692|364329471|FG004|Overall Study|Physician Decision|1|||
105635629|NCT01953692|364329472|FG005|Overall Study|Physician Decision|2|||
105635630|NCT01953692|364329473|FG006|Overall Study|Physician Decision|4|||
105635631|NCT01953692|364329474|FG007|Overall Study|Physician Decision|1|||
105635632|NCT01953692|364329475|FG008|Overall Study|Physician Decision|0|||
105635633|NCT01953692|364329467|FG000|Overall Study|Protocol Violation|0|||
105635634|NCT01953692|364329468|FG001|Overall Study|Protocol Violation|2|||
105635635|NCT01953692|364329469|FG002|Overall Study|Protocol Violation|1|||
105635636|NCT01953692|364329470|FG003|Overall Study|Protocol Violation|0|||
105635637|NCT01953692|364329471|FG004|Overall Study|Protocol Violation|0|||
105635638|NCT01953692|364329472|FG005|Overall Study|Protocol Violation|0|||
105635639|NCT01953692|364329473|FG006|Overall Study|Protocol Violation|0|||
105635640|NCT01953692|364329474|FG007|Overall Study|Protocol Violation|1|||
105635641|NCT01953692|364329475|FG008|Overall Study|Protocol Violation|0|||
105635642|NCT01953692|364329467|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635643|NCT01953692|364329468|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635644|NCT01953692|364329469|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635645|NCT01953692|364329470|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635646|NCT01953692|364329471|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635647|NCT01953692|364329472|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635648|NCT01953692|364329473|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635649|NCT01953692|364329474|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
105635650|NCT01953692|364329475|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635651|NCT01953692|364329467|FG000|Overall Study|Withdrawal by Subject|4|||
105635652|NCT01953692|364329468|FG001|Overall Study|Withdrawal by Subject|2|||
105635653|NCT01953692|364329469|FG002|Overall Study|Withdrawal by Subject|1|||
105635654|NCT01953692|364329470|FG003|Overall Study|Withdrawal by Subject|2|||
105635655|NCT01953692|364329471|FG004|Overall Study|Withdrawal by Subject|0|||
105635656|NCT01953692|364329472|FG005|Overall Study|Withdrawal by Subject|3|||
105635657|NCT01953692|364329473|FG006|Overall Study|Withdrawal by Subject|2|||
105635658|NCT01953692|364329474|FG007|Overall Study|Withdrawal by Subject|1|||
105635659|NCT01953692|364329475|FG008|Overall Study|Withdrawal by Subject|1|||
105635660|NCT01759862|364329479|FG000|Overall Study|Physician Decision|3|||
105635661|NCT01759862|364329480|FG001|Overall Study|Physician Decision|1|||
105635662|NCT01759862|364329479|FG000|Overall Study|Adverse Event|0|||
105635663|NCT01759862|364329480|FG001|Overall Study|Adverse Event|1|||
105635664|NCT01160354|364329481|FG000|Overall Study|Death|0|||
105635665|NCT01160354|364329482|FG001|Overall Study|Death|1|||
105635666|NCT01160354|364329483|FG002|Overall Study|Death|1|||
105635667|NCT01328496|364329486|FG000|Overall Study|Significant Change in Health Status|1|||
105635668|NCT01328496|364329487|FG001|Overall Study|Significant Change in Health Status|0|||
105635669|NCT00756574|364329493|FG000|Overall Study|Withdrawal by Subject|9|||
105635670|NCT00756574|364329494|FG001|Overall Study|Withdrawal by Subject|7|||
105635671|NCT00756574|364329493|FG000|Overall Study|Lost to Follow-up|4|||
105635672|NCT00756574|364329494|FG001|Overall Study|Lost to Follow-up|4|||
105635673|NCT02743819|364329496|FG000|Overall Study|Lack of Efficacy|5|||
105635674|NCT02743819|364329496|FG000|Overall Study|Death|2|||
105635675|NCT02743819|364329496|FG000|Overall Study|Adverse Event|1|||
105635676|NCT00274261|364329497|FG000|Overall Study|Adverse Event|19|||
105635677|NCT00274261|364329498|FG001|Overall Study|Adverse Event|11|||
105635678|NCT00274261|364329497|FG000|Overall Study|Pregnancy|114|||
105635679|NCT00274261|364329498|FG001|Overall Study|Pregnancy|83|||
105635680|NCT00274261|364329497|FG000|Overall Study|Withdrawal by Subject|179|||
105635681|NCT00274261|364329498|FG001|Overall Study|Withdrawal by Subject|126|||
105635682|NCT00274261|364329497|FG000|Overall Study|Protocol Violation|71|||
105635683|NCT00274261|364329498|FG001|Overall Study|Protocol Violation|42|||
105635684|NCT00274261|364329497|FG000|Overall Study|Lost to Follow-up|106|||
105635685|NCT00274261|364329498|FG001|Overall Study|Lost to Follow-up|75|||
105635686|NCT00553332|364329504|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
105635687|NCT02744066|364329506|FG000|Overall Study|Withdrawal by parent|0|||
105635688|NCT02744066|364329507|FG001|Overall Study|Withdrawal by parent|1|||
105635689|NCT02744066|364329506|FG000|Overall Study|Discharged from NICU prior to completion|0|||
105635690|NCT02744066|364329507|FG001|Overall Study|Discharged from NICU prior to completion|4|||
105635691|NCT03102034|364329508|FG000|Overall Study|Withdrawal by Subject|1|||
105635692|NCT03102034|364329509|FG001|Overall Study|Withdrawal by Subject|0|||
105635693|NCT04066075|364329516|FG000|Overall Study|Lost to Follow-up|3|||
105635694|NCT04066075|364329517|FG001|Overall Study|Lost to Follow-up|3|||
105635695|NCT04066075|364329516|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
105635696|NCT04066075|364329517|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
105635697|NCT04066075|364329516|FG000|Overall Study|Withdrawal by Subject|2|||
105635698|NCT04066075|364329517|FG001|Overall Study|Withdrawal by Subject|2|||
105635699|NCT02208362|364329518|FG000|Overall Study|Participant did not complete treatment|0|||
105635700|NCT02208362|364329519|FG001|Overall Study|Participant did not complete treatment|1|||
105635701|NCT02208362|364329520|FG002|Overall Study|Participant did not complete treatment|0|||
105635702|NCT02208362|364329521|FG003|Overall Study|Participant did not complete treatment|0|||
105635703|NCT02208362|364329522|FG004|Overall Study|Participant did not complete treatment|0|||
105635704|NCT02208362|364329523|FG005|Overall Study|Participant did not complete treatment|0|||
105635705|NCT02208362|364329524|FG006|Overall Study|Participant did not complete treatment|1|||
105635706|NCT02208362|364329525|FG007|Overall Study|Participant did not complete treatment|1|||
105635707|NCT02208362|364329526|FG008|Overall Study|Participant did not complete treatment|2|||
105635708|NCT02208362|364329527|FG009|Overall Study|Participant did not complete treatment|0|||
105635709|NCT02208362|364329528|FG010|Overall Study|Participant did not complete treatment|1|||
105635710|NCT02208362|364329529|FG011|Overall Study|Participant did not complete treatment|0|||
105635711|NCT02208362|364329518|FG000|Overall Study|Participant received disallowed treatment|0|||
105635712|NCT02208362|364329519|FG001|Overall Study|Participant received disallowed treatment|0|||
105635713|NCT02208362|364329520|FG002|Overall Study|Participant received disallowed treatment|0|||
105635714|NCT02208362|364329521|FG003|Overall Study|Participant received disallowed treatment|0|||
105635715|NCT02208362|364329522|FG004|Overall Study|Participant received disallowed treatment|0|||
105635716|NCT02208362|364329523|FG005|Overall Study|Participant received disallowed treatment|0|||
105635717|NCT02208362|364329524|FG006|Overall Study|Participant received disallowed treatment|0|||
105635718|NCT02208362|364329525|FG007|Overall Study|Participant received disallowed treatment|0|||
105635719|NCT02208362|364329526|FG008|Overall Study|Participant received disallowed treatment|1|||
105635720|NCT02208362|364329527|FG009|Overall Study|Participant received disallowed treatment|0|||
105635721|NCT02208362|364329528|FG010|Overall Study|Participant received disallowed treatment|0|||
105635722|NCT02208362|364329529|FG011|Overall Study|Participant received disallowed treatment|0|||
105635723|NCT05432986|364329530|FG000|Overall Study|Withdrawal by Subject|2|||
105635724|NCT05432986|364329530|FG000|Overall Study|incomplete measurement|7|||
105635725|NCT02036970|364330924|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
105635726|NCT02036970|364330925|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
105635727|NCT02036970|364330926|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
105635728|NCT02036970|364330927|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
105635729|NCT02036970|364330928|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
105635730|NCT02036970|364330929|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
105635731|NCT02036970|364330930|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
105635732|NCT02036970|364330931|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
105635733|NCT02036970|364330932|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
105635734|NCT02036970|364330933|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
105635735|NCT02036970|364330924|FG000|Part 1: Day 1 Through Week 16|Death|0|||
105635736|NCT02036970|364330925|FG001|Part 1: Day 1 Through Week 16|Death|0|||
105635737|NCT02036970|364330926|FG002|Part 1: Day 1 Through Week 16|Death|0|||
105635738|NCT02036970|364330927|FG003|Part 1: Day 1 Through Week 16|Death|0|||
105635739|NCT02036970|364330928|FG004|Part 1: Day 1 Through Week 16|Death|0|||
105635740|NCT02036970|364330929|FG005|Part 1: Day 1 Through Week 16|Death|0|||
105635741|NCT02036970|364330930|FG006|Part 1: Day 1 Through Week 16|Death|0|||
105635742|NCT02036970|364330931|FG007|Part 1: Day 1 Through Week 16|Death|0|||
105635743|NCT02036970|364330932|FG008|Part 1: Day 1 Through Week 16|Death|1|||
105635744|NCT02036970|364330933|FG009|Part 1: Day 1 Through Week 16|Death|0|||
105635745|NCT02036970|364330924|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
105635746|NCT02036970|364330925|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
105635747|NCT02036970|364330926|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
105635748|NCT02036970|364330927|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
105635749|NCT02036970|364330928|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
105635750|NCT02036970|364330929|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
105635751|NCT02036970|364330930|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
105635752|NCT02036970|364330931|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
105635753|NCT02036970|364330932|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
105635754|NCT02036970|364330933|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
105635755|NCT02036970|364330924|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
105635756|NCT02036970|364330925|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
105635757|NCT02036970|364330926|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
105635758|NCT02036970|364330927|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
105635759|NCT02036970|364330928|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
105635760|NCT02036970|364330929|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
105635761|NCT02036970|364330930|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
105635762|NCT02036970|364330931|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
105635763|NCT02036970|364330932|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
105635764|NCT02036970|364330933|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
105635765|NCT02036970|364330924|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635766|NCT02036970|364330925|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635767|NCT02036970|364330926|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635768|NCT02036970|364330927|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
105635769|NCT02036970|364330928|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635770|NCT02036970|364330929|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635771|NCT02036970|364330930|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635772|NCT02036970|364330931|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635773|NCT02036970|364330932|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635774|NCT02036970|364330933|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635775|NCT02036970|364330924|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
105635776|NCT02036970|364330925|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
105635777|NCT02036970|364330926|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
105635778|NCT02036970|364330927|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
105635779|NCT02036970|364330928|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
105635780|NCT02036970|364330929|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
105635781|NCT02036970|364330930|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
105635782|NCT02036970|364330931|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
105635783|NCT02036970|364330932|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
105635784|NCT02036970|364330933|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
105635785|NCT02036970|364330924|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635786|NCT02036970|364330925|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635787|NCT02036970|364330926|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635788|NCT02036970|364330927|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635789|NCT02036970|364330928|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635790|NCT02036970|364330929|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635791|NCT02036970|364330930|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635792|NCT02036970|364330931|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
105635793|NCT02036970|364330932|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635794|NCT02036970|364330933|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635795|NCT02036970|364330924|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
105635796|NCT02036970|364330925|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
105635797|NCT02036970|364330926|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
105635798|NCT02036970|364330927|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
105635799|NCT02036970|364330928|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
105635800|NCT02036970|364330929|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
105635801|NCT02036970|364330930|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
105635802|NCT02036970|364330931|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
105635803|NCT02036970|364330932|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
105635804|NCT02036970|364330933|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
105635805|NCT02036970|364330924|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
105635806|NCT02036970|364330925|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
105635807|NCT02036970|364330926|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
105635808|NCT02036970|364330927|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
105635809|NCT02036970|364330928|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
105635810|NCT02036970|364330929|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
105635811|NCT02036970|364330930|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
105635812|NCT02036970|364330931|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
105635813|NCT02036970|364330932|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
105635814|NCT02036970|364330933|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
105635815|NCT04705051|364330934|FG000|Overall Study|Enrolled but not treated|1|||
105635816|NCT04705051|364330934|FG000|Overall Study|Study terminated by sponsor|23|||
105635817|NCT03116464|364330940|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
105635818|NCT01372085|364330946|FG000|Washout Period 2|Physician Decision|0|||
105635819|NCT01372085|364330947|FG001|Washout Period 2|Physician Decision|0|||
105635820|NCT01372085|364330948|FG002|Washout Period 2|Physician Decision|0|||
105635821|NCT01372085|364330949|FG003|Washout Period 2|Physician Decision|0|||
105635822|NCT01372085|364330950|FG004|Washout Period 2|Physician Decision|1|||
105635823|NCT01372085|364330951|FG005|Washout Period 2|Physician Decision|0|||
105635824|NCT01372085|364330952|FG006|Washout Period 2|Physician Decision|0|||
105635825|NCT01372085|364330953|FG007|Washout Period 2|Physician Decision|0|||
105635826|NCT01372085|364330954|FG008|Washout Period 2|Physician Decision|0|||
105635827|NCT01372085|364330955|FG009|Washout Period 2|Physician Decision|0|||
105635828|NCT01372085|364330946|FG000|Washout Period 3|Withdrawal by Subject|0|||
105635829|NCT01372085|364330947|FG001|Washout Period 3|Withdrawal by Subject|0|||
105635830|NCT01372085|364330948|FG002|Washout Period 3|Withdrawal by Subject|0|||
105635831|NCT01372085|364330949|FG003|Washout Period 3|Withdrawal by Subject|0|||
105635832|NCT01372085|364330950|FG004|Washout Period 3|Withdrawal by Subject|0|||
105635833|NCT01372085|364330951|FG005|Washout Period 3|Withdrawal by Subject|2|||
105635834|NCT01372085|364330952|FG006|Washout Period 3|Withdrawal by Subject|0|||
105635835|NCT01372085|364330953|FG007|Washout Period 3|Withdrawal by Subject|0|||
105635836|NCT01372085|364330954|FG008|Washout Period 3|Withdrawal by Subject|0|||
105635837|NCT01372085|364330955|FG009|Washout Period 3|Withdrawal by Subject|0|||
105635838|NCT02824198|364330956|FG000|Overall Study|Non-compliance with the protocol|5|||
105635839|NCT02824198|364330957|FG001|Overall Study|Non-compliance with the protocol|1|||
105635840|NCT02824198|364330956|FG000|Overall Study|Lost to Follow-up|5|||
105635841|NCT02824198|364330957|FG001|Overall Study|Lost to Follow-up|2|||
105635842|NCT02824198|364330956|FG000|Overall Study|Withdrawal by Subject|5|||
105635843|NCT02824198|364330957|FG001|Overall Study|Withdrawal by Subject|0|||
105635844|NCT00777049|364330958|FG000|Overall Study|Withdrawal by Subject|1|||
105635845|NCT00777049|364330959|FG001|Overall Study|Withdrawal by Subject|0|||
105635846|NCT00777049|364330958|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
105635847|NCT00777049|364330959|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
105635848|NCT00562094|364330960|FG000|Overall Study|Lost to Follow-up|62|||
105635849|NCT00790569|364330963|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
105635850|NCT00790569|364330964|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
105635851|NCT00790569|364330965|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
105635852|NCT00790569|364330963|FG000|End of Treatment (6 Month Interview)|Death|0|||
105635853|NCT00790569|364330964|FG001|End of Treatment (6 Month Interview)|Death|2|||
105635854|NCT00790569|364330965|FG002|End of Treatment (6 Month Interview)|Death|1|||
105635855|NCT00790569|364330963|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
105635856|NCT00790569|364330964|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
105635857|NCT00790569|364330965|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
105635858|NCT00790569|364330963|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
105635859|NCT00790569|364330964|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
105635860|NCT00790569|364330965|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
105635861|NCT00790569|364330963|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
105635862|NCT00790569|364330964|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
105635863|NCT00790569|364330965|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
105635864|NCT00790569|364330963|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
105635865|NCT00790569|364330964|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
105635866|NCT00790569|364330965|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
105635867|NCT03274076|364330967|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
105635868|NCT03274076|364330968|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
105635869|NCT03274076|364330969|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
105635870|NCT03274076|364330970|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
105635871|NCT03274076|364330967|FG000|24 Weeks Open Label|Adverse Event|0|||
105635872|NCT03274076|364330968|FG001|24 Weeks Open Label|Adverse Event|0|||
105635873|NCT03274076|364330969|FG002|24 Weeks Open Label|Adverse Event|2|||
105635874|NCT03274076|364330970|FG003|24 Weeks Open Label|Adverse Event|0|||
105635875|NCT03274076|364330967|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
105635876|NCT03274076|364330968|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
105635877|NCT03274076|364330969|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
105635878|NCT03274076|364330970|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
105635879|NCT00975585|364330971|FG000|Overall Study|Adverse Event|0|||
105635880|NCT00975585|364330972|FG001|Overall Study|Adverse Event|4|||
105635881|NCT00975585|364330971|FG000|Overall Study|Lost to Follow-up|3|||
105635882|NCT00975585|364330972|FG001|Overall Study|Lost to Follow-up|5|||
105635883|NCT00975585|364330971|FG000|Overall Study|Withdrawal by Subject|2|||
105635884|NCT00975585|364330972|FG001|Overall Study|Withdrawal by Subject|1|||
105635885|NCT00975585|364330971|FG000|Overall Study|Lens issue|2|||
105635886|NCT00975585|364330972|FG001|Overall Study|Lens issue|2|||
105635887|NCT01953224|364330973|FG000|Overall Study|Lost to Follow-up|1|||
105635888|NCT01953224|364330974|FG001|Overall Study|Lost to Follow-up|1|||
105635889|NCT01953224|364330973|FG000|Overall Study|Withdrawal by Subject|1|||
105635890|NCT01953224|364330974|FG001|Overall Study|Withdrawal by Subject|2|||
105635891|NCT02079649|364330976|FG000|Overall Study|Lost to Follow-up|0|||
105635892|NCT02079649|364330977|FG001|Overall Study|Lost to Follow-up|0|||
105635893|NCT02079649|364330978|FG002|Overall Study|Lost to Follow-up|0|||
105635894|NCT02079649|364330979|FG003|Overall Study|Lost to Follow-up|1|||
105635895|NCT02079649|364330976|FG000|Overall Study|Withdrawal by Subject|0|||
105635896|NCT02079649|364330977|FG001|Overall Study|Withdrawal by Subject|0|||
105635897|NCT02079649|364330978|FG002|Overall Study|Withdrawal by Subject|0|||
105635898|NCT02079649|364330979|FG003|Overall Study|Withdrawal by Subject|1|||
105635899|NCT02079649|364330976|FG000|Overall Study|Randomization error (prior to treatment)|1|||
105635900|NCT02079649|364330977|FG001|Overall Study|Randomization error (prior to treatment)|0|||
105635901|NCT02079649|364330978|FG002|Overall Study|Randomization error (prior to treatment)|1|||
105635902|NCT02079649|364330979|FG003|Overall Study|Randomization error (prior to treatment)|0|||
105635903|NCT03113409|364330984|FG000|Overall Study|Withdrawal by Subject|5|||
105635904|NCT03113409|364330985|FG001|Overall Study|Withdrawal by Subject|0|||
105635905|NCT03113409|364330986|FG002|Overall Study|Withdrawal by Subject|0|||
105635906|NCT00388726|364330987|FG000|Overall Study|Adverse Event|50|||
105635907|NCT00388726|364330988|FG001|Overall Study|Adverse Event|24|||
105635908|NCT00388726|364330987|FG000|Overall Study|Progressive Disease|336|||
105635909|NCT00388726|364330988|FG001|Overall Study|Progressive Disease|153|||
105635910|NCT00388726|364330987|FG000|Overall Study|Clinical Progression|61|||
105635911|NCT00388726|364330988|FG001|Overall Study|Clinical Progression|36|||
105635912|NCT00388726|364330987|FG000|Overall Study|Withdrawal by Subject|10|||
105635913|NCT00388726|364330988|FG001|Overall Study|Withdrawal by Subject|7|||
105635914|NCT00388726|364330987|FG000|Overall Study|Administrative|6|||
105635915|NCT00388726|364330988|FG001|Overall Study|Administrative|9|||
105635916|NCT00388726|364330987|FG000|Overall Study|Physician Decision|18|||
105635917|NCT00388726|364330988|FG001|Overall Study|Physician Decision|13|||
105635918|NCT00388726|364330987|FG000|Overall Study|Death|3|||
105635919|NCT00388726|364330988|FG001|Overall Study|Death|2|||
105635920|NCT01437319|364330989|FG000|Phase I|Lost to Follow-up|2|||
105635921|NCT01437319|364330990|FG001|Phase I|Lost to Follow-up|0|||
105635922|NCT01437319|364330991|FG002|Phase I|Lost to Follow-up|0|||
105635923|NCT01437319|364330989|FG000|Phase I|Protocol Violation|1|||
105635924|NCT01437319|364330990|FG001|Phase I|Protocol Violation|0|||
105635925|NCT01437319|364330991|FG002|Phase I|Protocol Violation|0|||
105635926|NCT01437319|364330989|FG000|Phase I|Study related symptoms/complaints|27|||
105635927|NCT01437319|364330990|FG001|Phase I|Study related symptoms/complaints|0|||
105635928|NCT01437319|364330991|FG002|Phase I|Study related symptoms/complaints|0|||
105635929|NCT01437319|364330989|FG000|Phase I|Withdrawal by Subject|25|||
105635930|NCT01437319|364330990|FG001|Phase I|Withdrawal by Subject|0|||
105635931|NCT01437319|364330991|FG002|Phase I|Withdrawal by Subject|0|||
105635932|NCT01437319|364330989|FG000|Phase II|Withdrawal by Subject|0|||
105635933|NCT01437319|364330990|FG001|Phase II|Withdrawal by Subject|8|||
105635934|NCT01437319|364330991|FG002|Phase II|Withdrawal by Subject|16|||
105635935|NCT01437319|364330989|FG000|Phase II|Lost to Follow-up|0|||
105635936|NCT01437319|364330990|FG001|Phase II|Lost to Follow-up|7|||
105635937|NCT01437319|364330991|FG002|Phase II|Lost to Follow-up|2|||
105635938|NCT01437319|364330989|FG000|Phase II|Study related symptoms/complaints|0|||
105635939|NCT01437319|364330990|FG001|Phase II|Study related symptoms/complaints|28|||
105635940|NCT01437319|364330991|FG002|Phase II|Study related symptoms/complaints|19|||
105635941|NCT01437319|364330989|FG000|Phase II|Protocol Violation|0|||
105635942|NCT01437319|364330990|FG001|Phase II|Protocol Violation|1|||
105635943|NCT01437319|364330991|FG002|Phase II|Protocol Violation|0|||
105635944|NCT01499849|364330992|FG000|Overall Study|Adverse Event|28|||
105635945|NCT01499849|364330993|FG001|Overall Study|Adverse Event|32|||
105635946|NCT01499849|364330992|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
105635947|NCT01499849|364330993|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
105635948|NCT01499849|364330992|FG000|Overall Study|Withdrawal by Subject|43|||
105635949|NCT01499849|364330993|FG001|Overall Study|Withdrawal by Subject|43|||
105635950|NCT01499849|364330992|FG000|Overall Study|Death|5|||
105635951|NCT01499849|364330993|FG001|Overall Study|Death|7|||
105635952|NCT01499849|364330992|FG000|Overall Study|Disease Progression|11|||
105635953|NCT01499849|364330993|FG001|Overall Study|Disease Progression|10|||
105635954|NCT01499849|364330992|FG000|Overall Study|Protocol Violation|11|||
105635955|NCT01499849|364330993|FG001|Overall Study|Protocol Violation|11|||
105635956|NCT01499849|364330992|FG000|Overall Study|Physician Decision|20|||
105635957|NCT01499849|364330993|FG001|Overall Study|Physician Decision|19|||
105635958|NCT01499849|364330992|FG000|Overall Study|Lack of Efficacy|3|||
105635959|NCT01499849|364330993|FG001|Overall Study|Lack of Efficacy|4|||
105635960|NCT01499849|364330992|FG000|Overall Study|Lost to Follow-up|6|||
105635961|NCT01499849|364330993|FG001|Overall Study|Lost to Follow-up|3|||
105635962|NCT01499849|364330992|FG000|Overall Study|Other Reasons|27|||
105635963|NCT01499849|364330993|FG001|Overall Study|Other Reasons|30|||
105635964|NCT00853593|364330994|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
105635965|NCT00853593|364330994|FG000|Overall Study|Model 4396 lead not attempted|29|||
105635966|NCT00853593|364330994|FG000|Overall Study|Implant not attempted|4|||
105635967|NCT03611556|364330995|FG000|Overall Study|Death|7|||
105635968|NCT03611556|364330996|FG001|Overall Study|Death|7|||
105635969|NCT03611556|364330997|FG002|Overall Study|Death|3|||
105635970|NCT03611556|364330998|FG003|Overall Study|Death|8|||
105635971|NCT03611556|364330999|FG004|Overall Study|Death|47|||
105635972|NCT03611556|364331000|FG005|Overall Study|Death|32|||
105635973|NCT03611556|364331001|FG006|Overall Study|Death|53|||
105635974|NCT03611556|364330995|FG000|Overall Study|Withdrawal by Subject|0|||
105635975|NCT03611556|364330996|FG001|Overall Study|Withdrawal by Subject|0|||
105635976|NCT03611556|364330997|FG002|Overall Study|Withdrawal by Subject|0|||
105635977|NCT03611556|364330998|FG003|Overall Study|Withdrawal by Subject|0|||
105635978|NCT03611556|364330999|FG004|Overall Study|Withdrawal by Subject|4|||
105635979|NCT03611556|364331000|FG005|Overall Study|Withdrawal by Subject|2|||
105635980|NCT03611556|364331001|FG006|Overall Study|Withdrawal by Subject|4|||
105635981|NCT03611556|364330995|FG000|Overall Study|Sponsor decision|0|||
105635982|NCT03611556|364330996|FG001|Overall Study|Sponsor decision|0|||
105635983|NCT03611556|364330997|FG002|Overall Study|Sponsor decision|0|||
105635984|NCT03611556|364330998|FG003|Overall Study|Sponsor decision|0|||
105635985|NCT03611556|364330999|FG004|Overall Study|Sponsor decision|9|||
105635986|NCT03611556|364331000|FG005|Overall Study|Sponsor decision|4|||
105635987|NCT03611556|364331001|FG006|Overall Study|Sponsor decision|12|||
105635988|NCT03611556|364330995|FG000|Overall Study|Reasons|0|||
105635989|NCT03611556|364330996|FG001|Overall Study|Reasons|0|||
105635990|NCT03611556|364330997|FG002|Overall Study|Reasons|0|||
105635991|NCT03611556|364330998|FG003|Overall Study|Reasons|0|||
105635992|NCT03611556|364330999|FG004|Overall Study|Reasons|2|||
105635993|NCT03611556|364331000|FG005|Overall Study|Reasons|0|||
105635994|NCT03611556|364331001|FG006|Overall Study|Reasons|1|||
105635995|NCT03229408|364331006|FG000|Overall Study|Withdrawal by Subject|4|||
105635996|NCT03229408|364331007|FG001|Overall Study|Withdrawal by Subject|1|||
105635997|NCT03229408|364331006|FG000|Overall Study|Adverse Event|2|||
105635998|NCT03229408|364331007|FG001|Overall Study|Adverse Event|0|||
105635999|NCT03229408|364331006|FG000|Overall Study|Pregnancy|0|||
105636000|NCT03229408|364331007|FG001|Overall Study|Pregnancy|1|||
105636001|NCT03229408|364331006|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
105636002|NCT03229408|364331007|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
105636003|NCT04200664|364331008|FG000|Overall Study|Withdrawal by Subject|1|||
105636004|NCT04200664|364331009|FG001|Overall Study|Withdrawal by Subject|0|||
105636005|NCT04200664|364331010|FG002|Overall Study|Withdrawal by Subject|0|||
105636006|NCT02426138|364331012|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
105636007|NCT02426138|364331013|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
105636008|NCT02453282|364331018|FG000|Overall Study|Death|275|||
105636009|NCT02453282|364331019|FG001|Overall Study|Death|277|||
105636010|NCT02453282|364331020|FG002|Overall Study|Death|296|||
105636011|NCT02453282|364331018|FG000|Overall Study|Lost to Follow-up|1|||
105636012|NCT02453282|364331019|FG001|Overall Study|Lost to Follow-up|0|||
105636013|NCT02453282|364331020|FG002|Overall Study|Lost to Follow-up|2|||
105636014|NCT02453282|364331018|FG000|Overall Study|Withdrawal by Subject|12|||
105636015|NCT02453282|364331019|FG001|Overall Study|Withdrawal by Subject|10|||
105636016|NCT02453282|364331020|FG002|Overall Study|Withdrawal by Subject|11|||
105636017|NCT02453282|364331018|FG000|Overall Study|Participants ongoing at data cut-off|85|||
105636018|NCT02453282|364331019|FG001|Overall Study|Participants ongoing at data cut-off|84|||
105636019|NCT02453282|364331020|FG002|Overall Study|Participants ongoing at data cut-off|62|||
105636020|NCT02453282|364331018|FG000|Overall Study|Other|1|||
105636021|NCT02453282|364331019|FG001|Overall Study|Other|1|||
105636022|NCT02453282|364331020|FG002|Overall Study|Other|1|||
105636023|NCT00687219|364331021|FG000|Overall Study|Adverse Event|8|||
105636024|NCT00687219|364331021|FG000|Overall Study|Discontinuance criteria met|7|||
105636025|NCT00687219|364331021|FG000|Overall Study|HCV-RNA positive conversion|34|||
105636026|NCT00687219|364331021|FG000|Overall Study|Withdrawal by Subject|1|||
105636027|NCT00687219|364331021|FG000|Overall Study|Lack of Efficacy|1|||
105636028|NCT02235298|364331030|FG000|Overall Study|Lost to Follow-up|6|||
105636029|NCT02235298|364331031|FG001|Overall Study|Lost to Follow-up|5|||
105636030|NCT02235298|364331030|FG000|Overall Study|Adverse Event|2|||
105636031|NCT02235298|364331031|FG001|Overall Study|Adverse Event|2|||
105636032|NCT02235298|364331030|FG000|Overall Study|Withdrawal by Subject|0|||
105636033|NCT02235298|364331031|FG001|Overall Study|Withdrawal by Subject|1|||
105636034|NCT01827839|364331032|FG000|Overall Study|Adverse Event|1|||
105636035|NCT01827839|364331032|FG000|Overall Study|Consent Withdrawal|2|||
105636036|NCT00467272|364331037|FG000|Overall Study|Pneumonia|2|||
105636037|NCT00467272|364331037|FG000|Overall Study|Thrombophlebitis|1|||
105636038|NCT02454959|364331038|FG000|Overall Study|Protocol-Specified Criteria|3|||
105636039|NCT02454959|364331038|FG000|Overall Study|Physician Decision|1|||
105636040|NCT02454959|364331038|FG000|Overall Study|Withdrawal by Subject|3|||
105636041|NCT02454959|364331038|FG000|Overall Study|Adverse Event|2|||
105636042|NCT02350634|364331039|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
105636043|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
105636044|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
105636045|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
105636046|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
105636047|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
105636048|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
105636049|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
105636050|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
105636051|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
105636052|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
105636053|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
105636054|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
105636055|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
105636056|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
105636057|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
105636058|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
105636059|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
105636060|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
105636061|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
105636062|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
105636063|NCT02222493|364331050|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
105636064|NCT02222493|364331051|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
105636065|NCT02222493|364331050|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
105636066|NCT02222493|364331051|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
105636067|NCT02222493|364331050|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
105636068|NCT02222493|364331051|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
105636069|NCT02222493|364331050|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
105636070|NCT02222493|364331051|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
105636071|NCT02222493|364331050|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
105636072|NCT02222493|364331051|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
105636073|NCT02222493|364331050|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
105636074|NCT02222493|364331051|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
105636075|NCT02222493|364331050|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
105636076|NCT02222493|364331051|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
105636077|NCT02222493|364331050|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
105636078|NCT02222493|364331051|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
105636079|NCT02222493|364331050|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
105636080|NCT02222493|364331051|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
105636081|NCT02222493|364331050|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
105636082|NCT02222493|364331051|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
105636083|NCT02222493|364331050|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
105636084|NCT02222493|364331051|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
105636085|NCT02222493|364331050|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
105636086|NCT02222493|364331051|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
105636087|NCT02130557|364331052|FG000|Overall Study|Withdrawal by Subject|12|||
105636088|NCT02130557|364331053|FG001|Overall Study|Withdrawal by Subject|12|||
105636089|NCT02130557|364331052|FG000|Overall Study|Investigator Request|0|||
105636090|NCT02130557|364331053|FG001|Overall Study|Investigator Request|2|||
105636091|NCT02130557|364331052|FG000|Overall Study|Deceased|14|||
105636092|NCT02130557|364331053|FG001|Overall Study|Deceased|14|||
105636093|NCT02130557|364331052|FG000|Overall Study|Lost to Follow-up|6|||
105636094|NCT02130557|364331053|FG001|Overall Study|Lost to Follow-up|7|||
105636095|NCT02130557|364331052|FG000|Overall Study|Other|2|||
105636096|NCT02130557|364331053|FG001|Overall Study|Other|1|||
105636097|NCT02130557|364331052|FG000|Overall Study|Missing|2|||
105636098|NCT02130557|364331053|FG001|Overall Study|Missing|1|||
105636099|NCT03924869|364331054|FG000|Overall Study|Death|66|||
105636100|NCT03924869|364331055|FG001|Overall Study|Death|53|||
105636101|NCT03924869|364331054|FG000|Overall Study|Lost to Follow-up|2|||
105636102|NCT03924869|364331055|FG001|Overall Study|Lost to Follow-up|0|||
105636103|NCT03924869|364331054|FG000|Overall Study|Physician Decision|0|||
105636104|NCT03924869|364331055|FG001|Overall Study|Physician Decision|3|||
105636105|NCT03924869|364331054|FG000|Overall Study|Withdrawal by Subject|5|||
105636106|NCT03924869|364331055|FG001|Overall Study|Withdrawal by Subject|1|||
105636107|NCT03924869|364331054|FG000|Overall Study|Participants Ongoing|154|||
105636108|NCT03924869|364331055|FG001|Overall Study|Participants Ongoing|164|||
105636109|NCT05824559|364331059|FG000|Overall Study|Adverse Event|2|||
105636110|NCT05824559|364331059|FG000|Overall Study|Physician Decision|2|||
105636111|NCT05824559|364331059|FG000|Overall Study|Progressive Disease|16|||
105636112|NCT05824559|364331059|FG000|Overall Study|Study Terminated by Sponsor|1|||
105636113|NCT05824559|364331059|FG000|Overall Study|Withdrawal by Subject|2|||
105636114|NCT02409680|364331060|FG000|Overall Study|Lost to Follow-up|15|||
105636115|NCT02409680|364331061|FG001|Overall Study|Lost to Follow-up|30|||
105636116|NCT03343704|364331062|FG000|Overall Study|Refused to complete follow up|0|||
105636117|NCT03343704|364331063|FG001|Overall Study|Refused to complete follow up|1|||
105636118|NCT03343704|364331062|FG000|Overall Study|Death|0|||
105636119|NCT03343704|364331063|FG001|Overall Study|Death|1|||
105636120|NCT03343704|364331062|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
105636121|NCT03343704|364331063|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
105636122|NCT04535414|364331064|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
105636123|NCT04535414|364331065|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
105636124|NCT04535414|364331064|FG000|Overall Study|Cancelled appointment|1|||
105636125|NCT04535414|364331065|FG001|Overall Study|Cancelled appointment|0|||
105636126|NCT04535414|364331064|FG000|Overall Study|cancelled - food in stomach|2|||
105636127|NCT04535414|364331065|FG001|Overall Study|cancelled - food in stomach|0|||
105636128|NCT04535414|364331064|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
105636129|NCT04535414|364331065|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
105636130|NCT04535414|364331064|FG000|Overall Study|Withdrawal by Subject|0|||
105636131|NCT04535414|364331065|FG001|Overall Study|Withdrawal by Subject|1|||
105636132|NCT03662659|364331066|FG000|Pre-treatment|Participant no longer met study criteria|1|||
105636133|NCT03662659|364331067|FG001|Pre-treatment|Participant no longer met study criteria|1|||
105636134|NCT03662659|364331066|FG000|Pre-treatment|Other reasons|1|||
105636135|NCT03662659|364331067|FG001|Pre-treatment|Other reasons|0|||
105636136|NCT03662659|364331066|FG000|Treatment|Completed Treatment|0|||
105636137|NCT03662659|364331067|FG001|Treatment|Completed Treatment|2|||
105636138|NCT03662659|364331066|FG000|Treatment|Disease Progression|85|||
105636139|NCT03662659|364331067|FG001|Treatment|Disease Progression|97|||
105636140|NCT03662659|364331066|FG000|Treatment|Study Drug Toxicity|19|||
105636141|NCT03662659|364331067|FG001|Treatment|Study Drug Toxicity|9|||
105636142|NCT03662659|364331066|FG000|Treatment|Death|11|||
105636143|NCT03662659|364331067|FG001|Treatment|Death|9|||
105636144|NCT03662659|364331066|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
105636145|NCT03662659|364331067|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
105636146|NCT03662659|364331066|FG000|Treatment|Withdrawal by Subject|1|||
105636147|NCT03662659|364331067|FG001|Treatment|Withdrawal by Subject|1|||
105636148|NCT03662659|364331066|FG000|Treatment|Poor/Non-compliance|1|||
105636149|NCT03662659|364331067|FG001|Treatment|Poor/Non-compliance|0|||
105636150|NCT03662659|364331066|FG000|Treatment|Participant no longer meets study criteria|1|||
105636151|NCT03662659|364331067|FG001|Treatment|Participant no longer meets study criteria|0|||
105636152|NCT03662659|364331066|FG000|Treatment|Other reasons|10|||
105636153|NCT03662659|364331067|FG001|Treatment|Other reasons|8|||
105636154|NCT03662659|364331066|FG000|Treatment|Administrative reasons by sponsor|1|||
105636155|NCT03662659|364331067|FG001|Treatment|Administrative reasons by sponsor|0|||
105636156|NCT03662659|364331066|FG000|Treatment|maximum clinical benefit|0|||
105636157|NCT03662659|364331067|FG001|Treatment|maximum clinical benefit|2|||
105636158|NCT03083366|364332736|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
105636159|NCT03083366|364332737|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
105636160|NCT03083366|364332736|FG000|Enrollment Period|Lack of Efficacy|1|||
105636161|NCT03083366|364332737|FG001|Enrollment Period|Lack of Efficacy|0|||
105636162|NCT05029284|364332742|FG000|Overall Study|Lost to Follow-up|1|||
105636163|NCT02972034|364332743|FG000|Overall Study|Death|11|||
105636164|NCT02972034|364332744|FG001|Overall Study|Death|1|||
105636165|NCT02972034|364332745|FG002|Overall Study|Death|3|||
105636166|NCT02972034|364332746|FG003|Overall Study|Death|3|||
105636167|NCT02972034|364332747|FG004|Overall Study|Death|2|||
105636168|NCT02972034|364332748|FG005|Overall Study|Death|2|||
105636169|NCT02972034|364332749|FG006|Overall Study|Death|3|||
105636170|NCT02972034|364332750|FG007|Overall Study|Death|4|||
105636171|NCT02972034|364332751|FG008|Overall Study|Death|8|||
105636172|NCT02972034|364332752|FG009|Overall Study|Death|11|||
105636173|NCT02972034|364332753|FG010|Overall Study|Death|3|||
105636174|NCT02972034|364332754|FG011|Overall Study|Death|2|||
105636175|NCT02972034|364332755|FG012|Overall Study|Death|11|||
105636176|NCT02972034|364332756|FG013|Overall Study|Death|10|||
105636177|NCT02972034|364332757|FG014|Overall Study|Death|9|||
105636178|NCT02972034|364332743|FG000|Overall Study|Lost to Follow-up|0|||
105636179|NCT02972034|364332744|FG001|Overall Study|Lost to Follow-up|0|||
105636180|NCT02972034|364332745|FG002|Overall Study|Lost to Follow-up|0|||
105636181|NCT02972034|364332746|FG003|Overall Study|Lost to Follow-up|0|||
105636182|NCT02972034|364332747|FG004|Overall Study|Lost to Follow-up|1|||
105636183|NCT02972034|364332748|FG005|Overall Study|Lost to Follow-up|0|||
105636184|NCT02972034|364332749|FG006|Overall Study|Lost to Follow-up|0|||
105636185|NCT02972034|364332750|FG007|Overall Study|Lost to Follow-up|1|||
105636186|NCT02972034|364332751|FG008|Overall Study|Lost to Follow-up|0|||
105636187|NCT02972034|364332752|FG009|Overall Study|Lost to Follow-up|0|||
105636188|NCT02972034|364332753|FG010|Overall Study|Lost to Follow-up|0|||
105636189|NCT02972034|364332754|FG011|Overall Study|Lost to Follow-up|0|||
105636190|NCT02972034|364332755|FG012|Overall Study|Lost to Follow-up|0|||
105636191|NCT02972034|364332756|FG013|Overall Study|Lost to Follow-up|0|||
105636192|NCT02972034|364332757|FG014|Overall Study|Lost to Follow-up|1|||
105636193|NCT02972034|364332743|FG000|Overall Study|Physician Decision|0|||
105636194|NCT02972034|364332744|FG001|Overall Study|Physician Decision|0|||
105636195|NCT02972034|364332745|FG002|Overall Study|Physician Decision|0|||
105636196|NCT02972034|364332746|FG003|Overall Study|Physician Decision|0|||
105636197|NCT02972034|364332747|FG004|Overall Study|Physician Decision|0|||
105636198|NCT02972034|364332748|FG005|Overall Study|Physician Decision|0|||
105636199|NCT02972034|364332749|FG006|Overall Study|Physician Decision|0|||
105636200|NCT02972034|364332750|FG007|Overall Study|Physician Decision|1|||
105636201|NCT02972034|364332751|FG008|Overall Study|Physician Decision|0|||
105636202|NCT02972034|364332752|FG009|Overall Study|Physician Decision|0|||
105636203|NCT02972034|364332753|FG010|Overall Study|Physician Decision|1|||
105636204|NCT02972034|364332754|FG011|Overall Study|Physician Decision|0|||
105636205|NCT02972034|364332755|FG012|Overall Study|Physician Decision|0|||
105636206|NCT02972034|364332756|FG013|Overall Study|Physician Decision|0|||
105636207|NCT02972034|364332757|FG014|Overall Study|Physician Decision|0|||
105636208|NCT02972034|364332743|FG000|Overall Study|Sponsor Decision|0|||
105636209|NCT02972034|364332744|FG001|Overall Study|Sponsor Decision|0|||
105636210|NCT02972034|364332745|FG002|Overall Study|Sponsor Decision|0|||
105636211|NCT02972034|364332746|FG003|Overall Study|Sponsor Decision|1|||
105636212|NCT02972034|364332747|FG004|Overall Study|Sponsor Decision|0|||
105636213|NCT02972034|364332748|FG005|Overall Study|Sponsor Decision|0|||
105636214|NCT02972034|364332749|FG006|Overall Study|Sponsor Decision|1|||
105636215|NCT02972034|364332750|FG007|Overall Study|Sponsor Decision|1|||
105636216|NCT02972034|364332751|FG008|Overall Study|Sponsor Decision|1|||
105636217|NCT02972034|364332752|FG009|Overall Study|Sponsor Decision|2|||
105636218|NCT02972034|364332753|FG010|Overall Study|Sponsor Decision|2|||
105636219|NCT02972034|364332754|FG011|Overall Study|Sponsor Decision|0|||
105636220|NCT02972034|364332755|FG012|Overall Study|Sponsor Decision|1|||
105636221|NCT02972034|364332756|FG013|Overall Study|Sponsor Decision|0|||
105636222|NCT02972034|364332757|FG014|Overall Study|Sponsor Decision|1|||
105636223|NCT02972034|364332743|FG000|Overall Study|Withdrawal by Subject|3|||
105636224|NCT02972034|364332744|FG001|Overall Study|Withdrawal by Subject|0|||
105636225|NCT02972034|364332745|FG002|Overall Study|Withdrawal by Subject|0|||
105636226|NCT02972034|364332746|FG003|Overall Study|Withdrawal by Subject|0|||
105636227|NCT02972034|364332747|FG004|Overall Study|Withdrawal by Subject|1|||
105636228|NCT02972034|364332748|FG005|Overall Study|Withdrawal by Subject|1|||
105636229|NCT02972034|364332749|FG006|Overall Study|Withdrawal by Subject|0|||
105636230|NCT02972034|364332750|FG007|Overall Study|Withdrawal by Subject|0|||
105636231|NCT02972034|364332751|FG008|Overall Study|Withdrawal by Subject|1|||
105636232|NCT02972034|364332752|FG009|Overall Study|Withdrawal by Subject|1|||
105636233|NCT02972034|364332753|FG010|Overall Study|Withdrawal by Subject|2|||
105636234|NCT02972034|364332754|FG011|Overall Study|Withdrawal by Subject|1|||
105636235|NCT02972034|364332755|FG012|Overall Study|Withdrawal by Subject|1|||
105636236|NCT02972034|364332756|FG013|Overall Study|Withdrawal by Subject|1|||
105636237|NCT02972034|364332757|FG014|Overall Study|Withdrawal by Subject|0|||
105636238|NCT02972034|364332743|FG000|Overall Study|Screen Failure|0|||
105636239|NCT02972034|364332744|FG001|Overall Study|Screen Failure|0|||
105636240|NCT02972034|364332745|FG002|Overall Study|Screen Failure|0|||
105636241|NCT02972034|364332746|FG003|Overall Study|Screen Failure|0|||
105636242|NCT02972034|364332747|FG004|Overall Study|Screen Failure|0|||
105636243|NCT02972034|364332748|FG005|Overall Study|Screen Failure|0|||
105636244|NCT02972034|364332749|FG006|Overall Study|Screen Failure|0|||
105636245|NCT02972034|364332750|FG007|Overall Study|Screen Failure|0|||
105636246|NCT02972034|364332751|FG008|Overall Study|Screen Failure|0|||
105636247|NCT02972034|364332752|FG009|Overall Study|Screen Failure|0|||
105636248|NCT02972034|364332753|FG010|Overall Study|Screen Failure|0|||
105636249|NCT02972034|364332754|FG011|Overall Study|Screen Failure|0|||
105636250|NCT02972034|364332755|FG012|Overall Study|Screen Failure|1|||
105636251|NCT02972034|364332756|FG013|Overall Study|Screen Failure|0|||
105636252|NCT02972034|364332757|FG014|Overall Study|Screen Failure|0|||
105636253|NCT03861052|364332758|FG000|Overall Study|Adverse Event|1|||
105636254|NCT03861052|364332759|FG001|Overall Study|Adverse Event|1|||
105636255|NCT03861052|364332760|FG002|Overall Study|Adverse Event|2|||
105636256|NCT03861052|364332761|FG003|Overall Study|Adverse Event|4|||
105636257|NCT03861052|364332758|FG000|Overall Study|Lost to Follow-up|0|||
105636258|NCT03861052|364332759|FG001|Overall Study|Lost to Follow-up|0|||
105636259|NCT03861052|364332760|FG002|Overall Study|Lost to Follow-up|0|||
105636260|NCT03861052|364332761|FG003|Overall Study|Lost to Follow-up|1|||
105636261|NCT03861052|364332758|FG000|Overall Study|Physician Decision|0|||
105636262|NCT03861052|364332759|FG001|Overall Study|Physician Decision|1|||
105636263|NCT03861052|364332760|FG002|Overall Study|Physician Decision|0|||
105636264|NCT03861052|364332761|FG003|Overall Study|Physician Decision|0|||
105636265|NCT03861052|364332758|FG000|Overall Study|Withdrawal by Subject|2|||
105636266|NCT03861052|364332759|FG001|Overall Study|Withdrawal by Subject|5|||
105636267|NCT03861052|364332760|FG002|Overall Study|Withdrawal by Subject|3|||
105636268|NCT03861052|364332761|FG003|Overall Study|Withdrawal by Subject|0|||
105636269|NCT03861052|364332758|FG000|Overall Study|Relocation to other city|1|||
105636270|NCT03861052|364332759|FG001|Overall Study|Relocation to other city|0|||
105636271|NCT03861052|364332760|FG002|Overall Study|Relocation to other city|0|||
105636272|NCT03861052|364332761|FG003|Overall Study|Relocation to other city|0|||
105636273|NCT03678688|364332762|FG000|Overall Study|Reason not Specified|0|||
105636274|NCT03678688|364332763|FG001|Overall Study|Reason not Specified|0|||
105636275|NCT03678688|364332764|FG002|Overall Study|Reason not Specified|3|||
105636276|NCT03678688|364332765|FG003|Overall Study|Reason not Specified|0|||
105636277|NCT03678688|364332766|FG004|Overall Study|Reason not Specified|1|||
105636278|NCT03678688|364332767|FG005|Overall Study|Reason not Specified|0|||
105636279|NCT03678688|364332768|FG006|Overall Study|Reason not Specified|0|||
105636280|NCT03678688|364332769|FG007|Overall Study|Reason not Specified|0|||
105636281|NCT03678688|364332770|FG008|Overall Study|Reason not Specified|0|||
105636282|NCT03678688|364332762|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
105636283|NCT03678688|364332763|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
105636284|NCT03678688|364332764|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
105636285|NCT03678688|364332765|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
105636286|NCT03678688|364332766|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
105636287|NCT03678688|364332767|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
105636288|NCT03678688|364332768|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
105636289|NCT03678688|364332769|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
105636290|NCT03678688|364332770|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
105636291|NCT03678688|364332762|FG000|Overall Study|Covid Related Adverse Event|0|||
105636292|NCT03678688|364332763|FG001|Overall Study|Covid Related Adverse Event|0|||
105636293|NCT03678688|364332764|FG002|Overall Study|Covid Related Adverse Event|0|||
105636294|NCT03678688|364332765|FG003|Overall Study|Covid Related Adverse Event|0|||
105636295|NCT03678688|364332766|FG004|Overall Study|Covid Related Adverse Event|0|||
105636296|NCT03678688|364332767|FG005|Overall Study|Covid Related Adverse Event|3|||
105636297|NCT03678688|364332768|FG006|Overall Study|Covid Related Adverse Event|1|||
105636298|NCT03678688|364332769|FG007|Overall Study|Covid Related Adverse Event|1|||
105636299|NCT03678688|364332770|FG008|Overall Study|Covid Related Adverse Event|0|||
105636300|NCT03678688|364332762|FG000|Overall Study|Physician Decision|0|||
105636301|NCT03678688|364332763|FG001|Overall Study|Physician Decision|0|||
105636302|NCT03678688|364332764|FG002|Overall Study|Physician Decision|0|||
105636303|NCT03678688|364332765|FG003|Overall Study|Physician Decision|0|||
105636304|NCT03678688|364332766|FG004|Overall Study|Physician Decision|0|||
105636305|NCT03678688|364332767|FG005|Overall Study|Physician Decision|1|||
105636306|NCT03678688|364332768|FG006|Overall Study|Physician Decision|0|||
105636307|NCT03678688|364332769|FG007|Overall Study|Physician Decision|0|||
105636308|NCT03678688|364332770|FG008|Overall Study|Physician Decision|0|||
105636309|NCT03678688|364332762|FG000|Overall Study|Withdrawal by Subject|0|||
105636310|NCT03678688|364332763|FG001|Overall Study|Withdrawal by Subject|0|||
105636311|NCT03678688|364332764|FG002|Overall Study|Withdrawal by Subject|0|||
105636312|NCT03678688|364332765|FG003|Overall Study|Withdrawal by Subject|0|||
105636313|NCT03678688|364332766|FG004|Overall Study|Withdrawal by Subject|0|||
105636314|NCT03678688|364332767|FG005|Overall Study|Withdrawal by Subject|0|||
105636315|NCT03678688|364332768|FG006|Overall Study|Withdrawal by Subject|2|||
105636316|NCT03678688|364332769|FG007|Overall Study|Withdrawal by Subject|1|||
105636317|NCT03678688|364332770|FG008|Overall Study|Withdrawal by Subject|0|||
105636318|NCT00551421|364332771|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
105636319|NCT03136159|364332772|FG000|Overall Study|chorioamnionitis|2|||
105636320|NCT03136159|364332773|FG001|Overall Study|chorioamnionitis|0|||
105636321|NCT03136159|364332772|FG000|Overall Study|vertical skin incision|1|||
105636322|NCT03136159|364332773|FG001|Overall Study|vertical skin incision|0|||
105636323|NCT03136159|364332772|FG000|Overall Study|additional dressing|1|||
105636324|NCT03136159|364332773|FG001|Overall Study|additional dressing|0|||
105636325|NCT03136159|364332772|FG000|Overall Study|never got dressing placed|1|||
105636326|NCT03136159|364332773|FG001|Overall Study|never got dressing placed|0|||
105636327|NCT04131556|364332774|FG000|Overall Study|Adverse Event|1|||
105636328|NCT04131556|364332774|FG000|Overall Study|Withdrawal by Subject|1|||
105636329|NCT03137459|364332775|FG000|2-month Assessment|Withdrawal by Subject|13|||
105636330|NCT03137459|364332776|FG001|2-month Assessment|Withdrawal by Subject|3|||
105636331|NCT03137459|364332775|FG000|2-month Assessment|Unable to reach|42|||
105636332|NCT03137459|364332776|FG001|2-month Assessment|Unable to reach|32|||
105636333|NCT03137459|364332775|FG000|2-month Assessment|Refused assessment|7|||
105636334|NCT03137459|364332776|FG001|2-month Assessment|Refused assessment|5|||
105636335|NCT03137459|364332775|FG000|2-month Assessment|Acutely ill|6|||
105636336|NCT03137459|364332776|FG001|2-month Assessment|Acutely ill|2|||
105636337|NCT03137459|364332775|FG000|4-month Assessment|Death|4|||
105636338|NCT03137459|364332776|FG001|4-month Assessment|Death|2|||
105636339|NCT03137459|364332775|FG000|4-month Assessment|Withdrawal by Subject|4|||
105636340|NCT03137459|364332776|FG001|4-month Assessment|Withdrawal by Subject|2|||
105636341|NCT03137459|364332775|FG000|4-month Assessment|Unable to reach|44|||
105636342|NCT03137459|364332776|FG001|4-month Assessment|Unable to reach|29|||
105636343|NCT03137459|364332775|FG000|4-month Assessment|Refused assessment|24|||
105636344|NCT03137459|364332776|FG001|4-month Assessment|Refused assessment|10|||
105636345|NCT03137459|364332775|FG000|4-month Assessment|Acutely ill|2|||
105636346|NCT03137459|364332776|FG001|4-month Assessment|Acutely ill|3|||
105636347|NCT03137459|364332775|FG000|6-months|Lost to Follow-up|14|||
105636348|NCT03137459|364332776|FG001|6-months|Lost to Follow-up|11|||
105636349|NCT03137459|364332775|FG000|6-months|Death|0|||
105636350|NCT03137459|364332776|FG001|6-months|Death|2|||
105636351|NCT03137459|364332775|FG000|6-months|Refused assessment|6|||
105636352|NCT03137459|364332776|FG001|6-months|Refused assessment|3|||
105636353|NCT03137459|364332775|FG000|6-months|Acutely ill|1|||
105636354|NCT03137459|364332776|FG001|6-months|Acutely ill|1|||
105636355|NCT00985088|364332777|FG000|Overall Study|Serious Adverse Event|1|||
105636356|NCT00985088|364332778|FG001|Overall Study|Serious Adverse Event|1|||
105636357|NCT00985088|364332779|FG002|Overall Study|Serious Adverse Event|0|||
105636358|NCT00985088|364332780|FG003|Overall Study|Serious Adverse Event|0|||
105636359|NCT00985088|364332781|FG004|Overall Study|Serious Adverse Event|0|||
105636360|NCT00985088|364332782|FG005|Overall Study|Serious Adverse Event|0|||
105636361|NCT00985088|364332783|FG006|Overall Study|Serious Adverse Event|0|||
105636362|NCT00985088|364332784|FG007|Overall Study|Serious Adverse Event|1|||
105636363|NCT00985088|364332777|FG000|Overall Study|Adverse Event|0|||
105636364|NCT00985088|364332778|FG001|Overall Study|Adverse Event|0|||
105636365|NCT00985088|364332779|FG002|Overall Study|Adverse Event|1|||
105636366|NCT00985088|364332780|FG003|Overall Study|Adverse Event|0|||
105636367|NCT00985088|364332781|FG004|Overall Study|Adverse Event|0|||
105636368|NCT00985088|364332782|FG005|Overall Study|Adverse Event|0|||
105636369|NCT00985088|364332783|FG006|Overall Study|Adverse Event|0|||
105636370|NCT00985088|364332784|FG007|Overall Study|Adverse Event|0|||
105636371|NCT00985088|364332777|FG000|Overall Study|Withdrawal by Subject|4|||
105636372|NCT00985088|364332778|FG001|Overall Study|Withdrawal by Subject|0|||
105636373|NCT00985088|364332779|FG002|Overall Study|Withdrawal by Subject|0|||
105636374|NCT00985088|364332780|FG003|Overall Study|Withdrawal by Subject|1|||
105636375|NCT00985088|364332781|FG004|Overall Study|Withdrawal by Subject|3|||
105636376|NCT00985088|364332782|FG005|Overall Study|Withdrawal by Subject|2|||
105636377|NCT00985088|364332783|FG006|Overall Study|Withdrawal by Subject|1|||
105636378|NCT00985088|364332784|FG007|Overall Study|Withdrawal by Subject|2|||
105636379|NCT00985088|364332777|FG000|Overall Study|Migrated/moved from study area|0|||
105636380|NCT00985088|364332778|FG001|Overall Study|Migrated/moved from study area|0|||
105636381|NCT00985088|364332779|FG002|Overall Study|Migrated/moved from study area|1|||
105636382|NCT00985088|364332780|FG003|Overall Study|Migrated/moved from study area|0|||
105636383|NCT00985088|364332781|FG004|Overall Study|Migrated/moved from study area|0|||
105636384|NCT00985088|364332782|FG005|Overall Study|Migrated/moved from study area|0|||
105636385|NCT00985088|364332783|FG006|Overall Study|Migrated/moved from study area|0|||
105636386|NCT00985088|364332784|FG007|Overall Study|Migrated/moved from study area|1|||
105636387|NCT00985088|364332777|FG000|Overall Study|Lost to Follow-up|6|||
105636388|NCT00985088|364332778|FG001|Overall Study|Lost to Follow-up|1|||
105636389|NCT00985088|364332779|FG002|Overall Study|Lost to Follow-up|2|||
105636390|NCT00985088|364332780|FG003|Overall Study|Lost to Follow-up|6|||
105636391|NCT00985088|364332781|FG004|Overall Study|Lost to Follow-up|6|||
105636392|NCT00985088|364332782|FG005|Overall Study|Lost to Follow-up|5|||
105636393|NCT00985088|364332783|FG006|Overall Study|Lost to Follow-up|3|||
105636394|NCT00985088|364332784|FG007|Overall Study|Lost to Follow-up|2|||
105636395|NCT02232737|364332785|FG000|Overall Study|Lost to Follow-up|18|||
105636396|NCT02232737|364332786|FG001|Overall Study|Lost to Follow-up|28|||
105636397|NCT02232737|364332787|FG002|Overall Study|Lost to Follow-up|33|||
105636398|NCT02232737|364332785|FG000|Overall Study|Personal reasons|7|||
105636399|NCT02232737|364332786|FG001|Overall Study|Personal reasons|8|||
105636400|NCT02232737|364332787|FG002|Overall Study|Personal reasons|14|||
105636401|NCT02232737|364332785|FG000|Overall Study|Adverse Event|6|||
105636402|NCT02232737|364332786|FG001|Overall Study|Adverse Event|3|||
105636403|NCT02232737|364332787|FG002|Overall Study|Adverse Event|8|||
105636404|NCT02232737|364332785|FG000|Overall Study|Incarcerated|2|||
105636405|NCT02232737|364332786|FG001|Overall Study|Incarcerated|1|||
105636406|NCT02232737|364332787|FG002|Overall Study|Incarcerated|2|||
105636407|NCT02232737|364332785|FG000|Overall Study|Withdrawal by Subject|0|||
105636408|NCT02232737|364332786|FG001|Overall Study|Withdrawal by Subject|1|||
105636409|NCT02232737|364332787|FG002|Overall Study|Withdrawal by Subject|2|||
105636410|NCT02232737|364332785|FG000|Overall Study|Death|0|||
105636411|NCT02232737|364332786|FG001|Overall Study|Death|1|||
105636412|NCT02232737|364332787|FG002|Overall Study|Death|1|||
105636413|NCT02232737|364332785|FG000|Overall Study|Physician Decision|1|||
105636414|NCT02232737|364332786|FG001|Overall Study|Physician Decision|3|||
105636415|NCT02232737|364332787|FG002|Overall Study|Physician Decision|1|||
105636416|NCT02232737|364332785|FG000|Overall Study|Protocol Violation|1|||
105636417|NCT02232737|364332786|FG001|Overall Study|Protocol Violation|0|||
105636418|NCT02232737|364332787|FG002|Overall Study|Protocol Violation|1|||
105636419|NCT02232737|364332785|FG000|Overall Study|Reason unknown|1|||
105636420|NCT02232737|364332786|FG001|Overall Study|Reason unknown|0|||
105636421|NCT02232737|364332787|FG002|Overall Study|Reason unknown|0|||
105636422|NCT05171816|364332791|FG000|Overall Study|Death|18|||
105636423|NCT05171816|364332792|FG001|Overall Study|Death|16|||
105636424|NCT00491400|364332793|FG000|Overall Study|Withdrawal by Subject|5|||
105636425|NCT00491400|364332794|FG001|Overall Study|Withdrawal by Subject|4|||
105636426|NCT02132949|364332795|FG000|Overall Study|Death|7|||
105636427|NCT02132949|364332796|FG001|Overall Study|Death|13|||
105636428|NCT02132949|364332795|FG000|Overall Study|Lost to Follow-up|14|||
105636429|NCT02132949|364332796|FG001|Overall Study|Lost to Follow-up|4|||
105636430|NCT02132949|364332795|FG000|Overall Study|Withdrawal by Subject|6|||
105636431|NCT02132949|364332796|FG001|Overall Study|Withdrawal by Subject|5|||
105636432|NCT02132949|364332795|FG000|Overall Study|Noncompliance|5|||
105636433|NCT02132949|364332796|FG001|Overall Study|Noncompliance|1|||
105636434|NCT02132949|364332795|FG000|Overall Study|Physician Decision|3|||
105636435|NCT02132949|364332796|FG001|Overall Study|Physician Decision|1|||
105636436|NCT02132949|364332795|FG000|Overall Study|Disease Progression|3|||
105636437|NCT02132949|364332796|FG001|Overall Study|Disease Progression|0|||
105636438|NCT02132949|364332795|FG000|Overall Study|Adverse Event|2|||
105636439|NCT02132949|364332796|FG001|Overall Study|Adverse Event|1|||
105636440|NCT02132949|364332795|FG000|Overall Study|Withdrew Prior to Treatment|1|||
105636441|NCT02132949|364332796|FG001|Overall Study|Withdrew Prior to Treatment|2|||
105636442|NCT02132949|364332795|FG000|Overall Study|Reason Unspecified|0|||
105636443|NCT02132949|364332796|FG001|Overall Study|Reason Unspecified|1|||
105636444|NCT00599196|364332799|FG000|Overall Study|Lack of Efficacy|22|||
105636445|NCT00599196|364332799|FG000|Overall Study|Adverse Event|93|||
105636446|NCT00599196|364332799|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
105636447|NCT00599196|364332799|FG000|Overall Study|Subject withdrew consent|43|||
105636448|NCT00599196|364332799|FG000|Overall Study|Study ended per sponsor|197|||
105636449|NCT00599196|364332799|FG000|Overall Study|Lost to Follow-up|17|||
105636450|NCT00599196|364332799|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
105636451|NCT00599196|364332799|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
105636452|NCT00599196|364332799|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
105636453|NCT00599196|364332799|FG000|Overall Study|Other: Pt Moved To Australia|1|||
105636454|NCT00599196|364332799|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
105636455|NCT00599196|364332799|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
105636456|NCT00622700|364332819|FG000|Core Treatment Period|Randomized but Not Treated|0|||
105636457|NCT00622700|364332820|FG001|Core Treatment Period|Randomized but Not Treated|2|||
105636458|NCT00622700|364332821|FG002|Core Treatment Period|Randomized but Not Treated|2|||
105636459|NCT00622700|364332822|FG003|Core Treatment Period|Randomized but Not Treated|0|||
105636460|NCT00622700|364332823|FG004|Core Treatment Period|Randomized but Not Treated|0|||
105636461|NCT00622700|364332824|FG005|Core Treatment Period|Randomized but Not Treated|0|||
105636462|NCT00622700|364332825|FG006|Core Treatment Period|Randomized but Not Treated|0|||
105636463|NCT00622700|364332819|FG000|Core Treatment Period|Adverse Event|18|||
105636464|NCT00622700|364332820|FG001|Core Treatment Period|Adverse Event|25|||
105636465|NCT00622700|364332821|FG002|Core Treatment Period|Adverse Event|18|||
105636466|NCT00622700|364332822|FG003|Core Treatment Period|Adverse Event|0|||
105636467|NCT00622700|364332823|FG004|Core Treatment Period|Adverse Event|0|||
105636468|NCT00622700|364332824|FG005|Core Treatment Period|Adverse Event|0|||
105636469|NCT00622700|364332825|FG006|Core Treatment Period|Adverse Event|0|||
105636470|NCT00622700|364332819|FG000|Core Treatment Period|Lack of Efficacy|19|||
105636471|NCT00622700|364332820|FG001|Core Treatment Period|Lack of Efficacy|6|||
105636472|NCT00622700|364332821|FG002|Core Treatment Period|Lack of Efficacy|12|||
105636473|NCT00622700|364332822|FG003|Core Treatment Period|Lack of Efficacy|0|||
105636474|NCT00622700|364332823|FG004|Core Treatment Period|Lack of Efficacy|0|||
105636475|NCT00622700|364332824|FG005|Core Treatment Period|Lack of Efficacy|0|||
105636476|NCT00622700|364332825|FG006|Core Treatment Period|Lack of Efficacy|0|||
105636477|NCT00622700|364332819|FG000|Core Treatment Period|Lost to Follow-up|1|||
105636478|NCT00622700|364332820|FG001|Core Treatment Period|Lost to Follow-up|1|||
105636479|NCT00622700|364332821|FG002|Core Treatment Period|Lost to Follow-up|1|||
105636480|NCT00622700|364332822|FG003|Core Treatment Period|Lost to Follow-up|0|||
105636481|NCT00622700|364332823|FG004|Core Treatment Period|Lost to Follow-up|0|||
105636482|NCT00622700|364332824|FG005|Core Treatment Period|Lost to Follow-up|0|||
105636483|NCT00622700|364332825|FG006|Core Treatment Period|Lost to Follow-up|0|||
105636484|NCT00622700|364332819|FG000|Core Treatment Period|Death|1|||
105636485|NCT00622700|364332820|FG001|Core Treatment Period|Death|0|||
105636486|NCT00622700|364332821|FG002|Core Treatment Period|Death|0|||
105636487|NCT00622700|364332822|FG003|Core Treatment Period|Death|0|||
105636488|NCT00622700|364332823|FG004|Core Treatment Period|Death|0|||
105636489|NCT00622700|364332824|FG005|Core Treatment Period|Death|0|||
105636490|NCT00622700|364332825|FG006|Core Treatment Period|Death|0|||
105636491|NCT00622700|364332819|FG000|Core Treatment Period|Progressive Disease|3|||
105636492|NCT00622700|364332820|FG001|Core Treatment Period|Progressive Disease|1|||
105636493|NCT00622700|364332821|FG002|Core Treatment Period|Progressive Disease|0|||
105636494|NCT00622700|364332822|FG003|Core Treatment Period|Progressive Disease|0|||
105636495|NCT00622700|364332823|FG004|Core Treatment Period|Progressive Disease|0|||
105636496|NCT00622700|364332824|FG005|Core Treatment Period|Progressive Disease|0|||
105636497|NCT00622700|364332825|FG006|Core Treatment Period|Progressive Disease|0|||
105636498|NCT00622700|364332819|FG000|Core Treatment Period|Withdrawal by Subject|12|||
105636499|NCT00622700|364332820|FG001|Core Treatment Period|Withdrawal by Subject|18|||
105636500|NCT00622700|364332821|FG002|Core Treatment Period|Withdrawal by Subject|15|||
105636501|NCT00622700|364332822|FG003|Core Treatment Period|Withdrawal by Subject|0|||
105636502|NCT00622700|364332823|FG004|Core Treatment Period|Withdrawal by Subject|0|||
105636503|NCT00622700|364332824|FG005|Core Treatment Period|Withdrawal by Subject|0|||
105636504|NCT00622700|364332825|FG006|Core Treatment Period|Withdrawal by Subject|0|||
105636505|NCT00622700|364332819|FG000|Core Treatment Period|Other than specified above|2|||
105636506|NCT00622700|364332820|FG001|Core Treatment Period|Other than specified above|2|||
105636507|NCT00622700|364332821|FG002|Core Treatment Period|Other than specified above|5|||
105636508|NCT00622700|364332822|FG003|Core Treatment Period|Other than specified above|0|||
105636509|NCT00622700|364332823|FG004|Core Treatment Period|Other than specified above|0|||
105636510|NCT00622700|364332824|FG005|Core Treatment Period|Other than specified above|0|||
105636511|NCT00622700|364332825|FG006|Core Treatment Period|Other than specified above|0|||
105636512|NCT00622700|364332819|FG000|Extension Treatment Period|Adverse Event|0|||
105636513|NCT00622700|364332820|FG001|Extension Treatment Period|Adverse Event|0|||
105636514|NCT00622700|364332821|FG002|Extension Treatment Period|Adverse Event|0|||
105636515|NCT00622700|364332822|FG003|Extension Treatment Period|Adverse Event|5|||
105636516|NCT00622700|364332823|FG004|Extension Treatment Period|Adverse Event|9|||
105636517|NCT00622700|364332824|FG005|Extension Treatment Period|Adverse Event|6|||
105636518|NCT00622700|364332825|FG006|Extension Treatment Period|Adverse Event|8|||
105636519|NCT00622700|364332819|FG000|Extension Treatment Period|Lack of Efficacy|0|||
105636520|NCT00622700|364332820|FG001|Extension Treatment Period|Lack of Efficacy|0|||
105636521|NCT00622700|364332821|FG002|Extension Treatment Period|Lack of Efficacy|0|||
105636522|NCT00622700|364332822|FG003|Extension Treatment Period|Lack of Efficacy|2|||
105636523|NCT00622700|364332823|FG004|Extension Treatment Period|Lack of Efficacy|8|||
105636524|NCT00622700|364332824|FG005|Extension Treatment Period|Lack of Efficacy|1|||
105636525|NCT00622700|364332825|FG006|Extension Treatment Period|Lack of Efficacy|9|||
105636526|NCT00622700|364332819|FG000|Extension Treatment Period|Protocol Violation|0|||
105636527|NCT00622700|364332820|FG001|Extension Treatment Period|Protocol Violation|0|||
105636528|NCT00622700|364332821|FG002|Extension Treatment Period|Protocol Violation|0|||
105636529|NCT00622700|364332822|FG003|Extension Treatment Period|Protocol Violation|0|||
105636530|NCT00622700|364332823|FG004|Extension Treatment Period|Protocol Violation|0|||
105636531|NCT00622700|364332824|FG005|Extension Treatment Period|Protocol Violation|2|||
105636532|NCT00622700|364332825|FG006|Extension Treatment Period|Protocol Violation|0|||
105636533|NCT00622700|364332819|FG000|Extension Treatment Period|Lost to Follow-up|0|||
105636534|NCT00622700|364332820|FG001|Extension Treatment Period|Lost to Follow-up|0|||
105636535|NCT00622700|364332821|FG002|Extension Treatment Period|Lost to Follow-up|0|||
105636536|NCT00622700|364332822|FG003|Extension Treatment Period|Lost to Follow-up|0|||
105636537|NCT00622700|364332823|FG004|Extension Treatment Period|Lost to Follow-up|1|||
105636538|NCT00622700|364332824|FG005|Extension Treatment Period|Lost to Follow-up|0|||
105636539|NCT00622700|364332825|FG006|Extension Treatment Period|Lost to Follow-up|0|||
105636540|NCT00622700|364332819|FG000|Extension Treatment Period|Progressive Disease|0|||
105636541|NCT00622700|364332820|FG001|Extension Treatment Period|Progressive Disease|0|||
105636542|NCT00622700|364332821|FG002|Extension Treatment Period|Progressive Disease|0|||
105636543|NCT00622700|364332822|FG003|Extension Treatment Period|Progressive Disease|1|||
105636544|NCT00622700|364332823|FG004|Extension Treatment Period|Progressive Disease|2|||
105636545|NCT00622700|364332824|FG005|Extension Treatment Period|Progressive Disease|0|||
105636546|NCT00622700|364332825|FG006|Extension Treatment Period|Progressive Disease|2|||
105636547|NCT00622700|364332819|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
105636548|NCT00622700|364332820|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
105636549|NCT00622700|364332821|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
105636550|NCT00622700|364332822|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
105636551|NCT00622700|364332823|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
105636552|NCT00622700|364332824|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
105636553|NCT00622700|364332825|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
105636554|NCT00622700|364332819|FG000|Extension Treatment Period|Missing|0|||
105636555|NCT00622700|364332820|FG001|Extension Treatment Period|Missing|0|||
105636556|NCT00622700|364332821|FG002|Extension Treatment Period|Missing|0|||
105636557|NCT00622700|364332822|FG003|Extension Treatment Period|Missing|2|||
105636558|NCT00622700|364332823|FG004|Extension Treatment Period|Missing|3|||
105636559|NCT00622700|364332824|FG005|Extension Treatment Period|Missing|1|||
105636560|NCT00622700|364332825|FG006|Extension Treatment Period|Missing|0|||
105636561|NCT00622700|364332819|FG000|Extension Treatment Period|Other than specified above|0|||
105636562|NCT00622700|364332820|FG001|Extension Treatment Period|Other than specified above|0|||
105636563|NCT00622700|364332821|FG002|Extension Treatment Period|Other than specified above|0|||
105636564|NCT00622700|364332822|FG003|Extension Treatment Period|Other than specified above|0|||
105636565|NCT00622700|364332823|FG004|Extension Treatment Period|Other than specified above|0|||
105636566|NCT00622700|364332824|FG005|Extension Treatment Period|Other than specified above|1|||
105636567|NCT00622700|364332825|FG006|Extension Treatment Period|Other than specified above|1|||
105636568|NCT00942266|364332826|FG000|Overall Study|Withdrawal by Subject|1|||
105636569|NCT00942266|364332827|FG001|Overall Study|Withdrawal by Subject|0|||
105636570|NCT00942266|364332826|FG000|Overall Study|Adverse Event|2|||
105636571|NCT00942266|364332827|FG001|Overall Study|Adverse Event|1|||
105636572|NCT00942266|364332826|FG000|Overall Study|Disease Progression|38|||
105636573|NCT00942266|364332827|FG001|Overall Study|Disease Progression|11|||
105636574|NCT00942266|364332826|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
105636575|NCT00942266|364332827|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
105636576|NCT00942266|364332826|FG000|Overall Study|Intercurrent illness|0|||
105636577|NCT00942266|364332827|FG001|Overall Study|Intercurrent illness|1|||
105636578|NCT00942266|364332826|FG000|Overall Study|Physician Decision|2|||
105636579|NCT00942266|364332827|FG001|Overall Study|Physician Decision|0|||
105636580|NCT00942266|364332826|FG000|Overall Study|medical deterioration (pneumonia)|0|||
105636581|NCT00942266|364332827|FG001|Overall Study|medical deterioration (pneumonia)|1|||
105636582|NCT02630966|364332832|FG000|Overall Study|Adverse Event|1|||
105636583|NCT02630966|364332833|FG001|Overall Study|Adverse Event|3|||
105636584|NCT02630966|364332832|FG000|Overall Study|Significant Protocol Deviation|0|||
105636585|NCT02630966|364332833|FG001|Overall Study|Significant Protocol Deviation|2|||
105636586|NCT02630966|364332832|FG000|Overall Study|Voluntary Withdrawal|1|||
105636587|NCT02630966|364332833|FG001|Overall Study|Voluntary Withdrawal|1|||
105636588|NCT02630966|364332832|FG000|Overall Study|Lack of Efficacy|0|||
105636589|NCT02630966|364332833|FG001|Overall Study|Lack of Efficacy|2|||
105636590|NCT00600353|364332834|FG000|Overall Study|history of malignancy within 5 years|1|||
105636591|NCT00600353|364332835|FG001|Overall Study|history of malignancy within 5 years|0|||
105636592|NCT00600353|364332834|FG000|Overall Study|History of prepartive regimen|0|||
105636593|NCT00600353|364332835|FG001|Overall Study|History of prepartive regimen|1|||
105636594|NCT04035447|364332836|FG000|Treatment Period|Lost to Follow-up|6|||
105636595|NCT04035447|364332837|FG001|Treatment Period|Lost to Follow-up|5|||
105636596|NCT04035447|364332836|FG000|Treatment Period|Physician Decision|0|||
105636597|NCT04035447|364332837|FG001|Treatment Period|Physician Decision|2|||
105636598|NCT05966155|364332838|FG000|Overall Study|Death|1|||
105636599|NCT05966155|364332839|FG001|Overall Study|Death|2|||
105636600|NCT05966155|364332838|FG000|Overall Study|Lost to Follow-up|63|||
105636601|NCT05966155|364332839|FG001|Overall Study|Lost to Follow-up|67|||
105636602|NCT05966155|364332838|FG000|Overall Study|Protocol Violation|1|||
105636603|NCT05966155|364332839|FG001|Overall Study|Protocol Violation|0|||
105636604|NCT05966155|364332838|FG000|Overall Study|Withdrawal by Subject|8|||
105636605|NCT05966155|364332839|FG001|Overall Study|Withdrawal by Subject|9|||
105636606|NCT05966155|364332838|FG000|Overall Study|Enrolled Erroneously|0|||
105636607|NCT05966155|364332839|FG001|Overall Study|Enrolled Erroneously|1|||
105636608|NCT05966155|364332838|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
105636609|NCT05966155|364332839|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
105636610|NCT01638000|364332842|FG000|Overall Study|Randomized but Never Received Drug|7|||
105636611|NCT01638000|364332843|FG001|Overall Study|Randomized but Never Received Drug|10|||
105636612|NCT01638000|364332842|FG000|Overall Study|Adverse Event|14|||
105636613|NCT01638000|364332843|FG001|Overall Study|Adverse Event|16|||
105636614|NCT01638000|364332842|FG000|Overall Study|Lack of Efficacy|5|||
105636615|NCT01638000|364332843|FG001|Overall Study|Lack of Efficacy|6|||
105636616|NCT01638000|364332842|FG000|Overall Study|Protocol Violation|11|||
105636617|NCT01638000|364332843|FG001|Overall Study|Protocol Violation|13|||
105636618|NCT01638000|364332842|FG000|Overall Study|Withdrawal by Subject|21|||
105636619|NCT01638000|364332843|FG001|Overall Study|Withdrawal by Subject|24|||
105636620|NCT01638000|364332842|FG000|Overall Study|Miscellaneous|2|||
105636621|NCT01638000|364332843|FG001|Overall Study|Miscellaneous|2|||
105636622|NCT04541589|364332844|FG000|Treatment Period|Adverse Event|8|||
105636623|NCT04541589|364332845|FG001|Treatment Period|Adverse Event|2|||
105636624|NCT04541589|364332844|FG000|Treatment Period|Physician Decision|3|||
105636625|NCT04541589|364332845|FG001|Treatment Period|Physician Decision|1|||
105636626|NCT04541589|364332844|FG000|Treatment Period|Subject decision|7|||
105636627|NCT04541589|364332845|FG001|Treatment Period|Subject decision|4|||
105636628|NCT04541589|364332844|FG000|Treatment Period|Withdrawal by Subject|1|||
105636629|NCT04541589|364332845|FG001|Treatment Period|Withdrawal by Subject|0|||
105636630|NCT04541589|364332844|FG000|Safety Follow-up Period|Adverse Event|2|||
105636631|NCT04541589|364332845|FG001|Safety Follow-up Period|Adverse Event|1|||
105636632|NCT04541589|364332844|FG000|Safety Follow-up Period|Physician Decision|1|||
105636633|NCT04541589|364332845|FG001|Safety Follow-up Period|Physician Decision|0|||
105636634|NCT04541589|364332844|FG000|Safety Follow-up Period|Subject decision|5|||
105636635|NCT04541589|364332845|FG001|Safety Follow-up Period|Subject decision|3|||
105636636|NCT04541589|364332844|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
105636637|NCT04541589|364332845|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
105636638|NCT03890289|364332846|FG000|Overall Study|Adverse Event|1|||
105636639|NCT03890289|364332846|FG000|Overall Study|Physician Decision|1|||
105636640|NCT03890289|364332846|FG000|Overall Study|Lack of Efficacy|2|||
105636641|NCT03362190|364332847|FG000|Overall Study|Adverse Event|0|||
105636642|NCT03362190|364332848|FG001|Overall Study|Adverse Event|0|||
105636643|NCT03362190|364332849|FG002|Overall Study|Adverse Event|0|||
105636644|NCT03362190|364332850|FG003|Overall Study|Adverse Event|1|||
105636645|NCT03362190|364332847|FG000|Overall Study|Withdrawal by Subject|0|||
105636646|NCT03362190|364332848|FG001|Overall Study|Withdrawal by Subject|0|||
105636647|NCT03362190|364332849|FG002|Overall Study|Withdrawal by Subject|0|||
105636648|NCT03362190|364332850|FG003|Overall Study|Withdrawal by Subject|1|||
105636649|NCT03775486|364332851|FG000|Initial Therapy Phase|Other reason provided|0|||
105636650|NCT03775486|364332852|FG001|Initial Therapy Phase|Other reason provided|15|||
105636651|NCT03775486|364332851|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
105636652|NCT03775486|364332852|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
105636653|NCT03775486|364332851|FG000|Initial Therapy Phase|Protocol Violation|0|||
105636654|NCT03775486|364332852|FG001|Initial Therapy Phase|Protocol Violation|2|||
105636655|NCT03775486|364332851|FG000|Initial Therapy Phase|Adverse Event|0|||
105636656|NCT03775486|364332852|FG001|Initial Therapy Phase|Adverse Event|34|||
105636657|NCT03775486|364332851|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
105636658|NCT03775486|364332852|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
105636659|NCT03775486|364332851|FG000|Maintenance Phase|Withdrawal by Subject|13|||
105636660|NCT03775486|364332852|FG001|Maintenance Phase|Withdrawal by Subject|12|||
105636661|NCT03775486|364332851|FG000|Maintenance Phase|Death|44|||
105636662|NCT03775486|364332852|FG001|Maintenance Phase|Death|45|||
105636663|NCT00989196|364332853|FG000|Treatment Period|Lost to Follow-up|1|||
105636664|NCT00989196|364332854|FG001|Treatment Period|Lost to Follow-up|0|||
105636665|NCT01000805|364332855|FG000|Overall Study|Adverse Event|21|||
105636666|NCT01000805|364332856|FG001|Overall Study|Adverse Event|9|||
105636667|NCT01000805|364332855|FG000|Overall Study|Lack of Efficacy|5|||
105636668|NCT01000805|364332856|FG001|Overall Study|Lack of Efficacy|16|||
105636669|NCT01000805|364332855|FG000|Overall Study|Lost to Follow-up|16|||
105636670|NCT01000805|364332856|FG001|Overall Study|Lost to Follow-up|21|||
105636671|NCT01000805|364332855|FG000|Overall Study|Physician Decision|0|||
105636672|NCT01000805|364332856|FG001|Overall Study|Physician Decision|1|||
105636673|NCT01000805|364332855|FG000|Overall Study|Protocol Violation|12|||
105636674|NCT01000805|364332856|FG001|Overall Study|Protocol Violation|8|||
105636675|NCT01000805|364332855|FG000|Overall Study|Withdrawal by Subject|16|||
105636676|NCT01000805|364332856|FG001|Overall Study|Withdrawal by Subject|6|||
105636677|NCT01000805|364332855|FG000|Overall Study|Sponsor Decision|0|||
105636678|NCT01000805|364332856|FG001|Overall Study|Sponsor Decision|1|||
105636679|NCT02542943|364332860|FG000|Overall Study|Lost to Follow-up|1|||
105636680|NCT02542943|364332861|FG001|Overall Study|Lost to Follow-up|0|||
105636681|NCT02542943|364332862|FG002|Overall Study|Lost to Follow-up|0|||
105636682|NCT02542943|364332860|FG000|Overall Study|Withdrawal by Subject|0|||
105636683|NCT02542943|364332861|FG001|Overall Study|Withdrawal by Subject|1|||
105636684|NCT02542943|364332862|FG002|Overall Study|Withdrawal by Subject|0|||
105636685|NCT03598907|364332865|FG000|Overall Study|Physician Decision|14|||
105636686|NCT03598907|364332866|FG001|Overall Study|Physician Decision|19|||
105636687|NCT02485925|364332869|FG000|Overall Study|Withdrawal by Subject|3|||
105636688|NCT02485925|364332869|FG000|Overall Study|Death|1|||
105636689|NCT02485925|364332869|FG000|Overall Study|Lost to Follow-up|11|||
105636690|NCT04001829|364334224|FG000|Overall Study|Never start protocol therapy|5|||
105636691|NCT04001829|364334225|FG001|Overall Study|Never start protocol therapy|5|||
105636692|NCT04001829|364334224|FG000|Overall Study|Adverse Event|11|||
105636693|NCT04001829|364334225|FG001|Overall Study|Adverse Event|7|||
105636694|NCT04001829|364334224|FG000|Overall Study|Alternative therapy|1|||
105636695|NCT04001829|364334225|FG001|Overall Study|Alternative therapy|2|||
105636696|NCT04001829|364334224|FG000|Overall Study|Disease progression/relapse|2|||
105636697|NCT04001829|364334225|FG001|Overall Study|Disease progression/relapse|1|||
105636698|NCT04001829|364334224|FG000|Overall Study|Other complicating disease|1|||
105636699|NCT04001829|364334225|FG001|Overall Study|Other complicating disease|0|||
105636700|NCT04001829|364334224|FG000|Overall Study|Withdrawal by Subject|1|||
105636701|NCT04001829|364334225|FG001|Overall Study|Withdrawal by Subject|4|||
105636702|NCT04001829|364334224|FG000|Overall Study|Ineligible|2|||
105636703|NCT04001829|364334225|FG001|Overall Study|Ineligible|2|||
105636704|NCT04001829|364334224|FG000|Overall Study|Reason missing due to delinquent data|1|||
105636705|NCT04001829|364334225|FG001|Overall Study|Reason missing due to delinquent data|0|||
105636706|NCT01278030|364334226|FG000|Overall Study|Withdrawal by Subject|8|||
105636707|NCT01278030|364334227|FG001|Overall Study|Withdrawal by Subject|4|||
105636708|NCT01737398|364334228|FG000|Overall Study|Adverse event or SAE|16|||
105636709|NCT01737398|364334229|FG001|Overall Study|Adverse event or SAE|1|||
105636710|NCT01737398|364334228|FG000|Overall Study|Stopping rule met|2|||
105636711|NCT01737398|364334229|FG001|Overall Study|Stopping rule met|1|||
105636712|NCT01737398|364334228|FG000|Overall Study|Voluntary withdrawal|2|||
105636713|NCT01737398|364334229|FG001|Overall Study|Voluntary withdrawal|3|||
105636714|NCT01737398|364334228|FG000|Overall Study|Ineligibility|1|||
105636715|NCT01737398|364334229|FG001|Overall Study|Ineligibility|0|||
105636716|NCT01737398|364334228|FG000|Overall Study|Liver transplant|1|||
105636717|NCT01737398|364334229|FG001|Overall Study|Liver transplant|0|||
105636718|NCT01737398|364334228|FG000|Overall Study|Disease progression|2|||
105636719|NCT01737398|364334229|FG001|Overall Study|Disease progression|3|||
105636720|NCT01737398|364334228|FG000|Overall Study|Sponsor's decision|2|||
105636721|NCT01737398|364334229|FG001|Overall Study|Sponsor's decision|0|||
105636722|NCT03437733|364334230|FG000|Overall Study|Eligibility criteria not met|0|||
105636723|NCT03437733|364334231|FG001|Overall Study|Eligibility criteria not met|3|||
105636724|NCT04921358|364334232|FG000|Overall Study|Withdrawal by Subject|6|||
105636725|NCT04921358|364334233|FG001|Overall Study|Withdrawal by Subject|13|||
105636726|NCT04921358|364334232|FG000|Overall Study|Lost to Follow-up|3|||
105636727|NCT04921358|364334233|FG001|Overall Study|Lost to Follow-up|6|||
105636728|NCT04921358|364334232|FG000|Overall Study|Study Terminated by Sponsor|86|||
105636729|NCT04921358|364334233|FG001|Overall Study|Study Terminated by Sponsor|89|||
105636730|NCT04921358|364334232|FG000|Overall Study|Death|92|||
105636731|NCT04921358|364334233|FG001|Overall Study|Death|82|||
105636732|NCT02698475|364334234|FG000|Main Study Period|Lack of Efficacy|1|||
105636733|NCT02698475|364334234|FG000|Main Study Period|Protocol Violation|2|||
105636734|NCT02698475|364334234|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
105636735|NCT02698475|364334234|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
105636736|NCT02698475|364334234|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
105636737|NCT02698475|364334234|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
105636738|NCT02698475|364334234|FG000|Long-Term Extension Period|Other|1|||
105636739|NCT01555138|364334235|FG000|Overall Study|Death|0|||
105636740|NCT01555138|364334236|FG001|Overall Study|Death|1|||
105636741|NCT01555138|364334235|FG000|Overall Study|Lost to Follow-up|1|||
105636742|NCT01555138|364334236|FG001|Overall Study|Lost to Follow-up|0|||
105636743|NCT01555138|364334235|FG000|Overall Study|Abnormal Lab reults|1|||
105636744|NCT01555138|364334236|FG001|Overall Study|Abnormal Lab reults|3|||
105636745|NCT01555138|364334235|FG000|Overall Study|Lack of Efficacy|2|||
105636746|NCT01555138|364334236|FG001|Overall Study|Lack of Efficacy|2|||
105636747|NCT01555138|364334235|FG000|Overall Study|Protocol Violation|5|||
105636748|NCT01555138|364334236|FG001|Overall Study|Protocol Violation|3|||
105636749|NCT01555138|364334235|FG000|Overall Study|Administrative problems|8|||
105636750|NCT01555138|364334236|FG001|Overall Study|Administrative problems|0|||
105636751|NCT01555138|364334235|FG000|Overall Study|Withdrawal by Subject|16|||
105636752|NCT01555138|364334236|FG001|Overall Study|Withdrawal by Subject|15|||
105636753|NCT01555138|364334235|FG000|Overall Study|Adverse Event|14|||
105636754|NCT01555138|364334236|FG001|Overall Study|Adverse Event|14|||
105636755|NCT02357966|364334240|FG000|Overall Study|Death|0|||
105636756|NCT02357966|364334241|FG001|Overall Study|Death|0|||
105636757|NCT02357966|364334242|FG002|Overall Study|Death|1|||
105636758|NCT02357966|364334243|FG003|Overall Study|Death|0|||
105636759|NCT02357966|364334244|FG004|Overall Study|Death|2|||
105636760|NCT02357966|364334245|FG005|Overall Study|Death|0|||
105636761|NCT02357966|364334240|FG000|Overall Study|Physician Decision|1|||
105636762|NCT02357966|364334241|FG001|Overall Study|Physician Decision|0|||
105636763|NCT02357966|364334242|FG002|Overall Study|Physician Decision|0|||
105636764|NCT02357966|364334243|FG003|Overall Study|Physician Decision|0|||
105636765|NCT02357966|364334244|FG004|Overall Study|Physician Decision|1|||
105636766|NCT02357966|364334245|FG005|Overall Study|Physician Decision|0|||
105636767|NCT00705406|364334246|FG000|Overall Study|Lost to Follow-up|3|||
105636768|NCT00705406|364334247|FG001|Overall Study|Lost to Follow-up|3|||
105636769|NCT00705406|364334246|FG000|Overall Study|Did not receive study drug|1|||
105636770|NCT00705406|364334247|FG001|Overall Study|Did not receive study drug|2|||
105636771|NCT01079806|364334248|FG000|Day 1 to Week 96|Adverse Event|0|||
105636772|NCT01079806|364334249|FG001|Day 1 to Week 96|Adverse Event|3|||
105636773|NCT01079806|364334248|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
105636774|NCT01079806|364334249|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
105636775|NCT01079806|364334248|FG000|Day 1 to Week 96|Pregnancy|0|||
105636776|NCT01079806|364334249|FG001|Day 1 to Week 96|Pregnancy|1|||
105636777|NCT01079806|364334248|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
105636778|NCT01079806|364334249|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
105636779|NCT01079806|364334248|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
105636780|NCT01079806|364334249|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
105636781|NCT01079806|364334248|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
105636782|NCT01079806|364334249|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
105636783|NCT01079806|364334248|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
105636784|NCT01079806|364334249|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
105636785|NCT01079806|364334248|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
105636786|NCT01079806|364334249|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
105636787|NCT01079806|364334248|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
105636788|NCT01079806|364334249|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
105636789|NCT01079806|364334248|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
105636790|NCT01079806|364334249|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
105636791|NCT00019604|364334250|FG000|Overall Study|Death|1|||
105636792|NCT00019604|364334250|FG000|Overall Study|Progressive disease|23|||
105636793|NCT00019604|364334250|FG000|Overall Study|Refused treatment|1|||
105636794|NCT00019604|364334250|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
105636795|NCT00019604|364334250|FG000|Overall Study|Going to have liver transplant|1|||
105636796|NCT00019604|364334250|FG000|Overall Study|Move to a different study|1|||
105636797|NCT00019604|364334250|FG000|Overall Study|Non compliant on systemic CH|1|||
105636798|NCT00019604|364334250|FG000|Overall Study|Non compliant|1|||
105636799|NCT00019604|364334250|FG000|Overall Study|Resectable disease|1|||
105636800|NCT00019604|364334250|FG000|Overall Study|Started new chemo regimen|1|||
105636801|NCT00019604|364334250|FG000|Overall Study|Pt going to immunotherapy study|1|||
105636802|NCT00019604|364334250|FG000|Overall Study|Too much disease|1|||
105636803|NCT00019604|364334250|FG000|Overall Study|Unable to evaluate|1|||
105636804|NCT00019604|364334250|FG000|Overall Study|Details for other not available|4|||
105636805|NCT03205566|364334258|FG000|Phase 1|Protocol Violation|1|||
105636806|NCT03205566|364334259|FG001|Phase 1|Protocol Violation|1|||
105636807|NCT03739866|364334260|FG000|Overall Study|Lost to Follow-up|0|||
105636808|NCT03739866|364334261|FG001|Overall Study|Lost to Follow-up|0|||
105636809|NCT03739866|364334262|FG002|Overall Study|Lost to Follow-up|0|||
105636810|NCT03739866|364334263|FG003|Overall Study|Lost to Follow-up|1|||
105636811|NCT03739866|364334264|FG004|Overall Study|Lost to Follow-up|0|||
105636812|NCT03739866|364334265|FG005|Overall Study|Lost to Follow-up|0|||
105636813|NCT03739866|364334266|FG006|Overall Study|Lost to Follow-up|0|||
105636814|NCT03739866|364334267|FG007|Overall Study|Lost to Follow-up|0|||
105636815|NCT03739866|364334260|FG000|Overall Study|Enrolled but not treated|0|||
105636816|NCT03739866|364334261|FG001|Overall Study|Enrolled but not treated|0|||
105636817|NCT03739866|364334262|FG002|Overall Study|Enrolled but not treated|1|||
105636818|NCT03739866|364334263|FG003|Overall Study|Enrolled but not treated|0|||
105636819|NCT03739866|364334264|FG004|Overall Study|Enrolled but not treated|1|||
105636820|NCT03739866|364334265|FG005|Overall Study|Enrolled but not treated|0|||
105636821|NCT03739866|364334266|FG006|Overall Study|Enrolled but not treated|0|||
105636822|NCT03739866|364334267|FG007|Overall Study|Enrolled but not treated|0|||
105636823|NCT00853580|364334268|FG000|Overall Study|Lost to Follow-up|3|||
105636824|NCT00853580|364334269|FG001|Overall Study|Lost to Follow-up|5|||
105636825|NCT00853580|364334268|FG000|Overall Study|Protocol Violation|2|||
105636826|NCT00853580|364334269|FG001|Overall Study|Protocol Violation|1|||
105636827|NCT00853580|364334268|FG000|Overall Study|Withdrawal by Subject|2|||
105636828|NCT00853580|364334269|FG001|Overall Study|Withdrawal by Subject|8|||
105636829|NCT00853580|364334268|FG000|Overall Study|Commenced contraindicated therapy|0|||
105636830|NCT00853580|364334269|FG001|Overall Study|Commenced contraindicated therapy|2|||
105636831|NCT01034306|364334270|FG000|Overall Study|Adverse Event|1|||
105636832|NCT01034306|364334271|FG001|Overall Study|Adverse Event|0|||
105636833|NCT01034306|364334270|FG000|Overall Study|Lost to Follow-up|0|||
105636834|NCT01034306|364334271|FG001|Overall Study|Lost to Follow-up|1|||
105636835|NCT01034306|364334270|FG000|Overall Study|Withdrawal by Subject|2|||
105636836|NCT01034306|364334271|FG001|Overall Study|Withdrawal by Subject|2|||
105636837|NCT01034306|364334270|FG000|Overall Study|hospitalized and decided to stop|1|||
105636838|NCT01034306|364334271|FG001|Overall Study|hospitalized and decided to stop|0|||
105636839|NCT01034306|364334270|FG000|Overall Study|Noncomplience|1|||
105636840|NCT01034306|364334271|FG001|Overall Study|Noncomplience|0|||
105636841|NCT02040870|364334276|FG000|Overall Study|Completed treatment phase|6|||
105636842|NCT02040870|364334276|FG000|Overall Study|Adverse Event|7|||
105636843|NCT02040870|364334276|FG000|Overall Study|Progressive disease|58|||
105636844|NCT02040870|364334276|FG000|Overall Study|Physician Decision|6|||
105636845|NCT02040870|364334276|FG000|Overall Study|Subject/guardian decision|10|||
105636846|NCT02040870|364334276|FG000|Overall Study|Lost to Follow-up|3|||
105636847|NCT02040870|364334276|FG000|Overall Study|Death|13|||
105636848|NCT01957163|364334286|FG000|Overall Study|Adverse Event|5|||
105636849|NCT01957163|364334287|FG001|Overall Study|Adverse Event|2|||
105636850|NCT01957163|364334288|FG002|Overall Study|Adverse Event|4|||
105636851|NCT01957163|364334286|FG000|Overall Study|Lack of Efficacy|5|||
105636852|NCT01957163|364334287|FG001|Overall Study|Lack of Efficacy|4|||
105636853|NCT01957163|364334288|FG002|Overall Study|Lack of Efficacy|9|||
105636854|NCT01957163|364334286|FG000|Overall Study|Protocol Violation|1|||
105636855|NCT01957163|364334287|FG001|Overall Study|Protocol Violation|2|||
105636856|NCT01957163|364334288|FG002|Overall Study|Protocol Violation|0|||
105636857|NCT01957163|364334286|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
105636858|NCT01957163|364334287|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
105636859|NCT01957163|364334288|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
105636860|NCT01957163|364334286|FG000|Overall Study|Lost to Follow-up|0|||
105636861|NCT01957163|364334287|FG001|Overall Study|Lost to Follow-up|1|||
105636862|NCT01957163|364334288|FG002|Overall Study|Lost to Follow-up|0|||
105636863|NCT01957163|364334286|FG000|Overall Study|Withdrawal by Subject|4|||
105636864|NCT01957163|364334287|FG001|Overall Study|Withdrawal by Subject|2|||
105636865|NCT01957163|364334288|FG002|Overall Study|Withdrawal by Subject|4|||
105636866|NCT03582475|364334291|FG000|Treatment Period|Withdrawal by Subject|0|||
105636867|NCT03582475|364334292|FG001|Treatment Period|Withdrawal by Subject|1|||
105636868|NCT03582475|364334291|FG000|Follow-up Period|Withdrawal by Subject|0|||
105636869|NCT03582475|364334292|FG001|Follow-up Period|Withdrawal by Subject|1|||
105636870|NCT02686658|364334293|FG000|Overall Study|Adverse Event|0|||
105636871|NCT02686658|364334294|FG001|Overall Study|Adverse Event|0|||
105636872|NCT02686658|364334295|FG002|Overall Study|Adverse Event|1|||
105636873|NCT02686658|364334296|FG003|Overall Study|Adverse Event|1|||
105636874|NCT02686658|364334297|FG004|Overall Study|Adverse Event|2|||
105636875|NCT02686658|364334298|FG005|Overall Study|Adverse Event|1|||
105636876|NCT02686658|364334293|FG000|Overall Study|Investigator decision|0|||
105636877|NCT02686658|364334294|FG001|Overall Study|Investigator decision|0|||
105636878|NCT02686658|364334295|FG002|Overall Study|Investigator decision|0|||
105636879|NCT02686658|364334296|FG003|Overall Study|Investigator decision|1|||
105636880|NCT02686658|364334297|FG004|Overall Study|Investigator decision|2|||
105636881|NCT02686658|364334298|FG005|Overall Study|Investigator decision|1|||
105636882|NCT02686658|364334293|FG000|Overall Study|Sponsor decision|1|||
105636883|NCT02686658|364334294|FG001|Overall Study|Sponsor decision|2|||
105636884|NCT02686658|364334295|FG002|Overall Study|Sponsor decision|1|||
105636885|NCT02686658|364334296|FG003|Overall Study|Sponsor decision|5|||
105636886|NCT02686658|364334297|FG004|Overall Study|Sponsor decision|13|||
105636887|NCT02686658|364334298|FG005|Overall Study|Sponsor decision|2|||
105636888|NCT02686658|364334293|FG000|Overall Study|Lost to Follow-up|0|||
105636889|NCT02686658|364334294|FG001|Overall Study|Lost to Follow-up|0|||
105636890|NCT02686658|364334295|FG002|Overall Study|Lost to Follow-up|2|||
105636891|NCT02686658|364334296|FG003|Overall Study|Lost to Follow-up|0|||
105636892|NCT02686658|364334297|FG004|Overall Study|Lost to Follow-up|0|||
105636893|NCT02686658|364334298|FG005|Overall Study|Lost to Follow-up|1|||
105636894|NCT02686658|364334293|FG000|Overall Study|Death|1|||
105636895|NCT02686658|364334294|FG001|Overall Study|Death|0|||
105636896|NCT02686658|364334295|FG002|Overall Study|Death|0|||
105636897|NCT02686658|364334296|FG003|Overall Study|Death|1|||
105636898|NCT02686658|364334297|FG004|Overall Study|Death|1|||
105636899|NCT02686658|364334298|FG005|Overall Study|Death|1|||
105636900|NCT02686658|364334293|FG000|Overall Study|Withdrawal by Subject|2|||
105636901|NCT02686658|364334294|FG001|Overall Study|Withdrawal by Subject|5|||
105636902|NCT02686658|364334295|FG002|Overall Study|Withdrawal by Subject|4|||
105636903|NCT02686658|364334296|FG003|Overall Study|Withdrawal by Subject|4|||
105636904|NCT02686658|364334297|FG004|Overall Study|Withdrawal by Subject|17|||
105636905|NCT02686658|364334298|FG005|Overall Study|Withdrawal by Subject|8|||
105636906|NCT02686658|364334293|FG000|Overall Study|Placed in hospice care|0|||
105636907|NCT02686658|364334294|FG001|Overall Study|Placed in hospice care|0|||
105636908|NCT02686658|364334295|FG002|Overall Study|Placed in hospice care|1|||
105636909|NCT02686658|364334296|FG003|Overall Study|Placed in hospice care|0|||
105636910|NCT02686658|364334297|FG004|Overall Study|Placed in hospice care|0|||
105636911|NCT02686658|364334298|FG005|Overall Study|Placed in hospice care|0|||
105636912|NCT02686658|364334293|FG000|Overall Study|Participant non-compliance|0|||
105636913|NCT02686658|364334294|FG001|Overall Study|Participant non-compliance|0|||
105636914|NCT02686658|364334295|FG002|Overall Study|Participant non-compliance|0|||
105636915|NCT02686658|364334296|FG003|Overall Study|Participant non-compliance|0|||
105636916|NCT02686658|364334297|FG004|Overall Study|Participant non-compliance|0|||
105636917|NCT02686658|364334298|FG005|Overall Study|Participant non-compliance|1|||
105636918|NCT02686658|364334293|FG000|Overall Study|Concern over coronavirus disease care|0|||
105636919|NCT02686658|364334294|FG001|Overall Study|Concern over coronavirus disease care|0|||
105636920|NCT02686658|364334295|FG002|Overall Study|Concern over coronavirus disease care|0|||
105636921|NCT02686658|364334296|FG003|Overall Study|Concern over coronavirus disease care|0|||
105636922|NCT02686658|364334297|FG004|Overall Study|Concern over coronavirus disease care|2|||
105636923|NCT02686658|364334298|FG005|Overall Study|Concern over coronavirus disease care|1|||
105636924|NCT02628626|364334299|FG000|Overall Study|Withdrawal by Subject|2|||
105636925|NCT02628626|364334300|FG001|Overall Study|Withdrawal by Subject|2|||
105636926|NCT00614614|364334301|FG000|Primary Vaccination Phase|Adverse Event|6|||
105636927|NCT00614614|364334302|FG001|Primary Vaccination Phase|Adverse Event|0|||
105636928|NCT00614614|364334303|FG002|Primary Vaccination Phase|Adverse Event|0|||
105636929|NCT00614614|364334304|FG003|Primary Vaccination Phase|Adverse Event|0|||
105636930|NCT00614614|364334305|FG004|Primary Vaccination Phase|Adverse Event|0|||
105636931|NCT00614614|364334301|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
105636932|NCT00614614|364334302|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
105636933|NCT00614614|364334303|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
105636934|NCT00614614|364334304|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
105636935|NCT00614614|364334305|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
105636936|NCT00614614|364334301|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
105636937|NCT00614614|364334302|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
105636938|NCT00614614|364334303|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
105636939|NCT00614614|364334304|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
105636940|NCT00614614|364334305|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
105636941|NCT00614614|364334301|FG000|Primary Vaccination Phase|Protocol Violation|9|||
105636942|NCT00614614|364334302|FG001|Primary Vaccination Phase|Protocol Violation|3|||
105636943|NCT00614614|364334303|FG002|Primary Vaccination Phase|Protocol Violation|0|||
105636944|NCT00614614|364334304|FG003|Primary Vaccination Phase|Protocol Violation|0|||
105636945|NCT00614614|364334305|FG004|Primary Vaccination Phase|Protocol Violation|0|||
105636946|NCT00614614|364334301|FG000|Primary Vaccination Phase|Other|4|||
105636947|NCT00614614|364334302|FG001|Primary Vaccination Phase|Other|0|||
105636948|NCT00614614|364334303|FG002|Primary Vaccination Phase|Other|0|||
105636949|NCT00614614|364334304|FG003|Primary Vaccination Phase|Other|0|||
105636950|NCT00614614|364334305|FG004|Primary Vaccination Phase|Other|0|||
105636951|NCT00614614|364334301|FG000|Booster Vaccination Phase|Adverse Event|0|||
105636952|NCT00614614|364334302|FG001|Booster Vaccination Phase|Adverse Event|0|||
105636953|NCT00614614|364334303|FG002|Booster Vaccination Phase|Adverse Event|1|||
105636954|NCT00614614|364334304|FG003|Booster Vaccination Phase|Adverse Event|1|||
105636955|NCT00614614|364334305|FG004|Booster Vaccination Phase|Adverse Event|0|||
105636956|NCT00614614|364334301|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
105636957|NCT00614614|364334302|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
105636958|NCT00614614|364334303|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
105636959|NCT00614614|364334304|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
105636960|NCT00614614|364334305|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
105636961|NCT00614614|364334301|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
105636962|NCT00614614|364334302|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
105636963|NCT00614614|364334303|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
105636964|NCT00614614|364334304|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
105636965|NCT00614614|364334305|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
105636966|NCT00614614|364334301|FG000|Booster Vaccination Phase|Protocol Violation|0|||
105636967|NCT00614614|364334302|FG001|Booster Vaccination Phase|Protocol Violation|0|||
105636968|NCT00614614|364334303|FG002|Booster Vaccination Phase|Protocol Violation|2|||
105636969|NCT00614614|364334304|FG003|Booster Vaccination Phase|Protocol Violation|3|||
105636970|NCT00614614|364334305|FG004|Booster Vaccination Phase|Protocol Violation|0|||
105636971|NCT00614614|364334301|FG000|Booster Vaccination Phase|Other|0|||
105636972|NCT00614614|364334302|FG001|Booster Vaccination Phase|Other|1|||
105636973|NCT00614614|364334303|FG002|Booster Vaccination Phase|Other|3|||
105636974|NCT00614614|364334304|FG003|Booster Vaccination Phase|Other|2|||
105636975|NCT00614614|364334305|FG004|Booster Vaccination Phase|Other|1|||
105636976|NCT00145470|364334306|FG000|Overall Study|Adverse Event|19|||
105636977|NCT00145470|364334307|FG001|Overall Study|Adverse Event|25|||
105636978|NCT00145470|364334306|FG000|Overall Study|Lack of Efficacy|27|||
105636979|NCT00145470|364334307|FG001|Overall Study|Lack of Efficacy|13|||
105636980|NCT00145470|364334306|FG000|Overall Study|Withdrawal by Subject|36|||
105636981|NCT00145470|364334307|FG001|Overall Study|Withdrawal by Subject|34|||
105636982|NCT00145470|364334306|FG000|Overall Study|Lost to Follow-up|21|||
105636983|NCT00145470|364334307|FG001|Overall Study|Lost to Follow-up|17|||
105636984|NCT00145470|364334306|FG000|Overall Study|Reason Not Reported|9|||
105636985|NCT00145470|364334307|FG001|Overall Study|Reason Not Reported|9|||
105636986|NCT00933270|364334308|FG000|Overall Study|Withdrawal by Subject|26|||
105636987|NCT00933270|364334308|FG000|Overall Study|Insufficient Follow-up|10|||
105636988|NCT00933270|364334308|FG000|Overall Study|Lost to Follow-up|14|||
105636989|NCT00933270|364334308|FG000|Overall Study|Adverse Event|1|||
105636990|NCT00933270|364334308|FG000|Overall Study|Missed Visit|2|||
105636991|NCT00933270|364334308|FG000|Overall Study|Death|24|||
105636992|NCT00933270|364334308|FG000|Overall Study|Moved or would not return|10|||
105636993|NCT03476798|364334310|FG000|Overall Study|Death|1|||
105636994|NCT03476798|364334310|FG000|Overall Study|Withdrawal by Subject|2|||
105636995|NCT03476798|364334310|FG000|Overall Study|Protocol Violation|2|||
105636996|NCT04602728|364334320|FG000|Overall Study|Lost to Follow-up|4|||
105636997|NCT04602728|364334321|FG001|Overall Study|Lost to Follow-up|4|||
105636998|NCT02831049|364334324|FG000|Overall Study|Lost to Follow-up|0|||
105636999|NCT02831049|364334325|FG001|Overall Study|Lost to Follow-up|0|||
105637000|NCT02831049|364334326|FG002|Overall Study|Lost to Follow-up|1|||
105637001|NCT02831049|364334324|FG000|Overall Study|Withdrawal by Subject|0|||
105637002|NCT02831049|364334325|FG001|Overall Study|Withdrawal by Subject|1|||
105637003|NCT02831049|364334326|FG002|Overall Study|Withdrawal by Subject|1|||
105637004|NCT02831049|364334324|FG000|Overall Study|Pandemic shutdown|1|||
105637005|NCT02831049|364334325|FG001|Overall Study|Pandemic shutdown|0|||
105637006|NCT02831049|364334326|FG002|Overall Study|Pandemic shutdown|0|||
105637007|NCT00491894|364334327|FG000|Overall Study|Adverse Event|14|||
105637008|NCT00491894|364334327|FG000|Overall Study|Withdrawal by Subject|5|||
105637009|NCT00491894|364334327|FG000|Overall Study|Death|3|||
105637010|NCT00491894|364334327|FG000|Overall Study|Lost to Follow-up|3|||
105637011|NCT00491894|364334327|FG000|Overall Study|Lack of Efficacy|2|||
105637012|NCT00491894|364334327|FG000|Overall Study|Other-Failed to meet any criteria|2|||
105637013|NCT00491894|364334327|FG000|Overall Study|Physician Decision|2|||
105637014|NCT00491894|364334327|FG000|Overall Study|Protocol Violation|2|||
105637015|NCT00491894|364334327|FG000|Overall Study|Other-Intake of prohibited medication|1|||
105637016|NCT03009344|364335627|FG000|Overall Study|Lack of Efficacy|5|||
105637017|NCT03009344|364335627|FG000|Overall Study|Withdrawal by Subject|1|||
105637018|NCT03009344|364335627|FG000|Overall Study|Adverse Event|1|||
105637019|NCT00925548|364335628|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
105637020|NCT00925548|364335629|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
105637021|NCT00667017|364335630|FG000|Overall Study|Withdrawal by Subject|1|||
105637022|NCT02148705|364335631|FG000|Overall Study|Death|2|||
105637023|NCT02148705|364335632|FG001|Overall Study|Death|0|||
105637024|NCT02148705|364335633|FG002|Overall Study|Death|0|||
105637025|NCT02148705|364335631|FG000|Overall Study|Lost to Follow-up|13|||
105637026|NCT02148705|364335632|FG001|Overall Study|Lost to Follow-up|4|||
105637027|NCT02148705|364335633|FG002|Overall Study|Lost to Follow-up|10|||
105637028|NCT02148705|364335631|FG000|Overall Study|Withdrawal by Subject|3|||
105637029|NCT02148705|364335632|FG001|Overall Study|Withdrawal by Subject|0|||
105637030|NCT02148705|364335633|FG002|Overall Study|Withdrawal by Subject|2|||
105637031|NCT02148705|364335631|FG000|Overall Study|Not Treated|0|||
105637032|NCT02148705|364335632|FG001|Overall Study|Not Treated|1|||
105637033|NCT02148705|364335633|FG002|Overall Study|Not Treated|5|||
105637034|NCT00345046|364335634|FG000|Overall Study|Protocol Violation|1|||
105637035|NCT00345046|364335635|FG001|Overall Study|Protocol Violation|1|||
105637036|NCT00345046|364335636|FG002|Overall Study|Protocol Violation|2|||
105637037|NCT03689946|364335637|FG000|Overall Study|Withdrawal by Subject|3|||
105637038|NCT03689946|364335637|FG000|Overall Study|Lost to Follow-up|3|||
105637039|NCT03689946|364335637|FG000|Overall Study|Data corruption|2|||
105637040|NCT01613417|364335638|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
105637041|NCT01613417|364335639|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
105637042|NCT04608409|364335640|FG000|Overall Study|Physician Decision|1|||
105637043|NCT04608409|364335641|FG001|Overall Study|Physician Decision|1|||
105637044|NCT04608409|364335642|FG002|Overall Study|Physician Decision|2|||
105637045|NCT04497415|364335649|FG000|Overall Study|Lost to Follow-up|43|||
105637046|NCT04497415|364335650|FG001|Overall Study|Lost to Follow-up|27|||
105637047|NCT02827201|364335651|FG000|Overall Study|Death|1|||
105637048|NCT02827201|364335652|FG001|Overall Study|Death|2|||
105637049|NCT02827201|364335651|FG000|Overall Study|Patients not treated|1|||
105637050|NCT02827201|364335652|FG001|Overall Study|Patients not treated|1|||
105637051|NCT04237792|364335654|FG000|Treatment (Day 1)|Adverse Event|1|||
105637052|NCT04237792|364335655|FG001|Treatment (Day 1)|Adverse Event|0|||
105637053|NCT04237792|364335656|FG002|Treatment (Day 1)|Adverse Event|0|||
105637054|NCT04237792|364335657|FG003|Treatment (Day 1)|Adverse Event|0|||
105637055|NCT04237792|364335658|FG004|Treatment (Day 1)|Adverse Event|1|||
105637056|NCT04237792|364335659|FG005|Treatment (Day 1)|Adverse Event|1|||
105637057|NCT04237792|364335654|FG000|Treatment (Day 1)|Other|0|||
105637058|NCT04237792|364335655|FG001|Treatment (Day 1)|Other|0|||
105637059|NCT04237792|364335656|FG002|Treatment (Day 1)|Other|1|||
105637060|NCT04237792|364335657|FG003|Treatment (Day 1)|Other|0|||
105637061|NCT04237792|364335658|FG004|Treatment (Day 1)|Other|0|||
105637062|NCT04237792|364335659|FG005|Treatment (Day 1)|Other|1|||
105637063|NCT04237792|364335654|FG000|Treatment (Day 1)|Not treated|1|||
105637064|NCT04237792|364335655|FG001|Treatment (Day 1)|Not treated|1|||
105637065|NCT04237792|364335656|FG002|Treatment (Day 1)|Not treated|2|||
105637066|NCT04237792|364335657|FG003|Treatment (Day 1)|Not treated|1|||
105637067|NCT04237792|364335658|FG004|Treatment (Day 1)|Not treated|0|||
105637068|NCT04237792|364335659|FG005|Treatment (Day 1)|Not treated|1|||
105637069|NCT04693637|364335660|FG000|Overall Study|Death|4|||
105637070|NCT04693637|364335660|FG000|Overall Study|Withdrawal by Subject|3|||
105637071|NCT04693637|364335660|FG000|Overall Study|Physician Decision|2|||
105637072|NCT04693637|364335660|FG000|Overall Study|Lost to Follow-up|1|||
105637073|NCT02085941|364335661|FG000|Overall Study|Lack of Efficacy|1|||
105637074|NCT02085941|364335662|FG001|Overall Study|Lack of Efficacy|0|||
105637075|NCT02085941|364335661|FG000|Overall Study|Death|6|||
105637076|NCT02085941|364335662|FG001|Overall Study|Death|1|||
105637077|NCT02085941|364335661|FG000|Overall Study|Lost to Follow-up|1|||
105637078|NCT02085941|364335662|FG001|Overall Study|Lost to Follow-up|0|||
105637079|NCT02085941|364335661|FG000|Overall Study|Physician Decision|0|||
105637080|NCT02085941|364335662|FG001|Overall Study|Physician Decision|2|||
105637081|NCT04652726|364335666|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
105637082|NCT04652726|364335667|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
105637083|NCT04652726|364335668|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
105637084|NCT04652726|364335666|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
105637085|NCT04652726|364335667|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
105637086|NCT04652726|364335668|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
105637087|NCT02022657|364335669|FG000|Overall Study|Withdrawal by Subject|2|||
105637088|NCT02022657|364335670|FG001|Overall Study|Withdrawal by Subject|0|||
105637089|NCT02022657|364335671|FG002|Overall Study|Withdrawal by Subject|1|||
105637090|NCT02022657|364335672|FG003|Overall Study|Withdrawal by Subject|0|||
105637091|NCT02022657|364335673|FG004|Overall Study|Withdrawal by Subject|0|||
105637092|NCT02022657|364335674|FG005|Overall Study|Withdrawal by Subject|0|||
105637093|NCT02022657|364335669|FG000|Overall Study|Physician Decision|0|||
105637094|NCT02022657|364335670|FG001|Overall Study|Physician Decision|0|||
105637095|NCT02022657|364335671|FG002|Overall Study|Physician Decision|0|||
105637096|NCT02022657|364335672|FG003|Overall Study|Physician Decision|0|||
105637097|NCT02022657|364335673|FG004|Overall Study|Physician Decision|0|||
105637098|NCT02022657|364335674|FG005|Overall Study|Physician Decision|1|||
105637099|NCT03381274|364335675|FG000|Overall Study|Death|2|||
105637100|NCT03381274|364335676|FG001|Overall Study|Death|9|||
105637101|NCT03381274|364335677|FG002|Overall Study|Death|3|||
105637102|NCT03381274|364335678|FG003|Overall Study|Death|2|||
105637103|NCT03381274|364335679|FG004|Overall Study|Death|3|||
105637104|NCT03381274|364335675|FG000|Overall Study|Lost to Follow-up|0|||
105637105|NCT03381274|364335676|FG001|Overall Study|Lost to Follow-up|0|||
105637106|NCT03381274|364335677|FG002|Overall Study|Lost to Follow-up|0|||
105637107|NCT03381274|364335678|FG003|Overall Study|Lost to Follow-up|1|||
105637108|NCT03381274|364335679|FG004|Overall Study|Lost to Follow-up|0|||
105637109|NCT03381274|364335675|FG000|Overall Study|Withdrawal by Subject|2|||
105637110|NCT03381274|364335676|FG001|Overall Study|Withdrawal by Subject|1|||
105637111|NCT03381274|364335677|FG002|Overall Study|Withdrawal by Subject|3|||
105637112|NCT03381274|364335678|FG003|Overall Study|Withdrawal by Subject|1|||
105637113|NCT03381274|364335679|FG004|Overall Study|Withdrawal by Subject|0|||
105637114|NCT03381274|364335675|FG000|Overall Study|Other|1|||
105637115|NCT03381274|364335676|FG001|Overall Study|Other|11|||
105637116|NCT03381274|364335677|FG002|Overall Study|Other|0|||
105637117|NCT03381274|364335678|FG003|Overall Study|Other|2|||
105637118|NCT03381274|364335679|FG004|Overall Study|Other|2|||
105637119|NCT00836498|364335680|FG000|Overall Study|Adverse Event|1|||
105637120|NCT00836498|364335681|FG001|Overall Study|Adverse Event|0|||
105637121|NCT00836498|364335680|FG000|Overall Study|Lost to Follow-up|1|||
105637122|NCT00836498|364335681|FG001|Overall Study|Lost to Follow-up|0|||
105637123|NCT00836498|364335680|FG000|Overall Study|Withdrawal by Subject|2|||
105637124|NCT00836498|364335681|FG001|Overall Study|Withdrawal by Subject|1|||
105637125|NCT01728324|364335682|FG000|Termination of DBV|Adverse Event|14|||
105637126|NCT01728324|364335683|FG001|Termination of DBV|Adverse Event|13|||
105637127|NCT01728324|364335684|FG002|Termination of DBV|Adverse Event|4|||
105637128|NCT01728324|364335682|FG000|Termination of DBV|Lack of Efficacy|14|||
105637129|NCT01728324|364335683|FG001|Termination of DBV|Lack of Efficacy|12|||
105637130|NCT01728324|364335684|FG002|Termination of DBV|Lack of Efficacy|8|||
105637131|NCT01728324|364335682|FG000|Termination of DBV|Withdrawal by Subject|9|||
105637132|NCT01728324|364335683|FG001|Termination of DBV|Withdrawal by Subject|6|||
105637133|NCT01728324|364335684|FG002|Termination of DBV|Withdrawal by Subject|2|||
105637134|NCT01728324|364335682|FG000|Termination of DBV|Other than stated|1|||
105637135|NCT01728324|364335683|FG001|Termination of DBV|Other than stated|3|||
105637136|NCT01728324|364335684|FG002|Termination of DBV|Other than stated|0|||
105637137|NCT01728324|364335682|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
105637138|NCT01728324|364335683|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
105637139|NCT01728324|364335684|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
105637140|NCT01728324|364335682|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
105637141|NCT01728324|364335683|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
105637142|NCT01728324|364335684|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
105637143|NCT01728324|364335682|FG000|Termination of FDV|Adverse Event|14|||
105637144|NCT01728324|364335683|FG001|Termination of FDV|Adverse Event|13|||
105637145|NCT01728324|364335684|FG002|Termination of FDV|Adverse Event|4|||
105637146|NCT01728324|364335682|FG000|Termination of FDV|Lack of Efficacy|14|||
105637147|NCT01728324|364335683|FG001|Termination of FDV|Lack of Efficacy|12|||
105637148|NCT01728324|364335684|FG002|Termination of FDV|Lack of Efficacy|8|||
105637149|NCT01728324|364335682|FG000|Termination of FDV|Withdrawal by Subject|9|||
105637150|NCT01728324|364335683|FG001|Termination of FDV|Withdrawal by Subject|6|||
105637151|NCT01728324|364335684|FG002|Termination of FDV|Withdrawal by Subject|2|||
105637152|NCT01728324|364335682|FG000|Termination of FDV|Other than stated|1|||
105637153|NCT01728324|364335683|FG001|Termination of FDV|Other than stated|3|||
105637154|NCT01728324|364335684|FG002|Termination of FDV|Other than stated|0|||
105637155|NCT01728324|364335682|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
105637156|NCT01728324|364335683|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
105637157|NCT01728324|364335684|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
105637158|NCT01728324|364335682|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
105637159|NCT01728324|364335683|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
105637160|NCT01728324|364335684|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
105637161|NCT01728324|364335682|FG000|Termination of RBV|Adverse Event|15|||
105637162|NCT01728324|364335683|FG001|Termination of RBV|Adverse Event|16|||
105637163|NCT01728324|364335684|FG002|Termination of RBV|Adverse Event|5|||
105637164|NCT01728324|364335682|FG000|Termination of RBV|Lack of Efficacy|14|||
105637165|NCT01728324|364335683|FG001|Termination of RBV|Lack of Efficacy|11|||
105637166|NCT01728324|364335684|FG002|Termination of RBV|Lack of Efficacy|7|||
105637167|NCT01728324|364335682|FG000|Termination of RBV|Withdrawal by Subject|9|||
105637168|NCT01728324|364335683|FG001|Termination of RBV|Withdrawal by Subject|5|||
105637169|NCT01728324|364335684|FG002|Termination of RBV|Withdrawal by Subject|2|||
105637170|NCT01728324|364335682|FG000|Termination of RBV|Other than stated|1|||
105637171|NCT01728324|364335683|FG001|Termination of RBV|Other than stated|3|||
105637172|NCT01728324|364335684|FG002|Termination of RBV|Other than stated|1|||
105637173|NCT01728324|364335682|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
105637174|NCT01728324|364335683|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
105637175|NCT01728324|364335684|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
105637176|NCT01728324|364335682|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
105637177|NCT01728324|364335683|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
105637178|NCT01728324|364335684|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
105637179|NCT01619059|364335685|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
105637180|NCT01619059|364335686|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
105637181|NCT01619059|364335685|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
105637182|NCT01619059|364335686|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
105637183|NCT01619059|364335685|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
105637184|NCT01619059|364335686|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
105637185|NCT01619059|364335685|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
105637186|NCT01619059|364335686|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
105637187|NCT01619059|364335685|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
105637188|NCT01619059|364335686|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
105637189|NCT01619059|364335685|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
105637190|NCT01619059|364335686|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
105637191|NCT01619059|364335685|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
105637192|NCT01619059|364335686|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
105637193|NCT01619059|364335685|FG000|Long-Term (LT) Treatment Period|Death|1|||
105637194|NCT01619059|364335686|FG001|Long-Term (LT) Treatment Period|Death|0|||
105637195|NCT01619059|364335685|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
105637196|NCT01619059|364335686|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
105637197|NCT01619059|364335685|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
105637198|NCT01619059|364335686|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
105637199|NCT03335488|364335689|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
105637200|NCT03335488|364335690|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
105637201|NCT03335488|364335689|FG000|Safety Extension Period|Adverse Event|1|||
105637202|NCT03335488|364335690|FG001|Safety Extension Period|Adverse Event|0|||
105637203|NCT03335488|364335689|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
105637204|NCT03335488|364335690|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
105637205|NCT02022670|364335691|FG000|Overall Study|Adverse Event|1|||
105637206|NCT02022670|364335692|FG001|Overall Study|Adverse Event|0|||
105637207|NCT02022670|364335693|FG002|Overall Study|Adverse Event|1|||
105637208|NCT04102098|364335694|FG000|Main Study Period|Ongoing in study|302|||
105637209|NCT04102098|364335695|FG001|Main Study Period|Ongoing in study|291|||
105637210|NCT04102098|364335694|FG000|Main Study Period|Death|20|||
105637211|NCT04102098|364335695|FG001|Main Study Period|Death|27|||
105637212|NCT04102098|364335694|FG000|Main Study Period|Lost to Follow-up|1|||
105637213|NCT04102098|364335695|FG001|Main Study Period|Lost to Follow-up|1|||
105637214|NCT04102098|364335694|FG000|Main Study Period|Physician Decision|0|||
105637215|NCT04102098|364335695|FG001|Main Study Period|Physician Decision|1|||
105637216|NCT04102098|364335694|FG000|Main Study Period|Withdrawal by Subject|11|||
105637217|NCT04102098|364335695|FG001|Main Study Period|Withdrawal by Subject|14|||
105637218|NCT04102098|364335694|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
105637219|NCT04102098|364335695|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
105637220|NCT04102098|364335694|FG000|Crossover: AS Who Crossed Over|Death|11|||
105637221|NCT04102098|364335695|FG001|Crossover: AS Who Crossed Over|Death|0|||
105637222|NCT04102098|364335694|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
105637223|NCT04102098|364335695|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
105637224|NCT01822756|364335698|FG000|Overall Study|Adverse Event|0|||
105637225|NCT01822756|364335699|FG001|Overall Study|Adverse Event|0|||
105637226|NCT01822756|364335700|FG002|Overall Study|Adverse Event|0|||
105637227|NCT01822756|364335701|FG003|Overall Study|Adverse Event|2|||
105637228|NCT01822756|364335702|FG004|Overall Study|Adverse Event|0|||
105637229|NCT01822756|364335698|FG000|Overall Study|Disease progression|11|||
105637230|NCT01822756|364335699|FG001|Overall Study|Disease progression|1|||
105637231|NCT01822756|364335700|FG002|Overall Study|Disease progression|7|||
105637232|NCT01822756|364335701|FG003|Overall Study|Disease progression|2|||
105637233|NCT01822756|364335702|FG004|Overall Study|Disease progression|6|||
105637234|NCT01822756|364335698|FG000|Overall Study|Death|2|||
105637235|NCT01822756|364335699|FG001|Overall Study|Death|2|||
105637236|NCT01822756|364335700|FG002|Overall Study|Death|1|||
105637237|NCT01822756|364335701|FG003|Overall Study|Death|0|||
105637238|NCT01822756|364335702|FG004|Overall Study|Death|0|||
105637239|NCT01822756|364335698|FG000|Overall Study|Lost to Follow-up|1|||
105637240|NCT01822756|364335699|FG001|Overall Study|Lost to Follow-up|0|||
105637241|NCT01822756|364335700|FG002|Overall Study|Lost to Follow-up|1|||
105637242|NCT01822756|364335701|FG003|Overall Study|Lost to Follow-up|0|||
105637243|NCT01822756|364335702|FG004|Overall Study|Lost to Follow-up|1|||
105637244|NCT01822756|364335698|FG000|Overall Study|Physician Decision|0|||
105637245|NCT01822756|364335699|FG001|Overall Study|Physician Decision|1|||
105637246|NCT01822756|364335700|FG002|Overall Study|Physician Decision|0|||
105637247|NCT01822756|364335701|FG003|Overall Study|Physician Decision|0|||
105637248|NCT01822756|364335702|FG004|Overall Study|Physician Decision|0|||
105637249|NCT01822756|364335698|FG000|Overall Study|disease progression & patient preference|2|||
105637250|NCT01822756|364335699|FG001|Overall Study|disease progression & patient preference|0|||
105637251|NCT01822756|364335700|FG002|Overall Study|disease progression & patient preference|1|||
105637252|NCT01822756|364335701|FG003|Overall Study|disease progression & patient preference|0|||
105637253|NCT01822756|364335702|FG004|Overall Study|disease progression & patient preference|0|||
105637254|NCT01989104|364335703|FG000|Overall Study|Withdrawal by Subject|3|||
105637255|NCT01989104|364335704|FG001|Overall Study|Withdrawal by Subject|0|||
105637256|NCT01989104|364335705|FG002|Overall Study|Withdrawal by Subject|0|||
105637257|NCT01989104|364335706|FG003|Overall Study|Withdrawal by Subject|0|||
105637258|NCT01989104|364335707|FG004|Overall Study|Withdrawal by Subject|0|||
105637259|NCT02542293|364335714|FG000|Overall Study|Death|367|||
105637260|NCT02542293|364335715|FG001|Overall Study|Death|377|||
105637261|NCT02542293|364335714|FG000|Overall Study|Withdrawal by Subject|8|||
105637262|NCT02542293|364335715|FG001|Overall Study|Withdrawal by Subject|19|||
105637263|NCT03697603|364335722|FG000|Overall Study|Adverse Event|3|||
105637264|NCT03697603|364335723|FG001|Overall Study|Adverse Event|18|||
105637265|NCT03697603|364335724|FG002|Overall Study|Adverse Event|3|||
105637266|NCT03697603|364335722|FG000|Overall Study|Physician Decision|1|||
105637267|NCT03697603|364335723|FG001|Overall Study|Physician Decision|0|||
105637268|NCT03697603|364335724|FG002|Overall Study|Physician Decision|2|||
105637269|NCT03697603|364335722|FG000|Overall Study|Protocol Violation|3|||
105637270|NCT03697603|364335723|FG001|Overall Study|Protocol Violation|8|||
105637271|NCT03697603|364335724|FG002|Overall Study|Protocol Violation|5|||
105637272|NCT03697603|364335722|FG000|Overall Study|Withdrawal by Subject|5|||
105637273|NCT03697603|364335723|FG001|Overall Study|Withdrawal by Subject|1|||
105637274|NCT03697603|364335724|FG002|Overall Study|Withdrawal by Subject|1|||
105637275|NCT03697603|364335722|FG000|Overall Study|Protocol Violation|0|||
105637276|NCT03697603|364335723|FG001|Overall Study|Protocol Violation|0|||
105637277|NCT03697603|364335724|FG002|Overall Study|Protocol Violation|1|||
105637278|NCT01683409|364335730|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
105637279|NCT01683409|364335731|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
105637280|NCT01683409|364335732|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
105637281|NCT01683409|364335733|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
105637282|NCT01683409|364335734|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
105637283|NCT01683409|364335730|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
105637284|NCT01683409|364335731|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
105637285|NCT01683409|364335732|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
105637286|NCT01683409|364335733|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
105637287|NCT01683409|364335734|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
105637288|NCT01683409|364335730|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
105637289|NCT01683409|364335731|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
105637290|NCT01683409|364335732|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
105637291|NCT01683409|364335733|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
105637292|NCT01683409|364335734|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
105637293|NCT01683409|364335730|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
105637294|NCT01683409|364335731|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
105637295|NCT01683409|364335732|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
105637296|NCT01683409|364335733|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
105637297|NCT01683409|364335734|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
105637298|NCT01683409|364335730|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
105637299|NCT01683409|364335731|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
105637300|NCT01683409|364335732|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
105637301|NCT01683409|364335733|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
105637302|NCT01683409|364335734|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
105637303|NCT01683409|364335730|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
105637304|NCT01683409|364335731|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
105637305|NCT01683409|364335732|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
105637306|NCT01683409|364335733|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
105637307|NCT01683409|364335734|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
105637308|NCT01683409|364335730|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
105637309|NCT01683409|364335731|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
105637310|NCT01683409|364335732|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
105637311|NCT01683409|364335733|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
105637312|NCT01683409|364335734|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
105637313|NCT01683409|364335730|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
105637314|NCT01683409|364335731|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
105637315|NCT01683409|364335732|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
105637316|NCT01683409|364335733|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
105637317|NCT01683409|364335734|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
105637318|NCT01683409|364335730|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
105637319|NCT01683409|364335731|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
105637320|NCT01683409|364335732|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
105637321|NCT01683409|364335733|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
105637322|NCT01683409|364335734|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
105637323|NCT01683409|364335730|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
105637324|NCT01683409|364335731|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
105637325|NCT01683409|364335732|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
105637326|NCT01683409|364335733|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
105637327|NCT01683409|364335734|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
105637328|NCT01683409|364335730|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
105637329|NCT01683409|364335731|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
105637330|NCT01683409|364335732|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
105637331|NCT01683409|364335733|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
105637332|NCT01683409|364335734|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
105637333|NCT01706159|364335737|FG000|Overall Study|Withdrawal Criteria|2|||
105637334|NCT01706159|364335738|FG001|Overall Study|Withdrawal Criteria|1|||
105637335|NCT01706159|364335737|FG000|Overall Study|Unclassified|6|||
105637336|NCT01706159|364335738|FG001|Overall Study|Unclassified|1|||
105637337|NCT04821271|364335740|FG000|Period 1|Withdrawal by Subject|2|||
105637338|NCT04821271|364335741|FG001|Period 1|Withdrawal by Subject|0|||
105637339|NCT01701401|364335743|FG000|Overall Study|Randomized But Not Treated|3|||
105637340|NCT01701401|364335744|FG001|Overall Study|Randomized But Not Treated|1|||
105637341|NCT01701401|364335745|FG002|Overall Study|Randomized But Not Treated|0|||
105637342|NCT01701401|364335746|FG003|Overall Study|Randomized But Not Treated|1|||
105637343|NCT01701401|364335743|FG000|Overall Study|Lost to Follow-up|5|||
105637344|NCT01701401|364335744|FG001|Overall Study|Lost to Follow-up|5|||
105637345|NCT01701401|364335745|FG002|Overall Study|Lost to Follow-up|1|||
105637346|NCT01701401|364335746|FG003|Overall Study|Lost to Follow-up|3|||
105637347|NCT01701401|364335743|FG000|Overall Study|Withdrew Consent|0|||
105637348|NCT01701401|364335744|FG001|Overall Study|Withdrew Consent|3|||
105637349|NCT01701401|364335745|FG002|Overall Study|Withdrew Consent|1|||
105637350|NCT01701401|364335746|FG003|Overall Study|Withdrew Consent|2|||
105637351|NCT01701401|364335743|FG000|Overall Study|Lack of Efficacy|1|||
105637352|NCT01701401|364335744|FG001|Overall Study|Lack of Efficacy|0|||
105637353|NCT01701401|364335745|FG002|Overall Study|Lack of Efficacy|2|||
105637354|NCT01701401|364335746|FG003|Overall Study|Lack of Efficacy|0|||
105637355|NCT01701401|364335743|FG000|Overall Study|Adverse Event|1|||
105637356|NCT01701401|364335744|FG001|Overall Study|Adverse Event|0|||
105637357|NCT01701401|364335745|FG002|Overall Study|Adverse Event|0|||
105637358|NCT01701401|364335746|FG003|Overall Study|Adverse Event|0|||
105637359|NCT01701401|364335743|FG000|Overall Study|Protocol Violation|0|||
105637360|NCT01701401|364335744|FG001|Overall Study|Protocol Violation|0|||
105637361|NCT01701401|364335745|FG002|Overall Study|Protocol Violation|1|||
105637362|NCT01701401|364335746|FG003|Overall Study|Protocol Violation|0|||
105637363|NCT05995977|364335749|FG000|Overall Study|Withdrawal by Subject|1|||
105637364|NCT05995977|364335750|FG001|Overall Study|Withdrawal by Subject|4|||
105637365|NCT05995977|364335749|FG000|Overall Study|Lost to Follow-up|2|||
105637366|NCT05995977|364335750|FG001|Overall Study|Lost to Follow-up|0|||
105637367|NCT04181788|364335751|FG000|TREATMENT|Adverse Event|0|||
105637368|NCT04181788|364335752|FG001|TREATMENT|Adverse Event|2|||
105637369|NCT04181788|364335753|FG002|TREATMENT|Adverse Event|1|||
105637370|NCT04181788|364335754|FG003|TREATMENT|Adverse Event|0|||
105637371|NCT04181788|364335755|FG004|TREATMENT|Adverse Event|1|||
105637372|NCT04181788|364335756|FG005|TREATMENT|Adverse Event|3|||
105637373|NCT04181788|364335751|FG000|TREATMENT|Death|0|||
105637374|NCT04181788|364335752|FG001|TREATMENT|Death|0|||
105637375|NCT04181788|364335753|FG002|TREATMENT|Death|0|||
105637376|NCT04181788|364335754|FG003|TREATMENT|Death|0|||
105637377|NCT04181788|364335755|FG004|TREATMENT|Death|8|||
105637378|NCT04181788|364335756|FG005|TREATMENT|Death|8|||
105637379|NCT04181788|364335751|FG000|TREATMENT|Physician Decision|0|||
105637380|NCT04181788|364335752|FG001|TREATMENT|Physician Decision|0|||
105637381|NCT04181788|364335753|FG002|TREATMENT|Physician Decision|0|||
105637382|NCT04181788|364335754|FG003|TREATMENT|Physician Decision|0|||
105637383|NCT04181788|364335755|FG004|TREATMENT|Physician Decision|0|||
105637384|NCT04181788|364335756|FG005|TREATMENT|Physician Decision|1|||
105637385|NCT04181788|364335751|FG000|TREATMENT|Progressive disease|3|||
105637386|NCT04181788|364335752|FG001|TREATMENT|Progressive disease|3|||
105637387|NCT04181788|364335753|FG002|TREATMENT|Progressive disease|5|||
105637388|NCT04181788|364335754|FG003|TREATMENT|Progressive disease|7|||
105637389|NCT04181788|364335755|FG004|TREATMENT|Progressive disease|20|||
105637390|NCT04181788|364335756|FG005|TREATMENT|Progressive disease|38|||
105637391|NCT04181788|364335751|FG000|TREATMENT|Global deterioration of health status|0|||
105637392|NCT04181788|364335752|FG001|TREATMENT|Global deterioration of health status|2|||
105637393|NCT04181788|364335753|FG002|TREATMENT|Global deterioration of health status|0|||
105637394|NCT04181788|364335754|FG003|TREATMENT|Global deterioration of health status|0|||
105637395|NCT04181788|364335755|FG004|TREATMENT|Global deterioration of health status|2|||
105637396|NCT04181788|364335756|FG005|TREATMENT|Global deterioration of health status|8|||
105637397|NCT04181788|364335751|FG000|TREATMENT|Withdrawal by Subject|1|||
105637398|NCT04181788|364335752|FG001|TREATMENT|Withdrawal by Subject|2|||
105637399|NCT04181788|364335753|FG002|TREATMENT|Withdrawal by Subject|0|||
105637400|NCT04181788|364335754|FG003|TREATMENT|Withdrawal by Subject|0|||
105637401|NCT04181788|364335755|FG004|TREATMENT|Withdrawal by Subject|3|||
105637402|NCT04181788|364335756|FG005|TREATMENT|Withdrawal by Subject|5|||
105637403|NCT04181788|364335751|FG000|TREATMENT|Other unspecified|0|||
105637404|NCT04181788|364335752|FG001|TREATMENT|Other unspecified|0|||
105637405|NCT04181788|364335753|FG002|TREATMENT|Other unspecified|0|||
105637406|NCT04181788|364335754|FG003|TREATMENT|Other unspecified|0|||
105637407|NCT04181788|364335755|FG004|TREATMENT|Other unspecified|0|||
105637408|NCT04181788|364335756|FG005|TREATMENT|Other unspecified|2|||
105637409|NCT04181788|364335751|FG000|TREATMENT|Ongoing|0|||
105637410|NCT04181788|364335752|FG001|TREATMENT|Ongoing|3|||
105637411|NCT04181788|364335753|FG002|TREATMENT|Ongoing|0|||
105637412|NCT04181788|364335754|FG003|TREATMENT|Ongoing|5|||
105637413|NCT04181788|364335755|FG004|TREATMENT|Ongoing|7|||
105637414|NCT04181788|364335756|FG005|TREATMENT|Ongoing|15|||
105637415|NCT04181788|364335751|FG000|FOLLOW-UP|Death|0|||
105637416|NCT04181788|364335752|FG001|FOLLOW-UP|Death|0|||
105637417|NCT04181788|364335753|FG002|FOLLOW-UP|Death|1|||
105637418|NCT04181788|364335754|FG003|FOLLOW-UP|Death|2|||
105637419|NCT04181788|364335755|FG004|FOLLOW-UP|Death|8|||
105637420|NCT04181788|364335756|FG005|FOLLOW-UP|Death|20|||
105637421|NCT04181788|364335751|FG000|FOLLOW-UP|Lost to Follow-up|0|||
105637422|NCT04181788|364335752|FG001|FOLLOW-UP|Lost to Follow-up|0|||
105637423|NCT04181788|364335753|FG002|FOLLOW-UP|Lost to Follow-up|0|||
105637424|NCT04181788|364335754|FG003|FOLLOW-UP|Lost to Follow-up|0|||
105637425|NCT04181788|364335755|FG004|FOLLOW-UP|Lost to Follow-up|0|||
105637426|NCT04181788|364335756|FG005|FOLLOW-UP|Lost to Follow-up|2|||
105637427|NCT04181788|364335751|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
105637428|NCT04181788|364335752|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
105637429|NCT04181788|364335753|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
105637430|NCT04181788|364335754|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
105637431|NCT04181788|364335755|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
105637432|NCT04181788|364335756|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
105637433|NCT04181788|364335751|FG000|FOLLOW-UP|Other unspecified|0|||
105637434|NCT04181788|364335752|FG001|FOLLOW-UP|Other unspecified|1|||
105637435|NCT04181788|364335753|FG002|FOLLOW-UP|Other unspecified|0|||
105637436|NCT04181788|364335754|FG003|FOLLOW-UP|Other unspecified|0|||
105637437|NCT04181788|364335755|FG004|FOLLOW-UP|Other unspecified|0|||
105637438|NCT04181788|364335756|FG005|FOLLOW-UP|Other unspecified|3|||
105637439|NCT04181788|364335751|FG000|FOLLOW-UP|Ongoing|0|||
105637440|NCT04181788|364335752|FG001|FOLLOW-UP|Ongoing|0|||
105637441|NCT04181788|364335753|FG002|FOLLOW-UP|Ongoing|1|||
105637442|NCT04181788|364335754|FG003|FOLLOW-UP|Ongoing|3|||
105637443|NCT04181788|364335755|FG004|FOLLOW-UP|Ongoing|2|||
105637444|NCT04181788|364335756|FG005|FOLLOW-UP|Ongoing|2|||
105637445|NCT04186247|364335757|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
105637446|NCT04186247|364335758|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
105637447|NCT04186247|364335759|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
105637448|NCT04186247|364335760|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
105637449|NCT04186247|364335761|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
105637450|NCT04118894|364335768|FG000|Overall Study|Lost to Follow-up|21|||
105637451|NCT04118894|364335768|FG000|Overall Study|Withdrawal by Subject|10|||
105637452|NCT04118894|364335768|FG000|Overall Study|Adverse Event|4|||
105659259|NCT00665223|364415764|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
105659260|NCT00665223|364415762|FG000|Randomized Phase (26 Weeks)|Death|0|||
105659261|NCT00665223|364415763|FG001|Randomized Phase (26 Weeks)|Death|0|||
105659262|NCT00665223|364415764|FG002|Randomized Phase (26 Weeks)|Death|1|||
105659263|NCT00665223|364415762|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
105659264|NCT00665223|364415763|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
105659265|NCT00665223|364415764|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
105659266|NCT00665223|364415762|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
105659267|NCT00665223|364415763|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
105659268|NCT00665223|364415764|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
105659269|NCT00665223|364415762|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
105659270|NCT00665223|364415763|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
105659271|NCT00665223|364415764|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
105659272|NCT00665223|364415762|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
105659273|NCT00665223|364415763|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
105659274|NCT00665223|364415764|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
105659275|NCT00665223|364415762|FG000|Open-Label Period (26 Weeks)|Death|0|||
105659276|NCT00665223|364415763|FG001|Open-Label Period (26 Weeks)|Death|1|||
105659277|NCT00665223|364415764|FG002|Open-Label Period (26 Weeks)|Death|0|||
105659278|NCT00665223|364415762|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
105659279|NCT00665223|364415763|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
105659280|NCT00665223|364415764|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
105659281|NCT00665223|364415762|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
105659282|NCT00665223|364415763|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
105659283|NCT00665223|364415764|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
105659284|NCT00665223|364415762|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
105659285|NCT00665223|364415763|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
105659286|NCT00665223|364415764|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
105659287|NCT00665223|364415762|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
105659288|NCT00665223|364415763|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
105659289|NCT00665223|364415764|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
105659290|NCT01278615|364415765|FG000|Overall Study|Withdrawal by Subject|2|||
105659291|NCT00905359|364415766|FG000|Overall Study|Lost to Follow-up|17|||
105659292|NCT00905359|364415767|FG001|Overall Study|Lost to Follow-up|10|||
105659293|NCT00905359|364415766|FG000|Overall Study|Death|2|||
105659294|NCT00905359|364415767|FG001|Overall Study|Death|0|||
105659295|NCT00905359|364415766|FG000|Overall Study|Withdrawal consent|5|||
105659296|NCT00905359|364415767|FG001|Overall Study|Withdrawal consent|6|||
105659297|NCT00591591|364415768|FG000|Overall Study|Withdrawal by Subject|1|||
105659298|NCT00591591|364415769|FG001|Overall Study|Withdrawal by Subject|37|||
105659299|NCT00591591|364415768|FG000|Overall Study|Lack of Efficacy|10|||
105659300|NCT00591591|364415769|FG001|Overall Study|Lack of Efficacy|2|||
105659301|NCT01880437|364415774|FG000|Overall Study|Death|12|||
105659302|NCT01880437|364415775|FG001|Overall Study|Death|4|||
105659303|NCT01880437|364415776|FG002|Overall Study|Death|17|||
105659304|NCT01880437|364415774|FG000|Overall Study|Study terminated by Sponsor|3|||
105659305|NCT01880437|364415775|FG001|Overall Study|Study terminated by Sponsor|0|||
105659306|NCT01880437|364415776|FG002|Overall Study|Study terminated by Sponsor|2|||
105659307|NCT01932762|364417266|FG000|Overall Study|Withdrawal by Subject|1|||
105659308|NCT01932762|364417267|FG001|Overall Study|Withdrawal by Subject|2|||
105659309|NCT01932762|364417268|FG002|Overall Study|Withdrawal by Subject|0|||
105659310|NCT01932762|364417269|FG003|Overall Study|Withdrawal by Subject|0|||
105659311|NCT01932762|364417266|FG000|Overall Study|Lost to Follow-up|4|||
105659312|NCT01932762|364417267|FG001|Overall Study|Lost to Follow-up|0|||
105659313|NCT01932762|364417268|FG002|Overall Study|Lost to Follow-up|0|||
105659314|NCT01932762|364417269|FG003|Overall Study|Lost to Follow-up|1|||
105659315|NCT01932762|364417266|FG000|Overall Study|Physician Decision|1|||
105659316|NCT01932762|364417267|FG001|Overall Study|Physician Decision|0|||
105659317|NCT01932762|364417268|FG002|Overall Study|Physician Decision|0|||
105659318|NCT01932762|364417269|FG003|Overall Study|Physician Decision|0|||
105659319|NCT00412880|364417275|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
105659320|NCT00412880|364417275|FG000|Overall Study|Consent withdrawn|1|||
105659321|NCT00412880|364417275|FG000|Overall Study|Adverse Event|1|||
105659322|NCT00412880|364417275|FG000|Overall Study|Progressive disease|20|||
105659323|NCT01660256|364417276|FG000|Overall Study|Adverse Event|4|||
105659324|NCT01660256|364417277|FG001|Overall Study|Adverse Event|0|||
105659325|NCT01660256|364417278|FG002|Overall Study|Adverse Event|2|||
105659326|NCT01660256|364417276|FG000|Overall Study|Withdrawal by Subject|1|||
105659327|NCT01660256|364417277|FG001|Overall Study|Withdrawal by Subject|0|||
105659328|NCT01660256|364417278|FG002|Overall Study|Withdrawal by Subject|2|||
105659329|NCT00551135|364417280|FG000|Overall Study|Adverse Event|1|||
105659330|NCT00551135|364417281|FG001|Overall Study|Adverse Event|0|||
105637453|NCT00378898|364336859|FG000|Overall Study|Withdrawal by Subject|10|||
105637454|NCT00378898|364336860|FG001|Overall Study|Withdrawal by Subject|5|||
105637455|NCT00378898|364336859|FG000|Overall Study|Protocol Violation|1|||
105637456|NCT00378898|364336860|FG001|Overall Study|Protocol Violation|1|||
105637457|NCT03823703|364336862|FG000|Overall Study|Sponsor request|0|||
105637458|NCT03823703|364336863|FG001|Overall Study|Sponsor request|3|||
105637459|NCT03823703|364336864|FG002|Overall Study|Sponsor request|4|||
105637460|NCT03823703|364336862|FG000|Overall Study|Adverse Event|3|||
105637461|NCT03823703|364336863|FG001|Overall Study|Adverse Event|1|||
105637462|NCT03823703|364336864|FG002|Overall Study|Adverse Event|0|||
105637463|NCT03823703|364336862|FG000|Overall Study|Withdrawal by Subject|0|||
105637464|NCT03823703|364336863|FG001|Overall Study|Withdrawal by Subject|1|||
105637465|NCT03823703|364336864|FG002|Overall Study|Withdrawal by Subject|0|||
105637466|NCT00458783|364336865|FG000|Overall Study|Protocol Violation|1228|||
105637467|NCT00458783|364336866|FG001|Overall Study|Protocol Violation|1220|||
105637468|NCT06571695|364336867|FG000|Overall Study|Lost to Follow-up|1|||
105637469|NCT06571695|364336868|FG001|Overall Study|Lost to Follow-up|6|||
105637470|NCT02637063|364336871|FG000|Overall Study|Lost to Follow-up|3|||
105637471|NCT02637063|364336872|FG001|Overall Study|Lost to Follow-up|2|||
105637472|NCT02637063|364336873|FG002|Overall Study|Lost to Follow-up|3|||
105637473|NCT02637063|364336871|FG000|Overall Study|Withdrawal by Subject|2|||
105637474|NCT02637063|364336872|FG001|Overall Study|Withdrawal by Subject|2|||
105637475|NCT02637063|364336873|FG002|Overall Study|Withdrawal by Subject|3|||
105637476|NCT01808534|364336876|FG000|Overall Study|Disease progression|3|||
105637477|NCT01808534|364336876|FG000|Overall Study|Physician Decision|1|||
105637478|NCT01532648|364336882|FG000|Overall Study|Lost to Follow-up|3|||
105637479|NCT01532648|364336883|FG001|Overall Study|Lost to Follow-up|4|||
105637480|NCT01532648|364336882|FG000|Overall Study|Lack of Efficacy|4|||
105637481|NCT01532648|364336883|FG001|Overall Study|Lack of Efficacy|1|||
105637482|NCT01532648|364336882|FG000|Overall Study|Protocol Violation|1|||
105637483|NCT01532648|364336883|FG001|Overall Study|Protocol Violation|1|||
105637484|NCT01532648|364336882|FG000|Overall Study|Adverse Event|12|||
105637485|NCT01532648|364336883|FG001|Overall Study|Adverse Event|9|||
105637486|NCT01532648|364336882|FG000|Overall Study|Withdrawal by Subject|16|||
105637487|NCT01532648|364336883|FG001|Overall Study|Withdrawal by Subject|2|||
105637488|NCT01737021|364336886|FG000|Overall Study|Lost to Follow-up|5|||
105637489|NCT01737021|364336887|FG001|Overall Study|Lost to Follow-up|3|||
105637490|NCT02310581|364336888|FG000|Overall Study|Adverse Event|1|||
105637491|NCT02310581|364336889|FG001|Overall Study|Adverse Event|1|||
105637492|NCT02310581|364336890|FG002|Overall Study|Adverse Event|1|||
105637493|NCT02310581|364336891|FG003|Overall Study|Adverse Event|0|||
105637494|NCT02310581|364336888|FG000|Overall Study|Withdrawal by Subject|2|||
105637495|NCT02310581|364336889|FG001|Overall Study|Withdrawal by Subject|1|||
105637496|NCT02310581|364336890|FG002|Overall Study|Withdrawal by Subject|0|||
105637497|NCT02310581|364336891|FG003|Overall Study|Withdrawal by Subject|1|||
105637498|NCT04652869|364336892|FG000|Overall Study|Withdrawal by Subject|0|||
105637499|NCT04652869|364336893|FG001|Overall Study|Withdrawal by Subject|2|||
105637500|NCT04652869|364336894|FG002|Overall Study|Withdrawal by Subject|0|||
105637501|NCT02605174|364336895|FG000|Overall Study|Adverse Event|0|||
105637502|NCT02605174|364336896|FG001|Overall Study|Adverse Event|0|||
105637503|NCT02605174|364336897|FG002|Overall Study|Adverse Event|1|||
105637504|NCT02605174|364336898|FG003|Overall Study|Adverse Event|0|||
105637505|NCT02605174|364336899|FG004|Overall Study|Adverse Event|4|||
105637506|NCT02605174|364336900|FG005|Overall Study|Adverse Event|0|||
105637507|NCT02605174|364336901|FG006|Overall Study|Adverse Event|0|||
105637508|NCT02605174|364336895|FG000|Overall Study|Lost to Follow-up|20|||
105637509|NCT02605174|364336896|FG001|Overall Study|Lost to Follow-up|7|||
105637510|NCT02605174|364336897|FG002|Overall Study|Lost to Follow-up|27|||
105637511|NCT02605174|364336898|FG003|Overall Study|Lost to Follow-up|10|||
105637512|NCT02605174|364336899|FG004|Overall Study|Lost to Follow-up|20|||
105637513|NCT02605174|364336900|FG005|Overall Study|Lost to Follow-up|10|||
105637514|NCT02605174|364336901|FG006|Overall Study|Lost to Follow-up|29|||
105637515|NCT02605174|364336895|FG000|Overall Study|Protocol Violation|10|||
105637516|NCT02605174|364336896|FG001|Overall Study|Protocol Violation|4|||
105637517|NCT02605174|364336897|FG002|Overall Study|Protocol Violation|14|||
105637518|NCT02605174|364336898|FG003|Overall Study|Protocol Violation|6|||
105637519|NCT02605174|364336899|FG004|Overall Study|Protocol Violation|7|||
105637520|NCT02605174|364336900|FG005|Overall Study|Protocol Violation|7|||
105637521|NCT02605174|364336901|FG006|Overall Study|Protocol Violation|12|||
105637522|NCT02605174|364336895|FG000|Overall Study|Pregnancy|1|||
105637523|NCT02605174|364336896|FG001|Overall Study|Pregnancy|0|||
105637524|NCT02605174|364336897|FG002|Overall Study|Pregnancy|0|||
105637525|NCT02605174|364336898|FG003|Overall Study|Pregnancy|2|||
105637526|NCT02605174|364336899|FG004|Overall Study|Pregnancy|0|||
105637527|NCT02605174|364336900|FG005|Overall Study|Pregnancy|0|||
105637528|NCT02605174|364336901|FG006|Overall Study|Pregnancy|0|||
105637529|NCT02605174|364336895|FG000|Overall Study|Withdrawal by Subject|9|||
105637530|NCT02605174|364336896|FG001|Overall Study|Withdrawal by Subject|6|||
105637531|NCT02605174|364336897|FG002|Overall Study|Withdrawal by Subject|14|||
105637532|NCT02605174|364336898|FG003|Overall Study|Withdrawal by Subject|11|||
105637533|NCT02605174|364336899|FG004|Overall Study|Withdrawal by Subject|6|||
105637534|NCT02605174|364336900|FG005|Overall Study|Withdrawal by Subject|4|||
105637535|NCT02605174|364336901|FG006|Overall Study|Withdrawal by Subject|15|||
105637536|NCT02605174|364336895|FG000|Overall Study|Physician Decision|2|||
105637537|NCT02605174|364336896|FG001|Overall Study|Physician Decision|0|||
105637538|NCT02605174|364336897|FG002|Overall Study|Physician Decision|0|||
105637539|NCT02605174|364336898|FG003|Overall Study|Physician Decision|0|||
105637540|NCT02605174|364336899|FG004|Overall Study|Physician Decision|0|||
105637541|NCT02605174|364336900|FG005|Overall Study|Physician Decision|0|||
105637542|NCT02605174|364336901|FG006|Overall Study|Physician Decision|3|||
105637543|NCT02605174|364336895|FG000|Overall Study|Randomization Failure|22|||
105637544|NCT02605174|364336896|FG001|Overall Study|Randomization Failure|6|||
105637545|NCT02605174|364336897|FG002|Overall Study|Randomization Failure|20|||
105637546|NCT02605174|364336898|FG003|Overall Study|Randomization Failure|7|||
105637547|NCT02605174|364336899|FG004|Overall Study|Randomization Failure|16|||
105637548|NCT02605174|364336900|FG005|Overall Study|Randomization Failure|11|||
105637549|NCT02605174|364336901|FG006|Overall Study|Randomization Failure|30|||
105637550|NCT04250636|364336904|FG000|Overall Study|Lost to Follow-up|2|||
105637551|NCT00887224|364336905|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
105637552|NCT00887224|364336906|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
105637553|NCT00887224|364336907|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
105637554|NCT00887224|364336905|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
105637555|NCT00887224|364336906|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
105637556|NCT00887224|364336907|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
105637557|NCT00887224|364336905|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
105637558|NCT00887224|364336906|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
105637559|NCT00887224|364336907|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
105637560|NCT00887224|364336905|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
105637561|NCT00887224|364336906|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
105637562|NCT00887224|364336907|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
105637563|NCT00887224|364336905|FG000|Open-label Response (OLR) Phase|Other|1|||
105637564|NCT00887224|364336906|FG001|Open-label Response (OLR) Phase|Other|0|||
105637565|NCT00887224|364336907|FG002|Open-label Response (OLR) Phase|Other|0|||
105637566|NCT00887224|364336905|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
105637567|NCT00887224|364336906|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
105637568|NCT00887224|364336907|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
105637569|NCT00887224|364336905|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
105637570|NCT00887224|364336906|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
105637571|NCT00887224|364336907|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
105637572|NCT00887224|364336905|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
105637573|NCT00887224|364336906|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
105637574|NCT00887224|364336907|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
105637575|NCT00887224|364336905|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
105637576|NCT00887224|364336906|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
105637577|NCT00887224|364336907|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
105637578|NCT00887224|364336905|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
105637579|NCT00887224|364336906|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
105637580|NCT00887224|364336907|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
105637581|NCT00887224|364336905|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
105637582|NCT00887224|364336906|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
105637583|NCT00887224|364336907|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
105637584|NCT00887224|364336905|FG000|Open-label Stability (OLS) Phase|Other|1|||
105637585|NCT00887224|364336906|FG001|Open-label Stability (OLS) Phase|Other|0|||
105637586|NCT00887224|364336907|FG002|Open-label Stability (OLS) Phase|Other|0|||
105637587|NCT00887224|364336905|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
105637588|NCT00887224|364336906|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
105637589|NCT00887224|364336907|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
105637590|NCT00887224|364336905|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
105637591|NCT00887224|364336906|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
105637592|NCT00887224|364336907|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
105637593|NCT00887224|364336905|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
105637594|NCT00887224|364336906|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
105637595|NCT00887224|364336907|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
105637596|NCT00887224|364336905|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
105637597|NCT00887224|364336906|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
105637598|NCT00887224|364336907|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
105637599|NCT00887224|364336905|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
105637600|NCT00887224|364336906|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
105637601|NCT00887224|364336907|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
105637602|NCT00887224|364336905|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
105637603|NCT00887224|364336906|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
105637604|NCT00887224|364336907|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
105637605|NCT00887224|364336905|FG000|OL Taper Phase / OL Follow Up|Other|30|||
105637606|NCT00887224|364336906|FG001|OL Taper Phase / OL Follow Up|Other|0|||
105637607|NCT00887224|364336907|FG002|OL Taper Phase / OL Follow Up|Other|0|||
105637608|NCT00887224|364336905|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
105637609|NCT00887224|364336906|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
105637610|NCT00887224|364336907|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
105637611|NCT00887224|364336905|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
105637612|NCT00887224|364336906|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
105637613|NCT00887224|364336907|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
105637614|NCT00887224|364336905|FG000|Double-blind (DB) Phase|Adverse Event|0|||
105637615|NCT00887224|364336906|FG001|Double-blind (DB) Phase|Adverse Event|7|||
105637616|NCT00887224|364336907|FG002|Double-blind (DB) Phase|Adverse Event|2|||
105637617|NCT00887224|364336905|FG000|Double-blind (DB) Phase|Failed to return|0|||
105637618|NCT00887224|364336906|FG001|Double-blind (DB) Phase|Failed to return|2|||
105637619|NCT00887224|364336907|FG002|Double-blind (DB) Phase|Failed to return|2|||
105637620|NCT00887224|364336905|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
105637621|NCT00887224|364336906|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
105637622|NCT00887224|364336907|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
105637623|NCT00887224|364336905|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
105637624|NCT00887224|364336906|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
105637625|NCT00887224|364336907|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
105637626|NCT00887224|364336905|FG000|Double-blind (DB) Phase|Other|0|||
105637627|NCT00887224|364336906|FG001|Double-blind (DB) Phase|Other|2|||
105637628|NCT00887224|364336907|FG002|Double-blind (DB) Phase|Other|0|||
105637629|NCT00887224|364336905|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
105637630|NCT00887224|364336906|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
105637631|NCT00887224|364336907|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
105637632|NCT00887224|364336905|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
105637633|NCT00887224|364336906|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
105637634|NCT00887224|364336907|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
105637635|NCT00887224|364336905|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
105637636|NCT00887224|364336906|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
105637637|NCT00887224|364336907|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
105637638|NCT00887224|364336905|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
105637639|NCT00887224|364336906|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
105637640|NCT00887224|364336907|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
105637641|NCT00887224|364336905|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
105637642|NCT00887224|364336906|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
105637643|NCT00887224|364336907|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
105637644|NCT00887224|364336905|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
105637645|NCT00887224|364336906|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
105637646|NCT00887224|364336907|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
105637647|NCT00887224|364336905|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
105637648|NCT00887224|364336906|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
105637649|NCT00887224|364336907|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
105637650|NCT00887224|364336905|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
105637651|NCT00887224|364336906|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
105637652|NCT00887224|364336907|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
105637653|NCT00887224|364336905|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
105637654|NCT00887224|364336906|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
105637655|NCT00887224|364336907|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
105637656|NCT03883828|364336908|FG000|Overall Study|Did not start radiotherapy|1|||
105637657|NCT03883828|364336909|FG001|Overall Study|Did not start radiotherapy|2|||
105637658|NCT03675321|364336913|FG000|Overall Study|Lack of Efficacy|2|||
105637659|NCT03675321|364336914|FG001|Overall Study|Lack of Efficacy|2|||
105637660|NCT03675321|364336913|FG000|Overall Study|Withdrawal by Subject|1|||
105637661|NCT03675321|364336914|FG001|Overall Study|Withdrawal by Subject|3|||
105637662|NCT02000752|364336917|FG000|Overall Study|Dystocic delivery|19|||
105637663|NCT02000752|364336918|FG001|Overall Study|Dystocic delivery|8|||
105637664|NCT02000752|364336917|FG000|Overall Study|Shift Changes|12|||
105637665|NCT02000752|364336918|FG001|Overall Study|Shift Changes|5|||
105637666|NCT04938453|364336921|FG000|Washout Period 1|Adverse Event|1|||
105637667|NCT04938453|364336922|FG001|Washout Period 1|Adverse Event|0|||
105637668|NCT04938453|364336921|FG000|Washout Period 1|Physician Decision|0|||
105637669|NCT04938453|364336922|FG001|Washout Period 1|Physician Decision|1|||
105637670|NCT00734578|364336924|FG000|Overall Study|Adverse Event|4|||
105637671|NCT00734578|364336925|FG001|Overall Study|Adverse Event|6|||
105637672|NCT00734578|364336926|FG002|Overall Study|Adverse Event|1|||
105637673|NCT00734578|364336924|FG000|Overall Study|Protocol Violation|8|||
105637674|NCT00734578|364336925|FG001|Overall Study|Protocol Violation|6|||
105637675|NCT00734578|364336926|FG002|Overall Study|Protocol Violation|3|||
105637676|NCT00734578|364336924|FG000|Overall Study|Withdrawal by Subject|7|||
105637677|NCT00734578|364336925|FG001|Overall Study|Withdrawal by Subject|8|||
105637678|NCT00734578|364336926|FG002|Overall Study|Withdrawal by Subject|11|||
105637679|NCT00734578|364336924|FG000|Overall Study|Lost to Follow-up|9|||
105637680|NCT00734578|364336925|FG001|Overall Study|Lost to Follow-up|3|||
105637681|NCT00734578|364336926|FG002|Overall Study|Lost to Follow-up|5|||
105637682|NCT00734578|364336924|FG000|Overall Study|Lack of Efficacy|3|||
105637683|NCT00734578|364336925|FG001|Overall Study|Lack of Efficacy|2|||
105637684|NCT00734578|364336926|FG002|Overall Study|Lack of Efficacy|5|||
105637685|NCT00734578|364336924|FG000|Overall Study|Randomized in error|1|||
105637686|NCT00734578|364336925|FG001|Overall Study|Randomized in error|0|||
105637687|NCT00734578|364336926|FG002|Overall Study|Randomized in error|0|||
105637688|NCT00734578|364336924|FG000|Overall Study|Exclusion criteria|1|||
105637689|NCT00734578|364336925|FG001|Overall Study|Exclusion criteria|0|||
105637690|NCT00734578|364336926|FG002|Overall Study|Exclusion criteria|0|||
105637691|NCT01124045|364336930|FG000|Overall Study|Lost to Follow-up|0|||
105637692|NCT01124045|364336931|FG001|Overall Study|Lost to Follow-up|1|||
105637693|NCT01124045|364336930|FG000|Overall Study|Physician Decision|0|||
105637694|NCT01124045|364336931|FG001|Overall Study|Physician Decision|2|||
105637695|NCT01530334|364336933|FG000|Overall Study|Adverse Event|3|||
105637696|NCT01530334|364336933|FG000|Overall Study|unknown reason|1|||
105637697|NCT01530334|364336933|FG000|Overall Study|Progressive disease|47|||
105637698|NCT01629589|364336934|FG000|Overall Study|Protocol Violation|4|||
105637699|NCT01629589|364336935|FG001|Overall Study|Protocol Violation|2|||
105637700|NCT01629589|364336934|FG000|Overall Study|Lost to Follow-up|2|||
105637701|NCT01629589|364336935|FG001|Overall Study|Lost to Follow-up|1|||
105637702|NCT01629589|364336934|FG000|Overall Study|Withdrawal by Subject|2|||
105637703|NCT01629589|364336935|FG001|Overall Study|Withdrawal by Subject|3|||
105637704|NCT01629589|364336934|FG000|Overall Study|Did not receive study vaccine|0|||
105637705|NCT01629589|364336935|FG001|Overall Study|Did not receive study vaccine|1|||
105637706|NCT02113449|364336939|FG000|Overall Study|Adverse Event|4|||
105637707|NCT03162614|364336940|FG000|Overall Study|Lost to Follow-up|2|||
105637708|NCT03162614|364336941|FG001|Overall Study|Lost to Follow-up|1|||
105637709|NCT03162614|364336942|FG002|Overall Study|Lost to Follow-up|1|||
105637710|NCT03162614|364336943|FG003|Overall Study|Lost to Follow-up|1|||
105637711|NCT03162614|364336944|FG004|Overall Study|Lost to Follow-up|2|||
105637712|NCT03162614|364336945|FG005|Overall Study|Lost to Follow-up|0|||
105637713|NCT03162614|364336940|FG000|Overall Study|Protocol Violation|0|||
105637714|NCT03162614|364336941|FG001|Overall Study|Protocol Violation|1|||
105637715|NCT03162614|364336942|FG002|Overall Study|Protocol Violation|0|||
105637716|NCT03162614|364336943|FG003|Overall Study|Protocol Violation|1|||
105637717|NCT03162614|364336944|FG004|Overall Study|Protocol Violation|0|||
105637718|NCT03162614|364336945|FG005|Overall Study|Protocol Violation|0|||
105637719|NCT03162614|364336940|FG000|Overall Study|Withdrawal by Subject|2|||
105637720|NCT03162614|364336941|FG001|Overall Study|Withdrawal by Subject|1|||
105637721|NCT03162614|364336942|FG002|Overall Study|Withdrawal by Subject|1|||
105637722|NCT03162614|364336943|FG003|Overall Study|Withdrawal by Subject|1|||
105637723|NCT03162614|364336944|FG004|Overall Study|Withdrawal by Subject|0|||
105637724|NCT03162614|364336945|FG005|Overall Study|Withdrawal by Subject|0|||
105637725|NCT03162614|364336940|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
105637726|NCT03162614|364336941|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
105637727|NCT03162614|364336942|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
105637728|NCT03162614|364336943|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
105637729|NCT03162614|364336944|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
105637730|NCT03162614|364336945|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
105637731|NCT03567616|364336948|FG000|Overall Study|Disease progression|4|||
105637732|NCT03567616|364336948|FG000|Overall Study|Withdrawal by Subject|1|||
105637733|NCT03567616|364336948|FG000|Overall Study|Physician Decision|1|||
105637734|NCT03567616|364336948|FG000|Overall Study|Death|1|||
105637735|NCT03567616|364336948|FG000|Overall Study|Adverse Event|1|||
105637736|NCT00109031|364336949|FG000|Overall Study|Adverse Event|0|||
105637737|NCT00109031|364336950|FG001|Overall Study|Adverse Event|0|||
105637738|NCT00109031|364336951|FG002|Overall Study|Adverse Event|1|||
105637739|NCT00109031|364336952|FG003|Overall Study|Adverse Event|0|||
105637740|NCT00109031|364336949|FG000|Overall Study|Withdrawal by Subject|0|||
105637741|NCT00109031|364336950|FG001|Overall Study|Withdrawal by Subject|1|||
105637742|NCT00109031|364336951|FG002|Overall Study|Withdrawal by Subject|0|||
105637743|NCT00109031|364336952|FG003|Overall Study|Withdrawal by Subject|0|||
105637744|NCT00109031|364336949|FG000|Overall Study|Physician Decision|0|||
105637745|NCT00109031|364336950|FG001|Overall Study|Physician Decision|1|||
105637746|NCT00109031|364336951|FG002|Overall Study|Physician Decision|0|||
105637747|NCT00109031|364336952|FG003|Overall Study|Physician Decision|0|||
105637748|NCT00109031|364336949|FG000|Overall Study|Protocol Violation|0|||
105637749|NCT00109031|364336950|FG001|Overall Study|Protocol Violation|0|||
105637750|NCT00109031|364336951|FG002|Overall Study|Protocol Violation|1|||
105637751|NCT00109031|364336952|FG003|Overall Study|Protocol Violation|0|||
105637752|NCT02309294|364336969|FG000|Overall Study|Withdrawal by Subject|2|||
105637753|NCT03520036|364336970|FG000|Overall Study|Adverse Event|1|||
105637754|NCT03520036|364336971|FG001|Overall Study|Adverse Event|2|||
105637755|NCT03520036|364336972|FG002|Overall Study|Adverse Event|0|||
105637756|NCT03520036|364336970|FG000|Overall Study|Protocol Violation|1|||
105637757|NCT03520036|364336971|FG001|Overall Study|Protocol Violation|0|||
105637758|NCT03520036|364336972|FG002|Overall Study|Protocol Violation|0|||
105637759|NCT03520036|364336970|FG000|Overall Study|Withdrawal by Subject|0|||
105637760|NCT03520036|364336971|FG001|Overall Study|Withdrawal by Subject|1|||
105637761|NCT03520036|364336972|FG002|Overall Study|Withdrawal by Subject|4|||
105637762|NCT03520036|364336970|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
105637763|NCT03520036|364336971|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
105637764|NCT03520036|364336972|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
105637765|NCT01227421|364336973|FG000|Overall Study|Lost to Follow-up|6|||
105637766|NCT01227421|364336974|FG001|Overall Study|Lost to Follow-up|7|||
105637767|NCT01227421|364336975|FG002|Overall Study|Lost to Follow-up|5|||
105637768|NCT01227421|364336973|FG000|Overall Study|Adverse Event|2|||
105637769|NCT01227421|364336974|FG001|Overall Study|Adverse Event|7|||
105637770|NCT01227421|364336975|FG002|Overall Study|Adverse Event|2|||
105637771|NCT01227421|364336973|FG000|Overall Study|Withdrawal by Subject|1|||
105637772|NCT01227421|364336974|FG001|Overall Study|Withdrawal by Subject|2|||
105637773|NCT01227421|364336975|FG002|Overall Study|Withdrawal by Subject|1|||
105637774|NCT01227421|364336973|FG000|Overall Study|Protocol Violation|1|||
105637775|NCT01227421|364336974|FG001|Overall Study|Protocol Violation|1|||
105637776|NCT01227421|364336975|FG002|Overall Study|Protocol Violation|2|||
105637777|NCT01227421|364336973|FG000|Overall Study|Randomized in error|1|||
105637778|NCT01227421|364336974|FG001|Overall Study|Randomized in error|1|||
105637779|NCT01227421|364336975|FG002|Overall Study|Randomized in error|0|||
105637780|NCT01218594|364336978|FG000|Overall Study|Death|1|||
105637781|NCT01218594|364336978|FG000|Overall Study|Withdrawal by Subject|3|||
105637782|NCT01218594|364336978|FG000|Overall Study|Adverse Event|2|||
105637783|NCT01218594|364336978|FG000|Overall Study|Physician Decision|6|||
105637784|NCT00570505|364336979|FG000|Overall Study|Adverse Event|7|||
105637785|NCT00570505|364336979|FG000|Overall Study|Withdrawal by Subject|7|||
105637786|NCT00570505|364336979|FG000|Overall Study|Lost to Follow-up|23|||
105637787|NCT00570505|364336979|FG000|Overall Study|Other loss to follow-up|4|||
105637788|NCT05426109|364336983|FG000|Overall Study|Withdrawal by Subject|0|||
105637789|NCT05426109|364336984|FG001|Overall Study|Withdrawal by Subject|1|||
105637790|NCT05865392|364336985|FG000|Overall Study|Withdrawal by Subject|4|||
105637791|NCT05865392|364336986|FG001|Overall Study|Withdrawal by Subject|0|||
105637792|NCT05865392|364336985|FG000|Overall Study|Didn't meet inclusion criteria|4|||
105637793|NCT05865392|364336986|FG001|Overall Study|Didn't meet inclusion criteria|0|||
105637794|NCT02710669|364338452|FG000|Overall Study|Physician Decision|2|||
105637795|NCT02710669|364338453|FG001|Overall Study|Physician Decision|1|||
105637796|NCT02710669|364338454|FG002|Overall Study|Physician Decision|0|||
105637797|NCT02710669|364338452|FG000|Overall Study|Institutional delays (including COVID)|2|||
105637798|NCT02710669|364338453|FG001|Overall Study|Institutional delays (including COVID)|2|||
105637799|NCT02710669|364338454|FG002|Overall Study|Institutional delays (including COVID)|0|||
105637800|NCT02710669|364338452|FG000|Overall Study|arrived in afib/aflutter|10|||
105637801|NCT02710669|364338453|FG001|Overall Study|arrived in afib/aflutter|8|||
105637802|NCT02710669|364338454|FG002|Overall Study|arrived in afib/aflutter|2|||
105637803|NCT04323800|364338455|FG000|Overall Study|Withdrawal by Subject|4|||
105637804|NCT04323800|364338456|FG001|Overall Study|Withdrawal by Subject|4|||
105637805|NCT04323800|364338455|FG000|Overall Study|Incomplete transfusion|1|||
105637806|NCT04323800|364338456|FG001|Overall Study|Incomplete transfusion|0|||
105637807|NCT04323800|364338455|FG000|Overall Study|Other|0|||
105637808|NCT04323800|364338456|FG001|Overall Study|Other|1|||
105637809|NCT04323800|364338455|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
105637810|NCT04323800|364338456|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
105637811|NCT00489554|364338457|FG000|Overall Study|Adverse Event|2|||
105637812|NCT00489554|364338457|FG000|Overall Study|Withdrawal by Subject|1|||
105637813|NCT00489554|364338457|FG000|Overall Study|Lost to Follow-up|1|||
105637814|NCT01732757|364338458|FG000|Overall Study|Lost to Follow-up|1|||
105637815|NCT01732757|364338459|FG001|Overall Study|Lost to Follow-up|0|||
105637816|NCT01732757|364338460|FG002|Overall Study|Lost to Follow-up|0|||
105637817|NCT01567852|364338461|FG000|Overall Study|Withdrawal by Subject|3|||
105637818|NCT01567852|364338462|FG001|Overall Study|Withdrawal by Subject|6|||
105637819|NCT01567852|364338461|FG000|Overall Study|ECT discontinued|1|||
105637820|NCT01567852|364338462|FG001|Overall Study|ECT discontinued|1|||
105637821|NCT02372799|364338466|FG000|Treatment Period|Adverse Event|3|||
105637822|NCT02372799|364338467|FG001|Treatment Period|Adverse Event|10|||
105637823|NCT02372799|364338468|FG002|Treatment Period|Adverse Event|6|||
105637824|NCT02372799|364338466|FG000|Treatment Period|Insufficient therapeutic response|2|||
105637825|NCT02372799|364338467|FG001|Treatment Period|Insufficient therapeutic response|2|||
105637826|NCT02372799|364338468|FG002|Treatment Period|Insufficient therapeutic response|0|||
105637827|NCT02372799|364338466|FG000|Treatment Period|Withdrawal by Subject|10|||
105637828|NCT02372799|364338467|FG001|Treatment Period|Withdrawal by Subject|10|||
105637829|NCT02372799|364338468|FG002|Treatment Period|Withdrawal by Subject|2|||
105637830|NCT02372799|364338466|FG000|Treatment Period|Lost to Follow-up|11|||
105637831|NCT02372799|364338467|FG001|Treatment Period|Lost to Follow-up|5|||
105637832|NCT02372799|364338468|FG002|Treatment Period|Lost to Follow-up|3|||
105637833|NCT02372799|364338466|FG000|Treatment Period|Protocol Violation|3|||
105637834|NCT02372799|364338467|FG001|Treatment Period|Protocol Violation|0|||
105637835|NCT02372799|364338468|FG002|Treatment Period|Protocol Violation|0|||
105637836|NCT02372799|364338466|FG000|Treatment Period|Non-compliance with study drug|4|||
105637837|NCT02372799|364338467|FG001|Treatment Period|Non-compliance with study drug|4|||
105637838|NCT02372799|364338468|FG002|Treatment Period|Non-compliance with study drug|4|||
105637839|NCT02372799|364338466|FG000|Treatment Period|Miscellaneous Reasons|1|||
105637840|NCT02372799|364338467|FG001|Treatment Period|Miscellaneous Reasons|1|||
105637841|NCT02372799|364338468|FG002|Treatment Period|Miscellaneous Reasons|0|||
105637842|NCT02372799|364338466|FG000|Down-taper Period|Lost to Follow-up|1|||
105637843|NCT02372799|364338467|FG001|Down-taper Period|Lost to Follow-up|2|||
105637844|NCT02372799|364338468|FG002|Down-taper Period|Lost to Follow-up|2|||
105637845|NCT00089609|364338469|FG000|Overall Study|Withdrawal by Subject|3|||
105637846|NCT00089609|364338470|FG001|Overall Study|Withdrawal by Subject|1|||
105637847|NCT01214200|364338471|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
105637848|NCT01214200|364338471|FG000|Overall Study|Withdrawal by Subject|2|||
105637849|NCT01823224|364338472|FG000|Overall Study|Lost to Follow-up|5|||
105637850|NCT01823224|364338473|FG001|Overall Study|Lost to Follow-up|6|||
105637851|NCT01823224|364338472|FG000|Overall Study|didn't qualify|1|||
105637852|NCT01823224|364338473|FG001|Overall Study|didn't qualify|2|||
105637853|NCT01823224|364338472|FG000|Overall Study|pharmacy error|0|||
105637854|NCT01823224|364338473|FG001|Overall Study|pharmacy error|1|||
105637855|NCT01823224|364338472|FG000|Overall Study|missed med dose|0|||
105637856|NCT01823224|364338473|FG001|Overall Study|missed med dose|1|||
105637857|NCT01823224|364338472|FG000|Overall Study|Withdrawal by Subject|0|||
105637858|NCT01823224|364338473|FG001|Overall Study|Withdrawal by Subject|1|||
105637859|NCT00745875|364338476|FG000|Overall Study|Continuing study treatment|4|||
105637860|NCT00745875|364338477|FG001|Overall Study|Continuing study treatment|4|||
105637861|NCT01833455|364338480|FG000|Overall Study|Withdrawal by Subject|1|||
105637862|NCT01833455|364338481|FG001|Overall Study|Withdrawal by Subject|0|||
105637863|NCT03041090|364338482|FG000|Overall Study|technical error|0|||
105637864|NCT03041090|364338483|FG001|Overall Study|technical error|3|||
105637865|NCT03960645|364338484|FG000|Overall Study|Protocol Violation|1|||
105637866|NCT03960645|364338485|FG001|Overall Study|Protocol Violation|0|||
105637867|NCT01536704|364338489|FG000|Washout Period 1|Withdrawal by Subject|1|||
105637868|NCT01536704|364338490|FG001|Washout Period 1|Withdrawal by Subject|2|||
105637869|NCT01536704|364338491|FG002|Washout Period 1|Withdrawal by Subject|0|||
105637870|NCT01536704|364338492|FG003|Washout Period 1|Withdrawal by Subject|0|||
105637871|NCT01536704|364338489|FG000|Washout Period 2|Adverse Event|1|||
105637872|NCT01536704|364338490|FG001|Washout Period 2|Adverse Event|0|||
105637873|NCT01536704|364338491|FG002|Washout Period 2|Adverse Event|0|||
105637874|NCT01536704|364338492|FG003|Washout Period 2|Adverse Event|0|||
105637875|NCT01536704|364338489|FG000|Washout Period 2|Withdrawal by Subject|0|||
105637876|NCT01536704|364338490|FG001|Washout Period 2|Withdrawal by Subject|0|||
105637877|NCT01536704|364338491|FG002|Washout Period 2|Withdrawal by Subject|0|||
105637878|NCT01536704|364338492|FG003|Washout Period 2|Withdrawal by Subject|1|||
105637879|NCT01536704|364338489|FG000|Period 3|Adverse Event|0|||
105637880|NCT01536704|364338490|FG001|Period 3|Adverse Event|0|||
105637881|NCT01536704|364338491|FG002|Period 3|Adverse Event|0|||
105637882|NCT01536704|364338492|FG003|Period 3|Adverse Event|1|||
105637883|NCT01536704|364338489|FG000|Washout Period 3|Adverse Event|0|||
105637884|NCT01536704|364338490|FG001|Washout Period 3|Adverse Event|0|||
105637885|NCT01536704|364338491|FG002|Washout Period 3|Adverse Event|1|||
105637886|NCT01536704|364338492|FG003|Washout Period 3|Adverse Event|0|||
105637887|NCT04658784|364338493|FG000|6-month Follow-up|Lost to Follow-up|2|||
105637888|NCT04658784|364338494|FG001|6-month Follow-up|Lost to Follow-up|5|||
105637889|NCT02575365|364338495|FG000|Overall Study|Lost to Follow-up|4|||
105637890|NCT01009645|364338503|FG000|Overall Study|Lost to Follow-up|2|||
105637891|NCT01009645|364338504|FG001|Overall Study|Lost to Follow-up|8|||
105637892|NCT01009645|364338505|FG002|Overall Study|Lost to Follow-up|4|||
105637893|NCT01009645|364338506|FG003|Overall Study|Lost to Follow-up|5|||
105637894|NCT03345979|364338507|FG000|Overall Study|Withdrawal by Subject|20|||
105637895|NCT03345979|364338508|FG001|Overall Study|Withdrawal by Subject|31|||
105637896|NCT03345979|364338507|FG000|Overall Study|Adverse Event|10|||
105637897|NCT03345979|364338508|FG001|Overall Study|Adverse Event|11|||
105637898|NCT03345979|364338507|FG000|Overall Study|Lost to Follow-up|8|||
105637899|NCT03345979|364338508|FG001|Overall Study|Lost to Follow-up|9|||
105637900|NCT03345979|364338507|FG000|Overall Study|Lack of Efficacy|4|||
105637901|NCT03345979|364338508|FG001|Overall Study|Lack of Efficacy|2|||
105637902|NCT03345979|364338507|FG000|Overall Study|Protocol Violation|1|||
105637903|NCT03345979|364338508|FG001|Overall Study|Protocol Violation|3|||
105637904|NCT03345979|364338507|FG000|Overall Study|Physician Decision|0|||
105637905|NCT03345979|364338508|FG001|Overall Study|Physician Decision|2|||
105637906|NCT00999596|364338511|FG000|Overall Study|Statistical population not required|101|||
105637907|NCT02095145|364338512|FG000|Overall Study|Withdrawal by Subject|1|||
105637908|NCT02095145|364338513|FG001|Overall Study|Withdrawal by Subject|0|||
105637909|NCT02630186|364338514|FG000|Overall Study|Withdrawal by Subject|1|||
105637910|NCT03176407|364338515|FG000|Overall Study|Protocol Violation|1|||
105637911|NCT03176407|364338515|FG000|Overall Study|human failure|1|||
105637912|NCT03176407|364338515|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
105637913|NCT02128269|364338516|FG000|Treatment Period|Adverse Event|1|||
105637914|NCT02128269|364338516|FG000|Treatment Period|Physician Decision|1|||
105637915|NCT01021748|364338517|FG000|Overall Study|Adverse Event|2|||
105637916|NCT01021748|364338518|FG001|Overall Study|Adverse Event|1|||
105637917|NCT01021748|364338519|FG002|Overall Study|Adverse Event|2|||
105637918|NCT01021748|364338520|FG003|Overall Study|Adverse Event|0|||
105637919|NCT01021748|364338521|FG004|Overall Study|Adverse Event|2|||
105637920|NCT01021748|364338522|FG005|Overall Study|Adverse Event|0|||
105637921|NCT01021748|364338523|FG006|Overall Study|Adverse Event|1|||
105637922|NCT01021748|364338524|FG007|Overall Study|Adverse Event|0|||
105637923|NCT01021748|364338525|FG008|Overall Study|Adverse Event|7|||
105637924|NCT01021748|364338517|FG000|Overall Study|Physician Decision|1|||
105637925|NCT01021748|364338518|FG001|Overall Study|Physician Decision|0|||
105637926|NCT01021748|364338519|FG002|Overall Study|Physician Decision|1|||
105637927|NCT01021748|364338520|FG003|Overall Study|Physician Decision|1|||
105637928|NCT01021748|364338521|FG004|Overall Study|Physician Decision|0|||
105637929|NCT01021748|364338522|FG005|Overall Study|Physician Decision|0|||
105637930|NCT01021748|364338523|FG006|Overall Study|Physician Decision|1|||
105637931|NCT01021748|364338524|FG007|Overall Study|Physician Decision|1|||
105637932|NCT01021748|364338525|FG008|Overall Study|Physician Decision|2|||
105637933|NCT01021748|364338517|FG000|Overall Study|Progressive Disease|3|||
105637934|NCT01021748|364338518|FG001|Overall Study|Progressive Disease|3|||
105637935|NCT01021748|364338519|FG002|Overall Study|Progressive Disease|4|||
105637936|NCT01021748|364338520|FG003|Overall Study|Progressive Disease|6|||
105637937|NCT01021748|364338521|FG004|Overall Study|Progressive Disease|7|||
105637938|NCT01021748|364338522|FG005|Overall Study|Progressive Disease|3|||
105637939|NCT01021748|364338523|FG006|Overall Study|Progressive Disease|0|||
105637940|NCT01021748|364338524|FG007|Overall Study|Progressive Disease|5|||
105637941|NCT01021748|364338525|FG008|Overall Study|Progressive Disease|6|||
105637942|NCT01021748|364338517|FG000|Overall Study|Withdrawal by Subject|0|||
105637943|NCT01021748|364338518|FG001|Overall Study|Withdrawal by Subject|0|||
105637944|NCT01021748|364338519|FG002|Overall Study|Withdrawal by Subject|0|||
105637945|NCT01021748|364338520|FG003|Overall Study|Withdrawal by Subject|0|||
105637946|NCT01021748|364338521|FG004|Overall Study|Withdrawal by Subject|0|||
105637947|NCT01021748|364338522|FG005|Overall Study|Withdrawal by Subject|0|||
105637948|NCT01021748|364338523|FG006|Overall Study|Withdrawal by Subject|1|||
105637949|NCT01021748|364338524|FG007|Overall Study|Withdrawal by Subject|0|||
105637950|NCT01021748|364338525|FG008|Overall Study|Withdrawal by Subject|1|||
105637951|NCT01021748|364338517|FG000|Overall Study|Not Treated|0|||
105637952|NCT01021748|364338518|FG001|Overall Study|Not Treated|1|||
105637953|NCT01021748|364338519|FG002|Overall Study|Not Treated|0|||
105637954|NCT01021748|364338520|FG003|Overall Study|Not Treated|0|||
105637955|NCT01021748|364338521|FG004|Overall Study|Not Treated|0|||
105637956|NCT01021748|364338522|FG005|Overall Study|Not Treated|0|||
105637957|NCT01021748|364338523|FG006|Overall Study|Not Treated|0|||
105637958|NCT01021748|364338524|FG007|Overall Study|Not Treated|0|||
105637959|NCT01021748|364338525|FG008|Overall Study|Not Treated|0|||
105637960|NCT01829711|364338529|FG000|Overall Study|Lost to Follow-up|2|||
105637961|NCT01829711|364338529|FG000|Overall Study|Withdrawal by Subject|3|||
105637962|NCT01829711|364338529|FG000|Overall Study|Death|4|||
105637963|NCT01829711|364338529|FG000|Overall Study|Started new therapies|17|||
105637964|NCT01829711|364338529|FG000|Overall Study|Adverse Event|3|||
105637965|NCT01829711|364338529|FG000|Overall Study|Due to progression of disease|13|||
105637966|NCT01829711|364338529|FG000|Overall Study|Due to lack of response|1|||
105637967|NCT02309515|364338532|FG000|Overall Study|Withdrawal by Subject|0|||
105637968|NCT02309515|364338533|FG001|Overall Study|Withdrawal by Subject|1|||
105637969|NCT01999335|364338536|FG000|Overall Study|Discontinued before receiving treatment|0|||
105637970|NCT01999335|364338537|FG001|Overall Study|Discontinued before receiving treatment|0|||
105637971|NCT01999335|364338538|FG002|Overall Study|Discontinued before receiving treatment|0|||
105637972|NCT01999335|364338539|FG003|Overall Study|Discontinued before receiving treatment|0|||
105637973|NCT01999335|364338540|FG004|Overall Study|Discontinued before receiving treatment|2|||
105637974|NCT01303510|364338541|FG000|Overall Study|Lost to Follow-up|1|||
105637975|NCT01303510|364338542|FG001|Overall Study|Lost to Follow-up|0|||
105637976|NCT01485887|364338543|FG000|Overall Study|Withdrawal by Subject|2|||
105637977|NCT01485887|364338543|FG000|Overall Study|Adverse Event|8|||
105637978|NCT01485887|364338543|FG000|Overall Study|Deterioration of primary disease|1|||
105637979|NCT01485887|364338543|FG000|Overall Study|Primary disease markedly improved|1|||
105637980|NCT02404441|364338544|FG000|Phase 1 Part|Adverse Event|1|||
105637981|NCT02404441|364338545|FG001|Phase 1 Part|Adverse Event|0|||
105637982|NCT02404441|364338546|FG002|Phase 1 Part|Adverse Event|0|||
105637983|NCT02404441|364338547|FG003|Phase 1 Part|Adverse Event|0|||
105637984|NCT02404441|364338548|FG004|Phase 1 Part|Adverse Event|0|||
105637985|NCT02404441|364338549|FG005|Phase 1 Part|Adverse Event|0|||
105637986|NCT02404441|364338550|FG006|Phase 1 Part|Adverse Event|0|||
105637987|NCT02404441|364338551|FG007|Phase 1 Part|Adverse Event|0|||
105637988|NCT02404441|364338552|FG008|Phase 1 Part|Adverse Event|0|||
105637989|NCT02404441|364338553|FG009|Phase 1 Part|Adverse Event|0|||
105637990|NCT02404441|364338544|FG000|Phase 1 Part|Physician Decision|0|||
105637991|NCT02404441|364338545|FG001|Phase 1 Part|Physician Decision|1|||
105637992|NCT02404441|364338546|FG002|Phase 1 Part|Physician Decision|0|||
105637993|NCT02404441|364338547|FG003|Phase 1 Part|Physician Decision|0|||
105637994|NCT02404441|364338548|FG004|Phase 1 Part|Physician Decision|0|||
105637995|NCT02404441|364338549|FG005|Phase 1 Part|Physician Decision|0|||
105637996|NCT02404441|364338550|FG006|Phase 1 Part|Physician Decision|0|||
105637997|NCT02404441|364338551|FG007|Phase 1 Part|Physician Decision|0|||
105637998|NCT02404441|364338552|FG008|Phase 1 Part|Physician Decision|0|||
105637999|NCT02404441|364338553|FG009|Phase 1 Part|Physician Decision|0|||
105638000|NCT02404441|364338544|FG000|Phase 1 Part|Progressive Disease|14|||
105638001|NCT02404441|364338545|FG001|Phase 1 Part|Progressive Disease|11|||
105638002|NCT02404441|364338546|FG002|Phase 1 Part|Progressive Disease|7|||
105638003|NCT02404441|364338547|FG003|Phase 1 Part|Progressive Disease|6|||
105638004|NCT02404441|364338548|FG004|Phase 1 Part|Progressive Disease|9|||
105638005|NCT02404441|364338549|FG005|Phase 1 Part|Progressive Disease|0|||
105638006|NCT02404441|364338550|FG006|Phase 1 Part|Progressive Disease|0|||
105638007|NCT02404441|364338551|FG007|Phase 1 Part|Progressive Disease|0|||
105638008|NCT02404441|364338552|FG008|Phase 1 Part|Progressive Disease|0|||
105638009|NCT02404441|364338553|FG009|Phase 1 Part|Progressive Disease|0|||
105638010|NCT02404441|364338544|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
105638011|NCT02404441|364338545|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
105638012|NCT02404441|364338546|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
105638013|NCT02404441|364338547|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
105638014|NCT02404441|364338548|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
105638015|NCT02404441|364338549|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
105638016|NCT02404441|364338550|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
105638017|NCT02404441|364338551|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
105638018|NCT02404441|364338552|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
105638019|NCT02404441|364338553|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
105638020|NCT02404441|364338544|FG000|Phase 1 Part|Death|1|||
105638021|NCT02404441|364338545|FG001|Phase 1 Part|Death|1|||
105638022|NCT02404441|364338546|FG002|Phase 1 Part|Death|1|||
105638023|NCT02404441|364338547|FG003|Phase 1 Part|Death|0|||
105638024|NCT02404441|364338548|FG004|Phase 1 Part|Death|1|||
105638025|NCT02404441|364338549|FG005|Phase 1 Part|Death|0|||
105638026|NCT02404441|364338550|FG006|Phase 1 Part|Death|0|||
105638027|NCT02404441|364338551|FG007|Phase 1 Part|Death|0|||
105638028|NCT02404441|364338552|FG008|Phase 1 Part|Death|0|||
105638029|NCT02404441|364338553|FG009|Phase 1 Part|Death|0|||
105638030|NCT02404441|364338544|FG000|Phase 2 Part|Adverse Event|0|||
105638031|NCT02404441|364338545|FG001|Phase 2 Part|Adverse Event|0|||
105638032|NCT02404441|364338546|FG002|Phase 2 Part|Adverse Event|0|||
105638033|NCT02404441|364338547|FG003|Phase 2 Part|Adverse Event|0|||
105638034|NCT02404441|364338548|FG004|Phase 2 Part|Adverse Event|0|||
105638035|NCT02404441|364338549|FG005|Phase 2 Part|Adverse Event|2|||
105638036|NCT02404441|364338550|FG006|Phase 2 Part|Adverse Event|3|||
105638037|NCT02404441|364338551|FG007|Phase 2 Part|Adverse Event|3|||
105638038|NCT02404441|364338552|FG008|Phase 2 Part|Adverse Event|6|||
105638039|NCT02404441|364338553|FG009|Phase 2 Part|Adverse Event|1|||
105638040|NCT02404441|364338544|FG000|Phase 2 Part|Physician Decision|0|||
105638041|NCT02404441|364338545|FG001|Phase 2 Part|Physician Decision|0|||
105638042|NCT02404441|364338546|FG002|Phase 2 Part|Physician Decision|0|||
105638043|NCT02404441|364338547|FG003|Phase 2 Part|Physician Decision|0|||
105638044|NCT02404441|364338548|FG004|Phase 2 Part|Physician Decision|0|||
105638045|NCT02404441|364338549|FG005|Phase 2 Part|Physician Decision|7|||
105638046|NCT02404441|364338550|FG006|Phase 2 Part|Physician Decision|9|||
105638047|NCT02404441|364338551|FG007|Phase 2 Part|Physician Decision|2|||
105638048|NCT02404441|364338552|FG008|Phase 2 Part|Physician Decision|1|||
105638049|NCT02404441|364338553|FG009|Phase 2 Part|Physician Decision|3|||
105638050|NCT02404441|364338544|FG000|Phase 2 Part|Progressive disease|0|||
105638051|NCT02404441|364338545|FG001|Phase 2 Part|Progressive disease|0|||
105638052|NCT02404441|364338546|FG002|Phase 2 Part|Progressive disease|0|||
105638053|NCT02404441|364338547|FG003|Phase 2 Part|Progressive disease|0|||
105638054|NCT02404441|364338548|FG004|Phase 2 Part|Progressive disease|0|||
105638055|NCT02404441|364338549|FG005|Phase 2 Part|Progressive disease|43|||
105638056|NCT02404441|364338550|FG006|Phase 2 Part|Progressive disease|32|||
105638057|NCT02404441|364338551|FG007|Phase 2 Part|Progressive disease|31|||
105638058|NCT02404441|364338552|FG008|Phase 2 Part|Progressive disease|39|||
105638059|NCT02404441|364338553|FG009|Phase 2 Part|Progressive disease|27|||
105638060|NCT02404441|364338544|FG000|Phase 2 Part|Subject/guardian decision|0|||
105638061|NCT02404441|364338545|FG001|Phase 2 Part|Subject/guardian decision|0|||
105638062|NCT02404441|364338546|FG002|Phase 2 Part|Subject/guardian decision|0|||
105638063|NCT02404441|364338547|FG003|Phase 2 Part|Subject/guardian decision|0|||
105638064|NCT02404441|364338548|FG004|Phase 2 Part|Subject/guardian decision|0|||
105638065|NCT02404441|364338549|FG005|Phase 2 Part|Subject/guardian decision|3|||
105638066|NCT02404441|364338550|FG006|Phase 2 Part|Subject/guardian decision|9|||
105638067|NCT02404441|364338551|FG007|Phase 2 Part|Subject/guardian decision|0|||
105638068|NCT02404441|364338552|FG008|Phase 2 Part|Subject/guardian decision|3|||
105638069|NCT02404441|364338553|FG009|Phase 2 Part|Subject/guardian decision|2|||
105638070|NCT02404441|364338544|FG000|Phase 2 Part|Death|0|||
105638071|NCT02404441|364338545|FG001|Phase 2 Part|Death|0|||
105638072|NCT02404441|364338546|FG002|Phase 2 Part|Death|0|||
105638073|NCT02404441|364338547|FG003|Phase 2 Part|Death|0|||
105638074|NCT02404441|364338548|FG004|Phase 2 Part|Death|0|||
105638075|NCT02404441|364338549|FG005|Phase 2 Part|Death|4|||
105638076|NCT02404441|364338550|FG006|Phase 2 Part|Death|8|||
105638077|NCT02404441|364338551|FG007|Phase 2 Part|Death|4|||
105638078|NCT02404441|364338552|FG008|Phase 2 Part|Death|10|||
105638079|NCT02404441|364338553|FG009|Phase 2 Part|Death|9|||
105638080|NCT02234141|364338554|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
105638081|NCT02234141|364338555|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
105638082|NCT02234141|364338556|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
105638083|NCT02234141|364338557|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
105638084|NCT02234141|364338558|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
105638085|NCT02234141|364338559|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
105638086|NCT02234141|364338560|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
105638087|NCT02234141|364338554|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
105638088|NCT02234141|364338555|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
105638089|NCT02234141|364338556|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
105638090|NCT02234141|364338557|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
105638091|NCT02234141|364338558|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
105638092|NCT02234141|364338559|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
105638093|NCT02234141|364338560|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
105638094|NCT02234141|364338554|FG000|Treatment Period (24 Weeks)|Death|1|||
105638095|NCT02234141|364338555|FG001|Treatment Period (24 Weeks)|Death|2|||
105638096|NCT02234141|364338556|FG002|Treatment Period (24 Weeks)|Death|0|||
105638097|NCT02234141|364338557|FG003|Treatment Period (24 Weeks)|Death|1|||
105638098|NCT02234141|364338558|FG004|Treatment Period (24 Weeks)|Death|0|||
105638099|NCT02234141|364338559|FG005|Treatment Period (24 Weeks)|Death|0|||
105638100|NCT02234141|364338560|FG006|Treatment Period (24 Weeks)|Death|0|||
105638101|NCT02234141|364338554|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
105638102|NCT02234141|364338555|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
105638103|NCT02234141|364338556|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
105638104|NCT02234141|364338557|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
105638105|NCT02234141|364338558|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
105638106|NCT02234141|364338559|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
105638107|NCT02234141|364338560|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
105638108|NCT02234141|364338554|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
105638109|NCT02234141|364338555|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
105638110|NCT02234141|364338556|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
105638111|NCT02234141|364338557|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
105638112|NCT02234141|364338558|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
105638113|NCT02234141|364338559|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
105638114|NCT02234141|364338560|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
105638115|NCT02234141|364338554|FG000|Long-Term Treatment Period|Death|0|||
105638116|NCT02234141|364338555|FG001|Long-Term Treatment Period|Death|0|||
105638117|NCT02234141|364338556|FG002|Long-Term Treatment Period|Death|0|||
105638118|NCT02234141|364338557|FG003|Long-Term Treatment Period|Death|0|||
105638119|NCT02234141|364338558|FG004|Long-Term Treatment Period|Death|0|||
105638120|NCT02234141|364338559|FG005|Long-Term Treatment Period|Death|1|||
105638121|NCT02234141|364338560|FG006|Long-Term Treatment Period|Death|0|||
105638122|NCT02234141|364338554|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
105638123|NCT02234141|364338555|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
105638124|NCT02234141|364338556|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
105638125|NCT02234141|364338557|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
105638126|NCT02234141|364338558|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
105638127|NCT02234141|364338559|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
105638128|NCT02234141|364338560|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
105638129|NCT02234141|364338554|FG000|Long-Term Treatment Period|Adverse Event|4|||
105638130|NCT02234141|364338555|FG001|Long-Term Treatment Period|Adverse Event|0|||
105638131|NCT02234141|364338556|FG002|Long-Term Treatment Period|Adverse Event|5|||
105638132|NCT02234141|364338557|FG003|Long-Term Treatment Period|Adverse Event|0|||
105638133|NCT02234141|364338558|FG004|Long-Term Treatment Period|Adverse Event|1|||
105638134|NCT02234141|364338559|FG005|Long-Term Treatment Period|Adverse Event|1|||
105638135|NCT02234141|364338560|FG006|Long-Term Treatment Period|Adverse Event|1|||
105638136|NCT02234141|364338554|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
105638137|NCT02234141|364338555|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
105638138|NCT02234141|364338556|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
105638139|NCT02234141|364338557|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
105638140|NCT02234141|364338558|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
105638141|NCT02234141|364338559|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
105638142|NCT02234141|364338560|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
105638143|NCT02234141|364338554|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
105638144|NCT02234141|364338555|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
105638145|NCT02234141|364338556|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
105638146|NCT02234141|364338557|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
105638147|NCT02234141|364338558|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
105638148|NCT02234141|364338559|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
105638149|NCT02234141|364338560|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
105638150|NCT03057600|364338561|FG000|Overall Study|Adverse Event|0|||
105638151|NCT03057600|364338562|FG001|Overall Study|Adverse Event|0|||
105638152|NCT03057600|364338563|FG002|Overall Study|Adverse Event|4|||
105638153|NCT03057600|364338564|FG003|Overall Study|Adverse Event|0|||
105638154|NCT03057600|364338561|FG000|Overall Study|Radiologic Disease Progression|8|||
105638155|NCT03057600|364338562|FG001|Overall Study|Radiologic Disease Progression|7|||
105638156|NCT03057600|364338563|FG002|Overall Study|Radiologic Disease Progression|13|||
105638157|NCT03057600|364338564|FG003|Overall Study|Radiologic Disease Progression|10|||
105638158|NCT03057600|364338561|FG000|Overall Study|Symptomatic Deterioration|0|||
105638159|NCT03057600|364338562|FG001|Overall Study|Symptomatic Deterioration|1|||
105638160|NCT03057600|364338563|FG002|Overall Study|Symptomatic Deterioration|1|||
105638161|NCT03057600|364338564|FG003|Overall Study|Symptomatic Deterioration|0|||
105638162|NCT03057600|364338561|FG000|Overall Study|Investigator Decision|0|||
105638163|NCT03057600|364338562|FG001|Overall Study|Investigator Decision|0|||
105638164|NCT03057600|364338563|FG002|Overall Study|Investigator Decision|1|||
105638165|NCT03057600|364338564|FG003|Overall Study|Investigator Decision|0|||
105638166|NCT03057600|364338561|FG000|Overall Study|Study Termination by Sponsor|0|||
105638167|NCT03057600|364338562|FG001|Overall Study|Study Termination by Sponsor|0|||
105638168|NCT03057600|364338563|FG002|Overall Study|Study Termination by Sponsor|0|||
105638169|NCT03057600|364338564|FG003|Overall Study|Study Termination by Sponsor|2|||
105638170|NCT03057600|364338561|FG000|Overall Study|Withdrawal by Subject|0|||
105638171|NCT03057600|364338562|FG001|Overall Study|Withdrawal by Subject|1|||
105638172|NCT03057600|364338563|FG002|Overall Study|Withdrawal by Subject|0|||
105638173|NCT03057600|364338564|FG003|Overall Study|Withdrawal by Subject|0|||
105638174|NCT03057600|364338561|FG000|Overall Study|Other, Not Specified|1|||
105638175|NCT03057600|364338562|FG001|Overall Study|Other, Not Specified|1|||
105638176|NCT03057600|364338563|FG002|Overall Study|Other, Not Specified|1|||
105638177|NCT03057600|364338564|FG003|Overall Study|Other, Not Specified|1|||
105638178|NCT02095678|364338565|FG000|Overall Study|Withdrawal by Subject|0|||
105638179|NCT02095678|364338566|FG001|Overall Study|Withdrawal by Subject|1|||
105638180|NCT02095678|364338565|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
105638181|NCT02095678|364338566|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
105638182|NCT02095678|364338565|FG000|Overall Study|lesion impacted by previous treatment|1|||
105638183|NCT02095678|364338566|FG001|Overall Study|lesion impacted by previous treatment|1|||
105638184|NCT02095678|364338565|FG000|Overall Study|No Confirmed Diagnosis|0|||
105638185|NCT02095678|364338566|FG001|Overall Study|No Confirmed Diagnosis|3|||
105638186|NCT02095678|364338565|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
105638187|NCT02095678|364338566|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
105638188|NCT02095678|364338565|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
105638189|NCT02095678|364338566|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
105638190|NCT03418545|364338567|FG000|Overall Study|Withdrawal by Participant|2|||
105638191|NCT03418545|364338568|FG001|Overall Study|Withdrawal by Participant|4|||
105638192|NCT03418545|364338567|FG000|Overall Study|Lost to Follow-up|3|||
105638193|NCT03418545|364338568|FG001|Overall Study|Lost to Follow-up|5|||
105638194|NCT03418545|364338567|FG000|Overall Study|Reason Not Specified|0|||
105638195|NCT03418545|364338568|FG001|Overall Study|Reason Not Specified|1|||
105638196|NCT03418545|364338567|FG000|Overall Study|Missing Completion Status|0|||
105638197|NCT03418545|364338568|FG001|Overall Study|Missing Completion Status|1|||
105638198|NCT01170208|364338569|FG000|Overall Study|Withdrawal by Subject|5|||
105638199|NCT01170208|364338570|FG001|Overall Study|Withdrawal by Subject|0|||
105638200|NCT01170208|364338571|FG002|Overall Study|Withdrawal by Subject|1|||
105638201|NCT01170208|364338569|FG000|Overall Study|Protocol Violation|1|||
105638202|NCT01170208|364338570|FG001|Overall Study|Protocol Violation|0|||
105638203|NCT01170208|364338571|FG002|Overall Study|Protocol Violation|1|||
105638204|NCT02161458|364338579|FG000|Overall Study|Withdrawal by Subject|0|||
105638205|NCT02161458|364338580|FG001|Overall Study|Withdrawal by Subject|4|||
105638206|NCT02161458|364338581|FG002|Overall Study|Withdrawal by Subject|4|||
105638207|NCT02161458|364338582|FG003|Overall Study|Withdrawal by Subject|0|||
105638208|NCT02161458|364338579|FG000|Overall Study|Lost to Follow-up|0|||
105638209|NCT02161458|364338580|FG001|Overall Study|Lost to Follow-up|2|||
105638210|NCT02161458|364338581|FG002|Overall Study|Lost to Follow-up|1|||
105638211|NCT02161458|364338582|FG003|Overall Study|Lost to Follow-up|0|||
105638212|NCT02384382|364338583|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
105638213|NCT02384382|364338583|FG000|Overall Study|Death|1|||
105638214|NCT02384382|364338583|FG000|Overall Study|Adverse Event|1|||
105638215|NCT02384382|364338583|FG000|Overall Study|Disease progression|16|||
105638216|NCT00705159|364338596|FG000|Overall Study|Withdrawal by Subject|0|||
105638217|NCT00705159|364338597|FG001|Overall Study|Withdrawal by Subject|1|||
105638218|NCT00705159|364338598|FG002|Overall Study|Withdrawal by Subject|1|||
105638219|NCT00705159|364338599|FG003|Overall Study|Withdrawal by Subject|1|||
105638220|NCT00705159|364338596|FG000|Overall Study|Protocol Violation|0|||
105638221|NCT00705159|364338597|FG001|Overall Study|Protocol Violation|1|||
105638222|NCT00705159|364338598|FG002|Overall Study|Protocol Violation|0|||
105638223|NCT00705159|364338599|FG003|Overall Study|Protocol Violation|0|||
105638224|NCT00705159|364338596|FG000|Overall Study|Adverse Event|0|||
105638225|NCT00705159|364338597|FG001|Overall Study|Adverse Event|0|||
105638226|NCT00705159|364338598|FG002|Overall Study|Adverse Event|1|||
105638227|NCT00705159|364338599|FG003|Overall Study|Adverse Event|0|||
105638228|NCT00705159|364338596|FG000|Overall Study|Lost to Follow-up|0|||
105638229|NCT00705159|364338597|FG001|Overall Study|Lost to Follow-up|0|||
105638230|NCT00705159|364338598|FG002|Overall Study|Lost to Follow-up|3|||
105638231|NCT00705159|364338599|FG003|Overall Study|Lost to Follow-up|2|||
105638232|NCT00705159|364338596|FG000|Overall Study|Screen Failure|0|||
105638233|NCT00705159|364338597|FG001|Overall Study|Screen Failure|0|||
105638234|NCT00705159|364338598|FG002|Overall Study|Screen Failure|0|||
105638235|NCT00705159|364338599|FG003|Overall Study|Screen Failure|1|||
105638236|NCT02091752|364338602|FG000|Overall Study|Study terminated by Sponsor|2|||
105638237|NCT02091752|364338602|FG000|Overall Study|Adverse Event|1|||
105638238|NCT00983294|364338603|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
105638239|NCT00983294|364338603|FG000|Colchicine With Azithromycin|Adverse Event|1|||
105638240|NCT04029090|364338604|FG000|Overall Study|Protocol Violation|1|||
105638241|NCT04029090|364338605|FG001|Overall Study|Protocol Violation|0|||
105638242|NCT04029090|364338606|FG002|Overall Study|Protocol Violation|0|||
105638243|NCT04029090|364338604|FG000|Overall Study|Withdrawal by Subject|0|||
105638244|NCT04029090|364338605|FG001|Overall Study|Withdrawal by Subject|1|||
105638245|NCT04029090|364338606|FG002|Overall Study|Withdrawal by Subject|0|||
105638246|NCT00680771|364338607|FG000|Overall Study|Withdrawal by Subject|1|||
105638247|NCT00680771|364338608|FG001|Overall Study|Withdrawal by Subject|0|||
105638248|NCT00680771|364338607|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
105638249|NCT00680771|364338608|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
105638250|NCT00680771|364338607|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
105638251|NCT00680771|364338608|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
105638252|NCT01604824|364338609|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
105638253|NCT01604824|364338610|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
105638254|NCT01604824|364338611|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
105638255|NCT01604824|364338612|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
105638256|NCT01604824|364338613|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
105638257|NCT01604824|364338614|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
105638258|NCT01604824|364338609|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
105638259|NCT01604824|364338610|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
105638260|NCT01604824|364338611|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
105638261|NCT01604824|364338612|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
105638262|NCT01604824|364338613|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
105638263|NCT01604824|364338614|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
105638264|NCT01316913|364338615|FG000|Overall Study|Adverse Event|17|||
105638265|NCT01316913|364338616|FG001|Overall Study|Adverse Event|20|||
105638266|NCT01316913|364338617|FG002|Overall Study|Adverse Event|15|||
105638267|NCT01316913|364338618|FG003|Overall Study|Adverse Event|11|||
105638268|NCT01316913|364338615|FG000|Overall Study|Lack of Efficacy|22|||
105638269|NCT01316913|364338616|FG001|Overall Study|Lack of Efficacy|12|||
105638270|NCT01316913|364338617|FG002|Overall Study|Lack of Efficacy|9|||
105638271|NCT01316913|364338618|FG003|Overall Study|Lack of Efficacy|13|||
105638272|NCT01316913|364338615|FG000|Overall Study|Protocol Violation|1|||
105638273|NCT01316913|364338616|FG001|Overall Study|Protocol Violation|4|||
105638274|NCT01316913|364338617|FG002|Overall Study|Protocol Violation|4|||
105638275|NCT01316913|364338618|FG003|Overall Study|Protocol Violation|1|||
105638276|NCT01316913|364338615|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
105638277|NCT01316913|364338616|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
105638278|NCT01316913|364338617|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
105638279|NCT01316913|364338618|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
105638280|NCT01316913|364338615|FG000|Overall Study|Lost to Follow-up|0|||
105638281|NCT01316913|364338616|FG001|Overall Study|Lost to Follow-up|1|||
105638282|NCT01316913|364338617|FG002|Overall Study|Lost to Follow-up|0|||
105638283|NCT01316913|364338618|FG003|Overall Study|Lost to Follow-up|2|||
105638284|NCT01316913|364338615|FG000|Overall Study|Withdrawal by Subject|10|||
105638285|NCT01316913|364338616|FG001|Overall Study|Withdrawal by Subject|9|||
105638286|NCT01316913|364338617|FG002|Overall Study|Withdrawal by Subject|10|||
105638287|NCT01316913|364338618|FG003|Overall Study|Withdrawal by Subject|6|||
105638288|NCT01801007|364338619|FG000|Overall Study|Adverse Event|2|||
105638289|NCT01801007|364338619|FG000|Overall Study|Lost to Follow-up|4|||
105638290|NCT01801007|364338619|FG000|Overall Study|Withdrawal by Subject|5|||
105638291|NCT03659136|364338629|FG000|Overall Study|Not treated|2|||
105638292|NCT03659136|364338630|FG001|Overall Study|Not treated|0|||
105638293|NCT03659136|364338629|FG000|Overall Study|Covid-19 related|1|||
105638294|NCT03659136|364338630|FG001|Overall Study|Covid-19 related|1|||
105638295|NCT03659136|364338629|FG000|Overall Study|Withdrawal by Subject|1|||
105638296|NCT03659136|364338630|FG001|Overall Study|Withdrawal by Subject|6|||
105638297|NCT03659136|364338629|FG000|Overall Study|Adverse Event|4|||
105638298|NCT03659136|364338630|FG001|Overall Study|Adverse Event|6|||
105638299|NCT03659136|364338629|FG000|Overall Study|Progressive disease|37|||
105638300|NCT03659136|364338630|FG001|Overall Study|Progressive disease|31|||
105638301|NCT03659136|364338629|FG000|Overall Study|Study closure|2|||
105638302|NCT03659136|364338630|FG001|Overall Study|Study closure|2|||
105638303|NCT03659136|364338629|FG000|Overall Study|Sponsor decision/recommendation|3|||
105638304|NCT03659136|364338630|FG001|Overall Study|Sponsor decision/recommendation|2|||
105638305|NCT03659136|364338629|FG000|Overall Study|Switched to other drug/therapy|2|||
105638306|NCT03659136|364338630|FG001|Overall Study|Switched to other drug/therapy|2|||
105638307|NCT03659136|364338629|FG000|Overall Study|Lack of clinical benefit|0|||
105638308|NCT03659136|364338630|FG001|Overall Study|Lack of clinical benefit|1|||
105638309|NCT00492050|364338631|FG000|Overall Study|Adverse Event|1|||
105638310|NCT00492050|364338631|FG000|Overall Study|Lack of Efficacy|1|||
105638311|NCT00492050|364338631|FG000|Overall Study|Withdrawal by Subject|3|||
105638312|NCT00492050|364338631|FG000|Overall Study|Unable to collect SCT|2|||
105638313|NCT00492050|364338631|FG000|Overall Study|Progressive Disease|2|||
105638314|NCT00799409|364340136|FG000|Overall Study|Withdrawal by Subject|1|||
105638315|NCT00799409|364340137|FG001|Overall Study|Withdrawal by Subject|0|||
105638316|NCT00799409|364340138|FG002|Overall Study|Withdrawal by Subject|0|||
105638317|NCT00799409|364340136|FG000|Overall Study|Lost to Follow-up|1|||
105638318|NCT00799409|364340137|FG001|Overall Study|Lost to Follow-up|0|||
105638319|NCT00799409|364340138|FG002|Overall Study|Lost to Follow-up|0|||
105638320|NCT00799409|364340136|FG000|Overall Study|Optimal Dose Not Achieved|2|||
105638321|NCT00799409|364340137|FG001|Overall Study|Optimal Dose Not Achieved|0|||
105638322|NCT00799409|364340138|FG002|Overall Study|Optimal Dose Not Achieved|0|||
105638323|NCT00799409|364340136|FG000|Overall Study|Failure to follow study protocol)|1|||
105638324|NCT00799409|364340137|FG001|Overall Study|Failure to follow study protocol)|0|||
105638325|NCT00799409|364340138|FG002|Overall Study|Failure to follow study protocol)|0|||
105638326|NCT00799409|364340136|FG000|Overall Study|Did not attend lab school day 1|1|||
105638327|NCT00799409|364340137|FG001|Overall Study|Did not attend lab school day 1|0|||
105638328|NCT00799409|364340138|FG002|Overall Study|Did not attend lab school day 1|0|||
105638329|NCT00799409|364340136|FG000|Overall Study|medication compliance|1|||
105638330|NCT00799409|364340137|FG001|Overall Study|medication compliance|0|||
105638331|NCT00799409|364340138|FG002|Overall Study|medication compliance|0|||
105638332|NCT03964974|364340140|FG000|Overall Study|Lost to Follow-up|3|||
105638333|NCT03964974|364340141|FG001|Overall Study|Lost to Follow-up|2|||
105638334|NCT03964974|364340140|FG000|Overall Study|Withdrawal by Subject|0|||
105638335|NCT03964974|364340141|FG001|Overall Study|Withdrawal by Subject|3|||
105638336|NCT00535626|364340142|FG000|Overall Study|Death|15|||
105638337|NCT00535626|364340142|FG000|Overall Study|Lost to Follow-up|29|||
105638338|NCT00535626|364340142|FG000|Overall Study|Withdrawal by Subject|20|||
105638339|NCT00535626|364340142|FG000|Overall Study|Removal/revision of study component|8|||
105638340|NCT00535626|364340142|FG000|Overall Study|Subject terminated|31|||
105638341|NCT00535626|364340142|FG000|Overall Study|Unable to return|2|||
105638342|NCT01970878|364340144|FG000|Overall Study|Withdrawal by Subject|11|||
105638343|NCT01970878|364340145|FG001|Overall Study|Withdrawal by Subject|10|||
105638344|NCT01970878|364340146|FG002|Overall Study|Withdrawal by Subject|14|||
105638345|NCT01970878|364340147|FG003|Overall Study|Withdrawal by Subject|7|||
105638346|NCT01970878|364340144|FG000|Overall Study|Lost to Follow-up|1|||
105638347|NCT01970878|364340145|FG001|Overall Study|Lost to Follow-up|3|||
105638348|NCT01970878|364340146|FG002|Overall Study|Lost to Follow-up|2|||
105638349|NCT01970878|364340147|FG003|Overall Study|Lost to Follow-up|4|||
105638350|NCT01970878|364340144|FG000|Overall Study|Administrative Reasons|1|||
105638351|NCT01970878|364340145|FG001|Overall Study|Administrative Reasons|0|||
105638352|NCT01970878|364340146|FG002|Overall Study|Administrative Reasons|0|||
105638353|NCT01970878|364340147|FG003|Overall Study|Administrative Reasons|4|||
105638354|NCT01970878|364340144|FG000|Overall Study|Lack of Efficacy|2|||
105638355|NCT01970878|364340145|FG001|Overall Study|Lack of Efficacy|1|||
105638356|NCT01970878|364340146|FG002|Overall Study|Lack of Efficacy|2|||
105638357|NCT01970878|364340147|FG003|Overall Study|Lack of Efficacy|0|||
105638358|NCT01970878|364340144|FG000|Overall Study|Adverse Event|12|||
105638359|NCT01970878|364340145|FG001|Overall Study|Adverse Event|7|||
105638360|NCT01970878|364340146|FG002|Overall Study|Adverse Event|4|||
105638361|NCT01970878|364340147|FG003|Overall Study|Adverse Event|3|||
105638362|NCT01970878|364340144|FG000|Overall Study|Protocol Specified Criteria|10|||
105638363|NCT01970878|364340145|FG001|Overall Study|Protocol Specified Criteria|4|||
105638364|NCT01970878|364340146|FG002|Overall Study|Protocol Specified Criteria|3|||
105638365|NCT01970878|364340147|FG003|Overall Study|Protocol Specified Criteria|6|||
105638366|NCT01970878|364340144|FG000|Overall Study|Physician Decision|0|||
105638367|NCT01970878|364340145|FG001|Overall Study|Physician Decision|1|||
105638368|NCT01970878|364340146|FG002|Overall Study|Physician Decision|1|||
105638369|NCT01970878|364340147|FG003|Overall Study|Physician Decision|0|||
105638370|NCT01970878|364340144|FG000|Overall Study|No Completion Status|0|||
105638371|NCT01970878|364340145|FG001|Overall Study|No Completion Status|1|||
105638372|NCT01970878|364340146|FG002|Overall Study|No Completion Status|0|||
105638373|NCT01970878|364340147|FG003|Overall Study|No Completion Status|0|||
105638374|NCT04809623|364340148|FG000|Overall Study|Study Terminated by Sponsor|1|||
105638375|NCT04809623|364340149|FG001|Overall Study|Study Terminated by Sponsor|0|||
105638376|NCT01380145|364340150|FG000|Overall Study|Progressive disease|4|||
105638377|NCT02634307|364340153|FG000|Overall Study|Adverse Event|50|||
105638378|NCT02634307|364340154|FG001|Overall Study|Adverse Event|24|||
105638379|NCT02634307|364340155|FG002|Overall Study|Adverse Event|14|||
105638380|NCT02634307|364340153|FG000|Overall Study|Lost to Follow-up|21|||
105638381|NCT02634307|364340154|FG001|Overall Study|Lost to Follow-up|5|||
105638382|NCT02634307|364340155|FG002|Overall Study|Lost to Follow-up|6|||
105638383|NCT02634307|364340153|FG000|Overall Study|Pregnancy|5|||
105638384|NCT02634307|364340154|FG001|Overall Study|Pregnancy|1|||
105638385|NCT02634307|364340155|FG002|Overall Study|Pregnancy|3|||
105638386|NCT02634307|364340153|FG000|Overall Study|Withdrawal by Subject|38|||
105638387|NCT02634307|364340154|FG001|Overall Study|Withdrawal by Subject|24|||
105638388|NCT02634307|364340155|FG002|Overall Study|Withdrawal by Subject|18|||
105638389|NCT02634307|364340153|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105638390|NCT02634307|364340154|FG001|Overall Study|Non-Compliance with Study Drug|2|||
105638391|NCT02634307|364340155|FG002|Overall Study|Non-Compliance with Study Drug|2|||
105638392|NCT02634307|364340153|FG000|Overall Study|Lack of Efficacy|1|||
105638393|NCT02634307|364340154|FG001|Overall Study|Lack of Efficacy|5|||
105638394|NCT02634307|364340155|FG002|Overall Study|Lack of Efficacy|3|||
105638395|NCT02634307|364340153|FG000|Overall Study|Physician Decision|7|||
105638396|NCT02634307|364340154|FG001|Overall Study|Physician Decision|5|||
105638397|NCT02634307|364340155|FG002|Overall Study|Physician Decision|5|||
105638398|NCT02634307|364340153|FG000|Overall Study|Reason not Specified|3|||
105638399|NCT02634307|364340154|FG001|Overall Study|Reason not Specified|5|||
105638400|NCT02634307|364340155|FG002|Overall Study|Reason not Specified|10|||
105638401|NCT01673594|364340156|FG000|Overall Study|Adverse Event|3|||
105638402|NCT01673594|364340157|FG001|Overall Study|Adverse Event|1|||
105638403|NCT01673594|364340156|FG000|Overall Study|Lost to Follow-up|1|||
105638404|NCT01673594|364340157|FG001|Overall Study|Lost to Follow-up|0|||
105638405|NCT01673594|364340156|FG000|Overall Study|Physician Decision|2|||
105638406|NCT01673594|364340157|FG001|Overall Study|Physician Decision|4|||
105638407|NCT01673594|364340156|FG000|Overall Study|Withdrawal by Subject|0|||
105638408|NCT01673594|364340157|FG001|Overall Study|Withdrawal by Subject|1|||
105638409|NCT02202317|364340163|FG000|Overall Study|Lost to Follow-up|1|||
105638410|NCT01353274|364340164|FG000|Overall Study|No case report form (CRF) collected|28|||
105638411|NCT01256359|364340165|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
105638412|NCT01256359|364340166|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
105638413|NCT01256359|364340165|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
105638414|NCT01256359|364340166|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
105638415|NCT03737110|364340167|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
105638416|NCT03737110|364340168|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
105638417|NCT03737110|364340169|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
105638418|NCT03737110|364340170|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
105638419|NCT03737110|364340171|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
105638420|NCT03737110|364340172|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
105638421|NCT03737110|364340167|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
105638422|NCT03737110|364340168|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
105638423|NCT03737110|364340169|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
105638424|NCT03737110|364340170|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
105638425|NCT03737110|364340171|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
105638426|NCT03737110|364340172|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
105638427|NCT03737110|364340167|FG000|Run-in (RI) Period|Adverse Event|4|||
105638428|NCT03737110|364340168|FG001|Run-in (RI) Period|Adverse Event|0|||
105638429|NCT03737110|364340169|FG002|Run-in (RI) Period|Adverse Event|0|||
105638430|NCT03737110|364340170|FG003|Run-in (RI) Period|Adverse Event|0|||
105638431|NCT03737110|364340171|FG004|Run-in (RI) Period|Adverse Event|0|||
105638432|NCT03737110|364340172|FG005|Run-in (RI) Period|Adverse Event|0|||
105638433|NCT03737110|364340167|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
105638434|NCT03737110|364340168|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
105638435|NCT03737110|364340169|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
105638436|NCT03737110|364340170|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
105638437|NCT03737110|364340171|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
105638438|NCT03737110|364340172|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
105638439|NCT03737110|364340167|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
105638440|NCT03737110|364340168|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
105638441|NCT03737110|364340169|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
105638442|NCT03737110|364340170|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
105638443|NCT03737110|364340171|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
105638444|NCT03737110|364340172|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
105638445|NCT03737110|364340167|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
105638446|NCT03737110|364340168|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
105638447|NCT03737110|364340169|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
105638448|NCT03737110|364340170|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
105638449|NCT03737110|364340171|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
105638450|NCT03737110|364340172|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
105638451|NCT03737110|364340167|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
105638452|NCT03737110|364340168|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
105638453|NCT03737110|364340169|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
105638454|NCT03737110|364340170|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
105638455|NCT03737110|364340171|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
105638456|NCT03737110|364340172|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
105638457|NCT03737110|364340167|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
105638458|NCT03737110|364340168|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
105638459|NCT03737110|364340169|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
105638460|NCT03737110|364340170|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
105638461|NCT03737110|364340171|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
105638462|NCT03737110|364340172|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
105638463|NCT00403494|364340173|FG000|Overall Study|Adverse Event|10|||
105638464|NCT00403494|364340174|FG001|Overall Study|Adverse Event|8|||
105638465|NCT00403494|364340173|FG000|Overall Study|Withdrew Consent|3|||
105638466|NCT00403494|364340174|FG001|Overall Study|Withdrew Consent|2|||
105638467|NCT00403494|364340173|FG000|Overall Study|Inappropriately enrolled|0|||
105638468|NCT00403494|364340174|FG001|Overall Study|Inappropriately enrolled|1|||
105638469|NCT00403494|364340173|FG000|Overall Study|Lost to Follow-up|0|||
105638470|NCT00403494|364340174|FG001|Overall Study|Lost to Follow-up|2|||
105638471|NCT00403494|364340173|FG000|Overall Study|Protocol noncompliance|0|||
105638472|NCT00403494|364340174|FG001|Overall Study|Protocol noncompliance|1|||
105638473|NCT00403494|364340173|FG000|Overall Study|Death|1|||
105638474|NCT00403494|364340174|FG001|Overall Study|Death|0|||
105638475|NCT00403494|364340173|FG000|Overall Study|Sponsor Request|1|||
105638476|NCT00403494|364340174|FG001|Overall Study|Sponsor Request|0|||
105638477|NCT00273052|364340180|FG000|Overall Study|Withdrawal by Subject|16|||
105638478|NCT00273052|364340181|FG001|Overall Study|Withdrawal by Subject|19|||
105638479|NCT00273052|364340180|FG000|Overall Study|Adverse Event|21|||
105638480|NCT00273052|364340181|FG001|Overall Study|Adverse Event|19|||
105638481|NCT00273052|364340180|FG000|Overall Study|Protocol Violation|14|||
105638482|NCT00273052|364340181|FG001|Overall Study|Protocol Violation|18|||
105638483|NCT00273052|364340180|FG000|Overall Study|Lost to Follow-up|7|||
105638484|NCT00273052|364340181|FG001|Overall Study|Lost to Follow-up|25|||
105638485|NCT00273052|364340180|FG000|Overall Study|Lack of Efficacy|6|||
105638486|NCT00273052|364340181|FG001|Overall Study|Lack of Efficacy|4|||
105638487|NCT00273052|364340180|FG000|Overall Study|Non-Compliance|3|||
105638488|NCT00273052|364340181|FG001|Overall Study|Non-Compliance|1|||
105638489|NCT00273052|364340180|FG000|Overall Study|Other|2|||
105638490|NCT00273052|364340181|FG001|Overall Study|Other|0|||
105638491|NCT00273052|364340180|FG000|Overall Study|Worsening serum lipid levels|0|||
105638492|NCT00273052|364340181|FG001|Overall Study|Worsening serum lipid levels|2|||
105638493|NCT00454194|364340185|FG000|Overall Study|Adverse Event|7|||
105638494|NCT00454194|364340186|FG001|Overall Study|Adverse Event|2|||
105638495|NCT00454194|364340185|FG000|Overall Study|Withdrawal by Subject|12|||
105638496|NCT00454194|364340186|FG001|Overall Study|Withdrawal by Subject|8|||
105638497|NCT00454194|364340185|FG000|Overall Study|Other Medical Problems|1|||
105638498|NCT00454194|364340186|FG001|Overall Study|Other Medical Problems|2|||
105638499|NCT00454194|364340185|FG000|Overall Study|Other Unspecified Reason|2|||
105638500|NCT00454194|364340186|FG001|Overall Study|Other Unspecified Reason|2|||
105638501|NCT03781375|364340189|FG000|Double-blind Phase|Adverse Event|0|||
105638502|NCT03781375|364340190|FG001|Double-blind Phase|Adverse Event|1|||
105638503|NCT03781375|364340189|FG000|Double-blind Phase|Lack of Response|6|||
105638504|NCT03781375|364340190|FG001|Double-blind Phase|Lack of Response|2|||
105638505|NCT03781375|364340189|FG000|Double-blind Phase|Other|1|||
105638506|NCT03781375|364340190|FG001|Double-blind Phase|Other|3|||
105638507|NCT03781375|364340189|FG000|Open-label Phase|Protocol Issues|0|||
105638508|NCT03781375|364340190|FG001|Open-label Phase|Protocol Issues|1|||
105638509|NCT03781375|364340189|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
105638510|NCT03781375|364340190|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
105638511|NCT03781375|364340189|FG000|Open-label Phase|Other|2|||
105638512|NCT03781375|364340190|FG001|Open-label Phase|Other|2|||
105638513|NCT01074242|364340197|FG000|Overall Study|Case report before date of contract|40|||
105638514|NCT01074242|364340197|FG000|Overall Study|Lost to Follow-up|1|||
105638515|NCT01074242|364340197|FG000|Overall Study|Case report unclear|6|||
105638516|NCT01074242|364340197|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
105638517|NCT01074242|364340197|FG000|Overall Study|Duplicate Case Report Form|5|||
105638518|NCT00526994|364340200|FG000|Overall Study|Lost to Follow-up|98|||
105638519|NCT00526994|364340201|FG001|Overall Study|Lost to Follow-up|108|||
105638520|NCT00526994|364340202|FG002|Overall Study|Lost to Follow-up|96|||
105638521|NCT00526994|364340200|FG000|Overall Study|Death|4|||
105638522|NCT00526994|364340201|FG001|Overall Study|Death|3|||
105638523|NCT00526994|364340202|FG002|Overall Study|Death|3|||
105638524|NCT00526994|364340200|FG000|Overall Study|Withdrawal by Subject|2|||
105638525|NCT00526994|364340201|FG001|Overall Study|Withdrawal by Subject|7|||
105638526|NCT00526994|364340202|FG002|Overall Study|Withdrawal by Subject|5|||
105638527|NCT00526994|364340200|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
105638528|NCT00526994|364340201|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
105638529|NCT00526994|364340202|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
105638530|NCT03026166|364340203|FG000|Overall Study|Death|22|||
105638531|NCT03026166|364340204|FG001|Overall Study|Death|7|||
105638532|NCT03026166|364340203|FG000|Overall Study|Physician Decision|2|||
105638533|NCT03026166|364340204|FG001|Overall Study|Physician Decision|0|||
105638534|NCT03026166|364340203|FG000|Overall Study|Withdrawal by Subject|1|||
105638535|NCT03026166|364340204|FG001|Overall Study|Withdrawal by Subject|2|||
105638536|NCT03026166|364340203|FG000|Overall Study|Lost to Follow-up|1|||
105638537|NCT03026166|364340204|FG001|Overall Study|Lost to Follow-up|0|||
105638538|NCT03026166|364340203|FG000|Overall Study|Study Terminated by Sponsor|3|||
105638539|NCT03026166|364340204|FG001|Overall Study|Study Terminated by Sponsor|3|||
105638540|NCT03026166|364340203|FG000|Overall Study|Other|1|||
105638541|NCT03026166|364340204|FG001|Overall Study|Other|0|||
105638542|NCT03035942|364340207|FG000|Overall Study|Adverse Event|8|||
105638543|NCT03035942|364340208|FG001|Overall Study|Adverse Event|4|||
105638544|NCT03035942|364340209|FG002|Overall Study|Adverse Event|5|||
105638545|NCT05270460|364340210|FG000|Overall Study|Adverse Event|0|||
105638546|NCT05270460|364340211|FG001|Overall Study|Adverse Event|1|||
105638547|NCT05270460|364340212|FG002|Overall Study|Adverse Event|0|||
105638548|NCT05270460|364340210|FG000|Overall Study|Early Termination|0|||
105638549|NCT05270460|364340211|FG001|Overall Study|Early Termination|1|||
105638550|NCT05270460|364340212|FG002|Overall Study|Early Termination|0|||
105638551|NCT03692871|364340214|FG000|Overall Study|Death|1|||
105638552|NCT03692871|364340215|FG001|Overall Study|Death|1|||
105638553|NCT03692871|364340214|FG000|Overall Study|Lost to Follow-up|24|||
105638554|NCT03692871|364340215|FG001|Overall Study|Lost to Follow-up|9|||
105638555|NCT03692871|364340214|FG000|Overall Study|Physician Decision|22|||
105638556|NCT03692871|364340215|FG001|Overall Study|Physician Decision|7|||
105638557|NCT03692871|364340214|FG000|Overall Study|Protocol Deviation|1|||
105638558|NCT03692871|364340215|FG001|Overall Study|Protocol Deviation|0|||
105638559|NCT03692871|364340214|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
105638560|NCT03692871|364340215|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
105638561|NCT01065779|364340217|FG000|Overall Study|Duplicate Investigation|1|||
105638562|NCT01065779|364340217|FG000|Overall Study|Investigation Before Contract Date|37|||
105638563|NCT01065779|364340217|FG000|Overall Study|Non-enrollment Period Administration|10|||
105638564|NCT01065779|364340217|FG000|Overall Study|Not Administered With Study Drug|17|||
105638565|NCT01065779|364340217|FG000|Overall Study|Failed to Follow-up|10|||
105638566|NCT01065779|364340217|FG000|Overall Study|Inclusion Criteria Violation|7|||
105638567|NCT02157948|364340221|FG000|Overall Study|Withdrawal by Subject|4|||
105638568|NCT02157948|364340222|FG001|Overall Study|Withdrawal by Subject|5|||
105638569|NCT02157948|364340221|FG000|Overall Study|Lost to Follow-up|3|||
105638570|NCT02157948|364340222|FG001|Overall Study|Lost to Follow-up|2|||
105638571|NCT02157948|364340221|FG000|Overall Study|Protocol Specified Criteria|2|||
105638572|NCT02157948|364340222|FG001|Overall Study|Protocol Specified Criteria|1|||
105638573|NCT02157948|364340221|FG000|Overall Study|Decision by Sponsor|0|||
105638574|NCT02157948|364340222|FG001|Overall Study|Decision by Sponsor|1|||
105638575|NCT02852824|364340225|FG000|Overall Study|Withdrawal by Subject|1|||
105638576|NCT02852824|364340226|FG001|Overall Study|Withdrawal by Subject|0|||
105638577|NCT02852824|364340227|FG002|Overall Study|Withdrawal by Subject|0|||
105638578|NCT02852824|364340228|FG003|Overall Study|Withdrawal by Subject|0|||
105638579|NCT02852824|364340229|FG004|Overall Study|Withdrawal by Subject|0|||
105638580|NCT02852824|364340230|FG005|Overall Study|Withdrawal by Subject|0|||
105638581|NCT02852824|364340231|FG006|Overall Study|Withdrawal by Subject|0|||
105638582|NCT02852824|364340225|FG000|Overall Study|Adverse Event|0|||
105638583|NCT02852824|364340226|FG001|Overall Study|Adverse Event|0|||
105638584|NCT02852824|364340227|FG002|Overall Study|Adverse Event|0|||
105638585|NCT02852824|364340228|FG003|Overall Study|Adverse Event|0|||
105638586|NCT02852824|364340229|FG004|Overall Study|Adverse Event|2|||
105638587|NCT02852824|364340230|FG005|Overall Study|Adverse Event|0|||
105638588|NCT02852824|364340231|FG006|Overall Study|Adverse Event|0|||
105638589|NCT05169684|364340232|FG000|Overall Study|Adverse Event|1|||
105638590|NCT05169684|364340233|FG001|Overall Study|Adverse Event|3|||
105638591|NCT05169684|364340232|FG000|Overall Study|Physician Decision|0|||
105638592|NCT05169684|364340233|FG001|Overall Study|Physician Decision|1|||
105638593|NCT05169684|364340232|FG000|Overall Study|Progressive Disease|1|||
105638594|NCT05169684|364340233|FG001|Overall Study|Progressive Disease|1|||
105638595|NCT05169684|364340232|FG000|Overall Study|Participant request to discontinue treatment|0|||
105638596|NCT05169684|364340233|FG001|Overall Study|Participant request to discontinue treatment|1|||
105638597|NCT05169684|364340232|FG000|Overall Study|Other Reason|0|||
105638598|NCT05169684|364340233|FG001|Overall Study|Other Reason|1|||
105638599|NCT01668719|364340234|FG000|Phase I|On treatment|1|||
105638600|NCT01668719|364340235|FG001|Phase I|On treatment|0|||
105638601|NCT01668719|364340236|FG002|Phase I|On treatment|0|||
105638602|NCT01668719|364340234|FG000|Phase I|Adverse Event|2|||
105638603|NCT01668719|364340235|FG001|Phase I|Adverse Event|0|||
105638604|NCT01668719|364340236|FG002|Phase I|Adverse Event|0|||
105638605|NCT01668719|364340234|FG000|Phase I|Progression/relapse|1|||
105638606|NCT01668719|364340235|FG001|Phase I|Progression/relapse|0|||
105638607|NCT01668719|364340236|FG002|Phase I|Progression/relapse|0|||
105638608|NCT01668719|364340234|FG000|Phase I|not protocol specified|2|||
105638609|NCT01668719|364340235|FG001|Phase I|not protocol specified|0|||
105638610|NCT01668719|364340236|FG002|Phase I|not protocol specified|0|||
105638611|NCT01668719|364340234|FG000|Phase II|On treatment|0|||
105638612|NCT01668719|364340235|FG001|Phase II|On treatment|4|||
105638613|NCT01668719|364340236|FG002|Phase II|On treatment|3|||
105638614|NCT01668719|364340234|FG000|Phase II|Adverse Event|0|||
105638615|NCT01668719|364340235|FG001|Phase II|Adverse Event|18|||
105638616|NCT01668719|364340236|FG002|Phase II|Adverse Event|18|||
105638617|NCT01668719|364340234|FG000|Phase II|Refusal unrelated to adverse event|0|||
105638618|NCT01668719|364340235|FG001|Phase II|Refusal unrelated to adverse event|4|||
105638619|NCT01668719|364340236|FG002|Phase II|Refusal unrelated to adverse event|1|||
105638620|NCT01668719|364340234|FG000|Phase II|Progression/relapse|0|||
105638621|NCT01668719|364340235|FG001|Phase II|Progression/relapse|13|||
105638622|NCT01668719|364340236|FG002|Phase II|Progression/relapse|17|||
105638623|NCT01668719|364340234|FG000|Phase II|Death|0|||
105638624|NCT01668719|364340235|FG001|Phase II|Death|0|||
105638625|NCT01668719|364340236|FG002|Phase II|Death|2|||
105638626|NCT01668719|364340234|FG000|Phase II|not protocol specified|0|||
105638627|NCT01668719|364340235|FG001|Phase II|not protocol specified|13|||
105638628|NCT01668719|364340236|FG002|Phase II|not protocol specified|7|||
105638629|NCT00452114|364340239|FG000|Overall Study|Physician Decision|3|||
105638630|NCT00452114|364340240|FG001|Overall Study|Physician Decision|3|||
105638631|NCT03905642|364340241|FG000|Overall Study|Withdrawal by Subject|3|||
105638632|NCT03905642|364340241|FG000|Overall Study|Pregnancy|1|||
105638633|NCT03905642|364340241|FG000|Overall Study|Adverse Event|1|||
105638634|NCT03905642|364340241|FG000|Overall Study|Lack of Efficacy|1|||
105638635|NCT03905642|364340241|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
105638636|NCT03786471|364340252|FG000|Overall Study|Death|254|||
105638637|NCT03786471|364340253|FG001|Overall Study|Death|223|||
105638638|NCT03786471|364340254|FG002|Overall Study|Death|37|||
105638639|NCT03786471|364340252|FG000|Overall Study|Lost to Follow-up|63|||
105638640|NCT03786471|364340253|FG001|Overall Study|Lost to Follow-up|50|||
105638641|NCT03786471|364340254|FG002|Overall Study|Lost to Follow-up|15|||
105638642|NCT03786471|364340252|FG000|Overall Study|Withdrawal by Subject|99|||
105638643|NCT03786471|364340253|FG001|Overall Study|Withdrawal by Subject|81|||
105638644|NCT03786471|364340254|FG002|Overall Study|Withdrawal by Subject|11|||
105638645|NCT00949117|364341709|FG000|Overall Study|Lack of Efficacy|2|||
105638646|NCT00949117|364341710|FG001|Overall Study|Lack of Efficacy|3|||
105638647|NCT00949117|364341709|FG000|Overall Study|Protocol Violation|1|||
105638648|NCT00949117|364341710|FG001|Overall Study|Protocol Violation|1|||
105638649|NCT00949117|364341709|FG000|Overall Study|Adverse Event|0|||
105638650|NCT00949117|364341710|FG001|Overall Study|Adverse Event|1|||
105638651|NCT02014402|364341711|FG000|Overall Study|Adverse Event|1|||
105638652|NCT02014402|364341712|FG001|Overall Study|Adverse Event|0|||
105638653|NCT02014402|364341713|FG002|Overall Study|Adverse Event|0|||
105638654|NCT02014402|364341714|FG003|Overall Study|Adverse Event|0|||
105638655|NCT02014402|364341711|FG000|Overall Study|Withdrawal by Subject|1|||
105638656|NCT02014402|364341712|FG001|Overall Study|Withdrawal by Subject|2|||
105638657|NCT02014402|364341713|FG002|Overall Study|Withdrawal by Subject|2|||
105638658|NCT02014402|364341714|FG003|Overall Study|Withdrawal by Subject|1|||
105638659|NCT02014402|364341711|FG000|Overall Study|Subject did not have transportation|0|||
105638660|NCT02014402|364341712|FG001|Overall Study|Subject did not have transportation|1|||
105659331|NCT00551135|364417282|FG002|Overall Study|Adverse Event|1|||
105638661|NCT02014402|364341713|FG002|Overall Study|Subject did not have transportation|0|||
105638662|NCT02014402|364341714|FG003|Overall Study|Subject did not have transportation|0|||
105638663|NCT02014402|364341711|FG000|Overall Study|Lost to Follow-up|0|||
105638664|NCT02014402|364341712|FG001|Overall Study|Lost to Follow-up|0|||
105638665|NCT02014402|364341713|FG002|Overall Study|Lost to Follow-up|1|||
105638666|NCT02014402|364341714|FG003|Overall Study|Lost to Follow-up|2|||
105638667|NCT01523392|364341715|FG000|Treatment Period 1|Withdrawal by Subject|2|||
105638668|NCT01523392|364341716|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105638669|NCT01523392|364341715|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
105638670|NCT01523392|364341716|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
105638671|NCT01523392|364341715|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
105638672|NCT01523392|364341716|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
105638673|NCT02038049|364341721|FG000|Overall Study|Lost to Follow-up|1|||
105638674|NCT02038049|364341722|FG001|Overall Study|Lost to Follow-up|0|||
105638675|NCT02771366|364341723|FG000|Period 1|Withdrawal by Subject|0|||
105638676|NCT02771366|364341724|FG001|Period 1|Withdrawal by Subject|2|||
105638677|NCT02771366|364341723|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
105638678|NCT02771366|364341724|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
105638679|NCT00671853|364341727|FG000|Overall Study|Lack of Efficacy|3|||
105638680|NCT00671853|364341728|FG001|Overall Study|Lack of Efficacy|7|||
105638681|NCT00671853|364341727|FG000|Overall Study|Adverse Event|7|||
105638682|NCT00671853|364341728|FG001|Overall Study|Adverse Event|1|||
105638683|NCT00671853|364341727|FG000|Overall Study|Withdrawal by Subject|1|||
105638684|NCT00671853|364341728|FG001|Overall Study|Withdrawal by Subject|5|||
105638685|NCT00671853|364341727|FG000|Overall Study|Lost to Follow-up|8|||
105638686|NCT00671853|364341728|FG001|Overall Study|Lost to Follow-up|8|||
105638687|NCT00671853|364341727|FG000|Overall Study|Physician Decision|0|||
105638688|NCT00671853|364341728|FG001|Overall Study|Physician Decision|2|||
105638689|NCT00671853|364341727|FG000|Overall Study|Non-adherence with study procedures|1|||
105638690|NCT00671853|364341728|FG001|Overall Study|Non-adherence with study procedures|4|||
105638691|NCT02660086|364341729|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
105638692|NCT02660086|364341730|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
105638693|NCT02660086|364341729|FG000|Overall Study- 12-month|Left full-time employment|12|||
105638694|NCT02660086|364341730|FG001|Overall Study- 12-month|Left full-time employment|20|||
105638695|NCT02660086|364341729|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
105638696|NCT02660086|364341730|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
105638697|NCT02660086|364341729|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
105638698|NCT02660086|364341730|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
105638699|NCT02660086|364341729|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
105638700|NCT02660086|364341730|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
105638701|NCT02660086|364341729|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
105638702|NCT02660086|364341730|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
105638703|NCT01719172|364341731|FG000|Overall Study|Lost to Follow-up|1|||
105638704|NCT01719172|364341731|FG000|Overall Study|Death|1|||
105638705|NCT01583166|364341732|FG000|Overall Study|Withdrawal by Subject|4|||
105638706|NCT01583166|364341733|FG001|Overall Study|Withdrawal by Subject|6|||
105638707|NCT03403036|364341734|FG000|Overall Study|Lack of Efficacy|5|||
105638708|NCT02701296|364341735|FG000|Overall Study|Incomplete Data|0|||
105638709|NCT02701296|364341736|FG001|Overall Study|Incomplete Data|2|||
105638710|NCT01409837|364341737|FG000|Overall Study|Withdrawal by Subject|2|||
105638711|NCT01409837|364341738|FG001|Overall Study|Withdrawal by Subject|1|||
105638712|NCT01409837|364341737|FG000|Overall Study|Lost to Follow-up|1|||
105638713|NCT01409837|364341738|FG001|Overall Study|Lost to Follow-up|0|||
105638714|NCT01409837|364341737|FG000|Overall Study|Physician Decision|0|||
105638715|NCT01409837|364341738|FG001|Overall Study|Physician Decision|1|||
105638716|NCT00240994|364341741|FG000|Overall Study|Lost to Follow-up|1|||
105638717|NCT00240994|364341741|FG000|Overall Study|Protocol Violation|1|||
105638718|NCT00240994|364341741|FG000|Overall Study|Graft failure|1|||
105638719|NCT00670488|364341743|FG000|Overall Study|Adverse Event|0|||
105638720|NCT00670488|364341744|FG001|Overall Study|Adverse Event|7|||
105638721|NCT00670488|364341745|FG002|Overall Study|Adverse Event|0|||
105638722|NCT00670488|364341746|FG003|Overall Study|Adverse Event|3|||
105638723|NCT00670488|364341747|FG004|Overall Study|Adverse Event|1|||
105638724|NCT00670488|364341748|FG005|Overall Study|Adverse Event|1|||
105638725|NCT00670488|364341749|FG006|Overall Study|Adverse Event|5|||
105638726|NCT00670488|364341750|FG007|Overall Study|Adverse Event|1|||
105638727|NCT00670488|364341751|FG008|Overall Study|Adverse Event|0|||
105638728|NCT00670488|364341752|FG009|Overall Study|Adverse Event|1|||
105638729|NCT00670488|364341743|FG000|Overall Study|Physician Decision|1|||
105638730|NCT00670488|364341744|FG001|Overall Study|Physician Decision|9|||
105638731|NCT00670488|364341745|FG002|Overall Study|Physician Decision|0|||
105638732|NCT00670488|364341746|FG003|Overall Study|Physician Decision|1|||
105638733|NCT00670488|364341747|FG004|Overall Study|Physician Decision|0|||
105638734|NCT00670488|364341748|FG005|Overall Study|Physician Decision|0|||
105638735|NCT00670488|364341749|FG006|Overall Study|Physician Decision|0|||
105638736|NCT00670488|364341750|FG007|Overall Study|Physician Decision|0|||
105638737|NCT00670488|364341751|FG008|Overall Study|Physician Decision|0|||
105638738|NCT00670488|364341752|FG009|Overall Study|Physician Decision|0|||
105638739|NCT00670488|364341743|FG000|Overall Study|Progressive Disease|2|||
105638740|NCT00670488|364341744|FG001|Overall Study|Progressive Disease|41|||
105638741|NCT00670488|364341745|FG002|Overall Study|Progressive Disease|3|||
105638742|NCT00670488|364341746|FG003|Overall Study|Progressive Disease|2|||
105638743|NCT00670488|364341747|FG004|Overall Study|Progressive Disease|2|||
105638744|NCT00670488|364341748|FG005|Overall Study|Progressive Disease|4|||
105638745|NCT00670488|364341749|FG006|Overall Study|Progressive Disease|11|||
105638746|NCT00670488|364341750|FG007|Overall Study|Progressive Disease|2|||
105638747|NCT00670488|364341751|FG008|Overall Study|Progressive Disease|2|||
105638748|NCT00670488|364341752|FG009|Overall Study|Progressive Disease|1|||
105638749|NCT00670488|364341743|FG000|Overall Study|Withdrawal by Subject|0|||
105638750|NCT00670488|364341744|FG001|Overall Study|Withdrawal by Subject|1|||
105638751|NCT00670488|364341745|FG002|Overall Study|Withdrawal by Subject|0|||
105638752|NCT00670488|364341746|FG003|Overall Study|Withdrawal by Subject|1|||
105638753|NCT00670488|364341747|FG004|Overall Study|Withdrawal by Subject|0|||
105638754|NCT00670488|364341748|FG005|Overall Study|Withdrawal by Subject|0|||
105638755|NCT00670488|364341749|FG006|Overall Study|Withdrawal by Subject|1|||
105638756|NCT00670488|364341750|FG007|Overall Study|Withdrawal by Subject|0|||
105638757|NCT00670488|364341751|FG008|Overall Study|Withdrawal by Subject|1|||
105638758|NCT00670488|364341752|FG009|Overall Study|Withdrawal by Subject|0|||
105638759|NCT00310037|364341753|FG000|Overall Study|Adverse Event|7|||
105638760|NCT00310037|364341754|FG001|Overall Study|Adverse Event|14|||
105638761|NCT00310037|364341753|FG000|Overall Study|Withdrawal by Subject|4|||
105638762|NCT00310037|364341754|FG001|Overall Study|Withdrawal by Subject|3|||
105638763|NCT00310037|364341753|FG000|Overall Study|Progression|6|||
105638764|NCT00310037|364341754|FG001|Overall Study|Progression|0|||
105638765|NCT00310037|364341753|FG000|Overall Study|Non-protocol treatment|1|||
105638766|NCT00310037|364341754|FG001|Overall Study|Non-protocol treatment|0|||
105638767|NCT02169414|364341758|FG000|Overall Study|Withdrawal by Subject|1|||
105638768|NCT02169414|364341759|FG001|Overall Study|Withdrawal by Subject|0|||
105638769|NCT02169414|364341760|FG002|Overall Study|Withdrawal by Subject|0|||
105638770|NCT02169414|364341761|FG003|Overall Study|Withdrawal by Subject|0|||
105638771|NCT02169414|364341758|FG000|Overall Study|Adverse Event|0|||
105638772|NCT02169414|364341759|FG001|Overall Study|Adverse Event|1|||
105638773|NCT02169414|364341760|FG002|Overall Study|Adverse Event|0|||
105638774|NCT02169414|364341761|FG003|Overall Study|Adverse Event|0|||
105638775|NCT03374254|364341762|FG000|Overall Study|Death|5|||
105638776|NCT03374254|364341763|FG001|Overall Study|Death|16|||
105638777|NCT03374254|364341764|FG002|Overall Study|Death|13|||
105638778|NCT03374254|364341765|FG003|Overall Study|Death|11|||
105638779|NCT03374254|364341766|FG004|Overall Study|Death|9|||
105638780|NCT03374254|364341767|FG005|Overall Study|Death|12|||
105638781|NCT03374254|364341768|FG006|Overall Study|Death|11|||
105638782|NCT03374254|364341769|FG007|Overall Study|Death|6|||
105638783|NCT03374254|364341770|FG008|Overall Study|Death|7|||
105638784|NCT03374254|364341762|FG000|Overall Study|Lost to Follow-up|0|||
105638785|NCT03374254|364341763|FG001|Overall Study|Lost to Follow-up|0|||
105638786|NCT03374254|364341764|FG002|Overall Study|Lost to Follow-up|0|||
105638787|NCT03374254|364341765|FG003|Overall Study|Lost to Follow-up|0|||
105638788|NCT03374254|364341766|FG004|Overall Study|Lost to Follow-up|0|||
105638789|NCT03374254|364341767|FG005|Overall Study|Lost to Follow-up|0|||
105638790|NCT03374254|364341768|FG006|Overall Study|Lost to Follow-up|2|||
105638791|NCT03374254|364341769|FG007|Overall Study|Lost to Follow-up|0|||
105638792|NCT03374254|364341770|FG008|Overall Study|Lost to Follow-up|0|||
105638793|NCT03374254|364341762|FG000|Overall Study|Sponsor Decision|1|||
105638794|NCT03374254|364341763|FG001|Overall Study|Sponsor Decision|0|||
105638795|NCT03374254|364341764|FG002|Overall Study|Sponsor Decision|2|||
105638796|NCT03374254|364341765|FG003|Overall Study|Sponsor Decision|3|||
105638797|NCT03374254|364341766|FG004|Overall Study|Sponsor Decision|2|||
105638798|NCT03374254|364341767|FG005|Overall Study|Sponsor Decision|3|||
105638799|NCT03374254|364341768|FG006|Overall Study|Sponsor Decision|3|||
105638800|NCT03374254|364341769|FG007|Overall Study|Sponsor Decision|3|||
105638801|NCT03374254|364341770|FG008|Overall Study|Sponsor Decision|4|||
105638802|NCT03374254|364341762|FG000|Overall Study|Withdrawal by Subject|0|||
105638803|NCT03374254|364341763|FG001|Overall Study|Withdrawal by Subject|0|||
105638804|NCT03374254|364341764|FG002|Overall Study|Withdrawal by Subject|0|||
105638805|NCT03374254|364341765|FG003|Overall Study|Withdrawal by Subject|2|||
105638806|NCT03374254|364341766|FG004|Overall Study|Withdrawal by Subject|0|||
105638807|NCT03374254|364341767|FG005|Overall Study|Withdrawal by Subject|1|||
105638808|NCT03374254|364341768|FG006|Overall Study|Withdrawal by Subject|0|||
105638809|NCT03374254|364341769|FG007|Overall Study|Withdrawal by Subject|0|||
105638810|NCT03374254|364341770|FG008|Overall Study|Withdrawal by Subject|0|||
105638811|NCT04803734|364341771|FG000|Overall Study|Withdrawal by Subject|0|||
105638812|NCT04803734|364341772|FG001|Overall Study|Withdrawal by Subject|1|||
105638813|NCT04803734|364341771|FG000|Overall Study|Protocol Violation|0|||
105638814|NCT04803734|364341772|FG001|Overall Study|Protocol Violation|1|||
105638815|NCT00195819|364341776|FG000|Double-Blind|Withdrawal by Subject|1|||
105638816|NCT00195819|364341777|FG001|Double-Blind|Withdrawal by Subject|0|||
105638817|NCT00195819|364341776|FG000|Double-Blind|Moved|1|||
105638818|NCT00195819|364341777|FG001|Double-Blind|Moved|0|||
105638819|NCT00195819|364341776|FG000|Open-label|Adverse Event|0|||
105638820|NCT00195819|364341777|FG001|Open-label|Adverse Event|9|||
105638821|NCT00195819|364341776|FG000|Open-label|Lack of Efficacy|0|||
105638822|NCT00195819|364341777|FG001|Open-label|Lack of Efficacy|2|||
105638823|NCT00195819|364341776|FG000|Open-label|Pregnancy|0|||
105638824|NCT00195819|364341777|FG001|Open-label|Pregnancy|1|||
105638825|NCT00195819|364341776|FG000|Open-label|Protocol Violation|0|||
105638826|NCT00195819|364341777|FG001|Open-label|Protocol Violation|2|||
105638827|NCT00195819|364341776|FG000|Open-label|Moved|0|||
105638828|NCT00195819|364341777|FG001|Open-label|Moved|1|||
105638829|NCT00195819|364341776|FG000|Open-label|Withdrawal by Subject|0|||
105638830|NCT00195819|364341777|FG001|Open-label|Withdrawal by Subject|5|||
105638831|NCT01858688|364341778|FG000|Overall Study|Withdrawal by Subject|8|||
105638832|NCT01858688|364341778|FG000|Overall Study|Participant began another therapy|3|||
105638833|NCT01858688|364341778|FG000|Overall Study|Physician Decision|2|||
105638834|NCT01858688|364341778|FG000|Overall Study|Progressive Disease|2|||
105638835|NCT01858688|364341778|FG000|Overall Study|Reason not reproted|5|||
105638836|NCT00822900|364341782|FG000|Overall Study|Withdrawal by Subject|14|||
105638837|NCT00822900|364341783|FG001|Overall Study|Withdrawal by Subject|14|||
105638838|NCT00822900|364341782|FG000|Overall Study|Lost to Follow-up|9|||
105638839|NCT00822900|364341783|FG001|Overall Study|Lost to Follow-up|9|||
105638840|NCT00822900|364341782|FG000|Overall Study|Death|83|||
105638841|NCT00822900|364341783|FG001|Overall Study|Death|69|||
105638842|NCT00822900|364341782|FG000|Overall Study|Became a ward of the state|2|||
105638843|NCT00822900|364341783|FG001|Overall Study|Became a ward of the state|1|||
105638844|NCT01972776|364341790|FG000|Part 1|Withdrawal by Subject|0|||
105638845|NCT01972776|364341791|FG001|Part 1|Withdrawal by Subject|0|||
105638846|NCT01972776|364341792|FG002|Part 1|Withdrawal by Subject|1|||
105638847|NCT01972776|364341793|FG003|Part 1|Withdrawal by Subject|0|||
105638848|NCT01972776|364341794|FG004|Part 1|Withdrawal by Subject|0|||
105638849|NCT01972776|364341795|FG005|Part 1|Withdrawal by Subject|0|||
105638850|NCT01972776|364341790|FG000|Part 1|Adverse Event|0|||
105638851|NCT01972776|364341791|FG001|Part 1|Adverse Event|0|||
105638852|NCT01972776|364341792|FG002|Part 1|Adverse Event|1|||
105638853|NCT01972776|364341793|FG003|Part 1|Adverse Event|1|||
105638854|NCT01972776|364341794|FG004|Part 1|Adverse Event|0|||
105638855|NCT01972776|364341795|FG005|Part 1|Adverse Event|0|||
105638856|NCT01972776|364341790|FG000|Part 2|Adverse Event|0|||
105638857|NCT01972776|364341791|FG001|Part 2|Adverse Event|0|||
105638858|NCT01972776|364341792|FG002|Part 2|Adverse Event|0|||
105638859|NCT01972776|364341793|FG003|Part 2|Adverse Event|0|||
105638860|NCT01972776|364341794|FG004|Part 2|Adverse Event|3|||
105638861|NCT01972776|364341795|FG005|Part 2|Adverse Event|0|||
105638862|NCT01972776|364341790|FG000|Part 2|Administrative problems|0|||
105638863|NCT01972776|364341791|FG001|Part 2|Administrative problems|0|||
105638864|NCT01972776|364341792|FG002|Part 2|Administrative problems|0|||
105638865|NCT01972776|364341793|FG003|Part 2|Administrative problems|0|||
105638866|NCT01972776|364341794|FG004|Part 2|Administrative problems|10|||
105638867|NCT01972776|364341795|FG005|Part 2|Administrative problems|7|||
105638868|NCT01220999|364341797|FG000|Overall Study|Progressive disease|0|||
105638869|NCT01220999|364341798|FG001|Overall Study|Progressive disease|0|||
105638870|NCT01220999|364341799|FG002|Overall Study|Progressive disease|1|||
105638871|NCT01220999|364341800|FG003|Overall Study|Progressive disease|0|||
105638872|NCT01220999|364341801|FG004|Overall Study|Progressive disease|0|||
105638873|NCT00380250|364341803|FG000|Overall Study|Withdrawal by Subject|39|||
105638874|NCT00380250|364341804|FG001|Overall Study|Withdrawal by Subject|28|||
105638875|NCT00380250|364341803|FG000|Overall Study|Adverse Event|20|||
105638876|NCT00380250|364341804|FG001|Overall Study|Adverse Event|9|||
105638877|NCT00380250|364341803|FG000|Overall Study|Lack of Efficacy|10|||
105638878|NCT00380250|364341804|FG001|Overall Study|Lack of Efficacy|8|||
105638879|NCT00380250|364341803|FG000|Overall Study|Protocol Violation|15|||
105638880|NCT00380250|364341804|FG001|Overall Study|Protocol Violation|5|||
105638881|NCT00380250|364341803|FG000|Overall Study|Lost to Follow-up|14|||
105638882|NCT00380250|364341804|FG001|Overall Study|Lost to Follow-up|5|||
105638883|NCT00380250|364341803|FG000|Overall Study|Physician Decision|1|||
105638884|NCT00380250|364341804|FG001|Overall Study|Physician Decision|0|||
105638885|NCT03288506|364341806|FG000|Overall Study|Withdrawal by Subject|52|||
105638886|NCT02833948|364341811|FG000|Overall Study|Death|2|||
105638887|NCT02833948|364341812|FG001|Overall Study|Death|3|||
105638888|NCT02833948|364341811|FG000|Overall Study|were not scanned|8|||
105638889|NCT02833948|364341812|FG001|Overall Study|were not scanned|13|||
105638890|NCT02833948|364341811|FG000|Overall Study|scans could not be evaluated|5|||
105638891|NCT02833948|364341812|FG001|Overall Study|scans could not be evaluated|2|||
105638892|NCT05484661|364341814|FG000|Overall Study|Withdrawal by Subject|1|||
105638893|NCT05484661|364341815|FG001|Overall Study|Withdrawal by Subject|0|||
105638894|NCT03775213|364341816|FG000|Overall Study|Withdrawal by Subject|51|||
105638895|NCT03775213|364341817|FG001|Overall Study|Withdrawal by Subject|53|||
105638896|NCT03775213|364341816|FG000|Overall Study|Incomplete Survey|7|||
105638897|NCT03775213|364341817|FG001|Overall Study|Incomplete Survey|7|||
105638898|NCT01880736|364341824|FG000|Overall Study|Adverse Event|0|||
105638899|NCT01880736|364341825|FG001|Overall Study|Adverse Event|0|||
105638900|NCT01880736|364341826|FG002|Overall Study|Adverse Event|0|||
105638901|NCT01880736|364341827|FG003|Overall Study|Adverse Event|1|||
105638902|NCT01880736|364341824|FG000|Overall Study|Withdrawal Criteria|1|||
105638903|NCT01880736|364341825|FG001|Overall Study|Withdrawal Criteria|2|||
105638904|NCT01880736|364341826|FG002|Overall Study|Withdrawal Criteria|1|||
105638905|NCT01880736|364341827|FG003|Overall Study|Withdrawal Criteria|5|||
105638906|NCT02203032|364341831|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
105638907|NCT02203032|364341832|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
105638908|NCT02203032|364341833|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
105638909|NCT02203032|364341834|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
105638910|NCT02203032|364341831|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
105638911|NCT02203032|364341832|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
105638912|NCT02203032|364341833|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
105638913|NCT02203032|364341834|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
105638914|NCT02203032|364341831|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
105638915|NCT02203032|364341832|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
105638916|NCT02203032|364341833|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
105638917|NCT02203032|364341834|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
105638918|NCT02203032|364341831|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
105638919|NCT02203032|364341832|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
105638920|NCT02203032|364341833|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
105638921|NCT02203032|364341834|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
105638922|NCT02203032|364341831|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
105638923|NCT02203032|364341832|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
105638924|NCT02203032|364341833|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
105638925|NCT02203032|364341834|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
105638926|NCT02203032|364341831|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
105638927|NCT02203032|364341832|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
105638928|NCT02203032|364341833|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
105638929|NCT02203032|364341834|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
105638930|NCT02203032|364341831|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
105638931|NCT02203032|364341832|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
105638932|NCT02203032|364341833|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
105638933|NCT02203032|364341834|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
105638934|NCT02203032|364341831|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
105638935|NCT02203032|364341832|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
105638936|NCT02203032|364341833|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
105638937|NCT02203032|364341834|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
105638938|NCT02203032|364341831|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
105638939|NCT02203032|364341832|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
105638940|NCT02203032|364341833|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
105638941|NCT02203032|364341834|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
105638942|NCT02203032|364341831|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
105638943|NCT02203032|364341832|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
105638944|NCT02203032|364341833|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
105638945|NCT02203032|364341834|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
105638946|NCT02203032|364341831|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
105638947|NCT02203032|364341832|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
105638948|NCT02203032|364341833|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
105638949|NCT02203032|364341834|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
105638950|NCT02203032|364341831|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
105638951|NCT02203032|364341832|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
105638952|NCT02203032|364341833|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
105638953|NCT02203032|364341834|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
105638954|NCT01915914|364341835|FG000|Acute Phase|Withdrawal by Subject|4|||
105638955|NCT01915914|364341836|FG001|Acute Phase|Withdrawal by Subject|0|||
105638956|NCT01915914|364341837|FG002|Acute Phase|Withdrawal by Subject|0|||
105638957|NCT01915914|364341838|FG003|Acute Phase|Withdrawal by Subject|0|||
105638958|NCT01915914|364341835|FG000|Acute Phase|Lost to Follow-up|4|||
105638959|NCT01915914|364341836|FG001|Acute Phase|Lost to Follow-up|0|||
105638960|NCT01915914|364341837|FG002|Acute Phase|Lost to Follow-up|0|||
105638961|NCT01915914|364341838|FG003|Acute Phase|Lost to Follow-up|0|||
105638962|NCT01915914|364341835|FG000|Acute Phase|Physician Decision|1|||
105638963|NCT01915914|364341836|FG001|Acute Phase|Physician Decision|0|||
105638964|NCT01915914|364341837|FG002|Acute Phase|Physician Decision|0|||
105638965|NCT01915914|364341838|FG003|Acute Phase|Physician Decision|0|||
105638966|NCT01915914|364341835|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
105638967|NCT01915914|364341836|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
105638968|NCT01915914|364341837|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
105638969|NCT01915914|364341838|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
105638970|NCT01915914|364341835|FG000|Acute Phase|"Not Achieved treatment success"|1|||
105638971|NCT01915914|364341836|FG001|Acute Phase|"Not Achieved treatment success"|0|||
105638972|NCT01915914|364341837|FG002|Acute Phase|"Not Achieved treatment success"|0|||
105638973|NCT01915914|364341838|FG003|Acute Phase|"Not Achieved treatment success"|0|||
105638974|NCT01915914|364341835|FG000|Acute Phase|Missing|1|||
105638975|NCT01915914|364341836|FG001|Acute Phase|Missing|0|||
105638976|NCT01915914|364341837|FG002|Acute Phase|Missing|0|||
105638977|NCT01915914|364341838|FG003|Acute Phase|Missing|0|||
105638978|NCT01915914|364341835|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105638979|NCT01915914|364341836|FG001|Maintenance Phase|Withdrawal by Subject|1|||
105638980|NCT01915914|364341837|FG002|Maintenance Phase|Withdrawal by Subject|1|||
105638981|NCT01915914|364341838|FG003|Maintenance Phase|Withdrawal by Subject|0|||
105638982|NCT01915914|364341835|FG000|Maintenance Phase|Lost to Follow-up|0|||
105638983|NCT01915914|364341836|FG001|Maintenance Phase|Lost to Follow-up|4|||
105638984|NCT01915914|364341837|FG002|Maintenance Phase|Lost to Follow-up|1|||
105638985|NCT01915914|364341838|FG003|Maintenance Phase|Lost to Follow-up|0|||
105638986|NCT01915914|364341835|FG000|Maintenance Phase|Missing|0|||
105638987|NCT01915914|364341836|FG001|Maintenance Phase|Missing|1|||
105638988|NCT01915914|364341837|FG002|Maintenance Phase|Missing|0|||
105638989|NCT01915914|364341838|FG003|Maintenance Phase|Missing|0|||
105638990|NCT01915914|364341835|FG000|Follow-up Phase|Withdrawal by Subject|0|||
105638991|NCT01915914|364341836|FG001|Follow-up Phase|Withdrawal by Subject|0|||
105659332|NCT00551135|364417283|FG003|Overall Study|Adverse Event|1|||
105638992|NCT01915914|364341837|FG002|Follow-up Phase|Withdrawal by Subject|0|||
105638993|NCT01915914|364341838|FG003|Follow-up Phase|Withdrawal by Subject|1|||
105638994|NCT01915914|364341835|FG000|Follow-up Phase|Physician Decision|0|||
105638995|NCT01915914|364341836|FG001|Follow-up Phase|Physician Decision|0|||
105638996|NCT01915914|364341837|FG002|Follow-up Phase|Physician Decision|0|||
105638997|NCT01915914|364341838|FG003|Follow-up Phase|Physician Decision|1|||
105638998|NCT00960206|364341839|FG000|Overall Study|Death|7|||
105638999|NCT00960206|364341840|FG001|Overall Study|Death|4|||
105639000|NCT00960206|364341841|FG002|Overall Study|Death|1|||
105639001|NCT00960206|364341839|FG000|Overall Study|Unwilling/Unable to return|1|||
105639002|NCT00960206|364341840|FG001|Overall Study|Unwilling/Unable to return|2|||
105639003|NCT00960206|364341841|FG002|Overall Study|Unwilling/Unable to return|0|||
105639004|NCT00960206|364341839|FG000|Overall Study|Lost to Follow-up|8|||
105639005|NCT00960206|364341840|FG001|Overall Study|Lost to Follow-up|14|||
105639006|NCT00960206|364341841|FG002|Overall Study|Lost to Follow-up|8|||
105639007|NCT00960206|364341839|FG000|Overall Study|Withdrawal by Subject|2|||
105639008|NCT00960206|364341840|FG001|Overall Study|Withdrawal by Subject|4|||
105639009|NCT00960206|364341841|FG002|Overall Study|Withdrawal by Subject|0|||
105639010|NCT00960206|364341839|FG000|Overall Study|Revision of study component|2|||
105639011|NCT00960206|364341840|FG001|Overall Study|Revision of study component|2|||
105639012|NCT00960206|364341841|FG002|Overall Study|Revision of study component|2|||
105639013|NCT00960206|364341839|FG000|Overall Study|Missing 10 year data|20|||
105639014|NCT00960206|364341840|FG001|Overall Study|Missing 10 year data|1|||
105639015|NCT00960206|364341841|FG002|Overall Study|Missing 10 year data|1|||
105639016|NCT02326220|364341844|FG000|Double-blind Treatment Period|Adverse Event|1|||
105639017|NCT02326220|364341845|FG001|Double-blind Treatment Period|Adverse Event|2|||
105639018|NCT02326220|364341846|FG002|Double-blind Treatment Period|Adverse Event|0|||
105639019|NCT02326220|364341844|FG000|Double-blind Treatment Period|Protocol Violation|0|||
105639020|NCT02326220|364341845|FG001|Double-blind Treatment Period|Protocol Violation|1|||
105639021|NCT02326220|364341846|FG002|Double-blind Treatment Period|Protocol Violation|0|||
105639022|NCT02326220|364341844|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
105639023|NCT02326220|364341845|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
105639024|NCT02326220|364341846|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105639025|NCT02326220|364341844|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
105639026|NCT02326220|364341845|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
105639027|NCT02326220|364341846|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
105639028|NCT02326220|364341844|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
105639029|NCT02326220|364341845|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
105639030|NCT02326220|364341846|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
105639031|NCT02659540|364341847|FG000|Overall Study|Adverse Event|3|||
105639032|NCT02659540|364341848|FG001|Overall Study|Adverse Event|2|||
105639033|NCT02659540|364341847|FG000|Overall Study|Death|1|||
105639034|NCT02659540|364341848|FG001|Overall Study|Death|0|||
105639035|NCT02659540|364341847|FG000|Overall Study|Progressive disease|2|||
105639036|NCT02659540|364341848|FG001|Overall Study|Progressive disease|6|||
105639037|NCT03890484|364341849|FG000|Overall Study|Lost to Follow-up|1|||
105639038|NCT03890484|364341850|FG001|Overall Study|Lost to Follow-up|1|||
105639039|NCT00070707|364343869|FG000|Overall Study|Adverse Event|1|||
105639040|NCT00070707|364343870|FG001|Overall Study|Adverse Event|2|||
105639041|NCT00070707|364343869|FG000|Overall Study|Lack of Efficacy|4|||
105639042|NCT00070707|364343870|FG001|Overall Study|Lack of Efficacy|1|||
105639043|NCT00070707|364343869|FG000|Overall Study|Protocol Violation|8|||
105639044|NCT00070707|364343870|FG001|Overall Study|Protocol Violation|4|||
105639045|NCT00070707|364343869|FG000|Overall Study|Unrelated to Study Medication|1|||
105639046|NCT00070707|364343870|FG001|Overall Study|Unrelated to Study Medication|0|||
105639047|NCT01779050|364343871|FG000|Overall Study|Withdrawal by Subject|1|||
105639048|NCT01779050|364343872|FG001|Overall Study|Withdrawal by Subject|0|||
105639049|NCT03292406|364343876|FG000|Overall Study|Progressive Disease|6|||
105639050|NCT03292406|364343877|FG001|Overall Study|Progressive Disease|3|||
105639051|NCT03292406|364343878|FG002|Overall Study|Progressive Disease|4|||
105639052|NCT03292406|364343876|FG000|Overall Study|Adverse Event|7|||
105639053|NCT03292406|364343877|FG001|Overall Study|Adverse Event|1|||
105639054|NCT03292406|364343878|FG002|Overall Study|Adverse Event|4|||
105639055|NCT03292406|364343876|FG000|Overall Study|Withdrawal by Subject|0|||
105639056|NCT03292406|364343877|FG001|Overall Study|Withdrawal by Subject|7|||
105639057|NCT03292406|364343878|FG002|Overall Study|Withdrawal by Subject|2|||
105639058|NCT03292406|364343876|FG000|Overall Study|Protocol Violation|0|||
105639059|NCT03292406|364343877|FG001|Overall Study|Protocol Violation|1|||
105639060|NCT03292406|364343878|FG002|Overall Study|Protocol Violation|1|||
105639061|NCT03292406|364343876|FG000|Overall Study|Other|0|||
105639062|NCT03292406|364343877|FG001|Overall Study|Other|1|||
105639063|NCT03292406|364343878|FG002|Overall Study|Other|2|||
105639064|NCT03851094|364343883|FG000|Overall Study|Withdrawal by Subject|0|||
105639065|NCT03851094|364343884|FG001|Overall Study|Withdrawal by Subject|1|||
105639066|NCT03851094|364343883|FG000|Overall Study|Participant lost device|0|||
105639067|NCT03851094|364343884|FG001|Overall Study|Participant lost device|1|||
105639068|NCT03851094|364343883|FG000|Overall Study|Participant returned device|0|||
105639069|NCT03851094|364343884|FG001|Overall Study|Participant returned device|2|||
105639070|NCT01332266|364343885|FG000|Phase 1b|Death|3|||
105639071|NCT01332266|364343886|FG001|Phase 1b|Death|3|||
105639072|NCT01332266|364343887|FG002|Phase 1b|Death|2|||
105639073|NCT01332266|364343888|FG003|Phase 1b|Death|0|||
105639074|NCT01332266|364343889|FG004|Phase 1b|Death|0|||
105639075|NCT01332266|364343885|FG000|Phase 1b|Lost to Follow-up|0|||
105639076|NCT01332266|364343886|FG001|Phase 1b|Lost to Follow-up|1|||
105639077|NCT01332266|364343887|FG002|Phase 1b|Lost to Follow-up|0|||
105639078|NCT01332266|364343888|FG003|Phase 1b|Lost to Follow-up|0|||
105639079|NCT01332266|364343889|FG004|Phase 1b|Lost to Follow-up|0|||
105639080|NCT01332266|364343885|FG000|Phase 1b|Withdrawal by Subject|1|||
105639081|NCT01332266|364343886|FG001|Phase 1b|Withdrawal by Subject|1|||
105639082|NCT01332266|364343887|FG002|Phase 1b|Withdrawal by Subject|1|||
105639083|NCT01332266|364343888|FG003|Phase 1b|Withdrawal by Subject|0|||
105639084|NCT01332266|364343889|FG004|Phase 1b|Withdrawal by Subject|0|||
105639085|NCT01332266|364343885|FG000|Phase 2|Death|0|||
105639086|NCT01332266|364343886|FG001|Phase 2|Death|0|||
105639087|NCT01332266|364343887|FG002|Phase 2|Death|0|||
105639088|NCT01332266|364343888|FG003|Phase 2|Death|33|||
105639089|NCT01332266|364343889|FG004|Phase 2|Death|36|||
105639090|NCT01332266|364343885|FG000|Phase 2|Lost to Follow-up|0|||
105639091|NCT01332266|364343886|FG001|Phase 2|Lost to Follow-up|0|||
105639092|NCT01332266|364343887|FG002|Phase 2|Lost to Follow-up|0|||
105639093|NCT01332266|364343888|FG003|Phase 2|Lost to Follow-up|2|||
105639094|NCT01332266|364343889|FG004|Phase 2|Lost to Follow-up|0|||
105639095|NCT01332266|364343885|FG000|Phase 2|Physician Decision|0|||
105639096|NCT01332266|364343886|FG001|Phase 2|Physician Decision|0|||
105639097|NCT01332266|364343887|FG002|Phase 2|Physician Decision|0|||
105639098|NCT01332266|364343888|FG003|Phase 2|Physician Decision|3|||
105639099|NCT01332266|364343889|FG004|Phase 2|Physician Decision|1|||
105639100|NCT01332266|364343885|FG000|Phase 2|Symptomatic deterioration|0|||
105639101|NCT01332266|364343886|FG001|Phase 2|Symptomatic deterioration|0|||
105639102|NCT01332266|364343887|FG002|Phase 2|Symptomatic deterioration|0|||
105639103|NCT01332266|364343888|FG003|Phase 2|Symptomatic deterioration|0|||
105639104|NCT01332266|364343889|FG004|Phase 2|Symptomatic deterioration|1|||
105639105|NCT01332266|364343885|FG000|Phase 2|Progression Disease|0|||
105639106|NCT01332266|364343886|FG001|Phase 2|Progression Disease|0|||
105639107|NCT01332266|364343887|FG002|Phase 2|Progression Disease|0|||
105639108|NCT01332266|364343888|FG003|Phase 2|Progression Disease|2|||
105639109|NCT01332266|364343889|FG004|Phase 2|Progression Disease|1|||
105639110|NCT01332266|364343885|FG000|Phase 2|Withdrawal by Subject|0|||
105639111|NCT01332266|364343886|FG001|Phase 2|Withdrawal by Subject|0|||
105639112|NCT01332266|364343887|FG002|Phase 2|Withdrawal by Subject|0|||
105639113|NCT01332266|364343888|FG003|Phase 2|Withdrawal by Subject|2|||
105639114|NCT01332266|364343889|FG004|Phase 2|Withdrawal by Subject|2|||
105639115|NCT03865732|364343890|FG000|Overall Study|Adverse Event|0|||
105639116|NCT03865732|364343891|FG001|Overall Study|Adverse Event|1|||
105639117|NCT01698918|364343892|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
105639118|NCT01698918|364343892|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
105639119|NCT01698918|364343892|FG000|First Line Treatment (Core+Extension)|Death|2|||
105639120|NCT01698918|364343892|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
105639121|NCT01698918|364343892|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
105639122|NCT01698918|364343892|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
105639123|NCT01698918|364343892|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
105639124|NCT01698918|364343892|FG000|Second Line Treatment (Core+Extension)|Death|1|||
105639125|NCT01698918|364343892|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
105639126|NCT01698918|364343892|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
105639127|NCT01019135|364343893|FG000|Overall Study|Did not receive allocated intervention|12|||
105639128|NCT01019135|364343894|FG001|Overall Study|Did not receive allocated intervention|6|||
105639129|NCT01019135|364343895|FG002|Overall Study|Did not receive allocated intervention|25|||
105639130|NCT01019135|364343893|FG000|Overall Study|Did not attend CR|8|||
105639131|NCT01019135|364343894|FG001|Overall Study|Did not attend CR|13|||
105639132|NCT01019135|364343895|FG002|Overall Study|Did not attend CR|6|||
105639133|NCT00439218|364343896|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
105639134|NCT05124210|364343897|FG000|Overall Study|Lost to Follow-up|1|||
105639135|NCT05124210|364343898|FG001|Overall Study|Lost to Follow-up|0|||
105639136|NCT05124210|364343897|FG000|Overall Study|Withdrawal by Subject|1|||
105639137|NCT05124210|364343898|FG001|Overall Study|Withdrawal by Subject|0|||
105639138|NCT00768755|364343899|FG000|Phase 1|Death|6|||
105639139|NCT00768755|364343900|FG001|Phase 1|Death|0|||
105639140|NCT00768755|364343901|FG002|Phase 1|Death|0|||
105639141|NCT00768755|364343902|FG003|Phase 1|Death|0|||
105639142|NCT00768755|364343899|FG000|Phase 1|Other|4|||
105639143|NCT00768755|364343900|FG001|Phase 1|Other|0|||
105639144|NCT00768755|364343901|FG002|Phase 1|Other|0|||
105639145|NCT00768755|364343902|FG003|Phase 1|Other|0|||
105639146|NCT00768755|364343899|FG000|Phase 2|Death|0|||
105639147|NCT00768755|364343900|FG001|Phase 2|Death|37|||
105639148|NCT00768755|364343901|FG002|Phase 2|Death|48|||
105639149|NCT00768755|364343902|FG003|Phase 2|Death|31|||
105639150|NCT00768755|364343899|FG000|Phase 2|Protocol Violation|0|||
105639151|NCT00768755|364343900|FG001|Phase 2|Protocol Violation|2|||
105639152|NCT00768755|364343901|FG002|Phase 2|Protocol Violation|0|||
105639153|NCT00768755|364343902|FG003|Phase 2|Protocol Violation|1|||
105639154|NCT00768755|364343899|FG000|Phase 2|Lost to Follow-up|0|||
105639155|NCT00768755|364343900|FG001|Phase 2|Lost to Follow-up|1|||
105639156|NCT00768755|364343901|FG002|Phase 2|Lost to Follow-up|1|||
105639157|NCT00768755|364343902|FG003|Phase 2|Lost to Follow-up|4|||
105639158|NCT00768755|364343899|FG000|Phase 2|Withdrawal by Subject|0|||
105639159|NCT00768755|364343900|FG001|Phase 2|Withdrawal by Subject|1|||
105639160|NCT00768755|364343901|FG002|Phase 2|Withdrawal by Subject|0|||
105639161|NCT00768755|364343902|FG003|Phase 2|Withdrawal by Subject|1|||
105639162|NCT00768755|364343899|FG000|Phase 2|Other|0|||
105639163|NCT00768755|364343900|FG001|Phase 2|Other|1|||
105639164|NCT00768755|364343901|FG002|Phase 2|Other|2|||
105639165|NCT00768755|364343902|FG003|Phase 2|Other|4|||
105639166|NCT00768755|364343899|FG000|Phase 2|Study Terminated by Sponsor|0|||
105639167|NCT00768755|364343900|FG001|Phase 2|Study Terminated by Sponsor|13|||
105639168|NCT00768755|364343901|FG002|Phase 2|Study Terminated by Sponsor|7|||
105639169|NCT00768755|364343902|FG003|Phase 2|Study Terminated by Sponsor|14|||
105639170|NCT00768755|364343899|FG000|Phase 2|Randomized but not treated|0|||
105639171|NCT00768755|364343900|FG001|Phase 2|Randomized but not treated|0|||
105639172|NCT00768755|364343901|FG002|Phase 2|Randomized but not treated|0|||
105639173|NCT00768755|364343902|FG003|Phase 2|Randomized but not treated|2|||
105639174|NCT00878189|364343905|FG000|Overall Study|Death|0|||
105639175|NCT00878189|364343906|FG001|Overall Study|Death|1|||
105639176|NCT00878189|364343907|FG002|Overall Study|Death|0|||
105639177|NCT00878189|364343908|FG003|Overall Study|Death|1|||
105639178|NCT00878189|364343909|FG004|Overall Study|Death|0|||
105639179|NCT00878189|364343910|FG005|Overall Study|Death|0|||
105639180|NCT00878189|364343911|FG006|Overall Study|Death|0|||
105639181|NCT00878189|364343912|FG007|Overall Study|Death|0|||
105639182|NCT00878189|364343913|FG008|Overall Study|Death|1|||
105639183|NCT00878189|364343905|FG000|Overall Study|Participant Refused to Follow-up|0|||
105639184|NCT00878189|364343906|FG001|Overall Study|Participant Refused to Follow-up|0|||
105639185|NCT00878189|364343907|FG002|Overall Study|Participant Refused to Follow-up|0|||
105639186|NCT00878189|364343908|FG003|Overall Study|Participant Refused to Follow-up|0|||
105639187|NCT00878189|364343909|FG004|Overall Study|Participant Refused to Follow-up|0|||
105639188|NCT00878189|364343910|FG005|Overall Study|Participant Refused to Follow-up|4|||
105639189|NCT00878189|364343911|FG006|Overall Study|Participant Refused to Follow-up|0|||
105639190|NCT00878189|364343912|FG007|Overall Study|Participant Refused to Follow-up|0|||
105639191|NCT00878189|364343913|FG008|Overall Study|Participant Refused to Follow-up|0|||
105639192|NCT00878189|364343905|FG000|Overall Study|Other|3|||
105639193|NCT00878189|364343906|FG001|Overall Study|Other|2|||
105639194|NCT00878189|364343907|FG002|Overall Study|Other|4|||
105639195|NCT00878189|364343908|FG003|Overall Study|Other|7|||
105639196|NCT00878189|364343909|FG004|Overall Study|Other|4|||
105639197|NCT00878189|364343910|FG005|Overall Study|Other|18|||
105639198|NCT00878189|364343911|FG006|Overall Study|Other|15|||
105639199|NCT00878189|364343912|FG007|Overall Study|Other|3|||
105639200|NCT00878189|364343913|FG008|Overall Study|Other|4|||
105639201|NCT00878189|364343905|FG000|Overall Study|Lost to Follow-up|0|||
105639202|NCT00878189|364343906|FG001|Overall Study|Lost to Follow-up|0|||
105639203|NCT00878189|364343907|FG002|Overall Study|Lost to Follow-up|0|||
105639204|NCT00878189|364343908|FG003|Overall Study|Lost to Follow-up|0|||
105639205|NCT00878189|364343909|FG004|Overall Study|Lost to Follow-up|0|||
105639206|NCT00878189|364343910|FG005|Overall Study|Lost to Follow-up|1|||
105639207|NCT00878189|364343911|FG006|Overall Study|Lost to Follow-up|1|||
105639208|NCT00878189|364343912|FG007|Overall Study|Lost to Follow-up|0|||
105639209|NCT00878189|364343913|FG008|Overall Study|Lost to Follow-up|0|||
105639210|NCT00878189|364343905|FG000|Overall Study|Objection Progression or Relapse|0|||
105639211|NCT00878189|364343906|FG001|Overall Study|Objection Progression or Relapse|0|||
105639212|NCT00878189|364343907|FG002|Overall Study|Objection Progression or Relapse|0|||
105639213|NCT00878189|364343908|FG003|Overall Study|Objection Progression or Relapse|0|||
105639214|NCT00878189|364343909|FG004|Overall Study|Objection Progression or Relapse|0|||
105639215|NCT00878189|364343910|FG005|Overall Study|Objection Progression or Relapse|0|||
105639216|NCT00878189|364343911|FG006|Overall Study|Objection Progression or Relapse|0|||
105639217|NCT00878189|364343912|FG007|Overall Study|Objection Progression or Relapse|0|||
105639218|NCT00878189|364343913|FG008|Overall Study|Objection Progression or Relapse|3|||
105639219|NCT02007070|364343914|FG000|Overall Study|Adverse Event|4|||
105639220|NCT02007070|364343914|FG000|Overall Study|Clinical Progression|4|||
105639221|NCT02007070|364343914|FG000|Overall Study|Death|1|||
105639222|NCT02007070|364343914|FG000|Overall Study|Protocol Violation|2|||
105639223|NCT02007070|364343914|FG000|Overall Study|Physician Decision|1|||
105639224|NCT02007070|364343914|FG000|Overall Study|Progressive Disease|21|||
105639225|NCT05260437|364343918|FG000|Overall Study|Lost to Follow-up|5|||
105639226|NCT05260437|364343919|FG001|Overall Study|Lost to Follow-up|2|||
105639227|NCT05260437|364343920|FG002|Overall Study|Lost to Follow-up|1|||
105639228|NCT05260437|364343921|FG003|Overall Study|Lost to Follow-up|2|||
105639229|NCT05260437|364343922|FG004|Overall Study|Lost to Follow-up|2|||
105639230|NCT05260437|364343918|FG000|Overall Study|Withdrawal by Subject|3|||
105639231|NCT05260437|364343919|FG001|Overall Study|Withdrawal by Subject|0|||
105639232|NCT05260437|364343920|FG002|Overall Study|Withdrawal by Subject|4|||
105639233|NCT05260437|364343921|FG003|Overall Study|Withdrawal by Subject|5|||
105639234|NCT05260437|364343922|FG004|Overall Study|Withdrawal by Subject|0|||
105639235|NCT05260437|364343918|FG000|Overall Study|Vaccine Not Administered|0|||
105639236|NCT05260437|364343919|FG001|Overall Study|Vaccine Not Administered|1|||
105639237|NCT05260437|364343920|FG002|Overall Study|Vaccine Not Administered|0|||
105639238|NCT05260437|364343921|FG003|Overall Study|Vaccine Not Administered|0|||
105639239|NCT05260437|364343922|FG004|Overall Study|Vaccine Not Administered|0|||
105639240|NCT00910962|364343925|FG000|Overall Study|Adverse Event|5|||
105639241|NCT00910962|364343926|FG001|Overall Study|Adverse Event|20|||
105639242|NCT00910962|364343927|FG002|Overall Study|Adverse Event|17|||
105639243|NCT00910962|364343925|FG000|Overall Study|Protocol Violation|1|||
105639244|NCT00910962|364343926|FG001|Overall Study|Protocol Violation|3|||
105639245|NCT00910962|364343927|FG002|Overall Study|Protocol Violation|3|||
105639246|NCT00910962|364343925|FG000|Overall Study|Lost to Follow-up|0|||
105639247|NCT00910962|364343926|FG001|Overall Study|Lost to Follow-up|3|||
105639248|NCT00910962|364343927|FG002|Overall Study|Lost to Follow-up|1|||
105639249|NCT00910962|364343925|FG000|Overall Study|Physician Decision|0|||
105639250|NCT00910962|364343926|FG001|Overall Study|Physician Decision|6|||
105639251|NCT00910962|364343927|FG002|Overall Study|Physician Decision|6|||
105639252|NCT00910962|364343925|FG000|Overall Study|Withdrawal by Subject|25|||
105639253|NCT00910962|364343926|FG001|Overall Study|Withdrawal by Subject|32|||
105639254|NCT00910962|364343927|FG002|Overall Study|Withdrawal by Subject|32|||
105639255|NCT00910962|364343925|FG000|Overall Study|Reached defined stopping criteria|12|||
105639256|NCT00910962|364343926|FG001|Overall Study|Reached defined stopping criteria|14|||
105639257|NCT00910962|364343927|FG002|Overall Study|Reached defined stopping criteria|17|||
105639258|NCT03547154|364343930|FG000|Overall Study|Disease Progression/Recurrence|6|||
105639259|NCT03547154|364343931|FG001|Overall Study|Disease Progression/Recurrence|14|||
105639260|NCT03547154|364343930|FG000|Overall Study|Adverse Event|26|||
105639261|NCT03547154|364343931|FG001|Overall Study|Adverse Event|31|||
105639262|NCT03547154|364343930|FG000|Overall Study|Protocol Violation|6|||
105639263|NCT03547154|364343931|FG001|Overall Study|Protocol Violation|1|||
105639264|NCT03547154|364343930|FG000|Overall Study|Physician Decision|4|||
105639265|NCT03547154|364343931|FG001|Overall Study|Physician Decision|3|||
105639266|NCT03547154|364343930|FG000|Overall Study|Insufficient Therapeutic Response|13|||
105639267|NCT03547154|364343931|FG001|Overall Study|Insufficient Therapeutic Response|10|||
105639268|NCT03547154|364343930|FG000|Overall Study|Withdrawal by Subject|10|||
105639269|NCT03547154|364343931|FG001|Overall Study|Withdrawal by Subject|6|||
105639270|NCT03547154|364343930|FG000|Overall Study|Not Selected|0|||
105639271|NCT03547154|364343931|FG001|Overall Study|Not Selected|1|||
105639272|NCT03547154|364343930|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
105639273|NCT03547154|364343931|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
105639274|NCT02706483|364343932|FG000|Overall Study|Adverse Event|97|||
105639275|NCT02706483|364343932|FG000|Overall Study|Death|1|||
105639276|NCT02706483|364343932|FG000|Overall Study|Lack of Efficacy|39|||
105639277|NCT02706483|364343932|FG000|Overall Study|Lost to Follow-up|101|||
105639278|NCT02706483|364343932|FG000|Overall Study|Non-compliance with study drug|15|||
105639279|NCT02706483|364343932|FG000|Overall Study|Physician Decision|6|||
105639280|NCT02706483|364343932|FG000|Overall Study|Pregnancy|6|||
105639281|NCT02706483|364343932|FG000|Overall Study|Protocol Violation|18|||
105639282|NCT02706483|364343932|FG000|Overall Study|Withdrawal by Subject|136|||
105639283|NCT02706483|364343932|FG000|Overall Study|Non-compliance with visits|6|||
105639284|NCT02706483|364343932|FG000|Overall Study|Site closure|4|||
105639285|NCT02706483|364343932|FG000|Overall Study|Subject moved|1|||
105639286|NCT04660799|364343933|FG000|Overall Study|Progressive Disease|1|||
105639287|NCT04660799|364343934|FG001|Overall Study|Progressive Disease|1|||
105639288|NCT04660799|364343933|FG000|Overall Study|Death|2|||
105639289|NCT04660799|364343934|FG001|Overall Study|Death|1|||
105639290|NCT04660799|364343933|FG000|Overall Study|Adverse Event|2|||
105639291|NCT04660799|364343934|FG001|Overall Study|Adverse Event|1|||
105639292|NCT04660799|364343933|FG000|Overall Study|Withdrawal by Subject|2|||
105639293|NCT04660799|364343934|FG001|Overall Study|Withdrawal by Subject|5|||
105639294|NCT00701415|364343935|FG000|Overall Study|Adverse Event|0|||
105639295|NCT00701415|364343936|FG001|Overall Study|Adverse Event|1|||
105639296|NCT00701415|364343935|FG000|Overall Study|Social/family issues and needle phobia|1|||
105639297|NCT00701415|364343936|FG001|Overall Study|Social/family issues and needle phobia|0|||
105639298|NCT02382640|364343939|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
105639299|NCT02382640|364343940|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
105639300|NCT02382640|364343941|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
105639301|NCT02382640|364343942|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
105639302|NCT01560429|364343943|FG000|Overall Study|Protocol Violation|3|||
105639303|NCT01560429|364343944|FG001|Overall Study|Protocol Violation|6|||
105639304|NCT03861234|364343945|FG000|Overall Study|Not treated|0|||
105639305|NCT03861234|364343946|FG001|Overall Study|Not treated|0|||
105639306|NCT03861234|364343947|FG002|Overall Study|Not treated|0|||
105639307|NCT03861234|364343948|FG003|Overall Study|Not treated|0|||
105639308|NCT03861234|364343949|FG004|Overall Study|Not treated|0|||
105639309|NCT03861234|364343950|FG005|Overall Study|Not treated|1|||
105639310|NCT03861234|364343951|FG006|Overall Study|Not treated|0|||
105639311|NCT03861234|364343952|FG007|Overall Study|Not treated|0|||
105639312|NCT03861234|364343945|FG000|Overall Study|Adverse Event|0|||
105639313|NCT03861234|364343946|FG001|Overall Study|Adverse Event|0|||
105639314|NCT03861234|364343947|FG002|Overall Study|Adverse Event|0|||
105639315|NCT03861234|364343948|FG003|Overall Study|Adverse Event|0|||
105639316|NCT03861234|364343949|FG004|Overall Study|Adverse Event|0|||
105639317|NCT03861234|364343950|FG005|Overall Study|Adverse Event|1|||
105639318|NCT03861234|364343951|FG006|Overall Study|Adverse Event|0|||
105639319|NCT03861234|364343952|FG007|Overall Study|Adverse Event|0|||
105639320|NCT03861234|364343945|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
105639321|NCT03861234|364343946|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
105639322|NCT03861234|364343947|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
105639323|NCT03861234|364343948|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
105639324|NCT03861234|364343949|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
105639325|NCT03861234|364343950|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
105639326|NCT03861234|364343951|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
105639327|NCT03861234|364343952|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
105639328|NCT03861234|364343945|FG000|Overall Study|As per sponsor decision|0|||
105639329|NCT03861234|364343946|FG001|Overall Study|As per sponsor decision|0|||
105639330|NCT03861234|364343947|FG002|Overall Study|As per sponsor decision|0|||
105639331|NCT03861234|364343948|FG003|Overall Study|As per sponsor decision|0|||
105639332|NCT03861234|364343949|FG004|Overall Study|As per sponsor decision|0|||
105639333|NCT03861234|364343950|FG005|Overall Study|As per sponsor decision|0|||
105639334|NCT03861234|364343951|FG006|Overall Study|As per sponsor decision|1|||
105639335|NCT03861234|364343952|FG007|Overall Study|As per sponsor decision|0|||
105639336|NCT03861234|364343945|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
105639337|NCT03861234|364343946|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
105639338|NCT03861234|364343947|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
105639339|NCT03861234|364343948|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
105639340|NCT03861234|364343949|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
105639341|NCT03861234|364343950|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
105639342|NCT03861234|364343951|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
105639343|NCT03861234|364343952|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
105639344|NCT00641537|364343953|FG000|96-week Period|Adverse Event|0|||
105639345|NCT00641537|364343954|FG001|96-week Period|Adverse Event|1|||
105639346|NCT00641537|364343955|FG002|96-week Period|Adverse Event|3|||
105639347|NCT00641537|364343956|FG003|96-week Period|Adverse Event|0|||
105639348|NCT00641537|364343957|FG004|96-week Period|Adverse Event|2|||
105639349|NCT00641537|364343958|FG005|96-week Period|Adverse Event|0|||
105639350|NCT00641537|364343959|FG006|96-week Period|Adverse Event|0|||
105639351|NCT00641537|364343960|FG007|96-week Period|Adverse Event|0|||
105639352|NCT00641537|364343953|FG000|96-week Period|Lost to Follow-up|3|||
105639353|NCT00641537|364343954|FG001|96-week Period|Lost to Follow-up|1|||
105639354|NCT00641537|364343955|FG002|96-week Period|Lost to Follow-up|2|||
105639355|NCT00641537|364343956|FG003|96-week Period|Lost to Follow-up|2|||
105639356|NCT00641537|364343957|FG004|96-week Period|Lost to Follow-up|4|||
105639357|NCT00641537|364343958|FG005|96-week Period|Lost to Follow-up|0|||
105639358|NCT00641537|364343959|FG006|96-week Period|Lost to Follow-up|1|||
105639359|NCT00641537|364343960|FG007|96-week Period|Lost to Follow-up|0|||
105639360|NCT00641537|364343953|FG000|96-week Period|Protocol Violation|0|||
105639361|NCT00641537|364343954|FG001|96-week Period|Protocol Violation|1|||
105639362|NCT00641537|364343955|FG002|96-week Period|Protocol Violation|0|||
105639363|NCT00641537|364343956|FG003|96-week Period|Protocol Violation|1|||
105639364|NCT00641537|364343957|FG004|96-week Period|Protocol Violation|0|||
105639365|NCT00641537|364343958|FG005|96-week Period|Protocol Violation|1|||
105639366|NCT00641537|364343959|FG006|96-week Period|Protocol Violation|0|||
105639367|NCT00641537|364343960|FG007|96-week Period|Protocol Violation|0|||
105639368|NCT00641537|364343953|FG000|96-week Period|Death|2|||
105639369|NCT00641537|364343954|FG001|96-week Period|Death|0|||
105639370|NCT00641537|364343955|FG002|96-week Period|Death|1|||
105639371|NCT00641537|364343956|FG003|96-week Period|Death|0|||
105639372|NCT00641537|364343957|FG004|96-week Period|Death|0|||
105639373|NCT00641537|364343958|FG005|96-week Period|Death|0|||
105639374|NCT00641537|364343959|FG006|96-week Period|Death|0|||
105639375|NCT00641537|364343960|FG007|96-week Period|Death|0|||
105639376|NCT00641537|364343953|FG000|96-week Period|Other|4|||
105639377|NCT00641537|364343954|FG001|96-week Period|Other|7|||
105639378|NCT00641537|364343955|FG002|96-week Period|Other|14|||
105639379|NCT00641537|364343956|FG003|96-week Period|Other|9|||
105639380|NCT00641537|364343957|FG004|96-week Period|Other|11|||
105639381|NCT00641537|364343958|FG005|96-week Period|Other|6|||
105639382|NCT00641537|364343959|FG006|96-week Period|Other|4|||
105639383|NCT00641537|364343960|FG007|96-week Period|Other|6|||
105639384|NCT00641537|364343953|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
105639385|NCT00641537|364343954|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
105639386|NCT00641537|364343955|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
105639387|NCT00641537|364343956|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
105639388|NCT00641537|364343957|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
105639389|NCT00641537|364343958|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
105639390|NCT00641537|364343959|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
105639391|NCT00641537|364343960|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
105639392|NCT00641537|364343953|FG000|24-Week Supplemental Follow-up Period|Other|0|||
105639393|NCT00641537|364343954|FG001|24-Week Supplemental Follow-up Period|Other|2|||
105639394|NCT00641537|364343955|FG002|24-Week Supplemental Follow-up Period|Other|2|||
105639395|NCT00641537|364343956|FG003|24-Week Supplemental Follow-up Period|Other|1|||
105639396|NCT00641537|364343957|FG004|24-Week Supplemental Follow-up Period|Other|3|||
105639397|NCT00641537|364343958|FG005|24-Week Supplemental Follow-up Period|Other|0|||
105639398|NCT00641537|364343959|FG006|24-Week Supplemental Follow-up Period|Other|1|||
105639399|NCT00641537|364343960|FG007|24-Week Supplemental Follow-up Period|Other|1|||
105639400|NCT00875706|364343961|FG000|Overall Study|Withdrawal by Subject|1|||
105639401|NCT00875706|364343962|FG001|Overall Study|Withdrawal by Subject|0|||
105639402|NCT00875706|364343963|FG002|Overall Study|Withdrawal by Subject|0|||
105639403|NCT01860079|364343964|FG000|Overall Study|Physician Decision|14|||
105639404|NCT01860079|364343965|FG001|Overall Study|Physician Decision|22|||
105639405|NCT00786188|364343966|FG000|Overall Study|Adverse Event|3|||
105639406|NCT00786188|364343967|FG001|Overall Study|Adverse Event|1|||
105639407|NCT00786188|364343966|FG000|Overall Study|Withdrawal by Subject|2|||
105639408|NCT00786188|364343967|FG001|Overall Study|Withdrawal by Subject|0|||
105639409|NCT00326183|364343968|FG000|Overall Study|Lost to Follow-up|104|||
105639410|NCT00326183|364343969|FG001|Overall Study|Lost to Follow-up|56|||
105639411|NCT00326183|364343968|FG000|Overall Study|Protocol Violation|6|||
105639412|NCT00326183|364343969|FG001|Overall Study|Protocol Violation|3|||
105639413|NCT00326183|364343968|FG000|Overall Study|Withdrawal by Subject|35|||
105639414|NCT00326183|364343969|FG001|Overall Study|Withdrawal by Subject|7|||
105639415|NCT00326183|364343968|FG000|Overall Study|Subject Moved|7|||
105639416|NCT00326183|364343969|FG001|Overall Study|Subject Moved|4|||
105639417|NCT00326183|364343968|FG000|Overall Study|Other|47|||
105639418|NCT00326183|364343969|FG001|Overall Study|Other|13|||
105639419|NCT00326183|364343968|FG000|Overall Study|Adverse Event|1|||
105639420|NCT00326183|364343969|FG001|Overall Study|Adverse Event|0|||
105639421|NCT02279732|364343970|FG000|Overall Study|Death|23|||
105639422|NCT02279732|364343971|FG001|Overall Study|Death|20|||
105639423|NCT02279732|364343970|FG000|Overall Study|Disease Progression|13|||
105639424|NCT02279732|364343971|FG001|Overall Study|Disease Progression|3|||
105639425|NCT02279732|364343970|FG000|Overall Study|Withdrawal by Subject|2|||
105639426|NCT02279732|364343971|FG001|Overall Study|Withdrawal by Subject|7|||
105639427|NCT02279732|364343970|FG000|Overall Study|Adverse Event|1|||
105639428|NCT02279732|364343971|FG001|Overall Study|Adverse Event|2|||
105639429|NCT02279732|364343970|FG000|Overall Study|Administrative Reason By Sponsor|0|||
105639430|NCT02279732|364343971|FG001|Overall Study|Administrative Reason By Sponsor|2|||
105639431|NCT02279732|364343970|FG000|Overall Study|Study Drug Toxicity|2|||
105639432|NCT02279732|364343971|FG001|Overall Study|Study Drug Toxicity|0|||
105639433|NCT02279732|364343970|FG000|Overall Study|Lost to Follow-up|0|||
105639434|NCT02279732|364343971|FG001|Overall Study|Lost to Follow-up|1|||
105639435|NCT02279732|364343970|FG000|Overall Study|Maximum Clinical Benefit|1|||
105639436|NCT02279732|364343971|FG001|Overall Study|Maximum Clinical Benefit|0|||
105639437|NCT02279732|364343970|FG000|Overall Study|Subject Requested to Discontinue|0|||
105639438|NCT02279732|364343971|FG001|Overall Study|Subject Requested to Discontinue|1|||
105639439|NCT02279732|364343970|FG000|Overall Study|Other|53|||
105639440|NCT02279732|364343971|FG001|Overall Study|Other|67|||
105639441|NCT02279732|364343970|FG000|Overall Study|Other|3|||
105639442|NCT02279732|364343971|FG001|Overall Study|Other|3|||
105639443|NCT02008916|364343976|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
105639444|NCT02008916|364343977|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
105639445|NCT02008916|364343978|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
105639446|NCT02008916|364343976|FG000|Week 16 - 156|Adverse Event|4|||
105639447|NCT02008916|364343977|FG001|Week 16 - 156|Adverse Event|2|||
105639448|NCT02008916|364343978|FG002|Week 16 - 156|Adverse Event|3|||
105639449|NCT02008916|364343976|FG000|Week 16 - 156|Withdrawal by Subject|7|||
105639450|NCT02008916|364343977|FG001|Week 16 - 156|Withdrawal by Subject|3|||
105639451|NCT02008916|364343978|FG002|Week 16 - 156|Withdrawal by Subject|5|||
105639452|NCT02008916|364343976|FG000|Week 16 - 156|No longer requires treatment|0|||
105639453|NCT02008916|364343977|FG001|Week 16 - 156|No longer requires treatment|1|||
105639454|NCT02008916|364343978|FG002|Week 16 - 156|No longer requires treatment|0|||
105639455|NCT02008916|364343976|FG000|Week 16 - 156|Lost to Follow-up|5|||
105639456|NCT02008916|364343977|FG001|Week 16 - 156|Lost to Follow-up|0|||
105639457|NCT02008916|364343978|FG002|Week 16 - 156|Lost to Follow-up|0|||
105639458|NCT02008916|364343976|FG000|Week 16 - 156|Lack of Efficacy|3|||
105639459|NCT02008916|364343977|FG001|Week 16 - 156|Lack of Efficacy|5|||
105639460|NCT02008916|364343978|FG002|Week 16 - 156|Lack of Efficacy|2|||
105639461|NCT02008916|364343976|FG000|Week 16 - 156|Pregnancy|0|||
105639462|NCT02008916|364343977|FG001|Week 16 - 156|Pregnancy|1|||
105639463|NCT02008916|364343978|FG002|Week 16 - 156|Pregnancy|0|||
105639464|NCT02008916|364343976|FG000|Week 16 - 156|Physician Decision|0|||
105639465|NCT02008916|364343977|FG001|Week 16 - 156|Physician Decision|1|||
105639466|NCT02008916|364343978|FG002|Week 16 - 156|Physician Decision|0|||
105639467|NCT03803475|364343979|FG000|Overall Study|Physician Decision|1|||
105639468|NCT03347396|364343981|FG000|Part A (26 Weeks)|Adverse Event|1|||
105639469|NCT03347396|364343982|FG001|Part A (26 Weeks)|Adverse Event|0|||
105639470|NCT03347396|364343981|FG000|Part A (26 Weeks)|Death|0|||
105639471|NCT03347396|364343982|FG001|Part A (26 Weeks)|Death|1|||
105639472|NCT03347396|364343981|FG000|Part B (149 Weeks)|Adverse Event|1|||
105639473|NCT03347396|364343982|FG001|Part B (149 Weeks)|Adverse Event|1|||
105639474|NCT03347396|364343981|FG000|Part B (149 Weeks)|Death|1|||
105639475|NCT03347396|364343982|FG001|Part B (149 Weeks)|Death|0|||
105639476|NCT01263496|364343983|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
105639477|NCT01263496|364343984|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639478|NCT01263496|364343985|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639479|NCT01263496|364343986|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639480|NCT01263496|364343987|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639481|NCT01263496|364343988|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639482|NCT01263496|364343989|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639483|NCT01263496|364343990|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639484|NCT01263496|364343991|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639485|NCT01263496|364343983|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105639486|NCT01263496|364343984|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105639487|NCT01263496|364343985|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105639488|NCT01263496|364343986|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
105639489|NCT01263496|364343987|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
105639490|NCT01263496|364343988|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105639491|NCT01263496|364343989|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105639492|NCT01263496|364343990|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105639493|NCT01263496|364343991|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105639494|NCT01263496|364343983|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
105639495|NCT01263496|364343984|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
105639496|NCT01263496|364343985|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
105639497|NCT01263496|364343986|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
105639498|NCT01263496|364343987|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
105639499|NCT01263496|364343988|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
105639500|NCT01263496|364343989|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
105639501|NCT01263496|364343990|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
105639502|NCT01263496|364343991|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
105639503|NCT01263496|364343983|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639504|NCT01263496|364343984|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
105639505|NCT01263496|364343985|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639506|NCT01263496|364343986|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639507|NCT01263496|364343987|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639508|NCT01263496|364343988|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639509|NCT01263496|364343989|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639510|NCT01263496|364343990|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639511|NCT01263496|364343991|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639512|NCT01263496|364343983|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105639513|NCT01263496|364343984|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105639514|NCT01263496|364343985|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
105639515|NCT01263496|364343986|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105639516|NCT01263496|364343987|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
105639517|NCT01263496|364343988|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105639518|NCT01263496|364343989|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105639519|NCT01263496|364343990|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
105639520|NCT01263496|364343991|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105639521|NCT01263496|364343983|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
105639522|NCT01263496|364343984|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
105639523|NCT01263496|364343985|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
105639524|NCT01263496|364343986|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
105639525|NCT01263496|364343987|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
105639526|NCT01263496|364343988|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
105639527|NCT01263496|364343989|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
105639528|NCT01263496|364343990|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
105639529|NCT01263496|364343991|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
105639530|NCT01263496|364343983|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639531|NCT01263496|364343984|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639532|NCT01263496|364343985|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639533|NCT01263496|364343986|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639534|NCT01263496|364343987|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639535|NCT01263496|364343988|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639536|NCT01263496|364343989|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639537|NCT01263496|364343990|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
105639538|NCT01263496|364343991|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639539|NCT02950961|364343995|FG000|Overall Study|Study had to stop due to COVID.|7|||
105639540|NCT03055988|364343998|FG000|Period 1|Adverse Event|0|||
105639541|NCT03055988|364343999|FG001|Period 1|Adverse Event|1|||
105639542|NCT03055988|364343998|FG000|Period 1|Lost to Follow-up|1|||
105639543|NCT03055988|364343999|FG001|Period 1|Lost to Follow-up|0|||
105639544|NCT03055988|364343998|FG000|Period 1|Withdrawal by Subject|0|||
105639545|NCT03055988|364343999|FG001|Period 1|Withdrawal by Subject|4|||
105639546|NCT03055988|364343998|FG000|Period 2|Adverse Event|0|||
105639547|NCT03055988|364343999|FG001|Period 2|Adverse Event|1|||
105639548|NCT03055988|364343998|FG000|Period 2|Other than listed|1|||
105639549|NCT03055988|364343999|FG001|Period 2|Other than listed|1|||
105639550|NCT04748341|364344000|FG000|Overall Study|Lost to Follow-up|1|||
105639551|NCT04748341|364344001|FG001|Overall Study|Lost to Follow-up|1|||
105639552|NCT00392197|364344004|FG000|Overall Study|Adverse Event|4|||
105639553|NCT00392197|364344005|FG001|Overall Study|Adverse Event|12|||
105639554|NCT00392197|364344004|FG000|Overall Study|Lack of Efficacy|3|||
105639555|NCT00392197|364344005|FG001|Overall Study|Lack of Efficacy|4|||
105639556|NCT00392197|364344004|FG000|Overall Study|Lost to Follow-up|0|||
105639557|NCT00392197|364344005|FG001|Overall Study|Lost to Follow-up|1|||
105639558|NCT00392197|364344004|FG000|Overall Study|Physician Decision|3|||
105639559|NCT00392197|364344005|FG001|Overall Study|Physician Decision|2|||
105639560|NCT00392197|364344004|FG000|Overall Study|Protocol Violation|7|||
105639561|NCT00392197|364344005|FG001|Overall Study|Protocol Violation|5|||
105639562|NCT00392197|364344004|FG000|Overall Study|Withdrawal by Subject|4|||
105639563|NCT00392197|364344005|FG001|Overall Study|Withdrawal by Subject|6|||
105639564|NCT02432274|364344007|FG000|Overall Study|Death|2|||
105639565|NCT02432274|364344008|FG001|Overall Study|Death|6|||
105639566|NCT02432274|364344009|FG002|Overall Study|Death|7|||
105639567|NCT02432274|364344010|FG003|Overall Study|Death|0|||
105639568|NCT02432274|364344011|FG004|Overall Study|Death|27|||
105639569|NCT02432274|364344012|FG005|Overall Study|Death|7|||
105639570|NCT02432274|364344013|FG006|Overall Study|Death|9|||
105639571|NCT02432274|364344014|FG007|Overall Study|Death|14|||
105639572|NCT02432274|364344007|FG000|Overall Study|Withdrawal of Consent|0|||
105639573|NCT02432274|364344008|FG001|Overall Study|Withdrawal of Consent|0|||
105639574|NCT02432274|364344009|FG002|Overall Study|Withdrawal of Consent|0|||
105639575|NCT02432274|364344010|FG003|Overall Study|Withdrawal of Consent|0|||
105639576|NCT02432274|364344011|FG004|Overall Study|Withdrawal of Consent|2|||
105639577|NCT02432274|364344012|FG005|Overall Study|Withdrawal of Consent|0|||
105639578|NCT02432274|364344013|FG006|Overall Study|Withdrawal of Consent|1|||
105639579|NCT02432274|364344014|FG007|Overall Study|Withdrawal of Consent|2|||
105639580|NCT00090519|364344015|FG000|Overall Study|Adverse Event|5|||
105639581|NCT00090519|364344016|FG001|Overall Study|Adverse Event|4|||
105639582|NCT00090519|364344015|FG000|Overall Study|Death|9|||
105639583|NCT00090519|364344016|FG001|Overall Study|Death|9|||
105639584|NCT00090519|364344015|FG000|Overall Study|Lost to Follow-up|26|||
105639585|NCT00090519|364344016|FG001|Overall Study|Lost to Follow-up|29|||
105639586|NCT00090519|364344015|FG000|Overall Study|Withdrawal by Subject|28|||
105639587|NCT00090519|364344016|FG001|Overall Study|Withdrawal by Subject|29|||
105639588|NCT00090519|364344015|FG000|Overall Study|Physician Decision|2|||
105639589|NCT00090519|364344016|FG001|Overall Study|Physician Decision|3|||
105639590|NCT00090519|364344015|FG000|Overall Study|Sponsor Decision|3|||
105639591|NCT00090519|364344016|FG001|Overall Study|Sponsor Decision|1|||
105639592|NCT00116649|364344017|FG000|Overall Study|Adverse Event|20|||
105639593|NCT00116649|364344017|FG000|Overall Study|Lack of Efficacy|1|||
105639594|NCT00116649|364344017|FG000|Overall Study|Lost to Follow-up|32|||
105639595|NCT00116649|364344017|FG000|Overall Study|Withdrawal by Subject|68|||
105639596|NCT00116649|364344017|FG000|Overall Study|Local Skin Reaction|9|||
105639597|NCT00116649|364344017|FG000|Overall Study|Various Reasons|18|||
105639598|NCT00116649|364344017|FG000|Overall Study|Protocol Specified|7|||
105639599|NCT02114515|364344026|FG000|Overall Study|Lost to Follow-up|52|||
105639600|NCT02114515|364344027|FG001|Overall Study|Lost to Follow-up|55|||
105639601|NCT02114515|364344026|FG000|Overall Study|Death|12|||
105639602|NCT02114515|364344027|FG001|Overall Study|Death|12|||
105639603|NCT02114515|364344026|FG000|Overall Study|Withdrawal by Subject|4|||
105639604|NCT02114515|364344027|FG001|Overall Study|Withdrawal by Subject|22|||
105639605|NCT02114515|364344026|FG000|Overall Study|Other|65|||
105639606|NCT02114515|364344027|FG001|Overall Study|Other|61|||
105639607|NCT01075152|364344031|FG000|Overall Study|Withdrawal by Subject|1|||
105639608|NCT01075152|364344032|FG001|Overall Study|Withdrawal by Subject|0|||
105639609|NCT04820491|364344033|FG000|Overall Study|Withdrawal by Subject|1|||
105639610|NCT04820491|364344034|FG001|Overall Study|Withdrawal by Subject|0|||
105639611|NCT00443820|364345504|FG000|Overall Study|Adverse Event|1|||
105639612|NCT00443820|364345505|FG001|Overall Study|Adverse Event|1|||
105639613|NCT00443820|364345506|FG002|Overall Study|Adverse Event|0|||
105639614|NCT00443820|364345507|FG003|Overall Study|Adverse Event|0|||
105639615|NCT00443820|364345504|FG000|Overall Study|Lack of Efficacy|3|||
105639616|NCT00443820|364345505|FG001|Overall Study|Lack of Efficacy|2|||
105639617|NCT00443820|364345506|FG002|Overall Study|Lack of Efficacy|1|||
105639618|NCT00443820|364345507|FG003|Overall Study|Lack of Efficacy|1|||
105639619|NCT00443820|364345504|FG000|Overall Study|Protocol Violation|2|||
105639620|NCT00443820|364345505|FG001|Overall Study|Protocol Violation|1|||
105639621|NCT00443820|364345506|FG002|Overall Study|Protocol Violation|2|||
105639622|NCT00443820|364345507|FG003|Overall Study|Protocol Violation|1|||
105639623|NCT00443820|364345504|FG000|Overall Study|Withdrawal by Subject|6|||
105639624|NCT00443820|364345505|FG001|Overall Study|Withdrawal by Subject|7|||
105639625|NCT00443820|364345506|FG002|Overall Study|Withdrawal by Subject|8|||
105639626|NCT00443820|364345507|FG003|Overall Study|Withdrawal by Subject|9|||
105639627|NCT00443820|364345504|FG000|Overall Study|Lost to Follow-up|9|||
105639628|NCT00443820|364345505|FG001|Overall Study|Lost to Follow-up|8|||
105639629|NCT00443820|364345506|FG002|Overall Study|Lost to Follow-up|6|||
105639630|NCT00443820|364345507|FG003|Overall Study|Lost to Follow-up|5|||
105639631|NCT00443820|364345504|FG000|Overall Study|Administrative problems|0|||
105639632|NCT00443820|364345505|FG001|Overall Study|Administrative problems|0|||
105639633|NCT00443820|364345506|FG002|Overall Study|Administrative problems|0|||
105639634|NCT00443820|364345507|FG003|Overall Study|Administrative problems|1|||
105639635|NCT00443820|364345504|FG000|Overall Study|Death|0|||
105639636|NCT00443820|364345505|FG001|Overall Study|Death|0|||
105639637|NCT00443820|364345506|FG002|Overall Study|Death|1|||
105639638|NCT00443820|364345507|FG003|Overall Study|Death|0|||
105639639|NCT04633200|364345509|FG000|Overall Study|Lost to Follow-up|3|||
105639640|NCT04633200|364345510|FG001|Overall Study|Lost to Follow-up|5|||
105639641|NCT03490032|364345513|FG000|Overall Study|family issue (child custody)|1|||
105639642|NCT03490032|364345514|FG001|Overall Study|family issue (child custody)|0|||
105639643|NCT03490032|364345515|FG002|Overall Study|family issue (child custody)|0|||
105639644|NCT01947491|364345516|FG000|Overall Study|Lost to Follow-up|5|||
105639645|NCT01947491|364345517|FG001|Overall Study|Lost to Follow-up|3|||
105639646|NCT01947491|364345518|FG002|Overall Study|Lost to Follow-up|1|||
105639647|NCT01947491|364345519|FG003|Overall Study|Lost to Follow-up|2|||
105639648|NCT01947491|364345516|FG000|Overall Study|Lack of Efficacy|1|||
105639649|NCT01947491|364345517|FG001|Overall Study|Lack of Efficacy|0|||
105639650|NCT01947491|364345518|FG002|Overall Study|Lack of Efficacy|0|||
105639651|NCT01947491|364345519|FG003|Overall Study|Lack of Efficacy|1|||
105639652|NCT01947491|364345516|FG000|Overall Study|Protocol Violation|1|||
105639653|NCT01947491|364345517|FG001|Overall Study|Protocol Violation|0|||
105639654|NCT01947491|364345518|FG002|Overall Study|Protocol Violation|0|||
105639655|NCT01947491|364345519|FG003|Overall Study|Protocol Violation|0|||
105639656|NCT01947491|364345516|FG000|Overall Study|Withdrawal by Subject|1|||
105639657|NCT01947491|364345517|FG001|Overall Study|Withdrawal by Subject|1|||
105639658|NCT01947491|364345518|FG002|Overall Study|Withdrawal by Subject|1|||
105639659|NCT01947491|364345519|FG003|Overall Study|Withdrawal by Subject|0|||
105639660|NCT01947491|364345516|FG000|Overall Study|Worsening of condition|0|||
105639661|NCT01947491|364345517|FG001|Overall Study|Worsening of condition|1|||
105639662|NCT01947491|364345518|FG002|Overall Study|Worsening of condition|0|||
105639663|NCT01947491|364345519|FG003|Overall Study|Worsening of condition|0|||
105639664|NCT01947491|364345516|FG000|Overall Study|Adverse Event|0|||
105639665|NCT01947491|364345517|FG001|Overall Study|Adverse Event|1|||
105639666|NCT01947491|364345518|FG002|Overall Study|Adverse Event|0|||
105639667|NCT01947491|364345519|FG003|Overall Study|Adverse Event|2|||
105639668|NCT01951703|364345522|FG000|First Intervention|Withdrawal by Subject|1|||
105639669|NCT01951703|364345523|FG001|First Intervention|Withdrawal by Subject|0|||
105639670|NCT01951703|364345522|FG000|First Intervention|Subject was not compliant|1|||
105639671|NCT01951703|364345523|FG001|First Intervention|Subject was not compliant|1|||
105639672|NCT01951703|364345522|FG000|First Intervention|Physician Decision|1|||
105639673|NCT01951703|364345523|FG001|First Intervention|Physician Decision|0|||
105639674|NCT01951703|364345522|FG000|Second Intervention|Protocol Violation|0|||
105639675|NCT01951703|364345523|FG001|Second Intervention|Protocol Violation|1|||
105639676|NCT01951703|364345522|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
105639677|NCT01951703|364345523|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
105639678|NCT01852045|364345524|FG000|Overall Study|Adverse Event|1|||
105639679|NCT01852045|364345525|FG001|Overall Study|Adverse Event|0|||
105639680|NCT01852045|364345526|FG002|Overall Study|Adverse Event|0|||
105639681|NCT01852045|364345524|FG000|Overall Study|Lack of Efficacy|3|||
105639682|NCT01852045|364345525|FG001|Overall Study|Lack of Efficacy|0|||
105639683|NCT01852045|364345526|FG002|Overall Study|Lack of Efficacy|0|||
105639684|NCT01852045|364345524|FG000|Overall Study|Lost to Follow-up|0|||
105639685|NCT01852045|364345525|FG001|Overall Study|Lost to Follow-up|1|||
105639686|NCT01852045|364345526|FG002|Overall Study|Lost to Follow-up|1|||
105639687|NCT01852045|364345524|FG000|Overall Study|Withdrawal by Subject|1|||
105639688|NCT01852045|364345525|FG001|Overall Study|Withdrawal by Subject|0|||
105639689|NCT01852045|364345526|FG002|Overall Study|Withdrawal by Subject|1|||
105639690|NCT01852045|364345524|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105639691|NCT01852045|364345525|FG001|Overall Study|Other Miscellaneous Reasons|3|||
105639692|NCT01852045|364345526|FG002|Overall Study|Other Miscellaneous Reasons|2|||
105639693|NCT00704340|364345527|FG000|Overall Study|Lost to Follow-up|2|||
105639694|NCT00704340|364345528|FG001|Overall Study|Lost to Follow-up|1|||
105639695|NCT00704340|364345527|FG000|Overall Study|Death|0|||
105639696|NCT00704340|364345528|FG001|Overall Study|Death|1|||
105639697|NCT00620854|364345529|FG000|Washout 1|Withdrawal by Subject|0|||
105639698|NCT00620854|364345530|FG001|Washout 1|Withdrawal by Subject|0|||
105639699|NCT00620854|364345531|FG002|Washout 1|Withdrawal by Subject|1|||
105639700|NCT00620854|364345532|FG003|Washout 1|Withdrawal by Subject|1|||
105639701|NCT00620854|364345533|FG004|Washout 1|Withdrawal by Subject|0|||
105639702|NCT00620854|364345534|FG005|Washout 1|Withdrawal by Subject|0|||
105639703|NCT03137784|364345535|FG000|Overall Study|Adverse Event|1|||
105639704|NCT03137784|364345536|FG001|Overall Study|Adverse Event|1|||
105639705|NCT03137784|364345537|FG002|Overall Study|Adverse Event|0|||
105639706|NCT03137784|364345538|FG003|Overall Study|Adverse Event|0|||
105639707|NCT03137784|364345539|FG004|Overall Study|Adverse Event|0|||
105639708|NCT03137784|364345540|FG005|Overall Study|Adverse Event|0|||
105639709|NCT03137784|364345535|FG000|Overall Study|Subject/guardian decision|1|||
105639710|NCT03137784|364345536|FG001|Overall Study|Subject/guardian decision|0|||
105639711|NCT03137784|364345537|FG002|Overall Study|Subject/guardian decision|0|||
105639712|NCT03137784|364345538|FG003|Overall Study|Subject/guardian decision|0|||
105639713|NCT03137784|364345539|FG004|Overall Study|Subject/guardian decision|0|||
105639714|NCT03137784|364345540|FG005|Overall Study|Subject/guardian decision|0|||
105639715|NCT03137784|364345535|FG000|Overall Study|Non-compliance with study treatment|0|||
105639716|NCT03137784|364345536|FG001|Overall Study|Non-compliance with study treatment|0|||
105639717|NCT03137784|364345537|FG002|Overall Study|Non-compliance with study treatment|0|||
105639718|NCT03137784|364345538|FG003|Overall Study|Non-compliance with study treatment|0|||
105639719|NCT03137784|364345539|FG004|Overall Study|Non-compliance with study treatment|1|||
105639720|NCT03137784|364345540|FG005|Overall Study|Non-compliance with study treatment|0|||
105639721|NCT00487240|364345541|FG000|Overall Study|Withdrawal by Subject|12|||
105639722|NCT00487240|364345542|FG001|Overall Study|Withdrawal by Subject|6|||
105639723|NCT00487240|364345541|FG000|Overall Study|Lost to Follow-up|7|||
105639724|NCT00487240|364345542|FG001|Overall Study|Lost to Follow-up|6|||
105639725|NCT00487240|364345541|FG000|Overall Study|Adverse Event|0|||
105639726|NCT00487240|364345542|FG001|Overall Study|Adverse Event|4|||
105639727|NCT00487240|364345541|FG000|Overall Study|Protocol Violation|5|||
105639728|NCT00487240|364345542|FG001|Overall Study|Protocol Violation|5|||
105639729|NCT00487240|364345541|FG000|Overall Study|Entry Criteria Not Met|3|||
105639730|NCT00487240|364345542|FG001|Overall Study|Entry Criteria Not Met|4|||
105639731|NCT00487240|364345541|FG000|Overall Study|Sponsor Decision|2|||
105639732|NCT00487240|364345542|FG001|Overall Study|Sponsor Decision|1|||
105639733|NCT00487240|364345541|FG000|Overall Study|Physician Decision|2|||
105639734|NCT00487240|364345542|FG001|Overall Study|Physician Decision|0|||
105639735|NCT01205126|364345545|FG000|Titration Phase|Adverse Event|5|||
105639736|NCT01205126|364345546|FG001|Titration Phase|Adverse Event|3|||
105639737|NCT01205126|364345545|FG000|Titration Phase|Withdrawal by Subject|5|||
105639738|NCT01205126|364345546|FG001|Titration Phase|Withdrawal by Subject|5|||
105639739|NCT01205126|364345545|FG000|Titration Phase|Lost to Follow-up|2|||
105639740|NCT01205126|364345546|FG001|Titration Phase|Lost to Follow-up|2|||
105639741|NCT01205126|364345545|FG000|Titration Phase|No stable titration dose|1|||
105639742|NCT01205126|364345546|FG001|Titration Phase|No stable titration dose|0|||
105639743|NCT01205126|364345545|FG000|Titration Phase|More than maximum dosage required|2|||
105639744|NCT01205126|364345546|FG001|Titration Phase|More than maximum dosage required|3|||
105639745|NCT01205126|364345545|FG000|Titration Phase|Other|8|||
105639746|NCT01205126|364345546|FG001|Titration Phase|Other|6|||
105639747|NCT01205126|364345545|FG000|Between Titration & Maintenance Phase|Other|0|||
105639748|NCT01205126|364345546|FG001|Between Titration & Maintenance Phase|Other|4|||
105639749|NCT01205126|364345545|FG000|Maintenance Phase|Adverse Event|3|||
105639750|NCT01205126|364345546|FG001|Maintenance Phase|Adverse Event|7|||
105639751|NCT01205126|364345545|FG000|Maintenance Phase|Death|4|||
105639752|NCT01205126|364345546|FG001|Maintenance Phase|Death|4|||
105639753|NCT01205126|364345545|FG000|Maintenance Phase|More than the maximum dosage required|5|||
105639754|NCT01205126|364345546|FG001|Maintenance Phase|More than the maximum dosage required|5|||
105639755|NCT01205126|364345545|FG000|Maintenance Phase|Prohibited drugs used|1|||
105639756|NCT01205126|364345546|FG001|Maintenance Phase|Prohibited drugs used|0|||
105639757|NCT01205126|364345545|FG000|Maintenance Phase|Other|11|||
105639758|NCT01205126|364345546|FG001|Maintenance Phase|Other|8|||
105639759|NCT01205126|364345545|FG000|Maintenance Phase|Lost to Follow-up|5|||
105639760|NCT01205126|364345546|FG001|Maintenance Phase|Lost to Follow-up|5|||
105639761|NCT01205126|364345545|FG000|Maintenance Phase|Withdrawal by Subject|8|||
105639762|NCT01205126|364345546|FG001|Maintenance Phase|Withdrawal by Subject|11|||
105639763|NCT00486954|364345547|FG000|Pilot Part|Adverse Event|4|||
105639764|NCT00486954|364345548|FG001|Pilot Part|Adverse Event|0|||
105639765|NCT00486954|364345549|FG002|Pilot Part|Adverse Event|5|||
105639766|NCT00486954|364345550|FG003|Pilot Part|Adverse Event|0|||
105639767|NCT00486954|364345551|FG004|Pilot Part|Adverse Event|0|||
105639768|NCT00486954|364345547|FG000|Pilot Part|Disease Progression|2|||
105639769|NCT00486954|364345548|FG001|Pilot Part|Disease Progression|0|||
105639770|NCT00486954|364345549|FG002|Pilot Part|Disease Progression|1|||
105639771|NCT00486954|364345550|FG003|Pilot Part|Disease Progression|0|||
105639772|NCT00486954|364345551|FG004|Pilot Part|Disease Progression|0|||
105639773|NCT00486954|364345547|FG000|Randomized Part|Lost to Follow-up|0|||
105639774|NCT00486954|364345548|FG001|Randomized Part|Lost to Follow-up|0|||
105639775|NCT00486954|364345549|FG002|Randomized Part|Lost to Follow-up|0|||
105639776|NCT00486954|364345550|FG003|Randomized Part|Lost to Follow-up|0|||
105639777|NCT00486954|364345551|FG004|Randomized Part|Lost to Follow-up|1|||
105639778|NCT00486954|364345547|FG000|Randomized Part|Withdrawal by Subject|0|||
105639779|NCT00486954|364345548|FG001|Randomized Part|Withdrawal by Subject|0|||
105639780|NCT00486954|364345549|FG002|Randomized Part|Withdrawal by Subject|0|||
105639781|NCT00486954|364345550|FG003|Randomized Part|Withdrawal by Subject|1|||
105639782|NCT00486954|364345551|FG004|Randomized Part|Withdrawal by Subject|0|||
105639783|NCT00486954|364345547|FG000|Randomized Part|Sponsor Terminated Study|0|||
105639784|NCT00486954|364345548|FG001|Randomized Part|Sponsor Terminated Study|0|||
105639785|NCT00486954|364345549|FG002|Randomized Part|Sponsor Terminated Study|0|||
105639786|NCT00486954|364345550|FG003|Randomized Part|Sponsor Terminated Study|19|||
105639787|NCT00486954|364345551|FG004|Randomized Part|Sponsor Terminated Study|13|||
105639788|NCT01428583|364345552|FG000|Overall Study|Adverse Event|75|||
105639789|NCT01428583|364345552|FG000|Overall Study|Withdrawal by Subject|51|||
105639790|NCT01428583|364345552|FG000|Overall Study|Lack of Efficacy|37|||
105639791|NCT01428583|364345552|FG000|Overall Study|Lost to Follow-up|17|||
105639792|NCT01428583|364345552|FG000|Overall Study|Death|1|||
105639793|NCT01428583|364345552|FG000|Overall Study|Pregnancy|1|||
105639794|NCT01428583|364345552|FG000|Overall Study|Protocol Violation|1|||
105639795|NCT01428583|364345552|FG000|Overall Study|Physician Decision|12|||
105639796|NCT01428583|364345552|FG000|Overall Study|Non-compliant|25|||
105639797|NCT01428583|364345552|FG000|Overall Study|Confirmed positive urine drug test|8|||
105639798|NCT01428583|364345552|FG000|Overall Study|Sponsor's request|3|||
105639799|NCT01428583|364345552|FG000|Overall Study|Other|6|||
105639800|NCT00703092|364345555|FG000|Overall Study|Withdrawal by Subject|2|||
105639801|NCT02708498|364345556|FG000|Overall Study|Death|20|||
105639802|NCT02708498|364345557|FG001|Overall Study|Death|19|||
105639803|NCT02708498|364345558|FG002|Overall Study|Death|0|||
105639804|NCT02708498|364345559|FG003|Overall Study|Death|0|||
105639805|NCT02708498|364345560|FG004|Overall Study|Death|1|||
105639806|NCT02708498|364345561|FG005|Overall Study|Death|0|||
105639807|NCT02708498|364345562|FG006|Overall Study|Death|0|||
105639808|NCT02708498|364345563|FG007|Overall Study|Death|0|||
105639809|NCT02708498|364345556|FG000|Overall Study|Unknown reason, missing data|0|||
105639810|NCT02708498|364345557|FG001|Overall Study|Unknown reason, missing data|0|||
105639811|NCT02708498|364345558|FG002|Overall Study|Unknown reason, missing data|62|||
105639812|NCT02708498|364345559|FG003|Overall Study|Unknown reason, missing data|51|||
105639813|NCT02708498|364345560|FG004|Overall Study|Unknown reason, missing data|195|||
105639814|NCT02708498|364345561|FG005|Overall Study|Unknown reason, missing data|132|||
105639815|NCT02708498|364345562|FG006|Overall Study|Unknown reason, missing data|0|||
105639816|NCT02708498|364345563|FG007|Overall Study|Unknown reason, missing data|0|||
105639817|NCT01480258|364345567|FG000|Infant Series|Protocol Violation|2|||
105639818|NCT01480258|364345568|FG001|Infant Series|Protocol Violation|0|||
105639819|NCT01480258|364345567|FG000|Infant Series|Physician Decision|0|||
105639820|NCT01480258|364345568|FG001|Infant Series|Physician Decision|1|||
105639821|NCT01480258|364345567|FG000|Infant Series|Not Vaccinated|3|||
105639822|NCT01480258|364345568|FG001|Infant Series|Not Vaccinated|0|||
105639823|NCT01480258|364345567|FG000|Infant Series|Adverse Event|1|||
105639824|NCT01480258|364345568|FG001|Infant Series|Adverse Event|1|||
105639825|NCT01480258|364345567|FG000|Infant Series|Withdrawal by Subject|1|||
105639826|NCT01480258|364345568|FG001|Infant Series|Withdrawal by Subject|6|||
105639827|NCT01480258|364345567|FG000|Interim Period|Lost to Follow-up|0|||
105639828|NCT01480258|364345568|FG001|Interim Period|Lost to Follow-up|2|||
105639829|NCT01480258|364345567|FG000|Interim Period|Physician Decision|1|||
105639830|NCT01480258|364345568|FG001|Interim Period|Physician Decision|0|||
105639831|NCT01480258|364345567|FG000|Interim Period|Protocol Violation|0|||
105639832|NCT01480258|364345568|FG001|Interim Period|Protocol Violation|1|||
105639833|NCT01480258|364345567|FG000|Interim Period|Withdrawal by Subject|9|||
105639834|NCT01480258|364345568|FG001|Interim Period|Withdrawal by Subject|6|||
105639835|NCT03316170|364345569|FG000|Overall Study|Death|1|||
105639836|NCT03316170|364345570|FG001|Overall Study|Death|0|||
105639837|NCT03316170|364345569|FG000|Overall Study|Lost to Follow-up|6|||
105639838|NCT03316170|364345570|FG001|Overall Study|Lost to Follow-up|7|||
105639839|NCT01836523|364345571|FG000|Overall Study|Adverse Event|15|||
105639840|NCT01836523|364345572|FG001|Overall Study|Adverse Event|41|||
105639841|NCT01836523|364345573|FG002|Overall Study|Adverse Event|49|||
105639842|NCT01836523|364345574|FG003|Overall Study|Adverse Event|14|||
105639843|NCT01836523|364345571|FG000|Overall Study|Protocol Violation|6|||
105639844|NCT01836523|364345572|FG001|Overall Study|Protocol Violation|3|||
105639845|NCT01836523|364345573|FG002|Overall Study|Protocol Violation|2|||
105639846|NCT01836523|364345574|FG003|Overall Study|Protocol Violation|4|||
105639847|NCT01836523|364345571|FG000|Overall Study|Met Withdrawal Criteria|13|||
105639848|NCT01836523|364345572|FG001|Overall Study|Met Withdrawal Criteria|13|||
105639849|NCT01836523|364345573|FG002|Overall Study|Met Withdrawal Criteria|21|||
105639850|NCT01836523|364345574|FG003|Overall Study|Met Withdrawal Criteria|27|||
105639851|NCT01836523|364345571|FG000|Overall Study|Unclassified|17|||
105639852|NCT01836523|364345572|FG001|Overall Study|Unclassified|28|||
105639853|NCT01836523|364345573|FG002|Overall Study|Unclassified|19|||
105639854|NCT01836523|364345574|FG003|Overall Study|Unclassified|29|||
105639855|NCT00923078|364345581|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
105639856|NCT00923078|364345582|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
105639857|NCT00923078|364345583|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
105639858|NCT00923078|364345581|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
105639859|NCT00923078|364345582|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
105639860|NCT00923078|364345583|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
105639861|NCT04361617|364345584|FG000|Overall Study|Withdrawal by Subject|0|||
105639862|NCT04361617|364345585|FG001|Overall Study|Withdrawal by Subject|1|||
105639863|NCT04679675|364345587|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
105639864|NCT04679675|364345588|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
105639865|NCT04679675|364345589|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
105639866|NCT04679675|364345590|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
105639867|NCT04679675|364345587|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
105639868|NCT04679675|364345588|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
105639869|NCT04679675|364345589|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
105639870|NCT04679675|364345590|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
105639871|NCT00681109|364345591|FG000|Overall Study|Lost to Follow-up|2|||
105639872|NCT00681109|364345592|FG001|Overall Study|Lost to Follow-up|6|||
105639873|NCT00681109|364345593|FG002|Overall Study|Lost to Follow-up|0|||
105639874|NCT03456856|364345594|FG000|Overall Study|Lost to Follow-up|2|||
105639875|NCT03456856|364345594|FG000|Overall Study|Withdrawal by Subject|1|||
105639876|NCT02037568|364345595|FG000|Overall Study|Withdrawal by Subject|17|||
105639877|NCT02037568|364345596|FG001|Overall Study|Withdrawal by Subject|24|||
105639878|NCT02037568|364345595|FG000|Overall Study|Lost to Follow-up|16|||
105639879|NCT02037568|364345596|FG001|Overall Study|Lost to Follow-up|13|||
105639880|NCT02037568|364345595|FG000|Overall Study|Screen Failure|3|||
105639881|NCT02037568|364345596|FG001|Overall Study|Screen Failure|1|||
105639882|NCT02037568|364345595|FG000|Overall Study|Patient did not receive transplant|0|||
105639883|NCT02037568|364345596|FG001|Overall Study|Patient did not receive transplant|1|||
105639884|NCT00621842|364345597|FG000|Overall Study|Adverse Event|6|||
105639885|NCT00621842|364345597|FG000|Overall Study|Withdrawal by Subject|7|||
105639886|NCT00621842|364345597|FG000|Overall Study|Protocol Violation|4|||
105639887|NCT00621842|364345597|FG000|Overall Study|Lack of Efficacy|2|||
105639888|NCT00068107|364345600|FG000|Overall Study|end-stage renal disease|6|||
105639889|NCT00068107|364345600|FG000|Overall Study|Death|2|||
105639890|NCT00068107|364345600|FG000|Overall Study|Withdrawal by Subject|1|||
105639891|NCT01419184|364345601|FG000|Overall Study|Site data not available|3|||
105639892|NCT01419184|364345602|FG001|Overall Study|Site data not available|2|||
105639893|NCT01419184|364345601|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
105639894|NCT01419184|364345602|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
105639895|NCT01419184|364345601|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
105639896|NCT01419184|364345602|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
105639897|NCT01419184|364345601|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
105639898|NCT01419184|364345602|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
105639899|NCT01419184|364345601|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
105639900|NCT01419184|364345602|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
105639901|NCT01419184|364345601|FG000|Overall Study|Participant randomized, not treated|1|||
105639902|NCT01419184|364345602|FG001|Overall Study|Participant randomized, not treated|0|||
105639903|NCT02644122|364345603|FG000|Overall Study|Withdrawal by Subject|1|||
105639904|NCT02060487|364345606|FG000|Overall Study|Other|1|||
105639905|NCT02060487|364345607|FG001|Overall Study|Other|2|||
105639906|NCT02060487|364345608|FG002|Overall Study|Other|1|||
105639907|NCT02060487|364345606|FG000|Overall Study|Lack of Efficacy|0|||
105639908|NCT02060487|364345607|FG001|Overall Study|Lack of Efficacy|1|||
105639909|NCT02060487|364345608|FG002|Overall Study|Lack of Efficacy|0|||
105639910|NCT02060487|364345606|FG000|Overall Study|Withdrawal by Subject|3|||
105639911|NCT02060487|364345607|FG001|Overall Study|Withdrawal by Subject|10|||
105639912|NCT02060487|364345608|FG002|Overall Study|Withdrawal by Subject|4|||
105639913|NCT02060487|364345606|FG000|Overall Study|Study Terminated By Sponsor|87|||
105639914|NCT02060487|364345607|FG001|Overall Study|Study Terminated By Sponsor|89|||
105639915|NCT02060487|364345608|FG002|Overall Study|Study Terminated By Sponsor|100|||
105639916|NCT02060487|364345606|FG000|Overall Study|Randomized in error|1|||
105639917|NCT02060487|364345607|FG001|Overall Study|Randomized in error|0|||
105639918|NCT02060487|364345608|FG002|Overall Study|Randomized in error|0|||
105639919|NCT02060487|364345606|FG000|Overall Study|Protocol Violation|0|||
105639920|NCT02060487|364345607|FG001|Overall Study|Protocol Violation|1|||
105639921|NCT02060487|364345608|FG002|Overall Study|Protocol Violation|1|||
105639922|NCT02060487|364345606|FG000|Overall Study|Lost to Follow-up|3|||
105639923|NCT02060487|364345607|FG001|Overall Study|Lost to Follow-up|0|||
105639924|NCT02060487|364345608|FG002|Overall Study|Lost to Follow-up|2|||
105639925|NCT02060487|364345606|FG000|Overall Study|Death|34|||
105639926|NCT02060487|364345607|FG001|Overall Study|Death|25|||
105639927|NCT02060487|364345608|FG002|Overall Study|Death|19|||
105639928|NCT02060487|364345606|FG000|Overall Study|Adverse Event|0|||
105639929|NCT02060487|364345607|FG001|Overall Study|Adverse Event|0|||
105639930|NCT02060487|364345608|FG002|Overall Study|Adverse Event|1|||
105639931|NCT01856569|364345616|FG000|Overall Study|Other|1|||
105639932|NCT01856569|364345616|FG000|Overall Study|Changed Site/Structure|1|||
105639933|NCT01856569|364345616|FG000|Overall Study|Lost to Follow-up|3|||
105639934|NCT01856569|364345616|FG000|Overall Study|Did not met inclusion criteria|8|||
105639935|NCT00824408|364345618|FG000|Run-in Phase|Progressive disease|4|||
105639936|NCT00824408|364345619|FG001|Run-in Phase|Progressive disease|4|||
105639937|NCT00824408|364345620|FG002|Run-in Phase|Progressive disease|0|||
105639938|NCT00824408|364345621|FG003|Run-in Phase|Progressive disease|0|||
105639939|NCT00824408|364345622|FG004|Run-in Phase|Progressive disease|0|||
105639940|NCT00824408|364345618|FG000|Run-in Phase|Adverse Event|1|||
105639941|NCT00824408|364345619|FG001|Run-in Phase|Adverse Event|1|||
105639942|NCT00824408|364345620|FG002|Run-in Phase|Adverse Event|0|||
105639943|NCT00824408|364345621|FG003|Run-in Phase|Adverse Event|0|||
105639944|NCT00824408|364345622|FG004|Run-in Phase|Adverse Event|0|||
105639945|NCT00824408|364345618|FG000|Run-in Phase|Refused to continue medication|1|||
105639946|NCT00824408|364345619|FG001|Run-in Phase|Refused to continue medication|0|||
105639947|NCT00824408|364345620|FG002|Run-in Phase|Refused to continue medication|0|||
105639948|NCT00824408|364345621|FG003|Run-in Phase|Refused to continue medication|0|||
105639949|NCT00824408|364345622|FG004|Run-in Phase|Refused to continue medication|0|||
105639950|NCT00824408|364345618|FG000|Run-in Phase|Other reason not defined above|0|||
105639951|NCT00824408|364345619|FG001|Run-in Phase|Other reason not defined above|1|||
105639952|NCT00824408|364345620|FG002|Run-in Phase|Other reason not defined above|0|||
105639953|NCT00824408|364345621|FG003|Run-in Phase|Other reason not defined above|0|||
105639954|NCT00824408|364345622|FG004|Run-in Phase|Other reason not defined above|0|||
105639955|NCT00824408|364345618|FG000|Randomized Phase|Not treated|0|||
105639956|NCT00824408|364345619|FG001|Randomized Phase|Not treated|0|||
105639957|NCT00824408|364345620|FG002|Randomized Phase|Not treated|1|||
105639958|NCT00824408|364345621|FG003|Randomized Phase|Not treated|1|||
105639959|NCT00824408|364345622|FG004|Randomized Phase|Not treated|1|||
105639960|NCT00824408|364345618|FG000|Randomized Phase|Progressive disease|0|||
105639961|NCT00824408|364345619|FG001|Randomized Phase|Progressive disease|0|||
105639962|NCT00824408|364345620|FG002|Randomized Phase|Progressive disease|25|||
105639963|NCT00824408|364345621|FG003|Randomized Phase|Progressive disease|36|||
105639964|NCT00824408|364345622|FG004|Randomized Phase|Progressive disease|34|||
105639965|NCT00824408|364345618|FG000|Randomized Phase|Adverse Event|0|||
105639966|NCT00824408|364345619|FG001|Randomized Phase|Adverse Event|0|||
105639967|NCT00824408|364345620|FG002|Randomized Phase|Adverse Event|4|||
105639968|NCT00824408|364345621|FG003|Randomized Phase|Adverse Event|5|||
105639969|NCT00824408|364345622|FG004|Randomized Phase|Adverse Event|5|||
105639970|NCT00824408|364345618|FG000|Randomized Phase|Refused to continue medication|0|||
105639971|NCT00824408|364345619|FG001|Randomized Phase|Refused to continue medication|0|||
105639972|NCT00824408|364345620|FG002|Randomized Phase|Refused to continue medication|2|||
105639973|NCT00824408|364345621|FG003|Randomized Phase|Refused to continue medication|2|||
105639974|NCT00824408|364345622|FG004|Randomized Phase|Refused to continue medication|2|||
105639975|NCT00824408|364345618|FG000|Randomized Phase|Other reason not defined above|0|||
105639976|NCT00824408|364345619|FG001|Randomized Phase|Other reason not defined above|0|||
105639977|NCT00824408|364345620|FG002|Randomized Phase|Other reason not defined above|4|||
105639978|NCT00824408|364345621|FG003|Randomized Phase|Other reason not defined above|2|||
105639979|NCT00824408|364345622|FG004|Randomized Phase|Other reason not defined above|4|||
105639980|NCT05445557|364345626|FG000|Double Blind Part|Lost to Follow-up|1|||
105639981|NCT02241785|364345638|FG000|Overall Study|Sponsor Termination|43|||
105639982|NCT02241785|364345638|FG000|Overall Study|Withdrawal by Subject|1|||
105639983|NCT02241785|364345638|FG000|Overall Study|Lost to Follow-up|2|||
105639984|NCT02241785|364345638|FG000|Overall Study|Adverse Event|1|||
105639985|NCT01964547|364345639|FG000|Overall Study|Adverse Event|8|||
105639986|NCT01964547|364345640|FG001|Overall Study|Adverse Event|2|||
105639987|NCT01964547|364345639|FG000|Overall Study|Withdrawal by Subject|4|||
105639988|NCT01964547|364345640|FG001|Overall Study|Withdrawal by Subject|7|||
105639989|NCT01964547|364345639|FG000|Overall Study|Lost to Follow-up|0|||
105639990|NCT01964547|364345640|FG001|Overall Study|Lost to Follow-up|1|||
105639991|NCT01964547|364345639|FG000|Overall Study|Withdrawal by Investigator|0|||
105639992|NCT01964547|364345640|FG001|Overall Study|Withdrawal by Investigator|1|||
105639993|NCT02161146|364345641|FG000|Overall Study|Adverse Event|1|||
105639994|NCT02161146|364345642|FG001|Overall Study|Adverse Event|1|||
105639995|NCT02161146|364345643|FG002|Overall Study|Adverse Event|0|||
105639996|NCT02161146|364345644|FG003|Overall Study|Adverse Event|1|||
105639997|NCT02161146|364345645|FG004|Overall Study|Adverse Event|0|||
105639998|NCT02161146|364345641|FG000|Overall Study|Lost to Follow-up|0|||
105639999|NCT02161146|364345642|FG001|Overall Study|Lost to Follow-up|1|||
105640000|NCT02161146|364345643|FG002|Overall Study|Lost to Follow-up|0|||
105640001|NCT02161146|364345644|FG003|Overall Study|Lost to Follow-up|0|||
105640002|NCT02161146|364345645|FG004|Overall Study|Lost to Follow-up|0|||
105640003|NCT02161146|364345641|FG000|Overall Study|Personal Reasons|0|||
105640004|NCT02161146|364345642|FG001|Overall Study|Personal Reasons|1|||
105640005|NCT02161146|364345643|FG002|Overall Study|Personal Reasons|0|||
105640006|NCT02161146|364345644|FG003|Overall Study|Personal Reasons|2|||
105640007|NCT02161146|364345645|FG004|Overall Study|Personal Reasons|1|||
105640008|NCT02161146|364345641|FG000|Overall Study|Other Miscellaneous Reasons|0|||
105640009|NCT02161146|364345642|FG001|Overall Study|Other Miscellaneous Reasons|1|||
105640010|NCT02161146|364345643|FG002|Overall Study|Other Miscellaneous Reasons|0|||
105640011|NCT02161146|364345644|FG003|Overall Study|Other Miscellaneous Reasons|0|||
105640012|NCT02161146|364345645|FG004|Overall Study|Other Miscellaneous Reasons|0|||
105640013|NCT01736475|364345646|FG000|Overall Study|Adverse Event|4|||
105640014|NCT01736475|364345647|FG001|Overall Study|Adverse Event|0|||
105640015|NCT01736475|364345646|FG000|Overall Study|Withdrawal by Subject|2|||
105640016|NCT01736475|364345647|FG001|Overall Study|Withdrawal by Subject|0|||
105640017|NCT01736475|364345646|FG000|Overall Study|Protocol Violation|4|||
105640018|NCT01736475|364345647|FG001|Overall Study|Protocol Violation|0|||
105640019|NCT01736475|364345646|FG000|Overall Study|Other - Screen failure|1|||
105640020|NCT01736475|364345647|FG001|Overall Study|Other - Screen failure|0|||
105640021|NCT01736475|364345646|FG000|Overall Study|Other - Surgical procedure|1|||
105640022|NCT01736475|364345647|FG001|Overall Study|Other - Surgical procedure|0|||
105640023|NCT02807857|364345648|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
105640024|NCT02807857|364345648|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
105640025|NCT02807857|364345648|FG000|Follow-Up Set|Withdrawal by Subject|8|||
105640026|NCT02807857|364345648|FG000|Follow-Up Set|Lost to Follow-up|7|||
105640027|NCT02807857|364345648|FG000|Follow-Up Set|Physician Decision|6|||
105640028|NCT02807857|364345648|FG000|Follow-Up Set|Adverse Event|3|||
105640029|NCT02807857|364345648|FG000|Follow-Up Set|Death|27|||
105640030|NCT02807857|364345648|FG000|Follow-Up Set|Relocation|2|||
105640031|NCT02106325|364345650|FG000|Phase 1|Lost to Follow-up|2|||
105640032|NCT02106325|364345651|FG001|Phase 1|Lost to Follow-up|2|||
105640033|NCT02106325|364345650|FG000|Phase 2|Lost to Follow-up|2|||
105640034|NCT02106325|364345651|FG001|Phase 2|Lost to Follow-up|3|||
105640035|NCT02106325|364345650|FG000|Phase 3|Lost to Follow-up|2|||
105640036|NCT02106325|364345651|FG001|Phase 3|Lost to Follow-up|1|||
105640037|NCT01079949|364345652|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
105640038|NCT01079949|364345653|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
105640039|NCT01079949|364345652|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
105640040|NCT01079949|364345653|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
105640041|NCT01079949|364345652|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
105640042|NCT01079949|364345653|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
105640043|NCT01079949|364345652|FG000|Overall Study|Randomized but not treated|1|||
105640044|NCT01079949|364345653|FG001|Overall Study|Randomized but not treated|0|||
105640045|NCT01529632|364345654|FG000|Overall Study|Administrative problem|2|||
105640046|NCT01529632|364345655|FG001|Overall Study|Administrative problem|1|||
105640047|NCT01529632|364345654|FG000|Overall Study|Protocol Violation|0|||
105640048|NCT01529632|364345655|FG001|Overall Study|Protocol Violation|1|||
105640049|NCT01529632|364345654|FG000|Overall Study|Adverse Event|1|||
105640050|NCT01529632|364345655|FG001|Overall Study|Adverse Event|1|||
105640051|NCT02334215|364345656|FG000|Overall Study|Death|1|||
105640052|NCT02334215|364345657|FG001|Overall Study|Death|1|||
105640053|NCT02334215|364345658|FG002|Overall Study|Death|0|||
105640054|NCT02334215|364345656|FG000|Overall Study|Lost to Follow-up|1|||
105640055|NCT02334215|364345657|FG001|Overall Study|Lost to Follow-up|0|||
105640056|NCT02334215|364345658|FG002|Overall Study|Lost to Follow-up|4|||
105640057|NCT02334215|364345656|FG000|Overall Study|Withdrawal by Subject|2|||
105640058|NCT02334215|364345657|FG001|Overall Study|Withdrawal by Subject|2|||
105640059|NCT02334215|364345658|FG002|Overall Study|Withdrawal by Subject|1|||
105640060|NCT02334215|364345656|FG000|Overall Study|Not released from incarceration on time|3|||
105640061|NCT02334215|364345657|FG001|Overall Study|Not released from incarceration on time|3|||
105640062|NCT02334215|364345658|FG002|Overall Study|Not released from incarceration on time|3|||
105640063|NCT02334215|364345656|FG000|Overall Study|Incarcerated|0|||
105640064|NCT02334215|364345657|FG001|Overall Study|Incarcerated|0|||
105640065|NCT02334215|364345658|FG002|Overall Study|Incarcerated|7|||
105640066|NCT04919499|364345659|FG000|Overall Study|Adverse Event|0|||
105640067|NCT04919499|364345660|FG001|Overall Study|Adverse Event|0|||
105640068|NCT04919499|364345661|FG002|Overall Study|Adverse Event|0|||
105640069|NCT04919499|364345662|FG003|Overall Study|Adverse Event|0|||
105640070|NCT04919499|364345663|FG004|Overall Study|Adverse Event|2|||
105640071|NCT04919499|364345659|FG000|Overall Study|Not treated|0|||
105640072|NCT04919499|364345660|FG001|Overall Study|Not treated|0|||
105640073|NCT04919499|364345661|FG002|Overall Study|Not treated|0|||
105640074|NCT04919499|364345662|FG003|Overall Study|Not treated|1|||
105640075|NCT04919499|364345663|FG004|Overall Study|Not treated|0|||
105640076|NCT04520256|364345664|FG000|Overall Study|Lost to Follow-up|6|||
105640077|NCT04520256|364345665|FG001|Overall Study|Lost to Follow-up|4|||
105640078|NCT04520256|364345666|FG002|Overall Study|Lost to Follow-up|2|||
105640079|NCT04520256|364345667|FG003|Overall Study|Lost to Follow-up|3|||
105640080|NCT04520256|364345668|FG004|Overall Study|Lost to Follow-up|6|||
105640081|NCT04520256|364345669|FG005|Overall Study|Lost to Follow-up|6|||
105640082|NCT04520256|364345670|FG006|Overall Study|Lost to Follow-up|4|||
105640083|NCT04520256|364345671|FG007|Overall Study|Lost to Follow-up|6|||
105640084|NCT04520256|364345672|FG008|Overall Study|Lost to Follow-up|1|||
105640085|NCT04520256|364345673|FG009|Overall Study|Lost to Follow-up|3|||
105640086|NCT04520256|364345674|FG010|Overall Study|Lost to Follow-up|3|||
105640087|NCT04520256|364345675|FG011|Overall Study|Lost to Follow-up|2|||
105640088|NCT04520256|364345676|FG012|Overall Study|Lost to Follow-up|5|||
105640089|NCT04520256|364345677|FG013|Overall Study|Lost to Follow-up|3|||
105640090|NCT04520256|364345678|FG014|Overall Study|Lost to Follow-up|3|||
105640091|NCT04520256|364345679|FG015|Overall Study|Lost to Follow-up|6|||
105640092|NCT04520256|364345680|FG016|Overall Study|Lost to Follow-up|6|||
105640093|NCT04520256|364345681|FG017|Overall Study|Lost to Follow-up|4|||
105640094|NCT04520256|364345682|FG018|Overall Study|Lost to Follow-up|3|||
105640095|NCT04520256|364345683|FG019|Overall Study|Lost to Follow-up|3|||
105640096|NCT04520256|364345684|FG020|Overall Study|Lost to Follow-up|7|||
105640097|NCT04520256|364345685|FG021|Overall Study|Lost to Follow-up|3|||
105640098|NCT04520256|364345686|FG022|Overall Study|Lost to Follow-up|3|||
105640099|NCT04520256|364345687|FG023|Overall Study|Lost to Follow-up|8|||
105640100|NCT04520256|364345688|FG024|Overall Study|Lost to Follow-up|5|||
105640101|NCT04520256|364345689|FG025|Overall Study|Lost to Follow-up|4|||
105640102|NCT04520256|364345690|FG026|Overall Study|Lost to Follow-up|3|||
105640103|NCT04520256|364345691|FG027|Overall Study|Lost to Follow-up|4|||
105640104|NCT04520256|364345692|FG028|Overall Study|Lost to Follow-up|3|||
105640105|NCT04520256|364345693|FG029|Overall Study|Lost to Follow-up|4|||
105640106|NCT04520256|364345694|FG030|Overall Study|Lost to Follow-up|4|||
105640107|NCT04520256|364345695|FG031|Overall Study|Lost to Follow-up|4|||
105640108|NCT02556918|364347611|FG000|Overall Study|Protocol Violation|5|||
105640109|NCT02556918|364347612|FG001|Overall Study|Protocol Violation|6|||
105640110|NCT02556918|364347611|FG000|Overall Study|Withdrawal by Subject|4|||
105640111|NCT02556918|364347612|FG001|Overall Study|Withdrawal by Subject|4|||
105640112|NCT01190124|364347613|FG000|Overall Study|Death|3|||
105640113|NCT01190124|364347614|FG001|Overall Study|Death|0|||
105640114|NCT01190124|364347615|FG002|Overall Study|Death|0|||
105640115|NCT01190124|364347613|FG000|Overall Study|Therapeutic Failure|12|||
105640116|NCT01190124|364347614|FG001|Overall Study|Therapeutic Failure|0|||
105640117|NCT01190124|364347615|FG002|Overall Study|Therapeutic Failure|1|||
105640118|NCT01190124|364347613|FG000|Overall Study|Lost to Follow-up|2|||
105640119|NCT01190124|364347614|FG001|Overall Study|Lost to Follow-up|0|||
105640120|NCT01190124|364347615|FG002|Overall Study|Lost to Follow-up|0|||
105640121|NCT00047385|364347617|FG000|Overall Study|Death before any screening|2|||
105640122|NCT00047385|364347618|FG001|Overall Study|Death before any screening|5|||
105640123|NCT00047385|364347617|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
105640124|NCT00047385|364347618|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
105640125|NCT00047385|364347617|FG000|Overall Study|Eligible for screening but had no screen|260|||
105640126|NCT00047385|364347618|FG001|Overall Study|Eligible for screening but had no screen|492|||
105640127|NCT03392194|364347620|FG000|Overall Study|Withdrawal by Subject|1|||
105640128|NCT03392194|364347621|FG001|Overall Study|Withdrawal by Subject|2|||
105640129|NCT03392194|364347620|FG000|Overall Study|Conflicts with personal schedule|1|||
105640130|NCT03392194|364347621|FG001|Overall Study|Conflicts with personal schedule|0|||
105640131|NCT02392507|364347622|FG000|Induction Regimen|Death|3|||
105640132|NCT02392507|364347622|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
105640133|NCT02392507|364347622|FG000|Induction Regimen|Physician Decision|1|||
105640134|NCT02392507|364347622|FG000|Induction Regimen|Withdrawal by Subject|2|||
105640135|NCT02392507|364347622|FG000|Maintenance Regimen|Death|1|||
105640136|NCT02392507|364347622|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
105640137|NCT02736188|364347623|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
105640138|NCT02736188|364347623|FG000|Overall Study|Adverse Event|1|||
105640139|NCT02736188|364347623|FG000|Overall Study|Withdrawal by Subject|1|||
105640140|NCT02736188|364347623|FG000|Overall Study|Other|6|||
105640141|NCT02245620|364347625|FG000|Overall Study|Physician Decision|1|||
105640142|NCT02245620|364347626|FG001|Overall Study|Physician Decision|1|||
105640143|NCT00787176|364347627|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
105640144|NCT00787176|364347628|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
105640145|NCT00787176|364347629|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
105659333|NCT00551135|364417280|FG000|Overall Study|Lost to Follow-up|0|||
105640146|NCT00787176|364347630|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
105640147|NCT00895245|364347631|FG000|Overall Study|Lack of Efficacy|6|||
105640148|NCT02203799|364347633|FG000|Overall Study|Withdrawal by Subject|3|||
105640149|NCT02106884|364347634|FG000|Overall Study|Change of diagnosis/exclusion|0|||
105640150|NCT02106884|364347635|FG001|Overall Study|Change of diagnosis/exclusion|1|||
105640151|NCT03006393|364347636|FG000|Overall Study|Withdrawal by Subject|1|||
105640152|NCT03006393|364347637|FG001|Overall Study|Withdrawal by Subject|1|||
105640153|NCT03006393|364347636|FG000|Overall Study|Pregnancy|0|||
105640154|NCT03006393|364347637|FG001|Overall Study|Pregnancy|1|||
105640155|NCT03006393|364347636|FG000|Overall Study|Lost to Follow-up|0|||
105640156|NCT03006393|364347637|FG001|Overall Study|Lost to Follow-up|1|||
105640157|NCT01584648|364347640|FG000|Overall Study|Death|136|||
105640158|NCT01584648|364347641|FG001|Overall Study|Death|146|||
105640159|NCT01584648|364347640|FG000|Overall Study|Lost to Follow-up|9|||
105640160|NCT01584648|364347641|FG001|Overall Study|Lost to Follow-up|9|||
105640161|NCT01584648|364347640|FG000|Overall Study|Investigator discretion|3|||
105640162|NCT01584648|364347641|FG001|Overall Study|Investigator discretion|2|||
105640163|NCT01584648|364347640|FG000|Overall Study|Withdrew consent|13|||
105640164|NCT01584648|364347641|FG001|Overall Study|Withdrew consent|4|||
105640165|NCT01584648|364347640|FG000|Overall Study|Study closed/terminated|50|||
105640166|NCT01584648|364347641|FG001|Overall Study|Study closed/terminated|23|||
105640167|NCT01584648|364347640|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
105640168|NCT01584648|364347641|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
105640169|NCT00659373|364347642|FG000|Overall Study|Withdrawal by Subject|3|||
105640170|NCT00659373|364347643|FG001|Overall Study|Withdrawal by Subject|5|||
105640171|NCT00659373|364347642|FG000|Overall Study|Assessment Missed|2|||
105640172|NCT00659373|364347643|FG001|Overall Study|Assessment Missed|2|||
105640173|NCT03042767|364347646|FG000|Overall Study|Lost to Follow-up|1|||
105640174|NCT03042767|364347647|FG001|Overall Study|Lost to Follow-up|2|||
105640175|NCT02362789|364347650|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
105640176|NCT02362789|364347651|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
105640177|NCT02362789|364347652|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
105640178|NCT02362789|364347650|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
105640179|NCT02362789|364347651|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
105640180|NCT02362789|364347652|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
105640181|NCT02362789|364347650|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
105640182|NCT02362789|364347651|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
105640183|NCT02362789|364347652|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
105640184|NCT02362789|364347650|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
105640185|NCT02362789|364347651|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
105640186|NCT02362789|364347652|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
105640187|NCT02362789|364347650|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
105640188|NCT02362789|364347651|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
105640189|NCT02362789|364347652|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
105640190|NCT00042939|364347653|FG000|Overall Study|Adverse Event|6|||
105640191|NCT00042939|364347654|FG001|Overall Study|Adverse Event|7|||
105640192|NCT00042939|364347653|FG000|Overall Study|Death|3|||
105640193|NCT00042939|364347654|FG001|Overall Study|Death|2|||
105640194|NCT00042939|364347653|FG000|Overall Study|Withdrawal by Subject|3|||
105640195|NCT00042939|364347654|FG001|Overall Study|Withdrawal by Subject|4|||
105640196|NCT00042939|364347653|FG000|Overall Study|Other disease|1|||
105640197|NCT00042939|364347654|FG001|Overall Study|Other disease|0|||
105640198|NCT00042939|364347653|FG000|Overall Study|Ineligible|2|||
105640199|NCT00042939|364347654|FG001|Overall Study|Ineligible|2|||
105640200|NCT00042939|364347653|FG000|Overall Study|Deterioration of health|3|||
105640201|NCT00042939|364347654|FG001|Overall Study|Deterioration of health|4|||
105640202|NCT00042939|364347653|FG000|Overall Study|QOL diminished|1|||
105640203|NCT00042939|364347654|FG001|Overall Study|QOL diminished|0|||
105640204|NCT00042939|364347653|FG000|Overall Study|Rising ca 19-9|1|||
105640205|NCT00042939|364347654|FG001|Overall Study|Rising ca 19-9|0|||
105640206|NCT00042939|364347653|FG000|Overall Study|Patient non-compliance|1|||
105640207|NCT00042939|364347654|FG001|Overall Study|Patient non-compliance|0|||
105640208|NCT00042939|364347653|FG000|Overall Study|Still on treatment|1|||
105640209|NCT00042939|364347654|FG001|Overall Study|Still on treatment|0|||
105640210|NCT00042939|364347653|FG000|Overall Study|Treatment break > 4 weeks|0|||
105640211|NCT00042939|364347654|FG001|Overall Study|Treatment break > 4 weeks|1|||
105640212|NCT00042939|364347653|FG000|Overall Study|Did not start treatment|2|||
105640213|NCT00042939|364347654|FG001|Overall Study|Did not start treatment|1|||
105640214|NCT00721734|364347656|FG000|Overall Study|Progressive Disease|3|||
105640215|NCT00721734|364347657|FG001|Overall Study|Progressive Disease|10|||
105640216|NCT00721734|364347658|FG002|Overall Study|Progressive Disease|4|||
105640217|NCT00721734|364347659|FG003|Overall Study|Progressive Disease|5|||
105640218|NCT00721734|364347660|FG004|Overall Study|Progressive Disease|2|||
105640219|NCT00721734|364347656|FG000|Overall Study|Adverse Event|3|||
105640220|NCT00721734|364347657|FG001|Overall Study|Adverse Event|1|||
105640221|NCT00721734|364347658|FG002|Overall Study|Adverse Event|4|||
105640222|NCT00721734|364347659|FG003|Overall Study|Adverse Event|0|||
105640223|NCT00721734|364347660|FG004|Overall Study|Adverse Event|3|||
105640224|NCT00721734|364347656|FG000|Overall Study|Withdrawal by Subject|2|||
105640225|NCT00721734|364347657|FG001|Overall Study|Withdrawal by Subject|1|||
105640226|NCT00721734|364347658|FG002|Overall Study|Withdrawal by Subject|0|||
105640227|NCT00721734|364347659|FG003|Overall Study|Withdrawal by Subject|0|||
105640228|NCT00721734|364347660|FG004|Overall Study|Withdrawal by Subject|1|||
105640229|NCT00721734|364347656|FG000|Overall Study|Other|0|||
105640230|NCT00721734|364347657|FG001|Overall Study|Other|0|||
105640231|NCT00721734|364347658|FG002|Overall Study|Other|0|||
105640232|NCT00721734|364347659|FG003|Overall Study|Other|1|||
105640233|NCT00721734|364347660|FG004|Overall Study|Other|0|||
105640234|NCT04617847|364347661|FG000|Overall Study|Withdrawal by Subject|1|||
105640235|NCT04617847|364347662|FG001|Overall Study|Withdrawal by Subject|0|||
105640236|NCT04617847|364347661|FG000|Overall Study|Adverse Event|0|||
105640237|NCT04617847|364347662|FG001|Overall Study|Adverse Event|2|||
105640238|NCT04617847|364347661|FG000|Overall Study|Death|0|||
105640239|NCT04617847|364347662|FG001|Overall Study|Death|1|||
105640240|NCT04617847|364347661|FG000|Overall Study|Termination of Study by Sponsor|2|||
105640241|NCT04617847|364347662|FG001|Overall Study|Termination of Study by Sponsor|21|||
105640242|NCT01989689|364347663|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
105640243|NCT01989689|364347664|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
105640244|NCT01989689|364347663|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
105640245|NCT01989689|364347664|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
105640246|NCT02066636|364347665|FG000|Overall Study|Disease progression|51|||
105640247|NCT02066636|364347666|FG001|Overall Study|Disease progression|60|||
105640248|NCT02066636|364347667|FG002|Overall Study|Disease progression|700|||
105640249|NCT02066636|364347665|FG000|Overall Study|Study drug toxicity|13|||
105640250|NCT02066636|364347666|FG001|Overall Study|Study drug toxicity|2|||
105640251|NCT02066636|364347667|FG002|Overall Study|Study drug toxicity|58|||
105640252|NCT02066636|364347665|FG000|Overall Study|Death|4|||
105640253|NCT02066636|364347666|FG001|Overall Study|Death|2|||
105640254|NCT02066636|364347667|FG002|Overall Study|Death|158|||
105640255|NCT02066636|364347665|FG000|Overall Study|Adverse event unrelated to study drug|6|||
105640256|NCT02066636|364347666|FG001|Overall Study|Adverse event unrelated to study drug|4|||
105640257|NCT02066636|364347667|FG002|Overall Study|Adverse event unrelated to study drug|45|||
105640258|NCT02066636|364347665|FG000|Overall Study|Participant request to discontinue treatment|12|||
105640259|NCT02066636|364347666|FG001|Overall Study|Participant request to discontinue treatment|12|||
105640260|NCT02066636|364347667|FG002|Overall Study|Participant request to discontinue treatment|70|||
105640261|NCT02066636|364347665|FG000|Overall Study|Participant withdrew consent|10|||
105640262|NCT02066636|364347666|FG001|Overall Study|Participant withdrew consent|18|||
105640263|NCT02066636|364347667|FG002|Overall Study|Participant withdrew consent|61|||
105640264|NCT02066636|364347665|FG000|Overall Study|Lost to Follow-up|0|||
105640265|NCT02066636|364347666|FG001|Overall Study|Lost to Follow-up|2|||
105640266|NCT02066636|364347667|FG002|Overall Study|Lost to Follow-up|2|||
105640267|NCT02066636|364347665|FG000|Overall Study|Maximum clinical benefit|2|||
105640268|NCT02066636|364347666|FG001|Overall Study|Maximum clinical benefit|2|||
105640269|NCT02066636|364347667|FG002|Overall Study|Maximum clinical benefit|3|||
105640270|NCT02066636|364347665|FG000|Overall Study|Poor/non-compliance|2|||
105640271|NCT02066636|364347666|FG001|Overall Study|Poor/non-compliance|1|||
105640272|NCT02066636|364347667|FG002|Overall Study|Poor/non-compliance|1|||
105640273|NCT02066636|364347665|FG000|Overall Study|Participant no loner meets study criteria|3|||
105640274|NCT02066636|364347666|FG001|Overall Study|Participant no loner meets study criteria|2|||
105640275|NCT02066636|364347667|FG002|Overall Study|Participant no loner meets study criteria|28|||
105640276|NCT02066636|364347665|FG000|Overall Study|Administrative reasons by sponsor|8|||
105640277|NCT02066636|364347666|FG001|Overall Study|Administrative reasons by sponsor|5|||
105640278|NCT02066636|364347667|FG002|Overall Study|Administrative reasons by sponsor|0|||
105640279|NCT02066636|364347665|FG000|Overall Study|Other reasons|16|||
105640280|NCT02066636|364347666|FG001|Overall Study|Other reasons|15|||
105640281|NCT02066636|364347667|FG002|Overall Study|Other reasons|50|||
105640282|NCT00391170|364347668|FG000|Overall Study|Withdrawal by Subject|1|||
105640283|NCT00391170|364347669|FG001|Overall Study|Withdrawal by Subject|0|||
105640284|NCT00391170|364347668|FG000|Overall Study|Adverse Event|3|||
105640285|NCT00391170|364347669|FG001|Overall Study|Adverse Event|2|||
105640286|NCT00391170|364347668|FG000|Overall Study|Physician Decision|2|||
105640287|NCT00391170|364347669|FG001|Overall Study|Physician Decision|2|||
105640288|NCT00103857|364347684|FG000|54-Week Base Study|Adverse Event|12|||
105640289|NCT00103857|364347685|FG001|54-Week Base Study|Adverse Event|9|||
105640290|NCT00103857|364347686|FG002|54-Week Base Study|Adverse Event|11|||
105640291|NCT00103857|364347687|FG003|54-Week Base Study|Adverse Event|6|||
105640292|NCT00103857|364347688|FG004|54-Week Base Study|Adverse Event|5|||
105640293|NCT00103857|364347689|FG005|54-Week Base Study|Adverse Event|11|||
105640294|NCT00103857|364347690|FG006|54-Week Base Study|Adverse Event|3|||
105640295|NCT00103857|364347684|FG000|54-Week Base Study|Death|0|||
105640296|NCT00103857|364347685|FG001|54-Week Base Study|Death|0|||
105640297|NCT00103857|364347686|FG002|54-Week Base Study|Death|0|||
105640298|NCT00103857|364347687|FG003|54-Week Base Study|Death|0|||
105640299|NCT00103857|364347688|FG004|54-Week Base Study|Death|1|||
105640300|NCT00103857|364347689|FG005|54-Week Base Study|Death|1|||
105640301|NCT00103857|364347690|FG006|54-Week Base Study|Death|0|||
105640302|NCT00103857|364347684|FG000|54-Week Base Study|Lack of Efficacy|11|||
105640303|NCT00103857|364347685|FG001|54-Week Base Study|Lack of Efficacy|14|||
105640304|NCT00103857|364347686|FG002|54-Week Base Study|Lack of Efficacy|8|||
105640305|NCT00103857|364347687|FG003|54-Week Base Study|Lack of Efficacy|4|||
105640306|NCT00103857|364347688|FG004|54-Week Base Study|Lack of Efficacy|3|||
105640307|NCT00103857|364347689|FG005|54-Week Base Study|Lack of Efficacy|14|||
105640308|NCT00103857|364347690|FG006|54-Week Base Study|Lack of Efficacy|19|||
105640309|NCT00103857|364347684|FG000|54-Week Base Study|Lost to Follow-up|5|||
105640310|NCT00103857|364347685|FG001|54-Week Base Study|Lost to Follow-up|4|||
105640311|NCT00103857|364347686|FG002|54-Week Base Study|Lost to Follow-up|7|||
105640312|NCT00103857|364347687|FG003|54-Week Base Study|Lost to Follow-up|5|||
105640313|NCT00103857|364347688|FG004|54-Week Base Study|Lost to Follow-up|10|||
105640314|NCT00103857|364347689|FG005|54-Week Base Study|Lost to Follow-up|9|||
105640315|NCT00103857|364347690|FG006|54-Week Base Study|Lost to Follow-up|3|||
105640316|NCT00103857|364347684|FG000|54-Week Base Study|Physician Decision|1|||
105640317|NCT00103857|364347685|FG001|54-Week Base Study|Physician Decision|1|||
105640318|NCT00103857|364347686|FG002|54-Week Base Study|Physician Decision|0|||
105640319|NCT00103857|364347687|FG003|54-Week Base Study|Physician Decision|0|||
105640320|NCT00103857|364347688|FG004|54-Week Base Study|Physician Decision|1|||
105640321|NCT00103857|364347689|FG005|54-Week Base Study|Physician Decision|0|||
105640322|NCT00103857|364347690|FG006|54-Week Base Study|Physician Decision|0|||
105640323|NCT00103857|364347684|FG000|54-Week Base Study|Pregnancy|1|||
105640324|NCT00103857|364347685|FG001|54-Week Base Study|Pregnancy|0|||
105640325|NCT00103857|364347686|FG002|54-Week Base Study|Pregnancy|0|||
105640326|NCT00103857|364347687|FG003|54-Week Base Study|Pregnancy|0|||
105640327|NCT00103857|364347688|FG004|54-Week Base Study|Pregnancy|1|||
105640328|NCT00103857|364347689|FG005|54-Week Base Study|Pregnancy|0|||
105640329|NCT00103857|364347690|FG006|54-Week Base Study|Pregnancy|1|||
105640330|NCT00103857|364347684|FG000|54-Week Base Study|Protocol Violation|6|||
105640331|NCT00103857|364347685|FG001|54-Week Base Study|Protocol Violation|4|||
105640332|NCT00103857|364347686|FG002|54-Week Base Study|Protocol Violation|2|||
105640333|NCT00103857|364347687|FG003|54-Week Base Study|Protocol Violation|4|||
105640334|NCT00103857|364347688|FG004|54-Week Base Study|Protocol Violation|0|||
105640335|NCT00103857|364347689|FG005|54-Week Base Study|Protocol Violation|3|||
105640336|NCT00103857|364347690|FG006|54-Week Base Study|Protocol Violation|3|||
105640337|NCT00103857|364347684|FG000|54-Week Base Study|Withdrawal by Subject|17|||
105640338|NCT00103857|364347685|FG001|54-Week Base Study|Withdrawal by Subject|16|||
105640339|NCT00103857|364347686|FG002|54-Week Base Study|Withdrawal by Subject|16|||
105640340|NCT00103857|364347687|FG003|54-Week Base Study|Withdrawal by Subject|15|||
105640341|NCT00103857|364347688|FG004|54-Week Base Study|Withdrawal by Subject|10|||
105640342|NCT00103857|364347689|FG005|54-Week Base Study|Withdrawal by Subject|15|||
105640343|NCT00103857|364347690|FG006|54-Week Base Study|Withdrawal by Subject|4|||
105640344|NCT00103857|364347684|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
105640345|NCT00103857|364347685|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
105640346|NCT00103857|364347686|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
105640347|NCT00103857|364347687|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
105640348|NCT00103857|364347688|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
105640349|NCT00103857|364347689|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
105640350|NCT00103857|364347690|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
105640351|NCT00103857|364347684|FG000|54-Week Base Study|patient moved|0|||
105640352|NCT00103857|364347685|FG001|54-Week Base Study|patient moved|1|||
105640353|NCT00103857|364347686|FG002|54-Week Base Study|patient moved|1|||
105640354|NCT00103857|364347687|FG003|54-Week Base Study|patient moved|2|||
105640355|NCT00103857|364347688|FG004|54-Week Base Study|patient moved|3|||
105640356|NCT00103857|364347689|FG005|54-Week Base Study|patient moved|1|||
105640357|NCT00103857|364347690|FG006|54-Week Base Study|patient moved|0|||
105640358|NCT00103857|364347684|FG000|54-Week Base Study|non-compliance with study procedures|1|||
105640359|NCT00103857|364347685|FG001|54-Week Base Study|non-compliance with study procedures|2|||
105640360|NCT00103857|364347686|FG002|54-Week Base Study|non-compliance with study procedures|0|||
105640361|NCT00103857|364347687|FG003|54-Week Base Study|non-compliance with study procedures|0|||
105640362|NCT00103857|364347688|FG004|54-Week Base Study|non-compliance with study procedures|0|||
105640363|NCT00103857|364347689|FG005|54-Week Base Study|non-compliance with study procedures|2|||
105640364|NCT00103857|364347690|FG006|54-Week Base Study|non-compliance with study procedures|0|||
105640365|NCT00103857|364347684|FG000|54-Week Base Study|patient incarcerated|0|||
105640366|NCT00103857|364347685|FG001|54-Week Base Study|patient incarcerated|0|||
105640367|NCT00103857|364347686|FG002|54-Week Base Study|patient incarcerated|0|||
105640368|NCT00103857|364347687|FG003|54-Week Base Study|patient incarcerated|0|||
105640369|NCT00103857|364347688|FG004|54-Week Base Study|patient incarcerated|1|||
105640370|NCT00103857|364347689|FG005|54-Week Base Study|patient incarcerated|1|||
105640371|NCT00103857|364347690|FG006|54-Week Base Study|patient incarcerated|0|||
105640372|NCT00103857|364347684|FG000|54-Week Base Study|laboratory reporting error|0|||
105640373|NCT00103857|364347685|FG001|54-Week Base Study|laboratory reporting error|0|||
105640374|NCT00103857|364347686|FG002|54-Week Base Study|laboratory reporting error|0|||
105640375|NCT00103857|364347687|FG003|54-Week Base Study|laboratory reporting error|0|||
105640376|NCT00103857|364347688|FG004|54-Week Base Study|laboratory reporting error|1|||
105640377|NCT00103857|364347689|FG005|54-Week Base Study|laboratory reporting error|0|||
105640378|NCT00103857|364347690|FG006|54-Week Base Study|laboratory reporting error|0|||
105640379|NCT00103857|364347684|FG000|54-Week Base Study|site error|0|||
105640380|NCT00103857|364347685|FG001|54-Week Base Study|site error|0|||
105640381|NCT00103857|364347686|FG002|54-Week Base Study|site error|0|||
105640382|NCT00103857|364347687|FG003|54-Week Base Study|site error|0|||
105640383|NCT00103857|364347688|FG004|54-Week Base Study|site error|0|||
105640384|NCT00103857|364347689|FG005|54-Week Base Study|site error|1|||
105640385|NCT00103857|364347690|FG006|54-Week Base Study|site error|0|||
105640386|NCT00103857|364347684|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
105640387|NCT00103857|364347685|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
105640388|NCT00103857|364347686|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
105640389|NCT00103857|364347687|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
105640390|NCT00103857|364347688|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
105640391|NCT00103857|364347689|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
105640392|NCT00103857|364347690|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
105640393|NCT00103857|364347684|FG000|50-Week Extension Study|Adverse Event|2|||
105640394|NCT00103857|364347685|FG001|50-Week Extension Study|Adverse Event|3|||
105640395|NCT00103857|364347686|FG002|50-Week Extension Study|Adverse Event|2|||
105640396|NCT00103857|364347687|FG003|50-Week Extension Study|Adverse Event|0|||
105640397|NCT00103857|364347688|FG004|50-Week Extension Study|Adverse Event|1|||
105640398|NCT00103857|364347689|FG005|50-Week Extension Study|Adverse Event|1|||
105640399|NCT00103857|364347690|FG006|50-Week Extension Study|Adverse Event|0|||
105640400|NCT00103857|364347684|FG000|50-Week Extension Study|Death|0|||
105640401|NCT00103857|364347685|FG001|50-Week Extension Study|Death|0|||
105640402|NCT00103857|364347686|FG002|50-Week Extension Study|Death|0|||
105640403|NCT00103857|364347687|FG003|50-Week Extension Study|Death|1|||
105640404|NCT00103857|364347688|FG004|50-Week Extension Study|Death|0|||
105640405|NCT00103857|364347689|FG005|50-Week Extension Study|Death|1|||
105640406|NCT00103857|364347690|FG006|50-Week Extension Study|Death|0|||
105640407|NCT00103857|364347684|FG000|50-Week Extension Study|Lack of Efficacy|26|||
105640408|NCT00103857|364347685|FG001|50-Week Extension Study|Lack of Efficacy|15|||
105640409|NCT00103857|364347686|FG002|50-Week Extension Study|Lack of Efficacy|13|||
105640410|NCT00103857|364347687|FG003|50-Week Extension Study|Lack of Efficacy|16|||
105640411|NCT00103857|364347688|FG004|50-Week Extension Study|Lack of Efficacy|8|||
105640412|NCT00103857|364347689|FG005|50-Week Extension Study|Lack of Efficacy|8|||
105640413|NCT00103857|364347690|FG006|50-Week Extension Study|Lack of Efficacy|0|||
105640414|NCT00103857|364347684|FG000|50-Week Extension Study|Lost to Follow-up|4|||
105640415|NCT00103857|364347685|FG001|50-Week Extension Study|Lost to Follow-up|0|||
105640416|NCT00103857|364347686|FG002|50-Week Extension Study|Lost to Follow-up|1|||
105640417|NCT00103857|364347687|FG003|50-Week Extension Study|Lost to Follow-up|4|||
105640418|NCT00103857|364347688|FG004|50-Week Extension Study|Lost to Follow-up|3|||
105640419|NCT00103857|364347689|FG005|50-Week Extension Study|Lost to Follow-up|3|||
105640420|NCT00103857|364347690|FG006|50-Week Extension Study|Lost to Follow-up|0|||
105640421|NCT00103857|364347684|FG000|50-Week Extension Study|Physician Decision|0|||
105640422|NCT00103857|364347685|FG001|50-Week Extension Study|Physician Decision|1|||
105640423|NCT00103857|364347686|FG002|50-Week Extension Study|Physician Decision|1|||
105640424|NCT00103857|364347687|FG003|50-Week Extension Study|Physician Decision|0|||
105640425|NCT00103857|364347688|FG004|50-Week Extension Study|Physician Decision|0|||
105640426|NCT00103857|364347689|FG005|50-Week Extension Study|Physician Decision|0|||
105640427|NCT00103857|364347690|FG006|50-Week Extension Study|Physician Decision|0|||
105640428|NCT00103857|364347684|FG000|50-Week Extension Study|Pregnancy|0|||
105640429|NCT00103857|364347685|FG001|50-Week Extension Study|Pregnancy|0|||
105640430|NCT00103857|364347686|FG002|50-Week Extension Study|Pregnancy|1|||
105640431|NCT00103857|364347687|FG003|50-Week Extension Study|Pregnancy|0|||
105640432|NCT00103857|364347688|FG004|50-Week Extension Study|Pregnancy|1|||
105640433|NCT00103857|364347689|FG005|50-Week Extension Study|Pregnancy|0|||
105640434|NCT00103857|364347690|FG006|50-Week Extension Study|Pregnancy|0|||
105640435|NCT00103857|364347684|FG000|50-Week Extension Study|Protocol Violation|1|||
105640436|NCT00103857|364347685|FG001|50-Week Extension Study|Protocol Violation|1|||
105640437|NCT00103857|364347686|FG002|50-Week Extension Study|Protocol Violation|1|||
105640438|NCT00103857|364347687|FG003|50-Week Extension Study|Protocol Violation|2|||
105640439|NCT00103857|364347688|FG004|50-Week Extension Study|Protocol Violation|0|||
105640440|NCT00103857|364347689|FG005|50-Week Extension Study|Protocol Violation|1|||
105640441|NCT00103857|364347690|FG006|50-Week Extension Study|Protocol Violation|0|||
105640442|NCT00103857|364347684|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
105640443|NCT00103857|364347685|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
105640444|NCT00103857|364347686|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
105640445|NCT00103857|364347687|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
105640446|NCT00103857|364347688|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
105640447|NCT00103857|364347689|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
105640448|NCT00103857|364347690|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
105640449|NCT00103857|364347684|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
105640450|NCT00103857|364347685|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
105640451|NCT00103857|364347686|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
105640452|NCT00103857|364347687|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
105640453|NCT00103857|364347688|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
105640454|NCT00103857|364347689|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
105640455|NCT00103857|364347690|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
105640456|NCT00103857|364347684|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
105640457|NCT00103857|364347685|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
105640458|NCT00103857|364347686|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
105640459|NCT00103857|364347687|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
105640460|NCT00103857|364347688|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
105640461|NCT00103857|364347689|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
105640462|NCT00103857|364347690|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
105640463|NCT00103857|364347684|FG000|50-Week Extension Study|patient moved|0|||
105640464|NCT00103857|364347685|FG001|50-Week Extension Study|patient moved|0|||
105640465|NCT00103857|364347686|FG002|50-Week Extension Study|patient moved|1|||
105640466|NCT00103857|364347687|FG003|50-Week Extension Study|patient moved|2|||
105640467|NCT00103857|364347688|FG004|50-Week Extension Study|patient moved|0|||
105640468|NCT00103857|364347689|FG005|50-Week Extension Study|patient moved|0|||
105640469|NCT00103857|364347690|FG006|50-Week Extension Study|patient moved|0|||
105640470|NCT00103857|364347684|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
105640471|NCT00103857|364347685|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
105640472|NCT00103857|364347686|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
105640473|NCT00103857|364347687|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
105640474|NCT00103857|364347688|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
105640475|NCT00103857|364347689|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
105640476|NCT00103857|364347690|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
105640477|NCT00103857|364347684|FG000|50-Week Extension Study|reason unspecified|0|||
105640478|NCT00103857|364347685|FG001|50-Week Extension Study|reason unspecified|0|||
105640479|NCT00103857|364347686|FG002|50-Week Extension Study|reason unspecified|0|||
105640480|NCT00103857|364347687|FG003|50-Week Extension Study|reason unspecified|0|||
105640481|NCT00103857|364347688|FG004|50-Week Extension Study|reason unspecified|1|||
105640482|NCT00103857|364347689|FG005|50-Week Extension Study|reason unspecified|0|||
105640483|NCT00103857|364347690|FG006|50-Week Extension Study|reason unspecified|0|||
105640484|NCT02691702|364347691|FG000|Overall Study|Adverse Event|1|||
105640485|NCT02691702|364347692|FG001|Overall Study|Adverse Event|0|||
105640486|NCT02691702|364347693|FG002|Overall Study|Adverse Event|0|||
105640487|NCT02691702|364347694|FG003|Overall Study|Adverse Event|0|||
105640488|NCT02691702|364347695|FG004|Overall Study|Adverse Event|0|||
105640489|NCT02691702|364347696|FG005|Overall Study|Adverse Event|0|||
105640490|NCT02691702|364347697|FG006|Overall Study|Adverse Event|0|||
105640491|NCT02691702|364347698|FG007|Overall Study|Adverse Event|0|||
105640492|NCT02691702|364347699|FG008|Overall Study|Adverse Event|1|||
105640493|NCT02691702|364347700|FG009|Overall Study|Adverse Event|0|||
105640494|NCT02691702|364347701|FG010|Overall Study|Adverse Event|1|||
105640495|NCT02691702|364347691|FG000|Overall Study|Lost to Follow-up|0|||
105640496|NCT02691702|364347692|FG001|Overall Study|Lost to Follow-up|0|||
105640497|NCT02691702|364347693|FG002|Overall Study|Lost to Follow-up|1|||
105640498|NCT02691702|364347694|FG003|Overall Study|Lost to Follow-up|0|||
105640499|NCT02691702|364347695|FG004|Overall Study|Lost to Follow-up|0|||
105640500|NCT02691702|364347696|FG005|Overall Study|Lost to Follow-up|2|||
105640501|NCT02691702|364347697|FG006|Overall Study|Lost to Follow-up|0|||
105640502|NCT02691702|364347698|FG007|Overall Study|Lost to Follow-up|0|||
105640503|NCT02691702|364347699|FG008|Overall Study|Lost to Follow-up|0|||
105640504|NCT02691702|364347700|FG009|Overall Study|Lost to Follow-up|0|||
105640505|NCT02691702|364347701|FG010|Overall Study|Lost to Follow-up|1|||
105640506|NCT02691702|364347691|FG000|Overall Study|Withdrawal by Subject|1|||
105640507|NCT02691702|364347692|FG001|Overall Study|Withdrawal by Subject|1|||
105640508|NCT02691702|364347693|FG002|Overall Study|Withdrawal by Subject|0|||
105640509|NCT02691702|364347694|FG003|Overall Study|Withdrawal by Subject|0|||
105640510|NCT02691702|364347695|FG004|Overall Study|Withdrawal by Subject|0|||
105640511|NCT02691702|364347696|FG005|Overall Study|Withdrawal by Subject|1|||
105640512|NCT02691702|364347697|FG006|Overall Study|Withdrawal by Subject|2|||
105640513|NCT02691702|364347698|FG007|Overall Study|Withdrawal by Subject|0|||
105640514|NCT02691702|364347699|FG008|Overall Study|Withdrawal by Subject|0|||
105640515|NCT02691702|364347700|FG009|Overall Study|Withdrawal by Subject|0|||
105640516|NCT02691702|364347701|FG010|Overall Study|Withdrawal by Subject|0|||
105640517|NCT02691702|364347691|FG000|Overall Study|Other|0|||
105640518|NCT02691702|364347692|FG001|Overall Study|Other|0|||
105640519|NCT02691702|364347693|FG002|Overall Study|Other|0|||
105640520|NCT02691702|364347694|FG003|Overall Study|Other|0|||
105640521|NCT02691702|364347695|FG004|Overall Study|Other|0|||
105640522|NCT02691702|364347696|FG005|Overall Study|Other|0|||
105640523|NCT02691702|364347697|FG006|Overall Study|Other|1|||
105640524|NCT02691702|364347698|FG007|Overall Study|Other|0|||
105640525|NCT02691702|364347699|FG008|Overall Study|Other|1|||
105640526|NCT02691702|364347700|FG009|Overall Study|Other|0|||
105640527|NCT02691702|364347701|FG010|Overall Study|Other|0|||
105640528|NCT02691702|364347691|FG000|Overall Study|Protocol Violation|0|||
105640529|NCT02691702|364347692|FG001|Overall Study|Protocol Violation|0|||
105640530|NCT02691702|364347693|FG002|Overall Study|Protocol Violation|0|||
105640531|NCT02691702|364347694|FG003|Overall Study|Protocol Violation|0|||
105640532|NCT02691702|364347695|FG004|Overall Study|Protocol Violation|0|||
105640533|NCT02691702|364347696|FG005|Overall Study|Protocol Violation|0|||
105640534|NCT02691702|364347697|FG006|Overall Study|Protocol Violation|0|||
105640535|NCT02691702|364347698|FG007|Overall Study|Protocol Violation|0|||
105640536|NCT02691702|364347699|FG008|Overall Study|Protocol Violation|0|||
105640537|NCT02691702|364347700|FG009|Overall Study|Protocol Violation|2|||
105640538|NCT02691702|364347701|FG010|Overall Study|Protocol Violation|0|||
105640539|NCT03539055|364347702|FG000|Overall Study|Death|4|||
105640540|NCT03539055|364347702|FG000|Overall Study|Lost to Follow-up|1|||
105640541|NCT03539055|364347702|FG000|Overall Study|Withdrawal by Subject|2|||
105640542|NCT03539055|364347702|FG000|Overall Study|Screen Fail|7|||
105640543|NCT03539055|364347702|FG000|Overall Study|Drug Intolerance|2|||
105640544|NCT03541369|364347703|FG000|Overall Study|Death|0|||
105640545|NCT03541369|364347704|FG001|Overall Study|Death|0|||
105640546|NCT03541369|364347705|FG002|Overall Study|Death|0|||
105640547|NCT03541369|364347706|FG003|Overall Study|Death|0|||
105640548|NCT03541369|364347707|FG004|Overall Study|Death|1|||
105640549|NCT03541369|364347708|FG005|Overall Study|Death|1|||
105640550|NCT03541369|364347709|FG006|Overall Study|Death|0|||
105640551|NCT03541369|364347710|FG007|Overall Study|Death|2|||
105640552|NCT03541369|364347711|FG008|Overall Study|Death|1|||
105640553|NCT03541369|364347712|FG009|Overall Study|Death|2|||
105640554|NCT03541369|364347713|FG010|Overall Study|Death|1|||
105640555|NCT03541369|364347714|FG011|Overall Study|Death|0|||
105640556|NCT03541369|364347715|FG012|Overall Study|Death|2|||
105640557|NCT03541369|364347716|FG013|Overall Study|Death|1|||
105640558|NCT03541369|364347717|FG014|Overall Study|Death|1|||
105640559|NCT03541369|364347718|FG015|Overall Study|Death|1|||
105640560|NCT03541369|364347719|FG016|Overall Study|Death|0|||
105640561|NCT03541369|364347720|FG017|Overall Study|Death|1|||
105640562|NCT03541369|364347703|FG000|Overall Study|Decision by sponsor|0|||
105640563|NCT03541369|364347704|FG001|Overall Study|Decision by sponsor|0|||
105640564|NCT03541369|364347705|FG002|Overall Study|Decision by sponsor|0|||
105640565|NCT03541369|364347706|FG003|Overall Study|Decision by sponsor|1|||
105640566|NCT03541369|364347707|FG004|Overall Study|Decision by sponsor|0|||
105640567|NCT03541369|364347708|FG005|Overall Study|Decision by sponsor|2|||
105640568|NCT03541369|364347709|FG006|Overall Study|Decision by sponsor|0|||
105640569|NCT03541369|364347710|FG007|Overall Study|Decision by sponsor|1|||
105640570|NCT03541369|364347711|FG008|Overall Study|Decision by sponsor|2|||
105640571|NCT03541369|364347712|FG009|Overall Study|Decision by sponsor|0|||
105640572|NCT03541369|364347713|FG010|Overall Study|Decision by sponsor|0|||
105640573|NCT03541369|364347714|FG011|Overall Study|Decision by sponsor|0|||
105640574|NCT03541369|364347715|FG012|Overall Study|Decision by sponsor|2|||
105640575|NCT03541369|364347716|FG013|Overall Study|Decision by sponsor|2|||
105640576|NCT03541369|364347717|FG014|Overall Study|Decision by sponsor|0|||
105640577|NCT03541369|364347718|FG015|Overall Study|Decision by sponsor|1|||
105640578|NCT03541369|364347719|FG016|Overall Study|Decision by sponsor|1|||
105640579|NCT03541369|364347720|FG017|Overall Study|Decision by sponsor|1|||
105640580|NCT03541369|364347703|FG000|Overall Study|Withdrawal by Subject|0|||
105640581|NCT03541369|364347704|FG001|Overall Study|Withdrawal by Subject|0|||
105640582|NCT03541369|364347705|FG002|Overall Study|Withdrawal by Subject|0|||
105640583|NCT03541369|364347706|FG003|Overall Study|Withdrawal by Subject|0|||
105640584|NCT03541369|364347707|FG004|Overall Study|Withdrawal by Subject|0|||
105640585|NCT03541369|364347708|FG005|Overall Study|Withdrawal by Subject|0|||
105640586|NCT03541369|364347709|FG006|Overall Study|Withdrawal by Subject|1|||
105640587|NCT03541369|364347710|FG007|Overall Study|Withdrawal by Subject|0|||
105640588|NCT03541369|364347711|FG008|Overall Study|Withdrawal by Subject|0|||
105640589|NCT03541369|364347712|FG009|Overall Study|Withdrawal by Subject|0|||
105640590|NCT03541369|364347713|FG010|Overall Study|Withdrawal by Subject|0|||
105640591|NCT03541369|364347714|FG011|Overall Study|Withdrawal by Subject|1|||
105640592|NCT03541369|364347715|FG012|Overall Study|Withdrawal by Subject|0|||
105640593|NCT03541369|364347716|FG013|Overall Study|Withdrawal by Subject|0|||
105640594|NCT03541369|364347717|FG014|Overall Study|Withdrawal by Subject|3|||
105640595|NCT03541369|364347718|FG015|Overall Study|Withdrawal by Subject|0|||
105659334|NCT00551135|364417281|FG001|Overall Study|Lost to Follow-up|0|||
105640596|NCT03541369|364347719|FG016|Overall Study|Withdrawal by Subject|4|||
105640597|NCT03541369|364347720|FG017|Overall Study|Withdrawal by Subject|2|||
105640598|NCT03541369|364347703|FG000|Overall Study|Lost to Follow-up|0|||
105640599|NCT03541369|364347704|FG001|Overall Study|Lost to Follow-up|0|||
105640600|NCT03541369|364347705|FG002|Overall Study|Lost to Follow-up|0|||
105640601|NCT03541369|364347706|FG003|Overall Study|Lost to Follow-up|0|||
105640602|NCT03541369|364347707|FG004|Overall Study|Lost to Follow-up|1|||
105640603|NCT03541369|364347708|FG005|Overall Study|Lost to Follow-up|0|||
105640604|NCT03541369|364347709|FG006|Overall Study|Lost to Follow-up|0|||
105640605|NCT03541369|364347710|FG007|Overall Study|Lost to Follow-up|0|||
105640606|NCT03541369|364347711|FG008|Overall Study|Lost to Follow-up|1|||
105640607|NCT03541369|364347712|FG009|Overall Study|Lost to Follow-up|0|||
105640608|NCT03541369|364347713|FG010|Overall Study|Lost to Follow-up|0|||
105640609|NCT03541369|364347714|FG011|Overall Study|Lost to Follow-up|0|||
105640610|NCT03541369|364347715|FG012|Overall Study|Lost to Follow-up|1|||
105640611|NCT03541369|364347716|FG013|Overall Study|Lost to Follow-up|0|||
105640612|NCT03541369|364347717|FG014|Overall Study|Lost to Follow-up|0|||
105640613|NCT03541369|364347718|FG015|Overall Study|Lost to Follow-up|0|||
105640614|NCT03541369|364347719|FG016|Overall Study|Lost to Follow-up|0|||
105640615|NCT03541369|364347720|FG017|Overall Study|Lost to Follow-up|0|||
105640616|NCT04867382|364347721|FG000|Overall Study|Did not complete the survey|2|||
105640617|NCT04867382|364347722|FG001|Overall Study|Did not complete the survey|1|||
105640618|NCT03065400|364347725|FG000|Overall Study|Adverse Event|1|||
105640619|NCT03065400|364347725|FG000|Overall Study|Physician Decision|3|||
105640620|NCT03065400|364347725|FG000|Overall Study|Withdrawal by Subject|1|||
105640621|NCT03065400|364347725|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
105640622|NCT00266656|364347726|FG000|Overall Study|Death|1|||
105640623|NCT00266656|364347727|FG001|Overall Study|Death|0|||
105640624|NCT00266656|364347726|FG000|Overall Study|Lost to Follow-up|4|||
105640625|NCT00266656|364347727|FG001|Overall Study|Lost to Follow-up|1|||
105640626|NCT00266656|364347726|FG000|Overall Study|Withdrawal by Subject|4|||
105640627|NCT00266656|364347727|FG001|Overall Study|Withdrawal by Subject|2|||
105640628|NCT00266656|364347726|FG000|Overall Study|Did Not Reach Final Height|4|||
105640629|NCT00266656|364347727|FG001|Overall Study|Did Not Reach Final Height|8|||
105640630|NCT00266656|364347726|FG000|Overall Study|Parent/Caregiver Decision|1|||
105640631|NCT00266656|364347727|FG001|Overall Study|Parent/Caregiver Decision|2|||
105640632|NCT02915783|364347729|FG000|Overall Study|Death|21|||
105640633|NCT02915783|364347729|FG000|Overall Study|Lost to Follow-up|1|||
105640634|NCT02915783|364347729|FG000|Overall Study|Withdrawal by Subject|2|||
105640635|NCT01156675|364347730|FG000|Overall Study|Death|5|||
105640636|NCT01156675|364347731|FG001|Overall Study|Death|3|||
105640637|NCT01156675|364347732|FG002|Overall Study|Death|0|||
105640638|NCT01156675|364347730|FG000|Overall Study|No data|29|||
105640639|NCT01156675|364347731|FG001|Overall Study|No data|22|||
105640640|NCT01156675|364347732|FG002|Overall Study|No data|2|||
105640641|NCT00912964|364347733|FG000|Overall Study|Eligibility criterion not met|1|||
105640642|NCT00912964|364347734|FG001|Overall Study|Eligibility criterion not met|1|||
105640643|NCT00912964|364347735|FG002|Overall Study|Eligibility criterion not met|0|||
105640644|NCT00912964|364347733|FG000|Overall Study|Adverse Event|15|||
105640645|NCT00912964|364347734|FG001|Overall Study|Adverse Event|18|||
105640646|NCT00912964|364347735|FG002|Overall Study|Adverse Event|12|||
105640647|NCT00912964|364347733|FG000|Overall Study|Lack of Efficacy|11|||
105640648|NCT00912964|364347734|FG001|Overall Study|Lack of Efficacy|4|||
105640649|NCT00912964|364347735|FG002|Overall Study|Lack of Efficacy|3|||
105640650|NCT00912964|364347733|FG000|Overall Study|Withdrawal by Subject|20|||
105640651|NCT00912964|364347734|FG001|Overall Study|Withdrawal by Subject|12|||
105640652|NCT00912964|364347735|FG002|Overall Study|Withdrawal by Subject|18|||
105640653|NCT00912964|364347733|FG000|Overall Study|Lost to Follow-up|4|||
105640654|NCT00912964|364347734|FG001|Overall Study|Lost to Follow-up|3|||
105640655|NCT00912964|364347735|FG002|Overall Study|Lost to Follow-up|3|||
105640656|NCT00912964|364347733|FG000|Overall Study|Protocol Violation|5|||
105640657|NCT00912964|364347734|FG001|Overall Study|Protocol Violation|3|||
105640658|NCT00912964|364347735|FG002|Overall Study|Protocol Violation|8|||
105640659|NCT00912964|364347733|FG000|Overall Study|Taking exclusionary medications|7|||
105640660|NCT00912964|364347734|FG001|Overall Study|Taking exclusionary medications|4|||
105640661|NCT00912964|364347735|FG002|Overall Study|Taking exclusionary medications|8|||
105640662|NCT00912964|364347733|FG000|Overall Study|Medical History|1|||
105640663|NCT00912964|364347734|FG001|Overall Study|Medical History|0|||
105640664|NCT00912964|364347735|FG002|Overall Study|Medical History|0|||
105640665|NCT00912964|364347733|FG000|Overall Study|Non-compliance with study procedures|2|||
105640666|NCT00912964|364347734|FG001|Overall Study|Non-compliance with study procedures|0|||
105640667|NCT00912964|364347735|FG002|Overall Study|Non-compliance with study procedures|0|||
105640668|NCT00912964|364347733|FG000|Overall Study|Violation of exclusion criterion|0|||
105640669|NCT00912964|364347734|FG001|Overall Study|Violation of exclusion criterion|0|||
105640670|NCT00912964|364347735|FG002|Overall Study|Violation of exclusion criterion|2|||
105640671|NCT00912964|364347733|FG000|Overall Study|Randomized but never received study drug|0|||
105659335|NCT00551135|364417282|FG002|Overall Study|Lost to Follow-up|0|||
105640672|NCT00912964|364347734|FG001|Overall Study|Randomized but never received study drug|1|||
105640673|NCT00912964|364347735|FG002|Overall Study|Randomized but never received study drug|0|||
105640674|NCT02147093|364347736|FG000|Period 1|Lost to Follow-up|0|||
105640675|NCT02147093|364347737|FG001|Period 1|Lost to Follow-up|1|||
105640676|NCT02147093|364347736|FG000|Period 2|Protocol Violation|2|||
105640677|NCT02147093|364347737|FG001|Period 2|Protocol Violation|0|||
105640678|NCT03246724|364347738|FG000|Overall Study|Withdrawal by Subject|5|||
105640679|NCT03246724|364347739|FG001|Overall Study|Withdrawal by Subject|2|||
105640680|NCT03246724|364347740|FG002|Overall Study|Withdrawal by Subject|4|||
105640681|NCT03246724|364347741|FG003|Overall Study|Withdrawal by Subject|2|||
105640682|NCT03246724|364347738|FG000|Overall Study|Ineligible on day of surgery|7|||
105640683|NCT03246724|364347739|FG001|Overall Study|Ineligible on day of surgery|2|||
105640684|NCT03246724|364347740|FG002|Overall Study|Ineligible on day of surgery|0|||
105640685|NCT03246724|364347741|FG003|Overall Study|Ineligible on day of surgery|3|||
105640686|NCT03246724|364347738|FG000|Overall Study|Study completed before surgical date|2|||
105640687|NCT03246724|364347739|FG001|Overall Study|Study completed before surgical date|1|||
105640688|NCT03246724|364347740|FG002|Overall Study|Study completed before surgical date|8|||
105640689|NCT03246724|364347741|FG003|Overall Study|Study completed before surgical date|1|||
105640690|NCT03246724|364347738|FG000|Overall Study|Transferred to other arm|0|||
105640691|NCT03246724|364347739|FG001|Overall Study|Transferred to other arm|0|||
105640692|NCT03246724|364347740|FG002|Overall Study|Transferred to other arm|1|||
105640693|NCT03246724|364347741|FG003|Overall Study|Transferred to other arm|0|||
105640694|NCT03246724|364347738|FG000|Overall Study|Unable to obtain medication timely|0|||
105640695|NCT03246724|364347739|FG001|Overall Study|Unable to obtain medication timely|2|||
105640696|NCT03246724|364347740|FG002|Overall Study|Unable to obtain medication timely|2|||
105640697|NCT03246724|364347741|FG003|Overall Study|Unable to obtain medication timely|1|||
105640698|NCT03246724|364347738|FG000|Overall Study|Re-consented to participate|0|||
105640699|NCT03246724|364347739|FG001|Overall Study|Re-consented to participate|0|||
105640700|NCT03246724|364347740|FG002|Overall Study|Re-consented to participate|0|||
105640701|NCT03246724|364347741|FG003|Overall Study|Re-consented to participate|1|||
105640702|NCT00845520|364347744|FG000|Overall Study|Death|1|||
105640703|NCT00845520|364347745|FG001|Overall Study|Death|2|||
105640704|NCT00845520|364347746|FG002|Overall Study|Death|0|||
105640705|NCT00845520|364347744|FG000|Overall Study|Lost to Follow-up|1|||
105640706|NCT00845520|364347745|FG001|Overall Study|Lost to Follow-up|0|||
105640707|NCT00845520|364347746|FG002|Overall Study|Lost to Follow-up|0|||
105640708|NCT00845520|364347744|FG000|Overall Study|Adverse Event|0|||
105640709|NCT00845520|364347745|FG001|Overall Study|Adverse Event|0|||
105640710|NCT00845520|364347746|FG002|Overall Study|Adverse Event|1|||
105640711|NCT02613403|364347747|FG000|Overall Study|Lost to Follow-up|0|||
105640712|NCT02613403|364347748|FG001|Overall Study|Lost to Follow-up|1|||
105640713|NCT02613403|364347749|FG002|Overall Study|Lost to Follow-up|0|||
105640714|NCT02613403|364347750|FG003|Overall Study|Lost to Follow-up|0|||
105640715|NCT02613403|364347751|FG004|Overall Study|Lost to Follow-up|0|||
105640716|NCT02613403|364347747|FG000|Overall Study|Withdrawal by Subject|2|||
105640717|NCT02613403|364347748|FG001|Overall Study|Withdrawal by Subject|0|||
105640718|NCT02613403|364347749|FG002|Overall Study|Withdrawal by Subject|0|||
105640719|NCT02613403|364347750|FG003|Overall Study|Withdrawal by Subject|0|||
105640720|NCT02613403|364347751|FG004|Overall Study|Withdrawal by Subject|0|||
105640721|NCT02470806|364347752|FG000|Overall Study|Lost to Follow-up|1|||
105640722|NCT02470806|364347753|FG001|Overall Study|Lost to Follow-up|1|||
105640723|NCT02470806|364347752|FG000|Overall Study|Adverse Event|5|||
105640724|NCT02470806|364347753|FG001|Overall Study|Adverse Event|2|||
105640725|NCT02470806|364347752|FG000|Overall Study|Protocol Violation|4|||
105640726|NCT02470806|364347753|FG001|Overall Study|Protocol Violation|11|||
105640727|NCT02470806|364347752|FG000|Overall Study|Physician Decision|0|||
105640728|NCT02470806|364347753|FG001|Overall Study|Physician Decision|3|||
105640729|NCT02470806|364347752|FG000|Overall Study|Withdrawal by Subject|3|||
105640730|NCT02470806|364347753|FG001|Overall Study|Withdrawal by Subject|10|||
105640731|NCT02470806|364347752|FG000|Overall Study|Lack of Efficacy|5|||
105640732|NCT02470806|364347753|FG001|Overall Study|Lack of Efficacy|15|||
105640733|NCT00513071|364347754|FG000|Overall Study|Adverse Event|1|||
105640734|NCT00513071|364347754|FG000|Overall Study|Withdrawal by Subject|1|||
105640735|NCT00513071|364347754|FG000|Overall Study|Physician Decision|3|||
105640736|NCT02699099|364347756|FG000|Overall Study|Adverse Event|1|||
105640737|NCT02699099|364347757|FG001|Overall Study|Adverse Event|0|||
105640738|NCT02699099|364347758|FG002|Overall Study|Adverse Event|2|||
105640739|NCT02699099|364347756|FG000|Overall Study|Lost to Follow-up|0|||
105640740|NCT02699099|364347757|FG001|Overall Study|Lost to Follow-up|1|||
105640741|NCT02699099|364347758|FG002|Overall Study|Lost to Follow-up|0|||
105640742|NCT02699099|364347756|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
105640743|NCT02699099|364347757|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
105640744|NCT02699099|364347758|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
105640745|NCT00667732|364347759|FG000|Run -In (8 Weeks)|Adverse Event|4|||
105640746|NCT00667732|364347760|FG001|Run -In (8 Weeks)|Adverse Event|0|||
105640747|NCT00667732|364347761|FG002|Run -In (8 Weeks)|Adverse Event|0|||
105640748|NCT00667732|364347759|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
105640749|NCT00667732|364347760|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
105640750|NCT00667732|364347761|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
105640751|NCT00667732|364347759|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
105640752|NCT00667732|364347760|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
105640753|NCT00667732|364347761|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
105640754|NCT01240590|364347767|FG000|Phase I|Refused further treatment|0|||
105640755|NCT01240590|364347768|FG001|Phase I|Refused further treatment|0|||
105640756|NCT01240590|364347769|FG002|Phase I|Refused further treatment|3|||
105640757|NCT01240590|364347770|FG003|Phase I|Refused further treatment|0|||
105640758|NCT01240590|364347771|FG004|Phase I|Refused further treatment|0|||
105640759|NCT01240590|364347767|FG000|Phase II|Refused further treatment|0|||
105640760|NCT01240590|364347768|FG001|Phase II|Refused further treatment|0|||
105640761|NCT01240590|364347769|FG002|Phase II|Refused further treatment|0|||
105640762|NCT01240590|364347770|FG003|Phase II|Refused further treatment|2|||
105640763|NCT01240590|364347771|FG004|Phase II|Refused further treatment|1|||
105640764|NCT02144285|364347772|FG000|Overall Study|Withdrawal by Subject|0|||
105640765|NCT02144285|364347773|FG001|Overall Study|Withdrawal by Subject|0|||
105640766|NCT02144285|364347774|FG002|Overall Study|Withdrawal by Subject|0|||
105640767|NCT02144285|364347775|FG003|Overall Study|Withdrawal by Subject|0|||
105640768|NCT02144285|364347776|FG004|Overall Study|Withdrawal by Subject|1|||
105640769|NCT02144285|364347777|FG005|Overall Study|Withdrawal by Subject|0|||
105640770|NCT02144285|364347778|FG006|Overall Study|Withdrawal by Subject|0|||
105640771|NCT02144285|364347779|FG007|Overall Study|Withdrawal by Subject|0|||
105640772|NCT02144285|364347780|FG008|Overall Study|Withdrawal by Subject|0|||
105640773|NCT02144285|364347781|FG009|Overall Study|Withdrawal by Subject|0|||
105640774|NCT04895085|364347783|FG000|Overall Study|Death|1|||
105640775|NCT04895085|364347783|FG000|Overall Study|Withdrawal by Subject|1|||
105640776|NCT04895085|364347783|FG000|Overall Study|No longer eligible: Moved from area|1|||
105640777|NCT05184062|364347784|FG000|Overall Study|Lost to Follow-up|5|||
105640778|NCT05184062|364347785|FG001|Overall Study|Lost to Follow-up|1|||
105640779|NCT05184062|364347784|FG000|Overall Study|Withdrawal by Subject|1|||
105640780|NCT05184062|364347785|FG001|Overall Study|Withdrawal by Subject|0|||
105640781|NCT03769090|364349296|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
105640782|NCT03769090|364349297|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
105640783|NCT03769090|364349298|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
105640784|NCT03769090|364349296|FG000|Overall Study|Withdrawal by Subject|52|||
105640785|NCT03769090|364349297|FG001|Overall Study|Withdrawal by Subject|62|||
105640786|NCT03769090|364349298|FG002|Overall Study|Withdrawal by Subject|74|||
105640787|NCT03769090|364349296|FG000|Overall Study|Death|4|||
105640788|NCT03769090|364349297|FG001|Overall Study|Death|2|||
105640789|NCT03769090|364349298|FG002|Overall Study|Death|2|||
105640790|NCT03769090|364349296|FG000|Overall Study|Adverse Event|7|||
105640791|NCT03769090|364349297|FG001|Overall Study|Adverse Event|7|||
105640792|NCT03769090|364349298|FG002|Overall Study|Adverse Event|8|||
105640793|NCT03769090|364349296|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
105640794|NCT03769090|364349297|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
105640795|NCT03769090|364349298|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
105640796|NCT03769090|364349296|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
105640797|NCT03769090|364349297|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
105640798|NCT03769090|364349298|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
105640799|NCT03769090|364349296|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
105640800|NCT03769090|364349297|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
105640801|NCT03769090|364349298|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
105640802|NCT03769090|364349296|FG000|Overall Study|Protocol Violation|5|||
105640803|NCT03769090|364349297|FG001|Overall Study|Protocol Violation|6|||
105640804|NCT03769090|364349298|FG002|Overall Study|Protocol Violation|8|||
105640805|NCT03769090|364349296|FG000|Overall Study|Pregnancy|1|||
105640806|NCT03769090|364349297|FG001|Overall Study|Pregnancy|0|||
105640807|NCT03769090|364349298|FG002|Overall Study|Pregnancy|3|||
105640808|NCT03769090|364349296|FG000|Overall Study|Lost to Follow-up|19|||
105640809|NCT03769090|364349297|FG001|Overall Study|Lost to Follow-up|25|||
105640810|NCT03769090|364349298|FG002|Overall Study|Lost to Follow-up|21|||
105640811|NCT03769090|364349296|FG000|Overall Study|Condition under investigation worsened|2|||
105640812|NCT03769090|364349297|FG001|Overall Study|Condition under investigation worsened|0|||
105640813|NCT03769090|364349298|FG002|Overall Study|Condition under investigation worsened|1|||
105640814|NCT03769090|364349296|FG000|Overall Study|Lack of Efficacy|1|||
105640815|NCT03769090|364349297|FG001|Overall Study|Lack of Efficacy|2|||
105640816|NCT03769090|364349298|FG002|Overall Study|Lack of Efficacy|2|||
105640817|NCT03769090|364349296|FG000|Overall Study|Other reasons|8|||
105640818|NCT03769090|364349297|FG001|Overall Study|Other reasons|12|||
105640819|NCT03769090|364349298|FG002|Overall Study|Other reasons|15|||
105640820|NCT02713594|364349299|FG000|Overall Study|Withdrawal by Subject|32|||
105640821|NCT02713594|364349300|FG001|Overall Study|Withdrawal by Subject|22|||
105640822|NCT02713594|364349299|FG000|Overall Study|Lost to Follow-up|358|||
105640823|NCT02713594|364349300|FG001|Overall Study|Lost to Follow-up|374|||
105640824|NCT02354417|364349301|FG000|Overall Study|Physician Decision|1|||
105640825|NCT00587171|364349302|FG000|Overall Study|Lost to Follow-up|1|||
105640826|NCT00587171|364349303|FG001|Overall Study|Lost to Follow-up|1|||
105640827|NCT01148017|364349304|FG000|Overall Study|Withdrawal by Subject|31|||
105640828|NCT01148017|364349305|FG001|Overall Study|Withdrawal by Subject|14|||
105640829|NCT01148017|364349306|FG002|Overall Study|Withdrawal by Subject|0|||
105640830|NCT01148017|364349307|FG003|Overall Study|Withdrawal by Subject|0|||
105640831|NCT01148017|364349304|FG000|Overall Study|Lost to Follow-up|23|||
105640832|NCT01148017|364349305|FG001|Overall Study|Lost to Follow-up|10|||
105640833|NCT01148017|364349306|FG002|Overall Study|Lost to Follow-up|0|||
105640834|NCT01148017|364349307|FG003|Overall Study|Lost to Follow-up|0|||
105640835|NCT01148017|364349304|FG000|Overall Study|Inappropriate enrollment|1|||
105640836|NCT01148017|364349305|FG001|Overall Study|Inappropriate enrollment|0|||
105640837|NCT01148017|364349306|FG002|Overall Study|Inappropriate enrollment|0|||
105640838|NCT01148017|364349307|FG003|Overall Study|Inappropriate enrollment|0|||
105640839|NCT01148017|364349304|FG000|Overall Study|Administrative reason|22|||
105640840|NCT01148017|364349305|FG001|Overall Study|Administrative reason|9|||
105640841|NCT01148017|364349306|FG002|Overall Study|Administrative reason|0|||
105640842|NCT01148017|364349307|FG003|Overall Study|Administrative reason|0|||
105640843|NCT01148017|364349304|FG000|Overall Study|Unable to classify|3|||
105640844|NCT01148017|364349305|FG001|Overall Study|Unable to classify|1|||
105640845|NCT01148017|364349306|FG002|Overall Study|Unable to classify|0|||
105640846|NCT01148017|364349307|FG003|Overall Study|Unable to classify|0|||
105640847|NCT02236611|364349309|FG000|Overall Study|Adverse Event|10|||
105640848|NCT02236611|364349310|FG001|Overall Study|Adverse Event|16|||
105640849|NCT02236611|364349309|FG000|Overall Study|Lack of Efficacy|4|||
105640850|NCT02236611|364349310|FG001|Overall Study|Lack of Efficacy|7|||
105640851|NCT02236611|364349309|FG000|Overall Study|Lost to Follow-up|0|||
105640852|NCT02236611|364349310|FG001|Overall Study|Lost to Follow-up|2|||
105640853|NCT02236611|364349309|FG000|Overall Study|Protocol deviation|3|||
105640854|NCT02236611|364349310|FG001|Overall Study|Protocol deviation|5|||
105640855|NCT02236611|364349309|FG000|Overall Study|Withdrew consent|9|||
105640856|NCT02236611|364349310|FG001|Overall Study|Withdrew consent|4|||
105640857|NCT00569166|364349314|FG000|Overall Study|Withdrawal by Subject|7|||
105640858|NCT00569166|364349315|FG001|Overall Study|Withdrawal by Subject|5|||
105640859|NCT00569166|364349316|FG002|Overall Study|Withdrawal by Subject|3|||
105640860|NCT00569166|364349314|FG000|Overall Study|Lost to Follow-up|2|||
105640861|NCT00569166|364349315|FG001|Overall Study|Lost to Follow-up|1|||
105640862|NCT00569166|364349316|FG002|Overall Study|Lost to Follow-up|1|||
105640863|NCT00022672|364349317|FG000|Main Phase: 24 Months|Adverse Event|6|||
105640864|NCT00022672|364349318|FG001|Main Phase: 24 Months|Adverse Event|0|||
105640865|NCT00022672|364349317|FG000|Main Phase: 24 Months|Death|0|||
105640866|NCT00022672|364349318|FG001|Main Phase: 24 Months|Death|3|||
105640867|NCT00022672|364349317|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
105640868|NCT00022672|364349318|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
105640869|NCT00022672|364349317|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
105640870|NCT00022672|364349318|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
105640871|NCT00022672|364349317|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
105640872|NCT00022672|364349318|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
105640873|NCT00022672|364349317|FG000|Main Phase: 24 Months|Refused Treatment|3|||
105640874|NCT00022672|364349318|FG001|Main Phase: 24 Months|Refused Treatment|4|||
105640875|NCT00022672|364349317|FG000|Main Phase: 24 Months|Failure to Return|1|||
105640876|NCT00022672|364349318|FG001|Main Phase: 24 Months|Failure to Return|1|||
105640877|NCT00022672|364349317|FG000|Main Phase: 24 Months|Other|1|||
105640878|NCT00022672|364349318|FG001|Main Phase: 24 Months|Other|0|||
105640879|NCT00022672|364349317|FG000|Extension Phase|Adverse Event|1|||
105640880|NCT00022672|364349318|FG001|Extension Phase|Adverse Event|3|||
105640881|NCT00022672|364349317|FG000|Extension Phase|Death|0|||
105640882|NCT00022672|364349318|FG001|Extension Phase|Death|1|||
105640883|NCT00022672|364349317|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
105640884|NCT00022672|364349318|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
105640885|NCT00022672|364349317|FG000|Extension Phase|Refused Treatment|0|||
105640886|NCT00022672|364349318|FG001|Extension Phase|Refused Treatment|2|||
105640887|NCT00022672|364349317|FG000|Extension Phase|Other|1|||
105640888|NCT00022672|364349318|FG001|Extension Phase|Other|1|||
105640889|NCT01450007|364349319|FG000|Overall Study|Late exclusion before treatment|2|||
105640890|NCT01450007|364349320|FG001|Overall Study|Late exclusion before treatment|3|||
105640891|NCT01450007|364349321|FG002|Overall Study|Late exclusion before treatment|2|||
105640892|NCT01450007|364349319|FG000|Overall Study|Protocol Violation|0|||
105640893|NCT01450007|364349320|FG001|Overall Study|Protocol Violation|1|||
105640894|NCT01450007|364349321|FG002|Overall Study|Protocol Violation|1|||
105640895|NCT01450007|364349319|FG000|Overall Study|Adverse Event|0|||
105640896|NCT01450007|364349320|FG001|Overall Study|Adverse Event|1|||
105640897|NCT01450007|364349321|FG002|Overall Study|Adverse Event|0|||
105640898|NCT00308308|364349322|FG000|Overall Study|Adverse Event|17|||
105640899|NCT00308308|364349323|FG001|Overall Study|Adverse Event|2|||
105640900|NCT00308308|364349322|FG000|Overall Study|Lost to Follow-up|5|||
105640901|NCT00308308|364349323|FG001|Overall Study|Lost to Follow-up|5|||
105640902|NCT00308308|364349322|FG000|Overall Study|Physician Decision|15|||
105640903|NCT00308308|364349323|FG001|Overall Study|Physician Decision|7|||
105640904|NCT00308308|364349322|FG000|Overall Study|Protocol Violation|3|||
105640905|NCT00308308|364349323|FG001|Overall Study|Protocol Violation|14|||
105640906|NCT00308308|364349322|FG000|Overall Study|Withdrawal by Subject|47|||
105640907|NCT00308308|364349323|FG001|Overall Study|Withdrawal by Subject|19|||
105640908|NCT00308308|364349322|FG000|Overall Study|Various|7|||
105640909|NCT00308308|364349323|FG001|Overall Study|Various|5|||
105640910|NCT00308308|364349322|FG000|Overall Study|Randomized but not dosed|8|||
105640911|NCT00308308|364349323|FG001|Overall Study|Randomized but not dosed|16|||
105640912|NCT00308308|364349322|FG000|Overall Study|Other|1|||
105640913|NCT00308308|364349323|FG001|Overall Study|Other|0|||
105640914|NCT03142932|364349324|FG000|Overall Study|Lost to Follow-up|2|||
105640915|NCT03142932|364349325|FG001|Overall Study|Lost to Follow-up|11|||
105640916|NCT04070105|364349330|FG000|Overall Study|Lost to Follow-up|0|||
105640917|NCT04070105|364349331|FG001|Overall Study|Lost to Follow-up|0|||
105640918|NCT04070105|364349332|FG002|Overall Study|Lost to Follow-up|0|||
105640919|NCT04070105|364349333|FG003|Overall Study|Lost to Follow-up|0|||
105640920|NCT04070105|364349334|FG004|Overall Study|Lost to Follow-up|0|||
105640921|NCT04070105|364349335|FG005|Overall Study|Lost to Follow-up|1|||
105640922|NCT04766996|364349336|FG000|Overall Study|Withdrawal by Subject|1|||
105640923|NCT04766996|364349337|FG001|Overall Study|Withdrawal by Subject|0|||
105640924|NCT04766996|364349338|FG002|Overall Study|Withdrawal by Subject|13|||
105640925|NCT01918033|364349339|FG000|Overall Study|Adverse Event|1|||
105640926|NCT01918033|364349340|FG001|Overall Study|Adverse Event|0|||
105640927|NCT01918033|364349341|FG002|Overall Study|Adverse Event|2|||
105640928|NCT01918033|364349339|FG000|Overall Study|Lost to Follow-up|0|||
105640929|NCT01918033|364349340|FG001|Overall Study|Lost to Follow-up|1|||
105640930|NCT01918033|364349341|FG002|Overall Study|Lost to Follow-up|0|||
105640931|NCT01918033|364349339|FG000|Overall Study|Protocol Violation|2|||
105640932|NCT01918033|364349340|FG001|Overall Study|Protocol Violation|0|||
105640933|NCT01918033|364349341|FG002|Overall Study|Protocol Violation|1|||
105640934|NCT01918033|364349339|FG000|Overall Study|Withdrawal by Subject|2|||
105640935|NCT01918033|364349340|FG001|Overall Study|Withdrawal by Subject|1|||
105640936|NCT01918033|364349341|FG002|Overall Study|Withdrawal by Subject|0|||
105640937|NCT03184987|364349342|FG000|Overall Study|Withdrawal by Subject|0|||
105640938|NCT03184987|364349343|FG001|Overall Study|Withdrawal by Subject|1|||
105640939|NCT03184987|364349344|FG002|Overall Study|Withdrawal by Subject|2|||
105640940|NCT03184987|364349342|FG000|Overall Study|Physician Decision|0|||
105640941|NCT03184987|364349343|FG001|Overall Study|Physician Decision|0|||
105640942|NCT03184987|364349344|FG002|Overall Study|Physician Decision|1|||
105640943|NCT03184987|364349342|FG000|Overall Study|Adverse Event|1|||
105640944|NCT03184987|364349343|FG001|Overall Study|Adverse Event|0|||
105640945|NCT03184987|364349344|FG002|Overall Study|Adverse Event|1|||
105640946|NCT03259568|364349348|FG000|Overall Study|Participant performance was low|3|||
105640947|NCT04248868|364349349|FG000|Overall Study|Death|1|||
105640948|NCT04248868|364349349|FG000|Overall Study|Lost to Follow-up|3|||
105640949|NCT04248868|364349349|FG000|Overall Study|Protocol Violation|2|||
105640950|NCT02208843|364349352|FG000|Overall Study|Clinical symptoms of progression|2|||
105640951|NCT02208843|364349352|FG000|Overall Study|Progression disease according to RECIST|24|||
105640952|NCT02208843|364349352|FG000|Overall Study|Adverse Event|12|||
105640953|NCT02208843|364349352|FG000|Overall Study|Protocol Violation|1|||
105640954|NCT02208843|364349352|FG000|Overall Study|Withdrawal by Subject|1|||
105640955|NCT02208843|364349352|FG000|Overall Study|Switched to commercial afatinib|20|||
105640956|NCT01976507|364349353|FG000|Overall Study|Adverse Event|6|||
105640957|NCT01976507|364349353|FG000|Overall Study|ablation not done, drug not given|1|||
105640958|NCT01794299|364349354|FG000|Overall Study|ATIR manufacturing not possible|1|||
105640959|NCT01794299|364349354|FG000|Overall Study|Death|14|||
105640960|NCT01794299|364349354|FG000|Overall Study|Graft failure|1|||
105640961|NCT01794299|364349354|FG000|Overall Study|ATIR batch rejected|2|||
105640962|NCT01794299|364349354|FG000|Overall Study|Relapse|2|||
105640963|NCT01794299|364349354|FG000|Overall Study|Discontinued from active follow-up|1|||
105640964|NCT01794299|364349354|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
105640965|NCT01029704|364349355|FG000|Overall Study|Adverse Event|0|||
105640966|NCT01029704|364349356|FG001|Overall Study|Adverse Event|0|||
105640967|NCT01029704|364349357|FG002|Overall Study|Adverse Event|0|||
105640968|NCT01029704|364349358|FG003|Overall Study|Adverse Event|0|||
105640969|NCT01029704|364349359|FG004|Overall Study|Adverse Event|0|||
105640970|NCT01029704|364349360|FG005|Overall Study|Adverse Event|0|||
105640971|NCT01029704|364349361|FG006|Overall Study|Adverse Event|1|||
105640972|NCT01029704|364349362|FG007|Overall Study|Adverse Event|1|||
105640973|NCT01029704|364349363|FG008|Overall Study|Adverse Event|0|||
105640974|NCT01029704|364349355|FG000|Overall Study|Withdrawal by Subject|0|||
105640975|NCT01029704|364349356|FG001|Overall Study|Withdrawal by Subject|0|||
105640976|NCT01029704|364349357|FG002|Overall Study|Withdrawal by Subject|0|||
105640977|NCT01029704|364349358|FG003|Overall Study|Withdrawal by Subject|0|||
105640978|NCT01029704|364349359|FG004|Overall Study|Withdrawal by Subject|2|||
105640979|NCT01029704|364349360|FG005|Overall Study|Withdrawal by Subject|1|||
105640980|NCT01029704|364349361|FG006|Overall Study|Withdrawal by Subject|1|||
105640981|NCT01029704|364349362|FG007|Overall Study|Withdrawal by Subject|1|||
105640982|NCT01029704|364349363|FG008|Overall Study|Withdrawal by Subject|0|||
105640983|NCT01029704|364349355|FG000|Overall Study|Lost to Follow-up|0|||
105640984|NCT01029704|364349356|FG001|Overall Study|Lost to Follow-up|0|||
105640985|NCT01029704|364349357|FG002|Overall Study|Lost to Follow-up|0|||
105640986|NCT01029704|364349358|FG003|Overall Study|Lost to Follow-up|0|||
105640987|NCT01029704|364349359|FG004|Overall Study|Lost to Follow-up|0|||
105640988|NCT01029704|364349360|FG005|Overall Study|Lost to Follow-up|0|||
105640989|NCT01029704|364349361|FG006|Overall Study|Lost to Follow-up|1|||
105640990|NCT01029704|364349362|FG007|Overall Study|Lost to Follow-up|1|||
105640991|NCT01029704|364349363|FG008|Overall Study|Lost to Follow-up|1|||
105640992|NCT01029704|364349355|FG000|Overall Study|Lack of Efficacy|0|||
105640993|NCT01029704|364349356|FG001|Overall Study|Lack of Efficacy|0|||
105640994|NCT01029704|364349357|FG002|Overall Study|Lack of Efficacy|0|||
105640995|NCT01029704|364349358|FG003|Overall Study|Lack of Efficacy|0|||
105640996|NCT01029704|364349359|FG004|Overall Study|Lack of Efficacy|2|||
105640997|NCT01029704|364349360|FG005|Overall Study|Lack of Efficacy|3|||
105640998|NCT01029704|364349361|FG006|Overall Study|Lack of Efficacy|1|||
105640999|NCT01029704|364349362|FG007|Overall Study|Lack of Efficacy|2|||
105641000|NCT01029704|364349363|FG008|Overall Study|Lack of Efficacy|0|||
105641001|NCT01029704|364349355|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
105641002|NCT01029704|364349356|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
105641003|NCT01029704|364349357|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
105641004|NCT01029704|364349358|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
105641005|NCT01029704|364349359|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
105641006|NCT01029704|364349360|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
105641007|NCT01029704|364349361|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
105641008|NCT01029704|364349362|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
105641009|NCT01029704|364349363|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
105641010|NCT02410278|364349368|FG000|Run-in Period|Adverse Event|5|||
105641011|NCT02410278|364349369|FG001|Run-in Period|Adverse Event|0|||
105641012|NCT02410278|364349370|FG002|Run-in Period|Adverse Event|0|||
105641013|NCT02410278|364349368|FG000|Run-in Period|GSRS Threshold Not Met|30|||
105641014|NCT02410278|364349369|FG001|Run-in Period|GSRS Threshold Not Met|0|||
105641015|NCT02410278|364349370|FG002|Run-in Period|GSRS Threshold Not Met|0|||
105641016|NCT02410278|364349368|FG000|Run-in Period|Lost to Follow-up|1|||
105641017|NCT02410278|364349369|FG001|Run-in Period|Lost to Follow-up|0|||
105641018|NCT02410278|364349370|FG002|Run-in Period|Lost to Follow-up|0|||
105641019|NCT02410278|364349368|FG000|Run-in Period|Withdrawal by Subject|1|||
105641020|NCT02410278|364349369|FG001|Run-in Period|Withdrawal by Subject|0|||
105641021|NCT02410278|364349370|FG002|Run-in Period|Withdrawal by Subject|0|||
105641022|NCT02410278|364349368|FG000|Run-in Period|Pregnancy|1|||
105641023|NCT02410278|364349369|FG001|Run-in Period|Pregnancy|0|||
105641024|NCT02410278|364349370|FG002|Run-in Period|Pregnancy|0|||
105641025|NCT02410278|364349368|FG000|Study Treatment Period|Adverse Event|0|||
105641026|NCT02410278|364349369|FG001|Study Treatment Period|Adverse Event|6|||
105641027|NCT02410278|364349370|FG002|Study Treatment Period|Adverse Event|3|||
105641028|NCT02410278|364349368|FG000|Study Treatment Period|Physician Decision|0|||
105641029|NCT02410278|364349369|FG001|Study Treatment Period|Physician Decision|0|||
105641030|NCT02410278|364349370|FG002|Study Treatment Period|Physician Decision|1|||
105641031|NCT02410278|364349368|FG000|Study Treatment Period|Withdrawal by Subject|0|||
105641032|NCT02410278|364349369|FG001|Study Treatment Period|Withdrawal by Subject|1|||
105641033|NCT02410278|364349370|FG002|Study Treatment Period|Withdrawal by Subject|0|||
105641034|NCT02410278|364349368|FG000|Study Treatment Period|Other|0|||
105641035|NCT02410278|364349369|FG001|Study Treatment Period|Other|3|||
105641036|NCT02410278|364349370|FG002|Study Treatment Period|Other|0|||
105641037|NCT02410278|364349368|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
105641038|NCT02410278|364349369|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
105641039|NCT02410278|364349370|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
105641040|NCT00148122|364349371|FG000|Overall Study|Withdrawal by Subject|2|||
105641041|NCT02137785|364349374|FG000|Overall Study|Lost to Follow-up|1|||
105641042|NCT02137785|364349375|FG001|Overall Study|Lost to Follow-up|0|||
105641043|NCT02137785|364349374|FG000|Overall Study|Withdrawal by Subject|1|||
105641044|NCT02137785|364349375|FG001|Overall Study|Withdrawal by Subject|4|||
105641045|NCT02137785|364349374|FG000|Overall Study|subject moved out of state|1|||
105641046|NCT02137785|364349375|FG001|Overall Study|subject moved out of state|0|||
105641047|NCT05376397|364349376|FG000|Overall Study|Lost to Follow-up|1|||
105641048|NCT01328756|364349377|FG000|Overall Study|Protocol Violation|4|||
105641049|NCT01328756|364349377|FG000|Overall Study|Adverse Event|39|||
105641050|NCT01328756|364349377|FG000|Overall Study|Lack of Efficacy|5|||
105641051|NCT01328756|364349377|FG000|Overall Study|Withdrawal by Subject|41|||
105641052|NCT01328756|364349377|FG000|Overall Study|Lost to Follow-up|5|||
105641053|NCT01328756|364349377|FG000|Overall Study|Other|29|||
105641054|NCT01137682|364349378|FG000|Overall Study|Adverse Event-CORE|2|||
105641055|NCT01137682|364349379|FG001|Overall Study|Adverse Event-CORE|4|||
105641056|NCT01137682|364349380|FG002|Overall Study|Adverse Event-CORE|0|||
105641057|NCT01137682|364349378|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
105641058|NCT01137682|364349379|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
105641059|NCT01137682|364349380|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
105641060|NCT01137682|364349378|FG000|Overall Study|Administrative problems-CORE|2|||
105641061|NCT01137682|364349379|FG001|Overall Study|Administrative problems-CORE|1|||
105641062|NCT01137682|364349380|FG002|Overall Study|Administrative problems-CORE|0|||
105641063|NCT01137682|364349378|FG000|Overall Study|Protocol Violation-CORE|0|||
105641064|NCT01137682|364349379|FG001|Overall Study|Protocol Violation-CORE|1|||
105641065|NCT01137682|364349380|FG002|Overall Study|Protocol Violation-CORE|1|||
105641066|NCT01137682|364349378|FG000|Overall Study|Adverse Event-Extension|4|||
105641067|NCT01137682|364349379|FG001|Overall Study|Adverse Event-Extension|8|||
105641068|NCT01137682|364349380|FG002|Overall Study|Adverse Event-Extension|7|||
105641069|NCT01137682|364349378|FG000|Overall Study|Lack of Efficacy-Extension|15|||
105641070|NCT01137682|364349379|FG001|Overall Study|Lack of Efficacy-Extension|9|||
105641071|NCT01137682|364349380|FG002|Overall Study|Lack of Efficacy-Extension|13|||
105641072|NCT01137682|364349378|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
105641073|NCT01137682|364349379|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
105641074|NCT01137682|364349380|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
105641075|NCT01137682|364349378|FG000|Overall Study|Lost to Follow Up-Extension|0|||
105641076|NCT01137682|364349379|FG001|Overall Study|Lost to Follow Up-Extension|1|||
105641077|NCT01137682|364349380|FG002|Overall Study|Lost to Follow Up-Extension|0|||
105641078|NCT01137682|364349378|FG000|Overall Study|Administrative problems-Extension|0|||
105641079|NCT01137682|364349379|FG001|Overall Study|Administrative problems-Extension|2|||
105641080|NCT01137682|364349380|FG002|Overall Study|Administrative problems-Extension|0|||
105641081|NCT01137682|364349378|FG000|Overall Study|Death-Extension|2|||
105641082|NCT01137682|364349379|FG001|Overall Study|Death-Extension|0|||
105641083|NCT01137682|364349380|FG002|Overall Study|Death-Extension|0|||
105641084|NCT01137682|364349378|FG000|Overall Study|Protocol Violation-Extension|2|||
105641085|NCT01137682|364349379|FG001|Overall Study|Protocol Violation-Extension|1|||
105641086|NCT01137682|364349380|FG002|Overall Study|Protocol Violation-Extension|0|||
105641087|NCT01137682|364349378|FG000|Overall Study|Did not enter extension|2|||
105641088|NCT01137682|364349379|FG001|Overall Study|Did not enter extension|3|||
105641089|NCT01137682|364349380|FG002|Overall Study|Did not enter extension|2|||
105641090|NCT01137682|364349378|FG000|Overall Study|Did not receive treatment in extension|0|||
105641091|NCT01137682|364349379|FG001|Overall Study|Did not receive treatment in extension|0|||
105641092|NCT01137682|364349380|FG002|Overall Study|Did not receive treatment in extension|1|||
105641093|NCT02449902|364349381|FG000|Overall Study|Adverse Event|0|||
105641094|NCT02449902|364349382|FG001|Overall Study|Adverse Event|1|||
105641095|NCT02449902|364349381|FG000|Overall Study|Withdrawal by Subject|0|||
105641096|NCT02449902|364349382|FG001|Overall Study|Withdrawal by Subject|1|||
105641097|NCT00795639|364349384|FG000|Overall Study|Death|1|||
105641098|NCT00795639|364349385|FG001|Overall Study|Death|6|||
105641099|NCT00795639|364349384|FG000|Overall Study|Withdrawal by Subject|1|||
105641100|NCT00795639|364349385|FG001|Overall Study|Withdrawal by Subject|3|||
105641101|NCT00795639|364349384|FG000|Overall Study|Pregnancy|1|||
105641102|NCT00795639|364349385|FG001|Overall Study|Pregnancy|0|||
105641103|NCT00795639|364349384|FG000|Overall Study|Adverse Event|5|||
105641104|NCT00795639|364349385|FG001|Overall Study|Adverse Event|2|||
105641105|NCT00795639|364349384|FG000|Overall Study|Other|0|||
105641106|NCT00795639|364349385|FG001|Overall Study|Other|2|||
105641107|NCT00795639|364349384|FG000|Overall Study|Terminated by sponsor|13|||
105641108|NCT00795639|364349385|FG001|Overall Study|Terminated by sponsor|12|||
105641109|NCT00795639|364349384|FG000|Overall Study|Randomized and not treated|0|||
105641110|NCT00795639|364349385|FG001|Overall Study|Randomized and not treated|1|||
105641111|NCT02525744|364349386|FG000|Period 1|Physician Decision|0|||
105641112|NCT02525744|364349387|FG001|Period 1|Physician Decision|0|||
105641113|NCT02525744|364349388|FG002|Period 1|Physician Decision|1|||
105641114|NCT02525744|364349389|FG003|Period 1|Physician Decision|0|||
105641115|NCT02525744|364349386|FG000|Period 3|Adverse Event|0|||
105641116|NCT02525744|364349387|FG001|Period 3|Adverse Event|1|||
105641117|NCT02525744|364349388|FG002|Period 3|Adverse Event|0|||
105641118|NCT02525744|364349389|FG003|Period 3|Adverse Event|0|||
105641119|NCT02525744|364349386|FG000|Period 4|Withdrawal by Subject|1|||
105641120|NCT02525744|364349387|FG001|Period 4|Withdrawal by Subject|0|||
105641121|NCT02525744|364349388|FG002|Period 4|Withdrawal by Subject|0|||
105641122|NCT02525744|364349389|FG003|Period 4|Withdrawal by Subject|0|||
105641123|NCT02525744|364349386|FG000|Period 5|Physician Decision|1|||
105641124|NCT02525744|364349387|FG001|Period 5|Physician Decision|0|||
105641125|NCT02525744|364349388|FG002|Period 5|Physician Decision|0|||
105641126|NCT02525744|364349389|FG003|Period 5|Physician Decision|0|||
105641127|NCT00879710|364349390|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
105641128|NCT00879710|364349391|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
105641129|NCT00879710|364349392|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
105641130|NCT00879710|364349393|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
105641131|NCT00879710|364349390|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
105641132|NCT00879710|364349391|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
105641133|NCT00879710|364349392|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
105641134|NCT00879710|364349393|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
105641135|NCT03200574|364349398|FG000|Overall Study|Death|4|||
105641136|NCT03200574|364349398|FG000|Overall Study|Withdrawal by Subject|8|||
105641137|NCT03200574|364349398|FG000|Overall Study|Long-Term need for anticoagulation|1|||
105641138|NCT03200574|364349398|FG000|Overall Study|Relocation|2|||
105641139|NCT03200574|364349398|FG000|Overall Study|Lost to Follow-up|2|||
105641140|NCT04183491|364349399|FG000|Overall Study|Withdrawal by Subject|0|||
105641141|NCT04183491|364349400|FG001|Overall Study|Withdrawal by Subject|0|||
105641142|NCT04183491|364349401|FG002|Overall Study|Withdrawal by Subject|1|||
105641143|NCT04183491|364349402|FG003|Overall Study|Withdrawal by Subject|0|||
105641144|NCT04183491|364349403|FG004|Overall Study|Withdrawal by Subject|0|||
105641145|NCT04183491|364349404|FG005|Overall Study|Withdrawal by Subject|1|||
105641146|NCT04183491|364349405|FG006|Overall Study|Withdrawal by Subject|0|||
105641147|NCT01262456|364349406|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
105641148|NCT01262456|364349407|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
105641149|NCT01262456|364349408|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
105641150|NCT01262456|364349406|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
105641151|NCT01262456|364349407|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
105641152|NCT01262456|364349408|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
105641153|NCT01262456|364349406|FG000|3-Month Double-Blind Period|Adverse Event|6|||
105641154|NCT01262456|364349407|FG001|3-Month Double-Blind Period|Adverse Event|4|||
105641155|NCT01262456|364349408|FG002|3-Month Double-Blind Period|Adverse Event|8|||
105641156|NCT01262456|364349406|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
105641157|NCT01262456|364349407|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
105641158|NCT01262456|364349408|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
105641159|NCT01262456|364349406|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
105641160|NCT01262456|364349407|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
105641161|NCT01262456|364349408|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
105641162|NCT01262456|364349406|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
105641163|NCT01262456|364349407|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
105641164|NCT01262456|364349408|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
105641165|NCT01262456|364349406|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
105641166|NCT01262456|364349407|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
105641167|NCT01262456|364349408|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
105641168|NCT01262456|364349406|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
105641169|NCT01262456|364349407|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
105641170|NCT01262456|364349408|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
105641171|NCT01262456|364349406|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
105641172|NCT01262456|364349407|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
105641173|NCT01262456|364349408|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
105641174|NCT03938272|364349409|FG000|Overall Study|Withdrawal by Subject|1|||
105641175|NCT03938272|364349410|FG001|Overall Study|Withdrawal by Subject|0|||
105641176|NCT03938272|364349409|FG000|Overall Study|Physician Decision|0|||
105641177|NCT03938272|364349410|FG001|Overall Study|Physician Decision|2|||
105641178|NCT03938272|364349409|FG000|Overall Study|Study termination by sponsor|10|||
105641179|NCT03938272|364349410|FG001|Overall Study|Study termination by sponsor|8|||
105641180|NCT00886834|364349411|FG000|Overall Study|Protocol Violation|0|||
105641181|NCT00886834|364349412|FG001|Overall Study|Protocol Violation|3|||
105641182|NCT04085614|364349413|FG000|Overall Study|Protocol Violation|9|||
105641183|NCT04085614|364349414|FG001|Overall Study|Protocol Violation|6|||
105641184|NCT03150589|364349415|FG000|Overall Study|Withdrawal by Subject|16|||
105641185|NCT03150589|364349416|FG001|Overall Study|Withdrawal by Subject|9|||
105641186|NCT03150589|364349415|FG000|Overall Study|Adverse Event|7|||
105641187|NCT03150589|364349416|FG001|Overall Study|Adverse Event|6|||
105641188|NCT03150589|364349415|FG000|Overall Study|Protocol Violation|4|||
105641189|NCT03150589|364349416|FG001|Overall Study|Protocol Violation|3|||
105641190|NCT03150589|364349415|FG000|Overall Study|Lost to Follow-up|3|||
105641191|NCT03150589|364349416|FG001|Overall Study|Lost to Follow-up|3|||
105641192|NCT03150589|364349415|FG000|Overall Study|Death|2|||
105641193|NCT03150589|364349416|FG001|Overall Study|Death|3|||
105641194|NCT03150589|364349415|FG000|Overall Study|IP non-compliance and other reasons|12|||
105641195|NCT03150589|364349416|FG001|Overall Study|IP non-compliance and other reasons|3|||
105641196|NCT02399449|364349421|FG000|Overall Study|Withdrawal by Subject|3|||
105641197|NCT02399449|364349422|FG001|Overall Study|Withdrawal by Subject|9|||
105641198|NCT02399449|364349421|FG000|Overall Study|Physician Decision|0|||
105641199|NCT02399449|364349422|FG001|Overall Study|Physician Decision|1|||
105641200|NCT02159352|364349423|FG000|Overall Study|Adverse Event|3|||
105641201|NCT02159352|364349424|FG001|Overall Study|Adverse Event|1|||
105641202|NCT02159352|364349423|FG000|Overall Study|Withdrawal by Subject|0|||
105641203|NCT02159352|364349424|FG001|Overall Study|Withdrawal by Subject|1|||
105641204|NCT00529529|364349425|FG000|Overall Study|Adverse Event|12|||
105641205|NCT00529529|364349426|FG001|Overall Study|Adverse Event|17|||
105641206|NCT00529529|364349427|FG002|Overall Study|Adverse Event|8|||
105641207|NCT00529529|364349425|FG000|Overall Study|Subject withdrew consent|12|||
105641208|NCT00529529|364349426|FG001|Overall Study|Subject withdrew consent|9|||
105641209|NCT00529529|364349427|FG002|Overall Study|Subject withdrew consent|12|||
105641210|NCT00529529|364349425|FG000|Overall Study|Protocol deviation|8|||
105641211|NCT00529529|364349426|FG001|Overall Study|Protocol deviation|12|||
105641212|NCT00529529|364349427|FG002|Overall Study|Protocol deviation|5|||
105641213|NCT00529529|364349425|FG000|Overall Study|Lost to Follow-up|5|||
105641214|NCT00529529|364349426|FG001|Overall Study|Lost to Follow-up|3|||
105641215|NCT00529529|364349427|FG002|Overall Study|Lost to Follow-up|1|||
105641216|NCT00529529|364349425|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105641217|NCT00529529|364349426|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105641218|NCT00529529|364349427|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
105641219|NCT00529529|364349425|FG000|Overall Study|Death|2|||
105641220|NCT00529529|364349426|FG001|Overall Study|Death|0|||
105641221|NCT00529529|364349427|FG002|Overall Study|Death|0|||
105641222|NCT00529529|364349425|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105641223|NCT00529529|364349426|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105641224|NCT00529529|364349427|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105641225|NCT00529529|364349425|FG000|Overall Study|Administrative problems|1|||
105641226|NCT00529529|364349426|FG001|Overall Study|Administrative problems|0|||
105641227|NCT00529529|364349427|FG002|Overall Study|Administrative problems|3|||
105641228|NCT00428714|364349429|FG000|Overall Study|Progressive Disease|28|||
105641229|NCT00428714|364349430|FG001|Overall Study|Progressive Disease|36|||
105641230|NCT00428714|364349429|FG000|Overall Study|Withdrawal by Subject|0|||
105641231|NCT00428714|364349430|FG001|Overall Study|Withdrawal by Subject|3|||
105641232|NCT00428714|364349429|FG000|Overall Study|Adverse Event|0|||
105641233|NCT00428714|364349430|FG001|Overall Study|Adverse Event|2|||
105641234|NCT00428714|364349429|FG000|Overall Study|Physician Decision|1|||
105641235|NCT00428714|364349430|FG001|Overall Study|Physician Decision|1|||
105641236|NCT00428714|364349429|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
105641237|NCT00428714|364349430|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
105641238|NCT00428714|364349429|FG000|Overall Study|Death due to other then PD|1|||
105641239|NCT00428714|364349430|FG001|Overall Study|Death due to other then PD|0|||
105641240|NCT03060525|364349431|FG000|Overall Study|moved out of state|1|||
105641241|NCT03060525|364349432|FG001|Overall Study|moved out of state|1|||
105641242|NCT03060525|364349433|FG002|Overall Study|moved out of state|1|||
105641243|NCT03060525|364349434|FG003|Overall Study|moved out of state|1|||
105641244|NCT03060525|364349431|FG000|Overall Study|unable to meet time commitment required of study|2|||
105641245|NCT03060525|364349432|FG001|Overall Study|unable to meet time commitment required of study|3|||
105641246|NCT03060525|364349433|FG002|Overall Study|unable to meet time commitment required of study|3|||
105641247|NCT03060525|364349434|FG003|Overall Study|unable to meet time commitment required of study|1|||
105641248|NCT03060525|364349431|FG000|Overall Study|no longer interested in doing intervention|0|||
105641249|NCT03060525|364349432|FG001|Overall Study|no longer interested in doing intervention|0|||
105641250|NCT03060525|364349433|FG002|Overall Study|no longer interested in doing intervention|0|||
105641251|NCT03060525|364349434|FG003|Overall Study|no longer interested in doing intervention|1|||
105641252|NCT02189759|364349448|FG000|Overall Study|Lost to Follow-up|0|||
105641253|NCT02189759|364349449|FG001|Overall Study|Lost to Follow-up|0|||
105641254|NCT02189759|364349450|FG002|Overall Study|Lost to Follow-up|2|||
105641255|NCT02189759|364349451|FG003|Overall Study|Lost to Follow-up|5|||
105641256|NCT01147471|364349452|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
105641257|NCT01147471|364349453|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
105641258|NCT01147471|364349452|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
105641259|NCT01147471|364349453|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
105641260|NCT01147471|364349452|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
105641261|NCT01147471|364349453|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
105641262|NCT01147471|364349452|FG000|3 Month Follow Up|Lost to Follow-up|1|||
105641263|NCT01147471|364349453|FG001|3 Month Follow Up|Lost to Follow-up|1|||
105641264|NCT01147471|364349452|FG000|3 Month Follow Up|Physician Decision|0|||
105641265|NCT01147471|364349453|FG001|3 Month Follow Up|Physician Decision|1|||
105641266|NCT01147471|364349452|FG000|6 Month Follow Up|Lost to Follow-up|4|||
105641267|NCT01147471|364349453|FG001|6 Month Follow Up|Lost to Follow-up|2|||
105641268|NCT01662505|364349458|FG000|Overall Study|Progressive disease|6|||
105641269|NCT01662505|364349459|FG001|Overall Study|Progressive disease|1|||
105641270|NCT01662505|364349460|FG002|Overall Study|Progressive disease|5|||
105641271|NCT01662505|364349458|FG000|Overall Study|Refused cont. medication|0|||
105641272|NCT01662505|364349459|FG001|Overall Study|Refused cont. medication|0|||
105641273|NCT01662505|364349460|FG002|Overall Study|Refused cont. medication|1|||
105641274|NCT01662505|364349458|FG000|Overall Study|Not specified above|1|||
105641275|NCT01662505|364349459|FG001|Overall Study|Not specified above|3|||
105641276|NCT01662505|364349460|FG002|Overall Study|Not specified above|2|||
105641277|NCT00731692|364351263|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
105641278|NCT00731692|364351264|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
105641279|NCT00731692|364351265|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
105641280|NCT00731692|364351263|FG000|Core Study (36 Months)|Physician Decision|1|||
105641281|NCT00731692|364351264|FG001|Core Study (36 Months)|Physician Decision|0|||
105641282|NCT00731692|364351265|FG002|Core Study (36 Months)|Physician Decision|2|||
105641283|NCT00731692|364351263|FG000|Core Study (36 Months)|Death|2|||
105641284|NCT00731692|364351264|FG001|Core Study (36 Months)|Death|1|||
105641285|NCT00731692|364351265|FG002|Core Study (36 Months)|Death|2|||
105641286|NCT00731692|364351263|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
105641287|NCT00731692|364351264|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
105641288|NCT00731692|364351265|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
105641289|NCT00731692|364351263|FG000|Core Study (36 Months)|Administrative|2|||
105641290|NCT00731692|364351264|FG001|Core Study (36 Months)|Administrative|2|||
105641291|NCT00731692|364351265|FG002|Core Study (36 Months)|Administrative|6|||
105641292|NCT00731692|364351263|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
105641293|NCT00731692|364351264|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
105641294|NCT00731692|364351265|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
105641295|NCT00731692|364351263|FG000|Core Study (36 Months)|Protocol Violation|4|||
105641296|NCT00731692|364351264|FG001|Core Study (36 Months)|Protocol Violation|5|||
105641297|NCT00731692|364351265|FG002|Core Study (36 Months)|Protocol Violation|8|||
105641298|NCT00731692|364351263|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
105641299|NCT00731692|364351264|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
105641300|NCT00731692|364351265|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
105641301|NCT00731692|364351263|FG000|Core Study (36 Months)|Adverse Event|25|||
105641302|NCT00731692|364351264|FG001|Core Study (36 Months)|Adverse Event|28|||
105641303|NCT00731692|364351265|FG002|Core Study (36 Months)|Adverse Event|29|||
105641304|NCT00731692|364351263|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
105641305|NCT00731692|364351264|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
105641306|NCT00731692|364351265|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
105641307|NCT00731692|364351263|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
105641308|NCT00731692|364351264|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
105641309|NCT00731692|364351265|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
105641310|NCT00731692|364351263|FG000|Extension Phase|Abnormal test procedure|0|||
105641311|NCT00731692|364351264|FG001|Extension Phase|Abnormal test procedure|0|||
105641312|NCT00731692|364351265|FG002|Extension Phase|Abnormal test procedure|1|||
105641313|NCT00731692|364351263|FG000|Extension Phase|Abnormal lab values|0|||
105641314|NCT00731692|364351264|FG001|Extension Phase|Abnormal lab values|0|||
105641315|NCT00731692|364351265|FG002|Extension Phase|Abnormal lab values|1|||
105641316|NCT00731692|364351263|FG000|Extension Phase|Lost to Follow-up|0|||
105641317|NCT00731692|364351264|FG001|Extension Phase|Lost to Follow-up|1|||
105641318|NCT00731692|364351265|FG002|Extension Phase|Lost to Follow-up|4|||
105641319|NCT00731692|364351263|FG000|Extension Phase|Withdrawal by Subject|4|||
105641320|NCT00731692|364351264|FG001|Extension Phase|Withdrawal by Subject|5|||
105641321|NCT00731692|364351265|FG002|Extension Phase|Withdrawal by Subject|3|||
105641322|NCT00731692|364351263|FG000|Extension Phase|Adverse Event|1|||
105641323|NCT00731692|364351264|FG001|Extension Phase|Adverse Event|1|||
105641324|NCT00731692|364351265|FG002|Extension Phase|Adverse Event|15|||
105641325|NCT03493282|364351267|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
105641326|NCT03493282|364351268|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
105641327|NCT03493282|364351269|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
105641328|NCT03493282|364351267|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
105641329|NCT03493282|364351268|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
105641330|NCT03493282|364351269|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
105641331|NCT00670449|364351270|FG000|Overall Study|Adverse Event|6|||
105641332|NCT00670449|364351271|FG001|Overall Study|Adverse Event|2|||
105641333|NCT00670449|364351272|FG002|Overall Study|Adverse Event|8|||
105641334|NCT00670449|364351273|FG003|Overall Study|Adverse Event|5|||
105641335|NCT00670449|364351270|FG000|Overall Study|Protocol Deviation|1|||
105641336|NCT00670449|364351271|FG001|Overall Study|Protocol Deviation|2|||
105641337|NCT00670449|364351272|FG002|Overall Study|Protocol Deviation|0|||
105641338|NCT00670449|364351273|FG003|Overall Study|Protocol Deviation|1|||
105641339|NCT00670449|364351270|FG000|Overall Study|Administrative Problems|0|||
105641340|NCT00670449|364351271|FG001|Overall Study|Administrative Problems|2|||
105641341|NCT00670449|364351272|FG002|Overall Study|Administrative Problems|0|||
105641342|NCT00670449|364351273|FG003|Overall Study|Administrative Problems|1|||
105641343|NCT00670449|364351270|FG000|Overall Study|Subject Withdrew Consent|0|||
105641344|NCT00670449|364351271|FG001|Overall Study|Subject Withdrew Consent|2|||
105641345|NCT00670449|364351272|FG002|Overall Study|Subject Withdrew Consent|0|||
105641346|NCT00670449|364351273|FG003|Overall Study|Subject Withdrew Consent|1|||
105641347|NCT00670449|364351270|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
105641348|NCT00670449|364351271|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105641349|NCT00670449|364351272|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
105641350|NCT00670449|364351273|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105641351|NCT00670449|364351270|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
105641352|NCT00670449|364351271|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
105641353|NCT00670449|364351272|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
105641354|NCT00670449|364351273|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
105641355|NCT01128959|364351278|FG000|Lead in Period|Adverse Event|3|||
105641356|NCT01128959|364351278|FG000|Treatment Period|Adverse Event|3|||
105641357|NCT01128959|364351278|FG000|Treatment Period|Withdrawal by Subject|1|||
105641358|NCT02338999|364351279|FG000|First Intervention|Withdrawal by Subject|3|||
105641359|NCT02338999|364351280|FG001|First Intervention|Withdrawal by Subject|1|||
105641360|NCT02338999|364351279|FG000|Washout Period|Withdrawal by Subject|0|||
105641361|NCT02338999|364351280|FG001|Washout Period|Withdrawal by Subject|2|||
105641362|NCT02338999|364351279|FG000|Second Intervention|Withdrawal by Subject|0|||
105641363|NCT02338999|364351280|FG001|Second Intervention|Withdrawal by Subject|2|||
105641364|NCT02958553|364351283|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
105641365|NCT02958553|364351283|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
105641366|NCT03340961|364351284|FG000|Overall Study|Adverse Event|1|||
105641367|NCT03340961|364351285|FG001|Overall Study|Adverse Event|3|||
105641368|NCT03340961|364351286|FG002|Overall Study|Adverse Event|2|||
105641369|NCT03340961|364351287|FG003|Overall Study|Adverse Event|4|||
105641370|NCT03340961|364351284|FG000|Overall Study|Lost to Follow-up|0|||
105641371|NCT03340961|364351285|FG001|Overall Study|Lost to Follow-up|1|||
105641372|NCT03340961|364351286|FG002|Overall Study|Lost to Follow-up|0|||
105641373|NCT03340961|364351287|FG003|Overall Study|Lost to Follow-up|1|||
105641374|NCT03340961|364351284|FG000|Overall Study|Withdrawal by Subject|3|||
105641375|NCT03340961|364351285|FG001|Overall Study|Withdrawal by Subject|2|||
105641376|NCT03340961|364351286|FG002|Overall Study|Withdrawal by Subject|4|||
105641377|NCT03340961|364351287|FG003|Overall Study|Withdrawal by Subject|7|||
105641378|NCT03340961|364351284|FG000|Overall Study|Use of prohibited treatment|0|||
105641379|NCT03340961|364351285|FG001|Overall Study|Use of prohibited treatment|3|||
105641380|NCT03340961|364351286|FG002|Overall Study|Use of prohibited treatment|2|||
105641381|NCT03340961|364351287|FG003|Overall Study|Use of prohibited treatment|4|||
105641382|NCT03340961|364351284|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
105641383|NCT03340961|364351285|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
105641384|NCT03340961|364351286|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
105641385|NCT03340961|364351287|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
105641386|NCT03340961|364351284|FG000|Overall Study|Subject developed an exclusion criterion|0|||
105641387|NCT03340961|364351285|FG001|Overall Study|Subject developed an exclusion criterion|1|||
105641388|NCT03340961|364351286|FG002|Overall Study|Subject developed an exclusion criterion|0|||
105641389|NCT03340961|364351287|FG003|Overall Study|Subject developed an exclusion criterion|0|||
105641390|NCT03340961|364351284|FG000|Overall Study|Protocol Violation|1|||
105641391|NCT03340961|364351285|FG001|Overall Study|Protocol Violation|0|||
105641392|NCT03340961|364351286|FG002|Overall Study|Protocol Violation|1|||
105641393|NCT03340961|364351287|FG003|Overall Study|Protocol Violation|0|||
105641394|NCT03340961|364351284|FG000|Overall Study|Adverse Event|1|||
105641395|NCT03340961|364351285|FG001|Overall Study|Adverse Event|1|||
105641396|NCT03340961|364351286|FG002|Overall Study|Adverse Event|0|||
105641397|NCT03340961|364351287|FG003|Overall Study|Adverse Event|0|||
105641398|NCT03340961|364351284|FG000|Overall Study|Lack of Efficacy|0|||
105641399|NCT03340961|364351285|FG001|Overall Study|Lack of Efficacy|0|||
105641400|NCT03340961|364351286|FG002|Overall Study|Lack of Efficacy|0|||
105641401|NCT03340961|364351287|FG003|Overall Study|Lack of Efficacy|1|||
105641402|NCT01802333|364351288|FG000|Overall Study|Ineligible|2|||
105641403|NCT01802333|364351289|FG001|Overall Study|Ineligible|6|||
105641404|NCT01802333|364351290|FG002|Overall Study|Ineligible|8|||
105641405|NCT01802333|364351288|FG000|Overall Study|Adverse Event|1|||
105641406|NCT01802333|364351289|FG001|Overall Study|Adverse Event|8|||
105641407|NCT01802333|364351290|FG002|Overall Study|Adverse Event|8|||
105641408|NCT01802333|364351288|FG000|Overall Study|Withdrawal by Subject|6|||
105641409|NCT01802333|364351289|FG001|Overall Study|Withdrawal by Subject|6|||
105641410|NCT01802333|364351290|FG002|Overall Study|Withdrawal by Subject|5|||
105641411|NCT01802333|364351288|FG000|Overall Study|Progression/relapse|1|||
105641412|NCT01802333|364351289|FG001|Overall Study|Progression/relapse|3|||
105641413|NCT01802333|364351290|FG002|Overall Study|Progression/relapse|0|||
105641414|NCT01802333|364351288|FG000|Overall Study|Death|7|||
105641415|NCT01802333|364351289|FG001|Overall Study|Death|14|||
105641416|NCT01802333|364351290|FG002|Overall Study|Death|13|||
105641417|NCT01802333|364351288|FG000|Overall Study|Other - not protocol specified|32|||
105641418|NCT01802333|364351289|FG001|Overall Study|Other - not protocol specified|22|||
105641419|NCT01802333|364351290|FG002|Overall Study|Other - not protocol specified|24|||
105641420|NCT01802333|364351288|FG000|Overall Study|Did not start treatment|0|||
105641421|NCT01802333|364351289|FG001|Overall Study|Did not start treatment|2|||
105641422|NCT01802333|364351290|FG002|Overall Study|Did not start treatment|5|||
105641423|NCT02224755|364351292|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
105641424|NCT02224755|364351293|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
105641425|NCT02224755|364351292|FG000|Two Year Follow up Post-implant|Death|103|||
105641426|NCT02224755|364351293|FG001|Two Year Follow up Post-implant|Death|98|||
105641427|NCT02224755|364351292|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
105641428|NCT02224755|364351293|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
105641429|NCT02224755|364351292|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
105641430|NCT02224755|364351293|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
105641431|NCT02224755|364351292|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
105641432|NCT02224755|364351293|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
105641433|NCT02067663|364351294|FG000|Overall Study|Lost to Follow-up|13|||
105641434|NCT02067663|364351295|FG001|Overall Study|Lost to Follow-up|14|||
105641435|NCT01437540|364351297|FG000|Overall Study|Not listed below|7|||
105641436|NCT01437540|364351298|FG001|Overall Study|Not listed below|6|||
105641437|NCT01437540|364351297|FG000|Overall Study|COPD exacerbation|13|||
105641438|NCT01437540|364351298|FG001|Overall Study|COPD exacerbation|3|||
105641439|NCT01437540|364351297|FG000|Overall Study|Lost to Follow-up|3|||
105641440|NCT01437540|364351298|FG001|Overall Study|Lost to Follow-up|5|||
105641441|NCT01437540|364351297|FG000|Overall Study|Lack of Efficacy|23|||
105641442|NCT01437540|364351298|FG001|Overall Study|Lack of Efficacy|11|||
105641443|NCT01437540|364351297|FG000|Overall Study|Protocol Violation|24|||
105641444|NCT01437540|364351298|FG001|Overall Study|Protocol Violation|12|||
105641445|NCT01437540|364351297|FG000|Overall Study|Adverse Event|26|||
105641446|NCT01437540|364351298|FG001|Overall Study|Adverse Event|13|||
105641447|NCT01437540|364351297|FG000|Overall Study|Withdrawal by Subject|31|||
105641448|NCT01437540|364351298|FG001|Overall Study|Withdrawal by Subject|15|||
105641449|NCT00929526|364351301|FG000|Overall Study|Withdrawal by Subject|1|||
105641450|NCT00929526|364351302|FG001|Overall Study|Withdrawal by Subject|11|||
105641451|NCT00929526|364351301|FG000|Overall Study|Lost to Follow-up|8|||
105641452|NCT00929526|364351302|FG001|Overall Study|Lost to Follow-up|12|||
105641453|NCT00929526|364351301|FG000|Overall Study|Other|8|||
105641454|NCT00929526|364351302|FG001|Overall Study|Other|6|||
105641455|NCT02547974|364351303|FG000|Overall Study|Withdrawal by Subject|1|||
105641456|NCT02547974|364351304|FG001|Overall Study|Withdrawal by Subject|0|||
105641457|NCT02547974|364351305|FG002|Overall Study|Withdrawal by Subject|0|||
105641458|NCT02547974|364351306|FG003|Overall Study|Withdrawal by Subject|0|||
105641459|NCT00624377|364351307|FG000|Overall Study|Lost to Follow-up|355|||
105641460|NCT00624377|364351307|FG000|Overall Study|Withdrawal by Subject|100|||
105641461|NCT00624377|364351307|FG000|Overall Study|Adverse Event|14|||
105641462|NCT00624377|364351307|FG000|Overall Study|Other|91|||
105641463|NCT00624377|364351307|FG000|Overall Study|Non-evaluable population|84|||
105641464|NCT00603798|364351308|FG000|Overall Study|Adverse Event|4|||
105641465|NCT00603798|364351309|FG001|Overall Study|Adverse Event|2|||
105641466|NCT00603798|364351310|FG002|Overall Study|Adverse Event|1|||
105641467|NCT00603798|364351308|FG000|Overall Study|Withdrawal by Subject|4|||
105641468|NCT00603798|364351309|FG001|Overall Study|Withdrawal by Subject|3|||
105641469|NCT00603798|364351310|FG002|Overall Study|Withdrawal by Subject|4|||
105641470|NCT00603798|364351308|FG000|Overall Study|Lost to Follow-up|1|||
105641471|NCT00603798|364351309|FG001|Overall Study|Lost to Follow-up|0|||
105641472|NCT00603798|364351310|FG002|Overall Study|Lost to Follow-up|1|||
105641473|NCT00603798|364351308|FG000|Overall Study|Non-compliance with study procedures|0|||
105641474|NCT00603798|364351309|FG001|Overall Study|Non-compliance with study procedures|1|||
105641475|NCT00603798|364351310|FG002|Overall Study|Non-compliance with study procedures|0|||
105641476|NCT00603798|364351308|FG000|Overall Study|Not due to AE|1|||
105641477|NCT00603798|364351309|FG001|Overall Study|Not due to AE|1|||
105641478|NCT00603798|364351310|FG002|Overall Study|Not due to AE|4|||
105641479|NCT00889863|364351318|FG000|Part I: Open Label|Death|1|||
105641480|NCT00889863|364351319|FG001|Part I: Open Label|Death|0|||
105641481|NCT00889863|364351318|FG000|Part I: Open Label|Adverse Event|4|||
105641482|NCT00889863|364351319|FG001|Part I: Open Label|Adverse Event|0|||
105641483|NCT00889863|364351318|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
105641484|NCT00889863|364351319|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
105641485|NCT00889863|364351318|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
105641486|NCT00889863|364351319|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
105641487|NCT00889863|364351318|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
105641488|NCT00889863|364351319|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
105641489|NCT00889863|364351318|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
105641490|NCT00889863|364351319|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
105641491|NCT00889863|364351318|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
105641492|NCT00889863|364351319|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
105641493|NCT00441168|364351320|FG000|Treatment Period|Death|3|||
105641494|NCT00441168|364351321|FG001|Treatment Period|Death|0|||
105641495|NCT00441168|364351320|FG000|Treatment Period|Adverse Event|1|||
105641496|NCT00441168|364351321|FG001|Treatment Period|Adverse Event|2|||
105641497|NCT00441168|364351320|FG000|Treatment Period|Progressive Disease|0|||
105641498|NCT00441168|364351321|FG001|Treatment Period|Progressive Disease|2|||
105641499|NCT00441168|364351320|FG000|Treatment Period|Protocol Violation|0|||
105641500|NCT00441168|364351321|FG001|Treatment Period|Protocol Violation|1|||
105641501|NCT00441168|364351320|FG000|Treatment Period|Lost to Follow-up|0|||
105641502|NCT00441168|364351321|FG001|Treatment Period|Lost to Follow-up|1|||
105641503|NCT00441168|364351320|FG000|Treatment Period|Withdrawal by Subject|3|||
105641504|NCT00441168|364351321|FG001|Treatment Period|Withdrawal by Subject|0|||
105641505|NCT00441168|364351320|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
105641506|NCT00441168|364351321|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
105641507|NCT00441168|364351320|FG000|Treatment Period|refractory disease|1|||
105641508|NCT00441168|364351321|FG001|Treatment Period|refractory disease|0|||
105641509|NCT00441168|364351320|FG000|Follow-up Period|Death|3|||
105641510|NCT00441168|364351321|FG001|Follow-up Period|Death|0|||
105641511|NCT00441168|364351320|FG000|Follow-up Period|Lost to Follow-up|5|||
105641512|NCT00441168|364351321|FG001|Follow-up Period|Lost to Follow-up|6|||
105641513|NCT00441168|364351320|FG000|Follow-up Period|Withdrawal by Subject|3|||
105641514|NCT00441168|364351321|FG001|Follow-up Period|Withdrawal by Subject|0|||
105641515|NCT00441168|364351320|FG000|Follow-up Period|Other|1|||
105641516|NCT00441168|364351321|FG001|Follow-up Period|Other|3|||
105641517|NCT01228734|364351330|FG000|Overall Study|Randomized, but not treated|0|||
105641518|NCT01228734|364351331|FG001|Overall Study|Randomized, but not treated|4|||
105641519|NCT00807599|364351334|FG000|Overall Study|Not treated on protocol study|0|||
105641520|NCT00807599|364351335|FG001|Overall Study|Not treated on protocol study|0|||
105641521|NCT00807599|364351336|FG002|Overall Study|Not treated on protocol study|2|||
105641522|NCT00807599|364351334|FG000|Overall Study|Adverse Event|0|||
105641523|NCT00807599|364351335|FG001|Overall Study|Adverse Event|0|||
105641524|NCT00807599|364351336|FG002|Overall Study|Adverse Event|5|||
105641525|NCT00807599|364351334|FG000|Overall Study|Inadequate response to induction|0|||
105641526|NCT00807599|364351335|FG001|Overall Study|Inadequate response to induction|0|||
105641527|NCT00807599|364351336|FG002|Overall Study|Inadequate response to induction|9|||
105641528|NCT00807599|364351334|FG000|Overall Study|Withdrawal by Subject|0|||
105641529|NCT00807599|364351335|FG001|Overall Study|Withdrawal by Subject|0|||
105641530|NCT00807599|364351336|FG002|Overall Study|Withdrawal by Subject|1|||
105641531|NCT01757288|364351341|FG000|Overall Study|Consent withdrawal|0|||
105641532|NCT01757288|364351342|FG001|Overall Study|Consent withdrawal|4|||
105641533|NCT01757288|364351343|FG002|Overall Study|Consent withdrawal|4|||
105641534|NCT01757288|364351341|FG000|Overall Study|Patient off study, IRB hold.|0|||
105641535|NCT01757288|364351342|FG001|Overall Study|Patient off study, IRB hold.|0|||
105641536|NCT01757288|364351343|FG002|Overall Study|Patient off study, IRB hold.|1|||
105641537|NCT01757288|364351341|FG000|Overall Study|Patient death prior to starting treatment|0|||
105641538|NCT01757288|364351342|FG001|Overall Study|Patient death prior to starting treatment|0|||
105641539|NCT01757288|364351343|FG002|Overall Study|Patient death prior to starting treatment|1|||
105641540|NCT01757288|364351341|FG000|Overall Study|Wrong medication administered|0|||
105641541|NCT01757288|364351342|FG001|Overall Study|Wrong medication administered|1|||
105641542|NCT01757288|364351343|FG002|Overall Study|Wrong medication administered|0|||
105641543|NCT01757288|364351341|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
105641544|NCT01757288|364351342|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
105641545|NCT01757288|364351343|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
105641546|NCT01757288|364351341|FG000|Overall Study|Not meeting protocol constraints|0|||
105641547|NCT01757288|364351342|FG001|Overall Study|Not meeting protocol constraints|1|||
105641548|NCT01757288|364351343|FG002|Overall Study|Not meeting protocol constraints|1|||
105641549|NCT01757288|364351341|FG000|Overall Study|Multiple missed appointments|0|||
105641550|NCT01757288|364351342|FG001|Overall Study|Multiple missed appointments|1|||
105641551|NCT01757288|364351343|FG002|Overall Study|Multiple missed appointments|0|||
105641552|NCT01757288|364351341|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
105641553|NCT01757288|364351342|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
105641554|NCT01757288|364351343|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
105641555|NCT01757288|364351341|FG000|Overall Study|>2 weeks treatment break|0|||
105641556|NCT01757288|364351342|FG001|Overall Study|>2 weeks treatment break|0|||
105641557|NCT01757288|364351343|FG002|Overall Study|>2 weeks treatment break|1|||
105641558|NCT02825550|364351344|FG000|Overall Study|Physician Decision|1|||
105641559|NCT01365546|364351345|FG000|Overall Study|Withdrawal by Subject|1|||
105641560|NCT01365546|364351345|FG000|Overall Study|Screen failure|9|||
105641561|NCT01365546|364351345|FG000|Overall Study|Study termination|1|||
105641562|NCT00761267|364351351|FG000|Overall Study|Death|1|||
105641563|NCT00761267|364351352|FG001|Overall Study|Death|2|||
105641564|NCT00761267|364351353|FG002|Overall Study|Death|5|||
105641565|NCT00761267|364351351|FG000|Overall Study|Lost to Follow-up|0|||
105641566|NCT00761267|364351352|FG001|Overall Study|Lost to Follow-up|0|||
105641567|NCT00761267|364351353|FG002|Overall Study|Lost to Follow-up|1|||
105641568|NCT00761267|364351351|FG000|Overall Study|Randomized but not treated|1|||
105641569|NCT00761267|364351352|FG001|Overall Study|Randomized but not treated|1|||
105641570|NCT00761267|364351353|FG002|Overall Study|Randomized but not treated|0|||
105641571|NCT00761267|364351351|FG000|Overall Study|Withdrawal by Subject|0|||
105641572|NCT00761267|364351352|FG001|Overall Study|Withdrawal by Subject|1|||
105641573|NCT00761267|364351353|FG002|Overall Study|Withdrawal by Subject|0|||
105641574|NCT04492475|364351354|FG000|Overall Study|Enrolled but not treated|8|||
105641575|NCT04492475|364351355|FG001|Overall Study|Enrolled but not treated|8|||
105641576|NCT04492475|364351354|FG000|Overall Study|Withdrawal by Subject|4|||
105641577|NCT04492475|364351355|FG001|Overall Study|Withdrawal by Subject|0|||
105641578|NCT04492475|364351354|FG000|Overall Study|Became ineligible after enrollment|2|||
105641579|NCT04492475|364351355|FG001|Overall Study|Became ineligible after enrollment|0|||
105641580|NCT02538094|364351358|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
105641581|NCT02538094|364351359|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
105641582|NCT02538094|364351358|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
105641583|NCT02538094|364351359|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
105641584|NCT03989232|364351360|FG000|Overall Study|Lost to Follow-up|3|||
105641585|NCT03989232|364351361|FG001|Overall Study|Lost to Follow-up|10|||
105641586|NCT03989232|364351360|FG000|Overall Study|Withdrawal by Subject|6|||
105641587|NCT03989232|364351361|FG001|Overall Study|Withdrawal by Subject|6|||
105641588|NCT03989232|364351360|FG000|Overall Study|Death|1|||
105641589|NCT03989232|364351361|FG001|Overall Study|Death|2|||
105641590|NCT02170207|364351366|FG000|Overall Study|Case report forms unavailable|5|||
105641591|NCT03122860|364351367|FG000|Overall Study|Discontinued Before Treatment|1|||
105641592|NCT03122860|364351368|FG001|Overall Study|Discontinued Before Treatment|1|||
105641593|NCT03122860|364351369|FG002|Overall Study|Discontinued Before Treatment|2|||
105641594|NCT03122860|364351370|FG003|Overall Study|Discontinued Before Treatment|0|||
105641595|NCT03122860|364351371|FG004|Overall Study|Discontinued Before Treatment|1|||
105641596|NCT03122860|364351372|FG005|Overall Study|Discontinued Before Treatment|0|||
105641597|NCT03122860|364351367|FG000|Overall Study|Adverse Event|1|||
105641598|NCT03122860|364351368|FG001|Overall Study|Adverse Event|0|||
105641599|NCT03122860|364351369|FG002|Overall Study|Adverse Event|1|||
105641600|NCT03122860|364351370|FG003|Overall Study|Adverse Event|1|||
105641601|NCT03122860|364351371|FG004|Overall Study|Adverse Event|0|||
105641602|NCT03122860|364351372|FG005|Overall Study|Adverse Event|0|||
105641603|NCT03122860|364351367|FG000|Overall Study|Lost to Follow-up|5|||
105641604|NCT03122860|364351368|FG001|Overall Study|Lost to Follow-up|2|||
105641605|NCT03122860|364351369|FG002|Overall Study|Lost to Follow-up|3|||
105641606|NCT03122860|364351370|FG003|Overall Study|Lost to Follow-up|3|||
105641607|NCT03122860|364351371|FG004|Overall Study|Lost to Follow-up|5|||
105641608|NCT03122860|364351372|FG005|Overall Study|Lost to Follow-up|4|||
105641609|NCT03122860|364351367|FG000|Overall Study|Subject Non-Compliance|0|||
105641610|NCT03122860|364351368|FG001|Overall Study|Subject Non-Compliance|0|||
105641611|NCT03122860|364351369|FG002|Overall Study|Subject Non-Compliance|1|||
105641612|NCT03122860|364351370|FG003|Overall Study|Subject Non-Compliance|0|||
105641613|NCT03122860|364351371|FG004|Overall Study|Subject Non-Compliance|0|||
105641614|NCT03122860|364351372|FG005|Overall Study|Subject Non-Compliance|0|||
105641615|NCT03122860|364351367|FG000|Overall Study|Withdrawal by Subject|3|||
105641616|NCT03122860|364351368|FG001|Overall Study|Withdrawal by Subject|2|||
105641617|NCT03122860|364351369|FG002|Overall Study|Withdrawal by Subject|5|||
105641618|NCT03122860|364351370|FG003|Overall Study|Withdrawal by Subject|7|||
105641619|NCT03122860|364351371|FG004|Overall Study|Withdrawal by Subject|9|||
105641620|NCT03122860|364351372|FG005|Overall Study|Withdrawal by Subject|8|||
105641621|NCT03875729|364351373|FG000|Overall Study|Adverse Event|0|||
105641622|NCT03875729|364351374|FG001|Overall Study|Adverse Event|5|||
105641623|NCT03875729|364351373|FG000|Overall Study|Withdrawal by Subject|8|||
105641624|NCT03875729|364351374|FG001|Overall Study|Withdrawal by Subject|11|||
105641625|NCT03875729|364351373|FG000|Overall Study|Pregnancy|0|||
105641626|NCT03875729|364351374|FG001|Overall Study|Pregnancy|1|||
105641627|NCT03875729|364351373|FG000|Overall Study|Lost to Follow-up|0|||
105641628|NCT03875729|364351374|FG001|Overall Study|Lost to Follow-up|5|||
105641629|NCT03875729|364351373|FG000|Overall Study|Personal reasons|2|||
105641630|NCT03875729|364351374|FG001|Overall Study|Personal reasons|0|||
105641631|NCT00337610|364351377|FG000|Overall Study|Adverse Event|2|||
105641632|NCT00337610|364351378|FG001|Overall Study|Adverse Event|2|||
105641633|NCT00337610|364351377|FG000|Overall Study|Death|0|||
105641634|NCT00337610|364351378|FG001|Overall Study|Death|1|||
105641635|NCT00337610|364351377|FG000|Overall Study|Lack of Efficacy|6|||
105641636|NCT00337610|364351378|FG001|Overall Study|Lack of Efficacy|3|||
105641637|NCT00337610|364351377|FG000|Overall Study|Lost to Follow-up|3|||
105641638|NCT00337610|364351378|FG001|Overall Study|Lost to Follow-up|3|||
105641639|NCT00337610|364351377|FG000|Overall Study|Withdrawal by Subject|6|||
105641640|NCT00337610|364351378|FG001|Overall Study|Withdrawal by Subject|5|||
105641641|NCT03205488|364351379|FG000|Overall Study|Adverse Event|1|||
105641642|NCT03205488|364351380|FG001|Overall Study|Adverse Event|2|||
105641643|NCT03205488|364351381|FG002|Overall Study|Adverse Event|4|||
105641644|NCT03205488|364351379|FG000|Overall Study|Protocol Violation|0|||
105641645|NCT03205488|364351380|FG001|Overall Study|Protocol Violation|0|||
105641646|NCT03205488|364351381|FG002|Overall Study|Protocol Violation|1|||
105641647|NCT01005914|364351384|FG000|Overall Study|Adverse Event|4|||
105641648|NCT01005914|364351384|FG000|Overall Study|Death|4|||
105641649|NCT01005914|364351384|FG000|Overall Study|Lack of Efficacy|1|||
105641650|NCT01005914|364351384|FG000|Overall Study|Withdrawal by Subject|1|||
105641651|NCT00632736|364351386|FG000|Overall Study|Adverse Event|104|||
105641652|NCT00632736|364351386|FG000|Overall Study|Lost to Follow-up|15|||
105641653|NCT00632736|364351386|FG000|Overall Study|Protocol Violation|14|||
105641654|NCT00632736|364351386|FG000|Overall Study|Withdrawal by Subject|99|||
105641655|NCT00632736|364351386|FG000|Overall Study|Lack of Efficacy|5|||
105641656|NCT00632736|364351386|FG000|Overall Study|Sponsor terminated study|5|||
105641657|NCT00632736|364351386|FG000|Overall Study|Non-compliance|10|||
105641658|NCT00632736|364351386|FG000|Overall Study|Other|16|||
105659336|NCT00551135|364417283|FG003|Overall Study|Lost to Follow-up|1|||
105641659|NCT02513667|364351387|FG000|Overall Study|Withdrawal by Subject|0|||
105641660|NCT02513667|364351388|FG001|Overall Study|Withdrawal by Subject|1|||
105641661|NCT01323790|364351389|FG000|Overall Study|Other|3|||
105641662|NCT01323790|364351390|FG001|Overall Study|Other|2|||
105641663|NCT01323790|364351391|FG002|Overall Study|Other|1|||
105641664|NCT01323790|364351389|FG000|Overall Study|Lost to Follow-up|11|||
105641665|NCT01323790|364351390|FG001|Overall Study|Lost to Follow-up|9|||
105641666|NCT01323790|364351391|FG002|Overall Study|Lost to Follow-up|9|||
105641667|NCT01323790|364351389|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
105641668|NCT01323790|364351390|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
105641669|NCT01323790|364351391|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
105641670|NCT01323790|364351389|FG000|Overall Study|Lack of Efficacy|3|||
105641671|NCT01323790|364351390|FG001|Overall Study|Lack of Efficacy|0|||
105641672|NCT01323790|364351391|FG002|Overall Study|Lack of Efficacy|3|||
105641673|NCT01323790|364351389|FG000|Overall Study|Adverse Event|11|||
105641674|NCT01323790|364351390|FG001|Overall Study|Adverse Event|24|||
105641675|NCT01323790|364351391|FG002|Overall Study|Adverse Event|12|||
105641676|NCT01323790|364351389|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
105641677|NCT01323790|364351390|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
105641678|NCT01323790|364351391|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
105641679|NCT01323790|364351389|FG000|Overall Study|Withdrawal by Subject|23|||
105641680|NCT01323790|364351390|FG001|Overall Study|Withdrawal by Subject|20|||
105641681|NCT01323790|364351391|FG002|Overall Study|Withdrawal by Subject|13|||
105641682|NCT01323790|364351389|FG000|Overall Study|Did Not Receive Treatment|2|||
105641683|NCT01323790|364351390|FG001|Overall Study|Did Not Receive Treatment|0|||
105641684|NCT01323790|364351391|FG002|Overall Study|Did Not Receive Treatment|1|||
105641685|NCT01323790|364351389|FG000|Overall Study|Severe non-compliance with protocol|2|||
105641686|NCT01323790|364351390|FG001|Overall Study|Severe non-compliance with protocol|2|||
105641687|NCT01323790|364351391|FG002|Overall Study|Severe non-compliance with protocol|2|||
105641688|NCT00655824|364351393|FG000|Overall Study|Adverse Event|3|||
105641689|NCT00655824|364351393|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
105641690|NCT00655824|364351393|FG000|Overall Study|Protocol Violation|1|||
105641691|NCT00655824|364351393|FG000|Overall Study|Withdrawal by Subject|4|||
105641692|NCT00655824|364351393|FG000|Overall Study|Deterioration of Trial Disease|2|||
105641693|NCT02978716|364351394|FG000|Overall Study|Death|25|||
105641694|NCT02978716|364351395|FG001|Overall Study|Death|13|||
105641695|NCT02978716|364351396|FG002|Overall Study|Death|20|||
105641696|NCT02978716|364351394|FG000|Overall Study|Lost to Follow-up|0|||
105641697|NCT02978716|364351395|FG001|Overall Study|Lost to Follow-up|0|||
105641698|NCT02978716|364351396|FG002|Overall Study|Lost to Follow-up|1|||
105641699|NCT02978716|364351394|FG000|Overall Study|Withdrawal by Subject|6|||
105641700|NCT02978716|364351395|FG001|Overall Study|Withdrawal by Subject|4|||
105641701|NCT02978716|364351396|FG002|Overall Study|Withdrawal by Subject|5|||
105641702|NCT02978716|364351394|FG000|Overall Study|Sponsor terminated|2|||
105641703|NCT02978716|364351395|FG001|Overall Study|Sponsor terminated|13|||
105641704|NCT02978716|364351396|FG002|Overall Study|Sponsor terminated|9|||
105641705|NCT02978716|364351394|FG000|Overall Study|Other|1|||
105641706|NCT02978716|364351395|FG001|Overall Study|Other|3|||
105641707|NCT02978716|364351396|FG002|Overall Study|Other|0|||
105641708|NCT01766206|364351401|FG000|Overall Study|Withdrawal by Subject|22|||
105641709|NCT01766206|364351401|FG000|Overall Study|Lost to Follow-up|10|||
105641710|NCT01766206|364351401|FG000|Overall Study|Inappropriate enrollment|18|||
105641711|NCT01766206|364351401|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
105641712|NCT02993926|364351402|FG000|Enantone Treatment Phase|Adverse Event|1|||
105641713|NCT02993926|364351403|FG001|Enantone Treatment Phase|Adverse Event|0|||
105641714|NCT02993926|364351404|FG002|Enantone Treatment Phase|Adverse Event|0|||
105641715|NCT02993926|364351402|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
105641716|NCT02993926|364351403|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
105641717|NCT02993926|364351404|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
105641718|NCT02993926|364351402|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
105641719|NCT02993926|364351403|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
105641720|NCT02993926|364351404|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
105641721|NCT02993926|364351402|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
105641722|NCT02993926|364351403|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
105641723|NCT02993926|364351404|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
105641724|NCT01084772|364351405|FG000|Baseline|Withdrawal by Subject|7|||
105641725|NCT01084772|364351406|FG001|Baseline|Withdrawal by Subject|6|||
105641726|NCT01084772|364351405|FG000|3 Months|Death|1|||
105641727|NCT01084772|364351406|FG001|3 Months|Death|0|||
105641728|NCT01084772|364351405|FG000|3 Months|Study Termination|2|||
105641729|NCT01084772|364351406|FG001|3 Months|Study Termination|2|||
105641730|NCT01084772|364351405|FG000|1 Year|Withdrawal by Subject|0|||
105641731|NCT01084772|364351406|FG001|1 Year|Withdrawal by Subject|1|||
105641732|NCT01084772|364351405|FG000|1 Year|Lost to Follow-up|3|||
105641733|NCT01084772|364351406|FG001|1 Year|Lost to Follow-up|0|||
105641734|NCT01084772|364351405|FG000|1 Year|Study Termination|0|||
105641735|NCT01084772|364351406|FG001|1 Year|Study Termination|7|||
105641736|NCT01084772|364351405|FG000|2 Years|Withdrawal by Subject|1|||
105641737|NCT01084772|364351406|FG001|2 Years|Withdrawal by Subject|0|||
105641738|NCT01084772|364351405|FG000|2 Years|Lost to Follow-up|5|||
105641739|NCT01084772|364351406|FG001|2 Years|Lost to Follow-up|2|||
105641740|NCT01084772|364351405|FG000|2 Years|Study Termination|3|||
105641741|NCT01084772|364351406|FG001|2 Years|Study Termination|2|||
105641742|NCT00518206|364351408|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
105641743|NCT00518206|364351409|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
105641744|NCT00518206|364351408|FG000|Overall Study|Withdrawal by Subject|2|||
105641745|NCT00518206|364351409|FG001|Overall Study|Withdrawal by Subject|0|||
105641746|NCT00518206|364351408|FG000|Overall Study|Drug Supply Issue|1|||
105641747|NCT00518206|364351409|FG001|Overall Study|Drug Supply Issue|0|||
105641748|NCT00518206|364351408|FG000|Overall Study|Reason Unknown|1|||
105641749|NCT00518206|364351409|FG001|Overall Study|Reason Unknown|0|||
105641750|NCT00518206|364351408|FG000|Overall Study|Completion Status Unknown|1|||
105641751|NCT00518206|364351409|FG001|Overall Study|Completion Status Unknown|0|||
105641752|NCT01294644|364351410|FG000|Overall Study|Adverse Event|2|||
105641753|NCT01294644|364351411|FG001|Overall Study|Adverse Event|0|||
105641754|NCT01294644|364351412|FG002|Overall Study|Adverse Event|1|||
105641755|NCT01294644|364351410|FG000|Overall Study|Withdrawal by Subject|3|||
105641756|NCT01294644|364351411|FG001|Overall Study|Withdrawal by Subject|7|||
105641757|NCT01294644|364351412|FG002|Overall Study|Withdrawal by Subject|4|||
105641758|NCT01294644|364351410|FG000|Overall Study|Lost to Follow-up|3|||
105641759|NCT01294644|364351411|FG001|Overall Study|Lost to Follow-up|2|||
105641760|NCT01294644|364351412|FG002|Overall Study|Lost to Follow-up|5|||
105641761|NCT01294644|364351410|FG000|Overall Study|Miscellaneous Reason|2|||
105641762|NCT01294644|364351411|FG001|Overall Study|Miscellaneous Reason|1|||
105641763|NCT01294644|364351412|FG002|Overall Study|Miscellaneous Reason|4|||
105641764|NCT00413283|364352880|FG000|Overall Study|Withdrawal by Subject|1|||
105641765|NCT00413283|364352881|FG001|Overall Study|Withdrawal by Subject|0|||
105641766|NCT00413283|364352882|FG002|Overall Study|Withdrawal by Subject|0|||
105641767|NCT00413283|364352883|FG003|Overall Study|Withdrawal by Subject|1|||
105641768|NCT00413283|364352880|FG000|Overall Study|Death|0|||
105641769|NCT00413283|364352881|FG001|Overall Study|Death|0|||
105641770|NCT00413283|364352882|FG002|Overall Study|Death|1|||
105641771|NCT00413283|364352883|FG003|Overall Study|Death|1|||
105641772|NCT00413283|364352880|FG000|Overall Study|Adverse Event|0|||
105641773|NCT00413283|364352881|FG001|Overall Study|Adverse Event|0|||
105641774|NCT00413283|364352882|FG002|Overall Study|Adverse Event|0|||
105641775|NCT00413283|364352883|FG003|Overall Study|Adverse Event|1|||
105641776|NCT00413283|364352880|FG000|Overall Study|Ineligibility determined|0|||
105641777|NCT00413283|364352881|FG001|Overall Study|Ineligibility determined|0|||
105641778|NCT00413283|364352882|FG002|Overall Study|Ineligibility determined|0|||
105641779|NCT00413283|364352883|FG003|Overall Study|Ineligibility determined|1|||
105641780|NCT00413283|364352880|FG000|Overall Study|Protocol deviation|0|||
105641781|NCT00413283|364352881|FG001|Overall Study|Protocol deviation|1|||
105641782|NCT00413283|364352882|FG002|Overall Study|Protocol deviation|0|||
105641783|NCT00413283|364352883|FG003|Overall Study|Protocol deviation|0|||
105641784|NCT00413283|364352880|FG000|Overall Study|Requirement for alternative therapy|0|||
105641785|NCT00413283|364352881|FG001|Overall Study|Requirement for alternative therapy|2|||
105641786|NCT00413283|364352882|FG002|Overall Study|Requirement for alternative therapy|0|||
105641787|NCT00413283|364352883|FG003|Overall Study|Requirement for alternative therapy|0|||
105641788|NCT00413283|364352880|FG000|Overall Study|Other|0|||
105641789|NCT00413283|364352881|FG001|Overall Study|Other|0|||
105641790|NCT00413283|364352882|FG002|Overall Study|Other|1|||
105641791|NCT00413283|364352883|FG003|Overall Study|Other|0|||
105641792|NCT02002689|364352888|FG000|Overall Study|Disease Progression|7|||
105641793|NCT02002689|364352888|FG000|Overall Study|Adverse Event|3|||
105641794|NCT01377844|364352889|FG000|Overall Study|Withdrawal by Subject|25|||
105641795|NCT01377844|364352890|FG001|Overall Study|Withdrawal by Subject|28|||
105641796|NCT01377844|364352889|FG000|Overall Study|Protocol Violation|2|||
105641797|NCT01377844|364352890|FG001|Overall Study|Protocol Violation|3|||
105641798|NCT01377844|364352889|FG000|Overall Study|Adverse Event|3|||
105641799|NCT01377844|364352890|FG001|Overall Study|Adverse Event|0|||
105641800|NCT01377844|364352889|FG000|Overall Study|Physician Decision|6|||
105641801|NCT01377844|364352890|FG001|Overall Study|Physician Decision|3|||
105641802|NCT01377844|364352889|FG000|Overall Study|Study terminated by Sponsor|0|||
105641803|NCT01377844|364352890|FG001|Overall Study|Study terminated by Sponsor|1|||
105641804|NCT01185340|364352892|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
105641805|NCT01185340|364352893|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105641806|NCT01185340|364352894|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105641807|NCT01185340|364352895|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105641808|NCT01185340|364352892|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
105641809|NCT01185340|364352893|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105641810|NCT01185340|364352894|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105641811|NCT01185340|364352895|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105641812|NCT01185340|364352892|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
105641813|NCT01185340|364352893|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105641814|NCT01185340|364352894|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105641815|NCT01185340|364352895|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105641816|NCT01185340|364352892|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
105641817|NCT01185340|364352893|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105641818|NCT01185340|364352894|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105641819|NCT01185340|364352895|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105641820|NCT01185340|364352892|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
105641821|NCT01185340|364352893|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105641822|NCT01185340|364352894|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105641823|NCT01185340|364352895|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105641824|NCT01185340|364352892|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
105641825|NCT01185340|364352893|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105641826|NCT01185340|364352894|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105641827|NCT01185340|364352895|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105641828|NCT01185340|364352892|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
105641829|NCT01185340|364352893|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105641830|NCT01185340|364352894|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105641831|NCT01185340|364352895|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105641832|NCT01185340|364352892|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
105641833|NCT01185340|364352893|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
105641834|NCT01185340|364352894|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
105641835|NCT01185340|364352895|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
105641836|NCT01185340|364352892|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
105641837|NCT01185340|364352893|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
105641838|NCT01185340|364352894|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
105641839|NCT01185340|364352895|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
105641840|NCT01185340|364352892|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
105641841|NCT01185340|364352893|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
105641842|NCT01185340|364352894|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
105641843|NCT01185340|364352895|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
105641844|NCT01185340|364352892|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
105641845|NCT01185340|364352893|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
105641846|NCT01185340|364352894|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
105641847|NCT01185340|364352895|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
105641848|NCT01185340|364352892|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
105641849|NCT01185340|364352893|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
105641850|NCT01185340|364352894|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
105641851|NCT01185340|364352895|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
105641852|NCT01185340|364352892|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
105641853|NCT01185340|364352893|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
105641854|NCT01185340|364352894|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
105641855|NCT01185340|364352895|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
105641856|NCT01185340|364352892|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
105641857|NCT01185340|364352893|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
105641858|NCT01185340|364352894|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
105641859|NCT01185340|364352895|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
105641860|NCT00087516|364352896|FG000|Overall Study|Adverse Event|10|||
105641861|NCT00087516|364352897|FG001|Overall Study|Adverse Event|10|||
105641862|NCT00087516|364352898|FG002|Overall Study|Adverse Event|3|||
105641863|NCT00087516|364352899|FG003|Overall Study|Adverse Event|6|||
105641864|NCT00087516|364352896|FG000|Overall Study|Lack of Efficacy|82|||
105641865|NCT00087516|364352897|FG001|Overall Study|Lack of Efficacy|80|||
105641866|NCT00087516|364352898|FG002|Overall Study|Lack of Efficacy|39|||
105641867|NCT00087516|364352899|FG003|Overall Study|Lack of Efficacy|29|||
105641868|NCT00087516|364352896|FG000|Overall Study|Lost to Follow-up|8|||
105641869|NCT00087516|364352897|FG001|Overall Study|Lost to Follow-up|6|||
105641870|NCT00087516|364352898|FG002|Overall Study|Lost to Follow-up|5|||
105641871|NCT00087516|364352899|FG003|Overall Study|Lost to Follow-up|5|||
105641872|NCT00087516|364352896|FG000|Overall Study|Protocol Violation|4|||
105641873|NCT00087516|364352897|FG001|Overall Study|Protocol Violation|8|||
105641874|NCT00087516|364352898|FG002|Overall Study|Protocol Violation|3|||
105641875|NCT00087516|364352899|FG003|Overall Study|Protocol Violation|6|||
105641876|NCT00087516|364352896|FG000|Overall Study|Withdrawal by Subject|16|||
105641877|NCT00087516|364352897|FG001|Overall Study|Withdrawal by Subject|27|||
105641878|NCT00087516|364352898|FG002|Overall Study|Withdrawal by Subject|11|||
105641879|NCT00087516|364352899|FG003|Overall Study|Withdrawal by Subject|12|||
105641880|NCT00087516|364352896|FG000|Overall Study|Site terminated|0|||
105641881|NCT00087516|364352897|FG001|Overall Study|Site terminated|2|||
105641882|NCT00087516|364352898|FG002|Overall Study|Site terminated|1|||
105641883|NCT00087516|364352899|FG003|Overall Study|Site terminated|0|||
105641884|NCT00087516|364352896|FG000|Overall Study|Protocol specified discontinuation|35|||
105641885|NCT00087516|364352897|FG001|Overall Study|Protocol specified discontinuation|33|||
105641886|NCT00087516|364352898|FG002|Overall Study|Protocol specified discontinuation|33|||
105641887|NCT00087516|364352899|FG003|Overall Study|Protocol specified discontinuation|26|||
105641888|NCT00087516|364352896|FG000|Overall Study|Patient moved|3|||
105641889|NCT00087516|364352897|FG001|Overall Study|Patient moved|2|||
105641890|NCT00087516|364352898|FG002|Overall Study|Patient moved|1|||
105641891|NCT00087516|364352899|FG003|Overall Study|Patient moved|0|||
105641892|NCT00087516|364352896|FG000|Overall Study|Patient was non-compliant|3|||
105641893|NCT00087516|364352897|FG001|Overall Study|Patient was non-compliant|1|||
105641894|NCT00087516|364352898|FG002|Overall Study|Patient was non-compliant|0|||
105641895|NCT00087516|364352899|FG003|Overall Study|Patient was non-compliant|0|||
105641896|NCT00087516|364352896|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
105641897|NCT00087516|364352897|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
105641898|NCT00087516|364352898|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
105641899|NCT00087516|364352899|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
105641900|NCT00087516|364352896|FG000|Overall Study|Other|0|||
105641901|NCT00087516|364352897|FG001|Overall Study|Other|0|||
105641902|NCT00087516|364352898|FG002|Overall Study|Other|1|||
105641903|NCT00087516|364352899|FG003|Overall Study|Other|0|||
105641904|NCT01848483|364352900|FG000|Overall Study|Death|2|||
105641905|NCT01848483|364352901|FG001|Overall Study|Death|1|||
105641906|NCT01848483|364352900|FG000|Overall Study|Lost to Follow-up|6|||
105641907|NCT01848483|364352901|FG001|Overall Study|Lost to Follow-up|8|||
105641908|NCT01848483|364352900|FG000|Overall Study|Withdrawal by Subject|1|||
105641909|NCT01848483|364352901|FG001|Overall Study|Withdrawal by Subject|0|||
105641910|NCT01848483|364352900|FG000|Overall Study|Incarceration|2|||
105641911|NCT01848483|364352901|FG001|Overall Study|Incarceration|2|||
105641912|NCT01853384|364352902|FG000|Randomized|Adverse Event|5|||
105641913|NCT01853384|364352903|FG001|Randomized|Adverse Event|3|||
105641914|NCT01853384|364352902|FG000|Randomized|Death|1|||
105641915|NCT01853384|364352903|FG001|Randomized|Death|2|||
105641916|NCT01853384|364352902|FG000|Randomized|Lost to Follow-up|1|||
105641917|NCT01853384|364352903|FG001|Randomized|Lost to Follow-up|1|||
105641918|NCT01853384|364352902|FG000|Randomized|Withdrawal by Subject|5|||
105641919|NCT01853384|364352903|FG001|Randomized|Withdrawal by Subject|3|||
105641920|NCT01853384|364352902|FG000|Randomized|Sponsor Decision|47|||
105641921|NCT01853384|364352903|FG001|Randomized|Sponsor Decision|34|||
105641922|NCT01853384|364352902|FG000|Randomized|Other|3|||
105641923|NCT01853384|364352903|FG001|Randomized|Other|3|||
105641924|NCT01853384|364352902|FG000|Completed Follow up Visit 1|Early Termination|13|||
105641925|NCT01853384|364352903|FG001|Completed Follow up Visit 1|Early Termination|9|||
105641926|NCT01853384|364352902|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
105641927|NCT01853384|364352903|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
105641928|NCT01853384|364352902|FG000|Completed Follow up Visit 2|Adverse Event|1|||
105641929|NCT01853384|364352903|FG001|Completed Follow up Visit 2|Adverse Event|0|||
105641930|NCT01853384|364352902|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
105641931|NCT01853384|364352903|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
105641932|NCT01853384|364352902|FG000|Completed Follow up Visit 2|Death|1|||
105641933|NCT01853384|364352903|FG001|Completed Follow up Visit 2|Death|0|||
105641934|NCT01853384|364352902|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
105641935|NCT01853384|364352903|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
105641936|NCT00638456|364352904|FG000|Overall Study|Withdrawal by Subject|6|||
105641937|NCT00638456|364352905|FG001|Overall Study|Withdrawal by Subject|2|||
105641938|NCT03236779|364352906|FG000|Overall Study|Lost to Follow-up|13|||
105641939|NCT03236779|364352907|FG001|Overall Study|Lost to Follow-up|21|||
105641940|NCT00805792|364352910|FG000|Overall Study|Death|3|||
105641941|NCT00805792|364352910|FG000|Overall Study|Lost to Follow-up|2|||
105641942|NCT01416285|364352913|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
105641943|NCT01416285|364352914|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
105641944|NCT02165202|364352915|FG000|Oral Phase|Refused further participation|5|||
105641945|NCT02165202|364352916|FG001|Oral Phase|Refused further participation|1|||
105641946|NCT02165202|364352915|FG000|Oral Phase|Study product Related Toxicity|1|||
105641947|NCT02165202|364352916|FG001|Oral Phase|Study product Related Toxicity|0|||
105641948|NCT02165202|364352915|FG000|Oral Phase|Unable to contact Participant|1|||
105641949|NCT02165202|364352916|FG001|Oral Phase|Unable to contact Participant|1|||
105641950|NCT02165202|364352915|FG000|Oral Phase|Clinical reasons|1|||
105641951|NCT02165202|364352916|FG001|Oral Phase|Clinical reasons|0|||
105641952|NCT02165202|364352915|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
105641953|NCT02165202|364352916|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
105641954|NCT02165202|364352915|FG000|Oral Phase|CMC advised termination|1|||
105641955|NCT02165202|364352916|FG001|Oral Phase|CMC advised termination|0|||
105641956|NCT02165202|364352915|FG000|Oral Phase|Relocated, no follow-up planned|1|||
105641957|NCT02165202|364352916|FG001|Oral Phase|Relocated, no follow-up planned|0|||
105641958|NCT02165202|364352915|FG000|Oral Phase|Abnormal EKG|0|||
105641959|NCT02165202|364352916|FG001|Oral Phase|Abnormal EKG|1|||
105641960|NCT02165202|364352915|FG000|Injection Phase|Abnormal Lab Value|5|||
105641961|NCT02165202|364352916|FG001|Injection Phase|Abnormal Lab Value|1|||
105641962|NCT02165202|364352915|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
105641963|NCT02165202|364352916|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
105641964|NCT02165202|364352915|FG000|Injection Phase|Unable to attend within Visit Window|1|||
105641965|NCT02165202|364352916|FG001|Injection Phase|Unable to attend within Visit Window|0|||
105641966|NCT02165202|364352915|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
105641967|NCT02165202|364352916|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
105641968|NCT02165202|364352915|FG000|Injection Phase|End of Study|2|||
105641969|NCT02165202|364352916|FG001|Injection Phase|End of Study|1|||
105641970|NCT02165202|364352915|FG000|Injection Phase|Study Product related Toxicity|1|||
105641971|NCT02165202|364352916|FG001|Injection Phase|Study Product related Toxicity|0|||
105641972|NCT02165202|364352915|FG000|Injection Phase|No longer interested|0|||
105641973|NCT02165202|364352916|FG001|Injection Phase|No longer interested|1|||
105641974|NCT02165202|364352915|FG000|Injection Phase|Participant unwilling to comply|1|||
105641975|NCT02165202|364352916|FG001|Injection Phase|Participant unwilling to comply|0|||
105641976|NCT03052517|364352917|FG000|Overall Study|Study Terminated By Sponsor|928|||
105641977|NCT03052517|364352918|FG001|Overall Study|Study Terminated By Sponsor|938|||
105641978|NCT03052517|364352919|FG002|Overall Study|Study Terminated By Sponsor|296|||
105641979|NCT03052517|364352917|FG000|Overall Study|Subject/Guardian Decision|50|||
105641980|NCT03052517|364352918|FG001|Overall Study|Subject/Guardian Decision|45|||
105641981|NCT03052517|364352919|FG002|Overall Study|Subject/Guardian Decision|22|||
105641982|NCT03052517|364352917|FG000|Overall Study|Lack of Efficacy|23|||
105641983|NCT03052517|364352918|FG001|Overall Study|Lack of Efficacy|14|||
105641984|NCT03052517|364352919|FG002|Overall Study|Lack of Efficacy|7|||
105641985|NCT03052517|364352917|FG000|Overall Study|Adverse Event|6|||
105641986|NCT03052517|364352918|FG001|Overall Study|Adverse Event|5|||
105641987|NCT03052517|364352919|FG002|Overall Study|Adverse Event|0|||
105641988|NCT03052517|364352917|FG000|Overall Study|Physician Decision|4|||
105641989|NCT03052517|364352918|FG001|Overall Study|Physician Decision|5|||
105641990|NCT03052517|364352919|FG002|Overall Study|Physician Decision|1|||
105641991|NCT03052517|364352917|FG000|Overall Study|Death|3|||
105641992|NCT03052517|364352918|FG001|Overall Study|Death|0|||
105641993|NCT03052517|364352919|FG002|Overall Study|Death|1|||
105641994|NCT03052517|364352917|FG000|Overall Study|Lost to Follow-up|2|||
105641995|NCT03052517|364352918|FG001|Overall Study|Lost to Follow-up|4|||
105641996|NCT03052517|364352919|FG002|Overall Study|Lost to Follow-up|0|||
105641997|NCT03052517|364352917|FG000|Overall Study|Pregnancy|1|||
105641998|NCT03052517|364352918|FG001|Overall Study|Pregnancy|0|||
105641999|NCT03052517|364352919|FG002|Overall Study|Pregnancy|1|||
105642000|NCT03052517|364352917|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
105642001|NCT03052517|364352918|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
105642002|NCT03052517|364352919|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
105642003|NCT03052517|364352917|FG000|Overall Study|Technical Problems|0|||
105642004|NCT03052517|364352918|FG001|Overall Study|Technical Problems|1|||
105642005|NCT03052517|364352919|FG002|Overall Study|Technical Problems|0|||
105642006|NCT01640288|364352922|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
105642007|NCT01640288|364352923|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
105642008|NCT01640288|364352922|FG000|Overall Study|Screen Failure|20|||
105642009|NCT01640288|364352923|FG001|Overall Study|Screen Failure|18|||
105642010|NCT01640288|364352922|FG000|Overall Study|Withdrawn by PI|5|||
105642011|NCT01640288|364352923|FG001|Overall Study|Withdrawn by PI|0|||
105642012|NCT01640288|364352922|FG000|Overall Study|Withdrawal by Subject|1|||
105642013|NCT01640288|364352923|FG001|Overall Study|Withdrawal by Subject|0|||
105642014|NCT01005602|364352924|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
105642015|NCT01005602|364352925|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
105642016|NCT00749944|364352926|FG000|Overall Study|Lost to Follow-up|2|||
105642017|NCT00749944|364352927|FG001|Overall Study|Lost to Follow-up|1|||
105642018|NCT00749944|364352926|FG000|Overall Study|Other|1|||
105642019|NCT00749944|364352927|FG001|Overall Study|Other|0|||
105642020|NCT00749944|364352926|FG000|Overall Study|Withdrawal by Subject|2|||
105642021|NCT00749944|364352927|FG001|Overall Study|Withdrawal by Subject|0|||
105642022|NCT01393600|364352928|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
105642023|NCT01393600|364352929|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
105642024|NCT01393600|364352930|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
105642025|NCT01393600|364352931|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
105642026|NCT01393600|364352928|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
105642027|NCT01393600|364352929|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
105642028|NCT01393600|364352930|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
105642029|NCT01393600|364352931|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
105642030|NCT01393600|364352928|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
105642031|NCT01393600|364352929|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
105642032|NCT01393600|364352930|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
105642033|NCT01393600|364352931|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
105642034|NCT01393600|364352928|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
105642035|NCT01393600|364352929|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
105642036|NCT01393600|364352930|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
105642037|NCT01393600|364352931|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
105642038|NCT01393600|364352928|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
105642039|NCT01393600|364352929|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
105642040|NCT01393600|364352930|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
105642041|NCT01393600|364352931|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
105642042|NCT01393600|364352928|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
105642043|NCT01393600|364352929|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
105642044|NCT01393600|364352930|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
105642045|NCT01393600|364352931|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
105642046|NCT01393600|364352928|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
105642047|NCT01393600|364352929|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
105642048|NCT01393600|364352930|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
105642049|NCT01393600|364352931|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
105642050|NCT02291861|364352932|FG000|Overall Study|Adverse Event|2|||
105642051|NCT02291861|364352933|FG001|Overall Study|Adverse Event|4|||
105642052|NCT02291861|364352934|FG002|Overall Study|Adverse Event|1|||
105642053|NCT02291861|364352935|FG003|Overall Study|Adverse Event|2|||
105642054|NCT02291861|364352932|FG000|Overall Study|Death|0|||
105642055|NCT02291861|364352933|FG001|Overall Study|Death|0|||
105642056|NCT02291861|364352934|FG002|Overall Study|Death|1|||
105642057|NCT02291861|364352935|FG003|Overall Study|Death|1|||
105642058|NCT02291861|364352932|FG000|Overall Study|Protocol Violation|1|||
105642059|NCT02291861|364352933|FG001|Overall Study|Protocol Violation|0|||
105642060|NCT02291861|364352934|FG002|Overall Study|Protocol Violation|0|||
105642061|NCT02291861|364352935|FG003|Overall Study|Protocol Violation|1|||
105642062|NCT02291861|364352932|FG000|Overall Study|Withdrawal by Subject|1|||
105642063|NCT02291861|364352933|FG001|Overall Study|Withdrawal by Subject|2|||
105642064|NCT02291861|364352934|FG002|Overall Study|Withdrawal by Subject|1|||
105642065|NCT02291861|364352935|FG003|Overall Study|Withdrawal by Subject|4|||
105642066|NCT02291861|364352932|FG000|Overall Study|Noncompliance|1|||
105642067|NCT02291861|364352933|FG001|Overall Study|Noncompliance|1|||
105642068|NCT02291861|364352934|FG002|Overall Study|Noncompliance|2|||
105642069|NCT02291861|364352935|FG003|Overall Study|Noncompliance|1|||
105642070|NCT02291861|364352932|FG000|Overall Study|Lost to Follow-up|2|||
105642071|NCT02291861|364352933|FG001|Overall Study|Lost to Follow-up|1|||
105642072|NCT02291861|364352934|FG002|Overall Study|Lost to Follow-up|4|||
105642073|NCT02291861|364352935|FG003|Overall Study|Lost to Follow-up|0|||
105642074|NCT02291861|364352932|FG000|Overall Study|Other|0|||
105642075|NCT02291861|364352933|FG001|Overall Study|Other|0|||
105642076|NCT02291861|364352934|FG002|Overall Study|Other|0|||
105642077|NCT02291861|364352935|FG003|Overall Study|Other|1|||
105642078|NCT00930644|364352936|FG000|Overall Study|Withdrawal by Subject|4|||
105642079|NCT00930644|364352936|FG000|Overall Study|Physician Decision|2|||
105642080|NCT00930644|364352936|FG000|Overall Study|Death|1|||
105642081|NCT00930644|364352936|FG000|Overall Study|Adverse Event|16|||
105642082|NCT02988713|364352939|FG000|Overall Study|Withdrawal by Subject|1|||
105642083|NCT02988713|364352939|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
105642084|NCT02823574|364352940|FG000|Randomization|Disease Progression|0|||
105642085|NCT02823574|364352941|FG001|Randomization|Disease Progression|0|||
105642086|NCT02823574|364352942|FG002|Randomization|Disease Progression|1|||
105642087|NCT02823574|364352943|FG003|Randomization|Disease Progression|0|||
105642088|NCT02823574|364352940|FG000|Randomization|AE unrelated to Study Drug|1|||
105642089|NCT02823574|364352941|FG001|Randomization|AE unrelated to Study Drug|0|||
105642090|NCT02823574|364352942|FG002|Randomization|AE unrelated to Study Drug|0|||
105642091|NCT02823574|364352943|FG003|Randomization|AE unrelated to Study Drug|0|||
105642092|NCT02823574|364352940|FG000|Treatment Period|Poor/Non Compliance|1|||
105642093|NCT02823574|364352941|FG001|Treatment Period|Poor/Non Compliance|0|||
105642094|NCT02823574|364352942|FG002|Treatment Period|Poor/Non Compliance|0|||
105642095|NCT02823574|364352943|FG003|Treatment Period|Poor/Non Compliance|1|||
105642096|NCT02823574|364352940|FG000|Treatment Period|Maximum Clinical Benefit|8|||
105642097|NCT02823574|364352941|FG001|Treatment Period|Maximum Clinical Benefit|4|||
105642098|NCT02823574|364352942|FG002|Treatment Period|Maximum Clinical Benefit|7|||
105642099|NCT02823574|364352943|FG003|Treatment Period|Maximum Clinical Benefit|1|||
105642100|NCT02823574|364352940|FG000|Treatment Period|Lost to Follow-up|1|||
105642101|NCT02823574|364352941|FG001|Treatment Period|Lost to Follow-up|1|||
105642102|NCT02823574|364352942|FG002|Treatment Period|Lost to Follow-up|0|||
105642103|NCT02823574|364352943|FG003|Treatment Period|Lost to Follow-up|0|||
105642104|NCT02823574|364352940|FG000|Treatment Period|Participant withdrew consent|4|||
105642105|NCT02823574|364352941|FG001|Treatment Period|Participant withdrew consent|0|||
105642106|NCT02823574|364352942|FG002|Treatment Period|Participant withdrew consent|0|||
105642107|NCT02823574|364352943|FG003|Treatment Period|Participant withdrew consent|1|||
105642108|NCT02823574|364352940|FG000|Treatment Period|Participant request to discontinue|5|||
105642109|NCT02823574|364352941|FG001|Treatment Period|Participant request to discontinue|0|||
105642110|NCT02823574|364352942|FG002|Treatment Period|Participant request to discontinue|3|||
105642111|NCT02823574|364352943|FG003|Treatment Period|Participant request to discontinue|2|||
105642112|NCT02823574|364352940|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
105642113|NCT02823574|364352941|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
105642114|NCT02823574|364352942|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
105642115|NCT02823574|364352943|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
105642116|NCT02823574|364352940|FG000|Treatment Period|Study Drug Toxicity|11|||
105642117|NCT02823574|364352941|FG001|Treatment Period|Study Drug Toxicity|2|||
105642118|NCT02823574|364352942|FG002|Treatment Period|Study Drug Toxicity|14|||
105642119|NCT02823574|364352943|FG003|Treatment Period|Study Drug Toxicity|4|||
105642120|NCT02823574|364352940|FG000|Treatment Period|Disease Progression|113|||
105642121|NCT02823574|364352941|FG001|Treatment Period|Disease Progression|64|||
105642122|NCT02823574|364352942|FG002|Treatment Period|Disease Progression|82|||
105642123|NCT02823574|364352943|FG003|Treatment Period|Disease Progression|43|||
105642124|NCT02823574|364352940|FG000|Treatment Period|Other reasons|5|||
105642125|NCT02823574|364352941|FG001|Treatment Period|Other reasons|9|||
105642126|NCT02823574|364352942|FG002|Treatment Period|Other reasons|3|||
105642127|NCT02823574|364352943|FG003|Treatment Period|Other reasons|6|||
105642128|NCT02823574|364352940|FG000|Treatment Period|Participant no longer meets study criteria|0|||
105642129|NCT02823574|364352941|FG001|Treatment Period|Participant no longer meets study criteria|0|||
105642130|NCT02823574|364352942|FG002|Treatment Period|Participant no longer meets study criteria|1|||
105642131|NCT02823574|364352943|FG003|Treatment Period|Participant no longer meets study criteria|0|||
105642132|NCT02823574|364352940|FG000|Treatment Period|Death|0|||
105642133|NCT02823574|364352941|FG001|Treatment Period|Death|0|||
105642134|NCT02823574|364352942|FG002|Treatment Period|Death|3|||
105642135|NCT02823574|364352943|FG003|Treatment Period|Death|1|||
105642136|NCT03909100|364352946|FG000|Overall Study|Protocol Deviation|2|||
105642137|NCT03909100|364352946|FG000|Overall Study|Technical Problems|4|||
105642138|NCT03909100|364352946|FG000|Overall Study|Withdrawal by Subject|4|||
105642139|NCT03909100|364352946|FG000|Overall Study|Lost to Follow-up|1|||
105642140|NCT03909100|364352946|FG000|Overall Study|Reason not Specified|4|||
105642141|NCT02671266|364352947|FG000|Overall Study|Withdrawal by Subject|1|||
105642142|NCT02671266|364352948|FG001|Overall Study|Withdrawal by Subject|1|||
105642143|NCT00666705|364352951|FG000|Overall Study|Withdrawal by Subject|1|||
105642144|NCT00687297|364352952|FG000|Randomization|Withdrawal by Subject|2|||
105642145|NCT00687297|364352953|FG001|Randomization|Withdrawal by Subject|0|||
105642146|NCT00687297|364352952|FG000|Randomization|Withdrew before treatment, ineligible|1|||
105642147|NCT00687297|364352953|FG001|Randomization|Withdrew before treatment, ineligible|1|||
105642148|NCT00687297|364352952|FG000|Induction|Withdrawal by Subject|4|||
105642149|NCT00687297|364352953|FG001|Induction|Withdrawal by Subject|4|||
105642150|NCT00687297|364352952|FG000|Induction|Adverse Event|16|||
105642151|NCT00687297|364352953|FG001|Induction|Adverse Event|15|||
105642152|NCT00687297|364352952|FG000|Induction|Death|7|||
105642153|NCT00687297|364352953|FG001|Induction|Death|11|||
105642154|NCT00687297|364352952|FG000|Induction|Lack of Efficacy|17|||
105642155|NCT00687297|364352953|FG001|Induction|Lack of Efficacy|21|||
105642156|NCT00687297|364352952|FG000|Induction|Ineligible|0|||
105642157|NCT00687297|364352953|FG001|Induction|Ineligible|1|||
105642158|NCT00687297|364352952|FG000|Induction|Patient Noncompliance|1|||
105642159|NCT00687297|364352953|FG001|Induction|Patient Noncompliance|0|||
105642160|NCT00687297|364352952|FG000|Induction|Physician Decision|0|||
105642161|NCT00687297|364352953|FG001|Induction|Physician Decision|2|||
105642162|NCT00687297|364352952|FG000|Induction|Other|0|||
105642163|NCT00687297|364352953|FG001|Induction|Other|1|||
105642164|NCT03128099|364352954|FG000|Overall Study|High dose task was too long|0|||
105642165|NCT03128099|364352955|FG001|Overall Study|High dose task was too long|4|||
105642166|NCT03128099|364352956|FG002|Overall Study|High dose task was too long|0|||
105642167|NCT03128099|364352954|FG000|Overall Study|Participant got a full time job.|1|||
105642168|NCT03128099|364352955|FG001|Overall Study|Participant got a full time job.|0|||
105642169|NCT03128099|364352956|FG002|Overall Study|Participant got a full time job.|0|||
105642170|NCT03128099|364352954|FG000|Overall Study|Became homeless and lost contact|1|||
105642171|NCT03128099|364352955|FG001|Overall Study|Became homeless and lost contact|0|||
105642172|NCT03128099|364352956|FG002|Overall Study|Became homeless and lost contact|0|||
105642173|NCT03128099|364352954|FG000|Overall Study|Did not complete all the assessments|0|||
105642174|NCT03128099|364352955|FG001|Overall Study|Did not complete all the assessments|0|||
105642175|NCT03128099|364352956|FG002|Overall Study|Did not complete all the assessments|1|||
105642176|NCT00089791|364352957|FG000|Overall Study|Physician Decision|6|||
105642177|NCT00089791|364352958|FG001|Overall Study|Physician Decision|3|||
105642178|NCT00089791|364352957|FG000|Overall Study|Adverse Event|81|||
105642179|NCT00089791|364352958|FG001|Overall Study|Adverse Event|93|||
105642180|NCT00089791|364352957|FG000|Overall Study|Withdrawal by Subject|403|||
105642181|NCT00089791|364352958|FG001|Overall Study|Withdrawal by Subject|344|||
105642182|NCT00089791|364352957|FG000|Overall Study|Death|78|||
105642183|NCT00089791|364352958|FG001|Overall Study|Death|62|||
105642184|NCT00089791|364352957|FG000|Overall Study|Disease progression|7|||
105642185|NCT00089791|364352958|FG001|Overall Study|Disease progression|3|||
105642186|NCT00089791|364352957|FG000|Overall Study|Ineligibility determined|12|||
105642187|NCT00089791|364352958|FG001|Overall Study|Ineligibility determined|9|||
105642188|NCT00089791|364352957|FG000|Overall Study|Lost to Follow-up|57|||
105642189|NCT00089791|364352958|FG001|Overall Study|Lost to Follow-up|57|||
105642190|NCT00089791|364352957|FG000|Overall Study|Noncompliance|17|||
105642191|NCT00089791|364352958|FG001|Overall Study|Noncompliance|13|||
105642192|NCT00089791|364352957|FG000|Overall Study|Other|20|||
105642193|NCT00089791|364352958|FG001|Overall Study|Other|32|||
105642194|NCT00089791|364352957|FG000|Overall Study|Protocol deviation|12|||
105642195|NCT00089791|364352958|FG001|Overall Study|Protocol deviation|10|||
105642196|NCT00089791|364352957|FG000|Overall Study|Requirement for alternative therapy|7|||
105642197|NCT00089791|364352958|FG001|Overall Study|Requirement for alternative therapy|4|||
105642198|NCT03695185|364352959|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
105642199|NCT03695185|364352959|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
105642200|NCT03695185|364352959|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
105642201|NCT03695185|364352959|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
105642202|NCT03695185|364352959|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
105642203|NCT03695185|364352959|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
105642204|NCT01405508|364352971|FG000|Overall Study|AE, non-serious non-fatal|1|||
105642205|NCT01405508|364352972|FG001|Overall Study|AE, non-serious non-fatal|1|||
105642206|NCT01405508|364352973|FG002|Overall Study|AE, non-serious non-fatal|0|||
105642207|NCT01405508|364352974|FG003|Overall Study|AE, non-serious non-fatal|0|||
105642208|NCT00476957|364352975|FG000|Overall Study|Lost to Follow-up|176|||
105642209|NCT00476957|364352976|FG001|Overall Study|Lost to Follow-up|193|||
105642210|NCT01000649|364352977|FG000|Overall Study|Adverse Event|5|||
105642211|NCT01000649|364352978|FG001|Overall Study|Adverse Event|1|||
105642212|NCT01000649|364352979|FG002|Overall Study|Adverse Event|2|||
105642213|NCT01000649|364352980|FG003|Overall Study|Adverse Event|4|||
105642214|NCT01000649|364352977|FG000|Overall Study|Lost to Follow-up|0|||
105642215|NCT01000649|364352978|FG001|Overall Study|Lost to Follow-up|2|||
105642216|NCT01000649|364352979|FG002|Overall Study|Lost to Follow-up|0|||
105642217|NCT01000649|364352980|FG003|Overall Study|Lost to Follow-up|2|||
105642218|NCT00346398|364352981|FG000|Overall Study|Lost to Follow-up|3|||
105642219|NCT00346398|364352982|FG001|Overall Study|Lost to Follow-up|0|||
105642220|NCT00346398|364352981|FG000|Overall Study|Withdrawal by Subject|0|||
105642221|NCT00346398|364352982|FG001|Overall Study|Withdrawal by Subject|2|||
105642222|NCT03652610|364352983|FG000|Overall Study|Lost to Follow-up|1|||
105642223|NCT03652610|364352984|FG001|Overall Study|Lost to Follow-up|0|||
105642224|NCT03652610|364352983|FG000|Overall Study|Withdrawal by Subject|3|||
105642225|NCT03652610|364352984|FG001|Overall Study|Withdrawal by Subject|5|||
105642226|NCT02707952|364352985|FG000|Overall Study|Adverse Event|1|||
105642227|NCT02707952|364352986|FG001|Overall Study|Adverse Event|0|||
105642228|NCT02707952|364352987|FG002|Overall Study|Adverse Event|0|||
105642229|NCT02707952|364352988|FG003|Overall Study|Adverse Event|0|||
105642230|NCT02707952|364352985|FG000|Overall Study|Lost to Follow-up|1|||
105642231|NCT02707952|364352986|FG001|Overall Study|Lost to Follow-up|0|||
105642232|NCT02707952|364352987|FG002|Overall Study|Lost to Follow-up|0|||
105642233|NCT02707952|364352988|FG003|Overall Study|Lost to Follow-up|0|||
105642234|NCT02707952|364352985|FG000|Overall Study|Withdrawal by Subject|0|||
105642235|NCT02707952|364352986|FG001|Overall Study|Withdrawal by Subject|1|||
105642236|NCT02707952|364352987|FG002|Overall Study|Withdrawal by Subject|2|||
105642237|NCT02707952|364352988|FG003|Overall Study|Withdrawal by Subject|0|||
105642238|NCT04108858|364352989|FG000|Overall Study|Adverse Event|1|||
105642239|NCT01240785|364352990|FG000|Overall Study|Lost to Follow-up|1|||
105642240|NCT01240785|364352991|FG001|Overall Study|Lost to Follow-up|0|||
105642241|NCT01240785|364352990|FG000|Overall Study|Protocol Violation|0|||
105642242|NCT01240785|364352991|FG001|Overall Study|Protocol Violation|3|||
105642243|NCT00237809|364352992|FG000|Overall Study|Lost to Follow-up|11|||
105642244|NCT00237809|364352993|FG001|Overall Study|Lost to Follow-up|10|||
105642245|NCT00237809|364352994|FG002|Overall Study|Lost to Follow-up|9|||
105642246|NCT00237809|364352995|FG003|Overall Study|Lost to Follow-up|9|||
105642247|NCT00696241|364352999|FG000|Overall Study|Adverse Event|11|||
105642248|NCT00696241|364353000|FG001|Overall Study|Adverse Event|3|||
105642249|NCT00696241|364353001|FG002|Overall Study|Adverse Event|6|||
105642250|NCT00696241|364353002|FG003|Overall Study|Adverse Event|4|||
105642251|NCT00696241|364353003|FG004|Overall Study|Adverse Event|5|||
105642252|NCT00696241|364352999|FG000|Overall Study|Protocol Violation|1|||
105642253|NCT00696241|364353000|FG001|Overall Study|Protocol Violation|1|||
105642254|NCT00696241|364353001|FG002|Overall Study|Protocol Violation|2|||
105642255|NCT00696241|364353002|FG003|Overall Study|Protocol Violation|0|||
105642256|NCT00696241|364353003|FG004|Overall Study|Protocol Violation|3|||
105642257|NCT00696241|364352999|FG000|Overall Study|Lost to Follow-up|1|||
105642258|NCT00696241|364353000|FG001|Overall Study|Lost to Follow-up|4|||
105642259|NCT00696241|364353001|FG002|Overall Study|Lost to Follow-up|1|||
105642260|NCT00696241|364353002|FG003|Overall Study|Lost to Follow-up|2|||
105642261|NCT00696241|364353003|FG004|Overall Study|Lost to Follow-up|0|||
105642262|NCT00696241|364352999|FG000|Overall Study|Withdrawal by Subject|4|||
105642263|NCT00696241|364353000|FG001|Overall Study|Withdrawal by Subject|8|||
105642264|NCT00696241|364353001|FG002|Overall Study|Withdrawal by Subject|6|||
105642265|NCT00696241|364353002|FG003|Overall Study|Withdrawal by Subject|1|||
105642266|NCT00696241|364353003|FG004|Overall Study|Withdrawal by Subject|0|||
105642267|NCT00696241|364352999|FG000|Overall Study|Lack of Efficacy|1|||
105642268|NCT00696241|364353000|FG001|Overall Study|Lack of Efficacy|5|||
105642269|NCT00696241|364353001|FG002|Overall Study|Lack of Efficacy|4|||
105642270|NCT00696241|364353002|FG003|Overall Study|Lack of Efficacy|5|||
105642271|NCT00696241|364353003|FG004|Overall Study|Lack of Efficacy|3|||
105642272|NCT00696241|364352999|FG000|Overall Study|Other|6|||
105642273|NCT00696241|364353000|FG001|Overall Study|Other|1|||
105642274|NCT00696241|364353001|FG002|Overall Study|Other|5|||
105642275|NCT00696241|364353002|FG003|Overall Study|Other|2|||
105642276|NCT00696241|364353003|FG004|Overall Study|Other|1|||
105642277|NCT02203513|364353004|FG000|Overall Study|Refused further treatment|2|||
105642278|NCT02203513|364353005|FG001|Overall Study|Refused further treatment|0|||
105642279|NCT02203513|364353006|FG002|Overall Study|Refused further treatment|1|||
105642280|NCT02203513|364353007|FG003|Overall Study|Refused further treatment|0|||
105642281|NCT02203513|364353008|FG004|Overall Study|Refused further treatment|0|||
105642282|NCT02203513|364353004|FG000|Overall Study|Switched to alternative treatment|3|||
105642283|NCT02203513|364353005|FG001|Overall Study|Switched to alternative treatment|4|||
105642284|NCT02203513|364353006|FG002|Overall Study|Switched to alternative treatment|0|||
105642285|NCT02203513|364353007|FG003|Overall Study|Switched to alternative treatment|0|||
105642286|NCT02203513|364353008|FG004|Overall Study|Switched to alternative treatment|4|||
105642287|NCT02203513|364353004|FG000|Overall Study|Did not receive investigational product (IP)|0|||
105642288|NCT02203513|364353005|FG001|Overall Study|Did not receive investigational product (IP)|1|||
105642289|NCT02203513|364353006|FG002|Overall Study|Did not receive investigational product (IP)|0|||
105642290|NCT02203513|364353007|FG003|Overall Study|Did not receive investigational product (IP)|0|||
105642291|NCT02203513|364353008|FG004|Overall Study|Did not receive investigational product (IP)|0|||
105642292|NCT02203513|364353004|FG000|Overall Study|Death (unrelated to study therapy)|1|||
105642293|NCT02203513|364353005|FG001|Overall Study|Death (unrelated to study therapy)|3|||
105642294|NCT02203513|364353006|FG002|Overall Study|Death (unrelated to study therapy)|1|||
105642295|NCT02203513|364353007|FG003|Overall Study|Death (unrelated to study therapy)|0|||
105642296|NCT02203513|364353008|FG004|Overall Study|Death (unrelated to study therapy)|2|||
105642297|NCT02203513|364353004|FG000|Overall Study|Lost to Follow-up|0|||
105642298|NCT02203513|364353005|FG001|Overall Study|Lost to Follow-up|0|||
105642299|NCT02203513|364353006|FG002|Overall Study|Lost to Follow-up|1|||
105642300|NCT02203513|364353007|FG003|Overall Study|Lost to Follow-up|1|||
105642301|NCT02203513|364353008|FG004|Overall Study|Lost to Follow-up|0|||
105642302|NCT00871715|364353009|FG000|Overall Study|Withdrawal by Subject|6|||
105642303|NCT00871715|364353010|FG001|Overall Study|Withdrawal by Subject|10|||
105642304|NCT00871715|364353011|FG002|Overall Study|Withdrawal by Subject|15|||
105642305|NCT00871715|364353009|FG000|Overall Study|Physician Decision|6|||
105642306|NCT00871715|364353010|FG001|Overall Study|Physician Decision|0|||
105642307|NCT00871715|364353011|FG002|Overall Study|Physician Decision|2|||
105642308|NCT00871715|364353009|FG000|Overall Study|Lost to Follow-up|3|||
105642309|NCT00871715|364353010|FG001|Overall Study|Lost to Follow-up|6|||
105642310|NCT00871715|364353011|FG002|Overall Study|Lost to Follow-up|9|||
105642311|NCT01681511|364353014|FG000|Overall Study|No Treatment Received|1|||
105642312|NCT01681511|364353015|FG001|Overall Study|No Treatment Received|3|||
105642313|NCT01681511|364353014|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
105642314|NCT01681511|364353015|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
105642315|NCT01681511|364353014|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
105642316|NCT01681511|364353015|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
105642317|NCT01681511|364353014|FG000|Overall Study|No Daily Urine Sample Collected|0|||
105642318|NCT01681511|364353015|FG001|Overall Study|No Daily Urine Sample Collected|1|||
105642319|NCT01681511|364353014|FG000|Overall Study|No post-catheter sample collected|11|||
105642320|NCT01681511|364353015|FG001|Overall Study|No post-catheter sample collected|4|||
105642321|NCT04447287|364353016|FG000|Period 1: Run-in Period|Adverse Event|3|||
105642322|NCT04447287|364353017|FG001|Period 1: Run-in Period|Adverse Event|0|||
105642323|NCT04447287|364353018|FG002|Period 1: Run-in Period|Adverse Event|0|||
105642324|NCT04447287|364353016|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
105642325|NCT04447287|364353017|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
105642326|NCT04447287|364353018|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
105642327|NCT04447287|364353016|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
105642328|NCT04447287|364353017|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
105642329|NCT04447287|364353018|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
105642330|NCT03075878|364353019|FG000|Overall Study|Physician Decision|1|||
105642331|NCT02188459|364353020|FG000|Overall Study|Lost to Follow-up|3|||
105642332|NCT02188459|364353021|FG001|Overall Study|Lost to Follow-up|4|||
105642333|NCT02188459|364353020|FG000|Overall Study|Early Termination|0|||
105642334|NCT02188459|364353021|FG001|Overall Study|Early Termination|3|||
105642335|NCT00824850|364353024|FG000|Overall Study|Withdrawal by Subject|0|||
105642336|NCT00824850|364353025|FG001|Overall Study|Withdrawal by Subject|1|||
105642337|NCT02367794|364353026|FG000|Overall Study|Death|252|||
105642338|NCT02367794|364353027|FG001|Overall Study|Death|245|||
105642339|NCT02367794|364353028|FG002|Overall Study|Death|243|||
105642340|NCT02367794|364353026|FG000|Overall Study|Lost to Follow-up|1|||
105642341|NCT02367794|364353027|FG001|Overall Study|Lost to Follow-up|2|||
105642342|NCT02367794|364353028|FG002|Overall Study|Lost to Follow-up|2|||
105642343|NCT02367794|364353026|FG000|Overall Study|Physician Decision|0|||
105642344|NCT02367794|364353027|FG001|Overall Study|Physician Decision|5|||
105642345|NCT02367794|364353028|FG002|Overall Study|Physician Decision|3|||
105642346|NCT02367794|364353026|FG000|Overall Study|Protocol Violation|1|||
105642347|NCT02367794|364353027|FG001|Overall Study|Protocol Violation|0|||
105642348|NCT02367794|364353028|FG002|Overall Study|Protocol Violation|1|||
105642349|NCT02367794|364353026|FG000|Overall Study|Withdrawal by Subject|25|||
105642350|NCT02367794|364353027|FG001|Overall Study|Withdrawal by Subject|12|||
105642351|NCT02367794|364353028|FG002|Overall Study|Withdrawal by Subject|20|||
105642352|NCT02367794|364353026|FG000|Overall Study|Brain metastasis|1|||
105642353|NCT02367794|364353027|FG001|Overall Study|Brain metastasis|0|||
105642354|NCT02367794|364353028|FG002|Overall Study|Brain metastasis|0|||
105642355|NCT02367794|364353026|FG000|Overall Study|Randomized in error|0|||
105642356|NCT02367794|364353027|FG001|Overall Study|Randomized in error|0|||
105642357|NCT02367794|364353028|FG002|Overall Study|Randomized in error|1|||
105642358|NCT02367794|364353026|FG000|Overall Study|Patient unable to receive carboplatin|0|||
105642359|NCT02367794|364353027|FG001|Overall Study|Patient unable to receive carboplatin|0|||
105642360|NCT02367794|364353028|FG002|Overall Study|Patient unable to receive carboplatin|1|||
105642361|NCT02367794|364353026|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
105642362|NCT02367794|364353027|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
105642363|NCT02367794|364353028|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
105642364|NCT02367794|364353026|FG000|Overall Study|Adverse Event|0|||
105642365|NCT02367794|364353027|FG001|Overall Study|Adverse Event|0|||
105642366|NCT02367794|364353028|FG002|Overall Study|Adverse Event|2|||
105642367|NCT02367794|364353026|FG000|Overall Study|Study Terminated By Sponsor|0|||
105642368|NCT02367794|364353027|FG001|Overall Study|Study Terminated By Sponsor|1|||
105642369|NCT02367794|364353028|FG002|Overall Study|Study Terminated By Sponsor|1|||
105642370|NCT02367794|364353026|FG000|Overall Study|Moved to Roll-Over Study|0|||
105642371|NCT02367794|364353027|FG001|Overall Study|Moved to Roll-Over Study|15|||
105642372|NCT02367794|364353028|FG002|Overall Study|Moved to Roll-Over Study|13|||
105642373|NCT02367794|364353026|FG000|Overall Study|Sponsor Request|60|||
105642374|NCT02367794|364353027|FG001|Overall Study|Sponsor Request|57|||
105642375|NCT02367794|364353028|FG002|Overall Study|Sponsor Request|45|||
105642376|NCT02367794|364353026|FG000|Overall Study|Moved into PTAP Study|0|||
105642377|NCT02367794|364353027|FG001|Overall Study|Moved into PTAP Study|2|||
105642378|NCT02367794|364353028|FG002|Overall Study|Moved into PTAP Study|3|||
105642379|NCT02367794|364353026|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
105642380|NCT02367794|364353027|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
105642381|NCT02367794|364353028|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
105642382|NCT02367794|364353026|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
105642383|NCT02367794|364353027|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
105642384|NCT02367794|364353028|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
105642385|NCT02367794|364353026|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
105642386|NCT02367794|364353027|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
105642387|NCT02367794|364353028|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
105642388|NCT02367794|364353026|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
105642389|NCT02367794|364353027|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
105642390|NCT02367794|364353028|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
105642391|NCT02935894|364353034|FG000|Overall Study|Subject dismissed|1|||
105642392|NCT02158806|364353035|FG000|Overall Study|Death|2|||
105642393|NCT02158806|364353036|FG001|Overall Study|Death|0|||
105642394|NCT02158806|364353035|FG000|Overall Study|Withdrawal by Subject|2|||
105642395|NCT02158806|364353036|FG001|Overall Study|Withdrawal by Subject|0|||
105642396|NCT02158806|364353035|FG000|Overall Study|Lost to Follow-up|0|||
105642397|NCT02158806|364353036|FG001|Overall Study|Lost to Follow-up|3|||
105642398|NCT02158806|364353035|FG000|Overall Study|Moved out of area|0|||
105642399|NCT02158806|364353036|FG001|Overall Study|Moved out of area|1|||
105642400|NCT02158806|364353035|FG000|Overall Study|Transferred to palliative care|0|||
105642401|NCT02158806|364353036|FG001|Overall Study|Transferred to palliative care|1|||
105642402|NCT00451906|364354939|FG000|Overall Study|Adverse Event|515|||
105642403|NCT00451906|364354939|FG000|Overall Study|Lost to Follow-up|31|||
105642404|NCT00451906|364354939|FG000|Overall Study|Withdrawal by Subject|111|||
105642405|NCT00451906|364354939|FG000|Overall Study|Protocol Violation|21|||
105642406|NCT00451906|364354939|FG000|Overall Study|Progressive disease|1328|||
105642407|NCT00451906|364354939|FG000|Overall Study|Termination of the study|108|||
105642408|NCT00451906|364354939|FG000|Overall Study|Other Reasons|121|||
105642409|NCT00451906|364354939|FG000|Overall Study|Did not complete final visit|4|||
105642410|NCT00484198|364354944|FG000|Overall Study|Participant Withdrew Consent|12|||
105642411|NCT00484198|364354945|FG001|Overall Study|Participant Withdrew Consent|21|||
105642412|NCT00484198|364354946|FG002|Overall Study|Participant Withdrew Consent|47|||
105642413|NCT00484198|364354947|FG003|Overall Study|Participant Withdrew Consent|59|||
105642414|NCT00484198|364354944|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
105642415|NCT00484198|364354945|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
105642416|NCT00484198|364354946|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
105642417|NCT00484198|364354947|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
105642418|NCT00484198|364354944|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
105642419|NCT00484198|364354945|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
105642420|NCT00484198|364354946|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
105642421|NCT00484198|364354947|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
105642422|NCT00484198|364354944|FG000|Overall Study|Adverse Event|3|||
105642423|NCT00484198|364354945|FG001|Overall Study|Adverse Event|11|||
105642424|NCT00484198|364354946|FG002|Overall Study|Adverse Event|32|||
105642425|NCT00484198|364354947|FG003|Overall Study|Adverse Event|31|||
105642426|NCT00484198|364354944|FG000|Overall Study|Protocol Violation|0|||
105642427|NCT00484198|364354945|FG001|Overall Study|Protocol Violation|5|||
105642428|NCT00484198|364354946|FG002|Overall Study|Protocol Violation|6|||
105642429|NCT00484198|364354947|FG003|Overall Study|Protocol Violation|8|||
105642430|NCT00484198|364354944|FG000|Overall Study|Other|7|||
105642431|NCT00484198|364354945|FG001|Overall Study|Other|10|||
105642432|NCT00484198|364354946|FG002|Overall Study|Other|31|||
105642433|NCT00484198|364354947|FG003|Overall Study|Other|28|||
105642434|NCT01686152|364354948|FG000|Overall Study|Withdrawal by Subject|11|||
105642435|NCT01686152|364354949|FG001|Overall Study|Withdrawal by Subject|11|||
105642436|NCT01686152|364354950|FG002|Overall Study|Withdrawal by Subject|3|||
105642437|NCT01686152|364354948|FG000|Overall Study|Drug Code Unblinded|0|||
105642438|NCT01686152|364354949|FG001|Overall Study|Drug Code Unblinded|1|||
105642439|NCT01686152|364354950|FG002|Overall Study|Drug Code Unblinded|0|||
105642440|NCT01686152|364354948|FG000|Overall Study|Protocol Violation|6|||
105642441|NCT01686152|364354949|FG001|Overall Study|Protocol Violation|1|||
105642442|NCT01686152|364354950|FG002|Overall Study|Protocol Violation|0|||
105642443|NCT01686152|364354948|FG000|Overall Study|Adverse Event|12|||
105642444|NCT01686152|364354949|FG001|Overall Study|Adverse Event|11|||
105642445|NCT01686152|364354950|FG002|Overall Study|Adverse Event|0|||
105642446|NCT01686152|364354948|FG000|Overall Study|Lack of Efficacy|0|||
105642447|NCT01686152|364354949|FG001|Overall Study|Lack of Efficacy|0|||
105642448|NCT01686152|364354950|FG002|Overall Study|Lack of Efficacy|1|||
105642449|NCT01686152|364354948|FG000|Overall Study|IP Non-compliance|5|||
105642450|NCT01686152|364354949|FG001|Overall Study|IP Non-compliance|5|||
105642451|NCT01686152|364354950|FG002|Overall Study|IP Non-compliance|0|||
105642452|NCT01686152|364354948|FG000|Overall Study|Lost to Follow-up|7|||
105642453|NCT01686152|364354949|FG001|Overall Study|Lost to Follow-up|6|||
105642454|NCT01686152|364354950|FG002|Overall Study|Lost to Follow-up|5|||
105642455|NCT02935673|364354954|FG000|Overall Study|Adverse Event|0|||
105642456|NCT02935673|364354955|FG001|Overall Study|Adverse Event|1|||
105642457|NCT02935673|364354956|FG002|Overall Study|Adverse Event|0|||
105642458|NCT02935673|364354954|FG000|Overall Study|Withdrawal by Subject|1|||
105642459|NCT02935673|364354955|FG001|Overall Study|Withdrawal by Subject|2|||
105642460|NCT02935673|364354956|FG002|Overall Study|Withdrawal by Subject|0|||
105642461|NCT00813709|364354959|FG000|Double Blind Period|Adverse Event|4|||
105642462|NCT00813709|364354960|FG001|Double Blind Period|Adverse Event|1|||
105642463|NCT00813709|364354961|FG002|Double Blind Period|Adverse Event|4|||
105642464|NCT00813709|364354962|FG003|Double Blind Period|Adverse Event|0|||
105642465|NCT00813709|364354963|FG004|Double Blind Period|Adverse Event|0|||
105642466|NCT00813709|364354964|FG005|Double Blind Period|Adverse Event|0|||
105642467|NCT00813709|364354959|FG000|Double Blind Period|Lost to Follow-up|3|||
105642468|NCT00813709|364354960|FG001|Double Blind Period|Lost to Follow-up|2|||
105642469|NCT00813709|364354961|FG002|Double Blind Period|Lost to Follow-up|2|||
105642470|NCT00813709|364354962|FG003|Double Blind Period|Lost to Follow-up|0|||
105642471|NCT00813709|364354963|FG004|Double Blind Period|Lost to Follow-up|0|||
105642472|NCT00813709|364354964|FG005|Double Blind Period|Lost to Follow-up|0|||
105642473|NCT00813709|364354959|FG000|Double Blind Period|Switched to open label phase|9|||
105642474|NCT00813709|364354960|FG001|Double Blind Period|Switched to open label phase|26|||
105642475|NCT00813709|364354961|FG002|Double Blind Period|Switched to open label phase|18|||
105642476|NCT00813709|364354962|FG003|Double Blind Period|Switched to open label phase|0|||
105642477|NCT00813709|364354963|FG004|Double Blind Period|Switched to open label phase|0|||
105642478|NCT00813709|364354964|FG005|Double Blind Period|Switched to open label phase|0|||
105642479|NCT00813709|364354959|FG000|Double Blind Period|Randomized but not treated|1|||
105642480|NCT00813709|364354960|FG001|Double Blind Period|Randomized but not treated|3|||
105642481|NCT00813709|364354961|FG002|Double Blind Period|Randomized but not treated|1|||
105642482|NCT00813709|364354962|FG003|Double Blind Period|Randomized but not treated|0|||
105642483|NCT00813709|364354963|FG004|Double Blind Period|Randomized but not treated|0|||
105642484|NCT00813709|364354964|FG005|Double Blind Period|Randomized but not treated|0|||
105642485|NCT00813709|364354959|FG000|Double Blind Period|Other|14|||
105642486|NCT00813709|364354960|FG001|Double Blind Period|Other|9|||
105642487|NCT00813709|364354961|FG002|Double Blind Period|Other|6|||
105642488|NCT00813709|364354962|FG003|Double Blind Period|Other|0|||
105642489|NCT00813709|364354963|FG004|Double Blind Period|Other|0|||
105642490|NCT00813709|364354964|FG005|Double Blind Period|Other|0|||
105642491|NCT00813709|364354959|FG000|Open Label Period|Adverse Event|0|||
105642492|NCT00813709|364354960|FG001|Open Label Period|Adverse Event|0|||
105642493|NCT00813709|364354961|FG002|Open Label Period|Adverse Event|0|||
105642494|NCT00813709|364354962|FG003|Open Label Period|Adverse Event|5|||
105642495|NCT00813709|364354963|FG004|Open Label Period|Adverse Event|4|||
105642496|NCT00813709|364354964|FG005|Open Label Period|Adverse Event|3|||
105642497|NCT00813709|364354959|FG000|Open Label Period|Lack of Efficacy|0|||
105642498|NCT00813709|364354960|FG001|Open Label Period|Lack of Efficacy|0|||
105642499|NCT00813709|364354961|FG002|Open Label Period|Lack of Efficacy|0|||
105642500|NCT00813709|364354962|FG003|Open Label Period|Lack of Efficacy|3|||
105642501|NCT00813709|364354963|FG004|Open Label Period|Lack of Efficacy|1|||
105642502|NCT00813709|364354964|FG005|Open Label Period|Lack of Efficacy|1|||
105642503|NCT00813709|364354959|FG000|Open Label Period|Randomized but not treated|0|||
105642504|NCT00813709|364354960|FG001|Open Label Period|Randomized but not treated|0|||
105642505|NCT00813709|364354961|FG002|Open Label Period|Randomized but not treated|0|||
105642506|NCT00813709|364354962|FG003|Open Label Period|Randomized but not treated|1|||
105642507|NCT00813709|364354963|FG004|Open Label Period|Randomized but not treated|0|||
105642508|NCT00813709|364354964|FG005|Open Label Period|Randomized but not treated|1|||
105642509|NCT00813709|364354959|FG000|Open Label Period|Other|0|||
105642510|NCT00813709|364354960|FG001|Open Label Period|Other|0|||
105642511|NCT00813709|364354961|FG002|Open Label Period|Other|0|||
105642512|NCT00813709|364354962|FG003|Open Label Period|Other|11|||
105642513|NCT00813709|364354963|FG004|Open Label Period|Other|5|||
105642514|NCT00813709|364354964|FG005|Open Label Period|Other|6|||
105642515|NCT02753075|364354965|FG000|Overall Study|Adverse Event|2|||
105642516|NCT02753075|364354966|FG001|Overall Study|Adverse Event|1|||
105642517|NCT02753075|364354967|FG002|Overall Study|Adverse Event|0|||
105642518|NCT02753075|364354965|FG000|Overall Study|Lost to Follow-up|2|||
105642519|NCT02753075|364354966|FG001|Overall Study|Lost to Follow-up|0|||
105642520|NCT02753075|364354967|FG002|Overall Study|Lost to Follow-up|0|||
105642521|NCT02753075|364354965|FG000|Overall Study|Withdrawal of Consent|1|||
105642522|NCT02753075|364354966|FG001|Overall Study|Withdrawal of Consent|1|||
105642523|NCT02753075|364354967|FG002|Overall Study|Withdrawal of Consent|3|||
105642524|NCT02753075|364354965|FG000|Overall Study|Physician Decision|3|||
105642525|NCT02753075|364354966|FG001|Overall Study|Physician Decision|1|||
105642526|NCT02753075|364354967|FG002|Overall Study|Physician Decision|0|||
105642527|NCT01102426|364354976|FG000|Overall Study|Randomized but not treated|4|||
105642528|NCT01102426|364354977|FG001|Overall Study|Randomized but not treated|1|||
105642529|NCT01102426|364354976|FG000|Overall Study|Adverse Events (treatment-related)|15|||
105642530|NCT01102426|364354977|FG001|Overall Study|Adverse Events (treatment-related)|8|||
105642531|NCT01102426|364354976|FG000|Overall Study|Physician Decision|9|||
105642532|NCT01102426|364354977|FG001|Overall Study|Physician Decision|6|||
105642533|NCT01102426|364354976|FG000|Overall Study|Progressive Disease|85|||
105642534|NCT01102426|364354977|FG001|Overall Study|Progressive Disease|44|||
105642535|NCT01102426|364354976|FG000|Overall Study|Adverse Events (unrelated to|9|||
105642536|NCT01102426|364354977|FG001|Overall Study|Adverse Events (unrelated to|1|||
105642537|NCT01102426|364354976|FG000|Overall Study|Patient Refusal|24|||
105642538|NCT01102426|364354977|FG001|Overall Study|Patient Refusal|12|||
105642539|NCT01102426|364354976|FG000|Overall Study|Death (due to adverse events|0|||
105642540|NCT01102426|364354977|FG001|Overall Study|Death (due to adverse events|1|||
105642541|NCT01102426|364354976|FG000|Overall Study|Death (non-related to the study|19|||
105642542|NCT01102426|364354977|FG001|Overall Study|Death (non-related to the study|8|||
105642543|NCT03344458|364354978|FG000|Overall Study|Physician Decision|1|||
105642544|NCT03344458|364354978|FG000|Overall Study|Withdrawal by Subject|16|||
105642545|NCT03344458|364354978|FG000|Overall Study|Other reasons|10|||
105642546|NCT03344458|364354978|FG000|Overall Study|Lost to Follow-up|9|||
105642547|NCT03344458|364354978|FG000|Overall Study|Protocol Violation|3|||
105642548|NCT01393964|364354980|FG000|Overall Study|Disease Progression|4|||
105642549|NCT01393964|364354981|FG001|Overall Study|Disease Progression|3|||
105642550|NCT01393964|364354982|FG002|Overall Study|Disease Progression|5|||
105642551|NCT01393964|364354980|FG000|Overall Study|Study drug toxicity|1|||
105642552|NCT01393964|364354981|FG001|Overall Study|Study drug toxicity|0|||
105642553|NCT01393964|364354982|FG002|Overall Study|Study drug toxicity|0|||
105642554|NCT01393964|364354980|FG000|Overall Study|Withdrawal by Subject|0|||
105642555|NCT01393964|364354981|FG001|Overall Study|Withdrawal by Subject|0|||
105642556|NCT01393964|364354982|FG002|Overall Study|Withdrawal by Subject|1|||
105642557|NCT01393964|364354980|FG000|Overall Study|Adverse event unrelated to study drug|0|||
105642558|NCT01393964|364354981|FG001|Overall Study|Adverse event unrelated to study drug|3|||
105642559|NCT01393964|364354982|FG002|Overall Study|Adverse event unrelated to study drug|0|||
105642560|NCT01393964|364354980|FG000|Overall Study|Subject request stop study treatment|0|||
105642561|NCT01393964|364354981|FG001|Overall Study|Subject request stop study treatment|1|||
105642562|NCT01393964|364354982|FG002|Overall Study|Subject request stop study treatment|0|||
105642563|NCT01393964|364354980|FG000|Overall Study|Subject decided to move to transplant|1|||
105642564|NCT01393964|364354981|FG001|Overall Study|Subject decided to move to transplant|0|||
105642565|NCT01393964|364354982|FG002|Overall Study|Subject decided to move to transplant|0|||
105642566|NCT01393964|364354980|FG000|Overall Study|Subject switched to commercial supply|1|||
105642567|NCT01393964|364354981|FG001|Overall Study|Subject switched to commercial supply|0|||
105642568|NCT01393964|364354982|FG002|Overall Study|Subject switched to commercial supply|2|||
105642569|NCT01393964|364354980|FG000|Overall Study|Subject plateaued in terms of effect|1|||
105642570|NCT01393964|364354981|FG001|Overall Study|Subject plateaued in terms of effect|0|||
105642571|NCT01393964|364354982|FG002|Overall Study|Subject plateaued in terms of effect|0|||
105642572|NCT01393964|364354980|FG000|Overall Study|Investigator removed subject from study|0|||
105642573|NCT01393964|364354981|FG001|Overall Study|Investigator removed subject from study|1|||
105642574|NCT01393964|364354982|FG002|Overall Study|Investigator removed subject from study|0|||
105642575|NCT01393964|364354980|FG000|Overall Study|Subject converted to roll-over study|0|||
105642576|NCT01393964|364354981|FG001|Overall Study|Subject converted to roll-over study|1|||
105642577|NCT01393964|364354982|FG002|Overall Study|Subject converted to roll-over study|0|||
105642578|NCT01393964|364354980|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
105642579|NCT01393964|364354981|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
105642580|NCT01393964|364354982|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
105642581|NCT03265132|364354983|FG000|Overall Study|Adverse Event|0|||
105642582|NCT03265132|364354984|FG001|Overall Study|Adverse Event|1|||
105642583|NCT03265132|364354983|FG000|Overall Study|Lack of Efficacy|0|||
105642584|NCT03265132|364354984|FG001|Overall Study|Lack of Efficacy|2|||
105642585|NCT03265132|364354983|FG000|Overall Study|Progressive disease|0|||
105642586|NCT03265132|364354984|FG001|Overall Study|Progressive disease|2|||
105642587|NCT03265132|364354983|FG000|Overall Study|Withdrawal by Subject|0|||
105642588|NCT03265132|364354984|FG001|Overall Study|Withdrawal by Subject|1|||
105642589|NCT00088166|364354985|FG000|Overall Study|Adverse Event|11|||
105642590|NCT00088166|364354986|FG001|Overall Study|Adverse Event|9|||
105642591|NCT00088166|364354985|FG000|Overall Study|Death|3|||
105642592|NCT00088166|364354986|FG001|Overall Study|Death|1|||
105642593|NCT00088166|364354985|FG000|Overall Study|Lost to Follow-up|0|||
105642594|NCT00088166|364354986|FG001|Overall Study|Lost to Follow-up|1|||
105642595|NCT00088166|364354985|FG000|Overall Study|Physician Decision|4|||
105642596|NCT00088166|364354986|FG001|Overall Study|Physician Decision|1|||
105642597|NCT00088166|364354985|FG000|Overall Study|Protocol Violation|1|||
105642598|NCT00088166|364354986|FG001|Overall Study|Protocol Violation|5|||
105642599|NCT00088166|364354985|FG000|Overall Study|Patient deterioration|29|||
105642600|NCT00088166|364354986|FG001|Overall Study|Patient deterioration|39|||
105642601|NCT00088166|364354985|FG000|Overall Study|Withdrawal by Subject|5|||
105642602|NCT00088166|364354986|FG001|Overall Study|Withdrawal by Subject|5|||
105642603|NCT03131713|364354987|FG000|Overall Study|Lost to Follow-up|5|||
105642604|NCT03131713|364354988|FG001|Overall Study|Lost to Follow-up|0|||
105642605|NCT02542696|364354999|FG000|Overall Study|Adverse Event|167|||
105642606|NCT02542696|364354999|FG000|Overall Study|Lack of Efficacy|26|||
105642607|NCT02542696|364354999|FG000|Overall Study|Lost to Follow-up|6|||
105642608|NCT02542696|364354999|FG000|Overall Study|Withdrawal by Subject|104|||
105642609|NCT02542696|364354999|FG000|Overall Study|Protocol Violation|5|||
105642610|NCT02542696|364354999|FG000|Overall Study|Death|8|||
105642611|NCT02542696|364354999|FG000|Overall Study|DECREASED OFF TIME|1|||
105642612|NCT02542696|364354999|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
105642613|NCT02542696|364354999|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
105642614|NCT02542696|364354999|FG000|Overall Study|MEDICAL HISTORY|1|||
105642615|NCT02542696|364354999|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
105642616|NCT02542696|364354999|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
105642617|NCT02542696|364354999|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
105642618|NCT02542696|364354999|FG000|Overall Study|SPONSOR DECISION|3|||
105642619|NCT02542696|364354999|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
105642620|NCT02542696|364354999|FG000|Overall Study|SUBJECT DECISION|2|||
105642621|NCT02584257|364355000|FG000|Period 1|Withdrawal by Subject|0|||
105642622|NCT02584257|364355001|FG001|Period 1|Withdrawal by Subject|0|||
105642623|NCT02584257|364355002|FG002|Period 1|Withdrawal by Subject|0|||
105642624|NCT02584257|364355003|FG003|Period 1|Withdrawal by Subject|0|||
105642625|NCT02584257|364355004|FG004|Period 1|Withdrawal by Subject|0|||
105642626|NCT02584257|364355005|FG005|Period 1|Withdrawal by Subject|0|||
105642627|NCT02584257|364355006|FG006|Period 1|Withdrawal by Subject|1|||
105642628|NCT02584257|364355007|FG007|Period 1|Withdrawal by Subject|0|||
105642629|NCT02584257|364355008|FG008|Period 1|Withdrawal by Subject|0|||
105642630|NCT02584257|364355000|FG000|Period 2|Physician Decision|1|||
105642631|NCT02584257|364355001|FG001|Period 2|Physician Decision|0|||
105642632|NCT02584257|364355002|FG002|Period 2|Physician Decision|0|||
105642633|NCT02584257|364355003|FG003|Period 2|Physician Decision|0|||
105642634|NCT02584257|364355004|FG004|Period 2|Physician Decision|0|||
105642635|NCT02584257|364355005|FG005|Period 2|Physician Decision|0|||
105642636|NCT02584257|364355006|FG006|Period 2|Physician Decision|0|||
105642637|NCT02584257|364355007|FG007|Period 2|Physician Decision|0|||
105642638|NCT02584257|364355008|FG008|Period 2|Physician Decision|0|||
105642639|NCT02584257|364355000|FG000|Period 2|Adverse Event|0|||
105642640|NCT02584257|364355001|FG001|Period 2|Adverse Event|1|||
105642641|NCT02584257|364355002|FG002|Period 2|Adverse Event|0|||
105642642|NCT02584257|364355003|FG003|Period 2|Adverse Event|0|||
105642643|NCT02584257|364355004|FG004|Period 2|Adverse Event|0|||
105642644|NCT02584257|364355005|FG005|Period 2|Adverse Event|0|||
105642645|NCT02584257|364355006|FG006|Period 2|Adverse Event|0|||
105642646|NCT02584257|364355007|FG007|Period 2|Adverse Event|0|||
105642647|NCT02584257|364355008|FG008|Period 2|Adverse Event|0|||
105642648|NCT01543204|364355009|FG000|Overall Study|Non-compliance|1|||
105642649|NCT01543204|364355009|FG000|Overall Study|Adverse Event|1|||
105642650|NCT01543204|364355009|FG000|Overall Study|Withdrawal by Subject|4|||
105642651|NCT01543204|364355009|FG000|Overall Study|Requirement for Alternative Therapy|1|||
105642652|NCT01543204|364355009|FG000|Overall Study|Lost to Follow-up|1|||
105642653|NCT03146845|364355010|FG000|Overall Study|Reference ulcer healed|1|||
105642654|NCT03146845|364355011|FG001|Overall Study|Reference ulcer healed|0|||
105642655|NCT03146845|364355010|FG000|Overall Study|Physician Decision|1|||
105642656|NCT03146845|364355011|FG001|Overall Study|Physician Decision|0|||
105642657|NCT03146845|364355010|FG000|Overall Study|Adverse Event|1|||
105642658|NCT03146845|364355011|FG001|Overall Study|Adverse Event|0|||
105642659|NCT03146845|364355010|FG000|Overall Study|Withdrawal by Subject|2|||
105642660|NCT03146845|364355011|FG001|Overall Study|Withdrawal by Subject|0|||
105642661|NCT03146845|364355010|FG000|Overall Study|Noncompliance|0|||
105642662|NCT03146845|364355011|FG001|Overall Study|Noncompliance|1|||
105642663|NCT03146845|364355010|FG000|Overall Study|Protocol Violation|0|||
105642664|NCT03146845|364355011|FG001|Overall Study|Protocol Violation|2|||
105642665|NCT03146845|364355010|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
105642666|NCT03146845|364355011|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
105642667|NCT01535261|364355015|FG000|Overall Study|Physician Decision|8|||
105642668|NCT01535261|364355015|FG000|Overall Study|Protocol Violation|3|||
105642669|NCT01535261|364355015|FG000|Overall Study|Death|5|||
105642670|NCT01535261|364355015|FG000|Overall Study|Lost to Follow-up|8|||
105642671|NCT01535261|364355015|FG000|Overall Study|Withdrawal by Subject|14|||
105642672|NCT01535261|364355015|FG000|Overall Study|Adverse Event|12|||
105642673|NCT03326856|364355018|FG000|Overall Study|Lost to Follow-up|1|||
105642674|NCT03326856|364355019|FG001|Overall Study|Lost to Follow-up|1|||
105642675|NCT03326856|364355020|FG002|Overall Study|Lost to Follow-up|0|||
105642676|NCT03326856|364355021|FG003|Overall Study|Lost to Follow-up|0|||
105642677|NCT03326856|364355022|FG004|Overall Study|Lost to Follow-up|0|||
105642678|NCT00472082|364355023|FG000|Overall Study|Study prematurely terminated|5|||
105642679|NCT02206607|364355024|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
105642680|NCT02206607|364355025|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
105642681|NCT02206607|364355026|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
105642682|NCT02206607|364355027|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
105642683|NCT02206607|364355028|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
105642684|NCT02206607|364355024|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
105642685|NCT02206607|364355025|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
105642686|NCT02206607|364355026|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
105642687|NCT02206607|364355027|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
105642688|NCT02206607|364355028|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
105642689|NCT02991118|364355029|FG000|Overall Study|Death|3|||
105642690|NCT02991118|364355030|FG001|Overall Study|Death|8|||
105642691|NCT02991118|364355029|FG000|Overall Study|Protocol Violation|0|||
105642692|NCT02991118|364355030|FG001|Overall Study|Protocol Violation|3|||
105642693|NCT02991118|364355029|FG000|Overall Study|Physician Decision|0|||
105642694|NCT02991118|364355030|FG001|Overall Study|Physician Decision|1|||
105642695|NCT02991118|364355029|FG000|Overall Study|Moved out of the country|0|||
105642696|NCT02991118|364355030|FG001|Overall Study|Moved out of the country|1|||
105642697|NCT02991118|364355029|FG000|Overall Study|Adverse Event|2|||
105642698|NCT02991118|364355030|FG001|Overall Study|Adverse Event|2|||
105642699|NCT02991118|364355029|FG000|Overall Study|Withdrawal by Subject|1|||
105642700|NCT02991118|364355030|FG001|Overall Study|Withdrawal by Subject|7|||
105642701|NCT02991118|364355029|FG000|Overall Study|Could not attend study visits|0|||
105642702|NCT02991118|364355030|FG001|Overall Study|Could not attend study visits|1|||
105642703|NCT02991118|364355029|FG000|Overall Study|Lost to Follow-up|1|||
105642704|NCT02991118|364355030|FG001|Overall Study|Lost to Follow-up|9|||
105642705|NCT01777932|364355034|FG000|Overall Study|Disease progression|136|||
105642706|NCT01777932|364355034|FG000|Overall Study|Death|3|||
105642707|NCT01777932|364355034|FG000|Overall Study|Adverse Event|34|||
105642708|NCT01777932|364355034|FG000|Overall Study|Lost to Follow-up|3|||
105642709|NCT01777932|364355034|FG000|Overall Study|Investigator decision|10|||
105642710|NCT01777932|364355034|FG000|Overall Study|Reimbursement limit|9|||
105642711|NCT01777932|364355034|FG000|Overall Study|Patient refused further treatment|10|||
105642712|NCT02514824|364355035|FG000|Overall Study|Withdrawal by Subject|1|||
105642713|NCT02514824|364355036|FG001|Overall Study|Withdrawal by Subject|0|||
105642714|NCT02514824|364355037|FG002|Overall Study|Withdrawal by Subject|0|||
105642715|NCT02514824|364355038|FG003|Overall Study|Withdrawal by Subject|0|||
105642716|NCT02514824|364355035|FG000|Overall Study|Dose-Limiting Toxicity|0|||
105642717|NCT02514824|364355036|FG001|Overall Study|Dose-Limiting Toxicity|1|||
105642718|NCT02514824|364355037|FG002|Overall Study|Dose-Limiting Toxicity|0|||
105642719|NCT02514824|364355038|FG003|Overall Study|Dose-Limiting Toxicity|0|||
105642720|NCT01138657|364355039|FG000|Overall Study|Adverse Event|3|||
105642721|NCT01138657|364355040|FG001|Overall Study|Adverse Event|10|||
105642722|NCT01138657|364355039|FG000|Overall Study|Lack of Efficacy|2|||
105642723|NCT01138657|364355040|FG001|Overall Study|Lack of Efficacy|1|||
105642724|NCT01138657|364355039|FG000|Overall Study|Lost to Follow-up|0|||
105642725|NCT01138657|364355040|FG001|Overall Study|Lost to Follow-up|3|||
105642726|NCT01138657|364355039|FG000|Overall Study|Miscellaneous Reasons|3|||
105642727|NCT01138657|364355040|FG001|Overall Study|Miscellaneous Reasons|4|||
105642728|NCT02574286|364355041|FG000|Overall Study|Adverse Event|3|||
105642729|NCT02574286|364355041|FG000|Overall Study|Withdrawal by Subject|2|||
105642730|NCT02764320|364355042|FG000|Overall Study|Withdrawal by Subject|35|||
105642731|NCT02764320|364355043|FG001|Overall Study|Withdrawal by Subject|38|||
105642732|NCT02764320|364355042|FG000|Overall Study|Protocol Violation|11|||
105642733|NCT02764320|364355043|FG001|Overall Study|Protocol Violation|6|||
105642734|NCT02764320|364355042|FG000|Overall Study|Adverse Event|2|||
105642735|NCT02764320|364355043|FG001|Overall Study|Adverse Event|0|||
105642736|NCT02764320|364355042|FG000|Overall Study|Health Issues unable to continue|2|||
105642737|NCT02764320|364355043|FG001|Overall Study|Health Issues unable to continue|0|||
105642738|NCT02764320|364355042|FG000|Overall Study|Did not meet inclusion criteria|1|||
105642739|NCT02764320|364355043|FG001|Overall Study|Did not meet inclusion criteria|0|||
105642740|NCT02764320|364355042|FG000|Overall Study|Subject moved|0|||
105642741|NCT02764320|364355043|FG001|Overall Study|Subject moved|2|||
105642742|NCT02764320|364355042|FG000|Overall Study|Overused medication unavailable|0|||
105642743|NCT02764320|364355043|FG001|Overall Study|Overused medication unavailable|1|||
105642744|NCT02764320|364355042|FG000|Overall Study|Seeking care outside site|0|||
105642745|NCT02764320|364355043|FG001|Overall Study|Seeking care outside site|1|||
105642746|NCT02764320|364355042|FG000|Overall Study|Technology barriers|0|||
105642747|NCT02764320|364355043|FG001|Overall Study|Technology barriers|1|||
105642748|NCT02516202|364355047|FG000|Overall Study|Withdrawal by Subject|1|||
105642749|NCT02516202|364355048|FG001|Overall Study|Withdrawal by Subject|0|||
105642750|NCT02516202|364355049|FG002|Overall Study|Withdrawal by Subject|1|||
105642751|NCT02516202|364355047|FG000|Overall Study|Lost to Follow-up|1|||
105642752|NCT02516202|364355048|FG001|Overall Study|Lost to Follow-up|1|||
105642753|NCT02516202|364355049|FG002|Overall Study|Lost to Follow-up|1|||
105642754|NCT02516202|364355047|FG000|Overall Study|Stopped Follow-up|0|||
105642755|NCT02516202|364355048|FG001|Overall Study|Stopped Follow-up|0|||
105642756|NCT02516202|364355049|FG002|Overall Study|Stopped Follow-up|1|||
105642757|NCT00409747|364355054|FG000|Overall Study|Withdrawal by Subject|1|||
105642758|NCT00636168|364355055|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
105642759|NCT00636168|364355056|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
105642760|NCT00636168|364355055|FG000|Randomized to Study Drug|Adverse Event|1|||
105642761|NCT00636168|364355056|FG001|Randomized to Study Drug|Adverse Event|0|||
105642762|NCT00636168|364355055|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
105642763|NCT00636168|364355056|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
105642764|NCT00636168|364355055|FG000|Treated With Study Drug|Recurrence of disease|135|||
105642765|NCT00636168|364355056|FG001|Treated With Study Drug|Recurrence of disease|282|||
105642766|NCT00636168|364355055|FG000|Treated With Study Drug|Adverse Event|250|||
105642767|NCT00636168|364355056|FG001|Treated With Study Drug|Adverse Event|22|||
105642768|NCT00636168|364355055|FG000|Treated With Study Drug|Participant withdrew consent|16|||
105642769|NCT00636168|364355056|FG001|Treated With Study Drug|Participant withdrew consent|21|||
105642770|NCT00636168|364355055|FG000|Treated With Study Drug|Poor/non-compliance|1|||
105642771|NCT00636168|364355056|FG001|Treated With Study Drug|Poor/non-compliance|3|||
105642772|NCT00636168|364355055|FG000|Treated With Study Drug|Death|3|||
105642773|NCT00636168|364355056|FG001|Treated With Study Drug|Death|0|||
105642774|NCT00636168|364355055|FG000|Treated With Study Drug|Pregnancy|1|||
105642775|NCT00636168|364355056|FG001|Treated With Study Drug|Pregnancy|0|||
105642776|NCT00636168|364355055|FG000|Treated With Study Drug|No longer meets study criteria|1|||
105642777|NCT00636168|364355056|FG001|Treated With Study Drug|No longer meets study criteria|0|||
105642778|NCT00636168|364355055|FG000|Treated With Study Drug|Other reason|1|||
105642779|NCT00636168|364355056|FG001|Treated With Study Drug|Other reason|3|||
105642780|NCT00636168|364355055|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
105642781|NCT00636168|364355056|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
105642782|NCT00636168|364355055|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
105642783|NCT00636168|364355056|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
105642784|NCT00636168|364355055|FG000|Long Term Follow-Up|Death|8|||
105642785|NCT00636168|364355056|FG001|Long Term Follow-Up|Death|9|||
105642786|NCT02006641|364355057|FG000|Overall Study|Withdrawal before treatment|2|||
105642787|NCT02006641|364355058|FG001|Overall Study|Withdrawal before treatment|5|||
105642788|NCT02006641|364355059|FG002|Overall Study|Withdrawal before treatment|3|||
105642789|NCT02006641|364355057|FG000|Overall Study|Adverse Event|15|||
105642790|NCT02006641|364355058|FG001|Overall Study|Adverse Event|11|||
105642791|NCT02006641|364355059|FG002|Overall Study|Adverse Event|15|||
105642792|NCT02006641|364355057|FG000|Overall Study|Protocol Violation|0|||
105642793|NCT02006641|364355058|FG001|Overall Study|Protocol Violation|2|||
105642794|NCT02006641|364355059|FG002|Overall Study|Protocol Violation|2|||
105642795|NCT02006641|364355057|FG000|Overall Study|Lost to Follow-up|0|||
105642796|NCT02006641|364355058|FG001|Overall Study|Lost to Follow-up|1|||
105642797|NCT02006641|364355059|FG002|Overall Study|Lost to Follow-up|0|||
105642798|NCT02006641|364355057|FG000|Overall Study|Withdrawal by Subject|7|||
105642799|NCT02006641|364355058|FG001|Overall Study|Withdrawal by Subject|12|||
105642800|NCT02006641|364355059|FG002|Overall Study|Withdrawal by Subject|11|||
105642801|NCT02006641|364355057|FG000|Overall Study|Other reason: patient didn't show up|1|||
105642802|NCT02006641|364355058|FG001|Overall Study|Other reason: patient didn't show up|0|||
105642803|NCT02006641|364355059|FG002|Overall Study|Other reason: patient didn't show up|0|||
105642804|NCT02006641|364355057|FG000|Overall Study|Other reason:patient didn't want to come|0|||
105642805|NCT02006641|364355058|FG001|Overall Study|Other reason:patient didn't want to come|0|||
105642806|NCT02006641|364355059|FG002|Overall Study|Other reason:patient didn't want to come|1|||
105642807|NCT02006641|364355057|FG000|Overall Study|Other reason: patient has moved|1|||
105642808|NCT02006641|364355058|FG001|Overall Study|Other reason: patient has moved|0|||
105642809|NCT02006641|364355059|FG002|Overall Study|Other reason: patient has moved|1|||
105642810|NCT02006641|364355057|FG000|Overall Study|Other reason: caregiver in hospital|0|||
105642811|NCT02006641|364355058|FG001|Overall Study|Other reason: caregiver in hospital|1|||
105642812|NCT02006641|364355059|FG002|Overall Study|Other reason: caregiver in hospital|0|||
105642813|NCT02006641|364355057|FG000|Overall Study|Other reason: patient's wife has died|0|||
105642814|NCT02006641|364355058|FG001|Overall Study|Other reason: patient's wife has died|0|||
105642815|NCT02006641|364355059|FG002|Overall Study|Other reason: patient's wife has died|1|||
105642816|NCT02006641|364355057|FG000|Overall Study|Other reason: hospitalisation|0|||
105642817|NCT02006641|364355058|FG001|Overall Study|Other reason: hospitalisation|1|||
105642818|NCT02006641|364355059|FG002|Overall Study|Other reason: hospitalisation|0|||
105642819|NCT02006641|364355057|FG000|Overall Study|Other reason: caregiver impossibility|0|||
105642820|NCT02006641|364355058|FG001|Overall Study|Other reason: caregiver impossibility|0|||
105642821|NCT02006641|364355059|FG002|Overall Study|Other reason: caregiver impossibility|1|||
105642822|NCT02006641|364355057|FG000|Overall Study|Other reason: protocol non-compliance|0|||
105642823|NCT02006641|364355058|FG001|Overall Study|Other reason: protocol non-compliance|0|||
105642824|NCT02006641|364355059|FG002|Overall Study|Other reason: protocol non-compliance|1|||
105642825|NCT02132195|364355064|FG000|Initial Assignment|Relapsed|14|||
105642826|NCT02132195|364355065|FG001|Initial Assignment|Relapsed|0|||
105642827|NCT02132195|364355066|FG002|Initial Assignment|Relapsed|0|||
105642828|NCT02132195|364355064|FG000|Rescue Therapy|Relapsed|0|||
105642829|NCT02132195|364355065|FG001|Rescue Therapy|Relapsed|0|||
105642830|NCT02132195|364355066|FG002|Rescue Therapy|Relapsed|7|||
105642831|NCT02132195|364355064|FG000|Rescue Therapy|Physician Decision|0|||
105642832|NCT02132195|364355065|FG001|Rescue Therapy|Physician Decision|0|||
105642833|NCT02132195|364355066|FG002|Rescue Therapy|Physician Decision|1|||
105642834|NCT02132195|364355064|FG000|Rescue Therapy|Withdrawal by Subject|0|||
105642835|NCT02132195|364355065|FG001|Rescue Therapy|Withdrawal by Subject|0|||
105642836|NCT02132195|364355066|FG002|Rescue Therapy|Withdrawal by Subject|1|||
105642837|NCT02132195|364355064|FG000|Rescue Therapy|Adverse Event|0|||
105642838|NCT02132195|364355065|FG001|Rescue Therapy|Adverse Event|0|||
105642839|NCT02132195|364355066|FG002|Rescue Therapy|Adverse Event|2|||
105642840|NCT02102724|364355069|FG000|Overall Study|Lost to Follow-up|1|||
105642841|NCT02102724|364355070|FG001|Overall Study|Lost to Follow-up|0|||
105642842|NCT02102724|364355069|FG000|Overall Study|surgery for brain aneurysm|1|||
105642843|NCT02102724|364355070|FG001|Overall Study|surgery for brain aneurysm|1|||
105642844|NCT00736502|364355071|FG000|Overall Study|Adverse Event|22|||
105642845|NCT00736502|364355071|FG000|Overall Study|Lack of Efficacy|16|||
105642846|NCT00736502|364355071|FG000|Overall Study|Lost to Follow-up|27|||
105642847|NCT01307800|364355072|FG000|Overall Study|Adverse Event|9|||
105642848|NCT01307800|364355073|FG001|Overall Study|Adverse Event|8|||
105642849|NCT01307800|364355074|FG002|Overall Study|Adverse Event|10|||
105642850|NCT01307800|364355075|FG003|Overall Study|Adverse Event|14|||
105642851|NCT01307800|364355072|FG000|Overall Study|Entry Criteria Not Met|0|||
105642852|NCT01307800|364355073|FG001|Overall Study|Entry Criteria Not Met|0|||
105642853|NCT01307800|364355074|FG002|Overall Study|Entry Criteria Not Met|0|||
105642854|NCT01307800|364355075|FG003|Overall Study|Entry Criteria Not Met|2|||
105642855|NCT01307800|364355072|FG000|Overall Study|Lost to Follow-up|5|||
105642856|NCT01307800|364355073|FG001|Overall Study|Lost to Follow-up|6|||
105642857|NCT01307800|364355074|FG002|Overall Study|Lost to Follow-up|2|||
105642858|NCT01307800|364355075|FG003|Overall Study|Lost to Follow-up|8|||
105642859|NCT01307800|364355072|FG000|Overall Study|Perceived Lack of Efficacy|24|||
105642860|NCT01307800|364355073|FG001|Overall Study|Perceived Lack of Efficacy|23|||
105642861|NCT01307800|364355074|FG002|Overall Study|Perceived Lack of Efficacy|20|||
105642862|NCT01307800|364355075|FG003|Overall Study|Perceived Lack of Efficacy|33|||
105642863|NCT01307800|364355072|FG000|Overall Study|Protocol Violation|0|||
105642864|NCT01307800|364355073|FG001|Overall Study|Protocol Violation|3|||
105642865|NCT01307800|364355074|FG002|Overall Study|Protocol Violation|4|||
105642866|NCT01307800|364355075|FG003|Overall Study|Protocol Violation|5|||
105642867|NCT01307800|364355072|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
105642868|NCT01307800|364355073|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
105642869|NCT01307800|364355074|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
105642870|NCT01307800|364355075|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
105642871|NCT01307800|364355072|FG000|Overall Study|Sponsor Decision|6|||
105642872|NCT01307800|364355073|FG001|Overall Study|Sponsor Decision|9|||
105642873|NCT01307800|364355074|FG002|Overall Study|Sponsor Decision|12|||
105642874|NCT01307800|364355075|FG003|Overall Study|Sponsor Decision|28|||
105642875|NCT01307800|364355072|FG000|Overall Study|Withdrawal by Subject|10|||
105642876|NCT01307800|364355073|FG001|Overall Study|Withdrawal by Subject|11|||
105642877|NCT01307800|364355074|FG002|Overall Study|Withdrawal by Subject|8|||
105642878|NCT01307800|364355075|FG003|Overall Study|Withdrawal by Subject|15|||
105642879|NCT01307800|364355072|FG000|Overall Study|Participant Moved|0|||
105642880|NCT01307800|364355073|FG001|Overall Study|Participant Moved|2|||
105642881|NCT01307800|364355074|FG002|Overall Study|Participant Moved|1|||
105642882|NCT01307800|364355075|FG003|Overall Study|Participant Moved|3|||
105642883|NCT01334606|364355076|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
105642884|NCT02255474|364355077|FG000|Overall Study|Lost to Follow-up|1|||
105642885|NCT02255474|364355078|FG001|Overall Study|Lost to Follow-up|1|||
105642886|NCT02255474|364355079|FG002|Overall Study|Lost to Follow-up|3|||
105642887|NCT02255474|364355077|FG000|Overall Study|Withdrawal by Subject|1|||
105642888|NCT02255474|364355078|FG001|Overall Study|Withdrawal by Subject|1|||
105642889|NCT02255474|364355079|FG002|Overall Study|Withdrawal by Subject|0|||
105642890|NCT00882050|364355081|FG000|Overall Study|Physician Decision|1|||
105642891|NCT00882050|364355082|FG001|Overall Study|Physician Decision|0|||
105642892|NCT00882050|364355083|FG002|Overall Study|Physician Decision|0|||
105642893|NCT02010684|364355084|FG000|Overall Study|Lost to Follow-up|8|||
105642894|NCT02010684|364355085|FG001|Overall Study|Lost to Follow-up|18|||
105642895|NCT02010684|364355084|FG000|Overall Study|Withdrawal by Subject|4|||
105642896|NCT02010684|364355085|FG001|Overall Study|Withdrawal by Subject|5|||
105642897|NCT02548585|364355086|FG000|Overall Study|Withdrawal by Subject|0|||
105642898|NCT02548585|364355087|FG001|Overall Study|Withdrawal by Subject|0|||
105642899|NCT02548585|364355088|FG002|Overall Study|Withdrawal by Subject|0|||
105642900|NCT02548585|364355089|FG003|Overall Study|Withdrawal by Subject|0|||
105642901|NCT02548585|364355090|FG004|Overall Study|Withdrawal by Subject|0|||
105642902|NCT02548585|364355091|FG005|Overall Study|Withdrawal by Subject|1|||
105642903|NCT02548585|364355092|FG006|Overall Study|Withdrawal by Subject|0|||
105642904|NCT02548585|364355086|FG000|Overall Study|Lost to Follow-up|1|||
105642905|NCT02548585|364355087|FG001|Overall Study|Lost to Follow-up|0|||
105642906|NCT02548585|364355088|FG002|Overall Study|Lost to Follow-up|0|||
105642907|NCT02548585|364355089|FG003|Overall Study|Lost to Follow-up|0|||
105642908|NCT02548585|364355090|FG004|Overall Study|Lost to Follow-up|0|||
105642909|NCT02548585|364355091|FG005|Overall Study|Lost to Follow-up|0|||
105642910|NCT02548585|364355092|FG006|Overall Study|Lost to Follow-up|0|||
105642911|NCT02548585|364355086|FG000|Overall Study|Other|1|||
105642912|NCT02548585|364355087|FG001|Overall Study|Other|0|||
105642913|NCT02548585|364355088|FG002|Overall Study|Other|0|||
105642914|NCT02548585|364355089|FG003|Overall Study|Other|2|||
105642915|NCT02548585|364355090|FG004|Overall Study|Other|3|||
105642916|NCT02548585|364355091|FG005|Overall Study|Other|0|||
105642917|NCT02548585|364355092|FG006|Overall Study|Other|1|||
105642918|NCT02548585|364355086|FG000|Overall Study|Randomized but not treated|0|||
105642919|NCT02548585|364355087|FG001|Overall Study|Randomized but not treated|0|||
105642920|NCT02548585|364355088|FG002|Overall Study|Randomized but not treated|0|||
105642921|NCT02548585|364355089|FG003|Overall Study|Randomized but not treated|0|||
105642922|NCT02548585|364355090|FG004|Overall Study|Randomized but not treated|0|||
105642923|NCT02548585|364355091|FG005|Overall Study|Randomized but not treated|1|||
105642924|NCT02548585|364355092|FG006|Overall Study|Randomized but not treated|0|||
105642925|NCT02612285|364355093|FG000|Overall Study|Withdrawal by Subject|1|||
105642926|NCT01986348|364355094|FG000|Overall Study|Death|8|||
105642927|NCT01986348|364355095|FG001|Overall Study|Death|22|||
105642928|NCT01986348|364355096|FG002|Overall Study|Death|10|||
105642929|NCT01986348|364355097|FG003|Overall Study|Death|21|||
105642930|NCT01986348|364355094|FG000|Overall Study|Lost to Follow-up|0|||
105642931|NCT01986348|364355095|FG001|Overall Study|Lost to Follow-up|0|||
105642932|NCT01986348|364355096|FG002|Overall Study|Lost to Follow-up|0|||
105642933|NCT01986348|364355097|FG003|Overall Study|Lost to Follow-up|2|||
105642934|NCT01986348|364355094|FG000|Overall Study|Physician Decision|0|||
105642935|NCT01986348|364355095|FG001|Overall Study|Physician Decision|0|||
105642936|NCT01986348|364355096|FG002|Overall Study|Physician Decision|0|||
105642937|NCT01986348|364355097|FG003|Overall Study|Physician Decision|1|||
105642938|NCT01986348|364355094|FG000|Overall Study|Progressive Disease|0|||
105642939|NCT01986348|364355095|FG001|Overall Study|Progressive Disease|0|||
105642940|NCT01986348|364355096|FG002|Overall Study|Progressive Disease|2|||
105642941|NCT01986348|364355097|FG003|Overall Study|Progressive Disease|0|||
105642942|NCT01986348|364355094|FG000|Overall Study|Withdrawal by Participant|0|||
105642943|NCT01986348|364355095|FG001|Overall Study|Withdrawal by Participant|1|||
105642944|NCT01986348|364355096|FG002|Overall Study|Withdrawal by Participant|2|||
105642945|NCT01986348|364355097|FG003|Overall Study|Withdrawal by Participant|1|||
105642946|NCT01986348|364355094|FG000|Overall Study|Study Terminated by Sponsor|0|||
105642947|NCT01986348|364355095|FG001|Overall Study|Study Terminated by Sponsor|0|||
105642948|NCT01986348|364355096|FG002|Overall Study|Study Terminated by Sponsor|0|||
105642949|NCT01986348|364355097|FG003|Overall Study|Study Terminated by Sponsor|3|||
105642950|NCT01986348|364355094|FG000|Overall Study|Other-unspecified|0|||
105642951|NCT01986348|364355095|FG001|Overall Study|Other-unspecified|1|||
105642952|NCT01986348|364355096|FG002|Overall Study|Other-unspecified|0|||
105642953|NCT01986348|364355097|FG003|Overall Study|Other-unspecified|2|||
105642954|NCT00805441|364355098|FG000|Overall Study|Adverse Event|5|||
105642955|NCT00805441|364355099|FG001|Overall Study|Adverse Event|2|||
105642956|NCT00805441|364355098|FG000|Overall Study|Lack of Efficacy|0|||
105642957|NCT00805441|364355099|FG001|Overall Study|Lack of Efficacy|2|||
105642958|NCT00805441|364355098|FG000|Overall Study|Protocol Violation|4|||
105642959|NCT00805441|364355099|FG001|Overall Study|Protocol Violation|8|||
105642960|NCT00805441|364355098|FG000|Overall Study|Lost to Follow-up|10|||
105642961|NCT00805441|364355099|FG001|Overall Study|Lost to Follow-up|13|||
105642962|NCT00805441|364355098|FG000|Overall Study|Withdrawal by Subject|15|||
105642963|NCT00805441|364355099|FG001|Overall Study|Withdrawal by Subject|9|||
105642964|NCT00805441|364355098|FG000|Overall Study|Physician Decision|0|||
105642965|NCT00805441|364355099|FG001|Overall Study|Physician Decision|1|||
105642966|NCT00805441|364355098|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
105642967|NCT00805441|364355099|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
105642968|NCT03242863|364355106|FG000|Study Week 1|Withdrawal by Subject|0|||
105642969|NCT03242863|364355107|FG001|Study Week 1|Withdrawal by Subject|1|||
105642970|NCT03242863|364355108|FG002|Study Week 1|Withdrawal by Subject|0|||
105642971|NCT03242863|364355109|FG003|Study Week 1|Withdrawal by Subject|0|||
105642972|NCT03242863|364355110|FG004|Study Week 1|Withdrawal by Subject|3|||
105642973|NCT03242863|364355111|FG005|Study Week 1|Withdrawal by Subject|0|||
105642974|NCT05487300|364357116|FG000|Overall Study|Withdrawal by Subject|1|||
105642975|NCT05487300|364357117|FG001|Overall Study|Withdrawal by Subject|0|||
105642976|NCT01286311|364357119|FG000|Overall Study|Physician did not want outreach sent|14|||
105642977|NCT01286311|364357120|FG001|Overall Study|Physician did not want outreach sent|0|||
105642978|NCT00403845|364357121|FG000|Treatment Period 1|Subject withdrew consent|1|||
105642979|NCT00403845|364357122|FG001|Treatment Period 1|Subject withdrew consent|0|||
105642980|NCT00403845|364357123|FG002|Treatment Period 1|Subject withdrew consent|0|||
105642981|NCT00403845|364357124|FG003|Treatment Period 1|Subject withdrew consent|0|||
105642982|NCT00403845|364357121|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
105642983|NCT00403845|364357122|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
105642984|NCT00403845|364357123|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
105642985|NCT00403845|364357124|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
105642986|NCT00403845|364357121|FG000|Treatment Period 2|Subject withdrew consent|1|||
105642987|NCT00403845|364357122|FG001|Treatment Period 2|Subject withdrew consent|0|||
105642988|NCT00403845|364357123|FG002|Treatment Period 2|Subject withdrew consent|0|||
105642989|NCT00403845|364357124|FG003|Treatment Period 2|Subject withdrew consent|0|||
105642990|NCT00403845|364357121|FG000|Treatment Period 3|Subject withdrew consent|0|||
105642991|NCT00403845|364357122|FG001|Treatment Period 3|Subject withdrew consent|0|||
105642992|NCT00403845|364357123|FG002|Treatment Period 3|Subject withdrew consent|0|||
105642993|NCT00403845|364357124|FG003|Treatment Period 3|Subject withdrew consent|1|||
105642994|NCT00403845|364357121|FG000|Treatment Period 3|Adverse Event|0|||
105642995|NCT00403845|364357122|FG001|Treatment Period 3|Adverse Event|0|||
105642996|NCT00403845|364357123|FG002|Treatment Period 3|Adverse Event|0|||
105642997|NCT00403845|364357124|FG003|Treatment Period 3|Adverse Event|1|||
105642998|NCT04328467|364357127|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
105642999|NCT04328467|364357128|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
105643000|NCT04328467|364357129|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
105643001|NCT03409276|364357130|FG000|Overall Study|Withdrawal by Subject|0|||
105643002|NCT03409276|364357131|FG001|Overall Study|Withdrawal by Subject|0|||
105643003|NCT03409276|364357132|FG002|Overall Study|Withdrawal by Subject|0|||
105643004|NCT03409276|364357133|FG003|Overall Study|Withdrawal by Subject|0|||
105643005|NCT03409276|364357134|FG004|Overall Study|Withdrawal by Subject|1|||
105643006|NCT03409276|364357130|FG000|Overall Study|Lost to Follow-up|0|||
105643007|NCT03409276|364357131|FG001|Overall Study|Lost to Follow-up|0|||
105643008|NCT03409276|364357132|FG002|Overall Study|Lost to Follow-up|0|||
105643009|NCT03409276|364357133|FG003|Overall Study|Lost to Follow-up|2|||
105643010|NCT03409276|364357134|FG004|Overall Study|Lost to Follow-up|2|||
105643011|NCT02011568|364357135|FG000|Overall Study|Withdrawal by Subject|8|||
105643012|NCT02011568|364357136|FG001|Overall Study|Withdrawal by Subject|10|||
105643013|NCT02011568|364357135|FG000|Overall Study|Physician Decision|1|||
105643014|NCT02011568|364357136|FG001|Overall Study|Physician Decision|3|||
105643015|NCT02152384|364357137|FG000|Period 1|Withdrawal by Subject|0|||
105643016|NCT02152384|364357138|FG001|Period 1|Withdrawal by Subject|1|||
105643017|NCT02152384|364357137|FG000|Period 1|Adverse Event|1|||
105643018|NCT02152384|364357138|FG001|Period 1|Adverse Event|1|||
105643019|NCT01322386|364357141|FG000|Overall Study|Protocol Violation|0|||
105643020|NCT01322386|364357142|FG001|Overall Study|Protocol Violation|1|||
105643021|NCT01322386|364357141|FG000|Overall Study|Physician Decision|0|||
105643022|NCT01322386|364357142|FG001|Overall Study|Physician Decision|1|||
105643023|NCT01109979|364357148|FG000|Overall Study|Physician Decision|2|||
105643024|NCT01109979|364357149|FG001|Overall Study|Physician Decision|0|||
105643025|NCT01109979|364357148|FG000|Overall Study|Withdrawal by Subject|0|||
105643026|NCT01109979|364357149|FG001|Overall Study|Withdrawal by Subject|1|||
105643027|NCT01670877|364357151|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
105643028|NCT01670877|364357152|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
105643029|NCT01670877|364357153|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
105643030|NCT01670877|364357154|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
105643031|NCT01670877|364357155|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
105643032|NCT01670877|364357156|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
105643033|NCT01670877|364357151|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
105643034|NCT01670877|364357152|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
105643035|NCT01670877|364357153|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
105643036|NCT01670877|364357154|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
105643037|NCT01670877|364357155|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
105643038|NCT01670877|364357156|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
105643039|NCT01670877|364357151|FG000|Part I and Part 2|Grade 2 vomiting|0|||
105643040|NCT01670877|364357152|FG001|Part I and Part 2|Grade 2 vomiting|0|||
105643041|NCT01670877|364357153|FG002|Part I and Part 2|Grade 2 vomiting|0|||
105643042|NCT01670877|364357154|FG003|Part I and Part 2|Grade 2 vomiting|1|||
105643043|NCT01670877|364357155|FG004|Part I and Part 2|Grade 2 vomiting|0|||
105643044|NCT01670877|364357156|FG005|Part I and Part 2|Grade 2 vomiting|0|||
105643045|NCT01670877|364357151|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
105643046|NCT01670877|364357152|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
105643047|NCT01670877|364357153|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
105643048|NCT01670877|364357154|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
105643049|NCT01670877|364357155|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
105643050|NCT01670877|364357156|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
105643051|NCT01670877|364357151|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
105643052|NCT01670877|364357152|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
105643053|NCT01670877|364357153|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
105643054|NCT01670877|364357154|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
105643055|NCT01670877|364357155|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
105643056|NCT01670877|364357156|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
105643057|NCT02009332|364357159|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
105643058|NCT02009332|364357160|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
105643059|NCT02009332|364357161|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
105643060|NCT02009332|364357162|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
105643061|NCT02009332|364357163|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
105643062|NCT02009332|364357164|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
105643063|NCT02009332|364357159|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
105643064|NCT02009332|364357160|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
105643065|NCT02009332|364357161|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
105643066|NCT02009332|364357162|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
105643067|NCT02009332|364357163|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
105643068|NCT02009332|364357164|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
105643069|NCT02009332|364357159|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
105643070|NCT02009332|364357160|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
105643071|NCT02009332|364357161|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
105643072|NCT02009332|364357162|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
105643073|NCT02009332|364357163|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
105643074|NCT02009332|364357164|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
105643075|NCT00648895|364357165|FG000|Overall Study|Lack of Efficacy|0|||
105643076|NCT00648895|364357166|FG001|Overall Study|Lack of Efficacy|1|||
105643077|NCT00274287|364357167|FG000|Overall Study|Withdrawal by Subject|1|||
105643078|NCT00274287|364357167|FG000|Overall Study|subject non-compliance|1|||
105643079|NCT00244751|364357168|FG000|Overall Study|Adverse Event|7|||
105643080|NCT00244751|364357169|FG001|Overall Study|Adverse Event|7|||
105643081|NCT00244751|364357170|FG002|Overall Study|Adverse Event|5|||
105643082|NCT00244751|364357168|FG000|Overall Study|Lost to Follow-up|0|||
105643083|NCT00244751|364357169|FG001|Overall Study|Lost to Follow-up|1|||
105643084|NCT00244751|364357170|FG002|Overall Study|Lost to Follow-up|0|||
105643085|NCT00244751|364357168|FG000|Overall Study|Protocol Violation|1|||
105643086|NCT00244751|364357169|FG001|Overall Study|Protocol Violation|0|||
105643087|NCT00244751|364357170|FG002|Overall Study|Protocol Violation|1|||
105643088|NCT00244751|364357168|FG000|Overall Study|Withdrawal by Subject|7|||
105643089|NCT00244751|364357169|FG001|Overall Study|Withdrawal by Subject|5|||
105643090|NCT00244751|364357170|FG002|Overall Study|Withdrawal by Subject|3|||
105643091|NCT00244751|364357168|FG000|Overall Study|Elevated liver enzymes|1|||
105643092|NCT00244751|364357169|FG001|Overall Study|Elevated liver enzymes|0|||
105643093|NCT00244751|364357170|FG002|Overall Study|Elevated liver enzymes|0|||
105643094|NCT00244751|364357168|FG000|Overall Study|Lack of compliance with protocol|0|||
105643095|NCT00244751|364357169|FG001|Overall Study|Lack of compliance with protocol|1|||
105643096|NCT00244751|364357170|FG002|Overall Study|Lack of compliance with protocol|0|||
105643097|NCT00244751|364357168|FG000|Overall Study|Safety reasons|0|||
105643098|NCT00244751|364357169|FG001|Overall Study|Safety reasons|1|||
105643099|NCT00244751|364357170|FG002|Overall Study|Safety reasons|0|||
105643100|NCT00244751|364357168|FG000|Overall Study|Participant randomized by mistake|0|||
105643101|NCT00244751|364357169|FG001|Overall Study|Participant randomized by mistake|0|||
105643102|NCT00244751|364357170|FG002|Overall Study|Participant randomized by mistake|1|||
105643103|NCT02077374|364357177|FG000|Overall Study|Withdrawal by Subject|0|||
105643104|NCT02077374|364357178|FG001|Overall Study|Withdrawal by Subject|1|||
105643105|NCT02077374|364357177|FG000|Overall Study|Protocol Violation|0|||
105643106|NCT02077374|364357178|FG001|Overall Study|Protocol Violation|1|||
105643107|NCT00446095|364357179|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
105643108|NCT00446095|364357180|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
105643109|NCT00446095|364357181|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
105643110|NCT00446095|364357182|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
105643111|NCT00446095|364357183|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
105643112|NCT00446095|364357179|FG000|Phase II (8 Weeks)|Adverse Event|0|||
105643113|NCT00446095|364357180|FG001|Phase II (8 Weeks)|Adverse Event|1|||
105643114|NCT00446095|364357181|FG002|Phase II (8 Weeks)|Adverse Event|1|||
105643115|NCT00446095|364357182|FG003|Phase II (8 Weeks)|Adverse Event|0|||
105643116|NCT00446095|364357183|FG004|Phase II (8 Weeks)|Adverse Event|0|||
105643117|NCT00446095|364357179|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
105643118|NCT00446095|364357180|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
105643119|NCT00446095|364357181|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
105643120|NCT00446095|364357182|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
105643121|NCT00446095|364357183|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
105643122|NCT00446095|364357179|FG000|Phase II (8 Weeks)|Physician Decision|1|||
105643123|NCT00446095|364357180|FG001|Phase II (8 Weeks)|Physician Decision|0|||
105643124|NCT00446095|364357181|FG002|Phase II (8 Weeks)|Physician Decision|0|||
105643125|NCT00446095|364357182|FG003|Phase II (8 Weeks)|Physician Decision|0|||
105643126|NCT00446095|364357183|FG004|Phase II (8 Weeks)|Physician Decision|0|||
105643127|NCT00446095|364357179|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
105643128|NCT00446095|364357180|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
105643129|NCT00446095|364357181|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
105643130|NCT00446095|364357182|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
105643131|NCT00446095|364357183|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
105643132|NCT00446095|364357179|FG000|Phase II (8 Weeks)|Ongoing|0|||
105643133|NCT00446095|364357180|FG001|Phase II (8 Weeks)|Ongoing|0|||
105643134|NCT00446095|364357181|FG002|Phase II (8 Weeks)|Ongoing|1|||
105643135|NCT00446095|364357182|FG003|Phase II (8 Weeks)|Ongoing|0|||
105643136|NCT00446095|364357183|FG004|Phase II (8 Weeks)|Ongoing|0|||
105643137|NCT00446095|364357179|FG000|Phase I (28 Days)|Adverse Event|0|||
105643138|NCT00446095|364357180|FG001|Phase I (28 Days)|Adverse Event|0|||
105643139|NCT00446095|364357181|FG002|Phase I (28 Days)|Adverse Event|0|||
105643140|NCT00446095|364357182|FG003|Phase I (28 Days)|Adverse Event|1|||
105643141|NCT00446095|364357183|FG004|Phase I (28 Days)|Adverse Event|0|||
105643142|NCT00446095|364357179|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
105643143|NCT00446095|364357180|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
105643144|NCT00446095|364357181|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
105643145|NCT00446095|364357182|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
105643146|NCT00446095|364357183|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
105643147|NCT01930188|364357184|FG000|Overall Study|unclassified|4|||
105643148|NCT01930188|364357185|FG001|Overall Study|unclassified|5|||
105643149|NCT01930188|364357186|FG002|Overall Study|unclassified|3|||
105643150|NCT01930188|364357184|FG000|Overall Study|Missing follow-up information|2|||
105643151|NCT01930188|364357185|FG001|Overall Study|Missing follow-up information|2|||
105643152|NCT01930188|364357186|FG002|Overall Study|Missing follow-up information|3|||
105643153|NCT01930188|364357184|FG000|Overall Study|Lost to Follow-up|5|||
105643154|NCT01930188|364357185|FG001|Overall Study|Lost to Follow-up|2|||
105643155|NCT01930188|364357186|FG002|Overall Study|Lost to Follow-up|2|||
105643156|NCT01930188|364357184|FG000|Overall Study|Death|2|||
105643157|NCT01930188|364357185|FG001|Overall Study|Death|1|||
105643158|NCT01930188|364357186|FG002|Overall Study|Death|3|||
105643159|NCT01930188|364357184|FG000|Overall Study|Withdrawal by Subject|9|||
105643160|NCT01930188|364357185|FG001|Overall Study|Withdrawal by Subject|11|||
105643161|NCT01930188|364357186|FG002|Overall Study|Withdrawal by Subject|8|||
105643162|NCT03979040|364357189|FG000|Overall Study|Withdrawal by Subject|24|||
105643163|NCT03979040|364357190|FG001|Overall Study|Withdrawal by Subject|32|||
105643164|NCT03979040|364357189|FG000|Overall Study|randomized but never started treatment|32|||
105643165|NCT03979040|364357190|FG001|Overall Study|randomized but never started treatment|39|||
105643166|NCT03979040|364357189|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
105643167|NCT03979040|364357190|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
105643168|NCT02607956|364357191|FG000|Double-Blinded Phase|Withdrew Consent|17|||
105643169|NCT02607956|364357192|FG001|Double-Blinded Phase|Withdrew Consent|19|||
105643170|NCT02607956|364357193|FG002|Double-Blinded Phase|Withdrew Consent|0|||
105643171|NCT02607956|364357194|FG003|Double-Blinded Phase|Withdrew Consent|0|||
105643172|NCT02607956|364357191|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
105643173|NCT02607956|364357192|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
105643174|NCT02607956|364357193|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
105643175|NCT02607956|364357194|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
105643176|NCT02607956|364357191|FG000|Double-Blinded Phase|Randomized but never treated|7|||
105643177|NCT02607956|364357192|FG001|Double-Blinded Phase|Randomized but never treated|5|||
105643178|NCT02607956|364357193|FG002|Double-Blinded Phase|Randomized but never treated|0|||
105643179|NCT02607956|364357194|FG003|Double-Blinded Phase|Randomized but never treated|0|||
105643180|NCT02607956|364357191|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
105643181|NCT02607956|364357192|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
105643182|NCT02607956|364357193|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
105643183|NCT02607956|364357194|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
105643184|NCT02607956|364357191|FG000|Double-Blinded Phase|Death|4|||
105643185|NCT02607956|364357192|FG001|Double-Blinded Phase|Death|4|||
105643186|NCT02607956|364357193|FG002|Double-Blinded Phase|Death|0|||
105643187|NCT02607956|364357194|FG003|Double-Blinded Phase|Death|0|||
105643188|NCT02607956|364357191|FG000|Double-Blinded Phase|Adverse Event|4|||
105643189|NCT02607956|364357192|FG001|Double-Blinded Phase|Adverse Event|3|||
105643190|NCT02607956|364357193|FG002|Double-Blinded Phase|Adverse Event|0|||
105643191|NCT02607956|364357194|FG003|Double-Blinded Phase|Adverse Event|0|||
105643192|NCT02607956|364357191|FG000|Double-Blinded Phase|Protocol Violation|3|||
105643193|NCT02607956|364357192|FG001|Double-Blinded Phase|Protocol Violation|1|||
105643194|NCT02607956|364357193|FG002|Double-Blinded Phase|Protocol Violation|0|||
105643195|NCT02607956|364357194|FG003|Double-Blinded Phase|Protocol Violation|0|||
105643196|NCT02607956|364357191|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
105643197|NCT02607956|364357192|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
105643198|NCT02607956|364357193|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
105643199|NCT02607956|364357194|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
105643200|NCT02607956|364357191|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
105643201|NCT02607956|364357192|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
105643202|NCT02607956|364357193|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
105643203|NCT02607956|364357194|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
105643204|NCT02607956|364357191|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
105643205|NCT02607956|364357192|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
105643206|NCT02607956|364357193|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
105643207|NCT02607956|364357194|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
105643208|NCT02607956|364357191|FG000|Open-Label Extension Phase|Death|0|||
105643209|NCT02607956|364357192|FG001|Open-Label Extension Phase|Death|0|||
105643210|NCT02607956|364357193|FG002|Open-Label Extension Phase|Death|1|||
105643211|NCT02607956|364357194|FG003|Open-Label Extension Phase|Death|3|||
105643212|NCT02607956|364357191|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
105643213|NCT02607956|364357192|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
105643214|NCT02607956|364357193|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
105643215|NCT02607956|364357194|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
105643216|NCT02607956|364357191|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
105643217|NCT02607956|364357192|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
105643218|NCT02607956|364357193|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
105643219|NCT02607956|364357194|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
105643220|NCT02607956|364357191|FG000|Open-Label Extension Phase|Protocol Violation|0|||
105643221|NCT02607956|364357192|FG001|Open-Label Extension Phase|Protocol Violation|0|||
105643222|NCT02607956|364357193|FG002|Open-Label Extension Phase|Protocol Violation|0|||
105643223|NCT02607956|364357194|FG003|Open-Label Extension Phase|Protocol Violation|2|||
105643224|NCT02607956|364357191|FG000|Open-Label Extension Phase|Pregnancy|0|||
105643225|NCT02607956|364357192|FG001|Open-Label Extension Phase|Pregnancy|0|||
105643226|NCT02607956|364357193|FG002|Open-Label Extension Phase|Pregnancy|0|||
105643227|NCT02607956|364357194|FG003|Open-Label Extension Phase|Pregnancy|1|||
105643228|NCT01916109|364357195|FG000|Overall Study|Withdrawal by Subject|1|||
105643229|NCT04749797|364357200|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
105643230|NCT04749797|364357201|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
105643231|NCT04749797|364357202|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
105643232|NCT03072862|364357203|FG000|Overall Study|Withdrawal by Subject|4|||
105643233|NCT03072862|364357203|FG000|Overall Study|Lost to Follow-up|6|||
105643234|NCT03072862|364357203|FG000|Overall Study|Protocol Violation|4|||
105643235|NCT03072862|364357203|FG000|Overall Study|Physician Decision|2|||
105643236|NCT03072862|364357203|FG000|Overall Study|Death|1|||
105643237|NCT03072862|364357203|FG000|Overall Study|Adverse Event|1|||
105643238|NCT01441596|364357204|FG000|Overall Study|Other reason not defined below|0|||
105643239|NCT01441596|364357205|FG001|Overall Study|Other reason not defined below|2|||
105643240|NCT01441596|364357206|FG002|Overall Study|Other reason not defined below|1|||
105643241|NCT01441596|364357204|FG000|Overall Study|Withdrawal by Subject|4|||
105643242|NCT01441596|364357205|FG001|Overall Study|Withdrawal by Subject|0|||
105643243|NCT01441596|364357206|FG002|Overall Study|Withdrawal by Subject|2|||
105643244|NCT01441596|364357204|FG000|Overall Study|Not treated|0|||
105643245|NCT01441596|364357205|FG001|Overall Study|Not treated|1|||
105643246|NCT01441596|364357206|FG002|Overall Study|Not treated|1|||
105643247|NCT03015220|364357209|FG000|Overall Study|Withdrawal by Subject|3|||
105643248|NCT03015220|364357210|FG001|Overall Study|Withdrawal by Subject|2|||
105643249|NCT03015220|364357211|FG002|Overall Study|Withdrawal by Subject|2|||
105643250|NCT03015220|364357212|FG003|Overall Study|Withdrawal by Subject|2|||
105643251|NCT03015220|364357209|FG000|Overall Study|Lost to Follow-up|0|||
105643252|NCT03015220|364357210|FG001|Overall Study|Lost to Follow-up|0|||
105643253|NCT03015220|364357211|FG002|Overall Study|Lost to Follow-up|1|||
105643254|NCT03015220|364357212|FG003|Overall Study|Lost to Follow-up|0|||
105643255|NCT01115309|364357214|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
105643256|NCT01115309|364357214|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
105643257|NCT01115309|364357214|FG000|Long-term Follow-up|Lost to Follow-up|6|||
105643258|NCT00589628|364357217|FG000|Overall Study|Lost to Follow-up|0|||
105643259|NCT00589628|364357218|FG001|Overall Study|Lost to Follow-up|1|||
105643260|NCT02260154|364357219|FG000|Overall Study|Screening failure|2|||
105643261|NCT03032198|364357227|FG000|Overall Study|Screen Fail|1|||
105643262|NCT00866619|364357228|FG000|Overall Study|Adverse Event|112|||
105643263|NCT00866619|364357229|FG001|Overall Study|Adverse Event|106|||
105643264|NCT00866619|364357230|FG002|Overall Study|Adverse Event|47|||
105643265|NCT00866619|364357231|FG003|Overall Study|Adverse Event|44|||
105643266|NCT00866619|364357228|FG000|Overall Study|Protocol Violation|2|||
105643267|NCT00866619|364357229|FG001|Overall Study|Protocol Violation|39|||
105643268|NCT00866619|364357230|FG002|Overall Study|Protocol Violation|2|||
105643269|NCT00866619|364357231|FG003|Overall Study|Protocol Violation|17|||
105643270|NCT00866619|364357228|FG000|Overall Study|Withdrawal by Subject|587|||
105643271|NCT00866619|364357229|FG001|Overall Study|Withdrawal by Subject|295|||
105643272|NCT00866619|364357230|FG002|Overall Study|Withdrawal by Subject|272|||
105643273|NCT00866619|364357231|FG003|Overall Study|Withdrawal by Subject|144|||
105643274|NCT00866619|364357228|FG000|Overall Study|Lost to Follow-up|1145|||
105643275|NCT00866619|364357229|FG001|Overall Study|Lost to Follow-up|830|||
105643276|NCT00866619|364357230|FG002|Overall Study|Lost to Follow-up|568|||
105643277|NCT00866619|364357231|FG003|Overall Study|Lost to Follow-up|425|||
105643278|NCT00645411|364357232|FG000|Overall Study|Adverse Event|0|||
105643279|NCT00645411|364357233|FG001|Overall Study|Adverse Event|0|||
105643280|NCT00645411|364357234|FG002|Overall Study|Adverse Event|0|||
105643281|NCT00645411|364357235|FG003|Overall Study|Adverse Event|2|||
105643282|NCT00645411|364357232|FG000|Overall Study|Withdrawal by Subject|2|||
105643283|NCT00645411|364357233|FG001|Overall Study|Withdrawal by Subject|1|||
105643284|NCT00645411|364357234|FG002|Overall Study|Withdrawal by Subject|19|||
105643285|NCT00645411|364357235|FG003|Overall Study|Withdrawal by Subject|21|||
105643286|NCT00645411|364357232|FG000|Overall Study|Lost to Follow-up|10|||
105643287|NCT00645411|364357233|FG001|Overall Study|Lost to Follow-up|5|||
105643288|NCT00645411|364357234|FG002|Overall Study|Lost to Follow-up|124|||
105643289|NCT00645411|364357235|FG003|Overall Study|Lost to Follow-up|75|||
105643290|NCT00645411|364357232|FG000|Overall Study|Protocol Violation|1|||
105643291|NCT00645411|364357233|FG001|Overall Study|Protocol Violation|0|||
105643292|NCT00645411|364357234|FG002|Overall Study|Protocol Violation|1|||
105643293|NCT00645411|364357235|FG003|Overall Study|Protocol Violation|0|||
105643294|NCT00645411|364357232|FG000|Overall Study|Inappropriate enrollment|0|||
105643295|NCT00645411|364357233|FG001|Overall Study|Inappropriate enrollment|0|||
105643296|NCT00645411|364357234|FG002|Overall Study|Inappropriate enrollment|4|||
105643297|NCT00645411|364357235|FG003|Overall Study|Inappropriate enrollment|1|||
105643298|NCT00645411|364357232|FG000|Overall Study|Unable to classify|0|||
105643299|NCT00645411|364357233|FG001|Overall Study|Unable to classify|0|||
105643300|NCT00645411|364357234|FG002|Overall Study|Unable to classify|3|||
105643301|NCT00645411|364357235|FG003|Overall Study|Unable to classify|4|||
105643302|NCT02923349|364357237|FG000|Overall Study|Other|1|||
105643303|NCT02923349|364357238|FG001|Overall Study|Other|2|||
105643304|NCT02923349|364357239|FG002|Overall Study|Other|4|||
105643305|NCT02923349|364357240|FG003|Overall Study|Other|1|||
105643306|NCT02923349|364357241|FG004|Overall Study|Other|3|||
105643307|NCT02923349|364357242|FG005|Overall Study|Other|0|||
105643308|NCT02923349|364357243|FG006|Overall Study|Other|1|||
105643309|NCT02923349|364357237|FG000|Overall Study|Withdrawal by Subject|2|||
105643310|NCT02923349|364357238|FG001|Overall Study|Withdrawal by Subject|2|||
105643311|NCT02923349|364357239|FG002|Overall Study|Withdrawal by Subject|8|||
105643312|NCT02923349|364357240|FG003|Overall Study|Withdrawal by Subject|10|||
105643313|NCT02923349|364357241|FG004|Overall Study|Withdrawal by Subject|12|||
105643314|NCT02923349|364357242|FG005|Overall Study|Withdrawal by Subject|3|||
105643315|NCT02923349|364357243|FG006|Overall Study|Withdrawal by Subject|0|||
105643316|NCT02923349|364357237|FG000|Overall Study|Physician Decision|0|||
105643317|NCT02923349|364357238|FG001|Overall Study|Physician Decision|0|||
105643318|NCT02923349|364357239|FG002|Overall Study|Physician Decision|0|||
105643319|NCT02923349|364357240|FG003|Overall Study|Physician Decision|1|||
105643320|NCT02923349|364357241|FG004|Overall Study|Physician Decision|1|||
105643321|NCT02923349|364357242|FG005|Overall Study|Physician Decision|0|||
105643322|NCT02923349|364357243|FG006|Overall Study|Physician Decision|2|||
105643323|NCT02923349|364357237|FG000|Overall Study|Lost to Follow-up|0|||
105643324|NCT02923349|364357238|FG001|Overall Study|Lost to Follow-up|0|||
105643325|NCT02923349|364357239|FG002|Overall Study|Lost to Follow-up|3|||
105643326|NCT02923349|364357240|FG003|Overall Study|Lost to Follow-up|0|||
105643327|NCT02923349|364357241|FG004|Overall Study|Lost to Follow-up|1|||
105643328|NCT02923349|364357242|FG005|Overall Study|Lost to Follow-up|1|||
105643329|NCT02923349|364357243|FG006|Overall Study|Lost to Follow-up|0|||
105643330|NCT02923349|364357237|FG000|Overall Study|Death|1|||
105643331|NCT02923349|364357238|FG001|Overall Study|Death|0|||
105643332|NCT02923349|364357239|FG002|Overall Study|Death|2|||
105643333|NCT02923349|364357240|FG003|Overall Study|Death|4|||
105643334|NCT02923349|364357241|FG004|Overall Study|Death|2|||
105643335|NCT02923349|364357242|FG005|Overall Study|Death|3|||
105643336|NCT02923349|364357243|FG006|Overall Study|Death|0|||
105643337|NCT00800176|364357246|FG000|Overall Study|Adverse Event|2|||
105643338|NCT00800176|364357247|FG001|Overall Study|Adverse Event|1|||
105643339|NCT00800176|364357248|FG002|Overall Study|Adverse Event|0|||
105643340|NCT00800176|364357249|FG003|Overall Study|Adverse Event|2|||
105643341|NCT00800176|364357250|FG004|Overall Study|Adverse Event|1|||
105643342|NCT00800176|364357251|FG005|Overall Study|Adverse Event|1|||
105643343|NCT00800176|364357246|FG000|Overall Study|Refused treatment|3|||
105643344|NCT00800176|364357247|FG001|Overall Study|Refused treatment|2|||
105643345|NCT00800176|364357248|FG002|Overall Study|Refused treatment|0|||
105643346|NCT00800176|364357249|FG003|Overall Study|Refused treatment|0|||
105643347|NCT00800176|364357250|FG004|Overall Study|Refused treatment|1|||
105643348|NCT00800176|364357251|FG005|Overall Study|Refused treatment|4|||
105643349|NCT00800176|364357246|FG000|Overall Study|Failure to return|3|||
105643350|NCT00800176|364357247|FG001|Overall Study|Failure to return|3|||
105643351|NCT00800176|364357248|FG002|Overall Study|Failure to return|0|||
105643352|NCT00800176|364357249|FG003|Overall Study|Failure to return|2|||
105643353|NCT00800176|364357250|FG004|Overall Study|Failure to return|0|||
105643354|NCT00800176|364357251|FG005|Overall Study|Failure to return|0|||
105643355|NCT00800176|364357246|FG000|Overall Study|Other|1|||
105643356|NCT00800176|364357247|FG001|Overall Study|Other|0|||
105643357|NCT00800176|364357248|FG002|Overall Study|Other|0|||
105643358|NCT00800176|364357249|FG003|Overall Study|Other|0|||
105643359|NCT00800176|364357250|FG004|Overall Study|Other|2|||
105643360|NCT00800176|364357251|FG005|Overall Study|Other|0|||
105643361|NCT03100370|364357254|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
105643362|NCT03100370|364357255|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
105643363|NCT03100370|364357256|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
105643364|NCT03100370|364357257|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
105643365|NCT03100370|364357258|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
105643366|NCT03100370|364357259|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
105643367|NCT03820024|364357260|FG000|Overall Study|Physician Decision|1|||
105643368|NCT03820024|364357261|FG001|Overall Study|Physician Decision|2|||
105643369|NCT03138499|364357262|FG000|Overall Study|Lost to Follow-up|1|||
105643370|NCT03138499|364357263|FG001|Overall Study|Lost to Follow-up|0|||
105643371|NCT03138499|364357262|FG000|Overall Study|Participants withdrew consent|1|||
105643372|NCT03138499|364357263|FG001|Overall Study|Participants withdrew consent|0|||
105643373|NCT03138499|364357262|FG000|Overall Study|Participant discontinued study before treatment|0|||
105643374|NCT03138499|364357263|FG001|Overall Study|Participant discontinued study before treatment|1|||
105643375|NCT03138499|364357262|FG000|Overall Study|Disease Progression|2|||
105643376|NCT03138499|364357263|FG001|Overall Study|Disease Progression|6|||
105643377|NCT03138499|364357262|FG000|Overall Study|Study drug toxicity|2|||
105643378|NCT03138499|364357263|FG001|Overall Study|Study drug toxicity|2|||
105643379|NCT03138499|364357262|FG000|Overall Study|Participant request to discontinue study treatment|1|||
105643380|NCT03138499|364357263|FG001|Overall Study|Participant request to discontinue study treatment|1|||
105643381|NCT03138499|364357262|FG000|Overall Study|Other reasons|2|||
105643382|NCT03138499|364357263|FG001|Overall Study|Other reasons|0|||
105643383|NCT02892019|364357264|FG000|Overall Study|randomized but not treated|0|||
105643384|NCT02892019|364357265|FG001|Overall Study|randomized but not treated|1|||
105643385|NCT02892019|364357264|FG000|Overall Study|Withdrawal by Subject|0|||
105643386|NCT02892019|364357265|FG001|Overall Study|Withdrawal by Subject|1|||
105643387|NCT02892019|364357264|FG000|Overall Study|Adverse Event|1|||
105643388|NCT02892019|364357265|FG001|Overall Study|Adverse Event|1|||
105643389|NCT00689351|364357266|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
105643390|NCT00689351|364357267|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
105643391|NCT00689351|364357266|FG000|Infant Series of Dosing|Adverse Event|1|||
105643392|NCT00689351|364357267|FG001|Infant Series of Dosing|Adverse Event|0|||
105643393|NCT00689351|364357266|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
105643394|NCT00689351|364357267|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
105643395|NCT00689351|364357266|FG000|After Infant Series|Parent/legal guardian request|1|||
105643396|NCT00689351|364357267|FG001|After Infant Series|Parent/legal guardian request|0|||
105643397|NCT01313663|364357268|FG000|Overall Study|Study Closed/Terminated|2|||
105643398|NCT01313663|364357269|FG001|Overall Study|Study Closed/Terminated|4|||
105643399|NCT01313663|364357268|FG000|Overall Study|Lost to Follow-up|0|||
105643400|NCT01313663|364357269|FG001|Overall Study|Lost to Follow-up|1|||
105643401|NCT01313663|364357268|FG000|Overall Study|Physician Decision|0|||
105643402|NCT01313663|364357269|FG001|Overall Study|Physician Decision|2|||
105643403|NCT01313663|364357268|FG000|Overall Study|Withdrawal by Subject|2|||
105643404|NCT01313663|364357269|FG001|Overall Study|Withdrawal by Subject|1|||
105643405|NCT01229176|364357271|FG000|Overall Study|Withdrawal by Subject|0|||
105643406|NCT01229176|364357272|FG001|Overall Study|Withdrawal by Subject|0|||
105643407|NCT01229176|364357273|FG002|Overall Study|Withdrawal by Subject|0|||
105643408|NCT01229176|364357274|FG003|Overall Study|Withdrawal by Subject|1|||
105643409|NCT01229176|364357275|FG004|Overall Study|Withdrawal by Subject|1|||
105643410|NCT01229176|364357276|FG005|Overall Study|Withdrawal by Subject|1|||
105643411|NCT01229176|364357277|FG006|Overall Study|Withdrawal by Subject|0|||
105643412|NCT01229176|364357278|FG007|Overall Study|Withdrawal by Subject|1|||
105643413|NCT01229176|364357271|FG000|Overall Study|Lost to Follow-up|0|||
105643414|NCT01229176|364357272|FG001|Overall Study|Lost to Follow-up|3|||
105643415|NCT01229176|364357273|FG002|Overall Study|Lost to Follow-up|0|||
105643416|NCT01229176|364357274|FG003|Overall Study|Lost to Follow-up|0|||
105643417|NCT01229176|364357275|FG004|Overall Study|Lost to Follow-up|1|||
105643418|NCT01229176|364357276|FG005|Overall Study|Lost to Follow-up|1|||
105643419|NCT01229176|364357277|FG006|Overall Study|Lost to Follow-up|0|||
105643420|NCT01229176|364357278|FG007|Overall Study|Lost to Follow-up|2|||
105643421|NCT01867307|364357281|FG000|Overall Study|Protocol Violation|2|||
105643422|NCT01867307|364357282|FG001|Overall Study|Protocol Violation|0|||
105643423|NCT01867307|364357281|FG000|Overall Study|Other Adverse Event|1|||
105643424|NCT01867307|364357282|FG001|Overall Study|Other Adverse Event|3|||
105643425|NCT01884571|364357287|FG000|Overall Study|Adverse Event|1|||
105643426|NCT01884571|364357287|FG000|Overall Study|Death|2|||
105643427|NCT01884571|364357287|FG000|Overall Study|Withdrawal by Subject|2|||
105643428|NCT01884571|364357287|FG000|Overall Study|Disease progression|3|||
105643429|NCT00853957|364357288|FG000|Overall Study|Adverse Event|9|||
105643430|NCT00853957|364357289|FG001|Overall Study|Adverse Event|3|||
105643431|NCT00853957|364357288|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105643432|NCT00853957|364357289|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105643433|NCT00853957|364357288|FG000|Overall Study|Subject withdrew consent|4|||
105643434|NCT00853957|364357289|FG001|Overall Study|Subject withdrew consent|5|||
105643435|NCT00853957|364357288|FG000|Overall Study|Lost to Follow-up|1|||
105643436|NCT00853957|364357289|FG001|Overall Study|Lost to Follow-up|6|||
105643437|NCT00853957|364357288|FG000|Overall Study|Protocol deviation|0|||
105643438|NCT00853957|364357289|FG001|Overall Study|Protocol deviation|3|||
105643439|NCT04097535|364357299|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
105643440|NCT02880293|364358833|FG000|Overall Study|Inevaluable|5|||
105643441|NCT01277302|364358836|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
105643442|NCT01277302|364358837|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
105643443|NCT01277302|364358838|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
105643444|NCT01277302|364358836|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
105643445|NCT01277302|364358837|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
105643446|NCT01277302|364358838|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
105643447|NCT01277302|364358836|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
105643448|NCT01277302|364358837|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
105643449|NCT01277302|364358838|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
105643450|NCT01277302|364358836|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
105643451|NCT01277302|364358837|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
105643452|NCT01277302|364358838|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
105643453|NCT01277302|364358836|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
105643454|NCT01277302|364358837|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
105643455|NCT01277302|364358838|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
105643456|NCT01277302|364358836|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
105643457|NCT01277302|364358837|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
105643458|NCT01277302|364358838|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
105643459|NCT01277302|364358836|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
105643460|NCT01277302|364358837|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
105643461|NCT01277302|364358838|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
105643462|NCT01277302|364358836|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
105643463|NCT01277302|364358837|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
105659337|NCT00551135|364417280|FG000|Overall Study|Other|3|||
105643464|NCT01277302|364358838|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
105643465|NCT01277302|364358836|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
105643466|NCT01277302|364358837|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
105643467|NCT01277302|364358838|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
105643468|NCT03332589|364358839|FG000|Overall Study|Lack of Efficacy|2|||
105643469|NCT03332589|364358840|FG001|Overall Study|Lack of Efficacy|0|||
105643470|NCT03332589|364358841|FG002|Overall Study|Lack of Efficacy|0|||
105643471|NCT03332589|364358839|FG000|Overall Study|Adverse Event|1|||
105643472|NCT03332589|364358840|FG001|Overall Study|Adverse Event|0|||
105643473|NCT03332589|364358841|FG002|Overall Study|Adverse Event|0|||
105643474|NCT03332589|364358839|FG000|Overall Study|Death|1|||
105643475|NCT03332589|364358840|FG001|Overall Study|Death|0|||
105643476|NCT03332589|364358841|FG002|Overall Study|Death|0|||
105643477|NCT00108355|364358845|FG000|Overall Study|Peritonitis at index paracentesis|1|||
105643478|NCT00108355|364358846|FG001|Overall Study|Peritonitis at index paracentesis|1|||
105643479|NCT00108355|364358845|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
105643480|NCT00108355|364358846|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
105643481|NCT02507297|364358847|FG000|Overall Study|Withdrawal by Subject|1|||
105643482|NCT02507297|364358848|FG001|Overall Study|Withdrawal by Subject|0|||
105643483|NCT02507297|364358847|FG000|Overall Study|Lost to Follow-up|0|||
105643484|NCT02507297|364358848|FG001|Overall Study|Lost to Follow-up|1|||
105643485|NCT00647699|364358849|FG000|Overall Study|Lost to Follow-up|5|||
105643486|NCT00647699|364358850|FG001|Overall Study|Lost to Follow-up|4|||
105643487|NCT00647699|364358849|FG000|Overall Study|Withdrawal by Subject|3|||
105643488|NCT00647699|364358850|FG001|Overall Study|Withdrawal by Subject|8|||
105643489|NCT03029585|364358853|FG000|Overall Study|Death|1|||
105643490|NCT03029585|364358854|FG001|Overall Study|Death|1|||
105643491|NCT03029585|364358853|FG000|Overall Study|Withdrawal by Subject|1|||
105643492|NCT03029585|364358854|FG001|Overall Study|Withdrawal by Subject|0|||
105643493|NCT01304940|364358856|FG000|Overall Study|not meet symptom severity requirement|3|||
105643494|NCT01304940|364358857|FG001|Overall Study|not meet symptom severity requirement|0|||
105643495|NCT00278395|364358858|FG000|Overall Study|Adverse Event|2|||
105643496|NCT00278395|364358858|FG000|Overall Study|Nonevaluable|1|||
105643497|NCT00246129|364358863|FG000|Overall Study|Lost to Follow-up|1|||
105643498|NCT00246129|364358864|FG001|Overall Study|Lost to Follow-up|0|||
105643499|NCT00246129|364358863|FG000|Overall Study|Death|2|||
105643500|NCT00246129|364358864|FG001|Overall Study|Death|1|||
105643501|NCT00246129|364358863|FG000|Overall Study|suffered primary non-function|1|||
105643502|NCT00246129|364358864|FG001|Overall Study|suffered primary non-function|0|||
105643503|NCT00246129|364358863|FG000|Overall Study|grafts failed|3|||
105643504|NCT00246129|364358864|FG001|Overall Study|grafts failed|1|||
105643505|NCT03740737|364358865|FG000|Overall Study|Protocol deviation|13|||
105643506|NCT03740737|364358866|FG001|Overall Study|Protocol deviation|0|||
105643507|NCT03740737|364358865|FG000|Overall Study|Adverse Event|2|||
105643508|NCT03740737|364358866|FG001|Overall Study|Adverse Event|0|||
105643509|NCT03740737|364358865|FG000|Overall Study|Lost to Follow-up|1|||
105643510|NCT03740737|364358866|FG001|Overall Study|Lost to Follow-up|0|||
105643511|NCT03740737|364358865|FG000|Overall Study|Randomization failure|1|||
105643512|NCT03740737|364358866|FG001|Overall Study|Randomization failure|0|||
105643513|NCT03740737|364358865|FG000|Overall Study|Participant withdrew consent|1|||
105643514|NCT03740737|364358866|FG001|Overall Study|Participant withdrew consent|0|||
105643515|NCT03740737|364358865|FG000|Overall Study|Participant withdrew from trial|2|||
105643516|NCT03740737|364358866|FG001|Overall Study|Participant withdrew from trial|1|||
105643517|NCT03928743|364358867|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
105643518|NCT03928743|364358868|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
105643519|NCT03928743|364358869|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
105643520|NCT03928743|364358867|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
105643521|NCT03928743|364358868|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
105643522|NCT03928743|364358869|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
105643523|NCT03928743|364358867|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
105643524|NCT03928743|364358868|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
105643525|NCT03928743|364358869|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
105643526|NCT03928743|364358867|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
105643527|NCT03928743|364358868|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
105643528|NCT03928743|364358869|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
105643529|NCT03928743|364358867|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
105643530|NCT03928743|364358868|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
105643531|NCT03928743|364358869|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
105643532|NCT03928743|364358867|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
105643533|NCT03928743|364358868|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
105643534|NCT03928743|364358869|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
105643535|NCT03928743|364358867|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
105643536|NCT03928743|364358868|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
105643537|NCT03928743|364358869|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
105643538|NCT03928743|364358867|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
105643539|NCT03928743|364358868|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
105643540|NCT03928743|364358869|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
105643541|NCT03928743|364358867|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
105643542|NCT03928743|364358868|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
105643543|NCT03928743|364358869|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
105643544|NCT03928743|364358867|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
105643545|NCT03928743|364358868|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
105643546|NCT03928743|364358869|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
105643547|NCT03928743|364358867|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
105643548|NCT03928743|364358868|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
105643549|NCT03928743|364358869|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
105643550|NCT05005247|364358870|FG000|Overall Study|Withdrawal by Subject|0|||
105643551|NCT05005247|364358871|FG001|Overall Study|Withdrawal by Subject|1|||
105643552|NCT05005247|364358872|FG002|Overall Study|Withdrawal by Subject|0|||
105643553|NCT01381549|364358878|FG000|Overall Study|Ineligible: No organisms isolated|0|||
105643554|NCT01381549|364358879|FG001|Overall Study|Ineligible: No organisms isolated|0|||
105643555|NCT01381549|364358880|FG002|Overall Study|Ineligible: No organisms isolated|1|||
105643556|NCT02889900|364358881|FG000|Overall Study|Adverse Event|11|||
105643557|NCT02889900|364358881|FG000|Overall Study|Condition under investigation worsened|32|||
105643558|NCT02889900|364358881|FG000|Overall Study|Other|5|||
105643559|NCT02889900|364358881|FG000|Overall Study|Withdrawal by Subject|7|||
105643560|NCT02889900|364358881|FG000|Overall Study|Not treated|2|||
105643561|NCT00080119|364358884|FG000|Overall Study|Discontinued because of study closure|0|||
105643562|NCT00080119|364358885|FG001|Overall Study|Discontinued because of study closure|0|||
105643563|NCT00080119|364358886|FG002|Overall Study|Discontinued because of study closure|130|||
105643564|NCT00080119|364358887|FG003|Overall Study|Discontinued because of study closure|141|||
105643565|NCT00080119|364358884|FG000|Overall Study|Unable to get to clinic|24|||
105643566|NCT00080119|364358885|FG001|Overall Study|Unable to get to clinic|24|||
105643567|NCT00080119|364358886|FG002|Overall Study|Unable to get to clinic|7|||
105643568|NCT00080119|364358887|FG003|Overall Study|Unable to get to clinic|1|||
105643569|NCT00080119|364358884|FG000|Overall Study|Consent withdrawn|13|||
105643570|NCT00080119|364358885|FG001|Overall Study|Consent withdrawn|17|||
105643571|NCT00080119|364358886|FG002|Overall Study|Consent withdrawn|4|||
105643572|NCT00080119|364358887|FG003|Overall Study|Consent withdrawn|6|||
105643573|NCT00080119|364358884|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
105643574|NCT00080119|364358885|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
105643575|NCT00080119|364358886|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
105643576|NCT00080119|364358887|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
105643577|NCT00080119|364358884|FG000|Overall Study|Lost to Follow-up|16|||
105643578|NCT00080119|364358885|FG001|Overall Study|Lost to Follow-up|19|||
105643579|NCT00080119|364358886|FG002|Overall Study|Lost to Follow-up|19|||
105643580|NCT00080119|364358887|FG003|Overall Study|Lost to Follow-up|14|||
105643581|NCT00871494|364358891|FG000|Overall Study|Protocol Violation|5|||
105643582|NCT00871494|364358891|FG000|Overall Study|Lack of Efficacy|4|||
105643583|NCT00871494|364358891|FG000|Overall Study|Adverse Event|4|||
105643584|NCT00871494|364358891|FG000|Overall Study|Lost to Follow-up|1|||
105643585|NCT04410445|364358892|FG000|Overall Study|Lost to Follow-up|3|||
105643586|NCT04410445|364358893|FG001|Overall Study|Lost to Follow-up|9|||
105643587|NCT04410445|364358892|FG000|Overall Study|Withdrawal by Subject|27|||
105643588|NCT04410445|364358893|FG001|Overall Study|Withdrawal by Subject|15|||
105643589|NCT01320683|364358894|FG000|Overall Study|Positive antibody response|1|||
105643590|NCT01123356|364358895|FG000|Overall Study|Adverse Event|2|||
105643591|NCT01123356|364358895|FG000|Overall Study|Lack of Efficacy|4|||
105643592|NCT01123356|364358895|FG000|Overall Study|Withdrawal by Subject|1|||
105643593|NCT03136861|364358903|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
105643594|NCT03136861|364358904|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
105643595|NCT03136861|364358905|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
105643596|NCT03136861|364358906|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
105643597|NCT03136861|364358907|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
105643598|NCT03136861|364358908|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
105643599|NCT03136861|364358909|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
105643600|NCT03136861|364358903|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
105643601|NCT03136861|364358904|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
105643602|NCT03136861|364358905|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
105643603|NCT03136861|364358906|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
105643604|NCT03136861|364358907|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
105643605|NCT03136861|364358908|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
105659338|NCT00551135|364417281|FG001|Overall Study|Other|2|||
105643606|NCT03136861|364358909|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
105643607|NCT03136861|364358903|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
105643608|NCT03136861|364358904|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
105643609|NCT03136861|364358905|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
105643610|NCT03136861|364358906|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
105643611|NCT03136861|364358907|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
105643612|NCT03136861|364358908|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
105643613|NCT03136861|364358909|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
105643614|NCT03136861|364358903|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
105643615|NCT03136861|364358904|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
105643616|NCT03136861|364358905|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
105643617|NCT03136861|364358906|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
105643618|NCT03136861|364358907|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
105643619|NCT03136861|364358908|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
105643620|NCT03136861|364358909|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
105643621|NCT03136861|364358903|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
105643622|NCT03136861|364358904|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
105643623|NCT03136861|364358905|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
105643624|NCT03136861|364358906|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
105643625|NCT03136861|364358907|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
105643626|NCT03136861|364358908|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
105643627|NCT03136861|364358909|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
105643628|NCT03136861|364358903|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
105643629|NCT03136861|364358904|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
105643630|NCT03136861|364358905|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
105643631|NCT03136861|364358906|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
105643632|NCT03136861|364358907|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
105643633|NCT03136861|364358908|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
105643634|NCT03136861|364358909|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
105643635|NCT03136861|364358903|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
105643636|NCT03136861|364358904|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
105643637|NCT03136861|364358905|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
105643638|NCT03136861|364358906|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
105643639|NCT03136861|364358907|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
105643640|NCT03136861|364358908|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
105643641|NCT03136861|364358909|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
105643642|NCT03136861|364358903|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
105643643|NCT03136861|364358904|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
105643644|NCT03136861|364358905|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
105643645|NCT03136861|364358906|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
105643646|NCT03136861|364358907|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
105643647|NCT03136861|364358908|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
105643648|NCT03136861|364358909|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
105643649|NCT03390166|364358910|FG000|Overall Study|Death|0|||
105643650|NCT03390166|364358911|FG001|Overall Study|Death|1|||
105643651|NCT03390166|364358910|FG000|Overall Study|Lost to Follow-up|6|||
105643652|NCT03390166|364358911|FG001|Overall Study|Lost to Follow-up|4|||
105643653|NCT03390166|364358910|FG000|Overall Study|Physician Decision|2|||
105643654|NCT03390166|364358911|FG001|Overall Study|Physician Decision|1|||
105643655|NCT03390166|364358910|FG000|Overall Study|Move from study area|3|||
105643656|NCT03390166|364358911|FG001|Overall Study|Move from study area|2|||
105643657|NCT03390166|364358910|FG000|Overall Study|To militarycamp for conscript|1|||
105643658|NCT03390166|364358911|FG001|Overall Study|To militarycamp for conscript|0|||
105643659|NCT03390166|364358910|FG000|Overall Study|To drug therapy course|0|||
105643660|NCT03390166|364358911|FG001|Overall Study|To drug therapy course|1|||
105643661|NCT03390166|364358910|FG000|Overall Study|Move to work oversea|0|||
105643662|NCT03390166|364358911|FG001|Overall Study|Move to work oversea|1|||
105643663|NCT03693989|364358915|FG000|Overall Study|Protocol Violation|3|||
105643664|NCT03693989|364358916|FG001|Overall Study|Protocol Violation|4|||
105643665|NCT01052272|364358917|FG000|Overall Study|Death|0|||
105643666|NCT01052272|364358918|FG001|Overall Study|Death|0|||
105643667|NCT01052272|364358919|FG002|Overall Study|Death|1|||
105643668|NCT01052272|364358920|FG003|Overall Study|Death|1|||
105643669|NCT01052272|364358917|FG000|Overall Study|Physician Decision|0|||
105643670|NCT01052272|364358918|FG001|Overall Study|Physician Decision|1|||
105643671|NCT01052272|364358919|FG002|Overall Study|Physician Decision|0|||
105643672|NCT01052272|364358920|FG003|Overall Study|Physician Decision|0|||
105643673|NCT01052272|364358917|FG000|Overall Study|patient refuses follow-up|5|||
105643674|NCT01052272|364358918|FG001|Overall Study|patient refuses follow-up|4|||
105643675|NCT01052272|364358919|FG002|Overall Study|patient refuses follow-up|2|||
105643676|NCT01052272|364358920|FG003|Overall Study|patient refuses follow-up|4|||
105643677|NCT01052272|364358917|FG000|Overall Study|Withdrawal by Subject|0|||
105643678|NCT01052272|364358918|FG001|Overall Study|Withdrawal by Subject|2|||
105643679|NCT01052272|364358919|FG002|Overall Study|Withdrawal by Subject|3|||
105643680|NCT01052272|364358920|FG003|Overall Study|Withdrawal by Subject|2|||
105643681|NCT01052272|364358917|FG000|Overall Study|placed in long-term care|0|||
105643682|NCT01052272|364358918|FG001|Overall Study|placed in long-term care|0|||
105643683|NCT01052272|364358919|FG002|Overall Study|placed in long-term care|1|||
105643684|NCT01052272|364358920|FG003|Overall Study|placed in long-term care|0|||
105643685|NCT01052272|364358917|FG000|Overall Study|decline in health|0|||
105643686|NCT01052272|364358918|FG001|Overall Study|decline in health|0|||
105643687|NCT01052272|364358919|FG002|Overall Study|decline in health|1|||
105643688|NCT01052272|364358920|FG003|Overall Study|decline in health|0|||
105643689|NCT00113529|364358921|FG000|Overall Study|Adverse Event|4|||
105643690|NCT00113529|364358921|FG000|Overall Study|Lack of Efficacy|20|||
105643691|NCT00113529|364358921|FG000|Overall Study|Decision of sponsor|6|||
105643692|NCT00113529|364358921|FG000|Overall Study|Withdrawal by Subject|4|||
105643693|NCT01722097|364358922|FG000|Overall Study|Patient sheets not returned|6|||
105643694|NCT01722097|364358923|FG001|Overall Study|Patient sheets not returned|5|||
105643695|NCT04908488|364358928|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
105643696|NCT04908488|364358929|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
105643697|NCT04908488|364358928|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
105643698|NCT04908488|364358929|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
105643699|NCT01014013|364358935|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
105643700|NCT01014013|364358936|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
105643701|NCT01014013|364358935|FG000|Overall Study|Clinical adverse experience|4|||
105643702|NCT01014013|364358936|FG001|Overall Study|Clinical adverse experience|2|||
105643703|NCT01014013|364358935|FG000|Overall Study|Laboratory adverse experience|1|||
105643704|NCT01014013|364358936|FG001|Overall Study|Laboratory adverse experience|1|||
105643705|NCT01014013|364358935|FG000|Overall Study|Protocol Violation|1|||
105643706|NCT01014013|364358936|FG001|Overall Study|Protocol Violation|3|||
105643707|NCT01014013|364358935|FG000|Overall Study|Withdrawal by Subject|7|||
105643708|NCT01014013|364358936|FG001|Overall Study|Withdrawal by Subject|4|||
105643709|NCT01014013|364358935|FG000|Overall Study|Clinical/microbiologic failure|1|||
105643710|NCT01014013|364358936|FG001|Overall Study|Clinical/microbiologic failure|2|||
105643711|NCT01014013|364358935|FG000|Overall Study|Pathogen culture = no growth|26|||
105643712|NCT01014013|364358936|FG001|Overall Study|Pathogen culture = no growth|34|||
105643713|NCT01014013|364358935|FG000|Overall Study|Negative urine culture|2|||
105643714|NCT01014013|364358936|FG001|Overall Study|Negative urine culture|0|||
105643715|NCT01014013|364358935|FG000|Overall Study|Pathogen resistant|7|||
105643716|NCT01014013|364358936|FG001|Overall Study|Pathogen resistant|4|||
105643717|NCT01014013|364358935|FG000|Overall Study|Physician Decision|0|||
105643718|NCT01014013|364358936|FG001|Overall Study|Physician Decision|1|||
105643719|NCT01014013|364358935|FG000|Overall Study|Another antibiotic therapy required|0|||
105643720|NCT01014013|364358936|FG001|Overall Study|Another antibiotic therapy required|1|||
105643721|NCT01014013|364358935|FG000|Overall Study|Appendectomy|1|||
105643722|NCT01014013|364358936|FG001|Overall Study|Appendectomy|0|||
105643723|NCT01014013|364358935|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
105643724|NCT01014013|364358936|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
105643725|NCT00595959|364358937|FG000|Overall Study|Withdrawal by Subject|1|||
105643726|NCT00595959|364358937|FG000|Overall Study|Lost to Follow-up|1|||
105643727|NCT01020435|364358945|FG000|Overall Study|Lost to Follow-up|0|||
105643728|NCT01020435|364358946|FG001|Overall Study|Lost to Follow-up|1|||
105643729|NCT02291549|364358949|FG000|Overall Study|Lost to Follow-up|1|||
105643730|NCT02291549|364358950|FG001|Overall Study|Lost to Follow-up|0|||
105643731|NCT02291549|364358949|FG000|Overall Study|Withdrawal by Subject|0|||
105643732|NCT02291549|364358950|FG001|Overall Study|Withdrawal by Subject|1|||
105643733|NCT01794689|364358951|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
105643734|NCT01794689|364358952|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
105643735|NCT01794689|364358953|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
105643736|NCT01794689|364358954|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
105643737|NCT01794689|364358951|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
105643738|NCT01794689|364358952|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
105643739|NCT01794689|364358953|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
105643740|NCT01794689|364358954|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
105643741|NCT01794689|364358951|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
105643742|NCT01794689|364358952|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
105643743|NCT01794689|364358953|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
105643744|NCT01794689|364358954|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
105643745|NCT01794689|364358951|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
105643746|NCT01794689|364358952|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
105643747|NCT01794689|364358953|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
105643748|NCT01794689|364358954|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
105643749|NCT01528605|364358956|FG000|Overall Study|Lost to Follow-up|1|||
105643750|NCT01528605|364358957|FG001|Overall Study|Lost to Follow-up|0|||
105643751|NCT01528605|364358958|FG002|Overall Study|Lost to Follow-up|1|||
105643752|NCT01528605|364358959|FG003|Overall Study|Lost to Follow-up|1|||
105643753|NCT01528605|364358960|FG004|Overall Study|Lost to Follow-up|0|||
105643754|NCT01528605|364358961|FG005|Overall Study|Lost to Follow-up|0|||
105643755|NCT01528605|364358956|FG000|Overall Study|Death|1|||
105643756|NCT01528605|364358957|FG001|Overall Study|Death|0|||
105643757|NCT01528605|364358958|FG002|Overall Study|Death|0|||
105643758|NCT01528605|364358959|FG003|Overall Study|Death|0|||
105643759|NCT01528605|364358960|FG004|Overall Study|Death|0|||
105643760|NCT01528605|364358961|FG005|Overall Study|Death|0|||
105643761|NCT02561195|364358962|FG000|Vaccination 1 to 3|Adverse Event|4|||
105643762|NCT02561195|364358963|FG001|Vaccination 1 to 3|Adverse Event|5|||
105643763|NCT02561195|364358964|FG002|Vaccination 1 to 3|Adverse Event|0|||
105643764|NCT02561195|364358965|FG003|Vaccination 1 to 3|Adverse Event|3|||
105643765|NCT02561195|364358966|FG004|Vaccination 1 to 3|Adverse Event|4|||
105643766|NCT02561195|364358967|FG005|Vaccination 1 to 3|Adverse Event|0|||
105643767|NCT02561195|364358968|FG006|Vaccination 1 to 3|Adverse Event|0|||
105643768|NCT02561195|364358969|FG007|Vaccination 1 to 3|Adverse Event|0|||
105643769|NCT02561195|364358970|FG008|Vaccination 1 to 3|Adverse Event|0|||
105643770|NCT02561195|364358971|FG009|Vaccination 1 to 3|Adverse Event|0|||
105643771|NCT02561195|364358972|FG010|Vaccination 1 to 3|Adverse Event|0|||
105643772|NCT02561195|364358973|FG011|Vaccination 1 to 3|Adverse Event|0|||
105643773|NCT02561195|364358974|FG012|Vaccination 1 to 3|Adverse Event|0|||
105643774|NCT02561195|364358975|FG013|Vaccination 1 to 3|Adverse Event|0|||
105643775|NCT02561195|364358962|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
105643776|NCT02561195|364358963|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
105643777|NCT02561195|364358964|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
105643778|NCT02561195|364358965|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
105643779|NCT02561195|364358966|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
105643780|NCT02561195|364358967|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
105643781|NCT02561195|364358968|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
105643782|NCT02561195|364358969|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
105643783|NCT02561195|364358970|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
105643784|NCT02561195|364358971|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
105643785|NCT02561195|364358972|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
105643786|NCT02561195|364358973|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
105643787|NCT02561195|364358974|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
105643788|NCT02561195|364358975|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
105643789|NCT02561195|364358962|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643790|NCT02561195|364358963|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
105643791|NCT02561195|364358964|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643792|NCT02561195|364358965|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
105643793|NCT02561195|364358966|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
105643794|NCT02561195|364358967|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
105643795|NCT02561195|364358968|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643796|NCT02561195|364358969|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643797|NCT02561195|364358970|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643798|NCT02561195|364358971|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643799|NCT02561195|364358972|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643800|NCT02561195|364358973|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643801|NCT02561195|364358974|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643802|NCT02561195|364358975|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643803|NCT02561195|364358962|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
105643804|NCT02561195|364358963|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
105643805|NCT02561195|364358964|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
105643806|NCT02561195|364358965|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
105643807|NCT02561195|364358966|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
105643808|NCT02561195|364358967|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
105643809|NCT02561195|364358968|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
105643810|NCT02561195|364358969|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
105643811|NCT02561195|364358970|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
105643812|NCT02561195|364358971|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
105643813|NCT02561195|364358972|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
105643814|NCT02561195|364358973|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
105643815|NCT02561195|364358974|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
105643816|NCT02561195|364358975|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
105643817|NCT02561195|364358962|FG000|Vaccination 1 to 3|Other|7|||
105643818|NCT02561195|364358963|FG001|Vaccination 1 to 3|Other|3|||
105643819|NCT02561195|364358964|FG002|Vaccination 1 to 3|Other|1|||
105643820|NCT02561195|364358965|FG003|Vaccination 1 to 3|Other|7|||
105643821|NCT02561195|364358966|FG004|Vaccination 1 to 3|Other|5|||
105643822|NCT02561195|364358967|FG005|Vaccination 1 to 3|Other|1|||
105643823|NCT02561195|364358968|FG006|Vaccination 1 to 3|Other|0|||
105643824|NCT02561195|364358969|FG007|Vaccination 1 to 3|Other|0|||
105643825|NCT02561195|364358970|FG008|Vaccination 1 to 3|Other|0|||
105643826|NCT02561195|364358971|FG009|Vaccination 1 to 3|Other|0|||
105643827|NCT02561195|364358972|FG010|Vaccination 1 to 3|Other|0|||
105643828|NCT02561195|364358973|FG011|Vaccination 1 to 3|Other|0|||
105643829|NCT02561195|364358974|FG012|Vaccination 1 to 3|Other|0|||
105643830|NCT02561195|364358975|FG013|Vaccination 1 to 3|Other|0|||
105643831|NCT02561195|364358962|FG000|Vaccination 1 to 3|Protocol Violation|1|||
105643832|NCT02561195|364358963|FG001|Vaccination 1 to 3|Protocol Violation|0|||
105643833|NCT02561195|364358964|FG002|Vaccination 1 to 3|Protocol Violation|1|||
105643834|NCT02561195|364358965|FG003|Vaccination 1 to 3|Protocol Violation|2|||
105643835|NCT02561195|364358966|FG004|Vaccination 1 to 3|Protocol Violation|5|||
105643836|NCT02561195|364358967|FG005|Vaccination 1 to 3|Protocol Violation|2|||
105643837|NCT02561195|364358968|FG006|Vaccination 1 to 3|Protocol Violation|0|||
105643838|NCT02561195|364358969|FG007|Vaccination 1 to 3|Protocol Violation|0|||
105643839|NCT02561195|364358970|FG008|Vaccination 1 to 3|Protocol Violation|0|||
105643840|NCT02561195|364358971|FG009|Vaccination 1 to 3|Protocol Violation|0|||
105643841|NCT02561195|364358972|FG010|Vaccination 1 to 3|Protocol Violation|0|||
105643842|NCT02561195|364358973|FG011|Vaccination 1 to 3|Protocol Violation|0|||
105643843|NCT02561195|364358974|FG012|Vaccination 1 to 3|Protocol Violation|0|||
105643844|NCT02561195|364358975|FG013|Vaccination 1 to 3|Protocol Violation|0|||
105643845|NCT02561195|364358962|FG000|Vaccination 1 to 3|Death|2|||
105643846|NCT02561195|364358963|FG001|Vaccination 1 to 3|Death|1|||
105643847|NCT02561195|364358964|FG002|Vaccination 1 to 3|Death|0|||
105643848|NCT02561195|364358965|FG003|Vaccination 1 to 3|Death|2|||
105643849|NCT02561195|364358966|FG004|Vaccination 1 to 3|Death|0|||
105643850|NCT02561195|364358967|FG005|Vaccination 1 to 3|Death|0|||
105643851|NCT02561195|364358968|FG006|Vaccination 1 to 3|Death|0|||
105643852|NCT02561195|364358969|FG007|Vaccination 1 to 3|Death|0|||
105643853|NCT02561195|364358970|FG008|Vaccination 1 to 3|Death|0|||
105643854|NCT02561195|364358971|FG009|Vaccination 1 to 3|Death|0|||
105643855|NCT02561195|364358972|FG010|Vaccination 1 to 3|Death|0|||
105643856|NCT02561195|364358973|FG011|Vaccination 1 to 3|Death|0|||
105643857|NCT02561195|364358974|FG012|Vaccination 1 to 3|Death|0|||
105643858|NCT02561195|364358975|FG013|Vaccination 1 to 3|Death|0|||
105643859|NCT02561195|364358962|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
105643860|NCT02561195|364358963|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
105643861|NCT02561195|364358964|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
105643862|NCT02561195|364358965|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
105643863|NCT02561195|364358966|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
105643864|NCT02561195|364358967|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643865|NCT02561195|364358968|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643866|NCT02561195|364358969|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643867|NCT02561195|364358970|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643868|NCT02561195|364358971|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643869|NCT02561195|364358972|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643870|NCT02561195|364358973|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643871|NCT02561195|364358974|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643872|NCT02561195|364358975|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643873|NCT02561195|364358962|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
105643874|NCT02561195|364358963|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
105643875|NCT02561195|364358964|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
105643876|NCT02561195|364358965|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
105643877|NCT02561195|364358966|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
105643878|NCT02561195|364358967|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
105643879|NCT02561195|364358968|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
105643880|NCT02561195|364358969|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
105643881|NCT02561195|364358970|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
105643882|NCT02561195|364358971|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
105643883|NCT02561195|364358972|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
105643884|NCT02561195|364358973|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
105643885|NCT02561195|364358974|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
105643886|NCT02561195|364358975|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
105643887|NCT02561195|364358962|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643888|NCT02561195|364358963|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643889|NCT02561195|364358964|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643890|NCT02561195|364358965|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643891|NCT02561195|364358966|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643892|NCT02561195|364358967|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643893|NCT02561195|364358968|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643894|NCT02561195|364358969|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643895|NCT02561195|364358970|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
105643896|NCT02561195|364358971|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
105643897|NCT02561195|364358972|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
105643898|NCT02561195|364358973|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
105643899|NCT02561195|364358974|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
105643900|NCT02561195|364358975|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643901|NCT02561195|364358962|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643902|NCT02561195|364358963|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643903|NCT02561195|364358964|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643904|NCT02561195|364358965|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643905|NCT02561195|364358966|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643906|NCT02561195|364358967|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643907|NCT02561195|364358968|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643908|NCT02561195|364358969|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643909|NCT02561195|364358970|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643910|NCT02561195|364358971|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643911|NCT02561195|364358972|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643912|NCT02561195|364358973|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643913|NCT02561195|364358974|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643914|NCT02561195|364358975|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
105643915|NCT02561195|364358962|FG000|Extension Stage (Vaccination 4)|Death|0|||
105643916|NCT02561195|364358963|FG001|Extension Stage (Vaccination 4)|Death|0|||
105643917|NCT02561195|364358964|FG002|Extension Stage (Vaccination 4)|Death|0|||
105643918|NCT02561195|364358965|FG003|Extension Stage (Vaccination 4)|Death|0|||
105643919|NCT02561195|364358966|FG004|Extension Stage (Vaccination 4)|Death|0|||
105643920|NCT02561195|364358967|FG005|Extension Stage (Vaccination 4)|Death|0|||
105643921|NCT02561195|364358968|FG006|Extension Stage (Vaccination 4)|Death|0|||
105643922|NCT02561195|364358969|FG007|Extension Stage (Vaccination 4)|Death|0|||
105643923|NCT02561195|364358970|FG008|Extension Stage (Vaccination 4)|Death|0|||
105643924|NCT02561195|364358971|FG009|Extension Stage (Vaccination 4)|Death|1|||
105643925|NCT02561195|364358972|FG010|Extension Stage (Vaccination 4)|Death|0|||
105643926|NCT02561195|364358973|FG011|Extension Stage (Vaccination 4)|Death|0|||
105643927|NCT02561195|364358974|FG012|Extension Stage (Vaccination 4)|Death|0|||
105643928|NCT02561195|364358975|FG013|Extension Stage (Vaccination 4)|Death|0|||
105643929|NCT02561195|364358962|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643930|NCT02561195|364358963|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643931|NCT02561195|364358964|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643932|NCT02561195|364358965|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643933|NCT02561195|364358966|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643934|NCT02561195|364358967|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643935|NCT02561195|364358968|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
105643936|NCT02561195|364358969|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
105643937|NCT02561195|364358970|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643938|NCT02561195|364358971|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643939|NCT02561195|364358972|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
105643940|NCT02561195|364358973|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
105643941|NCT02561195|364358974|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
105643942|NCT02561195|364358975|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
105643943|NCT02561195|364358962|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643944|NCT02561195|364358963|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643945|NCT02561195|364358964|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643946|NCT02561195|364358965|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643947|NCT02561195|364358966|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643948|NCT02561195|364358967|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643949|NCT02561195|364358968|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643950|NCT02561195|364358969|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643951|NCT02561195|364358970|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643952|NCT02561195|364358971|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643953|NCT02561195|364358972|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643954|NCT02561195|364358973|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
105643955|NCT02561195|364358974|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
105643956|NCT02561195|364358975|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
105643957|NCT02561195|364358962|FG000|Extension Stage (Vaccination 4)|Other|0|||
105643958|NCT02561195|364358963|FG001|Extension Stage (Vaccination 4)|Other|0|||
105643959|NCT02561195|364358964|FG002|Extension Stage (Vaccination 4)|Other|0|||
105643960|NCT02561195|364358965|FG003|Extension Stage (Vaccination 4)|Other|0|||
105643961|NCT02561195|364358966|FG004|Extension Stage (Vaccination 4)|Other|0|||
105643962|NCT02561195|364358967|FG005|Extension Stage (Vaccination 4)|Other|0|||
105659339|NCT00551135|364417282|FG002|Overall Study|Other|1|||
105643963|NCT02561195|364358968|FG006|Extension Stage (Vaccination 4)|Other|0|||
105643964|NCT02561195|364358969|FG007|Extension Stage (Vaccination 4)|Other|0|||
105643965|NCT02561195|364358970|FG008|Extension Stage (Vaccination 4)|Other|0|||
105643966|NCT02561195|364358971|FG009|Extension Stage (Vaccination 4)|Other|0|||
105643967|NCT02561195|364358972|FG010|Extension Stage (Vaccination 4)|Other|2|||
105643968|NCT02561195|364358973|FG011|Extension Stage (Vaccination 4)|Other|2|||
105643969|NCT02561195|364358974|FG012|Extension Stage (Vaccination 4)|Other|1|||
105643970|NCT02561195|364358975|FG013|Extension Stage (Vaccination 4)|Other|0|||
105643971|NCT02561195|364358962|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643972|NCT02561195|364358963|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643973|NCT02561195|364358964|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643974|NCT02561195|364358965|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643975|NCT02561195|364358966|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643976|NCT02561195|364358967|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643977|NCT02561195|364358968|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
105643978|NCT02561195|364358969|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643979|NCT02561195|364358970|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643980|NCT02561195|364358971|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643981|NCT02561195|364358972|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
105643982|NCT02561195|364358973|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
105643983|NCT02561195|364358974|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643984|NCT02561195|364358975|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
105643985|NCT04433091|364358986|FG000|Overall Study|Lost to Follow-up|1|||
105643986|NCT04433091|364358987|FG001|Overall Study|Lost to Follow-up|0|||
105643987|NCT04433091|364358986|FG000|Overall Study|Withdrawn .|2|||
105643988|NCT04433091|364358987|FG001|Overall Study|Withdrawn .|4|||
105643989|NCT02196259|364360300|FG000|Overall Study|Researcher choice|0|||
105643990|NCT02196259|364360301|FG001|Overall Study|Researcher choice|0|||
105643991|NCT02196259|364360302|FG002|Overall Study|Researcher choice|1|||
105643992|NCT02196259|364360300|FG000|Overall Study|Partial data analysis|0|||
105643993|NCT02196259|364360301|FG001|Overall Study|Partial data analysis|3|||
105643994|NCT02196259|364360302|FG002|Overall Study|Partial data analysis|0|||
105643995|NCT04783389|364360303|FG000|Overall Study|Withdrawal by Subject|2|||
105643996|NCT04783389|364360304|FG001|Overall Study|Withdrawal by Subject|0|||
105643997|NCT04783389|364360305|FG002|Overall Study|Withdrawal by Subject|0|||
105643998|NCT04783389|364360303|FG000|Overall Study|Termination of Study by Sponsor|10|||
105643999|NCT04783389|364360304|FG001|Overall Study|Termination of Study by Sponsor|12|||
105644000|NCT04783389|364360305|FG002|Overall Study|Termination of Study by Sponsor|14|||
105644001|NCT00215943|364360306|FG000|Overall Study|Disease Progression|3|||
105644002|NCT00215943|364360307|FG001|Overall Study|Disease Progression|5|||
105644003|NCT00215943|364360306|FG000|Overall Study|Alternate therapy|0|||
105644004|NCT00215943|364360307|FG001|Overall Study|Alternate therapy|1|||
105644005|NCT00215943|364360306|FG000|Overall Study|Adverse Event|3|||
105644006|NCT00215943|364360307|FG001|Overall Study|Adverse Event|6|||
105644007|NCT00215943|364360306|FG000|Overall Study|Other disease|0|||
105644008|NCT00215943|364360307|FG001|Overall Study|Other disease|1|||
105644009|NCT00215943|364360306|FG000|Overall Study|Other complications|3|||
105644010|NCT00215943|364360307|FG001|Overall Study|Other complications|1|||
105644011|NCT03469258|364360308|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
105644012|NCT04311983|364360309|FG000|Overall Study|Lost to Follow-up|421|||
105644013|NCT04311983|364360310|FG001|Overall Study|Lost to Follow-up|456|||
105644014|NCT04311983|364360309|FG000|Overall Study|Incomplete survey|7|||
105644015|NCT04311983|364360310|FG001|Overall Study|Incomplete survey|9|||
105644016|NCT04311983|364360309|FG000|Overall Study|Death|1|||
105644017|NCT04311983|364360310|FG001|Overall Study|Death|0|||
105644018|NCT02981953|364360311|FG000|Overall Study|Death|9|||
105644019|NCT02981953|364360311|FG000|Overall Study|Withdrawal by Subject|1|||
105644020|NCT02981953|364360311|FG000|Overall Study|Withdrawal to non-compliance|1|||
105644021|NCT01248715|364360315|FG000|Overall Study|Not influenza positive|501|||
105644022|NCT01248715|364360316|FG001|Overall Study|Not influenza positive|510|||
105644023|NCT04271254|364360323|FG000|Overall Study|Withdrawal by Subject|3|||
105644024|NCT01345253|364360324|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
105644025|NCT01345253|364360325|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
105644026|NCT01345253|364360324|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
105644027|NCT01345253|364360325|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
105644028|NCT01345253|364360324|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
105644029|NCT01345253|364360325|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
105644030|NCT01345253|364360324|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
105644031|NCT01345253|364360325|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
105644032|NCT01345253|364360324|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
105644033|NCT01345253|364360325|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
105644034|NCT01345253|364360324|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
105644035|NCT01345253|364360325|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
105644036|NCT01345253|364360324|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
105644037|NCT01345253|364360325|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
105644038|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
105644039|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
105644040|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
105644041|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
105644042|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
105644043|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
105644044|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
105644045|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
105644046|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
105644047|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
105644048|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
105644049|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
105644050|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
105644051|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
105644052|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
105644053|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
105644054|NCT05361304|364360326|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
105644055|NCT05361304|364360327|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
105644056|NCT05361304|364360326|FG000|Overall Study|COVID-19 Related|1|||
105644057|NCT05361304|364360327|FG001|Overall Study|COVID-19 Related|2|||
105644058|NCT05361304|364360326|FG000|Overall Study|Withdrawal by Subject|1|||
105644059|NCT05361304|364360327|FG001|Overall Study|Withdrawal by Subject|0|||
105644060|NCT01767376|364360328|FG000|Overall Study|Lost to Follow-up|3|||
105644061|NCT01767376|364360329|FG001|Overall Study|Lost to Follow-up|2|||
105644062|NCT01767376|364360330|FG002|Overall Study|Lost to Follow-up|0|||
105644063|NCT01767376|364360328|FG000|Overall Study|Withdrawal by Subject|1|||
105644064|NCT01767376|364360329|FG001|Overall Study|Withdrawal by Subject|1|||
105644065|NCT01767376|364360330|FG002|Overall Study|Withdrawal by Subject|0|||
105644066|NCT01113541|364360334|FG000|Overall Study|Withdrawal by Subject|1|||
105644067|NCT01113541|364360334|FG000|Overall Study|Protocol Violation|1|||
105644068|NCT01113541|364360334|FG000|Overall Study|Study Terminated by Sponsor|7|||
105644069|NCT01113541|364360334|FG000|Overall Study|Adverse Event|4|||
105644070|NCT02309892|364360335|FG000|Overall Study|Physician Decision|1|||
105644071|NCT02309892|364360336|FG001|Overall Study|Physician Decision|0|||
105644072|NCT02309892|364360337|FG002|Overall Study|Physician Decision|0|||
105644073|NCT02309892|364360338|FG003|Overall Study|Physician Decision|0|||
105644074|NCT02309892|364360339|FG004|Overall Study|Physician Decision|0|||
105644075|NCT02309892|364360340|FG005|Overall Study|Physician Decision|0|||
105644076|NCT02309892|364360341|FG006|Overall Study|Physician Decision|0|||
105644077|NCT02309892|364360335|FG000|Overall Study|Adverse Event|1|||
105644078|NCT02309892|364360336|FG001|Overall Study|Adverse Event|0|||
105644079|NCT02309892|364360337|FG002|Overall Study|Adverse Event|1|||
105644080|NCT02309892|364360338|FG003|Overall Study|Adverse Event|0|||
105644081|NCT02309892|364360339|FG004|Overall Study|Adverse Event|0|||
105644082|NCT02309892|364360340|FG005|Overall Study|Adverse Event|0|||
105644083|NCT02309892|364360341|FG006|Overall Study|Adverse Event|0|||
105644084|NCT02309892|364360335|FG000|Overall Study|Progressive Disease|0|||
105644085|NCT02309892|364360336|FG001|Overall Study|Progressive Disease|1|||
105644086|NCT02309892|364360337|FG002|Overall Study|Progressive Disease|0|||
105644087|NCT02309892|364360338|FG003|Overall Study|Progressive Disease|0|||
105644088|NCT02309892|364360339|FG004|Overall Study|Progressive Disease|1|||
105644089|NCT02309892|364360340|FG005|Overall Study|Progressive Disease|0|||
105644090|NCT02309892|364360341|FG006|Overall Study|Progressive Disease|0|||
105644091|NCT02309892|364360335|FG000|Overall Study|Death|0|||
105644092|NCT02309892|364360336|FG001|Overall Study|Death|0|||
105644093|NCT02309892|364360337|FG002|Overall Study|Death|0|||
105644094|NCT02309892|364360338|FG003|Overall Study|Death|0|||
105644095|NCT02309892|364360339|FG004|Overall Study|Death|0|||
105644096|NCT02309892|364360340|FG005|Overall Study|Death|1|||
105644097|NCT02309892|364360341|FG006|Overall Study|Death|0|||
105644098|NCT03262389|364360342|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
105644099|NCT03262389|364360342|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
105644100|NCT03262389|364360342|FG000|Overall Study|opted out of PET/MR|1|||
105644101|NCT02721147|364360343|FG000|Overall Study|Lost to Follow-up|2|||
105644102|NCT02721147|364360344|FG001|Overall Study|Lost to Follow-up|0|||
105644103|NCT02721147|364360345|FG002|Overall Study|Lost to Follow-up|0|||
105644104|NCT04739306|364360346|FG000|Main Study Period|Adverse Event|6|||
105644105|NCT04739306|364360347|FG001|Main Study Period|Adverse Event|7|||
105644106|NCT04739306|364360346|FG000|Main Study Period|Lost to Follow-up|4|||
105644107|NCT04739306|364360347|FG001|Main Study Period|Lost to Follow-up|6|||
105644108|NCT04739306|364360346|FG000|Main Study Period|Physician Decision|1|||
105644109|NCT04739306|364360347|FG001|Main Study Period|Physician Decision|1|||
105644110|NCT04739306|364360346|FG000|Main Study Period|Withdrawal by Subject|8|||
105644111|NCT04739306|364360347|FG001|Main Study Period|Withdrawal by Subject|6|||
105644112|NCT04739306|364360346|FG000|Main Study Period|Protocol Violation|0|||
105644113|NCT04739306|364360347|FG001|Main Study Period|Protocol Violation|1|||
105644114|NCT04739306|364360346|FG000|Main Study Period|War in Ukraine|1|||
105644115|NCT04739306|364360347|FG001|Main Study Period|War in Ukraine|1|||
105644116|NCT00096278|364360353|FG000|Overall Study|No follow-up data|15|||
105644117|NCT00096278|364360354|FG001|Overall Study|No follow-up data|18|||
105644118|NCT00096278|364360353|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
105644119|NCT00096278|364360354|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
105644120|NCT04421456|364360355|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
105644121|NCT04421456|364360356|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
105644122|NCT04421456|364360357|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
105644123|NCT04421456|364360355|FG000|Randomized Treatment Period|Adverse Event|0|||
105644124|NCT04421456|364360356|FG001|Randomized Treatment Period|Adverse Event|1|||
105644125|NCT04421456|364360357|FG002|Randomized Treatment Period|Adverse Event|0|||
105644126|NCT04421456|364360355|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
105644127|NCT04421456|364360356|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
105644128|NCT04421456|364360357|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
105644129|NCT04421456|364360355|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
105644130|NCT04421456|364360356|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
105644131|NCT04421456|364360357|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
105644132|NCT04421456|364360355|FG000|Randomized Treatment Period|Participant non-compliance|1|||
105644133|NCT04421456|364360356|FG001|Randomized Treatment Period|Participant non-compliance|1|||
105644134|NCT04421456|364360357|FG002|Randomized Treatment Period|Participant non-compliance|2|||
105644135|NCT04421456|364360355|FG000|Randomized Treatment Period|Other|0|||
105644136|NCT04421456|364360356|FG001|Randomized Treatment Period|Other|1|||
105644137|NCT04421456|364360357|FG002|Randomized Treatment Period|Other|3|||
105644138|NCT00963924|364360358|FG000|Overall Study|Adverse Event|1|||
105644139|NCT00963924|364360359|FG001|Overall Study|Adverse Event|0|||
105644140|NCT00963924|364360358|FG000|Overall Study|Withdrawal by Subject|0|||
105644141|NCT00963924|364360359|FG001|Overall Study|Withdrawal by Subject|1|||
105644142|NCT00963924|364360358|FG000|Overall Study|Changed antipsychotic|0|||
105644143|NCT00963924|364360359|FG001|Overall Study|Changed antipsychotic|1|||
105644144|NCT00963924|364360358|FG000|Overall Study|Lost to Follow-up|0|||
105644145|NCT00963924|364360359|FG001|Overall Study|Lost to Follow-up|1|||
105644146|NCT03031782|364360363|FG000|Treatment Period 1|Lack of Efficacy|3|||
105644147|NCT03031782|364360364|FG001|Treatment Period 1|Lack of Efficacy|0|||
105644148|NCT03031782|364360365|FG002|Treatment Period 1|Lack of Efficacy|0|||
105644149|NCT03031782|364360366|FG003|Treatment Period 1|Lack of Efficacy|0|||
105644150|NCT03031782|364360367|FG004|Treatment Period 1|Lack of Efficacy|0|||
105644151|NCT03031782|364360363|FG000|Treatment Period 2|Physician Decision|0|||
105644152|NCT03031782|364360364|FG001|Treatment Period 2|Physician Decision|1|||
105644153|NCT03031782|364360365|FG002|Treatment Period 2|Physician Decision|0|||
105644154|NCT03031782|364360366|FG003|Treatment Period 2|Physician Decision|0|||
105644155|NCT03031782|364360367|FG004|Treatment Period 2|Physician Decision|3|||
105644156|NCT03031782|364360363|FG000|Treatment Period 2|Lack of Efficacy|0|||
105644157|NCT03031782|364360364|FG001|Treatment Period 2|Lack of Efficacy|1|||
105644158|NCT03031782|364360365|FG002|Treatment Period 2|Lack of Efficacy|0|||
105644159|NCT03031782|364360366|FG003|Treatment Period 2|Lack of Efficacy|0|||
105644160|NCT03031782|364360367|FG004|Treatment Period 2|Lack of Efficacy|1|||
105644161|NCT03031782|364360363|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105644162|NCT03031782|364360364|FG001|Treatment Period 2|Withdrawal by Subject|3|||
105644163|NCT03031782|364360365|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105644164|NCT03031782|364360366|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105644165|NCT03031782|364360367|FG004|Treatment Period 2|Withdrawal by Subject|1|||
105644166|NCT03031782|364360363|FG000|Treatment Period 2|Adverse Event|0|||
105644167|NCT03031782|364360364|FG001|Treatment Period 2|Adverse Event|1|||
105644168|NCT03031782|364360365|FG002|Treatment Period 2|Adverse Event|2|||
105644169|NCT03031782|364360366|FG003|Treatment Period 2|Adverse Event|0|||
105644170|NCT03031782|364360367|FG004|Treatment Period 2|Adverse Event|0|||
105644171|NCT03031782|364360363|FG000|Treatment Period 3|Withdrawal by Subject|0|||
105644172|NCT03031782|364360364|FG001|Treatment Period 3|Withdrawal by Subject|0|||
105644173|NCT03031782|364360365|FG002|Treatment Period 3|Withdrawal by Subject|0|||
105644174|NCT03031782|364360366|FG003|Treatment Period 3|Withdrawal by Subject|1|||
105644175|NCT03031782|364360367|FG004|Treatment Period 3|Withdrawal by Subject|0|||
105644176|NCT00657709|364360369|FG000|Overall Study|AE or Death|7|||
105644177|NCT00657709|364360370|FG001|Overall Study|AE or Death|7|||
105644178|NCT00657709|364360371|FG002|Overall Study|AE or Death|6|||
105644179|NCT00657709|364360372|FG003|Overall Study|AE or Death|7|||
105644180|NCT00657709|364360373|FG004|Overall Study|AE or Death|1|||
105644181|NCT00657709|364360369|FG000|Overall Study|Withdrawal by Subject|7|||
105644182|NCT00657709|364360370|FG001|Overall Study|Withdrawal by Subject|15|||
105644183|NCT00657709|364360371|FG002|Overall Study|Withdrawal by Subject|15|||
105644184|NCT00657709|364360372|FG003|Overall Study|Withdrawal by Subject|5|||
105644185|NCT00657709|364360373|FG004|Overall Study|Withdrawal by Subject|9|||
105644186|NCT00657709|364360369|FG000|Overall Study|Lost to Follow-up|9|||
105644187|NCT00657709|364360370|FG001|Overall Study|Lost to Follow-up|9|||
105644188|NCT00657709|364360371|FG002|Overall Study|Lost to Follow-up|7|||
105644189|NCT00657709|364360372|FG003|Overall Study|Lost to Follow-up|1|||
105644190|NCT00657709|364360373|FG004|Overall Study|Lost to Follow-up|21|||
105644191|NCT00657709|364360369|FG000|Overall Study|Protocol Violation|0|||
105644192|NCT00657709|364360370|FG001|Overall Study|Protocol Violation|2|||
105644193|NCT00657709|364360371|FG002|Overall Study|Protocol Violation|0|||
105644194|NCT00657709|364360372|FG003|Overall Study|Protocol Violation|1|||
105644195|NCT00657709|364360373|FG004|Overall Study|Protocol Violation|2|||
105644196|NCT00442559|364360374|FG000|Overall Study|Lost to Follow-up|32|||
105644197|NCT00442559|364360375|FG001|Overall Study|Lost to Follow-up|34|||
105644198|NCT00442559|364360374|FG000|Overall Study|Protocol Violation|1|||
105644199|NCT00442559|364360375|FG001|Overall Study|Protocol Violation|1|||
105644200|NCT00442559|364360374|FG000|Overall Study|Withdrawal by Subject|1|||
105644201|NCT00442559|364360375|FG001|Overall Study|Withdrawal by Subject|0|||
105644202|NCT04765046|364360379|FG000|Overall Study|Screen Failure|2|||
105644203|NCT04765046|364360379|FG000|Overall Study|Withdrawal by Subject|4|||
105644204|NCT04765046|364360379|FG000|Overall Study|Physician Decision|4|||
105644205|NCT04765046|364360379|FG000|Overall Study|Surgery Cancelled|8|||
105644206|NCT03529942|364360380|FG000|Overall Study|Withdrawal by Subject|13|||
105644207|NCT03529942|364360380|FG000|Overall Study|Physician Decision|1|||
105644208|NCT03529942|364360380|FG000|Overall Study|Lost to Follow-up|7|||
105644209|NCT03529942|364360380|FG000|Overall Study|Needle inserted but no drug administered|1|||
105644210|NCT03529942|364360380|FG000|Overall Study|Personal reasons|1|||
105644211|NCT01287832|364360386|FG000|Overall Study|Adverse Event|1|||
105644212|NCT01287832|364360387|FG001|Overall Study|Adverse Event|0|||
105644213|NCT01287832|364360386|FG000|Overall Study|Death|0|||
105644214|NCT01287832|364360387|FG001|Overall Study|Death|1|||
105644215|NCT00321555|364360388|FG000|Overall Study|Developed antibodies|1|||
105644216|NCT00321555|364360388|FG000|Overall Study|Switched to alternative treatment|3|||
105644217|NCT00321555|364360388|FG000|Overall Study|Physician Decision|1|||
105644218|NCT00321555|364360388|FG000|Overall Study|Disease progression on study|1|||
105644219|NCT01670526|364360392|FG000|Overall Study|Withdrawal by Subject|3|||
105644220|NCT01670526|364360393|FG001|Overall Study|Withdrawal by Subject|1|||
105644221|NCT01670526|364360392|FG000|Overall Study|Lost to Follow-up|9|||
105644222|NCT01670526|364360393|FG001|Overall Study|Lost to Follow-up|5|||
105644223|NCT01697956|364360394|FG000|Overall Study|Protocol Violation|1|||
105644224|NCT01697956|364360395|FG001|Overall Study|Protocol Violation|1|||
105644225|NCT01970527|364360396|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
105644226|NCT01970527|364360397|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
105644227|NCT01970527|364360396|FG000|Treatment|Disease progression|0|||
105644228|NCT01970527|364360397|FG001|Treatment|Disease progression|1|||
105644229|NCT01970527|364360396|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
105644230|NCT01970527|364360397|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
105644231|NCT01970527|364360396|FG000|Treatment|Death|0|||
105644232|NCT01970527|364360397|FG001|Treatment|Death|1|||
105644233|NCT01970527|364360396|FG000|Follow-up Clinic Visit|Disease progression|1|||
105644234|NCT01970527|364360397|FG001|Follow-up Clinic Visit|Disease progression|1|||
105644235|NCT01970527|364360396|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
105644236|NCT01970527|364360397|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
105644237|NCT01970527|364360396|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
105644238|NCT01970527|364360397|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
105644239|NCT05700851|364360398|FG000|Overall Study|Received a kidney transplant|1|||
105644240|NCT05700851|364360398|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
105644241|NCT05700851|364360398|FG000|Overall Study|Withdrawal by Subject|1|||
105644242|NCT03560206|364360399|FG000|Overall Study|Lost to Follow-up|19|||
105644243|NCT03560206|364360400|FG001|Overall Study|Lost to Follow-up|11|||
105644244|NCT03560206|364360399|FG000|Overall Study|Withdrawal by Subject|2|||
105644245|NCT03560206|364360400|FG001|Overall Study|Withdrawal by Subject|4|||
105644246|NCT03560206|364360399|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
105644247|NCT03560206|364360400|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
105644248|NCT03560206|364360399|FG000|Overall Study|Busy schedule|14|||
105644249|NCT03560206|364360400|FG001|Overall Study|Busy schedule|2|||
105644250|NCT03560206|364360399|FG000|Overall Study|patients' new health condition such as cancer|10|||
105644251|NCT03560206|364360400|FG001|Overall Study|patients' new health condition such as cancer|1|||
105644252|NCT03987074|364360401|FG000|Overall Study|Withdrew Consent|1|||
105644253|NCT03987074|364360402|FG001|Overall Study|Withdrew Consent|1|||
105644254|NCT03987074|364360403|FG002|Overall Study|Withdrew Consent|0|||
105644255|NCT03987074|364360404|FG003|Overall Study|Withdrew Consent|2|||
105644256|NCT03987074|364360405|FG004|Overall Study|Withdrew Consent|1|||
105644257|NCT03987074|364360401|FG000|Overall Study|Adverse Event|2|||
105644258|NCT03987074|364360402|FG001|Overall Study|Adverse Event|1|||
105644259|NCT03987074|364360403|FG002|Overall Study|Adverse Event|0|||
105644260|NCT03987074|364360404|FG003|Overall Study|Adverse Event|0|||
105644261|NCT03987074|364360405|FG004|Overall Study|Adverse Event|1|||
105644262|NCT03987074|364360401|FG000|Overall Study|Lost to Follow-up|0|||
105644263|NCT03987074|364360402|FG001|Overall Study|Lost to Follow-up|0|||
105644264|NCT03987074|364360403|FG002|Overall Study|Lost to Follow-up|1|||
105644265|NCT03987074|364360404|FG003|Overall Study|Lost to Follow-up|1|||
105644266|NCT03987074|364360405|FG004|Overall Study|Lost to Follow-up|0|||
105644267|NCT03987074|364360401|FG000|Overall Study|Investigator's Discretion|0|||
105644268|NCT03987074|364360402|FG001|Overall Study|Investigator's Discretion|0|||
105644269|NCT03987074|364360403|FG002|Overall Study|Investigator's Discretion|0|||
105644270|NCT03987074|364360404|FG003|Overall Study|Investigator's Discretion|1|||
105644271|NCT03987074|364360405|FG004|Overall Study|Investigator's Discretion|0|||
105644272|NCT02138838|364360406|FG000|Overall Study|Study Closure|7|||
105644273|NCT02138838|364360407|FG001|Overall Study|Study Closure|6|||
105644274|NCT02138838|364360406|FG000|Overall Study|Withdrawal by Subject|1|||
105644275|NCT02138838|364360407|FG001|Overall Study|Withdrawal by Subject|5|||
105644276|NCT02009865|364360418|FG000|Overall Study|Adverse Event|0|||
105644277|NCT02009865|364360419|FG001|Overall Study|Adverse Event|2|||
105644278|NCT02009865|364360418|FG000|Overall Study|Protocol Violation|0|||
105644279|NCT02009865|364360419|FG001|Overall Study|Protocol Violation|2|||
105644280|NCT02009865|364360418|FG000|Overall Study|Withdrawal by Subject|1|||
105644281|NCT02009865|364360419|FG001|Overall Study|Withdrawal by Subject|1|||
105644282|NCT00990314|364360420|FG000|Overall Study|Death|2|||
105644283|NCT00990314|364360420|FG000|Overall Study|Adverse Event|2|||
105644284|NCT00990314|364360420|FG000|Overall Study|Withdrawal by Subject|3|||
105644285|NCT00990314|364360420|FG000|Overall Study|Non-Compliance|1|||
105644286|NCT00990314|364360420|FG000|Overall Study|Physician Decision|3|||
105644287|NCT00990314|364360420|FG000|Overall Study|Lack of Efficacy|1|||
105644288|NCT01760876|364360421|FG000|Overall Study|Non-cardiac death (head injury)|1|||
105644289|NCT01760876|364360421|FG000|Overall Study|Carcinoma of prostate|1|||
105644290|NCT01760876|364360421|FG000|Overall Study|Impaired renal function|1|||
105644291|NCT01760876|364360421|FG000|Overall Study|Major depression|1|||
105644292|NCT01760876|364360421|FG000|Overall Study|Very poor baseline OCT quality|2|||
105644293|NCT00091572|364360424|FG000|Overall Study|Lost to Follow-up|1|||
105644294|NCT00091572|364360425|FG001|Overall Study|Lost to Follow-up|1|||
105644295|NCT00091572|364360424|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
105644296|NCT00091572|364360425|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
105644297|NCT00091572|364360424|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
105644298|NCT00091572|364360425|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
105644299|NCT00091572|364360424|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
105644300|NCT00091572|364360425|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
105644301|NCT00091572|364360424|FG000|Overall Study|Other Reason|6|||
105644302|NCT00091572|364360425|FG001|Overall Study|Other Reason|13|||
105644303|NCT00091572|364360424|FG000|Overall Study|Ongoing (still on treatment)|8|||
105644304|NCT00091572|364360425|FG001|Overall Study|Ongoing (still on treatment)|12|||
105644305|NCT00091572|364360424|FG000|Overall Study|Major Protocol Violation|2|||
105644306|NCT00091572|364360425|FG001|Overall Study|Major Protocol Violation|0|||
105644307|NCT00091572|364360424|FG000|Overall Study|Toxicity (Related AE)|53|||
105644308|NCT00091572|364360425|FG001|Overall Study|Toxicity (Related AE)|9|||
105644309|NCT02942771|364360427|FG000|Overall Study|Adverse Event|1|||
105644310|NCT02942771|364360428|FG001|Overall Study|Adverse Event|0|||
105644311|NCT02942771|364360429|FG002|Overall Study|Adverse Event|0|||
105644312|NCT02942771|364360430|FG003|Overall Study|Adverse Event|0|||
105644313|NCT02942771|364360431|FG004|Overall Study|Adverse Event|2|||
105644314|NCT02942771|364360427|FG000|Overall Study|Lost to Follow-up|1|||
105644315|NCT02942771|364360428|FG001|Overall Study|Lost to Follow-up|0|||
105644316|NCT02942771|364360429|FG002|Overall Study|Lost to Follow-up|0|||
105644317|NCT02942771|364360430|FG003|Overall Study|Lost to Follow-up|0|||
105644318|NCT02942771|364360431|FG004|Overall Study|Lost to Follow-up|0|||
105644319|NCT02942771|364360427|FG000|Overall Study|Withdrawal by Subject|1|||
105644320|NCT02942771|364360428|FG001|Overall Study|Withdrawal by Subject|0|||
105644321|NCT02942771|364360429|FG002|Overall Study|Withdrawal by Subject|0|||
105644322|NCT02942771|364360430|FG003|Overall Study|Withdrawal by Subject|0|||
105644323|NCT02942771|364360431|FG004|Overall Study|Withdrawal by Subject|2|||
105644324|NCT01898299|364360432|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
105644325|NCT01898299|364360433|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
105644326|NCT01199302|364360434|FG000|Overall Study|Adverse Event|1|||
105644327|NCT01199302|364360435|FG001|Overall Study|Adverse Event|1|||
105644328|NCT01199302|364360436|FG002|Overall Study|Adverse Event|2|||
105644329|NCT01199302|364360437|FG003|Overall Study|Adverse Event|0|||
105644330|NCT01199302|364360434|FG000|Overall Study|Withdrawal by Subject|2|||
105644331|NCT01199302|364360435|FG001|Overall Study|Withdrawal by Subject|2|||
105644332|NCT01199302|364360436|FG002|Overall Study|Withdrawal by Subject|3|||
105644333|NCT01199302|364360437|FG003|Overall Study|Withdrawal by Subject|0|||
105644334|NCT01199302|364360434|FG000|Overall Study|Disease Progression|3|||
105644335|NCT01199302|364360435|FG001|Overall Study|Disease Progression|4|||
105644336|NCT01199302|364360436|FG002|Overall Study|Disease Progression|4|||
105644337|NCT01199302|364360437|FG003|Overall Study|Disease Progression|2|||
105644338|NCT01199302|364360434|FG000|Overall Study|Study Termination|13|||
105644339|NCT01199302|364360435|FG001|Overall Study|Study Termination|8|||
105644340|NCT01199302|364360436|FG002|Overall Study|Study Termination|11|||
105644341|NCT01199302|364360437|FG003|Overall Study|Study Termination|9|||
105644342|NCT01199302|364360434|FG000|Overall Study|Lost to Follow-up|0|||
105644343|NCT01199302|364360435|FG001|Overall Study|Lost to Follow-up|1|||
105644344|NCT01199302|364360436|FG002|Overall Study|Lost to Follow-up|0|||
105644345|NCT01199302|364360437|FG003|Overall Study|Lost to Follow-up|0|||
105644346|NCT01199302|364360434|FG000|Overall Study|Other|1|||
105644347|NCT01199302|364360435|FG001|Overall Study|Other|0|||
105644348|NCT01199302|364360436|FG002|Overall Study|Other|0|||
105644349|NCT01199302|364360437|FG003|Overall Study|Other|0|||
105644350|NCT02340806|364360438|FG000|Overall Study|Protocol Violation|2|||
105644351|NCT02340806|364360439|FG001|Overall Study|Protocol Violation|0|||
105644352|NCT02340806|364360438|FG000|Overall Study|epidural catheter replaced|2|||
105644353|NCT02340806|364360439|FG001|Overall Study|epidural catheter replaced|1|||
105644354|NCT02340806|364360438|FG000|Overall Study|history of chronic pain medication|1|||
105644355|NCT02340806|364360439|FG001|Overall Study|history of chronic pain medication|0|||
105644356|NCT02340806|364360438|FG000|Overall Study|re-dose < 90 min of CSE|1|||
105644357|NCT02340806|364360439|FG001|Overall Study|re-dose < 90 min of CSE|3|||
105644358|NCT00452452|364360442|FG000|Overall Study|Protocol Violation|0|||
105644359|NCT00452452|364360443|FG001|Overall Study|Protocol Violation|0|||
105644360|NCT00452452|364360444|FG002|Overall Study|Protocol Violation|1|||
105644361|NCT00452452|364360442|FG000|Overall Study|Withdrawal by Subject|1|||
105644362|NCT00452452|364360443|FG001|Overall Study|Withdrawal by Subject|0|||
105644363|NCT00452452|364360444|FG002|Overall Study|Withdrawal by Subject|0|||
105644364|NCT00452452|364360442|FG000|Overall Study|Lost to Follow-up|1|||
105644365|NCT00452452|364360443|FG001|Overall Study|Lost to Follow-up|0|||
105644366|NCT00452452|364360444|FG002|Overall Study|Lost to Follow-up|0|||
105644367|NCT01634165|364360445|FG000|Period 2|Adverse Event|0|||
105644368|NCT01634165|364360446|FG001|Period 2|Adverse Event|1|||
105644369|NCT01634165|364360447|FG002|Period 2|Adverse Event|0|||
105644370|NCT01634165|364360448|FG003|Period 2|Adverse Event|0|||
105644371|NCT03070301|364360449|FG000|Overall Study|Progression of disease|16|||
105644372|NCT03070301|364360449|FG000|Overall Study|Physician Decision|3|||
105644373|NCT03070301|364360449|FG000|Overall Study|Withdrawal by Subject|1|||
105644374|NCT01276509|364361887|FG000|Overall Study|Adverse Event|9|||
105644375|NCT01276509|364361888|FG001|Overall Study|Adverse Event|8|||
105644376|NCT01276509|364361889|FG002|Overall Study|Adverse Event|4|||
105644377|NCT01276509|364361890|FG003|Overall Study|Adverse Event|3|||
105644378|NCT01276509|364361887|FG000|Overall Study|Lack of Efficacy|2|||
105644379|NCT01276509|364361888|FG001|Overall Study|Lack of Efficacy|1|||
105644380|NCT01276509|364361889|FG002|Overall Study|Lack of Efficacy|1|||
105644381|NCT01276509|364361890|FG003|Overall Study|Lack of Efficacy|2|||
105644382|NCT01276509|364361887|FG000|Overall Study|Pregnancy|1|||
105644383|NCT01276509|364361888|FG001|Overall Study|Pregnancy|0|||
105644384|NCT01276509|364361889|FG002|Overall Study|Pregnancy|0|||
105644385|NCT01276509|364361890|FG003|Overall Study|Pregnancy|0|||
105644386|NCT01276509|364361887|FG000|Overall Study|Withdrawal by Subject|1|||
105644387|NCT01276509|364361888|FG001|Overall Study|Withdrawal by Subject|2|||
105644388|NCT01276509|364361889|FG002|Overall Study|Withdrawal by Subject|0|||
105644389|NCT01276509|364361890|FG003|Overall Study|Withdrawal by Subject|0|||
105644390|NCT01276509|364361887|FG000|Overall Study|Other|0|||
105644391|NCT01276509|364361888|FG001|Overall Study|Other|1|||
105644392|NCT01276509|364361889|FG002|Overall Study|Other|0|||
105644393|NCT01276509|364361890|FG003|Overall Study|Other|0|||
105644394|NCT00264576|364361894|FG000|Overall Study|Lost to Follow-up|1|||
105644395|NCT00264576|364361895|FG001|Overall Study|Lost to Follow-up|1|||
105644396|NCT01668355|364361898|FG000|Overall Study|Death|3|||
105644397|NCT01668355|364361899|FG001|Overall Study|Death|1|||
105644398|NCT01668355|364361898|FG000|Overall Study|Withdrawal by Subject|6|||
105644399|NCT01668355|364361899|FG001|Overall Study|Withdrawal by Subject|1|||
105644400|NCT02659059|364361900|FG000|Overall Study|Other reasons|6|||
105644401|NCT02659059|364361901|FG001|Overall Study|Other reasons|1|||
105644402|NCT02659059|364361900|FG000|Overall Study|Disease Progression|143|||
105644403|NCT02659059|364361901|FG001|Overall Study|Disease Progression|16|||
105644404|NCT02659059|364361900|FG000|Overall Study|Study Drug toxicity|56|||
105644405|NCT02659059|364361901|FG001|Overall Study|Study Drug toxicity|9|||
105644406|NCT02659059|364361900|FG000|Overall Study|Death|3|||
105644407|NCT02659059|364361901|FG001|Overall Study|Death|1|||
105644408|NCT02659059|364361900|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
105644409|NCT02659059|364361901|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
105644410|NCT02659059|364361900|FG000|Overall Study|Participant request to discontinue study treatment|5|||
105644411|NCT02659059|364361901|FG001|Overall Study|Participant request to discontinue study treatment|0|||
105644412|NCT02659059|364361900|FG000|Overall Study|Participant withdrew consent|6|||
105644413|NCT02659059|364361901|FG001|Overall Study|Participant withdrew consent|1|||
105644414|NCT02830893|364361902|FG000|Overall Study|Relocation to out of the country|1|||
105644415|NCT02830893|364361903|FG001|Overall Study|Relocation to out of the country|0|||
105644416|NCT02830893|364361902|FG000|Overall Study|Lost to Follow-up|0|||
105644417|NCT02830893|364361903|FG001|Overall Study|Lost to Follow-up|2|||
105644418|NCT02830893|364361902|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
105644419|NCT02830893|364361903|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
105644420|NCT03976102|364361904|FG000|Overall Study|Withdrawal by Subject|4|||
105644421|NCT03976102|364361905|FG001|Overall Study|Withdrawal by Subject|4|||
105644422|NCT03976102|364361904|FG000|Overall Study|Adverse Event|2|||
105644423|NCT03976102|364361905|FG001|Overall Study|Adverse Event|4|||
105644424|NCT03976102|364361904|FG000|Overall Study|Not related to Covid-19|9|||
105644425|NCT03976102|364361905|FG001|Overall Study|Not related to Covid-19|13|||
105644426|NCT03976102|364361904|FG000|Overall Study|Lost to Follow-up|0|||
105644427|NCT03976102|364361905|FG001|Overall Study|Lost to Follow-up|2|||
105644428|NCT03976102|364361904|FG000|Overall Study|Death|3|||
105644429|NCT03976102|364361905|FG001|Overall Study|Death|2|||
105644430|NCT03976102|364361904|FG000|Overall Study|Physician Decision|1|||
105644431|NCT03976102|364361905|FG001|Overall Study|Physician Decision|1|||
105644432|NCT04820023|364361910|FG000|Overall Study|Death|0|||
105644433|NCT04820023|364361911|FG001|Overall Study|Death|0|||
105644434|NCT04820023|364361912|FG002|Overall Study|Death|0|||
105644435|NCT04820023|364361913|FG003|Overall Study|Death|0|||
105644436|NCT04820023|364361914|FG004|Overall Study|Death|0|||
105644437|NCT04820023|364361915|FG005|Overall Study|Death|0|||
105644438|NCT04820023|364361916|FG006|Overall Study|Death|1|||
105644439|NCT04820023|364361917|FG007|Overall Study|Death|0|||
105644440|NCT04820023|364361918|FG008|Overall Study|Death|1|||
105644441|NCT04820023|364361910|FG000|Overall Study|Withdrawal by Subject|1|||
105644442|NCT04820023|364361911|FG001|Overall Study|Withdrawal by Subject|2|||
105644443|NCT04820023|364361912|FG002|Overall Study|Withdrawal by Subject|2|||
105644444|NCT04820023|364361913|FG003|Overall Study|Withdrawal by Subject|1|||
105644445|NCT04820023|364361914|FG004|Overall Study|Withdrawal by Subject|4|||
105644446|NCT04820023|364361915|FG005|Overall Study|Withdrawal by Subject|3|||
105644447|NCT04820023|364361916|FG006|Overall Study|Withdrawal by Subject|3|||
105644448|NCT04820023|364361917|FG007|Overall Study|Withdrawal by Subject|6|||
105644449|NCT04820023|364361918|FG008|Overall Study|Withdrawal by Subject|5|||
105644450|NCT04820023|364361910|FG000|Overall Study|Progressive Disease|3|||
105644451|NCT04820023|364361911|FG001|Overall Study|Progressive Disease|0|||
105644452|NCT04820023|364361912|FG002|Overall Study|Progressive Disease|2|||
105644453|NCT04820023|364361913|FG003|Overall Study|Progressive Disease|2|||
105644454|NCT04820023|364361914|FG004|Overall Study|Progressive Disease|2|||
105644455|NCT04820023|364361915|FG005|Overall Study|Progressive Disease|0|||
105644456|NCT04820023|364361916|FG006|Overall Study|Progressive Disease|1|||
105644457|NCT04820023|364361917|FG007|Overall Study|Progressive Disease|1|||
105644458|NCT04820023|364361918|FG008|Overall Study|Progressive Disease|0|||
105644459|NCT04820023|364361910|FG000|Overall Study|New anti-cancer therapy|0|||
105644460|NCT04820023|364361911|FG001|Overall Study|New anti-cancer therapy|0|||
105644461|NCT04820023|364361912|FG002|Overall Study|New anti-cancer therapy|0|||
105644462|NCT04820023|364361913|FG003|Overall Study|New anti-cancer therapy|0|||
105644463|NCT04820023|364361914|FG004|Overall Study|New anti-cancer therapy|2|||
105644464|NCT04820023|364361915|FG005|Overall Study|New anti-cancer therapy|0|||
105644465|NCT04820023|364361916|FG006|Overall Study|New anti-cancer therapy|0|||
105644466|NCT04820023|364361917|FG007|Overall Study|New anti-cancer therapy|0|||
105644467|NCT04820023|364361918|FG008|Overall Study|New anti-cancer therapy|0|||
105644468|NCT04820023|364361910|FG000|Overall Study|Other|0|||
105644469|NCT04820023|364361911|FG001|Overall Study|Other|1|||
105644470|NCT04820023|364361912|FG002|Overall Study|Other|0|||
105644471|NCT04820023|364361913|FG003|Overall Study|Other|0|||
105644472|NCT04820023|364361914|FG004|Overall Study|Other|0|||
105644473|NCT04820023|364361915|FG005|Overall Study|Other|0|||
105644474|NCT04820023|364361916|FG006|Overall Study|Other|0|||
105644475|NCT04820023|364361917|FG007|Overall Study|Other|2|||
105644476|NCT04820023|364361918|FG008|Overall Study|Other|0|||
105644477|NCT01562275|364361919|FG000|Stage 1|Adverse Event|0|||
105644478|NCT01562275|364361920|FG001|Stage 1|Adverse Event|0|||
105644479|NCT01562275|364361921|FG002|Stage 1|Adverse Event|0|||
105644480|NCT01562275|364361922|FG003|Stage 1|Adverse Event|1|||
105644481|NCT01562275|364361923|FG004|Stage 1|Adverse Event|1|||
105644482|NCT01562275|364361924|FG005|Stage 1|Adverse Event|0|||
105644483|NCT01562275|364361925|FG006|Stage 1|Adverse Event|0|||
105644484|NCT01562275|364361926|FG007|Stage 1|Adverse Event|0|||
105644485|NCT01562275|364361927|FG008|Stage 1|Adverse Event|0|||
105644486|NCT01562275|364361928|FG009|Stage 1|Adverse Event|1|||
105644487|NCT01562275|364361929|FG010|Stage 1|Adverse Event|0|||
105644488|NCT01562275|364361930|FG011|Stage 1|Adverse Event|0|||
105644489|NCT01562275|364361931|FG012|Stage 1|Adverse Event|0|||
105644490|NCT01562275|364361919|FG000|Stage 1|Death|1|||
105644491|NCT01562275|364361920|FG001|Stage 1|Death|0|||
105644492|NCT01562275|364361921|FG002|Stage 1|Death|0|||
105644493|NCT01562275|364361922|FG003|Stage 1|Death|0|||
105644494|NCT01562275|364361923|FG004|Stage 1|Death|0|||
105644495|NCT01562275|364361924|FG005|Stage 1|Death|0|||
105644496|NCT01562275|364361925|FG006|Stage 1|Death|0|||
105644497|NCT01562275|364361926|FG007|Stage 1|Death|0|||
105644498|NCT01562275|364361927|FG008|Stage 1|Death|0|||
105644499|NCT01562275|364361928|FG009|Stage 1|Death|0|||
105644500|NCT01562275|364361929|FG010|Stage 1|Death|0|||
105644501|NCT01562275|364361930|FG011|Stage 1|Death|0|||
105644502|NCT01562275|364361931|FG012|Stage 1|Death|0|||
105644503|NCT01562275|364361919|FG000|Stage 1|Non Compliance|0|||
105644504|NCT01562275|364361920|FG001|Stage 1|Non Compliance|0|||
105644505|NCT01562275|364361921|FG002|Stage 1|Non Compliance|1|||
105644506|NCT01562275|364361922|FG003|Stage 1|Non Compliance|0|||
105644507|NCT01562275|364361923|FG004|Stage 1|Non Compliance|0|||
105644508|NCT01562275|364361924|FG005|Stage 1|Non Compliance|0|||
105644509|NCT01562275|364361925|FG006|Stage 1|Non Compliance|0|||
105644510|NCT01562275|364361926|FG007|Stage 1|Non Compliance|0|||
105644511|NCT01562275|364361927|FG008|Stage 1|Non Compliance|0|||
105644512|NCT01562275|364361928|FG009|Stage 1|Non Compliance|0|||
105644513|NCT01562275|364361929|FG010|Stage 1|Non Compliance|0|||
105644514|NCT01562275|364361930|FG011|Stage 1|Non Compliance|0|||
105644515|NCT01562275|364361931|FG012|Stage 1|Non Compliance|0|||
105644516|NCT01562275|364361919|FG000|Stage 1|Physician Decision|0|||
105644517|NCT01562275|364361920|FG001|Stage 1|Physician Decision|0|||
105644518|NCT01562275|364361921|FG002|Stage 1|Physician Decision|0|||
105644519|NCT01562275|364361922|FG003|Stage 1|Physician Decision|0|||
105644520|NCT01562275|364361923|FG004|Stage 1|Physician Decision|1|||
105644521|NCT01562275|364361924|FG005|Stage 1|Physician Decision|0|||
105644522|NCT01562275|364361925|FG006|Stage 1|Physician Decision|1|||
105644523|NCT01562275|364361926|FG007|Stage 1|Physician Decision|0|||
105644524|NCT01562275|364361927|FG008|Stage 1|Physician Decision|1|||
105644525|NCT01562275|364361928|FG009|Stage 1|Physician Decision|0|||
105644526|NCT01562275|364361929|FG010|Stage 1|Physician Decision|0|||
105644527|NCT01562275|364361930|FG011|Stage 1|Physician Decision|0|||
105644528|NCT01562275|364361931|FG012|Stage 1|Physician Decision|0|||
105644529|NCT01562275|364361919|FG000|Stage 1|Progression of Disease|2|||
105644530|NCT01562275|364361920|FG001|Stage 1|Progression of Disease|6|||
105644531|NCT01562275|364361921|FG002|Stage 1|Progression of Disease|2|||
105644532|NCT01562275|364361922|FG003|Stage 1|Progression of Disease|1|||
105644533|NCT01562275|364361923|FG004|Stage 1|Progression of Disease|2|||
105644534|NCT01562275|364361924|FG005|Stage 1|Progression of Disease|4|||
105644535|NCT01562275|364361925|FG006|Stage 1|Progression of Disease|1|||
105644536|NCT01562275|364361926|FG007|Stage 1|Progression of Disease|7|||
105644537|NCT01562275|364361927|FG008|Stage 1|Progression of Disease|2|||
105644538|NCT01562275|364361928|FG009|Stage 1|Progression of Disease|5|||
105644539|NCT01562275|364361929|FG010|Stage 1|Progression of Disease|3|||
105644540|NCT01562275|364361930|FG011|Stage 1|Progression of Disease|0|||
105644541|NCT01562275|364361931|FG012|Stage 1|Progression of Disease|0|||
105644542|NCT01562275|364361919|FG000|Stage 1|Withdrawal by Subject|0|||
105644543|NCT01562275|364361920|FG001|Stage 1|Withdrawal by Subject|1|||
105644544|NCT01562275|364361921|FG002|Stage 1|Withdrawal by Subject|0|||
105644545|NCT01562275|364361922|FG003|Stage 1|Withdrawal by Subject|2|||
105644546|NCT01562275|364361923|FG004|Stage 1|Withdrawal by Subject|0|||
105644547|NCT01562275|364361924|FG005|Stage 1|Withdrawal by Subject|0|||
105644548|NCT01562275|364361925|FG006|Stage 1|Withdrawal by Subject|1|||
105644549|NCT01562275|364361926|FG007|Stage 1|Withdrawal by Subject|0|||
105644550|NCT01562275|364361927|FG008|Stage 1|Withdrawal by Subject|0|||
105644551|NCT01562275|364361928|FG009|Stage 1|Withdrawal by Subject|1|||
105644552|NCT01562275|364361929|FG010|Stage 1|Withdrawal by Subject|0|||
105644553|NCT01562275|364361930|FG011|Stage 1|Withdrawal by Subject|0|||
105644554|NCT01562275|364361931|FG012|Stage 1|Withdrawal by Subject|0|||
105644555|NCT01562275|364361919|FG000|Stage 2|Death|0|||
105644556|NCT01562275|364361920|FG001|Stage 2|Death|0|||
105644557|NCT01562275|364361921|FG002|Stage 2|Death|0|||
105644558|NCT01562275|364361922|FG003|Stage 2|Death|0|||
105644559|NCT01562275|364361923|FG004|Stage 2|Death|0|||
105644560|NCT01562275|364361924|FG005|Stage 2|Death|0|||
105644561|NCT01562275|364361925|FG006|Stage 2|Death|0|||
105644562|NCT01562275|364361926|FG007|Stage 2|Death|0|||
105644563|NCT01562275|364361927|FG008|Stage 2|Death|0|||
105644564|NCT01562275|364361928|FG009|Stage 2|Death|0|||
105644565|NCT01562275|364361929|FG010|Stage 2|Death|0|||
105644566|NCT01562275|364361930|FG011|Stage 2|Death|2|||
105644567|NCT01562275|364361931|FG012|Stage 2|Death|1|||
105644568|NCT01562275|364361919|FG000|Stage 2|Progression of Disease|0|||
105644569|NCT01562275|364361920|FG001|Stage 2|Progression of Disease|0|||
105644570|NCT01562275|364361921|FG002|Stage 2|Progression of Disease|0|||
105644571|NCT01562275|364361922|FG003|Stage 2|Progression of Disease|0|||
105644572|NCT01562275|364361923|FG004|Stage 2|Progression of Disease|0|||
105644573|NCT01562275|364361924|FG005|Stage 2|Progression of Disease|0|||
105644574|NCT01562275|364361925|FG006|Stage 2|Progression of Disease|0|||
105644575|NCT01562275|364361926|FG007|Stage 2|Progression of Disease|0|||
105644576|NCT01562275|364361927|FG008|Stage 2|Progression of Disease|0|||
105644577|NCT01562275|364361928|FG009|Stage 2|Progression of Disease|0|||
105644578|NCT01562275|364361929|FG010|Stage 2|Progression of Disease|0|||
105644579|NCT01562275|364361930|FG011|Stage 2|Progression of Disease|12|||
105644580|NCT01562275|364361931|FG012|Stage 2|Progression of Disease|4|||
105644581|NCT02065895|364361932|FG000|Overall Study|Protocol Violation|1|||
105644582|NCT02065895|364361933|FG001|Overall Study|Protocol Violation|0|||
105644583|NCT02065895|364361934|FG002|Overall Study|Protocol Violation|0|||
105644584|NCT02065895|364361935|FG003|Overall Study|Protocol Violation|1|||
105644585|NCT02065895|364361936|FG004|Overall Study|Protocol Violation|0|||
105644586|NCT02065895|364361937|FG005|Overall Study|Protocol Violation|0|||
105644587|NCT02065895|364361932|FG000|Overall Study|Scheduling conflicts|0|||
105644588|NCT02065895|364361933|FG001|Overall Study|Scheduling conflicts|1|||
105644589|NCT02065895|364361934|FG002|Overall Study|Scheduling conflicts|0|||
105644590|NCT02065895|364361935|FG003|Overall Study|Scheduling conflicts|0|||
105644591|NCT02065895|364361936|FG004|Overall Study|Scheduling conflicts|0|||
105644592|NCT02065895|364361937|FG005|Overall Study|Scheduling conflicts|0|||
105644593|NCT00578344|364361951|FG000|Overall Study|Insurance problems|1|||
105644594|NCT00578344|364361951|FG000|Overall Study|Graft failure|1|||
105644595|NCT00990184|364361952|FG000|Overall Study|Physician Decision|1|||
105644596|NCT01655498|364361953|FG000|Overall Study|Unrelated health issue|2|||
105644597|NCT01655498|364361953|FG000|Overall Study|Protocol Violation|2|||
105644598|NCT01655498|364361953|FG000|Overall Study|Withdrawal by Subject|1|||
105644599|NCT02446015|364361954|FG000|Overall Study|Adverse Event|0|||
105644600|NCT02446015|364361955|FG001|Overall Study|Adverse Event|1|||
105644601|NCT02446015|364361954|FG000|Overall Study|Withdrawal by Subject|1|||
105644602|NCT02446015|364361955|FG001|Overall Study|Withdrawal by Subject|0|||
105644603|NCT01072149|364361956|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644604|NCT01072149|364361957|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644605|NCT01072149|364361958|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
105644606|NCT01072149|364361959|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644607|NCT01072149|364361960|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644608|NCT01072149|364361961|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644609|NCT01072149|364361962|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644610|NCT01072149|364361963|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644611|NCT01072149|364361964|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644612|NCT01072149|364361965|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644613|NCT01072149|364361966|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644614|NCT01072149|364361967|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644615|NCT01072149|364361968|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644616|NCT01072149|364361969|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644617|NCT01072149|364361970|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644618|NCT01072149|364361971|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644619|NCT01072149|364361972|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644620|NCT01072149|364361973|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644621|NCT01072149|364361956|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644622|NCT01072149|364361957|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644623|NCT01072149|364361958|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644624|NCT01072149|364361959|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644625|NCT01072149|364361960|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644626|NCT01072149|364361961|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644627|NCT01072149|364361962|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644628|NCT01072149|364361963|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644629|NCT01072149|364361964|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644630|NCT01072149|364361965|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644631|NCT01072149|364361966|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644632|NCT01072149|364361967|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644633|NCT01072149|364361968|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644634|NCT01072149|364361969|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644635|NCT01072149|364361970|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644636|NCT01072149|364361971|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644637|NCT01072149|364361972|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644638|NCT01072149|364361973|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
105644639|NCT01072149|364361956|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644640|NCT01072149|364361957|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644641|NCT01072149|364361958|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644642|NCT01072149|364361959|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644643|NCT01072149|364361960|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644644|NCT01072149|364361961|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644645|NCT01072149|364361962|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644646|NCT01072149|364361963|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644647|NCT01072149|364361964|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644648|NCT01072149|364361965|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644649|NCT01072149|364361966|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
105644650|NCT01072149|364361967|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644651|NCT01072149|364361968|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644652|NCT01072149|364361969|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644653|NCT01072149|364361970|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644654|NCT01072149|364361971|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644655|NCT01072149|364361972|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644656|NCT01072149|364361973|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644657|NCT01072149|364361956|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644658|NCT01072149|364361957|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
105644659|NCT01072149|364361958|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644660|NCT01072149|364361959|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644661|NCT01072149|364361960|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644662|NCT01072149|364361961|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644663|NCT01072149|364361962|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644664|NCT01072149|364361963|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644665|NCT01072149|364361964|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644666|NCT01072149|364361965|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644667|NCT01072149|364361966|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644668|NCT01072149|364361967|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644669|NCT01072149|364361968|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644670|NCT01072149|364361969|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644671|NCT01072149|364361970|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644672|NCT01072149|364361971|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644673|NCT01072149|364361972|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644674|NCT01072149|364361973|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644675|NCT01072149|364361956|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644676|NCT01072149|364361957|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644677|NCT01072149|364361958|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
105644678|NCT01072149|364361959|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644679|NCT01072149|364361960|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644680|NCT01072149|364361961|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644681|NCT01072149|364361962|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644682|NCT01072149|364361963|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644683|NCT01072149|364361964|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644684|NCT01072149|364361965|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644685|NCT01072149|364361966|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644686|NCT01072149|364361967|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644687|NCT01072149|364361968|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644688|NCT01072149|364361969|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644689|NCT01072149|364361970|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644690|NCT01072149|364361971|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644691|NCT01072149|364361972|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644692|NCT01072149|364361973|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644693|NCT01072149|364361956|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644694|NCT01072149|364361957|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644695|NCT01072149|364361958|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644696|NCT01072149|364361959|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644697|NCT01072149|364361960|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644698|NCT01072149|364361961|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644699|NCT01072149|364361962|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644700|NCT01072149|364361963|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
105644701|NCT01072149|364361964|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644702|NCT01072149|364361965|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644703|NCT01072149|364361966|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644704|NCT01072149|364361967|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644705|NCT01072149|364361968|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644706|NCT01072149|364361969|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644707|NCT01072149|364361970|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644708|NCT01072149|364361971|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644709|NCT01072149|364361972|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644710|NCT01072149|364361973|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644711|NCT01072149|364361956|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
105644712|NCT01072149|364361957|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
105644713|NCT01072149|364361958|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
105644714|NCT01072149|364361959|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
105644715|NCT01072149|364361960|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
105644716|NCT01072149|364361961|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
105644717|NCT01072149|364361962|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
105644718|NCT01072149|364361963|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
105644719|NCT01072149|364361964|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
105644720|NCT01072149|364361965|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
105644721|NCT01072149|364361966|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
105644722|NCT01072149|364361967|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
105644723|NCT01072149|364361968|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
105644724|NCT01072149|364361969|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
105644725|NCT01072149|364361970|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
105644726|NCT01072149|364361971|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
105644727|NCT01072149|364361972|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
105644728|NCT01072149|364361973|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
105644729|NCT01072149|364361956|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644730|NCT01072149|364361957|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644731|NCT01072149|364361958|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644732|NCT01072149|364361959|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644733|NCT01072149|364361960|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644734|NCT01072149|364361961|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644735|NCT01072149|364361962|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644736|NCT01072149|364361963|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644737|NCT01072149|364361964|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644738|NCT01072149|364361965|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644739|NCT01072149|364361966|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644740|NCT01072149|364361967|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644741|NCT01072149|364361968|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644742|NCT01072149|364361969|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644743|NCT01072149|364361970|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644744|NCT01072149|364361971|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
105644745|NCT01072149|364361972|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644746|NCT01072149|364361973|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644747|NCT01072149|364361956|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
105644748|NCT01072149|364361957|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
105644749|NCT01072149|364361958|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
105644750|NCT01072149|364361959|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
105644751|NCT01072149|364361960|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
105644752|NCT01072149|364361961|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
105644753|NCT01072149|364361962|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
105644754|NCT01072149|364361963|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
105644755|NCT01072149|364361964|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
105644756|NCT01072149|364361965|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
105644757|NCT01072149|364361966|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
105644758|NCT01072149|364361967|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
105644759|NCT01072149|364361968|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
105644760|NCT01072149|364361969|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
105644761|NCT01072149|364361970|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
105644762|NCT01072149|364361971|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
105644763|NCT01072149|364361972|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
105644764|NCT01072149|364361973|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
105644765|NCT01072149|364361956|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644766|NCT01072149|364361957|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644767|NCT01072149|364361958|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644768|NCT01072149|364361959|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644769|NCT01072149|364361960|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644770|NCT01072149|364361961|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644771|NCT01072149|364361962|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644772|NCT01072149|364361963|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644773|NCT01072149|364361964|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644774|NCT01072149|364361965|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644775|NCT01072149|364361966|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644776|NCT01072149|364361967|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644777|NCT01072149|364361968|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
105644778|NCT01072149|364361969|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644779|NCT01072149|364361970|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644780|NCT01072149|364361971|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644781|NCT01072149|364361972|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644782|NCT01072149|364361973|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644783|NCT01072149|364361956|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644784|NCT01072149|364361957|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644785|NCT01072149|364361958|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
105644786|NCT01072149|364361959|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644787|NCT01072149|364361960|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644788|NCT01072149|364361961|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644789|NCT01072149|364361962|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644790|NCT01072149|364361963|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644791|NCT01072149|364361964|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644792|NCT01072149|364361965|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644793|NCT01072149|364361966|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644794|NCT01072149|364361967|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644795|NCT01072149|364361968|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644796|NCT01072149|364361969|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
105644797|NCT01072149|364361970|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644798|NCT01072149|364361971|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644799|NCT01072149|364361972|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644800|NCT01072149|364361973|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644801|NCT02784834|364361974|FG000|Overall Study|Lack of Efficacy|1|||
105644802|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
105644803|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
105644804|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
105644805|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
105644806|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Adverse Event|7|||
105644807|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Adverse Event|8|||
105644808|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Adverse Event|8|||
105644809|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Adverse Event|9|||
105644810|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
105644811|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
105644812|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
105644813|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
105644814|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
105644815|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
105644816|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
105644817|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
105644818|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Pregnancy|0|||
105644819|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Pregnancy|2|||
105644820|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Pregnancy|2|||
105644821|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Pregnancy|0|||
105644822|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Non-compliance|1|||
105644823|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Non-compliance|0|||
105644824|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Non-compliance|0|||
105644825|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Non-compliance|3|||
105644826|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Other|3|||
105644827|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Other|0|||
105644828|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Other|3|||
105644829|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Other|2|||
105644830|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
105644831|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
105644832|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
105644833|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
105644834|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
105644835|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
105644836|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
105644837|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
105644838|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
105644839|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
105644840|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
105644841|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
105644842|NCT02143713|364361975|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
105644843|NCT02143713|364361976|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
105644844|NCT02143713|364361977|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
105644845|NCT02143713|364361978|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
105644846|NCT02143713|364361975|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
105644847|NCT02143713|364361976|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
105644848|NCT02143713|364361977|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
105644849|NCT02143713|364361978|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
105644850|NCT02143713|364361975|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
105644851|NCT02143713|364361976|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
105644852|NCT02143713|364361977|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
105644853|NCT02143713|364361978|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
105644854|NCT02143713|364361975|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
105644855|NCT02143713|364361976|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
105644856|NCT02143713|364361977|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
105644857|NCT02143713|364361978|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
105644858|NCT02143713|364361975|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
105644859|NCT02143713|364361976|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
105644860|NCT02143713|364361977|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
105644861|NCT02143713|364361978|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
105644862|NCT02143713|364361975|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
105644863|NCT02143713|364361976|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
105644864|NCT02143713|364361977|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
105644865|NCT02143713|364361978|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
105644866|NCT01768572|364361979|FG000|Overall Study|Adverse Event|7|||
105644867|NCT01768572|364361980|FG001|Overall Study|Adverse Event|8|||
105644868|NCT01768572|364361981|FG002|Overall Study|Adverse Event|4|||
105644869|NCT01768572|364361979|FG000|Overall Study|Lack of Efficacy|1|||
105644870|NCT01768572|364361980|FG001|Overall Study|Lack of Efficacy|3|||
105644871|NCT01768572|364361981|FG002|Overall Study|Lack of Efficacy|1|||
105644872|NCT01768572|364361979|FG000|Overall Study|Other, Not due to an adverse event|1|||
105644873|NCT01768572|364361980|FG001|Overall Study|Other, Not due to an adverse event|1|||
105644874|NCT01768572|364361981|FG002|Overall Study|Other, Not due to an adverse event|1|||
105644875|NCT01279447|364361984|FG000|Overall Study|Lost to Follow-up|3|||
105644876|NCT01279447|364361985|FG001|Overall Study|Lost to Follow-up|1|||
105644877|NCT01215253|364361986|FG000|Overall Study|Withdrawal by Subject|57|||
105644878|NCT01215253|364361987|FG001|Overall Study|Withdrawal by Subject|35|||
105644879|NCT01215253|364361986|FG000|Overall Study|Physician Decision|9|||
105644880|NCT01215253|364361987|FG001|Overall Study|Physician Decision|12|||
105644881|NCT01215253|364361986|FG000|Overall Study|Lost to Follow-up|6|||
105644882|NCT01215253|364361987|FG001|Overall Study|Lost to Follow-up|4|||
105644883|NCT01215253|364361986|FG000|Overall Study|Other|14|||
105644884|NCT01215253|364361987|FG001|Overall Study|Other|12|||
105644885|NCT01919489|364361988|FG000|Overall Study|Rejected the need of injections|4|||
105644886|NCT01919489|364361989|FG001|Overall Study|Rejected the need of injections|7|||
105644887|NCT01919489|364361988|FG000|Overall Study|Adverse Event|10|||
105644888|NCT01919489|364361989|FG001|Overall Study|Adverse Event|0|||
105644889|NCT01919489|364361988|FG000|Overall Study|Hospital readmission|2|||
105644890|NCT01919489|364361989|FG001|Overall Study|Hospital readmission|9|||
105644891|NCT01919489|364361988|FG000|Overall Study|Death|2|||
105644892|NCT01919489|364361989|FG001|Overall Study|Death|1|||
105644893|NCT01919489|364361988|FG000|Overall Study|Lost to Follow-up|38|||
105644894|NCT01919489|364361989|FG001|Overall Study|Lost to Follow-up|27|||
105644895|NCT03761849|364361992|FG000|Overall Study|transferred to OpenLabelExtension|35|||
105644896|NCT03761849|364361993|FG001|Overall Study|transferred to OpenLabelExtension|34|||
105644897|NCT03761849|364361994|FG002|Overall Study|transferred to OpenLabelExtension|36|||
105644898|NCT03761849|364361995|FG003|Overall Study|transferred to OpenLabelExtension|0|||
105644899|NCT03761849|364361996|FG004|Overall Study|transferred to OpenLabelExtension|0|||
105644900|NCT03761849|364361997|FG005|Overall Study|transferred to OpenLabelExtension|0|||
105644901|NCT03761849|364361992|FG000|Overall Study|Adverse Event|1|||
105644902|NCT03761849|364361993|FG001|Overall Study|Adverse Event|0|||
105644903|NCT03761849|364361994|FG002|Overall Study|Adverse Event|0|||
105644904|NCT03761849|364361995|FG003|Overall Study|Adverse Event|0|||
105644905|NCT03761849|364361996|FG004|Overall Study|Adverse Event|2|||
105644906|NCT03761849|364361997|FG005|Overall Study|Adverse Event|3|||
105644907|NCT03761849|364361992|FG000|Overall Study|Withdrawal by Subject|0|||
105644908|NCT03761849|364361993|FG001|Overall Study|Withdrawal by Subject|0|||
105644909|NCT03761849|364361994|FG002|Overall Study|Withdrawal by Subject|0|||
105644910|NCT03761849|364361995|FG003|Overall Study|Withdrawal by Subject|41|||
105644911|NCT03761849|364361996|FG004|Overall Study|Withdrawal by Subject|43|||
105644912|NCT03761849|364361997|FG005|Overall Study|Withdrawal by Subject|35|||
105644913|NCT03761849|364361992|FG000|Overall Study|Lost to Follow-up|0|||
105644914|NCT03761849|364361993|FG001|Overall Study|Lost to Follow-up|1|||
105644915|NCT03761849|364361994|FG002|Overall Study|Lost to Follow-up|0|||
105644916|NCT03761849|364361995|FG003|Overall Study|Lost to Follow-up|2|||
105644917|NCT03761849|364361996|FG004|Overall Study|Lost to Follow-up|4|||
105644918|NCT03761849|364361997|FG005|Overall Study|Lost to Follow-up|5|||
105644919|NCT03761849|364361992|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
105644920|NCT03761849|364361993|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
105644921|NCT03761849|364361994|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
105644922|NCT03761849|364361995|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
105644923|NCT03761849|364361996|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
105644924|NCT03761849|364361997|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
105644925|NCT03761849|364361992|FG000|Overall Study|Physician Decision|0|||
105644926|NCT03761849|364361993|FG001|Overall Study|Physician Decision|0|||
105644927|NCT03761849|364361994|FG002|Overall Study|Physician Decision|0|||
105644928|NCT03761849|364361995|FG003|Overall Study|Physician Decision|1|||
105644929|NCT03761849|364361996|FG004|Overall Study|Physician Decision|4|||
105644930|NCT03761849|364361997|FG005|Overall Study|Physician Decision|4|||
105644931|NCT03761849|364361992|FG000|Overall Study|Death|0|||
105644932|NCT03761849|364361993|FG001|Overall Study|Death|0|||
105644933|NCT03761849|364361994|FG002|Overall Study|Death|0|||
105644934|NCT03761849|364361995|FG003|Overall Study|Death|1|||
105644935|NCT03761849|364361996|FG004|Overall Study|Death|1|||
105644936|NCT03761849|364361997|FG005|Overall Study|Death|3|||
105644937|NCT03761849|364361992|FG000|Overall Study|Protocol Violation|0|||
105644938|NCT03761849|364361993|FG001|Overall Study|Protocol Violation|0|||
105644939|NCT03761849|364361994|FG002|Overall Study|Protocol Violation|0|||
105644940|NCT03761849|364361995|FG003|Overall Study|Protocol Violation|2|||
105644941|NCT03761849|364361996|FG004|Overall Study|Protocol Violation|2|||
105644942|NCT03761849|364361997|FG005|Overall Study|Protocol Violation|1|||
105644943|NCT03761849|364361992|FG000|Overall Study|Participant could not come to site|0|||
105644944|NCT03761849|364361993|FG001|Overall Study|Participant could not come to site|0|||
105644945|NCT03761849|364361994|FG002|Overall Study|Participant could not come to site|0|||
105644946|NCT03761849|364361995|FG003|Overall Study|Participant could not come to site|0|||
105644947|NCT03761849|364361996|FG004|Overall Study|Participant could not come to site|1|||
105644948|NCT03761849|364361997|FG005|Overall Study|Participant could not come to site|0|||
105644949|NCT03761849|364361992|FG000|Overall Study|SF- safety Finding|0|||
105644950|NCT03761849|364361993|FG001|Overall Study|SF- safety Finding|0|||
105644951|NCT03761849|364361994|FG002|Overall Study|SF- safety Finding|0|||
105644952|NCT03761849|364361995|FG003|Overall Study|SF- safety Finding|0|||
105644953|NCT03761849|364361996|FG004|Overall Study|SF- safety Finding|0|||
105644954|NCT03761849|364361997|FG005|Overall Study|SF- safety Finding|1|||
105644955|NCT03761849|364361992|FG000|Overall Study|Patient did not attend visit|0|||
105644956|NCT03761849|364361993|FG001|Overall Study|Patient did not attend visit|0|||
105644957|NCT03761849|364361994|FG002|Overall Study|Patient did not attend visit|0|||
105644958|NCT03761849|364361995|FG003|Overall Study|Patient did not attend visit|0|||
105644959|NCT03761849|364361996|FG004|Overall Study|Patient did not attend visit|0|||
105644960|NCT03761849|364361997|FG005|Overall Study|Patient did not attend visit|1|||
105644961|NCT03840993|364362001|FG000|Overall Study|Adverse Event|1|||
105644962|NCT03840993|364362002|FG001|Overall Study|Adverse Event|0|||
105644963|NCT03840993|364362001|FG000|Overall Study|Lost to Follow-up|4|||
105644964|NCT03840993|364362002|FG001|Overall Study|Lost to Follow-up|0|||
105644965|NCT03840993|364362001|FG000|Overall Study|Physician Decision|0|||
105644966|NCT03840993|364362002|FG001|Overall Study|Physician Decision|1|||
105644967|NCT03840993|364362001|FG000|Overall Study|Pregnancy|0|||
105644968|NCT03840993|364362002|FG001|Overall Study|Pregnancy|1|||
105644969|NCT03840993|364362001|FG000|Overall Study|Withdrawal by Subject|1|||
105644970|NCT03840993|364362002|FG001|Overall Study|Withdrawal by Subject|3|||
105644971|NCT03840993|364362001|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
105644972|NCT03840993|364362002|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
105644973|NCT03884478|364362003|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
105644974|NCT03884478|364362004|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
105644975|NCT03884478|364362005|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
105644976|NCT03884478|364362003|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
105644977|NCT03884478|364362004|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
105644978|NCT03884478|364362005|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
105644979|NCT03884478|364362003|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
105644980|NCT03884478|364362004|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
105644981|NCT03884478|364362005|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
105644982|NCT03884478|364362003|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
105644983|NCT03884478|364362004|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
105644984|NCT03884478|364362005|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
105644985|NCT02213094|364362008|FG000|Overall Study|Adverse Event|1|||
105644986|NCT02213094|364362009|FG001|Overall Study|Adverse Event|0|||
105644987|NCT01090739|364362010|FG000|Enrollment|Withdrawal by Subject|24|||
105644988|NCT01090739|364362010|FG000|Enrollment|Protocol Violation|14|||
105440079|NCT05362058|363616699|FG001|Follow-Up Period|Protocol deviation|1|||
105440080|NCT05362058|363616698|FG000|Follow-Up Period|Withdrawal by Subject|0|||
105440081|NCT05362058|363616699|FG001|Follow-Up Period|Withdrawal by Subject|3|||
105440082|NCT02688985|363616702|FG000|Overall Study|Adverse Event|1|||
105440083|NCT02688985|363616703|FG001|Overall Study|Adverse Event|2|||
105440084|NCT02688985|363616704|FG002|Overall Study|Adverse Event|2|||
105440085|NCT02688985|363616705|FG003|Overall Study|Adverse Event|0|||
105440086|NCT02688985|363616706|FG004|Overall Study|Adverse Event|0|||
105440087|NCT02688985|363616702|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
105440088|NCT02688985|363616703|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
105440089|NCT02688985|363616704|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
105440090|NCT02688985|363616705|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
105440091|NCT02688985|363616706|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
105644989|NCT01090739|364362010|FG000|Enrollment|Lost to Follow-up|5|||
105644990|NCT01090739|364362010|FG000|Enrollment|Physician Decision|5|||
105644991|NCT01090739|364362010|FG000|Enrollment|Sponsor termination of site|4|||
105644992|NCT01090739|364362010|FG000|Enrollment|Study implant limit reached|2|||
105644993|NCT01090739|364362010|FG000|Enrollment|Adverse Event|1|||
105644994|NCT01090739|364362010|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
105644995|NCT01090739|364362010|FG000|12 Month Follow-up|Lost to Follow-up|1|||
105644996|NCT01090739|364362010|FG000|12 Month Follow-up|Physician Decision|1|||
105644997|NCT01090739|364362010|FG000|12 Month Follow-up|Death|1|||
105644998|NCT01090739|364362010|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
105644999|NCT01090739|364362010|FG000|24 Month Follow-up|Lost to Follow-up|1|||
105440092|NCT02688985|363616702|FG000|Overall Study|Death|0|||
105440093|NCT02688985|363616703|FG001|Overall Study|Death|0|||
105440094|NCT02688985|363616704|FG002|Overall Study|Death|0|||
105440095|NCT02688985|363616705|FG003|Overall Study|Death|0|||
105440096|NCT02688985|363616706|FG004|Overall Study|Death|1|||
105440097|NCT02688985|363616702|FG000|Overall Study|Lack of Efficacy|0|||
105440098|NCT02688985|363616703|FG001|Overall Study|Lack of Efficacy|0|||
105440099|NCT02688985|363616704|FG002|Overall Study|Lack of Efficacy|0|||
105440100|NCT02688985|363616705|FG003|Overall Study|Lack of Efficacy|0|||
105440101|NCT02688985|363616706|FG004|Overall Study|Lack of Efficacy|1|||
105440102|NCT02688985|363616702|FG000|Overall Study|Lost to Follow-up|2|||
105440103|NCT02688985|363616703|FG001|Overall Study|Lost to Follow-up|0|||
105440104|NCT02688985|363616704|FG002|Overall Study|Lost to Follow-up|1|||
105440105|NCT02688985|363616705|FG003|Overall Study|Lost to Follow-up|1|||
105440106|NCT02688985|363616706|FG004|Overall Study|Lost to Follow-up|1|||
105440107|NCT02688985|363616702|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105440108|NCT02688985|363616703|FG001|Overall Study|Non-Compliance With Study Drug|3|||
105440109|NCT02688985|363616704|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105440110|NCT02688985|363616705|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105440111|NCT02688985|363616706|FG004|Overall Study|Non-Compliance With Study Drug|1|||
105440112|NCT02688985|363616702|FG000|Overall Study|Other|3|||
105440113|NCT02688985|363616703|FG001|Overall Study|Other|4|||
105440114|NCT02688985|363616704|FG002|Overall Study|Other|1|||
105440115|NCT02688985|363616705|FG003|Overall Study|Other|0|||
105440116|NCT02688985|363616706|FG004|Overall Study|Other|0|||
105440117|NCT02688985|363616702|FG000|Overall Study|Physician Decision|2|||
105440118|NCT02688985|363616703|FG001|Overall Study|Physician Decision|2|||
105440119|NCT02688985|363616704|FG002|Overall Study|Physician Decision|0|||
105440120|NCT02688985|363616705|FG003|Overall Study|Physician Decision|0|||
105440121|NCT02688985|363616706|FG004|Overall Study|Physician Decision|1|||
105440122|NCT02688985|363616702|FG000|Overall Study|Pregnancy|0|||
105440123|NCT02688985|363616703|FG001|Overall Study|Pregnancy|0|||
105440124|NCT02688985|363616704|FG002|Overall Study|Pregnancy|2|||
105440125|NCT02688985|363616705|FG003|Overall Study|Pregnancy|1|||
105645000|NCT01090739|364362010|FG000|24 Month Follow-up|Death|1|||
105645001|NCT01090739|364362010|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
105645002|NCT01090739|364362010|FG000|36 Month Follow-up|Visit still pending|17|||
105645003|NCT00988429|364362011|FG000|Overall Study|Adverse Event|9|||
105645004|NCT00988429|364362012|FG001|Overall Study|Adverse Event|21|||
105645005|NCT00988429|364362013|FG002|Overall Study|Adverse Event|45|||
105645006|NCT00988429|364362011|FG000|Overall Study|Lack of Efficacy|0|||
105645007|NCT00988429|364362012|FG001|Overall Study|Lack of Efficacy|0|||
105645008|NCT00988429|364362013|FG002|Overall Study|Lack of Efficacy|1|||
105645009|NCT00988429|364362011|FG000|Overall Study|Non-Compliance with Study Drug|5|||
105645010|NCT00988429|364362012|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105645011|NCT00988429|364362013|FG002|Overall Study|Non-Compliance with Study Drug|3|||
105645012|NCT00988429|364362011|FG000|Overall Study|Physician Decision|1|||
105645013|NCT00988429|364362012|FG001|Overall Study|Physician Decision|0|||
105645014|NCT00988429|364362013|FG002|Overall Study|Physician Decision|3|||
105645015|NCT00988429|364362011|FG000|Overall Study|Pregnancy|2|||
105645016|NCT00988429|364362012|FG001|Overall Study|Pregnancy|1|||
105645017|NCT00988429|364362013|FG002|Overall Study|Pregnancy|0|||
105645018|NCT00988429|364362011|FG000|Overall Study|Protocol Violation|4|||
105645019|NCT00988429|364362012|FG001|Overall Study|Protocol Violation|3|||
105645020|NCT00988429|364362013|FG002|Overall Study|Protocol Violation|3|||
105645021|NCT00988429|364362011|FG000|Overall Study|Withdrawal by Subject|7|||
105645022|NCT00988429|364362012|FG001|Overall Study|Withdrawal by Subject|7|||
105645023|NCT00988429|364362013|FG002|Overall Study|Withdrawal by Subject|12|||
105645024|NCT00988429|364362011|FG000|Overall Study|Administrative Reasons|1|||
105645025|NCT00988429|364362012|FG001|Overall Study|Administrative Reasons|2|||
105645026|NCT00988429|364362013|FG002|Overall Study|Administrative Reasons|1|||
105645027|NCT00988429|364362011|FG000|Overall Study|other reasons|8|||
105645028|NCT00988429|364362012|FG001|Overall Study|other reasons|8|||
105645029|NCT00988429|364362013|FG002|Overall Study|other reasons|1|||
105645030|NCT02964234|364362014|FG000|Overall Study|Lost to Follow-up|22|||
105645031|NCT02964234|364362015|FG001|Overall Study|Lost to Follow-up|13|||
105645032|NCT01074229|364362016|FG000|Overall Study|Lost to Follow-up|1|||
105645033|NCT01074229|364362017|FG001|Overall Study|Lost to Follow-up|0|||
105645034|NCT01074229|364362018|FG002|Overall Study|Lost to Follow-up|0|||
105645035|NCT01074229|364362016|FG000|Overall Study|Change to open surgical procedure|1|||
105645036|NCT01074229|364362017|FG001|Overall Study|Change to open surgical procedure|3|||
105645037|NCT01074229|364362018|FG002|Overall Study|Change to open surgical procedure|4|||
105645038|NCT02163499|364362019|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
105645039|NCT02163499|364362019|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
105645040|NCT02163499|364362019|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
105645041|NCT02163499|364362019|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
105645042|NCT02163499|364362019|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
105440126|NCT02688985|363616706|FG004|Overall Study|Pregnancy|0|||
105645043|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
105645044|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
105645045|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
105645046|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
105645047|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
105645048|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
105645049|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
105645050|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
105645051|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
105645052|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Death|8|||
105645053|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
105645054|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
105645055|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
105645056|NCT00857311|364362020|FG000|Overall Study|Lost to Follow-up|1|||
105645057|NCT00857311|364362021|FG001|Overall Study|Lost to Follow-up|0|||
105645058|NCT00857311|364362022|FG002|Overall Study|Lost to Follow-up|0|||
105645059|NCT00857311|364362023|FG003|Overall Study|Lost to Follow-up|0|||
105645060|NCT00828139|364362028|FG000|Overall Study|Adverse Event|8|||
105645061|NCT00828139|364362029|FG001|Overall Study|Adverse Event|1|||
105645062|NCT00828139|364362030|FG002|Overall Study|Adverse Event|10|||
105645063|NCT00828139|364362031|FG003|Overall Study|Adverse Event|5|||
105645064|NCT00828139|364362028|FG000|Overall Study|Death|2|||
105645065|NCT00828139|364362029|FG001|Overall Study|Death|1|||
105645066|NCT00828139|364362030|FG002|Overall Study|Death|0|||
105645067|NCT00828139|364362031|FG003|Overall Study|Death|2|||
105645068|NCT00828139|364362028|FG000|Overall Study|Refusal unrelated to toxicity|3|||
105645069|NCT00828139|364362029|FG001|Overall Study|Refusal unrelated to toxicity|4|||
105645070|NCT00828139|364362030|FG002|Overall Study|Refusal unrelated to toxicity|5|||
105645071|NCT00828139|364362031|FG003|Overall Study|Refusal unrelated to toxicity|3|||
105645072|NCT00828139|364362028|FG000|Overall Study|Disease Progression|24|||
105645073|NCT00828139|364362029|FG001|Overall Study|Disease Progression|33|||
105645074|NCT00828139|364362030|FG002|Overall Study|Disease Progression|35|||
105645075|NCT00828139|364362031|FG003|Overall Study|Disease Progression|39|||
105645076|NCT00828139|364362028|FG000|Overall Study|Other|4|||
105645077|NCT00828139|364362029|FG001|Overall Study|Other|2|||
105645078|NCT00828139|364362030|FG002|Overall Study|Other|5|||
105645079|NCT00828139|364362031|FG003|Overall Study|Other|2|||
105645080|NCT01714947|364362032|FG000|Part B|Progressive Disease|3|||
105645081|NCT00700999|364362034|FG000|Overall Study|Lost to Follow-up|7|||
105645082|NCT00700999|364362035|FG001|Overall Study|Lost to Follow-up|7|||
105645083|NCT00700999|364362034|FG000|Overall Study|Excluded - did not meet study criteria|0|||
105645084|NCT00700999|364362035|FG001|Overall Study|Excluded - did not meet study criteria|1|||
105645085|NCT00700999|364362034|FG000|Overall Study|Withdrawal by Subject|8|||
105645086|NCT00700999|364362035|FG001|Overall Study|Withdrawal by Subject|1|||
105645087|NCT01280656|364362038|FG000|Overall Study|Adverse Event|1|||
105645088|NCT01280656|364362039|FG001|Overall Study|Adverse Event|14|||
105645089|NCT01280656|364362040|FG002|Overall Study|Adverse Event|13|||
105645090|NCT01280656|364362038|FG000|Overall Study|Lack of Efficacy|1|||
105645091|NCT01280656|364362039|FG001|Overall Study|Lack of Efficacy|22|||
105645092|NCT01280656|364362040|FG002|Overall Study|Lack of Efficacy|38|||
105645093|NCT01280656|364362038|FG000|Overall Study|Treatment shortening (RGT)|0|||
105645094|NCT01280656|364362039|FG001|Overall Study|Treatment shortening (RGT)|4|||
105645095|NCT01280656|364362040|FG002|Overall Study|Treatment shortening (RGT)|5|||
105645096|NCT01280656|364362038|FG000|Overall Study|Other|1|||
105645097|NCT01280656|364362039|FG001|Overall Study|Other|7|||
105645098|NCT01280656|364362040|FG002|Overall Study|Other|7|||
105645099|NCT02555397|364362045|FG000|Overall Study|Withdrawal by Subject|1|||
105645100|NCT02555397|364362046|FG001|Overall Study|Withdrawal by Subject|0|||
105645101|NCT02555397|364362047|FG002|Overall Study|Withdrawal by Subject|0|||
105645102|NCT02555397|364362048|FG003|Overall Study|Withdrawal by Subject|0|||
105645103|NCT02555397|364362049|FG004|Overall Study|Withdrawal by Subject|0|||
105645104|NCT00617708|364362050|FG000|Overall Study|Adverse Event|0|||
105645105|NCT00617708|364362051|FG001|Overall Study|Adverse Event|6|||
105645106|NCT00617708|364362052|FG002|Overall Study|Adverse Event|9|||
105645107|NCT00617708|364362050|FG000|Overall Study|Withdrawal by Subject|1|||
105645108|NCT00617708|364362051|FG001|Overall Study|Withdrawal by Subject|1|||
105645109|NCT00617708|364362052|FG002|Overall Study|Withdrawal by Subject|7|||
105645110|NCT00617708|364362050|FG000|Overall Study|Death|0|||
105645111|NCT00617708|364362051|FG001|Overall Study|Death|6|||
105645112|NCT00617708|364362052|FG002|Overall Study|Death|5|||
105645113|NCT00617708|364362050|FG000|Overall Study|Progression/Relapse|7|||
105645114|NCT00617708|364362051|FG001|Overall Study|Progression/Relapse|40|||
105645115|NCT00617708|364362052|FG002|Overall Study|Progression/Relapse|36|||
105645116|NCT00617708|364362050|FG000|Overall Study|Not protocol specified|1|||
105645117|NCT00617708|364362051|FG001|Overall Study|Not protocol specified|4|||
105645118|NCT00617708|364362052|FG002|Overall Study|Not protocol specified|2|||
105645119|NCT00617708|364362050|FG000|Overall Study|Not eligible|1|||
105645120|NCT00617708|364362051|FG001|Overall Study|Not eligible|3|||
105645121|NCT00617708|364362052|FG002|Overall Study|Not eligible|5|||
105645122|NCT01123200|364362055|FG000|Overall Study|Withdrawal by Subject|1|||
105645123|NCT03840200|364363471|FG000|Overall Study|Death|6|||
105645124|NCT03840200|364363472|FG001|Overall Study|Death|3|||
105645125|NCT03840200|364363473|FG002|Overall Study|Death|6|||
105645126|NCT03840200|364363474|FG003|Overall Study|Death|10|||
105645127|NCT03840200|364363471|FG000|Overall Study|Reason Not Specified|2|||
105645128|NCT03840200|364363472|FG001|Overall Study|Reason Not Specified|2|||
105645129|NCT03840200|364363473|FG002|Overall Study|Reason Not Specified|1|||
105645130|NCT03840200|364363474|FG003|Overall Study|Reason Not Specified|15|||
105645131|NCT03840200|364363471|FG000|Overall Study|Physician Decision|0|||
105645132|NCT03840200|364363472|FG001|Overall Study|Physician Decision|0|||
105645133|NCT03840200|364363473|FG002|Overall Study|Physician Decision|0|||
105645134|NCT03840200|364363474|FG003|Overall Study|Physician Decision|2|||
105645135|NCT03840200|364363471|FG000|Overall Study|Progressive Disease|0|||
105645136|NCT03840200|364363472|FG001|Overall Study|Progressive Disease|0|||
105645137|NCT03840200|364363473|FG002|Overall Study|Progressive Disease|0|||
105645138|NCT03840200|364363474|FG003|Overall Study|Progressive Disease|1|||
105645139|NCT03840200|364363471|FG000|Overall Study|Withdrawal by Subject|0|||
105645140|NCT03840200|364363472|FG001|Overall Study|Withdrawal by Subject|1|||
105645141|NCT03840200|364363473|FG002|Overall Study|Withdrawal by Subject|0|||
105645142|NCT03840200|364363474|FG003|Overall Study|Withdrawal by Subject|2|||
105645143|NCT05522777|364363475|FG000|Overall Study|Lack of Efficacy|1|||
105645144|NCT05522777|364363475|FG000|Overall Study|Withdrawal by Subject|1|||
105645145|NCT05379400|364363480|FG000|Overall Study|Lost to Follow-up|1|||
105645146|NCT05379400|364363481|FG001|Overall Study|Lost to Follow-up|1|||
105645147|NCT03020914|364363482|FG000|Overall Study|Surgery Cancelled|1|||
105645148|NCT03020914|364363483|FG001|Overall Study|Surgery Cancelled|0|||
105645149|NCT00092456|364363489|FG000|Overall Study|Adverse Event|0|||
105645150|NCT00092456|364363490|FG001|Overall Study|Adverse Event|0|||
105645151|NCT00092456|364363491|FG002|Overall Study|Adverse Event|1|||
105645152|NCT00092456|364363492|FG003|Overall Study|Adverse Event|1|||
105645153|NCT00092456|364363489|FG000|Overall Study|Lost to Follow-up|2|||
105645154|NCT00092456|364363490|FG001|Overall Study|Lost to Follow-up|2|||
105645155|NCT00092456|364363491|FG002|Overall Study|Lost to Follow-up|1|||
105645156|NCT00092456|364363492|FG003|Overall Study|Lost to Follow-up|2|||
105645157|NCT00092456|364363489|FG000|Overall Study|Protocol Violation|5|||
105645158|NCT00092456|364363490|FG001|Overall Study|Protocol Violation|7|||
105645159|NCT00092456|364363491|FG002|Overall Study|Protocol Violation|8|||
105645160|NCT00092456|364363492|FG003|Overall Study|Protocol Violation|6|||
105645161|NCT00092456|364363489|FG000|Overall Study|Withdrawal by Subject|13|||
105645162|NCT00092456|364363490|FG001|Overall Study|Withdrawal by Subject|5|||
105645163|NCT00092456|364363491|FG002|Overall Study|Withdrawal by Subject|16|||
105645164|NCT00092456|364363492|FG003|Overall Study|Withdrawal by Subject|6|||
105645165|NCT00092456|364363489|FG000|Overall Study|Moved|1|||
105645166|NCT00092456|364363490|FG001|Overall Study|Moved|1|||
105645167|NCT00092456|364363491|FG002|Overall Study|Moved|0|||
105645168|NCT00092456|364363492|FG003|Overall Study|Moved|1|||
105645169|NCT00092456|364363489|FG000|Overall Study|Other|4|||
105645170|NCT00092456|364363490|FG001|Overall Study|Other|2|||
105645171|NCT00092456|364363491|FG002|Overall Study|Other|3|||
105645172|NCT00092456|364363492|FG003|Overall Study|Other|0|||
105645173|NCT02164578|364363493|FG000|Treatment Period|Withdrawal by Subject|3|||
105645174|NCT02164578|364363494|FG001|Treatment Period|Withdrawal by Subject|3|||
105645175|NCT02164578|364363493|FG000|Treatment Period|Adverse Event|13|||
105645176|NCT02164578|364363494|FG001|Treatment Period|Adverse Event|6|||
105645177|NCT02164578|364363493|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
105645178|NCT02164578|364363494|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
105645179|NCT02164578|364363493|FG000|Treatment Period|Protocol Violation|0|||
105645180|NCT02164578|364363494|FG001|Treatment Period|Protocol Violation|2|||
105645181|NCT02164578|364363493|FG000|Extension Period|Withdrawal by Subject|2|||
105645182|NCT02164578|364363494|FG001|Extension Period|Withdrawal by Subject|0|||
105645183|NCT02164578|364363493|FG000|Extension Period|Adverse Event|4|||
105645184|NCT02164578|364363494|FG001|Extension Period|Adverse Event|0|||
105645185|NCT02164578|364363493|FG000|Extension Period|Expiry of study medication|1|||
105645186|NCT02164578|364363494|FG001|Extension Period|Expiry of study medication|0|||
105645187|NCT02164578|364363493|FG000|Extension Period|Protocol Violation|0|||
105645188|NCT02164578|364363494|FG001|Extension Period|Protocol Violation|1|||
105645189|NCT01018992|364363495|FG000|Overall Study|Adverse Event|8|||
105645190|NCT01018992|364363496|FG001|Overall Study|Adverse Event|3|||
105645191|NCT01018992|364363495|FG000|Overall Study|Withdrawal by Subject|3|||
105645192|NCT01018992|364363496|FG001|Overall Study|Withdrawal by Subject|8|||
105645193|NCT01018992|364363495|FG000|Overall Study|Protocol Violation|0|||
105645194|NCT01018992|364363496|FG001|Overall Study|Protocol Violation|4|||
105645195|NCT01018992|364363495|FG000|Overall Study|Lost to Follow-up|5|||
105645196|NCT01018992|364363496|FG001|Overall Study|Lost to Follow-up|1|||
105645197|NCT00476151|364363497|FG000|Overall Study|Adverse Event|0|||
105645198|NCT00476151|364363498|FG001|Overall Study|Adverse Event|2|||
105645199|NCT00476151|364363497|FG000|Overall Study|Protocol Violation|1|||
105645200|NCT00476151|364363498|FG001|Overall Study|Protocol Violation|3|||
105645201|NCT00476151|364363497|FG000|Overall Study|Withdrawal by Subject|2|||
105645202|NCT00476151|364363498|FG001|Overall Study|Withdrawal by Subject|0|||
105645203|NCT00476151|364363497|FG000|Overall Study|Physician Decision|0|||
105645204|NCT00476151|364363498|FG001|Overall Study|Physician Decision|2|||
105645205|NCT00267956|364363505|FG000|Controlled Period|Adverse Event|4|||
105645206|NCT00267956|364363506|FG001|Controlled Period|Adverse Event|1|||
105645207|NCT00267956|364363507|FG002|Controlled Period|Adverse Event|0|||
105645208|NCT00267956|364363508|FG003|Controlled Period|Adverse Event|0|||
105645209|NCT00267956|364363505|FG000|Controlled Period|Lack of Efficacy|4|||
105645210|NCT00267956|364363506|FG001|Controlled Period|Lack of Efficacy|2|||
105645211|NCT00267956|364363507|FG002|Controlled Period|Lack of Efficacy|0|||
105645212|NCT00267956|364363508|FG003|Controlled Period|Lack of Efficacy|0|||
105645213|NCT00267956|364363505|FG000|Controlled Period|Lost to Follow-up|2|||
105645214|NCT00267956|364363506|FG001|Controlled Period|Lost to Follow-up|0|||
105645215|NCT00267956|364363507|FG002|Controlled Period|Lost to Follow-up|0|||
105645216|NCT00267956|364363508|FG003|Controlled Period|Lost to Follow-up|0|||
105645217|NCT00267956|364363505|FG000|Controlled Period|Withdrew consent|3|||
105645218|NCT00267956|364363506|FG001|Controlled Period|Withdrew consent|1|||
105645219|NCT00267956|364363507|FG002|Controlled Period|Withdrew consent|0|||
105645220|NCT00267956|364363508|FG003|Controlled Period|Withdrew consent|0|||
105645221|NCT00267956|364363505|FG000|After Controlled Period|Adverse Event|0|||
105645222|NCT00267956|364363506|FG001|After Controlled Period|Adverse Event|0|||
105645223|NCT00267956|364363507|FG002|After Controlled Period|Adverse Event|2|||
105645224|NCT00267956|364363508|FG003|After Controlled Period|Adverse Event|1|||
105645225|NCT00267956|364363505|FG000|After Controlled Period|Lack of Efficacy|0|||
105645226|NCT00267956|364363506|FG001|After Controlled Period|Lack of Efficacy|0|||
105645227|NCT00267956|364363507|FG002|After Controlled Period|Lack of Efficacy|1|||
105645228|NCT00267956|364363508|FG003|After Controlled Period|Lack of Efficacy|1|||
105645229|NCT00267956|364363505|FG000|After Controlled Period|Lost to Follow-up|0|||
105645230|NCT00267956|364363506|FG001|After Controlled Period|Lost to Follow-up|0|||
105645231|NCT00267956|364363507|FG002|After Controlled Period|Lost to Follow-up|1|||
105645232|NCT00267956|364363508|FG003|After Controlled Period|Lost to Follow-up|0|||
105645233|NCT00267956|364363505|FG000|After Controlled Period|Withdrew consent|0|||
105645234|NCT00267956|364363506|FG001|After Controlled Period|Withdrew consent|0|||
105645235|NCT00267956|364363507|FG002|After Controlled Period|Withdrew consent|1|||
105645236|NCT00267956|364363508|FG003|After Controlled Period|Withdrew consent|0|||
105645237|NCT02005484|364363511|FG000|Overall Study|Death|1|||
105645238|NCT02005484|364363511|FG000|Overall Study|Disease progression|1|||
105645239|NCT02005484|364363511|FG000|Overall Study|Changed to a Different Study|1|||
105645240|NCT02005484|364363511|FG000|Overall Study|Sponsor decision|1|||
105645241|NCT01129011|364363512|FG000|Overall Study|Adverse Event|20|||
105645242|NCT01129011|364363513|FG001|Overall Study|Adverse Event|30|||
105645243|NCT01129011|364363512|FG000|Overall Study|Withdrawal by Subject|24|||
105645244|NCT01129011|364363513|FG001|Overall Study|Withdrawal by Subject|8|||
105645245|NCT01129011|364363512|FG000|Overall Study|Lost to Follow-up|6|||
105645246|NCT01129011|364363513|FG001|Overall Study|Lost to Follow-up|7|||
105645247|NCT01129011|364363512|FG000|Overall Study|Duodenal Ulcer|2|||
105645248|NCT01129011|364363513|FG001|Overall Study|Duodenal Ulcer|8|||
105645249|NCT01129011|364363512|FG000|Overall Study|misc|7|||
105645250|NCT01129011|364363513|FG001|Overall Study|misc|4|||
105645251|NCT02246647|364363514|FG000|Overall Study|Withdrawal by Subject|1|||
105645252|NCT02246647|364363515|FG001|Overall Study|Withdrawal by Subject|1|||
105645253|NCT03745651|364363516|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
105645254|NCT03745651|364363517|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
105645255|NCT03745651|364363518|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105645256|NCT03745651|364363519|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105645257|NCT03745651|364363520|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105645258|NCT03745651|364363521|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105645259|NCT03745651|364363522|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105645260|NCT03745651|364363516|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
105645261|NCT03745651|364363517|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
105645262|NCT03745651|364363518|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
105645263|NCT03745651|364363519|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105645264|NCT03745651|364363520|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105645265|NCT03745651|364363521|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105645266|NCT03745651|364363522|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105645267|NCT03745651|364363516|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
105645268|NCT03745651|364363517|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105645269|NCT03745651|364363518|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
105645270|NCT03745651|364363519|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105645271|NCT03745651|364363520|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105645272|NCT03745651|364363521|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105659340|NCT00551135|364417283|FG003|Overall Study|Other|2|||
105645273|NCT03745651|364363522|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105645274|NCT03745651|364363516|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105645275|NCT03745651|364363517|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
105645276|NCT03745651|364363518|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105645277|NCT03745651|364363519|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105645278|NCT03745651|364363520|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105645279|NCT03745651|364363521|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105645280|NCT03745651|364363522|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105645281|NCT03745651|364363516|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
105645282|NCT03745651|364363517|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
105645283|NCT03745651|364363518|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
105645284|NCT03745651|364363519|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105645285|NCT03745651|364363520|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105645286|NCT03745651|364363521|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105645287|NCT03745651|364363522|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105645288|NCT03745651|364363516|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
105645289|NCT03745651|364363517|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
105645290|NCT03745651|364363518|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
105645291|NCT03745651|364363519|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
105645292|NCT03745651|364363520|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
105645293|NCT03745651|364363521|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
105645294|NCT03745651|364363522|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
105645295|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105645296|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105645297|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105645298|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105645299|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105645300|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
105645301|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105645302|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105645303|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105645304|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105645305|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
105645306|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105645307|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
105645308|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
105645309|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
105645310|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
105645311|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
105645312|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
105645313|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
105645314|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
105645315|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
105645316|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105645317|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105645318|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105645319|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
105645320|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105645321|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
105645322|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
105645323|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
105645324|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
105645325|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
105645326|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
105645327|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
105645328|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
105645329|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
105645330|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105645331|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105645332|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105645333|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105645334|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105645335|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
105645336|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105645337|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
105645338|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
105645339|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
105645340|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
105645341|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
105645342|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
105645343|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
105645344|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
105645345|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
105645346|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
105645347|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
105645348|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
105645349|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
105645350|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
105645351|NCT01494467|364363535|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
105645352|NCT01494467|364363536|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
105645353|NCT01494467|364363535|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
105645354|NCT01494467|364363536|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
105645355|NCT01494467|364363535|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
105645356|NCT01494467|364363536|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
105645357|NCT01494467|364363535|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
105645358|NCT01494467|364363536|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
105645359|NCT01494467|364363535|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
105645360|NCT01494467|364363536|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
105645361|NCT01494467|364363535|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
105645362|NCT01494467|364363536|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
105645363|NCT01494467|364363535|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
105645364|NCT01494467|364363536|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
105645365|NCT01494467|364363535|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
105645366|NCT01494467|364363536|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
105645367|NCT01494467|364363535|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
105645368|NCT01494467|364363536|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
105645369|NCT01494467|364363535|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
105645370|NCT01494467|364363536|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
105645371|NCT01494467|364363535|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
105645372|NCT01494467|364363536|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
105645373|NCT01494467|364363535|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
105645374|NCT01494467|364363536|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
105645375|NCT01494467|364363535|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
105645376|NCT01494467|364363536|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
105645377|NCT01494467|364363535|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
105645378|NCT01494467|364363536|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
105645379|NCT00417885|364363537|FG000|Overall Study|Adverse Event|1|||
105645380|NCT00417885|364363537|FG000|Overall Study|Objective Progression or Relapse|3|||
105645381|NCT00417885|364363537|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
105645382|NCT03436797|364363538|FG000|Main Study|Withdrawal by Subject|2|||
105645383|NCT03436797|364363538|FG000|Main Study|Adverse Event|4|||
105645384|NCT03436797|364363538|FG000|Main Study|Lost to Follow-up|1|||
105645385|NCT03436797|364363538|FG000|Main Study|Death|1|||
105645386|NCT03436797|364363538|FG000|Main Study|Non-Specific|2|||
105645387|NCT03436797|364363538|FG000|Extended Dosing|Patient decision|1|||
105645388|NCT01912599|364363539|FG000|Overall Study|Withdrawal by Subject|0|||
105645389|NCT01912599|364363540|FG001|Overall Study|Withdrawal by Subject|1|||
105645390|NCT03386344|364363541|FG000|Overall Study|Adverse Event|6|||
105645391|NCT03386344|364363542|FG001|Overall Study|Adverse Event|3|||
105645392|NCT03386344|364363543|FG002|Overall Study|Adverse Event|1|||
105645393|NCT03386344|364363541|FG000|Overall Study|Poor Compliance to Protocol|0|||
105645394|NCT03386344|364363542|FG001|Overall Study|Poor Compliance to Protocol|1|||
105645395|NCT03386344|364363543|FG002|Overall Study|Poor Compliance to Protocol|0|||
105645396|NCT03386344|364363541|FG000|Overall Study|Study Terminated by Sponsor|101|||
105645397|NCT03386344|364363542|FG001|Overall Study|Study Terminated by Sponsor|102|||
105645398|NCT03386344|364363543|FG002|Overall Study|Study Terminated by Sponsor|106|||
105645399|NCT03386344|364363541|FG000|Overall Study|Lost to Follow-up|3|||
105645400|NCT03386344|364363542|FG001|Overall Study|Lost to Follow-up|2|||
105645401|NCT03386344|364363543|FG002|Overall Study|Lost to Follow-up|1|||
105645402|NCT03386344|364363541|FG000|Overall Study|At the Participant's own Request|7|||
105645403|NCT03386344|364363542|FG001|Overall Study|At the Participant's own Request|7|||
105645404|NCT03386344|364363543|FG002|Overall Study|At the Participant's own Request|8|||
105645405|NCT03386344|364363541|FG000|Overall Study|Reason not Specified|0|||
105645406|NCT03386344|364363542|FG001|Overall Study|Reason not Specified|1|||
105645407|NCT03386344|364363543|FG002|Overall Study|Reason not Specified|0|||
105645408|NCT01280721|364363544|FG000|Overall Study|Adverse Event|4|||
105645409|NCT01280721|364363544|FG000|Overall Study|Physician Decision|3|||
105645410|NCT01280721|364363544|FG000|Overall Study|Withdrawal by Subject|6|||
105645411|NCT01280721|364363544|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
105645412|NCT01280721|364363544|FG000|Overall Study|No tolerability for the lowest dose|2|||
105645413|NCT03349476|364363546|FG000|Overall Study|Physician Decision|3|||
105645414|NCT05104242|364363553|FG000|Overall Study|Withdrawal by Subject|1|||
105645415|NCT05104242|364363554|FG001|Overall Study|Withdrawal by Subject|5|||
105645416|NCT05104242|364363553|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
105645417|NCT05104242|364363554|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
105645418|NCT01864200|364363555|FG000|Overall Study|Lost to Follow-up|1|||
105645419|NCT01864200|364363556|FG001|Overall Study|Lost to Follow-up|3|||
105645420|NCT01864200|364363555|FG000|Overall Study|Protocol Violation|1|||
105645421|NCT01864200|364363556|FG001|Overall Study|Protocol Violation|0|||
105645422|NCT00316121|364363557|FG000|Overall Study|Death|1|||
105645423|NCT00316121|364363558|FG001|Overall Study|Death|0|||
105645424|NCT00316121|364363557|FG000|Overall Study|Lost to Follow-up|14|||
105645425|NCT00316121|364363558|FG001|Overall Study|Lost to Follow-up|8|||
105645426|NCT00316121|364363557|FG000|Overall Study|Withdrawal by Subject|2|||
105645427|NCT00316121|364363558|FG001|Overall Study|Withdrawal by Subject|0|||
105645428|NCT00316121|364363557|FG000|Overall Study|Reason is missing|1|||
105645429|NCT00316121|364363558|FG001|Overall Study|Reason is missing|0|||
105645430|NCT00316121|364363557|FG000|Overall Study|Subject relocated|1|||
105645431|NCT00316121|364363558|FG001|Overall Study|Subject relocated|1|||
105645432|NCT00316121|364363557|FG000|Overall Study|Subject refused to return|1|||
105645433|NCT00316121|364363558|FG001|Overall Study|Subject refused to return|0|||
105645434|NCT00316121|364363557|FG000|Overall Study|Subject no show for visit x 3|1|||
105645435|NCT00316121|364363558|FG001|Overall Study|Subject no show for visit x 3|0|||
105645436|NCT00316121|364363557|FG000|Overall Study|Subject did not have 24 month visit|1|||
105645437|NCT00316121|364363558|FG001|Overall Study|Subject did not have 24 month visit|0|||
105645438|NCT00424476|364363559|FG000|Overall Study|Withdrawal by Subject|7|||
105645439|NCT00424476|364363560|FG001|Overall Study|Withdrawal by Subject|6|||
105645440|NCT00424476|364363561|FG002|Overall Study|Withdrawal by Subject|3|||
105645441|NCT00424476|364363559|FG000|Overall Study|Adverse Event|19|||
105645442|NCT00424476|364363560|FG001|Overall Study|Adverse Event|16|||
105645443|NCT00424476|364363561|FG002|Overall Study|Adverse Event|15|||
105645444|NCT00424476|364363559|FG000|Overall Study|Lack of Efficacy|16|||
105645445|NCT00424476|364363560|FG001|Overall Study|Lack of Efficacy|12|||
105645446|NCT00424476|364363561|FG002|Overall Study|Lack of Efficacy|12|||
105645447|NCT00424476|364363559|FG000|Overall Study|Lack of Compliance|1|||
105645448|NCT00424476|364363560|FG001|Overall Study|Lack of Compliance|1|||
105645449|NCT00424476|364363561|FG002|Overall Study|Lack of Compliance|1|||
105645450|NCT00424476|364363559|FG000|Overall Study|Lost to Follow-up|4|||
105645451|NCT00424476|364363560|FG001|Overall Study|Lost to Follow-up|6|||
105645452|NCT00424476|364363561|FG002|Overall Study|Lost to Follow-up|3|||
105645453|NCT00424476|364363559|FG000|Overall Study|Protocol Violation|7|||
105645454|NCT00424476|364363560|FG001|Overall Study|Protocol Violation|2|||
105645455|NCT00424476|364363561|FG002|Overall Study|Protocol Violation|3|||
105645456|NCT00424476|364363559|FG000|Overall Study|Physician Decision|3|||
105645457|NCT00424476|364363560|FG001|Overall Study|Physician Decision|2|||
105645458|NCT00424476|364363561|FG002|Overall Study|Physician Decision|3|||
105645459|NCT00424476|364363559|FG000|Overall Study|Other|4|||
105645460|NCT00424476|364363560|FG001|Overall Study|Other|3|||
105645461|NCT00424476|364363561|FG002|Overall Study|Other|9|||
105645462|NCT00901459|364363562|FG000|Overall Study|Withdrawal by Subject|6|||
105645463|NCT03708744|364363565|FG000|Overall Study|Withdrawal by Subject|0|||
105645464|NCT03708744|364363566|FG001|Overall Study|Withdrawal by Subject|0|||
105645465|NCT03708744|364363567|FG002|Overall Study|Withdrawal by Subject|1|||
105645466|NCT03708744|364363568|FG003|Overall Study|Withdrawal by Subject|0|||
105645467|NCT04930263|364363569|FG000|Overall Study|Withdrawal by Subject|3|||
105645468|NCT04930263|364363570|FG001|Overall Study|Withdrawal by Subject|5|||
105645469|NCT02604199|364363576|FG000|Overall Study|Pregnancy|0|||
105645470|NCT02604199|364363577|FG001|Overall Study|Pregnancy|0|||
105645471|NCT02604199|364363578|FG002|Overall Study|Pregnancy|0|||
105645472|NCT02604199|364363579|FG003|Overall Study|Pregnancy|1|||
105645473|NCT02604199|364363576|FG000|Overall Study|Study terminated by sponsor|0|||
105645474|NCT02604199|364363577|FG001|Overall Study|Study terminated by sponsor|2|||
105645475|NCT02604199|364363578|FG002|Overall Study|Study terminated by sponsor|0|||
105645476|NCT02604199|364363579|FG003|Overall Study|Study terminated by sponsor|2|||
105645477|NCT02604199|364363576|FG000|Overall Study|Withdrawal by Subject|0|||
105645478|NCT02604199|364363577|FG001|Overall Study|Withdrawal by Subject|1|||
105645479|NCT02604199|364363578|FG002|Overall Study|Withdrawal by Subject|0|||
105645480|NCT02604199|364363579|FG003|Overall Study|Withdrawal by Subject|0|||
105645481|NCT02991456|364363581|FG000|Overall Study|Adverse Event|2|||
105645482|NCT02991456|364363582|FG001|Overall Study|Adverse Event|0|||
105645483|NCT02991456|364363581|FG000|Overall Study|Lost to Follow-up|0|||
105645484|NCT02991456|364363582|FG001|Overall Study|Lost to Follow-up|2|||
105645485|NCT02991456|364363581|FG000|Overall Study|Withdrawal by Subject|1|||
105645486|NCT02991456|364363582|FG001|Overall Study|Withdrawal by Subject|0|||
105645487|NCT02924051|364363585|FG000|Overall Study|Withdrawal by Subject|1|||
105645488|NCT02924051|364363586|FG001|Overall Study|Withdrawal by Subject|9|||
105645489|NCT00512902|364363587|FG000|Overall Study|Adverse Event|7|||
105645490|NCT00512902|364363587|FG000|Overall Study|Lost to Follow-up|1|||
105645491|NCT03905512|364363588|FG000|Overall Study|Withdrawal by Subject|9|||
105645492|NCT03905512|364363589|FG001|Overall Study|Withdrawal by Subject|8|||
105645493|NCT03905512|364363588|FG000|Overall Study|Adverse Event|1|||
105645494|NCT03905512|364363589|FG001|Overall Study|Adverse Event|2|||
105645495|NCT03905512|364363588|FG000|Overall Study|Lost to Follow-up|4|||
105645496|NCT03905512|364363589|FG001|Overall Study|Lost to Follow-up|3|||
105645497|NCT03905512|364363588|FG000|Overall Study|Other than Specified|7|||
105645498|NCT03905512|364363589|FG001|Overall Study|Other than Specified|4|||
105645499|NCT03547167|364363590|FG000|Overall Study|Withdrawal by Subject|34|||
105645500|NCT03547167|364363591|FG001|Overall Study|Withdrawal by Subject|12|||
105645501|NCT03547167|364363590|FG000|Overall Study|Screen Failure|0|||
105645502|NCT03547167|364363591|FG001|Overall Study|Screen Failure|1|||
105645503|NCT03547167|364363590|FG000|Overall Study|Lost to Follow-up|59|||
105645504|NCT03547167|364363591|FG001|Overall Study|Lost to Follow-up|15|||
105645505|NCT03547167|364363590|FG000|Overall Study|Death|4|||
105645506|NCT03547167|364363591|FG001|Overall Study|Death|2|||
105645507|NCT00070317|364363594|FG000|Overall Study|Inevaluable (Never Treated)|1|||
105645508|NCT00070317|364363594|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
105645509|NCT00070317|364363594|FG000|Overall Study|Ineligible required test not done|1|||
105645510|NCT00070317|364363594|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
105645511|NCT00070317|364363594|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
105645512|NCT01429285|364363595|FG000|Overall Study|Protocol Violation|9|||
105645513|NCT01429285|364363596|FG001|Overall Study|Protocol Violation|4|||
105645514|NCT01429285|364363595|FG000|Overall Study|Missing Data|5|||
105645515|NCT01429285|364363596|FG001|Overall Study|Missing Data|3|||
105645516|NCT01429285|364363595|FG000|Overall Study|Erroneously Enrolled Twice|8|||
105645517|NCT01429285|364363596|FG001|Overall Study|Erroneously Enrolled Twice|2|||
105645518|NCT00738400|364363597|FG000|Overall Study|Adverse Event|3|||
105645519|NCT00738400|364363598|FG001|Overall Study|Adverse Event|1|||
105645520|NCT00738400|364363597|FG000|Overall Study|Withdrawal by Subject|0|||
105645521|NCT00738400|364363598|FG001|Overall Study|Withdrawal by Subject|1|||
105645522|NCT00738400|364363597|FG000|Overall Study|Lack of Efficacy|0|||
105645523|NCT00738400|364363598|FG001|Overall Study|Lack of Efficacy|1|||
105645524|NCT00738400|364363597|FG000|Overall Study|Lost to Follow-up|0|||
105645525|NCT00738400|364363598|FG001|Overall Study|Lost to Follow-up|3|||
105645526|NCT00738400|364363597|FG000|Overall Study|Protocol Violation|1|||
105645527|NCT00738400|364363598|FG001|Overall Study|Protocol Violation|0|||
105645528|NCT00738400|364363597|FG000|Overall Study|Non-compliant with study medication|0|||
105645529|NCT00738400|364363598|FG001|Overall Study|Non-compliant with study medication|1|||
105645530|NCT02674399|364363599|FG000|Overall Study|Lost to Follow-up|2|||
105645531|NCT02674399|364363600|FG001|Overall Study|Lost to Follow-up|0|||
105645532|NCT00508144|364363601|FG000|Overall Study|Not eligible|6|||
105645533|NCT00508144|364363601|FG000|Overall Study|Death|5|||
105645534|NCT01517282|364363604|FG000|Overall Study|Consent withdrawn|0|||
105645535|NCT01517282|364363605|FG001|Overall Study|Consent withdrawn|1|||
105645536|NCT01517282|364363606|FG002|Overall Study|Consent withdrawn|1|||
105645537|NCT01517282|364363607|FG003|Overall Study|Consent withdrawn|1|||
105645538|NCT01517282|364363604|FG000|Overall Study|Physician Decision|1|||
105645539|NCT01517282|364363605|FG001|Overall Study|Physician Decision|0|||
105645540|NCT01517282|364363606|FG002|Overall Study|Physician Decision|0|||
105645541|NCT01517282|364363607|FG003|Overall Study|Physician Decision|0|||
105645542|NCT01159600|364363608|FG000|Overall Study|Not treated|0|||
105645543|NCT01159600|364363609|FG001|Overall Study|Not treated|0|||
105645544|NCT01159600|364363610|FG002|Overall Study|Not treated|1|||
105645545|NCT01159600|364363611|FG003|Overall Study|Not treated|0|||
105645546|NCT01159600|364363612|FG004|Overall Study|Not treated|0|||
105645547|NCT01159600|364363613|FG005|Overall Study|Not treated|1|||
105645548|NCT01159600|364363614|FG006|Overall Study|Not treated|2|||
105645549|NCT01159600|364363615|FG007|Overall Study|Not treated|2|||
105645550|NCT01159600|364363608|FG000|Overall Study|Adverse Event|7|||
105645551|NCT01159600|364363609|FG001|Overall Study|Adverse Event|2|||
105645552|NCT01159600|364363610|FG002|Overall Study|Adverse Event|5|||
105645553|NCT01159600|364363611|FG003|Overall Study|Adverse Event|1|||
105645554|NCT01159600|364363612|FG004|Overall Study|Adverse Event|8|||
105645555|NCT01159600|364363613|FG005|Overall Study|Adverse Event|6|||
105645556|NCT01159600|364363614|FG006|Overall Study|Adverse Event|7|||
105645557|NCT01159600|364363615|FG007|Overall Study|Adverse Event|5|||
105645558|NCT01159600|364363608|FG000|Overall Study|Lack of Efficacy|0|||
105645559|NCT01159600|364363609|FG001|Overall Study|Lack of Efficacy|0|||
105645560|NCT01159600|364363610|FG002|Overall Study|Lack of Efficacy|0|||
105645561|NCT01159600|364363611|FG003|Overall Study|Lack of Efficacy|0|||
105645562|NCT01159600|364363612|FG004|Overall Study|Lack of Efficacy|2|||
105645563|NCT01159600|364363613|FG005|Overall Study|Lack of Efficacy|0|||
105645564|NCT01159600|364363614|FG006|Overall Study|Lack of Efficacy|0|||
105645565|NCT01159600|364363615|FG007|Overall Study|Lack of Efficacy|1|||
105645566|NCT01159600|364363608|FG000|Overall Study|Non compliant with protocol|2|||
105645567|NCT01159600|364363609|FG001|Overall Study|Non compliant with protocol|1|||
105645568|NCT01159600|364363610|FG002|Overall Study|Non compliant with protocol|0|||
105645569|NCT01159600|364363611|FG003|Overall Study|Non compliant with protocol|0|||
105645570|NCT01159600|364363612|FG004|Overall Study|Non compliant with protocol|2|||
105645571|NCT01159600|364363613|FG005|Overall Study|Non compliant with protocol|0|||
105645572|NCT01159600|364363614|FG006|Overall Study|Non compliant with protocol|2|||
105645573|NCT01159600|364363615|FG007|Overall Study|Non compliant with protocol|0|||
105645574|NCT01159600|364363608|FG000|Overall Study|Lost to Follow-up|2|||
105645575|NCT01159600|364363609|FG001|Overall Study|Lost to Follow-up|3|||
105645576|NCT01159600|364363610|FG002|Overall Study|Lost to Follow-up|4|||
105645577|NCT01159600|364363611|FG003|Overall Study|Lost to Follow-up|3|||
105645578|NCT01159600|364363612|FG004|Overall Study|Lost to Follow-up|3|||
105645579|NCT01159600|364363613|FG005|Overall Study|Lost to Follow-up|0|||
105645580|NCT01159600|364363614|FG006|Overall Study|Lost to Follow-up|3|||
105645581|NCT01159600|364363615|FG007|Overall Study|Lost to Follow-up|2|||
105645582|NCT01159600|364363608|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
105645583|NCT01159600|364363609|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
105645584|NCT01159600|364363610|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
105645585|NCT01159600|364363611|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
105645586|NCT01159600|364363612|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
105645587|NCT01159600|364363613|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
105645588|NCT01159600|364363614|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
105645589|NCT01159600|364363615|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
105645590|NCT01159600|364363608|FG000|Overall Study|Other reason not defined above|3|||
105645591|NCT01159600|364363609|FG001|Overall Study|Other reason not defined above|0|||
105645592|NCT01159600|364363610|FG002|Overall Study|Other reason not defined above|4|||
105645593|NCT01159600|364363611|FG003|Overall Study|Other reason not defined above|2|||
105645594|NCT01159600|364363612|FG004|Overall Study|Other reason not defined above|5|||
105645595|NCT01159600|364363613|FG005|Overall Study|Other reason not defined above|7|||
105645596|NCT01159600|364363614|FG006|Overall Study|Other reason not defined above|3|||
105645597|NCT01159600|364363615|FG007|Overall Study|Other reason not defined above|3|||
105645598|NCT00747149|364364935|FG000|Overall Study|Adverse Event|0|||
105645599|NCT00747149|364364936|FG001|Overall Study|Adverse Event|15|||
105645600|NCT00747149|364364935|FG000|Overall Study|Lost to Follow-up|0|||
105645601|NCT00747149|364364936|FG001|Overall Study|Lost to Follow-up|10|||
105645602|NCT00747149|364364935|FG000|Overall Study|Withdrawal by Subject|0|||
105645603|NCT00747149|364364936|FG001|Overall Study|Withdrawal by Subject|6|||
105645604|NCT00747149|364364935|FG000|Overall Study|Did not receive treatment|0|||
105645605|NCT00747149|364364936|FG001|Overall Study|Did not receive treatment|1|||
105645606|NCT00747149|364364935|FG000|Overall Study|Incorrect enrollment|0|||
105645607|NCT00747149|364364936|FG001|Overall Study|Incorrect enrollment|6|||
105645608|NCT00747149|364364935|FG000|Overall Study|Severe non-compliance to protocol|0|||
105645609|NCT00747149|364364936|FG001|Overall Study|Severe non-compliance to protocol|1|||
105645610|NCT00747149|364364935|FG000|Overall Study|Not reported|1|||
105645611|NCT00747149|364364936|FG001|Overall Study|Not reported|4|||
105645612|NCT04369664|364364937|FG000|Overall Study|Physician Decision|1|||
105645613|NCT04369664|364364938|FG001|Overall Study|Physician Decision|0|||
105645614|NCT03072238|364364939|FG000|Overall Study|Withdrawal by Subject|44|||
105645615|NCT03072238|364364940|FG001|Overall Study|Withdrawal by Subject|64|||
105645616|NCT03072238|364364939|FG000|Overall Study|Lost to Follow-up|14|||
105645617|NCT03072238|364364940|FG001|Overall Study|Lost to Follow-up|5|||
105645618|NCT03072238|364364939|FG000|Overall Study|Physician Decision|4|||
105645619|NCT03072238|364364940|FG001|Overall Study|Physician Decision|6|||
105645620|NCT03072238|364364939|FG000|Overall Study|Death|351|||
105645621|NCT03072238|364364940|FG001|Overall Study|Death|318|||
105645622|NCT03072238|364364939|FG000|Overall Study|Progressive Disease|3|||
105645623|NCT03072238|364364940|FG001|Overall Study|Progressive Disease|4|||
105645624|NCT03072238|364364939|FG000|Overall Study|Reason Not Specified|138|||
105645625|NCT03072238|364364940|FG001|Overall Study|Reason Not Specified|150|||
105645626|NCT02489799|364364941|FG000|Overall Study|Lost to Follow-up|4|||
105645627|NCT02489799|364364942|FG001|Overall Study|Lost to Follow-up|1|||
105645628|NCT02489799|364364941|FG000|Overall Study|Failure to Maintain Eligibility|4|||
105645629|NCT02489799|364364942|FG001|Overall Study|Failure to Maintain Eligibility|6|||
105645630|NCT02489799|364364941|FG000|Overall Study|Withdrawal by Subject|1|||
105645631|NCT02489799|364364942|FG001|Overall Study|Withdrawal by Subject|1|||
105645632|NCT02489799|364364941|FG000|Overall Study|Death|0|||
105645633|NCT02489799|364364942|FG001|Overall Study|Death|1|||
105645634|NCT04909593|364364943|FG000|Overall Study|Withdrawal by Subject|1|||
105645635|NCT01241448|364364944|FG000|Overall Study|Adverse Event|1|||
105645636|NCT01241448|364364945|FG001|Overall Study|Adverse Event|0|||
105645637|NCT01241448|364364946|FG002|Overall Study|Adverse Event|2|||
105645638|NCT01241448|364364947|FG003|Overall Study|Adverse Event|2|||
105645639|NCT01241448|364364944|FG000|Overall Study|Lost to Follow-up|2|||
105645640|NCT01241448|364364945|FG001|Overall Study|Lost to Follow-up|1|||
105645641|NCT01241448|364364946|FG002|Overall Study|Lost to Follow-up|1|||
105645642|NCT01241448|364364947|FG003|Overall Study|Lost to Follow-up|1|||
105645643|NCT01241448|364364944|FG000|Overall Study|Physician Decision|0|||
105645644|NCT01241448|364364945|FG001|Overall Study|Physician Decision|2|||
105645645|NCT01241448|364364946|FG002|Overall Study|Physician Decision|0|||
105645646|NCT01241448|364364947|FG003|Overall Study|Physician Decision|0|||
105645647|NCT01241448|364364944|FG000|Overall Study|Protocol Violation|10|||
105645648|NCT01241448|364364945|FG001|Overall Study|Protocol Violation|5|||
105645649|NCT01241448|364364946|FG002|Overall Study|Protocol Violation|3|||
105645650|NCT01241448|364364947|FG003|Overall Study|Protocol Violation|6|||
105645651|NCT01241448|364364944|FG000|Overall Study|Sponsor Decision|17|||
105645652|NCT01241448|364364945|FG001|Overall Study|Sponsor Decision|14|||
105645653|NCT01241448|364364946|FG002|Overall Study|Sponsor Decision|12|||
105645654|NCT01241448|364364947|FG003|Overall Study|Sponsor Decision|6|||
105645655|NCT01241448|364364944|FG000|Overall Study|Withdrawal by Subject|4|||
105645656|NCT01241448|364364945|FG001|Overall Study|Withdrawal by Subject|5|||
105645657|NCT01241448|364364946|FG002|Overall Study|Withdrawal by Subject|3|||
105645658|NCT01241448|364364947|FG003|Overall Study|Withdrawal by Subject|6|||
105645659|NCT01241448|364364944|FG000|Overall Study|Excluded due to data integrity issues|3|||
105645660|NCT01241448|364364945|FG001|Overall Study|Excluded due to data integrity issues|2|||
105645661|NCT01241448|364364946|FG002|Overall Study|Excluded due to data integrity issues|2|||
105645662|NCT01241448|364364947|FG003|Overall Study|Excluded due to data integrity issues|2|||
105645663|NCT02400749|364364948|FG000|Week 0 -16|Withdrawal by Subject|5|||
105645664|NCT02400749|364364949|FG001|Week 0 -16|Withdrawal by Subject|5|||
105645665|NCT02400749|364364948|FG000|Week 0 -16|Adverse Event|3|||
105645666|NCT02400749|364364949|FG001|Week 0 -16|Adverse Event|1|||
105645667|NCT02400749|364364948|FG000|Week 0 -16|Lost to Follow-up|2|||
105645668|NCT02400749|364364949|FG001|Week 0 -16|Lost to Follow-up|0|||
105645669|NCT02400749|364364948|FG000|Week 0 -16|Protocol Violation|1|||
105645670|NCT02400749|364364949|FG001|Week 0 -16|Protocol Violation|0|||
105645671|NCT02400749|364364948|FG000|Week 17 - 32|Withdrawal by Subject|3|||
105645672|NCT02400749|364364949|FG001|Week 17 - 32|Withdrawal by Subject|2|||
105645673|NCT02400749|364364948|FG000|Week 17 - 32|Adverse Event|2|||
105645674|NCT02400749|364364949|FG001|Week 17 - 32|Adverse Event|1|||
105645675|NCT00307489|364364950|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
105645676|NCT00307489|364364951|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
105645677|NCT00307489|364364950|FG000|Baseline Through Week 48|Physician Decision|1|||
105645678|NCT00307489|364364951|FG001|Baseline Through Week 48|Physician Decision|0|||
105645679|NCT00307489|364364950|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
105645680|NCT00307489|364364951|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
105645681|NCT00307489|364364950|FG000|Week 48 Through Week 168|Adverse Event|1|||
105645682|NCT00307489|364364951|FG001|Week 48 Through Week 168|Adverse Event|0|||
105645683|NCT00307489|364364950|FG000|Week 48 Through Week 168|Physician Decision|1|||
105645684|NCT00307489|364364951|FG001|Week 48 Through Week 168|Physician Decision|0|||
105645685|NCT00307489|364364950|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
105645686|NCT00307489|364364951|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
105645687|NCT00307489|364364950|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
105645688|NCT00307489|364364951|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
105645689|NCT00307489|364364950|FG000|Week 48 Through Week 168|Death|0|||
105645690|NCT00307489|364364951|FG001|Week 48 Through Week 168|Death|1|||
105645691|NCT00307489|364364950|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
105645692|NCT00307489|364364951|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
105645693|NCT00307489|364364950|FG000|Week 48 Through Week 168|Seroconversion|1|||
105645694|NCT00307489|364364951|FG001|Week 48 Through Week 168|Seroconversion|0|||
105645695|NCT04425252|364364952|FG000|Overall Study|Withdrawal by Subject|2|||
105645696|NCT04425252|364364953|FG001|Overall Study|Withdrawal by Subject|1|||
105645697|NCT04425252|364364952|FG000|Overall Study|Lost to Follow-up|1|||
105645698|NCT04425252|364364953|FG001|Overall Study|Lost to Follow-up|0|||
105645699|NCT04425252|364364952|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
105645700|NCT04425252|364364953|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
105645701|NCT01945593|364364955|FG000|Overall Study|Adverse Event|0|||
105645702|NCT01945593|364364956|FG001|Overall Study|Adverse Event|0|||
105645703|NCT01945593|364364957|FG002|Overall Study|Adverse Event|0|||
105645704|NCT01945593|364364958|FG003|Overall Study|Adverse Event|5|||
105645705|NCT01945593|364364955|FG000|Overall Study|Physician Decision|0|||
105645706|NCT01945593|364364956|FG001|Overall Study|Physician Decision|0|||
105645707|NCT01945593|364364957|FG002|Overall Study|Physician Decision|1|||
105645708|NCT01945593|364364958|FG003|Overall Study|Physician Decision|1|||
105645709|NCT01945593|364364955|FG000|Overall Study|Withdrawal by Subject|0|||
105645710|NCT01945593|364364956|FG001|Overall Study|Withdrawal by Subject|2|||
105645711|NCT01945593|364364957|FG002|Overall Study|Withdrawal by Subject|0|||
105645712|NCT01945593|364364958|FG003|Overall Study|Withdrawal by Subject|4|||
105645713|NCT01945593|364364955|FG000|Overall Study|Protocol Violation|0|||
105645714|NCT01945593|364364956|FG001|Overall Study|Protocol Violation|2|||
105645715|NCT01945593|364364957|FG002|Overall Study|Protocol Violation|1|||
105645716|NCT01945593|364364958|FG003|Overall Study|Protocol Violation|3|||
105645717|NCT01945593|364364955|FG000|Overall Study|Death|0|||
105645718|NCT01945593|364364956|FG001|Overall Study|Death|0|||
105645719|NCT01945593|364364957|FG002|Overall Study|Death|1|||
105645720|NCT01945593|364364958|FG003|Overall Study|Death|0|||
105645721|NCT01945593|364364955|FG000|Overall Study|Other: Terminated|0|||
105645722|NCT01945593|364364956|FG001|Overall Study|Other: Terminated|0|||
105645723|NCT01945593|364364957|FG002|Overall Study|Other: Terminated|0|||
105645724|NCT01945593|364364958|FG003|Overall Study|Other: Terminated|1|||
105645725|NCT01945593|364364955|FG000|Overall Study|Other: Surgical Procedure|0|||
105645726|NCT01945593|364364956|FG001|Overall Study|Other: Surgical Procedure|2|||
105645727|NCT01945593|364364957|FG002|Overall Study|Other: Surgical Procedure|0|||
105645728|NCT01945593|364364958|FG003|Overall Study|Other: Surgical Procedure|6|||
105645729|NCT01945593|364364955|FG000|Overall Study|Other: Screen Failure|0|||
105645730|NCT01945593|364364956|FG001|Overall Study|Other: Screen Failure|2|||
105645731|NCT01945593|364364957|FG002|Overall Study|Other: Screen Failure|0|||
105645732|NCT01945593|364364958|FG003|Overall Study|Other: Screen Failure|0|||
105645733|NCT00841321|364364959|FG000|Overall Study|Lost to Follow-up|1|||
105645734|NCT00841321|364364960|FG001|Overall Study|Lost to Follow-up|1|||
105645735|NCT00841321|364364959|FG000|Overall Study|Adverse Event|0|||
105645736|NCT00841321|364364960|FG001|Overall Study|Adverse Event|2|||
105645737|NCT00379210|364364961|FG000|Overall Study|Withdrawal by Subject|10|||
105645738|NCT00379210|364364962|FG001|Overall Study|Withdrawal by Subject|7|||
105645739|NCT03651271|364364963|FG000|Overall Study|Death|4|||
105645740|NCT03651271|364364964|FG001|Overall Study|Death|37|||
105645741|NCT03651271|364364965|FG002|Overall Study|Death|0|||
105645742|NCT03651271|364364966|FG003|Overall Study|Death|2|||
105645743|NCT03651271|364364967|FG004|Overall Study|Death|6|||
105645744|NCT03651271|364364963|FG000|Overall Study|Lost to Follow-up|1|||
105645745|NCT03651271|364364964|FG001|Overall Study|Lost to Follow-up|5|||
105645746|NCT03651271|364364965|FG002|Overall Study|Lost to Follow-up|0|||
105645747|NCT03651271|364364966|FG003|Overall Study|Lost to Follow-up|1|||
105645748|NCT03651271|364364967|FG004|Overall Study|Lost to Follow-up|0|||
105645749|NCT03651271|364364963|FG000|Overall Study|Physician Decision|0|||
105645750|NCT03651271|364364964|FG001|Overall Study|Physician Decision|2|||
105645751|NCT03651271|364364965|FG002|Overall Study|Physician Decision|0|||
105645752|NCT03651271|364364966|FG003|Overall Study|Physician Decision|0|||
105645753|NCT03651271|364364967|FG004|Overall Study|Physician Decision|0|||
105645754|NCT03651271|364364963|FG000|Overall Study|Withdrawal by Subject|1|||
105645755|NCT03651271|364364964|FG001|Overall Study|Withdrawal by Subject|15|||
105645756|NCT03651271|364364965|FG002|Overall Study|Withdrawal by Subject|0|||
105645757|NCT03651271|364364966|FG003|Overall Study|Withdrawal by Subject|0|||
105645758|NCT03651271|364364967|FG004|Overall Study|Withdrawal by Subject|1|||
105645759|NCT03651271|364364963|FG000|Overall Study|Patient medically unable to continue|0|||
105645760|NCT03651271|364364964|FG001|Overall Study|Patient medically unable to continue|0|||
105645761|NCT03651271|364364965|FG002|Overall Study|Patient medically unable to continue|0|||
105645762|NCT03651271|364364966|FG003|Overall Study|Patient medically unable to continue|1|||
105645763|NCT03651271|364364967|FG004|Overall Study|Patient medically unable to continue|0|||
105645764|NCT03444155|364364972|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
105645765|NCT03444155|364364973|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
105645766|NCT00821093|364364974|FG000|Overall Study|Adverse Event|20|||
105645767|NCT00821093|364364975|FG001|Overall Study|Adverse Event|12|||
105645768|NCT00821093|364364974|FG000|Overall Study|Withdrawal by Subject|9|||
105645769|NCT00821093|364364975|FG001|Overall Study|Withdrawal by Subject|13|||
105645770|NCT00821093|364364974|FG000|Overall Study|Lost to Follow-up|9|||
105645771|NCT00821093|364364975|FG001|Overall Study|Lost to Follow-up|3|||
105645772|NCT00821093|364364974|FG000|Overall Study|Protocol deviation|3|||
105645773|NCT00821093|364364975|FG001|Overall Study|Protocol deviation|6|||
105645774|NCT00821093|364364974|FG000|Overall Study|Abnormal laboratory value(s)|2|||
105645775|NCT00821093|364364975|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105645776|NCT00821093|364364974|FG000|Overall Study|Lack of Efficacy|2|||
105645777|NCT00821093|364364975|FG001|Overall Study|Lack of Efficacy|2|||
105645778|NCT00821093|364364974|FG000|Overall Study|Death|2|||
105645779|NCT00821093|364364975|FG001|Overall Study|Death|1|||
105645780|NCT00821093|364364974|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105645781|NCT00821093|364364975|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105645782|NCT00821093|364364974|FG000|Overall Study|Administrative problems|1|||
105645783|NCT00821093|364364975|FG001|Overall Study|Administrative problems|2|||
105645784|NCT01601821|364364977|FG000|Overall Study|Death|2|||
105645785|NCT01601821|364364978|FG001|Overall Study|Death|5|||
105645786|NCT01601821|364364977|FG000|Overall Study|Protocol Violation|2|||
105645787|NCT01601821|364364978|FG001|Overall Study|Protocol Violation|2|||
105645788|NCT01601821|364364977|FG000|Overall Study|Lost to Follow-up|6|||
105645789|NCT01601821|364364978|FG001|Overall Study|Lost to Follow-up|14|||
105645790|NCT01601821|364364977|FG000|Overall Study|Withdrawal by Subject|1|||
105645791|NCT01601821|364364978|FG001|Overall Study|Withdrawal by Subject|0|||
105645792|NCT01601821|364364977|FG000|Overall Study|Graft Loss|6|||
105645793|NCT01601821|364364978|FG001|Overall Study|Graft Loss|6|||
105645794|NCT01601821|364364977|FG000|Overall Study|Study Events|7|||
105645795|NCT01601821|364364978|FG001|Overall Study|Study Events|1|||
105645796|NCT01601821|364364977|FG000|Overall Study|Other|5|||
105645797|NCT01601821|364364978|FG001|Overall Study|Other|1|||
105645798|NCT02446912|364364979|FG000|Overall Study|Adverse Event|3|||
105645799|NCT02446912|364364980|FG001|Overall Study|Adverse Event|13|||
105645800|NCT02446912|364364981|FG002|Overall Study|Adverse Event|5|||
105645801|NCT02446912|364364979|FG000|Overall Study|Condition under investigation worsened|0|||
105645802|NCT02446912|364364980|FG001|Overall Study|Condition under investigation worsened|1|||
105645803|NCT02446912|364364981|FG002|Overall Study|Condition under investigation worsened|1|||
105645804|NCT02446912|364364979|FG000|Overall Study|Study-specific withdrawal criteria|1|||
105645805|NCT02446912|364364980|FG001|Overall Study|Study-specific withdrawal criteria|0|||
105645806|NCT02446912|364364981|FG002|Overall Study|Study-specific withdrawal criteria|0|||
105645807|NCT02446912|364364979|FG000|Overall Study|Lack of Efficacy|1|||
105645808|NCT02446912|364364980|FG001|Overall Study|Lack of Efficacy|4|||
105645809|NCT02446912|364364981|FG002|Overall Study|Lack of Efficacy|7|||
105645810|NCT02446912|364364979|FG000|Overall Study|Lost to Follow-up|0|||
105645811|NCT02446912|364364980|FG001|Overall Study|Lost to Follow-up|0|||
105645812|NCT02446912|364364981|FG002|Overall Study|Lost to Follow-up|2|||
105645813|NCT02446912|364364979|FG000|Overall Study|Severe non-compliance to protocol|1|||
105645814|NCT02446912|364364980|FG001|Overall Study|Severe non-compliance to protocol|0|||
105645815|NCT02446912|364364981|FG002|Overall Study|Severe non-compliance to protocol|1|||
105645816|NCT02446912|364364979|FG000|Overall Study|Withdrawal by Subject|10|||
105645817|NCT02446912|364364980|FG001|Overall Study|Withdrawal by Subject|15|||
105645818|NCT02446912|364364981|FG002|Overall Study|Withdrawal by Subject|15|||
105645819|NCT02446912|364364979|FG000|Overall Study|Miscellaneous|2|||
105645820|NCT02446912|364364980|FG001|Overall Study|Miscellaneous|2|||
105645821|NCT02446912|364364981|FG002|Overall Study|Miscellaneous|4|||
105645822|NCT02877680|364364982|FG000|Overall Study|Lost to Follow-up|1|||
105645823|NCT02877680|364364983|FG001|Overall Study|Lost to Follow-up|1|||
105645824|NCT01133678|364364984|FG000|Overall Study|Death|1|||
105645825|NCT01133678|364364985|FG001|Overall Study|Death|1|||
105645826|NCT01901302|364364986|FG000|Overall Study|Adverse Event|2|||
105645827|NCT01901302|364364987|FG001|Overall Study|Adverse Event|1|||
105645828|NCT01901302|364364986|FG000|Overall Study|Lack of Efficacy|0|||
105645829|NCT01901302|364364987|FG001|Overall Study|Lack of Efficacy|2|||
105645830|NCT01901302|364364986|FG000|Overall Study|Study Terminated by Sponsor|23|||
105645831|NCT01901302|364364987|FG001|Overall Study|Study Terminated by Sponsor|20|||
105645832|NCT01901302|364364986|FG000|Overall Study|Withdrawal by Subject|2|||
105645833|NCT01901302|364364987|FG001|Overall Study|Withdrawal by Subject|0|||
105645834|NCT00753896|364364989|FG000|Overall Study|Adverse Event|4|||
105645835|NCT00753896|364364989|FG000|Overall Study|Death|1|||
105645836|NCT00753896|364364989|FG000|Overall Study|Lost to Follow-up|2|||
105645837|NCT00753896|364364989|FG000|Overall Study|Protocol Violation|1|||
105645838|NCT00753896|364364989|FG000|Overall Study|Withdrawal by Subject|4|||
105645839|NCT00753896|364364989|FG000|Overall Study|Entry Criteria Not Met|4|||
105645840|NCT02959866|364364990|FG000|Overall Study|Withdrawal by Subject|1|||
105645841|NCT00952523|364364991|FG000|Overall Study|Withdrawal by Subject|7|||
105645842|NCT00848198|364364992|FG000|Overall Study|Incomplete Case Report Forms|15|||
105645843|NCT01029925|364364996|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
105645844|NCT01029925|364364996|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
105645845|NCT01029925|364364996|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
105645846|NCT05265247|364364997|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
105645847|NCT05265247|364364998|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
105645848|NCT05265247|364364997|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
105645849|NCT05265247|364364998|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
105645850|NCT05265247|364364997|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
105645851|NCT05265247|364364998|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
105645852|NCT00134056|364365006|FG000|Randomization|Not eligible for assigned treatment|22|||
105645853|NCT00134056|364365007|FG001|Randomization|Not eligible for assigned treatment|20|||
105645854|NCT00134056|364365006|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
105645855|NCT00134056|364365007|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
105645856|NCT00134056|364365006|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
105645857|NCT00134056|364365007|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
105645858|NCT00134056|364365006|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
105645859|NCT00134056|364365007|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
105645860|NCT00134056|364365006|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
105645861|NCT00134056|364365007|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
105645862|NCT03166215|364365008|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
105645863|NCT03166215|364365009|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
105645864|NCT03166215|364365010|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
105645865|NCT03166215|364365008|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
105645866|NCT03166215|364365009|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
105645867|NCT03166215|364365010|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
105645868|NCT01536795|364365012|FG000|Overall Study|Lost to Follow-up|0|||
105645869|NCT01536795|364365013|FG001|Overall Study|Lost to Follow-up|2|||
105645870|NCT01536795|364365012|FG000|Overall Study|Lack of Efficacy|1|||
105645871|NCT01536795|364365013|FG001|Overall Study|Lack of Efficacy|0|||
105645872|NCT01812837|364365014|FG000|Overall Study|Lost to Follow-up|1|||
105645873|NCT01812837|364365015|FG001|Overall Study|Lost to Follow-up|1|||
105645874|NCT01812837|364365016|FG002|Overall Study|Lost to Follow-up|0|||
105645875|NCT01812837|364365014|FG000|Overall Study|Protocol Violation|1|||
105645876|NCT01812837|364365015|FG001|Overall Study|Protocol Violation|0|||
105645877|NCT01812837|364365016|FG002|Overall Study|Protocol Violation|0|||
105645878|NCT04598776|364365019|FG000|Overall Study|Protocol Violation|5|||
105645879|NCT04598776|364365019|FG000|Overall Study|Physician Decision|4|||
105645880|NCT06312566|364365023|FG000|Overall Study|Protocol Violation|0|||
105645881|NCT06312566|364365024|FG001|Overall Study|Protocol Violation|1|||
105645882|NCT02632045|364365025|FG000|Overall Study|Withdrawal by Subject|1|||
105645883|NCT02632045|364365026|FG001|Overall Study|Withdrawal by Subject|2|||
105645884|NCT05878522|364365027|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645885|NCT05878522|364365028|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645886|NCT05878522|364365029|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645887|NCT05878522|364365030|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645888|NCT05878522|364365031|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645889|NCT05878522|364365032|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645890|NCT05878522|364365033|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645891|NCT05878522|364365034|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645892|NCT05878522|364365035|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
105645893|NCT05878522|364365036|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645894|NCT05878522|364365037|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645895|NCT05878522|364365038|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645896|NCT05878522|364365027|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
105645897|NCT05878522|364365028|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645898|NCT05878522|364365029|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645899|NCT05878522|364365030|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645900|NCT05878522|364365031|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645901|NCT05878522|364365032|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645902|NCT05878522|364365033|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645903|NCT05878522|364365034|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645904|NCT05878522|364365035|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645905|NCT05878522|364365036|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
105645906|NCT05878522|364365037|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645907|NCT05878522|364365038|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645908|NCT05878522|364365027|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645909|NCT05878522|364365028|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
105645910|NCT05878522|364365029|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645911|NCT05878522|364365030|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
105645912|NCT05878522|364365031|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645913|NCT05878522|364365032|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645914|NCT05878522|364365033|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645915|NCT05878522|364365034|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645916|NCT05878522|364365035|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645917|NCT05878522|364365036|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645918|NCT05878522|364365037|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645919|NCT05878522|364365038|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645920|NCT05878522|364365027|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645921|NCT05878522|364365028|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645922|NCT05878522|364365029|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645923|NCT05878522|364365030|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645924|NCT05878522|364365031|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
105645925|NCT05878522|364365032|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645926|NCT05878522|364365033|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645927|NCT05878522|364365034|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645928|NCT05878522|364365035|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645929|NCT05878522|364365036|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645930|NCT05878522|364365037|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645931|NCT05878522|364365038|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645932|NCT01613599|364365039|FG000|Overall Study|Death|9|||
105645933|NCT01613599|364365039|FG000|Overall Study|Lost to Follow-up|5|||
105645934|NCT01613599|364365039|FG000|Overall Study|Withdrawal by Subject|8|||
105645935|NCT01613599|364365039|FG000|Overall Study|Reason not specified|3|||
105645936|NCT03503188|364365040|FG000|Overall Study|Non eligible in the sub study|0|||
105645937|NCT03503188|364365041|FG001|Overall Study|Non eligible in the sub study|1|||
105645938|NCT01699178|364365042|FG000|Overall Study|Adverse Event|1|||
105645939|NCT01699178|364365043|FG001|Overall Study|Adverse Event|5|||
105645940|NCT01699178|364365042|FG000|Overall Study|Lost to Follow-up|1|||
105645941|NCT01699178|364365043|FG001|Overall Study|Lost to Follow-up|6|||
105645942|NCT01699178|364365042|FG000|Overall Study|Non-compliance with Study Drug|3|||
105645943|NCT01699178|364365043|FG001|Overall Study|Non-compliance with Study Drug|1|||
105645944|NCT01699178|364365042|FG000|Overall Study|Physician Decision|1|||
105645945|NCT01699178|364365043|FG001|Overall Study|Physician Decision|0|||
105645946|NCT01699178|364365042|FG000|Overall Study|Withdrawal by Subject|4|||
105645947|NCT01699178|364365043|FG001|Overall Study|Withdrawal by Subject|12|||
105645948|NCT01699178|364365042|FG000|Overall Study|Hematocrit >54%|1|||
105645949|NCT01699178|364365043|FG001|Overall Study|Hematocrit >54%|1|||
105645950|NCT01699178|364365042|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
105645951|NCT01699178|364365043|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
105645952|NCT01699178|364365042|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
105645953|NCT01699178|364365043|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
105645954|NCT03005106|364365046|FG000|Overall Study|Lost to Follow-up|16|||
105645955|NCT03005106|364365046|FG000|Overall Study|Adverse Event|1|||
105645956|NCT03005106|364365046|FG000|Overall Study|Physician Decision|1|||
105645957|NCT03005106|364365046|FG000|Overall Study|Death|2|||
105645958|NCT03019289|364365049|FG000|Overall Study|Adverse Event|1|||
105645959|NCT03019289|364365050|FG001|Overall Study|Adverse Event|0|||
105645960|NCT03019289|364365051|FG002|Overall Study|Adverse Event|0|||
105645961|NCT03019289|364365052|FG003|Overall Study|Adverse Event|0|||
105645962|NCT03019289|364365053|FG004|Overall Study|Adverse Event|0|||
105645963|NCT03019289|364365054|FG005|Overall Study|Adverse Event|0|||
105645964|NCT03019289|364365055|FG006|Overall Study|Adverse Event|0|||
105645965|NCT03019289|364365056|FG007|Overall Study|Adverse Event|0|||
105645966|NCT03019289|364365057|FG008|Overall Study|Adverse Event|1|||
105645967|NCT03019289|364365049|FG000|Overall Study|Other|1|||
105645968|NCT03019289|364365050|FG001|Overall Study|Other|0|||
105645969|NCT03019289|364365051|FG002|Overall Study|Other|0|||
105645970|NCT03019289|364365052|FG003|Overall Study|Other|0|||
105645971|NCT03019289|364365053|FG004|Overall Study|Other|0|||
105645972|NCT03019289|364365054|FG005|Overall Study|Other|0|||
105645973|NCT03019289|364365055|FG006|Overall Study|Other|0|||
105645974|NCT03019289|364365056|FG007|Overall Study|Other|0|||
105645975|NCT03019289|364365057|FG008|Overall Study|Other|0|||
105645976|NCT00537914|364365058|FG000|Overall Study|Death|1|||
105645977|NCT00537914|364365058|FG000|Overall Study|Adverse Event|7|||
105645978|NCT00537914|364365058|FG000|Overall Study|Treatment failure|10|||
105645979|NCT00537914|364365058|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
105645980|NCT00537914|364365058|FG000|Overall Study|Lost to Follow-up|19|||
105645981|NCT00537914|364365058|FG000|Overall Study|Withdrawal of informed consent|59|||
105645982|NCT02312258|364365059|FG000|Overall Study|Lost to Follow-up|8|||
105645983|NCT02312258|364365060|FG001|Overall Study|Lost to Follow-up|8|||
105645984|NCT02312258|364365059|FG000|Overall Study|Withdrawal by Patient|49|||
105645985|NCT02312258|364365060|FG001|Overall Study|Withdrawal by Patient|76|||
105645986|NCT02312258|364365059|FG000|Overall Study|Reason not Specified|107|||
105645987|NCT02312258|364365060|FG001|Overall Study|Reason not Specified|159|||
105645988|NCT02312258|364365059|FG000|Overall Study|Missing|2|||
105645989|NCT02312258|364365060|FG001|Overall Study|Missing|1|||
105645990|NCT02312258|364365059|FG000|Overall Study|Death|115|||
105645991|NCT02312258|364365060|FG001|Overall Study|Death|181|||
105645992|NCT01468597|364365062|FG000|Overall Study|Found ineligible|17|||
105645993|NCT01468597|364365062|FG000|Overall Study|concomitant valves|12|||
105645994|NCT01468597|364365062|FG000|Overall Study|off-pump CABG|1|||
105645995|NCT01468597|364365062|FG000|Overall Study|no platelet function data|5|||
105645996|NCT01885559|364365070|FG000|Overall Study|Lost to Follow-up|15|||
105645997|NCT01885559|364365071|FG001|Overall Study|Lost to Follow-up|16|||
105645998|NCT01885559|364365070|FG000|Overall Study|Less than full participation|9|||
105645999|NCT01885559|364365071|FG001|Overall Study|Less than full participation|19|||
105646000|NCT01885559|364365070|FG000|Overall Study|Protocol Violation|0|||
105646001|NCT01885559|364365071|FG001|Overall Study|Protocol Violation|1|||
105646002|NCT01549951|364365076|FG000|Overall Study|Adverse Event|15|||
105646003|NCT01549951|364365076|FG000|Overall Study|Withdrawal by Subject|2|||
105646004|NCT01549951|364365076|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
105646005|NCT01549951|364365076|FG000|Overall Study|Progressive disease|29|||
105646006|NCT01549951|364365076|FG000|Overall Study|Symptomatic deterioration|1|||
105646007|NCT01549951|364365076|FG000|Overall Study|Other|2|||
105646008|NCT02312245|364365079|FG000|Overall Study|Death|0|||
105646009|NCT02312245|364365080|FG001|Overall Study|Death|0|||
105646010|NCT02312245|364365081|FG002|Overall Study|Death|0|||
105646011|NCT02312245|364365082|FG003|Overall Study|Death|1|||
105646012|NCT02312245|364365079|FG000|Overall Study|Withdrawal by Subject|1|||
105646013|NCT02312245|364365080|FG001|Overall Study|Withdrawal by Subject|1|||
105646014|NCT02312245|364365081|FG002|Overall Study|Withdrawal by Subject|0|||
105646015|NCT02312245|364365082|FG003|Overall Study|Withdrawal by Subject|2|||
105646016|NCT02312245|364365079|FG000|Overall Study|Alternative Therapy|1|||
105646017|NCT02312245|364365080|FG001|Overall Study|Alternative Therapy|0|||
105646018|NCT02312245|364365081|FG002|Overall Study|Alternative Therapy|0|||
105646019|NCT02312245|364365082|FG003|Overall Study|Alternative Therapy|0|||
105646020|NCT02312245|364365079|FG000|Overall Study|Progression|0|||
105646021|NCT02312245|364365080|FG001|Overall Study|Progression|0|||
105646022|NCT02312245|364365081|FG002|Overall Study|Progression|0|||
105646023|NCT02312245|364365082|FG003|Overall Study|Progression|5|||
105646024|NCT02312245|364365079|FG000|Overall Study|Patient went to hospice|0|||
105646025|NCT02312245|364365080|FG001|Overall Study|Patient went to hospice|0|||
105646026|NCT02312245|364365081|FG002|Overall Study|Patient went to hospice|0|||
105646027|NCT02312245|364365082|FG003|Overall Study|Patient went to hospice|1|||
105646028|NCT02312245|364365079|FG000|Overall Study|Ineligible|1|||
105646029|NCT02312245|364365080|FG001|Overall Study|Ineligible|0|||
105646030|NCT02312245|364365081|FG002|Overall Study|Ineligible|0|||
105646031|NCT02312245|364365082|FG003|Overall Study|Ineligible|0|||
105646032|NCT01661972|364365083|FG000|Overall Study|Adverse Event|1|||
105646033|NCT01661972|364365084|FG001|Overall Study|Adverse Event|2|||
105646034|NCT01661972|364365083|FG000|Overall Study|Death during Treatment period|1|||
105646035|NCT01661972|364365084|FG001|Overall Study|Death during Treatment period|1|||
105646036|NCT01661972|364365083|FG000|Overall Study|Withdrawal by Subject|0|||
105646037|NCT01661972|364365084|FG001|Overall Study|Withdrawal by Subject|1|||
105646038|NCT03122548|364365087|FG000|Overall Study|Death|2|||
105646039|NCT03122548|364365087|FG000|Overall Study|Progression - subject went into hospice|1|||
105646040|NCT03122548|364365087|FG000|Overall Study|Study Terminated by Sponsor|2|||
105646041|NCT01186809|364365090|FG000|Overall Study|Death|30|||
105646042|NCT05006703|364366866|FG000|Overall Study|Withdrawal by Subject|1|||
105646043|NCT05006703|364366867|FG001|Overall Study|Withdrawal by Subject|0|||
105646044|NCT05006703|364366866|FG000|Overall Study|Lost to Follow-up|13|||
105646045|NCT05006703|364366867|FG001|Overall Study|Lost to Follow-up|5|||
105646046|NCT02121808|364366870|FG000|Overall Study|Technical problem|3|||
105646047|NCT00538629|364366872|FG000|Overall Study|At subject's request|1|||
105646048|NCT00538629|364366872|FG000|Overall Study|Adverse Event|2|||
105646049|NCT00538629|364366872|FG000|Overall Study|Lack of Efficacy|12|||
105646050|NCT00538629|364366872|FG000|Overall Study|Lost to Follow-up|6|||
105646051|NCT00538629|364366872|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
105646052|NCT01540474|364366877|FG000|Vaccination Period|Lost to Follow-up|0|||
105646053|NCT01540474|364366878|FG001|Vaccination Period|Lost to Follow-up|1|||
105646054|NCT01540474|364366879|FG002|Vaccination Period|Lost to Follow-up|0|||
105646055|NCT01540474|364366880|FG003|Vaccination Period|Lost to Follow-up|0|||
105646056|NCT04454125|364366881|FG000|Overall Study|Lost to Follow-up|0|||
105646057|NCT04454125|364366882|FG001|Overall Study|Lost to Follow-up|1|||
105646058|NCT01587703|364366883|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
105646059|NCT01587703|364366884|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646060|NCT01587703|364366885|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646061|NCT01587703|364366886|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646062|NCT01587703|364366887|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646063|NCT01587703|364366888|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646064|NCT01587703|364366889|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646065|NCT01587703|364366890|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646066|NCT01587703|364366891|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646067|NCT01587703|364366892|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646068|NCT01587703|364366893|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646069|NCT01587703|364366894|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646070|NCT01587703|364366895|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646071|NCT01587703|364366896|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646072|NCT01587703|364366897|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646073|NCT01587703|364366898|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646074|NCT01587703|364366899|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646075|NCT01587703|364366900|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646076|NCT01587703|364366901|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646077|NCT01587703|364366883|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646078|NCT01587703|364366884|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646079|NCT01587703|364366885|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646080|NCT01587703|364366886|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646081|NCT01587703|364366887|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646082|NCT01587703|364366888|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
105646083|NCT01587703|364366889|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646084|NCT01587703|364366890|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
105646085|NCT01587703|364366891|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646086|NCT01587703|364366892|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646087|NCT01587703|364366893|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646088|NCT01587703|364366894|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646089|NCT01587703|364366895|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646090|NCT01587703|364366896|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646091|NCT01587703|364366897|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646092|NCT01587703|364366898|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646093|NCT01587703|364366899|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646094|NCT01587703|364366900|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646095|NCT01587703|364366901|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646096|NCT01587703|364366883|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646097|NCT01587703|364366884|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646098|NCT01587703|364366885|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646099|NCT01587703|364366886|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646100|NCT01587703|364366887|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646101|NCT01587703|364366888|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646102|NCT01587703|364366889|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
105646103|NCT01587703|364366890|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646104|NCT01587703|364366891|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646105|NCT01587703|364366892|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646106|NCT01587703|364366893|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646107|NCT01587703|364366894|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646108|NCT01587703|364366895|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646109|NCT01587703|364366896|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646110|NCT01587703|364366897|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646111|NCT01587703|364366898|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646112|NCT01587703|364366899|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646113|NCT01587703|364366900|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646114|NCT01587703|364366901|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646115|NCT01587703|364366883|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
105646116|NCT01587703|364366884|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
105646117|NCT01587703|364366885|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
105646118|NCT01587703|364366886|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
105646119|NCT01587703|364366887|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
105646120|NCT01587703|364366888|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
105646121|NCT01587703|364366889|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
105646122|NCT01587703|364366890|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
105646123|NCT01587703|364366891|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646124|NCT01587703|364366892|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646125|NCT01587703|364366893|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646126|NCT01587703|364366894|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646127|NCT01587703|364366895|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646128|NCT01587703|364366896|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646129|NCT01587703|364366897|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646130|NCT01587703|364366898|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646131|NCT01587703|364366899|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646132|NCT01587703|364366900|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646133|NCT01587703|364366901|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646134|NCT01587703|364366883|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646135|NCT01587703|364366884|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646136|NCT01587703|364366885|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646137|NCT01587703|364366886|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646138|NCT01587703|364366887|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646139|NCT01587703|364366888|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646140|NCT01587703|364366889|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646141|NCT01587703|364366890|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646142|NCT01587703|364366891|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
105646143|NCT01587703|364366892|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
105646144|NCT01587703|364366893|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
105646145|NCT01587703|364366894|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646146|NCT01587703|364366895|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646147|NCT01587703|364366896|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646148|NCT01587703|364366897|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646149|NCT01587703|364366898|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646150|NCT01587703|364366899|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646151|NCT01587703|364366900|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646152|NCT01587703|364366901|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646153|NCT01587703|364366883|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646154|NCT01587703|364366884|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646155|NCT01587703|364366885|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646156|NCT01587703|364366886|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646157|NCT01587703|364366887|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646158|NCT01587703|364366888|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646159|NCT01587703|364366889|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646160|NCT01587703|364366890|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646161|NCT01587703|364366891|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
105646162|NCT01587703|364366892|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646163|NCT01587703|364366893|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
105646164|NCT01587703|364366894|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646165|NCT01587703|364366895|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646166|NCT01587703|364366896|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646167|NCT01587703|364366897|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646168|NCT01587703|364366898|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646169|NCT01587703|364366899|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646170|NCT01587703|364366900|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646171|NCT01587703|364366901|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646172|NCT01587703|364366883|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646173|NCT01587703|364366884|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646174|NCT01587703|364366885|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646175|NCT01587703|364366886|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646176|NCT01587703|364366887|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646177|NCT01587703|364366888|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646178|NCT01587703|364366889|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646179|NCT01587703|364366890|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646180|NCT01587703|364366891|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646181|NCT01587703|364366892|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
105646182|NCT01587703|364366893|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
105646183|NCT01587703|364366894|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646184|NCT01587703|364366895|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646185|NCT01587703|364366896|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646186|NCT01587703|364366897|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646187|NCT01587703|364366898|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646188|NCT01587703|364366899|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646189|NCT01587703|364366900|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646190|NCT01587703|364366901|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646191|NCT01587703|364366883|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646192|NCT01587703|364366884|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646193|NCT01587703|364366885|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646194|NCT01587703|364366886|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646195|NCT01587703|364366887|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646196|NCT01587703|364366888|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646197|NCT01587703|364366889|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646198|NCT01587703|364366890|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646199|NCT01587703|364366891|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
105646200|NCT01587703|364366892|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646201|NCT01587703|364366893|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646202|NCT01587703|364366894|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646203|NCT01587703|364366895|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646204|NCT01587703|364366896|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646205|NCT01587703|364366897|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646206|NCT01587703|364366898|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646207|NCT01587703|364366899|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646208|NCT01587703|364366900|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646209|NCT01587703|364366901|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646210|NCT01587703|364366883|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646211|NCT01587703|364366884|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646212|NCT01587703|364366885|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646213|NCT01587703|364366886|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646214|NCT01587703|364366887|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646215|NCT01587703|364366888|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646216|NCT01587703|364366889|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646217|NCT01587703|364366890|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646218|NCT01587703|364366891|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646219|NCT01587703|364366892|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646220|NCT01587703|364366893|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646221|NCT01587703|364366894|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646222|NCT01587703|364366895|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646223|NCT01587703|364366896|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646224|NCT01587703|364366897|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646225|NCT01587703|364366898|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646226|NCT01587703|364366899|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646227|NCT01587703|364366900|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646228|NCT01587703|364366901|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
105646229|NCT01587703|364366883|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646230|NCT01587703|364366884|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646231|NCT01587703|364366885|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646232|NCT01587703|364366886|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646233|NCT01587703|364366887|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646234|NCT01587703|364366888|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646235|NCT01587703|364366889|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646236|NCT01587703|364366890|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646237|NCT01587703|364366891|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646238|NCT01587703|364366892|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646239|NCT01587703|364366893|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646240|NCT01587703|364366894|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646241|NCT01587703|364366895|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646242|NCT01587703|364366896|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646243|NCT01587703|364366897|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646244|NCT01587703|364366898|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646245|NCT01587703|364366899|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646246|NCT01587703|364366900|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
105646247|NCT01587703|364366901|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
105646248|NCT01587703|364366883|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646249|NCT01587703|364366884|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646250|NCT01587703|364366885|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646251|NCT01587703|364366886|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646252|NCT01587703|364366887|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646253|NCT01587703|364366888|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646254|NCT01587703|364366889|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646255|NCT01587703|364366890|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646256|NCT01587703|364366891|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646257|NCT01587703|364366892|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646258|NCT01587703|364366893|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646259|NCT01587703|364366894|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646260|NCT01587703|364366895|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646261|NCT01587703|364366896|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646262|NCT01587703|364366897|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646263|NCT01587703|364366898|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
105646264|NCT01587703|364366899|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646265|NCT01587703|364366900|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646266|NCT01587703|364366901|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646267|NCT01587703|364366883|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646268|NCT01587703|364366884|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646269|NCT01587703|364366885|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646270|NCT01587703|364366886|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646271|NCT01587703|364366887|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646272|NCT01587703|364366888|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646273|NCT01587703|364366889|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646274|NCT01587703|364366890|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646275|NCT01587703|364366891|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646276|NCT01587703|364366892|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646277|NCT01587703|364366893|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646278|NCT01587703|364366894|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
105646279|NCT01587703|364366895|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646280|NCT01587703|364366896|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646281|NCT01587703|364366897|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
105646282|NCT01587703|364366898|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646283|NCT01587703|364366899|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646284|NCT01587703|364366900|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646285|NCT01587703|364366901|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646286|NCT01587703|364366883|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646287|NCT01587703|364366884|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646288|NCT01587703|364366885|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646289|NCT01587703|364366886|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646290|NCT01587703|364366887|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646291|NCT01587703|364366888|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646292|NCT01587703|364366889|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646293|NCT01587703|364366890|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646294|NCT01587703|364366891|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646295|NCT01587703|364366892|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646296|NCT01587703|364366893|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646297|NCT01587703|364366894|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
105646298|NCT01587703|364366895|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
105646299|NCT01587703|364366896|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
105646300|NCT01587703|364366897|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
105646301|NCT01587703|364366898|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
105646302|NCT01587703|364366899|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
105646303|NCT01587703|364366900|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646304|NCT01587703|364366901|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646305|NCT01587703|364366883|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646306|NCT01587703|364366884|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646307|NCT01587703|364366885|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646308|NCT01587703|364366886|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646309|NCT01587703|364366887|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646310|NCT01587703|364366888|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646311|NCT01587703|364366889|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646312|NCT01587703|364366890|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646313|NCT01587703|364366891|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646314|NCT01587703|364366892|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646315|NCT01587703|364366893|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646316|NCT01587703|364366894|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
105646317|NCT01587703|364366895|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
105646318|NCT01587703|364366896|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
105646319|NCT01587703|364366897|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
105646320|NCT01587703|364366898|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
105646321|NCT01587703|364366899|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
105646322|NCT01587703|364366900|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646323|NCT01587703|364366901|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646324|NCT01587703|364366883|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646325|NCT01587703|364366884|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646326|NCT01587703|364366885|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646327|NCT01587703|364366886|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646328|NCT01587703|364366887|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646329|NCT01587703|364366888|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646330|NCT01587703|364366889|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646331|NCT01587703|364366890|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646332|NCT01587703|364366891|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646333|NCT01587703|364366892|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646334|NCT01587703|364366893|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646335|NCT01587703|364366894|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
105646336|NCT01587703|364366895|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646337|NCT01587703|364366896|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646338|NCT01587703|364366897|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646339|NCT01587703|364366898|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646340|NCT01587703|364366899|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646341|NCT01587703|364366900|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646342|NCT01587703|364366901|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646343|NCT01922102|364366902|FG000|Overall Study|Withdrawal by Subject|7|||
105646344|NCT01922102|364366903|FG001|Overall Study|Withdrawal by Subject|3|||
105646345|NCT01922102|364366904|FG002|Overall Study|Withdrawal by Subject|7|||
105646346|NCT01922102|364366902|FG000|Overall Study|Physician Decision|0|||
105646347|NCT01922102|364366903|FG001|Overall Study|Physician Decision|2|||
105646348|NCT01922102|364366904|FG002|Overall Study|Physician Decision|1|||
105646349|NCT01922102|364366902|FG000|Overall Study|Adverse Event|1|||
105646350|NCT01922102|364366903|FG001|Overall Study|Adverse Event|2|||
105646351|NCT01922102|364366904|FG002|Overall Study|Adverse Event|0|||
105646352|NCT01922102|364366902|FG000|Overall Study|Lost to Follow-up|1|||
105646353|NCT01922102|364366903|FG001|Overall Study|Lost to Follow-up|0|||
105646354|NCT01922102|364366904|FG002|Overall Study|Lost to Follow-up|0|||
105646355|NCT01922102|364366902|FG000|Overall Study|Administrative problems|0|||
105646356|NCT01922102|364366903|FG001|Overall Study|Administrative problems|2|||
105646357|NCT01922102|364366904|FG002|Overall Study|Administrative problems|0|||
105646358|NCT01799993|364366905|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
105646359|NCT01799993|364366906|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
105646360|NCT01799993|364366905|FG000|Overall Study|Death|61|||
105646361|NCT01799993|364366906|FG001|Overall Study|Death|45|||
105646362|NCT01799993|364366905|FG000|Overall Study|Withdrawal by Subject|23|||
105646363|NCT01799993|364366906|FG001|Overall Study|Withdrawal by Subject|24|||
105646364|NCT01799993|364366905|FG000|Overall Study|Lost to Follow-up|5|||
105646365|NCT01799993|364366906|FG001|Overall Study|Lost to Follow-up|8|||
105646366|NCT01799993|364366905|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
105646367|NCT01799993|364366906|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
105646368|NCT01799993|364366905|FG000|Overall Study|Protocol driven decision point|0|||
105646369|NCT01799993|364366906|FG001|Overall Study|Protocol driven decision point|3|||
105646370|NCT01799993|364366905|FG000|Overall Study|Protocol Violation|1|||
105646371|NCT01799993|364366906|FG001|Overall Study|Protocol Violation|1|||
105646372|NCT01799993|364366905|FG000|Overall Study|Deterioration of general conditions|2|||
105646373|NCT01799993|364366906|FG001|Overall Study|Deterioration of general conditions|0|||
105646374|NCT01799993|364366905|FG000|Overall Study|Screen failure|0|||
105646375|NCT01799993|364366906|FG001|Overall Study|Screen failure|1|||
105646376|NCT01799993|364366905|FG000|Overall Study|Adverse Event|1|||
105646377|NCT01799993|364366906|FG001|Overall Study|Adverse Event|0|||
105646378|NCT01799993|364366905|FG000|Overall Study|Lack of Efficacy|1|||
105646379|NCT01799993|364366906|FG001|Overall Study|Lack of Efficacy|0|||
105646380|NCT01799993|364366905|FG000|Overall Study|Recovery|0|||
105646381|NCT01799993|364366906|FG001|Overall Study|Recovery|1|||
105646382|NCT01799993|364366905|FG000|Overall Study|Logistical difficulties|1|||
105646383|NCT01799993|364366906|FG001|Overall Study|Logistical difficulties|0|||
105646384|NCT01799993|364366905|FG000|Overall Study|Protocol deviation|1|||
105646385|NCT01799993|364366906|FG001|Overall Study|Protocol deviation|0|||
105646386|NCT01799993|364366905|FG000|Overall Study|Non-compliance with medical device|1|||
105646387|NCT01799993|364366906|FG001|Overall Study|Non-compliance with medical device|0|||
105646388|NCT01799993|364366905|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105646389|NCT01799993|364366906|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105646390|NCT01799993|364366905|FG000|Overall Study|Other|1|||
105646391|NCT01799993|364366906|FG001|Overall Study|Other|0|||
105646392|NCT01799993|364366905|FG000|Overall Study|Subject didn't return for follow-up|0|||
105646393|NCT01799993|364366906|FG001|Overall Study|Subject didn't return for follow-up|1|||
105646394|NCT01816165|364366907|FG000|Overall Study|Adverse Event|1|||
105646395|NCT01816165|364366908|FG001|Overall Study|Adverse Event|0|||
105646396|NCT01816165|364366909|FG002|Overall Study|Adverse Event|0|||
105646397|NCT01816165|364366910|FG003|Overall Study|Adverse Event|0|||
105646398|NCT00759681|364366913|FG000|Overall Study|Death|2|||
105646399|NCT00759681|364366914|FG001|Overall Study|Death|5|||
105646400|NCT00759681|364366913|FG000|Overall Study|Lost to Follow-up|8|||
105646401|NCT00759681|364366914|FG001|Overall Study|Lost to Follow-up|5|||
105646402|NCT03557307|364366917|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
105646403|NCT03557307|364366917|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
105646404|NCT03557307|364366917|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
105646405|NCT03557307|364366917|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
105646406|NCT03557307|364366917|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
105646407|NCT03557307|364366917|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
105646408|NCT03557307|364366917|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
105646409|NCT03557307|364366917|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
105646410|NCT03557307|364366917|FG000|Period 2: Maintenance Phase|Death|3|||
105646411|NCT03557307|364366917|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
105646412|NCT03557307|364366917|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
105646413|NCT03557307|364366917|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
105646414|NCT03557307|364366917|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
105646415|NCT03557307|364366917|FG000|Period 2: Maintenance Phase|other|3|||
105646416|NCT01322347|364366918|FG000|Overall Study|Adverse Event|7|||
105646417|NCT01322347|364366919|FG001|Overall Study|Adverse Event|2|||
105646418|NCT01322347|364366918|FG000|Overall Study|Death|5|||
105646419|NCT01322347|364366919|FG001|Overall Study|Death|3|||
105646420|NCT01322347|364366918|FG000|Overall Study|Physician Decision|2|||
105646421|NCT01322347|364366919|FG001|Overall Study|Physician Decision|1|||
105646422|NCT01322347|364366918|FG000|Overall Study|Protocol Violation|5|||
105646423|NCT01322347|364366919|FG001|Overall Study|Protocol Violation|2|||
105646424|NCT01322347|364366918|FG000|Overall Study|Withdrawal by Subject|1|||
105646425|NCT01322347|364366919|FG001|Overall Study|Withdrawal by Subject|4|||
105646426|NCT01322347|364366918|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
105646427|NCT01322347|364366919|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
105646428|NCT01322347|364366918|FG000|Overall Study|blood transfusion|5|||
105646429|NCT01322347|364366919|FG001|Overall Study|blood transfusion|5|||
105646430|NCT01322347|364366918|FG000|Overall Study|sponsor decision|1|||
105646431|NCT01322347|364366919|FG001|Overall Study|sponsor decision|3|||
105646432|NCT01322347|364366918|FG000|Overall Study|ineligible|6|||
105646433|NCT01322347|364366919|FG001|Overall Study|ineligible|3|||
105646434|NCT01322347|364366918|FG000|Overall Study|kidney transplant|3|||
105646435|NCT01322347|364366919|FG001|Overall Study|kidney transplant|1|||
105646436|NCT01322347|364366918|FG000|Overall Study|study drug withheld > 12 wks|0|||
105646437|NCT01322347|364366919|FG001|Overall Study|study drug withheld > 12 wks|1|||
105646438|NCT01322347|364366918|FG000|Overall Study|moved/changed dialysis|2|||
105646439|NCT01322347|364366919|FG001|Overall Study|moved/changed dialysis|4|||
105646440|NCT04883541|364366920|FG000|Overall Study|Not attending regular yoga class|16|||
105646441|NCT04883541|364366921|FG001|Overall Study|Not attending regular yoga class|0|||
105646442|NCT04883541|364366920|FG000|Overall Study|Not attending the pregnancy school|0|||
105646443|NCT04883541|364366921|FG001|Overall Study|Not attending the pregnancy school|9|||
105646444|NCT00590759|364366926|FG000|Overall Study|Death|52|||
105646445|NCT00590759|364366926|FG000|Overall Study|Lost to Follow-up|28|||
105646446|NCT03345407|364366927|FG000|Overall Study|Withdrawal by Subject|11|||
105646447|NCT03345407|364366928|FG001|Overall Study|Withdrawal by Subject|1|||
105646448|NCT03345407|364366929|FG002|Overall Study|Withdrawal by Subject|5|||
105646449|NCT03345407|364366930|FG003|Overall Study|Withdrawal by Subject|6|||
105646450|NCT03345407|364366931|FG004|Overall Study|Withdrawal by Subject|3|||
105646451|NCT03345407|364366932|FG005|Overall Study|Withdrawal by Subject|6|||
105646452|NCT03345407|364366933|FG006|Overall Study|Withdrawal by Subject|16|||
105646453|NCT03345407|364366927|FG000|Overall Study|Physician Decision|3|||
105646454|NCT03345407|364366928|FG001|Overall Study|Physician Decision|1|||
105646455|NCT03345407|364366929|FG002|Overall Study|Physician Decision|0|||
105646456|NCT03345407|364366930|FG003|Overall Study|Physician Decision|0|||
105646457|NCT03345407|364366931|FG004|Overall Study|Physician Decision|1|||
105646458|NCT03345407|364366932|FG005|Overall Study|Physician Decision|2|||
105646459|NCT03345407|364366933|FG006|Overall Study|Physician Decision|3|||
105646460|NCT03345407|364366927|FG000|Overall Study|Lost to Follow-up|2|||
105646461|NCT03345407|364366928|FG001|Overall Study|Lost to Follow-up|0|||
105646462|NCT03345407|364366929|FG002|Overall Study|Lost to Follow-up|1|||
105646463|NCT03345407|364366930|FG003|Overall Study|Lost to Follow-up|0|||
105646464|NCT03345407|364366931|FG004|Overall Study|Lost to Follow-up|1|||
105646465|NCT03345407|364366932|FG005|Overall Study|Lost to Follow-up|2|||
105646466|NCT03345407|364366933|FG006|Overall Study|Lost to Follow-up|3|||
105646467|NCT03345407|364366927|FG000|Overall Study|Protocol-defined stopping criteria|9|||
105646468|NCT03345407|364366928|FG001|Overall Study|Protocol-defined stopping criteria|0|||
105646469|NCT03345407|364366929|FG002|Overall Study|Protocol-defined stopping criteria|0|||
105646470|NCT03345407|364366930|FG003|Overall Study|Protocol-defined stopping criteria|0|||
105646471|NCT03345407|364366931|FG004|Overall Study|Protocol-defined stopping criteria|2|||
105646472|NCT03345407|364366932|FG005|Overall Study|Protocol-defined stopping criteria|1|||
105646473|NCT03345407|364366933|FG006|Overall Study|Protocol-defined stopping criteria|1|||
105646474|NCT03345407|364366927|FG000|Overall Study|Protocol Violation|2|||
105646475|NCT03345407|364366928|FG001|Overall Study|Protocol Violation|0|||
105646476|NCT03345407|364366929|FG002|Overall Study|Protocol Violation|0|||
105646477|NCT03345407|364366930|FG003|Overall Study|Protocol Violation|0|||
105646478|NCT03345407|364366931|FG004|Overall Study|Protocol Violation|1|||
105646479|NCT03345407|364366932|FG005|Overall Study|Protocol Violation|0|||
105646480|NCT03345407|364366933|FG006|Overall Study|Protocol Violation|3|||
105646481|NCT03345407|364366927|FG000|Overall Study|Lack of Efficacy|1|||
105646482|NCT03345407|364366928|FG001|Overall Study|Lack of Efficacy|1|||
105646483|NCT03345407|364366929|FG002|Overall Study|Lack of Efficacy|1|||
105646484|NCT03345407|364366930|FG003|Overall Study|Lack of Efficacy|1|||
105646485|NCT03345407|364366931|FG004|Overall Study|Lack of Efficacy|1|||
105646486|NCT03345407|364366932|FG005|Overall Study|Lack of Efficacy|0|||
105646487|NCT03345407|364366933|FG006|Overall Study|Lack of Efficacy|3|||
105646488|NCT03345407|364366927|FG000|Overall Study|Adverse Event|4|||
105646489|NCT03345407|364366928|FG001|Overall Study|Adverse Event|0|||
105646490|NCT03345407|364366929|FG002|Overall Study|Adverse Event|5|||
105646491|NCT03345407|364366930|FG003|Overall Study|Adverse Event|4|||
105646492|NCT03345407|364366931|FG004|Overall Study|Adverse Event|6|||
105646493|NCT03345407|364366932|FG005|Overall Study|Adverse Event|5|||
105646494|NCT03345407|364366933|FG006|Overall Study|Adverse Event|16|||
105646495|NCT01077284|364366938|FG000|Overall Study|Adverse Event|2|||
105646496|NCT01077284|364366939|FG001|Overall Study|Adverse Event|0|||
105646497|NCT01077284|364366940|FG002|Overall Study|Adverse Event|1|||
105646498|NCT01077284|364366938|FG000|Overall Study|Lost to Follow-up|1|||
105646499|NCT01077284|364366939|FG001|Overall Study|Lost to Follow-up|2|||
105646500|NCT01077284|364366940|FG002|Overall Study|Lost to Follow-up|0|||
105646501|NCT01077284|364366938|FG000|Overall Study|Withdrawal by Subject|2|||
105646502|NCT01077284|364366939|FG001|Overall Study|Withdrawal by Subject|3|||
105646503|NCT01077284|364366940|FG002|Overall Study|Withdrawal by Subject|1|||
105646504|NCT01077284|364366938|FG000|Overall Study|Other|0|||
105646505|NCT01077284|364366939|FG001|Overall Study|Other|0|||
105646506|NCT01077284|364366940|FG002|Overall Study|Other|1|||
105646507|NCT01180400|364366941|FG000|Overall Study|Withdrawal by Subject|5|||
105646508|NCT01180400|364366942|FG001|Overall Study|Withdrawal by Subject|6|||
105646509|NCT01180400|364366941|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105646510|NCT01180400|364366942|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
105646511|NCT01180400|364366941|FG000|Overall Study|Adverse Event|12|||
105646512|NCT01180400|364366942|FG001|Overall Study|Adverse Event|10|||
105646513|NCT01180400|364366941|FG000|Overall Study|Severe non-compliance to protocol|1|||
105646514|NCT01180400|364366942|FG001|Overall Study|Severe non-compliance to protocol|2|||
105646515|NCT01180400|364366941|FG000|Overall Study|Condition under investigation worsened|2|||
105646516|NCT01180400|364366942|FG001|Overall Study|Condition under investigation worsened|1|||
105646517|NCT01180400|364366941|FG000|Overall Study|Lack of Efficacy|2|||
105646518|NCT01180400|364366942|FG001|Overall Study|Lack of Efficacy|0|||
105646519|NCT01180400|364366941|FG000|Overall Study|Study-specific withdrawal criteria|1|||
105646520|NCT01180400|364366942|FG001|Overall Study|Study-specific withdrawal criteria|2|||
105646521|NCT01180400|364366941|FG000|Overall Study|Lost to Follow-up|2|||
105646522|NCT01180400|364366942|FG001|Overall Study|Lost to Follow-up|3|||
105646523|NCT01180400|364366941|FG000|Overall Study|Other|0|||
105646524|NCT01180400|364366942|FG001|Overall Study|Other|1|||
105646525|NCT02812706|364366943|FG000|Phase 1|Adverse Event|0|||
105646526|NCT02812706|364366944|FG001|Phase 1|Adverse Event|2|||
105646527|NCT02812706|364366945|FG002|Phase 1|Adverse Event|0|||
105646528|NCT02812706|364366943|FG000|Phase 1|Progressive disease|3|||
105646529|NCT02812706|364366944|FG001|Phase 1|Progressive disease|3|||
105646530|NCT02812706|364366945|FG002|Phase 1|Progressive disease|0|||
105646531|NCT02812706|364366943|FG000|Phase 2|Adverse Event|0|||
105646532|NCT02812706|364366944|FG001|Phase 2|Adverse Event|0|||
105646533|NCT02812706|364366945|FG002|Phase 2|Adverse Event|2|||
105646534|NCT02812706|364366943|FG000|Phase 2|Progressive disease|0|||
105646535|NCT02812706|364366944|FG001|Phase 2|Progressive disease|0|||
105646536|NCT02812706|364366945|FG002|Phase 2|Progressive disease|22|||
105646537|NCT02812706|364366943|FG000|Phase 2|Other-Unspecified|0|||
105646538|NCT02812706|364366944|FG001|Phase 2|Other-Unspecified|0|||
105646539|NCT02812706|364366945|FG002|Phase 2|Other-Unspecified|4|||
105646540|NCT01989156|364366946|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
105646541|NCT01989156|364366947|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
105646542|NCT01989156|364366948|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
105646543|NCT01989156|364366946|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
105646544|NCT01989156|364366947|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
105646545|NCT01989156|364366948|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
105646546|NCT01989156|364366946|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
105646547|NCT01989156|364366947|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
105646548|NCT01989156|364366948|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
105646549|NCT01989156|364366946|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
105646550|NCT01989156|364366947|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
105646551|NCT01989156|364366948|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
105646552|NCT01989156|364366946|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
105646553|NCT01989156|364366947|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
105646554|NCT01989156|364366948|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
105646555|NCT01989156|364366946|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
105646556|NCT01989156|364366947|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
105646557|NCT01989156|364366948|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
105646558|NCT01989156|364366946|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
105646559|NCT01989156|364366947|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
105646560|NCT01989156|364366948|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
105646561|NCT01989156|364366946|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
105646562|NCT01989156|364366947|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
105646563|NCT01989156|364366948|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
105646564|NCT00665392|364366949|FG000|Overall Study|not treated|1|||
105646565|NCT05740371|364366951|FG000|Overall Study|Death|1|||
105646566|NCT03953079|364366952|FG000|Core Study|Withdrawal by Subject|1|||
105646567|NCT03953079|364366953|FG001|Core Study|Withdrawal by Subject|2|||
105646568|NCT03953079|364366954|FG002|Core Study|Withdrawal by Subject|1|||
105646569|NCT03953079|364366952|FG000|Core Study|COVID-19|0|||
105646570|NCT03953079|364366953|FG001|Core Study|COVID-19|1|||
105646571|NCT03953079|364366954|FG002|Core Study|COVID-19|0|||
105646572|NCT03953079|364366952|FG000|Core Study|Difficulties leaving the house|0|||
105646573|NCT03953079|364366953|FG001|Core Study|Difficulties leaving the house|1|||
105646574|NCT03953079|364366954|FG002|Core Study|Difficulties leaving the house|0|||
105646575|NCT03953079|364366952|FG000|Extension Study|Withdrawal by Subject|1|||
105646576|NCT03953079|364366953|FG001|Extension Study|Withdrawal by Subject|0|||
105646577|NCT03953079|364366954|FG002|Extension Study|Withdrawal by Subject|0|||
105646578|NCT03953079|364366952|FG000|Extension Study|Received Rescue Treatment|5|||
105646579|NCT03953079|364366953|FG001|Extension Study|Received Rescue Treatment|6|||
105646580|NCT03953079|364366954|FG002|Extension Study|Received Rescue Treatment|5|||
105646581|NCT00141271|364366956|FG000|Overall Study|Adverse Event|31|||
105646582|NCT00141271|364366957|FG001|Overall Study|Adverse Event|19|||
105646583|NCT00141271|364366958|FG002|Overall Study|Adverse Event|17|||
105646584|NCT00141271|364366956|FG000|Overall Study|Laboratory Abnormality|2|||
105646585|NCT00141271|364366957|FG001|Overall Study|Laboratory Abnormality|1|||
105646586|NCT00141271|364366958|FG002|Overall Study|Laboratory Abnormality|1|||
105646587|NCT00141271|364366956|FG000|Overall Study|Lack of Efficacy|7|||
105646588|NCT00141271|364366957|FG001|Overall Study|Lack of Efficacy|7|||
105646589|NCT00141271|364366958|FG002|Overall Study|Lack of Efficacy|3|||
105646590|NCT00141271|364366956|FG000|Overall Study|Lost to Follow-up|15|||
105646591|NCT00141271|364366957|FG001|Overall Study|Lost to Follow-up|15|||
105646592|NCT00141271|364366958|FG002|Overall Study|Lost to Follow-up|21|||
105646593|NCT00141271|364366956|FG000|Overall Study|Withdrawal by Subject|14|||
105646594|NCT00141271|364366957|FG001|Overall Study|Withdrawal by Subject|9|||
105646595|NCT00141271|364366958|FG002|Overall Study|Withdrawal by Subject|10|||
105646596|NCT00141271|364366956|FG000|Overall Study|Other|11|||
105646597|NCT00141271|364366957|FG001|Overall Study|Other|12|||
105646598|NCT00141271|364366958|FG002|Overall Study|Other|5|||
105646599|NCT01052714|364366961|FG000|Overall Study|Adverse Event|6|||
105646600|NCT01052714|364366962|FG001|Overall Study|Adverse Event|3|||
105646601|NCT01052714|364366963|FG002|Overall Study|Adverse Event|0|||
105646602|NCT01052714|364366961|FG000|Overall Study|Death|1|||
105646603|NCT01052714|364366962|FG001|Overall Study|Death|2|||
105646604|NCT01052714|364366963|FG002|Overall Study|Death|0|||
105646605|NCT01052714|364366961|FG000|Overall Study|Lost to Follow-up|2|||
105646606|NCT01052714|364366962|FG001|Overall Study|Lost to Follow-up|3|||
105646607|NCT01052714|364366963|FG002|Overall Study|Lost to Follow-up|0|||
105646608|NCT01052714|364366961|FG000|Overall Study|Physician Decision|9|||
105646609|NCT01052714|364366962|FG001|Overall Study|Physician Decision|9|||
105646610|NCT01052714|364366963|FG002|Overall Study|Physician Decision|1|||
105646611|NCT01052714|364366961|FG000|Overall Study|Withdrawal by Subject|7|||
105646612|NCT01052714|364366962|FG001|Overall Study|Withdrawal by Subject|12|||
105646613|NCT01052714|364366963|FG002|Overall Study|Withdrawal by Subject|1|||
105646614|NCT00525915|364366971|FG000|Overall Study|Non-Compliance|0|||
105646615|NCT00525915|364366972|FG001|Overall Study|Non-Compliance|1|||
105646616|NCT00525915|364366971|FG000|Overall Study|Disease Progression|5|||
105646617|NCT00525915|364366972|FG001|Overall Study|Disease Progression|6|||
105646618|NCT00525915|364366971|FG000|Overall Study|Withdrawal by Subject|1|||
105646619|NCT00525915|364366972|FG001|Overall Study|Withdrawal by Subject|0|||
105646620|NCT00525915|364366971|FG000|Overall Study|Refused Surgery|1|||
105646621|NCT00525915|364366972|FG001|Overall Study|Refused Surgery|2|||
105646622|NCT00525915|364366971|FG000|Overall Study|Unrelated illness|1|||
105646623|NCT00525915|364366972|FG001|Overall Study|Unrelated illness|0|||
105646624|NCT00732498|364366973|FG000|Overall Study|Ineligible|1|||
105646625|NCT00732498|364366973|FG000|Overall Study|Adverse Event|2|||
105646626|NCT00732498|364366973|FG000|Overall Study|Physician Decision|3|||
105646627|NCT02332889|364366979|FG000|Overall Study|Physician Decision|1|||
105646628|NCT02135445|364366981|FG000|Overall Study|Lost to Follow-up|1|||
105646629|NCT02135445|364366982|FG001|Overall Study|Lost to Follow-up|0|||
105646630|NCT02135445|364366981|FG000|Overall Study|Withdrawal by Subject|1|||
105646631|NCT02135445|364366982|FG001|Overall Study|Withdrawal by Subject|0|||
105646632|NCT04448561|364366988|FG000|Overall Study|Noncompliance|1|||
105646633|NCT04448561|364366989|FG001|Overall Study|Noncompliance|0|||
105646634|NCT03978130|364368188|FG000|Overall Study|Lost to Follow-up|13|||
105646635|NCT03978130|364368189|FG001|Overall Study|Lost to Follow-up|14|||
105646636|NCT03978130|364368188|FG000|Overall Study|Withdrawal by Subject|12|||
105646637|NCT03978130|364368189|FG001|Overall Study|Withdrawal by Subject|2|||
105646638|NCT03978130|364368188|FG000|Overall Study|Adverse Event|2|||
105646639|NCT03978130|364368189|FG001|Overall Study|Adverse Event|1|||
105646640|NCT05356130|364368190|FG000|Overall Study|Withdrawal by Subject|0|||
105646641|NCT05356130|364368191|FG001|Overall Study|Withdrawal by Subject|0|||
105646642|NCT05356130|364368192|FG002|Overall Study|Withdrawal by Subject|3|||
105646643|NCT03141177|364368193|FG000|Overall Study|Death|62|||
105646644|NCT03141177|364368194|FG001|Overall Study|Death|13|||
105646645|NCT03141177|364368195|FG002|Overall Study|Death|84|||
105646646|NCT03141177|364368193|FG000|Overall Study|Participant withdrew consent|9|||
105646647|NCT03141177|364368194|FG001|Overall Study|Participant withdrew consent|2|||
105646648|NCT03141177|364368195|FG002|Overall Study|Participant withdrew consent|13|||
105646649|NCT03141177|364368193|FG000|Overall Study|Not reported|1|||
105646650|NCT03141177|364368194|FG001|Overall Study|Not reported|0|||
105646651|NCT03141177|364368195|FG002|Overall Study|Not reported|1|||
105646652|NCT03141177|364368193|FG000|Overall Study|Lost to Follow-up|2|||
105646653|NCT03141177|364368194|FG001|Overall Study|Lost to Follow-up|1|||
105646654|NCT03141177|364368195|FG002|Overall Study|Lost to Follow-up|1|||
105646655|NCT03141177|364368193|FG000|Overall Study|Other reasons|4|||
105646656|NCT03141177|364368194|FG001|Overall Study|Other reasons|0|||
105646657|NCT03141177|364368195|FG002|Overall Study|Other reasons|11|||
105646658|NCT03141177|364368193|FG000|Overall Study|Participants did not start treatment period|3|||
105646659|NCT03141177|364368194|FG001|Overall Study|Participants did not start treatment period|0|||
105646660|NCT03141177|364368195|FG002|Overall Study|Participants did not start treatment period|8|||
105646661|NCT04620733|364368198|FG000|Overall Study|Adverse Event|4|||
105646662|NCT04620733|364368199|FG001|Overall Study|Adverse Event|3|||
105646663|NCT04620733|364368198|FG000|Overall Study|Withdrawal by Subject|2|||
105646664|NCT04620733|364368199|FG001|Overall Study|Withdrawal by Subject|5|||
105646665|NCT04620733|364368198|FG000|Overall Study|Lost to Follow-up|1|||
105646666|NCT04620733|364368199|FG001|Overall Study|Lost to Follow-up|1|||
105646667|NCT04620733|364368198|FG000|Overall Study|Protocol Deviation|1|||
105646668|NCT04620733|364368199|FG001|Overall Study|Protocol Deviation|1|||
105646669|NCT04620733|364368198|FG000|Overall Study|Reason Not Specified|0|||
105646670|NCT04620733|364368199|FG001|Overall Study|Reason Not Specified|1|||
105646671|NCT01350102|364368202|FG000|Overall Study|Adverse Event|0|||
105646672|NCT01350102|364368203|FG001|Overall Study|Adverse Event|0|||
105646673|NCT01350102|364368204|FG002|Overall Study|Adverse Event|1|||
105646674|NCT01350102|364368205|FG003|Overall Study|Adverse Event|0|||
105646675|NCT02136797|364368208|FG000|Overall Study|Not Treated|8|||
105646676|NCT03924193|364368214|FG000|Overall Study|Adverse Event|10|||
105646677|NCT03924193|364368215|FG001|Overall Study|Adverse Event|0|||
105646678|NCT03924193|364368216|FG002|Overall Study|Adverse Event|10|||
105646679|NCT03924193|364368214|FG000|Overall Study|Withdrawal by Subject|5|||
105646680|NCT03924193|364368215|FG001|Overall Study|Withdrawal by Subject|10|||
105646681|NCT03924193|364368216|FG002|Overall Study|Withdrawal by Subject|2|||
105646682|NCT01863368|364368217|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
105646683|NCT01863368|364368218|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
105646684|NCT01863368|364368217|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
105646685|NCT01863368|364368218|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
105646686|NCT01863368|364368217|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
105646687|NCT01863368|364368218|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
105646688|NCT01863368|364368217|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
105646689|NCT01863368|364368218|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
105646690|NCT01863368|364368217|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
105646691|NCT01863368|364368218|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
105646692|NCT01863368|364368217|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
105646693|NCT01863368|364368218|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
105646694|NCT04049578|364368220|FG000|Overall Study|Physician Decision|1|||
105646695|NCT02092285|364368223|FG000|Induction Phase|Adverse Event|7|||
105646696|NCT02092285|364368223|FG000|Induction Phase|Physician Decision|4|||
105646697|NCT02092285|364368223|FG000|Induction Phase|Pregnancy|1|||
105646698|NCT02092285|364368223|FG000|Induction Phase|Relapse/Recurrence|7|||
105646699|NCT02092285|364368223|FG000|Induction Phase|Withdrawal by Subject|2|||
105646700|NCT02092285|364368223|FG000|Induction Phase|Lack of Efficacy|14|||
105646701|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
105646702|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
105646703|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
105646704|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
105646705|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
105646706|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
105646707|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
105646708|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
105646709|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
105646710|NCT00304278|364368227|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
105646711|NCT00304278|364368227|FG000|Overall Study|PT had medical condition preventing TX|1|||
105646712|NCT00409006|364368229|FG000|Overall Study|Death|15|||
105646713|NCT00409006|364368230|FG001|Overall Study|Death|6|||
105646714|NCT00409006|364368229|FG000|Overall Study|Lost to Follow-up|1|||
105646715|NCT00409006|364368230|FG001|Overall Study|Lost to Follow-up|2|||
105646716|NCT00409006|364368229|FG000|Overall Study|Withdrawal by Subject|3|||
105646717|NCT00409006|364368230|FG001|Overall Study|Withdrawal by Subject|2|||
105646718|NCT00409006|364368229|FG000|Overall Study|Physician Decision|1|||
105646719|NCT00409006|364368230|FG001|Overall Study|Physician Decision|2|||
105646720|NCT03694210|364368231|FG000|Overall Study|Death|1|||
105646721|NCT03694210|364368231|FG000|Overall Study|Screen Failure|7|||
105646722|NCT00228813|364368234|FG000|Overall Study|Death|4|||
105646723|NCT04025762|364368235|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
105646724|NCT04025762|364368236|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
105646725|NCT03451292|364368237|FG000|Overall Study|Death|44|||
105646726|NCT03451292|364368238|FG001|Overall Study|Death|59|||
105646727|NCT03451292|364368237|FG000|Overall Study|Withdrawal by Subject|18|||
105646728|NCT03451292|364368238|FG001|Overall Study|Withdrawal by Subject|13|||
105646729|NCT03451292|364368237|FG000|Overall Study|Transplantation|18|||
105646730|NCT03451292|364368238|FG001|Overall Study|Transplantation|12|||
105646731|NCT03451292|364368237|FG000|Overall Study|Lost to Follow-up|4|||
105646732|NCT03451292|364368238|FG001|Overall Study|Lost to Follow-up|12|||
105646733|NCT03451292|364368237|FG000|Overall Study|Physician Decision|4|||
105646734|NCT03451292|364368238|FG001|Overall Study|Physician Decision|3|||
105646735|NCT03451292|364368237|FG000|Overall Study|Adverse Event|3|||
105646736|NCT03451292|364368238|FG001|Overall Study|Adverse Event|3|||
105646737|NCT03451292|364368237|FG000|Overall Study|Non-compliance with Study Drug|2|||
105646738|NCT03451292|364368238|FG001|Overall Study|Non-compliance with Study Drug|0|||
105646739|NCT00608959|364368239|FG000|Part 1|Did not meet eligibility criteria|1|||
105646740|NCT01975701|364368243|FG000|Overall Study|Lost to Follow-up|1|||
105646741|NCT01975701|364368243|FG000|Overall Study|Death|23|||
105646742|NCT01975701|364368243|FG000|Overall Study|Physician Decision|1|||
105646743|NCT00668746|364368249|FG000|Overall Study|Lost to Follow-up|2|||
105646744|NCT00668746|364368250|FG001|Overall Study|Lost to Follow-up|1|||
105646745|NCT02109172|364368251|FG000|Overall Study|Withdrawal by Subject|1|||
105646746|NCT02109172|364368252|FG001|Overall Study|Withdrawal by Subject|0|||
105646747|NCT02109172|364368253|FG002|Overall Study|Withdrawal by Subject|0|||
105646748|NCT02109172|364368254|FG003|Overall Study|Withdrawal by Subject|1|||
105646749|NCT02109172|364368255|FG004|Overall Study|Withdrawal by Subject|0|||
105646750|NCT02109172|364368256|FG005|Overall Study|Withdrawal by Subject|0|||
105646751|NCT02109172|364368251|FG000|Overall Study|Adverse Event|0|||
105646752|NCT02109172|364368252|FG001|Overall Study|Adverse Event|0|||
105646753|NCT02109172|364368253|FG002|Overall Study|Adverse Event|1|||
105646754|NCT02109172|364368254|FG003|Overall Study|Adverse Event|0|||
105646755|NCT02109172|364368255|FG004|Overall Study|Adverse Event|0|||
105646756|NCT02109172|364368256|FG005|Overall Study|Adverse Event|1|||
105646757|NCT02109172|364368251|FG000|Overall Study|Death|0|||
105646758|NCT02109172|364368252|FG001|Overall Study|Death|0|||
105646759|NCT02109172|364368253|FG002|Overall Study|Death|0|||
105646760|NCT02109172|364368254|FG003|Overall Study|Death|0|||
105646761|NCT02109172|364368255|FG004|Overall Study|Death|1|||
105646762|NCT02109172|364368256|FG005|Overall Study|Death|0|||
105646763|NCT03605745|364368259|FG000|Overall Study|Study was terminated for business reasons|47|||
105646764|NCT01131325|364368264|FG000|Overall Study|Adverse Event|1|||
105646765|NCT01131325|364368264|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
105646766|NCT00555620|364368265|FG000|Overall Study|Death|0|||
105646767|NCT00555620|364368266|FG001|Overall Study|Death|1|||
105646768|NCT00555620|364368267|FG002|Overall Study|Death|0|||
105646769|NCT00555620|364368268|FG003|Overall Study|Death|0|||
105646770|NCT00555620|364368269|FG004|Overall Study|Death|0|||
105646771|NCT00555620|364368270|FG005|Overall Study|Death|1|||
105646772|NCT00555620|364368265|FG000|Overall Study|Study terminated by sponsor|0|||
105646773|NCT00555620|364368266|FG001|Overall Study|Study terminated by sponsor|0|||
105646774|NCT00555620|364368267|FG002|Overall Study|Study terminated by sponsor|1|||
105646775|NCT00555620|364368268|FG003|Overall Study|Study terminated by sponsor|0|||
105646776|NCT00555620|364368269|FG004|Overall Study|Study terminated by sponsor|0|||
105646777|NCT00555620|364368270|FG005|Overall Study|Study terminated by sponsor|0|||
105646778|NCT00555620|364368265|FG000|Overall Study|Adverse Event|0|||
105646779|NCT00555620|364368266|FG001|Overall Study|Adverse Event|0|||
105646780|NCT00555620|364368267|FG002|Overall Study|Adverse Event|1|||
105646781|NCT00555620|364368268|FG003|Overall Study|Adverse Event|5|||
105646782|NCT00555620|364368269|FG004|Overall Study|Adverse Event|0|||
105646783|NCT00555620|364368270|FG005|Overall Study|Adverse Event|1|||
105646784|NCT00555620|364368265|FG000|Overall Study|Objective progression or relapse|6|||
105646785|NCT00555620|364368266|FG001|Overall Study|Objective progression or relapse|5|||
105646786|NCT00555620|364368267|FG002|Overall Study|Objective progression or relapse|12|||
105646787|NCT00555620|364368268|FG003|Overall Study|Objective progression or relapse|17|||
105646788|NCT00555620|364368269|FG004|Overall Study|Objective progression or relapse|3|||
105646789|NCT00555620|364368270|FG005|Overall Study|Objective progression or relapse|16|||
105646790|NCT00555620|364368265|FG000|Overall Study|Participant refused treatment|0|||
105646791|NCT00555620|364368266|FG001|Overall Study|Participant refused treatment|1|||
105646792|NCT00555620|364368267|FG002|Overall Study|Participant refused treatment|1|||
105646793|NCT00555620|364368268|FG003|Overall Study|Participant refused treatment|0|||
105646794|NCT00555620|364368269|FG004|Overall Study|Participant refused treatment|0|||
105646795|NCT00555620|364368270|FG005|Overall Study|Participant refused treatment|1|||
105646796|NCT00555620|364368265|FG000|Overall Study|Other|0|||
105646797|NCT00555620|364368266|FG001|Overall Study|Other|0|||
105646798|NCT00555620|364368267|FG002|Overall Study|Other|0|||
105646799|NCT00555620|364368268|FG003|Overall Study|Other|1|||
105646800|NCT00555620|364368269|FG004|Overall Study|Other|0|||
105646801|NCT00555620|364368270|FG005|Overall Study|Other|3|||
105646802|NCT00396409|364368271|FG000|Period 1 - 2007|Adverse Event|0|||
105646803|NCT00396409|364368272|FG001|Period 1 - 2007|Adverse Event|1|||
105646804|NCT00396409|364368271|FG000|Period 1 - 2007|Lack of Efficacy|0|||
105646805|NCT00396409|364368272|FG001|Period 1 - 2007|Lack of Efficacy|1|||
105646806|NCT00396409|364368271|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
105646807|NCT00396409|364368272|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
105646808|NCT00396409|364368271|FG000|Period 1 - 2007|Lost to Follow-up|2|||
105646809|NCT00396409|364368272|FG001|Period 1 - 2007|Lost to Follow-up|3|||
105646810|NCT00396409|364368271|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
105646811|NCT00396409|364368272|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
105646812|NCT00396409|364368271|FG000|Period 2 - 2008|Protocol Violation|1|||
105646813|NCT00396409|364368272|FG001|Period 2 - 2008|Protocol Violation|0|||
105646814|NCT00396409|364368271|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
105646815|NCT00396409|364368272|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
105646816|NCT00396409|364368271|FG000|Period 2 - 2008|Lost to Follow-up|3|||
105646817|NCT00396409|364368272|FG001|Period 2 - 2008|Lost to Follow-up|1|||
105646818|NCT05203822|364368273|FG000|Overall Study|Adverse Event|1|||
105646819|NCT05203822|364368273|FG000|Overall Study|Withdrawal by Subject|1|||
105646820|NCT00376259|364368274|FG000|Overall Study|Sponsor request - study termination|21|||
105646821|NCT00376259|364368275|FG001|Overall Study|Sponsor request - study termination|21|||
105646822|NCT00376259|364368274|FG000|Overall Study|Patient request|1|||
105646823|NCT00376259|364368275|FG001|Overall Study|Patient request|0|||
105646824|NCT01877720|364368276|FG000|Overall Study|Adverse Event|1|||
105646825|NCT01877720|364368277|FG001|Overall Study|Adverse Event|0|||
105646826|NCT00447499|364368278|FG000|Overall Study|Adverse Event|1|||
105646827|NCT00447499|364368278|FG000|Overall Study|Patient Decision|4|||
105646828|NCT00447499|364368278|FG000|Overall Study|Sponsor Decision|1|||
105646829|NCT00447499|364368278|FG000|Overall Study|Physician Decision|1|||
105646830|NCT01263223|364368281|FG000|Period 2|Withdrawal by Subject|0|||
105646831|NCT01263223|364368282|FG001|Period 2|Withdrawal by Subject|1|||
105646832|NCT01263223|364368281|FG000|7-day Follow-up|Withdrawal by Subject|0|||
105646833|NCT01263223|364368282|FG001|7-day Follow-up|Withdrawal by Subject|1|||
105646834|NCT01263223|364368281|FG000|7-day Follow-up|Lost to Follow-up|1|||
105646835|NCT01263223|364368282|FG001|7-day Follow-up|Lost to Follow-up|0|||
105646836|NCT03614923|364368283|FG000|Overall Study|Withdrawal by Subject|2|||
105646837|NCT03614923|364368284|FG001|Overall Study|Withdrawal by Subject|1|||
105646838|NCT03614923|364368285|FG002|Overall Study|Withdrawal by Subject|1|||
105646839|NCT03614923|364368283|FG000|Overall Study|Adverse Event|0|||
105646840|NCT03614923|364368284|FG001|Overall Study|Adverse Event|2|||
105646841|NCT03614923|364368285|FG002|Overall Study|Adverse Event|1|||
105646842|NCT03614923|364368283|FG000|Overall Study|Lost to Follow-up|1|||
105646843|NCT03614923|364368284|FG001|Overall Study|Lost to Follow-up|0|||
105646844|NCT03614923|364368285|FG002|Overall Study|Lost to Follow-up|1|||
105646845|NCT03614923|364368283|FG000|Overall Study|Lack of Efficacy|2|||
105646846|NCT03614923|364368284|FG001|Overall Study|Lack of Efficacy|0|||
105646847|NCT03614923|364368285|FG002|Overall Study|Lack of Efficacy|1|||
105646848|NCT03614923|364368283|FG000|Overall Study|Non-compliance|0|||
105646849|NCT03614923|364368284|FG001|Overall Study|Non-compliance|1|||
105646850|NCT03614923|364368285|FG002|Overall Study|Non-compliance|0|||
105646851|NCT03614923|364368283|FG000|Overall Study|Other|0|||
105646852|NCT03614923|364368284|FG001|Overall Study|Other|1|||
105646853|NCT03614923|364368285|FG002|Overall Study|Other|1|||
105646854|NCT03034772|364368286|FG000|Overall Study|Adverse Event|0|||
105646855|NCT03034772|364368287|FG001|Overall Study|Adverse Event|1|||
105646856|NCT03034772|364368286|FG000|Overall Study|Withdrawal by Subject|0|||
105646857|NCT03034772|364368287|FG001|Overall Study|Withdrawal by Subject|1|||
105646858|NCT01136733|364368288|FG000|Phase 1b|Adverse Event|0|||
105646859|NCT01136733|364368289|FG001|Phase 1b|Adverse Event|3|||
105646860|NCT01136733|364368290|FG002|Phase 1b|Adverse Event|1|||
105646861|NCT01136733|364368291|FG003|Phase 1b|Adverse Event|0|||
105646862|NCT01136733|364368292|FG004|Phase 1b|Adverse Event|0|||
105646863|NCT01136733|364368293|FG005|Phase 1b|Adverse Event|0|||
105646864|NCT01136733|364368294|FG006|Phase 1b|Adverse Event|0|||
105646865|NCT01136733|364368288|FG000|Phase 1b|Participant Choice|0|||
105646866|NCT01136733|364368289|FG001|Phase 1b|Participant Choice|0|||
105646867|NCT01136733|364368290|FG002|Phase 1b|Participant Choice|1|||
105646868|NCT01136733|364368291|FG003|Phase 1b|Participant Choice|0|||
105646869|NCT01136733|364368292|FG004|Phase 1b|Participant Choice|0|||
105646870|NCT01136733|364368293|FG005|Phase 1b|Participant Choice|0|||
105646871|NCT01136733|364368294|FG006|Phase 1b|Participant Choice|0|||
105646872|NCT01136733|364368288|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
105646873|NCT01136733|364368289|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
105646874|NCT01136733|364368290|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
105646875|NCT01136733|364368291|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
105646876|NCT01136733|364368292|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
105646877|NCT01136733|364368293|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
105646878|NCT01136733|364368294|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
105646879|NCT01136733|364368288|FG000|Phase 1b|Clinical Progression|1|||
105646880|NCT01136733|364368289|FG001|Phase 1b|Clinical Progression|1|||
105646881|NCT01136733|364368290|FG002|Phase 1b|Clinical Progression|0|||
105646882|NCT01136733|364368291|FG003|Phase 1b|Clinical Progression|0|||
105646883|NCT01136733|364368292|FG004|Phase 1b|Clinical Progression|0|||
105646884|NCT01136733|364368293|FG005|Phase 1b|Clinical Progression|0|||
105646885|NCT01136733|364368294|FG006|Phase 1b|Clinical Progression|0|||
105646886|NCT01136733|364368288|FG000|Phase 2|Disease Progression|0|||
105646887|NCT01136733|364368289|FG001|Phase 2|Disease Progression|0|||
105646888|NCT01136733|364368290|FG002|Phase 2|Disease Progression|0|||
105646889|NCT01136733|364368291|FG003|Phase 2|Disease Progression|0|||
105646890|NCT01136733|364368292|FG004|Phase 2|Disease Progression|30|||
105646891|NCT01136733|364368293|FG005|Phase 2|Disease Progression|32|||
105646892|NCT01136733|364368294|FG006|Phase 2|Disease Progression|38|||
105646893|NCT01136733|364368288|FG000|Phase 2|Adverse Event|0|||
105646894|NCT01136733|364368289|FG001|Phase 2|Adverse Event|0|||
105646895|NCT01136733|364368290|FG002|Phase 2|Adverse Event|0|||
105646896|NCT01136733|364368291|FG003|Phase 2|Adverse Event|0|||
105646897|NCT01136733|364368292|FG004|Phase 2|Adverse Event|11|||
105646898|NCT01136733|364368293|FG005|Phase 2|Adverse Event|13|||
105646899|NCT01136733|364368294|FG006|Phase 2|Adverse Event|5|||
105646900|NCT01136733|364368288|FG000|Phase 2|Participant Choice|0|||
105646901|NCT01136733|364368289|FG001|Phase 2|Participant Choice|0|||
105646902|NCT01136733|364368290|FG002|Phase 2|Participant Choice|0|||
105646903|NCT01136733|364368291|FG003|Phase 2|Participant Choice|0|||
105646904|NCT01136733|364368292|FG004|Phase 2|Participant Choice|3|||
105646905|NCT01136733|364368293|FG005|Phase 2|Participant Choice|0|||
105646906|NCT01136733|364368294|FG006|Phase 2|Participant Choice|1|||
105646907|NCT01136733|364368288|FG000|Phase 2|Administrative-Withdrew Consent|0|||
105646908|NCT01136733|364368289|FG001|Phase 2|Administrative-Withdrew Consent|0|||
105646909|NCT01136733|364368290|FG002|Phase 2|Administrative-Withdrew Consent|0|||
105646910|NCT01136733|364368291|FG003|Phase 2|Administrative-Withdrew Consent|0|||
105646911|NCT01136733|364368292|FG004|Phase 2|Administrative-Withdrew Consent|1|||
105646912|NCT01136733|364368293|FG005|Phase 2|Administrative-Withdrew Consent|0|||
105646913|NCT01136733|364368294|FG006|Phase 2|Administrative-Withdrew Consent|0|||
105646914|NCT01136733|364368288|FG000|Phase 2|Other|0|||
105646915|NCT01136733|364368289|FG001|Phase 2|Other|0|||
105646916|NCT01136733|364368290|FG002|Phase 2|Other|0|||
105646917|NCT01136733|364368291|FG003|Phase 2|Other|0|||
105646918|NCT01136733|364368292|FG004|Phase 2|Other|6|||
105646919|NCT01136733|364368293|FG005|Phase 2|Other|7|||
105646920|NCT01136733|364368294|FG006|Phase 2|Other|6|||
105646921|NCT04175834|364368295|FG000|Overall Study|Withdrawal by Subject|1|||
105646922|NCT04175834|364368296|FG001|Overall Study|Withdrawal by Subject|0|||
105646923|NCT02030847|364368297|FG000|Overall Study|Death|10|||
105646924|NCT02030847|364368297|FG000|Overall Study|Disease Progression|15|||
105646925|NCT02030847|364368297|FG000|Overall Study|New Cancer Therapy|8|||
105646926|NCT02030847|364368297|FG000|Overall Study|Physician Decision|3|||
105646927|NCT02030847|364368297|FG000|Overall Study|Withdrawal by Subject|1|||
105646928|NCT03184519|364368298|FG000|Overall Study|Lost to Follow-up|6|||
105646929|NCT03184519|364368298|FG000|Overall Study|Physician Decision|21|||
105646930|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
105646931|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
105646932|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
105646933|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
105646934|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Death|0|||
105646935|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Death|0|||
105646936|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Death|1|||
105646937|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Death|0|||
105646938|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
105646939|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
105646940|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
105646941|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
105646942|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
105646943|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
105646944|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
105646945|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
105646946|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
105646947|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
105646948|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
105646949|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
105646950|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
105646951|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
105646952|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
105646953|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
105646954|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
105646955|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
105646956|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
105646957|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
105646958|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Other|2|||
105646959|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Other|0|||
105646960|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Other|0|||
105646961|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Other|0|||
105646962|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
105646963|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
105646964|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
105646965|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
105646966|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
105646967|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
105646968|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
105646969|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
105646970|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
105646971|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
105646972|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
105646973|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
105646974|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
105646975|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
105646976|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
105646977|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
105646978|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Death|0|||
105646979|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Death|0|||
105646980|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Death|1|||
105646981|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Death|1|||
105646982|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
105646983|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
105646984|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
105646985|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
105646986|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
105646987|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
105646988|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
105646989|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
105646990|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
105646991|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
105646992|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
105646993|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
105646994|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Other|1|||
105646995|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Other|0|||
105646996|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Other|1|||
105646997|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Other|0|||
105646998|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
105646999|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
105647000|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
105647001|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
105647002|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
105647003|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
105647004|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
105647005|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
105647006|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
105647007|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
105647008|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
105647009|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
105647010|NCT01190436|364368307|FG000|Overall Study|Lost to Follow-up|35|||
105647011|NCT01190436|364368307|FG000|Overall Study|Other|4|||
105647012|NCT02256553|364368308|FG000|Period I|Adverse Event|5|||
105647013|NCT02256553|364368308|FG000|Period I|Protocol Violation|1|||
105647014|NCT02256553|364368308|FG000|Period II|Adverse Event|1|||
105647015|NCT02256553|364368308|FG000|Period II|Subject Moved|1|||
105647016|NCT02256553|364368308|FG000|Period III|Adverse Event|3|||
105647017|NCT02865083|364368309|FG000|Overall Study|Early Termination|3|||
105647018|NCT02865083|364368310|FG001|Overall Study|Early Termination|1|||
105647019|NCT03449979|364368311|FG000|Overall Study|Technical difficulty|0|||
105647020|NCT03449979|364368312|FG001|Overall Study|Technical difficulty|0|||
105647021|NCT03449979|364368313|FG002|Overall Study|Technical difficulty|0|||
105647022|NCT03449979|364368314|FG003|Overall Study|Technical difficulty|1|||
105647023|NCT02632747|364368315|FG000|Wash-out Period|Adverse Event|1|||
105647024|NCT02632747|364368316|FG001|Wash-out Period|Adverse Event|0|||
105647025|NCT01020487|364369885|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
105647026|NCT01020487|364369886|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
105647027|NCT01020487|364369887|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
105647028|NCT01020487|364369885|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
105647029|NCT01020487|364369886|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
105647030|NCT01020487|364369887|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
105647031|NCT01020487|364369885|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
105647032|NCT01020487|364369886|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
105647033|NCT01020487|364369887|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
105647034|NCT01020487|364369885|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
105647035|NCT01020487|364369886|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
105647036|NCT01020487|364369887|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
105647037|NCT01020487|364369885|FG000|Part 2 Open-label Period|Adverse Event|0|||
105647038|NCT01020487|364369886|FG001|Part 2 Open-label Period|Adverse Event|4|||
105647039|NCT01020487|364369887|FG002|Part 2 Open-label Period|Adverse Event|1|||
105647040|NCT01825785|364369888|FG000|Overall Study|Adverse Event|0|||
105647041|NCT01825785|364369889|FG001|Overall Study|Adverse Event|0|||
105647042|NCT01825785|364369890|FG002|Overall Study|Adverse Event|0|||
105647043|NCT01825785|364369891|FG003|Overall Study|Adverse Event|0|||
105647044|NCT01825785|364369892|FG004|Overall Study|Adverse Event|1|||
105647045|NCT01825785|364369893|FG005|Overall Study|Adverse Event|0|||
105647046|NCT01825785|364369894|FG006|Overall Study|Adverse Event|0|||
105647047|NCT01825785|364369888|FG000|Overall Study|Withdrawal by Subject|0|||
105647048|NCT01825785|364369889|FG001|Overall Study|Withdrawal by Subject|0|||
105647049|NCT01825785|364369890|FG002|Overall Study|Withdrawal by Subject|0|||
105647050|NCT01825785|364369891|FG003|Overall Study|Withdrawal by Subject|0|||
105647051|NCT01825785|364369892|FG004|Overall Study|Withdrawal by Subject|1|||
105647052|NCT01825785|364369893|FG005|Overall Study|Withdrawal by Subject|1|||
105647053|NCT01825785|364369894|FG006|Overall Study|Withdrawal by Subject|0|||
105647054|NCT00355784|364369895|FG000|Overall Study|Withdrawal by Subject|0|||
105647055|NCT00355784|364369896|FG001|Overall Study|Withdrawal by Subject|0|||
105647056|NCT00355784|364369897|FG002|Overall Study|Withdrawal by Subject|2|||
105647057|NCT01807234|364369898|FG000|Overall Study|Lost to Follow-up|2|||
105647058|NCT01807234|364369899|FG001|Overall Study|Lost to Follow-up|5|||
105647059|NCT01807234|364369900|FG002|Overall Study|Lost to Follow-up|1|||
105647060|NCT01807234|364369901|FG003|Overall Study|Lost to Follow-up|1|||
105647061|NCT01807234|364369902|FG004|Overall Study|Lost to Follow-up|1|||
105647062|NCT01807234|364369903|FG005|Overall Study|Lost to Follow-up|2|||
105647063|NCT01807234|364369898|FG000|Overall Study|Withdrawal by Subject|3|||
105647064|NCT01807234|364369899|FG001|Overall Study|Withdrawal by Subject|1|||
105647065|NCT01807234|364369900|FG002|Overall Study|Withdrawal by Subject|1|||
105647066|NCT01807234|364369901|FG003|Overall Study|Withdrawal by Subject|1|||
105647067|NCT01807234|364369902|FG004|Overall Study|Withdrawal by Subject|2|||
105647068|NCT01807234|364369903|FG005|Overall Study|Withdrawal by Subject|1|||
105647069|NCT01807234|364369898|FG000|Overall Study|Lack of Efficacy|0|||
105647070|NCT01807234|364369899|FG001|Overall Study|Lack of Efficacy|0|||
105647071|NCT01807234|364369900|FG002|Overall Study|Lack of Efficacy|0|||
105647072|NCT01807234|364369901|FG003|Overall Study|Lack of Efficacy|0|||
105647073|NCT01807234|364369902|FG004|Overall Study|Lack of Efficacy|1|||
105647074|NCT01807234|364369903|FG005|Overall Study|Lack of Efficacy|1|||
105647075|NCT03672188|364369904|FG000|Overall Study|Withdrawal by Subject|0|||
105647076|NCT03672188|364369905|FG001|Overall Study|Withdrawal by Subject|0|||
105647077|NCT03672188|364369906|FG002|Overall Study|Withdrawal by Subject|0|||
105647078|NCT03672188|364369907|FG003|Overall Study|Withdrawal by Subject|3|||
105647079|NCT03672188|364369908|FG004|Overall Study|Withdrawal by Subject|0|||
105647080|NCT03672188|364369909|FG005|Overall Study|Withdrawal by Subject|0|||
105647081|NCT03672188|364369910|FG006|Overall Study|Withdrawal by Subject|0|||
105647082|NCT03672188|364369911|FG007|Overall Study|Withdrawal by Subject|0|||
105647083|NCT03672188|364369912|FG008|Overall Study|Withdrawal by Subject|0|||
105647084|NCT03672188|364369913|FG009|Overall Study|Withdrawal by Subject|0|||
105647085|NCT03672188|364369914|FG010|Overall Study|Withdrawal by Subject|0|||
105647086|NCT03672188|364369915|FG011|Overall Study|Withdrawal by Subject|0|||
105647087|NCT03672188|364369916|FG012|Overall Study|Withdrawal by Subject|0|||
105647088|NCT03672188|364369917|FG013|Overall Study|Withdrawal by Subject|0|||
105647089|NCT03672188|364369918|FG014|Overall Study|Withdrawal by Subject|0|||
105647090|NCT03672188|364369904|FG000|Overall Study|Death|0|||
105647091|NCT03672188|364369905|FG001|Overall Study|Death|0|||
105647092|NCT03672188|364369906|FG002|Overall Study|Death|0|||
105647093|NCT03672188|364369907|FG003|Overall Study|Death|0|||
105647094|NCT03672188|364369908|FG004|Overall Study|Death|0|||
105647095|NCT03672188|364369909|FG005|Overall Study|Death|0|||
105647096|NCT03672188|364369910|FG006|Overall Study|Death|0|||
105647097|NCT03672188|364369911|FG007|Overall Study|Death|0|||
105647098|NCT03672188|364369912|FG008|Overall Study|Death|0|||
105647099|NCT03672188|364369913|FG009|Overall Study|Death|0|||
105647100|NCT03672188|364369914|FG010|Overall Study|Death|0|||
105647101|NCT03672188|364369915|FG011|Overall Study|Death|0|||
105647102|NCT03672188|364369916|FG012|Overall Study|Death|1|||
105647103|NCT03672188|364369917|FG013|Overall Study|Death|0|||
105647104|NCT03672188|364369918|FG014|Overall Study|Death|0|||
105647105|NCT03672188|364369904|FG000|Overall Study|Lost to Follow-up|0|||
105647106|NCT03672188|364369905|FG001|Overall Study|Lost to Follow-up|0|||
105647107|NCT03672188|364369906|FG002|Overall Study|Lost to Follow-up|1|||
105647108|NCT03672188|364369907|FG003|Overall Study|Lost to Follow-up|0|||
105647109|NCT03672188|364369908|FG004|Overall Study|Lost to Follow-up|0|||
105647110|NCT03672188|364369909|FG005|Overall Study|Lost to Follow-up|0|||
105647111|NCT03672188|364369910|FG006|Overall Study|Lost to Follow-up|0|||
105647112|NCT03672188|364369911|FG007|Overall Study|Lost to Follow-up|0|||
105647113|NCT03672188|364369912|FG008|Overall Study|Lost to Follow-up|0|||
105647114|NCT03672188|364369913|FG009|Overall Study|Lost to Follow-up|0|||
105647115|NCT03672188|364369914|FG010|Overall Study|Lost to Follow-up|0|||
105647116|NCT03672188|364369915|FG011|Overall Study|Lost to Follow-up|0|||
105647117|NCT03672188|364369916|FG012|Overall Study|Lost to Follow-up|0|||
105647118|NCT03672188|364369917|FG013|Overall Study|Lost to Follow-up|0|||
105647119|NCT03672188|364369918|FG014|Overall Study|Lost to Follow-up|0|||
105647120|NCT03696342|364369919|FG000|Overall Study|Lost to Follow-up|1|||
105647121|NCT03696342|364369920|FG001|Overall Study|Lost to Follow-up|0|||
105647122|NCT01012999|364369925|FG000|Overall Study|Protocol Violation|1|||
105647123|NCT03360071|364369927|FG000|Overall Study|Lost to Follow-up|1|||
105647124|NCT03360071|364369928|FG001|Overall Study|Lost to Follow-up|0|||
105647125|NCT00946088|364369929|FG000|Overall Study|Withdrawal by Subject|0|||
105647126|NCT00946088|364369930|FG001|Overall Study|Withdrawal by Subject|1|||
105647127|NCT02368691|364369931|FG000|Overall Study|Death|13|||
105647128|NCT02368691|364369931|FG000|Overall Study|Lack of Efficacy|15|||
105647129|NCT02368691|364369931|FG000|Overall Study|Physician Decision|4|||
105647130|NCT04239911|364369932|FG000|Overall Study|Lost to Follow-up|2|||
105647131|NCT04239911|364369933|FG001|Overall Study|Lost to Follow-up|1|||
105647132|NCT00584909|364369934|FG000|Overall Study|Adverse Event|4|||
105647133|NCT00460434|364369935|FG000|Overall Study|Lost to Follow-up|3|||
105647134|NCT00460434|364369936|FG001|Overall Study|Lost to Follow-up|7|||
105647135|NCT02092909|364369937|FG000|Overall Study|Adverse Event|0|||
105647136|NCT02092909|364369938|FG001|Overall Study|Adverse Event|0|||
105647137|NCT02092909|364369939|FG002|Overall Study|Adverse Event|4|||
105647138|NCT02092909|364369940|FG003|Overall Study|Adverse Event|2|||
105647139|NCT02092909|364369937|FG000|Overall Study|Lack of Efficacy|0|||
105647140|NCT02092909|364369938|FG001|Overall Study|Lack of Efficacy|2|||
105647141|NCT02092909|364369939|FG002|Overall Study|Lack of Efficacy|1|||
105647142|NCT02092909|364369940|FG003|Overall Study|Lack of Efficacy|0|||
105647143|NCT02092909|364369937|FG000|Overall Study|Withdrawal by Subject|0|||
105647144|NCT02092909|364369938|FG001|Overall Study|Withdrawal by Subject|0|||
105647145|NCT02092909|364369939|FG002|Overall Study|Withdrawal by Subject|2|||
105647146|NCT02092909|364369940|FG003|Overall Study|Withdrawal by Subject|1|||
105647147|NCT02092909|364369937|FG000|Overall Study|Study terminated by Sponsor|0|||
105647148|NCT02092909|364369938|FG001|Overall Study|Study terminated by Sponsor|0|||
105647149|NCT02092909|364369939|FG002|Overall Study|Study terminated by Sponsor|0|||
105647150|NCT02092909|364369940|FG003|Overall Study|Study terminated by Sponsor|2|||
105647151|NCT02092909|364369937|FG000|Overall Study|Miscellaneous|1|||
105647152|NCT02092909|364369938|FG001|Overall Study|Miscellaneous|1|||
105647153|NCT02092909|364369939|FG002|Overall Study|Miscellaneous|2|||
105647154|NCT02092909|364369940|FG003|Overall Study|Miscellaneous|1|||
105647155|NCT04626128|364369943|FG000|Overall Study|Withdrawal by Subject|0|||
105647156|NCT04626128|364369944|FG001|Overall Study|Withdrawal by Subject|1|||
105647157|NCT04626128|364369945|FG002|Overall Study|Withdrawal by Subject|0|||
105647158|NCT04626128|364369946|FG003|Overall Study|Withdrawal by Subject|0|||
105647159|NCT01182285|364369947|FG000|First Intervention Week 1-10|Disease progression|1|||
105647160|NCT01182285|364369948|FG001|First Intervention Week 1-10|Disease progression|0|||
105647161|NCT01182285|364369949|FG002|First Intervention Week 1-10|Disease progression|0|||
105647162|NCT01182285|364369947|FG000|First Intervention Week 1-10|Adverse Event|1|||
105647163|NCT01182285|364369948|FG001|First Intervention Week 1-10|Adverse Event|0|||
105647164|NCT01182285|364369949|FG002|First Intervention Week 1-10|Adverse Event|0|||
105647165|NCT01182285|364369947|FG000|First Intervention Week 1-10|Non-compliance|1|||
105647166|NCT01182285|364369948|FG001|First Intervention Week 1-10|Non-compliance|0|||
105647167|NCT01182285|364369949|FG002|First Intervention Week 1-10|Non-compliance|0|||
105647168|NCT01182285|364369947|FG000|Third Intervention Week 11-52|Disease Progression|0|||
105647169|NCT01182285|364369948|FG001|Third Intervention Week 11-52|Disease Progression|0|||
105647170|NCT01182285|364369949|FG002|Third Intervention Week 11-52|Disease Progression|6|||
105647171|NCT01182285|364369947|FG000|Third Intervention Week 11-52|Other|0|||
105647172|NCT01182285|364369948|FG001|Third Intervention Week 11-52|Other|0|||
105647173|NCT01182285|364369949|FG002|Third Intervention Week 11-52|Other|2|||
105647174|NCT00248794|364369952|FG000|Overall Study|Lost to Follow-up|6|||
105647175|NCT00248794|364369953|FG001|Overall Study|Lost to Follow-up|8|||
105647176|NCT00248794|364369954|FG002|Overall Study|Lost to Follow-up|3|||
105647177|NCT00203502|364369955|FG000|Overall Study|Death|1|||
105647178|NCT01951105|364369956|FG000|Overall Study|Adverse Event|0|||
105647179|NCT01951105|364369957|FG001|Overall Study|Adverse Event|5|||
105647180|NCT01951105|364369958|FG002|Overall Study|Adverse Event|0|||
105647181|NCT01951105|364369956|FG000|Overall Study|Lost to Follow-up|0|||
105647182|NCT01951105|364369957|FG001|Overall Study|Lost to Follow-up|1|||
105647183|NCT01951105|364369958|FG002|Overall Study|Lost to Follow-up|0|||
105647184|NCT01951105|364369956|FG000|Overall Study|Protocol Violation|1|||
105647185|NCT01951105|364369957|FG001|Overall Study|Protocol Violation|1|||
105647186|NCT01951105|364369958|FG002|Overall Study|Protocol Violation|1|||
105647187|NCT01951105|364369956|FG000|Overall Study|Withdrawal by Subject|0|||
105647188|NCT01951105|364369957|FG001|Overall Study|Withdrawal by Subject|3|||
105647189|NCT01951105|364369958|FG002|Overall Study|Withdrawal by Subject|1|||
105647190|NCT04175392|364369959|FG000|Overall Study|Withdrawal by Subject|3|||
105647191|NCT04175392|364369960|FG001|Overall Study|Withdrawal by Subject|2|||
105647192|NCT02069379|364369961|FG000|Baseline Measurements|Lost to Follow-up|1|||
105647193|NCT02069379|364369962|FG001|Baseline Measurements|Lost to Follow-up|0|||
105647194|NCT02069379|364369963|FG002|Baseline Measurements|Lost to Follow-up|0|||
105647195|NCT02069379|364369964|FG003|Baseline Measurements|Lost to Follow-up|0|||
105647196|NCT02069379|364369961|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
105647197|NCT02069379|364369962|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
105647198|NCT02069379|364369963|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
105647199|NCT02069379|364369964|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
105647200|NCT02069379|364369961|FG000|First Treatment Arm|Lost to Follow-up|0|||
105647201|NCT02069379|364369962|FG001|First Treatment Arm|Lost to Follow-up|1|||
105647202|NCT02069379|364369963|FG002|First Treatment Arm|Lost to Follow-up|1|||
105647203|NCT02069379|364369964|FG003|First Treatment Arm|Lost to Follow-up|0|||
105647204|NCT02069379|364369961|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
105647205|NCT02069379|364369962|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
105647206|NCT02069379|364369963|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
105647207|NCT02069379|364369964|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
105647208|NCT02069379|364369961|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
105647209|NCT02069379|364369962|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
105647210|NCT02069379|364369963|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
105647211|NCT02069379|364369964|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
105647212|NCT02069379|364369961|FG000|Second Treatment Arm|Lost to Follow-up|0|||
105647213|NCT02069379|364369962|FG001|Second Treatment Arm|Lost to Follow-up|0|||
105647214|NCT02069379|364369963|FG002|Second Treatment Arm|Lost to Follow-up|1|||
105647215|NCT02069379|364369964|FG003|Second Treatment Arm|Lost to Follow-up|0|||
105647216|NCT01469819|364369965|FG000|Overall Study|Withdrawal by Subject|1|||
105647217|NCT01469819|364369965|FG000|Overall Study|Did not meet inclusionary criteria|2|||
105647218|NCT01469819|364369965|FG000|Overall Study|Could not swallow SmartPill|2|||
105647219|NCT01469819|364369965|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
105647220|NCT02727998|364369966|FG000|Overall Study|Lost to Follow-up|3|||
105647221|NCT02727998|364369967|FG001|Overall Study|Lost to Follow-up|3|||
105647222|NCT02727998|364369966|FG000|Overall Study|Withdrawal by Subject|0|||
105647223|NCT02727998|364369967|FG001|Overall Study|Withdrawal by Subject|1|||
105647224|NCT00561678|364369968|FG000|Overall Study|Withdrawal by Subject|4|||
105647225|NCT00561678|364369969|FG001|Overall Study|Withdrawal by Subject|3|||
105647226|NCT00561678|364369968|FG000|Overall Study|surgery cancelled|1|||
105647227|NCT00561678|364369969|FG001|Overall Study|surgery cancelled|1|||
105647228|NCT00561678|364369968|FG000|Overall Study|surgery rescheduled to different site|2|||
105647229|NCT00561678|364369969|FG001|Overall Study|surgery rescheduled to different site|2|||
105647230|NCT00561678|364369968|FG000|Overall Study|anesthesia provider refusal|1|||
105647231|NCT00561678|364369969|FG001|Overall Study|anesthesia provider refusal|0|||
105647232|NCT01358175|364369970|FG000|Overall Study|Death|1|||
105647233|NCT01358175|364369971|FG001|Overall Study|Death|0|||
105647234|NCT01358175|364369972|FG002|Overall Study|Death|1|||
105647235|NCT01358175|364369970|FG000|Overall Study|Withdrawal by Subject|9|||
105647236|NCT01358175|364369971|FG001|Overall Study|Withdrawal by Subject|5|||
105647237|NCT01358175|364369972|FG002|Overall Study|Withdrawal by Subject|10|||
105647238|NCT01358175|364369970|FG000|Overall Study|Technical issues|0|||
105647239|NCT01358175|364369971|FG001|Overall Study|Technical issues|1|||
105647240|NCT01358175|364369972|FG002|Overall Study|Technical issues|0|||
105647241|NCT01358175|364369970|FG000|Overall Study|Pregnancy|0|||
105647242|NCT01358175|364369971|FG001|Overall Study|Pregnancy|1|||
105647243|NCT01358175|364369972|FG002|Overall Study|Pregnancy|0|||
105647244|NCT01358175|364369970|FG000|Overall Study|Physician Decision|1|||
105647245|NCT01358175|364369971|FG001|Overall Study|Physician Decision|0|||
105647246|NCT01358175|364369972|FG002|Overall Study|Physician Decision|0|||
105647247|NCT01358175|364369970|FG000|Overall Study|Non Compliance with Study Treatment|0|||
105647248|NCT01358175|364369971|FG001|Overall Study|Non Compliance with Study Treatment|1|||
105647249|NCT01358175|364369972|FG002|Overall Study|Non Compliance with Study Treatment|1|||
105647250|NCT01358175|364369970|FG000|Overall Study|Lost to Follow-up|1|||
105647251|NCT01358175|364369971|FG001|Overall Study|Lost to Follow-up|1|||
105647252|NCT01358175|364369972|FG002|Overall Study|Lost to Follow-up|3|||
105647253|NCT01358175|364369970|FG000|Overall Study|Lack of Efficacy|3|||
105647254|NCT01358175|364369971|FG001|Overall Study|Lack of Efficacy|8|||
105647255|NCT01358175|364369972|FG002|Overall Study|Lack of Efficacy|6|||
105647256|NCT01358175|364369970|FG000|Overall Study|Adverse Event|6|||
105647257|NCT01358175|364369971|FG001|Overall Study|Adverse Event|11|||
105647258|NCT01358175|364369972|FG002|Overall Study|Adverse Event|11|||
105647259|NCT02379078|364369973|FG000|Overall Study|Lost to Follow-up|33|||
105647260|NCT02379078|364369974|FG001|Overall Study|Lost to Follow-up|30|||
105647261|NCT02379078|364369973|FG000|Overall Study|Withdrawal by Subject|6|||
105647262|NCT02379078|364369974|FG001|Overall Study|Withdrawal by Subject|5|||
105647263|NCT03481725|364369975|FG000|Overall Study|Withdrawal by Subject|1|||
105647264|NCT03481725|364369976|FG001|Overall Study|Withdrawal by Subject|0|||
105647265|NCT05072795|364369979|FG000|Overall Study|Lost to Follow-up|5|||
105647266|NCT00472199|364369980|FG000|Overall Study|Adverse Event|19|||
105647267|NCT00472199|364369981|FG001|Overall Study|Adverse Event|23|||
105647268|NCT00472199|364369980|FG000|Overall Study|Lack of Efficacy|4|||
105647269|NCT00472199|364369981|FG001|Overall Study|Lack of Efficacy|25|||
105647270|NCT00472199|364369980|FG000|Overall Study|Lost to Follow-up|2|||
105647271|NCT00472199|364369981|FG001|Overall Study|Lost to Follow-up|4|||
105647272|NCT00472199|364369980|FG000|Overall Study|Protocol Violation|3|||
105647273|NCT00472199|364369981|FG001|Overall Study|Protocol Violation|2|||
105647274|NCT00472199|364369980|FG000|Overall Study|Withdrawal by Subject|6|||
105647275|NCT00472199|364369981|FG001|Overall Study|Withdrawal by Subject|5|||
105647276|NCT00472199|364369980|FG000|Overall Study|personal reason|0|||
105647277|NCT00472199|364369981|FG001|Overall Study|personal reason|1|||
105647278|NCT00472199|364369980|FG000|Overall Study|patient was asymptomatic|1|||
105647279|NCT00472199|364369981|FG001|Overall Study|patient was asymptomatic|0|||
105647280|NCT01107912|364369982|FG000|Period 1|Adverse Event|0|||
105647281|NCT01107912|364369983|FG001|Period 1|Adverse Event|0|||
105647282|NCT01107912|364369984|FG002|Period 1|Adverse Event|0|||
105647283|NCT01107912|364369985|FG003|Period 1|Adverse Event|0|||
105647284|NCT01107912|364369986|FG004|Period 1|Adverse Event|2|||
105647285|NCT01107912|364369987|FG005|Period 1|Adverse Event|0|||
105647286|NCT01107912|364369982|FG000|Period 1|Physician Decision|0|||
105647287|NCT01107912|364369983|FG001|Period 1|Physician Decision|0|||
105647288|NCT01107912|364369984|FG002|Period 1|Physician Decision|0|||
105647289|NCT01107912|364369985|FG003|Period 1|Physician Decision|0|||
105647290|NCT01107912|364369986|FG004|Period 1|Physician Decision|1|||
105647291|NCT01107912|364369987|FG005|Period 1|Physician Decision|0|||
105647292|NCT01107912|364369982|FG000|Period 1|Withdrawal by Subject|1|||
105647293|NCT01107912|364369983|FG001|Period 1|Withdrawal by Subject|0|||
105647294|NCT01107912|364369984|FG002|Period 1|Withdrawal by Subject|0|||
105647295|NCT01107912|364369985|FG003|Period 1|Withdrawal by Subject|0|||
105647296|NCT01107912|364369986|FG004|Period 1|Withdrawal by Subject|0|||
105647297|NCT01107912|364369987|FG005|Period 1|Withdrawal by Subject|0|||
105647298|NCT01107912|364369982|FG000|Period 2|Physician Decision|0|||
105647299|NCT01107912|364369983|FG001|Period 2|Physician Decision|0|||
105647300|NCT01107912|364369984|FG002|Period 2|Physician Decision|1|||
105647301|NCT01107912|364369985|FG003|Period 2|Physician Decision|0|||
105647302|NCT01107912|364369986|FG004|Period 2|Physician Decision|0|||
105647303|NCT01107912|364369987|FG005|Period 2|Physician Decision|0|||
105647304|NCT01107912|364369982|FG000|Period 3|Adverse Event|0|||
105647305|NCT01107912|364369983|FG001|Period 3|Adverse Event|1|||
105647306|NCT01107912|364369984|FG002|Period 3|Adverse Event|1|||
105647307|NCT01107912|364369985|FG003|Period 3|Adverse Event|0|||
105647308|NCT01107912|364369986|FG004|Period 3|Adverse Event|0|||
105647309|NCT01107912|364369987|FG005|Period 3|Adverse Event|0|||
105647310|NCT01107912|364369982|FG000|Period 3|Withdrawal by Subject|0|||
105647311|NCT01107912|364369983|FG001|Period 3|Withdrawal by Subject|0|||
105647312|NCT01107912|364369984|FG002|Period 3|Withdrawal by Subject|0|||
105647313|NCT01107912|364369985|FG003|Period 3|Withdrawal by Subject|1|||
105647314|NCT01107912|364369986|FG004|Period 3|Withdrawal by Subject|0|||
105647315|NCT01107912|364369987|FG005|Period 3|Withdrawal by Subject|0|||
105647316|NCT02522299|364369994|FG000|Overall Study|Adverse Event|2|||
105647317|NCT02522299|364369995|FG001|Overall Study|Adverse Event|0|||
105647318|NCT02522299|364369994|FG000|Overall Study|Physician Decision|0|||
105647319|NCT02522299|364369995|FG001|Overall Study|Physician Decision|1|||
105647320|NCT02522299|364369994|FG000|Overall Study|Withdrawal by Subject|2|||
105647321|NCT02522299|364369995|FG001|Overall Study|Withdrawal by Subject|0|||
105647322|NCT01426217|364369996|FG000|Overall Study|lost sample|8|||
105647323|NCT01426217|364369997|FG001|Overall Study|lost sample|14|||
105647324|NCT05008224|364369998|FG000|Overall Study|Death|3|||
105647325|NCT05008224|364369998|FG000|Overall Study|Lost to Follow-up|2|||
105647326|NCT05008224|364369998|FG000|Overall Study|Did Not Continue on Extension Study|39|||
105647327|NCT05008224|364369998|FG000|Overall Study|Transferred to Extension Study|100|||
105647328|NCT05008224|364369998|FG000|Overall Study|Withdrawal by Subject|2|||
105647329|NCT05234632|364369999|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
105647330|NCT05234632|364370000|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
105647331|NCT05234632|364369999|FG000|Overall Study|Withdrawal by Subject|2|||
105647332|NCT05234632|364370000|FG001|Overall Study|Withdrawal by Subject|0|||
105647333|NCT05234632|364369999|FG000|Overall Study|Adverse Event|0|||
105647334|NCT05234632|364370000|FG001|Overall Study|Adverse Event|4|||
105647335|NCT05234632|364369999|FG000|Overall Study|Physician Decision|1|||
105647336|NCT05234632|364370000|FG001|Overall Study|Physician Decision|1|||
105647337|NCT05234632|364369999|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
105647338|NCT05234632|364370000|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
105647339|NCT05234632|364369999|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
105647340|NCT05234632|364370000|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
105647341|NCT00658632|364370001|FG000|Overall Study|Adverse Event|13|||
105647342|NCT00658632|364370002|FG001|Overall Study|Adverse Event|11|||
105647343|NCT00658632|364370001|FG000|Overall Study|Lost to Follow-up|25|||
105647344|NCT00658632|364370002|FG001|Overall Study|Lost to Follow-up|23|||
105647345|NCT00658632|364370001|FG000|Overall Study|Withdrawal by Subject|10|||
105647346|NCT00658632|364370002|FG001|Overall Study|Withdrawal by Subject|7|||
105647347|NCT00658632|364370001|FG000|Overall Study|Lack of Efficacy|0|||
105647348|NCT00658632|364370002|FG001|Overall Study|Lack of Efficacy|1|||
105647349|NCT00658632|364370001|FG000|Overall Study|Withdrawal of consent|8|||
105647350|NCT00658632|364370002|FG001|Overall Study|Withdrawal of consent|14|||
105647351|NCT00658632|364370001|FG000|Overall Study|Pregnancy|1|||
105647352|NCT00658632|364370002|FG001|Overall Study|Pregnancy|1|||
105647353|NCT00658632|364370001|FG000|Overall Study|Other|7|||
105647354|NCT00658632|364370002|FG001|Overall Study|Other|8|||
105647355|NCT02058992|364370005|FG000|Overall Study|Lost to Follow-up|4|||
105647356|NCT02058992|364370005|FG000|Overall Study|Protocol Violation|92|||
105647357|NCT02058992|364370005|FG000|Overall Study|CRF Uncollected|20|||
105647358|NCT03747575|364370006|FG000|Overall Study|Withdrawal by Subject|6|||
105647359|NCT03747575|364370007|FG001|Overall Study|Withdrawal by Subject|3|||
105647360|NCT03747575|364370006|FG000|Overall Study|Lost to Follow-up|3|||
105647361|NCT03747575|364370007|FG001|Overall Study|Lost to Follow-up|3|||
105647362|NCT03747575|364370006|FG000|Overall Study|Adverse Event|0|||
105647363|NCT03747575|364370007|FG001|Overall Study|Adverse Event|1|||
105647364|NCT02577315|364370016|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
105647365|NCT02577315|364370017|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
105647366|NCT03686176|364370018|FG000|Overall Study|Procedure cancelled|1|||
105647367|NCT03686176|364370019|FG001|Overall Study|Procedure cancelled|0|||
105647368|NCT03686176|364370020|FG002|Overall Study|Procedure cancelled|0|||
105647369|NCT03686176|364370018|FG000|Overall Study|VR Malfunction|1|||
105647370|NCT03686176|364370019|FG001|Overall Study|VR Malfunction|0|||
105647371|NCT03686176|364370020|FG002|Overall Study|VR Malfunction|0|||
105647372|NCT00390806|364370021|FG000|Overall Study|Lost to Follow-up|7|||
105647373|NCT00390806|364370022|FG001|Overall Study|Lost to Follow-up|6|||
105647374|NCT00390806|364370021|FG000|Overall Study|Protocol Violation|2|||
105647375|NCT00390806|364370022|FG001|Overall Study|Protocol Violation|2|||
105647376|NCT00390806|364370021|FG000|Overall Study|Withdrawal by Subject|12|||
105647377|NCT00390806|364370022|FG001|Overall Study|Withdrawal by Subject|15|||
105647378|NCT00390806|364370021|FG000|Overall Study|Investigator Decision|4|||
105647379|NCT00390806|364370022|FG001|Overall Study|Investigator Decision|6|||
105647380|NCT00390806|364370021|FG000|Overall Study|Death|1|||
105647381|NCT00390806|364370022|FG001|Overall Study|Death|0|||
105647382|NCT00390806|364370021|FG000|Overall Study|Physician Decision|0|||
105647383|NCT00390806|364370022|FG001|Overall Study|Physician Decision|1|||
105647384|NCT00390806|364370021|FG000|Overall Study|Ongoing|4|||
105647385|NCT00390806|364370022|FG001|Overall Study|Ongoing|2|||
105647386|NCT04853394|364370023|FG000|Follow-up Interviews|Lost to Follow-up|22|||
105647387|NCT04853394|364370024|FG001|Follow-up Interviews|Lost to Follow-up|15|||
105647388|NCT04212299|364370025|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
105647389|NCT01268488|364371418|FG000|Overall Study|Adverse Event|3|||
105647390|NCT01268488|364371418|FG000|Overall Study|Physician Decision|2|||
105647391|NCT01894620|364371422|FG000|Overall Study|Withdrawal by Subject|0|||
105647392|NCT01894620|364371423|FG001|Overall Study|Withdrawal by Subject|1|||
105647393|NCT00147745|364371424|FG000|Overall Study|Withdrawal by Subject|1|||
105647394|NCT00147745|364371425|FG001|Overall Study|Withdrawal by Subject|0|||
105647395|NCT00147745|364371426|FG002|Overall Study|Withdrawal by Subject|0|||
105647396|NCT01106586|364371427|FG000|Overall Study|Adverse Event|9|||
105647397|NCT01106586|364371428|FG001|Overall Study|Adverse Event|15|||
105647398|NCT01106586|364371427|FG000|Overall Study|Death|1|||
105647399|NCT01106586|364371428|FG001|Overall Study|Death|3|||
105647400|NCT01106586|364371427|FG000|Overall Study|Pregnancy|2|||
105647401|NCT01106586|364371428|FG001|Overall Study|Pregnancy|2|||
105647402|NCT01106586|364371427|FG000|Overall Study|Lack of Efficacy|1|||
105647403|NCT01106586|364371428|FG001|Overall Study|Lack of Efficacy|0|||
105647404|NCT01106586|364371427|FG000|Overall Study|Investigator's Discretion|5|||
105647405|NCT01106586|364371428|FG001|Overall Study|Investigator's Discretion|8|||
105647406|NCT01106586|364371427|FG000|Overall Study|Withdrew Consent|18|||
105647407|NCT01106586|364371428|FG001|Overall Study|Withdrew Consent|30|||
105647408|NCT01106586|364371427|FG000|Overall Study|Lost to Follow-up|24|||
105647409|NCT01106586|364371428|FG001|Overall Study|Lost to Follow-up|20|||
105647410|NCT01106586|364371427|FG000|Overall Study|Participant Noncompliance|12|||
105647411|NCT01106586|364371428|FG001|Overall Study|Participant Noncompliance|10|||
105647412|NCT01106586|364371427|FG000|Overall Study|Protocol Violation|1|||
105647413|NCT01106586|364371428|FG001|Overall Study|Protocol Violation|0|||
105647414|NCT01106586|364371427|FG000|Overall Study|Participant Transferred to Another Study|212|||
105647415|NCT01106586|364371428|FG001|Overall Study|Participant Transferred to Another Study|197|||
105647416|NCT01721109|364371436|FG000|Overall Study|Lack of Efficacy|1|||
105647417|NCT01721109|364371436|FG000|Overall Study|Non- Compliance with Study Drug|3|||
105647418|NCT01721109|364371436|FG000|Overall Study|Withdrew Consent|1|||
105647419|NCT01721109|364371436|FG000|Overall Study|Lost to Follow-up|2|||
105647420|NCT04362176|364371437|FG000|Overall Study|Lost to Follow-up|5|||
105647421|NCT04362176|364371438|FG001|Overall Study|Lost to Follow-up|8|||
105647422|NCT04362176|364371437|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
105647423|NCT04362176|364371438|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
105647424|NCT00742560|364371439|FG000|Overall Study|Adverse Event|0|||
105647425|NCT00742560|364371440|FG001|Overall Study|Adverse Event|0|||
105647426|NCT00742560|364371441|FG002|Overall Study|Adverse Event|1|||
105647427|NCT00742560|364371442|FG003|Overall Study|Adverse Event|1|||
105647428|NCT00742560|364371443|FG004|Overall Study|Adverse Event|1|||
105647429|NCT00742560|364371439|FG000|Overall Study|Death|0|||
105647430|NCT00742560|364371440|FG001|Overall Study|Death|2|||
105647431|NCT00742560|364371441|FG002|Overall Study|Death|0|||
105647432|NCT00742560|364371442|FG003|Overall Study|Death|2|||
105647433|NCT00742560|364371443|FG004|Overall Study|Death|3|||
105647434|NCT00742560|364371439|FG000|Overall Study|Subject's Decision|1|||
105647435|NCT00742560|364371440|FG001|Overall Study|Subject's Decision|0|||
105647436|NCT00742560|364371441|FG002|Overall Study|Subject's Decision|2|||
105647437|NCT00742560|364371442|FG003|Overall Study|Subject's Decision|3|||
105647438|NCT00742560|364371443|FG004|Overall Study|Subject's Decision|3|||
105647439|NCT00742560|364371439|FG000|Overall Study|Investigator's Decision|0|||
105647440|NCT00742560|364371440|FG001|Overall Study|Investigator's Decision|0|||
105647441|NCT00742560|364371441|FG002|Overall Study|Investigator's Decision|4|||
105647442|NCT00742560|364371442|FG003|Overall Study|Investigator's Decision|1|||
105647443|NCT00742560|364371443|FG004|Overall Study|Investigator's Decision|0|||
105647444|NCT00742560|364371439|FG000|Overall Study|Disease Progression|1|||
105647445|NCT00742560|364371440|FG001|Overall Study|Disease Progression|0|||
105647446|NCT00742560|364371441|FG002|Overall Study|Disease Progression|5|||
105647447|NCT00742560|364371442|FG003|Overall Study|Disease Progression|17|||
105647448|NCT00742560|364371443|FG004|Overall Study|Disease Progression|16|||
105647449|NCT00742560|364371439|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
105647450|NCT00742560|364371440|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
105647451|NCT00742560|364371441|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
105647452|NCT00742560|364371442|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
105647453|NCT00742560|364371443|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
105647454|NCT00742560|364371439|FG000|Overall Study|Other|0|||
105647455|NCT00742560|364371440|FG001|Overall Study|Other|1|||
105647456|NCT00742560|364371441|FG002|Overall Study|Other|8|||
105647457|NCT00742560|364371442|FG003|Overall Study|Other|9|||
105647458|NCT00742560|364371443|FG004|Overall Study|Other|9|||
105647459|NCT00742560|364371439|FG000|Overall Study|MIssing|0|||
105647460|NCT00742560|364371440|FG001|Overall Study|MIssing|0|||
105647461|NCT00742560|364371441|FG002|Overall Study|MIssing|0|||
105647462|NCT00742560|364371442|FG003|Overall Study|MIssing|0|||
105647463|NCT00742560|364371443|FG004|Overall Study|MIssing|1|||
105647464|NCT02510560|364371444|FG000|Overall Study|Discontinued from Treatment|27|||
105647465|NCT02510560|364371445|FG001|Overall Study|Discontinued from Treatment|18|||
105647466|NCT02510560|364371446|FG002|Overall Study|Discontinued from Treatment|19|||
105647467|NCT02510560|364371444|FG000|Overall Study|Other|4|||
105647468|NCT02510560|364371445|FG001|Overall Study|Other|4|||
105647469|NCT02510560|364371446|FG002|Overall Study|Other|3|||
105647470|NCT03504397|364371447|FG000|Overall Study|Progressive Disease|151|||
105647471|NCT03504397|364371448|FG001|Overall Study|Progressive Disease|199|||
105647472|NCT03504397|364371447|FG000|Overall Study|Withdrawal by Subject|29|||
105647473|NCT03504397|364371448|FG001|Overall Study|Withdrawal by Subject|17|||
105647474|NCT03504397|364371447|FG000|Overall Study|Lost to Follow-up|1|||
105647475|NCT03504397|364371448|FG001|Overall Study|Lost to Follow-up|0|||
105647476|NCT03504397|364371447|FG000|Overall Study|Death|14|||
105647477|NCT03504397|364371448|FG001|Overall Study|Death|16|||
105647478|NCT03504397|364371447|FG000|Overall Study|Adverse Event|40|||
105647479|NCT03504397|364371448|FG001|Overall Study|Adverse Event|14|||
105647480|NCT03504397|364371447|FG000|Overall Study|miscellaneous|17|||
105647481|NCT03504397|364371448|FG001|Overall Study|miscellaneous|15|||
105647482|NCT03504397|364371447|FG000|Overall Study|Protocol deviation|1|||
105647483|NCT03504397|364371448|FG001|Overall Study|Protocol deviation|0|||
105647484|NCT03504397|364371447|FG000|Overall Study|Participants who did not take the study drug|4|||
105647485|NCT03504397|364371448|FG001|Overall Study|Participants who did not take the study drug|4|||
105647486|NCT03003962|364371450|FG000|Overall Study|Withdrawal by Subject|5|||
105647487|NCT03003962|364371451|FG001|Overall Study|Withdrawal by Subject|17|||
105647488|NCT03003962|364371450|FG000|Overall Study|Death|274|||
105647489|NCT03003962|364371451|FG001|Overall Study|Death|277|||
105647490|NCT03003962|364371450|FG000|Overall Study|Participants ongoing at DCO|55|||
105647491|NCT03003962|364371451|FG001|Overall Study|Participants ongoing at DCO|40|||
105647492|NCT02252172|364371452|FG000|Overall Study|Lost to Follow-up|3|||
105647493|NCT02252172|364371453|FG001|Overall Study|Lost to Follow-up|1|||
105647494|NCT02252172|364371452|FG000|Overall Study|Ongoing|276|||
105647495|NCT02252172|364371453|FG001|Overall Study|Ongoing|298|||
105647496|NCT01075815|364371456|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
105647497|NCT01075815|364371457|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
105647498|NCT01075815|364371456|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
105647499|NCT01075815|364371457|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
105647500|NCT01075815|364371456|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
105647501|NCT01075815|364371457|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
105647502|NCT02066389|364371460|FG000|Overall Study|Adverse Event|1|||
105647503|NCT02066389|364371461|FG001|Overall Study|Adverse Event|1|||
105647504|NCT02066389|364371462|FG002|Overall Study|Adverse Event|1|||
105647505|NCT02066389|364371463|FG003|Overall Study|Adverse Event|1|||
105647506|NCT02066389|364371464|FG004|Overall Study|Adverse Event|5|||
105647507|NCT02066389|364371465|FG005|Overall Study|Adverse Event|1|||
105647508|NCT02066389|364371460|FG000|Overall Study|Withdrawal by Subject|4|||
105647509|NCT02066389|364371461|FG001|Overall Study|Withdrawal by Subject|0|||
105647510|NCT02066389|364371462|FG002|Overall Study|Withdrawal by Subject|5|||
105647511|NCT02066389|364371463|FG003|Overall Study|Withdrawal by Subject|1|||
105647512|NCT02066389|364371464|FG004|Overall Study|Withdrawal by Subject|1|||
105647513|NCT02066389|364371465|FG005|Overall Study|Withdrawal by Subject|2|||
105647514|NCT02066389|364371460|FG000|Overall Study|Lost to Follow-up|0|||
105647515|NCT02066389|364371461|FG001|Overall Study|Lost to Follow-up|0|||
105647516|NCT02066389|364371462|FG002|Overall Study|Lost to Follow-up|0|||
105647517|NCT02066389|364371463|FG003|Overall Study|Lost to Follow-up|1|||
105647518|NCT02066389|364371464|FG004|Overall Study|Lost to Follow-up|1|||
105647519|NCT02066389|364371465|FG005|Overall Study|Lost to Follow-up|1|||
105647520|NCT02066389|364371460|FG000|Overall Study|Randomized in Error|0|||
105647521|NCT02066389|364371461|FG001|Overall Study|Randomized in Error|0|||
105647522|NCT02066389|364371462|FG002|Overall Study|Randomized in Error|0|||
105647523|NCT02066389|364371463|FG003|Overall Study|Randomized in Error|0|||
105647524|NCT02066389|364371464|FG004|Overall Study|Randomized in Error|0|||
105647525|NCT02066389|364371465|FG005|Overall Study|Randomized in Error|1|||
105647526|NCT01755598|364371466|FG000|Overall Study|Other|109|||
105647527|NCT01755598|364371467|FG001|Overall Study|Other|109|||
105647528|NCT01755598|364371466|FG000|Overall Study|Lost to Follow-up|32|||
105647529|NCT01755598|364371467|FG001|Overall Study|Lost to Follow-up|43|||
105647530|NCT01755598|364371466|FG000|Overall Study|Migrated/moved from study area|76|||
105647531|NCT01755598|364371467|FG001|Overall Study|Migrated/moved from study area|65|||
105647532|NCT01755598|364371466|FG000|Overall Study|Withdrawal by Subject|22|||
105647533|NCT01755598|364371467|FG001|Overall Study|Withdrawal by Subject|31|||
105647534|NCT01755598|364371466|FG000|Overall Study|Protocol Violation|7|||
105647535|NCT01755598|364371467|FG001|Overall Study|Protocol Violation|7|||
105647536|NCT01755598|364371466|FG000|Overall Study|Adverse Event|19|||
105647537|NCT01755598|364371467|FG001|Overall Study|Adverse Event|28|||
105647538|NCT01855399|364371470|FG000|6 Month|Lost to Follow-up|12|||
105647539|NCT01855399|364371471|FG001|6 Month|Lost to Follow-up|9|||
105647540|NCT01855399|364371470|FG000|6 Month|Withdrawal by Subject|8|||
105647541|NCT01855399|364371471|FG001|6 Month|Withdrawal by Subject|6|||
105647542|NCT01855399|364371470|FG000|12 Month|Lost to Follow-up|7|||
105647543|NCT01855399|364371471|FG001|12 Month|Lost to Follow-up|11|||
105647544|NCT00321672|364371472|FG000|Overall Study|Withdrawal by Subject|5|||
105647545|NCT00321672|364371473|FG001|Overall Study|Withdrawal by Subject|1|||
105647546|NCT00321672|364371474|FG002|Overall Study|Withdrawal by Subject|2|||
105647547|NCT00321672|364371475|FG003|Overall Study|Withdrawal by Subject|0|||
105647548|NCT00321672|364371472|FG000|Overall Study|Noncompliance|1|||
105647549|NCT00321672|364371473|FG001|Overall Study|Noncompliance|2|||
105647550|NCT00321672|364371474|FG002|Overall Study|Noncompliance|1|||
105647551|NCT00321672|364371475|FG003|Overall Study|Noncompliance|0|||
105647552|NCT00321672|364371472|FG000|Overall Study|Adverse Event|1|||
105647553|NCT00321672|364371473|FG001|Overall Study|Adverse Event|1|||
105647554|NCT00321672|364371474|FG002|Overall Study|Adverse Event|0|||
105647555|NCT00321672|364371475|FG003|Overall Study|Adverse Event|0|||
105647556|NCT00321672|364371472|FG000|Overall Study|Lack of Efficacy|1|||
105647557|NCT00321672|364371473|FG001|Overall Study|Lack of Efficacy|1|||
105647558|NCT00321672|364371474|FG002|Overall Study|Lack of Efficacy|0|||
105647559|NCT00321672|364371475|FG003|Overall Study|Lack of Efficacy|0|||
105647560|NCT00321672|364371472|FG000|Overall Study|Lost to Follow-up|2|||
105647561|NCT00321672|364371473|FG001|Overall Study|Lost to Follow-up|0|||
105647562|NCT00321672|364371474|FG002|Overall Study|Lost to Follow-up|4|||
105647563|NCT00321672|364371475|FG003|Overall Study|Lost to Follow-up|2|||
105647564|NCT00321672|364371472|FG000|Overall Study|Death|1|||
105647565|NCT00321672|364371473|FG001|Overall Study|Death|0|||
105647566|NCT00321672|364371474|FG002|Overall Study|Death|0|||
105647567|NCT00321672|364371475|FG003|Overall Study|Death|0|||
105647568|NCT00321672|364371472|FG000|Overall Study|Too far to travel for visits|1|||
105647569|NCT00321672|364371473|FG001|Overall Study|Too far to travel for visits|0|||
105647570|NCT00321672|364371474|FG002|Overall Study|Too far to travel for visits|0|||
105647571|NCT00321672|364371475|FG003|Overall Study|Too far to travel for visits|0|||
105647572|NCT00321672|364371472|FG000|Overall Study|Incarcerated|0|||
105647573|NCT00321672|364371473|FG001|Overall Study|Incarcerated|0|||
105647574|NCT00321672|364371474|FG002|Overall Study|Incarcerated|2|||
105647575|NCT00321672|364371475|FG003|Overall Study|Incarcerated|0|||
105647576|NCT00321672|364371472|FG000|Overall Study|Moved out of state|0|||
105647577|NCT00321672|364371473|FG001|Overall Study|Moved out of state|1|||
105647578|NCT00321672|364371474|FG002|Overall Study|Moved out of state|1|||
105647579|NCT00321672|364371475|FG003|Overall Study|Moved out of state|0|||
105647580|NCT00321672|364371472|FG000|Overall Study|Protocol Violation|0|||
105647581|NCT00321672|364371473|FG001|Overall Study|Protocol Violation|0|||
105647582|NCT00321672|364371474|FG002|Overall Study|Protocol Violation|1|||
105647583|NCT00321672|364371475|FG003|Overall Study|Protocol Violation|0|||
105647584|NCT00321672|364371472|FG000|Overall Study|Diagnosis of testicular cancer|0|||
105647585|NCT00321672|364371473|FG001|Overall Study|Diagnosis of testicular cancer|1|||
105647586|NCT00321672|364371474|FG002|Overall Study|Diagnosis of testicular cancer|0|||
105647587|NCT00321672|364371475|FG003|Overall Study|Diagnosis of testicular cancer|0|||
105647588|NCT00321672|364371472|FG000|Overall Study|Extensive travel required for new job|0|||
105647589|NCT00321672|364371473|FG001|Overall Study|Extensive travel required for new job|1|||
105647590|NCT00321672|364371474|FG002|Overall Study|Extensive travel required for new job|0|||
105647591|NCT00321672|364371475|FG003|Overall Study|Extensive travel required for new job|0|||
105647592|NCT03615404|364371476|FG000|Overall Study|Death|1|||
105647593|NCT03615404|364371476|FG000|Overall Study|vaccine did not pass quality assurance|1|||
105647594|NCT00936065|364371477|FG000|Overall Study|Adverse Event|1|||
105647595|NCT00936065|364371478|FG001|Overall Study|Adverse Event|0|||
105647596|NCT00936065|364371479|FG002|Overall Study|Adverse Event|1|||
105647597|NCT00936065|364371477|FG000|Overall Study|Lack of Efficacy|1|||
105647598|NCT00936065|364371478|FG001|Overall Study|Lack of Efficacy|0|||
105647599|NCT00936065|364371479|FG002|Overall Study|Lack of Efficacy|1|||
105647600|NCT00936065|364371477|FG000|Overall Study|Lost to Follow-up|1|||
105647601|NCT00936065|364371478|FG001|Overall Study|Lost to Follow-up|0|||
105647602|NCT00936065|364371479|FG002|Overall Study|Lost to Follow-up|0|||
105647603|NCT00936065|364371477|FG000|Overall Study|Protocol Violation|1|||
105647604|NCT00936065|364371478|FG001|Overall Study|Protocol Violation|2|||
105647605|NCT00936065|364371479|FG002|Overall Study|Protocol Violation|1|||
105647606|NCT00936065|364371477|FG000|Overall Study|Withdrawal by Subject|0|||
105647607|NCT00936065|364371478|FG001|Overall Study|Withdrawal by Subject|2|||
105647608|NCT00936065|364371479|FG002|Overall Study|Withdrawal by Subject|4|||
105647609|NCT02389894|364371480|FG000|Overall Study|Death|4|||
105647610|NCT02389894|364371481|FG001|Overall Study|Death|5|||
105647611|NCT02389894|364371482|FG002|Overall Study|Death|3|||
105647612|NCT02389894|364371480|FG000|Overall Study|Withdrawal by Subject|2|||
105647613|NCT02389894|364371481|FG001|Overall Study|Withdrawal by Subject|4|||
105647614|NCT02389894|364371482|FG002|Overall Study|Withdrawal by Subject|5|||
105647615|NCT02389894|364371480|FG000|Overall Study|Lost to Follow-up|2|||
105647616|NCT02389894|364371481|FG001|Overall Study|Lost to Follow-up|1|||
105647617|NCT02389894|364371482|FG002|Overall Study|Lost to Follow-up|1|||
105647618|NCT00145496|364371483|FG000|Overall Study|Adverse Event|42|||
105647619|NCT00145496|364371484|FG001|Overall Study|Adverse Event|30|||
105647620|NCT00145496|364371483|FG000|Overall Study|Lack of Efficacy|12|||
105647621|NCT00145496|364371484|FG001|Overall Study|Lack of Efficacy|7|||
105647622|NCT00145496|364371483|FG000|Overall Study|Withdrawal by Subject|32|||
105647623|NCT00145496|364371484|FG001|Overall Study|Withdrawal by Subject|26|||
105647624|NCT00145496|364371483|FG000|Overall Study|Lost to Follow-up|12|||
105647625|NCT00145496|364371484|FG001|Overall Study|Lost to Follow-up|5|||
105647626|NCT00145496|364371483|FG000|Overall Study|Other|25|||
105647627|NCT00145496|364371484|FG001|Overall Study|Other|13|||
105647628|NCT00448344|364371485|FG000|Overall Study|Lost to Follow-up|20|||
105647629|NCT00448344|364371486|FG001|Overall Study|Lost to Follow-up|22|||
105647630|NCT00448344|364371485|FG000|Overall Study|Withdrawal by Subject|6|||
105647631|NCT00448344|364371486|FG001|Overall Study|Withdrawal by Subject|8|||
105647632|NCT00448344|364371485|FG000|Overall Study|Death|3|||
105647633|NCT00448344|364371486|FG001|Overall Study|Death|4|||
105647634|NCT00448344|364371485|FG000|Overall Study|Physician Decision|1|||
105647635|NCT00448344|364371486|FG001|Overall Study|Physician Decision|2|||
105647636|NCT03689452|364371493|FG000|Overall Study|Lost to Follow-up|1|||
105647637|NCT03689452|364371494|FG001|Overall Study|Lost to Follow-up|1|||
105647638|NCT02676778|364371495|FG000|Overall Study|Disease Progression|7|||
105647639|NCT02676778|364371496|FG001|Overall Study|Disease Progression|3|||
105647640|NCT02676778|364371497|FG002|Overall Study|Disease Progression|1|||
105647641|NCT02676778|364371495|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
105647642|NCT02676778|364371496|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
105647643|NCT02676778|364371497|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
105647644|NCT02676778|364371495|FG000|Overall Study|Withdrawal by Subject|3|||
105647645|NCT02676778|364371496|FG001|Overall Study|Withdrawal by Subject|2|||
105647646|NCT02676778|364371497|FG002|Overall Study|Withdrawal by Subject|0|||
105647647|NCT02676778|364371495|FG000|Overall Study|Other|4|||
105647648|NCT02676778|364371496|FG001|Overall Study|Other|3|||
105647649|NCT02676778|364371497|FG002|Overall Study|Other|0|||
105647650|NCT02676778|364371495|FG000|Overall Study|Adverse Event|2|||
105647651|NCT02676778|364371496|FG001|Overall Study|Adverse Event|3|||
105647652|NCT02676778|364371497|FG002|Overall Study|Adverse Event|0|||
105647653|NCT03394508|364371501|FG000|Overall Study|Protocol Violation|0|||
105647654|NCT03394508|364371502|FG001|Overall Study|Protocol Violation|3|||
105647655|NCT03394508|364371501|FG000|Overall Study|Lost to Follow-up|1|||
105647656|NCT03394508|364371502|FG001|Overall Study|Lost to Follow-up|0|||
105647657|NCT01288729|364371503|FG000|Overall Study|Withdrawal by Subject|1|||
105647658|NCT01288729|364371504|FG001|Overall Study|Withdrawal by Subject|0|||
105647659|NCT03214198|364371505|FG000|Overall Study|Case Report Forms Uncollected|18|||
105647660|NCT03214198|364371505|FG000|Overall Study|Protocol Deviation|18|||
105647661|NCT00267865|364371506|FG000|Induction Treatment|Died before completing.|2|||
105647662|NCT00267865|364371506|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
105647663|NCT01636778|364371509|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
105647664|NCT01636778|364371510|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
105647665|NCT01636778|364371511|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
105647666|NCT01636778|364371509|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
105647667|NCT01636778|364371510|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
105647668|NCT01636778|364371511|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
105647669|NCT01636778|364371509|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
105647670|NCT01636778|364371510|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
105647671|NCT01636778|364371511|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
105647672|NCT01636778|364371509|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
105647673|NCT01636778|364371510|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
105647674|NCT01636778|364371511|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
105647675|NCT01636778|364371509|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
105647676|NCT01636778|364371510|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
105647677|NCT01636778|364371511|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
105647678|NCT01636778|364371509|FG000|Follow-up Period After Part 2|Other|0|||
105647679|NCT01636778|364371510|FG001|Follow-up Period After Part 2|Other|0|||
105647680|NCT01636778|364371511|FG002|Follow-up Period After Part 2|Other|1|||
105647681|NCT01636778|364371509|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
105647682|NCT01636778|364371510|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
105647683|NCT01636778|364371511|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
105647684|NCT01636778|364371509|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
105647685|NCT01636778|364371510|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
105647686|NCT01636778|364371511|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
105647687|NCT01945086|364371517|FG000|Overall Study|Withdrawal by Subject|1|||
105647688|NCT01945086|364371518|FG001|Overall Study|Withdrawal by Subject|0|||
105647689|NCT01945086|364371519|FG002|Overall Study|Withdrawal by Subject|1|||
105647690|NCT01945086|364371517|FG000|Overall Study|Adverse Event|0|||
105647691|NCT01945086|364371518|FG001|Overall Study|Adverse Event|0|||
105647692|NCT01945086|364371519|FG002|Overall Study|Adverse Event|1|||
105647693|NCT00748098|364371522|FG000|First Treatment Intervention Period|Adverse Event|1|||
105647694|NCT00748098|364371523|FG001|First Treatment Intervention Period|Adverse Event|1|||
105647695|NCT00748098|364371522|FG000|First Treatment Intervention Period|Protocol Violation|1|||
105647696|NCT00748098|364371523|FG001|First Treatment Intervention Period|Protocol Violation|0|||
105647697|NCT00748098|364371522|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
105647698|NCT00748098|364371523|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
105647699|NCT00748098|364371522|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
105647700|NCT00748098|364371523|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
105647701|NCT00748098|364371522|FG000|First Taper Period|Protocol Violation|1|||
105647702|NCT00748098|364371523|FG001|First Taper Period|Protocol Violation|0|||
105647703|NCT00748098|364371522|FG000|First Taper Period|Withdrawal by Subject|2|||
105647704|NCT00748098|364371523|FG001|First Taper Period|Withdrawal by Subject|0|||
105647705|NCT00748098|364371522|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
105647706|NCT00748098|364371523|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
105647707|NCT00748098|364371522|FG000|1-Week Washout Period|Adverse Event|0|||
105647708|NCT00748098|364371523|FG001|1-Week Washout Period|Adverse Event|1|||
105647709|NCT00748098|364371522|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
105647710|NCT00748098|364371523|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
105647711|NCT00748098|364371522|FG000|Second Treatment Intervention Period|Adverse Event|4|||
105647712|NCT00748098|364371523|FG001|Second Treatment Intervention Period|Adverse Event|1|||
105647713|NCT00748098|364371522|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
105647714|NCT00748098|364371523|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
105647715|NCT00748098|364371522|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
105659420|NCT00002597|364417320|FG001|Overall Study|Protocol Violation|17|||
105647716|NCT00748098|364371523|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
105647717|NCT02442622|364371526|FG000|Overall Study|Withdrawal by Subject|3|||
105647718|NCT02442622|364371527|FG001|Overall Study|Withdrawal by Subject|1|||
105647719|NCT00383500|364371528|FG000|Overall Study|Withdrawal by Subject|8|||
105647720|NCT00383500|364371529|FG001|Overall Study|Withdrawal by Subject|3|||
105647721|NCT00383500|364371530|FG002|Overall Study|Withdrawal by Subject|0|||
105647722|NCT00383500|364371528|FG000|Overall Study|Lost to Follow-up|0|||
105647723|NCT00383500|364371529|FG001|Overall Study|Lost to Follow-up|0|||
105647724|NCT00383500|364371530|FG002|Overall Study|Lost to Follow-up|2|||
105647725|NCT04341584|364371533|FG000|Overall Study|Withdrew consent|0|||
105647726|NCT04341584|364371534|FG001|Overall Study|Withdrew consent|2|||
105647727|NCT04341584|364371535|FG002|Overall Study|Withdrew consent|2|||
105647728|NCT04341584|364371536|FG003|Overall Study|Withdrew consent|1|||
105647729|NCT00760877|364373300|FG000|Overall Study|Protocol Violation|1|||
105647730|NCT00760877|364373301|FG001|Overall Study|Protocol Violation|0|||
105647731|NCT00760877|364373300|FG000|Overall Study|Non-compliance with protocol treatment|2|||
105647732|NCT00760877|364373301|FG001|Overall Study|Non-compliance with protocol treatment|1|||
105647733|NCT00760877|364373300|FG000|Overall Study|Pregnancy|1|||
105647734|NCT00760877|364373301|FG001|Overall Study|Pregnancy|4|||
105647735|NCT00760877|364373300|FG000|Overall Study|Death|2|||
105647736|NCT00760877|364373301|FG001|Overall Study|Death|1|||
105647737|NCT00760877|364373300|FG000|Overall Study|Withdrawal by Subject|7|||
105647738|NCT00760877|364373301|FG001|Overall Study|Withdrawal by Subject|3|||
105647739|NCT00760877|364373300|FG000|Overall Study|Adverse Event|19|||
105647740|NCT00760877|364373301|FG001|Overall Study|Adverse Event|12|||
105647741|NCT00760877|364373300|FG000|Overall Study|Participant diagnosed with AML|0|||
105647742|NCT00760877|364373301|FG001|Overall Study|Participant diagnosed with AML|1|||
105647743|NCT00760877|364373300|FG000|Overall Study|Participant not eligible to cross-over|0|||
105647744|NCT00760877|364373301|FG001|Overall Study|Participant not eligible to cross-over|1|||
105647745|NCT00760877|364373300|FG000|Overall Study|Physician Decision|1|||
105647746|NCT00760877|364373301|FG001|Overall Study|Physician Decision|2|||
105647747|NCT00760877|364373300|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
105647748|NCT00760877|364373301|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
105647749|NCT00760877|364373300|FG000|Overall Study|Treatment failure|1|||
105647750|NCT00760877|364373301|FG001|Overall Study|Treatment failure|0|||
105647751|NCT00711555|364373302|FG000|Overall Study|Adverse Event|3|||
105647752|NCT00946998|364373303|FG000|Overall Study|Exited prior to first outcome assessment|5|||
105647753|NCT00946998|364373304|FG001|Overall Study|Exited prior to first outcome assessment|3|||
105647754|NCT00489489|364373307|FG000|Overall Study|Not treated due to protocol violation|0|||
105647755|NCT00489489|364373308|FG001|Overall Study|Not treated due to protocol violation|1|||
105647756|NCT00489489|364373309|FG002|Overall Study|Not treated due to protocol violation|1|||
105647757|NCT00489489|364373307|FG000|Overall Study|Adverse Event|1|||
105647758|NCT00489489|364373308|FG001|Overall Study|Adverse Event|1|||
105647759|NCT00489489|364373309|FG002|Overall Study|Adverse Event|1|||
105647760|NCT00489489|364373307|FG000|Overall Study|Protocol Violation|1|||
105647761|NCT00489489|364373308|FG001|Overall Study|Protocol Violation|0|||
105647762|NCT00489489|364373309|FG002|Overall Study|Protocol Violation|1|||
105647763|NCT00489489|364373307|FG000|Overall Study|Progressive disease|0|||
105647764|NCT00489489|364373308|FG001|Overall Study|Progressive disease|1|||
105647765|NCT00489489|364373309|FG002|Overall Study|Progressive disease|0|||
105647766|NCT00489489|364373307|FG000|Overall Study|Participant did not wish to continue|1|||
105647767|NCT00489489|364373308|FG001|Overall Study|Participant did not wish to continue|1|||
105647768|NCT00489489|364373309|FG002|Overall Study|Participant did not wish to continue|0|||
105647769|NCT00489489|364373307|FG000|Overall Study|Other than above|0|||
105647770|NCT00489489|364373308|FG001|Overall Study|Other than above|1|||
105647771|NCT00489489|364373309|FG002|Overall Study|Other than above|0|||
105647772|NCT04851587|364373312|FG000|Overall Study|Lost to Follow-up|18|||
105647773|NCT03050372|364373313|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
105647774|NCT03050372|364373314|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
105647775|NCT03050372|364373313|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
105647776|NCT03050372|364373314|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
105647777|NCT03602053|364373315|FG000|Overall Study|Withdrawal by Subject|7|||
105647778|NCT03602053|364373316|FG001|Overall Study|Withdrawal by Subject|9|||
105647779|NCT03602053|364373317|FG002|Overall Study|Withdrawal by Subject|7|||
105647780|NCT03602053|364373315|FG000|Overall Study|Lost to Follow-up|5|||
105647781|NCT03602053|364373316|FG001|Overall Study|Lost to Follow-up|6|||
105647782|NCT03602053|364373317|FG002|Overall Study|Lost to Follow-up|0|||
105647783|NCT03602053|364373315|FG000|Overall Study|Protocol Violation|3|||
105647784|NCT03602053|364373316|FG001|Overall Study|Protocol Violation|0|||
105647785|NCT03602053|364373317|FG002|Overall Study|Protocol Violation|4|||
105647786|NCT03602053|364373315|FG000|Overall Study|Physician Decision|1|||
105647787|NCT03602053|364373316|FG001|Overall Study|Physician Decision|0|||
105647788|NCT03602053|364373317|FG002|Overall Study|Physician Decision|0|||
105647789|NCT03602053|364373315|FG000|Overall Study|migration|2|||
105647790|NCT03602053|364373316|FG001|Overall Study|migration|3|||
105647791|NCT03602053|364373317|FG002|Overall Study|migration|0|||
105647792|NCT03602053|364373315|FG000|Overall Study|Other|1|||
105647793|NCT03602053|364373316|FG001|Overall Study|Other|0|||
105647794|NCT03602053|364373317|FG002|Overall Study|Other|0|||
105647795|NCT03320941|364373329|FG000|Overall Study|subject/guardian decision|0|||
105647796|NCT03320941|364373330|FG001|Overall Study|subject/guardian decision|0|||
105647797|NCT03320941|364373331|FG002|Overall Study|subject/guardian decision|0|||
105647798|NCT03320941|364373332|FG003|Overall Study|subject/guardian decision|1|||
105647799|NCT03320941|364373333|FG004|Overall Study|subject/guardian decision|0|||
105647800|NCT03960437|364373336|FG000|Overall Study|Removed by PI|4|||
105647801|NCT03960437|364373336|FG000|Overall Study|Lost to Follow-up|2|||
105647802|NCT03960437|364373336|FG000|Overall Study|Withdrawal by Subject|1|||
105647803|NCT03960437|364373336|FG000|Overall Study|Death|2|||
105647804|NCT00473512|364373340|FG000|Period 1 (Phase 1)|Adverse Event|0|||
105647805|NCT00473512|364373341|FG001|Period 1 (Phase 1)|Adverse Event|0|||
105647806|NCT00473512|364373342|FG002|Period 1 (Phase 1)|Adverse Event|0|||
105647807|NCT00473512|364373343|FG003|Period 1 (Phase 1)|Adverse Event|5|||
105647808|NCT00473512|364373344|FG004|Period 1 (Phase 1)|Adverse Event|0|||
105647809|NCT00473512|364373340|FG000|Period 1 (Phase 1)|Death|0|||
105647810|NCT00473512|364373341|FG001|Period 1 (Phase 1)|Death|0|||
105647811|NCT00473512|364373342|FG002|Period 1 (Phase 1)|Death|0|||
105647812|NCT00473512|364373343|FG003|Period 1 (Phase 1)|Death|1|||
105647813|NCT00473512|364373344|FG004|Period 1 (Phase 1)|Death|0|||
105647814|NCT00473512|364373340|FG000|Period 1 (Phase 1)|Disease Progression|1|||
105647815|NCT00473512|364373341|FG001|Period 1 (Phase 1)|Disease Progression|1|||
105647816|NCT00473512|364373342|FG002|Period 1 (Phase 1)|Disease Progression|0|||
105647817|NCT00473512|364373343|FG003|Period 1 (Phase 1)|Disease Progression|10|||
105647818|NCT00473512|364373344|FG004|Period 1 (Phase 1)|Disease Progression|1|||
105647819|NCT00473512|364373340|FG000|Period 1 (Phase 1)|Other|0|||
105647820|NCT00473512|364373341|FG001|Period 1 (Phase 1)|Other|0|||
105647821|NCT00473512|364373342|FG002|Period 1 (Phase 1)|Other|0|||
105647822|NCT00473512|364373343|FG003|Period 1 (Phase 1)|Other|1|||
105647823|NCT00473512|364373344|FG004|Period 1 (Phase 1)|Other|0|||
105647824|NCT00473512|364373340|FG000|Period 2 (Phase 2)|Adverse Event|0|||
105647825|NCT00473512|364373341|FG001|Period 2 (Phase 2)|Adverse Event|0|||
105647826|NCT00473512|364373342|FG002|Period 2 (Phase 2)|Adverse Event|0|||
105647827|NCT00473512|364373343|FG003|Period 2 (Phase 2)|Adverse Event|1|||
105647828|NCT00473512|364373344|FG004|Period 2 (Phase 2)|Adverse Event|0|||
105647829|NCT00473512|364373340|FG000|Period 2 (Phase 2)|Death|0|||
105647830|NCT00473512|364373341|FG001|Period 2 (Phase 2)|Death|0|||
105647831|NCT00473512|364373342|FG002|Period 2 (Phase 2)|Death|0|||
105647832|NCT00473512|364373343|FG003|Period 2 (Phase 2)|Death|1|||
105647833|NCT00473512|364373344|FG004|Period 2 (Phase 2)|Death|1|||
105647834|NCT00473512|364373340|FG000|Period 2 (Phase 2)|Disease Progression|0|||
105647835|NCT00473512|364373341|FG001|Period 2 (Phase 2)|Disease Progression|2|||
105647836|NCT00473512|364373342|FG002|Period 2 (Phase 2)|Disease Progression|2|||
105647837|NCT00473512|364373343|FG003|Period 2 (Phase 2)|Disease Progression|17|||
105647838|NCT00473512|364373344|FG004|Period 2 (Phase 2)|Disease Progression|1|||
105647839|NCT00473512|364373340|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
105647840|NCT00473512|364373341|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
105647841|NCT00473512|364373342|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
105647842|NCT00473512|364373343|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
105647843|NCT00473512|364373344|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
105647844|NCT00473512|364373340|FG000|Period 2 (Phase 2)|Other|1|||
105647845|NCT00473512|364373341|FG001|Period 2 (Phase 2)|Other|0|||
105647846|NCT00473512|364373342|FG002|Period 2 (Phase 2)|Other|0|||
105647847|NCT00473512|364373343|FG003|Period 2 (Phase 2)|Other|3|||
105647848|NCT00473512|364373344|FG004|Period 2 (Phase 2)|Other|0|||
105647849|NCT01636258|364373345|FG000|Overall Study|Lost to Follow-up|1|||
105647850|NCT01636258|364373346|FG001|Overall Study|Lost to Follow-up|0|||
105647851|NCT01369147|364373350|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
105647852|NCT01369147|364373351|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
105647853|NCT01369147|364373352|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
105647854|NCT02722278|364373353|FG000|Overall Study|Withdrawal by Subject|5|||
105647855|NCT02722278|364373354|FG001|Overall Study|Withdrawal by Subject|3|||
105647856|NCT02722278|364373353|FG000|Overall Study|Adverse Event|4|||
105647857|NCT02722278|364373354|FG001|Overall Study|Adverse Event|1|||
105647858|NCT02722278|364373353|FG000|Overall Study|Lost to Follow-up|2|||
105647859|NCT02722278|364373354|FG001|Overall Study|Lost to Follow-up|0|||
105647860|NCT02722278|364373353|FG000|Overall Study|Protocol Violation|1|||
105647861|NCT02722278|364373354|FG001|Overall Study|Protocol Violation|0|||
105647862|NCT02722278|364373353|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
105647863|NCT02722278|364373354|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
105647864|NCT02722278|364373353|FG000|Overall Study|Subject declined after tx assignment|0|||
105647865|NCT02722278|364373354|FG001|Overall Study|Subject declined after tx assignment|1|||
105647866|NCT02722278|364373353|FG000|Overall Study|Site closure not study related|0|||
105647867|NCT02722278|364373354|FG001|Overall Study|Site closure not study related|1|||
105647868|NCT02023099|364373355|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
105647869|NCT02023099|364373356|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
105647870|NCT02023099|364373357|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
105440127|NCT02688985|363616702|FG000|Overall Study|Study Terminated By Sponsor|0|||
105440128|NCT02688985|363616703|FG001|Overall Study|Study Terminated By Sponsor|0|||
105440129|NCT02688985|363616704|FG002|Overall Study|Study Terminated By Sponsor|0|||
105440130|NCT02688985|363616705|FG003|Overall Study|Study Terminated By Sponsor|1|||
105440131|NCT02688985|363616706|FG004|Overall Study|Study Terminated By Sponsor|0|||
105440132|NCT02688985|363616702|FG000|Overall Study|Withdrawal by Subject|2|||
105440133|NCT02688985|363616703|FG001|Overall Study|Withdrawal by Subject|8|||
105440134|NCT02688985|363616704|FG002|Overall Study|Withdrawal by Subject|7|||
105440135|NCT02688985|363616705|FG003|Overall Study|Withdrawal by Subject|1|||
105440136|NCT02688985|363616706|FG004|Overall Study|Withdrawal by Subject|4|||
105440137|NCT00930553|363616707|FG000|Overall Study|Adverse Event|1|||
105440138|NCT00930553|363616707|FG000|Overall Study|Lack of Efficacy|7|||
105440139|NCT00930553|363616707|FG000|Overall Study|Physician Decision|39|||
105440140|NCT00930553|363616707|FG000|Overall Study|Protocol Violation|1|||
105440141|NCT00930553|363616707|FG000|Overall Study|Pregnancy|1|||
105647871|NCT02023099|364373355|FG000|Overall Study|Withdrawn Consent|3|||
105647872|NCT02023099|364373356|FG001|Overall Study|Withdrawn Consent|0|||
105647873|NCT02023099|364373357|FG002|Overall Study|Withdrawn Consent|1|||
105647874|NCT02023099|364373355|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
105647875|NCT02023099|364373356|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
105647876|NCT02023099|364373357|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
105647877|NCT02592434|364373358|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
105647878|NCT02592434|364373359|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
105647879|NCT02592434|364373360|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
105647880|NCT02592434|364373358|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
105647881|NCT02592434|364373359|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
105647882|NCT02592434|364373360|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
105647883|NCT02592434|364373358|FG000|Open-Label Phase (18 Weeks)|Other|3|||
105647884|NCT02592434|364373359|FG001|Open-Label Phase (18 Weeks)|Other|0|||
105647885|NCT02592434|364373360|FG002|Open-Label Phase (18 Weeks)|Other|0|||
105647886|NCT02592434|364373358|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
105647887|NCT02592434|364373359|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
105647888|NCT02592434|364373360|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
105647889|NCT02592434|364373358|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
105647890|NCT02592434|364373359|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
105647891|NCT02592434|364373360|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
105647892|NCT02592434|364373358|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
105647893|NCT02592434|364373359|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
105647894|NCT02592434|364373360|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
105647895|NCT02592434|364373358|FG000|Double Blind Phase (26 Weeks)|Other|0|||
105647896|NCT02592434|364373359|FG001|Double Blind Phase (26 Weeks)|Other|1|||
105647897|NCT02592434|364373360|FG002|Double Blind Phase (26 Weeks)|Other|0|||
105647898|NCT02592434|364373358|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
105647899|NCT02592434|364373359|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
105647900|NCT02592434|364373360|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
105647901|NCT02592434|364373358|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
105647902|NCT02592434|364373359|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
105647903|NCT02592434|364373360|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
105647904|NCT02592434|364373358|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
105647905|NCT02592434|364373359|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
105647906|NCT02592434|364373360|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
105647907|NCT01525875|364373361|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
105647908|NCT01525875|364373362|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
105647909|NCT01525875|364373361|FG000|Open-label Period|Lost to Follow-up|0|||
105647910|NCT01525875|364373362|FG001|Open-label Period|Lost to Follow-up|2|||
105647911|NCT01103141|364373363|FG000|Overall Study|Death|0|||
105647912|NCT01103141|364373364|FG001|Overall Study|Death|1|||
105647913|NCT01103141|364373363|FG000|Overall Study|Lost to Follow-up|2|||
105647914|NCT01103141|364373364|FG001|Overall Study|Lost to Follow-up|1|||
105647915|NCT01762345|364373365|FG000|Overall Study|Adverse Event|5|||
105647916|NCT01762345|364373365|FG000|Overall Study|Protocol Violation|2|||
105647917|NCT01403805|364373366|FG000|Overall Study|Withdrawal by Subject|0|||
105647918|NCT01403805|364373367|FG001|Overall Study|Withdrawal by Subject|4|||
105647919|NCT01403805|364373366|FG000|Overall Study|Lost to Follow-up|0|||
105647920|NCT01403805|364373367|FG001|Overall Study|Lost to Follow-up|2|||
105647921|NCT01403805|364373366|FG000|Overall Study|Death|0|||
105647922|NCT01403805|364373367|FG001|Overall Study|Death|1|||
105647923|NCT01124916|364373372|FG000|Overall Study|Lost to Follow-up|3|||
105647924|NCT01124916|364373373|FG001|Overall Study|Lost to Follow-up|2|||
105647925|NCT00938041|364373374|FG000|Overall Study|Lost to Follow-up|6|||
105647926|NCT00938041|364373374|FG000|Overall Study|Received Alternative Therapy|1|||
105440142|NCT00930553|363616707|FG000|Overall Study|Withdrawal by Subject|88|||
105647927|NCT00938041|364373374|FG000|Overall Study|Progressive Disease|5|||
105647928|NCT00938041|364373374|FG000|Overall Study|Death|12|||
105647929|NCT00938041|364373374|FG000|Overall Study|Adrenal Insufficiency|3|||
105647930|NCT02475733|364373379|FG000|Overall Study|Withdrawal by Subject|1|||
105647931|NCT02475733|364373380|FG001|Overall Study|Withdrawal by Subject|0|||
105647932|NCT02475733|364373379|FG000|Overall Study|Physician Decision|1|||
105647933|NCT02475733|364373380|FG001|Overall Study|Physician Decision|0|||
105647934|NCT00510783|364373385|FG000|Overall Study|Lost to Follow-up|29|||
105647935|NCT00510783|364373386|FG001|Overall Study|Lost to Follow-up|25|||
105647936|NCT00510783|364373385|FG000|Overall Study|Withdrawal by Subject|2|||
105647937|NCT00510783|364373386|FG001|Overall Study|Withdrawal by Subject|3|||
105647938|NCT00510783|364373385|FG000|Overall Study|Protocol Violation|0|||
105647939|NCT00510783|364373386|FG001|Overall Study|Protocol Violation|1|||
105647940|NCT02305797|364373387|FG000|Overall Study|Adverse Event|11|||
105647941|NCT02305797|364373388|FG001|Overall Study|Adverse Event|2|||
105647942|NCT02305797|364373387|FG000|Overall Study|Withdrawal by Subject|9|||
105647943|NCT02305797|364373388|FG001|Overall Study|Withdrawal by Subject|10|||
105647944|NCT02305797|364373387|FG000|Overall Study|Lack of Efficacy|6|||
105647945|NCT02305797|364373388|FG001|Overall Study|Lack of Efficacy|0|||
105647946|NCT02305797|364373387|FG000|Overall Study|Lost to Follow-up|5|||
105647947|NCT02305797|364373388|FG001|Overall Study|Lost to Follow-up|11|||
105647948|NCT02305797|364373387|FG000|Overall Study|Pregnancy|0|||
105647949|NCT02305797|364373388|FG001|Overall Study|Pregnancy|2|||
105647950|NCT02305797|364373387|FG000|Overall Study|Noncompliance|14|||
105647951|NCT02305797|364373388|FG001|Overall Study|Noncompliance|12|||
105647952|NCT02305797|364373387|FG000|Overall Study|Reason not collected|0|||
105647953|NCT02305797|364373388|FG001|Overall Study|Reason not collected|1|||
105647954|NCT00422162|364373389|FG000|Overall Study|Adverse Event|11|||
105647955|NCT00422162|364373390|FG001|Overall Study|Adverse Event|9|||
105647956|NCT00422162|364373389|FG000|Overall Study|Lack of Efficacy|4|||
105647957|NCT00422162|364373390|FG001|Overall Study|Lack of Efficacy|10|||
105647958|NCT00422162|364373389|FG000|Overall Study|Withdrawal by Subject|7|||
105647959|NCT00422162|364373390|FG001|Overall Study|Withdrawal by Subject|6|||
105647960|NCT00422162|364373389|FG000|Overall Study|Lost to Follow-up|1|||
105647961|NCT00422162|364373390|FG001|Overall Study|Lost to Follow-up|2|||
105647962|NCT00422162|364373389|FG000|Overall Study|Non-Compliant with Protocol|1|||
105647963|NCT00422162|364373390|FG001|Overall Study|Non-Compliant with Protocol|1|||
105647964|NCT00422162|364373389|FG000|Overall Study|Other|0|||
105647965|NCT00422162|364373390|FG001|Overall Study|Other|1|||
105647966|NCT00422162|364373389|FG000|Overall Study|Didn't Receive Treatment|0|||
105647967|NCT00422162|364373390|FG001|Overall Study|Didn't Receive Treatment|1|||
105647968|NCT05274906|364373391|FG000|Overall Study|Withdrawal by Subject|2|||
105647969|NCT05274906|364373392|FG001|Overall Study|Withdrawal by Subject|1|||
105647970|NCT03508830|364373393|FG000|Overall Study|Withdrawal by Subject|3|||
105647971|NCT03508830|364373394|FG001|Overall Study|Withdrawal by Subject|4|||
105647972|NCT03508830|364373393|FG000|Overall Study|Physician Decision|2|||
105647973|NCT03508830|364373394|FG001|Overall Study|Physician Decision|2|||
105647974|NCT03906240|364373397|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
105647975|NCT03906240|364373398|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
105647976|NCT03906240|364373397|FG000|Overall Study|Lost to Follow-up|1|||
105647977|NCT03906240|364373398|FG001|Overall Study|Lost to Follow-up|0|||
105647978|NCT03906240|364373397|FG000|Overall Study|Withdrawal by Subject|0|||
105647979|NCT03906240|364373398|FG001|Overall Study|Withdrawal by Subject|1|||
105647980|NCT04908800|364373403|FG000|Overall Study|Adverse Event|0|||
105647981|NCT04908800|364373404|FG001|Overall Study|Adverse Event|0|||
105647982|NCT04908800|364373405|FG002|Overall Study|Adverse Event|0|||
105647983|NCT04908800|364373406|FG003|Overall Study|Adverse Event|0|||
105647984|NCT04908800|364373407|FG004|Overall Study|Adverse Event|0|||
105647985|NCT04908800|364373408|FG005|Overall Study|Adverse Event|0|||
105647986|NCT04908800|364373409|FG006|Overall Study|Adverse Event|0|||
105647987|NCT04908800|364373410|FG007|Overall Study|Adverse Event|0|||
105647988|NCT04908800|364373411|FG008|Overall Study|Adverse Event|0|||
105647989|NCT04908800|364373412|FG009|Overall Study|Adverse Event|0|||
105647990|NCT04908800|364373413|FG010|Overall Study|Adverse Event|1|||
105647991|NCT04908800|364373414|FG011|Overall Study|Adverse Event|0|||
105647992|NCT04908800|364373415|FG012|Overall Study|Adverse Event|0|||
105647993|NCT00157209|364373416|FG000|Overall Study|Ongoing at data cut-off|10|||
105647994|NCT00157209|364373417|FG001|Overall Study|Ongoing at data cut-off|0|||
105647995|NCT04474691|364373418|FG000|Overall Study|Withdrawal by Subject|9|||
105647996|NCT01047306|364373419|FG000|Overall Study|Withdrawal by Subject|2|||
105647997|NCT01047306|364373420|FG001|Overall Study|Withdrawal by Subject|0|||
105647998|NCT01047306|364373419|FG000|Overall Study|Lost to Follow-up|1|||
105647999|NCT01047306|364373420|FG001|Overall Study|Lost to Follow-up|0|||
105648000|NCT01878253|364373421|FG000|Overall Study|Death|1|||
105648001|NCT01878253|364373421|FG000|Overall Study|SIdus System Removal|3|||
105648002|NCT01878253|364373421|FG000|Overall Study|Withdrawal by Subject|1|||
105648003|NCT01878253|364373421|FG000|Overall Study|Lost to Follow-up|2|||
105648004|NCT01878253|364373421|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
105648005|NCT03647709|364373422|FG000|Overall Study|Lost to Follow-up|5|||
105648006|NCT03647709|364373422|FG000|Overall Study|Physician Decision|6|||
105648007|NCT03647709|364373422|FG000|Overall Study|Withdrawal by Subject|3|||
105648008|NCT00850993|364373423|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
105648009|NCT00850993|364373424|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
105648010|NCT00850993|364373425|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
105648011|NCT00850993|364373426|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
105648012|NCT03839355|364373427|FG000|Overall Study|Withdrawal by Subject|1|||
105648013|NCT03839355|364373428|FG001|Overall Study|Withdrawal by Subject|0|||
105648014|NCT02809677|364373435|FG000|Overall Study|Withdrawal by Subject|8|||
105648015|NCT04736472|364373436|FG000|Overall Study|Lost to Follow-up|1|||
105648016|NCT04736472|364373437|FG001|Overall Study|Lost to Follow-up|0|||
105648017|NCT04736472|364373438|FG002|Overall Study|Lost to Follow-up|0|||
105648018|NCT04736472|364373436|FG000|Overall Study|Withdrawal by Subject|2|||
105648019|NCT04736472|364373437|FG001|Overall Study|Withdrawal by Subject|0|||
105648020|NCT04736472|364373438|FG002|Overall Study|Withdrawal by Subject|0|||
105648021|NCT04736472|364373436|FG000|Overall Study|Protocol Violation|48|||
105648022|NCT04736472|364373437|FG001|Overall Study|Protocol Violation|0|||
105648023|NCT04736472|364373438|FG002|Overall Study|Protocol Violation|6|||
105648024|NCT02374476|364373439|FG000|VT Induced Ablation|Screening Failures|36|||
105648025|NCT02374476|364373440|FG001|VT Induced Ablation|Screening Failures|0|||
105648026|NCT02374476|364373441|FG002|VT Induced Ablation|Screening Failures|0|||
105648027|NCT02374476|364373439|FG000|Arm Assignment|Withdrawal by Subject|0|||
105648028|NCT02374476|364373440|FG001|Arm Assignment|Withdrawal by Subject|0|||
105648029|NCT02374476|364373441|FG002|Arm Assignment|Withdrawal by Subject|1|||
105648030|NCT03219216|364373442|FG000|Overall Study|Lost to Follow-up|0|||
105648031|NCT03219216|364373443|FG001|Overall Study|Lost to Follow-up|1|||
105648032|NCT03305458|364373444|FG000|Overall Study|Withdrawal by Subject|50|||
105648033|NCT03305458|364373445|FG001|Overall Study|Withdrawal by Subject|46|||
105648034|NCT03305458|364373446|FG002|Overall Study|Withdrawal by Subject|93|||
105648035|NCT03305458|364373444|FG000|Overall Study|Lost to Follow-up|85|||
105648036|NCT03305458|364373445|FG001|Overall Study|Lost to Follow-up|85|||
105648037|NCT03305458|364373446|FG002|Overall Study|Lost to Follow-up|35|||
105648038|NCT02332824|364373447|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
105648039|NCT02332824|364373448|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
105648040|NCT02332824|364373449|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
105648041|NCT02332824|364373450|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
105648042|NCT02332824|364373451|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
105648043|NCT02332824|364373452|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
105648044|NCT02332824|364373447|FG000|Overall Study|Voluntary Withdrawal|1|||
105648045|NCT02332824|364373448|FG001|Overall Study|Voluntary Withdrawal|0|||
105648046|NCT02332824|364373449|FG002|Overall Study|Voluntary Withdrawal|0|||
105648047|NCT02332824|364373450|FG003|Overall Study|Voluntary Withdrawal|0|||
105648048|NCT02332824|364373451|FG004|Overall Study|Voluntary Withdrawal|0|||
105648049|NCT02332824|364373452|FG005|Overall Study|Voluntary Withdrawal|0|||
105648050|NCT02332824|364373447|FG000|Overall Study|Inconvenient schedule|1|||
105648051|NCT02332824|364373448|FG001|Overall Study|Inconvenient schedule|1|||
105648052|NCT02332824|364373449|FG002|Overall Study|Inconvenient schedule|0|||
105648053|NCT02332824|364373450|FG003|Overall Study|Inconvenient schedule|0|||
105648054|NCT02332824|364373451|FG004|Overall Study|Inconvenient schedule|0|||
105648055|NCT02332824|364373452|FG005|Overall Study|Inconvenient schedule|0|||
105648056|NCT02332824|364373447|FG000|Overall Study|Transfer|0|||
105648057|NCT02332824|364373448|FG001|Overall Study|Transfer|0|||
105648058|NCT02332824|364373449|FG002|Overall Study|Transfer|1|||
105648059|NCT02332824|364373450|FG003|Overall Study|Transfer|1|||
105648060|NCT02332824|364373451|FG004|Overall Study|Transfer|0|||
105648061|NCT02332824|364373452|FG005|Overall Study|Transfer|0|||
105648062|NCT00914732|364373453|FG000|Overall Study|Lost to Follow-up|6|||
105648063|NCT00914732|364373454|FG001|Overall Study|Lost to Follow-up|7|||
105648064|NCT00914732|364373455|FG002|Overall Study|Lost to Follow-up|9|||
105648065|NCT00914732|364373453|FG000|Overall Study|Withdrawal by Subject|3|||
105648066|NCT00914732|364373454|FG001|Overall Study|Withdrawal by Subject|0|||
105648067|NCT00914732|364373455|FG002|Overall Study|Withdrawal by Subject|2|||
105648068|NCT00914732|364373453|FG000|Overall Study|Adverse Event|1|||
105648069|NCT00914732|364373454|FG001|Overall Study|Adverse Event|0|||
105648070|NCT00914732|364373455|FG002|Overall Study|Adverse Event|0|||
105648071|NCT02130401|364373456|FG000|Overall Study|Poor enrollment|6|||
105648072|NCT03840148|364373457|FG000|Study Drug Disposition|Adverse Event|13|||
105648073|NCT03840148|364373458|FG001|Study Drug Disposition|Adverse Event|2|||
105648074|NCT03840148|364373457|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
105648075|NCT03840148|364373458|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
105648076|NCT03840148|364373457|FG000|Study Drug Disposition|Lack of Efficacy|3|||
105648077|NCT03840148|364373458|FG001|Study Drug Disposition|Lack of Efficacy|0|||
105648078|NCT03840148|364373457|FG000|Study Drug Disposition|Physician Decision|2|||
105648079|NCT03840148|364373458|FG001|Study Drug Disposition|Physician Decision|0|||
105648080|NCT03840148|364373457|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
105648081|NCT03840148|364373458|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
105648082|NCT03840148|364373457|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
105648083|NCT03840148|364373458|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
105648084|NCT03840148|364373457|FG000|Study Completion Disposition|Physician Decision|2|||
105648085|NCT03840148|364373458|FG001|Study Completion Disposition|Physician Decision|0|||
105648086|NCT03840148|364373457|FG000|Study Completion Disposition|Covid-19 related|2|||
105648087|NCT03840148|364373458|FG001|Study Completion Disposition|Covid-19 related|0|||
105648088|NCT03840148|364373457|FG000|Study Completion Disposition|Lost to Follow-up|1|||
105648089|NCT03840148|364373458|FG001|Study Completion Disposition|Lost to Follow-up|1|||
105648090|NCT03840148|364373457|FG000|Study Completion Disposition|Death|1|||
105648091|NCT03840148|364373458|FG001|Study Completion Disposition|Death|0|||
105648092|NCT03840148|364373457|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
105648093|NCT03840148|364373458|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
105648094|NCT04394624|364373462|FG000|Overall Study|Adverse Event|6|||
105648095|NCT04394624|364373463|FG001|Overall Study|Adverse Event|0|||
105648096|NCT04394624|364373462|FG000|Overall Study|Progressive disease|24|||
105648097|NCT04394624|364373463|FG001|Overall Study|Progressive disease|0|||
105648098|NCT04394624|364373462|FG000|Overall Study|Not related to COVID-19|1|||
105648099|NCT04394624|364373463|FG001|Overall Study|Not related to COVID-19|0|||
105648100|NCT01774929|364373464|FG000|Overall Study|Adverse Event|3|||
105648101|NCT04374253|364373466|FG000|Overall Study|Adverse Event|0|||
105648102|NCT04374253|364373467|FG001|Overall Study|Adverse Event|26|||
105648103|NCT04374253|364373468|FG002|Overall Study|Adverse Event|2|||
105648104|NCT04374253|364373469|FG003|Overall Study|Adverse Event|12|||
105648105|NCT04374253|364373466|FG000|Overall Study|Study terminated by sponsor|13|||
105648106|NCT04374253|364373467|FG001|Overall Study|Study terminated by sponsor|593|||
105648107|NCT04374253|364373468|FG002|Overall Study|Study terminated by sponsor|21|||
105648108|NCT04374253|364373469|FG003|Overall Study|Study terminated by sponsor|567|||
105648109|NCT04374253|364373466|FG000|Overall Study|Withdrawal by Subject|0|||
105648110|NCT04374253|364373467|FG001|Overall Study|Withdrawal by Subject|55|||
105648111|NCT04374253|364373468|FG002|Overall Study|Withdrawal by Subject|3|||
105648112|NCT04374253|364373469|FG003|Overall Study|Withdrawal by Subject|40|||
105648113|NCT04374253|364373466|FG000|Overall Study|Physician Decision|1|||
105648114|NCT04374253|364373467|FG001|Overall Study|Physician Decision|10|||
105648115|NCT04374253|364373468|FG002|Overall Study|Physician Decision|1|||
105648116|NCT04374253|364373469|FG003|Overall Study|Physician Decision|10|||
105648117|NCT04374253|364373466|FG000|Overall Study|Protocol Violation|0|||
105648118|NCT04374253|364373467|FG001|Overall Study|Protocol Violation|0|||
105648119|NCT04374253|364373468|FG002|Overall Study|Protocol Violation|0|||
105648120|NCT04374253|364373469|FG003|Overall Study|Protocol Violation|2|||
105648121|NCT04374253|364373466|FG000|Overall Study|Death|0|||
105648122|NCT04374253|364373467|FG001|Overall Study|Death|3|||
105648123|NCT04374253|364373468|FG002|Overall Study|Death|1|||
105648124|NCT04374253|364373469|FG003|Overall Study|Death|1|||
105648125|NCT04374253|364373466|FG000|Overall Study|Lack of Efficacy|0|||
105648126|NCT04374253|364373467|FG001|Overall Study|Lack of Efficacy|0|||
105648127|NCT04374253|364373468|FG002|Overall Study|Lack of Efficacy|0|||
105648128|NCT04374253|364373469|FG003|Overall Study|Lack of Efficacy|1|||
105648129|NCT04374253|364373466|FG000|Overall Study|Lost to Follow-up|1|||
105648130|NCT04374253|364373467|FG001|Overall Study|Lost to Follow-up|1|||
105648131|NCT04374253|364373468|FG002|Overall Study|Lost to Follow-up|0|||
105648132|NCT04374253|364373469|FG003|Overall Study|Lost to Follow-up|2|||
105648133|NCT04374253|364373466|FG000|Overall Study|Reason Not Specified|0|||
105648134|NCT04374253|364373467|FG001|Overall Study|Reason Not Specified|8|||
105648135|NCT04374253|364373468|FG002|Overall Study|Reason Not Specified|0|||
105648136|NCT04374253|364373469|FG003|Overall Study|Reason Not Specified|8|||
105648137|NCT04413149|364374842|FG000|Overall Study|Death|10|||
105648138|NCT04413149|364374843|FG001|Overall Study|Death|5|||
105648139|NCT04413149|364374842|FG000|Overall Study|Lung transplantation|1|||
105648140|NCT04413149|364374843|FG001|Overall Study|Lung transplantation|0|||
105648141|NCT02878590|364374844|FG000|Overall Study|Withdrawal by Subject|2|||
105648142|NCT01730118|364374845|FG000|Dose Escalation|Death on study|5|||
105648143|NCT01730118|364374846|FG001|Dose Escalation|Death on study|7|||
105648144|NCT01730118|364374847|FG002|Dose Escalation|Death on study|2|||
105648145|NCT01730118|364374848|FG003|Dose Escalation|Death on study|6|||
105648146|NCT01730118|364374849|FG004|Dose Escalation|Death on study|0|||
105648147|NCT01730118|364374850|FG005|Dose Escalation|Death on study|0|||
105648148|NCT01730118|364374851|FG006|Dose Escalation|Death on study|0|||
105648149|NCT01730118|364374845|FG000|Dose Escalation|Died before treatment|0|||
105648150|NCT01730118|364374846|FG001|Dose Escalation|Died before treatment|0|||
105648151|NCT01730118|364374847|FG002|Dose Escalation|Died before treatment|0|||
105648152|NCT01730118|364374848|FG003|Dose Escalation|Died before treatment|0|||
105648153|NCT01730118|364374849|FG004|Dose Escalation|Died before treatment|0|||
105648154|NCT01730118|364374850|FG005|Dose Escalation|Died before treatment|0|||
105440143|NCT00930553|363616707|FG000|Overall Study|Lost to Follow-up|25|||
105648155|NCT01730118|364374851|FG006|Dose Escalation|Died before treatment|1|||
105648156|NCT01730118|364374845|FG000|Dose Escalation|Chose to start a different treatment|1|||
105648157|NCT01730118|364374846|FG001|Dose Escalation|Chose to start a different treatment|0|||
105648158|NCT01730118|364374847|FG002|Dose Escalation|Chose to start a different treatment|0|||
105648159|NCT01730118|364374848|FG003|Dose Escalation|Chose to start a different treatment|0|||
105648160|NCT01730118|364374849|FG004|Dose Escalation|Chose to start a different treatment|0|||
105648161|NCT01730118|364374850|FG005|Dose Escalation|Chose to start a different treatment|0|||
105648162|NCT01730118|364374851|FG006|Dose Escalation|Chose to start a different treatment|0|||
105648163|NCT01730118|364374845|FG000|Dose Escalation|Withdrawal by Subject|0|||
105648164|NCT01730118|364374846|FG001|Dose Escalation|Withdrawal by Subject|0|||
105648165|NCT01730118|364374847|FG002|Dose Escalation|Withdrawal by Subject|1|||
105648166|NCT01730118|364374848|FG003|Dose Escalation|Withdrawal by Subject|0|||
105648167|NCT01730118|364374849|FG004|Dose Escalation|Withdrawal by Subject|0|||
105648168|NCT01730118|364374850|FG005|Dose Escalation|Withdrawal by Subject|0|||
105648169|NCT01730118|364374851|FG006|Dose Escalation|Withdrawal by Subject|0|||
105648170|NCT01730118|364374845|FG000|Dose Escalation|Disease progression prior to treatment|0|||
105648171|NCT01730118|364374846|FG001|Dose Escalation|Disease progression prior to treatment|0|||
105648172|NCT01730118|364374847|FG002|Dose Escalation|Disease progression prior to treatment|0|||
105648173|NCT01730118|364374848|FG003|Dose Escalation|Disease progression prior to treatment|0|||
105648174|NCT01730118|364374849|FG004|Dose Escalation|Disease progression prior to treatment|0|||
105648175|NCT01730118|364374850|FG005|Dose Escalation|Disease progression prior to treatment|0|||
105648176|NCT01730118|364374851|FG006|Dose Escalation|Disease progression prior to treatment|1|||
105648177|NCT01730118|364374845|FG000|Dose Expansion|Death|0|||
105648178|NCT01730118|364374846|FG001|Dose Expansion|Death|0|||
105648179|NCT01730118|364374847|FG002|Dose Expansion|Death|0|||
105648180|NCT01730118|364374848|FG003|Dose Expansion|Death|0|||
105648181|NCT01730118|364374849|FG004|Dose Expansion|Death|1|||
105648182|NCT01730118|364374850|FG005|Dose Expansion|Death|0|||
105648183|NCT01730118|364374851|FG006|Dose Expansion|Death|0|||
105648184|NCT01730118|364374845|FG000|Dose Expansion|Other medical condition|0|||
105648185|NCT01730118|364374846|FG001|Dose Expansion|Other medical condition|0|||
105648186|NCT01730118|364374847|FG002|Dose Expansion|Other medical condition|0|||
105648187|NCT01730118|364374848|FG003|Dose Expansion|Other medical condition|0|||
105648188|NCT01730118|364374849|FG004|Dose Expansion|Other medical condition|1|||
105648189|NCT01730118|364374850|FG005|Dose Expansion|Other medical condition|0|||
105648190|NCT01730118|364374851|FG006|Dose Expansion|Other medical condition|0|||
105648191|NCT01730118|364374845|FG000|Dose Expansion|Withdrawal by Subject|0|||
105648192|NCT01730118|364374846|FG001|Dose Expansion|Withdrawal by Subject|0|||
105648193|NCT01730118|364374847|FG002|Dose Expansion|Withdrawal by Subject|0|||
105648194|NCT01730118|364374848|FG003|Dose Expansion|Withdrawal by Subject|0|||
105648195|NCT01730118|364374849|FG004|Dose Expansion|Withdrawal by Subject|1|||
105648196|NCT01730118|364374850|FG005|Dose Expansion|Withdrawal by Subject|0|||
105648197|NCT01730118|364374851|FG006|Dose Expansion|Withdrawal by Subject|0|||
105648198|NCT01730118|364374845|FG000|Dose Expansion|Disease progression|0|||
105648199|NCT01730118|364374846|FG001|Dose Expansion|Disease progression|0|||
105648200|NCT01730118|364374847|FG002|Dose Expansion|Disease progression|0|||
105648201|NCT01730118|364374848|FG003|Dose Expansion|Disease progression|0|||
105648202|NCT01730118|364374849|FG004|Dose Expansion|Disease progression|0|||
105648203|NCT01730118|364374850|FG005|Dose Expansion|Disease progression|1|||
105648204|NCT01730118|364374851|FG006|Dose Expansion|Disease progression|0|||
105648205|NCT01730118|364374845|FG000|Dose Expansion|Inability to return|0|||
105648206|NCT01730118|364374846|FG001|Dose Expansion|Inability to return|0|||
105648207|NCT01730118|364374847|FG002|Dose Expansion|Inability to return|0|||
105648208|NCT01730118|364374848|FG003|Dose Expansion|Inability to return|0|||
105648209|NCT01730118|364374849|FG004|Dose Expansion|Inability to return|0|||
105648210|NCT01730118|364374850|FG005|Dose Expansion|Inability to return|1|||
105648211|NCT01730118|364374851|FG006|Dose Expansion|Inability to return|0|||
105648212|NCT01730118|364374845|FG000|Dose Expansion|Physician Decision|0|||
105648213|NCT01730118|364374846|FG001|Dose Expansion|Physician Decision|0|||
105648214|NCT01730118|364374847|FG002|Dose Expansion|Physician Decision|0|||
105648215|NCT01730118|364374848|FG003|Dose Expansion|Physician Decision|0|||
105648216|NCT01730118|364374849|FG004|Dose Expansion|Physician Decision|0|||
105648217|NCT01730118|364374850|FG005|Dose Expansion|Physician Decision|1|||
105648218|NCT01730118|364374851|FG006|Dose Expansion|Physician Decision|0|||
105648219|NCT05066230|364374853|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
105648220|NCT05066230|364374854|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
105648221|NCT05066230|364374853|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
105648222|NCT05066230|364374854|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
105648223|NCT05066230|364374853|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
105648224|NCT05066230|364374854|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
105648225|NCT05066230|364374853|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
105648226|NCT05066230|364374854|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
105648227|NCT05066230|364374853|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
105648228|NCT05066230|364374854|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
105648229|NCT05066230|364374853|FG000|After Week 48|Adverse Event|1|||
105648230|NCT05066230|364374854|FG001|After Week 48|Adverse Event|0|||
105648231|NCT05066230|364374853|FG000|After Week 48|Non-compliance with study schedule|1|||
105648232|NCT05066230|364374854|FG001|After Week 48|Non-compliance with study schedule|0|||
105648233|NCT05066230|364374853|FG000|After Week 48|Withdrawal by Subject|0|||
105648234|NCT05066230|364374854|FG001|After Week 48|Withdrawal by Subject|1|||
105648235|NCT05066230|364374853|FG000|After Week 48|Lost to Follow-up|3|||
105648236|NCT05066230|364374854|FG001|After Week 48|Lost to Follow-up|3|||
105648237|NCT05066230|364374853|FG000|After Week 48|Sponsor Request|115|||
105648238|NCT05066230|364374854|FG001|After Week 48|Sponsor Request|111|||
105648239|NCT04523571|364374855|FG000|Received 2 Doses|Withdrawal by Subject|0|||
105648240|NCT04523571|364374856|FG001|Received 2 Doses|Withdrawal by Subject|0|||
105648241|NCT04523571|364374857|FG002|Received 2 Doses|Withdrawal by Subject|0|||
105648242|NCT04523571|364374858|FG003|Received 2 Doses|Withdrawal by Subject|1|||
105648243|NCT04523571|364374859|FG004|Received 2 Doses|Withdrawal by Subject|1|||
105648244|NCT04523571|364374860|FG005|Received 2 Doses|Withdrawal by Subject|0|||
105648245|NCT04523571|364374855|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
105648246|NCT04523571|364374856|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
105648247|NCT04523571|364374857|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
105648248|NCT04523571|364374858|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
105648249|NCT04523571|364374859|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
105648250|NCT04523571|364374860|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
105648251|NCT04523571|364374855|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
105648252|NCT04523571|364374856|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
105648253|NCT04523571|364374857|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
105648254|NCT04523571|364374858|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
105648255|NCT04523571|364374859|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
105648256|NCT04523571|364374860|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
105648257|NCT04523571|364374855|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
105648258|NCT04523571|364374856|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
105648259|NCT04523571|364374857|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
105648260|NCT04523571|364374858|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
105648261|NCT04523571|364374859|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
105648262|NCT04523571|364374860|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
105648263|NCT00515112|364374861|FG000|Overall Study|Death|0|||
105648264|NCT00515112|364374862|FG001|Overall Study|Death|1|||
105648265|NCT00515112|364374861|FG000|Overall Study|The study was terminated|3|||
105648266|NCT00515112|364374862|FG001|Overall Study|The study was terminated|2|||
105648267|NCT01375777|364374869|FG000|Overall Study|Withdrawal by Subject|0|||
105648268|NCT01375777|364374870|FG001|Overall Study|Withdrawal by Subject|2|||
105648269|NCT01375777|364374871|FG002|Overall Study|Withdrawal by Subject|1|||
105648270|NCT01375777|364374872|FG003|Overall Study|Withdrawal by Subject|0|||
105648271|NCT01375777|364374873|FG004|Overall Study|Withdrawal by Subject|1|||
105648272|NCT01375777|364374874|FG005|Overall Study|Withdrawal by Subject|1|||
105648273|NCT01375777|364374875|FG006|Overall Study|Withdrawal by Subject|1|||
105648274|NCT01375777|364374876|FG007|Overall Study|Withdrawal by Subject|2|||
105648275|NCT01375777|364374877|FG008|Overall Study|Withdrawal by Subject|1|||
105648276|NCT01375777|364374869|FG000|Overall Study|Lost to Follow-up|1|||
105648277|NCT01375777|364374870|FG001|Overall Study|Lost to Follow-up|0|||
105648278|NCT01375777|364374871|FG002|Overall Study|Lost to Follow-up|0|||
105648279|NCT01375777|364374872|FG003|Overall Study|Lost to Follow-up|0|||
105648280|NCT01375777|364374873|FG004|Overall Study|Lost to Follow-up|0|||
105648281|NCT01375777|364374874|FG005|Overall Study|Lost to Follow-up|0|||
105648282|NCT01375777|364374875|FG006|Overall Study|Lost to Follow-up|1|||
105648283|NCT01375777|364374876|FG007|Overall Study|Lost to Follow-up|0|||
105648284|NCT01375777|364374877|FG008|Overall Study|Lost to Follow-up|0|||
105648285|NCT01375777|364374869|FG000|Overall Study|Other|1|||
105648286|NCT01375777|364374870|FG001|Overall Study|Other|1|||
105648287|NCT01375777|364374871|FG002|Overall Study|Other|0|||
105648288|NCT01375777|364374872|FG003|Overall Study|Other|0|||
105648289|NCT01375777|364374873|FG004|Overall Study|Other|0|||
105648290|NCT01375777|364374874|FG005|Overall Study|Other|0|||
105648291|NCT01375777|364374875|FG006|Overall Study|Other|0|||
105648292|NCT01375777|364374876|FG007|Overall Study|Other|0|||
105648293|NCT01375777|364374877|FG008|Overall Study|Other|1|||
105648294|NCT02409732|364374878|FG000|Overall Study|Withdrawal by Subject|4|||
105648295|NCT02409732|364374878|FG000|Overall Study|Lost to Follow-up|2|||
105648296|NCT01090076|364374879|FG000|Overall Study|Death|1|||
105648297|NCT01090076|364374880|FG001|Overall Study|Death|1|||
105648298|NCT01090076|364374879|FG000|Overall Study|Withdrawal by Subject|0|||
105648299|NCT01090076|364374880|FG001|Overall Study|Withdrawal by Subject|1|||
105648300|NCT01870999|364374882|FG000|Overall Study|Adverse Event|0|||
105648301|NCT01870999|364374883|FG001|Overall Study|Adverse Event|4|||
105648302|NCT01870999|364374884|FG002|Overall Study|Adverse Event|1|||
105648303|NCT01870999|364374882|FG000|Overall Study|Subject met withdrawal criteria|3|||
105648304|NCT01870999|364374883|FG001|Overall Study|Subject met withdrawal criteria|2|||
105648305|NCT01870999|364374884|FG002|Overall Study|Subject met withdrawal criteria|0|||
105648306|NCT01870999|364374882|FG000|Overall Study|Subject withdrawn by Investigator|1|||
105648307|NCT01870999|364374883|FG001|Overall Study|Subject withdrawn by Investigator|0|||
105648308|NCT01870999|364374884|FG002|Overall Study|Subject withdrawn by Investigator|0|||
105648309|NCT01870999|364374882|FG000|Overall Study|Withdrawal by Subject|0|||
105648310|NCT01870999|364374883|FG001|Overall Study|Withdrawal by Subject|2|||
105648311|NCT01870999|364374884|FG002|Overall Study|Withdrawal by Subject|5|||
105648312|NCT01870999|364374882|FG000|Overall Study|Protocol Violation|0|||
105648313|NCT01870999|364374883|FG001|Overall Study|Protocol Violation|0|||
105648314|NCT01870999|364374884|FG002|Overall Study|Protocol Violation|1|||
105648315|NCT03314233|364374888|FG000|Overall Study|No longer eligible at time of delivery|1|||
105648316|NCT01114217|364374889|FG000|Overall Study|Adverse Event|5|||
105648317|NCT01114217|364374890|FG001|Overall Study|Adverse Event|3|||
105648318|NCT01114217|364374889|FG000|Overall Study|Lost to Follow-up|17|||
105648319|NCT01114217|364374890|FG001|Overall Study|Lost to Follow-up|33|||
105648320|NCT01114217|364374889|FG000|Overall Study|Withdrawal by Subject|21|||
105648321|NCT01114217|364374890|FG001|Overall Study|Withdrawal by Subject|28|||
105648322|NCT01114217|364374889|FG000|Overall Study|Other-Clerical Error|3|||
105648323|NCT01114217|364374890|FG001|Overall Study|Other-Clerical Error|0|||
105648324|NCT01114217|364374889|FG000|Overall Study|Other-Early termination|6|||
105648325|NCT01114217|364374890|FG001|Overall Study|Other-Early termination|10|||
105648326|NCT01114217|364374889|FG000|Overall Study|Other-Procedure|1|||
105648327|NCT01114217|364374890|FG001|Overall Study|Other-Procedure|1|||
105648328|NCT01114217|364374889|FG000|Overall Study|Other-Pregnancy|2|||
105648329|NCT01114217|364374890|FG001|Overall Study|Other-Pregnancy|4|||
105648330|NCT01114217|364374889|FG000|Overall Study|Other-Protocol Violation|1|||
105648331|NCT01114217|364374890|FG001|Overall Study|Other-Protocol Violation|3|||
105648332|NCT01114217|364374889|FG000|Overall Study|Other-Lack of Efficacy|1|||
105648333|NCT01114217|364374890|FG001|Overall Study|Other-Lack of Efficacy|0|||
105648334|NCT01114217|364374889|FG000|Overall Study|Other-Non Compliance|2|||
105648335|NCT01114217|364374890|FG001|Overall Study|Other-Non Compliance|0|||
105648336|NCT01114217|364374889|FG000|Overall Study|Other-Physician Decision|1|||
105648337|NCT01114217|364374890|FG001|Overall Study|Other-Physician Decision|1|||
105648338|NCT01114217|364374889|FG000|Overall Study|Other-Sponsor Decision|10|||
105648339|NCT01114217|364374890|FG001|Overall Study|Other-Sponsor Decision|12|||
105648340|NCT01114217|364374889|FG000|Overall Study|Other-Study Termination|0|||
105648341|NCT01114217|364374890|FG001|Overall Study|Other-Study Termination|1|||
105648342|NCT01114217|364374889|FG000|Overall Study|Other-Study Withdrawn|1|||
105648343|NCT01114217|364374890|FG001|Overall Study|Other-Study Withdrawn|1|||
105648344|NCT01114217|364374889|FG000|Overall Study|Other-Site Stopped Communicating|2|||
105648345|NCT01114217|364374890|FG001|Overall Study|Other-Site Stopped Communicating|0|||
105648346|NCT01114217|364374889|FG000|Overall Study|Other-Lost to Follow-up|1|||
105648347|NCT01114217|364374890|FG001|Overall Study|Other-Lost to Follow-up|0|||
105648348|NCT01114217|364374889|FG000|Overall Study|Other-Withdrawal by Subject|1|||
105648349|NCT01114217|364374890|FG001|Overall Study|Other-Withdrawal by Subject|1|||
105648350|NCT02465866|364374895|FG000|Period 3|Withdrawal by Subject|0|||
105648351|NCT02465866|364374896|FG001|Period 3|Withdrawal by Subject|1|||
105648352|NCT02465866|364374897|FG002|Period 3|Withdrawal by Subject|0|||
105648353|NCT02465866|364374898|FG003|Period 3|Withdrawal by Subject|0|||
105648354|NCT01757171|364374899|FG000|Overall Study|Adverse Event|5|||
105648355|NCT01757171|364374900|FG001|Overall Study|Adverse Event|1|||
105648356|NCT01757171|364374899|FG000|Overall Study|Disease Progression|1|||
105648357|NCT01757171|364374900|FG001|Overall Study|Disease Progression|0|||
105648358|NCT01757171|364374899|FG000|Overall Study|Hospitalization|1|||
105648359|NCT01757171|364374900|FG001|Overall Study|Hospitalization|0|||
105648360|NCT01757171|364374899|FG000|Overall Study|ECOG decline|1|||
105648361|NCT01757171|364374900|FG001|Overall Study|ECOG decline|0|||
105648362|NCT01446042|364374905|FG000|Overall Study|Withdrawal by Subject|12|||
105648363|NCT01446042|364374906|FG001|Overall Study|Withdrawal by Subject|2|||
105648364|NCT01446042|364374907|FG002|Overall Study|Withdrawal by Subject|4|||
105648365|NCT01446042|364374905|FG000|Overall Study|Adverse Event|1|||
105648366|NCT01446042|364374906|FG001|Overall Study|Adverse Event|0|||
105648367|NCT01446042|364374907|FG002|Overall Study|Adverse Event|4|||
105648368|NCT01446042|364374905|FG000|Overall Study|Lost to Follow-up|5|||
105648369|NCT01446042|364374906|FG001|Overall Study|Lost to Follow-up|0|||
105648370|NCT01446042|364374907|FG002|Overall Study|Lost to Follow-up|0|||
105648371|NCT01446042|364374905|FG000|Overall Study|Other reasons|2|||
105648372|NCT01446042|364374906|FG001|Overall Study|Other reasons|1|||
105648373|NCT01446042|364374907|FG002|Overall Study|Other reasons|1|||
105648374|NCT03751280|364374911|FG000|Overall Study|Adverse Event|0|||
105648375|NCT03751280|364374912|FG001|Overall Study|Adverse Event|1|||
105648376|NCT03751280|364374911|FG000|Overall Study|Lost to Follow-up|3|||
105648377|NCT03751280|364374912|FG001|Overall Study|Lost to Follow-up|5|||
105648378|NCT03751280|364374911|FG000|Overall Study|Physician Decision|0|||
105648379|NCT03751280|364374912|FG001|Overall Study|Physician Decision|2|||
105648380|NCT03751280|364374911|FG000|Overall Study|Protocol Violation|0|||
105648381|NCT03751280|364374912|FG001|Overall Study|Protocol Violation|2|||
105648382|NCT03751280|364374911|FG000|Overall Study|Withdrawal by Subject|5|||
105648383|NCT03751280|364374912|FG001|Overall Study|Withdrawal by Subject|2|||
105648384|NCT00460577|364374914|FG000|Overall Study|Protocol Violation|2|||
105648385|NCT00460577|364374915|FG001|Overall Study|Protocol Violation|6|||
105648386|NCT00296504|364374916|FG000|Interim Analysis|Withdrawal by Subject|8|||
105648387|NCT00296504|364374917|FG001|Interim Analysis|Withdrawal by Subject|0|||
105648388|NCT00296504|364374918|FG002|Interim Analysis|Withdrawal by Subject|12|||
105648389|NCT00296504|364374919|FG003|Interim Analysis|Withdrawal by Subject|0|||
105648390|NCT00296504|364374920|FG004|Interim Analysis|Withdrawal by Subject|5|||
105648391|NCT00296504|364374921|FG005|Interim Analysis|Withdrawal by Subject|5|||
105648392|NCT00296504|364374922|FG006|Interim Analysis|Withdrawal by Subject|9|||
105648393|NCT00296504|364374923|FG007|Interim Analysis|Withdrawal by Subject|3|||
105648394|NCT00296504|364374924|FG008|Interim Analysis|Withdrawal by Subject|0|||
105648395|NCT00296504|364374916|FG000|Interim Analysis|Lost to Follow-up|13|||
105648396|NCT00296504|364374917|FG001|Interim Analysis|Lost to Follow-up|3|||
105648397|NCT00296504|364374918|FG002|Interim Analysis|Lost to Follow-up|26|||
105648398|NCT00296504|364374919|FG003|Interim Analysis|Lost to Follow-up|8|||
105648399|NCT00296504|364374920|FG004|Interim Analysis|Lost to Follow-up|14|||
105648400|NCT00296504|364374921|FG005|Interim Analysis|Lost to Follow-up|4|||
105648401|NCT00296504|364374922|FG006|Interim Analysis|Lost to Follow-up|11|||
105648402|NCT00296504|364374923|FG007|Interim Analysis|Lost to Follow-up|4|||
105648403|NCT00296504|364374924|FG008|Interim Analysis|Lost to Follow-up|0|||
105648404|NCT00296504|364374916|FG000|Interim Analysis|Clinical Progression|1|||
105648405|NCT00296504|364374917|FG001|Interim Analysis|Clinical Progression|0|||
105648406|NCT00296504|364374918|FG002|Interim Analysis|Clinical Progression|1|||
105648407|NCT00296504|364374919|FG003|Interim Analysis|Clinical Progression|1|||
105648408|NCT00296504|364374920|FG004|Interim Analysis|Clinical Progression|0|||
105648409|NCT00296504|364374921|FG005|Interim Analysis|Clinical Progression|2|||
105648410|NCT00296504|364374922|FG006|Interim Analysis|Clinical Progression|1|||
105648411|NCT00296504|364374923|FG007|Interim Analysis|Clinical Progression|2|||
105648412|NCT00296504|364374924|FG008|Interim Analysis|Clinical Progression|0|||
105648413|NCT00296504|364374916|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
105648414|NCT00296504|364374917|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
105648415|NCT00296504|364374918|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
105648416|NCT00296504|364374919|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
105648417|NCT00296504|364374920|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
105648418|NCT00296504|364374921|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
105648419|NCT00296504|364374922|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
105648420|NCT00296504|364374923|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
105648421|NCT00296504|364374924|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
105648422|NCT00296504|364374916|FG000|Interim Analysis|Adverse Event|0|||
105648423|NCT00296504|364374917|FG001|Interim Analysis|Adverse Event|0|||
105648424|NCT00296504|364374918|FG002|Interim Analysis|Adverse Event|13|||
105648425|NCT00296504|364374919|FG003|Interim Analysis|Adverse Event|4|||
105648426|NCT00296504|364374920|FG004|Interim Analysis|Adverse Event|6|||
105648427|NCT00296504|364374921|FG005|Interim Analysis|Adverse Event|3|||
105648428|NCT00296504|364374922|FG006|Interim Analysis|Adverse Event|4|||
105648429|NCT00296504|364374923|FG007|Interim Analysis|Adverse Event|5|||
105648430|NCT00296504|364374924|FG008|Interim Analysis|Adverse Event|0|||
105648431|NCT00296504|364374916|FG000|Interim Analysis|Protocol Violation|0|||
105648432|NCT00296504|364374917|FG001|Interim Analysis|Protocol Violation|0|||
105648433|NCT00296504|364374918|FG002|Interim Analysis|Protocol Violation|2|||
105648434|NCT00296504|364374919|FG003|Interim Analysis|Protocol Violation|0|||
105648435|NCT00296504|364374920|FG004|Interim Analysis|Protocol Violation|1|||
105648436|NCT00296504|364374921|FG005|Interim Analysis|Protocol Violation|0|||
105648437|NCT00296504|364374922|FG006|Interim Analysis|Protocol Violation|0|||
105648438|NCT00296504|364374923|FG007|Interim Analysis|Protocol Violation|1|||
105648439|NCT00296504|364374924|FG008|Interim Analysis|Protocol Violation|0|||
105648440|NCT00296504|364374916|FG000|Interim Analysis|Insufficient CD4 Response|0|||
105648441|NCT00296504|364374917|FG001|Interim Analysis|Insufficient CD4 Response|0|||
105648442|NCT00296504|364374918|FG002|Interim Analysis|Insufficient CD4 Response|0|||
105648443|NCT00296504|364374919|FG003|Interim Analysis|Insufficient CD4 Response|0|||
105648444|NCT00296504|364374920|FG004|Interim Analysis|Insufficient CD4 Response|1|||
105648445|NCT00296504|364374921|FG005|Interim Analysis|Insufficient CD4 Response|1|||
105648446|NCT00296504|364374922|FG006|Interim Analysis|Insufficient CD4 Response|0|||
105648447|NCT00296504|364374923|FG007|Interim Analysis|Insufficient CD4 Response|0|||
105648448|NCT00296504|364374924|FG008|Interim Analysis|Insufficient CD4 Response|0|||
105648449|NCT00296504|364374916|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
105648450|NCT00296504|364374917|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
105648451|NCT00296504|364374918|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
105648452|NCT00296504|364374919|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
105648453|NCT00296504|364374920|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
105648454|NCT00296504|364374921|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
105648455|NCT00296504|364374922|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
105648456|NCT00296504|364374923|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
105648457|NCT00296504|364374924|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
105648458|NCT00296504|364374916|FG000|Interim Analysis|Pregnancy|4|||
105648459|NCT00296504|364374917|FG001|Interim Analysis|Pregnancy|1|||
105648460|NCT00296504|364374918|FG002|Interim Analysis|Pregnancy|4|||
105648461|NCT00296504|364374919|FG003|Interim Analysis|Pregnancy|2|||
105648462|NCT00296504|364374920|FG004|Interim Analysis|Pregnancy|0|||
105648463|NCT00296504|364374921|FG005|Interim Analysis|Pregnancy|1|||
105648464|NCT00296504|364374922|FG006|Interim Analysis|Pregnancy|1|||
105648465|NCT00296504|364374923|FG007|Interim Analysis|Pregnancy|1|||
105648466|NCT00296504|364374924|FG008|Interim Analysis|Pregnancy|0|||
105648467|NCT00296504|364374916|FG000|Interim Analysis|Death|1|||
105648468|NCT00296504|364374917|FG001|Interim Analysis|Death|0|||
105648469|NCT00296504|364374918|FG002|Interim Analysis|Death|3|||
105648470|NCT00296504|364374919|FG003|Interim Analysis|Death|0|||
105648471|NCT00296504|364374920|FG004|Interim Analysis|Death|0|||
105648472|NCT00296504|364374921|FG005|Interim Analysis|Death|0|||
105648473|NCT00296504|364374922|FG006|Interim Analysis|Death|0|||
105648474|NCT00296504|364374923|FG007|Interim Analysis|Death|0|||
105648475|NCT00296504|364374924|FG008|Interim Analysis|Death|0|||
105648476|NCT00296504|364374916|FG000|Interim Analysis|Participant Non-compliant|0|||
105648477|NCT00296504|364374917|FG001|Interim Analysis|Participant Non-compliant|1|||
105648478|NCT00296504|364374918|FG002|Interim Analysis|Participant Non-compliant|2|||
105648479|NCT00296504|364374919|FG003|Interim Analysis|Participant Non-compliant|1|||
105648480|NCT00296504|364374920|FG004|Interim Analysis|Participant Non-compliant|1|||
105648481|NCT00296504|364374921|FG005|Interim Analysis|Participant Non-compliant|3|||
105648482|NCT00296504|364374922|FG006|Interim Analysis|Participant Non-compliant|6|||
105648483|NCT00296504|364374923|FG007|Interim Analysis|Participant Non-compliant|2|||
105648484|NCT00296504|364374924|FG008|Interim Analysis|Participant Non-compliant|0|||
105648485|NCT00296504|364374916|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
105648486|NCT00296504|364374917|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
105648487|NCT00296504|364374918|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
105648488|NCT00296504|364374919|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
105648489|NCT00296504|364374920|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
105648490|NCT00296504|364374921|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
105648491|NCT00296504|364374922|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
105648492|NCT00296504|364374923|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
105648493|NCT00296504|364374924|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
105648494|NCT00296504|364374916|FG000|Interim Analysis|To Simplify Treatment|0|||
105648495|NCT00296504|364374917|FG001|Interim Analysis|To Simplify Treatment|0|||
105648496|NCT00296504|364374918|FG002|Interim Analysis|To Simplify Treatment|1|||
105648497|NCT00296504|364374919|FG003|Interim Analysis|To Simplify Treatment|0|||
105648498|NCT00296504|364374920|FG004|Interim Analysis|To Simplify Treatment|0|||
105648499|NCT00296504|364374921|FG005|Interim Analysis|To Simplify Treatment|0|||
105648500|NCT00296504|364374922|FG006|Interim Analysis|To Simplify Treatment|2|||
105648501|NCT00296504|364374923|FG007|Interim Analysis|To Simplify Treatment|0|||
105648502|NCT00296504|364374924|FG008|Interim Analysis|To Simplify Treatment|0|||
105648503|NCT00296504|364374916|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648504|NCT00296504|364374917|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648505|NCT00296504|364374918|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
105648506|NCT00296504|364374919|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648507|NCT00296504|364374920|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648508|NCT00296504|364374921|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648509|NCT00296504|364374922|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648510|NCT00296504|364374923|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648511|NCT00296504|364374924|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648512|NCT00296504|364374916|FG000|Interim Analysis|Participant Moved|1|||
105648513|NCT00296504|364374917|FG001|Interim Analysis|Participant Moved|0|||
105648514|NCT00296504|364374918|FG002|Interim Analysis|Participant Moved|1|||
105648515|NCT00296504|364374919|FG003|Interim Analysis|Participant Moved|0|||
105648516|NCT00296504|364374920|FG004|Interim Analysis|Participant Moved|0|||
105648517|NCT00296504|364374921|FG005|Interim Analysis|Participant Moved|1|||
105648518|NCT00296504|364374922|FG006|Interim Analysis|Participant Moved|1|||
105648519|NCT00296504|364374923|FG007|Interim Analysis|Participant Moved|0|||
105648520|NCT00296504|364374924|FG008|Interim Analysis|Participant Moved|0|||
105648521|NCT00296504|364374916|FG000|Interim Analysis|Participant Was Incarcerated|2|||
105648522|NCT00296504|364374917|FG001|Interim Analysis|Participant Was Incarcerated|0|||
105648523|NCT00296504|364374918|FG002|Interim Analysis|Participant Was Incarcerated|1|||
105648524|NCT00296504|364374919|FG003|Interim Analysis|Participant Was Incarcerated|0|||
105648525|NCT00296504|364374920|FG004|Interim Analysis|Participant Was Incarcerated|0|||
105648526|NCT00296504|364374921|FG005|Interim Analysis|Participant Was Incarcerated|0|||
105648527|NCT00296504|364374922|FG006|Interim Analysis|Participant Was Incarcerated|0|||
105648528|NCT00296504|364374923|FG007|Interim Analysis|Participant Was Incarcerated|0|||
105648529|NCT00296504|364374924|FG008|Interim Analysis|Participant Was Incarcerated|0|||
105648530|NCT00296504|364374916|FG000|Interim Analysis|Resistance to FPV|0|||
105648531|NCT00296504|364374917|FG001|Interim Analysis|Resistance to FPV|0|||
105648532|NCT00296504|364374918|FG002|Interim Analysis|Resistance to FPV|1|||
105648533|NCT00296504|364374919|FG003|Interim Analysis|Resistance to FPV|0|||
105648534|NCT00296504|364374920|FG004|Interim Analysis|Resistance to FPV|0|||
105648535|NCT00296504|364374921|FG005|Interim Analysis|Resistance to FPV|0|||
105648536|NCT00296504|364374922|FG006|Interim Analysis|Resistance to FPV|0|||
105648537|NCT00296504|364374923|FG007|Interim Analysis|Resistance to FPV|0|||
105648538|NCT00296504|364374924|FG008|Interim Analysis|Resistance to FPV|0|||
105648539|NCT00296504|364374916|FG000|Interim Analysis|Physician Decision|0|||
105648540|NCT00296504|364374917|FG001|Interim Analysis|Physician Decision|0|||
105648541|NCT00296504|364374918|FG002|Interim Analysis|Physician Decision|1|||
105648542|NCT00296504|364374919|FG003|Interim Analysis|Physician Decision|0|||
105648543|NCT00296504|364374920|FG004|Interim Analysis|Physician Decision|0|||
105648544|NCT00296504|364374921|FG005|Interim Analysis|Physician Decision|0|||
105648545|NCT00296504|364374922|FG006|Interim Analysis|Physician Decision|0|||
105648546|NCT00296504|364374923|FG007|Interim Analysis|Physician Decision|0|||
105648547|NCT00296504|364374924|FG008|Interim Analysis|Physician Decision|0|||
105648548|NCT00296504|364374916|FG000|Interim Analysis|Principle Investigator Discretion|2|||
105648549|NCT00296504|364374917|FG001|Interim Analysis|Principle Investigator Discretion|0|||
105648550|NCT00296504|364374918|FG002|Interim Analysis|Principle Investigator Discretion|1|||
105648551|NCT00296504|364374919|FG003|Interim Analysis|Principle Investigator Discretion|1|||
105648552|NCT00296504|364374920|FG004|Interim Analysis|Principle Investigator Discretion|0|||
105648553|NCT00296504|364374921|FG005|Interim Analysis|Principle Investigator Discretion|0|||
105648554|NCT00296504|364374922|FG006|Interim Analysis|Principle Investigator Discretion|0|||
105648555|NCT00296504|364374923|FG007|Interim Analysis|Principle Investigator Discretion|0|||
105648556|NCT00296504|364374924|FG008|Interim Analysis|Principle Investigator Discretion|0|||
105648557|NCT00296504|364374916|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
105648558|NCT00296504|364374917|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
105648559|NCT00296504|364374918|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
105648560|NCT00296504|364374919|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
105648561|NCT00296504|364374920|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
105648562|NCT00296504|364374921|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
105648563|NCT00296504|364374922|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
105648564|NCT00296504|364374923|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
105648565|NCT00296504|364374924|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
105648566|NCT00296504|364374916|FG000|Interim Analysis|Non-adherence|2|||
105648567|NCT00296504|364374917|FG001|Interim Analysis|Non-adherence|0|||
105648568|NCT00296504|364374918|FG002|Interim Analysis|Non-adherence|0|||
105648569|NCT00296504|364374919|FG003|Interim Analysis|Non-adherence|0|||
105648570|NCT00296504|364374920|FG004|Interim Analysis|Non-adherence|1|||
105648571|NCT00296504|364374921|FG005|Interim Analysis|Non-adherence|0|||
105648572|NCT00296504|364374922|FG006|Interim Analysis|Non-adherence|0|||
105648573|NCT00296504|364374923|FG007|Interim Analysis|Non-adherence|1|||
105648574|NCT00296504|364374924|FG008|Interim Analysis|Non-adherence|0|||
105648575|NCT00296504|364374916|FG000|Interim Analysis|Site Closing|1|||
105648576|NCT00296504|364374917|FG001|Interim Analysis|Site Closing|0|||
105648577|NCT00296504|364374918|FG002|Interim Analysis|Site Closing|0|||
105648578|NCT00296504|364374919|FG003|Interim Analysis|Site Closing|0|||
105648579|NCT00296504|364374920|FG004|Interim Analysis|Site Closing|0|||
105648580|NCT00296504|364374921|FG005|Interim Analysis|Site Closing|1|||
105648581|NCT00296504|364374922|FG006|Interim Analysis|Site Closing|2|||
105648582|NCT00296504|364374923|FG007|Interim Analysis|Site Closing|0|||
105648583|NCT00296504|364374924|FG008|Interim Analysis|Site Closing|0|||
105648584|NCT00296504|364374916|FG000|Interim Analysis|Lack of Personnel at Site|1|||
105648585|NCT00296504|364374917|FG001|Interim Analysis|Lack of Personnel at Site|0|||
105648586|NCT00296504|364374918|FG002|Interim Analysis|Lack of Personnel at Site|0|||
105648587|NCT00296504|364374919|FG003|Interim Analysis|Lack of Personnel at Site|0|||
105648588|NCT00296504|364374920|FG004|Interim Analysis|Lack of Personnel at Site|0|||
105648589|NCT00296504|364374921|FG005|Interim Analysis|Lack of Personnel at Site|0|||
105648590|NCT00296504|364374922|FG006|Interim Analysis|Lack of Personnel at Site|0|||
105648591|NCT00296504|364374923|FG007|Interim Analysis|Lack of Personnel at Site|0|||
105648592|NCT00296504|364374924|FG008|Interim Analysis|Lack of Personnel at Site|0|||
105648593|NCT00296504|364374916|FG000|Interim Analysis|Missed Schedule Date|1|||
105648594|NCT00296504|364374917|FG001|Interim Analysis|Missed Schedule Date|0|||
105648595|NCT00296504|364374918|FG002|Interim Analysis|Missed Schedule Date|0|||
105648596|NCT00296504|364374919|FG003|Interim Analysis|Missed Schedule Date|0|||
105648597|NCT00296504|364374920|FG004|Interim Analysis|Missed Schedule Date|0|||
105440144|NCT00930553|363616707|FG000|Overall Study|Death|9|||
105648598|NCT00296504|364374921|FG005|Interim Analysis|Missed Schedule Date|0|||
105648599|NCT00296504|364374922|FG006|Interim Analysis|Missed Schedule Date|0|||
105648600|NCT00296504|364374923|FG007|Interim Analysis|Missed Schedule Date|0|||
105648601|NCT00296504|364374924|FG008|Interim Analysis|Missed Schedule Date|0|||
105648602|NCT00296504|364374916|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
105648603|NCT00296504|364374917|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
105648604|NCT00296504|364374918|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
105648605|NCT00296504|364374919|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
105648606|NCT00296504|364374920|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
105648607|NCT00296504|364374921|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
105648608|NCT00296504|364374922|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
105648609|NCT00296504|364374923|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
105648610|NCT00296504|364374924|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
105648611|NCT00296504|364374916|FG000|Interim Analysis|Participant Stopped|0|||
105648612|NCT00296504|364374917|FG001|Interim Analysis|Participant Stopped|0|||
105648613|NCT00296504|364374918|FG002|Interim Analysis|Participant Stopped|0|||
105648614|NCT00296504|364374919|FG003|Interim Analysis|Participant Stopped|0|||
105648615|NCT00296504|364374920|FG004|Interim Analysis|Participant Stopped|1|||
105648616|NCT00296504|364374921|FG005|Interim Analysis|Participant Stopped|0|||
105648617|NCT00296504|364374922|FG006|Interim Analysis|Participant Stopped|0|||
105648618|NCT00296504|364374923|FG007|Interim Analysis|Participant Stopped|0|||
105648619|NCT00296504|364374924|FG008|Interim Analysis|Participant Stopped|0|||
105648620|NCT00296504|364374916|FG000|Interim Analysis|Physician and Participant Decision|0|||
105648621|NCT00296504|364374917|FG001|Interim Analysis|Physician and Participant Decision|0|||
105648622|NCT00296504|364374918|FG002|Interim Analysis|Physician and Participant Decision|0|||
105648623|NCT00296504|364374919|FG003|Interim Analysis|Physician and Participant Decision|0|||
105648624|NCT00296504|364374920|FG004|Interim Analysis|Physician and Participant Decision|0|||
105648625|NCT00296504|364374921|FG005|Interim Analysis|Physician and Participant Decision|1|||
105648626|NCT00296504|364374922|FG006|Interim Analysis|Physician and Participant Decision|0|||
105648627|NCT00296504|364374923|FG007|Interim Analysis|Physician and Participant Decision|0|||
105648628|NCT00296504|364374924|FG008|Interim Analysis|Physician and Participant Decision|0|||
105648629|NCT00296504|364374916|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
105648630|NCT00296504|364374917|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
105648631|NCT00296504|364374918|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
105648632|NCT00296504|364374919|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
105648633|NCT00296504|364374920|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
105648634|NCT00296504|364374921|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
105648635|NCT00296504|364374922|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
105648636|NCT00296504|364374923|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
105648637|NCT00296504|364374924|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
105648638|NCT00296504|364374916|FG000|Interim Analysis|Study Ended|0|||
105648639|NCT00296504|364374917|FG001|Interim Analysis|Study Ended|0|||
105648640|NCT00296504|364374918|FG002|Interim Analysis|Study Ended|0|||
105648641|NCT00296504|364374919|FG003|Interim Analysis|Study Ended|0|||
105648642|NCT00296504|364374920|FG004|Interim Analysis|Study Ended|0|||
105648643|NCT00296504|364374921|FG005|Interim Analysis|Study Ended|0|||
105648644|NCT00296504|364374922|FG006|Interim Analysis|Study Ended|1|||
105648645|NCT00296504|364374923|FG007|Interim Analysis|Study Ended|0|||
105648646|NCT00296504|364374924|FG008|Interim Analysis|Study Ended|0|||
105648647|NCT00296504|364374916|FG000|Interim Analysis|Participant Needed Interferon|0|||
105648648|NCT00296504|364374917|FG001|Interim Analysis|Participant Needed Interferon|0|||
105648649|NCT00296504|364374918|FG002|Interim Analysis|Participant Needed Interferon|0|||
105648650|NCT00296504|364374919|FG003|Interim Analysis|Participant Needed Interferon|0|||
105648651|NCT00296504|364374920|FG004|Interim Analysis|Participant Needed Interferon|0|||
105648652|NCT00296504|364374921|FG005|Interim Analysis|Participant Needed Interferon|0|||
105648653|NCT00296504|364374922|FG006|Interim Analysis|Participant Needed Interferon|0|||
105648654|NCT00296504|364374923|FG007|Interim Analysis|Participant Needed Interferon|1|||
105648655|NCT00296504|364374924|FG008|Interim Analysis|Participant Needed Interferon|0|||
105648656|NCT00296504|364374916|FG000|Interim Analysis|Ongoing|32|||
105648657|NCT00296504|364374917|FG001|Interim Analysis|Ongoing|12|||
105648658|NCT00296504|364374918|FG002|Interim Analysis|Ongoing|16|||
105648659|NCT00296504|364374919|FG003|Interim Analysis|Ongoing|22|||
105648660|NCT00296504|364374920|FG004|Interim Analysis|Ongoing|0|||
105648661|NCT00296504|364374921|FG005|Interim Analysis|Ongoing|0|||
105648662|NCT00296504|364374922|FG006|Interim Analysis|Ongoing|30|||
105648663|NCT00296504|364374923|FG007|Interim Analysis|Ongoing|1|||
105648664|NCT00296504|364374924|FG008|Interim Analysis|Ongoing|0|||
105648665|NCT00296504|364374916|FG000|Final Analysis|Withdrawal by Subject|0|||
105648666|NCT00296504|364374917|FG001|Final Analysis|Withdrawal by Subject|0|||
105648667|NCT00296504|364374918|FG002|Final Analysis|Withdrawal by Subject|0|||
105648668|NCT00296504|364374919|FG003|Final Analysis|Withdrawal by Subject|0|||
105648669|NCT00296504|364374920|FG004|Final Analysis|Withdrawal by Subject|0|||
105648670|NCT00296504|364374921|FG005|Final Analysis|Withdrawal by Subject|0|||
105648671|NCT00296504|364374922|FG006|Final Analysis|Withdrawal by Subject|0|||
105648672|NCT00296504|364374923|FG007|Final Analysis|Withdrawal by Subject|0|||
105648673|NCT00296504|364374924|FG008|Final Analysis|Withdrawal by Subject|1|||
105648674|NCT00296504|364374916|FG000|Final Analysis|Lost to Follow-up|0|||
105648675|NCT00296504|364374917|FG001|Final Analysis|Lost to Follow-up|0|||
105648676|NCT00296504|364374918|FG002|Final Analysis|Lost to Follow-up|0|||
105648677|NCT00296504|364374919|FG003|Final Analysis|Lost to Follow-up|0|||
105648678|NCT00296504|364374920|FG004|Final Analysis|Lost to Follow-up|0|||
105648679|NCT00296504|364374921|FG005|Final Analysis|Lost to Follow-up|0|||
105648680|NCT00296504|364374922|FG006|Final Analysis|Lost to Follow-up|0|||
105648681|NCT00296504|364374923|FG007|Final Analysis|Lost to Follow-up|0|||
105648682|NCT00296504|364374924|FG008|Final Analysis|Lost to Follow-up|5|||
105648683|NCT00296504|364374916|FG000|Final Analysis|Insufficient Viral Load Response|0|||
105648684|NCT00296504|364374917|FG001|Final Analysis|Insufficient Viral Load Response|0|||
105648685|NCT00296504|364374918|FG002|Final Analysis|Insufficient Viral Load Response|0|||
105648686|NCT00296504|364374919|FG003|Final Analysis|Insufficient Viral Load Response|0|||
105648687|NCT00296504|364374920|FG004|Final Analysis|Insufficient Viral Load Response|0|||
105648688|NCT00296504|364374921|FG005|Final Analysis|Insufficient Viral Load Response|0|||
105648689|NCT00296504|364374922|FG006|Final Analysis|Insufficient Viral Load Response|0|||
105648690|NCT00296504|364374923|FG007|Final Analysis|Insufficient Viral Load Response|0|||
105648691|NCT00296504|364374924|FG008|Final Analysis|Insufficient Viral Load Response|6|||
105648692|NCT00296504|364374916|FG000|Final Analysis|Adverse Event|0|||
105648693|NCT00296504|364374917|FG001|Final Analysis|Adverse Event|0|||
105648694|NCT00296504|364374918|FG002|Final Analysis|Adverse Event|0|||
105648695|NCT00296504|364374919|FG003|Final Analysis|Adverse Event|0|||
105648696|NCT00296504|364374920|FG004|Final Analysis|Adverse Event|0|||
105648697|NCT00296504|364374921|FG005|Final Analysis|Adverse Event|0|||
105648698|NCT00296504|364374922|FG006|Final Analysis|Adverse Event|0|||
105648699|NCT00296504|364374923|FG007|Final Analysis|Adverse Event|0|||
105648700|NCT00296504|364374924|FG008|Final Analysis|Adverse Event|2|||
105648701|NCT00296504|364374916|FG000|Final Analysis|Pregnancy|0|||
105648702|NCT00296504|364374917|FG001|Final Analysis|Pregnancy|0|||
105648703|NCT00296504|364374918|FG002|Final Analysis|Pregnancy|0|||
105648704|NCT00296504|364374919|FG003|Final Analysis|Pregnancy|0|||
105648705|NCT00296504|364374920|FG004|Final Analysis|Pregnancy|0|||
105648706|NCT00296504|364374921|FG005|Final Analysis|Pregnancy|0|||
105648707|NCT00296504|364374922|FG006|Final Analysis|Pregnancy|0|||
105648708|NCT00296504|364374923|FG007|Final Analysis|Pregnancy|0|||
105648709|NCT00296504|364374924|FG008|Final Analysis|Pregnancy|4|||
105648710|NCT00296504|364374916|FG000|Final Analysis|Tuberculosis|0|||
105648711|NCT00296504|364374917|FG001|Final Analysis|Tuberculosis|0|||
105648712|NCT00296504|364374918|FG002|Final Analysis|Tuberculosis|0|||
105648713|NCT00296504|364374919|FG003|Final Analysis|Tuberculosis|0|||
105648714|NCT00296504|364374920|FG004|Final Analysis|Tuberculosis|0|||
105648715|NCT00296504|364374921|FG005|Final Analysis|Tuberculosis|0|||
105648716|NCT00296504|364374922|FG006|Final Analysis|Tuberculosis|0|||
105648717|NCT00296504|364374923|FG007|Final Analysis|Tuberculosis|0|||
105648718|NCT00296504|364374924|FG008|Final Analysis|Tuberculosis|1|||
105648719|NCT00296504|364374916|FG000|Final Analysis|Participant Moved to Another Country|0|||
105648720|NCT00296504|364374917|FG001|Final Analysis|Participant Moved to Another Country|0|||
105648721|NCT00296504|364374918|FG002|Final Analysis|Participant Moved to Another Country|0|||
105648722|NCT00296504|364374919|FG003|Final Analysis|Participant Moved to Another Country|0|||
105648723|NCT00296504|364374920|FG004|Final Analysis|Participant Moved to Another Country|0|||
105648724|NCT00296504|364374921|FG005|Final Analysis|Participant Moved to Another Country|0|||
105648725|NCT00296504|364374922|FG006|Final Analysis|Participant Moved to Another Country|0|||
105648726|NCT00296504|364374923|FG007|Final Analysis|Participant Moved to Another Country|0|||
105648727|NCT00296504|364374924|FG008|Final Analysis|Participant Moved to Another Country|1|||
105648728|NCT00296504|364374916|FG000|Final Analysis|Poor Adherence|0|||
105648729|NCT00296504|364374917|FG001|Final Analysis|Poor Adherence|0|||
105648730|NCT00296504|364374918|FG002|Final Analysis|Poor Adherence|0|||
105648731|NCT00296504|364374919|FG003|Final Analysis|Poor Adherence|0|||
105648732|NCT00296504|364374920|FG004|Final Analysis|Poor Adherence|0|||
105648733|NCT00296504|364374921|FG005|Final Analysis|Poor Adherence|0|||
105648734|NCT00296504|364374922|FG006|Final Analysis|Poor Adherence|0|||
105648735|NCT00296504|364374923|FG007|Final Analysis|Poor Adherence|0|||
105648736|NCT00296504|364374924|FG008|Final Analysis|Poor Adherence|1|||
105648737|NCT01348763|364374930|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
105648738|NCT01348763|364374930|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
105648739|NCT02213458|364374941|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
105648740|NCT02213458|364374942|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
105648741|NCT02213458|364374941|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
105648742|NCT02213458|364374942|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
105648743|NCT02213458|364374941|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
105648744|NCT02213458|364374942|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
105648745|NCT02213458|364374941|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
105648746|NCT02213458|364374942|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
105648747|NCT02213458|364374941|FG000|Overall Study|Refused re-consent|6|||
105648748|NCT02213458|364374942|FG001|Overall Study|Refused re-consent|0|||
105648749|NCT02213458|364374941|FG000|Overall Study|Lost to Follow-up|2|||
105648750|NCT02213458|364374942|FG001|Overall Study|Lost to Follow-up|2|||
105648751|NCT02213458|364374941|FG000|Overall Study|Withdrawal by Subject|26|||
105648752|NCT02213458|364374942|FG001|Overall Study|Withdrawal by Subject|8|||
105648753|NCT01257698|364374944|FG000|Overall Study|Protocol Violation|4|||
105648754|NCT01257698|364374945|FG001|Overall Study|Protocol Violation|0|||
105648755|NCT03802513|364374946|FG000|Overall Study|Lost to Follow-up|1|||
105648756|NCT01622088|364374957|FG000|Overall Study|Adverse Event|20|||
105648757|NCT01622088|364374957|FG000|Overall Study|Lost to Follow-up|1|||
105648758|NCT01622088|364374957|FG000|Overall Study|Withdrawal by Subject|20|||
105648759|NCT01622088|364374957|FG000|Overall Study|Investigator Decision|1|||
105648760|NCT01622088|364374957|FG000|Overall Study|Death|53|||
105648761|NCT01622088|364374957|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
105648762|NCT03045302|364374958|FG000|Overall Study|Pre-treatment adverse event|1|||
105648763|NCT05287178|364374959|FG000|Overall Study|Lost to Follow-up|2|||
105648764|NCT01648699|364374960|FG000|Overall Study|Death|1|||
105648765|NCT01648699|364374960|FG000|Overall Study|Lost to Follow-up|2|||
105648766|NCT01648699|364374960|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
105648767|NCT02038803|364374965|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
105648768|NCT02038803|364374965|FG000|Overall Study|Lost to Follow-up|1|||
105648769|NCT04799587|364374966|FG000|Overall Study|Withdrawal by Subject|0|||
105648770|NCT04799587|364374967|FG001|Overall Study|Withdrawal by Subject|1|||
105648771|NCT00728884|364374968|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
105648772|NCT00728884|364374968|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
105648773|NCT00348283|364374969|FG000|Induction|Adverse Event|0|||
105648774|NCT00348283|364374970|FG001|Induction|Adverse Event|2|||
105648775|NCT00348283|364374969|FG000|Induction|Protocol Violation|0|||
105648776|NCT00348283|364374970|FG001|Induction|Protocol Violation|4|||
105648777|NCT00348283|364374969|FG000|Double Blind|Adverse Event|2|||
105648778|NCT00348283|364374970|FG001|Double Blind|Adverse Event|5|||
105648779|NCT00348283|364374969|FG000|Double Blind|Withdrawal by Subject|1|||
105648780|NCT00348283|364374970|FG001|Double Blind|Withdrawal by Subject|1|||
105648781|NCT00348283|364374969|FG000|Double Blind|Protocol Violation|0|||
105648782|NCT00348283|364374970|FG001|Double Blind|Protocol Violation|1|||
105648783|NCT00348283|364374969|FG000|Double Blind|Lack of Efficacy|2|||
105648784|NCT00348283|364374970|FG001|Double Blind|Lack of Efficacy|2|||
105648785|NCT00348283|364374969|FG000|Double Blind|Pregnancy|0|||
105648786|NCT00348283|364374970|FG001|Double Blind|Pregnancy|1|||
105648787|NCT00348283|364374969|FG000|Open Label|Adverse Event|0|||
105648788|NCT00348283|364374970|FG001|Open Label|Adverse Event|8|||
105648789|NCT00348283|364374969|FG000|Open Label|Withdrawal by Subject|0|||
105648790|NCT00348283|364374970|FG001|Open Label|Withdrawal by Subject|4|||
105648791|NCT00348283|364374969|FG000|Open Label|Lost to Follow-up|0|||
105648792|NCT00348283|364374970|FG001|Open Label|Lost to Follow-up|1|||
105648793|NCT00348283|364374969|FG000|Open Label|Lack of Efficacy|0|||
105648794|NCT00348283|364374970|FG001|Open Label|Lack of Efficacy|13|||
105648795|NCT00348283|364374969|FG000|Open Label|Administrative reasons|0|||
105648796|NCT00348283|364374970|FG001|Open Label|Administrative reasons|5|||
105648797|NCT00348283|364374969|FG000|Open Label|Subject moved to the United States|0|||
105648798|NCT00348283|364374970|FG001|Open Label|Subject moved to the United States|1|||
105648799|NCT00348283|364374969|FG000|Open Label|Pregnancy|0|||
105648800|NCT00348283|364374970|FG001|Open Label|Pregnancy|1|||
105648801|NCT00348283|364374969|FG000|Open Label|Sponsor decision|0|||
105648802|NCT00348283|364374970|FG001|Open Label|Sponsor decision|1|||
105648803|NCT02133131|364374971|FG000|Overall Study|Adverse Event|0|||
105648804|NCT02133131|364374972|FG001|Overall Study|Adverse Event|0|||
105648805|NCT02133131|364374973|FG002|Overall Study|Adverse Event|0|||
105648806|NCT02133131|364374974|FG003|Overall Study|Adverse Event|1|||
105648807|NCT02133131|364374975|FG004|Overall Study|Adverse Event|0|||
105648808|NCT02133131|364374976|FG005|Overall Study|Adverse Event|0|||
105648809|NCT02133131|364374977|FG006|Overall Study|Adverse Event|0|||
105648810|NCT02133131|364374971|FG000|Overall Study|Lost to Follow-up|1|||
105648811|NCT02133131|364374972|FG001|Overall Study|Lost to Follow-up|0|||
105648812|NCT02133131|364374973|FG002|Overall Study|Lost to Follow-up|0|||
105648813|NCT02133131|364374974|FG003|Overall Study|Lost to Follow-up|1|||
105648814|NCT02133131|364374975|FG004|Overall Study|Lost to Follow-up|0|||
105648815|NCT02133131|364374976|FG005|Overall Study|Lost to Follow-up|0|||
105648816|NCT02133131|364374977|FG006|Overall Study|Lost to Follow-up|0|||
105648817|NCT02133131|364374971|FG000|Overall Study|Status not recorded|4|||
105648818|NCT02133131|364374972|FG001|Overall Study|Status not recorded|5|||
105648819|NCT02133131|364374973|FG002|Overall Study|Status not recorded|1|||
105648820|NCT02133131|364374974|FG003|Overall Study|Status not recorded|4|||
105648821|NCT02133131|364374975|FG004|Overall Study|Status not recorded|0|||
105648822|NCT02133131|364374976|FG005|Overall Study|Status not recorded|0|||
105648823|NCT02133131|364374977|FG006|Overall Study|Status not recorded|0|||
105648824|NCT02133131|364374971|FG000|Overall Study|Ongoing in study|0|||
105648825|NCT02133131|364374972|FG001|Overall Study|Ongoing in study|0|||
105648826|NCT02133131|364374973|FG002|Overall Study|Ongoing in study|0|||
105648827|NCT02133131|364374974|FG003|Overall Study|Ongoing in study|0|||
105648828|NCT02133131|364374975|FG004|Overall Study|Ongoing in study|15|||
105648829|NCT02133131|364374976|FG005|Overall Study|Ongoing in study|14|||
105648830|NCT02133131|364374977|FG006|Overall Study|Ongoing in study|11|||
105648831|NCT02133131|364374971|FG000|Overall Study|Protocol Violation|0|||
105648832|NCT02133131|364374972|FG001|Overall Study|Protocol Violation|0|||
105648833|NCT02133131|364374973|FG002|Overall Study|Protocol Violation|0|||
105648834|NCT02133131|364374974|FG003|Overall Study|Protocol Violation|0|||
105648835|NCT02133131|364374975|FG004|Overall Study|Protocol Violation|0|||
105648836|NCT02133131|364374976|FG005|Overall Study|Protocol Violation|0|||
105648837|NCT02133131|364374977|FG006|Overall Study|Protocol Violation|1|||
105648838|NCT00990821|364374980|FG000|Overall Study|Withdrawal by Subject|0|||
105648839|NCT00990821|364374981|FG001|Overall Study|Withdrawal by Subject|2|||
105648840|NCT00990821|364374982|FG002|Overall Study|Withdrawal by Subject|0|||
105648841|NCT00990821|364374983|FG003|Overall Study|Withdrawal by Subject|0|||
105648842|NCT00990821|364374984|FG004|Overall Study|Withdrawal by Subject|3|||
105648843|NCT00990821|364374985|FG005|Overall Study|Withdrawal by Subject|3|||
105648844|NCT00990821|364374986|FG006|Overall Study|Withdrawal by Subject|1|||
105648845|NCT00990821|364374987|FG007|Overall Study|Withdrawal by Subject|0|||
105648846|NCT00990821|364374988|FG008|Overall Study|Withdrawal by Subject|0|||
105648847|NCT00990821|364374989|FG009|Overall Study|Withdrawal by Subject|1|||
105648848|NCT00990821|364374990|FG010|Overall Study|Withdrawal by Subject|3|||
105648849|NCT00990821|364374991|FG011|Overall Study|Withdrawal by Subject|5|||
105648850|NCT00990821|364374992|FG012|Overall Study|Withdrawal by Subject|2|||
105648851|NCT00990821|364374993|FG013|Overall Study|Withdrawal by Subject|1|||
105648852|NCT03530345|364374994|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
105648853|NCT03530345|364374995|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
105648854|NCT03530345|364374994|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
105648855|NCT03530345|364374995|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
105648856|NCT03530345|364374994|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
105648857|NCT03530345|364374995|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
105648858|NCT03530345|364374994|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
105648859|NCT03530345|364374995|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
105648860|NCT00308113|364374998|FG000|Overall Study|Protocol closure|0|||
105648861|NCT00308113|364374999|FG001|Overall Study|Protocol closure|0|||
105648862|NCT00308113|364375000|FG002|Overall Study|Protocol closure|0|||
105648863|NCT00308113|364375001|FG003|Overall Study|Protocol closure|1|||
105648864|NCT02316171|364375004|FG000|Overall Study|difficulties with urinary catheter|1|||
105648865|NCT02316171|364375005|FG001|Overall Study|difficulties with urinary catheter|0|||
105648866|NCT02316171|364375006|FG002|Overall Study|difficulties with urinary catheter|0|||
105648867|NCT02316171|364375007|FG003|Overall Study|difficulties with urinary catheter|0|||
105648868|NCT00170950|364375008|FG000|Overall Study|Death|236|||
105648869|NCT00170950|364375009|FG001|Overall Study|Death|274|||
105648870|NCT00170950|364375008|FG000|Overall Study|Withdrawal by Subject|496|||
105648871|NCT00170950|364375009|FG001|Overall Study|Withdrawal by Subject|498|||
105648872|NCT00170950|364375008|FG000|Overall Study|Lost to Follow-up|134|||
105648873|NCT00170950|364375009|FG001|Overall Study|Lost to Follow-up|115|||
105648874|NCT00170950|364375008|FG000|Overall Study|Missing|2|||
105648875|NCT00170950|364375009|FG001|Overall Study|Missing|1|||
105648876|NCT00170950|364375008|FG000|Overall Study|Termination Data Not Recorded|17|||
105648877|NCT00170950|364375009|FG001|Overall Study|Termination Data Not Recorded|22|||
105648878|NCT04050722|364376883|FG000|Overall Study|Withdrawal by Subject|1|||
105648879|NCT04050722|364376884|FG001|Overall Study|Withdrawal by Subject|0|||
105648880|NCT02762500|364376885|FG000|Overall Study|Lack of Efficacy|1|||
105648881|NCT02762500|364376886|FG001|Overall Study|Lack of Efficacy|0|||
105648882|NCT02762500|364376885|FG000|Overall Study|Withdrawal by Subject|1|||
105648883|NCT02762500|364376886|FG001|Overall Study|Withdrawal by Subject|1|||
105648884|NCT02762500|364376885|FG000|Overall Study|Adverse Event|0|||
105648885|NCT02762500|364376886|FG001|Overall Study|Adverse Event|2|||
105648886|NCT03087851|364376887|FG000|Overall Study|Withdraw on medical grounds|0|||
105648887|NCT03087851|364376888|FG001|Overall Study|Withdraw on medical grounds|1|||
105648888|NCT03087851|364376889|FG002|Overall Study|Withdraw on medical grounds|2|||
105648889|NCT00443755|364376890|FG000|Overall Study|Withdrawal by Subject|2|||
105648890|NCT00443755|364376891|FG001|Overall Study|Withdrawal by Subject|1|||
105648891|NCT00678899|364376892|FG000|Overall Study|Adverse Event|1|||
105648892|NCT04385849|364376893|FG000|Overall Study|Lost to Follow-up|1|||
105648893|NCT04385849|364376894|FG001|Overall Study|Lost to Follow-up|0|||
105648894|NCT05878990|364376895|FG000|Overall Study|Lost to Follow-up|7|||
105648895|NCT05878990|364376895|FG000|Overall Study|Withdrawal by Subject|1|||
105648896|NCT00839306|364376896|FG000|Overall Study|Adverse Event|3|||
105648897|NCT00839306|364376897|FG001|Overall Study|Adverse Event|5|||
105648898|NCT00839306|364376896|FG000|Overall Study|Lost to Follow-up|6|||
105648899|NCT00839306|364376897|FG001|Overall Study|Lost to Follow-up|9|||
105648900|NCT00839306|364376896|FG000|Overall Study|Withdrawal by Subject|5|||
105648901|NCT00839306|364376897|FG001|Overall Study|Withdrawal by Subject|7|||
105648902|NCT00839306|364376896|FG000|Overall Study|Lack of Efficacy|5|||
105648903|NCT00839306|364376897|FG001|Overall Study|Lack of Efficacy|4|||
105648904|NCT00839306|364376896|FG000|Overall Study|Other|6|||
105648905|NCT00839306|364376897|FG001|Overall Study|Other|18|||
105648906|NCT02339506|364376902|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
105648907|NCT02339506|364376903|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
105648908|NCT02339506|364376902|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
105648909|NCT02339506|364376903|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
105648910|NCT01234675|364376904|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
105648911|NCT01234675|364376905|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
105648912|NCT01234675|364376904|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
105648913|NCT01234675|364376905|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
105648914|NCT00609245|364376906|FG000|Overall Study|Adverse Event|1|||
105648915|NCT00331799|364376907|FG000|Overall Study|Withdrawal by Subject|2|||
105648916|NCT00331799|364376907|FG000|Overall Study|Sedation|1|||
105648917|NCT04203199|364376910|FG000|First Intervention Period|Lost to Follow-up|0|||
105648918|NCT04203199|364376911|FG001|First Intervention Period|Lost to Follow-up|1|||
105648919|NCT04203199|364376910|FG000|Second Intervention Period|Medication change|1|||
105648920|NCT04203199|364376911|FG001|Second Intervention Period|Medication change|0|||
105648921|NCT02068352|364376915|FG000|Overall Study|Lost to Follow-up|0|||
105648922|NCT02068352|364376916|FG001|Overall Study|Lost to Follow-up|2|||
105648923|NCT02068352|364376917|FG002|Overall Study|Lost to Follow-up|0|||
105648924|NCT02068352|364376915|FG000|Overall Study|Adverse Event|4|||
105648925|NCT02068352|364376916|FG001|Overall Study|Adverse Event|2|||
105648926|NCT02068352|364376917|FG002|Overall Study|Adverse Event|7|||
105648927|NCT02068352|364376915|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
105648928|NCT02068352|364376916|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
105648929|NCT02068352|364376917|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
105648930|NCT02068352|364376915|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
105648931|NCT02068352|364376916|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
105648932|NCT02068352|364376917|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
105648933|NCT02068352|364376915|FG000|Overall Study|Protocol Deviation|0|||
105648934|NCT02068352|364376916|FG001|Overall Study|Protocol Deviation|0|||
105648935|NCT02068352|364376917|FG002|Overall Study|Protocol Deviation|1|||
105648936|NCT01838499|364376922|FG000|Overall Study|Protocol Violation|0|||
105648937|NCT01838499|364376923|FG001|Overall Study|Protocol Violation|1|||
105648938|NCT01838499|364376922|FG000|Overall Study|Lost to Follow-up|2|||
105648939|NCT01838499|364376923|FG001|Overall Study|Lost to Follow-up|4|||
105648940|NCT01838499|364376922|FG000|Overall Study|Lack of Efficacy|1|||
105648941|NCT01838499|364376923|FG001|Overall Study|Lack of Efficacy|2|||
105648942|NCT01838499|364376922|FG000|Overall Study|Adverse Event|2|||
105648943|NCT01838499|364376923|FG001|Overall Study|Adverse Event|1|||
105648944|NCT01838499|364376922|FG000|Overall Study|Withdrawal by Subject|19|||
105648945|NCT01838499|364376923|FG001|Overall Study|Withdrawal by Subject|9|||
105648946|NCT01107353|364376934|FG000|Overall Study|Positive Drug Screen|1|||
105648947|NCT01107353|364376935|FG001|Overall Study|Positive Drug Screen|0|||
105648948|NCT00809783|364376936|FG000|Overall Study|Death|1|||
105648949|NCT00809783|364376937|FG001|Overall Study|Death|0|||
105648950|NCT00809783|364376938|FG002|Overall Study|Death|0|||
105648951|NCT00809783|364376936|FG000|Overall Study|Adverse Event|34|||
105648952|NCT00809783|364376937|FG001|Overall Study|Adverse Event|52|||
105648953|NCT00809783|364376938|FG002|Overall Study|Adverse Event|71|||
105648954|NCT00809783|364376936|FG000|Overall Study|Lack of Efficacy|39|||
105648955|NCT00809783|364376937|FG001|Overall Study|Lack of Efficacy|52|||
105648956|NCT00809783|364376938|FG002|Overall Study|Lack of Efficacy|63|||
105648957|NCT00809783|364376936|FG000|Overall Study|Lost to Follow-up|0|||
105648958|NCT00809783|364376937|FG001|Overall Study|Lost to Follow-up|3|||
105648959|NCT00809783|364376938|FG002|Overall Study|Lost to Follow-up|4|||
105648960|NCT00809783|364376936|FG000|Overall Study|Withdrawal by Subject|47|||
105648961|NCT00809783|364376937|FG001|Overall Study|Withdrawal by Subject|72|||
105648962|NCT00809783|364376938|FG002|Overall Study|Withdrawal by Subject|64|||
105648963|NCT00809783|364376936|FG000|Overall Study|Protocol Violation|2|||
105648964|NCT00809783|364376937|FG001|Overall Study|Protocol Violation|6|||
105648965|NCT00809783|364376938|FG002|Overall Study|Protocol Violation|5|||
105648966|NCT00809783|364376936|FG000|Overall Study|Randomized, but not treated|3|||
105648967|NCT00809783|364376937|FG001|Overall Study|Randomized, but not treated|0|||
105648968|NCT00809783|364376938|FG002|Overall Study|Randomized, but not treated|2|||
105648969|NCT00809783|364376936|FG000|Overall Study|Study Terminated by Sponsor|378|||
105648970|NCT00809783|364376937|FG001|Overall Study|Study Terminated by Sponsor|626|||
105648971|NCT00809783|364376938|FG002|Overall Study|Study Terminated by Sponsor|565|||
105648972|NCT00809783|364376936|FG000|Overall Study|Other|21|||
105648973|NCT00809783|364376937|FG001|Overall Study|Other|21|||
105648974|NCT00809783|364376938|FG002|Overall Study|Other|16|||
105648975|NCT01745380|364376939|FG000|Overall Study|Lost to Follow-up|1|||
105648976|NCT01745380|364376940|FG001|Overall Study|Lost to Follow-up|0|||
105648977|NCT01745380|364376939|FG000|Overall Study|Lack of Efficacy|0|||
105648978|NCT01745380|364376940|FG001|Overall Study|Lack of Efficacy|1|||
105648979|NCT02660034|364376943|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
105648980|NCT02660034|364376944|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
105648981|NCT02660034|364376945|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
105648982|NCT02660034|364376946|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
105648983|NCT02660034|364376947|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
105648984|NCT02660034|364376948|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
105648985|NCT02660034|364376949|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
105648986|NCT02660034|364376950|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
105648987|NCT02660034|364376951|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
105648988|NCT02660034|364376952|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
105648989|NCT02660034|364376953|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
105648990|NCT02660034|364376954|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
105648991|NCT02660034|364376955|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
105648992|NCT02660034|364376956|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
105648993|NCT02660034|364376943|FG000|Overall Study|Progressive Disease (Clinical)|7|||
105648994|NCT02660034|364376944|FG001|Overall Study|Progressive Disease (Clinical)|8|||
105648995|NCT02660034|364376945|FG002|Overall Study|Progressive Disease (Clinical)|3|||
105648996|NCT02660034|364376946|FG003|Overall Study|Progressive Disease (Clinical)|9|||
105648997|NCT02660034|364376947|FG004|Overall Study|Progressive Disease (Clinical)|3|||
105648998|NCT02660034|364376948|FG005|Overall Study|Progressive Disease (Clinical)|0|||
105648999|NCT02660034|364376949|FG006|Overall Study|Progressive Disease (Clinical)|0|||
105649000|NCT02660034|364376950|FG007|Overall Study|Progressive Disease (Clinical)|0|||
105649001|NCT02660034|364376951|FG008|Overall Study|Progressive Disease (Clinical)|0|||
105649002|NCT02660034|364376952|FG009|Overall Study|Progressive Disease (Clinical)|0|||
105649003|NCT02660034|364376953|FG010|Overall Study|Progressive Disease (Clinical)|0|||
105649004|NCT02660034|364376954|FG011|Overall Study|Progressive Disease (Clinical)|0|||
105649005|NCT02660034|364376955|FG012|Overall Study|Progressive Disease (Clinical)|0|||
105649006|NCT02660034|364376956|FG013|Overall Study|Progressive Disease (Clinical)|0|||
105649007|NCT02660034|364376943|FG000|Overall Study|Lost to Follow-up|0|||
105649008|NCT02660034|364376944|FG001|Overall Study|Lost to Follow-up|0|||
105649009|NCT02660034|364376945|FG002|Overall Study|Lost to Follow-up|1|||
105649010|NCT02660034|364376946|FG003|Overall Study|Lost to Follow-up|1|||
105649011|NCT02660034|364376947|FG004|Overall Study|Lost to Follow-up|0|||
105649012|NCT02660034|364376948|FG005|Overall Study|Lost to Follow-up|0|||
105649013|NCT02660034|364376949|FG006|Overall Study|Lost to Follow-up|0|||
105649014|NCT02660034|364376950|FG007|Overall Study|Lost to Follow-up|0|||
105649015|NCT02660034|364376951|FG008|Overall Study|Lost to Follow-up|0|||
105649016|NCT02660034|364376952|FG009|Overall Study|Lost to Follow-up|1|||
105649017|NCT02660034|364376953|FG010|Overall Study|Lost to Follow-up|1|||
105649018|NCT02660034|364376954|FG011|Overall Study|Lost to Follow-up|1|||
105649019|NCT02660034|364376955|FG012|Overall Study|Lost to Follow-up|0|||
105649020|NCT02660034|364376956|FG013|Overall Study|Lost to Follow-up|0|||
105649021|NCT02660034|364376943|FG000|Overall Study|Participant moved into special access scheme|1|||
105649022|NCT02660034|364376944|FG001|Overall Study|Participant moved into special access scheme|2|||
105649023|NCT02660034|364376945|FG002|Overall Study|Participant moved into special access scheme|0|||
105649024|NCT02660034|364376946|FG003|Overall Study|Participant moved into special access scheme|0|||
105649025|NCT02660034|364376947|FG004|Overall Study|Participant moved into special access scheme|0|||
105649026|NCT02660034|364376948|FG005|Overall Study|Participant moved into special access scheme|0|||
105649027|NCT02660034|364376949|FG006|Overall Study|Participant moved into special access scheme|0|||
105649028|NCT02660034|364376950|FG007|Overall Study|Participant moved into special access scheme|0|||
105649029|NCT02660034|364376951|FG008|Overall Study|Participant moved into special access scheme|0|||
105649030|NCT02660034|364376952|FG009|Overall Study|Participant moved into special access scheme|0|||
105649031|NCT02660034|364376953|FG010|Overall Study|Participant moved into special access scheme|0|||
105649032|NCT02660034|364376954|FG011|Overall Study|Participant moved into special access scheme|0|||
105649033|NCT02660034|364376955|FG012|Overall Study|Participant moved into special access scheme|0|||
105649034|NCT02660034|364376956|FG013|Overall Study|Participant moved into special access scheme|0|||
105649035|NCT02660034|364376943|FG000|Overall Study|Adverse Event|1|||
105649036|NCT02660034|364376944|FG001|Overall Study|Adverse Event|0|||
105649037|NCT02660034|364376945|FG002|Overall Study|Adverse Event|0|||
105649038|NCT02660034|364376946|FG003|Overall Study|Adverse Event|0|||
105649039|NCT02660034|364376947|FG004|Overall Study|Adverse Event|0|||
105649040|NCT02660034|364376948|FG005|Overall Study|Adverse Event|0|||
105649041|NCT02660034|364376949|FG006|Overall Study|Adverse Event|0|||
105649042|NCT02660034|364376950|FG007|Overall Study|Adverse Event|0|||
105649043|NCT02660034|364376951|FG008|Overall Study|Adverse Event|0|||
105649044|NCT02660034|364376952|FG009|Overall Study|Adverse Event|0|||
105649045|NCT02660034|364376953|FG010|Overall Study|Adverse Event|0|||
105649046|NCT02660034|364376954|FG011|Overall Study|Adverse Event|0|||
105649047|NCT02660034|364376955|FG012|Overall Study|Adverse Event|0|||
105649048|NCT02660034|364376956|FG013|Overall Study|Adverse Event|0|||
105649049|NCT02660034|364376943|FG000|Overall Study|Sponsor Decision|0|||
105649050|NCT02660034|364376944|FG001|Overall Study|Sponsor Decision|1|||
105649051|NCT02660034|364376945|FG002|Overall Study|Sponsor Decision|2|||
105649052|NCT02660034|364376946|FG003|Overall Study|Sponsor Decision|2|||
105649053|NCT02660034|364376947|FG004|Overall Study|Sponsor Decision|3|||
105649054|NCT02660034|364376948|FG005|Overall Study|Sponsor Decision|0|||
105649055|NCT02660034|364376949|FG006|Overall Study|Sponsor Decision|0|||
105649056|NCT02660034|364376950|FG007|Overall Study|Sponsor Decision|0|||
105649057|NCT02660034|364376951|FG008|Overall Study|Sponsor Decision|0|||
105649058|NCT02660034|364376952|FG009|Overall Study|Sponsor Decision|0|||
105649059|NCT02660034|364376953|FG010|Overall Study|Sponsor Decision|0|||
105649060|NCT02660034|364376954|FG011|Overall Study|Sponsor Decision|0|||
105649061|NCT02660034|364376955|FG012|Overall Study|Sponsor Decision|0|||
105649062|NCT02660034|364376956|FG013|Overall Study|Sponsor Decision|1|||
105649063|NCT02660034|364376943|FG000|Overall Study|Withdrawal by Subject|0|||
105649064|NCT02660034|364376944|FG001|Overall Study|Withdrawal by Subject|0|||
105649065|NCT02660034|364376945|FG002|Overall Study|Withdrawal by Subject|0|||
105649066|NCT02660034|364376946|FG003|Overall Study|Withdrawal by Subject|0|||
105649067|NCT02660034|364376947|FG004|Overall Study|Withdrawal by Subject|0|||
105649068|NCT02660034|364376948|FG005|Overall Study|Withdrawal by Subject|0|||
105649069|NCT02660034|364376949|FG006|Overall Study|Withdrawal by Subject|1|||
105649070|NCT02660034|364376950|FG007|Overall Study|Withdrawal by Subject|1|||
105649071|NCT02660034|364376951|FG008|Overall Study|Withdrawal by Subject|1|||
105649072|NCT02660034|364376952|FG009|Overall Study|Withdrawal by Subject|0|||
105649073|NCT02660034|364376953|FG010|Overall Study|Withdrawal by Subject|0|||
105649074|NCT02660034|364376954|FG011|Overall Study|Withdrawal by Subject|1|||
105649075|NCT02660034|364376955|FG012|Overall Study|Withdrawal by Subject|2|||
105649076|NCT02660034|364376956|FG013|Overall Study|Withdrawal by Subject|0|||
105649077|NCT02660034|364376943|FG000|Overall Study|Death|0|||
105649078|NCT02660034|364376944|FG001|Overall Study|Death|0|||
105649079|NCT02660034|364376945|FG002|Overall Study|Death|0|||
105649080|NCT02660034|364376946|FG003|Overall Study|Death|0|||
105649081|NCT02660034|364376947|FG004|Overall Study|Death|0|||
105649082|NCT02660034|364376948|FG005|Overall Study|Death|13|||
105649083|NCT02660034|364376949|FG006|Overall Study|Death|14|||
105649084|NCT02660034|364376950|FG007|Overall Study|Death|10|||
105649085|NCT02660034|364376951|FG008|Overall Study|Death|9|||
105649086|NCT02660034|364376952|FG009|Overall Study|Death|21|||
105649087|NCT02660034|364376953|FG010|Overall Study|Death|17|||
105649088|NCT02660034|364376954|FG011|Overall Study|Death|15|||
105649089|NCT02660034|364376955|FG012|Overall Study|Death|18|||
105649090|NCT02660034|364376956|FG013|Overall Study|Death|7|||
105649091|NCT02660034|364376943|FG000|Overall Study|Physician Decision|0|||
105649092|NCT02660034|364376944|FG001|Overall Study|Physician Decision|0|||
105649093|NCT02660034|364376945|FG002|Overall Study|Physician Decision|0|||
105649094|NCT02660034|364376946|FG003|Overall Study|Physician Decision|0|||
105649095|NCT02660034|364376947|FG004|Overall Study|Physician Decision|0|||
105649096|NCT02660034|364376948|FG005|Overall Study|Physician Decision|0|||
105649097|NCT02660034|364376949|FG006|Overall Study|Physician Decision|0|||
105649098|NCT02660034|364376950|FG007|Overall Study|Physician Decision|0|||
105649099|NCT02660034|364376951|FG008|Overall Study|Physician Decision|0|||
105649100|NCT02660034|364376952|FG009|Overall Study|Physician Decision|0|||
105649101|NCT02660034|364376953|FG010|Overall Study|Physician Decision|0|||
105649102|NCT02660034|364376954|FG011|Overall Study|Physician Decision|0|||
105649103|NCT02660034|364376955|FG012|Overall Study|Physician Decision|0|||
105649104|NCT02660034|364376956|FG013|Overall Study|Physician Decision|1|||
105649105|NCT02660034|364376943|FG000|Overall Study|Participants transferred to LTE|0|||
105649106|NCT02660034|364376944|FG001|Overall Study|Participants transferred to LTE|0|||
105649107|NCT02660034|364376945|FG002|Overall Study|Participants transferred to LTE|0|||
105649108|NCT02660034|364376946|FG003|Overall Study|Participants transferred to LTE|0|||
105649109|NCT02660034|364376947|FG004|Overall Study|Participants transferred to LTE|0|||
105649110|NCT02660034|364376948|FG005|Overall Study|Participants transferred to LTE|10|||
105649111|NCT02660034|364376949|FG006|Overall Study|Participants transferred to LTE|8|||
105649112|NCT02660034|364376950|FG007|Overall Study|Participants transferred to LTE|8|||
105649113|NCT02660034|364376951|FG008|Overall Study|Participants transferred to LTE|10|||
105649114|NCT02660034|364376952|FG009|Overall Study|Participants transferred to LTE|1|||
105649115|NCT02660034|364376953|FG010|Overall Study|Participants transferred to LTE|2|||
105649116|NCT02660034|364376954|FG011|Overall Study|Participants transferred to LTE|4|||
105649117|NCT02660034|364376955|FG012|Overall Study|Participants transferred to LTE|1|||
105649118|NCT02660034|364376956|FG013|Overall Study|Participants transferred to LTE|1|||
105649119|NCT02995733|364376962|FG000|Overall Study|Study site closed|9|||
105649120|NCT02995733|364376963|FG001|Overall Study|Study site closed|10|||
105649121|NCT02995733|364376962|FG000|Overall Study|Death|3|||
105649122|NCT02995733|364376963|FG001|Overall Study|Death|4|||
105649123|NCT02995733|364376962|FG000|Overall Study|Withdrawal by Subject|6|||
105649124|NCT02995733|364376963|FG001|Overall Study|Withdrawal by Subject|2|||
105649125|NCT02995733|364376962|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
105649126|NCT02995733|364376963|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
105649127|NCT02995733|364376962|FG000|Overall Study|Lost to Follow-up|48|||
105649128|NCT02995733|364376963|FG001|Overall Study|Lost to Follow-up|37|||
105649129|NCT02995733|364376962|FG000|Overall Study|Other|0|||
105649130|NCT02995733|364376963|FG001|Overall Study|Other|1|||
105649131|NCT01183013|364376966|FG000|Overall Study|Adverse Event|6|||
105649132|NCT01183013|364376967|FG001|Overall Study|Adverse Event|8|||
105649133|NCT01183013|364376968|FG002|Overall Study|Adverse Event|5|||
105649134|NCT01183013|364376969|FG003|Overall Study|Adverse Event|5|||
105649135|NCT01183013|364376970|FG004|Overall Study|Adverse Event|10|||
105649136|NCT01183013|364376971|FG005|Overall Study|Adverse Event|10|||
105649137|NCT01183013|364376972|FG006|Overall Study|Adverse Event|6|||
105649138|NCT01183013|364376966|FG000|Overall Study|Lack of Efficacy|3|||
105649139|NCT01183013|364376967|FG001|Overall Study|Lack of Efficacy|2|||
105649140|NCT01183013|364376968|FG002|Overall Study|Lack of Efficacy|1|||
105649141|NCT01183013|364376969|FG003|Overall Study|Lack of Efficacy|2|||
105649142|NCT01183013|364376970|FG004|Overall Study|Lack of Efficacy|1|||
105649143|NCT01183013|364376971|FG005|Overall Study|Lack of Efficacy|2|||
105649144|NCT01183013|364376972|FG006|Overall Study|Lack of Efficacy|0|||
105649145|NCT01183013|364376966|FG000|Overall Study|Protocol Violation|5|||
105649146|NCT01183013|364376967|FG001|Overall Study|Protocol Violation|2|||
105649147|NCT01183013|364376968|FG002|Overall Study|Protocol Violation|4|||
105649148|NCT01183013|364376969|FG003|Overall Study|Protocol Violation|0|||
105649149|NCT01183013|364376970|FG004|Overall Study|Protocol Violation|4|||
105649150|NCT01183013|364376971|FG005|Overall Study|Protocol Violation|3|||
105649151|NCT01183013|364376972|FG006|Overall Study|Protocol Violation|3|||
105649152|NCT01183013|364376966|FG000|Overall Study|Lost to Follow-up|7|||
105649153|NCT01183013|364376967|FG001|Overall Study|Lost to Follow-up|3|||
105649154|NCT01183013|364376968|FG002|Overall Study|Lost to Follow-up|4|||
105649155|NCT01183013|364376969|FG003|Overall Study|Lost to Follow-up|3|||
105649156|NCT01183013|364376970|FG004|Overall Study|Lost to Follow-up|2|||
105649157|NCT01183013|364376971|FG005|Overall Study|Lost to Follow-up|6|||
105649158|NCT01183013|364376972|FG006|Overall Study|Lost to Follow-up|5|||
105649159|NCT01183013|364376966|FG000|Overall Study|Withdrawal by Subject|9|||
105649160|NCT01183013|364376967|FG001|Overall Study|Withdrawal by Subject|13|||
105649161|NCT01183013|364376968|FG002|Overall Study|Withdrawal by Subject|10|||
105649162|NCT01183013|364376969|FG003|Overall Study|Withdrawal by Subject|8|||
105649163|NCT01183013|364376970|FG004|Overall Study|Withdrawal by Subject|7|||
105649164|NCT01183013|364376971|FG005|Overall Study|Withdrawal by Subject|9|||
105649165|NCT01183013|364376972|FG006|Overall Study|Withdrawal by Subject|10|||
105649166|NCT01183013|364376966|FG000|Overall Study|Reasons other than stated above|15|||
105649167|NCT01183013|364376967|FG001|Overall Study|Reasons other than stated above|11|||
105649168|NCT01183013|364376968|FG002|Overall Study|Reasons other than stated above|17|||
105649169|NCT01183013|364376969|FG003|Overall Study|Reasons other than stated above|12|||
105649170|NCT01183013|364376970|FG004|Overall Study|Reasons other than stated above|12|||
105649171|NCT01183013|364376971|FG005|Overall Study|Reasons other than stated above|15|||
105649172|NCT01183013|364376972|FG006|Overall Study|Reasons other than stated above|13|||
105649173|NCT04879823|364376976|FG000|Overall Study|Physician Decision|3|||
105649174|NCT04879823|364376977|FG001|Overall Study|Physician Decision|1|||
105649175|NCT04879823|364376976|FG000|Overall Study|Protocol Violation|2|||
105649176|NCT04879823|364376977|FG001|Overall Study|Protocol Violation|3|||
105649177|NCT04879823|364376976|FG000|Overall Study|Lost to Follow-up|43|||
105649178|NCT04879823|364376977|FG001|Overall Study|Lost to Follow-up|35|||
105649179|NCT04468633|364376978|FG000|Overall Study|Withdrawal by Subject|4|||
105649180|NCT04468633|364376979|FG001|Overall Study|Withdrawal by Subject|0|||
105649181|NCT01498445|364376982|FG000|Overall Study|Lack of Efficacy|0|||
105649182|NCT01498445|364376983|FG001|Overall Study|Lack of Efficacy|0|||
105649183|NCT01498445|364376984|FG002|Overall Study|Lack of Efficacy|1|||
105649184|NCT01498445|364376985|FG003|Overall Study|Lack of Efficacy|2|||
105649185|NCT01498445|364376986|FG004|Overall Study|Lack of Efficacy|0|||
105649186|NCT01498445|364376987|FG005|Overall Study|Lack of Efficacy|0|||
105649187|NCT01498445|364376982|FG000|Overall Study|Screen Failure|0|||
105649188|NCT01498445|364376983|FG001|Overall Study|Screen Failure|0|||
105649189|NCT01498445|364376984|FG002|Overall Study|Screen Failure|0|||
105649190|NCT01498445|364376985|FG003|Overall Study|Screen Failure|0|||
105649191|NCT01498445|364376986|FG004|Overall Study|Screen Failure|1|||
105649192|NCT01498445|364376987|FG005|Overall Study|Screen Failure|1|||
105649193|NCT03209492|364376990|FG000|Overall Study|Case Report Forms Uncollected|5|||
105649194|NCT02105688|364376991|FG000|Part A: Double-Blind|Adverse Event|1|||
105649195|NCT02105688|364376992|FG001|Part A: Double-Blind|Adverse Event|0|||
105649196|NCT02105688|364376991|FG000|Part A: Double-Blind|Death|0|||
105649197|NCT02105688|364376992|FG001|Part A: Double-Blind|Death|1|||
105649198|NCT02105688|364376991|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
105649199|NCT02105688|364376992|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
105649200|NCT02105688|364376991|FG000|Part A: Double-Blind|Physician Decision|0|||
105649201|NCT02105688|364376992|FG001|Part A: Double-Blind|Physician Decision|1|||
105649202|NCT02105688|364376991|FG000|Part A: Double-Blind|Status Unknown|0|||
105649203|NCT02105688|364376992|FG001|Part A: Double-Blind|Status Unknown|2|||
105649204|NCT02105688|364376991|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
105649205|NCT02105688|364376992|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
105649206|NCT02105688|364376991|FG000|Part B: Observational Follow-up|Death|2|||
105649207|NCT02105688|364376992|FG001|Part B: Observational Follow-up|Death|1|||
105649208|NCT02105688|364376991|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
105649209|NCT02105688|364376992|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
105649210|NCT02105688|364376991|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
105649211|NCT02105688|364376992|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
105649212|NCT02105688|364376991|FG000|Part B: Observational Follow-up|Physician Decision|3|||
105649213|NCT02105688|364376992|FG001|Part B: Observational Follow-up|Physician Decision|1|||
105649214|NCT02498418|364377015|FG000|Overall Study|Lack of Efficacy|0|||
105649215|NCT02498418|364377016|FG001|Overall Study|Lack of Efficacy|0|||
105649216|NCT02498418|364377017|FG002|Overall Study|Lack of Efficacy|1|||
105649217|NCT02498418|364377015|FG000|Overall Study|Withdrawal by Subject|2|||
105649218|NCT02498418|364377016|FG001|Overall Study|Withdrawal by Subject|0|||
105649219|NCT02498418|364377017|FG002|Overall Study|Withdrawal by Subject|3|||
105649220|NCT02498418|364377015|FG000|Overall Study|Lost to Follow-up|0|||
105649221|NCT02498418|364377016|FG001|Overall Study|Lost to Follow-up|1|||
105649222|NCT02498418|364377017|FG002|Overall Study|Lost to Follow-up|1|||
105649223|NCT02498418|364377015|FG000|Overall Study|Participant taken prohibited medication|0|||
105649224|NCT02498418|364377016|FG001|Overall Study|Participant taken prohibited medication|1|||
105649225|NCT02498418|364377017|FG002|Overall Study|Participant taken prohibited medication|1|||
105649226|NCT03575572|364377019|FG000|Overall Study|Withdrawal by Subject|2|||
105649227|NCT03575572|364377019|FG000|Overall Study|Physician Decision|2|||
105649228|NCT04393779|364377020|FG000|Overall Study|Death|1|||
105649229|NCT04393779|364377020|FG000|Overall Study|Device reintervention or explant|4|||
105649230|NCT02267746|364377021|FG000|Overall Study|Adverse Event|0|||
105649231|NCT02267746|364377022|FG001|Overall Study|Adverse Event|2|||
105649232|NCT02267746|364377023|FG002|Overall Study|Adverse Event|1|||
105649233|NCT02267746|364377021|FG000|Overall Study|Protocol Violation|8|||
105649234|NCT02267746|364377022|FG001|Overall Study|Protocol Violation|7|||
105649235|NCT02267746|364377023|FG002|Overall Study|Protocol Violation|3|||
105649236|NCT02267746|364377021|FG000|Overall Study|Lack of Efficacy|11|||
105649237|NCT02267746|364377022|FG001|Overall Study|Lack of Efficacy|11|||
105649238|NCT02267746|364377023|FG002|Overall Study|Lack of Efficacy|15|||
105649239|NCT02267746|364377021|FG000|Overall Study|Protocol Violation|1|||
105649240|NCT02267746|364377022|FG001|Overall Study|Protocol Violation|2|||
105649241|NCT02267746|364377023|FG002|Overall Study|Protocol Violation|1|||
105649242|NCT02267746|364377021|FG000|Overall Study|Miscellaneous|1|||
105649243|NCT02267746|364377022|FG001|Overall Study|Miscellaneous|0|||
105649244|NCT02267746|364377023|FG002|Overall Study|Miscellaneous|1|||
105649245|NCT04372186|364377028|FG000|Overall Study|Death|24|||
105649246|NCT04372186|364377029|FG001|Overall Study|Death|11|||
105649247|NCT04372186|364377028|FG000|Overall Study|Transferred to a different facility for care|0|||
105649248|NCT04372186|364377029|FG001|Overall Study|Transferred to a different facility for care|2|||
105649249|NCT02116582|364377030|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
105649250|NCT02116582|364377030|FG000|Overall Study|Adverse Event|22|||
105649251|NCT02116582|364377030|FG000|Overall Study|Death|9|||
105649252|NCT02116582|364377030|FG000|Overall Study|Progressive Disease|148|||
105649253|NCT02116582|364377030|FG000|Overall Study|Protocol Violation|3|||
105649254|NCT02116582|364377030|FG000|Overall Study|Withdrawal by Subject|8|||
105649255|NCT02116582|364377030|FG000|Overall Study|Other: Miscellaneous|11|||
105649256|NCT02116582|364377030|FG000|Overall Study|Lost to Follow-up|1|||
105649257|NCT02116582|364377030|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
105649258|NCT03861078|364377031|FG000|Overall Study|COVID-19 shut down|4|||
105649259|NCT03861078|364377031|FG000|Overall Study|Lost to Follow-up|1|||
105649260|NCT03861078|364377031|FG000|Overall Study|Protocol Violation|2|||
105649261|NCT03861078|364377031|FG000|Overall Study|lack of venous access|1|||
105649262|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
105649263|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
105649264|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
105649265|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
105649266|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
105649267|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
105649268|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
105649269|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
105649270|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
105649271|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
105649272|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
105649273|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
105649274|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
105649275|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
105649276|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
105649277|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
105649278|NCT02971683|364377032|FG000|Open-Label|Lost to Follow-up|1|||
105649279|NCT02971683|364377033|FG001|Open-Label|Lost to Follow-up|0|||
105649280|NCT02971683|364377032|FG000|Open-Label|Participants withdrew consent|0|||
105649281|NCT02971683|364377033|FG001|Open-Label|Participants withdrew consent|2|||
105649282|NCT02971683|364377032|FG000|Open-Label|Participant request to discontinue study treatment|1|||
105649283|NCT02971683|364377033|FG001|Open-Label|Participant request to discontinue study treatment|0|||
105649284|NCT02971683|364377032|FG000|Open-Label|Lack of Efficacy|2|||
105649285|NCT02971683|364377033|FG001|Open-Label|Lack of Efficacy|0|||
105649286|NCT02971683|364377032|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
105649287|NCT02971683|364377033|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
105649288|NCT02971683|364377032|FG000|Long-Term Open Label|Participant withdrew consent|1|||
105649289|NCT02971683|364377033|FG001|Long-Term Open Label|Participant withdrew consent|0|||
105649290|NCT02971683|364377032|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
105649291|NCT02971683|364377033|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
105649292|NCT02971683|364377032|FG000|Long-Term Open Label|Adverse Event|1|||
105649293|NCT02971683|364377033|FG001|Long-Term Open Label|Adverse Event|2|||
105649294|NCT02971683|364377032|FG000|Long-Term Open Label|Lack of Efficacy|1|||
105649295|NCT02971683|364377033|FG001|Long-Term Open Label|Lack of Efficacy|1|||
105649296|NCT05431543|364377043|FG000|Overall Study|Medical History|1|||
105649297|NCT05431543|364377044|FG001|Overall Study|Medical History|0|||
105649298|NCT05431543|364377045|FG002|Overall Study|Medical History|0|||
105649299|NCT00440037|364377046|FG000|Overall Study|Withdrawal by Subject|6|||
105649300|NCT00440037|364377046|FG000|Overall Study|Administrative decision|3|||
105649301|NCT00498797|364377047|FG000|Overall Study|Withdrawal by Subject|4|||
105649302|NCT00498797|364377048|FG001|Overall Study|Withdrawal by Subject|2|||
105649303|NCT00498797|364377047|FG000|Overall Study|Adverse Event|12|||
105649304|NCT00498797|364377048|FG001|Overall Study|Adverse Event|5|||
105649305|NCT00498797|364377047|FG000|Overall Study|Condition under investigation worsened|19|||
105649306|NCT00498797|364377048|FG001|Overall Study|Condition under investigation worsened|21|||
105649307|NCT00498797|364377047|FG000|Overall Study|Other|3|||
105649308|NCT00498797|364377048|FG001|Overall Study|Other|1|||
105649309|NCT03928821|364377049|FG000|Overall Study|Death|0|||
105649310|NCT03928821|364377050|FG001|Overall Study|Death|1|||
105649311|NCT03928821|364377051|FG002|Overall Study|Death|0|||
105649312|NCT03928821|364377052|FG003|Overall Study|Death|0|||
105649313|NCT03928821|364377049|FG000|Overall Study|Lost to Follow-up|0|||
105649314|NCT03928821|364377050|FG001|Overall Study|Lost to Follow-up|2|||
105649315|NCT03928821|364377051|FG002|Overall Study|Lost to Follow-up|3|||
105649316|NCT03928821|364377052|FG003|Overall Study|Lost to Follow-up|0|||
105649317|NCT03928821|364377049|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
105649318|NCT03928821|364377050|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
105649319|NCT03928821|364377051|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
105649320|NCT03928821|364377052|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
105649321|NCT00985621|364377053|FG000|Overall Study|Adverse Event|2|||
105649322|NCT00985621|364377054|FG001|Overall Study|Adverse Event|3|||
105649323|NCT00985621|364377055|FG002|Overall Study|Adverse Event|4|||
105649324|NCT00985621|364377056|FG003|Overall Study|Adverse Event|16|||
105649325|NCT00985621|364377053|FG000|Overall Study|Lack of Efficacy|10|||
105649326|NCT00985621|364377054|FG001|Overall Study|Lack of Efficacy|6|||
105649327|NCT00985621|364377055|FG002|Overall Study|Lack of Efficacy|5|||
105649328|NCT00985621|364377056|FG003|Overall Study|Lack of Efficacy|12|||
105649329|NCT00985621|364377053|FG000|Overall Study|Lost to Follow-up|2|||
105649330|NCT00985621|364377054|FG001|Overall Study|Lost to Follow-up|3|||
105649331|NCT00985621|364377055|FG002|Overall Study|Lost to Follow-up|4|||
105649332|NCT00985621|364377056|FG003|Overall Study|Lost to Follow-up|4|||
105649333|NCT00985621|364377053|FG000|Overall Study|Study Terminated by Sponsor|89|||
105649334|NCT00985621|364377054|FG001|Overall Study|Study Terminated by Sponsor|108|||
105649335|NCT00985621|364377055|FG002|Overall Study|Study Terminated by Sponsor|99|||
105649336|NCT00985621|364377056|FG003|Overall Study|Study Terminated by Sponsor|92|||
105649337|NCT00985621|364377053|FG000|Overall Study|Protocol Violation|1|||
105649338|NCT00985621|364377054|FG001|Overall Study|Protocol Violation|1|||
105649339|NCT00985621|364377055|FG002|Overall Study|Protocol Violation|1|||
105649340|NCT00985621|364377056|FG003|Overall Study|Protocol Violation|0|||
105649341|NCT00985621|364377053|FG000|Overall Study|Withdrawal by Subject|8|||
105649342|NCT00985621|364377054|FG001|Overall Study|Withdrawal by Subject|10|||
105649343|NCT00985621|364377055|FG002|Overall Study|Withdrawal by Subject|8|||
105649344|NCT00985621|364377056|FG003|Overall Study|Withdrawal by Subject|12|||
105649345|NCT00985621|364377053|FG000|Overall Study|Other|1|||
105649346|NCT00985621|364377054|FG001|Overall Study|Other|0|||
105649347|NCT00985621|364377055|FG002|Overall Study|Other|0|||
105649348|NCT00985621|364377056|FG003|Overall Study|Other|0|||
105649349|NCT00985621|364377053|FG000|Overall Study|Randomized but not Treated|1|||
105649350|NCT00985621|364377054|FG001|Overall Study|Randomized but not Treated|0|||
105649351|NCT00985621|364377055|FG002|Overall Study|Randomized but not Treated|2|||
105649352|NCT00985621|364377056|FG003|Overall Study|Randomized but not Treated|1|||
105649353|NCT01911819|364377057|FG000|Overall Study|Adverse Event|0|||
105649354|NCT01911819|364377058|FG001|Overall Study|Adverse Event|1|||
105649355|NCT01911819|364377059|FG002|Overall Study|Adverse Event|0|||
105649356|NCT01911819|364377057|FG000|Overall Study|Withdrawal by Subject|1|||
105649357|NCT01911819|364377058|FG001|Overall Study|Withdrawal by Subject|1|||
105649358|NCT01911819|364377059|FG002|Overall Study|Withdrawal by Subject|0|||
105649359|NCT01524887|364377061|FG000|Overall Study|Withdrawal by Subject|6|||
105649360|NCT01524887|364377062|FG001|Overall Study|Withdrawal by Subject|2|||
105649361|NCT01524887|364377063|FG002|Overall Study|Withdrawal by Subject|3|||
105649362|NCT01524887|364377061|FG000|Overall Study|Adverse Event|5|||
105649363|NCT01524887|364377062|FG001|Overall Study|Adverse Event|1|||
105649364|NCT01524887|364377063|FG002|Overall Study|Adverse Event|1|||
105649365|NCT01524887|364377061|FG000|Overall Study|Protocol Violation|0|||
105649366|NCT01524887|364377062|FG001|Overall Study|Protocol Violation|0|||
105649367|NCT01524887|364377063|FG002|Overall Study|Protocol Violation|1|||
105649368|NCT01524887|364377061|FG000|Overall Study|Study termination|73|||
105649369|NCT01524887|364377062|FG001|Overall Study|Study termination|87|||
105649370|NCT01524887|364377063|FG002|Overall Study|Study termination|79|||
105649371|NCT01524887|364377061|FG000|Overall Study|Withdrawal by Caregiver|0|||
105649372|NCT01524887|364377062|FG001|Overall Study|Withdrawal by Caregiver|0|||
105649373|NCT01524887|364377063|FG002|Overall Study|Withdrawal by Caregiver|2|||
105649374|NCT01524887|364377061|FG000|Overall Study|Use of prohibited medication|1|||
105649375|NCT01524887|364377062|FG001|Overall Study|Use of prohibited medication|0|||
105649376|NCT01524887|364377063|FG002|Overall Study|Use of prohibited medication|0|||
105649377|NCT02785900|364377064|FG000|Overall Study|Study Termination by Sponsor|64|||
105649378|NCT02785900|364377065|FG001|Overall Study|Study Termination by Sponsor|81|||
105649379|NCT02785900|364377064|FG000|Overall Study|Death|46|||
105649380|NCT02785900|364377065|FG001|Overall Study|Death|32|||
105649381|NCT02785900|364377064|FG000|Overall Study|Withdrawal by Subject|4|||
105649382|NCT02785900|364377065|FG001|Overall Study|Withdrawal by Subject|8|||
105649383|NCT02785900|364377064|FG000|Overall Study|Physician Decision|3|||
105649384|NCT02785900|364377065|FG001|Overall Study|Physician Decision|2|||
105649385|NCT01808144|364377066|FG000|Overall Study|Death|1|||
105649386|NCT01808144|364377067|FG001|Overall Study|Death|0|||
105649387|NCT01808144|364377066|FG000|Overall Study|Withdrawal by Subject|16|||
105649388|NCT01808144|364377067|FG001|Overall Study|Withdrawal by Subject|23|||
105649389|NCT01808144|364377066|FG000|Overall Study|Lost to Follow-up|6|||
105649390|NCT01808144|364377067|FG001|Overall Study|Lost to Follow-up|3|||
105649391|NCT01808144|364377066|FG000|Overall Study|Protocol Violation|6|||
105649392|NCT01808144|364377067|FG001|Overall Study|Protocol Violation|6|||
105649393|NCT01808144|364377066|FG000|Overall Study|Gout flare|0|||
105649394|NCT01808144|364377067|FG001|Overall Study|Gout flare|1|||
105649395|NCT01808144|364377066|FG000|Overall Study|Adverse Event|11|||
105649396|NCT01808144|364377067|FG001|Overall Study|Adverse Event|15|||
105649397|NCT04380688|364377068|FG000|Overall Study|Death|2|||
105649398|NCT04380688|364377069|FG001|Overall Study|Death|2|||
105649399|NCT04380688|364377068|FG000|Overall Study|Lost to Follow-up|2|||
105649400|NCT04380688|364377069|FG001|Overall Study|Lost to Follow-up|4|||
105649401|NCT04380688|364377068|FG000|Overall Study|Withdrawal by Subject|3|||
105649402|NCT04380688|364377069|FG001|Overall Study|Withdrawal by Subject|3|||
105649403|NCT02081196|364378501|FG000|Overall Study|Lost to Follow-up|1|||
105649404|NCT00961298|364378502|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
105649405|NCT00961298|364378502|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
105649406|NCT00961298|364378502|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
105649407|NCT01904019|364378504|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
105649408|NCT01904019|364378504|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
105649409|NCT01904019|364378504|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
105649410|NCT01904019|364378504|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
105649411|NCT01904019|364378504|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
105649412|NCT01904019|364378504|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
105649413|NCT01537120|364378505|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
105649414|NCT01537120|364378505|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
105649415|NCT05335005|364378509|FG000|Overall Study|Lost to Follow-up|1|||
105649416|NCT01503515|364378510|FG000|Overall Study|Adverse Event|4|||
105649417|NCT01503515|364378511|FG001|Overall Study|Adverse Event|5|||
105649418|NCT01503515|364378510|FG000|Overall Study|Death|0|||
105649419|NCT01503515|364378511|FG001|Overall Study|Death|1|||
105649420|NCT01503515|364378510|FG000|Overall Study|Physician Decision|14|||
105649421|NCT01503515|364378511|FG001|Overall Study|Physician Decision|23|||
105649422|NCT01503515|364378510|FG000|Overall Study|Withdrawal by Subject|0|||
105649423|NCT01503515|364378511|FG001|Overall Study|Withdrawal by Subject|1|||
105649424|NCT01503515|364378510|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
105649425|NCT01503515|364378511|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
105649426|NCT01503515|364378510|FG000|Overall Study|Ineligible|1|||
105649427|NCT01503515|364378511|FG001|Overall Study|Ineligible|1|||
105649428|NCT00755716|364378512|FG000|Overall Study|Adverse Event|1|||
105649429|NCT00755716|364378513|FG001|Overall Study|Adverse Event|4|||
105649430|NCT00755716|364378514|FG002|Overall Study|Adverse Event|1|||
105649431|NCT00755716|364378512|FG000|Overall Study|Lack of Efficacy|2|||
105649432|NCT00755716|364378513|FG001|Overall Study|Lack of Efficacy|0|||
105649433|NCT00755716|364378514|FG002|Overall Study|Lack of Efficacy|0|||
105649434|NCT00755716|364378512|FG000|Overall Study|Lost to Follow-up|5|||
105649435|NCT00755716|364378513|FG001|Overall Study|Lost to Follow-up|3|||
105649436|NCT00755716|364378514|FG002|Overall Study|Lost to Follow-up|1|||
105649437|NCT00755716|364378512|FG000|Overall Study|work schedule issues|0|||
105649438|NCT00755716|364378513|FG001|Overall Study|work schedule issues|1|||
105649439|NCT00755716|364378514|FG002|Overall Study|work schedule issues|1|||
105649440|NCT02101554|364378515|FG000|Overall Study|Protocol Violation|0|||
105649441|NCT02101554|364378516|FG001|Overall Study|Protocol Violation|1|||
105649442|NCT02101554|364378517|FG002|Overall Study|Protocol Violation|0|||
105649443|NCT02101554|364378515|FG000|Overall Study|Insufficient Clinical Response|0|||
105649444|NCT02101554|364378516|FG001|Overall Study|Insufficient Clinical Response|2|||
105649445|NCT02101554|364378517|FG002|Overall Study|Insufficient Clinical Response|0|||
105649446|NCT02101554|364378515|FG000|Overall Study|Adverse Event|2|||
105649447|NCT02101554|364378516|FG001|Overall Study|Adverse Event|1|||
105649448|NCT02101554|364378517|FG002|Overall Study|Adverse Event|1|||
105649449|NCT02101554|364378515|FG000|Overall Study|Lost to Follow-up|0|||
105649450|NCT02101554|364378516|FG001|Overall Study|Lost to Follow-up|1|||
105649451|NCT02101554|364378517|FG002|Overall Study|Lost to Follow-up|0|||
105649452|NCT02101554|364378515|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
105649453|NCT02101554|364378516|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
105649454|NCT02101554|364378517|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
105649455|NCT00726388|364378522|FG000|Overall Study|Withdrawal by Subject|5|||
105649456|NCT00726388|364378522|FG000|Overall Study|Adverse Event|3|||
105649457|NCT00726388|364378522|FG000|Overall Study|Lost to Follow-up|10|||
105649458|NCT00726388|364378522|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
105649459|NCT00726388|364378522|FG000|Overall Study|Other|5|||
105649460|NCT00726388|364378522|FG000|Overall Study|Enrolled, Not Treated|79|||
105649461|NCT00644332|364378523|FG000|Overall Study|Adverse Event|11|||
105649462|NCT00644332|364378523|FG000|Overall Study|Withdrawal by Subject|6|||
105649463|NCT00644332|364378523|FG000|Overall Study|Completion Status Unknown|2|||
105649464|NCT00644332|364378523|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
105649465|NCT00644332|364378523|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
105649466|NCT02706834|364378527|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
105649467|NCT02706834|364378528|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
105649468|NCT02706834|364378529|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
105649469|NCT02706834|364378530|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
105649470|NCT02706834|364378531|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
105649471|NCT02706834|364378532|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
105649472|NCT02706834|364378533|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
105649473|NCT02706834|364378534|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
105649474|NCT02706834|364378535|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
105649475|NCT02706834|364378536|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
105649476|NCT02706834|364378537|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
105649477|NCT02706834|364378527|FG000|Overall Study|Lost to Follow-up|0|||
105649478|NCT02706834|364378528|FG001|Overall Study|Lost to Follow-up|0|||
105649479|NCT02706834|364378529|FG002|Overall Study|Lost to Follow-up|1|||
105649480|NCT02706834|364378530|FG003|Overall Study|Lost to Follow-up|0|||
105649481|NCT02706834|364378531|FG004|Overall Study|Lost to Follow-up|0|||
105649482|NCT02706834|364378532|FG005|Overall Study|Lost to Follow-up|0|||
105649483|NCT02706834|364378533|FG006|Overall Study|Lost to Follow-up|0|||
105649484|NCT02706834|364378534|FG007|Overall Study|Lost to Follow-up|0|||
105649485|NCT02706834|364378535|FG008|Overall Study|Lost to Follow-up|0|||
105649486|NCT02706834|364378536|FG009|Overall Study|Lost to Follow-up|0|||
105649487|NCT02706834|364378537|FG010|Overall Study|Lost to Follow-up|0|||
105649488|NCT02706834|364378527|FG000|Overall Study|Voluntary Withdrawal|1|||
105649489|NCT02706834|364378528|FG001|Overall Study|Voluntary Withdrawal|0|||
105649490|NCT02706834|364378529|FG002|Overall Study|Voluntary Withdrawal|0|||
105649491|NCT02706834|364378530|FG003|Overall Study|Voluntary Withdrawal|0|||
105649492|NCT02706834|364378531|FG004|Overall Study|Voluntary Withdrawal|0|||
105649493|NCT02706834|364378532|FG005|Overall Study|Voluntary Withdrawal|0|||
105649494|NCT02706834|364378533|FG006|Overall Study|Voluntary Withdrawal|0|||
105649495|NCT02706834|364378534|FG007|Overall Study|Voluntary Withdrawal|0|||
105649496|NCT02706834|364378535|FG008|Overall Study|Voluntary Withdrawal|0|||
105649497|NCT02706834|364378536|FG009|Overall Study|Voluntary Withdrawal|1|||
105649498|NCT02706834|364378537|FG010|Overall Study|Voluntary Withdrawal|0|||
105649499|NCT02706834|364378527|FG000|Overall Study|Other Reason Not Specified|1|||
105649500|NCT02706834|364378528|FG001|Overall Study|Other Reason Not Specified|0|||
105649501|NCT02706834|364378529|FG002|Overall Study|Other Reason Not Specified|0|||
105649502|NCT02706834|364378530|FG003|Overall Study|Other Reason Not Specified|0|||
105649503|NCT02706834|364378531|FG004|Overall Study|Other Reason Not Specified|1|||
105649504|NCT02706834|364378532|FG005|Overall Study|Other Reason Not Specified|0|||
105649505|NCT02706834|364378533|FG006|Overall Study|Other Reason Not Specified|0|||
105649506|NCT02706834|364378534|FG007|Overall Study|Other Reason Not Specified|0|||
105649507|NCT02706834|364378535|FG008|Overall Study|Other Reason Not Specified|0|||
105649508|NCT02706834|364378536|FG009|Overall Study|Other Reason Not Specified|0|||
105649509|NCT02706834|364378537|FG010|Overall Study|Other Reason Not Specified|0|||
105649510|NCT00762723|364378538|FG000|Overall Study|Study Terminated slow enrollement|5|||
105649511|NCT00762723|364378539|FG001|Overall Study|Study Terminated slow enrollement|5|||
105649512|NCT00762723|364378540|FG002|Overall Study|Study Terminated slow enrollement|3|||
105649513|NCT00507429|364378543|FG000|Treatment Phase|Disease Progression|12|||
105649514|NCT00507429|364378544|FG001|Treatment Phase|Disease Progression|5|||
105649515|NCT00507429|364378543|FG000|Treatment Phase|Adverse Event|12|||
105649516|NCT00507429|364378544|FG001|Treatment Phase|Adverse Event|5|||
105649517|NCT00507429|364378543|FG000|Treatment Phase|Withdrawal by Subject|3|||
105649518|NCT00507429|364378544|FG001|Treatment Phase|Withdrawal by Subject|3|||
105649519|NCT00507429|364378543|FG000|Treatment Phase|Physician Decision|4|||
105649520|NCT00507429|364378544|FG001|Treatment Phase|Physician Decision|2|||
105649521|NCT00507429|364378543|FG000|Treatment Phase|Other|6|||
105649522|NCT00507429|364378544|FG001|Treatment Phase|Other|3|||
105649523|NCT00507429|364378543|FG000|Maintenance Phase|Progressive Disease|14|||
105649524|NCT00507429|364378544|FG001|Maintenance Phase|Progressive Disease|0|||
105649525|NCT00627523|364378548|FG000|Overall Study|Lack of Efficacy|1|||
105649526|NCT00627523|364378549|FG001|Overall Study|Lack of Efficacy|0|||
105649527|NCT00627523|364378548|FG000|Overall Study|Withdrawal by Subject|0|||
105649528|NCT00627523|364378549|FG001|Overall Study|Withdrawal by Subject|2|||
105649529|NCT00627523|364378548|FG000|Overall Study|Other|1|||
105649530|NCT00627523|364378549|FG001|Overall Study|Other|0|||
105649531|NCT02543294|364378551|FG000|Overall Study|Lost to Follow-up|3|||
105649532|NCT02543294|364378551|FG000|Overall Study|Physician Decision|2|||
105649533|NCT02543294|364378551|FG000|Overall Study|Withdrawal by Subject|7|||
105649534|NCT01038128|364378556|FG000|Overall Study|Lack of Efficacy|1|||
105649535|NCT01038128|364378556|FG000|Overall Study|Lost to Follow-up|1|||
105649536|NCT01038128|364378556|FG000|Overall Study|Withdrawal by Subject|2|||
105649537|NCT01753323|364378561|FG000|Overall Study|Lack of Efficacy|0|||
105649538|NCT01753323|364378562|FG001|Overall Study|Lack of Efficacy|0|||
105649539|NCT01753323|364378563|FG002|Overall Study|Lack of Efficacy|8|||
105649540|NCT01753323|364378561|FG000|Overall Study|Protocol deviation|1|||
105649541|NCT01753323|364378562|FG001|Overall Study|Protocol deviation|0|||
105649542|NCT01753323|364378563|FG002|Overall Study|Protocol deviation|0|||
105649543|NCT01753323|364378561|FG000|Overall Study|Adverse Event|0|||
105649544|NCT01753323|364378562|FG001|Overall Study|Adverse Event|0|||
105649545|NCT01753323|364378563|FG002|Overall Study|Adverse Event|1|||
105649546|NCT00116584|364378566|FG000|Overall Study|Withdrawal by Subject|1|||
105649547|NCT00116584|364378567|FG001|Overall Study|Withdrawal by Subject|0|||
105649548|NCT00116584|364378566|FG000|Overall Study|Protocol Violation|1|||
105649549|NCT00116584|364378567|FG001|Overall Study|Protocol Violation|1|||
105649550|NCT01882088|364378568|FG000|Overall Study|Intolerance of esophageal manometry|1|||
105649551|NCT01882088|364378568|FG000|Overall Study|no possibility to place the catheter|1|||
105649552|NCT01882088|364378568|FG000|Overall Study|Protocol Violation|1|||
105649553|NCT01882088|364378568|FG000|Overall Study|inadequate pH-impedance tracings|2|||
105649554|NCT01838447|364378569|FG000|Overall Study|Change in surgical plan|1|||
105649555|NCT01838447|364378570|FG001|Overall Study|Change in surgical plan|2|||
105649556|NCT01838447|364378569|FG000|Overall Study|Withdrawal by Subject|1|||
105649557|NCT01838447|364378570|FG001|Overall Study|Withdrawal by Subject|1|||
105649558|NCT01533181|364378571|FG000|Overall Study|Disease progression pre-active treatment|0|||
105649559|NCT01533181|364378572|FG001|Overall Study|Disease progression pre-active treatment|1|||
105649560|NCT01533181|364378571|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
105649561|NCT01533181|364378572|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
105649562|NCT01695993|364378573|FG000|Overall Study|Lost to Follow-up|2|||
105649563|NCT01695993|364378574|FG001|Overall Study|Lost to Follow-up|1|||
105649564|NCT01695993|364378575|FG002|Overall Study|Lost to Follow-up|3|||
105649565|NCT01695993|364378573|FG000|Overall Study|Withdrawal by Subject|2|||
105649566|NCT01695993|364378574|FG001|Overall Study|Withdrawal by Subject|2|||
105649567|NCT01695993|364378575|FG002|Overall Study|Withdrawal by Subject|2|||
105649568|NCT01695993|364378573|FG000|Overall Study|To ill to continue|1|||
105649569|NCT01695993|364378574|FG001|Overall Study|To ill to continue|2|||
105649570|NCT01695993|364378575|FG002|Overall Study|To ill to continue|0|||
105649571|NCT01695993|364378573|FG000|Overall Study|Changed Medical Facility|0|||
105649572|NCT01695993|364378574|FG001|Overall Study|Changed Medical Facility|0|||
105649573|NCT01695993|364378575|FG002|Overall Study|Changed Medical Facility|1|||
105649574|NCT01078571|364378578|FG000|Overall Study|Adverse Event|36|||
105649575|NCT01078571|364378578|FG000|Overall Study|Lack of effectiveness|36|||
105649576|NCT01078571|364378578|FG000|Overall Study|Reason not reported|21|||
105649577|NCT01078571|364378578|FG000|Overall Study|Withdrawal by Subject|12|||
105649578|NCT01078571|364378578|FG000|Overall Study|Lost to Follow-up|8|||
105649579|NCT01078571|364378578|FG000|Overall Study|Protocol Violation|2|||
105649580|NCT04043806|364378580|FG000|Overall Study|Commercial drug is available for participants|13|||
105649581|NCT04043806|364378580|FG000|Overall Study|Physician Decision|2|||
105649582|NCT04043806|364378580|FG000|Overall Study|Other|12|||
105649583|NCT04043806|364378580|FG000|Overall Study|Adverse Event|2|||
105649584|NCT04043806|364378580|FG000|Overall Study|Lost to Follow-up|6|||
105649585|NCT04043806|364378580|FG000|Overall Study|Other non-compliance|2|||
105649586|NCT04043806|364378580|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
105649587|NCT04043806|364378580|FG000|Overall Study|Never Dosed|1|||
105649588|NCT00449033|364378581|FG000|Treatment Period|Adverse Event|117|||
105649589|NCT00449033|364378582|FG001|Treatment Period|Adverse Event|83|||
105649590|NCT00449033|364378581|FG000|Treatment Period|Death|21|||
105649591|NCT00449033|364378582|FG001|Treatment Period|Death|12|||
105649592|NCT00449033|364378581|FG000|Treatment Period|Lost to Follow-up|0|||
105649593|NCT00449033|364378582|FG001|Treatment Period|Lost to Follow-up|2|||
105649594|NCT00449033|364378581|FG000|Treatment Period|Physician Decision|4|||
105649595|NCT00449033|364378582|FG001|Treatment Period|Physician Decision|5|||
105649596|NCT00449033|364378581|FG000|Treatment Period|Protocol Violation|8|||
105649597|NCT00449033|364378582|FG001|Treatment Period|Protocol Violation|7|||
105649598|NCT00449033|364378581|FG000|Treatment Period|Disease Progression|231|||
105649599|NCT00449033|364378582|FG001|Treatment Period|Disease Progression|288|||
105649600|NCT00449033|364378581|FG000|Treatment Period|Consent Withdrawn|36|||
105649601|NCT00449033|364378582|FG001|Treatment Period|Consent Withdrawn|20|||
105649602|NCT00449033|364378581|FG000|Treatment Period|Amended Protocol Criteria|22|||
105649603|NCT00449033|364378582|FG001|Treatment Period|Amended Protocol Criteria|18|||
105649604|NCT00449033|364378581|FG000|Treatment Period|Non-compliance|7|||
105649605|NCT00449033|364378582|FG001|Treatment Period|Non-compliance|8|||
105649606|NCT00449033|364378581|FG000|Treatment Period|Second Malignancy|0|||
105649607|NCT00449033|364378582|FG001|Treatment Period|Second Malignancy|1|||
105649608|NCT00449033|364378581|FG000|Treatment Period|Reason Missing|0|||
105649609|NCT00449033|364378582|FG001|Treatment Period|Reason Missing|4|||
105649610|NCT00449033|364378581|FG000|Treatment Period|Treatment Ongoing|6|||
105649611|NCT00449033|364378582|FG001|Treatment Period|Treatment Ongoing|4|||
105649612|NCT00449033|364378581|FG000|Follow-up Period|Death|299|||
105649613|NCT00449033|364378582|FG001|Follow-up Period|Death|311|||
105649614|NCT00449033|364378581|FG000|Follow-up Period|Lost to Follow-up|6|||
105649615|NCT00449033|364378582|FG001|Follow-up Period|Lost to Follow-up|10|||
105649616|NCT00449033|364378581|FG000|Follow-up Period|Reason Missing|120|||
105649617|NCT00449033|364378582|FG001|Follow-up Period|Reason Missing|113|||
105649618|NCT02268526|364378583|FG000|Overall Study|Adverse Event|0|||
105649619|NCT02268526|364378584|FG001|Overall Study|Adverse Event|2|||
105649620|NCT02268526|364378585|FG002|Overall Study|Adverse Event|1|||
105649621|NCT02268526|364378583|FG000|Overall Study|Death|1|||
105649622|NCT02268526|364378584|FG001|Overall Study|Death|11|||
105649623|NCT02268526|364378585|FG002|Overall Study|Death|0|||
105649624|NCT02268526|364378583|FG000|Overall Study|protocol deviation|0|||
105649625|NCT02268526|364378584|FG001|Overall Study|protocol deviation|1|||
105649626|NCT02268526|364378585|FG002|Overall Study|protocol deviation|0|||
105649627|NCT02268526|364378583|FG000|Overall Study|Physician Decision|0|||
105649628|NCT02268526|364378584|FG001|Overall Study|Physician Decision|0|||
105649629|NCT02268526|364378585|FG002|Overall Study|Physician Decision|1|||
105649630|NCT02268526|364378583|FG000|Overall Study|Subject/guardian decision|0|||
105649631|NCT02268526|364378584|FG001|Overall Study|Subject/guardian decision|7|||
105649632|NCT02268526|364378585|FG002|Overall Study|Subject/guardian decision|3|||
105649633|NCT00596960|364378586|FG000|Overall Study|Death|1|||
105649634|NCT00596960|364378587|FG001|Overall Study|Death|2|||
105649635|NCT00596960|364378586|FG000|Overall Study|Lost to Follow-up|6|||
105649636|NCT00596960|364378587|FG001|Overall Study|Lost to Follow-up|5|||
105649637|NCT00596960|364378586|FG000|Overall Study|Withdrawal by Subject|1|||
105649638|NCT00596960|364378587|FG001|Overall Study|Withdrawal by Subject|0|||
105649639|NCT00596960|364378586|FG000|Overall Study|Incarcerated|2|||
105649640|NCT00596960|364378587|FG001|Overall Study|Incarcerated|0|||
105649641|NCT00596960|364378586|FG000|Overall Study|Physician Decision|1|||
105649642|NCT00596960|364378587|FG001|Overall Study|Physician Decision|0|||
105649643|NCT00596960|364378586|FG000|Overall Study|Protocol Violation|0|||
105649644|NCT00596960|364378587|FG001|Overall Study|Protocol Violation|1|||
105649645|NCT00596960|364378586|FG000|Overall Study|No alcohol use data|0|||
105649646|NCT00596960|364378587|FG001|Overall Study|No alcohol use data|1|||
105649647|NCT00794573|364378600|FG000|Overall Study|Death|3|||
105649648|NCT00794573|364378601|FG001|Overall Study|Death|0|||
105649649|NCT00794573|364378600|FG000|Overall Study|Withdrawal by Subject|9|||
105649650|NCT00794573|364378601|FG001|Overall Study|Withdrawal by Subject|12|||
105649651|NCT00794573|364378600|FG000|Overall Study|Lost to Follow-up|26|||
105649652|NCT00794573|364378601|FG001|Overall Study|Lost to Follow-up|33|||
105649653|NCT00257556|364378602|FG000|Overall Study|Adverse Event|1|||
105649654|NCT00257556|364378603|FG001|Overall Study|Adverse Event|4|||
105649655|NCT00257556|364378602|FG000|Overall Study|Physician Decision|6|||
105649656|NCT00257556|364378603|FG001|Overall Study|Physician Decision|0|||
105649657|NCT00257556|364378602|FG000|Overall Study|Did not meet hCG criterion|3|||
105649658|NCT00257556|364378603|FG001|Overall Study|Did not meet hCG criterion|0|||
105649659|NCT00257556|364378602|FG000|Overall Study|other reason|4|||
105649660|NCT00257556|364378603|FG001|Overall Study|other reason|6|||
105649661|NCT04839289|364378606|FG000|Overall Study|Withdrawal by Subject|1|||
105649662|NCT04839289|364378607|FG001|Overall Study|Withdrawal by Subject|0|||
105649663|NCT00603278|364378608|FG000|Overall Study|Lack of Efficacy|35|||
105649664|NCT00603278|364378609|FG001|Overall Study|Lack of Efficacy|10|||
105649665|NCT00603278|364378610|FG002|Overall Study|Lack of Efficacy|11|||
105649666|NCT00603278|364378611|FG003|Overall Study|Lack of Efficacy|8|||
105649667|NCT00603278|364378612|FG004|Overall Study|Lack of Efficacy|7|||
105649668|NCT00603278|364378613|FG005|Overall Study|Lack of Efficacy|14|||
105649669|NCT00603278|364378608|FG000|Overall Study|Adverse Event|0|||
105649670|NCT00603278|364378609|FG001|Overall Study|Adverse Event|3|||
105649671|NCT00603278|364378610|FG002|Overall Study|Adverse Event|1|||
105649672|NCT00603278|364378611|FG003|Overall Study|Adverse Event|0|||
105649673|NCT00603278|364378612|FG004|Overall Study|Adverse Event|2|||
105649674|NCT00603278|364378613|FG005|Overall Study|Adverse Event|1|||
105649675|NCT00603278|364378608|FG000|Overall Study|Withdrawal by Subject|2|||
105649676|NCT00603278|364378609|FG001|Overall Study|Withdrawal by Subject|3|||
105649677|NCT00603278|364378610|FG002|Overall Study|Withdrawal by Subject|1|||
105649678|NCT00603278|364378611|FG003|Overall Study|Withdrawal by Subject|2|||
105649679|NCT00603278|364378612|FG004|Overall Study|Withdrawal by Subject|1|||
105649680|NCT00603278|364378613|FG005|Overall Study|Withdrawal by Subject|2|||
105649681|NCT00603278|364378608|FG000|Overall Study|Protocol Violation|3|||
105649682|NCT00603278|364378609|FG001|Overall Study|Protocol Violation|0|||
105649683|NCT00603278|364378610|FG002|Overall Study|Protocol Violation|1|||
105649684|NCT00603278|364378611|FG003|Overall Study|Protocol Violation|1|||
105649685|NCT00603278|364378612|FG004|Overall Study|Protocol Violation|0|||
105649686|NCT00603278|364378613|FG005|Overall Study|Protocol Violation|1|||
105649687|NCT00603278|364378608|FG000|Overall Study|Physician Decision|0|||
105649688|NCT00603278|364378609|FG001|Overall Study|Physician Decision|1|||
105649689|NCT00603278|364378610|FG002|Overall Study|Physician Decision|0|||
105649690|NCT00603278|364378611|FG003|Overall Study|Physician Decision|0|||
105649691|NCT00603278|364378612|FG004|Overall Study|Physician Decision|2|||
105649692|NCT00603278|364378613|FG005|Overall Study|Physician Decision|1|||
105649693|NCT00603278|364378608|FG000|Overall Study|Lost to Follow-up|1|||
105649694|NCT00603278|364378609|FG001|Overall Study|Lost to Follow-up|0|||
105649695|NCT00603278|364378610|FG002|Overall Study|Lost to Follow-up|0|||
105649696|NCT00603278|364378611|FG003|Overall Study|Lost to Follow-up|0|||
105649697|NCT00603278|364378612|FG004|Overall Study|Lost to Follow-up|1|||
105649698|NCT00603278|364378613|FG005|Overall Study|Lost to Follow-up|0|||
105649699|NCT01207453|364378614|FG000|First Intervention|Adverse Event|2|||
105649700|NCT01207453|364378615|FG001|First Intervention|Adverse Event|1|||
105649701|NCT01207453|364378614|FG000|Washout|Adverse Event|1|||
105649702|NCT01207453|364378615|FG001|Washout|Adverse Event|0|||
105649703|NCT01207453|364378614|FG000|Washout|Lost to Follow-up|1|||
105649704|NCT01207453|364378615|FG001|Washout|Lost to Follow-up|0|||
105649705|NCT01207453|364378614|FG000|2nd Intervention|Adverse Event|1|||
105649706|NCT01207453|364378615|FG001|2nd Intervention|Adverse Event|2|||
105649707|NCT01207453|364378614|FG000|2nd Intervention|Lost to Follow-up|1|||
105649708|NCT01207453|364378615|FG001|2nd Intervention|Lost to Follow-up|0|||
105649709|NCT04382053|364378620|FG000|Overall Study|Death|6|||
105649710|NCT04382053|364378621|FG001|Overall Study|Death|8|||
105649711|NCT04382053|364378620|FG000|Overall Study|Lost to Follow-up|0|||
105649712|NCT04382053|364378621|FG001|Overall Study|Lost to Follow-up|2|||
105649713|NCT04382053|364378620|FG000|Overall Study|Protocol Deviation|1|||
105649714|NCT04382053|364378621|FG001|Overall Study|Protocol Deviation|2|||
105649715|NCT04382053|364378620|FG000|Overall Study|Withdrawal by Subject|2|||
105649716|NCT04382053|364378621|FG001|Overall Study|Withdrawal by Subject|1|||
105649717|NCT01399905|364378625|FG000|Overall Study|Withdrawal by Subject|1|||
105649718|NCT01399905|364378626|FG001|Overall Study|Withdrawal by Subject|1|||
105649719|NCT00417989|364378629|FG000|Overall Study|Withdrawal by Subject|13|||
105649720|NCT00417989|364378630|FG001|Overall Study|Withdrawal by Subject|13|||
105649721|NCT00417989|364378629|FG000|Overall Study|Lost to Follow-up|1|||
105649722|NCT00417989|364378630|FG001|Overall Study|Lost to Follow-up|6|||
105649723|NCT00417989|364378629|FG000|Overall Study|Protocol Violation|1|||
105649724|NCT00417989|364378630|FG001|Overall Study|Protocol Violation|0|||
105649725|NCT00417989|364378629|FG000|Overall Study|Death|0|||
105649726|NCT00417989|364378630|FG001|Overall Study|Death|1|||
105649727|NCT00417989|364378629|FG000|Overall Study|Physician Decision|5|||
105649728|NCT00417989|364378630|FG001|Overall Study|Physician Decision|2|||
105649729|NCT01032200|364378633|FG000|Overall Study|Death|1|||
105649730|NCT01032200|364378634|FG001|Overall Study|Death|1|||
105649731|NCT01032200|364378633|FG000|Overall Study|Withdrawal by Subject|1|||
105649732|NCT01032200|364378634|FG001|Overall Study|Withdrawal by Subject|3|||
105649733|NCT01032200|364378633|FG000|Overall Study|Toxicity|0|||
105649734|NCT01032200|364378634|FG001|Overall Study|Toxicity|2|||
105649735|NCT01032200|364378633|FG000|Overall Study|Progression|1|||
105649736|NCT01032200|364378634|FG001|Overall Study|Progression|0|||
105649737|NCT01032200|364378633|FG000|Overall Study|Multiple|1|||
105649738|NCT01032200|364378634|FG001|Overall Study|Multiple|1|||
105649739|NCT04295499|364378640|FG000|Overall Study|moving out of state|1|||
105649740|NCT04295499|364378641|FG001|Overall Study|moving out of state|0|||
105649741|NCT04295499|364378640|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
105649742|NCT04295499|364378641|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
105649743|NCT01116440|364380209|FG000|Treatment|Withdrawal by Subject|2|||
105649744|NCT01116440|364380210|FG001|Treatment|Withdrawal by Subject|2|||
105649745|NCT01116440|364380209|FG000|Treatment|Lost to Follow-up|1|||
105649746|NCT01116440|364380210|FG001|Treatment|Lost to Follow-up|1|||
105649747|NCT01116440|364380209|FG000|Treatment|Protocol Violation|0|||
105649748|NCT01116440|364380210|FG001|Treatment|Protocol Violation|2|||
105649749|NCT01116440|364380209|FG000|Treatment|Lack of Efficacy|0|||
105649750|NCT01116440|364380210|FG001|Treatment|Lack of Efficacy|1|||
105649751|NCT01116440|364380209|FG000|Treatment|Adverse Event|0|||
105649752|NCT01116440|364380210|FG001|Treatment|Adverse Event|1|||
105649753|NCT01116440|364380209|FG000|Withdrawal|Withdrawal by Subject|0|||
105649754|NCT01116440|364380210|FG001|Withdrawal|Withdrawal by Subject|1|||
105649755|NCT01116440|364380209|FG000|Withdrawal|Lost to Follow-up|0|||
105649756|NCT01116440|364380210|FG001|Withdrawal|Lost to Follow-up|1|||
105649757|NCT01116440|364380209|FG000|Follow-up|Lost to Follow-up|0|||
105649758|NCT01116440|364380210|FG001|Follow-up|Lost to Follow-up|1|||
105649759|NCT01116440|364380209|FG000|Follow-up|Withdrawal by Subject|0|||
105649760|NCT01116440|364380210|FG001|Follow-up|Withdrawal by Subject|1|||
105649761|NCT00511147|364380213|FG000|Overall Study|Withdrawal by Subject|1|||
105649762|NCT00511147|364380213|FG000|Overall Study|Disease progression|5|||
105649763|NCT00511147|364380213|FG000|Overall Study|Required platelet transfusion|1|||
105649764|NCT02798861|364380216|FG000|Overall Study|Lost to Follow-up|22|||
105649765|NCT02798861|364380216|FG000|Overall Study|Withdrawal by Subject|1|||
105649766|NCT00907517|364380217|FG000|Overall Study|Progressive Disease|3|||
105649767|NCT00907517|364380218|FG001|Overall Study|Progressive Disease|3|||
105649768|NCT00907517|364380219|FG002|Overall Study|Progressive Disease|4|||
105649769|NCT00907517|364380220|FG003|Overall Study|Progressive Disease|4|||
105649770|NCT00907517|364380221|FG004|Overall Study|Progressive Disease|4|||
105649771|NCT00907517|364380217|FG000|Overall Study|Symptomatic Deterioration|0|||
105649772|NCT00907517|364380218|FG001|Overall Study|Symptomatic Deterioration|0|||
105649773|NCT00907517|364380219|FG002|Overall Study|Symptomatic Deterioration|0|||
105649774|NCT00907517|364380220|FG003|Overall Study|Symptomatic Deterioration|0|||
105649775|NCT00907517|364380221|FG004|Overall Study|Symptomatic Deterioration|1|||
105649776|NCT02986659|364380222|FG000|First Intervention Period|Adverse Event|3|||
105649777|NCT02986659|364380223|FG001|First Intervention Period|Adverse Event|1|||
105649778|NCT02986659|364380222|FG000|First Intervention Period|Lost to Follow-up|1|||
105649779|NCT02986659|364380223|FG001|First Intervention Period|Lost to Follow-up|0|||
105649780|NCT02986659|364380222|FG000|First Intervention Period|Withdrawal by Subject|0|||
105649781|NCT02986659|364380223|FG001|First Intervention Period|Withdrawal by Subject|1|||
105649782|NCT02986659|364380222|FG000|Second Intervention Period|Adverse Event|0|||
105649783|NCT02986659|364380223|FG001|Second Intervention Period|Adverse Event|6|||
105649784|NCT01797705|364380225|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
105649785|NCT01797705|364380225|FG000|Overall Study|Withdrawal by Subject|1|||
105649786|NCT00168805|364380226|FG000|Overall Study|Adverse Event|7|||
105649787|NCT00168805|364380227|FG001|Overall Study|Adverse Event|11|||
105649788|NCT00168805|364380228|FG002|Overall Study|Adverse Event|16|||
105649789|NCT00168805|364380226|FG000|Overall Study|Protocol Violation|12|||
105649790|NCT00168805|364380227|FG001|Overall Study|Protocol Violation|11|||
105649791|NCT00168805|364380228|FG002|Overall Study|Protocol Violation|8|||
105649792|NCT00168805|364380226|FG000|Overall Study|Lost to Follow-up|12|||
105649793|NCT00168805|364380227|FG001|Overall Study|Lost to Follow-up|17|||
105649794|NCT00168805|364380228|FG002|Overall Study|Lost to Follow-up|11|||
105649795|NCT00168805|364380226|FG000|Overall Study|Withdrawal by Subject|16|||
105649796|NCT00168805|364380227|FG001|Overall Study|Withdrawal by Subject|18|||
105649797|NCT00168805|364380228|FG002|Overall Study|Withdrawal by Subject|21|||
105649798|NCT00168805|364380226|FG000|Overall Study|Other|24|||
105649799|NCT00168805|364380227|FG001|Overall Study|Other|21|||
105649800|NCT00168805|364380228|FG002|Overall Study|Other|22|||
105649801|NCT00168805|364380226|FG000|Treatment|Adverse Event|25|||
105649802|NCT00168805|364380227|FG001|Treatment|Adverse Event|26|||
105649803|NCT00168805|364380228|FG002|Treatment|Adverse Event|32|||
105649804|NCT00168805|364380226|FG000|Treatment|Protocol Violation|3|||
105649805|NCT00168805|364380227|FG001|Treatment|Protocol Violation|5|||
105649806|NCT00168805|364380228|FG002|Treatment|Protocol Violation|5|||
105649807|NCT00168805|364380226|FG000|Treatment|Withdrawal by Subject|3|||
105649808|NCT00168805|364380227|FG001|Treatment|Withdrawal by Subject|7|||
105649809|NCT00168805|364380228|FG002|Treatment|Withdrawal by Subject|8|||
105649810|NCT00168805|364380226|FG000|Treatment|Other|18|||
105649811|NCT00168805|364380227|FG001|Treatment|Other|18|||
105649812|NCT00168805|364380228|FG002|Treatment|Other|17|||
105649813|NCT01837719|364380232|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
105649814|NCT01837719|364380232|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
105649815|NCT01703988|364380233|FG000|Overall Study|Investigator Judgment|0|||
105649816|NCT01703988|364380234|FG001|Overall Study|Investigator Judgment|0|||
105649817|NCT01703988|364380235|FG002|Overall Study|Investigator Judgment|0|||
105649818|NCT01703988|364380236|FG003|Overall Study|Investigator Judgment|1|||
105649819|NCT06247488|364380237|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
105649820|NCT06247488|364380238|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
105649821|NCT06247488|364380239|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
105649822|NCT06247488|364380240|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
105649823|NCT06247488|364380241|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
105649824|NCT06247488|364380242|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
105649825|NCT06247488|364380237|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
105649826|NCT06247488|364380238|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
105649827|NCT06247488|364380239|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
105649828|NCT06247488|364380240|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
105649829|NCT06247488|364380241|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
105649830|NCT06247488|364380242|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
105649831|NCT06247488|364380237|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
105649832|NCT06247488|364380238|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
105649833|NCT06247488|364380239|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
105649834|NCT06247488|364380240|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
105649835|NCT06247488|364380241|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
105649836|NCT06247488|364380242|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
105649837|NCT06247488|364380237|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
105649838|NCT06247488|364380238|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
105649839|NCT06247488|364380239|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
105649840|NCT06247488|364380240|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
105649841|NCT06247488|364380241|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
105649842|NCT06247488|364380242|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
105649843|NCT06247488|364380237|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
105649844|NCT06247488|364380238|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
105649845|NCT06247488|364380239|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
105649846|NCT06247488|364380240|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
105649847|NCT06247488|364380241|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
105649848|NCT06247488|364380242|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
105649849|NCT06247488|364380237|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
105649850|NCT06247488|364380238|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
105649851|NCT06247488|364380239|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
105649852|NCT06247488|364380240|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
105649853|NCT06247488|364380241|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
105649854|NCT06247488|364380242|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
105649855|NCT06247488|364380237|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
105649856|NCT06247488|364380238|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
105649857|NCT06247488|364380239|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
105649858|NCT06247488|364380240|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
105649859|NCT06247488|364380241|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
105649860|NCT06247488|364380242|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
105649861|NCT03785210|364380243|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
105649862|NCT03785210|364380244|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
105649863|NCT02402465|364380245|FG000|Overall Study|Withdrawal by Subject|0|||
105649864|NCT02402465|364380246|FG001|Overall Study|Withdrawal by Subject|0|||
105649865|NCT02402465|364380247|FG002|Overall Study|Withdrawal by Subject|0|||
105649866|NCT02402465|364380248|FG003|Overall Study|Withdrawal by Subject|0|||
105649867|NCT02402465|364380249|FG004|Overall Study|Withdrawal by Subject|0|||
105649868|NCT02402465|364380250|FG005|Overall Study|Withdrawal by Subject|1|||
105649869|NCT02402465|364380245|FG000|Overall Study|Lost to Follow-up|0|||
105649870|NCT02402465|364380246|FG001|Overall Study|Lost to Follow-up|1|||
105649871|NCT02402465|364380247|FG002|Overall Study|Lost to Follow-up|0|||
105649872|NCT02402465|364380248|FG003|Overall Study|Lost to Follow-up|0|||
105649873|NCT02402465|364380249|FG004|Overall Study|Lost to Follow-up|1|||
105649874|NCT02402465|364380250|FG005|Overall Study|Lost to Follow-up|0|||
105649875|NCT01732588|364380251|FG000|First Intervention (7 Days)|Adverse Event|0|||
105649876|NCT01732588|364380252|FG001|First Intervention (7 Days)|Adverse Event|1|||
105649877|NCT01732588|364380253|FG002|First Intervention (7 Days)|Adverse Event|0|||
105649878|NCT02005029|364380254|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
105649879|NCT02005029|364380255|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
105649880|NCT05012397|364380260|FG000|Overall Study|Death|10|||
105649881|NCT05012397|364380260|FG000|Overall Study|Physician Decision|9|||
105649882|NCT05012397|364380260|FG000|Overall Study|Withdrawal by Subject|5|||
105649883|NCT05012397|364380260|FG000|Overall Study|Lost to Follow-up|2|||
105649884|NCT00730925|364380263|FG000|Overall Study|Progressive Disease|21|||
105649885|NCT00730925|364380263|FG000|Overall Study|Dose reducing Event|2|||
105649886|NCT00730925|364380263|FG000|Overall Study|Other Averse Event|7|||
105649887|NCT00730925|364380263|FG000|Overall Study|Protocol Violation|1|||
105649888|NCT00730925|364380263|FG000|Overall Study|Withdrawal by Subject|1|||
105649889|NCT00730925|364380263|FG000|Overall Study|Switch to combination therapy|8|||
105649890|NCT00730925|364380263|FG000|Overall Study|Other|1|||
105649891|NCT01732627|364380264|FG000|Overall Study|Withdrawal by Subject|1|||
105649892|NCT01732627|364380265|FG001|Overall Study|Withdrawal by Subject|0|||
105649893|NCT02567227|364380266|FG000|9 Weeks|Adverse Event|5|||
105649894|NCT02567227|364380267|FG001|9 Weeks|Adverse Event|5|||
105649895|NCT02567227|364380266|FG000|9 Weeks|Withdrawal by Subject|18|||
105649896|NCT02567227|364380267|FG001|9 Weeks|Withdrawal by Subject|8|||
105649897|NCT02567227|364380266|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
105649898|NCT02567227|364380267|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
105649899|NCT02567227|364380266|FG000|6 Month|Death|2|||
105649900|NCT02567227|364380267|FG001|6 Month|Death|0|||
105649901|NCT02567227|364380266|FG000|6 Month|Lost to Follow-up|43|||
105649902|NCT02567227|364380267|FG001|6 Month|Lost to Follow-up|40|||
105649903|NCT02567227|364380266|FG000|12 Months|Lost to Follow-up|31|||
105649904|NCT02567227|364380267|FG001|12 Months|Lost to Follow-up|32|||
105649905|NCT02567227|364380266|FG000|12 Months|Death|0|||
105649906|NCT02567227|364380267|FG001|12 Months|Death|2|||
105649907|NCT04057937|364380268|FG000|Placebo-controlled Phase|Adverse Event|3|||
105649908|NCT04057937|364380269|FG001|Placebo-controlled Phase|Adverse Event|0|||
105649909|NCT04057937|364380268|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
105649910|NCT04057937|364380269|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
105649911|NCT04057937|364380268|FG000|Active-treatment Phase|Pregnancy|0|||
105649912|NCT04057937|364380269|FG001|Active-treatment Phase|Pregnancy|1|||
105649913|NCT04057937|364380268|FG000|Active-treatment Phase|Physician Decision|0|||
105649914|NCT04057937|364380269|FG001|Active-treatment Phase|Physician Decision|1|||
105649915|NCT00005908|364380271|FG000|Overall Study|Withdrawal by Subject|1|||
105649916|NCT00005908|364380272|FG001|Overall Study|Withdrawal by Subject|0|||
105649917|NCT00274846|364380288|FG000|Overall Study|Did not receive adequate NK cells|1|||
105649918|NCT03023878|364380298|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
105649919|NCT03023878|364380298|FG000|Pre-Study Run-In Period|Death|1|||
105649920|NCT03023878|364380298|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
105649921|NCT03023878|364380298|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
105649922|NCT03023878|364380298|FG000|Treatment Period|Disease Progression|1|||
105649923|NCT03023878|364380298|FG000|Treatment Period|Withdrawal by Subject|1|||
105649924|NCT03023878|364380298|FG000|Treatment Period|Adverse Event|1|||
105649925|NCT03023878|364380298|FG000|Long Term Follow-Up Period|Death|2|||
105649926|NCT02784535|364380300|FG000|Overall Study|Adverse Event|1|||
105649927|NCT02784535|364380301|FG001|Overall Study|Adverse Event|0|||
105649928|NCT02784535|364380300|FG000|Overall Study|Withdrawal by Subject|0|||
105649929|NCT02784535|364380301|FG001|Overall Study|Withdrawal by Subject|1|||
105649930|NCT02784535|364380300|FG000|Overall Study|Physician Decision|0|||
105649931|NCT02784535|364380301|FG001|Overall Study|Physician Decision|1|||
105649932|NCT03873038|364380305|FG000|Part 2|Withdrawal by Subject|0|||
105649933|NCT03873038|364380306|FG001|Part 2|Withdrawal by Subject|0|||
105649934|NCT03873038|364380307|FG002|Part 2|Withdrawal by Subject|0|||
105649935|NCT03873038|364380308|FG003|Part 2|Withdrawal by Subject|0|||
105649936|NCT03873038|364380309|FG004|Part 2|Withdrawal by Subject|0|||
105649937|NCT03873038|364380310|FG005|Part 2|Withdrawal by Subject|1|||
105649938|NCT03873038|364380305|FG000|Part 2|Unknon|0|||
105649939|NCT03873038|364380306|FG001|Part 2|Unknon|0|||
105649940|NCT03873038|364380307|FG002|Part 2|Unknon|0|||
105649941|NCT03873038|364380308|FG003|Part 2|Unknon|0|||
105649942|NCT03873038|364380309|FG004|Part 2|Unknon|1|||
105649943|NCT03873038|364380310|FG005|Part 2|Unknon|0|||
105649944|NCT00905255|364380311|FG000|Overall Study|Adverse Event|7|||
105649945|NCT00905255|364380312|FG001|Overall Study|Adverse Event|5|||
105649946|NCT00905255|364380311|FG000|Overall Study|Withdrawal by Subject|5|||
105649947|NCT00905255|364380312|FG001|Overall Study|Withdrawal by Subject|4|||
105649948|NCT00905255|364380311|FG000|Overall Study|Familial and Personal Reasons|1|||
105649949|NCT00905255|364380312|FG001|Overall Study|Familial and Personal Reasons|0|||
105649950|NCT03849300|364380313|FG000|Overall Study|move out to different area|1|||
105649951|NCT03849300|364380314|FG001|Overall Study|move out to different area|3|||
105649952|NCT03849300|364380315|FG002|Overall Study|move out to different area|1|||
105649953|NCT03849300|364380316|FG003|Overall Study|move out to different area|4|||
105649954|NCT03849300|364380313|FG000|Overall Study|scheduling/transportation conflict|4|||
105649955|NCT03849300|364380314|FG001|Overall Study|scheduling/transportation conflict|4|||
105649956|NCT03849300|364380315|FG002|Overall Study|scheduling/transportation conflict|3|||
105649957|NCT03849300|364380316|FG003|Overall Study|scheduling/transportation conflict|2|||
105649958|NCT04150250|364380322|FG000|Overall Study|Lost to Follow-up|0|||
105649959|NCT04150250|364380323|FG001|Overall Study|Lost to Follow-up|2|||
105649960|NCT01804140|364380328|FG000|Overall Study|No sampling or biopsy procedures done|114|||
105649961|NCT00547300|364380329|FG000|Overall Study|Study was Administratively Terminated|25|||
105649962|NCT00547300|364380330|FG001|Overall Study|Study was Administratively Terminated|24|||
105649963|NCT00547300|364380329|FG000|Overall Study|Did not Meet Entry Criteria|0|||
105649964|NCT00547300|364380330|FG001|Overall Study|Did not Meet Entry Criteria|2|||
105649965|NCT00230971|364380331|FG000|Randomization|No study drug administered|3|||
105649966|NCT00230971|364380332|FG001|Randomization|No study drug administered|3|||
105649967|NCT00230971|364380331|FG000|Baseline Participants|Lost to Follow-up|5|||
105649968|NCT00230971|364380332|FG001|Baseline Participants|Lost to Follow-up|12|||
105649969|NCT00230971|364380331|FG000|Baseline Participants|Death|6|||
105649970|NCT00230971|364380332|FG001|Baseline Participants|Death|5|||
105649971|NCT00230971|364380331|FG000|Baseline Participants|Withdrawal by Subject|7|||
105649972|NCT00230971|364380332|FG001|Baseline Participants|Withdrawal by Subject|1|||
105649973|NCT00230971|364380331|FG000|Baseline Participants|Adverse Event|1|||
105649974|NCT00230971|364380332|FG001|Baseline Participants|Adverse Event|0|||
105649975|NCT00230971|364380331|FG000|Baseline Participants|No bacteria observed|1|||
105649976|NCT00230971|364380332|FG001|Baseline Participants|No bacteria observed|0|||
105649977|NCT00230971|364380331|FG000|Baseline Participants|Failure to return|1|||
105649978|NCT00230971|364380332|FG001|Baseline Participants|Failure to return|1|||
105649979|NCT00230971|364380331|FG000|Baseline Participants|Reintervention|1|||
105649980|NCT00230971|364380332|FG001|Baseline Participants|Reintervention|0|||
105649981|NCT03302559|364380333|FG000|Overall Study|Adverse Event|2|||
105649982|NCT03302559|364380333|FG000|Overall Study|Lost to Follow-up|1|||
105649983|NCT03302559|364380333|FG000|Overall Study|Withdrew Consent|3|||
105649984|NCT00497198|364380336|FG000|Overall Study|Adverse Event|4|||
105649985|NCT00497198|364380337|FG001|Overall Study|Adverse Event|2|||
105649986|NCT00497198|364380336|FG000|Overall Study|Physician Decision|1|||
105649987|NCT00497198|364380337|FG001|Overall Study|Physician Decision|2|||
105649988|NCT00497198|364380336|FG000|Overall Study|Withdrawal by Subject|0|||
105649989|NCT00497198|364380337|FG001|Overall Study|Withdrawal by Subject|1|||
105649990|NCT04267393|364380348|FG000|Randomization|Adverse Event|1|||
105649991|NCT04267393|364380349|FG001|Randomization|Adverse Event|0|||
105649992|NCT04267393|364380350|FG002|Randomization|Adverse Event|0|||
105649993|NCT04267393|364380348|FG000|Randomization|Administrative Reasons by Sponsor|0|||
105649994|NCT04267393|364380349|FG001|Randomization|Administrative Reasons by Sponsor|1|||
105649995|NCT04267393|364380350|FG002|Randomization|Administrative Reasons by Sponsor|0|||
105649996|NCT04267393|364380348|FG000|Treatment Period|Adverse Event|0|||
105649997|NCT04267393|364380349|FG001|Treatment Period|Adverse Event|2|||
105649998|NCT04267393|364380350|FG002|Treatment Period|Adverse Event|3|||
105649999|NCT04267393|364380348|FG000|Treatment Period|Participant Withdrew Consent|0|||
105650000|NCT04267393|364380349|FG001|Treatment Period|Participant Withdrew Consent|0|||
105650001|NCT04267393|364380350|FG002|Treatment Period|Participant Withdrew Consent|1|||
105650002|NCT04267393|364380348|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
105650003|NCT04267393|364380349|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
105650004|NCT04267393|364380350|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
105650005|NCT02799745|364380351|FG000|Overall Study|Participant moved out of state|1|||
105650006|NCT02799745|364380352|FG001|Overall Study|Participant moved out of state|0|||
105650007|NCT02799745|364380351|FG000|Overall Study|Discontinued due to planned surgery|1|||
105650008|NCT02799745|364380352|FG001|Overall Study|Discontinued due to planned surgery|0|||
105650009|NCT02799745|364380351|FG000|Overall Study|Withdrawal by Subject|16|||
105650010|NCT02799745|364380352|FG001|Overall Study|Withdrawal by Subject|25|||
105650011|NCT02799745|364380351|FG000|Overall Study|Protocol Deviation|4|||
105650012|NCT02799745|364380352|FG001|Overall Study|Protocol Deviation|5|||
105650013|NCT02799745|364380351|FG000|Overall Study|Progressive Disease|28|||
105650014|NCT02799745|364380352|FG001|Overall Study|Progressive Disease|38|||
105650015|NCT02799745|364380351|FG000|Overall Study|Lost to Follow-up|3|||
105650016|NCT02799745|364380352|FG001|Overall Study|Lost to Follow-up|2|||
105650017|NCT02799745|364380351|FG000|Overall Study|Death|3|||
105650018|NCT02799745|364380352|FG001|Overall Study|Death|0|||
105650019|NCT02799745|364380351|FG000|Overall Study|Adverse Event|0|||
105650020|NCT02799745|364380352|FG001|Overall Study|Adverse Event|1|||
105650021|NCT02661490|364381970|FG000|Overall Study|Lost to Follow-up|0|||
105650022|NCT02661490|364381971|FG001|Overall Study|Lost to Follow-up|1|||
105650023|NCT02661490|364381972|FG002|Overall Study|Lost to Follow-up|0|||
105650024|NCT02661490|364381973|FG003|Overall Study|Lost to Follow-up|0|||
105650025|NCT02661490|364381974|FG004|Overall Study|Lost to Follow-up|2|||
105650026|NCT02661490|364381970|FG000|Overall Study|Withdrawal by Subject|2|||
105650027|NCT02661490|364381971|FG001|Overall Study|Withdrawal by Subject|0|||
105650028|NCT02661490|364381972|FG002|Overall Study|Withdrawal by Subject|2|||
105650029|NCT02661490|364381973|FG003|Overall Study|Withdrawal by Subject|0|||
105650030|NCT02661490|364381974|FG004|Overall Study|Withdrawal by Subject|0|||
105650031|NCT02661490|364381970|FG000|Overall Study|Death|1|||
105650032|NCT02661490|364381971|FG001|Overall Study|Death|1|||
105650033|NCT02661490|364381972|FG002|Overall Study|Death|0|||
105650034|NCT02661490|364381973|FG003|Overall Study|Death|1|||
105650035|NCT02661490|364381974|FG004|Overall Study|Death|0|||
105650036|NCT02661490|364381970|FG000|Overall Study|Reason not Specified|0|||
105650037|NCT02661490|364381971|FG001|Overall Study|Reason not Specified|0|||
105650038|NCT02661490|364381972|FG002|Overall Study|Reason not Specified|0|||
105650039|NCT02661490|364381973|FG003|Overall Study|Reason not Specified|0|||
105650040|NCT02661490|364381974|FG004|Overall Study|Reason not Specified|1|||
105650041|NCT03322514|364381975|FG000|Overall Study|Withdrawal by Subject|1|||
105650042|NCT03322514|364381976|FG001|Overall Study|Withdrawal by Subject|1|||
105650043|NCT01193283|364381977|FG000|Overall Study|Death|1|||
105650044|NCT01370018|364381978|FG000|Overall Study|Did not meet criteria for analysis|1|||
105650045|NCT03772041|364381979|FG000|Overall Study|Adverse Event|8|||
105650046|NCT03772041|364381980|FG001|Overall Study|Adverse Event|3|||
105650047|NCT03772041|364381979|FG000|Overall Study|Withdrawal by Subject|0|||
105650048|NCT03772041|364381980|FG001|Overall Study|Withdrawal by Subject|2|||
105650049|NCT03772041|364381979|FG000|Overall Study|Protocol Violation|4|||
105650050|NCT03772041|364381980|FG001|Overall Study|Protocol Violation|2|||
105650051|NCT03772041|364381979|FG000|Overall Study|Physician Decision|2|||
105650052|NCT03772041|364381980|FG001|Overall Study|Physician Decision|3|||
105650053|NCT02720198|364381981|FG000|Overall Study|Withdrawal by Subject|0|||
105650054|NCT02720198|364381982|FG001|Overall Study|Withdrawal by Subject|1|||
105650055|NCT01061775|364381983|FG000|Overall Study|Physician Decision|2|||
105650056|NCT01061775|364381983|FG000|Overall Study|Lost to Follow-up|1|||
105650057|NCT03334747|364381984|FG000|Treatment Phase|Technical problems|0|||
105650058|NCT03334747|364381985|FG001|Treatment Phase|Technical problems|0|||
105650059|NCT03334747|364381986|FG002|Treatment Phase|Technical problems|0|||
105650060|NCT03334747|364381987|FG003|Treatment Phase|Technical problems|0|||
105650061|NCT03334747|364381988|FG004|Treatment Phase|Technical problems|1|||
105650062|NCT03334747|364381989|FG005|Treatment Phase|Technical problems|0|||
105650063|NCT03334747|364381990|FG006|Treatment Phase|Technical problems|0|||
105650064|NCT03334747|364381991|FG007|Treatment Phase|Technical problems|0|||
105650065|NCT03334747|364381992|FG008|Treatment Phase|Technical problems|0|||
105650066|NCT03334747|364381984|FG000|Treatment Phase|Subject/guardian decision|1|||
105650067|NCT03334747|364381985|FG001|Treatment Phase|Subject/guardian decision|0|||
105650068|NCT03334747|364381986|FG002|Treatment Phase|Subject/guardian decision|0|||
105650069|NCT03334747|364381987|FG003|Treatment Phase|Subject/guardian decision|0|||
105650070|NCT03334747|364381988|FG004|Treatment Phase|Subject/guardian decision|0|||
105650071|NCT03334747|364381989|FG005|Treatment Phase|Subject/guardian decision|1|||
105650072|NCT03334747|364381990|FG006|Treatment Phase|Subject/guardian decision|0|||
105650073|NCT03334747|364381991|FG007|Treatment Phase|Subject/guardian decision|0|||
105650074|NCT03334747|364381992|FG008|Treatment Phase|Subject/guardian decision|0|||
105650075|NCT03334747|364381984|FG000|Follow-Up Phase|Subject/guardian decision|0|||
105650076|NCT03334747|364381985|FG001|Follow-Up Phase|Subject/guardian decision|0|||
105650077|NCT03334747|364381986|FG002|Follow-Up Phase|Subject/guardian decision|0|||
105650078|NCT03334747|364381987|FG003|Follow-Up Phase|Subject/guardian decision|0|||
105650079|NCT03334747|364381988|FG004|Follow-Up Phase|Subject/guardian decision|0|||
105650080|NCT03334747|364381989|FG005|Follow-Up Phase|Subject/guardian decision|0|||
105650081|NCT03334747|364381990|FG006|Follow-Up Phase|Subject/guardian decision|1|||
105650082|NCT03334747|364381991|FG007|Follow-Up Phase|Subject/guardian decision|0|||
105650083|NCT03334747|364381992|FG008|Follow-Up Phase|Subject/guardian decision|1|||
105650084|NCT02029521|364381995|FG000|Overall Study|Protocol Violation|1|||
105650085|NCT02029521|364381996|FG001|Overall Study|Protocol Violation|0|||
105650086|NCT02029521|364381995|FG000|Overall Study|Withdrawal by Subject|1|||
105650087|NCT02029521|364381996|FG001|Overall Study|Withdrawal by Subject|1|||
105650088|NCT01072396|364381997|FG000|Period One|Adverse Event|1|||
105650089|NCT01072396|364381998|FG001|Period One|Adverse Event|1|||
105650090|NCT01072396|364381997|FG000|Period One|Protocol Violation|2|||
105650091|NCT01072396|364381998|FG001|Period One|Protocol Violation|1|||
105650092|NCT01072396|364381997|FG000|Period One|Withdrawal by Subject|2|||
105650093|NCT01072396|364381998|FG001|Period One|Withdrawal by Subject|0|||
105650094|NCT01072396|364381997|FG000|Washout Period|Missing termination information|0|||
105650095|NCT01072396|364381998|FG001|Washout Period|Missing termination information|1|||
105650096|NCT01072396|364381997|FG000|Period Two|Adverse Event|0|||
105650097|NCT01072396|364381998|FG001|Period Two|Adverse Event|3|||
105650098|NCT01072396|364381997|FG000|Period Two|Lost to Follow-up|1|||
105650099|NCT01072396|364381998|FG001|Period Two|Lost to Follow-up|0|||
105650100|NCT04748445|364382001|FG000|Overall Study|No longer met eligibility criteria|12|||
105650101|NCT04748445|364382001|FG000|Overall Study|Other|36|||
105650102|NCT04748445|364382001|FG000|Overall Study|Withdrawal by Subject|553|||
105650103|NCT04748445|364382001|FG000|Overall Study|Lost to Follow-up|30|||
105650104|NCT04736602|364382002|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
105650105|NCT04736602|364382002|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
105650106|NCT01379521|364382003|FG000|Overall Study -Treatment Period|Adverse Event|3|||
105650107|NCT01379521|364382004|FG001|Overall Study -Treatment Period|Adverse Event|0|||
105650108|NCT01379521|364382003|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
105650109|NCT01379521|364382004|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
105650110|NCT01379521|364382003|FG000|Overall Study -Treatment Period|Disease Progression|23|||
105650111|NCT01379521|364382004|FG001|Overall Study -Treatment Period|Disease Progression|22|||
105650112|NCT01379521|364382003|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
105650113|NCT01379521|364382004|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
105650114|NCT01379521|364382003|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
105650115|NCT01379521|364382004|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
105650116|NCT01379521|364382003|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
105650117|NCT01379521|364382004|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
105650118|NCT01379521|364382003|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
105650119|NCT01379521|364382004|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
105650120|NCT01379521|364382003|FG000|Overall Study -Treatment Period|Death|2|||
105650121|NCT01379521|364382004|FG001|Overall Study -Treatment Period|Death|1|||
105650122|NCT01379521|364382003|FG000|Post-Treatment Evaluations|Disease Progression|22|||
105650123|NCT01379521|364382004|FG001|Post-Treatment Evaluations|Disease Progression|20|||
105650124|NCT01379521|364382003|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
105650125|NCT01379521|364382004|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
105650126|NCT01379521|364382003|FG000|Post-Treatment Evaluations|Death|1|||
105650127|NCT01379521|364382004|FG001|Post-Treatment Evaluations|Death|0|||
105650128|NCT01026103|364382005|FG000|Overall Study|Physician Decision|1|||
105650129|NCT01026103|364382005|FG000|Overall Study|did not receive study device bc of error|1|||
105650130|NCT00105521|364382007|FG000|Overall Study|Other|1|||
105650131|NCT00105521|364382008|FG001|Overall Study|Other|1|||
105650132|NCT00105521|364382009|FG002|Overall Study|Other|2|||
105650133|NCT00105521|364382010|FG003|Overall Study|Other|0|||
105650134|NCT00105521|364382007|FG000|Overall Study|Adverse Event|10|||
105650135|NCT00105521|364382008|FG001|Overall Study|Adverse Event|4|||
105650136|NCT00105521|364382009|FG002|Overall Study|Adverse Event|10|||
105650137|NCT00105521|364382010|FG003|Overall Study|Adverse Event|8|||
105650138|NCT00105521|364382007|FG000|Overall Study|Withdrawal by Subject|1|||
105650139|NCT00105521|364382008|FG001|Overall Study|Withdrawal by Subject|0|||
105650140|NCT00105521|364382009|FG002|Overall Study|Withdrawal by Subject|1|||
105650141|NCT00105521|364382010|FG003|Overall Study|Withdrawal by Subject|4|||
105650142|NCT00105521|364382007|FG000|Overall Study|Lack of Efficacy|0|||
105650143|NCT00105521|364382008|FG001|Overall Study|Lack of Efficacy|0|||
105650144|NCT00105521|364382009|FG002|Overall Study|Lack of Efficacy|0|||
105650145|NCT00105521|364382010|FG003|Overall Study|Lack of Efficacy|1|||
105650146|NCT00105521|364382007|FG000|Overall Study|Protocol Violation|3|||
105650147|NCT00105521|364382008|FG001|Overall Study|Protocol Violation|5|||
105650148|NCT00105521|364382009|FG002|Overall Study|Protocol Violation|4|||
105650149|NCT00105521|364382010|FG003|Overall Study|Protocol Violation|4|||
105650150|NCT00105521|364382007|FG000|Overall Study|Lost to Follow-up|0|||
105650151|NCT00105521|364382008|FG001|Overall Study|Lost to Follow-up|1|||
105650152|NCT00105521|364382009|FG002|Overall Study|Lost to Follow-up|0|||
105650153|NCT00105521|364382010|FG003|Overall Study|Lost to Follow-up|0|||
105650154|NCT02504502|364382011|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
105650155|NCT02504502|364382012|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
105650156|NCT02504502|364382011|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
105650157|NCT02504502|364382012|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
105650158|NCT00762502|364382013|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
105650159|NCT00762502|364382014|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
105650160|NCT00762502|364382015|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
105650161|NCT00762502|364382013|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
105650162|NCT00762502|364382014|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
105650163|NCT00762502|364382015|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
105650164|NCT00762502|364382013|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
105650165|NCT00762502|364382014|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
105650166|NCT00762502|364382015|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
105650167|NCT03042559|364382016|FG000|Overall Study|drop out|1|||
105650168|NCT03042559|364382017|FG001|Overall Study|drop out|1|||
105650169|NCT00428441|364382022|FG000|Overall Study|Lost to Follow-up|1|||
105650170|NCT00404547|364382025|FG000|Overall Study|Adverse Event|39|||
105650171|NCT00404547|364382026|FG001|Overall Study|Adverse Event|6|||
105650172|NCT00404547|364382025|FG000|Overall Study|Withdrawal by Subject|19|||
105650173|NCT00404547|364382026|FG001|Overall Study|Withdrawal by Subject|2|||
105650174|NCT00404547|364382025|FG000|Overall Study|Protocol Violation|0|||
105650175|NCT00404547|364382026|FG001|Overall Study|Protocol Violation|1|||
105650176|NCT00404547|364382025|FG000|Overall Study|Lost to Follow-up|20|||
105650177|NCT00404547|364382026|FG001|Overall Study|Lost to Follow-up|9|||
105650178|NCT00404547|364382025|FG000|Overall Study|Lack of compliance|5|||
105650179|NCT00404547|364382026|FG001|Overall Study|Lack of compliance|1|||
105650180|NCT00404547|364382025|FG000|Overall Study|Other|4|||
105650181|NCT00404547|364382026|FG001|Overall Study|Other|0|||
105650182|NCT00404547|364382025|FG000|Overall Study|Reason not stated|3|||
105650183|NCT00404547|364382026|FG001|Overall Study|Reason not stated|6|||
105650184|NCT01475370|364382027|FG000|Overall Study|Exacerbation of primary disease|2|||
105650185|NCT01475370|364382028|FG001|Overall Study|Exacerbation of primary disease|2|||
105650186|NCT01475370|364382029|FG002|Overall Study|Exacerbation of primary disease|2|||
105650187|NCT01475370|364382027|FG000|Overall Study|Study drug administration difficult|0|||
105650188|NCT01475370|364382028|FG001|Overall Study|Study drug administration difficult|1|||
105650189|NCT01475370|364382029|FG002|Overall Study|Study drug administration difficult|1|||
105650190|NCT01475370|364382027|FG000|Overall Study|Other than specified|1|||
105650191|NCT01475370|364382028|FG001|Overall Study|Other than specified|0|||
105650192|NCT01475370|364382029|FG002|Overall Study|Other than specified|0|||
105650193|NCT02538471|364382030|FG000|Overall Study|Progression of disease|2|||
105650194|NCT02131155|364382031|FG000|Overall Study|Adverse Event|1|||
105650195|NCT02131155|364382032|FG001|Overall Study|Adverse Event|0|||
105650196|NCT02131155|364382031|FG000|Overall Study|Treatment completed|1|||
105650197|NCT02131155|364382032|FG001|Overall Study|Treatment completed|0|||
105650198|NCT02131155|364382031|FG000|Overall Study|Primary tumour recurrence|2|||
105650199|NCT02131155|364382032|FG001|Overall Study|Primary tumour recurrence|1|||
105650200|NCT02131155|364382031|FG000|Overall Study|Refused to continue study medication|1|||
105650201|NCT02131155|364382032|FG001|Overall Study|Refused to continue study medication|0|||
105650202|NCT02131155|364382031|FG000|Overall Study|Study early termination|20|||
105650203|NCT02131155|364382032|FG001|Overall Study|Study early termination|10|||
105650204|NCT01675050|364382035|FG000|Period One Treatment|Withdrawal by Subject|1|||
105650205|NCT01675050|364382036|FG001|Period One Treatment|Withdrawal by Subject|0|||
105650206|NCT01887418|364382037|FG000|Overall Study|Travelling difficulties|0|||
105650207|NCT01887418|364382038|FG001|Overall Study|Travelling difficulties|0|||
105650208|NCT01887418|364382039|FG002|Overall Study|Travelling difficulties|1|||
105650209|NCT00475735|364382040|FG000|Treatment Period 1|Adverse Event|2|||
105650210|NCT00475735|364382041|FG001|Treatment Period 1|Adverse Event|0|||
105650211|NCT00475735|364382042|FG002|Treatment Period 1|Adverse Event|0|||
105650212|NCT00475735|364382043|FG003|Treatment Period 1|Adverse Event|0|||
105650213|NCT00475735|364382044|FG004|Treatment Period 1|Adverse Event|0|||
105650214|NCT00475735|364382045|FG005|Treatment Period 1|Adverse Event|0|||
105650215|NCT00475735|364382040|FG000|Treatment Period 1|Lack of Efficacy|1|||
105650216|NCT00475735|364382041|FG001|Treatment Period 1|Lack of Efficacy|0|||
105650217|NCT00475735|364382042|FG002|Treatment Period 1|Lack of Efficacy|0|||
105650218|NCT00475735|364382043|FG003|Treatment Period 1|Lack of Efficacy|0|||
105650219|NCT00475735|364382044|FG004|Treatment Period 1|Lack of Efficacy|0|||
105650220|NCT00475735|364382045|FG005|Treatment Period 1|Lack of Efficacy|0|||
105650221|NCT00475735|364382040|FG000|Treatment Period 1|Lost to Follow-up|0|||
105650222|NCT00475735|364382041|FG001|Treatment Period 1|Lost to Follow-up|0|||
105650223|NCT00475735|364382042|FG002|Treatment Period 1|Lost to Follow-up|0|||
105650224|NCT00475735|364382043|FG003|Treatment Period 1|Lost to Follow-up|0|||
105650225|NCT00475735|364382044|FG004|Treatment Period 1|Lost to Follow-up|0|||
105650226|NCT00475735|364382045|FG005|Treatment Period 1|Lost to Follow-up|1|||
105650227|NCT00475735|364382040|FG000|Treatment Period 1|Protocol Violation|0|||
105650228|NCT00475735|364382041|FG001|Treatment Period 1|Protocol Violation|0|||
105650229|NCT00475735|364382042|FG002|Treatment Period 1|Protocol Violation|0|||
105650230|NCT00475735|364382043|FG003|Treatment Period 1|Protocol Violation|1|||
105650231|NCT00475735|364382044|FG004|Treatment Period 1|Protocol Violation|0|||
105650232|NCT00475735|364382045|FG005|Treatment Period 1|Protocol Violation|0|||
105650233|NCT00475735|364382040|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105650234|NCT00475735|364382041|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105650235|NCT00475735|364382042|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105650236|NCT00475735|364382043|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105650237|NCT00475735|364382044|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105650238|NCT00475735|364382045|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105650239|NCT00475735|364382040|FG000|Treatment Period 1|DC due to AE but continuing|0|||
105650240|NCT00475735|364382041|FG001|Treatment Period 1|DC due to AE but continuing|0|||
105650241|NCT00475735|364382042|FG002|Treatment Period 1|DC due to AE but continuing|0|||
105650242|NCT00475735|364382043|FG003|Treatment Period 1|DC due to AE but continuing|1|||
105650243|NCT00475735|364382044|FG004|Treatment Period 1|DC due to AE but continuing|2|||
105650244|NCT00475735|364382045|FG005|Treatment Period 1|DC due to AE but continuing|2|||
105650245|NCT00475735|364382040|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
105650246|NCT00475735|364382041|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
105650247|NCT00475735|364382042|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
105650248|NCT00475735|364382043|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
105650249|NCT00475735|364382044|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
105650250|NCT00475735|364382045|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
105650251|NCT00475735|364382040|FG000|Treatment Washout|Lost to Follow-up|0|||
105650252|NCT00475735|364382041|FG001|Treatment Washout|Lost to Follow-up|1|||
105650253|NCT00475735|364382042|FG002|Treatment Washout|Lost to Follow-up|0|||
105650254|NCT00475735|364382043|FG003|Treatment Washout|Lost to Follow-up|0|||
105650255|NCT00475735|364382044|FG004|Treatment Washout|Lost to Follow-up|0|||
105650256|NCT00475735|364382045|FG005|Treatment Washout|Lost to Follow-up|0|||
105650257|NCT00475735|364382040|FG000|Treatment Washout|Protocol Violation|0|||
105650258|NCT00475735|364382041|FG001|Treatment Washout|Protocol Violation|1|||
105650259|NCT00475735|364382042|FG002|Treatment Washout|Protocol Violation|0|||
105650260|NCT00475735|364382043|FG003|Treatment Washout|Protocol Violation|0|||
105650261|NCT00475735|364382044|FG004|Treatment Washout|Protocol Violation|0|||
105650262|NCT00475735|364382045|FG005|Treatment Washout|Protocol Violation|0|||
105650263|NCT00475735|364382040|FG000|Treatment Period 2|Adverse Event|0|||
105650264|NCT00475735|364382041|FG001|Treatment Period 2|Adverse Event|1|||
105650265|NCT00475735|364382042|FG002|Treatment Period 2|Adverse Event|0|||
105650266|NCT00475735|364382043|FG003|Treatment Period 2|Adverse Event|2|||
105650267|NCT00475735|364382044|FG004|Treatment Period 2|Adverse Event|0|||
105650268|NCT00475735|364382045|FG005|Treatment Period 2|Adverse Event|0|||
105650269|NCT00475735|364382040|FG000|Treatment Period 2|Lack of Efficacy|0|||
105650270|NCT00475735|364382041|FG001|Treatment Period 2|Lack of Efficacy|0|||
105650271|NCT00475735|364382042|FG002|Treatment Period 2|Lack of Efficacy|0|||
105650272|NCT00475735|364382043|FG003|Treatment Period 2|Lack of Efficacy|0|||
105650273|NCT00475735|364382044|FG004|Treatment Period 2|Lack of Efficacy|0|||
105650274|NCT00475735|364382045|FG005|Treatment Period 2|Lack of Efficacy|1|||
105650275|NCT00475735|364382040|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105650276|NCT00475735|364382041|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105650277|NCT00475735|364382042|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105650278|NCT00475735|364382043|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105650279|NCT00475735|364382044|FG004|Treatment Period 2|Withdrawal by Subject|1|||
105650280|NCT00475735|364382045|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105650281|NCT03132753|364382048|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
105650282|NCT03132753|364382049|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
105650283|NCT03132753|364382048|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
105650284|NCT03132753|364382049|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
105650285|NCT00084747|364382050|FG000|Overall Study|Relapsed|8|||
105650286|NCT00084747|364382050|FG000|Overall Study|Death|3|||
105650287|NCT00084747|364382050|FG000|Overall Study|Withdrawal by Subject|2|||
105650288|NCT03794609|364382055|FG000|Overall Study|Other|10|||
105650289|NCT03794609|364382055|FG000|Overall Study|Withdrawal by Subject|66|||
105650290|NCT03794609|364382055|FG000|Overall Study|The child is enrolled in an interventional study|70|||
105650291|NCT03794609|364382055|FG000|Overall Study|Inclusion/exclusion criteria|8|||
105650292|NCT03794609|364382055|FG000|Overall Study|At sponsor's request|151|||
105650293|NCT03794609|364382055|FG000|Overall Study|Physician Decision|1|||
105650294|NCT03794609|364382055|FG000|Overall Study|Lost to Follow-up|5|||
105650295|NCT02744898|364382056|FG000|Overall Study|Progressive Disease|2|||
105650296|NCT02744898|364382056|FG000|Overall Study|Physician Decision|1|||
105650297|NCT02744898|364382056|FG000|Overall Study|Toxicity|1|||
105650298|NCT04543942|364382057|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
105650299|NCT04543942|364382058|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
105650300|NCT04543942|364382057|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
105650301|NCT04543942|364382058|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
105650302|NCT02205476|364382059|FG000|Overall Study|Study termination by Sponsor|7|||
105650303|NCT02205476|364382060|FG001|Overall Study|Study termination by Sponsor|3|||
105650304|NCT02350127|364382068|FG000|4-Month Assessment|Withdrawal by Subject|10|||
105650305|NCT02350127|364382069|FG001|4-Month Assessment|Withdrawal by Subject|9|||
105650306|NCT02350127|364382068|FG000|4-Month Assessment|Death|1|||
105650307|NCT02350127|364382069|FG001|4-Month Assessment|Death|0|||
105650308|NCT02350127|364382068|FG000|8-Month Assessment|Death|1|||
105650309|NCT02350127|364382069|FG001|8-Month Assessment|Death|1|||
105650310|NCT02350127|364382068|FG000|8-Month Assessment|Withdrawal by Subject|5|||
105650311|NCT02350127|364382069|FG001|8-Month Assessment|Withdrawal by Subject|8|||
105650312|NCT02097056|364382070|FG000|Overall Study|Protocol Violation|2|||
105650313|NCT02097056|364382070|FG000|Overall Study|Withdrawal by Subject|15|||
105650314|NCT02097056|364382070|FG000|Overall Study|Lost to Follow-up|2|||
105650315|NCT02097056|364382070|FG000|Overall Study|Adverse Event|37|||
105650316|NCT02097056|364382070|FG000|Overall Study|Other|2|||
105650317|NCT01323309|364382079|FG000|Overall Study|Death|9|||
105650318|NCT01323309|364382080|FG001|Overall Study|Death|15|||
105650319|NCT01323309|364382081|FG002|Overall Study|Death|5|||
105650320|NCT01323309|364382079|FG000|Overall Study|Lost to Follow-up|11|||
105650321|NCT01323309|364382080|FG001|Overall Study|Lost to Follow-up|14|||
105650322|NCT01323309|364382081|FG002|Overall Study|Lost to Follow-up|24|||
105650323|NCT01323309|364382079|FG000|Overall Study|Withdrawal by Subject|14|||
105650324|NCT01323309|364382080|FG001|Overall Study|Withdrawal by Subject|14|||
105650325|NCT01323309|364382081|FG002|Overall Study|Withdrawal by Subject|18|||
105650326|NCT01323309|364382079|FG000|Overall Study|Disease progression|5|||
105650327|NCT01323309|364382080|FG001|Overall Study|Disease progression|11|||
105650328|NCT01323309|364382081|FG002|Overall Study|Disease progression|4|||
105650329|NCT02625922|364382082|FG000|Overall Study|Non-availability of IMP|1|||
105650330|NCT02625922|364382083|FG001|Overall Study|Non-availability of IMP|1|||
105650331|NCT02625922|364382082|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
105650332|NCT02625922|364382083|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
105650333|NCT00910871|364382084|FG000|Overall Study|Adverse Event|5|||
105650334|NCT00910871|364382084|FG000|Overall Study|Death|12|||
105650335|NCT00910871|364382084|FG000|Overall Study|Lost to Follow-up|8|||
105650336|NCT00910871|364382084|FG000|Overall Study|Protocol Violation|11|||
105650337|NCT00910871|364382084|FG000|Overall Study|Withdrawal by Subject|12|||
105650338|NCT00910871|364382084|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
105650339|NCT00910871|364382084|FG000|Overall Study|Undefined|1|||
105650340|NCT00050167|364382088|FG000|Overall Study|not eligible not invasive|1|||
105650341|NCT00050167|364382089|FG001|Overall Study|not eligible not invasive|1|||
105650342|NCT00676663|364382090|FG000|Overall Study|Death|43|||
105650343|NCT00676663|364382091|FG001|Overall Study|Death|27|||
105650344|NCT00676663|364382090|FG000|Overall Study|Withdrew Consent|1|||
105650345|NCT00676663|364382091|FG001|Overall Study|Withdrew Consent|8|||
105650346|NCT00676663|364382090|FG000|Overall Study|Lost to Follow-up|1|||
105650347|NCT00676663|364382091|FG001|Overall Study|Lost to Follow-up|3|||
105650348|NCT01544153|364382092|FG000|Overall Study|Under 18|0|||
105650349|NCT01544153|364382093|FG001|Overall Study|Under 18|1|||
105650350|NCT01544153|364382094|FG002|Overall Study|Under 18|0|||
105650351|NCT01544153|364382095|FG003|Overall Study|Under 18|0|||
105650352|NCT01544153|364382092|FG000|Overall Study|Non-smoker|0|||
105650353|NCT01544153|364382093|FG001|Overall Study|Non-smoker|0|||
105650354|NCT01544153|364382094|FG002|Overall Study|Non-smoker|1|||
105650355|NCT01544153|364382095|FG003|Overall Study|Non-smoker|0|||
105650356|NCT00884793|364382096|FG000|Overall Study|Withdrawal by Subject|1|||
105650357|NCT03169530|364382097|FG000|Overall Study|Study ended by NIH|15|||
105650358|NCT03169530|364382098|FG001|Overall Study|Study ended by NIH|17|||
105650359|NCT00714688|364382106|FG000|Overall Study|Lack of Efficacy|14|||
105650360|NCT00714688|364382107|FG001|Overall Study|Lack of Efficacy|1|||
105650361|NCT00714688|364382108|FG002|Overall Study|Lack of Efficacy|4|||
105650362|NCT00714688|364382106|FG000|Overall Study|Withdrawal by Subject|4|||
105650363|NCT00714688|364382107|FG001|Overall Study|Withdrawal by Subject|3|||
105650364|NCT00714688|364382108|FG002|Overall Study|Withdrawal by Subject|3|||
105650365|NCT00714688|364382106|FG000|Overall Study|Lost to Follow-up|5|||
105650366|NCT00714688|364382107|FG001|Overall Study|Lost to Follow-up|2|||
105650367|NCT00714688|364382108|FG002|Overall Study|Lost to Follow-up|0|||
105650368|NCT00714688|364382106|FG000|Overall Study|Adverse Event|2|||
105650369|NCT00714688|364382107|FG001|Overall Study|Adverse Event|15|||
105650370|NCT00714688|364382108|FG002|Overall Study|Adverse Event|19|||
105650371|NCT00714688|364382106|FG000|Overall Study|Subject Non-compliant|3|||
105650372|NCT00714688|364382107|FG001|Overall Study|Subject Non-compliant|5|||
105650373|NCT00714688|364382108|FG002|Overall Study|Subject Non-compliant|5|||
105650374|NCT00714688|364382106|FG000|Overall Study|Ineligible to Continue the Study|0|||
105650375|NCT00714688|364382107|FG001|Overall Study|Ineligible to Continue the Study|1|||
105650376|NCT00714688|364382108|FG002|Overall Study|Ineligible to Continue the Study|1|||
105650377|NCT00714688|364382106|FG000|Overall Study|Sponsor's Decision|0|||
105650378|NCT00714688|364382107|FG001|Overall Study|Sponsor's Decision|2|||
105650379|NCT00714688|364382108|FG002|Overall Study|Sponsor's Decision|0|||
105650380|NCT00714688|364382106|FG000|Overall Study|Other|1|||
105650381|NCT00714688|364382107|FG001|Overall Study|Other|6|||
105650382|NCT00714688|364382108|FG002|Overall Study|Other|5|||
105650383|NCT00500539|364382109|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
105650384|NCT00500539|364382109|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
105650385|NCT00500539|364382109|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
105650386|NCT00500539|364382109|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
105650387|NCT00500539|364382109|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
105650388|NCT00500539|364382109|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
105650389|NCT00500539|364382109|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
105650390|NCT00500539|364382109|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
105650391|NCT00500539|364382109|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
105650392|NCT00500539|364382109|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
105650393|NCT00500539|364382109|FG000|Follow-up Period (16 Weeks)|Death|1|||
105650394|NCT00500539|364382109|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
105650395|NCT00500539|364382109|FG000|Follow-up Period (16 Weeks)|Missing|3|||
105650396|NCT00774306|364384056|FG000|Overall Study|Adverse Event|3|||
105650397|NCT00774306|364384057|FG001|Overall Study|Adverse Event|0|||
105650398|NCT00774306|364384058|FG002|Overall Study|Adverse Event|0|||
105650399|NCT00774306|364384059|FG003|Overall Study|Adverse Event|0|||
105650400|NCT00774306|364384056|FG000|Overall Study|Protocol Violation|2|||
105650401|NCT00774306|364384057|FG001|Overall Study|Protocol Violation|0|||
105650402|NCT00774306|364384058|FG002|Overall Study|Protocol Violation|3|||
105650403|NCT00774306|364384059|FG003|Overall Study|Protocol Violation|0|||
105650404|NCT00774306|364384056|FG000|Overall Study|Withdrawal by Subject|6|||
105650405|NCT00774306|364384057|FG001|Overall Study|Withdrawal by Subject|1|||
105650406|NCT00774306|364384058|FG002|Overall Study|Withdrawal by Subject|1|||
105650407|NCT00774306|364384059|FG003|Overall Study|Withdrawal by Subject|0|||
105650408|NCT00774306|364384056|FG000|Overall Study|Lost to Follow-up|6|||
105650409|NCT00774306|364384057|FG001|Overall Study|Lost to Follow-up|0|||
105650410|NCT00774306|364384058|FG002|Overall Study|Lost to Follow-up|4|||
105650411|NCT00774306|364384059|FG003|Overall Study|Lost to Follow-up|5|||
105650412|NCT00774306|364384056|FG000|Overall Study|Death|1|||
105650413|NCT00774306|364384057|FG001|Overall Study|Death|1|||
105650414|NCT00774306|364384058|FG002|Overall Study|Death|0|||
105650415|NCT00774306|364384059|FG003|Overall Study|Death|0|||
105650416|NCT03568708|364384062|FG000|Overall Study|Withdrawal by Subject|1|||
105650417|NCT03568708|364384063|FG001|Overall Study|Withdrawal by Subject|1|||
105650418|NCT03568708|364384062|FG000|Overall Study|Lost to Follow-up|0|||
105650419|NCT03568708|364384063|FG001|Overall Study|Lost to Follow-up|1|||
105650420|NCT01126879|364384066|FG000|Overall Study|Progressive Disease|3|||
105650421|NCT01126879|364384067|FG001|Overall Study|Progressive Disease|1|||
105650422|NCT01126879|364384066|FG000|Overall Study|Withdrawal by Subject|1|||
105650423|NCT01126879|364384067|FG001|Overall Study|Withdrawal by Subject|0|||
105650424|NCT01126879|364384066|FG000|Overall Study|Adverse Event|0|||
105650425|NCT01126879|364384067|FG001|Overall Study|Adverse Event|1|||
105650426|NCT01126879|364384066|FG000|Overall Study|Physician Decision|1|||
105650427|NCT01126879|364384067|FG001|Overall Study|Physician Decision|0|||
105650428|NCT00126555|364384074|FG000|Overall Study|Withdrawal by Subject|1|||
105650429|NCT00126555|364384074|FG000|Overall Study|Adverse Event|2|||
105650430|NCT00126555|364384074|FG000|Overall Study|Progressive Disease|3|||
105650431|NCT02186015|364384080|FG000|Overall Study|Physician Decision|1|||
105650432|NCT02186015|364384081|FG001|Overall Study|Physician Decision|0|||
105650433|NCT00139659|364384086|FG000|Overall Study|Adverse Event|12|||
105650434|NCT00139659|364384087|FG001|Overall Study|Adverse Event|1|||
105650435|NCT00139659|364384086|FG000|Overall Study|Lack of Efficacy|1|||
105650436|NCT00139659|364384087|FG001|Overall Study|Lack of Efficacy|1|||
105650437|NCT00139659|364384086|FG000|Overall Study|Lost to Follow-up|7|||
105650438|NCT00139659|364384087|FG001|Overall Study|Lost to Follow-up|3|||
105650439|NCT00139659|364384086|FG000|Overall Study|Reason not Specified|6|||
105650440|NCT00139659|364384087|FG001|Overall Study|Reason not Specified|3|||
105650441|NCT00139659|364384086|FG000|Overall Study|Withdrawal by Subject|14|||
105650442|NCT00139659|364384087|FG001|Overall Study|Withdrawal by Subject|10|||
105650443|NCT02162771|364384088|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
105650444|NCT02162771|364384089|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
105650445|NCT02162771|364384088|FG000|Core Study Period (Part 2)|Adverse Event|4|||
105650446|NCT02162771|364384089|FG001|Core Study Period (Part 2)|Adverse Event|1|||
105650447|NCT02162771|364384088|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
105650448|NCT02162771|364384089|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
105650449|NCT02162771|364384088|FG000|Core Study Period (Part 2)|Physician Decision|0|||
105650450|NCT02162771|364384089|FG001|Core Study Period (Part 2)|Physician Decision|2|||
105650451|NCT02162771|364384088|FG000|Core Study Period (Part 2)|Death|1|||
105650452|NCT02162771|364384089|FG001|Core Study Period (Part 2)|Death|0|||
105650453|NCT02162771|364384088|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
105650454|NCT02162771|364384089|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
105650455|NCT02162771|364384088|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
105650456|NCT02162771|364384089|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
105650457|NCT02162771|364384088|FG000|Maintenance Study Period (Part 2)|Death|2|||
105650458|NCT02162771|364384089|FG001|Maintenance Study Period (Part 2)|Death|1|||
105650459|NCT02162771|364384088|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
105650460|NCT02162771|364384089|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
105650461|NCT02162771|364384088|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
105650462|NCT02162771|364384089|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
105650463|NCT02162771|364384088|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
105650464|NCT02162771|364384089|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
105650465|NCT01190228|364384094|FG000|Overall Study|Protocol Violation|4|||
105650466|NCT01190228|364384095|FG001|Overall Study|Protocol Violation|0|||
105650467|NCT01190228|364384096|FG002|Overall Study|Protocol Violation|0|||
105650468|NCT01190228|364384094|FG000|Overall Study|Withdrawal by Subject|1|||
105650469|NCT01190228|364384095|FG001|Overall Study|Withdrawal by Subject|0|||
105650470|NCT01190228|364384096|FG002|Overall Study|Withdrawal by Subject|0|||
105650471|NCT00607789|364384100|FG000|Overall Study|Adverse Event|3|||
105650472|NCT00607789|364384101|FG001|Overall Study|Adverse Event|0|||
105650473|NCT00607789|364384100|FG000|Overall Study|Lack of Efficacy|0|||
105650474|NCT00607789|364384101|FG001|Overall Study|Lack of Efficacy|1|||
105650475|NCT00607789|364384100|FG000|Overall Study|Inadequate adherence|3|||
105650476|NCT00607789|364384101|FG001|Overall Study|Inadequate adherence|0|||
105650477|NCT00607789|364384100|FG000|Overall Study|Lost to Follow-up|0|||
105650478|NCT00607789|364384101|FG001|Overall Study|Lost to Follow-up|5|||
105650479|NCT00607789|364384100|FG000|Overall Study|Withdrawal by Subject|1|||
105650480|NCT00607789|364384101|FG001|Overall Study|Withdrawal by Subject|0|||
105650481|NCT04414397|364384102|FG000|Control Period|Withdrawal by Subject|2|||
105650482|NCT04414397|364384103|FG001|Control Period|Withdrawal by Subject|2|||
105650483|NCT04414397|364384102|FG000|Control Period|Lost to Follow-up|0|||
105650484|NCT04414397|364384103|FG001|Control Period|Lost to Follow-up|4|||
105650485|NCT04414397|364384102|FG000|Control Period|Protocol deviation|0|||
105650486|NCT04414397|364384103|FG001|Control Period|Protocol deviation|1|||
105650487|NCT04414397|364384102|FG000|Post-Control Period|Withdrawal by Subject|3|||
105650488|NCT04414397|364384103|FG001|Post-Control Period|Withdrawal by Subject|6|||
105650489|NCT04414397|364384102|FG000|Post-Control Period|Lost to Follow-up|4|||
105650490|NCT04414397|364384103|FG001|Post-Control Period|Lost to Follow-up|9|||
105650491|NCT04414397|364384102|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
105650492|NCT04414397|364384103|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
105650493|NCT04414397|364384102|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
105650494|NCT04414397|364384103|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
105650495|NCT01313299|364384105|FG000|Overall Study|Adverse Event|3|||
105650496|NCT01313299|364384106|FG001|Overall Study|Adverse Event|1|||
105650497|NCT01313299|364384107|FG002|Overall Study|Adverse Event|1|||
105650498|NCT01313299|364384105|FG000|Overall Study|Lost to Follow-up|1|||
105650499|NCT01313299|364384106|FG001|Overall Study|Lost to Follow-up|0|||
105650500|NCT01313299|364384107|FG002|Overall Study|Lost to Follow-up|0|||
105650501|NCT01313299|364384105|FG000|Overall Study|Protocol Violation|2|||
105650502|NCT01313299|364384106|FG001|Overall Study|Protocol Violation|0|||
105650503|NCT01313299|364384107|FG002|Overall Study|Protocol Violation|0|||
105650504|NCT01313299|364384105|FG000|Overall Study|Withdrawal by Subject|1|||
105650505|NCT01313299|364384106|FG001|Overall Study|Withdrawal by Subject|0|||
105650506|NCT01313299|364384107|FG002|Overall Study|Withdrawal by Subject|2|||
105650507|NCT01313299|364384105|FG000|Overall Study|Family reason and moved out of state|0|||
105650508|NCT01313299|364384106|FG001|Overall Study|Family reason and moved out of state|2|||
105650509|NCT01313299|364384107|FG002|Overall Study|Family reason and moved out of state|0|||
105650510|NCT01313299|364384105|FG000|Overall Study|Lack of subject compliance|0|||
105650511|NCT01313299|364384106|FG001|Overall Study|Lack of subject compliance|0|||
105650512|NCT01313299|364384107|FG002|Overall Study|Lack of subject compliance|1|||
105650513|NCT02391545|364384108|FG000|Overall Study|Death|0|||
105650514|NCT02391545|364384109|FG001|Overall Study|Death|2|||
105650515|NCT02391545|364384108|FG000|Overall Study|Lost to Follow-up|0|||
105650516|NCT02391545|364384109|FG001|Overall Study|Lost to Follow-up|1|||
105650517|NCT02391545|364384108|FG000|Overall Study|Termination of study by sponsor|20|||
105650518|NCT02391545|364384109|FG001|Overall Study|Termination of study by sponsor|20|||
105650519|NCT02391545|364384108|FG000|Overall Study|Withdrawal by Subject|0|||
105650520|NCT02391545|364384109|FG001|Overall Study|Withdrawal by Subject|1|||
105650521|NCT02391545|364384108|FG000|Overall Study|Other Reasons|6|||
105650522|NCT02391545|364384109|FG001|Overall Study|Other Reasons|4|||
105650523|NCT04089332|364384110|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
105650524|NCT04089332|364384110|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
105650525|NCT04089332|364384110|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
105650526|NCT04754594|364384114|FG000|Blinded Period|Withdrawal by Subject|4|||
105650527|NCT04754594|364384115|FG001|Blinded Period|Withdrawal by Subject|9|||
105650528|NCT04754594|364384116|FG002|Blinded Period|Withdrawal by Subject|0|||
105650529|NCT04754594|364384117|FG003|Blinded Period|Withdrawal by Subject|0|||
105650530|NCT04754594|364384114|FG000|Blinded Period|Protocol Violation|2|||
105650531|NCT04754594|364384115|FG001|Blinded Period|Protocol Violation|2|||
105650532|NCT04754594|364384116|FG002|Blinded Period|Protocol Violation|0|||
105650533|NCT04754594|364384117|FG003|Blinded Period|Protocol Violation|0|||
105650534|NCT04754594|364384114|FG000|Blinded Period|Lost to Follow-up|1|||
105650535|NCT04754594|364384115|FG001|Blinded Period|Lost to Follow-up|1|||
105650536|NCT04754594|364384116|FG002|Blinded Period|Lost to Follow-up|0|||
105650537|NCT04754594|364384117|FG003|Blinded Period|Lost to Follow-up|0|||
105650538|NCT04754594|364384114|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
105650539|NCT04754594|364384115|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
105650540|NCT04754594|364384116|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
105650541|NCT04754594|364384117|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
105650542|NCT04754594|364384114|FG000|Unblinded Period|Withdrawal by Subject|6|||
105650543|NCT04754594|364384115|FG001|Unblinded Period|Withdrawal by Subject|8|||
105650544|NCT04754594|364384116|FG002|Unblinded Period|Withdrawal by Subject|0|||
105650545|NCT04754594|364384117|FG003|Unblinded Period|Withdrawal by Subject|0|||
105650546|NCT04754594|364384114|FG000|Unblinded Period|Lost to Follow-up|5|||
105650547|NCT04754594|364384115|FG001|Unblinded Period|Lost to Follow-up|3|||
105650548|NCT04754594|364384116|FG002|Unblinded Period|Lost to Follow-up|0|||
105650549|NCT04754594|364384117|FG003|Unblinded Period|Lost to Follow-up|0|||
105650550|NCT04754594|364384114|FG000|Unblinded Period|Protocol Violation|2|||
105650551|NCT04754594|364384115|FG001|Unblinded Period|Protocol Violation|4|||
105650552|NCT04754594|364384116|FG002|Unblinded Period|Protocol Violation|0|||
105650553|NCT04754594|364384117|FG003|Unblinded Period|Protocol Violation|0|||
105650554|NCT04754594|364384114|FG000|Unblinded Period|Other|3|||
105650555|NCT04754594|364384115|FG001|Unblinded Period|Other|0|||
105650556|NCT04754594|364384116|FG002|Unblinded Period|Other|0|||
105650557|NCT04754594|364384117|FG003|Unblinded Period|Other|0|||
105650558|NCT04754594|364384114|FG000|Infant Participants|Withdrawal by Subject|0|||
105650559|NCT04754594|364384115|FG001|Infant Participants|Withdrawal by Subject|0|||
105650560|NCT04754594|364384116|FG002|Infant Participants|Withdrawal by Subject|9|||
105650561|NCT04754594|364384117|FG003|Infant Participants|Withdrawal by Subject|17|||
105650562|NCT04754594|364384114|FG000|Infant Participants|Lost to Follow-up|0|||
105650563|NCT04754594|364384115|FG001|Infant Participants|Lost to Follow-up|0|||
105650564|NCT04754594|364384116|FG002|Infant Participants|Lost to Follow-up|4|||
105650565|NCT04754594|364384117|FG003|Infant Participants|Lost to Follow-up|10|||
105650566|NCT04754594|364384114|FG000|Infant Participants|Death|0|||
105650567|NCT04754594|364384115|FG001|Infant Participants|Death|0|||
105650568|NCT04754594|364384116|FG002|Infant Participants|Death|1|||
105650569|NCT04754594|364384117|FG003|Infant Participants|Death|1|||
105650570|NCT04754594|364384114|FG000|Infant Participants|Other|0|||
105650571|NCT04754594|364384115|FG001|Infant Participants|Other|0|||
105650572|NCT04754594|364384116|FG002|Infant Participants|Other|1|||
105650573|NCT04754594|364384117|FG003|Infant Participants|Other|1|||
105650574|NCT00495612|364384120|FG000|Overall Study|Lost to Follow-up|1|||
105650575|NCT00495612|364384121|FG001|Overall Study|Lost to Follow-up|0|||
105650576|NCT00495612|364384120|FG000|Overall Study|Subject's Decision to Withdraw|3|||
105650577|NCT00495612|364384121|FG001|Overall Study|Subject's Decision to Withdraw|0|||
105650578|NCT06016127|364384122|FG000|Overall Study|Withdrawal by Subject|4|||
105650579|NCT06016127|364384123|FG001|Overall Study|Withdrawal by Subject|3|||
105650580|NCT02588027|364384128|FG000|Overall Study|Withdrawal by Subject|1|||
105650581|NCT02588027|364384129|FG001|Overall Study|Withdrawal by Subject|3|||
105650582|NCT02588027|364384128|FG000|Overall Study|Protocol Violation|4|||
105650583|NCT02588027|364384129|FG001|Overall Study|Protocol Violation|1|||
105650584|NCT02849509|364384130|FG000|Overall Study|Worsening of disease under study|1|||
105650585|NCT02849509|364384131|FG001|Overall Study|Worsening of disease under study|1|||
105650586|NCT02849509|364384132|FG002|Overall Study|Worsening of disease under study|1|||
105650587|NCT02849509|364384130|FG000|Overall Study|Worsening of other pre-existing disease|0|||
105650588|NCT02849509|364384131|FG001|Overall Study|Worsening of other pre-existing disease|1|||
105650589|NCT02849509|364384132|FG002|Overall Study|Worsening of other pre-existing disease|2|||
105650590|NCT02849509|364384130|FG000|Overall Study|Other adverse event|36|||
105650591|NCT02849509|364384131|FG001|Overall Study|Other adverse event|41|||
105650592|NCT02849509|364384132|FG002|Overall Study|Other adverse event|8|||
105650593|NCT02849509|364384130|FG000|Overall Study|Withdrawal by Subject|6|||
105650594|NCT02849509|364384131|FG001|Overall Study|Withdrawal by Subject|17|||
105650595|NCT02849509|364384132|FG002|Overall Study|Withdrawal by Subject|12|||
105650596|NCT02849509|364384130|FG000|Overall Study|Lost to Follow-up|27|||
105650597|NCT02849509|364384131|FG001|Overall Study|Lost to Follow-up|67|||
105650598|NCT02849509|364384132|FG002|Overall Study|Lost to Follow-up|36|||
105650599|NCT02849509|364384130|FG000|Overall Study|Other, reason not specified|14|||
105650600|NCT02849509|364384131|FG001|Overall Study|Other, reason not specified|29|||
105650601|NCT02849509|364384132|FG002|Overall Study|Other, reason not specified|25|||
105650602|NCT02849509|364384130|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
105650603|NCT02849509|364384131|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
105650604|NCT02849509|364384132|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
105650605|NCT00975130|364384133|FG000|Study Part 1|Adverse Event|150|||
105650606|NCT00975130|364384134|FG001|Study Part 1|Adverse Event|0|||
105650607|NCT00975130|364384135|FG002|Study Part 1|Adverse Event|0|||
105650608|NCT00975130|364384133|FG000|Study Part 1|Lost to Follow-up|19|||
105650609|NCT00975130|364384134|FG001|Study Part 1|Lost to Follow-up|0|||
105650610|NCT00975130|364384135|FG002|Study Part 1|Lost to Follow-up|0|||
105650611|NCT00975130|364384133|FG000|Study Part 1|Withdrawal by Subject|61|||
105650612|NCT00975130|364384134|FG001|Study Part 1|Withdrawal by Subject|0|||
105650613|NCT00975130|364384135|FG002|Study Part 1|Withdrawal by Subject|0|||
105650614|NCT00975130|364384133|FG000|Study Part 1|Protocol Violation|13|||
105650615|NCT00975130|364384134|FG001|Study Part 1|Protocol Violation|0|||
105650616|NCT00975130|364384135|FG002|Study Part 1|Protocol Violation|0|||
105650617|NCT00975130|364384133|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
105650618|NCT00975130|364384134|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
105650619|NCT00975130|364384135|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
105650620|NCT00975130|364384133|FG000|Study Part 1|Administrative|4|||
105650621|NCT00975130|364384134|FG001|Study Part 1|Administrative|0|||
105650622|NCT00975130|364384135|FG002|Study Part 1|Administrative|0|||
105650623|NCT00975130|364384133|FG000|Study Part 1|Withdrew Consent|24|||
105650624|NCT00975130|364384134|FG001|Study Part 1|Withdrew Consent|0|||
105650625|NCT00975130|364384135|FG002|Study Part 1|Withdrew Consent|0|||
105650626|NCT00975130|364384133|FG000|Study Part 2|Adverse Event|0|||
105650627|NCT00975130|364384134|FG001|Study Part 2|Adverse Event|14|||
105650628|NCT00975130|364384135|FG002|Study Part 2|Adverse Event|7|||
105650629|NCT00975130|364384133|FG000|Study Part 2|Lost to Follow-up|0|||
105650630|NCT00975130|364384134|FG001|Study Part 2|Lost to Follow-up|0|||
105650631|NCT00975130|364384135|FG002|Study Part 2|Lost to Follow-up|1|||
105650632|NCT00975130|364384133|FG000|Study Part 2|Withdrawal by Subject|0|||
105650633|NCT00975130|364384134|FG001|Study Part 2|Withdrawal by Subject|13|||
105650634|NCT00975130|364384135|FG002|Study Part 2|Withdrawal by Subject|5|||
105650635|NCT00975130|364384133|FG000|Study Part 2|Withdrew Consent|0|||
105650636|NCT00975130|364384134|FG001|Study Part 2|Withdrew Consent|6|||
105650637|NCT00975130|364384135|FG002|Study Part 2|Withdrew Consent|2|||
105650638|NCT00975130|364384133|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
105650639|NCT00975130|364384134|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
105650640|NCT00975130|364384135|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
105650641|NCT00975130|364384133|FG000|Study Part 2|Administrative|0|||
105650642|NCT00975130|364384134|FG001|Study Part 2|Administrative|1|||
105650643|NCT00975130|364384135|FG002|Study Part 2|Administrative|0|||
105650644|NCT00975130|364384133|FG000|Study Part 2|Protocol Violation|0|||
105650645|NCT00975130|364384134|FG001|Study Part 2|Protocol Violation|0|||
105650646|NCT00975130|364384135|FG002|Study Part 2|Protocol Violation|1|||
105650647|NCT01261793|364384136|FG000|Overall Study|Lack of Efficacy|44|||
105650648|NCT01261793|364384137|FG001|Overall Study|Lack of Efficacy|37|||
105650649|NCT01261793|364384138|FG002|Overall Study|Lack of Efficacy|32|||
105650650|NCT01261793|364384136|FG000|Overall Study|Protocol Violation|3|||
105650651|NCT01261793|364384137|FG001|Overall Study|Protocol Violation|5|||
105650652|NCT01261793|364384138|FG002|Overall Study|Protocol Violation|6|||
105650653|NCT01261793|364384136|FG000|Overall Study|Lost to Follow-up|10|||
105650654|NCT01261793|364384137|FG001|Overall Study|Lost to Follow-up|3|||
105650655|NCT01261793|364384138|FG002|Overall Study|Lost to Follow-up|7|||
105650656|NCT01261793|364384136|FG000|Overall Study|Withdrawal by Subject|12|||
105650657|NCT01261793|364384137|FG001|Overall Study|Withdrawal by Subject|14|||
105650658|NCT01261793|364384138|FG002|Overall Study|Withdrawal by Subject|14|||
105650659|NCT01261793|364384136|FG000|Overall Study|Death|3|||
105650660|NCT01261793|364384137|FG001|Overall Study|Death|1|||
105650661|NCT01261793|364384138|FG002|Overall Study|Death|0|||
105650662|NCT01261793|364384136|FG000|Overall Study|Adverse Event|9|||
105650663|NCT01261793|364384137|FG001|Overall Study|Adverse Event|24|||
105650664|NCT01261793|364384138|FG002|Overall Study|Adverse Event|19|||
105650665|NCT01261793|364384136|FG000|Overall Study|Patient non-availability|1|||
105650666|NCT01261793|364384137|FG001|Overall Study|Patient non-availability|1|||
105650667|NCT01261793|364384138|FG002|Overall Study|Patient non-availability|1|||
105650668|NCT01261793|364384136|FG000|Overall Study|Suspected pregnancy|1|||
105650669|NCT01261793|364384137|FG001|Overall Study|Suspected pregnancy|1|||
105650670|NCT01261793|364384138|FG002|Overall Study|Suspected pregnancy|0|||
105650671|NCT01261793|364384136|FG000|Overall Study|Patient non-compliance|1|||
105650672|NCT01261793|364384137|FG001|Overall Study|Patient non-compliance|0|||
105650673|NCT01261793|364384138|FG002|Overall Study|Patient non-compliance|1|||
105650674|NCT01261793|364384136|FG000|Overall Study|Patient pregnant|1|||
105650675|NCT01261793|364384137|FG001|Overall Study|Patient pregnant|0|||
105650676|NCT01261793|364384138|FG002|Overall Study|Patient pregnant|0|||
105650677|NCT01261793|364384136|FG000|Overall Study|Outside the study area|0|||
105650678|NCT01261793|364384137|FG001|Overall Study|Outside the study area|2|||
105650679|NCT01261793|364384138|FG002|Overall Study|Outside the study area|1|||
105650680|NCT01261793|364384136|FG000|Overall Study|Lack of efficacy & patient not available|0|||
105650681|NCT01261793|364384137|FG001|Overall Study|Lack of efficacy & patient not available|1|||
105650682|NCT01261793|364384138|FG002|Overall Study|Lack of efficacy & patient not available|0|||
105650683|NCT01261793|364384136|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
105650684|NCT01261793|364384137|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
105650685|NCT01261793|364384138|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
105650686|NCT01261793|364384136|FG000|Overall Study|Randomization error|0|||
105650687|NCT01261793|364384137|FG001|Overall Study|Randomization error|1|||
105650688|NCT01261793|364384138|FG002|Overall Study|Randomization error|0|||
105650689|NCT01261793|364384136|FG000|Overall Study|Patient unable to start IV line|0|||
105650690|NCT01261793|364384137|FG001|Overall Study|Patient unable to start IV line|0|||
105650691|NCT01261793|364384138|FG002|Overall Study|Patient unable to start IV line|1|||
105650692|NCT00577096|364384139|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
105650693|NCT00577096|364384140|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
105650694|NCT00577096|364384139|FG000|Short Term Participation|Withdrawal by Subject|3|||
105650695|NCT00577096|364384140|FG001|Short Term Participation|Withdrawal by Subject|5|||
105650696|NCT00577096|364384139|FG000|Short Term Participation|Death|1|||
105650697|NCT00577096|364384140|FG001|Short Term Participation|Death|1|||
105650698|NCT00734851|364384141|FG000|Overall Study|Withdrawal by Subject|2|||
105650699|NCT00734851|364384141|FG000|Overall Study|Lost to Follow-up|1|||
105650700|NCT00734851|364384141|FG000|Overall Study|Physician Decision|18|||
105650701|NCT01770509|364384142|FG000|Overall Study|Injury|0|||
105650702|NCT01770509|364384143|FG001|Overall Study|Injury|1|||
105650703|NCT01770509|364384142|FG000|Overall Study|Lost to Follow-up|1|||
105650704|NCT01770509|364384143|FG001|Overall Study|Lost to Follow-up|2|||
105650705|NCT00818519|364384144|FG000|Overall Study|Adverse Event|2|||
105650706|NCT00818519|364384145|FG001|Overall Study|Adverse Event|2|||
105650707|NCT00818519|364384144|FG000|Overall Study|Lost to Follow-up|4|||
105650708|NCT00818519|364384145|FG001|Overall Study|Lost to Follow-up|6|||
105650709|NCT00818519|364384144|FG000|Overall Study|Protocol Violation|2|||
105650710|NCT00818519|364384145|FG001|Overall Study|Protocol Violation|1|||
105650711|NCT00818519|364384144|FG000|Overall Study|Pregnancy|0|||
105650712|NCT00818519|364384145|FG001|Overall Study|Pregnancy|1|||
105650713|NCT00818519|364384144|FG000|Overall Study|Withdrawal by Subject|4|||
105650714|NCT00818519|364384145|FG001|Overall Study|Withdrawal by Subject|9|||
105650715|NCT00818519|364384144|FG000|Overall Study|participant recovered completely|1|||
105650716|NCT00818519|364384145|FG001|Overall Study|participant recovered completely|0|||
105650717|NCT00818519|364384144|FG000|Overall Study|participant will leave for long tme|1|||
105650718|NCT00818519|364384145|FG001|Overall Study|participant will leave for long tme|0|||
105650719|NCT00832650|364384149|FG000|Overall Study|Randomized but not treated|0|||
105650720|NCT00832650|364384150|FG001|Overall Study|Randomized but not treated|0|||
105650721|NCT00832650|364384151|FG002|Overall Study|Randomized but not treated|1|||
105650722|NCT01196741|364384157|FG000|Overall Study|Disease progression|34|||
105650723|NCT01196741|364384158|FG001|Overall Study|Disease progression|14|||
105650724|NCT01196741|364384157|FG000|Overall Study|Adverse Event|10|||
105650725|NCT01196741|364384158|FG001|Overall Study|Adverse Event|6|||
105650726|NCT01196741|364384157|FG000|Overall Study|Serious Adverse Event|3|||
105650727|NCT01196741|364384158|FG001|Overall Study|Serious Adverse Event|1|||
105650728|NCT01196741|364384157|FG000|Overall Study|Dose limiting Adverse Event|2|||
105650729|NCT01196741|364384158|FG001|Overall Study|Dose limiting Adverse Event|1|||
105650730|NCT01196741|364384157|FG000|Overall Study|Withdrawal by Subject|3|||
105650731|NCT01196741|364384158|FG001|Overall Study|Withdrawal by Subject|0|||
105650732|NCT01196741|364384157|FG000|Overall Study|Other reason|3|||
105650733|NCT01196741|364384158|FG001|Overall Study|Other reason|3|||
105650734|NCT01196741|364384157|FG000|Overall Study|Other|3|||
105650735|NCT01196741|364384158|FG001|Overall Study|Other|2|||
105650736|NCT01196741|364384157|FG000|Overall Study|Protocol Violation|2|||
105650737|NCT01196741|364384158|FG001|Overall Study|Protocol Violation|1|||
105650738|NCT03562117|364384161|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
105650739|NCT03562117|364384162|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
105650740|NCT03562117|364384163|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
105650741|NCT01294358|364384164|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
105650742|NCT01294358|364384165|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
105650743|NCT01294358|364384166|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
105650744|NCT01294358|364384167|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
105650745|NCT01294358|364384168|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
105650746|NCT01294358|364384164|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
105650747|NCT01294358|364384165|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
105650748|NCT01294358|364384166|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
105650749|NCT01294358|364384167|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
105650750|NCT01294358|364384168|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
105650751|NCT01294358|364384164|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
105650752|NCT01294358|364384165|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
105650753|NCT01294358|364384166|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
105650754|NCT01294358|364384167|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
105650755|NCT01294358|364384168|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
105650756|NCT01294358|364384164|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
105650757|NCT01294358|364384165|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
105650758|NCT01294358|364384166|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
105650759|NCT01294358|364384167|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
105650760|NCT01294358|364384168|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
105650761|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
105650762|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
105650763|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
105650764|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Other|1|||
105650765|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Other|0|||
105650766|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Other|0|||
105650767|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Physician Decision|3|||
105650768|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Physician Decision|0|||
105650769|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Physician Decision|0|||
105650770|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
105650771|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
105650772|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
105650773|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
105650774|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
105650775|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
105650776|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Adverse Event|18|||
105650777|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Adverse Event|0|||
105650778|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Adverse Event|0|||
105650779|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
105650780|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
105650781|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
105650782|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
105650783|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
105650784|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
105650785|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
105650786|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
105650787|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
105650788|NCT03030599|364384169|FG000|Stable Dose|Protocol deviation|3|||
105650789|NCT03030599|364384170|FG001|Stable Dose|Protocol deviation|0|||
105650790|NCT03030599|364384171|FG002|Stable Dose|Protocol deviation|0|||
105650791|NCT03030599|364384169|FG000|Stable Dose|Adverse Event|1|||
105650792|NCT03030599|364384170|FG001|Stable Dose|Adverse Event|0|||
105650793|NCT03030599|364384171|FG002|Stable Dose|Adverse Event|0|||
105650794|NCT03030599|364384169|FG000|Stable Dose|Lost to Follow-up|1|||
105650795|NCT03030599|364384170|FG001|Stable Dose|Lost to Follow-up|0|||
105650796|NCT03030599|364384171|FG002|Stable Dose|Lost to Follow-up|0|||
105650797|NCT03030599|364384169|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
105650798|NCT03030599|364384170|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
105650799|NCT03030599|364384171|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
105650800|NCT03030599|364384169|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
105650801|NCT03030599|364384170|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
105650802|NCT03030599|364384171|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
105650803|NCT03030599|364384169|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
105650804|NCT03030599|364384170|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
105650805|NCT03030599|364384171|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
105650806|NCT03030599|364384169|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
105650807|NCT03030599|364384170|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
105650808|NCT03030599|364384171|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
105650809|NCT03030599|364384169|FG000|Open-label Extension|Adverse Event|3|||
105650810|NCT03030599|364384170|FG001|Open-label Extension|Adverse Event|0|||
105650811|NCT03030599|364384171|FG002|Open-label Extension|Adverse Event|0|||
105650812|NCT03030599|364384169|FG000|Open-label Extension|Lost to Follow-up|2|||
105650813|NCT03030599|364384170|FG001|Open-label Extension|Lost to Follow-up|0|||
105650814|NCT03030599|364384171|FG002|Open-label Extension|Lost to Follow-up|0|||
105650815|NCT03030599|364384169|FG000|Open-label Extension|Lack of Efficacy|1|||
105650816|NCT03030599|364384170|FG001|Open-label Extension|Lack of Efficacy|0|||
105650817|NCT03030599|364384171|FG002|Open-label Extension|Lack of Efficacy|0|||
105650818|NCT03030599|364384169|FG000|Open-label Extension|Other Reason|1|||
105650819|NCT03030599|364384170|FG001|Open-label Extension|Other Reason|0|||
105650820|NCT03030599|364384171|FG002|Open-label Extension|Other Reason|0|||
105650821|NCT03356145|364384172|FG000|Overall Study|Withdrawal by Subject|2|||
105650822|NCT03356145|364384173|FG001|Overall Study|Withdrawal by Subject|1|||
105650823|NCT03356145|364384172|FG000|Overall Study|Did not meet inclusion criteria|1|||
105650824|NCT03356145|364384173|FG001|Overall Study|Did not meet inclusion criteria|0|||
105650825|NCT03613454|364384174|FG000|Overall Study|Protocol Violation|1|||
105650826|NCT03613454|364384175|FG001|Overall Study|Protocol Violation|0|||
105650827|NCT03613454|364384174|FG000|Overall Study|Protocol Violation|0|||
105650828|NCT03613454|364384175|FG001|Overall Study|Protocol Violation|1|||
105650829|NCT02963922|364384176|FG000|Overall Study|Adverse Event|15|||
105650830|NCT02963922|364384177|FG001|Overall Study|Adverse Event|6|||
105650831|NCT02963922|364384176|FG000|Overall Study|Protocol deviation|6|||
105650832|NCT02963922|364384177|FG001|Overall Study|Protocol deviation|6|||
105650833|NCT02963922|364384176|FG000|Overall Study|Lack of Efficacy|1|||
105650834|NCT02963922|364384177|FG001|Overall Study|Lack of Efficacy|1|||
105650835|NCT02963922|364384176|FG000|Overall Study|Lost to Follow-up|2|||
105650836|NCT02963922|364384177|FG001|Overall Study|Lost to Follow-up|3|||
105650837|NCT02963922|364384176|FG000|Overall Study|Other|8|||
105650838|NCT02963922|364384177|FG001|Overall Study|Other|14|||
105650839|NCT00655668|364384196|FG000|Overall Study|Adverse Event|6|||
105650840|NCT00655668|364384196|FG000|Overall Study|Death|5|||
105650841|NCT00655668|364384196|FG000|Overall Study|Disease Progression|27|||
105650842|NCT00655668|364384196|FG000|Overall Study|Study Terminated|9|||
105650843|NCT00655668|364384196|FG000|Overall Study|Other|1|||
105650844|NCT00655668|364384196|FG000|Overall Study|New Lymphoma Treatment Started|4|||
105650845|NCT00655668|364384196|FG000|Overall Study|Withdrawal by Subject|2|||
105650846|NCT03740919|364384197|FG000|Lead-in Period|Lost to Follow-up|1|||
105650847|NCT03740919|364384198|FG001|Lead-in Period|Lost to Follow-up|0|||
105650848|NCT03740919|364384199|FG002|Lead-in Period|Lost to Follow-up|0|||
105650849|NCT03740919|364384200|FG003|Lead-in Period|Lost to Follow-up|0|||
105650850|NCT03740919|364384197|FG000|Lead-in Period|Physician Decision|2|||
105650851|NCT03740919|364384198|FG001|Lead-in Period|Physician Decision|0|||
105650852|NCT03740919|364384199|FG002|Lead-in Period|Physician Decision|0|||
105650853|NCT03740919|364384200|FG003|Lead-in Period|Physician Decision|0|||
105650854|NCT03740919|364384197|FG000|Lead-in Period|Protocol Violation|1|||
105650855|NCT03740919|364384198|FG001|Lead-in Period|Protocol Violation|0|||
105650856|NCT03740919|364384199|FG002|Lead-in Period|Protocol Violation|0|||
105650857|NCT03740919|364384200|FG003|Lead-in Period|Protocol Violation|0|||
105650858|NCT03740919|364384197|FG000|Lead-in Period|Withdrawal by Subject|10|||
105650859|NCT03740919|364384198|FG001|Lead-in Period|Withdrawal by Subject|0|||
105650860|NCT03740919|364384199|FG002|Lead-in Period|Withdrawal by Subject|0|||
105650861|NCT03740919|364384200|FG003|Lead-in Period|Withdrawal by Subject|0|||
105650862|NCT03740919|364384197|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
105650863|NCT03740919|364384198|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
105650864|NCT03740919|364384199|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
105650865|NCT03740919|364384200|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
105650866|NCT03740919|364384197|FG000|Lead-in Period|Study Task Too Burdensome|1|||
105650867|NCT03740919|364384198|FG001|Lead-in Period|Study Task Too Burdensome|0|||
105650868|NCT03740919|364384199|FG002|Lead-in Period|Study Task Too Burdensome|0|||
105650869|NCT03740919|364384200|FG003|Lead-in Period|Study Task Too Burdensome|0|||
105650870|NCT03740919|364384197|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
105650871|NCT03740919|364384198|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
105650872|NCT03740919|364384199|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
105650873|NCT03740919|364384200|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
105650874|NCT03740919|364384197|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
105650875|NCT03740919|364384198|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
105650876|NCT03740919|364384199|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
105650877|NCT03740919|364384200|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
105650878|NCT03740919|364384197|FG000|Treatment Period|Adverse Event|0|||
105650879|NCT03740919|364384198|FG001|Treatment Period|Adverse Event|0|||
105650880|NCT03740919|364384199|FG002|Treatment Period|Adverse Event|2|||
105650881|NCT03740919|364384200|FG003|Treatment Period|Adverse Event|0|||
105650882|NCT03740919|364384197|FG000|Treatment Period|Protocol Violation|0|||
105650883|NCT03740919|364384198|FG001|Treatment Period|Protocol Violation|1|||
105650884|NCT03740919|364384199|FG002|Treatment Period|Protocol Violation|0|||
105650885|NCT03740919|364384200|FG003|Treatment Period|Protocol Violation|0|||
105650886|NCT03740919|364384197|FG000|Treatment Period|Withdrawal by Subject|0|||
105650887|NCT03740919|364384198|FG001|Treatment Period|Withdrawal by Subject|7|||
105650888|NCT03740919|364384199|FG002|Treatment Period|Withdrawal by Subject|6|||
105650889|NCT03740919|364384200|FG003|Treatment Period|Withdrawal by Subject|2|||
105650890|NCT03740919|364384197|FG000|Treatment Period|Terminated by Sponsor|0|||
105650891|NCT03740919|364384198|FG001|Treatment Period|Terminated by Sponsor|1|||
105650892|NCT03740919|364384199|FG002|Treatment Period|Terminated by Sponsor|0|||
105650893|NCT03740919|364384200|FG003|Treatment Period|Terminated by Sponsor|0|||
105650894|NCT03740919|364384197|FG000|Treatment Period|Issue with Insulin Pump|0|||
105650895|NCT03740919|364384198|FG001|Treatment Period|Issue with Insulin Pump|1|||
105650896|NCT03740919|364384199|FG002|Treatment Period|Issue with Insulin Pump|0|||
105650897|NCT03740919|364384200|FG003|Treatment Period|Issue with Insulin Pump|0|||
105650898|NCT03740919|364384197|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
105650899|NCT03740919|364384198|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
105650900|NCT03740919|364384199|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
105650901|NCT03740919|364384200|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
105650902|NCT03740919|364384197|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
105650903|NCT03740919|364384198|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
105650904|NCT03740919|364384199|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
105650905|NCT03740919|364384200|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
105650906|NCT03740919|364384197|FG000|Treatment Period|Not Completing Diary|0|||
105650907|NCT03740919|364384198|FG001|Treatment Period|Not Completing Diary|0|||
105650908|NCT03740919|364384199|FG002|Treatment Period|Not Completing Diary|1|||
105650909|NCT03740919|364384200|FG003|Treatment Period|Not Completing Diary|0|||
105650910|NCT03740919|364384197|FG000|Treatment Period|Insulin Painful to Participant|0|||
105650911|NCT03740919|364384198|FG001|Treatment Period|Insulin Painful to Participant|0|||
105650912|NCT03740919|364384199|FG002|Treatment Period|Insulin Painful to Participant|1|||
105650913|NCT03740919|364384200|FG003|Treatment Period|Insulin Painful to Participant|0|||
105650914|NCT04222088|364384204|FG000|Overall Study|Lost to Follow-up|5|||
105650915|NCT04222088|364384205|FG001|Overall Study|Lost to Follow-up|1|||
105650916|NCT04222088|364384204|FG000|Overall Study|Withdrawal by Subject|4|||
105650917|NCT04222088|364384205|FG001|Overall Study|Withdrawal by Subject|0|||
105650918|NCT00595764|364384206|FG000|Overall Study|Protocol Violation|24|||
105650919|NCT00595764|364384207|FG001|Overall Study|Protocol Violation|19|||
105650920|NCT00595764|364384206|FG000|Overall Study|Missed Medication >1 week|10|||
105650921|NCT00595764|364384207|FG001|Overall Study|Missed Medication >1 week|17|||
105650922|NCT00595764|364384206|FG000|Overall Study|Missed 3 PM visits|1|||
105650923|NCT00595764|364384207|FG001|Overall Study|Missed 3 PM visits|7|||
105650924|NCT00595764|364384206|FG000|Overall Study|Withdrawal by Subject|4|||
105650925|NCT00595764|364384207|FG001|Overall Study|Withdrawal by Subject|0|||
105650926|NCT01071317|364384208|FG000|Overall Study|Lost to Follow-up|2|||
105650927|NCT01071317|364384209|FG001|Overall Study|Lost to Follow-up|2|||
105650928|NCT02418819|364384210|FG000|Overall Study|Adverse Event|0|||
105650929|NCT02418819|364384211|FG001|Overall Study|Adverse Event|0|||
105650930|NCT02418819|364384212|FG002|Overall Study|Adverse Event|1|||
105650931|NCT02418819|364384213|FG003|Overall Study|Adverse Event|0|||
105650932|NCT02418819|364384210|FG000|Overall Study|Lost to Follow-up|1|||
105650933|NCT02418819|364384211|FG001|Overall Study|Lost to Follow-up|0|||
105650934|NCT02418819|364384212|FG002|Overall Study|Lost to Follow-up|0|||
105650935|NCT02418819|364384213|FG003|Overall Study|Lost to Follow-up|0|||
105650936|NCT02418819|364384210|FG000|Overall Study|No longer meets eligibility criteria|0|||
105650937|NCT02418819|364384211|FG001|Overall Study|No longer meets eligibility criteria|0|||
105650938|NCT02418819|364384212|FG002|Overall Study|No longer meets eligibility criteria|1|||
105650939|NCT02418819|364384213|FG003|Overall Study|No longer meets eligibility criteria|0|||
105650940|NCT02418819|364384210|FG000|Overall Study|No longer willing to participate|0|||
105650941|NCT02418819|364384211|FG001|Overall Study|No longer willing to participate|0|||
105650942|NCT02418819|364384212|FG002|Overall Study|No longer willing to participate|2|||
105650943|NCT02418819|364384213|FG003|Overall Study|No longer willing to participate|1|||
105650944|NCT04743999|364384217|FG000|3-month Questionnaire|Death|1|||
105650945|NCT04743999|364384217|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
105650946|NCT04743999|364384217|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
105650947|NCT04743999|364384217|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
105650948|NCT01721759|364384218|FG000|Treatment Period|Disease Progression|85|||
105650949|NCT01721759|364384218|FG000|Treatment Period|Study drug toxicity|14|||
105650950|NCT01721759|364384218|FG000|Treatment Period|Death|1|||
105650951|NCT01721759|364384218|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
105650952|NCT01721759|364384218|FG000|Treatment Period|Participant request to withdraw|3|||
105650953|NCT01721759|364384218|FG000|Treatment Period|Other Reasons|3|||
105650954|NCT01721759|364384218|FG000|End of Study Period|Participant Withdrew Consent|5|||
105650955|NCT01721759|364384218|FG000|End of Study Period|Death|101|||
105650956|NCT01721759|364384218|FG000|End of Study Period|Lost to Follow-up|1|||
105650957|NCT01721759|364384218|FG000|End of Study Period|Other Reasons|10|||
105650958|NCT00464737|364384219|FG000|Overall Study|Adverse Event|12|||
105650959|NCT00464737|364384220|FG001|Overall Study|Adverse Event|17|||
105650960|NCT00464737|364384221|FG002|Overall Study|Adverse Event|33|||
105650961|NCT00464737|364384219|FG000|Overall Study|Lack of Efficacy|7|||
105650962|NCT00464737|364384220|FG001|Overall Study|Lack of Efficacy|7|||
105650963|NCT00464737|364384221|FG002|Overall Study|Lack of Efficacy|4|||
105650964|NCT00464737|364384219|FG000|Overall Study|Withdrawal by Subject|5|||
105650965|NCT00464737|364384220|FG001|Overall Study|Withdrawal by Subject|3|||
105650966|NCT00464737|364384221|FG002|Overall Study|Withdrawal by Subject|5|||
105650967|NCT00464737|364384219|FG000|Overall Study|Protocol Violation|1|||
105650968|NCT00464737|364384220|FG001|Overall Study|Protocol Violation|1|||
105650969|NCT00464737|364384221|FG002|Overall Study|Protocol Violation|5|||
105650970|NCT00464737|364384219|FG000|Overall Study|Non-compliance|0|||
105650971|NCT00464737|364384220|FG001|Overall Study|Non-compliance|1|||
105650972|NCT00464737|364384221|FG002|Overall Study|Non-compliance|1|||
105650973|NCT00464737|364384219|FG000|Overall Study|Lost to Follow-up|5|||
105650974|NCT00464737|364384220|FG001|Overall Study|Lost to Follow-up|2|||
105650975|NCT00464737|364384221|FG002|Overall Study|Lost to Follow-up|5|||
105650976|NCT00464737|364384219|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
105650977|NCT00464737|364384220|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
105650978|NCT00464737|364384221|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
105650979|NCT00464737|364384219|FG000|Overall Study|Other: Subject left town; family illness|1|||
105650980|NCT00464737|364384220|FG001|Overall Study|Other: Subject left town; family illness|0|||
105650981|NCT00464737|364384221|FG002|Overall Study|Other: Subject left town; family illness|0|||
105650982|NCT00464737|364384219|FG000|Overall Study|Other: Study demands too great|0|||
105650983|NCT00464737|364384220|FG001|Overall Study|Other: Study demands too great|1|||
105650984|NCT00464737|364384221|FG002|Overall Study|Other: Study demands too great|0|||
105650985|NCT00464737|364384219|FG000|Overall Study|Other: Personal family reasons|0|||
105650986|NCT00464737|364384220|FG001|Overall Study|Other: Personal family reasons|0|||
105650987|NCT00464737|364384221|FG002|Overall Study|Other: Personal family reasons|1|||
105650988|NCT00464737|364384219|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
105650989|NCT00464737|364384220|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
105650990|NCT00464737|364384221|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
105650991|NCT00580047|364384226|FG000|Overall Study|Lost to Follow-up|1|||
105650992|NCT00580047|364384227|FG001|Overall Study|Lost to Follow-up|1|||
105650993|NCT00580047|364384228|FG002|Overall Study|Lost to Follow-up|0|||
105650994|NCT00580047|364384226|FG000|Overall Study|Withdrawal by Subject|1|||
105650995|NCT00580047|364384227|FG001|Overall Study|Withdrawal by Subject|1|||
105650996|NCT00580047|364384228|FG002|Overall Study|Withdrawal by Subject|2|||
105650997|NCT00580047|364384226|FG000|Overall Study|Withdrawal by Subject|1|||
105650998|NCT00580047|364384227|FG001|Overall Study|Withdrawal by Subject|0|||
105650999|NCT00580047|364384228|FG002|Overall Study|Withdrawal by Subject|0|||
105651000|NCT01894256|364384229|FG000|Part A|Adverse Event|0|||
105651001|NCT01894256|364384230|FG001|Part A|Adverse Event|1|||
105651002|NCT01894256|364384231|FG002|Part A|Adverse Event|0|||
105651003|NCT01894256|364384229|FG000|Part B|Death|0|||
105651004|NCT01894256|364384230|FG001|Part B|Death|1|||
105651005|NCT01894256|364384231|FG002|Part B|Death|1|||
105651006|NCT01894256|364384229|FG000|Part B|Withdrawal by Subject|0|||
105651007|NCT01894256|364384230|FG001|Part B|Withdrawal by Subject|1|||
105651008|NCT01894256|364384231|FG002|Part B|Withdrawal by Subject|0|||
105651009|NCT01894256|364384229|FG000|Part B|Lack of Efficacy|15|||
105651010|NCT01894256|364384230|FG001|Part B|Lack of Efficacy|12|||
105651011|NCT01894256|364384231|FG002|Part B|Lack of Efficacy|13|||
105651012|NCT03640754|364384232|FG000|Overall Study|Withdrawal by Subject|1|||
105651013|NCT03640754|364384233|FG001|Overall Study|Withdrawal by Subject|0|||
105651014|NCT03640754|364384232|FG000|Overall Study|Lost to Follow-up|0|||
105651015|NCT03640754|364384233|FG001|Overall Study|Lost to Follow-up|1|||
105651016|NCT03993054|364384241|FG000|Overall Study|PI Decision|1|||
105651017|NCT01002547|364385719|FG000|Overall Study|Withdrawal by Subject|4|||
105651018|NCT01002547|364385720|FG001|Overall Study|Withdrawal by Subject|0|||
105651019|NCT01002547|364385721|FG002|Overall Study|Withdrawal by Subject|5|||
105651020|NCT01002547|364385719|FG000|Overall Study|Lost to Follow-up|2|||
105651021|NCT01002547|364385720|FG001|Overall Study|Lost to Follow-up|1|||
105651022|NCT01002547|364385721|FG002|Overall Study|Lost to Follow-up|1|||
105651023|NCT01002547|364385719|FG000|Overall Study|Physician Decision|1|||
105651024|NCT01002547|364385720|FG001|Overall Study|Physician Decision|0|||
105651025|NCT01002547|364385721|FG002|Overall Study|Physician Decision|0|||
105651026|NCT01002547|364385719|FG000|Overall Study|Death|0|||
105651027|NCT01002547|364385720|FG001|Overall Study|Death|2|||
105651028|NCT01002547|364385721|FG002|Overall Study|Death|2|||
105651029|NCT01002547|364385719|FG000|Overall Study|Adverse Event|1|||
105651030|NCT01002547|364385720|FG001|Overall Study|Adverse Event|0|||
105651031|NCT01002547|364385721|FG002|Overall Study|Adverse Event|0|||
105651032|NCT00705614|364385728|FG000|Initial Intervention|Adverse Event|40|||
105651033|NCT00705614|364385729|FG001|Initial Intervention|Adverse Event|21|||
105651034|NCT00705614|364385728|FG000|Initial Intervention|Lost to Follow-up|310|||
105651035|NCT00705614|364385729|FG001|Initial Intervention|Lost to Follow-up|191|||
105651036|NCT00705614|364385728|FG000|Initial Intervention|Withdrawal by Subject|114|||
105651037|NCT00705614|364385729|FG001|Initial Intervention|Withdrawal by Subject|71|||
105651038|NCT00705614|364385728|FG000|Initial Intervention|Administrative Reason|51|||
105651039|NCT00705614|364385729|FG001|Initial Intervention|Administrative Reason|38|||
105651040|NCT00705614|364385728|FG000|Initial Intervention|Status completion unknown|3|||
105651041|NCT00705614|364385729|FG001|Initial Intervention|Status completion unknown|0|||
105651042|NCT00705614|364385728|FG000|Switch to Remicade|Adverse Event|0|||
105651043|NCT00705614|364385729|FG001|Switch to Remicade|Adverse Event|5|||
105651044|NCT00705614|364385728|FG000|Switch to Remicade|Lost to Follow-up|0|||
105651045|NCT00705614|364385729|FG001|Switch to Remicade|Lost to Follow-up|23|||
105651046|NCT00705614|364385728|FG000|Switch to Remicade|Withdrawal by Subject|0|||
105651047|NCT00705614|364385729|FG001|Switch to Remicade|Withdrawal by Subject|12|||
105651048|NCT00705614|364385728|FG000|Switch to Remicade|Administrative Reason|0|||
105651049|NCT00705614|364385729|FG001|Switch to Remicade|Administrative Reason|9|||
105651050|NCT00676195|364385730|FG000|Overall Study|Lost to Follow-up|1|||
105651051|NCT00676195|364385730|FG000|Overall Study|Adverse Event|1|||
105651052|NCT00676195|364385730|FG000|Overall Study|Physician Decision|1|||
105651053|NCT00925288|364385731|FG000|Overall Study|Lost to Follow-up|9|||
105651054|NCT00925288|364385732|FG001|Overall Study|Lost to Follow-up|7|||
105651055|NCT02093897|364385733|FG000|Overall Study|Physician Decision|1|||
105651056|NCT02093897|364385733|FG000|Overall Study|Planned age group closure - no's reached|17|||
105651057|NCT02093897|364385733|FG000|Overall Study|Adverse event, non-fatal|1|||
105651058|NCT00088452|364385734|FG000|Overall Study|Did not receive intervention|1|||
105651059|NCT00088452|364385735|FG001|Overall Study|Did not receive intervention|0|||
105651060|NCT00088452|364385736|FG002|Overall Study|Did not receive intervention|1|||
105651061|NCT01232569|364385739|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
105651062|NCT01232569|364385740|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
105651063|NCT01232569|364385741|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105651064|NCT01232569|364385742|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
105651065|NCT01232569|364385739|FG000|Double-blind Treatment Period|Escape|2|||
105651066|NCT01232569|364385740|FG001|Double-blind Treatment Period|Escape|2|||
105651067|NCT01232569|364385741|FG002|Double-blind Treatment Period|Escape|0|||
105651068|NCT01232569|364385742|FG003|Double-blind Treatment Period|Escape|0|||
105651069|NCT01232569|364385739|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
105651070|NCT01232569|364385740|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
105651071|NCT01232569|364385741|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
105651072|NCT01232569|364385742|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
105651073|NCT01232569|364385739|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
105651074|NCT01232569|364385740|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
105651075|NCT01232569|364385741|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
105651076|NCT01232569|364385742|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
105651077|NCT01232569|364385739|FG000|Double-blind Treatment Period|Physician Decision|1|||
105651078|NCT01232569|364385740|FG001|Double-blind Treatment Period|Physician Decision|0|||
105651079|NCT01232569|364385741|FG002|Double-blind Treatment Period|Physician Decision|0|||
105651080|NCT01232569|364385742|FG003|Double-blind Treatment Period|Physician Decision|0|||
105651081|NCT01232569|364385739|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
105651082|NCT01232569|364385740|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
105651083|NCT01232569|364385741|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
105651084|NCT01232569|364385742|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
105651085|NCT01232569|364385739|FG000|Double-blind Treatment Period|Death|2|||
105651086|NCT01232569|364385740|FG001|Double-blind Treatment Period|Death|0|||
105651087|NCT01232569|364385741|FG002|Double-blind Treatment Period|Death|0|||
105651088|NCT01232569|364385742|FG003|Double-blind Treatment Period|Death|0|||
105651089|NCT03675308|364385743|FG000|Overall Study|Adverse Event|3|||
105651090|NCT03675308|364385744|FG001|Overall Study|Adverse Event|2|||
105651091|NCT03675308|364385743|FG000|Overall Study|Withdrawal by Subject|6|||
105651092|NCT03675308|364385744|FG001|Overall Study|Withdrawal by Subject|4|||
105651093|NCT03675308|364385743|FG000|Overall Study|Lost to Follow-up|3|||
105651094|NCT03675308|364385744|FG001|Overall Study|Lost to Follow-up|0|||
105651095|NCT03675308|364385743|FG000|Overall Study|Lack of Efficacy|1|||
105651096|NCT03675308|364385744|FG001|Overall Study|Lack of Efficacy|1|||
105651097|NCT03675308|364385743|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
105651098|NCT03675308|364385744|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
105651099|NCT03675308|364385743|FG000|Overall Study|Other|0|||
105651100|NCT03675308|364385744|FG001|Overall Study|Other|1|||
105651101|NCT00814632|364385745|FG000|Overall Study|Lack of Efficacy|2|||
105651102|NCT04816708|364385753|FG000|Overall Study|Lost to Follow-up|10|||
105651103|NCT04816708|364385754|FG001|Overall Study|Lost to Follow-up|4|||
105651104|NCT00111839|364385760|FG000|Overall Study|Disease Progression|30|||
105651105|NCT00111839|364385761|FG001|Overall Study|Disease Progression|33|||
105651106|NCT00111839|364385762|FG002|Overall Study|Disease Progression|33|||
105651107|NCT00111839|364385760|FG000|Overall Study|Adverse Event|5|||
105651108|NCT00111839|364385761|FG001|Overall Study|Adverse Event|3|||
105651109|NCT00111839|364385762|FG002|Overall Study|Adverse Event|1|||
105651110|NCT00111839|364385760|FG000|Overall Study|Protocol Violation|2|||
105651111|NCT00111839|364385761|FG001|Overall Study|Protocol Violation|4|||
105651112|NCT00111839|364385762|FG002|Overall Study|Protocol Violation|2|||
105651113|NCT00111839|364385760|FG000|Overall Study|Death|1|||
105651114|NCT00111839|364385761|FG001|Overall Study|Death|1|||
105651115|NCT00111839|364385762|FG002|Overall Study|Death|6|||
105651116|NCT00111839|364385760|FG000|Overall Study|Withdrawal by Subject|2|||
105651117|NCT00111839|364385761|FG001|Overall Study|Withdrawal by Subject|2|||
105651118|NCT00111839|364385762|FG002|Overall Study|Withdrawal by Subject|2|||
105651119|NCT00111839|364385760|FG000|Overall Study|Lost to Follow-up|1|||
105651120|NCT00111839|364385761|FG001|Overall Study|Lost to Follow-up|0|||
105651121|NCT00111839|364385762|FG002|Overall Study|Lost to Follow-up|0|||
105651122|NCT00111839|364385760|FG000|Overall Study|Logistical Constraint|1|||
105651123|NCT00111839|364385761|FG001|Overall Study|Logistical Constraint|0|||
105651124|NCT00111839|364385762|FG002|Overall Study|Logistical Constraint|0|||
105651125|NCT00111839|364385760|FG000|Overall Study|Other|6|||
105651126|NCT00111839|364385761|FG001|Overall Study|Other|3|||
105651127|NCT00111839|364385762|FG002|Overall Study|Other|3|||
105651128|NCT00111839|364385760|FG000|Overall Study|Randomized but Not Treated|0|||
105651129|NCT00111839|364385761|FG001|Overall Study|Randomized but Not Treated|0|||
105651130|NCT00111839|364385762|FG002|Overall Study|Randomized but Not Treated|2|||
105651131|NCT02123797|364385765|FG000|Baseline Intervention|Death|9|||
105651132|NCT02123797|364385766|FG001|Baseline Intervention|Death|16|||
105651133|NCT02123797|364385767|FG002|Baseline Intervention|Death|0|||
105651134|NCT02123797|364385768|FG003|Baseline Intervention|Death|0|||
105651135|NCT02123797|364385769|FG004|Baseline Intervention|Death|0|||
105651136|NCT02123797|364385765|FG000|Baseline Intervention|Withdrawal by Subject|2|||
105651137|NCT02123797|364385766|FG001|Baseline Intervention|Withdrawal by Subject|8|||
105651138|NCT02123797|364385767|FG002|Baseline Intervention|Withdrawal by Subject|0|||
105651139|NCT02123797|364385768|FG003|Baseline Intervention|Withdrawal by Subject|0|||
105651140|NCT02123797|364385769|FG004|Baseline Intervention|Withdrawal by Subject|0|||
105651141|NCT02123797|364385765|FG000|Baseline Intervention|Relocation|2|||
105651142|NCT02123797|364385766|FG001|Baseline Intervention|Relocation|0|||
105651143|NCT02123797|364385767|FG002|Baseline Intervention|Relocation|0|||
105651144|NCT02123797|364385768|FG003|Baseline Intervention|Relocation|0|||
105651145|NCT02123797|364385769|FG004|Baseline Intervention|Relocation|0|||
105651146|NCT02123797|364385765|FG000|Baseline Intervention|Out of window for initial survey|6|||
105651147|NCT02123797|364385766|FG001|Baseline Intervention|Out of window for initial survey|13|||
105651148|NCT02123797|364385767|FG002|Baseline Intervention|Out of window for initial survey|0|||
105651149|NCT02123797|364385768|FG003|Baseline Intervention|Out of window for initial survey|0|||
105651150|NCT02123797|364385769|FG004|Baseline Intervention|Out of window for initial survey|0|||
105651151|NCT02123797|364385765|FG000|Baseline Intervention|Lost to Follow-up|0|||
105651152|NCT02123797|364385766|FG001|Baseline Intervention|Lost to Follow-up|5|||
105651153|NCT02123797|364385767|FG002|Baseline Intervention|Lost to Follow-up|0|||
105651154|NCT02123797|364385768|FG003|Baseline Intervention|Lost to Follow-up|0|||
105651155|NCT02123797|364385769|FG004|Baseline Intervention|Lost to Follow-up|0|||
105651156|NCT02123797|364385765|FG000|Baseline Intervention|Other Disease|3|||
105651157|NCT02123797|364385766|FG001|Baseline Intervention|Other Disease|0|||
105651158|NCT02123797|364385767|FG002|Baseline Intervention|Other Disease|0|||
105651159|NCT02123797|364385768|FG003|Baseline Intervention|Other Disease|0|||
105651160|NCT02123797|364385769|FG004|Baseline Intervention|Other Disease|0|||
105651161|NCT02123797|364385765|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
105651162|NCT02123797|364385766|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
105651163|NCT02123797|364385767|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
105651164|NCT02123797|364385768|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
105651165|NCT02123797|364385769|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
105651166|NCT02123797|364385765|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
105651167|NCT02123797|364385766|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
105651168|NCT02123797|364385767|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
105651169|NCT02123797|364385768|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
105651170|NCT02123797|364385769|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
105651171|NCT02123797|364385765|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
105651172|NCT02123797|364385766|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
105651173|NCT02123797|364385767|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
105651174|NCT02123797|364385768|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
105651175|NCT02123797|364385769|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
105651176|NCT02123797|364385765|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
105651177|NCT02123797|364385766|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
105651178|NCT02123797|364385767|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
105651179|NCT02123797|364385768|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
105651180|NCT02123797|364385769|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
105651181|NCT02123797|364385765|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
105651182|NCT02123797|364385766|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
105651183|NCT02123797|364385767|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
105651184|NCT02123797|364385768|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
105651185|NCT02123797|364385769|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
105651186|NCT02123797|364385765|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
105651187|NCT02123797|364385766|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
105651188|NCT02123797|364385767|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
105651189|NCT02123797|364385768|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
105651190|NCT02123797|364385769|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
105651191|NCT02123797|364385765|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
105651192|NCT02123797|364385766|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
105651193|NCT02123797|364385767|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
105651194|NCT02123797|364385768|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
105651195|NCT02123797|364385769|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
105651196|NCT02123797|364385765|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
105651197|NCT02123797|364385766|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
105651198|NCT02123797|364385767|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
105651199|NCT02123797|364385768|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
105651200|NCT02123797|364385769|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
105651201|NCT02123797|364385765|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
105651202|NCT02123797|364385766|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
105651203|NCT02123797|364385767|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
105651204|NCT02123797|364385768|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
105651205|NCT02123797|364385769|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
105651206|NCT00377312|364385770|FG000|Overall Study|Adverse Event|1|||
105651207|NCT00377312|364385771|FG001|Overall Study|Adverse Event|1|||
105651208|NCT01572493|364385772|FG000|Overall Study|Physician Decision|1|||
105651209|NCT01572493|364385773|FG001|Overall Study|Physician Decision|0|||
105651210|NCT01572493|364385774|FG002|Overall Study|Physician Decision|0|||
105651211|NCT01572493|364385775|FG003|Overall Study|Physician Decision|0|||
105651212|NCT01572493|364385776|FG004|Overall Study|Physician Decision|0|||
105651213|NCT01572493|364385777|FG005|Overall Study|Physician Decision|0|||
105651214|NCT01572493|364385778|FG006|Overall Study|Physician Decision|0|||
105651215|NCT01572493|364385779|FG007|Overall Study|Physician Decision|0|||
105651216|NCT01572493|364385780|FG008|Overall Study|Physician Decision|0|||
105651217|NCT01572493|364385772|FG000|Overall Study|Switched to alternative treatment|0|||
105651218|NCT01572493|364385773|FG001|Overall Study|Switched to alternative treatment|1|||
105651219|NCT01572493|364385774|FG002|Overall Study|Switched to alternative treatment|2|||
105651220|NCT01572493|364385775|FG003|Overall Study|Switched to alternative treatment|1|||
105651221|NCT01572493|364385776|FG004|Overall Study|Switched to alternative treatment|2|||
105651222|NCT01572493|364385777|FG005|Overall Study|Switched to alternative treatment|0|||
105651223|NCT01572493|364385778|FG006|Overall Study|Switched to alternative treatment|2|||
105651224|NCT01572493|364385779|FG007|Overall Study|Switched to alternative treatment|0|||
105651225|NCT01572493|364385780|FG008|Overall Study|Switched to alternative treatment|2|||
105651226|NCT01572493|364385772|FG000|Overall Study|Death|0|||
105651227|NCT01572493|364385773|FG001|Overall Study|Death|0|||
105651228|NCT01572493|364385774|FG002|Overall Study|Death|0|||
105651229|NCT01572493|364385775|FG003|Overall Study|Death|1|||
105651230|NCT01572493|364385776|FG004|Overall Study|Death|0|||
105651231|NCT01572493|364385777|FG005|Overall Study|Death|1|||
105651232|NCT01572493|364385778|FG006|Overall Study|Death|0|||
105651233|NCT01572493|364385779|FG007|Overall Study|Death|0|||
105651234|NCT01572493|364385780|FG008|Overall Study|Death|0|||
105651235|NCT01572493|364385772|FG000|Overall Study|Adverse Event|0|||
105651236|NCT01572493|364385773|FG001|Overall Study|Adverse Event|0|||
105651237|NCT01572493|364385774|FG002|Overall Study|Adverse Event|0|||
105651238|NCT01572493|364385775|FG003|Overall Study|Adverse Event|0|||
105651239|NCT01572493|364385776|FG004|Overall Study|Adverse Event|0|||
105651240|NCT01572493|364385777|FG005|Overall Study|Adverse Event|0|||
105651241|NCT01572493|364385778|FG006|Overall Study|Adverse Event|1|||
105651242|NCT01572493|364385779|FG007|Overall Study|Adverse Event|0|||
105651243|NCT01572493|364385780|FG008|Overall Study|Adverse Event|0|||
105651244|NCT02889809|364385781|FG000|Overall Study|Withdrawal by Subject|30|||
105651245|NCT02889809|364385782|FG001|Overall Study|Withdrawal by Subject|21|||
105651246|NCT02889809|364385781|FG000|Overall Study|Lost to Follow-up|1|||
105651247|NCT02889809|364385782|FG001|Overall Study|Lost to Follow-up|1|||
105651248|NCT02889809|364385781|FG000|Overall Study|Site Closed|12|||
105651249|NCT02889809|364385782|FG001|Overall Study|Site Closed|11|||
105651250|NCT01066897|364385783|FG000|Overall Study|Withdrawal by Subject|1|||
105651251|NCT01066897|364385784|FG001|Overall Study|Withdrawal by Subject|0|||
105651252|NCT01066897|364385783|FG000|Overall Study|stopped study after developing the flu.|1|||
105651253|NCT01066897|364385784|FG001|Overall Study|stopped study after developing the flu.|0|||
105651254|NCT03997409|364385785|FG000|Overall Study|Protocol Violation|1|||
105651255|NCT03997409|364385786|FG001|Overall Study|Protocol Violation|1|||
105651256|NCT03997409|364385787|FG002|Overall Study|Protocol Violation|0|||
105651257|NCT03997409|364385785|FG000|Overall Study|Withdrawal by Subject|3|||
105651258|NCT03997409|364385786|FG001|Overall Study|Withdrawal by Subject|0|||
105651259|NCT03997409|364385787|FG002|Overall Study|Withdrawal by Subject|0|||
105651260|NCT03997409|364385785|FG000|Overall Study|Lost to Follow-up|0|||
105651261|NCT03997409|364385786|FG001|Overall Study|Lost to Follow-up|0|||
105651262|NCT03997409|364385787|FG002|Overall Study|Lost to Follow-up|1|||
105651263|NCT03319719|364385793|FG000|Overall Study|Lost to Follow-up|1|||
105651264|NCT03303521|364385797|FG000|Overall Study|Withdrawal by Subject|2|||
105651265|NCT03303521|364385798|FG001|Overall Study|Withdrawal by Subject|0|||
105651266|NCT03303521|364385797|FG000|Overall Study|Death|1|||
105651267|NCT03303521|364385798|FG001|Overall Study|Death|0|||
105651268|NCT03303521|364385797|FG000|Overall Study|Kidney transplantation|0|||
105651269|NCT03303521|364385798|FG001|Overall Study|Kidney transplantation|1|||
105651270|NCT03303521|364385797|FG000|Overall Study|Investigational product discontinuation|0|||
105651271|NCT03303521|364385798|FG001|Overall Study|Investigational product discontinuation|1|||
105651272|NCT03303521|364385797|FG000|Overall Study|Transferred to non-study dialysis center|1|||
105651273|NCT03303521|364385798|FG001|Overall Study|Transferred to non-study dialysis center|0|||
105651274|NCT03303521|364385797|FG000|Overall Study|Non-comliance to study protocol|0|||
105651275|NCT03303521|364385798|FG001|Overall Study|Non-comliance to study protocol|1|||
105651276|NCT03303521|364385797|FG000|Overall Study|Adverse Event|1|||
105651277|NCT03303521|364385798|FG001|Overall Study|Adverse Event|0|||
105651278|NCT01485991|364385799|FG000|Overall Study|Adverse Event|0|||
105651279|NCT01485991|364385800|FG001|Overall Study|Adverse Event|4|||
105651280|NCT01485991|364385799|FG000|Overall Study|Lost to Follow-up|13|||
105651281|NCT01485991|364385800|FG001|Overall Study|Lost to Follow-up|10|||
105651282|NCT01485991|364385799|FG000|Overall Study|Withdrawal by Subject|13|||
105651283|NCT01485991|364385800|FG001|Overall Study|Withdrawal by Subject|20|||
105651284|NCT01485991|364385799|FG000|Overall Study|randomized but not treated|6|||
105651285|NCT01485991|364385800|FG001|Overall Study|randomized but not treated|2|||
105651286|NCT00125853|364385801|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
105651287|NCT00125853|364385802|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
105651288|NCT02359552|364385810|FG000|Overall Study|Lost to Follow-up|3|||
105651289|NCT02359552|364385811|FG001|Overall Study|Lost to Follow-up|4|||
105651290|NCT00776984|364385812|FG000|Overall Study|Adverse Event|8|||
105651291|NCT00776984|364385813|FG001|Overall Study|Adverse Event|2|||
105651292|NCT00776984|364385812|FG000|Overall Study|Protocol Violation|4|||
105651293|NCT00776984|364385813|FG001|Overall Study|Protocol Violation|2|||
105651294|NCT00776984|364385812|FG000|Overall Study|Lost to Follow-up|2|||
105651295|NCT00776984|364385813|FG001|Overall Study|Lost to Follow-up|0|||
105651296|NCT00776984|364385812|FG000|Overall Study|Withdrawal by Subject|12|||
105651297|NCT00776984|364385813|FG001|Overall Study|Withdrawal by Subject|7|||
105651298|NCT00776984|364385812|FG000|Overall Study|Lack of Efficacy|0|||
105651299|NCT00776984|364385813|FG001|Overall Study|Lack of Efficacy|1|||
105651300|NCT00776984|364385812|FG000|Overall Study|Other|5|||
105651301|NCT00776984|364385813|FG001|Overall Study|Other|9|||
105651302|NCT02391116|364385816|FG000|Treatment|Withdrawal by Subject|1|||
105651303|NCT02391116|364385816|FG000|Treatment|Protocol Violation|1|||
105651304|NCT02391116|364385816|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
105651305|NCT02391116|364385816|FG000|Treatment|AE with Clinical PD|3|||
105651306|NCT02391116|364385816|FG000|Safety Follow-up|Adverse Event|1|||
105651307|NCT02391116|364385816|FG000|Safety Follow-up|Withdrawal by Subject|4|||
105651308|NCT02391116|364385816|FG000|Safety Follow-up|Switching to Other Therapy|4|||
105651309|NCT02391116|364385816|FG000|Safety Follow-up|No Follow Up|1|||
105651310|NCT02391116|364385816|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
105651311|NCT02391116|364385816|FG000|Active Follow-up|Withdrawal by Subject|1|||
105651312|NCT02391116|364385816|FG000|Active Follow-up|Switching to Other Therapy|2|||
105651313|NCT02391116|364385816|FG000|Survival Follow-up|Withdrawal by Subject|3|||
105651314|NCT02391116|364385816|FG000|Survival Follow-up|Switching to Other Therapy|1|||
105651315|NCT01247922|364385820|FG000|Overall Study|Disease progression|4|||
105651316|NCT02335242|364385821|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
105651317|NCT02335242|364385822|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
105440145|NCT00930553|363616707|FG000|Overall Study|Study terminated by sponsor|24|||
105651318|NCT02335242|364385821|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
105651319|NCT02335242|364385822|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
105651320|NCT02335242|364385821|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
105651321|NCT02335242|364385822|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
105651322|NCT01332318|364385823|FG000|Overall Study|Adverse Event|0|||
105651323|NCT01332318|364385824|FG001|Overall Study|Adverse Event|3|||
105651324|NCT01332318|364385825|FG002|Overall Study|Adverse Event|0|||
105651325|NCT01332318|364385826|FG003|Overall Study|Adverse Event|0|||
105651326|NCT01332318|364385823|FG000|Overall Study|Withdrawal by Subject|1|||
105651327|NCT01332318|364385824|FG001|Overall Study|Withdrawal by Subject|1|||
105651328|NCT01332318|364385825|FG002|Overall Study|Withdrawal by Subject|0|||
105651329|NCT01332318|364385826|FG003|Overall Study|Withdrawal by Subject|1|||
105651330|NCT01332318|364385823|FG000|Overall Study|Protocol Violation|1|||
105651331|NCT01332318|364385824|FG001|Overall Study|Protocol Violation|0|||
105651332|NCT01332318|364385825|FG002|Overall Study|Protocol Violation|1|||
105651333|NCT01332318|364385826|FG003|Overall Study|Protocol Violation|1|||
105651334|NCT00942188|364385828|FG000|Overall Study|Adverse Event|0|||
105651335|NCT00942188|364385829|FG001|Overall Study|Adverse Event|3|||
105651336|NCT00942188|364385830|FG002|Overall Study|Adverse Event|2|||
105651337|NCT00942188|364385831|FG003|Overall Study|Adverse Event|0|||
105651338|NCT00942188|364385828|FG000|Overall Study|Lack of Efficacy|0|||
105651339|NCT00942188|364385829|FG001|Overall Study|Lack of Efficacy|0|||
105651340|NCT00942188|364385830|FG002|Overall Study|Lack of Efficacy|0|||
105651341|NCT00942188|364385831|FG003|Overall Study|Lack of Efficacy|1|||
105651342|NCT00942188|364385828|FG000|Overall Study|Protocol Violation|1|||
105651343|NCT00942188|364385829|FG001|Overall Study|Protocol Violation|1|||
105651344|NCT00942188|364385830|FG002|Overall Study|Protocol Violation|0|||
105651345|NCT00942188|364385831|FG003|Overall Study|Protocol Violation|0|||
105651346|NCT00942188|364385828|FG000|Overall Study|Lost to Follow-up|2|||
105651347|NCT00942188|364385829|FG001|Overall Study|Lost to Follow-up|1|||
105651348|NCT00942188|364385830|FG002|Overall Study|Lost to Follow-up|2|||
105651349|NCT00942188|364385831|FG003|Overall Study|Lost to Follow-up|0|||
105651350|NCT00942188|364385828|FG000|Overall Study|Withdrawal by Subject|1|||
105651351|NCT00942188|364385829|FG001|Overall Study|Withdrawal by Subject|3|||
105651352|NCT00942188|364385830|FG002|Overall Study|Withdrawal by Subject|4|||
105651353|NCT00942188|364385831|FG003|Overall Study|Withdrawal by Subject|2|||
105651354|NCT00942188|364385828|FG000|Overall Study|Physician Decision|0|||
105651355|NCT00942188|364385829|FG001|Overall Study|Physician Decision|0|||
105651356|NCT00942188|364385830|FG002|Overall Study|Physician Decision|1|||
105651357|NCT00942188|364385831|FG003|Overall Study|Physician Decision|0|||
105651358|NCT00942188|364385828|FG000|Overall Study|Sponsor Decision|0|||
105651359|NCT00942188|364385829|FG001|Overall Study|Sponsor Decision|2|||
105651360|NCT00942188|364385830|FG002|Overall Study|Sponsor Decision|0|||
105651361|NCT00942188|364385831|FG003|Overall Study|Sponsor Decision|1|||
105651362|NCT02273180|364385832|FG000|Overall Study|Adverse Event|2|||
105651363|NCT02273180|364385833|FG001|Overall Study|Adverse Event|2|||
105651364|NCT02273180|364385832|FG000|Overall Study|Lack of Efficacy|1|||
105651365|NCT02273180|364385833|FG001|Overall Study|Lack of Efficacy|0|||
105651366|NCT02273180|364385832|FG000|Overall Study|Protocol Violation|1|||
105651367|NCT02273180|364385833|FG001|Overall Study|Protocol Violation|7|||
105651368|NCT02273180|364385832|FG000|Overall Study|Randomized but not treated|1|||
105651369|NCT02273180|364385833|FG001|Overall Study|Randomized but not treated|0|||
105651370|NCT02273180|364385832|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
105651371|NCT02273180|364385833|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
105651372|NCT02273180|364385832|FG000|Overall Study|Other than specified above|21|||
105651373|NCT02273180|364385833|FG001|Overall Study|Other than specified above|10|||
105651374|NCT01786551|364385834|FG000|Overall Study|Participant withdrew consent|2|||
105651375|NCT00663923|364385835|FG000|Overall Study|Lost to Follow-up|2|||
105651376|NCT04853238|364385837|FG000|Overall Study|Death|4|||
105651377|NCT04853238|364385838|FG001|Overall Study|Death|0|||
105651378|NCT04853238|364385839|FG002|Overall Study|Death|2|||
105651379|NCT04853238|364385837|FG000|Overall Study|Lost to Follow-up|16|||
105651380|NCT04853238|364385838|FG001|Overall Study|Lost to Follow-up|2|||
105651381|NCT04853238|364385839|FG002|Overall Study|Lost to Follow-up|37|||
105651382|NCT04853238|364385837|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
105651383|NCT04853238|364385838|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
105651384|NCT04853238|364385839|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
105651385|NCT04853238|364385837|FG000|Overall Study|Withdrawal by Subject|6|||
105651386|NCT04853238|364385838|FG001|Overall Study|Withdrawal by Subject|0|||
105651387|NCT04853238|364385839|FG002|Overall Study|Withdrawal by Subject|21|||
105651388|NCT04853238|364385837|FG000|Overall Study|Physician Decision|0|||
105651389|NCT04853238|364385838|FG001|Overall Study|Physician Decision|0|||
105651390|NCT04853238|364385839|FG002|Overall Study|Physician Decision|2|||
105651391|NCT04853238|364385837|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
105651392|NCT04853238|364385838|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
105651393|NCT04853238|364385839|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
105651394|NCT02294461|364385840|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
105651395|NCT02294461|364385841|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
105651396|NCT02294461|364385840|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
105651397|NCT02294461|364385841|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
105651398|NCT02294461|364385840|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
105651399|NCT02294461|364385841|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
105659498|NCT02635386|364417348|FG001|Overall Study|Moved Out of State|1|||
105651400|NCT02294461|364385840|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
105651401|NCT02294461|364385841|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
105651402|NCT02294461|364385840|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
105651403|NCT02294461|364385841|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
105651404|NCT02294461|364385840|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
105651405|NCT02294461|364385841|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
105651406|NCT02294461|364385840|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
105651407|NCT02294461|364385841|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
105651408|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
105651409|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
105651410|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
105651411|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
105651412|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
105651413|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
105651414|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
105651415|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
105651416|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
105651417|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
105651418|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
105651419|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
105651420|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
105651421|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
105651422|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
105651423|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
105651424|NCT02859558|364387210|FG000|Step 1|Not Eligible|0|||
105651425|NCT02859558|364387211|FG001|Step 1|Not Eligible|0|||
105651426|NCT02859558|364387212|FG002|Step 1|Not Eligible|0|||
105651427|NCT02859558|364387213|FG003|Step 1|Not Eligible|0|||
105651428|NCT02859558|364387214|FG004|Step 1|Not Eligible|3|||
105651429|NCT02859558|364387210|FG000|Step 1|Lost to Follow-up|1|||
105651430|NCT02859558|364387211|FG001|Step 1|Lost to Follow-up|3|||
105651431|NCT02859558|364387212|FG002|Step 1|Lost to Follow-up|3|||
105651432|NCT02859558|364387213|FG003|Step 1|Lost to Follow-up|0|||
105651433|NCT02859558|364387214|FG004|Step 1|Lost to Follow-up|0|||
105651434|NCT02859558|364387210|FG000|Step 1|Did Not Return to Clinic|2|||
105651435|NCT02859558|364387211|FG001|Step 1|Did Not Return to Clinic|3|||
105651436|NCT02859558|364387212|FG002|Step 1|Did Not Return to Clinic|4|||
105651437|NCT02859558|364387213|FG003|Step 1|Did Not Return to Clinic|0|||
105651438|NCT02859558|364387214|FG004|Step 1|Did Not Return to Clinic|0|||
105651439|NCT02859558|364387210|FG000|Step 1|Moved|0|||
105651440|NCT02859558|364387211|FG001|Step 1|Moved|1|||
105651441|NCT02859558|364387212|FG002|Step 1|Moved|1|||
105651442|NCT02859558|364387213|FG003|Step 1|Moved|0|||
105651443|NCT02859558|364387214|FG004|Step 1|Moved|0|||
105651444|NCT02859558|364387210|FG000|Step 1|Withdrawal By Participant|1|||
105651445|NCT02859558|364387211|FG001|Step 1|Withdrawal By Participant|2|||
105651446|NCT02859558|364387212|FG002|Step 1|Withdrawal By Participant|1|||
105651447|NCT02859558|364387213|FG003|Step 1|Withdrawal By Participant|0|||
105651448|NCT02859558|364387214|FG004|Step 1|Withdrawal By Participant|0|||
105651449|NCT02859558|364387210|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
105651450|NCT02859558|364387211|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
105651451|NCT02859558|364387212|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
105651452|NCT02859558|364387213|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
105651453|NCT02859558|364387214|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
105651454|NCT02859558|364387210|FG000|Step 1|Incarceration|0|||
105651455|NCT02859558|364387211|FG001|Step 1|Incarceration|1|||
105651456|NCT02859558|364387212|FG002|Step 1|Incarceration|0|||
105651457|NCT02859558|364387213|FG003|Step 1|Incarceration|0|||
105651458|NCT02859558|364387214|FG004|Step 1|Incarceration|0|||
105651459|NCT02859558|364387210|FG000|Step 1|Non-Adherence to Study Drug|2|||
105651460|NCT02859558|364387211|FG001|Step 1|Non-Adherence to Study Drug|0|||
105651461|NCT02859558|364387212|FG002|Step 1|Non-Adherence to Study Drug|1|||
105651462|NCT02859558|364387213|FG003|Step 1|Non-Adherence to Study Drug|0|||
105651463|NCT02859558|364387214|FG004|Step 1|Non-Adherence to Study Drug|0|||
105651464|NCT02859558|364387210|FG000|Step 1|Non-Adherence to Study Requirements|3|||
105651465|NCT02859558|364387211|FG001|Step 1|Non-Adherence to Study Requirements|1|||
105651466|NCT02859558|364387212|FG002|Step 1|Non-Adherence to Study Requirements|0|||
105651467|NCT02859558|364387213|FG003|Step 1|Non-Adherence to Study Requirements|0|||
105651468|NCT02859558|364387214|FG004|Step 1|Non-Adherence to Study Requirements|0|||
105651469|NCT02859558|364387210|FG000|Step 1|Virologic Failure|2|||
105651470|NCT02859558|364387211|FG001|Step 1|Virologic Failure|1|||
105651471|NCT02859558|364387212|FG002|Step 1|Virologic Failure|1|||
105651472|NCT02859558|364387213|FG003|Step 1|Virologic Failure|0|||
105651473|NCT02859558|364387214|FG004|Step 1|Virologic Failure|0|||
105651474|NCT02859558|364387210|FG000|Step 2|Active On Study|23|||
105651475|NCT02859558|364387211|FG001|Step 2|Active On Study|38|||
105651476|NCT02859558|364387212|FG002|Step 2|Active On Study|20|||
105651477|NCT02859558|364387213|FG003|Step 2|Active On Study|0|||
105651478|NCT02859558|364387214|FG004|Step 2|Active On Study|0|||
105651479|NCT02859558|364387210|FG000|Step 2|Did Not Return to Clinic|2|||
105651480|NCT02859558|364387211|FG001|Step 2|Did Not Return to Clinic|0|||
105651481|NCT02859558|364387212|FG002|Step 2|Did Not Return to Clinic|0|||
105651482|NCT02859558|364387213|FG003|Step 2|Did Not Return to Clinic|0|||
105651483|NCT02859558|364387214|FG004|Step 2|Did Not Return to Clinic|0|||
105651484|NCT02859558|364387210|FG000|Step 2|Unexpected Closure of Site|0|||
105651485|NCT02859558|364387211|FG001|Step 2|Unexpected Closure of Site|1|||
105651486|NCT02859558|364387212|FG002|Step 2|Unexpected Closure of Site|1|||
105651487|NCT02859558|364387213|FG003|Step 2|Unexpected Closure of Site|0|||
105651488|NCT02859558|364387214|FG004|Step 2|Unexpected Closure of Site|0|||
105651489|NCT01123642|364387217|FG000|Overall Study|Lost to Follow-up|23|||
105651490|NCT01123642|364387217|FG000|Overall Study|Withdrawal by Subject|9|||
105651491|NCT01123642|364387217|FG000|Overall Study|ineligible at baseline assessment|36|||
105651492|NCT01184859|364387218|FG000|Period 1: Single Dose|Insufficient urine production|0|||
105651493|NCT01184859|364387219|FG001|Period 1: Single Dose|Insufficient urine production|1|||
105651494|NCT01184859|364387220|FG002|Period 1: Single Dose|Insufficient urine production|0|||
105651495|NCT01184859|364387221|FG003|Period 1: Single Dose|Insufficient urine production|0|||
105651496|NCT01184859|364387222|FG004|Period 1: Single Dose|Insufficient urine production|0|||
105651497|NCT01184859|364387218|FG000|Period 1: Single Dose|Protocol Violation|0|||
105651498|NCT01184859|364387219|FG001|Period 1: Single Dose|Protocol Violation|1|||
105651499|NCT01184859|364387220|FG002|Period 1: Single Dose|Protocol Violation|0|||
105651500|NCT01184859|364387221|FG003|Period 1: Single Dose|Protocol Violation|0|||
105651501|NCT01184859|364387222|FG004|Period 1: Single Dose|Protocol Violation|0|||
105651502|NCT01184859|364387218|FG000|Period 1: Single Dose|Adverse Event|0|||
105651503|NCT01184859|364387219|FG001|Period 1: Single Dose|Adverse Event|0|||
105651504|NCT01184859|364387220|FG002|Period 1: Single Dose|Adverse Event|0|||
105651505|NCT01184859|364387221|FG003|Period 1: Single Dose|Adverse Event|0|||
105651506|NCT01184859|364387222|FG004|Period 1: Single Dose|Adverse Event|1|||
105651507|NCT01184859|364387218|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
105651508|NCT01184859|364387219|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
105651509|NCT01184859|364387220|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
105651510|NCT01184859|364387221|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
105651511|NCT01184859|364387222|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
105651512|NCT01184859|364387218|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
105651513|NCT01184859|364387219|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
105651514|NCT01184859|364387220|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
105651515|NCT01184859|364387221|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
105651516|NCT01184859|364387222|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
105651517|NCT03098797|364387224|FG000|Part 2 Open Label Extension|Adverse Event|2|||
105651518|NCT03098797|364387225|FG001|Part 2 Open Label Extension|Adverse Event|0|||
105651519|NCT02329223|364387228|FG000|Overall Study|Withdrawal by Subject|1|||
105651520|NCT02329223|364387229|FG001|Overall Study|Withdrawal by Subject|2|||
105651521|NCT02329223|364387230|FG002|Overall Study|Withdrawal by Subject|5|||
105651522|NCT02329223|364387228|FG000|Overall Study|Physician Decision|0|||
105651523|NCT02329223|364387229|FG001|Overall Study|Physician Decision|0|||
105651524|NCT02329223|364387230|FG002|Overall Study|Physician Decision|1|||
105651525|NCT02329223|364387228|FG000|Overall Study|Adverse Event|0|||
105651526|NCT02329223|364387229|FG001|Overall Study|Adverse Event|1|||
105651527|NCT02329223|364387230|FG002|Overall Study|Adverse Event|0|||
105651528|NCT04044352|364387231|FG000|Overall Study|Lost to Follow-up|9|||
105651529|NCT04044352|364387231|FG000|Overall Study|Withdrawal by Subject|2|||
105651530|NCT00651937|364387232|FG000|Overall Study|Withdrawal by Subject|4|||
105651531|NCT00651937|364387233|FG001|Overall Study|Withdrawal by Subject|1|||
105651532|NCT02176356|364387237|FG000|Overall Study|Screen Failure|14|||
105651533|NCT02176356|364387237|FG000|Overall Study|Lost to Follow-up|4|||
105651534|NCT02176356|364387237|FG000|Overall Study|Personal Reasons|3|||
105651535|NCT02176356|364387237|FG000|Overall Study|Other Miscellaneous Reasons|2|||
105651536|NCT00506922|364387243|FG000|Overall Study|Physician Decision|0|||
105651537|NCT00506922|364387244|FG001|Overall Study|Physician Decision|0|||
105651538|NCT00506922|364387245|FG002|Overall Study|Physician Decision|0|||
105651539|NCT00506922|364387246|FG003|Overall Study|Physician Decision|2|||
105651540|NCT00506922|364387247|FG004|Overall Study|Physician Decision|0|||
105651541|NCT00506922|364387243|FG000|Overall Study|Withdrawal by Subject|0|||
105651542|NCT00506922|364387244|FG001|Overall Study|Withdrawal by Subject|0|||
105651543|NCT00506922|364387245|FG002|Overall Study|Withdrawal by Subject|0|||
105651544|NCT00506922|364387246|FG003|Overall Study|Withdrawal by Subject|0|||
105651545|NCT00506922|364387247|FG004|Overall Study|Withdrawal by Subject|1|||
105651546|NCT00792259|364387248|FG000|Overall Study|Poor Quality Scans|1|||
105651547|NCT00792259|364387249|FG001|Overall Study|Poor Quality Scans|0|||
105651548|NCT00792259|364387250|FG002|Overall Study|Poor Quality Scans|0|||
105651549|NCT00332488|364387251|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
105651550|NCT00332488|364387252|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
105659499|NCT02635386|364417349|FG002|Overall Study|Moved Out of State|0|||
105651551|NCT00332488|364387253|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
105651552|NCT00332488|364387251|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
105651553|NCT00332488|364387252|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
105651554|NCT00332488|364387253|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
105651555|NCT00332488|364387251|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
105651556|NCT00332488|364387252|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
105651557|NCT00332488|364387253|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
105651558|NCT00332488|364387251|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
105651559|NCT00332488|364387252|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
105651560|NCT00332488|364387253|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
105651561|NCT00332488|364387251|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
105651562|NCT00332488|364387252|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
105651563|NCT00332488|364387253|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
105651564|NCT00332488|364387251|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
105651565|NCT00332488|364387252|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
105651566|NCT00332488|364387253|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
105651567|NCT00332488|364387251|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
105651568|NCT00332488|364387252|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
105651569|NCT00332488|364387253|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
105651570|NCT00332488|364387251|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
105651571|NCT00332488|364387252|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
105651572|NCT00332488|364387253|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
105651573|NCT00332488|364387251|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
105651574|NCT00332488|364387252|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
105651575|NCT00332488|364387253|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
105651576|NCT00332488|364387251|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
105651577|NCT00332488|364387252|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
105651578|NCT00332488|364387253|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
105651579|NCT00332488|364387251|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
105651580|NCT00332488|364387252|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
105651581|NCT00332488|364387253|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
105651582|NCT00332488|364387251|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
105651583|NCT00332488|364387252|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
105651584|NCT00332488|364387253|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
105651585|NCT00371462|364387254|FG000|Overall Study|Withdrawal by Subject|1|||
105651586|NCT00371462|364387255|FG001|Overall Study|Withdrawal by Subject|0|||
105651587|NCT00371462|364387254|FG000|Overall Study|Other|7|||
105651588|NCT00371462|364387255|FG001|Overall Study|Other|8|||
105651589|NCT03721978|364387256|FG000|Overall Study|Withdrawal by Subject|6|||
105651590|NCT03721978|364387257|FG001|Overall Study|Withdrawal by Subject|1|||
105651591|NCT03721978|364387256|FG000|Overall Study|Adverse Event|1|||
105651592|NCT03721978|364387257|FG001|Overall Study|Adverse Event|1|||
105651593|NCT03721978|364387256|FG000|Overall Study|Progressive Disease|1|||
105651594|NCT03721978|364387257|FG001|Overall Study|Progressive Disease|0|||
105651595|NCT03721978|364387256|FG000|Overall Study|Lost to Follow-up|5|||
105651596|NCT03721978|364387257|FG001|Overall Study|Lost to Follow-up|1|||
105651597|NCT03721978|364387256|FG000|Overall Study|Reason not Specified|0|||
105651598|NCT03721978|364387257|FG001|Overall Study|Reason not Specified|2|||
105651599|NCT05244226|364387258|FG000|Overall Study|Adverse Event|1|||
105651600|NCT05244226|364387259|FG001|Overall Study|Adverse Event|0|||
105651601|NCT05244226|364387260|FG002|Overall Study|Adverse Event|0|||
105651602|NCT05244226|364387258|FG000|Overall Study|Lost to Follow-up|0|||
105651603|NCT05244226|364387259|FG001|Overall Study|Lost to Follow-up|0|||
105651604|NCT05244226|364387260|FG002|Overall Study|Lost to Follow-up|1|||
105651605|NCT05244226|364387258|FG000|Overall Study|Protocol Violation|0|||
105651606|NCT05244226|364387259|FG001|Overall Study|Protocol Violation|2|||
105651607|NCT05244226|364387260|FG002|Overall Study|Protocol Violation|2|||
105651608|NCT04357964|364387264|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
105651609|NCT04357964|364387265|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
105651610|NCT04357964|364387264|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
105651611|NCT04357964|364387265|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
105651612|NCT04357964|364387264|FG000|Overall Study|Adipose sample was insufficient quality|0|||
105651613|NCT04357964|364387265|FG001|Overall Study|Adipose sample was insufficient quality|1|||
105651614|NCT00733226|364387266|FG000|Overall Study|Withdrawal by Subject|1|||
105651615|NCT00733226|364387267|FG001|Overall Study|Withdrawal by Subject|0|||
105651616|NCT00733226|364387266|FG000|Overall Study|Lost to Follow-up|2|||
105651617|NCT00733226|364387267|FG001|Overall Study|Lost to Follow-up|0|||
105651618|NCT00733226|364387266|FG000|Overall Study|moved to another place|2|||
105651619|NCT00733226|364387267|FG001|Overall Study|moved to another place|0|||
105651620|NCT02388932|364387270|FG000|Overall Study|Death|1|||
105651621|NCT03681353|364387276|FG000|Overall Study|Lost to Follow-up|2|||
105651622|NCT03681353|364387276|FG000|Overall Study|Withdrawal by Subject|3|||
105651623|NCT03681353|364387276|FG000|Overall Study|withdrawn by PI|2|||
105651624|NCT02679079|364387277|FG000|Overall Study|Adverse Event|2|||
105651625|NCT02679079|364387278|FG001|Overall Study|Adverse Event|0|||
105651626|NCT02679079|364387279|FG002|Overall Study|Adverse Event|2|||
105651627|NCT02679079|364387277|FG000|Overall Study|Protocol Violation|0|||
105651628|NCT02679079|364387278|FG001|Overall Study|Protocol Violation|1|||
105651629|NCT02679079|364387279|FG002|Overall Study|Protocol Violation|0|||
105651630|NCT02679079|364387277|FG000|Overall Study|Withdrawal by Subject|2|||
105651631|NCT02679079|364387278|FG001|Overall Study|Withdrawal by Subject|1|||
105651632|NCT02679079|364387279|FG002|Overall Study|Withdrawal by Subject|0|||
105651633|NCT02775214|364387282|FG000|Overall Study|Withdrawal by Subject|2|||
105651634|NCT02775214|364387283|FG001|Overall Study|Withdrawal by Subject|0|||
105651635|NCT00382408|364387284|FG000|Overall Study|Did not meet protocol requirement|3|||
105651636|NCT00382408|364387285|FG001|Overall Study|Did not meet protocol requirement|3|||
105651637|NCT00382408|364387284|FG000|Overall Study|Protocol Violation|2|||
105651638|NCT00382408|364387285|FG001|Overall Study|Protocol Violation|2|||
105651639|NCT00382408|364387284|FG000|Overall Study|Physician Decision|1|||
105651640|NCT00382408|364387285|FG001|Overall Study|Physician Decision|0|||
105651641|NCT00382408|364387284|FG000|Overall Study|Withdrawal by Subject|17|||
105651642|NCT00382408|364387285|FG001|Overall Study|Withdrawal by Subject|6|||
105651643|NCT00382408|364387284|FG000|Overall Study|Pregnancy|2|||
105651644|NCT00382408|364387285|FG001|Overall Study|Pregnancy|0|||
105651645|NCT00382408|364387284|FG000|Overall Study|Lost to Follow-up|19|||
105651646|NCT00382408|364387285|FG001|Overall Study|Lost to Follow-up|8|||
105651647|NCT00382408|364387284|FG000|Overall Study|Other|100|||
105651648|NCT00382408|364387285|FG001|Overall Study|Other|35|||
105651649|NCT00352053|364387288|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
105651650|NCT00352053|364387289|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
105651651|NCT00352053|364387288|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
105651652|NCT00352053|364387289|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
105651653|NCT00352053|364387288|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
105651654|NCT00352053|364387289|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
105651655|NCT00352053|364387288|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
105651656|NCT00352053|364387289|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
105651657|NCT00352053|364387288|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
105651658|NCT00352053|364387289|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
105651659|NCT00352053|364387288|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
105651660|NCT00352053|364387289|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
105651661|NCT00352053|364387288|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
105651662|NCT00352053|364387289|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
105651663|NCT00352053|364387288|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
105651664|NCT00352053|364387289|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
105651665|NCT00352053|364387288|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
105651666|NCT00352053|364387289|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
105651667|NCT00352053|364387288|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
105651668|NCT00352053|364387289|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
105651669|NCT00352053|364387288|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
105651670|NCT00352053|364387289|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
105651671|NCT00352053|364387288|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
105651672|NCT00352053|364387289|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
105651673|NCT00352053|364387288|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
105651674|NCT00352053|364387289|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
105651675|NCT01145417|364387290|FG000|Overall Study|Death|1|||
105651676|NCT01145417|364387291|FG001|Overall Study|Death|0|||
105651677|NCT01145417|364387290|FG000|Overall Study|Lost to Follow-up|2|||
105651678|NCT01145417|364387291|FG001|Overall Study|Lost to Follow-up|1|||
105651679|NCT01145417|364387290|FG000|Overall Study|Withdrawal by Subject|1|||
105651680|NCT01145417|364387291|FG001|Overall Study|Withdrawal by Subject|2|||
105651681|NCT01145417|364387290|FG000|Overall Study|Pregnancy|1|||
105651682|NCT01145417|364387291|FG001|Overall Study|Pregnancy|0|||
105651683|NCT01145417|364387290|FG000|Overall Study|Adverse Event|0|||
105651684|NCT01145417|364387291|FG001|Overall Study|Adverse Event|1|||
105651685|NCT01145417|364387290|FG000|Overall Study|Study terminated by sponsor|35|||
105651686|NCT01145417|364387291|FG001|Overall Study|Study terminated by sponsor|43|||
105651687|NCT01145417|364387290|FG000|Overall Study|Other|1|||
105651688|NCT01145417|364387291|FG001|Overall Study|Other|0|||
105651689|NCT01797562|364387292|FG000|Overall Study|Protocol Violation|5|||
105651690|NCT00632931|364387295|FG000|Part 1, Period 1|Protocol Violation|1|||
105659500|NCT02635386|364417350|FG003|Overall Study|Moved Out of State|0|||
105651691|NCT00632931|364387296|FG001|Part 1, Period 1|Protocol Violation|0|||
105651692|NCT00632931|364387297|FG002|Part 1, Period 1|Protocol Violation|0|||
105651693|NCT00632931|364387295|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
105651694|NCT00632931|364387296|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
105651695|NCT00632931|364387297|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
105651696|NCT00632931|364387295|FG000|Part 2|Adverse Event|0|||
105651697|NCT00632931|364387296|FG001|Part 2|Adverse Event|0|||
105651698|NCT00632931|364387297|FG002|Part 2|Adverse Event|3|||
105651699|NCT00632931|364387295|FG000|Part 2|Death|0|||
105651700|NCT00632931|364387296|FG001|Part 2|Death|0|||
105651701|NCT00632931|364387297|FG002|Part 2|Death|1|||
105651702|NCT00632931|364387295|FG000|Part 2|Lack of Efficacy|0|||
105651703|NCT00632931|364387296|FG001|Part 2|Lack of Efficacy|0|||
105651704|NCT00632931|364387297|FG002|Part 2|Lack of Efficacy|17|||
105651705|NCT00632931|364387295|FG000|Part 2|Withdrawal by Subject|0|||
105651706|NCT00632931|364387296|FG001|Part 2|Withdrawal by Subject|0|||
105651707|NCT00632931|364387297|FG002|Part 2|Withdrawal by Subject|3|||
105651708|NCT03341312|364387298|FG000|Period 1|Withdrawal by Subject|0|||
105651709|NCT03341312|364387299|FG001|Period 1|Withdrawal by Subject|1|||
105651710|NCT03341312|364387300|FG002|Period 1|Withdrawal by Subject|0|||
105651711|NCT03341312|364387301|FG003|Period 1|Withdrawal by Subject|0|||
105651712|NCT04491006|364387305|FG000|Overall Study|Adverse Event|0|||
105651713|NCT04491006|364387306|FG001|Overall Study|Adverse Event|3|||
105651714|NCT04491006|364387307|FG002|Overall Study|Adverse Event|5|||
105651715|NCT04491006|364387305|FG000|Overall Study|Withdrawal by Subject|1|||
105651716|NCT04491006|364387306|FG001|Overall Study|Withdrawal by Subject|0|||
105651717|NCT04491006|364387307|FG002|Overall Study|Withdrawal by Subject|2|||
105651718|NCT02581189|364387311|FG000|Overall Study|Failure to return|36|||
105651719|NCT02581189|364387311|FG000|Overall Study|Withdrew consent|5|||
105651720|NCT02581189|364387311|FG000|Overall Study|Death|3|||
105651721|NCT02581189|364387311|FG000|Overall Study|Insufficient virological response|2|||
105651722|NCT02581189|364387311|FG000|Overall Study|Other, not specified|7|||
105651723|NCT05372913|364387312|FG000|Overall Study|Withdrawal by Subject|0|||
105651724|NCT05372913|364387313|FG001|Overall Study|Withdrawal by Subject|2|||
105651725|NCT05372913|364387312|FG000|Overall Study|Protocol Violation|2|||
105651726|NCT05372913|364387313|FG001|Overall Study|Protocol Violation|2|||
105651727|NCT05372913|364387312|FG000|Overall Study|Adverse Event|0|||
105651728|NCT05372913|364387313|FG001|Overall Study|Adverse Event|1|||
105651729|NCT03193216|364387314|FG000|Overall Study|Lost to Follow-up|1|||
105651730|NCT03193216|364387315|FG001|Overall Study|Lost to Follow-up|0|||
105651731|NCT03193216|364387314|FG000|Overall Study|Withdrawal by Subject|5|||
105651732|NCT03193216|364387315|FG001|Overall Study|Withdrawal by Subject|0|||
105651733|NCT03193216|364387314|FG000|Overall Study|Physician Decision|4|||
105651734|NCT03193216|364387315|FG001|Overall Study|Physician Decision|0|||
105651735|NCT05135156|364387316|FG000|Overall Study|Lost to Follow-up|0|||
105651736|NCT05135156|364387317|FG001|Overall Study|Lost to Follow-up|0|||
105651737|NCT05135156|364387318|FG002|Overall Study|Lost to Follow-up|2|||
105651738|NCT03461211|364387321|FG000|Overall Study|Adverse Event|1|||
105651739|NCT03461211|364387322|FG001|Overall Study|Adverse Event|1|||
105651740|NCT03461211|364387321|FG000|Overall Study|Lack of Efficacy|0|||
105651741|NCT03461211|364387322|FG001|Overall Study|Lack of Efficacy|1|||
105651742|NCT01284634|364387323|FG000|Overall Study|Adverse Event|1|||
105651743|NCT01284634|364387324|FG001|Overall Study|Adverse Event|0|||
105651744|NCT01284634|364387325|FG002|Overall Study|Adverse Event|2|||
105651745|NCT01284634|364387326|FG003|Overall Study|Adverse Event|1|||
105651746|NCT03807700|364387327|FG000|Overall Study|Withdrawal by Subject|2|||
105651747|NCT03807700|364387328|FG001|Overall Study|Withdrawal by Subject|1|||
105651748|NCT01059526|364387329|FG000|Overall Study|Patient enrolled but not treated|20|||
105651749|NCT01059526|364387330|FG001|Overall Study|Patient enrolled but not treated|17|||
105651750|NCT01059526|364387329|FG000|Overall Study|Adverse Event|2|||
105651751|NCT01059526|364387330|FG001|Overall Study|Adverse Event|2|||
105651752|NCT01059526|364387329|FG000|Overall Study|Protocol Violation|0|||
105651753|NCT01059526|364387330|FG001|Overall Study|Protocol Violation|1|||
105651754|NCT01059526|364387329|FG000|Overall Study|Withdrawal by Subject|3|||
105651755|NCT01059526|364387330|FG001|Overall Study|Withdrawal by Subject|1|||
105651756|NCT01059526|364387329|FG000|Overall Study|Lost to Follow-up|4|||
105651757|NCT01059526|364387330|FG001|Overall Study|Lost to Follow-up|1|||
105651758|NCT01059526|364387329|FG000|Overall Study|Patient found to be dermatographic|1|||
105651759|NCT01059526|364387330|FG001|Overall Study|Patient found to be dermatographic|0|||
105651760|NCT02720081|364387331|FG000|Overall Study|Adverse Event|0|||
105651761|NCT02720081|364387332|FG001|Overall Study|Adverse Event|3|||
105651762|NCT02720081|364387331|FG000|Overall Study|Protocol Violation|4|||
105651763|NCT02720081|364387332|FG001|Overall Study|Protocol Violation|1|||
105651764|NCT02316847|364387334|FG000|Overall Study|Adverse Event|0|||
105651765|NCT02316847|364387335|FG001|Overall Study|Adverse Event|3|||
105651766|NCT02316847|364387334|FG000|Overall Study|Lost to Follow-up|0|||
105651767|NCT02316847|364387335|FG001|Overall Study|Lost to Follow-up|2|||
105651768|NCT02316847|364387334|FG000|Overall Study|Physician Decision|0|||
105651769|NCT02316847|364387335|FG001|Overall Study|Physician Decision|1|||
105651770|NCT02316847|364387334|FG000|Overall Study|Pregnancy|0|||
105651771|NCT02316847|364387335|FG001|Overall Study|Pregnancy|1|||
105651772|NCT02316847|364387334|FG000|Overall Study|Withdrawal by Subject|2|||
105651773|NCT02316847|364387335|FG001|Overall Study|Withdrawal by Subject|9|||
105651774|NCT02316847|364387334|FG000|Overall Study|Noncompliance with study drug|0|||
105651775|NCT02316847|364387335|FG001|Overall Study|Noncompliance with study drug|3|||
105651776|NCT02316847|364387334|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
105651777|NCT02316847|364387335|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
105651778|NCT02845375|364387336|FG000|Overall Study|upper airway obstruction|1|||
105651779|NCT02845375|364387337|FG001|Overall Study|upper airway obstruction|2|||
105651780|NCT02845375|364387338|FG002|Overall Study|upper airway obstruction|1|||
105651781|NCT02236598|364387339|FG000|Overall Study|Adverse Event|0|||
105651782|NCT02236598|364387340|FG001|Overall Study|Adverse Event|1|||
105651783|NCT02236598|364387339|FG000|Overall Study|Withdrawal by Subject|0|||
105651784|NCT02236598|364387340|FG001|Overall Study|Withdrawal by Subject|1|||
105651785|NCT00191984|364387341|FG000|Overall Study|Disease Progression|21|||
105651786|NCT00191984|364387341|FG000|Overall Study|Adverse Event|4|||
105651787|NCT00191984|364387341|FG000|Overall Study|Death|2|||
105651788|NCT00191984|364387341|FG000|Overall Study|Entry Criteria Exclusion|1|||
105651789|NCT00191984|364387341|FG000|Overall Study|Withdrawal by Subject|7|||
105651790|NCT00191984|364387341|FG000|Overall Study|Physician Decision|4|||
105651791|NCT04194541|364387342|FG000|Day 1 Through 13|Lost to Follow-up|3|||
105651792|NCT04194541|364387342|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
105651793|NCT04194541|364387342|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
105651794|NCT01536535|364387351|FG000|Overall Study|Withdrawal by Subject|10|||
105651795|NCT01536535|364387352|FG001|Overall Study|Withdrawal by Subject|5|||
105651796|NCT01536535|364387351|FG000|Overall Study|Lost to Follow-up|4|||
105651797|NCT01536535|364387352|FG001|Overall Study|Lost to Follow-up|6|||
105651798|NCT01536535|364387351|FG000|Overall Study|Physician Decision|1|||
105651799|NCT01536535|364387352|FG001|Overall Study|Physician Decision|1|||
105651800|NCT01536535|364387351|FG000|Overall Study|Participant moved|0|||
105651801|NCT01536535|364387352|FG001|Overall Study|Participant moved|1|||
105651802|NCT00635570|364388875|FG000|Overall Study|Lost to Follow-up|8|||
105651803|NCT00635570|364388876|FG001|Overall Study|Lost to Follow-up|8|||
105651804|NCT00635570|364388875|FG000|Overall Study|Withdrawal by Subject|1|||
105651805|NCT00635570|364388876|FG001|Overall Study|Withdrawal by Subject|1|||
105651806|NCT00635570|364388875|FG000|Overall Study|Adverse Event|2|||
105651807|NCT00635570|364388876|FG001|Overall Study|Adverse Event|0|||
105651808|NCT00635570|364388875|FG000|Overall Study|Physician Decision|1|||
105651809|NCT00635570|364388876|FG001|Overall Study|Physician Decision|0|||
105651810|NCT00635570|364388875|FG000|Overall Study|Did not complete survey|2|||
105651811|NCT00635570|364388876|FG001|Overall Study|Did not complete survey|1|||
105651812|NCT00635570|364388875|FG000|Overall Study|Early termination(No sexual activity)|1|||
105651813|NCT00635570|364388876|FG001|Overall Study|Early termination(No sexual activity)|1|||
105651814|NCT02514577|364388880|FG000|Overall Study|Lost to Follow-up|6|||
105651815|NCT02514577|364388881|FG001|Overall Study|Lost to Follow-up|6|||
105651816|NCT02514577|364388880|FG000|Overall Study|Protocol Violation|1|||
105651817|NCT02514577|364388881|FG001|Overall Study|Protocol Violation|0|||
105651818|NCT02514577|364388880|FG000|Overall Study|Withdrawal by Subject|6|||
105651819|NCT02514577|364388881|FG001|Overall Study|Withdrawal by Subject|6|||
105651820|NCT02514577|364388880|FG000|Overall Study|Adverse Event|1|||
105651821|NCT02514577|364388881|FG001|Overall Study|Adverse Event|1|||
105651822|NCT02675998|364388882|FG000|8-Week Treatment Period|Adverse Event|6|||
105651823|NCT02675998|364388883|FG001|8-Week Treatment Period|Adverse Event|5|||
105651824|NCT02675998|364388884|FG002|8-Week Treatment Period|Adverse Event|6|||
105651825|NCT02675998|364388885|FG003|8-Week Treatment Period|Adverse Event|0|||
105651826|NCT02675998|364388882|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
105651827|NCT02675998|364388883|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
105651828|NCT02675998|364388884|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
105651829|NCT02675998|364388885|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
105651830|NCT02675998|364388882|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
105651831|NCT02675998|364388883|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
105651832|NCT02675998|364388884|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
105651833|NCT02675998|364388885|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
105651834|NCT02675998|364388882|FG000|8-Week Treatment Period|Physician Decision|1|||
105651835|NCT02675998|364388883|FG001|8-Week Treatment Period|Physician Decision|0|||
105651836|NCT02675998|364388884|FG002|8-Week Treatment Period|Physician Decision|2|||
105651837|NCT02675998|364388885|FG003|8-Week Treatment Period|Physician Decision|0|||
105651838|NCT02675998|364388882|FG000|8-Week Treatment Period|GI side Effects|1|||
105651839|NCT02675998|364388883|FG001|8-Week Treatment Period|GI side Effects|4|||
105651840|NCT02675998|364388884|FG002|8-Week Treatment Period|GI side Effects|2|||
105651841|NCT02675998|364388885|FG003|8-Week Treatment Period|GI side Effects|0|||
105651842|NCT02675998|364388882|FG000|8-Week Treatment Period|Protocol Violation|1|||
105651843|NCT02675998|364388883|FG001|8-Week Treatment Period|Protocol Violation|1|||
105651844|NCT02675998|364388884|FG002|8-Week Treatment Period|Protocol Violation|1|||
105651845|NCT02675998|364388885|FG003|8-Week Treatment Period|Protocol Violation|0|||
105651846|NCT02675998|364388882|FG000|8-Week Treatment Period|Other|3|||
105651847|NCT02675998|364388883|FG001|8-Week Treatment Period|Other|1|||
105651848|NCT02675998|364388884|FG002|8-Week Treatment Period|Other|2|||
105651849|NCT02675998|364388885|FG003|8-Week Treatment Period|Other|0|||
105651850|NCT02675998|364388882|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
105651851|NCT02675998|364388883|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
105651852|NCT02675998|364388884|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
105651853|NCT02675998|364388885|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
105651854|NCT02675998|364388882|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
105651855|NCT02675998|364388883|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
105651856|NCT02675998|364388884|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
105651857|NCT02675998|364388885|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
105651858|NCT02675998|364388882|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
105651859|NCT02675998|364388883|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
105651860|NCT02675998|364388884|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
105651861|NCT02675998|364388885|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
105651862|NCT02675998|364388882|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
105651863|NCT02675998|364388883|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
105651864|NCT02675998|364388884|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
105651865|NCT02675998|364388885|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
105651866|NCT02675998|364388882|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
105651867|NCT02675998|364388883|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
105651868|NCT02675998|364388884|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
105651869|NCT02675998|364388885|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
105651870|NCT02916706|364388886|FG000|Overall Study|Adverse Event|0|||
105651871|NCT02916706|364388887|FG001|Overall Study|Adverse Event|1|||
105651872|NCT02916706|364388886|FG000|Overall Study|Lost to Follow-up|0|||
105651873|NCT02916706|364388887|FG001|Overall Study|Lost to Follow-up|1|||
105651874|NCT02916706|364388886|FG000|Overall Study|Physician Decision|1|||
105651875|NCT02916706|364388887|FG001|Overall Study|Physician Decision|0|||
105651876|NCT02916706|364388886|FG000|Overall Study|Protocol Violation|3|||
105651877|NCT02916706|364388887|FG001|Overall Study|Protocol Violation|1|||
105651878|NCT02916706|364388886|FG000|Overall Study|Withdrawal by Subject|6|||
105651879|NCT02916706|364388887|FG001|Overall Study|Withdrawal by Subject|9|||
105651880|NCT02916706|364388886|FG000|Overall Study|Other|5|||
105651881|NCT02916706|364388887|FG001|Overall Study|Other|19|||
105651882|NCT01194271|364388890|FG000|Overall Study|Withdrawal by Subject|1|||
105651883|NCT01194271|364388890|FG000|Overall Study|Ineligible, Screen Failure|1|||
105651884|NCT01194271|364388890|FG000|Overall Study|Death|1|||
105651885|NCT00381797|364388893|FG000|Overall Study|Withdrawal by Subject|1|||
105651886|NCT00381797|364388894|FG001|Overall Study|Withdrawal by Subject|1|||
105651887|NCT00381797|364388895|FG002|Overall Study|Withdrawal by Subject|0|||
105651888|NCT00381797|364388896|FG003|Overall Study|Withdrawal by Subject|0|||
105651889|NCT00381797|364388897|FG004|Overall Study|Withdrawal by Subject|2|||
105651890|NCT00381797|364388893|FG000|Overall Study|Ineligible|0|||
105651891|NCT00381797|364388894|FG001|Overall Study|Ineligible|0|||
105651892|NCT00381797|364388895|FG002|Overall Study|Ineligible|0|||
105651893|NCT00381797|364388896|FG003|Overall Study|Ineligible|1|||
105651894|NCT00381797|364388897|FG004|Overall Study|Ineligible|0|||
105651895|NCT00443898|364388898|FG000|Overall Study|Adverse Event|0|||
105651896|NCT00443898|364388899|FG001|Overall Study|Adverse Event|0|||
105651897|NCT00443898|364388900|FG002|Overall Study|Adverse Event|1|||
105651898|NCT00443898|364388901|FG003|Overall Study|Adverse Event|1|||
105651899|NCT00443898|364388898|FG000|Overall Study|Lack of Efficacy|2|||
105651900|NCT00443898|364388899|FG001|Overall Study|Lack of Efficacy|3|||
105651901|NCT00443898|364388900|FG002|Overall Study|Lack of Efficacy|3|||
105651902|NCT00443898|364388901|FG003|Overall Study|Lack of Efficacy|1|||
105651903|NCT00443898|364388898|FG000|Overall Study|Protocol Violation|1|||
105651904|NCT00443898|364388899|FG001|Overall Study|Protocol Violation|1|||
105651905|NCT00443898|364388900|FG002|Overall Study|Protocol Violation|1|||
105651906|NCT00443898|364388901|FG003|Overall Study|Protocol Violation|0|||
105651907|NCT00443898|364388898|FG000|Overall Study|Withdrawal by Subject|11|||
105651908|NCT00443898|364388899|FG001|Overall Study|Withdrawal by Subject|10|||
105651909|NCT00443898|364388900|FG002|Overall Study|Withdrawal by Subject|10|||
105651910|NCT00443898|364388901|FG003|Overall Study|Withdrawal by Subject|6|||
105651911|NCT00443898|364388898|FG000|Overall Study|Lost to Follow-up|10|||
105651912|NCT00443898|364388899|FG001|Overall Study|Lost to Follow-up|10|||
105651913|NCT00443898|364388900|FG002|Overall Study|Lost to Follow-up|14|||
105651914|NCT00443898|364388901|FG003|Overall Study|Lost to Follow-up|10|||
105651915|NCT00443898|364388898|FG000|Overall Study|Death|0|||
105651916|NCT00443898|364388899|FG001|Overall Study|Death|1|||
105651917|NCT00443898|364388900|FG002|Overall Study|Death|0|||
105651918|NCT00443898|364388901|FG003|Overall Study|Death|0|||
105651919|NCT00958711|364388902|FG000|Overall Study|Withdrawal by Subject|0|||
105651920|NCT00958711|364388903|FG001|Overall Study|Withdrawal by Subject|4|||
105651921|NCT00958711|364388902|FG000|Overall Study|Physician Decision|5|||
105651922|NCT00958711|364388903|FG001|Overall Study|Physician Decision|7|||
105651923|NCT00958711|364388902|FG000|Overall Study|Lost to Follow-up|4|||
105651924|NCT00958711|364388903|FG001|Overall Study|Lost to Follow-up|1|||
105651925|NCT00958711|364388902|FG000|Overall Study|Other|2|||
105651926|NCT00958711|364388903|FG001|Overall Study|Other|5|||
105651927|NCT00958711|364388902|FG000|Overall Study|Death|1|||
105651928|NCT00958711|364388903|FG001|Overall Study|Death|2|||
105651929|NCT00958711|364388902|FG000|Overall Study|Adverse Event|1|||
105651930|NCT00958711|364388903|FG001|Overall Study|Adverse Event|2|||
105651931|NCT03722485|364388904|FG000|Overall Study|Withdrawal by Subject|1|||
105651932|NCT03722485|364388905|FG001|Overall Study|Withdrawal by Subject|0|||
105651933|NCT03722485|364388904|FG000|Overall Study|Adverse Event|0|||
105651934|NCT03722485|364388905|FG001|Overall Study|Adverse Event|2|||
105651935|NCT03722485|364388904|FG000|Overall Study|subject discharged prior to study completion|1|||
105651936|NCT03722485|364388905|FG001|Overall Study|subject discharged prior to study completion|5|||
105651937|NCT03722485|364388904|FG000|Overall Study|eligibility criteria not met|2|||
105651938|NCT03722485|364388905|FG001|Overall Study|eligibility criteria not met|0|||
105651939|NCT00349622|364388906|FG000|Overall Study|Death|168|||
105651940|NCT00349622|364388907|FG001|Overall Study|Death|86|||
105651941|NCT00349622|364388906|FG000|Overall Study|Lost to Follow-up|5|||
105651942|NCT00349622|364388907|FG001|Overall Study|Lost to Follow-up|1|||
105651943|NCT00349622|364388906|FG000|Overall Study|Withdrawal by Subject|5|||
105651944|NCT00349622|364388907|FG001|Overall Study|Withdrawal by Subject|9|||
105651945|NCT00508274|364388912|FG000|Overall Study|Adverse Event|5|||
105651946|NCT00508274|364388912|FG000|Overall Study|Death|7|||
105651947|NCT00508274|364388912|FG000|Overall Study|Disease progression|32|||
105651948|NCT00508274|364388912|FG000|Overall Study|Withdrawal by Subject|1|||
105651949|NCT00508274|364388912|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
105651950|NCT00508274|364388912|FG000|Overall Study|Missing|3|||
105651951|NCT01902381|364388913|FG000|Overall Study|Withdrawal by Subject|1|||
105651952|NCT02229396|364388918|FG000|Overall Study|Adverse Event|6|||
105651953|NCT02229396|364388919|FG001|Overall Study|Adverse Event|12|||
105651954|NCT02229396|364388920|FG002|Overall Study|Adverse Event|12|||
105651955|NCT02229396|364388918|FG000|Overall Study|Death|2|||
105651956|NCT02229396|364388919|FG001|Overall Study|Death|3|||
105651957|NCT02229396|364388920|FG002|Overall Study|Death|1|||
105651958|NCT02229396|364388918|FG000|Overall Study|Lost to Follow-up|14|||
105651959|NCT02229396|364388919|FG001|Overall Study|Lost to Follow-up|14|||
105651960|NCT02229396|364388920|FG002|Overall Study|Lost to Follow-up|21|||
105651961|NCT02229396|364388918|FG000|Overall Study|Protocol Violation|2|||
105651962|NCT02229396|364388919|FG001|Overall Study|Protocol Violation|1|||
105651963|NCT02229396|364388920|FG002|Overall Study|Protocol Violation|0|||
105651964|NCT02229396|364388918|FG000|Overall Study|Patient Incorrectly Randomized|0|||
105651965|NCT02229396|364388919|FG001|Overall Study|Patient Incorrectly Randomized|0|||
105651966|NCT02229396|364388920|FG002|Overall Study|Patient Incorrectly Randomized|1|||
105651967|NCT02229396|364388918|FG000|Overall Study|Other|10|||
105651968|NCT02229396|364388919|FG001|Overall Study|Other|18|||
105651969|NCT02229396|364388920|FG002|Overall Study|Other|15|||
105651970|NCT02229396|364388918|FG000|Overall Study|Withdrawal by Subject|42|||
105651971|NCT02229396|364388919|FG001|Overall Study|Withdrawal by Subject|28|||
105651972|NCT02229396|364388920|FG002|Overall Study|Withdrawal by Subject|41|||
105651973|NCT02229396|364388918|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
105651974|NCT02229396|364388919|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
105651975|NCT02229396|364388920|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
105651976|NCT02229396|364388918|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
105651977|NCT02229396|364388919|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
105651978|NCT02229396|364388920|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
105651979|NCT02396953|364388921|FG000|Overall Study|Withdrawal by Subject|0|||
105651980|NCT02396953|364388922|FG001|Overall Study|Withdrawal by Subject|0|||
105651981|NCT02396953|364388923|FG002|Overall Study|Withdrawal by Subject|1|||
105651982|NCT02396953|364388921|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
105651983|NCT02396953|364388922|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
105651984|NCT02396953|364388923|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
105651985|NCT02396953|364388921|FG000|Overall Study|Personal Reasons|1|||
105651986|NCT02396953|364388922|FG001|Overall Study|Personal Reasons|1|||
105651987|NCT02396953|364388923|FG002|Overall Study|Personal Reasons|0|||
105651988|NCT01812707|364388927|FG000|Overall Study|Adverse Event|0|||
105651989|NCT01812707|364388928|FG001|Overall Study|Adverse Event|0|||
105651990|NCT01812707|364388929|FG002|Overall Study|Adverse Event|0|||
105651991|NCT01812707|364388930|FG003|Overall Study|Adverse Event|2|||
105651992|NCT01812707|364388927|FG000|Overall Study|Poor compliance to protocol|1|||
105651993|NCT01812707|364388928|FG001|Overall Study|Poor compliance to protocol|0|||
105651994|NCT01812707|364388929|FG002|Overall Study|Poor compliance to protocol|0|||
105651995|NCT01812707|364388930|FG003|Overall Study|Poor compliance to protocol|0|||
105651996|NCT01812707|364388927|FG000|Overall Study|Consent withdrawn by participant|1|||
105651997|NCT01812707|364388928|FG001|Overall Study|Consent withdrawn by participant|0|||
105651998|NCT01812707|364388929|FG002|Overall Study|Consent withdrawn by participant|0|||
105651999|NCT01812707|364388930|FG003|Overall Study|Consent withdrawn by participant|0|||
105652000|NCT01697592|364388931|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
105652001|NCT01697592|364388932|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652002|NCT01697592|364388933|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652003|NCT01697592|364388934|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652004|NCT01697592|364388935|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652005|NCT01697592|364388936|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652006|NCT01697592|364388937|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652007|NCT01697592|364388938|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652008|NCT01697592|364388939|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652009|NCT01697592|364388940|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652010|NCT01697592|364388931|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652011|NCT01697592|364388932|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652012|NCT01697592|364388933|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652013|NCT01697592|364388934|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652014|NCT01697592|364388935|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652015|NCT01697592|364388936|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
105652016|NCT01697592|364388937|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652017|NCT01697592|364388938|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652018|NCT01697592|364388939|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652019|NCT01697592|364388940|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652020|NCT01697592|364388931|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
105652021|NCT01697592|364388932|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652022|NCT01697592|364388933|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652023|NCT01697592|364388934|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652024|NCT01697592|364388935|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652025|NCT01697592|364388936|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652026|NCT01697592|364388937|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652027|NCT01697592|364388938|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652028|NCT01697592|364388939|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652029|NCT01697592|364388940|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652030|NCT01697592|364388931|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
105652031|NCT01697592|364388932|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
105652032|NCT01697592|364388933|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
105652033|NCT01697592|364388934|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
105652034|NCT01697592|364388935|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
105652035|NCT01697592|364388936|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
105652036|NCT01697592|364388937|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
105652037|NCT01697592|364388938|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
105652038|NCT01697592|364388939|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
105652039|NCT01697592|364388940|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
105652040|NCT01697592|364388931|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
105652041|NCT01697592|364388932|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
105652042|NCT01697592|364388933|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
105652043|NCT01697592|364388934|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
105652044|NCT01697592|364388935|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
105652045|NCT01697592|364388936|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
105652046|NCT01697592|364388937|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
105652047|NCT01697592|364388938|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
105652048|NCT01697592|364388939|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
105652049|NCT01697592|364388940|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
105652050|NCT01697592|364388931|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
105652051|NCT01697592|364388932|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652052|NCT01697592|364388933|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652053|NCT01697592|364388934|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
105652054|NCT01697592|364388935|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652055|NCT01697592|364388936|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652056|NCT01697592|364388937|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652057|NCT01697592|364388938|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652058|NCT01697592|364388939|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652059|NCT01697592|364388940|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652060|NCT01697592|364388931|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
105652061|NCT01697592|364388932|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
105652062|NCT01697592|364388933|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
105652063|NCT01697592|364388934|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
105652064|NCT01697592|364388935|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
105652065|NCT01697592|364388936|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
105652066|NCT01697592|364388937|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
105652067|NCT01697592|364388938|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
105652068|NCT01697592|364388939|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
105652069|NCT01697592|364388940|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
105652070|NCT01697592|364388931|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
105652071|NCT01697592|364388932|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
105652072|NCT01697592|364388933|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
105652073|NCT01697592|364388934|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
105652074|NCT01697592|364388935|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
105652075|NCT01697592|364388936|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
105652076|NCT01697592|364388937|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
105652077|NCT01697592|364388938|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
105652078|NCT01697592|364388939|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
105652079|NCT01697592|364388940|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
105652080|NCT01631825|364388941|FG000|Overall Study|Adverse Event|42|||
105652081|NCT01631825|364388941|FG000|Overall Study|Lack of Efficacy|7|||
105652082|NCT01631825|364388941|FG000|Overall Study|Withdrawal by Subject|9|||
105652083|NCT01631825|364388941|FG000|Overall Study|Protocol Violation|4|||
105652084|NCT01631825|364388941|FG000|Overall Study|Discontinuation criteria|1|||
105652085|NCT01631825|364388941|FG000|Overall Study|Physician Decision|2|||
105652086|NCT02110225|364388942|FG000|Overall Study|Lost to Follow-up|0|||
105652087|NCT02110225|364388943|FG001|Overall Study|Lost to Follow-up|1|||
105652088|NCT02110225|364388944|FG002|Overall Study|Lost to Follow-up|0|||
105652089|NCT03972137|364388948|FG000|Overall Study|Lost to Follow-up|2|||
105652090|NCT03972137|364388948|FG000|Overall Study|Withdrawal by Subject|4|||
105652091|NCT03029234|364388949|FG000|Overall Study|Sponsor Decision|1|||
105652092|NCT03029234|364388949|FG000|Overall Study|Withdrawal by Subject|5|||
105652093|NCT03029234|364388949|FG000|Overall Study|Death|91|||
105652094|NCT03029234|364388949|FG000|Overall Study|Lost to Follow-up|2|||
105652095|NCT03275402|364388957|FG000|Overall Study|Death|17|||
105652096|NCT03275402|364388957|FG000|Overall Study|Study terminated by sponsor|21|||
105652097|NCT03275402|364388957|FG000|Overall Study|Withdrawal by Subject|1|||
105652098|NCT02254681|364388962|FG000|Overall Study|Lack of Efficacy|6|||
105652099|NCT00396097|364388963|FG000|Overall Study|Withdrawal by Subject|17|||
105652100|NCT00396097|364388964|FG001|Overall Study|Withdrawal by Subject|17|||
105652101|NCT00396097|364388963|FG000|Overall Study|Lost to Follow-up|4|||
105652102|NCT00396097|364388964|FG001|Overall Study|Lost to Follow-up|9|||
105652103|NCT00396097|364388963|FG000|Overall Study|Other|3|||
105652104|NCT00396097|364388964|FG001|Overall Study|Other|5|||
105652105|NCT00396097|364388963|FG000|Overall Study|Protocol Violation|0|||
105652106|NCT00396097|364388964|FG001|Overall Study|Protocol Violation|6|||
105652107|NCT00396097|364388963|FG000|Overall Study|Adverse Event|1|||
105652108|NCT00396097|364388964|FG001|Overall Study|Adverse Event|5|||
105652109|NCT00396097|364388963|FG000|Overall Study|Insufficient Clinical Response|1|||
105652110|NCT00396097|364388964|FG001|Overall Study|Insufficient Clinical Response|4|||
105652111|NCT01525641|364388965|FG000|Overall Study|Case report form not collected|25|||
105652112|NCT01525641|364388965|FG000|Overall Study|No visit since the first visit|16|||
105652113|NCT01525641|364388965|FG000|Overall Study|Adverse Event|73|||
105652114|NCT01525641|364388965|FG000|Overall Study|Lack of Efficacy|24|||
105652115|NCT01525641|364388965|FG000|Overall Study|Improvement|5|||
105652116|NCT01525641|364388965|FG000|Overall Study|Lost to follow-up (relocation)|1|||
105652117|NCT01525641|364388965|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
105652118|NCT01525641|364388965|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
105652119|NCT01525641|364388965|FG000|Overall Study|Other than stated above|7|||
105652120|NCT01264887|364388977|FG000|Overall Study|Adverse Event|5|||
105652121|NCT01264887|364388977|FG000|Overall Study|Death|7|||
105652122|NCT01264887|364388977|FG000|Overall Study|Lack of Efficacy|5|||
105652123|NCT01264887|364388977|FG000|Overall Study|Physician Decision|4|||
105652124|NCT01264887|364388977|FG000|Overall Study|Withdrawal by Subject|6|||
105652125|NCT01264887|364388977|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
105652126|NCT01264887|364388977|FG000|Overall Study|Other|2|||
105652127|NCT00745121|364388978|FG000|Overall Study|Death|3|||
105652128|NCT00745121|364388979|FG001|Overall Study|Death|0|||
105652129|NCT00745121|364388978|FG000|Overall Study|Adverse Event|1|||
105652130|NCT00745121|364388979|FG001|Overall Study|Adverse Event|0|||
105652131|NCT00745121|364388978|FG000|Overall Study|Lost to Follow-up|1|||
105652132|NCT00745121|364388979|FG001|Overall Study|Lost to Follow-up|0|||
105652133|NCT00745121|364388978|FG000|Overall Study|Withdrawal by Subject|4|||
105652134|NCT00745121|364388979|FG001|Overall Study|Withdrawal by Subject|2|||
105652135|NCT00297778|364388980|FG000|Overall Study|Adverse Event|16|||
105652136|NCT00297778|364388981|FG001|Overall Study|Adverse Event|10|||
105652137|NCT00297778|364388980|FG000|Overall Study|Withdrawal by Subject|1|||
105652138|NCT00297778|364388981|FG001|Overall Study|Withdrawal by Subject|5|||
105652139|NCT00297778|364388980|FG000|Overall Study|Lack of Efficacy|2|||
105652140|NCT00297778|364388981|FG001|Overall Study|Lack of Efficacy|1|||
105652141|NCT00297778|364388980|FG000|Overall Study|Non-compliant with trial protocol|0|||
105652142|NCT00297778|364388981|FG001|Overall Study|Non-compliant with trial protocol|3|||
105652143|NCT00297778|364388980|FG000|Overall Study|Other|0|||
105652144|NCT00297778|364388981|FG001|Overall Study|Other|1|||
105652145|NCT01820637|364388984|FG000|Overall Study|Death|2|||
105652146|NCT01820637|364388984|FG000|Overall Study|Withdrawal by Subject|1|||
105652147|NCT00583115|364388985|FG000|Overall Study|Death|1|||
105652148|NCT00264498|364388986|FG000|Randomized Treatment|Death|0|||
105652149|NCT00264498|364388987|FG001|Randomized Treatment|Death|3|||
105652150|NCT00264498|364388986|FG000|Randomized Treatment|Withdrawal by Subject|0|||
105652151|NCT00264498|364388987|FG001|Randomized Treatment|Withdrawal by Subject|1|||
105652152|NCT00264498|364388986|FG000|Randomized Treatment|Objective disease Progression|13|||
105652153|NCT00264498|364388987|FG001|Randomized Treatment|Objective disease Progression|14|||
105652154|NCT00264498|364388986|FG000|Randomized Treatment|Physician Decision|1|||
105652155|NCT00264498|364388987|FG001|Randomized Treatment|Physician Decision|0|||
105652156|NCT00264498|364388986|FG000|Randomized Treatment|Incorrectly randomized|1|||
105652157|NCT00264498|364388987|FG001|Randomized Treatment|Incorrectly randomized|0|||
105652158|NCT00264498|364388986|FG000|Randomized Treatment|Study Closure|1|||
105652159|NCT00264498|364388987|FG001|Randomized Treatment|Study Closure|0|||
105652160|NCT00264498|364388986|FG000|Randomized Treatment|Protocol Violation|1|||
105652161|NCT00264498|364388987|FG001|Randomized Treatment|Protocol Violation|0|||
105652162|NCT00264498|364388986|FG000|Crossover Treatment|Death|1|||
105652163|NCT00264498|364388987|FG001|Crossover Treatment|Death|3|||
105652164|NCT00264498|364388986|FG000|Crossover Treatment|Objective disease progression|4|||
105652165|NCT00264498|364388987|FG001|Crossover Treatment|Objective disease progression|5|||
105652166|NCT00264498|364388986|FG000|Crossover Treatment|Study closure|0|||
105652167|NCT00264498|364388987|FG001|Crossover Treatment|Study closure|1|||
105652168|NCT00264498|364388986|FG000|Crossover Treatment|Withdrawal by Subject|1|||
105652169|NCT00264498|364388987|FG001|Crossover Treatment|Withdrawal by Subject|0|||
105652170|NCT02382406|364388988|FG000|Study Treatment|Disease Progression|8|||
105652171|NCT02382406|364388989|FG001|Study Treatment|Disease Progression|0|||
105652172|NCT02382406|364388990|FG002|Study Treatment|Disease Progression|20|||
105652173|NCT02382406|364388988|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
105652174|NCT02382406|364388989|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
105652175|NCT02382406|364388990|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
105652176|NCT02382406|364388988|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
105652177|NCT02382406|364388989|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
105652178|NCT02382406|364388990|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
105652179|NCT02382406|364388988|FG000|Study Treatment|symptomatic deterioration|1|||
105652180|NCT02382406|364388989|FG001|Study Treatment|symptomatic deterioration|0|||
105652181|NCT02382406|364388990|FG002|Study Treatment|symptomatic deterioration|1|||
105652182|NCT02382406|364388988|FG000|Study Treatment|Death|0|||
105652183|NCT02382406|364388989|FG001|Study Treatment|Death|0|||
105652184|NCT02382406|364388990|FG002|Study Treatment|Death|2|||
105652185|NCT02382406|364388988|FG000|Follow up|Death|11|||
105652186|NCT02382406|364388989|FG001|Follow up|Death|0|||
105652187|NCT02382406|364388990|FG002|Follow up|Death|19|||
105652188|NCT02382406|364388988|FG000|Follow up|Symptomatic deterioration|1|||
105652189|NCT02382406|364388989|FG001|Follow up|Symptomatic deterioration|0|||
105652190|NCT02382406|364388990|FG002|Follow up|Symptomatic deterioration|1|||
105652191|NCT02382406|364388988|FG000|Follow up|Patient Refused Follow-up|1|||
105652192|NCT02382406|364388989|FG001|Follow up|Patient Refused Follow-up|0|||
105652193|NCT02382406|364388990|FG002|Follow up|Patient Refused Follow-up|0|||
105652194|NCT02382406|364388988|FG000|Follow up|Study Terminated|1|||
105652195|NCT02382406|364388989|FG001|Follow up|Study Terminated|0|||
105652196|NCT02382406|364388990|FG002|Follow up|Study Terminated|8|||
105652197|NCT02382406|364388988|FG000|Follow up|Withdrawal by Subject|0|||
105652198|NCT02382406|364388989|FG001|Follow up|Withdrawal by Subject|0|||
105652199|NCT02382406|364388990|FG002|Follow up|Withdrawal by Subject|2|||
105652200|NCT01713998|364388991|FG000|Overall Study|Lost to Follow-up|2|||
105652201|NCT01713998|364388992|FG001|Overall Study|Lost to Follow-up|0|||
105652202|NCT01713998|364388993|FG002|Overall Study|Lost to Follow-up|2|||
105652203|NCT01713998|364388991|FG000|Overall Study|Withdrawal by Subject|1|||
105652204|NCT01713998|364388992|FG001|Overall Study|Withdrawal by Subject|0|||
105652205|NCT01713998|364388993|FG002|Overall Study|Withdrawal by Subject|0|||
105652206|NCT03638258|364388994|FG000|Overall Study|Adverse Event|1|||
105652207|NCT03638258|364388995|FG001|Overall Study|Adverse Event|0|||
105652208|NCT03638258|364388996|FG002|Overall Study|Adverse Event|2|||
105652209|NCT03638258|364388994|FG000|Overall Study|Lost to Follow-up|2|||
105652210|NCT03638258|364388995|FG001|Overall Study|Lost to Follow-up|4|||
105652211|NCT03638258|364388996|FG002|Overall Study|Lost to Follow-up|5|||
105652212|NCT03638258|364388994|FG000|Overall Study|Pregnancy|0|||
105652213|NCT03638258|364388995|FG001|Overall Study|Pregnancy|0|||
105652214|NCT03638258|364388996|FG002|Overall Study|Pregnancy|1|||
105652215|NCT03638258|364388994|FG000|Overall Study|Protocol Violation|0|||
105652216|NCT03638258|364388995|FG001|Overall Study|Protocol Violation|0|||
105652217|NCT03638258|364388996|FG002|Overall Study|Protocol Violation|1|||
105652218|NCT03638258|364388994|FG000|Overall Study|Withdrawal by Subject|4|||
105652219|NCT03638258|364388995|FG001|Overall Study|Withdrawal by Subject|5|||
105652220|NCT03638258|364388996|FG002|Overall Study|Withdrawal by Subject|12|||
105652221|NCT03638258|364388994|FG000|Overall Study|Lack of Efficacy|0|||
105652222|NCT03638258|364388995|FG001|Overall Study|Lack of Efficacy|0|||
105652223|NCT03638258|364388996|FG002|Overall Study|Lack of Efficacy|2|||
105652224|NCT03048058|364388998|FG000|Overall Study|Lost to Follow-up|4|||
105652225|NCT03048058|364388999|FG001|Overall Study|Lost to Follow-up|0|||
105652226|NCT03048058|364388998|FG000|Overall Study|Withdrawal by Subject|0|||
105652227|NCT03048058|364388999|FG001|Overall Study|Withdrawal by Subject|4|||
105652228|NCT01527500|364389000|FG000|Part A|Administrative|11|||
105652229|NCT01527500|364389001|FG001|Part A|Administrative|7|||
105652230|NCT01527500|364389000|FG000|Part A|Adverse Event|4|||
105652231|NCT01527500|364389001|FG001|Part A|Adverse Event|2|||
105652232|NCT01527500|364389000|FG000|Part A|Death|4|||
105652233|NCT01527500|364389001|FG001|Part A|Death|1|||
105652234|NCT01527500|364389000|FG000|Part A|Lost to Follow-up|0|||
105652235|NCT01527500|364389001|FG001|Part A|Lost to Follow-up|1|||
105652236|NCT01527500|364389000|FG000|Part A|Protocol Deviation|9|||
105652237|NCT01527500|364389001|FG001|Part A|Protocol Deviation|2|||
105652238|NCT01527500|364389000|FG000|Part A|Withdrawal by Subject|2|||
105652239|NCT01527500|364389001|FG001|Part A|Withdrawal by Subject|0|||
105652240|NCT01527500|364389000|FG000|Part B|Adverse Event|1|||
105652241|NCT01527500|364389001|FG001|Part B|Adverse Event|0|||
105652242|NCT01287416|364389002|FG000|Pre-post Training|Withdrawal by Subject|17|||
105652243|NCT01287416|364389003|FG001|Pre-post Training|Withdrawal by Subject|24|||
105652244|NCT01287416|364389002|FG000|Pre-post Training|Lost to Follow-up|5|||
105652245|NCT01287416|364389003|FG001|Pre-post Training|Lost to Follow-up|1|||
105652246|NCT01287416|364389002|FG000|6 Month Follow-up|Lost to Follow-up|3|||
105652247|NCT01287416|364389003|FG001|6 Month Follow-up|Lost to Follow-up|2|||
105652248|NCT01747629|364389006|FG000|Overall Study|Adverse Event|1|||
105652249|NCT01747629|364389007|FG001|Overall Study|Adverse Event|2|||
105652250|NCT01747629|364389006|FG000|Overall Study|Withdrawal by Subject|2|||
105652251|NCT01747629|364389007|FG001|Overall Study|Withdrawal by Subject|2|||
105652252|NCT01747629|364389006|FG000|Overall Study|Noncompliance|1|||
105652253|NCT01747629|364389007|FG001|Overall Study|Noncompliance|1|||
105652254|NCT01747629|364389006|FG000|Overall Study|Inclusion criteria not met|1|||
105652255|NCT01747629|364389007|FG001|Overall Study|Inclusion criteria not met|0|||
105652256|NCT01747629|364389006|FG000|Overall Study|Not treated|1|||
105652257|NCT01747629|364389007|FG001|Overall Study|Not treated|0|||
105652258|NCT01747629|364389006|FG000|Overall Study|Other|2|||
105652259|NCT01747629|364389007|FG001|Overall Study|Other|1|||
105652260|NCT02016690|364389008|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
105652261|NCT02016690|364389008|FG000|Overall Study|Excluded from SAS: Duplication|2|||
105652262|NCT02016690|364389008|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
105652263|NCT02016690|364389008|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
105652264|NCT02016690|364389008|FG000|Overall Study|Did not meet inclusion criteria|13|||
105652265|NCT02016690|364389008|FG000|Overall Study|Hospitalized for RSV at study start|3|||
105652266|NCT02865135|364389009|FG000|Overall Study|Death|0|||
105652267|NCT02865135|364389010|FG001|Overall Study|Death|1|||
105652268|NCT02865135|364389011|FG002|Overall Study|Death|0|||
105652269|NCT02865135|364389009|FG000|Overall Study|Progression|6|||
105652270|NCT02865135|364389010|FG001|Overall Study|Progression|2|||
105652271|NCT02865135|364389011|FG002|Overall Study|Progression|2|||
105652272|NCT01078584|364389013|FG000|Overall Study|Final Status Unknown|1073|||
105652273|NCT01078584|364389013|FG000|Overall Study|Lost to Follow-up|670|||
105652274|NCT01078584|364389013|FG000|Overall Study|Non-serious Adverse Event|577|||
105652275|NCT01078584|364389013|FG000|Overall Study|Withdrawal of Consent|244|||
105652276|NCT01078584|364389013|FG000|Overall Study|Physician Withdrew from Study|90|||
105652277|NCT01078584|364389013|FG000|Overall Study|Non-compliance|67|||
105652278|NCT01078584|364389013|FG000|Overall Study|Blood Pressure Controlled|49|||
105652279|NCT01078584|364389013|FG000|Overall Study|Physician Switched Medication|26|||
105652280|NCT01078584|364389013|FG000|Overall Study|Physician Discontinued Patient|12|||
105652281|NCT01078584|364389013|FG000|Overall Study|Lack of Efficacy|98|||
105652282|NCT01078584|364389013|FG000|Overall Study|Protocol Violation|75|||
105652283|NCT01078584|364389013|FG000|Overall Study|Serious Adverse Event|27|||
105652284|NCT01078584|364389013|FG000|Overall Study|Multiple Reasons|2|||
105652285|NCT01121185|364389014|FG000|Overall Study|Not infused|0|||
105652286|NCT01121185|364389015|FG001|Overall Study|Not infused|1|||
105652287|NCT01121185|364389014|FG000|Overall Study|Not transplanted|1|||
105652288|NCT01121185|364389015|FG001|Overall Study|Not transplanted|0|||
105652289|NCT01077622|364389016|FG000|Overall Study|Physician Decision|2|||
105652290|NCT01077622|364389016|FG000|Overall Study|Withdrawal by Subject|1|||
105652291|NCT01177228|364389017|FG000|Overall Study|Positive tuberculosis test|0|||
105652292|NCT01177228|364389018|FG001|Overall Study|Positive tuberculosis test|1|||
105652293|NCT01177228|364389019|FG002|Overall Study|Positive tuberculosis test|0|||
105652294|NCT01177228|364389020|FG003|Overall Study|Positive tuberculosis test|0|||
105652295|NCT01177228|364389017|FG000|Overall Study|Worsening disease activity|1|||
105652296|NCT01177228|364389018|FG001|Overall Study|Worsening disease activity|0|||
105652297|NCT01177228|364389019|FG002|Overall Study|Worsening disease activity|0|||
105652298|NCT01177228|364389020|FG003|Overall Study|Worsening disease activity|0|||
105652299|NCT01177228|364389017|FG000|Overall Study|Withdrawal by Subject|0|||
105652300|NCT01177228|364389018|FG001|Overall Study|Withdrawal by Subject|1|||
105652301|NCT01177228|364389019|FG002|Overall Study|Withdrawal by Subject|0|||
105652302|NCT01177228|364389020|FG003|Overall Study|Withdrawal by Subject|0|||
105652303|NCT01180790|364389021|FG000|Overall Study|Adverse Event|1|||
105652304|NCT01180790|364389022|FG001|Overall Study|Adverse Event|1|||
105652305|NCT01180790|364389023|FG002|Overall Study|Adverse Event|2|||
105652306|NCT01180790|364389024|FG003|Overall Study|Adverse Event|0|||
105652307|NCT01180790|364389025|FG004|Overall Study|Adverse Event|1|||
105652308|NCT01180790|364389026|FG005|Overall Study|Adverse Event|3|||
105652309|NCT01180790|364389027|FG006|Overall Study|Adverse Event|0|||
105652310|NCT01180790|364389021|FG000|Overall Study|Withdrawal by Subject|3|||
105652311|NCT01180790|364389022|FG001|Overall Study|Withdrawal by Subject|0|||
105652312|NCT01180790|364389023|FG002|Overall Study|Withdrawal by Subject|5|||
105652313|NCT01180790|364389024|FG003|Overall Study|Withdrawal by Subject|0|||
105652314|NCT01180790|364389025|FG004|Overall Study|Withdrawal by Subject|2|||
105652315|NCT01180790|364389026|FG005|Overall Study|Withdrawal by Subject|1|||
105652316|NCT01180790|364389027|FG006|Overall Study|Withdrawal by Subject|0|||
105652317|NCT01180790|364389021|FG000|Overall Study|Lost to Follow-up|3|||
105652318|NCT01180790|364389022|FG001|Overall Study|Lost to Follow-up|1|||
105652319|NCT01180790|364389023|FG002|Overall Study|Lost to Follow-up|0|||
105652320|NCT01180790|364389024|FG003|Overall Study|Lost to Follow-up|2|||
105652321|NCT01180790|364389025|FG004|Overall Study|Lost to Follow-up|1|||
105652322|NCT01180790|364389026|FG005|Overall Study|Lost to Follow-up|0|||
105652323|NCT01180790|364389027|FG006|Overall Study|Lost to Follow-up|1|||
105652324|NCT01180790|364389021|FG000|Overall Study|Physician Decision|1|||
105652325|NCT01180790|364389022|FG001|Overall Study|Physician Decision|0|||
105652326|NCT01180790|364389023|FG002|Overall Study|Physician Decision|0|||
105652327|NCT01180790|364389024|FG003|Overall Study|Physician Decision|1|||
105652328|NCT01180790|364389025|FG004|Overall Study|Physician Decision|0|||
105652329|NCT01180790|364389026|FG005|Overall Study|Physician Decision|0|||
105652330|NCT01180790|364389027|FG006|Overall Study|Physician Decision|0|||
105652331|NCT01180790|364389021|FG000|Overall Study|Lack of Efficacy|1|||
105652332|NCT01180790|364389022|FG001|Overall Study|Lack of Efficacy|2|||
105652333|NCT01180790|364389023|FG002|Overall Study|Lack of Efficacy|5|||
105652334|NCT01180790|364389024|FG003|Overall Study|Lack of Efficacy|6|||
105652335|NCT01180790|364389025|FG004|Overall Study|Lack of Efficacy|1|||
105652336|NCT01180790|364389026|FG005|Overall Study|Lack of Efficacy|3|||
105652337|NCT01180790|364389027|FG006|Overall Study|Lack of Efficacy|0|||
105652338|NCT01180790|364389021|FG000|Overall Study|compliance|0|||
105652339|NCT01180790|364389022|FG001|Overall Study|compliance|1|||
105652340|NCT01180790|364389023|FG002|Overall Study|compliance|0|||
105652341|NCT01180790|364389024|FG003|Overall Study|compliance|0|||
105652342|NCT01180790|364389025|FG004|Overall Study|compliance|0|||
105652343|NCT01180790|364389026|FG005|Overall Study|compliance|0|||
105652344|NCT01180790|364389027|FG006|Overall Study|compliance|0|||
105652345|NCT01180790|364389021|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
105652346|NCT01180790|364389022|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
105652347|NCT01180790|364389023|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
105652348|NCT01180790|364389024|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
105652349|NCT01180790|364389025|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
105652350|NCT01180790|364389026|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
105652351|NCT01180790|364389027|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
105652352|NCT02040532|364389028|FG000|Overall Study|Lost to Follow-up|1|||
105652353|NCT02040532|364389028|FG000|Overall Study|Physician Decision|4|||
105652354|NCT02040532|364389028|FG000|Overall Study|Adverse Event|4|||
105652355|NCT02040532|364389028|FG000|Overall Study|Withdrawal by Subject|3|||
105652356|NCT02820298|364389031|FG000|Overall Study|Withdrawal by Subject|0|||
105652357|NCT02820298|364389032|FG001|Overall Study|Withdrawal by Subject|1|||
105652358|NCT02820298|364389031|FG000|Overall Study|Physician Decision|1|||
105652359|NCT02820298|364389032|FG001|Overall Study|Physician Decision|0|||
105652360|NCT02820298|364389031|FG000|Overall Study|Protocol Violation|0|||
105652361|NCT02820298|364389032|FG001|Overall Study|Protocol Violation|1|||
105652362|NCT00562484|364389033|FG000|Overall Study|Adverse Event|6|||
105652363|NCT00562484|364389034|FG001|Overall Study|Adverse Event|1|||
105652364|NCT00562484|364389033|FG000|Overall Study|Protocol Violation|11|||
105652365|NCT00562484|364389034|FG001|Overall Study|Protocol Violation|2|||
105652366|NCT00562484|364389033|FG000|Overall Study|Withdrawal by Subject|12|||
105652367|NCT00562484|364389034|FG001|Overall Study|Withdrawal by Subject|9|||
105652368|NCT00562484|364389033|FG000|Overall Study|Moved away from the study area|20|||
105652369|NCT00562484|364389034|FG001|Overall Study|Moved away from the study area|9|||
105652370|NCT00562484|364389033|FG000|Overall Study|Lost to Follow-up|132|||
105652371|NCT00562484|364389034|FG001|Overall Study|Lost to Follow-up|71|||
105652372|NCT00562484|364389033|FG000|Overall Study|Reason not provided or not specified|25|||
105652373|NCT00562484|364389034|FG001|Overall Study|Reason not provided or not specified|12|||
105652374|NCT03749616|364389035|FG000|Overall Study|Lost to Follow-up|4|||
105652375|NCT03749616|364389036|FG001|Overall Study|Lost to Follow-up|7|||
105652376|NCT03749616|364389035|FG000|Overall Study|Screen Failure|1|||
105652377|NCT03749616|364389036|FG001|Overall Study|Screen Failure|1|||
105652378|NCT03749616|364389035|FG000|Overall Study|Withdrawal by Subject|2|||
105652379|NCT03749616|364389036|FG001|Overall Study|Withdrawal by Subject|0|||
105652380|NCT00919061|364389037|FG000|Overall Study|Adverse Event|1|||
105652381|NCT00919061|364389037|FG000|Overall Study|Withdrawal by Subject|1|||
105652382|NCT00837096|364390436|FG000|Overall Study|Physician Decision|1|||
105652383|NCT00837096|364390437|FG001|Overall Study|Physician Decision|1|||
105652384|NCT00837096|364390436|FG000|Overall Study|Not reported|9|||
105652385|NCT00837096|364390437|FG001|Overall Study|Not reported|8|||
105652386|NCT01084239|364390440|FG000|28-Day Follow-up|Lost to Follow-up|4|||
105652387|NCT01084239|364390441|FG001|28-Day Follow-up|Lost to Follow-up|9|||
105652388|NCT00550771|364390442|FG000|Overall Study|Adverse Event|11|||
105652389|NCT00550771|364390443|FG001|Overall Study|Adverse Event|3|||
105652390|NCT00550771|364390442|FG000|Overall Study|Discontinued for study-related reasons|0|||
105652391|NCT00550771|364390443|FG001|Overall Study|Discontinued for study-related reasons|1|||
105652392|NCT00550771|364390442|FG000|Overall Study|Physician Decision|2|||
105652393|NCT00550771|364390443|FG001|Overall Study|Physician Decision|0|||
105652394|NCT00550771|364390442|FG000|Overall Study|Withdrawal by Subject|0|||
105652395|NCT00550771|364390443|FG001|Overall Study|Withdrawal by Subject|1|||
105652396|NCT00550771|364390442|FG000|Overall Study|Protocol Violation|4|||
105652397|NCT00550771|364390443|FG001|Overall Study|Protocol Violation|5|||
105652398|NCT01011049|364390448|FG000|Overall Study|Protocol Violation|0|||
105652399|NCT01011049|364390449|FG001|Overall Study|Protocol Violation|0|||
105652400|NCT01011049|364390450|FG002|Overall Study|Protocol Violation|2|||
105652401|NCT01011049|364390451|FG003|Overall Study|Protocol Violation|0|||
105652402|NCT01011049|364390448|FG000|Overall Study|Lost to Follow-up|1|||
105652403|NCT01011049|364390449|FG001|Overall Study|Lost to Follow-up|2|||
105652404|NCT01011049|364390450|FG002|Overall Study|Lost to Follow-up|1|||
105652405|NCT01011049|364390451|FG003|Overall Study|Lost to Follow-up|0|||
105652406|NCT01011049|364390448|FG000|Overall Study|Withdrawal by Subject|0|||
105652407|NCT01011049|364390449|FG001|Overall Study|Withdrawal by Subject|0|||
105652408|NCT01011049|364390450|FG002|Overall Study|Withdrawal by Subject|1|||
105652409|NCT01011049|364390451|FG003|Overall Study|Withdrawal by Subject|0|||
105652410|NCT02435381|364390452|FG000|Overall Study|Lost to Follow-up|2|||
105652411|NCT02435381|364390453|FG001|Overall Study|Lost to Follow-up|1|||
105652412|NCT00833898|364390454|FG000|Overall Study|Withdrawal by Subject|33|||
105652413|NCT00833898|364390455|FG001|Overall Study|Withdrawal by Subject|27|||
105652414|NCT00833898|364390454|FG000|Overall Study|Lost to Follow-up|7|||
105652415|NCT00833898|364390455|FG001|Overall Study|Lost to Follow-up|7|||
105652416|NCT00833898|364390454|FG000|Overall Study|Patient did not receive transplant|0|||
105652417|NCT00833898|364390455|FG001|Overall Study|Patient did not receive transplant|2|||
105652418|NCT05109117|364390456|FG000|Overall Study|Lost to Follow-up|1|||
105652419|NCT05109117|364390456|FG000|Overall Study|Discontinued for non-compliance|1|||
105652420|NCT03220776|364390457|FG000|Overall Study|Claustrophobia|0|||
105652421|NCT03220776|364390458|FG001|Overall Study|Claustrophobia|1|||
105652422|NCT03220776|364390459|FG002|Overall Study|Claustrophobia|1|||
105652423|NCT03220776|364390460|FG003|Overall Study|Claustrophobia|0|||
105652424|NCT03220776|364390461|FG004|Overall Study|Claustrophobia|1|||
105652425|NCT03220776|364390462|FG005|Overall Study|Claustrophobia|0|||
105652426|NCT03220776|364390457|FG000|Overall Study|MRI Equipment Failure|1|||
105652427|NCT03220776|364390458|FG001|Overall Study|MRI Equipment Failure|0|||
105652428|NCT03220776|364390459|FG002|Overall Study|MRI Equipment Failure|0|||
105652429|NCT03220776|364390460|FG003|Overall Study|MRI Equipment Failure|0|||
105652430|NCT03220776|364390461|FG004|Overall Study|MRI Equipment Failure|0|||
105652431|NCT03220776|364390462|FG005|Overall Study|MRI Equipment Failure|0|||
105652432|NCT03220776|364390457|FG000|Overall Study|Inclimate Weather|0|||
105652433|NCT03220776|364390458|FG001|Overall Study|Inclimate Weather|0|||
105652434|NCT03220776|364390459|FG002|Overall Study|Inclimate Weather|0|||
105652435|NCT03220776|364390460|FG003|Overall Study|Inclimate Weather|0|||
105652436|NCT03220776|364390461|FG004|Overall Study|Inclimate Weather|0|||
105652437|NCT03220776|364390462|FG005|Overall Study|Inclimate Weather|1|||
105652438|NCT03220776|364390457|FG000|Overall Study|Physician Decision|0|||
105652439|NCT03220776|364390458|FG001|Overall Study|Physician Decision|0|||
105652440|NCT03220776|364390459|FG002|Overall Study|Physician Decision|0|||
105652441|NCT03220776|364390460|FG003|Overall Study|Physician Decision|1|||
105652442|NCT03220776|364390461|FG004|Overall Study|Physician Decision|0|||
105652443|NCT03220776|364390462|FG005|Overall Study|Physician Decision|0|||
105652444|NCT03220776|364390457|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
105652445|NCT03220776|364390458|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
105652446|NCT03220776|364390459|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
105652447|NCT03220776|364390460|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
105652448|NCT03220776|364390461|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
105652449|NCT03220776|364390462|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
105652450|NCT03220776|364390457|FG000|Overall Study|Protocol Violation|0|||
105652451|NCT03220776|364390458|FG001|Overall Study|Protocol Violation|0|||
105652452|NCT03220776|364390459|FG002|Overall Study|Protocol Violation|0|||
105652453|NCT03220776|364390460|FG003|Overall Study|Protocol Violation|2|||
105652454|NCT03220776|364390461|FG004|Overall Study|Protocol Violation|0|||
105652455|NCT03220776|364390462|FG005|Overall Study|Protocol Violation|1|||
105652456|NCT03220776|364390457|FG000|Overall Study|Withdrawal by Subject|1|||
105652457|NCT03220776|364390458|FG001|Overall Study|Withdrawal by Subject|0|||
105652458|NCT03220776|364390459|FG002|Overall Study|Withdrawal by Subject|0|||
105652459|NCT03220776|364390460|FG003|Overall Study|Withdrawal by Subject|0|||
105652460|NCT03220776|364390461|FG004|Overall Study|Withdrawal by Subject|0|||
105652461|NCT03220776|364390462|FG005|Overall Study|Withdrawal by Subject|0|||
105652462|NCT03168425|364390463|FG000|Overall Study|Lost to Follow-up|5|||
105652463|NCT03168425|364390464|FG001|Overall Study|Lost to Follow-up|8|||
105652464|NCT03168425|364390463|FG000|Overall Study|unable to confirm post op opioids|2|||
105652465|NCT03168425|364390464|FG001|Overall Study|unable to confirm post op opioids|3|||
105652466|NCT00744796|364390465|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
105652467|NCT00588341|364390469|FG000|Overall Study|Withdrawal by Subject|3|||
105652468|NCT00588341|364390469|FG000|Overall Study|Not treated due to metastatic disease|1|||
105652469|NCT00588341|364390469|FG000|Overall Study|Patient ineligible|1|||
105652470|NCT02642159|364390470|FG000|Overall Study|Randomized but not treated|1|||
105652471|NCT02642159|364390471|FG001|Overall Study|Randomized but not treated|0|||
105652472|NCT02642159|364390470|FG000|Overall Study|Adverse Event|10|||
105652473|NCT02642159|364390471|FG001|Overall Study|Adverse Event|4|||
105652474|NCT02642159|364390470|FG000|Overall Study|Withdrawal by Subject|9|||
105652475|NCT02642159|364390471|FG001|Overall Study|Withdrawal by Subject|1|||
105652476|NCT02642159|364390470|FG000|Overall Study|Poor compliance to study protocol|1|||
105652477|NCT02642159|364390471|FG001|Overall Study|Poor compliance to study protocol|0|||
105652478|NCT02642159|364390470|FG000|Overall Study|Other than specified above|10|||
105652479|NCT02642159|364390471|FG001|Overall Study|Other than specified above|3|||
105652480|NCT00679549|364390476|FG000|Overall Study|dropout|2|||
105652481|NCT00679549|364390477|FG001|Overall Study|dropout|4|||
105652482|NCT00679549|364390476|FG000|Overall Study|missing outcome echocardiograms|4|||
105652483|NCT00679549|364390477|FG001|Overall Study|missing outcome echocardiograms|5|||
105652484|NCT02282917|364390486|FG000|Overall Study|Withdrawal by Subject|1|||
105652485|NCT02282917|364390486|FG000|Overall Study|Screen Failure/Not Eligible|1|||
105652486|NCT03340766|364390497|FG000|Overall Study|Withdrawal by Subject|2|||
105652487|NCT03340766|364390498|FG001|Overall Study|Withdrawal by Subject|1|||
105652488|NCT03340766|364390499|FG002|Overall Study|Withdrawal by Subject|3|||
105652489|NCT03340766|364390497|FG000|Overall Study|Lost to Follow-up|0|||
105652490|NCT03340766|364390498|FG001|Overall Study|Lost to Follow-up|0|||
105652491|NCT03340766|364390499|FG002|Overall Study|Lost to Follow-up|1|||
105652492|NCT03340766|364390497|FG000|Overall Study|Death|6|||
105652493|NCT03340766|364390498|FG001|Overall Study|Death|7|||
105652494|NCT03340766|364390499|FG002|Overall Study|Death|4|||
105652495|NCT01876823|364390500|FG000|Overall Study|Withdrawal by Subject|5|||
105652496|NCT01876823|364390500|FG000|Overall Study|Physician Decision|2|||
105652497|NCT01876823|364390500|FG000|Overall Study|Patients moved|2|||
105652498|NCT02256488|364390503|FG000|Overall Study|Lost to Follow-up|6|||
105652499|NCT02256488|364390504|FG001|Overall Study|Lost to Follow-up|6|||
105652500|NCT02256488|364390505|FG002|Overall Study|Lost to Follow-up|9|||
105652501|NCT02256488|364390506|FG003|Overall Study|Lost to Follow-up|3|||
105652502|NCT02256488|364390503|FG000|Overall Study|OTHER|1|||
105652503|NCT02256488|364390504|FG001|Overall Study|OTHER|0|||
105652504|NCT02256488|364390505|FG002|Overall Study|OTHER|1|||
105652505|NCT02256488|364390506|FG003|Overall Study|OTHER|1|||
105652506|NCT02256488|364390503|FG000|Overall Study|Withdrawal by Subject|1|||
105652507|NCT02256488|364390504|FG001|Overall Study|Withdrawal by Subject|0|||
105652508|NCT02256488|364390505|FG002|Overall Study|Withdrawal by Subject|0|||
105652509|NCT02256488|364390506|FG003|Overall Study|Withdrawal by Subject|2|||
105652510|NCT02864147|364390510|FG000|Overall Study|Withdrawal by Subject|3|||
105652511|NCT02864147|364390511|FG001|Overall Study|Withdrawal by Subject|2|||
105652512|NCT02864147|364390512|FG002|Overall Study|Withdrawal by Subject|1|||
105652513|NCT02864147|364390510|FG000|Overall Study|Lost to Follow-up|0|||
105652514|NCT02864147|364390511|FG001|Overall Study|Lost to Follow-up|4|||
105652515|NCT02864147|364390512|FG002|Overall Study|Lost to Follow-up|0|||
105652516|NCT02864147|364390510|FG000|Overall Study|Adverse Event|0|||
105652517|NCT02864147|364390511|FG001|Overall Study|Adverse Event|1|||
105652518|NCT02864147|364390512|FG002|Overall Study|Adverse Event|0|||
105652519|NCT02864147|364390510|FG000|Overall Study|Pregnancy|4|||
105652520|NCT02864147|364390511|FG001|Overall Study|Pregnancy|0|||
105652521|NCT02864147|364390512|FG002|Overall Study|Pregnancy|0|||
105440146|NCT00930553|363616707|FG000|Overall Study|Other than specified above|28|||
105652522|NCT02864147|364390510|FG000|Overall Study|Physician Decision|0|||
105652523|NCT02864147|364390511|FG001|Overall Study|Physician Decision|0|||
105652524|NCT02864147|364390512|FG002|Overall Study|Physician Decision|1|||
105652525|NCT02864147|364390510|FG000|Overall Study|Opted for excisional procedures|0|||
105652526|NCT02864147|364390511|FG001|Overall Study|Opted for excisional procedures|0|||
105652527|NCT02864147|364390512|FG002|Overall Study|Opted for excisional procedures|3|||
105652528|NCT00240097|364390513|FG000|Part I|Adverse Event|1|||
105652529|NCT00240097|364390513|FG000|Part I|Death|1|||
105652530|NCT00240097|364390513|FG000|Part I|histology|1|||
105652531|NCT00240097|364390513|FG000|Part I|unevaluable|1|||
105652532|NCT00240097|364390513|FG000|Part II|did not continue from Part I|23|||
105652533|NCT02383927|364390514|FG000|Overall Study|Disease Progression|8|||
105652534|NCT02383927|364390515|FG001|Overall Study|Disease Progression|8|||
105652535|NCT02383927|364390516|FG002|Overall Study|Disease Progression|15|||
105652536|NCT02383927|364390517|FG003|Overall Study|Disease Progression|4|||
105652537|NCT02383927|364390514|FG000|Overall Study|Physician Decision|0|||
105652538|NCT02383927|364390515|FG001|Overall Study|Physician Decision|0|||
105652539|NCT02383927|364390516|FG002|Overall Study|Physician Decision|2|||
105652540|NCT02383927|364390517|FG003|Overall Study|Physician Decision|0|||
105652541|NCT02383927|364390514|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
105652542|NCT02383927|364390515|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
105652543|NCT02383927|364390516|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
105652544|NCT02383927|364390517|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
105652545|NCT02383927|364390514|FG000|Overall Study|Adverse Event|4|||
105652546|NCT02383927|364390515|FG001|Overall Study|Adverse Event|1|||
105652547|NCT02383927|364390516|FG002|Overall Study|Adverse Event|3|||
105652548|NCT02383927|364390517|FG003|Overall Study|Adverse Event|5|||
105652549|NCT02383927|364390514|FG000|Overall Study|Miscellaneous|1|||
105652550|NCT02383927|364390515|FG001|Overall Study|Miscellaneous|0|||
105652551|NCT02383927|364390516|FG002|Overall Study|Miscellaneous|0|||
105652552|NCT02383927|364390517|FG003|Overall Study|Miscellaneous|1|||
105652553|NCT02383927|364390514|FG000|Overall Study|Withdrawal by Subject|0|||
105652554|NCT02383927|364390515|FG001|Overall Study|Withdrawal by Subject|1|||
105652555|NCT02383927|364390516|FG002|Overall Study|Withdrawal by Subject|4|||
105652556|NCT02383927|364390517|FG003|Overall Study|Withdrawal by Subject|0|||
105652557|NCT00981578|364390518|FG000|Overall Study|Death|1|||
105652558|NCT00981578|364390518|FG000|Overall Study|Withdrawal by Subject|2|||
105652559|NCT01592383|364390521|FG000|Overall Study|Adverse Event|1|||
105652560|NCT04582864|364390524|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
105652561|NCT04582864|364390524|FG000|Overall Study|Death|1|||
105652562|NCT01064856|364390526|FG000|Double-blind (DB) Period|Adverse Event|1|||
105652563|NCT01064856|364390527|FG001|Double-blind (DB) Period|Adverse Event|0|||
105652564|NCT01064856|364390528|FG002|Double-blind (DB) Period|Adverse Event|0|||
105652565|NCT01064856|364390529|FG003|Double-blind (DB) Period|Adverse Event|0|||
105652566|NCT01064856|364390526|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
105652567|NCT01064856|364390527|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
105652568|NCT01064856|364390528|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
105652569|NCT01064856|364390529|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
105652570|NCT01064856|364390526|FG000|Open-label (OL) Period|Adverse Event|0|||
105652571|NCT01064856|364390527|FG001|Open-label (OL) Period|Adverse Event|0|||
105652572|NCT01064856|364390528|FG002|Open-label (OL) Period|Adverse Event|12|||
105652573|NCT01064856|364390529|FG003|Open-label (OL) Period|Adverse Event|6|||
105652574|NCT01064856|364390526|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
105652575|NCT01064856|364390527|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
105652576|NCT01064856|364390528|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
105652577|NCT01064856|364390529|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
105652578|NCT01064856|364390526|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
105652579|NCT01064856|364390527|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
105652580|NCT01064856|364390528|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
105652581|NCT01064856|364390529|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
105652582|NCT01064856|364390526|FG000|Open-label (OL) Period|Other|0|||
105652583|NCT01064856|364390527|FG001|Open-label (OL) Period|Other|0|||
105652584|NCT01064856|364390528|FG002|Open-label (OL) Period|Other|7|||
105652585|NCT01064856|364390529|FG003|Open-label (OL) Period|Other|7|||
105652586|NCT01780584|364390532|FG000|Overall Study|Death|1|||
105652587|NCT01780584|364390533|FG001|Overall Study|Death|0|||
105652588|NCT01780584|364390534|FG002|Overall Study|Death|1|||
105652589|NCT01780584|364390532|FG000|Overall Study|Adverse Event|0|||
105652590|NCT01780584|364390533|FG001|Overall Study|Adverse Event|1|||
105652591|NCT01780584|364390534|FG002|Overall Study|Adverse Event|0|||
105652592|NCT01780584|364390532|FG000|Overall Study|Protocol Violation|0|||
105652593|NCT01780584|364390533|FG001|Overall Study|Protocol Violation|0|||
105652594|NCT01780584|364390534|FG002|Overall Study|Protocol Violation|1|||
105652595|NCT00702520|364390535|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
105652596|NCT00702520|364390536|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
105652597|NCT00702520|364390537|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
105652598|NCT00702520|364390538|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
105652599|NCT00702520|364390535|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
105652600|NCT00702520|364390536|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
105652601|NCT00702520|364390537|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
105652602|NCT00702520|364390538|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
105652603|NCT00702520|364390535|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
105652604|NCT00702520|364390536|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
105652605|NCT00702520|364390537|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
105652606|NCT00702520|364390538|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
105652607|NCT02481934|364390541|FG000|Overall Study|Death|2|||
105652608|NCT01204775|364390544|FG000|Overall Study|Poor/non-compliance|0|||
105652609|NCT01204775|364390545|FG001|Overall Study|Poor/non-compliance|1|||
105652610|NCT01204775|364390544|FG000|Overall Study|Withdrawal by Subject|1|||
105652611|NCT01204775|364390545|FG001|Overall Study|Withdrawal by Subject|0|||
105652612|NCT04783519|364390546|FG000|Overall Study|Withdrawal by Subject|2|||
105652613|NCT04783519|364390547|FG001|Overall Study|Withdrawal by Subject|7|||
105652614|NCT04783519|364390548|FG002|Overall Study|Withdrawal by Subject|3|||
105652615|NCT04783519|364390546|FG000|Overall Study|Lost to Follow-up|9|||
105652616|NCT04783519|364390547|FG001|Overall Study|Lost to Follow-up|7|||
105652617|NCT04783519|364390548|FG002|Overall Study|Lost to Follow-up|6|||
105652618|NCT05041439|364390549|FG000|Overall Study|Withdrawal by Subject|1|||
105652619|NCT05041439|364390550|FG001|Overall Study|Withdrawal by Subject|1|||
105652620|NCT05041439|364390549|FG000|Overall Study|Death|1|||
105652621|NCT05041439|364390550|FG001|Overall Study|Death|0|||
105652622|NCT00727259|364390551|FG000|Overall Study|Not all questionnaires completed|1055|||
105652623|NCT01021683|364390552|FG000|Overall Study|Lack of Efficacy|12|||
105652624|NCT01021683|364390552|FG000|Overall Study|Recovery of neutrophil count|51|||
105652625|NCT01021683|364390552|FG000|Overall Study|Other|8|||
105652626|NCT00509925|364390553|FG000|Overall Study|Personal reasons|0|||
105652627|NCT00509925|364390554|FG001|Overall Study|Personal reasons|1|||
105652628|NCT00645099|364390555|FG000|Overall Study|Lack of Efficacy|15|||
105652629|NCT00645099|364390556|FG001|Overall Study|Lack of Efficacy|6|||
105652630|NCT00645099|364390555|FG000|Overall Study|Withdrawal by Subject|30|||
105652631|NCT00645099|364390556|FG001|Overall Study|Withdrawal by Subject|22|||
105652632|NCT00645099|364390555|FG000|Overall Study|Lost to Follow-up|6|||
105652633|NCT00645099|364390556|FG001|Overall Study|Lost to Follow-up|4|||
105652634|NCT00645099|364390555|FG000|Overall Study|Adverse Event|11|||
105652635|NCT00645099|364390556|FG001|Overall Study|Adverse Event|5|||
105652636|NCT00645099|364390555|FG000|Overall Study|Other|9|||
105652637|NCT00645099|364390556|FG001|Overall Study|Other|5|||
105652638|NCT01201915|364390557|FG000|Overall Study|Adverse Event|2|||
105652639|NCT01201915|364390558|FG001|Overall Study|Adverse Event|1|||
105652640|NCT01201915|364390559|FG002|Overall Study|Adverse Event|1|||
105652641|NCT01201915|364390557|FG000|Overall Study|Lost to Follow-up|0|||
105652642|NCT01201915|364390558|FG001|Overall Study|Lost to Follow-up|4|||
105652643|NCT01201915|364390559|FG002|Overall Study|Lost to Follow-up|0|||
105652644|NCT01201915|364390557|FG000|Overall Study|Physician Decision|3|||
105652645|NCT01201915|364390558|FG001|Overall Study|Physician Decision|0|||
105652646|NCT01201915|364390559|FG002|Overall Study|Physician Decision|0|||
105652647|NCT01201915|364390557|FG000|Overall Study|Subject Decision|3|||
105652648|NCT01201915|364390558|FG001|Overall Study|Subject Decision|3|||
105652649|NCT01201915|364390559|FG002|Overall Study|Subject Decision|5|||
105652650|NCT01201915|364390557|FG000|Overall Study|Target Lesion Progression|0|||
105652651|NCT01201915|364390558|FG001|Overall Study|Target Lesion Progression|3|||
105652652|NCT01201915|364390559|FG002|Overall Study|Target Lesion Progression|0|||
105652653|NCT02154516|364390560|FG000|Overall Study|Withdrawal by Subject|0|||
105652654|NCT02154516|364390561|FG001|Overall Study|Withdrawal by Subject|1|||
105652655|NCT02154516|364390560|FG000|Overall Study|Lost to Follow-up|1|||
105652656|NCT02154516|364390561|FG001|Overall Study|Lost to Follow-up|0|||
105652657|NCT02154516|364390560|FG000|Overall Study|Removal/revision of device|1|||
105652658|NCT02154516|364390561|FG001|Overall Study|Removal/revision of device|0|||
105652659|NCT02154516|364390560|FG000|Overall Study|Death|2|||
105652660|NCT02154516|364390561|FG001|Overall Study|Death|1|||
105652661|NCT03406507|364390562|FG000|Extension Period|Lack of Efficacy|0|||
105652662|NCT03406507|364390563|FG001|Extension Period|Lack of Efficacy|1|||
105652663|NCT02965599|364390564|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
105652664|NCT02965599|364390565|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
105652665|NCT04435522|364390571|FG000|Overall Study|Withdrawal by Subject|2|||
105652666|NCT04944784|364390574|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
105652667|NCT04944784|364390575|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
105652668|NCT04944784|364390576|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
105652669|NCT04944784|364390577|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
105652670|NCT04944784|364390574|FG000|Double-blind Period|Adverse Event|20|||
105652671|NCT04944784|364390575|FG001|Double-blind Period|Adverse Event|4|||
105652672|NCT04944784|364390576|FG002|Double-blind Period|Adverse Event|0|||
105652673|NCT04944784|364390577|FG003|Double-blind Period|Adverse Event|0|||
105652674|NCT04944784|364390574|FG000|Double-blind Period|Withdrawal by Subject|15|||
105652675|NCT04944784|364390575|FG001|Double-blind Period|Withdrawal by Subject|4|||
105652676|NCT04944784|364390576|FG002|Double-blind Period|Withdrawal by Subject|0|||
105652677|NCT04944784|364390577|FG003|Double-blind Period|Withdrawal by Subject|0|||
105652678|NCT04944784|364390574|FG000|Double-blind Period|Death|7|||
105652679|NCT04944784|364390575|FG001|Double-blind Period|Death|2|||
105652680|NCT04944784|364390576|FG002|Double-blind Period|Death|0|||
105652681|NCT04944784|364390577|FG003|Double-blind Period|Death|0|||
105652682|NCT04944784|364390574|FG000|Double-blind Period|Physician Decision|2|||
105440147|NCT01235234|363616708|FG000|Overall Study|Adverse Event|2|||
105652683|NCT04944784|364390575|FG001|Double-blind Period|Physician Decision|1|||
105652684|NCT04944784|364390576|FG002|Double-blind Period|Physician Decision|0|||
105652685|NCT04944784|364390577|FG003|Double-blind Period|Physician Decision|0|||
105652686|NCT04944784|364390574|FG000|Double-blind Period|Lack of Efficacy|0|||
105652687|NCT04944784|364390575|FG001|Double-blind Period|Lack of Efficacy|1|||
105652688|NCT04944784|364390576|FG002|Double-blind Period|Lack of Efficacy|0|||
105652689|NCT04944784|364390577|FG003|Double-blind Period|Lack of Efficacy|0|||
105652690|NCT04944784|364390574|FG000|Double-blind Period|Sponsor Request|2|||
105652691|NCT04944784|364390575|FG001|Double-blind Period|Sponsor Request|1|||
105652692|NCT04944784|364390576|FG002|Double-blind Period|Sponsor Request|0|||
105652693|NCT04944784|364390577|FG003|Double-blind Period|Sponsor Request|0|||
105652694|NCT04944784|364390574|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
105652695|NCT04944784|364390575|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
105652696|NCT04944784|364390576|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
105652697|NCT04944784|364390577|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
105652698|NCT04944784|364390574|FG000|Double-blind Period|Participant Choice|1|||
105652699|NCT04944784|364390575|FG001|Double-blind Period|Participant Choice|1|||
105652700|NCT04944784|364390576|FG002|Double-blind Period|Participant Choice|0|||
105652701|NCT04944784|364390577|FG003|Double-blind Period|Participant Choice|0|||
105652702|NCT04944784|364390574|FG000|Double-blind Period|Progressive Disease|2|||
105652703|NCT04944784|364390575|FG001|Double-blind Period|Progressive Disease|2|||
105652704|NCT04944784|364390576|FG002|Double-blind Period|Progressive Disease|0|||
105652705|NCT04944784|364390577|FG003|Double-blind Period|Progressive Disease|0|||
105652706|NCT04944784|364390574|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
105652707|NCT04944784|364390575|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
105652708|NCT04944784|364390576|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
105652709|NCT04944784|364390577|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
105652710|NCT04944784|364390574|FG000|Active Drug Period|Adverse Event|0|||
105652711|NCT04944784|364390575|FG001|Active Drug Period|Adverse Event|0|||
105652712|NCT04944784|364390576|FG002|Active Drug Period|Adverse Event|3|||
105652713|NCT04944784|364390577|FG003|Active Drug Period|Adverse Event|6|||
105652714|NCT04944784|364390574|FG000|Active Drug Period|Withdrawal by Subject|0|||
105652715|NCT04944784|364390575|FG001|Active Drug Period|Withdrawal by Subject|0|||
105652716|NCT04944784|364390576|FG002|Active Drug Period|Withdrawal by Subject|4|||
105652717|NCT04944784|364390577|FG003|Active Drug Period|Withdrawal by Subject|7|||
105652718|NCT04944784|364390574|FG000|Active Drug Period|Death|0|||
105652719|NCT04944784|364390575|FG001|Active Drug Period|Death|0|||
105652720|NCT04944784|364390576|FG002|Active Drug Period|Death|3|||
105652721|NCT04944784|364390577|FG003|Active Drug Period|Death|4|||
105652722|NCT04944784|364390574|FG000|Active Drug Period|Lack of Efficacy|0|||
105652723|NCT04944784|364390575|FG001|Active Drug Period|Lack of Efficacy|0|||
105652724|NCT04944784|364390576|FG002|Active Drug Period|Lack of Efficacy|2|||
105652725|NCT04944784|364390577|FG003|Active Drug Period|Lack of Efficacy|2|||
105652726|NCT04944784|364390574|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
105652727|NCT04944784|364390575|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
105652728|NCT04944784|364390576|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
105652729|NCT04944784|364390577|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
105652730|NCT04944784|364390574|FG000|Active Drug Period|Participant Choice|0|||
105652731|NCT04944784|364390575|FG001|Active Drug Period|Participant Choice|0|||
105652732|NCT04944784|364390576|FG002|Active Drug Period|Participant Choice|0|||
105652733|NCT04944784|364390577|FG003|Active Drug Period|Participant Choice|1|||
105652734|NCT04944784|364390574|FG000|Active Drug Period|Progressive Disease|0|||
105652735|NCT04944784|364390575|FG001|Active Drug Period|Progressive Disease|0|||
105652736|NCT04944784|364390576|FG002|Active Drug Period|Progressive Disease|4|||
105652737|NCT04944784|364390577|FG003|Active Drug Period|Progressive Disease|4|||
105652738|NCT04944784|364390574|FG000|Active Drug Period|Lost to Follow-up|0|||
105652739|NCT04944784|364390575|FG001|Active Drug Period|Lost to Follow-up|0|||
105652740|NCT04944784|364390576|FG002|Active Drug Period|Lost to Follow-up|0|||
105652741|NCT04944784|364390577|FG003|Active Drug Period|Lost to Follow-up|1|||
105652742|NCT05294328|364390580|FG000|Overall Study|Adverse Event|1|||
105652743|NCT05294328|364390581|FG001|Overall Study|Adverse Event|0|||
105652744|NCT05294328|364390582|FG002|Overall Study|Adverse Event|0|||
105652745|NCT05294328|364390580|FG000|Overall Study|Physician Decision|1|||
105652746|NCT05294328|364390581|FG001|Overall Study|Physician Decision|1|||
105652747|NCT05294328|364390582|FG002|Overall Study|Physician Decision|0|||
105652748|NCT05294328|364390580|FG000|Overall Study|Withdrawal by Subject|0|||
105652749|NCT05294328|364390581|FG001|Overall Study|Withdrawal by Subject|2|||
105652750|NCT05294328|364390582|FG002|Overall Study|Withdrawal by Subject|1|||
105652751|NCT05294328|364390580|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
105652752|NCT05294328|364390581|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
105652753|NCT05294328|364390582|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
105652754|NCT01568112|364390583|FG000|Overall Study|Randomized But Not Treated|0|||
105652755|NCT01568112|364390584|FG001|Overall Study|Randomized But Not Treated|1|||
105440148|NCT01235234|363616709|FG001|Overall Study|Adverse Event|2|||
105652756|NCT01568112|364390585|FG002|Overall Study|Randomized But Not Treated|0|||
105652757|NCT01568112|364390586|FG003|Overall Study|Randomized But Not Treated|0|||
105652758|NCT01568112|364390583|FG000|Overall Study|Withdrew due to Adverse Event|2|||
105652759|NCT01568112|364390584|FG001|Overall Study|Withdrew due to Adverse Event|4|||
105652760|NCT01568112|364390585|FG002|Overall Study|Withdrew due to Adverse Event|6|||
105652761|NCT01568112|364390586|FG003|Overall Study|Withdrew due to Adverse Event|3|||
105652762|NCT01568112|364390583|FG000|Overall Study|Lost to Follow-up|0|||
105652763|NCT01568112|364390584|FG001|Overall Study|Lost to Follow-up|0|||
105652764|NCT01568112|364390585|FG002|Overall Study|Lost to Follow-up|0|||
105652765|NCT01568112|364390586|FG003|Overall Study|Lost to Follow-up|1|||
105652766|NCT01568112|364390583|FG000|Overall Study|Withdrawal by Subject|2|||
105652767|NCT01568112|364390584|FG001|Overall Study|Withdrawal by Subject|3|||
105652768|NCT01568112|364390585|FG002|Overall Study|Withdrawal by Subject|0|||
105652769|NCT01568112|364390586|FG003|Overall Study|Withdrawal by Subject|7|||
105652770|NCT01568112|364390583|FG000|Overall Study|Withdrawal by Physician|1|||
105652771|NCT01568112|364390584|FG001|Overall Study|Withdrawal by Physician|0|||
105652772|NCT01568112|364390585|FG002|Overall Study|Withdrawal by Physician|1|||
105652773|NCT01568112|364390586|FG003|Overall Study|Withdrawal by Physician|1|||
105652774|NCT02056873|364390587|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
105652775|NCT01772147|364392398|FG000|Overall Study|Adverse Event|13|||
105652776|NCT01772147|364392399|FG001|Overall Study|Adverse Event|10|||
105652777|NCT01772147|364392400|FG002|Overall Study|Adverse Event|6|||
105652778|NCT01772147|364392398|FG000|Overall Study|Withdrew Consent|7|||
105652779|NCT01772147|364392399|FG001|Overall Study|Withdrew Consent|8|||
105652780|NCT01772147|364392400|FG002|Overall Study|Withdrew Consent|4|||
105652781|NCT01772147|364392398|FG000|Overall Study|Lost to Follow-up|1|||
105652782|NCT01772147|364392399|FG001|Overall Study|Lost to Follow-up|0|||
105652783|NCT01772147|364392400|FG002|Overall Study|Lost to Follow-up|1|||
105652784|NCT01772147|364392398|FG000|Overall Study|Protocol Deviation|2|||
105652785|NCT01772147|364392399|FG001|Overall Study|Protocol Deviation|1|||
105652786|NCT01772147|364392400|FG002|Overall Study|Protocol Deviation|1|||
105652787|NCT01772147|364392398|FG000|Overall Study|Lack of Efficacy|8|||
105652788|NCT01772147|364392399|FG001|Overall Study|Lack of Efficacy|6|||
105652789|NCT01772147|364392400|FG002|Overall Study|Lack of Efficacy|6|||
105652790|NCT02956278|364392402|FG000|Overall Study|Withdrawal by Subject|6|||
105652791|NCT02956278|364392403|FG001|Overall Study|Withdrawal by Subject|2|||
105652792|NCT02956278|364392404|FG002|Overall Study|Withdrawal by Subject|0|||
105652793|NCT00434577|364392405|FG000|Months 0-3|Serious Adverse Event|0|||
105652794|NCT00434577|364392406|FG001|Months 0-3|Serious Adverse Event|0|||
105652795|NCT00434577|364392407|FG002|Months 0-3|Serious Adverse Event|1|||
105652796|NCT00434577|364392408|FG003|Months 0-3|Serious Adverse Event|0|||
105652797|NCT00434577|364392409|FG004|Months 0-3|Serious Adverse Event|0|||
105652798|NCT00434577|364392405|FG000|Months 0-3|Adverse Event|0|||
105652799|NCT00434577|364392406|FG001|Months 0-3|Adverse Event|1|||
105652800|NCT00434577|364392407|FG002|Months 0-3|Adverse Event|1|||
105652801|NCT00434577|364392408|FG003|Months 0-3|Adverse Event|0|||
105652802|NCT00434577|364392409|FG004|Months 0-3|Adverse Event|0|||
105652803|NCT00434577|364392405|FG000|Months 0-3|Lost to Follow-up|0|||
105652804|NCT00434577|364392406|FG001|Months 0-3|Lost to Follow-up|0|||
105652805|NCT00434577|364392407|FG002|Months 0-3|Lost to Follow-up|0|||
105652806|NCT00434577|364392408|FG003|Months 0-3|Lost to Follow-up|0|||
105652807|NCT00434577|364392409|FG004|Months 0-3|Lost to Follow-up|2|||
105652808|NCT00434577|364392405|FG000|Months 0-3|Protocol Violation|1|||
105652809|NCT00434577|364392406|FG001|Months 0-3|Protocol Violation|0|||
105652810|NCT00434577|364392407|FG002|Months 0-3|Protocol Violation|1|||
105652811|NCT00434577|364392408|FG003|Months 0-3|Protocol Violation|0|||
105652812|NCT00434577|364392409|FG004|Months 0-3|Protocol Violation|0|||
105652813|NCT00434577|364392405|FG000|Months 0-3|Withdrawal by Subject|2|||
105652814|NCT00434577|364392406|FG001|Months 0-3|Withdrawal by Subject|1|||
105652815|NCT00434577|364392407|FG002|Months 0-3|Withdrawal by Subject|1|||
105652816|NCT00434577|364392408|FG003|Months 0-3|Withdrawal by Subject|1|||
105652817|NCT00434577|364392409|FG004|Months 0-3|Withdrawal by Subject|1|||
105652818|NCT01967719|364392410|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
105652819|NCT01967719|364392411|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
105652820|NCT01967719|364392412|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
105652821|NCT01967719|364392413|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
105652822|NCT01967719|364392410|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
105652823|NCT01967719|364392411|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
105652824|NCT01967719|364392412|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
105652825|NCT01967719|364392413|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
105652826|NCT00796614|364392419|FG000|Overall Study|Adverse Event|1|||
105652827|NCT00796614|364392420|FG001|Overall Study|Adverse Event|2|||
105652828|NCT00796614|364392421|FG002|Overall Study|Adverse Event|0|||
105652829|NCT00796614|364392422|FG003|Overall Study|Adverse Event|0|||
105652830|NCT00796614|364392419|FG000|Overall Study|Protocol Violation|0|||
105652831|NCT00796614|364392420|FG001|Overall Study|Protocol Violation|0|||
105652832|NCT00796614|364392421|FG002|Overall Study|Protocol Violation|2|||
105652833|NCT00796614|364392422|FG003|Overall Study|Protocol Violation|0|||
105652834|NCT00796614|364392419|FG000|Overall Study|Lost to Follow-up|2|||
105652835|NCT00796614|364392420|FG001|Overall Study|Lost to Follow-up|2|||
105652836|NCT00796614|364392421|FG002|Overall Study|Lost to Follow-up|1|||
105652837|NCT00796614|364392422|FG003|Overall Study|Lost to Follow-up|0|||
105652838|NCT00796614|364392419|FG000|Overall Study|Withdrawal by Subject|1|||
105652839|NCT00796614|364392420|FG001|Overall Study|Withdrawal by Subject|0|||
105652840|NCT00796614|364392421|FG002|Overall Study|Withdrawal by Subject|0|||
105652841|NCT00796614|364392422|FG003|Overall Study|Withdrawal by Subject|1|||
105652842|NCT00796614|364392419|FG000|Overall Study|Other than stated|1|||
105652843|NCT00796614|364392420|FG001|Overall Study|Other than stated|0|||
105652844|NCT00796614|364392421|FG002|Overall Study|Other than stated|0|||
105652845|NCT00796614|364392422|FG003|Overall Study|Other than stated|0|||
105652846|NCT00961896|364392423|FG000|Overall Study|Abnormal laboratory value|0|||
105652847|NCT00961896|364392424|FG001|Overall Study|Abnormal laboratory value|0|||
105652848|NCT00961896|364392425|FG002|Overall Study|Abnormal laboratory value|1|||
105652849|NCT00957996|364392426|FG000|Overall Study|Death|4|||
105652850|NCT00957996|364392427|FG001|Overall Study|Death|10|||
105652851|NCT00957996|364392426|FG000|Overall Study|Lost to Follow-up|4|||
105652852|NCT00957996|364392427|FG001|Overall Study|Lost to Follow-up|7|||
105652853|NCT00957996|364392426|FG000|Overall Study|Withdrawal by Subject|9|||
105652854|NCT00957996|364392427|FG001|Overall Study|Withdrawal by Subject|2|||
105652855|NCT00957996|364392426|FG000|Overall Study|Adverse Event|2|||
105652856|NCT00957996|364392427|FG001|Overall Study|Adverse Event|1|||
105652857|NCT00957996|364392426|FG000|Overall Study|Physician Decision|1|||
105652858|NCT00957996|364392427|FG001|Overall Study|Physician Decision|1|||
105652859|NCT00957996|364392426|FG000|Overall Study|Influenza-related complication|0|||
105652860|NCT00957996|364392427|FG001|Overall Study|Influenza-related complication|1|||
105652861|NCT00957996|364392426|FG000|Overall Study|Missing|1|||
105652862|NCT00957996|364392427|FG001|Overall Study|Missing|0|||
105652863|NCT00957996|364392426|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
105652864|NCT00957996|364392427|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
105652865|NCT00488319|364392432|FG000|Overall Study|Adverse Event|1|||
105652866|NCT00488319|364392433|FG001|Overall Study|Adverse Event|2|||
105652867|NCT00488319|364392434|FG002|Overall Study|Adverse Event|23|||
105652868|NCT00488319|364392432|FG000|Overall Study|Lack of Efficacy|6|||
105652869|NCT00488319|364392433|FG001|Overall Study|Lack of Efficacy|12|||
105652870|NCT00488319|364392434|FG002|Overall Study|Lack of Efficacy|27|||
105652871|NCT00488319|364392432|FG000|Overall Study|Lost to Follow-up|3|||
105652872|NCT00488319|364392433|FG001|Overall Study|Lost to Follow-up|5|||
105652873|NCT00488319|364392434|FG002|Overall Study|Lost to Follow-up|16|||
105652874|NCT00488319|364392432|FG000|Overall Study|Withdrawal by Subject|5|||
105652875|NCT00488319|364392433|FG001|Overall Study|Withdrawal by Subject|20|||
105652876|NCT00488319|364392434|FG002|Overall Study|Withdrawal by Subject|44|||
105652877|NCT00488319|364392432|FG000|Overall Study|Other reasons for withdrawal|0|||
105652878|NCT00488319|364392433|FG001|Overall Study|Other reasons for withdrawal|4|||
105652879|NCT00488319|364392434|FG002|Overall Study|Other reasons for withdrawal|12|||
105652880|NCT02815735|364392435|FG000|First Intervention (4 Weeks)|Discomfort|1|||
105652881|NCT02815735|364392436|FG001|First Intervention (4 Weeks)|Discomfort|0|||
105652882|NCT02815735|364392435|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
105652883|NCT02815735|364392436|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
105652884|NCT02815735|364392435|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
105652885|NCT02815735|364392436|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
105652886|NCT02815735|364392435|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
105652887|NCT02815735|364392436|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
105652888|NCT00520403|364392440|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
105652889|NCT00520403|364392440|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
105652890|NCT00520403|364392440|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
105652891|NCT00520403|364392440|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
105652892|NCT00520403|364392440|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
105652893|NCT00520403|364392440|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
105652894|NCT00520403|364392440|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
105652895|NCT00520403|364392440|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
105652896|NCT00405912|364392441|FG000|Overall Study|Withdrawal by Subject|12|||
105652897|NCT00405912|364392442|FG001|Overall Study|Withdrawal by Subject|11|||
105652898|NCT00405912|364392443|FG002|Overall Study|Withdrawal by Subject|12|||
105652899|NCT00405912|364392441|FG000|Overall Study|Lost to Follow-up|4|||
105652900|NCT00405912|364392442|FG001|Overall Study|Lost to Follow-up|8|||
105652901|NCT00405912|364392443|FG002|Overall Study|Lost to Follow-up|4|||
105652902|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
105652903|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
105652904|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
105652905|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
105652906|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
105652907|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
105652908|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
105652909|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
105652910|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Death|6|||
105652911|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Death|2|||
105652912|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Death|2|||
105652913|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Death|9|||
105652914|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
105652915|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
105652916|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
105652917|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
105652918|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
105652919|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
105652920|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
105652921|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
105652922|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
105652923|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
105652924|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
105652925|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
105652926|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
105652927|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
105652928|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
105652929|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
105652930|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
105652931|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
105652932|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
105652933|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
105652934|NCT03730662|364392444|FG000|Variable Treatment Period|Adverse Event|1|||
105652935|NCT03730662|364392445|FG001|Variable Treatment Period|Adverse Event|2|||
105652936|NCT03730662|364392446|FG002|Variable Treatment Period|Adverse Event|0|||
105652937|NCT03730662|364392447|FG003|Variable Treatment Period|Adverse Event|7|||
105652938|NCT03730662|364392444|FG000|Variable Treatment Period|Death|9|||
105652939|NCT03730662|364392445|FG001|Variable Treatment Period|Death|0|||
105652940|NCT03730662|364392446|FG002|Variable Treatment Period|Death|6|||
105652941|NCT03730662|364392447|FG003|Variable Treatment Period|Death|26|||
105652942|NCT03730662|364392444|FG000|Variable Treatment Period|Lost to Follow-up|2|||
105652943|NCT03730662|364392445|FG001|Variable Treatment Period|Lost to Follow-up|1|||
105652944|NCT03730662|364392446|FG002|Variable Treatment Period|Lost to Follow-up|4|||
105652945|NCT03730662|364392447|FG003|Variable Treatment Period|Lost to Follow-up|11|||
105652946|NCT03730662|364392444|FG000|Variable Treatment Period|Personal Reason|0|||
105652947|NCT03730662|364392445|FG001|Variable Treatment Period|Personal Reason|2|||
105652948|NCT03730662|364392446|FG002|Variable Treatment Period|Personal Reason|1|||
105652949|NCT03730662|364392447|FG003|Variable Treatment Period|Personal Reason|6|||
105652950|NCT03730662|364392444|FG000|Variable Treatment Period|Physician Decision|0|||
105652951|NCT03730662|364392445|FG001|Variable Treatment Period|Physician Decision|0|||
105652952|NCT03730662|364392446|FG002|Variable Treatment Period|Physician Decision|0|||
105652953|NCT03730662|364392447|FG003|Variable Treatment Period|Physician Decision|3|||
105652954|NCT03730662|364392444|FG000|Variable Treatment Period|Protocol Violation|0|||
105652955|NCT03730662|364392445|FG001|Variable Treatment Period|Protocol Violation|1|||
105652956|NCT03730662|364392446|FG002|Variable Treatment Period|Protocol Violation|1|||
105652957|NCT03730662|364392447|FG003|Variable Treatment Period|Protocol Violation|1|||
105652958|NCT03730662|364392444|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
105652959|NCT03730662|364392445|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
105652960|NCT03730662|364392446|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
105652961|NCT03730662|364392447|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
105652962|NCT05060237|364392448|FG000|Overall Study|Withdrawal by Subject|4|||
105652963|NCT05060237|364392448|FG000|Overall Study|Screening failure|8|||
105652964|NCT03226353|364392449|FG000|Overall Study|Withdrawal by Subject|1|||
105652965|NCT03226353|364392449|FG000|Overall Study|Screen Failure|5|||
105652966|NCT03441789|364392451|FG000|Overall Study|Withdrawal by Subject|1|||
105652967|NCT03441789|364392452|FG001|Overall Study|Withdrawal by Subject|1|||
105652968|NCT03441789|364392451|FG000|Overall Study|Adverse Event|0|||
105652969|NCT03441789|364392452|FG001|Overall Study|Adverse Event|1|||
105652970|NCT03441789|364392451|FG000|Overall Study|Protocol Violation|0|||
105652971|NCT03441789|364392452|FG001|Overall Study|Protocol Violation|1|||
105652972|NCT03441789|364392451|FG000|Overall Study|Lost to Follow-up|0|||
105652973|NCT03441789|364392452|FG001|Overall Study|Lost to Follow-up|1|||
105652974|NCT00498433|364392453|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
105652975|NCT00498433|364392454|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
105652976|NCT00498433|364392455|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
105652977|NCT00498433|364392453|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
105652978|NCT00498433|364392454|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
105652979|NCT00498433|364392455|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
105652980|NCT00498433|364392453|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
105652981|NCT00498433|364392454|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
105652982|NCT00498433|364392455|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
105652983|NCT00498433|364392453|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
105652984|NCT00498433|364392454|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
105652985|NCT00498433|364392455|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
105652986|NCT01514864|364392457|FG000|Overall Study|Disease progression|7|||
105652987|NCT01514864|364392458|FG001|Overall Study|Disease progression|5|||
105652988|NCT01514864|364392457|FG000|Overall Study|Study drug toxicity|2|||
105652989|NCT01514864|364392458|FG001|Overall Study|Study drug toxicity|0|||
105652990|NCT01960114|364392459|FG000|Overall Study|Adverse Event|1|||
105652991|NCT01960114|364392460|FG001|Overall Study|Adverse Event|0|||
105652992|NCT01960114|364392459|FG000|Overall Study|Could not swallow study medication|0|||
105652993|NCT01960114|364392460|FG001|Overall Study|Could not swallow study medication|1|||
105652994|NCT02253147|364392464|FG000|Overall Study|Protocol Violation|30|||
105652995|NCT02253147|364392464|FG000|Overall Study|Did not consent to study extension|9|||
105652996|NCT02253147|364392464|FG000|Overall Study|Conditional re-treatment at W52|5|||
105652997|NCT02253147|364392464|FG000|Overall Study|Lost to Follow-up|2|||
105652998|NCT02253147|364392464|FG000|Overall Study|Withdrawal by Subject|1|||
105652999|NCT00922441|364392465|FG000|Overall Study|Protocol Violation|0|||
105653000|NCT00922441|364392466|FG001|Overall Study|Protocol Violation|0|||
105653001|NCT00922441|364392467|FG002|Overall Study|Protocol Violation|2|||
105653002|NCT00922441|364392465|FG000|Overall Study|Withdrawal by Subject|0|||
105653003|NCT00922441|364392466|FG001|Overall Study|Withdrawal by Subject|0|||
105653004|NCT00922441|364392467|FG002|Overall Study|Withdrawal by Subject|1|||
105653005|NCT02469077|364392472|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
105653006|NCT02469077|364392473|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
105653007|NCT02469077|364392472|FG000|Post Randomization/Intervention Period|Relocated|1|||
105653008|NCT02469077|364392473|FG001|Post Randomization/Intervention Period|Relocated|1|||
105653009|NCT02469077|364392472|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
105653010|NCT02469077|364392473|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
105653011|NCT02469077|364392472|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
105653012|NCT02469077|364392473|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
105653013|NCT02959177|364392474|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
105653014|NCT02959177|364392475|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
105653015|NCT02959177|364392476|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
105653016|NCT02959177|364392474|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
105653017|NCT02959177|364392475|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
105653018|NCT02959177|364392476|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
105653019|NCT02959177|364392474|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
105653020|NCT02959177|364392475|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
105653021|NCT02959177|364392476|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
105653022|NCT02959177|364392474|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
105653023|NCT02959177|364392475|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
105653024|NCT02959177|364392476|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
105653025|NCT02959177|364392474|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
105653026|NCT02959177|364392475|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
105653027|NCT02959177|364392476|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
105653028|NCT02959177|364392474|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
105653029|NCT02959177|364392475|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
105653030|NCT02959177|364392476|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
105653031|NCT02959177|364392474|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
105653032|NCT02959177|364392475|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
105653033|NCT02959177|364392476|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
105653034|NCT04531813|364392477|FG000|Overall Study|Protocol Violation|1|||
105653035|NCT04531813|364392477|FG000|Overall Study|Withdrawal by Subject|1|||
105653036|NCT02853305|364392478|FG000|Overall Study|Death|287|||
105653037|NCT02853305|364392479|FG001|Overall Study|Death|249|||
105653038|NCT02853305|364392480|FG002|Overall Study|Death|300|||
105653039|NCT02853305|364392478|FG000|Overall Study|Withdrawal by Subject|2|||
105653040|NCT02853305|364392479|FG001|Overall Study|Withdrawal by Subject|8|||
105653041|NCT02853305|364392480|FG002|Overall Study|Withdrawal by Subject|3|||
105653042|NCT02853305|364392478|FG000|Overall Study|Transferred to Extension Study|46|||
105653043|NCT02853305|364392479|FG001|Overall Study|Transferred to Extension Study|30|||
105653044|NCT02853305|364392480|FG002|Overall Study|Transferred to Extension Study|25|||
105653045|NCT02853305|364392478|FG000|Overall Study|Did Not Continue on Extension Study|16|||
105653046|NCT02853305|364392479|FG001|Overall Study|Did Not Continue on Extension Study|20|||
105653047|NCT02853305|364392480|FG002|Overall Study|Did Not Continue on Extension Study|24|||
105653048|NCT02381652|364392481|FG000|Overall Study|Withdrawal by Subject|0|||
105653049|NCT02381652|364392482|FG001|Overall Study|Withdrawal by Subject|0|||
105653050|NCT02381652|364392483|FG002|Overall Study|Withdrawal by Subject|1|||
105653051|NCT01654289|364392490|FG000|Overall Study|Withdrawal by Subject|10|||
105653052|NCT01654289|364392491|FG001|Overall Study|Withdrawal by Subject|8|||
105653053|NCT01654289|364392492|FG002|Overall Study|Withdrawal by Subject|5|||
105653054|NCT01654289|364392490|FG000|Overall Study|Withdrew from intervention only|17|||
105653055|NCT01654289|364392491|FG001|Overall Study|Withdrew from intervention only|20|||
105653056|NCT01654289|364392492|FG002|Overall Study|Withdrew from intervention only|0|||
105653057|NCT03746483|364392493|FG000|Overall Study|Adverse Event|0|||
105653058|NCT03746483|364392494|FG001|Overall Study|Adverse Event|1|||
105653059|NCT03746483|364392493|FG000|Overall Study|Lack of Efficacy|3|||
105653060|NCT03746483|364392494|FG001|Overall Study|Lack of Efficacy|2|||
105653061|NCT03746483|364392493|FG000|Overall Study|Lost to Follow-up|1|||
105653062|NCT03746483|364392494|FG001|Overall Study|Lost to Follow-up|0|||
105653063|NCT03746483|364392493|FG000|Overall Study|Protocol Violation|2|||
105653064|NCT03746483|364392494|FG001|Overall Study|Protocol Violation|0|||
105653065|NCT01924806|364392495|FG000|Overall Study|Physician Decision|2|||
105653066|NCT01924806|364392496|FG001|Overall Study|Physician Decision|1|||
105653067|NCT03635775|364392499|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
105653068|NCT03635775|364392500|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
105653069|NCT03635775|364392501|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
105653070|NCT03635775|364392502|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
105653071|NCT00385697|364392503|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
105653072|NCT00385697|364392504|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
105653073|NCT00385697|364392505|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
105653074|NCT00385697|364392506|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
105653075|NCT00385697|364392507|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
105653076|NCT00385697|364392503|FG000|Open-label Segment 1|Lost to Follow-up|1|||
105653077|NCT00385697|364392504|FG001|Open-label Segment 1|Lost to Follow-up|0|||
105653078|NCT00385697|364392505|FG002|Open-label Segment 1|Lost to Follow-up|0|||
105653079|NCT00385697|364392506|FG003|Open-label Segment 1|Lost to Follow-up|0|||
105653080|NCT00385697|364392507|FG004|Open-label Segment 1|Lost to Follow-up|0|||
105653081|NCT00385697|364392503|FG000|Double-blind Segment 2|Adverse Event|0|||
105653082|NCT00385697|364392504|FG001|Double-blind Segment 2|Adverse Event|3|||
105653083|NCT00385697|364392505|FG002|Double-blind Segment 2|Adverse Event|1|||
105653084|NCT00385697|364392506|FG003|Double-blind Segment 2|Adverse Event|0|||
105653085|NCT00385697|364392507|FG004|Double-blind Segment 2|Adverse Event|0|||
105653086|NCT00385697|364392503|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
105653087|NCT00385697|364392504|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
105653088|NCT00385697|364392505|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
105653089|NCT00385697|364392506|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
105653090|NCT00385697|364392507|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
105653091|NCT00385697|364392503|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
105653092|NCT00385697|364392504|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
105653093|NCT00385697|364392505|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
105653094|NCT00385697|364392506|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
105653095|NCT00385697|364392507|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
105653096|NCT00385697|364392503|FG000|Double-blind Segment 2|Other|0|||
105653097|NCT00385697|364392504|FG001|Double-blind Segment 2|Other|2|||
105653098|NCT00385697|364392505|FG002|Double-blind Segment 2|Other|0|||
105653099|NCT00385697|364392506|FG003|Double-blind Segment 2|Other|0|||
105653100|NCT00385697|364392507|FG004|Double-blind Segment 2|Other|0|||
105653101|NCT01920178|364392509|FG000|Overall Study|Lost to Follow-up|2|||
105653102|NCT01920178|364392510|FG001|Overall Study|Lost to Follow-up|1|||
105653103|NCT01919398|364392511|FG000|Overall Study|Progressive Disease|0|||
105653104|NCT01919398|364392512|FG001|Overall Study|Progressive Disease|0|||
105653105|NCT01919398|364392513|FG002|Overall Study|Progressive Disease|4|||
105653106|NCT01363297|364392515|FG000|Overall Study|Other|0|||
105653107|NCT01363297|364392516|FG001|Overall Study|Other|0|||
105653108|NCT01363297|364392517|FG002|Overall Study|Other|0|||
105653109|NCT01363297|364392518|FG003|Overall Study|Other|0|||
105653110|NCT01363297|364392519|FG004|Overall Study|Other|1|||
105653111|NCT01363297|364392515|FG000|Overall Study|Death|3|||
105653112|NCT01363297|364392516|FG001|Overall Study|Death|6|||
105653113|NCT01363297|364392517|FG002|Overall Study|Death|6|||
105653114|NCT01363297|364392518|FG003|Overall Study|Death|10|||
105653115|NCT01363297|364392519|FG004|Overall Study|Death|30|||
105653116|NCT02515097|364392520|FG000|Overall Study|Lost to Follow-up|4|||
105653117|NCT02515097|364392521|FG001|Overall Study|Lost to Follow-up|2|||
105653118|NCT02515097|364392520|FG000|Overall Study|Withdrawal by Subject|1|||
105653119|NCT02515097|364392521|FG001|Overall Study|Withdrawal by Subject|3|||
105653120|NCT02515097|364392520|FG000|Overall Study|Adverse Event|2|||
105653121|NCT02515097|364392521|FG001|Overall Study|Adverse Event|1|||
105653122|NCT04688086|364392522|FG000|Overall Study|Lost to Follow-up|164|||
105653123|NCT04688086|364392522|FG000|Overall Study|Imaging error;|64|||
105653124|NCT03915951|364392527|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
105653125|NCT03915951|364392528|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
105653126|NCT03915951|364392527|FG000|Overall Study|Adverse Event|12|||
105653127|NCT03915951|364392528|FG001|Overall Study|Adverse Event|6|||
105653128|NCT03915951|364392527|FG000|Overall Study|Disease progression (radiological)|17|||
105653129|NCT03915951|364392528|FG001|Overall Study|Disease progression (radiological)|15|||
105653130|NCT03915951|364392527|FG000|Overall Study|Disease progression (clinical)|4|||
105659501|NCT02635386|364417351|FG004|Overall Study|Moved Out of State|0|||
105653131|NCT03915951|364392528|FG001|Overall Study|Disease progression (clinical)|1|||
105653132|NCT03915951|364392527|FG000|Overall Study|Patient decision|0|||
105653133|NCT03915951|364392528|FG001|Overall Study|Patient decision|4|||
105653134|NCT03915951|364392527|FG000|Overall Study|Investigator decision|0|||
105653135|NCT03915951|364392528|FG001|Overall Study|Investigator decision|1|||
105653136|NCT03915951|364392527|FG000|Overall Study|Consent withdrawn|1|||
105653137|NCT03915951|364392528|FG001|Overall Study|Consent withdrawn|1|||
105653138|NCT03915951|364392527|FG000|Overall Study|Death|0|||
105653139|NCT03915951|364392528|FG001|Overall Study|Death|3|||
105653140|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
105653141|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
105653142|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
105653143|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
105653144|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
105653145|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
105653146|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
105653147|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
105653148|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
105653149|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
105653150|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
105653151|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
105653152|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
105653153|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
105653154|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
105653155|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
105653156|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
105653157|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
105653158|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
105653159|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
105653160|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
105653161|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
105653162|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
105653163|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
105653164|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
105653165|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
105653166|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
105653167|NCT02269917|364392532|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
105653168|NCT02269917|364392533|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
105653169|NCT02269917|364392534|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
105653170|NCT02269917|364392532|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
105653171|NCT02269917|364392533|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
105653172|NCT02269917|364392534|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
105653173|NCT02269917|364392532|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
105653174|NCT02269917|364392533|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
105653175|NCT02269917|364392534|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
105653176|NCT02269917|364392532|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
105653177|NCT02269917|364392533|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
105653178|NCT02269917|364392534|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
105653179|NCT02269917|364392532|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
105653180|NCT02269917|364392533|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
105653181|NCT02269917|364392534|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
105653182|NCT02269917|364392532|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
105653183|NCT02269917|364392533|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
105653184|NCT02269917|364392534|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
105653185|NCT02269917|364392532|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
105653186|NCT02269917|364392533|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
105653187|NCT02269917|364392534|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
105653188|NCT01679613|364392540|FG000|Overall Study|other than stated above|0|||
105653189|NCT01679613|364392541|FG001|Overall Study|other than stated above|1|||
105653190|NCT01679613|364392542|FG002|Overall Study|other than stated above|2|||
105653191|NCT01679613|364392543|FG003|Overall Study|other than stated above|2|||
105653192|NCT02473913|364392545|FG000|Overall Study|Lost to Follow-up|3|||
105653193|NCT02473913|364392546|FG001|Overall Study|Lost to Follow-up|3|||
105653194|NCT01190449|364392554|FG000|Overall Study|Ineligible|0|||
105653195|NCT01190449|364392555|FG001|Overall Study|Ineligible|4|||
105653196|NCT02250183|364392556|FG000|Overall Study|Withdrawal by Subject|2|||
105653197|NCT02250183|364392556|FG000|Overall Study|Adverse Event|5|||
105653198|NCT02250183|364392556|FG000|Overall Study|Lost to Follow-up|1|||
105653199|NCT00951171|364392560|FG000|Overall Study|Adverse Event|2|||
105653200|NCT00951171|364392561|FG001|Overall Study|Adverse Event|0|||
105653201|NCT04130061|364392562|FG000|Overall Study|OR team forgot to request membrane|1|||
105653202|NCT04130061|364392563|FG001|Overall Study|OR team forgot to request membrane|0|||
105653203|NCT00275301|364394963|FG000|Overall Study|Adverse Event|5|||
105653204|NCT00848393|364394970|FG000|Overall Study|Protocol Violation|0|||
105653205|NCT00848393|364394971|FG001|Overall Study|Protocol Violation|0|||
105653206|NCT00848393|364394972|FG002|Overall Study|Protocol Violation|1|||
105653207|NCT00848393|364394970|FG000|Overall Study|surgical complications unrelated to stud|0|||
105653208|NCT00848393|364394971|FG001|Overall Study|surgical complications unrelated to stud|0|||
105653209|NCT00848393|364394972|FG002|Overall Study|surgical complications unrelated to stud|2|||
105653210|NCT02561078|364394973|FG000|Overall Study|Adverse Event|5|||
105653211|NCT02561078|364394974|FG001|Overall Study|Adverse Event|2|||
105653212|NCT02561078|364394973|FG000|Overall Study|Death|2|||
105653213|NCT02561078|364394974|FG001|Overall Study|Death|1|||
105653214|NCT02561078|364394973|FG000|Overall Study|Lost to Follow-up|2|||
105653215|NCT02561078|364394974|FG001|Overall Study|Lost to Follow-up|6|||
105653216|NCT02561078|364394973|FG000|Overall Study|Non-Compliance with Study Drug|6|||
105653217|NCT02561078|364394974|FG001|Overall Study|Non-Compliance with Study Drug|3|||
105653218|NCT02561078|364394973|FG000|Overall Study|Physician Decision|2|||
105653219|NCT02561078|364394974|FG001|Overall Study|Physician Decision|3|||
105653220|NCT02561078|364394973|FG000|Overall Study|Withdrawal by Subject|13|||
105653221|NCT02561078|364394974|FG001|Overall Study|Withdrawal by Subject|10|||
105653222|NCT00043186|364394975|FG000|Overall Study|Physician Decision|0|||
105653223|NCT00043186|364394976|FG001|Overall Study|Physician Decision|0|||
105653224|NCT00043186|364394977|FG002|Overall Study|Physician Decision|3|||
105653225|NCT00043186|364394978|FG003|Overall Study|Physician Decision|0|||
105653226|NCT00043186|364394979|FG004|Overall Study|Physician Decision|1|||
105653227|NCT00043186|364394980|FG005|Overall Study|Physician Decision|0|||
105653228|NCT00043186|364394981|FG006|Overall Study|Physician Decision|0|||
105653229|NCT00043186|364394982|FG007|Overall Study|Physician Decision|1|||
105653230|NCT00043186|364394983|FG008|Overall Study|Physician Decision|1|||
105653231|NCT00043186|364394975|FG000|Overall Study|Adverse Event|2|||
105653232|NCT00043186|364394976|FG001|Overall Study|Adverse Event|2|||
105653233|NCT00043186|364394977|FG002|Overall Study|Adverse Event|2|||
105653234|NCT00043186|364394978|FG003|Overall Study|Adverse Event|3|||
105653235|NCT00043186|364394979|FG004|Overall Study|Adverse Event|2|||
105653236|NCT00043186|364394980|FG005|Overall Study|Adverse Event|1|||
105653237|NCT00043186|364394981|FG006|Overall Study|Adverse Event|2|||
105653238|NCT00043186|364394982|FG007|Overall Study|Adverse Event|1|||
105653239|NCT00043186|364394983|FG008|Overall Study|Adverse Event|3|||
105653240|NCT00043186|364394975|FG000|Overall Study|Withdrawal by Subject|11|||
105653241|NCT00043186|364394976|FG001|Overall Study|Withdrawal by Subject|8|||
105653242|NCT00043186|364394977|FG002|Overall Study|Withdrawal by Subject|11|||
105653243|NCT00043186|364394978|FG003|Overall Study|Withdrawal by Subject|13|||
105653244|NCT00043186|364394979|FG004|Overall Study|Withdrawal by Subject|14|||
105653245|NCT00043186|364394980|FG005|Overall Study|Withdrawal by Subject|6|||
105653246|NCT00043186|364394981|FG006|Overall Study|Withdrawal by Subject|12|||
105653247|NCT00043186|364394982|FG007|Overall Study|Withdrawal by Subject|9|||
105653248|NCT00043186|364394983|FG008|Overall Study|Withdrawal by Subject|10|||
105653249|NCT00043186|364394975|FG000|Overall Study|Death|0|||
105653250|NCT00043186|364394976|FG001|Overall Study|Death|0|||
105653251|NCT00043186|364394977|FG002|Overall Study|Death|1|||
105653252|NCT00043186|364394978|FG003|Overall Study|Death|0|||
105653253|NCT00043186|364394979|FG004|Overall Study|Death|0|||
105653254|NCT00043186|364394980|FG005|Overall Study|Death|0|||
105653255|NCT00043186|364394981|FG006|Overall Study|Death|2|||
105653256|NCT00043186|364394982|FG007|Overall Study|Death|0|||
105653257|NCT00043186|364394983|FG008|Overall Study|Death|0|||
105653258|NCT00043186|364394975|FG000|Overall Study|Disease progression|1|||
105653259|NCT00043186|364394976|FG001|Overall Study|Disease progression|0|||
105653260|NCT00043186|364394977|FG002|Overall Study|Disease progression|0|||
105653261|NCT00043186|364394978|FG003|Overall Study|Disease progression|3|||
105653262|NCT00043186|364394979|FG004|Overall Study|Disease progression|0|||
105653263|NCT00043186|364394980|FG005|Overall Study|Disease progression|0|||
105653264|NCT00043186|364394981|FG006|Overall Study|Disease progression|0|||
105653265|NCT00043186|364394982|FG007|Overall Study|Disease progression|4|||
105653266|NCT00043186|364394983|FG008|Overall Study|Disease progression|0|||
105653267|NCT00043186|364394975|FG000|Overall Study|Ineligibility determined|0|||
105653268|NCT00043186|364394976|FG001|Overall Study|Ineligibility determined|0|||
105653269|NCT00043186|364394977|FG002|Overall Study|Ineligibility determined|0|||
105653270|NCT00043186|364394978|FG003|Overall Study|Ineligibility determined|0|||
105653271|NCT00043186|364394979|FG004|Overall Study|Ineligibility determined|0|||
105653272|NCT00043186|364394980|FG005|Overall Study|Ineligibility determined|0|||
105653273|NCT00043186|364394981|FG006|Overall Study|Ineligibility determined|0|||
105653274|NCT00043186|364394982|FG007|Overall Study|Ineligibility determined|0|||
105653275|NCT00043186|364394983|FG008|Overall Study|Ineligibility determined|1|||
105653276|NCT00043186|364394975|FG000|Overall Study|Lost to Follow-up|3|||
105653277|NCT00043186|364394976|FG001|Overall Study|Lost to Follow-up|5|||
105653278|NCT00043186|364394977|FG002|Overall Study|Lost to Follow-up|1|||
105653279|NCT00043186|364394978|FG003|Overall Study|Lost to Follow-up|1|||
105653280|NCT00043186|364394979|FG004|Overall Study|Lost to Follow-up|1|||
105653281|NCT00043186|364394980|FG005|Overall Study|Lost to Follow-up|1|||
105653282|NCT00043186|364394981|FG006|Overall Study|Lost to Follow-up|1|||
105653283|NCT00043186|364394982|FG007|Overall Study|Lost to Follow-up|1|||
105653284|NCT00043186|364394983|FG008|Overall Study|Lost to Follow-up|2|||
105653285|NCT00043186|364394975|FG000|Overall Study|Noncompliance|0|||
105653286|NCT00043186|364394976|FG001|Overall Study|Noncompliance|0|||
105653287|NCT00043186|364394977|FG002|Overall Study|Noncompliance|1|||
105653288|NCT00043186|364394978|FG003|Overall Study|Noncompliance|1|||
105653289|NCT00043186|364394979|FG004|Overall Study|Noncompliance|0|||
105653290|NCT00043186|364394980|FG005|Overall Study|Noncompliance|0|||
105653291|NCT00043186|364394981|FG006|Overall Study|Noncompliance|0|||
105653292|NCT00043186|364394982|FG007|Overall Study|Noncompliance|0|||
105653293|NCT00043186|364394983|FG008|Overall Study|Noncompliance|0|||
105653294|NCT00043186|364394975|FG000|Overall Study|Other|0|||
105653295|NCT00043186|364394976|FG001|Overall Study|Other|0|||
105653296|NCT00043186|364394977|FG002|Overall Study|Other|1|||
105653297|NCT00043186|364394978|FG003|Overall Study|Other|1|||
105653298|NCT00043186|364394979|FG004|Overall Study|Other|0|||
105653299|NCT00043186|364394980|FG005|Overall Study|Other|0|||
105653300|NCT00043186|364394981|FG006|Overall Study|Other|0|||
105653301|NCT00043186|364394982|FG007|Overall Study|Other|0|||
105653302|NCT00043186|364394983|FG008|Overall Study|Other|0|||
105653303|NCT00719212|364394984|FG000|Overall Study|Death|41|||
105653304|NCT00719212|364394984|FG000|Overall Study|Lost to Follow-up|2|||
105653305|NCT00719212|364394984|FG000|Overall Study|Withdrawal by Subject|1|||
105653306|NCT02151643|364394985|FG000|Overall Study|Adverse Event|2|||
105653307|NCT02151643|364394986|FG001|Overall Study|Adverse Event|0|||
105653308|NCT02151643|364394987|FG002|Overall Study|Adverse Event|1|||
105653309|NCT02151643|364394988|FG003|Overall Study|Adverse Event|4|||
105653310|NCT02151643|364394989|FG004|Overall Study|Adverse Event|0|||
105653311|NCT02151643|364394985|FG000|Overall Study|Withdrawal by Subject|0|||
105653312|NCT02151643|364394986|FG001|Overall Study|Withdrawal by Subject|1|||
105653313|NCT02151643|364394987|FG002|Overall Study|Withdrawal by Subject|1|||
105653314|NCT02151643|364394988|FG003|Overall Study|Withdrawal by Subject|1|||
105653315|NCT02151643|364394989|FG004|Overall Study|Withdrawal by Subject|1|||
105653316|NCT02151643|364394985|FG000|Overall Study|Hyperphosphataemia|1|||
105653317|NCT02151643|364394986|FG001|Overall Study|Hyperphosphataemia|0|||
105653318|NCT02151643|364394987|FG002|Overall Study|Hyperphosphataemia|0|||
105653319|NCT02151643|364394988|FG003|Overall Study|Hyperphosphataemia|0|||
105653320|NCT02151643|364394989|FG004|Overall Study|Hyperphosphataemia|1|||
105653321|NCT02151643|364394985|FG000|Overall Study|High Ferritin levels|3|||
105653322|NCT02151643|364394986|FG001|Overall Study|High Ferritin levels|3|||
105653323|NCT02151643|364394987|FG002|Overall Study|High Ferritin levels|2|||
105653324|NCT02151643|364394988|FG003|Overall Study|High Ferritin levels|2|||
105653325|NCT02151643|364394989|FG004|Overall Study|High Ferritin levels|1|||
105653326|NCT03296566|364394990|FG000|Overall Study|Lost to Follow-up|19|||
105653327|NCT03296566|364394991|FG001|Overall Study|Lost to Follow-up|46|||
105653328|NCT03296566|364394990|FG000|Overall Study|Withdrawal by Subject|0|||
105653329|NCT03296566|364394991|FG001|Overall Study|Withdrawal by Subject|3|||
105653330|NCT01990313|364394992|FG000|Overall Study|Lost to Follow-up|1|||
105653331|NCT03226106|364394993|FG000|Overall Study|Withdrawal by Subject|2|||
105653332|NCT03226106|364394994|FG001|Overall Study|Withdrawal by Subject|0|||
105653333|NCT03226106|364394993|FG000|Overall Study|Adverse Event|1|||
105653334|NCT03226106|364394994|FG001|Overall Study|Adverse Event|0|||
105653335|NCT03226106|364394993|FG000|Overall Study|Lost to Follow-up|2|||
105653336|NCT03226106|364394994|FG001|Overall Study|Lost to Follow-up|0|||
105653337|NCT03022578|364394996|FG000|Overall Study|Adverse Event|1|||
105653338|NCT03022578|364394996|FG000|Overall Study|Lack of Efficacy|2|||
105653339|NCT03022578|364394996|FG000|Overall Study|Withdrawal by Subject|1|||
105653340|NCT00510198|364394997|FG000|Overall Study|Withdrawal by Subject|5|||
105653341|NCT00510198|364394998|FG001|Overall Study|Withdrawal by Subject|4|||
105653342|NCT00329550|364394999|FG000|Overall Study|Adverse Event|3|||
105440149|NCT01235234|363616710|FG002|Overall Study|Adverse Event|1|||
105653343|NCT00329550|364395000|FG001|Overall Study|Adverse Event|4|||
105653344|NCT00329550|364395001|FG002|Overall Study|Adverse Event|2|||
105653345|NCT00329550|364394999|FG000|Overall Study|Withdrawal of Consent|1|||
105653346|NCT00329550|364395000|FG001|Overall Study|Withdrawal of Consent|0|||
105653347|NCT00329550|364395001|FG002|Overall Study|Withdrawal of Consent|1|||
105653348|NCT00329550|364394999|FG000|Overall Study|Due to Relocation|0|||
105653349|NCT00329550|364395000|FG001|Overall Study|Due to Relocation|0|||
105653350|NCT00329550|364395001|FG002|Overall Study|Due to Relocation|1|||
105653351|NCT04150341|364395006|FG000|Overall Study|Physician Decision|0|||
105653352|NCT04150341|364395007|FG001|Overall Study|Physician Decision|0|||
105653353|NCT04150341|364395008|FG002|Overall Study|Physician Decision|1|||
105653354|NCT04150341|364395009|FG003|Overall Study|Physician Decision|0|||
105653355|NCT04150341|364395010|FG004|Overall Study|Physician Decision|0|||
105653356|NCT04150341|364395011|FG005|Overall Study|Physician Decision|0|||
105653357|NCT04150341|364395006|FG000|Overall Study|Adverse Event|0|||
105653358|NCT04150341|364395007|FG001|Overall Study|Adverse Event|0|||
105653359|NCT04150341|364395008|FG002|Overall Study|Adverse Event|0|||
105653360|NCT04150341|364395009|FG003|Overall Study|Adverse Event|0|||
105653361|NCT04150341|364395010|FG004|Overall Study|Adverse Event|1|||
105653362|NCT04150341|364395011|FG005|Overall Study|Adverse Event|0|||
105653363|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
105653364|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
105653365|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
105653366|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
105653367|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Death|0|||
105653368|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Death|1|||
105653369|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
105653370|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
105653371|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
105653372|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
105653373|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
105653374|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
105653375|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
105653376|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
105653377|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
105653378|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
105653379|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
105653380|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
105653381|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
105653382|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
105653383|NCT01309243|364395018|FG000|Extension Phase|Lost to Follow-up|6|||
105653384|NCT01309243|364395019|FG001|Extension Phase|Lost to Follow-up|0|||
105653385|NCT00917462|364395022|FG000|Overall Study|Clinical Deterioration|1|||
105653386|NCT01402063|364395023|FG000|Overall Study|Withdrawal by Subject|3|||
105653387|NCT01402063|364395024|FG001|Overall Study|Withdrawal by Subject|3|||
105653388|NCT01441583|364395025|FG000|Overall Study|Withdrawal by Subject|1|||
105653389|NCT01441583|364395026|FG001|Overall Study|Withdrawal by Subject|1|||
105653390|NCT01441583|364395027|FG002|Overall Study|Withdrawal by Subject|1|||
105653391|NCT01441583|364395025|FG000|Overall Study|Death|1|||
105653392|NCT01441583|364395026|FG001|Overall Study|Death|0|||
105653393|NCT01441583|364395027|FG002|Overall Study|Death|4|||
105653394|NCT01441583|364395025|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
105653395|NCT01441583|364395026|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
105653396|NCT01441583|364395027|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
105653397|NCT01191697|364395028|FG000|Overall Study|Death|1|||
105653398|NCT01191697|364395028|FG000|Overall Study|Physician Decision|2|||
105653399|NCT01191697|364395028|FG000|Overall Study|Pursue chemoradiation|2|||
105653400|NCT01191697|364395028|FG000|Overall Study|Break from chemotherapy|2|||
105653401|NCT01191697|364395028|FG000|Overall Study|Withdrawal by Subject|1|||
105653402|NCT01191697|364395028|FG000|Overall Study|Surveillance|1|||
105653403|NCT01191697|364395028|FG000|Overall Study|Adverse Event|2|||
105653404|NCT01191697|364395028|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
105653405|NCT01191697|364395028|FG000|Overall Study|Not completed but analyzed|25|||
105653406|NCT02396758|364395030|FG000|Overall Study|Withdrawal by Subject|2|||
105653407|NCT02396758|364395031|FG001|Overall Study|Withdrawal by Subject|0|||
105653408|NCT02396758|364395032|FG002|Overall Study|Withdrawal by Subject|0|||
105653409|NCT02396758|364395033|FG003|Overall Study|Withdrawal by Subject|1|||
105653410|NCT02396758|364395030|FG000|Overall Study|Lost to Follow-up|8|||
105653411|NCT02396758|364395031|FG001|Overall Study|Lost to Follow-up|5|||
105653412|NCT02396758|364395032|FG002|Overall Study|Lost to Follow-up|3|||
105653413|NCT02396758|364395033|FG003|Overall Study|Lost to Follow-up|3|||
105653414|NCT02396758|364395030|FG000|Overall Study|Death|1|||
105653415|NCT02396758|364395031|FG001|Overall Study|Death|1|||
105653416|NCT02396758|364395032|FG002|Overall Study|Death|0|||
105653417|NCT02396758|364395033|FG003|Overall Study|Death|1|||
105653418|NCT02396758|364395030|FG000|Overall Study|Randomized but not treated|1|||
105653419|NCT02396758|364395031|FG001|Overall Study|Randomized but not treated|0|||
105653420|NCT02396758|364395032|FG002|Overall Study|Randomized but not treated|1|||
105653421|NCT02396758|364395033|FG003|Overall Study|Randomized but not treated|0|||
105653422|NCT02176018|364395034|FG000|Overall Study|Adverse Event|0|||
105653423|NCT02176018|364395035|FG001|Overall Study|Adverse Event|2|||
105653424|NCT02176018|364395034|FG000|Overall Study|Lost to Follow-up|3|||
105653425|NCT02176018|364395035|FG001|Overall Study|Lost to Follow-up|1|||
105653426|NCT02176018|364395034|FG000|Overall Study|Protocol Violation|1|||
105653427|NCT02176018|364395035|FG001|Overall Study|Protocol Violation|1|||
105653428|NCT02176018|364395034|FG000|Overall Study|Withdrawal by Subject|1|||
105653429|NCT02176018|364395035|FG001|Overall Study|Withdrawal by Subject|2|||
105653430|NCT05153499|364395036|FG000|Overall Study|Withdrawal by Subject|1|||
105653431|NCT05153499|364395037|FG001|Overall Study|Withdrawal by Subject|0|||
105653432|NCT05153499|364395036|FG000|Overall Study|Clinical Hold|1|||
105653433|NCT05153499|364395037|FG001|Overall Study|Clinical Hold|0|||
105653434|NCT05153499|364395036|FG000|Overall Study|Study Termination|6|||
105653435|NCT05153499|364395037|FG001|Overall Study|Study Termination|5|||
105653436|NCT00265096|364395038|FG000|Overall Study|Adverse Event|14|||
105653437|NCT00265096|364395039|FG001|Overall Study|Adverse Event|18|||
105653438|NCT00265096|364395040|FG002|Overall Study|Adverse Event|18|||
105653439|NCT00265096|364395038|FG000|Overall Study|Lost to Follow-up|2|||
105653440|NCT00265096|364395039|FG001|Overall Study|Lost to Follow-up|5|||
105653441|NCT00265096|364395040|FG002|Overall Study|Lost to Follow-up|3|||
105653442|NCT00265096|364395038|FG000|Overall Study|Death|0|||
105653443|NCT00265096|364395039|FG001|Overall Study|Death|1|||
105653444|NCT00265096|364395040|FG002|Overall Study|Death|2|||
105653445|NCT00265096|364395038|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
105653446|NCT00265096|364395039|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
105653447|NCT00265096|364395040|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
105653448|NCT00265096|364395038|FG000|Overall Study|Other|11|||
105653449|NCT00265096|364395039|FG001|Overall Study|Other|19|||
105653450|NCT00265096|364395040|FG002|Overall Study|Other|10|||
105653451|NCT03022045|364395041|FG000|Overall Study|Adverse Event|0|||
105653452|NCT03022045|364395042|FG001|Overall Study|Adverse Event|1|||
105653453|NCT03022045|364395041|FG000|Overall Study|Withdrawal by Subject|1|||
105653454|NCT03022045|364395042|FG001|Overall Study|Withdrawal by Subject|1|||
105653455|NCT00666835|364395043|FG000|Overall Study|Withdrawal by Subject|5|||
105653456|NCT00666835|364395044|FG001|Overall Study|Withdrawal by Subject|2|||
105653457|NCT00666835|364395043|FG000|Overall Study|Lack of Efficacy|0|||
105653458|NCT00666835|364395044|FG001|Overall Study|Lack of Efficacy|1|||
105653459|NCT00666835|364395043|FG000|Overall Study|Incl./excl. not fulfilled|7|||
105653460|NCT00666835|364395044|FG001|Overall Study|Incl./excl. not fulfilled|2|||
105653461|NCT00666835|364395043|FG000|Overall Study|Adverse Event|7|||
105653462|NCT00666835|364395044|FG001|Overall Study|Adverse Event|6|||
105653463|NCT00666835|364395043|FG000|Overall Study|Protocol Violation|2|||
105653464|NCT00666835|364395044|FG001|Overall Study|Protocol Violation|0|||
105653465|NCT00666835|364395043|FG000|Overall Study|Death|15|||
105653466|NCT00666835|364395044|FG001|Overall Study|Death|4|||
105653467|NCT00666835|364395043|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
105653468|NCT00666835|364395044|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
105653469|NCT00666835|364395043|FG000|Overall Study|Hemoglobulin concentration|4|||
105653470|NCT00666835|364395044|FG001|Overall Study|Hemoglobulin concentration|3|||
105653471|NCT00666835|364395043|FG000|Overall Study|Planned operation|2|||
105653472|NCT00666835|364395044|FG001|Overall Study|Planned operation|0|||
105653473|NCT00666835|364395043|FG000|Overall Study|Physician Decision|1|||
105653474|NCT00666835|364395044|FG001|Overall Study|Physician Decision|2|||
105653475|NCT02499835|364395045|FG000|Overall Study|Withdrawal by Subject|1|||
105653476|NCT02499835|364395046|FG001|Overall Study|Withdrawal by Subject|0|||
105653477|NCT02499835|364395047|FG002|Overall Study|Withdrawal by Subject|0|||
105653478|NCT02499835|364395048|FG003|Overall Study|Withdrawal by Subject|1|||
105653479|NCT02499835|364395045|FG000|Overall Study|Physician Decision|0|||
105653480|NCT02499835|364395046|FG001|Overall Study|Physician Decision|3|||
105653481|NCT02499835|364395047|FG002|Overall Study|Physician Decision|18|||
105653482|NCT02499835|364395048|FG003|Overall Study|Physician Decision|7|||
105653483|NCT02499835|364395045|FG000|Overall Study|Adverse Event|0|||
105653484|NCT02499835|364395046|FG001|Overall Study|Adverse Event|0|||
105653485|NCT02499835|364395047|FG002|Overall Study|Adverse Event|0|||
105653486|NCT02499835|364395048|FG003|Overall Study|Adverse Event|1|||
105653487|NCT02499835|364395045|FG000|Overall Study|Disease progression|2|||
105653488|NCT02499835|364395046|FG001|Overall Study|Disease progression|1|||
105653489|NCT02499835|364395047|FG002|Overall Study|Disease progression|0|||
105653490|NCT02499835|364395048|FG003|Overall Study|Disease progression|7|||
105653491|NCT00899379|364395049|FG000|Overall Study|Adverse Event|2|||
105653492|NCT00899379|364395050|FG001|Overall Study|Adverse Event|2|||
105653493|NCT00899379|364395051|FG002|Overall Study|Adverse Event|1|||
105653494|NCT00899379|364395052|FG003|Overall Study|Adverse Event|1|||
105653495|NCT00899379|364395053|FG004|Overall Study|Adverse Event|2|||
105653496|NCT00899379|364395049|FG000|Overall Study|Lack of Efficacy|0|||
105653497|NCT00899379|364395050|FG001|Overall Study|Lack of Efficacy|4|||
105653498|NCT00899379|364395051|FG002|Overall Study|Lack of Efficacy|3|||
105653499|NCT00899379|364395052|FG003|Overall Study|Lack of Efficacy|0|||
105653500|NCT00899379|364395053|FG004|Overall Study|Lack of Efficacy|1|||
105653501|NCT00899379|364395049|FG000|Overall Study|Lost to Follow-up|9|||
105653502|NCT00899379|364395050|FG001|Overall Study|Lost to Follow-up|3|||
105653503|NCT00899379|364395051|FG002|Overall Study|Lost to Follow-up|0|||
105653504|NCT00899379|364395052|FG003|Overall Study|Lost to Follow-up|6|||
105653505|NCT00899379|364395053|FG004|Overall Study|Lost to Follow-up|2|||
105653506|NCT00899379|364395049|FG000|Overall Study|Protocol Violation|0|||
105653507|NCT00899379|364395050|FG001|Overall Study|Protocol Violation|0|||
105653508|NCT00899379|364395051|FG002|Overall Study|Protocol Violation|1|||
105653509|NCT00899379|364395052|FG003|Overall Study|Protocol Violation|1|||
105653510|NCT00899379|364395053|FG004|Overall Study|Protocol Violation|0|||
105653511|NCT00899379|364395049|FG000|Overall Study|Withdrawal by Subject|2|||
105653512|NCT00899379|364395050|FG001|Overall Study|Withdrawal by Subject|4|||
105653513|NCT00899379|364395051|FG002|Overall Study|Withdrawal by Subject|2|||
105653514|NCT00899379|364395052|FG003|Overall Study|Withdrawal by Subject|3|||
105653515|NCT00899379|364395053|FG004|Overall Study|Withdrawal by Subject|6|||
105653516|NCT00899379|364395049|FG000|Overall Study|Pregnancy|0|||
105653517|NCT00899379|364395050|FG001|Overall Study|Pregnancy|0|||
105653518|NCT00899379|364395051|FG002|Overall Study|Pregnancy|1|||
105653519|NCT00899379|364395052|FG003|Overall Study|Pregnancy|0|||
105653520|NCT00899379|364395053|FG004|Overall Study|Pregnancy|1|||
105653521|NCT00899379|364395049|FG000|Overall Study|Patient Uncooperative|0|||
105653522|NCT00899379|364395050|FG001|Overall Study|Patient Uncooperative|1|||
105653523|NCT00899379|364395051|FG002|Overall Study|Patient Uncooperative|0|||
105653524|NCT00899379|364395052|FG003|Overall Study|Patient Uncooperative|1|||
105653525|NCT00899379|364395053|FG004|Overall Study|Patient Uncooperative|2|||
105653526|NCT00899379|364395049|FG000|Overall Study|Abnormal Baseline ECG|0|||
105653527|NCT00899379|364395050|FG001|Overall Study|Abnormal Baseline ECG|0|||
105653528|NCT00899379|364395051|FG002|Overall Study|Abnormal Baseline ECG|0|||
105653529|NCT00899379|364395052|FG003|Overall Study|Abnormal Baseline ECG|1|||
105653530|NCT00899379|364395053|FG004|Overall Study|Abnormal Baseline ECG|0|||
105653531|NCT00899379|364395049|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
105653532|NCT00899379|364395050|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
105653533|NCT00899379|364395051|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
105653534|NCT00899379|364395052|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
105653535|NCT00899379|364395053|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
105653536|NCT00899379|364395049|FG000|Overall Study|Not Completed/Entered Extn|5|||
105653537|NCT00899379|364395050|FG001|Overall Study|Not Completed/Entered Extn|1|||
105653538|NCT00899379|364395051|FG002|Overall Study|Not Completed/Entered Extn|6|||
105653539|NCT00899379|364395052|FG003|Overall Study|Not Completed/Entered Extn|4|||
105653540|NCT00899379|364395053|FG004|Overall Study|Not Completed/Entered Extn|3|||
105653541|NCT00899379|364395049|FG000|Overall Study|Study Terminated|3|||
105653542|NCT00899379|364395050|FG001|Overall Study|Study Terminated|0|||
105653543|NCT00899379|364395051|FG002|Overall Study|Study Terminated|3|||
105653544|NCT00899379|364395052|FG003|Overall Study|Study Terminated|3|||
105653545|NCT00899379|364395053|FG004|Overall Study|Study Terminated|1|||
105653546|NCT00899379|364395049|FG000|Overall Study|Lost to Follow-up|3|||
105653547|NCT00899379|364395050|FG001|Overall Study|Lost to Follow-up|1|||
105653548|NCT00899379|364395051|FG002|Overall Study|Lost to Follow-up|0|||
105653549|NCT00899379|364395052|FG003|Overall Study|Lost to Follow-up|2|||
105653550|NCT00899379|364395053|FG004|Overall Study|Lost to Follow-up|5|||
105653551|NCT00899379|364395049|FG000|Overall Study|Withdrawal by Subject|4|||
105653552|NCT00899379|364395050|FG001|Overall Study|Withdrawal by Subject|7|||
105653553|NCT00899379|364395051|FG002|Overall Study|Withdrawal by Subject|4|||
105653554|NCT00899379|364395052|FG003|Overall Study|Withdrawal by Subject|7|||
105653555|NCT00899379|364395053|FG004|Overall Study|Withdrawal by Subject|2|||
105653556|NCT00899379|364395049|FG000|Overall Study|Pregnancy|1|||
105653557|NCT00899379|364395050|FG001|Overall Study|Pregnancy|0|||
105653558|NCT00899379|364395051|FG002|Overall Study|Pregnancy|0|||
105653559|NCT00899379|364395052|FG003|Overall Study|Pregnancy|0|||
105653560|NCT00899379|364395053|FG004|Overall Study|Pregnancy|0|||
105653561|NCT00899379|364395049|FG000|Overall Study|Patient Uncooperative|0|||
105653562|NCT00899379|364395050|FG001|Overall Study|Patient Uncooperative|0|||
105653563|NCT00899379|364395051|FG002|Overall Study|Patient Uncooperative|0|||
105653564|NCT00899379|364395052|FG003|Overall Study|Patient Uncooperative|1|||
105653565|NCT00899379|364395053|FG004|Overall Study|Patient Uncooperative|0|||
105653566|NCT00899379|364395049|FG000|Overall Study|Abnormal Prestudy Labs|0|||
105653567|NCT00899379|364395050|FG001|Overall Study|Abnormal Prestudy Labs|0|||
105653568|NCT00899379|364395051|FG002|Overall Study|Abnormal Prestudy Labs|0|||
105653569|NCT00899379|364395052|FG003|Overall Study|Abnormal Prestudy Labs|0|||
105653570|NCT00899379|364395053|FG004|Overall Study|Abnormal Prestudy Labs|2|||
105653571|NCT00899379|364395049|FG000|Overall Study|Abnormal Baseline ECG|0|||
105653572|NCT00899379|364395050|FG001|Overall Study|Abnormal Baseline ECG|0|||
105653573|NCT00899379|364395051|FG002|Overall Study|Abnormal Baseline ECG|1|||
105653574|NCT00899379|364395052|FG003|Overall Study|Abnormal Baseline ECG|1|||
105653575|NCT00899379|364395053|FG004|Overall Study|Abnormal Baseline ECG|0|||
105653576|NCT00899379|364395049|FG000|Overall Study|No Attack Pretreatment|3|||
105653577|NCT00899379|364395050|FG001|Overall Study|No Attack Pretreatment|5|||
105653578|NCT00899379|364395051|FG002|Overall Study|No Attack Pretreatment|5|||
105653579|NCT00899379|364395052|FG003|Overall Study|No Attack Pretreatment|6|||
105653580|NCT00899379|364395053|FG004|Overall Study|No Attack Pretreatment|4|||
105653581|NCT00899379|364395049|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
105653582|NCT00899379|364395050|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
105653583|NCT00899379|364395051|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
105653584|NCT00899379|364395052|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
105653585|NCT00899379|364395053|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
105653586|NCT00899379|364395049|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
105653587|NCT00899379|364395050|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
105653588|NCT00899379|364395051|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
105653589|NCT00899379|364395052|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
105653590|NCT00899379|364395053|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
105653591|NCT01780545|364395058|FG000|Overall Study|Withdrawal by Subject|3|||
105653592|NCT01780545|364395059|FG001|Overall Study|Withdrawal by Subject|1|||
105653593|NCT01780545|364395058|FG000|Overall Study|Lost to Follow-up|1|||
105653594|NCT01780545|364395059|FG001|Overall Study|Lost to Follow-up|1|||
105653595|NCT01732926|364395065|FG000|Overall Study|Study Terminated by Sponsor|168|||
105653596|NCT01732926|364395066|FG001|Overall Study|Study Terminated by Sponsor|80|||
105653597|NCT01732926|364395065|FG000|Overall Study|Withdrawal by Subject|46|||
105653598|NCT01732926|364395066|FG001|Overall Study|Withdrawal by Subject|8|||
105653599|NCT01732926|364395065|FG000|Overall Study|Physician Decision|24|||
105653600|NCT01732926|364395066|FG001|Overall Study|Physician Decision|11|||
105653601|NCT01732926|364395065|FG000|Overall Study|Other Reason|21|||
105653602|NCT01732926|364395066|FG001|Overall Study|Other Reason|4|||
105653603|NCT01732926|364395065|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
105653604|NCT01732926|364395066|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
105653605|NCT01732926|364395065|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
105653606|NCT01732926|364395066|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
105653607|NCT02262364|364395067|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
105653608|NCT00797511|364395069|FG000|Overall Study|Withdrawal by Subject|1|||
105653609|NCT00053352|364395073|FG000|Overall Study|Lost to Follow-up|0|||
105653610|NCT00053352|364395074|FG001|Overall Study|Lost to Follow-up|1|||
105653611|NCT00053352|364395073|FG000|Overall Study|Physician Decision|11|||
105653612|NCT00053352|364395074|FG001|Overall Study|Physician Decision|1|||
105653613|NCT00053352|364395073|FG000|Overall Study|Withdrawal by Subject|1|||
105653614|NCT00053352|364395074|FG001|Overall Study|Withdrawal by Subject|0|||
105653615|NCT00053352|364395073|FG000|Overall Study|Ineligible|8|||
105653616|NCT00053352|364395074|FG001|Overall Study|Ineligible|8|||
105653617|NCT00053352|364395073|FG000|Overall Study|Disease at new site|1|||
105653618|NCT00053352|364395074|FG001|Overall Study|Disease at new site|0|||
105653619|NCT02621047|364395075|FG000|Overall Study|Adverse Event|0|||
105653620|NCT02621047|364395076|FG001|Overall Study|Adverse Event|0|||
105653621|NCT02621047|364395077|FG002|Overall Study|Adverse Event|1|||
105653622|NCT01037413|364395078|FG000|Part A: Skin Testing|Adverse Event|1|||
105653623|NCT01037413|364395079|FG001|Part A: Skin Testing|Adverse Event|0|||
105653624|NCT01037413|364395078|FG000|Part A: Skin Testing|Protocol Violation|1|||
105653625|NCT01037413|364395079|FG001|Part A: Skin Testing|Protocol Violation|0|||
105653626|NCT01037413|364395078|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
105653627|NCT01037413|364395079|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
105653628|NCT01037413|364395078|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
105653629|NCT01037413|364395079|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
105653630|NCT02204319|364395083|FG000|Overall Study|Pregnancy|1|||
105653631|NCT02204319|364395083|FG000|Overall Study|Withdrawal by Subject|2|||
105653632|NCT01177137|364395084|FG000|Overall Study|Withdrawal by Subject|10|||
105653633|NCT01177137|364395085|FG001|Overall Study|Withdrawal by Subject|10|||
105653634|NCT01177137|364395086|FG002|Overall Study|Withdrawal by Subject|2|||
105653635|NCT01340300|364395095|FG000|Overall Study|Lost to Follow-up|3|||
105653636|NCT01340300|364395096|FG001|Overall Study|Lost to Follow-up|0|||
105653637|NCT01340300|364395097|FG002|Overall Study|Lost to Follow-up|5|||
105653638|NCT01340300|364395098|FG003|Overall Study|Lost to Follow-up|10|||
105653639|NCT01340300|364395095|FG000|Overall Study|Withdrawal by Subject|5|||
105653640|NCT01340300|364395096|FG001|Overall Study|Withdrawal by Subject|6|||
105653641|NCT01340300|364395097|FG002|Overall Study|Withdrawal by Subject|6|||
105653642|NCT01340300|364395098|FG003|Overall Study|Withdrawal by Subject|3|||
105653643|NCT01340300|364395095|FG000|Overall Study|Adverse Event|1|||
105653644|NCT01340300|364395096|FG001|Overall Study|Adverse Event|0|||
105653645|NCT01340300|364395097|FG002|Overall Study|Adverse Event|4|||
105653646|NCT01340300|364395098|FG003|Overall Study|Adverse Event|0|||
105653647|NCT01340300|364395095|FG000|Overall Study|Physician Decision|0|||
105653648|NCT01340300|364395096|FG001|Overall Study|Physician Decision|1|||
105653649|NCT01340300|364395097|FG002|Overall Study|Physician Decision|0|||
105653650|NCT01340300|364395098|FG003|Overall Study|Physician Decision|0|||
105653651|NCT01340300|364395095|FG000|Overall Study|Unrelated sickness|0|||
105653652|NCT01340300|364395096|FG001|Overall Study|Unrelated sickness|2|||
105653653|NCT01340300|364395097|FG002|Overall Study|Unrelated sickness|0|||
105653654|NCT01340300|364395098|FG003|Overall Study|Unrelated sickness|1|||
105653655|NCT02460562|364395100|FG000|Overall Study|Lost to Follow-up|15|||
105653656|NCT02460562|364395101|FG001|Overall Study|Lost to Follow-up|16|||
105653657|NCT01093222|364395102|FG000|Overall Study|Ineligible|6|||
105653658|NCT01093222|364395102|FG000|Overall Study|Adverse Event|7|||
105653659|NCT01093222|364395102|FG000|Overall Study|Progression/relapse|24|||
105653660|NCT01093222|364395102|FG000|Overall Study|Death|2|||
105653661|NCT01093222|364395102|FG000|Overall Study|Not protocol specified|1|||
105653662|NCT02137239|364395105|FG000|Overall Study|Discontinued Study Treatment|0|||
105653663|NCT02137239|364395106|FG001|Overall Study|Discontinued Study Treatment|3|||
105653664|NCT02137239|364395105|FG000|Overall Study|Withdrew Consent|1|||
105653665|NCT02137239|364395106|FG001|Overall Study|Withdrew Consent|1|||
105653666|NCT02137239|364395105|FG000|Overall Study|Adverse Event|2|||
105653667|NCT02137239|364395106|FG001|Overall Study|Adverse Event|2|||
105653668|NCT00187135|364395107|FG000|Visit One|Withdrawal by Subject|1|||
105653669|NCT00187135|364395108|FG001|Visit One|Withdrawal by Subject|0|||
105653670|NCT00187135|364395109|FG002|Visit One|Withdrawal by Subject|0|||
105653671|NCT00187135|364395110|FG003|Visit One|Withdrawal by Subject|0|||
105653672|NCT00187135|364395111|FG004|Visit One|Withdrawal by Subject|0|||
105653673|NCT00187135|364395112|FG005|Visit One|Withdrawal by Subject|1|||
105653674|NCT00187135|364395107|FG000|Visit One|Physician Decision|3|||
105653675|NCT00187135|364395108|FG001|Visit One|Physician Decision|1|||
105653676|NCT00187135|364395109|FG002|Visit One|Physician Decision|0|||
105653677|NCT00187135|364395110|FG003|Visit One|Physician Decision|0|||
105653678|NCT00187135|364395111|FG004|Visit One|Physician Decision|0|||
105653679|NCT00187135|364395112|FG005|Visit One|Physician Decision|1|||
105653680|NCT00187135|364395107|FG000|Visit Two|Death|0|||
105653681|NCT00187135|364395108|FG001|Visit Two|Death|0|||
105653682|NCT00187135|364395109|FG002|Visit Two|Death|0|||
105653683|NCT00187135|364395110|FG003|Visit Two|Death|1|||
105653684|NCT00187135|364395111|FG004|Visit Two|Death|0|||
105653685|NCT00187135|364395112|FG005|Visit Two|Death|1|||
105653686|NCT00187135|364395107|FG000|Visit Two|Physician Decision|1|||
105653687|NCT00187135|364395108|FG001|Visit Two|Physician Decision|0|||
105653688|NCT00187135|364395109|FG002|Visit Two|Physician Decision|0|||
105653689|NCT00187135|364395110|FG003|Visit Two|Physician Decision|0|||
105653690|NCT00187135|364395111|FG004|Visit Two|Physician Decision|0|||
105653691|NCT00187135|364395112|FG005|Visit Two|Physician Decision|0|||
105653692|NCT00187135|364395107|FG000|Visit Two|Withdrawal by Subject|1|||
105653693|NCT00187135|364395108|FG001|Visit Two|Withdrawal by Subject|1|||
105653694|NCT00187135|364395109|FG002|Visit Two|Withdrawal by Subject|1|||
105653695|NCT00187135|364395110|FG003|Visit Two|Withdrawal by Subject|0|||
105653696|NCT00187135|364395111|FG004|Visit Two|Withdrawal by Subject|1|||
105653697|NCT00187135|364395112|FG005|Visit Two|Withdrawal by Subject|1|||
105653698|NCT00187135|364395107|FG000|Visit Two|Study Discontinued|3|||
105653699|NCT00187135|364395108|FG001|Visit Two|Study Discontinued|2|||
105653700|NCT00187135|364395109|FG002|Visit Two|Study Discontinued|1|||
105653701|NCT00187135|364395110|FG003|Visit Two|Study Discontinued|7|||
105653702|NCT00187135|364395111|FG004|Visit Two|Study Discontinued|5|||
105653703|NCT00187135|364395112|FG005|Visit Two|Study Discontinued|6|||
105653704|NCT00187135|364395107|FG000|Visit Three|Death|0|||
105653705|NCT00187135|364395108|FG001|Visit Three|Death|0|||
105653706|NCT00187135|364395109|FG002|Visit Three|Death|1|||
105653707|NCT00187135|364395110|FG003|Visit Three|Death|0|||
105653708|NCT00187135|364395111|FG004|Visit Three|Death|1|||
105653709|NCT00187135|364395112|FG005|Visit Three|Death|0|||
105653710|NCT00187135|364395107|FG000|Visit Three|Withdrawal by Subject|0|||
105653711|NCT00187135|364395108|FG001|Visit Three|Withdrawal by Subject|1|||
105653712|NCT00187135|364395109|FG002|Visit Three|Withdrawal by Subject|1|||
105653713|NCT00187135|364395110|FG003|Visit Three|Withdrawal by Subject|2|||
105653714|NCT00187135|364395111|FG004|Visit Three|Withdrawal by Subject|0|||
105653715|NCT00187135|364395112|FG005|Visit Three|Withdrawal by Subject|0|||
105653716|NCT00187135|364395107|FG000|Visit Three|Study Discontinued|7|||
105653717|NCT00187135|364395108|FG001|Visit Three|Study Discontinued|6|||
105653718|NCT00187135|364395109|FG002|Visit Three|Study Discontinued|7|||
105653719|NCT00187135|364395110|FG003|Visit Three|Study Discontinued|7|||
105653720|NCT00187135|364395111|FG004|Visit Three|Study Discontinued|7|||
105653721|NCT00187135|364395112|FG005|Visit Three|Study Discontinued|6|||
105653722|NCT01951261|364395113|FG000|Overall Study|Death|1|||
105653723|NCT01951261|364395114|FG001|Overall Study|Death|0|||
105653724|NCT01951261|364395113|FG000|Overall Study|Lost to Follow-up|4|||
105653725|NCT01951261|364395114|FG001|Overall Study|Lost to Follow-up|3|||
105653726|NCT01951261|364395113|FG000|Overall Study|Protocol Violation|4|||
105653727|NCT01951261|364395114|FG001|Overall Study|Protocol Violation|3|||
105653728|NCT01670188|364395115|FG000|Overall Study|Death|0|||
105653729|NCT01670188|364395116|FG001|Overall Study|Death|1|||
105653730|NCT01954771|364395117|FG000|Overall Study|Missing HbA1c of end-point|1|||
105653731|NCT01954771|364395118|FG001|Overall Study|Missing HbA1c of end-point|1|||
105653732|NCT01954771|364395119|FG002|Overall Study|Missing HbA1c of end-point|0|||
105653733|NCT01954771|364395117|FG000|Overall Study|Missing CGMS of end-point|1|||
105653734|NCT01954771|364395118|FG001|Overall Study|Missing CGMS of end-point|1|||
105653735|NCT01954771|364395119|FG002|Overall Study|Missing CGMS of end-point|0|||
105653736|NCT01954771|364395117|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
105653737|NCT01954771|364395118|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
105653738|NCT01954771|364395119|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
105653739|NCT03175198|364395120|FG000|Overall Study|Adverse Event|480|||
105653740|NCT03175198|364395120|FG000|Overall Study|No actual visit|120|||
105653741|NCT03175198|364395120|FG000|Overall Study|Registration rule not followed|4|||
105653742|NCT03175198|364395120|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
105653743|NCT03175198|364395120|FG000|Overall Study|Other personal reason|509|||
105653744|NCT03175198|364395120|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
105653745|NCT03175198|364395120|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
105653746|NCT03175198|364395120|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
105653747|NCT03175198|364395120|FG000|Overall Study|To conduct invasive treatment of operation|53|||
105653748|NCT03175198|364395120|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
105653749|NCT03280108|364395121|FG000|Overall Study|Lost to Follow-up|2|||
105653750|NCT03280108|364395122|FG001|Overall Study|Lost to Follow-up|0|||
105653751|NCT02996097|364395123|FG000|Overall Study|Lost to Follow-up|11|||
105653752|NCT02996097|364395124|FG001|Overall Study|Lost to Follow-up|11|||
105653753|NCT02201771|364395125|FG000|Overall Study|Death|3|||
105653754|NCT02201771|364395126|FG001|Overall Study|Death|2|||
105653755|NCT02201771|364395127|FG002|Overall Study|Death|0|||
105653756|NCT02201771|364395125|FG000|Overall Study|Protocol Violation|10|||
105653757|NCT02201771|364395126|FG001|Overall Study|Protocol Violation|8|||
105653758|NCT02201771|364395127|FG002|Overall Study|Protocol Violation|10|||
105653759|NCT01200485|364395131|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
105653760|NCT01200485|364395132|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
105653761|NCT01200485|364395133|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
105653762|NCT01200485|364395131|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
105653763|NCT01200485|364395132|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
105653764|NCT01200485|364395133|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
105653765|NCT06080438|364395134|FG000|Overall Study|Lost to Follow-up|2|||
105653766|NCT03569475|364395135|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
105653767|NCT03569475|364395136|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
105653768|NCT03569475|364395137|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
105653769|NCT03569475|364395135|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
105653770|NCT03569475|364395136|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
105653771|NCT03569475|364395137|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
105653772|NCT03569475|364395135|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
105653773|NCT03569475|364395136|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
105653774|NCT03569475|364395137|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
105653775|NCT03569475|364395135|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
105653776|NCT03569475|364395136|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
105653777|NCT03569475|364395137|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
105653778|NCT03569475|364395135|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
105653779|NCT03569475|364395136|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
105653780|NCT03569475|364395137|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
105653781|NCT03569475|364395135|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
105653782|NCT03569475|364395136|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
105653783|NCT03569475|364395137|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
105653784|NCT03569475|364395135|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
105653785|NCT03569475|364395136|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
105653786|NCT03569475|364395137|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
105653787|NCT03569475|364395135|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
105653788|NCT03569475|364395136|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
105653789|NCT03569475|364395137|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
105653790|NCT03569475|364395135|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
105653791|NCT03569475|364395136|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
105653792|NCT03569475|364395137|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
105653793|NCT02132117|364395138|FG000|Overall Study|Adverse Event|6|||
105653794|NCT02132117|364395139|FG001|Overall Study|Adverse Event|1|||
105653795|NCT02132117|364395138|FG000|Overall Study|Lost to Follow-up|2|||
105653796|NCT02132117|364395139|FG001|Overall Study|Lost to Follow-up|2|||
105653797|NCT02132117|364395138|FG000|Overall Study|Personal Reasons|1|||
105653798|NCT02132117|364395139|FG001|Overall Study|Personal Reasons|2|||
105653799|NCT02132117|364395138|FG000|Overall Study|Other Miscellaneous Reasons|2|||
105653800|NCT02132117|364395139|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105653801|NCT01678898|364395140|FG000|PB-102-F01|Adverse Event|0|||
105653802|NCT01678898|364395141|FG001|PB-102-F01|Adverse Event|1|||
105653803|NCT01678898|364395142|FG002|PB-102-F01|Adverse Event|0|||
105653804|NCT01678898|364395140|FG000|PB-102-F01|Physician Decision|0|||
105653805|NCT01678898|364395141|FG001|PB-102-F01|Physician Decision|1|||
105653806|NCT01678898|364395142|FG002|PB-102-F01|Physician Decision|0|||
105653807|NCT01544309|364395145|FG000|Overall Study|Withdrawal by Subject|12|||
105653808|NCT01544309|364395146|FG001|Overall Study|Withdrawal by Subject|7|||
105653809|NCT01544309|364395145|FG000|Overall Study|Protocol Violation|2|||
105653810|NCT01544309|364395146|FG001|Overall Study|Protocol Violation|1|||
105653811|NCT01544309|364395145|FG000|Overall Study|Physician Decision|4|||
105653812|NCT01544309|364395146|FG001|Overall Study|Physician Decision|1|||
105653813|NCT01544309|364395145|FG000|Overall Study|Not performed pre-dose examination|1|||
105653814|NCT01544309|364395146|FG001|Overall Study|Not performed pre-dose examination|2|||
105653815|NCT01544309|364395145|FG000|Overall Study|Administered prohibit prior medication|1|||
105653816|NCT01544309|364395146|FG001|Overall Study|Administered prohibit prior medication|0|||
105653817|NCT01395914|364395147|FG000|Overall Study|Unrelated to study drug AE|6|||
105653818|NCT01395914|364395148|FG001|Overall Study|Unrelated to study drug AE|1|||
105653819|NCT01395914|364395147|FG000|Overall Study|Death|23|||
105653820|NCT01395914|364395148|FG001|Overall Study|Death|17|||
105653821|NCT01395914|364395147|FG000|Overall Study|Other|9|||
105653822|NCT01395914|364395148|FG001|Overall Study|Other|3|||
105653823|NCT01395914|364395147|FG000|Overall Study|Withdrawal by patient|27|||
105653824|NCT01395914|364395148|FG001|Overall Study|Withdrawal by patient|14|||
105653825|NCT01395914|364395147|FG000|Overall Study|Study drug-related AE|1|||
105653826|NCT01395914|364395148|FG001|Overall Study|Study drug-related AE|0|||
105653827|NCT01395914|364395147|FG000|Overall Study|Lost to Follow-up|6|||
105653828|NCT01395914|364395148|FG001|Overall Study|Lost to Follow-up|2|||
105653829|NCT00511836|364396930|FG000|Double-blind Period|Lost to Follow-up|1|||
105653830|NCT00511836|364396931|FG001|Double-blind Period|Lost to Follow-up|0|||
105653831|NCT02166047|364396932|FG000|Overall Study|Withdrawal by Participant|0|||
105653832|NCT02166047|364396933|FG001|Overall Study|Withdrawal by Participant|1|||
105653833|NCT02166047|364396934|FG002|Overall Study|Withdrawal by Participant|2|||
105653834|NCT02166047|364396935|FG003|Overall Study|Withdrawal by Participant|0|||
105653835|NCT02166047|364396936|FG004|Overall Study|Withdrawal by Participant|0|||
105653836|NCT02166047|364396937|FG005|Overall Study|Withdrawal by Participant|0|||
105653837|NCT02166047|364396938|FG006|Overall Study|Withdrawal by Participant|1|||
105653838|NCT02166047|364396939|FG007|Overall Study|Withdrawal by Participant|0|||
105653839|NCT02166047|364396940|FG008|Overall Study|Withdrawal by Participant|0|||
105653840|NCT02166047|364396941|FG009|Overall Study|Withdrawal by Participant|0|||
105653841|NCT02166047|364396942|FG010|Overall Study|Withdrawal by Participant|0|||
105653842|NCT02166047|364396943|FG011|Overall Study|Withdrawal by Participant|0|||
105653843|NCT02166047|364396932|FG000|Overall Study|Adverse Event|0|||
105653844|NCT02166047|364396933|FG001|Overall Study|Adverse Event|0|||
105653845|NCT02166047|364396934|FG002|Overall Study|Adverse Event|0|||
105653846|NCT02166047|364396935|FG003|Overall Study|Adverse Event|0|||
105653847|NCT02166047|364396936|FG004|Overall Study|Adverse Event|1|||
105653848|NCT02166047|364396937|FG005|Overall Study|Adverse Event|0|||
105653849|NCT02166047|364396938|FG006|Overall Study|Adverse Event|1|||
105653850|NCT02166047|364396939|FG007|Overall Study|Adverse Event|0|||
105653851|NCT02166047|364396940|FG008|Overall Study|Adverse Event|0|||
105653852|NCT02166047|364396941|FG009|Overall Study|Adverse Event|0|||
105653853|NCT02166047|364396942|FG010|Overall Study|Adverse Event|2|||
105653854|NCT02166047|364396943|FG011|Overall Study|Adverse Event|0|||
105653855|NCT02847637|364396945|FG000|Overall Study|Withdrawal by Subject|0|||
105653856|NCT02847637|364396946|FG001|Overall Study|Withdrawal by Subject|1|||
105653857|NCT02847637|364396947|FG002|Overall Study|Withdrawal by Subject|1|||
105653858|NCT02847637|364396948|FG003|Overall Study|Withdrawal by Subject|0|||
105653859|NCT02847637|364396945|FG000|Overall Study|Lost to Follow-up|1|||
105653860|NCT02847637|364396946|FG001|Overall Study|Lost to Follow-up|1|||
105653861|NCT02847637|364396947|FG002|Overall Study|Lost to Follow-up|0|||
105653862|NCT02847637|364396948|FG003|Overall Study|Lost to Follow-up|0|||
105653863|NCT01040403|364396949|FG000|Overall Study|Adverse Event|10|||
105653864|NCT01040403|364396949|FG000|Overall Study|Protocol Violation|2|||
105653865|NCT01040403|364396949|FG000|Overall Study|Lost to Follow-up|1|||
105653866|NCT01040403|364396949|FG000|Overall Study|Not treated|1|||
105653867|NCT01040403|364396949|FG000|Overall Study|Other reason not defined above|6|||
105653868|NCT03036150|364396950|FG000|Overall Study|Withdrawal by Subject|8|||
105653869|NCT03036150|364396951|FG001|Overall Study|Withdrawal by Subject|3|||
105653870|NCT03036150|364396950|FG000|Overall Study|Lost to Follow-up|2|||
105653871|NCT03036150|364396951|FG001|Overall Study|Lost to Follow-up|2|||
105653872|NCT01990664|364396954|FG000|Overall Study|Lost to Follow-up|2|||
105653873|NCT01990664|364396955|FG001|Overall Study|Lost to Follow-up|6|||
105653874|NCT01990664|364396954|FG000|Overall Study|Withdrawal by Subject|2|||
105653875|NCT01990664|364396955|FG001|Overall Study|Withdrawal by Subject|3|||
105653876|NCT01990664|364396954|FG000|Overall Study|Protocol Violation|1|||
105653877|NCT01990664|364396955|FG001|Overall Study|Protocol Violation|0|||
105653878|NCT01990664|364396954|FG000|Overall Study|Lens Discomfort|1|||
105653879|NCT01990664|364396955|FG001|Overall Study|Lens Discomfort|1|||
105653880|NCT01990664|364396954|FG000|Overall Study|Lens Handling Difficulties|1|||
105653881|NCT01990664|364396955|FG001|Overall Study|Lens Handling Difficulties|0|||
105653882|NCT01990664|364396954|FG000|Overall Study|Unsatisfactory Visual Response|0|||
105653883|NCT01990664|364396955|FG001|Overall Study|Unsatisfactory Visual Response|1|||
105653884|NCT00570921|364396956|FG000|Overall Study|Protocol Violation|1|||
105653885|NCT00570921|364396956|FG000|Overall Study|Physician Decision|1|||
105653886|NCT03891641|364396957|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
105653887|NCT03891641|364396958|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
105653888|NCT00784277|364396959|FG000|IR Treatment|Adverse Event|4|||
105653889|NCT00784277|364396960|FG001|IR Treatment|Adverse Event|8|||
105653890|NCT00784277|364396961|FG002|IR Treatment|Adverse Event|19|||
105653891|NCT00784277|364396962|FG003|IR Treatment|Adverse Event|35|||
105653892|NCT00784277|364396963|FG004|IR Treatment|Adverse Event|0|||
105653893|NCT00784277|364396964|FG005|IR Treatment|Adverse Event|0|||
105653894|NCT00784277|364396965|FG006|IR Treatment|Adverse Event|0|||
105653895|NCT00784277|364396959|FG000|IR Treatment|Lack of Efficacy|4|||
105653896|NCT00784277|364396960|FG001|IR Treatment|Lack of Efficacy|4|||
105653897|NCT00784277|364396961|FG002|IR Treatment|Lack of Efficacy|1|||
105653898|NCT00784277|364396962|FG003|IR Treatment|Lack of Efficacy|0|||
105653899|NCT00784277|364396963|FG004|IR Treatment|Lack of Efficacy|0|||
105653900|NCT00784277|364396964|FG005|IR Treatment|Lack of Efficacy|0|||
105653901|NCT00784277|364396965|FG006|IR Treatment|Lack of Efficacy|0|||
105653902|NCT00784277|364396959|FG000|IR Treatment|Lost to Follow-up|1|||
105653903|NCT00784277|364396960|FG001|IR Treatment|Lost to Follow-up|0|||
105653904|NCT00784277|364396961|FG002|IR Treatment|Lost to Follow-up|1|||
105653905|NCT00784277|364396962|FG003|IR Treatment|Lost to Follow-up|0|||
105653906|NCT00784277|364396963|FG004|IR Treatment|Lost to Follow-up|0|||
105653907|NCT00784277|364396964|FG005|IR Treatment|Lost to Follow-up|0|||
105653908|NCT00784277|364396965|FG006|IR Treatment|Lost to Follow-up|0|||
105653909|NCT00784277|364396959|FG000|IR Treatment|Withdrawal by Subject|5|||
105653910|NCT00784277|364396960|FG001|IR Treatment|Withdrawal by Subject|1|||
105653911|NCT00784277|364396961|FG002|IR Treatment|Withdrawal by Subject|4|||
105653912|NCT00784277|364396962|FG003|IR Treatment|Withdrawal by Subject|6|||
105653913|NCT00784277|364396963|FG004|IR Treatment|Withdrawal by Subject|0|||
105653914|NCT00784277|364396964|FG005|IR Treatment|Withdrawal by Subject|0|||
105653915|NCT00784277|364396965|FG006|IR Treatment|Withdrawal by Subject|0|||
105653916|NCT00784277|364396959|FG000|IR Treatment|Resolution Of Pain|0|||
105653917|NCT00784277|364396960|FG001|IR Treatment|Resolution Of Pain|1|||
105653918|NCT00784277|364396961|FG002|IR Treatment|Resolution Of Pain|0|||
105653919|NCT00784277|364396962|FG003|IR Treatment|Resolution Of Pain|0|||
105653920|NCT00784277|364396963|FG004|IR Treatment|Resolution Of Pain|0|||
105653921|NCT00784277|364396964|FG005|IR Treatment|Resolution Of Pain|0|||
105653922|NCT00784277|364396965|FG006|IR Treatment|Resolution Of Pain|0|||
105653923|NCT00784277|364396959|FG000|IR Treatment|Other|2|||
105653924|NCT00784277|364396960|FG001|IR Treatment|Other|3|||
105653925|NCT00784277|364396961|FG002|IR Treatment|Other|3|||
105653926|NCT00784277|364396962|FG003|IR Treatment|Other|2|||
105653927|NCT00784277|364396963|FG004|IR Treatment|Other|0|||
105653928|NCT00784277|364396964|FG005|IR Treatment|Other|0|||
105653929|NCT00784277|364396965|FG006|IR Treatment|Other|0|||
105653930|NCT00784277|364396959|FG000|ER Treatment|Adverse Event|0|||
105653931|NCT00784277|364396960|FG001|ER Treatment|Adverse Event|0|||
105653932|NCT00784277|364396961|FG002|ER Treatment|Adverse Event|0|||
105653933|NCT00784277|364396962|FG003|ER Treatment|Adverse Event|0|||
105653934|NCT00784277|364396963|FG004|ER Treatment|Adverse Event|1|||
105653935|NCT00784277|364396964|FG005|ER Treatment|Adverse Event|7|||
105653936|NCT00784277|364396965|FG006|ER Treatment|Adverse Event|7|||
105653937|NCT00784277|364396959|FG000|ER Treatment|Lack of Efficacy|0|||
105653938|NCT00784277|364396960|FG001|ER Treatment|Lack of Efficacy|0|||
105653939|NCT00784277|364396961|FG002|ER Treatment|Lack of Efficacy|0|||
105653940|NCT00784277|364396962|FG003|ER Treatment|Lack of Efficacy|0|||
105653941|NCT00784277|364396963|FG004|ER Treatment|Lack of Efficacy|3|||
105653942|NCT00784277|364396964|FG005|ER Treatment|Lack of Efficacy|4|||
105653943|NCT00784277|364396965|FG006|ER Treatment|Lack of Efficacy|0|||
105653944|NCT00784277|364396959|FG000|ER Treatment|Lost to Follow-up|0|||
105653945|NCT00784277|364396960|FG001|ER Treatment|Lost to Follow-up|0|||
105653946|NCT00784277|364396961|FG002|ER Treatment|Lost to Follow-up|0|||
105653947|NCT00784277|364396962|FG003|ER Treatment|Lost to Follow-up|0|||
105653948|NCT00784277|364396963|FG004|ER Treatment|Lost to Follow-up|0|||
105653949|NCT00784277|364396964|FG005|ER Treatment|Lost to Follow-up|2|||
105653950|NCT00784277|364396965|FG006|ER Treatment|Lost to Follow-up|0|||
105653951|NCT00784277|364396959|FG000|ER Treatment|Withdrawal by Subject|0|||
105653952|NCT00784277|364396960|FG001|ER Treatment|Withdrawal by Subject|0|||
105653953|NCT00784277|364396961|FG002|ER Treatment|Withdrawal by Subject|0|||
105653954|NCT00784277|364396962|FG003|ER Treatment|Withdrawal by Subject|0|||
105653955|NCT00784277|364396963|FG004|ER Treatment|Withdrawal by Subject|2|||
105653956|NCT00784277|364396964|FG005|ER Treatment|Withdrawal by Subject|5|||
105653957|NCT00784277|364396965|FG006|ER Treatment|Withdrawal by Subject|3|||
105653958|NCT00784277|364396959|FG000|ER Treatment|Study Medication Non-Compliant|0|||
105653959|NCT00784277|364396960|FG001|ER Treatment|Study Medication Non-Compliant|0|||
105653960|NCT00784277|364396961|FG002|ER Treatment|Study Medication Non-Compliant|0|||
105653961|NCT00784277|364396962|FG003|ER Treatment|Study Medication Non-Compliant|0|||
105653962|NCT00784277|364396963|FG004|ER Treatment|Study Medication Non-Compliant|2|||
105653963|NCT00784277|364396964|FG005|ER Treatment|Study Medication Non-Compliant|3|||
105653964|NCT00784277|364396965|FG006|ER Treatment|Study Medication Non-Compliant|3|||
105653965|NCT00784277|364396959|FG000|ER Treatment|Other|0|||
105653966|NCT00784277|364396960|FG001|ER Treatment|Other|0|||
105653967|NCT00784277|364396961|FG002|ER Treatment|Other|0|||
105653968|NCT00784277|364396962|FG003|ER Treatment|Other|0|||
105653969|NCT00784277|364396963|FG004|ER Treatment|Other|1|||
105653970|NCT00784277|364396964|FG005|ER Treatment|Other|3|||
105653971|NCT00784277|364396965|FG006|ER Treatment|Other|2|||
105653972|NCT02212301|364396966|FG000|Period 1|Lost to Follow-up|0|||
105653973|NCT02212301|364396967|FG001|Period 1|Lost to Follow-up|1|||
105653974|NCT00578318|364396973|FG000|Overall Study|Lost to Follow-up|2|||
105653975|NCT00578318|364396974|FG001|Overall Study|Lost to Follow-up|0|||
105653976|NCT00578318|364396973|FG000|Overall Study|Physician Decision|1|||
105653977|NCT00578318|364396974|FG001|Overall Study|Physician Decision|0|||
105653978|NCT02025985|364396975|FG000|Overall Study|Consent withdrawn|0|||
105653979|NCT02025985|364396976|FG001|Overall Study|Consent withdrawn|0|||
105653980|NCT02025985|364396977|FG002|Overall Study|Consent withdrawn|1|||
105653981|NCT02025985|364396978|FG003|Overall Study|Consent withdrawn|0|||
105653982|NCT02025985|364396979|FG004|Overall Study|Consent withdrawn|0|||
105653983|NCT02025985|364396975|FG000|Overall Study|Termination of study by Sponsor|4|||
105653984|NCT02025985|364396976|FG001|Overall Study|Termination of study by Sponsor|3|||
105653985|NCT02025985|364396977|FG002|Overall Study|Termination of study by Sponsor|1|||
105653986|NCT02025985|364396978|FG003|Overall Study|Termination of study by Sponsor|1|||
105653987|NCT02025985|364396979|FG004|Overall Study|Termination of study by Sponsor|3|||
105653988|NCT02025985|364396975|FG000|Overall Study|Death|21|||
105653989|NCT02025985|364396976|FG001|Overall Study|Death|20|||
105653990|NCT02025985|364396977|FG002|Overall Study|Death|23|||
105653991|NCT02025985|364396978|FG003|Overall Study|Death|20|||
105653992|NCT02025985|364396979|FG004|Overall Study|Death|17|||
105653993|NCT03041701|364396980|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
105653994|NCT03041701|364396981|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
105653995|NCT03041701|364396982|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
105653996|NCT03041701|364396980|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
105653997|NCT03041701|364396981|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
105653998|NCT03041701|364396982|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
105653999|NCT01978236|364396988|FG000|Overall Study|Discontinued due to study close|2|||
105654000|NCT02506881|364396989|FG000|First Intervention (Day 1)|Protocol Violation|0|||
105654001|NCT02506881|364396990|FG001|First Intervention (Day 1)|Protocol Violation|0|||
105654002|NCT02506881|364396991|FG002|First Intervention (Day 1)|Protocol Violation|1|||
105654003|NCT02506881|364396992|FG003|First Intervention (Day 1)|Protocol Violation|0|||
105654004|NCT02506881|364396989|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
105654005|NCT02506881|364396990|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
105654006|NCT02506881|364396991|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
105654007|NCT02506881|364396992|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
105654008|NCT02506881|364396989|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
105654009|NCT02506881|364396990|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
105654010|NCT02506881|364396991|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
105654011|NCT02506881|364396992|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
105654012|NCT02175745|364397003|FG000|Overall Study|Not Eligible|1|||
105654013|NCT03120949|364397004|FG000|Overall Study|randomized in error|1|||
105654014|NCT03120949|364397005|FG001|Overall Study|randomized in error|0|||
105654015|NCT03120949|364397004|FG000|Overall Study|Death|13|||
105654016|NCT03120949|364397005|FG001|Overall Study|Death|13|||
105654017|NCT03120949|364397004|FG000|Overall Study|Lost to Follow-up|23|||
105654018|NCT03120949|364397005|FG001|Overall Study|Lost to Follow-up|13|||
105654019|NCT03120949|364397004|FG000|Overall Study|Withdrawal by Subject|139|||
105654020|NCT03120949|364397005|FG001|Overall Study|Withdrawal by Subject|124|||
105654021|NCT03120949|364397004|FG000|Overall Study|Covid-19|43|||
105654022|NCT03120949|364397005|FG001|Overall Study|Covid-19|34|||
105654023|NCT03120949|364397004|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
105654024|NCT03120949|364397005|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
105654025|NCT03120949|364397004|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
105654026|NCT03120949|364397005|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
105654027|NCT03120949|364397004|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
105654028|NCT03120949|364397005|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
105654029|NCT03120949|364397004|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
105654030|NCT03120949|364397005|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
105654031|NCT03120949|364397004|FG000|Overall Study|Site was closed|2|||
105654032|NCT03120949|364397005|FG001|Overall Study|Site was closed|3|||
105654033|NCT03120949|364397004|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
105654034|NCT03120949|364397005|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
105654035|NCT03120949|364397004|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
105654036|NCT03120949|364397005|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
105659502|NCT02635386|364417347|FG000|Overall Study|Noncompliant|0|||
105654037|NCT03120949|364397004|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
105654038|NCT03120949|364397005|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
105654039|NCT03120949|364397004|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
105654040|NCT03120949|364397005|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
105654041|NCT03120949|364397004|FG000|Overall Study|Other: Adverse Event|0|||
105654042|NCT03120949|364397005|FG001|Overall Study|Other: Adverse Event|1|||
105654043|NCT03120949|364397004|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
105654044|NCT03120949|364397005|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
105654045|NCT03120949|364397004|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
105654046|NCT03120949|364397005|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
105654047|NCT03120949|364397004|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
105654048|NCT03120949|364397005|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
105654049|NCT03120949|364397004|FG000|Overall Study|Personal Reasons|0|||
105654050|NCT03120949|364397005|FG001|Overall Study|Personal Reasons|1|||
105654051|NCT03120949|364397004|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
105654052|NCT03120949|364397005|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
105654053|NCT03120949|364397004|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
105654054|NCT03120949|364397005|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
105654055|NCT03120949|364397004|FG000|Overall Study|Compliance With Medication|0|||
105654056|NCT03120949|364397005|FG001|Overall Study|Compliance With Medication|1|||
105654057|NCT03120949|364397004|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
105654058|NCT03120949|364397005|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
105654059|NCT03120949|364397004|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
105654060|NCT03120949|364397005|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
105654061|NCT03120949|364397004|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
105654062|NCT03120949|364397005|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
105654063|NCT00312845|364397007|FG000|Overall Study|Adverse Event|19|||
105654064|NCT00312845|364397008|FG001|Overall Study|Adverse Event|5|||
105654065|NCT00312845|364397007|FG000|Overall Study|Death|2|||
105654066|NCT00312845|364397008|FG001|Overall Study|Death|2|||
105654067|NCT00312845|364397007|FG000|Overall Study|Withdrawal by Subject|14|||
105654068|NCT00312845|364397008|FG001|Overall Study|Withdrawal by Subject|6|||
105654069|NCT00312845|364397007|FG000|Overall Study|Disease Progression|56|||
105654070|NCT00312845|364397008|FG001|Overall Study|Disease Progression|77|||
105654071|NCT00312845|364397007|FG000|Overall Study|Lost to Follow-up|2|||
105654072|NCT00312845|364397008|FG001|Overall Study|Lost to Follow-up|0|||
105654073|NCT00312845|364397007|FG000|Overall Study|Other|6|||
105654074|NCT00312845|364397008|FG001|Overall Study|Other|5|||
105654075|NCT04088500|364397011|FG000|Overall Study|Reason unknown|1|||
105654076|NCT04088500|364397011|FG000|Overall Study|Participant withdrew consent|1|||
105654077|NCT04088500|364397011|FG000|Overall Study|Disease progression|3|||
105654078|NCT04206384|364397012|FG000|Overall Study|Withdrawal by Subject|8|||
105654079|NCT04206384|364397012|FG000|Overall Study|Adverse Event|2|||
105654080|NCT01208870|364397013|FG000|Overall Study|Lost to Follow-up|2|||
105654081|NCT01208870|364397014|FG001|Overall Study|Lost to Follow-up|8|||
105654082|NCT03015181|364397015|FG000|Overall Study|Enrolled, but product never administered|1|||
105654083|NCT03015181|364397016|FG001|Overall Study|Enrolled, but product never administered|0|||
105654084|NCT03015181|364397017|FG002|Overall Study|Enrolled, but product never administered|0|||
105654085|NCT03015181|364397018|FG003|Overall Study|Enrolled, but product never administered|0|||
105654086|NCT03015181|364397019|FG004|Overall Study|Enrolled, but product never administered|0|||
105654087|NCT03015181|364397020|FG005|Overall Study|Enrolled, but product never administered|0|||
105654088|NCT03015181|364397021|FG006|Overall Study|Enrolled, but product never administered|0|||
105654089|NCT03015181|364397015|FG000|Overall Study|Withdrawal by Subject|0|||
105654090|NCT03015181|364397016|FG001|Overall Study|Withdrawal by Subject|0|||
105654091|NCT03015181|364397017|FG002|Overall Study|Withdrawal by Subject|0|||
105654092|NCT03015181|364397018|FG003|Overall Study|Withdrawal by Subject|0|||
105654093|NCT03015181|364397019|FG004|Overall Study|Withdrawal by Subject|0|||
105654094|NCT03015181|364397020|FG005|Overall Study|Withdrawal by Subject|1|||
105654095|NCT03015181|364397021|FG006|Overall Study|Withdrawal by Subject|0|||
105654096|NCT03015181|364397015|FG000|Overall Study|Physician Decision|0|||
105654097|NCT03015181|364397016|FG001|Overall Study|Physician Decision|0|||
105654098|NCT03015181|364397017|FG002|Overall Study|Physician Decision|0|||
105654099|NCT03015181|364397018|FG003|Overall Study|Physician Decision|0|||
105654100|NCT03015181|364397019|FG004|Overall Study|Physician Decision|0|||
105654101|NCT03015181|364397020|FG005|Overall Study|Physician Decision|0|||
105654102|NCT03015181|364397021|FG006|Overall Study|Physician Decision|1|||
105654103|NCT01091519|364397025|FG000|Overall Study|Adverse Event|12|||
105654104|NCT01091519|364397026|FG001|Overall Study|Adverse Event|16|||
105654105|NCT01091519|364397025|FG000|Overall Study|Death|1|||
105654106|NCT01091519|364397026|FG001|Overall Study|Death|0|||
105654107|NCT01091519|364397025|FG000|Overall Study|Lack of Efficacy|16|||
105654108|NCT01091519|364397026|FG001|Overall Study|Lack of Efficacy|19|||
105654109|NCT01091519|364397025|FG000|Overall Study|Lost to Follow-up|14|||
105654110|NCT01091519|364397026|FG001|Overall Study|Lost to Follow-up|24|||
105654111|NCT01091519|364397025|FG000|Overall Study|Withdrawal by Subject|2|||
105654112|NCT01091519|364397026|FG001|Overall Study|Withdrawal by Subject|2|||
105654113|NCT01091519|364397025|FG000|Overall Study|Other|6|||
105654114|NCT01091519|364397026|FG001|Overall Study|Other|8|||
105654115|NCT01091519|364397025|FG000|Overall Study|Randomized not treated|4|||
105654116|NCT01091519|364397026|FG001|Overall Study|Randomized not treated|4|||
105654117|NCT04159805|364397027|FG000|Overall Study|Withdrawal by Subject|0|||
105654118|NCT04159805|364397028|FG001|Overall Study|Withdrawal by Subject|2|||
105654119|NCT04159805|364397029|FG002|Overall Study|Withdrawal by Subject|2|||
105654120|NCT04167085|364397030|FG000|Baseline|Withdrawal by Subject|2|||
105654121|NCT04167085|364397031|FG001|Baseline|Withdrawal by Subject|1|||
105654122|NCT04167085|364397030|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
105654123|NCT04167085|364397031|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
105654124|NCT00006436|364397037|FG000|Overall Study|Refused further treatment|2|||
105654125|NCT00006436|364397037|FG000|Overall Study|Declined to participate (before treatment started)|1|||
105654126|NCT00316589|364397038|FG000|Overall Study|Withdrawal by Subject|0|||
105654127|NCT00316589|364397039|FG001|Overall Study|Withdrawal by Subject|5|||
105654128|NCT00316589|364397040|FG002|Overall Study|Withdrawal by Subject|0|||
105654129|NCT00316589|364397041|FG003|Overall Study|Withdrawal by Subject|1|||
105654130|NCT00316589|364397038|FG000|Overall Study|Subject unwilling/unable to comply|0|||
105654131|NCT00316589|364397039|FG001|Overall Study|Subject unwilling/unable to comply|6|||
105654132|NCT00316589|364397040|FG002|Overall Study|Subject unwilling/unable to comply|0|||
105654133|NCT00316589|364397041|FG003|Overall Study|Subject unwilling/unable to comply|2|||
105654134|NCT00316589|364397038|FG000|Overall Study|Adverse Event|1|||
105654135|NCT00316589|364397039|FG001|Overall Study|Adverse Event|0|||
105654136|NCT00316589|364397040|FG002|Overall Study|Adverse Event|0|||
105654137|NCT00316589|364397041|FG003|Overall Study|Adverse Event|1|||
105654138|NCT00316589|364397038|FG000|Overall Study|Physician Decision|0|||
105654139|NCT00316589|364397039|FG001|Overall Study|Physician Decision|1|||
105654140|NCT00316589|364397040|FG002|Overall Study|Physician Decision|0|||
105654141|NCT00316589|364397041|FG003|Overall Study|Physician Decision|0|||
105654142|NCT00316589|364397038|FG000|Overall Study|Other reason|0|||
105654143|NCT00316589|364397039|FG001|Overall Study|Other reason|12|||
105654144|NCT00316589|364397040|FG002|Overall Study|Other reason|1|||
105654145|NCT00316589|364397041|FG003|Overall Study|Other reason|1|||
105654146|NCT01482819|364397042|FG000|Overall Study|Lost to Follow-up|2|||
105654147|NCT03325608|364397048|FG000|Overall Study|Lost to Follow-up|23|||
105654148|NCT03325608|364397049|FG001|Overall Study|Lost to Follow-up|23|||
105654149|NCT03325608|364397050|FG002|Overall Study|Lost to Follow-up|30|||
105654150|NCT03325608|364397051|FG003|Overall Study|Lost to Follow-up|30|||
105654151|NCT03325608|364397048|FG000|Overall Study|Death of Caregiver|0|||
105654152|NCT03325608|364397049|FG001|Overall Study|Death of Caregiver|0|||
105654153|NCT03325608|364397050|FG002|Overall Study|Death of Caregiver|2|||
105654154|NCT03325608|364397051|FG003|Overall Study|Death of Caregiver|2|||
105654155|NCT03325608|364397048|FG000|Overall Study|Death of Care Recipient|34|||
105654156|NCT03325608|364397049|FG001|Overall Study|Death of Care Recipient|34|||
105654157|NCT03325608|364397050|FG002|Overall Study|Death of Care Recipient|28|||
105654158|NCT03325608|364397051|FG003|Overall Study|Death of Care Recipient|28|||
105654159|NCT03325608|364397048|FG000|Overall Study|Withdrawal by Subject|49|||
105654160|NCT03325608|364397049|FG001|Overall Study|Withdrawal by Subject|49|||
105654161|NCT03325608|364397050|FG002|Overall Study|Withdrawal by Subject|35|||
105654162|NCT03325608|364397051|FG003|Overall Study|Withdrawal by Subject|35|||
105654163|NCT03325608|364397048|FG000|Overall Study|Ineligible|7|||
105654164|NCT03325608|364397049|FG001|Overall Study|Ineligible|7|||
105654165|NCT03325608|364397050|FG002|Overall Study|Ineligible|5|||
105654166|NCT03325608|364397051|FG003|Overall Study|Ineligible|5|||
105654167|NCT02188784|364397052|FG000|Overall Study|Death|3|||
105654168|NCT02188784|364397053|FG001|Overall Study|Death|1|||
105654169|NCT02188784|364397052|FG000|Overall Study|Lost to Follow-up|1|||
105654170|NCT02188784|364397053|FG001|Overall Study|Lost to Follow-up|0|||
105654171|NCT02188784|364397052|FG000|Overall Study|Withdrawal by Subject|3|||
105654172|NCT02188784|364397053|FG001|Overall Study|Withdrawal by Subject|9|||
105654173|NCT02188784|364397052|FG000|Overall Study|Physician Decision|2|||
105654174|NCT02188784|364397053|FG001|Overall Study|Physician Decision|3|||
105654175|NCT00276016|364397054|FG000|Intervention 1|Withdrawal by Subject|0|||
105654176|NCT00276016|364397055|FG001|Intervention 1|Withdrawal by Subject|1|||
105654177|NCT00276016|364397056|FG002|Intervention 1|Withdrawal by Subject|0|||
105654178|NCT00276016|364397057|FG003|Intervention 1|Withdrawal by Subject|0|||
105654179|NCT00276016|364397058|FG004|Intervention 1|Withdrawal by Subject|0|||
105654180|NCT00276016|364397059|FG005|Intervention 1|Withdrawal by Subject|0|||
105654181|NCT03151551|364397060|FG000|Open-Label Treatment Period|Adverse Event|0|||
105654182|NCT03151551|364397061|FG001|Open-Label Treatment Period|Adverse Event|2|||
105654183|NCT03151551|364397060|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
105654184|NCT03151551|364397061|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
105654185|NCT03151551|364397060|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
105654186|NCT03151551|364397061|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
105654187|NCT03151551|364397060|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
105654188|NCT03151551|364397061|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
105654189|NCT03151551|364397060|FG000|Open-Label Treatment Period|Physician Decision|3|||
105654190|NCT03151551|364397061|FG001|Open-Label Treatment Period|Physician Decision|0|||
105654191|NCT03151551|364397060|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
105654192|NCT03151551|364397061|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
105654193|NCT03151551|364397060|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
105654194|NCT03151551|364397061|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
105654195|NCT03151551|364397060|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
105654196|NCT03151551|364397061|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
105654197|NCT03151551|364397060|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
105654198|NCT03151551|364397061|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
105654199|NCT03151551|364397060|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
105654200|NCT03151551|364397061|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
105654201|NCT01374971|364397064|FG000|Overall Study|Withdrawal by Subject|1|||
105654202|NCT00514813|364397067|FG000|Overall Study|Study terminated|14|||
105654203|NCT00514813|364397068|FG001|Overall Study|Study terminated|74|||
105654204|NCT00514813|364397069|FG002|Overall Study|Study terminated|40|||
105654205|NCT00514813|364397070|FG003|Overall Study|Study terminated|2|||
105654206|NCT00514813|364397067|FG000|Overall Study|Adverse Event|0|||
105654207|NCT00514813|364397068|FG001|Overall Study|Adverse Event|2|||
105654208|NCT00514813|364397069|FG002|Overall Study|Adverse Event|2|||
105654209|NCT00514813|364397070|FG003|Overall Study|Adverse Event|0|||
105654210|NCT00514813|364397067|FG000|Overall Study|Protocol Violation|1|||
105654211|NCT00514813|364397068|FG001|Overall Study|Protocol Violation|0|||
105654212|NCT00514813|364397069|FG002|Overall Study|Protocol Violation|0|||
105654213|NCT00514813|364397070|FG003|Overall Study|Protocol Violation|0|||
105654214|NCT00514813|364397067|FG000|Overall Study|Withdrawal by Subject|0|||
105654215|NCT00514813|364397068|FG001|Overall Study|Withdrawal by Subject|1|||
105654216|NCT00514813|364397069|FG002|Overall Study|Withdrawal by Subject|0|||
105654217|NCT00514813|364397070|FG003|Overall Study|Withdrawal by Subject|0|||
105654218|NCT00514813|364397067|FG000|Overall Study|Lack of Efficacy|0|||
105654219|NCT00514813|364397068|FG001|Overall Study|Lack of Efficacy|1|||
105654220|NCT00514813|364397069|FG002|Overall Study|Lack of Efficacy|0|||
105654221|NCT00514813|364397070|FG003|Overall Study|Lack of Efficacy|0|||
105654222|NCT00514813|364397067|FG000|Overall Study|Kidney transplant|0|||
105654223|NCT00514813|364397068|FG001|Overall Study|Kidney transplant|6|||
105654224|NCT00514813|364397069|FG002|Overall Study|Kidney transplant|2|||
105654225|NCT00514813|364397070|FG003|Overall Study|Kidney transplant|0|||
105654226|NCT00514813|364397067|FG000|Overall Study|Death|0|||
105654227|NCT00514813|364397068|FG001|Overall Study|Death|2|||
105654228|NCT00514813|364397069|FG002|Overall Study|Death|3|||
105654229|NCT00514813|364397070|FG003|Overall Study|Death|2|||
105654230|NCT02979613|364397071|FG000|Double-Blind Phase|Withdrew Consent|2|||
105654231|NCT02979613|364397072|FG001|Double-Blind Phase|Withdrew Consent|4|||
105654232|NCT02979613|364397071|FG000|Double-Blind Phase|Pregnancy|2|||
105654233|NCT02979613|364397072|FG001|Double-Blind Phase|Pregnancy|2|||
105654234|NCT02979613|364397071|FG000|Double-Blind Phase|Adverse Event|2|||
105654235|NCT02979613|364397072|FG001|Double-Blind Phase|Adverse Event|0|||
105654236|NCT02979613|364397071|FG000|Double-Blind Phase|Lost to Follow-up|1|||
105654237|NCT02979613|364397072|FG001|Double-Blind Phase|Lost to Follow-up|1|||
105654238|NCT02979613|364397071|FG000|Double-Blind Phase|Protocol Violation|1|||
105654239|NCT02979613|364397072|FG001|Double-Blind Phase|Protocol Violation|1|||
105654240|NCT02979613|364397071|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
105654241|NCT02979613|364397072|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
105654242|NCT02979613|364397071|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
105654243|NCT02979613|364397072|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
105654244|NCT02979613|364397071|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
105654245|NCT02979613|364397072|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
105654246|NCT02979613|364397071|FG000|Open-Label Extension (OLE) Phase|Death|0|||
105654247|NCT02979613|364397072|FG001|Open-Label Extension (OLE) Phase|Death|1|||
105654248|NCT02979613|364397071|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
105654249|NCT02979613|364397072|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
105654250|NCT01075100|364397077|FG000|Overall Study|Adverse Event|15|||
105654251|NCT01075100|364397078|FG001|Overall Study|Adverse Event|18|||
105654252|NCT01075100|364397077|FG000|Overall Study|Patient Request|4|||
105654253|NCT01075100|364397078|FG001|Overall Study|Patient Request|4|||
105654254|NCT01075100|364397077|FG000|Overall Study|Investigator Request|2|||
105654255|NCT01075100|364397078|FG001|Overall Study|Investigator Request|1|||
105654256|NCT01075100|364397077|FG000|Overall Study|Disease Progression|25|||
105654257|NCT01075100|364397078|FG001|Overall Study|Disease Progression|29|||
105654258|NCT01075100|364397077|FG000|Overall Study|Other|3|||
105654259|NCT01075100|364397078|FG001|Overall Study|Other|1|||
105654260|NCT03282799|364397079|FG000|Overall Study|Pregnancy|1|||
105654261|NCT03282799|364397080|FG001|Overall Study|Pregnancy|0|||
105654262|NCT03282799|364397079|FG000|Overall Study|Physician Decision|1|||
105654263|NCT03282799|364397080|FG001|Overall Study|Physician Decision|0|||
105654264|NCT00509821|364398338|FG000|Study Period 1 (Induction)|Death|0|||
105654265|NCT00509821|364398339|FG001|Study Period 1 (Induction)|Death|1|||
105654266|NCT00509821|364398338|FG000|Study Period 1 (Induction)|Adverse Event|0|||
105654267|NCT00509821|364398339|FG001|Study Period 1 (Induction)|Adverse Event|2|||
105654268|NCT00509821|364398338|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
105654269|NCT00509821|364398339|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
105654270|NCT00740597|364398340|FG000|Overall Study|insurance would not cover treatment|1|||
105654271|NCT00552513|364398344|FG000|Overall Study|Lost to Follow-up|5|||
105654272|NCT00552513|364398345|FG001|Overall Study|Lost to Follow-up|1|||
105654273|NCT01816685|364398346|FG000|Overall Study|Lost to Follow-up|7|||
105654274|NCT01816685|364398347|FG001|Overall Study|Lost to Follow-up|9|||
105654275|NCT01816685|364398346|FG000|Overall Study|Surgery Cancelled|3|||
105654276|NCT01816685|364398347|FG001|Overall Study|Surgery Cancelled|2|||
105654277|NCT02720185|364398348|FG000|Overall Study|Lost to Follow-up|1|||
105654278|NCT01157351|364398349|FG000|Overall Study|Adverse Event|5|||
105654279|NCT01157351|364398350|FG001|Overall Study|Adverse Event|4|||
105654280|NCT01157351|364398349|FG000|Overall Study|Death|1|||
105654281|NCT01157351|364398350|FG001|Overall Study|Death|0|||
105654282|NCT01157351|364398349|FG000|Overall Study|Lost to Follow-up|53|||
105654283|NCT01157351|364398350|FG001|Overall Study|Lost to Follow-up|55|||
105654284|NCT01157351|364398349|FG000|Overall Study|Withdrawal by Subject|37|||
105654285|NCT01157351|364398350|FG001|Overall Study|Withdrawal by Subject|27|||
105654286|NCT01157351|364398349|FG000|Overall Study|Physician Decision|5|||
105654287|NCT01157351|364398350|FG001|Overall Study|Physician Decision|4|||
105654288|NCT01157351|364398349|FG000|Overall Study|Protocol Violation|0|||
105654289|NCT01157351|364398350|FG001|Overall Study|Protocol Violation|1|||
105654290|NCT01157351|364398349|FG000|Overall Study|Other|32|||
105654291|NCT01157351|364398350|FG001|Overall Study|Other|36|||
105654292|NCT01157351|364398349|FG000|Overall Study|Noncompliance with Study Drug|0|||
105654293|NCT01157351|364398350|FG001|Overall Study|Noncompliance with Study Drug|3|||
105654294|NCT01157351|364398349|FG000|Overall Study|Randomized but not Treated|4|||
105654295|NCT01157351|364398350|FG001|Overall Study|Randomized but not Treated|2|||
105654296|NCT00560313|364398351|FG000|Overall Study|Adverse Events or Death|2|||
105654297|NCT00560313|364398351|FG000|Overall Study|Withdrawal by Subject|2|||
105654298|NCT00560313|364398351|FG000|Overall Study|Lost to Follow-up|1|||
105654299|NCT00560313|364398351|FG000|Overall Study|Protocol Violation|1|||
105654300|NCT01231464|364398352|FG000|Overall Study|Adverse Event|0|||
105654301|NCT01231464|364398353|FG001|Overall Study|Adverse Event|1|||
105654302|NCT01231464|364398352|FG000|Overall Study|Protocol Violation|1|||
105654303|NCT01231464|364398353|FG001|Overall Study|Protocol Violation|2|||
105654304|NCT01231464|364398352|FG000|Overall Study|Lost to Follow-up|1|||
105654305|NCT01231464|364398353|FG001|Overall Study|Lost to Follow-up|2|||
105654306|NCT01231464|364398352|FG000|Overall Study|Withdrawal by Subject|3|||
105654307|NCT01231464|364398353|FG001|Overall Study|Withdrawal by Subject|2|||
105654308|NCT03449134|364398354|FG000|52-Week Treatment Period|Death|2|||
105654309|NCT03449134|364398355|FG001|52-Week Treatment Period|Death|1|||
105654310|NCT03449134|364398356|FG002|52-Week Treatment Period|Death|0|||
105654311|NCT03449134|364398354|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
105654312|NCT03449134|364398355|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
105654313|NCT03449134|364398356|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
105654314|NCT03449134|364398354|FG000|52-Week Treatment Period|Physician Decision|2|||
105654315|NCT03449134|364398355|FG001|52-Week Treatment Period|Physician Decision|3|||
105654316|NCT03449134|364398356|FG002|52-Week Treatment Period|Physician Decision|3|||
105654317|NCT03449134|364398354|FG000|52-Week Treatment Period|Screen Failure|1|||
105654318|NCT03449134|364398355|FG001|52-Week Treatment Period|Screen Failure|0|||
105654319|NCT03449134|364398356|FG002|52-Week Treatment Period|Screen Failure|1|||
105654320|NCT03449134|364398354|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
105654321|NCT03449134|364398355|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
105654322|NCT03449134|364398356|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
105654323|NCT03449134|364398354|FG000|52-Week Treatment Period|Site Closure|1|||
105654324|NCT03449134|364398355|FG001|52-Week Treatment Period|Site Closure|0|||
105654325|NCT03449134|364398356|FG002|52-Week Treatment Period|Site Closure|0|||
105654326|NCT01589523|364398363|FG000|Overall Study|Withdrawal by Subject|1|||
105654327|NCT02507687|364398369|FG000|Overall Study|Adverse Event|3|||
105654328|NCT02507687|364398370|FG001|Overall Study|Adverse Event|2|||
105654329|NCT02507687|364398371|FG002|Overall Study|Adverse Event|2|||
105654330|NCT02507687|364398372|FG003|Overall Study|Adverse Event|2|||
105654331|NCT02507687|364398369|FG000|Overall Study|Withdrawal by Subject|1|||
105654332|NCT02507687|364398370|FG001|Overall Study|Withdrawal by Subject|4|||
105654333|NCT02507687|364398371|FG002|Overall Study|Withdrawal by Subject|6|||
105654334|NCT02507687|364398372|FG003|Overall Study|Withdrawal by Subject|6|||
105654335|NCT02507687|364398369|FG000|Overall Study|Protocol Violation|1|||
105654336|NCT02507687|364398370|FG001|Overall Study|Protocol Violation|0|||
105654337|NCT02507687|364398371|FG002|Overall Study|Protocol Violation|2|||
105654338|NCT02507687|364398372|FG003|Overall Study|Protocol Violation|0|||
105654339|NCT02507687|364398369|FG000|Overall Study|Lost to Follow-up|0|||
105654340|NCT02507687|364398370|FG001|Overall Study|Lost to Follow-up|0|||
105654341|NCT02507687|364398371|FG002|Overall Study|Lost to Follow-up|2|||
105654342|NCT02507687|364398372|FG003|Overall Study|Lost to Follow-up|1|||
105654343|NCT02507687|364398369|FG000|Overall Study|Screen Failure|0|||
105654344|NCT02507687|364398370|FG001|Overall Study|Screen Failure|0|||
105654345|NCT02507687|364398371|FG002|Overall Study|Screen Failure|1|||
105654346|NCT02507687|364398372|FG003|Overall Study|Screen Failure|0|||
105654347|NCT02507687|364398369|FG000|Overall Study|Other, Not Specified|0|||
105654348|NCT02507687|364398370|FG001|Overall Study|Other, Not Specified|0|||
105654349|NCT02507687|364398371|FG002|Overall Study|Other, Not Specified|2|||
105654350|NCT02507687|364398372|FG003|Overall Study|Other, Not Specified|4|||
105654351|NCT01580995|364398373|FG000|Overall Study|Lost to Follow-up|2|||
105654352|NCT01580995|364398374|FG001|Overall Study|Lost to Follow-up|2|||
105654353|NCT00598871|364398375|FG000|Overall Study|Adverse Event|0|||
105654354|NCT00598871|364398376|FG001|Overall Study|Adverse Event|1|||
105654355|NCT04140266|364398377|FG000|Overall Study|Physician Decision|2|||
105654356|NCT04140266|364398378|FG001|Overall Study|Physician Decision|0|||
105654357|NCT04140266|364398377|FG000|Overall Study|Withdrawal by Subject|4|||
105654358|NCT04140266|364398378|FG001|Overall Study|Withdrawal by Subject|2|||
105654359|NCT00730847|364398379|FG000|Overall Study|Adverse Event|1|||
105654360|NCT00730847|364398379|FG000|Overall Study|Protocol Violation|2|||
105654361|NCT00730847|364398379|FG000|Overall Study|Withdrawal by Subject|16|||
105654362|NCT00730847|364398379|FG000|Overall Study|Lost to Follow-up|67|||
105654363|NCT00730847|364398379|FG000|Overall Study|Unknown completion status|21|||
105654364|NCT00730847|364398379|FG000|Overall Study|Other|24|||
105654365|NCT04544865|364398386|FG000|Overall Study|Death|0|||
105654366|NCT04544865|364398387|FG001|Overall Study|Death|2|||
105654367|NCT04544865|364398386|FG000|Overall Study|Lost to Follow-up|11|||
105654368|NCT04544865|364398387|FG001|Overall Study|Lost to Follow-up|7|||
105654369|NCT04544865|364398386|FG000|Overall Study|Withdrawal by Subject|0|||
105654370|NCT04544865|364398387|FG001|Overall Study|Withdrawal by Subject|1|||
105654371|NCT04544865|364398386|FG000|Overall Study|Other|0|||
105654372|NCT04544865|364398387|FG001|Overall Study|Other|1|||
105654373|NCT00702650|364398388|FG000|Overall Study|Withdrawal by Subject|9|||
105654374|NCT00702650|364398388|FG000|Overall Study|Non-Compliance of Study Drug|3|||
105654375|NCT00702650|364398388|FG000|Overall Study|Lost to Follow-up|2|||
105654376|NCT00702650|364398388|FG000|Overall Study|Non-Compliance with Site Directives|1|||
105654377|NCT00702650|364398388|FG000|Overall Study|Sponsor Request|1|||
105654378|NCT00702650|364398388|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
105654379|NCT00702650|364398388|FG000|Overall Study|Adverse Event|3|||
105654380|NCT01649297|364398389|FG000|Overall Study|Adverse Event|5|||
105654381|NCT01649297|364398390|FG001|Overall Study|Adverse Event|5|||
105654382|NCT01649297|364398391|FG002|Overall Study|Adverse Event|4|||
105654383|NCT01649297|364398392|FG003|Overall Study|Adverse Event|13|||
105654384|NCT01649297|364398393|FG004|Overall Study|Adverse Event|1|||
105654385|NCT01649297|364398389|FG000|Overall Study|Lack of Efficacy|0|||
105654386|NCT01649297|364398390|FG001|Overall Study|Lack of Efficacy|0|||
105654387|NCT01649297|364398391|FG002|Overall Study|Lack of Efficacy|0|||
105654388|NCT01649297|364398392|FG003|Overall Study|Lack of Efficacy|0|||
105654389|NCT01649297|364398393|FG004|Overall Study|Lack of Efficacy|1|||
105654390|NCT01649297|364398389|FG000|Overall Study|Non compliant with Protocol|1|||
105654391|NCT01649297|364398390|FG001|Overall Study|Non compliant with Protocol|0|||
105654392|NCT01649297|364398391|FG002|Overall Study|Non compliant with Protocol|3|||
105654393|NCT01649297|364398392|FG003|Overall Study|Non compliant with Protocol|2|||
105654394|NCT01649297|364398393|FG004|Overall Study|Non compliant with Protocol|1|||
105654395|NCT01649297|364398389|FG000|Overall Study|Lost to Follow-up|1|||
105654396|NCT01649297|364398390|FG001|Overall Study|Lost to Follow-up|1|||
105654397|NCT01649297|364398391|FG002|Overall Study|Lost to Follow-up|4|||
105654398|NCT01649297|364398392|FG003|Overall Study|Lost to Follow-up|3|||
105654399|NCT01649297|364398393|FG004|Overall Study|Lost to Follow-up|0|||
105654400|NCT01649297|364398389|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
105654401|NCT01649297|364398390|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
105654402|NCT01649297|364398391|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
105654403|NCT01649297|364398392|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
105654404|NCT01649297|364398393|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
105654405|NCT01649297|364398389|FG000|Overall Study|For other reason|4|||
105654406|NCT01649297|364398390|FG001|Overall Study|For other reason|1|||
105654407|NCT01649297|364398391|FG002|Overall Study|For other reason|2|||
105654408|NCT01649297|364398392|FG003|Overall Study|For other reason|0|||
105654409|NCT01649297|364398393|FG004|Overall Study|For other reason|0|||
105654410|NCT00523549|364398395|FG000|Overall Study|Adverse Event|6|||
105654411|NCT00523549|364398396|FG001|Overall Study|Adverse Event|3|||
105654412|NCT00523549|364398395|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105654413|NCT00523549|364398396|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105654414|NCT00523549|364398395|FG000|Overall Study|Protocol Deviation|3|||
105654415|NCT00523549|364398396|FG001|Overall Study|Protocol Deviation|1|||
105654416|NCT00523549|364398395|FG000|Overall Study|Patient withdrew consent|7|||
105654417|NCT00523549|364398396|FG001|Overall Study|Patient withdrew consent|6|||
105654418|NCT00523549|364398395|FG000|Overall Study|Lost to Follow-up|3|||
105654419|NCT00523549|364398396|FG001|Overall Study|Lost to Follow-up|5|||
105654420|NCT00439647|364398397|FG000|Overall Study|Withdrawal by Subject|25|||
105654421|NCT00439647|364398398|FG001|Overall Study|Withdrawal by Subject|22|||
105654422|NCT00439647|364398397|FG000|Overall Study|Death|15|||
105654423|NCT00439647|364398398|FG001|Overall Study|Death|18|||
105654424|NCT00439647|364398397|FG000|Overall Study|Adverse Event|11|||
105654425|NCT00439647|364398398|FG001|Overall Study|Adverse Event|11|||
105654426|NCT00439647|364398397|FG000|Overall Study|Lost to Follow-up|4|||
105654427|NCT00439647|364398398|FG001|Overall Study|Lost to Follow-up|12|||
105654428|NCT00439647|364398397|FG000|Overall Study|Protocol Violation|3|||
105654429|NCT00439647|364398398|FG001|Overall Study|Protocol Violation|4|||
105654430|NCT00439647|364398397|FG000|Overall Study|Lack of Efficacy|0|||
105654431|NCT00439647|364398398|FG001|Overall Study|Lack of Efficacy|4|||
105654432|NCT00843115|364398399|FG000|Overall Study|Death|4|||
105654433|NCT00843115|364398399|FG000|Overall Study|Adverse Event|30|||
105654434|NCT00843115|364398399|FG000|Overall Study|Lost to Follow-up|4|||
105654435|NCT00843115|364398399|FG000|Overall Study|Withdrawal by Subject|17|||
105654436|NCT00843115|364398399|FG000|Overall Study|Family wanted meds stopped|1|||
105654437|NCT00843115|364398399|FG000|Overall Study|Family does not want continuation|1|||
105654438|NCT00843115|364398399|FG000|Overall Study|Patient forgot to take meds|1|||
105654439|NCT00843115|364398399|FG000|Overall Study|Does not meet entrance criteria|1|||
105654440|NCT00843115|364398399|FG000|Overall Study|Physician Decision|1|||
105654441|NCT00843115|364398399|FG000|Overall Study|Family discontinued meds|1|||
105654442|NCT00843115|364398399|FG000|Overall Study|patient took for 2 days then stopped|1|||
105654443|NCT00843115|364398399|FG000|Overall Study|patient never took the medication|1|||
105654444|NCT00843115|364398399|FG000|Overall Study|hospitalized due to deterioration|1|||
105654445|NCT00843115|364398399|FG000|Overall Study|week 12 not done|1|||
105654446|NCT00843115|364398399|FG000|Overall Study|Syndrome De Glissement|1|||
105654447|NCT01388478|364398400|FG000|Overall Study|Adverse Event|4|||
105654448|NCT01388478|364398400|FG000|Overall Study|Withdrawal by Subject|1|||
105654449|NCT00931918|364398401|FG000|Overall Study|Adverse Event|4|||
105654450|NCT00931918|364398402|FG001|Overall Study|Adverse Event|6|||
105654451|NCT00931918|364398401|FG000|Overall Study|Progressive Disease|2|||
105654452|NCT00931918|364398402|FG001|Overall Study|Progressive Disease|1|||
105654453|NCT00931918|364398401|FG000|Overall Study|Symptomatic Deterioration|1|||
105654454|NCT00931918|364398402|FG001|Overall Study|Symptomatic Deterioration|0|||
105654455|NCT00931918|364398401|FG000|Overall Study|Withdrawal by Patient|3|||
105654456|NCT00931918|364398402|FG001|Overall Study|Withdrawal by Patient|4|||
105654457|NCT00931918|364398401|FG000|Overall Study|Other Reason not Specified|4|||
105654458|NCT00931918|364398402|FG001|Overall Study|Other Reason not Specified|4|||
105654459|NCT00931918|364398401|FG000|Overall Study|Did not receive study drug|3|||
105654460|NCT00931918|364398402|FG001|Overall Study|Did not receive study drug|2|||
105654461|NCT00496626|364398403|FG000|Overall Study|Lost to Follow-up|0|||
105654462|NCT00496626|364398404|FG001|Overall Study|Lost to Follow-up|1|||
105654463|NCT00496626|364398403|FG000|Overall Study|Protocol Violation|1|||
105654464|NCT00496626|364398404|FG001|Overall Study|Protocol Violation|0|||
105654465|NCT00496626|364398403|FG000|Overall Study|Withdrawal by Subject|5|||
105654466|NCT00496626|364398404|FG001|Overall Study|Withdrawal by Subject|4|||
105654467|NCT00496626|364398403|FG000|Overall Study|Relocated|0|||
105654468|NCT00496626|364398404|FG001|Overall Study|Relocated|1|||
105654469|NCT03371485|364398405|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
105654470|NCT03371485|364398405|FG000|2-year Follow-up|Death|5|||
105654471|NCT03544229|364398408|FG000|Overall Study|Adverse Event|1|||
105654472|NCT03544229|364398409|FG001|Overall Study|Adverse Event|0|||
105654473|NCT03544229|364398410|FG002|Overall Study|Adverse Event|1|||
105654474|NCT03544229|364398411|FG003|Overall Study|Adverse Event|0|||
105654475|NCT03544229|364398408|FG000|Overall Study|Protocol Deviation|0|||
105654476|NCT03544229|364398409|FG001|Overall Study|Protocol Deviation|0|||
105654477|NCT03544229|364398410|FG002|Overall Study|Protocol Deviation|1|||
105654478|NCT03544229|364398411|FG003|Overall Study|Protocol Deviation|0|||
105654479|NCT03544229|364398408|FG000|Overall Study|Lost to Follow-up|3|||
105654480|NCT03544229|364398409|FG001|Overall Study|Lost to Follow-up|0|||
105654481|NCT03544229|364398410|FG002|Overall Study|Lost to Follow-up|0|||
105654482|NCT03544229|364398411|FG003|Overall Study|Lost to Follow-up|2|||
105654483|NCT03544229|364398408|FG000|Overall Study|Voluntary Withdrawal|2|||
105654484|NCT03544229|364398409|FG001|Overall Study|Voluntary Withdrawal|1|||
105654485|NCT03544229|364398410|FG002|Overall Study|Voluntary Withdrawal|3|||
105654486|NCT03544229|364398411|FG003|Overall Study|Voluntary Withdrawal|0|||
105654487|NCT03544229|364398408|FG000|Overall Study|Lack of Efficacy|0|||
105654488|NCT03544229|364398409|FG001|Overall Study|Lack of Efficacy|1|||
105654489|NCT03544229|364398410|FG002|Overall Study|Lack of Efficacy|0|||
105654490|NCT03544229|364398411|FG003|Overall Study|Lack of Efficacy|0|||
105654491|NCT00527514|364398412|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
105654492|NCT00527514|364398412|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
105654493|NCT00527514|364398412|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
105654494|NCT00527514|364398412|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
105654495|NCT00527514|364398412|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
105654496|NCT00527514|364398412|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
105654497|NCT00527514|364398412|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
105654498|NCT00576823|364398430|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
105654499|NCT00576823|364398431|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
105654500|NCT00576823|364398432|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
105654501|NCT00576823|364398430|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
105654502|NCT00576823|364398431|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
105654503|NCT00576823|364398432|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
105654504|NCT00839332|364398436|FG000|Phase 1|Disease Progression|38|||
105654505|NCT00839332|364398437|FG001|Phase 1|Disease Progression|0|||
105654506|NCT00839332|364398438|FG002|Phase 1|Disease Progression|0|||
105654507|NCT00839332|364398436|FG000|Phase 1|Adverse Event|6|||
105654508|NCT00839332|364398437|FG001|Phase 1|Adverse Event|0|||
105654509|NCT00839332|364398438|FG002|Phase 1|Adverse Event|0|||
105654510|NCT00839332|364398436|FG000|Phase 1|Withdrawal by Subject|4|||
105654511|NCT00839332|364398437|FG001|Phase 1|Withdrawal by Subject|0|||
105654512|NCT00839332|364398438|FG002|Phase 1|Withdrawal by Subject|0|||
105654513|NCT00839332|364398436|FG000|Phase 1|Physician Decision|2|||
105654514|NCT00839332|364398437|FG001|Phase 1|Physician Decision|0|||
105654515|NCT00839332|364398438|FG002|Phase 1|Physician Decision|0|||
105654516|NCT00839332|364398436|FG000|Phase 2|Protocol Violation|0|||
105654517|NCT00839332|364398437|FG001|Phase 2|Protocol Violation|1|||
105654518|NCT00839332|364398438|FG002|Phase 2|Protocol Violation|0|||
105654519|NCT00839332|364398436|FG000|Phase 2|Disease Progression|0|||
105654520|NCT00839332|364398437|FG001|Phase 2|Disease Progression|46|||
105654521|NCT00839332|364398438|FG002|Phase 2|Disease Progression|21|||
105654522|NCT00839332|364398436|FG000|Phase 2|Adverse Event|0|||
105654523|NCT00839332|364398437|FG001|Phase 2|Adverse Event|8|||
105654524|NCT00839332|364398438|FG002|Phase 2|Adverse Event|6|||
105654525|NCT00839332|364398436|FG000|Phase 2|Death|0|||
105654526|NCT00839332|364398437|FG001|Phase 2|Death|4|||
105654527|NCT00839332|364398438|FG002|Phase 2|Death|2|||
105654528|NCT00839332|364398436|FG000|Phase 2|Withdrawal by Subject|0|||
105654529|NCT00839332|364398437|FG001|Phase 2|Withdrawal by Subject|5|||
105654530|NCT00839332|364398438|FG002|Phase 2|Withdrawal by Subject|8|||
105654531|NCT00839332|364398436|FG000|Phase 2|Physician Decision|0|||
105654532|NCT00839332|364398437|FG001|Phase 2|Physician Decision|4|||
105654533|NCT00839332|364398438|FG002|Phase 2|Physician Decision|1|||
105654534|NCT00839332|364398436|FG000|Phase 2|Lost to Follow-up|0|||
105654535|NCT00839332|364398437|FG001|Phase 2|Lost to Follow-up|0|||
105654536|NCT00839332|364398438|FG002|Phase 2|Lost to Follow-up|1|||
105654537|NCT00640042|364398439|FG000|Enrollment|Did not receive study drug|83|||
105654538|NCT02109107|364398444|FG000|Overall Study|Lost to Follow-up|2|||
105654539|NCT02573883|364398448|FG000|Six Month Follow Up|Lost to Follow-up|1|||
105654540|NCT02573883|364398449|FG001|Six Month Follow Up|Lost to Follow-up|0|||
105654541|NCT02573883|364398450|FG002|Six Month Follow Up|Lost to Follow-up|0|||
105654542|NCT02573883|364398451|FG003|Six Month Follow Up|Lost to Follow-up|0|||
105654543|NCT02573883|364398448|FG000|One Year Follow Up|Lost to Follow-up|2|||
105654544|NCT02573883|364398449|FG001|One Year Follow Up|Lost to Follow-up|1|||
105654545|NCT02573883|364398450|FG002|One Year Follow Up|Lost to Follow-up|0|||
105654546|NCT02573883|364398451|FG003|One Year Follow Up|Lost to Follow-up|0|||
105654547|NCT03078751|364398452|FG000|Overall Study|Adverse Event|4|||
105654548|NCT03078751|364398453|FG001|Overall Study|Adverse Event|0|||
105654549|NCT03078751|364398452|FG000|Overall Study|Physician Decision|1|||
105654550|NCT03078751|364398453|FG001|Overall Study|Physician Decision|0|||
105654551|NCT03078751|364398452|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
105654552|NCT03078751|364398453|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
105654553|NCT03078751|364398452|FG000|Overall Study|Subject/guardian decision|8|||
105654554|NCT03078751|364398453|FG001|Overall Study|Subject/guardian decision|1|||
105654555|NCT03078751|364398452|FG000|Overall Study|Untreated|0|||
105654556|NCT03078751|364398453|FG001|Overall Study|Untreated|4|||
105654557|NCT00118703|364398454|FG000|Overall Study|Protocol Violation|1|||
105654558|NCT00118703|364398455|FG001|Overall Study|Protocol Violation|0|||
105654559|NCT00118703|364398454|FG000|Overall Study|Adverse Event|1|||
105654560|NCT00118703|364398455|FG001|Overall Study|Adverse Event|1|||
105654561|NCT00118703|364398454|FG000|Overall Study|Participant took two different treatment|0|||
105654562|NCT00118703|364398455|FG001|Overall Study|Participant took two different treatment|1|||
105654563|NCT00118703|364398454|FG000|Overall Study|Withdrawal by Subject|2|||
105654564|NCT00118703|364398455|FG001|Overall Study|Withdrawal by Subject|5|||
105654565|NCT00118703|364398454|FG000|Overall Study|Lost to Follow-up|1|||
105654566|NCT00118703|364398455|FG001|Overall Study|Lost to Follow-up|2|||
105654567|NCT03512288|364398460|FG000|Overall Study|Adverse Event|1|||
105654568|NCT03512288|364398461|FG001|Overall Study|Adverse Event|0|||
105654569|NCT03512288|364398460|FG000|Overall Study|Lost to Follow-up|12|||
105654570|NCT03512288|364398461|FG001|Overall Study|Lost to Follow-up|15|||
105654571|NCT03512288|364398460|FG000|Overall Study|Physician Decision|0|||
105654572|NCT03512288|364398461|FG001|Overall Study|Physician Decision|2|||
105654573|NCT03512288|364398460|FG000|Overall Study|Protocol Violation|6|||
105654574|NCT03512288|364398461|FG001|Overall Study|Protocol Violation|4|||
105654575|NCT03512288|364398460|FG000|Overall Study|Medication error without associated adverse event|1|||
105654576|NCT03512288|364398461|FG001|Overall Study|Medication error without associated adverse event|0|||
105654577|NCT03512288|364398460|FG000|Overall Study|No longer met eligibility criteria|5|||
105654578|NCT03512288|364398461|FG001|Overall Study|No longer met eligibility criteria|2|||
105654579|NCT03512288|364398460|FG000|Overall Study|Withdrawal by parent/guardian|14|||
105654580|NCT03512288|364398461|FG001|Overall Study|Withdrawal by parent/guardian|18|||
105654581|NCT03512288|364398460|FG000|Overall Study|Other|1|||
105654582|NCT03512288|364398461|FG001|Overall Study|Other|1|||
105654583|NCT03512288|364398460|FG000|Overall Study|Randomized but not treated|1|||
105654584|NCT03512288|364398461|FG001|Overall Study|Randomized but not treated|1|||
105654585|NCT00424177|364398464|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
105654586|NCT00424177|364398464|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
105654587|NCT00424177|364398464|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
105654588|NCT00424177|364398464|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
105654589|NCT00424177|364398464|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
105654590|NCT00424177|364398464|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
105654591|NCT00424177|364398464|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
105654592|NCT00424177|364398464|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
105654593|NCT00424177|364398464|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
105654594|NCT00424177|364398464|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
105654595|NCT02551692|364398465|FG000|Overall Study|Lost to Follow-up|0|||
105654596|NCT02551692|364398466|FG001|Overall Study|Lost to Follow-up|1|||
105654597|NCT02551692|364398467|FG002|Overall Study|Lost to Follow-up|4|||
105654598|NCT02551692|364398465|FG000|Overall Study|Withdrawal by Subject|1|||
105654599|NCT02551692|364398466|FG001|Overall Study|Withdrawal by Subject|0|||
105654600|NCT02551692|364398467|FG002|Overall Study|Withdrawal by Subject|1|||
105654601|NCT00496834|364398476|FG000|Overall Study|Withdrawal by Subject|4|||
105654602|NCT00496834|364398477|FG001|Overall Study|Withdrawal by Subject|6|||
105654603|NCT00496834|364398476|FG000|Overall Study|Contraindicated medication administered|0|||
105654604|NCT00496834|364398477|FG001|Overall Study|Contraindicated medication administered|1|||
105654605|NCT00496834|364398476|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
105654606|NCT00496834|364398477|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
105654607|NCT00496834|364398476|FG000|Overall Study|Adverse Event|5|||
105654608|NCT00496834|364398477|FG001|Overall Study|Adverse Event|3|||
105654609|NCT00496834|364398476|FG000|Overall Study|IP administration violation|2|||
105654610|NCT00496834|364398477|FG001|Overall Study|IP administration violation|0|||
105654611|NCT00496834|364398476|FG000|Overall Study|Lost to Follow-up|2|||
105654612|NCT00496834|364398477|FG001|Overall Study|Lost to Follow-up|0|||
105654613|NCT00496834|364398476|FG000|Overall Study|Blood Pressure control failure|2|||
105654614|NCT00496834|364398477|FG001|Overall Study|Blood Pressure control failure|1|||
105654615|NCT04088136|364398480|FG000|Overall Study|Withdrawal by Subject|5|||
105654616|NCT04088136|364398481|FG001|Overall Study|Withdrawal by Subject|0|||
105654617|NCT04088136|364398480|FG000|Overall Study|Lack of Efficacy|0|||
105654618|NCT04088136|364398481|FG001|Overall Study|Lack of Efficacy|1|||
105654619|NCT01960348|364399763|FG000|Overall Study|Adverse event, not serious|2|||
105654620|NCT01960348|364399764|FG001|Overall Study|Adverse event, not serious|2|||
105654621|NCT01960348|364399763|FG000|Overall Study|Adverse event, serious fatal|6|||
105654622|NCT01960348|364399764|FG001|Overall Study|Adverse event, serious fatal|5|||
105654623|NCT01960348|364399763|FG000|Overall Study|Adverse event, serious non-fatal|0|||
105654624|NCT01960348|364399764|FG001|Overall Study|Adverse event, serious non-fatal|3|||
105654625|NCT01960348|364399763|FG000|Overall Study|Withdrawal by Subject|1|||
105654626|NCT01960348|364399764|FG001|Overall Study|Withdrawal by Subject|11|||
105654627|NCT01960348|364399763|FG000|Overall Study|Physician Decision|0|||
105654628|NCT01960348|364399764|FG001|Overall Study|Physician Decision|1|||
105654629|NCT01960348|364399763|FG000|Overall Study|Protocol Violation|1|||
105654630|NCT01960348|364399764|FG001|Overall Study|Protocol Violation|0|||
105654631|NCT05446714|364399770|FG000|Overall Study|Lost to Follow-up|1|||
105654632|NCT05446714|364399771|FG001|Overall Study|Lost to Follow-up|3|||
105654633|NCT05446714|364399772|FG002|Overall Study|Lost to Follow-up|2|||
105654634|NCT05446714|364399770|FG000|Overall Study|Protocol Violation|2|||
105654635|NCT05446714|364399771|FG001|Overall Study|Protocol Violation|0|||
105654636|NCT05446714|364399772|FG002|Overall Study|Protocol Violation|0|||
105654637|NCT00197106|364399775|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
105654638|NCT00197106|364399776|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
105654639|NCT00197106|364399777|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
105654640|NCT00197106|364399775|FG000|Overall Treatment Period|Lack of Efficacy|0|||
105654641|NCT00197106|364399776|FG001|Overall Treatment Period|Lack of Efficacy|1|||
105654642|NCT00197106|364399777|FG002|Overall Treatment Period|Lack of Efficacy|0|||
105654643|NCT00197106|364399775|FG000|Overall Treatment Period|Lost to Follow-up|0|||
105654644|NCT00197106|364399776|FG001|Overall Treatment Period|Lost to Follow-up|0|||
105654645|NCT00197106|364399777|FG002|Overall Treatment Period|Lost to Follow-up|2|||
105654646|NCT00197106|364399775|FG000|Overall Treatment Period|Protocol Violation|0|||
105654647|NCT00197106|364399776|FG001|Overall Treatment Period|Protocol Violation|0|||
105654648|NCT00197106|364399777|FG002|Overall Treatment Period|Protocol Violation|2|||
105654649|NCT00197106|364399775|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
105654650|NCT00197106|364399776|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
105654651|NCT00197106|364399777|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
105654652|NCT03511378|364399780|FG000|Overall Study|Withdrawal by Subject|2|||
105654653|NCT03511378|364399781|FG001|Overall Study|Withdrawal by Subject|2|||
105654654|NCT03511378|364399780|FG000|Overall Study|Patient not coming or schedule visit|1|||
105654655|NCT03511378|364399781|FG001|Overall Study|Patient not coming or schedule visit|0|||
105654656|NCT05006417|364399784|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
105654657|NCT00280683|364399785|FG000|Overall Study|Withdrawal by Subject|1|||
105654658|NCT00280683|364399786|FG001|Overall Study|Withdrawal by Subject|2|||
105654659|NCT00280683|364399785|FG000|Overall Study|Adverse Event|1|||
105654660|NCT00280683|364399786|FG001|Overall Study|Adverse Event|1|||
105654661|NCT02705625|364399789|FG000|Overall Study|Protocol Violation|1|||
105654662|NCT02705625|364399790|FG001|Overall Study|Protocol Violation|0|||
105654663|NCT02705625|364399791|FG002|Overall Study|Protocol Violation|0|||
105654664|NCT02705625|364399789|FG000|Overall Study|Adverse Event|6|||
105654665|NCT02705625|364399790|FG001|Overall Study|Adverse Event|5|||
105654666|NCT02705625|364399791|FG002|Overall Study|Adverse Event|2|||
105654667|NCT02705625|364399789|FG000|Overall Study|Death|0|||
105654668|NCT02705625|364399790|FG001|Overall Study|Death|0|||
105654669|NCT02705625|364399791|FG002|Overall Study|Death|1|||
105654670|NCT02705625|364399789|FG000|Overall Study|Withdrawal by Subject|1|||
105654671|NCT02705625|364399790|FG001|Overall Study|Withdrawal by Subject|4|||
105654672|NCT02705625|364399791|FG002|Overall Study|Withdrawal by Subject|5|||
105654673|NCT02705625|364399789|FG000|Overall Study|Lost to Follow-up|0|||
105654674|NCT02705625|364399790|FG001|Overall Study|Lost to Follow-up|0|||
105654675|NCT02705625|364399791|FG002|Overall Study|Lost to Follow-up|1|||
105654676|NCT02705625|364399789|FG000|Overall Study|Non-compliance|0|||
105654677|NCT02705625|364399790|FG001|Overall Study|Non-compliance|1|||
105654678|NCT02705625|364399791|FG002|Overall Study|Non-compliance|1|||
105654679|NCT02705625|364399789|FG000|Overall Study|Overdosing|0|||
105654680|NCT02705625|364399790|FG001|Overall Study|Overdosing|0|||
105654681|NCT02705625|364399791|FG002|Overall Study|Overdosing|1|||
105654682|NCT02158247|364399792|FG000|Overall Study|Invisible vocal cords|5|||
105654683|NCT01649557|364399796|FG000|Overall Study|Lost to Follow-up|5|||
105654684|NCT01649557|364399797|FG001|Overall Study|Lost to Follow-up|0|||
105654685|NCT01649557|364399798|FG002|Overall Study|Lost to Follow-up|3|||
105654686|NCT01649557|364399796|FG000|Overall Study|Adverse Event|7|||
105654687|NCT01649557|364399797|FG001|Overall Study|Adverse Event|5|||
105654688|NCT01649557|364399798|FG002|Overall Study|Adverse Event|1|||
105654689|NCT01649557|364399796|FG000|Overall Study|Met withdrawal criteria|4|||
105654690|NCT01649557|364399797|FG001|Overall Study|Met withdrawal criteria|0|||
105654691|NCT01649557|364399798|FG002|Overall Study|Met withdrawal criteria|0|||
105654692|NCT01649557|364399796|FG000|Overall Study|Physician Decision|8|||
105654693|NCT01649557|364399797|FG001|Overall Study|Physician Decision|2|||
105654694|NCT01649557|364399798|FG002|Overall Study|Physician Decision|1|||
105654695|NCT01649557|364399796|FG000|Overall Study|Withdrawal by Subject|15|||
105654696|NCT01649557|364399797|FG001|Overall Study|Withdrawal by Subject|5|||
105654697|NCT01649557|364399798|FG002|Overall Study|Withdrawal by Subject|4|||
105654698|NCT01649557|364399796|FG000|Overall Study|Protocol deviation|0|||
105654699|NCT01649557|364399797|FG001|Overall Study|Protocol deviation|2|||
105654700|NCT01649557|364399798|FG002|Overall Study|Protocol deviation|0|||
105654701|NCT01649557|364399796|FG000|Overall Study|Lack of Efficacy|5|||
105654702|NCT01649557|364399797|FG001|Overall Study|Lack of Efficacy|0|||
105654703|NCT01649557|364399798|FG002|Overall Study|Lack of Efficacy|0|||
105654704|NCT03924947|364399800|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
105654705|NCT03924947|364399801|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
105654706|NCT03924947|364399802|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
105654707|NCT03924947|364399803|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
105654708|NCT03924947|364399804|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
105654709|NCT03924947|364399805|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
105654710|NCT01685047|364399808|FG000|Overall Study|Withdrawal by Subject|20|||
105654711|NCT01685047|364399808|FG000|Overall Study|Death|26|||
105654712|NCT01685047|364399808|FG000|Overall Study|Lost to Follow-up|8|||
105654713|NCT01685047|364399808|FG000|Overall Study|Physician Decision|25|||
105654714|NCT01685047|364399808|FG000|Overall Study|Adverse Event|5|||
105654715|NCT01685047|364399808|FG000|Overall Study|patient withdrawn by sponsor|1|||
105654716|NCT02490878|364399812|FG000|Overall Study|deemed ineligible|0|||
105654717|NCT02490878|364399813|FG001|Overall Study|deemed ineligible|1|||
105654718|NCT02490878|364399812|FG000|Overall Study|progression prior to treatment|0|||
105654719|NCT02490878|364399813|FG001|Overall Study|progression prior to treatment|1|||
105654720|NCT02490878|364399812|FG000|Overall Study|only submitted baseline QOL|0|||
105654721|NCT02490878|364399813|FG001|Overall Study|only submitted baseline QOL|1|||
105654722|NCT02973477|364399819|FG000|First Intervention|Lost to Follow-up|0|||
105654723|NCT02973477|364399820|FG001|First Intervention|Lost to Follow-up|2|||
105654724|NCT02973477|364399819|FG000|Washout|Withdrawal by Subject|1|||
105654725|NCT02973477|364399820|FG001|Washout|Withdrawal by Subject|0|||
105654726|NCT02973477|364399819|FG000|Second Intervention|Lost to Follow-up|1|||
105654727|NCT02973477|364399820|FG001|Second Intervention|Lost to Follow-up|0|||
105654728|NCT01885936|364399821|FG000|Overall Study|Withdrawal by Subject|1|||
105654729|NCT01885936|364399822|FG001|Overall Study|Withdrawal by Subject|0|||
105654730|NCT00317603|364399825|FG000|Overall Study|Progressive Disease|3|||
105654731|NCT02741713|364399827|FG000|Overall Study|Surgery type changed intra-operatively|2|||
105654732|NCT02741713|364399828|FG001|Overall Study|Surgery type changed intra-operatively|1|||
105654733|NCT00619983|364399829|FG000|Test Drug Alone|Withdrawal by Subject|1|||
105654734|NCT00619983|364399830|FG001|Test Drug Alone|Withdrawal by Subject|0|||
105654735|NCT00619983|364399831|FG002|Test Drug Alone|Withdrawal by Subject|0|||
105654736|NCT00619983|364399832|FG003|Test Drug Alone|Withdrawal by Subject|1|||
105654737|NCT00619983|364399829|FG000|Test Drug Alone|Failure of daily diary device|1|||
105654738|NCT00619983|364399830|FG001|Test Drug Alone|Failure of daily diary device|1|||
105654739|NCT00619983|364399831|FG002|Test Drug Alone|Failure of daily diary device|2|||
105654740|NCT00619983|364399832|FG003|Test Drug Alone|Failure of daily diary device|2|||
105654741|NCT02172950|364399833|FG000|Overall Study|Physician Decision|3|||
105654742|NCT02172950|364399834|FG001|Overall Study|Physician Decision|3|||
105654743|NCT02172950|364399833|FG000|Overall Study|Lack of Efficacy|1|||
105654744|NCT02172950|364399834|FG001|Overall Study|Lack of Efficacy|0|||
105654745|NCT02172950|364399833|FG000|Overall Study|Adverse Event|4|||
105654746|NCT02172950|364399834|FG001|Overall Study|Adverse Event|1|||
105654747|NCT02172950|364399833|FG000|Overall Study|Withdrawal by Subject|10|||
105654748|NCT02172950|364399834|FG001|Overall Study|Withdrawal by Subject|0|||
105654749|NCT02172950|364399833|FG000|Overall Study|Protocol Violation|1|||
105654750|NCT02172950|364399834|FG001|Overall Study|Protocol Violation|0|||
105654751|NCT02172950|364399833|FG000|Overall Study|Lost to Follow-up|1|||
105654752|NCT02172950|364399834|FG001|Overall Study|Lost to Follow-up|0|||
105654753|NCT02172950|364399833|FG000|Overall Study|Death|1|||
105654754|NCT02172950|364399834|FG001|Overall Study|Death|0|||
105654755|NCT02172950|364399833|FG000|Overall Study|Patient traveling|1|||
105654756|NCT02172950|364399834|FG001|Overall Study|Patient traveling|0|||
105654757|NCT02172950|364399833|FG000|Overall Study|Patient went to other country|1|||
105654758|NCT02172950|364399834|FG001|Overall Study|Patient went to other country|0|||
105654759|NCT02172950|364399833|FG000|Overall Study|Patient relocated overseas|1|||
105654760|NCT02172950|364399834|FG001|Overall Study|Patient relocated overseas|1|||
105654761|NCT02172950|364399833|FG000|Overall Study|Patient moving|1|||
105654762|NCT02172950|364399834|FG001|Overall Study|Patient moving|0|||
105654763|NCT00809341|364399835|FG000|Overall Study|Physician Decision|0|||
105654764|NCT00809341|364399836|FG001|Overall Study|Physician Decision|1|||
105654765|NCT00225277|364399841|FG000|Overall Study|Adverse Event|30|||
105654766|NCT00225277|364399842|FG001|Overall Study|Adverse Event|34|||
105654767|NCT00225277|364399841|FG000|Overall Study|Lack of Efficacy|4|||
105654768|NCT00225277|364399842|FG001|Overall Study|Lack of Efficacy|1|||
105654769|NCT00225277|364399841|FG000|Overall Study|Lost to Follow-up|4|||
105654770|NCT00225277|364399842|FG001|Overall Study|Lost to Follow-up|6|||
105654771|NCT00225277|364399841|FG000|Overall Study|Physician Decision|6|||
105654772|NCT00225277|364399842|FG001|Overall Study|Physician Decision|8|||
105654773|NCT00225277|364399841|FG000|Overall Study|Protocol Violation|6|||
105654774|NCT00225277|364399842|FG001|Overall Study|Protocol Violation|3|||
105654775|NCT00225277|364399841|FG000|Overall Study|Withdrawal by Subject|40|||
105654776|NCT00225277|364399842|FG001|Overall Study|Withdrawal by Subject|34|||
105654777|NCT00225277|364399841|FG000|Overall Study|Other|7|||
105654778|NCT00225277|364399842|FG001|Overall Study|Other|9|||
105654779|NCT04582669|364399854|FG000|Overall Study|Subject missed appointment(s).|1|||
105654780|NCT04582669|364399855|FG001|Overall Study|Subject missed appointment(s).|0|||
105654781|NCT04582669|364399856|FG002|Overall Study|Subject missed appointment(s).|1|||
105654782|NCT04582669|364399857|FG003|Overall Study|Subject missed appointment(s).|2|||
105654783|NCT04582669|364399854|FG000|Overall Study|Protocol Violation|0|||
105654784|NCT04582669|364399855|FG001|Overall Study|Protocol Violation|1|||
105654785|NCT04582669|364399856|FG002|Overall Study|Protocol Violation|1|||
105654786|NCT04582669|364399857|FG003|Overall Study|Protocol Violation|0|||
105654787|NCT02171130|364399858|FG000|Overall Study|Death|1|||
105654788|NCT02171130|364399858|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
105654789|NCT02171130|364399858|FG000|Overall Study|Discontinued; Site Termination|5|||
105654790|NCT02171130|364399858|FG000|Overall Study|Withdrawal by Subject|3|||
105654791|NCT02171130|364399858|FG000|Overall Study|Physician Decision|1|||
105654792|NCT02171130|364399858|FG000|Overall Study|Lost to Follow-up|1|||
105654793|NCT02171130|364399858|FG000|Overall Study|Met Exclusion Criteria|1|||
105654794|NCT00591409|364399859|FG000|Overall Study|Not Treated|0|||
105654795|NCT00591409|364399860|FG001|Overall Study|Not Treated|0|||
105654796|NCT00591409|364399861|FG002|Overall Study|Not Treated|0|||
105654797|NCT00591409|364399862|FG003|Overall Study|Not Treated|0|||
105654798|NCT00591409|364399863|FG004|Overall Study|Not Treated|1|||
105654799|NCT00591409|364399864|FG005|Overall Study|Not Treated|0|||
105654800|NCT00591409|364399865|FG006|Overall Study|Not Treated|0|||
105654801|NCT00591409|364399866|FG007|Overall Study|Not Treated|0|||
105654802|NCT00591409|364399867|FG008|Overall Study|Not Treated|0|||
105654803|NCT00591409|364399868|FG009|Overall Study|Not Treated|1|||
105654804|NCT02215954|364399869|FG000|Overall Study|Adverse Event|0|||
105654805|NCT02215954|364399870|FG001|Overall Study|Adverse Event|0|||
105654806|NCT02215954|364399871|FG002|Overall Study|Adverse Event|1|||
105654807|NCT02215954|364399869|FG000|Overall Study|Withdrawal by Subject|0|||
105654808|NCT02215954|364399870|FG001|Overall Study|Withdrawal by Subject|0|||
105654809|NCT02215954|364399871|FG002|Overall Study|Withdrawal by Subject|2|||
105654810|NCT02215954|364399869|FG000|Overall Study|Not exposed|1|||
105654811|NCT02215954|364399870|FG001|Overall Study|Not exposed|1|||
105654812|NCT02215954|364399871|FG002|Overall Study|Not exposed|3|||
105654813|NCT03503162|364399872|FG000|Overall Study|did not meet eligibility|1|||
105654814|NCT00920699|364399881|FG000|Overall Study|Withdrawal by Subject|2|||
105654815|NCT00920699|364399882|FG001|Overall Study|Withdrawal by Subject|0|||
105654816|NCT00920699|364399883|FG002|Overall Study|Withdrawal by Subject|2|||
105654817|NCT00920699|364399881|FG000|Overall Study|no longer met eligibility|0|||
105654818|NCT00920699|364399882|FG001|Overall Study|no longer met eligibility|1|||
105654819|NCT00920699|364399883|FG002|Overall Study|no longer met eligibility|0|||
105654820|NCT00920699|364399881|FG000|Overall Study|Lost to Follow-up|0|||
105654821|NCT00920699|364399882|FG001|Overall Study|Lost to Follow-up|0|||
105654822|NCT00920699|364399883|FG002|Overall Study|Lost to Follow-up|2|||
105654823|NCT03723915|364399884|FG000|Screening|Failed to meet screening requirements.|2|||
105654824|NCT03723915|364399884|FG000|On Treatment|Failed to meet treatment requirements|2|||
105654825|NCT00740870|364399886|FG000|Overall Study|Not Catheterized|4|||
105654826|NCT00740870|364399886|FG000|Overall Study|Further testing contraindicated implant|17|||
105654827|NCT04947436|364399887|FG000|Overall Study|Lost to Follow-up|3|||
105654828|NCT04947436|364399888|FG001|Overall Study|Lost to Follow-up|7|||
105654829|NCT04947436|364399889|FG002|Overall Study|Lost to Follow-up|5|||
105654830|NCT04947436|364399887|FG000|Overall Study|Death|1|||
105654831|NCT04947436|364399888|FG001|Overall Study|Death|1|||
105654832|NCT04947436|364399889|FG002|Overall Study|Death|1|||
105654833|NCT02630706|364399893|FG000|Overall Study|Adverse Event|2|||
105654834|NCT02630706|364399894|FG001|Overall Study|Adverse Event|1|||
105654835|NCT02630706|364399895|FG002|Overall Study|Adverse Event|1|||
105654836|NCT02630706|364399893|FG000|Overall Study|Lost to Follow-up|0|||
105654837|NCT02630706|364399894|FG001|Overall Study|Lost to Follow-up|1|||
105654838|NCT02630706|364399895|FG002|Overall Study|Lost to Follow-up|2|||
105654839|NCT02630706|364399893|FG000|Overall Study|Physician Decision|1|||
105654840|NCT02630706|364399894|FG001|Overall Study|Physician Decision|1|||
105654841|NCT02630706|364399895|FG002|Overall Study|Physician Decision|0|||
105654842|NCT02630706|364399893|FG000|Overall Study|Pregnancy|0|||
105654843|NCT02630706|364399894|FG001|Overall Study|Pregnancy|1|||
105654844|NCT02630706|364399895|FG002|Overall Study|Pregnancy|0|||
105654845|NCT02630706|364399893|FG000|Overall Study|Withdrawal by Subject|4|||
105654846|NCT02630706|364399894|FG001|Overall Study|Withdrawal by Subject|5|||
105654847|NCT02630706|364399895|FG002|Overall Study|Withdrawal by Subject|7|||
105654848|NCT02161185|364399900|FG000|Treatment Phase|Administrative/Other|7|||
105654849|NCT00372255|364399902|FG000|Overall Study|Withdrawn for other reasons|2|||
105654850|NCT00372255|364399903|FG001|Overall Study|Withdrawn for other reasons|1|||
105654851|NCT02864342|364399904|FG000|Overall Study|Eligibility Criteria Deviation|2|||
105654852|NCT02864342|364399905|FG001|Overall Study|Eligibility Criteria Deviation|3|||
105654853|NCT02864342|364399904|FG000|Overall Study|Withdrawal by Subject|4|||
105654854|NCT02864342|364399905|FG001|Overall Study|Withdrawal by Subject|2|||
105654855|NCT02864342|364399904|FG000|Overall Study|Device Technology Issue|6|||
105654856|NCT02864342|364399905|FG001|Overall Study|Device Technology Issue|7|||
105654857|NCT02864342|364399904|FG000|Overall Study|Death|0|||
105654858|NCT02864342|364399905|FG001|Overall Study|Death|1|||
105654859|NCT02864342|364399904|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
105654860|NCT02864342|364399905|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
105654861|NCT02864342|364399904|FG000|Overall Study|Lost to Follow-up|1|||
105654862|NCT02864342|364399905|FG001|Overall Study|Lost to Follow-up|5|||
105654863|NCT02864342|364399904|FG000|Overall Study|Lost Device|1|||
105654864|NCT02864342|364399905|FG001|Overall Study|Lost Device|0|||
105654865|NCT02864342|364399904|FG000|Overall Study|Adverse Event|1|||
105654866|NCT02864342|364399905|FG001|Overall Study|Adverse Event|0|||
105654867|NCT00808899|364399906|FG000|Overall Study|Death|1|||
105654868|NCT00808899|364399906|FG000|Overall Study|Physician Decision|3|||
105654869|NCT02517528|364401740|FG000|Overall Study|Withdrawal by Subject|1|||
105654870|NCT03440047|364401743|FG000|Overall Study|Withdrawal by Subject|2|||
105654871|NCT01181609|364401744|FG000|Overall Study|Adverse Event|1|||
105654872|NCT01181609|364401744|FG000|Overall Study|Withdrawal by Subject|1|||
105654873|NCT01181609|364401744|FG000|Overall Study|Lost to Follow-up|1|||
105654874|NCT01181609|364401744|FG000|Overall Study|Death|50|||
105654875|NCT00684203|364401756|FG000|Overall Study|Adverse Event|6|||
105654876|NCT00684203|364401757|FG001|Overall Study|Adverse Event|4|||
105654877|NCT00684203|364401758|FG002|Overall Study|Adverse Event|8|||
105654878|NCT00684203|364401759|FG003|Overall Study|Adverse Event|0|||
105654879|NCT00684203|364401760|FG004|Overall Study|Adverse Event|0|||
105654880|NCT00684203|364401761|FG005|Overall Study|Adverse Event|0|||
105654881|NCT00684203|364401756|FG000|Overall Study|Protocol-defined clinical event|3|||
105654882|NCT00684203|364401757|FG001|Overall Study|Protocol-defined clinical event|1|||
105654883|NCT00684203|364401758|FG002|Overall Study|Protocol-defined clinical event|0|||
105654884|NCT00684203|364401759|FG003|Overall Study|Protocol-defined clinical event|0|||
105654885|NCT00684203|364401760|FG004|Overall Study|Protocol-defined clinical event|0|||
105654886|NCT00684203|364401761|FG005|Overall Study|Protocol-defined clinical event|0|||
105654887|NCT00684203|364401756|FG000|Overall Study|Withdrawal by Subject|0|||
105654888|NCT00684203|364401757|FG001|Overall Study|Withdrawal by Subject|2|||
105654889|NCT00684203|364401758|FG002|Overall Study|Withdrawal by Subject|1|||
105654890|NCT00684203|364401759|FG003|Overall Study|Withdrawal by Subject|0|||
105654891|NCT00684203|364401760|FG004|Overall Study|Withdrawal by Subject|0|||
105654892|NCT00684203|364401761|FG005|Overall Study|Withdrawal by Subject|0|||
105654893|NCT00684203|364401756|FG000|Overall Study|Did not meet protocol eligibility|0|||
105654894|NCT00684203|364401757|FG001|Overall Study|Did not meet protocol eligibility|1|||
105654895|NCT00684203|364401758|FG002|Overall Study|Did not meet protocol eligibility|0|||
105654896|NCT00684203|364401759|FG003|Overall Study|Did not meet protocol eligibility|0|||
105654897|NCT00684203|364401760|FG004|Overall Study|Did not meet protocol eligibility|0|||
105654898|NCT00684203|364401761|FG005|Overall Study|Did not meet protocol eligibility|0|||
105654899|NCT00721214|364401763|FG000|Overall Study|Chose another center for transplant|1|||
105654900|NCT00721214|364401763|FG000|Overall Study|Death|3|||
105654901|NCT00983905|364401764|FG000|Theophylline Alone|Adverse Event|1|||
105654902|NCT00983905|364401764|FG000|Colchicine Alone|Adverse Event|2|||
105654903|NCT01243411|364401765|FG000|Overall Study|Withdrawal by Subject|18|||
105654904|NCT01243411|364401765|FG000|Overall Study|Lost to Follow-up|10|||
105654905|NCT01243411|364401765|FG000|Overall Study|Adverse Event|5|||
105654906|NCT01243411|364401765|FG000|Overall Study|Other|8|||
105654907|NCT01169636|364401766|FG000|Overall Study|Adverse Event|0|||
105654908|NCT01169636|364401767|FG001|Overall Study|Adverse Event|0|||
105654909|NCT01169636|364401768|FG002|Overall Study|Adverse Event|1|||
105654910|NCT01169636|364401769|FG003|Overall Study|Adverse Event|1|||
105654911|NCT01169636|364401770|FG004|Overall Study|Adverse Event|0|||
105654912|NCT01169636|364401766|FG000|Overall Study|Screen failure|0|||
105654913|NCT01169636|364401767|FG001|Overall Study|Screen failure|0|||
105654914|NCT01169636|364401768|FG002|Overall Study|Screen failure|2|||
105654915|NCT01169636|364401769|FG003|Overall Study|Screen failure|0|||
105654916|NCT01169636|364401770|FG004|Overall Study|Screen failure|0|||
105654917|NCT01169636|364401766|FG000|Overall Study|Withdrawal by Subject|0|||
105654918|NCT01169636|364401767|FG001|Overall Study|Withdrawal by Subject|0|||
105654919|NCT01169636|364401768|FG002|Overall Study|Withdrawal by Subject|0|||
105654920|NCT01169636|364401769|FG003|Overall Study|Withdrawal by Subject|0|||
105654921|NCT01169636|364401770|FG004|Overall Study|Withdrawal by Subject|3|||
105654922|NCT01951378|364401771|FG000|Overall Study|Study Terminated-Not completed|23|||
105654923|NCT01951378|364401772|FG001|Overall Study|Study Terminated-Not completed|17|||
105654924|NCT00494026|364401773|FG000|Overall Study|Sponsor Decision|4|||
105654925|NCT02466243|364401775|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
105654926|NCT02466243|364401776|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
105654927|NCT02466243|364401775|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
105654928|NCT02466243|364401776|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
105654929|NCT02466243|364401775|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
105654930|NCT02466243|364401776|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
105654931|NCT02466243|364401775|FG000|Part B Open-label Treatment Period|Missing|2|||
105654932|NCT02466243|364401776|FG001|Part B Open-label Treatment Period|Missing|2|||
105654933|NCT00477464|364401777|FG000|Overall Study|Lost to Follow-up|1|||
105654934|NCT00477464|364401777|FG000|Overall Study|Death|36|||
105654935|NCT00477464|364401777|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
105654936|NCT00784147|364401780|FG000|Overall Study|Lost to Follow-up|2|||
105654937|NCT00784147|364401781|FG001|Overall Study|Lost to Follow-up|4|||
105654938|NCT00784147|364401780|FG000|Overall Study|Withdrawal by Subject|1|||
105654939|NCT00784147|364401781|FG001|Overall Study|Withdrawal by Subject|3|||
105654940|NCT00784147|364401780|FG000|Overall Study|Physician Decision|2|||
105654941|NCT00784147|364401781|FG001|Overall Study|Physician Decision|1|||
105654942|NCT00784147|364401780|FG000|Overall Study|Protocol Violation|1|||
105654943|NCT00784147|364401781|FG001|Overall Study|Protocol Violation|1|||
105654944|NCT00784147|364401780|FG000|Overall Study|Death|2|||
105654945|NCT00784147|364401781|FG001|Overall Study|Death|0|||
105654946|NCT02973802|364401782|FG000|Overall Study|Lost to Follow-up|1|||
105654947|NCT02973802|364401782|FG000|Overall Study|Withdrawal by Subject|1|||
105654948|NCT00706914|364401783|FG000|Overall Study|Lack of Efficacy|0|||
105654949|NCT00706914|364401784|FG001|Overall Study|Lack of Efficacy|1|||
105654950|NCT00706914|364401785|FG002|Overall Study|Lack of Efficacy|0|||
105654951|NCT00706914|364401783|FG000|Overall Study|Lost to Follow-up|1|||
105654952|NCT00706914|364401784|FG001|Overall Study|Lost to Follow-up|0|||
105654953|NCT00706914|364401785|FG002|Overall Study|Lost to Follow-up|0|||
105654954|NCT00706914|364401783|FG000|Overall Study|Adverse Event|2|||
105654955|NCT00706914|364401784|FG001|Overall Study|Adverse Event|2|||
105654956|NCT00706914|364401785|FG002|Overall Study|Adverse Event|0|||
105654957|NCT00706914|364401783|FG000|Overall Study|Protocol Violation|3|||
105654958|NCT00706914|364401784|FG001|Overall Study|Protocol Violation|1|||
105654959|NCT00706914|364401785|FG002|Overall Study|Protocol Violation|1|||
105654960|NCT02330562|364401786|FG000|Overall Study|Adverse Event|0|||
105654961|NCT02330562|364401787|FG001|Overall Study|Adverse Event|0|||
105654962|NCT02330562|364401788|FG002|Overall Study|Adverse Event|3|||
105654963|NCT02330562|364401789|FG003|Overall Study|Adverse Event|0|||
105654964|NCT02330562|364401790|FG004|Overall Study|Adverse Event|3|||
105654965|NCT02330562|364401791|FG005|Overall Study|Adverse Event|1|||
105654966|NCT02330562|364401792|FG006|Overall Study|Adverse Event|0|||
105654967|NCT02330562|364401793|FG007|Overall Study|Adverse Event|0|||
105654968|NCT02330562|364401794|FG008|Overall Study|Adverse Event|0|||
105654969|NCT02330562|364401795|FG009|Overall Study|Adverse Event|1|||
105654970|NCT02330562|364401796|FG010|Overall Study|Adverse Event|1|||
105654971|NCT02330562|364401786|FG000|Overall Study|Participant decision|1|||
105654972|NCT02330562|364401787|FG001|Overall Study|Participant decision|0|||
105654973|NCT02330562|364401788|FG002|Overall Study|Participant decision|4|||
105654974|NCT02330562|364401789|FG003|Overall Study|Participant decision|1|||
105654975|NCT02330562|364401790|FG004|Overall Study|Participant decision|5|||
105654976|NCT02330562|364401791|FG005|Overall Study|Participant decision|2|||
105654977|NCT02330562|364401792|FG006|Overall Study|Participant decision|0|||
105654978|NCT02330562|364401793|FG007|Overall Study|Participant decision|0|||
105654979|NCT02330562|364401794|FG008|Overall Study|Participant decision|0|||
105654980|NCT02330562|364401795|FG009|Overall Study|Participant decision|3|||
105654981|NCT02330562|364401796|FG010|Overall Study|Participant decision|0|||
105654982|NCT02330562|364401786|FG000|Overall Study|Disease progression|5|||
105654983|NCT02330562|364401787|FG001|Overall Study|Disease progression|3|||
105654984|NCT02330562|364401788|FG002|Overall Study|Disease progression|20|||
105654985|NCT02330562|364401789|FG003|Overall Study|Disease progression|28|||
105654986|NCT02330562|364401790|FG004|Overall Study|Disease progression|23|||
105654987|NCT02330562|364401791|FG005|Overall Study|Disease progression|7|||
105654988|NCT02330562|364401792|FG006|Overall Study|Disease progression|1|||
105654989|NCT02330562|364401793|FG007|Overall Study|Disease progression|1|||
105654990|NCT02330562|364401794|FG008|Overall Study|Disease progression|1|||
105654991|NCT02330562|364401795|FG009|Overall Study|Disease progression|0|||
105654992|NCT02330562|364401796|FG010|Overall Study|Disease progression|5|||
105654993|NCT02330562|364401786|FG000|Overall Study|Other reasons|0|||
105654994|NCT02330562|364401787|FG001|Overall Study|Other reasons|0|||
105654995|NCT02330562|364401788|FG002|Overall Study|Other reasons|0|||
105654996|NCT02330562|364401789|FG003|Overall Study|Other reasons|1|||
105654997|NCT02330562|364401790|FG004|Overall Study|Other reasons|0|||
105654998|NCT02330562|364401791|FG005|Overall Study|Other reasons|0|||
105654999|NCT02330562|364401792|FG006|Overall Study|Other reasons|0|||
105655000|NCT02330562|364401793|FG007|Overall Study|Other reasons|0|||
105655001|NCT02330562|364401794|FG008|Overall Study|Other reasons|0|||
105655002|NCT02330562|364401795|FG009|Overall Study|Other reasons|0|||
105655003|NCT02330562|364401796|FG010|Overall Study|Other reasons|0|||
105655004|NCT02330562|364401786|FG000|Overall Study|Withdrawal by Subject|0|||
105655005|NCT02330562|364401787|FG001|Overall Study|Withdrawal by Subject|0|||
105655006|NCT02330562|364401788|FG002|Overall Study|Withdrawal by Subject|0|||
105655007|NCT02330562|364401789|FG003|Overall Study|Withdrawal by Subject|0|||
105655008|NCT02330562|364401790|FG004|Overall Study|Withdrawal by Subject|0|||
105655009|NCT02330562|364401791|FG005|Overall Study|Withdrawal by Subject|0|||
105655010|NCT02330562|364401792|FG006|Overall Study|Withdrawal by Subject|0|||
105655011|NCT02330562|364401793|FG007|Overall Study|Withdrawal by Subject|0|||
105655012|NCT02330562|364401794|FG008|Overall Study|Withdrawal by Subject|0|||
105655013|NCT02330562|364401795|FG009|Overall Study|Withdrawal by Subject|1|||
105655014|NCT02330562|364401796|FG010|Overall Study|Withdrawal by Subject|0|||
105655015|NCT00875615|364401797|FG000|Overall Study|Withdrawal by Subject|1|||
105655016|NCT00943722|364401798|FG000|Base Study|Adverse Event|0|||
105655017|NCT00943722|364401799|FG001|Base Study|Adverse Event|0|||
105655018|NCT00943722|364401800|FG002|Base Study|Adverse Event|0|||
105655019|NCT00943722|364401801|FG003|Base Study|Adverse Event|1|||
105655020|NCT00943722|364401802|FG004|Base Study|Adverse Event|0|||
105655021|NCT00943722|364401803|FG005|Base Study|Adverse Event|0|||
105655022|NCT00943722|364401804|FG006|Base Study|Adverse Event|0|||
105655023|NCT00943722|364401798|FG000|Base Study|Lost to Follow-up|12|||
105655024|NCT00943722|364401799|FG001|Base Study|Lost to Follow-up|8|||
105655025|NCT00943722|364401800|FG002|Base Study|Lost to Follow-up|10|||
105655026|NCT00943722|364401801|FG003|Base Study|Lost to Follow-up|8|||
105655027|NCT00943722|364401802|FG004|Base Study|Lost to Follow-up|11|||
105655028|NCT00943722|364401803|FG005|Base Study|Lost to Follow-up|0|||
105655029|NCT00943722|364401804|FG006|Base Study|Lost to Follow-up|0|||
105655030|NCT00943722|364401798|FG000|Base Study|Physician Decision|1|||
105655031|NCT00943722|364401799|FG001|Base Study|Physician Decision|0|||
105655032|NCT00943722|364401800|FG002|Base Study|Physician Decision|0|||
105655033|NCT00943722|364401801|FG003|Base Study|Physician Decision|0|||
105655034|NCT00943722|364401802|FG004|Base Study|Physician Decision|1|||
105655035|NCT00943722|364401803|FG005|Base Study|Physician Decision|0|||
105655036|NCT00943722|364401804|FG006|Base Study|Physician Decision|0|||
105655037|NCT00943722|364401798|FG000|Base Study|Pregnancy|0|||
105655038|NCT00943722|364401799|FG001|Base Study|Pregnancy|0|||
105655039|NCT00943722|364401800|FG002|Base Study|Pregnancy|1|||
105655040|NCT00943722|364401801|FG003|Base Study|Pregnancy|0|||
105655041|NCT00943722|364401802|FG004|Base Study|Pregnancy|2|||
105655042|NCT00943722|364401803|FG005|Base Study|Pregnancy|0|||
105655043|NCT00943722|364401804|FG006|Base Study|Pregnancy|0|||
105655044|NCT00943722|364401798|FG000|Base Study|Protocol Violation|0|||
105655045|NCT00943722|364401799|FG001|Base Study|Protocol Violation|1|||
105655046|NCT00943722|364401800|FG002|Base Study|Protocol Violation|0|||
105655047|NCT00943722|364401801|FG003|Base Study|Protocol Violation|0|||
105655048|NCT00943722|364401802|FG004|Base Study|Protocol Violation|2|||
105655049|NCT00943722|364401803|FG005|Base Study|Protocol Violation|0|||
105655050|NCT00943722|364401804|FG006|Base Study|Protocol Violation|0|||
105655051|NCT00943722|364401798|FG000|Base Study|Withdrawal by Subject|12|||
105655052|NCT00943722|364401799|FG001|Base Study|Withdrawal by Subject|13|||
105655053|NCT00943722|364401800|FG002|Base Study|Withdrawal by Subject|2|||
105655054|NCT00943722|364401801|FG003|Base Study|Withdrawal by Subject|13|||
105655055|NCT00943722|364401802|FG004|Base Study|Withdrawal by Subject|8|||
105655056|NCT00943722|364401803|FG005|Base Study|Withdrawal by Subject|0|||
105655057|NCT00943722|364401804|FG006|Base Study|Withdrawal by Subject|0|||
105655058|NCT00943722|364401798|FG000|Base Study|Month 12 visit not completed|0|||
105655059|NCT00943722|364401799|FG001|Base Study|Month 12 visit not completed|0|||
105655060|NCT00943722|364401800|FG002|Base Study|Month 12 visit not completed|0|||
105655061|NCT00943722|364401801|FG003|Base Study|Month 12 visit not completed|0|||
105655062|NCT00943722|364401802|FG004|Base Study|Month 12 visit not completed|2|||
105655063|NCT00943722|364401803|FG005|Base Study|Month 12 visit not completed|0|||
105655064|NCT00943722|364401804|FG006|Base Study|Month 12 visit not completed|0|||
105655065|NCT00943722|364401798|FG000|First Extension Study: EXT 1|Adverse Event|0|||
105655066|NCT00943722|364401799|FG001|First Extension Study: EXT 1|Adverse Event|0|||
105655067|NCT00943722|364401800|FG002|First Extension Study: EXT 1|Adverse Event|0|||
105655068|NCT00943722|364401801|FG003|First Extension Study: EXT 1|Adverse Event|0|||
105655069|NCT00943722|364401802|FG004|First Extension Study: EXT 1|Adverse Event|0|||
105655070|NCT00943722|364401803|FG005|First Extension Study: EXT 1|Adverse Event|1|||
105655071|NCT00943722|364401804|FG006|First Extension Study: EXT 1|Adverse Event|0|||
105655072|NCT00943722|364401798|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
105655073|NCT00943722|364401799|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
105655074|NCT00943722|364401800|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
105655075|NCT00943722|364401801|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
105655076|NCT00943722|364401802|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
105655077|NCT00943722|364401803|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
105655078|NCT00943722|364401804|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
105655079|NCT00943722|364401798|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
105655080|NCT00943722|364401799|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
105655081|NCT00943722|364401800|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
105655082|NCT00943722|364401801|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
105655083|NCT00943722|364401802|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
105655084|NCT00943722|364401803|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
105655085|NCT00943722|364401804|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
105655086|NCT00943722|364401798|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
105655087|NCT00943722|364401799|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
105655088|NCT00943722|364401800|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
105655089|NCT00943722|364401801|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
105655090|NCT00943722|364401802|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
105655091|NCT00943722|364401803|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
105655092|NCT00943722|364401804|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
105655093|NCT00943722|364401798|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
105655094|NCT00943722|364401799|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
105655095|NCT00943722|364401800|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
105655096|NCT00943722|364401801|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
105655097|NCT00943722|364401802|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
105655098|NCT00943722|364401803|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
105655099|NCT00943722|364401804|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
105655100|NCT00943722|364401798|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
105655101|NCT00943722|364401799|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
105655102|NCT00943722|364401800|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
105655103|NCT00943722|364401801|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
105655104|NCT00943722|364401802|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
105655105|NCT00943722|364401803|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
105655106|NCT00943722|364401804|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
105655107|NCT00943722|364401798|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
105655108|NCT00943722|364401799|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
105655109|NCT00943722|364401800|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
105655110|NCT00943722|364401801|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
105655111|NCT00943722|364401802|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
105655112|NCT00943722|364401803|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
105655113|NCT00943722|364401804|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
105655114|NCT00943722|364401798|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
105655115|NCT00943722|364401799|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
105655116|NCT00943722|364401800|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
105655117|NCT00943722|364401801|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
105655118|NCT00943722|364401802|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
105655119|NCT00943722|364401803|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
105655120|NCT00943722|364401804|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
105655121|NCT00943722|364401798|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
105655122|NCT00943722|364401799|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
105655123|NCT00943722|364401800|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
105655124|NCT00943722|364401801|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
105655125|NCT00943722|364401802|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
105655126|NCT00943722|364401803|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
105655127|NCT00943722|364401804|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
105655128|NCT01772823|364401805|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
105655129|NCT01772823|364401806|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
105655130|NCT01772823|364401805|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
105655131|NCT01772823|364401806|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
105655132|NCT01772823|364401805|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
105655133|NCT01772823|364401806|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
105655134|NCT01772823|364401805|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
105655135|NCT01772823|364401806|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
105655136|NCT01772823|364401805|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
105655137|NCT01772823|364401806|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
105655138|NCT01772823|364401805|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
105655139|NCT01772823|364401806|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
105655140|NCT01772823|364401805|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
105655141|NCT01772823|364401806|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
105655142|NCT01772823|364401805|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
105655143|NCT01772823|364401806|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
105655144|NCT01772823|364401805|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
105655145|NCT01772823|364401806|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
105655146|NCT01772823|364401805|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
105655147|NCT01772823|364401806|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
105655148|NCT01772823|364401805|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
105655149|NCT01772823|364401806|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
105655150|NCT01772823|364401805|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
105655151|NCT01772823|364401806|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
105655152|NCT01772823|364401805|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
105655153|NCT01772823|364401806|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
105655154|NCT01772823|364401805|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
105655155|NCT01772823|364401806|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
105655156|NCT01772823|364401805|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
105655157|NCT01772823|364401806|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
105655158|NCT01772823|364401805|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
105655159|NCT01772823|364401806|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
105655160|NCT00805285|364401807|FG000|Overall Study|Lack of Efficacy|1|||
105655161|NCT03712449|364401811|FG000|Overall Study|Withdraw Consent|0|||
105655162|NCT03712449|364401812|FG001|Overall Study|Withdraw Consent|1|||
105655163|NCT00666198|364401815|FG000|Overall Study|Protocol Violation|10|||
105655164|NCT00666198|364401815|FG000|Overall Study|No Visit After First Day of Treatment|13|||
105655165|NCT00666198|364401815|FG000|Overall Study|Safety Not Assessable|6|||
105655166|NCT00666198|364401815|FG000|Overall Study|No Drug Administration|4|||
105655167|NCT02544113|364401819|FG000|Overall Study|Death|3|||
105655168|NCT02544113|364401820|FG001|Overall Study|Death|4|||
105655169|NCT01049984|364401822|FG000|Overall Study|Withdrawal by Subject|1|||
105655170|NCT01049984|364401823|FG001|Overall Study|Withdrawal by Subject|5|||
105655171|NCT01049984|364401822|FG000|Overall Study|Protocol Violation|3|||
105655172|NCT01049984|364401823|FG001|Overall Study|Protocol Violation|4|||
105655173|NCT01049984|364401822|FG000|Overall Study|Lost to Follow-up|2|||
105655174|NCT01049984|364401823|FG001|Overall Study|Lost to Follow-up|1|||
105655175|NCT01049984|364401822|FG000|Overall Study|Adverse Event|13|||
105655176|NCT01049984|364401823|FG001|Overall Study|Adverse Event|7|||
105655177|NCT01049984|364401822|FG000|Overall Study|Treatment failure|0|||
105655178|NCT01049984|364401823|FG001|Overall Study|Treatment failure|2|||
105655179|NCT00451555|364401824|FG000|Overall Study|Protocol Violation|2|||
105655180|NCT00451555|364401825|FG001|Overall Study|Protocol Violation|2|||
105655181|NCT00451555|364401824|FG000|Overall Study|Adverse Event|3|||
105655182|NCT00451555|364401825|FG001|Overall Study|Adverse Event|1|||
105655183|NCT00451555|364401824|FG000|Overall Study|Withdrawal by Subject|6|||
105655184|NCT00451555|364401825|FG001|Overall Study|Withdrawal by Subject|0|||
105655185|NCT00451555|364401824|FG000|Overall Study|Physician Decision|2|||
105655186|NCT00451555|364401825|FG001|Overall Study|Physician Decision|1|||
105655187|NCT02512861|364401828|FG000|Overall Study|Protocol Violation|3|||
105655188|NCT02512861|364401829|FG001|Overall Study|Protocol Violation|7|||
105655189|NCT02512861|364401828|FG000|Overall Study|Physician Decision|3|||
105655190|NCT02512861|364401829|FG001|Overall Study|Physician Decision|1|||
105655191|NCT02512861|364401828|FG000|Overall Study|Withdrawal by Subject|0|||
105655192|NCT02512861|364401829|FG001|Overall Study|Withdrawal by Subject|1|||
105655193|NCT03214250|364401834|FG000|Overall Study|Death|5|||
105655194|NCT03214250|364401835|FG001|Overall Study|Death|5|||
105655195|NCT03214250|364401836|FG002|Overall Study|Death|7|||
105655196|NCT03214250|364401837|FG003|Overall Study|Death|4|||
105655197|NCT03214250|364401838|FG004|Overall Study|Death|23|||
105655198|NCT03214250|364401839|FG005|Overall Study|Death|23|||
105655199|NCT03214250|364401840|FG006|Overall Study|Death|24|||
105655200|NCT03214250|364401834|FG000|Overall Study|Lost to Follow-up|0|||
105655201|NCT03214250|364401835|FG001|Overall Study|Lost to Follow-up|0|||
105655202|NCT03214250|364401836|FG002|Overall Study|Lost to Follow-up|0|||
105655203|NCT03214250|364401837|FG003|Overall Study|Lost to Follow-up|1|||
105655204|NCT03214250|364401838|FG004|Overall Study|Lost to Follow-up|1|||
105655205|NCT03214250|364401839|FG005|Overall Study|Lost to Follow-up|2|||
105655206|NCT03214250|364401840|FG006|Overall Study|Lost to Follow-up|0|||
105655207|NCT03214250|364401834|FG000|Overall Study|Other|0|||
105655208|NCT03214250|364401835|FG001|Overall Study|Other|0|||
105655209|NCT03214250|364401836|FG002|Overall Study|Other|0|||
105655210|NCT03214250|364401837|FG003|Overall Study|Other|0|||
105655211|NCT03214250|364401838|FG004|Overall Study|Other|1|||
105655212|NCT03214250|364401839|FG005|Overall Study|Other|1|||
105655213|NCT03214250|364401840|FG006|Overall Study|Other|2|||
105655214|NCT03214250|364401834|FG000|Overall Study|Remains on Study|2|||
105655215|NCT03214250|364401835|FG001|Overall Study|Remains on Study|2|||
105655216|NCT03214250|364401836|FG002|Overall Study|Remains on Study|0|||
105655217|NCT03214250|364401837|FG003|Overall Study|Remains on Study|1|||
105655218|NCT03214250|364401838|FG004|Overall Study|Remains on Study|7|||
105655219|NCT03214250|364401839|FG005|Overall Study|Remains on Study|5|||
105655220|NCT03214250|364401840|FG006|Overall Study|Remains on Study|3|||
105655221|NCT03214250|364401834|FG000|Overall Study|Withdrawal by Subject|0|||
105655222|NCT03214250|364401835|FG001|Overall Study|Withdrawal by Subject|0|||
105655223|NCT03214250|364401836|FG002|Overall Study|Withdrawal by Subject|1|||
105655224|NCT03214250|364401837|FG003|Overall Study|Withdrawal by Subject|2|||
105655225|NCT03214250|364401838|FG004|Overall Study|Withdrawal by Subject|5|||
105655226|NCT03214250|364401839|FG005|Overall Study|Withdrawal by Subject|0|||
105655227|NCT03214250|364401840|FG006|Overall Study|Withdrawal by Subject|2|||
105655228|NCT00427778|364401841|FG000|First Intervention (4 Weeks)|no longer interested|1|||
105655229|NCT00427778|364401842|FG001|First Intervention (4 Weeks)|no longer interested|0|||
105655230|NCT00427778|364401841|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
105655231|NCT00427778|364401842|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
105655232|NCT00427778|364401841|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
105655233|NCT00427778|364401842|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
105655234|NCT00427778|364401841|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
105655235|NCT00427778|364401842|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
105655236|NCT01836198|364401846|FG000|Part A, Period 2|Protocol Violation|0|||
105655237|NCT01836198|364401847|FG001|Part A, Period 2|Protocol Violation|1|||
105655238|NCT01836198|364401848|FG002|Part A, Period 2|Protocol Violation|0|||
105655239|NCT03187353|364401849|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
105655240|NCT03187353|364401850|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
105655241|NCT03187353|364401849|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
105655242|NCT03187353|364401850|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
105655243|NCT03187353|364401849|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
105655244|NCT03187353|364401850|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
105655245|NCT03187353|364401849|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
105655246|NCT03187353|364401850|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
105655247|NCT03187353|364401849|FG000|Washout (2 Weeks)|Adverse Event|2|||
105655248|NCT03187353|364401850|FG001|Washout (2 Weeks)|Adverse Event|0|||
105655249|NCT03187353|364401849|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
105655250|NCT03187353|364401850|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
105655251|NCT01281917|364401851|FG000|Overall Study|Withdrawal by Subject|1|||
105655252|NCT00634920|364401854|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
105655253|NCT00634920|364401855|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
105655254|NCT00634920|364401856|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
105655255|NCT00634920|364401854|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
105655256|NCT00634920|364401855|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
105655257|NCT00634920|364401856|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
105655258|NCT00634920|364401854|FG000|Period 1 - Pre-Randomization|Rejections|0|||
105655259|NCT00634920|364401855|FG001|Period 1 - Pre-Randomization|Rejections|0|||
105655260|NCT00634920|364401856|FG002|Period 1 - Pre-Randomization|Rejections|55|||
105655261|NCT00634920|364401854|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
105655262|NCT00634920|364401855|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
105655263|NCT00634920|364401856|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
105655264|NCT00634920|364401854|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
105655265|NCT00634920|364401855|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
105655266|NCT00634920|364401856|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
105655267|NCT00634920|364401854|FG000|Period 1 - Pre-Randomization|Other issues|0|||
105655268|NCT00634920|364401855|FG001|Period 1 - Pre-Randomization|Other issues|0|||
105655269|NCT00634920|364401856|FG002|Period 1 - Pre-Randomization|Other issues|6|||
105655270|NCT00634920|364401854|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
105655271|NCT00634920|364401855|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
105655272|NCT00634920|364401856|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
105655273|NCT00634920|364401854|FG000|Period 2 - Post-Randomization|Rejection|11|||
105655274|NCT00634920|364401855|FG001|Period 2 - Post-Randomization|Rejection|5|||
105655275|NCT00634920|364401856|FG002|Period 2 - Post-Randomization|Rejection|0|||
105655276|NCT00634920|364401854|FG000|Period 2 - Post-Randomization|Death|2|||
105655277|NCT00634920|364401855|FG001|Period 2 - Post-Randomization|Death|5|||
105655278|NCT00634920|364401856|FG002|Period 2 - Post-Randomization|Death|0|||
105655279|NCT00634920|364401854|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
105655280|NCT00634920|364401855|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
105655281|NCT00634920|364401856|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
105655282|NCT00634920|364401854|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
105655283|NCT00634920|364401855|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
105655284|NCT00634920|364401856|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
105655285|NCT02101268|364401857|FG000|Randomized Treatment Phase|Subject Decision|8|||
105655286|NCT02101268|364401858|FG001|Randomized Treatment Phase|Subject Decision|4|||
105655287|NCT02101268|364401859|FG002|Randomized Treatment Phase|Subject Decision|0|||
105655288|NCT02101268|364401860|FG003|Randomized Treatment Phase|Subject Decision|0|||
105655289|NCT02101268|364401857|FG000|Randomized Treatment Phase|Physician Decision|4|||
105655290|NCT02101268|364401858|FG001|Randomized Treatment Phase|Physician Decision|1|||
105655291|NCT02101268|364401859|FG002|Randomized Treatment Phase|Physician Decision|0|||
105655292|NCT02101268|364401860|FG003|Randomized Treatment Phase|Physician Decision|0|||
105655293|NCT02101268|364401857|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
105655294|NCT02101268|364401858|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
105655295|NCT02101268|364401859|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
105655296|NCT02101268|364401860|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
105655297|NCT02101268|364401857|FG000|Randomized Treatment Phase|Adverse Event|6|||
105655298|NCT02101268|364401858|FG001|Randomized Treatment Phase|Adverse Event|0|||
105655299|NCT02101268|364401859|FG002|Randomized Treatment Phase|Adverse Event|0|||
105655300|NCT02101268|364401860|FG003|Randomized Treatment Phase|Adverse Event|0|||
105655301|NCT02101268|364401857|FG000|Randomized Treatment Phase|Death|5|||
105655302|NCT02101268|364401858|FG001|Randomized Treatment Phase|Death|4|||
105655303|NCT02101268|364401859|FG002|Randomized Treatment Phase|Death|0|||
105655304|NCT02101268|364401860|FG003|Randomized Treatment Phase|Death|0|||
105655305|NCT02101268|364401857|FG000|Randomized Treatment Phase|Disease Progression|4|||
105655306|NCT02101268|364401858|FG001|Randomized Treatment Phase|Disease Progression|1|||
105655307|NCT02101268|364401859|FG002|Randomized Treatment Phase|Disease Progression|0|||
105655308|NCT02101268|364401860|FG003|Randomized Treatment Phase|Disease Progression|0|||
105655309|NCT02101268|364401857|FG000|Extended Treatment Phase|Subject Decision|0|||
105655310|NCT02101268|364401858|FG001|Extended Treatment Phase|Subject Decision|0|||
105655311|NCT02101268|364401859|FG002|Extended Treatment Phase|Subject Decision|3|||
105655312|NCT02101268|364401860|FG003|Extended Treatment Phase|Subject Decision|2|||
105655313|NCT02101268|364401857|FG000|Extended Treatment Phase|Physician Decision|0|||
105655314|NCT02101268|364401858|FG001|Extended Treatment Phase|Physician Decision|0|||
105655315|NCT02101268|364401859|FG002|Extended Treatment Phase|Physician Decision|5|||
105655316|NCT02101268|364401860|FG003|Extended Treatment Phase|Physician Decision|2|||
105655317|NCT02101268|364401857|FG000|Extended Treatment Phase|Adverse Event|0|||
105655318|NCT02101268|364401858|FG001|Extended Treatment Phase|Adverse Event|0|||
105655319|NCT02101268|364401859|FG002|Extended Treatment Phase|Adverse Event|14|||
105655320|NCT02101268|364401860|FG003|Extended Treatment Phase|Adverse Event|18|||
105655321|NCT02101268|364401857|FG000|Extended Treatment Phase|Death|0|||
105655322|NCT02101268|364401858|FG001|Extended Treatment Phase|Death|0|||
105655323|NCT02101268|364401859|FG002|Extended Treatment Phase|Death|5|||
105655324|NCT02101268|364401860|FG003|Extended Treatment Phase|Death|1|||
105655325|NCT02101268|364401857|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
105655326|NCT02101268|364401858|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
105655327|NCT02101268|364401859|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
105655328|NCT02101268|364401860|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
105655329|NCT02101268|364401857|FG000|Extended Treatment Phase|Disease Progression|0|||
105655330|NCT02101268|364401858|FG001|Extended Treatment Phase|Disease Progression|0|||
105655331|NCT02101268|364401859|FG002|Extended Treatment Phase|Disease Progression|13|||
105655332|NCT02101268|364401860|FG003|Extended Treatment Phase|Disease Progression|6|||
105655333|NCT02101268|364401857|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
105655334|NCT02101268|364401858|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
105655335|NCT02101268|364401859|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
105655336|NCT02101268|364401860|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
105655337|NCT01193218|364401861|FG000|0-12 Weeks|Adverse Event|6|||
105655338|NCT01193218|364401862|FG001|0-12 Weeks|Adverse Event|0|||
105655339|NCT01193218|364401863|FG002|0-12 Weeks|Adverse Event|1|||
105655340|NCT01193218|364401864|FG003|0-12 Weeks|Adverse Event|0|||
105655341|NCT01193218|364401865|FG004|0-12 Weeks|Adverse Event|0|||
105655342|NCT01193218|364401866|FG005|0-12 Weeks|Adverse Event|2|||
105655343|NCT01193218|364401867|FG006|0-12 Weeks|Adverse Event|2|||
105655344|NCT01193218|364401868|FG007|0-12 Weeks|Adverse Event|0|||
105655345|NCT01193218|364401861|FG000|0-12 Weeks|Protocol Violation|0|||
105655346|NCT01193218|364401862|FG001|0-12 Weeks|Protocol Violation|0|||
105655347|NCT01193218|364401863|FG002|0-12 Weeks|Protocol Violation|0|||
105655348|NCT01193218|364401864|FG003|0-12 Weeks|Protocol Violation|0|||
105655349|NCT01193218|364401865|FG004|0-12 Weeks|Protocol Violation|1|||
105655350|NCT01193218|364401866|FG005|0-12 Weeks|Protocol Violation|1|||
105655351|NCT01193218|364401867|FG006|0-12 Weeks|Protocol Violation|0|||
105655352|NCT01193218|364401868|FG007|0-12 Weeks|Protocol Violation|0|||
105655353|NCT01193218|364401861|FG000|0-12 Weeks|Withdrawal by Subject|3|||
105655354|NCT01193218|364401862|FG001|0-12 Weeks|Withdrawal by Subject|0|||
105655355|NCT01193218|364401863|FG002|0-12 Weeks|Withdrawal by Subject|2|||
105655356|NCT01193218|364401864|FG003|0-12 Weeks|Withdrawal by Subject|0|||
105655357|NCT01193218|364401865|FG004|0-12 Weeks|Withdrawal by Subject|0|||
105655358|NCT01193218|364401866|FG005|0-12 Weeks|Withdrawal by Subject|0|||
105655359|NCT01193218|364401867|FG006|0-12 Weeks|Withdrawal by Subject|1|||
105655360|NCT01193218|364401868|FG007|0-12 Weeks|Withdrawal by Subject|0|||
105655361|NCT01193218|364401861|FG000|12-52 Weeks|Adverse Event|1|||
105655362|NCT01193218|364401862|FG001|12-52 Weeks|Adverse Event|0|||
105655363|NCT01193218|364401863|FG002|12-52 Weeks|Adverse Event|1|||
105655364|NCT01193218|364401864|FG003|12-52 Weeks|Adverse Event|2|||
105655365|NCT01193218|364401865|FG004|12-52 Weeks|Adverse Event|3|||
105655366|NCT01193218|364401866|FG005|12-52 Weeks|Adverse Event|3|||
105655367|NCT01193218|364401867|FG006|12-52 Weeks|Adverse Event|1|||
105655368|NCT01193218|364401868|FG007|12-52 Weeks|Adverse Event|2|||
105655369|NCT01193218|364401861|FG000|12-52 Weeks|Lack of Efficacy|0|||
105655370|NCT01193218|364401862|FG001|12-52 Weeks|Lack of Efficacy|0|||
105655371|NCT01193218|364401863|FG002|12-52 Weeks|Lack of Efficacy|0|||
105655372|NCT01193218|364401864|FG003|12-52 Weeks|Lack of Efficacy|0|||
105655373|NCT01193218|364401865|FG004|12-52 Weeks|Lack of Efficacy|0|||
105655374|NCT01193218|364401866|FG005|12-52 Weeks|Lack of Efficacy|0|||
105655375|NCT01193218|364401867|FG006|12-52 Weeks|Lack of Efficacy|1|||
105655376|NCT01193218|364401868|FG007|12-52 Weeks|Lack of Efficacy|0|||
105655377|NCT01193218|364401861|FG000|12-52 Weeks|Withdrawal by Subject|3|||
105655378|NCT01193218|364401862|FG001|12-52 Weeks|Withdrawal by Subject|0|||
105655379|NCT01193218|364401863|FG002|12-52 Weeks|Withdrawal by Subject|3|||
105655380|NCT01193218|364401864|FG003|12-52 Weeks|Withdrawal by Subject|0|||
105655381|NCT01193218|364401865|FG004|12-52 Weeks|Withdrawal by Subject|0|||
105655382|NCT01193218|364401866|FG005|12-52 Weeks|Withdrawal by Subject|2|||
105655383|NCT01193218|364401867|FG006|12-52 Weeks|Withdrawal by Subject|1|||
105655384|NCT01193218|364401868|FG007|12-52 Weeks|Withdrawal by Subject|2|||
105655385|NCT01193218|364401861|FG000|12-52 Weeks|Other reason than above|1|||
105655386|NCT01193218|364401862|FG001|12-52 Weeks|Other reason than above|0|||
105655387|NCT01193218|364401863|FG002|12-52 Weeks|Other reason than above|0|||
105655388|NCT01193218|364401864|FG003|12-52 Weeks|Other reason than above|1|||
105655389|NCT01193218|364401865|FG004|12-52 Weeks|Other reason than above|1|||
105655390|NCT01193218|364401866|FG005|12-52 Weeks|Other reason than above|0|||
105655391|NCT01193218|364401867|FG006|12-52 Weeks|Other reason than above|0|||
105655392|NCT01193218|364401868|FG007|12-52 Weeks|Other reason than above|0|||
105655393|NCT01013740|364401869|FG000|Overall Study|Lost to Follow-up|3|||
105655394|NCT01013740|364401870|FG001|Overall Study|Lost to Follow-up|5|||
105655395|NCT01013740|364401869|FG000|Overall Study|Physician Decision|2|||
105655396|NCT01013740|364401870|FG001|Overall Study|Physician Decision|0|||
105655397|NCT01013740|364401869|FG000|Overall Study|Withdrawal by Subject|2|||
105655398|NCT01013740|364401870|FG001|Overall Study|Withdrawal by Subject|10|||
105655399|NCT01013740|364401869|FG000|Overall Study|study close / terminated : done in error|2|||
105655400|NCT01013740|364401870|FG001|Overall Study|study close / terminated : done in error|1|||
105655401|NCT01013740|364401869|FG000|Overall Study|Missing|2|||
105655402|NCT01013740|364401870|FG001|Overall Study|Missing|1|||
105655403|NCT01013740|364401869|FG000|Overall Study|Ongoing: Study records not completed|0|||
105655404|NCT01013740|364401870|FG001|Overall Study|Ongoing: Study records not completed|2|||
105655405|NCT00607997|364401871|FG000|Overall Study|Lack of Efficacy|6|||
105655406|NCT00607997|364401872|FG001|Overall Study|Lack of Efficacy|20|||
105655407|NCT00607997|364401873|FG002|Overall Study|Lack of Efficacy|14|||
105655408|NCT00607997|364401874|FG003|Overall Study|Lack of Efficacy|10|||
105655409|NCT00607997|364401871|FG000|Overall Study|Death|8|||
105655410|NCT00607997|364401872|FG001|Overall Study|Death|5|||
105655411|NCT00607997|364401873|FG002|Overall Study|Death|2|||
105655412|NCT00607997|364401874|FG003|Overall Study|Death|5|||
105655413|NCT00607997|364401871|FG000|Overall Study|Adverse Event|3|||
105655414|NCT00607997|364401872|FG001|Overall Study|Adverse Event|1|||
105655415|NCT00607997|364401873|FG002|Overall Study|Adverse Event|2|||
105655416|NCT00607997|364401874|FG003|Overall Study|Adverse Event|0|||
105655417|NCT00607997|364401871|FG000|Overall Study|Physician Decision|4|||
105655418|NCT00607997|364401872|FG001|Overall Study|Physician Decision|1|||
105655419|NCT00607997|364401873|FG002|Overall Study|Physician Decision|0|||
105655420|NCT00607997|364401874|FG003|Overall Study|Physician Decision|0|||
105655421|NCT00607997|364401871|FG000|Overall Study|Relapse, recurrent illness|4|||
105655422|NCT00607997|364401872|FG001|Overall Study|Relapse, recurrent illness|0|||
105655423|NCT00607997|364401873|FG002|Overall Study|Relapse, recurrent illness|2|||
105655424|NCT00607997|364401874|FG003|Overall Study|Relapse, recurrent illness|0|||
105655425|NCT00607997|364401871|FG000|Overall Study|Other without explanation|2|||
105655426|NCT00607997|364401872|FG001|Overall Study|Other without explanation|0|||
105655427|NCT00607997|364401873|FG002|Overall Study|Other without explanation|4|||
105655428|NCT00607997|364401874|FG003|Overall Study|Other without explanation|1|||
105655429|NCT01209286|364401876|FG000|Overall Study|Adverse Event|4|||
105655430|NCT01209286|364401877|FG001|Overall Study|Adverse Event|3|||
105655431|NCT01209286|364401878|FG002|Overall Study|Adverse Event|1|||
105655432|NCT01209286|364401876|FG000|Overall Study|Hematological Relapse After Remission|0|||
105655433|NCT01209286|364401877|FG001|Overall Study|Hematological Relapse After Remission|1|||
105655434|NCT01209286|364401878|FG002|Overall Study|Hematological Relapse After Remission|1|||
105655435|NCT01209286|364401876|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
105655436|NCT01209286|364401877|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
105655437|NCT01209286|364401878|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
105655438|NCT01209286|364401876|FG000|Overall Study|Physician Decision|0|||
105655439|NCT01209286|364401877|FG001|Overall Study|Physician Decision|2|||
105655440|NCT01209286|364401878|FG002|Overall Study|Physician Decision|0|||
105655441|NCT01209286|364401876|FG000|Overall Study|Other|0|||
105655442|NCT01209286|364401877|FG001|Overall Study|Other|1|||
105655443|NCT01209286|364401878|FG002|Overall Study|Other|0|||
105655444|NCT03796208|364401879|FG000|Overall Study|Withdrawal by Subject|3|||
105655445|NCT03796208|364401880|FG001|Overall Study|Withdrawal by Subject|0|||
105655446|NCT03796208|364401879|FG000|Overall Study|Loss of pregnancy|1|||
105655447|NCT03796208|364401880|FG001|Overall Study|Loss of pregnancy|1|||
105655448|NCT03796208|364401879|FG000|Overall Study|Changed prenatal clinics|0|||
105655449|NCT03796208|364401880|FG001|Overall Study|Changed prenatal clinics|5|||
105655450|NCT03796208|364401879|FG000|Overall Study|Lost to Follow-up|20|||
105655451|NCT03796208|364401880|FG001|Overall Study|Lost to Follow-up|16|||
105655452|NCT02881047|364401883|FG000|Overall Study|Adverse Event|1|||
105655453|NCT02881047|364401883|FG000|Overall Study|Withdrawal by Subject|1|||
105655454|NCT01424189|364401889|FG000|Overall Study|Adverse Event|1|||
105655455|NCT01424189|364401890|FG001|Overall Study|Adverse Event|0|||
105655456|NCT01424189|364401889|FG000|Overall Study|Lost to Follow-up|4|||
105655457|NCT01424189|364401890|FG001|Overall Study|Lost to Follow-up|1|||
105655458|NCT01424189|364401889|FG000|Overall Study|Withdrawal by Subject|4|||
105655459|NCT01424189|364401890|FG001|Overall Study|Withdrawal by Subject|4|||
105655460|NCT01424189|364401889|FG000|Overall Study|Subject moved|1|||
105655461|NCT01424189|364401890|FG001|Overall Study|Subject moved|0|||
105655462|NCT01424189|364401889|FG000|Overall Study|Death|3|||
105655463|NCT01424189|364401890|FG001|Overall Study|Death|1|||
105655464|NCT01705145|364401891|FG000|Part B|Adverse Event|1|||
105655465|NCT01024036|364401900|FG000|Blinded Treatment|Adverse Event|1|||
105655466|NCT01024036|364401901|FG001|Blinded Treatment|Adverse Event|1|||
105655467|NCT01024036|364401900|FG000|Blinded Treatment|Lack of Efficacy|16|||
105655468|NCT01024036|364401901|FG001|Blinded Treatment|Lack of Efficacy|14|||
105655469|NCT01024036|364401900|FG000|Blinded Treatment|Physician Decision|1|||
105655470|NCT01024036|364401901|FG001|Blinded Treatment|Physician Decision|0|||
105655471|NCT01024036|364401900|FG000|Blinded Treatment|Death|0|||
105655472|NCT01024036|364401901|FG001|Blinded Treatment|Death|2|||
105655473|NCT01024036|364401900|FG000|Blinded Treatment|Withdrawal by Subject|4|||
105655474|NCT01024036|364401901|FG001|Blinded Treatment|Withdrawal by Subject|3|||
105655475|NCT01024036|364401900|FG000|Unblinded Treatment|Adverse Event|0|||
105655476|NCT01024036|364401901|FG001|Unblinded Treatment|Adverse Event|1|||
105655477|NCT01024036|364401900|FG000|Unblinded Treatment|Lack of Efficacy|0|||
105655478|NCT01024036|364401901|FG001|Unblinded Treatment|Lack of Efficacy|2|||
105655479|NCT01024036|364401900|FG000|Follow-Up Period|Lost to Follow-up|1|||
105655480|NCT01024036|364401901|FG001|Follow-Up Period|Lost to Follow-up|1|||
105655481|NCT01024036|364401900|FG000|Follow-Up Period|Withdrawal by Subject|0|||
105655482|NCT01024036|364401901|FG001|Follow-Up Period|Withdrawal by Subject|1|||
105655483|NCT01024036|364401900|FG000|Follow-Up Period|Adverse Event|4|||
105655484|NCT01024036|364401901|FG001|Follow-Up Period|Adverse Event|1|||
105655485|NCT00361842|364401902|FG000|Overall Study|Withdrawal by Subject|2|||
105655486|NCT00361842|364401903|FG001|Overall Study|Withdrawal by Subject|3|||
105655487|NCT00361842|364401902|FG000|Overall Study|Death|2|||
105655488|NCT00361842|364401903|FG001|Overall Study|Death|1|||
105655489|NCT00361842|364401902|FG000|Overall Study|Disease progression|19|||
105655490|NCT00361842|364401903|FG001|Overall Study|Disease progression|20|||
105655491|NCT00361842|364401902|FG000|Overall Study|Adverse Event|2|||
105655492|NCT00361842|364401903|FG001|Overall Study|Adverse Event|3|||
105655493|NCT00361842|364401902|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
105655494|NCT00361842|364401903|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
105655495|NCT00361842|364401902|FG000|Overall Study|Other|1|||
105655496|NCT00361842|364401903|FG001|Overall Study|Other|0|||
105655497|NCT00361842|364401902|FG000|Overall Study|Other|0|||
105655498|NCT00361842|364401903|FG001|Overall Study|Other|2|||
105655499|NCT04814992|364401908|FG000|Overall Study|Withdrawal by Subject|6|||
105655500|NCT04814992|364401909|FG001|Overall Study|Withdrawal by Subject|3|||
105655501|NCT04814992|364401908|FG000|Overall Study|Lost to Follow-up|1|||
105655502|NCT04814992|364401909|FG001|Overall Study|Lost to Follow-up|4|||
105655503|NCT02212197|364401910|FG000|Overall Study|Need for radiotherapy|1|||
105655504|NCT02212197|364401911|FG001|Overall Study|Need for radiotherapy|0|||
105655505|NCT02212197|364401912|FG002|Overall Study|Need for radiotherapy|0|||
105655506|NCT01260142|364401913|FG000|Treatment Period 1|Study on hold|1|||
105655507|NCT01260142|364401914|FG001|Treatment Period 1|Study on hold|1|||
105655508|NCT01260142|364401915|FG002|Treatment Period 1|Study on hold|0|||
105655509|NCT01260142|364401916|FG003|Treatment Period 1|Study on hold|0|||
105655510|NCT01260142|364401917|FG004|Treatment Period 1|Study on hold|1|||
105655511|NCT01260142|364401918|FG005|Treatment Period 1|Study on hold|2|||
105655512|NCT01260142|364401913|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
105655513|NCT01260142|364401914|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
105655514|NCT01260142|364401915|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
105655515|NCT01260142|364401916|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
105655516|NCT01260142|364401917|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
105655517|NCT01260142|364401918|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
105655518|NCT01260142|364401913|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105655519|NCT01260142|364401914|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105655520|NCT01260142|364401915|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105655521|NCT01260142|364401916|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105655522|NCT01260142|364401917|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105655523|NCT01260142|364401918|FG005|Treatment Period 1|Withdrawal by Subject|1|||
105655524|NCT01494298|364401919|FG000|Overall Study|Protocol Violation|2|||
105655525|NCT01494298|364401920|FG001|Overall Study|Protocol Violation|8|||
105655526|NCT01393613|364401921|FG000|Overall Study|Adverse Event|11|||
105655527|NCT01393613|364401922|FG001|Overall Study|Adverse Event|11|||
105655528|NCT01393613|364401923|FG002|Overall Study|Adverse Event|13|||
105655529|NCT01393613|364401924|FG003|Overall Study|Adverse Event|22|||
105655530|NCT01393613|364401921|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
105655531|NCT01393613|364401922|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
105655532|NCT01393613|364401923|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
105655533|NCT01393613|364401924|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
105655534|NCT01393613|364401921|FG000|Overall Study|Physician Decision|2|||
105655535|NCT01393613|364401922|FG001|Overall Study|Physician Decision|0|||
105655536|NCT01393613|364401923|FG002|Overall Study|Physician Decision|0|||
105655537|NCT01393613|364401924|FG003|Overall Study|Physician Decision|1|||
105655538|NCT01393613|364401921|FG000|Overall Study|Withdrawal by Subject|15|||
105655539|NCT01393613|364401922|FG001|Overall Study|Withdrawal by Subject|25|||
105655540|NCT01393613|364401923|FG002|Overall Study|Withdrawal by Subject|23|||
105655541|NCT01393613|364401924|FG003|Overall Study|Withdrawal by Subject|21|||
105655542|NCT01393613|364401921|FG000|Overall Study|Protocol Deviation|2|||
105655543|NCT01393613|364401922|FG001|Overall Study|Protocol Deviation|1|||
105655544|NCT01393613|364401923|FG002|Overall Study|Protocol Deviation|0|||
105655545|NCT01393613|364401924|FG003|Overall Study|Protocol Deviation|0|||
105655546|NCT01393613|364401921|FG000|Overall Study|Lack of Efficacy|9|||
105655547|NCT01393613|364401922|FG001|Overall Study|Lack of Efficacy|20|||
105655548|NCT01393613|364401923|FG002|Overall Study|Lack of Efficacy|16|||
105655549|NCT01393613|364401924|FG003|Overall Study|Lack of Efficacy|21|||
105655550|NCT03821064|364401927|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
105655551|NCT01283971|364401928|FG000|Overall Study|Adverse Event|3|||
105655552|NCT01283971|364401929|FG001|Overall Study|Adverse Event|5|||
105655553|NCT01283971|364401928|FG000|Overall Study|Insufficient therapeutic responses|3|||
105655554|NCT01283971|364401929|FG001|Overall Study|Insufficient therapeutic responses|3|||
105655555|NCT01283971|364401928|FG000|Overall Study|Protocol Violation|5|||
105655556|NCT01283971|364401929|FG001|Overall Study|Protocol Violation|1|||
105655557|NCT01283971|364401928|FG000|Overall Study|Refused treatment|3|||
105655558|NCT01283971|364401929|FG001|Overall Study|Refused treatment|1|||
105655559|NCT01283971|364401928|FG000|Overall Study|Failure to return|0|||
105655560|NCT01283971|364401929|FG001|Overall Study|Failure to return|1|||
105655561|NCT01283971|364401928|FG000|Overall Study|Administrative reasons|1|||
105655562|NCT01283971|364401929|FG001|Overall Study|Administrative reasons|1|||
105655563|NCT01502371|364401930|FG000|Overall Study|Withdrawal by Subject|1|||
105655564|NCT01502371|364401931|FG001|Overall Study|Withdrawal by Subject|2|||
105655565|NCT01502371|364401932|FG002|Overall Study|Withdrawal by Subject|1|||
105655566|NCT01502371|364401933|FG003|Overall Study|Withdrawal by Subject|1|||
105655567|NCT01502371|364401934|FG004|Overall Study|Withdrawal by Subject|1|||
105655568|NCT01502371|364401930|FG000|Overall Study|Adverse Event|2|||
105655569|NCT01502371|364401931|FG001|Overall Study|Adverse Event|1|||
105655570|NCT01502371|364401932|FG002|Overall Study|Adverse Event|0|||
105655571|NCT01502371|364401933|FG003|Overall Study|Adverse Event|4|||
105655572|NCT01502371|364401934|FG004|Overall Study|Adverse Event|3|||
105655573|NCT01502371|364401930|FG000|Overall Study|Treatment Failure|22|||
105655574|NCT01502371|364401931|FG001|Overall Study|Treatment Failure|20|||
105655575|NCT01502371|364401932|FG002|Overall Study|Treatment Failure|12|||
105655576|NCT01502371|364401933|FG003|Overall Study|Treatment Failure|19|||
105655577|NCT01502371|364401934|FG004|Overall Study|Treatment Failure|30|||
105655578|NCT01502371|364401930|FG000|Overall Study|Lack of Efficacy|3|||
105655579|NCT01502371|364401931|FG001|Overall Study|Lack of Efficacy|3|||
105655580|NCT01502371|364401932|FG002|Overall Study|Lack of Efficacy|2|||
105655581|NCT01502371|364401933|FG003|Overall Study|Lack of Efficacy|2|||
105655582|NCT01502371|364401934|FG004|Overall Study|Lack of Efficacy|4|||
105655583|NCT01502371|364401930|FG000|Overall Study|Physician Decision|3|||
105655584|NCT01502371|364401931|FG001|Overall Study|Physician Decision|0|||
105655585|NCT01502371|364401932|FG002|Overall Study|Physician Decision|0|||
105655586|NCT01502371|364401933|FG003|Overall Study|Physician Decision|0|||
105655587|NCT01502371|364401934|FG004|Overall Study|Physician Decision|1|||
105655588|NCT01502371|364401930|FG000|Overall Study|Noncompliance with Study Drug|0|||
105655589|NCT01502371|364401931|FG001|Overall Study|Noncompliance with Study Drug|0|||
105655590|NCT01502371|364401932|FG002|Overall Study|Noncompliance with Study Drug|1|||
105655591|NCT01502371|364401933|FG003|Overall Study|Noncompliance with Study Drug|2|||
105655592|NCT01502371|364401934|FG004|Overall Study|Noncompliance with Study Drug|1|||
105655593|NCT01502371|364401930|FG000|Overall Study|Technical Problems|1|||
105655594|NCT01502371|364401931|FG001|Overall Study|Technical Problems|0|||
105655595|NCT01502371|364401932|FG002|Overall Study|Technical Problems|2|||
105655596|NCT01502371|364401933|FG003|Overall Study|Technical Problems|4|||
105655597|NCT01502371|364401934|FG004|Overall Study|Technical Problems|1|||
105655598|NCT01502371|364401930|FG000|Overall Study|Protocol Violation|9|||
105655599|NCT01502371|364401931|FG001|Overall Study|Protocol Violation|5|||
105655600|NCT01502371|364401932|FG002|Overall Study|Protocol Violation|6|||
105655601|NCT01502371|364401933|FG003|Overall Study|Protocol Violation|5|||
105655602|NCT01502371|364401934|FG004|Overall Study|Protocol Violation|10|||
105655603|NCT01502371|364401930|FG000|Overall Study|Excluded Medication|0|||
105655604|NCT01502371|364401931|FG001|Overall Study|Excluded Medication|1|||
105655605|NCT01502371|364401932|FG002|Overall Study|Excluded Medication|1|||
105655606|NCT01502371|364401933|FG003|Overall Study|Excluded Medication|0|||
105655607|NCT01502371|364401934|FG004|Overall Study|Excluded Medication|1|||
105655608|NCT01929876|364403496|FG000|Period 2|Non-Compliance|1|||
105655609|NCT01036165|364403499|FG000|Overall Study|Adverse Event|6|||
105655610|NCT01036165|364403499|FG000|Overall Study|Lost to Follow-up|2|||
105655611|NCT01036165|364403499|FG000|Overall Study|Withdrawal by Subject|3|||
105655612|NCT01036165|364403499|FG000|Overall Study|Device Related Issues|3|||
105655613|NCT01036165|364403499|FG000|Overall Study|Problems finding proper area to inject|1|||
105655614|NCT01167192|364403501|FG000|Overall Study|Adverse Event|1|||
105655615|NCT01167192|364403501|FG000|Overall Study|Death|1|||
105655616|NCT01167192|364403501|FG000|Overall Study|Withdrawal by Subject|1|||
105655617|NCT01167192|364403501|FG000|Overall Study|Insurance denial|1|||
105655618|NCT02246218|364403502|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105655619|NCT02246218|364403503|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
105655620|NCT02246218|364403502|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
105655621|NCT02246218|364403503|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
105655622|NCT02246218|364403502|FG000|Overall Study|Adverse Event|1|||
105655623|NCT02246218|364403503|FG001|Overall Study|Adverse Event|1|||
105655624|NCT02246218|364403502|FG000|Overall Study|Lost to Follow-up|1|||
105655625|NCT02246218|364403503|FG001|Overall Study|Lost to Follow-up|0|||
105655626|NCT03927222|364403504|FG000|Overall Study|Progression|3|||
105655627|NCT03927222|364403504|FG000|Overall Study|CMV testing results inconclusive|1|||
105655628|NCT03927222|364403504|FG000|Overall Study|Unable to generate enough vaccines|1|||
105655629|NCT03927222|364403504|FG000|Overall Study|Early study termination|1|||
105655630|NCT00866918|364403508|FG000|Overall Study|Death|1|||
105655631|NCT00866918|364403509|FG001|Overall Study|Death|5|||
105655632|NCT00866918|364403508|FG000|Overall Study|Lack of Efficacy|1|||
105655633|NCT00866918|364403509|FG001|Overall Study|Lack of Efficacy|1|||
105655634|NCT00866918|364403508|FG000|Overall Study|Physician Decision|10|||
105655635|NCT00866918|364403509|FG001|Overall Study|Physician Decision|2|||
105655636|NCT00866918|364403508|FG000|Overall Study|Ineligible|2|||
105655637|NCT00866918|364403509|FG001|Overall Study|Ineligible|4|||
105655638|NCT00866918|364403508|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
105655639|NCT00866918|364403509|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
105655640|NCT00866918|364403508|FG000|Overall Study|Secondary malignancy|1|||
105655641|NCT00866918|364403509|FG001|Overall Study|Secondary malignancy|0|||
105655642|NCT03974100|364403512|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
105655643|NCT03974100|364403513|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
105655644|NCT03974100|364403514|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
105655645|NCT03974100|364403515|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
105655646|NCT03974100|364403516|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
105655647|NCT03974100|364403512|FG000|TP1 - Day 1 to Week 52|Death|1|||
105655648|NCT03974100|364403513|FG001|TP1 - Day 1 to Week 52|Death|0|||
105655649|NCT03974100|364403514|FG002|TP1 - Day 1 to Week 52|Death|0|||
105655650|NCT03974100|364403515|FG003|TP1 - Day 1 to Week 52|Death|0|||
105655651|NCT03974100|364403516|FG004|TP1 - Day 1 to Week 52|Death|0|||
105655652|NCT03974100|364403512|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
105655653|NCT03974100|364403513|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
105655654|NCT03974100|364403514|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
105655655|NCT03974100|364403515|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
105655656|NCT03974100|364403516|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
105655657|NCT03974100|364403512|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
105655658|NCT03974100|364403513|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
105655659|NCT03974100|364403514|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
105655660|NCT03974100|364403515|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
105655661|NCT03974100|364403516|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
105655662|NCT03974100|364403512|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
105655663|NCT03974100|364403513|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
105655664|NCT03974100|364403514|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
105655665|NCT03974100|364403515|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
105655666|NCT03974100|364403516|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
105655667|NCT03974100|364403512|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
105655668|NCT03974100|364403513|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
105655669|NCT03974100|364403514|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
105655670|NCT03974100|364403515|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
105655671|NCT03974100|364403516|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
105655672|NCT03974100|364403512|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
105655673|NCT03974100|364403513|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
105655674|NCT03974100|364403514|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
105655675|NCT03974100|364403515|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
105655676|NCT03974100|364403516|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
105655677|NCT00001941|364403517|FG000|Overall Study|not treated- rapidly progressing disease|0|||
105655678|NCT00001941|364403518|FG001|Overall Study|not treated- rapidly progressing disease|0|||
105655679|NCT00001941|364403519|FG002|Overall Study|not treated- rapidly progressing disease|0|||
105655680|NCT00001941|364403520|FG003|Overall Study|not treated- rapidly progressing disease|0|||
105655681|NCT00001941|364403521|FG004|Overall Study|not treated- rapidly progressing disease|1|||
105655682|NCT02287883|364403525|FG000|Overall Study|Death|8|||
105655683|NCT02287883|364403526|FG001|Overall Study|Death|7|||
105655684|NCT02287883|364403525|FG000|Overall Study|No longer eligible|222|||
105655685|NCT02287883|364403526|FG001|Overall Study|No longer eligible|182|||
105655686|NCT02287883|364403525|FG000|Overall Study|Non-response to survey|229|||
105655687|NCT02287883|364403526|FG001|Overall Study|Non-response to survey|237|||
105655688|NCT03410108|364403527|FG000|Overall Study|Ongoing|41|||
105655689|NCT03410108|364403527|FG000|Overall Study|Adverse Event|4|||
105655690|NCT03410108|364403527|FG000|Overall Study|Progressive Disease|58|||
105655691|NCT03410108|364403527|FG000|Overall Study|Withdrawal by Subject|1|||
105655692|NCT00802438|364403532|FG000|Overall Study|Screen Failure|20|||
105655693|NCT00802438|364403532|FG000|Overall Study|Withdrawal by Subject|7|||
105655694|NCT00802438|364403532|FG000|Overall Study|Physician Decision|1|||
105655695|NCT01187407|364403533|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
105655696|NCT01187407|364403534|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105655697|NCT01187407|364403535|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105655698|NCT01187407|364403536|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105655699|NCT01187407|364403537|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105655700|NCT01187407|364403533|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
105655701|NCT01187407|364403534|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105655702|NCT01187407|364403535|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105655703|NCT01187407|364403536|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105655704|NCT01187407|364403537|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105655705|NCT01187407|364403533|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
105655706|NCT01187407|364403534|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105655707|NCT01187407|364403535|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105655708|NCT01187407|364403536|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105655709|NCT01187407|364403537|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105655710|NCT01187407|364403533|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
105655711|NCT01187407|364403534|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105655712|NCT01187407|364403535|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105655713|NCT01187407|364403536|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105655714|NCT01187407|364403537|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105655715|NCT01187407|364403533|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
105655716|NCT01187407|364403534|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105655717|NCT01187407|364403535|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105655718|NCT01187407|364403536|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105655719|NCT01187407|364403537|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105655720|NCT01187407|364403533|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
105655721|NCT01187407|364403534|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105655722|NCT01187407|364403535|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105655723|NCT01187407|364403536|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105655724|NCT01187407|364403537|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105655725|NCT01187407|364403533|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
105655726|NCT01187407|364403534|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105659503|NCT02635386|364417348|FG001|Overall Study|Noncompliant|2|||
105655727|NCT01187407|364403535|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105655728|NCT01187407|364403536|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105655729|NCT01187407|364403537|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105655730|NCT01187407|364403533|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
105655731|NCT01187407|364403534|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
105655732|NCT01187407|364403535|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
105655733|NCT01187407|364403536|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
105655734|NCT01187407|364403537|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
105655735|NCT01187407|364403533|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
105655736|NCT01187407|364403534|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
105655737|NCT01187407|364403535|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
105655738|NCT01187407|364403536|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
105655739|NCT01187407|364403537|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
105655740|NCT01187407|364403533|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
105655741|NCT01187407|364403534|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
105655742|NCT01187407|364403535|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
105655743|NCT01187407|364403536|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
105655744|NCT01187407|364403537|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
105655745|NCT01187407|364403533|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
105655746|NCT01187407|364403534|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
105655747|NCT01187407|364403535|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
105655748|NCT01187407|364403536|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
105655749|NCT01187407|364403537|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
105655750|NCT01187407|364403533|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
105655751|NCT01187407|364403534|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
105655752|NCT01187407|364403535|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
105655753|NCT01187407|364403536|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
105655754|NCT01187407|364403537|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
105655755|NCT01187407|364403533|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
105655756|NCT01187407|364403534|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
105655757|NCT01187407|364403535|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
105655758|NCT01187407|364403536|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
105655759|NCT01187407|364403537|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
105655760|NCT01187407|364403533|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
105655761|NCT01187407|364403534|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
105655762|NCT01187407|364403535|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
105655763|NCT01187407|364403536|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
105655764|NCT01187407|364403537|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
105655765|NCT00819013|364403538|FG000|Overall Study|Not meeting continuing study eligibility|2|||
105655766|NCT00819013|364403539|FG001|Overall Study|Not meeting continuing study eligibility|1|||
105655767|NCT00819013|364403540|FG002|Overall Study|Not meeting continuing study eligibility|2|||
105655768|NCT00819013|364403541|FG003|Overall Study|Not meeting continuing study eligibility|1|||
105655769|NCT00819013|364403538|FG000|Overall Study|Adverse Event|0|||
105655770|NCT00819013|364403539|FG001|Overall Study|Adverse Event|0|||
105655771|NCT00819013|364403540|FG002|Overall Study|Adverse Event|1|||
105655772|NCT00819013|364403541|FG003|Overall Study|Adverse Event|0|||
105655773|NCT00819013|364403538|FG000|Overall Study|Withdrawal by Subject|1|||
105655774|NCT00819013|364403539|FG001|Overall Study|Withdrawal by Subject|0|||
105655775|NCT00819013|364403540|FG002|Overall Study|Withdrawal by Subject|1|||
105655776|NCT00819013|364403541|FG003|Overall Study|Withdrawal by Subject|0|||
105655777|NCT00819013|364403538|FG000|Overall Study|Lost to Follow-up|0|||
105655778|NCT00819013|364403539|FG001|Overall Study|Lost to Follow-up|0|||
105655779|NCT00819013|364403540|FG002|Overall Study|Lost to Follow-up|1|||
105655780|NCT00819013|364403541|FG003|Overall Study|Lost to Follow-up|2|||
105655781|NCT00819013|364403538|FG000|Overall Study|Death|0|||
105655782|NCT00819013|364403539|FG001|Overall Study|Death|0|||
105655783|NCT00819013|364403540|FG002|Overall Study|Death|0|||
105655784|NCT00819013|364403541|FG003|Overall Study|Death|1|||
105655785|NCT00363649|364403544|FG000|Overall Study|Withdrawal by Subject|1|||
105655786|NCT00363649|364403545|FG001|Overall Study|Withdrawal by Subject|1|||
105655787|NCT00363649|364403544|FG000|Overall Study|Adverse Event|6|||
105655788|NCT00363649|364403545|FG001|Overall Study|Adverse Event|0|||
105655789|NCT00338949|364403546|FG000|Subject Screening|Screen failures|11|||
105655790|NCT00338949|364403547|FG001|Subject Screening|Screen failures|11|||
105655791|NCT00338949|364403546|FG000|Randomization|Withdrawal by Subject|1|||
105655792|NCT00338949|364403547|FG001|Randomization|Withdrawal by Subject|0|||
105655793|NCT00338949|364403546|FG000|Randomization|Adverse Event|0|||
105655794|NCT00338949|364403547|FG001|Randomization|Adverse Event|5|||
105655795|NCT03188536|364403548|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
105655796|NCT03188536|364403548|FG000|Overall Study|Not participated/met inclusion criteria|1|||
105655797|NCT01930214|364403550|FG000|Overall Study|Death|4|||
105655798|NCT01930214|364403551|FG001|Overall Study|Death|4|||
105655799|NCT01930214|364403552|FG002|Overall Study|Death|11|||
105655800|NCT01930214|364403550|FG000|Overall Study|Lost to Follow-up|12|||
105655801|NCT01930214|364403551|FG001|Overall Study|Lost to Follow-up|13|||
105655802|NCT01930214|364403552|FG002|Overall Study|Lost to Follow-up|12|||
105655803|NCT01930214|364403550|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
105655804|NCT01930214|364403551|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
105655805|NCT01930214|364403552|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
105655806|NCT01930214|364403550|FG000|Overall Study|Physician Decision|2|||
105655807|NCT01930214|364403551|FG001|Overall Study|Physician Decision|0|||
105655808|NCT01930214|364403552|FG002|Overall Study|Physician Decision|0|||
105655809|NCT00025662|364403553|FG000|Overall Study|Withdrawal by Subject|2|||
105655810|NCT00025662|364403553|FG000|Overall Study|Technical failure of manipulation|1|||
105655811|NCT02604342|364403556|FG000|Overall Study|Death|32|||
105655812|NCT02604342|364403557|FG001|Overall Study|Death|16|||
105655813|NCT02604342|364403556|FG000|Overall Study|Progression of disease|1|||
105655814|NCT02604342|364403557|FG001|Overall Study|Progression of disease|0|||
105655815|NCT02604342|364403556|FG000|Overall Study|Withdrawal by Subject|5|||
105655816|NCT02604342|364403557|FG001|Overall Study|Withdrawal by Subject|6|||
105655817|NCT02604342|364403556|FG000|Overall Study|Other|1|||
105655818|NCT02604342|364403557|FG001|Overall Study|Other|0|||
105655819|NCT02604342|364403556|FG000|Overall Study|Study Termination by Sponsor|1|||
105655820|NCT02604342|364403557|FG001|Overall Study|Study Termination by Sponsor|0|||
105655821|NCT02604342|364403556|FG000|Overall Study|Lost to Follow-up|1|||
105655822|NCT02604342|364403557|FG001|Overall Study|Lost to Follow-up|1|||
105655823|NCT02604342|364403556|FG000|Overall Study|Physician Decision|2|||
105655824|NCT02604342|364403557|FG001|Overall Study|Physician Decision|0|||
105655825|NCT00130728|364403558|FG000|Overall Study|Death|258|||
105655826|NCT00130728|364403559|FG001|Overall Study|Death|258|||
105655827|NCT00130728|364403558|FG000|Overall Study|Lost to Follow-up|4|||
105655828|NCT00130728|364403559|FG001|Overall Study|Lost to Follow-up|0|||
105655829|NCT00130728|364403558|FG000|Overall Study|Withdrawal by Subject|0|||
105655830|NCT00130728|364403559|FG001|Overall Study|Withdrawal by Subject|2|||
105655831|NCT02725008|364403561|FG000|Overall Study|Lost to Follow-up|7|||
105655832|NCT02725008|364403562|FG001|Overall Study|Lost to Follow-up|9|||
105655833|NCT02725008|364403561|FG000|Overall Study|Withdrawal by Subject|2|||
105655834|NCT02725008|364403562|FG001|Overall Study|Withdrawal by Subject|2|||
105655835|NCT02725008|364403561|FG000|Overall Study|Admitted to hospital|0|||
105655836|NCT02725008|364403562|FG001|Overall Study|Admitted to hospital|1|||
105655837|NCT01560585|364403563|FG000|Overall Study|Physician Decision|3|||
105655838|NCT00519285|364403564|FG000|Overall Study|Adverse Event|127|||
105655839|NCT00519285|364403565|FG001|Overall Study|Adverse Event|266|||
105655840|NCT00519285|364403564|FG000|Overall Study|Disease progression|334|||
105655841|NCT00519285|364403565|FG001|Overall Study|Disease progression|186|||
105655842|NCT00519285|364403564|FG000|Overall Study|Physician Decision|75|||
105655843|NCT00519285|364403565|FG001|Overall Study|Physician Decision|47|||
105655844|NCT00519285|364403564|FG000|Overall Study|Participant's request|53|||
105655845|NCT00519285|364403565|FG001|Overall Study|Participant's request|84|||
105655846|NCT00519285|364403564|FG000|Overall Study|Consent withdrawn|4|||
105655847|NCT00519285|364403565|FG001|Overall Study|Consent withdrawn|5|||
105655848|NCT00519285|364403564|FG000|Overall Study|Poor compliance to protocol|5|||
105655849|NCT00519285|364403565|FG001|Overall Study|Poor compliance to protocol|7|||
105655850|NCT00519285|364403564|FG000|Overall Study|Reason unspecified|5|||
105655851|NCT00519285|364403565|FG001|Overall Study|Reason unspecified|8|||
105655852|NCT00519285|364403564|FG000|Overall Study|Not treated|8|||
105655853|NCT00519285|364403565|FG001|Overall Study|Not treated|7|||
105655854|NCT00519285|364403564|FG000|Overall Study|Treatment ongoing|1|||
105655855|NCT00519285|364403565|FG001|Overall Study|Treatment ongoing|2|||
105655856|NCT03028012|364403566|FG000|Overall Study|Lost to Follow-up|2|||
105655857|NCT03028012|364403567|FG001|Overall Study|Lost to Follow-up|3|||
105655858|NCT03028012|364403568|FG002|Overall Study|Lost to Follow-up|3|||
105655859|NCT01726517|364403569|FG000|Overall Study|Withdrawal by Subject|0|||
105655860|NCT01726517|364403570|FG001|Overall Study|Withdrawal by Subject|0|||
105655861|NCT01726517|364403571|FG002|Overall Study|Withdrawal by Subject|1|||
105655862|NCT01726517|364403572|FG003|Overall Study|Withdrawal by Subject|0|||
105655863|NCT01726517|364403573|FG004|Overall Study|Withdrawal by Subject|0|||
105655864|NCT03765164|364403575|FG000|Pre-intervention|Withdrawal by Subject|5|||
105655865|NCT03765164|364403576|FG001|Pre-intervention|Withdrawal by Subject|6|||
105655866|NCT01813305|364403577|FG000|Overall Study|Withdrawal by Subject|12|||
105655867|NCT01813305|364403578|FG001|Overall Study|Withdrawal by Subject|5|||
105655868|NCT01813305|364403577|FG000|Overall Study|Safety Concern|4|||
105655869|NCT01813305|364403578|FG001|Overall Study|Safety Concern|0|||
105655870|NCT01813305|364403577|FG000|Overall Study|Ulcer became worse|4|||
105655871|NCT01813305|364403578|FG001|Overall Study|Ulcer became worse|0|||
105655872|NCT01813305|364403577|FG000|Overall Study|Physician Decision|4|||
105655873|NCT01813305|364403578|FG001|Overall Study|Physician Decision|0|||
105655874|NCT01813305|364403577|FG000|Overall Study|Lost to Follow-up|3|||
105655875|NCT01813305|364403578|FG001|Overall Study|Lost to Follow-up|1|||
105655876|NCT01813305|364403577|FG000|Overall Study|Protocol Violation|1|||
105655877|NCT01813305|364403578|FG001|Overall Study|Protocol Violation|0|||
105655878|NCT01813305|364403577|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
105655879|NCT01813305|364403578|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
105655880|NCT01665599|364403582|FG000|Overall Study|Adverse Event|1|||
105655881|NCT01665599|364403582|FG000|Overall Study|Consent Withdrawn|1|||
105655882|NCT01665599|364403582|FG000|Overall Study|Investigator/Sponsor decision|1|||
105655883|NCT01665599|364403582|FG000|Overall Study|Death|1|||
105655884|NCT01665599|364403582|FG000|Overall Study|Lost to Follow-up|2|||
105655885|NCT01665599|364403582|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
105655886|NCT01665599|364403582|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
105655887|NCT01837797|364403587|FG000|Period 1|Adverse Event|9|||
105655888|NCT01837797|364403588|FG001|Period 1|Adverse Event|0|||
105655889|NCT01837797|364403589|FG002|Period 1|Adverse Event|0|||
105655890|NCT01837797|364403590|FG003|Period 1|Adverse Event|0|||
105655891|NCT01837797|364403591|FG004|Period 1|Adverse Event|0|||
105655892|NCT01837797|364403587|FG000|Period 1|Withdrawal by Subject|6|||
105655893|NCT01837797|364403588|FG001|Period 1|Withdrawal by Subject|0|||
105655894|NCT01837797|364403589|FG002|Period 1|Withdrawal by Subject|0|||
105655895|NCT01837797|364403590|FG003|Period 1|Withdrawal by Subject|0|||
105655896|NCT01837797|364403591|FG004|Period 1|Withdrawal by Subject|0|||
105655897|NCT01837797|364403587|FG000|Period 1|Administrative reasons|76|||
105655898|NCT01837797|364403588|FG001|Period 1|Administrative reasons|0|||
105655899|NCT01837797|364403589|FG002|Period 1|Administrative reasons|0|||
105655900|NCT01837797|364403590|FG003|Period 1|Administrative reasons|0|||
105655901|NCT01837797|364403591|FG004|Period 1|Administrative reasons|0|||
105655902|NCT01837797|364403587|FG000|Period 1|Withdrawal of consent before treatment|1|||
105655903|NCT01837797|364403588|FG001|Period 1|Withdrawal of consent before treatment|0|||
105655904|NCT01837797|364403589|FG002|Period 1|Withdrawal of consent before treatment|0|||
105655905|NCT01837797|364403590|FG003|Period 1|Withdrawal of consent before treatment|0|||
105655906|NCT01837797|364403591|FG004|Period 1|Withdrawal of consent before treatment|0|||
105655907|NCT01837797|364403587|FG000|Period 1|Other|10|||
105655908|NCT01837797|364403588|FG001|Period 1|Other|0|||
105655909|NCT01837797|364403589|FG002|Period 1|Other|0|||
105655910|NCT01837797|364403590|FG003|Period 1|Other|0|||
105655911|NCT01837797|364403591|FG004|Period 1|Other|0|||
105655912|NCT01837797|364403587|FG000|Period 2|Administrative or other reasons|0|||
105655913|NCT01837797|364403588|FG001|Period 2|Administrative or other reasons|5|||
105655914|NCT01837797|364403589|FG002|Period 2|Administrative or other reasons|2|||
105655915|NCT01837797|364403590|FG003|Period 2|Administrative or other reasons|4|||
105655916|NCT01837797|364403591|FG004|Period 2|Administrative or other reasons|0|||
105655917|NCT01837797|364403587|FG000|Period 2|Adverse Event|0|||
105655918|NCT01837797|364403588|FG001|Period 2|Adverse Event|0|||
105655919|NCT01837797|364403589|FG002|Period 2|Adverse Event|0|||
105655920|NCT01837797|364403590|FG003|Period 2|Adverse Event|1|||
105655921|NCT01837797|364403591|FG004|Period 2|Adverse Event|0|||
105655922|NCT01837797|364403587|FG000|Period 3|Adverse Event|0|||
105655923|NCT01837797|364403588|FG001|Period 3|Adverse Event|0|||
105655924|NCT01837797|364403589|FG002|Period 3|Adverse Event|0|||
105655925|NCT01837797|364403590|FG003|Period 3|Adverse Event|0|||
105655926|NCT01837797|364403591|FG004|Period 3|Adverse Event|1|||
105655927|NCT01837797|364403587|FG000|Period 3|Administrative reasons|0|||
105655928|NCT01837797|364403588|FG001|Period 3|Administrative reasons|0|||
105655929|NCT01837797|364403589|FG002|Period 3|Administrative reasons|0|||
105655930|NCT01837797|364403590|FG003|Period 3|Administrative reasons|0|||
105655931|NCT01837797|364403591|FG004|Period 3|Administrative reasons|20|||
105655932|NCT01837797|364403587|FG000|Period 3|Other|0|||
105655933|NCT01837797|364403588|FG001|Period 3|Other|0|||
105655934|NCT01837797|364403589|FG002|Period 3|Other|0|||
105655935|NCT01837797|364403590|FG003|Period 3|Other|0|||
105655936|NCT01837797|364403591|FG004|Period 3|Other|2|||
105655937|NCT00988117|364403592|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
105655938|NCT00988117|364403592|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
105655939|NCT01982448|364403593|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
105655940|NCT01982448|364403594|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
105655941|NCT01982448|364403593|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
105655942|NCT01982448|364403594|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
105655943|NCT01982448|364403593|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
105655944|NCT01982448|364403594|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
105655945|NCT01982448|364403593|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
105655946|NCT01982448|364403594|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
105655947|NCT01203956|364403596|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
105655948|NCT01203956|364403597|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
105655949|NCT00853021|364403598|FG000|Overall Study|Adverse Event|2|||
105655950|NCT00853021|364403598|FG000|Overall Study|Withdrawal by Subject|2|||
105655951|NCT00853021|364403598|FG000|Overall Study|Death|1|||
105655952|NCT01329419|364403599|FG000|Overall Study|Protocol Violation|235|||
105655953|NCT04522778|364403600|FG000|Overall Study|Patient did not want to wear the device|1|||
105655954|NCT04522778|364403601|FG001|Overall Study|Patient did not want to wear the device|0|||
105655955|NCT04522778|364403600|FG000|Overall Study|Lost to Follow-up|0|||
105655956|NCT04522778|364403601|FG001|Overall Study|Lost to Follow-up|1|||
105655957|NCT04052997|364403602|FG000|Overall Study|Withdrawal by Subject|17|||
105655958|NCT04052997|364403602|FG000|Overall Study|Physician Decision|50|||
105655959|NCT04052997|364403602|FG000|Overall Study|Death|43|||
105655960|NCT04052997|364403602|FG000|Overall Study|Lost to Follow-up|5|||
105655961|NCT04052997|364403602|FG000|Overall Study|Progression of Disease|1|||
105655962|NCT00069277|364403605|FG000|Overall Study|Adverse Event|3|||
105655963|NCT00069277|364403605|FG000|Overall Study|Withdrawal by Subject|1|||
105655964|NCT00069277|364403605|FG000|Overall Study|Progressive Disease|15|||
105655965|NCT00069277|364403605|FG000|Overall Study|Physician Decision|2|||
105655966|NCT01225159|364403606|FG000|Overall Study|Change operation|1|||
105655967|NCT01225159|364403607|FG001|Overall Study|Change operation|0|||
105655968|NCT02230306|364403608|FG000|Overall Study|Did not receive study treatment|1|||
105655969|NCT01220856|364403609|FG000|Overall Study|graft loss|3|||
105655970|NCT01220856|364403610|FG001|Overall Study|graft loss|3|||
105655971|NCT01220856|364403609|FG000|Overall Study|Lost to Follow-up|1|||
105655972|NCT01220856|364403610|FG001|Overall Study|Lost to Follow-up|0|||
105655973|NCT00691678|364403611|FG000|Overall Study|Adverse Event|5|||
105655974|NCT00691678|364403611|FG000|Overall Study|life events, pain|11|||
105655975|NCT01503164|364403612|FG000|Overall Study|Withdrawal by Subject|2|||
105655976|NCT01503164|364403613|FG001|Overall Study|Withdrawal by Subject|1|||
105655977|NCT00934700|364403616|FG000|Overall Study|missing scan|5|||
105655978|NCT00934700|364403617|FG001|Overall Study|missing scan|9|||
105655979|NCT00934700|364403616|FG000|Overall Study|Death|8|||
105655980|NCT00934700|364403617|FG001|Overall Study|Death|3|||
105655981|NCT01831726|364403618|FG000|Overall Study|Adverse Event|16|||
105655982|NCT01831726|364403618|FG000|Overall Study|Death|7|||
105655983|NCT01831726|364403618|FG000|Overall Study|Disease Progression|49|||
105655984|NCT01831726|364403618|FG000|Overall Study|Physician Decision|1|||
105655985|NCT01831726|364403618|FG000|Overall Study|Subject/guardian decision|7|||
105655986|NCT02998918|364403622|FG000|Overall Study|Withdrawal by Subject|1|||
105655987|NCT02998918|364403623|FG001|Overall Study|Withdrawal by Subject|0|||
105655988|NCT00443599|364403626|FG000|Overall Study|Physician Decision|2|||
105655989|NCT00443599|364403627|FG001|Overall Study|Physician Decision|1|||
105655990|NCT00443599|364403626|FG000|Overall Study|Death|1|||
105655991|NCT00443599|364403627|FG001|Overall Study|Death|1|||
105655992|NCT00443599|364403626|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
105655993|NCT00443599|364403627|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
105655994|NCT02598934|364403630|FG000|Overall Study|Adverse Event|11|||
105655995|NCT02598934|364403631|FG001|Overall Study|Adverse Event|13|||
105655996|NCT02598934|364403630|FG000|Overall Study|Failure to Return|3|||
105655997|NCT02598934|364403631|FG001|Overall Study|Failure to Return|3|||
105655998|NCT02598934|364403630|FG000|Overall Study|Withdrawal by Subject|2|||
105655999|NCT02598934|364403631|FG001|Overall Study|Withdrawal by Subject|3|||
105656000|NCT02598934|364403630|FG000|Overall Study|Administrative|2|||
105656001|NCT02598934|364403631|FG001|Overall Study|Administrative|1|||
105656002|NCT02598934|364403630|FG000|Overall Study|Protocol Violation|1|||
105656003|NCT02598934|364403631|FG001|Overall Study|Protocol Violation|2|||
105656004|NCT03049306|364403632|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
105656005|NCT03049306|364403633|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
105656006|NCT02154347|364403634|FG000|Double-blind Period|Adverse Event|1|||
105656007|NCT02154347|364403635|FG001|Double-blind Period|Adverse Event|2|||
105656008|NCT02154347|364403634|FG000|Double-blind Period|Lack of Efficacy|1|||
105656009|NCT02154347|364403635|FG001|Double-blind Period|Lack of Efficacy|0|||
105656010|NCT02154347|364403634|FG000|Double-blind Period|Physician Decision|0|||
105656011|NCT02154347|364403635|FG001|Double-blind Period|Physician Decision|1|||
105656012|NCT02154347|364403634|FG000|Double-blind Period|Withdrawal by Subject|1|||
105656013|NCT02154347|364403635|FG001|Double-blind Period|Withdrawal by Subject|1|||
105656014|NCT02154347|364403634|FG000|Open-label Period|Adverse Event|3|||
105656015|NCT02154347|364403635|FG001|Open-label Period|Adverse Event|4|||
105656016|NCT02154347|364403634|FG000|Open-label Period|Lack of Efficacy|4|||
105656017|NCT02154347|364403635|FG001|Open-label Period|Lack of Efficacy|19|||
105656018|NCT02154347|364403634|FG000|Open-label Period|Protocol Violation|0|||
105656019|NCT02154347|364403635|FG001|Open-label Period|Protocol Violation|1|||
105656020|NCT02154347|364403634|FG000|Open-label Period|Withdrawal by Subject|0|||
105656021|NCT02154347|364403635|FG001|Open-label Period|Withdrawal by Subject|1|||
105656022|NCT04811339|364403636|FG000|Overall Study|lack of transportation not wanting to return|4|||
105656023|NCT04811339|364403637|FG001|Overall Study|lack of transportation not wanting to return|8|||
105656024|NCT04811339|364403638|FG002|Overall Study|lack of transportation not wanting to return|0|||
105656025|NCT04811339|364403636|FG000|Overall Study|Adverse Event|3|||
105656026|NCT04811339|364403637|FG001|Overall Study|Adverse Event|0|||
105656027|NCT04811339|364403638|FG002|Overall Study|Adverse Event|0|||
105656028|NCT04811339|364403636|FG000|Overall Study|Lost to Follow-up|1|||
105656029|NCT04811339|364403637|FG001|Overall Study|Lost to Follow-up|0|||
105656030|NCT04811339|364403638|FG002|Overall Study|Lost to Follow-up|0|||
105656031|NCT04811339|364403636|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
105656032|NCT04811339|364403637|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
105656033|NCT04811339|364403638|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
105656034|NCT04811339|364403636|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
105656035|NCT04811339|364403637|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
105656036|NCT04811339|364403638|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
105656037|NCT04811339|364403636|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
105656038|NCT04811339|364403637|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
105656039|NCT04811339|364403638|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
105656040|NCT04811339|364403636|FG000|Overall Study|Withdrawal by Subject|0|||
105656041|NCT04811339|364403637|FG001|Overall Study|Withdrawal by Subject|3|||
105656042|NCT04811339|364403638|FG002|Overall Study|Withdrawal by Subject|0|||
105656043|NCT04811339|364403636|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
105656044|NCT04811339|364403637|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
105656045|NCT04811339|364403638|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
105656046|NCT04811339|364403636|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
105656047|NCT04811339|364403637|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
105656048|NCT04811339|364403638|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
105656049|NCT05896696|364403639|FG000|Overall Study|Screening Failure|7|||
105656050|NCT05896696|364403639|FG000|Overall Study|Withdrawal by Subject|2|||
105656051|NCT00143598|364403640|FG000|Overall Study|Lost to Follow-up|23|||
105656052|NCT00143598|364403641|FG001|Overall Study|Lost to Follow-up|21|||
105656053|NCT00143598|364403640|FG000|Overall Study|Withdrawal by Subject|33|||
105656054|NCT00143598|364403641|FG001|Overall Study|Withdrawal by Subject|37|||
105656055|NCT00143598|364403640|FG000|Overall Study|Death|36|||
105656056|NCT00143598|364403641|FG001|Overall Study|Death|36|||
105656057|NCT03900715|364403644|FG000|Overall Study|Protocol Deviation|1|||
105656058|NCT03900715|364403644|FG000|Overall Study|Lack of Efficacy|1|||
105656059|NCT03900715|364403644|FG000|Overall Study|Progressive Disease|6|||
105656060|NCT03900715|364403644|FG000|Overall Study|Adverse Event|2|||
105656061|NCT03900715|364403644|FG000|Overall Study|Other reasons|11|||
105656062|NCT02972242|364405768|FG000|Overall Study|Withdrawal by Subject|1|||
105656063|NCT02972242|364405769|FG001|Overall Study|Withdrawal by Subject|0|||
105656064|NCT04572997|364405770|FG000|Overall Study|Adverse Event|1|||
105656065|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
105656066|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
105656067|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
105656068|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
105656069|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
105656070|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
105656071|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
105656072|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
105656073|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
105656074|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
105656075|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
105656076|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
105656077|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
105656078|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
105656079|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
105656080|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
105656081|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
105656082|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
105656083|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
105656084|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
105656085|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
105656086|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
105656087|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
105656088|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
105656089|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
105656090|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
105656091|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
105656092|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
105656093|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
105656094|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
105656095|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
105656096|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
105656097|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
105656098|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
105656099|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
105656100|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
105656101|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
105656102|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
105656103|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
105656104|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
105656105|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
105656106|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
105656107|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
105656108|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
105656109|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
105656110|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
105656111|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
105656112|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
105656113|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Death|2|||
105656114|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Death|0|||
105656115|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Death|1|||
105656116|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Death|0|||
105656117|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
105656118|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
105656119|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
105656120|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
105656121|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
105656122|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
105656123|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
105656124|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
105656125|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
105656126|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
105656127|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
105656128|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
105656129|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Moved|32|||
105656130|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Moved|2|||
105656131|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Moved|28|||
105656132|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Moved|0|||
105656133|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
105656134|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
105656135|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
105656136|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
105656137|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Travel|2|||
105656138|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Travel|0|||
105656139|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Travel|0|||
105656140|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Travel|0|||
105656141|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
105656142|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
105656143|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
105656144|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
105656145|NCT00092521|364405771|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
105656146|NCT00092521|364405772|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
105656147|NCT00092521|364405773|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
105656148|NCT00092521|364405774|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
105656149|NCT00092521|364405771|FG000|Extension Study (Group 4)|Adverse Event|0|||
105656150|NCT00092521|364405772|FG001|Extension Study (Group 4)|Adverse Event|0|||
105656151|NCT00092521|364405773|FG002|Extension Study (Group 4)|Adverse Event|0|||
105656152|NCT00092521|364405774|FG003|Extension Study (Group 4)|Adverse Event|2|||
105656153|NCT00092521|364405771|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
105656154|NCT00092521|364405772|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
105656155|NCT00092521|364405773|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
105656156|NCT00092521|364405774|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
105656157|NCT00092521|364405771|FG000|Extension Study (Group 4)|Pregnancy|0|||
105656158|NCT00092521|364405772|FG001|Extension Study (Group 4)|Pregnancy|0|||
105656159|NCT00092521|364405773|FG002|Extension Study (Group 4)|Pregnancy|0|||
105656160|NCT00092521|364405774|FG003|Extension Study (Group 4)|Pregnancy|4|||
105656161|NCT00092521|364405771|FG000|Extension Study (Group 4)|Protocol Violation|0|||
105656162|NCT00092521|364405772|FG001|Extension Study (Group 4)|Protocol Violation|0|||
105656163|NCT00092521|364405773|FG002|Extension Study (Group 4)|Protocol Violation|0|||
105656164|NCT00092521|364405774|FG003|Extension Study (Group 4)|Protocol Violation|2|||
105656165|NCT00092521|364405771|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
105656166|NCT00092521|364405772|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
105656167|NCT00092521|364405773|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
105656168|NCT00092521|364405774|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
105656169|NCT00092521|364405771|FG000|Extension Study (Group 4)|Moved|0|||
105656170|NCT00092521|364405772|FG001|Extension Study (Group 4)|Moved|0|||
105656171|NCT00092521|364405773|FG002|Extension Study (Group 4)|Moved|0|||
105656172|NCT00092521|364405774|FG003|Extension Study (Group 4)|Moved|16|||
105656173|NCT00092521|364405771|FG000|Extension Study (Group 4)|Site Terminated|0|||
105656174|NCT00092521|364405772|FG001|Extension Study (Group 4)|Site Terminated|0|||
105656175|NCT00092521|364405773|FG002|Extension Study (Group 4)|Site Terminated|0|||
105656176|NCT00092521|364405774|FG003|Extension Study (Group 4)|Site Terminated|4|||
105656177|NCT00092521|364405771|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
105656178|NCT00092521|364405772|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
105656179|NCT00092521|364405773|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
105656180|NCT00092521|364405774|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
105656181|NCT03464383|364405775|FG000|Overall Study|Lost to Follow-up|1|||
105656182|NCT03464383|364405776|FG001|Overall Study|Lost to Follow-up|0|||
105656183|NCT03464383|364405777|FG002|Overall Study|Lost to Follow-up|0|||
105656184|NCT03464383|364405775|FG000|Overall Study|Withdrawal by Subject|0|||
105656185|NCT03464383|364405776|FG001|Overall Study|Withdrawal by Subject|1|||
105656186|NCT03464383|364405777|FG002|Overall Study|Withdrawal by Subject|0|||
105656187|NCT00381888|364405780|FG000|Overall Study|Death|1|||
105656188|NCT00381888|364405780|FG000|Overall Study|Withdrawal by Subject|1|||
105656189|NCT00381888|364405780|FG000|Overall Study|Physician Decision|1|||
105656190|NCT00381888|364405780|FG000|Overall Study|Protocol Violation|9|||
105656191|NCT00381888|364405780|FG000|Overall Study|Had laparoscopic surgery|2|||
105656192|NCT00381888|364405780|FG000|Overall Study|Surgery was cancelled|2|||
105656193|NCT00381888|364405780|FG000|Overall Study|Adverse Event|1|||
105656194|NCT00746785|364405781|FG000|Overall Study|Lost to Follow-up|29|||
105656195|NCT00746785|364405782|FG001|Overall Study|Lost to Follow-up|25|||
105656196|NCT00746785|364405783|FG002|Overall Study|Lost to Follow-up|27|||
105656197|NCT00113269|364405784|FG000|Overall Study|Not transplanted, donor issues|4|||
105656198|NCT00113269|364405785|FG001|Overall Study|Not transplanted, donor issues|0|||
105656199|NCT00113269|364405786|FG002|Overall Study|Not transplanted, donor issues|2|||
105656200|NCT00113269|364405787|FG003|Overall Study|Not transplanted, donor issues|2|||
105656201|NCT00113269|364405784|FG000|Overall Study|Not transplanted, recipient issues|2|||
105656202|NCT00113269|364405785|FG001|Overall Study|Not transplanted, recipient issues|1|||
105656203|NCT00113269|364405786|FG002|Overall Study|Not transplanted, recipient issues|7|||
105656204|NCT00113269|364405787|FG003|Overall Study|Not transplanted, recipient issues|4|||
105656205|NCT00113269|364405784|FG000|Overall Study|Early graft loss, technical|0|||
105656206|NCT00113269|364405785|FG001|Overall Study|Early graft loss, technical|0|||
105656207|NCT00113269|364405786|FG002|Overall Study|Early graft loss, technical|2|||
105656208|NCT00113269|364405787|FG003|Overall Study|Early graft loss, technical|0|||
105656209|NCT00113269|364405784|FG000|Overall Study|Death in operating room|0|||
105656210|NCT00113269|364405785|FG001|Overall Study|Death in operating room|0|||
105656211|NCT00113269|364405786|FG002|Overall Study|Death in operating room|0|||
105656212|NCT00113269|364405787|FG003|Overall Study|Death in operating room|1|||
105656213|NCT00113269|364405784|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
105656214|NCT00113269|364405785|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
105656215|NCT00113269|364405786|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
105656216|NCT00113269|364405787|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
105656217|NCT00113269|364405784|FG000|Overall Study|Adverse Event|2|||
105656218|NCT00113269|364405785|FG001|Overall Study|Adverse Event|7|||
105656219|NCT00113269|364405786|FG002|Overall Study|Adverse Event|11|||
105656220|NCT00113269|364405787|FG003|Overall Study|Adverse Event|7|||
105656221|NCT00113269|364405784|FG000|Overall Study|Withdrawal by Subject|4|||
105656222|NCT00113269|364405785|FG001|Overall Study|Withdrawal by Subject|3|||
105656223|NCT00113269|364405786|FG002|Overall Study|Withdrawal by Subject|4|||
105656224|NCT00113269|364405787|FG003|Overall Study|Withdrawal by Subject|2|||
105656225|NCT00113269|364405784|FG000|Overall Study|Graft loss|6|||
105656226|NCT00113269|364405785|FG001|Overall Study|Graft loss|6|||
105656227|NCT00113269|364405786|FG002|Overall Study|Graft loss|4|||
105656228|NCT00113269|364405787|FG003|Overall Study|Graft loss|9|||
105656229|NCT00113269|364405784|FG000|Overall Study|Protocol Violation|1|||
105656230|NCT00113269|364405785|FG001|Overall Study|Protocol Violation|0|||
105656231|NCT00113269|364405786|FG002|Overall Study|Protocol Violation|4|||
105656232|NCT00113269|364405787|FG003|Overall Study|Protocol Violation|2|||
105656233|NCT00113269|364405784|FG000|Overall Study|Lost to Follow-up|2|||
105656234|NCT00113269|364405785|FG001|Overall Study|Lost to Follow-up|3|||
105656235|NCT00113269|364405786|FG002|Overall Study|Lost to Follow-up|6|||
105656236|NCT00113269|364405787|FG003|Overall Study|Lost to Follow-up|3|||
105656237|NCT00113269|364405784|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
105656238|NCT00113269|364405785|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
105656239|NCT00113269|364405786|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
105656240|NCT00113269|364405787|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
105656241|NCT00113269|364405784|FG000|Overall Study|Discontinued due to rejection|0|||
105656242|NCT00113269|364405785|FG001|Overall Study|Discontinued due to rejection|0|||
105656243|NCT00113269|364405786|FG002|Overall Study|Discontinued due to rejection|1|||
105656244|NCT00113269|364405787|FG003|Overall Study|Discontinued due to rejection|0|||
105656245|NCT00113269|364405784|FG000|Overall Study|Moved|0|||
105656246|NCT00113269|364405785|FG001|Overall Study|Moved|1|||
105656247|NCT00113269|364405786|FG002|Overall Study|Moved|0|||
105656248|NCT00113269|364405787|FG003|Overall Study|Moved|3|||
105656249|NCT00113269|364405784|FG000|Overall Study|Received pancreas transplant|0|||
105656250|NCT00113269|364405785|FG001|Overall Study|Received pancreas transplant|0|||
105656251|NCT00113269|364405786|FG002|Overall Study|Received pancreas transplant|0|||
105656252|NCT00113269|364405787|FG003|Overall Study|Received pancreas transplant|2|||
105656253|NCT00113269|364405784|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
105656254|NCT00113269|364405785|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
105656255|NCT00113269|364405786|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
105656256|NCT00113269|364405787|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
105656257|NCT00113269|364405784|FG000|Overall Study|Did not meet eligibility criteria|1|||
105656258|NCT00113269|364405785|FG001|Overall Study|Did not meet eligibility criteria|0|||
105656259|NCT00113269|364405786|FG002|Overall Study|Did not meet eligibility criteria|0|||
105656260|NCT00113269|364405787|FG003|Overall Study|Did not meet eligibility criteria|1|||
105656261|NCT00113269|364405784|FG000|Overall Study|Unable to return for follow up|2|||
105656262|NCT00113269|364405785|FG001|Overall Study|Unable to return for follow up|1|||
105656263|NCT00113269|364405786|FG002|Overall Study|Unable to return for follow up|0|||
105656264|NCT00113269|364405787|FG003|Overall Study|Unable to return for follow up|0|||
105656265|NCT01171183|364405788|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
105656266|NCT01171183|364405789|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
105656267|NCT01171183|364405788|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
105656268|NCT01171183|364405789|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
105656269|NCT01171183|364405788|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
105656270|NCT01171183|364405789|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
105656271|NCT01171183|364405788|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
105656272|NCT01171183|364405789|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
105656273|NCT01171183|364405788|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
105656274|NCT01171183|364405789|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
105656275|NCT01171183|364405788|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
105656276|NCT01171183|364405789|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
105656277|NCT01066936|364405793|FG000|Overall Study|Death|2|||
105656278|NCT01066936|364405793|FG000|Overall Study|Device revised/removed|1|||
105656279|NCT01066936|364405793|FG000|Overall Study|Lost to Follow-up|3|||
105656280|NCT01066936|364405793|FG000|Overall Study|Withdrawal by Subject|4|||
105656281|NCT01093599|364405799|FG000|Overall Study|Lost to Follow-up|32|||
105656282|NCT01093599|364405800|FG001|Overall Study|Lost to Follow-up|46|||
105656283|NCT01703845|364405801|FG000|Overall Study|Adverse Event|1|||
105656284|NCT01703845|364405802|FG001|Overall Study|Adverse Event|0|||
105656285|NCT01703845|364405801|FG000|Overall Study|Protocol Violation|1|||
105656286|NCT01703845|364405802|FG001|Overall Study|Protocol Violation|0|||
105656287|NCT01703845|364405801|FG000|Overall Study|other than stated above|1|||
105656288|NCT01703845|364405802|FG001|Overall Study|other than stated above|0|||
105656289|NCT01845649|364405803|FG000|Overall Study|Adverse Event|7|||
105656290|NCT01845649|364405804|FG001|Overall Study|Adverse Event|10|||
105656291|NCT01845649|364405803|FG000|Overall Study|Lack of Efficacy|1|||
105656292|NCT01845649|364405804|FG001|Overall Study|Lack of Efficacy|1|||
105656293|NCT01845649|364405803|FG000|Overall Study|Lost to Follow-up|2|||
105656294|NCT01845649|364405804|FG001|Overall Study|Lost to Follow-up|2|||
105656295|NCT01845649|364405803|FG000|Overall Study|Withdrew Consent|12|||
105656296|NCT01845649|364405804|FG001|Overall Study|Withdrew Consent|4|||
105656297|NCT01845649|364405803|FG000|Overall Study|Protocol Deviation|7|||
105656298|NCT01845649|364405804|FG001|Overall Study|Protocol Deviation|4|||
105656299|NCT01845649|364405803|FG000|Overall Study|Reason not Specified|2|||
105656300|NCT01845649|364405804|FG001|Overall Study|Reason not Specified|1|||
105656301|NCT01983462|364405805|FG000|Overall Study|Adverse Event|1|||
105656302|NCT01983462|364405806|FG001|Overall Study|Adverse Event|0|||
105656303|NCT01983462|364405807|FG002|Overall Study|Adverse Event|0|||
105656304|NCT01222533|364405809|FG000|Overall Study|Adverse Event|5|||
105656305|NCT01222533|364405809|FG000|Overall Study|Withdrawal by Subject|5|||
105656306|NCT01222533|364405809|FG000|Overall Study|Other|4|||
105656307|NCT03418493|364405810|FG000|Overall Study|Adverse Event|1|||
105656308|NCT03418493|364405811|FG001|Overall Study|Adverse Event|0|||
105656309|NCT03418493|364405812|FG002|Overall Study|Adverse Event|0|||
105656310|NCT03418493|364405813|FG003|Overall Study|Adverse Event|0|||
105656311|NCT03418493|364405814|FG004|Overall Study|Adverse Event|0|||
105656312|NCT03418493|364405815|FG005|Overall Study|Adverse Event|0|||
105656313|NCT03418493|364405816|FG006|Overall Study|Adverse Event|0|||
105656314|NCT03418493|364405817|FG007|Overall Study|Adverse Event|0|||
105656315|NCT03418493|364405818|FG008|Overall Study|Adverse Event|0|||
105656316|NCT03418493|364405819|FG009|Overall Study|Adverse Event|0|||
105656317|NCT03418493|364405820|FG010|Overall Study|Adverse Event|0|||
105656318|NCT03418493|364405810|FG000|Overall Study|Protocol Violation|0|||
105656319|NCT03418493|364405811|FG001|Overall Study|Protocol Violation|0|||
105656320|NCT03418493|364405812|FG002|Overall Study|Protocol Violation|0|||
105656321|NCT03418493|364405813|FG003|Overall Study|Protocol Violation|0|||
105656322|NCT03418493|364405814|FG004|Overall Study|Protocol Violation|0|||
105656323|NCT03418493|364405815|FG005|Overall Study|Protocol Violation|0|||
105656324|NCT03418493|364405816|FG006|Overall Study|Protocol Violation|0|||
105656325|NCT03418493|364405817|FG007|Overall Study|Protocol Violation|0|||
105656326|NCT03418493|364405818|FG008|Overall Study|Protocol Violation|0|||
105656327|NCT03418493|364405819|FG009|Overall Study|Protocol Violation|1|||
105656328|NCT03418493|364405820|FG010|Overall Study|Protocol Violation|0|||
105656329|NCT00966979|364405824|FG000|Overall Study|Death|1|||
105656330|NCT00966979|364405824|FG000|Overall Study|Lost to Follow-up|6|||
105656331|NCT00966979|364405824|FG000|Overall Study|Withdrawal by Subject|14|||
105656332|NCT00966979|364405824|FG000|Overall Study|Adverse Event|5|||
105656333|NCT00966979|364405824|FG000|Overall Study|Sponsor terminated early|49|||
105656334|NCT00966979|364405824|FG000|Overall Study|Censored because surgery not done|2|||
105656335|NCT00966979|364405824|FG000|Overall Study|Censored because study device was not implanted|14|||
105656336|NCT00966979|364405824|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
105656337|NCT03713281|364405825|FG000|Overall Study|Lens handling difficuluties|2|||
105656338|NCT03713281|364405825|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
105656339|NCT03119688|364405826|FG000|Overall Study|Adverse Event|4|||
105656340|NCT01057251|364405828|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
105656341|NCT01057251|364405829|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
105656342|NCT01057251|364405828|FG000|Overall Study|Adverse Event|4|||
105656343|NCT01057251|364405829|FG001|Overall Study|Adverse Event|2|||
105656344|NCT01057251|364405828|FG000|Overall Study|Lack of Efficacy|2|||
105656345|NCT01057251|364405829|FG001|Overall Study|Lack of Efficacy|11|||
105656346|NCT01057251|364405828|FG000|Overall Study|Protocol Violation|6|||
105656347|NCT01057251|364405829|FG001|Overall Study|Protocol Violation|2|||
105656348|NCT01057251|364405828|FG000|Overall Study|Withdrawal by Subject|4|||
105656349|NCT01057251|364405829|FG001|Overall Study|Withdrawal by Subject|5|||
105656350|NCT01057251|364405828|FG000|Overall Study|Lost to Follow-up|7|||
105656351|NCT01057251|364405829|FG001|Overall Study|Lost to Follow-up|6|||
105656352|NCT01057251|364405828|FG000|Overall Study|Other Reason|1|||
105656353|NCT01057251|364405829|FG001|Overall Study|Other Reason|1|||
105656354|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
105656355|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
105656356|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
105656357|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
105656358|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
105656359|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
105656360|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
105656361|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
105656362|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
105656363|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
105656364|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
105656365|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
105656366|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
105656367|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
105656368|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
105656369|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
105656370|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
105656371|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
105656372|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
105656373|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
105656374|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
105656375|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
105656376|NCT02637856|364405830|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
105656377|NCT02637856|364405831|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
105656378|NCT02637856|364405830|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
105656379|NCT02637856|364405831|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
105656380|NCT03357471|364405837|FG000|Overall Study|Adverse Event|1|||
105656381|NCT03357471|364405838|FG001|Overall Study|Adverse Event|0|||
105656382|NCT03357471|364405837|FG000|Overall Study|Lost to Follow-up|1|||
105656383|NCT03357471|364405838|FG001|Overall Study|Lost to Follow-up|0|||
105656384|NCT03294941|364405839|FG000|Overall Study|Withdrawal by Subject|0|||
105656385|NCT03294941|364405840|FG001|Overall Study|Withdrawal by Subject|2|||
105656386|NCT01547117|364405844|FG000|Overall Study|Physician Decision|0|||
105656387|NCT01547117|364405845|FG001|Overall Study|Physician Decision|1|||
105656388|NCT01547117|364405846|FG002|Overall Study|Physician Decision|1|||
105656389|NCT01547117|364405847|FG003|Overall Study|Physician Decision|3|||
105656390|NCT01547117|364405844|FG000|Overall Study|Withdrawal by Subject|1|||
105656391|NCT01547117|364405845|FG001|Overall Study|Withdrawal by Subject|2|||
105656392|NCT01547117|364405846|FG002|Overall Study|Withdrawal by Subject|1|||
105656393|NCT01547117|364405847|FG003|Overall Study|Withdrawal by Subject|2|||
105656394|NCT01844726|364405851|FG000|Overall Study|Withdrawal by Subject|0|||
105656395|NCT01844726|364405852|FG001|Overall Study|Withdrawal by Subject|1|||
105656396|NCT01844726|364405851|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
105656397|NCT01844726|364405852|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
105656398|NCT00307164|364405855|FG000|Overall Study|Death|1|||
105656399|NCT00307164|364405856|FG001|Overall Study|Death|0|||
105656400|NCT00307164|364405855|FG000|Overall Study|Severe debilitation, unable to continue|1|||
105656401|NCT00307164|364405856|FG001|Overall Study|Severe debilitation, unable to continue|0|||
105656402|NCT00307164|364405855|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
105656403|NCT00307164|364405856|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
105656404|NCT00307164|364405855|FG000|Overall Study|Withdrawal by Subject|1|||
105656405|NCT00307164|364405856|FG001|Overall Study|Withdrawal by Subject|8|||
105656406|NCT00307164|364405855|FG000|Overall Study|Not compliant with requirements|4|||
105656407|NCT00307164|364405856|FG001|Overall Study|Not compliant with requirements|4|||
105656408|NCT00307164|364405855|FG000|Overall Study|Lost to Follow-up|6|||
105656409|NCT00307164|364405856|FG001|Overall Study|Lost to Follow-up|1|||
105656410|NCT01202409|364405860|FG000|Overall Study|Adverse Event|1|||
105656411|NCT01202409|364405860|FG000|Overall Study|Ineligible - KRAS mutants|7|||
105656412|NCT00858247|364405861|FG000|Baseline Assessment|Withdrawal by Subject|1|||
105656413|NCT00858247|364405862|FG001|Baseline Assessment|Withdrawal by Subject|1|||
105656414|NCT00858247|364405861|FG000|Baseline Assessment|Poor IV access|1|||
105656415|NCT00858247|364405862|FG001|Baseline Assessment|Poor IV access|0|||
105656416|NCT00858247|364405861|FG000|Baseline Assessment|Protocol Violation|0|||
105656417|NCT00858247|364405862|FG001|Baseline Assessment|Protocol Violation|1|||
105656418|NCT00858247|364405861|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
105656419|NCT00858247|364405862|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
105656420|NCT00337285|364405865|FG000|Overall Study|Withdrawal by Subject|42|||
105656421|NCT00337285|364405865|FG000|Overall Study|Lost to Follow-up|41|||
105656422|NCT00337285|364405865|FG000|Overall Study|Adverse Event|28|||
105656423|NCT00337285|364405865|FG000|Overall Study|Protocol Violation|27|||
105656424|NCT00337285|364405865|FG000|Overall Study|Lack of Efficacy|11|||
105656425|NCT00337285|364405865|FG000|Overall Study|Death|1|||
105656426|NCT00337285|364405865|FG000|Overall Study|Physician Decision|1|||
105656427|NCT00337285|364405865|FG000|Overall Study|Lack of protocol compliance|7|||
105656428|NCT01746108|364405868|FG000|Overall Study|Migrated /moved from study area|0|||
105656429|NCT01746108|364405869|FG001|Overall Study|Migrated /moved from study area|1|||
105656430|NCT01746108|364405870|FG002|Overall Study|Migrated /moved from study area|0|||
105656431|NCT01746108|364405868|FG000|Overall Study|Adverse event, non-fatal|0|||
105656432|NCT01746108|364405869|FG001|Overall Study|Adverse event, non-fatal|1|||
105656433|NCT01746108|364405870|FG002|Overall Study|Adverse event, non-fatal|0|||
105656434|NCT01746108|364405868|FG000|Overall Study|Withdrawal by Subject|0|||
105656435|NCT01746108|364405869|FG001|Overall Study|Withdrawal by Subject|1|||
105656436|NCT01746108|364405870|FG002|Overall Study|Withdrawal by Subject|0|||
105656437|NCT01746108|364405868|FG000|Overall Study|Lost to Follow-up|0|||
105656438|NCT01746108|364405869|FG001|Overall Study|Lost to Follow-up|1|||
105656439|NCT01746108|364405870|FG002|Overall Study|Lost to Follow-up|0|||
105656440|NCT01774019|364405871|FG000|Overall Study|No longer meets protocol criteria|2|||
105656441|NCT01774019|364405872|FG001|Overall Study|No longer meets protocol criteria|0|||
105656442|NCT01774019|364405871|FG000|Overall Study|Withdrawal by Subject|1|||
105656443|NCT01774019|364405872|FG001|Overall Study|Withdrawal by Subject|0|||
105656444|NCT01774019|364405871|FG000|Overall Study|Surgery delayed > 120 days|1|||
105656445|NCT01774019|364405872|FG001|Overall Study|Surgery delayed > 120 days|0|||
105656446|NCT01774019|364405871|FG000|Overall Study|Patient refused surgery|1|||
105656447|NCT01774019|364405872|FG001|Overall Study|Patient refused surgery|1|||
105656448|NCT01774019|364405871|FG000|Overall Study|Unable to implant study device|1|||
105656449|NCT01774019|364405872|FG001|Overall Study|Unable to implant study device|0|||
105656450|NCT01774019|364405871|FG000|Overall Study|Lost to Follow-up|0|||
105656451|NCT01774019|364405872|FG001|Overall Study|Lost to Follow-up|3|||
105656452|NCT00553605|364405873|FG000|Overall Study|Did not meet entrance criteria|1|||
105656453|NCT00553605|364405874|FG001|Overall Study|Did not meet entrance criteria|3|||
105656454|NCT00553605|364405873|FG000|Overall Study|Did not receive full dose|1|||
105656455|NCT00553605|364405874|FG001|Overall Study|Did not receive full dose|0|||
105656456|NCT00553605|364405873|FG000|Overall Study|Randomized but not treated|2|||
105656457|NCT00553605|364405874|FG001|Overall Study|Randomized but not treated|0|||
105656458|NCT03463577|364405882|FG000|Overall Study|Lost to Follow-up|238|||
105656459|NCT03463577|364405883|FG001|Overall Study|Lost to Follow-up|435|||
105656460|NCT03463577|364405884|FG002|Overall Study|Lost to Follow-up|0|||
105656461|NCT03463577|364405885|FG003|Overall Study|Lost to Follow-up|0|||
105656462|NCT03463577|364405886|FG004|Overall Study|Lost to Follow-up|0|||
105656463|NCT03463577|364405887|FG005|Overall Study|Lost to Follow-up|0|||
105656464|NCT03463577|364405882|FG000|Overall Study|With unknown pregnancy outcome|0|||
105656465|NCT03463577|364405883|FG001|Overall Study|With unknown pregnancy outcome|5|||
105656466|NCT03463577|364405884|FG002|Overall Study|With unknown pregnancy outcome|0|||
105656467|NCT03463577|364405885|FG003|Overall Study|With unknown pregnancy outcome|0|||
105656468|NCT03463577|364405886|FG004|Overall Study|With unknown pregnancy outcome|0|||
105656469|NCT03463577|364405887|FG005|Overall Study|With unknown pregnancy outcome|0|||
105656470|NCT03463577|364405882|FG000|Overall Study|Maternal death|2|||
105656471|NCT03463577|364405883|FG001|Overall Study|Maternal death|0|||
105656472|NCT03463577|364405884|FG002|Overall Study|Maternal death|0|||
105656473|NCT03463577|364405885|FG003|Overall Study|Maternal death|0|||
105656474|NCT03463577|364405886|FG004|Overall Study|Maternal death|0|||
105656475|NCT03463577|364405887|FG005|Overall Study|Maternal death|0|||
105656476|NCT03463577|364405882|FG000|Overall Study|Neonatal death|0|||
105656477|NCT03463577|364405883|FG001|Overall Study|Neonatal death|0|||
105656478|NCT03463577|364405884|FG002|Overall Study|Neonatal death|0|||
105656479|NCT03463577|364405885|FG003|Overall Study|Neonatal death|15|||
105656480|NCT03463577|364405886|FG004|Overall Study|Neonatal death|17|||
105656481|NCT03463577|364405887|FG005|Overall Study|Neonatal death|0|||
105656482|NCT00292981|364405888|FG000|Overall Study|Adverse Event|1|||
105656483|NCT00292981|364405888|FG000|Overall Study|Lost to Follow-up|13|||
105656484|NCT00292981|364405888|FG000|Overall Study|Withdrawal by Subject|22|||
105656485|NCT00292981|364405888|FG000|Overall Study|Other|3|||
105656486|NCT00594178|364405889|FG000|Overall Study|Physician Decision|5|||
105656487|NCT00611715|364405900|FG000|Overall Study|Disease Progression|24|||
105656488|NCT00611715|364405901|FG001|Overall Study|Disease Progression|4|||
105656489|NCT00611715|364405900|FG000|Overall Study|Withdrawal by Subject|5|||
105656490|NCT00611715|364405901|FG001|Overall Study|Withdrawal by Subject|1|||
105656491|NCT00611715|364405900|FG000|Overall Study|Adverse Event|9|||
105656492|NCT00611715|364405901|FG001|Overall Study|Adverse Event|1|||
105656493|NCT00611715|364405900|FG000|Overall Study|Death|1|||
105656494|NCT00611715|364405901|FG001|Overall Study|Death|0|||
105656495|NCT00611715|364405900|FG000|Overall Study|two patients are still on treatment|2|||
105656496|NCT00611715|364405901|FG001|Overall Study|two patients are still on treatment|0|||
105656497|NCT00727415|364405902|FG000|Phase I|Dose Limiting Toxicity|2|||
105656498|NCT04191148|364405903|FG000|Overall Study|Withdrawal by Subject|1|||
105656499|NCT04191148|364405904|FG001|Overall Study|Withdrawal by Subject|0|||
105656500|NCT04191148|364405903|FG000|Overall Study|Adverse Event|1|||
105656501|NCT04191148|364405904|FG001|Overall Study|Adverse Event|0|||
105656502|NCT01274559|364405907|FG000|Overall Study|Adverse Event|57|||
105656503|NCT01274559|364405908|FG001|Overall Study|Adverse Event|13|||
105656504|NCT01274559|364405907|FG000|Overall Study|Death|1|||
105656505|NCT01274559|364405908|FG001|Overall Study|Death|1|||
105656506|NCT01274559|364405907|FG000|Overall Study|Lost to Follow-up|3|||
105656507|NCT01274559|364405908|FG001|Overall Study|Lost to Follow-up|3|||
105656508|NCT01274559|364405907|FG000|Overall Study|Non-compliance with Study Drug|2|||
105656509|NCT01274559|364405908|FG001|Overall Study|Non-compliance with Study Drug|4|||
105656510|NCT01274559|364405907|FG000|Overall Study|Physician Decision|2|||
105656511|NCT01274559|364405908|FG001|Overall Study|Physician Decision|1|||
105656512|NCT01274559|364405907|FG000|Overall Study|Protocol Violation|28|||
105656513|NCT01274559|364405908|FG001|Overall Study|Protocol Violation|23|||
105656514|NCT01274559|364405907|FG000|Overall Study|Study Terminated by Sponsor|79|||
105656515|NCT01274559|364405908|FG001|Overall Study|Study Terminated by Sponsor|87|||
105656516|NCT01274559|364405907|FG000|Overall Study|Withdrawal by Subject|25|||
105656517|NCT01274559|364405908|FG001|Overall Study|Withdrawal by Subject|13|||
105656518|NCT00677092|364405909|FG000|Overall Study|Adverse Event|1|||
105656519|NCT00677092|364405909|FG000|Overall Study|Lost to Follow-up|1|||
105656520|NCT00677092|364405909|FG000|Overall Study|Withdrawal by Subject|3|||
105656521|NCT00677092|364405909|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
105656522|NCT00853229|364405912|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
105656523|NCT00853229|364405913|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
105656524|NCT04772313|364405914|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
105656525|NCT04772313|364405914|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
105656526|NCT02560389|364405915|FG000|Overall Study|Lost to Follow-up|1|||
105656527|NCT02560389|364405916|FG001|Overall Study|Lost to Follow-up|2|||
105656528|NCT02560389|364405917|FG002|Overall Study|Lost to Follow-up|2|||
105656529|NCT02560389|364405915|FG000|Overall Study|Tested positive for illicit substance|0|||
105656530|NCT02560389|364405916|FG001|Overall Study|Tested positive for illicit substance|1|||
105656531|NCT02560389|364405917|FG002|Overall Study|Tested positive for illicit substance|0|||
105656532|NCT00550446|364405924|FG000|Up To Week 12|Adverse Event|2|||
105656533|NCT00550446|364405925|FG001|Up To Week 12|Adverse Event|2|||
105656534|NCT00550446|364405926|FG002|Up To Week 12|Adverse Event|0|||
105656535|NCT00550446|364405927|FG003|Up To Week 12|Adverse Event|0|||
105656536|NCT00550446|364405928|FG004|Up To Week 12|Adverse Event|2|||
105656537|NCT00550446|364405929|FG005|Up To Week 12|Adverse Event|2|||
105656538|NCT00550446|364405930|FG006|Up To Week 12|Adverse Event|1|||
105656539|NCT00550446|364405931|FG007|Up To Week 12|Adverse Event|0|||
105656540|NCT00550446|364405932|FG008|Up To Week 12|Adverse Event|0|||
105656541|NCT00550446|364405933|FG009|Up To Week 12|Adverse Event|0|||
105656542|NCT00550446|364405934|FG010|Up To Week 12|Adverse Event|0|||
105656543|NCT00550446|364405924|FG000|Up To Week 12|Lack of Efficacy|3|||
105656544|NCT00550446|364405925|FG001|Up To Week 12|Lack of Efficacy|1|||
105656545|NCT00550446|364405926|FG002|Up To Week 12|Lack of Efficacy|0|||
105656546|NCT00550446|364405927|FG003|Up To Week 12|Lack of Efficacy|1|||
105656547|NCT00550446|364405928|FG004|Up To Week 12|Lack of Efficacy|0|||
105656548|NCT00550446|364405929|FG005|Up To Week 12|Lack of Efficacy|3|||
105656549|NCT00550446|364405930|FG006|Up To Week 12|Lack of Efficacy|3|||
105656550|NCT00550446|364405931|FG007|Up To Week 12|Lack of Efficacy|0|||
105656551|NCT00550446|364405932|FG008|Up To Week 12|Lack of Efficacy|0|||
105656552|NCT00550446|364405933|FG009|Up To Week 12|Lack of Efficacy|0|||
105656553|NCT00550446|364405934|FG010|Up To Week 12|Lack of Efficacy|0|||
105656554|NCT00550446|364405924|FG000|Up To Week 12|Lost to Follow-up|0|||
105656555|NCT00550446|364405925|FG001|Up To Week 12|Lost to Follow-up|1|||
105656556|NCT00550446|364405926|FG002|Up To Week 12|Lost to Follow-up|0|||
105656557|NCT00550446|364405927|FG003|Up To Week 12|Lost to Follow-up|0|||
105656558|NCT00550446|364405928|FG004|Up To Week 12|Lost to Follow-up|1|||
105656559|NCT00550446|364405929|FG005|Up To Week 12|Lost to Follow-up|1|||
105656560|NCT00550446|364405930|FG006|Up To Week 12|Lost to Follow-up|2|||
105656561|NCT00550446|364405931|FG007|Up To Week 12|Lost to Follow-up|0|||
105656562|NCT00550446|364405932|FG008|Up To Week 12|Lost to Follow-up|0|||
105656563|NCT00550446|364405933|FG009|Up To Week 12|Lost to Follow-up|0|||
105656564|NCT00550446|364405934|FG010|Up To Week 12|Lost to Follow-up|0|||
105656565|NCT00550446|364405924|FG000|Up To Week 12|Withdrawal by Subject|2|||
105656566|NCT00550446|364405925|FG001|Up To Week 12|Withdrawal by Subject|0|||
105656567|NCT00550446|364405926|FG002|Up To Week 12|Withdrawal by Subject|3|||
105656568|NCT00550446|364405927|FG003|Up To Week 12|Withdrawal by Subject|2|||
105656569|NCT00550446|364405928|FG004|Up To Week 12|Withdrawal by Subject|0|||
105656570|NCT00550446|364405929|FG005|Up To Week 12|Withdrawal by Subject|1|||
105656571|NCT00550446|364405930|FG006|Up To Week 12|Withdrawal by Subject|3|||
105656572|NCT00550446|364405931|FG007|Up To Week 12|Withdrawal by Subject|0|||
105656573|NCT00550446|364405932|FG008|Up To Week 12|Withdrawal by Subject|0|||
105656574|NCT00550446|364405933|FG009|Up To Week 12|Withdrawal by Subject|0|||
105656575|NCT00550446|364405934|FG010|Up To Week 12|Withdrawal by Subject|0|||
105656576|NCT00550446|364405924|FG000|Up To Week 12|Other|3|||
105656577|NCT00550446|364405925|FG001|Up To Week 12|Other|0|||
105656578|NCT00550446|364405926|FG002|Up To Week 12|Other|0|||
105656579|NCT00550446|364405927|FG003|Up To Week 12|Other|0|||
105656580|NCT00550446|364405928|FG004|Up To Week 12|Other|0|||
105656581|NCT00550446|364405929|FG005|Up To Week 12|Other|1|||
105656582|NCT00550446|364405930|FG006|Up To Week 12|Other|4|||
105656583|NCT00550446|364405931|FG007|Up To Week 12|Other|0|||
105656584|NCT00550446|364405932|FG008|Up To Week 12|Other|0|||
105656585|NCT00550446|364405933|FG009|Up To Week 12|Other|0|||
105656586|NCT00550446|364405934|FG010|Up To Week 12|Other|0|||
105656587|NCT00550446|364405924|FG000|Up To Week 12|Randomized not treated|0|||
105656588|NCT00550446|364405925|FG001|Up To Week 12|Randomized not treated|1|||
105656589|NCT00550446|364405926|FG002|Up To Week 12|Randomized not treated|1|||
105656590|NCT00550446|364405927|FG003|Up To Week 12|Randomized not treated|0|||
105656591|NCT00550446|364405928|FG004|Up To Week 12|Randomized not treated|0|||
105656592|NCT00550446|364405929|FG005|Up To Week 12|Randomized not treated|0|||
105656593|NCT00550446|364405930|FG006|Up To Week 12|Randomized not treated|0|||
105656594|NCT00550446|364405931|FG007|Up To Week 12|Randomized not treated|0|||
105656595|NCT00550446|364405932|FG008|Up To Week 12|Randomized not treated|0|||
105656596|NCT00550446|364405933|FG009|Up To Week 12|Randomized not treated|0|||
105656597|NCT00550446|364405934|FG010|Up To Week 12|Randomized not treated|0|||
105656598|NCT00550446|364405924|FG000|Post Week 12|Adverse Event|2|||
105656599|NCT00550446|364405925|FG001|Post Week 12|Adverse Event|1|||
105656600|NCT00550446|364405926|FG002|Post Week 12|Adverse Event|1|||
105656601|NCT00550446|364405927|FG003|Post Week 12|Adverse Event|1|||
105656602|NCT00550446|364405928|FG004|Post Week 12|Adverse Event|1|||
105656603|NCT00550446|364405929|FG005|Post Week 12|Adverse Event|1|||
105656604|NCT00550446|364405930|FG006|Post Week 12|Adverse Event|0|||
105656605|NCT00550446|364405931|FG007|Post Week 12|Adverse Event|0|||
105656606|NCT00550446|364405932|FG008|Post Week 12|Adverse Event|0|||
105656607|NCT00550446|364405933|FG009|Post Week 12|Adverse Event|4|||
105656608|NCT00550446|364405934|FG010|Post Week 12|Adverse Event|0|||
105656609|NCT00550446|364405924|FG000|Post Week 12|Lack of Efficacy|0|||
105656610|NCT00550446|364405925|FG001|Post Week 12|Lack of Efficacy|0|||
105656611|NCT00550446|364405926|FG002|Post Week 12|Lack of Efficacy|1|||
105656612|NCT00550446|364405927|FG003|Post Week 12|Lack of Efficacy|0|||
105656613|NCT00550446|364405928|FG004|Post Week 12|Lack of Efficacy|0|||
105656614|NCT00550446|364405929|FG005|Post Week 12|Lack of Efficacy|0|||
105656615|NCT00550446|364405930|FG006|Post Week 12|Lack of Efficacy|0|||
105656616|NCT00550446|364405931|FG007|Post Week 12|Lack of Efficacy|1|||
105656617|NCT00550446|364405932|FG008|Post Week 12|Lack of Efficacy|1|||
105656618|NCT00550446|364405933|FG009|Post Week 12|Lack of Efficacy|2|||
105656619|NCT00550446|364405934|FG010|Post Week 12|Lack of Efficacy|1|||
105656620|NCT00550446|364405924|FG000|Post Week 12|Lost to Follow-up|0|||
105656621|NCT00550446|364405925|FG001|Post Week 12|Lost to Follow-up|0|||
105656622|NCT00550446|364405926|FG002|Post Week 12|Lost to Follow-up|1|||
105656623|NCT00550446|364405927|FG003|Post Week 12|Lost to Follow-up|1|||
105656624|NCT00550446|364405928|FG004|Post Week 12|Lost to Follow-up|0|||
105656625|NCT00550446|364405929|FG005|Post Week 12|Lost to Follow-up|0|||
105656626|NCT00550446|364405930|FG006|Post Week 12|Lost to Follow-up|1|||
105656627|NCT00550446|364405931|FG007|Post Week 12|Lost to Follow-up|0|||
105656628|NCT00550446|364405932|FG008|Post Week 12|Lost to Follow-up|0|||
105656629|NCT00550446|364405933|FG009|Post Week 12|Lost to Follow-up|0|||
105656630|NCT00550446|364405934|FG010|Post Week 12|Lost to Follow-up|0|||
105656631|NCT00550446|364405924|FG000|Post Week 12|Withdrawal by Subject|0|||
105656632|NCT00550446|364405925|FG001|Post Week 12|Withdrawal by Subject|0|||
105656633|NCT00550446|364405926|FG002|Post Week 12|Withdrawal by Subject|0|||
105656634|NCT00550446|364405927|FG003|Post Week 12|Withdrawal by Subject|0|||
105656635|NCT00550446|364405928|FG004|Post Week 12|Withdrawal by Subject|1|||
105656636|NCT00550446|364405929|FG005|Post Week 12|Withdrawal by Subject|0|||
105656637|NCT00550446|364405930|FG006|Post Week 12|Withdrawal by Subject|0|||
105656638|NCT00550446|364405931|FG007|Post Week 12|Withdrawal by Subject|0|||
105656639|NCT00550446|364405932|FG008|Post Week 12|Withdrawal by Subject|0|||
105656640|NCT00550446|364405933|FG009|Post Week 12|Withdrawal by Subject|0|||
105656641|NCT00550446|364405934|FG010|Post Week 12|Withdrawal by Subject|0|||
105656642|NCT00550446|364405924|FG000|Post Week 12|Other|1|||
105656643|NCT00550446|364405925|FG001|Post Week 12|Other|1|||
105656644|NCT00550446|364405926|FG002|Post Week 12|Other|0|||
105656645|NCT00550446|364405927|FG003|Post Week 12|Other|1|||
105656646|NCT00550446|364405928|FG004|Post Week 12|Other|0|||
105656647|NCT00550446|364405929|FG005|Post Week 12|Other|0|||
105656648|NCT00550446|364405930|FG006|Post Week 12|Other|1|||
105656649|NCT00550446|364405931|FG007|Post Week 12|Other|0|||
105656650|NCT00550446|364405932|FG008|Post Week 12|Other|1|||
105656651|NCT00550446|364405933|FG009|Post Week 12|Other|1|||
105656652|NCT00550446|364405934|FG010|Post Week 12|Other|0|||
105656653|NCT02716298|364405935|FG000|First Intervention (1 Month)|Lens discomfort|1|||
105656654|NCT02716298|364405936|FG001|First Intervention (1 Month)|Lens discomfort|1|||
105656655|NCT02760485|364405937|FG000|Phase 1|Death|3|||
105656656|NCT02760485|364405938|FG001|Phase 1|Death|6|||
105656657|NCT02760485|364405939|FG002|Phase 1|Death|0|||
105656658|NCT02760485|364405937|FG000|Phase 1|Withdrawal by Subject|2|||
105656659|NCT02760485|364405938|FG001|Phase 1|Withdrawal by Subject|0|||
105656660|NCT02760485|364405939|FG002|Phase 1|Withdrawal by Subject|0|||
105656661|NCT02760485|364405937|FG000|Phase 1|Progressive Disease|1|||
105656662|NCT02760485|364405938|FG001|Phase 1|Progressive Disease|0|||
105656663|NCT02760485|364405939|FG002|Phase 1|Progressive Disease|0|||
105656664|NCT02760485|364405937|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
105656665|NCT02760485|364405938|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
105656666|NCT02760485|364405939|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
105656667|NCT02760485|364405937|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
105656668|NCT02760485|364405938|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
105656669|NCT02760485|364405939|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
105656670|NCT02760485|364405937|FG000|Phase 2|Death|0|||
105656671|NCT02760485|364405938|FG001|Phase 2|Death|0|||
105656672|NCT02760485|364405939|FG002|Phase 2|Death|12|||
105656673|NCT02760485|364405937|FG000|Phase 2|Withdrawal by Subject|0|||
105656674|NCT02760485|364405938|FG001|Phase 2|Withdrawal by Subject|0|||
105656675|NCT02760485|364405939|FG002|Phase 2|Withdrawal by Subject|3|||
105656676|NCT02760485|364405937|FG000|Phase 2|Progressive Disease|0|||
105656677|NCT02760485|364405938|FG001|Phase 2|Progressive Disease|0|||
105656678|NCT02760485|364405939|FG002|Phase 2|Progressive Disease|1|||
105656679|NCT02760485|364405937|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
105656680|NCT02760485|364405938|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
105656681|NCT02760485|364405939|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
105656682|NCT01349036|364405940|FG000|Overall Study|Disease progression|13|||
105656683|NCT01349036|364405941|FG001|Overall Study|Disease progression|22|||
105656684|NCT01349036|364405940|FG000|Overall Study|Other|1|||
105656685|NCT01349036|364405941|FG001|Overall Study|Other|0|||
105656686|NCT01349036|364405940|FG000|Overall Study|Withdrawal by Subject|0|||
105656687|NCT01349036|364405941|FG001|Overall Study|Withdrawal by Subject|2|||
105656688|NCT01878383|364407422|FG000|Overall Study|Lost to Follow-up|0|||
105656689|NCT01878383|364407423|FG001|Overall Study|Lost to Follow-up|1499|||
105656690|NCT00605566|364407424|FG000|Overall Study|Adverse Event|1|||
105656691|NCT00605566|364407424|FG000|Overall Study|Clinical deterioration|1|||
105656692|NCT00605566|364407424|FG000|Overall Study|Poor compliance in run-in period|1|||
105656693|NCT01101334|364407425|FG000|Overall Study|Adverse Event|9|||
105656694|NCT01101334|364407426|FG001|Overall Study|Adverse Event|4|||
105656695|NCT01101334|364407425|FG000|Overall Study|Death|7|||
105656696|NCT01101334|364407426|FG001|Overall Study|Death|1|||
105656697|NCT01101334|364407425|FG000|Overall Study|Withdrawal by Subject|4|||
105656698|NCT01101334|364407426|FG001|Overall Study|Withdrawal by Subject|3|||
105656699|NCT01101334|364407425|FG000|Overall Study|Withdrawal by Sponsor|1|||
105656700|NCT01101334|364407426|FG001|Overall Study|Withdrawal by Sponsor|1|||
105656701|NCT01101334|364407425|FG000|Overall Study|Progressive Disease|22|||
105656702|NCT01101334|364407426|FG001|Overall Study|Progressive Disease|35|||
105656703|NCT01101334|364407425|FG000|Overall Study|Other|2|||
105656704|NCT01101334|364407426|FG001|Overall Study|Other|1|||
105656705|NCT01904136|364407433|FG000|Overall Study|Physician Decision|0|||
105656706|NCT01904136|364407434|FG001|Overall Study|Physician Decision|0|||
105656707|NCT01904136|364407435|FG002|Overall Study|Physician Decision|0|||
105656708|NCT01904136|364407436|FG003|Overall Study|Physician Decision|0|||
105656709|NCT01904136|364407437|FG004|Overall Study|Physician Decision|0|||
105656710|NCT01904136|364407438|FG005|Overall Study|Physician Decision|1|||
105656711|NCT01904136|364407439|FG006|Overall Study|Physician Decision|0|||
105656712|NCT01904136|364407440|FG007|Overall Study|Physician Decision|0|||
105656713|NCT01904136|364407441|FG008|Overall Study|Physician Decision|0|||
105656714|NCT00695136|364407442|FG000|Overall Study|Withdrawal by Subject|1|||
105656715|NCT00695136|364407442|FG000|Overall Study|unrelated adverse event|1|||
105656716|NCT00853372|364407443|FG000|Overall Study|Death|30|||
105656717|NCT00853372|364407444|FG001|Overall Study|Death|26|||
105656718|NCT00853372|364407443|FG000|Overall Study|Lost to Follow-up|1|||
105656719|NCT00853372|364407444|FG001|Overall Study|Lost to Follow-up|2|||
105656720|NCT00853372|364407443|FG000|Overall Study|Full Consent Withdrawn|1|||
105656721|NCT00853372|364407444|FG001|Overall Study|Full Consent Withdrawn|1|||
105656722|NCT01821729|364407445|FG000|Overall Study|Withdrawal by Subject|1|||
105656723|NCT03596242|364407446|FG000|Overall Study|Lost to Follow-up|2|||
105656724|NCT03596242|364407447|FG001|Overall Study|Lost to Follow-up|2|||
105656725|NCT02509312|364407448|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
105656726|NCT02509312|364407449|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
105656727|NCT02509312|364407448|FG000|Overall Study|Obstetrician refusal|0|||
105656728|NCT02509312|364407449|FG001|Overall Study|Obstetrician refusal|1|||
105656729|NCT02509312|364407448|FG000|Overall Study|Patient elected for TOLAC|1|||
105656730|NCT02509312|364407449|FG001|Overall Study|Patient elected for TOLAC|0|||
105656731|NCT02509312|364407448|FG000|Overall Study|Cesarean deemed stat|1|||
105656732|NCT02509312|364407449|FG001|Overall Study|Cesarean deemed stat|0|||
105656733|NCT02509312|364407448|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
105656734|NCT02509312|364407449|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
105656735|NCT00713206|364407455|FG000|Overall Study|Lost to Follow-up|4|||
105656736|NCT00713206|364407456|FG001|Overall Study|Lost to Follow-up|4|||
105656737|NCT00713206|364407455|FG000|Overall Study|Death|1|||
105656738|NCT00713206|364407456|FG001|Overall Study|Death|0|||
105656739|NCT02561806|364407457|FG000|Induction Period|Adverse Event|0|||
105656740|NCT02561806|364407458|FG001|Induction Period|Adverse Event|2|||
105656741|NCT02561806|364407457|FG000|Induction Period|Lack of Efficacy|1|||
105656742|NCT02561806|364407458|FG001|Induction Period|Lack of Efficacy|0|||
105656743|NCT02561806|364407457|FG000|Induction Period|Withdrawal by Subject|0|||
105656744|NCT02561806|364407458|FG001|Induction Period|Withdrawal by Subject|2|||
105656745|NCT02561806|364407457|FG000|Induction Period|Site staff became unblinded|1|||
105656746|NCT02561806|364407458|FG001|Induction Period|Site staff became unblinded|0|||
105656747|NCT02561806|364407457|FG000|Induction Period|Randomized but not treated|0|||
105656748|NCT02561806|364407458|FG001|Induction Period|Randomized but not treated|1|||
105656749|NCT02561806|364407457|FG000|Maintenance Period|Adverse Event|2|||
105656750|NCT02561806|364407458|FG001|Maintenance Period|Adverse Event|1|||
105656751|NCT02561806|364407457|FG000|Maintenance Period|Lack of Efficacy|3|||
105656752|NCT02561806|364407458|FG001|Maintenance Period|Lack of Efficacy|1|||
105656753|NCT02561806|364407457|FG000|Maintenance Period|Lost to Follow-up|2|||
105656754|NCT02561806|364407458|FG001|Maintenance Period|Lost to Follow-up|2|||
105656755|NCT02561806|364407457|FG000|Maintenance Period|Protocol Violation|1|||
105656756|NCT02561806|364407458|FG001|Maintenance Period|Protocol Violation|0|||
105656757|NCT02561806|364407457|FG000|Maintenance Period|Withdrawal by Subject|5|||
105656758|NCT02561806|364407458|FG001|Maintenance Period|Withdrawal by Subject|3|||
105656759|NCT02561806|364407457|FG000|Maintenance Period|Site staff became unblinded|0|||
105656760|NCT02561806|364407458|FG001|Maintenance Period|Site staff became unblinded|1|||
105656761|NCT02561806|364407457|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
105656762|NCT02561806|364407458|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
105656763|NCT02561806|364407457|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
105656764|NCT02561806|364407458|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
105656765|NCT02547441|364407462|FG000|Double-Blind Study Period|Adverse Event|4|||
105656766|NCT02547441|364407463|FG001|Double-Blind Study Period|Adverse Event|9|||
105656767|NCT02547441|364407462|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
105656768|NCT02547441|364407463|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
105656769|NCT02547441|364407462|FG000|Double-Blind Study Period|Physician Decision|1|||
105656770|NCT02547441|364407463|FG001|Double-Blind Study Period|Physician Decision|0|||
105656771|NCT02547441|364407462|FG000|Double-Blind Study Period|Protocol Violation|1|||
105656772|NCT02547441|364407463|FG001|Double-Blind Study Period|Protocol Violation|2|||
105656773|NCT02547441|364407462|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
105656774|NCT02547441|364407463|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
105656775|NCT02547441|364407462|FG000|Double-Blind Study Period|Sponsor Decision|1|||
105656776|NCT02547441|364407463|FG001|Double-Blind Study Period|Sponsor Decision|0|||
105656777|NCT02547441|364407462|FG000|Open-Label Study Period|Adverse Event|10|||
105656778|NCT02547441|364407463|FG001|Open-Label Study Period|Adverse Event|11|||
105656779|NCT02547441|364407462|FG000|Open-Label Study Period|Lack of Efficacy|3|||
105656780|NCT02547441|364407463|FG001|Open-Label Study Period|Lack of Efficacy|2|||
105656781|NCT02547441|364407462|FG000|Open-Label Study Period|Lost to Follow-up|7|||
105656782|NCT02547441|364407463|FG001|Open-Label Study Period|Lost to Follow-up|8|||
105656783|NCT02547441|364407462|FG000|Open-Label Study Period|Physician Decision|1|||
105656784|NCT02547441|364407463|FG001|Open-Label Study Period|Physician Decision|0|||
105656785|NCT02547441|364407462|FG000|Open-Label Study Period|Protocol Violation|2|||
105656786|NCT02547441|364407463|FG001|Open-Label Study Period|Protocol Violation|0|||
105656787|NCT02547441|364407462|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
105656788|NCT02547441|364407463|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
105656789|NCT02547441|364407462|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
105656790|NCT02547441|364407463|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
105656791|NCT01657877|364407464|FG000|Overall Study|Withdrawal by Subject|4|||
105656792|NCT01657877|364407464|FG000|Overall Study|Protocol Violation|6|||
105656793|NCT01657877|364407464|FG000|Overall Study|Adverse Event|2|||
105656794|NCT01657877|364407464|FG000|Overall Study|Other Reason|2|||
105656795|NCT02299427|364407468|FG000|Overall Study|Withdrawal by Subject|1|||
105656796|NCT02299427|364407469|FG001|Overall Study|Withdrawal by Subject|0|||
105656797|NCT02299427|364407468|FG000|Overall Study|Lost to Follow-up|1|||
105656798|NCT02299427|364407469|FG001|Overall Study|Lost to Follow-up|3|||
105656799|NCT02299427|364407468|FG000|Overall Study|not adherent to dog website use|21|||
105656800|NCT02299427|364407469|FG001|Overall Study|not adherent to dog website use|0|||
105656801|NCT03318783|364407478|FG000|Overall Study|Withdrawal by Subject|0|||
105656802|NCT03318783|364407479|FG001|Overall Study|Withdrawal by Subject|1|||
105656803|NCT03318783|364407478|FG000|Overall Study|Death|0|||
105656804|NCT03318783|364407479|FG001|Overall Study|Death|1|||
105656805|NCT00545571|364407482|FG000|Overall Study|Administrative Reasons|1|||
105656806|NCT00545571|364407482|FG000|Overall Study|Adverse Event|2|||
105656807|NCT00545571|364407482|FG000|Overall Study|Death|5|||
105656808|NCT00545571|364407482|FG000|Overall Study|Lack of Efficacy|1|||
105656809|NCT00545571|364407482|FG000|Overall Study|Protocol Violation|2|||
105656810|NCT00545571|364407482|FG000|Overall Study|Refused Treatment|1|||
105656811|NCT00545571|364407482|FG000|Overall Study|Screen Failure|16|||
105656812|NCT00545571|364407482|FG000|Overall Study|Transfusion|12|||
105656813|NCT00545571|364407482|FG000|Overall Study|Early Termination of Study|24|||
105656814|NCT00545571|364407482|FG000|Overall Study|Kidney Transplantation|3|||
105656815|NCT03269695|364407483|FG000|Overall Study|Adverse Event|2|||
105656816|NCT03269695|364407484|FG001|Overall Study|Adverse Event|1|||
105656817|NCT03269695|364407483|FG000|Overall Study|Lack of Efficacy|0|||
105656818|NCT03269695|364407484|FG001|Overall Study|Lack of Efficacy|1|||
105656819|NCT03269695|364407483|FG000|Overall Study|Withdrawal by Subject|0|||
105656820|NCT03269695|364407484|FG001|Overall Study|Withdrawal by Subject|1|||
105656821|NCT00505414|364407486|FG000|Titration Phase|Adverse Event|0|||
105656822|NCT00505414|364407487|FG001|Titration Phase|Adverse Event|0|||
105656823|NCT00505414|364407488|FG002|Titration Phase|Adverse Event|0|||
105656824|NCT00505414|364407489|FG003|Titration Phase|Adverse Event|8|||
105656825|NCT00505414|364407490|FG004|Titration Phase|Adverse Event|3|||
105656826|NCT00505414|364407486|FG000|Titration Phase|Death|0|||
105656827|NCT00505414|364407487|FG001|Titration Phase|Death|0|||
105656828|NCT00505414|364407488|FG002|Titration Phase|Death|0|||
105656829|NCT00505414|364407489|FG003|Titration Phase|Death|2|||
105656830|NCT00505414|364407490|FG004|Titration Phase|Death|0|||
105656831|NCT00505414|364407486|FG000|Titration Phase|Lack of Efficacy|0|||
105656832|NCT00505414|364407487|FG001|Titration Phase|Lack of Efficacy|0|||
105656833|NCT00505414|364407488|FG002|Titration Phase|Lack of Efficacy|0|||
105656834|NCT00505414|364407489|FG003|Titration Phase|Lack of Efficacy|10|||
105656835|NCT00505414|364407490|FG004|Titration Phase|Lack of Efficacy|1|||
105656836|NCT00505414|364407486|FG000|Titration Phase|Protocol Violation|0|||
105656837|NCT00505414|364407487|FG001|Titration Phase|Protocol Violation|0|||
105656838|NCT00505414|364407488|FG002|Titration Phase|Protocol Violation|0|||
105656839|NCT00505414|364407489|FG003|Titration Phase|Protocol Violation|0|||
105656840|NCT00505414|364407490|FG004|Titration Phase|Protocol Violation|1|||
105656841|NCT00505414|364407486|FG000|Titration Phase|Withdrawal by Subject|0|||
105656842|NCT00505414|364407487|FG001|Titration Phase|Withdrawal by Subject|0|||
105656843|NCT00505414|364407488|FG002|Titration Phase|Withdrawal by Subject|0|||
105656844|NCT00505414|364407489|FG003|Titration Phase|Withdrawal by Subject|3|||
105656845|NCT00505414|364407490|FG004|Titration Phase|Withdrawal by Subject|4|||
105656846|NCT00505414|364407486|FG000|Titration Phase|Underlying disease and therapy required|0|||
105656847|NCT00505414|364407487|FG001|Titration Phase|Underlying disease and therapy required|0|||
105656848|NCT00505414|364407488|FG002|Titration Phase|Underlying disease and therapy required|0|||
105656849|NCT00505414|364407489|FG003|Titration Phase|Underlying disease and therapy required|7|||
105656850|NCT00505414|364407490|FG004|Titration Phase|Underlying disease and therapy required|3|||
105656851|NCT00505414|364407486|FG000|Maintenance Phase|Adverse Event|2|||
105656852|NCT00505414|364407487|FG001|Maintenance Phase|Adverse Event|2|||
105656853|NCT00505414|364407488|FG002|Maintenance Phase|Adverse Event|3|||
105656854|NCT00505414|364407489|FG003|Maintenance Phase|Adverse Event|0|||
105656855|NCT00505414|364407490|FG004|Maintenance Phase|Adverse Event|0|||
105656856|NCT00505414|364407486|FG000|Maintenance Phase|Death|2|||
105656857|NCT00505414|364407487|FG001|Maintenance Phase|Death|0|||
105656858|NCT00505414|364407488|FG002|Maintenance Phase|Death|1|||
105656859|NCT00505414|364407489|FG003|Maintenance Phase|Death|0|||
105656860|NCT00505414|364407490|FG004|Maintenance Phase|Death|0|||
105656861|NCT00505414|364407486|FG000|Maintenance Phase|Lack of Efficacy|2|||
105656862|NCT00505414|364407487|FG001|Maintenance Phase|Lack of Efficacy|1|||
105656863|NCT00505414|364407488|FG002|Maintenance Phase|Lack of Efficacy|1|||
105656864|NCT00505414|364407489|FG003|Maintenance Phase|Lack of Efficacy|0|||
105656865|NCT00505414|364407490|FG004|Maintenance Phase|Lack of Efficacy|0|||
105656866|NCT00505414|364407486|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105656867|NCT00505414|364407487|FG001|Maintenance Phase|Withdrawal by Subject|0|||
105656868|NCT00505414|364407488|FG002|Maintenance Phase|Withdrawal by Subject|1|||
105656869|NCT00505414|364407489|FG003|Maintenance Phase|Withdrawal by Subject|0|||
105656870|NCT00505414|364407490|FG004|Maintenance Phase|Withdrawal by Subject|0|||
105656871|NCT00505414|364407486|FG000|Maintenance Phase|underlying disease and therapy required|0|||
105656872|NCT00505414|364407487|FG001|Maintenance Phase|underlying disease and therapy required|2|||
105656873|NCT00505414|364407488|FG002|Maintenance Phase|underlying disease and therapy required|2|||
105656874|NCT00505414|364407489|FG003|Maintenance Phase|underlying disease and therapy required|0|||
105656875|NCT00505414|364407490|FG004|Maintenance Phase|underlying disease and therapy required|0|||
105656876|NCT04353817|364407491|FG000|Overall Study|Adverse Event|0|||
105656877|NCT04353817|364407492|FG001|Overall Study|Adverse Event|1|||
105656878|NCT04358068|364407493|FG000|Overall Study|Did not initiate study treatment|2|||
105656879|NCT04358068|364407494|FG001|Overall Study|Did not initiate study treatment|2|||
105656880|NCT01841112|364407498|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
105656881|NCT01841112|364407499|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
105656882|NCT01841112|364407500|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
105656883|NCT01841112|364407501|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
105656884|NCT01841112|364407502|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
105656885|NCT03811834|364407503|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
105656886|NCT01242371|364407504|FG000|Overall Study|Withdrawal by Subject|2|||
105656887|NCT01242371|364407505|FG001|Overall Study|Withdrawal by Subject|2|||
105656888|NCT01242371|364407504|FG000|Overall Study|Protocol Violation|0|||
105656889|NCT01242371|364407505|FG001|Overall Study|Protocol Violation|3|||
105656890|NCT00510146|364407506|FG000|Double-Blind Treatment|Adverse Event|30|||
105656891|NCT00510146|364407507|FG001|Double-Blind Treatment|Adverse Event|13|||
105656892|NCT00510146|364407506|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
105656893|NCT00510146|364407507|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
105656894|NCT00510146|364407506|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
105656895|NCT00510146|364407507|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
105656896|NCT00510146|364407506|FG000|Double-Blind Treatment|Physician Decision|6|||
105656897|NCT00510146|364407507|FG001|Double-Blind Treatment|Physician Decision|0|||
105656898|NCT00510146|364407506|FG000|Double-Blind Treatment|Protocol Violation|1|||
105656899|NCT00510146|364407507|FG001|Double-Blind Treatment|Protocol Violation|2|||
105656900|NCT00510146|364407506|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
105656901|NCT00510146|364407507|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
105656902|NCT00510146|364407506|FG000|Double-Blind Treatment|Clinical Relapse|0|||
105656903|NCT00510146|364407507|FG001|Double-Blind Treatment|Clinical Relapse|1|||
105656904|NCT00510146|364407506|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
105656905|NCT00510146|364407507|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
105656906|NCT00510146|364407506|FG000|Open-Label Treatment|Adverse Event|22|||
105656907|NCT00510146|364407507|FG001|Open-Label Treatment|Adverse Event|8|||
105656908|NCT00510146|364407506|FG000|Open-Label Treatment|Death|1|||
105656909|NCT00510146|364407507|FG001|Open-Label Treatment|Death|1|||
105656910|NCT00510146|364407506|FG000|Open-Label Treatment|Lack of Efficacy|4|||
105656911|NCT00510146|364407507|FG001|Open-Label Treatment|Lack of Efficacy|0|||
105656912|NCT00510146|364407506|FG000|Open-Label Treatment|Lost to Follow-up|10|||
105656913|NCT00510146|364407507|FG001|Open-Label Treatment|Lost to Follow-up|1|||
105656914|NCT00510146|364407506|FG000|Open-Label Treatment|Physician Decision|3|||
105656915|NCT00510146|364407507|FG001|Open-Label Treatment|Physician Decision|1|||
105656916|NCT00510146|364407506|FG000|Open-Label Treatment|Protocol Violation|4|||
105656917|NCT00510146|364407507|FG001|Open-Label Treatment|Protocol Violation|2|||
105656918|NCT00510146|364407506|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
105656919|NCT00510146|364407507|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
105656920|NCT00510146|364407506|FG000|Open-Label Treatment|Clinical Relapse|1|||
105656921|NCT00510146|364407507|FG001|Open-Label Treatment|Clinical Relapse|1|||
105656922|NCT00510146|364407506|FG000|Open-Label Treatment|Sponsor Decision|2|||
105656923|NCT00510146|364407507|FG001|Open-Label Treatment|Sponsor Decision|0|||
105656924|NCT04354168|364407510|FG000|Overall Study|Lost to Follow-up|22|||
105656925|NCT01438840|364407511|FG000|Core Study|Adverse Event|0|||
105656926|NCT01438840|364407512|FG001|Core Study|Adverse Event|3|||
105656927|NCT01438840|364407513|FG002|Core Study|Adverse Event|0|||
105656928|NCT01438840|364407511|FG000|Core Study|Lack of Efficacy|15|||
105656929|NCT01438840|364407512|FG001|Core Study|Lack of Efficacy|7|||
105656930|NCT01438840|364407513|FG002|Core Study|Lack of Efficacy|0|||
105656931|NCT01438840|364407511|FG000|Core Study|Withdrawal of consent|1|||
105656932|NCT01438840|364407512|FG001|Core Study|Withdrawal of consent|0|||
105656933|NCT01438840|364407513|FG002|Core Study|Withdrawal of consent|0|||
105656934|NCT01438840|364407511|FG000|Extension Phase|Adverse Event|0|||
105656935|NCT01438840|364407512|FG001|Extension Phase|Adverse Event|0|||
105656936|NCT01438840|364407513|FG002|Extension Phase|Adverse Event|3|||
105656937|NCT01438840|364407511|FG000|Extension Phase|Lost to Follow-up|0|||
105656938|NCT01438840|364407512|FG001|Extension Phase|Lost to Follow-up|0|||
105656939|NCT01438840|364407513|FG002|Extension Phase|Lost to Follow-up|1|||
105656940|NCT01438840|364407511|FG000|Extension Phase|Withdrawal by Subject|0|||
105656941|NCT01438840|364407512|FG001|Extension Phase|Withdrawal by Subject|0|||
105656942|NCT01438840|364407513|FG002|Extension Phase|Withdrawal by Subject|3|||
105656943|NCT01438840|364407511|FG000|Extension Phase|Lack of Efficacy|0|||
105656944|NCT01438840|364407512|FG001|Extension Phase|Lack of Efficacy|0|||
105656945|NCT01438840|364407513|FG002|Extension Phase|Lack of Efficacy|2|||
105656946|NCT01438840|364407511|FG000|Extension Phase|Other|0|||
105656947|NCT01438840|364407512|FG001|Extension Phase|Other|0|||
105656948|NCT01438840|364407513|FG002|Extension Phase|Other|1|||
105656949|NCT03589300|364407516|FG000|Overall Study|Adverse Event|2|||
105656950|NCT03589300|364407516|FG000|Overall Study|Death|4|||
105656951|NCT03589300|364407516|FG000|Overall Study|Lost to Follow-up|12|||
105656952|NCT03589300|364407516|FG000|Overall Study|Withdrawal by Subject|5|||
105656953|NCT00461123|364407517|FG000|Overall Study|Adverse Event|1|||
105656954|NCT00461123|364407518|FG001|Overall Study|Adverse Event|0|||
105656955|NCT00461123|364407517|FG000|Overall Study|Lost to Follow-up|1|||
105656956|NCT00461123|364407518|FG001|Overall Study|Lost to Follow-up|1|||
105656957|NCT00461123|364407517|FG000|Overall Study|Protocol Violation|3|||
105656958|NCT00461123|364407518|FG001|Overall Study|Protocol Violation|2|||
105656959|NCT00461123|364407517|FG000|Overall Study|Withdrawal by Subject|1|||
105656960|NCT00461123|364407518|FG001|Overall Study|Withdrawal by Subject|3|||
105656961|NCT02261285|364407519|FG000|Overall Study|Disease progression|0|||
105656962|NCT02261285|364407520|FG001|Overall Study|Disease progression|0|||
105656963|NCT02261285|364407521|FG002|Overall Study|Disease progression|1|||
105656964|NCT03738397|364407522|FG000|Overall Study|Adverse Event|3|||
105656965|NCT03738397|364407523|FG001|Overall Study|Adverse Event|7|||
105656966|NCT03738397|364407522|FG000|Overall Study|Withdrawal by Subject|8|||
105656967|NCT03738397|364407523|FG001|Overall Study|Withdrawal by Subject|11|||
105656968|NCT03738397|364407522|FG000|Overall Study|Lost to Follow-up|7|||
105656969|NCT03738397|364407523|FG001|Overall Study|Lost to Follow-up|5|||
105656970|NCT03738397|364407522|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
105656971|NCT03738397|364407523|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
105656972|NCT03738397|364407522|FG000|Overall Study|Other|4|||
105656973|NCT03738397|364407523|FG001|Overall Study|Other|6|||
105656974|NCT00904722|364407524|FG000|Overall Study|Physician Decision|1|||
105656975|NCT01891890|364407525|FG000|Overall Study|Lost to Follow-up|0|||
105656976|NCT01891890|364407526|FG001|Overall Study|Lost to Follow-up|0|||
105656977|NCT01891890|364407527|FG002|Overall Study|Lost to Follow-up|1|||
105656978|NCT01891890|364407525|FG000|Overall Study|Study ended before endpoint reached|7|||
105656979|NCT01891890|364407526|FG001|Overall Study|Study ended before endpoint reached|3|||
105656980|NCT01891890|364407527|FG002|Overall Study|Study ended before endpoint reached|6|||
105656981|NCT04969224|364407528|FG000|Overall Study|Adverse Event|1|||
105656982|NCT04969224|364407528|FG000|Overall Study|Enrolled but never dosed|1|||
105656983|NCT03605368|364407538|FG000|Overall Study|Lost to Follow-up|2|||
105656984|NCT03605368|364407539|FG001|Overall Study|Lost to Follow-up|1|||
105656985|NCT03605368|364407540|FG002|Overall Study|Lost to Follow-up|3|||
105656986|NCT03605368|364407541|FG003|Overall Study|Lost to Follow-up|2|||
105656987|NCT03605368|364407538|FG000|Overall Study|Withdrawal by Subject|0|||
105656988|NCT03605368|364407539|FG001|Overall Study|Withdrawal by Subject|0|||
105656989|NCT03605368|364407540|FG002|Overall Study|Withdrawal by Subject|4|||
105656990|NCT03605368|364407541|FG003|Overall Study|Withdrawal by Subject|3|||
105656991|NCT01215032|364407542|FG000|Overall Study|Adverse Event|3|||
105656992|NCT01215032|364407542|FG000|Overall Study|Lack of Efficacy|17|||
105656993|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
105656994|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
105656995|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
105656996|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
105656997|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
105656998|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
105656999|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
105657000|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
105657001|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
105657002|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
105657003|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
105657004|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
105657005|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
105657006|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
105657007|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
105657008|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
105657009|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
105657010|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
105657011|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
105657012|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
105657013|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
105657014|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
105657015|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
105657016|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
105657017|NCT01125566|364407543|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
105657018|NCT01125566|364407544|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
105657019|NCT01125566|364407545|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
105657020|NCT01125566|364407543|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
105657021|NCT01125566|364407544|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
105657022|NCT01125566|364407545|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
105657023|NCT01125566|364407543|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
105657024|NCT01125566|364407544|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
105657025|NCT01125566|364407545|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
105657026|NCT01125566|364407543|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
105657027|NCT01125566|364407544|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
105657028|NCT01125566|364407545|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
105657029|NCT01020747|364407548|FG000|Overall Study|Withdrawal by Subject|1|||
105657030|NCT01222078|364407549|FG000|Overall Study|Early termination of the study|1|||
105657031|NCT02970305|364407551|FG000|Overall Study|Adverse Event|10|||
105657032|NCT02970305|364407552|FG001|Overall Study|Adverse Event|6|||
105657033|NCT02970305|364407551|FG000|Overall Study|Lack of Efficacy|1|||
105657034|NCT02970305|364407552|FG001|Overall Study|Lack of Efficacy|1|||
105657035|NCT02970305|364407551|FG000|Overall Study|Noncompliance with study drug|2|||
105657036|NCT02970305|364407552|FG001|Overall Study|Noncompliance with study drug|4|||
105657037|NCT02970305|364407551|FG000|Overall Study|Protocol Violation|2|||
105657038|NCT02970305|364407552|FG001|Overall Study|Protocol Violation|2|||
105657039|NCT02970305|364407551|FG000|Overall Study|Withdrawal by Subject|12|||
105657040|NCT02970305|364407552|FG001|Overall Study|Withdrawal by Subject|11|||
105657041|NCT02970305|364407551|FG000|Overall Study|Not further specified|1|||
105657042|NCT02970305|364407552|FG001|Overall Study|Not further specified|2|||
105657043|NCT02970305|364407551|FG000|Overall Study|Lost to Follow-up|1|||
105657044|NCT02970305|364407552|FG001|Overall Study|Lost to Follow-up|2|||
105657045|NCT00983892|364407553|FG000|Overall Study|Withdrawal by Subject|10|||
105657046|NCT00983892|364407554|FG001|Overall Study|Withdrawal by Subject|12|||
105657047|NCT02650466|364407555|FG000|Overall Study|Physician Decision|1|||
105657048|NCT02650466|364407555|FG000|Overall Study|Withdrawal by Subject|5|||
105657049|NCT02650466|364407555|FG000|Overall Study|Lost to Follow-up|1|||
105657050|NCT00573651|364407559|FG000|Overall Study|Lost to Follow-up|3|||
105657051|NCT00573651|364407559|FG000|Overall Study|Withdrawal by Subject|1|||
105657052|NCT02484547|364407560|FG000|Placebo-Controlled Period|Adverse Event|10|||
105657053|NCT02484547|364407561|FG001|Placebo-Controlled Period|Adverse Event|13|||
105657054|NCT02484547|364407562|FG002|Placebo-Controlled Period|Adverse Event|20|||
105657055|NCT02484547|364407563|FG003|Placebo-Controlled Period|Adverse Event|0|||
105657056|NCT02484547|364407564|FG004|Placebo-Controlled Period|Adverse Event|0|||
105657057|NCT02484547|364407565|FG005|Placebo-Controlled Period|Adverse Event|0|||
105657058|NCT02484547|364407566|FG006|Placebo-Controlled Period|Adverse Event|0|||
105657059|NCT02484547|364407560|FG000|Placebo-Controlled Period|Change of Treatment|0|||
105657060|NCT02484547|364407561|FG001|Placebo-Controlled Period|Change of Treatment|0|||
105657061|NCT02484547|364407562|FG002|Placebo-Controlled Period|Change of Treatment|1|||
105657062|NCT02484547|364407563|FG003|Placebo-Controlled Period|Change of Treatment|0|||
105657063|NCT02484547|364407564|FG004|Placebo-Controlled Period|Change of Treatment|0|||
105657064|NCT02484547|364407565|FG005|Placebo-Controlled Period|Change of Treatment|0|||
105657065|NCT02484547|364407566|FG006|Placebo-Controlled Period|Change of Treatment|0|||
105657066|NCT02484547|364407560|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
105657067|NCT02484547|364407561|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
105657068|NCT02484547|364407562|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
105657069|NCT02484547|364407563|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
105657070|NCT02484547|364407564|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
105657071|NCT02484547|364407565|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
105657072|NCT02484547|364407566|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
105657073|NCT02484547|364407560|FG000|Placebo-Controlled Period|Death|5|||
105657074|NCT02484547|364407561|FG001|Placebo-Controlled Period|Death|0|||
105657075|NCT02484547|364407562|FG002|Placebo-Controlled Period|Death|6|||
105657076|NCT02484547|364407563|FG003|Placebo-Controlled Period|Death|0|||
105657077|NCT02484547|364407564|FG004|Placebo-Controlled Period|Death|0|||
105657078|NCT02484547|364407565|FG005|Placebo-Controlled Period|Death|0|||
105657079|NCT02484547|364407566|FG006|Placebo-Controlled Period|Death|0|||
105657080|NCT02484547|364407560|FG000|Placebo-Controlled Period|Disease Progression|2|||
105657081|NCT02484547|364407561|FG001|Placebo-Controlled Period|Disease Progression|0|||
105657082|NCT02484547|364407562|FG002|Placebo-Controlled Period|Disease Progression|1|||
105657083|NCT02484547|364407563|FG003|Placebo-Controlled Period|Disease Progression|0|||
105657084|NCT02484547|364407564|FG004|Placebo-Controlled Period|Disease Progression|0|||
105657085|NCT02484547|364407565|FG005|Placebo-Controlled Period|Disease Progression|0|||
105657086|NCT02484547|364407566|FG006|Placebo-Controlled Period|Disease Progression|0|||
105657087|NCT02484547|364407560|FG000|Placebo-Controlled Period|Investigator Decision|2|||
105657088|NCT02484547|364407561|FG001|Placebo-Controlled Period|Investigator Decision|2|||
105657089|NCT02484547|364407562|FG002|Placebo-Controlled Period|Investigator Decision|5|||
105657090|NCT02484547|364407563|FG003|Placebo-Controlled Period|Investigator Decision|0|||
105657091|NCT02484547|364407564|FG004|Placebo-Controlled Period|Investigator Decision|0|||
105657092|NCT02484547|364407565|FG005|Placebo-Controlled Period|Investigator Decision|0|||
105657093|NCT02484547|364407566|FG006|Placebo-Controlled Period|Investigator Decision|0|||
105657094|NCT02484547|364407560|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
105657095|NCT02484547|364407561|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
105657096|NCT02484547|364407562|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
105657097|NCT02484547|364407563|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
105657098|NCT02484547|364407564|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
105657099|NCT02484547|364407565|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
105657100|NCT02484547|364407566|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
105657101|NCT02484547|364407560|FG000|Placebo-Controlled Period|Relocation|1|||
105657102|NCT02484547|364407561|FG001|Placebo-Controlled Period|Relocation|1|||
105657103|NCT02484547|364407562|FG002|Placebo-Controlled Period|Relocation|1|||
105657104|NCT02484547|364407563|FG003|Placebo-Controlled Period|Relocation|0|||
105657105|NCT02484547|364407564|FG004|Placebo-Controlled Period|Relocation|0|||
105657106|NCT02484547|364407565|FG005|Placebo-Controlled Period|Relocation|0|||
105657107|NCT02484547|364407566|FG006|Placebo-Controlled Period|Relocation|0|||
105657108|NCT02484547|364407560|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
105657109|NCT02484547|364407561|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
105657110|NCT02484547|364407562|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
105657111|NCT02484547|364407563|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
105657112|NCT02484547|364407564|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
105657113|NCT02484547|364407565|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
105657114|NCT02484547|364407566|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
105657115|NCT02484547|364407560|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
105657116|NCT02484547|364407561|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
105657117|NCT02484547|364407562|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
105657118|NCT02484547|364407563|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105657119|NCT02484547|364407564|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105657120|NCT02484547|364407565|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105657121|NCT02484547|364407566|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105657122|NCT02484547|364407560|FG000|Placebo-Controlled Period|Reason not Specified|216|||
105657123|NCT02484547|364407561|FG001|Placebo-Controlled Period|Reason not Specified|194|||
105657124|NCT02484547|364407562|FG002|Placebo-Controlled Period|Reason not Specified|183|||
105657125|NCT02484547|364407563|FG003|Placebo-Controlled Period|Reason not Specified|0|||
105657126|NCT02484547|364407564|FG004|Placebo-Controlled Period|Reason not Specified|0|||
105657127|NCT02484547|364407565|FG005|Placebo-Controlled Period|Reason not Specified|0|||
105657128|NCT02484547|364407566|FG006|Placebo-Controlled Period|Reason not Specified|0|||
105657129|NCT02484547|364407560|FG000|Long-Term Extension Period|Adverse Event|0|||
105657130|NCT02484547|364407561|FG001|Long-Term Extension Period|Adverse Event|0|||
105657131|NCT02484547|364407562|FG002|Long-Term Extension Period|Adverse Event|0|||
105657132|NCT02484547|364407563|FG003|Long-Term Extension Period|Adverse Event|0|||
105657133|NCT02484547|364407564|FG004|Long-Term Extension Period|Adverse Event|1|||
105657134|NCT02484547|364407565|FG005|Long-Term Extension Period|Adverse Event|3|||
105657135|NCT02484547|364407566|FG006|Long-Term Extension Period|Adverse Event|2|||
105657136|NCT02484547|364407560|FG000|Long-Term Extension Period|Death|0|||
105657137|NCT02484547|364407561|FG001|Long-Term Extension Period|Death|0|||
105657138|NCT02484547|364407562|FG002|Long-Term Extension Period|Death|0|||
105657139|NCT02484547|364407563|FG003|Long-Term Extension Period|Death|0|||
105657140|NCT02484547|364407564|FG004|Long-Term Extension Period|Death|0|||
105657141|NCT02484547|364407565|FG005|Long-Term Extension Period|Death|3|||
105657142|NCT02484547|364407566|FG006|Long-Term Extension Period|Death|0|||
105657143|NCT02484547|364407560|FG000|Long-Term Extension Period|Disease Progression|0|||
105657144|NCT02484547|364407561|FG001|Long-Term Extension Period|Disease Progression|0|||
105657145|NCT02484547|364407562|FG002|Long-Term Extension Period|Disease Progression|0|||
105657146|NCT02484547|364407563|FG003|Long-Term Extension Period|Disease Progression|0|||
105657147|NCT02484547|364407564|FG004|Long-Term Extension Period|Disease Progression|2|||
105657148|NCT02484547|364407565|FG005|Long-Term Extension Period|Disease Progression|4|||
105657149|NCT02484547|364407566|FG006|Long-Term Extension Period|Disease Progression|0|||
105657150|NCT02484547|364407560|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
105657151|NCT02484547|364407561|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
105657152|NCT02484547|364407562|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
105657153|NCT02484547|364407563|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
105657154|NCT02484547|364407564|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
105657155|NCT02484547|364407565|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
105657156|NCT02484547|364407566|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
105657157|NCT02484547|364407560|FG000|Long-Term Extension Period|Loss of Capacity|0|||
105657158|NCT02484547|364407561|FG001|Long-Term Extension Period|Loss of Capacity|0|||
105657159|NCT02484547|364407562|FG002|Long-Term Extension Period|Loss of Capacity|0|||
105657160|NCT02484547|364407563|FG003|Long-Term Extension Period|Loss of Capacity|0|||
105657161|NCT02484547|364407564|FG004|Long-Term Extension Period|Loss of Capacity|1|||
105657162|NCT02484547|364407565|FG005|Long-Term Extension Period|Loss of Capacity|0|||
105657163|NCT02484547|364407566|FG006|Long-Term Extension Period|Loss of Capacity|0|||
105657164|NCT02484547|364407560|FG000|Long-Term Extension Period|Change of Treatment|0|||
105657165|NCT02484547|364407561|FG001|Long-Term Extension Period|Change of Treatment|0|||
105657166|NCT02484547|364407562|FG002|Long-Term Extension Period|Change of Treatment|0|||
105657167|NCT02484547|364407563|FG003|Long-Term Extension Period|Change of Treatment|0|||
105657168|NCT02484547|364407564|FG004|Long-Term Extension Period|Change of Treatment|0|||
105657169|NCT02484547|364407565|FG005|Long-Term Extension Period|Change of Treatment|0|||
105657170|NCT02484547|364407566|FG006|Long-Term Extension Period|Change of Treatment|1|||
105657171|NCT02484547|364407560|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
105657172|NCT02484547|364407561|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
105657173|NCT02484547|364407562|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
105657174|NCT02484547|364407563|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
105657175|NCT02484547|364407564|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
105657176|NCT02484547|364407565|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
105657177|NCT02484547|364407566|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
105657178|NCT02484547|364407560|FG000|Long-Term Extension Period|Investigator Decision|0|||
105657179|NCT02484547|364407561|FG001|Long-Term Extension Period|Investigator Decision|0|||
105657180|NCT02484547|364407562|FG002|Long-Term Extension Period|Investigator Decision|0|||
105657181|NCT02484547|364407563|FG003|Long-Term Extension Period|Investigator Decision|2|||
105657182|NCT02484547|364407564|FG004|Long-Term Extension Period|Investigator Decision|1|||
105657183|NCT02484547|364407565|FG005|Long-Term Extension Period|Investigator Decision|0|||
105657184|NCT02484547|364407566|FG006|Long-Term Extension Period|Investigator Decision|1|||
105657185|NCT02484547|364407560|FG000|Long-Term Extension Period|Relocation|0|||
105657186|NCT02484547|364407561|FG001|Long-Term Extension Period|Relocation|0|||
105657187|NCT02484547|364407562|FG002|Long-Term Extension Period|Relocation|0|||
105657188|NCT02484547|364407563|FG003|Long-Term Extension Period|Relocation|1|||
105657189|NCT02484547|364407564|FG004|Long-Term Extension Period|Relocation|1|||
105657190|NCT02484547|364407565|FG005|Long-Term Extension Period|Relocation|0|||
105657191|NCT02484547|364407566|FG006|Long-Term Extension Period|Relocation|0|||
105657192|NCT02484547|364407560|FG000|Long-Term Extension Period|Study Visit Burden|0|||
105657193|NCT02484547|364407561|FG001|Long-Term Extension Period|Study Visit Burden|0|||
105657194|NCT02484547|364407562|FG002|Long-Term Extension Period|Study Visit Burden|0|||
105657195|NCT02484547|364407563|FG003|Long-Term Extension Period|Study Visit Burden|2|||
105657196|NCT02484547|364407564|FG004|Long-Term Extension Period|Study Visit Burden|0|||
105657197|NCT02484547|364407565|FG005|Long-Term Extension Period|Study Visit Burden|0|||
105657198|NCT02484547|364407566|FG006|Long-Term Extension Period|Study Visit Burden|3|||
105657199|NCT02484547|364407560|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
105657200|NCT02484547|364407561|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
105657201|NCT02484547|364407562|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
105657202|NCT02484547|364407563|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
105657203|NCT02484547|364407564|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
105657204|NCT02484547|364407565|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
105657205|NCT02484547|364407566|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
105657206|NCT02484547|364407560|FG000|Long-Term Extension Period|Reason not Specified|0|||
105657207|NCT02484547|364407561|FG001|Long-Term Extension Period|Reason not Specified|0|||
105657208|NCT02484547|364407562|FG002|Long-Term Extension Period|Reason not Specified|0|||
105657209|NCT02484547|364407563|FG003|Long-Term Extension Period|Reason not Specified|119|||
105657210|NCT02484547|364407564|FG004|Long-Term Extension Period|Reason not Specified|117|||
105657211|NCT02484547|364407565|FG005|Long-Term Extension Period|Reason not Specified|223|||
105657212|NCT02484547|364407566|FG006|Long-Term Extension Period|Reason not Specified|231|||
105657213|NCT01227928|364407569|FG000|Overall Study|Lost to Follow-up|4|||
105657214|NCT01227928|364407570|FG001|Overall Study|Lost to Follow-up|2|||
105657215|NCT01227928|364407569|FG000|Overall Study|Withdrawal by Subject|4|||
105657216|NCT01227928|364407570|FG001|Overall Study|Withdrawal by Subject|3|||
105657217|NCT01227928|364407569|FG000|Overall Study|Death|14|||
105657218|NCT01227928|364407570|FG001|Overall Study|Death|12|||
105657219|NCT00474383|364407575|FG000|Main Study|Adverse Event|11|||
105657220|NCT00474383|364407576|FG001|Main Study|Adverse Event|0|||
105657221|NCT00474383|364407575|FG000|Main Study|Symptomatic Deterioration|1|||
105657222|NCT00474383|364407576|FG001|Main Study|Symptomatic Deterioration|0|||
105657223|NCT00474383|364407575|FG000|Main Study|Progressive Disease|23|||
105657224|NCT00474383|364407576|FG001|Main Study|Progressive Disease|0|||
105657225|NCT00474383|364407575|FG000|Main Study|Other|1|||
105657226|NCT00474383|364407576|FG001|Main Study|Other|0|||
105657227|NCT00474383|364407575|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
105657228|NCT00474383|364407576|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
105657229|NCT00474383|364407575|FG000|Extension|Progressive Disease|0|||
105657230|NCT00474383|364407576|FG001|Extension|Progressive Disease|5|||
105657231|NCT01268098|364409777|FG000|Overall Study|Adverse Event|1|||
105657232|NCT01268098|364409778|FG001|Overall Study|Adverse Event|0|||
105657233|NCT02806505|364409779|FG000|Overall Study|Adverse event/intercurrent illness|1|||
105657234|NCT02806505|364409780|FG001|Overall Study|Adverse event/intercurrent illness|3|||
105657235|NCT02806505|364409779|FG000|Overall Study|Death|4|||
105657236|NCT02806505|364409780|FG001|Overall Study|Death|0|||
105657237|NCT02806505|364409779|FG000|Overall Study|Did not cooperate/refused treatment|3|||
105657238|NCT02806505|364409780|FG001|Overall Study|Did not cooperate/refused treatment|3|||
105657239|NCT02806505|364409779|FG000|Overall Study|Failure to return|0|||
105657240|NCT02806505|364409780|FG001|Overall Study|Failure to return|1|||
105657241|NCT02806505|364409779|FG000|Overall Study|Insufficient therapeutic response|2|||
105657242|NCT02806505|364409780|FG001|Overall Study|Insufficient therapeutic response|4|||
105657243|NCT04156399|364409785|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
105657244|NCT04156399|364409785|FG000|Overall Study|study suspension due to COVID pandemic|3|||
105657245|NCT04732871|364409786|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
105657246|NCT04732871|364409787|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
105657247|NCT04732871|364409788|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
105657248|NCT04732871|364409786|FG000|Overall Study|Lost to Follow-up|7|||
105657249|NCT04732871|364409787|FG001|Overall Study|Lost to Follow-up|4|||
105657250|NCT04732871|364409788|FG002|Overall Study|Lost to Follow-up|3|||
105657251|NCT04732871|364409786|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
105657252|NCT04732871|364409787|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
105657253|NCT04732871|364409788|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
105657254|NCT04732871|364409786|FG000|Overall Study|Migrated / moved from the study area|5|||
105657255|NCT04732871|364409787|FG001|Overall Study|Migrated / moved from the study area|0|||
105657256|NCT04732871|364409788|FG002|Overall Study|Migrated / moved from the study area|0|||
105657257|NCT04732871|364409786|FG000|Overall Study|Other|1|||
105657258|NCT04732871|364409787|FG001|Overall Study|Other|0|||
105657259|NCT04732871|364409788|FG002|Overall Study|Other|1|||
105657260|NCT04732871|364409786|FG000|Overall Study|Ongoing|6|||
105657261|NCT04732871|364409787|FG001|Overall Study|Ongoing|0|||
105657262|NCT04732871|364409788|FG002|Overall Study|Ongoing|1|||
105657263|NCT04732871|364409786|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
105657264|NCT04732871|364409787|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
105657265|NCT04732871|364409788|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
105657266|NCT03458728|364409789|FG000|Overall Study|Adverse Event|1|||
105657267|NCT03458728|364409790|FG001|Overall Study|Adverse Event|0|||
105657268|NCT03458728|364409789|FG000|Overall Study|Physician Decision|1|||
105657269|NCT03458728|364409790|FG001|Overall Study|Physician Decision|0|||
105657270|NCT03458728|364409789|FG000|Overall Study|Progressive disease - clinical assessment|1|||
105657271|NCT03458728|364409790|FG001|Overall Study|Progressive disease - clinical assessment|0|||
105657272|NCT03458728|364409789|FG000|Overall Study|Progressive disease - radiological progression|21|||
105657273|NCT03458728|364409790|FG001|Overall Study|Progressive disease - radiological progression|6|||
105657274|NCT03458728|364409789|FG000|Overall Study|Withdrawal by Subject|0|||
105657275|NCT03458728|364409790|FG001|Overall Study|Withdrawal by Subject|1|||
105657276|NCT01644188|364409791|FG000|Overall Study|Adverse Event|44|||
105657277|NCT01644188|364409792|FG001|Overall Study|Adverse Event|20|||
105657278|NCT01644188|364409791|FG000|Overall Study|Poor compliance to protocol|26|||
105657279|NCT01644188|364409792|FG001|Overall Study|Poor compliance to protocol|14|||
105657280|NCT01644188|364409791|FG000|Overall Study|Physician Decision|1|||
105657281|NCT01644188|364409792|FG001|Overall Study|Physician Decision|3|||
105657282|NCT01644188|364409791|FG000|Overall Study|Participant moved|7|||
105657283|NCT01644188|364409792|FG001|Overall Study|Participant moved|2|||
105657284|NCT01644188|364409791|FG000|Overall Study|Related to auto-injector administration|2|||
105657285|NCT01644188|364409792|FG001|Overall Study|Related to auto-injector administration|2|||
105657286|NCT01644188|364409791|FG000|Overall Study|Consent withdrawn by participant|14|||
105657287|NCT01644188|364409792|FG001|Overall Study|Consent withdrawn by participant|7|||
105657288|NCT01644188|364409791|FG000|Overall Study|Selection criteria finally not met|2|||
105657289|NCT01644188|364409792|FG001|Overall Study|Selection criteria finally not met|0|||
105657290|NCT01644188|364409791|FG000|Overall Study|Lost to Follow-up|1|||
105657291|NCT01644188|364409792|FG001|Overall Study|Lost to Follow-up|0|||
105657292|NCT01644188|364409791|FG000|Overall Study|Death|4|||
105657293|NCT01644188|364409792|FG001|Overall Study|Death|3|||
105657294|NCT01644188|364409791|FG000|Overall Study|Last visit outside protocol visit window|14|||
105657295|NCT01644188|364409792|FG001|Overall Study|Last visit outside protocol visit window|16|||
105657296|NCT01644188|364409791|FG000|Overall Study|Site closure|1|||
105657297|NCT01644188|364409792|FG001|Overall Study|Site closure|1|||
105657298|NCT01644188|364409791|FG000|Overall Study|Other than specified above|6|||
105657299|NCT01644188|364409792|FG001|Overall Study|Other than specified above|7|||
105657300|NCT00766142|364409793|FG000|Overall Study|Protocol Violation|4|||
105657301|NCT00761956|364409795|FG000|Overall Study|Lost to Follow-up|6|||
105657302|NCT00761956|364409796|FG001|Overall Study|Lost to Follow-up|11|||
105657303|NCT00761956|364409795|FG000|Overall Study|Withdrawal by Subject|3|||
105657304|NCT00761956|364409796|FG001|Overall Study|Withdrawal by Subject|8|||
105657305|NCT00761956|364409795|FG000|Overall Study|Death|0|||
105657306|NCT00761956|364409796|FG001|Overall Study|Death|1|||
105657307|NCT00761956|364409795|FG000|Overall Study|Adverse Event|26|||
105657308|NCT00761956|364409796|FG001|Overall Study|Adverse Event|34|||
105657309|NCT01755546|364409802|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
105657310|NCT01755546|364409802|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
105657311|NCT01755546|364409802|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
105657312|NCT01755546|364409802|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
105657313|NCT01755546|364409802|FG000|Titration Phase|Adverse Event|11|||
105657314|NCT01755546|364409802|FG000|Titration Phase|Lack of Efficacy|18|||
105657315|NCT01755546|364409802|FG000|Titration Phase|Protocol Violation|9|||
105657316|NCT01755546|364409802|FG000|Titration Phase|Lost to Follow-up|2|||
105657317|NCT01755546|364409802|FG000|Titration Phase|Other and Continuing|22|||
105657318|NCT01755546|364409802|FG000|Titration Phase|Withdrawal by Subject|8|||
105657319|NCT01755546|364409802|FG000|Long Term Treatment|Adverse Event|12|||
105657320|NCT01755546|364409802|FG000|Long Term Treatment|Lack of Efficacy|6|||
105657321|NCT01755546|364409802|FG000|Long Term Treatment|Protocol Violation|10|||
105657322|NCT01755546|364409802|FG000|Long Term Treatment|Withdrawal by Subject|35|||
105657323|NCT01755546|364409802|FG000|Long Term Treatment|Lost to Follow-up|17|||
105657324|NCT01755546|364409802|FG000|Long Term Treatment|other and ongoing|41|||
105657325|NCT02166476|364409803|FG000|Overall Study|Withdrawal by Subject|5|||
105657326|NCT02166476|364409804|FG001|Overall Study|Withdrawal by Subject|7|||
105657327|NCT02166476|364409803|FG000|Overall Study|Adverse Event|3|||
105657328|NCT02166476|364409804|FG001|Overall Study|Adverse Event|3|||
105657329|NCT02166476|364409803|FG000|Overall Study|Lost to Follow-up|5|||
105657330|NCT02166476|364409804|FG001|Overall Study|Lost to Follow-up|10|||
105657331|NCT02166476|364409803|FG000|Overall Study|Physician Decision|1|||
105657332|NCT02166476|364409804|FG001|Overall Study|Physician Decision|0|||
105657333|NCT02166476|364409803|FG000|Overall Study|Unable to Come for Visit|0|||
105657334|NCT02166476|364409804|FG001|Overall Study|Unable to Come for Visit|3|||
105657335|NCT01114139|364409806|FG000|Overall Study|Adverse Event|3|||
105657336|NCT01114139|364409807|FG001|Overall Study|Adverse Event|2|||
105657337|NCT01114139|364409806|FG000|Overall Study|Lost to Follow-up|15|||
105657338|NCT01114139|364409807|FG001|Overall Study|Lost to Follow-up|3|||
105657339|NCT01114139|364409806|FG000|Overall Study|Withdrawal by Subject|17|||
105657340|NCT01114139|364409807|FG001|Overall Study|Withdrawal by Subject|6|||
105657341|NCT01114139|364409806|FG000|Overall Study|Other-Missed 1 visit|1|||
105657342|NCT01114139|364409807|FG001|Overall Study|Other-Missed 1 visit|0|||
105657343|NCT01114139|364409806|FG000|Overall Study|Other-Protocol Violation|1|||
105657344|NCT01114139|364409807|FG001|Overall Study|Other-Protocol Violation|0|||
105657345|NCT01114139|364409806|FG000|Overall Study|Other-Out of window for study drug dose|1|||
105657346|NCT01114139|364409807|FG001|Overall Study|Other-Out of window for study drug dose|0|||
105657347|NCT01114139|364409806|FG000|Overall Study|Other-Participant falsified records|0|||
105657348|NCT01114139|364409807|FG001|Overall Study|Other-Participant falsified records|1|||
105657349|NCT01114139|364409806|FG000|Overall Study|Other-Participant went on hospice|0|||
105657350|NCT01114139|364409807|FG001|Overall Study|Other-Participant went on hospice|1|||
105657351|NCT01114139|364409806|FG000|Overall Study|Other-Physician changed treatment|1|||
105657352|NCT01114139|364409807|FG001|Overall Study|Other-Physician changed treatment|0|||
105657353|NCT01114139|364409806|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
105657354|NCT01114139|364409807|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
105657355|NCT00639769|364409808|FG000|Overall Study|Death|2|||
105657356|NCT00639769|364409808|FG000|Overall Study|Adverse Event|7|||
105657357|NCT00639769|364409808|FG000|Overall Study|Lack of Efficacy|1|||
105657358|NCT00639769|364409808|FG000|Overall Study|Disease progression|26|||
105657359|NCT00639769|364409808|FG000|Overall Study|Withdrawal by Subject|4|||
105657360|NCT00863798|364409809|FG000|Overall Study|Adverse Event|5|||
105657361|NCT00863798|364409810|FG001|Overall Study|Adverse Event|2|||
105657362|NCT00863798|364409811|FG002|Overall Study|Adverse Event|4|||
105657363|NCT00863798|364409809|FG000|Overall Study|Participant failed to return|2|||
105657364|NCT00863798|364409810|FG001|Overall Study|Participant failed to return|1|||
105657365|NCT00863798|364409811|FG002|Overall Study|Participant failed to return|0|||
105657366|NCT00863798|364409809|FG000|Overall Study|Investigator request|1|||
105657367|NCT00863798|364409810|FG001|Overall Study|Investigator request|2|||
105657368|NCT00863798|364409811|FG002|Overall Study|Investigator request|1|||
105657369|NCT00863798|364409809|FG000|Overall Study|Lack of Efficacy|4|||
105657370|NCT00863798|364409810|FG001|Overall Study|Lack of Efficacy|3|||
105657371|NCT00863798|364409811|FG002|Overall Study|Lack of Efficacy|6|||
105657372|NCT00863798|364409809|FG000|Overall Study|Lost to Follow-up|6|||
105657373|NCT00863798|364409810|FG001|Overall Study|Lost to Follow-up|9|||
105657374|NCT00863798|364409811|FG002|Overall Study|Lost to Follow-up|5|||
105657375|NCT00863798|364409809|FG000|Overall Study|Other|2|||
105657376|NCT00863798|364409810|FG001|Overall Study|Other|3|||
105657377|NCT00863798|364409811|FG002|Overall Study|Other|1|||
105657378|NCT00863798|364409809|FG000|Overall Study|Protocol Violation|0|||
105657379|NCT00863798|364409810|FG001|Overall Study|Protocol Violation|1|||
105657380|NCT00863798|364409811|FG002|Overall Study|Protocol Violation|1|||
105657381|NCT00863798|364409809|FG000|Overall Study|Withdrawal by Subject|8|||
105657382|NCT00863798|364409810|FG001|Overall Study|Withdrawal by Subject|7|||
105657383|NCT00863798|364409811|FG002|Overall Study|Withdrawal by Subject|4|||
105657384|NCT00863798|364409809|FG000|Overall Study|Randomized not treated|4|||
105657385|NCT00863798|364409810|FG001|Overall Study|Randomized not treated|2|||
105657386|NCT00863798|364409811|FG002|Overall Study|Randomized not treated|3|||
105657387|NCT00195442|364409812|FG000|Overall Study|Less than expected therapeutic effect|38|||
105657388|NCT00195442|364409812|FG000|Overall Study|Lost to Follow-up|27|||
105657389|NCT00195442|364409812|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
105657390|NCT00195442|364409812|FG000|Overall Study|Intermittent product shortage|21|||
105657391|NCT00195442|364409812|FG000|Overall Study|Death|7|||
105657392|NCT00195442|364409812|FG000|Overall Study|No reason specified|4|||
105657393|NCT00195442|364409812|FG000|Overall Study|Poor cooperation|2|||
105657394|NCT00195442|364409812|FG000|Overall Study|Other|14|||
105657395|NCT00847132|364409815|FG000|Overall Study|Death|1|||
105657396|NCT00847132|364409816|FG001|Overall Study|Death|1|||
105657397|NCT03546816|364409817|FG000|Overall Study|Adverse Event|5|||
105657398|NCT03546816|364409818|FG001|Overall Study|Adverse Event|3|||
105657399|NCT03546816|364409817|FG000|Overall Study|Lack of Efficacy|2|||
105657400|NCT03546816|364409818|FG001|Overall Study|Lack of Efficacy|4|||
105657401|NCT03546816|364409817|FG000|Overall Study|Pregnancy|1|||
105657402|NCT03546816|364409818|FG001|Overall Study|Pregnancy|0|||
105657403|NCT03546816|364409817|FG000|Overall Study|Physician Decision|2|||
105657404|NCT03546816|364409818|FG001|Overall Study|Physician Decision|0|||
105657405|NCT03546816|364409817|FG000|Overall Study|Withdrawal by Subject|8|||
105657406|NCT03546816|364409818|FG001|Overall Study|Withdrawal by Subject|10|||
105657407|NCT03546816|364409817|FG000|Overall Study|Lost to Follow-up|3|||
105657408|NCT03546816|364409818|FG001|Overall Study|Lost to Follow-up|2|||
105657409|NCT03927690|364409819|FG000|Overall Study|Withdrawal by Subject|3|||
105657410|NCT03927690|364409820|FG001|Overall Study|Withdrawal by Subject|1|||
105657411|NCT03927690|364409821|FG002|Overall Study|Withdrawal by Subject|1|||
105657412|NCT03927690|364409819|FG000|Overall Study|Adverse Event|1|||
105657413|NCT03927690|364409820|FG001|Overall Study|Adverse Event|0|||
105657414|NCT03927690|364409821|FG002|Overall Study|Adverse Event|0|||
105657415|NCT03927690|364409819|FG000|Overall Study|Death|1|||
105657416|NCT03927690|364409820|FG001|Overall Study|Death|0|||
105657417|NCT03927690|364409821|FG002|Overall Study|Death|0|||
105657418|NCT03927690|364409819|FG000|Overall Study|Lost to Follow-up|2|||
105657419|NCT03927690|364409820|FG001|Overall Study|Lost to Follow-up|2|||
105657420|NCT03927690|364409821|FG002|Overall Study|Lost to Follow-up|1|||
105657421|NCT00913523|364409826|FG000|Overall Study|Withdrawal by Subject|3|||
105657422|NCT00913523|364409827|FG001|Overall Study|Withdrawal by Subject|2|||
105657423|NCT00913523|364409828|FG002|Overall Study|Withdrawal by Subject|2|||
105657424|NCT00913523|364409826|FG000|Overall Study|Lost to Follow-up|1|||
105657425|NCT00913523|364409827|FG001|Overall Study|Lost to Follow-up|1|||
105657426|NCT00913523|364409828|FG002|Overall Study|Lost to Follow-up|1|||
105657427|NCT00913523|364409826|FG000|Overall Study|Adverse Event|1|||
105657428|NCT00913523|364409827|FG001|Overall Study|Adverse Event|0|||
105657429|NCT00913523|364409828|FG002|Overall Study|Adverse Event|0|||
105657430|NCT00913523|364409826|FG000|Overall Study|Protocol Violation|5|||
105657431|NCT00913523|364409827|FG001|Overall Study|Protocol Violation|8|||
105657432|NCT00913523|364409828|FG002|Overall Study|Protocol Violation|8|||
105657433|NCT00913523|364409826|FG000|Overall Study|Pregnancy|1|||
105657434|NCT00913523|364409827|FG001|Overall Study|Pregnancy|3|||
105657435|NCT00913523|364409828|FG002|Overall Study|Pregnancy|0|||
105657436|NCT00913523|364409826|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
105657437|NCT00913523|364409827|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
105657438|NCT00913523|364409828|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
105657439|NCT03021551|364409829|FG000|Overall Study|Equipment Issues|2|||
105657440|NCT03021551|364409829|FG000|Overall Study|Protocol Violation|1|||
105657441|NCT03491215|364409833|FG000|Overall Study|Death|6|||
105657442|NCT03491215|364409834|FG001|Overall Study|Death|2|||
105657443|NCT03491215|364409835|FG002|Overall Study|Death|1|||
105657444|NCT03491215|364409836|FG003|Overall Study|Death|0|||
105657445|NCT03491215|364409833|FG000|Overall Study|Physician Decision|1|||
105657446|NCT03491215|364409834|FG001|Overall Study|Physician Decision|0|||
105657447|NCT03491215|364409835|FG002|Overall Study|Physician Decision|0|||
105657448|NCT03491215|364409836|FG003|Overall Study|Physician Decision|0|||
105657449|NCT01162135|364409837|FG000|Overall Study|Withdrawal by Subject|1|||
105657450|NCT01162135|364409837|FG000|Overall Study|Severe back pain|1|||
105657451|NCT01162135|364409837|FG000|Overall Study|Ineligible|1|||
105657452|NCT00468858|364409840|FG000|Overall Study|Adverse Event|0|||
105657453|NCT00468858|364409841|FG001|Overall Study|Adverse Event|1|||
105657454|NCT00468858|364409842|FG002|Overall Study|Adverse Event|0|||
105657455|NCT00468858|364409840|FG000|Overall Study|Withdrawal by Subject|7|||
105657456|NCT00468858|364409841|FG001|Overall Study|Withdrawal by Subject|4|||
105657457|NCT00468858|364409842|FG002|Overall Study|Withdrawal by Subject|5|||
105657458|NCT00468858|364409840|FG000|Overall Study|Relocation|1|||
105657459|NCT00468858|364409841|FG001|Overall Study|Relocation|3|||
105657460|NCT00468858|364409842|FG002|Overall Study|Relocation|3|||
105657461|NCT00468858|364409840|FG000|Overall Study|Lost to Follow-up|1|||
105657462|NCT00468858|364409841|FG001|Overall Study|Lost to Follow-up|2|||
105657463|NCT00468858|364409842|FG002|Overall Study|Lost to Follow-up|5|||
105657464|NCT00468858|364409840|FG000|Overall Study|Other|0|||
105657465|NCT00468858|364409841|FG001|Overall Study|Other|0|||
105657466|NCT00468858|364409842|FG002|Overall Study|Other|1|||
105657467|NCT01085812|364409843|FG000|Open-Label Period|Adverse Event|0|||
105657468|NCT01085812|364409844|FG001|Open-Label Period|Adverse Event|80|||
105657469|NCT01085812|364409843|FG000|Open-Label Period|Lack of Efficacy|0|||
105657470|NCT01085812|364409844|FG001|Open-Label Period|Lack of Efficacy|26|||
105657471|NCT01085812|364409843|FG000|Open-Label Period|Protocol Violation|0|||
105657472|NCT01085812|364409844|FG001|Open-Label Period|Protocol Violation|39|||
105657473|NCT01085812|364409843|FG000|Open-Label Period|Withdrawal by Subject|0|||
105657474|NCT01085812|364409844|FG001|Open-Label Period|Withdrawal by Subject|53|||
105657475|NCT01085812|364409843|FG000|Open-Label Period|Lost to Follow-up|0|||
105657476|NCT01085812|364409844|FG001|Open-Label Period|Lost to Follow-up|42|||
105657477|NCT01085812|364409843|FG000|Double-Blind Period|Adverse Event|3|||
105657478|NCT01085812|364409844|FG001|Double-Blind Period|Adverse Event|8|||
105657479|NCT01085812|364409843|FG000|Double-Blind Period|Protocol Violation|2|||
105657480|NCT01085812|364409844|FG001|Double-Blind Period|Protocol Violation|7|||
105657481|NCT01085812|364409843|FG000|Double-Blind Period|Withdrawal by Subject|11|||
105657482|NCT01085812|364409844|FG001|Double-Blind Period|Withdrawal by Subject|24|||
105657483|NCT01085812|364409843|FG000|Double-Blind Period|Lost to Follow-up|5|||
105657484|NCT01085812|364409844|FG001|Double-Blind Period|Lost to Follow-up|17|||
105657485|NCT01085812|364409843|FG000|Double-Blind Period|Other Reasons|0|||
105657486|NCT01085812|364409844|FG001|Double-Blind Period|Other Reasons|2|||
105657487|NCT01085812|364409843|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
105657488|NCT01085812|364409844|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
105657489|NCT01085812|364409843|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
105657490|NCT01085812|364409844|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
105657491|NCT01085812|364409843|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
105657492|NCT01085812|364409844|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
105657493|NCT01085812|364409843|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
105657494|NCT01085812|364409844|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
105657495|NCT01085812|364409843|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
105657496|NCT01085812|364409844|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
105657497|NCT01101997|364409845|FG000|Overall Study|Withdrawal by Subject|2|||
105657498|NCT00302159|364409852|FG000|Overall Study|pt declined before treatment started|1|||
105657499|NCT00302159|364409852|FG000|Overall Study|pt started Avastin|1|||
105657500|NCT03245619|364409853|FG000|Part A (Up to Day 22)|Physician Decision|4|||
105657501|NCT03245619|364409854|FG001|Part A (Up to Day 22)|Physician Decision|6|||
105657502|NCT03245619|364409855|FG002|Part A (Up to Day 22)|Physician Decision|6|||
105657503|NCT03245619|364409856|FG003|Part A (Up to Day 22)|Physician Decision|0|||
105657504|NCT03245619|364409857|FG004|Part A (Up to Day 22)|Physician Decision|0|||
105657505|NCT03245619|364409858|FG005|Part A (Up to Day 22)|Physician Decision|0|||
105657506|NCT03245619|364409859|FG006|Part A (Up to Day 22)|Physician Decision|0|||
105657507|NCT03245619|364409860|FG007|Part A (Up to Day 22)|Physician Decision|0|||
105657508|NCT03245619|364409861|FG008|Part A (Up to Day 22)|Physician Decision|0|||
105657509|NCT03245619|364409862|FG009|Part A (Up to Day 22)|Physician Decision|0|||
105657510|NCT03245619|364409863|FG010|Part A (Up to Day 22)|Physician Decision|0|||
105657511|NCT03245619|364409864|FG011|Part A (Up to Day 22)|Physician Decision|0|||
105657512|NCT03245619|364409865|FG012|Part A (Up to Day 22)|Physician Decision|0|||
105657513|NCT03245619|364409866|FG013|Part A (Up to Day 22)|Physician Decision|0|||
105657514|NCT03245619|364409867|FG014|Part A (Up to Day 22)|Physician Decision|0|||
105657515|NCT03245619|364409868|FG015|Part A (Up to Day 22)|Physician Decision|0|||
105657516|NCT03245619|364409869|FG016|Part A (Up to Day 22)|Physician Decision|0|||
105657517|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
105657518|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
105657519|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
105657520|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
105657521|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
105657522|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
105657523|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
105657524|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
105657525|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
105657526|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
105657527|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
105657528|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
105657529|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
105657530|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
105657531|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
105657532|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
105657533|NCT01664923|364409873|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
105657534|NCT01664923|364409874|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
105657535|NCT01664923|364409873|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
105657536|NCT01664923|364409874|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
105657537|NCT01664923|364409873|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
105657538|NCT01664923|364409874|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
105657539|NCT01664923|364409873|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
105657540|NCT01664923|364409874|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
105657541|NCT01664923|364409873|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
105657542|NCT01664923|364409874|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
105657543|NCT01664923|364409873|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
105657544|NCT01664923|364409874|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
105657545|NCT00394589|364409877|FG000|Overall Study|Adverse Event|2|||
105657546|NCT00394589|364409878|FG001|Overall Study|Adverse Event|1|||
105657547|NCT00394589|364409879|FG002|Overall Study|Adverse Event|2|||
105657548|NCT00394589|364409877|FG000|Overall Study|Lack of Efficacy|2|||
105657549|NCT00394589|364409878|FG001|Overall Study|Lack of Efficacy|2|||
105657550|NCT00394589|364409879|FG002|Overall Study|Lack of Efficacy|3|||
105657551|NCT00394589|364409877|FG000|Overall Study|Protocol Violation|4|||
105657552|NCT00394589|364409878|FG001|Overall Study|Protocol Violation|0|||
105657553|NCT00394589|364409879|FG002|Overall Study|Protocol Violation|2|||
105657554|NCT01114672|364409881|FG000|Overall Study|Death|0|||
105657555|NCT01114672|364409882|FG001|Overall Study|Death|1|||
105657556|NCT01114672|364409881|FG000|Overall Study|Withdrawal by Subject|2|||
105657557|NCT01114672|364409882|FG001|Overall Study|Withdrawal by Subject|1|||
105657558|NCT01114672|364409881|FG000|Overall Study|Lost to Follow-up|1|||
105657559|NCT01114672|364409882|FG001|Overall Study|Lost to Follow-up|0|||
105657560|NCT01114672|364409881|FG000|Overall Study|transplanted|1|||
105657561|NCT01114672|364409882|FG001|Overall Study|transplanted|0|||
105657562|NCT02777242|364409892|FG000|Overall Study|Other|2|||
105657563|NCT02777242|364409892|FG000|Overall Study|Lost to Follow-up|1|||
105657564|NCT02777242|364409892|FG000|Overall Study|Multiple|1|||
105657565|NCT02777242|364409892|FG000|Overall Study|Sponsor's request|1|||
105657566|NCT02777242|364409892|FG000|Overall Study|Withdrawal by Subject|1|||
105657567|NCT04545476|364409893|FG000|Overall Study|Lost to Follow-up|1|||
105657568|NCT04545476|364409894|FG001|Overall Study|Lost to Follow-up|1|||
105657569|NCT04545476|364409895|FG002|Overall Study|Lost to Follow-up|0|||
105657570|NCT04545476|364409896|FG003|Overall Study|Lost to Follow-up|0|||
105657571|NCT02427958|364409897|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
105657572|NCT02427958|364409897|FG000|Overall Study|Lost to Follow-up|6|||
105657573|NCT02427958|364409897|FG000|Overall Study|Withdrawal by Subject|14|||
105657574|NCT02427958|364409897|FG000|Overall Study|Lack of Efficacy|1|||
105657575|NCT01704547|364409905|FG000|Overall Study|Physician Decision|4|||
105657576|NCT01704547|364409905|FG000|Overall Study|Withdrawal by Subject|1|||
105657577|NCT00690378|364409906|FG000|Overall Study|Adverse Event|1|||
105657578|NCT00690378|364409907|FG001|Overall Study|Adverse Event|0|||
105657579|NCT00690378|364409906|FG000|Overall Study|Withdrawal by Subject|2|||
105657580|NCT00690378|364409907|FG001|Overall Study|Withdrawal by Subject|0|||
105657581|NCT00690378|364409906|FG000|Overall Study|Protocol Violation|1|||
105657582|NCT00690378|364409907|FG001|Overall Study|Protocol Violation|0|||
105657583|NCT00690378|364409906|FG000|Overall Study|Lost to Follow-up|2|||
105657584|NCT00690378|364409907|FG001|Overall Study|Lost to Follow-up|3|||
105657585|NCT00690378|364409906|FG000|Overall Study|Did not meet inc/exc criteria|13|||
105657586|NCT00690378|364409907|FG001|Overall Study|Did not meet inc/exc criteria|11|||
105657587|NCT00690378|364409906|FG000|Overall Study|Social problem|1|||
105657588|NCT00690378|364409907|FG001|Overall Study|Social problem|0|||
105657589|NCT04016805|364409908|FG000|Overall Study|Sponsor's Discretion|30|||
105657590|NCT04016805|364409909|FG001|Overall Study|Sponsor's Discretion|6|||
105657591|NCT04016805|364409910|FG002|Overall Study|Sponsor's Discretion|5|||
105657592|NCT00104637|364409911|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
105657593|NCT00104637|364409912|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
105657594|NCT01560871|364409913|FG000|Overall Study|transportation issues|2|||
105657595|NCT01560871|364409914|FG001|Overall Study|transportation issues|1|||
105657596|NCT01560871|364409913|FG000|Overall Study|relocation|1|||
105657597|NCT01560871|364409914|FG001|Overall Study|relocation|0|||
105657598|NCT01560871|364409913|FG000|Overall Study|readmission to a hospital|2|||
105657599|NCT01560871|364409914|FG001|Overall Study|readmission to a hospital|1|||
105657600|NCT01560871|364409913|FG000|Overall Study|Lost to Follow-up|1|||
105657601|NCT01560871|364409914|FG001|Overall Study|Lost to Follow-up|0|||
105657602|NCT00582114|364409917|FG000|Overall Study|Death|4|||
105657603|NCT00582114|364409918|FG001|Overall Study|Death|4|||
105657604|NCT00582114|364409917|FG000|Overall Study|Kidney Transplant|3|||
105657605|NCT00582114|364409918|FG001|Overall Study|Kidney Transplant|1|||
105657606|NCT00582114|364409917|FG000|Overall Study|Lost to Follow-up|7|||
105657607|NCT00582114|364409918|FG001|Overall Study|Lost to Follow-up|6|||
105657608|NCT00582114|364409917|FG000|Overall Study|Withdrawal by Subject|8|||
105657609|NCT00582114|364409918|FG001|Overall Study|Withdrawal by Subject|16|||
105657610|NCT00582114|364409917|FG000|Overall Study|Adverse Event|1|||
105657611|NCT00582114|364409918|FG001|Overall Study|Adverse Event|1|||
105657612|NCT00582114|364409917|FG000|Overall Study|Physician Decision|0|||
105657613|NCT00582114|364409918|FG001|Overall Study|Physician Decision|6|||
105657614|NCT00582114|364409917|FG000|Overall Study|Stopped by data safety monitoring board|19|||
105657615|NCT00582114|364409918|FG001|Overall Study|Stopped by data safety monitoring board|20|||
105657616|NCT03772613|364409919|FG000|Overall Study|Lost to Follow-up|0|||
105657617|NCT03772613|364409920|FG001|Overall Study|Lost to Follow-up|1|||
105657618|NCT03772613|364409921|FG002|Overall Study|Lost to Follow-up|1|||
105659504|NCT02635386|364417349|FG002|Overall Study|Noncompliant|1|||
105659505|NCT02635386|364417350|FG003|Overall Study|Noncompliant|1|||
105657619|NCT01182207|364409922|FG000|First Intervention|Positive Hepatitis Results|0|||
105657620|NCT01182207|364409923|FG001|First Intervention|Positive Hepatitis Results|1|||
105657621|NCT01182207|364409922|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
105659506|NCT02635386|364417351|FG004|Overall Study|Noncompliant|1|||
105659507|NCT02635386|364417347|FG000|Overall Study|side effects|0|||
105659508|NCT02635386|364417348|FG001|Overall Study|side effects|0|||
105657622|NCT01182207|364409923|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
105659509|NCT02635386|364417349|FG002|Overall Study|side effects|1|||
105657623|NCT00746356|364409924|FG000|Overall Study|Withdrawal by Subject|2|||
105657624|NCT00746356|364409925|FG001|Overall Study|Withdrawal by Subject|3|||
105657625|NCT00746356|364409924|FG000|Overall Study|Death|7|||
105657626|NCT00746356|364409925|FG001|Overall Study|Death|3|||
105657627|NCT00746356|364409924|FG000|Overall Study|Lost to Follow-up|1|||
105657628|NCT00746356|364409925|FG001|Overall Study|Lost to Follow-up|0|||
105657629|NCT00746356|364409924|FG000|Overall Study|Removal of Device|0|||
105657630|NCT00746356|364409925|FG001|Overall Study|Removal of Device|1|||
105657631|NCT00746356|364409924|FG000|Overall Study|Patient relocated|1|||
105657632|NCT00746356|364409925|FG001|Overall Study|Patient relocated|0|||
105657633|NCT04680637|364409948|FG000|Overall Study|Lost to Follow-up|0|||
105657634|NCT04680637|364409949|FG001|Overall Study|Lost to Follow-up|1|||
105657635|NCT04680637|364409950|FG002|Overall Study|Lost to Follow-up|0|||
105657636|NCT04680637|364409951|FG003|Overall Study|Lost to Follow-up|1|||
105657637|NCT04680637|364409948|FG000|Overall Study|Death|1|||
105657638|NCT04680637|364409949|FG001|Overall Study|Death|0|||
105657639|NCT04680637|364409950|FG002|Overall Study|Death|0|||
105657640|NCT04680637|364409951|FG003|Overall Study|Death|0|||
105657641|NCT04680637|364409948|FG000|Overall Study|Withdrawal by Subject|7|||
105657642|NCT04680637|364409949|FG001|Overall Study|Withdrawal by Subject|10|||
105657643|NCT04680637|364409950|FG002|Overall Study|Withdrawal by Subject|17|||
105657644|NCT04680637|364409951|FG003|Overall Study|Withdrawal by Subject|15|||
105657645|NCT04680637|364409948|FG000|Overall Study|Decision by Sponsor|21|||
105657646|NCT04680637|364409949|FG001|Overall Study|Decision by Sponsor|15|||
105657647|NCT04680637|364409950|FG002|Overall Study|Decision by Sponsor|7|||
105657648|NCT04680637|364409951|FG003|Overall Study|Decision by Sponsor|32|||
105657649|NCT02037256|364409956|FG000|Overall Study|Protocol Violation|0|||
105657650|NCT02037256|364409957|FG001|Overall Study|Protocol Violation|1|||
105657651|NCT02037256|364409956|FG000|Overall Study|Withdrawn prior to Velcade|0|||
105657652|NCT02037256|364409957|FG001|Overall Study|Withdrawn prior to Velcade|2|||
105657653|NCT04599907|364409958|FG000|Overall Study|Withdrawal by Subject|1|||
105657654|NCT04599907|364409959|FG001|Overall Study|Withdrawal by Subject|7|||
105657655|NCT04599907|364409960|FG002|Overall Study|Withdrawal by Subject|6|||
105657656|NCT04599907|364409958|FG000|Overall Study|Lost to Follow-up|0|||
105657657|NCT04599907|364409959|FG001|Overall Study|Lost to Follow-up|1|||
105657658|NCT04599907|364409960|FG002|Overall Study|Lost to Follow-up|0|||
105657659|NCT00356759|364409961|FG000|Overall Study|Death|5|||
105657660|NCT00356759|364409962|FG001|Overall Study|Death|2|||
105657661|NCT00356759|364409961|FG000|Overall Study|Withdrawal by Subject|2|||
105657662|NCT00356759|364409962|FG001|Overall Study|Withdrawal by Subject|2|||
105657663|NCT00356759|364409961|FG000|Overall Study|Adverse Event|1|||
105657664|NCT00356759|364409962|FG001|Overall Study|Adverse Event|3|||
105657665|NCT00356759|364409961|FG000|Overall Study|Lost to Follow-up|1|||
105657666|NCT00356759|364409962|FG001|Overall Study|Lost to Follow-up|1|||
105657667|NCT00356759|364409961|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
105657668|NCT00356759|364409962|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
105657669|NCT02930837|364409963|FG000|Overall Study|Adverse Event|6|||
105657670|NCT02930837|364409963|FG000|Overall Study|Lost to Follow-up|5|||
105657671|NCT02930837|364409963|FG000|Overall Study|Withdrawal by Subject|1|||
105657672|NCT02633397|364409964|FG000|Overall Study|Adverse Event|8|||
105657673|NCT02633397|364409965|FG001|Overall Study|Adverse Event|8|||
105657674|NCT02633397|364409964|FG000|Overall Study|Study Burden|4|||
105657675|NCT02633397|364409965|FG001|Overall Study|Study Burden|1|||
105657676|NCT02633397|364409964|FG000|Overall Study|Treatment interruption|2|||
105657677|NCT02633397|364409965|FG001|Overall Study|Treatment interruption|5|||
105657678|NCT02633397|364409964|FG000|Overall Study|Death|2|||
105657679|NCT02633397|364409965|FG001|Overall Study|Death|2|||
105657680|NCT02633397|364409964|FG000|Overall Study|Physician Decision|0|||
105657681|NCT02633397|364409965|FG001|Overall Study|Physician Decision|1|||
105657682|NCT03864341|364411854|FG000|Overall Study|Withdrawal by Subject|1|||
105657683|NCT01726049|364411856|FG000|Overall Study|Death|1|||
105657684|NCT01726049|364411857|FG001|Overall Study|Death|1|||
105657685|NCT01726049|364411856|FG000|Overall Study|Adverse Event|4|||
105657686|NCT01726049|364411857|FG001|Overall Study|Adverse Event|1|||
105657687|NCT01726049|364411856|FG000|Overall Study|refused second HC|0|||
105657688|NCT01726049|364411857|FG001|Overall Study|refused second HC|2|||
105657689|NCT00263211|364411858|FG000|Overall Study|Death|1|||
105657690|NCT00263211|364411859|FG001|Overall Study|Death|0|||
105657691|NCT00263211|364411858|FG000|Overall Study|Withdrawal by Subject|3|||
105657692|NCT00263211|364411859|FG001|Overall Study|Withdrawal by Subject|0|||
105657693|NCT00263211|364411858|FG000|Overall Study|Protocol Violation|1|||
105657694|NCT00263211|364411859|FG001|Overall Study|Protocol Violation|0|||
105657695|NCT00263211|364411858|FG000|Overall Study|Disease Progression|0|||
105657696|NCT00263211|364411859|FG001|Overall Study|Disease Progression|1|||
105657697|NCT03991988|364411865|FG000|Overall Study|Withdrawal by Subject|2|||
105657698|NCT03991988|364411866|FG001|Overall Study|Withdrawal by Subject|2|||
105657699|NCT03834623|364411867|FG000|Overall Study|Progression|0|||
105657700|NCT03834623|364411868|FG001|Overall Study|Progression|1|||
105657701|NCT01947517|364411869|FG000|Overall Study|Withdrawal by Subject|1|||
105657702|NCT01947517|364411870|FG001|Overall Study|Withdrawal by Subject|1|||
105657703|NCT00478647|364411871|FG000|Overall Study|Adverse Event|1|||
105657704|NCT00478647|364411871|FG000|Overall Study|Withdrawal by Subject|1|||
105657705|NCT00526097|364411872|FG000|Overall Study|Adverse Event|6|||
105657706|NCT00526097|364411873|FG001|Overall Study|Adverse Event|44|||
105657707|NCT00526097|364411872|FG000|Overall Study|Protocol Violation|4|||
105657708|NCT00526097|364411873|FG001|Overall Study|Protocol Violation|10|||
105657709|NCT00526097|364411872|FG000|Overall Study|Withdrawal by Subject|3|||
105657710|NCT00526097|364411873|FG001|Overall Study|Withdrawal by Subject|1|||
105657711|NCT00526097|364411872|FG000|Overall Study|Other|2|||
105657712|NCT00526097|364411873|FG001|Overall Study|Other|1|||
105657713|NCT00460564|364411874|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
105657714|NCT00460564|364411875|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
105657715|NCT00460564|364411876|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105657716|NCT00460564|364411877|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105657717|NCT00460564|364411878|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105657718|NCT00460564|364411879|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105657719|NCT00460564|364411880|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105657720|NCT00460564|364411881|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105657721|NCT00460564|364411874|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
105657722|NCT00460564|364411875|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105657723|NCT00460564|364411876|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105657724|NCT00460564|364411877|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105657725|NCT00460564|364411878|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105657726|NCT00460564|364411879|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105657727|NCT00460564|364411880|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105657728|NCT00460564|364411881|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105657729|NCT00460564|364411874|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
105657730|NCT00460564|364411875|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
105657731|NCT00460564|364411876|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
105657732|NCT00460564|364411877|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
105657733|NCT00460564|364411878|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
105657734|NCT00460564|364411879|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
105657735|NCT00460564|364411880|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
105657736|NCT00460564|364411881|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
105657737|NCT00460564|364411874|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105657738|NCT00460564|364411875|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105657739|NCT00460564|364411876|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105657740|NCT00460564|364411877|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105657741|NCT00460564|364411878|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
105657742|NCT00460564|364411879|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
105657743|NCT00460564|364411880|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105657744|NCT00460564|364411881|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105657745|NCT00460564|364411874|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
105657746|NCT00460564|364411875|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
105657747|NCT00460564|364411876|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
105657748|NCT00460564|364411877|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
105657749|NCT00460564|364411878|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
105657750|NCT00460564|364411879|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
105657751|NCT00460564|364411880|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
105657752|NCT00460564|364411881|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
105657753|NCT00030823|364411884|FG000|Overall Study|Withdrawal by Subject|1|||
105657754|NCT00891046|364411888|FG000|Overall Study|Protocol Violation|1|||
105657755|NCT00891046|364411889|FG001|Overall Study|Protocol Violation|1|||
105657756|NCT00891046|364411890|FG002|Overall Study|Protocol Violation|0|||
105657757|NCT00891046|364411891|FG003|Overall Study|Protocol Violation|0|||
105657758|NCT00891046|364411892|FG004|Overall Study|Protocol Violation|1|||
105657759|NCT00891046|364411888|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
105657760|NCT00891046|364411889|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105657761|NCT00891046|364411890|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
105657762|NCT00891046|364411891|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
105657763|NCT00891046|364411892|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
105657764|NCT00891046|364411888|FG000|Overall Study|Administrative problems|0|||
105657765|NCT00891046|364411889|FG001|Overall Study|Administrative problems|0|||
105657766|NCT00891046|364411890|FG002|Overall Study|Administrative problems|0|||
105657767|NCT00891046|364411891|FG003|Overall Study|Administrative problems|0|||
105657768|NCT00891046|364411892|FG004|Overall Study|Administrative problems|1|||
105657769|NCT00891046|364411888|FG000|Overall Study|Participant no longer required drug|0|||
105657770|NCT00891046|364411889|FG001|Overall Study|Participant no longer required drug|2|||
105657771|NCT00891046|364411890|FG002|Overall Study|Participant no longer required drug|0|||
105657772|NCT00891046|364411891|FG003|Overall Study|Participant no longer required drug|0|||
105657773|NCT00891046|364411892|FG004|Overall Study|Participant no longer required drug|1|||
105657774|NCT00891046|364411888|FG000|Overall Study|Adverse Event|4|||
105657775|NCT00891046|364411889|FG001|Overall Study|Adverse Event|3|||
105657776|NCT00891046|364411890|FG002|Overall Study|Adverse Event|2|||
105657777|NCT00891046|364411891|FG003|Overall Study|Adverse Event|0|||
105657778|NCT00891046|364411892|FG004|Overall Study|Adverse Event|14|||
105657779|NCT00891046|364411888|FG000|Overall Study|Withdrawal by Subject|2|||
105657780|NCT00891046|364411889|FG001|Overall Study|Withdrawal by Subject|1|||
105657781|NCT00891046|364411890|FG002|Overall Study|Withdrawal by Subject|2|||
105657782|NCT00891046|364411891|FG003|Overall Study|Withdrawal by Subject|1|||
105657783|NCT00891046|364411892|FG004|Overall Study|Withdrawal by Subject|1|||
105657784|NCT00891046|364411888|FG000|Overall Study|Lost to Follow-up|0|||
105657785|NCT00891046|364411889|FG001|Overall Study|Lost to Follow-up|0|||
105657786|NCT00891046|364411890|FG002|Overall Study|Lost to Follow-up|0|||
105657787|NCT00891046|364411891|FG003|Overall Study|Lost to Follow-up|0|||
105657788|NCT00891046|364411892|FG004|Overall Study|Lost to Follow-up|1|||
105657789|NCT04333147|364411893|FG000|Overall Study|Adverse Event|43|||
105657790|NCT04333147|364411894|FG001|Overall Study|Adverse Event|40|||
105657791|NCT04333147|364411893|FG000|Overall Study|Lack of Efficacy|49|||
105657792|NCT04333147|364411894|FG001|Overall Study|Lack of Efficacy|48|||
105657793|NCT04333147|364411893|FG000|Overall Study|Lost to Follow-up|19|||
105657794|NCT04333147|364411894|FG001|Overall Study|Lost to Follow-up|16|||
105657795|NCT04333147|364411893|FG000|Overall Study|Physician Decision|17|||
105657796|NCT04333147|364411894|FG001|Overall Study|Physician Decision|20|||
105657797|NCT04333147|364411893|FG000|Overall Study|Withdrawal by Subject|65|||
105657798|NCT04333147|364411894|FG001|Overall Study|Withdrawal by Subject|68|||
105657799|NCT04333147|364411893|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
105657800|NCT04333147|364411894|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
105657801|NCT04333147|364411893|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
105657802|NCT04333147|364411894|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
105657803|NCT04333147|364411893|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
105657804|NCT04333147|364411894|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
105657805|NCT04984239|364411895|FG000|Overall Study|Lost to Follow-up|1|||
105657806|NCT00630552|364411909|FG000|Overall Study|Adverse Event|0|||
105657807|NCT00630552|364411910|FG001|Overall Study|Adverse Event|1|||
105657808|NCT00630552|364411911|FG002|Overall Study|Adverse Event|5|||
105657809|NCT00630552|364411912|FG003|Overall Study|Adverse Event|4|||
105657810|NCT00630552|364411913|FG004|Overall Study|Adverse Event|2|||
105657811|NCT00630552|364411909|FG000|Overall Study|Disease progression|5|||
105657812|NCT00630552|364411910|FG001|Overall Study|Disease progression|6|||
105657813|NCT00630552|364411911|FG002|Overall Study|Disease progression|27|||
105657814|NCT00630552|364411912|FG003|Overall Study|Disease progression|22|||
105657815|NCT00630552|364411913|FG004|Overall Study|Disease progression|31|||
105657816|NCT00630552|364411909|FG000|Overall Study|Never received IP|0|||
105657817|NCT00630552|364411910|FG001|Overall Study|Never received IP|0|||
105657818|NCT00630552|364411911|FG002|Overall Study|Never received IP|0|||
105657819|NCT00630552|364411912|FG003|Overall Study|Never received IP|2|||
105657820|NCT00630552|364411913|FG004|Overall Study|Never received IP|2|||
105657821|NCT00630552|364411909|FG000|Overall Study|Ineligibility determined|0|||
105657822|NCT00630552|364411910|FG001|Overall Study|Ineligibility determined|0|||
105657823|NCT00630552|364411911|FG002|Overall Study|Ineligibility determined|0|||
105657824|NCT00630552|364411912|FG003|Overall Study|Ineligibility determined|0|||
105657825|NCT00630552|364411913|FG004|Overall Study|Ineligibility determined|1|||
105657826|NCT00630552|364411909|FG000|Overall Study|Protocol Violation|0|||
105657827|NCT00630552|364411910|FG001|Overall Study|Protocol Violation|0|||
105657828|NCT00630552|364411911|FG002|Overall Study|Protocol Violation|0|||
105657829|NCT00630552|364411912|FG003|Overall Study|Protocol Violation|1|||
105657830|NCT00630552|364411913|FG004|Overall Study|Protocol Violation|0|||
105657831|NCT00630552|364411909|FG000|Overall Study|Physician Decision|0|||
105657832|NCT00630552|364411910|FG001|Overall Study|Physician Decision|0|||
105657833|NCT00630552|364411911|FG002|Overall Study|Physician Decision|0|||
105657834|NCT00630552|364411912|FG003|Overall Study|Physician Decision|0|||
105657835|NCT00630552|364411913|FG004|Overall Study|Physician Decision|1|||
105657836|NCT00630552|364411909|FG000|Overall Study|Death|0|||
105657837|NCT00630552|364411910|FG001|Overall Study|Death|0|||
105657838|NCT00630552|364411911|FG002|Overall Study|Death|1|||
105657839|NCT00630552|364411912|FG003|Overall Study|Death|2|||
105657840|NCT00630552|364411913|FG004|Overall Study|Death|2|||
105657841|NCT00630552|364411909|FG000|Overall Study|Withdrawal by Subject|0|||
105657842|NCT00630552|364411910|FG001|Overall Study|Withdrawal by Subject|0|||
105657843|NCT00630552|364411911|FG002|Overall Study|Withdrawal by Subject|0|||
105657844|NCT00630552|364411912|FG003|Overall Study|Withdrawal by Subject|1|||
105657845|NCT00630552|364411913|FG004|Overall Study|Withdrawal by Subject|0|||
105657846|NCT00630552|364411909|FG000|Overall Study|Other|0|||
105657847|NCT00630552|364411910|FG001|Overall Study|Other|0|||
105657848|NCT00630552|364411911|FG002|Overall Study|Other|4|||
105657849|NCT00630552|364411912|FG003|Overall Study|Other|2|||
105657850|NCT00630552|364411913|FG004|Overall Study|Other|0|||
105657851|NCT04606199|364411914|FG000|Overall Study|Withdrawal by Subject|2|||
105657852|NCT04349644|364411915|FG000|Allocation/Pretest|Lost to pretest|0|||
105657853|NCT04349644|364411916|FG001|Allocation/Pretest|Lost to pretest|3|||
105657854|NCT04349644|364411915|FG000|Posttest|Lost to posttest|0|||
105657855|NCT04349644|364411916|FG001|Posttest|Lost to posttest|8|||
105657856|NCT04349644|364411915|FG000|Posttest|Discontinued intervention|6|||
105657857|NCT04349644|364411916|FG001|Posttest|Discontinued intervention|0|||
105657858|NCT04349644|364411915|FG000|Follow-up|Lost to Follow-up|0|||
105657859|NCT04349644|364411916|FG001|Follow-up|Lost to Follow-up|2|||
105657860|NCT00408928|364411917|FG000|Overall Study|Withdrawal by Subject|1|||
105657861|NCT00408928|364411917|FG000|Overall Study|Death|1|||
105657862|NCT00408928|364411917|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
105657863|NCT02438371|364411918|FG000|Overall Study|Lost to Follow-up|3|||
105657864|NCT02438371|364411919|FG001|Overall Study|Lost to Follow-up|2|||
105657865|NCT02438371|364411918|FG000|Overall Study|Withdrawal by Subject|1|||
105657866|NCT02438371|364411919|FG001|Overall Study|Withdrawal by Subject|1|||
105657867|NCT01850823|364411923|FG000|Overall Study|Early Visit Window|0|||
105657868|NCT01850823|364411924|FG001|Overall Study|Early Visit Window|1|||
105657869|NCT01850823|364411925|FG002|Overall Study|Early Visit Window|4|||
105657870|NCT01850823|364411923|FG000|Overall Study|Enrolled in Error|0|||
105657871|NCT01850823|364411924|FG001|Overall Study|Enrolled in Error|1|||
105657872|NCT01850823|364411925|FG002|Overall Study|Enrolled in Error|2|||
105657873|NCT01850823|364411923|FG000|Overall Study|Lack of Efficacy|1|||
105657874|NCT01850823|364411924|FG001|Overall Study|Lack of Efficacy|0|||
105657875|NCT01850823|364411925|FG002|Overall Study|Lack of Efficacy|0|||
105657876|NCT01850823|364411923|FG000|Overall Study|Lost to Follow-up|0|||
105657877|NCT01850823|364411924|FG001|Overall Study|Lost to Follow-up|0|||
105657878|NCT01850823|364411925|FG002|Overall Study|Lost to Follow-up|1|||
105657879|NCT01850823|364411923|FG000|Overall Study|Restricted Medication|0|||
105657880|NCT01850823|364411924|FG001|Overall Study|Restricted Medication|0|||
105657881|NCT01850823|364411925|FG002|Overall Study|Restricted Medication|2|||
105657882|NCT01850823|364411923|FG000|Overall Study|Significant worstening of SAR|0|||
105657883|NCT01850823|364411924|FG001|Overall Study|Significant worstening of SAR|1|||
105657884|NCT01850823|364411925|FG002|Overall Study|Significant worstening of SAR|0|||
105657885|NCT01850823|364411923|FG000|Overall Study|Withdrawal by Subject|2|||
105657886|NCT01850823|364411924|FG001|Overall Study|Withdrawal by Subject|0|||
105657887|NCT01850823|364411925|FG002|Overall Study|Withdrawal by Subject|1|||
105657888|NCT01751165|364411926|FG000|Overall Study|Adverse event, serious fatal|1|||
105657889|NCT01751165|364411927|FG001|Overall Study|Adverse event, serious fatal|0|||
105657890|NCT01751165|364411928|FG002|Overall Study|Adverse event, serious fatal|1|||
105657891|NCT01751165|364411926|FG000|Overall Study|Withdrawal by Subject|0|||
105657892|NCT01751165|364411927|FG001|Overall Study|Withdrawal by Subject|0|||
105657893|NCT01751165|364411928|FG002|Overall Study|Withdrawal by Subject|1|||
105657894|NCT01751165|364411926|FG000|Overall Study|Serious adverse event|0|||
105657895|NCT01751165|364411927|FG001|Overall Study|Serious adverse event|2|||
105657896|NCT01751165|364411928|FG002|Overall Study|Serious adverse event|0|||
105657897|NCT01751165|364411926|FG000|Overall Study|Lost to Follow-up|1|||
105657898|NCT01751165|364411927|FG001|Overall Study|Lost to Follow-up|1|||
105657899|NCT01751165|364411928|FG002|Overall Study|Lost to Follow-up|1|||
105657900|NCT00988533|364411931|FG000|Overall Study|Lost to Follow-up|3|||
105657901|NCT02895360|364411936|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
105657902|NCT02895360|364411937|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
105657903|NCT02895360|364411938|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
105657904|NCT02895360|364411939|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
105657905|NCT02895360|364411940|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
105657906|NCT02895360|364411941|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
105657907|NCT02895360|364411936|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
105657908|NCT02895360|364411937|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
105657909|NCT02895360|364411938|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
105657910|NCT02895360|364411939|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
105657911|NCT02895360|364411940|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
105657912|NCT02895360|364411941|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
105657913|NCT02895360|364411936|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
105657914|NCT02895360|364411937|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
105657915|NCT02895360|364411938|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
105657916|NCT02895360|364411939|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
105657917|NCT02895360|364411940|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
105657918|NCT02895360|364411941|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
105657919|NCT02895360|364411936|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
105657920|NCT02895360|364411937|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
105657921|NCT02895360|364411938|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
105657922|NCT02895360|364411939|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
105657923|NCT02895360|364411940|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
105657924|NCT02895360|364411941|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
105657925|NCT02895360|364411936|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
105657926|NCT02895360|364411937|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
105657927|NCT02895360|364411938|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
105657928|NCT02895360|364411939|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
105657929|NCT02895360|364411940|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
105657930|NCT02895360|364411941|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
105657931|NCT02895360|364411936|FG000|Phase 2a|Adverse Event|0|||
105657932|NCT02895360|364411937|FG001|Phase 2a|Adverse Event|0|||
105657933|NCT02895360|364411938|FG002|Phase 2a|Adverse Event|0|||
105657934|NCT02895360|364411939|FG003|Phase 2a|Adverse Event|0|||
105657935|NCT02895360|364411940|FG004|Phase 2a|Adverse Event|0|||
105657936|NCT02895360|364411941|FG005|Phase 2a|Adverse Event|1|||
105657937|NCT02895360|364411936|FG000|Phase 2a|Progressive disease|0|||
105657938|NCT02895360|364411937|FG001|Phase 2a|Progressive disease|0|||
105657939|NCT02895360|364411938|FG002|Phase 2a|Progressive disease|0|||
105657940|NCT02895360|364411939|FG003|Phase 2a|Progressive disease|0|||
105657941|NCT02895360|364411940|FG004|Phase 2a|Progressive disease|11|||
105657942|NCT02895360|364411941|FG005|Phase 2a|Progressive disease|11|||
105657943|NCT00916305|364411942|FG000|Overall Study|Lost to Follow-up|21|||
105657944|NCT00916305|364411943|FG001|Overall Study|Lost to Follow-up|27|||
105657945|NCT00916305|364411942|FG000|Overall Study|Withdrawal by Subject|0|||
105657946|NCT00916305|364411943|FG001|Overall Study|Withdrawal by Subject|1|||
105657947|NCT04051242|364411944|FG000|Overall Study|Withdrawal by Subject|1|||
105657948|NCT04051242|364411944|FG000|Overall Study|Physician Decision|1|||
105657949|NCT00107978|364411951|FG000|Overall Study|Adverse Event|1|||
105657950|NCT00107978|364411952|FG001|Overall Study|Adverse Event|5|||
105657951|NCT00107978|364411951|FG000|Overall Study|Death|3|||
105657952|NCT00107978|364411952|FG001|Overall Study|Death|3|||
105657953|NCT00107978|364411951|FG000|Overall Study|Lost to Follow-up|20|||
105657954|NCT00107978|364411952|FG001|Overall Study|Lost to Follow-up|28|||
105657955|NCT00107978|364411951|FG000|Overall Study|Withdrawal by Subject|4|||
105657956|NCT00107978|364411952|FG001|Overall Study|Withdrawal by Subject|9|||
105657957|NCT00107978|364411951|FG000|Overall Study|Protocol Violation|0|||
105440150|NCT02352753|363616711|FG000|6-Month Dosing Period|Decision by sponsor|2|||
105657958|NCT00107978|364411952|FG001|Overall Study|Protocol Violation|1|||
105657959|NCT00107978|364411951|FG000|Overall Study|Other|5|||
105657960|NCT00107978|364411952|FG001|Overall Study|Other|4|||
105657961|NCT02669407|364411953|FG000|Overall Study|Physician Decision|3|||
105657962|NCT01874665|364411956|FG000|Overall Study|Adverse Event|6|||
105657963|NCT01874665|364411957|FG001|Overall Study|Adverse Event|2|||
105657964|NCT01874665|364411956|FG000|Overall Study|Withdrawal by Subject|4|||
105657965|NCT01874665|364411957|FG001|Overall Study|Withdrawal by Subject|1|||
105657966|NCT01874665|364411956|FG000|Overall Study|Physician Decision|3|||
105657967|NCT01874665|364411957|FG001|Overall Study|Physician Decision|0|||
105657968|NCT01874665|364411956|FG000|Overall Study|Clinical Progressive Disease|4|||
105657969|NCT01874665|364411957|FG001|Overall Study|Clinical Progressive Disease|3|||
105657970|NCT01874665|364411956|FG000|Overall Study|Study Terminated by Sponsor|0|||
105657971|NCT01874665|364411957|FG001|Overall Study|Study Terminated by Sponsor|2|||
105657972|NCT01874665|364411956|FG000|Overall Study|Documented Progressive Disease|11|||
105657973|NCT01874665|364411957|FG001|Overall Study|Documented Progressive Disease|7|||
105657974|NCT01874665|364411956|FG000|Overall Study|Other|2|||
105657975|NCT01874665|364411957|FG001|Overall Study|Other|0|||
105657976|NCT00350298|364411960|FG000|Overall Study|Death|7|||
105657977|NCT00350298|364411961|FG001|Overall Study|Death|8|||
105657978|NCT00350298|364411960|FG000|Overall Study|Lost to Follow-up|1|||
105657979|NCT00350298|364411961|FG001|Overall Study|Lost to Follow-up|2|||
105657980|NCT00350298|364411960|FG000|Overall Study|Withdrawal by Subject|1|||
105657981|NCT00350298|364411961|FG001|Overall Study|Withdrawal by Subject|3|||
105657982|NCT01588366|364411964|FG000|Overall Study|Adverse Event|0|||
105657983|NCT01588366|364411965|FG001|Overall Study|Adverse Event|1|||
105657984|NCT01588366|364411966|FG002|Overall Study|Adverse Event|0|||
105657985|NCT01588366|364411967|FG003|Overall Study|Adverse Event|1|||
105657986|NCT01588366|364411968|FG004|Overall Study|Adverse Event|0|||
105657987|NCT01588366|364411969|FG005|Overall Study|Adverse Event|2|||
105657988|NCT04962698|364411970|FG000|Motor Imagery|Technical difficulty|1|||
105657989|NCT04962698|364411971|FG001|Motor Imagery|Technical difficulty|0|||
105657990|NCT04962698|364411970|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
105657991|NCT04962698|364411971|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
105657992|NCT04962698|364411970|FG000|Kinesthetic MI|Technical difficulty|1|||
105657993|NCT04962698|364411971|FG001|Kinesthetic MI|Technical difficulty|0|||
105657994|NCT04962698|364411970|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
105657995|NCT04962698|364411971|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
105659510|NCT02635386|364417350|FG003|Overall Study|side effects|4|||
105657996|NCT04962698|364411970|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
105657997|NCT04962698|364411971|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
105657998|NCT04962698|364411970|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
105659511|NCT02635386|364417351|FG004|Overall Study|side effects|6|||
105657999|NCT04962698|364411971|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
105658000|NCT04962698|364411970|FG000|Virtual-hand Interaction|Technical difficulty|1|||
105658001|NCT04962698|364411971|FG001|Virtual-hand Interaction|Technical difficulty|0|||
105658002|NCT04962698|364411970|FG000|Robotic Action Observation|Technical difficulty|1|||
105658003|NCT04962698|364411971|FG001|Robotic Action Observation|Technical difficulty|0|||
105658004|NCT04962698|364411970|FG000|Rest|Technical difficulty|1|||
105658005|NCT04962698|364411971|FG001|Rest|Technical difficulty|0|||
105658006|NCT04962698|364411970|FG000|Rest|Exclusion criteria met after enrollment|0|||
105658007|NCT04962698|364411971|FG001|Rest|Exclusion criteria met after enrollment|2|||
105658008|NCT03201900|364411972|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
105658009|NCT03201900|364411972|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
105658010|NCT03201900|364411972|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
105658011|NCT03201900|364411972|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
105658012|NCT03201900|364411972|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
105658013|NCT03201900|364411972|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
105658014|NCT03201900|364411972|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
105658015|NCT03201900|364411972|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
105658016|NCT03201900|364411972|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
105658017|NCT03201900|364411972|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
105658018|NCT03201900|364411972|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
105658019|NCT03201900|364411972|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
105658020|NCT03201900|364411972|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
105658021|NCT02971228|364411988|FG000|Overall Study|Withdrawal by Subject|1|||
105658022|NCT02971228|364411989|FG001|Overall Study|Withdrawal by Subject|1|||
105658023|NCT02971228|364411990|FG002|Overall Study|Withdrawal by Subject|0|||
105658024|NCT02971228|364411991|FG003|Overall Study|Withdrawal by Subject|0|||
105658025|NCT02971228|364411992|FG004|Overall Study|Withdrawal by Subject|0|||
105658026|NCT02971228|364411988|FG000|Overall Study|Logistical challenges|0|||
105658027|NCT02971228|364411989|FG001|Overall Study|Logistical challenges|1|||
105658028|NCT02971228|364411990|FG002|Overall Study|Logistical challenges|0|||
105658029|NCT02971228|364411991|FG003|Overall Study|Logistical challenges|0|||
105658030|NCT02971228|364411992|FG004|Overall Study|Logistical challenges|0|||
105658031|NCT01233999|364411995|FG000|Overall Study|Withdrawal by Subject|1|||
105658032|NCT01233999|364411995|FG000|Overall Study|Lost to Follow-up|1|||
105658033|NCT03082612|364411996|FG000|Overall Study|Lost to Follow-up|2|||
105658034|NCT03082612|364411997|FG001|Overall Study|Lost to Follow-up|0|||
105658035|NCT03414047|364412000|FG000|Overall Study|Adverse Event|0|||
105658036|NCT03414047|364412001|FG001|Overall Study|Adverse Event|0|||
105658037|NCT03414047|364412002|FG002|Overall Study|Adverse Event|1|||
105658038|NCT03414047|364412003|FG003|Overall Study|Adverse Event|1|||
105658039|NCT03414047|364412000|FG000|Overall Study|Physician Decision|1|||
105658040|NCT03414047|364412001|FG001|Overall Study|Physician Decision|0|||
105658041|NCT03414047|364412002|FG002|Overall Study|Physician Decision|0|||
105658042|NCT03414047|364412003|FG003|Overall Study|Physician Decision|1|||
105659588|NCT03845023|364417396|FG003|Follow-Up (14 Days)|Adverse Event|1|||
105658043|NCT03414047|364412000|FG000|Overall Study|Withdrawal by Subject|1|||
105440151|NCT02352753|363616711|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
105440152|NCT02352753|363616711|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
105440153|NCT02352753|363616711|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
105440154|NCT02352753|363616711|FG000|3-Month Dosing Period|Decision by sponsor|14|||
105440155|NCT02352753|363616711|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
105440156|NCT01279616|363616712|FG000|Overall Study|donor could not be located|5|||
105440157|NCT01279616|363616712|FG000|Overall Study|no signs of sickle cell disease|2|||
105440158|NCT02206035|363616714|FG000|Overall Study|Physician Decision|10|||
105440159|NCT02206035|363616715|FG001|Overall Study|Physician Decision|0|||
105440160|NCT02206035|363616716|FG002|Overall Study|Physician Decision|175|||
105440161|NCT01934010|363616717|FG000|Overall Study|Adverse Event|1|||
105440162|NCT01934010|363616718|FG001|Overall Study|Adverse Event|1|||
105440163|NCT01934010|363616719|FG002|Overall Study|Adverse Event|0|||
105440164|NCT01934010|363616717|FG000|Overall Study|Withdrawal by Subject|15|||
105440165|NCT01934010|363616718|FG001|Overall Study|Withdrawal by Subject|6|||
105440166|NCT01934010|363616719|FG002|Overall Study|Withdrawal by Subject|2|||
105440167|NCT01934010|363616717|FG000|Overall Study|Lost to Follow-up|7|||
105440168|NCT01934010|363616718|FG001|Overall Study|Lost to Follow-up|4|||
105440169|NCT01934010|363616719|FG002|Overall Study|Lost to Follow-up|0|||
105440170|NCT01068769|363616720|FG000|Overall Study|Ineligible|1|||
105440171|NCT03245398|363616724|FG000|Overall Study|Travelled to another island|1|||
105440172|NCT03245398|363616725|FG001|Overall Study|Travelled to another island|0|||
105440173|NCT00887926|363616726|FG000|Overall Study|Withdrawal by Subject|0|||
105440174|NCT00887926|363616727|FG001|Overall Study|Withdrawal by Subject|1|||
105440175|NCT00887926|363616728|FG002|Overall Study|Withdrawal by Subject|0|||
105440176|NCT00887926|363616729|FG003|Overall Study|Withdrawal by Subject|0|||
105440177|NCT00880191|363616730|FG000|Overall Study|Refused further treatment|4|||
105440178|NCT00880191|363616731|FG001|Overall Study|Refused further treatment|1|||
105440179|NCT00880191|363616730|FG000|Overall Study|Adverse Event|8|||
105440180|NCT00880191|363616731|FG001|Overall Study|Adverse Event|6|||
105440181|NCT00880191|363616730|FG000|Overall Study|Hospitalization/efficacy|1|||
105440182|NCT00880191|363616731|FG001|Overall Study|Hospitalization/efficacy|1|||
105440183|NCT01331109|363616732|FG000|Overall Study|Adverse Event|6|||
105440184|NCT01331109|363616732|FG000|Overall Study|Lack of Efficacy|2|||
105440185|NCT01331109|363616732|FG000|Overall Study|Protocol Violation|3|||
105440186|NCT01331109|363616732|FG000|Overall Study|Withdrawal by Subject|7|||
105440187|NCT01331109|363616732|FG000|Overall Study|Lost to Follow-up|1|||
105440188|NCT01331109|363616732|FG000|Overall Study|Study Terminated by Sponsor|38|||
105440189|NCT00988091|363616733|FG000|Double-blind Period|Withdrawal by Subject|15|||
105440190|NCT00988091|363616734|FG001|Double-blind Period|Withdrawal by Subject|13|||
105440191|NCT00988091|363616733|FG000|Double-blind Period|Lost to Follow-up|12|||
105440192|NCT00988091|363616734|FG001|Double-blind Period|Lost to Follow-up|14|||
105440193|NCT00988091|363616733|FG000|Double-blind Period|Other|8|||
105440194|NCT00988091|363616734|FG001|Double-blind Period|Other|8|||
105440195|NCT00988091|363616733|FG000|Double-blind Period|Adverse Event|6|||
105440196|NCT00988091|363616734|FG001|Double-blind Period|Adverse Event|9|||
105440197|NCT00988091|363616733|FG000|Double-blind Period|Use of exclusionary medication|2|||
105440198|NCT00988091|363616734|FG001|Double-blind Period|Use of exclusionary medication|3|||
105440199|NCT00988091|363616733|FG000|Open-label Period|Adverse Event|4|||
105440200|NCT00988091|363616734|FG001|Open-label Period|Adverse Event|7|||
105440201|NCT00988091|363616733|FG000|Open-label Period|Use of exclusionary medication|1|||
105440202|NCT00988091|363616734|FG001|Open-label Period|Use of exclusionary medication|1|||
105440203|NCT00988091|363616733|FG000|Open-label Period|Protocol Violation|1|||
105440204|NCT00988091|363616734|FG001|Open-label Period|Protocol Violation|1|||
105440205|NCT00988091|363616733|FG000|Open-label Period|Withdrawal by Subject|10|||
105440206|NCT00988091|363616734|FG001|Open-label Period|Withdrawal by Subject|16|||
105440207|NCT00988091|363616733|FG000|Open-label Period|Lost to Follow-up|3|||
105440208|NCT00988091|363616734|FG001|Open-label Period|Lost to Follow-up|5|||
105440209|NCT00988091|363616733|FG000|Open-label Period|Other|2|||
105440210|NCT00988091|363616734|FG001|Open-label Period|Other|3|||
105440211|NCT02649894|363616737|FG000|Overall Study|Adverse Event|1|||
105440212|NCT02649894|363616738|FG001|Overall Study|Adverse Event|0|||
105440213|NCT02649894|363616737|FG000|Overall Study|Physician Decision|0|||
105440214|NCT02649894|363616738|FG001|Overall Study|Physician Decision|1|||
105440215|NCT02649894|363616737|FG000|Overall Study|Withdrawal by Subject|5|||
105440216|NCT02649894|363616738|FG001|Overall Study|Withdrawal by Subject|2|||
105440217|NCT02649894|363616737|FG000|Overall Study|Lost to Follow-up|2|||
105440218|NCT02649894|363616738|FG001|Overall Study|Lost to Follow-up|1|||
105440219|NCT02649894|363616737|FG000|Overall Study|Death|30|||
105440220|NCT02649894|363616738|FG001|Overall Study|Death|7|||
105440221|NCT02649894|363616737|FG000|Overall Study|Other, not specified|6|||
105440222|NCT02649894|363616738|FG001|Overall Study|Other, not specified|0|||
105440223|NCT04302545|363616741|FG000|Overall Study|Lost to Follow-up|3|||
105440224|NCT04302545|363616742|FG001|Overall Study|Lost to Follow-up|4|||
105440225|NCT02473367|363616746|FG000|Wait 1|Withdrawal by Subject|1|||
105440226|NCT02473367|363616746|FG000|Period 4|Lost to Follow-up|1|||
105440227|NCT00428389|363616749|FG000|Core Phase|Adverse Event|6|||
105440228|NCT00428389|363616750|FG001|Core Phase|Adverse Event|4|||
105440229|NCT00428389|363616749|FG000|Core Phase|Lack of Efficacy|2|||
105440230|NCT00428389|363616750|FG001|Core Phase|Lack of Efficacy|0|||
105440231|NCT00428389|363616749|FG000|Core Phase|Abnormal test procedure result(s)|0|||
105440232|NCT00428389|363616750|FG001|Core Phase|Abnormal test procedure result(s)|1|||
105440233|NCT00428389|363616749|FG000|Core Phase|Withdrawal by Subject|3|||
105440234|NCT00428389|363616750|FG001|Core Phase|Withdrawal by Subject|4|||
105440235|NCT00428389|363616749|FG000|Core Phase|Protocol deviation|0|||
105440236|NCT00428389|363616750|FG001|Core Phase|Protocol deviation|2|||
105440237|NCT00428389|363616749|FG000|Extension Phase|Adverse Event|17|||
105440238|NCT00428389|363616750|FG001|Extension Phase|Adverse Event|11|||
105440239|NCT00428389|363616749|FG000|Extension Phase|Lack of Efficacy|4|||
105440240|NCT00428389|363616750|FG001|Extension Phase|Lack of Efficacy|3|||
105440241|NCT00428389|363616749|FG000|Extension Phase|Withdrawal by Subject|6|||
105440242|NCT00428389|363616750|FG001|Extension Phase|Withdrawal by Subject|6|||
105440243|NCT00428389|363616749|FG000|Extension Phase|Lost to Follow-up|0|||
105440244|NCT00428389|363616750|FG001|Extension Phase|Lost to Follow-up|3|||
105440245|NCT00428389|363616749|FG000|Extension Phase|Death|1|||
105440246|NCT00428389|363616750|FG001|Extension Phase|Death|0|||
105440247|NCT00428389|363616749|FG000|Extension Phase|Protocol Violation|3|||
105440248|NCT00428389|363616750|FG001|Extension Phase|Protocol Violation|2|||
105440249|NCT00428389|363616749|FG000|Extension Phase|Administrative problems|1|||
105440250|NCT00428389|363616750|FG001|Extension Phase|Administrative problems|1|||
105440251|NCT04079114|363616751|FG000|Overall Study|Study prematuely terminated.|166|||
105440252|NCT01007838|363616752|FG000|Overall Study|Withdrawal by Subject|1|||
105440253|NCT01007838|363616753|FG001|Overall Study|Withdrawal by Subject|0|||
105440254|NCT01007838|363616754|FG002|Overall Study|Withdrawal by Subject|0|||
105440255|NCT01007838|363616755|FG003|Overall Study|Withdrawal by Subject|0|||
105440256|NCT01007838|363616752|FG000|Overall Study|Physician Decision|1|||
105440257|NCT01007838|363616753|FG001|Overall Study|Physician Decision|0|||
105440258|NCT01007838|363616754|FG002|Overall Study|Physician Decision|0|||
105440259|NCT01007838|363616755|FG003|Overall Study|Physician Decision|0|||
105440260|NCT01007838|363616752|FG000|Overall Study|Started home haemodialysis|1|||
105440261|NCT01007838|363616753|FG001|Overall Study|Started home haemodialysis|0|||
105440262|NCT01007838|363616754|FG002|Overall Study|Started home haemodialysis|0|||
105440263|NCT01007838|363616755|FG003|Overall Study|Started home haemodialysis|0|||
105440264|NCT00408434|363616756|FG000|Overall Study|Adverse Event|0|||
105440265|NCT00408434|363616757|FG001|Overall Study|Adverse Event|0|||
105440266|NCT00408434|363616758|FG002|Overall Study|Adverse Event|1|||
105440267|NCT00408434|363616759|FG003|Overall Study|Adverse Event|0|||
105440268|NCT00408434|363616760|FG004|Overall Study|Adverse Event|0|||
105440269|NCT00408434|363616761|FG005|Overall Study|Adverse Event|0|||
105440270|NCT00408434|363616762|FG006|Overall Study|Adverse Event|0|||
105440271|NCT00408434|363616756|FG000|Overall Study|Progressive disease|6|||
105440272|NCT00408434|363616757|FG001|Overall Study|Progressive disease|3|||
105440273|NCT00408434|363616758|FG002|Overall Study|Progressive disease|4|||
105440274|NCT00408434|363616759|FG003|Overall Study|Progressive disease|3|||
105440275|NCT00408434|363616760|FG004|Overall Study|Progressive disease|3|||
105440276|NCT00408434|363616761|FG005|Overall Study|Progressive disease|1|||
105440277|NCT00408434|363616762|FG006|Overall Study|Progressive disease|4|||
105440278|NCT00408434|363616756|FG000|Overall Study|Other|0|||
105440279|NCT00408434|363616757|FG001|Overall Study|Other|0|||
105440280|NCT00408434|363616758|FG002|Overall Study|Other|1|||
105440281|NCT00408434|363616759|FG003|Overall Study|Other|0|||
105658044|NCT03414047|364412001|FG001|Overall Study|Withdrawal by Subject|0|||
105658045|NCT03414047|364412002|FG002|Overall Study|Withdrawal by Subject|2|||
105658046|NCT03414047|364412003|FG003|Overall Study|Withdrawal by Subject|0|||
105658047|NCT00025506|364412004|FG000|Overall Study|Ineligible: clerical error|1|||
105658048|NCT00025506|364412004|FG000|Overall Study|Ineligible: wrong cell type|5|||
105658049|NCT00025506|364412004|FG000|Overall Study|Ineligible: inadequate pathology|2|||
105658050|NCT00025506|364412004|FG000|Overall Study|Never Treated|2|||
105658051|NCT01321723|364412005|FG000|Overall Study|Adverse Event|3|||
105658052|NCT01321723|364412006|FG001|Overall Study|Adverse Event|5|||
105658053|NCT01321723|364412007|FG002|Overall Study|Adverse Event|2|||
105658054|NCT01321723|364412005|FG000|Overall Study|Withdrawal by Subject|2|||
105658055|NCT01321723|364412006|FG001|Overall Study|Withdrawal by Subject|0|||
105658056|NCT01321723|364412007|FG002|Overall Study|Withdrawal by Subject|2|||
105658057|NCT01710800|364412008|FG000|Overall Study|Withdrawal by Subject|21|||
105658058|NCT01710800|364412008|FG000|Overall Study|Protocol Violation|1|||
105658059|NCT02586415|364412009|FG000|Overall Study|Death|13|||
105658060|NCT02586415|364412010|FG001|Overall Study|Death|23|||
105658061|NCT02586415|364412009|FG000|Overall Study|Lost to Follow-up|1|||
105658062|NCT02586415|364412010|FG001|Overall Study|Lost to Follow-up|2|||
105658063|NCT00827775|364412011|FG000|Overall Study|Withdrawal by Subject|0|||
105658064|NCT00827775|364412012|FG001|Overall Study|Withdrawal by Subject|5|||
105658065|NCT02872311|364412014|FG000|Overall Study|Death|2|||
105658066|NCT02872311|364412015|FG001|Overall Study|Death|0|||
105658067|NCT02872311|364412016|FG002|Overall Study|Death|0|||
105658068|NCT02872311|364412017|FG003|Overall Study|Death|0|||
105658069|NCT02872311|364412018|FG004|Overall Study|Death|0|||
105658070|NCT02872311|364412014|FG000|Overall Study|Lost to Follow-up|2|||
105658071|NCT02872311|364412015|FG001|Overall Study|Lost to Follow-up|0|||
105658072|NCT02872311|364412016|FG002|Overall Study|Lost to Follow-up|0|||
105658073|NCT02872311|364412017|FG003|Overall Study|Lost to Follow-up|0|||
105658074|NCT02872311|364412018|FG004|Overall Study|Lost to Follow-up|0|||
105658075|NCT02872311|364412014|FG000|Overall Study|Protocol Violation|0|||
105658076|NCT02872311|364412015|FG001|Overall Study|Protocol Violation|2|||
105658077|NCT02872311|364412016|FG002|Overall Study|Protocol Violation|1|||
105658078|NCT02872311|364412017|FG003|Overall Study|Protocol Violation|0|||
105658079|NCT02872311|364412018|FG004|Overall Study|Protocol Violation|0|||
105658080|NCT01585298|364412019|FG000|Overall Study|Study completion was not documented.|1|||
105658081|NCT01585298|364412019|FG000|Overall Study|Protocol deviation|1|||
105658082|NCT01585298|364412019|FG000|Overall Study|Administrative problems|4|||
105658083|NCT01585298|364412019|FG000|Overall Study|Lost to Follow-up|2|||
105658084|NCT01585298|364412019|FG000|Overall Study|Withdrawal by Subject|4|||
105658085|NCT01585298|364412019|FG000|Overall Study|Abnormal test procedure results|1|||
105658086|NCT01585298|364412019|FG000|Overall Study|Adverse Event|24|||
105658087|NCT00511797|364412020|FG000|Overall Study|Adverse Event|1|||
105658088|NCT00511797|364412021|FG001|Overall Study|Adverse Event|2|||
105658089|NCT00511797|364412022|FG002|Overall Study|Adverse Event|2|||
105658090|NCT00511797|364412023|FG003|Overall Study|Adverse Event|2|||
105658091|NCT00511797|364412020|FG000|Overall Study|Lost to Follow-up|1|||
105658092|NCT00511797|364412021|FG001|Overall Study|Lost to Follow-up|0|||
105658093|NCT00511797|364412022|FG002|Overall Study|Lost to Follow-up|0|||
105658094|NCT00511797|364412023|FG003|Overall Study|Lost to Follow-up|1|||
105658095|NCT00511797|364412020|FG000|Overall Study|Pregnancy|0|||
105658096|NCT00511797|364412021|FG001|Overall Study|Pregnancy|0|||
105658097|NCT00511797|364412022|FG002|Overall Study|Pregnancy|0|||
105658098|NCT00511797|364412023|FG003|Overall Study|Pregnancy|1|||
105658099|NCT00511797|364412020|FG000|Overall Study|Protocol Violation|0|||
105658100|NCT00511797|364412021|FG001|Overall Study|Protocol Violation|2|||
105658101|NCT00511797|364412022|FG002|Overall Study|Protocol Violation|2|||
105658102|NCT00511797|364412023|FG003|Overall Study|Protocol Violation|3|||
105658103|NCT00511797|364412020|FG000|Overall Study|Withdrawal by Subject|3|||
105658104|NCT00511797|364412021|FG001|Overall Study|Withdrawal by Subject|3|||
105658105|NCT00511797|364412022|FG002|Overall Study|Withdrawal by Subject|4|||
105658106|NCT00511797|364412023|FG003|Overall Study|Withdrawal by Subject|2|||
105658107|NCT00511797|364412020|FG000|Overall Study|Never dispensed|1|||
105658108|NCT00511797|364412021|FG001|Overall Study|Never dispensed|0|||
105658109|NCT00511797|364412022|FG002|Overall Study|Never dispensed|1|||
105658110|NCT00511797|364412023|FG003|Overall Study|Never dispensed|3|||
105658111|NCT00511797|364412020|FG000|Overall Study|Study drug not taken|0|||
105658112|NCT00511797|364412021|FG001|Overall Study|Study drug not taken|1|||
105658113|NCT00511797|364412022|FG002|Overall Study|Study drug not taken|0|||
105658114|NCT00511797|364412023|FG003|Overall Study|Study drug not taken|1|||
105658115|NCT00511797|364412020|FG000|Overall Study|Partially missing diary|0|||
105658116|NCT00511797|364412021|FG001|Overall Study|Partially missing diary|0|||
105658117|NCT00511797|364412022|FG002|Overall Study|Partially missing diary|1|||
105658118|NCT00511797|364412023|FG003|Overall Study|Partially missing diary|0|||
105658119|NCT00511797|364412020|FG000|Overall Study|Other (moving etc)|1|||
105658120|NCT00511797|364412021|FG001|Overall Study|Other (moving etc)|0|||
105658121|NCT00511797|364412022|FG002|Overall Study|Other (moving etc)|1|||
105658122|NCT00511797|364412023|FG003|Overall Study|Other (moving etc)|2|||
105658123|NCT01313624|364412024|FG000|Double-Blind Phase|Adverse Event|27|||
105658124|NCT01313624|364412025|FG001|Double-Blind Phase|Adverse Event|4|||
105658125|NCT01313624|364412024|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
105658126|NCT01313624|364412025|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
105658127|NCT01313624|364412024|FG000|Double-Blind Phase|Lost to Follow-up|0|||
105658128|NCT01313624|364412025|FG001|Double-Blind Phase|Lost to Follow-up|2|||
105658129|NCT01313624|364412024|FG000|Double-Blind Phase|Physician Decision|1|||
105658130|NCT01313624|364412025|FG001|Double-Blind Phase|Physician Decision|0|||
105658131|NCT01313624|364412024|FG000|Double-Blind Phase|Lack of Efficacy|1|||
105658132|NCT01313624|364412025|FG001|Double-Blind Phase|Lack of Efficacy|0|||
105658133|NCT01313624|364412024|FG000|Open-Label Phase|Adverse Event|1|||
105658134|NCT01313624|364412025|FG001|Open-Label Phase|Adverse Event|10|||
105658135|NCT01313624|364412024|FG000|Open-Label Phase|Withdrawal by Subject|2|||
105658136|NCT01313624|364412025|FG001|Open-Label Phase|Withdrawal by Subject|2|||
105658137|NCT01313624|364412024|FG000|Open-Label Phase|Lost to Follow-up|1|||
105658138|NCT01313624|364412025|FG001|Open-Label Phase|Lost to Follow-up|1|||
105658139|NCT02143063|364412029|FG000|Overall Study|Lost to Follow-up|16|||
105658140|NCT02143063|364412030|FG001|Overall Study|Lost to Follow-up|28|||
105658141|NCT02143063|364412031|FG002|Overall Study|Lost to Follow-up|29|||
105658142|NCT02143063|364412029|FG000|Overall Study|Withdrawal by Subject|0|||
105658143|NCT02143063|364412030|FG001|Overall Study|Withdrawal by Subject|1|||
105658144|NCT02143063|364412031|FG002|Overall Study|Withdrawal by Subject|0|||
105658145|NCT02143063|364412029|FG000|Overall Study|Death|0|||
105658146|NCT02143063|364412030|FG001|Overall Study|Death|1|||
105658147|NCT02143063|364412031|FG002|Overall Study|Death|1|||
105658148|NCT01157377|364412034|FG000|Overall Study|Lost to Follow-up|0|||
105658149|NCT01157377|364412035|FG001|Overall Study|Lost to Follow-up|0|||
105658150|NCT01157377|364412036|FG002|Overall Study|Lost to Follow-up|1|||
105658151|NCT01157377|364412037|FG003|Overall Study|Lost to Follow-up|0|||
105658152|NCT01157377|364412038|FG004|Overall Study|Lost to Follow-up|1|||
105658153|NCT01157377|364412039|FG005|Overall Study|Lost to Follow-up|1|||
105658154|NCT01157377|364412040|FG006|Overall Study|Lost to Follow-up|0|||
105658155|NCT01157377|364412034|FG000|Overall Study|Personal Reasons|2|||
105658156|NCT01157377|364412035|FG001|Overall Study|Personal Reasons|1|||
105658157|NCT01157377|364412036|FG002|Overall Study|Personal Reasons|0|||
105658158|NCT01157377|364412037|FG003|Overall Study|Personal Reasons|1|||
105658159|NCT01157377|364412038|FG004|Overall Study|Personal Reasons|0|||
105658160|NCT01157377|364412039|FG005|Overall Study|Personal Reasons|0|||
105658161|NCT01157377|364412040|FG006|Overall Study|Personal Reasons|0|||
105658162|NCT01157377|364412034|FG000|Overall Study|Protocol Violation|0|||
105658163|NCT01157377|364412035|FG001|Overall Study|Protocol Violation|0|||
105658164|NCT01157377|364412036|FG002|Overall Study|Protocol Violation|0|||
105658165|NCT01157377|364412037|FG003|Overall Study|Protocol Violation|0|||
105658166|NCT01157377|364412038|FG004|Overall Study|Protocol Violation|0|||
105658167|NCT01157377|364412039|FG005|Overall Study|Protocol Violation|1|||
105658168|NCT01157377|364412040|FG006|Overall Study|Protocol Violation|0|||
105658169|NCT01157377|364412034|FG000|Overall Study|Lack of Efficacy|0|||
105658170|NCT01157377|364412035|FG001|Overall Study|Lack of Efficacy|0|||
105658171|NCT01157377|364412036|FG002|Overall Study|Lack of Efficacy|0|||
105658172|NCT01157377|364412037|FG003|Overall Study|Lack of Efficacy|0|||
105658173|NCT01157377|364412038|FG004|Overall Study|Lack of Efficacy|0|||
105658174|NCT01157377|364412039|FG005|Overall Study|Lack of Efficacy|0|||
105658175|NCT01157377|364412040|FG006|Overall Study|Lack of Efficacy|1|||
105658176|NCT01157377|364412034|FG000|Overall Study|Other Miscellaneous Reasons|0|||
105658177|NCT01157377|364412035|FG001|Overall Study|Other Miscellaneous Reasons|2|||
105658178|NCT01157377|364412036|FG002|Overall Study|Other Miscellaneous Reasons|0|||
105658179|NCT01157377|364412037|FG003|Overall Study|Other Miscellaneous Reasons|0|||
105658180|NCT01157377|364412038|FG004|Overall Study|Other Miscellaneous Reasons|1|||
105658181|NCT01157377|364412039|FG005|Overall Study|Other Miscellaneous Reasons|1|||
105658182|NCT01157377|364412040|FG006|Overall Study|Other Miscellaneous Reasons|1|||
105658183|NCT05523219|364412041|FG000|Overall Study|Wrong inclusion|1|||
105658184|NCT05523219|364412041|FG000|Overall Study|Lost to Follow-up|7|||
105658185|NCT01702519|364412042|FG000|Washout Period|Lost to Follow-up|1|||
105658186|NCT01702519|364412043|FG001|Washout Period|Lost to Follow-up|0|||
105658187|NCT01702519|364412042|FG000|Washout Period|Withdrawal by Subject|0|||
105658188|NCT01702519|364412043|FG001|Washout Period|Withdrawal by Subject|2|||
105658189|NCT00826228|364414115|FG000|Overall Study|Withdrawal by Subject|1|||
105658190|NCT03475056|364414116|FG000|Overall Study|Lost to Follow-up|0|||
105658191|NCT03475056|364414117|FG001|Overall Study|Lost to Follow-up|1|||
105658192|NCT03475056|364414116|FG000|Overall Study|Moved from Area|0|||
105658193|NCT03475056|364414117|FG001|Overall Study|Moved from Area|2|||
105658194|NCT02080403|364414118|FG000|Overall Study|Adverse Event|5|||
105658195|NCT02080403|364414119|FG001|Overall Study|Adverse Event|1|||
105658196|NCT02080403|364414118|FG000|Overall Study|Death|0|||
105658197|NCT02080403|364414119|FG001|Overall Study|Death|2|||
105658198|NCT02080403|364414118|FG000|Overall Study|Lost to Follow-up|2|||
105658199|NCT02080403|364414119|FG001|Overall Study|Lost to Follow-up|0|||
105658200|NCT02080403|364414118|FG000|Overall Study|Pregnancy|0|||
105658201|NCT02080403|364414119|FG001|Overall Study|Pregnancy|1|||
105658202|NCT02080403|364414118|FG000|Overall Study|Protocol Violation|3|||
105658203|NCT02080403|364414119|FG001|Overall Study|Protocol Violation|7|||
105658204|NCT02080403|364414118|FG000|Overall Study|Withdrawal by Subject|5|||
105658205|NCT02080403|364414119|FG001|Overall Study|Withdrawal by Subject|1|||
105658206|NCT01999972|364414120|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
105658207|NCT01999972|364414121|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
105658208|NCT01999972|364414122|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
105658209|NCT01999972|364414123|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
105658210|NCT01999972|364414124|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
105658211|NCT01999972|364414125|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
105658212|NCT01999972|364414120|FG000|Dose Escalation Part|Death|0|||
105658213|NCT01999972|364414121|FG001|Dose Escalation Part|Death|1|||
105658214|NCT01999972|364414122|FG002|Dose Escalation Part|Death|0|||
105658215|NCT01999972|364414123|FG003|Dose Escalation Part|Death|0|||
105658216|NCT01999972|364414124|FG004|Dose Escalation Part|Death|0|||
105658217|NCT01999972|364414125|FG005|Dose Escalation Part|Death|0|||
105658218|NCT01999972|364414120|FG000|Dose Escalation Part|Enrolled but not treated|0|||
105658219|NCT01999972|364414121|FG001|Dose Escalation Part|Enrolled but not treated|0|||
105658220|NCT01999972|364414122|FG002|Dose Escalation Part|Enrolled but not treated|1|||
105658221|NCT01999972|364414123|FG003|Dose Escalation Part|Enrolled but not treated|1|||
105658222|NCT01999972|364414124|FG004|Dose Escalation Part|Enrolled but not treated|0|||
105658223|NCT01999972|364414125|FG005|Dose Escalation Part|Enrolled but not treated|0|||
105658224|NCT01999972|364414120|FG000|Dose Escalation Part|Disease progression|3|||
105658225|NCT01999972|364414121|FG001|Dose Escalation Part|Disease progression|2|||
105658226|NCT01999972|364414122|FG002|Dose Escalation Part|Disease progression|3|||
105658227|NCT01999972|364414123|FG003|Dose Escalation Part|Disease progression|6|||
105658228|NCT01999972|364414124|FG004|Dose Escalation Part|Disease progression|0|||
105658229|NCT01999972|364414125|FG005|Dose Escalation Part|Disease progression|0|||
105658230|NCT01999972|364414120|FG000|Dose Escalation Part|Adverse Event|0|||
105658231|NCT01999972|364414121|FG001|Dose Escalation Part|Adverse Event|0|||
105658232|NCT01999972|364414122|FG002|Dose Escalation Part|Adverse Event|0|||
105658233|NCT01999972|364414123|FG003|Dose Escalation Part|Adverse Event|2|||
105658234|NCT01999972|364414124|FG004|Dose Escalation Part|Adverse Event|0|||
105658235|NCT01999972|364414125|FG005|Dose Escalation Part|Adverse Event|0|||
105658236|NCT01999972|364414120|FG000|Dose Escalation Part|Global deterioration of health status|1|||
105658237|NCT01999972|364414121|FG001|Dose Escalation Part|Global deterioration of health status|0|||
105658238|NCT01999972|364414122|FG002|Dose Escalation Part|Global deterioration of health status|0|||
105658239|NCT01999972|364414123|FG003|Dose Escalation Part|Global deterioration of health status|1|||
105658240|NCT01999972|364414124|FG004|Dose Escalation Part|Global deterioration of health status|0|||
105658241|NCT01999972|364414125|FG005|Dose Escalation Part|Global deterioration of health status|0|||
105658242|NCT01999972|364414120|FG000|Dose Expansion Part|Death|0|||
105658243|NCT01999972|364414121|FG001|Dose Expansion Part|Death|0|||
105658244|NCT01999972|364414122|FG002|Dose Expansion Part|Death|0|||
105658245|NCT01999972|364414123|FG003|Dose Expansion Part|Death|0|||
105658246|NCT01999972|364414124|FG004|Dose Expansion Part|Death|2|||
105658247|NCT01999972|364414125|FG005|Dose Expansion Part|Death|1|||
105658248|NCT01999972|364414120|FG000|Dose Expansion Part|Disease progression|0|||
105658249|NCT01999972|364414121|FG001|Dose Expansion Part|Disease progression|0|||
105658250|NCT01999972|364414122|FG002|Dose Expansion Part|Disease progression|0|||
105658251|NCT01999972|364414123|FG003|Dose Expansion Part|Disease progression|0|||
105658252|NCT01999972|364414124|FG004|Dose Expansion Part|Disease progression|9|||
105658253|NCT01999972|364414125|FG005|Dose Expansion Part|Disease progression|3|||
105658254|NCT01999972|364414120|FG000|Dose Expansion Part|Sponsor decision|0|||
105658255|NCT01999972|364414121|FG001|Dose Expansion Part|Sponsor decision|0|||
105658256|NCT01999972|364414122|FG002|Dose Expansion Part|Sponsor decision|0|||
105658257|NCT01999972|364414123|FG003|Dose Expansion Part|Sponsor decision|0|||
105658258|NCT01999972|364414124|FG004|Dose Expansion Part|Sponsor decision|1|||
105658259|NCT01999972|364414125|FG005|Dose Expansion Part|Sponsor decision|0|||
105658260|NCT01999972|364414120|FG000|Dose Expansion Part|Adverse Event|0|||
105658261|NCT01999972|364414121|FG001|Dose Expansion Part|Adverse Event|0|||
105658262|NCT01999972|364414122|FG002|Dose Expansion Part|Adverse Event|0|||
105658263|NCT01999972|364414123|FG003|Dose Expansion Part|Adverse Event|0|||
105658264|NCT01999972|364414124|FG004|Dose Expansion Part|Adverse Event|4|||
105658265|NCT01999972|364414125|FG005|Dose Expansion Part|Adverse Event|2|||
105658266|NCT01999972|364414120|FG000|Dose Expansion Part|Participant's non-compliance|0|||
105658267|NCT01999972|364414121|FG001|Dose Expansion Part|Participant's non-compliance|0|||
105658268|NCT01999972|364414122|FG002|Dose Expansion Part|Participant's non-compliance|0|||
105658269|NCT01999972|364414123|FG003|Dose Expansion Part|Participant's non-compliance|0|||
105658270|NCT01999972|364414124|FG004|Dose Expansion Part|Participant's non-compliance|0|||
105658271|NCT01999972|364414125|FG005|Dose Expansion Part|Participant's non-compliance|1|||
105658272|NCT01999972|364414120|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
105658273|NCT01999972|364414121|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
105658274|NCT01999972|364414122|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
105658275|NCT01999972|364414123|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
105658276|NCT01999972|364414124|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
105658277|NCT01999972|364414125|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
105658278|NCT01999972|364414120|FG000|Dose Expansion Part|Changed to standard of care|0|||
105658279|NCT01999972|364414121|FG001|Dose Expansion Part|Changed to standard of care|0|||
105658280|NCT01999972|364414122|FG002|Dose Expansion Part|Changed to standard of care|0|||
105658281|NCT01999972|364414123|FG003|Dose Expansion Part|Changed to standard of care|0|||
105658282|NCT01999972|364414124|FG004|Dose Expansion Part|Changed to standard of care|1|||
105658283|NCT01999972|364414125|FG005|Dose Expansion Part|Changed to standard of care|0|||
105658284|NCT02210208|364414126|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
105658285|NCT02210208|364414126|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
105658286|NCT02210208|364414126|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
105658287|NCT02826798|364414130|FG000|Overall Study|Withdrawal by Subject|0|||
105658288|NCT02826798|364414131|FG001|Overall Study|Withdrawal by Subject|1|||
105658289|NCT02826798|364414132|FG002|Overall Study|Withdrawal by Subject|0|||
105658290|NCT02826798|364414133|FG003|Overall Study|Withdrawal by Subject|1|||
105658291|NCT02826798|364414134|FG004|Overall Study|Withdrawal by Subject|0|||
105658292|NCT02202109|364414135|FG000|Overall Study|Lost to Follow-up|88|||
105658293|NCT02202109|364414136|FG001|Overall Study|Lost to Follow-up|87|||
105658294|NCT02202109|364414135|FG000|Overall Study|Withdrawal by Subject|2|||
105658295|NCT02202109|364414136|FG001|Overall Study|Withdrawal by Subject|0|||
105658296|NCT01722045|364414140|FG000|Overall Study|Adverse Event|8|||
105658297|NCT01722045|364414140|FG000|Overall Study|Death|3|||
105658298|NCT01722045|364414140|FG000|Overall Study|Withdrawal by Subject|8|||
105658299|NCT01722045|364414140|FG000|Overall Study|Lost to Follow-up|4|||
105658300|NCT01722045|364414140|FG000|Overall Study|Protocol Deviation|1|||
105658301|NCT01722045|364414140|FG000|Overall Study|Physician Decision|3|||
105658302|NCT01722045|364414140|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
105658303|NCT01333111|364414141|FG000|Overall Study|patient undergoing major surgery|0|||
105658304|NCT01333111|364414142|FG001|Overall Study|patient undergoing major surgery|2|||
105658305|NCT01333111|364414143|FG002|Overall Study|patient undergoing major surgery|0|||
105658306|NCT01333111|364414141|FG000|Overall Study|personal reasons|0|||
105658307|NCT01333111|364414142|FG001|Overall Study|personal reasons|0|||
105658308|NCT01333111|364414143|FG002|Overall Study|personal reasons|1|||
105658309|NCT01333111|364414141|FG000|Overall Study|unclassified|1|||
105658310|NCT01333111|364414142|FG001|Overall Study|unclassified|0|||
105658311|NCT01333111|364414143|FG002|Overall Study|unclassified|0|||
105658312|NCT01333111|364414141|FG000|Overall Study|withdrawal criteria|0|||
105658313|NCT01333111|364414142|FG001|Overall Study|withdrawal criteria|1|||
105658314|NCT01333111|364414143|FG002|Overall Study|withdrawal criteria|0|||
105658315|NCT01333111|364414141|FG000|Overall Study|Non-compliance|1|||
105658316|NCT01333111|364414142|FG001|Overall Study|Non-compliance|0|||
105658317|NCT01333111|364414143|FG002|Overall Study|Non-compliance|0|||
105658318|NCT01333111|364414141|FG000|Overall Study|Ineffective therapy|0|||
105658319|NCT01333111|364414142|FG001|Overall Study|Ineffective therapy|0|||
105658320|NCT01333111|364414143|FG002|Overall Study|Ineffective therapy|1|||
105658321|NCT00612352|364414144|FG000|Overall Study|Adverse Event|1|||
105658322|NCT00612352|364414145|FG001|Overall Study|Adverse Event|0|||
105658323|NCT00612352|364414144|FG000|Overall Study|Withdrawal by Subject|3|||
105658324|NCT00612352|364414145|FG001|Overall Study|Withdrawal by Subject|5|||
105658325|NCT00612352|364414144|FG000|Overall Study|moved out of state|1|||
105658326|NCT00612352|364414145|FG001|Overall Study|moved out of state|0|||
105658327|NCT00612352|364414144|FG000|Overall Study|didn't return calls/show up on test date|4|||
105658328|NCT00612352|364414145|FG001|Overall Study|didn't return calls/show up on test date|1|||
105658329|NCT00760513|364414150|FG000|Overall Study|Withdrawal by Subject|5|||
105658330|NCT00760513|364414151|FG001|Overall Study|Withdrawal by Subject|7|||
105658331|NCT00908349|364414152|FG000|Overall Study|Adverse Event|10|||
105658332|NCT00908349|364414152|FG000|Overall Study|Withdrawal by Subject|9|||
105658333|NCT00908349|364414152|FG000|Overall Study|Physician Decision|5|||
105658334|NCT00908349|364414152|FG000|Overall Study|Lost to Follow-up|5|||
105658335|NCT00908349|364414152|FG000|Overall Study|Various|6|||
105658336|NCT04523207|364414154|FG000|Overall Study|Adverse Event|5|||
105658337|NCT04523207|364414155|FG001|Overall Study|Adverse Event|1|||
105658338|NCT04523207|364414154|FG000|Overall Study|Lost to Follow-up|2|||
105658339|NCT04523207|364414155|FG001|Overall Study|Lost to Follow-up|0|||
105658340|NCT04523207|364414154|FG000|Overall Study|Withdrawal by Subject|2|||
105658341|NCT04523207|364414155|FG001|Overall Study|Withdrawal by Subject|0|||
105658342|NCT04523207|364414154|FG000|Overall Study|Progressive Disease|2|||
105658343|NCT04523207|364414155|FG001|Overall Study|Progressive Disease|1|||
105658344|NCT04523207|364414154|FG000|Overall Study|Other|7|||
105658345|NCT04523207|364414155|FG001|Overall Study|Other|1|||
105658346|NCT00487552|364414156|FG000|Overall Study|Unsuccessful magnet placements|3|||
105658347|NCT00487552|364414156|FG000|Overall Study|Death due to progressive malignancy|2|||
105658348|NCT00487552|364414156|FG000|Overall Study|Stent not placed|1|||
105658349|NCT02412111|364414157|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
105658350|NCT02412111|364414158|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
105658351|NCT02412111|364414159|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
105658352|NCT02412111|364414157|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
105658353|NCT02412111|364414158|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
105658354|NCT02412111|364414159|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
105658355|NCT02412111|364414157|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
105658356|NCT02412111|364414158|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
105658357|NCT02412111|364414159|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
105658358|NCT02412111|364414157|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
105658359|NCT02412111|364414158|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
105658360|NCT02412111|364414159|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
105658361|NCT02412111|364414157|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
105658362|NCT02412111|364414158|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
105658363|NCT02412111|364414159|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
105658364|NCT02412111|364414157|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
105658365|NCT02412111|364414158|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
105658366|NCT02412111|364414159|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
105658367|NCT02412111|364414157|FG000|Active Comparator Period (8 Weeks)|Other|0|||
105658368|NCT02412111|364414158|FG001|Active Comparator Period (8 Weeks)|Other|0|||
105658369|NCT02412111|364414159|FG002|Active Comparator Period (8 Weeks)|Other|2|||
105658370|NCT00320398|364414160|FG000|Overall Study|Adverse Event|1|||
105658371|NCT00320398|364414161|FG001|Overall Study|Adverse Event|4|||
105658372|NCT00320398|364414160|FG000|Overall Study|Other|1|||
105658373|NCT00320398|364414161|FG001|Overall Study|Other|0|||
105658374|NCT04702893|364414162|FG000|Overall Study|Other reasons than listed|11|||
105658375|NCT04702893|364414162|FG000|Overall Study|Withdrawal by Subject|3|||
105658376|NCT04702893|364414162|FG000|Overall Study|Lost to Follow-up|7|||
105658377|NCT04702893|364414162|FG000|Overall Study|Death|10|||
105658378|NCT04702893|364414162|FG000|Overall Study|Not treated|6|||
105658379|NCT04469465|364414163|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
105658380|NCT04469465|364414164|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
105658381|NCT04469465|364414163|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
105658382|NCT04469465|364414164|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
105658383|NCT04469465|364414163|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
105658384|NCT04469465|364414164|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
105658385|NCT04469465|364414163|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
105658386|NCT04469465|364414164|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
105658387|NCT04469465|364414163|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
105658388|NCT04469465|364414164|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
105658389|NCT04469465|364414163|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
105658390|NCT04469465|364414164|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
105658391|NCT04469465|364414163|FG000|Long-Term Extension (LTE)|Death|0|||
105658392|NCT04469465|364414164|FG001|Long-Term Extension (LTE)|Death|1|||
105658393|NCT04469465|364414163|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
105658394|NCT04469465|364414164|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
105658395|NCT04190225|364414165|FG000|Overall Study|Lost to Follow-up|2|||
105658396|NCT04190225|364414166|FG001|Overall Study|Lost to Follow-up|3|||
105658397|NCT04190225|364414165|FG000|Overall Study|Withdrawal by Subject|3|||
105658398|NCT04190225|364414166|FG001|Overall Study|Withdrawal by Subject|2|||
105658399|NCT04190225|364414165|FG000|Overall Study|Unrelated health condition|2|||
105658400|NCT04190225|364414166|FG001|Overall Study|Unrelated health condition|0|||
105658401|NCT02624869|364414169|FG000|Overall Study|Lost to Follow-up|0|||
105658402|NCT02624869|364414170|FG001|Overall Study|Lost to Follow-up|0|||
105658403|NCT02624869|364414171|FG002|Overall Study|Lost to Follow-up|1|||
105658404|NCT02624869|364414169|FG000|Overall Study|Withdrawal by Subject|1|||
105658405|NCT02624869|364414170|FG001|Overall Study|Withdrawal by Subject|3|||
105658406|NCT02624869|364414171|FG002|Overall Study|Withdrawal by Subject|1|||
105658407|NCT02994784|364414172|FG000|6 Months Follow-up|Lost to Follow-up|3|||
105658408|NCT04238520|364414174|FG000|Overall Study|Withdrawal by Subject|1|||
105658409|NCT04238520|364414175|FG001|Overall Study|Withdrawal by Subject|1|||
105658410|NCT04238520|364414174|FG000|Overall Study|Lost to Follow-up|1|||
105658411|NCT04238520|364414175|FG001|Overall Study|Lost to Follow-up|2|||
105658412|NCT04238520|364414174|FG000|Overall Study|Death|0|||
105658413|NCT04238520|364414175|FG001|Overall Study|Death|2|||
105658414|NCT04238520|364414174|FG000|Overall Study|Unsafe home environment for research staff|0|||
105658415|NCT04238520|364414175|FG001|Overall Study|Unsafe home environment for research staff|1|||
105658416|NCT01470599|364414176|FG000|Overall Study|Did not meet entrance criteria|1|||
105658417|NCT01470599|364414177|FG001|Overall Study|Did not meet entrance criteria|0|||
105658418|NCT01470599|364414176|FG000|Overall Study|Lost to Follow-up|2|||
105658419|NCT01470599|364414177|FG001|Overall Study|Lost to Follow-up|1|||
105658420|NCT01470599|364414176|FG000|Overall Study|Withdrawal by Subject|3|||
105658421|NCT01470599|364414177|FG001|Overall Study|Withdrawal by Subject|4|||
105658422|NCT01470599|364414176|FG000|Overall Study|Other|1|||
105658423|NCT01470599|364414177|FG001|Overall Study|Other|0|||
105658424|NCT01470599|364414176|FG000|Overall Study|Protocol Violation|3|||
105658425|NCT01470599|364414177|FG001|Overall Study|Protocol Violation|1|||
105658426|NCT01470599|364414176|FG000|Overall Study|Adverse event related to study drug|2|||
105658427|NCT01470599|364414177|FG001|Overall Study|Adverse event related to study drug|5|||
105658428|NCT01470599|364414176|FG000|Overall Study|Insufficient clinical response|6|||
105658429|NCT01470599|364414177|FG001|Overall Study|Insufficient clinical response|27|||
105658430|NCT01470599|364414176|FG000|Overall Study|Adverse event not related to study drug|1|||
105658431|NCT01470599|364414177|FG001|Overall Study|Adverse event not related to study drug|5|||
105658432|NCT01917006|364414178|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
105658433|NCT01917006|364414179|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
105658434|NCT01917006|364414180|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
105658435|NCT01917006|364414181|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
105658436|NCT01917006|364414182|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
105658437|NCT01917006|364414183|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
105658438|NCT01917006|364414184|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
105658439|NCT01917006|364414185|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
105658440|NCT01917006|364414178|FG000|Randomized-treatment Period|Personal Reasons|0|||
105658441|NCT01917006|364414179|FG001|Randomized-treatment Period|Personal Reasons|0|||
105658442|NCT01917006|364414180|FG002|Randomized-treatment Period|Personal Reasons|0|||
105658443|NCT01917006|364414181|FG003|Randomized-treatment Period|Personal Reasons|0|||
105658444|NCT01917006|364414182|FG004|Randomized-treatment Period|Personal Reasons|0|||
105658445|NCT01917006|364414183|FG005|Randomized-treatment Period|Personal Reasons|1|||
105658446|NCT01917006|364414184|FG006|Randomized-treatment Period|Personal Reasons|0|||
105658447|NCT01917006|364414185|FG007|Randomized-treatment Period|Personal Reasons|0|||
105658448|NCT01917006|364414178|FG000|Randomized-treatment Period|Protocol Violation|1|||
105658449|NCT01917006|364414179|FG001|Randomized-treatment Period|Protocol Violation|0|||
105658450|NCT01917006|364414180|FG002|Randomized-treatment Period|Protocol Violation|0|||
105658451|NCT01917006|364414181|FG003|Randomized-treatment Period|Protocol Violation|0|||
105658452|NCT01917006|364414182|FG004|Randomized-treatment Period|Protocol Violation|0|||
105658453|NCT01917006|364414183|FG005|Randomized-treatment Period|Protocol Violation|0|||
105658454|NCT01917006|364414184|FG006|Randomized-treatment Period|Protocol Violation|0|||
105658455|NCT01917006|364414185|FG007|Randomized-treatment Period|Protocol Violation|0|||
105658456|NCT01917006|364414178|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
105658457|NCT01917006|364414179|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
105658458|NCT01917006|364414180|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
105658459|NCT01917006|364414181|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
105658460|NCT01917006|364414182|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
105658461|NCT01917006|364414183|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
105658462|NCT01917006|364414184|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
105658463|NCT01917006|364414185|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
105658464|NCT01917006|364414178|FG000|Open-label Period|Adverse Event|0|||
105658465|NCT01917006|364414179|FG001|Open-label Period|Adverse Event|0|||
105658466|NCT01917006|364414180|FG002|Open-label Period|Adverse Event|0|||
105658467|NCT01917006|364414181|FG003|Open-label Period|Adverse Event|0|||
105658468|NCT01917006|364414182|FG004|Open-label Period|Adverse Event|0|||
105658469|NCT01917006|364414183|FG005|Open-label Period|Adverse Event|0|||
105658470|NCT01917006|364414184|FG006|Open-label Period|Adverse Event|0|||
105658471|NCT01917006|364414185|FG007|Open-label Period|Adverse Event|1|||
105658472|NCT01917006|364414178|FG000|Open-label Period|Lost to Follow-up|0|||
105658473|NCT01917006|364414179|FG001|Open-label Period|Lost to Follow-up|0|||
105658474|NCT01917006|364414180|FG002|Open-label Period|Lost to Follow-up|0|||
105658475|NCT01917006|364414181|FG003|Open-label Period|Lost to Follow-up|0|||
105658476|NCT01917006|364414182|FG004|Open-label Period|Lost to Follow-up|0|||
105658477|NCT01917006|364414183|FG005|Open-label Period|Lost to Follow-up|0|||
105658478|NCT01917006|364414184|FG006|Open-label Period|Lost to Follow-up|0|||
105658479|NCT01917006|364414185|FG007|Open-label Period|Lost to Follow-up|1|||
105658480|NCT02447432|364414188|FG000|Epoch 001|Adverse Event|1|||
105658481|NCT02447432|364414189|FG001|Epoch 001|Adverse Event|1|||
105658482|NCT02447432|364414188|FG000|Epoch 001|Withdrawal by Subject|0|||
105658483|NCT02447432|364414189|FG001|Epoch 001|Withdrawal by Subject|4|||
105658484|NCT02447432|364414188|FG000|Epoch 001|Migrated/moved from study area|3|||
105658485|NCT02447432|364414189|FG001|Epoch 001|Migrated/moved from study area|5|||
105658486|NCT02447432|364414188|FG000|Epoch 001|Lost to Follow-up|1|||
105658487|NCT02447432|364414189|FG001|Epoch 001|Lost to Follow-up|3|||
105658488|NCT00719043|364414190|FG000|Overall Study|Adverse Event|5|||
105658489|NCT00719043|364414191|FG001|Overall Study|Adverse Event|1|||
105658490|NCT00719043|364414192|FG002|Overall Study|Adverse Event|2|||
105658491|NCT00719043|364414193|FG003|Overall Study|Adverse Event|2|||
105658492|NCT00719043|364414194|FG004|Overall Study|Adverse Event|1|||
105658493|NCT00719043|364414195|FG005|Overall Study|Adverse Event|4|||
105658494|NCT00719043|364414196|FG006|Overall Study|Adverse Event|4|||
105658495|NCT00719043|364414190|FG000|Overall Study|Lost to Follow-up|14|||
105658496|NCT00719043|364414191|FG001|Overall Study|Lost to Follow-up|10|||
105658497|NCT00719043|364414192|FG002|Overall Study|Lost to Follow-up|8|||
105658498|NCT00719043|364414193|FG003|Overall Study|Lost to Follow-up|9|||
105658499|NCT00719043|364414194|FG004|Overall Study|Lost to Follow-up|10|||
105658500|NCT00719043|364414195|FG005|Overall Study|Lost to Follow-up|9|||
105658501|NCT00719043|364414196|FG006|Overall Study|Lost to Follow-up|9|||
105658502|NCT00719043|364414190|FG000|Overall Study|Protocol Violation|0|||
105658503|NCT00719043|364414191|FG001|Overall Study|Protocol Violation|0|||
105658504|NCT00719043|364414192|FG002|Overall Study|Protocol Violation|0|||
105658505|NCT00719043|364414193|FG003|Overall Study|Protocol Violation|0|||
105658506|NCT00719043|364414194|FG004|Overall Study|Protocol Violation|0|||
105658507|NCT00719043|364414195|FG005|Overall Study|Protocol Violation|1|||
105658508|NCT00719043|364414196|FG006|Overall Study|Protocol Violation|0|||
105658509|NCT00719043|364414190|FG000|Overall Study|Other|1|||
105658510|NCT00719043|364414191|FG001|Overall Study|Other|0|||
105658511|NCT00719043|364414192|FG002|Overall Study|Other|1|||
105658512|NCT00719043|364414193|FG003|Overall Study|Other|2|||
105658513|NCT00719043|364414194|FG004|Overall Study|Other|0|||
105658514|NCT00719043|364414195|FG005|Overall Study|Other|2|||
105658515|NCT00719043|364414196|FG006|Overall Study|Other|1|||
105658516|NCT00719043|364414190|FG000|Overall Study|Withdrawal by Subject|12|||
105658517|NCT00719043|364414191|FG001|Overall Study|Withdrawal by Subject|14|||
105658518|NCT00719043|364414192|FG002|Overall Study|Withdrawal by Subject|9|||
105658519|NCT00719043|364414193|FG003|Overall Study|Withdrawal by Subject|10|||
105658520|NCT00719043|364414194|FG004|Overall Study|Withdrawal by Subject|16|||
105658521|NCT00719043|364414195|FG005|Overall Study|Withdrawal by Subject|18|||
105658522|NCT00719043|364414196|FG006|Overall Study|Withdrawal by Subject|14|||
105658523|NCT00813098|364414197|FG000|Overall Study|Adverse Event|2|||
105658524|NCT00813098|364414198|FG001|Overall Study|Adverse Event|4|||
105658525|NCT00813098|364414199|FG002|Overall Study|Adverse Event|1|||
105658526|NCT00813098|364414197|FG000|Overall Study|Withdrawal by Subject|0|||
105658527|NCT00813098|364414198|FG001|Overall Study|Withdrawal by Subject|1|||
105658528|NCT00813098|364414199|FG002|Overall Study|Withdrawal by Subject|0|||
105658529|NCT00813098|364414197|FG000|Overall Study|Inability to complete study procedures|1|||
105658530|NCT00813098|364414198|FG001|Overall Study|Inability to complete study procedures|0|||
105658531|NCT00813098|364414199|FG002|Overall Study|Inability to complete study procedures|0|||
105658532|NCT00813098|364414197|FG000|Overall Study|Lost to Follow-up|0|||
105658533|NCT00813098|364414198|FG001|Overall Study|Lost to Follow-up|1|||
105658534|NCT00813098|364414199|FG002|Overall Study|Lost to Follow-up|0|||
105658535|NCT00813098|364414197|FG000|Overall Study|Protocol Violation|0|||
105658536|NCT00813098|364414198|FG001|Overall Study|Protocol Violation|0|||
105658537|NCT00813098|364414199|FG002|Overall Study|Protocol Violation|1|||
105658538|NCT00813098|364414197|FG000|Overall Study|Principal Investigator decision|0|||
105658539|NCT00813098|364414198|FG001|Overall Study|Principal Investigator decision|1|||
105658540|NCT00813098|364414199|FG002|Overall Study|Principal Investigator decision|0|||
105658541|NCT00813098|364414197|FG000|Overall Study|Withdrew Consent|0|||
105658542|NCT00813098|364414198|FG001|Overall Study|Withdrew Consent|1|||
105658543|NCT00813098|364414199|FG002|Overall Study|Withdrew Consent|0|||
105658544|NCT00776659|364414205|FG000|Overall Study|Lost to Follow-up|15|||
105658545|NCT00776659|364414205|FG000|Overall Study|Withdrawal by Subject|10|||
105658546|NCT00776659|364414205|FG000|Overall Study|Study Terminated by Sponsor|1|||
105658547|NCT01336205|364414212|FG000|Overall Study|Other|22|||
105658548|NCT01336205|364414213|FG001|Overall Study|Other|9|||
105658549|NCT01336205|364414212|FG000|Overall Study|Lost to Follow-up|40|||
105658550|NCT01336205|364414213|FG001|Overall Study|Lost to Follow-up|20|||
105658551|NCT01336205|364414212|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
105658552|NCT01336205|364414213|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
105658553|NCT01336205|364414212|FG000|Overall Study|Lack of Efficacy|4|||
105658554|NCT01336205|364414213|FG001|Overall Study|Lack of Efficacy|0|||
105658555|NCT01336205|364414212|FG000|Overall Study|Severe noncompliance with protocol|9|||
105658556|NCT01336205|364414213|FG001|Overall Study|Severe noncompliance with protocol|2|||
105658557|NCT01336205|364414212|FG000|Overall Study|Adverse Event|56|||
105658558|NCT01336205|364414213|FG001|Overall Study|Adverse Event|6|||
105658559|NCT01336205|364414212|FG000|Overall Study|Death|1|||
105658560|NCT01336205|364414213|FG001|Overall Study|Death|1|||
105658561|NCT01336205|364414212|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
105658562|NCT01336205|364414213|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
105658563|NCT01336205|364414212|FG000|Overall Study|Withdrawal by Subject|72|||
105658564|NCT01336205|364414213|FG001|Overall Study|Withdrawal by Subject|38|||
105658565|NCT01336205|364414212|FG000|Overall Study|Did not receive treatment|4|||
105658566|NCT01336205|364414213|FG001|Overall Study|Did not receive treatment|0|||
105658567|NCT01006616|364414214|FG000|Period 1 (6 Months)|Adverse Event|10|||
105658568|NCT01006616|364414215|FG001|Period 1 (6 Months)|Adverse Event|31|||
105658569|NCT01006616|364414216|FG002|Period 1 (6 Months)|Adverse Event|37|||
105658570|NCT01006616|364414217|FG003|Period 1 (6 Months)|Adverse Event|9|||
105658571|NCT01006616|364414214|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
105658572|NCT01006616|364414215|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
105658573|NCT01006616|364414216|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
105658574|NCT01006616|364414217|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
105658575|NCT01006616|364414214|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
105658576|NCT01006616|364414215|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
105658577|NCT01006616|364414216|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
105658578|NCT01006616|364414217|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
105658579|NCT01006616|364414214|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
105658580|NCT01006616|364414215|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
105658581|NCT01006616|364414216|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
105658582|NCT01006616|364414217|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
105658583|NCT01006616|364414214|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
105658584|NCT01006616|364414215|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
105658585|NCT01006616|364414216|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
105658586|NCT01006616|364414217|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
105658587|NCT01006616|364414214|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
105658588|NCT01006616|364414215|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
105658589|NCT01006616|364414216|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
105658590|NCT01006616|364414217|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
105658591|NCT01006616|364414214|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
105658592|NCT01006616|364414215|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
105658593|NCT01006616|364414216|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
105658594|NCT01006616|364414217|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
105658595|NCT01006616|364414214|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
105658596|NCT01006616|364414215|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
105658597|NCT01006616|364414216|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
105658598|NCT01006616|364414217|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
105658599|NCT01006616|364414214|FG000|Period 1 (6 Months)|Not Treated|0|||
105658600|NCT01006616|364414215|FG001|Period 1 (6 Months)|Not Treated|0|||
105658601|NCT01006616|364414216|FG002|Period 1 (6 Months)|Not Treated|1|||
105658602|NCT01006616|364414217|FG003|Period 1 (6 Months)|Not Treated|1|||
105658603|NCT01006616|364414214|FG000|Period 2 (18 Months)|Adverse Event|6|||
105658604|NCT01006616|364414215|FG001|Period 2 (18 Months)|Adverse Event|6|||
105658605|NCT01006616|364414216|FG002|Period 2 (18 Months)|Adverse Event|6|||
105658606|NCT01006616|364414217|FG003|Period 2 (18 Months)|Adverse Event|4|||
105658607|NCT01006616|364414214|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
105658608|NCT01006616|364414215|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
105658609|NCT01006616|364414216|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
105658610|NCT01006616|364414217|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
105658611|NCT01006616|364414214|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
105658612|NCT01006616|364414215|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
105658613|NCT01006616|364414216|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
105658614|NCT01006616|364414217|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
105658615|NCT01006616|364414214|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
105658616|NCT01006616|364414215|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
105658617|NCT01006616|364414216|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
105658618|NCT01006616|364414217|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
105658619|NCT01006616|364414214|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
105658620|NCT01006616|364414215|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
105658621|NCT01006616|364414216|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
105658622|NCT01006616|364414217|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
105658623|NCT01006616|364414214|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
105658624|NCT01006616|364414215|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
105658625|NCT01006616|364414216|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
105658626|NCT01006616|364414217|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
105658627|NCT01006616|364414214|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
105658628|NCT01006616|364414215|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
105658629|NCT01006616|364414216|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
105658630|NCT01006616|364414217|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
105658631|NCT01006616|364414214|FG000|Period 2 (18 Months)|Study Terminated|63|||
105658632|NCT01006616|364414215|FG001|Period 2 (18 Months)|Study Terminated|46|||
105658633|NCT01006616|364414216|FG002|Period 2 (18 Months)|Study Terminated|44|||
105658634|NCT01006616|364414217|FG003|Period 2 (18 Months)|Study Terminated|70|||
105658635|NCT03672175|364414218|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
105658636|NCT03672175|364414219|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
105658637|NCT03672175|364414220|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
105658638|NCT03672175|364414218|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
105658639|NCT03672175|364414219|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
105658640|NCT03672175|364414220|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
105658641|NCT03672175|364414218|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
105658642|NCT03672175|364414219|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
105658643|NCT03672175|364414220|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
105658644|NCT03672175|364414218|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
105658645|NCT03672175|364414219|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
105658646|NCT03672175|364414220|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
105658647|NCT03672175|364414218|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
105658648|NCT03672175|364414219|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
105658649|NCT03672175|364414220|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
105658650|NCT03672175|364414218|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
105658651|NCT03672175|364414219|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
105658652|NCT03672175|364414220|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
105658653|NCT03672175|364414218|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
105658654|NCT03672175|364414219|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
105658655|NCT03672175|364414220|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
105658656|NCT03672175|364414218|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
105658657|NCT03672175|364414219|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
105658658|NCT03672175|364414220|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
105658659|NCT03672175|364414218|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
105658660|NCT03672175|364414219|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
105658661|NCT03672175|364414220|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
105658662|NCT03672175|364414218|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
105658663|NCT03672175|364414219|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
105658664|NCT03672175|364414220|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
105658665|NCT03672175|364414218|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
105658666|NCT03672175|364414219|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
105658667|NCT03672175|364414220|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
105658668|NCT03672175|364414218|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
105658669|NCT03672175|364414219|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
105658670|NCT03672175|364414220|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
105658671|NCT00129649|364414221|FG000|Overall Study|Withdrawal by Subject|76|||
105658672|NCT00129649|364414222|FG001|Overall Study|Withdrawal by Subject|65|||
105658673|NCT02482935|364414226|FG000|Period 1|Withdrawal by Subject|1|||
105658674|NCT02482935|364414227|FG001|Period 1|Withdrawal by Subject|0|||
105658675|NCT02835092|364414228|FG000|Overall Study|Withdrawal by Subject|3|||
105658676|NCT02835092|364414229|FG001|Overall Study|Withdrawal by Subject|6|||
105658677|NCT02835092|364414230|FG002|Overall Study|Withdrawal by Subject|3|||
105658678|NCT02835092|364414228|FG000|Overall Study|Lost to Follow-up|0|||
105658679|NCT02835092|364414229|FG001|Overall Study|Lost to Follow-up|2|||
105658680|NCT02835092|364414230|FG002|Overall Study|Lost to Follow-up|0|||
105658681|NCT04952701|364414231|FG000|Control Lens|Physician Decision|4|||
105658682|NCT04952701|364414231|FG000|Test Lens|Physician Decision|1|||
105658683|NCT00905034|364414233|FG000|Overall Study|Withdrawal by Subject|1|||
105658684|NCT03409731|364414234|FG000|Overall Study|Withdrawal by Subject|17|||
105658685|NCT03409731|364414234|FG000|Overall Study|Death|4|||
105658686|NCT00217022|364414235|FG000|Overall Study|Withdrawal by Subject|1|||
105658687|NCT00217022|364414236|FG001|Overall Study|Withdrawal by Subject|1|||
105658688|NCT02725567|364414240|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
105658689|NCT02725567|364414241|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
105658690|NCT02725567|364414240|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
105658691|NCT02725567|364414241|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
105658692|NCT02725567|364414240|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
105658693|NCT02725567|364414241|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
105658694|NCT00878553|364414242|FG000|Sleep Study|Withdrawal by Subject|2|||
105658695|NCT00878553|364414243|FG001|Sleep Study|Withdrawal by Subject|0|||
105658696|NCT00878553|364414244|FG002|Sleep Study|Withdrawal by Subject|0|||
105658697|NCT00878553|364414245|FG003|Sleep Study|Withdrawal by Subject|0|||
105658698|NCT00878553|364414246|FG004|Sleep Study|Withdrawal by Subject|0|||
105658699|NCT00878553|364414242|FG000|Sleep Study|Lost to Follow-up|1|||
105658700|NCT00878553|364414243|FG001|Sleep Study|Lost to Follow-up|0|||
105658701|NCT00878553|364414244|FG002|Sleep Study|Lost to Follow-up|0|||
105658702|NCT00878553|364414245|FG003|Sleep Study|Lost to Follow-up|0|||
105658703|NCT00878553|364414246|FG004|Sleep Study|Lost to Follow-up|0|||
105658704|NCT00878553|364414242|FG000|Sleep Study|car accident|1|||
105658705|NCT00878553|364414243|FG001|Sleep Study|car accident|0|||
105658706|NCT00878553|364414244|FG002|Sleep Study|car accident|0|||
105658707|NCT00878553|364414245|FG003|Sleep Study|car accident|0|||
105658708|NCT00878553|364414246|FG004|Sleep Study|car accident|0|||
105658709|NCT00878553|364414242|FG000|Sleep Study|family emergency|1|||
105658710|NCT00878553|364414243|FG001|Sleep Study|family emergency|0|||
105658711|NCT00878553|364414244|FG002|Sleep Study|family emergency|0|||
105658712|NCT00878553|364414245|FG003|Sleep Study|family emergency|0|||
105658713|NCT00878553|364414246|FG004|Sleep Study|family emergency|0|||
105658714|NCT00878553|364414242|FG000|PK Study|Withdrawal by Subject|0|||
105658715|NCT00878553|364414243|FG001|PK Study|Withdrawal by Subject|0|||
105658716|NCT00878553|364414244|FG002|PK Study|Withdrawal by Subject|0|||
105658717|NCT00878553|364414245|FG003|PK Study|Withdrawal by Subject|1|||
105658718|NCT00878553|364414246|FG004|PK Study|Withdrawal by Subject|0|||
105658719|NCT00912223|364414247|FG000|Overall Study|Withdrawal by Subject|1|||
105658720|NCT00912223|364414247|FG000|Overall Study|Not transplanted|1|||
105658721|NCT00912223|364414247|FG000|Overall Study|Transformed disease|1|||
105658722|NCT00623363|364414248|FG000|Overall Study|Adverse Event|2|||
105658723|NCT00623363|364414249|FG001|Overall Study|Adverse Event|2|||
105658724|NCT00621192|364414250|FG000|Overall Study|Withdrawal by Subject|0|||
105658725|NCT00621192|364414251|FG001|Overall Study|Withdrawal by Subject|0|||
105658726|NCT00621192|364414252|FG002|Overall Study|Withdrawal by Subject|2|||
105658727|NCT00621192|364414253|FG003|Overall Study|Withdrawal by Subject|0|||
105658728|NCT00621192|364414250|FG000|Overall Study|Physician Decision|1|||
105658729|NCT00621192|364414251|FG001|Overall Study|Physician Decision|3|||
105658730|NCT00621192|364414252|FG002|Overall Study|Physician Decision|0|||
105658731|NCT00621192|364414253|FG003|Overall Study|Physician Decision|0|||
105658732|NCT00621192|364414250|FG000|Overall Study|Protocol Violation|1|||
105658733|NCT00621192|364414251|FG001|Overall Study|Protocol Violation|0|||
105658734|NCT00621192|364414252|FG002|Overall Study|Protocol Violation|0|||
105658735|NCT00621192|364414253|FG003|Overall Study|Protocol Violation|1|||
105658736|NCT00621192|364414250|FG000|Overall Study|Adverse Event|0|||
105658737|NCT00621192|364414251|FG001|Overall Study|Adverse Event|1|||
105658738|NCT00621192|364414252|FG002|Overall Study|Adverse Event|0|||
105658739|NCT00621192|364414253|FG003|Overall Study|Adverse Event|1|||
105658740|NCT00621192|364414250|FG000|Overall Study|Death|2|||
105658741|NCT00621192|364414251|FG001|Overall Study|Death|5|||
105658742|NCT00621192|364414252|FG002|Overall Study|Death|0|||
105658743|NCT00621192|364414253|FG003|Overall Study|Death|0|||
105658744|NCT00621192|364414250|FG000|Overall Study|Final Assessments not Completed|0|||
105658745|NCT00621192|364414251|FG001|Overall Study|Final Assessments not Completed|0|||
105658746|NCT00621192|364414252|FG002|Overall Study|Final Assessments not Completed|3|||
105658747|NCT00621192|364414253|FG003|Overall Study|Final Assessments not Completed|1|||
105658748|NCT02725528|364414254|FG000|Overall Study|Lost to Follow-up|1|||
105658749|NCT02725528|364414255|FG001|Overall Study|Lost to Follow-up|4|||
105658750|NCT02725528|364414254|FG000|Overall Study|Withdrawal by Subject|0|||
105658751|NCT02725528|364414255|FG001|Overall Study|Withdrawal by Subject|1|||
105658752|NCT01781832|364414256|FG000|Overall Study|Withdrawal by Subject|1|||
105658753|NCT01163474|364414257|FG000|Overall Study|Withdrawal by Subject|1|||
105658754|NCT01163474|364414257|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
105658755|NCT01163474|364414257|FG000|Overall Study|Lost to Follow-up|3|||
105658756|NCT00087555|364414258|FG000|Overall Study|Adverse Event|3|||
105658757|NCT00087555|364414259|FG001|Overall Study|Adverse Event|6|||
105658758|NCT00087555|364414260|FG002|Overall Study|Adverse Event|14|||
105658759|NCT00087555|364414258|FG000|Overall Study|Lost to Follow-up|0|||
105658760|NCT00087555|364414259|FG001|Overall Study|Lost to Follow-up|1|||
105658761|NCT00087555|364414260|FG002|Overall Study|Lost to Follow-up|1|||
105658762|NCT00087555|364414258|FG000|Overall Study|Non - Compliance|1|||
105658763|NCT00087555|364414259|FG001|Overall Study|Non - Compliance|0|||
105658764|NCT00087555|364414260|FG002|Overall Study|Non - Compliance|0|||
105658765|NCT00087555|364414258|FG000|Overall Study|Protocol Violation|0|||
105658766|NCT00087555|364414259|FG001|Overall Study|Protocol Violation|0|||
105658767|NCT00087555|364414260|FG002|Overall Study|Protocol Violation|2|||
105658768|NCT00087555|364414258|FG000|Overall Study|Screen Failure|1|||
105658769|NCT00087555|364414259|FG001|Overall Study|Screen Failure|1|||
105658770|NCT00087555|364414260|FG002|Overall Study|Screen Failure|0|||
105658771|NCT00087555|364414258|FG000|Overall Study|Pregnancy|0|||
105658772|NCT00087555|364414259|FG001|Overall Study|Pregnancy|1|||
105658773|NCT00087555|364414260|FG002|Overall Study|Pregnancy|1|||
105658774|NCT00087555|364414258|FG000|Overall Study|Withdrawal by Subject|3|||
105658775|NCT00087555|364414259|FG001|Overall Study|Withdrawal by Subject|2|||
105658776|NCT00087555|364414260|FG002|Overall Study|Withdrawal by Subject|1|||
105658777|NCT00087555|364414258|FG000|Overall Study|Lack of Efficacy|2|||
105658778|NCT00087555|364414259|FG001|Overall Study|Lack of Efficacy|0|||
105658779|NCT00087555|364414260|FG002|Overall Study|Lack of Efficacy|1|||
105658780|NCT00087555|364414258|FG000|Overall Study|Non Compliance|0|||
105658781|NCT00087555|364414259|FG001|Overall Study|Non Compliance|0|||
105658782|NCT00087555|364414260|FG002|Overall Study|Non Compliance|1|||
105658783|NCT00087555|364414258|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
105658784|NCT00087555|364414259|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
105658785|NCT00087555|364414260|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
105658786|NCT00087555|364414258|FG000|Overall Study|Patient wanted to go back on Med|1|||
105658787|NCT00087555|364414259|FG001|Overall Study|Patient wanted to go back on Med|0|||
105658788|NCT00087555|364414260|FG002|Overall Study|Patient wanted to go back on Med|0|||
105658789|NCT02024750|364414261|FG000|Overall Study|Withdrawal by Subject|2|||
105658790|NCT02024750|364414262|FG001|Overall Study|Withdrawal by Subject|1|||
105658791|NCT01161628|364414263|FG000|Overall Study|Death|6|||
105658792|NCT01161628|364414263|FG000|Overall Study|Lack of Efficacy|2|||
105658793|NCT03029819|364414264|FG000|Overall Study|Lost to Follow-up|3|||
105658794|NCT03029819|364414265|FG001|Overall Study|Lost to Follow-up|5|||
105658795|NCT03029819|364414264|FG000|Overall Study|Removed due to disruptive behavior|0|||
105658796|NCT03029819|364414265|FG001|Overall Study|Removed due to disruptive behavior|1|||
105658797|NCT03797989|364414275|FG000|VAC069A|Withdrawal by Subject|0|||
105658798|NCT03797989|364414276|FG001|VAC069A|Withdrawal by Subject|0|||
105658799|NCT03797989|364414277|FG002|VAC069A|Withdrawal by Subject|1|||
105658800|NCT03797989|364414278|FG003|VAC069A|Withdrawal by Subject|0|||
105658801|NCT03797989|364414279|FG004|VAC069A|Withdrawal by Subject|0|||
105658802|NCT03797989|364414280|FG005|VAC069A|Withdrawal by Subject|0|||
105658803|NCT03797989|364414281|FG006|VAC069A|Withdrawal by Subject|0|||
105658804|NCT03797989|364414282|FG007|VAC069A|Withdrawal by Subject|0|||
105658805|NCT03797989|364414283|FG008|VAC069A|Withdrawal by Subject|0|||
105658806|NCT03797989|364414284|FG009|VAC069A|Withdrawal by Subject|0|||
105658807|NCT03797989|364414285|FG010|VAC069A|Withdrawal by Subject|0|||
105658808|NCT03797989|364414286|FG011|VAC069A|Withdrawal by Subject|0|||
105658809|NCT00604188|364414287|FG000|Overall Study|Adverse Event|1|||
105658810|NCT00604188|364414288|FG001|Overall Study|Adverse Event|4|||
105658811|NCT00604188|364414287|FG000|Overall Study|Lost to Follow-up|17|||
105658812|NCT00604188|364414288|FG001|Overall Study|Lost to Follow-up|15|||
105658813|NCT00604188|364414287|FG000|Overall Study|Withdrawal by Subject|5|||
105658814|NCT00604188|364414288|FG001|Overall Study|Withdrawal by Subject|1|||
105658815|NCT00604188|364414287|FG000|Overall Study|Non-compliance with protocol|4|||
105658816|NCT00604188|364414288|FG001|Overall Study|Non-compliance with protocol|4|||
105658817|NCT00604188|364414287|FG000|Overall Study|Did not receive study drug|0|||
105658818|NCT00604188|364414288|FG001|Overall Study|Did not receive study drug|1|||
105658819|NCT02647645|364414289|FG000|Overall Study|Lost to Follow-up|2|||
105658820|NCT02647645|364414290|FG001|Overall Study|Lost to Follow-up|1|||
105658821|NCT00664105|364415648|FG000|Overall Study|Death|3|||
105658822|NCT00664105|364415648|FG000|Overall Study|Withdrawal by Subject|5|||
105658823|NCT00664105|364415648|FG000|Overall Study|Adverse Event|9|||
105658824|NCT00664105|364415648|FG000|Overall Study|Disease progression|7|||
105658825|NCT03602586|364415649|FG000|Overall Study|Withdrawal by Subject|3|||
105658826|NCT00362375|364415650|FG000|Overall Study|Lost to Follow-up|40|||
105658827|NCT00362375|364415651|FG001|Overall Study|Lost to Follow-up|35|||
105658828|NCT02106195|364415652|FG000|Overall Study|Adverse Event|2|||
105658829|NCT02106195|364415652|FG000|Overall Study|Protocol Violation|1|||
105658830|NCT00943618|364415653|FG000|Overall Study|Lost to Follow-up|38|||
105658831|NCT00943618|364415654|FG001|Overall Study|Lost to Follow-up|48|||
105658832|NCT00943618|364415655|FG002|Overall Study|Lost to Follow-up|20|||
105658833|NCT00943618|364415653|FG000|Overall Study|Discontinued Medication|17|||
105658834|NCT00943618|364415654|FG001|Overall Study|Discontinued Medication|29|||
105658835|NCT00943618|364415655|FG002|Overall Study|Discontinued Medication|11|||
105658836|NCT03062449|364415658|FG000|Overall Study|Withdrawal by Subject|7|||
105658837|NCT03062449|364415659|FG001|Overall Study|Withdrawal by Subject|1|||
105658838|NCT04014790|364415662|FG000|Overall Study|Death|4|||
105658839|NCT04014790|364415662|FG000|Overall Study|Adverse Event|1|||
105658840|NCT04014790|364415662|FG000|Overall Study|Withdrawal by Subject|1|||
105658841|NCT01004185|364415665|FG000|Overall Study|Adverse Event|1|||
105658842|NCT01004185|364415666|FG001|Overall Study|Adverse Event|1|||
105658843|NCT01004185|364415665|FG000|Overall Study|Lost to Follow-up|0|||
105658844|NCT01004185|364415666|FG001|Overall Study|Lost to Follow-up|1|||
105658845|NCT01004185|364415665|FG000|Overall Study|Lack of Efficacy|2|||
105658846|NCT01004185|364415666|FG001|Overall Study|Lack of Efficacy|1|||
105658847|NCT01004185|364415665|FG000|Overall Study|Sponsor Terminated Study|4|||
105658848|NCT01004185|364415666|FG001|Overall Study|Sponsor Terminated Study|5|||
105658849|NCT01004185|364415665|FG000|Overall Study|Withdrawal by Subject|2|||
105658850|NCT01004185|364415666|FG001|Overall Study|Withdrawal by Subject|1|||
105658851|NCT01379703|364415667|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
105658852|NCT01379703|364415668|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
105658853|NCT01379703|364415669|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
105658854|NCT01379703|364415667|FG000|Study Start Through 9 Months|Adverse Event|0|||
105658855|NCT01379703|364415668|FG001|Study Start Through 9 Months|Adverse Event|14|||
105658856|NCT01379703|364415669|FG002|Study Start Through 9 Months|Adverse Event|10|||
105658857|NCT01379703|364415667|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
105658858|NCT01379703|364415668|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
105658859|NCT01379703|364415669|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
105658860|NCT01379703|364415667|FG000|Study Start Through 9 Months|Treatment Failure|0|||
105658861|NCT01379703|364415668|FG001|Study Start Through 9 Months|Treatment Failure|2|||
105658862|NCT01379703|364415669|FG002|Study Start Through 9 Months|Treatment Failure|2|||
105658863|NCT01379703|364415667|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
105658864|NCT01379703|364415668|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
105658865|NCT01379703|364415669|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
105658866|NCT01379703|364415667|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
105658867|NCT01379703|364415668|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
105658868|NCT01379703|364415669|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
105658869|NCT01379703|364415667|FG000|Study Start Through 9 Months|Medication not available|0|||
105658870|NCT01379703|364415668|FG001|Study Start Through 9 Months|Medication not available|2|||
105658871|NCT01379703|364415669|FG002|Study Start Through 9 Months|Medication not available|1|||
105658872|NCT01379703|364415667|FG000|Study Start Through 9 Months|Poor general condition|0|||
105658873|NCT01379703|364415668|FG001|Study Start Through 9 Months|Poor general condition|1|||
105658874|NCT01379703|364415669|FG002|Study Start Through 9 Months|Poor general condition|0|||
105658875|NCT01379703|364415667|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
105658876|NCT01379703|364415668|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
105658877|NCT01379703|364415669|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
105768765|NCT03399786|364804541|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
105768766|NCT03399786|364804542|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
105658878|NCT01379703|364415667|FG000|Study Start Through 9 Months|Reason unknown|2|||
105768767|NCT03399786|364804539|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
105768768|NCT03399786|364804540|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
105658879|NCT01379703|364415668|FG001|Study Start Through 9 Months|Reason unknown|31|||
105658880|NCT01379703|364415669|FG002|Study Start Through 9 Months|Reason unknown|24|||
105658881|NCT01379703|364415667|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
105658882|NCT01379703|364415668|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
105658883|NCT01379703|364415669|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
105658884|NCT01379703|364415667|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
105658885|NCT01379703|364415668|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
105658886|NCT01379703|364415669|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
105658887|NCT01379703|364415667|FG000|9 Months Through 18 Months|Adverse Event|0|||
105658888|NCT01379703|364415668|FG001|9 Months Through 18 Months|Adverse Event|6|||
105658889|NCT01379703|364415669|FG002|9 Months Through 18 Months|Adverse Event|0|||
105658890|NCT01379703|364415667|FG000|9 Months Through 18 Months|Treatment failure|0|||
105658891|NCT01379703|364415668|FG001|9 Months Through 18 Months|Treatment failure|5|||
105658892|NCT01379703|364415669|FG002|9 Months Through 18 Months|Treatment failure|0|||
105658893|NCT01379703|364415667|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
105658894|NCT01379703|364415668|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
105658895|NCT01379703|364415669|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
105658896|NCT01379703|364415667|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
105658897|NCT01379703|364415668|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
105658898|NCT01379703|364415669|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
105658899|NCT01379703|364415667|FG000|9 Months Through 18 Months|Fatigue|0|||
105658900|NCT01379703|364415668|FG001|9 Months Through 18 Months|Fatigue|1|||
105658901|NCT01379703|364415669|FG002|9 Months Through 18 Months|Fatigue|0|||
105658902|NCT01379703|364415667|FG000|9 Months Through 18 Months|Reason Unknown|0|||
105658903|NCT01379703|364415668|FG001|9 Months Through 18 Months|Reason Unknown|23|||
105658904|NCT01379703|364415669|FG002|9 Months Through 18 Months|Reason Unknown|0|||
105658905|NCT03481556|364415670|FG000|Overall Study|Adverse Event|1|||
105658906|NCT03481556|364415671|FG001|Overall Study|Adverse Event|0|||
105658907|NCT03481556|364415672|FG002|Overall Study|Adverse Event|0|||
105658908|NCT03481556|364415673|FG003|Overall Study|Adverse Event|0|||
105658909|NCT03481556|364415670|FG000|Overall Study|Death|4|||
105658910|NCT03481556|364415671|FG001|Overall Study|Death|2|||
105658911|NCT03481556|364415672|FG002|Overall Study|Death|3|||
105658912|NCT03481556|364415673|FG003|Overall Study|Death|16|||
105658913|NCT03481556|364415670|FG000|Overall Study|Study Terminated by Sponsor|10|||
105658914|NCT03481556|364415671|FG001|Overall Study|Study Terminated by Sponsor|5|||
105658915|NCT03481556|364415672|FG002|Overall Study|Study Terminated by Sponsor|2|||
105658916|NCT03481556|364415673|FG003|Overall Study|Study Terminated by Sponsor|9|||
105658917|NCT01172639|364415674|FG000|Overall Study|Death|1|||
105658918|NCT01172639|364415675|FG001|Overall Study|Death|1|||
105658919|NCT01172639|364415676|FG002|Overall Study|Death|0|||
105658920|NCT01172639|364415677|FG003|Overall Study|Death|0|||
105658921|NCT01172639|364415678|FG004|Overall Study|Death|0|||
105658922|NCT01172639|364415674|FG000|Overall Study|Lost to Follow-up|9|||
105658923|NCT01172639|364415675|FG001|Overall Study|Lost to Follow-up|7|||
105658924|NCT01172639|364415676|FG002|Overall Study|Lost to Follow-up|11|||
105658925|NCT01172639|364415677|FG003|Overall Study|Lost to Follow-up|6|||
105658926|NCT01172639|364415678|FG004|Overall Study|Lost to Follow-up|6|||
105658927|NCT01172639|364415674|FG000|Overall Study|Withdrawal by Subject|3|||
105658928|NCT01172639|364415675|FG001|Overall Study|Withdrawal by Subject|3|||
105658929|NCT01172639|364415676|FG002|Overall Study|Withdrawal by Subject|5|||
105658930|NCT01172639|364415677|FG003|Overall Study|Withdrawal by Subject|5|||
105658931|NCT01172639|364415678|FG004|Overall Study|Withdrawal by Subject|0|||
105658932|NCT01316887|364415679|FG000|Overall Study|Adverse Event|13|||
105658933|NCT01316887|364415680|FG001|Overall Study|Adverse Event|21|||
105658934|NCT01316887|364415681|FG002|Overall Study|Adverse Event|17|||
105658935|NCT01316887|364415679|FG000|Overall Study|Lack of Efficacy|9|||
105658936|NCT01316887|364415680|FG001|Overall Study|Lack of Efficacy|3|||
105658937|NCT01316887|364415681|FG002|Overall Study|Lack of Efficacy|1|||
105658938|NCT01316887|364415679|FG000|Overall Study|Protocol Violation|2|||
105658939|NCT01316887|364415680|FG001|Overall Study|Protocol Violation|6|||
105658940|NCT01316887|364415681|FG002|Overall Study|Protocol Violation|6|||
105658941|NCT01316887|364415679|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
105658942|NCT01316887|364415680|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
105658943|NCT01316887|364415681|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
105658944|NCT01316887|364415679|FG000|Overall Study|Study Closed/Terminated|2|||
105658945|NCT01316887|364415680|FG001|Overall Study|Study Closed/Terminated|4|||
105658946|NCT01316887|364415681|FG002|Overall Study|Study Closed/Terminated|3|||
105658947|NCT01316887|364415679|FG000|Overall Study|Lost to Follow-up|1|||
105658948|NCT01316887|364415680|FG001|Overall Study|Lost to Follow-up|7|||
105658949|NCT01316887|364415681|FG002|Overall Study|Lost to Follow-up|5|||
105658950|NCT01316887|364415679|FG000|Overall Study|Withdrawal by Subject|8|||
105658951|NCT01316887|364415680|FG001|Overall Study|Withdrawal by Subject|16|||
105658952|NCT01316887|364415681|FG002|Overall Study|Withdrawal by Subject|15|||
105658953|NCT00469456|364415682|FG000|Overall Study|Adverse Event|4|||
105658954|NCT00469456|364415683|FG001|Overall Study|Adverse Event|3|||
105658955|NCT00469456|364415682|FG000|Overall Study|Protocol Violation|1|||
105658956|NCT00469456|364415683|FG001|Overall Study|Protocol Violation|0|||
105658957|NCT00469456|364415682|FG000|Overall Study|Withdrawal by Subject|4|||
105658958|NCT00469456|364415683|FG001|Overall Study|Withdrawal by Subject|1|||
105658959|NCT00704171|364415687|FG000|Overall Study|Withdrawal by Subject|1|||
105658960|NCT00704171|364415688|FG001|Overall Study|Withdrawal by Subject|0|||
105658961|NCT03634839|364415689|FG000|First Intervention (2 Hours)|Adverse Event|0|||
105658962|NCT03634839|364415690|FG001|First Intervention (2 Hours)|Adverse Event|2|||
105658963|NCT02647788|364415691|FG000|Overall Study|Lost to Follow-up|13|||
105658964|NCT02647788|364415692|FG001|Overall Study|Lost to Follow-up|11|||
105658965|NCT02647788|364415691|FG000|Overall Study|Did not want opiate|0|||
105658966|NCT02647788|364415692|FG001|Overall Study|Did not want opiate|1|||
105658967|NCT02647788|364415691|FG000|Overall Study|Withdrawal by Subject|1|||
105658968|NCT02647788|364415692|FG001|Overall Study|Withdrawal by Subject|0|||
105658969|NCT02647788|364415691|FG000|Overall Study|Felt itchy with assigned medication|1|||
105658970|NCT02647788|364415692|FG001|Overall Study|Felt itchy with assigned medication|0|||
105658971|NCT02647788|364415691|FG000|Overall Study|Felt nauseous with assigned medication|1|||
105658972|NCT02647788|364415692|FG001|Overall Study|Felt nauseous with assigned medication|1|||
105658973|NCT00233389|364415693|FG000|Overall Study|Adverse Event|5|||
105658974|NCT00233389|364415694|FG001|Overall Study|Adverse Event|5|||
105658975|NCT00233389|364415693|FG000|Overall Study|Lack of Efficacy|11|||
105658976|NCT00233389|364415694|FG001|Overall Study|Lack of Efficacy|8|||
105658977|NCT00233389|364415693|FG000|Overall Study|Lost to Follow-up|1|||
105658978|NCT00233389|364415694|FG001|Overall Study|Lost to Follow-up|1|||
105658979|NCT00233389|364415693|FG000|Overall Study|Physician Decision|1|||
105658980|NCT00233389|364415694|FG001|Overall Study|Physician Decision|0|||
105658981|NCT00233389|364415693|FG000|Overall Study|Protocol Violation|0|||
105658982|NCT00233389|364415694|FG001|Overall Study|Protocol Violation|1|||
105658983|NCT00233389|364415693|FG000|Overall Study|Withdrawal by Subject|0|||
105658984|NCT00233389|364415694|FG001|Overall Study|Withdrawal by Subject|1|||
105658985|NCT01898442|364415695|FG000|Overall Study|Hemolysis/technical problems|1|||
105658986|NCT01898442|364415696|FG001|Overall Study|Hemolysis/technical problems|2|||
105658987|NCT01898442|364415697|FG002|Overall Study|Hemolysis/technical problems|2|||
105658988|NCT01898442|364415695|FG000|Overall Study|Patient vomited pills|0|||
105658989|NCT01898442|364415696|FG001|Overall Study|Patient vomited pills|0|||
105658990|NCT01898442|364415697|FG002|Overall Study|Patient vomited pills|1|||
105658991|NCT00255944|364415698|FG000|Overall Study|Lost to Follow-up|797|||
105658992|NCT00255944|364415699|FG001|Overall Study|Lost to Follow-up|834|||
105658993|NCT05178979|364415700|FG000|Overall Study|Death|0|||
105658994|NCT05178979|364415701|FG001|Overall Study|Death|5|||
105658995|NCT05178979|364415702|FG002|Overall Study|Death|0|||
105658996|NCT05178979|364415703|FG003|Overall Study|Death|3|||
105658997|NCT05178979|364415700|FG000|Overall Study|Adverse Event|0|||
105658998|NCT05178979|364415701|FG001|Overall Study|Adverse Event|1|||
105658999|NCT05178979|364415702|FG002|Overall Study|Adverse Event|0|||
105659000|NCT05178979|364415703|FG003|Overall Study|Adverse Event|0|||
105659001|NCT05178979|364415700|FG000|Overall Study|Lost to Follow-up|1|||
105659002|NCT05178979|364415701|FG001|Overall Study|Lost to Follow-up|8|||
105659003|NCT05178979|364415702|FG002|Overall Study|Lost to Follow-up|3|||
105659004|NCT05178979|364415703|FG003|Overall Study|Lost to Follow-up|8|||
105659005|NCT01129115|364415705|FG000|Overall Study|Adverse Event|1|||
105659006|NCT01129115|364415706|FG001|Overall Study|Adverse Event|2|||
105659007|NCT01129115|364415707|FG002|Overall Study|Adverse Event|3|||
105659008|NCT01129115|364415708|FG003|Overall Study|Adverse Event|3|||
105659009|NCT01129115|364415705|FG000|Overall Study|Withdrawal by Subject|1|||
105659010|NCT01129115|364415706|FG001|Overall Study|Withdrawal by Subject|3|||
105659011|NCT01129115|364415707|FG002|Overall Study|Withdrawal by Subject|1|||
105659012|NCT01129115|364415708|FG003|Overall Study|Withdrawal by Subject|4|||
105659013|NCT01129115|364415705|FG000|Overall Study|Protocol Violation|0|||
105659014|NCT01129115|364415706|FG001|Overall Study|Protocol Violation|2|||
105659015|NCT01129115|364415707|FG002|Overall Study|Protocol Violation|2|||
105659016|NCT01129115|364415708|FG003|Overall Study|Protocol Violation|2|||
105659017|NCT01747837|364415710|FG000|Overall Study|Lost to Follow-up|5|||
105659018|NCT01747837|364415711|FG001|Overall Study|Lost to Follow-up|2|||
105659019|NCT01747837|364415710|FG000|Overall Study|Death|4|||
105659020|NCT01747837|364415711|FG001|Overall Study|Death|4|||
105659021|NCT00817336|364415713|FG000|Overall Study|Withdrawal by Subject|1|||
105659022|NCT00817336|364415714|FG001|Overall Study|Withdrawal by Subject|1|||
105659023|NCT01435798|364415715|FG000|Overall Study|Withdrawal by Subject|1|||
105659024|NCT02108652|364415716|FG000|Overall Study|Death|253|||
105659025|NCT02108652|364415716|FG000|Overall Study|Lost to Follow-up|2|||
105659026|NCT02108652|364415716|FG000|Overall Study|Withdrawal by Subject|16|||
105659027|NCT02108652|364415716|FG000|Overall Study|Study Terminated By Sponsor|31|||
105659028|NCT02108652|364415716|FG000|Overall Study|Non-Compliance|1|||
105659029|NCT02108652|364415716|FG000|Overall Study|Physician Decision|6|||
105659030|NCT02108652|364415716|FG000|Overall Study|Progression Of Disease|1|||
105659031|NCT01182181|364415717|FG000|First Intervention|Adverse Event|1|||
105659032|NCT01182181|364415718|FG001|First Intervention|Adverse Event|0|||
105659033|NCT01182181|364415717|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
105659034|NCT01182181|364415718|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
105659035|NCT01121913|364415719|FG000|First Intervention Period|Adverse Event|0|||
105659036|NCT01121913|364415720|FG001|First Intervention Period|Adverse Event|0|||
105659037|NCT01121913|364415721|FG002|First Intervention Period|Adverse Event|1|||
105659038|NCT01121913|364415722|FG003|First Intervention Period|Adverse Event|0|||
105659039|NCT01121913|364415719|FG000|First Washout Period|Withdrawal by Subject|1|||
105659040|NCT01121913|364415720|FG001|First Washout Period|Withdrawal by Subject|0|||
105659041|NCT01121913|364415721|FG002|First Washout Period|Withdrawal by Subject|0|||
105659042|NCT01121913|364415722|FG003|First Washout Period|Withdrawal by Subject|0|||
105659043|NCT01121913|364415719|FG000|Second Intervention Period|Adverse Event|0|||
105659044|NCT01121913|364415720|FG001|Second Intervention Period|Adverse Event|0|||
105659045|NCT01121913|364415721|FG002|Second Intervention Period|Adverse Event|1|||
105659046|NCT01121913|364415722|FG003|Second Intervention Period|Adverse Event|0|||
105659047|NCT01121913|364415719|FG000|Second Washout Period|Withdrawal by Subject|0|||
105659048|NCT01121913|364415720|FG001|Second Washout Period|Withdrawal by Subject|0|||
105659049|NCT01121913|364415721|FG002|Second Washout Period|Withdrawal by Subject|1|||
105659050|NCT01121913|364415722|FG003|Second Washout Period|Withdrawal by Subject|0|||
105659051|NCT01121913|364415719|FG000|Third Washout Period|Adverse Event|1|||
105659052|NCT01121913|364415720|FG001|Third Washout Period|Adverse Event|0|||
105659053|NCT01121913|364415721|FG002|Third Washout Period|Adverse Event|0|||
105659054|NCT01121913|364415722|FG003|Third Washout Period|Adverse Event|0|||
105659055|NCT03845075|364415723|FG000|Part 1 - DB|Withdrawal by Subject|1|||
105659056|NCT03845075|364415724|FG001|Part 1 - DB|Withdrawal by Subject|1|||
105659057|NCT03845075|364415725|FG002|Part 1 - DB|Withdrawal by Subject|0|||
105659058|NCT03845075|364415726|FG003|Part 1 - DB|Withdrawal by Subject|0|||
105659059|NCT03845075|364415723|FG000|Part 1 - DB|Adverse Event|0|||
105659060|NCT03845075|364415724|FG001|Part 1 - DB|Adverse Event|1|||
105659061|NCT03845075|364415725|FG002|Part 1 - DB|Adverse Event|0|||
105659062|NCT03845075|364415726|FG003|Part 1 - DB|Adverse Event|0|||
105659063|NCT03845075|364415723|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
105659064|NCT03845075|364415724|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
105659065|NCT03845075|364415725|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
105659066|NCT03845075|364415726|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
105659067|NCT00935259|364415727|FG000|Period 1|Administrative (scheduling conflict)|1|||
105659068|NCT00935259|364415728|FG001|Period 1|Administrative (scheduling conflict)|1|||
105659069|NCT02019641|364415729|FG000|10-Week Follow up|Withdrawal by investigator|2|||
105659070|NCT02019641|364415730|FG001|10-Week Follow up|Withdrawal by investigator|0|||
105659071|NCT02019641|364415731|FG002|10-Week Follow up|Withdrawal by investigator|0|||
105659072|NCT02019641|364415729|FG000|10-Week Follow up|Withdrawal by Subject|1|||
105659073|NCT02019641|364415730|FG001|10-Week Follow up|Withdrawal by Subject|1|||
105659074|NCT02019641|364415731|FG002|10-Week Follow up|Withdrawal by Subject|0|||
105659075|NCT02019641|364415729|FG000|20-Week Follow up|Withdrawal by investigator|0|||
105659076|NCT02019641|364415730|FG001|20-Week Follow up|Withdrawal by investigator|0|||
105659077|NCT02019641|364415731|FG002|20-Week Follow up|Withdrawal by investigator|1|||
105659078|NCT06390826|364415732|FG000|Overall Study|Never Start Protocol Therapy|1|||
105659079|NCT06390826|364415732|FG000|Overall Study|Adverse Event|1|||
105659080|NCT06390826|364415732|FG000|Overall Study|Disease Progression|8|||
105659081|NCT00937521|364415734|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
105659082|NCT00937521|364415735|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
105659083|NCT00937521|364415736|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
105659084|NCT00937521|364415737|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
105659085|NCT00937521|364415738|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
105659086|NCT00937521|364415739|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
105659087|NCT00937521|364415740|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
105659088|NCT00937521|364415741|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
105659089|NCT00937521|364415734|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
105659090|NCT00937521|364415735|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
105659091|NCT00937521|364415736|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
105659092|NCT00937521|364415737|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
105659093|NCT00937521|364415738|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
105659094|NCT00937521|364415739|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
105659095|NCT00937521|364415740|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
105659096|NCT00937521|364415741|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
105659097|NCT00937521|364415734|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
105659098|NCT00937521|364415735|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
105659099|NCT00937521|364415736|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
105659100|NCT00937521|364415737|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
105659101|NCT00937521|364415738|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
105659102|NCT00937521|364415739|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
105659103|NCT00937521|364415740|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
105659104|NCT00937521|364415741|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
105659105|NCT00937521|364415734|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
105659106|NCT00937521|364415735|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
105659107|NCT00937521|364415736|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
105659108|NCT00937521|364415737|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
105659109|NCT00937521|364415738|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
105659110|NCT00937521|364415739|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
105659111|NCT00937521|364415740|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
105659112|NCT00937521|364415741|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
105659113|NCT00937521|364415734|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
105659114|NCT00937521|364415735|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
105659115|NCT00937521|364415736|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
105768769|NCT03399786|364804541|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
105768770|NCT03399786|364804542|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
105768771|NCT00887068|364804549|FG000|Overall Study|Withdrawal by Subject|2|||
105768772|NCT00887068|364804550|FG001|Overall Study|Withdrawal by Subject|0|||
105768773|NCT00887068|364804549|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
105768774|NCT00887068|364804550|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
105768775|NCT01388491|364804556|FG000|Overall Study|Adverse Event|10|||
105768776|NCT01388491|364804557|FG001|Overall Study|Adverse Event|9|||
105768777|NCT01388491|364804556|FG000|Overall Study|Sponsor Request|9|||
105768778|NCT01388491|364804557|FG001|Overall Study|Sponsor Request|7|||
105768779|NCT01388491|364804556|FG000|Overall Study|Withdrawal by Subject|6|||
105768780|NCT01388491|364804557|FG001|Overall Study|Withdrawal by Subject|10|||
105768781|NCT01388491|364804556|FG000|Overall Study|Lost to Follow-up|4|||
105768782|NCT01388491|364804557|FG001|Overall Study|Lost to Follow-up|3|||
105768783|NCT01388491|364804556|FG000|Overall Study|Protocol Violation|2|||
105768784|NCT01388491|364804557|FG001|Overall Study|Protocol Violation|0|||
105768785|NCT01388491|364804556|FG000|Overall Study|Noncompliance|2|||
105768786|NCT01388491|364804557|FG001|Overall Study|Noncompliance|0|||
105768787|NCT01388491|364804556|FG000|Overall Study|Pregnancy|1|||
105768788|NCT01388491|364804557|FG001|Overall Study|Pregnancy|0|||
105768789|NCT02116361|364804562|FG000|Overall Study|Pregnancy|0|||
105768790|NCT02116361|364804563|FG001|Overall Study|Pregnancy|0|||
105768791|NCT02116361|364804564|FG002|Overall Study|Pregnancy|0|||
105768792|NCT02116361|364804565|FG003|Overall Study|Pregnancy|1|||
105768793|NCT02116361|364804562|FG000|Overall Study|Protocol Violation|1|||
105768794|NCT02116361|364804563|FG001|Overall Study|Protocol Violation|0|||
105768795|NCT02116361|364804564|FG002|Overall Study|Protocol Violation|0|||
105768796|NCT02116361|364804565|FG003|Overall Study|Protocol Violation|2|||
105768797|NCT02116361|364804562|FG000|Overall Study|Physician Decision|2|||
105768798|NCT02116361|364804563|FG001|Overall Study|Physician Decision|3|||
105768799|NCT02116361|364804564|FG002|Overall Study|Physician Decision|0|||
105768800|NCT02116361|364804565|FG003|Overall Study|Physician Decision|0|||
105768801|NCT02116361|364804562|FG000|Overall Study|Adverse Event|1|||
105768802|NCT02116361|364804563|FG001|Overall Study|Adverse Event|0|||
105768803|NCT02116361|364804564|FG002|Overall Study|Adverse Event|0|||
105768804|NCT02116361|364804565|FG003|Overall Study|Adverse Event|3|||
105768805|NCT02116361|364804562|FG000|Overall Study|Other Reasons|3|||
105768806|NCT02116361|364804563|FG001|Overall Study|Other Reasons|3|||
105768807|NCT02116361|364804564|FG002|Overall Study|Other Reasons|3|||
105768808|NCT02116361|364804565|FG003|Overall Study|Other Reasons|3|||
105768809|NCT02116361|364804562|FG000|Overall Study|Lack of Efficacy|5|||
105768810|NCT02116361|364804563|FG001|Overall Study|Lack of Efficacy|7|||
105768811|NCT02116361|364804564|FG002|Overall Study|Lack of Efficacy|4|||
105768812|NCT02116361|364804565|FG003|Overall Study|Lack of Efficacy|3|||
105768813|NCT02116361|364804562|FG000|Overall Study|Lost to Follow-up|4|||
105768814|NCT02116361|364804563|FG001|Overall Study|Lost to Follow-up|5|||
105768815|NCT02116361|364804564|FG002|Overall Study|Lost to Follow-up|7|||
105768816|NCT02116361|364804565|FG003|Overall Study|Lost to Follow-up|5|||
105768817|NCT02116361|364804562|FG000|Overall Study|Personal Reasons|6|||
105768818|NCT02116361|364804563|FG001|Overall Study|Personal Reasons|6|||
105768819|NCT02116361|364804564|FG002|Overall Study|Personal Reasons|4|||
105768820|NCT02116361|364804565|FG003|Overall Study|Personal Reasons|9|||
105768821|NCT02116361|364804562|FG000|Overall Study|Investigator Decision - Relapse|9|||
105768822|NCT02116361|364804563|FG001|Overall Study|Investigator Decision - Relapse|7|||
105768823|NCT02116361|364804564|FG002|Overall Study|Investigator Decision - Relapse|8|||
105768824|NCT02116361|364804565|FG003|Overall Study|Investigator Decision - Relapse|5|||
105768825|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
105768826|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
105768827|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
105768828|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
105768829|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
105768830|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
105768831|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
105768832|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
105768833|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
105768834|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
105768835|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
105768836|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
105768837|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
105768838|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
105768839|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
105768840|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
105768841|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
105768842|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
105768843|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
105768844|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
105768845|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
105768846|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
105768847|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
105768848|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
105768849|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
105768850|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
105768851|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
105768852|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
105768853|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
105768854|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
105768855|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
105768856|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
105768857|NCT03227224|364804566|FG000|Follow-up Phase (2 Weeks)|Other|4|||
105768858|NCT03227224|364804567|FG001|Follow-up Phase (2 Weeks)|Other|4|||
105768859|NCT03227224|364804568|FG002|Follow-up Phase (2 Weeks)|Other|6|||
105768860|NCT03227224|364804569|FG003|Follow-up Phase (2 Weeks)|Other|3|||
105768861|NCT02406027|364804570|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
105768862|NCT02406027|364804571|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
105768863|NCT02406027|364804572|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
105768864|NCT02406027|364804573|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
105768865|NCT02406027|364804574|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
105768866|NCT02406027|364804575|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
105768867|NCT02406027|364804576|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
105768868|NCT02406027|364804570|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
105768869|NCT02406027|364804571|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
105768870|NCT02406027|364804572|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
105768871|NCT02406027|364804573|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
105768872|NCT02406027|364804574|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
105768873|NCT02406027|364804575|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
105768874|NCT02406027|364804576|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
105768875|NCT02406027|364804570|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
105768876|NCT02406027|364804571|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
105768877|NCT02406027|364804572|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
105768878|NCT02406027|364804573|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
105768879|NCT02406027|364804574|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
105768880|NCT02406027|364804575|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
105768881|NCT02406027|364804576|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
105768882|NCT02406027|364804570|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
105768883|NCT02406027|364804571|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
105768884|NCT02406027|364804572|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
105768885|NCT02406027|364804573|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
105768886|NCT02406027|364804574|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
105768887|NCT02406027|364804575|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
105768888|NCT02406027|364804576|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
105768889|NCT02406027|364804570|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
105768890|NCT02406027|364804571|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
105768891|NCT02406027|364804572|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
105768892|NCT02406027|364804573|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
105768893|NCT02406027|364804574|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
105768894|NCT02406027|364804575|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
105768895|NCT02406027|364804576|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
105768896|NCT02406027|364804570|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
105768897|NCT02406027|364804571|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
105768898|NCT02406027|364804572|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
105768899|NCT02406027|364804573|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
105768900|NCT02406027|364804574|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
105768901|NCT02406027|364804575|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
105768902|NCT02406027|364804576|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
105768903|NCT02406027|364804570|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
105768904|NCT02406027|364804571|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
105768905|NCT02406027|364804572|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
105768906|NCT02406027|364804573|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
105768907|NCT02406027|364804574|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
105768908|NCT02406027|364804575|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
105768909|NCT02406027|364804576|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
105768910|NCT02406027|364804570|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
105768911|NCT02406027|364804571|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
105768912|NCT02406027|364804572|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
105768913|NCT02406027|364804573|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
105768914|NCT02406027|364804574|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
105768915|NCT02406027|364804575|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
105768916|NCT02406027|364804576|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
105768917|NCT02406027|364804570|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
105768918|NCT02406027|364804571|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
105768919|NCT02406027|364804572|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
105768920|NCT02406027|364804573|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
105768921|NCT02406027|364804574|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
105768922|NCT02406027|364804575|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
105768923|NCT02406027|364804576|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
105768924|NCT02406027|364804570|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
105768925|NCT02406027|364804571|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
105768926|NCT02406027|364804572|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
105768927|NCT02406027|364804573|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
105768928|NCT02406027|364804574|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
105768929|NCT02406027|364804575|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
105768930|NCT02406027|364804576|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
105768931|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
105768932|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
105768933|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
105768934|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
105768935|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Other|13|||
105768936|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
105768937|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
105768938|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
105768939|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
105768940|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
105768941|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
105768942|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
105768943|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
105768944|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
105768945|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
105768946|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
105768947|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
105768948|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
105768949|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
105768950|NCT02497287|364804577|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
105768951|NCT02497287|364804577|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
105768952|NCT02497287|364804577|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
105768953|NCT02497287|364804577|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
105768954|NCT02497287|364804577|FG000|Follow-up Phase (4 Week)|Other|1|||
105768955|NCT02254304|364804583|FG000|Overall Study|Adverse Event|2|||
105768956|NCT02254304|364804584|FG001|Overall Study|Adverse Event|1|||
105768957|NCT02254304|364804583|FG000|Overall Study|Lost to Follow-up|2|||
105768958|NCT02254304|364804584|FG001|Overall Study|Lost to Follow-up|2|||
105768959|NCT02254304|364804583|FG000|Overall Study|Protocol Violation|1|||
105768960|NCT02254304|364804584|FG001|Overall Study|Protocol Violation|0|||
105768961|NCT02254304|364804583|FG000|Overall Study|Withdrawal by Subject|3|||
105768962|NCT02254304|364804584|FG001|Overall Study|Withdrawal by Subject|0|||
105768963|NCT02254304|364804583|FG000|Overall Study|Injection site pain and Injection fear|1|||
105768964|NCT02254304|364804584|FG001|Overall Study|Injection site pain and Injection fear|0|||
105768965|NCT02254304|364804583|FG000|Overall Study|Personal causes|4|||
105768966|NCT02254304|364804584|FG001|Overall Study|Personal causes|1|||
105768967|NCT02254304|364804583|FG000|Overall Study|Personal decision|1|||
105768968|NCT02254304|364804584|FG001|Overall Study|Personal decision|0|||
105768969|NCT00464620|364805679|FG000|Overall Study|Physician Decision|1|||
105768970|NCT00464620|364805680|FG001|Overall Study|Physician Decision|0|||
105768971|NCT00464620|364805681|FG002|Overall Study|Physician Decision|0|||
105768972|NCT00464620|364805679|FG000|Overall Study|Withdrawal by Subject|1|||
105768973|NCT00464620|364805680|FG001|Overall Study|Withdrawal by Subject|0|||
105768974|NCT00464620|364805681|FG002|Overall Study|Withdrawal by Subject|3|||
105768975|NCT00464620|364805679|FG000|Overall Study|Ineligible sarcoma subtype|0|||
105768976|NCT00464620|364805680|FG001|Overall Study|Ineligible sarcoma subtype|2|||
105768977|NCT00464620|364805681|FG002|Overall Study|Ineligible sarcoma subtype|2|||
105768978|NCT00464620|364805679|FG000|Overall Study|Use of prohibited concomitant medication|0|||
105768979|NCT00464620|364805680|FG001|Overall Study|Use of prohibited concomitant medication|0|||
105768980|NCT00464620|364805681|FG002|Overall Study|Use of prohibited concomitant medication|2|||
105768981|NCT01080625|364805688|FG000|Overall Study|Physician Decision|0|||
105768982|NCT01080625|364805689|FG001|Overall Study|Physician Decision|2|||
105768983|NCT01080625|364805690|FG002|Overall Study|Physician Decision|1|||
105768984|NCT00589602|364805694|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
105768985|NCT03887052|364805702|FG000|Overall Study|Adverse Event|2|||
105768986|NCT03887052|364805702|FG000|Overall Study|Physician Decision|2|||
105768987|NCT03887052|364805702|FG000|Overall Study|Withdrawal by Subject|3|||
105768988|NCT03887052|364805702|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
105768989|NCT03887052|364805702|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
105768990|NCT03687827|364805704|FG000|Treatment Period 1|Death|0|||
105768991|NCT03687827|364805705|FG001|Treatment Period 1|Death|1|||
105768992|NCT03687827|364805704|FG000|Treatment Period 1|Lost to Follow-up|2|||
105768993|NCT03687827|364805705|FG001|Treatment Period 1|Lost to Follow-up|2|||
105768994|NCT03687827|364805704|FG000|Treatment Period 1|Physician Decision|5|||
105768995|NCT03687827|364805705|FG001|Treatment Period 1|Physician Decision|2|||
105768996|NCT03687827|364805704|FG000|Treatment Period 1|Withdrawal by Subject|7|||
105768997|NCT03687827|364805705|FG001|Treatment Period 1|Withdrawal by Subject|3|||
105768998|NCT03687827|364805704|FG000|Treatment Period 2|Physician Decision|4|||
105768999|NCT03687827|364805705|FG001|Treatment Period 2|Physician Decision|1|||
105769000|NCT03687827|364805704|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105769001|NCT03687827|364805705|FG001|Treatment Period 2|Withdrawal by Subject|2|||
105769002|NCT00068822|364805706|FG000|First Randomized Intervention|Lost to Follow-up|1|||
105769003|NCT00068822|364805707|FG001|First Randomized Intervention|Lost to Follow-up|2|||
105769004|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
105769005|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
105769006|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
105769007|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
105769008|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
105769009|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
105769010|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
105769011|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
105769012|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
105769013|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
105769014|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
105769015|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
105769016|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
105769017|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
105769018|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
105769019|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
105769020|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Death|1|||
105769021|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Death|0|||
105769022|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
105769023|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
105769024|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
105769025|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
105769026|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
105769027|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
105769028|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
105769029|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
105769030|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
105769031|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
105769032|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
105769033|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
105769034|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
105769035|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
105769036|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
105769037|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
105769038|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Death|1|||
105769039|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Death|0|||
105769040|NCT00981292|364805710|FG000|Day 1|Protocol Violation|1|||
105769041|NCT00981292|364805711|FG001|Day 1|Protocol Violation|0|||
105769042|NCT00981292|364805712|FG002|Day 1|Protocol Violation|0|||
105769043|NCT00981292|364805713|FG003|Day 1|Protocol Violation|0|||
105769044|NCT00981292|364805714|FG004|Day 1|Protocol Violation|0|||
105769045|NCT00981292|364805715|FG005|Day 1|Protocol Violation|2|||
105769046|NCT00981292|364805710|FG000|Day 2|Protocol Violation|2|||
105769047|NCT00981292|364805711|FG001|Day 2|Protocol Violation|0|||
105769048|NCT00981292|364805712|FG002|Day 2|Protocol Violation|0|||
105769049|NCT00981292|364805713|FG003|Day 2|Protocol Violation|0|||
105769050|NCT00981292|364805714|FG004|Day 2|Protocol Violation|0|||
105769051|NCT00981292|364805715|FG005|Day 2|Protocol Violation|0|||
105769052|NCT00981292|364805710|FG000|Day 3|Protocol Violation|0|||
105769053|NCT00981292|364805711|FG001|Day 3|Protocol Violation|0|||
105769054|NCT00981292|364805712|FG002|Day 3|Protocol Violation|0|||
105769055|NCT00981292|364805713|FG003|Day 3|Protocol Violation|0|||
105769056|NCT00981292|364805714|FG004|Day 3|Protocol Violation|0|||
105769057|NCT00981292|364805715|FG005|Day 3|Protocol Violation|1|||
105769058|NCT00939341|364805716|FG000|Overall Study|Adverse Event|15|||
105769059|NCT00939341|364805716|FG000|Overall Study|Pregnancy|1|||
105769060|NCT00939341|364805716|FG000|Overall Study|Lost to Follow-up|23|||
105769061|NCT00939341|364805716|FG000|Overall Study|Withdrawal by Subject|13|||
105769062|NCT00939341|364805716|FG000|Overall Study|Protocol Violation|6|||
105769063|NCT00939341|364805716|FG000|Overall Study|Incorrect enrolment|8|||
105769064|NCT01131130|364805717|FG000|Period 1 - Baseline|Pregnancy|1|||
105769065|NCT01131130|364805717|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
105769066|NCT00557323|364805720|FG000|Overall Study|Death|3|||
105769067|NCT00557323|364805720|FG000|Overall Study|Withdrawal by Subject|2|||
105769068|NCT00557323|364805720|FG000|Overall Study|Administrative change|2|||
105769069|NCT00498368|364805730|FG000|Overall Study|Withdrawal by Subject|3|||
105769070|NCT00498368|364805731|FG001|Overall Study|Withdrawal by Subject|2|||
105769071|NCT02266004|364805732|FG000|Overall Study|unrelated adverse event|1|||
105769072|NCT02266004|364805732|FG000|Overall Study|Physician Decision|1|||
105769073|NCT02736929|364805734|FG000|Main Study|Lost to Follow-up|7|||
105769074|NCT02736929|364805735|FG001|Main Study|Lost to Follow-up|1|||
105769075|NCT02736929|364805736|FG002|Main Study|Lost to Follow-up|0|||
105769076|NCT02736929|364805734|FG000|Main Study|Withdrawal by Subject|1|||
105769077|NCT02736929|364805735|FG001|Main Study|Withdrawal by Subject|1|||
105769078|NCT02736929|364805736|FG002|Main Study|Withdrawal by Subject|0|||
105769079|NCT02736929|364805734|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
105769080|NCT02736929|364805735|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
105769081|NCT02736929|364805736|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
105769082|NCT00610207|364805737|FG000|Overall Study|Lost to Follow-up|3|||
105769083|NCT03369704|364805741|FG000|Treatment Epoch|technical problems|1|||
105769084|NCT03369704|364805742|FG001|Treatment Epoch|technical problems|0|||
105769085|NCT03369704|364805741|FG000|Treatment Epoch|Protocol Violation|1|||
105769086|NCT03369704|364805742|FG001|Treatment Epoch|Protocol Violation|0|||
105769087|NCT03369704|364805741|FG000|Treatment Epoch|Lost to Follow-up|0|||
105769088|NCT03369704|364805742|FG001|Treatment Epoch|Lost to Follow-up|1|||
105769089|NCT03369704|364805741|FG000|Treatment Epoch|Lack of Efficacy|0|||
105769090|NCT03369704|364805742|FG001|Treatment Epoch|Lack of Efficacy|2|||
105769091|NCT03369704|364805741|FG000|Treatment Epoch|Adverse Event|2|||
105769092|NCT03369704|364805742|FG001|Treatment Epoch|Adverse Event|0|||
105769093|NCT03369704|364805741|FG000|Follow-up Epoch|Lost to Follow-up|1|||
105769094|NCT03369704|364805742|FG001|Follow-up Epoch|Lost to Follow-up|0|||
105769095|NCT01600105|364805743|FG000|Total Participants|Withdrawal by Subject|1|||
105769096|NCT01600105|364805744|FG001|Total Participants|Withdrawal by Subject|0|||
105769097|NCT01600105|364805743|FG000|Total Participants|No images in PACS|10|||
105769098|NCT01600105|364805744|FG001|Total Participants|No images in PACS|0|||
105769099|NCT01600105|364805743|FG000|Total Participants|Insufficient image quality|30|||
105769100|NCT01600105|364805744|FG001|Total Participants|Insufficient image quality|10|||
105769101|NCT01600105|364805743|FG000|Sub Study I|Insufficient image quality|0|||
105769102|NCT01600105|364805744|FG001|Sub Study I|Insufficient image quality|10|||
105769103|NCT01600105|364805743|FG000|Sub Study II|Withdrawal by Subject|1|||
105769104|NCT01600105|364805744|FG001|Sub Study II|Withdrawal by Subject|0|||
105769105|NCT01600105|364805743|FG000|Sub Study II|No images in PACS|1|||
105769106|NCT01600105|364805744|FG001|Sub Study II|No images in PACS|0|||
105769107|NCT01600105|364805743|FG000|Sub Study II|Insufficient image quality|3|||
105769108|NCT01600105|364805744|FG001|Sub Study II|Insufficient image quality|0|||
105769109|NCT01600105|364805743|FG000|Sub Study III|Insufficient image quality|5|||
105769110|NCT01600105|364805744|FG001|Sub Study III|Insufficient image quality|0|||
105769111|NCT01600105|364805743|FG000|Sub Study V|Poor Image Quality|2|||
105769112|NCT01600105|364805744|FG001|Sub Study V|Poor Image Quality|0|||
105769113|NCT04007367|364805745|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
105769114|NCT04007367|364805746|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
105769115|NCT04007367|364805747|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
105769116|NCT04007367|364805745|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
105769117|NCT04007367|364805746|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
105769118|NCT04007367|364805747|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
105769119|NCT04007367|364805745|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
105769120|NCT04007367|364805746|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
105769121|NCT04007367|364805747|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
105769122|NCT04007367|364805745|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
105769123|NCT04007367|364805746|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
105769124|NCT04007367|364805747|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
105769125|NCT04007367|364805745|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
105769126|NCT04007367|364805746|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
105769127|NCT04007367|364805747|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
105769128|NCT04043416|364805750|FG000|Washout|Change in health condition|0|||
105769129|NCT04043416|364805751|FG001|Washout|Change in health condition|1|||
105769130|NCT02865928|364805752|FG000|Overall Study|Withdrawal by Subject|1|||
105769131|NCT02865928|364805753|FG001|Overall Study|Withdrawal by Subject|0|||
105769132|NCT02865928|364805752|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
105769133|NCT02865928|364805753|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
105769134|NCT02865928|364805752|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
105769135|NCT02865928|364805753|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
105769136|NCT01512693|364805756|FG000|Overall Study|Withdrawal by Subject|0|||
105769137|NCT01512693|364805757|FG001|Overall Study|Withdrawal by Subject|1|||
105769138|NCT01975376|364805758|FG000|Overall Study|Adverse Event|5|||
105769139|NCT01975376|364805759|FG001|Overall Study|Adverse Event|5|||
105769140|NCT01975376|364805758|FG000|Overall Study|Death|65|||
105769141|NCT01975376|364805759|FG001|Overall Study|Death|72|||
105769142|NCT01975376|364805758|FG000|Overall Study|Lost to Follow-up|70|||
105769143|NCT01975376|364805759|FG001|Overall Study|Lost to Follow-up|66|||
105769144|NCT01975376|364805758|FG000|Overall Study|Withdrew consent|68|||
105769145|NCT01975376|364805759|FG001|Overall Study|Withdrew consent|62|||
105769146|NCT01975376|364805758|FG000|Overall Study|Other|2|||
105769147|NCT01975376|364805759|FG001|Overall Study|Other|4|||
105769148|NCT01975376|364805758|FG000|Overall Study|Randomized, Not Treated|16|||
105769149|NCT01975376|364805759|FG001|Overall Study|Randomized, Not Treated|8|||
105769150|NCT02343952|364805762|FG000|Study Treatment|Disease Progression|23|||
105769151|NCT02343952|364805762|FG000|Study Treatment|Death|3|||
105769152|NCT02343952|364805762|FG000|Study Treatment|Adverse Event|19|||
105769153|NCT02343952|364805762|FG000|Study Treatment|Withdrawal by Subject|7|||
105769154|NCT02343952|364805762|FG000|Study Treatment|other complicating Diseases|1|||
105769155|NCT02343952|364805762|FG000|Follow up|Withdrawal by Subject|3|||
105769156|NCT02343952|364805762|FG000|Follow up|Death|33|||
105769157|NCT02343952|364805762|FG000|Follow up|Patient does not meet eligibility for study.|1|||
105769158|NCT02343952|364805762|FG000|Follow up|Research department closed by the practice.|5|||
105769159|NCT02343952|364805762|FG000|Follow up|Patient went home to Russia|1|||
105769160|NCT02343952|364805762|FG000|Follow up|Disease Progression|1|||
105769161|NCT02343952|364805762|FG000|Follow up|study terminated|1|||
105769162|NCT01947894|364805767|FG000|Overall Study|Other|3|||
105769163|NCT01947894|364805768|FG001|Overall Study|Other|4|||
105769164|NCT01947894|364805769|FG002|Overall Study|Other|3|||
105769165|NCT01947894|364805767|FG000|Overall Study|Withdrawal by Subject|12|||
105769166|NCT01947894|364805768|FG001|Overall Study|Withdrawal by Subject|4|||
105769167|NCT01947894|364805769|FG002|Overall Study|Withdrawal by Subject|1|||
105769168|NCT01947894|364805767|FG000|Overall Study|Death|12|||
105769169|NCT01947894|364805768|FG001|Overall Study|Death|1|||
105769170|NCT01947894|364805769|FG002|Overall Study|Death|0|||
105769171|NCT01947894|364805767|FG000|Overall Study|Physician Decision|2|||
105769172|NCT01947894|364805768|FG001|Overall Study|Physician Decision|0|||
105769173|NCT01947894|364805769|FG002|Overall Study|Physician Decision|0|||
105769174|NCT01947894|364805767|FG000|Overall Study|Adverse Event|5|||
105769175|NCT01947894|364805768|FG001|Overall Study|Adverse Event|1|||
105769176|NCT01947894|364805769|FG002|Overall Study|Adverse Event|0|||
105769177|NCT01947894|364805767|FG000|Overall Study|Switched to other growth hormone brand|53|||
105769178|NCT01947894|364805768|FG001|Overall Study|Switched to other growth hormone brand|8|||
105769179|NCT01947894|364805769|FG002|Overall Study|Switched to other growth hormone brand|23|||
105769180|NCT01302691|364805772|FG000|Overall Study|Adverse Event|2|||
105769181|NCT01302691|364805773|FG001|Overall Study|Adverse Event|0|||
105769182|NCT01302691|364805772|FG000|Overall Study|Death|0|||
105769183|NCT01302691|364805773|FG001|Overall Study|Death|1|||
105769184|NCT01302691|364805772|FG000|Overall Study|Lost to Follow-up|1|||
105769185|NCT01302691|364805773|FG001|Overall Study|Lost to Follow-up|0|||
105769186|NCT01302691|364805772|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
105769187|NCT01302691|364805773|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
105769188|NCT01302691|364805772|FG000|Overall Study|Physician Decision|0|||
105769189|NCT01302691|364805773|FG001|Overall Study|Physician Decision|1|||
105769190|NCT01302691|364805772|FG000|Overall Study|Protocol Violation|1|||
105769191|NCT01302691|364805773|FG001|Overall Study|Protocol Violation|0|||
105769192|NCT00423592|364805774|FG000|Overall Study|Adverse Event (through Week 12)|2|||
105769193|NCT00423592|364805774|FG000|Overall Study|Adverse Event (post Week 12)|5|||
105769194|NCT03446612|364805775|FG000|Overall Study|Protocol defined stopping criteria|0|||
105769195|NCT03446612|364805776|FG001|Overall Study|Protocol defined stopping criteria|1|||
105769196|NCT03934203|364805779|FG000|Overall Study|Adverse Event|0|||
105769197|NCT03934203|364805780|FG001|Overall Study|Adverse Event|0|||
105769198|NCT03934203|364805781|FG002|Overall Study|Adverse Event|1|||
105769199|NCT03934203|364805782|FG003|Overall Study|Adverse Event|0|||
105769200|NCT03934203|364805783|FG004|Overall Study|Adverse Event|1|||
105769201|NCT03934203|364805784|FG005|Overall Study|Adverse Event|0|||
105769202|NCT03934203|364805785|FG006|Overall Study|Adverse Event|2|||
105769203|NCT03934203|364805786|FG007|Overall Study|Adverse Event|0|||
105769204|NCT03934203|364805787|FG008|Overall Study|Adverse Event|0|||
105769205|NCT03934203|364805788|FG009|Overall Study|Adverse Event|0|||
105769206|NCT03934203|364805789|FG010|Overall Study|Adverse Event|0|||
105769207|NCT03934203|364805790|FG011|Overall Study|Adverse Event|0|||
105769208|NCT03934203|364805791|FG012|Overall Study|Adverse Event|0|||
105769209|NCT03934203|364805792|FG013|Overall Study|Adverse Event|1|||
105769210|NCT03934203|364805793|FG014|Overall Study|Adverse Event|0|||
105769211|NCT03796195|364805796|FG000|Overall Study|Study closed early|1|||
105769212|NCT04195750|364805800|FG000|Overall Study|Death|245|||
105440282|NCT00408434|363616760|FG004|Overall Study|Other|2|||
105440283|NCT00408434|363616761|FG005|Overall Study|Other|1|||
105440284|NCT00408434|363616762|FG006|Overall Study|Other|0|||
105440285|NCT00408434|363616756|FG000|Overall Study|Terminated by Investigator|0|||
105440286|NCT00408434|363616757|FG001|Overall Study|Terminated by Investigator|0|||
105440287|NCT00408434|363616758|FG002|Overall Study|Terminated by Investigator|0|||
105440288|NCT00408434|363616759|FG003|Overall Study|Terminated by Investigator|0|||
105440289|NCT00408434|363616760|FG004|Overall Study|Terminated by Investigator|1|||
105440290|NCT00408434|363616761|FG005|Overall Study|Terminated by Investigator|1|||
105440291|NCT00408434|363616762|FG006|Overall Study|Terminated by Investigator|0|||
105440292|NCT00588354|363616763|FG000|Baseline to 2 Weeks|Adverse Event|1|||
105440293|NCT00588354|363616764|FG001|Baseline to 2 Weeks|Adverse Event|0|||
105440294|NCT00588354|363616763|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
105440295|NCT00588354|363616764|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
105440296|NCT00588354|363616763|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
105440297|NCT00588354|363616764|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
105440298|NCT00895453|363616765|FG000|Overall Study|Lost to Follow-up|25|||
105659116|NCT00937521|364415737|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
105659117|NCT00937521|364415738|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
105659118|NCT00937521|364415739|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
105659119|NCT00937521|364415740|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
105659120|NCT00937521|364415741|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
105659121|NCT00937521|364415734|FG000|Booster Phase|Adverse Event|0|||
105659122|NCT00937521|364415735|FG001|Booster Phase|Adverse Event|0|||
105659123|NCT00937521|364415736|FG002|Booster Phase|Adverse Event|0|||
105659124|NCT00937521|364415737|FG003|Booster Phase|Adverse Event|0|||
105659125|NCT00937521|364415738|FG004|Booster Phase|Adverse Event|0|||
105659126|NCT00937521|364415739|FG005|Booster Phase|Adverse Event|0|||
105659127|NCT00937521|364415740|FG006|Booster Phase|Adverse Event|1|||
105659128|NCT00937521|364415741|FG007|Booster Phase|Adverse Event|0|||
105659129|NCT00937521|364415734|FG000|Booster Phase|Withdrawal by Subject|1|||
105659130|NCT00937521|364415735|FG001|Booster Phase|Withdrawal by Subject|0|||
105659131|NCT00937521|364415736|FG002|Booster Phase|Withdrawal by Subject|0|||
105659132|NCT00937521|364415737|FG003|Booster Phase|Withdrawal by Subject|1|||
105659133|NCT00937521|364415738|FG004|Booster Phase|Withdrawal by Subject|0|||
105659134|NCT00937521|364415739|FG005|Booster Phase|Withdrawal by Subject|0|||
105659135|NCT00937521|364415740|FG006|Booster Phase|Withdrawal by Subject|0|||
105659136|NCT00937521|364415741|FG007|Booster Phase|Withdrawal by Subject|2|||
105659137|NCT00937521|364415734|FG000|Booster Phase|Lost to Follow-up|2|||
105659138|NCT00937521|364415735|FG001|Booster Phase|Lost to Follow-up|2|||
105659139|NCT00937521|364415736|FG002|Booster Phase|Lost to Follow-up|4|||
105659140|NCT00937521|364415737|FG003|Booster Phase|Lost to Follow-up|2|||
105659141|NCT00937521|364415738|FG004|Booster Phase|Lost to Follow-up|4|||
105659142|NCT00937521|364415739|FG005|Booster Phase|Lost to Follow-up|4|||
105659143|NCT00937521|364415740|FG006|Booster Phase|Lost to Follow-up|3|||
105659144|NCT00937521|364415741|FG007|Booster Phase|Lost to Follow-up|0|||
105659145|NCT00937521|364415734|FG000|Booster Phase|Administrative Reason|0|||
105659146|NCT00937521|364415735|FG001|Booster Phase|Administrative Reason|0|||
105659147|NCT00937521|364415736|FG002|Booster Phase|Administrative Reason|1|||
105659148|NCT00937521|364415737|FG003|Booster Phase|Administrative Reason|0|||
105659149|NCT00937521|364415738|FG004|Booster Phase|Administrative Reason|1|||
105659150|NCT00937521|364415739|FG005|Booster Phase|Administrative Reason|1|||
105659151|NCT00937521|364415740|FG006|Booster Phase|Administrative Reason|0|||
105659152|NCT00937521|364415741|FG007|Booster Phase|Administrative Reason|0|||
105659153|NCT00937521|364415734|FG000|Booster Phase|Protocol Deviation|0|||
105659154|NCT00937521|364415735|FG001|Booster Phase|Protocol Deviation|0|||
105659155|NCT00937521|364415736|FG002|Booster Phase|Protocol Deviation|0|||
105659156|NCT00937521|364415737|FG003|Booster Phase|Protocol Deviation|0|||
105659157|NCT00937521|364415738|FG004|Booster Phase|Protocol Deviation|0|||
105659158|NCT00937521|364415739|FG005|Booster Phase|Protocol Deviation|0|||
105659159|NCT00937521|364415740|FG006|Booster Phase|Protocol Deviation|1|||
105659160|NCT00937521|364415741|FG007|Booster Phase|Protocol Deviation|0|||
105659161|NCT00874497|364415745|FG000|Overall Study|Lost to Follow-up|2|||
105659162|NCT00874497|364415746|FG001|Overall Study|Lost to Follow-up|4|||
105659163|NCT00874497|364415745|FG000|Overall Study|Adverse Event|9|||
105659164|NCT00874497|364415746|FG001|Overall Study|Adverse Event|4|||
105659165|NCT00874497|364415745|FG000|Overall Study|Sponsor Discontinued Trial|7|||
105659166|NCT00874497|364415746|FG001|Overall Study|Sponsor Discontinued Trial|3|||
105659167|NCT00874497|364415745|FG000|Overall Study|Met Withdrawal Criteria|4|||
105659168|NCT00874497|364415746|FG001|Overall Study|Met Withdrawal Criteria|2|||
105769213|NCT04195750|364805801|FG001|Overall Study|Death|253|||
105769214|NCT04195750|364805802|FG002|Overall Study|Death|5|||
105659169|NCT00874497|364415745|FG000|Overall Study|Physician Decision|1|||
105659170|NCT00874497|364415746|FG001|Overall Study|Physician Decision|1|||
105659171|NCT00874497|364415745|FG000|Overall Study|Withdrawal by Subject|5|||
105659172|NCT00874497|364415746|FG001|Overall Study|Withdrawal by Subject|4|||
105659173|NCT04035577|364415747|FG000|Overall Study|Lost to Follow-up|1|||
105659174|NCT04035577|364415747|FG000|Overall Study|Withdrawal by Subject|1|||
105659175|NCT00846768|364415748|FG000|Overall Study|Adverse Event|0|||
105659176|NCT00846768|364415749|FG001|Overall Study|Adverse Event|1|||
105659177|NCT00846768|364415750|FG002|Overall Study|Adverse Event|0|||
105659178|NCT00846768|364415751|FG003|Overall Study|Adverse Event|0|||
105659179|NCT01721746|364415752|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
105659180|NCT01721746|364415753|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
105659181|NCT01721746|364415752|FG000|Pre-Treatment|Withdrawal by Subject|1|||
105659182|NCT01721746|364415753|FG001|Pre-Treatment|Withdrawal by Subject|16|||
105659183|NCT01721746|364415752|FG000|Pre-Treatment|Poor/Non-compliance|1|||
105659184|NCT01721746|364415753|FG001|Pre-Treatment|Poor/Non-compliance|0|||
105659185|NCT01721746|364415752|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
105659186|NCT01721746|364415753|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
105659187|NCT01721746|364415752|FG000|Treatment|Disease Progression|192|||
105659188|NCT01721746|364415753|FG001|Treatment|Disease Progression|74|||
105659189|NCT01721746|364415752|FG000|Treatment|Study Drug Toxicity|19|||
105659190|NCT01721746|364415753|FG001|Treatment|Study Drug Toxicity|11|||
105769215|NCT04195750|364805800|FG000|Overall Study|Physician Decision|0|||
105769216|NCT04195750|364805801|FG001|Overall Study|Physician Decision|1|||
105769217|NCT04195750|364805802|FG002|Overall Study|Physician Decision|0|||
105769218|NCT04195750|364805800|FG000|Overall Study|Withdrawal by Subject|9|||
105769219|NCT04195750|364805801|FG001|Overall Study|Withdrawal by Subject|8|||
105769220|NCT04195750|364805802|FG002|Overall Study|Withdrawal by Subject|0|||
105769221|NCT04195750|364805800|FG000|Overall Study|Ongoing|120|||
105769222|NCT04195750|364805801|FG001|Overall Study|Ongoing|110|||
105769223|NCT04195750|364805802|FG002|Overall Study|Ongoing|4|||
105769224|NCT01226472|364805806|FG000|Overall Study|Progressive Disease|1|||
105769225|NCT03573804|364805807|FG000|Overall Study|claustrophobia or MRI table problems|10|||
105659191|NCT01721746|364415752|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
105440299|NCT00895453|363616766|FG001|Overall Study|Lost to Follow-up|25|||
105440300|NCT00895453|363616767|FG002|Overall Study|Lost to Follow-up|23|||
105440301|NCT00999518|363616768|FG000|Overall Study|Adverse Event|1|||
105440302|NCT00999518|363616769|FG001|Overall Study|Adverse Event|6|||
105440303|NCT00999518|363616770|FG002|Overall Study|Adverse Event|3|||
105440304|NCT00999518|363616771|FG003|Overall Study|Adverse Event|1|||
105440305|NCT00999518|363616772|FG004|Overall Study|Adverse Event|2|||
105440306|NCT00999518|363616768|FG000|Overall Study|Lack of Efficacy|2|||
105440307|NCT00999518|363616769|FG001|Overall Study|Lack of Efficacy|0|||
105440308|NCT00999518|363616770|FG002|Overall Study|Lack of Efficacy|0|||
105440309|NCT00999518|363616771|FG003|Overall Study|Lack of Efficacy|2|||
105440310|NCT00999518|363616772|FG004|Overall Study|Lack of Efficacy|2|||
105440311|NCT00999518|363616768|FG000|Overall Study|Lost to Follow-up|0|||
105440312|NCT00999518|363616769|FG001|Overall Study|Lost to Follow-up|0|||
105440313|NCT00999518|363616770|FG002|Overall Study|Lost to Follow-up|0|||
105440314|NCT00999518|363616771|FG003|Overall Study|Lost to Follow-up|4|||
105440315|NCT00999518|363616772|FG004|Overall Study|Lost to Follow-up|1|||
105440316|NCT00999518|363616768|FG000|Overall Study|Did not meet entrance criteria|0|||
105440317|NCT00999518|363616769|FG001|Overall Study|Did not meet entrance criteria|0|||
105440318|NCT00999518|363616770|FG002|Overall Study|Did not meet entrance criteria|0|||
105440319|NCT00999518|363616771|FG003|Overall Study|Did not meet entrance criteria|0|||
105440320|NCT00999518|363616772|FG004|Overall Study|Did not meet entrance criteria|1|||
105440321|NCT00999518|363616768|FG000|Overall Study|Study terminated by sponsor|10|||
105440322|NCT00999518|363616769|FG001|Overall Study|Study terminated by sponsor|6|||
105440323|NCT00999518|363616770|FG002|Overall Study|Study terminated by sponsor|5|||
105440324|NCT00999518|363616771|FG003|Overall Study|Study terminated by sponsor|5|||
105440325|NCT00999518|363616772|FG004|Overall Study|Study terminated by sponsor|9|||
105440326|NCT00999518|363616768|FG000|Overall Study|Pregnancy|0|||
105440327|NCT00999518|363616769|FG001|Overall Study|Pregnancy|0|||
105440328|NCT00999518|363616770|FG002|Overall Study|Pregnancy|1|||
105440329|NCT00999518|363616771|FG003|Overall Study|Pregnancy|0|||
105440330|NCT00999518|363616772|FG004|Overall Study|Pregnancy|0|||
105440331|NCT00999518|363616768|FG000|Overall Study|Protocol Violation|0|||
105440332|NCT00999518|363616769|FG001|Overall Study|Protocol Violation|1|||
105440333|NCT00999518|363616770|FG002|Overall Study|Protocol Violation|0|||
105440334|NCT00999518|363616771|FG003|Overall Study|Protocol Violation|0|||
105440335|NCT00999518|363616772|FG004|Overall Study|Protocol Violation|2|||
105440336|NCT00999518|363616768|FG000|Overall Study|Withdrawal by Subject|5|||
105440337|NCT00999518|363616769|FG001|Overall Study|Withdrawal by Subject|4|||
105440338|NCT00999518|363616770|FG002|Overall Study|Withdrawal by Subject|10|||
105440339|NCT00999518|363616771|FG003|Overall Study|Withdrawal by Subject|6|||
105440340|NCT00999518|363616772|FG004|Overall Study|Withdrawal by Subject|1|||
105440341|NCT00999518|363616768|FG000|Overall Study|Other|5|||
105440342|NCT00999518|363616769|FG001|Overall Study|Other|7|||
105440343|NCT00999518|363616770|FG002|Overall Study|Other|1|||
105440344|NCT00999518|363616771|FG003|Overall Study|Other|4|||
105440345|NCT00999518|363616772|FG004|Overall Study|Other|5|||
105440346|NCT00999518|363616768|FG000|Overall Study|Randomized but not Treated|1|||
105440347|NCT00999518|363616769|FG001|Overall Study|Randomized but not Treated|1|||
105440348|NCT00999518|363616770|FG002|Overall Study|Randomized but not Treated|2|||
105440349|NCT00999518|363616771|FG003|Overall Study|Randomized but not Treated|0|||
105440350|NCT00999518|363616772|FG004|Overall Study|Randomized but not Treated|1|||
105440351|NCT00061633|363616775|FG000|Overall Study|Adverse Event|1|||
105440352|NCT00061633|363616776|FG001|Overall Study|Adverse Event|2|||
105440353|NCT00061633|363616775|FG000|Overall Study|Withdrawal by Subject|2|||
105440354|NCT00061633|363616776|FG001|Overall Study|Withdrawal by Subject|2|||
105440355|NCT00061633|363616775|FG000|Overall Study|Lost to Follow-up|1|||
105440356|NCT00061633|363616776|FG001|Overall Study|Lost to Follow-up|4|||
105440357|NCT00061633|363616775|FG000|Overall Study|Other|1|||
105440358|NCT00061633|363616776|FG001|Overall Study|Other|1|||
105440359|NCT00061633|363616775|FG000|Overall Study|Never received study treatment|0|||
105440360|NCT00061633|363616776|FG001|Overall Study|Never received study treatment|2|||
105440361|NCT02301624|363616777|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
105440362|NCT02301624|363616778|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
105440363|NCT02301624|363616777|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
105440364|NCT02301624|363616778|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
105440365|NCT02301624|363616777|FG000|Open-label Maintenance Phase|Adverse Event|2|||
105440366|NCT02301624|363616778|FG001|Open-label Maintenance Phase|Adverse Event|5|||
105440367|NCT02301624|363616777|FG000|Open-label Maintenance Phase|Physician Decision|3|||
105440368|NCT02301624|363616778|FG001|Open-label Maintenance Phase|Physician Decision|3|||
105440369|NCT02301624|363616777|FG000|Open-label Maintenance Phase|Death|2|||
105440370|NCT02301624|363616778|FG001|Open-label Maintenance Phase|Death|1|||
105440371|NCT02301624|363616777|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
105440372|NCT02301624|363616778|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
105440373|NCT00895310|363616779|FG000|Overall Study|Withdrawal by Subject|1|||
105440374|NCT00534976|363616780|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
105440375|NCT00534976|363616781|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
105440376|NCT00534976|363616780|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
105440377|NCT00534976|363616781|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
105440378|NCT00534976|363616780|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
105440379|NCT00534976|363616781|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
105440380|NCT02069392|363616782|FG000|Overall Study|Withdrawal by Subject|4|||
105440381|NCT02069392|363616783|FG001|Overall Study|Withdrawal by Subject|2|||
105440382|NCT00269633|363616784|FG000|Overall Study|Withdrawal by Subject|1|||
105440383|NCT00269633|363616785|FG001|Overall Study|Withdrawal by Subject|0|||
105440384|NCT03857542|363616786|FG000|Overall Study|Adverse Event|1|||
105440385|NCT03857542|363616787|FG001|Overall Study|Adverse Event|3|||
105440386|NCT03857542|363616786|FG000|Overall Study|Withdrawal by Subject|2|||
105440387|NCT03857542|363616787|FG001|Overall Study|Withdrawal by Subject|1|||
105440388|NCT03857542|363616786|FG000|Overall Study|Lost to Follow-up|2|||
105440389|NCT03857542|363616787|FG001|Overall Study|Lost to Follow-up|1|||
105440390|NCT03857542|363616786|FG000|Overall Study|Reason not Specified|1|||
105440391|NCT03857542|363616787|FG001|Overall Study|Reason not Specified|0|||
105440392|NCT02927938|363616788|FG000|Overall Study|Death|0|||
105440393|NCT02927938|363616789|FG001|Overall Study|Death|1|||
105440394|NCT02927938|363616790|FG002|Overall Study|Death|0|||
105440395|NCT02927938|363616791|FG003|Overall Study|Death|4|||
105440396|NCT02927938|363616788|FG000|Overall Study|Early Study Termination|1|||
105440397|NCT02927938|363616789|FG001|Overall Study|Early Study Termination|5|||
105440398|NCT02927938|363616790|FG002|Overall Study|Early Study Termination|4|||
105440399|NCT02927938|363616791|FG003|Overall Study|Early Study Termination|3|||
105440400|NCT02834247|363616792|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
105440401|NCT02834247|363616793|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
105440402|NCT02834247|363616794|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
105440403|NCT02834247|363616795|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
105440404|NCT02834247|363616792|FG000|Dose Escalation Phase|Death|5|||
105440405|NCT02834247|363616793|FG001|Dose Escalation Phase|Death|6|||
105440406|NCT02834247|363616794|FG002|Dose Escalation Phase|Death|5|||
105440407|NCT02834247|363616795|FG003|Dose Escalation Phase|Death|0|||
105440408|NCT02834247|363616792|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
105440409|NCT02834247|363616793|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
105440410|NCT02834247|363616794|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
105440411|NCT02834247|363616795|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
105440412|NCT02834247|363616792|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
105440413|NCT02834247|363616793|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
105440414|NCT02834247|363616794|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
105440415|NCT02834247|363616795|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
105440416|NCT02834247|363616792|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
105440417|NCT02834247|363616793|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
105440418|NCT02834247|363616794|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
105440419|NCT02834247|363616795|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
105440424|NCT02834247|363616792|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
105440425|NCT02834247|363616793|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
105440426|NCT02834247|363616794|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
105440427|NCT02834247|363616795|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
105440428|NCT02834247|363616792|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
105440429|NCT02834247|363616793|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
105440430|NCT02834247|363616794|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
105440431|NCT02834247|363616795|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
105659192|NCT01721746|364415753|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
105659193|NCT01721746|364415752|FG000|Treatment|Participant request to discontinue Study treatment|26|||
105659194|NCT01721746|364415753|FG001|Treatment|Participant request to discontinue Study treatment|7|||
105659195|NCT01721746|364415752|FG000|Treatment|Participant withdrew consent|4|||
105659196|NCT01721746|364415753|FG001|Treatment|Participant withdrew consent|2|||
105659197|NCT01721746|364415752|FG000|Treatment|Maximum Clinical Benefit|9|||
105659198|NCT01721746|364415753|FG001|Treatment|Maximum Clinical Benefit|3|||
105659199|NCT01721746|364415752|FG000|Treatment|Poor/Non-compliance|2|||
105659200|NCT01721746|364415753|FG001|Treatment|Poor/Non-compliance|0|||
105659201|NCT01721746|364415752|FG000|Treatment|Participant no longer met Study criteria|4|||
105659202|NCT01721746|364415753|FG001|Treatment|Participant no longer met Study criteria|0|||
105659203|NCT01721746|364415752|FG000|Treatment|Other reasons|6|||
105659204|NCT01721746|364415753|FG001|Treatment|Other reasons|2|||
105659205|NCT00644878|364415754|FG000|Overall Study|Adverse Event|2|||
105659206|NCT00644878|364415754|FG000|Overall Study|Abnormal laboratory value|3|||
105659207|NCT00644878|364415754|FG000|Overall Study|Protocol deviation|2|||
105659208|NCT00644878|364415754|FG000|Overall Study|Treatment duration completed as per protocol|11|||
105659209|NCT00239681|364415755|FG000|Overall Study|Adverse Event|100|||
105659210|NCT00239681|364415756|FG001|Overall Study|Adverse Event|99|||
105659211|NCT00239681|364415755|FG000|Overall Study|Withdrawal by Subject|458|||
105659212|NCT00239681|364415756|FG001|Overall Study|Withdrawal by Subject|489|||
105659213|NCT00239681|364415755|FG000|Overall Study|Lost to Follow-up|28|||
105659214|NCT00239681|364415756|FG001|Overall Study|Lost to Follow-up|22|||
105659215|NCT00239681|364415755|FG000|Overall Study|Protocol Violation|4|||
105659216|NCT00239681|364415756|FG001|Overall Study|Protocol Violation|4|||
105659217|NCT00239681|364415755|FG000|Overall Study|Physician Decision|13|||
105659218|NCT00239681|364415756|FG001|Overall Study|Physician Decision|17|||
105659219|NCT00239681|364415755|FG000|Overall Study|No information chacked on CaseReportForm|90|||
105659220|NCT00239681|364415756|FG001|Overall Study|No information chacked on CaseReportForm|84|||
105659221|NCT03599622|364415757|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
105659222|NCT03599622|364415758|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
105659223|NCT03599622|364415759|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
105659224|NCT03599622|364415760|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
105659225|NCT03599622|364415757|FG000|Pre-Treatment Period|Other reasons|1|||
105659226|NCT03599622|364415758|FG001|Pre-Treatment Period|Other reasons|1|||
105659227|NCT03599622|364415759|FG002|Pre-Treatment Period|Other reasons|1|||
105659228|NCT03599622|364415760|FG003|Pre-Treatment Period|Other reasons|0|||
105659229|NCT03599622|364415757|FG000|Treatment Period|Adverse Event|11|||
105659230|NCT03599622|364415758|FG001|Treatment Period|Adverse Event|20|||
105659231|NCT03599622|364415759|FG002|Treatment Period|Adverse Event|18|||
105659232|NCT03599622|364415760|FG003|Treatment Period|Adverse Event|2|||
105659233|NCT03599622|364415757|FG000|Treatment Period|Lack of Efficacy|18|||
105659234|NCT03599622|364415758|FG001|Treatment Period|Lack of Efficacy|12|||
105659235|NCT03599622|364415759|FG002|Treatment Period|Lack of Efficacy|13|||
105659236|NCT03599622|364415760|FG003|Treatment Period|Lack of Efficacy|2|||
105659237|NCT03599622|364415757|FG000|Treatment Period|Withdrawal by Subject|5|||
105659238|NCT03599622|364415758|FG001|Treatment Period|Withdrawal by Subject|11|||
105659239|NCT03599622|364415759|FG002|Treatment Period|Withdrawal by Subject|16|||
105659240|NCT03599622|364415760|FG003|Treatment Period|Withdrawal by Subject|1|||
105659241|NCT03599622|364415757|FG000|Treatment Period|Other reasons|4|||
105659242|NCT03599622|364415758|FG001|Treatment Period|Other reasons|6|||
105659243|NCT03599622|364415759|FG002|Treatment Period|Other reasons|7|||
105659244|NCT03599622|364415760|FG003|Treatment Period|Other reasons|0|||
105659245|NCT03599622|364415757|FG000|Treatment Period|Lost to Follow-up|1|||
105659246|NCT03599622|364415758|FG001|Treatment Period|Lost to Follow-up|0|||
105659247|NCT03599622|364415759|FG002|Treatment Period|Lost to Follow-up|0|||
105659248|NCT03599622|364415760|FG003|Treatment Period|Lost to Follow-up|0|||
105659249|NCT03599622|364415757|FG000|Treatment Period|Study terminated by sponsor|7|||
105659250|NCT03599622|364415758|FG001|Treatment Period|Study terminated by sponsor|20|||
105659251|NCT03599622|364415759|FG002|Treatment Period|Study terminated by sponsor|15|||
105659252|NCT03599622|364415760|FG003|Treatment Period|Study terminated by sponsor|0|||
105659253|NCT03599622|364415757|FG000|Treatment Period|Site terminated by sponsor|0|||
105659254|NCT03599622|364415758|FG001|Treatment Period|Site terminated by sponsor|1|||
105659255|NCT03599622|364415759|FG002|Treatment Period|Site terminated by sponsor|0|||
105659256|NCT03599622|364415760|FG003|Treatment Period|Site terminated by sponsor|0|||
105659257|NCT00665223|364415762|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
105659258|NCT00665223|364415763|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
105659341|NCT00551135|364417280|FG000|Overall Study|Withdrawal by Subject|1|||
105659342|NCT00551135|364417281|FG001|Overall Study|Withdrawal by Subject|0|||
105659343|NCT00551135|364417282|FG002|Overall Study|Withdrawal by Subject|3|||
105659344|NCT00551135|364417283|FG003|Overall Study|Withdrawal by Subject|1|||
105659345|NCT02165397|364417286|FG000|Overall Study|Death|7|||
105659346|NCT02165397|364417287|FG001|Overall Study|Death|10|||
105659347|NCT02165397|364417288|FG002|Overall Study|Death|8|||
105659348|NCT02165397|364417286|FG000|Overall Study|Lost to Follow-up|1|||
105659349|NCT02165397|364417287|FG001|Overall Study|Lost to Follow-up|3|||
105659350|NCT02165397|364417288|FG002|Overall Study|Lost to Follow-up|0|||
105659351|NCT02165397|364417286|FG000|Overall Study|Withdrawal by Subject|6|||
105659352|NCT02165397|364417287|FG001|Overall Study|Withdrawal by Subject|6|||
105659353|NCT02165397|364417288|FG002|Overall Study|Withdrawal by Subject|1|||
105659354|NCT02165397|364417286|FG000|Overall Study|Other, Not Specified|0|||
105659355|NCT02165397|364417287|FG001|Overall Study|Other, Not Specified|0|||
105659356|NCT02165397|364417288|FG002|Overall Study|Other, Not Specified|1|||
105659357|NCT03898960|364417289|FG000|Overall Study|Death|10|||
105659358|NCT00548847|364417290|FG000|Overall Study|Disease progression|7|||
105659359|NCT03297398|364417291|FG000|Overall Study|Sponsor's decision|6|||
105659360|NCT03297398|364417292|FG001|Overall Study|Sponsor's decision|9|||
105659361|NCT03297398|364417293|FG002|Overall Study|Sponsor's decision|7|||
105659362|NCT03297398|364417291|FG000|Overall Study|Adverse Event|1|||
105659363|NCT03297398|364417292|FG001|Overall Study|Adverse Event|4|||
105659364|NCT03297398|364417293|FG002|Overall Study|Adverse Event|4|||
105659365|NCT03297398|364417291|FG000|Overall Study|Withdrawal by Subject|1|||
105659366|NCT03297398|364417292|FG001|Overall Study|Withdrawal by Subject|2|||
105659367|NCT03297398|364417293|FG002|Overall Study|Withdrawal by Subject|2|||
105659368|NCT03297398|364417291|FG000|Overall Study|Protocol Violation|0|||
105659369|NCT03297398|364417292|FG001|Overall Study|Protocol Violation|2|||
105659370|NCT03297398|364417293|FG002|Overall Study|Protocol Violation|0|||
105659371|NCT03297398|364417291|FG000|Overall Study|Physician Decision|0|||
105659372|NCT03297398|364417292|FG001|Overall Study|Physician Decision|0|||
105659373|NCT03297398|364417293|FG002|Overall Study|Physician Decision|1|||
105659374|NCT03297398|364417291|FG000|Overall Study|Lost to Follow-up|0|||
105659375|NCT03297398|364417292|FG001|Overall Study|Lost to Follow-up|0|||
105659376|NCT03297398|364417293|FG002|Overall Study|Lost to Follow-up|1|||
105659377|NCT04175912|364417296|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
105659378|NCT04175912|364417297|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
105659379|NCT04175912|364417296|FG000|Overall Study|Adverse Event|0|||
105659380|NCT04175912|364417297|FG001|Overall Study|Adverse Event|3|||
105659381|NCT04175912|364417296|FG000|Overall Study|Never started treatment|3|||
105659382|NCT04175912|364417297|FG001|Overall Study|Never started treatment|3|||
105659383|NCT04175912|364417296|FG000|Overall Study|Death|0|||
105659384|NCT04175912|364417297|FG001|Overall Study|Death|1|||
105659385|NCT01322009|364417307|FG000|Overall Study|Death|0|||
105659386|NCT01322009|364417308|FG001|Overall Study|Death|1|||
105659387|NCT01322009|364417307|FG000|Overall Study|Adverse Event|0|||
105659388|NCT01322009|364417308|FG001|Overall Study|Adverse Event|1|||
105659389|NCT01322009|364417307|FG000|Overall Study|ng tube discontinued|0|||
105659390|NCT01322009|364417308|FG001|Overall Study|ng tube discontinued|1|||
105659391|NCT04081389|364417309|FG000|Overall Study|Withdrawal by Subject|0|||
105659392|NCT04081389|364417310|FG001|Overall Study|Withdrawal by Subject|0|||
105659393|NCT04081389|364417311|FG002|Overall Study|Withdrawal by Subject|1|||
105659394|NCT04081389|364417312|FG003|Overall Study|Withdrawal by Subject|0|||
105659395|NCT02980705|364417313|FG000|Overall Study|Adverse Event|0|||
105659396|NCT02980705|364417314|FG001|Overall Study|Adverse Event|1|||
105659397|NCT02980705|364417313|FG000|Overall Study|Withdrawal by Subject|6|||
105659398|NCT02980705|364417314|FG001|Overall Study|Withdrawal by Subject|9|||
105659399|NCT02980705|364417313|FG000|Overall Study|withdrew participation|0|||
105659400|NCT02980705|364417314|FG001|Overall Study|withdrew participation|1|||
105659401|NCT02980705|364417313|FG000|Overall Study|Lost to Follow-up|2|||
105659402|NCT02980705|364417314|FG001|Overall Study|Lost to Follow-up|0|||
105659403|NCT02447718|364417315|FG000|Overall Study|Lost to Follow-up|8|||
105659404|NCT02447718|364417316|FG001|Overall Study|Lost to Follow-up|0|||
105659405|NCT02447718|364417315|FG000|Overall Study|Withdrawal by Subject|3|||
105659406|NCT02447718|364417316|FG001|Overall Study|Withdrawal by Subject|0|||
105659407|NCT02447718|364417315|FG000|Overall Study|Screen Failure|1|||
105659408|NCT02447718|364417316|FG001|Overall Study|Screen Failure|0|||
105659409|NCT02138253|364417317|FG000|Overall Study|Adverse Event|3|||
105659410|NCT02138253|364417318|FG001|Overall Study|Adverse Event|3|||
105659411|NCT02138253|364417317|FG000|Overall Study|Lost to Follow-up|2|||
105659412|NCT02138253|364417318|FG001|Overall Study|Lost to Follow-up|1|||
105659413|NCT02138253|364417317|FG000|Overall Study|Physician Decision|2|||
105659414|NCT02138253|364417318|FG001|Overall Study|Physician Decision|0|||
105659415|NCT02138253|364417317|FG000|Overall Study|Non compliance|1|||
105659416|NCT02138253|364417318|FG001|Overall Study|Non compliance|0|||
105659417|NCT02138253|364417317|FG000|Overall Study|Withdrawal by Subject|1|||
105659418|NCT02138253|364417318|FG001|Overall Study|Withdrawal by Subject|0|||
105659419|NCT00002597|364417319|FG000|Overall Study|Protocol Violation|19|||
105659421|NCT00002597|364417319|FG000|Overall Study|Withdrawal by Subject|7|||
105659422|NCT00002597|364417320|FG001|Overall Study|Withdrawal by Subject|6|||
105659423|NCT01426113|364417321|FG000|Overall Study|Study Discontinued|1|||
105659424|NCT01426113|364417322|FG001|Overall Study|Study Discontinued|1|||
105659425|NCT01426113|364417321|FG000|Overall Study|Adverse Event|0|||
105659426|NCT01426113|364417322|FG001|Overall Study|Adverse Event|1|||
105659427|NCT02654132|364417323|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
105659428|NCT02654132|364417324|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
105659429|NCT02654132|364417323|FG000|Treatment Period|Disease progression|43|||
105659430|NCT02654132|364417324|FG001|Treatment Period|Disease progression|38|||
105659431|NCT02654132|364417323|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
105659432|NCT02654132|364417324|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
105659433|NCT02654132|364417323|FG000|Treatment Period|Other reasons|4|||
105659434|NCT02654132|364417324|FG001|Treatment Period|Other reasons|2|||
105659435|NCT02654132|364417323|FG000|Treatment Period|Study drug toxicity|2|||
105659436|NCT02654132|364417324|FG001|Treatment Period|Study drug toxicity|2|||
105659437|NCT02654132|364417323|FG000|Treatment Period|Withdrawal by Subject|2|||
105659438|NCT02654132|364417324|FG001|Treatment Period|Withdrawal by Subject|1|||
105659439|NCT02654132|364417323|FG000|Treatment Period|Maximum Clinical Benefit|0|||
105659440|NCT02654132|364417324|FG001|Treatment Period|Maximum Clinical Benefit|2|||
105659441|NCT02654132|364417323|FG000|Treatment Period|Participant request to discontinue|2|||
105659442|NCT02654132|364417324|FG001|Treatment Period|Participant request to discontinue|0|||
105659443|NCT02654132|364417323|FG000|Treatment Period|Administrative reasons by sponsor|0|||
105659444|NCT02654132|364417324|FG001|Treatment Period|Administrative reasons by sponsor|1|||
105659445|NCT02654132|364417323|FG000|Treatment Period|Death|1|||
105659446|NCT02654132|364417324|FG001|Treatment Period|Death|0|||
105659447|NCT00468130|364417329|FG000|Overall Study|Adverse Event|2|||
105659448|NCT00468130|364417330|FG001|Overall Study|Adverse Event|1|||
105659449|NCT00468130|364417329|FG000|Overall Study|Withdrawal by Subject|0|||
105659450|NCT00468130|364417330|FG001|Overall Study|Withdrawal by Subject|1|||
105659451|NCT02485899|364417331|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
105659452|NCT02485899|364417332|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105659453|NCT02485899|364417331|FG000|Overall Study|Withdrawal by Subject|1|||
105659454|NCT02485899|364417332|FG001|Overall Study|Withdrawal by Subject|0|||
105659455|NCT02485899|364417331|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
105659456|NCT02485899|364417332|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
105659457|NCT00436956|364417333|FG000|Overall Study|Not evaluable|1|||
105659458|NCT00436956|364417334|FG001|Overall Study|Not evaluable|0|||
105659459|NCT01918371|364417335|FG000|Overall Study|Missing Data|1|||
105659460|NCT01918371|364417336|FG001|Overall Study|Missing Data|1|||
105659461|NCT01006889|364417337|FG000|Overall Study|Withdrawal by Subject|3|||
105659462|NCT01130168|364417338|FG000|Period 1|Withdrawal by Subject|0|||
105659463|NCT01130168|364417339|FG001|Period 1|Withdrawal by Subject|1|||
105659464|NCT01130168|364417340|FG002|Period 1|Withdrawal by Subject|0|||
105659465|NCT01130168|364417341|FG003|Period 1|Withdrawal by Subject|1|||
105659466|NCT01130168|364417342|FG004|Period 1|Withdrawal by Subject|0|||
105659467|NCT01130168|364417343|FG005|Period 1|Withdrawal by Subject|0|||
105659468|NCT01130168|364417338|FG000|Period 1|Discontinued For Other Reason|0|||
105659469|NCT01130168|364417339|FG001|Period 1|Discontinued For Other Reason|0|||
105659470|NCT01130168|364417340|FG002|Period 1|Discontinued For Other Reason|1|||
105659471|NCT01130168|364417341|FG003|Period 1|Discontinued For Other Reason|1|||
105659472|NCT01130168|364417342|FG004|Period 1|Discontinued For Other Reason|0|||
105659473|NCT01130168|364417343|FG005|Period 1|Discontinued For Other Reason|0|||
105659474|NCT01130168|364417338|FG000|Period 1|Adverse Event|0|||
105659475|NCT01130168|364417339|FG001|Period 1|Adverse Event|0|||
105659476|NCT01130168|364417340|FG002|Period 1|Adverse Event|0|||
105659477|NCT01130168|364417341|FG003|Period 1|Adverse Event|1|||
105659478|NCT01130168|364417342|FG004|Period 1|Adverse Event|0|||
105659479|NCT01130168|364417343|FG005|Period 1|Adverse Event|0|||
105659480|NCT02569957|364417344|FG000|Overall Study|Withdrawal by Subject|0|||
105659481|NCT02569957|364417345|FG001|Overall Study|Withdrawal by Subject|1|||
105659482|NCT02635386|364417347|FG000|Overall Study|Pregnancy|2|||
105659483|NCT02635386|364417348|FG001|Overall Study|Pregnancy|0|||
105659484|NCT02635386|364417349|FG002|Overall Study|Pregnancy|0|||
105659485|NCT02635386|364417350|FG003|Overall Study|Pregnancy|0|||
105659486|NCT02635386|364417351|FG004|Overall Study|Pregnancy|2|||
105659487|NCT02635386|364417347|FG000|Overall Study|Withdrawal by Subject|1|||
105659488|NCT02635386|364417348|FG001|Overall Study|Withdrawal by Subject|1|||
105659489|NCT02635386|364417349|FG002|Overall Study|Withdrawal by Subject|0|||
105659490|NCT02635386|364417350|FG003|Overall Study|Withdrawal by Subject|1|||
105659491|NCT02635386|364417351|FG004|Overall Study|Withdrawal by Subject|0|||
105659492|NCT02635386|364417347|FG000|Overall Study|Physician Decision|0|||
105659493|NCT02635386|364417348|FG001|Overall Study|Physician Decision|1|||
105659494|NCT02635386|364417349|FG002|Overall Study|Physician Decision|0|||
105659495|NCT02635386|364417350|FG003|Overall Study|Physician Decision|0|||
105659496|NCT02635386|364417351|FG004|Overall Study|Physician Decision|0|||
105659497|NCT02635386|364417347|FG000|Overall Study|Moved Out of State|0|||
105659512|NCT02635386|364417347|FG000|Overall Study|needed other major surgery|0|||
105659513|NCT02635386|364417348|FG001|Overall Study|needed other major surgery|1|||
105659514|NCT02635386|364417349|FG002|Overall Study|needed other major surgery|0|||
105659515|NCT02635386|364417350|FG003|Overall Study|needed other major surgery|0|||
105659516|NCT02635386|364417351|FG004|Overall Study|needed other major surgery|0|||
105659517|NCT02635386|364417347|FG000|Overall Study|Other medical problems not drug related|0|||
105659518|NCT02635386|364417348|FG001|Overall Study|Other medical problems not drug related|0|||
105659519|NCT02635386|364417349|FG002|Overall Study|Other medical problems not drug related|0|||
105659520|NCT02635386|364417350|FG003|Overall Study|Other medical problems not drug related|1|||
105659521|NCT02635386|364417351|FG004|Overall Study|Other medical problems not drug related|0|||
105659522|NCT02719743|364417352|FG000|Overall Study|Consent withdrawal|0|||
105659523|NCT02719743|364417353|FG001|Overall Study|Consent withdrawal|2|||
105659524|NCT02719743|364417354|FG002|Overall Study|Consent withdrawal|0|||
105659525|NCT02719743|364417355|FG003|Overall Study|Consent withdrawal|1|||
105659526|NCT02719743|364417356|FG004|Overall Study|Consent withdrawal|0|||
105659527|NCT02719743|364417352|FG000|Overall Study|Migrated/moved from study area|0|||
105659528|NCT02719743|364417353|FG001|Overall Study|Migrated/moved from study area|0|||
105659529|NCT02719743|364417354|FG002|Overall Study|Migrated/moved from study area|0|||
105659530|NCT02719743|364417355|FG003|Overall Study|Migrated/moved from study area|0|||
105659531|NCT02719743|364417356|FG004|Overall Study|Migrated/moved from study area|2|||
105659532|NCT02719743|364417352|FG000|Overall Study|Lost to Follow-up|1|||
105659533|NCT02719743|364417353|FG001|Overall Study|Lost to Follow-up|1|||
105659534|NCT02719743|364417354|FG002|Overall Study|Lost to Follow-up|0|||
105659535|NCT02719743|364417355|FG003|Overall Study|Lost to Follow-up|0|||
105659536|NCT02719743|364417356|FG004|Overall Study|Lost to Follow-up|0|||
105659537|NCT01209598|364417359|FG000|Overall Study|Withdrawal by Subject|1|||
105659538|NCT01209598|364417360|FG001|Overall Study|Withdrawal by Subject|0|||
105659539|NCT02062645|364417363|FG000|Overall Study|Adverse Event|2|||
105659540|NCT02062645|364417363|FG000|Overall Study|Protocol Violation|8|||
105659541|NCT02062645|364417363|FG000|Overall Study|Lost to Follow-up|5|||
105659542|NCT02804399|364417364|FG000|Period 2|Adverse Event|0|||
105659543|NCT02804399|364417365|FG001|Period 2|Adverse Event|1|||
105659544|NCT00572533|364417366|FG000|Overall Study|Death|4|||
105659545|NCT00572533|364417367|FG001|Overall Study|Death|1|||
105659546|NCT00572533|364417366|FG000|Overall Study|Received Kidney Transplant|2|||
105659547|NCT00572533|364417367|FG001|Overall Study|Received Kidney Transplant|1|||
105659548|NCT00572533|364417366|FG000|Overall Study|Social Issues|1|||
105659549|NCT00572533|364417367|FG001|Overall Study|Social Issues|0|||
105659550|NCT00572533|364417366|FG000|Overall Study|Transfer out of Facility|0|||
105659551|NCT00572533|364417367|FG001|Overall Study|Transfer out of Facility|1|||
105659552|NCT00798304|364417371|FG000|Overall Study|Adverse Event|0|||
105659553|NCT00798304|364417372|FG001|Overall Study|Adverse Event|1|||
105659554|NCT00798304|364417373|FG002|Overall Study|Adverse Event|1|||
105659555|NCT00798304|364417371|FG000|Overall Study|Discontinuation by Sponsor|14|||
105659556|NCT00798304|364417372|FG001|Overall Study|Discontinuation by Sponsor|21|||
105659557|NCT00798304|364417373|FG002|Overall Study|Discontinuation by Sponsor|9|||
105659558|NCT02168478|364417375|FG000|Overall Study|Withdrawal by Subject|1|||
105659559|NCT02168478|364417375|FG000|Overall Study|Did Not Consent to Participation|2|||
105659560|NCT02168478|364417375|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
105659561|NCT01062971|364417378|FG000|Overall Study|Protocol Violation|1|||
105659562|NCT01062971|364417379|FG001|Overall Study|Protocol Violation|3|||
105659563|NCT01062971|364417378|FG000|Overall Study|Lost to Follow-up|3|||
105659564|NCT01062971|364417379|FG001|Overall Study|Lost to Follow-up|4|||
105659565|NCT00927901|364417388|FG000|Treatment Period 1|Subject withdrew consent|0|||
105659566|NCT00927901|364417389|FG001|Treatment Period 1|Subject withdrew consent|0|||
105659567|NCT00927901|364417390|FG002|Treatment Period 1|Subject withdrew consent|1|||
105659568|NCT00927901|364417391|FG003|Treatment Period 1|Subject withdrew consent|0|||
105659569|NCT00927901|364417388|FG000|Treatment Period 4|Adverse Event|0|||
105659570|NCT00927901|364417389|FG001|Treatment Period 4|Adverse Event|0|||
105659571|NCT00927901|364417390|FG002|Treatment Period 4|Adverse Event|0|||
105659572|NCT00927901|364417391|FG003|Treatment Period 4|Adverse Event|1|||
105659573|NCT00927901|364417388|FG000|Treatment Period 4|Subject withdrew consent|0|||
105659574|NCT00927901|364417389|FG001|Treatment Period 4|Subject withdrew consent|0|||
105659575|NCT00927901|364417390|FG002|Treatment Period 4|Subject withdrew consent|1|||
105659576|NCT00927901|364417391|FG003|Treatment Period 4|Subject withdrew consent|0|||
105659577|NCT02344173|364417392|FG000|Procedure|Ablation Procedure Not Performed|7|||
105659578|NCT02344173|364417392|FG000|12-month Visit|Death|8|||
105659579|NCT02344173|364417392|FG000|12-month Visit|Withdrawal by Subject|30|||
105659580|NCT02344173|364417392|FG000|12-month Visit|Lost to Follow-up|58|||
105659581|NCT03845023|364417393|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
105659582|NCT03845023|364417394|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
105659583|NCT03845023|364417395|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
105659584|NCT03845023|364417396|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
105659585|NCT03845023|364417393|FG000|Follow-Up (14 Days)|Adverse Event|0|||
105659586|NCT03845023|364417394|FG001|Follow-Up (14 Days)|Adverse Event|0|||
105659587|NCT03845023|364417395|FG002|Follow-Up (14 Days)|Adverse Event|1|||
105659589|NCT01087814|364417399|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
105659590|NCT01087814|364417400|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
105659591|NCT01087814|364417399|FG000|Second Intervention (5 Days)|Physician Decision|1|||
105659592|NCT01087814|364417400|FG001|Second Intervention (5 Days)|Physician Decision|0|||
105659593|NCT01263925|364417405|FG000|Overall Study|Protocol Violation|1|||
105659594|NCT01263925|364417406|FG001|Overall Study|Protocol Violation|0|||
105659595|NCT01263925|364417405|FG000|Overall Study|Lack of Efficacy|0|||
105659596|NCT01263925|364417406|FG001|Overall Study|Lack of Efficacy|1|||
105659597|NCT01263925|364417405|FG000|Overall Study|Adverse Event|23|||
105659598|NCT01263925|364417406|FG001|Overall Study|Adverse Event|22|||
105659599|NCT01263925|364417405|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
105659600|NCT01263925|364417406|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
105659601|NCT01263925|364417405|FG000|Overall Study|Withdrawal by Subject|6|||
105659602|NCT01263925|364417406|FG001|Overall Study|Withdrawal by Subject|8|||
105659603|NCT01263925|364417405|FG000|Overall Study|Other|4|||
105659604|NCT01263925|364417406|FG001|Overall Study|Other|4|||
105659605|NCT01263925|364417405|FG000|Overall Study|Lost to Follow-up|3|||
105659606|NCT01263925|364417406|FG001|Overall Study|Lost to Follow-up|1|||
105659607|NCT01263925|364417405|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
105659608|NCT01263925|364417406|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
105659609|NCT01263925|364417405|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
105659610|NCT01263925|364417406|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
105659611|NCT01263925|364417405|FG000|Overall Study|AE/ Withdrawal|1|||
105659612|NCT01263925|364417406|FG001|Overall Study|AE/ Withdrawal|4|||
105659613|NCT01263925|364417405|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
105659614|NCT01263925|364417406|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
105659615|NCT01263925|364417405|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
105659616|NCT01263925|364417406|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
105659617|NCT01263925|364417405|FG000|Overall Study|Withdrawal/ Not specified|0|||
105659618|NCT01263925|364417406|FG001|Overall Study|Withdrawal/ Not specified|1|||
105659619|NCT02918292|364417409|FG000|Study Enrollment Prior to Transplant|Death|1|||
105659620|NCT02918292|364417409|FG000|Study Follow up After Transplant|Death|6|||
105659621|NCT00715117|364417411|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
105659622|NCT00715117|364417412|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
105659623|NCT01482429|364417413|FG000|Care Usual|Protocol Violation|0|||
105659624|NCT01482429|364417414|FG001|Care Usual|Protocol Violation|172|||
105659625|NCT01482429|364417413|FG000|Care Usual|Lost to Follow-up|0|||
105659626|NCT01482429|364417414|FG001|Care Usual|Lost to Follow-up|1|||
105659627|NCT01482429|364417413|FG000|Protocol|Protocol Violation|275|||
105659628|NCT01482429|364417414|FG001|Protocol|Protocol Violation|0|||
105659629|NCT03783871|364417418|FG000|Overall Study|Withdrawal by Subject|15|||
105659630|NCT03783871|364417418|FG000|Overall Study|Death|13|||
105659631|NCT03783871|364417418|FG000|Overall Study|Lost to Follow-up|2|||
105659632|NCT03595878|364417423|FG000|Overall Study|Death|2|||
105659633|NCT03595878|364417424|FG001|Overall Study|Death|1|||
105659634|NCT03595878|364417425|FG002|Overall Study|Death|0|||
105659635|NCT03595878|364417423|FG000|Overall Study|Disease progression|2|||
105659636|NCT03595878|364417424|FG001|Overall Study|Disease progression|1|||
105659637|NCT03595878|364417425|FG002|Overall Study|Disease progression|2|||
105659638|NCT03036124|364417426|FG000|Overall Study|Lost to Follow-up|0|||
105659639|NCT03036124|364417427|FG001|Overall Study|Lost to Follow-up|2|||
105659640|NCT03036124|364417426|FG000|Overall Study|Withdrawal by Subject|5|||
105659641|NCT03036124|364417427|FG001|Overall Study|Withdrawal by Subject|4|||
